<SEC-DOCUMENT>0001121404-23-000008.txt : 20230224
<SEC-HEADER>0001121404-23-000008.hdr.sgml : 20230224
<ACCEPTANCE-DATETIME>20230224102548
ACCESSION NUMBER:		0001121404-23-000008
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		273
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230224
DATE AS OF CHANGE:		20230224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanofi
		CENTRAL INDEX KEY:			0001121404
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133529324
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31368
		FILM NUMBER:		23663390

	BUSINESS ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017
		BUSINESS PHONE:		33153774400

	MAIL ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI-AVENTIS
		DATE OF NAME CHANGE:	20040826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI SYNTHELABO SA
		DATE OF NAME CHANGE:	20010104
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>sny-20221231.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:89d6bfca-a5b4-4bcd-ad12-f1718d876f14,g:8278f0b1-e8dc-472d-9868-3f575a842a56,d:52f57172a9d7443580346c2d8f39cd2b--><html xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sny="http://www.sanofi.com/20221231" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sny-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83L2ZyYWc6N2U3YjdiMmYwZTEyNGM0MjhlOTg0NDk2NGJlMzhlMzQvdGFibGU6OTFkYmVjN2M5YzEyNGFmODhjMmMzZTU0MGNjNWMxMzcvdGFibGVyYW5nZTo5MWRiZWM3YzljMTI0YWY4OGMyYzNlNTQwY2M1YzEzN18xLTEtMS0xLTM2NDA2MA_02aeee8d-3a9e-426f-8f20-51fbf05064b6">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83L2ZyYWc6N2U3YjdiMmYwZTEyNGM0MjhlOTg0NDk2NGJlMzhlMzQvdGFibGU6OTFkYmVjN2M5YzEyNGFmODhjMmMzZTU0MGNjNWMxMzcvdGFibGVyYW5nZTo5MWRiZWM3YzljMTI0YWY4OGMyYzNlNTQwY2M1YzEzN18yLTEtMS0xLTM2NDA2MA_599ee778-cc31-48d8-9e89-250a87caa514">2022</ix:nonNumeric><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83L2ZyYWc6N2U3YjdiMmYwZTEyNGM0MjhlOTg0NDk2NGJlMzhlMzQvdGFibGU6OTFkYmVjN2M5YzEyNGFmODhjMmMzZTU0MGNjNWMxMzcvdGFibGVyYW5nZTo5MWRiZWM3YzljMTI0YWY4OGMyYzNlNTQwY2M1YzEzN18zLTEtMS0xLTM2NDA2MA_1900076c-e7c6-4829-9a30-9a47f02e4372">FY</ix:nonNumeric><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83L2ZyYWc6N2U3YjdiMmYwZTEyNGM0MjhlOTg0NDk2NGJlMzhlMzQvdGFibGU6OTFkYmVjN2M5YzEyNGFmODhjMmMzZTU0MGNjNWMxMzcvdGFibGVyYW5nZTo5MWRiZWM3YzljMTI0YWY4OGMyYzNlNTQwY2M1YzEzN180LTEtMS0xLTM2NDA2MA_7cc5329d-d893-45f2-9420-aa707ee8976d">0001121404</ix:nonNumeric><ix:nonNumeric contextRef="ic6d609e772664d4dabc2be8000f12dcc_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTQvZnJhZzozZjc4YjJjMzg5MjM0NWI3OWUwMWQxNGFjYzI2ODQxNS90ZXh0cmVnaW9uOjNmNzhiMmMzODkyMzQ1Yjc5ZTAxZDE0YWNjMjY4NDE1XzUxMDY_a0f11f8d-0f58-4332-81c5-b171f9da546e">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i8a3c0c053efb4732adcd801d2a0a398f_D20220101-20221231" name="sny:PossibleIncreaseInMortalityTableInYears" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDkvZnJhZzplYzVjNDk3ZWExNjA0NjJjOTdmYTgwODhhZGJkNDRkNS90YWJsZTowM2U3MGFiZWI0Mzk0ZTg5YjdjNmQ4ZDlmM2ExY2I5Yy90YWJsZXJhbmdlOjAzZTcwYWJlYjQzOTRlODliN2M2ZDhkOWYzYTFjYjljXzItMi0xLTEtMzY0MDYw_bc0c8599-bf0e-493b-8022-b5c8397b5930">1</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="iab27c8ba011e427586eb8baebc4580ce_D20200101-20201231" decimals="4" name="sny:CapitalLossesUsedAgainstCapitalGainsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDkvZnJhZzplYzVjNDk3ZWExNjA0NjJjOTdmYTgwODhhZGJkNDRkNS90ZXh0cmVnaW9uOmVjNWM0OTdlYTE2MDQ2MmM5N2ZhODA4OGFkYmQ0NGQ1XzE5_41efb929-a7bb-41d3-861d-893665eaddb6">33.33</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sny-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51d2972f62c44302800dd88abed05207_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8623615aa6f453286593426ee1e8b04_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">sny:AmericanDepositorySharesNASDAQGlobalSelectMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22690d5a55c7403c964aa8af7ad10ad5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">sny:OrdinarySharesNASDAQGlobalSelectMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6beef57f0ff142ac829ee75f07d8469f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-10</xbrli:startDate><xbrli:endDate>2022-05-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i9f887633b9c1418f97d4bb30260bb881_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:ErnstYoungEtAutresMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0645fdc11d9d433a8306a1a8019152d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0566192b2355417fa9d42170481d811a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i8167f91dae314f4eaa1e5e23abf0fcae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b29272f0f8e444e8185ac9de81d8964_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2180880b8f3d4518b6d13260c4b00509_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a649176e103430588e7d82e8b4b2eae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideadd6fc92744c689451476829e9bf88_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30f1c21919c94f78ac899771e9dc6747_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79431d18a64048a3a31458a8519c8577_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7ec55dbabba4baeaa5077aa469ea0b9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i091093d5d8a34da889e3748a9b22dca7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i628f75ce25844ff8b7d482c8c7b43c78_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9fd8343fd3c47a2b272658a928ae800_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38ee6479a7a24540a49f0870e964ced9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i918e8adb634840c39e00f014e91457f5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0555249224484a73af0282b1a26fae99_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82a067b6228743299309f26020eedd15_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6e671cfe56146318823f0ae1232ffd4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i433315b6bd834cb68354e5a52b56773d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37a894ed8b0d4cc88bdaa2442942a150_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ca205c9d7904bcd84d4f88ddec8328a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b7f53f9cf764e73bd0e72cef8b7390f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46b4d1e50bc43e489fc0520c892a40d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58dddc96bde6438a903a080d6f6acb31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i468fc46d6073421aa776f6c974d1f45d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44a6cd71a87a4d59ad6055e7b101e7e5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a305363936e4b86afca45f34eb6b080_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if87626104e564cce8dc2afa187c5f744_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35c163cbd49a4859ac64117df33aca94_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05354df582904ca187452170ab40afab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dc0731d8fb949fe81ed2ae0a256af2b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i203e64c16cf348b2a1f3041af709228d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0475ae1c115247ef98cdcb07ea3cc9fe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46555157a0b04f06bf0709e9682eadac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbedee479b66410dae9bbe7401f7af56_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9132ddbceaa74f6eb21b9ebb8cf0837b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6bb87ee615b46b99718617248bfa891_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i907c3d71d3014745b11f4974adf6844d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i037c746f41544e359176f1f7ef73ab39_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="if12be8423b674ce99c50f89b01868fbb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92e8a87ffe214bca94b143308473a86c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b77bf6a7f474a47a49a3925dd91d87e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if59ff530abc54fa08a014d04b57eaad1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b84fb2a0f16464b8dc3f00b6942258d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ce76960e4fc410f94b0f8b63e7fdfbf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d0b91cd724e43e6ab4bbbc7982d3314_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe38939ea4194d299b03b4d0b2ea279b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fbc748bc4044c1a959e7a991c5cca4d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57b24b05b9274679b2b5dd6df7fdac00_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i156b20e6df6a4eefa561591d7405481d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i385db0023f404198889a2d10e37da000_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17591b56caee4f43b8f0bbb8ca58a6f4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2835fe4d12b49b097239c6dbd3d3396_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:SeprafilmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic03c35218a744afe9fa35a7119858f22_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfcbd6492da644e8b979ce9b73f2b1f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c78a0e7ebc747c594c4ee6e77570478_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:TR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7312feb82fb447ea49510fc80480c6a_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:USGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:CollaborationAgreementWithGSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vaccine_dose"><xbrli:measure>sny:vaccine_dose</xbrli:measure></xbrli:unit><xbrli:context id="i5f8e75f8110e4de1a9b126cfa19e1f6e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:USGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:CollaborationAgreementWithGSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35c351f036c247cf83d680f6986c15c5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:USGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:CollaborationAgreementWithGSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2c1a983cbcf45f48b7833d558393c4b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:USGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:CollaborationAgreementWithGSKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f1d395438c74a0b8cfbd33931e2e3a4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:RU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if71752f1ad474bd485d853a961833b1f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:RU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6c74b8a63546e290d8ab591aaaf997_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:RU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6d609e772664d4dabc2be8000f12dcc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05ab760cbec74ca2a64af3ee573e8c46_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if28c01d5f14941678f17df4612ae4e2e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i394e8a86c251479586bc1a0eb8f50130_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i409bda424dac45a59c28668ef940f123_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc5cb17ac157419a907518a7604ebc0d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i605cb1d6e0f14943b4f0ef24b77e12f7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf712b8801ed48b59b68a97d6c1d8c34_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica7d78006d9b4c9e8f46c61a015c748a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8675329b37394bd5b4b2fd333c7a391a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i713b01806f0b4962bdcf1fb4904578c5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie922fff56e5f419ab3f601913c0b7064_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:StockOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cc28f89fac74c419543f702bf0f7dca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>sny:segment</xbrli:measure></xbrli:unit><xbrli:context id="i20ae7da9383f4e3ab6826ded2379ded9_D20071101-20071130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2007-11-01</xbrli:startDate><xbrli:endDate>2007-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>sny:agreement</xbrli:measure></xbrli:unit><xbrli:context id="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia94d77530caa412a8f0882f4cd79aa5f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:NewAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i2ecbe16a2f5243648f9c51e3a70306d7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:PriorAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8340ae2fb6694e37bcf4ae4303e9d61f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b0305aa6f27497eb6fa4104c0ca63f4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OutsideUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81e1dceb236f4caa96e65fbb39f6b94d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OutsideUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic51500ccf0de43918f2456787048ab13_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OutsideUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="bond"><xbrli:measure>sny:bond</xbrli:measure></xbrli:unit><xbrli:context id="i61da00769f834eaa98878f6f1e9776d7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesFirstAchievementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ifedcadc8c03743abbb94c99cad356d95_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesSecondAchievementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i272b0b38e1734e68a43df1ce789e2493_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:AntibodiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesFirstAchievementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77c108aa7495480c98890a86800bc863_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesSecondAchievementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:AntibodiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aeff9d4cfe84f959b330be0f13f0ab9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:AntibodiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesThirdAchievementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a8c2e8daf4d45b0bcc16547962ef088_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesThirdAchievementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac784bc58da74b4aa8644c7bf23d67b9_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OutsideUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98602d43a3714a12b2caa518ebc7b26d_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:PriorAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id427dce20c2b4d7697237ead9c24a9f7_D20150701-20150701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-07-01</xbrli:startDate><xbrli:endDate>2015-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78b6b504abcb44898dfcb15e0cbcf437_I20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:DevelopmentOfCemiplimabREGN2810Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8a9426091cb480c8f68708490b978f0_D20150101-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:DevelopmentOfCemiplimabREGN2810Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i050c4dcdac6845d58381cc5689aef318_D20210930-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:DevelopmentOfCemiplimabREGN2810Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-30</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc2546af5e7749c8beb48751c8dc0bf5_D20150101-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4868bf0ce374326a873eb079a2f01ee_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">sny:MajorCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f408d44df6a499394b5c347b1c34f80_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fbbad3af70b4c90a3eb35e084814290_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">sny:MajorCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8076a1036c53486c9cf0fadf596f4f82_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0515044855e14c60a51bff4d7c49cee9_D20140101-20140131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:TwoThousandFourteenAmendedInvestmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3e2037ecf8e496eaf3ae27c42505f70_D20200529-20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:SaleOfStockAxis">sny:PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-29</xbrli:startDate><xbrli:endDate>2020-05-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8cdba1a7ee34963bcb9d8c5981f4337_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:BristolMyersSquibbMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>sny:product</xbrli:measure></xbrli:unit><xbrli:context id="i314c45a3e1e647bcae2d4dabeea5fe4d_D20181201-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:BristolMyersSquibbMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i860a838707c64bfb8b697db6c3bbeeb6_I20200228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EntitiesAndCompaniesManagedByBristolMyersSquibbMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9016dbf3a1c5430f9125964cc371f4de_D20200228-20200228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EntitiesAndCompaniesManagedByBristolMyersSquibbMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-28</xbrli:startDate><xbrli:endDate>2020-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia24e436ffce44c968c4694148c6aaf8d_I20220208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65f4119d82404c94a1b140ad21401ade_D20220208-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-08</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fc2b038dd1b4b99af69531ba3b92293_D20220317-20220317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-17</xbrli:startDate><xbrli:endDate>2022-03-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ae83ecb331f49f8875bcbe2fd731a7e_I20220317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:EPICBPIFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cb73aa7ccfe4ce5ae53a260cb785a4c_D20220317-20220317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:EPICBPIFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-17</xbrli:startDate><xbrli:endDate>2022-03-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id97d7b03002b4aba8b5f84d88ed212ab_D20220510-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-10</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9f02c4c8a3b46c8b47a31e54332ecc1_D20220510-20220510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-10</xbrli:startDate><xbrli:endDate>2022-05-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75540facaacb400d8502084443749f05_D20220503-20220503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-03</xbrli:startDate><xbrli:endDate>2022-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i869e6282be074d28b9a1712822c9f46b_I20220510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31105a7d607d4af49033461835874947_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1363015e33be4996b0e8a89139d4895f_D20220617-20220617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:EPICBPIFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-17</xbrli:startDate><xbrli:endDate>2022-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50fb7abe554a4e5b9bda9e50cdfd1966_I20220617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:EPICBPIFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc8f06a841e6428180d8121555e73740_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67af3f0fc7dd4b2eaa2a63d60e4251a0_I20220510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieddf1529368346c285a415c5ccebe6b7_I20220510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RegulatoryComplianceCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34419df6f45d4271bd03deeb7650e44d_D20211001-20211001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:ManufactureAndSupplyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b3edabed67d4c528f7b9b3aa5532b9e_I20211001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:ManufactureAndSupplyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77db5a6ce6f941378dabe84d0fb99691_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:ManufactureAndSupplyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee572facf17d4fcf8b3895371e7c97f1_I20210408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KymabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b42acc0514d4e10970ac15d3afcb8ad_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KymabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11073bbcc0a14c62b570fb898e98d18d_I20201102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KiadisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa7ce4e64a0145088c122905f0dc3331_D20210416-20210416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KiadisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-16</xbrli:startDate><xbrli:endDate>2021-04-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3392c86b77ce4ec1ae56d2c26b0f10f0_D20210429-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KiadisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-29</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e3f5c0fbd854b0887ac60561bc8bbe1_I20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KiadisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1ab1eca87aa42b79b79ae7cb8a40079_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KiadisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37e52c8c761c4a2c94bcd4c10a298624_I20210409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KymabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91ee802320a44a84b28df3ca02a2a4c6_I20210409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TidalTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50186dc8e2144cf580cb8c90422239bc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TidalTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i779663ca39724fff9eb372087b37e45b_I20210803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i346802ed216643f29cf03ce4f829ef06_I20210914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0befa4372a524fab81e8c4d403d76062_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81cc2b2f8e09437a9a99b63d42e7b55e_I20200623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bf9f268a35e45dbace519548e4267f3_I20211109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KadmonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e41032ba4984bdcbc1251beafa9fb22_D20211109-20211109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KadmonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-09</xbrli:startDate><xbrli:endDate>2021-11-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ba12f5a779c416ea0550b3a72a82b6c_I20211203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OrigimmBiotechnologyGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab5f424031af478da77b305846219403_D20211203-20211203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OrigimmBiotechnologyGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-03</xbrli:startDate><xbrli:endDate>2021-12-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:PrincipiaBiopharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1818566194634dcfabc96b128a36c2bf_I20200123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:SynthorxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie19b56352bc54cc6a3dff49f358c669e_I20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i502d25752fbb41198b743f7ae7a986d8_D20200529-20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:SaleOfStockAxis">sny:PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-29</xbrli:startDate><xbrli:endDate>2020-05-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87164f7d070f43bebcd477c11338759b_I20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:SaleOfStockAxis">sny:PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e547fa7f10d4ba49513412e133bcd62_I20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:SaleOfStockAxis">sny:RepurchaseFromTheCounterpartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i169847bcb5da4bf9a458b8021feaeb0c_D20200529-20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:SaleOfStockAxis">sny:RepurchaseFromTheCounterpartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-29</xbrli:startDate><xbrli:endDate>2020-05-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-29</xbrli:startDate><xbrli:endDate>2020-05-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i755f9def05814a168296cd241a1146d3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:TwoThousandEighteenLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f42c6e0f02b45889491a52aa65d4c26_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:TwoThousandEighteenLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7727cfd3e20341039f39e0046c5ed90b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie109280c1ab2461ab5fe2322cf084ae3_D20200529-20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-29</xbrli:startDate><xbrli:endDate>2020-05-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ae209da62af48d0802dbf6f8ad4a942_D20200214-20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-14</xbrli:startDate><xbrli:endDate>2020-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a1fb47c77a7402d896ae4afa489dc32_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fdd7a020cd743c782be74d0b156d3ff_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44a98fba01634bd9886289ce37e699bd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6ce85fa444d4547b8275916d66fba2e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5025c5e64e0e4238ad981ac8500d4184_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a5f73156d8942cc9aff9b90aa0a20d9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0206267cac4b43ff9378718b8008875d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa29c61d6aa54e0c83530917f533df1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfb17be627054bbcaeb8bb573eb2dabf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fce9fd8a39949fea1857356f2487678_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e81b12e473e49b5abc85d3e576474fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4f8821720944d1680e7ed8837430cc6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87d0af8348104bf887f908169ce200b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d6fee5315414ad1a751bc8615b564e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42c95bc466b242eba66c21cf83df94ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93db76f9896b4f74ba29861299f846f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23e8b78ba6e14985bdaf0561022d2fcb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife09bcb0dbc442368e0599e166c05925_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d532913ef384fd19661d028233c6947_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd94ddf5b0e84f649ad3f3ba6b5cafb5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76a1d3dce1104aa6a7d778f1999c90d9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb39c23a34044e26bef23d011e133535_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2162c82bdeb4391aa0ecd936cefcc6c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd00cfd5016342eaaea60535f74305b3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b2466da63bc4da892390e4aed261abc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i476392303b7e4abba1d96716ae9615ab_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied331c3fd4b94f45b143e83a62a935f2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ecc234cc9eb49568130c6b4fc616c68_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f095d969a564ac0a9de8f80291ff734_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c26e169435e4e9e9fe6193807419216_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc8a6784630a4f6dacd4f922e9fdcfda_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10c25791faca434abad3dcc87c335545_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if76ef11240a9484db66b6a0b5b09f16b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00ddc700bee94a3ebc732201c1d35de9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2f730ae7e334d48893db2ae20047ece_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i472690aecacc4395b411b03484ad169e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96cfd3c2e6874abd9afce4c2d4d64ffd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bd6e4b32cb345028d31ec8dc75abdea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i955321bf2dce441dae3876de61625fc6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id90f926826c348e58cc61d5392337455_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69399acab7a64ab497728ec8f97b3699_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c7e1a121231436aba2eaeb9b1fe7924_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9127d80c07874bffb0988e2f80d522b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c0b39229285466da452d51712d250f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i193fe7806c2641f3b83fb65146f5ee65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida5c0c7399ab4f90ab42e89c5e29af71_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9404661ce5304598a545950eb1e7bf70_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba41b88a1c3648cbb1015bbea8998f1d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fee7647f4f24f3491f03f1226afcc68_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0f0050d932c48cbad2e4bb3e8838afa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6326e3e444e4d0fa59364df7efee398_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d73c6b22ae6491dbc37944b398879b4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib371a75679dd4f838651914ccd2f7845_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d233b94b150441c965315e4c2cdb970_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i460186f58d964578bb57d83f6b52c068_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a427587471c4b43b5afa2d98b323de7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c53e563aead4f239fdd2a1346eaa2ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28edbc201159440baec039fe6f9edab4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0aae04a72c84e138d05a17aa6e4adc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i038f209f31d04ec4baba797bedf7ede2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib020c89f73574f31811c48672a7d702a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5df9065660c4e1184ba88ea30322027_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id09d5d649b4446e3a4a10a599d8c7820_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib493cbd2620f4ebeb6ea7d83ee096a61_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29b79d594c5948f5abb69e79838735ed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cd5556f3abe48f5a8eab0fd94631f19_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15ac112e5ca84ab9a152812eaa4b795c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb589cf6b30d4f85b2a6924184520710_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb790736d7c44dc0aece34570e7aa9d1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia71d61fb176c44bc85d8a7131e07caca_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia21cdedb03d541ac8ce4c21e0f09243a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:IndustrialFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d87c5192beb4f79a9a215eefde80519_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:IndustrialFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e59794b9da94a948e8aa70b12c8ff88_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:IndustrialFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if815506776604f328ffbe1f64040e104_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:ResearchSitesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7903da3784d448cfb09ae68817994cc1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:ResearchSitesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4dd16005bec44a7bfe5627a199fe9be_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:ResearchSitesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if781d7295c08487ea51c6503613eb526_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf174122818644c48b0a0c91bb27b307_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa82abad241d465ebfe6912fd6e39476_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50f963fe7eb242389c52c58a27841042_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec69c452bde4d2e9c935c00c627ed10_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73d9e784d85c4861808c14effc04b733_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5d1685308d744b99b0b8ffe90f18bf9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec6fc9c2bb8247b2b49f3c157447c542_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8a4cde136ee4ba6867518e84f629759_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2a9d85e3600439fa8021956ade9fb27_D20181201-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:CambridgeMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>sny:lease</xbrli:measure></xbrli:unit><xbrli:context id="idf46653d45ba47878e79284f8a9651fe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:OfficeSpaceCambridgeMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i521770fd159a444e8b290a2b366d3120_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:LaboratoryFacilitiesCambridgeMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9975866b6f0948c4b2dc3d5202c3a8e7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie04ea8d3bc0f4c5ba8c8a671c1dfec8a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ddd2e8b048c4aceb5e20e5ee54cfd35_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04c2256e354744d2b996810e1b4ce23b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d3b42ca90c45d9a60556ebff587fa1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccfd390288694500897be21beb1f90d6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e1d225964344fc99aa88194ac03758e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18beae5325a24e4b91ab73391d713a14_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i805096a31a54493f98690df2512c4182_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice04a6b9957a4d6db37a912faaaaa4fb_I20220208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i972f543731c343078d24518f433fa726_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i479eecf06f384cd28a6d6234aded995c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib655a021196d4cdfbe4475108064a5fd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcc8c91558474195b7619d926905f4a8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0012231543ff4a8da7fc419bff0a9e67_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2d610536ebf4dbf8b9a88106c67353f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic16020b4a1554e8a9cf89178c464111a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a0da2ecaa04eeb814d811ee982a0af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f1973ece55247c7bfca1df0959ed390_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i738d8bb190154e6885638cf09b03af8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i212426e60cf24241b201ace1b0732af7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c347307f4a945aeaeb2aa62d4b9c418_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4bbdd4e400844a79a5da75e3ae604c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fdd2720629d4afcb9cb4ca0934ff100_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1e50048305543d09b31dcbeb40df282_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89f73a7c69a540c59681a9b3cdc360f5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eaa16fcabab488eaa79bd1b746613c6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58368e802e1c49819f70d00a80e9b758_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f5e538c39c74bc1bda08a15d67a3de9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i808e5c06bdd646ccbbe77ddc9e3f1433_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8053a4d07214c0c8866abb7aa242822_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4e712c22a384fdf9a6a92f6d8363ca3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic159b371543149fe98e5dbe979df7b29_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86724a133aba4372861b17fd7cc5dcc4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dd35aac58414697b4cc3b232d182e78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5661f3ac3eb046019a9fd43280b32b15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idddba6af7c6d4af7bbd01c92c017cb84_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c01ebbf5a814bd68303efe91ff455cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if22620dc4746433ea7ede1e7e434757f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4736438590b4561bf1bcf564c1f1016_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa0f7fa9eea84ac4a2c28706473cc2e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b534838cd34410bbdd454b2427db95c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2b9c32fec7247f5b6cf4d373a4bdfdc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83d587327ece400fb1dc4a4ed917f95c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief8f9ac9127344e5a1d9e4dc7468661d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5633c4724ce148ac9ddfe510b1f65f4e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i958343bdb078497db2b964d690e99d81_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaabb9095a1ff42f9a914e504f9b48258_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i425bfebf084d448791653b647ddc68bb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:IOLicenseAndCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09b51cc206164edcae17c3cfc4b8be23_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84439ea7fd4f41189f4efa5cce7f5dee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab92fc7553f84732a53070d96b07d717_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1da231f2f58464e95b73ab82f7a6ea5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cb82f850b314453a6ec5d1921dc1d46_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if35c01a7371643bc9842164b984ee110_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac2d7ed11f724c0ebcd3e81759fc9219_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08203211b0d245c4b6d1cc85ee868582_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id773f103dc28473da6dce61b97b4599f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i327e5ac314c147afbbac34d3cd5154e6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie35c53e81e9249b386cd4ca320340845_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d83b887fd184dc780e366b282c56ac1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12436be5245a454fb08492a29387c400_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibecbd6a1102148a4b1cdae4692855a35_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8df75a742b2b432f8ed86c2c047454fd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide1da35c16a04b58969940528c31dca4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0256bda43a0b401793ad67599d6f854f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49fae0c938264bbeade9dbd853b7285a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i340660daa522440ba21086f7ad5848cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6daac2f7de947078866a970b9af341b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3d27352e1d547bc80849f473b0bc333_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94646d0f821b41aa99fc727b5160ed48_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c421b52b59042909b5e110415a07634_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71c2f33574774918a3d21a0ac64c1257_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief7e1240661e4b40847321005295df4b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63e0783c68d542939a2d058ea87add2d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25232be32cd74ac0a93373b678e59630_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ce30f864e704909a1e2a6e1f5ee8e5e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b23c81c20fc4794914a0250573bd609_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1228690812c49ad88631d95ed6c90e1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50b0b8ed81ed46e8be5e882078a4d6fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i026e8f42a4b84878bffe5af0996e6fd4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf18b6d1ad6c4d90924bd6cb8c0e44bf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b24fec1ff334b3caffadd87b1917a88_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fe69425172b4ed3b1a78c4b0afa1443_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf8439c477204ed5bb7b9c50513f4458_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40fb8c5a2d6649cc9bc68e43de8013db_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc41e3bc2b9345fc876440577f2e644d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i041ab8c4596a46c7bb5f0667d7c6bc14_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c5e6ecfa9074b3e8f20927944000385_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica7f84b515f546d8bda9c71bbe43ec0e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i026473957d65465ea3db2de3e9751210_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i792f1cc45ec547c3a499357b17b066ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f4deabc2c274c3babd78470045f1453_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530f7df295184dd9a99b515e6d74ca8d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i296acdd1f99f4541a48fd22b1964d943_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i708d728675864096b68be3e4e5fffa80_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8566075f1554143b73513ddf54ad64f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04aac2d172a44ccc919acc1227192e67_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i637119bb5a7b42f8afb86de0c5d5219f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dcc5fc52d7a4d7aba03c1b54a2a3571_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae48efe4b3334259807bafd602c70de7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa812a8430e74c7e8e6a760b5a84e493_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5cc7ce98c2143698b9d193c4906485d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45f265c078e647a6a3dda117ab01eed7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dd016314ae6400591f48c4e6f72f4f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebcd0b91b7444542b0c79aa4c96b7801_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc35a3cbc8c4534b90c96bf47118eb5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie24b60956389422e8f541e06b844991b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea694613587d485fa04b5eb768f73f00_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i293dc949848347408815145576461710_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ed6aa800df24aecae7a3964ffbedd63_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45d75dd4cd4f4947b431c2b6a34e7c1f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae3e84046d214495840027e2c3540430_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:OtherIntangibleAssetsExcludingSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafe00cfe38914facb60fe02e8320fc90_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:EnjaymoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7fddf7e73a04c67bd9d437a86bbdabf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:EnjaymoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:ExpenseCategoriesAxis">sny:AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:ExpenseCategoriesAxis">sny:AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:ExpenseCategoriesAxis">sny:AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee7cb4947a1c4854876868c8e2fb82d1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16582892e01c4bb3be453ed03f64b2ae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5146ddfb19c5499c89ad75916030806b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21d16f2eeeb44e9abc4e0d2fff1623bc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashGeneratingUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea1750e2b68b4202b8af152deb123cba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashGeneratingUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacd98ed640914415ae9a8c8cb5f49656_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashGeneratingUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6291343ad8be4f14b06b056b796a9012_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashGeneratingUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib359277c5a6e4155b350cf434d57f618_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bc6ed2a91ca4c32a13fd8fb9df67c92_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ad3f91fb64465ea39c823dc7f679b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4cde3de3d25485abc32561745035697_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b27476d93554df89ad49b3ee11c7c77_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3068d0c640bc435e891dadca47642b8f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c54b1010c23469cab4bb3eff3e7d353_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28d5de7a4fc14b2593071a0d5fdc0a8a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b91f780cb5b4a2ea49c0de8b0410b7b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a363d9f71a4498e9eb6d77ce4ae1ce1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe47f0460c6443d7aac34037c1a7776f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia20f460d071c4c28a7e9a76758243fbd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dc0f8a6677d425cbf34a6827f35eec7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if951db4e148548b0ab33c185a8187b15_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccf65087a3c74152a1319c345dad3d4a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia45e141afabe465e85ec0f96fdaf178a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43261e364b9346549b6c2f1839b5914b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaebb948c909c492e932578257e1ad2fc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd554b41fcbb47338ebb6b86fee85e2c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8cc913bbe0246f79a657a1446f40d4b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00ff7bddddd7454291874636f6fcda0c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic32352d1a6b84884aee10c01c7d2556a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b81437bb0bc49abac2a243bae255b03_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:EloctateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib78ba3c2232f4c65ac54a211433313c6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:EloctateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75a477cfdbfd407296126150806dc8ac_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:EloctateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4af100e170394112bab4a52fece35962_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:EloctateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5742d95426994746862eae78944333b8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SAR444245Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb5a0f3994f84521ab2fd69b67690383_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i495abeb0c8ec43bd9a8672fcf415b572_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5f95cfdf0c2482a8e6ae4ea1b83aeed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i987f61ccd11547579d7e7f53a35371e8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa479340569c4f32a4dccb3228f32e50_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeb832a3c66e4a378f24c3a521e9cf5c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f3efa364fdd42cf927933b24fd4755d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i782f27e42e1d446bb06029d7b6d07d77_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i669940f41ad04996a28f45d5787d6ddb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63e035f853e24b69a878f537955ad35a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82151e9cc3d943a69133a8307efdb603_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91ae659ae5f74464822bc2b56b6fbf88_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i957f812f550347fabcd2ee14c0bc75b0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if13d5090e3fb4ebaa88f2f834e7b85d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5f292fbae704649bdd7f44efd9dc45f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i092bf3d6ba454bcd8193568dd0f4509b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:MCMVaccineBVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic49924175296420b805d168c7336e31d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58223acf6fb24980bc8feacdb2bfeae8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c41e8bd45074b609022a18dba83404d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1d40d00a4f940f4b8c4db3de85057f3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75f7fd33c99141b0834d8cd0bde8d7e4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i116430c7eca24b8ebbfa85cbe5cf6fb8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i147d77d0cdbc43f8a3861edb09fba518_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife8c65e63c7b45eb9f4a9c39837733fd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fab8659aed84831a2579ade0399d130_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5ceb0532e334611ab935fb0364427b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id92cabfe863843afa6b89218300e3c36_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if09b2251983a4669a88b8ff54f8690c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2598979394db469aaf140d5bfe9a797e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0b1bc46ffe04f0299592c1fa440af75_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i672c84847c6c48278feb34e54f8c653e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec71259f6414571a2d78f044395b234_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18dfacac600544adb63df420cb892c4a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i947289ceb8754aafa7862f600d091bb9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35f0fcaaff094ff283b1ab8503932dab_D20220107-20220107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ExscientiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-07</xbrli:startDate><xbrli:endDate>2022-01-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7acd3285a64b18bcadb39dc8467fe9_D20220329-20220329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:IGMBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-29</xbrli:startDate><xbrli:endDate>2022-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85d4d256594b464a8880f4ff83e76312_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i747f411b1b5b4dc38fd872cb94543817_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30ef28538e274977b05fe65db2be8141_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06d47704541e4ee1a797c39f08654082_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d0712e20c454b3c96fcf98e68a25960_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:InnoventBiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0d86ac7238f4dd59ab63269350d8d09_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:InnoventBiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57ad482a322b4fc0a81c53a3afc3d8d6_I20210914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:TranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58dc338d3859459eb1381af00a929009_D20200529-20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-29</xbrli:startDate><xbrli:endDate>2020-05-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib198bd6cc6604c2b9675491c47738ca5_I20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7488dcfd6c2945918eaf022e244867f7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie64fc8634a414cf0b229f5f5231182b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:TranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6436922a2ad48e6aa3486427a648935_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cb860a561454a50b32cf9b3ef5bf20a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if350acb0ea304e1380f8a7daa4bf3d34_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58761417deb34e4789711c949bf2754c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i737d6d075cd24a3fa0a94d9a8769b9f8_D20221001-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DisposalGroupNameAxis">sny:OnduoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c302b94ca2e4d78b8e9a5e1966760e7_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58d99ec61b724625ba3cf5fe5d54f353_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:QuotedEuroDenominatedSeniorBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0316f32ab41848ccaa532657cf32b68f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:QuotedEuroDenominatedSeniorBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7bc7c1140af4531b7bb1f0aa3a64394_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:SeniorBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbc81c6777a247f3a55a9409731b937f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:SeniorBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if636e1b1d9c94752b6e7d2f5d093ad9c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:IncreaseOfTenPercentBasisPointInMarketInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a89cf5df5aa43cd9b53e1ca3064c250_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:IncreaseOfTenPercentBasisPointInMarketInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib26b365d63504886a705909c700dad19_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f1cbd8e523544a09df5288b9e682c8b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i187a52d9d71643088cd196df81c6809f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b47ba7fd49a4339a1546e28df0f6cc1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">sny:FairValueOfSPMSDContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89ef6966eae49a3b34c0c5c4c087cbc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:SPMSDContingentConsiderationAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i545b36dad89549698a7358e61f470fae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">sny:FairValueOfSPMSDContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2790c19603340069463669a1121103c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:SPMSDContingentConsiderationAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29f5271fd56c4132b303c64792c7e68b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">sny:FairValueOfSPMSDContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i008006b7cc834a49a4178a0fd6d1f590_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:SPMSDContingentConsiderationAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd6801a467d04340b8c2bbb32208b916_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">sny:FairValueOfSPMSDContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d2d460cf184fc7aa2916de537a8f07_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:FinancialAssetsHeldToFundDeferredCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8b445cb2507415fb152acdc9b875a90_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:FinancialAssetsHeldToFundDeferredCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f597a89a6d040349370742d7e4695ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:FinancialAssetsHeldToFundDeferredCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b12ab871b274e9aa1aa68c28cd74514_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bbf8d410b244301ac8ff091e2c31cd3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41f3c0f9515d4e13aa74179f5b5a3840_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib647a1698a86427cb8d4b97bbad379d5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">sny:WriteDownMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac996783058743dc90c8e8829cd97b94_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">sny:WriteDownMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b3cc5ff69f34488be79292aa20b972d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">sny:WriteDownMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa4b63bd7db44ad5911b73e3491dd4a3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AllowanceForCreditLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05f28cd38d0841ebb218af6930d501eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AllowanceForCreditLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i032944e42df3482bbe716ed7bc4d8482_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AllowanceForCreditLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib366bca9838a4f858834d488788aa1aa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92676380068543619922d35317997de3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51c89819a09a4a869b9cf28d9487e9a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ef2f8187cfa4407be68d0b5b25618ad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i204cf38410c44c62bd596f2773e81a5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ba3ac339a504f58a90dc11aa1e8caef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec0ca9779e2a464985b051e55ada2803_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa0f24f6bcc446849ba76127738f68fb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id20ecec6f1584de38800aacb975d6350_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fe124e0795a41ebac762da9097bb875_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71a39145bca34b95ae9166213239a5c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd3ffc9d285a4ee5b56664fc9405500a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8bfa977878c49e4801932e083d9a1d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c1337c5561d4086b729fb3b2df1d049_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e7cdf1797e949f6abdf600757d84aa3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a92ec01ab6f4056bb7dd2fe7b28bbd6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d71f901edbb4fc9b19eac52b6dd1c63_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64bff274bc764511ad68b85e40be4102_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bdbc198b14747a6b443e5f51b4c57c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f35300ff6594e66a950dbb07f57d751_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68712353db49491990d250cab1dc2b7c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9902da71fc7c466694af634d0376287c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6a2320406ec4131b78807bdb61adf57_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i868a0e34292946128d179703085f0318_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if227ca69b6764bd5aa2743a5eec6c517_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3e0e6f2fc174daaa294b5fd344eaae5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1c712a9f5e240d0a223b5fc4d7f3821_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie034a80e75204f5a86d6d8868b8ca40b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57c74edeb8724bff9b4a8ade725f2f63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57c1816e408f4146980929ba115caa65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id78484142d96470daaa4465a88fd1465_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf554ea45834ed891abe8817a179274_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic934f45d8eef45ffb86db0dbaebcbbb6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e83c9ceee8d4973a9fd9afd3eb6f554_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98d98d655e2840c6a7097e85707ab978_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0725e56c610b4ef8a9c778e1f873a5f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b13fd34daea45cb93c23eb68b1d9997_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i440fc3ad28704a76ac9e4456da1c6091_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifddadc6b0fd44b5e968e11dd8e284db1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i506eefd0acc64aa98a0ea2812e1edab1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba6ab0a538b548faafe7034677544b54_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbdcbc2963214d8c9842c9ab0a7d99f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if091001a8a224ba884e81e875ef8f51a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c615a591b8421183c5124409777d8c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic16171d1dc9b4826902326dab2989ff4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idedbd6af27cc45138105bd954312850d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66f1507ff6024854ab28cb15b8139bb7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae8f42e29e44a80a767329003e96b3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4e1f6dffa3f4033a907e381fe585927_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icce038f9032149768e955222f2aca120_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib63df7edcf044cccad9f0d666c02d417_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6edb24c7b7614f5e8426e248ad8c0012_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9e0f64911dd4a9591b9bc586892e8ba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia33a4f9a84e44e238ebd55018effc821_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93162a8ef8d44ceca6e6bc7a60a8fc3d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ee383251d8a4a5db431280d0829da5b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i251a1285ee9d49388641e59f23f6241c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbeac9cc516e4ecaa016f7b5a9919939_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i812479914b214ae5b372315aab8728a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if21f555fdb8141dc8dcdbc4a99f03044_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9a5c31a587e4a009e48f3ae090ae3d4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5b50aeecb014f088d04f8708033fed4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i865d3e2ccf184a1fa3395fe6567538b9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5e602ade1a84742b797ec53b6d74912_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibde8b2ab03584ae4a5bca97d80502c95_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i226f7c29cfb84987a2a9deb701ed1907_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85306855f61b45f28134e4c906e484e2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6268251951114f5db755d35912bbb195_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefc2bf19aa14458e8c2c9dce268786a8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9510f1a95a7b43ac86ee6d4c0b128d24_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2f822898ca84cb8a79415a6cdc45e3d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a0738d4f3a648699d252a97ba3e6ee4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i158b44cdb3244768945b39667ddac6f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia10bc441f3d34c13ac07f05030c62cf5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1d93a2e51b44726bd0f629ca403921b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8ac539935374b558f669ee77dac8db6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia936cebd16574ca3b1b0522bc2565698_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ecabc225dcf456c8163959683eaac2f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf455571305f4064b0c27c09d9e0779e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24ce970c3de542ecacf624dcc54c068f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a85f9f5746b442bad900c30146e6957_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f9513c503d647e5864a3f1b67b93937_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bf17373c5694449bcc60449faab13ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac92dbfb0dc490aa7026799fe831566_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42bcfaacf8014b70b45f0bc2e3826df0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4363d5a964d4bf9a405bbc5ad84d075_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f59a0aed26e461d8f59cef0d6162389_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa6146ee4dc34054b4f2c8dd934ce7b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2a400aeea96455eac5efbbfaac85997_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i414ace804d3948748fb5516ef6e3c93d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dd8126dfa704004be857e04a1d63621_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bce6c62ac7e458790049ac23f730d7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55736011d7504217b288feccd10003c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a742bafd34b4be09b40358da2f7f5c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0e53d257a5b4cfb9ef9a43db3e18a44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3df519902364806b6b4df1fa5fcaecd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4cbd6b4a3914b4bb22bc2cb56989463_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i409a2ac80199410c9d2f13738b9c1fc5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i361a9c2e95a54cbb9685b3e4db0de703_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2b4a0233a76467f9da9303ec9617568_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a4ec58f212240f98494aef951fe0ab2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c5b69a1242e4ce3bbd8d3803a17f77b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id87ff9e380354502a2cc0a654bd50c36_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba95b079275c4adc847b0cd47a476111_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6f8c9f62f344106bee9e868531813a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice8470e3cc6242f0b1b1e15732ab662f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0814cdc2bc444fe0a82e40cb939eaf13_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ff19b8f7bc742c39dd5d0c627b6945b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i628eeffca97848fbbca2d84940ef2052_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13bdffd21ca54bcdb0343b795ab7b63f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadd128658e52488aa52e2432c171e6ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e7a672e44841db8d883f1ef6d50e41_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb9560b7bb344d8783c8a3d70ed140a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f86412d6fcd48e59fdae513888795c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e655abf2eff4f648351419b666b1cce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie70a21fbce684182b63354cd9500f730_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i777128a1566043dfaae4b53b65022410_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id02c995274e4478396f61da8899c1b7a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb908d2f93ff4a659991e90bcf70ab55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14178e4bb8cb402f92a63d6707574a90_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4d269e6493342a1a5a259b8a23aeeaf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d4b6ce60161438c8fbc24e68b71336b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3234a98630243148d78d87d71b9384a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5223d477aaa341c6b4d55fe7ea7d4cea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i080f9c0694bf4d54922bdd4f999a0643_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48e7503106404209990dfdc490c457ce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36ed13ff5ab544e187d2fa000ff3f53a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3edf6fd8a7cd4c6991b85fa8d8833a29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80b048bc5e924696bc290cf8e154d08d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadeed4d1a84740f08d7f77eb1d523def_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e6725118f5948a789bfbbbf3550d8f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f777088d46d4dcd985ba538a27bed29_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0baef8b28597402d8adf6cee9aa0d5d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58e1e7cad9164a70839fa03c11e4a3cb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66f8461c0f524353bb1ff3afc8b439e3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd997e2d59284fdcbf55f9fc4a2d1a5b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7ab76bd67b74ffc8af89529ba43e4b1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic727bbbef1ae42deb05bb6a11214c40f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3754841fd7614021b0d3d454afce5cb4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife3e8160c2604592a96fe70b98af7419_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c3722d2c71b40a5b0cd3fbdd62a14fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f77768527954a3ea0a87e7081b338cf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic866f02ab74b43c6bbab392d315c36e5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i980e5c837107458eb2f70d743a451e27_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia48366d62ce64d6e94246e1a6b554bac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2363afabce5c46a3b4c953bd0582795e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77d7a7bdcbff48a69181f857e54c25ee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ee0b2e050a04774bbcc876af9b05e2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aebbb6cd5394ffa80a4acb7f23fbc26_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9edaf00d040343fb95831f3cc2313b2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41e7d57ea4de4fb2acde34fb25042f3c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic054a9f7342d452997b69f83837ad01d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6c1c44bc60f4d718bf8a08c96042e61_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i391e0993fafa4e8194f1cee9bc292cb8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98a96a99ad894d939a8ef2cf79d189ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a9ba46c71214fe8bdd739e06a5e2cea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b2f10037fac4641824455bcae113474_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea19c792195c46bd9032528e794b669f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4022972c8bde4a9ca3cb288456a68271_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42e844a6d4cb450f9d291a2abe40dd93_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ac22998c1824a71b163369ba9107fc3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e3b3ef271ab427b944675c91e586c90_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90897d7067434c91a8f8652d33ff01ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a15ff2465a24f9d8f467e861eace688_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff6099dca9e44fc83c5aa691e056e44_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40563d22b6d240b1938338dc3cb44c4d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dae2c57e4564bc098cf95f1a6b088e2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6370e3221d264c9283fc7256385a72e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c52f444ed0f4bda84a42b7e930f8420_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ConsolidationAdjustmentsIntragroupMarginInInventoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id11eb7058089436a9aff2a514b26afe8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ConsolidationAdjustmentsIntragroupMarginInInventoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56a5626912de40e39e4a075cd3ebc7bc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ConsolidationAdjustmentsIntragroupMarginInInventoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadbc77437f194c4b9714d27bea45d27d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ProvisionForPensionsAndOtherEmployeeBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fed9cb1446a49ffa3cc1ec60473ea51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ProvisionForPensionsAndOtherEmployeeBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c1f1c7a87a147aea05b154acab7ecac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ProvisionForPensionsAndOtherEmployeeBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2d0541f761144ae8559c1ccc9e1c928_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0b71582500946dba2dcb41e5a262822_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifad5fc92533e41a7aeaa856fcb32b3ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i812946d6d99c488b913e652bf22c35e2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i592524c5425b4fd687989aa3fa4c2fc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6ac37e52785466095dc8e783f91f5bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e2dcbba0a064e75ab731959eaa3eb3c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib906ba086bbe4f30abe707134e42e386_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5535831de3647578a867ea9e090f1b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cfc74b847364b73b4c2966e30b347c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0499e2936c14c57a7abc3de327bb2ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i079e44824551470ebf2ecdbe82c78c53_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7470aa0bd046445ba5d903e0903f429a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:StockOptionsAndShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9fdcded8d294930941d9b9619419474_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:StockOptionsAndShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa8eaa248f964dcc9b6c43fc5fe3997b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:StockOptionsAndShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idabd22ffeca842938dbb461d8aeb992f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20ddd88784fd4401811a5d58a1e0998c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9380121dcb2b4c5f96096a046caefe54_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i066e7decba3b4361be385e2553f7c453_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if38e6ef7aed243b8ac91bf5307d108ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec4651d9b55449be9cc5bd98617ca794_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i443cce1a00af49c5b31e138daebd4921_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:BioverativMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b62979a6fe9440786e1d336c8029542_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:PrincipiaBiopharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i410ae0b344fc43a3ab2cf3899b851c5e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AblynxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia53cda7c749e46b1af9080f7e52833cf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4d4bab9b0aa4d6a9547cfc9fb7b0e8d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a265fee43744c58b5ca31c83714d579_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:DeferredTaxRelatingToRestructuringProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f17ae20601144ea9e0f23d12022ca1a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:DeferredTaxRelatingToRestructuringProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9ca24cbf2ff42778b6960dcc8505438_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:DeferredTaxRelatingToRestructuringProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife7c44a9a1e84cb7b6b4f6fe06b1ebab_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ea79a68514c4efeb70ef0c35a2baf70_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f94df52faeb4018aac422ffccd0adf5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e29bbd050a542b6994f56c5f2fafee4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26c6820c3ece4e2aad2f35e051f8b181_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id75833e7c0144f56ab9eac0ea4d607f3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d88a2edb81648e6afc4f83c69c424a9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia39e689409964bfa8f99f19cbd6e41c3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia196461989f240c08680cf2183a306d3_D20200728-20200728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-28</xbrli:startDate><xbrli:endDate>2020-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36f49e4cf39f434fb5ea2349696ed58f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib03aa1724e294ec09dd7edb58b1d4e63_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7e77578600e4c639e9d27feb554081b_D20210728-20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e9f1e47319c48d5a2202f889bf79fd8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85f3af7ddeb746839ba726053d9da1d4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcfbe4403ae14242851e1ae3cd6f979c_D20220727-20220727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-27</xbrli:startDate><xbrli:endDate>2022-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1f20d3235444723a9c023e3b4339f8d_D20221214-20221214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-14</xbrli:startDate><xbrli:endDate>2022-12-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i515ddb2455da44eaa66b43d874f42983_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0692613954647719cf5a55f8b2600b8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafa20f1425b74849a9afed9c64bbbccc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f5d73d4345431eb6e2b0feaf16ec74_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice0df2b13649423eb9b2868f28d11017_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c3bd86d2c1b44d7a257e61844c2fd3d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id12efe7d6a7346ab84d22f390dff95a3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc7b7077ef674419ba3fb299aa9d4fd6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f883da95dd949dfb22ee5967a73f21a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4abe87f00861469a8648dc66935cc3a9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf17328999f949ebab31efd9a5ca0b93_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91a183f0e6fb407f97a8c1b19774a395_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4923e9cc73c846eaa19bc82128326804_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5563efbc666d49d292f620bd6319cea2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iace7c690ea614bcaac762af51caa6166_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be6784fc06342efab44ff95725d2986_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96dc54b1575f45aa9360b1da2d463ea9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d45edc6cd6941ef9b03d7003f0afd1f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ad138fe89454c15a781c584d7c0212d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5cad4f0687a4cc08c2c4b21b29e7459_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55ee43f980e74742950602d7ecd1c557_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie92c2dbc9c094b098879979d51afa004_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cdf739ed9644e06b67f23711ab2839d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6484d0f5c354afc941fe76a527c5cbe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00edc5105e9f4951893c539899a4e361_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aef65cbc35b4a7bb1424c660441fa25_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib550dc9e8fed49219de32ab81c00e68c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d14025c7c424adab3048e4636420277_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2efdc68378814672ad2455c0e7526d09_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if37df78c7cb74666ad31409c6077db06_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98e5eb6aef8d43febb13411a27d3bb45_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i005faca79d6b45eca0b9960a7a8cccf2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4874a200b94b4652b806a566996b1830_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia63ef8082fe642f691db7df32a40dac2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19a68be4db394b5d8547b3806e810a60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e0a10794cf6434dac120f4b0fd4e858_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i175a0715b16947179dca2850b07e59eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5952ef337321480da9d9eb91e066f493_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9eebc27712f4a14983ed16a7f0cdc1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i200a7f91a38845258783cd5f4f247240_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd3026e0c94449659a50317d98e7f973_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71429c4358e24efc9d002898f6394ae5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7950c585f21f43c9b757252673571f29_I20220203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79da5b5df5a44ed2819eb15a236aea21_I20210204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46fda90bd8224cb8aab66c2e4efa5317_I20200205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66d14f14ca8849fa99dc8c0918792fb1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1516dd6e9d447e8a114d4530d0dc9ef_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63eadec211ae4265a25589628b710de1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bcc53d1b46b433eb833bb6a2091a218_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:April302021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icceb8678190f4fc092c24a26a6eb8a8b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:May32022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib996bb209f3341dea9daa277aacec9ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:April282020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabf63d973d864585b86699f4855bc32b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2022ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcea4ad6a0f44a998a9b40d108e25d03_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2022ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i133ad2daf2c744769bc88969889d854c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2021ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie98122f205404008bf0c4d6ef91f8cd9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2021ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47de2d9d1a944092a8be630f2ab66718_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2021ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7de3c0be32cc48acacb91c4afe0b5475_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2021ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id93a545773b04620ac8f01558b1daf08_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1b2461e749440a5bdbb736ccaf68050_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e27f23597f74a1c9ecae2a85d4ccc94_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i880490f8dfd74492ab0ebb0a198871b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c119e3c395a473f9ea5f13d6ebdde04_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2019ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb20c7e9683948fcb26fb328baed1c91_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2019ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2b3c17bccc5485fa012a841128e0541_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i343a67603f674e36a4e9acecfd848af6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b49431edc8942d0a4afa8a40fe26c46_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf9aeb01b7384684be3ef0b4bc47fc8e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i101060c5a55146ab94a8e716c499c73b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fbf93c7ecb84b3c99fe4d603cce5cca_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:EquityInstrumentsIncludedInFinancialAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:EquityInstrumentsIncludedInFinancialAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:EquityInstrumentsIncludedInFinancialAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaddc5f29d63d46fabf82586a2abfd3ce_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5642b66a094b41b78ecf737cf0fb29ee_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c7268343e3c4b149282aaac720d320c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5f0f8400faf41899e56a9f755aa798b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84e5f74193b24fd0a09abc9140858b91_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01a11c5677794ada9a35a69fc37af36b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4949eb4dec9442ac85100f908e6972f1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:CashFlowAndFairValueHedgeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f6d2fa7ab6e42599794a051ecd2b89e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:CashFlowAndFairValueHedgeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd31d9498df742b0b80e99888ab0fd03_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:CashFlowAndFairValueHedgeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49080ce7345480abd6e11f6e27bc713_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i386bf60e102f452f92cd64f880c74114_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5e403b7788e477a853eef59c1c0ea76_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcee24e1452447f784500be45b06d7e8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica78b7fc4ed34047b47a514ea2899e83_D20120305-20120305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-03-05</xbrli:startDate><xbrli:endDate>2012-03-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7e65738a1c54e028a8f9ed3e5c8f6ab_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a0dc1e4f1cb4d699ec65237a7102e35_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fdbb4a4b5c641fc830a0a4bf600f878_D20130305-20130305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-03-05</xbrli:startDate><xbrli:endDate>2013-03-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i850f42283b4b45f5af5a9e3cb5bcb9fe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7a863d7a3b84e16ada34b5dd5363074_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70e570beee9247dd9373015a21c81447_D20140305-20140305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-03-05</xbrli:startDate><xbrli:endDate>2014-03-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46fad837e04947e195c6de7464520552_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8eceb614c7954b4a9e69dda6979655f9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0423b3f235d249af9b6c602495486f3f_D20150624-20150624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-06-24</xbrli:startDate><xbrli:endDate>2015-06-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i761f2bdb34ff43adaab4025fbadfd268_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e0102d8ca1542de9dd7e5b5292bff6d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9991ac00c4ee4f6795e497369e9998ea_D20160504-20160504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-05-04</xbrli:startDate><xbrli:endDate>2016-05-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeac6a9bfcdb48f68a24eab465620944_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c11a2397029406fb3e60037da96b3b9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb730a8c0b4f4f30bd170f0b73b2ae58_D20170510-20170510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-10</xbrli:startDate><xbrli:endDate>2017-05-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i123d774d41684985a2a86c269755103e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ff9ac16b7da4a46b910521e9f05b3e2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b8cc6b5bfa042099e14b29e8ca19daa_D20180502-20180502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-02</xbrli:startDate><xbrli:endDate>2018-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab81166fd8d041fd9836ffd1e59632a1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b3f2d5eb1ab430482c82afc1c357df2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e201b70b2444c88a26affb3d73de9ad_D20190430-20190430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanTenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-30</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac1fbcaf85814c7a9412ccfa10736712_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanTenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ade5b12cb694090a8bb2346378f9880_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanTenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7761f45b2c44f4b874bfeb6104744cb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia81dd6015449467683cda683d3e36cf4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:StockSubscriptionOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07c7f8bc45bc439083fadaebe0c772c2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43789de88f2946b3a8bd5af44ea50d3c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdedad23dad54fc796d50896cba79d31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifadd309e52db44428b4ecb9771537123_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0091f830a3594684afe0ab456649287b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4927989d9967442c8996bd62b8ad73e2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i821889f0ea344561b6b623f1569dcf5a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8bf080bbe314c159376eab8228e0259_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96d625b90bc5415ea3c4f123b942d689_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86600d52210546e48c0c267d156433a2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i761cd5d2d3af436abebf5b7972feb90e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ddb1db14dc74affb6c0eddc366fa6ee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if945729d6a4149c98bb12ede0a766d47_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e790c51810745d39c5f898d13e4d429_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ed25668eab49c2b6083a9d4b1afed6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23039a6ebb6044c893c2b3b14a2e0be0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c0322302b7940e2b62b4e9d6b0dd997_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb96c4c54f0e4c9593d667cdb20954ef_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica46b5f804e3417dad93336ac31a2ecb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8cf06b4cc8747228729190e580e0310_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AmortizedCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16062e084b99460599219bf6d4ffa60c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AdjustmentToDebtMeasuredAtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10309ee26b644653875a9ef939afe780_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i821c164ee86d4851828efe3ab80b5250_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2ad2e7b83694c51aa8ec5759b996a3a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i610ac40ea4444926b8ca4fc00340297b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7460dad569314917928c609f43188c3e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d1e362d6a2340b88d664b8d7109b86e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2a418ab95d54008afcb49dc0cee1dcb_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:OneBillionFiveHundredMillionBondsIssuedInApril2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>sny:tranche</xbrli:measure></xbrli:unit><xbrli:context id="i9b7d742e8ca14e02bbba4212b5f9df28_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63eaa2695fc84ccdbf9aa943ad509de8_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="patient"><xbrli:measure>sny:patient</xbrli:measure></xbrli:unit><xbrli:unit id="country"><xbrli:measure>sny:Country</xbrli:measure></xbrli:unit><xbrli:context id="if33294fda4e34c3097e959eb6003c057_I20140930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:OneBillionBondsMaturingJanuary2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9fabfa6d35447128880bf4259339f29_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:EightHundredFiftyMillionBondsMaturingFebruary2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i119b8f75feb74fbeabff0df24440bb94_I20160930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:EightHundredFiftyMillionBondsMaturingJune2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="credit_facility"><xbrli:measure>sny:credit_facility</xbrli:measure></xbrli:unit><xbrli:context id="i2d6f40c3d9f341be8626293e79a24136_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SyndicatedCreditFacilityTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c67233c3b0e4833a40cd61543f883b4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SyndicatedCreditFacilityOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if95b13db708a44338258d8529b0ec6c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SanofiSustainabilityLinkedCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="performance_indicator"><xbrli:measure>sny:performance_indicator</xbrli:measure></xbrli:unit><xbrli:context id="i63e6bd162fc34a0b91feb5978e757f6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02963f181d634b7694e608faefff4b63_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d73cdea800649ee9ff0d7d7f47de6b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98ecbb3b780b4531b583aa429548a360_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i234aab96cb044325aa2b96beec593299_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i655df7026f214593b7b2e1587e041a19_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7c961701531461c8f912e9bbcf2d37f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf2f817c4f5c4ccb9efc1f90f92e9aac_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2247b882007d40f5aa3b115073c4c840_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb8cd7971d4e413399ac7063abbb76f0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a5299283064409797a6cbcb77b3b87f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5d7fb6953864b25b91382e68b89172f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aae788d334a48228c148b2c1872c556_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70a0c7eafe734caf82992697ac0ae048_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdf61719dfa64d609696094dbfb37080_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id85f695673f24baba6ff5f3c480383e8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00f6bb1b41d7431b8ba45da9f097bcd9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i607a722971b34cabb5fbb67804411532_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i023658cb94d842df8f9033585b3df0f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9db61024b8a64a5b8c29aec2980c480c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04c2510d77e942f4ba7a8de27cabcaff_I20131130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:November2013EMTNISINFR0011625433Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2469ac21b7364be09f669cb500520319_I20140930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:April2022EMTNISINFR0014009KS6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i047b177ba24344cb92a1ff94db833558_I20140930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:September2014EMTNISINFR0012146801Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id114c1320b834ff0b585507080df2d3e_I20140930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:April2022EMTNISINFR0014009KQ0Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f75dc1fff81450490afa0858e34619f_I20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:September2015EMTNISINFR0012969038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i199175f15b1046ac837513acb744cede_I20160430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:April2016EMTNISINFR0013143997Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6594737bb0244237b737e165845993d7_I20160430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:April2016EMTNISINFR0013144003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5205edb0a2ef44219261e0dd5e52acdd_I20160930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:September2016EMTNISINFR0013201639Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if56de4286562416281bd1e12783b1be7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2020EMTNISINFR0013505104Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id77eb5dc6f4f42379ad386e2e02634c1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2020EMTNISINFR0013505112Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id10b1bea133a4963a7fdd17e91652506_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2018EMTNISINFR0013324332Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia72c42b97a864e11a83f480f49ccae83_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2018EMTNISINFR0013324340Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75cf2627ef3e4b49a60bffdc84713fe3_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2018EMTNISINFR0013324357Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad984e38fb9c4661b085d5217e565409_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2018EMTNISINFR0013324373Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32f8fe30afa14a24ac9c7eaceaaadef0_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2019EMTNISINFR0013409844Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bd94679eb80436b822cc5a86b620280_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2019EMTNISINFR0013409851Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1513a029052410e867702910e46272a_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:June2018SNFISINUS801060AC87Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:ShelfRegistrationStatementProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e560b0683e3415f88c8eea18541347e_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:June2018SNFISINUS801060AD60Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:ShelfRegistrationStatementProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d556347116c4d7392f113ed4a0ab9d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:ParticipatingSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04b9380769a449a58e37ee1407a157ae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SyndicatedCreditFacilityOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idee5b77afc724b18b9ed606b041a8f3c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SyndicatedCreditFacilityTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i584b670205654f298de6bc6c82719f4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInFranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie51595be9dd743b794627696bbc95347_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d46e42d80ad40f7be7642c3218b547b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e52293342884ce98adab12df87659e0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dd5166beaa6485c85ddd0224ec13658_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib184294f2a0c4d208ca2e78abb18309d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fe6c9761ca64c7aab44286a6857190b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41838b0e904d41fcb05555d3c2e53142_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a3a064108104fec8f96446ec19e35c6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21b97dca30ff4878a0d00522d024354b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9863724d6eed4da18629877e392fd908_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8115851386c448bb86584a094cd62be1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77d77717242846fd97fead9e9cab3d8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b3ff41fb31042fc9459840da1383005_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc5db8aced27474ba3858b0e92719936_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53a7d3d78c00403dae90e229c492b7a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if08e91bcc6334394ac4b4571ec9d184f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89a9437a10b6436496ce43c3ca4ffc12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a4898d404904d67b54841026f034dd5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if371f65cec7140efb6785f6076d8ef3e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cc7bfcd54b84c8fa9042c040773a262_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib62bd4c9703147a99540e67827ebfc0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebd2bcba58ef4b558528913b09bfaea2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i540f25e289fc4a81b2b603c1ce544e8e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75c02dbe746a4f0c8dd0bf49930dcd0f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7d499e8c9264feb8703281a726ff271_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b6083f115234231b8a9cb18a0d9cf1c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00b59f839f7a4230acf9e7674e11930f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6834ab2b35104783bf996d12d8b5b3be_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bae5a0d6a9e4f738590405a5e507f88_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icda6c69534d246a48a04830eb613df01_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c3e0f4218054eae8d6f0cd63d414c89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieffdd3fdeffd433ea7df1b20775e6aad_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b5db8eab4b64e88973da38da595851d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01fe7149c70b4165ab567b66b5f5a43e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i689114ca44ed42ee9df9e1c418d03d2e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib102efb6dc8143618a1e6b93d00e10a0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fab70a599804fa892e143f5459a87bc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7670912ed6048a3915926c30a98416b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic557830f381f4210be0d6833c36f65fc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8041942870dd4730b5723c5dc68d38e9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia21f3e9de40f435e9c254cf2a6cde7d5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i562d7157b7e8481a9b91191e18e64665_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ce628e107bf47078ecfcfdb13f3e5cc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedf903d1811b48a5b959ad28581d7e2e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91024893bd7f4842a6956080118265db_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c93c6fb82d542b198701a104373ae59_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida6442fa725647e9a4886d876f008303_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0145a96971e41eda0b8dbf9c0cc4308_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1adf194cc771430ba20e49e1d9df2cca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e9f3675bc884686b9346c2cc4bc46d0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82de31322c4840e9965d37b0c2de087e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36278eb71056497db2592c9bb8341cf9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifda4536c10fc4da7bddd520da0e7f941_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7fdb3550f04484b8bcc3e27a74136e3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if252267932914e47aa7eb646796d3c93_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i588d16a72b9a43e2ad82c0a0a94a5919_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fc6504724b94686b7b9c04f189e7e73_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cc8bc76c35d41f08399d789a26cfdc6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="currency"><xbrli:measure>sny:currency</xbrli:measure></xbrli:unit><xbrli:context id="ibb27d0c0e23e426ea143647091a7d102_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26aaac9784564a11983a342fbd429be1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i891c90b7df6d4e61a27d601eeae750a6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9aa711fcb6a40d2b80db74ac171cc0c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a0b0e6e459f41638acacc3fc37a42fb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fd5aa573ef4460cbfad34c55a86f731_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49b804d9ed614704907b110f70a5cdfb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i506dffc0627c41909915d7e8817418b5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57012484148948689f89fea0aa3009eb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1774eefc6c64ab0af41316d805ee58e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbcc5028550249b08609aa6bfdc653b1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77fea54f24f24e5daa16b8e9af0ec3ba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cedacf54d4441efb351a26b12b34b7d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d7c1443a2d7463e82df2174db1636ee_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5c92790c66c4fb89e2306e62a806e24_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie769b358c2a7430eaa9c327866a428af_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id275ba29b8e14859b191132d6c2cac69_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibee927ede2a140759f0c5c12d11794c0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib91f94ba7e664e9a82b38a8746af0b80_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i237bae27b00946af9d0b8a11f902a571_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35a06cbd066c4a6385ffce5cd1bcaa31_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab4a2932b5504a659476a2c7ba6d88ef_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb312bd23a3443b3bd0d8c41cd9225c2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1a1452ac88b47cdba83dde78ded377f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57ad0dfa87a84703b12af704a04f6d7d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf7e07a4b08c413f97b8d93e97d582ae_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf8910c273344e81baf6be3ce9cebda0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9ad47fc844b46bc80ec5166c7202ecf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68a66f1fea5a498aa1aa1217323de722_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9829d8804884a12b2a996bb924f52c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b4aebf768c5437dbb995a69b847a59c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88fe0cc7b26a444897204bd0cd68ce16_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id463ae47153a4acca4d4ce0cd4105e45_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i017628a6bb05492681816fc312f67c17_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd131014a277431580f16bdaa1cf4dea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee3f28b6afc141c89ce5d05cee0c9373_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b2abede0f3b4da6acb6ca1d80672165_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76094c0250834f1a85e51ab92e040912_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fe1d1477b9f4783b9f56a9968687afb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c9b9d646ff44a8a69e68756acb7765_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44ca61b134c947c4bee18de7bfc7e7ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia15a0d49ecac416c8e39472c771744ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29b764a8ef7e489b91978a7eb7e69313_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i460a31d6345a47c1a7b3e2578b9ba86d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:WeightedAverageInterestRateBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2b6d2511d0e4766a94389d42ac8728d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:WeightedAverageInterestRateAfterDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic41f4a5b56624a49a78f6fe5ac261c4d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:PlusHundredBasisPointsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:ChangeInEuroAndUSDollarShortTermInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d14a3445818400e945ec968094e1c76_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:PlusTwentyFiveBasisPointsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:ChangeInEuroAndUSDollarShortTermInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16680b6fb943448fb282d180578aad71_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:MinusTwentyFiveBasisPointsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:ChangeInEuroAndUSDollarShortTermInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bfdac81298541228d40dcfd2166cf4a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:MinusHundredBasisPointsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:ChangeInEuroAndUSDollarShortTermInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57bb5023f2b84d4487314592d0f4240a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cbeba8a8bea4164a2c6d181bd02c2bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i986c2ee021b44ce3b4b179b044998da2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fe5b918c28d40af8499fc1cc0b70c9a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdd755aac0fc48e689e14a6274f310fb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i276f12c0b8124b55895020cdb1b4f4c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice55484dadfb417dadb944cba1425875_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0053ae4d634f454d9610544b49d8cde1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b2c283754f141868e981361c2f48440_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie96001907d3e48d1868c019e1a785aa1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7e673112a4142d6a878b6f0f4052237_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">sny:OtherCurrenciesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf44e1ea006f438d8d586516b03c1f93_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">sny:OtherCurrenciesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d361595b981448ab1d50f6b03da6881_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33739fde16464d6e90fb87630cb2feca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if126614dea4c41a48da8c2ad61a16c94_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9110312ee2f64746a22d9a66d04adf9b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9b4ea343f3047468f2f5d10fc5c9122_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">sny:OtherCurrenciesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i762332be16fa4365b2cc90d3d0037dc0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">sny:OtherCurrenciesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic291b624a38e421d9afc1f580652e23d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtMarketValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e4e5ad251f94a3f8a8756af248a86b1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtMarketValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffeccf1af73449d2a5ed59864455f0d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtMarketValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1935e628d70046c1966e7d84061601fd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeb107e71e654a8ba62720ba4f39052b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea4dd6e2c1634f6a8d800a040260a39e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i280298edcb0840438a14b90d970fec63_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8d0defeba8840ebb20ca36929efec5f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1804f6719b7a4579ae1189ca0b6fb642_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fda103b354c454696639116746e4ce6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i986561ae95484c06b7698d7d6959e8c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3388b8c97b14858be97adc9fa1bb28f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34c7881faa9548c999a9a866d7049120_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib80a3cdc90b542b3872bb71805fbced2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93a3872d72bb4c82af731fdb78c50918_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5544555c01764c4b8d8f64867b09aee6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36e91efc121046df8f37594a45bf2954_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03200b0530124cf6b744c38cef9f2c64_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82c963ffba184f95b526d153ee99815a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b10dc3381f24884b9901897b6d650eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59dc276763734d8fa431523f6ec5e6b7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff1ff8d4b3a145be98d0790e4617ed52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie428880947a544b49bb0e7d00760fd8c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff9a6cfc0d3c4fb393a0f42915753ff1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i597d4960121a42bbb65d0137e78d145a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c3121bafadb4e4f8e35a95800cbc2f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4a75584545048bb9fe869e325a3208b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:CambridgeMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e622d8cb4934c84ad1e319b2aff140b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f5f52dce766446e8aa8c13efb12df1f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a26a676a71148dbbed13648e1ad3400_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d472a3e57b147aeb03a38a1c58e1c64_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida0de68516d145a58b76c93f372cbcc5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf3de6cf917a44899ea3e45a8a4818fc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e44cd8b091f420abc8a03afa2bb16e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96eb878aad884bb1836b938d8ed8cb7b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bc6ab03815b40d8abfda40457a31676_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7a524009bd4455fa39f388d2372d26c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86bc2d12cd7842f099841197a912ae1d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cde6022813d4c0faf7f41e7da37f957_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i276543f6767c4836beb195c81c4f8a9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia42d31397cec4401901cafed6f408fdf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b6de6418317488f82c440f54eb0498c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic709e4b4631c4e698a72e76c85ee85b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad675e551ad149f2bef90277d9fc9dfd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5321b815afeb4a57a109cf015f023977_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c1ada8ab8e643c880ed5b7be15fcdd3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7c05c49e9a749a280011ae480cc3b0d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9028475126f24188932b789c9c3a8b88_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4be94d08066947e295889299f946ac89_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48e232fbe36749e39b797ba6bb47d688_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d884695eeb435a925fbec2c89281ad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6840db205a344f3a3a3624ad1fe3d84_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ff7c27b940f47dc8db4744efa5751f9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe52215125434d49876df22db77015d8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39a7aeb71d26483d91e0c2fa09f8bace_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TranslateBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61a0d34e548c452b80e7527cff0720d1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerScheringPharmaAGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59afdb4fc3d74ad98a57783363180e8f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerScheringPharmaAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffd5a4bf38dc4532a6905a24f9510e2b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerScheringPharmaAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie797eb00f7304dddbf2cde22a2826442_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerScheringPharmaAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f26ac7c041844fa84f5ccaf51563dde_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerScheringPharmaAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8794718e5aa14c49a27eea0403dcf813_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireHumanGeneticTherapiesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i532881433aa7423d869b4ec57f911c53_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i414d2c248b5a458dae7e76250a0ff9b5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43dfdc134bf04195b896b412124e7194_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f290bd30874504995867d89e80c3d9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife22dbb70240483fb59abe97371c1713_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida1b0b7fd59a4db78494bb22968fdd7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4751a46e76748978b422a63571faf77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie016f1bfac62464f88ec010a81d0e1ba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ef08d9911e24c519c5cd052d066245a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6287d4b535a408eaad25228f5b4da0d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53403a31e97c40538e551d37a2a4daa8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87f7b547836c49bfbc71cc2d0e1e129e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93c8eb824f4249b3bfda0339bc01253c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99f14dae6c344820b8cfd29600e3d5a5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i166b657852b1433a9e018a31616ff84f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68ec19e5d4dd47f99a2b91bffaf44998_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38e42cc577a14225b39b09272fa72a61_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia10e6503fcc842d0a8ec71b5c5ce2538_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:LumpSumRetirementBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1658b22a6e4540a0807eac410291250d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:DefinedBenefitPensionPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i144ca30e0cf646e2b838836778d7d0b4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:TopUpDefinedBenefitPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief705d2690d74284bfafb92aae683ade_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:SanofiaventisPlusPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84d47ba9760945e48ac11bae1f3b3f30_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:MultiemployerDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie22c0c0a8b924a2b9eb8114a97aa2197_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:MultiemployerDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae25acad84cd4329ab2b319e35f1cf11_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:MultiemployerDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plan"><xbrli:measure>sny:plan</xbrli:measure></xbrli:unit><xbrli:context id="i72b834d66c174249a0c347659203c14e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:DefinedBenefitPensionPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">sny:QualifiedDefinedBenefitPensionPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib27399813eb6424abd019f16bfa18111_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">sny:NonQualifiedDefinedBenefitPensionPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:DefinedBenefitPensionPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07e1ed072e3e438e9fa21f2b6b669c94_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:HealthcareCoverAndLifeInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76c3583de96148c4885a50242b9c6cbd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:HealthcareCoverAndLifeInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f22c7c899354b0cb94d9107f4fd1d7b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idce85fea541d4dca84fd5c265ae2ce3d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="age"><xbrli:measure>sny:age</xbrli:measure></xbrli:unit><xbrli:context id="iaa0767613c3f411ca54f05839ea4dfcd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:DefinedBenefitPensionPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2fc70c201ea485293d21743a8c878ce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2161c01fcdb543bf903af67ad7c742bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib109e7b8a7804e8faf5db8da9efa7002_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad383d0b40904aa78c611003295b9f75_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37dc156184d44185ad77a05f3d1c8e7d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d1dddd9218a466d80295b2cd0ba570a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib64132cf06b441e783c6365e8d7e0777_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d969a5687574442a05c8b81a0fdc221_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ead7b007eb34735a7448b53948b4495_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32eff8213db3483b9be806abce4ca9e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5ccc5f405134715b9e46b9feb0319b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i058d3dfb4d72464288d47993d2264238_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b87b7d69412417d8a10e4771f17da62_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11aa53d3dc864e008f9e1088d764b254_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41bece1da3a74bb9b590430977baca7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c985daced504fa199baee84c35b8e0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7848ab0fc3954d42a48de56c4b377354_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6da39a10f36d460086ee95d7fcc030b7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2b8dfeed67443e4a6e31f8a92ee2680_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia930b4de9f06488eb2a27b3206081e50_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61f3d4e904be4545a74ce3fa06c1a204_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib07bedf4fd5b4afd80a58bc9cb0aec36_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a09555de5d2475e921b22b01c4067e0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb0e67934e9342fe8d11bdef892de277_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia76aa13b727547f4b1f27cd2781c256a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b4ab3d8a6a24c718f4ce304e594594a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389422a893e247e09550b1c3b9924585_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2b883217a0b47c1809f32a00d79e510_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5064ea492ff44ec88d332c35c309d9a2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">sny:MinimumPlan1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieceff523a9144294a083d40ae6a52b9a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">sny:MaximumPlan1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie625e49612cb42ce92fe5437d2292431_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">sny:MinimumPlan2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ed6f92d51e8497998956b0d5d310672_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">sny:MaximumPlan2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7102fede0d146a4b433b8edd4bfc772_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb62e344ae904638b2180924543f92ea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9847d7e6def4b7581c9458c55a23404_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e3c25fe823d4ad6b20f9c54e9bbb046_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a7882fdbd5e4e05aa9602a3893e9063_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e44e9528b734db79cc3d65a8189939d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f0a85e9edb0438fafb910e5b162bdb1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4384e1a2f0a448db27dfc68742b600e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4a60f88d3bf4ef7820610f341e5d953_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79da83e967ea4e5e90e0bf72928c2373_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4785a07760e04fa78307171b6792c3eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i869eae3e607c4fe0a4413a6a56efb7f1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i328a8d284f6846269cfae2148edfd6c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ccfe837400547adbd518f52980bff84_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aaf7a0ab28f49108002d2f4290bd493_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8f6bcd683c14b17bea138ad1208ab88_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8332aad05ed4409494a56fb553b8cf48_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if40430fe8c9b45feb6dc9b6f4a03573b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i148b4cdc5ea1410fa268363a20cffc49_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58cc77a855b44d93866738bd3c23f42e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie526c1d298584ae8972260efcc9808b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">sny:ActuarialAssumptionOfMortalityTableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127c8206a4a849dbbb0fd4ceee30d8aa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">sny:ActuarialAssumptionOfMortalityTableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54a79349271f4e4fb33e85139f76607f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">sny:ActuarialAssumptionOfMortalityTableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaefca5f76804fce8b04f617795c3068_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">sny:ActuarialAssumptionOfMortalityTableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aeea4ef448d4878b040aca58e59cef7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46a2a2a21d77490d9398a698d3aec8c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d7223a21f0b4cee97becbcdd1bb2efc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifda432649e3d4b16b2b65809871ae47a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04bc92eea38a43168f452b170f5b5971_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fcfaf4afb0a4150a2e4eb7dcb4551b3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5920c792a4ae4e7d86f79510124b3f82_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i937300c73128444c840c7f1ad48a02a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e44f785b99b48ba805fc2c0db8dde02_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4ae11f178054227a9f097d1bc819c0f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6201b78a9f6446cdb01a79735208e131_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia26a9a0089c24d36a14fba4dc1693ac2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:EffectOfAssetCeilingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i807618602bfb425397cffdd414a540ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:EffectOfAssetCeilingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5072e9250f7c4f3d89d1b407dd2508a4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:EffectOfAssetCeilingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3092ea35a054f4882eb46f7d877613d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7cf90fb83ae431ca29e7217f1d29cc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74c83face2414740ae5f9026f45db6e2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39d668fce64249f697434c38ca01ade9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i196a10f493ab454b9274ca3eb5246334_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89777d1856946948f3ab287b274b7b3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d7547d361d44bc7bc51287f8d63fa39_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i735c553a649d4710a2f06d4ea8c8f3eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f74e0cfe57246efbeaadd68666dbd3c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9658a2abf9a5478fa9e50db338221664_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i625df457bbfd46169d9a20d074aae8b1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d15ea0bd3b14ac3b41652e59b0e1991_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef5204976824f79a913930fb94f085b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52f9ed0a9cdd406e836a0653d1da4b33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i372ca78f06fe4df388ba26d79d02bc31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c3bd7580bba402387e084f56f6be553_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i385f7ed33c244c8f9865082c29418042_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d9cb083d13740c7ac9847d70e575e46_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd245ab0bb874dd9b68d83d0e2a73768_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i132794e24a974e33a6a21b07c9e18759_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieceadb4bd3734ed687be7e86ad699c73_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied5cdd7108ef4bde8a190a1fdd725e36_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:EquityInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9322df58abf645a38feae4db48a58ebd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:EquityInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a4f3a465b6f42b98396a6e356f30a9e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:EquityInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb517efada3a407d847b0ca69894e99a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:BondsAndSimilarInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e4be19b26a049e1bf1e91bab2e11e5c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:BondsAndSimilarInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39da8a2d60674ff4ae5c11c70259b5e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:BondsAndSimilarInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a41dc31c3e74eedb023bf10eb8a0e7c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i251e98323a6443539777c4746f73c0a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cf3f0fc2b4e4980a5a3b2ffa0064c5f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ff9752dc8ff4ccda97e1df53f25b146_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad8a1b698baa4703b83d370174975b1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i312bbd7a70ac416b96b1efb30fc8419b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15aa7ea7a17149d88f714ad7ee033ef2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CommoditiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecbde7dd3ae84c15a00c868d439658cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CommoditiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ee30b965d34426b8572cbfbe3d99ab5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CommoditiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2bab82be0a94d3385be51baf05b2e8a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a3027be885242dda3901c2d93f03d2f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i208f6ffa4b1f4aef954fb58bed015cee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4072b208f40b416c93f385cd81718d4c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c9573f4723f496886c9527af11cd414_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib77de26cb736428ea323b4bf71486e1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45d69c6b976b4b52b4b221ada5523cf3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:InsurancePoliciesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4202392dc954ef699a4858b3b2f3d28_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:InsurancePoliciesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7625f2a35e3415980a56f594344ef2c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:InsurancePoliciesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78812fafeb0749c2a649f288162412a1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f180432287e48bab7a2788e97c95000_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief62dbe824b9481f89598dded18264cd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic96e413d27b649b6818c4939894846d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i083a34cade7349a9809e1628fbacf89d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia031999e21bb4be09427968a148fae23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1b909a4273c42b5a19aef1f040188d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie22b5bc62d6a4722a5151ce86a8d9c8b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82dd25c00891486492e8fec0de4ec5a3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia75be383078e44f5a715dc5a129e531c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fe5b990d9de45b49b7bf7c02a4be68c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf679ad39d3c42948615b8c3d8c06913_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbdcdcb4253747a694c0b2a3d28a086b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie76d9750fed74c6ab5c5827885cabb66_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i972b0ef516064ace86f839ae7759f600_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fbc3ff0245c49bca7590dacfde5337a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc226cab822a45fa830781a2276243b5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia144a9826d65474fa13a4d6d05757814_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f42213a78854baf93af23eb78fbfbfa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6a2ab1329f9438bb6a95f98aaf0e3f3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73bcd0e9416b405280b71184e77d390e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03a64532928a45bea416e80a24fbb2e0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb0eb02549864f8ea6aea2b8ba55c46d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d19463a7a444bcd984e9d3b9d49979e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4105798cd2d14971b1fec1fe37a7bd83_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib06b988b7e3c4c2e94ff11744b627571_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dbde64047a84c3ca07ea93b5743b0e4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3fae2f714c94f67af54f0be875a5384_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2f17bc572b546a0b59fd7c5297ae445_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47dfa2f710b1453fb0ad595e495e2a09_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9deef6d5e7a4bcfbd422deaf4dc5fa4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09a717365a084772ae035c13b5a5f7f3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22228827eb244f83a0287d5644da5318_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie01edb6a55dd423487fb757d28bf4ea0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2194e5d4a094d0582dcc78661f5b256_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3de22f04eb7e4c70949d28adf82e0abf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie18cdcaf451b4e6a822ac250b33acd0a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf005e09f52c4e098f1b0faabc27a76e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f2fa5376a74486b8e858119d96d0922_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i078b4c1ea24c4f69852b61428b6e2fdb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b5e5589175949ed969ff4a1ccb121bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d087e9dddd44337a0f1832768419409_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec7a123c92024f24b8e10eced658e625_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i475f28cce8a2420887453fd4e83fb711_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab4710282aa04343af3461b3a5005198_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief42aa8c7cfe4ac888627eeabf185c37_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64534b6ebaf2429c9abcfa76a80980aa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8672ddeb9f334dfaa7ff3d1ce467ff9c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ad395b96a2a4d64958e0dd07a82a258_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5afebb992674818a78a7834ac446ae9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb5f9e7c6185477aa7f9a156dc214f20_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i845514465d3444229b0025c52ed9385a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7b1f1d64d014db48f48a68a6832b64a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3a804cc972b46818508faabd25873f4_D20221231-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f39e329592f4ecf907cc503dcb00e16_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76c0ea6a3dee45298522d8ae0b039615_D20201231-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-31</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3ede158a1804cc89e2cbf56a9146440_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief8448635aed42ec8bd010e6d8d33e6f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i733d9f9b2b73442f8f3ee6d411efc319_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i727bd67c94b846ec879e26bf1451a28b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5abb9e9b2d645b687214ebf5e5b917b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4217022461624166b066799e52ed0ae2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0b14f40a60345cfbb888ce3b1583ed8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf14e75b5e984c98bc6e960753b80f31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66df5d0d41d6428d9debc9c4c2f80889_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54ab42bc5dab418284d3709b3f894736_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i836df9a1ca87450a9ed9f75118770f04_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i688e526d505647cca548bad7d372816f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6d8865e8b32416f920b803df1461469_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f7f02d43ee94a4280406be5c3292239_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic901448a78764b3c9b5def1dfdd7fbee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide13b51197a24ee9b4038dac78c62afc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i158f70bc52794d319fedf9a855b45b25_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21e0cbf5e58a47feb6bd62e37f9b2bb2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f92b31b598b40a7b5f13a153bfbadba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46f2414fec014acf824049d7ef8a26af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0593a502ce6b4cd49c8af7a40f39e801_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c31592c4cfa491e9223f6491673f1a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff57e235495f4a5589b5d11d2537313e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i370f9ca08eec4c64933f63c4154c6168_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcc9f8081cf140aba4e01d0be09d50e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb626ed9d7754d599f6dcb43cd6f78a7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:OtherEnvironmentRelatedProvisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f1c485ac1cf4f59b3dec0c221bf9747_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">sny:UncertaintiesOverIncomeTaxTreatmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0067e056654b438e962ebd27feb406c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">sny:UncertaintiesOverIncomeTaxTreatmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if40304953a534c06a43b1715cc0c7ffa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">sny:UncertaintiesOverIncomeTaxTreatmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7182e8a5acb84acb81eb76efa4a859af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:USLegalRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b16a68d75504188ac3d7a2cb2687840_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:USLegalRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a3c0c053efb4732adcd801d2a0a398f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">sny:ActuarialAssumptionOfMortalityTableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab27c8ba011e427586eb8baebc4580ce_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:USLegalRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba446060ed747fd8a37852a575bc1dd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f34920cef9945fd969c11ea4e857b12_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb00596e224b4b3eb3c4df739ff52cc1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fc828012b3e4f69a32944391c782b1f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesOperatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb368c61c98d4f5f804fb045a97d08e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesOperatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeca42fd3faa45ae94e5c1bb85088c87_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesOperatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd45c8db737d4629b5ae31523cf4b669_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesFinancialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9bce47aac6f476b9ddd183a1b48c82a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesFinancialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77add1a06a69418dab94e867b2a86d41_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesFinancialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a3dbc85683e464fa9ae058e17335a6d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01f241b2e7334652930d2a5f3bcae23d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd6f6afab5064092a3ab474b0a93921f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad5d34f9d74d4248b507d41261086914_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:EquityDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3c4833a597b445e8ac99a4bbe634506_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:EquityDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i579725acb4414ac980d9c04bf21d1baa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:EquityDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c02fd8df4a441dcb9995176d3a629bf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72c3586a9fd0496ba3bc0f02039968e7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c9d5d1deb134833b4e2036bf3f18d5a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10922d814e24467cb216f9da5b9d4241_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie786e671f2514434bb2cc23e067013a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id08df1158473419092d42e5efbd09182_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3077a750c45649c4b6777546b6550f85_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i670bfd8fbb1f496cb197f8a8d7aead50_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib47972465c6744dbb2af277f58822cc3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1515e825367145dab2111f5b97ac20ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9a877b2db5f4ef5a898f9ab4cd8c3bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f0d14b4b851424096254509ca5ce614_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0b930fe86134a789ba869c99ac6922a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53b2dc71058f462a964f7f92010a94f8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6369626ceda6440e9ae77971eb0af8ce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31b628cae9e04ffc99774dc92b5b02b7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ed9108e10a7437da4ce7e1145d235d2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i844c3e2c764c42c38c639fff0e73a5d9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616809455ece420c96191218acbd4402_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2600795f42b14e488938c37089a03fdc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72fe87984bc64e35af0fdf8b4f5b3af7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i023e473680f74d54a9e6f6b0424ff693_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d190f1e3f654825a7689ee2a7e9ed59_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ea0c8b9510b4cdd91fa96778338156d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd085483ffc4410e9d0c190b8c42df88_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i386b0ada740d403b80ec57b202d9925f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e328aedd84b49a29a910cbaa90fbe33_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4781504261424f1e922ae06f843e805b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34e173a6429643fbb1fc2fe0c4485b3e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic08ec36e888244fc9d534271f013c502_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id22287e14b1647b7b35da64ef2a0bcd0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i554177ec4f184e20b73e2d228590a9f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bbeb6793ff24719922e66a138d80cb6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f8fdd2d956b482b956d8f11d789446d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i490e720986f8468298889ed58d2712f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i736a15874177466a8cdf1da7d0053f24_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a7f408bac704d3190ff4e36dacdffd1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ff96e7abe6440fa939c031c8fda0ea9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i833ebae90f784a20b1d78388fc99a799_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55b54f75fd784f738ba0c199ae6088a1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc588cc6b9f54f1d963f8d24ad61d2ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i255506009ec44c939308e99a6b52e9f1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d7af22b9f714cb2ac911c16230f1007_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id027bcc05cc942509383921729fab6a8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i876113a89cb44346a3da543cb98fe7ae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34bc3f2e19ed40ab8850869c31eaaf6c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e0dfe2b1623470f91db3c18ce68dcc4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ba2fcfafbe54bd7bf7de2bb6f55eaba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22da51d7b0254bd880ea050847a615f1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf9617caf734e5585971e11ab4b6606_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35ea3b55ed754a60a864ed8442dc2c4e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8566044ec104b54875bbc56afc2d6c6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia61ae8b4b03e49bba08e79f0b7a8f8c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c24dfa0a78b4e9d9bc86d6f52203580_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i548e00dab5dc4ee7bdbfe1756bcb7839_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0c5b59aa68d49298a45a2a610f5c5e0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9668fa019664db492a7ff6c75a6318d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97148636de194a33893bec4aee4aa41c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecc031691818425087e6d05be7c7c9bf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieff7a0389c9140eb879d380758dff38a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d0dcd53f94b45319eafd4558d70f360_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a186c3f32f5484f8ac45bfb18dc2330_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ea8e0414ea34508ab58fd08342971ae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee6addbe47a440138b52bf3611a17ceb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb5f65eb694a459d87948dc73311f144_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icab460a6e7e941308427a83c3d253601_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e4cadaf5b0845cba7f9cde445b6c92a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i900cd87f4c904d21a069da0f48a921a7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e3485983e3542ef8b9c5940a6e4d2cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bd90408fdb848f4a168d4d2dcbc0549_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i614be5021c604d959a144279ba0b4526_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bae6aad36b1448fa535c41175f48601_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7276b76a402b473f9e7c127ecbf662be_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93c37d30370944a2826ff37e9d34e8a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i589c2dbf17b348879dc721a9525fc177_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50449c405d664c4dbd84b341ea3b257a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ab17fcfc4d84fa99bdf75244c2ebf9a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad4ce0de849d4cbab8c710e2aed2c4b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d052a4d832444a98b95347523810eae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf8f1eeaa8714aa7be4e39be402dcc41_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cfdfea2209d4ccbbc523a777b090e42_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90a937537aa44ba09a3f7643066da725_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48b4da387756465aa5c44aacdc958949_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38fc2554622a4d10a204d1c010febc3f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48e2f84695a246b1b0d8229ae8e26267_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i922eeb9c64b04920a294d8178d09fe8b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73a34cffa66544deb36e7732558b3762_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97c8f085dafb45a2992095d4c7dae629_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i682f1cd2c61447218a7903da70602a00_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16bad98d4d934e91a14f1d7988740778_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideb5cf2c7c144e379dcc2ea51539478a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee1024eeb9314f339e519f511c666ea0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a170b12241f484083d21f6e5794807e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f9c05daae0d40f886aa6ba7000ba3ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64087778cca74bc4a526a10b569636b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20618940d10145199825568865ca8d66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i854bab973a0144a9aea65d7db2440733_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffcabbbf635b4fd992b8a41b9510b915_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f2ea65d6c9a47f6814f3d31cd2df80c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a1f01f9052d425aa69dcfe3b06dc17c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i183f0ed5ed164cb5b4ea5ee09dc73278_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf0eceeae6d4eeebbc0e8defaee5b65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2fe78b5e0fa46828e0f0ab6e8f5bd07_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dc453015c43417f8a310403dafbf8fe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07769fdb0fe34d908e96c647c0db6d12_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if36d1070ee9d4489a4cade29dd0771b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i384079b1f8bd40cca5b521eecc67173d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7d3fc2dde0f4fc1bd61c1025d30ee5a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e1a8164b01f454a9ef85a1f93c00105_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35ccacb194c94c69b5d085bc5ff5e589_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4fc30d0563c4651b04f28750beea307_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc51c3a8b7fc41a092d0d1730df7f963_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7a90a0ef0ed4c3b8eb42178924b637d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i471fcc10e8564dd98a67fb349fdc3a8e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18559c6c0cb3430ca0132b84801f9e99_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac26642cffbd4b2999baeeb3a1685db5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib23b2da676d5492e802ac4c812a506f2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5da383083c0c4afda0ee7c969ad8b27f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dada3962cd44c1da2ef4a630f6b1ed1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i434e5e043aa94881a6a3e2eedff9adc9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if34f2b53c7d045a18844b31f4a900e41_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i894a76d0d7de48e58253294db3627dac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9c39b6d14e84ae4b1b24e007a9e3786_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc12122f258749a5bd2e6732f1d304f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida1a51f00f9f43e2addea3cff1a8fe07_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5281a2a2dd074a66a4481d353042fc10_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i930fc256127049c79f51ecf59663a752_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="twd"><xbrli:measure>iso4217:TWD</xbrli:measure></xbrli:unit><xbrli:context id="id5f5c206bbe041ae839e26cfe2a55dd9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i837cfe78d2b645d98705c95b25994752_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ab3ed6ee531495f95aea44cf44b1526_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e0e7ef8f62a445ab7615b93e8c6e5b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ebf4555124a4b54be1588e86a3da403_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i193a8989856645a48abe7f92509a5f9e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic80c137f25e045a9822774580063fe84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia18a712428304812b70e53d9693ee063_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7109eb1c65b04a438909883fca4c7d28_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5f09375512f4606be23527c48462237_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2cbb135c3a0433ca0c3b69c5501968f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a0830338f724cbdb4b9b9bfd6adeda3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia56a7d86f76a4d05b6d08eae7ee6f6bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if71d9bd7d43e496e93db1925af2e1b60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2a16b777ba940a4ac181e8a001d2faf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4903495579f44e64ac57f0cc1e2d7ad9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2c01ed8a41d4db787af4ee204db1fdc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec6eb2436d6e40a0a872d2bbf400d795_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8106356ac1984ab9be68b54b74eb94cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica7586eadbbc44c880e8d163aad962c9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i044093d165864adcae409f5f0044ffbf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51dd419d2cd9485bae987d880a7bcdf0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5324129041d4c7a8cffd51b410c8dff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i302a876c87b44ee3a7af953022d71a40_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3825d70a3a964b628a2d61ffeb07d222_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10d98c3b5e3140ec951a12de228261fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibacaf6d36f6a46e6b159f5aa7231b80f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36c63ba9c19349b1b82e245f1b2c64d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0abd8e7f1e841f7ada74773a2015b61_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1c9d16b1d5543db83b717cb805a3054_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie53d539627af4726a35780f1cc08e507_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id73c46ce75c74139a8bcba359c49f997_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i456a2daa913c419c8e6c1a03257e474e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbca91ac9abf4c87a69b47abbd03d727_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e4f8aee86404215976b9646e9d9edb6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9d14b72ec254084ba3095230da92d21_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f99799f7a8d4e2d84ecd1fff82653b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd3753fbe0a74c589d523cfd5c6b89fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i054783a0dd0a4f84aa2d451d39159d7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icad712c978144c3084e0faa45a0c85ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b8b8a03c8b14a00b47b0e84291b29d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9928943949d54771ad5e72bd36d1e3ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6586fee6173645e78e13348b13791844_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i545bd8a737bf4fb3af3076a7c330b2c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i602ce8f41d414b48b5a84661a31d706c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i027058e0a496449eaf197cdfafc45b2c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34b226c1622a45528a50ce7d8f2d8fb5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73141eca736d4bc5afd3a96cdac8bbef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56bcc4da86dc4c3e9d1f700ddb1fbd10_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6fbda346e6a493cb16800f488f83cc2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6ea9e1f7b784baea9d9e983ef781098_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0872c944abfa45428950a1bd06308fb9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if75a6d9165a94a1cbf4f47aa2183cdaa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6b4d5b53fda43ea851ebdc43262033d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95d0c7bc51184d8e8639aa78338ad663_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c5ef4bfd1f14291bfa73144e9052516_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i486d9cec4cb24d9da261820e6f2216cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib51cb586079a4e04bbd72dcec69da0bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5697cb7cf4d04dfc8add48c1c94cbbaa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34aa0682772c44b4a0ff76dc79d28958_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a8cb6cb5af547b28dce285b9c653502_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e76f8051bde43d3a56dc6270370a1b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i147b071b30a142d6810201f12247d61b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f071c0f18bd445eacee2517362cdc08_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i181e7ef5bdff4cf6876e51eea6ca820c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf14d2129bc34c2bb2bdb6c97085b4d8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3db42c94517e4705b4da1eed3d57e340_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i252c5890b2344a738c0f89c1f5f5c87a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4346d9e3152d432bb116ca1410c35048_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a69b4b219ce4e26a3a79c96b68b5c95_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id227c1ffc144495b9c6a929875311feb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2257aad4e93045328f47a96258ab2005_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4037de80178a4bd687c7efac29bc15d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4f7f8938c7042c39938f0852b1bca3a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89025c2ce61749fe87850d73eded6ec2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9be9642933af42f8b0cd6d23298b5018_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ae1d237af784d4f8fa137d708f60517_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ffbb59d6cc44d84854b689b538ed0ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae1a4d3dba24ffba6d892dbaa92e78a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d0474adac6b45b1a78fc524e09f71de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc5ec7415a4f46fd80b575baa7648a15_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief09a86e6cd4415eb08a6914a33e295b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4ccb84c532546b9b5869e4d9f81c989_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7b4d7c8c509402c8eca5e791875f3c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3431bfe1daa41098f327267164dd835_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9e5de3ab1f64c9ab3bdcb2c553d1039_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27152c3f2bae46278e43f8d1a81dd8f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i840dda0508654caba7f51026ebdafdd4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d0481cacd274b2fa681c5bf9890a2b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3906596ab71d4692bfd9c38d60ea6188_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58183268ba544f91b20e9bc30b6797b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f96ec8ab49a456fb96eb444552e80b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia344078238f4464196932e8c0a5ab334_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68cf8057519245799cdf12687b2a6f93_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37726d73b17249feaa902d38b48653b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c91d2ed118d4954bc375ef4b66d5e48_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e1cdda7b2be454db539353df19db57c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc3cb9493e1444f82f06a80cb7a29d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf56910613674139b60ad8c9e882447b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7a02300cd2f47f99a98237e0dd5a58f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07e6a5b18f544c01aaa9836f457f7bd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1195cba0e9c94a3699b59f45259287a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dda0ea5c90b4325865f424eeb8327d3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8e6703b549e47efa32fac9619c9ae51_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bdf7cf5cfbc4d09bc7c7ce7da7a3262_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0415e276f844457af7bd49394e36866_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99eef181a9e24ffc834f4feda4476a7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c698af52bd241a89b377b3e2aa21704_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba0b876a446f49b586a44a97e9d18648_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iace2c7895f8f48599dab84606e9dce17_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5e4d74fde564a0c9ea5bbbc53197031_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7921f1ac6904419daeff3fe087f5224d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88dee4ccc2704017b2c902c331437292_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d6d099311ed413981c361852e147d39_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47fd53236cf54f4f82c3f29a86f18f6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d03c5a45fb74275ad0ddab937a7a0c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03f818d2869744ecb3692c1dfa0777b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87c7d8e2747146e2801b216c717facb7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib05e9a15a2a54bceb63e80175a9eb481_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2acba41953a4a5780da364938d0473f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82128cfb81e44472a2b78b3caf2eeef5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7e05b379fae4bec9455bd5a1185a73b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f9e8576bdae4d2f82d0d3347ee01107_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i050b28520fab4a6f9bc88d51dfbef06a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ab71783130b4442bcae86e594469499_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15ed755082ec489cb3e55190fe799c9e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cb3114c2cfc4748bb24e171ddf88d3f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3fce9cf02c444aeaedf9dbb530518b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib880c2e4796e464d9fd6ca3f922f0c21_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dc8281e891142dc8ce362dd453c8adb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6854f04e5b34f0a90f6a8809433364b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide85e2c1b3c54f9b982f9dbd2e31dc36_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c053f5646db456cb456a7f6cab34418_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i256e776c3ef949d8a602d77944076c95_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i669dc41a3e9d430285a05154e6987cfe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f760561a25c455ca863173bc85ba050_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f736a955d6d426fa14bccb7f20423fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27e3afc8cd9a466b85b73154f1fcc426_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8b931a3e7974af8baab435cd83f842c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6ee14014d724beba49280ee27bd0579_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i079d026d077e4c1ca6b37005c231329a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bf8f4e0a00a442d95a5b6f57d0965db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dbfe93bcc924f1db627a13c4e7d0036_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5129bf60276249ea8a7084e5aa6f5c82_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98b58c7d8626470da2fc804347bb6886_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2960e5bbc9504987a45ca0885c28f42e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bbbfeca962641258e5e78ffca35be1c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2efe7553ba0c46a08b7712adb8057d20_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ea8eeea954c47c9a00eb5c671577819_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id972eac7d0f34a4a884e97419ab42e7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if037f28f69f94e49ae8653fe85139f4f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1df7d3e3f334428885ea11342334450_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a8231394bbe4689b1cbffe0f2e8bd63_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ca8b2205d5e44f28738ffac6b5a6556_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i004c9565807d44089939621542e2100f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica05527dd8e340a49bb52e01b20aa348_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6009351116f4a2c9676eee17f694438_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i861fbccf765e48598186ff8685f2297a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic28b8006d92e44a99432611f84570817_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eaa77b9d15142e09240ccba86255414_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64c5dbb2401d4d34a576efb6df99ddf8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ecb8839526441e789fcc73987406208_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94437cc84d09476a840a8eb6ec207dae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic79ef551074942af9ecbdc5716db6ce2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb40125de23e47f4b691beb3f8caaf8a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic710cde7f07241878fb45bc80807b33e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie43506936ad84ce5a6554679ac752b3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09d9373e22c04796932fe109e2e7e74a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5ccc85c23444dce9bae65bbd26a864a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e84a1e2fa8d414cab3bdca6d9e37a42_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85aaa6f19d1c4e41892f9efb28e339cb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55b98a7738694729859cf1f701a3036c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cfed40ed16b475a994112d539fb98df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e141872c7da4fd0a0923c8056541885_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id35af5750eb94d1194ede73371ab7443_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i227270b1fc19499f93797d6f9434612c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie029e1cca2a447a4a3a3fab3f837ab58_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4f729e37a504044b70b5df154cba02c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e5347dec1084a829aea7d78ec58effa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44dc35f3195448b4a394aa1a99ee422d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied6aa1c882654c8f9b00c1a4695ec3e0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic171ffaf34c443418e622acadcc523a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbad1a772c8243ff9be90c4d20a4e525_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0ec4b8e46114ca2b35eaca06a75d8c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6f16cedceff4ae3b093541f0395f25f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if49ca5a45afd4b6290deff09c0f6bc9b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencySwapsInUSDToEURMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06dc5a5dfd664b289378fb47e3556afb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencySwapsInUSDToEURMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i661e3141aef34374bc5a4c2b0282a005_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sgd"><xbrli:measure>iso4217:SGD</xbrli:measure></xbrli:unit><xbrli:context id="i11d47edbce414914a613eb9ba3ddd387_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15aff7b3369844169fb17236f6500876_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18a2fd58cbc9469c87f4b9177e7354bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i895f035f5ef54ff6a621aa415748dd18_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i069619337dbc4ccc847e26e6b2556b7c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i893adc22890b4055af537741a376b6f4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a837a3f9b545248b617c5023b8eca8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if03b358d41cb407d8e96408c4edd4151_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee9d3e0b60fa489ba2e1a59ccd300754_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb30bf0b28ef4c6eb5494ffbe2ef90b3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5ac4648736544d5be682b0545f039b8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b24d6ead4f44d549106fd85b92a18ba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67dfb600319c4c0e8957725369f434bf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9cb8f93e1b846d58430281df87402c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0486b9ddaf8740c29301347caa547205_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i436fb0a145f24198b631657a4b307c84_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0cea86ea6bc459e9837c24b4130bdd6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44734cb0c2064272a0ad777ee49ce42c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0622cdaa9da64461a96fb0292ec0eea0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34c19e263a4b4b1081b0aff21bbca864_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i426ef0ef517c427a8af20107114ef8ca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i191f61c5f38f4bf69380a073349229ea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8474639b23494b81bb367f15d980ea45_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5d1a7773b0f41d5865caf10d0769e53_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8899ba6d4f7742d8bef35ffd6e411f61_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i487c7bae36874cfa83dd6d27aeaaf611_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c78a322e0c7481982834bec3a307bfd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bef3049f3174f4daeeb2b280ca9d62a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i968d0b61e3c442b8a646491f66efac4e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9adf3d9fad074a0c935d684bd36535ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i271929f8b0414f61a36fcd512a84ce24_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b3b4a9f07684b9fad388a8d3257b3a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7006a90210804b1eba413146a647967f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aa5a36243114d7492f0b3b84690ce01_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i784bdfbab14c473da1d2cac7e203f118_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia97eb1a29ddb48e3ac11be4d8af016e5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i480a5ccfaf0a4d619969b512824c1c9e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3446baf8e2ff432d9469238fb5dc3fb8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e35d2d09ed94351a8a81acaa3338261_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc8c65ed2128473a8828f847b40cab4e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60f42132b5024da096b34e23a312678e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89aae2d2b1504df39f88a1146257c96d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ebe9e98e9c944fa9ac489f3e3801729_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c18a7ae7ef14a598a9312096c25ded0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fef17ad4b784d198f1d2c810f5555ca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6852770d10664fa7aa7420995a79c7df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b22da99f8e242f988414e346bbea953_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24369237e6074efaa812824f17d04b81_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8911505211274ebb8c960de64bb8c7f8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i415ddbc400be4e558c1b1cb09d9eae83_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib13971669f0845ea9bb525a15a7c1309_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i406525a21a61478ea46cc93649d471dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if93b383d587447b1baa059cdf91afb22_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bcbc6f1c89a4aee8b4962d00160fb87_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bb05a8539e2427eadb812e81fdc182b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c645944814e426cb0a58e0b62656c9a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id99d44b83ffb41fbb20bd144d592090a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6978d30ff20b420296da0d92dac7a1e2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5762f0e8002b4b5abe902947c5d662e6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic26bcbc2c757485d8d5a38c334f0d541_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i689b9e821d364e81a6228480dd2479ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i252e89fda19345c083603752e6118f19_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib17a33966126400e9c099f5178ff7db3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c2f529934674b7699d9daf02407ed9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bda9484385f4811a6cb4397402bad3c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aea5e7d1f14480c9b4c2b380e13a8ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e1181b5e1f94eb0afab79e5ead12d84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8da9f53c8b5e4025909bce39297919f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9237a2fe49694802969f89c436b00934_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d5f45eab86f43429c18bcd68ccecdec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae24cf8f5b9643f9ba49fa85b263ed29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1cf833a38674b19a98ce0b07e1f2fbb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i892f75e2092f4191a9eb1d67b804e93d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81056da6811b49d2aeff4320c2d985f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i231c93471cd24cd9a8425c657a55b8d0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a751e5dfe154e47bebcd411a4556b5f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ed3a0382bac4c6dbb4f81fb8b4510c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bf5b26909214f5c88e018a134323460_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2dd4c1e5ce840daaa3939c67f591aaf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d113eb1ff7649b097238d0d21ee6615_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07fca8f6f83a40b588dc84ee11762d60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia99138c4d7234b91b3fea8b6e94fa8c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60b7bade7cce4c9b8fd2a07220556816_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65eb896f1a3d432eae2f406e8163f8a6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i842ef60079fb4a788eb441c59eb01957_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d02dedf5e2f40de9a94dc76b5057ee4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f0e19dd29ee4a76a46262c50b166cf6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41c13ab9329b48849e3517bc4d5a7a56_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a6c75ffdef646cb8b9bc85acee5c836_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e04aa67c1b64442af65cb51690fb931_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0628e92d1cdb49db881f08e4556161e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bd23edce11d47f08572dcd6cef1c475_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1160917297df4a258637aeea6cbc8408_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i513d59d537cf409284ea93c1d7ee3074_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0be4069af744d4ebb72262d1c49c6c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7406e8367d044ac6a93b02c7fd8d0d7f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3406477180b408291805ed68b070663_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb7e6bf403b141899b31d01fc7aad5cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia21c8f6607e84aeba3d97b89e5ac81a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i344ad243d07147ce8a36b8ded9882056_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02be206b72714d4db901c0a669d074ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3670c40f29fa41288dc623d89f7afdda_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6287e5395dae4c4ab46cabbec24ae24c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9542809101c47f08405adbf19df6a9d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba70f10f62eb4b97a7aa7d41726b6a9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ff7d79feeaa43ff8fea8ebcd34aaf25_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29f59bc216884949bafcb1d15976757a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2c068ebbb0a4c8c9fe94deb9daad677_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef5d40bf8ab462bbc8e1f854f2fc952_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaadc8f4f98bd4e31ba053344ae90a5a2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida69b1ffd6a1453b8602532bc630b384_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia316589e705d4589bf786b0a1fa58345_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83bd333ecc5a45689ebc96365daf83a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14841d0962de4dcd830a6e6ec232552e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0959357ae6d442db6998d16a60afb3b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if90289f503234a0eb212cd627281795b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0b2b67ce2434e4c9bb4553d177ba27d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i696be015b6144d53970810bcddd34f8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf406a436f8543afa2b07724b0e77498_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c3d82ed507848a7bee6b5dcfc4b9add_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fa0165dae10416f9360d8ef68751988_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3005470a09144e07b9520bf27a0e096c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3448b7dc78d4dcba65212215c69d18e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccff00d7889c450492a7d84bcb6cd980_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i089150e0dfc24a74b7f19849daad27ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7500ac1bc0c9434c9d072c80aa083d52_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63d81c82ce534a6cbe657f9d4db19639_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75edfd05889740488fd52f90caf59de4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0da07b9b35de4e45b2743100b13eaa31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cf262c93d024154b2d0d308743e547d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib80b97abcc214e64a591648c1c81e225_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30c163ec956f41df837a5eca1f6f6b37_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i799cd607a2c24cbf8ce1dd45a6e411e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib09d73f6dafe467f9a1acd771011bef5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23f76b64e1e34fc6961e70aa8b9920f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia03794f3843a4cf3aca9226c900a741a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie16c564bf48f4da9a2d1edd6359a8bd6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i704b08a911a149928d59f0fe5f3da5dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84049923ad77487f9fa811c3372a7764_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c40cd1979af4ea2be50a3ad38051006_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1646cc36612494a895c40df0cbfdcd5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47848bc2a7334009b78e12456fc26c7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaa88d67818d446c976af2e5fbbe22d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic631820a8c0641ac9e9f460890aaec85_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53cfa96ea5124d07b04df526798c7f66_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i513c01d3044b4f8abd4b146fe577810d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fa3a9c279d04c76a24fbd4bca5acf08_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b48e75f4c634efc8eb26e95ef3cc591_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i063b1dc5829c4e8cb5617293416976a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5add9211f40f403aaf54c1ee281839d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieec97775a7de49ffb1a9c4cf02b086de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10ed642e6d39458d841e67fd6d9e99cf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebbcbd554d974218a72b9914fce1e919_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9a04df3d2ef496d98b3c993e83e59f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcac06c155c046cb8bab14fc84e911ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2c043c8ca5b4070a8a9a79320cf0244_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7974fd34e2524ff8b37923a5ebcf26a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9039d5a648d44eb6a6285e7a8f3ed6f5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5623b04048b44838b80378f94f84c892_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6c8f8b2dc504670a6689c9e6cb5a9c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib968055f931a4052831d81f2d009e0dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b23561502b7467e8dedcaa04bf23cac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbd6d8c2ec6646ddab12eb846faa1e2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11fe8f6851654698a4c3c1314f4cdb7e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74afaf7dd9d34e35b425f2ad9ab6c04c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30a27053b6e14def8c033d7349e920eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie69dcce667cd4fea93c09d624bf405e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc9a867ba32c4f5188edd4f852728ef7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if11a192ecef44797abf4e8a5c1ee30a1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i952a1cded8a74815937ca15f2edabb80_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88a1b5f415cf464e89d9ca13ca302777_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1467f4d4b42140c2abf929b4d833c3fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e4f05d47add459ab8040ffae65ac2ba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie62d1f5008e247f0a3ea8b6ca9f80dbb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i708d051a58c54e20b95d3176a3c77084_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b68e46221cb423b913a0db767409942_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b9836c97a3149258a9dcf5b0cd2ffc0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i799d40fa5c78466998a48db7ad50c332_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68a6cd0be59b4416bebc0edff829e3cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6efc8e80c8341db96a4ea42fb92ea80_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e72356c5a114d11bd9759a87e0029e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd430971a28b4ea0b9e3b9a41d1c2ec7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d96c431df54470d96145e5b8c4a4e5d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f30a6b3626548d68f342ca8d454fe33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i874556ffc208487cae49386049753a72_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2bb50c6933e41bfb10adb4d6e458270_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8387da968c3a4fec95af79eb735152fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8ed54d04df74d759a8be7cbf83b103a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i273afa0ec4ce4433806daee6d20d5529_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f6050765a2747e59fe7bf091298355d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7964ee5305d44c3802adf3c53126d12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1076d751ef0a41919289d3a7fd81eb08_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i631031048a414305b2d327250a95741d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i237b42e7bb904d21a79f9880001b2ae2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba962d9e6d694d2b8779612e3b767372_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i155d49744d8747b49c962b6edeeeb4e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied2d4b521a314246803eecd8ae01786c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3db7e4575054274b9fb7995816583e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icad7c8faf49747ac89ffe01efbd20b55_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib697f784925f45fb87aef20924b4c88b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21c5524f40ae4628ac06cf82feac300d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if160fc4f51bb485d81d5f05461afea9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32163ab576b64e3a95bbb62ebcbdb9cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia952b3d7417849c8ab7c1fd9d194c90e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d8db00ca8a8449db76cc5c3d45ca76d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifee9283d0d0f4705bf8cdb52374c5add_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:SuppliersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida98673a0c314cbbb23bda8debf1c3a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aecb43ad25f41bf8dc1c5d72a0787bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AblynxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34de2d5f0d404fe8b61b41f862084aa5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AblynxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1db7d23934de4ddd846d982ab6ddd48e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KymabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51d7f3d541c8470e916d2b51d66890f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KymabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a347be5f1b14fadbc39a77db3c13573_I20220107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ExscientiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="molecule"><xbrli:measure>sny:molecule</xbrli:measure></xbrli:unit><xbrli:context id="i2ee3b5635d9a4570b0eaa9262220df54_D20220111-20220111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ABLBioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-11</xbrli:startDate><xbrli:endDate>2022-01-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia237d1ef26b2453a9066a2c6db45411a_I20220111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ABLBioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bf703c7b65f49509efae3ab1093a037_D20220302-20220302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:AdageneIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-02</xbrli:startDate><xbrli:endDate>2022-03-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8577ba8bcc2641bd8f3f948974bf77da_I20220302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:AdageneIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e5b18318ed54f3eb42bb7d6fc7b7b2f_D20220315-20220315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:BlackstoneLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-15</xbrli:startDate><xbrli:endDate>2022-03-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee6d0db9a6b14019a9f01106b4265553_I20220329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:IGMBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="target"><xbrli:measure>sny:target</xbrli:measure></xbrli:unit><xbrli:context id="i44fe2a71b5884068beea16755e096330_D20220705-20220705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:SkyhawkTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-05</xbrli:startDate><xbrli:endDate>2022-07-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabdcdf0ea9e54926bd844b49811591f2_I20220705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:SkyhawkTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4412024b1ca64ec595944d1b8a39c157_D20220817-20220817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:AtomwiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-17</xbrli:startDate><xbrli:endDate>2022-08-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefe35c5798714318b57d812dd4c261dc_I20220817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:AtomwiseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ce31d589886460a8d3fa4ad454d29e9_D20220927-20220927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ScribeTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-27</xbrli:startDate><xbrli:endDate>2022-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e57da6edcd64cc0855f5deeb43a3a3e_I20220927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ScribeTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3acc15b07f7340ec878d66dfd3f468d7_D20221004-20221004"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:MiReculeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-04</xbrli:startDate><xbrli:endDate>2022-10-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28364fce90bf409d98323009a8de319e_I20221004"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:MiReculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69e8fa7b0e3e42d4a5776c81a67f605c_D20221108-20221108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:InsilicoMedicineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-08</xbrli:startDate><xbrli:endDate>2022-11-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i627c20e57c964355b8bcb250eb638da3_I20221108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:InsilicoMedicineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i466e422ce31947d2b1f05591f8974461_D20221219-20221219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:InnatePharmaSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-19</xbrli:startDate><xbrli:endDate>2022-12-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b248f6ef872486e91c5718d675cc163_I20221219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:InnatePharmaSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if937d6453c6841d8b3e41feedb2e553c_D20160101-20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:DiceMoleculesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia86bd221eba9446a8f9f749cb46b9a8a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf593c1decbc4ca188f74599b1b99ff6_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ecee33decbb47918bc45c5d39b6e2d8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if08a539d4d40455d827bc164ddb96d57_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib16cb21631ad4c40a1073da4e54006b2_I20170227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:LonzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9a55e06161b4bc6ab47f39f7831c794_D20170227-20170227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:LonzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-27</xbrli:startDate><xbrli:endDate>2017-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if77c8aea29ef447792cb9de0a457cec9_D20170227-20170227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-27</xbrli:startDate><xbrli:endDate>2017-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7297bd667dcc407e9d3a685feb63aa85_I20140228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:WorldHealthOrganizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf03bba2a0f04d1188d25f148f36a72d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesGivenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i939fa095546f44a393ce805aaaade10d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesGivenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d70051b63048b482c6e8dc47988e25_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesGivenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1de0a6f85434a9b9e97775863357700_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1b027a016e14cfe88b71b1c3fb15eca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bc3ba5245904e0a90bb4d29a9cc145e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0d813bb627146f2ad3035a585e98181_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:OtherGuaranteesGivenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i044e8ccf5872470daae5e14174d0c4c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:OtherGuaranteesGivenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieeeb99efde1d442fa44fecb8bdbed1f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:OtherGuaranteesGivenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ee6a60b930541f79b2560c7e63bdae3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesReceivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i214032b872604476b3988af269c27156_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesReceivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a28592851c14211acba46221b993eb6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesReceivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2d901acae514e5e8280c783c251f450_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:SanofiPasteurHepatitisBVaccineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>sny:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="ide8e1ec806db4932b7eba982cc52419e_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:TaxotereProductLitigationInTheUSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plaintiff"><xbrli:measure>sny:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="i9812f0f2ab434fd5b26f297a36264169_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:TaxotereProductLitigationInTheUSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="trial"><xbrli:measure>sny:trial</xbrli:measure></xbrli:unit><xbrli:context id="i3c1b80392c24483ea3270088e8c3d341_D20181001-20181031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:TaxotereMississippiAttorneyGeneralLitigationInTheUSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id03ce38671d242c5b423a1d25f8c6f7e_I20221206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>sny:case</xbrli:measure></xbrli:unit><xbrli:unit id="cancer"><xbrli:measure>sny:cancer</xbrli:measure></xbrli:unit><xbrli:context id="iacdab6e288ea48229984fd6fdc5f672d_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:ZantacLitigationInTheUSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="complaint"><xbrli:measure>sny:complaint</xbrli:measure></xbrli:unit><xbrli:context id="ife35047b3efb48d49565a8abefe87bdd_D20190101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:ZantacLitigationInCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="action"><xbrli:measure>sny:action</xbrli:measure></xbrli:unit><xbrli:context id="i69ade77d4014436cb24fe9c6b800b42c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>sny:claim</xbrli:measure></xbrli:unit><xbrli:unit id="person"><xbrli:measure>sny:person</xbrli:measure></xbrli:unit><xbrli:context id="ifd9713c0f3b84a2087189ac6adf31e26_I20220820"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="ruling"><xbrli:measure>sny:ruling</xbrli:measure></xbrli:unit><xbrli:context id="id0a6ca82125c4345addbd9134859f4dc_I20220512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a57a25d53544b7bbc8e58ad797964d3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a12953bef7249c18a068db579937b2f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff1b7c5dd354bbca260343d8976c984_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8fbf1dee4e248d398715fa56ef2544a_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="family"><xbrli:measure>sny:family</xbrli:measure></xbrli:unit><xbrli:context id="iea2e083a765b4ce7902705ed5cd966e7_D20220901-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="expert"><xbrli:measure>sny:expert</xbrli:measure></xbrli:unit><xbrli:context id="i5b0489fbbf76442ab038901380310b9f_D20221001-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="medical_assessment"><xbrli:measure>sny:medical_assessment</xbrli:measure></xbrli:unit><xbrli:context id="i82f5b65dd97e478faf4feebb1a461d65_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="proceeding"><xbrli:measure>sny:proceeding</xbrli:measure></xbrli:unit><xbrli:context id="i38c648e7e3d449e7a4ef085d255a725f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInSwitzerlandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5914be30840a424e9ba15aac06bfd84a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInSpainMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="children"><xbrli:measure>sny:children</xbrli:measure></xbrli:unit><xbrli:context id="ie3099953088a4d92b74521a460c6296a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInBelgiumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d1a1e91d76a423db829d84274c18752_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInGermanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31d63c85f8e441c7807a6e955b15559f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInIrelandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc705712fa1947ae879577c168f3f666_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInGreatBritainMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd45fd1ec3c449df97cba0f45eef2ae9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInNorthernIrelandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia799047f91fb498c88944dff7dc04fd0_D20180101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DengvaxiaProductLitigationInThePhilippinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f6eba28b15e4c47a8864e9a6806f73c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:RamiprilCanadaPatentLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="manufacturer"><xbrli:measure>sny:manufacturer</xbrli:measure></xbrli:unit><xbrli:context id="iad588bc5db4440fa968e52c2f65ca474_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d714fe0593a4f539299e40038a0ff5d_I20141118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-11-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>sny:patent</xbrli:measure></xbrli:unit><xbrli:context id="i7b37c3673570484dbdc61b7e2c0bf6bd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:JevtanaRelatedPatentLitigationInTheUSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1591035a52b44bfb8ab033baa46f80a7_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:JevtanaRelatedPatentLitigationInTheUSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53507d8a67164c8eb8d2fec1ab5c2dca_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:JevtanaRelatedPatentLitigationInTheUSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="decision"><xbrli:measure>sny:decision</xbrli:measure></xbrli:unit><xbrli:context id="i9e06dd78a2cc45e8b38a451ebfd53f19_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:JevtanaRelatedPatentLitigationInTheUSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a496f537a8d429ba5d2f470f546b3d4_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:JevtanaRelatedPatentLitigationInTheUSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:CommencementOfMajorLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91c653975b734c3bbbb90a324b0a9e43_I20130430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixLitigationCommonwealthInAustraliaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="aud"><xbrli:measure>iso4217:AUD</xbrli:measure></xbrli:unit><xbrli:context id="idc6e5447243c412aa0be53b3fe522c2b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixLitigationCommonwealthInAustraliaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fa9734152fe42adafe9a6457b51a172_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixLitigationCommonwealthInAustraliaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94f85a2e1aab46aab17b13a49d52aa0e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixLitigationCommonwealthInAustraliaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9db8ac12dc644388e59ef5e31d39357_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixAttorneyGeneralActionInHawaiiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9903703ab204fe0a894254df0aaa506_D20130514-20130514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixRelatedLitigationInFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-14</xbrli:startDate><xbrli:endDate>2013-05-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5016791206545f1a8de98c53126c448_D20170901-20170930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixRelatedLitigationInFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-09-01</xbrli:startDate><xbrli:endDate>2017-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if95f17244f744589bad8e963d5814997_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:A340BDrugPricingProgramInTheUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3575a00a4d2941dbb8f4491a3d7966d1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:AventisCropScienceRetainedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ContingenciesArisingFromCertainBusinessDivestituresMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14c2910d62e54d579f8a84cb7af92bab_I19971231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:InfraservHoechstRetainedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ContingenciesArisingFromCertainBusinessDivestituresMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>1997-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b692bdf75f2434fb133bc7a3bb3fdb5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bca265b5de846a49ff7d66d365cd3f5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c7d49c8079f45a984607afd055f6141_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a5e4694eeae43cb9ed974f712d64133_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616d5f0474774329bb2e1a83718aa3db_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0581727a37ae4f2d83f10871f2fa2679_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ed9f546c418470cba11c23974e26f46_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9769bd55d48b434eb6a92677ad1f68f5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd15f26a3ce6450ca2aca80db285ee51_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b61014391a14c5fb1683b9dc341e3d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic01ffee4e6cd43d784f593303e505e23_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b84d1d2c5a14568bc00a2d9f3f9825d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85baff112a0f450580f65baeb088ac0e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3e70d031c364b549f2725ec8740c482_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i344fce21336047d085f98ba60b6a24d1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ccd90377a634c1ba0858901f0b24074_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3b2786a0eee40519674a931fd7e4b4f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63ca5f593dcd4e829883dd52c4e652e1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64d9d93ffb0648ffbad6d150cda752c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibded5a5821924d39b6d1c07b0695c6d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99b5e4f93c1a49cd8ea204607473a1ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3210673a6874b43b966528be2cf0794_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i233e41249a394b40b74263dc10afafe5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b9aaaedaaea4f29a759d257cad38085_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib46e8377d3f94800bd25709bd341fc00_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib22a0224790241248f93cd93a45b1232_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f228d50520f41bc92115db7843c0ad7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4116d4bfc3b743c3a4f8f2de755afa63_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie16e60a90d774109bacdee057e8bca89_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f6bf0d8ac1b4edb9f472e86394d3706_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72900069921b42fea99c263ebf35ef00_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cca6f8175204ac1bc6a07e79e2ef411_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cdb48ddcab543e797bec062453e8560_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7d6e7f31f0449ad8c055ca0af7ee098_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff9f3b36e4cf420295883612ede99cca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f9eac0c1cdb4f5c83bcb43211427c90_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i290ce668686b44a794845d7477734f86_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c1eb476973a44889e6ab4746c231250_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85bcc857ce00463eac390d699613b102_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib426e8d70a6d4415bc4d1dad51db673f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90191c61996943178db939f24e430160_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5007c17b33544991b3dbdb064cc3f736_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8af58300a9146fc82e82e9c13c202cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i852b799422a14eaba1c477f4f3c8a31d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebbc786d5e4e406c8d9fb17fb74e7b2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>sny:employee</xbrli:measure></xbrli:unit><xbrli:context id="i91602956c5a04e7d8e221b1a2b3c3fd3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie12b73fd2da74dce969b70268e0ff95e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa3510029eb8449b898dcffcb36596d8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff607e4176ca4b068613990b2582eabf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f958208733644e1aae6fda659400f4e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa10c8ec5cac4f29a0a9183bbd94bd99_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e57a41f946d4ff4a313d21852bdba8b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i970b0685e8954a3aa5ddf4a490518870_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:DaiichiSankyoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie13a4afd7b1b4e79b6db10af437058d8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i018625c9ec8b468a9ff0873e7d03260a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52bffdb81007440da92ed6b97e6d9231_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c405e8e7d324c77bfd2af173dcbb932_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62fee9f3c5744551bbe06227b0c173fa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fd5132ee30d4c7493ae9545f5714b73_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d08b9ad0c254c1e8eeeba6476b35c2e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if958d5b745e54738bf294167a5124ac7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i171827e88bc74a668b2a39c3176ab65f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8348d8dee22140afbaa6845ac4456f2b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bcd495e13694c26aed02fa8a7200ca9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a34f2d952b641fa9a97150c939ad0be_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55a8693d305047af919fadebbfac7084_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2326a92e2034921aa2a51bf11bc0d93_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ce30596c49c4242b0c04b915f6f7e57_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:ImmunooncologyAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i717efcfa32c548de8e23d8e05d058bc2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:ImmunooncologyAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia56a9ae0556147629310bbf5d7bcda1a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:ImmunooncologyAllianceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i622bf4fa192846ca9f1f1cdce02e4c83_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:OthersCounterpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7937d433de14ca7932134a404b27d2f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:OthersCounterpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib79d267fb5b34f5cbd786c75b48c5759_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:OthersCounterpartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i088be89f9d1b4730a785c0f6445acec8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4a2186378404e3987bb8fd7e88f511f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i552611be812d4cebb9f4bf048999a643_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">sny:InterestRateAndCurrencyDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ace254a2ef1455c83c5985dd96fa2cb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">sny:InterestRateAndCurrencyDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie87ee93c6896489f80ceecb2f2e91ea3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">sny:InterestRateAndCurrencyDerivativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4e374af20434124bd68044ee5c3132d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibed5e5583149430ea92a3d05d5060125_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a01c0bbd2d41d7b151eaf603f54f9d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="executives"><xbrli:measure>sny:executives</xbrli:measure></xbrli:unit><xbrli:context id="i1dd1a6b04c6b4be9b142d30598f7a4f6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:LargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5945bf292aba43d3b3933ee4fa267f48_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f0c3f56ec94246b15c17488b0f280b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i043c68f74cf54dd3b12ca0cbc0859d62_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf706ed1467c4a3396b7c74584527eea_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f723776de7640daa8cd4b9421bfd338_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cada9bee6d546aa93544736eadd46de_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18e5dd1b4b0649eeb4cae77cc5f1744f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56aabda8aa634a87b93f96b0ae541185_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3906e38c7744d118e2d80ee3ff3beb4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib75c6578c3a84cb08fa98e7e6b8a4a4e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia960f25762194eed8ba9198f645620cf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i388b2e8292964dd488b8e5822ff441b9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i703eee8c3cf4450398c63faaf2b2713f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6ec4264f7b41eeb79ce7df60d9b024_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cc915a3e8304b36b9aaea6a3b1e923a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a0eef0b887c463b978e082705e53ff2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf8fcf146c8248ec9b16d57552fb0679_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1b32034d89d4c5492894716caf75760_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie001d812cbaa42849ff65fc0f25fc9df_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf451e85e36d430f80d3e0dea3554d74_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6966a3cdac584a90877a12600daac3a9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97ab9118674344ae90b1ec5cdd6d8dc7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fddbef245ff4118abb1ece0065f767a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eb99c9f11e04cc6a1c3cc09537ceea1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice90a87f313444cda4f67ec7f33659da_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia60703fcf4f34ef79aa5696b24dc5b76_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7d5b31e23b846449b9dc6aca6c543d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bf14ecb83e341a28f96acd5106c6361_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38f46c66004f45f79c7d14d33e786167_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cb348a72bfd43a8ae3327734c1b4a43_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i497f9ba9e48b486f9aabba34acb6dda3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d31cf6a543b41fd88ed835cb7b080e1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dd47a8ee94b4ecba12d3409c2d6307e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4c50ff163de4a81822ecca972401b9d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aee59f02c404957a63d2c6a84ac1bc7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7da96c92143e4cfe87cbc8ec12bb9393_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63350fb6564e4bfab92644debffad89e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7d1991136ac485ca3f17d7bf6664386_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic536b741856d496fbbc9ceb07260b2bd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd98da43cc404ca08771230fbf198841_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i275946a1cae9496ca4567cbb23511dc8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i925d323dd481457dbb437525932095e7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1297a94f7ed45e493c05001e0b81533_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e35850252ee49c29e37a747602844b1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia65102e90b134f118e220863c8b48f53_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7e375fc233a4357934b4c0cff27f093_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i356311f03967464ebffc32cc1749c915_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ce1b6e300ae49b8975bcd687f09500b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8632a72e1dc41958e1a40418be2dcdf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86bfa094225f4f33bf2caa26f75ea5df_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05e5dbe4e5c6497f9fd313a217ef2eba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51d60da5814d4da3b4582525b5ea5de6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39dae50c59ff444589960d8b83241824_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id26f8eb73c594a90a9c4cd301b065133_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fc91d54abbf41ea870eb45075d2c54f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3331011dc076449c99047a7dc1945e0e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6399fd1af9d411d8a47300f12f1d9b3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba80ab3e00743088ed870250562c4c3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5351a9412414364a48f29bc495d1b51_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5755c87fa7584572873b015a8e208548_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5a6dbcefd8a4ab68267b53708933123_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i833eb11d63f9442f9f7f72021922e8f5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadb9c19bb94841d2a79288d7aadecaa2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42ab938545594eb992053504011e4252_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5726d6cac7a14f3ca1568529807b8c90_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2664f2da4914ced8cdc3fc6e2aaabcc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6654ba9bc13481fb4f6e2d9755a7d57_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27e8629a7974464c91e36e4aecb175e6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c4ada02638b4ae29081e603d6b495da_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f851b224ec6401c881a9da5f983599a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i009300f656604097800d9b7ea2a83bb6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c3c8fc92f834ca0afc1d103c341e47c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36ab119d8f59472ca95eacef7ad659cc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id739f18cd5204257b8c191b419d8e59b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e37e052f4f34e379c2230b24e177d6e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02995abbcb574be98f1b4b8903dd790d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66ebcdcc275242988ca39be9aeed1808_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59f7875640d940d4be71548d2d02155c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i679a528164774d5291f5852f0e21e383_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i008880cfdcf84137bd2c2e9958802471_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic75317c2c30b470f935f8f50ca516dcc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e2f07f1f1914db2861375b158d6e829_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if482478107224ecfa98b4d25e9684b0c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e50d845481a46298dce1596b91bb672_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19d85e03aecd4441bc80d278e7bbeff9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bb0c08a9b19417e99fceb3e2de828cf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice3ea0298e5348ebb9595f08b6d49ff5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c1dd865175f445a94c92d1bf48727a9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d009dcb0eb04ef3a021faa9a7402b4f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12bd9173dbaf4c49aa86481e27892395_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied76f2bed5094e9699ba62ae5eddf190_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i530dfd00d80842dbafce7ae5cb9655ad_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1e5d0b8029b4a8a8b1f4ac574af7ad1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb8ac8a0ccce4b5a934f205497b715e0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24e00e485b8e45618986356e620c908c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i885a178675c5451191389ab0cef8985d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i434b726907294409b29412431a7c19bb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83a9ef0ccd5b487fbb118b7e76ceb612_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7205b4923fa543c7813a6878b9485c35_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86f4b2048c414e2e9c5eb44cc0eaedcf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ee1d4e1116f4243b99c352e87d1d74c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b9df25140174f39b8d25fa4bbda653b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c86f2f0b2854fcba45877b8058bd8e8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c53ce511bba449da99749a8e4ce6d4d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9f8b9f4a590449496b876034d80b8e8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice20f96fb0cf4de0b3ca3965e622ae3a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b81cb6976ea4348881ae7d19e9b64be_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cc0ccf1590e4affab7ef2e75874f65e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17ab8be945b245c6ab4bcad11716698c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ab393d2fde64052a23ce4a484c207d8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icee2e75239b54a6691515f6280082f01_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7818bd4346ec4748b6753e13dc4eb6e9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07c0978e52b444298d8618c3d2159678_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9a280e56f3a41af88aba2bd4cb1d48c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4288c1aa9dc6416cb56c247f3a5ea4ba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c4fc1b2d404bcaa190fa35d3838578_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ef47532b8bd443d92c96e9744f3c55c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i117b2d1cc5d346c9877ebace612c1ed6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i657d3f930d0d4905af0b5e1b5dbefe0c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b3ebdaa8d354f83993ea4311de0e5ca_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85143d1ef2a047ef8d1509cff1b4eb35_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie090a33d5f6e4860a9db0e69a9cdb4df_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8d7968a46b648a4b7ca0e2438afd8aa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i381585a218bc4a21bc9dbccd82b92f3c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i296a8f4baeea42e78a0dd8f1a3fd6a56_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51bdb13aba434060a597a9097458c3a0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f792c072bf54f60b88192d56f584272_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id67bfe76694f4de1839334ce8b69a261_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i474ddfd1c7664510913a9d53823fe524_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecd790138e5f4caeb22913e385a783c6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bbac3b89df045bca004b76f88dbfb78_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if58bda7003d64454ae0b3769c32c45bc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07798b22999e4551bc98330cd328ac58_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i808feb017bbb47b2a5990030172ae9e9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide523dbe8589413aabe48647cf02a037_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1ac7e39036e4bb5b0a39b7b97512708_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58eaa30a28f4407f804608f379faab0d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if17af11c5d8a41feb31c45c868fe9eae_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib70be66dcfd54b8fa1967dc6ba0bb5eb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf5a3b324da94b91b08eaac503473be5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cb49f4f811244b596cd629fe1ff04e0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b3b532d87ee4f92b20b6eca2f77a81c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d67cad1157445109898fc8120f7683d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e64c845eeb246f59dfd656899a27837_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35c6e946c3624b76905a8cbf979857ba_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a4839221a9b478a8e315985b0c6c6c9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aac4d6ed7044a869f2ab2a402ed6891_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie188b535c20b4152b071cec5896f8a8e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5193ccd45f664a6e87c2cd7ffebea135_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7242f99862ee418daa94f18ea3004d14_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42189e03c07c4dc89544b5314ae6fa7f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2343ab2aad5e4a75bc999c5ed10f2dc8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb2d3cf6268242e1a113cb343e29cbe1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3bbdee34574428b81d52395573a7a50_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89bbec019eba4315ac544fc5b16a8ee1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7b892ef3d1141339a371a9d6ee5b705_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d9408eb958d47f9970a1477c454e52b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cefce5d6bf34ac6b51f91739b702fb3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bc5e144c1a04076b51456626e9cd1fe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i758a45c283f3434ca1c881ffb264058b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd17ee78068b4d03a01620b3f9a48899_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7534c54d521e42bfa11f4ec26a7237df_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d735f3d6a394c9cb978c28c14f66ec5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6780792481f84d549561c3ae8139f8fe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c8ed8009e0749b5ab9de034c8837959_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ffc44bf8e0f41e781b7e2ebbb1e69d2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3a725010cd94a3c834bc25a5093a46c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied5995be0e4745d280c9b295e1a23e20_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90de959467104871a3e22682cf4131f8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22138736e8ca42b38ff8c48941f38409_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69f76298218f4254bc305200c960f426_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52cf9837e6ed40aa85632eec92ba6f45_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i727e0782da3d46ec8fe5ab5e632fc070_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic44928021d4f4236870f0bf6d6fd1311_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0e28c706e6d4bf18081e809b52dd3f7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id861d9b153c74477a49abd477eddc226_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i357469340a86491ab237157cde1612d1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60d25e37a08049dcb2fb97d0a8b25b0a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57dd079515644fe69b73d21d94ac3e9d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a1a5c473c9b4cce9650d795bfaece4c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e76cbde32b54813adf63f05934bec59_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib446fc017cbe473c8fee4d2dad31e01b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i370d5592a1da444699977335ae0d6aa4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3025efe993694823a88967c4a6ddda1c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie718eb6f98704abebab8e41cf0bb433d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c5ee5de6db4c66bc2a5def80cb3630_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17834d1f197042f1a682ebdde3f1bfb1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i998de8ae593247f495156ca0fd001bbf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0977ba6fd2084d8ca30b097662a249d1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b17aab75c004d718993f2b67a67ff5c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i740678f4087c45798717797b54332317_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49540aeddfb1476badc6b4db7a86037c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53367ae84f81438ea1f7429170ac4341_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9d5c0a2194149e9829332b644e91e78_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16768b64d8324f648ba3dcd8ea1743bc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95951b5818aa458b8d05be95e32f6f29_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93e54f78f854e94acd0d345f631c76f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92984c0d697e42b69afe6d9913419c61_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i997357ba5e0d4103a854138682dbad0c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97f55be8ce6645d5a550bfa46ae5aefa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib18bf96fce9840e79199255e69961a1a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16b5d5a19be44034bdb35c036e33c369_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48989f71da6140a4beb9df8f40518550_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i343f9ebee6b943a7bf2931dd320e3aa0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i167b4765e010409db6a9ef1c2724d107_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i628fcb0013224533ae759b38ed4a9e8b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37db7c2f8d7b469997221d1aa218fe6f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i925f6b2d5b5d40a58aa0860a22c1fbea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0aa66e4f08254a8eb5827d9da0511d7d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6918b42287543ffae67f45e89689571_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83b5b2fcccc6496684aa6cb171a11b8e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae87558939404363b5fccfefd97a00fd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40fa65e1893444b2b1d53b7ce6e4f2ca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8eac199a2aa4dea9ca5e52b9f0bba8a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if706c3f3b7c64218b54c47278fdff29b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i902260c2fc46471c9838a41c2d4ee190_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fa99407fd0d465dad206a1e0d6e807e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad567579f11c4396ad1e56f97b7462ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb3ceb86dd6c4368b68c2adc32c3298f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if613bbe5c0594318b016b497ee91c597_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b001a8470a941d89da632e7bc9daf72_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22153967fac6428b833321479fdb1306_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5594aa252dab4309b3116b07f116ccac_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea483c0a6b6e49a5b4641fed43699ded_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i312af4a1d5294779ba7c9a2e218b6b4b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i578a1693685b4648b843c7591f102024_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic943869cbe084442b9752f3125562eba_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59b03d0aa3374a76a09ad675f12ec5fd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45eb32fbd1db4afe99ef24b30301d967_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f63b529f1744fbc83d583f5b12c35e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i866a97436e854d82a86d47a3f7c2e9cd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf055ce7cd0d4b41b0974d84a4828176_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c2f60a295184259a5e98824572dc354_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7161276da0fb46c8a7f757ed66cd6b74_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75a5f2ec92a94a89b3aae509e3a5cae0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73a08d51def1454d9443a2bc8b6580e2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadb91c4ffea14a4c86b46fa219e8e8e9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic496482793684b30af908ea4b53e6237_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34ae4ee5253743af84111345f0f31775_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i466ea9984a9746c1b1788273a8e951fe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77618a8613ca4289b3b3a2b779826d72_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9552a01052c443f87d515d5c3a5020e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i912066ccddd243118e3de68640de9dcf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c5c4713cc814bd7ab49ed66efb4c628_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a90a9627ee244f28f6e326030e8fb04_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i202bd69ea7354e44a25c96c53391e267_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46f1f42e50b94bfb85ebce0b53ffcb95_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5269963529c04271bdd98254675e07ba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95373a070bcb4ebc8e62a097d81bc07b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f756c850c4f43a6aa9a408f9b93eb20_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60f2bf9e9e914ea3872005fd530433e3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6decca1f9a94e3caad98da2fcdc75d0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i085e1c70e50641f2962c6964513071a1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ce62b370fd24f39a199e1d375dfb6d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i093e51cb9252485a94109d38a8fa4702_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53c5d7935c7b4937a7191d5857435346_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66e48178e270445b9442f66c6b94104d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id543945583c840488898c47cb6f44f8a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52bb756b60e14df9a45298f4b3784a0e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24cc0a91048b4fdebadcb26d0ef92277_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86187c82c19c4cb9a375fa90f77d5b4a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d424d7a10774447a1a4b8b5e0ae7689_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib056f7eee5db49e6ad47e9f71e8c6ed8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ae926d85669499cb9afa33c7d9241d8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e6ac042ac204ffa91527696c60c97e4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8467dbc5770446939551b7a699d503f2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd94df2c80d743d8a13502c39a73b7ed_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i566185ab6e264c6a8db7216893997e35_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28a1069b3bb642b693c980f6b28c3e84_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4df972df975b43f0ba3ed94f3ac9b0f0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9c5ed55783540d9aa5ba29544a1b58e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88db9dd7ec104b49aa9f5cad7c6b5d8f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e5b7dc49ebf4382a4ae26de2ebc180f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5531b6cfd28445d29737a2bfa6bc7241_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f061cdc8a4049e298e7ce678ecba5fe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9421508acd14db08ec0028a7eef9bb4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7092d8f4e2046b9860885a474a6d5db_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90cb244705d34e58b4ef04e3600b013d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i456fa2153dc446f5bce91beff992d477_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bfa10bd76b546309489629a22ee1f6d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bed6a217a124ce2832a0c652eb14a8f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacff9073d13f4103810361e59ee490ad_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib25f8d53a5414fe19f6ae1ed1c367b75_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic25e96d4bc874fc5a518e3a62b557388_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66b75c69b5de4e3d8a0d43182fa87920_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i336524d5d81f4a39bf61ca920af300b4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ee49f3c004543aaa32444ea5f031578_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie898ae59a55b46f0bd8bd709eb4f822a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdd8d6dad55c4232b49ae3d7899b823e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if882abae01c8491aa97cc0f3708f8398_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7b09c85efa64008a5815fa2c2c3a477_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8f643c30d914f8ab4e03c092efb3091_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e5094b910954c5f8c2098e2be4c991a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i500abf386db74b7f9515899bb2358a6d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8336020a29448de861074ef317b627f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d97b9f2b2384d5fb8b3e7b0afa2a5a1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d653af939404c578466f638984d2422_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0407751659c54020a63e3b5e93476585_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66d6c454ffb244d98228a677f46b2fac_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bda1c567b1c49029b875aa4febc16bc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c22a1098e3e46b3b86d47b9cf5ba970_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i156e9e8a21b449018c4bd18d3570d698_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5cdd431c5ae43a593b7cfa1f7bdbfd9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a2f8c0d377e4c1283f5b111722e1ba9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9082ca4896f544149c5fa993fc76e11a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i255d9fe68622490197bffdba2a258f3f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a047d0a5c8a445f9834ff3fbe6bb785_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9b0bb905111472f9a11100558b1571c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c459d45e7794c9597c5651cd4ef947b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84d4767234f44fd1b5d3a8968daa3946_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia50a50591809469c9fb3b18d4811f6c6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i214d7e38fa714fa9b73acc2b9f341911_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia473b953f05b4b35b5b13789c70d761c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6e4519162104b64a22cc688d15044cd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacefe436e3af422292acb5714b1bb8b4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i259f4b387d9c42eb93ef585b678f7f77_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id551965a5ec24ec7b5833702fead3db8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i116a1c4972304262b4654d3e3720dd45_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78407570f0dd4b788e9539bca72b8480_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9539a37f5b634f80a45b018298a7e6bf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a60f0418a2945d6816d55ba2ee00395_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3637ba1108d64738a99a8947658367e5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cb20a306adc460d867ea28b00dea2fc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i756f63fcc9aa4b528eaafce6b9d10810_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1680427a219746dd8d52e2b51d87bbeb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia572af328eb04f15a08f4b4be0b3c642_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i122e1cf42c504ef281c0148bcb08bfa4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90e43d267391440f976deaffa7f1ee2c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia15f03b10746440791e34cb56493eec6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22e0e6e055ed470d9bf214946d58ab2d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8ac8b1054ed482a8e8960303293a8d7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i329b514f506f477d9329c03ae9d60a33_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60bd3898aea54bd1923c045dc3905730_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01fe34367f704a4d9280d0e481946add_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48f608014a524624a2b5d9789797f352_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e829ee2f99a465ab88b9472b399fb82_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d62960d62de4d168f734a97be14a478_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf60334e241640fe96a7903ed2e9b3ad_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f77a621c718482c8212f4c353b4d1b7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0034d62b9984b9c819c9089b17c9dff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a8f83aca4714f6ab0e8c9bb8b1a50a2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i013162020a33403bb8ab3a5b4d6acf5b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86bdcc50c470440b9f04a89cc25fc25e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10a2eadc160a461e8aa95a317634efc4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49530103426b457c9644701cc0be276d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i029d1d8f14bf48ff95eda3b544a4736b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e9e1a94b89044af91d3720935c6c41b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6b0b143fa7e4ffd8648c6d67f7caaa0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a2427f9f19e4111a878f552385abb20_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3776772d55d454e9e161ef283add8c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id755af668f8b430fbfe6cc864db69bba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8feda8bd457f4a26b64959caa430dd5e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d0c0e35669c4d7aae59762151215c68_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ccf1608d43245e99567d6f375c33201_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i556d066cc252454daf37eb98b7987866_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26e900f47f5a43c1af34c00b6fbd86f1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa27b1484913467086d8717268468676_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f6aa7c2c0a940db95a9895599a8e561_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib54fed9458034a4eac2a4487edc9c09e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3abc51abaff14a808a53308dacb0555b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c05f2b9a58842bf9131e7d74f48ec7e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f4f45d36c37402780501202da882836_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68c4deea6e6b470da44d7eb61f99c2c4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7997885ee5a421a93ddf5ffca11ea96_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54e8e37c74a24991b87c1d67d7375882_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibff824acb702445385e0da9d25b4b793_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26f8ec3e990b4a519b49cf861ce481c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a967f1a2afd4c4aa4177d1e5ef46e32_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc6d783c6be84509bbd905f3377753b0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd3e8e0424b04715b821e32eeb629ba6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id92a273efd0e45db9787db6e8508d895_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c09e143fbea445f8efdabebb4865bc8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic65c1b0f25e14bc0a163de986a44369b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AuditorsNameAxis">sny:ErnstAndYoungMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AuditorsNameAxis">sny:ErnstAndYoungMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AuditorsNameAxis">sny:PricewaterhousecoopersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sny:AuditorsNameAxis">sny:PricewaterhousecoopersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i498c1591947b45fdadb2bb6778e0ea74_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:HoechstGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5ae387e2cbe47c3912417d8623bf900_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDeutschlandGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4adfb7da9ccb448d9ad8c9e69d0b3cc1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:A.NattermannCie.GmbHMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idebf15d680cb4a1184f7f35728f60030_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1051a7b1a8d549b19efe21164afc8517_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiBelgiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63571a41cac6407491245bad0632cf43_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AblynxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica986457aa234217a2fac7fc80955729_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeFlandersBVBAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b7192d1177f41e6939a7a9bad74bf5a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiASMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i285cbecf53934809bfc57407935033d4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24ec77a85f5e48ed937a7403fd09b34b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareSpainSLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic074678a420e47758b62873cc4d859f6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic74f613c0cb646968c6021eb3f15c61c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb45d02df4dc419e8ddda8153ae34b79_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisFranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2205f57d9c8449cb0e0f24d60269bc5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiWinthropIndustriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2121a047ee3e4de3bdbdc5ce00e809ba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisRechercheEtDeveloppementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i080fdac6aa0d43588960255f9f17f975_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisGroupeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16069c2bafd44ad0bea3a6b3957889c1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiChimieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79acb16ef6f74dfd8a5afee5b7eaaf0b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisParticipationsSASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id75e41a2a8d44456a85dddcb895d6379_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurFranceSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1564bffc0f94330a56e53eb941e410c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisPharmaSAFranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13936cffe69644268b73faa1e0f1222c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiBiotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4e1d630778d4bdf98e7975d7d41370e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiMatureIPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i351193f373d14cfba556201ad238e512_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurNVLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13a2d009465c4ed2b62b3c4ce7bedf35_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c5bc0d0654d49e484d5bda422c95c96_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SECIPESASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0538adb5d86145d8b2614a4783bcd071_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurMerieuxSASMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib51944e0d29846a1b0a6665d934c0d7a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:Sanofi2015DSASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa2e5413dd9a4c5c8f7d90b8a94df128_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareInternationalSASMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ca8f4e855884896957fe5976fc46f0b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareFranceSASMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i325731cb5882403b849f26ad9d4954b9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareGroupSASMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e5219940fdd4088915a6be208a8c941_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiaventisAEBEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaaa67301b32448ea984ea8286dd1dd8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisPrivateCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4631c1fb362a4507ad8496f0043f8818_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:ChinoinPrivateCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc230f3aa6da4dc1830276e62e498a05_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareHungaryCommercialKFTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i589ccb194ca14fd289b658aeea655731_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:CarraigInsuranceDACMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0941b5e1401244aeb011299f6b18762c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeIrelandLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dfafa70e252425495ec4aa84c0b3462_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisHoldingsIrelandLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5c98b61ee6a49c6bbe6745fbe8903f0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiSRLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4db465cfb48243f681f6c69e00a03120_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareItalySRLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa21535e233747e191e1efe06e939f24_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeGlobalSarlMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9be7cc0cfdc4c01bd3cdefbc2db8865_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeLuxembourgSarlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4a729e9da034ba9ba366e137ead0039_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisNorgeASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fd91674dc3f4546ab4d9ec18c77344c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeEuropeBVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefa5c464887543849754b364afb61226_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiForeignParticipationsB.V.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i806cb8bde2da41fa864ebe59f6439f93_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiaventisSpZooMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5677045852f43c3b14b4e3424e84806_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcarePolandSpZOOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07d862e00e454435ba5778981fdd8d86_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurSpZooMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d8c1c94ceb5454aaa207f9ba7d1e1d4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiProdutosFarmaceuticosLdaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a16e6db8221468eb5b3b7969c6b0832_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisSROMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id426e598bb94421cb6e62308d8f1efee_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareCzechSroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d8b86bfb5a2496495c7585dc69b8b27_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisRomaniaSRLMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecc505bcb14d4f708a5e5b413b0da850_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareRomaniaSRLMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58ff366114fa423c816fd9c7d12c6ee5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisUkHoldingsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5935a593578b42bd992125d84fde4c2b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisPharmaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ab8aa458b2e4741896b715f331173c5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiSynthelaboUKLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea8d1294ee8a48b2acfe1c079ae36761_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisPharmaHoldingsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7457f5f4052d410aada699fd4a19b6f6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareUKLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba8eb10b04bf4f299d1a467e30b4255c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AOSanofiRussiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd6d3494d7da437f8fd0c9e1b7dcbdda_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57aa1c00eabf4f6f995aa00fe1f4cad3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiABMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52f9faf9cfa44dc0a653f6ac823bbff6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisSuisseSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5770860577043ba89757912c7144758_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeGlobalSarlBaarIntellectualPropertyBranchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88db3e6c62364ad8b70611ef3579c3e0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiIlacSanayiVeTicaretASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i516dd1cd29b84843b7e8aab3e5a4c6e7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurAsiTicaretASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i005b6ed2aeb1435ea08d3315ae40197b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiSaglikUrunleriLimitedSirketiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic41db69eadcd4e9c982ed089e1167d58_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeTherapeuticProductsLimitedPartnershipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f0515138f7c418c9bcbb13c636c695c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08e2f2cccd464d70abbd1e5f42eed60f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiUSServicesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b9857f92eb49a8a8c2d24791c3ce46_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisUSLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4d77d7546954bb39c5739590d22ed90_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:ChattemIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdfce984527840aa9096f39e4c594c81_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisubLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcba81032cc44b6d96e7841acb4c6f8e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84f6147917444bc85ac41f1fe48a282_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa9d541bb2af4c559dbbaf5d6692d189_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:VaxServeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5307b0935b94772a58f8ea12f188818_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:BioverativIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08d853212613473facfe866d69b99234_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:BioverativUSLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bbdc75c43824eb8a3de899e259da76c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:BioverativTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb9a553ac7e54b47a1eaa3597816db8e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:PrincipiaBiopharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37c82d3e1df445788ff372833849ae27_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiResearchInvestLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87693c70bb4c4820b200f85cae0c40fe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiBioverativHoldingsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8482c94334704ac2a9f5d46f5b538414_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:RPRUSLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcf097d2e4454d87b7c58b76251a2385_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:KadmonHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b8053816d6a4e6c9e20fc4c30f781aa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:KadmonCorporationLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide7f7e63784f41a183803f0ac8a137e7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AmunixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i718def90f99b44c1ace694608132b059_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SynthorxIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i983da08a0b754be2b43b04b0c13ea843_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:TranslateBioIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34818f54408849b78b0de1673856f0f8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisSouthAfricaPtyLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i825c57dbd8964e30b031dee0899ee99f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisAlgerieMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e42794c886e4988b9410e7875fa4ea3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiArabiaTradingCompanyLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41868f27b25346e1b0eebd1483e1fc50_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisArgentinaSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica13971ef10f4193b4a67e7c1af3ebf7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeDeArgentinaSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i493a9c684cd24c618768ad51fe4c99b0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareArgentinaSAUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeb9cb68f7eb4fca8a15ce101f73ec2d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisHealthcarePtyLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8be1a4c0cf864ca580eeff34de647013_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisAustraliaPtyLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id38ab6ac3a3140ee8c774a6c879777f4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiMedleyFarmaceuticaLtdaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42d8188e7be34beb9c79c609575725ce_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisCanadaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7703f57c8434b53a13de4396f59696f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d8105546d9a43eba6a5ba0d273ef35d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:MerieuxCanadaHoldingsULCCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic71d57fdeec447afb3b584aff6e7e598_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDeChileSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61fc86f2e0d54b88a9ae5af651e73bbf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiHangzhouPharmaceuticalsCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5762c3305eac419d9d4d578ae3517cec_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiChinaInvestmentCoLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if523ef2e47944973b93e0232412ed5db_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiBeijingPharmaceuticalsCoLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i319f41b8a18c4cf6b5f956ed40fbfa70_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurBiologiesCo.LtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72b45e8b7e194f42be530027f55dbd36_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:ShenzhenSanofiPasteurBiologicalProductsCoLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic82939cbfa4e4308b5c954a528b904b3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:ShanghaiRonghengPharmaceuticalCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21ea9e0d97b84ea8bed89d96c90b4a4c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenfarSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a61deb6118546cca9152a3d19ca7ded_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDeColombiaSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b77c884d5cf4c459d41322e688941e2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisKoreaCoLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d8c63a1688f487f8f48b66b144d7b14_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i235e682ab77a4e1b83eb628a686cb67d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareKoreaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94cfec9a31f2484bbf3be22fda030c95_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisGulfFZEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9265b4b9635b4f268661bb9af41d4910_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiEgyptSAEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ac69def9695452fa8056d9a9cf37f80_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareEgyptLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7215e66652242c888d9188932de83ef_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiHongKongLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd902f48e4e0470789302c7c306a7226_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiIndiaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3427ee82661045e69654d0f7f3c81b5f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiHealthcareIndiaPrivateLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i931de8c63c0a4132b7dc27fd739de9ee_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisIsraelLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if83f0c24152340948edc3fce389f90bc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiKKMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia183f27f20164e5db33ab876c94506f6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SspCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4658ecaa90e474bbf5ced2fcc7ac5a2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisMalaysiaSDNBHDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id812b34881814260a4fde8dbd44c51c6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisMarocMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic471ab2e84ae4923a1e2dd798a44a353_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDeMexicoSADeCVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05626dc1fd684848a779e5531a41d341_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurS.A.deC.V.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18812706bbaf4fcd8256d1807ae64a5c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AztecaVacunasSADeCVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dfc1df9889e46c0a941ac9f24266a01_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisPakistanLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id621d1155a9144f2a85532c3bfa7cd75_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDePanamaSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81604c6ae3a740b7ab7f5a449eff82c5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDelPeruSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f0dab49c934466b9cc002391f7bc3f0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisPuertoRicoIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d7249e960a449009edd04541ebb0a9a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisPhilippinesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5941a7f40b04bed9aab3ca1870c53f3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcarePhilippinesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aa25010b3d247be8ea308b7d38e3498_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisSingaporePteLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4036a3cf2bd8487cabda1ea457bd5fcf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisPharmaManufacturingPTELTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d6ea91a03cb4a04ba283518cfb3a3b8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiManufacturingPteLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8ba60949d764ee68bd5fa3cae3fd182_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiTaiwanCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ad82677839649138379e9cf405edc11_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisThailandLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d616d9fdf31436c85f6dd196bbba8da_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDeVenezuelaSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3ab1d4e7a0b42c08245f856927cb942_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisVietnamCompanyLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dfc5328cd614aacab6fbc5dcd73b515_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiVietnamShareholdingCompanyLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8a871b1ed6b455f8d1c0cea30f525e8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:GlaxoSmithKlineConsumerHealthcareLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52895c33c77b401c852cf418dd101085_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7effbd9d99be4fa09eb11d6a24112790_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:MapharMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9db2167110a34e338dda46b7b37c973b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:MCMVaccineBVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57640986aa3c447c9a69578a8c50672a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i634adddc2f7149a6b915f960673b1b38_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:EuroapiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTMtMS0xLTM2NDA2MA_217e0ead-39cc-4dbd-abcd-ae1f822db699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTMtMS0xLTM2NDA2MA_217e0ead-39cc-4dbd-abcd-ae1f822db699" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTctMS0xLTM2NDA2MA_c0c113d9-32b7-4444-a088-c2774c355f21" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTctMS0xLTM2NDA2MA_c0c113d9-32b7-4444-a088-c2774c355f21" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTMtMS0xLTM2NDA2MA_a3cc8a2b-319d-4917-9c92-6369a3ca6160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTMtMS0xLTM2NDA2MA_a3cc8a2b-319d-4917-9c92-6369a3ca6160" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTQtMS0xLTM2NDA2MA_a54887eb-413f-4b98-aa4f-8a4294525ef9" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTQtMS0xLTM2NDA2MA_a54887eb-413f-4b98-aa4f-8a4294525ef9" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTQtMS0xLTM2NDA2MA_c0f9ae73-8f74-48e5-80b3-a5993099957c" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTQtMS0xLTM2NDA2MA_c0f9ae73-8f74-48e5-80b3-a5993099957c" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktNS0xLTEtMzY0MDYw_753747be-20ce-4c5c-88ce-259f463a8b67" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktNS0xLTEtMzY0MDYw_753747be-20ce-4c5c-88ce-259f463a8b67" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQz_4413e2d3-0704-4581-a253-6ac595b10cd5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTUtMS0xLTM2NDA2MA_f7575fc6-2ec7-4422-9290-f9eb402e6ed8" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTUtMS0xLTM2NDA2MA_f7575fc6-2ec7-4422-9290-f9eb402e6ed8" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ1_51450c7d-26aa-43d2-ada2-6a14149956df" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTctMS0xLTM2NDA2MA_cf7f4845-b348-4256-9769-f70e15885bba" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTctMS0xLTM2NDA2MA_cf7f4845-b348-4256-9769-f70e15885bba" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTUtMS0xLTM2NDA2MA_9c0bd19e-35c4-4872-af6a-47f8e4217b03" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTUtMS0xLTM2NDA2MA_9c0bd19e-35c4-4872-af6a-47f8e4217b03" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ0_06a9dadf-45f8-44b4-82fa-41db2fe39be6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTktMS0xLTM2NDA2MA_4583d946-900e-45c5-9fef-2daede5d4639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTktMS0xLTM2NDA2MA_4583d946-900e-45c5-9fef-2daede5d4639" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTktMS0xLTM2NDA2MA_d8a8feb1-1cfa-42fb-bf37-81ef1afefc31" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTktMS0xLTM2NDA2MA_d8a8feb1-1cfa-42fb-bf37-81ef1afefc31" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtNS0xLTEtMzY0MDYw_659a6192-01c2-43a4-bc97-bcef7fd46f67" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQx_05e590d1-51db-4ca8-b860-337a3c2ef7a6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtNS0xLTEtMzY0MDYw_659a6192-01c2-43a4-bc97-bcef7fd46f67" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTQtMS0xLTM2NDA2MA_7ccde0a3-7066-40e2-8a3b-eaaff4071556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTQtMS0xLTM2NDA2MA_7ccde0a3-7066-40e2-8a3b-eaaff4071556" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTEtMS0xLTM2NDA2MA_d98f69dc-b0f1-4cc8-b70b-7984fd78a6c5" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTEtMS0xLTM2NDA2MA_d98f69dc-b0f1-4cc8-b70b-7984fd78a6c5" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTUtMS0xLTM2NDA2MA_86f873a5-ea9d-496d-9826-7012e349d45f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTUtMS0xLTM2NDA2MA_86f873a5-ea9d-496d-9826-7012e349d45f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ2_7c2dd840-1374-4610-964f-c966ea4bc4b5" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTUtMS0xLTM2NDA2MA_4ed2c3d5-36ff-4dc1-9b89-c7736363a07b" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTUtMS0xLTM2NDA2MA_4ed2c3d5-36ff-4dc1-9b89-c7736363a07b" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ3_eca3b69e-ddc5-40c4-8c60-b88736c10615" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTktMS0xLTM2NDA2MA_0c6b15d9-7af1-4550-b2ef-c670cd3ad5bf" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTktMS0xLTM2NDA2MA_0c6b15d9-7af1-4550-b2ef-c670cd3ad5bf" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctNS0xLTEtMzY0MDYw_28c8f930-0ea6-4980-abbd-c6e02f40ffad" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQy_cf6c8d9b-a5aa-4ad1-a1e9-53e2186cf56f" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctNS0xLTEtMzY0MDYw_28c8f930-0ea6-4980-abbd-c6e02f40ffad" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTEtMS0xLTM2NDA2MA_3b202fd8-00e4-487b-87e9-9a7b27f67620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTEtMS0xLTM2NDA2MA_3b202fd8-00e4-487b-87e9-9a7b27f67620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTItMS0xLTM2NDA2MA_83a539ae-f2b8-47b7-9f22-1165eb4c8b79" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTItMS0xLTM2NDA2MA_83a539ae-f2b8-47b7-9f22-1165eb4c8b79" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NzQ4Mg_2c17decc-29d6-4783-a5a8-9d236cef3b39" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ4_35ca4623-8801-4945-8e8e-9bd5409bc25f" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NzQ4Mg_2c17decc-29d6-4783-a5a8-9d236cef3b39" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTctMS0xLTM2NDA2MA_a399014e-7c97-4436-a95a-792d15aba016" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTctMS0xLTM2NDA2MA_a399014e-7c97-4436-a95a-792d15aba016" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTUtMS0xLTM2NDA2MA_77055e13-a439-40d7-b46e-ed1a0852390e" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTUtMS0xLTM2NDA2MA_77055e13-a439-40d7-b46e-ed1a0852390e" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ5_a854f423-a49a-4d25-83ec-b6c61a89c384" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTEtMS0xLTM2NDA2MA_33fae6b3-9207-4d19-9d97-7ee96a7e8cb0" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTEtMS0xLTM2NDA2MA_33fae6b3-9207-4d19-9d97-7ee96a7e8cb0" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTItMS0xLTM2NDA2MA_7d7feed9-e45b-4567-ae2c-b2271c3b7e4c" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTItMS0xLTM2NDA2MA_7d7feed9-e45b-4567-ae2c-b2271c3b7e4c" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTItMS0xLTM2NDA2MA_c4a51e91-2309-4fbe-b254-e8eb14d6d2dd" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTItMS0xLTM2NDA2MA_c4a51e91-2309-4fbe-b254-e8eb14d6d2dd" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTMtMS0xLTM2NDA2MA_ca2b6a8e-c22e-4f5c-b27f-219af0cd4527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTMtMS0xLTM2NDA2MA_ca2b6a8e-c22e-4f5c-b27f-219af0cd4527" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTMtMS0xLTM2NzQ3MA_47f62225-cc47-4815-8201-aeb2b6746255 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTItMS0xLTM2NzQ3OQ_936bff2b-5c05-4544-b8a8-f59222607c67" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ4_35ca4623-8801-4945-8e8e-9bd5409bc25f" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM2LTUtMS0xLTM2NDA2MA_f3b5168f-b60d-481f-b2f9-0bb8d1bf62bf id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMwLTUtMS0xLTM2NDA2MA_d97178c3-e549-40aa-89d0-58737b61a38c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ1LTUtMS0xLTM2NDA2MA_ed1062a4-594a-4fc8-99f0-7c16dbf21f94 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM5LTUtMS0xLTM2NDA2MA_7dfd024d-6cb7-47b0-8d2a-309b7cafe760 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI4LTUtMS0xLTM2NDA2MA_c4db135c-f14b-48b6-90a1-2f41650c4e3b id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE1LTUtMS0xLTM2NDA2MA_f9adf783-6975-40b3-ae86-95facc12396c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI3LTUtMS0xLTM2NDA2MA_5d91a65c-b49b-48c5-8f9f-76e35ca388c0 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzUtNS0xLTEtMzY0MDYw_037866be-74fb-4379-95c5-7391b8f0a643 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE2LTUtMS0xLTM2NDA2MA_08b6afa3-6337-4c4a-bb0a-3379dc726454 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM3LTUtMS0xLTM2NDA2MA_5d3d6b03-c339-483e-b43d-69ccb0089d93 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ0LTUtMS0xLTM2NDA2MA_ae5b4a07-2634-44a8-95cf-f6f030408c0f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzExLTUtMS0xLTM2NDA2MA_22f5816e-e976-407b-a33f-32aeb0615a40 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQxLTUtMS0xLTM2NDA2MA_54ce4fb9-1abe-44c5-b71d-58f396cbf084 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMzLTUtMS0xLTM2NDA2MA_63eb69a4-450d-440b-950d-c52013cdb3a4 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQzLTUtMS0xLTM2NDA2MA_f282ed48-ec02-4893-9201-9d1039bb256a id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE4LTUtMS0xLTM2NDA2MA_3784fba6-0647-4205-9f33-f3778deaae45 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM1LTUtMS0xLTM2NDA2MA_4fbb4788-3acc-4c59-93b1-ea49ead9c567 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE0LTUtMS0xLTM2NDA2MA_31c45ffd-1947-40f9-ad6a-89ca1c9f0bbd id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE3LTUtMS0xLTM2NDA2MA_bd5603e6-aced-48de-980d-85d04fadce07 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEwLTUtMS0xLTM2NDA2MA_dc5f33b7-186d-441b-8fb1-8eb19a94a3dd id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzgtNS0xLTEtMzY0MDYw_42fd12c3-44d7-4452-833d-9a4e29d9f0dc id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQtNS0xLTEtMzY0MDYw_dc70927f-9041-43c6-879f-2565b16819ee id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMtNS0xLTEtMzY0MDYw_64118034-3ca5-4b9b-8c19-e2ae333dc82e id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NDA2MA_80b331d7-f29e-4957-9b17-0946b17201e5 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ2LTUtMS0xLTM2NDA2MA_b73eca4b-a452-40df-974d-91a078599ec9 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMyLTUtMS0xLTM2NDA2MA_443a4622-44ef-476a-9baf-ad2ba6cdc5ff id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIyLTUtMS0xLTM2NDA2MA_28ccd4d4-b955-4456-a936-7c6235cf39ab id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI0LTUtMS0xLTM2NDA2MA_05a9ca15-42e7-4edf-8810-aed4004b5a47" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtNS0xLTEtMzY0MDYw_435d1f07-5eb4-4598-9330-b197305f6473 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTMtMS0xLTM2NDA2MA_3c5b5f3e-8f21-491f-84f6-b27988fa054c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItMy0xLTEtMzY0MDYw_f6ab6b9e-394d-47cd-b041-d9ebde2baa91 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtNS0xLTEtMzY0MDYw_237a3dc2-ea8e-4818-9ceb-9f36d1ecd979 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktMy0xLTEtMzY0MDYw_2d1e94df-65e1-4c7e-85d2-19e5cc554ff7 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTUtMS0xLTM2NDA2MA_7af04be4-34b5-46f5-a8ab-415095093659 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTUtMS0xLTM2NDA2MA_50dfd5b6-6e1f-483c-8373-bc3fafbd00c5 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTMtMS0xLTM2NDA2MA_367bcc0a-3a06-4fd3-9495-15ee61eae0d8 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTUtMS0xLTM2NDA2MA_41d5471b-40b4-46ab-84c7-ded290c4ae26 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTMtMS0xLTM2NDA2MA_752d051b-3bab-45fe-976e-9867c1e053ae id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtMy0xLTEtMzY0MDYw_d183fbe3-704a-461f-9c29-4665a5781c24 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTUtMS0xLTM2NDA2MA_e66fe460-ee48-4282-b2d7-bcd045c240a8 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTUtMS0xLTM2NDA2MA_8174f1f3-2466-4f1c-8542-a62d0087c44c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtNS0xLTEtMzY0MDYw_de3a6b38-03fc-415d-8bd9-c7a22adf516d id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtMy0xLTEtMzY0MDYw_5f84f4ad-c99d-4497-aad8-aeead8e33aab id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktNS0xLTEtMzY0MDYw_907e71fe-0dea-4046-ab34-b67490b5d9c1 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItNS0xLTEtMzY0MDYw_2ca57e2b-4d8a-4c29-aa5a-b9735714fe38 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtMy0xLTEtMzY0MDYw_36757908-4a31-49e1-8460-b9a6a6098871 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtNS0xLTEtMzY0MDYw_fb721cb2-cbc5-4cdf-9e8c-d27869d08598 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctNS0xLTEtMzY0MDYw_18e9fb42-cb58-4dce-bbf7-d09d691c0b1e id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTUtMS0xLTM2NDA2MA_d7129fd9-ad9b-4a70-973b-204286aca61a id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTMtMS0xLTM2NDA2MA_b0fd60b7-e57d-45a7-aef5-8cd1c0ea561a id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTUtMS0xLTM2NDA2MA_e29579b8-4dc3-46e3-bc20-f37e964677de id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTMtMS0xLTM2NDA2MA_6bb5bac3-ab4e-47b0-90a4-afbf89a19b46 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctMy0xLTEtMzY0MDYw_5b5cd334-de8f-4210-9dfa-e3106b3a71d0 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtMy0xLTEtMzY0MDYw_32714259-ecc6-4423-923f-e5e0eaa08e52 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTUtMS0xLTM2NDA2MA_2077b0a9-191f-434f-9f6a-2135a5630397 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTMtMS0xLTM2NDA2MA_aebab50d-8f4e-40ec-aae9-07cc65f9432c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtMy0xLTEtMzY0MDYw_15720d29-f51d-4243-a724-b51aaed82f61 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtNS0xLTEtMzY0MDYw_2bc5e8b8-b88f-47eb-845e-563d02b2636d id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTMtMS0xLTM2NDA2MA_aeb01230-3b21-4937-bdf3-3f527d689c1d id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTMtMS0xLTM2NDA2MA_cd7bfc58-ac84-4fd5-a22b-ce2f411ac841" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTQtMS0xLTM2NDA2MA_39a3dc95-e4cd-42bb-99dd-3455fc0e3fa0 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTctMS0xLTM2NDA2MA_858bc692-12bb-4cb4-803b-4d0fbb3367e6 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTktMS0xLTM2NDA2MA_0c77d10e-004c-46bb-8b5e-0931a9be0c1b" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMQ_b6e1becc-c779-46d0-aceb-3700af176d39" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTItMS0xLTM2NDA2MA_adc3dc98-3752-4217-a201-9469b1c6159f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTMtMS0xLTM2NDA2MA_20ba23d9-4985-4b1e-be44-744953373bd2" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ1_51450c7d-26aa-43d2-ada2-6a14149956df" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE0LTUtMS0xLTM2NDA2MA_a44438d9-b628-47fb-a335-543bf48cd46d id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE3LTUtMS0xLTM2NDA2MA_7b3251b8-a49d-4693-8c38-c06be8eeb196 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIwLTUtMS0xLTM2NDA2MA_bb62ad5f-a735-41f9-a43f-912a735a61b5 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI4LTUtMS0xLTM2NDA2MA_dcdc1738-eede-4f82-87b8-4634e2789a12 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzQtNS0xLTEtMzY0MDYw_6060efcb-4070-45cc-ad4c-ce7dfd6dba32 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI3LTUtMS0xLTM2NDA2MA_36bf6641-8869-4953-bd21-3b5bb82e56a3 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI1LTUtMS0xLTM2NDA2MA_429b1ea7-b870-47ee-afaf-6f379bdc6039 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzktNS0xLTEtMzY0MDYw_6cb8cfb2-5f44-49c5-b960-bd869b8ee64c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEwLTUtMS0xLTM2NDA2MA_bf7d83a0-334e-40fc-815b-9b25757dca0c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE2LTUtMS0xLTM2NDA2MA_1e23d4f5-79b1-4158-906a-fed081b744dd id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIzLTUtMS0xLTM2NDA2MA_b1dd7d32-6f38-4252-800d-22bffe8f0002 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE1LTUtMS0xLTM2NDA2MA_335e6c35-0a30-42ea-82ff-ae43ee8ea3aa id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzItNS0xLTEtMzY0MDYw_cf52530c-11fa-46ba-90b8-387200a923e7 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE5LTUtMS0xLTM2NDA2MA_807f6c25-77e1-4ca9-83f3-d32acbeecd71 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE4LTUtMS0xLTM2NDA2MA_cbca7a9d-da63-4a54-9d0c-49869ce7380b id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzUtNS0xLTEtMzY0MDYw_c770a930-6359-40b0-adc4-16255141bbaa id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI2LTUtMS0xLTM2NDA2MA_dec78f17-eab8-4dc7-bf28-c3da212f14f4 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzYtNS0xLTEtMzY0MDYw_d3b3027b-8ab1-47d8-8dbe-5d66d8c882e1 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMwLTUtMS0xLTM2NDA2MA_7343f7fd-6b65-4861-a0d6-934588b1df3f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEzLTUtMS0xLTM2NDA2MA_b72771e9-2b22-4bd1-a83b-77ace7d6b757 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzgtNS0xLTEtMzY0MDYw_c52471fc-b44a-4284-bbb7-b21e467d606d id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEyLTUtMS0xLTM2NDA2MA_f57e5083-426b-493f-be5b-89c43cd7ec16 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEtNS0xLTEtMzY0MDYw_6e292d38-2475-4ad2-adc1-3bf58534aa46 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMtNS0xLTEtMzY0MDYw_19873626-8f8e-4608-b3cc-067baf62fd00 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzctNS0xLTEtMzY0MDYw_ea377980-eec3-471b-8e64-babf0ac31163 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI0LTUtMS0xLTM2NDA2MA_d0916b5d-41f1-4c2d-b244-c9d2fe8487af id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzExLTUtMS0xLTM2NDA2MA_cf422f4c-90d8-4d65-b9f8-9da3635513d5" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMi0xLTEtMzY0MDYw_d05550c3-6c5b-4a1f-a950-e57307732990 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMy0xLTEtMzY0MDYw_82231aef-55eb-412a-9b0d-2a1af2ca02af" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQy_cf6c8d9b-a5aa-4ad1-a1e9-53e2186cf56f" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtOS0xLTEtNDA0Njk0_4f3465d3-e06d-4e0a-945e-ef98d44a023f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNC0xLTEtNDA0Njk0_85714117-9f74-4cd3-93b2-0175fc92848f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNy0xLTEtNDA0Njk0_3f2777e7-72dd-447f-b207-67436a3ec3eb" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzI2OTM4MDM0ODgxNjE2_fe6723a9-d270-4eed-8051-fedf99786726" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTItMS0xLTM2NDA2MA_ba2d8fea-11e9-4854-8b94-0515718b611f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTMtMS0xLTM2NDA2MA_f9534676-afa5-4f61-8123-c6c164d57420" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ3_eca3b69e-ddc5-40c4-8c60-b88736c10615" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMy0xLTEtMzY0MDYw_ebaf5874-e148-403c-83d1-a3dc652c54d9 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMi0xLTEtMzY0MDYw_68a96ae1-18df-4f0e-90c4-483a7863bbdd" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQx_05e590d1-51db-4ca8-b860-337a3c2ef7a6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzExLTUtMS0xLTM2NDA2MA_ec029af8-8e2f-4373-9f92-3f80319bb69d id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzgtNS0xLTEtMzY0MDYw_9ed4f556-0f63-42a3-9ecf-c0593883b300 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzYtNS0xLTEtMzY0MDYw_09466f4c-f691-4b48-87b8-9c6619c32bc6 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEzLTUtMS0xLTM2NDA2MA_5632a6c6-fe9b-4b6f-be3e-74a4762c8079 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEyLTUtMS0xLTM2NDA2MA_8354b5dd-7731-4c1a-a502-f93591cbc690 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE5LTUtMS0xLTM2NDA2MA_518f424c-a583-4582-91e0-f12572c1f305 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzItNS0xLTEtMzY0MDYw_a425cef0-9e19-4636-b4c9-8d7457aca7e2 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzQtNS0xLTEtMzY0MDYw_c2c9944f-49cf-473b-963a-80a47b9ccad9 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzUtNS0xLTEtMzY0MDYw_1b79d766-e040-4ce2-9087-b12025f05dc2 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzktNS0xLTEtMzY0MDYw_6ac9401c-2c5b-4d43-b1c8-59656b9f5a14 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE3LTUtMS0xLTM2NDA2MA_ee6bf62b-79dc-4852-ab0a-44f5e6cd48d9 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzctNS0xLTEtMzY0MDYw_88a3ff41-5db5-4c72-8750-60b6b561fdc1 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEtNS0xLTEtMzY0MDYw_7d7ee084-2a92-441f-bb7e-f3dfd1d51c0d id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE1LTUtMS0xLTM2NDA2MA_3f6bc7c9-ddfd-4ea8-97a6-9560945be031 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE4LTUtMS0xLTM2NDA2MA_d4a09a5b-f67e-45f7-bbbc-5112f4ccf1ac id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE0LTUtMS0xLTM2NDA2MA_c77f84c4-9b06-439c-b2c2-446f2531fab1 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE2LTUtMS0xLTM2NDA2MA_abdea380-4305-424a-aa70-27d966ed1801 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzMtNS0xLTEtMzY0MDYw_4be8cb3c-bb9d-44c3-8eb5-28d6e296f468 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEwLTUtMS0xLTM2NDA2MA_aa53763e-ddcb-4157-8799-62448793999a" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTItMS0xLTM2NDA2MA_14fc05d6-202f-402c-97a5-aa05fc624d48 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTMtMS0xLTM2NDA2MA_d71cb872-410e-4d33-b50f-03fc06485f4f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ2_7c2dd840-1374-4610-964f-c966ea4bc4b5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMi0xLTEtMzY0MDYw_a2b5688d-defb-4ded-ac13-3ba426e6f75e id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMy0xLTEtMzY0MDYw_b88f5582-854c-44f8-bbdc-f448e42a6399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQz_4413e2d3-0704-4581-a253-6ac595b10cd5" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTItMS0xLTM2NDA2MA_b807f41b-dc17-4fab-9c7a-5edc7a9ddf37 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTMtMS0xLTM2NDA2MA_838ddb06-59ce-45d0-bd06-5ad48488f600" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ0_06a9dadf-45f8-44b4-82fa-41db2fe39be6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTgtMS0xLTM2NDA2MA_66b952c4-dd45-40ca-b631-a61c26f81d02 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTctMS0xLTM2NDA2MA_e3abb3d3-cf48-47c9-b9e2-037b404aa01f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTktMS0xLTM2NDA2MA_357b481e-b9f2-4d99-9307-e25cca9bb8c8" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMQ_98bd5f86-b9de-4fe0-8b4c-07b961a7f844" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctNy0xLTEtMzY0MDYw_c1ae37c7-0636-4eb5-a37d-1fe172200b6d id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtNy0xLTEtMzY0MDYw_80f47a56-a29d-4996-b77c-12bd76af1562 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctMy0xLTEtMzY0MDYw_d7773337-9244-43fc-bbaa-cfef96bffdda id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTItMS0xLTM2NDA2MA_59b04cfd-6682-4d1c-a629-33077e6ffe2c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctOS0xLTEtMzY0MDYw_c02723a3-2291-4b9c-8635-75fbddffe076 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMS0xLTEtMzY0MDYw_af7b7cbd-9a7f-49a4-98d4-85e25892f5b9 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctOS0xLTEtMzY0MDYw_88979adf-c420-4d86-86ac-4d172e42c928 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTItMS0xLTM2NDA2MA_dc1f79e8-2ad8-417d-98c5-247116579faa id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTktMS0xLTM2NDA2MA_d2d61b17-f46d-45c7-a1c5-9aacd7ed7565 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTItMS0xLTM2NDA2MA_01061c07-03f6-4b1a-880a-d3f05103e41f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTctMS0xLTM2NDA2MA_986cf489-8ff4-4209-ad3e-fe78494e8b5a id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTEtMS0xLTM2NDA2MA_d697ad7c-a266-4ec0-852c-7a3b8fe77e34 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTMtMS0xLTM2NDA2MA_4d3f5d84-0e38-4849-96ea-70ecac235e1f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTctMS0xLTM2NDA2MA_a7795b9e-f39e-4240-a4a6-e37101e11a18 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTctMS0xLTM2NDA2MA_ea315a7f-252f-419b-8d4f-db0e553b3e76 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTItMS0xLTM2NDA2MA_cfaed0ab-1e26-4a37-bca1-077606cbdc5a id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTktMS0xLTM2NDA2MA_9ac65895-eb89-4cb3-966c-6affa541fe43 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTctMS0xLTM2NDA2MA_93c318bd-c64d-47b6-bff2-9f2bf1368cb6 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtOS0xLTEtMzY0MDYw_054eede4-8ea9-4866-aeab-74dd86e513ad id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMi0xLTEtMzY0MDYw_4fbe68a1-d00d-41d8-8219-b4f35de27b96 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTktMS0xLTM2NDA2MA_9bd07696-1dde-4504-9b5e-530204637e84 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctNy0xLTEtMzY0MDYw_b3b85699-074d-4b7a-a51b-bb2b00ffeac4 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTktMS0xLTM2NDA2MA_e12d1ed9-a847-4dcb-9553-d3ae72a6114e id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTEtMS0xLTM2NDA2MA_e5014827-23a4-4ba5-bb24-c7e7fae6dc81 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTItMS0xLTM2NDA2MA_f9b8e3a2-a116-441b-87d1-f1c4ecc26dc4 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctMy0xLTEtMzY0MDYw_843c78b6-7768-4ec0-89a4-98462d66f6a5 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTEtMS0xLTM2NDA2MA_3708407a-51d1-4dbe-85b9-85c10719e785 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTctMS0xLTM2NDA2MA_dece824f-4712-4939-ba41-a6b138a7be2f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTctMS0xLTM2NDA2MA_3761d949-ac3c-4c18-bfca-42fb105b8059 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTEtMS0xLTM2NDA2MA_e1f4057a-3d3e-477a-9a08-4c4524aaf0b0 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTktMS0xLTM2NDA2MA_7bc1440f-ea82-44cc-8743-b7ffed1f06ce id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTktMS0xLTM2NDA2MA_2cd2613d-9aa8-490f-937a-c8d907ef0693 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTItMS0xLTM2NDA2MA_b6549c65-de99-4001-8799-8f8e98f4e1e5 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTctMS0xLTM2NDA2MA_a440e3b1-17e1-4af9-a70c-6a3ed6d07c76 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTktMS0xLTM2NDA2MA_5195a35a-d9e7-4bcb-999f-1d0f95a44696 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMy0xLTEtMzY0MDYw_9f35d2b3-a513-4223-921a-aba617b755fc id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTEtMS0xLTM2NDA2MA_74a27fce-bb34-46a6-aa1a-129f0a994827" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEyLTUtMS0xLTM2NDA2MA_46ddbf80-0050-4426-8b6c-24dba48cfd92 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzctNS0xLTEtMzY0MDYw_201dbd4f-11f6-43c8-9ca5-f9512970bc4f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEzLTUtMS0xLTM2NDA2MA_5ee4cc7b-0628-42e2-9a04-07b791d69c0d id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEtNS0xLTEtMzY0MDYw_e1be1a81-e804-4732-bbd2-564fdf52fe38 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzUtNS0xLTEtMzY0MDYw_927575f3-68ba-42ad-a314-702918da5fc8 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzktNS0xLTEtMzY0MDYw_f304b90b-e524-4f21-8eb1-823b3262fd06 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE2LTUtMS0xLTM2NDA2MA_3178df5e-f94d-47a9-a40f-fc62ba791e00 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE1LTUtMS0xLTM2NDA2MA_94cb78bb-07be-4df9-9abd-d3cf5839f88a id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE3LTUtMS0xLTM2NDA2MA_573f49c8-ea1e-458d-9c33-a9f41a087d5c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEwLTUtMS0xLTM2NDA2MA_e5c9c9f0-357f-405f-ae45-814e5df5c370 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzYtNS0xLTEtMzY0MDYw_0ae7ec9b-0808-4d33-ad31-74547492351f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzExLTUtMS0xLTM2NDA2MA_2f978d1d-2381-44fc-9063-65875d18faaf id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzgtNS0xLTEtMzY0MDYw_4989c65b-3d5e-4e45-a863-797e05effa8e id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzItNS0xLTEtMzY0MDYw_c395c9a6-ee3e-41a3-a7f2-da456af52e8f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE0LTUtMS0xLTM2NDA2MA_5abda22f-ef3c-4f38-b583-bdf4dacc3d29 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzMtNS0xLTEtMzY0MDYw_ff64a706-323f-41b7-8aa2-64abbc9e338c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzQtNS0xLTEtMzY0MDYw_ffb8d1e8-2909-41f6-ae5e-8fb6750f17e1" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTItMS0xLTM2NDA2MA_9e18e429-fe52-4c81-a708-2073d2babcf8 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOS0xLTEtMzY0MDYw_3ac6378f-f68a-4f1a-8888-ff27c1940bd6 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNC0xLTEtMzY0MDYw_8375809a-87a8-4244-a166-9de316ecd262 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNi0xLTEtMzY0MDYw_33eaa7e7-913c-45e1-95c3-1eb2f72cee81 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOS0xLTEtMzY0MDYw_96be92e2-3e8d-4f73-aa9d-01e2d758605c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTMtMS0xLTM2NDA2MA_7ec2f7d8-f54d-4e3d-be28-978ea5def617 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNC0xLTEtMzY0MDYw_92ac7881-3d55-420a-b4c2-2fb93c8b0d16 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNC0xLTEtMzY0MDYw_f8be43f1-b0d8-4be1-afb2-aee2ca1e815f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNS0xLTEtMzY0MDYw_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNS0xLTEtMzY0MDYw_85024497-8f3f-4693-bd13-5573dd0fcfc6 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMi0xLTEtMzY0MDYw_9e18e429-fe52-4c81-a708-2073d2babcf8 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOS0xLTEtMzY0MDYw_eb447b21-2a14-46ed-807e-30dd4a2864df id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOC0xLTEtMzY0MDYw_456437df-583f-4c00-9f6b-cd0b97e72e21 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNy0xLTEtMzY0MDYw_e8780054-fa54-4ab7-b9bd-3971d22c2a23 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNy0xLTEtMzY0MDYw_8fe9842c-2530-452e-8bcb-bf5f2008673f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOS0xLTEtMzY0MDYw_023a6c6b-fba0-42f8-9428-48306bc6c7ac id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNi0xLTEtMzY0MDYw_b48cb9d0-b1a6-4e2f-a0c7-3197e8992a22 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOC0xLTEtMzY0MDYw_8d50453b-88c4-41cc-bb0f-46fbbd783c17 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNy0xLTEtMzY0MDYw_019c0649-48f9-40cf-a9ef-572100611c48 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMS0xLTEtMzY0MDYw_54c82653-9a92-445e-8ab8-a3b427009f86 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNi0xLTEtMzY0MDYw_38cc5712-2e8d-47a4-9fb2-b23709a48d33 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNy0xLTEtMzY0MDYw_ef6cb36e-a284-4b73-9bfe-1aa48de80519 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOC0xLTEtMzY0MDYw_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTEtMS0xLTM2NDA2MA_54c82653-9a92-445e-8ab8-a3b427009f86 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTQtMS0xLTM2NDA2MA_100ab860-fe28-4fae-a197-702bde1a726b id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNC0xLTEtMzY0MDYw_140fe7cd-ce4a-4e11-ad35-986fdf070bc4 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTktMS0xLTM2NDA2MA_19f875f9-870d-403b-aca5-d3d399246b17 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTgtMS0xLTM2NDA2MA_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNy0xLTEtMzY0MDYw_c44cfc7a-13ba-4cb5-9268-ca68969a17c6 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMi0xLTEtMzY0MDYw_ac125ec7-8c00-456b-a926-eae2e5fe9e21 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNC0xLTEtMzY0MDYw_100ab860-fe28-4fae-a197-702bde1a726b id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOS0xLTEtMzY0MDYw_19f875f9-870d-403b-aca5-d3d399246b17 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNi0xLTEtMzY0MDYw_4d873dbd-5b16-420c-bc86-3b872b223384 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTUtMS0xLTM2NDA2MA_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTYtMS0xLTM2NDA2MA_33eaa7e7-913c-45e1-95c3-1eb2f72cee81 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOC0xLTEtMzY0MDYw_17dc2a9e-c0a5-4c32-a0f2-c7461a8a0ea5 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOC0xLTEtMzY0MDYw_697a50ed-0ca3-4e2c-9508-8d2b84920b9d id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTctMS0xLTM2NDA2MA_8fe9842c-2530-452e-8bcb-bf5f2008673f id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMS0xLTEtMzY0MDYw_e9272b1a-fe3d-426b-a99f-53e92de05eb9 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMy0xLTEtMzY0MDYw_7ec2f7d8-f54d-4e3d-be28-978ea5def617 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMy0xLTEtMzY0MDYw_98439be4-0899-45a9-8c40-1f08323f2f80" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTMtMS0xLTM2NDA2MA_7d53f1df-0fe1-412c-8d7a-c85744a33900 id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTItMS0xLTM2NDA2MA_fccf220d-081e-4f3e-b8d9-b22352996dc9" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ5_a854f423-a49a-4d25-83ec-b6c61a89c384" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i52f57172a9d7443580346c2d8f39cd2b_1"></div><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_6875"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_4"></div><hr style="page-break-after:always"/><div style="min-height:36.85pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Washington,&#160;D.C. 20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTU0_e4776ca6-ad20-4a85-b9c5-d7bc41b11ccc">20-F</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:DocumentRegistrationStatement" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6Y2NkZDRjYTIxZjcyNGNjMmI1MTQwZjVhOTk3MmJlOGIvdGFibGVyYW5nZTpjY2RkNGNhMjFmNzI0Y2MyYjUxNDBmNWE5OTcyYmU4Yl8wLTAtMS0xLTM2NDA2MA_944e3a85-5386-4ed6-94af-cb299426ac00">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">REGISTRATION STATEMENT PURSUANT TO SECTION&#160;12(b) OR (g)&#160;OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Or</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6Y2NkZDRjYTIxZjcyNGNjMmI1MTQwZjVhOTk3MmJlOGIvdGFibGVyYW5nZTpjY2RkNGNhMjFmNzI0Y2MyYjUxNDBmNWE5OTcyYmU4Yl8yLTAtMS0xLTM2NDA2MA_ba46a748-d96b-49a5-ad0c-fbab95fd7784">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQx_e137de07-fd43-463a-8f4c-4e7cea309e96"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQx_9e574c33-ca9a-453c-b084-fd681f3b2b52">December 31</ix:nonNumeric>, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Or</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6YzBhMmE4YzQ4OTZhNGU5NmJkMTM3MjE5ZWZkN2UzMDUvdGFibGVyYW5nZTpjMGEyYThjNDg5NmE0ZTk2YmQxMzcyMTllZmQ3ZTMwNV8wLTAtMS0xLTM2NDA2MA_6814a180-a6b8-4609-becc-3324fa18088b">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Or</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:DocumentShellCompanyReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6YzBhMmE4YzQ4OTZhNGU5NmJkMTM3MjE5ZWZkN2UzMDUvdGFibGVyYW5nZTpjMGEyYThjNDg5NmE0ZTk2YmQxMzcyMTllZmQ3ZTMwNV8yLTAtMS0xLTM2NDA2MA_d7dd6f7f-847b-4fc4-b96c-b5d0cca317a2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">SHELL COMPANY REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of event requiring this shell company report </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQy_9cb1ca4d-d862-46c9-b153-7f5eb5f4e9e6">001-31368</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQ2_3454d525-cff2-4ea1-8adc-2973ad62e445">Sanofi</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">N/A </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Translation of registrant&#8217;s name into English)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQz_e5fb61d7-ac70-48cf-b382-769fcea7eb96">France</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Jurisdiction of incorporation or organization)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">46<ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM0_adbf5d79-450c-429c-9dce-77de3ad98954">,&#160;avenue de la Grande Arm&#233;e</ix:nonNumeric>, <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTU1_32816357-97c3-4831-a32e-9de70f599c7c">75017</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQ0_790ade07-6a08-443f-bb75-53cd34f0464e">Paris</ix:nonNumeric>, <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQ3_5a55ddc1-cebc-45f0-9597-e77acce072ed">France</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231" name="dei:ContactPersonnelName" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM3_30381c0a-3050-4d25-89f5-b81e327dee32">Roy Papatheodorou</ix:nonNumeric> , Executive Vice President, General Counsel &amp; Head of Legal, Ethics and Business Integrity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">46<ix:nonNumeric contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTU2_83652973-edd6-4f23-ad85-edf49b363d23">,&#160;avenue de la Grande Arm&#233;e</ix:nonNumeric>, <ix:nonNumeric contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM1_84112a4a-30ab-4fdc-9783-f1bf3e70e15c">75017</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTU3_c63f5f20-8846-4764-9cf2-d34557aaed94">Paris</ix:nonNumeric>, <ix:nonNumeric contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM4_a74fc454-d9a3-4c15-831f-8a36895f17c3">France</ix:nonNumeric>. Fax: 011&#160;+&#160;<ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:ContactPersonnelFaxNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM5_45563b60-9420-4194-b99c-cedb15814bd3">33 1 53 77 43 03</ix:nonNumeric>. Tel: 011&#160;+&#160;<ix:nonNumeric contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTUw_e0bc4378-7d5c-4959-a4ef-6fe09790eaee">33</ix:nonNumeric> <ix:nonNumeric contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTUx_0bdb5f67-ad60-41e7-94f5-45524ea9d801">1 53 77 40 00</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Securities registered or to be registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.681%"><tr><td style="width:1.0%"></td><td style="width:42.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.743%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Title of each class:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Trading Symbol</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib8623615aa6f453286593426ee1e8b04_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjE4ZDQwYjE0MWI3NGMxMGE0OTU1NGYzNzY1OTE0MzIvdGFibGVyYW5nZToyMThkNDBiMTQxYjc0YzEwYTQ5NTU0ZjM3NjU5MTQzMl8xLTAtMS0xLTM2NDA2MA_6b34dfbe-f959-4893-8de5-fdf967beeb59">American&#160;Depositary&#160;Shares,&#160;each&#160;representing one half of one ordinary share, par value &#8364;2&#160;per&#160;share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib8623615aa6f453286593426ee1e8b04_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjE4ZDQwYjE0MWI3NGMxMGE0OTU1NGYzNzY1OTE0MzIvdGFibGVyYW5nZToyMThkNDBiMTQxYjc0YzEwYTQ5NTU0ZjM3NjU5MTQzMl8xLTEtMS0xLTUwNzYyMA_cb4a4051-9e14-47aa-85d6-f9f6b7ccc6e9">SNY</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib8623615aa6f453286593426ee1e8b04_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjE4ZDQwYjE0MWI3NGMxMGE0OTU1NGYzNzY1OTE0MzIvdGFibGVyYW5nZToyMThkNDBiMTQxYjc0YzEwYTQ5NTU0ZjM3NjU5MTQzMl8xLTItMS0xLTM2NDA2MA_b691cbc5-c73a-4274-b116-1fe906aff8ac">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i22690d5a55c7403c964aa8af7ad10ad5_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjE4ZDQwYjE0MWI3NGMxMGE0OTU1NGYzNzY1OTE0MzIvdGFibGVyYW5nZToyMThkNDBiMTQxYjc0YzEwYTQ5NTU0ZjM3NjU5MTQzMl8yLTAtMS0xLTM2NDA2MA_dfad37e0-33f0-4ffe-a48b-65f1a15476a6">Ordinary shares, par value &#8364;2&#160;per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i22690d5a55c7403c964aa8af7ad10ad5_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjE4ZDQwYjE0MWI3NGMxMGE0OTU1NGYzNzY1OTE0MzIvdGFibGVyYW5nZToyMThkNDBiMTQxYjc0YzEwYTQ5NTU0ZjM3NjU5MTQzMl8yLTItMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjBhYTcxMjM5NTFjMjQyZTliODUzZWQ1ZGYxNTk2YzEzXzQ_aeb4e946-e6dd-4c3d-a7e0-7573ae40ec0f">NASDAQ Global Select Market</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">*</span></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Securities registered or to be registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Securities for which there is a reporting obligation pursuant to Section&#160;15(d) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">The number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of December&#160;31, 2022 was:</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Ordinary shares: <ix:nonFraction unitRef="shares" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV8xMzQx_89d97625-1efb-48e3-be0c-082184b79f9d">1,260,835,732</ix:nonFraction></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM2_e4ea6c9a-7d1a-4af9-8c4e-57f1b35747b3">Yes</ix:nonNumeric> &#9746;&#160;No &#9744;.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or&#160;15(d) of the Securities Exchange Act of 1934.&#160;&#160;&#160;&#160;Yes &#9744;&#160;&#160;<ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQw_33878abe-008e-453b-a508-f2dad37a5f3d">No</ix:nonNumeric> &#9746;.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or&#160;15(d) of the Securities Exchange Act of&#160;1934 during the preceding 12&#160;months (or&#160;for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTUy_6640f777-e913-4ea4-a034-2a1c051d41df">Yes</ix:nonNumeric> &#9746;&#160;&#160;No &#9744;.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during&#160;the&#160;preceding 12&#160;months (or&#160;for such shorter period that the registrant was required to submit such&#160;files).&#160;  &#160;&#160;&#160;<ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTUz_b6a41c3e-7e32-404e-99c6-72bcf568b051">Yes</ix:nonNumeric> &#9746;&#160;&#160;No &#9744;.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or an emerging growth company. See definition of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221; or &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.465%"><tr><td style="width:1.0%"></td><td style="width:23.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjAwODQzMzNjMzk5NGZlNWJjNDhhNTY4ZTM4NGI0YWIvdGFibGVyYW5nZToyMDA4NDMzM2MzOTk0ZmU1YmM0OGE1NjhlMzg0YjRhYl8wLTAtMS0xLTM2NDA2MA_c1f880d9-c878-4cfe-a00b-4e32abb74e96">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Emerging&#160;growth&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjAwODQzMzNjMzk5NGZlNWJjNDhhNTY4ZTM4NGI0YWIvdGFibGVyYW5nZToyMDA4NDMzM2MzOTk0ZmU1YmM0OGE1NjhlMzg0YjRhYl8wLTctMS0xLTM2NDA2MA_e5a7e529-e224-4dda-a6dc-d28b38644fc5">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> provided pursuant to&#160;Section&#160;13(a) of the Exchange Act.&#160;&#160; &#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)&#160;The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April&#160;5, 2012.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section&#160;404(b) of the Sarbanes-Oxley Act (15&#160;U.S.C.&#160;7262(b)) by the registered public accounting firm that prepared or issued its audit report&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQ4_a48279d3-e93b-4bbd-a48b-6b8cef824cb2" continuedAt="i175fad70942e49879214918581fac184">&#9746;</ix:nonNumeric></span></div><ix:continuation id="i175fad70942e49879214918581fac184"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section&#160;12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive- based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this&#160;filing:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:57.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:DocumentAccountingStandard" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6ZmNlYjI3ZTI1MDRkNDgxOGIzYzU1MTY1ZGY3Mzg0ODgvdGFibGVyYW5nZTpmY2ViMjdlMjUwNGQ0ODE4YjNjNTUxNjVkZjczODQ4OF8wLTItMS0xLTM2NDA2MA_993972a8-acb4-4946-8a67-209f4dcb96ae">International Financial Reporting Standards</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">U.S.&#160;GAAP</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">as issued by the International Accounting Standards Board</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#9744;</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to&#160;follow. Item&#160;17.&#160;&#160; &#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Item&#160;18.&#160;&#160; &#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If this is an annual report, indicate by check mark whether the registrant is a shell company (as&#160;defined in Rule&#160;12b-2 of the Exchange&#160;Act). Yes &#9744; No <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQ1_05dc1da0-3743-4639-8d77-3105e4e8ee27">&#9746;</ix:nonNumeric>. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Not for trading but only in connection with the registration of American Depositary Shares representing such ordinary shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36.85pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_10"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:26pt;font-style:italic;font-weight:400;line-height:120%">Presentation of financial<br/>and&#160;other&#160;information</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements contained in this annual report on Form&#160;20-F have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB) and with IFRS as endorsed by the European Union, as of December&#160;31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Unless the context requires otherwise, the terms &#8220;Sanofi&#8221;, the &#8220;Company&#8221;, the &#8220;Group&#8221;, &#8220;we&#8221;, &#8220;our&#8221; or &#8220;us&#8221; refer to Sanofi and its consolidated subsidiaries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All references herein to &#8220;United&#160;States&#8221; or &#8220;US&#8221; are to the United&#160;States of America, references to &#8220;dollars&#8221; or &#8220;$&#8221; are to the currency of the United&#160;States, references to &#8220;France&#8221; are to the Republic of France, and references to &#8220;euro&#8221; and &#8220;&#8364;&#8221; are to the currency of the European Union member states (including France) participating in the European Monetary&#160;Union.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Brand names appearing in this annual report are trademarks of Sanofi and/or its affiliates, with the exception&#160;of:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">trademarks used or that may be or have been used under license by Sanofi and/or its affiliates, such as Actonel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Actavis or Procter &amp; Gamble depending on the country; Aldurazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of the Biomarin/Genzyme LLC Joint Venture; Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Swedish Orphan Biovitrum AB in Europe; ALTUVIIIO&#8482;, a trademark of Sobi in Europe and in Africa; ANKET&#8482;, a trademark of Innate Pharma; AtomNet</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Atomwise, Inc.; Cialis</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Eli Lilly; Elaprase</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Shire Human Genetic Therapies, Inc.; Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Swedish Orphan Biovitrum AB in Europe; Stamaril</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Institut Pasteur; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Tamiflu</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Hoffmann-La Roche; Vaxelis</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of MSP Vaccine Company (US) and MCM Vaccine B.V. (Netherlands); Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Regeneron in the United States;  </span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">trademarks sold by Sanofi and/or its affiliates to a third party, such as Altace</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of King Pharmaceuticals in the United States; Hyalgan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Fidia Farmaceutici S.p.A.;  Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Regeneron; Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Regeneron in the United States; Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Baxter International Inc.;  StarLink</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Bayer;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">other third party trademarks such as Eylea</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Regeneron; Humalog</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Eli Lilly; Novolog</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and Novorapid</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, trademarks of Novo Nordisk A/S; Plan Bee</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Am&#233;lie Perennou in France; Revlimid</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Celgene Corporation; Stoxx</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Stoxx Ltd; Unisom</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of J&amp;J on certain geographic areas and Paladin Labs Inc. in Canada; Velcade</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Millenium Pharmaceuticals Inc.; and Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a trademark of Glaxo Group Limited (except in the US and Canada).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Not all trademarks related to products under development have been authorized as of the date of this annual report by the relevant health authorities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The data relating to market shares and ranking information for pharmaceutical products, in particular as presented in&#160;&#8220;Item&#160;4.&#160;Information on the Company &#8212;&#160;B.&#160;Business Overview &#8212;&#160;B.6.&#160;Markets &#8212;&#160;B.6.1.&#160;Marketing and distribution&#8221;, are based primarily on sales data excluding vaccines and in constant euros (unless otherwise indicated) on a September&#160;2022 MAT (Moving Annual Total) basis. The data are primarily from a IQVIA local sales audit, supplemented by country-specific sources.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Product indications described in this annual report are composite summaries of the major indications approved in the product&#8217;s principal markets. Not all indications are necessarily available in each of the markets in which the products are approved. The summaries presented herein for the purpose of financial reporting do not substitute for careful consideration of the full labeling approved in each&#160;market.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_13"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:26pt;font-style:italic;font-weight:400;line-height:120%">Cautionary statement regarding<br/>forward-looking statements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This annual report contains certain forward-looking statements within the meaning of applicable federal securities law, including the Private Securities Litigation Reform Act of 1995, as amended. We may also make written or oral forward-looking statements in our periodic reports to the Securities and Exchange Commission on Form&#160;6-K, in our annual report to shareholders, in our offering circulars and prospectuses, in press releases and other written materials and in oral statements made by our officers, directors or employees to third parties. Examples of such forward-looking statements include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">projections of operating revenues, net income, business net income, earnings per share, business earnings per share, capital expenditures, cost savings, restructuring costs, positive or negative synergies, dividends, capital structure or other financial items or ratios;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">statements of our profit forecasts, trends, plans, objectives or goals, including those relating to products, clinical trials, regulatory approvals and competition; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">statements about our future events and economic performance or that of France, the United States or any other countries in which we operate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Words such as &#8220;believe&#8221;, &#8220;anticipate&#8221;, &#8220;can&#8221;, &#8220;contemplate&#8221;, &#8220;could&#8221;, &#8220;plan&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;is designed to&#8221;, &#8220;may&#8221;, &#8220;might&#8221;, &#8220;plan&#8221;, &#8220;potential&#8221;, &#8220;objective&#8221; &#8220;target&#8221;, &#8220;estimate&#8221;, &#8220;project&#8221;, &#8220;predict&#8221;, &#8220;forecast&#8221;, &#8220;ambition&#8221;, &#8220;guideline&#8221;, &#8220;should&#8221;, &#8220;will&#8221;, or the negative of these and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Forward-looking statements involve inherent, known and unknown risks and uncertainties associated with the regulatory, economic, financial and competitive environment, and other factors that could cause actual future results to differ materially from those expressed or implied in the forward-looking statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These risks and uncertainties include risk factors, which could affect future results and cause actual results to differ materially from those contained in any forward-looking statements, and which include those discussed under &#8220;Item&#160;3.&#160;Key Information &#8212;&#160;D.&#160;Risk Factors&#8221;. Additional risks, not currently known or that are currently considered immaterial by the Group, may have the same unfavorable effect and investors may lose all or part of their investment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As a result of these factors, we cannot assure you that the forward-looking statements in this annual report will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame or at all. Moreover, forward-looking statements speak only as of the date they are made. Other than required by law, we do not undertake any obligation to update them in light of new information, future developments or otherwise, except as required by law. These forward-looking statements are based upon information, assumptions and estimates available to us as of the date of this annual report, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">You should read this annual report and the documents that we reference in this annual report and have filed as exhibits completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these statements.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_16"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Abbreviations</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Principal abbreviations used in the Annual Report on Form&#160;20-F</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ADR</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">American Depositary Receipt</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ADS</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">American Depositary Share</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">AFEP</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:2pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Association fran&#231;aise des entreprises priv&#233;es </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(French Association of Large Companies)</span></div></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">AMF</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:2pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Autorit&#233; des march&#233;s financiers </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(the French market regulator)</span></div></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ANDA</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Abbreviated New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">BLA</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Biologic License Application</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">BMS</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bristol-Myers Squibb</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">CEO</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">CER</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Constant exchange rates</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">CGU</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash generating unit</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">CHC</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Consumer Healthcare</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">CHMP</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Committee for Medicinal Products for Human Use</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">COVALIS</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi committee for internal occupational exposure limits </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(Comit&#233; des Valeurs Limites Internes Sanofi)</span></div></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">CVR</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent value right</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">EFPIA</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">European Federation of Pharmaceutical Industries and Associations</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">EMA</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">European Medicines Agency</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">EU</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">European Union</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FCF</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Free cash flow</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FDA</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US Food and Drug Administration</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">GAVI</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Global Alliance for Vaccines and Immunisation</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">GBU</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Global Business Unit</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">GERS</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Groupement pour l'&#201;laboration et la R&#233;alisation de Statistiques</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (French pharmaceutical industry statistics partnership)</span></div></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">GCP</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Good clinical practices</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">GDP</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Good distribution practices</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">GLP</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Good laboratory practices</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">GLP-1</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Glucagon-like peptide-1</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">GMP</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Good manufacturing practices</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">GRI</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Global Reporting Initiative</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hib</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Haemophilus influenzae type b</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">HSE</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Health, Safety and Environment</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">IASB</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ICH</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International Council for Harmonization</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">IFPMA</span></div></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International Federation of Pharmaceutical Manufacturers&#160;&amp; Associations</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">IFRIC</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International Financial Reporting Interpretations Committee</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">IFRS</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International Financial Reporting Standards</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">IPV</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inactivated polio vaccine</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ISIN</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International Securities Identification Number</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">J-MHLW</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japanese Ministry of Health, Labor and Welfare</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LSD</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lysosomal storage disorder</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MEDEF</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:2pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Mouvement des entreprises de France </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(French business confederation)</span></div></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MS</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Multiple sclerosis</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">NASDAQ</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">National Association of Securities Dealers Automated Quotations</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">NDA</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">NHI</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">National Health Insurance (Japan)</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">NYSE</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New York Stock Exchange</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">OECD</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Organisation for Economic Co-operation and Development</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">OPV</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Oral polio vaccine</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">OTC</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Over the counter</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PhRMA</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceutical Research and Manufacturers of America</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PMDA</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals and Medical Devices Agency (Japan)</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PRV</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Priority Review Voucher</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PTE</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patent Term Extension</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">QIV</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Quadrivalent influenza vaccine</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ROA</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Return on assets</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">SA</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:2pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Soci&#233;t&#233; anonyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (French public limited corporation)</span></div></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">SEC</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">SPC</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Supplementary Protection Certificate</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">TRIBIO</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Committee for Biological Risk Prevention (Biosafety, Biosecurity, Biosurveillance)</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">TSR</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total shareholder return</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UNICEF</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Nations Children&#8217;s Emergency Fund</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States of America</span></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-bottom:1pt solid #919191;border-top:1pt solid #919191;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">WHO</span></td><td colspan="3" style="border-bottom:1pt solid #919191;border-top:1pt solid #919191;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">World Health Organization</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_19"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:18.678%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.144%"><tr><td style="width:1.0%"></td><td style="width:4.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.787%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.311%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"><a style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_22">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:right"><span style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_22">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_25">IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_25">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_28">OFFER STATISTICS AND EXPECTED TIMETABLE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_28">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_31">KEY INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_31">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_34">A. Selected Financial Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_34">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_37">B. Capitalization and Indebtedness</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_37">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_40">C. Reasons for Offer and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_40">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_43">D. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_43">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_46">INFORMATION ON THE COMPANY</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_46">16</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_52">A. History and Development of&#160;the&#160;Company</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_52">16</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_55">B. Business Overview</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_55">17</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_115">C. Organizational Structure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_115">53</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_127">D. Property, Plant and Equipment</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_127">54</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;4.A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_142">UNRESOLVED STAFF COMMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_142">56</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_145">OPERATING AND&#160;FINANCIAL REVIEW AND PROSPECTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_145">57</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%">A. <a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_148">Operating results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_148">57</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_217">B. Liquidity and Capital Resources</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_217">78</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_232">C. Off Balance Sheet Arrangements / Contractual Obligations and Other Commercial Commitments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_232">81</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_235">DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_235">83</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_238">A. Directors and Senior Management</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_238">83</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_292">B. Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_292">113</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_316">C. Board Practices</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_316">135</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_319">D. Employees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_319">143</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_322">E. Share Ownership</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_322">144</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_7092">F. Disclosure of action to recover erroneously awarded compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_7092">147</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_325">MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_325">148</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_328">A. Major Shareholders</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_328">148</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_334">B. Related Party Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_334">149</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_337">C. Interests of Experts and Counsel</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_337">149</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_340">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_340">150</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_343">A. Consolidated Financial Statements and Other Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_343">150</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_346">B. Significant Changes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_346">152</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_349">THE OFFER AND LISTING</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_349">153</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_352">A. Offer and Listing Details</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_352">153</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_355">B. Plan of Distribution</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_355">153</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_358">C. Markets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_361">153</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_361">D. Selling Shareholders</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_361">153</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_364">E. Dilution</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_364">153</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_367">F. Expenses of the Issue</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_367">153</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.154%"><tr><td style="width:1.0%"></td><td style="width:4.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.317%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_370">ADDITIONAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_370">154</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_370">A. Share Capital</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_370">154</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%">B<a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_373">. Memorandum and Articles of Association</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_373">154</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_376">C. Material Contracts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_376">158</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_379">D. Exchange Controls</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_379">158</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_382">E. Taxation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_382">158</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_385">F. Dividends and Paying Agents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_385">162</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_388">G. Statement by Experts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_388">162</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_391">H. Documents on Display</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_391">162</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_394">I. Subsidiary Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_394">162</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_397">QUANTITATIVE AND&#160;QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_397">163</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_400">DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_400">167</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"><a style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_415">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:right"><span style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"><a style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_415">169</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_418">DEFAULTS,&#160;DIVIDEND&#160;ARREARAGES AND DELINQUENCIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_418">169</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_421">MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_421">169</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_424">CONTROLS AND PROCEDURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_424">169</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;16A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_427">AUDIT COMMITTEE FINANCIAL EXPERT</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_427">170</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;16B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_430">CODE OF ETHICS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_430">170</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;16C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_433">PRINCIPAL ACCOUNTANTS&#8217; FEES AND&#160;SERVICES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_433">170</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;16D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_436">EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_436">170</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;16E.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_439">PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_439">171</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;16F.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_442">CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_442">171</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;16G.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_445">CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_445">171</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;16H.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_448">MINE SAFETY DISCLOSURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_448">173</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;16I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_451">DISCLOSURES REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_451">173</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"><a style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_454">PART III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:right"><span style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"><a style="color:#7802e6;font-family:'Georgia',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_454">174</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;17.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_457">FINANCIAL STATEMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_457">174</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item&#160;18.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_460">FINANCIAL STATEMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_460">174</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Item 19.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_463">EXHIBITS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_463">174</a></span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_6802"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.096%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr style="height:50pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g1.jpg" alt="sny-20221231_g1.jpg" style="height:52px;margin-bottom:5pt;vertical-align:text-bottom;width:175px"/></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#23004c;font-family:'Arial',sans-serif;font-size:56pt;font-weight:700;line-height:120%">1994</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#86588e;font-family:'Sanofi Serif',serif;font-size:18pt;font-weight:700;line-height:120%">FOUNDED</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:29.068%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.331%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.065%"></td><td style="width:0.1%"></td></tr><tr style="height:59pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:0 1pt"><div style="margin-bottom:8pt;text-align:center"><img src="sny-20221231_g2.jpg" alt="sny-20221231_g2.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:80px"/></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:15pt;font-weight:400;line-height:120%">GLOBAL HEALTHCARE</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#23004c;font-family:'Sanofi Serif',serif;font-size:20pt;font-weight:700;line-height:120%">LEADER</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:8pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:71pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"><div style="margin-bottom:8pt;text-align:center"><img src="sny-20221231_g3.jpg" alt="sny-20221231_g3.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:80px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #7802e6;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"><div style="margin-bottom:8pt;text-align:center"><img src="sny-20221231_g4.jpg" alt="sny-20221231_g4.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:80px"/></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:center"><span style="color:#23004c;font-family:'Sanofi Serif',serif;font-size:24pt;font-weight:700;line-height:120%">90 COUNTRIES</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #7802e6;padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:center"><span style="color:#23004c;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:80%">MARKET CAP</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#23004c;font-family:'Arial',sans-serif;font-size:30pt;font-weight:700;line-height:80%">No.&#160;5</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:center"><span style="color:#7802e6;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">WHERE WE OPERATE</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #7802e6;padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-weight:700;line-height:120%">IN THE CAC 40, DECEMBER 31, 2022</span></td></tr><tr style="height:60pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"><div style="margin-bottom:8pt;text-align:center"><img src="sny-20221231_g5.jpg" alt="sny-20221231_g5.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:80px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #7802e6;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"><div style="margin-bottom:8pt;text-align:center"><img src="sny-20221231_g6.jpg" alt="sny-20221231_g6.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:80px"/></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:center"><span style="color:#23004c;font-family:'Arial',sans-serif;font-size:32pt;font-weight:700;line-height:120%">180</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #7802e6;padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:center"><span style="color:#23004c;font-family:'Arial',sans-serif;font-size:32pt;font-weight:700;line-height:120%">&#8776; 91,000</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#7802e6;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">COUNTRIES WHERE WE DISTRIBUTE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #7802e6;padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#7802e6;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">EMPLOYEES</span></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.093%"><tr><td style="width:1.0%"></td><td style="width:26.294%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.294%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.298%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:63pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:8pt;text-align:center"><img src="sny-20221231_g7.gif" alt="sny-20221231_g7.gif" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:80px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:8pt;text-align:center"><img src="sny-20221231_g8.gif" alt="sny-20221231_g8.gif" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:80px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:8pt;text-align:center"><img src="sny-20221231_g9.gif" alt="sny-20221231_g9.gif" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:80px"/></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">&#8364;31.7bn</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">&#8364;10.3bn</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">&#8364;43.0bn</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:700;line-height:120%">GROSS PROFIT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:700;line-height:120%">BUSINESS NET INCOME</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:700;line-height:120%">NET SALES</span></td></tr></table></div><div style="height:0pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_22"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;1. Identity of Directors, Senior Management and Advisers</span></td></tr></table></div></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:18pt;font-weight:400;line-height:120%">Part&#160;I</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_25"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;1. Identity of Directors, Senior Management and Advisers</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_28"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;2. Offer Statistics and Expected Timetable</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_31"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;3. Key Information</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_34"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A. Selected financial data</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_37"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B. Capitalization and indebtedness</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_40"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C. Reasons for offer and use of proceeds</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_43"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D. Risk factors</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Important factors that could cause actual financial, business, research or operating results to differ materially from expectations are disclosed in this annual report, including without limitation the following risk factors. Investors should carefully consider all the information set forth in the following risk factors and elsewhere in this document before deciding to invest in any of the Company's securities. In addition to the risks listed below, we may be subject to other material risks that as of the date of this report are not currently known to us or that we deem immaterial at this&#160;time.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Risks relating to legal and regulatory matters</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product liability claims could adversely affect our business, results of operations and financial condition</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Product liability is a significant risk for any pharmaceutical company, given that liability claims relating to our industry are unforeseeable by nature. The evolving regulatory environment worldwide (the ever-more stringent regulatory requirements applicable to the pharmaceutical industry, plus more stringent data, quality and supply obligations) clearly impacts our potential liability, and we may incur different liability claims to what we have handled in the past, with regard to their nature, scope and level. Substantial damages have been awarded by some jurisdictions and/or settlements agreed &#8211;&#160;notably in the United States and other common law jurisdictions&#160;&#8211; against pharmaceutical companies based on claims for injuries allegedly caused by the use of their products. Such claims can also lead to product recalls, withdrawals, or declining sales, and/or be accompanied by consumer fraud claims by customers, third-party payers seeking reimbursement of the cost of the product and/or other claims, including potential civil or criminal governmental actions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We are currently defending a number of product liability claims (see Note&#160;D.22.a.) to the consolidated financial statements included at Item&#160;18. of this annual report) notably with respect to Taxotere</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Depakine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and there can be no assurance that we will be successful in defending these claims, or that we will not face additional claims in the future.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Establishing the full side effect profile of a pharmaceutical drug goes beyond data derived from preapproval clinical studies which may only involve several hundred to several thousand patients. Routine review and analysis of the continually growing body of post-marketing safety data and clinical trials provide additional information &#8211;&#160;for example, potential evidence of rare, population-specific or long-term adverse events or of drug interactions that were not observed in preapproval clinical studies. This causes product labeling to evolve over time following interactions with regulatory authorities, which may include restrictions of therapeutic indications, new contraindications, warnings or precautions and occasionally even the suspension or withdrawal of a product marketing authorization. Following any of these events, pharmaceutical companies can face significant product liability claims (see Note&#160;D.22.a.) to the consolidated financial statements included at Item&#160;18. of this annual report).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Furthermore, we commercialize several devices (some of which use new technologies) which, if they malfunction, could cause unexpected damage and lead to product liability claims (see &#8220;Breaches of data security, disruptions of information technology systems and cyber threats could result in financial, legal, business or reputational harm&#8221; below).</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">1</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Although we continue to insure a portion of our product liability with third-party carriers, product liability coverage is increasingly difficult and costly to obtain, particularly in the United States. In the future, it is possible that self-insurance may become the sole commercially reasonable means available for managing the financial risk associated with product liability in our pharmaceuticals and vaccines businesses (see &#8220;Item&#160;4.&#160;Information on the Company &#8212;&#160;B. Business Overview &#8212;&#160;B.9. Insurance and Risk Coverage&#8221;). In cases where we self-insure, the legal costs that we would bear for handling such claims, and potential damage awards to be paid to claimants, could have a negative impact on our financial condition. Due to insurance conditions, even when we have insurance coverage, recoveries from insurers may not be totally successful due to market-driven insurance limitations and exclusions. Moreover, insolvency of an insurer could affect our ability to recover claims on policies for which we have already paid a premium.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Product liability claims, regardless of their merits or the ultimate success of the our defense, are costly, divert management&#8217;s attention, may harm our reputation, and can impact the demand for our products and generate speculative news flows and/or rumors relating to such claims. Substantial product liability claims could materially adversely affect our business, results of operations and financial condition, and/or may have an impact on market perception of our company and negatively affect our stock price.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Claims and investigations relating to ethics and business integrity, competition law, marketing practices, pricing, human rights of workers, data protection and other legal matters could adversely affect our business, results of operations and financial condition</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our industry is heavily regulated and legal requirements vary from country to country, and new requirements are imposed on our industry from time to time. Governments and regulatory authorities around the world have been strengthening implementation and enforcement activities in recent years, including in relation to anti-bribery, anti-corruption and ethical requirements with respect to medical and scientific research, interactions with healthcare professionals and payers, respect of the human rights of workers, and data protection legislation. We also operate in an environment that relies on the collection, processing, analysis and interpretation of large sets of patients&#8217; and other individuals&#8217; personal information, and the operation of our business requires data to flow freely across borders of numerous countries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have adopted a Code of Conduct that requires employees to comply with applicable laws and regulations, as well as the specific principles and rules of conduct set forth in the Code. We also have policies and procedures designed to help ensure that we, our officers, employees, agents, intermediaries and other third parties comply with applicable laws and regulations (including but not limited to the U.S. Foreign Corrupt Practices Act (FCPA), the UK Bribery Act, the OECD Anti-Bribery Convention, the French Anti-Corruption measures law (&#8220;Sapin&#160;II&#8221;), the French duty of vigilance law and other anti-bribery laws and regulations).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Notwithstanding these efforts, failure to comply with laws and regulations (including as a result of a business partner&#8217;s breach) may occur and could result in liabilities for us and/or our management.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">With respect to data protection, legislation such as the General Data Protection Regulation (GDPR) in Europe, the Personal Information Protection Law (PIPL) enacted in 2021 in China, or other significant privacy legislation, including in the United States the California Consumer Privacy Act (CCPA), and case law bring legal uncertainty regarding cross border data flows. Such uncertainty could result in an operational risk limiting or preventing the transfer of data across borders, which may have an impact on our activities (e.g. on clinical trials). The breach of these regulations could also carry financial sanctions and may also harm our reputation and those of our activities that rely on personal data processing. In addition, some uncertainty remains with respect to the legal and regulatory environment for these evolving privacy and data protection laws in the absence of clear guidance.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and certain of its subsidiaries could become the subject of investigations or proceedings by various government entities or could face audits and/or litigation, including allegations of corruption, claims related to employment matters, patent and intellectual property disputes, consumer law claims and tax audits. We are currently defending ourselves in a number of lawsuits relating to pricing and marketing practices (including, for example, &#8220;whistleblower&#8221; litigation in the United States). With respect to tax issues, the complexity of the fiscal environment is such that the ultimate resolution of any tax matter may result in payments that are greater or less than the amounts we have accrued. See &#8220;Item&#160;8.&#160;Financial Information &#8212;&#160;A.&#160;Consolidated Financial Statements and Other Financial Information &#8212;&#160;Information on Legal or Arbitration Proceedings&#8221; and Note&#160;D.22. to our consolidated financial statements included at Item&#160;18. of this annual report. In addition, responding to such investigations is costly and may divert management&#8217;s attention from our business.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Unfavorable outcomes in any of these matters, or in similar matters that may arise in the future, could preclude the commercialization of our products, harm our reputation, negatively affect the profitability of existing products and subject us to substantial fines, punitive damages, penalties and injunctive or administrative remedies, potentially leading to the imposition of additional regulatory controls, monitoring or self-reporting obligations, or exclusion from government reimbursement programs or markets, all of which could have a material adverse effect on our business, results of operations or financial condition.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:right;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The unpredictability of these proceedings could lead Sanofi, after consideration of all relevant factors, to enter into settlement agreements to settle certain claims. Such settlements may involve significant monetary payments and/or potential criminal penalties, and may include admissions of wrongdoing and may require entering into a Corporate Integrity Agreement (&#8220;CIA&#8221;) or a Deferred Prosecution Agreement (in the United States), which is intended to regulate company behavior for a specified number of years. For example, on February&#160;28, 2020, Sanofi US entered into a civil settlement with the United States Department of Justice and agreed to pay approximately $11.85&#160;million to resolve allegations regarding certain charitable donations Sanofi US made to an independent patient assistance foundation that assisted patients being treated for Multiple Sclerosis. In connection with this settlement, Sanofi US also entered into a CIA with the Office of the Inspector General for the United States Department of Health and Human Services effective the same day, which will require us to meet and maintain certain compliance requirements in the United States.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our activities (including our products and manufacturing activities) are subject to significant government regulations and regulatory approvals, which are often costly and could result in adverse consequences to our business if we fail to anticipate the regulations, comply with them, maintain the required approvals, and/or adapt to changes in applicable regulations</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Obtaining a marketing authorization for a product is a long and highly regulated process requiring us to present extensive documentation and data to the relevant regulatory authorities either at the time of the filing of the application for a marketing authorization or later during its review. Each regulatory authority may impose its own requirements which can evolve over time. Each regulatory authority may also delay or refuse to grant approval even though a product has already been approved in another country. Regulatory authorities are increasingly strengthening their requirements on product safety and risk/benefit profiles. All of these requirements, including post-marketing requirements, have increased the costs associated with maintaining marketing authorizations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Moreover, to monitor our compliance with applicable regulations, the FDA, EMA, WHO and comparable national agencies in other jurisdictions routinely conduct regulatory inspections of our facilities, distribution centers, commercial activities and development centers (including hospitals), and may identify potential deficiencies. For example, in November&#160;2020, the FDA issued a Complete Response Letter (CRL) regarding the Biologics License Application (BLA) for sutimlimab, an investigational monoclonal antibody being studied for the treatment of hemolysis in adults with cold agglutinin disease, referring to certain deficiencies identified by the agency during a pre-license inspection of a third-party facility responsible for manufacturing. More generally, if we fail to adequately respond to regulatory inspection observations identified during an inspection, or fail to comply with applicable regulatory requirements at all or within the targeted timeline, we could be subject to enforcement, remedial and/or punitive actions by the FDA (such as a Warning Letter, injunction, seizure or cease and desist order), the EMA or other regulatory authorities. In addition, we have an obligation to monitor and report adverse events and safety signals. In order to comply with these duties, we must regularly train our employees and certain third parties (such as external sales forces and distributor employees) on regulatory matters, including on pharmacovigilance. If we fail to train these people, or fail to train them appropriately, or if they do not comply with contractual requirements, we may be exposed to the risk that safety events are not reported or not reported in a timely manner in breach of our reporting obligations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Due to geopolitical constraints, we may face delays in our clinical trials due to restrictions imposed on clinical trial sites, and/or delays in the initiation and enrollment of patients in our clinical trials, and/or disruptions related to regulatory approvals and/or delays in label expansions for existing products. We may not be able to fully mitigate these delays, which could negatively impact the timing of our pipeline development programs and may have a negative impact on our product development and launches and hence on future product sales, business and results of operations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, all aspects of our business, including research and development, manufacturing, marketing, reimbursement, pricing and sales, are subject to extensive legislation and governmental regulation. Changes in applicable laws and the costs of compliance with such laws and regulations could have an adverse effect on our business.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For example, in response to the European Union regulations for Medical Devices (EU MDR), which entered into force in May&#160;2021, Sanofi created the EU MDR task force. This task force was commissioned to address the risk of potential delays in approvals (for new drug-device combination products, for substantial changes to the design or intended purpose of the device component of already approved drug-device combination products, and for medical devices) and of product discontinuation (for some legacy medical devices), as well as compliance risks for existing products due to increased requirements for post-marketing surveillance, clinical evaluations, traceability and transparency. A similar task force was set up in the first quarter of 2021 to examine risks related to the new regulations for In-Vitro Diagnostic Devices (IVDR) implemented in May&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For information about risks related to changes:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in proprietary rights rules and regulations, see &#8220;&#8211;&#160;We rely on our patents and other proprietary rights to provide exclusive rights to market certain of our products. If such patents and other rights were limited, invalidated or circumvented, our financial results could be adversely affected&#8221; below; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in environmental rules and regulations, see &#8220;&#8211;&#160;Management of the historical contamination related to our past industrial activities could adversely impact our results of operations and reputation&#8221; below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, changes in tax laws or regulations or their interpretation or exposures to additional tax liabilities around the world could negatively impact our operating results. Changes to tax laws or regulations may occur at any time, and any related expense or benefit recorded may be material to the fiscal quarter and year in which the law change is enacted.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">3</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Furthermore, most of the jurisdictions in which we operate have double tax treaties with other foreign jurisdictions, which provide a framework for mitigating the impact of double taxation on our revenues and capital gains. However, the outcome of those mechanisms developed to resolve such conflicting claims can be uncertain and can be expected to be very lengthy. Accruals for tax contingencies are made based on experience, interpretations of tax law, and judgments about potential actions by tax authorities. However, due to the complexity of tax contingencies, the ultimate resolution of any tax matter may result in payments materially different from the amounts accrued.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, the Organization for Economic Co-operation and Development (OECD) launched a new initiative to work toward a global tax framework that ensures inter alia a reallocation of taxing rights to market jurisdictions and also introduces a global standard on minimum taxation combined with new tax dispute resolution processes. We expect there to be a continued focus on tax reform, driven by initiatives by the OECD, as well as the European Union and several jurisdictions where we operate, to address the aforementioned tax challenges, which may result in significant changes to established tax principles and an increase in tax authority disputes. These may be costly, divert management attention and adversely impact our reputation and relationship with key stakeholders</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We rely on our patents and other proprietary rights to provide exclusive rights to market certain of our products. If such patents and other rights were limited, invalidated or circumvented, our financial results could be adversely affected</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Through patent and other proprietary rights, such as data exclusivity or supplementary protection certificates in Europe, we hold exclusivity rights for a number of our research-based products. However, the protection that we are able to obtain varies in its duration and scope. Furthermore, patents and other proprietary rights do not always provide effective protection for our products. We cannot be certain that we will obtain adequate patent protection for new products and technologies in important markets or that such protections, once granted, will last as long as originally anticipated.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For example, governmental authorities are increasingly looking to facilitate generic and biosimilar competition for existing products through new regulatory proposals intended to achieve, or resulting in, changes to the scope of patent or data exclusivity rights and through the use of accelerated regulatory pathways for generic and biosimilar drug approvals. Such regulatory proposals could make patent prosecution for new products more difficult and time consuming or could adversely affect the exclusivity period for our products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Moreover, manufacturers of generic products or biosimilars are increasingly seeking to challenge patent validity or coverage before the patents expire, and manufacturers of biosimilars or interchangeable versions of the products are seeking to have their version of the product approved before the exclusivity period ends. Furthermore, in an infringement suit against a third party, we may not prevail and the decision rendered may not conclude that our patent or other proprietary rights are valid, enforceable or infringed. Our competitors may also successfully avoid our patents. Even in cases where we ultimately prevail in an infringement claim, legal remedies available for harm caused to us by infringing products may be inadequate to make us whole. Moreover, a successful result against a competing product for a given patent or in a specific country is not necessarily predictive of our future success against another competing product or in another country because of local variations in the patents and patent laws.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, if we lose patent protection as a result of an adverse court decision or a settlement, we face the risk that government and private third-party payers and purchasers of pharmaceutical products may claim damages alleging they have over-reimbursed or overpaid for a drug. For example, in 2009, in Australia, our patent on clopidogrel was ultimately held invalid. Following this decision, the Australian Government sought damages for its alleged over-reimbursement of clopidogrel drugs due to the preliminary injunction we had secured against the sale of generic clopidogrel during the course of the litigation. The Australian Government&#8217;s claim was dismissed following a decision of the Federal Court of Australia on April&#160;28, 2020. Sanofi is awaiting the judgment to be delivered by the Federal Court of Australia, following the appeal of the first instance decision by the Australian Government on May&#160;26, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We also rely on unpatented proprietary technology, know-how, trade secrets and other confidential information, which we seek to protect through various measures, including confidentiality agreements with licensees, employees, third-party collaborators, and consultants who may have access to such information. If these agreements are breached or our other protective measures should fail, then our contractual or other remedies may not be adequate to cover our losses.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In certain cases, to terminate or avoid patent litigation we or our collaboration partners may be required to obtain licenses from the holders of third-party intellectual property rights. Any payments under these licenses may reduce our profits from such products and we may not be able to obtain these licenses on favorable terms or at all.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Third parties may also request a preliminary or permanent injunction in a country from a court of law to prevent us from marketing a product if they consider that we infringe their patent rights in that country. If third parties obtain a preliminary or permanent injunction or if we fail to obtain a required license for a country where valid third-party intellectual property rights as confirmed by a court of law exist, or if we are unable to alter the design of our technology to fall outside the scope of third-party intellectual property rights, we may be unable to market some of our products in certain countries, which may limit our profitability.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, the pursuit of valid business opportunities may require us to challenge intellectual property rights held by others that we believe were improperly granted, including through negotiation and litigation, and such challenges may not always be successful. Third parties may claim that our products infringe one or more patents owned or controlled by them. Claims of intellectual property infringement can be costly and time-consuming to resolve, may delay or prevent product launches, and may result in significant royalty payments or damages.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:right;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Furthermore, some countries may consider granting a compulsory license to a third party to use patents protecting an innovator&#8217;s product, which limits the value of the patent protection granted to such products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have increased the proportion of biological therapeutics in our pipeline relative to traditional small molecule pharmaceutical products. Typically, the development, manufacture, sale and distribution of biological therapeutics is complicated by third-party intellectual property rights (otherwise known as freedom to operate (FTO) issues), to a greater extent than for the small molecule therapeutics, because of the types of patents allowed by national patent offices. Further, our ability to successfully challenge third-party patent rights is dependent on the legal interpretation and case law of national courts. In addition, we expect to face increasing competition from biosimilars in the future. With the accelerated regulatory pathways provided in the United States and Europe for biosimilar drug approval, biosimilars can be a threat to the exclusivity of any biological therapeutics we sell or may market in the future and can pose the same issues as the small molecule generic threat described above. If a biosimilar version of one of our products were to be approved, it could reduce our sales and/or profitability of that product.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We currently hold trademark registrations and have trademark applications pending in many jurisdictions, any of which may be the subject of a governmental or third-party objection, which could prevent the maintenance or issuance of the trademark. As our products mature, our reliance on our trademarks and trade dress to differentiate us from our competitors increases and, as a result, our business could be adversely affected if we are unable to prevent third parties from adopting, registering or using trademarks and trade dress that infringe, dilute or otherwise violate our rights.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If our patents and/or proprietary rights to our products were limited or circumvented, our financial results could be adversely affected.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Risks relating to our business</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The pricing and reimbursement of our products is negatively affected by increasing cost containment pressures and decisions of governmental authorities and other third parties</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The commercial success of our existing products and our product candidates depends in part on their pricing and reimbursement conditions. Our products are negatively affected by continued downward pricing pressure and scrutiny due, inter alia, to:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">stricter price and access controls imposed by governments and other payers around the world:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">requirements for greater transparency around drug pricing and drug development costs,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">widespread use of international reference pricing and therapeutic reference pricing, among other pricing methodologies and caps,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">mandatory price cuts, renegotiations, industry payback and rebates,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">delisting from reimbursement and restrictions on the label population,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">access restrictions for high-priced innovative medicines,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">prescribing guidelines and binding medicine utilization controls,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">greater use of tendering and centralized procurement (national/regional/class-wide level),</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">cross-country cooperation in price negotiations, contracting or procurement, which is already occurring to some extent (for example the COVID-19 Vaccines Global Access (COVAX) initiative, the BeNeLuxA alliance in Europe, and the Pan American Health Organization (PAHO)),</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">shifting of the payment burden to US patients and access disruptions through co-pay accumulator and maximizer programs as well as alternative funding programs,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">increased utilization management and restrictive formularies (including stepped therapy, strict prior authorization criteria, formulary exclusions) mainly by US insurers and pharmacy benefits managers (PBMs), and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">discriminatory and non-transparent pricing and procurement policies (e.g. government procurement restrictions, import bans) in favor of domestic pharmaceutical companies;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">widespread use of health technology assessment (HTA) to inform coverage and reimbursement decisions:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">more stringent evidence and value requirements (e.g. comparative effectiveness, patient preferences, real-word evidence, health economic modelling) by payers and HTA authorities, raising the bar for market entry,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">unreasonable thresholds for cost-effectiveness, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">increasingly restrictive HTA decisions with significant variation across markets;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">increased generic and biosimilar competition, accelerating price erosion:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">next-generation biosimilars coming to the market across major therapeutic areas,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">potential savings from increased biosimilar use, expected to be a cumulative $285&#160;billion globally through 2025 according to the IQVIA Institute, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">evolving regulatory landscapes to support interchangeability (e.g. in the US and EU) and pharmacy substitution (e.g. in the EU Nordic countries, Germany and France).</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">5</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the United States, which accounted for 42.5% of our net sales in 2022, the Inflation Reduction Act (IRA) was enacted in August&#160;2022 with drug pricing provisions that became effective in 2022, and will become effective in 2025 and 2026. Key policies related to federal government price negotiations, inflation penalties and Medicare Part&#160;D benefit redesign are likely to have a negative impact on industry revenue growth and future innovation, though there remains significant uncertainty over the negotiation provision and the impact of Medicare reforms.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, the continuing vertical integration and consolidation of the US health insurance market exposes the industry to greater pricing pressure. With the three largest pharmacy benefit manager group purchasing organizations (PBM GPOs) (i.e.&#160;Ascent, Emisar and Zinc) now covering over 85% of prescription drug claims, consolidation has led to increased utilization management and restrictive formularies, resulting in strong bargaining power to negotiate discounted prices, thereby adversely impacting our sales.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other risks include the increasing focus on price transparency, persistent supply chain challenges due to high dependency on API&#160;imports and interest in &#8220;Buy American&#8221; procurement rules. If we had to source APIs from the US, where they are more expensive than in other countries, the current cost containments would not allow us to reflect the corresponding increase on our prices which would impact the margins on our products. Other risks also include continued growth of the federal 340B drug pricing program.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In China, we continue to face increasing local competition. Price pressure is likely to intensify across our portfolio as a growing number of our products are subject to national reimbursement drug list (NRDL) price negotiations and national volume-based procurement (VBP) tenders, with the lowest prices prevailing. Innovative oncology products, in particular, are experiencing additional access challenges, as seen with the exclusion of imported PD-1 inhibitors from the NRDL in the last two years, in favor of domestically developed treatments. Further expansion of the (VBP) policy to biologics and biosimilars also poses a growing threat to our key established products, with over 500&#160;drugs targeted for inclusion by 2025.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Europe, there are risks of tighter cost-containment policies exacerbated by the COVID-19 pandemic, rising inflation and volatile energy prices. Industry payback and mandatory rebates are expected to increase at unprecedented rates in 2023 in major EU markets, particularly in Germany and the UK.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At EU level, there continue to be growing concerns over the current direction of the European Commission&#8217;s wide-ranging Pharmaceutical Strategy for Europe, and the related ongoing review of intellectual property protections and the Orphan Medicines Regulation. The policies under consideration could have a far-reaching impact on our Rare Diseases pipelines, and have the potential to jeopardize incentives for EU innovation and competitiveness. We will pursue our current efforts towards shaping and improving the EU pharmaceutical legislation, while creating the conditions of an EU biopharma innovation ecosystem, based on a vision combining pharmaceutical and industrial strategies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, significant uncertainty remains regarding the impact of the EU HTA Regulation by 2025. Sanofi created an internal EU&#160;HTA task force in early 2022 in order to engage with stakeholders with one voice and ensure preparedness for the new EU&#160;framework.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Furthermore, the EU joint procurement initiative aimed at combining the procurement actions of two or more contracting authorities, as used in the context of COVID-19 pandemic, may gain traction outside the health emergency context, in particular for high-cost medicines and vaccines. We therefore anticipate greater pricing pressure and potential risk of net price transparency. This could have an impact an impact on our Specialty Care portfolio, especially for oncology and rare diseases.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our research and development efforts may not succeed in adequately renewing our product portfolio</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Discovering and developing a new product is a costly, lengthy and uncertain process. To be successful in the highly competitive pharmaceutical industry, we must commit substantial resources each year to research and development in order to develop new products to compensate for decreasing sales of products facing patent expiration and termination of regulatory data exclusivity, introduction of lower-priced generics, or competition from new products of competitors that are perceived as being superior or equivalent to our products. We must pursue both early-stage research and early and late development stages in order to propose a sustainable and well-balanced portfolio of products. In 2022, we spent &#8364;6,706&#160;million on research and development, amounting to 15.6% of our net&#160;sales. Failure to invest in the right technology platforms, therapeutic areas, product classes, geographic markets and/or licensing opportunities could adversely impact the productivity of our pipeline.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We prioritize five potentially transformative therapies in areas of high unmet patient need: fitusiran and ALTUVIIIO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(efanesoctocog alfa) for hemophilia; amlitelimab (atopic dermatitis); Beyfortus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(nirsevimab) for respiratory syncytial virus; and tolebrutinib (multiple sclerosis). We also announced our decision to discontinue our research efforts in diabetes and cardiovascular diseases and refocus our R&amp;D strategy on oncology, immunology and inflammation, multiple sclerosis, neurology and rare diseases and rare blood disorders. In&#160;2021, Sanofi acquired Translate Bio to accelerate the deployment of mRNA technology for the development of new vaccines, including for seasonal influenza, and beyond vaccines, therapeutics where there is a strong unmet medical need. However, mRNA technology is still in its early days and the ability of this technology to produce strong results and safety still remains to be fully asserted; we may also fail to improve our development productivity sufficiently to sustain our pipeline (see also &#8220;&#8211; We may fail to successfully identify external business opportunities or realize the anticipated benefits from our strategic investments or divestments&#8221; below). Other new innovations under investigations, such as natural killer (NK) cells and conditionally activated biologics, raise similar uncertainties.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">6</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:right;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, the competitive landscape includes a high level of uncertainty as numerous companies are working on or may be evaluating similar targets and a product considered as promising at the beginning of its development may become less attractive if a competitor addressing the same unmet need reaches the market earlier. There can be no assurance that any of our product candidates will be proven safe or effective (see &#8220;Item&#160;4. Information on the Company &#8212;&#160;B.&#160;Business Overview &#8212;&#160;B.5. Global Research &amp; Development&#8221;). Over these research and development cycles, usually spanning several years, there is a substantial risk at each stage of development &#8211;&#160;including pre-clinical activities and clinical trials&#160;&#8211; that we will not achieve our goals of safety and/or efficacy and that we will have to abandon a product in which we have invested substantial amounts of money and human resources. For instance, in 2022 patient enrollment of Phase&#160;III tolebrutinib trials paused globally after a decision of the FDA regarding potential side effects. As another example, the global clinical development program of amcenestrant (breast cancer) was discontinued in August&#160;2022 following the outcome of the prespecified interim analysis of a Phase III trial. More and more trials are designed with clinical endpoints of superiority; failure to achieve those endpoints could damage the product&#8217;s outlook and our overall development program.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Decisions concerning the studies to be carried out can have a significant impact on the marketing strategy for a given product. Multiple in-depth studies can demonstrate that a product has additional benefits, facilitating the product&#8217;s marketing, but such studies are expensive and time consuming and may delay the product&#8217;s submission to regulatory authorities for approval.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, following (or in some cases contemporaneously with) the marketing authorization, the dossier is also submitted to governmental agencies and/or national or regional third-party payers (HTA bodies) for review. These HTA bodies evaluate evidence on the value of the new product, assess the medical need it serves, and provide recommendations on the corresponding reimbursement. Such analyses may require additional studies, including comparative studies, which may effectively delay marketing, change the population which the new product treats, and add costs to its development. Our continuous investments in research and development for future products and for the launches of newly registered molecules could therefore result in increased costs without a proportionate increase in revenues, which would negatively affect our operating results and profitability.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Lastly, there can be no assurance that all the products approved or launched will achieve commercial success.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, even after a product reaches the market, certain developments following regulatory approval may decrease demand for our products. Clinical trials and post-marketing surveillance of certain marketed drugs have the potential to raise concerns among some prescribers and patients relating to the safety or efficacy of pharmaceutical products in general, which could negatively affect the sales of such products or lead to increased volatility in market reaction.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Breaches of data security, disruptions of information technology systems and cyber threats could result in financial, legal, competitive, operational, business or reputational harm</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our business depends heavily on the use of interdependent information technology systems, including internet-based systems and digital tools. Certain key areas such as research and development, production and sales are to a large extent dependent on our information systems (including cloud-based computing) or those of third-party providers (including for the storage and transfer of critical, confidential, sensitive or personal information regarding our patients, clinical trials, vendors, customers, employees, collaborators and others). We are therefore vulnerable to cybersecurity attacks and incidents and misuse or manipulation of any of these IT systems could result in exposure of confidential information or the modification of critical data.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We and our third-party service providers, suppliers, contract manufacturers, distributors or other contracting third parties use, to the best of our ability, secure information technology systems for the protection of data and threat detection. Like many companies, we may experience certain of the following events which pose a risk to the security and availability of these systems and networks, and the confidentiality, integrity, and availability of our sensitive data: breakdown, outages, service disruption or impairment, data loss or deterioration in the event of a system malfunction or increasing threat of data theft or corruption in the event of a cyber-attack, security breach, industrial espionage attacks, insider threat attacks, cybercrimes, including state-sponsored cybercrimes, malware, misplaced or lost data, programming or human errors or other similar events. Also, in the event of an attack, U.S. and European legislation related to the financing of terrorism imposes increasing restrictions on payments of ransom. As a result, our ability to recover the data might be limited. Therefore, our business continuity could be at risk if we are unable to recover data through back-ups and restorations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Each of these events could negatively impact important processes, such as scientific research and clinical trials, the submission of outcomes to health authorities for marketing authorizations, the functioning of production processes and the supply chain, compliance with legal requirements, trade secrets, security strategies and other key activities, including Sanofi&#8217;s employees&#8217; ability to communicate between themselves as well as with third parties (see also &#8220;&#8211;&#160;Product liability claims could adversely affect our business, results of operations and financial condition&#8221; above). This could result in material financial, legal, competitive, operational, business or reputational harm.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Although we maintain relevant insurance coverage, this insurance may not be sufficiently available in the future to cover the financial, legal, business or reputational losses that may result from an interruption or breach of our systems. For example, certain types of cyber-attacks could be considered as an Act of War subject to insurance exclusion.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">7</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The manufacture of our products is technically complex, and supply interruptions, product recalls or inventory losses caused by unforeseen events may reduce sales, adversely affect our operating results and financial condition, delay the launch of new products and negatively impact our image</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Many of our products are manufactured using technically complex processes with production constraints, including the need for specialized facilities, trained and certified employees, and highly specific raw materials. We must ensure that all manufacturing processes comply with (i)&#160;current Good Manufacturing Practices (cGMP), (ii)&#160;other applicable regulations issued by governmental health authorities around the world, as well as (iii)&#160;our own quality standards. Third parties supply us with a portion of our raw materials, active ingredients and medical devices, which exposes us to the risk of a supply shortage or interruption in the event that these suppliers are unable to manufacture our products in line with quality standards or if they experience financial difficulties. For example, in 2021 Genzyme sold a manufacturing facility located in Allston Landing in the United States to a third party, which is in particular involved in the production of Cerezyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. We now rely on that third party for certain manufacturing and testing operations pursuant to the terms and conditions of relevant contractual agreements with such third party. The manufacturing and testing operations performed on Genzyme&#8217;s behalf at the Allston Landing facility are subject to the terms of a consent decree requiring ongoing compliance therewith, which was entered into between Genzyme and the US government in&#160;2010. We now rely on the third party that acquired the Allston Landing site to perform manufacturing and testing services on our behalf and to ensure compliance with the terms and conditions of the aforementioned consent decree. We could be subject to product supply risk if the third party is unable to supply product to us and to regulatory action if the third party acquirer of the Allston Landing site fails to comply with applicable laws and regulations, including cGMP, when performing the relevant services.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Epidemics and other public health crises, such as the ongoing COVID-19 pandemic, expose us to risks of a slowdown or temporary suspension in the production of our APIs, raw materials, and some of our products. Any prolonged restrictive measures put in place in order to control an outbreak of contagious disease or other adverse public health development, in any of our principal production sites, may have a material and adverse effect on our manufacturing operations. Any of these factors could adversely affect our business, operating results or financial condition (see &#8220;Item&#160;4. Information on the Company &#8212;&#160;B.&#160;Business Overview &#8212;&#160;B.8.&#160;Production and Raw Materials&#8221; for a description of these outsourcing arrangements and &#8220;The extent to which the COVID-19 pandemic and related developments, including measures implemented in response thereto, may adversely impact our business, operations and financial performance remains uncertain&#8221; below).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our business may require the transformation and adaptation of our plants in order to ensure the continuity of production of our products in sufficient quantities to satisfy demand. This may be necessary to meet the need for the production of new products, including biologics, or to ensure the scaling up production of products under development once approved. This need may also result from new regulatory requirements; for example, the fact that insulin is no longer regulated by the FDA as a drug but rather as a biologic requires significant transformation and adaptation of our insulin manufacturing plant in Frankfurt, with no guarantee that we will manage to complete that plan within the expected time. Furthermore, our biological products, in particular, are subject to the risk of manufacturing stoppages or the risk of loss of inventory because of the difficulties inherent in the processing of biological materials and the potential difficulties in accessing adequate amounts of raw materials meeting required standards. In addition, specific storage and distribution conditions are required for many biological products (for example, cold storage is required for certain vaccines, insulin-based products and some hemophilia products). These production difficulties may also be encountered during testing, which is a mandatory requirement prior to drug products being released. For example, in early 2022, we encountered supply constraints of Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (sarilumab) due to an increase in the global demand for IL-6 receptor blockers and the tocilizumab shortage announced in mid-August&#160;2021. We therefore needed to prioritize access for indicated patients with rheumatoid arthritis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The complexity of our production processes, as well as standards required for the manufacture of our products, subject us to risks because the investigation and remediation of any identified or suspected problems can cause production delays, substantial expense, product recalls or lost sales and inventories, and delay the launch of new products; this could adversely affect our operating results and financial condition, and cause reputational damage and the risk of product liability (see &#8220;&#8211;&#160;Product liability claims could adversely affect our business, results of operations and financial condition&#8221; above). In addition, some of our production sites, and some of our suppliers' and/or contractors&#8217; sites, are located in areas exposed to natural disasters such as floods, earthquakes and hurricanes. Such disasters could be exacerbated by climate change. In the event of a major disaster, we could experience severe destruction or interruption of our operations and production capacity at these sites.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When manufacturing disruptions occur, we may not have alternate manufacturing capacity, particularly for certain biologics. In the event of manufacturing disruptions, our ability to use backup facilities or set up new facilities is more limited because biologics are more complex to manufacture and generally require dedicated facilities. Even though we aim to have backup sources of supply whenever possible, including by manufacturing backup supplies of our principal active ingredients at additional facilities when practicable, we cannot be certain they will be sufficient if our principal sources become unavailable. Switching sources and manufacturing facilities requires significant time and prior approval by health authorities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Supply shortages generate even greater negative reactions when they occur with respect to life saving medicines with limited or no viable therapeutic alternatives. Shortages of specific products can have a negative impact on the confidence of patients, customers and professional healthcare providers and the image of Sanofi and may lead to lower product revenues.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">8</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:right;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A substantial share of the revenue and income of Sanofi depends on the performance of certain flagship products</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As part of the presentation of our strategy in December&#160;2019 we announced our intent to prioritize our activities on growth drivers including Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and our Vaccines operations, which we have identified as key growth drivers. Nevertheless market expansion and new launches of medicines and vaccines may not deliver the expected benefits. We may also encounter failures or delays in our launch strategy (in terms of timing, pricing, market access, marketing efforts and dedicated sales forces), such that our products that may not deliver the expected benefits. The competitive environment for a given product may also have changed by the time of the actual launch, modifying our initial expectations. The need to prioritize the allocation of resources may also cause delays in or hamper the launch or expansion of some of our products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Also, we currently generate a substantial share of our net sales from certain key products (see &#8220;Item&#160;5.&#160;Operating and Financial&#160;Review and Prospects &#8212;&#160;A.2. Results of Operations &#8212;&#160;Year ended December&#160;31, 2022 compared with year ended December&#160;31,&#160;2021 &#8212;&#160;A.2.1.3/Net Sales &#8212;&#160;Pharmaceuticals segment&#8221;). For example, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> generated net sales of &#8364;8,293&#160;million in 2022 representing 19.3% of our net sales for the year and is Sanofi's biggest product in terms of sales.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Among our flagship products, Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> already face generic competition on the market. Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is particularly important; it was one of Sanofi&#8217;s leading products in 2022 with net sales of &#8364;2,259&#160;million. Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, another leading product, is expected to face generic competition in the U.S. starting from March&#160;2023, following a settlement agreement entered into in 2017.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Europe, Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">generic competition is expected in the fourth quarter of 2023. Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has faced generic competition since the end of March&#160;2021 in Europe.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">More generally, an expiration of effective intellectual property protections for our products typically results in the market entry of one or more lower-priced generic competitors, often leading to a rapid and significant decline in revenues on those products (for information regarding ongoing patent litigation see Note&#160;D.22.b.) to the consolidated financial statements included at Item&#160;18. of this annual report).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The introduction of a generic product results in adverse price and volume effects for our branded or genericized products. For example, although we do not believe it is possible to state with certainty what level of net sales would have been achieved in the absence of generic competition, a comparison of our consolidated net sales for 2022 and 2021 for the main products affected by generic and biosimilar competition shows a loss of &#8364;325&#160;million of net sales on a reported basis (see&#160;&#8220;Item&#160;5.&#160;Operating and Financial Review and Prospects &#8212;&#160;A.1.2.&#160;Impacts of Competition from Generics and Biosimilars&#8221;). However, other parameters may have contributed to the loss of sales, such as a fall in the average price of certain products (e.g. Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Furthermore, in general, if one or more of our flagship products were to encounter problems (such as material product liability litigation, unexpected side effects, product recalls, non-approval by the health authorities of a new indication for a marketed product, pricing pressure and manufacturing or supply issues), the adverse impact on our business, results of operations and financial condition could be significant.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We rely on third parties for the discovery, manufacture, marketing and distribution of some of our products</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our industry is both highly collaborative and competitive, whether in the discovery and development of new products, in-licensing, the marketing and distribution of approved products, or manufacturing activities. We expect that we will continue to rely on third parties for key aspects of our business and we need to ensure our attractiveness as a potential partner.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We conduct a number of significant research and development programs and market some of our products in collaboration with other biotechnology and pharmaceutical companies. For example, we currently have a global strategic collaboration with Regeneron on monoclonal antibodies for the development and commercialization of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (sarilumab) and SAR440340 (REGN3500- itepekimab) (see&#160;&#8220;Item&#160;5.&#160;Financial Presentation of Alliances &#8212;&#160;A.1.7.1/&#160;Alliance Arrangements with Regeneron Pharmaceuticals Inc&#8221;). We rely upon Regeneron to successfully carry out their responsibilities with regard to the manufacture and supply of these collaboration antibodies. (see&#160;&#8220;Item&#160;4.&#160;Information on the Company &#8212;&#160;B.&#160;Business Overview&#8221;). Finally, we may also rely on partners to design and manufacture medical devices, notably for the administration of our products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As regards products recently launched or under development for which we have a collaboration agreement with partners, the terms of the applicable alliance agreement may require us to share profits and losses arising from commercialization of such products with our partners. This differs from the treatment of revenue and costs generated by other products for which we have no alliance agreement, and such profit sharing may deliver a lower contribution to our financial results.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We could also be subject to the risk that we may not properly manage the decision-making process with our partners. Decisions may be controlled by, or subject to the approval of our collaboration partners, who may have views that differ from ours. We are also subject to the risk that our partners may not perform effectively, which could have a detrimental effect when our collaboration partners are responsible for the performance of certain key tasks or functions, for example related to manufacturing. Any such failures in the development process or differing priorities may adversely affect our business, including the activities conducted through our collaboration arrangements. We also cannot guarantee that third-party manufacturers will be able to meet our near-term or long-term manufacturing requirements. For instance, following the completion of the spin-off of EUROAPI in&#160;May&#160;2022, EUROAPI became a third-party manufacturer and will continue to manufacture a certain number of APIs for Sanofi. We are also subject to the risk that contract research organizations or other vendors (for instance regarding digital activities) retained by us or our collaboration partners may not perform effectively.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">9</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Any conflicts or difficulties with our partners during the course of these agreements or at the time of their renewal or renegotiation, or any disruption in the relationships with our partners, may affect the development, manufacturing, launch and/or marketing of certain of our products or product candidates and may cause a decline in our revenues or otherwise negatively affect our results of operations.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to the risk of non-payment by our customers</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We run the risk of delayed payments or even non-payment by our customers, which consist principally of wholesalers, distributors, pharmacies, hospitals, clinics and government agencies. This risk is accentuated by recent concentrations among distributors and retailers, as well as by uncertainties around global credit and economic conditions, in particular in emerging markets. As a result, we may be affected by fluctuations in the buying patterns of such customers. The United States poses particular customer credit risk issues because of the concentrated distribution system: our three main customers represented respectively 12%, 8% and 7% of our consolidated net sales in 2022. We are also exposed to large wholesalers in other markets, particularly in Europe. An inability of one or more of these wholesalers to honor their debts to us could adversely affect our financial condition (see Note&#160;D.34. to our consolidated financial statements included at Item&#160;18. of this annual report).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In some countries, some customers are public or subsidized health systems. The economic and credit conditions in these countries may lead to an increase in the average length of time needed to collect on accounts receivable or the ability to collect 100% of receivables outstanding. Because of this context, we may need to reassess the recoverable amount of our debts in these countries during future financial years.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Global economic conditions and an unfavorable financial environment could have negative consequences for our business</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Over the past several years, growth of the global pharmaceutical market has become increasingly tied to global economic growth. In this context, a substantial and lasting slowdown of the global economy, major national economies or emerging markets could negatively affect growth in the global pharmaceutical market and, as a result, adversely affect our business. For example, unpredictable political conditions that currently exist in various parts of the world could have a material negative impact on our business. In particular, armed conflict between Russia and Ukraine escalated in 2022. The degree of impact of the war between Russia and Ukraine is difficult to predict and will depend on developments outside Sanofi&#8217;s control, including, but not limited to the duration and severity of the conflict, and the consequences of the ongoing and additional financial and economic sanctions imposed by governments in response. Other related issues have arisen or are arising such as regional instability; geopolitical uncertainties; adverse effects on fuel and energy costs, supply chains, macroeconomic conditions, inflation, and currency exchange rates in various regions of the world; and exposure of third parties to gas shortages. Collectively, such unstable conditions could, among other things, disturb the international flow of goods and increase the costs and difficulties associated with international transactions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Unfavorable economic conditions have reduced the sources of funding for national social security systems, leading to austerity measures including heightened pressure on drug prices, increased substitution of generic drugs, and the exclusion of certain products from formularies among others (see&#160;&#8220;&#8212;&#160;The pricing and reimbursement of our products is negatively affected by increasing cost containment pressures and decisions of governments and other third parties&#8221; above).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Further, our net sales may be negatively impacted by the continuing challenging global economic environment, as high unemployment, increases in cost-sharing, and lack of developed third-party payer systems in certain regions may lead some patients to switch to generic products, delay treatments, skip doses or use other treatments to reduce their costs. In the United States there has been a significant increase in the number of beneficiaries in the Medicaid program, under which sales of pharmaceuticals are subject to substantial rebates and, in many US states, to formulary restrictions limiting access to brand-name drugs, including ours. Also, employers may seek to transfer a greater portion of healthcare costs to their employees due to rising costs, which could lead to further downward price pressure and/or lower demand.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Consumer Healthcare business could also be adversely impacted by difficult economic conditions, as the financial resources of our customers may be reduced as a result of the economic situation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If economic conditions worsen, or in the event of default or failure of major players including wholesalers or public sector buyers financed by insolvent states, our financial situation, the profitability and results of our operations and the distribution channels of our products may be adversely affected. See also&#160;&#8220;&#8212;&#160;We are subject to the risk of non-payment by our customers&#8221; above.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The extent to which the COVID-19 pandemic and related developments, including measures implemented in response thereto, may adversely impact our business, operations and financial performance remains uncertain</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We are unable to predict the impact on our business, operations and financial results that the COVID-19 pandemic would have if it continued or resumed with force, including insofar it could lead to lower sales and reduced patient demand and usage of certain of our products.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> The information in this section supplements the disclosures required under IFRS&#160;7 as presented in Notes&#160;B.8.7., D.10. and D.34. to our consolidated financial statements, provided at Item&#160;18. of this annual report.</span></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> The information in this section supplements the disclosures required under IFRS&#160;7 as presented in Note&#160;B.8.7. to our consolidated financial statements, provided at Item&#160;18. of this annual report.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">10</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:right;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">While economies around the world tend to reopen their economies, the degree to which COVID-19 adversely impacts our results in the future is outside the Company&#8217;s knowledge or control and will depend on the evolution of the outbreak, its mutation, its severity, the actions taken by government authorities to contain the virus or mitigate its impact, and how quickly and to what extent normal economic and operating conditions can resume. Any resurgence in COVID-19 infections or emergence of new epidemics could result in the imposition of new constraints and prolonged restrictive measures implemented in order to control the spread of the disease.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In an increasingly budget-constrained healthcare environment as economic disruption have continued due to the pandemic, we expect to see a higher pressure on drug prices worldwide and, in the longer term, a reallocation of funding across therapeutic areas, driven in particular by evolving public health priorities, which could negatively impact our business operations (see&#160;&#8220;&#8212;&#160;The pricing and reimbursement of our products is negatively affected by increasing cost containment pressures and decisions of governmental authorities and other third parties&#8221; above). For example, the pandemic may reduce our sales in targeted markets due to lower healthcare spending on other diseases and fewer promotional activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The global COVID-19 pandemic has also exposed us to a disruption or temporary suspension in production of APIs, raw materials and some of other products. A revival of the COVID-19 pandemic or any other pandemic could expose us to a revival of this risk. Extension of the restrictive measures put in place in order to control the pandemic may lead to manufacturing delays or disruptions and supply chain interruptions (including to the extent those measures apply to our third-party suppliers) and may have an adverse effect on our business (see&#160;&#8220;&#8212;&#160;The manufacture of our products is technically complex, and supply interruptions, product recalls or inventory losses caused by unforeseen events may reduce sales, adversely affect our operating results and financial condition, delay the launch of new products and negatively impact our image&#8221; above). Also, a sudden increase in demand for selected medicinal products can result in short-term unavailability or shortages of raw materials.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, we cannot predict or reasonably estimate the impact of any potential long-term changes to the healthcare and pharmaceutical industries from the COVID-19 pandemic.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The increasing use of social media platforms and new technologies present risks and challenges for our business and reputation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We increasingly rely on social media, new technologies and digital tools to communicate about our products and about diseases or to provide health services. The use of these media requires specific attention, monitoring programs and moderation of comments. Political and market pressures may be generated by social media because of rapid news cycles. This may result in commercial harm, overly restrictive regulatory actions and erratic share price performance. In addition, unauthorized communications, such as press releases or posts on social media, purported to be issued by Sanofi, may contain information that is false or otherwise damaging and could have an adverse impact on our image and reputation and on our stock price. Negative or inaccurate posts or comments about Sanofi, our business, directors or officers on any social networking website could seriously damage our reputation. In addition, our employees and partners may use social media and mobile technologies inappropriately, which may give rise to liability for Sanofi, or which could lead to breaches of data security, loss of trade secrets or other intellectual property or public disclosure of sensitive information. Such uses of social media and mobile technologies could have an adverse effect on our reputation, business, financial condition and results of operations.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Risks relating to Sanofi&#8217;s structure and strategy</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may fail to successfully identify external business opportunities or realize<br/>the anticipated benefits from our strategic investments or divestments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We pursue a strategy of selective acquisitions, in-licensing and collaborations in order to reinforce our pipeline and portfolio. We are also proceeding to selective divestments to focus on key business areas. The implementation of this strategy depends on our ability to identify transaction opportunities, mobilize the appropriate resources in order to enter into agreements in a timely manner, and execute these transactions on acceptable economic terms. Moreover, entering into in-licensing or collaboration agreements generally requires the payment of significant &#8220;milestones&#8221; well before the relevant products reach the market, without any assurance that such investments will ultimately become profitable in the long term (see Note&#160;D.21.1. to the consolidated financial statements included at Item&#160;18. of this annual report and also &#8220;&#8212;&#160;We rely on third parties for the discovery, manufacture, marketing and distribution of some of our products&#8221; above). Once a strategic transaction is agreed upon with a third party, we may not be able to complete the transaction in a timely manner or at all.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For newly acquired activities or businesses, our growth objectives could be delayed or ultimately not realized, and expected synergies could be adversely impacted if, for example:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">we are unable to quickly or efficiently integrate those activities or businesses;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">key employees leave; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">we have higher than anticipated integration costs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For instance, in 2019 we had to book a &#8364;2.8&#160;billion impairment on Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, acquired through the Bioverativ acquisition completed in 2018, due to revisions of previous sales projections. As another example, the Translate Bio acquisition referred to above which was completed in 2021 may not generate the expected results in terms of developing new mRNA-based products to meet existing or future needs, and the potential of Translate Bio&#8217;s mRNA platform may not be realized to its full extent or because of the difficulty of integrating the activity quickly and efficiently into the Group.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">11</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We may also miscalculate the risks associated with business development transactions at the time they are made or may lack the resources or ability to access all the relevant information to evaluate such risks properly, including with regard to the potential of research and development pipelines, manufacturing issues, tax or accounting issues, compliance issues, or the outcome of ongoing legal and other proceedings. It may also take a considerable amount of time and be difficult to implement a risk analysis and risk mitigation plan after the acquisition of an activity or business is completed due to lack of historical data. Acquired businesses may not always be in full compliance with legal, regulatory or Sanofi standards, including, for example, current Good Manufacturing Practices (cGMP), which can be costly and time consuming to remedy. As a result, risk management and coverage of such risks, particularly through insurance policies, may prove to be insufficient or ill-adapted.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">With respect to divestments, their financial benefit could be impacted if we face significant financial claims or significant post-closing price adjustments. Furthermore, the value of the assets to be divested may deteriorate while we are in the process of executing our divestment strategy, with the risk that we do not realize the anticipated benefits.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because of the active competition among pharmaceutical groups for business development opportunities, there can be no assurance of our success in completing these transactions when such opportunities are identified.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The globalization of our business exposes us to increased risks in specific areas</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As part of the presentation of our strategy in December&#160;2019, we identified our strong presence in China among our core drivers, with revenue amounting to 7.3% of our net sales in 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Nevertheless, the difficulties in operating in emerging markets, a significant decline in the anticipated growth rate or an unfavorable movement of the exchange rates of currencies against the euro could impair our ability to take advantage of growth opportunities and could adversely affect our business, results of operations or financial condition. For instance, while it continues to be impossible as of the date of this report to predict the economic impact and the magnitude of the ongoing COVID-19 pandemic, if a long-lasting epidemic and prolonged or repeated restrictive measures to control the outbreak were to result in an economic slowdown in any of our targeted markets, it would reduce our sales due to lower healthcare spending on other diseases and fewer promotional activities, and could significantly impact our business operations. Furthermore, it is not possible to predict if or how the current health crisis will impact any particular affected jurisdiction, or to what extent (see also &#8220;&#8212;&#160;Global economic conditions and an unfavorable financial environment could have negative consequences for our business&#8221; and &#8220;The extent to which the COVID-19 pandemic and related developmental authorities, including measures implemented in response thereto, may impact our business, operations and financial performance remains uncertain&#8221; above).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Emerging markets also expose us to more volatile economic conditions, political instability (including a backlash in certain areas against free trade), competition from multinational or locally based companies that are already well established in these markets, the inability to adequately respond to the unique characteristics of emerging markets (particularly with respect to their underdeveloped judicial systems and regulatory frameworks), difficulties in recruiting qualified personnel or maintaining the necessary internal control systems, potential exchange controls, weaker intellectual property protection, higher crime levels (particularly with respect to counterfeit products), and compliance issues including corruption and fraud (see particularly &#8220;&#8212;&#160;Claims and investigations relating to ethics and business integrity, competition law, marketing practices, pricing, human rights of workers, data protection and other legal matters could adversely affect our business, results of operations and financial condition&#8221; above).</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may fail to develop or take advantage of digitalization and prioritizing data as an organizational asset</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have undertaken a number of digital initiatives. Examples include the opening in March&#160;2022 of our Accelerator, an internal unit that functions like a startup within Sanofi to develop products and solutions that will support our mission to transform the practice of medicine with the use of digital, data and artificial intelligence; the Future4Care initiative of June&#160;2021, where we joined a startup incubator along with other CAC40 companies to help nurture the latest and greatest in health tech; our enabled manufacturing facility in the US; and our Darwin real-world data platform. Our success in these efforts will depend on many factors including data quality; technology architecture; entering into successful partnerships and alliances with technology companies; a profound transformation of the organization, including a cultural change among our employees and the development of relevant skills; attracting and retaining employees with appropriate skills and mindsets in a tight labor market; and successfully innovating across a variety of technology fields. The COVID-19 pandemic has accelerated our digital transformation, including in the ways we engage and interact with our stakeholders. However, there is no guarantee that our efforts toward a digital transformation will succeed. More generally, we may fail to capture the benefits of digitalization and valuing data as an enterprise asset at an appropriate cost and/or in a timely manner, and/or enter into appropriate partnerships. Competitors, including new entrants such as tech companies, may outpace us in this fast-moving area. If we fail to adequately integrate digital capabilities into our organization and business model, we could lose patients and market share. This could have an adverse impact on our business, prospects and results of operations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The success of digital initiatives will also depend on our ability to shift our culture to a data-driven culture. This calls for clear ownership and a collectively-owned operating model with supporting tools and competencies to manage data as an asset, and for the definition of a robust life-cycle management process for data that is applied consistently across Sanofi. Good overall management of data supports our overall operations and the delivery of exponential capabilities, including artificial intelligence and machine learning to fulfil our innovation and efficiency ambitions. Failure to do so could result in business, operational and financial harm.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">12</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:right;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may fail to accelerate our operational efficiency</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As part of our strategy, we announced our intent to improve our operating efficiencies to fund growth and expand our business operating income margin.  Nevertheless, there is no guarantee that we will be able to fully deliver these operating efficiencies within the targeted timeline or generate the expected benefits.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unsuccessful management of environmental, social and governance matters could adversely affect our reputation and we may experience difficulties to meet the expectations of our stakeholders</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Companies are increasingly expected to behave in a responsible manner on a variety of environmental, social and governance (ESG) matters, by governmental and regulatory authorities, counterparties such as vendors and suppliers, customers, investors, the public at large and others. This context, driven in part by a rapidly changing regulatory framework in the US and in Europe, is raising new challenges and influencing strategic decisions that companies must take if they wish to optimize their positive impact and mitigate their negative impact on ESG matters.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have adopted an ESG strategy that aims at ensuring global access and affordability, addressing unmet needs with transformative therapies, and minimizing the impact of our activities and products on the climate and the environment. The strategy includes leveraging our personnel&#8217;s experience and making societal impact a key driver of our employees&#8217; engagement. However, despite our strong commitment we could be unable to meet our ESG or other strategic objectives in an efficient and timely manner, or at all.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We may also be unable to meet the ever more demanding criteria used by rating agencies in their ESG assessments process, leading to a downgrading in our rating. Financial investments in companies which perform well in ESG assessments are increasingly popular, and major institutional investors have made known their interest in investing in such companies. Depending on ESG assessments and on the rapidly changing views on acceptable levels of action across a range of ESG topics from investors, we may be unable to meet society&#8217;s or investors&#8217; expectations, our reputation may be harmed, we may face increased compliance or other costs and demand for securities issued by us and our ability to participate in the debt and equity markets may decrease.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our success depends in part on our senior management team and other key employees and our ability to attract, integrate and retain key personnel and qualified individuals in the face of intense competition</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our success depends on the expertise of our senior management team and other key employees. In 2022, there were&#160;2,361&#160;&#8220;Senior Leaders&#8221; within Sanofi. In addition, we rely heavily on recruiting and retaining talented people to help us meet our strategic objectives. We face intense competition for qualified individuals for senior management positions, or in specific geographic regions or in specialized fields such as clinical development, biosciences and devices, or digital and artificial intelligence. Our ability to hire qualified personnel also depends in part on our ability to reward performance, incentivize our employees and pay competitive compensation. Laws and regulations on executive compensation may restrict our ability to attract, motivate and retain the required level of talented people. The inability to attract, integrate and/or retain highly skilled personnel, in particular those in leadership positions, may weaken our succession plans, may materially adversely affect the implementation of our strategy and our ability to meet our strategic objectives, and could ultimately adversely impact our business or results of operations.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Environmental and safety risks of our industrial activities</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks from manufacturing activities and the handling of hazardous materials could adversely affect our results of operations and reputation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Manufacturing activities, such as the chemical manufacturing of the active ingredients in our products and the related storage and transportation of raw materials, products and waste, expose us to risks of industrial accidents that may lead to discharges or releases of toxic or pathogenic substances or other events that can cause personal injury, property damage and environmental contamination, and may result in additional operational constraints, including the shutdown of affected facilities and/or the imposition of civil, administrative, criminal penalties and/or civil damages, and affect Sanofi's reputation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The occurrence of an industrial accident may significantly reduce the productivity and profitability of a particular manufacturing facility and adversely affect our operating results and reputation. Although we maintain property damage, business interruption and casualty insurance that we believe is in accordance with customary industry practices, this insurance may not be adequate to fully cover all potential hazards incidental to our business.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management of the historical contamination related to our past industrial activities could adversely impact our results of operations and reputation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The environmental laws of various jurisdictions impose actual and potential obligations on our Company to manage and/or remediate contaminated sites. These obligations may relate to sites:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">that we currently own or operate;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">that we formerly owned or operated; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">where waste from our operations was disposed.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">13</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These environmental remediation obligations could reduce our operating results. Sanofi accrues provisions for remediation when our management believes the need is probable and that it is reasonably possible to estimate the cost. See&#160;&#8220;Item&#160;4.&#160;Information on the Company &#8212;&#160;B.&#160;Business Overview &#8212;&#160;B.10.&#160;Health, Safety and Environment&#8221; for additional information regarding our environmental policies. In particular, our provisions for these obligations may be insufficient if the assumptions underlying these provisions prove incorrect or if we are held responsible for additional, currently undiscovered contamination. These judgments and estimates may later prove inaccurate, and any shortfalls could have an adverse effect on our results of operations and financial condition. For more detailed information on environmental issues, see&#160;&#8220;Item&#160;4.&#160;Information on the Company &#8212;&#160;B.&#160;Business Overview &#8212;&#160;B.10.&#160;Health, Safety and Environment and Notes&#160;B.12. and D.19.3. to the consolidated financial statements&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We are or may become involved in claims, lawsuits and administrative proceedings relating to environmental matters. Some&#160;current and former Sanofi subsidiaries have been named as &#8220;potentially responsible parties&#8221; or the equivalent under the&#160;US&#160;Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended (also known as&#160;&#8220;Superfund&#8221;), and similar statutes or obligations in France, Germany, Italy, Brazil and elsewhere. As a matter of statutory or contractual obligations, we and/or our subsidiaries may retain responsibility for environmental liabilities at some of the sites of our predecessor companies, or of subsidiaries that we demerged, divested or may divest. We have disputes outstanding regarding certain sites no longer owned or operated by the Company. An adverse outcome in such disputes might have an adverse effect on our operating results. See Note&#160;D.22.d) to the consolidated financial statements included at Item&#160;18. of this annual report and &#8220;Item&#160;8.&#160;Financial Information &#8212;&#160;A.&#160;Consolidated Financial Statements and Other Financial Information &#8212;&#160;Information on Legal or Arbitration Proceedings&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Environmental regulations are evolving</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For example, in Europe, new or evolving regulatory regimes include the Registration, Evaluation, Authorisation and Restriction of Chemicals Regulation; the Classification and Labelling regulations applicable to hazardous chemicals; directives related to the control of major-accident hazards (the &#8220;Seveso&#8221; directives); the Industrial Emission regulations; the Waste Framework</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Directive; the Emission Trading Scheme Directive; the Water</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Framework Directive; the Directive on Taxation of Energy Products and</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Electricity; as well as other regulations aimed at preventing climate change. Stricter environmental, safety and health laws and enforcement policies could result in substantial costs and liabilities to our Company and could subject our handling, manufacture, use, reuse or disposal of substances or pollutants, site restoration and compliance to more rigorous scrutiny than is currently the case. Consequently, compliance with these laws could result in capital expenditures as well as other costs and liabilities, thereby adversely affecting our business, results of operations or financial condition.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Risks related to financial markets</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7.15pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">(3)</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fluctuations in currency exchange rates could adversely affect our results of operations and financial condition</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because we sell our products in numerous countries, our results of operations and financial condition could be adversely affected by fluctuations in currency exchange rates. We are particularly sensitive to movements in exchange rates between the euro and the U.S.&#160;dollar, the Japanese yen, the Chinese yuan, and currencies in emerging markets. In 2022, 42.5% of our net sales were generated in the United&#160;States, </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">23.3% in Europe, and 34.2% </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the Rest of the World region (see the definition in &#8220;Item&#160;5.&#160;Operating and Financial Review and Prospects &#8212;&#160;A/&#160;Operating results&#8221;), including countries that are, or may in future become, subject to exchange controls (including 7.3% in China and 3.8% in Japan). While we incur expenses in those currencies, the impact of currency exchange rates on these expenses does not fully offset the impact of currency exchange rates on our revenues. As a result, currency exchange rate movements can have a considerable impact on our earnings. When deemed appropriate and when technically feasible, we enter into transactions to hedge our exposure to foreign exchange risks. These efforts, when undertaken, may fail to offset the effect of adverse currency exchange rate fluctuations on our&#160;results of operations or financial condition. For more information concerning our exchange rate exposure, see&#160;&#8220;Item&#160;11.&#160;Quantitative and Qualitative Disclosures about Market Risk&#8221;.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> The information in this section supplements the disclosures required under IFRS&#160;7 as presented in Note&#160;B.8.7. to our consolidated financial statements, provided at Item&#160;18. of this annual report.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">14</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:right;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;3. Key Information</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Risks relating to an investment in our shares or ADSs</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign exchange fluctuations may adversely affect the US&#160;dollar value of our ADSs and dividends (if&#160;any) regardless of our operating performance</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Holders of ADSs face exchange rate risks. Our ADSs trade in US&#160;dollars and our shares trade in euros. The value of the ADSs and our shares could fluctuate substantially as the exchange rates between these currencies fluctuate. If and when we pay dividends, they would be denominated in euros. Fluctuations in the exchange rate between the euro and the US&#160;dollar will affect the US&#160;dollar amounts received by owners of ADSs upon conversion by the depositary of cash dividends, if any. Moreover, these fluctuations may affect the US&#160;dollar price of the ADSs on the NASDAQ Global Select Market (NASDAQ) whether or not we pay dividends, in addition to any amounts that a holder would receive upon our liquidation or in the event of a sale of assets, merger, tender offer or similar transaction denominated in euros or any foreign currency other than US&#160;dollars.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Persons holding ADSs rather than shares may have difficulty exercising certain rights as a&#160;shareholder</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Holders of ADSs may have more difficulty exercising their rights as a shareholder than if they directly held shares. For example, if we issue new shares and existing shareholders have the right to subscribe for a pro rata portion of the new issuance, the depositary is allowed, at its own discretion, to sell this right to subscribe for new shares for the benefit of the ADS holders instead of making that right available to such holders. In that case, ADS holders could be substantially diluted. Holders of ADSs must also instruct the depositary how to vote their shares. Because of this additional procedural step involving the depositary, the process for exercising voting rights will take longer for holders of ADSs than for holders of shares. ADSs for which the depositary does not receive timely voting instructions will not be voted at any&#160;meeting. US investors may have difficulty in serving process or enforcing a judgment against us or our directors or executive officers.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales of our shares may cause the market price of our shares or ADSs to decline</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sales of large numbers of our shares, or a perception that such sales may occur, could adversely affect the market price for our shares and ADSs. To our knowledge, L&#8217;Or&#233;al, our largest shareholder, is not subject to any contractual restrictions on the sale of the shares it holds in our Company. L&#8217;Or&#233;al does not consider its stake in our Company as strategic.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our largest shareholder owns a significant percentage of the share capital and voting rights of&#160;Sanofi</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, L&#8217;Or&#233;al held approximately 9.38% of our issued share capital, accounting for approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">16.77</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">% of the voting rights (excluding treasury shares) of Sanofi. See&#160;&#8220;Item&#160;7.&#160;Major Shareholders and Related Party Transactions &#8212;&#160;A.&#160;Major Shareholders&#8221;. Affiliates of L&#8217;Or&#233;al currently serve on our Board of Directors. To the extent L&#8217;Or&#233;al continues to hold a large percentage of our share capital and voting rights, it will remain in a position to exert greater influence in the appointment of the directors and officers of Sanofi and in other corporate actions that require shareholders&#8217; approval.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">15</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_46"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;4. Information on the Company</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;4. Information on the Company</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_49"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Introduction</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is a leading global healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the remainder of this section, a product is referred to either by its international non-proprietary name (INN) or its brand name, which is generally exclusive to the company that markets it. In most cases, the brand names of our products, which may vary from country to country, are protected by specific registrations. In this document, products are identified by their brand names used in France and/or in the&#160;US.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has three principal activities: Pharmaceuticals, Consumer Healthcare, and Vaccines. These activities are operating segments within the meaning of the IFRS&#160;8 accounting standard (see&#160;Note&#160;D.35. to our consolidated financial statements, included at Item&#160;18. of this annual report).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our activities comprise: Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; Neurology &amp; Immunology; Rare Diseases; Oncology; Rare Blood Disorders; General Medicines Core products and General Medicines Non-Core products; Consumer Healthcare; and Vaccines. Unlike our Vaccines and Consumer Healthcare activities, which are also operating segments within the meaning of IFRS&#160;8, our Pharmaceuticals activities are franchises whose performance is monitored primarily on the basis of net sales; the products sold by each of those franchises are included in our Pharmaceuticals operating segment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a presentation of the net sales of our activities for the year ended December 31, 2022, refer to &#8220;Item&#160;5.A.2. &#8212;&#160;Results of Operations &#8212;&#160;Year Ended December 31, 2022 Compared with Year Ended December 31, 2021&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, healthcare authorities issued a number of marketing approvals for Sanofi products. In the United States and Europe, </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Dupixent</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(dupilumab) obtained full authorization for the treatment of eosinophilic esophagitis, and extensions to expand the severe asthma indication to children aged 6&#160;to 11&#160;years and the moderate-to-severe atopic dermatitis indication to children aged 6&#160;months to 5&#160;years. At the end of September&#160;2022, the US Food and Drug Administration (FDA) approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> as the first and only treatment indicated to treat prurigo nodularis for adult patients in the United States, and on December&#160;15, 2022, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> became the first and only targeted medicine approved by the European Commission (EC) to treat prurigo nodularis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA also approved </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Xenpozyme</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid sphingomyelinase deficiency (ASMD) in adult and pediatric patients.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The EC granted marketing authorization for </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (sutimlimab) for the treatment of hemolytic anemia in adult patients with cold agglutinin disease (CAD). CAD is a rare, serious and chronic autoimmune hemolytic anemia, in which the body&#8217;s immune system mistakenly attacks healthy red blood cells and causes their rupture, known as hemolysis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Vaccines, the EC approved </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Beyfortus</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their first RSV season. Beyfortus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is the first and only single-dose passive immunization for the broad infant population; it is being developed jointly by Sanofi and AstraZeneca. The EC also approved </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">VidPrevtyn</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta as a booster for the prevention of COVID-19 in adults aged 18&#160;years and older. Designed to provide broad protection against multiple variants, this protein-based vaccine is based on the Beta variant antigen and includes GSK&#8217;s pandemic adjuvant. VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta is indicated as a booster for active immunization against SARS-CoV-2 in adults who have previously received an mRNA or adenoviral COVID vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Collaborations are essential to our business and a certain number of our products, whether on the market or under development, are in-licensed products relying on third-party rights or technologies.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_52"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A. History and development of the Company</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The current Sanofi corporation was incorporated under the laws of France in 1994 as a </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">soci&#233;t&#233;&#160;anonyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a form of limited liability company, for a term of 99&#160;years. Since May&#160;2011, we have operated under the commercial name &#8220;Sanofi&#8221; (formerly known as Sanofi-Aventis). Our registered office is located at 46, avenue de la Grande Arm&#233;e &#8211; 75017&#160;Paris &#8211; France, our main telephone number is +33&#160;1&#160;53&#160;77&#160;40&#160;00, and our website (which contains information about the company and information filed with and provided to the SEC) is www.sanofi.com. Our principal US&#160;subsidiary&#8217;s office is located at 55&#160;Corporate Drive, Bridgewater, NJ&#160;08807; telephone:&#160;+1&#160;(908)&#160;981&#160;5000.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The SEC maintains an internet site at http://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Main events over the last three years</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On January&#160;23, 2020, following a tender offer, we acquired control of </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Synthorx</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a US clinical-stage biotechnology company based in La&#160;Jolla, California, focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;28, 2020, we completed the acquisition of </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Principia Biopharma&#160;Inc</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">., a late-stage biopharmaceutical company focused on developing treatments for autoimmune diseases.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;8, 2021, Sanofi acquired the entire share capital of </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Kymab</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">16</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;14, 2021, Sanofi finalized the acquisition of </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Translate Bio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a clinical-stage mRNA therapeutics company.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;9, 2021, Sanofi completed the acquisition of </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Kadmon Holdings,&#160;Inc</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. a biopharmaceutical company that discovers, develops, and markets transformative therapies for disease areas of significant unmet medical need.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;8, 2022, Sanofi acquired the entire share capital of the immuno-oncology company </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Amunix Pharmaceuticals, Inc. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(Amunix), thereby gaining access to Amunix&#8217;s innovative Pro-XTEN</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> technology and a promising pipeline of immunotherapies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;3, 2022, Sanofi's General Meeting of Shareholders approved the decision to distribute approximately 58% of the share&#160;capital of </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">EUROAPI</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a European leader in the development, manufacture, marketing and distribution of Active Pharmaceutical Ingredients (APIs), in the form of an exceptional dividend in kind to Sanofi shareholders. On the dividend payment&#160;date of May&#160;10,&#160;2022 (further to the admission of EUROAPI shares to listing on the regulated market of Euronext Paris on&#160;May&#160;6,&#160;2022), Sanofi divested control over EUROAPI and its subsidiaries, resulting in their deconsolidation from the Sanofi consolidated financial statements as of that date. On June&#160;17, 2022 (the date of delivery of the EUROAPI shares to the French State via the French Tech Souverainet&#233; fund), EPIC Bpifrance acquired a 12% equity interest in EUROAPI. Following completion of those transactions, Sanofi retains an equity interest of 30.1% in EUROAPI, which has been accounted for using the equity method since the date of loss of control (see note&#160;D.6. to the consolidated financial statements).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">More detailed information about these changes is provided in Note&#160;D.1. to our consolidated financial statements, included at Item&#160;18. of this Annual Report on Form 20-F.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_55"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B. Business overview</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_58"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.1. Strategy</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The market context for Sanofi</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A number of fundamental trends continue to point to a positive outlook for the pharmaceutical industry. The global population is growing, and aging, and unmet medical needs remain high. Since the beginning of the COVID-19 pandemic, health needs have further increased, strengthening the key roles of innovation in R&amp;D activities and cutting-edge manufacturing. The industry has taken steps to increase R&amp;D productivity, with the objective of launching a higher number of innovative medicines and vaccines. Patients around the world &#8211;&#160;including a rising middle class in emerging markets&#160;&#8211; are demanding better healthcare, empowered by access to more and more information. It is a particularly exciting time scientifically and technologically: the promise of genomics is being realized, immuno-oncology is transforming cancer treatments, and big data is generating new insights into how to diagnose and treat diseases. Digital technologies and advanced data analytics are having a transformative effect across sales and marketing activities, R&amp;D and manufacturing, and are acting as enablers for new businesses.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At the same time, increased geopolitical uncertainties, the economic crisis linked to the COVID-19 pandemic, inflation, supply shortages, and issues around budget tightening will continue to put pressure on healthcare costs, and on the entire healthcare value chain. Although we believe that pharmaceuticals and vaccines will remain a fundamentally attractive business within that value chain, the bar for innovation will most likely continue to rise. Payers will continue to put scrutiny on prices and reimbursement criteria, and demand demonstration of real-life outcomes to confirm the efficacy of medicines and vaccines. This will be coupled with more innovative pricing and contracting practices, and more transparent policies. In view of growing concerns over increasing healthcare costs across global markets, the pharmaceutical industry will be increasingly judged by its contribution to improved access for patients and to the development of innovative, highly cost-effective medicines.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategic framework</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Sanofi &#8220;Play to Win&#8221; strategy is organized around four key priorities: (1)&#160;focus on growth; (2)&#160;lead with innovation; (3)&#160;accelerate efficiency; and (4)&#160;reinvent how we work to drive innovation and growth.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">1) Focus on growth</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;padding-left:8.44pt">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> (dupilumab)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> &#8211; By leveraging the product's unique mechanism of action targeting the type&#160;2 inflammation pathway and its favorable safety profile. Sanofi has raised the Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales peak ambition to more than &#8364;13&#160;billion </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;padding-left:8.44pt">Vaccines</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> &#8211; Our Vaccines business is expected to deliver mid-to-high single digit net sales growth</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(6)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> through differentiated products, market expansions and launches. Contributors to growth are expected to be pediatric combinations, boosters, influenza vaccines, meningitis and the launch of nirsevimab, a monoclonal antibody addressing Respiratory Syncytial Virus (RSV)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(7)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Sanofi has progressed in the field of mRNA technology with the recently established Center of Excellence and the integration of Translate Bio. Of the 10&#160;new vaccine candidates planned to enter the clinic by 2025, 6&#160;will use mRNA technologies to target diseases with high unmet needs and disease burden such as chlamydia and acne. The long-term ambition is to more than double Vaccines sales by the end of the decade based on 2018 sales.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;padding-left:8.44pt">Pipeline</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> &#8211; We are focusing our investments on priority projects, including six potentially transformative therapies in oncology, immunology, hematology, neurology, and vaccines.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> In partnership with Regeneron.</span></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> This new ambition does not include the potential for further potential sales of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> to treat chronic obstructive pulmonary disease (COPD), and upcoming indications.</span></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(6)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Cumulative Annual Growth Rate (CAGR), 2018-2025.</span></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(7)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> In partnership with AstraZeneca.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">17</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">2) Lead with innovation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has prioritized five potentially practice-changing assets in areas of high unmet patient need. These investigational therapies are listed below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;padding-left:8.44pt">Fitusiran</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a small interference RNA therapeutic in development for the treatment of hemophilia&#160;A and&#160;B with or without inhibitors, with the potential to be a first-in-class therapeutic option.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;padding-left:8.44pt">ALTUVIIIO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> (efanesoctocog alpha / antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(8)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a new recombinant factor VIII to prolong protection against bleeding on a once-weekly prophylactic dose in adults and children with hemophilia A. The weekly dose has the ability to maintain factor concentrations at normal or near-normal levels for virtually the entire week, and to provide longer-lasting  protection. On February 22, 2023, the US Food and Drug Administration (FDA) approved ALTUVIIIO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;padding-left:8.44pt">Amlitelimab</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a non-depleting aOX40Ligand monoclonal antibody, has the potential to be a best-in-class treatment for a range of immune-mediated diseases and inflammatory disorders, including moderate-to-severe atopic dermatitis. By targeting OX40-Ligand, amlitelimab aims to restore immune homeostasis between pro-inflammatory and anti-inflammatory T&#160;cells.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;padding-left:8.44pt">Beyfortus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> (Nirsevimab) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(9)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> a monoclonal antibody, is a potentially cost-effective prevention against respiratory syncytial virus (RSV), for all infants. Its high affinity to RSV could potentially allow a single injection to cover the entire RSV season. On&#160;November&#160;4, 2022, the European Commission (EC) granted the first approval worldwide of Beyfortus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (nirsevimab) for the prevention of RSV disease in infants.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;padding-left:8.44pt">Tolebrutinib</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is an oral selective, brain penetrant BTK inhibitor with the potential to be the first disease-modifier to address sources of multiple sclerosis damage in the brain.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To continue fueling our promising pipeline and enhance our position in our core therapeutic areas, we have:</span></div><div style="margin-bottom:3pt;padding-left:14.17pt;text-align:justify;text-indent:-14.17pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.53pt">established a strategic research collaboration and license agreement with Exscientia to develop up to 15&#160;novel small-molecule candidates across oncology and immunology, leveraging Exscientia&#8217;s end-to-end AI-driven platform utilizing actual patient samples;</span></div><div style="margin-bottom:3pt;padding-left:14.17pt;text-align:justify;text-indent:-14.17pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.77pt">entered into a global collaboration and license agreement with ABL Bio, Inc. to advance ABL301 for the treatment of Parkinson's Disease;</span></div><div style="margin-bottom:3pt;padding-left:14.17pt;text-align:justify;text-indent:-14.17pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.01pt">completed the acquisition of Amunix Pharmaceuticals, Inc, adding a promising pipeline of T-cell engagers and cytokine therapies;</span></div><div style="margin-bottom:3pt;padding-left:14.17pt;text-align:justify;text-indent:-14.17pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">iv.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">signed a strategic risk-sharing collaboration with Blackstone under which funds managed by Blackstone Life Sciences (BXLS) will contribute up to &#8364;300&#160;million to accelerate global pivotal studies and the clinical development program for the subcutaneous formulation and delivery of the anti-CD38 antibody Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, to treat patients with multiple myeloma (MM);</span></div><div style="margin-bottom:3pt;padding-left:14.17pt;text-align:justify;text-indent:-14.17pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">v.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.2pt">entered into an exclusive collaboration agreement with Seagen Inc. to design, develop, and commercialize antibody-drug conjugates (ADCs) for up to three cancer targets;</span></div><div style="margin-bottom:3pt;padding-left:14.17pt;text-align:justify;text-indent:-14.17pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">vi.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">signed an exclusive worldwide collaboration agreement with IGM Biosciences, Inc. to create, develop, manufacture, and commercialize IgM antibody agonists against three oncology targets and three immunology/inflammation targets;</span></div><div style="margin-bottom:3pt;padding-left:14.17pt;text-align:justify;text-indent:-14.17pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">vii.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">signed an exclusive worldwide collaboration agreement with Skyhawk Therapeutics, Inc to discover and develop novel small molecules that modulate RNA splicing for challenging oncology and immunology targets;</span></div><div style="margin-bottom:3pt;padding-left:14.17pt;text-align:justify;text-indent:-14.17pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">viii.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:2.92pt">announced a strategic collaboration with Scribe Therapeutics Inc. for the use of Scribe&#8217;s CRISPR genome editing technologies to enable genetic modification of novel natural killer (NK) cell therapies for cancer. The agreement grants Sanofi non-exclusive rights to Scribe&#8217;s proprietary CRISPR platform of wholly-owned enzymes to create ex vivo NK cell therapies;</span></div><div style="margin-bottom:3pt;padding-left:14.17pt;text-align:justify;text-indent:-14.17pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">ix.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.77pt">entered into a co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab in the United States. Teplizumab, developed by Provention, is an anti-CD3 monoclonal antibody approved by the FDA on November&#160;17, 2022 for the delay of clinical type&#160;1 diabetes (T1D) in at-risk individuals, as indicated by the presence of two or more T1D-related autoantibodies.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">3) Accelerate efficiency</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We aim to increase our business operating income (BOI) margin through efficiency initiatives, and by the end of 2022, we had achieved &#8364;2.7&#160;billion of accumulated savings since 2019. We expect that these savings will fund investments in growth drivers, as well as support an increase in our BOI margin. In 2022, we achieved around &#8364;330&#160;million of savings from (i)&#160;limiting spending on lower priority business lines, (ii)&#160;smart spending initiatives in procurement, and (iii) operational excellence in manufacturing and organizational productivity.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To better adapt our industrial capability to our evolving manufacturing needs, we announced in February&#160;2020 a plan to create a leading European company, EUROAPI, dedicated to the development, production and marketing of active pharmaceutical ingredients (API) to third parties as well as to Sanofi. EUROAPI was listed on Euronext Paris in May&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To embrace the transformative effect offered by digital technologies and advanced data analytics, we are investing to become the leading digital healthcare platform for employees, patients and providers. This will help us discover, test and deliver medicines faster, run our business more efficiently, and create engaging digital experiences. The digital transformation required to meet our ambition is under way. We are using advanced algorithms to harvest real world data to support our R&amp;D efforts. We are also developing new go-to-market models by closer physician engagement through a variety of channels, building precision marketing, and providing better e-commerce capabilities. And in parallel, we are investigating the possibility of integrating drugs, devices, data and services, to bring innovative solutions to patients across many different disease areas such as diabetes and atopic dermatitis.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(8)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> In partnership with Swedish Orphan Biovitrum (Sobi).</span></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(9)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">In partnership with AstraZeneca.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">18</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">4) Reinvent how we work</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Transformation and simplification have started, with the aim of increasing empowerment and accountability. To drive implementation of our new culture built on stronger focus, diversity and teamwork, we have streamlined our executive leadership team from fifteen to ten members. One new member was appointed to the executive leadership team: Roy Papatheodorou as General Counsel and Head of Legal, Ethics &amp; Business Integrity in February&#160;2022 (succeeding Karen Linehan). The complete Sanofi Executive Committee now includes the four managers who head up our global business units (Specialty Care, Vaccines, General Medicines, and Consumer Healthcare) as well as the heads of each of the following support functions: Research and Development, Manufacturing &amp; Supply (previously named Industrial Affairs), Finance, People &amp; Culture, Digital and Legal, Ethics &amp; Business Integrity.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The creation of our standalone Consumer Healthcare business unit has progressed in 2022. By year end, we have set up almost all of the legal entities relating to this standalone business, with integrated R&amp;D and manufacturing functions plus dedicated support functions and information technology. We believe this is a unique opportunity to adapt our business model specifically to the needs of the Consumer Healthcare sector, helping us to gain in agility as well as to accelerate our digital transformation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s Corporate Social Responsibility (CSR) strategy aims to build a healthier, more resilient world by contributing access to healthcare for the world&#8217;s poorest people and bringing focus to addressing broader unmet needs. We will continue the fight against infectious diseases such as sleeping sickness and poliomyelitis, while seeking to reduce the environmental impact of our products and of our worldwide operations. Key to tackling the global challenges that face society are our people, who each have a role to play in building a diverse and inclusive workplace.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s CSR Strategy focuses on four building blocks aligned with our Play to Win core business strategy:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">affordable access &#8211; to ensure affordable global access to health, while helping healthcare systems to remain sustainable;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">R&amp;D for unmet needs &#8211; to be at the cutting edge of R&amp;D innovation, to help people live fully and drive growth;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Planet Care &#8211; to minimize the environmental impact of our business through environmental sustainability; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in &amp; beyond the workplace &#8211; to give all Sanofi colleagues the chance to become a leader of change, unlocking the potential of our diverse teams.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital allocation policy</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We will continue to pursue our focused and disciplined capital allocation policy. Our priorities in deploying the cash generated from our three core GBUs and the standalone CHC business are, in the following order: (i)&#160;organic investment; (ii)&#160;business development and merger &amp; acquisition activities, focusing on bolt-on, value-enhancing opportunities to drive scientific and commercial leadership in core therapeutic areas; (iii)&#160;growing the annual dividend; and (iv)&#160;anti-dilutive share buybacks. We also have the potential to raise capital through asset disposals, including streamlining &#8220;tail&#8221; brands in our Established Products and Consumer Healthcare business.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_61"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.2. Main pharmaceutical products</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The sections below provide additional information on our main products. Our intellectual property rights over our pharmaceutical products are material to our operations and are described at &#8220;B.7.&#160;Patents, Intellectual Property and Other Rights&#8221; below. As disclosed in&#160;&#8220;8.&#160;Financial Information &#8212;&#160;A.&#160;Consolidated Financial Statements and Other Financial Information &#8212;&#160;Patents&#8221; of this annual report, we are involved in significant litigation concerning the patent protection of a number of these&#160;products. For more information on sales performance, see&#160;&#8220;Item&#160;5.&#160;Operating and Financial Review and Prospects &#8212;&#160;A. Operating Results&#8221;.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_64"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Care</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (dupilumab) is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not an immunosuppressant. Dupilumab is jointly developed by Sanofi and Regeneron under a global collaboration agreement. To date, dupilumab has been studied across more than 60&#160;clinical trials involving more than&#160;10,000&#160;patients with various chronic diseases driven in part by type&#160;2 inflammation. The dupilumab development program has shown significant clinical benefit and a decrease in type&#160;2 inflammation in Phase&#160;III trials, establishing that IL-4 and IL-13 are key and central drivers of the type&#160;2 inflammation that plays a major role in multiple inflammatory diseases, such as atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis and prurigo nodularis. Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comes in either a pre-filled syringe for use in a clinic or at home by self-administration as a subcutaneous injection or in a pre-filled pen for at-home administration, providing patients with a more convenient option. Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is available in all major markets including the US (since April&#160;2017), most European Union countries (the first launch was in Germany in December&#160;2017), and Japan (since April&#160;2018).</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atopic Dermatitis</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Moderate-to-severe AD, a form of eczema and a chronic inflammatory disease, is characterized by rashes that sometimes cover much of the body and can include intense, persistent itching and skin dryness, cracking, redness, crusting and oozing. 85&#160;to 90&#160;percent of patients first develop symptoms before 5&#160;years of age, which can often continue through adulthood.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">19</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2014 the FDA granted Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Breakthrough Therapy designation and after a Priority Review evaluation, in March&#160;2017 it granted Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> marketing authorization for the treatment of adults with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable. In 2016, the FDA granted Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Breakthrough Therapy designation for adolescent patients aged 12 to 17&#160;years and in March&#160;2019, the FDA extended the marketing authorization for this age group.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2016, the FDA granted Breakthrough Therapy designation for Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the treatment of severe AD in children aged 6&#160;months to 11&#160;years. On May&#160;26, 2020, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved as the first biologic medicine for children aged 6&#160;to 11&#160;years with moderate-to-severe AD. On June&#160;7, 2022, after accepting Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for Priority Review in February, the FDA approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for children aged 6&#160;months to 5&#160;years with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable, making Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> the first biologic medicine to significantly reduce signs and symptoms in children as young as 6&#160;months.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The European Commission (EC) approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in September&#160;2017 for use in adults with moderate-to-severe AD who are candidates for systemic therapy, and extended the marketing authorization in August&#160;2019 to include adolescents aged 12&#160;to 17&#160;years. On&#8239;November&#160;30, 2020, the EC extended the marketing authorization to children aged 6&#160;to 11&#160;years with severe AD and on June&#160;28, 2021, the Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Summary of Product Characteristics (SmPC) was updated with long-term data for up to 3&#160;years, reinforcing the product's well-established safety profile in adults with moderate-to-severe AD. On January&#160;27, 2023 the CHMP adopted a positive opinion for Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> recommending expanded approval in the EU to treat severe atopic dermatitis in children 6&#160;months to 5&#160;years old who are candidates for systemic therapy. The EC is expected to announce a final decision on the Dupixent application in the coming months.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On June&#160;19, 2020, the National Medical Products Administration (NMPA) in China approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for adults for the treatment of moderate-to-severe AD after identifying dupilumab as an overseas medicine regarded as urgently needed in clinical practice, leading to an expedited review and approval process. On December&#160;28, 2020, the National Healthcare Security Administration (NHSA) officially announced the results of the 2020 National Reimbursement Drug List (NRDL) negotiations, with Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> 300&#160;mg included in the updated NRDL effective March&#160;1, 2021. Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved in China in September&#160;2021 for adolescents aged 12-17&#160;years with moderate-to-severe atopic dermatitis. The indication for children aged 6&#160;years and over, along with the adolescent and adult AD indications, was included in the current NRDL reimbursement scope, which was reviewed during the Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> NRDL renewal in 2022 in accordance with the two-year cycle for the China access process.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In March&#160;2022, at the annual meeting of the American Academy of Dermatology (AAD 2022), Sanofi presented results from a long-term efficacy open-label study where dupilumab demonstrated robust and sustained efficacy with progressive improvement of AD signs and symptoms in adults with moderate-to-severe AD who completed up to 4&#160;years of treatment: the longest duration of data for any biologic medicine in this disease. Additionally, the long-term safety data from a 52-week open-label extension trial in&#160;6&#160;months to 5&#160;years reinforces the well-established safety profile of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> observed across all other approved age groups. This data built on the existing wealth of evidence supporting the selective way Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> inhibits IL4/IL-13 pathways, both key and central drivers of the type&#160;2 inflammation, thereby significantly improving itch and skin lesions and other important measures that impact a patient&#8217;s quality of life.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asthma</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was granted marketing authorization by the FDA in October&#160;2018 as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12&#160;years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma. In May&#160;2019, the European Commission approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for use as an add-on maintenance treatment in severe asthma patients aged 12&#160;years and older with type&#160;2 inflammation whose symptoms are inadequately reduced by other treatments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2020, new long-term data from a Phase&#160;III open-label extension trial showed sustained improvement in lung function and reduction in severe exacerbations in adults and adolescents with moderate-to-severe asthma. On May&#160;17, 2021, detailed results from a Phase&#160;III trial showed Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> significantly</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">reduced severe asthma attacks, and within two weeks rapidly improved lung function in children aged 6&#160;to 11&#160;years with uncontrolled moderate-to-severe asthma with evidence of type&#160;2 inflammation. Moreover, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">significantly improved overall asthma symptom control and reduced an airway biomarker of type&#160;2 inflammation, called fractional exhaled nitric oxide (FeNO), that plays a major role in asthma.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In October&#160;2021, the FDA approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> as an add-on maintenance treatment for patients aged 6&#160;to 11&#160;years with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid-dependent asthma, thereby bringing a new treatment for children who may be suffering from life-threatening asthma attacks and poor lung function affecting their ability to breathe, which could potentially continue into adulthood. On April&#160;7, 2022, the European Commission approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for use in children aged 6&#160;to 11&#160;years as an add-on maintenance treatment for severe asthma with type&#160;2 inflammation characterized by raised blood eosinophils and/or raised fractional exhaled nitric oxide (FeNO), whose symptoms are inadequately reduced with medium to high dose inhaled corticosteroids (ICS) plus another medicinal product for maintenance treatment.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chronic rhinosinusitis with nasal polyposis (CRSwNP)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">CRSwNP is a chronic disease of the upper airway that obstructs the sinuses and nasal passages. It can lead to breathing difficulties, nasal congestion and discharge, reduced or loss of sense of smell and taste, and facial pressure.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;2019, the FDA approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for use with other medicines to treat CRSwNP in adults whose disease is not controlled. In October&#160;2019, the European Commission approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for use as an add-on therapy with intranasal corticosteroids in adults with severe CRSwNP for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eosinophilic esophagitis (EoE)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">EoE is a chronic and progressive inflammatory disease that damages the esophagus and prevents it from working properly; swallowing even small amounts of food can be a painful and worrisome choking experience. In severe cases, a feeding tube may be the only option to ensure proper calorific intake and adequate nutrition. Of the approximately 209,000&#160;patients aged 12&#160;years and older living with EoE in the&#8239;US who are currently treated with therapies not specifically approved for the disease, about&#160;42,000&#160;continue to experience symptoms despite multiple treatments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;14, 2020, the FDA granted Breakthrough Therapy designation to Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the treatment of patients 12&#160;years and older with EoE, and subsequently accepted the file for Priority Review on April&#160;4, 2022. On May&#160;20, 2022, the FDA approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to treat patients with EoE aged 12&#160;years and older. With this approval, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> became the first and only medicine specifically indicated to treat EoE in the U.S.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;16, 2022, EMA&#8217;s CHMP adopted a positive opinion, recommending the approval of dupilumab in the EU to treat adults and adolescents with EoE. On January&#160;30, 2023, the EC expanded marketing authorization for Dupixent in the EU to treat EoE in adults and adolescents 12&#160;years and older, submissions to regulatory authorities in additional countries are planned in&#160;2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">There are currently no approved treatments specifically indicated for children under 12&#160;years of age with EoE. On July&#160;14, 2022, a Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Phase&#160;III trial showed positive results in children aged 1&#160;to 11&#160;years with EoE, making this the fifth pediatric pivotal trial across three type&#160;2 inflammatory diseases to reinforce the well-established efficacy and safety profile of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The corresponding data will be submitted to regulatory authorities around the world, starting with the FDA in 2023.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prurigo Nodularis (PN)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Prurigo nodularis is a chronic, </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">debilitating skin disease with underlying type&#160;2 inflammation and has one of the highest impacts on a patient&#8217;s quality of life among inflammatory skin diseases due to the extreme itch it causes.</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Those</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> with prurigo nodularis experience intense, persistent itch, with thick skin lesions (called nodules) that can cover most of the body. The disease is often painful &#8211; with burning, stinging and tingling of the skin &#8211; and can negatively affect mental health, daily living activities and social interactions. High-potency topical steroids are commonly prescribed but are associated with safety risks if used long-term.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA evaluated the Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> application for prurigo nodularis under Priority Review on May&#160;31, 2022. On September&#160;29,&#160;2022, the FDA </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the treatment of adult patients with prurigo nodularis. With this approval, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> became the first and only medicine specifically indicated to treat prurigo nodularis in the US. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA approval was&#160;based on data from two Phase&#160;III trials evaluating the efficacy and safety of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in adults with prurigo nodularis. Efficacy in&#160;these trials assessed the proportion of subjects with clinically meaningful reduction in itch, clearing of skin, or both.&#160;On&#160;December&#160;15, 2022, the EC has expanded the marketing authorization for Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the EU to treat adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy, after the positive recommendation earlier on&#160;November&#160;11,&#160;2022.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chronic Spontaneous Urticaria (CSU)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">CSU is a chronic inflammatory skin disease characterized by the sudden onset of hives on the skin and/or swelling deep under the skin. Despite standard-of-care treatment, people with CSU often experience symptoms including a persistent itch or burning sensation, which can be debilitating and significantly impact quality of life. Swelling often occurs on the face, hands and feet, but can also affect the throat and upper airways. On July&#160;29, 2021 a pivotal Phase&#160;III trial evaluating Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in patients with moderate-to-severe CSU met its primary endpoints and all key secondary endpoints at 24&#160;weeks. Adding Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to standard-of-care antihistamines significantly reduced itch and hives for biologic-naive pa</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">tients, compared to those treated with antihistamines alone (placebo) in Study&#160;A (the first of two trials) of the LIBERTY CUPID clinical program.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Study&#160;B of the clinical trial evaluated Dupixent</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in adults and adolescents who remain symptomatic despite standard-of-care treatment and are intolerant or incomplete responders to an anti-IgE therapeutic (omalizumab). Although positive numerical trends in reducing itch and hives were observed, the study was stopped due to futility based on a pre-specified interim analysis. The safety data were generally consistent with the known safety profile of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in its approved indications. In&#160;December&#160;2022, CSU was submitted to FDA, if granted Dupixent</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">has the potential to add additional ~308K patients in the US.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Life cycle management</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently being evaluated in clinical development programs for diseases that are driven by type&#160;2 inflammation. These include, chronic obstructive pulmonary disease (COPD), chronic inducible cold urticaria (CINDU), bullous pemphigoid (BP), chronic rhinosinusitis without nasal polyposis (CRSsNP), and allergic fungal rhinosinusitis (AFRS). See &#8220;&#8212; B.5. Global Research &amp; Development&#8221;.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">21</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is developed and commercialized in collaboration with Regeneron. For additional information on the collaboration, see&#160;&#8220;Item&#160;5. Operating and Financial Review and Prospects &#8212; A.1.7.&#160;Financial Presentation of Alliances &#8212; Alliance Arrangements with Regeneron&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">There are ongoing opposition pro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ceedings in Europe related to Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">initiated by Sanofi and Regeneron against Amgen and Immunex. See Note&#160;D.22.b.) to the consolidated financial statements included at Item&#160;18. of this annual report.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Neurology &amp; Immunology</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiple Sclerosis</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Multiple sclerosis (MS) is an autoimmune neurological disease in which a person&#8217;s immune system attacks the central nervous system, damaging myelin, the protective sheath that covers nerve fibers. This causes a break in communication between the brain and the rest of the body, ultimately destroying the nerves themselves, and causing irreversible damage. More than&#160;2.5&#160;million people suffer from&#160;MS&#160;worldwide.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our MS franchise consists of Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (teriflunomide), a once-daily, oral immunomodulator, and Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (alemtuzumab), a monoclonal antibody. Both products treat patients with relapsing forms of MS.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (teriflunomide), a small molecule immunomodulatory agent with anti-inflammatory properties, is a once-daily oral therapy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is approved in more than 80&#160;countries around the world including the US (since September&#160;2012) for the treatment of patients with relapsing forms of MS; the EU (since August&#160;2013) for the treatment of adult patients with relapsing remitting MS; and China (since&#160;July&#160;2018). In June&#160;2021, the European Commission (EC) approved Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the treatment of pediatric patients aged 10&#160;to 17&#160;years with relapsing-remitting multiple sclerosis (RRMS). In the European Union, generic competition is expected in the fourth quarter of 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2017, Sanofi reached settlement with all 20&#160;generic Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> ANDA first filers, granting each a royalty-free license to enter the&#160;US&#160;market on March&#160;12, 2023.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (alemtuzumab) is a humanized monoclonal antibody targeting the CD52 antigen. Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is administered by intravenous infusion as two short courses 12&#160;months apart; for the majority of patients no further treatment is necessary, making Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> the only disease-modifying therapy (DMT) that can provide long term durable efficacy in the absence of continuous dosing.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is approved in more than 70&#160;countries including the EU (since September&#160;2013) and the US (since November&#160;2014). Because of its safety profile, the FDA approved the use of Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in patients with relapsing forms of MS who have had an inadequate response to two or more drugs indicated for the treatment of MS, and included a black-box warning on potential side effects. In the US, Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is only available through a restricted distribution program called the Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Risk Evaluation and Mitigation Strategy (REMS) Program. In January&#160;2020, the EMA updated the indication for Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to include treatment of relapsing-remitting multiple sclerosis if the disease is highly active despite treatment with at least one disease-modifying therapy, or if the disease is worsening rapidly. The EMA also added new contra-indications for patients with certain heart, circulation or bleeding disorders, and those who have autoimmune disorders other than MS.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bayer Healthcare receives contingent payments based on alemtuzumab global sales revenue. For additional information, see&#160;Note&#160;D.18.&#160;to our consolidated financial statements, included at Item&#160;18. of this annual report.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rheumatoid Arthritis</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease causing inflammation, pain, and eventually joint damage and disability.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (sarilumab) is a human monoclonal antibody that binds to the interleukin-6 receptor (IL-6R) and has been shown to inhibit IL-6R mediated signaling IL-6 is a cytokine in the body that, in excess and over time, can contribute to the inflammation associated with rheumatoid arthritis. Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is available in 20&#160;countries, including the US.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In May&#160;2017, the FDA approved Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the treatment of adult patients with moderately to severely active RA who have had an inadequate response or intolerance to one or more disease modifying anti-rheumatic drugs (DMARDs), such as methotrexate. In&#160;June&#160;2017, the European Commission granted marketing authorization for Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with methotrexate for the treatment of moderately to severely active RA in adult patients who have responded inadequately to &#8211;&#160;or who are intolerant to&#160;&#8211; one or more&#160;DMARDs, such as methotrexate. An sBLA for Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in polymyalgia rheumatica (PMR) is currently under priority review by the FDA, and the product is also being investigated in Polyarticular Juvenile Idiopathic Arthritis and Systemic Juvenile Arthritis. See &#8220;&#8212;&#160;B.5.&#160;Global Research&#160;&amp;&#160;Development&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is developed and commercialized in collaboration with Regeneron. For additional information, see&#160;&#8220;Item&#160;5.&#160;Operating and Financial Review and Prospects &#8212;&#160;A.1.7. Financial Presentation of Alliances &#8212;&#160;Alliance Arrangements with Regeneron&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">22</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Rare diseases</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Rare Diseases business is focused on products for the treatment of rare genetic diseases and other rare chronic debilitating diseases of high unmet medical need, including lysosomal storage disorders (LSDs), a group of metabolic disorders caused by enzyme deficiencies.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cerezyme</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Cerezyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (imiglucerase) is an enzyme replacement therapy used to treat Gaucher disease, a chronic, inherited, progressive and potentially life-threatening LSD. Gaucher disease is caused by deficiency of the enzyme glucocerebrosidase; this causes a fatty substance called glucosylceramide (also called GL-1) to build up in certain areas of the body including the spleen, liver, and bone. Gaucher disease exhibits diverse manifestations, a broad range of age of onset of symptoms, and a wide clinical spectrum of disease severity. It is estimated that Gaucher disease occurs in approximately one in 120,000&#160;newborns in the general population and one in 850&#160;in the Ashkenazi Jewish population worldwide, but incidence and patient severity vary among regions. Cerezyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has been marketed in the US since&#160;1994, in the EU since 1997, in Japan since 1998 and in China since 2008, and is approved to treat Type&#160;1 Gaucher disease in more than 85&#160;countries. It has also been approved to treat the systemic symptoms of Type&#160;3 Gaucher disease in most non-US markets, including the EU and Japan.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Cerezyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is typically given by</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">intravenous infusions for 1-2&#160;hours every two weeks at an infusion center, a doctor&#8217;s office, or at home as medically appropriate.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cerdelga</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Cerdelga</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (eliglustat) is the first and only first-line oral therapy for Gaucher disease Type&#160;1 adult patients. A potent, highly specific ceramide analog inhibitor of GL-1 synthesis with broad tissue distribution, Cerdelga</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has demonstrated efficacy in the treatment of naive Gaucher disease patients and in patients who switch from enzyme replacement therapy. Cerdelga</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has been approved to treat Type&#160;1&#160;Gaucher disease in the US (2014), and in the EU and Japan (2015). It is also in development for the treatment of type&#160;I Gaucher disease in pediatric patients. See &#8220;&#8212;&#160;B.5.&#160;Global Research &amp; Development&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Myozyme</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and Lumizyme</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Myozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (alglucosidase alfa) is an enzyme replacement therapy used to treat both Infantile Onset and Late Onset Pompe disease (IOPD and LOPD). Pompe disease is an inherited, progressive and often fatal neuromuscular disease, caused by a genetic deficiency or dysfunction of the lysosomal enzyme acid alpha-glucosidase (GAA) that results in the build-up of glycogen in the muscles&#8217; cells. For infantile-onset Pompe disease, symptoms begin within a few months of birth and there is impact to the heart in addition to skeletal muscle weakness. Other symptoms include difficulties breathing, frequent chest infections, problems feeding that result in failure to gain weight as expected, and failure to meet certain developmental milestones. Patients with late-onset Pompe disease typically present symptoms any time after the first year of life to late adulthood and rarely manifest cardiac problems. The hallmark symptom of late-onset Pompe disease is skeletal muscle weakness, which often leads to walking disability and reduced respiratory function. Patients often require wheelchairs to assist with mobility and may require mechanical ventilation to help with breathing. Pompe disease occurs in approximately one in 40,000&#160;newborns worldwide, but incidence and patient severity vary among regions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Myozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was first approved in 2006 in the EU and has since been approved in more than 70&#160;countries. In the US, alglucosidase alfa has been marketed as Lumizyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> since 2010.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nexviazyme</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (avalglucosidase alfa-ngpt) is a monotherapy treatment designed for the entire spectrum of infantile-onset and late-onset Pompe disease (IOPD, LOPD), for both switch and na&#239;ve patients. It is the first new treatment option approved for the Pompe community in more than 15&#160;years. Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was first approved in the US by the FDA on August&#160;6, 2021 for LOPD patients aged one and above, and has successfully launched in countries like the US, Japan and Australia, where the majority of eligible patients have switched to Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. On June&#160;24, 2022, the European Commission granted marketing authorization for Nexviadyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> as a potential new standard of care for the long-term treatment of both LOPD and IOPD.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In&#160;2023, it is anticipated that Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> will be launched in many additional&#160;markets worldwide. Investment in the clinical development of Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">continues with an ongoing trial in patients with IOPD aged less than 12&#160;months.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is administered as a monotherapy enzyme replacement therapy every two weeks.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fabrazyme</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Fabrazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (agalsidase beta) is an enzyme replacement therapy used to treat Fabry disease. Fabry disease (FD) is a multisystemic, progressive, X-linked inherited disorder of glycosphingolipid metabolism due to deficient or absent lysosomal &#945;-galactosidase&#160;A activity resulting in progressive globotriaosylceramide (GL-3) accumulation in the lysosomes of various tissues. Fabry disease affects both genders. With age, progressive organ damage develops, leading to potentially life-threatening renal, cardiac and/or cerebrovascular complications. Fabry disease is characterized by different symptom severities and rates of progression, ranging from classic disease with early symptom onset to late onset disease with cardiac and/or renal complications later in life. Fabry disease occurs in approximately one in 35,000&#160;newborns worldwide, but incidence and patient severity vary among regions. Fabrazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has been marketed in the&#160;EU since&#160;2001 and in the US since 2003, and is approved in more than&#160;70&#160;countries.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">23</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aldurazyme</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Aldurazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (laronidase) is the only approved enzyme replacement therapy for mucopolysaccharidosis type&#160;1 (MPS&#160;I), an inherited lysosomal storage disorder caused by a deficiency of alpha-L-iduronidase, a lysosomal enzyme normally required for the breakdown of certain complex carbohydrates known as glycosaminoglycans (GAGs). MPS&#160;I is multi-systemic, and children with MPS&#160;I are described as having either a severe or attenuated form of the disorder based on age of onset, severity of symptoms, rate of disease progression and whether there is early and direct involvement of the brain. MPS&#160;I occurs in approximately one per 100,000&#160;live births worldwide, but incidence and patient severity vary among regions. Aldurazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has been marketed in the EU and the US since 2003, and is approved in more than 75&#160;countries.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Xenpozyme</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Xenpozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(olipudase alfa) is an enzyme replacement therapy (ERT) designed to replace deficient or defective acid sphingomyelinase (ASMD), an enzyme that allows for the breakdown of the lipid sphingomyelin. In individuals with ASMD, an insufficiency of the ASM enzyme means sphingomyelin is poorly metabolized, potentially leading to lifelong accumulation in and damage to multiple organs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The significance of the unmet need that Xenpozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">addresses has been recognized by Japan&#8217;s PMDA with Sakigake designation, by the EU with PRIME designation, and by the FDA with Breakthrough designation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Xenpozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved first in Japan on March&#160;28, 2022, followed by Europe on June&#160;24, 2022, a few months before the&#160;FDA approval on August&#160;31, 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Xenpozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">is the first and only ERT for the&#8239;treatment of non central nervous system manifestations of ASMD, with demonstrated improvements in&#8239;hepatosplenomegaly, pulmonary, liver and&#8239;hematologic function, dyslipidemia, and growth (children only) in clinical trials of adults and&#8239;children with ASMD. Xenpozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is given as an intravenous infusion once every&#160;2&#160;weeks, and the dose is based on body weight.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Oncology</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sarclisa</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (isatuximab) is a monoclonal antibody that binds a specific epitope on the human CD38 receptor and has antitumor activity via multiple mechanisms of action. It was approved in March&#160;2020 in the US in combination with pomalidomide and dexamethasone for the treatment of adults with relapsed refractory multiple myeloma (RRMM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor, and by the European Commission in May&#160;2020 in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on the last therapy. Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is now approved for this indication in more than 50&#160;countries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved for a label extension in combination with carfilzomib and dexamethasone in March&#160;2021 in the US for the treatment of adults with relapsed or refractory multiple myeloma (RRMM) who have received one to three&#160;prior lines of therapy, and by the European Commission in April&#160;2021 for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therapy. The Japanese Ministry of Health, Labor and Welfare (MHLW) granted approval for Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with carfilzomib and dexamethasone, in combination with dexamethasone, and as monotherapy for RRMM patients in November&#160;2021. Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is under investigation in the phase&#160;III IMROZ trial as a first line treatment for patients with newly diagnosed multiple myeloma who are transplant ineligible. In addition, the phase&#160;III IRAKLIA trial investigating the development of a new subcutaneous formulation with an on-body device system was initiated in the second half of 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sarclisa is also being investigated in Phase&#160;II studies as a first/second line treatment for pediatric acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and warm autoimmune hemolytic anemia.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Libtayo</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (cemiplimab-rwlc), an immune therapy drug, is a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 (programmed cell death protein-1). This may restore immune function through the activation of cytotoxic T&#160;cells, thereby avoiding tumor evasion from host immunity.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2018, the FDA approved Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation. The European Commission granted conditional marketing authorization in July&#160;2019. Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is the only treatment specifically approved and available for advanced CSCC in the EU. CSCC is the second most common form of skin cancer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> received approval in the US for the treatment of adult patients with metastatic basal cell carcinoma (mBCC) and for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) in February&#160;2021. The European Commission granted marketing authorization for Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (laBCC or mBCC) who have progressed on or are intolerant to a hedgehog pathway inhibitor (HHI) in June&#160;2021. Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> received approval in the US in&#160;February&#160;2021 for the treatment of adult patients with non-small lung cancer (NSCLC) whose tumors have high PD-L1 expression (Tumor Proportion Score of at least&#160;50%) and are not candidates for surgical resection or definitive chemoradiation or have metastatic disease. In June&#160;2021, the European Commission granted marketing authorization for the first-line treatment of adult patients with NSCLC expressing PD-L1 (in 50% tumor cells), with no EGFR, ALK or ROS1 aberrations, who have locally advanced NSCLC and who are not candidates for definitive chemoradiation, or who have metastatic NSCLC. Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently approved in 37&#160;countries.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">24</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was filed for label extensions with the FDA and the EMA in 2L+ cervical cancer in 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On January&#160;27, 2022, Sanofi and Regeneron announced the voluntary withdrawal of the supplemental Biologics License Application. Discussions with regulatory authorities outside of the US are ongoing.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In November&#160;2022, Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> received approval in the US</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in combination with platinum&#8208;based chemotherapy for the first&#8208;line treatment of adult patients with locally advanced non-small cell lung cancer with no EGFR, ALK or ROS1 aberrations who are not candidates for surgical resection or definitive chemoradiation, or whose disease is metastatic. Discussions with regulatory authorities outside of the US are ongoing.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On June&#160;1, 2022, Sanofi and Regeneron restructured their IO License and </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Collaboration Agreement (IO LCA), as signed in 2015, amended in January&#160;2018 and subsequently in September&#160;2021. Under the terms of the Amended and Restated IO LCA, Regeneron holds exclusive worldwide licensing rights to Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> with effect from July&#160;1, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi received an upfront payment of $900&#160;million in July&#160;2022 and a regulatory milestone payment of $100&#160;million in&#160;December&#160;2022, following FDA approval of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with chemotherapy as a first line treatment for advanced&#160;NSCLC. A $65&#160;million sales-related milestone payment was also earned in December&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi stopped consolidating non-US Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales from the third quarter of 2022 and is entitled to receive a royalty of 11% on worldwide net sales of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, recognized in line with the pattern of sales. The transaction also includes a time-limited transitional services agreement with Regeneron which includes manufacturing, distribution (for which Sanofi acts as agent), and promotion.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jevtana</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (cabazitaxel), a chemotherapy drug and cytotoxic agent, is a semi-synthetic second-generation taxane that prevents many cancer cells from dividing, which ultimately results in destroying many such cells. It is approved in combination with prednisone for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel-containing treatment regimen. Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was granted marketing authorization by the FDA in June&#160;2010, by the European Commission in March&#160;2011, and in Japan in July&#160;2014. The product is marketed in over 75&#160;countries. In Europe, generic competition started for Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> from the end of March&#160;2021. In the US, the Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> composition of matter patent expired in&#160;September&#160;2021. Sanofi has filed patent infringement suits under the US Hatch-Waxman Act against generic manufacturers for cabazitaxel in the US&#160;District Court for the District of Delaware asserting three Orange Book listed US patents for Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Sanofi has entered settlement agreements with some of the defendants and the suit against the remaining defendants is ongoing; see Note&#160;D.22.b. to t</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">he consolidated financial statements, included at Item&#160;18. of this annual report.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fasturtec</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/Elitek</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Fasturtec</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Elitek</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is used for the management of plasma uric levels in patients with leukemia, lymphoma, and solid tumor malignancies receiving anticancer therapies.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Rare blood disorders</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Rare Blood Disorders franchise was created in 2018 following Sanofi's acquisition of Bioverativ and Ablynx </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(see&#160;&#8220;&#8212;&#160;A.&#160;History and Development of the Company&#8221;).</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eloctate</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (antihemophilic factor (recombinant), Fc fusion protein) is an extended half-life clotting-factor therapy to control and prevent bleeding episodes in adults and children with hemophilia&#160;A. In the US, it is indicated for use in adults and children with hemophilia&#160;A for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Hemophilia&#160;A is a rare, x-linked genetic bleeding disorder characterized by a deficiency of functional coagulation Factor&#160;VIII, resulting in a prolonged patient plasma-clotting time. As a consequence, people with hemophilia&#160;A bleed for a longer time than normal. Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> temporarily replaces the missing coagulation Factor&#160;VIII by intravenous injection.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We market Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> primarily in the US (since 2014), Japan, Canada, Australia, South Korea, Taiwan and Hong Kong.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is developed and commercialized in collaboration with Swedish Orphan Biovitrum AB (Sobi), whose territories include Europe, Russia, the Middle East, and some countries in North Africa.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alprolix</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (coagulation Factor&#160;IX (recombinant), Fc fusion protein) is an extended half-life clotting-factor therapy to control and prevent bleeding episodes in adults and children with hemophilia&#160;B. In the US, it is indicated for use in adults and children with hemophilia&#160;B for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Hemophilia&#160;B is a rare, x-linked genetic bleeding disorder characterized by a deficiency of functional coagulation Factor&#160;IX, resulting in a prolonged patient plasma-clotting time. As a consequence, people with hemophilia&#160;B bleed for a longer time than normal. Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> temporarily replaces the missing coagulation Factor&#160;IX by intravenous injection.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">25</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We market Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> primarily in the US (since&#160;2014), Japan, Canada, Australia, New Zealand, South Korea, Taiwan and Hong Kong.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is developed and commercialized in collaboration with Swedish Orphan Biovitrum&#160;AB (Sobi), whose territories include Europe, Russia, the Middle East, and some countries in North Africa.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cablivi</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (caplacizumab) is a bivalent anti-von Willebrand Factor (vWF) Nanobody</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the treatment of adults experiencing an episode of acquired thrombotic thrombocytopenic purpura (aTTP). Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is the first therapeutic specifically indicated for the treatment of aTTP.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acquired thrombotic thrombocytopenic purpura is an ultra-rare (3.5-4.5&#160;episodes per million of population), life-threatening, autoimmune-based blood clotting disorder characterized by extensive clot formation in small blood vessels throughout the body, leading to severe thrombocytopenia (very low platelet count); microangiopathic hemolytic anemia (loss of red blood cells through destruction); ischemia (restricted blood supply to parts of the body); and widespread organ damage, especially in the brain and heart. Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has an immediate effect on platelet adhesion and the ensuing formation and accumulation of the micro-clots.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was granted marketing authorization by the European Commission in September&#160;2018; by the FDA in February&#160;2019; and by the Japanese PMDA in September&#160;2022. Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently available in 25&#160;countries including the US, the majority of European countries (17), Brazil, Colombia, and five Greater Gulf region states. Additional commercial launches are ongoing.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was developed by Ablynx, a Sanofi company since mid-2018.</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> See&#160;&#8220;-&#160;A. History and Development of the Company&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enjaymo</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (sutimlimab; formerly known as BIVV009) is a monoclonal antibody targeting the classical complement pathway (CP) specific serine protease (C1s), thereby inhibiting CP activity which is associated with a variety of immune disorders involving the presence of autoantibodies. Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is the first-and-only approved therapeutic option approved for hemolytic anemia in adult patients with cold agglutinin disease (CAD).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">CAD is a rare, serious, and chronic autoimmune hemolytic anemia, where the body&#8217;s immune system mistakenly attacks healthy red blood cells and causes their rupture, known as hemolysis. The disease impacts the lives of an estimated 12,000&#160;people in the&#160;US, Europe, and Japan and is associated with profound fatigue and increased risk of thromboembolic events and mortality.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has previously received Breakthrough Therapy Designation (BTD) and Orphan Drug Designations (ODD) from the FDA, and orphan medicine designation by the European Medicines Agency. After priority review, the product was approved in&#160;February&#160;2022 as the first treatment to decrease the need for red blood cell transfusion due to hemolysis in adults with CAD. Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved by the Japanese Ministry of Health, Labor and Welfare in June&#160;2022 and granted marketing authorization by the European Commission in November&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Those approvals were based on the CARDINAL Phase III data, which were published in the New England Journal of Medicine. Additionally, the Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> efficacy sBLA has been granted priority review by the FDA based on the CADENZA trial, with the aim of broadening the indication and including long-term efficacy and safety data.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_67"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Medicines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has prioritized core assets with differentiated and/or established profiles that have significant opportunity for growth in key markets. Some of these well-established medicines are the standard-of-care for patients living with diabetes or cardiovascular disease. These core assets include Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Soliqua</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Multaq</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, and Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Core assets</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Toujeo</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (insulin glargine 300&#160;units/mL) is a long-acting analog of human insulin, indicated for the treatment of diabetes mellitus in adults. Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has been granted marketing authorization by the FDA (February&#160;2015); the EC (April&#160;2015); and the Ministry of Health, Labor and Welfare (J-MHLW) in Japan, where its approved brand name is Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> XR (June&#160;2015). Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has now been launched in more than 60&#160;countries, including China since the end of 2020. In January&#160;2020, the EC approved an expansion of the indication to include the treatment of diabetes in adolescents and children (aged 6&#160;years and above).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is available in Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> SoloSTAR</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a disposable prefilled pen which contains 450&#160;units of insulin glargine and requires one-third of the injection volume to deliver the same number of insulin units as Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">SoloSTAR</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. In the US (since 2018) and the&#160;EU (since&#160;2019), Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is also available in a disposable prefilled pen which contains 900&#160;units of insulin glargine. In India, Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is also available in a dedicated 450-unit cartridge in combination with a dedicated reusable pen (TouStar</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lovenox</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/Clexane</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or Clexane</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (enoxaparin sodium) is a low molecular weight heparin (LMWH) indicated for use in the prophylaxis and treatment of venous thromboembolism and in the treatment of acute coronary syndrome. Enoxaparin generics are available in the US, and biosimilar enoxaparin products have gradually become available across various European countries and in a growing number of international markets. Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or Clexane</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is marketed in more than 100&#160;countries.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">26</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/Iscover</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or Iscover</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (clopidogrel bisulfate) is a platelet adenosine diphosphate (ADP) receptor antagonist. It is indicated for the prevention of atherothrombotic events in patients with a history of recent myocardial infarction (MI), recent ischemic stroke or established peripheral arterial disease (PAD), and for patients with acute coronary syndrome (ACS). Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is also indicated in combination with acetylsalicylic acid (ASA) for the prevention of atherothrombotic and thromboembolic events in atrial fibrillation, including stroke.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">CoPlavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/DuoPlavin</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a fixed-dose combination of clopidogrel bisulfate and ASA, is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndrome who are already taking both clopidogrel and ASA.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A number of clopidogrel bisulfate generics have been launched in most markets. Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or Iscover</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> are available in more than&#160;80&#160;countries. For additional information on the commercialization of these products, see&#160;&#8220;Item&#160;5.&#160;Operating and Financial Review and Prospects &#8212;&#160;Financial Presentation of Alliances &#8212;&#160;Alliance Arrangements with Bristol-Myers Squibb&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is involved in two Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> product lawsuits. See Note&#160;D.22.c) to our consolidated financial statements, included at Item&#160;18. of this annual report.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Praluent</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (alirocumab) is a human monoclonal antibody (mAb) for self-administered injection every two weeks or once-monthly. It blocks the interaction of proprotein convertase subtilisin/kexin type&#160;9 (PCSK9) with low-density lipoprotein (LDL) receptors, increasing the recycling of LDL receptors and reducing LDL cholesterol levels.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is indicated as an adjunct to diet and maximally tolerated statin therapy in certain adult patients with uncontrolled LDL cholesterol. Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has been approved in more than 60&#160;countries worldwide, including the US (in 2015), Canada and Switzerland, as well as in the European Union (in 2015). In 2018, the FDA approved a Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> label update for some patients currently requiring LDL apheresis therapy. In March&#160;2019 in the EU and in April&#160;2019 in the US, Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved for use in patients with established cardiovascular disease to reduce the risk of cardiovascular events.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In December&#160;2019, Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved in China, where it started to be commercialized in May&#160;2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since April&#160;2020, Regeneron is responsible for commercialization of Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the US, and Sanofi is responsible for all other markets outside the US. For additional information on the commercialization of this product, see&#160;&#8220;Item&#160;5.&#160;Operating and Financial Review and Prospects &#8212;&#160;Financial Presentation of Alliances &#8212;&#160;Alliance Arrangements with&#160;Regeneron&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multaq</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Multaq</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (dronedarone) is an oral multichannel blocker with anti-arrhythmic properties for prevention of atrial fibrillation recurrences in certain patients with a history of paroxysmal or persistent atrial fibrillation. Multaq</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved in the US and in the EU in 2009. Multaq</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;is available in about 35&#160;countries.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thymoglobulin</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Thymoglobulin</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (anti-thymocyte Globulin) is a polyclonal anti-human thymocyte antibody preparation that acts as a broad immunosuppressive and immunomodulating agent. In the US, Thymoglobulin</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is indicated for the prophylaxis and treatment of&#160;acute rejection in patients receiving a kidney transplant, used in conjunction with concomitant immunosuppression. Outside the&#160;US, depending on the country, Thymoglobulin</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is indicated for the treatment and/or prevention of acute rejection in organ transplantation; immunosuppressive therapy in aplastic anemia; and the treatment and/or prevention of Graft-versus-Host Disease (GvHD) after allogeneic hematopoietic stem cell transplantation. Thymoglobulin</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently marketed in over&#160;65&#160;countries.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mozobil</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Mozobil</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (plerixafor injection) is a hematopoietic stem cell mobilizer. It is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin&#8217;s lymphoma (NHL) and multiple myeloma (MM). Mozobil</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is marketed in over&#160;65&#160;countries.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (belumosudil) is a selective ROCK2 (rho-associated coiled-coil&#8211;containing protein kinase-2) inhibitor. It was approved in&#160;July&#160;2021 by the FDA for the treatment of adult and pediatric patients aged 12&#160;years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy. Activities are ongoing to ensure registration in other territories. In April&#160;2022, results from a pooled analysis of Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> showed certain organ clinical responses correlated with clinically meaningful changes in patient-reported outcomes (PROs).</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">27</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Soliqua</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8211; Suliqua</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Soliqua</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> 100/33 or Suliqua</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a once-daily fixed-ratio combination of insulin glargine 100&#160;Units/mL, a long-acting analog of human insulin, and lixisenatide, a GLP-1 receptor agonist. The FDA approved Soliqua</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> 100/33 in November&#160;2016 for the treatment of adults with type&#160;2&#160;diabetes inadequately controlled on basal insulin (less than 60&#160;units daily) or lixisenatide; and in February&#160;2019 for patients uncontrolled on oral antidiabetic medicines. In January&#160;2017, Suliqua</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (the product&#8217;s brand name in Europe) was approved for use in combination with metformin for the treatment of adults with type&#160;2 diabetes to improve glycemic control, when this has not been provided either by metformin alone or by metformin combined with another oral glucose-lowering medicinal product or with basal insulin. In Japan, Soliqua</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved in May&#160;2020 for type&#160;2 diabetes mellitus, where treatment with insulin is required. Suliqua</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is available in over&#160;40&#160;countries.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Apidra</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Apidra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (insulin glulisine) is a rapid-acting analog of human insulin, indicated to improve glycemic control in adults and children with diabetes mellitus. It is administered around meal time, and is used in a regimen with an intermediate or long-acting insulin&#160;(Apidra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has a more rapid onset and shorter duration of action than fast-acting human insulin). Apidra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is available in over&#160;100&#160;countries worldwide.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Admelog</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/Insulin lispro Sanofi</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Admelog</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (or Insulin lispro Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) is a rapid-acting insulin similar to Humalog</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, another insulin lispro 100&#160;Units/mL. Admelog</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved by the FDA in December&#160;2017, and was also granted marketing authorization as a biosimilar (under the proprietary name Insulin lispro Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) by the European Commission in July&#160;2017. It is used to improve blood sugar control in adults with type&#160;2 diabetes and adults and children (aged 3&#160;years and above) with type&#160;1 diabetes. Admelog</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was launched in the US and several European countries during 2018.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Truvelog</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/Insulin aspart Sanofi</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Truvelog</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(also known as TruRapi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">or Insulin aspart Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) is a rapid-acting insulin similar to Novorapid</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Novolog</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, another insulin aspart 100&#160;Units/mL. It was granted marketing authorization as a biosimilar (under the proprietary name Insulin aspart Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) by the European Commission in June&#160;2020. It is used to improve blood sugar control in adults with type&#160;2 diabetes, and in adults and children (aged 1&#160;year and above) with type&#160;1 diabetes. Insulin aspart Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was launched in several European countries during&#160;2020.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Integrated Digital Care Solutions</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi, in collaboration with Abbott and Biocorp, Health2Sync and Roche, is building a connected set of digital tools and features to support people living with diabetes and taking insulin. Sanofi intends to use aggregated de-identified data to generate insights to inform patients and providers, and to evaluate additional clinical or quality-of-life outcomes. Successful launches in several countries demonstrate the value of the integration of digital tools into a fully connected ecosystem.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Non-Core Assets</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lantus</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (insulin glargine 100&#160;units/mL) is a long-acting analog of human insulin, indicated for once-daily administration for the treatment of diabetes mellitus in adults, adolescents and children aged 2&#160;years and above. Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> relies on more than 15&#160;years of clinical evidence in diabetes treatment and a well-established safety profile. Approved in the US and the EU in 2000 and in Japan in 2008, Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is available in over 130&#160;countries worldwide. Two insulin glargine biosimilars are available in the US, two in European markets, and two in Japan.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">There are ongoing patent infringement proceedings in the US against Mylan. See&#160;&#8220;Item&#160;8.&#160;Financial information &#8212; A.&#160;Information on Legal or Arbitration Proceedings&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aprovel</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/Avapro</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/Karvea</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Aprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, also known as Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or Karvea</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (irbesartan), is an angiotensin&#160;II receptor antagonist indicated as a first-line treatment for hypertension and for the treatment of nephropathy in hypertensive patients with type&#160;2 diabetes. We also market CoAprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Karvezide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a combination of irbesartan and the diuretic hydrochlorothiazide. A combination with amlodipine (Aprovasc</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) has been launched in several emerging market countries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A number of irbesartan generics have been launched in most markets. Aprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and CoAprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> are marketed in more than&#160;80&#160;countries. For additional information on the commercialization of this product, see&#160;&#8220;Item&#160;5.&#160;Financial Presentation of Alliances &#8212;&#160;Alliance Arrangements with Bristol-Myers Squibb&#8221;. In Japan, the product is licensed to Shionogi Co.&#160;Ltd and BMS KK. BMS KK has sublicensed the agreement to Dainippon Pharma Co.&#160;Ltd.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Renagel</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and Renvela</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Renagel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (sevelamer hydrochloride) and Renvela</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (sevelamer carbonate) are oral phosphate binders used by chronic kidney disease&#160;(CKD) patients on dialysis as well as late stage CKD patients in Europe to treat hyperphosphatemia, or elevated phosphorus levels, which is associated with heart and bone disease. Renvela</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a second-generation buffered phosphate binder.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Generics of sevelamer carbonate are available in the US and in various European countries. A generic of sevelamer hydrochloride was approved in the US in February&#160;2019, and was subsequently launched. Renagel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Renvela</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> are marketed in more than 85&#160;countries. In Japan and several Pacific Rim countries, Renagel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is marketed by Chugai Pharmaceutical Co.,&#160;Ltd and its sublicensee, Kyowa Hakko Kirin Co.,&#160;Ltd.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">28</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Synvisc</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/Synvisc-One</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Synvisc</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Synvisc-One</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (hylan G-F&#160;20) are viscosupplements used to treat pain associated with osteoarthritis. Synvisc</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Synvisc-One</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> are marketed in over 60&#160;countries.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depakine</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Depakine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (sodium valproate) is a broad-spectrum anti-epileptic that has been prescribed for more than 50&#160;years and remains a reference treatment for epilepsy worldwide. Depakine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is also a mood stabilizer, registered in the treatment of manic episodes associated with bipolar disorder (in some countries this indication is branded differently, for example as Depakote</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in France).</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We hold no rights to Depakine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the US, and sodium valproate generics are available in most markets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is involved in product litigation related to Depakine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. See Note&#160;D.22.a) to the consolidated financial statements included at Item&#160;18. of this annual report.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxotere</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Taxotere</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (docetaxel), a chemotherapy drug and cytotoxic agent, is a semi-synthetic taxane. It has been approved for use in 11&#160;indications in five different tumor types (breast, prostate, gastric, lung, and head and neck). Generics of docetaxel have been launched globally.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is involved in Taxotere</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> product litigation in the US. See Note&#160;D.22.a) to our consolidated financial statements, included at Item&#160;18. of this annual report.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eloxatin</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Eloxatin</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (oxaliplatin), a chemotherapy drug, is a platinum-based cytotoxic agent. In combination with the infusional administration of two&#160;other chemotherapy drugs (5-fluorouracil/leucovorin, in the FOLFOX regimen), Eloxatin</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is approved by the FDA for adjuvant treatment of people with stage&#160;III colon cancer who have had their primary tumors surgically removed. It is also approved for the treatment of advanced colorectal cancer and in some countries for the treatment of early-stage gastric cancer. Generics of oxaliplatin have been launched globally. Eloxatin</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is in-licensed from Debiopharm.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zaltrap</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (aflibercept/ziv-aflibercept) is a recombinant fusion protein. The FDA approved Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in August&#160;2012 for use in combination with FOLFIRI (a chemotherapy regimen made up of 5-fluorouracil/leucovorin/irinotecan), in patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen. To avoid confusion with Eylea</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the FDA assigned a new name, ziv-aflibercept, to the active ingredient. The European Commission approved Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (aflibercept) in February&#160;2013 to treat mCRC that is resistant to or has progressed after an oxaliplatin-containing regimen.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is marketed in 50&#160;countries. For additional information on the commercialization of Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, see&#160;&#8220;Item&#160;5. Operating and Financial Review and Prospects &#8212;&#160;Financial Presentation of Alliances &#8212;&#160;Alliance Arrangements with Regeneron&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amaryl</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/Amarel</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/Solosa</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amaryl</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (glimepiride) is an orally administered once-daily sulfonylurea available in single form or in combination with metformin, indicated as an adjunct to diet and exercise to improve glycemic control in patients with type&#160;2 diabetes. A number of glimepiride generics are available in most markets.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generics</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;30, 2018, we completed the divestment of our European generics business Zentiva to Advent International, a US&#160;global private equity firm. We have retained our presence in Generics in emerging markets, especially in Latin America with two top-of-mind brands &#8211;&#160;Medley (Brazil) and Genfar (Colombia, Peru, Ecuador and Central America) &#8211; and also in Russia, South Africa and Turkey.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_70"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.3. Vaccine products</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Vaccines division of Sanofi is a world leader in the vaccine industry and a key supplier of life-saving vaccines all over the world and for publicly funded international stakeholders such as UNICEF, the Pan American Health Organization (PAHO) and the Global Alliance for Vaccines and Immunization (GAVI).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Vaccines portfolio includes the following vaccines:</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Poliomyelitis, pertussis and Hib pediatric vaccines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is one of the key players in pediatric vaccines in both developed and emerging markets, with a broad portfolio of standalone and combination vaccines protecting against up to six diseases in a single injection. Due to the diversity of immunization schedules throughout the world, vaccines vary in composition according to regional specificities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Tetraxim</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a pediatric combination vaccine protecting against diphtheria, tetanus, pertussis and poliomyelitis (polio), was first marketed in&#160;1998. To date, the vaccine has been launched in close to 90&#160;countries outside the US.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Pentaxim</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a pediatric combination vaccine protecting against diphtheria, tetanus, pertussis, polio and Hemophilus influenzae type&#160;b (Hib), was first marketed in 1997. To date, the vaccine has been launched in more than 100&#160;countries outside the US. In most European, Latin American, Asian and Middle Eastern markets, Pentaxim</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is being gradually replaced by Hexaxim</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">29</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Hexaxim</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Hexyon</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Hexacima</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a fully liquid, ready-to-use 6-in-1 (hexavalent) pediatric combination vaccine that provides protection against diphtheria, tetanus, pertussis, polio, Hib and hepatitis&#160;B. Hexaxim</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is the only combination vaccine including acellular pertussis&#160;(acP) and inactivated polio vaccines (IPV) currently prequalified by the WHO. Hexaxim</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is now available in more than&#160;100&#160;countries outside the US.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Pentacel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a pediatric combination vaccine protecting against diphtheria, tetanus, pertussis, polio and Hib, was launched in the&#160;US in&#160;2008.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Quadracel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis and poliomyelitis, used in children aged 4&#160;through 6&#160;years as a fifth dose in the diphtheria, tetanus, pertussis vaccination (DTaP) series, and as a fourth or fifth dose in the inactivated poliovirus vaccination (IPV) series.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Shan5</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a 5-in-1 (whole-cell pertussis based) combination vaccine protecting against five diseases (diphtheria, tetanus, pertussis, Hib and hepatitis&#160;B). Following a strategic assessment of the whole-cell pertussis market, Sanofi has decided to cease the production of the Shan5</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Shan6</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> vaccines produced in Hyderabad, India.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Act-Hib</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a standalone vaccine protecting against Hib, and is mainly distributed in the US, Japan and China in conjunction with pertussis combination vaccines that do not contain the Hib valence.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is a leading provider of polio vaccines and has been a partner of the Global Polio Eradication Initiative (GPEI) for over&#160;30&#160;years, with more than 13&#160;billion doses of oral polio vaccines (OPV) delivered during that time.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Between 2014 and 2022, Sanofi has provided 395&#160;million doses of inactivated polio vaccine to Unicef , to support the WHO &#8220;Polio End Game&#8221; strategy for the world's 73&#160;poorest countries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Vaxelis</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a hexavalent combination vaccine protecting against diphtheria, tetanus, pertussis, polio, Hib and hepatitis&#160;B. This vaccine (developed and distributed in partnership with Merck) was approved in 2016 by the EMA and is distributed in various EU&#160;countries. Vaxelis</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved by the FDA in December&#160;2018, becoming the first hexavalent vaccine to be approved in the&#160;US, and launched in this country in June&#160;2021.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Meningitis vaccines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Menactra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the first quadrivalent conjugate vaccine against meningococcal meningitis (serogroups: A, C, Y, and W-135), one of the deadliest forms of meningitis, is indicated for people aged 9&#160;months through 55&#160;years. Since launch, it has become a strong leader in the meningitis quadrivalent market, globally and in the US. It is also commercialized in a number of countries including Canada, several Middle Eastern countries, and numerous other countries (excluding Europe). Menactra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was the first fully liquid (no reconstitution needed) meningitis quadrivalent conjugated vaccine, and more than 100&#160;million doses of this vaccine have been distributed since launch.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">MenQuadfi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a novel fully-liquid meningococcal quadrivalent conjugated vaccine expected to have a broad age indication from infants (6&#160;weeks) to the elderly, with flexible dosing schedules. MenQuadfi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is the first and only quadrivalent ACWY vaccine to demonstrate superior immune response against serogroup&#160;C in toddlers compared to a monovalent serogroup&#160;C vaccine (standard-of-care in multiple markets in Europe and internationally). It is expected to be available worldwide, progressively replacing Menactra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, and allowing Sanofi to enter the European meningococcal market. MenQuadfi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">was approved in the US in&#160;April&#160;2020 for people aged two&#160;years and above. It</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">was also approved in Australia, Canada, the EU and other European Economic Area countries in the fourth quarter of&#160;2020, and subsequently in Argentina, Brazil and Chile, for people aged 12&#160;months and above. MenQuadfi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">has also recently been approved in Japan, and marketing authorization is pending in numerous other countries. Extension of the age indication down to six weeks of age will follow submission of additional Phase&#160;III data. MenQuadfi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was launched in the US and Europe in&#160;2021.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Booster vaccines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Adacel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is the first trivalent booster vaccine offering protection against diphtheria, tetanus and pertussis. The vaccine can be used from 4&#160;years of age following primary immunization and is the first Tdap vaccine indicated for use during pregnancy for protection against pertussis in newborns. It is available in 55&#160;countries including the US and other countries mostly in Europe, Asia and Latin America.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Repevax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Adacel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">-Polio is a combination vaccine that provides protection against diphtheria, tetanus, pertussis and polio. It is the first Tdap-IPV vaccine indicated for use during pregnancy for protection against pertussis in newborns. It is currently marketed in 26&#160;countries outside the US, with a strong focus on European markets (such as France and Germany).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Travel and endemic vaccines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi provides a wide range of travel and endemic vaccines including hepatitis&#160;A, typhoid, cholera, yellow fever and rabies vaccines. These products are used in endemic settings in the developing world and are the foundation for important partnerships with governments and organizations such as UNICEF. They are also used by travelers and military personnel in industrialized countries and in endemic areas.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">30</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Influenza vaccines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is a world leader in the production and marketing of influenza vaccines, offering several distinct influenza vaccines that are sold globally to meet growing demand.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Fluzone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Quadrivalent is a quadrivalent inactivated influenza vaccine, produced in the US, containing two type&#160;A antigens and two type&#160;B antigens in order to provide increased protection against more circulating strains of influenza viruses. Fluzone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Quadrivalent/FluQuadri</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is available in 7&#160;countries (including the US) for children aged over six months, adolescents and adults. Fluzone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> 0.5&#160;ml&#160;QIV is the currently-licensed standard dose (15&#160;&#181;g/strain) quadrivalent influenza vaccine for ages 6&#160;months and older.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Fluzone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> High-Dose Quadrivalent, designed specifically to provide greater protection against influenza for people aged 65&#160;years and older, was approved by the FDA in November&#160;2019. It has now fully replaced Fluzone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> High-Dose Trivalent, and contains two influenza&#160;A and two influenza&#160;B strains at 60&#160;&#181;g/strain. Fluzone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> High-Dose Quadrivalent was approved in the EU in the second quarter of 2020, under the name Efluelda</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, indicated for adults aged 60&#160;years and above. Both Fluzone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> High-Dose Quadrivalent and Efluelda</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> have been available since the 2020/21 influenza season. To date, this product has been distributed to 16&#160;countries worldwide.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Flublok</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a quadrivalent recombinant protein based influenza vaccine indicated for adults aged&#160;18 years of age and older. Flublok</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently licensed in the US and Hong Kong. This same recombinant protein-based influenza vaccine is also licensed under the brand name Supemtek</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Canada, the United Kingdom, the European Union and Switzerland.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Vaxigrip</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">is a trivalent influenza vaccine, containing two antigens against type&#160;A influenza viruses and one antigen against type&#160;B influenza viruses. It has now been replaced by VaxigripTetra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in most countries in which it is commercialized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">VaxigripTetra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is the quadrivalent (QIV) version of Vaxigrip</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, including two antigens against A&#160;strains of influenza viruses and two antigens against B&#160;strains. Compared to the trivalent influenza vaccine, it contains an additional influenza&#160;B strain; it was licensed in 2016 and has been launched in more than 95&#160;countries since 2017. VaxigripTetra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is not licensed in the US where Fluzone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Quadrivalent, which is produced in the US, is distributed.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID Vaccine</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">COVID-19 recombinant adjuvanted vaccine: </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta is a recombinant spike protein vaccine developed in partnership with GSK and using GSK&#8217;s AS03 adjuvant. It is indicated as an adult booster to protect against SARS-CoV-2 infections. Phase&#160;III results demonstrated significant vaccine efficacy against symptomatic infection with a Beta variant-containing vaccine in the face of an Omicron variant predominated pandemic period. Significant efficacy was demonstrated in naive individuals and individuals previously infected or vaccinated. These results, coupled with data from comprehensive studies to evaluate the vaccine as a heterologous booster for people initially vaccinated with Emergency Use Authorization (EUA) vaccines, supported VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta's full marketing authorization for the booster indication in both the EU and the UK. The first doses were supplied at the end of 2022.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_73"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.4. Consumer Healthcare</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, we progressed further in building and simplifying our stand-alone Consumer Healthcare (CHC) organization within Sanofi. Almost all of the newly-created CHC legal entities required to establish the standalone organization are now operational, and our portfolio has been significantly simplified by way of divestments with just 140&#160;brands currently, down from 250&#160;eighteen months ago. Recently, additional critical support functions have been brought together under the single CHC umbrella including People &amp; Culture, Finance, Digital and Legal, Ethics &amp; Business Integrity. This represents a key step in our journey to build a stand-alone CHC business, accelerating the full integration of our operating model while enhancing the speed and relevancy of our engagement with our consumers.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our CHC sales are supported by a range of products, including the following brands:</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allergy, Cough &amp; Cold</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Allegra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comprises a range of fexofenadine HCl-based products. Fexofenadine is an anti-histamine for relief from allergy symptoms including sneezing, runny nose, itchy nose or throat, and itchy, watery eyes. The Allegra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> brand family is sold in more than&#160;80&#160;countries across the world.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Mucosolvan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a cough brand with many different formulations. It contains the mucoactive agent ambroxol; this stimulates synthesis and release of surfactant. It is sold in various countries in Europe, Latin America, Asia and Russia.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pain</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Doliprane</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> offers a range of paracetamol/acetaminophen-based products for pain and fever with a wide range of dosage options and pharmaceutical forms, and is sold mainly in France and various African countries.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The Buscopan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> range (hyoscine butylbromide) has an antispasmodic action that specifically targets the source of abdominal pain and discomfort. It is sold across the globe.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">We also have local pain brands such as Eve</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Japan; Dorflex</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Novalgina</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Brazil; and Icy Hot</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Aspercreme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the&#160;US.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">31</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digestive</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Dulcolax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> products offer a range of constipation solutions from predictable overnight relief to comfortable natural-feeling relief. The products are sold in over 80&#160;countries. Dulcolax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> tablets contain the active ingredient bisacodyl or sodium picosulfate, which works directly on the colon to produce a bowel movement.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Enterogermina</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a probiotic indicated for the maintenance and restoration of intestinal flora in the treatment of acute or chronic intestinal disorders. Enterogermina</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is sold primarily in Europe, and in Latin America and parts of Asia.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Essentiale</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a natural soybean remedy to improve liver health. It is composed of essential phospholipids extracted from highly purified soya and contains a high percentage of phosphatidylcholine, a major component of the cell membrane. Essentiale</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is used in fatty liver disease and is sold mainly in Russia, Eastern Europe, various countries in Southeast Asia, and China.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Zantac 360&#176;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> products are for the prevention and relief of heartburn, with a new formula launched in 2021 in North America.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nutritional</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Nutritionals include a range of products to maintain general health, provide immune system support, or supplement vitamin deficiencies. These products help manage energy, stress, sleep and anxiety, and include a number of brands across the globe&#160;including Nature&#8217;s Own</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Australia to improve and maintain health; Pharmaton</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (mainly in Europe and Latin America); Magne&#160;B6</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Europe; and a range of sleep brands, including Novanuit</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Europe, Unisom</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in US and Drewell</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Japan.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Gold Bond</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> offers a broad range of products including daily body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams and powders for eczema. Gold Bond</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is only sold in the US.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_76"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.5. Global research &amp; development</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s &#8216;Play to Win&#8217; strategy (see section&#160;&#8220;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;4.&#160;Information on the Company &#8212; B.&#160;Business Overview &#8212;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">B.1.&#160;Strategy&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) has been implemented to drive innovation and growth so that we can seek breakthroughs with our most promising medicines, to address significant patient needs.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Global research and development (R&amp;D) has focused efforts in therapeutic areas where patient needs are most urgent: oncology, immunology, neurology, rare diseases, and rare blood disorders. As part of our strategic framework, five potentially transformative therapies in areas of high unmet patient need were prioritized: fitusiran and efanesoctocog alfa (hemophilia); amlitelimab (Immunology &amp; Inflammation); tolebrutinib (multiple sclerosis); and nirsevimab (prevention of respiratory syncytial virus).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our aspiration is to build an R&amp;D pipeline of first-in-class or truly differentiated best-in-class medicines, with two-thirds of the biologic compounds and two-thirds of the pipeline directly derived from Sanofi internal research. However, discovering and developing new medicines is a costly, lengthy, and uncertain process and our continuous investments in R&amp;D for future products and for the launches of newly registered medicines could result in increased costs without a proportionate increase in revenues. See &#8220;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;3. Key Information &#8212; D. Risk Factors&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for further information.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the reshaping and consolidation of our R&amp;D portfolio in oncology and immune diseases was pursued, as exemplified by the acquisition of Amunix Pharmaceuticals, Inc. (adding to our early portfolio SAR446309, a HER2&#160;T&#160;cell engager, formerly known as AMX-818); the restructuring of our global immuno-oncology license and collaboration agreement with Regeneron Pharmaceuticals, Inc.; and collaboration and license agreements with Exscientia, Blackstone Life Sciences, Seagen, IGM Biosciences, Innovent Biologics and Innate Pharma (for further information, see sections&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item&#160;4.&#160;Information on the Company &#8212; A.&#160;History and development of the Company&#8221;; &#8220;&#8212;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">B.1.&#160;Strategy&#8221;; &#8220;&#8212;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">B.2.&#160;Main pharmaceutical products&#8221;; &#8220;Item&#160;5.&#160;Operating and Financial Review and Prospects &#8212; A.1.1.&#160;2022 Overview&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">). For more details on R&amp;D assets in the scope of these agreements, see section&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">B.5.1.1.&#160;Products in development</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and section&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">B.5.1.2.&#160;Line extensions</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> below.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">32</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_79"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.5.1. Pharmaceuticals</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2022, the main pipeline changes related to the pharmaceuticals portfolio were:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.933%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Project</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Potential Indication</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reason</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR444200 &#8211; Anti-GPC3/TCR NANOBODY</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> VHH </span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Solid tumors</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Added</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Entered confirmatory development</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:115%">SAR445877 &#8211; Anti-PD1 x IL15 fusion protein</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Solid tumors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Added</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Entered confirmatory development</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR446309 &#8211; HER2 T cell engager (AMX-818)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Solid tumors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Added</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquired from Amunix</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">SAR444419 &#8211; Anti-TNFa x IL6 NANOBODY</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:112%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%"> VHH</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inflammatory indication</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Added</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Entered confirmatory development</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR444559 &#8211; Anti-CD38 mAb &#8211; Next generation</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inflammatory indication</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Added</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Entered confirmatory development</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR446159 &#8211; Anti-alpha-synuclein x IGF1R mAb</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Parkinson&#8217;s disease</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Added</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Entered confirmatory development</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Xenpozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> &#8211; olipudase alfa</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acid sphingomyelinase deficiency</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Removed</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commercialized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> &#8211; sutimlimab</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cold agglutinin disease</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Removed</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commercialized</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> - cemiplimab</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">1st line NSCLC</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">(d) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> with chemotherapy</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Removed</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commercialized</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> - cemiplimab</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2nd line cervical cancer; Adjuvant CSCC</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Removed</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Development discontinued</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">amcenestrant &#8211; Selective estrogen receptor degrader</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Breast cancer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Removed</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Development discontinued</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR442720 &#8211; SHP2 inhibitor</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Solid tumors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Removed</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Development discontinued</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR442999 &#8211; Anti-TNFa/IL23A NANOBODY</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> VHH</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Inflammatory indication</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Removed</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Development discontinued</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SAR443726 &#8211; Anti-IL13/OX40L NANOBODY</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> VHH</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Atopic dermatitis</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Removed</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Development discontinued</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR339375 &#8211; miRNA-21</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Alport syndrome</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Removed</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Development discontinued</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">mAb: monoclonal antibody.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) SAR446159: developed in collaboration with ABL Bio.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">: worldwide exclusive license rights granted to Regeneron.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) SAR442720: termination of the collaborative agreement with Revolution Medicines.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) NSCLC: non-small cell lung cancer.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) CSCC: cutaneous squamous cell carcinoma.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">33</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The clinical portfolio of products as </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">of December&#160;31, 2022 </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">is summarized in the table below; where several indications are being developed for one product, each indication is regarded as a separate project and specified individually.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.830%"><tr><td style="width:1.0%"></td><td style="width:11.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Phase&#160;I</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Phase&#160;II</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Phase&#160;III/registration</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Oncology</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR444245 dose optimization (solid tumors)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR441000 (solid tumors)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR442257 (multiple myeloma/non Hodgkins lymphoma)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR444881 (solid tumors)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR445419 (acute myeloid leukemia)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR443216 (gastric cancer) </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR443579 (acute myeloid leukemia)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR445710 (solid tumors)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR446309 (solid tumors)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR444200 (solid tumors)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR445877 (solid tumors)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">alomfilimab (solid tumors)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">tusamitamab ravtansine + pembrolizumab (non-small cell lung cancer 1st line)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">tusamitamab ravtansine</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">+ ramucirumab (non-small cell lung cancer 2nd/3rd line)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">tusamitamab ravtansine (exploratory solid tumors)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">tusamitamab ravtansine + ramucirumab (gastric cancer)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (1st/2nd line acute myeloid leukemia/acute lymphoblastic leukemia)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> + combinations (relapsed, refractory multiple myeloma)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">tusamitamab ravtansine (non-small cell lung cancer 2nd/3rd line)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> + combinations (1st line newly diagnosed multiple myeloma not eligible for transplant)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> + combinations (1st line newly diagnosed multiple myeloma eligible for transplant)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> + combinations (smoldering multiple myeloma)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> subcutaneous + combinations (2nd/3rd line relapsed, refractory multiple myeloma)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Immunology&#160;&amp;<br/>Inflammation</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:115%">SAR441566 (inflammatory indication)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:115%">SAR444656 (atopic dermatitis) </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:115%">SAR442970 (inflammatory indication)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:115%">SAR443765 (inflammatory indication) </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:115%">SAR444336 (inflammatory indication)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:115%">SAR444419 (inflammatory indication)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:115%">SAR444559 (inflammatory indication)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">amlitelimab (atopic dermatitis)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">amlitelimab (asthma)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">rilzabrutinib (IgG4 related disease)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">rilzabrutinib (atopic dermatitis)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">rilzabrutinib (asthma)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">rilzabrutinib (chronic spontaneous urticaria)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">eclitasertib (cutaneous lupus erythematosus)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">eclitasertib (ulcerative colitis)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">atuzabrutinib (atopic dermatitis)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">frexalimab (Sjogren&#8217;s syndrome) frexalimab (systemic lupus erythematosus)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR445088 (antibody-mediated rejection)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (polyarticular juvenile idiopathic arthritis)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (systemic juvenile idiopathic arthritis)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">itepekimab (chronic obstructive pulmonary disease)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (bullous pemphigoid)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (chronic spontaneous urticaria)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (chronic obstructive pulmonary disease)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (chronic inducible cold urticaria)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (chronic rhinosinusitis without nasal polyposis)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (allergic fungal rhinosinusitis) </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (chronic pruritis of unknown origin)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Neurology</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR446159 (Parkinson&#8217;s disease)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">frexalimab (multiple sclerosis)<br/>SAR445088 (chronic inflammatory demyelinating polyneuropathy)<br/>SAR443820 (amyotrophic lateral sclerosis)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">tolebrutinib (relapsing multiple sclerosis)<br/>tolebrutinib (primary progressive multiple sclerosis)<br/>tolebrutinib (secondary progressive multiple sclerosis)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;Rare Diseases</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR442501 (achondroplasia)<br/>SAR443809 (rare renal diseases)<br/>SAR439459 (Osteogenesis imperfecta)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (Pompe disease &#8211; Infantile onset)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">venglustat (GM2 gangliosidosis)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">venglustat (Gaucher disease type 3)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">venglustat (Fabry disease)</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare Blood Disorders</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">rilzabrutinib (warm autoimmune hemolytic anemia)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR445088 (cold agglutinin disease)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (warm autoimmune hemolytic anemia)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">ALTUVIIIO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> (hemophilia A) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">fitusiran (hemophilia A&amp;B)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">fitusiran (hemophilia A&amp;B pediatric)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">rilzabrutinib (immune thrombocytopenia)</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) ALTUVIIIO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> was approved by the FDA on Feb 22nd, 2023.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Phase&#160;I studies are the first studies performed in humans, who are mainly healthy volunteers, except for studies in oncology, where Phase&#160;I studies are performed in patients. Their main objective is to assess the tolerability, the pharmacokinetic profile (the way the product is distributed and metabolized in the body and the manner by which it is eliminated) and where possible the pharmacodynamic profiles of the new drug (i.e. how the product may react on some receptors).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Phase&#160;II studies are early controlled studies in a limited number of patients under closely monitored conditions to show efficacy and short-term safety, and to determine the dose and regimen for Phase&#160;III studies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Phase&#160;III studies have the primary objective of demonstrating or confirming the therapeutic benefit and the safety of the new drug in the intended indication and population. They are designed to provide an adequate basis for registration.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">34</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">B.5.1.1. Products in development</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">a) Oncology</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Tusamitamab ravtansine (SAR408701)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is an antibody drug conjugate (ADC) that binds to CEACAM-5, a cell-surface glycoprotein that is highly expressed in non-small cell lung cancer (NSCLC), gastric cancer and other cancers. The compound is being evaluated in Phase&#160;III (CARMEN-LC03) for the second- and third-line treatment of metastatic non-squamous NSCLC (NSQ&#160;NSCLC) with CEACAM-5 positive tumors. In addition, two Phase&#160;II studies are ongoing to evaluate the activity of the drug in combination with ramucirumab (CARMEN-LC04) or with pembrolizumab (CARMEN-LC05) in patients with metastatic NSQ&#160;NSCLC. Tusamitamab ravtansine is also being evaluated in two Phase&#160;II studies, respectively in patients with CEACAM-5 positive advanced solid tumors (CARMEN-BT01) and in patients with gastric cancer in combination with ramucirumab (CARMEN-GC01). According to the agreement between Sanofi and Innovent Biologics (see details in section </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item&#160;4.&#160;Information on the Company &#8212; B.1.&#160;Strategy&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, both companies are committed to accelerating the development and commercialization of tusamitamab ravtansine, combining with sintilimab, the leading checkpoint inhibitor in China.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Alomfilimab (SAR445256</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) is a fully human IgG1 anti-ICOS antibody with a dual mode of action, depleting ICOS high intra-tumoral T regulatory cells and stimulating ICOS low T effector cells, currently being investigated in Phase II for the treatment of solid tumors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR444245</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">is a non-alpha durably pegylated interleukin-2 (IL-2) for which a new Phase&#160;I/II program is planned to be initiated in&#160;2023 in solid tumors, to solidify the foundation for a best-in-class target profile. The revision of the clinical program was based on emerging external and internal data about non-alpha IL-2&#8217;s mechanism of action and therapeutic potential. A decision was taken in 2022 to discontinue the Phase&#160;II trials (in advanced skin cancers, head &amp; neck cancers, non-small cell lung cancer/mesothelioma and lymphoma) with the current 3-weekly dose schedule, as the efficacy observed in an early look at the data was lower than projected; however, this decision was not based on any safety-related issues.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR441000</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">is an intratumoral immunotherapy that uses mRNA to encode cytokines and stimulate both innate and adaptive arms of the immune system to maximize anti-tumor activity. It is developed in collaboration with BioNTech for the treatment of solid tumors. A Phase&#160;I study assessing SAR441000 as monotherapy and in combination with cemiplimab in patients with advanced solid tumors, including melanoma, is ongoing.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR442257</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">an anti-CD3/CD28/CD38 trispecific </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">monoclonal antibody</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, is currently being evaluated in Phase&#160;I for the treatment of multiple myeloma/non-Hodgkin lymphoma.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR444881</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a monoclonal antibody targeting the Ig-like transcript&#160;2 (ILT2) receptor developed with Biond Biologics for the treatment of solid tumors, is currently being evaluated in Phase&#160;I.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR445419</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is an off-the-shelf NK cell therapy currently being evaluated in Phase&#160;I. A new patient cohort in the Ohio State University study evaluating SAR445419 for the treatment of relapsed/refractory acute myeloid leukemia started enrollment in&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR443216</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a T cell engager with a trispecific antibody format designed to target HER2 (on tumor cells), CD3 (on T cells) and CD28 (a co-receptor for T cell activation), respectively. SAR443216 is currently </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">being evaluated in Phase I </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">for the treatment of gastric cancer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR443579</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a NKp46/CD16-based NK cell engager with a multispecific antibody format developed in partnership with Innate Pharma. SAR443579 is being investigated in a Sanofi-sponsored Phase&#160;I/II clinical trial in patients with relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia or high risk-myelodysplasia.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR445710</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is an anti PD-L1/IL-15 fusion protein currently being evaluated in Phase&#160;I in patients with solid tumors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR446309</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (formerly AMX-818), an HER2-based T cell engager acquired from Amunix Pharmaceuticals, entered clinical development in 2022 for the treatment of solid tumors. SAR446309 is currently evaluated, alone and in combination with pembrolizumab, in a Phase&#160;I clinical trial in patients with locally advanced or metastatic HER2-expressing cancers.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR444200</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a GPC3-based T cell engager designed with a NANOBODY</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> VHH format that entered clinical development in&#160;2022. SAR444200 is currently being evaluated in Phase I in patients with advanced solid tumors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR445877</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is an anti PD1/IL-15 fusion protein that entered clinical development in 2022, with a Phase&#160;I trial initiated in patients with solid tumors.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">b) Immunology&#160;&amp; Inflammation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Itepekimab (SAR440340)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a human anti-IL33 monoclonal antibody derived from our alliance with Regeneron that is currently being evaluated in a Phase&#160;III clinical program (AERIFY-1 and AERIFY-2 studies) for the treatment of chronic obstructive pulmonary disease in former smokers; a cohort of current smokers is also assessed in AERIFY-2. In October&#160;2022, a two-part open label prospective mechanistic study in former and current smokers (AERIFY-3) enrolled its first patients.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Amlitelimab (SAR445229</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, an anti-OX40L monoclonal antibody, is currently in Phase&#160;II for the treatment of adults with moderate to severe atopic dermatitis. In 2022, a Phase&#160;II study (TIDE-asthma) was initiated to assess add-on therapy with amlitelimab in adults with moderate-to-severe asthma.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">35</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Rilzabrutinib (SAR444671)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a covalent and reversible inhibitor of Bruton&#8217;s tyrosine kinase </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">under development for the treatment of autoimmune/inflammatory diseases</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. In 2022, the ongoing Phase II trials </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">assessing rilzabrutinib </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">for the treatment of IgG4-related disease and atopic dermatitis, respectively, were pursued. In addition, two Phase&#160;II </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">studies have enrolled their first participants</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in adults with moderate-to-severe asthma</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and in chronic spontaneous urticaria (CSU)</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Rilzabrutinib is also being evaluated for the treatment of immune thrombocytopenia and </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">warm autoimmune hemolytic anemia </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(see details below in section&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">e) Rare Blood Disorders</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Eclitasertib (SAR443122)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a small molecule against the receptor-interacting serine/threonine-protein kinase&#160;1 (RIPK1) developed in collaboration with Denal</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">i. A </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">proof-of-concept Phase&#160;II study assessing the efficacy and safety of eclitasertib in patients with cutaneous lupus erythematosus is ongoing. In 2022, a Phase&#160;II study evaluating eclitasertib in patients with ulcerative colitis was initiated.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Atuzabrutinib (SAR444727)</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, an inhibitor of Bruton&#8217;s tyrosine kinase, is currently under investigation in Phase&#160;II as a topical agent for the treatment of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">atopic dermatitis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Frexalimab (SAR441344)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">an anti-CD40L monoclonal antibody developed in collaboration with Immunext, is being investigated in two Phase&#160;II trials for the treatment of Sjogren&#8217;s syndrome and systemic lupus erythematosus, respectively. SAR441344 is also being evaluated in multiple sclerosis (see section&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">c) Neurology</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR445088</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a complement C1s inhibitor already under clinical development (see details in section&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">e) Rare Blood Disorders</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and section&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">c) Neurology</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), entered an additional Phase&#160;II study in 2022, assessing the compound for the treatment of patients at risk of antibody-mediated rejection (AMR) or diagnosed with AMR.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR444656</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is an IRAK4 degrader with potential therapeutic application across multiple indications, including atopic dermatitis. SAR444656 is developed in collaboration with Kymera Therapeutics and is currently under evaluation in Phase&#160;I.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">SAR441566</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the first oral small molecule TNFa inhibitor currently evaluated in Phase&#160;I, is intended to provide patients an oral alternative to anti-TNFa monoclonal antibodies in the range of inflammatory indications where these have been approved.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">SAR442970</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a bispecific NANOBODY</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> VHH that combines blockade of TNFa and the immune co-stimulatory regulator OX40L for the treatment of inflammatory indications, is under evaluation in Phase&#160;I.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">SAR443765</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a bispecific NANOBODY</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> VHH targeting TSLP and IL-13 currently evaluated in Phase&#160;I for the treatment of inflammatory indications.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">SAR444336</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a pegylated non-beta IL-2 designed to selectively engage CD4+ regulatory T cells (and not on effector T or NK cells) for the treatment of inflammatory indications, is currently evaluated in Phase&#160;I.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">SAR444419</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a bispecific NANOBODY</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> VHH blocking TNFa and IL6 that entered clinical development in November&#160;2022 for the treatment of inflammatory indications.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">SAR444559</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, an anti-CD38 monoclonal antibody with engineered format, entered clinical development in December&#160;2022 for the treatment of inflammatory indications.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">c) Neurology</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Tolebrutinib (SAR442168)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, an orally administered Bruton&#8217;s tyrosine kinase (BTK) inhibitor designed to access the brain and spinal cord by crossing the blood-brain barrier and impacting immune cell and brain cell signaling, is currently being investigated in Phase&#160;III trials. Following written notification from the FDA in July&#160;2022 requesting additional data, Sanofi provided the information with the aim of lifting the partial clinical hold (recruitment pause). In relapsing multiple sclerosis (MS), the Phase&#160;III studies GEMINI&#160;1 and GEMINI&#160;2 reached their respective target enrollment in 2022. Recruitment was completed in December&#160;2022 in the Phase&#160;III trial HERCULES in non-relapsing secondary progressive MS, an area of highest unmet medical need in MS with no treatment currently available. In primary progressive MS, recruitment is ongoing in the Phase&#160;III trial PERSEUS. The Phase&#160;III study URSA evaluating tolebrutinib in patients with moderate-to-severe myasthenia gravis (MG) was discontinued&#160;in 2022 after careful evaluation of the emerging competitive treatment landscape.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Frexalimab (SAR441344)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">a monoclonal antibody against CD40L (see section&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">b) Immunology &amp; Inflammation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), a key immune costimulatory component involved in MS, currently being evaluated in a Phase&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">II</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> trial.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR445088</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a complement C1s inhibitor (see details in section&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">e) Rare Blood Disorders</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), is being assessed in a Phase&#160;II trial in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR443820</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (also known as DNL788) is a RIPK1 inhibitor developed in collaboration with Denali for the treatment of amyotrophic lateral sclerosis (ALS). In 2022, a Phase II study assessing the safety and efficacy of SAR443820 for the treatment of ALS started enrollment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR446159</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (also known as ABL301) is a bispecific antibody targeting both alpha-synuclein and insulin-like growth factor&#160;1 receptor (IGF1R) developed in collaboration with ABL Bio for the treatment of Parkinson&#8217;s disease; a Phase&#160;I study assessing the safety and tolerability of intravenous SAR446159 was initiated in December&#160;2022.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">36</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">d) Rare Diseases</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">(avalglucosidase alfa)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a long-term enzyme replacement therapy targeting the mannose-6-phosphate receptor to effectively clear glycogen build-up in muscle cells. This enzyme replacement therapy is approved in the US, in Japan and in Europe (see section below </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">&#8220;&#8212; B.5.1.2.&#160;Line extensions&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) for the treatment of patients with Pompe disease, a rare disease caused by a deficiency of the enzyme acid alpha-glucosidase (GAA). Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently being investigated in a Phase&#160;III study for the treatment of patients aged 6&#160;months or younger who are affected by infantile onset Pompe disease.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Venglustat (GZ402671)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is an orally administered brain penetrant glucosylceramide synthase (GCS) inhibitor that blocks the conversion of ceramide to glucosylceramide (GL-1). Venglustat is currently in development for the treatment of three lysosomal storage diseases: late-onset GM2 gangliosidosis (Tay-Sachs disease and Sandhoff disease), Fabry disease, and Gaucher disease type&#160;3. Recruitment of participants to the Phase&#160;III study in late-onset GM2 gangliosidosis was completed early 2022; in this trial, the efficacy and pharmacodynamics of venglustat is being assessed over a two-year period. In 2022, two Phase&#160;III trials were initiated to evaluate the impact of venglustat on Fabry disease-specific personalized endpoints. In respect to Gaucher disease type&#160;3, the Phase&#160;III study enrolled its first participants in 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR442501</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is an anti-FGFR3 (fibroblast growth factor receptor&#160;3) antibody (Fab format) that directly targets overactive FGFR3 in achondroplasia, a skeletal dysplasia with high unmet medical need. SAR442501 is being investigated in a Phase&#160;I study for the treatment of patients with achondroplasia with unfused growth plates (typically younger than 18&#160;years of age).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR443809</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a humanized monoclonal antibody that selectively inhibits the activated fragment of factor&#160;B (termed&#160;Bb) in the alternative pathway of the complement system, is being evaluated in a Phase&#160;I trial for the treatment of rare renal diseases.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR439459</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a monoclonal antibody targeting transforming growth factor beta (TGF&#946;); in December&#160;2022, a Phase&#160;I study was initiated to evaluate the safety, tolerability, and activity of a single dose of SAR439459 in adult participants with Osteogenesis imperfecta, also called brittle bone disease, a rare disease in which bones fracture easily. Orphan Drug Designation was granted by the FDA for this indication.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e) Rare Blood Disorders</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">ALTUVIIIO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline"> (efanesoctocog alfa/BIVV001)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">an investigational factor&#160;VIII replacement therapy developed in collaboration with Sobi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for people with hemophilia&#160;A, a rare and life-threatening bleeding disorder. In 2022, the FDA accepted for priority review the Biologics License Application (BLA) for ALTUVIIIOTM for the treatment of hemophilia&#160;A. On February 22, 2023, the US Food and Drug Administration (FDA) approved ALTUVIIIO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The approval was supported by data from the pivotal XTEND-1 Phase&#160;III study, that demonstrated a clinically meaningful prevention of bleeds and superiority to prior factor prophylaxis based on an intra-patient comparison in people 12&#160;years of age or older. A Phase&#160;III study evaluating efanesoctocog alfa in pediatric patients younger than 12&#160;years of age is ongoing; availability of data and regulatory submission in the European Union are expected in 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Fitusiran (SAR439774)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">is a siRNA targeting antithrombin developed in collaboration with Alnylam for the prophylactic treatment of patients with hemophilia&#160;A or&#160;B, rare congenital bleeding disorders caused by a deficiency of factor&#160;VIII and&#160;IX, respectively. In&#160;2022, positive data were reported from the Phase&#160;III ATLAS-PPX study evaluating the efficacy and safety of once-monthly fitusiran (80&#160;mg) in adults and adolescents (aged 12&#160;years and over) with severe hemophilia&#160;A or&#160;B who were previously treated with prior factor or bypassing agent prophylaxis. Collectively with results from the ATLAS&#160;A/B and ATLAS-INH Phase&#160;III studies, these data add to a growing body of evidence supporting the potential of 80&#160;mg dose, monthly fitusiran prophylaxis to transform treatment for all people with hemophilia. The clinical program is continuing with an amended protocol with two lower doses to optimize the benefit/risk profile of fitusiran. Data with lower doses are expected in the second half of 2023; the first submission is planned for 2024. The ATLAS-PEDS study assessing fitusiran in pediatric patients aged 12&#160;years and under is ongoing.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Rilzabrutinib (SAR444671)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is being investigated in a Phase&#160;III trial for the treatment of adults and adolescents with persistent or chronic immune thrombocytopenia (ITP); the FDA has granted Fast Track Designation for this indication. In 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">a Phase&#160;II study assessing rilzabrutinib in adults with warm autoimmune hemolytic anemia (wAIHA)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">enrolled its first participants.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">SAR445088</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a humanized IgG4 monoclonal antibody that binds to and inhibits C1s, thereby inhibiting classical pathway (CP) of complement activity. Activation of the CP of complement is associated with a variety of immune disorders involving the presence of autoantibodies. Inhibition of autoantibody-mediated CP activation on the surface of erythrocytes via C1s binding prevents complement opsonin deposition on red blood cells and protects them from phagocytosis and extravascular hemolysis in autoimmune hemolytic anemia such as cold agglutinin disease (CAD); SAR445088 is currently under evaluation in a Phase&#160;II study in this indication.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">B.5.1.2. Line extensions</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For more information on Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Cerdelga</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> see also </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Item&#160;4. Information on the Company &#8212; </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">B. Business Overview </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">B.2. Main Pharmaceutical Products</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline"> (isatuximab)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a monoclonal antibody designed to selectively bind to CD38, a cell surface antigen expressed in multiple myeloma (MM) cancer cells and other hematological malignancies. Based on the Phase&#160;III studies ICARIA-MM and IKEMA, Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is approved in several countries in combination settings for the treatment of adults with relapsed refractory multiple myeloma (RRMM).</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">37</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, R&amp;D efforts were pursued to evaluate Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with current standard and novel treatments across the MM treatment continuum:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the IMROZ Phase&#160;III study is assessing the clinical benefit of Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with bortezomib, lenalidomide and dexamethasone versus bortezomib, lenalidomide and dexamethasone in patients with newly diagnosed MM not eligible for transplant; filing in this indication is expected in 2024;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the IRAKLIA Phase&#160;III study comparing subcutaneous to intravenous administration of Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with pomalidomide and dexamethasone in RRMM patients who have received at least one prior line of therapy enrolled its first participants in July&#160;2022;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the GMMG HDF Phase&#160;III study is evaluating the clinical benefit of Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with lenalidomide, bortezomib and dexamethasone for induction and with lenalidomide for maintenance in patients with newly diagnosed MM. This study is being conducted in collaboration with the German-speaking Myeloma Multicenter Group (GMMG);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the ITHACA Phase&#160;III trial is assessing Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with lenalidomide and dexamethasone versus lenalidomide and dexamethasone in patients with high-risk smoldering MM;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a Phase&#160;II study is ongoing to evaluate Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in new combinations with emerging novel mechanisms of action in patients with RRMM or in newly diagnosed MM patients.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A Phase&#160;II study assessing Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with chemotherapy in pediatric patients with relapsed/refractory B or T acute lymphoblastic leukemia or acute myeloid leukemia in first or second relapse is ongoing.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is also under investigation in a Phase&#160;II trial for the subcutaneous treatment of adults with warm autoimmune hemolytic anemia (wAiHA), a rare blood disorder.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline"> (cemiplimab)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a monoclonal antibody targeting the immune checkpoint receptor PD-1 (programmed cell death protein-1), approved in several countries for the treatment of skin cancers (metastatic or locally advanced cutaneous squamous cell carcinoma and basal cell carcinoma), for the treatment of NSCLC, and for second-line treatment of cervical cancer. Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">has been jointly developed by Regeneron and Sanofi under a global collaboration agreement originally entered into in 2015. As detailed in section &#8220;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">&#8212; B.5.&#160;Global research &amp; development&#8221;,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> the agreement was amended and restated in June&#160;2022 and Sanofi granted Regeneron worldwide exclusive license rights to Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In January&#160;2022, Sanofi and Regeneron announced the voluntary withdrawal of the supplemental Biologics License Application for second-line treatment of cervical cancer in the US. In the last quarter of 2022, Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">was approved in Europe and in Japan for second-line treatment of cervical cancer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In November&#160;2022, Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in chemotherapy combination was approved by the FDA for the first-line treatment of non small cell lung cancer. Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">is currently under review by the EMA in the same indication; the final decision is expected in February&#160;2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">(dupilumab)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a human monoclonal antibody that binds to the IL-4 receptor &#945; subunit and inhibits IL-4 and IL-13 signaling, jointly developed with Regeneron. Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has received regulatory approvals in several countries for use in patients with AD, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), EoE or prurigo nodularis in different age populations; details are provided below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Atopic dermatitis</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2022, the product was approved in China for the treatment of children aged 6-11&#160;years with moderate-to-severe AD.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;2022, it</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">was approved in the US for the treatment of children aged 6&#160;months to 5&#160;years with moderate-to-severe AD.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Asthma</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved in the EU in April&#160;2022 for children aged 6&#160;to 11&#160;years with severe asthma with type&#160;2 inflammation. The approval was based on Phase&#160;III data showing significant reduction of severe asthma attacks and also improvement of lung function and health-related quality of life for children.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Eosinophilic esophagitis (EoE)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In May&#160;2022, the FDA approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to treat patients with EoE aged 12&#160;years and older after granting the medicine Priority Review. In January&#160;2023, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">was approved by European Commission for the treatment of patients with EoE aged 12&#160;years and older.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A Phase&#160;III trial assessing the investigational use of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in children aged 1&#160;to 11&#160;years with EoE met its primary endpoint of histological disease remission at 16&#160;weeks with both higher and lower dose weight-tiered regimens. Filing for the treatment of this pediatric population is expected in 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Prurigo nodularis</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved in the US in September&#160;2022 after Priority Review for the treatment of adults with prurigo nodularis. With this approval, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> became the first and only medicine specifically indicated to treat prurigo nodularis in the US. In&#160;December&#160;2022, the European Commission expanded the marketing authorization for Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (dupilumab) in the EU to treat adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Prurigo nodularis is a chronic, debilitating skin disease with underlying type&#160;2 inflammation and its impact on quality of life is one of the highest among inflammatory skin diseases.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">38</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other indications</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Phase&#160;III clinical studies are currently investigating Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the treatment of a range of dermatology and respiratory diseases:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">chronic spontaneous urticaria: submission of the product for this indication in the US was completed in December&#160;2022;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">bullous pemphigoid;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">chronic inducible cold urticaria;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">chronic pruritis of unknown origin;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">chronic obstructive pulmonary disease;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">chronic rhinosinusitis without nasal polyps; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">allergic fungal rhinosinusitis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> (</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">sarilumab</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a monoclonal antibody against the IL-6 receptor developed with Regeneron is already marketed in the treatment of moderate to severe rheumatoid arthritis. The product is currently being evaluated in pivotal Phase&#160;IIb studies in pediatric populations for two indications:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">polyarticular juvenile idiopathic arthritis; filing in this indication is expected in 2023; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">systemic juvenile idiopathic arthritis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Cerdelga</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> (</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">eliglustat</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">is a potent, highly specific ceramide analog inhibitor of GL-1 synthesis marketed for Gaucher disease type&#160;1 (GD1) in adult patients. A Phase&#160;III trial is currently evaluating Cerdelga</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the treatment of pediatric patients with GD1.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Nexviadyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">avalglucosidase alfa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">was approved in Europe in 2022</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">for the long-term treatment of both late-onset and infantile-onset Pompe disease, a rare, progressive and debilitating muscle disorder caused by a deficiency of the enzyme acid alpha-glucosidase (GAA). Outside of Europe, the treatment is marketed under the brand name Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) in September&#160;2022 for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP).</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_82"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.5.2. Vaccines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Vaccines R&amp;D portfolio includes 11&#160;projects in advanced development (including one monoclonal antibody candidate), as shown in the table below.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Phase I</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Phase II</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Phase III</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Registration</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">mRNA quadrivalent influenza vaccine </span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Meningococcal B Vaccine</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prevention of invasive disease caused by N.Meningitidis serogroup&#160;B</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:87%">MenQuadfi</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:87%">Advanced generation meningococcal ACYW conjugated vaccine</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:87%">US/EU infants aged 6&#160;weeks &amp; above</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:87%">Nirsevimab</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:87%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:87%">, mAb</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:87%">Passive prevention of RSV infections in all infants</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:87%">Licensed in EU and the UK; pending licensure in the US</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">mRNA RSV vaccine </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prevention of RSV infections in older adults</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">21-valent Pneumo Conjugate Vaccine (PCV21)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:112%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Prevention of pneumococcal disease</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:87%">VRVg<br/>Purifiied vero rabies vaccine</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:87%">Shan6</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:700;line-height:87%;position:relative;text-decoration:underline;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:87%"> DTwP-HepB-Polio-Hib</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:87%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:87%"> Pediatric hexavalent vaccine Licensed in India and WHO pre-qualified </span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">RSV vaccine (PhI/II)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Prevention of RSV infections in toddlers aged 6&#160;months &amp; older</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Vero Yellow Fever vaccine (vYF)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Fluzone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> QIV HD Quadrivalent inactivated influenza vaccine &#8211;</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">High dose for pediatric use</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Partnered and/or in collaboration: Sanofi may have limited or shared rights to some of these products.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Hib =&#160;Haemophilus influenzae type&#160;b.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">39</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Enhancements of existing vaccines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Fluzone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">: QIV HD is a higher dose quadrivalent influenza vaccine licensed in the US and in Europe for the elderly population, who do not respond as well to standard-dose influenza vaccines due to aging of the immune system (immuno-senescence). Safety and efficacy in the pediatric population will be assessed in a Phase&#160;III trial.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">mRNA Quadrivalent influenza vaccine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a quadrivalent influenza vaccine based on mRNA technology, which is currently in Phase&#160;I. Following results of Phase&#160;I, the product should be moving to Phase&#160;III in 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Shan6</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;text-decoration:underline;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">is an all-in-one liquid hexavalent combination vaccine. It comprises detoxified whole-cell pertussis as well as diphtheria toxoid, tetanus toxoid, Hemophilus influenzae type&#160;b PRP-T, inactivated poliovirus types&#160;1, 2, and&#160;3 and hepatitis&#160;B virus components. Shan6</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">has been approved in India and obtained WHO pre-qualification in November&#160;2022. Following a strategic assessment of the whole-cell pertussis market, Sanofi has decided to cease the production of the Shan5</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and Shan6</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> vaccines produced in Hyderabad, India.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">MenQuadfi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">: Sanofi&#8217;s Men ACYW-TT vaccine is our latest advance in meningococcal quadrivalent conjugate vaccination, designed to help protect an expanded patient group including infants and adolescents through older adults. MenQuadfi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is already licensed in the US (for people aged 2&#160;years and over), and in Europe and several other countries (for people aged 12&#160;months and over). Marketing authorization is also pending in additional countries. In January&#160;2022, MenQuadfi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> received WHO for pre-qualification for people aged 12&#160;months and above. Additionally, Phase&#160;III trials are ongoing to evaluate immunogenicity and safety in infants aged 6&#160;weeks and above, and allow for extension of the age indication down to 6&#160;weeks of age.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Rabies Vaccine:</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> a next-generation purified human rabies vaccine (VRVg) is under development, aimed at replacing both of Sanofi&#8217;s currently commercialized rabies vaccines (Imovax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Rabies and Verorab</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">). It will be cultured on Vero cells and will be free of animal or human material. VRVg is currently in Phase&#160;III trials in order to support pre and post exposure indications.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Vero Yellow Fever (vYF) vaccine </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">candidate is a next generation freeze-dried live-attenuated yellow fever vaccine produced on a Vero cell line, for subcutaneous and intra-muscular administration in people aged nine months and older. This vaccine aims to replace Stamaril</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and YF-VAX</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> with a single product. In January&#160;2020, the first Phase&#160;I/II trial was initiated in the US. In the first quarter of&#160;2023, Phase&#160;II data against standard of care will be available.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Novel targets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Nirsevimab</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a monoclonal antibody engineered to have a long half-life, so that only one dose would be needed for the entire respiratory syncytial virus (RSV) season to provide passive immunity and prevent RSV infection in all infants for their first RSV season (and in high-risk infants, for their first and second RSV seasons). Sanofi has an agreement with AstraZeneca to develop and commercialize nirsevimab. The positive primary analysis of the Phase&#160;IIb trial, published in the New England Journal of Medicine in July&#160;2020, which demonstrated the safety and efficacy of nirsevimab, has been confirmed and enhanced in other Phase&#160;II and Phase&#160;III trials. The Phase&#160;III MELODY study, initiated in 2019, achieved its primary endpoint of protection against medically attended RSV lower respiratory tract infection in healthy full-term and late pre-term infants. The MEDLEY Phase&#160;II/III study, conducted in preterm infants and infants with chronic lung disease or congenital heart disease, showed positive safety and pharmacokinetics when compared to standard of care. Regulatory submissions started in 2022. Nirsevimab, which will be commercialized under the name of Beyfortus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, received European and UK approvals in November&#160;2022. The file was also submitted in the US, and FDA acceptance was received in January&#160;2023. First launches are expected in 2023. Nirsevimab was also selected by the Japanese Agency for Medical Research and Development as a priority medicine, and received breakthrough therapy designation in China in January&#160;2021. We initiated a Phase&#160;III study in China in November&#160;2021</span><span style="background-color:#e6e6e6;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">RSV toddler vaccine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">: Sanofi has a Cooperative Research and Development Agreement (CRADA) with the US National Institute of Health (NIH) to develop a live attenuated RSV vaccine for immunization of infants aged 6&#160;months and older. We initiated the Phase&#160;I/II study in the US in September&#160;2020, evaluating the safety and effectiveness of two doses of an intranasal delivery device in infants, the goal being to extend the immunity offered by nirsevimab to additional RSV seasons. Positive data from this study were obtained in the fourth quarter of&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">RSV older adult vaccine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">: Sanofi initiated Phase&#160;I with an mRNA vaccine against RSV for the older adults population. This vaccine aims at providing protection against RSV as a standalone vaccine, and in combination with other respiratory viruses in the future.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Meningococcal Group&#160;B (Men&#160;B):</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">this vaccine candidate is intended to provide active immunization against invasive meningococcal disease caused by </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Neisseria meningitidis</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> serogroup&#160;B (Men&#160;B) for all age groups. A Phase&#160;I/II study was initiated in&#160;March&#160;2021 with positive interim data in the fourth quarter of&#160;2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Early-stage development studies are underway to combine the four meningococcal serogroups represented in MenQuadfi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">with Men&#160;B to advance a pentavalent meningococcal vaccine candidate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:underline">Pneumococcal Conjugate Vaccine (PCV)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">: Sanofi is collaborating with SK Chemicals (South Korea) to develop a 21-valent pneumococcal conjugate vaccine that will provide expanded protection against pneumococcal disease globally in at risk populations and in different age groups. Data from Phase&#160;II studies assembled between mid-2022 and mid-2023 will define the pathway to Phase&#160;III.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">40</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_85"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.5.3. R&amp;D Expenditures for late stage development</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Expenditures on research and development amounted to &#8364;6,706&#160;million in 2022 (&#8364;5,692&#160;million in 2021), comprising &#8364;5,067&#160;million in the Pharmaceuticals segment; &#8364;187&#160;million in the Consumer Healthcare segment; &#8364;936&#160;million in the Vaccines segment; and &#8364;516&#160;million allocated to &#8220;Other&#8221;, representing the R&amp;D support function. Research and development expenditures represented approximately 15.6% of our net sales in 2022, compared with approximately 15.1% in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The increase was mainly due to additional investments </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in Immunology and the </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">mRNA vaccines platform, while cost control efforts&#160;continue. Preclinic</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">al research expenditures in the Pharmaceuticals segment amounted to &#8364;884&#160;million in 2022, compared with&#160;&#8364;718&#160;million in 2021. Clinical development expenditure in the Pharmaceuticals segment amounted to &#8364;3,460&#160;million in 2022; compared with &#8364;2,892&#160;million in 2021.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_88"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.6. Markets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A breakdown of revenues by business segment and by geographical region for 2022, 2021, and 2020 can be found at Note&#160;D.35. to our consolidated financial statements, included at Item&#160;18. of this annual&#160;report.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following market shares and ranking information are based on consolidated national pharmaceutical sales data (excluding vaccines), in constant euros, on a September&#160;2022 MAT (Moving Annual Total) basis. The data are mainly from IQVIA local sales audit supplemented by various other country-specific sources including Knobloch (Mexico), GERS (France) and HMR (Portugal).</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_91"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.6.1. Marketing and distribution</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have business operations in approximately 90&#160;countries and our products are available in more than</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">180&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">c</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ountries. A&#160;breakdown of our aggregate net sales by geographical region is presented in &#8220;Item&#160;5. Operating and Financial Review and Prospects &#8212;&#160;Results of Operations &#8212;&#160;Year Ended December 31, 2022 Compared with Year Ended December 31, 2021.&#8221; Sanofi is the ninth largest pharmaceutical company globally by sales. Our main markets in terms of net sales are respectively:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">United States: we rank twelfth with a market share of 3.6%;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Europe: we are the sixth largest pharmaceutical company in France where our market share is 4.7%, and we rank eighth in Germany with a 3.3% market share; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">other countries: we are ranked eighteenth in Japan with a market share of 1.8%, and twelfth in China with a market share of 1.5%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Although specific distribution patterns vary by country, we sell prescription drugs primarily to wholesale drug distributors, independent and chain retail drug outlets, hospitals, clinics, managed-care organizations and government institutions. Some products in Rare Diseases and Oncology may also be sold directly to physicians. With the exception of Consumer Healthcare products, our drugs are ordinarily dispensed to patients by pharmacies upon presentation of a doctor&#8217;s prescription. Our Consumer Healthcare products are also sold and distributed through e-commerce, which is a growing trend in consumer behavior. Our vaccines are sold and distributed through multiple channels including physicians, pharmacies, hospitals, private companies and distributors in the private sector, and governmental entities and non-governmental organizations in the public and international donor markets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We use a range of channels from in-person to digital to disseminate information about and promote our products among healthcare professionals, ensuring that the channels not only cover our latest therapeutic advances but also our established prescription products, which satisfy patient needs in some therapy areas. We regularly exhibit at major medical congresses. In some countries, products are also marketed directly to patients by way of television, radio, newspapers and magazines, and digital channels (such as the internet). National education and prevention campaigns can be used to improve patients&#8217; knowledge of&#160;their conditions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our sales representatives, who work closely with healthcare professionals, use their expertise to promote and provide information on our drugs. They represent our values on a day-to-day basis and are required to adhere to a code of conduct and to internal policies on which they receive training.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Although we market most of our products through our own sales forces, we have entered into and continue to form partnerships to co-promote/co-market certain products in specific geographical areas. Our major alliances are detailed at &#8220;Item&#160;5.&#160;Operating and Financial Review and Prospects &#8212;&#160;Financial Presentation of Alliances.&#8221; See also &#8220;Item&#160;3.&#160;Key Information &#8212;&#160;D.&#160;Risk Factors &#8212;&#160;We rely on third parties for the discovery, manufacture and marketing of some of our&#160;products.&#8221;</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_94"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.6.2. Competition</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The pharmaceutical industry continues to experience significant changes in its competitive environment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">There are four primary types of competition in the prescription pharmaceutical market:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">competition among pharmaceutical companies to research and develop new patented products or address unmet medical needs;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">competition among different patented pharmaceutical products marketed for the same therapeutic indication;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">competition among original and generic products or original biological products and biosimilars, at the end of regulatory exclusivity or patent protection; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">competition among generic or biosimilar products.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">41</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Generics manufacturers who have received all necessary regulatory approvals for a product may decide to launch a generic version before the patent expiry date, even in cases where the owner of the original product has already commenced patent infringement litigation against the generics manufacturer. Such launches are said to be &#8220;at risk&#8221; for the promoter of the generic product because it may be required to pay damages to the owner of the original product in the context of patent infringement litigation; however, such launches may also significantly impair the profitability of the pharmaceutical company whose product is&#160;challenged.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Drug manufacturers may also face intra-product competition through parallel trading, or parallel importation or reimportation, where permitted. This may take place when drugs sold in a foreign market under the same brand name as in a domestic market are permitted to be imported into that domestic market by parallel traders or importers, who may repackage or resize the original product or sell it through alternative channels such as mail order or the internet. This situation is of particular relevance to the EU with its common market, where such practices have been encouraged by the current regulatory framework. Parallel traders or importers take advantage of the price differentials between markets arising from factors including sales costs, market conditions (such as intermediate trading stages), tax rates, or national regulation of&#160;prices.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, pharmaceutical companies face illegal competition from substandard and falsified drugs. The WHO estimates that falsified products account for 10% in low- and middle-income countries. All therapeutic areas are affected, including vaccines.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Worldwide, falsified products are an issue in part due to the exponential increase in internet connectivity of those engaged in the manufacture, distribution and supply of substandard and falsified medical products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The same types of competition apply in Consumer Healthcare, except that in this business there are two types of generic products: private labels and store brands.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Vaccines, there are two primary types of competition:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">competition among vaccine companies to research and develop new patented products or address unmet medical needs; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">competition among different patented (or non-patented) vaccine products marketed for the same therapeutic indication.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Generics and biosimilars are not an issue in vaccines at present, since vaccines are still mostly produced from proprietary viral or bacterial strains. As with pharmaceutical drugs, vaccine manufacturers can face competition through parallel trading. However, the extent of such practices is limited by the need for cold chain distribution of vaccines, and by the fact that vaccines are sold and administered through pharmacies or dispensing physicians.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_97"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.6.3. Regulatory framework</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The pharmaceutical and health-related biotechnology sectors are highly regulated. National and supranational health authorities administer a vast array of legal and regulatory requirements that dictate pre-approval testing (including testing in human subjects) and quality standards to maximize the safety and efficacy of a new medical product. These authorities also regulate product labeling, manufacturing, importation/exportation, safety reporting and marketing, as well as mandatory post-approval requirements and commitments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The submission of an application to a regulatory authority does not guarantee that a license or approval to market will be granted. Furthermore, each regulatory authority may impose its own requirements during product development or during the application review. It may refuse to grant approval or require additional data before granting approval, even in circumstances in which the same product has already been approved in other countries. Regulatory authorities also have the authority to request product recalls and product withdrawals, to impose penalties for violations of regulations, and ultimately the ability to revoke product licensure or approval.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Product review and approval can vary from six months or less to several years from the date of application submission depending upon the country and regulatory jurisdiction. Factors such as the quality of data and evidence, the review procedures, the nature of the product and the condition to be treated, play a major role in the length of time a product is under&#160;review, and whether or not the product is ultimately licensed or approved.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">In the EU</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, there are three main procedures for applying for marketing authorization:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the centralized procedure is mandatory for drugs derived from biotechnologies; new active substances designed for human use to treat&#160;HIV, viral diseases, cancer, neurodegenerative diseases, diabetes and auto-immune diseases; orphan drugs; and innovative products for veterinary use. When an application for human use is submitted to the EMA, the scientific evaluation of the application is carried out by the EMA's CHMP and a scientific opinion is prepared. This opinion is sent to the European Commission, which adopts the final decision and grants an EU marketing authorization. Such a marketing authorization is valid throughout the EU, and the drug may be marketed within all EU Member States;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if a company is seeking a national marketing authorization in more than one Member State, two procedures are available to facilitate the granting of harmonized national authorizations across Member States: the mutual recognition procedure or the decentralized procedure. Both procedures are based on the recognition by national competent authorities of a first assessment performed by the regulatory authority of one Member State;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">national authorizations are still possible, but are only for products intended for commercialization in a single EU Member State or for line extensions to existing national product licenses.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">In the EU</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, vaccines are treated as pharmaceutical products, and therefore have to obtain marketing authorization under the centralized procedures described above.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">42</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Generic products are subject to the same marketing authorization procedures. A generic product must contain the same active medicinal substance as a reference product approved in the EU. Generic applications are abridged: generic manufacturers only need to submit quality data and demonstrate that the generic drug is &#8220;bioequivalent&#8221; to the originator product (i.e., performs in the same manner in the patient&#8217;s body), but do not need to submit safety or efficacy data since regulatory authorities can refer to the reference product&#8217;s dossier.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Another relevant aspect in the EU regulatory framework is the &#8220;sunset clause&#8221; under which any marketing authorization ceases to be valid if it is not followed by marketing within three years, or if marketing is interrupted for a period of three consecutive years.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">In the US</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, applications for pharmaceutical approval and biological product licensure are submitted for review to the FDA, which has broad regulatory jurisdiction over all pharmaceutical and biological products that are intended for sale and marketing in the&#160;US. To commercialize a product in the US, a new drug application (NDA) under the Food, Drug and Cosmetic (FD&amp;C) Act, or a Biological License Application&#160;(BLA) under the Public Health Service (PHS) Act, must be submitted to the FDA for filing and pre-market review. Specifically, the FDA must decide whether the product is safe and effective for its proposed use; if the benefits of the product outweigh its risks; whether the product labeling is adequate; and if the manufacturing of the product and the controls used for maintaining quality are adequate to preserve the product's identity, strength, quality and purity. Based upon this review, the FDA can stipulate post-approval commitments and requirements. Changes to an approved product, including but not limited to a new indication, require submission of a supplemental NDA (sNDA) for a drug or a supplemental BLA (sBLA) for a biological product.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FD&amp;C Act provides another option for NDA product approval via the 505(b)(2) pathway. This 505(b)(2) application contains full reports of investigations of safety and effectiveness but at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. For example, under the 505(b)(2) pathway an applicant may seek to rely on literature or earlier FDA findings of safety and effectiveness for approved drugs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sponsors wishing to market a generic drug can file an Abbreviated NDA (ANDA) under 505(j) of the FD&amp;C Act. These applications are&#160;&#8220;abbreviated&#8221; because they are generally not required to include data to establish safety and efficacy but need to demonstrate that their product is bioequivalent (i.e., performs in humans in the same manner as the originator&#8217;s product) to a reference product. Consequently, the length of time and cost required for development of generics can be considerably less than for the innovator&#8217;s drug. The ANDA pathway in the US can only be used for generics of drugs that can be referenced as having been approved under the FD&amp;C&#160;Act.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">In Japan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the entire process of approval review from review-related inspections and clinical trial consultation to review for the drugs approved by the Ministry of Health, Labour and Welfare (MHLW) is undertaken by the Pharmaceuticals and Medical Devices Agency&#160;(PMDA). The PMDA conducts first scientific review of the NDA submitted, assessing particularly the safety, efficacy and quality of the product or medical device proposed. Results of this primary evaluation are then submitted to the PMDA&#8217;s external experts. After a second evaluation based on the external experts&#8217; feedback, a report is provided; the Pharmaceutical Affairs and Foods Sanitation Council&#160;(PAFCS) &#8211;&#160;one of the councils organized under the J-MHLW as advisory commission&#160;&#8211; is consulted, and advises the MHLW on final approvability.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For Japanese registrations, clinical data for Japanese patients are necessary. The regulatory authorities can require local clinical studies, though they also accept multi-regional studies including Japan. In some cases, bridging studies have been conducted to verify extrapolability of foreign clinical data to Japanese patients and to obtain data to determine the appropriateness of the dosages for Japanese patients.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The MHLW may require additional post-approval studies (Phase&#160;IV) for some specific cases, to further evaluate safety and/or to gather information on the use of the product under specified conditions. In approval of new drugs, new indications, new dosages or new administrations, the re-examination period is determined by the MHLW. Post-marketing information on a drug for the predetermined period after approval is collected to reconfirm its efficacy, safety and quality at the end of the period. This collection process involves both post-marketing surveillance (PMS), which is a non-interventional study, and post-marketing clinical trials.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For generic products, the data necessary for filing are similar to EU and US&#160;requirements. Companies only need to submit quality data, and data demonstrating bioequivalence to the originator product, unless the drug is biopharmaceutical. Common Technical Document (CTD) submission for generics has been mandatory since March&#160;2017.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) was created in&#160;1990 and reformed in 2015.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The ICH currently includes 20&#160;Members and 35&#160;Observers. Harmonization is achieved through the development of ICH Guidelines via a process of scientific consensus with regulatory and industry experts working side-by-side.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition to the joint efforts, Free Trade Agreements (FTAs) have proven to be one of the best ways to open up foreign markets to exporters and to allow for discussions on harmonization topics for regulatory authorities. Some agreements, such as the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS), are international in nature, while others are between specific countries. The requirements of many countries (including Japan and several EU Member States) to negotiate selling prices or reimbursement rates for pharmaceutical products with government regulators significantly extend the time to market entry beyond the initial marketing approval. While marketing authorizations for new pharmaceutical products in the EU have been largely centralized within the European Commission in collaboration with the EMA, pricing and reimbursement remain a matter of national competence.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">43</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_100"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.6.4. Pricing &amp; reimbursement</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We are operating in a </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">highly complex and volatile</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> market access and launch environment globally.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Faced with mounting budget pressure, governments and payers are using </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">various drug price control policies, among others,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> price referencing for imported drugs, increased patient co-payments, restrictive formularies, prescribing guidelines, tendering procedures, generic and biosimilar substitution, and medico-economic evaluations of healthcare products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, pharmaceutical companies are expected to continuously demonstrate value throughout the product life cycle (such as through comparative efficacy studies, real-world patient data, and budget modelling), while s</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">tringent payer evidence requirements</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> that differ from country to country are raising the bar for market entry.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Despite many challenges, payers and regulators are becoming more committed to providing </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">early access to new innovative therapies</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, with greater emphasis on real-world evidence (RWE).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These trends are likely to</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> continue in the coming year, mainly driven by the</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> COVID-19 pandemic, macroeconomic and geopolitical headwinds.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Overview of the US health insurance system:</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Commercial insurance is offered widely as part of employee benefit packages and is the main source of employee access to subsidized healthcare. Some individuals purchase private health plans directly or through marketplaces established under the Affordable Care Act, while publicly subsidized programs provide coverage for retirees, the indigent, the disabled, uninsured children, and serving or retired military personnel. Double coverage can occur.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Commercial insurance includes:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Managed Care Organizations (MCOs), which combine the functions of health insurance, delivery of care, and administration. MCOs use specific provider networks and specific services and products. There are four primary types of managed care plans: Health Maintenance Organizations (HMOs), Preferred Provider Organizations (PPOs), Exclusive Provider Organizations (EPOs), and Point of Service (POS) plans; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Pharmacy Benefit Managers (PBMs), which serve as intermediaries between insurance companies, pharmacies and manufacturers to negotiate rebates and discounts on formulary placement for commercial health plans, self-insured employer plans, Medicare Part&#160;D plans, and federal and state government employee plans.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Government insurance includes:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.44pt">Medicare</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, which provides health insurance for retirees and for people with permanent disabilities. The basic Medicare scheme (Part A) provides hospital insurance only, and the vast majority of retirees purchase additional cover through some or all of three other plans named Part&#160;B, Part&#160;C and Part&#160;D. Part&#160;D enables Medicare beneficiaries to obtain outpatient drug coverage. Almost two-thirds of all Medicare beneficiaries have enrolled in Part&#160;D plans; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.44pt">Medicaid</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, which provides health insurance for low-income families, certain qualified pregnant women and children, individuals receiving supplemental security income, and other eligible persons determined on a state-by-state basis;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.44pt">TRICARE</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, which provides health insurance for uniformed service members, retirees, and their families including comprehensive healthcare, prescription and dental coverage.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Biden administration&#8217;s efforts remain focused on lowering health care and prescription drug costs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">In August&#160;2022, the Inflation Reduction Act (IRA) was enacted with drug pricing provisions, which will be phased in over the next few years</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. For the first time, the federal government will negotiate the prices of selected drugs with high budget impact on Medicare Part&#160;B (physician-administered) and Part&#160;D (retail prescription drugs), starting with 10&#160;drugs in 2026 and increasing to&#160;20&#160;drugs in 2029 and beyond. Manufacturers will also be required to pay mandatory rebates if drug prices increase faster than&#160;the rate of inflation (based on the Consumer Price Index, all urban consumers [CPI-U]), beginning in October&#160;2022 for Part&#160;D and&#160;January&#160;2023 for Part&#160;B). Other measures of the Act will redesign the Medicare Part&#160;D benefit, including a monthly $35 insulin cap in 2023 and an annual $2,000 out-of-pocket (OOP) spending cap in 2025 for Medicare beneficiaries. Altogether, the IRA is expected to reduce federal drug spending by about $290&#160;billion over the next decade according to estimates from the Congressional Budget Office (CBO). The new legislation is also likely to have a negative impact on industry revenue growth and future innovation, through there remains significant uncertainty over the price negotiation provision and the impact of Medicare reforms.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Federal and state governments are also seeking to step up price transparency requirements</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">for hospitals, insurers and health plans</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> as contained in the CMS Transparency in Coverage Rule, officially effective since July&#160;1, 2022. In addition, more than half of US states have passed or are pursuing laws to bring greater transparency and prevent price gouging &#8211; an issue that has led to intense debate on insulin costs in recent years.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">After years of slow growth, biosimilar adoption is likely to accelerate </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">with 36&#160;biosimilars approved to date by the FDA, including two interchangeable products (insulin glargine and adalimumab). According to IQVIA, savings are projected to potentially exceed $100&#160;billion over the next five years, though uncertainty remains on the impact of interchangeability on biosimilar uptake and pricing in the long term.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Moreover, the continuing vertical integration and consolidation within the US health insurance market exposes the industry to greater pricing pressure</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. With the three largest PBM group purchasing organizations (GPOs) (i.e., Ascent, Emisar and Zinc) now covering over 85% of US prescription drug claims, consolidation has led to increased utilization management and restrictive formularies, resulting in strong bargaining power for negotiating discounted prices, thereby adversely impacting sales.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">44</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">China</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">China continues to pursue reforms</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">towards Healthy China 2030</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Healthcare is one of the growth priorities under the country&#8217;s 14th&#160;Five-Year Plan (2021-2025), with policies aimed at addressing a large and increasing burden of disease (especially cancer, diabetes and cardiovascular diseases), while balancing access to innovation and costs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">China continues to improve regulatory timelines. For example, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> received approval for the treatment of adults with moderate-to-severe atopic dermatitis in June&#160;2020, within 6&#160;months of filing through an accelerated review process.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Pricing pressure is expected to intensify </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as a growing number of products are subject to National Reimbursement Drug List (NRDL) price negotiations and volume-based procurement (VBP) tenders, with the lowest price prevailing to compete with domestic companies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Access to innovative therapies has been rapidly increasing in recent years, fueled by annual NRDL updates, albeit with steep price cuts across therapy areas.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> According to the National Healthcare Security Administration (NHSA), 111&#160;new drugs were added&#160;to the National Reimbursement Drug List (NRDL) in January&#160;2023, an increase of 36% over 2022. The latest additions included 23&#160;cancer drugs, 17&#160;treatments for infectious diseases, 7&#160;for rare diseases and 2&#160;for COVID-19, with an average price reduction of 60.1% &#8211; in line with recent years. Over the past five years, 618&#160;&#8211; drugs have been added to the NRDL, bringing the total number of covered medicines to 2,967 &#8211; 1,586&#160;Western drugs and 1,381&#160;traditional Chinese medicines.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Further expansion of the volume-based procurement (VBP) policy will drive down the prices of a growing number of products, with more than 500&#160;drugs targeted for inclusion by 2025.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Europe</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">In Europe, health systems are under mounting financial pressure caused by high public debt, rising inflation and slow economic growth. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Biosimilar uptake and tighter cost-containment policies will continue to exert downward pressure on EU drug prices. Importantly, industry payback and mandatory rebates are expected to increase at unprecedented rates in 2023 in major EU&#160;markets, particularly in Germany and the UK.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">The new EU HTA regulation was adopted in December&#160;2021,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> after years of joint work between Member States,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and will be implemented in a staged process by 2025. Under the new rules, Member States will be cooperating on conducting future joint clinical assessments (JCAs) and joint scientific consultations (JCSs). However, significant uncertainty remains over the implementation of the new framework.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Furthermore, the access environment is poised to become more challenging in the context of the European Commission's wide-ranging Pharmaceutical Strategy for Europe</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> adopted in November&#160;2020. The European Commission&#8217;s most concerning proposals relate to revamping incentives in unmet need areas such as rare and pediatric diseases, reducing intellectual property for earlier market entry of generics and biosimilars, promoting greater transparency around pricing and drug development costs, and cross-border collaboration on pricing and procurement. Policy options under consideration could have far-reaching impacts on the rare disease pipeline, and have the potential to undermine EU innovation and competitiveness.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Similar pressures are being felt in other regions and countries around the globe.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To address the multiple challenges mentioned above, we are continuously adapting and future-proofing our pricing and market access strategies.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_103"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.7. Patents, intellectual property and other rights</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.7.1. Patents</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Patent protection</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We own a broad portfolio of patents, patent applications and patent licenses worldwide. These patents are of various types and may cover: active ingredients; pharmaceutical formulations; product manufacturing processes; intermediate chemical compounds; therapeutic indications/methods of use; technology platforms; delivery systems; digital applications; and enabling technologies, such as assays.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Patent protection for individual products typically extends for 20&#160;years from the patent filing date in countries where we seek patent protection. A substantial part of the 20-year life span of a patent on a new molecule (small molecule or biologic) has generally already passed by the time the related product obtains marketing authorization. As a result, the effective period of patent protection for an approved product&#8217;s active ingredient is significantly shorter than 20&#160;years. In some cases, the period of effective protection may be extended by procedures established to compensate regulatory delay in Europe (via Supplementary Protection Certificate or SPC), in the US (via Patent Term Extension or PTE), and in Japan (PTE).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The protection a patent provides to the related product depends upon the type of patent and its scope of coverage, and may also vary from country to country.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Europe, applications for new patents may be submitted to the European Patent Office (EPO). A European Patent (EP) application may cover the 38&#160;European Patent Convention Member States, including all Member States of the EU. The granted EP establishes corresponding national patents with uniform patent claims among the Member States.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2013, EU legislation was adopted to create a European Unitary Patent and a Unified Patent Court. It is expected to come into force on June&#160;1, 2023.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">45</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We monitor our competitors and vigorously seek to challenge patent infringers when such infringement would negatively impact our business objectives. See &#8220;Item&#160;8. &#8212; A.&#160;Consolidated Financial Statements and Other Financial Information &#8212; Information on Legal or Arbitration Proceedings &#8212; Patents&#8221; of this annual report.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The expiration or loss of a patent covering a new molecule, typically referred to as a compound patent, may result in significant competition from generic products and can result in a dramatic reduction in sales of the original branded product (see &#8220;Item&#160;3. Key Information &#8212; D.&#160;Risk Factors&#8221;). In some cases, it is possible to continue to benefit from a commercial advantage through product manufacturing trade secrets or other types of patents. Certain categories of products, such as traditional vaccines and insulin, were historically relatively less reliant on patent protection and may in many cases have no patent coverage. It is nowadays increasingly frequent for novel vaccines also to be patent protected.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory exclusivity</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In some markets, including the EU and the US, many of our pharmaceutical products may also benefit from multi-year regulatory exclusivity periods, during which a generic or biosimilar competitor may not rely on our clinical trial and safety data in its drug application. This exclusivity operates independently of patent protection and may protect the product from generic competition even if there is no patent covering the product.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the US, the FDA will not grant final marketing authorization to a generic competitor for a New Chemical Entity (NCE) until the expiration of the regulatory exclusivity period (five years) that commences upon the first marketing authorization of the reference product. Significant line extensions of existing NCEs may qualify for an additional three years of regulatory exclusivity if certain conditions are met. In the US, a different regulatory exclusivity period applies to biological drugs. The BPCIA (Biologics Price Competition and Innovation Act) provides that the FDA may not approve a biosimilar application until 12&#160;years after the date on which the reference product was first licensed.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the EU, regulatory exclusivity is available in two forms: data exclusivity and marketing exclusivity. Generic drug applications will not be accepted for review until eight years after the first marketing authorization (data exclusivity). This eight-year period is followed by a two-year period during which generics cannot be marketed (marketing exclusivity). The marketing exclusivity period can be extended to three years if, during the first eight-year period, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which are deemed to provide a significant clinical benefit over existing therapies. This is known as the &#8220;8+2+1&#8221; rule.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Japan, the regulatory exclusivity period varies: four years for medicinal products with new indications, formulations, dosages, or compositions with related prescriptions; six years for new drugs containing a medicinal composition or requiring a new route of administration; eight years for drugs containing a new chemical entity; and ten years for orphan drugs or new drugs requiring pharmaco-epidemiological study.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Pediatric extension</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the US and the EU, under certain conditions, it is possible to extend a product&#8217;s regulatory exclusivity for an additional period of time by providing data on pediatric studies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the US, under certain conditions of the Hatch-Waxman Act, it may result in the FDA extending regulatory exclusivity and patent life by six months, to the extent these protections have not already expired (the so-called &#8220;pediatric exclusivity&#8221;).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Europe, a regulation on pediatric medicines provides for pediatric research obligations with potential associated rewards including extension of supplementary patent protection and six-month regulatory exclusivity for pediatric marketing authorization (for off-patent medicinal products).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Japan, there is no pediatric research extension of patent protection for patented medicinal products. However, regulatory exclusivity may be extended from eight to ten years.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Orphan drug exclusivity</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under certain conditions, orphan drug exclusivity may be granted in the US to drugs intended to treat rare diseases or conditions. Orphan drug exclusivities also exist in the EU and Japan.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging markets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">One of the main limitations on our operations in emerging market countries is the lack of effective intellectual property protection or enforcement for our products, which frequently do not provide non-patent exclusivity for innovative products. While the situation has gradually improved, the lack of protection for intellectual property rights or the lack of robust enforcement poses difficulties in certain countries. Additionally, in recent years and especially during the pandemic, a number of countries have waived or threatened to waive intellectual property protection for specific products, for example through compulsory licensing of generics. See &#8220;Item&#160;3. Key Information &#8212; D.&#160;Risk Factors &#8212; Risks Relating to Sanofi&#8217;s Structure and Strategy &#8212; The globalization of our business exposes us to increased risks in specific areas&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Product overview</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We summarize below the intellectual property coverage (in some cases through licenses) of our most significant marketed products in terms of sales, in our major markets. In the discussion of patents below, we focus on active ingredient patents (compound patents) and, in the case of NCEs, on any later filed patents listed as applicable in the FDA&#8217;s list of Approved Drug Products with Therapeutic Equivalence Evaluations (the &#8220;Orange Book&#8221;) or in its foreign equivalents. For biologics, the Orange Book listing does not apply.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">46</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These patents or their foreign equivalents tend to be the most relevant in the event of an application by a competitor to produce a generic or a biosimilar version of one of our products (see &#8220;&#8212; Challenges to Patented Products&#8221; below). In some cases, products may also benefit from pending patent applications or from patents not eligible for Orange Book listing (in the case of NCEs for example, patents claiming industrial processes). In each case below, we specify whether the active ingredient is claimed by an unexpired patent. Where patent terms have been extended to compensate for US Patent and Trademark Office (USPTO) delays in patent prosecution (Patent Term Adjustment &#8211; PTA) or for other regulatory delays, the extended dates are indicated below. The US patent expirations presented below reflect USPTO dates, and also reflect six-month pediatric extensions when applicable. Where patent terms have expired we indicate such information and mention whether generics are on the market.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We do not provide later filed patent information relating to formulations already available as an unlicensed generic. References below to patent protection in Europe indicate the existence of relevant patents in most major markets in the EU. Specific situations may vary by country.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We additionally set out any regulatory exclusivity from which these products continue to benefit in the US, EU or Japan. Regulatory exclusivities presented below incorporate any pediatric extensions obtained. While EU regulatory exclusivity is intended to be applied throughout the EU, in some cases Member States have taken positions prejudicial to our exclusivity rights.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:17.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">European Union</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Japan</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (teriflunomide)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patent: coverage ranging through September 2030</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patent: coverage ranging through March 2024</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory exclusivity: August 2024</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a) (b)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" rowspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (eftrenonacog alfa)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Use: March 2028 with PTA* and PTE*</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: May 2024 </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(May 2029 with SPC* in most EU countries)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: May 2024 (February 2026 with PTE*)</span></div></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through December 2037 (pending)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through December 2037 (pending)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through December 2037 (pending)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory exclusivity: March&#160;2026</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory exclusivity: May 2028</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerezyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (imiglucerase)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patent: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patent: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patent: expired</span></td></tr><tr style="height:20pt"><td colspan="3" rowspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (dupilumab)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: October 2027 (March 2031 with PTE*)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: October 2029 (September&#160;2032 with SPC*)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: October 2029 (May 2034 with PTE*)</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through October 2041 (pending)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through August 2040 (pending)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through August 2040 (pending)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory exclusivity: March 2029</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory exclusivity: September&#160;2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory exclusivity: January 2026</span></td></tr><tr style="height:26pt"><td colspan="3" rowspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (efmoroctocog alfa)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: June 2028 with PTA* and PTE*</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Use: May 2024 </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(November 2029 with SPC* in most EU countries)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: May 2024 (August 2026 with PTE*)</span></div></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through December 2037 (pending)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through December 2037 (pending)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through December 2037 (pending)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory exclusivity: June&#160;2026</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory exclusivity: November 2025</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" rowspan="2" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabrazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (agalsidase beta)</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patent: expired</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patent: expired</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patent: expired</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Generics/biosimilars on the market</span></div></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory exclusivity: March 2028 pediatric indication (ages 2-8 with confirmed Fabry disease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (cabazitaxel)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Compound: Expired </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Later filed patents: coverage ranging through October&#160;2030</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">NCE Regulatory exclusivity: December&#160;2023</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Compound: expired</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Later filed patents: coverage ranging through May 2036 (pending)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Regulatory exclusivity: expired</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Compound: expired</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Later filed patents: coverage ranging through November&#160;2030</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Regulatory exclusivity: July&#160;2022</span></div></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (insulin glargine)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents ranging through April&#160;2033</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patent: June&#160;2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patent: June&#160;2023</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Generics/biosimilars on the market</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Generics/biosimilars on the market</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Generics/biosimilars on the market</span></div></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (enoxaparin sodium)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Generics/biosimilars on the market</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Generics/biosimilars on the market</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lumizyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">/Myozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (alglucosidase alfa)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (clopidogrel bisulfate)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Generics on the market</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Generics on the market</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Generics on the market</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> (insulin glargine)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compound: expired</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through May&#160;2031</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through May&#160;2031</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Later filed patents: coverage ranging through July&#160;2033 with PTE*</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">  *  PTE: Patent Term Extension. &#8211; SPC: Supplementary Protection Certificate. &#8211; PTA: Patent Term Adjustment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) See also &#8220;Item&#160;5. &#8212; A.1.2.&#160;Impacts of competition from generics and biosimilars&#8221;.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In Europe, Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> competition with certain generic companies is expected in the fourth quarter of 2023.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">47</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Patents held or licensed by Sanofi do not in all cases provide effective protection against a competitor&#8217;s generic version of our products. For example, notwithstanding the presence of unexpired patents, competitors launched generic versions of Allegra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the US (prior to the product being switched to over-the-counter status) and Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the EU.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We caution the reader that there can be no assurance that we will prevail when we assert a patent in litigation and that there may be instances in which Sanofi determines that it does not have a sufficient basis to assert one or more of the patents mentioned in this report, for example in cases where a competitor proposes a formulation not appearing to fall within the claims of our formulation patent; a salt or crystalline form not claimed by our composition of matter patent; or an indication not covered by our method of use patent. See &#8220;Item&#160;3. Key Information &#8212; D.&#160;Risk Factors &#8212; Risks Relating to Legal and Regulatory Matters &#8212; We rely on our patents and other proprietary rights to provide exclusive rights to market certain of our products, and if such patents and other rights were limited, invalidated or circumvented, our financial results could be materially and adversely affected&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As disclosed in Item&#160;8. of this annual report, we are involved in significant litigation concerning the patent protection of a number of our products.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Challenges to patented products</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;&#160;Abbreviated New Drug Applications (ANDAs)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the US, generic companies have filed Abbreviated New Drug Applications (ANDAs) containing challenges to patents related to a number of our small molecule products. An ANDA is an application by a drug manufacturer to receive authority to market a generic version of another company&#8217;s approved product, by demonstrating that the purportedly generic version has the same properties (safety and other technical data) as the original approved product. As a result of regulatory protection of our safety and other technical data, ANDA applications are generally four years after FDA approval, and include a challenge to a patent listed in the FDA&#8217;s Orange Book. If the patent holder or licensee brings suit in response to the patent challenge within&#160;the&#160;statutory window, the FDA is barred from granting final approval to an ANDA during the 30&#160;months following the&#160;expiry of the&#160;5-year regulatory exclusivity (this bar is referred to in our industry as a &#8220;30-month stay&#8221;) unless, before the end of the&#160;30&#160;months, the parties reach settlement or a court decision has determined either that the ANDA does not infringe the listed patent or that the listed patent is invalid and/or unenforceable.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">FDA approval of an ANDA after this 30-month period does not resolve outstanding patent disputes, but it does remove the regulatory impediments to a product launch by a generic manufacturer willing to take the risk of later being ordered to pay damages to the patent holder.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Accelerated ANDA-type procedures are potentially applicable to many, but not all, of the products we manufacture. See &#8220;&#8212;&#160;B.6.3.&#160;Regulatory Framework &#8212; 6.3.2.&#160;Biosimilars&#8221; and &#8220;- Regulation&#8221; above. We seek to defend our patent rights vigorously in these cases. Success or failure in the assertion of a given patent against a competing product is not necessarily predictive of the future success or failure in the assertion of the same patent. See &#8220;Item&#160;3. Key Information &#8212; D.&#160;Risk Factors &#8212; Risks Relating to Legal and Regulatory Matters &#8212; We rely on our patents and other proprietary rights to provide exclusive rights to market certain of our products, and if such patents and other rights were limited, invalidated or circumvented, our financial results could be materially and adversely affected&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;&#160;Section&#160;505(b)(2) New Drug Applications in the US</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our products and patents are also subject to challenge by competitors via another abbreviated approval pathway, under section&#160;505(b)(2) of the Federal Food, Drug, and Cosmetic Act. This pathway allows for approval for a wide range of products, especially for those products that represent only a limited change from an existing approved drug. The 505(b)(2) pathway is distinct from the ANDA pathway, which allows for approval of a generic product based on a showing that it is equivalent to a previously approved product.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Similarly, entities wishing to market a generic biologic can utilize an abbreviated approval pathway established in the PHS Act. This &#167;351(k) pathway enables an applicant to rely on a reference product sponsor&#8217;s data when seeking approval of a biological product shown to be biosimilar (highly similar with no clinically meaningful differences) or interchangeable with an FDA-licensed reference BLA product.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;&#160;Europe</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the EU, a generic drug manufacturer may only reference the data of the regulatory file for the original approved product after data exclusivity has expired. However, there is no patent listing system in Europe comparable to the Orange Book, which would allow the patent holder to prevent the competent authorities from granting marketing authorization by bringing patent infringement litigation prior to approval. As a result, generic products may be approved for marketing following the expiration of marketing exclusivity without regard to the patent holder&#8217;s rights. Nevertheless, in most of these jurisdictions once the competing product is launched, and in some jurisdictions even prior to launch (once launch is imminent), the patent holder may seek an injunction against such marketing if it believes its patents are infringed. See Item&#160;8. of this annual report.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.7.2. Trademarks &#8211; Domain names &#8211; Copyright</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our products are sold around the world under trademarks that we consider to be of material importance in the aggregate. Our trademarks help to identify our products and to protect the sustainability of our growth. We generate new assets (trademarks, domain names, service marks) when creating global brands for new, innovative products. We support the development of the product, from the branding of biotech platforms to the protection of service marks for patient support programs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Trademarks are particularly important to the commercial success of our products and services in a competitive marketplace, providing a strong visibility and assuring patients of the origin of the products.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">48</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Domain names are essential to inform a range of communities about what we do. We also pay close attention to ensuring that no damage is done to our reputation online.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We aim to ensure that the product trademarks we submit to healthcare authorities to obtain marketing authorizations are available, and are protected. In certain cases, we may enter into a coexistence agreement with a third party that owns potentially conflicting rights in order to avoid any risk of confusion and to secure our rights.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Ongoing digitization emphasizes the importance of securing copyright protection for software and web layouts.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We monitor and defend our trademarks based on a specific policy designed to prevent counterfeiting, trademark infringement and/or unfair competition.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_106"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8. Production and raw materials</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have opted to manufacture the majority of our products in-house. There are three principal stages in our production process: the manufacture of active ingredients, the transformation of those ingredients into drug products or vaccines, and the final packaging.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our general policy is to produce our key active ingredients and main drug products at our own plants in order to reduce our dependence on external suppliers. We also rely on third parties for the manufacture and supply of specific active ingredients, drug products and medical devices. Active ingredients are manufactured using raw materials sourced from suppliers who have been subject to rigorous selection and approval procedures, in accordance with international standards and our own internal directives. We have outsourced some of our production under supply contracts associated with acquisitions of products or businesses or with Sanofi plant divestitures, or to establish a local presence to capitalize on growth in emerging markets. Our pharmaceutical subcontractors follow our general quality and logistics policies, as well as meeting other criteria.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our manufacturing activities require significant amounts of energy, the costs of which have increased in 2022 and are expected to increase in 2023 and beyond as a result of inflationary pressures and supply constraints due to the war in Ukraine. The Group uses supply contracts and hedging to mitigate these costs. See&#160;&#8220;Item&#160;3.&#160;Key Information &#8212;&#160;D.&#160;Risk Factors &#8212;&#160;Risks Relating to Our Business&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We also obtain active ingredients from third parties under collaboration agreements. This applies in particular to the monoclonal antibodies developed with Regeneron.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our production sites are divided into three categories:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">global sites, which serve all markets: located mainly in Europe, these facilities are dedicated to the manufacture of our active ingredients, injectable products, and a number of our main solid-form products;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">regional sites, which serve markets at regional level, giving us a strong industrial presence in emerging markets; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">local sites, which serve their domestic market only.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Vaccines produces vaccines at various sites, with the main locations situated in France, the United States, Canada, India, Mexico and China. The pharmaceutical site at Le&#160;Trait (France) also contributes to Vaccines' industrial operations by making its sterile filling facilities available for vaccine manufacturing.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All of our production facilities are good manufacturing practice (GMP) compliant, in line with international regulations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our main sites are approved by the US&#160;FDA:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the Specialty Care facilities in the United States (Framingham MA and Northborough MA), France (Lyon Gerland, Vitry-sur-Seine, Le&#160;Trait), Germany (Frankfurt), Ireland (Waterford) and Belgium (Geel);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the General Medicines facilities in Germany (Frankfurt), France (Aramon, Sisteron, Ploermel, Ambar&#232;s and Tours), Italy (Anagni and Scoppito), Singapore (Jurong) and the United States (Ridgefield NJ);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the Consumer Healthcare facilities in France (Compi&#232;gne) and the United States (Chattanooga TN); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the Vaccines facilities in France (Marcy l&#8217;&#201;toile, Le Trait, Val-de-Reuil and Neuville-sur-Sa&#244;ne), the United States (Swiftwater PA) and Canada (Toronto).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Wherever possible, we seek to have multiple plants approved for the production of key active ingredients and our strategic finished products (this is the case with Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, for example).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">More details about our manufacturing sites are given below at section&#160;&#8220;D.&#160;Property, Plant and Equipment&#8221;.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_109"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.9. Insurance and risk coverage</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We are protected by five main insurance programs, relying not only on the traditional corporate insurance and reinsurance market but also on our direct insurance company, Carraig Insurance DAC (Carraig).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These five key programs cover Property &amp; Business Interruption; General &amp; Product Liability; Stock &amp; Transit; loss and liability arising from cyber and digital risks; and Directors &amp; Officers Liability.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Carraig participates in our coverage for various lines of insurance including Property, Stock &amp; Transit, Cyber/Digital, and General &amp;&#160;Product Liability. Carraig is run under the supervision of the Irish and European regulatory authorities, is wholly owned by Sanofi, and has sufficient resources to meet those portions of our risks that it has agreed to cover.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Carraig sets premiums for our entities at market rates. Claims are assessed using the traditional models applied by insurance and reinsurance companies, and the company&#8217;s reserves are regularly verified and confirmed by independent actuaries.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">49</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Property &amp; Business Interruption program covers all our entities worldwide, in all territories where it is possible to use a centralized program operated by Carraig. By sharing risk between our entities, this approach enables us to set deductibles and cover appropriate to the needs of local entities before the market attachment point. It also incorporates a prevention program, including a comprehensive site visit schedule covering our production, storage, research and distribution facilities and standardized repair and maintenance procedures across all sites.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Stock &amp; Transit program protects all goods owned by Sanofi while they are in transit nationally or internationally whatever the means of transport, and all our inventories wherever they are located. Sharing risk between our entities through Carraig means that we can set deductibles at appropriate levels, for instance differentiating between goods that require temperature controlled distribution and those that do not. We have developed a prevention program with assistance from experts, implementing best practices in this area at our distribution sites.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Cyber/Digital insurance program protects our operations against loss originating from various sources, and against liability in respect of data security. Centralized through Carraig, the program enables us to set deductibles and cover appropriate to the needs of local entities before the market attachment point.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our General &amp; Product Liability program was renewed in 2022 for all our subsidiaries worldwide in all territories where it was possible to do so, despite reluctance in the insurance and reinsurance market to cover product liability risks for large pharma-biotech groups. For several years, insurers have been reducing product liability cover because of the difficulty of transferring risk for some products that have been subject to numerous claims.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal risk exposure for our pharmaceutical products is covered with low deductibles at country level, with a greater proportion of risk being retained. The level of risk self-insured by Sanofi (including via Carraig) before the market attachment point enables us to retain control over the management and prevention of risk. Our negotiations with third-party insurers and reinsurers are tailored to our specific risks. In particular, they allow for differential treatment of products in the development phase; for discrepancies in risk exposure between European countries and the United States; and for specific issues arising in certain jurisdictions, such as generics or biosimilar coverage in the United States. Coverage is adjusted every year to take account of the relative weight of new product liability risks such as those arising out of biotechnologies and new technology platforms.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our cover for risks that are not specific to the pharma-biotech industry (general liability) is designed to address the potential impacts of our operations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For all the insurance programs handled by Carraig, outstanding claims are covered by provisions for the estimated cost of settling all claims incurred but not paid at the balance sheet date, whether reported or not, together with all related claims handling expenses. Where there is sufficient data history from Sanofi or from the market for claims made and settled, management &#8211;&#160;with assistance from independent actuaries&#160;&#8211; prepares an actuarial estimate of our exposure to unreported claims for the risks covered. The actuaries perform an actuarial valuation of the company&#8217;s IBNR (Incurred But Not Reported) and ALAE (Allocated Loss Adjustment Expense) liabilities at year end. Two ultimate loss projections (based upon reported losses and paid losses, respectively) are computed each year using various actuarial methods including the Bornhuetter-Ferguson method; those projections form the basis for the provisions set.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Directors &amp; Officers Liability program protects all legal entities under our control, and their directors and officers. Carraig is not involved in this program.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We also operate other insurance programs, but these are of much lesser importance than those described above.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All our insurance programs are backed by highly-rated insurers and reinsurers and are intented to be designed in such a way that we can integrate most newly acquired businesses without interruption of cover. Our insurance cover has been designed to reflect our risk profile and the capacity available in the insurance market. By centralizing our major programs, we are able to provide excellent, cost effective protection.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_112"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.10. Health, Safety and Environment</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our manufacturing and research operations are subject to increasingly stringent health, safety and environmental (HSE) laws and regulations. These laws and regulations are complex and rapidly changing, and Sanofi invests the necessary sums in order to comply with them. This investment, which aims to respect health, safety and the environment, varies from year to year.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Applicable environmental laws and regulations may require us to eliminate or reduce the effects of chemical substance discharge at our various sites. The sites in question may belong to Sanofi, and may be currently operational, or may have been owned or operational in the past. In this regard, Sanofi may be held liable for the costs of removal or remediation of hazardous substances on, under or in the sites concerned, or on sites where waste from activities has been stored, without regard to whether the owner or operator knew of or under certain circumstances caused the presence of the contaminants, or at the time site operations occurred the discharge of those substances was authorized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As is the case for a number of companies in the pharmaceutical, chemical and intense agrochemical industries, soil and groundwater contamination has occurred at some of our sites in the past, and may still occur or be discovered at others. In Sanofi&#8217;s case, such sites are mainly located in the United States, Germany, France and the United Kingdom. As part of a program of environmental surveys conducted over the last few years, detailed assessments of the risk of soil and groundwater contamination have been carried out at current and former Sanofi sites. In cooperation with national and local authorities, Sanofi regularly assesses the rehabilitation work required and carries out such work when appropriate. Long-term rehabilitation work is in progress or planned in Mount Pleasant, Portland in the United States; Frankfurt in Germany; Dagenham in the United Kingdom; Valernes, Limay, Neuville and Vitry in France; and on a number of sites divested to third parties and covered by contractual environmental guarantees granted by Sanofi.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">50</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We may also have potential liability for investigation and cleanup at several other sites. We have established provisions for the sites already identified and to cover contractual guarantees for environmental liabilities for sites that have been divested. In France specifically, we have provided the financial guarantees to the authorities as required under French regulations for environmental protection in connection with the operation of activities on French sites.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Potential environmental contingencies arising from certain business divestitures are described in Note&#160;D.22.d. to the consolidated financial statements. In 2022, Sanofi spent &#8364;39&#160;million on rehabilitating sites previously contaminated by soil or groundwater pollution.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Due to changes in environmental regulations governing site remediation, our provisions for remediation obligations may not be adequate due to the multiple factors involved, such as the complexity of operational or previously operational sites, the nature of claims received, the rehabilitation techniques involved, the planned timetable for rehabilitation, and the outcome of discussions with national regulatory authorities or other potentially responsible parties, as in the case of multiparty sites. Given the long industrial history of some of our sites and the legacy obligations arising from the past involvement of Aventis in the chemical and agrochemical industries, it is impossible to quantify the future impact of these laws and regulations with precision. See&#160;&#8220;Item&#160;3.D.&#160;Risk Factors &#8212;&#160;Environmental and safety risks of Our Industrial Activities&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have established, in accordance with our current knowledge and projections, provisions for cases already identified and to cover contractual guarantees for environmental liabilities relating to sites that have been divested. In accordance with Sanofi&#160;standards, a comprehensive review is carried out once a year on the legacy of environmental pollution. In light of data&#160;collected&#160;during this review, we adjusted our provisions to &#8364;526&#160;million as of December 31, 2022 versus &#8364;650&#160;million as of&#160;December 31, 2021. The terms of certain business divestitures, and the environmental obligations and retained environmental liabilities relating thereto, are described in&#160;Note&#160;D.22. to our consolidated financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To our knowledge, Sanofi did not incur any liability in 2022 for non-compliance with current HSE laws and regulations that could be expected to significantly jeopardize its activities, financial situation or operating income. We also believe that we are in substantial compliance with current HSE laws and regulations and that all the environmental permits required to operate our facilities have been obtained.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Regular HSE audits are carried out by Sanofi in order to assess compliance with standards (which implies compliance with regulations) and to initiate corrective measures (36&#160;internal audits performed in 2022). Moreover, more than 100&#160;specific visits were performed jointly with experts representing our insurers.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has implemented a worldwide master policy on health, safety and environment to promote the health and well-being of the employees and contractors working on its sites and respect for the environment. We consider this master policy to be an integral part of our commitment to social responsibility. In order to implement this master policy, Sanofi key requirements have been drawn up in the key fields of HSE management, HSE leadership, safety in the workplace, process safety, occupational hygiene, health in the workplace and protection of the environment. However, despite these efforts, Sanofi may be unsuccessful in the implementation of its policy to reduce and mitigate the harmful effects of its activities on the health and safety of its employees, customers or the general public and on the environment more generally. See &#8220;Item&#160;3.B. Risk Factors&#8221; for further information.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">From the development of compounds to the commercial launch of new drugs, Sanofi research scientists continuously assess the effect of products on human health. This expertise is made available to employees through two committees responsible for chemical and biological risk assessment. Sanofi&#8217;s COVALIS </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Comit&#233; des Valeurs Limites Internes Sanofi)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Committee is responsible for the hazard determination and classification of all active pharmaceutical ingredients and synthesis intermediates handled at Sanofi facilities. This covers all active ingredients handled in production at company sites or in processes sub-contracted for manufacture. Any important issues involving raw materials or other substances that lack established occupational exposure limits may also be reviewed. The COVALIS Committee determines the occupational exposure limits required within Sanofi. Our TRIBIO Committee is responsible for classifying all biological agents according to their degree of pathogenicity, and applies rules for their containment and the preventive measures to be respected throughout Sanofi. See&#160;&#8220;Item&#160;3.&#160;Key Information &#8212;&#160;D. Risk Factors &#8212;&#160;Environmental and safety risks of Our Industrial Activities &#8212;&#160;Risks from manufacturing activities and the handling of hazardous materials could adversely affect our results of&#160;operations and reputation&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Appropriate occupational hygiene practices and programs are defined and implemented in each site. These practices consist essentially of containment measures for collective and individual protection against chemical and biological exposure in all workplaces where chemical substances or biological agents are handled. All personnel are monitored with an appropriate medical surveillance program, based on the results of professional risk evaluations linked to their&#160;duties.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, dedicated resources have been created to implement the European Regulation on Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) and the European Regulation on Classification, Labeling and Packaging of chemicals (CLP). To fully comply with REACH, Sanofi has registered the relevant hazardous chemical substances with the European Chemicals Agency&#160;(ECHA).</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">51</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Safety</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has rigorous policies to identify and evaluate safety risks and to develop preventive safety measures, and methods for checking their efficacy. Additionally, Sanofi invests in training that is designed to instill in all employees a sense of concern for safety, regardless of their duties. These policies are implemented on a worldwide scale to ensure the safety of all employees and to protect their health. Each project, whether in research, development or manufacturing, is subject to evaluation procedures, incorporating the chemical substance and process data communicated by the COVALIS and TRIBIO Committees described above. The preventive measures are designed primarily to reduce the number and seriousness of work accidents and to minimize exposures involving permanent and temporary Sanofi employees as well as our sub-contractors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The French chemical manufacturing sites in Aramon and Sisteron are listed Seveso&#160;III (from the name of the European directive that deals with potentially dangerous establishments where dangerous substances may be present in quantities exceeding certain thresholds to prevent major accidents and limit their consequences). In accordance with French law on technological risk prevention, the French sites are also subject to heightened security inspections due to the toxic or flammable materials stored on the sites and used in the operating processes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Risk assessments of processes and installations are drawn up according to standards and internal guidelines incorporating the best state of the art benchmarks for the industry. These assessments are used to fulfill regulatory requirements and are regularly updated. Particular attention is paid to any risk-generating changes such as process or installation changes, as well as changes in production scale and transfers between industrial or research&#160;units.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We are using specialized process safety-testing laboratories that are fully integrated into our chemical development activities, apply methods to obtain the physico-chemical parameters of manufactured chemical substances (intermediate chemical compounds and active ingredients) and apply models to measure the effect of potentially leachable substances in the event of a major accident. In these laboratories the parameters for qualifying hazardous reactions are also determined, in order to define scale-up process conditions while transferring from development stage to industrial scale. We use these data to enhance the relevance of our risk assessments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We believe that the safety management systems implemented at each site, the hazard studies carried out and the risk management methods implemented, as well as our third-party property insurance policies covering any third-party physical damage, are consistent with legal requirements and the best practices in the&#160;industry, although no guarantee can be given that they will prevent accidents of various kinds.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environment</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Beyond healthcare, we have committed to an ambitious policy aimed at minimizing the environmental impacts of our products and activities while strengthening our resilience in the face of environmental changes. We have identified six major environmental challenges relating to our businesses: greenhouse gas emissions and climate disruption; eco-design; water; pharmaceuticals in the environment; waste; and biodiversity.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The initiatives already implemented since&#160;2010 are continuing, and we have been keen to give them fresh impetus through the Planet Care program. Reflecting our environment strategy out to 2030 and 2045, the program sets more ambitious targets for reducing environmental impacts across the entire value chain. Planet Care is a global project that involves all of the Company&#8217;s resources in defining objectives and engaging with external partners.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Compared with 2019 figures, we are undertaking to reduce our carbon emissions by 55% (scope&#160;1 and&#160;2) by the end of 2030, building the path to carbon-neutral status by&#160;2030 on our scope&#160;1, 2 &amp;&#160;3 (direct and indirect emissions for all activities), and net zero by 2045. We have also set ourselves the target of achieving sustainable water resource management, especially at sites which are under hydric stress. On this new scope, by the end of&#160;2022, we had reduced CO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:1.19pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">emissions by 29% (scope&#160;1 and&#160;2) and water withdrawals by 13%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Overall waste valorization at sites is already above 86% and is expected to be more than 90% by the end of 2025. The landfill rate had dropped to 5% at the end of 2022 and we have committed to move towards no more than 1% by 2025. Biodiversity management at our sites is also a priority, with the aim of making all employees aware of this challenge and implementing risk assessment and management plans at priority sites by 2025.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, we are pursuing the policy we began in 2010 of managing pharmaceutical products in the environment throughout their life cycles. At the end of 2022, all priority production sites have engaged specific programs to monitor, manage and reduce emissions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In line with this approach, we have committed to the &#8220;Roadmap AMR 2020&#8221; initiative, which aims to combat microbial resistance to antibiotics. The initiative brings together thirteen of the major players in the pharmaceutical industry, and will involve co-producing reference guides and methodologies for sustainable management of antibiotics in the pharmaceutical sector. The&#160;initiative includes a specific commitment with respect to antibiotic production sites that are operated by signatories or their&#160;suppliers, involving firstly the definition and deployment of a shared framework for managing potential waste, and secondly the&#160;establishment of environmental thresholds. See &#8220;Cautionary statement regarding forward-looking statements&#8221; and &#8220;Item&#160;3.D.&#160;Risk Factors&#8221;.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">52</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_115"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C. Organizational Structure</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_118"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">C.1. Significant Subsidiaries</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is the holding company of a consolidated group consisting of almost 270&#160;companies. The table below sets forth our&#160;significant subsidiaries as of December 31, 2022. For a fuller list of the principal companies in our consolidated group, see Note&#160;F.&#160;to&#160;our consolidated financial statements, included in this annual report at Item&#160;18.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:28.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.004%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant subsidiary</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Date of<br/>incorporation</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Country of<br/>incorporation</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Principal&#160;activity</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial and&#160;</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">voting interest </span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis&#160;Inc.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 1968</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Corporation</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 21, 1991</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Europe B.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 24, 1991</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hoechst GmbH</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 8, 1974</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Deutschland GmbH</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 1997</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Participations SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 25, 2002</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Singapore Pte Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 14, 1997</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Biotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 23, 2013</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Foreign Participations B.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 29, 1998</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Winthrop Industrie</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 11, 1972</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Inc.</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 18, 1977</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since 2009, we have transformed Sanofi through numerous acquisitions and divestments (see main recent events&#160;in &#8220;A.&#160;History and Development of the Company&#8221; above), in particular those of Genzyme in April&#160;2011, Boehringer Ingelheim (BI) Consumer Healthcare in January&#160;2017, Bioverativ in March&#160;2018, Ablynx in June&#160;2018, Synthorx in&#160;January&#160;2020, Principia in&#160;September&#160;2020, Kymab in April&#160;2021,Translate Bio in September&#160;2021, Amunix Pharmaceuticals, Inc in February&#160;2022 and EUROAPI in May&#160;2022. The financial effects of the Genzyme acquisition are presented in Note&#160;D.1.3. to&#160;our consolidated financial statements for the year ended December&#160;31, 2013, included in our annual report on Form&#160;20-F for that year. At the end of&#160;December&#160;2016, Sanofi Pasteur and&#160;MSD (known as Merck in the United States and Canada) ended their Sanofi Pasteur MSD joint venture. The financial effects of the resulting divestment/acquisition are presented in Note&#160;D.1.2. to our consolidated financial statements for the year ended&#160;December&#160;31,&#160;2016, included in our annual report on Form&#160;20-F for that year. On&#160;January&#160;1, 2017, Sanofi and Boehringer Ingelheim (BI) finalized the strategic transaction agreed in June&#160;2016, involving the exchange of Sanofi&#8217;s Animal Health business (Merial) for BI&#8217;s Consumer Healthcare business. The financial effects of this transaction are presented in Note&#160;D.1. to our consolidated financial statements for the year ended December&#160;31, 2017, included in our annual report on Form&#160;20-F for that year. The financial effects of the Bioverativ and Ablynx acquisitions are presented in&#160;Note&#160;D.1.1. to our consolidated financial statements for the year ended&#160;December&#160;31,&#160;2018, included in our annual report on&#160;Form&#160;20-F for that year. The financial effects in 2020 of the Synthorx and Principia acquisitions, and the financial effects in&#160;2021 of the Kymab, Kiadis, Tidal, Translate Bio, Kadmon and Origimm acquisitions, are presented in Note&#160;D.2. to our consolidated financial statements for the year ended December 31, 2022, included in the annual report on Form&#160;20-F for that year. The financial effects of the acquisition of Amunix Pharmaceuticals, Inc in February&#160;2022 are presented in Note&#160;D.1. to our consolidated financial statements in our annual report on Form&#160;20-F for this year. The financial effects of the deconsolidation of EUROAPI are presented in Note&#160;D.1. to our consolidated financial statements in our annual report on Form&#160;20-F for this year.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In certain countries, we carry on some of our business operations through joint ventures with local partners. In addition, we have entered into worldwide collaboration agreements&#160;with Regeneron relating to Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. For further information, refer to Note&#160;C.&#160;&#8220;Principal Alliances&#8221; to&#160;our consolidated financial statements.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_121"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">C.2. Internal organization of activities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and its subsidiaries collectively form a group organized around three activities: Pharmaceuticals (General Medicines and Specialty Care), Vaccines, and Consumer Healthcare.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Within Sanofi, responsibility for R&amp;D in their respective fields rests with Sanofi and Genzyme Corporation in Pharmaceuticals, and with Sanofi Pasteur and Sanofi Pasteur,&#160;Inc. in Vaccines. However, within our integrated R&amp;D organization, strategic priorities are set and R&amp;D efforts coordinated on a worldwide scale. In fulfilling their role in R&amp;D, the aforementioned companies subcontract R&amp;D to those of their subsidiaries that have the necessary resources. They also license patents, manufacturing know-how and trademarks to certain of their French and foreign subsidiaries. Those licensee subsidiaries manufacture, commercialize and distribute the majority of our products, either directly or via local distribution entities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our industrial property rights, patents and trademarks are mainly held by the following companies:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">pharmaceuticals: Sanofi, Sanofi Mature IP, Sanofi Biotechnology SAS (France), Sanofi-Aventis Deutschland GmbH (Germany), Ablynx (Belgium), Genzyme Corporation, Bioverativ Inc., Kadmon Pharmaceuticals Inc., Amunix Pharmaceuticals, Inc., Kymab, and Principia Biopharma Inc.;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">vaccines: Sanofi Pasteur (France), Sanofi Pasteur,&#160;Inc. (US), Translate Bio (US) and Protein Sciences Corp;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">consumer healthcare: A. Nattermann Cie &amp; GmbH (Germany), Chattem Inc. (US), Opella Healthcare France SAS, Opella Healthcare Italy Srl et SSP Co. Ltd (Japan).</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">53</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a description of our principal items of property, plant and equipment, see&#160;&#8220;&#8212;&#160;D.&#160;Property, Plant and Equipment&#8221; below. Our property, plant and equipment is held mainly by the following companies:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in France: Sanofi Pasteur SA, Sanofi Chimie, Sanofi Winthrop Industrie, Opella Healthcare International SAS and Sanofi-Aventis Recherche&#160;&amp; D&#233;veloppement;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in the United States: Sanofi Pasteur, Inc., Genzyme Therapeutics Products LP, Genzyme Corporation and Translate Bio;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in Germany: Sanofi-Aventis Deutschland GmbH;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in Canada: Sanofi Pasteur Limited;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in Belgium: Genzyme Flanders BVBA; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in Ireland: Genzyme Ireland Limited.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_124"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">C.3. Financing and financial relationships between group companies</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Sanofi parent company raises the bulk of the Company&#8217;s external financing and uses the funds raised to meet, directly or indirectly, the financing needs of its subsidiaries. The parent company operates a cash pooling arrangement under which any surplus cash held by subsidiaries is managed centrally. There is also a centralized foreign exchange risk management system in place, whereby the parent company contracts hedges to meet the needs of its principal subsidiaries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Consequently, at December 31, 2022, the Sanofi parent company held 98% of our external financing and 91% of our surplus cash.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi European Treasury Center&#160;SA (SETC), a 100%-owned Sanofi subsidiary incorporated in 2012 under the laws of Belgium, is dedicated to providing financing and various financial services to our subsidiaries.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_127"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D. Property, plant and equipment</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_130"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.1. Overview</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our headquarters are located in Paris, France. See&#160;&#8220;&#8212;&#160;D.4.&#160;Office Space&#8221; below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We operate our business through office premises and research, production and logistics facilities in approximately 75&#160;countries around the world. Our office premises house all of our support functions, plus operational representatives from our subsidiaries and the&#160;Company.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A breakdown of our sites by use and by ownership status (owned versus leasehold) is provided below. This breakdown is based on surface area. All surface area figures are&#160;unaudited.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:40.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Breakdown of sites by use</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Breakdown of sites by ownership status</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Leasehold</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Owned</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Offices</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Logistics</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div id="i52f57172a9d7443580346c2d8f39cd2b_133"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.2. Description of our sites</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sanofi industrial sites</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As part of the process of transforming Sanofi and creating Global Business Units, we are continuing to adapt the organization of the Manufacturing &amp; Supply department in support of our new business model.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Manufacturing &amp; Supply department focuses on customer needs and service quality; the sharing of &#8220;Sanofi Manufacturing System&#8221; good manufacturing practices; and the development of a common culture committed to quality.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2020, Manufacturing &amp; Supply department modified its organization to align on the new Global Business Units structure comprising Specialty Care, General Medicines, Vaccines and Consumer Health Care.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2020, we announced a plan to create a major leading European company dedicated to the production and marketing of active pharmaceutical ingredients (API) to third&#160;parties as well as to Sanofi. This involved creating a standalone company combining our API commercial and development activities with six of our European API production sites: Brindisi (Italy), Frankfurt Chemistry (Germany), Haverhill (UK), Saint-Aubin-les-Elbeuf (France), &#218;jpest (Hungary), and Vertolaye (France). EUROAPI was listed on Euronext Paris on May&#160;6, 2022. See &#8220;Item&#160;4. Information on the Company &#8212; A.&#160;History and development of the Company&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Manufacturing &amp; Supply department is also responsible for Sanofi Global HSE and Global Supply Chain.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">54</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At the end of 2022, we were carrying out industrial production at 59&#160;sites in 28&#160;countries:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">8&#160;sites for our Specialty Care operations;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">29&#160;sites for our General Medicines operations;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">12&#160;sites for our Consumer Healthcare operations; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">10&#160;sites for the industrial operations of Vaccines.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The quantity of units s</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">old in 2022, including in-house and outsourced production and excluding EUROAPI, was 4.4&#160;billion. This comprised:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Pharmaceuticals: 2.4&#160;billion units;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Consumer Healthcare: 1.9&#160;billion units; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Vaccines: 175&#160;million boxes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We believe that our production facilities are in compliance with all material regulatory requirements, are properly maintained and are generally suitable for future needs. We regularly inspect and evaluate those facilities with regard to environmental, health, safety and security matters, quality compliance and capacity utilization. For more information about our property, plant and equipment, see Note&#160;D.3. to our consolidated financial statements, included at Item&#160;18. of this annual report, and section&#160;&#8220;B.8.&#160;Production and Raw Materials&#8221; above.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our main production sites by volume are:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Le Trait (France), Frankfurt (Germany), Waterford (Ireland), Geel (Belgium) and Framingham (United States) for Specialty Care;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Aramon, Sisteron and Ambar&#232;s (France), Frankfurt (Germany), Csanyikv&#246;lgy (Hungary), L&#252;leburgaz (Turkey), Campinas (Brazil), Jurong (Singapore) and Hangzhou (China) for General Medicines products;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Compi&#232;gne and Lisieux (France), Cologne (Germany), Origgio (Italy), Chattanooga (United States) and Ocoyoacac (Mexico) for Consumer Healthcare products;&#160;and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Marcy-l&#8217;&#201;toile and Val-de-Reuil (France), Toronto (Canada), Swiftwater (United States) and Hyderabad (India) for vaccines.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research &amp; Development sites</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Pharmaceuticals, research and development activities are conducted at the following sites:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">four operational sites in France: Chilly-Mazarin/Longjumeau, Montpellier, Strasbourg and Vitry-sur-Seine/Alfortville;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">three sites in the rest of Europe (Germany, Belgium and the Netherlands), the largest of which is in Frankfurt (Germany);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">six sites in the United States: Bridgewater, Cambridge, Framingham/Waltham, Great Valley, San Francisco and San Diego; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in Asia, three sites in China (Beijing, Shanghai and Chengdu).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Vaccines research and development sites are:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Swiftwater, Cambridge and Orlando (United States);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Marcy-l&#8217;&#201;toile/Lyon (France); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Toronto (Canada).</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_136"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.3. Acquisitions, capital expenditures and divestitures</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The carrying amount of our property, plant and equipment at December 31, 2022 was &#8364;9,869&#160;million. During 2022, we invested&#160;&#8364;1,748&#160;million (see&#160;Note&#160;D.3. to&#160;our consolidated financial statements, included at Item&#160;18. of this annual report), mainly in increasing capacity and improving productivity at our various production and R&amp;D&#160;sites.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our principal acquisitions, capital expenditures and divestitures in 2020, 2021 and 2022 are described in Notes&#160;D.1. &amp;&#160;D.2. (&#8220;Changes in the scope of consolidation&#8221;), D.3.&#160;(&#8220;Property, plant and equipment&#8221;) and D.4.&#160;(&#8220;Goodwill and other intangible assets&#8221;) to our consolidated financial statements, included at Item&#160;18. of this annual report.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, our firm commitments in respect of future capital expenditures amounted to &#8364;861&#160;million. The principal locations involved were: for the Pharmaceuticals segment, the industrial facilities at Frankfurt (Germany); Le Trait, Maisons-Alfort, Compi&#232;gne, and&#160;Ambares (France); Cambridge (United States); Geel (Belgium); Origgio, Anagni, Brindisi, and Scoppito (Italy); and for the Vaccines segment, the facilities at Swiftwater (United States), Toronto (Canada), Marcy-l&#8217;&#201;toile, Neuville-sur-Sa&#244;ne and Val-de-Reuil (France), and Singapore.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the medium term and assuming no changes in the scope of consolidation, we expect to invest on average some &#8364;1.4&#160;billion a year in property, plant and equipment. We believe that our own cash resources and the undrawn portion of our existing credit facilities will be sufficient to fund these expenditures.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our principal ongoing capital expenditures are described below.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:92.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">55</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 4. Information on the company</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Speciality care</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Specialty Care industrial operations are organized around two end-to-end clusters. We have four dedicated biotechnology hubs: Paris/Lyon (France), Frankfurt (Germany), Geel (Belgium) and Boston Area (United States). The Bioatrium project, a joint venture between Sanofi and Lonza (Switzerland) set up in 2017 to increase bioproduction capacity, is proceeding on schedule. Exploiting the innovative techniques on which biotech relies, including cell and microbiological culture and the development of viral vectors, calls for highly specific knowledge and expertise backed by dedicated production platforms to support global product launches.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Waterford and Le Trait sites manufacture pre-filled Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> syringes.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General medicines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our General Medicines in</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">dustrial operations are organized through end-to-end clusters, with chemistry, pharmaceutical and injectable sites organized through a network of over 28&#160;regional and local industrial sites in 18&#160;co</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">untries, supporting growth in those markets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This new organization encompasses a dedicated Launch Sites cluster from API manufacturing to finished goods packaging (Sisteron, Aramon, Ambar&#232;s, Scoppito).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Frankfurt facility is our principal site for the manufacture of diabetes treatments.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consumer healthcare</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The pharmaceutical industrial operations of our Consumer Healthcare (CHC) business are spread across a dedicated network. Global markets are supplied from our facilities at Compi&#232;gne (France) and Cologne (Germany). We have recently invested in new production capacities in Suzano (Brazil) and Narita (Japan).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vaccines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The industrial operations of our Vaccines business are in a major investment phase, preparing for the upcoming growth of our influenza and Polio/Pertussis/Hib franchises, plus the mid-term growth linked to our mRNA roadmap and New Vaccines pipeline. </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Major investments were announced in 2020 and&#160;2021 with a new Evolutive Facility in France (Neuville-Sur-Saone) and a new facility in Singapore for our New Vaccines pipeline</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Other major investments are under way in France (including construction of a new influenza vaccine building at Val-de-Reuil), Canada (a new pertussis vaccine building), the US and Mexico.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Innovation and culture of industrial excellence</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The ambition of our Manufacturing &amp; Supply department is to continue to raise safety, quality and operating standards in Sanofi&#8217;s production activities, and to remain a world leader and a benchmark in the global pharmaceutical industry. To achieve this goal, all our activities share a common culture of industrial excellence, enshrined in the Sanofi Manufacturing System. This sets out a series of priorities (such as customer service, constant improvement, site network optimization and transverse optimization) that constitute our industrial vision and will be crucial to our mutual success.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In terms of operational excellence, we continue to build on our Top Decile performance program, focused on core sites and fully leveraging digital opportunities and technology innovations. We are also reinforcing the Sanofi Manufacturing System to drive more improvement directly from the sites and reach our performance goals, while creating a culture of best practices shared across the industrial network.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_139"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.4. Office space</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As we progress on our Sanofi Work Experience journey, we continue to shape our work environment by bringing our teams together and transforming our workplaces into spaces where every Sanofian feels included, valued, and able to bring their best selves to work every day.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Along with state-of-the-art projects delivered in 2022, such as the renovation of the Gentilly Campus near Paris, the Cambridge Crossing Campus in the US, and the innovative new &#8220;La Maison Sanofi&#8221; site in Paris, our roadmap continues to evolve, covering all regions worldwide. A number of projects are currently under way to deliver the next generation of work experience and hybrid work.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Divestment of sites that our non-core to our business model and office space rationalization remain an important goal to help us achieve a responsible environmental footprint.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_142"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;4A. Unresolved Staff Comments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">56</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_145"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;5. Operating and Financial Review and Prospects</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">You should read the following discussion in conjunction with our consolidated financial statements and the notes thereto included in this annual report at Item&#160;18.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS)&#160;as issued by the International Accounting Standards Board (IASB) and with IFRS endorsed by the European Union as of&#160;December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following discussion contains forward-looking statements that involve inherent risks and uncertainties. Actual results may differ materially from those contained in such forward-looking statements. See &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; at the beginning of this document.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Unless otherwise stated, all financial variations in this item are given on a reported basis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The discussion of our operating and financial review and prospects for the years ended December&#160;31, 2021 and December&#160;31, 2020, can be found in Part&#160;I, Item&#160;5. of our Form&#160;20-F filed on February&#160;23, 2022, including a presentation of our consolidated income statements for the years ended December&#160;31, 2021 and December&#160;31, 2020 in &#8220;Item&#160;5. &#8212;&#160;A.2.&#160;Results of operations&#8221; of our Form&#160;20-F filed on&#160;February&#160;23,&#160;2022.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_148"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A. Operating results</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_151"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">A.1. Significant operating information</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_154"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.1.1. 2022 Overview</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During 2022, Sanofi continued to implement its &#8220;Play to Win&#8221; strategy, involving major decisions and positive actions to support and rebuild the competitive margins necessary for Sanofi to continue to deliver on its mission. The strategy is based on four major priorities: focus on growth, lead with innovation, accelerate efficiency, and reinvent how we work. For further information about our strategy, refer to &#8220;&#8212;&#160;Item&#160;4. &#8212;&#160;B.1.&#160;Strategy&#8221;. Other significant events of the year are described below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On January&#160;7, 2022, Sanofi announced a research collaboration and license agreement with </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Exscientia plc</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Exscientia) to develop up to 15&#160;novel small molecule candidates across oncology and immunology, leveraging Exscientia&#8217;s end-to-end AI-driven platform using actual patient samples. The companies have been working together since 2016 and in 2019, Sanofi in-licensed Exscientia&#8217;s novel bispecific small molecule candidate capable of targeting two distinct targets in inflammation and immunology.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;8, 2022, Sanofi announced the completion of its acquisition of</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> Amunix Pharmaceuticals, Inc</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Amunix), adding a pipeline of T-cell engager immunotherapies and cytokine therapies. The acquisition also gives Sanofi access to Amunix&#8217;s Pro-XTEN</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, XPAT, and XPAC technologies to deliver next-generation Conditionally Activated Biologics. This technology platform complements our existing R&amp;D platforms, and supports our efforts to accelerate and expand our contribution to developing innovative medicines for oncology patients, with approximately 20&#160;molecules currently in development.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On March&#160;15, 2022, Sanofi and </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Blackstone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> announced a strategic risk-sharing collaboration under which funds managed by Blackstone Life Sciences (BXLS) will invest up to &#8364;300&#160;million to accelerate the global pivotal studies and clinical development program for the subcutaneous formulation and delivery of the anti-CD38 antibody Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to treat patients with multiple myeloma (MM). That amount will be paid to Sanofi on the basis of development expenses incurred. In addition, Sanofi would be required to pay royalties on any future sales of any products developed as part of this program.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On March&#160;16, 2022, Sanofi and</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> Seagen Inc</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. announced an exclusive collaboration agreement to design, develop, and commercialize antibody-drug conjugates (ADCs) for up to three cancer targets. The collaboration will utilize Sanofi&#8217;s proprietary monoclonal antibody (mAb) technology and Seagen&#8217;s proprietary ADC technology. ADCs are antibodies engineered to deliver potent anti-cancer drugs to tumor cells expressing a specific protein, and Sanofi currently has one ADC in development.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During the March&#160;29, 2022 investor conference, Sanofi gave an update on how the company is advancing its immunology strategy. The focus of the event was on </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Dupixent</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (dupilumab), a key growth driver for Sanofi, and on the company&#8217;s rapidly advancing pipeline of other products which features dermatological, respiratory and gastrointestinal diseases as priority therapeutic areas. Sanofi has raised its peak sales ambition for Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. This new ambition does not include the potential for further potential sales of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to treat chronic obstructive pulmonary disease (COPD), with pivotal readouts from clinical trials in this indication anticipated in 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On March&#160;29, 2022, Sanofi and</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> IGM Biosciences, Inc</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. announced the signing of an exclusive worldwide collaboration agreement to create, develop, manufacture, and commercialize IgM (immunoglobulin M) antibody agonists against three oncology targets and three immunology/inflammation targets. Engineered IgM antibodies represent a new class of potential therapeutics that combine the multi-valency of IgM antibodies and have ten binding sites, as opposed to conventional IgG (immunoglobulin G) antibodies that have only two target binding sites.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">57</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On June&#160;2022, Sanofi and </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Regeneron</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> restructured their IO LCA. Under the terms of the Amended and Restated IO LCA, Regeneron holds exclusive worldwide licensing rights to Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> with effect from July&#160;1, 2022. In July&#160;2022, Sanofi received as consideration an upfront payment of $900&#160;million (&#8364;856&#160;million), which was recognized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> on&#160;the&#160;date of receipt. The same line item also includes a regulatory milestone payment of $100&#160;million (&#8364;96&#160;million) following the&#160;US&#160;FDA approval in November&#160;2022 of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with chemotherapy as a first line treatment for NSCLC. In addition, Sanofi is entitled to royalties of 11% and to milestone payments linked to global net sales of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, which are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Other operating income </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in line with the pattern of sales (&#8364;111&#160;million in 2022). For further information, see&#160;Note&#160;C. to our consolidated financial statements, included at Item&#160;18. of this Annual Report on Form&#160;20-F.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;3, 2022, Sanofi's General Meeting of Shareholders approved the decision to distribute approximately 58% of the share capital of </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">EUROAPI</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a European leader in the development, manufacture, marketing and distribution of Active Pharmaceutical Ingredients (APIs), in the form of an exceptional dividend in kind to Sanofi shareholders. The dividend was paid on May&#160;10, 2022 following the admission of EUROAPI shares to listing on the regulated market of Euronext Paris; on May&#160;6, 2022, Sanofi divested control over EUROAPI and its subsidiaries, resulting in their deconsolidation from the Sanofi consolidated financial statements as of that date. On June&#160;17, 2022 (the date of delivery of the EUROAPI shares to the French State via the French Tech Souverainet&#233; fund), EPIC Bpifrance acquired a 12% equity interest in EUROAPI. Following completion of those transactions, Sanofi retains an equity interest of 30.1% in EUROAPI, which has been accounted for using the equity method since the date of loss of control.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On August&#160;4, 2022, Sanofi and</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> Innovent Biologics</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Innovent) announced a collaboration to bring innovative medicines to patients in China with difficult-to-treat cancers and to accelerate the development and commercialization of two Sanofi key clinical stage oncology assets &#8211; Phase&#160;III SAR408701 (tusamitamab ravtansine, an anti-CEACAM5 antibody-drug conjugate) and Phase&#160;II SAR444245 (non-alpha IL-2) &#8211; in combination with sintilimab, the leading checkpoint inhibitor in China. In addition to the collaboration and license agreement, Sanofi has invested &#8364;300&#160;million in Innovent by subscribing to its new common shares.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On August&#160;17, 2022, Sanofi discontinued the global clinical development program of </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">amcenestrant</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, an investigational oral selective estrogen receptor degrader (SERD). The decision was based on the outcome of a prespecified interim analysis of the Phase&#160;III AMEERA-5 trial evaluating amcenestrant in combination with palbociclib compared to letrozole in combination with palbociclib in patients with estrogen receptor-positive (ER+)/human epidermal growth factor receptor&#160;2-negative (HER2-) advanced breast cancer. Sanofi will continue to review the data, and plans to share the results with the scientific community in the future. All other studies of amcenestrant, including in early-stage breast cancer (AMEERA-6), will be discontinued.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At the end of the third quarter&#160;of 2022, based on external and internal data about the mechanism of action and therapeutic potential of non-alpha IL2, a new Phase&#160;I/II program was programmed for </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">SAR444245</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, focused on schedule intensification to solidify the foundation for a best-in-class target profile. In parallel, the ongoing Phase&#160;II trials with the 3-weekly dose schedule were discontinued, as the efficacy observed in the early look at the data was lower than projected. This decision was not based on any safety-related issues.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;19, 2022, Sanofi and</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> Innate Pharma SA </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(Innate) announced an expansion of their collaboration, with Sanofi licensing a natural killer (NK) cell engager program targeting B7H3 from Innate&#8217;s ANKET</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Antibody-based NK Cell Engager Therapeutics) platform. Sanofi will also have the option to add up to two additional ANKET</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> targets. Upon candidate selection, Sanofi will be responsible for all development, manufacturing and commercialization. Innate and Sanofi signed a first NK cell engagers collaboration in 2016 for the generation and evaluation of up to two bispecific NK cell engagers; these are currently being evaluated by Sanofi&#8217;s R&amp;D team, with one of them already in clinical studies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, healthcare authorities issued a number of marketing approvals for Sanofi products. In the United States and Europe, </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Dupixent</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(dupilumab) obtained full authorization for the treatment of eosinophilic esophagitis, and extensions to expand the severe asthma indication to children aged 6&#160;to 11&#160;years and the moderate-to-severe atopic dermatitis indication to children aged 6&#160;months to 5&#160;years. At the end of September&#160;2022, the US Food and Drug Administration (FDA) approved Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> as the first and only treatment indicated to treat prurigo nodularis for adult patients in the United States, and on December&#160;15, 2022, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> became the first and only targeted medicine approved by the European Commission (EC) to treat prurigo nodularis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA also approved </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Xenpozyme</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid sphingomyelinase deficiency (ASMD) in adult and pediatric patients.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The EC granted marketing authorization for </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (sutimlimab) for the treatment of hemolytic anemia in adult patients with cold agglutinin disease (CAD). CAD is a rare, serious and chronic autoimmune hemolytic anemia, in which the body&#8217;s immune system mistakenly attacks healthy red blood cells and causes their rupture, known as hemolysis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Vaccines, the EC approved </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Beyfortus</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their first RSV season. Beyfortus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is the first and only single-dose passive immunization for the broad infant population; it is being developed jointly by Sanofi and AstraZeneca. The EC also approved </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">VidPrevtyn</span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta as a booster for the prevention of COVID-19 in adults aged 18&#160;years and older. Designed to provide broad protection against multiple variants, this protein-based vaccine is based on the Beta variant antigen and includes GSK&#8217;s pandemic adjuvant. VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta is indicated as a booster for active immunization against SARS-CoV-2 in adults who have previously received an mRNA or adenoviral COVID vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For further information about the pharmaceutical products and vaccines we sell, and about our research and development portfolio, refer to&#160;&#8220;&#8212;&#160;Item&#160;4.B. &#8212;&#160;Business Overview&#8221;.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">58</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our net sales for 2022 amounted to &#8364;42,997&#160;million, an increase of 13.9% from 2021. At constant exchange rates (CER</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(10)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), net sales rose by&#160;7.0%, mainly reflecting strong growth for Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and increased sales for our Vaccines business, more than offsetting lower sales for our Non Core assets franchise.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to equity holders of Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> amounted to &#8364;8,371&#160;million for 2022, compared with &#8364;6,223&#160;million in 2021, a&#160;&#8364;2,148&#160;million increase. Earnings per share was &#8364;6.69 in 2022, compared with &#8364;4.97 in 2021. Business net income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(11)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was&#160;&#8364;10,341&#160;million, up 25.9% on 2021, while business earnings per share (business EPS</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) was 25.9% higher than in 2021 at &#8364;8.26.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our net debt</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(12)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> decreased from &#8364;9,983&#160;million as of December&#160;31, 2021 to &#8364;6,437&#160;million as of December&#160;31, 2022. At the Annual General Meeting on May&#160;25, 2023, we will ask our shareholders to approve a dividend of &#8364;3.56 per share for the 2022 financial year, representing a payout of 43.1% of our Business net income (see &#8220;&#8212; Item&#160;5.B.2. &#8212; Consolidated balance sheet and debt.&#8221;).</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_157"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.1.2. Impacts of competition from generics and biosimilars</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Some of our flagship products continued to suffer sales erosion in 2022 under the impact of competition from generics and biosimilars. We do not believe it is possible to state with certainty what level of net sales would have been achieved in the absence of generic competition. A comparison of our consolidated net sales for the years ended&#160;December 31, 2022 and 2021 (see&#160;&#8220;&#8212;&#160;A.2.&#160;Results of Operations &#8212;&#160;Year Ended December 31, 2022 Compared with Year Ended December 31, 2021&#8221; below) for the main products affected by generic and biosimilar competition shows a loss of &#8364;325&#160;million of net sales on a reported basis. To be noted that other parameters can also contributed to the loss of sales, such as a fall in the average selling price of certain products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth the change by&#160;product.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:41.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change&#160;on&#160;a<br/>reported&#160;basis</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change&#160;on&#160;a<br/>reported&#160;basis&#160;(%)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> Europe</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.7&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> Europe</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> Europe</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> Europe</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> Europe</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(79)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-70.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> United States</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(104)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> United States</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-41.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> Japan</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+46.7&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> Japan</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-18.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japan</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-29.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,162</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,487</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(325)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-13.1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We expect the erosion caused by generic competition to continue in 2023, with a negative impact on our net income. The products likely to be impacted in 2023 include those that already faced generic competition in 2022, but whose sales can reasonably be expected to be subject to further sales erosion in 2023 (see products listed in the table above). We also expect generic competition in the United States for Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> from March&#160;2023 and for Mozobil</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> from August&#160;2023, following expiry of exclusivity in that country. In Europe, Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> generic competition is expected in the fourth quarter of 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the aggregate consolidated net sales of those products in Europe, the United States and Japan were &#8364;2,162&#160;million; this comprised &#8364;774&#160;million in the United States (including &#8364;757&#160;million in net sales of Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">); &#8364;1,300&#160;million in Europe; and &#8364;88&#160;million in Japan. The negative impact on our 2023 net sales is likely to represent a substantial portion of those sales, but the actual impact will depend on a number of factors such as the impact of generics and biosimilars on our molecules, but also the market entry of generics of molecules that are in competition with our products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In China, the authorities have implemented a range of healthcare cost containment measures, including the Volume Based Procurement&#160;(VBP) reverse auction that particularly impacts our insulin-based products, Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Aprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, and Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (see also &#8220;Item&#160;4. &#8212;&#160;B.6.4.&#160;Pricing &amp; Reimbursement&#8221;). A large number of molecules were selected to submit tenders under successive waves of the VBP program, with the successful bidders being awarded a high level of market share in return for offering lower prices. We participated in a number of VBP bids and were selected for only part of the volumes awarded for 2022 and 2023 in respect of insulins (Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Aprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, in return for a considerable reduction in unit prices.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(10)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Non-IFRS financial measure: see definition in &#8220;&#8212; A.1.6.&#160;Presentation of Net Sales&#8221; below.</span></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(11)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Non-IFRS financial measure: see definition in &#8220;&#8212;&#160;A.1.5.&#160;Segment Information &#8212;&#160;3.&#160;Business Net Income&#8221; below.</span></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(12)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Non-IFRS financial measure: see definition in &#8220;&#8212;&#160;B.&#160;Liquidity and Capital Resources&#8221; below.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">59</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_160"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.1.3. Purchase accounting effects</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our results of operations and financial condition for the years ended December&#160;31, 2022, and 2021 have been significantly affected by our past acquisitions (acquisition of Aventis in August&#160;2004, acquisition of Genzyme in April&#160;2011, exchange of our Animal Health business (Merial) for Boehringer Ingelheim&#8217;s Consumer Healthcare business in January&#160;2017, acquisition of Bioverativ in&#160;2018, and certain other transactions). See &#8220;&#8212;&#160;A.1.11.&#160;Critical accounting and reporting policies &#8212;&#160;2/ Business combinations&#8221; below for an explanation of the impact of business combinations on our results of operations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Genzyme business combination has generated significant amortization of intangible assets (&#8364;535&#160;million in 2022, and&#160;&#8364;529&#160;million in 2021). The exchange of Merial for Boehringer Ingelheim&#8217;s Consumer Healthcare business has generated amortization of intangible assets (&#8364;188&#160;million in 2022, and &#8364;195&#160;million in 2021). The Bioverativ business combination has generated significant amortization of intangible assets (&#8364;377&#160;million in 2022, and &#8364;320&#160;million in&#160;2021). The Kadmon acquisition has generated amortization of intangible assets (&#8364;159&#160;million in 2022, and &#8364;20&#160;million in 2021).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order to isolate the purchase accounting effects of all acquisitions and certain other items, we use a non-IFRS financial measure that we refer to as &#8220;business net income&#8221; (see definition in &#8220;&#8212;&#160;A.1.5.&#160;Segment Information &#8212;&#160;3.&#160;Business Net Income&#8221; below).</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_163"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.1.4. Sources of revenues and expenses</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Revenues. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Revenue arising from the sale of goods is presented in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Net sales comprise revenue from sales of pharmaceutical products, consumer health care products, active ingredients and vaccines, net of sales returns, of customer incentives and discounts, and of certain sales-based payments paid or payable to the healthcare authorities. Returns, discounts, incentives and rebates are recognized in the period in which the underlying sales are recognized, as a reduction of sales revenue. See&#160;Note&#160;B.13.1. to our consolidated financial statements included at Item&#160;18. of this annual report. We sell pharmaceutical products and vaccines directly, through alliances, and by licensing arrangements throughout the world. When we sell products directly, we record sales revenues as part of our consolidated net sales. When we sell products through alliances, the revenues reflected in our consolidated financial statements are based on the contractual arrangements governing those alliances. For more information about our alliances, see&#160;&#8220;&#8212;&#160;A.1.7.&#160;Financial Presentation of Alliances&#8221; below. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">The line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other revenues</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is used to recognize all revenue that falls within the scope of IFRS&#160;15 but does not relate to sales of Sanofi products. It mainly comprises (i)&#160;royalties received from licensing intellectual property rights to third parties; (ii)&#160;VaxServe sales of products sourced from third-party manufacturers; and (iii)&#160;revenue received under agreements for Sanofi to provide manufacturing services to third parties. Royalties received under licensing arrangements are recognized over the period during which the underlying sales are recognized. VaxServe is a Vaccines segment entity whose operations include the distribution within the United States of vaccines and other products manufactured by third parties.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Our cost of sales consists primarily of the cost of purchasing raw materials and active ingredients, labor and other costs relating to our manufacturing activities, packaging materials, payments made under licensing agreements and distribution costs. We have license agreements under which we manufacture, sell and distribute products that are patented by other companies. When we pay royalties, we record them in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating Income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Our operating income reflects our revenues, our cost of sales and the remainder of our operating expenses, the most significant of which are research and development expenses and selling and general expenses. For our operating segments, we also measure our results of operations through an indicator referred to as &#8220;Business Operating Income,&#8221; which we describe below under&#160;&#8220;A.1.5.&#160;Segment Information &#8212;&#160;2/ Business Operating Income&#8221;.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_166"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.1.5. Segment information and Business net income</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">1/ Operating segments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;8 (Operating Segments), the segment information reported by Sanofi is prepared on the basis of internal management data provided to the Chief Executive Officer, who is the chief operating decision maker. The performance of those segments is monitored individually using internal reports and common indicators. The operating segment disclosures required under IFRS&#160;8 are provided in Notes&#160;B.26. and&#160;D.35. (&#8220;Segment Information&#8221;) to our consolidated financial statements, included at&#160;Item&#160;18. of this annual report.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As indicated in Note&#160;B.26., Sanofi has three operating segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Pharmaceuticals segment comprises, for all geographical territories, the commercial operations of the following global franchises: Specialty Care (Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Neurology &amp; Immunology, Rare Diseases, Oncology, and Rare Blood Disorders) and General Medicines (Core and Non-Core Assets), together with research, development and production activities dedicated to the Pharmaceuticals segment. This segment also includes associates whose activities are related to pharmaceuticals.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Vaccines segment comprises, for all geographical territories, the commercial operations of Vaccines, together with research, development and production activities dedicated to vaccines.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for Sanofi&#8217;s Consumer Healthcare products, together with research, development and production activities dedicated to those products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inter-segment transactions are not material.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">60</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The costs of Sanofi's global support functions (Corporate Affairs, Finance, People &amp; Culture, Legal, Ethics &amp; Business Integrity, Information Solutions&#160;&amp; Technologies, Sanofi Business Services,&#160;etc.) are primarily managed centrally at the group-wide level. The costs of those functions are presented within the &#8220;Other&#8221; category. That category also includes other reconciling items such as retained commitments in respect of divested activities.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">2/ Business operating income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We report segment results on the basis of &#8220;Business operating income&#8221;. This indicator is used internally by Sanofi&#8217;s chief operating decision maker to measure the performance of each operating segment and to allocate resources. For a definition of &#8220;Business operating income&#8221;, and a reconciliation between that indicator and </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Income before tax and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, refer to Note&#160;D.35. to our consolidated financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Business operating income&#8221; at Group level is a non-IFRS financial measure, which is reconciled with IFRS </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. IFRS </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for 2022 amounted to &#8364;10,656&#160;million versus &#8364;8,126&#160;million for 2021. Our ratio of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating Income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net Sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was 24.8% in 2022 versus 21.5% in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our &#8220;Business operating income&#8221; for 2022 amounted to &#8364;13,040&#160;million, versus &#8364;10,714&#160;million for 2021, while our &#8220;Business operating income margin&#8221; was 30.3%, versus 28.4% for 2021. &#8220;Business operating income margin&#8221; is a non-IFRS financial measure, which we define as the ratio of our &#8220;Business operating income&#8221; to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because our &#8220;Business operating income&#8221; and &#8220;Business operating income margin&#8221; are not standardized measures, they may not be directly comparable with the non-IFRS financial measures of other companies using the same or similar non-IFRS financial measures. Although management uses those non-IFRS measures to set goals and measure performance, they have no standardized meaning prescribed by IFRS. These non-IFRS measures are presented solely to permit investors to more fully understand how Sanofi's management assesses underlying performance. These non-IFRS measures are not, and should not be viewed as, a substitute for IFRS measures, and should be viewed in conjunction with our IFRS financials and performance measures. As a result, such measures have limits in their usefulness to investors.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">3/ Business net income (non-IFRS Financial measure)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We believe that the understanding of our operational performance by our management and our investors is enhanced by reporting &#8220;Business net income&#8221;. This non-IFRS financial measure represents </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Business operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, less net financial expenses and the relevant income tax effects.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Business net income&#8221; is a non-IFRS financial measure, which is reconciled with IFRS </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to equity holders</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to equity holders of Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> amounted to &#8364;8,371&#160;million for 2022, compared with &#8364;6,223&#160;million in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our "Business net income" for 2022 was &#8364;10,341&#160;million, 25.9% up on 2021 (&#8364;8,213&#160;million).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We also report &#8220;Business earnings per share&#8221; (&#8220;Business EPS&#8221;), a non-IFRS financial measure we define as &#8220;Business net income&#8221; divided by the weighted average number of shares outstanding. &#8220;Business EPS&#8221; was &#8364;8.26&#160;for 2022, 25.9% higher than the 2021 figure of&#160;&#8364;6.56, based on an average number of shares outstanding of 1,251.9&#160;million for 2022 and 1,252.5&#160;million for&#160;2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below reconciles our &#8220;Business operating income&#8221; to our &#8220;Business net income&#8221;:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:68.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,040</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,714</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income and expenses</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(328)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,465)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,173)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business net income</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,341</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,213</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We define &#8220;Business net income&#8221; as </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to equity holders</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">of Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> determined under IFRS, excluding the following items:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">amortization and impairment losses charged against intangible assets (other than software and other rights of an industrial or operational nature);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">fair value remeasurements of contingent consideration relating to business combinations or divestments or acquisition of intangible assets;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">other impacts associated with acquisitions (including impacts relating to investments accounted for using the equity method);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">restructuring costs and similar items (presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Restructuring costs and similar items</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">gains and losses on major disposals of assets, asset groups or operations (presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">costs related to major litigation (presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">upfront payments and regulatory milestone payments recognized with the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and arising from transactions outside the scope of Sanofi's ordinary activities;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the tax effects of the items listed above, and the effects of major tax disputes;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the share of profits/losses from investments accounted for using the equity method, except for joint ventures and associates with which Sanofi has a strategic alliance;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">acquisition-related effects and restructuring costs relating to investments accounted for using the equity method (joint ventures and associates with which Sanofi has a strategic alliance); and</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">61</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the portion attributable to non-controlling interests of the items listed above.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below reconciles our &#8220;Business net income&#8221; to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to equity holders of Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:70.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi (IFRS)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,371</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,223</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,580&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expenses arising from the impact of acquisitions on inventories</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income from out-licensing</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,336&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax effects of the items listed above:</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(459)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(614)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.95pt">amortization and impairment of intangible assets</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(415)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.95pt">fair value remeasurement of contingent consideration</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.95pt">restructuring costs and similar items</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(200)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.95pt">other tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other items</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Business net income (non-IFRS Financial measure)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,341</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,213</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Average number of shares outstanding (million)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,251.9&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,252.5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic earnings per share (&#8364;)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.69&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reconciling items per share (&#8364;)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Business earnings per share (&#8364;)</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.26&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.56&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.98pt">Includes amortization expense related to accounting for business combinations: &#8364;1,719&#160;million in 2022 and &#8364;1,463&#160;million in 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.92pt">For 2022, this line includes a reversal of &#8364;2,154 million on Eloctate franchise products following FDA approval of ALTUVIIIO </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">dated February 22, 2023, partially offset by an impairment of &#8364;1,586&#160;million relating to the development project for SAR444245 (non-alpha interleukin-2), based on revised cash flow projections reflecting unfavorable developments in the launch schedule in key indications. For 2021, this line mainly comprises the discontinuation of the development of sutimlimab in the treatment of Immune Thrombocytopenic Purpura (ITP), and to the termination of various research projects in Vaccines.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;For 2022, this line includes an upfront payment of $900&#160;million and a regulatory milestone payment of $100&#160;million in connection with the out-licensing of Libtayo&#174; following the restructuring of the Immuno-Oncology collaboration agreement with Regeneron (see Note&#160;C.1. to our consolidated financial statements, included at Item&#160;18. of this Annual Report on Form&#160;20-F).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;For 2022, this line includes an impact of &#8364;(80)&#160;million attributable to non-controlling interests, related to a remeasurement of contingent consideration within a subsidiary of Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The most significant reconciling items between &#8220;Business net income&#8221; and </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to equity holders</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> of Sanofi relate to&#160;(i)&#160;the purchase accounting effects of our acquisitions and business combinations, particularly the amortization and impairment of intangible assets (other than software and other rights of an industrial or operational nature) and (ii)&#160;the impacts of restructurings or transactions regarded as non-recurring, where the amounts involved are particularly significant. We believe that excluding those impacts enhances an investor&#8217;s understanding of our underlying economic performance, because it gives a better representation of our recurring operating performance.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We believe that eliminating charges related to the purchase accounting effect of our acquisitions and business combinations (particularly amortization and impairment of some intangible assets) enhances comparability of our ongoing operating performance relative to our peers. Those intangible assets (principally rights relating to research, development and commercialization of products) are accounted for in accordance with IFRS&#160;3 (Business Combinations) and hence may be subject to remeasurement. Such remeasurements are not made other than in a business combination.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We also believe that eliminating the other effects of business combinations (such as the incremental cost of sales arising from the workdown of acquired inventories remeasured at fair value in business combinations) gives a better understanding of our recurring operating performance.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Eliminating restructuring costs and similar items enhances comparability with our peers because those costs are incurred in connection with reorganization and transformation processes intended to optimize our operations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, we believe that eliminating the effects of transactions that we regard as non-recurring and that involve particularly significant amounts (such as major gains and losses on disposals, and costs and provisions associated with major litigation and other major non-recurring items) improves comparability from one period to the next.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We remind investors, however, that &#8220;Business net income&#8221; should not be considered in isolation from, or as a substitute for, </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to equity holders</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">of Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> reported in accordance with IFRS. In addition, we strongly encourage investors and potential investors not to rely on any single financial measure but to review our financial statements, including the notes thereto, carefully and in their entirety.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We compensate for the material limitations described above by using &#8220;Business net income&#8221; only to supplement our IFRS financial reporting and by ensuring that our disclosures provide sufficient information for a full understanding of all adjustments included in&#160;&#8220;Business net income&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because our &#8220;Business net income&#8221; and &#8220;Business EPS&#8221; are not standardized measures, they may not be directly comparable with the non-IFRS financial measures of other companies using the same or similar non-IFRS financial measures.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">62</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_169"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.1.6. Presentation of net sales</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the discussion below, we present our consolidated net sales for 2022 and 2021. We analyze our net sales by various categories including segment, franchise, product, and geographical region. In addition to reported net sales, we analyze non-IFRS financial measures designed to isolate the impact on our net sales of currency exchange rates and changes in the structure of our&#160;group.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When we refer to changes in our net sales at constant exchange rates (CER), that means that we have excluded the effect of exchange rates by recalculating net sales for the relevant period using the exchange rates that were used for the previous period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When we refer to changes in our net sales on a constant structure basis, that means that we eliminate the effect of changes in structure by restating the net sales for the previous period as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">by including sales generated by entities or product rights acquired in the current period for a portion of the previous period equal to the portion of the current period during which we owned them, based on sales information we receive from the party from whom we make the acquisition;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">similarly, by excluding sales for a portion of the previous period when we have sold an entity or rights to a product in the current period;&#160;and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">for a change in consolidation method, by recalculating the previous period on the basis of the method used for the current period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A presentation of consolidated net sales for 2021 compared with 2020 is available in our Form&#160;20-F filed on February&#160;23, 2022, Item&#160;5., section&#160;&#8220;A.2.1.&#160;Net Sales&#8221;.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_172"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.1.7. Financial presentation of alliances</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have entered into a number of alliances for the development, co-promotion and/or co-marketing of our products. We believe that a presentation of our two principal alliances is useful to an understanding of our financial statements.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">1/ Alliance arrangements with Regeneron Pharmaceuticals Inc. (Regeneron)</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaboration agreements on human therapeutic antibodies</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In November&#160;2007, Sanofi and Regeneron signed two agreements (amended in November&#160;2009) relating to human therapeutic antibodies: (i)&#160;the Discovery and Preclinical Development Agreement, and (ii)&#160;the License and Collaboration Agreement, relating to clinical development and commercialization. Under the License and Collaboration Agreement, Sanofi had an option to develop and commercialize antibodies discovered by Regeneron under the Discovery and Preclinical Development Agreement.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Discovery and development</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because Sanofi decided not to exercise its option to extend the Discovery and Preclinical Development Agreement, that agreement expired on December&#160;31, 2017.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As a result of Sanofi's exercise of an option with respect to an antibody under the Discovery and Preclinical Development Agreement, such antibody became a &#8220;Licensed Product&#8221; under the License and Collaboration Agreement, pursuant to which Sanofi and Regeneron co-develop the antibody with Sanofi initially being wholly responsible for funding the development program. On receipt of the first positive Phase III trial results for any antibody being developed under the License and Collaboration Agreement, the subsequent development costs for that antibody are split 80% Sanofi, 20% Regeneron. Amounts received from Regeneron under the License and Collaboration Agreement are recognized by Sanofi as a reduction in the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Co-development with Regeneron of the antibodies Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and REGN3500 (SAR440340 - itepekimab) is ongoing under the License and Collaboration Agreement as of December&#160;31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Once a product begins to be commercialized, and provided that the share of quarterly results under the agreement represents a profit, Sanofi is entitled to an additional portion of Regeneron&#8217;s profit-share (capped at 20% of Regeneron&#8217;s share of quarterly profits since April&#160;1, 2022, and at 10% until March&#160;31, 2022) until Regeneron has paid 50% of the cumulative development costs incurred by the parties in the collaboration (see Note&#160;D.21.1.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On the later of (i)&#160;24 months before the scheduled launch date or (ii)&#160;the first positive Phase&#160;III trial results, Sanofi and Regeneron share the commercial expenses of the antibodies co-developed under the License and Collaboration Agreement.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commercialization</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is the lead party with respect to the commercialization of all co-developed antibodies, and Regeneron has certain option rights to co-promote the antibodies. Regeneron has exercised its co-promotion rights in the United States and in certain other countries. Sanofi recognizes all sales of the antibodies. Profits and losses arising from commercial operations in the United States are split 50/50. Outside the United States, Sanofi is entitled to between 55% and 65% of profits depending on sales of the antibodies, and bears 55% of any losses. The share of profits and losses due to or from Regeneron under the agreement is recognized within the line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income or Other operating expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, which are components of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, Regeneron is entitled to receive payments contingent on the attainment of specified levels of aggregate sales on all antibodies outside the United States, on a rolling twelve-month basis. A liability for those payments is recognized on the balance sheet when it is probable that the specified level of aggregate sales will be met. The opposite entry for that liability is capitalized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> on the balance sheet. Two payments of $50&#160;million each were made in 2022, following attainment first of $2.0&#160;billion and then of $2.5&#160;billion in sales of all antibodies outside the United States on a rolling twelve-month basis. In the event that $3.0&#160;billion in sales on a rolling twelve-month basis is attained, Regeneron is entitled to a final milestone payment of $50&#160;million.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">63</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amendments to the collaboration agreements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In January&#160;2018, Sanofi and Regeneron signed a set of amendments to their collaboration agreements, including an amendment that allowed for the funding of additional programs on Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and REGN3500 (SAR440340 &#8211; itepekimab) with an intended focus on extending the current range of indications, finding new indications, and improving co-morbidity between multiple pathologies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective April&#160;1, 2020, Sanofi and Regeneron signed a Cross License and Commercialization Agreement for Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, whereby Sanofi obtained sole ex-US rights to Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, and Regeneron obtained sole US rights to Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> along with a right to 5% royalties on Sanofi&#8217;s sales of Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> outside the United States. Each party is solely responsible for funding the development, manufacturing and commercialization of Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in their respective territories. Although each party has responsibility for supplying Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in its respective territory, Sanofi and Regeneron have entered into agreements to support manufacturing needs for each other.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective September&#160;30, 2021, Sanofi and Regeneron signed an amendment to their collaboration agreement in order to specify allocations of responsibilities and associated resources between the two parties in connection with the co-promotion of&#160;Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in certain countries. The terms of the collaboration relating to REGN3500 (SAR440340 &#8211; itepekimab) are unchanged.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective July&#160;1, 2022, Sanofi and Regeneron signed an amendment to their collaboration agreement in order to increase the additional portion of Regeneron&#8217;s share of quarterly profits attributable to Sanofi from 10% to 20% with retroactive impact as of April&#160;1, 2022.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Immuno-oncology (IO) collaboration agreements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On July&#160;1, 2015, Sanofi and Regeneron signed two agreements &#8211;&#160;the IO Discovery and Development Agreement and the IO License and Collaboration Agreement (IO LCA)&#160;&#8211; relating to new antibody cancer treatments in the field of immuno-oncology.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Amended IO Discovery Agreement, effective from December&#160;31, 2018, was terminated through a Letter Amendment dated March&#160;16,&#160;2021 in which Sanofi formalized its opt-out from the BCMAxCD3 and MUC16xCD3 programs. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> (cemiplimab)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the 2015 IO LCA as amended in January&#160;2018, Sanofi and Regeneron committed funding of no more than $1,640 million, split on a 50/50 basis ($820 million per company), for the development of REGN2810 (cemiplimab, trademark Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), a PD-1 inhibitor antibody. The funding was raised to $1,840&#160;million by way of amendment effective on September&#160;30, 2021. Regeneron was responsible for the commercialization of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the United States, and Sanofi in all other territories. Sanofi has exercised its option to co-promote Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the United States. In 2021, Regeneron exercised its option to co-promote Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in certain other countries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The IO LCA also provided for a one-time milestone payment of $375 million by Sanofi to Regeneron in the event that sales of a PD-1 product were to exceed, in the aggregate, $2 billion in any consecutive 12-month period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the IO LCA Sanofi and Regeneron shared equally in profits and losses generated by the commercialization of collaboration products, except that Sanofi was entitled to an additional portion of Regeneron&#8217;s profit-share (capped at 10% of Regeneron&#8217;s share of quarterly profits) until Regeneron had paid 50% of the cumulative development costs incurred by the parties under the IO Discovery Agreement, as amended.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is approved in the United States and Europe for the treatment of two types of locally advanced or metastatic skin cancer (cutaneous squamous cell carcinoma and basal cell carcinoma) and non-small cell lung cancer (NSCLC). It is also approved in Brazil and Canada as a second line treatment for recurring or metastatic cervical cancer. In the fourth quarter of 2022, it was approved in the United States in association with chemotherapy for the treatment of NSCLC, and in Europe and Japan as a second line treatment for recurring or metastatic cervical cancer. Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently approved in more than 30&#160;countries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;2022, Sanofi and Regeneron restructured their IO LCA. Under the terms of the Amended and Restated IO LCA, Regeneron holds exclusive worldwide licensing rights to Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> with effect from July&#160;1, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In July&#160;2022, Sanofi received as consideration an upfront payment of $900&#160;million (&#8364;856&#160;million), which was recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> on the date of receipt. The same line item also includes a regulatory milestone payment of $100&#160;million (&#8364;96&#160;million) following the US FDA approval in November&#160;2022 of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with chemotherapy as a first line treatment for NSCLC. In addition, Sanofi is entitled to royalties of 11% and to milestone payments (&#8364;111&#160;million in 2022) linked to global net sales of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> which are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in line with the pattern of sales. All of the cash inflows relating to the above items (&#8364;967&#160;million for the year ended December&#160;31, 2022) are presented within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net cash provided by/(used in) operating activities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amendment to the terms of the IO LCA resulted in Sanofi recognizing an accelerated amortization charge of &#8364;226&#160;million; this was allocated to the Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">product rights included within the residual carrying amount of the intangible asset recognized in July&#160;2015 to reflect rights to an antibody targeting the immune checkpoint receptor PD-1 (programmed cell death protein-1) under the Sanofi/Regeneron alliance.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The transaction also includes a time-limited transitional services agreement with Regeneron which includes manufacturing, distribution (for which Sanofi acts as agent), and promotion.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">64</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investor agreement</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2014 and 2020, Sanofi and Regeneron amended the investor agreement entered into by the two companies in 2007. Under the terms of the amendments, Sanofi accepted various restrictions, including &#8220;standstill&#8221; provisions that contractually prohibit Sanofi from seeking to directly or indirectly exert control of Regeneron or acquiring more than 30% of Regeneron&#8217;s capital stock (consisting of the outstanding shares of common stock and the shares of Class A stock). This prohibition remains in place until the earlier of (i)&#160;the later of the fifth anniversaries of the expiration or earlier termination of the Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> collaboration agreement with Regeneron (related to the development and commercialization of Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) or the collaboration agreement with Regeneron on monoclonal antibodies (see &#8220;Collaboration agreements on human therapeutic antibodies&#8221; above), each as amended and (ii)&#160;other specified events.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Starting in 2018 Sanofi began to sell shares of Regeneron stock and announced on May&#160;29,&#160;2020 the closing of its sale of 13&#160;million shares of Regeneron common stock in a registered offering and a private sale to Regeneron (see Note&#160;D.2.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Pursuant to subsequent sales, as of December&#160;31, 2022 Sanofi no longer holds any shares of Regeneron stock.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">2/ Alliance arrangements with Bristol-Myers Squibb (BMS)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Two of Sanofi&#8217;s products were jointly developed with BMS: the anti-hypertensive agent irbesartan (Aprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Karvea</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) and the anti-atherothrombosis treatment clopidogrel bisulfate (Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Iscover</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;27, 2012, Sanofi and BMS signed an agreement relating to their alliance following the loss of exclusivity of Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in many major markets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the terms of this agreement, effective January&#160;1, 2013, BMS returned to Sanofi its rights to Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in all markets worldwide with the exception of Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the United States and Puerto Rico (&#8220;Territory&#160;B&#8221;), giving Sanofi sole control and freedom to operate commercially in respect of those products. In exchange, BMS received royalty payments on Sanofi&#8217;s sales of branded and unbranded Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> worldwide (except for Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Territory&#160;B) until 2018, and also received a payment of $200 million from Sanofi in December&#160;2018, part of which is for buying out the non-controlling interests. Rights to Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Territory&#160;B remained unchanged and continued to be governed by the terms of the original agreement until&#160;February&#160;28, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In all of the territories managed by Sanofi (including the United States and Puerto Rico for Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) as defined in the new agreement, Sanofi recognized in its consolidated financial statements the revenue and expenses generated by its own operations. Since January&#160;2019 onwards, there has no longer been any share of profits reverting to BMS (previously presented within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to non-controlling interests </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the income statement).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Territory&#160;B for Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, which was managed by BMS, the Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> business was conducted through the Territory&#160;B partnerships, which were jointly owned by BMS and Sanofi. Sanofi recognized its share of profits and losses within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;28, 2020, Sanofi purchased all BMS&#8217;s interests (50.1%) in each of the Territory&#160;B partnerships for a cumulative purchase price of $12&#160;million. Following a transition period, Sanofi has been commercializing Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> under its own label since&#160;July&#160;1, 2020.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_175"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.1.8. Impact of exchange rates</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We report our consolidated financial statements in euros. Because we earn a significant portion of our revenues in countries where the euro is not the local currency, our results of operations can be significantly affected by exchange rate movements between the euro and other currencies, primarily the US dollar and, to a lesser extent, the Japanese yen, and currencies in emerging countries. We experience these effects even though certain of these countries do not account for a large portion of our net sales. In 2022, we earned 42.5% of our net sales in the United States. An increase in the value of the US dollar against the euro has a positive impact on both our revenues and our operating income. A decrease in the value of the US dollar against the euro has a negative impact on our revenues, which is not offset by an equal reduction in our costs and therefore negatively affects our operating income. A variation in the value of the US dollar has a particularly significant impact on our operating income, which is higher in the United States than elsewhere.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a description of arrangements entered into to manage operating foreign exchange risks as well as our hedging policy, see&#160;&#8220;Item&#160;11.&#160;Quantitative and Qualitative Disclosures about Market Risk&#8221;, and &#8220;Item&#160;3.&#160;Key Information &#8212;&#160;D.&#160;Risk Factors &#8212;&#160;Risks Related to Financial Markets &#8212;&#160;Fluctuations in currency exchange rates could adversely affect our results of operations and financial condition&#8221;.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">65</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_178"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.1.9. Divestments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;3, 2022, Sanofi's General Meeting of Shareholders approved the decision to distribute approximately 58% of the share&#160;capital of </span><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">EUROAPI</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a European leader in the development, manufacture, marketing and distribution of Active Pharmaceutical Ingredients (APIs), in the form of an exceptional dividend in kind to Sanofi shareholders. On the dividend payment date of May&#160;10, 2022 (further to the admission of EUROAPI shares to listing on the regulated market of Euronext Paris on May&#160;6,&#160;2022), Sanofi divested control over EUROAPI and its subsidiaries, resulting in their deconsolidation from the Sanofi consolidated financial statements as of that date. On June&#160;17, 2022 (the date of delivery of the EUROAPI shares to the French&#160;State via the French Tech Souverainet&#233; fund), EPIC Bpifrance acquired a 12% equity interest in EUROAPI. Following completion of those transactions, Sanofi retains an equity interest of 30.1% in EUROAPI, which has been accounted for using the equity method since the date of loss of control. The cash impact of the deconsolidation of EUROAPI, presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Disposals of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the statement of cash flows, was a net cash inflow of &#8364;<ix:nonFraction unitRef="eur" contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510" decimals="-6" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl8xNzgvZnJhZzo1ZWNkYzA4ODZmOTk0ZTI3OWZmMDAyNDc2ZTk1MjkzMy90ZXh0cmVnaW9uOjVlY2RjMDg4NmY5OTRlMjc5ZmYwMDI0NzZlOTUyOTMzXzI3NDg3NzkwNzA5MDM_6d35a61e-f444-4997-bbbb-7d442b4906fd">101</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For further details about the divestments mentioned above, see Note&#160;D.1. to our consolidated financial statements included at&#160;Item&#160;18. of this annual report.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_181"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.1.10. Acquisitions</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;8, 2022, Sanofi acquired the entire share capital of the immuno-oncology company Amunix Pharmaceuticals, Inc. (Amunix), thereby gaining access to Amunix&#8217;s innovative Pro-XTEN</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> technology and a promising pipeline of immunotherapies. The acquisition price of Amunix comprises a fixed payment of &#8364;970&#160;million, plus contingent consideration in the form of milestone payments based on attainment of certain future development objectives of up to $225&#160;million, the fair value of which as of the acquisition date was &#8364;156&#160;million. The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;852 million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;8, 2021, Sanofi acquired the entire share capital of Kymab for an upfront payment of $1.1 billion (&#8364;973 million) and up to&#160;$350 million (&#8364;295&#160;million) contingent upon reaching certain development milestones. The purchase price allocation resulted in the recognition of &#8364;965 million of other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;932 million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;16, 2021, Sanofi completed the public offering for Kiadis. As of the end of the post-closing acceptance period on April&#160;29,&#160;2021, Sanofi held 97.39% of the share capital of Kiadis, and launched a statutory public buy-out procedure in order to obtain 100% of the share capital. The purchase price allocation resulted in the recognition of &#8364;339 million of other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and&#160;investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of&#160;&#8364;326 million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;9, 2021, Sanofi acquired Tidal Therapeutics for an upfront payment of $160&#160;million (&#8364;136&#160;million), and up to $310&#160;million (&#8364;261&#160;million) contingent upon reaching certain development milestones. The purchase price allocation resulted in the recognition of &#8364;130&#160;million of other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;135&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;14, 2021, Sanofi completed the acquisition of Translate Bio for a purchase price of &#8364;2.6&#160;billion. The purchase price allocation resulted in the recognition of goodwill amounting to &#8364;2,118&#160;million. The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;2,333&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;9, 2021, Sanofi completed the acquisition of Kadmon in a transaction valued at $1.9&#160;billion (&#8364;1.6&#160;billion) on a fully-diluted basis. The purchase price allocation resulted in the recognition of &#8364;1,739&#160;million of other intangible assets. The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the consolidated statement of cash flows is a net cash outflow of &#8364;1,575&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;3, 2021, Sanofi completed the acquisition of Origimm Biotechnology GmbH, for an initial payment of &#8364;55&#160;million, and up to&#160;&#8364;95&#160;million contingent upon reaching certain development phases. The purchase price allocation resulted in the recognition of &#8364;55&#160;million of other intangible assets. The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows for the year ended&#160;December&#160;31, 2021 is a net cash outflow of &#8364;50&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For further information about the acquisitions mentioned above, see Notes&#160;D.1. and&#160;D.2. to our consolidated financial statements included at Item&#160;18. of this Annual Report on Form&#160;20-F.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">66</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_184"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.1.11. Critical accounting and reporting policies</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our consolidated financial statements are affected by the accounting and reporting policies that we use. Certain of our accounting and reporting policies are critical to an understanding of our results of operations and financial condition, and in some cases the application of these critical policies can be significantly affected by the estimates, judgments and assumptions made by management during the preparation of our consolidated financial statements. The accounting and reporting policies that we have identified as fundamental to a full understanding of our results of operations and financial condition are the following:</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">1/ Revenue recognition</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our policies with respect to revenue recognition are discussed in Note&#160;B.13. to our consolidated financial statements included at&#160;Item&#160;18. of this annual report. Revenue arising from the sale of goods is presented in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comprise revenue from sales of pharmaceutical products, consumer healthcare products, active ingredients and vaccines, net of sales returns, of customer incentives and discounts, and of certain sales-based payments paid or payable to the healthcare authorities. In accordance with IFRS&#160;15 (Revenue from Contracts with Customers), such revenue is recognized when Sanofi transfers control over the product to the customer. Control refers to the ability to direct the use of, and obtain substantially all of the remaining benefits from, the products. For the vast majority of contracts, revenue is recognized when the product is physically transferred, in accordance with the delivery and acceptance terms agreed with the customer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For contracts entered into by Sanofi Pasteur, transfer of control is usually determined by reference to the terms of release (immediate or deferred) and acceptance of batches of vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As regards contracts with distributors, Sanofi does not recognize revenue when the product is physically transferred to the distributor in case of products sold on consignment, or if the distributor acts as an agent. In such cases, revenue is recognized when control is transferred to the end customer, and the distributor&#8217;s commission is presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Selling and general expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We offer various types of price reductions on our products. In particular, products sold in the United States are covered by various programs (such as Medicare and Medicaid) under which products are sold at a discount. Rebates are granted to healthcare authorities, and under contractual arrangements with certain customers. Some wholesalers are entitled to chargeback incentives based on the selling price to the end customer, under specific contractual arrangements. Cash discounts may also be granted for prompt payment. The discounts, incentives and rebates described above are estimated on the basis of specific contractual arrangements with our customers or of specific terms of the relevant regulations and/or agreements applicable for transactions with healthcare authorities, and of assumptions about the attainment of sales targets. We also estimate the amount of sales returns, on the basis of contractual sales terms and reliable historical data. Discounts, incentives, rebates and sales returns are recognized in the period in which the underlying sales are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net Sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, as a reduction of gross sales. For additional details regarding the financial impact of discounts, incentives, rebates and sales returns, see Note&#160;D.23. to our consolidated financial statements included at Item&#160;18. of this annual report.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Revenues from non-Sanofi products, mainly comprising royalty income from license arrangements and sales of non-Sanofi products by our US-based entity VaxServe, are presented within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other revenues</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. This line item also includes revenues arising from the distribution of Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> under Sanofi&#8217;s agreements with Swedish Orphan Biovitrum AB (Sobi) and revenue received under agreements for Sanofi to provide manufacturing services to third parties.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">2/ Business combinations</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As discussed in Note&#160;B.3. &#8220;Business combinations and transactions with non-controlling interests&#8221; to our consolidated financial statements included at Item&#160;18. of this annual report, business combinations are accounted for by the acquisition method. The&#160;acquiree&#8217;s identifiable assets and liabilities that satisfy the recognition criteria of IFRS&#160;3 (Business Combinations) are measured initially at their fair values as at the acquisition date, except for (i)&#160;non-current assets classified as held for sale, which are&#160;measured at fair value less costs to sell and&#160;(ii)&#160;assets and liabilities that fall within the scope of IAS&#160;12 (Income Taxes) and&#160;IAS&#160;19&#160;(Employee Benefits). Business combinations completed on or after January&#160;1, 2010 are accounted for in accordance with the revised IFRS&#160;3 and IFRS&#160;10 (Consolidated Financial Statements). In particular, contingent consideration payable to former owners agreed in a business combination, e.g. in the form of payments upon the achievement of certain R&amp;D&#160;milestones, is recognized as a liability at fair value as of the acquisition date irrespective of the probability of payment. If the contingent consideration was originally recognized as a liability, subsequent adjustments to the liability are recognized in profit or loss (see&#160;Note&#160;D.18.&#160;&#8220;Liabilities related to business combinations and non-controlling interests&#8221; to our consolidated financial statements included at&#160;Item&#160;18. of this annual report).</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">3/ Impairment of goodwill and intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As discussed in Note&#160;B.6. &#8220;Impairment of property, plant and equipment, intangible assets, and investments accounted for using the equity method&#8221; and in Note&#160;D.5. &#8220;Impairment of intangible assets and property, plant and equipment&#8221; to our consolidated financial statements included at Item&#160;18. of this annual report, we test our intangible assets for impairment periodically or when there is any internal or external indication of impairment. Such indicators could include primarily but not exclusively (i)&#160;increased market competition resulting from (for example) the introduction of a competitor&#8217;s product; (ii)&#160;earlier than expected loss of exclusivity; (iii)&#160;increased pricing pressure; (iv)&#160;restrictions imposed by regulatory authorities on the manufacture or sale of a product; (v)&#160;delay in the projected launch of a product;&#160;(vi)&#160;different from expected clinical trial results; (vii)&#160;higher than expected development costs or (viii)&#160;lower than expected economic performance.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We test for impairment on the basis of the same objective criteria that were used for the initial valuation. Our initial valuation and ongoing tests are based on the relationship of the value of our projected future cash flows associated with the asset to either the purchase price of the asset (for its initial valuation) or the carrying amount of the asset (for ongoing tests for impairment).</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">67</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Significant underlying assumptions requiring the exercise of considerable judgement are applied in the future cash flow projections used to determine the recoverability of intangible assets, including primarily but not exclusively (i)&#160;therapeutic class market growth drivers; (ii)&#160;expected impacts from competing products (including but not exclusively generics and biosimilars); (iii)&#160;projected pricing and operating margin levels; (iv)&#160;likely changes in the regulatory, legal or tax environment; and (v)&#160;management&#8217;s estimates of terminal growth or attrition rates.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The recoverable amounts of intangible assets related to research and development projects are determined based on future net cash flows, which reflect the development stage of the project and the associated probability of success of marketization of the compound.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The projected cash flows are discounted to present value using a discount rate, which factors in the risks inherent in cash flow projections.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in facts and circumstances, assumptions and/or estimates may lead to future additional impairment losses or reversal of impairment previously recorded.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Key assumptions relating to goodwill impairment are the perpetual growth rate and the post-tax discount rate. A sensitivity analysis to the key assumptions is disclosed in Note&#160;D.5.&#160;&#8220;Impairment of intangible assets and property, plant and equipment&#8221; to our consolidated financial statements included at Item&#160;18. of this annual report.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">4/ Pensions and post-retirement benefits</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As described in Note&#160;B.23. &#8220;Employee benefit obligations&#8221; to our consolidated financial statements included at Item&#160;18. of this annual report, we recognize our pension and retirement benefit commitments as liabilities on the basis of an actuarial estimate of the rights vested in employees and retirees at the end of the reporting period, net of the fair value of plan assets held to meet those obligations. We prepare this estimate at least on an annual basis taking into account financial assumptions (such as discount rates) and demographic assumptions (such as life expectancy, retirement age, employee turnover, and the rate of salary increases).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We recognize all actuarial gains and losses (including the impact of a change in discount rate) immediately through equity.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Depending on the key assumptions used, the pension and post-retirement benefit expense could vary within a range of outcomes and have a material effect on reported earnings. A sensitivity analysis to these key assumptions is set forth in&#160;Note&#160;D.19.1. &#8220;Provisions for pensions and other benefits&#8221; to our consolidated financial statements included at Item&#160;18. of this annual report.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">5/ Taxes</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As discussed in Note&#160;B.22. &#8220;Income tax expense&#8221; to our consolidated financial statements included at Item&#160;18. of this annual report, we recognize deferred income taxes on tax loss carry-forwards and on temporary differences between the tax base and carrying amount of assets and liabilities. We calculate our deferred tax assets and liabilities using enacted tax rates applicable for the years during which we estimate that the temporary differences are expected to reverse. We do not recognize deferred tax assets when it is more likely than not that the deferred tax assets will not be realized. The recognition of deferred tax assets is determined on the basis of profit forecasts for each tax group, and of the tax consequences of the strategic opportunities available to Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The positions adopted by Sanofi in tax matters are based on its interpretation of tax laws and regulations. Some of those positions may be subject to uncertainty. In such cases, Sanofi assesses the amount of the tax liability on the basis of the following assumptions: that its position will be examined by one or more tax authorities on the basis of all relevant information; that a technical assessment is carried out with reference to legislation, case law, regulations, and established practice; and that each position is assessed individually (or collectively where appropriate), with no offset or aggregation between positions. Those assumptions are assessed on the basis of facts and circumstances existing at the end of the reporting period. When an uncertain tax liability is regarded as probable, it is measured on the basis of Sanofi&#8217;s best estimate and recognized as a liability; uncertain tax assets are not recognized.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">6/ Provisions for risks</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and its subsidiaries and affiliates may be involved in litigation, arbitration or other legal proceedings. These proceedings typically are related to product liability claims, intellectual property rights, compliance and trade practices, commercial claims, employment and wrongful discharge claims, tax assessment claims, waste disposal and pollution claims, and claims under warranties or indemnification arrangements relating to business divestitures. As discussed in Note&#160;B.12. &#8220;Provisions for risks&#8221; to our consolidated financial statements included at Item&#160;18. of this annual report, we record a provision where we have a present obligation, whether legal or constructive, as a result of a past event; it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation; and a reliable estimate can be made of the amount of the outflow of resources. We also disclose a contingent liability in circumstances where we are unable to make a reasonable estimate of the expected financial effect that will result from the ultimate resolution of the proceeding, or a cash outflow is not probable.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For additional details regarding the financial impact of provisions for risks see Notes&#160;D.19.3. &#8220;Other provisions&#8221; and&#160;D.22. &#8220;Legal and Arbitral Proceedings&#8221; to our consolidated financial statements included at Item&#160;18. of this annual report.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">68</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">7/ Provisions for restructuring costs</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Provisions for restructuring costs include collective redundancy or early retirement benefits, compensation for early termination of contracts, and rationalization costs relating to restructured sites. Refer to Note&#160;D.19.2. to our consolidated financial statements included at Item&#160;18. of this annual report.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Provisions are estimated on the basis of events and circumstances related to present obligations at the end of the reporting period and of past experience, and to the best of management&#8217;s knowledge at the date of preparation of the financial statements. The assessment of provisions can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. Given the inherent uncertainties related to these estimates and assumptions, the actual outflows resulting from the realization of those risks could differ from our estimates.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_187"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">A.2. Results of operations &#8211;&#160;Year ended December 31, 2022 compared with year ended December 31, 2021</span></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Consolidated income statements</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.676%"><tr><td style="width:1.0%"></td><td style="width:48.743%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.439%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.440%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">as&#160;%&#160;of&#160;net</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">sales</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">as&#160;%&#160;of&#160;net</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">sales</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,997</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,761</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,695)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-31.9&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,255)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-32.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31,694</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">73.7</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26,920</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">71.3</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,706)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-15.6&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,692)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-15.1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,492)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-24.4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,555)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,531)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,053)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,580)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment of intangible assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(192)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,336)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(820)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other gains and losses, and litigation</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,656</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.8</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,126</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.5</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial expenses</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(368)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income before tax and investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,422</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,798</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20.7</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,006)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,558)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,484</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.7</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,279</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16.6</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,371</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.5</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,223</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16.5</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Average number of shares outstanding (million)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,251.9&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,252.5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Average number of shares after dilution (million)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,256.9&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,257.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Basic earnings per share (&#8364;)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.69&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Diluted earnings per share (&#8364;)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.66&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">69</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_190"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.2.1. Net sales</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Consolidated net sales for the year ended December 31, 2022 amounted to &#8364;42,997&#160;million, 13.9% higher than in 2021 in a reported basis. Exchange rate fluctuations had a positive effect of</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> 6.9</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;percentage points overall, due mainly to favorable trends of the US&#160;dollar and Chinese yuan against the euro. At constant exchange rates (CER</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(13)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), net sales rose by&#160;7.0%, mainly reflecting strong growth for Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and increased sales for our Vaccines business, more than offsetting lower sales for our Non Core Assets franchise.</span></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Reconciliation of net sales to net sales at constant exchange&#160;rates</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales (IFRS)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,997</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,761</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.9</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of exchange rates</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,585)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales at constant exchange rates (non-IFRS financial measure)</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">40,412</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,761</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+7.0</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We calculate net sales CER by recalculating net sales for the relevant period using the exchange rates that were used for the previous period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To facilitate analysis and comparisons with prior periods, some figures are given at constant exchange rates (CER).</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_193"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">1/ Net sales by operating segment and global business unit (GBU)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our net sales comprise the net sales generated by our Pharmaceuticals, Vaccines and Consumer Healthcare segments.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:49.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change on a reported basis</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change at constant exchange rates</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals segment</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,688</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26,970</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.8</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+6.9</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines GBU/segment</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,229</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,323</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+14.3</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+6.3</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer Healthcare GBU/segment</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,080</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,468</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.7</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+8.6</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,997</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,761</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+7.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(13)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Non-IFRS financial measure: see definition in &#8220;&#8212; A.1.6.&#160;Presentation of Net Sales&#8221;.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">70</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_196"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">2/ Net sales by franchise, geographical region and product</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:28.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(&#8364; million)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Change (CER)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Change (reported)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Change (CER)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Change (CER)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Rest of the world</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Change (CER)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">8,293</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+43.8</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+58.0</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6,346</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+41.6</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">940</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+44.4</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,007</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+56.6</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,031&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,420&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-26.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total Neurology &amp; Immunology</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,450</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">-2.5</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+5.4</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,637</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">639</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+0.2</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">174</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-15.7</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerezyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerdelga</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">Gaucher</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">995</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+3.7</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+6.2</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">354</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+3.0</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">350</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+0.3</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">291</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+8.8</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fabrazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Xenpozyme</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1900.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2000.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1400.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Myozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">/Lumizyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-24.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+952.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1052.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+833.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+750.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">Pompe</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">1,154</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+7.3</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+13.1</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">476</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+9.0</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">425</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+3.2</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">253</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aldurazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Elaprase</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">MPS</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">337</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+1.9</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+4.0</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">86</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+2.4</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">190</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">+2.2</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total Rare Diseases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,445</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+5.7</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+10.2</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,367</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+6.3</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,104</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+3.3</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">974</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+7.8</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-70.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fasturtec</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-34.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-31.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-34.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-33.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+60.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+67.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+68.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+35.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+82.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total Oncology</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">952</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">-1.5</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+4.4</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">515</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+12.0</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">239</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">-27.5</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">198</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+15.4</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+17.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+28.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+200.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total Rare Blood Disorders</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,317</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+5.6</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+15.4</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">983</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+3.8</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+16.0</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">240</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+8.7</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-48.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-19.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Multaq</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+65.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+72.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+860.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+41.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+61.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Thymoglobulin</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+27.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mozobil</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Soliqua</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">/Suliqua</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+815.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+935.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+815.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other Core Assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-30.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total Core Assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6,389</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+5.2</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+10.8</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,653</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+11.6</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,917</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+2.9</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,819</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">+3.7</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-22.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,076&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">/Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-40.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other Non-Core Assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,485&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total Non-Core Assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">7,222</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">-9.0</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,176</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">-18.6</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,637</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">-10.9</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">4,409</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Industrial Sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.25pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">620</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.25pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">-26.2</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.25pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.25pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">-23.3</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.25pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.25pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.25pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">-63.4</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.25pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.25pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">587</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.25pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">-21.9</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.25pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.25pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.25pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-63.6&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Pharmaceuticals</span></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,688</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+6.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.8</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,694</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+15.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,157</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-0.8</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,837</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.8</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Polio/Pertussis/Hib vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Booster vaccines (incl. Adacel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+55.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Meningitis vaccines</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1400.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Influenza vaccines</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,977&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Travel and endemics vaccines</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+57.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+66.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+57.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+123.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+42.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+86.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+98.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+22.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Vaccines</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,229</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+6.3</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+14.3</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,291</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,341</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+9.7</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,597</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+8.4</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Allergy</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+19.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+19.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cough, Cold and Flu</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+46.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+49.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+69.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Pain Care</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Digestive Wellness</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Physical Wellness</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mental Wellness</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-75.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Non-Core/Other</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-200.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-18.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Consumer Healthcare</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,080</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+8.6</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.7</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,290</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+0.8</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,501</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,289</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+10.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Sanofi</span></td><td colspan="2" style="background-color:#21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,997</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+7.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,275</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+12.2</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,999</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.4</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,723</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+4.8</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">71</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_199"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">3/ Net sales &#8211; Pharmaceuticals segment</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, net sales for the Pharmaceuticals segment amounted to &#8364;30,688&#160;million, up 13.8% on a reported basis and 6.9% at constant exchange rates (CER). The year-on-year reported-basis increase of &#8364;3,718&#160;million reflects positive exchange rate effects of &#8364;1,849&#160;million, and the following principal effects at constant exchange rates:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">solid performances from Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (+&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2,297</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;million), the launch of Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (+&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">162</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;million), and sales growth for Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (+&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">106</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;million)</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">growth for the Core Assets franchise within the General Medicines GBU (+&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">302&#160;million), partly offsetting lower sales for the Non Core Assets franchise (-&#8364;689&#160;million).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Comments on the performances of our major Pharmaceuticals segment products are provided below.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Specialty Care</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dupixent</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (developed in collaboration with Regeneron) generated net sales of &#8364;8,293&#160;million in 2022, up 58.0% versus 2021 on a reported basis and&#160;43.8% at constant exchange rates. In the United States, sales of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> reached &#8364;6,346&#160;million in 2022, up&#160;41.6% CER, boosted by continuing strong demand in the product's approved indications (atopic dermatitis, asthma and nasal polyps); the launches in atopic dermatitis for children aged 6&#160;months and over, eosinophilic esophagitis, and prurigo nodularis. Total prescriptions of Dupixent rose by 38%, and new-to-brand prescriptions by 41% compared to 2021. In Europe, the product posted 2022 net sales of&#160;&#8364;940&#160;million, up</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">44.4% CER, driven by continuing growth in atopic dermatitis, asthma and nasal polyps. In the Rest of the World</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">region, Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> posted net sales of &#8364;1,007&#160;million (+56.6% CER), including &#8364;364&#160;million in Japan (+33.0% CER) and &#8364;237&#160;million in China (+197.3% CER).</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Neurology and immunology</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> Neurology and Immunology </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">franchise generated net sales of &#8364;2,450&#160;million, up 5.4% on a reported basis and down 2.5% CER, mainly reflecting lower sales of Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> posted net sales of &#8364;2,031&#160;million in 2022 (-4.3% CER), due to negative price effects and to lower sales in the United States (-3.8% CER at &#8364;1,420&#160;million, due to increased competition) and the Rest of the World region </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(-26.0% CER at &#8364;100&#160;million)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. In the United States, </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> generic competition will be able to enter the market on March&#160;12, 2023, as agreed in 2017 with the generics manufacturers. In Europe, </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> generic competition is expected in the fourth quarter of 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> amounted to &#8364;80&#160;million, down 8.5% CER, on a decline in sales in the United States (-20.0% CER at&#160;&#8364;31&#160;million) and Europe (-8.3% CER at &#8364;22&#160;million).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (developed in collaboration with Regeneron) in 2022 reached &#8364;339&#160;million, up 11.8% CER.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rare diseases</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, net sales for the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Rare Diseases</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> franchise totaled &#8364;3,445&#160;million, up 10.2% on a reported basis and 5.7% at constant exchange rates (CER), reflecting a rise in all three regions and franchises. The Rest of the World region is driving growth with net sales up 7.8% CER at &#8364;974&#160;million, followed by the United States, where net sales advanced by 6.3% CER to &#8364;1,367&#160;million. In Europe, net sales for the franchise rose by 3.3% CER to &#8364;1,104&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales for the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Gaucher disease </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">franchise (</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Cerezyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> Cerdelga</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) reached &#8364;995&#160;million in 2022, up 3.7% CER. Cerezyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were up 2.6% CER at &#8364;707&#160;million, helped by a solid performance in the Rest of the World region (+9.0% CER at&#160;&#8364;274&#160;million), driven by new patients on therapy and benefiting from favorable pricing. In parallel, sales of Cerdelga</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> rose by&#160;6.7% CER to &#8364;288&#160;million, driven by the United States (+7.6% CER at&#160;&#8364;160&#160;million), Europe (+5.7%&#160;CER at &#8364;111&#160;million), and the Rest of the World region (+</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">5.9% CER at &#8364;17&#160;million)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> as new patients adopted the product or switched treatment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Pompe disease franchise</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Myozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Lumizyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and&#160;Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) were up 7.3% CER in 2022 at &#8364;1,154&#160;million, driven by the Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> launch&#160;in the United States, Europe and Japan. Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales reached &#8364;196&#160;million, including &#8364;158&#160;million in the United States. Sales of Myozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Lumizyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">were down year-on-year (</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">-8.8%</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> CER at &#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">958&#160;million) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">due to switches of eligible Pompe patients (advanced stage) to Nexviazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Fabry disease</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> treatment </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Fabrazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in 2022 were &#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">938</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;million (+</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">5.2%</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;CER), propelled by the United States (+</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">5.8% CER at&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">471</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;million), the Rest of the World region (+</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">7.1%</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> CER at &#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">239</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;million) and Europe (+</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2.2%</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> CER at&#160;&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">228</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;million), due to more patients adopting the product and better observance of the treatment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Xenpozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(olipudase alfa), the first and only treatment for non-neurological manifestations of Acid Sphingomyelinase Deficiency (ASMD) has been approved by the FDA and EMA, in Japan, and in Brazil. Xenpozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">has been launched in six&#160;countries and reported sales of &#8364;15&#160;million in Europe, &#8364;5&#160;million in the US and &#8364;1&#160;million in the Rest of the World region.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oncology</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, net sales for the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Oncology</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> franchise amounted to &#8364;952&#160;million, up 4.4% on a reported basis and down 1.5% CER, reflecting the end of consolidation of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales from the beginning of July. Excluding Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Oncology sales were up 3.8% CER, as strong growth for Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> more than offset the impact of declining Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales due to generic competition in Europe and increased competition in the US.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">72</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Sanofi stopped consolidating non-US Libtayo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> sales from the start of the third quarter of 2022 following the restructuring of its immuno-oncology collaboration with Regeneron, pursuant to which Regeneron obtained the worldwide exclusive licensing rights to Libtayo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">. Previously, the companies had split Libtayo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> worldwide operating profits equally and co-commercialized Libtayo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> in the US, with Sanofi solely responsible for commercialization in the rest of the world.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> reached &#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">294&#160;million, up 60.2% </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">CER</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, driven by a very strong performance in the United States        (+&#8364;127&#160;million, up 68.7% CER), in Europe (&#8364;88&#160;million, up 35.9% CER), and in Japan (&#8364;66&#160;million, u</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">p 75.0% CER).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> posted net sales of &#8364;391&#160;million in 2022 (-20.0% CER), as sales decreased in Europe (-70.5% CER at &#8364;33&#160;million) following the arrival of generic competition in some European markets at end March&#160;2021. In the United States, Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently covered by four Orange Book listed patents: US&#160;7,241,907, US&#160;8,927,592, US&#160;10,583,110 and US&#160;10,716,777. Sanofi has&#160;filed patent infringement suits under Hatch-Waxman against generic filers asserting the &#8216;110&#160;patent, the &#8216;777&#160;patent and the&#160;'592&#160;patent in the US District Court for the District of Delaware. Sanofi has since reached settlement agreements with most of the defendants, and the suit against the remaining defendant (Sandoz) is ongoing. In August&#160;2022, the district court dismissed Sanofi&#8217;s infringement claim related to the &#8216;592&#160;patent. A three-day trial took place on January&#160;11 through January&#160;13, 2023, and Sandoz agreed not to launch any generic cabazitaxel product until the earlier of a district court decision in favor of Sandoz or four months after the completion of the post-trial briefing. Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales in the United States were down </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">3.2% CER at &#8364;275&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rare Blood Disorders</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Rare Blood Disorders</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> franchise generated net sales of &#8364;1,317&#160;million, up 15.4% on a reported basis and 5.6% at constant exchange rates, mainly as a result of growth for Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> and the launch of Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">more than offsetting lower sales of Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> indicated in the treatment of hemophilia&#160;A, generated net sales of &#8364;580&#160;million in 2022, down 5.9% CER, due to competitive pressure and lower sales in the Rest of the World region (</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">-3.0% CER).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, indicated in the treatment of hemophilia&#160;B, were &#8364;504&#160;million, up 10.4% CER. In the&#160;United&#160;States, sales of the product reached &#8364;406&#160;million, up 8.7% CER, reflecting patient switching to prophylactic treatments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">which treats acquired thrombotic thrombocytopenic purpura (aTTP) in adults, posted net sales of &#8364;211&#160;million in 2022, up&#160;20.7% CER, reflecting increased ATTP awareness and treatment in line with guidelines from the International Society on Thrombosis and Haemostasis (ISTH) recommending first line use of Cablivi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for all aTTP patients. Sales reached &#8364;110&#160;million in the United States (+21.0% CER), while in Europe net sales were up 16.0% CER at &#8364;94&#160;million mainly due to higher market penetration as a result of increased product awareness.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the first-ever treatment for cold agglutinin disease, reached &#8364;22&#160;million. The product was launched in the United States and Japan during 2022, and approved in Europe in November&#160;2022.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">General Medicines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, net sales for the General Medicines GBU decreased by 4.2%. Core assets accounted for 47% of total General Medicines sales in 2022, compared with 43% in 2021 (excluding industrial sales). Divestments of non-core assets had a negative impact of 0.8&#160;ppt, and the deconsolidation of EUROAPI third party sales, a negative impact of 2.4&#160;ppt. In 2022, Industrial sales were &#8364;620&#160;million, down 26.2%, reflecting the impact of the deconsolidation of EUROAPI third party sales.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Core Assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, global </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Core Assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;6,389&#160;million, up 10.8% on a reported basis and 5.2% at constant exchange rates, with double-digit growth for Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Thymoglobulin</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and a strong contribution from Toujeo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Multaq</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, partly offset by lower sales of Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Sales rose in all geographies during the period, with the strongest growth in China (+19.1% CER at &#8364;795&#160;million).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;1,310&#160;million in 2022, down 13.8% CER, reflecting lower COVID-19-related demand compared to&#160;2021, which also led to a contraction in the Low Weight Molecular Heparins market. At the same time, penetration of biosimilars increased.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">posted net sales of &#8364;1,117&#160;million, up 9.8% CER, driven by the Rest of the World region (+23.7% CER at&#160;&#8364;413&#160;million. In China, there was increased demand and a favorable comparative base, reflecting price and inventory adjustments in the fourth quarter of 2021 in anticipation of the implementation of the Value Based Procurement program for insulins. Europe also reported growth (+</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">7.1% CER at &#8364;421&#160;million).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were up by </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2.5%</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> at &#8364;983&#160;million in 2022, reflecting consistent volume growth in China (+10.3% CER at &#8364;462&#160;million) more than offset lower sales in Europe (</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">-12.2% CER) and in the US (-11.1% CER)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Multaq</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> totaled &#8364;383&#160;million in 2022, up 4.3% CER, mainly due to growth in US sales (+5.5% CER).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022 net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;376&#160;million, up 65.1% CER, reflecting a solid performance in Europe (+41.6% CER, at &#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">229&#160;million)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and an accelerated ramp-up in China due to inclusion in the National Drug Reimbursement List (NDRL) effective January&#160;2022.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">73</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Soliqua</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were up 1.5% CER at &#8364;215&#160;million in 2022. Growth was driven by the Rest of the World region (+23.5% CER at&#160;&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">67&#160;million</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), partly offset by a decrease in US sales to &#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">119&#160;million (-7.8% CER). </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Soliqua</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was approved in China in January&#160;2022, and Sanofi will work with the authorities with a view to the product being added to the NRDL.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sales of Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;207&#160;million in 2022. Since its launch, more than 1,400&#160;patients have been treated with Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (over&#160;30% of the current potential patient population worldwide), with strong persistency rates.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Core Assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, net sales of Non-Core Assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">amounted to &#8364;7,222&#160;million, down 5.5% on a reported basis and 9.0% at constant exchange rates (and down 7.4% excluding the impact of divestments), reflecting the impact of VBP in China on sales of Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Eloxatin</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Taxotere</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, along with lower sales of Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the United States.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in 2022 were down 14.4% CER at &#8364;2,259&#160;million, reflecting lower sales in the United States (-22.1% CER), impacted by prior formulary losses and erosion of the basal insulin market. In Europe, Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were down </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">10.1% at &#8364;426&#160;million, due to biosimilar competition and switches to Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. In the Rest of the World region, sales were also down, by 10.4% CER at &#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,076&#160;million, mainly as a result of the rollout of the VBP program in China in May&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In China, Sanofi participated in the VBP tender for basal insulin analogs in November&#160;2021, and was among the bidding winners in Group&#160;A with Toujeo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Lantus</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. In 2022, sales of Toujeo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and Lantus</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in China amounted to &#8364;447&#160;million (-10.7%), reflecting high volumes but at significantly lower prices.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Aprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">/Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">were &#8364;478&#160;million, up 7.6% CER, driven by regaining market share in the Rest of the World region following supply constraints in the previous year.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_202"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">4/ Net sales &#8211; Vaccines segment/GBU</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the Vaccines segment posted net sales of &#8364;7,229&#160;million, up 14.3% on a reported basis and 6.3% CER. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">he main drivers were the progressive recovery of travel vaccines (+57.8% CER, at &#8364;510&#160;million), other vaccines (+86.9% CER at &#8364;167&#160;million), and influenza vaccines (+2.4% CER at &#8364;2,977&#160;million). At the same time, </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">sales of meningitis vaccines decreased by </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">3.6% CER to</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> &#8364;703&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">influenza vaccines </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">rose by </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2.4 %</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> CER in 2022 to &#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2,977</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;million, as new manufacturing capacity in the US took influenza vaccines sales to record levels. This perfrormance was once again driven by the ongoing conversion to differentiated premium priced vaccines, such as Fluzone</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> HD in the US and Efluelda</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Europe, that have demonstrated improved efficacy against a standard dose vaccine in randomized controlled trials.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Polio/Pertussis/Hib (PPH) vaccines</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> generated net sales of &#8364;2,285&#160;million in 2022, up 2.5% CER, sustained by growth in the Rest of the World region (+</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">7.2%&#160;CER at &#8364;1,504&#160;million), especially in </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">China. In Europe, net sales of PPH vaccines were up&#160;6.9% CER at &#8364;325&#160;million, while in the United States sales were down </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">13.8%&#160;CER at &#8364;456&#160;million. As a reminder, Vaxelis</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> US sales are not consolidated, and the profits are shared equally between Sanofi and Merck &amp; co.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Meningitis/Pneumonia vaccines</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for 2022 were &#8364;703&#160;million, down 3.6% CER, mainly on lower sales in the United States (-4.9% CER at&#160;&#8364;531&#160;million). Sales in the Rest of the World region were down 8.2% CER at &#8364;157&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Booster vaccines</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> advanced by 11.3% CER to &#8364;587&#160;million, driven by the Rest of the World region.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">travel and endemics vaccines</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in 2022 were &#8364;510&#160;million, up 57.8% CER, reflecting growth across all geographies in a post-pandemic environment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net sales of other vaccines were &#8364;167&#160;million (+86.9% CER), and include sales of the recently approved monovalent recombinant-protein COVID-19 booster vaccine VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_205"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">5/ Net sales &#8211; Consumer Healthcare segment/GBU</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, net sales for the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Consumer Healthcare </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(CHC) segment increased by 13.7% on a reported basis and 8.6% at CER to &#8364;5,080&#160;million, driven by double-digit growth in Europe and the Rest of the World region. In 2022, divestments of non-core products had a negative impact of 1.0&#160;ppt. CHC therefore achieved organic growth of 9.6% in 2022 excluding divestments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">United States</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, CHC net sales amounted to &#8364;1,290&#160;million in 2022, up 0.8% CER.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Europe</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, CHC net sales were up 13.1% CER in 2022 at &#8364;1,501&#160;million, reflecting a more intense Cough &amp; Cold season.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Rest of the World </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">region, CHC net sales were up 10.0% CER at &#8364;2,289&#160;million in 2022, driven mainly by growth in Cough, Cold and Allergy products.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">74</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_208"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">6/ Net sales by geographical region</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth our net sales for 2022 and 2021 by geographical region:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:49.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change on a&#160;reported basis</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change at&#160;constant exchange rates</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,275&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,385&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+27.0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,999&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rest of the World</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,723&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,617&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which China</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,123&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+6.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">-2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Brazil</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+13.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">-2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Russia</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">575&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+17.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,997</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,761</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+7.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, net sales in the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">United States</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> reached &#8364;18,275&#160;million, up 27.0% on a reported basis and 12.2% at constant exchange rates, reflecting a strong performance from Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (+41.6 CER at &#8364;6,346&#160;million) and the Core Assets franchise (&#8364;1,653&#160;million, representing 11.6 % growth).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Europe</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, net sales advanced by 2.5% on a reported basis and 2.4% at constant exchange rates in 2022 to &#8364;9,999&#160;million. A substantial rise in sales for Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(+44.4% CER at &#8364;940&#160;million) and sales growth for the CHC GBU</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (+13.1% CER at &#8364;1,501&#160;million) more than offset lower sales for the Non Core Assets franchise (-10.9% CER).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Rest of the World</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> region, net sales for 2022 increased by 8.1% on a reported basis and 4.8% at constant exchange rates to&#160;&#8364;14,723&#160;million, due to exceptional performances from Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (+56.6% CER, at &#8364;1,007&#160;million), Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (+82.2% CER, at &#8364;79&#160;million) and Booster and Travel Vaccines. </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">China led the way in terms of growth, with net sales up </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">6.2% CER at &#8364;3,123&#160;million, driven by an acceleration in sales of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. In</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> Japan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, net sales rose by +3.1% CER to &#8364;1,613&#160;million, also on higher sales of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Sales in Turkey also registered a very strong rise (+53.4% CER at &#8364;405&#160;million). Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">was also a growth driver in </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Russia</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, with sales of the product up 88.9%. Total sales in Russia increased by 0.7% CER. In March&#160;2022, Sanofi suspended new spending not directly related to the supply of its essential medicines and vaccines in Russia. This includes advertising and promotional activities. Although the long-term repercussions of Russia&#8217;s invasion of Ukraine are difficult to predict at this time, the financial impact of the conflict in 2022, including accounts receivable and inventory reserves, was not material. During the year ended December&#160;31, 2022, the activities of our subsidiaries in Russia and Ukraine represented less than 1% of our consolidated assets and revenues.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_211"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.2.2. Other income statement items</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">1/ Other revenues</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other revenues increased by 69.2% to &#8364;2,392&#160;million in 2022 (versus &#8364;1,414&#160;million in 2021). This line item mainly comprises VaxServe sales of non-Sanofi products (&#8364;1,567&#160;million in 2022 versus &#8364;1,078&#160;million in 2021, recorded within the Vaccines segment). The year-on-year increase also reflects higher revenues from manufacturing services contracts, including those related to the COVID-19 vaccine.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">2/ Gross profit</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Gross profit for 2022 amounted to &#8364;31,694&#160;million compared with &#8364;26,920&#160;million in 2021, an increase of 17.7%. Gross margin (the ratio of gross profit to net sales) also rose, reaching 73.7% in 2022, versus 71.3% in 2021. The year-on-year increase in gross margin reflects in particular stronger gross margin for the Pharmaceuticals segment, which reached 77.7% in 2022 versus 75.2% in 2021, driven largely by productivity gains in Manufacturing &amp; Supply and a favorable portfolio mix. It also reflects an improvement in gross margin for&#160;the Vaccines segment to 66.3% in 2022 (versus 63.1% in 2021), largely due to growth in other revenues (</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">23.0%, versus 17.3% in 2021).</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">3/ Research and development expenses</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Research and development (R&amp;D) expenses amounted to &#8364;6,706&#160;million in 2022, versus &#8364;5,692&#160;million in 2021, an increase of&#160;17.8%. </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The increase was mainly due to additional expenditures </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in pharmaceuticals priority assets and early-stage projects</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, as well as the mRNA vaccines platform. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">R&amp;D expenses represented 15.6% of net sales in 2022, versus 15.1% in 2021.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">4/ Selling and general expenses</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Selling and general expenses amounted to &#8364;10,492&#160;million in 2022 (24.4% of net sales), versus &#8364;9,555&#160;million in 2021 (25.3% of net sales); the 9.8% increase was a result of increased promotional </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">expenditures</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, mainly in Specialty Care. The reduction in the ratio of selling and general expenses to net sales was due to operational excellence.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">5/ Other operating income and expenses</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other operating income amounted to &#8364;1,969&#160;million in 2022 (versus &#8364;859&#160;million in 2021), and other operating expenses to&#160;&#8364;2,531&#160;million, versus &#8364;1,805&#160;million in 2021.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">75</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Overall, this represented a net expense of &#8364;562&#160;million in 2022, compared with a net expense of &#8364;946&#160;million in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:61.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1,110&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,531)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other operating income/(expenses), net</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(562)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(946)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+384</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The increase of &#8364;384&#160;million mainly reflects&#160;(i)&#160;an increase of &#8364;237 million in gains on asset disposals and (ii)&#160;a decrease of &#8364;142 million in the net expense relating to our pharmaceutical alliance partners, following the recognition of the proceeds derived from the restructuring of the Immuno-Oncology (IO) collaboration agreement between Sanofi and Regeneron applicable effective July&#160;1, 2022 (see Note&#160;C.1. to our consolidated financial statements, included at Item 18 of this Annual Report on Form 20-F); those effects were partly offset by an increase in the share of profits/losses generated by the Regeneron alliance under the collaboration agreement (see Note C.1. to our consolidated financial statements due mainly to higher sales of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2021, other operating income also includes a payment of &#8364;119&#160;million received from Daiichi Sankyo relating to the ending of a vaccines collaboration agreement in Japan.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The contribution of our alliance with Regeneron to this line item is as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:74.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income &amp; expense related to (profit)/loss sharing under the Monoclonal Antibody Alliance</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,325)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,253)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional share of profit paid by Regeneron towards development costs </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reimbursement to Regeneron of selling expenses incurred</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(476)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total: Monoclonal Antibody Alliance</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,367)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,429)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Immuno-Oncology Alliance</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">68</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other (mainly Zaltrap</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"> and Libtayo</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,120</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other operating income/(expenses), net related to the Regeneron Alliance</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,231)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,373)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Following the restructuring of the Immuno-Oncology (IO) collaboration agreement between Sanofi and Regeneron effective July&#160;1, 2022 (see Note&#160;C. to our consolidated financial statements, included at Item&#160;18. of this Annual Report on Form&#160;20-F).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) As of December 31, 2022, the commitment received by Sanofi in respect of the additional profit share payable by Regeneron towards development costs amounted</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">6/ Amortization of intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amortization charged against intangible assets amounted to &#8364;2,053&#160;million in 2022, compared with &#8364;1,580&#160;million in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This &#8364;473&#160;million increase was mainly due to (i)&#160;an accelerated amortization charge of &#8364;226&#160;million taken against Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> rights following the restructuring of the IO LCA with Regeneron (see Note&#160;C.1. to our consolidated financial statements, included at Item&#160;18. of this Annual report on Form&#160;20-F); and (ii) the impact of the acquisition of Kadmon in November&#160;2021, which triggered the amortization of the intangible asset relating to Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as from that date (&#8364;159&#160;million).</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">7/ Impairment of intangible assets, net of reversals</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2022, this line shows a net gain of &#8364;454&#160;million, mainly comprising:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">- &#160;&#160;&#160;&#160;a reversal of &#8364;2,154 million relating to Eloctate franchise assets, following FDA approval of the marketing authorization request for ALTUVIIIO&#8482; (the commercial name of efanesoctocog alpha, corresponding to the BIVV001 project); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">- &#160;&#160;&#160;&#160;an impairment loss of &#8364;1,586&#160;million relating to the development project for SAR444245 (non-alpha interleukin-2), based on revised cash flow projections reflecting unfavorable developments in the launch schedule.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2021, this line item shows net impairment losses of &#8364;192&#160;million taken against intangible assets, relating primarily to the discontinuation of the development of sutimlimab in Immune Thrombocytopenic Purpura (ITP) and the termination of various research projects in Vaccines.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">8/ Fair value remeasurement of contingent consideration</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Fair value remeasurements of contingent consideration recognized in acquisitions represented a net gain of &#8364;27&#160;million in 2022, versus a net loss of &#8364;4&#160;million in 2021.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">9/ Restructuring costs and similar items</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restructuring costs and similar items represented a total charge of &#8364;1,336&#160;million in 2022, versus a charge of &#8364;820&#160;million in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount charged in 2022 includes employee-related expenses of &#8364;507&#160;million and net expenses, gains and losses on assets (including asset write-downs and accelerated depreciation and amortization) of &#8364;261&#160;million. The year-on-year increase mainly reflects provisions for separation costs associated with announcements made in 2022. Charges, gains and losses on assets mainly reflect a strategic decision to close an industrial facility outside France. The costs of Sanofi's transformation program (as defined in Note&#160;B.19. to our consolidated financial statements, included at Item&#160;18. of this Annual Report on Form&#160;20-F) amounted to &#8364;547 million in 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2021, restructuring costs and similar items represented a total charge of &#8364;820&#160;million, including employee-related expenses of&#160;&#8364;193&#160;million, relating primarily to the creation of the new standalone Consumer Healthcare entity and of EUROAPI (the new </span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">76</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">European market leader in active pharmaceutical ingredients), and to the implementation of Sanofi&#8217;s new digital strategy. The&#160;2021 figure also includes net expenses, gains and losses on assets (including asset write-downs and accelerated depreciation and amortization) of &#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">110&#160;million</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">10/ Other gains and losses, and litigation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2022, this line item showed a net loss of &#8364;370&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">million, </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">including the pre-tax loss arising on the deconsolidation of EUROAPI (see Note&#160;D.1. to our consolidated financial statements, included at Item&#160;18. of this Annual Report on Form&#160;20-F) and costs associated with major litigation (including estimated future defense costs to which Sanofi may be exposed in connection with the Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> litigation)</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2021, this line item shows a net loss of &#8364;5&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">11/ Operating income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Operating income amounted to &#8364;10,656&#160;million in 2022, versus &#8364;8,126&#160;million in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The year-on-year increase was largely due to the reversal of imparment losses totaling &#8364;2,154 million following the approval by the FDA on February 22, 2023 of the marketing authorization application for ALTUVIIIO&#8482;, part of the Eloctate franchise.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">12/ Financial income and expenses</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net financial expenses were &#8364;234&#160;million in 2022, versus &#8364;328&#160;million in 2021, a decrease of &#8364;94&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The cost of our net debt (see the definition in &#8220;B.&#160;Liquidity and Capital Resources&#8221; below) was &#8364;124&#160;million in 2022, compared with&#160;&#8364;259&#160;million in 2021; the reduction of &#8364;135&#160;million was largely due to an increased return on cash, cash equivalents and associated derivatives (&#8364;241&#160;million in 2022 versus &#8364;54&#160;million in 2021, an increase of &#8364;187&#160;million).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A further factor was an increase in expenses arising from the unwinding of discounting of provisions and net interest costs on employee benefits and leases, which amounted to &#8364;107&#160;million in 2022 compared with &#8364;90&#160;million in 2021, a rise of &#8364;17&#160;million (see Note&#160;D.29. to our consolidated financial statements, included at Item&#160;18. of this Annual Report on Form&#160;20-F).</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">13/ Income before tax and investments accounted for using the equity method</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Income before tax and investments accounted for using the equity method reached &#8364;10,422&#160;million in 2022, versus &#8364;7,798&#160;million in 2021.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">14/ Income tax expense</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Income tax expense represented &#8364;2,006&#160;million in 2022, versus &#8364;1,558&#160;million in 2021, giving an effective tax rate based on consolidated net income of 19.2% in 2022, compared with 20.0% in 2021. The increase in income tax expense was mainly due to taxation of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> income from out-licensing (&#8364;246 million in 2022) and the reversal of impairment losses relating to ALTUVIIIO&#8482; (&#8364;503 million in 2022) following FDA approval. The increase in tax expense is partly offset by the positive tax effect of the divestment of a 70% equity interest in EUROAPI recognized in the period (&#8364;111 million in 2022).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The effective tax rate on our business net income is a non-IFRS financial measure (see definition under &#8220;A.1.5.&#160;Segment information &#8212;&#160;3.&#160;Business Net Income&#8221; above). It is calculated on the basis of business operating income, minus net financial expenses and before (i)&#160;the share of profit/loss from investments accounted for using the equity method and (ii)&#160;net income attributable to non-controlling interests. We believe the presentation of this measure, used by our management, is also useful for investors as it provides a means to analyze the effective tax cost of our current business activities. It should not be seen as a substitute for the effective tax rate based on consolidated net income.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When calculated on business net income, our effective tax rate was 19.3% in 2022, compared with 20.9% in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below reconciles our effective tax rate based on consolidated net income to our effective tax rate based on business net income:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:74.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(as a percentage)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective tax rate based on consolidated net income</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20.0</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax effects:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization and impairment of intangible assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective tax rate based on business net income</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.3</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">15/ Share of profit/(loss) from investments accounted for using the equity method</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Investments accounted for using the equity method contributed net income of &#8364;68&#160;million in 2022, versus &#8364;39&#160;million in 2021.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">16/ Net income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net income amounted to &#8364;8,484&#160;million in 2022, compared with &#8364;6,279&#160;million in 2021.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">17/ Net income attributable to non-controlling interests</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net income attributable to non-controlling interests was &#8364;113&#160;million in 2022, versus &#8364;56&#160;million in 2021.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">77</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">18/ Net income attributable to equity holders of Sanofi</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net income attributable to equity holders of Sanofi amounted to &#8364;8,371&#160;million in 2022, compared with &#8364;6,223&#160;million in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Basic earnings per share for 2022 was &#8364;6.69 versus &#8364;4.97 for 2021, based on an average number of shares outstanding of&#160;1,251.9&#160;million in 2022 and 1,252.5&#160;million in 2021. Diluted earnings per share for 2022 was &#8364;6.66 versus &#8364;4.95 for 2021, based on an average number of shares after dilution of 1,256.9&#160;million in 2022 and 1,257.9&#160;million in 2021.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_214"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.2.3. Segment results</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our business operating income, as defined in Note&#160;D.35. (&#8220;Segment information&#8221;) to our consolidated financial statements, amounted to&#160;&#8364;13,040&#160;million in 2022, compared with &#8364;10,714&#160;million in 2021, an increase of 21.7%. That represents 30.3% of our net sales, compared with 28.4% in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth our business operating income for the years ended December 31, 2022 and 2021:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:55.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,043&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,409&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+17.4&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As percentage of sales</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+34.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vaccines</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,168&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,609&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+21.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As percentage of sales</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+41.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Consumer Healthcare</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,810&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+21.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As percentage of sales</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+33.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,981)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,797)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Business operating income (non-IFRS Financial measure)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,040</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,714</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+21.7</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div id="i52f57172a9d7443580346c2d8f39cd2b_217"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B. Liquidity and capital resources</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our operations generate significant positive cash flows. We fund our day-to-day investments (with the exception of significant acquisitions) primarily with operating cash flow, and pay regular dividends on our shares.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Net debt&#8221; is a non-IFRS financial indicator which is reviewed by our management, and which we believe provides useful information to measure our overall liquidity and capital resources. We define &#8220;net debt&#8221; as (i)&#160;the sum total of short term debt, long term debt, and interest rate derivatives and currency derivatives used to manage debt, minus (ii)&#160;the sum total of cash and cash equivalents and interest rate derivatives and currency derivatives used to manage cash and cash equivalents. Lease liabilities are not included in net debt.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022 our net debt was &#8364;6,437&#160;million, compared with &#8364;9,983&#160;million as of December 31, 2021 mainly reflecting the free cash flow generated in the year as described below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order to assess our financing risk, we also use the &#8220;gearing ratio&#8221;, a non-IFRS financial measure (see table in section&#160;&#8220;B.2.&#160;Consolidated Balance Sheet and Debt&#8221; below). We define the gearing ratio as the ratio of net debt to total equity. As of&#160;December 31, 2022, our gearing ratio was 8.6%, compared with 14.5% as of December 31, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because our net debt and gearing ratio are not standardized measures, they may not be directly comparable with the non-IFRS financial measures of other companies using the same or similar non-IFRS financial measures. Despite the use of non-IFRS measures by management in setting goals and measuring performance, these are non-IFRS measures that have no standardized meaning prescribed by IFRS.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_220"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.1. Consolidated statement of cash flows</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Generally, factors that affect our earnings &#8211;&#160;for example, pricing, volume, costs and exchange rates&#160;&#8211; flow through to cash from operations. The most significant source of cash from operations is sales of our branded pharmaceutical products and vaccines. Receipts of royalty payments also contribute to cash from operations.</span></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Summarized consolidated statements of cash flows</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:70.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net cash provided by/(used in) operating activities</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,526&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,522&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net cash provided by/(used in) investing activities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,075)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,298)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net cash provided by/(used in) financing activities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,821)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,056)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impact of exchange rates on cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,638</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,817)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="i52f57172a9d7443580346c2d8f39cd2b_223"></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net cash provided by/used in operating activities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> represented a net cash inflow of</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8364;10,526&#160;million in 2022, compared with&#160;&#8364;10,522&#160;million in 2021. This increase mainly resulted from an improvement in operating cash flow before changes in working capital (which amounted to &#8364;11,233&#160;million in 2022, versus &#8364;9,113&#160;million in 2021) and a net reduction of &#8364;707&#160;million in the working capital requirement in 2022, versus a net increase of &#8364;1,409&#160;million in 2021.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">78</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net cash provided by/used in investing activities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">represented a net cash outflow of &#8364;2,075&#160;million in 2022, compared with a net outflow of &#8364;7,298&#160;million in 2021. In 2022, the net cash outflow was mainly due to the acquisition of Amunix Pharmaceuticals, Inc (&#8364;852&#160;million), partly offset by the proceeds of &#8364;150&#160;million from the sale of a 12% equity interest in EUROAPI to EPIC Bpifrance. The net cash outflow in 2021 was attributable mainly to the acquisitions of Translate&#160;Bio (&#8364;2,333&#160;million), Kadmon</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (&#8364;1,575&#160;million), Kymab (&#8364;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">932 million), Kiadis (326 million), Tidal (&#8364;135&#160;million) and Origimm (&#8364;5</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">0&#160;million)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acquisitions of property, plant and equipment and intangible assets amounted to &#8364;2,201&#160;million, versus &#8364;2,043&#160;million in 2021. There were&#160;&#8364;1,606&#160;million of acquisitions of property, plant and equipment (versus &#8364;1,479&#160;million in 2021), most of which (&#8364;1,025&#160;million) related to the Pharmaceuticals segment, primarily in industrial facilities. The Vaccines segment accounted for&#160;&#8364;504&#160;million of acquisitions of property, plant and equipment during 2022. Acquisitions of intangible assets (&#8364;595&#160;million, versus &#8364;564&#160;million in 2021) mainly comprised contractual payments for intangible rights under license and collaboration agreements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">After-tax proceeds from disposals (&#8364;1,488&#160;million in 2022, &#8364;676&#160;million in 2021) included divestments of assets and activities related to the streamlining of the portfolio, and disposals of equity and debt instruments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net cash provided by/used in financing activities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">represented a net cash outflow of &#8364;5,821&#160;million in 2022, compared with a net cash outflow of &#8364;7,056&#160;million in 2021. The 2022 figure includes the redemption of bond issues totaling &#8364;2,700&#160;million, and a new bond issue of &#8364;1,500&#160;million carried out in April&#160;2022. Other movements included the dividend payout to our shareholders of&#160;&#8364;4,168&#160;million (versus &#8364;4,008&#160;million in 2021), and the effect of changes in our share capital (repurchases of our own shares, net of capital increases), representing a net cash outflow of&#160;&#8364;309&#160;million in 2022 versus a net cash outflow of &#8364;196&#160;million in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">net change in cash and cash equivalents</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in 2022 was an increase of &#8364;2,638&#160;million, versus an increase of &#8364;3,817&#160;million in&#160;2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8220;Free cash flow&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2022 was &#8364;8,483&#160;million, an increase on the 2021 figure of &#8364;8,096&#160;million. This reflects our operational performance (including the effect of cost containment measures), and proceeds from disposal made during the period (see the table below).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Free cash flow&#8221; is a non-IFRS financial indicator which is reviewed by our management, and which we believe provides useful information to measure the net cash generated from our operations that is available for strategic investments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(14)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (net of divestments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), for debt repayment, and for payments to shareholders. &#8220;Free cash flow&#8221; is determined from our &#8220;Business net income&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(15)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> after adding back (in the case of expenses and losses) or deducting (in the case of income and gains) the following items: depreciation, amortization and impairment, share of undistributed earnings from investments accounted for using the equity method, gains &amp; losses on disposals, net change in provisions including pensions and other post-employment benefits, deferred taxes, share-based payment expense and other non-cash items. It also includes net changes in working capital, capital expenditures and other asset acquisitions</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(16)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> net of disposal proceeds</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, and payments related to restructuring and similar items. &#8220;Free cash flow&#8221; is not defined by IFRS, and is not a substitute for </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net cash provided by operating activities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> as reported under IFRS. Management recognizes that the term &#8220;Free cash flow&#8221; may be interpreted differently by other companies and under different circumstances.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth a reconciliation between</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Net cash provided by operating activities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and &#8220;Free cash flow&#8221;:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:72.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.611%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by operating activities (IFRS)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,526</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,522</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment and software</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,656)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,516)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of intangible assets, equity interests and other non-current financial assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(824)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,488)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from disposals of property, plant and equipment, intangible assets and other </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">non-current assets, net of tax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repayments of lease liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(149)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other items</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(803)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Free cash flow (non-IFRS Financial measure)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,483</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,096</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.98pt">Free cash flow includes investments and divestments not exceeding a cap of &#8364;500&#160;million per transaction.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.92pt">Cash outflows relating to repayments of the principal portion of lease liabilities (IFRS&#160;16) are included in free cash flow.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:3.36pt">In 2022, includes an upfront payment of $900 million and a regulatory milestone payment of $100&#160;million related to the granting of the Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">license.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(14)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Above a cap of &#8364;500&#160;million per transaction.</span></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(15)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Non-IFRS financial measure, as defined in "&#8212;&#160;A.1.5. &#8212;&#160;Segment Information &#8212;&#160;3.&#160;Business Net income" above.</span></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(16)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Not exceeding a cap of &#8364;500&#160;million per transaction.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">79</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_226"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.2. Consolidated balance sheet and debt</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Total assets were &#8364;126,722&#160;million as of December 31, 2022, compared with &#8364;120,242&#160;million as of December 31, 2021, an increase of&#160;&#8364;6,480&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Total </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">equity </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">was &#8364;75,152&#160;million as of December 31, 2022, versus &#8364;69,031&#160;million as of December 31, 2021. The year-on-year net change reflects the following principal factors:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">increases: our net income for 2022 (&#8364;8,484&#160;million), and positive currency translation differences (&#8364;2,278&#160;million); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">decreases: the dividend paid to our shareholders in respect of the 2021 financial year (&#8364;4,168&#160;million), and repurchases of our own shares (&#8364;497&#160;million).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net debt</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">was &#8364;6,437&#160;million as of December 31, 2022, versus &#8364;9,983&#160;million as of December 31, 2021. The decrease in 2022 reflects the &#8364;8,483&#160;million of free cash flow generated in the year, more than offsetting cash outflows that included </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8364;992&#160;million on </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">acquisitions of consolidated entities and the &#8364;4,168&#160;million dividend payout to our shareholders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Net debt&#8221; is a non-IFRS financial measure which is reviewed by our management, and which we believe provides useful information to measure our overall liquidity and capital resources. We define &#8220;net debt&#8221; as (i)&#160;the sum total of short term debt, long term debt, and interest rate derivatives and currency derivatives used to manage debt, minus (ii)&#160;the sum total of cash and cash equivalents and interest rate derivatives and currency derivatives used to manage cash and cash equivalents.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:70.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,857</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,123</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,174</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,183</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-56</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,218</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,250</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12,736</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-10,098</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-45</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-169</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a) </span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(IFRS)</span></div></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,437</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,983</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,152</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69,031</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gearing ratio (non-IFRS financial measure)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.6</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.5</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.98pt">Net debt does not include lease liabilities, which amounted to &#8364;2,181&#160;million as of December&#160;31, 2022 and &#8364;2,108&#160;million as of December&#160;31, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To assess our financing risk, we use the &#8220;gearing ratio&#8221;, a non-IFRS financial measure. This ratio (which we define as the ratio of net debt to total equity) decreased from 14.5% as of December&#160;31, 2021 to 8.6% as of December&#160;31, 2022. Analyses of debt as of&#160;December 31, 2022 and December 31, 2021, by type, maturity, interest rate and currency, are provided in Note&#160;D.17.1. to our consolidated financial statements, included at Item&#160;18. of this Annual Report on Form&#160;20-F.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We expect that the future cash flows generated by our operating activities will be sufficient to repay our debt. The financing arrangements in place as of December&#160;31, 2022 at the Sanofi parent company level are not subject to covenants regarding financial ratios and do not contain any clauses linking fees to Sanofi&#8217;s credit rating.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, we held 8.2&#160;million of our own shares, recorded as a deduction from equity and representing 0.65% of our share&#160;capital.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other intangible assets </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(&#8364;71,532&#160;million in total) increased by &#8364;2,069&#160;million year-on-year, the main factors being the acquisition of Amunix, partly offset by impairment losses net of impairment reversals recognized on certain intangible assets (in particular, an impairment loss against IL-2, and a reversal relating to Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> franchise assets).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(&#8364;677&#160;million) increased by &#8364;427&#160;million, mainly reflecting the equity investment of EUROAPI from May&#160;10, 2022 (see Note&#160;D.1. to our consolidated financial statements, included at Item&#160;18. of this Annual Report on Form&#160;20-F)</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other non-current assets </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">amounted to &#8364;3,095&#160;million, a year-on-year decrease of &#8364;32&#160;million, with a reduction in funds held to cover pension obligations partly offset by an increase in prepaid expenses.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Net deferred tax assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> amounted to &#8364;3,540&#160;million as of December 31, 2022, versus &#8364;2,981&#160;million as of December 31, 2021, a year-on-year increase of &#8364;559&#160;million. This mainly reflects deferred taxes arising on the capitalization of R&amp;D expenses,  and consolidation adjustments for intragroup margin in inventory.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Non-current provisions and other non-current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (&#8364;6,341&#160;million) showed a decrease of &#8364;380&#160;million, mainly related to actuarial gains on defined-benefit plans (recognized in Other comprehensive income).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations and to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (&#8364;779&#160;million) were &#8364;65&#160;million higher year-on-year. The main movement in this line item during 2022 was the recognition of</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> the &#8364;156&#160;million </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">contingent consideration liability arising on the acquisition of Amunix.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">80</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_229"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.3. Liquidity</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We expect that our existing cash resources and cash from operations will be sufficient to finance our foreseeable working capital requirements, in both the short term (i.e. the 12&#160;months following the year ended December&#160;31, 2022) and the long term (i.e.&#160;beyond such additional 12-month period). At year-end 2022, we held cash and cash equivalents amounting to &#8364;12,736&#160;million, substantially all of which were held in&#160;euros (see Note&#160;D.13. to our consolidated financial statements, included at Item&#160;18. of this Annual Report on Form&#160;20-F). As at December 31, 2022, &#8364;439 million of our cash and cash equivalents were held by captive insurance and reinsurance companies in accordance with insurance regulations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We run the risk of delayed payments or even non-payment by our customers, who consist principally of wholesalers, distributors, pharmacies, hospitals, clinics and government agencies (see &#8220;Item&#160;3.D.&#160;Risk Factors &#8212;&#160;2.&#160;Risks Relating to Our Business &#8212;&#160;We are subject to the risk of non-payment by our customers&#8221;). Deteriorating credit and economic conditions and other factors in some countries have resulted in, and may continue to result in an increase in the average length of time taken to collect our accounts receivable in these countries. Should these factors continue, it may require us to re-evaluate the collectability of these receivables in future periods. We carefully monitor sovereign debt issues and economic conditions and evaluate accounts receivable in these countries for potential collection risks. We have been conducting an active recovery policy, adapted to each country and including intense communication with customers, negotiations of payment plans, charging of interest for late payments, and legal action. Over our business as a whole, the amount of trade receivables overdue by more than 12&#160;months (which primarily consists of amounts due from public sector bodies) decreased from &#8364;56&#160;million as of December&#160;31, 2021 to&#160;&#8364;51&#160;million as of December 31, 2022 (see Note&#160;D.10. to our consolidated financial statements).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At year-end 2022, we had no commitments for capital expenditures that we consider to be material to our consolidated financial position. Undrawn confirmed credit facilities amounted to a total of &#8364;8,000&#160;million at December 31, 2022. For a discussion of our treasury policies, see &#8220;Item&#160;11. Quantitative and Qualitative Disclosures about Market Risk.&#8221;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We expect that cash from our operations will be sufficient to repay our debt. For a discussion of our liquidity risks, see&#160;&#8220;Item&#160;11.&#160;Quantitative and Qualitative Disclosures about Market Risk.&#8221;</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_232"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C. Off balance sheet arrangements/Contractual obligations and&#160;other commercial commitments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have various contractual obligations and other commercial commitments arising from our operations. Our contractual obligations and our other commercial commitments as of December 31, 2022 are shown in Notes&#160;D.3., D.17., D.18., and D.21. to our consolidated financial statements, included at Item&#160;18. of this annual report. Note&#160;D.21. to our consolidated financial statements discloses details of commitments under our principal research and development collaboration agreements. For a description of the principal contingencies arising from certain business divestitures, refer to Note&#160;D.22.d.) to our 2022 consolidated financial statements.</span></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Sanofi&#8217;s contractual obligations and other commercial commitments are set forth in the table below</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:47.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less than<br/>1 year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1 to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3 to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5 years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Future&#160;contractual cash flows&#160;relating&#160;to&#160;debt&#160;and&#160;debt hedging instruments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,617</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,230</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,769</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,529</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,089</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principal payments related to lease liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,400</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">320</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">515</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">436</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,129</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other lease obligations (with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">38</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Irrevocable purchase commitments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">given</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,921</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,957</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,922</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,062</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">980</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">received</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,025)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(482)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(335)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(86)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(122)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research&#160;&amp; development license agreements</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Commitments related to R&amp;D and other commitments</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">259</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">197</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Potential milestone payments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,919</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">203</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">875</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">889</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">952</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Obligations relating to business combinations</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">604</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">145</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">355</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Estimated benefit payments on unfunded pensions and post employment benefits</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,188</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">74</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">116</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">139</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">859</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total contractual obligations and other commitments</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,921</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,629</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,050</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,982</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,260</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Undrawn general-purpose credit facilities</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) See Note&#160;D.17.1. to our consolidated financial statements, included at Item&#160;18. of this annual report.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) See Note&#160;D.17.2. to our consolidated financial statements, included at Item&#160;18. of this annual report.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) See Note&#160;D.21.1. to our consolidated financial statements, included at Item&#160;18. of this annual report.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) These comprise irrevocable commitments to suppliers of (i)&#160;property, plant and equipment, net of down payments (see Note&#160;D.3. to our consolidated financial statements, included at Item&#160;18. of this annual report) and (ii)&#160;goods and services.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) This line includes all potential milestone payments on projects regarded as reasonably possible, i.e. on projects in the development phase.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(f) See Note&#160;D.18. to our consolidated financial statements, included at Item&#160;18. of this annual report.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g) See Note&#160;D.19.1. to our consolidated financial statements, included at Item&#160;18. of this annual report. The table above does not include ongoing annual employer&#8217;s contributions to plan assets, estimated at &#8364;38&#160;million for 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">81</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;5. Operating and financial review and prospects</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We may have payments due to our current or former research and development partners under collaboration agreements. These agreements typically cover multiple products, and give us the option to participate in development on a product-by-product basis. When we exercise our option with respect to a product, we pay our collaboration partner a fee and receive intellectual property rights to the product in exchange. We are also generally required to fund some or all of the development costs for the products that we select, and to make payments to our partners when those products reach development milestones.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have entered into collaboration agreements under which we have rights to acquire products or technology from third parties through the acquisition of shares, loans, license agreements, joint development, co-marketing and other contractual arrangements. In addition to upfront payments on signature of the agreement, our contracts frequently require us to make payments contingent upon the completion of development milestones by our alliance partner or upon the granting of approvals or licenses.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because of the uncertain nature of development work, it is impossible to predict (i)&#160;whether Sanofi will exercise further options for products, or (ii)&#160;whether the expected milestones will be achieved, or (iii)&#160;the number of compounds that will reach the relevant milestones. It is therefore impossible to estimate the maximum aggregate amount that Sanofi will actually pay in the future under existing collaboration agreements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Given the nature of its business, it is highly unlikely that Sanofi will exercise all options for all products or that all milestones will be achieved.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main collaboration agreements relating to development projects are described in Note&#160;D.21.1. to our consolidated financial statements, included at Item&#160;18. of this annual report. Milestone payments relating to development projects under these agreements included in the table above exclude projects still in the research phase (&#8364;18.0&#160;billion in 2022, and &#8364;6.7&#160;billion in 2021) and payments contingent upon the attainment of sales targets once a product is on the market (&#8364;18.5&#160;billion in 2022, and&#160;&#8364;8.1&#160;billion in 2021).</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">82</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_235"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;6. Directors, Senior Management and Employees</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_238"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.&#160;Directors and Senior Management</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since January&#160;1, 2007, Sanofi has separated the offices of Chairman and Chief Executive Officer. Annual evaluations conducted since that date have indicated that this governance structure is appropriate to Sanofi&#8217;s current configuration. With the term of office of the current Chairman, Serge Weinberg, coming to an end, the Board of Directors has decided to continue separating the offices of Chairman and Chief Executive Officer. The Board believes this governance structure is still appropriate to the current context in which Sanofi operates and its share ownership structure, as well as protecting the rights of all of its stakeholders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Chairman</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> organizes and directs the work of the Board, and is responsible for ensuring the proper functioning of the corporate decision-making bodies in compliance with good governance principles. The Chairman coordinates the work of the Board of Directors with that of its Committees. He ensures that the Company&#8217;s management bodies function properly, and in particular that the directors are able to fulfil their duties. The Chairman is accountable to the Shareholders&#8217; General Meeting, which he chairs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition to these roles conferred by law, the Chairman:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in coordination with the Chief Executive Officer, liaises between the Board of Directors and the shareholders of the Company;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">is kept regularly informed by the Chief Executive Officer of significant events and situations affecting the affairs of the Company, and may request from the Chief Executive Officer any information useful to the Board of Directors;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">may, in close collaboration with the Chief Executive Officer, represent the Company in high-level dealings with governmental bodies and with key partners of the Company and/or of its subsidiaries, both nationally and internationally;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">seeks to prevent any conflict of interest and manages any situation that might give rise to a conflict of interest. He also gives rulings, in the name of the Board, on requests to take up external directorships of which he may become aware or that may be submitted to him by a director;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">may interview the statutory auditors in preparation for the work of the Board of Directors and the Audit Committee; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">strives to promote in all circumstances the values and image of the Company.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chairman is also required to develop and maintain a proper relationship of trust between the Board and the Chief Executive Officer, so as to ensure that the latter consistently and continuously implements the orientations determined by the Board.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In fulfilling his remit, the Chairman may meet with any individual, including senior executives of the Company, while avoiding any involvement in directing the Company or managing its operations, which are exclusively the responsibility of the Chief Executive Officer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, the Chairman reports to the Board on the fulfilment of his remit.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chairman carries out his duties during the entire period of his term of office, subject to the caveat that a director who is a natural person may not be appointed or reappointed once that director has reached the age of&#160;70.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Chief Executive Officer</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> manages the Company, and represents it in dealings with third parties within the limit of the corporate purpose. The Chief Executive Officer has the broadest powers to act in all circumstances in the name of the Company, subject to the powers that are attributed by law to the Board of Directors and to the Shareholders&#8217; General Meeting and within the limits set by the Board of Directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chief Executive Officer must be less than 65&#160;years old.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Limitations on the powers of the Chief Executive Officer set by&#160;the&#160;Board</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">With effect from March&#160;6, 2018, the limitations on the powers of the Chief Executive Officer are specified in the Board Charter. Without prejudice to legal provisions regarding authorizations that must be granted by the Board (regulated agreements, guarantees, divestments of equity holdings or real estate,&#160;etc.), prior approval from the Board of Directors is required for transactions or decisions resulting in an investment or divestment, or an expenditure or guarantee commitment, made by the Company and its subsidiaries, in excess of:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a cap of &#8364;500&#160;million (per transaction) for transactions, decisions or commitments pertaining to a previously approved strategy; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a cap of &#8364;150&#160;million (per transaction) for transactions, decisions or commitments not pertaining to a previously approved strategy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When such transactions, decisions or commitments give rise to installment payments to the contracting third party (or parties) that are contingent upon future results or objectives, such as the registration of one or more products, attainment of the caps is calculated by aggregating the various payments due from signature of the contract until (and including) the filing of the first application for marketing authorization in the United States or in Europe.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">83</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Attainment of the above caps is also assessed after taking into account all commitments to make payments upon exercising a firm or conditional option with immediate or deferred effect, and all guarantees or collateral to be provided to third parties over the duration of such commitments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The prior approval procedure does not apply to transactions and decisions that result in the signature of agreements that solely involve subsidiaries and the Company itself.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Board of Directors</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Composition</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 our Board of Directors had 16 directors, including ten independent directors and two directors representing employees. It also has one non-voting member since September 2, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Each year, the Board of Directors conducts a review to ensure that there is an appropriate balance in its composition and in the composition of its Committees. In particular, the Board seeks to ensure gender balance and a broad diversity of competencies, experiences, nationalities and ages, reflecting our status as a diversified global business. The Board investigates and evaluates not only potential candidates, but also whether existing directors should seek reappointment. Above all, the Board seeks directors who show independence of mind and are competent, dedicated and committed, with compatible and complementary personalities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">43% of the directors (excluding directors representing employees and the non-voting member, in accordance with regulations) are women, and 47% of the directors (including directors representing employees and the non-voting member) are non-French nationals.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acting on proposals from the Chief Executive Officer and in liaison with the Appointments, Governance and CSR Committee, the Board sets objectives for gender balance on Sanofi&#8217;s executive bodies, and more generally ensures that an inclusion (non-discrimination) and diversity policy is applied within the Company. That policy is fully embedded in our Play to Win strategy. As of December&#160;31, 2022, 20% of the ten&#160;Executive Committee members were women, and 73% were non-French nationals. For more details on changes to our Executive Committee, see the section entitled &#8220;Executive Committee&#8221; below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors is also kept informed, in particular on the occasion of its annual discussion on equal opportunity and equal pay policy, on how Sanofi's inclusion and diversity policy is cascaded down to &#8220;Senior Leaders&#8221; and &#8220;Executives&#8221; (the positions in Sanofi with the highest level of responsibility).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Mission</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors establishes the orientation of the Company's activities and ensures that they are implemented, paying due consideration to social and environmental issues. Subject to those powers expressly attributed to Shareholders&#8217; General Meetings and within the limits set by the corporate purpose, it addresses any issue of relevance to the proper conduct of the Company&#8217;s affairs and, through its deliberations, settles matters concerning the Company.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board monitors progress on our CSR strategy, as recalibrated in 2021, paying particularly close attention to tracking delivery on our CSR program including our climate commitments. Since 2020, 15% of the annual variable compensation of our CEO has been linked to CSR criteria, including an objective to cut our greenhouse gas emissions; and starting in 2023, our equity-based compensation plans will also include CSR criteria - see section B. below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board committees are also involved in sustainable development issues &#8211; see section &#8220;&#8212; C. Board practices below&#8221; &#8211; and their members work together on specific topics. For example, discussions have taken place between the Compensation Committee and the Appointments, Governance &amp; CSR Committee on determination of the extra-financial criteria applicable to the various elements of compensation awarded to the Chief Executive Officer and other beneficiaries of variable compensation (annual variable compensation, equity-based compensation).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The rules and operating procedures of our Board of Directors are defined by law, by our Articles of Association, and by our Board&#160;Charter (English language versions of which are reproduced in full as Exhibit&#160;1.1 and Exhibit&#160;1.2 to this Annual Report on Form&#160;20-F).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Term of Office</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The term of office of directors is four years. Directors are required to seek reappointment by rotation, such that members of the Board are required to seek reappointment on a regular basis in the most equal proportions possible. Exceptionally, the Shareholders&#8217; Ordinary General Meeting may appoint a director to serve for a term of one, two or three years, in order to ensure adequate rotation of Board members. Each director standing down is eligible for reappointment. Should one or more directorships fall vacant as a result of death or resignation, the Board of Directors may make provisional appointments in the period between two Shareholders&#8217; General Meetings, in accordance with applicable laws.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Directors may be removed from office at any time by a Shareholders&#8217; General Meeting.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A natural person cannot be appointed or reappointed as a director once he or she reaches the age of&#160;70. As soon as the number of directors aged over&#160;70 represents more than one-third of the directors in office, the oldest director shall be deemed to have resigned; his or her term of office shall end at the date of the next Shareholders&#8217; Ordinary General Meeting.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">84</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Selection Process for Board members</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Appointments, Governance and CSR Committee has a remit to organize a procedure for selecting future independent directors. Once the desired profile and skillset for a new director has been defined, a search for potential candidates is conducted by external consultants.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Once a shortlist has been established, the Committee interviews two or three candidates. After completing the interviews, the Committee makes a recommendation to the Board on the candidate with the best fit for the profile, supporting that recommendation with an explanation of how the interviews were conducted and giving reasons why a candidate was selected.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of selection process for Board members</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.276%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.276%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.276%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.276%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.646%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b38ef4;padding:0 1pt"></td><td colspan="3" style="background-color:#b38ef4;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Definition of profile and skillset</span></td><td colspan="3" style="background-color:#b38ef4;padding:0 1pt"></td><td colspan="3" style="background-color:#8c56ee;padding:0 1pt"></td><td colspan="3" style="background-color:#8c56ee;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Search</span></td><td colspan="3" style="background-color:#8c56ee;padding:0 1pt"></td><td colspan="3" style="background-color:#4c16ae;padding:0 1pt"></td><td colspan="3" style="background-color:#4c16ae;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selection</span></td><td colspan="3" style="background-color:#4c16ae;padding:0 1pt"></td><td colspan="3" style="background-color:#330e74;padding:0 1pt"></td><td colspan="3" style="background-color:#330e74;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Appointment</span></td><td colspan="3" style="background-color:#330e74;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr style="height:32pt"><td colspan="3" rowspan="2" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Independent directors</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-left:1pt solid #b38ef4;border-top:1pt solid #b38ef4;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Appointments, Governance &amp; CSR Committee defines the profile and skillset</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #b38ef4;padding:0 1pt"><span style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><br/></span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-left:1pt solid #8c56ee;border-top:1pt solid #8c56ee;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Appointments, Governance &amp; CSR Committee pre-selects three potential candidates from a long-list suggested by external consultants</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #8c56ee;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-left:1pt solid #b38ef4;border-top:1pt solid #b38ef4;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Appointments, Governance &amp; CSR Committee interviews two or three short-listed candidates</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #b38ef4;padding:0 1pt"><span style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br/></span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-left:1pt solid #b38ef4;border-top:1pt solid #b38ef4;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Appointments, Governance &amp; CSR Committee recommends a candidate, and explains the reasons for its recommendation</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #b38ef4;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #b38ef4;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #b38ef4;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #8c56ee;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #8c56ee;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #b38ef4;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #b38ef4;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #b38ef4;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #b38ef4;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #b38ef4;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #8c56ee;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #b38ef4;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #b38ef4;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="4" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Directors representing employees</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-left:1pt solid #330e74;border-top:1pt solid #330e74;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Designated by the trade unions in accordance with Sanofi's Articles of Association</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #330e74;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="21" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #330e74;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #330e74;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #330e74;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #330e74;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Independence of Board Members</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the terms of the AFEP-MEDEF corporate governance code (the AFEP-MEDEF Code), a director is independent when he or she has no relationship of any kind whatsoever with the Company, its group or its senior management that may color his or her judgment. More specifically, a director can only be regarded as independent if he or she:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">is not (and has not been during the past five years):</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">an employee or executive officer of the Company,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">an employee, executive officer or director of an entity consolidated by the Company, or</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">an employee, executive officer or director of the Company&#8217;s parent, or of an entity consolidated by that parent (criterion&#160;1);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">is not an executive officer of an entity in which (i)&#160;the Company directly or indirectly holds a directorship or (ii)&#160;an employee of the Company is designated as a director or (iii)&#160;an executive officer of the Company (currently, or who has held office within the past five&#160;years) holds a directorship (criterion&#160;2);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">is not a customer, supplier, investment banker or corporate banker that is material to the Company or its group, or for whom the Company or its group represents a significant proportion of its business (criterion&#160;3);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">has no close family ties with a corporate officer of the Company (criterion&#160;4);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">has not acted as an auditor for the Company over the course of the past five years (criterion&#160;5);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">has not been a director of the Company for more than twelve years (criterion&#160;6);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">does not receive variable compensation in cash or in the form of shares or any compensation linked to the performance of the Company or its group (criterion&#160;7); or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">does not represent a shareholder that has a significant or controlling interest in the Company (criterion&#160;8).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The influence of other factors such as the ability to understand challenges and risks, and the courage to express ideas and form a judgment, is also evaluated before it is decided whether a director can be regarded as independent.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with our Board Charter and pursuant to the AFEP-MEDEF Code, the Board of Directors&#8217; meeting of February&#160;22,&#160;2023 discussed the independence of the current directors. Of the 16&#160;directors in office on that date, 10&#160;were deemed to be independent directors by reference to the independence criteria used by the Board of Directors pursuant to the AFEP-MEDEF Code: Rachel Duan, Carole Ferrand, Lise&#160;Kingo, Patrick Kron, Fabienne Lecorvaisier, Gilles Schnepp, Diane Souza, Thomas S&#252;dhof, Emile Voest and Antoine Yver.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with the rules described above, Paul Hudson (who is an executive director of Sanofi), Serge Weinberg (who has been a director for more than 12&#160;years), and Barbara Lavernos and Christophe&#160;Babule </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(who were appointed on the recommendation of L'Or&#233;al, a major shareholder of Sanofi), are not deemed independent.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Consequently, the proportion of independent directors is 71%. This complies with the AFEP-MEDEF recommendation of at least&#160;50% in companies with dispersed ownership and no controlling shareholder (which is the case for Sanofi). In accordance with the recommendations of the AFEP-MEDEF Code, directors representing employees and elected by trade unions are excluded when calculating the proportion of independent directors.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">85</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:23.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serge Weinberg</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Paul Hudson</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Christophe Babule</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rachel Duan</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carole Ferrand</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lise Kingo</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patrick Kron</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Barbara Lavernos</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabienne Lecorvaisier</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gilles Schnepp</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diane Souza</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thomas S&#252;dhof</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Emile Voest</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Antoine Yver</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Criterion&#160;1:&#160;</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">not&#160;an employee/executive officer&#160;in&#160;past&#160;5&#160;years</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">NO</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Criterion&#160;2:&#160;</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">n</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">o&#160;cross-directorships</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Criterion 3: </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">no significant business relationship </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Criterion 4: </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">no close family ties</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Criterion&#160;5: </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">not an auditor</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Criterion&#160;6: </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">not held office for &gt;&#160;12&#160;years</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">NO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Criterion&#160;7: </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">no variable or performance-linked compensation</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Criterion&#160;8: </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">not a significant&#160;</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">shareholder</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">NO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">NO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deemed independent</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">NO</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">NO</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">NO</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">NO</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">YES</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Failure to fulfil one of the criteria does not automatically disqualify a director from being independent.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In assessing the criterion related to significant business relationships (criterion&#160;3), the Board of Directors took into account the various relationships between directors and Sanofi and concluded that no relationships were of a kind that might undermine their independence. The Board of Directors noted that the Company and its subsidiaries had, in the normal course of business, over the past three years, sold products and provided services to, and/or purchased products and received services from, companies in which certain of the Company&#8217;s directors who are classified as independent (or their close family members) were senior executives or employees during&#160;2022. In each case, the amounts paid to or received from such companies over the past three years were determined on an arm&#8217;s length basis and not at amounts that the Board regarded as undermining the independence of the directors in question.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other information about Board members</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, no corporate officer has been the subject of any conviction or court order, or been associated with any bankruptcy or winding-up order. As of this day, there is no potential conflict of interest between any corporate officer and Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under current French legislation, and given that employees own less than 3% of our share capital, the Board does not include a director representing employee shareholders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the members of our Board of Directors collectively held (directly, or via the employee share ownership fund associated with the Group savings scheme) 23,831&#160;of our shares, representing 0.0019% of our share capital.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">86</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Board evaluation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the terms of the Board Charter, a discussion of the operating procedures of the Board and its committees must be included on the agenda of one Board meeting every year. The Charter also requires a formal evaluation to be performed at least every three years under the direction of the Appointments, Governance and CSR Committee, with assistance from an independent consultant.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2021, a formal evaluation was conducted under the direction of the Appointments, Governance and CSR Committee, with the assistance of a specialist consulting firm (the same one as conducted the previous formal evaluation). Following this evaluation, a series of actions were taken in 2022 to address the areas of progress and vigilance summarized below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Areas of progress and vigilance identified in the 2021 evaluation</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Actions taken in 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The preparation of the Chairman's succession must be continued and accelerated, under the leadership of an independent director.</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At the instigation of Serge Weinberg, and subsequently under the chairmanship of Giles Schnepp, the Appointments, Governance &amp; CSR Committee carried out preparatory work with assistance from a consultancy firm, including consideration of the profile required for the new Chairman&#160;and discussions with Board members. That work was picked up and&#160;formalized by the Committee in 2022. Following the selection process,&#160;Fr&#233;d&#233;ric Oud&#233;a was appointed as non-voting member on September&#160;2,&#160;2022, with the intention of proposing that he be appointed as an independent director at the 2023 Annual General Meeting, and subsequently of appointing him to succeed Serge Weinberg as Chairman.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Implementation of the CSR strategy will have to be subject to tighter monitoring.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">In 2022, the Appointments, Governance &amp; CSR Committee held an extra meeting compared to previous years, giving it an opportunity to examine each of the four pillars of our CSR strategy as well as extra-financial ratings.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Strategic seminars should be more devoted to discussing strategy rather than reviewing activities.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The strategy seminars held in April and October&#160;2022 each devoted half a day to Sanofi strategy.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The duration of the two executive sessions should be extended to allow for more in-depth discussion.</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Executive sessions were extended from one hour to one and a half hours.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The induction program for new directors, made difficult due to the health crisis linked to COVID-19, will have to be reinforced.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Until 2021, the induction program for new directors was devised on an ad hoc basis. In 2022, Sanofi provided an induction session on risks for each new director.</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board members stated that COVID had not harmed the working of the Board but they expressed a desire for a rapid return to physical meetings as well as normal social activities.</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The format of meetings returned to normal in 2022.</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chairman provided feedback on each Board member's individual performance over the course of the year.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The 2022 evaluation was conducted internally, using a detailed questionnaire sent to directors by the Secretary to the Board. Each director was allowed a few weeks to complete the questionnaire using a secure digital platform. At the end of that period, the responses were analyzed by the Secretary to the Board, and supplemented by one-on-one interviews. The results were then presented to, and discussed by, a meeting of the Appointments, Governance and CSR Committee. The detailed report prepared for that meeting was then submitted to the Board meeting of February&#160;22, 2023.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The results of this 2022 evaluation show continuous improvement in the functioning of the Board:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the directors particularly emphasized the quality of relations with management, which have become more fluid, especially due to the return of physical meetings;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the work of the Board gained in scientific expertise as well as in strategic vision;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the further development and increased length of executive sessions mean that they are seen positively as a necessary space to discuss critical issues without management present;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">finance and compensation issues, and HR policy, are adequately covered, and the Board is properly involved in areas around strategy, business, operations and risks;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the Chairman succession process has been very well received; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">directors who followed the enhanced induction program expressed themselves satisfied.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The areas of improvement identified are:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">there is room for improvement in the information and documentation supplied to the Board, and in reports on the work of the Committees;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">some directors felt the Board should be more involved in research and development issues;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the Board should be even more involved in CSR and research and development issues;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">delivery on CSR strategy should continue to be monitored;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the focus on the global review of the strategy through strategic seminars should be continued; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">field trips should be resumed, with directors keen to visit sites, especially research and devel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">opment sites.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">87</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Succession&#160;planning</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General principles</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The remit of the Appointments, Governance and CSR Committee includes preparing for the future of the Company&#8217;s executive bodies, in particular through the establishment of a succession plan for executive officers.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The succession plan, which is reviewed at meetings of the Appointments, Governance and CSR Committee, addresses various scenarios:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">unplanned vacancy due to prohibition, resignation or death;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">forced vacancy due to poor performance, mismanagement or misconduct; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">planned vacancy due to retirement or expiration of term of office.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Through its work and discussions, the Committee seeks to devise a succession plan that is adaptable to situations arising in the short, medium or long term, but which also builds in diversity &#8211;&#160;in all its facets&#160;&#8211; as a key factor.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To fulfill its remit, the Appointments, Governance and CSR Committee:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">provides the Board with progress reports, in particular at executive sessions;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">co-ordinates with the Compensation Committee. In that regard, having a director that sits on both Committees is a great advantage;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">works closely with the Chief Executive Officer to (i)&#160;ensure the succession plan is consistent with the Company&#8217;s own practices and market practices, (ii)&#160;ensure high-potential internal prospects receive appropriate support and training, and (iii)&#160;check there is adequate monitoring of key posts likely to fall vacant;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">meets with key executives as needed; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">involves the Chairman and the Chief Executive Officer insofar as each has a key role in planning for his own successor, though without them directing the process.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In fulfilling their remit, Committee members are acutely conscious of confidentiality issues.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Although aware that separating the offices of Chairman and Chief Executive Officer provides continuity of power, the Committee nonetheless assesses the situation of the Chairman as well as that of the executive team.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Succession of Serge Weinberg</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Serge Weinberg&#8217;s current term of office expires at the end of the Annual General Meeting of Sanofi shareholders called to approve the financial statements for the year ended December&#160;31, 2022, and cannot be renewed as he will have reached the age limit stipulated in the Articles of Association. At the instigation of Serge Weinberg, and subsequently under the chairmanship of Gilles Schnepp, the Appointments, Governance &amp; CSR Committee carried out preparatory work with assistance from a consultancy firm, including consideration of the profile required for the new Chairman and discussions with Board members. That work was formalized by the Appointments, Governance &amp; CSR Committee as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a long-list of potential candidates was put forward by external consultants;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">three candidates were short-listed by the Appointments, Governance &amp; CSR Committee;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the three candidates were interviewed by members of the Appointments, Governance &amp; CSR Committee, after which the Committee ranked the candidates; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the highest-ranked candidate was then interviewed by the Chair of each of the Board committees.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On completion of this process, and there being no vacancies on the Board, the Board decided to appoint Fr&#233;d&#233;ric Oud&#233;a as a non-voting member on a transitional basis, with the intention of proposing his appointment as a director at the Annual General Meeting of May&#160;25, 2023, and to appoint him as Chairman of the Board of Directors after the close of that meeting.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Succession planning for the Chief Executive Officer is subject to regular review by the Appointments, Governance and CSR Committee.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Charter</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Board Charter describes the rights and obligations of Board members; the composition, role and operating procedures of the Board of Directors and Board Committees; and the roles and powers of the Chairman and the Chief Executive Officer. It is prepared in accordance with the French Commercial Code and our Articles of Association.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">88</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Composition of the Board of Directors as of December&#160;31, 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, our Board of Directors comprised 16&#160;directors and one non-voting member:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gender</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nationality</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number<br/>of<br/>shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">directorships</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">in listed</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">companies</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Independent</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">First<br/>appointed</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Term<br/>expires</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Years<br/>of Board<br/>service</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">AC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">AGC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">CC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">SC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">SciC</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Serge&#160;Weinberg, Chairman of the Board</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">French</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,636</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2009</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2023 AGM</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">C</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Paul Hudson, Chief Executive Officer</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">British</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">5,600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2026&#160;AGM</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Christophe Babule</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">French</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2026&#160;AGM</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Rachel Duan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">F</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Chinese</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2024 AGM</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Carole Ferrand</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">F</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">French</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2025 AGM</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lise Kingo</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">F</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Danish</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2024 AGM</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Patrick Kron</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">French</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2026&#160;AGM</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">C</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Wolfgang Laux</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">German</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3,482&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2025 AGM</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Barbara Lavernos</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">F</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">French</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">500</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2025 AGM</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fabienne Lecorvaisier</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">F</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">French</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2025 AGM</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">C</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Gilles Schnepp</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">French</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2026&#160;AGM</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">C</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Diane Souza</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">F</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">American</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,208</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2024 AGM</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Thomas S&#252;dhof</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">American/<br/>German</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2024 AGM</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">C</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yann Tran</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">French</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2025 AGM</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Emile Voest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Dutch</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2025 AGM</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Antoine Yver</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">French/American/Swiss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2025 AGM</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Independent directors </span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(c)</span></div></td><td colspan="12" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Female directors </span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(c)</span></div></td><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Non-French&#160;directors</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#21004c;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">71%</span></td><td colspan="12" style="background-color:#21004c;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">43%</span></td><td colspan="15" style="background-color:#21004c;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">40%</span></td><td colspan="3" style="background-color:#21004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-voting member</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gender</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nationality</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number<br/>of<br/>shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">directorships</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">in listed</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">companies</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Independent</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">First<br/>appointed</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Term<br/>expires</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Years<br/>of Board<br/>service</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">AC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">AGC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">CC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">SC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">SciC</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fr&#233;d&#233;ric Oud&#233;a</span></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">M</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">French</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">500</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">AC:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Audit Committee.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">AGC:&#160;&#160;&#160;&#160;Appointments, Governance and CSR Committee.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">CC:&#160;&#160;&#160;&#160;Compensation Committee.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">SC:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Strategy Committee.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">SciC:&#160;&#160;&#160;&#160;Scientific Committee.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">C:&#160;&#160;&#160;&#160;Chairman/Chairwoman.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">M: &#160;&#160;&#160;&#160;Member.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes all non-executive and executive (and equivalent) directorships held in listed companies. The office held within Sanofi is included in the calculation of this rate.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Director representing employees.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Directors representing employees are not taken into consideration for the calculation of these percentages.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Competencies of Board members</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors, in liaison with the Appointments, Governance and CSR Committee, must ensure that the composition of the Board is balanced, diverse and fit for purpose.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In assessing its composition, the Board takes account of the new challenges facing Sanofi and the corporate strategy, and determines whether the qualities of serving directors are sufficient for the Board to deliver on its remit.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Over the past several years, the Board has adapted its composition in line with its roadmap by:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">bringing additional scientific expertise onto the Board;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">further raising the proportion of non-French directors, especially those with experience of the Chinese market;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">developing its knowledge of CSR issues; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">maintaining the level of core competencies, especially in accounting and finance.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">89</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board has completed an overview of the competencies currently represented. The matrix below</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(a) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">shows a comprehensive, balanced spread of the types of competencies required, both in general terms and by reference to our strategic ambitions (the matrix shows the number of directors possessing each of those competencies)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.595%"><tr><td style="width:1.0%"></td><td style="width:31.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.491%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Scientific training</span></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3</span><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Healthcare/pharmaceutical industry experience</span></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5</span><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior executive role in international group</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11</span><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board membership in international group</span></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7</span><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International experience</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(h)</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(i)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mergers &amp; acquisitions</span></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7</span><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(j)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finance/Accounting</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-left:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5</span><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(k)</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Based on the composition of the Board as of February&#160;22, 2023.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) The information shown excludes directors representing employees.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Thomas S&#252;dhof, Emile Voest and Antoine Yver.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Paul Hudson, Rachel Duan, Lise Kingo, Diane Souza and Antoine Yver.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) Executive Committee member within an international group.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(f) Serge Weinberg, Paul Hudson, Christophe Babule, Rachel Duan, Carole Ferrand, Lise KIngo, Patrick Kron, Barbara Lavernos, Fabienne Lecorvaisier, Gilles Schnepp and Antoine Yver.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g) Serge Weinberg, Rachel Duan, Carole Ferrand, Patrick Kron, Fabienne Lecorvaisier, Lise Kingo and Gilles Schnepp.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(h) Operational role within an international group.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(i) Serge Weinberg, Paul Hudson, Christophe Babule, Rachel Duan, Lise Kingo, Patrick Kron, Barbara Lavernos, Fabienne Lecorvaisier, Gilles Schnepp, Diane Souza and Antoine Yver.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(j) Serge Weinberg, Paul Hudson, Christophe Babule, Patrick Kron, Fabienne Lecorvaisier, Gilles Schnepp and Diane Souza.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(k) Christophe Babule, Fabienne Lecorvaisier, Carole Ferrand, Gilles Schnepp and Diane Souza.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All members of our Board or Directors are engaged with CSR issues, and have complementary skills and experience in the field, for example (non-exhaustive list):</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Serge Weinberg founded Weinberg Capital Partners, a responsible investment fund that takes sustainability criteria into account in its investment decisions and measures the impact of its investments on society and the environment, in 2005;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Christophe Babule, as CFO of L'Or&#233;al, is in charge of financing the group's sustainable transition. He is also a director of the L'Or&#233;al for Women endowment fund;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Lise Kingo holds a Master degree in Responsibility &amp; Business Practice from the University of Bath in the United Kingdom. She was Professor of Sustainability and Innovation at the Vrije Universiteit Amsterdam (The Netherlands) from&#160;2006 to&#160;2015, and in parallel held various CSR-related positions including Director of Environmental Affairs at Novozymes and Executive Vice President, Corporate Relations at Novo Nordisk, before becoming CEO &amp; Executive Director of the United Nations Global Compact from 2015 to 2020 - a key tole at the Paris COP21 climate change conference in 2015;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Fabienne Lecorvaisier has experience as Executive Vice President of Air Liquide with responsibiliy for sustainable development, public and international affairs, along with experience acquired through her involvement in societal programs such as the Air Liquide Foundation and Inclusive Business;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Gilles Schnepp led Legrand's CSR policy as Chairman and CEO from&#160;2006 to&#160;2018, and since March&#160;2021 has been Chairman of the Board of Directors of Danone, a </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">soci&#233;t&#233; &#224; mission</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (social purpose company). He also chaired the Ecological and Economic Transition Commission of MEDEF (the French employer's federation) from 2018 to 2021; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Carole Ferrand, as Chief Financial Officer of Capgemini, is an active member of the CFO Coalition for SDGs (Sustainable Development Goals).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future appointments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The term of office of Serge Weinberg will expire at the Annual General Meeting to be held on May&#160;25, 20</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">23. Consequently, that meeting will be asked to appoint Fr&#233;d&#233;ric Oud&#233;a to succeed him. The appointment would bring to the Board of Directors the following competencies/experiences:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">experience as a senior executive in an international group;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Board membership in an international group; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Finance/Accounting expertise.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For more information, refer to his career r&#233;sum&#233; below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">90</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Detailed information about Board members</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following pages provide key information about each Board member individually:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">directorships and appointments held during 2022 (directorships in listed companies are indicated by an asterisk, and each director&#8217;s principal position is indicated in bold);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">other directorships held during the last five years;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">training and professional experience; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">competencies (as identified in the Board competencies matrix above).</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">91</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_241"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Serge&#160;Weinberg</span></td></tr><tr style="height:11pt"><td colspan="3" rowspan="7" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g10.jpg" alt="sny-20221231_g10.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: February&#160;10, 1951 (aged&#160;72)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: French</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: December&#160;2009</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Last reappointment: April&#160;2019</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2023</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 1,636&#160;shares</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Director and Chairman of the Board of Directors </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of the Strategy Committee </span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Appointments, Governance and CSR Committee</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Scientific Committee </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Director of Kering *</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of the Appointments and Governance Committee</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Audit Committee</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Remuneration Committee</span></div><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Chairman of Weinberg Capital Partners:</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of Maremma</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Manager of Alret</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Permanent representative of Weinberg Capital Partners on the Board of Directors of ADIT (ended October&#160;4, 2019)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Madrigall (ended June&#160;19, 2019)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of the Supervisory Boards of Financi&#232;re Climater SAS (ended October&#160;31, 2018) and Financi&#232;re Tess SAS (ended October&#160;4, 2019)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of Financi&#232;re Piasa and Piasa Holding (ended October&#160;5, 2018)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Graduate in law, degree from the </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:130%">Institut d&#8217;&#201;tudes Politiques</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Graduate of ENA (</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:130%">&#201;cole Nationale d&#8217;Administration</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%">)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since 2005</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Chairman of Weinberg Capital Partners</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2005-2010</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Vice Chairman of the Supervisory Board of Schneider Electric*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2006-2009</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chairman of the Board of Accor*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1990-2005</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various positions at PPR* Group (now Kering *) including Chairman of the Management Board for 10&#160;years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1987-1990</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chief Executive Officer of Pallas Finance</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1982-1987</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Deputy General Manager of FR3 (French television channel) and then Chief Executive Officer of Havas Tourisme</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1976-1982</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Sous-pr&#233;fet</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> and then Chief of Staff of the French Budget Minister (1981)</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior executive in international group, Board membership in international group, International experience, Mergers &amp; acquisitions</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">92</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_244"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Paul Hudson</span></td></tr><tr style="height:17pt"><td colspan="3" rowspan="7" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g11.jpg" alt="sny-20221231_g11.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Date of birth: October&#160;14, 1967 (aged&#160;55)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nationality: British</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">First appointed: September&#160;2019</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Last reappointment: May&#160;2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Term expires: 2026</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 5,600&#160;shares</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Chief Executive Officer </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></div></td></tr><tr style="height:11pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of the Executive Committee </span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director </span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Strategy Committee </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Degree in economics from Manchester Metropolitan University, UK</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Diploma in marketing from the Chartered Institute of Marketing, UK</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Honorary Doctorate in Business Administration, Manchester Metropolitan University, UK</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">From September&#160;1, 2019</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Chief Executive Officer of Sanofi*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2016-2019</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">CEO of Novartis Pharmaceuticals, member of Executive Committee</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2006-2016</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various operational and managerial positions at AstraZeneca (including President, AstraZeneca US; Executive Vice President, North America; Representative Director &amp; President, AstraZeneca KK, Japan; President of AstraZeneca Spain; and Vice-President and head of Primary Care United Kingdom)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Before 2006</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various operational and managerial positions at Schering-Plough, including Head of Global Marketing for biologicals.<br/>Various sales and marketing positions at GlaxoSmithKline UK and Sanofi-Synth&#233;labo UK</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Healthcare/pharmaceutical industry experience, Senior executive role in international group, International experience, Mergers &amp; acquisitions</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">93</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_247"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Christophe Babule</span></td></tr><tr style="height:17pt"><td colspan="3" rowspan="7" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g12.jpg" alt="sny-20221231_g12.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Date of birth: September&#160;20, 1965 (aged&#160;57)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nationality: French</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">First appointed: February&#160;2019</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Last reappointment: May 2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Term expires: 2026</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 1,000&#160;shares</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Director </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Audit Committee</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of the &#8220;L'Or&#233;al Fund for Women&#8221; charitable endowment fund</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:130%">L'Or&#233;al* Group:</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of L'Or&#233;al US Inc. (United States) </span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Education and professional experience</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since February&#160;2019</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Chief Financial Officer at L'Or&#233;al*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 1988</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various positions within the L&#8217;Or&#233;al* Group, including as Director of Administration &amp; Finance for China, then Mexico; Director of Internal Audit; and Administration &amp; Financial Director for the Asia Pacific Zone</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior executive role in international groups, International experience, Mergers &amp; acquisitions, Finance/Accounting, CSR</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">94</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_250"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Rachel Duan</span></div></td></tr><tr style="height:12pt"><td colspan="3" rowspan="6" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g13.jpg" alt="sny-20221231_g13.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: July&#160;25, 1970 (aged&#160;52)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: Chinese</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: April&#160;2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2024</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 1,000&#160;shares</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Independent director </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Compensation Committee </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Independent director of AXA*</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Independent director of HSBC*</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Independent director of Adecco Group*</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">MBA, University of Wisconsin-Madison (United States)</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Bachelor&#8217;s degree in Economics and International Trade, Shanghai International Studies University (China)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since September 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Independent Director, HSBC*</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since April 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Independent Director, Adecco Group*</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since April 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Independent Director, AXA*</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1996-2020</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Senior Vice President of General Electric* (United States) and President &amp; CEO of GE Global Markets (China)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:107%">Healthcare/pharmaceutical industry experience, Senior executive role in international groups</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%">, </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:107%">Board membership in international groups, International experience</span></div></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">95</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_6705"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carole Ferrand</span></div></td></tr><tr style="height:12pt"><td colspan="3" rowspan="6" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g14.jpg" alt="sny-20221231_g14.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: April&#160;2, 1970 (aged&#160;52)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: French</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: May&#160;2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 1,000 shares</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Independent director </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Audit Committee </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Honorary President and Director of Terra Nova (non-profit association)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">President of Capgemini Ventures SAS</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Capgemini Solutions Canada Inc. (Canada)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Capgemini UK plc. (United Kingdom)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of CGS Holdings Ltd. (United Kingdom)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Capgemini Espana SL (Spain)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Altran Innovacion S.L.U (Spain)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Independent Director and Chair of the Audit Committee of Fnac Darty</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Executive Committee of June&#160;21 SAS</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Capgemini</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Sebdo, Le Point</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Archer Obligations (previously Artemis 21)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Editions Tallandier</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Audit Committee of Capgemini</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Collection Pinault-Paris</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of June&#160;21 SAS</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Substitute of Alain de Marcellus, Capgemini Brasil SA (Brazil)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Pallazzo Grassi (Italy)</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">HEC School of Management, Master's degree</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since 2018</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Chief Financial Officer of Capgemini</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2013-2018</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Financing Operations Director of Groupe Art&#233;mis</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2011-2012</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chief Financial Officer of EuropaCorp</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2000-2011</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chief Financial Officer and General Counsel of Sony France</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1992-2000</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Audit and Transaction Services at PricewaterhouseCoopers (PwC)</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:107%">Senior executive role in international groups</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%">, </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:107%">Board membership in international groups, Finance/Accounting</span></div></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">96</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_253"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Lise Kingo</span></div></td></tr><tr style="height:16pt"><td colspan="3" rowspan="6" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g15.jpg" alt="sny-20221231_g15.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: August&#160;3, 1961 (aged&#160;61)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: Danish</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: April&#160;2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2024</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 1,000&#160;shares</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Independent director </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Appointments, Governance &amp; CSR Committee </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Independent director of Danone*</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Independent director of Covestro AG* (Germany)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Independent director of Aker Horizons ASA* (Norway)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Bachelor&#8217;s degree in Religions and Ancient Greek Art, University of Aarhus (Denmark)</span></div></td></tr><tr><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Bachelor&#8217;s degree in Marketing and Economics, Copenhagen Business School (Denmark)</span></div></td></tr><tr><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Master&#8217;s degree in Responsibility &amp; Business, University of Bath (United Kingdom)</span></div></td></tr><tr><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director Certification, INSEAD (France)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Independent Director, Danone*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Independent Director, Covestro AG* (Germany)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Independent Director, Aker Horizons ASA* (Norway)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2020</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Advisory Panel for Humanitarian and Development Coordination, Novo Nordisk Foundation (Denmark)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2020</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chair of Blueprint for Denmark Initiative (Denmark)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2015-2020</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Director of Principles for Responsible Investment, UN PRI (UK)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2015-2020</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">CEO &amp; Executive Director of United Nations Global Compact (US)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2014-2015</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Deputy chair of the Danish Foundation for Nature Preservation (Denmark)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2013-2015</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the &#8220;Scale for Good&#8221; Advisory Panel, Tesco Plc, (United Kingdom)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2012-2015</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chair of the Danish Council for Corporate Social Responsibility (Denmark)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2012-2015</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Independent Director of Grieg Star Shipping (Norway)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2010-2014</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chair, Steno Diabetes Center (Denmark)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2006-2015</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Professor of Sustainable Development and Innovation at Vrije Universiteit Amsterdam (Netherlands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2005-2009</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Independent Director and Deputy Chairwoman, GN Store Nord (Denmark)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2002-2014</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Executive Vice President Corporate Relations &amp; Chief of Staff at Novo Nordisk A/S (Denmark)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1999-2002</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Senior Vice President, Stakeholder Relations at Novo Holding (Denmark)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1995-2006</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the HRH Prince of Wales Cambridge University Faculty for Sustainability Leadership (United Kingdom)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1988-1999</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various positions at the Bioindustrial Novo Industry Group, now Novozymes (Denmark), including Promotion Coordinator and Director, Corporate Environmental Affairs.</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Healthcare/pharmaceutical industry experience, Senior executive role in international groups, Board membership in international groups, International experience</span></div></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">97</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_256"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Patrick Kron</span></div></td></tr><tr style="height:11pt"><td colspan="3" rowspan="7" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g16.jpg" alt="sny-20221231_g16.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: September&#160;26, 1953 (aged&#160;69)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: French</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: May&#160;2014</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Last reappointment: May&#160;2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2026</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 1,000&#160;shares</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Independent director </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of the Compensation Committee</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Appointments, Governance and CSR Committee </span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Strategy Committee</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of Imerys*</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of Truffle Capital SAS</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of PKC&amp;I SAS:</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Permanent representative of PKC&amp;I on the Supervisory Board of Segula Technologies</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Holcim* (Switzerland)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Viohalco* (Belgium)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Interim Chief Executive Officer of Imerys*</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">ElvalHalcor* (Greece)</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Degree from </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#201;cole Polytechnique</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> and </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#201;cole Nationale Sup&#233;rieure des Mines de Paris</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since 2019</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Chairman of Imerys* (and Interim Chief Executive Officer from October&#160;2019 to February&#160;2020)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since 2016</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Chairman of Truffle Capital SAS</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since 2016</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Chairman of PKC&amp;I SAS</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2003-2016</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chief Executive Officer, then Chairman and Chief Executive Officer, of Alstom*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1998-2002</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chairman of the Managing Board of Imerys</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1995-1997</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Manager of the Food and Health Care Packaging Sector at Pechiney, and Chief Operating Officer of American National Can Company in Chicago (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1993-1997</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chairman and Chief Executive Officer of Carbone Lorraine</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1993</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Executive Committee of the Pechiney Group</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1988-1993</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various senior operational and financial positions within the Pechiney Group</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1984-1988</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Operational responsibilities in one of the Pechiney Group&#8217;s biggest factories in Greece, then manager of the Greek subsidiary of Pechiney</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1979-1984</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various positions at the French Ministry of Industry, including as project officer at the Direction r&#233;gionale de l&#8217;Industrie, de la Recherche et de l&#8217;Environnement (DRIRE) and in the Ministry&#8217;s general directorate</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior executive role in international groups, Board membership in international group, International experience, Mergers &amp; acquisitions</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">98</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_259"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Wolfgang Laux</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="6" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g17.jpg" alt="sny-20221231_g17.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: January&#160;24, 1968 (aged&#160;55)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: German</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: April&#160;2021</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2025</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 3,482&#160;shares</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Director representing the employees</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr style="height:11pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Compensation Committee</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr style="height:11pt"><td colspan="9" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Post-doctoral research fellow at the State University of New York at Stony Brook (1998-2000) and at the University of Montpellier (1996-1997)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Ph.D. in organic chemistry from the University of Frankfurt am Main</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Corporate Director&#8217;s Certificate from SciencesPo/IFA </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:130%">(Certificat Administrateur de Soci&#233;t&#233;s)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">European Board Diploma by ecoDa</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td></tr><tr style="height:33pt"><td colspan="9" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since 2006</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Industrialization Coordinator at Sanofi Chimie headquarters, Croix-de-Berny and Gentilly (France)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2014</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Staff representative on the CFE-CGC ticket</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2016-2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Union delegate</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2014-2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Works Council, Sanofi Chimie headquarters</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2016-2019</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Committee on health, safety and working conditions (CHSCT)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2000-2006</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Senior scientist in Process Development at the Frankfurt site of H&#246;chst AG</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Scientific training, Healthcare/pharmaceutical industry experience, International experience. </span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">99</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_262"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Barbara Lavernos</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="6" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g18.jpg" alt="sny-20221231_g18.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: April&#160;22, 1968 (aged&#160;54)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: French</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: April&#160;2021</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2025</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 500&#160;shares</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Director </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Appointments, Governance and CSR Committee</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Bpifrance Investment and Bpifrance Participations</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Graduate of the HEI chemical engineering school at Lille (HEI France)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since May&#160;2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Deputy CEO of L'Or&#233;al* in charge of Research, Innovation and Technology</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">February&#160;2021-May&#160;2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">President Research, Innovation and Technologies at L&#8217;Or&#233;al*&#8211; Member of the Executive Committee at L&#8217;Or&#233;al*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2018-2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chief Technology and Operations Officer at L&#8217;Or&#233;al* &#8211; Member of the Executive Committee at L&#8217;Or&#233;al*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2014-2018</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Executive Vice-President Operations at L&#8217;Or&#233;al* &#8211; Member of the Executive Committee at L&#8217;Or&#233;al*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2011-2014</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Managing Director of Travel Retail at L'Or&#233;al*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2004-2011</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Global Chief Procurement Officer at L'Or&#233;al*</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior executive role in international groups, International experience, Scientific training</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">100</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_265"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fabienne Lecorvaisier</span></div></td></tr><tr style="height:11pt"><td colspan="3" rowspan="7" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g19.jpg" alt="sny-20221231_g19.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: August&#160;27, 1962 (aged&#160;60)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: French</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: May&#160;2013</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Last reappointment: April&#160;2021</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2025</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 1,000&#160;shares</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Independent director </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chair of the Audit Committee </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Air Liquide Group*:</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Air Liquide International</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of The Hydrogen Company</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Safran Group*:</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Independent Director</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Audit and Risk Committee</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Air Liquide Group*:</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Executive Vice President of Air Liquide International Corporation</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of American Air Liquide Holdings, Inc.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Air Liquide Group*:</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of Air Liquide Finance, Air Liquide Eastern Europe, Aqualung International, Air Liquide Welding SA and SOAEO&#160;&#160;&#160;&#160;</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Director of ANSA (Association Nationale des Soci&#233;t&#233;s par Actions)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairwoman of Air Liquide US LLC</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.200%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Civil engineer, graduate of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:130%">&#201;cole Nationale des Ponts et Chauss&#233;es</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since July&#160;2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Executive Vice President in charge of Sustainable Development, Public and International Affairs, Social Programs and General Secretariat of Air Liquide*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">July&#160;2017-July&#160;2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Executive Vice President of Air Liquide*</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2008</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Executive Committee member of Air Liquide*</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2008-2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chief Financial Officer of Air Liquide*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1993-2008</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various positions within Essilor* including Group Chief Financial Officer (2001-2007) and Chief Strategy and Acquisitions Officer (2007-2008)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1990-1993</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Assistant General Manager of Banque du Louvre, Taittinger Group</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1989-1990</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Senior Banking Executive in charge of the LBO Department (Paris)/Corporate Finance Department (Paris and London) at Barclays</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1985-1989</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Corporate Finance Department, then Mergers and Acquisitions Department of Soci&#233;t&#233; G&#233;n&#233;rale*</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior executive role in international groups, Board membership in international groups, International experience, Mergers &amp; acquisitions, Finance/Accounting</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">101</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_274"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Gilles Schnepp</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="7" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g20.jpg" alt="sny-20221231_g20.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: October&#160;16, 1958 (aged&#160;64)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: French</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: May&#160;2020</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Last reappointment: May&#160;2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2026</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 1,000&#160;shares</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Independent director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of the Appointments, Governance and CSR Committee </span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Strategy Committee </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Board of Directors of Saint Gobain*  </span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of the Board of Directors of Danone*</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Board of Directors of Socotec</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="text-indent:18pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Vice-Chairman of the Supervisory Board of PSA* </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Board of Directors of Legrand*</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Graduate of HEC business school</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Chairman of Danone*</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2006-2018</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chairman &amp; CEO of Legrand</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2004-2006</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">CEO of Legrand</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2001-2004</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Deputy CEO of Legrand</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1989-2001</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various positions within the Legrand Group </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1983</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Merrill Lynch</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior executive role in international groups, Board membership in international groups, International experience, Mergers &amp; acquisitions, Finance/Accounting</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">102</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_277"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Diane Souza</span></td></tr><tr style="height:11pt"><td colspan="3" rowspan="7" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g21.jpg" alt="sny-20221231_g21.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: July&#160;3, 1952 (aged&#160;70)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: American</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: May&#160;2016</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Last reappointment: April&#160;2020</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2024</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: </span><span style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2,416&#160;American Depositary Receipts, equivalent to 1,208&#160;shares</span></div></td></tr></table></div><div style="margin-bottom:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:49.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Independent director </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Compensation Committee </span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Audit Committee </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Amica Insurance Companies (United States):</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Board of Directors</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Compensation </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%">and Investment Committees</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">UnitedHealth Group:</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Board of Directors of Unimerica Insurance Company, Unimerica Life Insurance Company of New York, National Pacific Dental, Inc., Nevada Pacific Dental, DBP Services of New York, IPA, Dental Benefits Providers of California, Inc., Dental Benefit Providers of Illinois, Inc., Dental Benefit Providers, Inc., Spectera, Inc. and Spectera of New York, IPA, Inc. United&#160;States</span></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Farm Credit East (United States)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Board of Directors</span></div></td></tr></table></div><div style="margin-bottom:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Degree in Accounting from University of Massachusetts</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Honorary doctorate in Business Administration from University of Massachusetts Dartmouth</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Certified Public Accountant</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Diploma in Dental Hygiene from Northeastern University, Forsyth School for Dental Hygienists</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2008-2014</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chief Operating Officer of OptumHealth Specialty Benefits (2008), then Chief Executive Officer of UnitedHealthcare Specialty Benefits (2009-2014) (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2007-2008</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Principal consultant at Strategic Business Solutions, LLC (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1994-2006</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various positions at Aetna Inc. including Deputy Vice President Federal and State Taxes; Vice President and Chief Financial Officer, Large Case Pensions; Vice President and Head of Global Internal Audit Services; Vice President, National Customer Operations; and finally Vice President, Strategic Systems&#160;&amp; Processes (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1988-1994</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various positions at Price Waterhouse from Senior Tax Manager to Head of the Northeast Insurance Tax Region (United&#160;States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1980-1988</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Various positions at Deloitte Haskins&#160;&amp; Sells, from Audit Staff Accountant to Senior Tax Manager-in-Charge (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1979</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Audit Staff Accountant at Price Waterhouse (United States)</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:18.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.268%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Healthcare/pharmaceutical industry experience, International experience, Mergers &amp; acquisitions, Finance/Accounting</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">103</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_280"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Thomas S&#252;dhof</span></div></td></tr><tr style="height:11pt"><td colspan="3" rowspan="7" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g22.jpg" alt="sny-20221231_g22.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: December&#160;22, 1955 (aged&#160;67)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: German and American</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: May&#160;2016</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Last reappointment: April&#160;2020</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2024</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: </span><span style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2,485&#160;American Depositary Receipts, equivalent to 1,242&#160;shares</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Independent director </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of the Scientific Committee </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Independent director of CytoDel Inc. (United States) (since 2021)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Scientific Advisory Committee of NeuroCentria (United States) (since 2022)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Independent director of Abide Therapeutics (United States) (2019-2020)</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Degree in medicine from the Faculty of Medicine of the University of G&#246;ttingen (Germany)</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Elected member of the National Academy of Sciences of the US (2002)</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Elected member of the National Academy of Medicine (2007)</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Bernard Katz Prize of the Biophysical Society, jointly with Reinhard Jahn (2008)</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Elected member of the American Academy of Arts and Sciences (2010)</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Nobel Prize for Physiology or Medicine, jointly with James Rothman and Randy Schekman (2013)</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Albert Lasker Prize for Basic Medical Research, jointly with Richard Scheller (2013)</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Elected foreign member of the German Academy Leopoldina (2015)</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Elected foreign member of the Royal Society of London for Improving Natural Knowledge (2017)</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Elected member of the Norwegian Society of Sciences </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2008</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Avram Goldstein Professor in the Molecular &amp; Cellular Physiology, Neurosurgery, Psychiatry, and Neurology Department in the School of Medicine at Stanford University (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2020</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of Danaher Corporation (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2020</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Co-founder and member of the Scientific Advisory Board of Boost, Inc. and Recognify, Inc. (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2020</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of NeuroCure, Charite, Berlin (Germany)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2019 </span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of the Neuroscience Department at the Institut Pasteur (France) </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2019</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of the Chinese Institute for Brain Research, Beijing (China)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2019</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Advisor to Camden Venture Partners (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2018</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of Jupiter, Inc. (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2018</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chairman of the Scientific Advisory Board of Capital Medical University, Beijing (China)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2018</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of Alector, Inc. (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2017</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of Cytodel, Inc. (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2017</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of the Chinese Academy of Sciences Institute of Guangzhou (China)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2016</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of the Picower Institute, MIT Boston (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2016</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of Simcere, Inc. (China)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2014</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of Elysium, Inc. (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2013</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of the Shemyakin-Ovchinnikov Institute of Bio-Organic Chemistry (Russia)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2002</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Co-founder and member of the Scientific Advisory Board of REATA Pharmaceuticals (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 1986</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Investigator at the Howard Hughes Medical Institute (United States)</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2017-2019</span></td><td colspan="6" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of C-Bridge Everest Medical (China)</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">104</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2017-2018</span></td><td colspan="6" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of Abide (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2014-2018</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Committee of the Institute of Cellular and Molecular Biology of A*Star (China)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2014-2018</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of the Chinese Academy Institute of Biophysics (China)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2014-2018</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Scientific Advisory Board of the Singapore National Research Foundation (Singapore)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2014-2017</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Co-founder and member of the Scientific Advisory Board of Bluenobel, Inc. (China)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2013-2016</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Review Board of Genentech Neuroscience (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2011-2019</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Co-founder and member of the Scientific Advisory Board of Circuit Therapeutics, Inc. (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1986-2008</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Professor and subsequently Chair of the Neuroscience Department at the University of Texas Southwestern Medical School (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1983-1986</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Postdoctoral Fellow, Dept. of Molecular Genetics, UT Southwestern Medical School (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1981-1982</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Intern at the University Hospital of G&#246;ttingen (Germany)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1979</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Student on exchange clerkship program at Harvard Medical School (United States)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1978-1981</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Research assistant at the Max Planck Institute for Biophysical Chemistry (Germany)</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Scientific training</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">105</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_283"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Yann Tran</span></div></td></tr><tr style="height:12pt"><td colspan="3" rowspan="6" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g23.jpg" alt="sny-20221231_g23.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: December&#160;5, 1965 (aged&#160;57)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: French</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: May&#160;2021</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2025</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 1,235&#160;shares</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Director representing the employees </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Coordinator for IndustriALL Europe on the Sanofi European Works Council</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the French Strategy Committee for the Healthcare Industries and Technologies Sector</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">DEA in Biochemistry: Integrative Protein Biology from the University of Paris VII (France)</span></div></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Master's degree in Biochemical and Biological Engineering Sciences and Techniques from the University of Paris XII (France)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since 2010</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Head of Labor Relations, France at Sanofi</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Coordinator for IndustriALL Europe on the Sanofi European Works Council</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2014-2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Federation delegate for the Pharmaceuticals industry, in charge of negotiating and monitoring of industry agreements and national collective agreements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2014-2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FCE-CFDT federation delegate for social welfare</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2010-2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Trade union leader in labor relations in the Sanofi Group</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2010-2014</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Member of the Supervisory Board of Sanofi employee savings plans (PEG and PERCO) and member of the Sanofi Group Committee</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2006-2010</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Bioinformatics researcher at Sanofi R&amp;D</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1995-2006</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Researcher in molecular biology at Sanofi and Aventis</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Scientific training, Healthcare/pharmaceutical industry experience</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">106</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_6719"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Emile Voest</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="6" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g24.jpg" alt="sny-20221231_g24.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: August&#160;20, 1959 (aged&#160;63)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: Dutch</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: May&#160;2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="background-color:#ffffff;color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held:</span><span style="background-color:#ffffff;color:#5064a9;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">5</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">00</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Independent director </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Scientific Committee</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chairman of the Board of Cancer Core Europe</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Board Member of the Center for Personalized Cancer Treatment</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Supervisory Board of Hartwig Medical Foundation</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:130%;padding-left:6.11pt">None</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Ph.D. in Medicine, cum laude, University of Utrecht</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Founder of Mosaic Therapeutics and Strategic Advisor</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2019</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Senior Group Leader of the Oncode Institute</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Director of Cancer Core Europe</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2015</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Founder and Member of Supervisory Board of the Hartwig Medical Foundation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2015-2020</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ESMO (European Society for Medical Oncology)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chair of the Publications Committee (2016-2020)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Executive Board (2015-2020)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2014</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">The Netherlands Cancer Institute</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Medical Oncologist (since 2014)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Executive Medical Director (2014-2020) and senior group leader</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2013-2016</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Co-founder and Non-Executive Medical Director of Hubrecht Organoid Technology</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2010</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Co-founder and Member of the Executive Board of the Center for Personalized Cancer Treatment (CPCT)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 1999</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Professor of Medical Oncology at UMC Utrecht</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Scientific training</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">107</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_6724"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Antoine Yver</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="6" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g25.jpg" alt="sny-20221231_g25.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: January&#160;31, 1958 (aged 65)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: French, American, Swiss</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed: May&#160;2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Term expires: 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2,000&#160;American Depositary Receipts, equivalent to 1,000&#160;shares</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Independent director </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Member of the Scientific Committee </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%">Board Member of Spotlight Therapeutics</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Doctor of Medicine and Pediatrics, University of Paris-Sud 11</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2021-2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chairman of Development of Centessa Pharmaceuticals</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2016-2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">EVP Global Head Oncology R&amp;D at Daiichi Sankyo, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2009-2016</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">AstraZeneca</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">SVP Head Oncology Global Medicines Development &amp; Lead China GMD (2013-2016)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">VP Head Oncology Global Medicines Development &amp; Lead China GMD (2012-2013)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">VP Clinical Oncology &amp; New Opportunities (2011-2012)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">VP Clinical Oncology &amp; Infection (2009-2011)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2006-2009</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Executive Director in Oncology at the Schering-Plough Research Institute</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2005-2006</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Senior Director Oncology at Johnson &amp; Johnson</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1990-2005</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Senior Director Clinical Research at Aventis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1981-1990</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Medical doctor at the Assistance Publique des H&#244;pitaux de Paris</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Scientific training, Healthcare/pharmaceutical industry experience, Senior executive role in international groups, International experience</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">108</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_7042"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.207%"><tr><td style="width:1.0%"></td><td style="width:15.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fr&#233;d&#233;ric Oud&#233;a - Non-voting Board member</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="6" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g26.jpg" alt="sny-20221231_g26.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Date of birth: July&#160;3, 1963 (aged&#160;59)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Nationality: French</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">First appointed as a non-voting Board member: September&#160;2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Appointment as a director proposed at the 2023 General Meeting</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Business address: Sanofi - 46, avenue de la Grande Arm&#233;e - 75017&#160;Paris - France</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Number of shares held: 500 shares</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:48.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Current directorships and appointments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Non-voting Board member</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Chief Executive Officer of Soci&#233;t&#233; G&#233;n&#233;rale*</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Board member of Capgemini*</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Board member of ALD*</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Past directorships expiring within the last five years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">WITHIN THE SANOFI GROUP</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OUTSIDE THE SANOFI GROUP</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In French companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In foreign companies</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">None</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Education and professional experience</span></td></tr><tr><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Graduate of ENA (</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:130%">&#201;cole Nationale d'Administration</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%">)</span></div><div style="padding-left:8.5pt;text-indent:-8.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:130%;padding-left:6.11pt">Degree from </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:130%">&#201;cole Polytechnique</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Since 2015</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Chief Executive Officer of Soci&#233;t&#233; G&#233;n&#233;rale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Since 2010 </span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chairman of the Steering Committee on Regulatory Capital of the Institute of International Finance</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2009-2015</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chief Executive Officer and Chairman of the Board of Soci&#233;t&#233; G&#233;n&#233;rale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2008-2009</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Chief Executive Officer of Soci&#233;t&#233; G&#233;n&#233;rale </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2003-2008</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Group Chief Financial Officer of Soci&#233;t&#233; G&#233;n&#233;rale </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2002-2003</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Deputy Group Chief Financial Officer of Soci&#233;t&#233; G&#233;n&#233;rale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1998-2002</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Head of global supervision and development of the Equity Department of Soci&#233;t&#233; G&#233;n&#233;rale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1995-1998</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Assistant Manager, then Manager of the Corporate Banking department in London at Soci&#233;t&#233; G&#233;n&#233;rale</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Competencies</span></td></tr><tr><td colspan="15" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior executive role in international groups, Board membership in international groups, Finance/Accounting</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">109</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_286"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in the composition of the Board of Directors</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows changes in the composition of the Board of Directors during 2021 and 2022, and the changes that will be submitted for approval by our shareholders at the Annual General Meeting of May&#160;25, 2023:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:19.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.549%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual&#160;General&#160;Meeting <br/>of April&#160;30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual&#160;General&#160;Meeting <br/>of May&#160;3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual General Meeting <br/>of May&#160;25, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">End of term of office</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Marion Palme<br/>Christian Senectaire<br/>Laurent Attal<br/>Bernard Charl&#232;s</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Melanie Lee</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carole Piwnica</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serge Weinberg</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Renewal of term of office</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabienne Lecorvaisier <br/>Melanie Lee</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Paul Hudson </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Christophe Babule</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patrick Kron</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gilles Schnepp</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proposed new appointments</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Barbara Lavernos</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carole Ferrand</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Emile Voest</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Antoine Yver</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fr&#233;d&#233;ric Oud&#233;a</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Co-opted</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gilles Schnepp</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wolfgang Laux<br/>Yann Tran</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">None</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Melanie Lee and Carole Piwnica </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">left the Board of Directors ahead of the General Meeting of May&#160;3, 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;On a proposal from the Board of Directors, Carole Ferrand, Emile Voest and Antoine Yver were appointed as directors at the General Meeting held on May&#160;3, 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) The term of office of Serge Weinberg will expire at the Annual General Meeting held to approve the financial statements for the year ended December&#160;31,&#160;2022, and cannot be renewed (see below). Acting on a recommendation from the Appointments, Governance and CSR Committee, the Board of Directors appointed Fr&#233;d&#233;ric Oud&#233;a as a non-voting member of the Board on September&#160;2, 2022. The Board meeting of February&#160;22, 2023 decided to ask the Annual General Meeting of May&#160;25, 2023 to approve the appointment of Fr&#233;d&#233;ric Oud&#233;a as an independent director, to replace Serge Weinberg. The Board then intends to appoint Fr&#233;d&#233;ric Oud&#233;a as Chairman on the conclusion of that meeting.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If the appointment of Fr&#233;d&#233;ric Oud&#233;a as an independent director were to be approved, the proportion of independent directors</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(17)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> would be increased from 71% to 79%.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_289"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Executive Committee</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Executive Committee is chaired by the Chief Executive Officer. The Committee meets at least twice a month.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">There were changes in the composition of the Executive Committee in 2022 and early 2023. One new member, Roy Papatheodorou (Executive Vice President, General Counsel &amp; Head of Legal, Ethics &amp; Business Integrity), joined on&#160;February&#160;1, 2022; and two members, Arnaud Robert (Executive Vice President, Chief Digital Officer) and John Reed (Executive Vice President, Global Head of Research and Development) respectively in December 2022 and February 2023, respectively. Arnaud Robert and John Reed's functions are being performed internally until the appointment of their respective successors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of February&#160;24, 2023, the </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Executive Committee had nine&#160;members, two of whom are women. In accordance with our Board Charter, the Board of Directors &#8211;&#160;in liaison with the Compensation Committee and the Appointments, Governance and CSR Committee, and on a proposal from the Chief Executive Officer&#160;&#8211; has established a policy on gender balance within Sanofi's executive bodies. A key objective of this policy is to support the creation of a talent pool of both women and men who can potentially join the Executive Committee in future.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Paul Hudson</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Date of birth: October&#160;14, 1967.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Paul Hudson joined Sanofi as Chief Executive Officer on September&#160;1, 2019.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Previously CEO of Novartis Pharmaceuticals (2016-2019), where he was a member of the Executive Committee, Paul has had an extensive international career in healthcare that spans the US, Japan and Europe.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and most recently carried out the roles of President, AstraZeneca United States and Executive Vice President, North America.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synth&#233;labo UK.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Paul holds a degree in economics from Manchester Metropolitan University in the UK and last year his alma mater awarded him an honorary Doctor of Business Administration for his achievements in industry. He also holds a diploma in marketing from the Chartered Institute of Marketing, also in the UK.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Paul Hudson is a citizen of the United Kingdom.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(17)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Calculated in accordance with currently applicable rules.</span></div><div style="height:41.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">110</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Natalie Bickford</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Chief People Officer</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Date of birth: July&#160;16, 1970.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Natalie Bickford joined Sanofi on August&#160;1, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">She holds a degree in French and International Politics from the University of Warwick in the UK.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">She has worked in HR and HR leadership for more than 20&#160;years and brings a wealth of experience in consumer-facing industries to Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Prior to joining Sanofi, Natalie was Group HR Director at Merlin Entertainments, the world&#8217;s second largest location-based entertainment business, where she was responsible for 30,000&#160;employees across Europe, North America, and Asia Pacific. She also held senior HR&#160;positions at Sodexo, AstraZeneca and Kingfisher Plc.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Natalie has a solid track record of transforming organizations, with a strong focus on inclusion and diversity. She was awarded &#8220;HR&#160;Diversity Champion of the Year&#8221; at the European Diversity Awards in November&#160;2019. Natalie is also Board member of the Kronos Workforce Institute, a reflection of her deep interest in understanding and shaping the future of work.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Natalie Bickford is a citizen of the United Kingdom.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Olivier Charmeil</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, General Medicines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Date of birth: February&#160;19, 1963.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Olivier Charmeil is a graduate of HEC (</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">&#201;cole des Hautes &#201;tudes Commerciales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) and of the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Institut d&#8217;&#201;tudes Politiques</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Paris. From&#160;1989 to&#160;1994, he worked in the Mergers &amp; Acquisitions department of Banque de l&#8217;Union Europ&#233;enne. He joined Sanofi Pharma in 1994 as head of Business Development. Subsequently, he held various positions within Sanofi, including Chief Financial Officer (Asia) of Sanofi-Synth&#233;labo in 1999 and Attach&#233; to the Chairman, Jean-Fran&#231;ois Dehecq, in 2000, before being appointed as Vice President, Development within the Sanofi-Synth&#233;labo International Operations Directorate, where he was responsible for China and support functions. In 2003, Olivier Charmeil was appointed Chairman and Chief Executive Officer of Sanofi-Synth&#233;labo France, before taking the position of Senior&#160;Vice President, Business Management and Support within the Pharmaceutical Operations Directorate. In this role, he piloted the operational integration of Sanofi-Synth&#233;labo and Aventis. He was appointed Senior Vice President Asia/Pacific, Pharmaceutical Operations in February&#160;2006; Operations Japan reported to him from January&#160;1, 2008, as did Asia/Pacific and Japan Vaccines from February&#160;2009. On January&#160;1, 2011, Olivier Charmeil was appointed Executive Vice President Vaccines, and joined our Executive Committee.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In May&#160;2015, Olivier Charmeil and Andr&#233; Syrota were appointed as Co-Leaders of &#8220;Medicine of the Future&#8221;, an initiative developed by the French Minister for Economy, Industry and Digital Affairs, the French Minister for Social Affairs, Health and Women&#8217;s Rights and the French Minister for National and Higher Education and Research. They have been tasked with assembling a group of industrialists and academics, with the objective of imagining how French industry can accelerate the launch and export of innovative industrial products, with an emphasis on new biotechnologies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">From June&#160;2016 to December&#160;2018, Olivier Charmeil served as Executive Vice President of our General Medicines and Emerging Markets Global Business Unit.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">He took up the position of Executive Vice President China &amp; Emerging Markets in January&#160;2019. In February&#160;2020 he was appointed to lead the General Medicines GBU, created out of the former Primary Care and China &amp; Emerging Markets GBUs. He also serves as sponsor for China. Also in 2020, Olivier became a Board Member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Olivier Charmeil is a citizen of France.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Jean-Baptiste Chasseloup de Chatillon</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Chief Financial Officer</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Date of birth: March&#160;19, 1965.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Jean-Baptiste Chasseloup de Chatillon</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> joined Sanofi on </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">October&#160;1, 2018</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Jean-Baptiste Chasseloup de Chatillon holds a Masters from Paris Dauphine University and studied Finance in the United Kingdom at Lancaster University.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Until July&#160;2018, he served as Chief Financial Officer and Executive Vice President of the PSA Group. In that capacity, he was also a member of the Managing Board and Executive Committee. He held various manage</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ment positions within the PSA Group in finance (Treasurer in Spain, Chief Financial Officer in the United Kingdom) and in sales and marketing (Business units: Bank/Insurance, Spare parts, Used vehicles, Proprietary dealership network).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">He was also Chairman of the Board of Banque PSA Finance (BPF) from 2012 to June&#160;2</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">016. He joined the Peugeot S.A. Managing Board in 2012.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">He was appointed as Director and member of the Audit Committee of Sodexo (a French listed company) on December&#160;14, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Jean-Baptiste Chasseloup de Chatillon is a citizen of France.</span></div><div style="height:41.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">111</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Brendan O'Callaghan</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Global Manufacturing &amp; Supply</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Date of birth: </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">July&#160;16, 1961.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Brendan O'Callaghan joined Sanofi on January&#160;1, 2015. He joined the Executive Committee on October&#160;1, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Brendan graduated in chemical engineering from the University College of Dublin, where he currently serves as an honorary adjunct Professor of Chemical and Biochemical Engineering.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Brendan joined Sanofi in 2015 and was previously Global Head of Biologics and Industrial Affairs Head of the Specialty Care portfolio. He has played a key role in supporting our transformation to a fully integrated BioPharma company and advancing the digital transformation of our manufacturing network.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Prior to Sanofi, Brendan worked at Schering-Plough before moving to Merck/MSD as Head of Biologics and later Vice President of its Europe, Middle East and Africa Operations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Brendan O'Callaghan is a citizen of Ireland.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Julie Van Ongevalle</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Consumer Healthcare</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Date of birth: November&#160;22, 1974.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Julie Van Ongevalle joined Sanofi on September&#160;1, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">She graduated from the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Institut Catholique des Hautes &#201;tudes Commerciales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Belgium) with a Master of Science in Commercial and Financial Sciences.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">With over 20&#160;years of international experience, Julie has a deep knowledge of consumers and digital, as well as a proven track record in brand building, from identifying growth opportunities to building and implementing delivery strategies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Prior to joining Sanofi, Julie worked at the Est&#233;e Lauder Companies, where she held roles of increasing responsibility across the company, starting in 2004. As Global Brand President of the Origins brand from 2016, she led a global organization of&#160;4,000&#160;people, growing the company&#8217;s market share across geographies. Prior to Origins, she spent eight years in the M.A.C.&#160;Cosmetics division, first as General Manager Benelux, then of the EMEA Region and finally North America.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Julie started her career as a marketing manager at GSK Consumer Healthcare and Clinique.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Julie Van Ongevalle is a citizen of Belgium.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_7059"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Roy Papatheodorou</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, General Counsel &amp; Head of Legal, Ethics &amp; Business Integrity</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Date of birth: May&#160;15, 1978.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Roy Papatheodorou joined Sanofi on February&#160;1, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Prior to joining Sanofi, Roy was General Counsel of Novartis Pharmaceuticals. He has a wealth of experience in leading global and diverse teams, having also headed the Legal Transactions team at Novartis and having previously been the General Counsel of the Actavis Group, one of the largest generics companies at the time.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">He started his career at international law firm Linklaters, where he specialized in international M&amp;A, corporate and private equity based in London, with time also spent in Russia and Brazil.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Roy Papatheodorou is a citizen of Cyprus and Italy.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bill Sibold</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Specialty Care</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Date of birth: October&#160;29, 1966.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bill Sibold holds an MBA from Harvard Business School and a B.A. in Molecular Biophysics and Biochemistry from the Yale University. He has more than thirty years of experience in the biopharmaceutical industry. Bill Sibold began his career with Eli Lilly and then held a number of leadership positions within Biogen, including driving their US commercial operations in neurology, oncology and rheumatology. He also worked for Biogen in Australia and the Asia-Pacific region, and served as Chief Commercial Officer at Avanir Pharmaceuticals. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bill&#160;Sibold joined Sanofi in late 2011 as head of the MS franchise where he oversaw the successful launches of Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Lemtrada</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. From&#160;January&#160;2016 to June&#160;2017 he served as head of Specialty Care&#8217;s Global Multiple Sclerosis, Oncology and Immunology organization, where he led preparation for the global launches of Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and Kevzara</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bill Sibold has headed up Specialty Care global business unit, since July&#160;1, 2017. He has also served as President for North America since February&#160;2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bill Sibold is a citizen of Canada and of the United&#160;States of America.</span></div><div style="height:41.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">112</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_7280"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Thomas Triomphe</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Vaccines</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Date of birth: August&#160;6, 1974.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Thomas Triomphe earned his MSc in industrial engineering from &#201;cole des Ponts ParisTech and the IFP School, and he also holds an&#160;MBA from INSEAD.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Thomas joined Vaccines in 2004 and has since advanced within the company in several roles of increasing responsibility in sales and marketing at country, regional and global levels. From 2015 to 2018, he was Head of the Asia-Pacific Region, based in Singapore. Before that, he served as Head of Vaccines Japan from 2012 to 2015. In 2010, he became Associate Vice President, Head of the&#160;Influenza-Pneumo Franchise after three years as Director for the same franchise, based in the United States. Earlier in his career, Thomas worked in banking and strategic consulting.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Thomas served as Vice President and Head of Franchise &amp; Product Strategy for Vaccines from January&#160;2018, in which position he implemented the strategy for our vaccine franchises, in close collaboration with Manufacturing &amp; Supply and R&amp;D.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">He was appointed to his current position on June&#160;15, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Thomas Triomphe is a citizen of France.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_292"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.&#160;Compensation</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Compensation and other arrangements for corporate officers</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation policy for corporate officers</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This section describes the compensation policy for corporate officers of Sanofi, as established pursuant to Article&#160;L.&#160;22-10-8 of the French Commercial Code. That policy describes all the components of compensation awarded to corporate officers of Sanofi as consideration for holding office, and explains the process by which it is determined, divided, reviewed and implemented.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our compensation policy for corporate officers has three distinct elements: (i)&#160;the compensation policy for directors; (ii)&#160;the compensation policy for the Chairman of the Board; and (iii)&#160;the compensation policy for the Chief Executive Officer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Each of those policies is submitted for approval by our shareholders at the Annual General Meeting, in accordance with&#160;Article&#160;L.&#160;22-10-8&#160;II of the French Commercial Code. The compensation policy approved in any given year applies to any person holding corporate office in that year. Moreover, when a corporate officer is appointed between two Annual General Meetings, their compensation is defined applying the terms of the compensation policy approved by the most recent Annual General Meeting of shareholders.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Process for determining the compensation policy for corporate officers</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The compensation policy for corporate officers is established by the Board of Directors, acting on the recommendation of the Compensation Committee. The Board of Directors applies the AFEP-MEDEF Code when determining the compensation and benefits awarded to our executive and non-executive corporate officers.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All members of the Compensation Committee are independent, and were chosen for their technical competencies and their good understanding of current standards, emerging trends and Sanofi&#8217;s practices.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To fulfill their remit, the Committee regularly invites the Chief People Officer and the Head of Reward and Performance of the Group to attend their meetings, although the latter absent themselves when the Committee deliberates. Committee members also work with the Chairman and the Secretary of the Board, who have contacts with our principal institutional shareholders ahead of the Annual General Meeting.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, the Chairman of the Committee:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">discusses the financial, accounting and tax impacts of the proposed compensation policy with the Chairman of the Audit Committee;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">plays an active role at meetings of the Appointments, Governance and CSR Committee and the Strategy Committee (to both of which he belongs), thereby gaining assurance that the proposed performance criteria are consistent and appropriate in light of Sanofi&#8217;s strategic ambitions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The compensation policy is not subject to annual review, although some arrangements for implementing the policy &#8211;&#160;such as the performance criteria applicable to the Chief Executive Officer&#8217;s annual variable compensation, for example&#160;&#8211; are defined by the Board of Directors on an annual basis.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">113</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">After consulting the Compensation Committee and as the case may be the other Board Committees, the Board of Directors may, under the second paragraph of item&#160;III of Article&#160;L.&#160;225-37-2 of the French Commercial Code, temporarily derogate from the approved compensation policy for the Chief Executive Officer in exceptional circumstances and to the extent that the changes are aligned with the corporate interest and necessary to safeguard the continuity or viability of Sanofi. Derogations from the approved policy are possible in respect of the performance conditions applied to the Chief Executive Officer&#8217;s compensation, and may result in either an increase or a decrease in compensation. The circumstances in which it is possible to apply such a derogation are (i)&#160;a change in the structure of the Sanofi group or (ii)&#160;major events affecting the markets. Such derogation may only be temporary and must be properly substantiated. Moreover, it will remain subject to approval by the next General Meeting of Sanofi shareholders.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">General principles and objectives</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our compensation policy is based on the following general principles:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the policy must be simple;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the policy must prioritize long-term performance;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the level of compensation must be competitive, so that we can attract and retain talent; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">there must be a fair balance between the corporate interest, the challenges of delivering on our strategy, and the expectations of our stakeholders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Compensation Committee must ensure that trends in the compensation of corporate officers over the medium term are not uncorrelated with trends in the compensation of all our employees. In terms of annual variable compensation and equity-based compensation, the Compensation Committee aims to achieve convergence between the performance criteria applied to our Senior Leaders and those applied to the Chief Executive Officer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our equity-based compensation policy, which aims to align employee and shareholder interests and reinforce loyalty to Sanofi, is a critical tool for our worldwide attractiveness as an employer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">With effect from June&#160;2019, grantees of equity based compensation plans (including our Chief Executive Officer) can only be awarded performance shares. Awarding performance shares reduces the dilutive effect of equity based compensation plans while maintaining the same level of motivation for grantees.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acting on the recommendation of the Compensation Committee, the Board of Directors determines the performance conditions attached to equity-based compensation for all beneficiaries at Sanofi and its subsidiaries worldwide, thereby furthering the attainment of our objectives. Our equity-based compensation plan rules are made available to our shareholders on the governance page of our website&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(www.sanofi.com)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the same form as that distributed to our employees.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors makes any grant of performance shares contingent on multiple, exacting multi-year performance criteria in order to ensure that our equity-based compensation plans incentivize overall performance. Failure to achieve those criteria over the entire performance measurement period results in a reduction or loss of the initial grant.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order to align equity-based compensation with our long-term performance, performance is measured over three financial years (the &#8220;vesting period&#8221;). Awards of performance shares are also contingent on continued employment in the Sanofi group during the vesting period, followed by stringent lock-up obligations in the case of the Chief Executive Officer (see below).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The terms of prior awards cannot be reset subsequently, for instance with less exacting performance conditions.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation policy for directors</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Directors hold office for a four-year term, as specified in our Articles of Association. They may be removed from office by a shareholders' meeting, at any time and without restriction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The maximum annual amount of overall compensation allocated to the directors has been set at &#8364;2,000,000 since&#160;2020. Given the increasing number of Board and committee meetings and in order to be able to compensate the Directors in accordance with the compensation policy, the forthcoming Annual General Meeting of Sanofi shareholders will be asked to amend this maximum annual amount to &#8364;2,500,000, with effect from the 2023 financial year. The fixed and variable compensation for directors will remain unchanged.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The arrangements for allocating the overall annual amount set by the Annual General Meeting between the directors are determined by the Board of Directors, acting on a recommendation from the Compensation Committee. Directors&#8217; compensation comprises (i)&#160;an annual fixed amount of &#8364;30,000, apportioned on a time basis for directors who assumed or left office during the year, and (ii)&#160;a variable amount, allocated by the Board according to actual attendance at Board and Committee meetings. As required by the AFEP-MEDEF Code, directors&#8217; compensation is allocated predominantly on a variable basis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows how the variable amount payable to directors for attendance at Board and committee meetings is determined; the allocation was last changed in 2020</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">114</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:35.653%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Compensation per meeting</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Directors<br/>resident in France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Directors&#160;resident outside France but within Europe</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Directors&#160;resident outside Europe</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chairman/Chairwoman</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board of Directors</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;5,500</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,250</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;11,000</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Audit Committee</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,250</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,250</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,250</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;11,000</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compensation Committee</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;5,500</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,250</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;11,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,250</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Appointments, Governance and&#160;CSR Committee </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;5,500</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,250</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,250</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,250</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Strategy Committee</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;5,500</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,250</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;11,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Determined by reference</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;to place of residence</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Scientific Committee</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;5,500</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,250</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;11,000</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Determined by reference </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to place of residence</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Directors who take part via videoconference receive compensation equivalent to that paid to a director resident in France attending in person. Committee Chairs continue to receive the usual compensation in respect of the Committee they chair.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As an exception, in certain cases two meetings held on the same day give entitlement only to a single payment:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if on the day of a Shareholders&#8217; General Meeting, the Board of Directors meets both before and after the Meeting, only one payment is made for the two Board meetings; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if on the same day a director participates in a meeting of the Compensation Committee and a meeting of the Appointments, Governance and CSR Committee, only the higher of the two payments is made to cover both meetings.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The introduction of a separate compensation scale depending on whether or not the director is a European resident is intended to take into account the significantly longer travel time required to attend meetings in person.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Directors do not receive any exceptional compensation or equity-based compensation and have no entitlement to a top-up pension plan.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Neither the Chairman of the Board nor the Chief Executive Officer receives any compensation for serving as a director.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with Sanofi's Articles of Association, the Board may compensate non-voting members by allocating sums from the annual amount allotted by the Annual General Meeting to Board members (see above). Acting on a recommendation from the Compensation Committee, which took into account the time spent by the non-voting member on the induction process ahead of his future appointment as Chairman of the Board, the Board of Directors decided to allocate him the same compensation as is allocated to the other Board members.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation policy for the Chairman of the Board of Directors</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The term of office of the Chairman of the Board is the same as that of the other directors (four years), and the Chairman&#8217;s term is aligned with his term of office as a director. He may be removed from office at any time by the Board of Directors. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The compensation policy for the Chairman of the Board of Directors is discussed by the Compensation Committee, which then makes a recommendation to the Board of Directors. The Chairman of the Board is not a member of the Committee, and does not attend meetings where his compensation is discussed. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The compensation of the Chairman of the Board of Directors (where the office of Chairman is separate from that of Chief Executive Officer, as is currently the case) consists solely of fixed compensation and benefits in kind and excludes any variable or exceptional compensation, any awards of stock options or performance shares, and any compensation for serving as a director.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The annual fixed compensation awarded to the current Chairman of the Board of Directors is&#160;&#8364;800,000&#160;gross, unchanged since 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At its meeting of February 22, 2023, the Board of Directors considered the compensation of the future Chairman of the Board of Directors. Acting on a recommendation from the Compensation Committee, which took into account the practices of comparable CAC 40 companies, the Board set the compensation of the future Chairman of the Board of Directors at &#8364;880,000 gross&#160;with effect from May&#160;26, 2023. That amount also takes account of the specific remit of the Chairman of the Board of Directors as described in the Sanofi Board Charter, and of the intention to propose that the future Chairman of the Board of Directors will sit on the same committees as the current Chairman of the Board of Directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The compensation of the Chairman of the Board of Directors is not subject to annual review.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Where the office of Chairman is separate from that of Chief Executive Officer, the Chairman of the Board is not entitled to the Sanofi top-up defined-contribution pension plan.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Nor is he entitled to a termination benefit or a non-compete indemnity.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chairman of the Board does not receive compensation for chairing Board meetings, or as a member of Board committees.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">115</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation policy for the Chief Executive Officer</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">General principles</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Chief Executive Officer is not appointed for a fixed term of office. He may be removed from office on legitimate grounds  at any time by the Board of Directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The compensation policy for the Chief Executive Officer is established by the Board of Directors, acting on the recommendation of the Compensation Committee. The compensation structure is not subject to annual review and is applicable for as long as it remains unchanged. The arrangements for implementing the policy may vary from year to year; a table showing the changes made to those arrangements in 2023 and 2022 is provided at the end of the present section.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The compensation of the Chief Executive Officer is determined with reference to compensation awarded to the chief executive officers of the following 12&#160;leading global pharmaceutical companies</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">: Amgen, AstraZeneca plc, Bayer AG, Bristol-Myers-Squibb Inc., Eli Lilly and Company Inc., GlaxoSmithKline plc, Johnson &amp; Johnson Inc., Merck Inc., Novartis AG, Novo Nordisk, Pfizer Inc., and Roche Holding Ltd. This panel comprises companies that are comparable to Sanofi, with no limitation as to geographical region given that Sanofi operates in a particularly competitive international environment. Consistency with market practice is fundamental in order to attract and retain the talents necessary to our success. In 2022, on the basis of information published as of the date of this Annual Report on Form&#160;20-F, the median fixed compe</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">nsation of the chief executive officers of the aforementioned twelve leading global pharmaceutical companies was in the region of &#8364;1,613,000; the median of the annual variable compensation awarded was in the region of &#8364;2,665,000; and the median of the long-term compensation awarded (whether equity-based or in cash) represented around 790% of fixed compensat</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ion. Within this peer group, Paul Hudson's overall compensation (fixed, variable and equity-based compensation) lies in the low range of the second quartile </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">of the compensation paid by the panel companies.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> The practices of the main CAC&#160;40 companies are also tak</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">en into account</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(18)</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">On taking up office</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When the Chief Executive Officer is an outside appointment, the Board of Directors may decide, acting on a recommendation from the Compensation Committee, to compensate the appointee for some or all of the benefits he may have forfeited on leaving his previous employer. In such a case, the terms on which the Chief Executive Officer is hired aim to replicate the diversity of what was forfeited, with a comparable level of risk (variable portion, medium-term equity-based or cash compensation).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">During the term of office</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Compensation structure</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our policy aims at achieving and maintaining a balance in the compensation structure between fixed compensation, benefits in kind, short-term variable cash compensation, and medium-term variable equity-based compensation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The compensation policy for the Chief Executive Officer is designed to motivate and reward performance by ensuring that a significant portion of compensation is contingent on the attainment of financial, operational and extra-financial criteria that reflect Sanofi&#8217;s objectives, and are aligned with the corporate interest and with the creation of shareholder value. Variable cash compensation and equity-based compensation are the two principal levers for action, and are intended to align the interests of the Chief Executive Officer with those of our shareholders and stakeholders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During the meeting that follows the Board meeting held to close off the financial statements for the previous year, the Compensation Committee examines the levels of attainment of variable compensation for that year. In advance of that meeting, the Chief Executive Officer presents the Committee with a report containing narrative and quantitative information necessary to measure attainment of the objectives. The members of the Compensation Committee then discuss the information provided and report to the Board on those discussions, giving an evaluation of the Chief Executive Officer&#8217;s performance against each of the criteria (determining the level of attainment for quantitative objectives, and evaluating the level of attainment for qualitative objectives).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Annual fixed compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The annual fixed compensation of the Chief Executive Officer has been set at &#8364;1,400,000 gross since 2022. It had previously remained unchanged since 2019.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of fixed compensation is not subject to annual review. It may however be changed, provided that such changes are not material:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on the appointment of a new Chief Executive Officer, to reflect the new appointee&#8217;s competencies and/or then current market practice; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in exceptional circumstances, to take account of changes in (i)&#160;the role or responsibilities of the Chief Executive Officer, for example in terms of market conditions or the size of the Sanofi group or (ii)&#160;the performance level of Sanofi over a given period.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(18)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Surveys conducted on the basis of data communicated by Pay Governance and Boracay.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">116</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Annual variable compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Annual variable compensation is in a range between 0% and 250% of fixed compensation, with a target of 150%. It is subject to a&#160;range of varied and exacting performance criteria, both quantitative and qualitative. The criteria are reviewed annually in light of&#160;the strategic objectives determined by Sanofi. The Board of Directors sets the criteria for each year at the start of that year on&#160;the recommendation of the Compensation Committee. For 2023, the criteria are</span><span style="background-color:#def3c0;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">50% based on financial indicators published by the Company: sales growth, business net income (BNI), free cash flow (FCF) and business operating income (BOI) margin and growth in new assets, each accounting for 10%. FCF and BOI margin were chosen because they are in line with the Company's strategic roadmap; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">50% based on specific individual objectives, including criteria linked to CSR criteria for Sanofi (partly quantitative), underlining the Board&#8217;s commitment to long-term value creation. The individual objectives set for variable remuneration for 2023 are described in &#8220;&#8212;&#160;Compensation and benefits of all kinds awarded to corporate officers in respect of&#160;2023&#8221; below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Overall, the quantitative element of the financial and individual objectives is in a range between 65% and 70%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The percentage of variable compensation linked to the attainment of quantitative criteria may be scaled down regardless of actual performance, in order to give greater weight to the attainment of qualitative criteria. This flexibility can only operate to reduce the amount of variable compensation, and cannot compensate for underperformance on quantitative criteria.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Payment of annual variable compensation in a given year in respect of the previous year is contingent on a favorable shareholder vote at the Annual General Meeting.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Equity-based compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chief Executive Officer&#8217;s equity-based compensation, which can only be in the form of performance shares, may not exceed 250% of his target short-term compensation (fixed plus variable).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chief Executive Officer&#8217;s equity-based compensation is contingent upon attainment of exacting performance conditions, all of them quantitative, measured over a three-year-period. Such awards are contingent upon both:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">internal criteria based upon:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">BNI and FCF &#8211; financial criteria, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">Affordable Access and Healthy Planet &#8211; extra-financial criteria; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">an external criterion based upon total shareholder return (TSR) relative to a benchmark panel of twelve of the leading global pharmaceutical companies: Amgen, AstraZeneca plc, Bayer AG, Bristol-Myers-Squibb Inc., Eli Lilly and Company Inc., GlaxoSmithKline plc, Johnson &amp; Johnson Inc., Merck Inc., Novartis AG, Novo Nordisk, Pfizer Inc., and Roche Holding Ltd.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The inclusion in equity-based compensation plans from 2023 of measurable, material extra-financial criteria aligned with Sanofi's strategy follows a recommendation from the Compensation Committee, which took the view that such a policy would embed a link in the long-term compensation of the Chief Executive Officer and all other beneficiaries of equity-based compensation plans.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The valuation of performance shares is calculated at the date of grant, weighted between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;the market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Each award to our Chief Executive Officer takes into account previous awards and his overall compensation. In any event, the maximum number of shares to be delivered may not be more than the number of performance shares initially awarded.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For details of the award to the Chief Executive Officer in respect of 2023, refer to &#8220;&#8212;&#160;Compensation and benefits of all kinds awarded to corporate officers in respect of&#160;2023&#8221; below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">Share ownership and lock-up obligation of the Chief Executive Officer</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chief Executive Officer is bound by the same obligations regarding share ownership specified in our Articles of Association and Board Charter as our other corporate officers.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, until he ceases to hold office the Chief Executive Officer is required to retain a quantity of Sanofi shares equivalent to&#160;50% of any gain (net of taxes and social contributions) arising on the vesting of performance shares, calculated as of the date on which those shares vest. Those shares must be retained in registered form until he ceases to hold office.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In compliance with the AFEP-MEDEF Code and our Board Charter, the Chief Executive Officer must undertake to refrain from entering into speculative or hedging transactions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Multi-year variable compensation</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chief Executive Officer does not receive multi-year variable compensation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Compensation for serving as a director</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Executive officers of Sanofi do not receive any compensation for serving as directors. Consequently, the Chief Executive Officer does not receive compensation in his capacity as a director or as a member of the Strategy Committee.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Exceptional compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No exceptional compensation can be awarded to the Chief Executive Officer.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">117</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">On leaving office</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chief Executive Officer is entitled to a top-up defined-contribution pension plan, a termination</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> benefit, and a non-compete indemnity.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Such arrangements are part of the overall compensation package generally awarded to executive officers; in line with recommendations of the AFEP-MEDEF code, there are very strict rules about how they are implemented. The termination benefit and non-compete indemnity are intended to compensate for the fact that the Chief Executive Officer may be dismissed at any time.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Each of those benefits is taken into account by the Board of Directors when fixing the overall compensation of the Chief Executive Officer.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Pension arrangements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chief Executive Officer is entitled to benefits under the top-up defined-contribution pension plan introduced within Sanofi on January&#160;1, 2020. This is a collective plan falling within the scope of Article&#160;82 of the French General Tax Code. It is also offered to members of our Executive Committee and all senior executives whose position is classified within the Sanofi grade scale as&#160;&#8220;Executive&#160;Level&#160;1 or&#160;2&#8221;. The Chief Executive Officer's entitlement under this plan may be withdrawn by a decision of the Board of Directors, but not retroactively.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the terms of the plan, the Chief Executive Officer receives an annual contribution the amount of which (subject to attainment of a performance condition) may be up to 25% of his reference compensation (annual fixed and variable cash-based compensation only; all other compensation is excluded). The rights accruing under the plan are those that are generated by the capitalization contract taken out with the insurer, and vest even if the Chief Executive Officer does not remain with Sanofi until retirement. The Chief Executive Officer may elect for the rights to be transferable as a survivor's pension.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The performance condition is as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if the level of attainment for variable compensation is equal to or greater than the target (i.e. 150% of fixed compensation), 100% of the contribution is paid;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if the level of attainment for variable compensation is less than 100% of fixed compensation, no contribution is paid; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">between those two limits, the contribution is calculated on a prorata basis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because this performance condition is linked to the attainment of the performance criteria for annual variable compensation (which itself is determined with reference to the strategic objectives of Sanofi), it ensures that no pension contributions could be made in the event that the Chief Executive Officer fails to deliver.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The plan is wholly funded by Sanofi, which pays the full amount of the gross contributions. Because it is treated as equivalent to compensation, the contribution is subject to payroll taxes and employer&#8217;s social security charges, and to income tax in the hands of the Chief Executive Officer; all of the above are charged on the basis of the bands, rates and other conditions applicable to compensation, paid and declared on his payslips for the contribution period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subject to (i)&#160;formal confirmation by the Board of Directors that the performance condition for the previous year has been met and (ii)&#160;approval of the Chief Executive Officer's compensation package for that year by the Annual General Meeting of our shareholders, the annual gross contribution is paid as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">50% as a gross insurance premium to the fund manager; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">50% to the Chief Executive Officer, to indemnify him for the social security and tax charges for which he will become immediately liable.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with Article&#160;39.5&#160;bis of the French General Tax Code, deferred compensation as defined in section&#160;4 of&#160;Article&#160;L.&#160;22-10.9 of the French Commercial Code can be offset against corporate profits as a taxable expense up to a limit set at three times the annual social security ceiling per beneficiary.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The pension entitlement is not cumulative with (i)&#160;any termination benefit paid in the event of forced departure or (ii)&#160;any non-compete indemnity.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Termination arrangements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The termination benefit only becomes payable if the departure of the Chief Executive Officer is forced, i.e. in the event of removal from office or resignation linked to a change in strategy or control of the Company. Compensation for non-renewal of the term of office is irrelevant in the case of the Chief Executive Officer, because this office is held for an indefinite term.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, no termination benefit is payable and the arrangement is deemed to have been rescinded in the following circumstances:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">removal from office for gross or serious misconduct </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(faute grave ou lourde)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if the Chief Executive Officer elects to leave Sanofi to take up another position;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if the Chief Executive Officer is assigned to another position within Sanofi; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if the Chief Executive Officer takes his pension.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Payment of the termination benefit is contingent upon fulfillment of a performance condition, which is deemed to have been met if the attainment rate for the individual variable compensation objectives exceeded 90% of the target; that condition is assessed over the three financial years preceding the Chief Executive Officer leaving office.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">118</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of the termination benefit is capped at 24&#160;months of the Chief Executive Officer&#8217;s most recent total compensation on the basis of (i)&#160;the fixed compensation effective on the date of leaving office and (ii)&#160;the last variable compensation received prior to that date subject to fulfilment of the performance condition.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of the termination benefit is reduced by any amount received as consideration for the non-compete undertaking, such that the aggregate amount of those two benefits may never exceed two years of total fixed and variable compensation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Non-compete undertaking</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the event of his departure from the Company, the Chief Executive Officer undertakes, during the 12-month period following his departure, not to join a competitor of Sanofi as an employee or corporate officer, or to provide services to or cooperate with such a competitor.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In return for this undertaking, he receives an indemnity corresponding to one year&#8217;s total compensation, based on his fixed compensation effective on the day he leaves office and on the last individual variable compensation he received prior to that date. This indemnity is payable in 12&#160;monthly installments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">However, the Board of Directors reserves the right to release the Chief Executive Officer from that undertaking for some or all of that 12-month period. In such cases, the non-compete indemnity would not be due for the period of time waived by the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Consequences of the Chief Executive Officer&#8217;s departure for equity-based compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If the Chief Executive Officer leaves Sanofi for reasons other than resignation or removal from office for gross or serious misconduct (in which case any award of equity-based compensation is forfeited in full), the overall allocation percentage is prorated to reflect the amount of time the Chief Executive Officer remained with Sanofi during the vesting period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If at any time prior to the expiration of the vesting period of his performance shares the Chief Executive Officer joins a competitor of Sanofi as an employee or corporate officer, or provides services to or cooperates with such a competitor, he irrevocably loses those performance shares regardless of any full or partial discharge by the Board of Directors of the non-compete undertaking relating to his office as Chief Executive Officer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since 2021, if the Chief Executive Officer retires at statutory retirement age prior to the expiration of the vesting period of his performance shares, the overall allocation rate will be apportioned on a prorata basis to reflect the amount of time for which the Chief Executive Officer remained in the employment of Sanofi during the vesting period.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Summary of benefits awarded to the Chief Executive Officer on leaving office</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below presents a summary of the benefits (as described above) that could be claimed by the Chief Executive Officer on leaving office, depending on the terms of his departure. The information provided in this summary is without prejudice to any decisions that may be made by the Board of Directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:15.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.557%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Voluntary departure/Removal from office for gross or serious misconduct</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forced departure</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retirement </span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Termination benefit</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24 months of fixed compensation as of the date of leaving office</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24 months of most recent individual variable compensation received</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts received as non-compete indemnity</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">/</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-compete indemnity</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12 months of fixed compensation as of the date of leaving office<br/>+<br/>12 months of most recent individual variable compensation received prior to leaving office </span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12 months of fixed compensation as of date of leaving office</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+</span></div><div style="margin-bottom:1pt;padding-right:6.75pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;months&#160;of&#160;most&#160;recent individual variable compensation&#160;received prior to leaving office</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">/</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Top-up pension</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Annual contribution of up to 25% of reference compensation </span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Performance share plans not yet vested</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeited in full</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rights retained prorata to period of employment within Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rights retained prorata to period of employment within Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">i(f)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The amount of the termination benefit is reduced by any indemnity received as consideration for the non-compete undertaking, such that the aggregate amount of those two benefits may never exceed two years of total fixed and variable compensation.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Board of Directors may decide to release the Chief Executive Officer from the non-compete undertaking for some or all of the 12-month period. In that case, the non-compete indemnity would not be due, or would be scaled down proportionately.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Defined-contribution pension plan, within the scope of Article&#160;82 of the French General Tax Code. Subject to fulfillment of the performance condition, assessed annually.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Subject to fulfillment of the performance condition assessed over the three financial years preceding departure from office, as described above.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Subject to the Board of Directors enforcing the non-compete undertaking, the amount of the termination benefit is reduced by any indemnity received as consideration for the non-compete undertaking, such that the aggregate amount of those two benefits may never exceed two years of total fixed and variable compensation.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;In this case, the Chief Executive Officer remains subject to the terms of the plans, including the performance conditions and the non-compete clause.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">119</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Policy to recover erroneously-awarded compensation (&#8220;clawback&#8221;)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November 28, 2022, the SEC adopted rules, pursuant to Section 10D-1 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, requiring national securities exchanges and national securities associations, such as the NASDAQ, to amend their relevant listing standards no later than November 28, 2023 to require companies with listed securities to put in place a policy whereby listed</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> companies will recover erroneously-awarded variable compensation from the Chief Executive Officer and certain other &#8220;executive officers&#8221; as defined in Section 10D-1(d). As of the date of publication of this Annual Report on Form 20-F, the NASDAQ listing standards have not yet been amended pursuant to Section 10D-1 of the Exchange Act. Consequently, Sanofi will adopt a clawback mechanism once the final rules are adopted. In particular, in accordance with Section 10D-1 of the Exchange Act and the requirements to be adopte</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">d by NASDAQ in its revised listing rules, the Board of Directors will adopt a clause requiring the recovery in full or in part of the components of the Chief Executive Officer's compensation that are wholly or partially contingent on the attainment of financial performance criteria based on financial information that has been determined to be erroneous and has required restatement of the financial statements for accounting purposes. The compensation policy of the Chief Executive Officer will be presented to our shareholders at our Annual General Meeting to be held on May 25, 2023.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:9pt;font-weight:400;line-height:120%">Summary of changes made to the compensation policy for the Chief Executive Officer</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below summarizes adjustments made to how the compensation policy for the Chief Executive Officer is implemented. Some of them been thoroughly discussed with our shareholders.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:48.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify;text-indent:6.66pt"><span><br/></span></div><div style="padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">&#160;&#160;Annual variable compensation:</span></div><div style="padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:6.93pt">To reflect shareholder expectations, Sanofi is from now on disclosing the content of the qualitative criteria.</span></div><div style="text-align:justify;text-indent:6.66pt"><span><br/></span></div><div style="padding-left:14.17pt;text-align:justify;text-indent:-14.18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:11.79pt">Variable equity-based compensation:</span></div><div style="padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:6.93pt">In order to link share-based compensation (long-term compensation) to the execution of the Group's CSR strategy, measurable and material CSR criteria have been introduced into performance share plans awarded in or after 2023.</span></div><div style="text-align:justify;text-indent:6.66pt"><span><br/></span></div><div style="padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Clawback Policy:</span></div><div style="padding-left:22.68pt;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:6.93pt">Pursuant to Section 10D-1 of the Exchange Act, SEC regulations and NASDAQ listing rules, the Board of Directors will adopt  a clause allowing for the recovery of some or all of the components of the Chief Executive Officer's compensation that are wholly or partially contingent on the attainment of financial performance criteria based on erroneous financial information (see above).</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%;padding-left:8.95pt">Annual fixed compensation:</span></div><div style="padding-left:22.68pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%;padding-left:6.93pt">Annual fixed compensation is increased to &#8364;1,400,000 gross with effect from 2022.</span></div><div style="text-indent:6.66pt"><span><br/></span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%;padding-left:8.95pt">Annual variable compensation:</span></div><div style="padding-left:22.68pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%;padding-left:6.93pt">Sanofi now publishes the content of the individual CSR performance objective (sub-criteria).</span></div><div style="text-indent:6.66pt"><span><br/></span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%;padding-left:8.95pt">Variable equity-based compensation:</span></div><div style="padding-left:22.68pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%;padding-left:6.93pt">The external criterion based on Total Shareholder Return (TSR) will no longer be measured in absolute value (ranking) but in relative terms (variation from the previous ranking), with the caveat  that for the Chief Executive Officer any TSR-linked payment will remain contingent on Sanofi achieving a rank greater than or equal to the median of the TSR panel.</span></div></td></tr></table></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Arrangements in favor of executive officers in office as of December&#160;31, 2022 (table No.&#160;11 of the AFEP-MEDEF Code)</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:17.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Executive officer </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Contract&#160;of employment</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Top-up<br/>pension plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Indemnities or benefits<br/>payable or<br/>potentially payable<br/>on&#160;cessation of office</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Indemnities<br/>payable under<br/>non-compete clause</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chairman of the Board</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">No</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Yes</span></td></tr></table></div><div id="i52f57172a9d7443580346c2d8f39cd2b_295"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation and benefits of all kinds paid during 2022 or awarded in&#160;respect of 2022 to&#160;corporate officers</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The section below constitutes the report on compensation of corporate officers required by Article&#160;L.&#160;225-37 of the French Commercial Code. The arrangements described therein will be submitted for approval by our shareholders at the Annual General Meeting called to approve the financial statements for the year ended December&#160;31, 2022 pursuant to Article&#160;L.&#160;22-10-34 of the French Commercial Code.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_298"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Compensation elements and benefits of all kinds paid during 2022 or awarded in respect of 2022 to directors (table No.&#160;3 of the AFEP-MEDEF Code)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The compensation policy for directors (as described above in the section entitled &#8220;&#8212;&#160;Compensation policy for directors&#8221;) defines the fixed amount of compensation, and the principles for allocating the variable portion between directors, up to the limit of the overall amount approved by the Annual General Meeting.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Directors&#8217; compensation includes an annual fixed payment, apportioned on a time basis for directors who assumed or left office during the year; and a variable amount, allocated by the Board according to actual attendance at Board and Committee meetings. As required by the AFEP-MEDEF Code, directors&#8217; compensation is allocated predominantly on a variable basis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2022, directors&#8217; compensation was determined in accordance with the compensation policy for directors as described above in the section entitled &#8220;&#8212;&#160;Compensation policy for directors&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows amounts paid in respect of 2022 and 2021 to each member of our Board of Directors, including those whose term of office ended during those years.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Directors&#8217; compensation for 2021, the amount of which was approved at the Board meeting of February&#160;22, 2022, was partially paid in July&#160;2021, with an additional payment in 2022.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">120</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Directors&#8217; compensation for 2022, the amount of which was approved at the Board meeting of February&#160;22, 2023, was partially paid in July&#160;2022, with an additional payment to be made in 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The notional amount of compensation to which directors were entitled for 2022 exceeded the maximum annual amount set by the Annual General Meeting, due to more Board and committee meetings (eight extra meetings in total) being held in 2022; (ii)&#160;most of those meetings being face-to-face; and the international profile of two of the new directors. As a result, compensation was apportioned between the directors on a pro rata basis, such that directors had to be paid less than the agreed amount per meeting (variable portion).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acting on a recommendation from the Compensation Committee, which took into account the time spent by the non-voting member on the induction process ahead of his future appointment as Chairman of the Board, the Board of Directors decided to allocate him the same compensation as is allocated to the other Board members.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:20.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364;)</span></div></td><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Compensation in respect of 2022</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Compensation in respect of 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fixed<br/>portion</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Variable<br/>portion</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total amount (variable + fixed portion)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total gross compensation apportioned on a pro rata basis</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(*)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fixed<br/>portion</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Variable<br/>portion</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total gross<br/>compensation</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Laurent Attal </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33,000&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43,000&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Christophe Babule</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129,250&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">159,250&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">134,912&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bernard Charl&#232;s </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rachel Duan </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115,500&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145,500&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123,263&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Carole Ferrand</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82,500&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">102,500&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86,835&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lise Kingo </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">140,250&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">170,250&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">144,231&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patrick Kron</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">134,750&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">164,750&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">139,571&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">148,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wofgang Laux </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)(f)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99,966&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Barbara Lavernos</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">109,285&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabienne Lecorvaisier</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">143,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146,560&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Melanie Lee </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46,750&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56,750&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56,750&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">107,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Marion Palme </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(h)</span></div></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carole Piwnica </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35,750&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45,750&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45,750&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gilles Schnepp</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">154,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">184,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155,879&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">151,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Christian Senectaire</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diane Souza </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206,250&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">236,250&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,144&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">167,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thomas S&#252;dhof </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203,500&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">233,500&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">197,814&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Yann Tran </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)(i)(j)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">107,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90,647&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Emile Voest </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)(k)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">101,750&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121,750&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">103,143&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Antoine Yver </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)(k)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137,500&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157,500&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">133,429&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fr&#233;d&#233;ric Oud&#233;a </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(l)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27,500&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37,500&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31,769&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">420,000</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,922,250</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,342,250</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,999,948</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">400,000</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,199,000</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,599,000</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total&#160;</span></td><td colspan="11" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,999,948</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="9" style="background-color:#23004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(*) Due to the high number of Board and committee meetings in 2022, the theoretical amount of compensation payable to directors exceeded the maximum amount set by the Annual General Meeting of our shareholders. Consequently, the amount payable to each director has been scaled down on a pro rata basis. </span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">The amounts reported are gross amounts before taxes.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Director who resigned from office in 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Director who left office on April&#160;30, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Director resident outside Europe.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Director resident outside France but within Europe.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) Director appointed by the European Works Council.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(f) Director representing employees.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g) Director who resigned from office on May 2, 2022. </span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(h) Director who left office on April&#160;28, 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(i) Compensation due to Yann Tran is paid directly to F&#233;d&#233;ration Chimie &#201;nergie CFDT.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(j) Director appointed by the CFDT, the leading trade union organization with Sanofi in France.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(k) Director appointed by the General Meeting of May 3, 2022. </span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(l) Non-voting board member appointed by the Board on September 2, 2022. </span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Each of the two directors representing employees has a contract of employment with a Sanofi subsidiary, under which they receive compensation unrelated to their office as director. Consequently, that remuneration is not disclosed.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Variable compensation allocated to directors in respect of 2022 represented 82% of their total compensation.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">121</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_301"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Compensation and benefits of all kinds paid during 2022 or awarded in respect of&#160;2022 to Serge&#160;Weinberg, Chairman of the Board of Directors</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Serge Weinberg has held the office of Chairman of the Board of Directors since May&#160;17, 2010. He has never had, and does not currently have, a contract of employment with Sanofi. He will leave office at the conclusion of the Annual General Meeting on&#160;May&#160;25, 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chairman of the Board is a member of the Appointments, Governance and CSR Committee (which he chaired until December&#160;15, 2021), the Scientific Committee and the Strategy Committee.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The remit of the Chairman of the Board is specified in the Board Charter, which is reproduced in its entirety in Exhibit&#160;1.2. to this Annual Report on Form&#160;20-F.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During the course of 2022, the Chairman&#8217;s activities included:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">chairing all the meetings of the Board of Directors (12&#160;in 2022) and of the Committees of which he is a member (six meetings of the Appointments, Governance and CSR Committee, four meetings of the Strategy Committee and six meetings of the Scientific Committee), and participating in Committee meetings to which he was invited (Audit Committee and Compensation Committee);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">close monitoring of the proper implementation of the decisions taken by the Board;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">meetings with directors, including (i)&#160;on the appointment of Carole Ferrand, Emile Voest and Antoine Yver, to explain to them how the Board operates and answer their questions, (ii)&#160;in connection with the evaluation of the Board&#8217;s operating procedures, and (iii)&#160;on matters relating to the projects presented to the Board;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">regular meetings with the members of the Executive Committee;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">meetings with Sanofi employees;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">visits to subsidiaries of Sanofi;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">meetings with biotechs and medtechs;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">organizing two strategy seminars, in April and October&#160;2022; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">representing Sanofi at events or official meetings (in France and abroad) with representatives of the public authorities and other stakeholders, in line with his remit as defined by the Board Charter.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chairman also has a role in explaining positions taken by the Board within its sphere of competence, especially in terms of strategy, governance and executive compensation. In furtherance of this role, Serge Weinberg drew on his experience of corporate communication&#160;in:</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">answering letters from investors and shareholders;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">holding meetings with certain shareholders and proxy advisors; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">attending a meeting of the Individual Shareholders Committee at Sanofi headquarters in March&#160;2022, to discuss what Sanofi had achieved in 2021 and answer questions about the Company&#8217;s latest news, future prospects and dividend policy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Those tasks were carried out in coordination with the Chief Executive Officer.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Compensation awarded in respect of the 2022 financial year</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;22, 2022, acting on a recommendation from the Compensation Committee, the Board of Directors determined the components of Serge Weinberg&#8217;s compensation for the 2022 financial year, taking into account the nature of his duties and the level of his involvement in the work of the Board and in broader corporate governance matters.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For the 2022 financial year, Serge Weinberg&#8217;s annual fixed compensation was &#8364;800,000, unchanged from 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In line with our compensation policy for the Chairman of the Board, as approved by our shareholders at the Annual General Meeting of May&#160;3, 2022, he did not receive any variable compensation and was not awarded any stock options or performance shares. He received no compensation for serving as a director, and no compensation from any company included in Sanofi&#8217;s scope of consolidation within the meaning of Article&#160;L.&#160;233-16 of the French Commercial Code.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount reported for benefits in k</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ind (&#8364;7,740 in 2</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">022) relates to a company car with a driver.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Serge Weinberg is not covered by the Sanofi defined-contribution pension plan.</span></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Compensation, options and shares awarded to Serge Weinberg (table No.&#160;1 of the AFEP-MEDEF Code)</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:70.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364;)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compensation awarded for the year (details provided in the following table)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">807,740</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">807,740</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Valuation of stock options awarded during the year</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Valuation of performance shares awarded during the year</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Valuation of other long-term compensation plans</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">807,740</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">807,740</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">122</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Compensation awarded to Serge Weinberg (table No.&#160;2 of the AFEP-MEDEF Code)</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:41.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364;)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amounts <br/>due </span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amounts <br/>paid</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amounts <br/>due</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amounts <br/>paid</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixed compensation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">800,000</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">800,000</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">800,000</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">800,000</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Annual variable compensation</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exceptional compensation</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compensation for serving as a director</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits in kind</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,740</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,740</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,740</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,740</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">807,740</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">807,740</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">807,740</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">807,740</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">The amounts reported are gross amounts before taxes.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Fixed compensation due in respect of a given year is paid during that year.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_304"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Compensation and benefits of all kinds paid during 2022 or awarded in respect of&#160;2022 to Paul Hudson, Chief Executive Officer</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Paul Hudson has served as Chief Executive Officer of Sanofi since September&#160;1, 2019, and holds office for an indeterminate period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Paul Hudson does not have a contract of employment with Sanofi, and receives no compensation from any company included in Sanofi&#8217;s scope of consolidation within the meaning of Article&#160;L.&#160;233-16 of the French Commercial Code.</span></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Compensation awarded to Paul Hudson (table No.&#160;1 of the AFEP-MEDEF Code)</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:66.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364;)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compensation awarded for the year (details provided in the following table)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,750,797</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,731,332</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Valuation of performance shares awarded during the year</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,967,950</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,347,500</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,718,747</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,078,832</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The parameters used to calculate the valuations are market parameters available in the financial press.</span></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Fixed and variable compensation awarded to Paul Hudson (table No.&#160;2 of the AFEP-MEDEF Code)</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:32.743%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.102%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364;)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amounts <br/>due</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amounts </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">paid </span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amounts <br/>due</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amounts <br/>paid</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixed compensation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,400,000</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,400,000</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,300,000</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,300,000</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Annual variable compensation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,337,300</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,308,800</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,308,800</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,213,250</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash bonus (sign-on bonus)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,013,534</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,013,534</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,011,750</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exceptional compensation</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compensation for serving as a director</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits in kind</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,497</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,998</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,998</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,998</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,750,797</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,731,332</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,631,332</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,533,998</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">The amounts reported are gross amounts before taxes.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Fixed compensation due in respect of a given year is paid during that year.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Variable compensation in respect of a given year is determined at the start of the following year and paid after the Annual General Meeting in that year, subject to shareholder approval.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Cash bonus in respect of the 2020 financial year (First Tranche of the Phantom Stock Units plan), vesting of which was subject to performance conditions (see separate section below). Paul Hudson was awarded 25,000&#160;Phantom Stock Units in respect of 2020. The amount mentioned corresponds to the final valuation of the&#160;25,000&#160;Phantom Stock Units, determined as of March&#160;30, 2021 (the vesting date of the First Tranche).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Cash bonus in respect of the 2021 financial year (Second Tranche of the Phantom Stock Units plan), vesting of which was subject to performance conditions (see separate section below). The Board meeting of February&#160;22, 2022 formally noted the attainment level of the performance conditions, and the overall allocation rate. Paul Hudson was awarded 21,775&#160;Phantom Stock Units in respect of 2021. The amount disclosed in this table represents the final valuation of the 21,775&#160;Phantom Stock Units in respect of 2021 determined as of March&#160;31, 2022 (the vesting date of the Second Tranche).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fixed and variable compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;22, 2023, acting on a recommendation from the Compensation Committee, the Board of Directors determined the components of Paul Hudson&#8217;s compensation for the 2022 financial year.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chief Executive Officer's annual compensation for 2022 comp</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">rises (i)&#160;annual fixed gross compensation of &#8364;1,400,000; and&#160;(ii)&#160;in line with our compensation policy for the Chief Executive Officer as approved by our shareholders at the Annual General Meeting of May&#160;3, 2022, annual variable compensation in a range from 0% to 250% of his annual fixed compensation, with a target of 150%, and subject to both quantitative and qualitative criteria.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">123</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The objectives applicable to annual variable compensation are:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">50% based on financial indicators (sales growth, BNI, FCF, BOI margin and growth of new assets, each accounting for one-fifth); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">50% based on specific individual objectives. For 2022, the individual objectives set by the Board were:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">business transformation (15%) &#8211;&#160;quantitative and qualitative objective;</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">development pipeline (12.5%) &#8211;&#160;quantitative objective;</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">people and culture (7.5%) &#8211;&#160;quantitative and qualitative objective; and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">CSR (15%) &#8211;&#160;quantitative and qualitative objective.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Overall, the quantitative element of the financial and individual objectives is in a range between 65% and 70%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At the start of 2022, the Board established a precise matrix for determining each individual objective. For confidentiality reasons, the level of attainment required (target) for the quantitative criteria cannot be disclosed. To reflect shareholder expectations, Sanofi is from now on disclosing the content of the qualitative criteria. Those criteria are always assessed by reference to the performances of the leading global pharmaceutical companies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acting on a recommendation from the Compensation Committee, the Board of Directors meeting of February&#160;22, 2023 reviewed the attainment level of each criterion and sub-criterion. The Board&#8217;s conclusions are summarized in the table below.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#e3e3e3;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Criterion</span></td><td colspan="3" style="background-color:#e3e3e3;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Type</span></td><td colspan="3" style="background-color:#e3e3e3;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weight</span></td><td colspan="3" style="background-color:#e3e3e3;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Target/Maximum<br/>(as % of fixed compensation)</span></td><td colspan="3" style="background-color:#e3e3e3;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Attainment level</span></td><td colspan="3" style="background-color:#e3e3e3;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comments</span></td><td colspan="3" style="background-color:#e3e3e3;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payout<br/>(as % of fixed compensation)</span></td></tr><tr><td colspan="24" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial objectives</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Sales growth</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Quantitative</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">10%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">15% / 25%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">114.25%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Confidential target,</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Performance above budget</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">17.14&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Business net</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">income </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:112%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Quantitative</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">10%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">15% / 25%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">132.49%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Confidential target,</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Performance above budget</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">19.87&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Free cash flow</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Quantitative</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">10%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">15% / 25%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">118.49%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Confidential target,</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Performance above budget</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">17.77&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Business operating income margin</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Quantitative</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">10%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">15% / 25%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">102.0 %</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Confidential target,</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Performance equal to budget</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">15.30&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Growth in new key assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Quantitative</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">10%</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">15% / 25%</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">108.98%</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:112%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%"> and vaccines over budget, China under budget</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">16.35&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">%</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">124</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Criterion</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Type</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weight</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Target/Maximum<br/>(as % of fixed compensation)</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Attainment level</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comments</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payout<br/>(as % of fixed compensation)</span></td></tr><tr><td colspan="24" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Individual objectives</span></td></tr><tr style="height:90pt"><td colspan="6" rowspan="6" style="border-bottom:0.25pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Business Transformation</span></td><td colspan="3" rowspan="6" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Quantitative/</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Qualitative</span></div></td><td colspan="3" rowspan="6" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">15%</span></div></td><td colspan="3" rowspan="6" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">22.5% / 37.5%</span></div></td><td colspan="3" rowspan="6" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">100.50%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Specialty Care: </span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> sales: performance above target (quantitative)</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Market leadership achieved in the US for Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">On track to achieve pre-launch awareness goal on tolebrutinib</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Strong external engagement with key stakeholders, including Key Opinion Leaders (KOLs)</span></div></td><td colspan="2" rowspan="6" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">22.61&#160;</span></td><td rowspan="6" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">%</span></td></tr><tr style="height:105pt"><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Vaccines:</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Completion of critical activities to finalize the creation of the mRNA Center of Excellence (CoE) and advance mRNA + lipid nanoparticle (LNP) technology and pipeline across vaccines and specialty care</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Translate Bio integration completed with high retention rate of Translate Bio employees</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Prelaunch of Beyfortus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> (Nirsevimab) on track with key regulatory and commercial milestones achieved</span></div></td></tr><tr style="height:89pt"><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">General Medicines:</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Drive growth of core assets almost at budget  (quantitative),</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Successful launch of Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> in the US</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">New business models implemented in Europe, Eurasia, Africa and Indonesia in 2022</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Portfolio simplification, reaching 122 Product Families at year end, exceeding the 2022 target </span></div></td></tr><tr style="height:80pt"><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">CHC:</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Acceleration on digital, e-commerce sales below budget (quantitative)</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Carve-in: Deployment of standalone CHC with minimal business disruption (quantitative)</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Shift in timelines for Cialis</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> and Tamiflu</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> switches due to ongoing discussions with FDA</span></div></td></tr><tr style="height:113pt"><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Industrial Affairs:</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">IA transformation executed on plan</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> 2022 growth enabled by supply (quantitative) </span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Global launches: Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> successfully approved and launched, Olipudase successfully approved and launched, Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> growth, ALTUVIIIO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> (Efanesoctocog alpha): US submission completed and on track to launch</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Acceleration of IA performance through Digital: 4 pilot sites successfully launched for Sanofi Manufacturing System (SMS) 2.0 </span></div></td></tr><tr style="height:105pt"><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Digital:</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Contribution to BOI above budget target due to value creation (quantitative)</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Increase Health Care Provider engagement from digital: target met in all markets where digital solutions have been deployed</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Completion of all major digital, data and technology foundations (harmonized enterprise governance / single source of truth)</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:8.95pt">Commercial deployments slightly ahead of schedule</span></div></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">125</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Criterion</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Type</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weight</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Target/Maximum<br/>(as % of fixed compensation)</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Attainment level</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comments</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payout<br/>(as % of fixed compensation)</span></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">People &amp; Culture</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Quantitative/</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Qualitative</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">7.5%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">11.25% / 18.75%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">98.00%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Number of women recruited to positions at Level 5 and above - slightly below target (quantitative)  </span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Strong progress in embedding Play to Win culture (engagement score increased) (quantitative)</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Great progress in strengthening the succession pipeline for Key Value Driving Roles</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">New Employee Value Proposition built and launched in line with overall rebrand initiative in Q1</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Acceleration of the processes&#8217; simplification (above the original goal)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">11.03&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">%</span></td></tr><tr style="height:107pt"><td colspan="3" rowspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">CSR</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Further reinforce and expand on the CSR agenda </span></div></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Quantitative/</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Qualitative</span></div></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">15%</span></div></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">22.5% / 37.5%</span></div></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">110.00%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">CO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:112%;position:relative;top:0.98pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%"> emissions reduced by 3.8% above target (Scopes 1&amp;2) (quantitative)</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Leaders to citizens launched with completion of eLearning by senior leaders (quantitative)</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Successful launch of the Global Health Unit (GHU) in July 2022: Launch of non-profit Impact brand for 30 medicines in low-income countries, first concrete investment in Dec 2022</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Reached 185K patients with Non-Communicable Diseases (NCDs) over target (quantitative)</span></div></td><td colspan="2" rowspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">24.75&#160;</span></td><td rowspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">%</span></td></tr><tr style="height:51pt"><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Image and Reputation &amp; Compliance</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Successful launch of Sanofi&#8217;s ambition, purpose and brand identity (adoption of a single company ambition and a unifying purpose for all 4 GBUs, adoption of a single brand integrating Genzyme and Pasteur under One Sanofi) </span></div></td></tr><tr style="height:36pt"><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Compliance / Ethics &amp; Business Integrity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Development of the new Code of Conduct </span></div></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Development </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">pipeline</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Quantitative</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">12.5%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">18.75% / 31.25%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">118.0%</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">R&amp;D (Pharma + Vaccines) has achieved above execution focused KPI : 22 entries into M1, 12 development candidates M2, 9 assets entered clinical trials (FIH), 6 Ph 3 studies have been initiated, 7 submissions have been completed</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">14 approvals (vs 11 in 2021), among which are 2 NMEs (pharma) and 3 vaccines</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Progress in R&amp;D productivity</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Reinforcement of the pipeline through</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%"> Business Development or Acquisitions: 16 pharma and 6 vaccines partnerships signed, Acquisition and full integration of Amunix (pharma) and Origi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">mm Bio (vaccines)</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%;padding-left:8.95pt">Modernization of our portfolio management solutions for </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">long-term portfolio projections and simulations to support strategic decision and workforce planning</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">22.13&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;border-top:0.25pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;border-top:0.25pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100%</span></td><td colspan="3" style="background-color:#7802e6;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">150% / 250%</span></td><td colspan="3" style="background-color:#7802e6;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">111.30%</span></td><td colspan="3" style="background-color:#7802e6;border-top:0.25pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;border-top:0.25pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">166.95</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.25pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) For a definition, see &#8220;Item 5. Operating and Financial Review and Prospects &#8211; A.1.5. Business net income&#8221; in Sanofi&#8217;s 2022 Annual Report on Form 20-F.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acting on a recommendation from the Compensation Committee, the Board of Directors meeting of February&#160;22, 2023 set Paul&#160;Hudson&#8217;s variable compensation for 2022 at &#8364;2,337,300, equivalent to 166.95% of h</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">is fixed</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> compensation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Payment of Paul Hudson&#8217;s variable compensation in respect of the 2022 financial year is contingent on approval of his compensation package by the shareholders in an Ordinary General Meeting, on the terms stipulated in Article&#160;L.&#160;22-10-34&#160;II of the French Commercial&#160;Code.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">126</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Phantom stock units</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Having waived all equity-based compensation not yet vested when he left his previous employer, upon joining Sanofi, Paul Hudson was awarded on joining Sanofi a medium-term incentive plan providing for a cash bonus subject to continuous presence and&#160;performance conditions. Under the terms of the plan, which compensated for approximately 50% of the incentive plans that Paul&#160;Hudson waived, he was awarded Phantom Stock Units, the vesting of which was contingent on (i)&#160;his continuous presence and (ii)&#160;attainment of performance conditions, with the attainment level of those conditions to be determined for half of the award, i.e. 25,000&#160;phantom stock units, as of March&#160;30, 2021 (the &#8220;First Tranche&#8221;) and for the other half of the award, i.e.&#160;25,000&#160;phantom stock units, as of March&#160;31, 2022 (the &#8220;Second Tranche&#8221;). The cash bonuses corresponding to the 50,000&#160;Phantom Stock Units were paid in 2021 (First Tranche) and 2022 (Second Tranche); the bonus for the Second Tranche amounted to &#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2,013,534</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The main terms of the plan, including the performance conditions applicable to the Phantom Stock Units, are described on pages&#160;114 to&#160;116 of our 2021 Annual Report on Form&#160;20-F</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Equity-based compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Using the authorizations granted by our shareholders via the 24th&#160;resolution at the Annual General Meeting of April&#160;30, 2021, and acting on the recommendations of the Compensation Committee, the Board of Directors meeting of May 3, 2022 decided to&#160;award Paul Hudson 82,500&#160;performance shares in respect of 2022. The valuation of that award as of May&#160;3, 2022, determined in accordance with&#160;IFRS and incorporating a market-related condition, was &#8364;6,967,950, equivalent to </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">4.97</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;times his fixed compensation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The entire amount of the award is contingent upon both internal criteria based upon BNI and FCF, and upon an external criterion based on improvement in TSR relative to that of a benchmark panel of twelve leading global pharmaceutical companies (plus Sanofi): Amgen, AstraZeneca plc, Bayer AG, Bristol-Myers-Squibb Inc., Eli Lilly and Company Inc., GlaxoSmithKline plc, Johnson &amp; Johnson Inc., Merck Inc., Novartis AG, Novo Nordisk, Pfizer Inc., and Roche Holding Ltd.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To align equity-based compensation on our medium-term performance, a three-year period (2022-2024) is used to measure performance.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The above criteria were selected because they align medium-term equity-based compensation on the strategy adopted by Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The arrangements relating to these awards are as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the performance criterion based on BNI accounts for 50% of the award. That criterion corresponds to the ratio, at constant exchange rates, of actual BNI to budgeted BNI. It represents the average actual-to-budget ratio attained over the entire period. Budgeted BNI is derived from the budget as approved by the Board of Directors at the beginning of each financial year. The BNI objective may not be lower than the bottom end of the full-year guidance range publicly announced by Sanofi at the beginning of each year. If the attainment level is less than 95%, the corresponding performance shares are forfeited.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:70.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">BNI actual-to-budget attainment level (&#8220;B&#8221;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">BNI allocation rate</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B &lt;&#160;95%</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B =&#160;95%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B is &gt;&#160;95% but &lt;&#160;98%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(50 + [(B - 95) x 16])%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B is &#8805;&#160;98% but &#8804;&#160;105%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">B%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B is &gt;&#160;105% but &lt;&#160;110%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(105 + [(B - 105) x 3])%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B is &#8805;&#160;110%</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">120%</span></td></tr></table></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the FCF criterion accounts for 30% of the award. This criterion was selected because it is aligned with Sanofi&#8217;s current strategic objectives, and is transparent both within and outside the company.</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FCF criterion represents the average actual-to-budget FCF ratio attained over the entire period. The award is based on a target FCF, below which some or all of the performance shares are forfeited.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:70.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FCF actual-to-budget attainment level (&#8220;F&#8221;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FCF allocation rate</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F is &#8804;&#160;70%</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F is &gt;&#160;70% but &lt;&#160;80% </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">[(F - 70) x 5]%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F =&#160;80%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F is &gt;&#160;80% but &lt;&#160;100%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(50 + [(F &#8211; 80) x 2.5])%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F =&#160;100%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F is &gt;&#160;100% but &lt;&#160;120%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">F%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F is &#8805;&#160;120% </span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">120%</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">127</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The criterion based on the Total Shareholder Return (&#8220;TSR&#8221;) Rank Improvement accounts for 20% of the award. It corresponds to the evolution in rank of Sanofi's TSR when compared to the TSR of peer companies included in a panel. The TSR corresponds to the trading price of Sanofi shares increased by the dividends per share during the measurement periods, without reinvestment. Sanofi TSR Rank Improvement is determined by comparing the Endpoint Sanofi TSR rank to the Baseline Sanofi TSR rank.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:15.1pt">The Baseline Sanofi TSR is equal to the following formula: (average prices of 2021 &#8211; average prices of 2020 + dividends per share 2021) / average prices of 2020.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:15.1pt">The Endpoint Sanofi TSR is equal to the following formula: (average  prices of 2024 &#8211; average prices of 2021 + dividends per share 2022 to 2024) / average prices of 2021. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our TSR is compared with the benchmark panel of twelve companies listed above, so as to determine the ranking of Sanofi within the panel. The number of performance shares vesting depends upon the improvement in our TSR ranking, as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:49.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.905%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sanofi's improvement in the rankings</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">TSR allocation rate</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3 or more</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">No improvement</span></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Even if there is an improvement in Sanofi's TSR ranking based on the principles set out above, no TSR allocation can be made if Sanofi's ranking is below median TSR, defined as the performance of the company ranked 7th in the panel.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Paul Hudson is under an obligation to retain, until he ceases to hold office, a quantity of Sanofi shares equivalent to 50% of any gain (net of taxes and social contributions) arising on the vesting of his performance shares, calculated as of the date on which those shares vest.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In compliance with the AFEP-MEDEF Code and our Board Charter, Paul Hudson has undertaken to refrain from entering into speculative or hedging transactions, and so far as Sanofi is aware no hedging instruments have been contracted.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the interests of transparency, we disclose below attainment levels and allocation rates for the most recent performance-linked equity-based compensation plans awarded to our Chief Executive Officer (bearing in mind that only the April&#160;28, 2020 Plan applies to Paul Hudson, since this was the first plan he was awarded following his appointment in 2019):</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.217%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Attainment level</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Allocation rate</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">BNI</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ROA</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">TSR</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May&#160;2, 2018 plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2018-2020: 100.7%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2018-2020: 87.9%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2018-2020: 0% </span></div><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> of 11)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2018-2020: 76.72%<br/></span><span style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">i.e. 168,784 stock options and 38,360&#160;performance shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">BNI</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FCF</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">TSR</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April&#160;30, 2019 plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2019-2021: 101.99%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2019-2021: 127.67% </span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2018-2020: 50% </span></div><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> of 11)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2019-2021: 97.00%<br/></span><span style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">i.e. 213,400 stock options and 48,500&#160;performance shares</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April&#160;28, 2020 plans</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020-2022: 103.27%</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020-2022: 117.67%</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020-2022: 0%</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020-2022: 86.94%<br/></span><span style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">i.e. 65,205 performance shares</span></td></tr></table></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Performance shares awarded to Paul Hudson in 2022 (table No.&#160;6 of the AFEP-MEDEF Code)</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Source</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Plan date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Valuation of <br/>performance shares (&#8364;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of performance<br/>shares awarded<br/>during the period</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vesting<br/>date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Availability</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">date</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance conditions</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/03/2022</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,967,950&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">82,500</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">05/03/2025</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">05/03/2025</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Yes</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Under the terms of our Board Charter, Paul Hudson is required to retain a quantity of shares corresponding to 50% of the capital gain arising on the vesting of the shares, net of the associated taxes and social contributions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Each performance share awarded on May&#160;3</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, 2022, was valued at &#8364;84.46, valuing the total benefit at &#8364;6,967,950.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The General Meeting of May&#160;3, 2022 decided to restrict the number of performance shares that can be awarded to executive&#160;officers to 5% of the overall limit (1.5% of the share capital). The number of shares awarded to Paul Hudson in 2022 r</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">epresents&#160;0.43% of the total limit approved by that Meeting and 0.006% of our share capital at the date of grant.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">128</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Performance shares awarded to Paul Hudson which became available in 2022 (table No.&#160;7 of the AFEP-MEDEF Code)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because Paul Hudson took office on September&#160;1, 2019, he was not awarded any performance shares prior to the 2020 financial year. Consequently, no performance shares became available to him in 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Source</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Plan date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Valuation<br/>of performance<br/>shares (&#8364;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of performance<br/>shares awarded<br/>during the period</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vesting<br/>date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Availability<br/>date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;Performance conditions</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">None</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8211;</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because awards of stock options to our Chief Executive Officer are not permitted under our compensation policy, tables No.4 and No.&#160;5 of the AFEP-MEDEF Code are not applicable.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pension rights</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Paul Hudson is entitled to benefits under the top-up defined-contribution pension plan introduced within Sanofi on January&#160;1,&#160;2020. Under the terms of the plan, the Chief Executive Officer receives (subject to attainment of a performance condition) an annual contribution of up to 25% of his reference compensation (annual fixed and variable compensation).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The performance condition for the vesting of pension rights is linked to the attainment of the performance criteria for 2022 variable compensation. The Board of Directors, at its meeting of February&#160;22, 2023, ascertained whether that performance condition had been met, noting that the attainment level for the variable portion of Paul Hudson&#8217;s compensation for the 2022 financial year was 111.30%, i.e. 166.95% of his fixed compensation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The annual gross contribution is paid as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">50% as a gross insurance premium to the fund manager &#8211;&#160;the amount due to the fund manager with respect to 2022 is &#8364;467,162.50; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">50% to Paul Hudson, to indemnify him for the social security and tax charges for which he will become immediately liable. The amount due to Paul Hudson with respect to 2022 was set by the Board of Directors at its meeting of February&#160;22, 2023 at&#160;&#8364;467,162.50.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Payment of those amounts is contingent on approval of the Chief Executive Officer&#8217;s compensation package by the shareholders in an Ordinary General Meeting, on the terms stipulated in Article&#160;L.&#160;22-10-34&#160;II of the French Commercial Code.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Social welfare and health insurance</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Paul Hudson is subject to, benefits from and contributes to the same health cover, and death and disability plans as are applicable to other employees of Sanofi based in France. He also benefits from an unemployment insurance scheme.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Benefits in kind</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The benefits in kind received by Paul Hudson in 2022 were v</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">alued at &#8364;13,497, and correspond to a company car with a driver.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_307"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Pay ratio between compensation of executive officers and average/median compensation of Sanofi employees &#8211; changes in compensation of executive officers and employees relative to the performance of Sanofi</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This information is disclosed in accordance with Article&#160;L.&#160;22-10-9&#160;6&#176; of the French Commercial Code, further to the enactment of the&#160;&#8220;Pacte&#8221; law.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Explanations of calculation methods and of year-on-year changes in the executive pay ratio:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the scope includes Sanofi SA (the parent company) and all of its direct and indirect subsidiaries located in France, and hence covers more than 80% of total payroll of permanent employees in France. No separate ratios are published for Sanofi SA (the parent company), as the low headcount at Sanofi SA means that such ratios would not be representative of our total headcount in France;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the employee compensation used in the calculation is the full time equivalent (FTE) compensation of permanent employees with at least two financial years of uninterrupted employment;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">compensation includes fixed compensation awarded during the reference year, and variable compensation related to the previous year and paid during the reference year. All compensation amounts are gross amounts;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in order to maintain consistency, we have excluded from the numerator (i)&#160;compensation items not included in the denominator and (ii)&#160;non-recurring compensation items. This applies in particular to accommodation expenses related to the relocation to France of the Chief Executive Officer (Paul Hudson) in 2020, and to expenses related to unemployment insurance;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">long term variable compensation: performance shares and stock options awarded during each reference year are valued at the date of grant in accordance with international financial reporting standards. The valuation of performance shares that include the Total Shareholder Return (TSR) performance condition incorporates market conditions where applicable. Awards are subject to a continuing employment condition (three years minimum) and to performance conditions. Consequently, the valuation at the date of grant is not necessarily indicative of the value of stock options and performance shares at the end of the vesting period, especially if the performance conditions are not met;</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">129</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">since Olivier Brandicourt (our previous Chief Executive Officer) received the same number of stock options and performance shares each year from 2016 to 2019, fluctuations in the Sanofi share price had a significant impact on the pay ratio during this period;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">2018 and 2019 figures have been restated for comparative purposes, to (i)&#160;exclude Sanofi's equity-accounted share of Regeneron's net profits (see note&#160;D.2. to our consolidated financial statements, included at Item&#160;18. of this Annual Report on Form&#160;20-F) and (ii)&#160;include the effects of IFRS&#160;16;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">regular benchmarking reviews are conducted to ensure that the level of compensation awarded to our employees and CEO is competitive and consistent with pharmaceutical industry levels.</span></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Comparison of compensation of Sanofi executive officers with employee compensation (parent company and all direct and indirect subsidiaries located in France)</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:29.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chief Executive Officer</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ratio versus average compensation</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">93.8</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106.6</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110.6</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">111.4</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124.6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in %</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ratio versus median compensation</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">120.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">135.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142.1</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">159.2</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in %</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chairman of the Board (Serge Weinberg)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ratio versus average compensation</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.2</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.2</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.4</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in %</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.3&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ratio versus median compensation</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.9</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.0</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in %</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.1&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.1&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;2019: Olivier Brandicourt left office on August&#160;31. Paul Hudson was appointed as CEO on September&#160;1, 2019.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2020: The 2020 CEO compensation includes Paul Hudson's 2020 fixed compensation (&#8364;1.3&#160;million), his 2019 variable compensation as paid in 2020 and annualized (&#8364;1.95&#160;million), and 75,000&#160;performance shares awarded in 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Based on full-time equivalent permanent employees of all Sanofi legal entities worldwide with at least two years of uninterrupted employment, the ratios for 2022 were as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">CEO:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">ratio versus average compensation: 136.9, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">ratio versus median compensation: 200.5;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Chairman of the Board of Directors:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">ratio versus average compensation: 10.34, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">ratio versus median compensation: 115.1.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These ratios were calculated on the basis of annualized basic compensation, variable compensation in respect of the previous year, and performance shares awarded during 2022, applying 2022 average exchange rates.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">130</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Annual change in compensation, company performance and average employee compensation (parent company and all direct and indirect subsidiaries located in France)</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:31.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2018 <br/>vs 2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">vs 2018 </span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">vs 2019 </span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2022 <br/>vs 2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chief Executive Officer (in &#8364; thousand)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,916&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,213&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,200&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,870&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,690&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in &#8364; thousand</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,703)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(89)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in %</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-27.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.52&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chairman of the Board (in &#8364; thousand)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">708.35&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">708.36&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">708.19&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">807.72&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">807.74&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">807.74&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in &#8364; thousand</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in %</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average employee compensation on FTE basis (in &#8364; thousand)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77.40&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76.87&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76.93&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80.97&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">79.59&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85.83&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in &#8364; thousand</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.53)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.03&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.23&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in %</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.83&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;(c)</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business net income (in &#8364; million)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Business net income</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,943&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,411&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,050&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,346&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,213&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,341&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in &#8364; thousand</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(532)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,128&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in %</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.66&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.97&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.80&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.91&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) 2019: Olivier Brandicourt left office on August&#160;31. Paul Hudson was appointed as CEO on September&#160;1, 2019. His 2019 variable compensation, paid in&#160;2020, has been annualized for the purpose of calculating the ratios.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) 2020: Paul Hudson took office on September&#160;1, 2019. The 2020 CEO compensation includes Paul Hudson's 2020 fixed compensation (&#8364;1.3&#160;million), his&#160;2019 variable compensation paid in 2020 and annualized (&#8364;1,950&#160;million), and 75,000&#160;performance shares awarded in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) The change in average employee compensation in France between 2020 and 2021 was driven primarily by differences in the average compensation levels of employees who left the company versus those who joined.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_310"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation and benefits of all kinds awarded to corporate officers in respect of 2023</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Compensation and benefits of all kinds awarded to directors in respect of 2023</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amounts awarded to directors in respect of 2023 will be determined in accordance with the principles described above in&#160;&#8220;Compensation policy for directors&#8221;, within the section entitled &#8220;Compensation policy for corporate officers&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Compensation and benefits of all kinds awarded in respect of 2023 to the Chairman&#160;of the Board of Directors</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The components of the compensation awarded to the Chairman of the Board of Directors are described above in &#8220;Compensation policy for the Chairman of the Board of Directors&#8221;, within the section entitled &#8220;Compensation policy for corporate officers&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acting on a recommendation from the Compensation Committee, the Board of Directors meeting of February&#160;22, 2023 determined the following components of compensation (i)&#160;for Serge Weinberg, for the period from January&#160;1, 2023 to May&#160;25,&#160;2023, when his term of office will expire and (ii)&#160;for his successor, with effect from May&#160;26, 2023:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Serge Weinberg: annual fixed compensation of &#8364;800,000 (the same amount as for 2022); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#def3c0;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">his successor: annual fixed compensation of &#8364;880,000; see the explanations provided  above in&#160;&#8220;Compensation policy for the the Board of Directors&#8221;, within the section entitled &#8220;Compensation policy for corporate officers&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chairman of the Board of Directors does not receive any variable compensation, stock options or performance shares. In accordance with AMF&#160;recommendations, he does not receive any compensation (i)&#160;for serving as a director or (ii)&#160;from any company included in Sanofi&#8217;s scope of consolidation within the meaning of Article&#160;L.&#160;233-16 of the French Commercial Code.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Benefits in kind for 2023 comprise a company car with a driver.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">131</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Compensation and benefits of all kinds awarded in respect of 2023 to Paul Hudson, Chief&#160;Executive Officer</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed and variable compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acting on a recommendation from the Compensation Committee, the Board of Directors meeting of February&#160;22, 2023 determined the components of Paul Hudson&#8217;s compensation for the 2023 financial year.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Paul Hudson&#8217;s annual compensation comprises (i)&#160;annual fixed gross compensation of &#8364;1,400,000 (see the explanations provided under &#8220;Compensation policy for the Chief Executive Officer&#8221; in the section entitled &#8220;Compensation policy for corporate officers&#8221; above) and (ii)&#160;annual variable compensation in a range from 0% to 250% of his annual fixed compensation, with a target of 150%, and subject to both quantitative and qualitative criteria.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Those objectives are 50% based on financial indicators (sales growth, BNI, FCF, BOI margin, and growth of new assets, each accounting for 10%), and 50% based on specific individual objectives. The individual objectives for 2023 are shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:41.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 individual objectives</span></td><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 individual objectives *</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Business transformation </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(CHC, Vaccines, General Medicines, Manufacturing &amp; Supply, Digital &amp; Information Systems, Specialty Care)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Business transformation </span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">People and Culture</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(Diversity, Culture, Succession Pipeline, Simplification)</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.5%</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Organization and people </span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.5%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Development pipeline </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">M1 (Lead selection), M2 (Candidate selection), First in Human, Pivotal Studies, Submissions, Approvals</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.5%</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Development pipeline </span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.5%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">CSR</span></div><div style="padding-left:7.08pt;text-indent:-7.09pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%;padding-left:2.68pt">Enhancement and progress on CSR program: CO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:0.98pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"> emissions, Affordable Access,  Development of Sanofi Global Health Unit (GHU)</span></div><div style="padding-left:7.08pt;text-indent:-7.09pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%;padding-left:2.68pt">Image &amp; Reputation: ongoing rollout of new corporate branding), </span></div><div style="padding-left:7.08pt;text-indent:-7.09pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%;padding-left:2.68pt">Compliance/ Ethics &amp; Business Integrity: launch of new Code of Conduct</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">CSR </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(*) For details of individual objectives for 2022 refer to "&#8212; Compensation and benefits of all kinds paid during 2022 or awarded in respect of&#160;2022 to Paul Hudson, Chief Executive Officer" above. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity-based compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acting on a recommendation from the Compensation Committee, the Board of Directors meeting of February&#160;22, 2023 proposes awarding&#160;82,500&#160;performance shares to Paul Hudson in respect of 2023. In accordance with the AFEP-MEDEF Code, the entire award will be subject to criteria that are both internal (based on our BNI, FCF and CSR) and external (based on the improvement in TSR as compared with that of a panel of the&#160;12&#160;leading global pharmaceutical companies: Amgen, AstraZeneca plc, Bayer AG, Bristol-Myers-Squibb Inc., Eli&#160;Lilly and Company Inc., GlaxoSmithKline plc, Johnson &amp; Johnson Inc., Merck Inc., Novartis AG, Novo Nordisk, Pfizer Inc., and Roche Holding Ltd.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For the plan applicable to Executive Committee members, the TSR criterion is measured in relative terms (variation from the previous ranking). That&#160;variation (the &#8220;Sanofi TSR Rank Improvement&#8221;) is determined by comparing the Endpoint Sanofi TSR Rank (established over a 3-year measurement period) to the Baseline Sanofi TSR Rank (established over a 1-year measurement period). TSR-linked awards would be 50% if the ranking improved by 1; 100% if it improved by 2; and 150% if it improved by 3. For the Chief Executive Officer, any TSR-linked payment will remain contingent on Sanofi achieving an Endpoint Rank greater than or equal to the median of the TSR panel. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">With effect from the 2023 awards, the plan applicable to the Chief Executive Officer and top executives includes the following extra-financial criteria, both of which are quantitative and which count for 10% of the award:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:13.36pt">Affordable Access: providing essential medicines to non-communicable disease patients through Sanofi Global Health.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Planet Care: Carbon Footprint Reduction, scope 1&amp;2 (CO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:1.19pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> emissions reduction vs 2019).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Following the introduction of the CSR criteria, the business net income criterion counts for 45%; the free cash flow criterion for 25%; and the TSR Rank Improvement criterion for 10% (unchanged). We will make details of the terms of the plan available to shareholders on the governance page of our corporate website (www.sanofi.com) in advance of the Annual General Meeting of May&#160;25, 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with the AFEP-MEDEF Code, Paul Hudson is bound by rules on insider trading that impose blackout periods, as contained in our Board Charter.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with the AFEP-MEDEF Code and with our Board Charter, Paul Hudson has undertaken not to engage in speculative or hedging transactions, and as far as the company as aware no hedging instruments have been contracted.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Service contracts</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Neither we nor our subsidiaries have entered into service contracts with members of our Board of Directors or executive officers providing for any benefits.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">132</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_313"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Compensation and arrangements for other Executive Committee members</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The compensation of Executive Committee members other than the Chief Executive Officer is reviewed by the Compensation Committee, taking into consideration the practices of leading global pharmaceutical companies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition to fixed compensation, they receive variable compensation. Their target variable compensation depends on their position, and can represent up to 100% of their fixed compensation. The target amount of individual variable compensation is determined in line with market practice. It rewards the joint contribution of all Executive Committee members to Sanofi&#8217;s performance.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Fo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">r 2022, the variable component consisted of two elements:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">attainment of quantitative objectives (accounting for 50%) which are measured at consolidated level: sales growth 30%, ratio of BOI to net sales (&#8220;BOI margin&#8221;) 35%, research and development outcomes 20%, and FCF&#160;15%; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">attainment of quantitative and qualitative objectives both individually (30%) and collectively (20%) within the Executive Committee (together accounting for 50%).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The indicators used are intended to</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> measure Sanofi&#8217;s annual performance objectives; individual objectives; and the attainment of people objectives like gender parity in senior executive roles, individual career development plans, and transformation of the corporate culture to align with the &#8220;Play to Win&#8221; strategy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, Executive Committee members may be awarded performance shares.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2022, the total gross compensation paid and accrued in respect of members of the Executive Committee (excluding the Chief Executive Officer) was &#8364;17&#160;million, including &#8364;8&#160;million in fixed compensation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A total of </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">189,887</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;performance shares were awarded in 2022 to members of the Executive Committee (excluding the award to the Chief Executive Officer). No stock options were awarded in 2022 to members of the Executive Committee or the Chief Executive Officer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In compliance with the AFEP-MEDEF Code, these entire awards are contingent upon two internal criteria, based on BNI</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(19)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, FCF; and on an external criterion, based on TSR. Those criteria were selected because they align medium-term equity-based compensation with the strategy adopted by Sanofi. The Board believes that the performance conditions applied are good indicators of shareholder value creation in terms of the quality of investment decision and the commitment to deliver exacting financial results in a difficult economic environment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The arrangements relating to these awards are as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the BNI performance criterion accounts for 50% of the award. This criterion corresponds to the ratio, at constant exchange rates, of actual BNI to budgeted BNI. It represents the average actual-to-budget ratio attained over the entire period. Budgeted BNI is derived from the budget as approved by the Board of Directors at the beginning of each financial year. The BNI objective may not be lower than the bottom end of the full-year guidance range publicly announced by Sanofi at the beginning of each year. If the ratio is less than 95%, the corresponding performance shares are forfeited.</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.676%"><tr><td style="width:1.0%"></td><td style="width:75.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">BNI actual-to-budget attainment level (&#8220;B&#8221;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">BNI allocation rate</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B is &lt;&#160;95%</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B =&#160;95%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B is &gt;&#160;95% but &lt;&#160;98%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(50 + [(B &#8211;95) x 16])%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B is &#8805;&#160;98% but &#8804;&#160;105%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">B%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B is &gt;&#160;105% but &lt;&#160;110%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(105 + [(B &#8211;105) x 3])%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If B is &#8805;&#160;110%</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">120%</span></td></tr></table></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the FCF criterion accounts for 30% of the award. It represents the average actual-to-budget ratio of FCF attained over the entire period. The award is based on a target FCF, below which some or all of our performance shares are forfeited.</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.523%"><tr><td style="width:1.0%"></td><td style="width:75.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FCF actual-to-budget attainment level (&#8220;F&#8221;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FCF allocation rate</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F is &#8804;&#160;70%</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F is &gt;&#160;70% but &lt;&#160;80%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">[(F &#8211; 70) x 5]%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F =&#160;80%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F is &gt;&#160;80% but &lt;&#160;100%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(50 + [(F &#8211; 80) x 2.5])%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F =&#160;100%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F is &gt;&#160;100% but &lt;&#160;120%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">F%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If F is &gt;&#160;120% </span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">120%</span></td></tr></table></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The criterion based on the Total Shareholder Return (&#8220;TSR&#8221;) Rank Improvement accounts for 20% of the award. It corresponds to the evolution in rank of Sanofi's TSR when compared to the TSR of peer companies included in a panel. The TSR corresponds to the trading price of Sanofi shares increased by the dividends per share during the measurement periods, </span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(19)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Non-IFRS financial measure. For a definition, see &#8220;Item&#160;5. &#8211; Operating and Financial Review and Prospects &#8211; Business Net Income&#8221;.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">133</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">without reinvestment. Sanofi TSR Rank Improvement is determined by comparing the Endpoint Sanofi TSR rank to the Baseline Sanofi TSR rank.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-21.26pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:18.36pt">The Baseline Sanofi TSR is equal to the following formula: (average prices of 2021 &#8211; average prices of 2020 + dividends per share 2021) / average prices of 2020</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-21.26pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:18.36pt">The Endpoint Sanofi TSR is equal to the following formula: (average prices of 2024 &#8211; average prices of 2021 + dividends per share 2022 to 2024) / average prices of 2021</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The TSR obtained will be compared with that of each of the companies in a panel of peers to generate a ranking that includes Sanofi and the 12&#160;companies in the panel: Amgen, AstraZeneca plc, Bayer AG, Bristol-Myers-Squibb Inc., Eli Lilly and Company Inc., GlaxoSmithKline plc, Johnson &amp; Johnson Inc., Merck Inc., Novartis AG, Novo Nordisk, Pfizer Inc., and Roche Holding Ltd;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">definitions:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">median TSR (&#8220;M&#8221;) is the performance of the company ranked seventh in the panel,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">the upper bound (&#8220;H&#8221;) is the arithmetical average of the performances of the panel companies ranked first, second and third, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">the intermediate level is calculated as M + [(H&#8211;M)/2];</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the TSR allocation rate will be calculated as follows based on Sanofi&#8217;s ranking within the panel:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if Sanofi&#8217;s TSR is below M, the TSR allocation rate will be 0%,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if Sanofi&#8217;s TSR is M, the TSR allocation rate will be 50%,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if Sanofi&#8217;s TSR is equal to the intermediate level, the TSR allocation rate will be 100%,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if Sanofi&#8217;s TSR is &#8805; H, the TSR allocation rate will be 150%, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if Sanofi&#8217;s TSR is above M but below H, the TSR allocation rate will be calculated using linear interpolation;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">with effect from the 2022 awards, for the plan applicable to members of the Executive Committee, the mechanism of the TSR&#160;criterion was modified as follows:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">the TSR criterion is no longer measured in absolute value (ranking) but in relative terms (variation from the previous ranking). That variation (the &#8220;Sanofi TSR Rank Improvement&#8221;) will be determined by comparing the Endpoint Sanofi TSR Rank (established over a 3-year measurement period) to the Baseline Sanofi TSR Rank (established over a 1-year measurement period). TSR-linked awards would be 50% if the ranking improved by 1, 100% if it improved by 2, and 150% if it improved by 3, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">a multiplier is applied that will uplift the number of performance shares vesting by 10% if (i) the maximum TSR allocation rate is attained and (ii) Sanofi ranks greater than or equal to the median for the TSR benchmark panel;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the number of performance shares actually vesting depends on the overall allocation rate, which for the vesting period is the weighted average of the BNI allocation rate (50%), the FCF allocation rate (30%) and the TSR allocation rate for the vesting period (20%);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in order to align equity-based compensation with medium-term performance, performance is measured over three financial years;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">vesting is subject to a non-compete clause;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the entire award is forfeited in the event of resignation, or dismissal for gross or serious misconduct;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in the event of individual dismissal other than for gross or serious misconduct or retirement before the age of 60, or if the beneficiary&#8217;s employer ceases to be part of the Sanofi group, the overall allocation percentage is prorated to reflect the amount of time the person remained with the Sanofi group during the vesting period;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if any of the following events occur, full rights to the award are retained: (i)&#160;dismissal as part of a collective redundancy plan or of an equivalent collective plan negotiated and approved by the Chief Executive Officer of Sanofi; (ii)&#160;retirement on or after reaching the statutory retirement age, or early retirement under a statutory or contractual early retirement plan implemented by the relevant Sanofi entity and duly approved by the Chief Executive Officer of Sanofi; (iii)&#160;disability classified in the second or third categories stipulated in Article&#160;L.&#160;314-4 of the French Social Security Code; or (iv)&#160;death of the beneficiary.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension arrangements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The total amount accrued as of December&#160;31, 2022 in respect of corporate pension plans for persons who have held an executive position during the year 2021 was &#8364;10&#160;million. That amount includes an expense of &#8364;1&#160;million recognized in profit or loss during&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">134</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_316"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C. Board Practices</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Neither we nor our subsidiaries have entered into service contracts with members of our Board of Directors or corporate officers providing for benefits upon termination of employment. With respect to the Chief Executive Officer, see also &#8220;&#8212;&#160;B.&#160;Compensation &#8212;&#160;Compensation and arrangements for corporate officers&#8221; above.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Application of the AFEP-MEDEF Code</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The AFEP-MEDEF Code requires us to report specifically on the application of its recommendations and if any of them have not been applied, explain why.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At the close of the Annual General Meeting of Sanofi shareholders held on May&#160;3, 2022, a director representing employees was appointed as a member if the Compensation Committee. Consequently, Sanofi no longer diverges from the AFEP-MEDEF code on that point.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Currently, our departures from this Code are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:16.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Paragraph of the<br/>AFEP-MEDEF&#160;Code</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recommendation of the<br/>AFEP-MEDEF Code</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Application by Sanofi</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">10.2 Evaluation of the Board of Directors</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The evaluation has three objectives:</span></div><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">.../...;</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Actual individual contributions are assessed during formal evaluations conducted every three years with the help of a specialist consulting firm, the most recent of which took place at the end of 2021.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">measure the actual contribution of each director to the Board&#8217;s work.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">More generally, the issue of competence and individual contribution to the work of the Board and its Committees is addressed on a continuous basis, with a specific review when a director is up for reappointment as a Board member or appointment as a Committee member.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The Appointments, Governance and CSR Committee examined this point during its meeting of February 15, 2023 and plans to change the practice from 2023 towards an assessment of the individual contribution of directors.</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">24.4 Non-competition agreement</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">In any event, no benefit can be paid over the age of 65.</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Under the compensation policy for our Chief Executive Officer, he undertakes in the event he leaves the Company not to join a competitor of the Company as an employee or corporate officer, or to provide services to or cooperate with such a competitor.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">In return for this undertaking, he receives an indemnity corresponding to one year&#8217;s total compensation based on his fixed compensation effective on the day he ceases to hold office and the last individual variable compensation received prior to that date. The indemnity is payable in 12 monthly installments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">However, the Board of Directors may decide at the time the Chief Executive Officer leaves office (regardless of his age) to release him from the non-compete undertaking for some or all of the 12-month period. In such a case, the non-compete indemnity would not be due for the period of time waived by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">The Board of Directors, acting on a recommendation of the Compensation Committee, decided not to alter the compensation policy and non-compete undertaking of the Chief Executive Officer such that his indemnity would not be payable after he reaches the age of&#160;65, on the basis that this is out of line with the actual situation. In practice, many executive officers continue to work after they leave office, often in a consultancy role. Consequently, enforcing such a rule could deprive Sanofi of legal protection in the event that the Chief Executive Officer were to engage in a competing activity immediately after leaving the Company.</span></div></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Activities of the Board of Directors in 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During 2022, the Board of Directors met 14&#160;times (including strategy seminars), with an overall attendance rate among Board members of&#160;95%. Individual attendance rates of serving directors varied between 86</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">% and 100%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following persons attended meetings of the Board of Directors:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the directors;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the Secretary to the Board;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">frequently: members of the Executive Committee; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">occasionally: the statutory auditors, managers of our global support functions, and other company employees.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The agenda for each meeting of the Board is prepared by the Secretary after consultation with the Chairman, taking account of the agendas for the meetings of the specialist Committees and the suggestions of the directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Approximately one week prior to each meeting of the Board of Directors, the directors each receive a file containing the agenda, the minutes of the previous meeting, and documentation relating to the agenda.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The minutes of each meeting are expressly approved at the next meeting of the Board of Directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In compliance with our Board Charter, certain issues are examined in advance by the various Committees according to their areas of competence to enable them to make a recommendation; those issues are then submitted for a decision by the Board of Directors.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">135</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since 2016, acting on a recommendation from the Appointments, Governance and CSR Committee, the Board has held at least two executive sessions (i.e. meetings held without the Chief Executive Officer present) per year. If the Chairman of the Board so decides, such sessions may also be held without the directors representing employees (or any other Sanofi employee) being present. The primary purpose of such sessions is to evaluate the way the Board and its Committees operate, discuss the performance of the Chief Executive Officer, and to debate succession planning. Two executive sessions each lasting an hour and a half were held in 2022, in February and December.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the main activities of the Board of Directors related to the following issues:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:18.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial statements and financial management</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of the individual company and consolidated financial statements for the 2021 financial year and for the first half of 2022, review of the consolidated financial statements for the first three quarters of 2022, and review of draft press releases and presentations to analysts relating to the publication of those financial statements.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of forward-looking management documents.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Projected 2022 accounting close, presentation of 2023 budget, 2023-2025 financial forecasts.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Proposed dividend for 2021, in particular the proposal to distribute a dividend in kind in connection with the EUROAPI carve-out.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Delegation of authority to the Chief Executive Officer to issue bonds and guarantees.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Renewal of the share repurchase program.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Recording the amount of share capital, reducing the share capital through cancellation of treasury shares, and amending the Articles of Association accordingly.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operations, strategy and risk management</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Drafting a new chapter in the Play to Win</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">strategy.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Situation in Ukraine.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Alliances (Innovent, IGM).</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">EUROAPI project and the spin-off of EUROAPI.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Updates on Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> litigation.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Update on the agreement to transfer worldwide exclusive license rights for Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to Regeneron.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Update on Industrial Affairs (now Manufacturing and Supply).</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Update on Digital.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of the minutes of the Strategy Committee and the Scientific Committee.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Update on risks, review of Sanofi's 2022 risk management activity report and risk profile analysis.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of acquisition projects.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Relocation of Sanofi's headquarters to 46, avenue de la Grande Arm&#233;e, Paris 17th.</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Appointments and governance</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Composition of the Board and its Committees:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">proposal to renew the terms of office of </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Paul Hudson, Christophe Babule, Patrick Kron and Gilles Schnepp, and to appoint Carole Ferrand, Emile Voest and Antoine Yver as directors; at the 2022 Annual General Meeting;</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">appointment of Carole Ferrand to the Audit Committee, Barbara Lavernos to the Appointments, Governance and CSR Committee, Wolfgang Laux to the Compensation Committee, and Emile Voest and Antoine Yver to the Scientific Committee; and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">implementation of the succession plan for the Chairman of the Board, and appointment of Fr&#233;d&#233;ric Oud&#233;a as a non-voting member of the Board.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of succession planning for the Chief Executive Officer.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of director independence.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Reviews of the Board of Directors&#8217; Management Report, the report on corporate governance, and the reports of the statutory auditors.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Adoption of the draft resolutions, the report of the Board of Directors on the resolutions, and the special reports on the awards of stock options and performance shares.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Annual evaluation of the work of the Board and its Committees.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of previously-approved related party agreements.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Update on the Action 2022 employee share ownership plan.</span></div></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">136</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:18.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Determination of the compensation of corporate officers (note that the Board deliberates in executive session without the corporate officers present: the situation of the Chairman of the Board of Directors is dealt with first in his absence, and then the Chief Executive Officer's compensation is dealt with in the presence of the Chairman but with the Chief Executive Officer absent):</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">review of Paul Hudson's fixed compensation and determination of the objectives of his variable compensation for&#160;2022; and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">determination of the 2022 compensation of the Chairman of the Board of Directors.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Allocation of the amount of directors' compensation for 2021, and principles for allocating directors' compensation for 2022.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of the fixed and variable compensation of the Executive Committee for 2021 and 2022.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Adoption of the performance share plans for 2022, and determination of the fulfilment of performance conditions of previous equity-based compensation plans.</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CSR</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;padding-left:14.17pt;text-indent:-14.18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:700;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%;padding-left:11.45pt">Monitoring of progress on Sanofi's CSR strategy.</span></div><div style="margin-bottom:5pt;padding-left:14.17pt;text-indent:-14.18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:700;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%;padding-left:11.45pt">Monitoring of objectives for gender balance on executive bodies, and more generally of Sanofi's diversity policy.</span></div><div style="margin-bottom:5pt;padding-left:14.17pt;text-indent:-14.18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:700;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%;padding-left:11.45pt">Monitoring of Sanofi's equal pay and equal opportunity policy.</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addit</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ion, two strategy seminars were held, in April and October&#160;2022, in which all members of the Executive Committee took part. The seminar gave directors an opportunity to address issues including:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">preparing the 2nd&#160;phase&#160;of the Play to Win strategy;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">research platforms;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">use of da</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ta and AI in decision-making;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">leadership in immunology and inflammation;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">update on oncology and alliance strategies;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Play to Win culture within Sanofi;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">strategic planning and ambitions for each GBU; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">our financial roadmap.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Activities of the Board Committees in 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Board of Directors is assisted in its deliberations and decisions by five specialist Committees (for a description of the remit of each Committee, refer to our Board Charter, provided as Exhibit&#160;1.2 to this Annual Report on Form&#160;20-F). Chairs and members of these Committees are chosen by the Board from among its members, based on their experience.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Committees are responsible for the preparation of certain items on the agenda of the Board of Directors. Decisions of the Committees are adopted by a simple majority with the Chair of the Committee having a casting vote. Minutes are drafted, and approved by the Committee members.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chair of each Committee reports to the Board on the work of that Committee, so that the Board is fully informed whenever it takes a decision.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Composition of the committees during the 2022 financial year:</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.686%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Audit Committee</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Composition as of January 1, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Composition as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chair</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabienne Lecorvaisier (independent director)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabienne Lecorvaisier (independent director)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Members</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diane Souza (independent director)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Christophe Babule</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diane Souza (independent director)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Christophe Babule</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carole Ferrand (independent director)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proportion of independent directors: 66% (2/3)</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proportion of independent directors: 75% (3/4)</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Carole Ferrand was appointed a member of the Audit Committee by decision of the Board of Directors on May&#160;3, 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.686%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Appointments, Governance and CSR Committee</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Composition as of January&#160;1, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Composition as of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chair</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gilles Schnepp (independent director)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gilles Schnepp (independent director)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Members</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serge Weinberg<br/>Patrick Kron (independent director)<br/>Melanie Lee (independent director)<br/>Lise Kingo (independent director)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serge Weinberg</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patrick Kron (independent director)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lise Kingo (independent director)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Barbara Lavernos</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proportion of independent directors: 80%&#160;(4/5)</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proportion of independent directors:&#160;60%&#160;(3/5)</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Barbara Lavernos was appointed a member of the Appointments, Governance and CSR Committee by decision of the Board of Directors on May&#160;3,&#160;2022.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">137</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.686%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Compensation Committee</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Composition as of January&#160;1, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Composition as of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chair</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patrick Kron (independent director)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patrick Kron (independent director)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Members</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carole Piwnica (independent director)<br/>Diane Souza (independent director)<br/>Rachel Duan (independent director)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wolfgang Laux</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diane Souza (independent director)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rachel Duan (independent director)</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proportion of independent directors: 100% (4/4)</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proportion of independent directors: 75% (3/4)</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Wolfgang Laux was appointed a member of the Compensation Committee by decision of the Board of Directors on May&#160;3, 2022.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:11.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Strategy Committee</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Composition as of January&#160;1, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Composition as of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chair</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serge Weinberg</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serge Weinberg</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Members</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Paul Hudson<br/>Patrick Kron (independent director)<br/>Gilles Schnepp (independent director)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Paul Hudson<br/>Patrick Kron (independent director)<br/>Gilles Schnepp (independent director)</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proportion of independent directors: 50% (2/4)</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proportion of independent directors: 50% (2/4)</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:9.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Scientific Committee</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Composition as of January&#160;1, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Composition as of December&#160;31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chair</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thomas S&#252;dhof (independent director)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thomas S&#252;dhof (independent director)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Members</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Melanie Lee (independent director)<br/>Serge Weinberg</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Emile Voest (independent director)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Antoine Yver (independent director)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serge Weinberg</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proportion of independent directors: 66% (2/3)</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proportion of independent directors: 75% (3/4)</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Emile Voest and Antoine Yver were appointed as members of the Scientific Committee by decision of the Board of Directors on May&#160;3, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Audit Committee</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Three of the four members of the Audit Committee (Fabienne Lecorvaisier, Diane Souza and Carole Ferrand) qualify as independent pursuant to the criteria adopted by the Board of Directors. All three members have financial or accounting expertise as a consequence of their training and professional experience, and all are deemed to be financial experts as defined by the Sarbanes-Oxley Act and by Article&#160;L.&#160;823-19 of the French Commercial Code. See &#8220;Item&#160;16A. Audit Committee Financial Expert&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Audit Committee met </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">seven</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> times in 2022, including prior to the meetings of the Board of Directors during which the financial statements were approved. In addition to the statutory auditors, the principal financial officers, the Senior Vice President Group Internal Audit and other members of the senior management team attended meetings of the Audit Committee.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Committee members had an exemplary attendance record, with an overall attendance rate of 100%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The statutory auditors attend all meetings of the Audit Committee; they presented their opinions on the annual and half-year financial statements at the Committee meetings of February&#160;1 and July&#160;26, 2022, respectively. The Committee meets regularly with the statutory auditors without management present.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Chairman of the Committee also meets regularly with certain members of management, in particular the heads of Internal Audit, Risk Management and Ethics/Compliance.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">138</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2021, the main activities of the Audit Committee related to:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:18.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">Financial position</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Preliminary review </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of the individual company and consolidated financial statements for the 2021 financial year, review of the individual company and consolidated financial statements for the first half of 2022, review of the consolidated financial statements for the first three quarters of 2022, and review of draft press releases.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Analysis of gross sales relative to net sales, and contribution to improving gross margin.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Update on the EUROAPI project.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Sanofi&#8217;s financial position, indebtedness and liquidity.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">Internal audit, internal control and risk management</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of the work of the Internal Control function and evaluation of that work for 2021 as certified by the statutory auditors pursuant to Section&#160;404 of the Sarbanes-Oxley Act, and examination of the 2021 Annual Report on Form&#160;20-F.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Principal risks (risk management and risk profiles) facing Sanofi; Risk Committee report; review of whistleblowing and material compliance investigations; review of geopolitical risks arising from the conflict between Russia and Ukraine; review of tax risks and deferred tax assets, and changes in tax legislation; review of material litigation.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Conclusions of Sanofi senior management on internal control procedures and review of the Board of Directors' 2021 Management Report, in particular the description of risk factors in the Universal Registration Document.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Internal audit report and audit program for 2022.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Update on digital, including cybersecurity.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Update on the process for supervising outsourced activities.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Reporting on guarantees and endorsements.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">Strategy and compensation</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Presentation of the 2023 budget.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Assessment of fulfilment of performance conditions of the 2019 equity-based compensation plans.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">Compliance, ethics and business integrity, and CSR</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Update on the data protection compliance program.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Presentation of the new 2026 Ethics &amp; Business Integrity strategy.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of the European Green Taxonomy indicators.</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">Relations with the statutory auditors</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Tendering process for a new statutory auditor from 2024, when the term of office of Ernst &amp; Young expires.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Audit engagement and fees.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of and budget for non-audit services (audit-related services, tax, and other services).</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Committee did not use external consultants in 2022.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">139</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Compensation Committee</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Three of the four members of the Compensation Committee (i.e. 75%) are deemed to be independent.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Compensation Committee met three times in 2021, with an overall attendance rate of 100%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When the Committee discusses the compensation policy for members of senior management who are not corporate officers, i.e.&#160;the members of the Executive Committee, the Committee invites the Chief Executive Officer to attend.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the Compensation Committee dealt with the following issues:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:18.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">Compensation of corporate officers</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Components of the compensation of corporate officers (Chief Executive Officer and Chairman of the Board).</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of performance criteria applicable to the compensation of the Chief Executive Officer, in particular CSR criteria.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Consideration of potential CSR criteria to be applied to equity-based compensation starting from&#160;2023, in conjunction with the Appointments, Governance and CSR Committee.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Allocation of the amount of directors&#8217; compensation for 2021, and review of the compensation policy applicable to directors.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of the disclosures about compensation contained in the corporate governance section of the 2021 French-language </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Document d&#8217;enregistrement univer</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">sel</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and the Annual Report on Form&#160;20-F, and of equal pay ratios.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of the draft resolutions to be submitted to the Annual General Meeting of May&#160;13, 2022.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Governance roadshow campaign arranged for the main investors in Sanofi, and an analysis of the policies adopted by proxy advisors.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Compensation for the non-voting member of the Board.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">Equity-based compensation</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of the equity-based compensation policy consisting of performance shares, including consideration of the introduction of a CSR-based criterion.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Implementation of share-based compensation plans awarded in previous years (level of attainment of performance conditions for 2019 plans.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Status report on awards of performance shares, and proposal for off-cycle awards.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">Employee share ownership plan </span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Status report and analysis on 2022 employee share ownership plan.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Consideration of next employee share ownership plan, and implementation of Plan Action 2023.</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">Compensation of Executive Committee members</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Monitoring of fixed and variable remuneration of Executive Committee members in 2021 and 2022.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">New SEC rules on clawback clauses.</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Committee did not use external consultants in 2022.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">140</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Appointments, Governance and CSR Committee</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Three of the five members of the Committee are deemed to be independent.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Committee met </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">six </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">times in 2022, with an overall attendance rate of 97%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the Appointments, Governance and CSR Committee dealt with the following issues:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:18.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">Appointments</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Succession planning for the Chairman, the Chief Executive Officer and the Executive Committee.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Changes in the composition of the Board and its Committees.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of expiring terms of office, and appointment of directors.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Implementation of the process for onboarding the future Chairman, short-listing of candidates, and recommendation to appoint Fr&#233;d&#233;ric Oud&#233;a as a non-voting member of the Board.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">Corporate governance</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Annual evaluation of the work of the Board and its Committees.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of director independence.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Review of the Management Report and the corporate governance section of the 2021 French-language </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Document d'enregistrement univers</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">el</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and the Annual Report on Form 20-F.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The governance roadshow campaign arranged for the main investors in Sanofi, and an analysis of the policies adopted by proxy advisors.</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:107%">CSR</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Update on the four pillars of Sanofi's CSR strategy:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">Ensuring Affordable Access to Healthcare;</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">Innovating for Unmet Needs;</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">Planet Care; and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">Building an Inclusive Workplace.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Update on extra-financial ratings. </span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Equity-based compensation plans (consideration of potential CSR criteria to be applied to equity-based compensation from 2023, in conjunction with the Compensation Committee).</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Committee used external consultants in 2022.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Strategy Committee</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Two of the four members of the Strategy Committee are deemed to be independent: Patrick Kron and Gilles Schnepp.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Strategy Committee met four times in 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Committee members had an exemplary attendance record, with an overall attendance rate of 100%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the main activities of the Strategy Committee related to:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">report on the Bioverativ and Ablynx acquisitions;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">transfer to Regeneron of the exclusive license rights to Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">divestment and acquisition proposals, and business development priorities;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">opening of the next chapter in the the Play to Win strategy; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">opportunities for alliances.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Committee did not use external consultants in 2022.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Scientific Committee</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Three of the four members of the Scientific Committee are deemed to be independent. The Committee's main roles are to:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">assist the Board in scrutinizing the strategic orientation and investments proposed by senior management from a scientific standpoint;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">identify and discuss emerging trends and new challenges in science and technology, and ensure that Sanofi is as well prepared as possible to meet those challenges;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">ensure that processes are in place to enable optimal decision-making on investments in R&amp;D, consistent with the strategy determined by the Board; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">review and evaluate the quality of Sanofi&#8217;s scientific expertise, and advise the Board accordingly.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Committee met six times in 2022, with a 100% attendance rate.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">141</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the Committee dealt with the following issues:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">third-party analysis of the development portfolio and its key assets;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Immunology and Inflammation;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">oncology;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">chemistry, manufacturing, and controls (CMC);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">neurology; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">organization of R&amp;D.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Committee used external consultants in 2022.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Attendance rate of Board members</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:60.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Attendance&#160;rate&#160;<br/>at&#160;Board meetings</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Attendance&#160;rate&#160;<br/>at&#160;Committee meetings</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serge Weinberg, Chairman of the Board</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Paul Hudson, Chief Executive Officer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Christophe Babule</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rachel Duan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carole Ferrand </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lise Kingo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patrick Kron</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wolfgang Laux</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Barbara Lavernos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabienne Lecorvaisier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Melanie Lee</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (e)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carole Piwnica </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gilles Schnepp</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diane Souza</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thomas S&#252;dhof</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Yann Tran</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Emile Voest </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Antoine Yver </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fr&#233;d&#233;ric Oud&#233;a </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:60.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.123%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average attendance rate <br/>at Board meetings</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average attendance rate <br/>at Committee meetings</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:0 1pt"></td><td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">95</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">99.5</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#23004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Carole Ferrand, Emile Voest and Antoine Yver joined the Board during 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Carole Ferrand joined the Audit Committee in May&#160;2022 and attended all three meetings held after her appointment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Wolfgang Laux joined the Compensation Committee in May&#160;2022 and attended both of the meetings held after his appointment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Barbara Lavernos joined the Appointments, Governance and CSR Committee in May&#160;2022 and attended all five meetings meetings held after her appointment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) Melanie Lee and Carole Piwnica left the Board during 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Emile Voest and Antoine Yver joined the Scientific Committee in May&#160;2022 and attended both of the meetings held after their appointment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g) Fr&#233;d&#233;ric Oud&#233;a joined the Board of Directors as a non-voting Board member in September 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Directors who were absent from some meetings provided clear and substantiated explanations for their absence, which related mainly to personal matters or to unscheduled meetings called at short notice (especially where sudden developments on an ongoing project necessitated a Board meeting).</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">142</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_319"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.&#160;Employees</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Number of Employees</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, Sanofi e</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">mployed 91,573,442&#160;people</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> worldwide, 3,869&#160;fewer than in 2021. The tables below give a breakdown of employees by geographical area and function as of December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Employees by Geographical Area</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:25.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35,815&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47,039&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46,761&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47.0&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,444&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rest of the World</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43,314&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47.3&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">91,573</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">95,442</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">99,412</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Employees by Function</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:49.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sales Force</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,613&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,113&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25,203&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26,178&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and Development</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16,487&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Production</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34,310&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Marketing and Support Functions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,163&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">91,573</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">95,442</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">99,412</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100,409</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Industrial Relations</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In all countries where we operate, we seek to strike a balance between our economic interests and those of our employees, which we regard as inseparable.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our responsibility towards our employees is based on the basic principles of our Social Charter, which outlines the rights and duties of all Sanofi employees. The Social Charter addresses our key commitments towards our workforce: equal opportunity for all people without discrimination, the right to health and safety, respect for privacy, the right to information and professional training, social protection for employees and their families, freedom of association and the right to collective bargaining, and respect for the principles contained in the Global Compact on labor relations and ILO conventions governing the physical and emotional well-being and safety of children.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our labor relations are based on respect and dialogue. In this spirit, management and employee representatives meet regularly to exchange views, negotiate, sign agreements and ensure that agreements are being implemented.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Employee dialogue takes place in different ways from country to country, as dictated by specific local circumstances. Depending on the circumstances, employee dialogue relating to information, consultation and negotiation processes may take place at national, regional or company level. It may be organized on an interprofessional or sectorial basis, or both. Employee dialogue may be informal or implemented through a specific formal body, or a combination of both methods. Whatever the situation, Sanofi encourages employees to voice their opinions, help create a stimulating work environment and take part in decisions aiming to improve the way we work. These efforts reflect one of the principles of the Social Charter, whereby improving working conditions and the necessary adaptation to our business environment go hand-in-hand.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Profit-sharing Schemes, Employee Savings Schemes and Employee Share Ownership</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Profit-sharing schemes</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All employees of our French companies belong to voluntary and statutory profit-sharing schemes.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">143</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voluntary schemes</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Voluntary schemes </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(int&#233;ressement des salari&#233;s)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> are collective schemes that are optional for the employer and contingent upon performance. The aim is to give employees an interest in the growth of the business and improvements in its performance.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">unt distributed by our French companies during 2022 in respect of the voluntary scheme for the year ended December&#160;31, 2021 represented 2.53% of total payroll.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi did not distribute any profit-sharing in 2021 under voluntary schemes in respect of the 2020 financial year, as the special profit-sharing reserve exceeded the maximum amount, as determined by application of the criteria defined by the profit-sharing agreement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In April&#160;2020, we entered into a new fixed-term statutory profit-sharing agreement for the 2020, 2021 and 2022 financial years, which applies to all employees of our French companies. Under the agreement, Sanofi pays collective variable compensation determined on the basis of the more favorable of (i)&#160;growth in consolidated net sales (at constant exchange rates and on a constant structure basis) or (ii)&#160;BOI margin. For each of those criteria, a matrix determines what percentage of total payroll is to be allocated to the scheme. An additional sum may be distributed, based on a CSR-related performance condition reflecting progress in environmental matters (reduction in greenhouse gas emissions) and capped at 0.5% of total payroll.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This overall allocation is reduced by the amount required by law to be transferred to a special profit-sharing reserve. The balance is then distributed between the employees unless the transfer to the reserve equals or exceeds the maximum amount determined under the specified criteria, in which case no profit share is paid to the employees.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Statutory scheme</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The statutory scheme </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(participation des salari&#233;s aux r&#233;sultats de l&#8217;entreprise)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is a French legal obligation for companies with more than 50&#160;employees that made a profit in the previous financial year.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">unt distributed by our French companies during 2022 in respect of the statutory scheme for the year ended December&#160;31, 2021 represented 8.52% of total payroll.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distribution formula</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order to favor lower-paid employees, the voluntary and statutory profit-sharing agreements entered into since 2005 split the benefit between those entitled as&#160;follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">60% prorated on the basis of time spent in the Company&#8217;s employment in the year; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">40% prorated on the basis of gross annual salary received during the year, subject to a lower limit equal to the social security ceiling and an upper limit of three times the social security ceiling.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee savings schemes and collective retirement savings plan</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The employee savings arrangements operated by Sanofi are based on a collective savings scheme </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Plan d&#8217;&#201;pargne Groupe)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and a collective retirement savings scheme </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Plan d&#8217;&#201;pargne pour la Retraite Collectif)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Those schemes reinvest the sums derived from the statutory and voluntary profit-sharing schemes, plus voluntary contributions from employees.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;20</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">22, 89.1% o</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">f the employees who benefited from the profit-sharing schemes opted to invest in the collective savings scheme, and nea</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">rly 80.3% </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">opted to invest in the collective retirement savings scheme.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi supplements the amount invested by employees in these schemes by making a top-up contribution.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 202</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2, &#8364;143.4&#160;mill</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ion</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and &#8364;60.1&#160;m</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">illion were invested in the collective savings scheme and the collective retirement savings scheme respectively through the voluntary and statutory schemes for 2021, and through top-up contributions.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee share ownership</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, shares held under the collective savings scheme or in registered form by employees of Sanofi, employees of related companies and former employees amoun</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ted to 2.05% of o</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ur share capital.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For more information about our most recent employee share ownership plan, refer to &#8220;Item&#160;10.&#160;Additional Information &#8212;&#160;Changes in Share Capital &#8212;&#160;Increases in Share Capital&#8221;.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_322"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">E. Share Ownership</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Senior Management</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Members of the Executive Committee hold shares of our Company amounting in the aggregate to less than 1% of our share capital.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Existing Option Plans as of December&#160;31, 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2019, the Board of Directors reviewed Sanofi&#8217;s compensation policy and decided that stock options would no longer be awarded from 2020 onwards. That decision was taken to standardize the terms of equity-based compensation awards within Sanofi, and in response to feedback from some shareholders and proxy advisors who had concerns about stock options given their dilutive effect and potential unintended consequences.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">144</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Share Purchase Option Plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 there were no stock purchase option plans outstanding.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Share Subscription Option Plans</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:8.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Source</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Date of <br/>shareholder <br/>authorization</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Date of <br/>grant</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total number of options granted</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">to corporate officers</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">to the 10 employees awarded the most options</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Start date of exercise period</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Expiry <br/>date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Exercise price<br/>(&#8364;)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Number of shares subscribed as of<br/>12/31/2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Number of options canceled </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">as of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">12/31/2022</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Number of options <br/>outstanding</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 6,<br/>2011</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2012</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">574,050&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">274,500&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 6,<br/>2016</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2022</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">56.44&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">478,107&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">95,943&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 6,<br/>2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2012</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 6,<br/>2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">56.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">204,720&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">35,280&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 6,<br/>2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2013</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">548,725&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">261,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 6,<br/>2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">72.19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">361,571&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">109,065&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">78,089&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 6,<br/>2011</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2013</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 6,<br/>2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">72.19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">175,920&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">64,080&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2013</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2014</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">769,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">364,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 6,<br/>2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">73.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">354,023&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">102,625&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">312,602&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2013</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2014</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 6,<br/>2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">March 5,<br/>2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">73.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,560&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">193,440&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2013</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">June 24,<br/>2015</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">June 25,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">June 24,<br/>2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">89.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8,500&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2013</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">June 24,<br/>2015</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">202,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">202,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">June 25,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">June 24,<br/>2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">89.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">157,500&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2013</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">June 24,<br/>2015</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">June 25,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">June 24,<br/>2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">89.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">41,536&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">178,464&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2016</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 5,<br/>2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">9,750&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2016</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">165,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">165,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 5,<br/>2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82,500&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82,500&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2016</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 5,<br/>2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">41,250&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">178,750&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 10,<br/>2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 10,<br/>2017</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">158,040&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">157,140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 11,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 10,<br/>2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">88.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">22,754&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">44,276&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">91,010&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 10,<br/>2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 10,<br/>2017</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 11,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 10,<br/>2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">88.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">42,570&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">177,430&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2018</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">65.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">51,216&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">168,784&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2023</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2029</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">76.71&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6,600&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">213,400&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Comprises the Chief Executive Officer, and any Deputy Chief Executive Officers or members of the Management Board in office at the date of grant.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In office at the date of grant.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Includes 234,856&#160;options cancelled due to partial non-fulfilment of performance conditions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, 19,362&#160;stock options were exercised by individuals who were Executive Committee members as of December&#160;31, 2022. All of the plans involved post-date the creation of the Executive Committee: Sanofi plan of March&#160;5, 2012, exercise price &#8364;56.44; and Sanofi plan of March&#160;5, 2013, exercise price &#8364;72.19.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, a total of 1,837,969&#160;stock subscription options remained outstanding. As of the same date, 1,624,569&#160;options were immediately exercisable.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Existing Performance Share Plans as of December&#160;31, 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors awards shares to certain employees in order to give them a direct stake in our future and performances via trends in the share price, as a partial substitute for the granting of stock options.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Shares are awarded to employees by the Board of Directors on the basis of a list submitted to the Compensation Committee. The Board of Directors sets terms of the awards, including continuing employment conditions and performance conditions (measured over three financial years).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The employee plans have a three-year vesting period, with no lock-up period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At its meeting of May&#160;3, 2022, the Board of Directors awarded a share performance plan, cascaded down into three sub-plans:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a plan under which 459&#160;beneficiaries classified as &#8220;Senior Executives&#8221; were awarded a total of 1,146,431&#160;shares;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a plan under which 1,869&#160;beneficiaries not classified as &#8220;Senior Executives&#8221; were awarded a total of 2,000,627&#160;shares;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a plan under which 82,500&#160;performance shares were awarded to the Chief Executive Officer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the 7,277&#160;beneficiaries, 48% were women.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">145</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At its meeting of December&#160;14, 2022, the Board of Directors awarded a share performance plan, cascaded down into two sub-plans:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a plan under which 16&#160;beneficiaries classified as &#8220;Senior Executives&#8221; were awarded a total of 90,580&#160;performance shares;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a plan under which 6&#160;beneficiaries not classified as &#8220;Senior Executives&#8221; were awarded a total of 10,335&#160;performance shares.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of those 22&#160;beneficiaries, 55% were women.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The entirety of those awards is contingent upon criteria based on business net income (BNI) and free cash flow (FCF); in the case of employees classified as &#8220;Senior Executives&#8221;, an additional criterion based on total shareholder return (TSR) is added, accounting for 20% of the total. Vesting is subject to a non-compete clause.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The number of shares awarded to the Chief Executive Officer in 2022 represents 0.4% of the total limit approved by our shareholders at the Annual General Meeting of April&#160;30, 2021 (1.5% of our share capital) and 2.48% of the total amount awarded to all beneficiaries in 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The 2022 awards represent a dilution of approximately 0.26% of our undiluted share capital as of December&#160;31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Not all of our employees were awarded performance shares, but a new voluntary profit-sharing agreement was signed in&#160;April&#160;2020 which gives all of our employees an interest in Sanofi&#8217;s performance (for more details refer to &#8220;&#8212;&#160;Profit-Sharing Schemes, Employee Savings Schemes and Employee Share Ownership&#8221;, above).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Performance Share Plans</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Source</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Date of <br/>shareholder <br/>authorization</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Date of award</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total number of shares awarded</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">to </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">corporate officers</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(a) </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">to the 10</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">employees awarded the most shares</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Start date of vesting </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">period</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Vesting date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">End of lock-up period</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Number of shares<br/>vested as of 12/31/2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Number of rights canceled </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">as of 12/31/2022</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Number of shares not yet vested</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">48,500&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,243,434&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">142,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2022</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,176,358&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">67,076&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,504,148&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">219,990&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2022</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,841,498&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">662,650&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 28,<br/>2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 28,<br/>2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2023</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 28,<br/>2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">328,113&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">120,951&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 28,<br/>2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2023</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">45 118</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">282,995&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 28,<br/>2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">400,495&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">151,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 28,<br/>2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2023</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">116,832&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">283,663&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 28,<br/>2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">753,720&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">19,027&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 28,<br/>2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2023</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">32,820&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">720,615&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 28,<br/>2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,783,173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">26,542&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 28,<br/>2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 2,<br/>2023</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">394,855&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,387,759&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">October 28,<br/>2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">73,027&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">73,027&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">October 28,<br/>2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">October 29,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">October 30,<br/>2023</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,878&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">67,149&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,614,023&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">19,407&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2024</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">233,035&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,380,541&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">701,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">163,877&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2024</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">108,906&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">592,918&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">595,878&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,918&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2024</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">27,090&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">568,788&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">497,695&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">150,339&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2024</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">30,932&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">466,763&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 1,<br/>2024</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">October 27,<br/>2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">13,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">13,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">October 27,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">October 28,<br/>2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">October 28,<br/>2024</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">13,521&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,000,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25,882&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2025</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70,060&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,930,567&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,146,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">192,542&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2025</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">53,552&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,092,879&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 3,<br/>2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">May 4,<br/>2025</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82,500&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Dec. 14, 2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">90,580&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">77,111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Dec. 14,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Dec. 14,<br/>2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Dec. 15,<br/>2025</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">90,580&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">April 30,<br/>2021</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Dec. 14, 2022</span></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,335&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,335&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Dec. 14,<br/>2022</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Dec. 14, 2025</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Dec. 15,<br/>2025</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,335&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Comprises the Chairman&#160;&amp; Chief Executive Officer, the Chief Executive Officer, and any Deputy Chief Executive Officers or members of the Management Board in office at the date of grant.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In office at the date of grant.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Subject to the conditions set.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;No&#160;rights were cancelled due to partial non-fulfilment of performance conditions.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">146</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;6. Directors, senior management and employees</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, 9,121,573&#160;shares had not yet vested pending fulfilment of performance conditions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the ten employees (other than corporate officers) awarded the most shares were collectively awarded a total of 192,542&#160;shares.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="background-color:#ffffff;color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Shares Owned by Members of the Board of Directors</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, members of our Board of Directors held in the aggregate 23,831&#160;shares, or under 1% of the share capital and of the voting rights, excluding the beneficial ownership of 118,227,307&#160;shares held by L&#8217;Or&#233;al as of such date which may be attributed to Barbara Lavernos or Christophe Babule (who disclaim beneficial ownership of such shares).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="background-color:#ffffff;color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Transactions in Shares by Members of the Board of Directors and Equivalent Persons in 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As far as Sanofi is aware, transactions in our securities carried out during 2022 by (i)&#160;Board members, (ii)&#160;executives with the power to make management decisions affecting our future development and corporate strategy and (iii)&#160;persons with close personal ties to such individuals (as per Article&#160;L.&#160;621-18-2 of the French Monetary and Financial Code), were as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">June&#160;14, 2022: Wolfgang Laux, a director representing employees, sold 52&#160;shares at a price of &#8364;94.54 per share;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">June&#160;16, 2022: Wolfgang Laux acquired 10.71&#160;units in the FCPE (employee share ownership fund) at a price of &#8364;93.33 per unit;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">June&#160;23, 2022: Antoine Yver, director, acquired 1,000&#160;American Depositary Receipts (ADRs) at a price of $50.34 per ADR;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">July&#160;26, 2022: Wolfgang Laux subscribed 250&#160;units in the FCPE at a price of &#8364;80.21 per unit;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">September&#160;6, 2022: Carole Ferrand, director, acquired 1,000&#160;shares at a price of &#8364;80.62 per share; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">September&#160;23, 2022: Fr&#233;d&#233;ric Oud&#233;a, non-voting Board member, acquired 320&#160;shares at a price of &#8364;79.51 per share and&#160;180&#160;shares at a price of &#8364;78.59 per share.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_7092"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">F. Disclosure of action to recover erroneously awarded compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">147</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_325"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;7. Major shareholders and related party transactions</span></div></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;7. Major Shareholders and Related Party Transactions</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_328"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.&#160;Major Shareholders</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the ownership of our shares as of January&#160;31, 2023, indicating the beneficial owners of our shares. To the best of our knowledge and on the basis of the notifications received as disclosed below, except for L&#8217;Or&#233;al and BlackRock, Inc., no other shareholder currently holds more than 5% of our share capital or voting&#160;rights.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:28.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total number of</span></div><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">issued shares</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of actual</span></div><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">voting rights</span></div><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(excluding&#160;treasury&#160;shares)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Theoretical number</span></div><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of voting rights</span></div><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(including&#160;treasury&#160;shares)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">L&#8217;Or&#233;al</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118,227,307&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.38&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">236,454,614&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16.81&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">236,454,614&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16.67&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BlackRock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89,036,452&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89,036,452&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89,036,452&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employees</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25,384,441&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.01&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55,766,082&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55,766,082&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Public</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,015,992,138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,025,036,142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72.89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,025,036,142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Treasury shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,195,470&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,195,470&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,260,835,808</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,406,293,290</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,418,488,760</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Based on BlackRock&#8217;s declaration dated January&#160;31, 2023.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Shares held through the Group Saving Plan and shares held directly by present employees.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Number of shares repurchased as of January&#160;31, 2023 under the share repurchase program in force.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Based on the total number of voting rights as of January&#160;31, 2023.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Based on the total number of voting rights as of January&#160;31, 2023 as published in accordance with article&#160;223-11 and seq. of the General Regulations of the Autorit&#233; des march&#233;s financiers (i.e. including treasury shares, the voting rights of which are suspended).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Articles of Association provide for double voting rights for shares held in registered form for at least two years. All of our shareholders may benefit from double voting rights if these conditions are met, and no shareholder benefits from specific voting rights. For more information relating to our shares, see &#8220;Item&#160;10.&#160;Additional Information &#8212;&#160;B.&#160;Memorandum and Articles of Association.&#8221;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Neither L&#8217;Or&#233;al nor BlackRock holds different voting rights from those of our other shareholders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To the best of our knowledge, no other shareholder currently holds, directly or indirectly and acting alone or in concert, more than 5% of our share capital or voting rights. Furthermore, we believe that we are not directly or indirectly owned or controlled by another corporation or government, or by any other natural or legal persons. To our knowledge, there are no arrangements that may result in a change of control.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022 we received several share ownership declarations informing us that a legal threshold had been&#160;passed, as required under Article&#160;L.&#160;233-7 of the French Commercial Code.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Dodge &amp; Cox, acting on behalf of its clients and funds under its management, declared that on June&#160;22, 2022 it had passed below the&#160;5% threshold in terms of share capital, and holds, on behalf of its clients and funds, 4.96% of the share capital and&#160;4.42% of the voting rights.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Dodge &amp; Cox, acting on behalf of its clients and funds under its management, declared that on October&#160;14, 2022 it had passed above the&#160;5% threshold in terms of voting rights, and holds, on behalf of its clients and funds, 5.01% of the share capital and&#160;4.45% of the voting rights.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition to the statutory requirement to inform the Company and the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Autorit&#233; des march&#233;s financiers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (AMF, the French Financial Markets Regulator) that they hold a number of shares (or of securities equivalent to shares or of voting rights pursuant&#160;to Article&#160;L.&#160;233-9 of the French Commercial Code) representing more than one-twentieth (5%), one-tenth (10%), three-twentieths (15%), one-fifth (20%), one-quarter (25%), three-tenths (30%), one-third (1/3), one-half (50%), two-thirds (2/3), nine-tenths (90%) or nineteen-twentieths (95%) of the share capital or theoretical voting rights within four trading days after crossing any such ownership threshold (Article&#160;L.&#160;233-7 of the French Commercial Code), any natural or legal person who directly or indirectly comes to hold a percentage of the share capital, voting rights or securities giving future access to the Company&#8217;s capital that is equal to or greater than 1% or any multiple of that percentage, is obliged to inform the Company thereof by registered mail, return receipt requested, indicating the number of securities held, within five trading days following the date on which each of the thresholds was crossed.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If such declaration is not made, the shares in excess of the fraction that should have been declared will be stripped of voting rights at shareholders&#8217; meetings, if on the occasion of such meeting, the failure to declare has been formally noted and one or more shareholders collectively holding at least 5% of the Company&#8217;s share capital or voting rights so request at that meeting.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Any natural or legal person is also required to inform the Company, in the forms and within the time limits stipulated above for passing above a specified threshold, if their direct or indirect holding passes below any of the aforementioned thresholds.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since January&#160;1, 2023 Sanofi has only received share ownership declarations of statutory threshold.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">148</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_331"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;7. Major shareholders and related party transactions</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, individual shareholders (including employees of Sanofi and its subsidiaries, as well as retired employees holding shares via the Sanofi Group Employee Savings Plan) held approximately 7.85% of our share capital. Institutional shareholders (excluding L&#8217;Or&#233;al) held approximately 77.35% of our share capital. Such shareholders are primarily American (32.44%), French (11.19%) and British (13.75%). German institutions held 4.18% of our share capital, Swiss institutions held 2.17%, institutions from other European countries held 2.04% and Canadian institutions held 1.63% of our share capital. Other international institutional investors (excluding those from Europe and North America) held approximately 1.19% of our share capital. In France, our home country, we have 10,440 identified shareholders of record. In the United States, our host country, we have 54 identified shareholders of record and 18,471 identified ADS holders of record.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(Source: analysis performed by NASDAQ as of December 31, 2022, and internal information).</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_334"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Shareholders&#8217; Agreement</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We are unaware of any shareholders&#8217; agreement currently in force.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.&#160;Related Party Transactions</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">See Note&#160;D.33. to our consolidated financial statements included at Item&#160;18. of this annual&#160;report.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_337"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.&#160;Interests of Experts and Counsel</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">149</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_340"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;8. Financial information</span></div></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;8. Financial&#160;Information</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_343"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.&#160;Consolidated Financial Statements and Other Financial Information</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our consolidated financial statements as of and for the years ended December 31, 2022, 2021 and 2020 are included in this annual report at &#8220;Item&#160;18. Financial Statements.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Dividends on Ordinary Shares</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We paid annual dividends for the years ended December&#160;31, 2018, 2019, 2020 and 2021 and our shareholders will be asked to approve the payment of an annual dividend of 3.56&#160;per share for the 2022 fiscal year at our next annual shareholders&#8217; meeting. If approved, this dividend will be paid on June&#160;1, 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We expect that we will continue to pay regular dividends based on our financial condition and results of operations. The proposed 2022 dividend equates to a distribution of 43.1% of our business net income. For information on the non-IFRS financial measure &#8220;business earnings per share&#8221; see &#8220;Item&#160;5. Operating and Financial Review and Prospects &#8212;&#160;Business Net Income.&#8221;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following table sets forth information with respect to the dividends paid by our Company in respect of the 2018, 2019, 2020 and 2021 fiscal years and the dividend that will be proposed for approval by our shareholders in respect of the 2022 fiscal year at our May&#160;25, 2023 shareholders&#8217; meeting.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividend per Share (&#8364;)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.15&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.96&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividend per Share ($)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.91&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.53&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.52&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.63&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.12&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Proposal, subject to shareholder approval.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Based on the relevant year-end exchange rate.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) And a dividend in kind of EUROAPI shares, at a ratio of one EUROAPI share per 23&#160;Sanofi shares.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The declaration, amount and payment of any future dividends will be determined by majority vote of the holders of our shares at an ordinary general meeting, following the recommendation of our Board of Directors. Any declaration will depend on our results of operations, financial condition, cash requirements, future prospects and other factors deemed relevant by our shareholders. Accordingly, we cannot assure you that we will pay dividends in the future on a continuous and regular basis. Under French law, we are required to pay dividends approved by an ordinary general meeting of shareholders within nine months following the meeting at which they are approved.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Disclosure pursuant to Section&#160;13(r) of the United&#160;States Exchange Act of 1934</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi engages in limited business activities with Iran related to human health products &#8211; namely, sales of bulk and branded pharmaceuticals and vaccines. These activities, which are disclosed pursuant to Section&#160;13(r) of the United States Exchange Act of 1934, as amended, are not financially material to Sanofi and contributed well under 1% of Sanofi&#8217;s consolidated net sales in&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s US affiliates and non-US affiliates owned or controlled by Sanofi&#8217;s US affiliates either do not engage in Iran-related activities or act under licenses issued by the US Department of the Treasury&#8217;s Office of Foreign Assets Control (OFAC).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and certain non-US Sanofi affiliates engage in limited business activities that neither are expressly authorized by OFAC nor require such authorization.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2016, Sanofi and the Iran Food and Drug Administration (IFDA), an entity affiliated with the Iranian Ministry of Health and Medical Education, signed a Memorandum of Cooperation (MOC) regarding: (i)&#160;potential future projects to reinforce current partnerships with reputable Iranian manufacturers (in particular, to enhance industrial quality standards); (ii)&#160;collaborating with the Ministry of Health and Medical Education on programs for the prevention and control of certain chronic and non-communicable diseases (in particular, diabetes); and (iii)&#160;potential future collaboration on epidemiological studies. In 2022, activities conducted under the MOC did not generate any revenue or net profits.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Certain non-US Sanofi affiliates engage in limited business with Iranian counterparties associated with the Iranian Ministry of Health, such as public hospitals or distributors. In 2022, those business activities generated approximately &#8364;28.2&#160;million in gross revenue and contributed no more than &#8364;7.6&#160;million in net profits.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, a representative office in Tehran incurs incidental expenses from state-owned utilities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi believes that it and its affiliates&#8217; activities are compliant with applicable law, and in light of the nature of the activities concerned, Sanofi and its affiliates intend to continue their ongoing activities in Iran.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">150</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;8. Financial information</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Information on Legal or Arbitration Proceedings</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This Item&#160;8. incorporates by reference the disclosures found in Note&#160;D.22. to&#160;the consolidated financial statements at Item&#160;18. of&#160;this annual report; material updates thereto as of the date of this annual report are found below under the heading &#8220;&#8212;&#160;B.&#160;Significant Changes &#8212;&#160;Updates to Note&#160;D.22.&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and its subsidiaries are involved in litigation, arbitration and other legal proceedings. These proceedings typically are related to product liability claims, intellectual property rights (particularly claims against generic companies seeking to limit the patent protection of Sanofi products), competition law and trade practices, commercial claims, employment and wrongful discharge claims, tax assessment claims, waste disposal and pollution claims, and claims under warranties or indemnification arrangements relating to business divestitures. As a result, we may become subject to substantial liabilities that may not be covered by insurance and could affect our business and reputation. While we do not currently believe that any of these legal proceedings will have a material adverse effect on our financial position, litigation is inherently unpredictable. As a consequence, we may in the future incur judgments or enter into settlements of claims that could have a material adverse effect on results of operations, cash flows and/or our&#160;reputation.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government investigations and related litigation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">From time to time, subsidiaries of Sanofi are subject to governmental investigations and information requests from regulatory authorities inquiring as to the practices of Sanofi with respect to the sales, marketing, and promotion of its products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">From 2017 through 2022, several government agencies issued Civil Investigative Demands (CIDs) or other discovery requests calling for the production of documents and information relating to Sanofi&#8217;s trade and pricing practices for its insulin products and/or Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">-related litigation. Sanofi US is cooperating with each of the previously reported investigations, (including those by the State Attorney General&#8217;s offices in Washington, California, New York, Colorado and Vermont); none of which has been closed. In addition, Sanofi US is cooperating with investigations initiated by the US Federal Trade Commission in June of 2022, by the Texas State Attorney General&#8217;s office in August 2022, and by the Ohio Attorney General&#8217;s office in October 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2019, Sanofi US received a Civil Investigative Demand (CID) from the US Department of Justice concerning Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. In June&#160;2021, the government declined to intervene in the underlying complaint which was filed in November&#160;2018. The government investigation into this matter is now closed. Relators, however, filed their First Amended Complaint in October&#160;2021 and Defendants filed motions to dismiss in January&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2020, Genzyme Corporation received a CID from the US Department of Justice. The CID requests documents and information relating to Genzyme Corporation&#8217;s payments made to vendors or developers of electronic health record technology. Genzyme Corporation is cooperating with this investigation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In October&#160;2022, Sanofi US received a CID from the Ohio State Attorney General&#8217;s office, seeking documents and information about the pricing, sale, and distribution of pharmaceuticals and pharmacy benefit manager services in the State of Ohio. Sanofi US is cooperating with this investigation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Insulin Related Litigation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In December&#160;2016 and January&#160;2017, two putative class actions were filed against Sanofi US and Sanofi GmbH in the US Federal Court in Massachusetts on behalf of direct purchasers of Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> alleging certain antitrust violations. Sanofi GmbH was later dismissed from the actions. In January&#160;2018, the Court dismissed Plaintiffs&#8217; consolidated amended complaint against Sanofi US. Plaintiffs appealed that order to the Court of Appeals for the First Circuit, which issued its decision on February&#160;13, 2020 reversing and remanding to the district court. In January&#160;2021, Sanofi-Aventis Puerto Rico, Inc. (&#8220;Sanofi PR&#8221;) was added as a defendant. In&#160;October&#160;2022, Plaintiffs informed Sanofi US and Sanofi PR that they would proceed via joinder rather than move for class certification. Consistent with the Court's joinder deadline, new plaintiffs moved to intervene on January&#160;3, 2023. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">There are a number of insulin-related litigation matters pending in the US federal and state courts. These include cases brought on behalf of putative classes of consumers, wholesale purchasers of insulin, and state and local governments. The cases, which have been filed against Sanofi&#160;US along with other insulin manufacturers and, in some cases, pharmacy benefit managers, challenge those entities&#8217; insulin pricing practices (including Sanofi&#8217;s pricing practices for Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Apidra</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and/or Soliqua</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">). The suits allege some combination of: violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO Act&#8221;); violations of various state unfair/deceptive trade practices statutes, unjust enrichment, common-law fraud, and civil conspiracy. The status of these matters varies from initial motions to dismiss the complaints to active discovery.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">151</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_346"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;8. Financial information</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.&#160;Significant Changes</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Updates to Note&#160;D.22.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other Changes</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On January&#160;5, 2023, Sanofi announced that the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) has accepted the Biologics License Application (BLA) for nirsevimab for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants entering or during their first RSV season and for children up to&#160;24&#160;months of age who remain vulnerable to severe RSV disease through their second RSV season.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On January&#160;11, 2023, Sanofi Ventures announced an additional multi-year commitment from Sanofi, with an increase in capital to more than $750&#160;million to the evergreen venture fund. In addition to serving as a financial partner to top-tier early-to-mid-stage portfolio companies, the fund supports future efforts for business development and M&amp;A opportunities within Sanofi. The additional capital, confirmed by the executive committee, will also fuel the expansion and investment capacity of the Sanofi Ventures investment team on a global scale.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On January&#160;30, 2023, the European Commission (EC) expanded the marketing authorization for Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (dupilumab) in the European Union (EU) to treat eosinophilic esophagitis (EoE) in adults and adolescents 12&#160;years and older, weighing at least 40&#160;kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy. With this approval, Dupixent is the first and only targeted medicine specifically indicated to treat EoE in Europe and the U.S.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February 13, 2023, Sanofi announced that Dr. John Reed, its Global Head of R&amp;D, will be leaving the company to pursue a new opportunity outside Sanofi. The company warmly thanks Dr. Reed for his leadership over these last years. Since joining Sanofi in 2018, John has laid the foundation for the company&#8217;s R&amp;D transformation. He helped reshape Sanofi&#8217;s discovery and development of therapeutics, focusing efforts on first and best in class medicines that have the potential to transform the practice of medicine and improve the lives of people with serious diseases, whilst managing the integration and development of new technology platforms and partnerships, and driving R&amp;D productivity.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February 23, 2023, the U.S. Food and Drug Administration (FDA) has approved ALTUVIIIO&#8482; [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl], previously referred to as efanesoctocog alfa, a first-in-class, high-sustained factor VIII replacement therapy. ALTUVIIIO&#8482; is indicated for routine prophylaxis and on-demand treatment to control bleeding episodes, as well as perioperative management (surgery) for adults and children with hemophilia A. ALTUVIIIO&#8482; is the first and only hemophilia A treatment that delivers normal to near-normal factor activity levels (over 40%) for most of the week with once-weekly dosing, and significantly reduces bleeds compared to prior factor VIII prophylaxis.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">152</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_349"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;9. The offer and listing</span></div></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;9. The Offer and Listing</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_352"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A. Offer and Listing Details</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have one class of shares. Each American Depositary Share, or ADS, represents one-half of one share. The ADSs are evidenced by American Depositary Receipts, or ADRs, which are issued by JPMorgan Chase Bank,&#160;N.A.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our shares trade on Compartment&#160;A of the regulated market of Euronext Paris, and our ADSs trade on the Nasdaq Global Select Market, or&#160;Nasdaq.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_355"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.&#160;Plan of Distribution</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_358"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.&#160;Markets</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Shares and ADSs</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our shares are listed on Euronext Paris under the symbol &#8220;SAN&#8221; and our ADSs are listed on the Nasdaq under the symbol&#160;&#8220;SNY&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of the date of this annual report, our shares are included in a large number of indexes, including the &#8220;CAC&#160;40&#160;Index&#8221;, the principal French index published by Euronext Paris. This index contains 40&#160;stocks selected among the top 100&#160;companies based on free-float capitalization and the most active stocks listed on the Euronext Paris market. The CAC&#160;40&#160;Index indicates trends in the French stock market as a whole and is one of the most widely followed stock price indices in France.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our shares are included in European indexes, such as the EURO STOXX&#160;50, STOXX Europe&#160;600 index, FTSE Eurofirst&#160;300, MSCI&#160;Europe, MSCI Pan Euro, Euronext&#160;100, and STOXX Europe&#160;600 Health Care. They are also included in American and international indexes, such as the NASDAQ Composite, NASDAQ Health Care, S&amp;P Global&#160;100, MSCI World, and MSCI World Pharmaceuticals, Biotechnology and Life Sciences.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our shares are also part of the main extra-financial rating indices, taking into account environmental, social, and governance criteria (FTSE4Good, ATM index, STOXX</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Global ESG Leaders, and EURO STOXX&#160;50 Low Carbon).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Trading by Sanofi in our own Shares</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under French law, a company may not issue shares to itself, but it may purchase its own shares in the limited cases described at&#160;&#8220;Item&#160;10.&#160;Additional Information &#8212;&#160;B.&#160;Memorandum and Articles of Association &#8212;&#160;Trading in Our Own&#160;Shares.&#8221;</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_361"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D. Selling Shareholders</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_364"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">E. Dilution</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_367"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">F. Expenses of the Issue</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">153</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_370"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;10. Additional information</span></div></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;10. Additional Information</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A. Share Capital</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_373"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B. Memorandum and Articles of Association</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">General</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Company is a </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">soci&#233;t&#233; anonyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a form of limited liability company, organized under the laws of France. The LEI number of the Company is 549300E9PC51EN656011.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In this section, we summarize material information concerning our share capital, together with material provisions of applicable French law and our Articles of Association </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(statuts)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, an English translation of which has been filed as an exhibit to this annual report. For a description of certain provisions of our Articles of Association relating to our Board of Directors and statutory auditors, see &#8220;Item&#160;6. Directors, Senior Management and Employees&#8221;. You may obtain copies of our Articles of Association in French from the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">greffe</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Clerk) of the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Registre du Commerce et des Soci&#233;t&#233;s de Paris</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Registry of Commerce and Companies of Paris, France, registration number: 395&#160;030&#160;844). Please refer to that full document for additional details.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Articles of Association specify that our corporate affairs are governed by:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">applicable laws and regulations (in particular, Title&#160;II of the French Commercial Code); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the Articles of Association themselves.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Article&#160;3 of our Articles of Association specifies that the Company&#8217;s corporate purpose, in France and abroad,&#160;is:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">acquiring interests and holdings, in any form whatsoever, in any company or enterprise, in existence or to be created, connected directly or indirectly with the health and fine chemistry sectors, human and animal therapeutics, nutrition and bio-industry;</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">in the following areas:</span></div><div style="margin-bottom:5pt;padding-left:34.02pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">purchase and sale of all raw materials and products necessary for these activities,</span></div><div style="margin-bottom:5pt;padding-left:34.02pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">research, study and development of new products, techniques and processes,</span></div><div style="margin-bottom:5pt;padding-left:34.02pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">manufacture and sale of all chemical, biological, dietary and hygienic products,</span></div><div style="margin-bottom:5pt;padding-left:34.02pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">obtaining or acquiring all intellectual property rights related to results obtained and, in particular, filing all patents, trademarks and models, processes or inventions,</span></div><div style="margin-bottom:5pt;padding-left:34.02pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">operating directly or indirectly, purchasing, and transferring &#8211;&#160;for free or for consideration&#160;&#8211; pledging or securing all intellectual property rights, particularly all patents, trademarks and models, processes or inventions,</span></div><div style="margin-bottom:5pt;padding-left:34.02pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">obtaining, operating, holding and granting all licenses,</span></div><div style="margin-bottom:5pt;padding-left:34.02pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">within the framework of a group-wide policy and subject to compliance with the relevant legislation, participating in treasury management transactions, whether as lead company or otherwise, in the form of centralized currency risk management or intra-group netting, or any other form permitted under the relevant laws and regulations,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">and, more generally:</span></div><div style="margin-bottom:5pt;padding-left:34.02pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">all commercial, industrial, real or personal property, financial or other transactions, connected directly or indirectly, totally or partially, with the activities described above and with all similar or related activities and even with any other purposes likely to encourage or develop the Company&#8217;s activities.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in which directors are materially interested</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under French law, any agreement entered into (directly or through an intermediary) between our Company and any one of the members of the Board of Directors that is not entered into (i)&#160;in the ordinary course of our business and (ii)&#160;under normal conditions, is subject to the prior authorization of the disinterested members of the Board of Directors. The same provision applies to agreements between our Company and another company if one of the members of the Board of Directors is the owner, general partner, manager, director, general manager or member of the executive or supervisory board of the other company, as well as to agreements in which one of the members of the Board of Directors has an indirect interest.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors must also approve any undertaking taken by our Company for the benefit of our Chairman, Chief Executive Officer </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(directeur g&#233;n&#233;ral)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or his delegates </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(directeurs g&#233;n&#233;raux d&#233;l&#233;gu&#233;s)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> pursuant to which such persons will or may be granted compensation, benefits or any other advantages as a result of the termination of or a change in their offices or following such termination or change, in accordance with Article&#160;L.&#160;22-10-8 of the French Commercial Code. Each such undertaking must be included in our compensation policy for corporate officers, which is submitted for approval by our shareholders at the Annual General Meeting in accordance with Article&#160;L.&#160;22-10-8 II of the French Commercial Code. No such compensation or undertaking may be determined, awarded or paid unless in accordance with such compensation policy. </span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">154</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;10. Additional information</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">See&#160;&#8220;Item 6. Directors, Senior Management and Employees &#8212;&#160;B.&#160;Compensation&#8221; for a description of the process for establishing and authorizing such compensation policy.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Directors&#8217; compensation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The aggregate amount of compensation of the Board of Directors is determined at the Shareholders&#8217; Ordinary General Meeting. The Board of Directors then divides this aggregate amount among its members by a simple majority vote. In addition, the Board of Directors may grant exceptional compensation </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(r&#233;mun&#233;rations exceptionnelles)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to individual directors on a case-by-case basis for special assignments following the procedures described above at &#8220;&#8212;&#160;Transactions in which directors are materially Interested&#8221;. The Board of Directors may also authorize the reimbursement of travel and accommodation expenses, as well as other expenses incurred by Directors in the corporate interest. See also &#8220;Item&#160;6. Directors, Senior Management and&#160;Employees.&#8221; Furthermore, under our Articles of Association, the Board of Directors may compensate any observers </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(censeurs)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to the Board of Directors, which would reduce by the same amount the total annual compensation available for allocation to the Board of Directors.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Board of Directors&#8217; borrowing powers</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All loans or borrowings on behalf of the Company may be decided by the Board of Directors within the limits, if any, imposed by the Shareholders&#8217; Extraordinary General Meeting. There are currently no limits imposed on the amounts of loans or borrowings that the Board of Directors may&#160;approve.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Directors&#8217; age limits</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a description of the provisions of our Articles of Association relating to age limits applicable to our Directors, see &#8220;Item&#160;6.&#160;Directors, Senior Management and&#160;Employees &#8211; A. Directors and Senior Management&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Directors&#8217; share ownership requirements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Pursuant to our Articles of Association, each director appointed by a Shareholders&#8217; Ordinary General Meeting must own at least&#160;500&#160;shares throughout their term of office. In addition, pursuant to the Board Charter, our Directors must within no more than two years from their appointment hold at least 1,000&#160;Sanofi shares in their own name, which must be retained until they cease to hold office.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholders&#8217; meetings</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">General</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with the provisions of the French Commercial Code, there are three types of shareholders&#8217; meetings: ordinary, extraordinary and&#160;special.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Ordinary general meetings of shareholders are required for matters such as:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">electing, replacing and removing Directors;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">appointing independent auditors;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">approving the annual financial statements;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">declaring dividends or authorizing dividends to be paid in shares, provided the Articles of Association contain a provision to that effect; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">approving share repurchase programs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Extraordinary general meetings of shareholders are required for approval of matters such as amendments to our Articles of Association, including any amendment required in connection with extraordinary corporate actions. Extraordinary corporate actions include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">changing our Company&#8217;s name or corporate purpose;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">increasing or decreasing our share capital;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">creating a new class of equity securities;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">authorizing the issuance of:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">shares giving access to our share capital or giving the right to receive debt instruments, or</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">other securities giving access to our share capital;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">establishing any other rights to equity securities;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">selling or transferring substantially all of our assets; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the voluntary liquidation of our Company.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Special meetings of shareholders of a certain category of shares or shares with certain specific rights (such as shares with double voting rights) are required for any modification of the rights derived from that category of shares. The resolutions of the shareholders&#8217; general meeting affecting these rights are effective only after approval by the relevant special meeting.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">155</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;10. Additional information</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Annual ordinary meetings</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The French Commercial Code requires the Board of Directors to convene an annual ordinary general shareholders&#8217; meeting to approve the annual financial statements. This meeting must be held within six months of the end of each fiscal year.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors may also convene an ordinary or extraordinary general shareholders&#8217; meeting upon proper notice at any time during the year. If the Board of Directors fails to convene a shareholders&#8217; meeting, our independent auditors may call the meeting. In case of bankruptcy, the liquidator or court-appointed agent may also call a shareholders&#8217; meeting in some instances. In addition, any of the following may request the court to appoint an agent for the purpose of calling a shareholders&#8217; meeting:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">one or several shareholders holding at least 5% of our share capital;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">duly qualified associations of shareholders who have held their shares in registered form for at least two years and who together hold at least 1% of our voting rights;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the works council in cases of urgency; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">any interested party in cases of urgency.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under our Articles of Association, the Board of Directors may take decisions by written consultation under the conditions permitted by law and as specified in the Board Charter (an English language version of which is reproduced in full as Exhibit&#160;1.2 to this Annual Report on Form&#160;20-F), including the possibility to convene an ordinary or extraordinary general meeting,</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Notice of shareholders&#8217; meetings</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All prior notice periods provided for below are minimum periods required by French law and cannot be shortened, except in case of a public tender offer for our&#160;shares.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We must announce general meetings at least thirty-five days in advance by means of a preliminary notice </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(avis de r&#233;union)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, which is published in the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Bulletin des Annonces L&#233;gales Obligatoires</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, or </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">BALO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The preliminary notice must first be sent to the French Financial markets authority (</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Autorit&#233; des march&#233;s financiers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the &#8220;AMF&#8221;), with an indication of the date on which it will be published in the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">BALO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. It must be published on our website at least twenty-one days prior to the general meeting. The preliminary notice must contain, among other things, the agenda, a draft of the resolutions to be submitted to the shareholders for consideration at the general meeting and a detailed description of the voting procedures (proxy voting, electronic voting or voting by mail), the procedures permitting shareholders to submit additional resolutions or items to the agenda and to ask written questions to the Board of Directors. The AMF also recommends that, prior to or simultaneously with the publication of the preliminary notice, we publish a summary of the notice indicating the date, time and place of the meeting in a newspaper of national circulation in France and on our&#160;website.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At least fifteen days prior to the date set for a first convening, and at least ten days prior to any second convening, we must send a final notice </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(avis de convocation)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> containing the final agenda, the date, time and place of the meeting and other information related to the meeting. Such final notice must be sent by mail to all registered shareholders who have held shares in registered form for more than one month prior to the date of the final notice and by registered mail, if shareholders have asked for it and paid the corresponding charges. The final notice must also be published in a newspaper authorized to publish legal announcements in the local administrative department </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(d&#233;partement)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in which our Company is registered as well as in the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">BALO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, with prior notice having been given to the AMF for informational purposes. Even if there are no proposals for new resolutions or items to be submitted to the shareholders at the meeting, we must publish a final notice in a newspaper authorized to publish legal announcements in the local administrative department </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(d&#233;partement)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in which our Company is registered as well as in the&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">BALO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Other issues</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In general, shareholders can only take action at shareholders&#8217; meetings on matters listed on the agenda. As an exception to this rule, shareholders may take action with respect to the appointment and dismissal of directors even if this action has not been included on the&#160;agenda.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Additional resolutions to be submitted for approval by the shareholders at the shareholders&#8217; meeting may be proposed to the Board of Directors, for recommendation to the shareholders at any time from the publication of the preliminary notice in the&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">BALO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> until twenty-five days prior to the general meeting and in any case no later than twenty days following the publication of the preliminary notice in the&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">BALO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;by:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">one or several shareholders together holding a specified percentage of shares;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a duly qualified association of shareholders who have held their shares in registered form for at least two years and who together hold at least 1% of our voting rights; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the works council.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Within the same period, the shareholders may also propose additional items (</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">points</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) to be submitted and discussed during the shareholders&#8217; meeting, without a shareholders&#8217; vote. The shareholders must substantiate the reasons for their proposals of additional items.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The resolutions and the list of items added to the agenda of the shareholders&#8217; meeting must be promptly published on our&#160;website.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors must submit the resolutions to a vote of the shareholders after having made a recommendation thereon. The Board of Directors may also comment on the items that are submitted to the shareholders&#8217; meeting.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">156</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;10. Additional information</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Following the date on which documents must be made available to the shareholders (including documents to be submitted to the shareholders&#8217; meeting and resolutions proposed by the Board of Directors, which must be published on our website at least twenty-one days prior to the general meeting), shareholders may submit written questions to the Board of Directors relating to the agenda for the meeting until the fourth business day prior to the general meeting. The Board of Directors must respond to these questions during the meeting or may refer to a Q&amp;A section located on our website in which the question submitted by a shareholder has already been&#160;answered.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Attendance at shareholders&#8217; meetings; proxies and votes by mail</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In general, all shareholders may participate in general meetings either in person or by proxy. Shareholders may vote in person, by proxy or by&#160;mail.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The right of shareholders to participate in general meetings is subject to the recording </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(inscription en compte)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> of their shares on the second business day, 12:00&#160;a.m. (Paris time), preceding the general meeting:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">for holders of registered shares: in the registered shareholder account held by the Company or on its behalf by an agent appointed by&#160;it; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">for holders of bearer shares: in the bearer shareholder account held by the accredited financial intermediary with whom such holders have deposited their shares; such financial intermediaries shall deliver to holders of bearer shares a shareholding certificate </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(attestation de participation)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> enabling them to participate in the general meeting.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Attendance in person</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Any shareholder may attend ordinary general meetings and extraordinary general meetings and exercise its voting rights subject to the conditions specified in the French Commercial Code, the French Civil Code and our Articles of&#160;Association.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An attendance sheet and written minutes are established for each shareholders' meeting; failure to do so could lead to cancellation of the decisions at the shareholders' meeting.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Proxies and votes by mail</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Proxies are sent to any shareholder upon a request received between the publication of the final notice of meeting and six days before the general meeting and must be made available on our website at least twenty-one days before the general meeting. In order to be counted, such proxies must be received at our registered office, or at any other address indicated on the notice of the meeting or by any electronic mail indicated on the notice of the meeting, prior to the date of the meeting (in&#160;practice, we request that shareholders return proxies at least three business days prior to the meeting; electronic proxies must be returned before&#160;3&#160;p.m. Paris time, on the day prior to the general meeting). A shareholder may grant proxies to any natural person or legal entity. The agent may be required to disclose certain information to the shareholder or to the&#160;public.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A proxy is only valid for one meeting (or by way of exception for two meetings, one being ordinary and the other extraordinary, held on the same day or within a single 15-day period); it remains valid in the event such meeting is convened multiple times for the same agenda, and may be revoked by written statement of the shareholder granting the proxy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Alternatively, the shareholder may send us a blank proxy without nominating any representative. In this case, the chairman of the meeting will vote the blank proxies in favor of all resolutions proposed or approved by the Board of Directors and against all&#160;others.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">With respect to votes by mail, we must send shareholders a voting form upon request or must make available a voting form on our website at least twenty-one days before the general meeting. The completed form must be returned to us at least three days prior to the date of the shareholders&#8217; meeting. For holders of registered shares, in addition to traditional voting by mail, instructions may also be given via the&#160;internet.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quorum</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The French Commercial Code requires that shareholders holding in the aggregate at least 20% of the shares entitled to vote must be present in person, or vote by mail or by proxy, in order to fulfill the quorum requirement&#160;for:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">an ordinary general meeting; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">an extraordinary general meeting where the only resolutions pertain to either (a)&#160;a proposed increase in our share capital through incorporation of reserves, profits or share premium, or (b)&#160;the potential issuance of free share warrants in the event of a public tender offer for our shares (Article&#160;L.&#160;233-32 of the French Commercial Code).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For any other extraordinary general meeting the quorum requirement is at least 25% of the shares entitled to vote, held by shareholders present in person, voting by mail or by&#160;proxy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a special meeting of holders of a certain category of shares, the quorum requirement is one third of the shares entitled to vote in that category, held by shareholders present in person, voting by mail or by&#160;proxy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If a quorum is not present at a meeting, the meeting is adjourned. However, only questions that were on the agenda of the adjourned meeting may be discussed and voted upon once the meeting resumes.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">157</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;10. Additional information</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When an adjourned meeting is resumed, there is no quorum requirement for meetings cited in the first paragraph of this &#8220;Quorum&#8221; section. In the case of any other reconvened extraordinary general meeting or special meeting, the quorum requirement is 20% of the shares entitled to vote (or&#160;voting shares belonging to the relevant category for special meetings of holders of shares of such specific category), held by shareholders present in person or voting by mail or by proxy. If a quorum is not met, the reconvened meeting may be adjourned for a maximum of two months with the same quorum requirement. No deliberation or action by the shareholders may take place without a&#160;quorum.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_376"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.&#160;Material Contracts</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_379"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.&#160;Exchange Controls</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">French exchange control regulations currently do not limit the amount of payments that we may remit to non-residents of France. Laws and regulations concerning foreign exchange controls do require, however, that all payments or transfers of funds made by a French resident to a non-resident be handled by an accredited intermediary.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_382"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">E.&#160;Taxation</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">General</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following generally summarizes the material French and US&#160;federal income tax consequences to US&#160;holders (as&#160;defined below) of purchasing, owning and disposing of our ADSs and ordinary shares (collectively the &#8220;Securities&#8221;). This discussion is intended only as a descriptive summary and does not purport to be a complete analysis or listing of all potential tax effects of the purchase, ownership or disposition of our Securities. All of the following is subject to change. Such changes could apply retroactively and could affect the consequences described below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">This summary does not constitute a legal opinion or tax advice. Holders are urged to consult their own tax advisers regarding the tax consequences of the purchase, ownership and disposition of Securities in light of their particular circumstances, including the effect of any US&#160;federal, state, local or other national tax&#160;laws.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A set of tax rules is applicable to French assets that are held by or in foreign trusts. These rules provide inter&#160;alia for the inclusion of trust assets in the settlor&#8217;s net assets for purpose of applying the French real estate wealth tax, for the application of French gift and death duties to French assets held in trust, for a specific tax on capital on the French assets of foreign trusts not already subject to the French real estate wealth tax and for a number of French tax reporting and disclosure obligations. The following discussion does not address the French tax consequences applicable to Securities held in trusts. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">If Securities are held in trust, the grantor, trustee and beneficiary are urged to consult their own tax adviser regarding the specific tax consequences of acquiring, owning and disposing of&#160;Securities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The description of the French and US&#160;federal income tax consequences set forth below is based on the laws (including, for US&#160;federal income tax purposes, the Internal Revenue Code of 1986, as amended (the&#160;&#8220;Code&#8221;), final, temporary and proposed US&#160;Treasury Regulations promulgated thereunder and administrative and judicial interpretations thereof) in force as of the date of this annual report, the Convention Between the Government of the United&#160;States of America and the Government of the French Republic for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Income and Capital of August&#160;31, 1994 (the&#160;&#8220;Treaty&#8221;), which entered into force on December&#160;30, 1995 (as&#160;amended by any subsequent protocols, including the protocol of January&#160;13, 2009), and the tax regulations issued by the French tax authorities within the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Bulletin Officiel des Finances Publiques-Imp&#244;ts</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (the&#160;&#8220;Regulations&#8221;) in force as of the date of this report. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">US&#160;holders are advised to consult their own tax advisers regarding their eligibility for Treaty benefits, especially with regard to the &#8220;Limitations on Benefits&#8221; provision, in light of their own particular circumstances.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No advance ruling has been obtained with respect to the tax consequences of the acquisition, ownership or disposition of the Securities from either the French or US tax authorities. Thus, there can no assurances that either or both of such authorities will not take a position concerning said tax consequences different from that set out herein or that such a position would not be sustained by a court.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For the purposes of this discussion, a US&#160;holder is a beneficial owner of Securities that is (i)&#160;an individual who is a US&#160;citizen or resident for US&#160;federal income tax purposes, (ii)&#160;a US&#160;domestic corporation created or organized in or under the laws of the United&#160;States or any state thereof, including the District of Columbia, or (iii)&#160;certain estates or trusts that are subject to US tax jurisdiction. A non-US&#160;holder is a person other than a US&#160;holder.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If a partnership holds Securities, the tax treatment of a partner generally will depend upon the status of the partner and the activities of the partnership. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">If a US&#160;holder is an estate or trust or</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">partner in a partnership that holds Securities, the holder is urged to consult its own tax adviser regarding the specific tax consequences of acquiring, owning and disposing of&#160;Securities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This discussion is intended only as a general summary and does not purport to be a complete analysis or listing of all potential tax effects of the acquisition, ownership or disposition of the Securities to any particular investor, and does not discuss tax considerations that arise from rules of general application or that are generally assumed to be known by investors. The discussion applies only to investors that hold our Securities as capital assets that have the US&#160;dollar as their functional currency, that are entitled to Treaty benefits under the &#8220;Limitation on Benefits&#8221; provision contained in the Treaty, and whose ownership of the Securities is not effectively connected to a permanent establishment or a fixed base in France. Certain holders (including, but not </span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">158</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;10. Additional information</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">limited to, US&#160;expatriates, partnerships or other entities classified as partnerships for US&#160;federal income tax purposes, banks, insurance companies, regulated investment companies, tax-exempt organizations, financial institutions, persons subject to the alternative minimum tax, persons who acquired the Securities pursuant to the exercise of employee stock options or otherwise as compensation, persons that own (directly, indirectly or by attribution) 5% or more of our voting stock or 5% or more of our outstanding share capital, dealers in securities or currencies, persons that elect to mark their securities to market for US&#160;federal income tax purposes, persons that acquire ADSs in &#8220;pre-release&#8221; transactions (i.e. prior to deposit of the relevant ordinary shares, although our depositary has indicated that such transactions have been halted) and persons holding Securities as a position in a synthetic security, straddle or conversion transaction) may be subject to special rules not discussed below. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Holders of Securities are advised to consult their own tax advisers with regard to the application of French tax law and US&#160;federal tax law to their particular situations, as well as any tax consequences arising under the laws of any state, local or other foreign jurisdiction.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">French taxes</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Estate and gift taxes and transfer taxes</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In general, a transfer of Securities by gift or by reason of death of a US&#160;holder that would otherwise be subject to French gift or inheritance tax, respectively, will not be subject to such French tax by reason of the Convention between the Government of the United&#160;States of America and the Government of the French Republic for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Estates, Inheritances and Gifts, dated November&#160;24, 1978, unless the donor or the transferor is domiciled in France at the time of making the gift or at the time of his or her death, or the Securities were used in, or held for use in, the conduct of a business through a permanent establishment or a fixed base in&#160;France.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Pursuant to Article&#160;235&#160;ter&#160;ZD of the French General Tax Code, purchases of Securities are subject to a 0.3% French tax on financial transactions (the&#160;&#8220;FTFF&#8221;) provided that Sanofi&#8217;s market capitalization exceeds &#8364;1&#160;billion as of December&#160;1 of the year preceding the taxation year. A list of companies whose market capitalization exceeds &#8364;1&#160;billion as of December&#160;1 of the year preceding the taxation year used to be published annually by the French Ministry of Economy. It is now published by the French&#160;tax authorities, and could be amended at any time. Pursuant to Regulations BOI-ANNX-000467-21/12/2022 issued on&#160;Decemb</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">er&#160;21, 2022, purch</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ases of Sanofi&#8217;s Securities in&#160;2022 should be subject to the FTFF as the market capitalization of Sanofi exceeded &#8364;1&#160;billion as of December&#160;1, 2022. In accordance with Article&#160;726-II-d of the French General Tax Code, purchases which are subject to the FTFF should however not be subject to transfer taxes </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(droits d&#8217;enregistrement)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in&#160;France.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Wealth tax</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The French wealth tax </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(imp&#244;t de solidarit&#233; sur la fortune)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> has been replaced with a French real estate wealth tax </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(imp&#244;t sur la fortune immobili&#232;re)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> with effect from January&#160;1, 2018. French real estate wealth tax applies only to individuals and does not generally apply to the Securities if the holder is a US&#160;resident, as defined pursuant to the provisions of the Treaty, provided that the individual does not own directly or indirectly a shareholding exceeding 10% of the financial rights and voting rights.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">US&#160;taxes</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Ownership of the securities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Deposits and withdrawals by a US&#160;holder of ordinary shares in exchange for ADSs, will not be taxable events for US&#160;federal income tax purposes. For US&#160;tax purposes, holders of ADSs will be treated as owners of the ordinary shares represented by such ADSs. Accordingly, the discussion that follows regarding the US&#160;federal income tax consequences of acquiring, owning and disposing of ordinary shares is equally applicable to&#160;ADSs.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Information reporting and backup withholding tax</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Distributions made to holders and proceeds paid from the sale, exchange, redemption or disposal of Securities may be subject to information reporting to the Internal Revenue Service. Such payments may be subject to backup withholding taxes unless the holder (i)&#160;is a corporation or other exempt recipient or (ii)&#160;provides a taxpayer identification number and certifies that no loss of exemption from backup withholding has occurred. Holders that are not US&#160;persons generally are not subject to information reporting or backup withholding. However, such a holder may be required to provide a certification of its non-US&#160;status in connection with payments received within the United&#160;States or through a US-related financial intermediary to establish that it is an exempt recipient. Backup withholding is not an additional tax. Amounts withheld as backup withholding may be credited against a holder&#8217;s US&#160;federal income tax liability. A holder may obtain a refund of any excess amounts withheld under the backup withholding rules by filing the appropriate claim for refund with the Internal Revenue Service and furnishing any required information.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Foreign asset reporting</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, a US&#160;holder that is an individual (and, to the extent provided in future regulations, an entity), may be subject to recently-enacted reporting obligations with respect to ordinary shares and ADSs if the aggregate value of these and certain&#160;other &#8220;specified foreign financial assets&#8221; exceeds $50,000. If required, this disclosure is made by filing Form&#160;8938 with the&#160;US&#160;Internal Revenue Service. Significant penalties can apply if holders are required to make this disclosure and fail to do so. In addition, a US&#160;holder should consider the possible obligation to file&#160;online a FinCEN Form&#160;114 &#8211; Foreign Bank and Financial Accounts Report as a result of holding ordinary shares or ADSs. Holders are encouraged to consult their US&#160;tax advisors with respect to these and other reporting requirements that may apply to their acquisition of ordinary shares and&#160;ADSs.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">159</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;10. Additional information</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">State and local taxes</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition to US&#160;federal income tax, US&#160;holders of Securities may be subject to US&#160;state and local taxes with respect to such Securities. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Holders of Securities are advised to consult their own tax advisers with regard to the application of US&#160;state and local income tax law to their particular situation.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">ADSs-Ordinary Shares</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">French taxes</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Taxation of dividends</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under French law, dividends paid by a French corporation, such as Sanofi, to non-residents of France are generally subject to French withholding tax at a rate of (i)&#160;25% for payments benefiting legal persons who are not French tax residents (and 15% for distributions made to not-for-profit organizations with a head office in a Member State of the European Economic Area which would be subject to the tax regime set forth under article&#160;206 paragraph&#160;2 of the French General Tax Code if its head office were located in France and which meet the criteria set forth in the Regulations BOI-RPPM-RCM-30-30-10-70-24/12/2019, No.&#160;130), and (ii)&#160;12.8% for payments benefiting individuals who are not French tax residents. Dividends paid by a French corporation, such as Sanofi, towards non-cooperative States or territories, as defined in Article&#160;238-0&#160;A of the French General Tax Code, will generally be subject to French withholding tax at a rate of 75%, irrespective of the tax residence of the beneficiary of the dividends if the dividends are received in such States or territories; however, eligible US&#160;holders entitled to Treaty benefits under the &#8220;Limitation on Benefits&#8221; provision contained in the Treaty who are US&#160;residents, as defined pursuant to the provisions of the Treaty and who receive dividends in non-cooperative States or territories, will not be subject to this 75% withholding tax&#160;rate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the Treaty, the rate of French withholding tax on dividends paid to an eligible US&#160;holder who is a US&#160;resident as defined pursuant to the provisions of the Treaty and whose ownership of the ordinary shares or ADSs is not effectively connected with a permanent establishment or fixed base that such US&#160;holder has in France, is reduced to 15%, or to 5% if such US&#160;holder is a corporation and owns directly or indirectly at least 10% of the share capital of the issuing company; such US&#160;holder may claim a refund from the French tax authorities of the amount withheld in excess of the Treaty rates of 15% or 5%, if any. For US&#160;holders that are not individuals but are US&#160;residents, as defined pursuant to the provisions of the Treaty, the requirements for eligibility for Treaty benefits, including the reduced 5% or 15% withholding tax rates contained in the &#8220;Limitation on Benefits&#8221; provision of&#160;the Treaty, are complicated, and certain technical changes were made to these requirements by the protocol of January&#160;13,&#160;2009. US&#160;holders are advised to consult their own tax advisers regarding their eligibility for Treaty benefits in light of their own particular circumstances.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Dividends paid to an eligible US&#160;holder may immediately be subject to the reduced rates of 5% or 15% provided that such holder establishes before the date of payment that it is a US&#160;resident under the Treaty by completing and providing the depositary with a treaty form (Form&#160;5000). Dividends paid to a US&#160;holder that has not filed the Form&#160;5000 before the dividend payment date will be subject to French withholding tax at the rate of 25% and then reduced at a later date to 5% or 15%, provided that such holder duly completes and provides the French tax authorities with the treaty forms Form&#160;5000 and Form&#160;5001 before December&#160;31 of the second calendar year following the year during which the dividend is paid. Pension funds and certain other tax-exempt entities are subject to the same general filing requirements as other US&#160;holders except that they may have to supply additional documentation evidencing their entitlement to these benefits.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The depositary agrees to use reasonable efforts to follow the procedures established, or that may be established, by the French tax authorities (i)&#160;to enable eligible US&#160;holders to qualify for the reduced withholding tax rate provided by the Treaty, if available at the time the dividends are paid, or (ii)&#160;to recover any excess French withholding taxes initially withheld or deducted with respect to dividends and other distributions to which such US&#160;holders may be eligible from the French tax authorities and (iii)&#160;to recover any other available tax credits. In particular, associated forms (including Form&#160;5000 and Form&#160;5001, together with their instructions), will be made available by the depositary to all US&#160;holders registered with the depositary, and are also generally available from the US&#160;Internal Revenue Service.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The withholding tax refund, if any, ordinarily is paid within 12&#160;months of filing the applicable French Treasury Form, but not before January&#160;15 of the year following the calendar year in which the related dividend is&#160;paid.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Tax on sale or other disposition</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In general, under the Treaty, a US&#160;holder who is a US&#160;resident for purposes of the Treaty will not be subject to French tax on any capital gain from the redemption (other than redemption proceeds characterized as dividends under French domestic law), sale or exchange of ordinary shares or ADSs unless the ordinary shares or the ADSs form part of the business property of a permanent establishment or fixed base that the US&#160;holder has in France. Special rules apply to holders who are residents of more than one&#160;country.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">160</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;10. Additional information</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">US&#160;Taxes</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Taxation of dividends</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For US&#160;federal income tax purposes, the gross amount of any distribution paid to US&#160;holders (that is, the net distribution received plus any tax withheld therefrom) will be treated as ordinary dividend income to the extent paid or deemed paid out of the current or accumulated earnings and profits of Sanofi (as&#160;determined under US&#160;federal income tax principles). Dividends paid by Sanofi will not be eligible for the dividends-received deduction generally allowed to corporate US&#160;holders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subject to certain exceptions for short-term and hedged positions, the US&#160;dollar amount of dividends received by an individual US&#160;holder with respect to the ADSs or our ordinary shares is currently subject to taxation at a maximum rate of 20% if the dividends are &#8220;qualified dividends&#8221;. Dividends paid on the ordinary shares or ADSs will be treated as qualified dividends if (i)&#160;the issuer is eligible for the benefits of a comprehensive income tax treaty with the United&#160;States that the Internal Revenue Service has approved for the purposes of the qualified dividend rules and (ii)&#160;the issuer was not, in the year prior to the year in which the dividend was paid, and is not, in the year in which the dividend is paid, a passive foreign investment company (&#8220;PFIC&#8221;). The Treaty has been approved for the purposes of the qualified dividend rules. Based on our financial statements and relevant market and shareholder data, we believe Sanofi was not a PFIC for US&#160;federal income tax purposes with respect to its 2021 taxable year. In addition, based on its current expectations regarding the value and nature of its assets, the sources and nature of its income, and relevant market and shareholder data, we do not anticipate that Sanofi will become a PFIC for its 2022 taxable year. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Holders of ordinary shares and ADSs should consult their own tax advisers regarding the availability of the reduced dividend tax rate in light of their own particular circumstances.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If you are a US&#160;holder, dividend income received by you with respect to ADSs or ordinary shares generally will be treated as foreign source income for foreign tax credit purposes. The limitation on foreign taxes eligible for credit is calculated separately with respect to specific classes of income. Distributions out of earnings and profits with respect to the ADSs or ordinary shares generally will be treated as &#8220;passive category&#8221; income (or, in the case of certain US&#160;holders, &#8220;general category&#8221; income). Subject to certain limitations, French income tax withheld in connection with any distribution with respect to the ADSs or ordinary shares may be claimed as a credit against the US&#160;federal income tax liability of a US&#160;holder if such US&#160;holder elects for that year to credit all foreign income taxes. Alternatively, such French withholding tax may be taken as a deduction against taxable income. Foreign tax credits will not be allowed for withholding taxes imposed in respect of certain short-term or hedged positions in Securities and may not be allowed in respect of certain arrangements in which a US&#160;holder&#8217;s expected economic profit is insubstantial. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">The&#160;US&#160;federal income tax rules governing the availability and</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">computation of foreign tax credits are complex. US&#160;holders should consult their own tax advisers concerning the implications of these rules in light of their particular circumstances.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To the extent that an amount received by a US&#160;holder exceeds the allocable share of our current and accumulated earnings and profits, such excess will be applied first to reduce such US&#160;holder&#8217;s tax basis in its ordinary shares or ADSs and then, to the extent it exceeds the US&#160;holder&#8217;s tax basis, it will constitute capital gain from a deemed sale or exchange of such ordinary shares or ADSs (see &#8220;&#8212;&#160;Tax on Sale or Other Disposition&#8221;, below).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of any distribution paid in euros will be equal to the US&#160;dollar value of the euro amount distributed, calculated by reference to the exchange rate in effect on the date the dividend is received by a US&#160;holder of ordinary shares (or&#160;by the depositary, in the case of ADSs) regardless of whether the payment is in fact converted into US&#160;dollars on such date. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">US&#160;holders should consult their own tax advisers regarding the treatment of foreign currency gain or loss, if any, on any euros received by a US&#160;holder that are converted into US&#160;dollars on a date subsequent to&#160;receipt.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Distributions to holders of additional ordinary shares (or&#160;ADSs) with respect to their ordinary shares (or&#160;ADSs) that are made as part of a pro&#160;rata distribution to all ordinary shareholders generally will not be subject to US&#160;federal income tax. However, if a US&#160;holder has the option to receive a distribution in shares (or&#160;ADSs) or to receive cash in lieu of such shares (or&#160;ADSs), the distribution of shares (or&#160;ADSs) will be taxable as if the holder had received an amount equal to the fair market value of the distributed shares (or&#160;ADSs), and such holder&#8217;s tax basis in the distributed shares (or&#160;ADSs) will be equal to such&#160;amount.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Tax on sale or other disposition</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In general, for US&#160;federal income tax purposes, a US&#160;holder that sells, exchanges or otherwise disposes of its ordinary shares or ADSs will recognize capital gain or loss in an amount equal to the US&#160;dollar value of the difference between the amount realized for the ordinary shares or ADSs and the US&#160;holder&#8217;s adjusted tax basis (determined in US&#160;dollars and under US&#160;federal income tax rules) in the ordinary shares or ADSs. Such gain or loss generally will be US-source gain or loss, and will be treated as long-term capital gain or loss if the US&#160;holder&#8217;s holding period in the ordinary shares or ADSs exceeds one year at the time of disposition. If the US&#160;holder is an individual, any capital gain generally will be subject to US&#160;federal income tax at preferential rates (currently a maximum of 20%) if specified minimum holding periods are met. The deductibility of capital losses is subject to significant limitations.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Medicare tax</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Certain US&#160;holders who are individuals, estates or trusts are required to pay a Medicare tax of 3.8% (in&#160;addition to taxes they would otherwise be subject to) on their &#8220;net investment income&#8221; which would include, among other things, dividends and capital gains from the ordinary shares and&#160;ADSs.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">161</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_385"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;10. Additional information</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">F.&#160;Dividends and Paying Agents</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_388"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">G.&#160;Statement by Experts</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_391"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">H.&#160;Documents on Display</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We are subject to the information requirements of the US&#160;Securities Exchange Act of 1934, as amended, or Exchange Act, and, in&#160;accordance therewith, we are required to file reports, including this annual report on Form&#160;20-F, and other information with the&#160;US&#160;Securities and Exchange Commission, or Commission, by electronic means.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">You may review a copy of our filings with the Commission, as well as other information furnished to the Commission, including exhibits and schedules filed with it, at the Commission&#8217;s public reference room at 100&#160;F Street, N.E., Room&#160;1580, Washington,&#160;D.C. 20549. Please call the SEC at 1-800-SEC-0330&#160;for further information. In addition, the Commission maintains an Internet site at http://www.sec.gov that contains reports and other information regarding issuers that file electronically with the Commission (these documents are not incorporated by reference in this annual&#160;report).</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_394"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I.&#160;Subsidiary Information</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">162</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_397"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;11. Quantitative and qualitative disclosures about market risk</span></div></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;11. Quantitative and Qualitative Disclosures about Market&#160;Risk</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10.4pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-5.6pt;vertical-align:baseline">(20)</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General policy</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Liquidity risk, foreign exchange risk and interest rate risk, as well as related counterparty risks, are managed centrally by our dedicated treasury team within the Group Finance Department. Where it is not possible to manage those risks centrally &#8211;&#160;in particular due to regulatory restrictions (such as foreign exchange controls) or local tax restrictions&#160;&#8211; credit facilities and/or currency lines, guaranteed whenever necessary by the parent company, are contracted by our subsidiaries locally with banks, under the supervision of the central treasury&#160;team.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our financing and investment strategies, and our interest rate and currency hedging strategies, are reviewed monthly by the Group Finance Department.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our policy prohibits the use of derivatives for speculative purposes.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Counterparty risk</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our financing and investing transactions, and our currency and interest rate hedges, are contracted with leading counterparties. We set limits for investment and derivative transactions with individual financial institutions, depending on the rating of each institution. Compliance with these limits, which are based on the notional amounts of the investments and the fair value of the hedging instruments, is monitored on a daily&#160;basis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows our total exposure as of December 31, 2022 by rating and in terms of our percentage exposure to the dominant counterparty.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:23.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash&#160;and&#160;cash</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">equivalents</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(excluding&#160;mutual</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">funds)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">amounts of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">currency</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">hedges </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value of currency hedges</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">amounts of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">interest&#160;rate</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">hedges </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value of interest rate hedges</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">General<br/>corporate<br/>purpose<br/>credit&#160;facilities</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">AA</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,280&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">AA-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,668&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">A+</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,237&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:1pt;text-align:right"><span><br/></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">A</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,585&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">A-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BBB+</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,179</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21,408</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">113</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,434</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(232)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,000</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%&#160;/&#160;rating of dominant counterparty</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30.0%/AA-</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16.8%/A+</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.3%/A+</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6%/A</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Cash equivalents include mutual fund investments of &#8364;9,537&#160;million.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) The notional amounts are translated into euros at the relevant closing exchange rate as of December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, we held investments in euro and US dollar denominated money-market mutual funds. Those instruments have low volatility, low sensitivity to interest rate risk, and a very low probability of loss of principal. The depositary banks of the mutual funds, and of Sanofi itself, have a long-term rating of at least&#160;A. Realization of counterparty risk could impact our liquidity in certain circumstances.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(20)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> The disclosures in this section supplement those provided in Note&#160;B.8.7. to the consolidated financial statements as regards the disclosure requirements of&#160;IFRS&#160;7, and are covered by the independent registered public accounting firms' opinion on the consolidated financial statements.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">163</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;11. Quantitative and qualitative disclosures about market risk</span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Foreign exchange risk</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">A.&#160;Operating foreign exchange risk</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A substantial portion of our net sales is generated in countries where the euro, which is our reporting currency, is not the functional currency. In 2022, for example, 42.5% of our net sales were generated in the United&#160;States; 23.3% in Europe; and 34.2% in the Rest of the World region (see the definition in &#8220;Item&#160;5. Operating and Financial Review and Prospects &#8212;&#160;A/&#160;Operating results), including countries that are, or may in the future become, subject to exchange controls, of which 7.3% was generated in China and 3.8% in Japan. Although we also incur expenses in those countries, the impact of those expenses is not enough wholly to offset the impact of exchange rates on our net sales. Consequently, our operating income may be materially affected by fluctuations in exchange rates between the euro and other currencies. Sanofi operates a foreign exchange risk hedging policy to reduce the exposure of operating income to exchange rate movements. That policy involves regular assessments of Sanofi&#8217;s worldwide foreign currency exposure, based on foreign currency transactions carried out by the parent company and its subsidiaries. Those transactions mainly comprise sales, purchases, research costs, co-marketing and co-promotion expenses, and royalties. To reduce the exposure of those transactions to exchange rate movements, Sanofi contracts hedges using liquid derivative instruments, mainly forward currency purchases and sales, and also foreign exchange swaps.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows operating currency hedging instruments in place as of December 31, 2022, with the notional amount translated into euros at the relevant closing exchange rate (see Note&#160;D.20. to the consolidated financial statements for the accounting classification of those instruments as of December 31, 2022).</span></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Operating foreign exchange derivatives as of December 31, 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:73.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,403</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">49</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,732</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">576</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">240</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Korean won</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">179</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,459</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(27)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,047</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">375</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Korean won</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">130</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Taiwan dollar</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">84</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The above positions mainly hedge future material foreign-currency cash flows arising after the end of the reporting period in relation to transactions carried out during the year ended December 31, 2022 and recognized in the balance sheet at that date. Gains and losses on hedging instruments (forward contracts) are calculated and recognized in parallel with the recognition of gains and losses on the hedged items. Due to this hedging relationship, the commercial foreign exchange profit or loss on these items (hedging instruments and hedged transactions) will be immaterial in 2022.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B. Financial foreign exchange risk</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The cash pooling arrangements for foreign subsidiaries outside the euro zone, and some of Sanofi&#8217;s financing activities, expose certain Sanofi entities to financial foreign exchange risk (i.e. the risk of changes in the value of borrowings and loans denominated in a currency other than the functional currency of the borrower or lender). That foreign exchange exposure is hedged using derivative instruments (foreign exchange swaps, forward contracts or currency swaps) that alter the currency split of Sanofi&#8217;s net debt once those instruments are taken into account.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows financial currency hedging instruments in place as of December 31, 2022, with the notional amounts translated into euros at the relevant closing exchange rate (see also Note&#160;D.20. to&#160;the consolidated financial statements for the accounting classification of these instruments as of December 31, 2022).</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">164</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;11. Quantitative and qualitative disclosures about market risk</span></div></td></tr></table></div></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Financial foreign exchange derivatives as of December 31, 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:53.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,559</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">66</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">6,114&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Pound sterling</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,997</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,011&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(b) (c)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,556</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">90</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes forward sales with a notional amount of $3,615 million expiring in 2023, designated as a hedge of Sanofi&#8217;s net investment in Bioverativ. As of December 31, 2022, the fair value of these forward contracts represented an asset of &#8364;38 million; the opposite entry was recognized in &#8220;Other comprehensive income&#8221;, with the impact on financial income and expense being immaterial.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Includes forward purchases with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of $1,000 million of bond issues to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of &#8364;3 million, the opposite entry for &#8364;0.6&#160;million of which was debited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting treatment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Includes receiver currency swaps with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the swaps was a liability of &#8364;2 million, the opposite entry for &#8364;1.4&#160;million of which was credited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting treatment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Includes forward purchases with a notional amount of SGD1,500 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/SGD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of&#160;&#8364;33 million, the opposite entry for &#8364;2.5&#160;million of which was credited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These hedging instruments generate a net financial gain or loss arising from the interest rate differential between the hedged currency and the euro, given that the foreign exchange gain or loss on the foreign-currency borrowing and loans is offset by the change in the intrinsic value of the hedging instruments. The interest rate differential is recognized within cost of net debt (see&#160;Note&#160;D.29. to our consolidated financial statements). We may also hedge some future foreign-currency investment or divestment cash&#160;flows.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">C. Other foreign exchange risks</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A significant proportion of our net assets is denominated in US&#160;dollars (see&#160;Note&#160;D.35. to&#160;the consolidated financial statements). As a result, any fluctuation in the exchange rate of the US&#160;dollar against the euro automatically impacts the amount of our equity as expressed in euros.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, we use the euro as our reporting currency. Consequently, if one or more European Union Member States were to abandon the euro as a currency, the resulting economic upheavals &#8211;&#160;in particular, fluctuations in exchange rates&#160;&#8211; could have a significant impact on the terms under which we can obtain financing and on our financial results, the extent and consequences of which are not currently foreseeable.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidity risk</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We operate a centralized treasury platform whereby all surplus cash and financing needs of our subsidiaries are invested with or funded by the parent company (where permitted by local legislation). The central treasury department manages our current and projected financing, and ensures that Sanofi is able to meet its financial commitments by maintaining sufficient cash and confirmed credit facilities for the size of our operations and the maturity of our debt (see&#160;Notes&#160;D.17.1.c. and&#160;D.17.1.g. to the consolidated financial statements).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We diversify our short-term investments with leading counterparties using money-market products with instant access or with a maturity of less than three months.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, cash and cash equivalents amounted to &#8364;12,736 million, and short-term investments predominantly comprised:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">collective investments in euro and US dollar denominated money-market mutual funds. All such funds can be traded on a daily basis and the amount invested in each fund may not exceed 10% of the aggregate amount invested in such funds;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">amounts invested directly with banks and non-financial institutions in the form of instant access deposits, term deposits, and Negotiable European Commercial Paper with a maturity of no more than three months.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, to optimize the liquidity/return profile of our short-term investments, we had &#8364;196&#160;million invested in term deposits as of&#160;December 31, 2022, expiring in June&#160;2023 and presented within &#8220;Other current financial assets&#8221; (see Note&#160;D.11.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 we also had &#8364;8&#160;billion of undrawn general corporate purpose confirmed credit facilities, half of which expires in December&#160;2023 and half in December&#160;2027. Those credit facilities are not subject to financial covenant ratios.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">165</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;11. Quantitative and qualitative disclosures about market risk</span></div></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our policy is to diversify our sources of funding through public or private issuances of debt securities, in the United&#160;States (shelf registration statement) and Europe (Euro Medium Term Note program). In addition, our A-1+/P-1&#160;short-term rating gives us access to commercial paper programs in the United&#160;States, and to Negotiable European Commercial Paper programs in France. The average maturity of our total debt was 4.71&#160;years as of December 31, 2022, compared with 5.5&#160;years as of December 31, 2021. During 2022, we did not draw down on our Negotiable European Commercial Paper programs in France. Average drawdowns under the US&#160;commercial paper program during 2022 were &#8364;2.2&#160;billion (with a maximum of &#8364;3.8&#160;billion); the average maturity of those drawdowns was two months. As of December 31, 2022, neither of those programs was being utilized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the event of a liquidity crisis, we could be exposed to difficulties in calling up our available cash, a scarcity of sources of funding including the above-mentioned programs, and/or a deterioration in their terms. This situation could damage our capacity to refinance our debt or to issue new debt on reasonable terms.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest rate risk</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi issues debt in two currencies, the euro and the US dollar, and also invests its cash and cash equivalents in those currencies. Sanofi also operates cash pooling arrangements to manage the surplus cash and short-term liquidity needs of foreign subsidiaries located outside the euro zone.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To optimize the cost of debt or reduce the volatility of debt and manage its exposure to financial foreign exchange risk, Sanofi uses derivative instruments (interest rate swaps, currency swaps, foreign exchange swaps and forward contracts) that alter the fixed/floating rate split and the currency split of its net debt.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The projected full-year sensitivity to interest rate fluctuations of our debt, net of cash and cash equivalents for 2023 is as&#160;follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:70.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in short-term interest rates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact&#160;on&#160;pre-tax<br/>net income<br/>(&#8364;&#160;million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact&#160;on&#160;pre-tax<br/>income/(expense)<br/>recognized&#160;directly<br/>in&#160;equity<br/>(&#8364; million)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+100&#160;bp</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+25&#160;bp</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25&#160;bp</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-100&#160;bp</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(98)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock market risk</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is our policy not to trade on the stock market for speculative purposes.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">166</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_400"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;12. Description of Securities other than Equity Securities</span></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;12. Description of Securities other than Equity Securities</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_403"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.A.&#160;Debt securities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_406"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.B. Warrants and rights</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_409"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.C.&#160;Other securities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_412"></div><div style="-sec-extract:summary;margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.D.&#160;American depositary shares</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">General</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">JPMorgan Chase Bank, N.A. (&#8220;JPMorgan&#8221;), as depositary, issues Sanofi ADSs in certificated form (evidenced by an ADR) or book-entry form. Each ADR is a certificate evidencing a specific number of Sanofi ADSs. Each Sanofi ADS represents one-half of one Sanofi ordinary share (or&#160;the right to receive one-half of one Sanofi ordinary share) deposited with the Paris, France office of BNP Paribas, as custodian. Each Sanofi ADS also represents an interest in any other securities, cash or other property that may be held&#160;by the depositary under the Second Amended and Restated Deposit Agreement between Sanofi and JPMorgan dated February&#160;13, 2015, as amended by Amendment No.&#160;1 dated July&#160;23, 2020 (&#8220;Amendment No.&#160;1&#8221;), and as may be further amended from time to time (together, the &#8220;deposit agreement&#8221;). The depositary&#8217;s principal executive office is located at 383&#160;Madison Avenue, 11</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;Floor, New&#160;York, New&#160;York&#160;10179.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For additional information on our ADSs, please refer to Exhibit&#160;2.2 &#8220;Description of Securities&#8221; of this Annual Report.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Fees and expenses</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fees payable by ADS holders</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Pursuant to the deposit agreement, holders of our ADSs may have to pay to JPMorgan, either directly or indirectly, fees or charges up to the amounts set forth in the table&#160;below.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Associated Fee</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Depositary Action</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$5.00 or less per 100&#160;ADSs (or&#160;portion thereof)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Execution and delivery of ADRs for distributions and dividends in shares and rights to subscribe for additional shares or rights of any other nature and surrender of ADRs for the purposes of withdrawal, including the termination of the deposit agreement.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$0.05 or less per ADS (or&#160;portion thereof)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Any cash distribution made pursuant to the deposit agreement, including, among other things:</span></div><div style="padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">cash distributions or dividends;</span></div><div style="padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">distributions other than cash, shares or rights;</span></div><div style="padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">distributions in shares; and</span></div><div style="padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">rights of any other nature, including rights to subscribe for additional shares.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">$0.05 or less per ADS per calendar year (or portion thereof)</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Services performed in administering the ADRs (which fee may be charged on a periodic basis during each calendar year)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Registration fees in effect for the registration of transfers of shares generally on the share register of the company or foreign registrar and applicable to transfers of shares to or from the name of JPMorgan or its nominee to the custodian or its nominee on the making of deposits and withdrawals</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">As applicable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">A fee equal to the fee for the execution and delivery of ADSs which would have been charged as a result of the deposit of such securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions of securities other than cash, shares or rights</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">A fee for the reimbursement of such fees, charges and expenses as are incurred by JPMorgan, its agents (and&#160;their agents), including BNP Paribas, as custodian (by&#160;deductions from cash dividends or other cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compliance with foreign exchange control regulations or any law or regulation relating to foreign investment, servicing of shares or other deposited securities, sale of securities, delivery of deposited securities or otherwise</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expenses incurred by JPMorgan</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Cable, telex and facsimile transmission (where expressly provided for in the deposit agreement)</span></div><div style="padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Foreign currency conversion into US&#160;dollars</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition to the fees outlined above, each holder will be responsible for any taxes or other governmental charges payable on his or her Sanofi ADSs or on the deposited securities underlying his or her Sanofi ADSs. The depositary may refuse to transfer a holder&#8217;s Sanofi ADSs or allow a holder to withdraw the deposited securities underlying his or her Sanofi ADSs until such taxes or other charges are paid. It may apply payments owed to a holder or sell deposited securities underlying a holder&#8217;s Sanofi ADSs to pay any taxes owed, and the holder will remain liable for any deficiency. If it sells deposited securities, it will, if appropriate, reduce the number of Sanofi ADSs to reflect the sale and pay to the holder any proceeds, or send to the holder any property, remaining after it has paid the taxes. For additional information regarding taxation, see &#8220;Item&#160;10. Additional Information &#8212;&#160;E.&#160;Taxation&#8221;.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">167</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="-sec-extract:summary;padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;12. Description of Securities other than Equity Securities</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fees paid to Sanofi by the depositary</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">JPMorgan, as depositary, has agreed to reimburse Sanofi for certain expenses that Sanofi incurs relating to the establishment and maintenance of the ADR program, as agreed from time to time. Pursuant to a letter agreement dated October&#160;4, 2022 (the &#8220;letter agreement&#8221;), JPMorgan as our ADS depositary has agreed to make (i)&#160;an initial contribution to Sanofi, within 30&#160;days of the commencement date of the letter agreement and (ii)&#160;with respect to each 12-month period beginning on the anniversary of the effective date of the agreement (each such 12-month period, a &#8220;Contract Year&#8221;), a contribution, paid at the end of such Contract Year quarter, equal to the aggregate of the program share (equal to 100% of routine program revenues and 50% of non-routine program revenues) of any program revenues, less the aggregate of any program costs for the applicable Contract Year and any invoiced supplementary costs not paid within 60&#160;days of the date of the applicable invoice.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To the extent in any given Contract Year the depositary does not collect/recoup the entirety of the program costs and unpaid supplementary costs, no contribution shall be payable to Sanofi and such excess will, at the discretion of the depositary, either be deducted from future contributions or be payable to the depositary by Sanofi promptly upon invoicing as supplementary costs under the letter agreement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">JPMorgan has further agreed to waive the $0.05 per ADS issuance fees that would normally be owed by Sanofi in connection with our deposits of shares as part of our employee stock purchase plans. Sanofi is responsible for reimbursing JPMorgan for all taxes and governmental charges in connection with payments to JPMorgan under the letter agreement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">From January&#160;1, 2022 to December&#160;31, 2022, we received a total amount of $26,104,126.68 from JPMorgan pursuant to the letter agreement.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">168</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_415"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART II</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 13. Defaults, dividend arrearages and delinquencies</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:18pt;font-weight:400;line-height:120%">Part II</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_418"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;13. Defaults, Dividend Arrearages and Delinquencies</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_421"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;14. Material Modifications to the Rights of Security Holders</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_424"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;15. Controls and Procedures</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.86pt">Our Chief Executive Officer and principal financial officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rule&#160;13a-15(e)) as of the end of the period covered by this Form&#160;20-F, have concluded that, as of such date, our disclosure controls and procedures were effective to ensure that material information relating to Sanofi was timely made known to them by others within Sanofi.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.25pt">Report of Management on Internal Control Over Financial Reporting.</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule&#160;13a-15(f). Management assessed the effectiveness of internal control&#160;over financial reporting as of December 31, 2022 based on the framework in &#8220;Internal Control &#8212;&#160;Integrated Framework&#8221; (2013&#160;framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Based on that assessment, management has concluded that the Company&#8217;s internal control over financial reporting was effective as of December 31, 2022 to provide reasonable assurance regarding the reliability of its financial reporting and the preparation of its financial statements for external purposes, in accordance with generally accepted accounting principles.</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Due to its inherent limitations, internal control over financial reporting may not prevent or detect misstatements, and can only provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The effectiveness of the Company&#8217;s internal control over financial reporting has been audited by PricewaterhouseCoopers Audit (PCAOB&#160;ID&#160;<ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80MjQvZnJhZzo1Njc0ZmUxM2YwM2U0ZGZmODkxODk0YjJlMTc1Y2RkNS90ZXh0cmVnaW9uOjU2NzRmZTEzZjAzZTRkZmY4OTE4OTRiMmUxNzVjZGQ1XzE5ODU_c066f7b0-4d9d-4e3a-bf97-c948382ea865">1347</ix:nonNumeric>) and Ernst&#160;&amp; Young et Autres (PCAOB&#160;ID&#160;<ix:nonNumeric contextRef="i9f887633b9c1418f97d4bb30260bb881_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80MjQvZnJhZzo1Njc0ZmUxM2YwM2U0ZGZmODkxODk0YjJlMTc1Y2RkNS90ZXh0cmVnaW9uOjU2NzRmZTEzZjAzZTRkZmY4OTE4OTRiMmUxNzVjZGQ1XzIwMjc_f17a495d-1b3e-4d3b-9abd-51659bbb2868">1704</ix:nonNumeric>) independent registered public accounting firms, as stated in their report on the Company&#8217;s internal control over financial reporting as of December 31, 2022, which is included herein. See paragraph&#160;(c) of the present Item&#160;15.,&#160;below.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.78pt">See report of PricewaterhouseCoopers Audit and Ernst&#160;&amp; Young et Autres, independent registered public accounting firms, included under &#8220;Item&#160;18. Financial Statements&#8221; on page&#160;F-3.</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.25pt">There were no changes to our internal control over financial reporting that occurred during the period covered by this Form&#160;20-F that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:5pt;padding-left:11.25pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">169</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_427"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART II</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;16A. Audit Committee Financial Expert</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;16A. Audit Committee Financial Expert</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Audit Committee is composed of Fabienne Lecorvaisier, Christophe Babule, Carole Ferrand and Diane Souza.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our Board of Directors has determined that all directors are independent financial experts within the meaning of Section&#160;407 of the Sarbanes-Oxley Act of&#160;2002.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors deemed Fabienne Lecorvaisier to be a financial expert based on her education and experience in corporate finance in various international banks and as Chief Financial Officer of Essilor and Air Liquide. She is now Executive Vice President, in charge of Sustainable Development, Public and International Affairs as well as the supervision of the Social Programs and the General Secretariat of Air Liquide Group.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors deemed Christophe Babule to be a financial expert based on his education and experience in audit and corporate finance in major corporations and as Executive Vice President and Chief Financial Officer of L&#8217;Or&#233;al. He has also served as a director of L&#8217;Or&#233;al US&#160;Inc.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors deemed Carole Ferrand to be a financial expert based on her education and experience in audit at PriceWaterhouseCoopers and as Chief Financial Officer of Sony France, EuropaCorp and Groupe Art&#233;mis. She is now Chief Financial Officer of Capgemini.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors deemed Diane Souza to be a financial expert based on her education (she is a certified public accountant) and experience in audit and tax in major international corporations, as Chief Financial Officer of Aetna&#8217;s Guaranteed Products b</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">usiness, and as Chief Executive Officer of the UnitedHealthcare Specialty Benefits.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors has determined that all four directors meet the independence criteria of US&#160;Securities and Exchange Commission Rule&#160;10A-3, although only Fabienne Lecorvaisier, Carole Ferrand and Diane Souza meet the French AFEP-MEDEF Code criteria of independence applied by the Board of Directors for general corporate governance purposes (see&#160;Item&#160;16G.,&#160;below).</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_430"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;16B. Code of Ethics</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have adopted a code of ethics (hereafter the "Code of conduct"), as defined in Item&#160;16B. of Form&#160;20-F under the Exchange Act, containing specific rules relating to financial ethics. Our Code of conduct applies to our Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer and other officers performing similar functions, as designated from time to time. Our Code of conduct is available on our website at www.sanofi.com (information on our website is not incorporated by reference in this annual report). A copy of our Code of conduct may also be obtained free of charge by addressing a written request to the attention of Individual Shareholder Relations at our headquarters in Paris. We will disclose any amendment to the provisions of such financial code of conduct on our&#160;website.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_433"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;16C. Principal Accountants&#8217; Fees and Services</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">See Note&#160;E. to&#160;our consolidated financial statements included at Item&#160;18 of this annual&#160;report.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_436"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;16D. Exemptions from the Listing Standards for Audit Committees</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">170</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_439"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART II</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 16E. Purchases of Equity Securities by the Issuer and&#160;Affiliated Purchasers</span></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item 16E. Purchases of Equity Securities by the Issuer and&#160;Affiliated Purchasers</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, Sanofi made the following purchases of its ordinary shares.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:33.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.289%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(A) Total Number of&#160;Shares Purchased</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(B)&#160;Average Price&#160;Paid per&#160;Share</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(C)&#160;Total&#160;Number of Shares Purchased as Part&#160;of&#160;Publicly Announced Plans or Programs</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(D)&#160;Approximate Value&#160;of&#160;Shares that&#160;May&#160;Yet&#160;Be Purchased&#160;Under the Plans or Programs</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 2022</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,976,992&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90.21&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,976,992&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,285&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 2022</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,510,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,510,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,817&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,486,992</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) The Company was authorized to repurchase up to &#8364;18,884,575,950 of shares for a period of eighteen months (i.e., through October&#160;30, 2022) by the Annual Shareholders&#8217; Meeting held on April&#160;30, 2021. Then, the Company was authorized to repurchase up to &#8364;18,953,410,350&#160;of shares for a period of eighteen months (i.e., through November&#160;3, 2023) by the Annual Shareholders&#8217; Meeting held on May&#160;3, 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Millions of euros.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For more information see &#8220;Item&#160;10.B. Memorandum and Articles of Association &#8212; Use of Share Repurchase Programs&#8221;.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_442"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;16F. Change in Registrant&#8217;s Certifying Accountant</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The terms of office of Ernst &amp; Young et Autres, joint statutory auditor of the Company since 1986, will expire expire at the end of the Annual Shareholders&#8217; Meeting called in 2024. Ernst &amp; Young et Autres&#8217; terms of office could not be legally extended as they had reached the maximum legal duration. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The selection procedure of the auditors to be appointed by the Annual Shareholders&#8217; Meeting in 2024 was overseen by the Audit Committee, following which a recommendation to the Board of Directors was issued. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors, at its meeting of October 27, 2022 approved the Audit Committee&#8217;s recommendation and decided to propose the appointment of Mazars as statutory auditor. Consequently, the Board of Directors will propose to the Annual Shareholders&#8217; Meeting to be held in 2024 to appoint Mazars as new joint statutory auditor for a 6-year term, i.e. until the Annual Shareholders&#8217; Meeting to be held in 2030, which will approve the financial statements for the year 2029.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The report of Ernst &amp; Young et Autres on the consolidated financial statements for each of the years ended December 31, 2022 and 2021 did not contain an adverse opinion or a disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles. During each of the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">there were no &#8220;disagreements&#8221; (as that term is described in Item 16F.(a)(1)(iv) of the Instructions to Form 20-F and the instructions to Item&#160;16F.) between Sanofi and Ernst &amp;&#160;Young et Autres on any matters of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreement(s), if not resolved to Ernst &amp; Young et Autres&#8217; satisfaction, would have caused Ernst &amp; Young et Autres to make reference to the subject matter of the disagreement(s) in connection with its report; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">there were no &#8220;reportable events&#8221; (as that term is defined in Item 16F.(a)(1)(v) of the Instructions to Form 20-F).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A copy of Ernst &amp; Young et Autres&#8217; letter, dated February 24, 2023, is filed as Exhibit 23.1 to this Annual Report on Form 20-F.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_445"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;16G. Corporate Governance</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is incorporated under the laws of France, with securities listed on regulated public markets in the United&#160;States (Nasdaq Global Select Market - NASDAQ) and France (Euronext Paris). Consequently, as described further in this Annual Report on Form 20-F, our corporate governance framework reflects the mandatory provisions of French corporate law, the securities laws and regulations of France and the United&#160;States and the rules of the aforementioned public markets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As a &#8220;foreign private issuer,&#8221; as defined in the rules promulgated under the US&#160;Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;), Sanofi is permitted, pursuant to NASDAQ Listing Rule&#160;5615(a)(3), to follow its home country practice in lieu of certain NASDAQ corporate governance requirements applicable to US&#160;corporations listed on the NASDAQ. Sanofi has informed NASDAQ that it intends to follow corporate governance standards under French law to the extent permitted by the NASDAQ listing rules and US&#160;securities laws, as further discussed below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We generally follow the &#8220;AFEP-MEDEF&#8221; corporate governance recommendations for French listed issuers (hereafter referred to as the &#8220;AFEP-MEDEF Code&#8221;). As a result, our corporate governance framework is similar in many respects to, and provides investor protections that are comparable to &#8211;&#160;or in some cases, more stringent than&#160;&#8211; the corresponding rules of the NASDAQ. Nevertheless, there are certain important differences.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In line with NASDAQ listing rules applicable to domestic issuers, a majority of Sanofi&#8217;s Board of Directors is comprised of independent directors. Sanofi evaluates the independence of members of our Board of Directors using the standards of the </span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">171</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART II</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM&#160;16G. Corporate Governance</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">French AFEP-MEDEF Code as the principal reference. We believe that AFEP-MEDEF&#8217;s overarching criteria for independence &#8211;&#160;that Board members have no relationship of any kind whatsoever with the Company, its group or the management of either such as to color a Board member&#8217;s judgment&#160;&#8211; is on the whole consistent with the goals of the NASDAQ's listing rules; however, the specific tests proposed under the two standards may vary on some points. Our Audit Committee complies with the&#160;independence and other requirements of Rule&#160;10A-3 under the Exchange Act, adopted pursuant to the Sarbanes-Oxley Act&#160;of&#160;2002. Our Audit Committee includes one member, Christophe Babule, who is considered non-independent under the AFEP-MEDEF Code, and which is permitted under the AFEP-MEDEF Code, although this would not be permitted under the listing rules of the NASDAQ for domestic issuers. Three out of the four members of our Compensation Committee meet the independence standards of the AFEP-MEDEF Code (the Director representing employees is not considered as independent) and the independence requirements of NASDAQ&#8217;s listing rules.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi follows the recommendation of the AFEP-MEDEF Code that at least one meeting of the Board of Directors not attended by the company&#8217;s executive officers be organized each year. Accordingly, Sanofi&#8217;s Board Charter provides that the Board of Directors shall organize at least two meetings a year without its executive officers, thereby providing the Chairman with the option of whether to include directors representing employees or any other Group employee, as the case may require, depending on the agenda of the meeting. Sanofi&#8217;s practice in that respect departs from NASDAQ Listing Rule&#160;5605(b)(2), which provides that independent directors must have regularly scheduled meetings at which only independent directors are present.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under French law, the committees of our Board of Directors are advisory only, and where the NASDAQ Listing Rule&#160;5600 series would vest certain decision-making powers with specific committees by delegation (e.g.&#160;the appointment of Sanofi&#8217;s auditors by the Audit Committee), under French law, our Board of Directors remains the only competent body to take such decisions, albeit taking into account the recommendation of the relevant committees. Additionally, under French corporate law, it is the shareholders of Sanofi voting at the Shareholders&#8217; General Meeting that have the authority to appoint our auditors upon consideration of the proposal of our Board of Directors, although our Board Charter provides that the Board of Directors will make its proposal on the basis of the recommendation of our Audit Committee. We believe that this requirement of French law, together with the additional legal requirement that two sets of statutory auditors be appointed, is in line with the NASDAQ's underlying goal of ensuring that the audit of our accounts be conducted by auditors independent from company management.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition to the oversight role of our Compensation Committee for questions of management compensation including by way of equity, under French law any option or restricted share plans or other share capital increases, whether for the benefit of senior management or employees, may only be adopted by the Board of Directors pursuant to and within the limits of a shareholder resolution approving the related capital increase and delegating to the Board the authority to implement such operations. While NASDAQ rules require shareholder approval when a plan or other equity compensation arrangement is established or materially amended, under French law our shareholders must decide any issuance of equity, as a general matter. We intend to follow our French home country practice and ask our shareholders to delegate their authority to issue incentive equity and define the final terms of any equity compensation plan or arrangements to our Board of Directors. We may, from time to time, ask for our shareholders&#8217; subsequent approval on an equity compensation arrangement in order to obtain advantageous tax treatment or otherwise. In addition, under French law, our Board of Directors must obtain the prior approval of our shareholders before establishing or amending a plan or arrangement that would exceed the limits of the granted delegation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As described above, a number of issues, which could be resolved directly by a board or its committees in the United&#160;States, require the additional protection of direct shareholder consultation in France.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because we are a &#8220;foreign private issuer&#8221; as described above, our Chief Executive Officer and our Chief Financial Officer issue the certifications required by Section&#160;302 and Section&#160;906 of the Sarbanes-Oxley Act of 2002 on an annual basis (with the filing of our&#160;Annual Report on Form&#160;20-F) rather than on a quarterly basis as would be the case of a US&#160;corporation filing quarterly reports on Form&#160;10-&#160;Q.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">French corporate law provides that the Board of Directors must vote to approve a broadly defined range of transactions that could potentially create conflicts of interest between Sanofi on the one hand and its directors and Chief Executive Officer on the other hand, which are then presented to shareholders for approval at the next annual meeting. This legal safeguard operates in place of certain provisions of the NASDAQ listing rules.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is governed by the French Commercial Code, which provides that an ordinary general meeting of the shareholders may validly deliberate when first convened if the shareholders present or represented hold at least one-fifth of the voting shares. If it is reconvened, no quorum is required. The French Commercial Code further provides that the shareholders at an extraordinary general meeting may validly deliberate when first convened only if the shareholders present or represented hold at least one-quarter of the voting shares and, if reconvened, one-fifth of the voting shares. Therefore, Sanofi will not follow NASDAQ&#8217;s Listing Rule&#160;5620(c), which provides that the minimum quorum requirement for a meeting of shareholders is 33</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8260;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:1.19pt;vertical-align:baseline">3</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">% of the outstanding common voting shares of the company. In accordance with the provisions of the French Commercial Code, the required majority for the adoption of a decision is a simple majority (for an ordinary general meeting of the shareholders) or a two-thirds majority (for an extraordinary general meeting) of the votes cast by the shareholders present or represented.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Company intends, in accordance with Section&#160;10D-1 of the Exchange Act, to introduce a recovery policy for compensation erroneously paid to &#8220;executive officers&#8221; (as defined in Section&#160;10D-1(d) of the Exchange Act) based in whole or in part on any financial reporting measures, at such time as required by the applicable NASDAQ listing rules, Section&#160;10D-1 of the Exchange Act and applicable interpretive guidance.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">172</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_448"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART II</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 16H. Mine Safety Disclosure</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;16H. Mine Safety Disclosure</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_451"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;16I. Disclosure regarding foreign jurisdictions that prevent inspections</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">N/A</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">173</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_454"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">PART III</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">ITEM 17. Financial Statements</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:18pt;font-weight:400;line-height:120%">Part III</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_457"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item 17. Financial Statements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">See Item&#160;18.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_460"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item 18. Financial Statements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">See pages&#160;F-1 through</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.511%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i52f57172a9d7443580346c2d8f39cd2b_706">F-</a><a style="color:#0000ff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i52f57172a9d7443580346c2d8f39cd2b_706">102</a></span></div></td></tr></table><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">incorporated herein by reference.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_463"></div><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Item 19. Exhibits</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit11.htm">Articles of association (statuts) of Sanofi (English translation).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit12.htm">Board Charter (R&#232;glement Int&#233;rieur) of Sanofi (English translation).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.1.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The total amount of long-term debt securities authorized under any instrument does not exceed 10% of the total assets of the Company and its subsidiaries on a consolidated basis. We hereby agree to furnish to the SEC, upon its request, a copy of any instrument defining the rights of holders of long-term debt of the Company or of its subsidiaries for which consolidated or unconsolidated financial statements are required to be filed. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit22.htm">Description of securities registered under sect</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit22.htm">ion 12 of the </a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit22.htm">E</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit22.htm">xchange </a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit22.htm">A</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit22.htm">ct</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.1.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">List of significant subsidiaries, see &#8220;Item 4. Information on the Company &#8212;&#160;C.&#160;Organizational Structure&#8221; of this 20-F. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.1.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit121.htm">Certification by Paul Hudson, Chief Executive Officer, required by Section&#160;302 of the Sarbanes-Oxley Act of 2002. </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.2.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit122.htm">Certification by Jean-Baptiste Chasseloup de Chatillon, Principal Financial Officer, required by Section&#160;302 of the Sarbanes-Oxley Act of 2002. </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.1.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit131.htm">Certification by Paul Hudson, Chief Executive Officer, required by Section&#160;906 of the Sarbanes-Oxley Act of 2002. </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.2.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit132.htm">Certification by Jean-Baptiste Chasseloup de Chatillon, Principal Financial Officer, required by Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23.1.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit231.htm">Consent of Ernst&#160;&amp; Young et Autres dated February&#160;2</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit231.htm">4</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit231.htm">, 202</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit231.htm">3</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit231.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23.2.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit232.htm">Consent of PricewaterhouseCoopers Audit dated February&#160;2</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit232.htm">4</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit232.htm">, 202</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit232.htm">3</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit232.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022-exhibit233.htm">EY change in auditors 16F item letter</a></span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">.</span></div></td></tr></table></div><div id="i52f57172a9d7443580346c2d8f39cd2b_466"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Signatures</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The registrant hereby certifies that it meets all of the requirements for filing on Form&#160;20-F and&#160;that it has duly caused and authorized the undersigned to sign this annual report on its&#160;behalf.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.642%"><tr><td style="width:1.0%"></td><td style="width:16.179%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">/s/ PAUL HUDSON&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Paul Hudson</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Date: February&#160;24, 2023.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">174</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_469"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firms</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firms</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Sanofi,</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Sanofi and its subsidiaries (together the &#8220;Company&#8221;) as of December 31, 2022, 2021, and 2020, the related consolidated income statements, statements of comprehensive income, statements of changes in equity and statements of cash flows for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, 2021, and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board and in conformity with International Financial Reporting Standards as endorsed by the European Union.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the Company&#8217;s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control &#8211; Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 24, 2023 expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management.  Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits.  We are public accounting firms registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB.  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.  Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks.  Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements.  Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">175</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firms</span></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Recoverable amount of other intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:14.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.127%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Description</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of the Matter</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Other intangible assets amounted to &#8364;21,640 million at December 31, 2022. Management recognized a net gain of &#8364;454 million relating to impairment charges and reversals for the year ended December 31, 2022. As described in Notes B.6.1., D.4. and D.5. to the consolidated financial statements, other intangible assets not yet available for use are tested for impairment annually and whenever events or circumstances indicate that impairment might exist. Other intangible assets that generate separate cash flows and assets included in cash-generating units (CGUs) are assessed for impairment when events or changes in circumstances indicate that the asset or CGU may be impaired. Management estimates the recoverable amount of the asset and recognizes an impairment loss if the carrying amount of the asset exceeds its recoverable amount. The recoverable amount of the asset is the higher of its fair value less costs to sell or its value in use. Value in use is determined by management using estimated future cash flows generated by the asset or CGU which are discounted and prepared using the same methods as those used in the initial measurement of the assets and on the basis of medium-term strategic plans. Management cash flow projections include significant assumptions related to mid and long-term sales forecasts; perpetual growth or attrition rate, where applicable; discount rate; and probability of success of current research and development projects. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">The principal considerations for our determination that auditing the recoverable amount of other intangible assets is especially challenging, subjective, and required complex auditor judgment related to the significant judgments made by management when developing the significant assumptions utilized in the future cash flow projections as described above.</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed<br/>the Matter in Our Audit</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These audit procedures included obtaining an understanding of the process and assessing the design and testing the operating effectiveness of controls relating to management&#8217;s other intangible assets impairment assessment, including controls over the significant assumptions used in the impairment testing of the other intangible assets. These audit procedures also included, among others, evaluating the appropriateness of the discounted cash flow model; testing the completeness, accuracy, and relevance of underlying data used in the model; and evaluating the significant assumptions used by management as described above. Evaluating management&#8217;s assumptions involved evaluating whether the assumptions used by management were reasonable by considering the current and past performance of other intangible assets in comparison to management&#8217;s previous forecasts and current trends, the consistency of certain assumptions with external market and industry data, and whether these assumptions were consistent with evidence obtained in other areas of the audit such as internal company communications and presentations and external communications. We involved our professionals with specialized skills and knowledge to assist us notably in the assessment of the discount rate used by management. </span></div></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Valuation of the provisions for rebates relating to Sanofi&#8217;s business in the United States &#8211; Medicaid, Medicare and Managed Care</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:14.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.127%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:115%">Description </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:115%">of the Matter</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">As described in Notes B.13.1. and D.23. to the consolidated financial statements, products sold in the United States are covered by various Government and State programs (of which Medicaid and Medicare are the most significant) and are subject to commercial agreements with healthcare authorities and certain customers and distributors. Estimates of discounts and rebates incentives (hereinafter the &#8220;Rebates&#8221;) to be provided to customers under those arrangements are recognized as a reduction of gross sales in the period in which the underlying sales are recognized. Provisions for the Medicaid, Medicare and Managed Care Rebates amounted to &#8364;1,307 million, &#8364;775 million and &#8364;934 million, respectively, at December 31, 2022. The Rebates estimated by management are based on the nature and patient profile of the underlying product; the applicable regulations or the specific terms and conditions of contracts with governmental authorities, wholesalers and other customers; historical data relating to similar contracts; past experience and sales growth trends for the same or similar products; actual inventory levels in distribution channels, monitored by Sanofi using internal sales data and externally provided data; market trends including competition, pricing and demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The principal considerations for our determination that auditing the provisions for Rebates relating to the Company&#8217;s business in the United States is especially challenging and required complex auditor judgment related to the significant judgment by management due to significant measurement uncertainty involved in developing these provisions. These provisions are estimated based on multiple factors as described above.</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:115%">How We Addressed </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:115%">the Matter in Our Audit</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These audit procedures included obtaining an understanding of the process and assessing the design and testing the operating effectiveness of controls relating to management&#8217;s estimates of the provisions for Rebates relating to the Company&#8217;s business in the United States, including controls over the assumptions used to estimate these Rebates. These procedures also included, among others, developing an independent estimate of the provisions for Rebates by utilizing third party data on inventory levels in distribution channels, volume, changes to price, the terms of the specific rebate programs, and the historical trend of actual rebate claims paid. The independent estimate was compared to the provisions recorded by the Company. Additionally, these procedures included testing actual rebate claims paid and evaluating the contractual terms of the Company&#8217;s rebate agreements. </span></div></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">176</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firms</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Provisions for product liability risks, litigation and other and contingent liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Provisions for product liability risks, litigation and other risks were recorded in an amount of &#8364;1,652 million at December 31, 2022. As described in Notes B.12., D.19.3. and D.22. to the consolidated financial statements, the Company records such provisions when an outflow of resources is probable and the amount of the outflow can be reliably estimated. The Company also discloses the contingent liabilities in circumstances where management is unable to make a reasonable estimate of the expected financial effect that will result from ultimate resolution of the proceeding, or a cash outflow is not probable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">The pharmaceutical industry is highly regulated, which increases the inherent risk of litigation and arbitration. The Company is involved in litigation, arbitration and other legal proceedings. These proceedings are typically related to litigation concerning product liability claims, intellectual property rights, competition law and trade practices, as well as claims under warranties or indemnification arrangements relating to business divestments. The issues raised by these claims are highly complex and subject to substantial uncertainties; therefore, the probability of loss and an estimation of damages are difficult to ascertain. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">The principal considerations for our determination that auditing the provision for product liability risks, litigation and other, and auditing the contingent liabilities is especially challenging, subjective and required complex auditor judgment resulted from the determination that the measurement of the provisions can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions by management. There is inherent uncertainty related to these cases and in estimating the likelihood and outcome of the cases. </span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These audit procedures included obtaining an understanding of the process and assessing the design and testing the operating effectiveness of controls relating to management&#8217;s evaluation of the provisions for product liability risks, litigation and other, including controls over determining whether a loss is probable and whether the amount of loss can be reasonably estimated, as well as the need for and the level of financial statement disclosures. These procedures also included, among others, obtaining and evaluating the letters of audit inquiry with internal and external legal counsels, evaluating management&#8217;s assessment regarding whether an unfavorable outcome is reasonably possible or probable and reasonably estimable through the evaluation of the legal letters and summaries of the proceedings and lawsuit correspondence. We also evaluated the Company&#8217;s disclosures for contingent liabilities. </span></div></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Uncertain tax positions</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">As described in Notes B.22. and D.19.4. to the consolidated financial statements, the Company has recorded liabilities pertaining to uncertain tax positions of &#8364;1,520 million at December 31, 2022. The Company operates in multiple tax jurisdictions, carrying out potentially complex transactions that require management to make judgments and estimates as to the tax impact of those transactions. The positions adopted by the Company in tax matters are based on its interpretation of tax laws and regulations. Some of those positions may be subject to uncertainty. In such cases, the Company assesses the amount of the tax liability on the basis of the following assumptions: that its position will be examined by one or more tax authorities on the basis of all relevant information; that a technical assessment is carried out with reference to legislation, case law, regulations, and established practice; and that each position is assessed individually (or collectively where appropriate), with no offset or aggregation between positions. Those assumptions are assessed on the basis of facts and circumstances existing at the end of the reporting period. When an uncertain tax liability is regarded as probable, it is measured on the basis of the Company&#8217;s best estimate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">The principal considerations for our determination that auditing uncertain tax positions is especially challenging, subjective and required complex auditor judgment related to the significant judgment by management when determining the liability for uncertain tax positions, including a high degree of estimation uncertainty of certain assumptions and interpretations of the tax laws and regulations underlying the positions.</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:112%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These audit procedures included obtaining an understanding of the process and assessing the design and testing the operating effectiveness of controls relating to the identification and recognition of the liability for uncertain tax positions, management&#8217;s assessment and interpretation of tax laws and its evaluation of which tax positions may not be sustained upon audit and controls over measurement of the liability. These procedures also included, among others, testing the completeness and accuracy of the underlying data used in the calculation of the liability for uncertain tax positions and evaluating the assumptions used by management when determining its tax positions, the status of tax audits and investigations, and the potential impact of past claims. Our tax professionals assisted in evaluating management&#8217;s assessments by comparing the positions taken by management with tax regulations and past decisions from tax authorities and where applicable, evaluating opinions from the Company&#8217;s external tax advisors. We also evaluated the disclosures provided in the notes to the consolidated financial statements concerning uncertain tax positions.</span></div></td></tr></table><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">/s/ PricewaterhouseCoopers Audit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">/s/ Ernst&#160;&amp; Young et Autres</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f887633b9c1418f97d4bb30260bb881_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NjkvZnJhZzo3YWVhZTBkNDE5YjY0ZTM0YjYxM2MyYjkzNWYxOTBhZC90ZXh0cmVnaW9uOjdhZWFlMGQ0MTliNjRlMzRiNjEzYzJiOTM1ZjE5MGFkXzkwODI_f9d4c568-2e78-4c19-9586-627f8998522c">Ernst&#160;&amp; Young et Autres</ix:nonNumeric> and <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NjkvZnJhZzo3YWVhZTBkNDE5YjY0ZTM0YjYxM2MyYjkzNWYxOTBhZC90ZXh0cmVnaW9uOjdhZWFlMGQ0MTliNjRlMzRiNjEzYzJiOTM1ZjE5MGFkXzkwODM_90b94920-5d16-4fcb-9837-f93c3e2c7b74">PricewaterhouseCoopers Audit</ix:nonNumeric> have served as the Company&#8217;s auditors since 1986 and 1999, respectively.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f887633b9c1418f97d4bb30260bb881_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NjkvZnJhZzo3YWVhZTBkNDE5YjY0ZTM0YjYxM2MyYjkzNWYxOTBhZC90ZXh0cmVnaW9uOjdhZWFlMGQ0MTliNjRlMzRiNjEzYzJiOTM1ZjE5MGFkXzkwODU_97a9c5bf-0e58-48cd-b989-ceb8d44acbed">Neuilly-sur-Seine</ix:nonNumeric> and <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NjkvZnJhZzo3YWVhZTBkNDE5YjY0ZTM0YjYxM2MyYjkzNWYxOTBhZC90ZXh0cmVnaW9uOjdhZWFlMGQ0MTliNjRlMzRiNjEzYzJiOTM1ZjE5MGFkXzkwODA_bd4bb431-903b-4e9c-bf5e-525f3df9b57c">Paris-La D&#233;fense</ix:nonNumeric>, France, February&#160;24, 2023</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">177</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firms</span></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firms</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Sanofi,</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We have audited Sanofi and its subsidiaries&#8217; (together the &#8220;Company&#8221;) internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control &#8211; Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the &#8220;COSO criteria&#8221;). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on the COSO criteria.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the consolidated balance sheets of the Company as of December 31, 2022, 2021, and 2020, the related consolidated income statements, statements of comprehensive income, statements of changes in equity and statements of cash flows for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). Our report dated February 24, 2023 expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Report of Management on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We are public accounting firms registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">/s/ PricewaterhouseCoopers Audit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">/s/ Ernst&#160;&amp; Young et Autres</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Neuilly-sur-Seine and Paris-La D&#233;fense, France, February&#160;24, 2023</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">178</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_472"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:18pt;font-weight:400;line-height:120%">2022 Consolidated financial statements</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The financial statements are presented in accordance with International Financial Reporting Standards (IFRS).</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:80.523%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.277%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_475">CONSOLIDATED BALANCE SHEETS &#8211; ASSETS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_475">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_475">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_478">CONSOLIDATED BALANCE SHEETS &#8211; EQUITY AND LIABILITIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_478">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_478">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_481">CONSOLIDATED INCOME STATEMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_481">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_481">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_484">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_484">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_484">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_487">CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_487">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_487">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_490">CONSOLIDATED STATEMENTS OF CASH FLOWS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_490">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_490">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_493">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_493">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_493">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:13.5pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_496">INTRODUCTION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_496">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_496">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:27pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_499">A/ Basis of preparation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_499">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_499">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:27pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_502">B/ Summary of significant accounting policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_502">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_502">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:27pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_586">C/ Principal alliances</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_586">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_586">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:27pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_589">D/ Presentation of the financial statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_589">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_589">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:27pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_700">E/ Principal accountants&#8217; fees and services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_700">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_700">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:27pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_703">F/ List of principal companies included in the consolidation during 20</a>22</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_703">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_703">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:27pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_706">G/ Events subsequent to December&#160;31, 20</a>22</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_706">F-</a><a style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i52f57172a9d7443580346c2d8f39cd2b_706">102</a></span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-1</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_475"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Consolidated balance sheets - assets</span></td></tr></table></div></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:18pt;font-weight:400;line-height:120%">Consolidated balance sheets - assets</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:42.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.254%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.3.1.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEtMi0xLTEtMzY0MDYw_53c346b3-7734-412a-81d4-b853b4bdf787">9,869</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEtMy0xLTEtMzY0MDYw_bfc25234-dad7-4ae5-89b4-9e15ac3907c0">10,028</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEtNS0xLTEtMzY0MDYw_e1be1a81-e804-4732-bbd2-564fdf52fe38">9,365</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.3.2.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzItMi0xLTEtMzY0MDYw_8adb04bb-7721-4935-92da-8132102ba5ce">1,815</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzItMy0xLTEtMzY0MDYw_94e73674-d819-4f0d-babb-30c6095f636b">1,948</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzItNS0xLTEtMzY0MDYw_c395c9a6-ee3e-41a3-a7f2-da456af52e8f">1,198</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.4.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzMtMi0xLTEtMzY0MDYw_8d00049b-a1ce-466e-b4ac-761754dadc7d">49,892</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzMtMy0xLTEtMzY0MDYw_2acc94e6-f4cb-48ba-9947-9319ec7a3a45">48,056</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzMtNS0xLTEtMzY0MDYw_ff64a706-323f-41b7-8aa2-64abbc9e338c">44,364</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.4.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzQtMi0xLTEtMzY0MDYw_8069de26-8d1f-4b32-8cfc-621f793d0e59">21,640</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzQtMy0xLTEtMzY0MDYw_6ebee9f6-6e57-4597-a3fb-d54cbfd6fd6d">21,407</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzQtNS0xLTEtMzY0MDYw_ffb8d1e8-2909-41f6-ae5e-8fb6750f17e1">18,341</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investments accounted for using the equity method</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.6.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:InvestmentAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzUtMi0xLTEtMzY0MDYw_0a2c1f26-9020-45f1-a955-a7354a3a1005">677</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:InvestmentAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzUtMy0xLTEtMzY0MDYw_e75d8ec9-8b9d-4ac6-9d50-0fda6f971fb2">250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:InvestmentAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzUtNS0xLTEtMzY0MDYw_927575f3-68ba-42ad-a314-702918da5fc8">201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzYtMi0xLTEtMzY0MDYw_b055f221-a389-4054-b4e8-2309b1f8ecb3">3,095</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzYtMy0xLTEtMzY0MDYw_fb7507f4-517d-47d5-9da6-9f6c62bc7340">3,127</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzYtNS0xLTEtMzY0MDYw_0ae7ec9b-0808-4d33-ad31-74547492351f">2,734</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current income tax assets </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentTaxAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzctMi0xLTEtMzY0MDYw_752bd9c8-34cb-47fc-9f0d-130ad324013a">242</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentTaxAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzctMy0xLTEtMzY0MDYw_3a1bfa4e-3552-4529-9d6d-ab57464d2d04">175</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentTaxAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzctNS0xLTEtMzY0MDYw_201dbd4f-11f6-43c8-9ca5-f9512970bc4f">248</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.14.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzgtMi0xLTEtMzY0MDYw_cb12f8d1-336f-42b0-accd-99138fbcab97">5,381</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzgtMy0xLTEtMzY0MDYw_7ac75bac-6381-4570-a9be-d258eeeb058f">4,598</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzgtNS0xLTEtMzY0MDYw_4989c65b-3d5e-4e45-a863-797e05effa8e">4,176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzktMi0xLTEtMzY0MDYw_cc44aee7-f428-4330-aa01-a62341c260b8">92,611</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzktMy0xLTEtMzY0MDYw_75fe60f0-a5df-4950-974c-379b7c1c6e18">89,589</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzktNS0xLTEtMzY0MDYw_f304b90b-e524-4f21-8eb1-823b3262fd06">80,627</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.9.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEwLTItMS0xLTM2NDA2MA_d06f48ab-bdbf-4546-a8de-700c7d787d60">8,960</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEwLTMtMS0xLTM2NDA2MA_d328cfda-35c8-4b29-a264-0afdb9105451">8,715</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEwLTUtMS0xLTM2NDA2MA_e5c9c9f0-357f-405f-ae45-814e5df5c370">8,352</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.10.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzExLTItMS0xLTM2NDA2MA_e7ec45bb-3d89-4bc4-9cf8-db160e7d73b1">8,424</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzExLTMtMS0xLTM2NDA2MA_16636615-8190-4cee-8915-a4390ab43102">7,568</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzExLTUtMS0xLTM2NDA2MA_2f978d1d-2381-44fc-9063-65875d18faaf">7,491</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.11.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:OtherCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEyLTItMS0xLTM2NDA2MA_a9451272-394b-4244-b3bf-fed86571e4a6">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:OtherCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEyLTMtMS0xLTM2NDA2MA_abe46f97-a62c-45de-94c4-2c804f14454d">3,571</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:OtherCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEyLTUtMS0xLTM2NDA2MA_46ddbf80-0050-4426-8b6c-24dba48cfd92">2,737</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current income tax assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentTaxAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEzLTItMS0xLTM2NDA2MA_f27be8ed-5206-4203-be08-b86affb406a4">374</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentTaxAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEzLTMtMS0xLTM2NDA2MA_225e643a-2965-49f8-9547-8bdd8bdba9fd">612</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentTaxAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEzLTUtMS0xLTM2NDA2MA_5ee4cc7b-0628-42e2-9a04-07b791d69c0d">1,208</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.13.&#160;-&#160;D.17.1.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE0LTItMS0xLTM2NDA2MA_0099939d-279e-4dfe-967d-9da6511dcb3f">12,736</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE0LTMtMS0xLTM2NDA2MA_6bbfc1f2-a8bf-4b93-a229-31329b316089">10,098</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE0LTUtMS0xLTM2NDA2MA_5abda22f-ef3c-4f38-b583-bdf4dacc3d29">13,915</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE1LTItMS0xLTM2NDA2MA_cf2d71be-8799-418f-8b07-b16eaafd5175">34,026</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE1LTMtMS0xLTM2NDA2MA_a7cc9081-1fe1-4229-95da-9b60a532c33d">30,564</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE1LTUtMS0xLTM2NDA2MA_94cb78bb-07be-4df9-9abd-d3cf5839f88a">33,703</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Assets held for sale or exchange</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.8.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE2LTItMS0xLTM2NDA2MA_56ba2e9e-884e-4440-8108-dc15b98dcf66">85</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE2LTMtMS0xLTM2NDA2MA_b5c9bbc9-c75d-4cec-a1d2-1069bec1151c">89</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE2LTUtMS0xLTM2NDA2MA_3178df5e-f94d-47a9-a40f-fc62ba791e00">83</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE3LTItMS0xLTM2NDA2MA_06e812df-56fb-4df6-bc64-84e396692361">126,722</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE3LTMtMS0xLTM2NDA2MA_1360da6d-cd04-4a32-8ccd-06cf46e7cdef">120,242</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE3LTUtMS0xLTM2NDA2MA_573f49c8-ea1e-458d-9c33-a9f41a087d5c">114,413</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.98pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c" footnoteRole="http://www.xbrl.org/2003/role/footnote">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</ix:footnote></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_478"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Consolidated balance sheets - equity&#160;and&#160;liabilities</span></td></tr></table></div></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:18pt;font-weight:400;line-height:120%">Consolidated balance sheets &#8211; equity&#160;and&#160;liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:43.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.254%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity attributable to equity holders of Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:EquityAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEtMi0xLTEtMzY0MDYw_49ebfc94-cbbd-4de0-9d5b-edb2a9aa06da">74,784</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:EquityAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEtMy0xLTEtMzY0MDYw_10fc1422-a274-4d9a-b55d-1598fb90f401">68,681</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:EquityAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEtNS0xLTEtMzY0MDYw_7d7ee084-2a92-441f-bb7e-f3dfd1d51c0d">63,106</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity attributable to non-controlling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.16.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzItMi0xLTEtMzY0MDYw_fa53801c-0518-4eac-a4b2-294a4a788ee7">368</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzItMy0xLTEtMzY0MDYw_f751c431-c79c-46a5-af28-074d189ad087">350</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzItNS0xLTEtMzY0MDYw_a425cef0-9e19-4636-b4c9-8d7457aca7e2">146</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total equity</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzMtMi0xLTEtMzY0MDYw_46e033f1-b432-4e62-b80d-1de76d86da3d">75,152</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzMtMy0xLTEtMzY0MDYw_32499739-67c0-48c3-828f-62010fe2b535">69,031</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzMtNS0xLTEtMzY0MDYw_4be8cb3c-bb9d-44c3-8eb5-28d6e296f468">63,252</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.1.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzQtMi0xLTEtMzY0MDYw_5512f5a6-410a-443b-8801-9114dc3d871c">14,857</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzQtMy0xLTEtMzY0MDYw_f35b2f4c-1d4b-4206-9268-a200c309ad18">17,123</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzQtNS0xLTEtMzY0MDYw_c2c9944f-49cf-473b-963a-80a47b9ccad9">19,745</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.2.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzUtMi0xLTEtMzY0MDYw_6e8bdfe4-09f0-4c3f-8290-ba0dc39f07cd">1,904</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzUtMy0xLTEtMzY0MDYw_7b681a46-08a0-4e39-8a48-3aafa4f0eae6">1,839</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncurrentLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzUtNS0xLTEtMzY0MDYw_1b79d766-e040-4ce2-9087-b12025f05dc2">931</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current liabilities related to business combinations <br/>and to non-controlling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.18.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzYtMi0xLTEtMzY0MDYw_24b1508f-95b6-47c7-9ad8-d90abc6248d7">674</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzYtMy0xLTEtMzY0MDYw_36c7c765-f939-44e2-b94c-3350cd528334">577</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzYtNS0xLTEtMzY0MDYw_09466f4c-f691-4b48-87b8-9c6619c32bc6">387</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current provisions and other non-current liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.19.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzctMi0xLTEtMzY0MDYw_639b3696-48f5-4157-82bd-75e5a042cc97">6,341</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzctMy0xLTEtMzY0MDYw_cc1ca1f6-24b8-4c51-b5b8-38d8691eda2d">6,721</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzctNS0xLTEtMzY0MDYw_88a3ff41-5db5-4c72-8750-60b6b561fdc1">7,315</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current income tax liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.19.4.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzgtMi0xLTEtMzY0MDYw_55202c3d-b356-4e8b-96aa-8e2283164071">1,979</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzgtMy0xLTEtMzY0MDYw_9fff55cf-8a91-4573-b334-c94c967ef54a">2,039</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzgtNS0xLTEtMzY0MDYw_9ed4f556-0f63-42a3-9ecf-c0593883b300">1,733</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.14.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzktMi0xLTEtMzY0MDYw_6ec50a74-fe14-47c8-838c-c0184efa171c">1,841</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzktMy0xLTEtMzY0MDYw_bcc4a195-3ea3-4217-b120-9fa6c8b5c3d7">1,617</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzktNS0xLTEtMzY0MDYw_6ac9401c-2c5b-4d43-b1c8-59656b9f5a14">1,770</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEwLTItMS0xLTM2NDA2MA_017e5d13-0631-4418-b9f5-fe1d3cd7a6b1">27,596</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEwLTMtMS0xLTM2NDA2MA_98b8fc73-49a4-44ab-bf64-64b10f6ad665">29,916</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEwLTUtMS0xLTM2NDA2MA_aa53763e-ddcb-4157-8799-62448793999a">31,881</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzExLTItMS0xLTM2NDA2MA_4260e833-3d4e-407e-83e7-39ddefc2a08c">6,813</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzExLTMtMS0xLTM2NDA2MA_3bfddaac-b5f8-4241-91ff-7560955b5110">6,180</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzExLTUtMS0xLTM2NDA2MA_ec029af8-8e2f-4373-9f92-3f80319bb69d">5,295</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current liabilities related to business combinations <br/>and to non-controlling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.18.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEyLTItMS0xLTM2NDA2MA_daa3a85e-578c-4a94-aff2-24fa17d0d2bd">105</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEyLTMtMS0xLTM2NDA2MA_899ea4e5-4900-4ed9-a9ed-9fc4f3f47fac">137</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEyLTUtMS0xLTM2NDA2MA_8354b5dd-7731-4c1a-a502-f93591cbc690">218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current provisions and other current liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.19.5.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CurrentProvisionsAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEzLTItMS0xLTM2NDA2MA_b2d26eb1-ebe7-4bab-9d15-611b0435980a">12,021</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CurrentProvisionsAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEzLTMtMS0xLTM2NDA2MA_278e172f-46fe-4712-a0f0-a5199bd56bff">11,217</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CurrentProvisionsAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEzLTUtMS0xLTM2NDA2MA_5632a6c6-fe9b-4b6f-be3e-74a4762c8079">10,132</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current income tax liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE0LTItMS0xLTM2NDA2MA_f2275f31-81bb-4a4c-b914-71056cdc632b">574</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE0LTMtMS0xLTM2NDA2MA_7715bf1a-4593-489c-a6d1-d93df5c07a3d">309</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE0LTUtMS0xLTM2NDA2MA_c77f84c4-9b06-439c-b2c2-446f2531fab1">604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.2.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE1LTItMS0xLTM2NDA2MA_fc4a9883-2b1c-4cd5-bc37-a89c926dbf88">277</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE1LTMtMS0xLTM2NDA2MA_cdf8a14f-8749-4643-8cf6-768091a80a9c">269</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE1LTUtMS0xLTM2NDA2MA_3f6bc7c9-ddfd-4ea8-97a6-9560945be031">232</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.1.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE2LTItMS0xLTM2NDA2MA_9f14e616-fb0a-4f28-8f1e-ead19275ad68">4,174</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE2LTMtMS0xLTM2NDA2MA_113b2b13-6c8a-4a3e-b30f-8d9ea4ecd3b3">3,183</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE2LTUtMS0xLTM2NDA2MA_abdea380-4305-424a-aa70-27d966ed1801">2,767</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE3LTItMS0xLTM2NDA2MA_8660bbad-baa3-44dd-9a7f-cecae174b239">23,964</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE3LTMtMS0xLTM2NDA2MA_bcfd4e41-625f-4ad2-aa17-9af610c5fc6d">21,295</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE3LTUtMS0xLTM2NDA2MA_ee6bf62b-79dc-4852-ab0a-44f5e6cd48d9">19,248</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale or exchange</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.8.&#160;</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE4LTItMS0xLTM2NDA2MA_75d0d7ff-eac6-4dd7-97d4-ea3d2dd10211">10</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE4LTMtMS0xLTM2NDA2MA_21ce88f8-cf6c-417f-99e2-84caca945fde">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE4LTUtMS0xLTM2NDA2MA_d4a09a5b-f67e-45f7-bbbc-5112f4ccf1ac">32</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total equity and liabilities</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:EquityAndLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE5LTItMS0xLTM2NDA2MA_0678f0b3-8361-4607-8892-ae2e555234e5">126,722</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:EquityAndLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE5LTMtMS0xLTM2NDA2MA_f4c39b40-7550-46dd-94a3-95a708377473">120,242</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:EquityAndLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE5LTUtMS0xLTM2NDA2MA_518f424c-a583-4582-91e0-f12572c1f305">114,413</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e" footnoteRole="http://www.xbrl.org/2003/role/footnote">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-3</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_481"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Consolidated income statements</span></td></tr></table></div></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:18pt;font-weight:400;line-height:120%">Consolidated income statements</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:41.013%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.254%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.35.1.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEtMi0xLTEtMzY0MDYw_ecc5ab4b-8a28-4130-a701-0e0c7b90247b">42,997</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEtMy0xLTEtMzY0MDYw_c0541969-b441-4ead-8686-b555a0861d22">37,761</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEtNS0xLTEtMzY0MDYw_6e292d38-2475-4ad2-adc1-3bf58534aa46">36,041</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:OtherRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzItMi0xLTEtMzY0MDYw_a5d80bf3-d40e-49cd-be43-a0b1b5fe9e6f">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:OtherRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzItMy0xLTEtMzY0MDYw_51a712bb-5828-45e9-beac-7a03e9b788e7">1,414</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:OtherRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzItNS0xLTEtMzY0MDYw_cf52530c-11fa-46ba-90b8-387200a923e7">1,328</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMtMi0xLTEtMzY0MDYw_41e85cdb-2fd0-4382-abb6-fdbd317cd708">13,695</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMtMy0xLTEtMzY0MDYw_e25a87f3-b89b-4a1a-9bff-5f8af37fb1f2">12,255</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMtNS0xLTEtMzY0MDYw_19873626-8f8e-4608-b3cc-067baf62fd00">12,159</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross profit</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzQtMi0xLTEtMzY0MDYw_b18d6717-053f-45a8-a144-3576d6785a82">31,694</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzQtMy0xLTEtMzY0MDYw_9ee2db1b-1b6b-4723-92e7-dd17b6d52f06">26,920</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzQtNS0xLTEtMzY0MDYw_6060efcb-4070-45cc-ad4c-ce7dfd6dba32">25,210</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzUtMi0xLTEtMzY0MDYw_fb894249-711a-48cb-b285-9dfcde51d7dd">6,706</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzUtMy0xLTEtMzY0MDYw_165f2233-ba36-4863-9d3a-8e33e1215536">5,692</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzUtNS0xLTEtMzY0MDYw_c770a930-6359-40b0-adc4-16255141bbaa">5,530</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzYtMi0xLTEtMzY0MDYw_2ae4a311-7c4d-4413-b3e2-fbcd73678180">10,492</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzYtMy0xLTEtMzY0MDYw_cde29085-665d-4c41-9086-d4a25f996dcd">9,555</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzYtNS0xLTEtMzY0MDYw_d3b3027b-8ab1-47d8-8dbe-5d66d8c882e1">9,391</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.25.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzctMi0xLTEtMzY0MDYw_abd17a11-c4d4-4b31-ae59-f36fd401de7f">1,969</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzctMy0xLTEtMzY0MDYw_71a4bd41-d0e8-408f-8408-6745ecd99942">859</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzctNS0xLTEtMzY0MDYw_ea377980-eec3-471b-8e64-babf0ac31163">697</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.26.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzgtMi0xLTEtMzY0MDYw_d38f5c24-4e57-44e3-bc54-1bbd70c34d60">2,531</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzgtMy0xLTEtMzY0MDYw_83715857-2f91-45b4-a3c0-dcde15562a11">1,805</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzgtNS0xLTEtMzY0MDYw_c52471fc-b44a-4284-bbb7-b21e467d606d">1,415</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.4.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzktMi0xLTEtMzY0MDYw_3ad5fc37-dc42-4ae0-a97a-dd686e2fbd22">2,053</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzktMy0xLTEtMzY0MDYw_4ae6712d-2ede-4bc4-aaf0-6a189204695e">1,580</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzktNS0xLTEtMzY0MDYw_6cb8cfb2-5f44-49c5-b960-bd869b8ee64c">1,681</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment of intangible assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.5.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEwLTItMS0xLTM2NDA2MA_af43230a-fa75-4deb-98e0-c60e3469d5d5">454</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEwLTMtMS0xLTM2NDA2MA_04401d69-da0f-4420-ac29-6504ce2daa1c">192</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEwLTUtMS0xLTM2NDA2MA_bf7d83a0-334e-40fc-815b-9b25757dca0c">330</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.12. - D.18.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzExLTItMS0xLTM2NDA2MA_c7e2d3ab-951e-4c18-9696-540b678f759c">27</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzExLTMtMS0xLTM2NDA2MA_38c804e3-aa54-4d6d-83e7-a857b02048d6">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzExLTUtMS0xLTM2NDA2MA_cf422f4c-90d8-4d65-b9f8-9da3635513d5">124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.27.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEyLTItMS0xLTM2NDA2MA_638f036a-fc20-490e-bc73-ae601d35b37c">1,336</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEyLTMtMS0xLTM2NDA2MA_f84ce421-ab83-4ad2-8880-1975ae5bcd74">820</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEyLTUtMS0xLTM2NDA2MA_f57e5083-426b-493f-be5b-89c43cd7ec16">1,089</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other gains and losses, and litigation</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.28.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="sny:OtherGainsLossesAndLitigation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEzLTItMS0xLTM2NDA2MA_a01bf90d-26b5-4002-980c-87ba8c60c072">370</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="sny:OtherGainsLossesAndLitigation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEzLTMtMS0xLTM2NDA2MA_5f8c8838-6776-4f55-991e-55c716307f42">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:OtherGainsLossesAndLitigation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEzLTUtMS0xLTM2NDA2MA_b72771e9-2b22-4bd1-a83b-77ace7d6b757">136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gain on Regeneron investment arising from transaction of&#160;May&#160;29, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.2.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:GainsOnDisposalsOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE0LTItMS0xLTM2NDA2MA_7025bc2c-57f7-4bb3-80e2-4a3f47a75295">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:GainsOnDisposalsOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE0LTMtMS0xLTM2NDA2MA_a1051584-0a93-4318-a63b-866f2daea5e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:GainsOnDisposalsOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE0LTUtMS0xLTM2NDA2MA_a44438d9-b628-47fb-a335-543bf48cd46d">7,382</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE1LTItMS0xLTM2NDA2MA_fa20ab29-1a7e-43a8-9632-2aecdbf3dde5">10,656</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE1LTMtMS0xLTM2NDA2MA_2d89a1c0-3cda-4126-a9a3-799c969e0a50">8,126</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE1LTUtMS0xLTM2NDA2MA_335e6c35-0a30-42ea-82ff-ae43ee8ea3aa">14,113</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial expenses</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.29.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE2LTItMS0xLTM2NDA2MA_fd8f181e-cdec-4233-9a08-80bcc88c7006">440</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE2LTMtMS0xLTM2NDA2MA_98dbe931-1abb-4ebf-97f0-fa23a69cba9d">368</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE2LTUtMS0xLTM2NDA2MA_1e23d4f5-79b1-4158-906a-fed081b744dd">388</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.29.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE3LTItMS0xLTM2NDA2MA_40570148-40d9-424d-b20d-547d415166eb">206</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE3LTMtMS0xLTM2NDA2MA_7b4d036f-3b8a-48ce-b7d6-f27c4e05b9e2">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE3LTUtMS0xLTM2NDA2MA_7b3251b8-a49d-4693-8c38-c06be8eeb196">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income before tax and investments accounted for using <br/>the equity method</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.35.1.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE4LTItMS0xLTM2NDA2MA_a67a7535-d463-4219-99e5-91867ba0535b">10,422</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE4LTMtMS0xLTM2NDA2MA_bc8aae17-900c-424d-9392-f27504ae5e5a">7,798</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE4LTUtMS0xLTM2NDA2MA_cbca7a9d-da63-4a54-9d0c-49869ce7380b">13,778</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.30.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE5LTItMS0xLTM2NDA2MA_811aef88-0caf-4e58-96c1-bdc44c33f454">2,006</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE5LTMtMS0xLTM2NDA2MA_f9172ccc-dce0-4bfb-9a0a-169ba8c31b6e">1,558</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE5LTUtMS0xLTM2NDA2MA_807f6c25-77e1-4ca9-83f3-d32acbeecd71">1,807</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using <br/>the equity method</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.31.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIwLTItMS0xLTM2NDA2MA_c2787a53-84f2-4461-bc2d-bc0a9d690abf">68</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIwLTMtMS0xLTM2NDA2MA_7acb8075-cfda-4bba-8cc9-0a118fa1e1e6">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIwLTUtMS0xLTM2NDA2MA_bb62ad5f-a735-41f9-a43f-912a735a61b5">359</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIzLTItMS0xLTM2NDA2MA_7d6f8084-a931-484f-b6c3-347a28efa325">8,484</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIzLTMtMS0xLTM2NDA2MA_103df97f-3c26-4a40-adcf-52daa47141aa">6,279</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIzLTUtMS0xLTM2NDA2MA_b1dd7d32-6f38-4252-800d-22bffe8f0002">12,330</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.32.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI0LTItMS0xLTM2NDA2MA_614aace1-ca6e-40aa-8f38-05994406d0fb">113</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI0LTMtMS0xLTM2NDA2MA_d4a69564-bac1-4f21-aacf-979f8bd14a48">56</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI0LTUtMS0xLTM2NDA2MA_d0916b5d-41f1-4c2d-b244-c9d2fe8487af">36</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI1LTItMS0xLTM2NDA2MA_5f855f4a-2c4e-411a-95a1-5e7870e8fb0f">8,371</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI1LTMtMS0xLTM2NDA2MA_dc8abe1c-a63c-4e5f-9628-9855b5c96788">6,223</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI1LTUtMS0xLTM2NDA2MA_429b1ea7-b870-47ee-afaf-6f379bdc6039">12,294</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Average number of shares outstanding (million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.9.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-5" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI2LTItMS0xLTM2NDA2MA_1ec64694-737c-4efe-8d4c-77a786182da9">1,251.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-5" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI2LTMtMS0xLTM2NDA2MA_2a710b10-bd2c-4094-9442-3b65a37c81a4">1,252.5</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-5" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI2LTUtMS0xLTM2NDA2MA_dec78f17-eab8-4dc7-bf28-c3da212f14f4">1,253.6</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Average number of shares after dilution (million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.9.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-5" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI3LTItMS0xLTM2NDA2MA_15bcebb2-9846-4b1b-b44e-46bb861a3d58">1,256.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-5" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI3LTMtMS0xLTM2NDA2MA_d87f6e4e-d005-42a6-95cf-0b64a76d46a6">1,257.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-5" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI3LTUtMS0xLTM2NDA2MA_36bf6641-8869-4953-bd21-3b5bb82e56a3">1,260.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Basic earnings per share (in euros)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="2" name="sny:BasicEarningsLossPerShareAttributableToOwnersOfParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI4LTItMS0xLTM2NDA2MA_69a05bb5-cd34-4017-80bc-cc59072aa21b">6.69</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="2" name="sny:BasicEarningsLossPerShareAttributableToOwnersOfParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI4LTMtMS0xLTM2NDA2MA_52c8c7a5-810b-449c-9055-25cacd1b5f01">4.97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="2" name="sny:BasicEarningsLossPerShareAttributableToOwnersOfParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI4LTUtMS0xLTM2NDA2MA_dcdc1738-eede-4f82-87b8-4634e2789a12">9.81</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Diluted earnings per share (in euros)</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="2" name="sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMwLTItMS0xLTM2NDA2MA_33082f2a-97e0-4ee6-a145-f7aa75a0f018">6.66</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="2" name="sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMwLTMtMS0xLTM2NDA2MA_211d2793-9591-422f-a895-283a5c7243b1">4.95</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="2" name="sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMwLTUtMS0xLTM2NDA2MA_7343f7fd-6b65-4861-a0d6-934588b1df3f">9.76</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9" footnoteRole="http://www.xbrl.org/2003/role/footnote">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_484"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Consolidated statements of comprehensive income</span></td></tr></table></div></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:18pt;font-weight:400;line-height:120%">Consolidated statements of comprehensive income</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:46.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.254%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtMi0xLTEtMzY0MDYw_c18d2d94-9e98-4740-9dea-b3b5bb3e6624">8,484</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtMy0xLTEtMzY0MDYw_15720d29-f51d-4243-a724-b51aaed82f61">6,279</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtNS0xLTEtMzY0MDYw_de3a6b38-03fc-415d-8bd9-c7a22adf516d">12,330</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Attributable to equity holders of Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItMi0xLTEtMzY0MDYw_a4c122bc-68a2-4d4b-88d5-dfb5a07f6f30">8,371</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItMy0xLTEtMzY0MDYw_f6ab6b9e-394d-47cd-b041-d9ebde2baa91">6,223</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItNS0xLTEtMzY0MDYw_2ca57e2b-4d8a-4c29-aa5a-b9735714fe38">12,294</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Attributable to non-controlling interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtMi0xLTEtMzY0MDYw_7da84930-cdb5-4b45-a117-805b6c255aef">113</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtMy0xLTEtMzY0MDYw_d183fbe3-704a-461f-9c29-4665a5781c24">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtNS0xLTEtMzY0MDYw_237a3dc2-ea8e-4818-9ceb-9f36d1ecd979">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other comprehensive income:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Actuarial gains/(losses)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.7.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtMi0xLTEtMzY0MDYw_6d60d19f-fc47-4360-8d92-9e5d4dcfcd5c">654</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtMy0xLTEtMzY0MDYw_36757908-4a31-49e1-8460-b9a6a6098871">686</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtNS0xLTEtMzY0MDYw_435d1f07-5eb4-4598-9330-b197305f6473">267</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value of equity instruments included in&#160;financial assets and financial liabilities</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.7.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtMi0xLTEtMzY0MDYw_4df7fbc7-2f35-4bea-b1e3-cc5e25f82305">13</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtMy0xLTEtMzY0MDYw_5f84f4ad-c99d-4497-aad8-aeead8e33aab">165</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtNS0xLTEtMzY0MDYw_2bc5e8b8-b88f-47eb-845e-563d02b2636d">320</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.7.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctMi0xLTEtMzY0MDYw_bb997a2b-777a-475b-b1c7-91f3063d31e4">216</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctMy0xLTEtMzY0MDYw_5b5cd334-de8f-4210-9dfa-e3106b3a71d0">54</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctNS0xLTEtMzY0MDYw_18e9fb42-cb58-4dce-bbf7-d09d691c0b1e">39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sub-total: items not subsequently reclassifiable to profit or loss (A)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtMi0xLTEtMzY0MDYw_082d0377-9d8d-4f4e-9015-65ddde6b4f31">451</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtMy0xLTEtMzY0MDYw_32714259-ecc6-4423-923f-e5e0eaa08e52">797</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtNS0xLTEtMzY0MDYw_fb721cb2-cbc5-4cdf-9e8c-d27869d08598">14</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value of debt instruments included in financial assets</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.7.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktMi0xLTEtMzY0MDYw_970d131b-d7da-4ce2-b656-b245bbaa187d">77</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktMy0xLTEtMzY0MDYw_2d1e94df-65e1-4c7e-85d2-19e5cc554ff7">21</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktNS0xLTEtMzY0MDYw_907e71fe-0dea-4046-ab34-b67490b5d9c1">15</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value of cash flow hedges</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.7.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTItMS0xLTM2NDA2MA_dc18bfc4-9a41-4e4d-b0db-9f28719aa0e9">7</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTMtMS0xLTM2NDA2MA_367bcc0a-3a06-4fd3-9495-15ee61eae0d8">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTUtMS0xLTM2NDA2MA_50dfd5b6-6e1f-483c-8373-bc3fafbd00c5">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in currency translation differences</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.7.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTItMS0xLTM2NDA2MA_0c972dbc-8317-44f8-98de-36fd683e658a">2,278</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTMtMS0xLTM2NDA2MA_cd7bfc58-ac84-4fd5-a22b-ce2f411ac841">2,459</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTUtMS0xLTM2NDA2MA_e66fe460-ee48-4282-b2d7-bcd045c240a8">3,976</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.7.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTItMS0xLTM2NDA2MA_600b1ed7-8c93-4540-87ce-b2ad34b891a8">105</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTMtMS0xLTM2NDA2MA_aeb01230-3b21-4937-bdf3-3f527d689c1d">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTUtMS0xLTM2NDA2MA_8174f1f3-2466-4f1c-8542-a62d0087c44c">64</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sub-total: items subsequently reclassifiable to profit or loss (B)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTItMS0xLTM2NDA2MA_2fdf661f-89c3-4f58-be82-b7e75ca061f3">2,313</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTMtMS0xLTM2NDA2MA_aebab50d-8f4e-40ec-aae9-07cc65f9432c">2,510</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTUtMS0xLTM2NDA2MA_7af04be4-34b5-46f5-a8ab-415095093659">4,021</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other comprehensive income for the period, net of taxes (A+B)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTItMS0xLTM2NDA2MA_7d3e569c-7895-4d99-b7e5-733b1a89241a">2,764</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTMtMS0xLTM2NDA2MA_b0fd60b7-e57d-45a7-aef5-8cd1c0ea561a">3,307</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTUtMS0xLTM2NDA2MA_d7129fd9-ad9b-4a70-973b-204286aca61a">4,007</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTItMS0xLTM2NDA2MA_f02c581c-13bb-4fe0-8284-f88c5c7cdba7">11,248</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTMtMS0xLTM2NDA2MA_752d051b-3bab-45fe-976e-9867c1e053ae">9,586</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTUtMS0xLTM2NDA2MA_41d5471b-40b4-46ab-84c7-ded290c4ae26">8,323</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Attributable to equity holders of Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTItMS0xLTM2NDA2MA_88775fda-c370-41f7-9ef4-829643046d9d">11,130</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTMtMS0xLTM2NDA2MA_3c5b5f3e-8f21-491f-84f6-b27988fa054c">9,519</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTUtMS0xLTM2NDA2MA_e29579b8-4dc3-46e3-bc20-f37e964677de">8,307</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Attributable to non-controlling interests</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTItMS0xLTM2NDA2MA_66962799-6bb7-4f2a-ad10-555474eaef80">118</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTMtMS0xLTM2NDA2MA_6bb5bac3-ab4e-47b0-90a4-afbf89a19b46">67</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTUtMS0xLTM2NDA2MA_2077b0a9-191f-434f-9f6a-2135a5630397">16</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.98pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36" footnoteRole="http://www.xbrl.org/2003/role/footnote">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-5</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_487"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Consolidated statements of changes in&#160;equity</span></td></tr></table></div></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:18pt;font-weight:400;line-height:120%">Consolidated statements of changes in&#160;equity</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:22.789%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Share<br/>capital</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Treasury<br/>shares</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Reserves and retained earnings</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Stock<br/>options&#160;and<br/>other&#160;share-<br/>based<br/>payments</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Other<br/>comprehensive<br/>income</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Attributable</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">to&#160;equity</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">holders of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Sanofi&#160;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Attributable<br/>to&#160;non-<br/>controlling<br/>interests</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Total&#160;equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8167f91dae314f4eaa1e5e23abf0fcae_I20191231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMS0xLTEtMzY0MDYw_e9272b1a-fe3d-426b-a99f-53e92de05eb9">2,508</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7b29272f0f8e444e8185ac9de81d8964_I20191231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMi0xLTEtMzY0MDYw_ac125ec7-8c00-456b-a926-eae2e5fe9e21">147</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2180880b8f3d4518b6d13260c4b00509_I20191231" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMy0xLTEtMzY0MDYw_98439be4-0899-45a9-8c40-1f08323f2f80">9</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0a649176e103430588e7d82e8b4b2eae_I20191231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNC0xLTEtMzY0MDYw_92ac7881-3d55-420a-b4c2-2fb93c8b0d16">51,902</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ideadd6fc92744c689451476829e9bf88_I20191231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNS0xLTEtMzY0MDYw_85024497-8f3f-4693-bd13-5573dd0fcfc6">3,863</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i30f1c21919c94f78ac899771e9dc6747_I20191231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNi0xLTEtMzY0MDYw_4d873dbd-5b16-420c-bc86-3b872b223384">645</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79431d18a64048a3a31458a8519c8577_I20191231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNy0xLTEtMzY0MDYw_019c0649-48f9-40cf-a9ef-572100611c48">59,056</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic7ec55dbabba4baeaa5077aa469ea0b9_I20191231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOC0xLTEtMzY0MDYw_456437df-583f-4c00-9f6b-cd0b97e72e21">174</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOS0xLTEtMzY0MDYw_023a6c6b-fba0-42f8-9428-48306bc6c7ac">59,230</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">for the period</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNC0xLTEtMzY0MDYw_f8be43f1-b0d8-4be1-afb2-aee2ca1e815f">14</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i091093d5d8a34da889e3748a9b22dca7_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNi0xLTEtMzY0MDYw_b48cb9d0-b1a6-4e2f-a0c7-3197e8992a22">4,001</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNy0xLTEtMzY0MDYw_c44cfc7a-13ba-4cb5-9268-ca68969a17c6">3,987</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i628f75ce25844ff8b7d482c8c7b43c78_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOC0xLTEtMzY0MDYw_17dc2a9e-c0a5-4c32-a0f2-c7461a8a0ea5">20</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOS0xLTEtMzY0MDYw_96be92e2-3e8d-4f73-aa9d-01e2d758605c">4,007</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income for the period</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNC0xLTEtMzY0MDYw_8375809a-87a8-4244-a166-9de316ecd262">12,294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNy0xLTEtMzY0MDYw_ef6cb36e-a284-4b73-9bfe-1aa48de80519">12,294</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i628f75ce25844ff8b7d482c8c7b43c78_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOC0xLTEtMzY0MDYw_697a50ed-0ca3-4e2c-9508-8d2b84920b9d">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOS0xLTEtMzY0MDYw_eb447b21-2a14-46ed-807e-30dd4a2864df">12,330</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comprehensive income </span></div><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">for the period</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNC0xLTEtMzY0MDYw_140fe7cd-ce4a-4e11-ad35-986fdf070bc4">12,308</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i091093d5d8a34da889e3748a9b22dca7_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNi0xLTEtMzY0MDYw_38cc5712-2e8d-47a4-9fb2-b23709a48d33">4,001</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNy0xLTEtMzY0MDYw_e8780054-fa54-4ab7-b9bd-3971d22c2a23">8,307</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i628f75ce25844ff8b7d482c8c7b43c78_D20200101-20201231" decimals="-6" name="ifrs-full:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOC0xLTEtMzY0MDYw_8d50453b-88c4-41cc-bb0f-46fbbd783c17">16</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOS0xLTEtMzY0MDYw_3ac6378f-f68a-4f1a-8888-ff27c1940bd6">8,323</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividend paid out of 2019 earnings (&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="INF" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzgtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246OGZiNTE4ZTgzZGNhNDg3ZGE2YzNhODJjODg0YWEyMDJfNDA_53b51296-93ad-4305-bd97-d67464345df2">3.15</ix:nonFraction> per share)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzgtNC0xLTEtMzY0MDYw_b505bd14-40c6-45fd-a490-b968ff00c9ea">3,937</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzgtNy0xLTEtMzY0MDYw_08351441-0982-4ab4-b80c-20d0796f1873">3,937</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzgtOS0xLTEtMzY0MDYw_1667736a-149d-4812-9b3e-b70bc0b2058d">3,937</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payment of dividends to <br/>non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzktNy0xLTEtMzY0MDYw_128a40e2-b02d-4acf-bf75-67c837366e9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i628f75ce25844ff8b7d482c8c7b43c78_D20200101-20201231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzktOC0xLTEtMzY0MDYw_7637a89d-eb19-4852-b9d0-07f72ef97dfe">44</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzktOS0xLTEtMzY0MDYw_65482607-a190-45d2-b859-3296ce4aaf3e">44</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share repurchase program</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if9fd8343fd3c47a2b272658a928ae800_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfTreasuryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTMtMS0xLTM2NDA2MA_4d3f5d84-0e38-4849-96ea-70ecac235e1f">822</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfTreasuryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTctMS0xLTM2NDA2MA_3761d949-ac3c-4c18-bfca-42fb105b8059">822</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfTreasuryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTktMS0xLTM2NDA2MA_5195a35a-d9e7-4bcb-999f-1d0f95a44696">822</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based payment plans:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Exercise of stock options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i38ee6479a7a24540a49f0870e964ced9_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTEtMS0xLTM2NDA2MA_e1f4057a-3d3e-477a-9a08-4c4524aaf0b0">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i918e8adb634840c39e00f014e91457f5_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTItMS0xLTM2NDA2MA_f9b8e3a2-a116-441b-87d1-f1c4ecc26dc4">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTctMS0xLTM2NDA2MA_a440e3b1-17e1-4af9-a70c-6a3ed6d07c76">51</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTktMS0xLTM2NDA2MA_9bd07696-1dde-4504-9b5e-530204637e84">51</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Issuance of restricted shares and vesting of existing restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)/(d)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i38ee6479a7a24540a49f0870e964ced9_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTEtMS0xLTM2NDA2MA_33fae6b3-9207-4d19-9d97-7ee96a7e8cb0">3</ix:nonFraction></span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i918e8adb634840c39e00f014e91457f5_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTItMS0xLTM2NDA2MA_83a539ae-f2b8-47b7-9f22-1165eb4c8b79">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if9fd8343fd3c47a2b272658a928ae800_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTMtMS0xLTM2NDA2MA_a3cc8a2b-319d-4917-9c92-6369a3ca6160">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTQtMS0xLTM2NDA2MA_a54887eb-413f-4b98-aa4f-8a4294525ef9">126</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTctMS0xLTM2NDA2MA_cf7f4845-b348-4256-9769-f70e15885bba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTktMS0xLTM2NDA2MA_0c6b15d9-7af1-4550-b2ef-c670cd3ad5bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Employee share ownership plan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i38ee6479a7a24540a49f0870e964ced9_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTEtMS0xLTM2NDA2MA_d697ad7c-a266-4ec0-852c-7a3b8fe77e34">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i918e8adb634840c39e00f014e91457f5_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTItMS0xLTM2NDA2MA_cfaed0ab-1e26-4a37-bca1-077606cbdc5a">169</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTctMS0xLTM2NDA2MA_a7795b9e-f39e-4240-a4a6-e37101e11a18">174</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTktMS0xLTM2NDA2MA_9ac65895-eb89-4cb3-966c-6affa541fe43">174</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Value of services obtained from employees</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0555249224484a73af0282b1a26fae99_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE3LTUtMS0xLTM2NDA2MA_7b1c5b38-1a4d-468a-a4bb-a65437fc1999">274</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE3LTctMS0xLTM2NDA2MA_16a5feeb-10db-4601-8416-135bd79b3b01">274</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE3LTktMS0xLTM2NDA2MA_fe200c58-6b6b-40a0-b99d-f045bfa00339">274</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects of the exercise of&#160;stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0555249224484a73af0282b1a26fae99_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE4LTUtMS0xLTM2NDA2MA_633de78a-feac-415c-8bfe-cb8803abe3c9">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE4LTctMS0xLTM2NDA2MA_1d7bc62b-ea0b-4bc5-b615-e43c329449e2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE4LTktMS0xLTM2NDA2MA_560cabe6-dca3-454b-9702-ee86a513f240">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other changes arising from issuance of restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTQtMS0xLTM2NDA2MA_39a3dc95-e4cd-42bb-99dd-3455fc0e3fa0">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTctMS0xLTM2NDA2MA_858bc692-12bb-4cb4-803b-4d0fbb3367e6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTktMS0xLTM2NDA2MA_0c77d10e-004c-46bb-8b5e-0931a9be0c1b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December&#160;31, 2020</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i82a067b6228743299309f26020eedd15_I20201231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTEtMS0xLTM2NDA2MA_54c82653-9a92-445e-8ab8-a3b427009f86">2,518</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie6e671cfe56146318823f0ae1232ffd4_I20201231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTItMS0xLTM2NDA2MA_9e18e429-fe52-4c81-a708-2073d2babcf8">362</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i433315b6bd834cb68354e5a52b56773d_I20201231" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTMtMS0xLTM2NDA2MA_7ec2f7d8-f54d-4e3d-be28-978ea5def617">705</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i37a894ed8b0d4cc88bdaa2442942a150_I20201231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTQtMS0xLTM2NDA2MA_100ab860-fe28-4fae-a197-702bde1a726b">60,149</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3ca205c9d7904bcd84d4f88ddec8328a_I20201231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTUtMS0xLTM2NDA2MA_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c">4,138</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2b7f53f9cf764e73bd0e72cef8b7390f_I20201231" decimals="-6" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTYtMS0xLTM2NDA2MA_33eaa7e7-913c-45e1-95c3-1eb2f72cee81">3,356</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic46b4d1e50bc43e489fc0520c892a40d_I20201231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTctMS0xLTM2NDA2MA_8fe9842c-2530-452e-8bcb-bf5f2008673f">63,106</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i58dddc96bde6438a903a080d6f6acb31_I20201231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTgtMS0xLTM2NDA2MA_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17">146</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTktMS0xLTM2NDA2MA_19f875f9-870d-403b-aca5-d3d399246b17">63,252</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:22.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Share<br/>capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Treasury<br/>shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Reserves and retained earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Stock<br/>options&#160;and<br/>other&#160;share-<br/>based<br/>payments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Other<br/>comprehensive<br/>income</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Attributable</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">to&#160;equity</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">holders of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Sanofi&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Attributable<br/>to&#160;non-<br/>controlling<br/>interests</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Total&#160;equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2021</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i82a067b6228743299309f26020eedd15_I20201231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMS0xLTEtMzY0MDYw_54c82653-9a92-445e-8ab8-a3b427009f86">2,518</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie6e671cfe56146318823f0ae1232ffd4_I20201231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMi0xLTEtMzY0MDYw_9e18e429-fe52-4c81-a708-2073d2babcf8">362</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i433315b6bd834cb68354e5a52b56773d_I20201231" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMy0xLTEtMzY0MDYw_7ec2f7d8-f54d-4e3d-be28-978ea5def617">705</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i37a894ed8b0d4cc88bdaa2442942a150_I20201231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNC0xLTEtMzY0MDYw_100ab860-fe28-4fae-a197-702bde1a726b">60,149</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3ca205c9d7904bcd84d4f88ddec8328a_I20201231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNS0xLTEtMzY0MDYw_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c">4,138</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2b7f53f9cf764e73bd0e72cef8b7390f_I20201231" decimals="-6" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNi0xLTEtMzY0MDYw_33eaa7e7-913c-45e1-95c3-1eb2f72cee81">3,356</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic46b4d1e50bc43e489fc0520c892a40d_I20201231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNy0xLTEtMzY0MDYw_8fe9842c-2530-452e-8bcb-bf5f2008673f">63,106</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i58dddc96bde6438a903a080d6f6acb31_I20201231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOC0xLTEtMzY0MDYw_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17">146</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOS0xLTEtMzY0MDYw_19f875f9-870d-403b-aca5-d3d399246b17">63,252</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income for&#160;the period</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzItNC0xLTEtMzY0MDYw_2a4ce0dd-21e6-41fb-845c-3bad46540a4d">797</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i468fc46d6073421aa776f6c974d1f45d_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzItNi0xLTEtMzY0MDYw_952d6f6e-b244-4523-bc9a-fa323a1f8bcd">2,499</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzItNy0xLTEtMzY0MDYw_29fcb0eb-9cd3-4cb0-a39d-aab44c8d2580">3,296</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzItOC0xLTEtMzY0MDYw_ebdcecef-cf3d-4b48-baf8-c3234d3ee481">11</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzItOS0xLTEtMzY0MDYw_b0d25be0-20f6-4de9-903b-df5fad575d48">3,307</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income for the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzMtNC0xLTEtMzY0MDYw_6dd5ed10-2522-4ee9-94c0-97f2db62e876">6,223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzMtNy0xLTEtMzY0MDYw_39305ac1-a81a-4324-a5dc-40d727c5c32c">6,223</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzMtOC0xLTEtMzY0MDYw_afc7158d-5a91-49f2-a308-20d2c6d5663e">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzMtOS0xLTEtMzY0MDYw_41d42015-9f3a-4b97-af8c-15e1fe711bd6">6,279</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comprehensive income for&#160;the&#160;period</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzQtNC0xLTEtMzY0MDYw_e404461d-185d-468e-ad80-555443ac3b84">7,020</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i468fc46d6073421aa776f6c974d1f45d_D20210101-20211231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzQtNi0xLTEtMzY0MDYw_e3b5c4e9-2577-4225-92ba-cb11df51fb45">2,499</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzQtNy0xLTEtMzY0MDYw_a1e4992a-0dca-4560-9f55-f42c1f7476a1">9,519</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231" decimals="-6" name="ifrs-full:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzQtOC0xLTEtMzY0MDYw_cf1ce047-3510-47d5-82c0-45991cbb9ea0">67</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzQtOS0xLTEtMzY0MDYw_ae53e442-059b-40b9-8bf6-fde9c2f551fe">9,586</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividend paid out of 2020 earnings (&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="INF" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246MDE3YTQzZWE0MjBlNDNmYzg0ZDNhYzM1OTNiNDNmNjFfNDA_b033f814-723e-4125-b2c9-55ba44eb1c0b">3.20</ix:nonFraction> per share)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzUtNC0xLTEtMzY0MDYw_33779d22-3399-4229-97be-22f1d8ee7aaf">4,008</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzUtNy0xLTEtMzY0MDYw_512cb026-71e3-4ece-881f-74199a796237">4,008</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzUtOS0xLTEtMzY0MDYw_015696a0-9480-4cc1-a46e-7b79333f3634">4,008</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payment of dividends to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzYtNy0xLTEtMzY0MDYw_44a9757c-2bdf-4808-9cf6-072ff7c9265a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzYtOC0xLTEtMzY0MDYw_e865978d-de3c-4d65-b20e-f51271454727">49</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzYtOS0xLTEtMzY0MDYw_363a0e25-8a24-4023-8461-3ad21bb3530e">49</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share repurchase program</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i44a6cd71a87a4d59ad6055e7b101e7e5_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfTreasuryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctMy0xLTEtMzY0MDYw_d7773337-9244-43fc-bbaa-cfef96bffdda">382</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfTreasuryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctNy0xLTEtMzY0MDYw_b3b85699-074d-4b7a-a51b-bb2b00ffeac4">382</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfTreasuryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctOS0xLTEtMzY0MDYw_c02723a3-2291-4b9c-8635-75fbddffe076">382</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based payment plans:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Exercise of stock options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0a305363936e4b86afca45f34eb6b080_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTItMS0xLTM2NDA2MA_59b04cfd-6682-4d1c-a629-33077e6ffe2c">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTctMS0xLTM2NDA2MA_dece824f-4712-4939-ba41-a6b138a7be2f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTktMS0xLTM2NDA2MA_7bc1440f-ea82-44cc-8743-b7ffed1f06ce">11</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Issuance of restricted shares and vesting of existing restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)/(d)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if87626104e564cce8dc2afa187c5f744_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTEtMS0xLTM2NDA2MA_d98f69dc-b0f1-4cc8-b70b-7984fd78a6c5">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0a305363936e4b86afca45f34eb6b080_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTItMS0xLTM2NDA2MA_c4a51e91-2309-4fbe-b254-e8eb14d6d2dd">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i44a6cd71a87a4d59ad6055e7b101e7e5_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTMtMS0xLTM2NDA2MA_217e0ead-39cc-4dbd-abcd-ae1f822db699">148</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTQtMS0xLTM2NDA2MA_c0f9ae73-8f74-48e5-80b3-a5993099957c">148</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTctMS0xLTM2NDA2MA_a399014e-7c97-4436-a95a-792d15aba016">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTktMS0xLTM2NDA2MA_4583d946-900e-45c5-9fef-2daede5d4639">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Employee share ownership plan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if87626104e564cce8dc2afa187c5f744_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTEtMS0xLTM2NDA2MA_3708407a-51d1-4dbe-85b9-85c10719e785">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0a305363936e4b86afca45f34eb6b080_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTItMS0xLTM2NDA2MA_01061c07-03f6-4b1a-880a-d3f05103e41f">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTctMS0xLTM2NDA2MA_986cf489-8ff4-4209-ad3e-fe78494e8b5a">168</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTktMS0xLTM2NDA2MA_d2d61b17-f46d-45c7-a1c5-9aacd7ed7565">168</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Value of services obtained from&#160;employees</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i35c163cbd49a4859ac64117df33aca94_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE0LTUtMS0xLTM2NDA2MA_f65494f0-c9cf-421c-8c99-a7bd42aa5db6">244</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE0LTctMS0xLTM2NDA2MA_2eedfe8a-ccb1-4626-af20-ec703df7fdc4">244</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE0LTktMS0xLTM2NDA2MA_f0a94797-76e7-4d0e-a0ba-0ab887eeee43">244</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects of the exercise of&#160;stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i35c163cbd49a4859ac64117df33aca94_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE1LTUtMS0xLTM2NDA2MA_7daee9c0-2866-4ccc-b2d5-0a9be3064963">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE1LTctMS0xLTM2NDA2MA_dad2a824-4a91-4283-8014-6bbb1b3ba538">23</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE1LTktMS0xLTM2NDA2MA_5d948728-be37-4ad8-be08-6016145492b0">23</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other changes in non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTctMS0xLTM2NDA2MA_e3abb3d3-cf48-47c9-b9e2-037b404aa01f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTgtMS0xLTM2NDA2MA_66b952c4-dd45-40ca-b631-a61c26f81d02">186</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTktMS0xLTM2NDA2MA_357b481e-b9f2-4d99-9307-e25cca9bb8c8">186</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December&#160;31, 2021</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i05354df582904ca187452170ab40afab_I20211231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTEtMS0xLTM2NDA2MA_55aabf27-33d3-4557-a185-a6a993efc283">2,527</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1dc0731d8fb949fe81ed2ae0a256af2b_I20211231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTItMS0xLTM2NDA2MA_2cfd5a0d-a788-4aea-bdfc-d4d688b66e84">532</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i203e64c16cf348b2a1f3041af709228d_I20211231" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTMtMS0xLTM2NDA2MA_c7aae293-aadf-4df8-9461-b62dd37d0f1f">939</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0475ae1c115247ef98cdcb07ea3cc9fe_I20211231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTQtMS0xLTM2NDA2MA_40ea7980-81f8-4e71-b191-dbb5b6751758">63,013</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i46555157a0b04f06bf0709e9682eadac_I20211231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTUtMS0xLTM2NDA2MA_bbc4da14-4b12-4c0a-8153-873eb8301110">4,405</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifbedee479b66410dae9bbe7401f7af56_I20211231" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTYtMS0xLTM2NDA2MA_e90aee12-e90b-436f-98ca-85fafd20d022">857</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9132ddbceaa74f6eb21b9ebb8cf0837b_I20211231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTctMS0xLTM2NDA2MA_5440aa48-3754-4f27-98ac-66eb07135302">68,681</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6bb87ee615b46b99718617248bfa891_I20211231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTgtMS0xLTM2NDA2MA_df07d499-23cf-4886-b63f-a6abbfcc3b3e">350</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTktMS0xLTM2NDA2MA_4b1c521b-edbe-4266-bd9a-a33fb8fbcc49">69,031</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-6</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Consolidated statements of changes in&#160;equity</span></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:22.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Share<br/>capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Treasury<br/>shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Reserves and retained earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Stock</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">options&#160;and</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">other&#160;share-</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">based</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">payments</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Other<br/>comprehensive<br/>income</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Attributable<br/>to equity<br/>holders of<br/>Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Attributable<br/>to non-<br/>controlling<br/>interests</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Total equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2022</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i05354df582904ca187452170ab40afab_I20211231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtMS0xLTEtMzY0MDYw_a37863dc-f973-4494-835a-06d65bbb64d5">2,527</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1dc0731d8fb949fe81ed2ae0a256af2b_I20211231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtMi0xLTEtMzY0MDYw_ee1c2108-0e5c-4055-bb82-1cce045f346f">532</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i203e64c16cf348b2a1f3041af709228d_I20211231" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtMy0xLTEtMzY0MDYw_cab31171-0c4b-4ab5-a7d1-36f4cecaa870">939</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0475ae1c115247ef98cdcb07ea3cc9fe_I20211231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtNC0xLTEtMzY0MDYw_314cb026-70be-4d26-8751-000e5db5feb6">63,013</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i46555157a0b04f06bf0709e9682eadac_I20211231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtNS0xLTEtMzY0MDYw_d377d5e5-f903-4fd1-bd58-274a0fec02cb">4,405</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifbedee479b66410dae9bbe7401f7af56_I20211231" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtNi0xLTEtMzY0MDYw_642afeeb-7293-42e7-a4f3-07c2ac5028bd">857</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9132ddbceaa74f6eb21b9ebb8cf0837b_I20211231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtNy0xLTEtMzY0MDYw_264fb611-dbf2-4ff5-9206-140eda6a35f5">68,681</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6bb87ee615b46b99718617248bfa891_I20211231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtOC0xLTEtMzY0MDYw_554a3b9b-0c04-4da7-9e86-9cf86791c8cf">350</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtOS0xLTEtMzY0MDYw_ee50cff5-e1bd-45a7-9ede-11c3c5342b6f">69,031</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income for&#160;the period</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzItNC0xLTEtMzY0MDYw_f6477137-ed24-4e02-b287-edfc2d5d801f">451</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i907c3d71d3014745b11f4974adf6844d_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzItNi0xLTEtMzY0MDYw_286c5606-6c5a-40fe-a207-bf7e5bbb21ee">2,308</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzItNy0xLTEtMzY0MDYw_4f76faca-abc3-4e13-aca7-008a6e408ee5">2,759</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i037c746f41544e359176f1f7ef73ab39_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzItOC0xLTEtMzY0MDYw_d56c2fb5-461d-4d85-b7b3-7cbba47eabc9">5</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzItOS0xLTEtMzY0MDYw_84b746e0-d321-4e3d-837e-54ebeaab2aff">2,764</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income for the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzMtNC0xLTEtMzY0MDYw_d1fdd47a-6277-4cea-9383-715b6bce4c28">8,371</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzMtNy0xLTEtMzY0MDYw_7ce2eab9-7444-4584-8930-ff352d55f39f">8,371</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i037c746f41544e359176f1f7ef73ab39_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzMtOC0xLTEtMzY0MDYw_ef434e7f-ce6f-4efb-84b8-7a86c4369849">113</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzMtOS0xLTEtMzY0MDYw_32c7219f-7377-431e-a015-54dc7168e554">8,484</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comprehensive income for&#160;the&#160;period</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzQtNC0xLTEtMzY0MDYw_5fccd643-82eb-40e0-9025-c5ad4492e9f4">8,822</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i907c3d71d3014745b11f4974adf6844d_D20220101-20221231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzQtNi0xLTEtMzY0MDYw_5b12ce87-ec95-4150-a3d4-1055b15e5731">2,308</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzQtNy0xLTEtMzY0MDYw_c07f9683-9d9a-4df7-a615-efc0da51836a">11,130</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i037c746f41544e359176f1f7ef73ab39_D20220101-20221231" decimals="-6" name="ifrs-full:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzQtOC0xLTEtMzY0MDYw_375b6b6e-1509-44d4-9272-a224da7ca1bc">118</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzQtOS0xLTEtMzY0MDYw_4789c1f5-7615-4306-8929-98aa69107289">11,248</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividend paid out </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">of 2021 earnings</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246NjJhNDY5NTRjMTE4NDNjYzhiNzhjN2YxYTFlMWM1NTZfNDA_a6f20625-e294-4c50-a621-7746a4ffcc68">3.33</ix:nonFraction> per </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">share)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzUtNC0xLTEtMzY0MDYw_945f2bd0-3b08-4d92-8d66-e3c5641b89fc">4,168</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzUtNy0xLTEtMzY0MDYw_10cb5a44-c9d4-4ba9-a92f-80f184cba776">4,168</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzUtOS0xLTEtMzY0MDYw_2e56355f-7f9b-43b3-9195-b5ed6d4c44ec">4,168</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of the distribution of an exceptional supplementary dividend of <ix:nonFraction unitRef="number" contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510" decimals="2" name="sny:ExceptionalSupplementaryDividendPercentageOfShareCapital" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtMC0xLTEtNDY3Nzk3L3RleHRyZWdpb246NzI0YWYxNTJkNWQ0NDExMDkwNTY5MzI5YTljN2Y0NjdfMTk3OTEyMDkzMDAxMTM_6b7a7082-776c-478e-84e1-746d4ef6d37d">58</ix:nonFraction>% of the shares of EUROAPI to the equity holders of Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231" decimals="-6" name="sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNC0xLTEtNDA0Njk0_85714117-9f74-4cd3-93b2-0175fc92848f">793</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNy0xLTEtNDA0Njk0_3f2777e7-72dd-447f-b207-67436a3ec3eb">793</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtOS0xLTEtNDA0Njk0_4f3465d3-e06d-4e0a-945e-ef98d44a023f">793</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payment of dividends to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNy0xLTEtMzY0MDYw_0d49aed0-2a6e-4fe7-841e-ba17279d555e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i037c746f41544e359176f1f7ef73ab39_D20220101-20221231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtOC0xLTEtMzY0MDYw_3f13ada2-ae16-425e-a6ae-f5ca08c92892">100</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtOS0xLTEtMzY0MDYw_4ca7467d-adf1-4d28-b03a-ee196794df14">100</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share repurchase program</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if12be8423b674ce99c50f89b01868fbb_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfTreasuryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctMy0xLTEtMzY0MDYw_843c78b6-7768-4ec0-89a4-98462d66f6a5">497</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfTreasuryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctNy0xLTEtMzY0MDYw_c1ae37c7-0636-4eb5-a37d-1fe172200b6d">497</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfTreasuryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctOS0xLTEtMzY0MDYw_88979adf-c420-4d86-86ac-4d172e42c928">497</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reduction in share capital</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i92e8a87ffe214bca94b143308473a86c_D20220101-20221231" decimals="-6" name="ifrs-full:ReductionOfIssuedCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMS0xLTEtMzY0MDYw_af7b7cbd-9a7f-49a4-98d4-85e25892f5b9">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9b77bf6a7f474a47a49a3925dd91d87e_D20220101-20221231" decimals="-6" name="ifrs-full:ReductionOfIssuedCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMi0xLTEtMzY0MDYw_4fbe68a1-d00d-41d8-8219-b4f35de27b96">587</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if12be8423b674ce99c50f89b01868fbb_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ReductionOfIssuedCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMy0xLTEtMzY0MDYw_9f35d2b3-a513-4223-921a-aba617b755fc">600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="ifrs-full:ReductionOfIssuedCapital" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtNy0xLTEtMzY0MDYw_80f47a56-a29d-4996-b77c-12bd76af1562">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ReductionOfIssuedCapital" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtOS0xLTEtMzY0MDYw_054eede4-8ea9-4866-aeab-74dd86e513ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based payment plans:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Exercise of stock options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i92e8a87ffe214bca94b143308473a86c_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTEtMS0xLTM2NDA2MA_e5014827-23a4-4ba5-bb24-c7e7fae6dc81">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b77bf6a7f474a47a49a3925dd91d87e_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTItMS0xLTM2NDA2MA_dc1f79e8-2ad8-417d-98c5-247116579faa">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTctMS0xLTM2NDA2MA_93c318bd-c64d-47b6-bff2-9f2bf1368cb6">35</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTktMS0xLTM2NDA2MA_e12d1ed9-a847-4dcb-9553-d3ae72a6114e">35</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Issuance of restricted shares and vesting of existing restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)/(d)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i92e8a87ffe214bca94b143308473a86c_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTEtMS0xLTM2NDA2MA_3b202fd8-00e4-487b-87e9-9a7b27f67620">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9b77bf6a7f474a47a49a3925dd91d87e_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTItMS0xLTM2NDA2MA_7d7feed9-e45b-4567-ae2c-b2271c3b7e4c">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if12be8423b674ce99c50f89b01868fbb_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTMtMS0xLTM2NDA2MA_ca2b6a8e-c22e-4f5c-b27f-219af0cd4527">130</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTQtMS0xLTM2NDA2MA_7ccde0a3-7066-40e2-8a3b-eaaff4071556">130</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTctMS0xLTM2NDA2MA_c0c113d9-32b7-4444-a088-c2774c355f21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTktMS0xLTM2NDA2MA_d8a8feb1-1cfa-42fb-bf37-81ef1afefc31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Employee share ownership plan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i92e8a87ffe214bca94b143308473a86c_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTEtMS0xLTM2NDA2MA_74a27fce-bb34-46a6-aa1a-129f0a994827">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b77bf6a7f474a47a49a3925dd91d87e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTItMS0xLTM2NDA2MA_b6549c65-de99-4001-8799-8f8e98f4e1e5">149</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTctMS0xLTM2NDA2MA_ea315a7f-252f-419b-8d4f-db0e553b3e76">153</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTktMS0xLTM2NDA2MA_2cd2613d-9aa8-490f-937a-c8d907ef0693">153</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Value of services obtained from&#160;employees</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if59ff530abc54fa08a014d04b57eaad1_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE1LTUtMS0xLTM2NDA2MA_41320e38-bd52-4ae1-bf36-1c98ba3d0718">245</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE1LTctMS0xLTM2NDA2MA_6ea40163-d42d-4e01-8854-ec00129f69d7">245</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE1LTktMS0xLTM2NDA2MA_ea4c839e-2cc8-4305-ab90-2102e81faee2">245</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects of the exercise of&#160;stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if59ff530abc54fa08a014d04b57eaad1_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE2LTUtMS0xLTM2NDA2MA_27411cae-1a00-432a-acde-abb05dd8c628">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE2LTctMS0xLTM2NDA2MA_28220d62-f571-4a15-a2b0-1476cb6f72dd">8</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE2LTktMS0xLTM2NDA2MA_326aa980-9e02-445c-a192-c867b9a9382f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other changes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE5LTQtMS0xLTM2NDA2MA_073e41f2-61d1-487a-876c-c6881c3bff12">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE5LTctMS0xLTM2NDA2MA_1211d7eb-a5a2-4d64-8955-7f8542ca1c54">10</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE5LTktMS0xLTM2NDA2MA_f262f3c3-0b40-4576-addb-08a41158145b">10</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December&#160;31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8b84fb2a0f16464b8dc3f00b6942258d_I20221231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTEtMS0xLTM2NDA2MA_07f1d734-e95e-4c4d-9a0c-6a7bdf3c06a8">2,522</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3ce76960e4fc410f94b0f8b63e7fdfbf_I20221231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTItMS0xLTM2NDA2MA_db59833c-757d-409c-9b13-a816c227ab0b">125</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0d0b91cd724e43e6ab4bbbc7982d3314_I20221231" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTMtMS0xLTM2NDA2MA_7e1367bf-dd48-4dc1-800d-78a63e606d16">706</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibe38939ea4194d299b03b4d0b2ea279b_I20221231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTQtMS0xLTM2NDA2MA_668f2e6b-a4b8-4a3d-a441-18876fee97aa">66,734</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1fbc748bc4044c1a959e7a991c5cca4d_I20221231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTUtMS0xLTM2NDA2MA_6075bec9-c307-4909-b17a-e43199485d89">4,658</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57b24b05b9274679b2b5dd6df7fdac00_I20221231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTYtMS0xLTM2NDA2MA_d6515ebf-aa00-4246-9b34-a859834ab25f">1,451</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i156b20e6df6a4eefa561591d7405481d_I20221231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTctMS0xLTM2NDA2MA_31735b82-2cd6-456c-ae3d-e07f0279727c">74,784</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i385db0023f404198889a2d10e37da000_I20221231" decimals="-6" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTgtMS0xLTM2NDA2MA_d73550ab-e6a7-432f-89b8-d08c2c5c644b">368</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTktMS0xLTM2NDA2MA_89b5fc1c-1795-4378-9002-9140802f7a00">75,152</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8" footnoteRole="http://www.xbrl.org/2003/role/footnote">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" footnoteRole="http://www.xbrl.org/2003/role/footnote">See Notes&#160;D.15.1., D.15.3., D.15.4. and D.15.5.</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMQ_b6e1becc-c779-46d0-aceb-3700af176d39" footnoteRole="http://www.xbrl.org/2003/role/footnote">Issuance of restricted shares to former employees of the European Generics business subsequent to the date of divestment.</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" footnoteRole="http://www.xbrl.org/2003/role/footnote">This line includes the use of existing shares to fulfill vested rights under restricted share plans.</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMQ_98bd5f86-b9de-4fe0-8b4c-07b961a7f844" footnoteRole="http://www.xbrl.org/2003/role/footnote">This line includes changes in non-controlling interests arising from divestments and acquisitions.</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(f) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzI2OTM4MDM0ODgxNjE2_fe6723a9-d270-4eed-8051-fedf99786726" footnoteRole="http://www.xbrl.org/2003/role/footnote">This amount includes the valuation of the shares distributed as a dividend in kind, at a price of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510" decimals="2" name="ifrs-full:WeightedAverageSharePrice2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzgwODE0MTA0NjQyNjcz_79da13e6-ffb2-4d20-b8ae-48887a01ac4c">14.58</ix:nonFraction> per share, as of May&#160;10, 2022 (see note&#160;D.1.).</ix:footnote></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-7</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_490"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Consolidated statements of cash flows</span></td></tr></table></div></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:18pt;font-weight:400;line-height:120%">Consolidated statements of cash flows</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:51.120%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.926%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(j)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEtMi0xLTEtMzY0MDYw_ac47a6a1-980d-4ea8-b632-d5131f55fbeb">8,371</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEtMy0xLTEtMzY0MDYw_37247f4a-ac3b-4e3f-a73b-d5891c3be3aa">6,223</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEtNS0xLTEtMzY0MDYw_0c3db353-dc6b-4d8f-9a4e-5190e3e18604">12,294</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-controlling interests</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.32.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMtMi0xLTEtMzY0MDYw_da223f16-cbc9-4eb8-a179-b0fe7130ffc2">113</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMtMy0xLTEtMzY0MDYw_2bf655b6-4cb1-41a5-aead-a25839851d61">56</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMtNS0xLTEtMzY0MDYw_64118034-3ca5-4b9b-8c19-e2ae333dc82e">36</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of undistributed earnings from investments accounted for using the&#160;equity method</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQtMi0xLTEtMzY0MDYw_4c62adfa-7aa4-47ef-b4ed-ef8f8deb6391">48</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQtMy0xLTEtMzY0MDYw_0ea5cef6-7adf-4642-8951-5933d6f9a9f8">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQtNS0xLTEtMzY0MDYw_dc70927f-9041-43c6-879f-2565b16819ee">339</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation, amortization and impairment of property, plant and equipment, right-of-use assets and intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzUtMi0xLTEtMzY0MDYw_e7f5be26-1ad9-48ac-9683-a3cc49deebdc">3,420</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzUtMy0xLTEtMzY0MDYw_1e3cd627-d1a6-4fef-b9bc-f963354d0e72">3,351</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzUtNS0xLTEtMzY0MDYw_037866be-74fb-4379-95c5-7391b8f0a643">3,671</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains and losses on disposals of non-current assets, net of tax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMi0xLTEtMzY0MDYw_68a96ae1-18df-4f0e-90c4-483a7863bbdd">711</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMy0xLTEtMzY0MDYw_ebaf5874-e148-403c-83d1-a3dc652c54d9">300</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtNS0xLTEtMzY0MDYw_659a6192-01c2-43a4-bc97-bcef7fd46f67">301</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gain on Regeneron investment arising from transaction of May 29, 2020, net&#160;of tax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.2.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMi0xLTEtMzY0MDYw_d05550c3-6c5b-4a1f-a950-e57307732990">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMy0xLTEtMzY0MDYw_82231aef-55eb-412a-9b0d-2a1af2ca02af">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctNS0xLTEtMzY0MDYw_28c8f930-0ea6-4980-abbd-c6e02f40ffad">6,880</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in deferred taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDeferredTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzgtMi0xLTEtMzY0MDYw_a7a4b4e6-d3d5-4fff-bce9-6d783bacccfb">578</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDeferredTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzgtMy0xLTEtMzY0MDYw_66ef1487-b493-40e7-90f9-949cf1d266ff">356</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDeferredTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzgtNS0xLTEtMzY0MDYw_42fd12c3-44d7-4452-833d-9a4e29d9f0dc">221</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in non-current provisions and other non-current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMi0xLTEtMzY0MDYw_a2b5688d-defb-4ded-ac13-3ba426e6f75e">280</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMy0xLTEtMzY0MDYw_b88f5582-854c-44f8-bbdc-f448e42a6399">37</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktNS0xLTEtMzY0MDYw_753747be-20ce-4c5c-88ce-259f463a8b67">133</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of employee benefits (stock options and other share-based payments)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.2.</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">.&#160;-&#160;D.15.3.</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-&#160;D.15.8.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEwLTItMS0xLTM2NDA2MA_07b667dc-64f8-4121-bb5e-32e0bf57ef1e">245</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEwLTMtMS0xLTM2NDA2MA_3b2b587e-f4ec-45b8-bf14-aaf042aa28c4">244</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEwLTUtMS0xLTM2NDA2MA_dc5f33b7-186d-441b-8fb1-8eb19a94a3dd">274</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impact of the workdown of acquired inventories remeasured at fair value</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.35.1.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzExLTItMS0xLTM2NDA2MA_fbd4c60f-cb1e-4fa6-8e54-45858457c001">3</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzExLTMtMS0xLTM2NDA2MA_b074cd7f-5d59-49b0-955b-9fb6ef90c4d2">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzExLTUtMS0xLTM2NDA2MA_22f5816e-e976-407b-a33f-32aeb0615a40">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other profit or loss items with no cash effect on cash flows generated by&#160;operating activities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTItMS0xLTM2NDA2MA_b807f41b-dc17-4fab-9c7a-5edc7a9ddf37">138</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTMtMS0xLTM2NDA2MA_838ddb06-59ce-45d0-bd06-5ad48488f600">57</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTUtMS0xLTM2NDA2MA_9c0bd19e-35c4-4872-af6a-47f8e4217b03">711</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating cash flow before changes in working capital</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE0LTItMS0xLTM2NDA2MA_cbdd70db-b4f7-4105-bc35-7b653f9f5019">11,233</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE0LTMtMS0xLTM2NDA2MA_c0b0084a-2ac0-4dea-acb0-575a24b379f0">9,113</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE0LTUtMS0xLTM2NDA2MA_31c45ffd-1947-40f9-ad6a-89ca1c9f0bbd">7,743</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Increase)/decrease in inventories</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE1LTItMS0xLTM2NDA2MA_05fcb4ae-6c81-4fc7-a631-b87158b8685b">927</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE1LTMtMS0xLTM2NDA2MA_d8ca15e3-d6b5-4a3e-a7c9-958ba121aa15">357</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE1LTUtMS0xLTM2NDA2MA_f9adf783-6975-40b3-ae86-95facc12396c">593</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Increase)/decrease in accounts receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE2LTItMS0xLTM2NDA2MA_9bb11f8f-99b2-4d97-98a7-e95f5fe429a1">777</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE2LTMtMS0xLTM2NDA2MA_918a2803-25c1-4f99-8de3-b30365643a9e">185</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE2LTUtMS0xLTM2NDA2MA_08b6afa3-6337-4c4a-bb0a-3379dc726454">134</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increase/(decrease) in accounts payable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE3LTItMS0xLTM2NDA2MA_c6b93155-8e17-4acb-8863-30e87341f2d2">452</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE3LTMtMS0xLTM2NDA2MA_695b700c-b553-48cd-80f3-c8471e0775fd">451</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE3LTUtMS0xLTM2NDA2MA_bd5603e6-aced-48de-980d-85d04fadce07">86</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in other current assets and other current liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE4LTItMS0xLTM2NDA2MA_84b3ff75-42d3-48fc-b381-a339f9ef69cb">545</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE4LTMtMS0xLTM2NDA2MA_5b7fee67-d341-4b33-9805-1e3ce2d60710">1,130</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE4LTUtMS0xLTM2NDA2MA_3784fba6-0647-4205-9f33-f3778deaae45">316</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by/(used in) operating activities</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTItMS0xLTM2NDA2MA_adc3dc98-3752-4217-a201-9469b1c6159f">10,526</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTMtMS0xLTM2NDA2MA_20ba23d9-4985-4b1e-be44-744953373bd2">10,522</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTUtMS0xLTM2NDA2MA_f7575fc6-2ec7-4422-9290-f9eb402e6ed8">7,418</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment and intangible assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.3.&#160;-&#160;D.4.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIyLTItMS0xLTM2NDA2MA_83785c42-73bd-4082-89e2-28c6194a5398">2,201</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIyLTMtMS0xLTM2NDA2MA_59cb6ba6-f2bb-4e78-b952-49b496a061ac">2,043</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIyLTUtMS0xLTM2NDA2MA_28ccd4d4-b955-4456-a936-7c6235cf39ab">2,083</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of consolidated undertakings and investments accounted for&#160;using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.1.</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-&#160;D.18.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTItMS0xLTM2NDA2MA_14fc05d6-202f-402c-97a5-aa05fc624d48">992</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTMtMS0xLTM2NDA2MA_d71cb872-410e-4d33-b50f-03fc06485f4f">5,594</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTUtMS0xLTM2NDA2MA_86f873a5-ea9d-496d-9826-7012e349d45f">5,336</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of other equity investments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7. </span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI0LTItMS0xLTM2NDA2MA_97a09df5-497c-4388-a5a6-fb91e9c73766">488</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI0LTMtMS0xLTM2NDA2MA_b3d0cddc-f8e7-4f5d-b9ce-06af44aa9047">311</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI0LTUtMS0xLTM2NDA2MA_05a9ca15-42e7-4edf-8810-aed4004b5a47">137</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets, net of tax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTItMS0xLTM2NDA2MA_ba2d8fea-11e9-4854-8b94-0515718b611f">1,488</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTMtMS0xLTM2NDA2MA_f9534676-afa5-4f61-8123-c6c164d57420">676</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTUtMS0xLTM2NDA2MA_4ed2c3d5-36ff-4dc1-9b89-c7736363a07b">918</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposal of consolidated undertakings and investments accounted for using the equity method, net of tax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(h)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTItMS0xLTM2NzQ3OQ_936bff2b-5c05-4544-b8a8-f59222607c67">134</ix:nonFraction></span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTMtMS0xLTM2NzQ3MA_47f62225-cc47-4815-8201-aeb2b6746255">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NzQ4Mg_2c17decc-29d6-4783-a5a8-9d236cef3b39">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net proceeds from sale of Regeneron shares on May&#160;29, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.2.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTItMS0xLTM2NDA2MA_70cfa844-bdc5-4428-9af3-53d7f8c38481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTMtMS0xLTM2NDA2MA_7c179423-4a69-4e78-93d1-4370987efe3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NDA2MA_80b331d7-f29e-4957-9b17-0946b17201e5">10,370</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in other non-current assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="sny:NetChangeInOtherNonCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI3LTItMS0xLTM2NDA2MA_2473f4a7-f976-4591-a1f4-0ede2578f74f">16</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="sny:NetChangeInOtherNonCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI3LTMtMS0xLTM2NDA2MA_91d06df8-a591-4767-8ddd-b706f45fe7c3">68</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="sny:NetChangeInOtherNonCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI3LTUtMS0xLTM2NDA2MA_5d91a65c-b49b-48c5-8f9f-76e35ca388c0">113</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by/(used in) investing activities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI4LTItMS0xLTM2NDA2MA_a4e43bd3-1831-40a2-9519-b92e929cff02">2,075</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI4LTMtMS0xLTM2NDA2MA_0ea705da-cd61-4729-ad99-3131efdfc589">7,298</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI4LTUtMS0xLTM2NDA2MA_c4db135c-f14b-48b6-90a1-2f41650c4e3b">3,619</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of Sanofi shares</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.1.</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProceedsFromIssuingShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMwLTItMS0xLTM2NDA2MA_6b687395-16a4-4bdb-8059-674535549935">188</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProceedsFromIssuingShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMwLTMtMS0xLTM2NDA2MA_77a60e4b-44c3-4074-9150-a4c58c695d68">186</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProceedsFromIssuingShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMwLTUtMS0xLTM2NDA2MA_d97178c3-e549-40aa-89d0-58737b61a38c">203</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends paid:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">to shareholders of Sanofi</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMyLTItMS0xLTM2NDA2MA_465fbbe5-fffd-4dee-ac05-8b1cc64bef55">4,168</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMyLTMtMS0xLTM2NDA2MA_1cebe570-88c5-4066-8f35-6fee795d4bc8">4,008</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMyLTUtMS0xLTM2NDA2MA_443a4622-44ef-476a-9baf-ad2ba6cdc5ff">3,937</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">to non-controlling interests</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMzLTItMS0xLTM2NDA2MA_5ea0b439-0539-4172-b283-7102b04691bd">99</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMzLTMtMS0xLTM2NDA2MA_e32d9656-8411-4b4f-8e38-7a116a497de3">48</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMzLTUtMS0xLTM2NDA2MA_63eb69a4-450d-440b-950d-c52013cdb3a4">44</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional long-term debt contracted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.1.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProceedsFromNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM1LTItMS0xLTM2NDA2MA_efbc2543-3cb8-4046-a2e7-d100ab54709d">1,549</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProceedsFromNoncurrentBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM1LTMtMS0xLTM2NDA2MA_657dcb84-34a9-43f2-ad84-a60de8751412">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProceedsFromNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM1LTUtMS0xLTM2NDA2MA_4fbb4788-3acc-4c59-93b1-ea49ead9c567">2,019</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.1.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM2LTItMS0xLTM2NDA2MA_821fa717-b44a-41ea-9865-2fa9b0653e0e">2,718</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM2LTMtMS0xLTM2NDA2MA_921b84b8-1349-44cc-820c-e6af63ba40a7">2,241</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM2LTUtMS0xLTM2NDA2MA_f3b5168f-b60d-481f-b2f9-0bb8d1bf62bf">3,952</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repayments of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM3LTItMS0xLTM2NDA2MA_361f3bd1-0add-4294-a980-95467425dc6c">291</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM3LTMtMS0xLTM2NDA2MA_bdfe0653-13a1-41fa-8e75-3f81a57c8cb6">149</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM3LTUtMS0xLTM2NDA2MA_5d3d6b03-c339-483e-b43d-69ccb0089d93">234</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in short-term debt and other financial instruments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTItMS0xLTM2NDA2MA_fccf220d-081e-4f3e-b8d9-b22352996dc9">215</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTMtMS0xLTM2NDA2MA_7d53f1df-0fe1-412c-8d7a-c85744a33900">414</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTUtMS0xLTM2NDA2MA_77055e13-a439-40d7-b46e-ed1a0852390e">282</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of treasury shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.15.4.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM5LTItMS0xLTM2NDA2MA_34e5cbbb-56a3-4acb-8e46-91f05186bd18">497</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM5LTMtMS0xLTM2NDA2MA_865684c3-5be4-44ed-bf6c-15bc2ed2c1cd">382</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM5LTUtMS0xLTM2NDA2MA_7dfd024d-6cb7-47b0-8d2a-309b7cafe760">822</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by/(used in) financing activities </span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQxLTItMS0xLTM2NDA2MA_d0777f8b-7e4d-42e2-ba40-fe960430759f">5,821</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQxLTMtMS0xLTM2NDA2MA_706dc5e9-0348-42a4-8269-7d3d130c3450">7,056</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQxLTUtMS0xLTM2NDA2MA_54ce4fb9-1abe-44c5-b71d-58f396cbf084">6,485</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact of exchange rates on cash and cash equivalents</span></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQzLTItMS0xLTM2NDA2MA_ea621fc1-0ef2-49bd-acc7-ff045bc63c9b">8</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQzLTMtMS0xLTM2NDA2MA_1290e8c8-47a5-4495-9b7e-d72cc476e205">15</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQzLTUtMS0xLTM2NDA2MA_f282ed48-ec02-4893-9201-9d1039bb256a">64</ix:nonFraction>)</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="3" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ0LTItMS0xLTM2NDA2MA_3245d7c4-2801-4e81-b582-4abf8739c9d7">2,638</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ0LTMtMS0xLTM2NDA2MA_51cd9737-1823-467c-bcf3-ab56af4980af">3,817</ix:nonFraction>)</span></td><td style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ0LTUtMS0xLTM2NDA2MA_ae5b4a07-2634-44a8-95cf-f6f030408c0f">4,488</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ1LTItMS0xLTM2NDA2MA_9f3c2241-c348-48bc-b44f-7b5a1f9050b3">10,098</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ1LTMtMS0xLTM2NDA2MA_00786d81-88ba-431a-9ed1-604c75167071">13,915</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ1LTUtMS0xLTM2NDA2MA_ed1062a4-594a-4fc8-99f0-7c16dbf21f94">9,427</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#23004c;border-bottom:0.5pt solid #23004c;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash and cash equivalents, end of period</span></td><td colspan="3" style="background-color:#23004c;border-bottom:0.5pt solid #23004c;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.13.</span></td><td colspan="2" style="background-color:#23004c;border-bottom:0.5pt solid #23004c;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ2LTItMS0xLTM2NDA2MA_89c6649a-df9b-4706-a743-348b542ccbf7">12,736</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;border-bottom:0.5pt solid #23004c;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#23004c;border-bottom:0.5pt solid #23004c;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ2LTMtMS0xLTM2NDA2MA_4ebb6ed9-f40b-4613-a9dd-d539ffd3abeb">10,098</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;border-bottom:0.5pt solid #23004c;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#23004c;border-bottom:0.5pt solid #23004c;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ2LTUtMS0xLTM2NDA2MA_b73eca4b-a452-40df-974d-91a078599ec9">13,915</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;border-bottom:0.5pt solid #23004c;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#23004c;border-bottom:0.5pt solid #23004c;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQx_05e590d1-51db-4ca8-b860-337a3c2ef7a6" footnoteRole="http://www.xbrl.org/2003/role/footnote">(a) Includes non-current financial assets.</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQy_cf6c8d9b-a5aa-4ad1-a1e9-53e2186cf56f" footnoteRole="http://www.xbrl.org/2003/role/footnote">(b) The gain on the sale of Regeneron shares is presented net of taxes, including deferred taxes of &#8364;<ix:nonFraction unitRef="eur" contextRef="i17591b56caee4f43b8f0bbb8ca58a6f4_D20200101-20201231" decimals="-6" name="sny:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzQzNDMwNzA5MzA0NTI5_f4814ad5-ae53-4177-9733-aac576c1171d">115</ix:nonFraction>&#160;million.</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQz_4413e2d3-0704-4581-a253-6ac595b10cd5" footnoteRole="http://www.xbrl.org/2003/role/footnote">(c) This line item includes contributions paid to pension funds (see Note&#160;D.19.1.).</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ0_06a9dadf-45f8-44b4-82fa-41db2fe39be6" footnoteRole="http://www.xbrl.org/2003/role/footnote">(d) This line item mainly comprises unrealized foreign exchange gains and losses arising on the remeasurement of monetary items in non-functional currencies and on instruments used to hedge such items.</ix:footnote></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-8</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2022 CONSOLIDATED FINANCIAL STATEMENTS</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Consolidated statements of cash flows</span></td></tr></table></div></div><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ1_51450c7d-26aa-43d2-ada2-6a14149956df" footnoteRole="http://www.xbrl.org/2003/role/footnote"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) Including:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:56.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Income tax paid</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzEtMS0xLTEtMzY0MDYw_483d6e38-d77c-47a9-b69c-8ed62754a27b">2,452</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzEtMi0xLTEtMzY0MDYw_285523af-6f38-4af6-8784-7b813d4a011a">1,280</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzEtMy0xLTEtMzY0MDYw_e2a5a8e4-7e90-451f-af85-17d687888e20">2,051</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Interest paid</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzItMS0xLTEtMzY0MDYw_40c77b41-46fb-45dc-95ae-af57471c3308">380</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzItMi0xLTEtMzY0MDYw_811997fb-fda0-433f-949d-e4e1d9844c7c">334</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzItMy0xLTEtMzY0MDYw_7c5b4b9e-db80-40e7-a603-f3c3bb54a5ff">315</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Interest received</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzMtMS0xLTEtMzY0MDYw_6860a8c6-4f2c-44d8-9218-e956201a6a89">173</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzMtMi0xLTEtMzY0MDYw_299c6ef8-07c7-40d5-8c5b-ea99f1618389">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzMtMy0xLTEtMzY0MDYw_5399f2a6-ceaa-4929-87e5-630ccb958993">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Dividends received from non-consolidated entities</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzQtMS0xLTEtMzY0MDYw_e4629d4e-5bd5-401b-b4aa-62a0ac0447fd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzQtMi0xLTEtMzY0MDYw_7b127681-a142-4e10-ac37-77d185ec89b0">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzQtMy0xLTEtMzY0MDYw_cf0eacb0-fc0b-4210-b485-9bf799687b9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:footnote><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ2_7c2dd840-1374-4610-964f-c966ea4bc4b5" footnoteRole="http://www.xbrl.org/2003/role/footnote">(f)&#160;&#160;&#160;&#160;This line item includes payments made in respect of contingent consideration identified and recognized as a liability in business combinations. For 2022, it includes the net cash outflow on the acquisition of Amunix (see Note&#160;D.1.). For 2021, it includes the net cash outflows on the acquisitions of Kymab, Kiadis, Tidal, Translate Bio, Kadmon and Origimm (see Note&#160;D.2.1.). For 2020, it includes the net cash outflows on the acquisitions of Synthorx and Principia (see Note&#160;D.2.2.).</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ3_eca3b69e-ddc5-40c4-8c60-b88736c10615" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">For 2022, 2021 and 2020, this line item mainly comprises disposals of assets and activities related to portfolio streamlining and disposals of equity and debt instruments.</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> For 2020, it also includes the sale to Baxter of operations relating to Seprafilm</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> for a selling price (before taxes) of &#8364;<ix:nonFraction unitRef="eur" contextRef="if2835fe4d12b49b097239c6dbd3d3396_D20200101-20201231" decimals="-6" name="ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzExMTE_742ecfce-154c-4114-a8c0-cb1ee77b13ad">311</ix:nonFraction>&#160;million. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(see&#160;Note&#160;D.7.1.).</span></ix:footnote></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ4_35ca4623-8801-4945-8e8e-9bd5409bc25f" footnoteRole="http://www.xbrl.org/2003/role/footnote">(h)&#160;&#160;&#160;&#160;For 2022, this line item includes the net cash inflows (before taxes) of &#8364;<ix:nonFraction unitRef="eur" contextRef="ic03c35218a744afe9fa35a7119858f22_D20220101-20221231" decimals="-6" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDE3_95b8f957-44d6-450f-98f2-21bcc45d31d1">101</ix:nonFraction>&#160;million on the divestment of EUROAPI (see Note&#160;D.1).</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ5_a854f423-a49a-4d25-83ec-b6c61a89c384" footnoteRole="http://www.xbrl.org/2003/role/footnote">(i)&#160;&#160;&#160;&#160;This line item includes realized foreign exchange differences on (i)&#160;cash and cash equivalents in non-functional currencies (primarily the US dollar) and (ii)&#160;derivative instruments used to manage such cash and cash equivalents.</ix:footnote></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" footnoteRole="http://www.xbrl.org/2003/role/footnote">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</ix:footnote></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-9</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_493"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:18pt;font-weight:400;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_496"></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTYvZnJhZzphZmUyOTRiY2I4OGU0NjhmYTZjNTMyYzJlN2Y4NGQ4Yi90ZXh0cmVnaW9uOmFmZTI5NGJjYjg4ZTQ2OGZhNmM1MzJjMmU3Zjg0ZDhiXzQ2Nw_c342f277-3566-4db3-9166-e3e475930815" escape="true"><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Introduction</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi, together with its subsidiaries (collectively &#8220;Sanofi&#8221;, &#8220;the Group&#8221; or &#8220;the Company&#8221;), is a global healthcare leader engaged in the research, development and marketing of therapeutic solutions focused on patient needs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is listed in Paris (Euronext: SAN) and New&#160;York (Nasdaq: SNY).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements for the year ended December 31, 2022, and the notes thereto, were signed off by the Sanofi Board of Directors on</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> February&#160;23,&#160;2023.</span></div></ix:nonNumeric><div id="i52f57172a9d7443580346c2d8f39cd2b_499"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">A/ <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDg3_2528bdfa-196a-4fd9-982d-72c502963ecf" continuedAt="if9052990d4d84b4c95302e259fbedef6" escape="true">Basis of preparation</ix:nonNumeric></span></div><ix:continuation id="if9052990d4d84b4c95302e259fbedef6" continuedAt="if573017937d5421ca744245109d74207"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.1. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:StatementOfIFRSCompliance" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDc0_c17d52c5-0af1-4f52-864a-cf18f084cab9" continuedAt="ifb39c6b3879e4d6da6e27275850ab574" escape="true">International financial reporting standards (IFRS)</ix:nonNumeric></span></div><ix:continuation id="ifb39c6b3879e4d6da6e27275850ab574"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements cover the twelve-month periods ended December 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with Regulation No.&#160;1606/2002 of the European Parliament and Council of July&#160;19, 2002 on the application of&#160;international accounting standards, Sanofi has presented its consolidated financial statements in accordance with IFRS since&#160;January&#160;1, 2005. The term &#8220;IFRS&#8221; refers collectively to international accounting and financial reporting standards (IASs&#160;and&#160;IFRSs) and to interpretations of the interpretations committees (SIC and IFRIC) with mandatory application as of December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements of Sanofi as of December 31, 2022 have been prepared in compliance with IFRS as&#160;issued&#160;by the International Accounting Standards Board (IASB) and with IFRS as endorsed by the European Union as of December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">IFRS as endorsed by the European Union as of December 31, 2022 are available under the heading &#8220;IFRS Financial Statements&#8221; via the following web&#160;link:</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">https://www.efrag.org/Endorsement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in accordance with the IFRS general principles of fair presentation, going concern, accrual basis of accounting, consistency of presentation, materiality, and aggregation.</span></div></ix:continuation><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.2. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDg1_263e9a5d-5fff-48f4-82ef-f1d00e809457" continuedAt="i25d2c34d047c4d39af5f93829fc2d91b" escape="true">New standards, amendments and interpretations</ix:nonNumeric></span></div><ix:continuation id="i25d2c34d047c4d39af5f93829fc2d91b"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">A.2.1. New standards applicable from January 1, 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following amendments are applicable from January&#160;1, 2022, and have had no material impact: &#8220;Reference to the Conceptual Framework&#8221; (amendment to IFRS&#160;3); &#8220;Proceeds before Intended Use&#8221; (amendment to IAS&#160;16); &#8220;Onerous Contracts &#8212; Cost of Fulfilling a Contract&#8221; (amendment to IAS&#160;37); and &#8220;Annual Improvements to IFRS standards 2018-2020&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As a reminder, Sanofi adopted in its consolidated financial statements for the year ended December&#160;31, 2021 the IFRS&#160;IC final agenda decision (published in the March&#160;2021 IFRS&#160;IC update) clarifying how to account for costs of configuring or customising a supplier&#8217;s application software in a Software as a Service (SaaS) arrangement, which requires such costs to be recognized as an expense.</span></div></ix:continuation><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">A.2.2. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDgy_6a3f6e8f-49a3-4e12-8e85-213e59234bd5" continuedAt="ic7a5d8154d0f47cfb9523a9d0a8c10e1" escape="true">New pronouncements issued by the IASB and applicable from 2023 or later</ix:nonNumeric></span></div><ix:continuation id="ic7a5d8154d0f47cfb9523a9d0a8c10e1" continuedAt="i61e637c5341f43bc83090e64902c830b"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This note describes standards, amendments and interpretations issued by the IASB that will have mandatory application in 2023 or subsequent years, and Sanofi&#8217;s position regarding future application.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;12, 2021, the IASB issued &#8220;Disclosure of Accounting Policies&#8221;, an amendment to IAS&#160;1, and &#8220;Definition of Accounting Estimates&#8221;, an amendment to IAS&#160;8. On May&#160;7, 2021, the IASB issued an amendment to IAS&#160;12, relating to deferred tax assets and liabilities arising from a single transaction. Sanofi does not expect a material impact from those amendments, which are applicable at the earliest from January&#160;1, 2023, and will not early adopt them.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;22, 2022, the IASB issued an amendment to IFRS&#160;16 (Leases), relating to lease liabilities in a sale-and-leaseback arrangement, which is applicable at the earliest from January&#160;1, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (subject to endorsement by the European Union); it will not have a material impact on the Sanofi financial statements, and </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi will not early adopt it.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On January&#160;23, 2020, the IASB issued &#8220;Classification of Liabilities as Current or Non-current&#8221;, an amendment to IAS&#160;1, and then on&#160;October&#160;31, 2022 issued &#8220;Non-current Liabilities with Covenants&#8221;, a further amendment to IAS&#160;1. The amendments are applicable at the earliest from January&#160;1, 2024 </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(subject to endorsement by the European Union)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; they will not have a material impact on the Sanofi financial statements, and Sanofi will not early adopt them.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-10</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="if573017937d5421ca744245109d74207" continuedAt="ia335017442904d779f387c13ae2d7b06"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:continuation id="i61e637c5341f43bc83090e64902c830b">IFRS&#160;17 (Insurance Contracts), issued on May&#160;18, 2017 and applicable on or after January&#160;1, 2023, will not apply to the Sanofi consolidated financial statements because the insurance activities carried on by Sanofi's captive insurance companies are internal within the Sanofi group (the sole policyholders being subsidiaries of Sanofi), and hence are eliminated on consolidation.</ix:continuation></span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.3. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDc2_4028726c-0f51-4a92-ac56-3aec800190a1" continuedAt="i861948c7e1c04e68a2bb7527fcb53682" escape="true">Use of estimates and judgments</ix:nonNumeric></span></div><ix:continuation id="i861948c7e1c04e68a2bb7527fcb53682"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The preparation of financial statements requires management to make reasonable estimates and assumptions based on information available at the date of the finalization of the financial statements. Those estimates and assumptions may affect the reported amounts of assets, liabilities, revenues and expenses in the financial statements, and disclosures of contingent assets and contingent liabilities as of the date of the review of the financial statements. Examples of estimates and assumptions include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">amounts deducted from sales for projected sales returns, chargeback incentives, rebates and price reductions (see Notes&#160;B.13. and&#160;D.23.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">impairment of property, plant and equipment and intangible assets (see Notes&#160;B.6. and D.5.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the valuation of goodwill and the valuation and estimated useful life of acquired intangible assets (see Notes&#160;B.3.2., B.4., D.4. and&#160;D.5.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the measurement of contingent consideration receivable in connection with asset divestments (see Notes&#160;B.8.5. and&#160;D.12.) and of contingent consideration payable (see Notes&#160;B.3. and&#160;D.18.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the measurement of financial assets at amortized cost (see Note&#160;B.8.5.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of post-employment benefit obligations (see Notes&#160;B.23. and&#160;D.19.1.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of liabilities or provisions for restructuring, litigation, tax risks relating to corporate income taxes, and environmental risks (see Notes&#160;B.12., B.19., B.20., D.19. and&#160;D.22.); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of deferred tax assets resulting from tax losses available for carry-forward and deductible temporary differences (see Notes&#160;B.22. and&#160;D.14.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Actual results could differ from these estimates.</span></div></ix:continuation><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.4. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfHyperinflationaryReportingExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDgz_40d5112d-abb7-4af9-adce-d63ab2a5cf94" continuedAt="i5c3052703fab4cdc8c44d6ca5237500d" escape="true">Hyperinflation</ix:nonNumeric></span></div><ix:continuation id="i5c3052703fab4cdc8c44d6ca5237500d"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, Sanofi continued to account for subsidiaries based in Venezuela using the full consolidation method, on the basis that the criteria for control as specified in IFRS&#160;10 (Consolidated Financial Statements) are still met. In 2018, following changes to the Venezuelan foreign exchange system, the &#8220;DICOM&#8221; rate was replaced by the &#8220;PETRO&#8221; rate (with a floating US dollar/bolivar parity) and the strong bolivar (&#8220;VEF&#8221;) was replaced by the sovereign bolivar (&#8220;VES&#8221;), reflecting a 1-for-100,000 devaluation. Finally, in October&#160;2021 a new currency called the &#8220;Digital Bolivar&#8221; (VED) was introduced at a rate of 1&#160;VED to 1,000,000&#160;sovereign bolivars. Consequently, the contribution of the Venezuelan subsidiaries to the consolidated financial statements is immaterial.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Argentina, the cumulative rate of inflation over the last three years is in excess of <ix:nonFraction unitRef="number" contextRef="idfcbd6492da644e8b979ce9b73f2b1f6_I20221231" decimals="2" name="sny:CumulativeConsumerPriceInflationOverTheLastThreeYears" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzk4MjU_8ed269c7-cf4f-4c53-b1c5-1a322a12657f">100</ix:nonFraction>%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has since July&#160;1, 2018 treated Argentina as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since the beginning of 2022, inflation in Turkey has increased significantly and the cumulative inflation rate over the past three years has been above <ix:nonFraction unitRef="number" contextRef="i2c78a0e7ebc747c594c4ee6e77570478_I20221231" decimals="2" name="sny:CumulativeConsumerPriceInflationOverTheLastThreeYears" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzI2OTM4MDM0OTAzODY3_0aad7146-b3ea-4e0a-b1ae-5de7e0a5900f">100</ix:nonFraction>% since the end of February&#160;2022. Qualitative indicators following the deterioration of the economic situation and exchange controls also support the consensus conclusion that Turkey is a hyperinflationary country from 2022. Consequently, Sanofi has since January&#160;1, 2022 treated Turkey as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level.</span></div></ix:continuation><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.5. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDk0_91094253-4a57-4c6e-b3c0-6f37c6bd6894" continuedAt="ib83c02c7364c47fa9fb2028d91946ad6" escape="true">Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK</ix:nonNumeric></span></div><ix:continuation id="ib83c02c7364c47fa9fb2028d91946ad6" continuedAt="if9dcd8ba4986421c9bf54c093dba7131"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;18, 2020, Sanofi and the US Department of Health and Human Services extended their research and development partnership to leverage Sanofi&#8217;s previous development work on a SARS vaccine to attempt to unlock a fast path forward for developing a COVID-19 vaccine. Under the terms of the collaboration, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the US Department of Health and Human Services, is helping to fund the research and development undertaken by Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;14, 2020, Sanofi and GlaxoSmithKline (GSK) entered into a collaboration agreement to develop a recombinant COVID-19 vaccine candidate, with Sanofi contributing its S&#8209;protein COVID-19 antigen (based on recombinant DNA technology) and GSK contributing its pandemic adjuvant technology. Sanofi is leading clinical development and the registration process for the vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On July&#160;31, 2020, the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK was selected by the US&#160;government&#8217;s Operation Warp Speed (OWS) program. Under the OWS, the US government is providing funds to support further development of the vaccine, including clinical trials and scaling-up of manufacturing capacity. Initially, the agreement also provided for the supply of <ix:nonFraction unitRef="vaccine_dose" contextRef="if7312feb82fb447ea49510fc80480c6a_D20200701-20200731" decimals="-6" name="sny:NumberOfVaccineDosesToBeSupplied" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzEzMzc4_dab4f8c6-f694-432f-b8c8-3665a8fbc470">100</ix:nonFraction>&#160;million doses of the vaccine, with payment due at the time vaccine doses are provided. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has recognized the funding received from the US government as a deduction from the development expenses incurred, in accordance with IAS&#160;20 (Accounting for Government Grants and Disclosure of Government Assistance).</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-11</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ia335017442904d779f387c13ae2d7b06" continuedAt="i5bb21967fcf34a2998a09fc4acc584e1"><ix:continuation id="if9dcd8ba4986421c9bf54c093dba7131"><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of government aid received from the US federal government and BARDA and recognized </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as a deduction from development expenses</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and other operating expenses was &#8364;<ix:nonFraction unitRef="eur" contextRef="i5f8e75f8110e4de1a9b126cfa19e1f6e_D20220101-20221231" decimals="-6" name="sny:GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDky_a54cb222-c750-41eb-aa17-23b85261bba3">265</ix:nonFraction>&#160;million in 2022, compared with &#8364;<ix:nonFraction unitRef="eur" contextRef="i35c351f036c247cf83d680f6986c15c5_D20210101-20211231" decimals="-6" name="sny:GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzEzODM3_ea23bc32-98d3-44e7-b1d5-dd60a286b9ed">147</ix:nonFraction>&#160;million in 2021 and an <ix:nonFraction unitRef="eur" contextRef="if2c1a983cbcf45f48b7833d558393c4b_D20200101-20201231" decimals="INF" name="sny:GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MTA1_ae6f7867-e7c0-4212-a8d7-b0b67e979cef">immaterial</ix:nonFraction> amount in 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2020, Sanofi and GSK signed pre-order contracts with the Canadian and UK governments and with the European Union for doses of the vaccine candidate. During 2021, Sanofi and GSK contractualized with the Canadian and UK governments and with the European Union on the number of doses ordered.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;15, 2021, Sanofi and GSK announced positive preliminary data on their COVID-19 booster vaccine candidate and indicated that their Phase&#160;III trial was to continue, based on recommendations from an independent monitoring board.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;10, 2022, in line with the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency, the European Commission approved VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta vaccine as booster for the prevention of COVID-19 in adults aged 18&#160;years and older. Designed to provide broad protection against multiple variants, this protein-based COVID-19 booster vaccine is based on the Beta variant antigen and includes GSK&#8217;s pandemic adjuvant. VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Beta is indicated as a booster for active immunization against SARS-CoV-2 in adults who have previously received an mRNA or adenoviral COVID-19 vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;21, 2022, following the European Commission approval, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta vaccine for the prevention of COVID-19 in adults aged 18 and over within the UK.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there had been no material change in the commitments entered into by the United States in 2020, or in the pre-order arrangements with Canada, the United Kingdom and the European Union.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;15 (see Note&#160;B.13.1.), Sanofi recognizes revenue when control over the product is transferred to the customer (for vaccines, transfer of control is determined by reference to the terms of release and acceptance of batches of vaccine). Payments received subsequent to signature of vaccine pre-order contracts relating to doses not yet delivered are customer contract liabilities (i.e. an obligation for the entity to supply goods to a customer, for which consideration has been received from the customer). They are presented within &#8220;Customer contract liabilities&#8221; in the balance sheet (see Note&#160;D.19.5.), and within &#8220;Net change in other current assets and other current liabilities&#8221; in the statement of cash flows.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of&#160;December&#160;31, 2022, customer contract liabilities amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentContractLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDA0_cdb8fa35-319c-4f7b-b7c1-0dd9092ec52c">264</ix:nonFraction>&#160;million, compared with &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentContractLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDMx_b2f36e0d-b721-4cef-99b4-89063148f5a4">319</ix:nonFraction>&#160;million as of&#160;December&#160;31,&#160;2021 (see Note&#160;D.19.5., &#8220;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Current provisions and other current liabilities&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">). The portion of the December&#160;31, 2021 balance recognized in profit or loss during 2022 was &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:ContractLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDQ1_2cf56e9f-16cd-49a5-a61e-3a4d32b8474f">85</ix:nonFraction>&#160;million (<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="INF" name="ifrs-full:ContractLiabilities" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE5NzkxMjA5MzQwMDMy_379a742f-d611-431f-8945-15356431fc2e">no</ix:nonFraction> amounts were recognized in profit or loss during 2021).</span></div></ix:continuation><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.6. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDg4_54118667-8498-4ade-aeb6-4356f46b88ab" continuedAt="ia679c4b47e6a425683cb752552e856a8" escape="true">Effects of climate change</ix:nonNumeric></span></div><ix:continuation id="ia679c4b47e6a425683cb752552e856a8"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Risks associated with climate change as assessed to date, and the commitments made by Sanofi on carbon neutrality and cutting greenhouse gas emissions, do not have a material impact on the financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Risks associated with trends in carbon costs, raw material shortages, supply chain disruption,&#160;etc. have been taken into account in the measurement of assets and liabilities.</span></div></ix:continuation><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.7. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzI2OTM4MDM0OTAzODcz_789aaac8-9652-4d03-96c1-0d4e7482ada2" continuedAt="i29ccb626965841529a900dda9f62dd1c" escape="true">War in Ukraine</ix:nonNumeric></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:continuation id="i29ccb626965841529a900dda9f62dd1c" continuedAt="i47407c4d0a2745a1b2d40a95f8192614">The conflict triggered by the Russian invasion of Ukraine on February&#160;24, 2022 led to the imposition of sanctions by the European Union and other countries. While complying with those sanctions inherent to its operations, Sanofi continues to carry on commercial and industrial activities in Russia under its direct control so as to meet patient needs. In 2022, Sanofi generated net sales of &#8364;<ix:nonFraction unitRef="eur" contextRef="i0f1d395438c74a0b8cfbd33931e2e3a4_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDU4_626e74ba-d88c-48ab-b24e-fc05f7f01d0b">674</ix:nonFraction>&#160;million in Russia (compared with &#8364;<ix:nonFraction unitRef="eur" contextRef="if71752f1ad474bd485d853a961833b1f_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDcy_cdcc0992-adc0-44e8-ab2a-c4bbb342f006">575</ix:nonFraction>&#160;million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="icb6c74b8a63546e290d8ab591aaaf997_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgwODE0MTA0Njk3Mjkw_ce7483e3-dbd3-4bd9-8850-ae80f39d9b9b">641</ix:nonFraction>&#160;million in 2020), representing <ix:nonFraction unitRef="number" contextRef="i0f1d395438c74a0b8cfbd33931e2e3a4_D20220101-20221231" decimals="3" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDg2_152e6378-b741-4c8e-b8e3-71a4e7607c16">1.6</ix:nonFraction>% of consolidated net sales.</ix:continuation></span></div></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:continuation id="i5bb21967fcf34a2998a09fc4acc584e1"><ix:continuation id="i47407c4d0a2745a1b2d40a95f8192614">The conflict had no material direct or indirect impact on the financial statements ended December&#160;31, 2022. Sanofi will continue to monitor the situation, and will update its estimates and assumptions accordingly</ix:continuation></ix:continuation>.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-12</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_502"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">B/ <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MDIvZnJhZzphNWExM2U0OTQ1MmY0YjYxOTljYWNjM2EwY2UzMzgwNS90ZXh0cmVnaW9uOmE1YTEzZTQ5NDUyZjRiNjE5OWNhY2MzYTBjZTMzODA1XzUx_ea46b2f7-6886-43a1-bbc5-f403aa38cf3a" continuedAt="i8807f5222ea54e73b08f7a7a5e327a36" escape="true">Summary of significant accounting policies</ix:nonNumeric></span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_505"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.1. <ix:continuation id="i8807f5222ea54e73b08f7a7a5e327a36" continuedAt="i03886142aa164438be48a4295e820f86"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MDUvZnJhZzo1ZDZhNjNmNDM2Y2U0Yjg4OTI3NzI3MDdiZjJmNWZlOS90ZXh0cmVnaW9uOjVkNmE2M2Y0MzZjZTRiODg5Mjc3MjcwN2JmMmY1ZmU5XzMzOTc_e4b4b3a8-d63a-4289-a3db-b97754ee8d20" continuedAt="i2553f839e2d04026ae788239821b59c6" escape="true">Basis of consolidation</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i03886142aa164438be48a4295e820f86" continuedAt="i9036f3a28a4045d8a998e9b871237a58"><ix:continuation id="i2553f839e2d04026ae788239821b59c6"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;10 (Consolidated Financial Statements), the consolidated financial statements of Sanofi include the financial statements of entities that Sanofi controls directly or indirectly, regardless of the level of the equity interest in those entities. An entity is controlled when Sanofi has power over the entity, exposure or rights to variable returns from its involvement with the entity, and the ability to affect those returns through its power over the entity. In determining whether control exists, potential voting rights must be taken into account if those rights are substantive, in other words they can be exercised on a timely basis when decisions about the relevant activities of the entity are to be taken.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Entities consolidated by Sanofi are referred to as &#8220;subsidiaries&#8221;. Entities that Sanofi controls by means other than voting rights are referred to as &#8220;consolidated structured entities&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;11 (Joint Arrangements), Sanofi classifies its joint arrangements (i.e. arrangements in which Sanofi exercises joint control with one or more other parties) either as a joint operation (in which case, Sanofi recognizes the assets and liabilities of the operation in proportion to its rights and obligations relating to those assets and liabilities) or as a joint venture.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi exercises joint control over a joint arrangement when decisions relating to the relevant activities of the arrangement require the unanimous consent of Sanofi and the other parties with whom control is shared.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi exercises significant influence over an entity when it has the power to participate in the financial and operating policy decisions of that entity, but does not have the power to exercise control or joint control over those policies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), the equity method is used to account for joint ventures (i.e.&#160;entities over which Sanofi exercises joint control) and for associates (i.e. entities over which Sanofi exercises significant influence).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the equity method, the investment is initially recognized at cost, and subsequently adjusted to reflect changes in the net assets of the associate or joint venture. IAS&#160;28 does not specify the treatment to be adopted on first-time application of the equity method to an investee following a step acquisition. Consequently, by reference to paragraph&#160;10 of IAS&#160;28, Sanofi has opted to apply the cost method, whereby the carrying amount of the investment represents the sum of the historical cost amounts for each step in the acquisition. As of the date on which the equity method is first applied, goodwill (which is included in the carrying amount of the investment) is determined for each acquisition step. The same applies to subsequent increases in the percentage interest in the equity-accounted investment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When the criteria of IFRS&#160;5 are met, Sanofi recognizes the equity interest within the balance sheet line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The equity method is not applied to equity interests that are classified as held-for-sale assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Transactions between consolidated companies are eliminated, as are intragroup profits.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A list of the principal companies included in the consolidation in 2022 is presented in Note&#160;F.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_508"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.2. <ix:continuation id="i9036f3a28a4045d8a998e9b871237a58" continuedAt="iedf857d72d5842ffb6e37dda25272505"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MDgvZnJhZzo4NWRhZDgwOWE5NDk0YTgyOGIzMzQ1OTBmZTM4Mzg5My90ZXh0cmVnaW9uOjg1ZGFkODA5YTk0OTRhODI4YjMzNDU5MGZlMzgzODkzXzE4NTA_0310b73a-3c8f-459f-8393-42cfc3833dfd" continuedAt="i8711e192b0e840d7928effdfd6063b82" escape="true">Foreign currency translation</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="iedf857d72d5842ffb6e37dda25272505" continuedAt="i870e681ac4cd4e92bf17d094fa5e6f22"><ix:continuation id="i8711e192b0e840d7928effdfd6063b82"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.2.1. Accounting for foreign currency transactions in the financial statements of consolidated entities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Non-current assets (other than receivables) and inventories acquired in foreign currencies are translated into the functional currency using the exchange rate prevailing at the acquisition date.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the end of the reporting period. The gains and losses resulting from foreign currency translation are recorded in the income statement. However, foreign exchange gains and losses arising from the translation of advances between consolidated subsidiaries for which settlement is neither planned nor likely to occur in the foreseeable future are recognized in equity, in the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Change in currency translation differences.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.2.2. Foreign currency translation of the financial statements of foreign entities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi presents its consolidated financial statements in euros (&#8364;). In accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates), each subsidiary accounts for its transactions in the currency that is most representative of its economic environment (the functional currency).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All assets and liabilities are translated into euros using the exchange rate of the subsidiary&#8217;s functional currency prevailing at the end of the reporting period. Income statements are translated using a weighted average exchange rate for the period, except in the case of foreign subsidiaries in a hyperinflationary economy. The resulting currency translation difference is recognized as a separate component of equity in the consolidated statement of comprehensive income, and is recognized in the income statement only when the subsidiary is sold or is wholly or partially liquidated.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-13</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_511"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.3. <ix:continuation id="i870e681ac4cd4e92bf17d094fa5e6f22" continuedAt="i1104b6f1ca3e4bd595efd07afcffd876"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTEvZnJhZzphZTJkZDk0ODI4MGY0YzFhYTM1ZDczZjA1OGMyMjQ2ZS90ZXh0cmVnaW9uOmFlMmRkOTQ4MjgwZjRjMWFhMzVkNzNmMDU4YzIyNDZlXzQ0NDc_52739c07-69c7-431c-b412-d1b9f236b1fd" continuedAt="i73223f05d7f94af5873a7e12a4238229" escape="true">Business combinations and transactions with non-controlling interests</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i1104b6f1ca3e4bd595efd07afcffd876" continuedAt="i20d1e72157374bb79eef3e7142d390df"><ix:continuation id="i73223f05d7f94af5873a7e12a4238229"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.3.1. Accounting for business combinations, transactions with non-controlling interests and loss of control</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Business combinations are accounted for in accordance with IFRS&#160;3 (Business Combinations) and IFRS&#160;10 (Consolidated Financial Statements).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Business combinations are accounted for using the acquisition method. Under this method, the acquiree&#8217;s identifiable assets and liabilities that satisfy the recognition criteria of IFRS&#160;3 (Business Combinations) are measured initially at their fair values at the date of acquisition, except for (i)&#160;non-current assets classified as held for sale (which are measured at fair value less costs to sell) and (ii)&#160;assets and liabilities that fall within the scope of IAS&#160;12 (Income Taxes) and IAS&#160;19 (Employee Benefits). Restructuring liabilities are recognized as a liability of the acquiree only if the acquiree has an obligation as of the acquisition date to carry out the restructuring.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal accounting rules applicable to business combinations and transactions with non-controlling interests include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">acquisition-related costs are recognized as an expense, as a component of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">contingent consideration is recognized in equity if the contingent payment is settled by delivery of a fixed number of the acquirer&#8217;s equity instruments; otherwise, it is recognized in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Contingent consideration is recognized at fair value at the acquisition date irrespective of the probability of payment. If the contingent consideration was originally recognized as a financial liability, subsequent adjustments to the liability are recognized in profit or loss in the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, unless the adjustment is made within the twelve months following the acquisition date and relates to facts and circumstances existing as of that date;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">goodwill may be calculated on the basis of either (i)&#160;the entire fair value of the acquiree, or (ii)&#160;a share of the fair value of the acquiree proportionate to the interest acquired. This option is elected for each acquisition individually.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Purchase price allocations are performed under the responsibility of management, with assistance from an independent valuer in the case of major acquisitions. IFRS&#160;3 does not specify an accounting treatment for contingent consideration arising from a business combination made by an entity prior to the acquisition of control in that entity and carried as a liability in the acquired entity&#8217;s balance sheet. The accounting treatment applied by Sanofi to such a liability is to measure it at fair value as of the acquisition date and to report it in the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations and to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, with subsequent remeasurements recognized in profit or loss. This treatment is consistent with the accounting applied to contingent consideration in the books of the&#160;acquirer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, management may where it deems fit elect to apply the optional test to identify concentration of fair value permitted under IFRS&#160;3 in order to determine whether a transaction is a business combination within the meaning of IFRS&#160;3, or merely the acquisition of an asset or of a group of similar assets.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.3.2. Goodwill</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The excess of the cost of an acquisition over Sanofi&#8217;s interest in the fair value of the identifiable assets and liabilities of the acquiree is recognized as goodwill at the date of the business combination.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill arising on the acquisition of subsidiaries is shown in a separate balance sheet line item, whereas goodwill arising on the acquisition of investments accounted for using the equity method is recorded in</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Investments accounted for using the equity method.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill arising on foreign operations is expressed in the functional currency of the country concerned and translated into euros using the exchange rate prevailing at the end of the reporting period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;36 (Impairment of Assets), goodwill is carried at cost less accumulated impairment (see Note&#160;B.6.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually and whenever events or circumstances indicate that impairment might exist. Such events or circumstances include significant changes more likely than not to have an other-than-temporary impact on the substance of the original investment.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_514"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.4. <ix:continuation id="i20d1e72157374bb79eef3e7142d390df" continuedAt="i4522925dab21428c8377d07ab8ccb2cb"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTQvZnJhZzozZjc4YjJjMzg5MjM0NWI3OWUwMWQxNGFjYzI2ODQxNS90ZXh0cmVnaW9uOjNmNzhiMmMzODkyMzQ1Yjc5ZTAxZDE0YWNjMjY4NDE1XzYzMzU_ad532899-428c-4d23-9903-edc1b5cc718c" continuedAt="i85720a6e737b4137a6a8e18d38ce32d9" escape="true">Other intangible assets</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i4522925dab21428c8377d07ab8ccb2cb" continuedAt="i61dd771f8f2d48138250c9ba888ceac7"><ix:continuation id="i85720a6e737b4137a6a8e18d38ce32d9" continuedAt="ie4e6228c70874ed1a46a22d8c9e4d45a"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other intangible assets are initially measured at acquisition cost or production cost, including any directly attributable costs of preparing the asset for its intended use, or (in the case of assets acquired in a business combination) at fair value as of the date of the business combination. Intangible assets are amortized on a straight line basis over their useful&#160;lives.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The useful lives of other intangible assets are reviewed at the end of each reporting period. The effect of any adjustment to useful lives is recognized prospectively as a change in accounting estimate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amortization of other intangible assets is recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Amortization of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> except for amortization charged against (i)&#160;acquired or internally-developed software and (ii)&#160;other rights of an industrial or operational nature, which is recognized in the relevant classification of expense by function.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-14</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i61dd771f8f2d48138250c9ba888ceac7" continuedAt="i211a4da9418b42af9094b8499bc87085"><ix:continuation id="ie4e6228c70874ed1a46a22d8c9e4d45a"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi does not own any intangible assets with an indefinite useful life, other than goodwill.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Intangible assets (other than goodwill) are carried at cost less accumulated amortization and accumulated impairment, if any, in accordance with IAS&#160;36 (see Note&#160;B.6.).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.4.1. Research and development not acquired in a business combination</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internally generated research and development</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under IAS&#160;38, research expenses are recognized in profit or loss when incurred.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Internally generated development expenses are recognized as an intangible asset if, and only if, all the following six criteria can be demonstrated: (a)&#160;the technical feasibility of completing the development project; (b)&#160;Sanofi&#8217;s intention to complete the project; (c)&#160;Sanofi&#8217;s ability to use the project; (d)&#160;the probability that the project will generate future economic benefits; (e)&#160;the availability of adequate technical, financial and other resources to complete the project; and (f)&#160;the ability to measure the development expenditure reliably.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Due to the risks and uncertainties relating to regulatory approval and to the research and development process, the six criteria for capitalization are usually considered not to have been met until the product has obtained marketing approval from the regulatory authorities. Consequently, internally generated development expenses arising before marketing approval has been obtained, mainly the cost of clinical trials, are generally expensed as incurred within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Some industrial development expenses (such as those incurred in developing a second-generation synthesis process) are incurred after marketing approval has been obtained, in order to improve the industrial process for an active ingredient. To the extent that the six IAS&#160;38 criteria are considered as having been met, such expenses are recognized as an asset in the balance sheet within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> as incurred. Similarly, some clinical trials, for example those undertaken to obtain a geographical extension for a molecule that has already obtained marketing approval in a major market, may in certain circumstances meet the six capitalization criteria under IAS&#160;38, in which case the related expenses are recognized as an asset in the balance sheet within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Separately acquired research and development</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Payments for separately acquired research and development are capitalized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> provided that they meet the definition of an intangible asset: a resource that is (i)&#160;controlled by Sanofi, (ii)&#160;expected to provide future economic benefits for Sanofi, and (iii)&#160;identifiable (i.e.&#160;it is either separable or arises from contractual or legal rights). Under paragraph&#160;25 of&#160;IAS&#160;38, the first condition for capitalization (the probability that the expected future economic benefits from the asset will flow to the entity) is considered to be satisfied for separately acquired research and development. Consequently, upfront and milestone payments to third parties related to pharmaceutical products for which marketing approval has not yet been obtained are recognized as intangible assets, and amortized on a straight line basis over their useful lives beginning when marketing approval is&#160;obtained.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Payments under research and development arrangements relating to access to technology or to databases, and payments made to purchase generics dossiers, are also capitalized, and amortized over the useful life of the intangible asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subcontracting arrangements, payments for research and development services, and continuous payments under research and development collaborations which are unrelated to the outcome of that collaboration, are expensed over the service term.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.4.2. Other intangible assets not acquired in a business combination</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Licenses other than those related to pharmaceutical products and research projects, in particular software licenses, are capitalized at acquisition cost, including any directly attributable cost of preparing the software for its intended use. Software licenses are amortized on a straight line basis over their useful lives for Sanofi (<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTQvZnJhZzozZjc4YjJjMzg5MjM0NWI3OWUwMWQxNGFjYzI2ODQxNS90ZXh0cmVnaW9uOjNmNzhiMmMzODkyMzQ1Yjc5ZTAxZDE0YWNjMjY4NDE1XzUxMDY_a0f11f8d-0f58-4332-81c5-b171f9da546e">three</span> to <ix:nonNumeric contextRef="i05ab760cbec74ca2a64af3ee573e8c46_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTQvZnJhZzozZjc4YjJjMzg5MjM0NWI3OWUwMWQxNGFjYzI2ODQxNS90ZXh0cmVnaW9uOjNmNzhiMmMzODkyMzQ1Yjc5ZTAxZDE0YWNjMjY4NDE1XzUxMTI_80411f39-331c-4740-bf0e-933e397e4a8c">five years</ix:nonNumeric>).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Internally generated costs incurred to develop or upgrade software are capitalized if the IAS&#160;38 recognition criteria are satisfied, and amortized on a straight line basis over the useful life of the software from the date on which the software is ready for use.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.4.3. Other intangible assets acquired in a business combination</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other intangible assets acquired in a business combination (in-process research and development, technology platforms, and currently marketed products) that are reliably measurable are identified separately from goodwill, measured at fair value, and capitalized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IFRS&#160;3 (Business Combinations) and IAS&#160;38 (Intangible Assets). The related deferred tax liability is also recognized if a deductible or taxable temporary difference exists.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In-process research and development acquired in a business combination is amortized on a straight line basis over its useful life from the date of receipt of marketing approval.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Rights to technology platforms and to products currently marketed by Sanofi are amortized on a straight line basis over their useful lives, determined (in particular for marketed products) on the basis of cash flow forecasts which take into account the patent protection period of the marketed product.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-15</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_517"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.5. <ix:continuation id="i211a4da9418b42af9094b8499bc87085" continuedAt="i5853e16265244c21af566a6b81efb3a3"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90ZXh0cmVnaW9uOjFiN2IxYjM0N2M2YjQ5OGI4ZGI0NDQ2MTBjOWUzODk4XzM5OTY_2dac0a13-6212-4d6c-90d2-b1602e0a290a" continuedAt="ia9945266b14b44fdb394990a6491a0fa" escape="true">Property, plant and equipment owned and leased</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i5853e16265244c21af566a6b81efb3a3" continuedAt="i4da299cb4e5f47948cc8c560eaf802ce"><ix:continuation id="ia9945266b14b44fdb394990a6491a0fa"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.5.1. Property, plant and equipment owned</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Property, plant and equipment is initially measured and recognized at acquisition cost, including any directly attributable cost of preparing the asset for its intended use, or (in&#160;the case of assets acquired in a business combination) at fair value as of the date of the business combination. The component-based approach to accounting for property, plant and equipment is applied. Under this approach, each component of an item of property, plant and equipment with a cost which is significant in relation to the total cost of the item and which has a different useful life from the other components must be depreciated separately.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">After initial measurement, property, plant and equipment is carried at cost less accumulated depreciation and impairment, except for land which is carried at cost less impairment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subsequent costs are not recognized as assets unless (i)&#160;it is probable that future economic benefits associated with those costs will flow to Sanofi and (ii)&#160;the costs can be measured reliably.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Borrowing costs attributable to the financing of items of property, plant and equipment, and incurred during the construction period, are capitalized as part of the acquisition cost of the&#160;item.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Government grants relating to property, plant and equipment are deducted from the acquisition cost of the asset to which they&#160;relate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The depreciable amount of items of property, plant and equipment, net of any residual value, is depreciated on a straight line basis over the useful life of the asset. The useful life of an asset is usually equivalent to its economic life.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90ZXh0cmVnaW9uOjFiN2IxYjM0N2M2YjQ5OGI4ZGI0NDQ2MTBjOWUzODk4XzM5OTM_28318561-848b-4c49-b93c-e6997b273b9b" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The customary useful lives of property, plant and equipment are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:49.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if28c01d5f14941678f17df4612ae4e2e_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzAtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246OTNkMjllOGUwNjA2NDhkOGE5YjRiZDk1NWU1NTU5YmRfNA_72eab562-ccfe-48e3-bbe9-8a8928b5d689">15</ix:nonNumeric>&#160;to&#160;<ix:nonNumeric contextRef="i394e8a86c251479586bc1a0eb8f50130_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzAtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246OTNkMjllOGUwNjA2NDhkOGE5YjRiZDk1NWU1NTU5YmRfMTA_485e371f-21fd-4916-988e-90403189cc49">40</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixtures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i409bda424dac45a59c28668ef940f123_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzEtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDU4NDFiNzg2MDhkNDg1NGEwZDYzZGM3MWY3OTM2YWNfNA_d1053e80-0221-4dfb-ba5c-d7bb83ea3a8a">10</ix:nonNumeric> to <ix:nonNumeric contextRef="ibc5cb17ac157419a907518a7604ebc0d_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzEtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDU4NDFiNzg2MDhkNDg1NGEwZDYzZGM3MWY3OTM2YWNfMTA_b7928de2-72a8-44a8-bda0-ae9b7ef9ca65">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i605cb1d6e0f14943b4f0ef24b77e12f7_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzItMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ODE3NjZjMzZhYTExNDAxNmIxYWZkZmI5N2I3Mzg0ZDdfNA_38110661-a5b0-4855-a107-d491907f5095">5</ix:nonNumeric> to <ix:nonNumeric contextRef="iaf712b8801ed48b59b68a97d6c1d8c34_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzItMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ODE3NjZjMzZhYTExNDAxNmIxYWZkZmI5N2I3Mzg0ZDdfMTA_44c5a949-d148-4482-8160-0a0ea9d4d268">15</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ica7d78006d9b4c9e8f46c61a015c748a_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzMtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246MTQ3MzU4YmIwNGI5NGI3ZTgzMWIxYTNmMmRhZGY2ZDhfNA_ad869bc8-0602-4cd6-8ac4-a93c513d0c10">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i8675329b37394bd5b4b2fd333c7a391a_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzMtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246MTQ3MzU4YmIwNGI5NGI3ZTgzMWIxYTNmMmRhZGY2ZDhfMTA_64382695-1762-4725-8054-c32d90f1158a">15</ix:nonNumeric> years</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Useful lives and residual values of property, plant and equipment are reviewed annually. The effect of any adjustment to useful lives or residual values is recognized prospectively as a change in accounting estimate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Depreciation of property, plant and equipment is recognized as an expense in the income statement, in the relevant classification of expense by function.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.5.2. Property, plant and equipment leased</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective from January&#160;1, 2019 leases contracted by Sanofi have been accounted for in accordance with IFRS&#160;16 (Leases). Sanofi recognizes a right-of-use asset and a lease liability for all of its lease contracts, except for (i)&#160;leases relating to low-value assets and&#160;(ii)&#160;short-term leases (12&#160;months or less). Payments made in respect of leases not recognized on the balance sheet are recognized as an operating expense on a straight line basis over the lease term.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On commencement of a lease, the liability for future lease payments is discounted at the incremental borrowing rate, which is a risk-free rate adjusted to reflect the specific risk profile of each Sanofi entity. Because lease payments are spread over the lease term, Sanofi applies a discount rate based on the duration of those payments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The payments used to determine the liability for future lease payments exclude non-lease components, but include fixed payments that Sanofi expects to make to the lessor over the estimated lease term.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">After commencement of the lease, the liability for future lease payments is reduced by the amount of the lease payments made, and increased to reflect interest on the liability. In the event of a reassessment or modification of future lease payments, the lease liability is remeasured. The right-of-use asset &#8211;&#160;which is initially measured at cost including direct costs of the lessee, prepayments made at or prior to the commencement date, less lease incentives received and restoration costs&#160;&#8211; is depreciated on a straight line basis over the lease term, and tested for impairment as required.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi recognizes deferred taxes in respect of right-of-use assets and lease liabilities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over their economic life, which is capped at the lease term as determined under&#160;IFRS&#160;16.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_520"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.6. <ix:continuation id="i4da299cb4e5f47948cc8c560eaf802ce" continuedAt="ic3e29870232044bd85b0421a3e2e02cf"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MjAvZnJhZzoyY2M5ZDkyOTEzYmI0MzZkYmI2NTQxMjFjNzg5MzQ1ZS90ZXh0cmVnaW9uOjJjYzlkOTI5MTNiYjQzNmRiYjY1NDEyMWM3ODkzNDVlXzUzMzk_60c2ac33-aa41-4bf3-8e6d-f2c25a826194" continuedAt="i73d3a6e5879c4c06b8a05f8075a376b1" escape="true">Impairment of property, plant and equipment, intangible assets, and&#160;investments accounted for using the equity method</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="ic3e29870232044bd85b0421a3e2e02cf" continuedAt="i0b0f320a55f04b3185c4939d6d9f68a5"><ix:continuation id="i73d3a6e5879c4c06b8a05f8075a376b1" continuedAt="i1bbe8a9359ac4f9293033685729ca68d"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.6.1. Impairment of property, plant and equipment and intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;36 (Impairment of Assets), assets that generate separate cash flows and assets included in cash-generating units&#160;(CGUs) are assessed for impairment when events or changes in circumstances indicate that the asset or CGU may be impaired. A&#160;CGU is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-16</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i0b0f320a55f04b3185c4939d6d9f68a5" continuedAt="i828ebd13d19044cc9a8498a5125c1fd1"><ix:continuation id="i1bbe8a9359ac4f9293033685729ca68d"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under IAS&#160;36, each CGU or group of CGUs to which goodwill is allocated must (i)&#160;represent the lowest level within the entity at which the goodwill is monitored for internal management purposes, and (ii)&#160;not be larger than an operating segment determined in accordance with IFRS&#160;8 (Operating Segments), before application of the IFRS&#160;8 aggregation criteria (see Note&#160;B.26.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Quantitative and qualitative indications of impairment (primarily relating to the status of the research and development portfolio, pharmacovigilance, patent litigation, and the launch of competing products) are reviewed at the end of each reporting period. If there is any internal or external indication of impairment, Sanofi estimates the recoverable amount of the asset or CGU.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other intangible assets not yet available for use (such as capitalized in-process research and development), and CGUs or groups of CGUs that include goodwill, are tested for impairment annually whether or not there is any indication of impairment, and more frequently if any event or circumstance indicates that they might be impaired. Such assets are not amortized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When there is an internal or external indication of impairment, Sanofi estimates the recoverable amount of the asset and recognizes an impairment loss if the carrying amount of the asset exceeds its recoverable amount. The recoverable amount of the asset is the higher of its fair value less costs to sell or its value in use. To determine value in use, Sanofi uses estimates of future cash flows generated by the asset or CGU, prepared using the same methods as those used in the initial measurement of the asset or CGU on the basis of medium-term strategic plans.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of goodwill, estimates of future cash flows are based on a six-year strategic plan and a terminal value. In the case of other intrangible assets, the period used is based on the economic life of the asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Estimated cash flows are discounted at long-term market interest rates that reflect the best estimate by Sanofi of the time value of money, the risks specific to the asset or CGU, and economic conditions in the geographical regions in which the business activity associated with the asset or CGU is located.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Certain assets and liabilities that are not directly attributable to a specific CGU are allocated between CGUs on a basis that is reasonable, and consistent with the allocation of the corresponding goodwill.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Impairment losses arising on property, plant and equipment, on software and on certain rights are recognized in the relevant classification of expense by function.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Impairment losses arising on other intangible assets are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Impairment of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.6.2. Impairment of investments accounted for using the equity method</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), Sanofi determines whether investments accounted for using the equity method may be impaired based on indicators such as default in contractual payments, significant financial difficulties, probability of bankruptcy, or a prolonged or significant decline in quoted market price. If an investment is impaired, the amount of the impairment loss is determined by applying IAS&#160;36 (see Note&#160;B.6.1.) and recognized in </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.6.3. Reversals of impairment losses charged against property, plant and equipment, intangible assets, and investments accounted for using the equity method</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At the end of each reporting period, Sanofi assesses whether events or changes in circumstances indicate that an impairment loss recognized in a prior period in respect of an asset (other than goodwill) or an investment accounted for using the equity method can be reversed. If this is the case, and the recoverable amount as determined based on the revised estimates exceeds the carrying amount of the asset, Sanofi reverses the impairment loss only to the extent of the carrying amount that would have been determined had no impairment loss been recognized for the asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Reversals of impairment losses in respect of other intangible assets are recognized within the income statement line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Impairment of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, while reversals of impairment losses in respect of investments accounted for using the equity method are recognized within the income statement line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Impairment losses taken against goodwill are never reversed, unless the goodwill is part of the carrying amount of an investment accounted for using the equity method.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_523"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.7. <ix:continuation id="i828ebd13d19044cc9a8498a5125c1fd1" continuedAt="i3348acb357a34f34965e6e4e3c8edd04"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MjMvZnJhZzo0ZGM1OTNkZjlhOTI0NDk1OWU4YWYzYjRjYWVkODlkYy90ZXh0cmVnaW9uOjRkYzU5M2RmOWE5MjQ0OTU5ZThhZjNiNGNhZWQ4OWRjXzUwNTM_36422c2a-3f52-46e1-8a1f-7d38910ebf0d" continuedAt="ie3c9c9c00c02431288c2f6c8b6f712d7" escape="true">Assets held for sale or exchange and liabilities related to assets held for sale or exchange</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i3348acb357a34f34965e6e4e3c8edd04" continuedAt="i9b2cf91feca24182a947f1dcbb54f412"><ix:continuation id="ie3c9c9c00c02431288c2f6c8b6f712d7" continuedAt="i717370687dd147d38dfc2cbc5a17aa67"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;5 (Non-Current Assets Held for Sale and Discontinued Operations), non-current assets and groups of assets are classified as held for sale in the balance sheet if their carrying amount will be recovered principally through a sale transaction rather than through continuing use. Within the meaning of IFRS&#160;5, the term &#8220;sale&#8221; also includes exchanges for other assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Non-current assets or asset groups held for sale must be available for immediate sale in their present condition, subject only to terms that are usual and customary for sales of such assets, and a sale must be highly probable. Criteria used to determine whether a sale is highly probable include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the appropriate level of management must be committed to a plan to sell;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">an active program to locate a buyer and complete the plan must have been initiated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the asset must be actively marketed for sale at a price that is reasonable in relation to its current fair value;</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-17</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i9b2cf91feca24182a947f1dcbb54f412" continuedAt="ifbd71108bd8c419388cab65214ddf896"><ix:continuation id="i717370687dd147d38dfc2cbc5a17aa67"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">completion of the sale should be foreseeable within the twelve months following the date of reclassification to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">actions required to complete the plan should indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Before initial reclassification of the non-current asset (or asset group) to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the carrying amounts of the asset (or of all the assets and liabilities in the asset group) must be measured in accordance with the applicable standards.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subsequent to reclassification to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the non-current asset (or asset group) is measured at the lower of carrying amount or fair value less costs to sell, with any write-down recognized by means of an impairment loss. Once a non-current asset has been reclassified as held for sale or exchange, it is no longer depreciated or amortized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In a disposal of an equity interest leading to loss of control, all the assets and liabilities of the entity involved are classified as held-for-sale assets or liabilities within the balance sheet line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange or Liabilities related to assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, provided that the disposal satisfies the IFRS&#160;5 classification criteria.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The profit or loss generated by a held-for-sale asset group is reported in a separate line item in the income statement for the current period and for the comparative periods presented, provided that the asset group:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">represents a separate major line of business or geographical area of operations; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">is a subsidiary acquired exclusively with a view to resale.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;10, transactions between companies that are held for sale or treated as discontinued operations and other consolidated companies are eliminated.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Events or circumstances beyond Sanofi&#8217;s control may extend the period to complete the sale or exchange beyond one year without precluding classification of the asset (or disposal group) in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> provided that there is sufficient evidence that Sanofi remains committed to the planned sale or exchange. Finally, in the event of changes to a plan of sale that requires an asset no longer to be classified as held for sale, IFRS&#160;5 specifies the following treatment:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the assets and liabilities previously classified as held for sale are reclassified to the appropriate balance sheet line items, with no restatement of comparative periods;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">each asset is measured at the lower of (a)&#160;its carrying amount before the asset was reclassified as held for sale, adjusted for any depreciation, amortization or revaluation that would have been recognized if the asset had not been reclassified as held for sale, or&#160;(b)&#160;its recoverable amount at the date of reclassification;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the backlog of depreciation, amortization and impairment not recognized while non-current assets were classified as held for sale must be reported in the same income statement line item that was used to report impairment losses arising on initial reclassification of assets as held for sale and gains or losses arising on the sale of such assets. In the consolidated income statement, those impacts are reported within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the net income of a business previously classified as discontinued or as held for sale or exchange and reported on a separate line in the income statement must be reclassified and included in net income from continuing operations, for all periods presented;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in addition, segment information relating to the income statement and the statement of cash flows (acquisitions of non-current assets) must be disclosed in the notes to the financial statements in accordance with IFRS&#160;8 (Operating Segments), and must also be restated for all prior periods presented.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_526"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.8. <ix:continuation id="ifbd71108bd8c419388cab65214ddf896" continuedAt="i840faeee38cc475a971fc335a60e47db"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MjYvZnJhZzozMzA5OTAxM2I1Y2U0ZGJlOWNkNmI3YmJlZDlkYmEyNi90ZXh0cmVnaW9uOjMzMDk5MDEzYjVjZTRkYmU5Y2Q2YjdiYmVkOWRiYTI2XzE2MTIw_955b83ed-715d-4f47-8962-217ec934fb46" continuedAt="i84f3d7c6e53b454d87c72d2b90b10636" escape="true">Financial instruments</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i840faeee38cc475a971fc335a60e47db" continuedAt="ic85f8a4c92b6439a87c1c95f8c71f991"><ix:continuation id="i84f3d7c6e53b454d87c72d2b90b10636" continuedAt="id7de7a424981444cb3d2b3a8beafeb4b"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.1. Non-derivative financial assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;9 (Financial Instruments) and IAS&#160;32 (Financial Instruments: Presentation), Sanofi has adopted the classification of non-derivative financial assets described below. The classification used depends on (i)&#160;the characteristics of the contractual cash flows (i.e.&#160;whether they represent interest or principal) and (ii)&#160;the business model for managing the asset applied at the time of initial recognition.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial assets at fair value through other comprehensive income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These mainly comprise:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">quoted and unquoted equity investments that Sanofi does not hold for trading purposes and that management has designated at &#8220;fair value through other comprehensive income&#8221; on initial recognition. Gains and losses arising from changes in fair value are recognized in equity within the statement of comprehensive income in the period in which they occur. When such instruments are derecognized, the previously-recognized changes in fair value remain within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, as does the gain or loss on divestment. Dividends received are recognized in profit or loss for the period, within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">debt instruments whose contractual cash flows represent payments of interest or repayments of principal, and which are managed with a view to collecting cash flows and selling the asset. Gains and losses arising from changes in fair value are recognized in equity within the statement of comprehensive income in the period in which they occur. When such assets are derecognized, the cumulative gains and losses previously recognized in equity are reclassified to profit or loss for the period within the line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-18</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ic85f8a4c92b6439a87c1c95f8c71f991" continuedAt="i8364c089ae794fec8e3597b28397f919"><ix:continuation id="id7de7a424981444cb3d2b3a8beafeb4b" continuedAt="i50e0df68e17d455682fd8aa9f17d7121"><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial assets at fair value through profit or loss</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These mainly comprise:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">contingent consideration already carried in the books of an acquired entity or granted in connection with a business combination;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">instruments whose contractual cash flows represent payments of interest and repayments of principal, which are managed with a view to selling the asset;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">instruments that management has designated at &#8220;fair value through profit or loss&#8221; on initial recognition; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">quoted and unquoted equity investments: equity instruments that are not held for trading and which management did not designate at &#8220;fair value through other comprehensive income&#8221; on initial recognition, and instruments that do not meet the IFRS definition of &#8220;equity instruments&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Gains and losses arising from changes in fair value are recognized in profit or loss within the line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Dividends received are recognized in profit or loss for the period, within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value of equity investments in unquoted entities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On initial recognition of an equity investment in an entity not quoted in an active market, the fair value of the investment is the acquisition cost. Cost ceases to be a representative measure of the fair value of an unquoted equity investment when Sanofi identifies significant changes in the investee, or in the environment in which it operates. In such cases, an internal valuation is carried out, based mainly on growth forecasts or by reference to similar transactions contracted with third parties.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial assets measured at amortized cost</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Financial assets at amortized cost comprise instruments whose contractual cash flows represent payments of interest and repayments of principal and which are managed with a view to collecting cash flows. The main assets in this category are loans and receivables. They are presented within the line items</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Accounts receivable </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Cash and cash equivalents</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Loans with a maturity of more than 12&#160;months are presented in &#8220;Long-term loans and advances&#8221; within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. These financial assets are measured at amortized cost using the effective interest method.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of financial assets measured at amortized cost</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main assets involved are accounts receivable. Accounts receivable are initially recognized at the amount invoiced to the customer. Impairment losses on trade accounts receivable are estimated using the expected loss method, in order to take account of the risk of payment default throughout the lifetime of the receivables. The expected credit loss is estimated collectively for all accounts receivable at each reporting date using an average expected loss rate, determined primarily on the basis of historical credit loss rates. However, that average expected loss rate may be adjusted if there are indications of a likely significant increase in credit risk. If a receivable is subject to a known credit risk, a specific impairment loss is recognized for that receivable. The amount of expected losses is recognized in the balance sheet as a reduction in the gross amount of accounts receivable. Impairment losses on accounts receivable are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Selling and general expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.2. Derivative instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Derivative instruments that do not qualify for hedge accounting are initially and subsequently measured at fair value, with changes in fair value recognized in the income statement in</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, depending on the nature of the underlying economic item which is hedged.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Derivative instruments that qualify for hedge accounting are measured using the policies described in Note&#160;B.8.3. below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">IFRS&#160;13 (Fair Value Measurement) requires counterparty credit risk to be taken into account when measuring the fair value of financial instruments. That risk is estimated on the basis of observable, publicly-available statistical data.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policy on offsetting</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order for a financial asset and a financial liability to be presented as a net amount in the balance sheet under IAS&#160;32, there must be:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a) a legally enforceable right to offset; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(b) the intention either to settle on a net basis, or to realize the asset and settle the liability simultaneously.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-19</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i8364c089ae794fec8e3597b28397f919" continuedAt="i74e6c2141f0c43228519185e2c0ed98f"><ix:continuation id="i50e0df68e17d455682fd8aa9f17d7121" continuedAt="i5889737fcbd54dbf8be35dc63ae5a76b"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.3. Hedging</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As part of its overall market risk management policy, Sanofi enters into various hedging transactions involving derivative or non-derivative instruments; these may include forward contracts, currency swaps or options, interest rate swaps or options, cross-currency swaps, and debt placings or issues.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Such financial instruments are designated as hedging instruments and recognized using the hedge accounting principles of&#160;IFRS&#160;9 when (a)&#160;there is formal designation and documentation of the hedging relationship, of how the effectiveness of the hedging relationship will be assessed, and of the underlying market risk management objective and strategy; (b)&#160;the hedged item and the hedging instrument are eligible for hedge accounting; and (c)&#160;there is an economic relationship between the hedged item and the hedging instrument, defined on the basis of a hedge ratio that is consistent with the underlying market risk management strategy, and the residual credit risk does not dominate the value changes that result from that economic relationship.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value hedge</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A fair value hedge is a hedge of the exposure to changes in fair value of an asset, liability or firm commitment that is attributable to one or more risk components and could affect profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in fair value of the hedging instrument and changes in fair value of the hedged item attributable to the hedged risk components are generally recognized in the income statement, within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to operating activities, or within</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to investing or financing activities.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flow hedge</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A cash flow hedge is a hedge of the exposure to variability in cash flows from an asset, liability or highly probable forecast transaction that is attributable to one or more risk components and could affect profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in fair value of the hedging instrument attributable to the effective portion of the hedge are recognized directly in equity in the consolidated statement of comprehensive income. Changes in fair value attributable to the ineffective portion of the hedge are recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">for hedges related to operating activities, and within</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to investing or financing activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Cumulative changes in fair value of the hedging instrument previously recognized in equity are reclassified to the income statement when the hedged transaction affects profit or loss. Those reclassified gains and losses are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to operating activities, and within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to investing or financing activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When a forecast transaction results in the recognition of a non-financial asset or liability, cumulative changes in the fair value of the hedging instrument previously recognized in equity are incorporated in the initial carrying amount of that asset or liability.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When the hedging instrument expires or is sold, terminated or exercised, the cumulative gain or loss previously recognized in equity remains separately recognized in equity and is not reclassified to the income statement, or recognized as an adjustment to the initial cost of the related non-financial asset or liability, until the forecast transaction occurs. However, if Sanofi no longer expects the forecast transaction to occur, the cumulative gain or loss previously recognized in equity is recognized immediately in profit or loss.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hedge of a net investment in a foreign operation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In a hedge of a net investment in a foreign operation, changes in the fair value of the hedging instrument attributable to the effective portion of the hedge are recognized directly in equity in the consolidated statement of comprehensive income. Changes in fair value attributable to the ineffective portion of the hedge are recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. When the investment in the foreign operation is sold, the changes in the fair value of the hedging instrument previously recognized in equity are reclassified to the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of hedging</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As part of its market risk management policy, Sanofi may designate currency options or interest rate options as hedging instruments, the effectiveness of which is measured on the basis of changes in intrinsic value. In such cases, the time value of the option is treated as a hedging cost and accounted for as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if the option includes a component that is not aligned on the critical features of the hedged item, the corresponding change in the time value is taken to profit or loss;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">otherwise, the change in the time value is taken to equity within the statement of comprehensive income, and then:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if the hedged item is linked to a transaction that results in the recognition of a financial asset or liability, the change in the time value is reclassified to profit or loss symmetrically with the hedged item, or</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if the hedged item is linked to a transaction that results in the recognition of a non-financial asset or liability, the change in the time value is incorporated in the initial carrying amount of that asset or liability, or</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if the hedged item is linked to a period of time, the change in time value is reclassified to profit or loss on a straight line basis over the life of the hedging relationship.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i74e6c2141f0c43228519185e2c0ed98f" continuedAt="i96ff8653eb5647f7a8dab2e96e266bd7"><ix:continuation id="i5889737fcbd54dbf8be35dc63ae5a76b" continuedAt="i0954357d594f4cda975fbbda5183554b"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of forward contracts and foreign exchange swaps, and of cross-currency swaps that qualify for hedge accounting on the basis of changes in spot rates, Sanofi may elect for each transaction to use the option whereby the premium/discount or foreign currency basis spread are treated in the same way as the time value of an option.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinuation of hedge accounting</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Hedge accounting is discontinued when the eligibility criteria are no longer met (in particular, when the hedging instrument expires or is sold, terminated or exercised), or if there is a change in the market risk management objective of the hedging relationship.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.4. Non-derivative financial liabilities</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Borrowings and debt</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bank borrowings and debt instruments are initially measured at fair value of the consideration received, net of directly attributable transaction costs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subsequently, they are measured at amortized cost using the effective interest method. All costs related to the issuance of borrowings or debt instruments, and all differences between the issue proceeds net of transaction costs and the value on redemption, are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement over the term of the debt using the effective interest method.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities related to business combinations and to non-controlling interests</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These line items record the fair value of (i)&#160;contingent consideration payable in connection with business combinations and (ii)&#160;commitments to buy out equity holders of subsidiaries, including put options granted to non-controlling interests.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Adjustments to the fair value of commitments to buy out equity holders of subsidiaries, including put options granted to non-controlling interests, are recognized in equity.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other non-derivative financial liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other non-derivative financial liabilities include trade accounts payable, which are measured at fair value (which in most cases equates to face value) on initial recognition, and subsequently at amortized cost.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.5. Fair value of financial instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under IFRS&#160;13 (Fair Value Measurement) and IFRS&#160;7 (Financial Instruments: Disclosures), fair value measurements must be classified using a hierarchy based on the inputs used to measure the fair value of the instrument. This hierarchy has three levels:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.86pt">level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.25pt">level&#160;2: quoted prices in active markets for similar assets and liabilities, or valuation techniques in which all important inputs are derived from observable market data; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.78pt">level&#160;3: valuation techniques in which not all important inputs are derived from observable market data.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-21</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i96ff8653eb5647f7a8dab2e96e266bd7" continuedAt="ia48bc519d1134aa18e7f65f8daa58882"><ix:continuation id="i0954357d594f4cda975fbbda5183554b" continuedAt="ia80c06e4601743ca93cc075c9a064264"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MjYvZnJhZzozMzA5OTAxM2I1Y2U0ZGJlOWNkNmI3YmJlZDlkYmEyNi90ZXh0cmVnaW9uOjMzMDk5MDEzYjVjZTRkYmU5Y2Q2YjdiYmVkOWRiYTI2XzE2MTIx_72509bb0-a33a-4882-9fa8-91dd87e27ecb" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the disclosures required under IFRS&#160;7 relating to the measurement principles applied to financial instruments.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:5.178%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.362%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Type&#160;of financial&#160;instrument</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Measurement<br/>principle</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in<br/>fair&#160;value<br/>hierarchy</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Valuation<br/>technique</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Method used to determine fair value</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Valuation<br/>model</span></td><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market data</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exchange rate</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (quoted equity instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market&#160;price</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (quoted debt instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (unquoted equity instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cost/Approach based on comparables</span></div></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">If cost ceases to be a representative measure of fair value, an internal valuation is carried out, based mainly on comparables.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (contingent consideration receivable)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;D.7.3.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value held to meet obligations under post-employment benefit plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets designated at fair value held to meet obligations under deferred compensation plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Long-term loans and advances and other non-current receivables</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The amortized cost of long-term loans and advances and other non-current receivables at the end of the reporting period is not materially different from their fair value.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.13.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Investments in mutual funds</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Net asset value</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.13.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Negotiable debt instruments, commercial paper, instant access deposits and term deposits</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Because these instruments have a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.1.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">In the case of debt with a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.<br/>For debt with a maturity of more than 3&#160;months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.2.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The liability for future lease payments is discounted using the incremental borrowing rate.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160; year:</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid Money Market</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&gt;&#160;1&#160;year:&#160;</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid Zero Coupon</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market<br/>Spot</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160;year:</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid&#160;Money&#160;Market  and LIFFE interest rate futures</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&gt;&#160;1&#160;year: </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid&#160;Zero Coupon</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present&#160;value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market<br/>Spot</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160; year:<br/>Mid&#160;Money Market and LIFFE interest rate futures<br/>&gt;&#160;1&#160;year: <br/>Mid Zero Coupon</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.18.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Liabilities related to business combinations and to non-controlling interests (CVRs)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.18.</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Liabilities related to business combinations and to non-controlling interests (other than CVRs)</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Under IAS&#160;32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;B.8.4.</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s).</span></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-22</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ia48bc519d1134aa18e7f65f8daa58882" continuedAt="i9128c9d8552a494ea46da76553214f6c"><ix:continuation id="ia80c06e4601743ca93cc075c9a064264"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.6. Derecognition of financial instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Financial assets are derecognized when the contractual rights to cash flows from the asset have ended or have been transferred and when Sanofi has transferred substantially all the risks and rewards of ownership of the asset. If Sanofi has neither transferred nor retained substantially all the risks and rewards of ownership of a financial asset, it is derecognized if Sanofi does not retain control of the asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A financial liability is derecognized when Sanofi&#8217;s contractual obligations in respect of the liability are discharged, cancelled or extinguished.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.7. Risks relating to financial instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Market risks in respect of non-current financial assets, cash equivalents, derivative instruments and debt are described in the discussions of risk factors presented in Item&#160;3.D. and Item&#160;11. of Sanofi&#8217;s Annual Report on Form&#160;20-F for 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Credit risk is the risk that customers may fail to pay their debts. For a description of credit risk, refer to &#8220;We are subject to the risk of non-payment by our customers&#8221; within Item&#160;3.D. and Item&#160;11. of Sanofi&#8217;s Annual Report on Form&#160;20-F for 2022.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_529"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.9. <ix:continuation id="i9128c9d8552a494ea46da76553214f6c" continuedAt="i7e0498f1ef9546a9bb5001f50f660cef"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MjkvZnJhZzo5ZjYyOWI3NDNmOTg0NWI0YTNiZjBkNjEwZGQ4N2ExZS90ZXh0cmVnaW9uOjlmNjI5Yjc0M2Y5ODQ1YjRhM2JmMGQ2MTBkZDg3YTFlXzEwMjI_a5f0174e-9664-4863-8aa8-108b9dacb4ce" continuedAt="i3e4f411fdb9a48c18a0c7e041e66ba41" escape="true">Inventories</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i7e0498f1ef9546a9bb5001f50f660cef" continuedAt="i7e683944de5e4977844ba61de3ef17a6"><ix:continuation id="i3e4f411fdb9a48c18a0c7e041e66ba41"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inventories are measured at the lower of cost or net realizable value. Cost is calculated using the weighted average cost method or the first-in, first-out method, depending on the nature of the inventory.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The cost of finished goods inventories includes costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During the launch phase of a new product, any inventories of that product are written down to zero pending regulatory approval, other than in specific circumstances which make it possible to estimate that there is a high probability at the end of the reporting period that the carrying amount of the inventories will be recoverable. The write-down is reversed once it becomes highly probable that marketing approval will be obtained.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_532"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.10. <ix:continuation id="i7e683944de5e4977844ba61de3ef17a6" continuedAt="id3ec5b8b5b8d42b082415eb38d5d3af4"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzIvZnJhZzowMjVkZWRmNDFjYTc0OTZlOTZiNjkzMDE5YmM0N2ZmNi90ZXh0cmVnaW9uOjAyNWRlZGY0MWNhNzQ5NmU5NmI2OTMwMTliYzQ3ZmY2XzMzMQ_4b4c85ca-f520-404a-900a-0a05da4cd71b" continuedAt="ie027cd27cc274dafb19115e28488dbd3" escape="true">Cash and cash equivalents</ix:nonNumeric></ix:continuation></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:continuation id="id3ec5b8b5b8d42b082415eb38d5d3af4" continuedAt="i9cd056b1dd1544e59493854e701f6506"><ix:continuation id="ie027cd27cc274dafb19115e28488dbd3">Cash and cash equivalents as shown in the consolidated balance sheet and statement of cash flows comprise cash, plus liquid short-term investments that are&#160;readily convertible into cash and are&#160;subject to an insignificant risk of changes in value in the event of movements in interest rates.</ix:continuation></ix:continuation></span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_535"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.11. <ix:continuation id="i9cd056b1dd1544e59493854e701f6506" continuedAt="ie2baabe5096741f1b61fee4b9c33d549"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzUvZnJhZzplMjBkNTBlMDVjMzQ0YmIzOGIwZGM4ZmRkYjM3ZjgxYS90ZXh0cmVnaW9uOmUyMGQ1MGUwNWMzNDRiYjM4YjBkYzhmZGRiMzdmODFhXzI4Mg_0bd10e2f-925b-4db3-a6ee-7a6ef23b0912" continuedAt="i5b8d70b664da40329015a1a28248857d" escape="true">Treasury shares</ix:nonNumeric></ix:continuation></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:continuation id="ie2baabe5096741f1b61fee4b9c33d549" continuedAt="i47f7cd8908ea4f92b0ff84dd58e99347"><ix:continuation id="i5b8d70b664da40329015a1a28248857d">In accordance with IAS&#160;32, Sanofi treasury shares are deducted from equity, irrespective of the purpose for which they are held. <ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:GainLossOnPurchaseOfTreasuryShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzUvZnJhZzplMjBkNTBlMDVjMzQ0YmIzOGIwZGM4ZmRkYjM3ZjgxYS90ZXh0cmVnaW9uOmUyMGQ1MGUwNWMzNDRiYjM4YjBkYzhmZGRiMzdmODFhXzE1Ng_13958afe-8258-447d-bcde-4a094c528520"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:GainLossOnSaleOfTreasuryShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzUvZnJhZzplMjBkNTBlMDVjMzQ0YmIzOGIwZGM4ZmRkYjM3ZjgxYS90ZXh0cmVnaW9uOmUyMGQ1MGUwNWMzNDRiYjM4YjBkYzhmZGRiMzdmODFhXzE1Ng_4deaf6b2-37c8-4dd2-8ff5-d39837919005"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:GainLossOnImpairmentOfTreasuryShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzUvZnJhZzplMjBkNTBlMDVjMzQ0YmIzOGIwZGM4ZmRkYjM3ZjgxYS90ZXh0cmVnaW9uOmUyMGQ1MGUwNWMzNDRiYjM4YjBkYzhmZGRiMzdmODFhXzE1Ng_b1ce71f5-489b-41e3-8747-811d72b05718"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:GainLossOnCancellationOfTreasuryShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzUvZnJhZzplMjBkNTBlMDVjMzQ0YmIzOGIwZGM4ZmRkYjM3ZjgxYS90ZXh0cmVnaW9uOmUyMGQ1MGUwNWMzNDRiYjM4YjBkYzhmZGRiMzdmODFhXzE1Ng_b334f1ca-2054-4c3c-9f64-bd0f5aaccf5f">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> gain or loss is recognized in the income statement on the purchase, sale, impairment or cancellation of treasury shares.</ix:continuation></ix:continuation></span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_538"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.12. <ix:continuation id="i47f7cd8908ea4f92b0ff84dd58e99347" continuedAt="i8a96806d03704978a91ecae0af00b688"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzgvZnJhZzpmMTMzNWIwNDkxNGE0MGU2OTJiNWU2ZmUxYTM1OWI1ZC90ZXh0cmVnaW9uOmYxMzM1YjA0OTE0YTQwZTY5MmI1ZTZmZTFhMzU5YjVkXzI5NDE_2ff3ff4d-414b-437c-b0f6-14bda8e3da78" continuedAt="ic9cd63763df34029b97390153023840d" escape="true">Provisions for risks</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i8a96806d03704978a91ecae0af00b688" continuedAt="i9c51329f54cc47f797a48fb3ae94a432"><ix:continuation id="ic9cd63763df34029b97390153023840d" continuedAt="iafc1cd057cee4afd9fad84b33508f293"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;37 (Provisions, Contingent Liabilities and Contingent Assets), Sanofi records a provision when it has a present obligation, whether legal or constructive, as a result of a past event; it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation; and a reliable estimate can be made of the amount of the outflow of resources.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If the obligation is expected to be settled more than twelve months after the end of the reporting period, or has no definite settlement date, the provision is recorded within Non-current provisions and other non-current liabilities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Provisions relating to the insurance programs in which Sanofi&#8217;s captive insurance company participates are based on risk exposure estimates calculated by management, with assistance from independent actuaries, using IBNR (Incurred But Not Reported) techniques. Those techniques use past claims experience, within Sanofi and in the market, to estimate future trends in the cost of&#160;claims.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Contingent liabilities are not recognized, but are disclosed in the notes to the financial statements unless the possibility of an outflow of economic resources is&#160;remote.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi estimates provisions on the basis of events and circumstances related to present obligations at the end of the reporting period and of past experience, and to the best of management&#8217;s knowledge at the date of preparation of the financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Reimbursements offsetting the probable outflow of resources are recognized as assets only if it is virtually certain that they will be received. Contingent assets are not recognized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restructuring provisions are recognized if Sanofi has a detailed, formal restructuring plan at the end of the reporting period and has announced its intention to implement this plan to those affected by it.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:ProvisionsRecordedForFutureOperatingLosses" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzgvZnJhZzpmMTMzNWIwNDkxNGE0MGU2OTJiNWU2ZmUxYTM1OWI1ZC90ZXh0cmVnaW9uOmYxMzM1YjA0OTE0YTQwZTY5MmI1ZTZmZTFhMzU5YjVkXzE4NzQ_ad8950c9-2aa2-48c0-a344-cf2a1ddea724">No</ix:nonFraction> provisions are recorded for future operating losses.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-23</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i9c51329f54cc47f797a48fb3ae94a432" continuedAt="i429d60c941c941eba6daf9ad3296fc83"><ix:continuation id="iafc1cd057cee4afd9fad84b33508f293"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi records non-current provisions for certain obligations, such as legal or constructive obligations, where an outflow of resources is probable and the amount of the outflow can be reliably estimated.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of environmental risks, including at sites where operations are ongoing, Sanofi recognizes a provision where there is a violation of integrity in respect of human health or the environment resulting from past contamination at a site that requires remediation. The amount of the provision is a best estimate of the future expenditures to be incurred on the remediation plan.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Where the effect of the time value of money is material, those provisions are measured at the present value of the expenditures expected to be required to settle the obligation, calculated using a discount rate that reflects an estimate of the time value of money and the risks specific to the obligation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Increases in provisions to reflect the effects of the passage of time are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_541"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.13. <ix:continuation id="i429d60c941c941eba6daf9ad3296fc83" continuedAt="i692fe67e3ee64eb8b01b8a8e2ff636b6"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NDEvZnJhZzo0N2E2Mzc2NzkwMTM0NjQzYTZiODIzYjM1N2NlMzA3ZS90ZXh0cmVnaW9uOjQ3YTYzNzY3OTAxMzQ2NDNhNmI4MjNiMzU3Y2UzMDdlXzYwNDk_a8cd2b2e-6170-401b-95d6-7e4a6d0fe91d" continuedAt="i10c0c99ce0794b3b81a01c7e61fb9def" escape="true">Revenue recognition</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i692fe67e3ee64eb8b01b8a8e2ff636b6" continuedAt="i5f2d8f0e6fa0450b8f59544abdb6994a"><ix:continuation id="i10c0c99ce0794b3b81a01c7e61fb9def" continuedAt="ida1a592e145a4f4c96ea8f03d502c000"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.13.1. Net sales</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Revenue arising from the sale of goods is presented in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Net sales comprise revenue from sales of pharmaceutical products, consumer healthcare products, active ingredients and vaccines, net of sales returns, of customer incentives and discounts, and of certain sales-based payments paid or payable to the healthcare authorities. Analyses of net sales are provided in Note&#160;D.35.1. &#8220;Segment Information&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;15 (Revenue from Contracts with Customers), such revenue is recognized when Sanofi transfers control over the product to the customer; control of an asset refers to the ability to direct the use of, and obtain substantially all of the remaining benefits from that asset. For the vast majority of contracts, revenue is recognized when the product is physically transferred, in accordance with the delivery and acceptance terms agreed with the customer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For contracts entered into by Sanofi Pasteur, transfer of control is usually determined by reference to the terms of release (immediate or deferred) and acceptance of batches of vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of contracts with distributors, Sanofi does not recognize revenue when the product is physically transferred to the distributor if the products are sold on consignment, or if the distributor acts as agent. In such cases, revenue is recognized when control is transferred to the end customer, and the distributor&#8217;s commission is presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Selling and general expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of revenue recognized reflects the various types of price reductions or rights of return offered by Sanofi to its customers on certain products. Such price reductions and rights of return qualify as variable consideration under IFRS&#160;15.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In particular, products sold in the United States are covered by various Government and State programs (such as Medicare and Medicaid) under which products are sold at a discount. Rebates are granted to healthcare authorities, and under contractual arrangements with certain customers. Some wholesalers are entitled to chargeback incentives based on the selling price to the end customer, under specific contractual arrangements. Cash discounts may also be granted for prompt payment. Returns, discounts, incentives and rebates, as described above, are recognized in the period in which the underlying sales are recognized as a reduction of gross sales.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These amounts are calculated as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of chargeback incentives is estimated on the basis of the relevant subsidiary&#8217;s standard sales terms and conditions, and in certain cases on the basis of specific contractual arrangements with the customer;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of rebates based on attainment of sales targets is estimated and accrued as each of the underlying sales transactions is recognized;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of price reductions under Government and State programs, largely in the United States, is estimated on the basis of the specific terms of the relevant regulations or agreements, and accrued as each of the underlying sales transactions is recognized;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of sales returns is calculated on the basis of management&#8217;s best estimate of the amount of product that will ultimately be returned by customers. In countries where product returns are possible, Sanofi operates a returns policy that allows the customer to return products within a certain period either side of the expiry date (usually 12&#160;months after the expiry date). The amount recognized for returns is estimated on the basis of past experience of sales returns. Sanofi also takes into account factors such as levels of inventory in its various distribution channels, product expiry dates, information about potential discontinuation of products, the entry of competing generics into the market, and the launch of over-the-counter medicines. Most product return clauses relate solely to date-expired products, which cannot be resold and are destroyed. Sanofi does not recognize a right of return asset in the balance sheet for contracts that allow for the return of time-expired products, since those products have no value.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The estimated amounts described above are recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as a reduction of gross sales, and within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the balance sheet. They are subject to regular review and adjustment as appropriate based on the most recent data available to management. Sanofi believes that it has the ability to measure each of the above amounts reliably, using the following factors in developing its estimates:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the nature and patient profile of the underlying product;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the applicable regulations or the specific terms and conditions of contracts with governmental authorities, wholesalers and other customers;</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-24</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i5f2d8f0e6fa0450b8f59544abdb6994a" continuedAt="i4047a8cd1a8641c7b3b1376543501d28"><ix:continuation id="ida1a592e145a4f4c96ea8f03d502c000"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">historical data relating to similar contracts, in the case of qualitative and quantitative rebates and chargeback incentives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">past experience and sales growth trends for the same or similar products;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">actual inventory levels in distribution channels, monitored by Sanofi using internal sales data and externally provided data;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the shelf life of Sanofi products; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">market trends including competition, pricing and demand.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of provisions for discounts, rebates and sales returns is provided in Note&#160;D.23.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.13.2. Other revenues</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">The line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other revenues</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is used to recognize all revenue that falls within the scope of IFRS&#160;15 but does not relate to sales of Sanofi products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It mainly comprises (i)&#160;royalties received from licensing intellectual property rights to third parties; (ii)&#160;VaxServe sales of products sourced from third-party manufacturers; and (iii)&#160;revenue received under agreements for Sanofi to provide manufacturing services to third parties.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Royalties received under licensing arrangements are recognized over the period during which the underlying sales are recognized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">VaxServe is a Vaccines segment entity whose operations include the distribution within the United States of vaccines and other products manufactured by third parties. VaxServe sales of products sourced from third-party manufacturers are presented within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other revenues</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_544"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.14. <ix:continuation id="i4047a8cd1a8641c7b3b1376543501d28" continuedAt="i3cd5157c623b4cd3943004e648e32ce3"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DescriptionOfAccountingPolicyForCostOfSalesExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NDQvZnJhZzpiOWE3MzdmODU1MDM0NGI0YjBmZDM5NGY4MmI5MDg4Zi90ZXh0cmVnaW9uOmI5YTczN2Y4NTUwMzQ0YjRiMGZkMzk0ZjgyYjkwODhmXzM2Ng_4cf3aa24-0de3-4409-9873-f99b98ac8eef" continuedAt="i85581e91f8d64022b85293734170b4c8" escape="true">Cost of sales</ix:nonNumeric></ix:continuation></span></div><div style="margin-bottom:5pt;text-align:justify"><ix:continuation id="i3cd5157c623b4cd3943004e648e32ce3" continuedAt="ia6fcb4781fb5428e85991ad7e7f9f948"><ix:continuation id="i85581e91f8d64022b85293734170b4c8"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> consists primarily of the industrial cost of goods sold, payments made under licensing agreements, and distribution costs. The industrial cost of goods sold includes the cost of materials, depreciation of property, plant and equipment, amortization of software, personnel costs, and other expenses attributable to production.</span></ix:continuation></ix:continuation></div><div id="i52f57172a9d7443580346c2d8f39cd2b_547"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.15. <ix:continuation id="ia6fcb4781fb5428e85991ad7e7f9f948" continuedAt="ia1a66d7d53654b0497c2396809e7a782"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NDcvZnJhZzo2NDg3MmE3MjVmMGU0OGNjOTZjODYzNTM4MGUzMWRmNC90ZXh0cmVnaW9uOjY0ODcyYTcyNWYwZTQ4Y2M5NmM4NjM1MzgwZTMxZGY0XzQwNg_c338753e-fc9e-492c-9a36-7f18ba996691" continuedAt="ic3b61c87f6164ae8ba1d5e2dbe4e3db8" escape="true">Research and development</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="ia1a66d7d53654b0497c2396809e7a782" continuedAt="if62e93c3c36a46f7b157fc5841ae8de7"><ix:continuation id="ic3b61c87f6164ae8ba1d5e2dbe4e3db8"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Note&#160;B.4.1. &#8220;Research and development not acquired in a business combination&#8221; and Note&#160;B.4.3. &#8220;Other intangible assets acquired in a business combination&#8221; describe the principles applied to the recognition of research and development costs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Contributions or reimbursements received from alliance partners are recorded as a reduction of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_550"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.16. <ix:continuation id="if62e93c3c36a46f7b157fc5841ae8de7" continuedAt="i8253d310f08549c9be0664412994df01"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NTAvZnJhZzo2ODM1ZTdhMWExY2Q0MGY3ODBmZjRjYjI2YTNiYzg2Mi90ZXh0cmVnaW9uOjY4MzVlN2ExYTFjZDQwZjc4MGZmNGNiMjZhM2JjODYyXzc2Nw_ab8e112a-09be-42f0-8aba-78b8393a1fa7" continuedAt="ib40e8e7156534cd38dda933fab4e9358" escape="true">Other operating income and expenses</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i8253d310f08549c9be0664412994df01" continuedAt="i918b1e2b232144149ebabd3ed0ca1d06"><ix:continuation id="ib40e8e7156534cd38dda933fab4e9358"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.16.1. Other operating income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes the share of profits that Sanofi is entitled to receive from alliance partners in respect of product marketing agreements. It also includes revenues generated under certain agreements, which may include partnership, co-promotion arrangements and licenses not included in Other revenues.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This line item also includes realized and unrealized foreign exchange gains and losses on operating activities (see Note&#160;B.8.3.), and operating gains on disposals not regarded as major disposals (see Note&#160;B.20.).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.16.2. Other operating expenses</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> mainly comprise the share of profits that alliance partners are entitled to receive from Sanofi under product marketing agreements.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_553"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.17. <ix:continuation id="i918b1e2b232144149ebabd3ed0ca1d06" continuedAt="i0177268f74a34f35ad3b57f8388d95ae"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NTMvZnJhZzo2YjcyY2ZjNTkyMjI0NWYxOGEwZTQyOGY3NzNhZWYwMS90ZXh0cmVnaW9uOjZiNzJjZmM1OTIyMjQ1ZjE4YTBlNDI4Zjc3M2FlZjAxXzg2NA_25838b34-e09d-4efb-ab5b-26a00c3e3fcc" continuedAt="i117af85f6099460ab080d7a0d0ab5bef" escape="true">Amortization and impairment of intangible assets</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i0177268f74a34f35ad3b57f8388d95ae" continuedAt="ibbdf7cfe463a43e9a48dbe5d203e5e0f"><ix:continuation id="i117af85f6099460ab080d7a0d0ab5bef"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.17.1. Amortization of intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The expenses recorded in this line item comprise amortization of product rights and other intangible assets (see Note&#160;D.4.), given that the benefit of those rights to Sanofi&#8217;s commercial, industrial and development functions cannot be separately identified.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amortization of software, and of other rights of an industrial or operational nature, is recognized as an expense in the income statement, in the relevant line items of expense by function.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.17.2. Impairment of intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This line item records impairment losses (other than those associated with restructuring) recognized against intangible assets (including goodwill, but excluding software and other rights of an industrial or operational nature), and any reversals of such impairment losses.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-25</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_556"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.18. <ix:continuation id="ibbdf7cfe463a43e9a48dbe5d203e5e0f" continuedAt="i7ea56f7ebd454658b79ae51dee070174"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NTYvZnJhZzo3ZWU4N2U1NTYwMDM0M2NlODU1N2ZjYzJhZWUxNzQyZS90ZXh0cmVnaW9uOjdlZTg3ZTU1NjAwMzQzY2U4NTU3ZmNjMmFlZTE3NDJlXzg4Nw_2059bea1-6436-4c7e-83a9-0a6b29c4c776" continuedAt="if819b53ef37741b6a6cd1c40ab95ec38" escape="true">Fair value remeasurement of contingent consideration</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i7ea56f7ebd454658b79ae51dee070174" continuedAt="id1b75161965846ee8c1e0408c20a2862"><ix:continuation id="if819b53ef37741b6a6cd1c40ab95ec38"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in the fair value of contingent consideration that was (i)&#160;already carried in the books of an acquired entity, or (ii)&#160;granted in connection with a business combination and initially recognized as a liability in accordance with IFRS&#160;3, are reported in profit or loss. Such adjustments are reported separately in the income statement, in the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This line item also includes changes in the fair value of contingent consideration receivable in connection with a divestment and classified as a financial asset at fair value through profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, it includes the effect of the unwinding of discount, and of exchange rate movements where the asset or liability is expressed in a currency other than the functional currency of the reporting entity.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_559"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.19. <ix:continuation id="id1b75161965846ee8c1e0408c20a2862" continuedAt="ibbc11dad4641448399bc1235cc2dbbe3"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NTkvZnJhZzoxMDJiOGIxOWE3YWY0OThkOTAxNGEwMTU4MzljNmMyYi90ZXh0cmVnaW9uOjEwMmI4YjE5YTdhZjQ5OGQ5MDE0YTAxNTgzOWM2YzJiXzExNDA_9d2a8fbb-9c66-49b7-b76b-eb7f779f9c1d" continuedAt="i09a5b56b30454f019ecd197fdcb6da02" escape="true">Restructuring costs and similar items</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="ibbc11dad4641448399bc1235cc2dbbe3" continuedAt="i7bcda68a318e4a75bbb77f2c9d0f56db"><ix:continuation id="i09a5b56b30454f019ecd197fdcb6da02"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restructuring costs are expenses incurred in connection with the transformation or reorganization of Sanofi&#8217;s operations or support functions. Such costs include collective redundancy plans, compensation to third parties for early termination of contracts, and commitments made in connection with transformation or reorganization decisions. They also include accelerated depreciation charges arising from site closures (including closures of leased sites), and losses on asset disposals resulting from such decisions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, this line item includes expenses incurred in connection with programs implemented as part of the transformation strategy announced in December&#160;2019 (and previously in November&#160;2015), and intended primarily to (i)&#160;deliver a global information systems solution, further supported by the implementation in 2021 of Sanofi's new digital strategy; (ii)&#160;create a standalone Consumer Healthcare entity; and (iii)&#160;as announced on February&#160;24, 2020, create a European leader in the production and marketing to third parties of active pharmaceutical ingredients (API).</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_562"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.20. <ix:continuation id="i7bcda68a318e4a75bbb77f2c9d0f56db" continuedAt="i1ac8611c57424bd780e92dd3c0479ce0"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NjIvZnJhZzpmMzc1OTNhNmFkMWU0OGExOGMxNTMwNjExYWNkM2M2Yy90ZXh0cmVnaW9uOmYzNzU5M2E2YWQxZTQ4YTE4YzE1MzA2MTFhY2QzYzZjXzk2Mw_410c9dca-f0fe-4448-baa1-23d5134036ec" continuedAt="ief697073b24046379cbc04d63d9ca29c" escape="true">Other gains and losses, and litigation</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i1ac8611c57424bd780e92dd3c0479ce0" continuedAt="i6720d3925b454fcc81d3b644e65571fd"><ix:continuation id="ief697073b24046379cbc04d63d9ca29c"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes the impact of material transactions of an unusual nature or amount which Sanofi believes it necessary to report separately in the income statement in order to improve the relevance of the financial statements, such as:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">gains and losses on major disposals of property, plant and equipment, of intangible assets, of assets (or groups of assets and liabilities) held for sale, or of a business within the meaning of IFRS&#160;3, other than those considered to be restructuring costs;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">impairment losses and reversals of impairment losses on assets (or groups of assets and liabilities) held for sale, other than those considered to be restructuring costs;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">gains on bargain purchases;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">costs relating to major litigation; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">pre-tax separation costs associated with the process of disinvesting from operations in the event of a major divestment.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_565"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.21. <ix:continuation id="i6720d3925b454fcc81d3b644e65571fd" continuedAt="i7ce5c5c68ceb43cbbf86d883b6bdbbc7"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NjUvZnJhZzpjY2M3MTEyMzdkMDM0ZWE4OWUzYzI2NjA2ZWZhZDIyYS90ZXh0cmVnaW9uOmNjYzcxMTIzN2QwMzRlYTg5ZTNjMjY2MDZlZmFkMjJhXzExMDM_be0d72b6-dfa0-401f-8c8e-38e32a568e46" continuedAt="i34246b6c921c4ffd88e52a5e1404b94f" escape="true">Financial expenses and income</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i7ce5c5c68ceb43cbbf86d883b6bdbbc7" continuedAt="i301dfd3bc6b34cb6b4be5db3c7e313b2"><ix:continuation id="i34246b6c921c4ffd88e52a5e1404b94f"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.21.1. Financial expenses</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> mainly comprise interest charges on debt financing; negative changes in the fair value of certain financial instruments (where changes in fair value are recognized in profit or loss); realized and unrealized foreign exchange losses on financing and investing activities; impairment losses on financial instruments; and any reversals of impairment losses on financial instruments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> also include expenses arising from the unwinding of discount on long-term provisions, and the net interest cost related to employee benefits. This line item does not include commercial cash discounts, which are deducted from net sales.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.21.2. Financial income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes interest and dividend income; positive changes in the fair value of certain financial instruments (where changes in fair value are recognized in profit or loss); realized and unrealized foreign exchange gains on financing and investing activities; and gains on disposals of financial assets at fair value through profit or loss.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_568"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.22. <ix:continuation id="i301dfd3bc6b34cb6b4be5db3c7e313b2" continuedAt="i3fd22659596549c1ace69811dfa3d701"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NjgvZnJhZzoyZWU3ZDdhNjI1OWQ0NzRjYjM5ZDI1NjYxMzY2YzUxZi90ZXh0cmVnaW9uOjJlZTdkN2E2MjU5ZDQ3NGNiMzlkMjU2NjEzNjZjNTFmXzU2NDA_118d5c21-37d3-4e69-95cc-2fa427e29572" continuedAt="if3c8d4af6d98480eafc47f1c38198404" escape="true">Income tax expense</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i3fd22659596549c1ace69811dfa3d701" continuedAt="ia4287546aeab4513ad7b2edf882b1664"><ix:continuation id="if3c8d4af6d98480eafc47f1c38198404" continuedAt="i51421ec64ca048c4ae025e551e82f877"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">includes all current and deferred taxes of consolidated companies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi accounts for deferred taxes in accordance with IAS&#160;12 (Income Taxes), using the methods described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred tax assets and liabilities are recognized on taxable and deductible temporary differences, and on tax loss carry-forwards. Temporary differences are differences between the carrying amount of an asset or liability in the balance sheet and its tax base;</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-26</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ia4287546aeab4513ad7b2edf882b1664" continuedAt="i495a01b11e304cdd98297ebaee43cc93"><ix:continuation id="i51421ec64ca048c4ae025e551e82f877"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">French business taxes include a value added based component: &#8220;CVAE&#8221; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Cotisation sur la Valeur Ajout&#233;e des Entreprises)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Given that CVAE is (i)&#160;calculated as the amount by which certain revenues exceed certain expenses and (ii)&#160;borne primarily by companies that own intellectual property rights on income derived from those rights (royalties, and margin on sales to third parties and to Sanofi entities), it is regarded as meeting the definition of income taxes specified in IAS&#160;12, paragraph&#160;2 (&#8220;taxes which are based on taxable profits&#8221;);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred tax assets and liabilities are calculated using the tax rate expected to apply in the period when the corresponding temporary differences are expected to reverse, based on tax rates enacted or substantively enacted at the end of the reporting period;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred tax assets are recognized in respect of deductible temporary differences, tax losses available for carry-forward and unused tax credits to the extent that future recovery is regarded as probable. The recoverability of deferred tax assets is assessed on a case-by-case basis, taking into account the profit forecasts contained in Sanofi&#8217;s medium-term business plan;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a deferred tax liability is recognized for temporary differences relating to interests in subsidiaries, associates and joint ventures, except in cases where Sanofi is able to control the timing of the reversal of the temporary differences. This applies in particular when Sanofi is able to control dividend policy and it is probable that the temporary differences will not reverse in the foreseeable future;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">no deferred tax is recognized on eliminations of intragroup transfers of interests in subsidiaries, associates or joint ventures;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">each tax entity calculates its own net deferred tax position. All net deferred tax asset and liability positions are then aggregated and shown in separate line items on the relevant side of the consolidated balance sheet. Deferred tax assets and liabilities are offset only if (i)&#160;Sanofi has a legally enforceable right to offset current tax assets and current tax liabilities, and (ii)&#160;the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation authority;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred taxes are not discounted, except implicitly in the case of deferred taxes on assets and liabilities which are already impacted by discounting. In addition, Sanofi has elected not to discount current taxes payable or receivable where the amounts in question are payable or receivable in the long term;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">withholding taxes on intragroup royalties and dividends, and on royalties and dividends collected from third parties, are accounted for as current income taxes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accounting for business combinations, Sanofi complies with IFRS&#160;3 as regards the recognition of deferred tax assets after the initial accounting period. Consequently, any deferred tax assets recognized by the acquiree after the end of that period in respect of temporary differences or tax loss carry-forwards existing at the acquisition date are recognized in profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The positions adopted by Sanofi in tax matters are based on its interpretation of tax laws and regulations. Some of those positions may be subject to uncertainty. In such cases, Sanofi assesses the amount of the tax liability on the basis of the following assumptions: that its position will be examined by one or more tax authorities on the basis of all relevant information; that a technical assessment is carried out with reference to legislation, case law, regulations, and established practice; and that each position is assessed individually (or collectively where appropriate), with no offset or aggregation between positions. Those assumptions are assessed on the basis of facts and circumstances existing at the end of the reporting period. When an uncertain tax liability is regarded as probable, it is measured on the basis of Sanofi&#8217;s best estimate and recognized as a liability; uncertain tax assets are not recognized. The amount of the liability includes any penalties and late payment interest. The line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Income tax expense</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes the effects of tax reassessments and tax disputes, and any penalties and late payment interest arising from such disputes that have the characteristics of income taxes within the meaning of paragraph&#160;2 of IAS&#160;12 (&#8220;taxes which are based on taxable profits&#8221;). Tax exposures relating to corporate income taxes are presented separately within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Non-current income tax liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (see Note&#160;D.19.4.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="eur" contextRef="i713b01806f0b4962bdcf1fb4904578c5_D20220101-20221231" decimals="INF" name="ifrs-full:DeferredTaxExpenseIncome" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NjgvZnJhZzoyZWU3ZDdhNjI1OWQ0NzRjYjM5ZDI1NjYxMzY2YzUxZi90ZXh0cmVnaW9uOjJlZTdkN2E2MjU5ZDQ3NGNiMzlkMjU2NjEzNjZjNTFmXzUwMDU_d9203262-c271-4fbe-9795-a43507d35295">No</ix:nonFraction> deferred taxation is recognized on temporary differences that are liable to be subject to US global intangible low taxed income (GILTI) provisions. The related tax expense is recognized in the year in which it is declared in the tax return to the extent that it arises from the existence of non-US profits that exceed the theoretical return on investment specified in the GILTI provisions and are taxed at a rate lower than the applicable US tax rate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;1 (Presentation of Financial Statements), current income tax assets and liabilities are presented as separate line items in the consolidated balance sheet.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_571"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.23. <ix:continuation id="i495a01b11e304cdd98297ebaee43cc93" continuedAt="ifcfa9d53b0e04982b9cbe0929bc89dfb"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NzEvZnJhZzo5YzFmMmI0NTYyNzk0ZDEzYjE1MzFhN2M4ZDZjMjc0Ni90ZXh0cmVnaW9uOjljMWYyYjQ1NjI3OTRkMTNiMTUzMWE3YzhkNmMyNzQ2XzI4NDI_7409e4df-6dc4-4ed2-a73d-9f09f4c4ff8d" continuedAt="i966d7f0a7aa0421c933d63318640e0c9" escape="true">Employee benefit obligations</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="ifcfa9d53b0e04982b9cbe0929bc89dfb" continuedAt="i41234ce3968944829edc8c915521cc17"><ix:continuation id="i966d7f0a7aa0421c933d63318640e0c9" continuedAt="ibd1655f45c4249e3a619224a3c322899"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi offers retirement benefits to employees and retirees. Such benefits are accounted for in accordance with IAS&#160;19 (Employee Benefits).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Benefits are provided in the form of either defined contribution plans or defined benefit plans. In the case of defined contribution plans, the cost is recognized immediately in the period in which it is incurred, and equates to the amount of the contributions paid by Sanofi. For defined benefit plans, Sanofi generally recognizes its obligations to pay pensions and similar benefits to employees as a liability, based on an actuarial estimate of the rights vested or currently vesting in employees and retirees, using the projected unit credit method. Estimates are performed at least once a year, and rely on financial assumptions (such as discount rates) and demographic assumptions (such as life expectancy, retirement age, employee turnover, and the rate of salary increases).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Obligations relating to other post-employment benefits (healthcare and life insurance) offered by Sanofi companies to employees are also recognized as a liability based on an actuarial estimate of the rights vested or currently vesting in employees and retirees at the end of the reporting period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Such liabilities are recognized net of the fair value of plan assets.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-27</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i41234ce3968944829edc8c915521cc17" continuedAt="ie96420c526744629b39817e2ffec8bd8"><ix:continuation id="ibd1655f45c4249e3a619224a3c322899"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of multi-employer defined benefit plans where plan assets cannot be allocated to each participating employer with sufficient reliability, the plan is accounted for as a defined contribution plan, in accordance with paragraph&#160;34 of IAS&#160;19.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The benefit cost for the period consists primarily of current service cost, past service cost, net interest cost, gains or losses arising from plan settlements not specified in the terms of the plan, and actuarial gains or losses arising from plan curtailments. Net interest cost for the period is determined by applying the discount rate specified in IAS&#160;19 to the net liability (i.e. the amount of the obligation, net of plan assets) recognized in respect of defined benefit plans. Past service cost is recognized immediately in profit or loss in the period in which it is incurred, regardless of whether or not the rights have vested at the time of adoption (in&#160;the case of a new plan) or of amendment (in&#160;the case of an existing&#160;plan).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Actuarial gains and losses on defined benefit plans (pensions and other post-employment benefits), also referred to as&#160;&#8220;Remeasurements of the net defined benefit liability (asset)&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> arise as a result of changes in financial and demographic assumptions, experience adjustments, and the difference between the actual return and interest cost on plan assets. The impacts of those remeasurements are recognized in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, net of deferred taxes; they are not subsequently reclassifiable to profit or&#160;loss.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_574"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.24. <ix:continuation id="ie96420c526744629b39817e2ffec8bd8" continuedAt="ic2b356aac48f45678de2784f8e9b190f"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NzQvZnJhZzozZjhlMzlmOGM0Mzc0OGM2YjlhYjVjZGRkNTNkOTNlNy90ZXh0cmVnaW9uOjNmOGUzOWY4YzQzNzQ4YzZiOWFiNWNkZGQ1M2Q5M2U3XzI2NTc_1160521d-1054-4c8d-94fe-487f4b28915c" continuedAt="i85e7b5d6a2564f64b2ae78468cd22896" escape="true">Share-based payment</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="ic2b356aac48f45678de2784f8e9b190f" continuedAt="i446c4ccba68b42e18796536d00f7196d"><ix:continuation id="i85e7b5d6a2564f64b2ae78468cd22896"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Share-based payment expense is recognized as a component of operating income, in the relevant classification of expense by function. In measuring the expense, the level of attainment of any performance conditions is taken into account.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.24.1. Stock option plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has granted a number of equity-settled share-based payment plans (stock option plans) to some of its employees. The terms of those plans may make the award contingent on the attainment of performance criteria for some of the grantees.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;2 (Share-Based Payment), services received from employees as consideration for stock options are recognized as an expense in the income statement, with the opposite entry recognized in equity. The expense corresponds to the fair value of the stock option plans, and is charged to income on a straight-line basis over the <ix:nonNumeric contextRef="ie922fff56e5f419ab3f601913c0b7064_D20220101-20221231" name="sny:OptionVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NzQvZnJhZzozZjhlMzlmOGM0Mzc0OGM2YjlhYjVjZGRkNTNkOTNlNy90ZXh0cmVnaW9uOjNmOGUzOWY4YzQzNzQ4YzZiOWFiNWNkZGQ1M2Q5M2U3XzI2NjI_6c03d95c-9ca5-493c-8787-9d006f5a37ff">four-year</ix:nonNumeric> vesting period of the plan.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of stock option plans is measured at the date of grant using the Black-Scholes valuation model, taking into account the expected life of the options. The resulting expense also takes into account the expected cancellation rate of the options. The expense is adjusted over the vesting period to reflect actual cancellation rates resulting from option-holders ceasing to be employed by Sanofi.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.24.2. Employee share ownership plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi may offer its employees the opportunity to subscribe to reserved share issues at a discount to the reference market price. Shares awarded to employees under such plans fall within the scope of IFRS&#160;2. Consequently, an expense is recognized at the subscription date, based on the value of the discount offered to employees.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.24.3. Restricted share plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi may award restricted share plans to certain of its employees. The terms of those plans may make the award contingent on the attainment of performance criteria for some of the grantees.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;2, an expense equivalent to the fair value of such plans is recognized in profit or loss on a straight line basis over the vesting period of the plan, with the opposite entry recognized in equity. The vesting period is <ix:nonNumeric contextRef="i1cc28f89fac74c419543f702bf0f7dca_D20220101-20221231" name="sny:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NzQvZnJhZzozZjhlMzlmOGM0Mzc0OGM2YjlhYjVjZGRkNTNkOTNlNy90ZXh0cmVnaW9uOjNmOGUzOWY4YzQzNzQ4YzZiOWFiNWNkZGQ1M2Q5M2U3XzIxNTk_06b3aeea-1f0c-4ae4-a957-6b4a07a78648">three years</ix:nonNumeric>.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of restricted share plans is based on the quoted market price of Sanofi shares at the date of grant, adjusted for expected dividends during the vesting period; it also takes account of any vesting conditions contingent on stock market performance, measured using the Monte-Carlo valuation model. Other vesting conditions are taken into account in the estimate of the number of shares awarded during the vesting period; that number is then definitively adjusted based on the actual number of shares awarded on the vesting date.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_577"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.25. <ix:continuation id="i446c4ccba68b42e18796536d00f7196d" continuedAt="i91e44e41008b493d89a12ba9db0af030"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NzcvZnJhZzo1ZTEzNjgwOTliYjM0ZTI1OGMzNGViZTNmMjE4NGZhMi90ZXh0cmVnaW9uOjVlMTM2ODA5OWJiMzRlMjU4YzM0ZWJlM2YyMTg0ZmEyXzczMw_6d49d8ce-1eae-4121-aeb0-efcb762a8f9a" continuedAt="iff9521d4b2af41939db9d919c8884246" escape="true">Earnings per share</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i91e44e41008b493d89a12ba9db0af030" continuedAt="ie5ed89c502f247718d43c8784f3aed10"><ix:continuation id="iff9521d4b2af41939db9d919c8884246"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Basic earnings per share is calculated using the weighted average number of shares outstanding during the reporting period, adjusted on a time-weighted basis from the acquisition date to reflect the number of own shares held by Sanofi. Diluted earnings per share is calculated on the basis of the weighted average number of ordinary shares, computed using the treasury stock method.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This method assumes that (i)&#160;all outstanding dilutive options and warrants are exercised, and (ii)&#160;Sanofi acquires its own shares at the quoted market price for an amount equivalent to the cash received as consideration for the exercise of the options or warrants, plus the expense arising on unamortized stock options.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-28</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_580"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.26. <ix:continuation id="ie5ed89c502f247718d43c8784f3aed10" continuedAt="i8be422270d9b4ab0976b8c2282a92b69"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODAvZnJhZzplNDg4OTc4Y2Y4MDk0ZmMxYmFiZDllMGM5ZGYxOTA4Ny90ZXh0cmVnaW9uOmU0ODg5NzhjZjgwOTRmYzFiYWJkOWUwYzlkZjE5MDg3XzMxNTg_4e85080b-c774-4d64-864e-757e7d710799" continuedAt="i72eb7b78a3264e48b014095f39340feb" escape="true">Segment information</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i8be422270d9b4ab0976b8c2282a92b69" continuedAt="ia4a82709693f4858a50195d240d52e01"><ix:continuation id="i72eb7b78a3264e48b014095f39340feb"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;8 (Operating Segments), the segment information reported by Sanofi is prepared on the basis of internal management data provided to the Chief Executive Officer, who is the chief operating decision maker. The performance of those segments is monitored individually using internal reports and common indicators. Disclosures about operating segments required under IFRS&#160;8 are presented in Note&#160;D.35. &#8220;Segment information&#8221; to the consolidated financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has <ix:nonFraction unitRef="segment" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODAvZnJhZzplNDg4OTc4Y2Y4MDk0ZmMxYmFiZDllMGM5ZGYxOTA4Ny90ZXh0cmVnaW9uOmU0ODg5NzhjZjgwOTRmYzFiYWJkOWUwYzlkZjE5MDg3XzUyNw_9184c7a1-f49c-4d22-a851-b4dc86a3131b">three</ix:nonFraction> operating segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Pharmaceuticals segment comprises, for all geographical territories, the commercial operations of the following global franchises: Specialty Care (Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Neurology &amp; Immunology, Rare Diseases, Oncology, and Rare Blood Disorders) and General Medicines (Core and Non-Core Assets), together with research, development and production activities dedicated to the Pharmaceuticals segment. This segment also includes associates whose activities are related to pharmaceuticals. Following the transaction of May&#160;29, 2020, Regeneron is no longer an associate of Sanofi (see Note&#160;D.2.). Consequently, the Pharmaceuticals segment no longer includes Sanofi&#8217;s equity-accounted share of Regeneron&#8217;s profits for all the periods presented.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Vaccines segment comprises, for all geographical territories, the commercial operations of Vaccines, together with research, development and production activities dedicated to vaccines.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for Sanofi's Consumer Healthcare products, together with research, development and production activities dedicated to those products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inter-segment transactions are not material.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The costs of Sanofi&#8217;s global functions (Corporate Affairs, Finance, People &amp; Culture, Legal, Ethics &amp; Business Integrity, Information Solutions&#160;&amp; Technologies, Sanofi Business Services,&#160;etc.) are managed centrally at group-wide level, and are presented within the &#8220;Other&#8221; category. That category also includes other reconciling items such as retained commitments in respect of divested activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Information about operating segments for the years ended December 31, 2022, 2021 and 2020 is presented in Note&#160;D.35</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">., </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Segment information&#8221;.</span></div></ix:continuation></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_583"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.27. <ix:continuation id="ia4a82709693f4858a50195d240d52e01" continuedAt="i8848a66fc1bf4ce18ac6490e2052cb5a"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODMvZnJhZzpiNDNlMWI2ZWQ5Njc0NTI1YjlhZjhmZGFiYmQ1YjI0Yi90ZXh0cmVnaW9uOmI0M2UxYjZlZDk2NzQ1MjViOWFmOGZkYWJiZDViMjRiXzE5NzI_364a5418-7161-414b-9062-79ed10648555" continuedAt="icd7065bf2d7b416fb30ced32761b5ac6" escape="true">Management of capital</ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i8848a66fc1bf4ce18ac6490e2052cb5a"><ix:continuation id="icd7065bf2d7b416fb30ced32761b5ac6"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order to maintain or adjust the capital structure, Sanofi can adjust the amount of dividends paid to shareholders, repurchase its own shares, issue new shares, or issue securities giving access to its capital.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following objectives are defined under the terms of Sanofi&#8217;s share repurchase programs:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the implementation of any stock option plan giving entitlement to purchase shares in the Sanofi parent company;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the allotment or sale of shares to employees under statutory profit sharing schemes and employee savings plans;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the consideration-free allotment of shares (i.e. restricted share plans);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the cancellation of some or all of the repurchased shares;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">market-making in the secondary market by an investment services provider under a liquidity contract in compliance with the ethical code recognized by the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Autorit&#233; des march&#233;s financiers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (AMF);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the delivery of shares on the exercise of rights attached to securities giving access to the capital by redemption, conversion, exchange, presentation of a warrant or any other means;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the delivery of shares (in exchange, as payment, or otherwise) in connection with mergers and acquisitions;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the execution by an investment services provider of purchases, sales or transfers by any means, in particular via off-market trading; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">any other purpose that is or may in the future be authorized under the applicable laws and regulations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is not subject to any constraints on equity capital imposed by third parties.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Total equity includes </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Equity attributable to equity holders of Sanofi and Equity attributable to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, as shown in the consolidated balance sheet.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi defines &#8220;Net debt&#8221; as (i)&#160;the sum of short-term debt, long-term debt and interest rate derivatives and currency derivatives used to hedge debt, minus (ii)&#160;the sum of cash and cash equivalents and interest rate derivatives and currency derivatives used to hedge cash and cash equivalents.</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-29</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_586"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">C/ <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfPrincipalAlliancesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzEzNDY4_247009db-901d-4c55-bd72-f57ed1d29059" continuedAt="ifbb849fb56014b038772da7960d7be9a" escape="true">Principal alliances</ix:nonNumeric></span></div><ix:continuation id="ifbb849fb56014b038772da7960d7be9a" continuedAt="ib10bc6c3604842a4bf13c056ed1fa3a3"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.1. Alliance arrangements with Regeneron Pharmaceuticals,&#160;Inc. (Regeneron)</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Collaboration agreements on human therapeutic antibodies</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In November&#160;2007, Sanofi and Regeneron signed <ix:nonFraction unitRef="agreement" contextRef="i20ae7da9383f4e3ab6826ded2379ded9_D20071101-20071130" decimals="INF" name="sny:NumberOfAgreementsSigned" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzIwNw_74d85d24-4b1c-45f4-a86e-1be5145bb1bb">two</ix:nonFraction> agreements (amended in November&#160;2009) relating to human therapeutic antibodies: (i)&#160;the Discovery and Preclinical Development Agreement, and (ii)&#160;the License and Collaboration Agreement, relating to clinical development and commercialization. Under the License and Collaboration Agreement, Sanofi had an option to develop and commercialize antibodies discovered by Regeneron under the Discovery and Preclinical Development Agreement.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discovery and development</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because Sanofi decided not to exercise its option to extend the Discovery and Preclinical Development Agreement, that agreement expired on December&#160;31, 2017.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As a result of Sanofi's exercise of an option with respect to an antibody under the Discovery and Preclinical Development Agreement, such antibody became a &#8220;Licensed Product&#8221; under the License and Collaboration Agreement, pursuant to which Sanofi and Regeneron co-develop the antibody with Sanofi initially being wholly responsible for funding the development program. On receipt of the first positive Phase III trial results for any antibody being developed under the License and Collaboration Agreement, the subsequent development costs for that antibody are split <ix:nonFraction unitRef="number" contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231" decimals="2" name="sny:PercentageOfSecondPartOfDevelopmentCostsFunded" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzEzOTU_59c1deca-6b3c-4b6e-bf16-e7e4b7841964">80</ix:nonFraction>% Sanofi, <ix:nonFraction unitRef="number" contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231" decimals="2" name="sny:PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE0MDY_dd07ae63-9ab6-4aa9-8a3b-c834652f1895">20</ix:nonFraction>% Regeneron. Amounts received from Regeneron under the License and Collaboration Agreement are recognized by Sanofi as a reduction in the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Co-development with Regeneron of the antibodies Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and REGN3500 (SAR440340 - itepekimab) is ongoing under the License and Collaboration Agreement as of December&#160;31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Once a product begins to be commercialized, and provided that the share of quarterly results under the agreement represents a profit, Sanofi is entitled to an additional portion of Regeneron&#8217;s profit-share (capped at <ix:nonFraction unitRef="rate" contextRef="ia94d77530caa412a8f0882f4cd79aa5f_D20220101-20221231" decimals="INF" name="sny:PercentageOfProfitShareOnCounterpartiesProfit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTIy_269a96ca-a005-42df-9e76-bf239371dda0">20</ix:nonFraction>% of Regeneron&#8217;s share of quarterly profits since April&#160;1, 2022, and at <ix:nonFraction unitRef="rate" contextRef="i2ecbe16a2f5243648f9c51e3a70306d7_D20220101-20221231" decimals="INF" name="sny:PercentageOfProfitShareOnCounterpartiesProfit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTI4_d8f688e7-b08d-4a72-8e7b-e057fa8501a0">10</ix:nonFraction>% until March&#160;31, 2022) until Regeneron has paid <ix:nonFraction unitRef="number" contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231" decimals="2" name="sny:PercentageOfCumulativeDevelopmentCostsReimbursed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNzA5_e3abce9d-f99a-43d0-ba23-e63b4d32fcc2">50</ix:nonFraction>% of the cumulative development costs incurred by the parties in the collaboration (see Note&#160;D.21.1.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On the later of (i)&#160;<ix:nonNumeric contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231" name="sny:PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzIyOTY_73ed3b2c-5e36-4fa9-88bd-e56eadd0b183">24</ix:nonNumeric> months before the scheduled launch date or (ii)&#160;the first positive Phase&#160;III trial results, Sanofi and Regeneron share the commercial expenses of the antibodies co-developed under the License and Collaboration Agreement.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercialization</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is the lead party with respect to the commercialization of all co-developed antibodies, and Regeneron has certain option rights to co-promote the antibodies. Regeneron has exercised its co-promotion rights in the United States and in certain other countries. Sanofi recognizes all sales of the antibodies. Profits and losses arising from commercial operations in the United States are split <ix:nonFraction unitRef="number" contextRef="i8340ae2fb6694e37bcf4ae4303e9d61f_D20220101-20221231" decimals="2" name="sny:PercentageOfProfitsAndLossesArisingFromCommercialOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI5Mjk_9bff84c1-f928-42e6-9fcc-f9a0fb9ae5c2">50</ix:nonFraction>/50. Outside the United States, Sanofi is entitled to between <ix:nonFraction unitRef="number" contextRef="i7b0305aa6f27497eb6fa4104c0ca63f4_D20220101-20221231" decimals="2" name="sny:PercentageOfProfitsArisingFromCommercialOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI5OTM_9d362c51-27a7-458d-a630-f23c0fd351fe">55</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i81e1dceb236f4caa96e65fbb39f6b94d_D20220101-20221231" decimals="2" name="sny:PercentageOfProfitsArisingFromCommercialOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzMwMDA_0d6dc57d-bd58-4c53-ba28-f51877a79774">65</ix:nonFraction>% of profits depending on sales of the antibodies, and bears <ix:nonFraction unitRef="number" contextRef="ic51500ccf0de43918f2456787048ab13_D20220101-20221231" decimals="2" name="sny:PercentageOfLossesArisingFromCommercialOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzMwNjI_1824c53e-d43d-4c55-8f02-135022bb0303">55</ix:nonFraction>% of any losses. The share of profits and losses due to or from Regeneron under the agreement is recognized within the line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income or Other operating expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, which are components of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, Regeneron is entitled to receive payments contingent on the attainment of specified levels of aggregate sales on all antibodies outside the United States, on a rolling twelve-month basis. A liability for those payments is recognized on the balance sheet when it is probable that the specified level of aggregate sales will be met. The opposite entry for that liability is capitalized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> on the balance sheet. <ix:nonFraction unitRef="bond" contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231" decimals="INF" name="sny:NumberOfPayments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTYz_6610d018-eb84-4945-82f2-1f61601ead30">Two</ix:nonFraction> payments of $<ix:nonFraction unitRef="usd" contextRef="i61da00769f834eaa98878f6f1e9776d7_D20220101-20221231" decimals="-6" name="sny:PaymentRelatedToAttainmentOfGoal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNTg0_e8ff34c4-1c43-41e6-a31b-de932508ccae"><ix:nonFraction unitRef="usd" contextRef="ifedcadc8c03743abbb94c99cad356d95_D20220101-20221231" decimals="-6" name="sny:PaymentRelatedToAttainmentOfGoal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNTg0_f9d135ef-0093-48e3-a903-ae98b76b3517">50</ix:nonFraction></ix:nonFraction>&#160;million each were made in 2022, following attainment first of $<ix:nonFraction unitRef="usd" contextRef="i272b0b38e1734e68a43df1ce789e2493_D20220101-20221231" decimals="-8" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNjc1_bd743a4e-b1d8-4afb-9a94-3494312c7216">2.0</ix:nonFraction>&#160;billion and then of $<ix:nonFraction unitRef="usd" contextRef="i77c108aa7495480c98890a86800bc863_D20220101-20221231" decimals="-8" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNjkw_e51fc43a-9716-4fed-aeb5-bbf659e64ca0">2.5</ix:nonFraction>&#160;billion in sales of all antibodies outside the United States on a rolling twelve-month basis. In the event that $<ix:nonFraction unitRef="usd" contextRef="i4aeff9d4cfe84f959b330be0f13f0ab9_D20220101-20221231" decimals="-8" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTM0_d056fc91-b0e2-4446-b4e7-395b81b8d823">3.0</ix:nonFraction>&#160;billion in sales on a rolling twelve-month basis is attained, Regeneron is entitled to a final milestone payment of $<ix:nonFraction unitRef="usd" contextRef="i7a8c2e8daf4d45b0bcc16547962ef088_D20220101-20221231" decimals="-6" name="sny:PaymentRelatedToAttainmentOfGoal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTQ4_ad55794f-2ec2-4925-8dde-76c38457969a">50</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amendments to the collaboration agreements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In January&#160;2018, Sanofi and Regeneron signed a set of amendments to their collaboration agreements, including an amendment that allowed for the funding of additional programs on Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and REGN3500 (SAR440340 &#8211; itepekimab) with an intended focus on extending the current range of indications, finding new indications, and improving co-morbidity between multiple pathologies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective April&#160;1, 2020, Sanofi and Regeneron signed a Cross License and Commercialization Agreement for Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, whereby Sanofi obtained sole ex-US rights to Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, and Regeneron obtained sole US rights to Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> along with a right to <ix:nonFraction unitRef="number" contextRef="iac784bc58da74b4aa8644c7bf23d67b9_D20200401-20200401" decimals="2" name="sny:RoyaltyExpensePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzQ1NDg_dc8dba95-69df-4739-9d1a-41f8bd66e534">5</ix:nonFraction>% royalties on Sanofi&#8217;s sales of Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> outside the United States. Each party is solely responsible for funding the development, manufacturing and commercialization of Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in their respective territories. Although each party has responsibility for supplying Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in its respective territory, Sanofi and Regeneron have entered into agreements to support manufacturing needs for each other.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective September&#160;30, 2021, Sanofi and Regeneron signed an amendment to their collaboration agreement in order to specify allocations of responsibilities and associated resources between the two parties in connection with the co-promotion of&#160;Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in certain countries. The terms of the collaboration relating to REGN3500 (SAR440340 &#8211; itepekimab) are unchanged.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-30</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ib10bc6c3604842a4bf13c056ed1fa3a3" continuedAt="ia92b9bcb6c2648488e7e2f104f0a74e5"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective July&#160;1, 2022, Sanofi and Regeneron signed an amendment to their collaboration agreement in order to increase the additional portion of Regeneron&#8217;s share of quarterly profits attributable to Sanofi from <ix:nonFraction unitRef="rate" contextRef="i98602d43a3714a12b2caa518ebc7b26d_D20220401-20221231" decimals="INF" name="sny:PercentageOfProfitShareOnCounterpartiesProfit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzUzODI4_dab501c3-fe7a-45f1-b1b7-7c82d92e0800">10</ix:nonFraction>% to <ix:nonFraction unitRef="rate" contextRef="ia94d77530caa412a8f0882f4cd79aa5f_D20220101-20221231" decimals="INF" name="sny:PercentageOfProfitShareOnCounterpartiesProfit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzUzODM0_7f53bded-4546-4269-891d-6734ab4960e7">20</ix:nonFraction>% with retroactive impact as of April&#160;1, 2022.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Immuno-oncology (IO) collaboration agreements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On July&#160;1, 2015, Sanofi and Regeneron signed <ix:nonFraction unitRef="agreement" contextRef="id427dce20c2b4d7697237ead9c24a9f7_D20150701-20150701" decimals="INF" name="sny:NumberOfAgreementsSigned" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzUzOTg_15653a7a-0982-4701-b4f4-e55200d07f2f">two</ix:nonFraction> agreements &#8211;&#160;the IO Discovery and Development Agreement and the IO License and Collaboration Agreement (IO LCA)&#160;&#8211; relating to new antibody cancer treatments in the field of immuno-oncology.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Amended IO Discovery Agreement, effective from December&#160;31, 2018, was terminated through a Letter Amendment dated March&#160;16,&#160;2021 in which Sanofi formalized its opt-out from the BCMAxCD3 and MUC16xCD3 programs. </span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(cemiplimab)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the 2015 IO LCA as amended in January&#160;2018, Sanofi and Regeneron committed funding of no more than $<ix:nonFraction unitRef="usd" contextRef="i78b6b504abcb44898dfcb15e0cbcf437_I20151231" decimals="-6" name="sny:PriorDevelopmentBudget" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzU5MzM_804bce63-a897-4103-b5ec-388cadaaf214">1,640</ix:nonFraction> million, split on a&#160;<ix:nonFraction unitRef="number" contextRef="i78b6b504abcb44898dfcb15e0cbcf437_I20151231" decimals="INF" name="sny:ContractualAgreementForAntiProgrammedCellDeathProtein1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzU5NDg_cf811249-bfce-464a-bba3-d4cd9d802c7f">50</ix:nonFraction>/50 basis ($<ix:nonFraction unitRef="usd" contextRef="ic8a9426091cb480c8f68708490b978f0_D20150101-20151231" decimals="-6" name="sny:MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzU5NjI_e2590d91-d848-4176-a89a-75a646807fc0">820</ix:nonFraction> million per company), for the development of REGN2810 (cemiplimab, trademark Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), a PD-1 inhibitor antibody. The funding was raised to $<ix:nonFraction unitRef="usd" contextRef="i050c4dcdac6845d58381cc5689aef318_D20210930-20210930" decimals="-6" name="sny:MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzYwOTg_2759cd81-f1e6-413e-b064-18833e2a86f2">1,840</ix:nonFraction>&#160;million by way of amendment effective on September&#160;30, 2021. Regeneron was responsible for the commercialization of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the United States, and Sanofi in all other territories. Sanofi has exercised its option to co-promote Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the United States. In 2021, Regeneron exercised its option to co-promote Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in certain other countries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The IO LCA also provided for a one-time milestone payment of $<ix:nonFraction unitRef="usd" contextRef="ic8a9426091cb480c8f68708490b978f0_D20150101-20151231" decimals="-6" name="sny:AntiProgrammedCellDeathProtein1SalesMilestonePayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzY1MDU_877cfcf9-675a-4051-b08a-6abb3d005807">375</ix:nonFraction> million by Sanofi to Regeneron in the event that sales of a PD-1 product were to exceed, in the aggregate, $<ix:nonFraction unitRef="usd" contextRef="ic8a9426091cb480c8f68708490b978f0_D20150101-20151231" decimals="-9" name="sny:MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzY2MDc_512f5b60-1f3d-4862-9269-c5496815d394">2</ix:nonFraction> billion in any consecutive 12-month period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the IO LCA Sanofi and Regeneron shared equally in profits and losses generated by the commercialization of collaboration products, except that Sanofi was entitled to an additional portion of Regeneron&#8217;s profit-share (capped at <ix:nonFraction unitRef="number" contextRef="ibc2546af5e7749c8beb48751c8dc0bf5_D20150101-20151231" decimals="2" name="sny:PercentageOfProfitShareOnCounterpartiesProfit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzY4ODM_cf3f59d6-ba38-4192-bb3f-e209487954d6">10</ix:nonFraction>% of Regeneron&#8217;s share of quarterly profits) until Regeneron had paid <ix:nonFraction unitRef="number" contextRef="ibc2546af5e7749c8beb48751c8dc0bf5_D20150101-20151231" decimals="2" name="sny:PercentageOfCumulativeDevelopmentCostsReimbursed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzY5NTQ_b4fda46f-659c-470d-a175-3481798b0235">50</ix:nonFraction>% of the cumulative development costs incurred by the parties under the IO Discovery Agreement, as amended.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is approved in the United States and Europe for the treatment of two types of locally advanced or metastatic skin cancer (cutaneous squamous cell carcinoma and basal cell carcinoma) and non-small cell lung cancer (NSCLC). It is also approved in Brazil and Canada as a second line treatment for recurring or metastatic cervical cancer. In the fourth quarter of 2022, it was approved in the United States in association with chemotherapy for the treatment of NSCLC, and in Europe and Japan as a second line treatment for recurring or metastatic cervical cancer. Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently approved in more than 30&#160;countries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;2022, Sanofi and Regeneron restructured their IO LCA. Under the terms of the Amended and Restated IO LCA, Regeneron holds exclusive worldwide licensing rights to Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> with effect from July&#160;1, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In July&#160;2022, Sanofi received as consideration an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ia4868bf0ce374326a873eb079a2f01ee_D20220701-20220731" decimals="-6" name="sny:UpfrontPaymentsForProjectsUnderCollaborationAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzgzMDEzMTI3OTQxMTY2_b18673cb-b4a4-4c27-b68d-04eada2fc553">900</ix:nonFraction>&#160;million (&#8364;<ix:nonFraction unitRef="eur" contextRef="ia4868bf0ce374326a873eb079a2f01ee_D20220701-20220731" decimals="-6" name="sny:UpfrontPaymentsForProjectsUnderCollaborationAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTc0_8bf6b6f0-bf88-4869-9bda-cd67bcc7276a">856</ix:nonFraction>&#160;million), which was recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> on the date of receipt. The same line item also includes a regulatory milestone payment of $<ix:nonFraction unitRef="usd" contextRef="i8f408d44df6a499394b5c347b1c34f80_D20220601-20220630" decimals="-6" name="sny:RegularMilestonePaymentsForProjectsUnderCollaborationAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzgzMDEzMTI3OTQxMTkz_395c0c27-f414-4d03-ab76-e66a66dfafcd">100</ix:nonFraction>&#160;million (&#8364;<ix:nonFraction unitRef="eur" contextRef="i8f408d44df6a499394b5c347b1c34f80_D20220601-20220630" decimals="-6" name="sny:RegularMilestonePaymentsForProjectsUnderCollaborationAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTg5_11d048e5-1137-4f85-b25e-d663935a090e">96</ix:nonFraction>&#160;million) following the US FDA approval in November&#160;2022 of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with chemotherapy as a first line treatment for NSCLC. In addition, Sanofi is entitled to royalties of <ix:nonFraction unitRef="number" contextRef="ia4868bf0ce374326a873eb079a2f01ee_D20220701-20220731" decimals="2" name="sny:RoyaltyIncomePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzgwODE0MTA0Njk1Mzg5_7e7482fc-a061-4358-89eb-203a738bbd38">11</ix:nonFraction>% and to milestone payments (&#8364;<ix:nonFraction unitRef="eur" contextRef="i6fbbad3af70b4c90a3eb35e084814290_D20220101-20221231" decimals="-6" name="ifrs-full:OtherOperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzU0MzA1_771cb001-b822-4916-849f-194bb8da7baa">111</ix:nonFraction>&#160;million in 2022) linked to global net sales of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> which are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in line with the pattern of sales . All of the cash inflows relating to the above items (&#8364;<ix:nonFraction unitRef="eur" contextRef="i6fbbad3af70b4c90a3eb35e084814290_D20220101-20221231" decimals="-6" name="sny:ProceedsFromCollaborationAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MjAy_1ce0f82e-3a1b-41cb-9e88-7c4c35841d7d">967</ix:nonFraction>&#160;million for the year ended December&#160;31, 2022) are presented within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net cash provided by/(used in) operating activities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amendment to the terms of the IO LCA resulted in Sanofi recognizing an accelerated amortization charge of &#8364;<ix:nonFraction unitRef="eur" contextRef="i8076a1036c53486c9cf0fadf596f4f82_I20221231" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzgzMDEzMTI3OTQxMjIw_f40ea14d-e24c-4c6f-9eb4-7442a6489855">226</ix:nonFraction>&#160;million; this was allocated to the Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">product rights included within the residual carrying amount of the intangible asset recognized in July&#160;2015 to reflect rights to an antibody targeting the immune checkpoint receptor PD-1 (programmed cell death protein-1) under the Sanofi/Regeneron alliance.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The transaction also includes a time-limited transitional services agreement with Regeneron which includes manufacturing, distribution (for which Sanofi acts as agent), and promotion.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Investor agreement</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2014 and 2020, Sanofi and Regeneron amended the investor agreement entered into by the two companies in 2007. Under the terms of the amendments, Sanofi accepted various restrictions, including &#8220;standstill&#8221; provisions that contractually prohibit Sanofi from seeking to directly or indirectly exert control of Regeneron or acquiring more than <ix:nonFraction unitRef="number" contextRef="i0515044855e14c60a51bff4d7c49cee9_D20140101-20140131" decimals="INF" name="sny:MaximumOwnershipPercentageAllowedToAcquire" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNzI0_80c55718-eacf-4ef0-bd62-4059f64383df">30</ix:nonFraction>% of Regeneron&#8217;s capital stock (consisting of the outstanding shares of common stock and the shares of Class A stock). This prohibition remains in place until the earlier of (i)&#160;the later of the fifth anniversaries of the expiration or earlier termination of the Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> collaboration agreement with Regeneron (related to the development and commercialization of Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) or the collaboration agreement with Regeneron on monoclonal antibodies (see &#8220;Collaboration agreements on human therapeutic antibodies&#8221; above), each as amended and (ii)&#160;other specified events.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Starting in 2018 Sanofi began to sell shares of Regeneron stock and announced on May&#160;29,&#160;2020 the closing of its sale of <ix:nonFraction unitRef="shares" contextRef="id3e2037ecf8e496eaf3ae27c42505f70_D20200529-20200529" decimals="INF" name="sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNzI5_1c839b55-f561-419a-a74d-673f711bdf96">13</ix:nonFraction>&#160;million shares of Regeneron common stock in a registered offering and a private sale to Regeneron (see Note&#160;D.2.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Pursuant to subsequent sales, as of December&#160;31, 2022 Sanofi no longer holds any shares of Regeneron stock.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-31</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ia92b9bcb6c2648488e7e2f104f0a74e5"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.2. Alliance arrangements with Bristol-Myers Squibb (BMS)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="product" contextRef="ie8cdba1a7ee34963bcb9d8c5981f4337_D20220101-20221231" decimals="INF" name="sny:NumberOfProductsJointlyDeveloped" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzExMjcw_7152f01a-9032-4495-9d5a-4388ec5aac1b">Two</ix:nonFraction> of Sanofi&#8217;s products were jointly developed with BMS: the anti-hypertensive agent irbesartan (Aprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Karvea</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) and the anti-atherothrombosis treatment clopidogrel bisulfate (Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Iscover</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;27, 2012, Sanofi and BMS signed an agreement relating to their alliance following the loss of exclusivity of Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in many major markets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the terms of this agreement, effective January&#160;1, 2013, BMS returned to Sanofi its rights to Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in all markets worldwide with the exception of Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the United States and Puerto Rico (&#8220;Territory&#160;B&#8221;), giving Sanofi sole control and freedom to operate commercially in respect of those products. In exchange, BMS received royalty payments on Sanofi&#8217;s sales of branded and unbranded Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> worldwide (except for Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Territory&#160;B) until 2018, and also received a payment of $<ix:nonFraction unitRef="usd" contextRef="i314c45a3e1e647bcae2d4dabeea5fe4d_D20181201-20181231" decimals="-6" name="sny:RoyaltiesPaymentsMadeBySanofi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzEyMTkx_2357e523-2a04-467f-b447-50addedaa203">200</ix:nonFraction> million from Sanofi in December&#160;2018, part of which is for buying out the non-controlling interests. Rights to Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Territory&#160;B remained unchanged and continued to be governed by the terms of the original agreement until&#160;February&#160;28, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In all of the territories managed by Sanofi (including the United States and Puerto Rico for Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) as defined in the new agreement, Sanofi recognized in its consolidated financial statements the revenue and expenses generated by its own operations. Since January&#160;2019 onwards, there has no longer been any share of profits reverting to BMS (previously presented within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to non-controlling interests </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the income statement).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Territory&#160;B for Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, which was managed by BMS, the Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> business was conducted through the Territory&#160;B partnerships, which were jointly owned by BMS and Sanofi. Sanofi recognized its share of profits and losses within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;28, 2020, Sanofi purchased all BMS&#8217;s interests (<ix:nonFraction unitRef="number" contextRef="i860a838707c64bfb8b697db6c3bbeeb6_I20200228" decimals="3" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzEzMjcz_eea54d08-2fb2-4453-9033-9b5267078c5a">50.1</ix:nonFraction>%) in each of the Territory&#160;B partnerships for a cumulative purchase price of $<ix:nonFraction unitRef="usd" contextRef="i9016dbf3a1c5430f9125964cc371f4de_D20200228-20200228" decimals="-6" name="ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzEzMzUy_c9ab7b42-e7f6-4ee4-8139-9d2ce7bb652f">12</ix:nonFraction>&#160;million. Following a transition period, Sanofi has been commercializing Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> under its own label since&#160;July&#160;1, 2020.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_589"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">D/ <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODkvZnJhZzpkZTFkOWJkNDYxMmI0NmNiYjM1NDRkNmMwZjU2NDAzYS90ZXh0cmVnaW9uOmRlMWQ5YmQ0NjEyYjQ2Y2JiMzU0NGQ2YzBmNTY0MDNhXzQ4_7b7ecc7a-5b12-4a0c-9811-aaef33156844" continuedAt="i2e5a7d05d9134b28aa1cb85095de5126" escape="true">Presentation of the financial statements</ix:nonNumeric></span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_592"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.1. <ix:continuation id="i2e5a7d05d9134b28aa1cb85095de5126" continuedAt="i0f0a779b882749d89a1fa32b0b380bba">Principal changes in the scope of consolidation in 2022</ix:continuation></span></div><ix:continuation id="i0f0a779b882749d89a1fa32b0b380bba" continuedAt="ice4e98cbfa1f484facfb8fbe617016c2"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Amunix Pharmaceuticals, Inc.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;8, 2022, Sanofi acquired the entire share capital of the immuno-oncology company Amunix Pharmaceuticals, Inc. (Amunix), thereby gaining access to Amunix&#8217;s innovative Pro-XTEN</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> technology and a promising pipeline of immunotherapies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition price of Amunix comprises a fixed cash payment of &#8364;<ix:nonFraction unitRef="eur" contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208" decimals="-6" name="ifrs-full:CashTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDU1_43992b91-26fb-48ab-9ae4-8d59b551f218">970</ix:nonFraction>&#160;million, plus contingent consideration in the form of milestone payments based on attainment of certain future development objectives of up to $<ix:nonFraction unitRef="usd" contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208" decimals="-6" name="sny:CommitmentsRelatedToMilestonePaymentsBusinessCombinations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDYz_787b690d-5a5f-4958-8316-bbeb758c655d">225</ix:nonFraction>&#160;million, the fair value of which as of the acquisition date was &#8364;<ix:nonFraction unitRef="eur" contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208" decimals="-6" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDcw_934fbad8-b30f-4113-9655-5507078f3e63">156</ix:nonFraction>&#160;million. In accordance with IFRS&#160;3, this contingent purchase consideration was recognized in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations and non-controlling interests </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(see Note&#160;D.18.).</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzI2OTM4MDM0OTEyMTMz_74b8526d-ef3d-4aa4-9fa5-42392850c720" continuedAt="ida9b822892b74c69a7184b1430e548a4" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation led to the recognition of &#8364;<ix:nonFraction unitRef="eur" contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDc4_0e0bffe2-ee22-4124-82a4-d4de7e767f9d">609</ix:nonFraction>&#160;million of goodwill, determined as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:72.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzEtMS0xLTEtNDExMjM0_1cf60165-8398-46a6-8aee-fa3be6913c62">493</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208" decimals="-6" sign="-" name="sny:OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzQtMS0xLTEtNDExMjQ0_2666674e-6a28-4a9f-a6b1-556e70032b86">13</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208" decimals="-6" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzUtMS0xLTEtNDExMjQ0_7a4fd7e8-cc57-46d3-b713-ad8c7e121bf5">118</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred taxes, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208" decimals="-6" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzYtMS0xLTEtNDExMjQ0_a7a4162c-5357-497a-8b5e-1a85eee9b265">81</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Amunix</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208" decimals="-6" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzctMS0xLTEtNDExMjQ0_52a4efab-806b-403e-9072-fac0f6b215cc">517</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzgtMS0xLTEtNDExMjQ0_eebca1a0-183c-40db-ac65-ebd768a2359d">609</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208" decimals="-6" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzktMS0xLTEtNDExMjQ0_e43da90e-55fa-461a-836f-f635d67e75da">1,126</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Other intangible assets&#8221; comprise Pro-XTEN</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, an innovative universal protease-releasable masking technology platform for the discovery and development of transformative cytokine therapies and T-cell engager (TCE) immunotherapies for patients with cancer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill mainly represents the value of Amunix&#8217;s upstream research and development pipeline of immuno-oncology therapies based on next-generation conditionally activated biologics, especially when combined with Sanofi&#8217;s existing oncology portfolio.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition does not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amunix has no commercial operations, and has made a negative contribution of &#8364;<ix:nonFraction unitRef="eur" contextRef="i65f4119d82404c94a1b140ad21401ade_D20220208-20221231" decimals="-6" sign="-" name="ifrs-full:ProfitLossOfAcquiree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDg2_e24ec0f0-4bda-4c1f-ab5f-b27ea1d19a4c">56</ix:nonFraction>&#160;million to Sanofi&#8217;s consolidated net income since the acquisition date.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acquisition-related costs were recognized in profit or loss during 2021, primarily within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; the amount involved was immaterial.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a cash outflow of &#8364;<ix:nonFraction unitRef="eur" contextRef="i65f4119d82404c94a1b140ad21401ade_D20220208-20221231" decimals="-6" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDk1_efdd6b68-197d-4966-90d1-c1bb7bf16e29">852</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-32</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ice4e98cbfa1f484facfb8fbe617016c2" continuedAt="ie02d17b66b7a474a99697c1fd5653bea"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">EUROAPI - Loss of control and accounting implications</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On March&#160;17, 2022, the Sanofi Board of Directors approved a decision to put to a shareholder vote the proposed distribution in&#160;kind of approximately <ix:nonFraction unitRef="number" contextRef="i8fc2b038dd1b4b99af69531ba3b92293_D20220317-20220317" decimals="2" name="sny:ExceptionalSupplementaryDividendProposedPercentageOfShareCapital" scale="4" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTMzODQ_99d23af7-4392-4928-9d51-9010d4e74d59">58</ix:nonFraction>% of the share capital of EUROAPI, thereby confirming Sanofi&#8217;s commitment (announced in February&#160;2020) to discontinue its active pharmaceutical ingredient operations. As part of the same corporate action and on the same date, Sanofi entered into an investment agreement with EPIC Bpifrance, which undertook to acquire from Sanofi &#8211; via the French Tech Souverainet&#233; fund &#8211; a <ix:nonFraction unitRef="number" contextRef="i8ae83ecb331f49f8875bcbe2fd731a7e_I20220317" decimals="2" name="sny:PercentageOfVotingEquityInterestsDivested" scale="4" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTMzODg_77b64eb9-9eb3-46fd-8f51-c822ff4f2413">12</ix:nonFraction>% equity interest in EUROAPI at a price not exceeding &#8364;<ix:nonFraction unitRef="eur" contextRef="i5cb73aa7ccfe4ce5ae53a260cb785a4c_D20220317-20220317" decimals="-6" name="sny:ConsiderationTransferredMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTMzOTI_ac9b5544-090e-4d28-963b-ad92eba6c45f">150</ix:nonFraction>&#160;million and to be determined on the basis of the volume weighted average price (VWAP) of EUROAPI shares on the Euronext Paris regulated market over the&#160;<ix:nonNumeric contextRef="i5cb73aa7ccfe4ce5ae53a260cb785a4c_D20220317-20220317" name="sny:ConsiderationTransferredValuationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzI2OTM4MDM0OTEyMTE3_f7ac03ba-feab-4d1d-a1a4-ec5427e6fe12">thirty-day</ix:nonNumeric> period starting from the date of initial listing, i.e. May&#160;6, 2022. On completion of those transactions, Sanofi holds an equity interest of <ix:nonFraction unitRef="number" contextRef="id97d7b03002b4aba8b5f84d88ed212ab_D20220510-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInAssociate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzgwODE0MTA0NjkyMzkz_1f8e9100-9167-4f1e-91d4-a0901aaf46a9">30.1</ix:nonFraction>% in EUROAPI, which it has undertaken to retain for at least <ix:nonNumeric contextRef="ib9f02c4c8a3b46c8b47a31e54332ecc1_D20220510-20220510" name="sny:OwnershipInterestInSubsidiaryMinimumHoldingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzI2OTM4MDM0OTEyMTE4_c0103bd6-ea6f-4b69-88e7-395fb375f33e">two years</ix:nonNumeric> from the date of the distribution, subject to the customary exceptions. With effect from that date, Sanofi exercises significant influence over EUROAPI as a result of (i)&#160;its equity interest, and (ii)&#160;having one representative on the EUROAPI Board of Directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;3, 2022, the General Meeting of Sanofi shareholders approved the decision of the Board of Directors to distribute approximately <ix:nonFraction unitRef="number" contextRef="i75540facaacb400d8502084443749f05_D20220503-20220503" decimals="2" name="sny:ExceptionalSupplementaryDividendPercentageOfShareCapital" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0MjE_4659817a-21d2-4c08-be47-b2a50c5a8ffb">58</ix:nonFraction>% of the share capital of EUROAPI in the form of an exceptional dividend in kind.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;10, 2022, the payment date of the dividend in kind in the days following the admission to listing of EUROAPI shares, those Sanofi shareholders who had retained their Sanofi shares received <ix:nonFraction unitRef="shares" contextRef="i869e6282be074d28b9a1712822c9f46b_I20220510" decimals="INF" name="sny:SpecialDistributionSharesReceivedPerConversionOfParentShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzMxNzUx_f1c4062d-ff10-4542-9e1c-38aafcc33648">1</ix:nonFraction>&#160;EUROAPI share per <ix:nonFraction unitRef="shares" contextRef="i869e6282be074d28b9a1712822c9f46b_I20220510" decimals="INF" name="sny:SpecialDistributionNumberOfSharesConverted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzMxNzU0_9ab304be-f7be-4f6e-a145-6d1f3f707b8b">23</ix:nonFraction>&#160;Sanofi shares, representing in total&#160;<ix:nonFraction unitRef="number" contextRef="i869e6282be074d28b9a1712822c9f46b_I20220510" decimals="4" name="sny:SpecialDistributionPercentageOfShareCapitalDistributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0MjY_1ebcb667-e462-4c5c-92ac-03e6f128f51e">57.88</ix:nonFraction>% of the share capital of EUROAPI. As of that date, Sanofi lost control over the EUROAPI entities, based on an assessment of the criteria specified in IFRS&#160;10 (Consolidated financial statements). The assets and liabilities of EUROAPI, which since March&#160;17, 2022 had been presented as assets and liabilities held for sale within the Sanofi statement of financial position in accordance with IFRS&#160;5 (Non-Current Assets Held for Sale), were deconsolidated. In addition, because EUROAPI operations do not constitute a discontinued operation under IFRS&#160;5, the contribution from EUROAPI has not been presented within separate line items in the income statement and statement of cash flows or in information for prior comparative periods. The contribution of EUROAPI operations to the consolidated net sales of Sanofi in the year ended December&#160;31, 2021 was &#8364;<ix:nonFraction unitRef="eur" contextRef="i31105a7d607d4af49033461835874947_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0MzA_7d23d005-5925-407c-8ed5-a4ba0c9744fc">486</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal consequences of the deconsolidation of EUROAPI are described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the derecognition of the carrying amount of all the assets and liabilities of EUROAPI, representing a net amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510" decimals="-6" name="sny:DecreaseThroughLossOfControlOfSubsidiaryNetAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0NDI_fa3925cc-ca67-4b46-940b-e93809551e6f">1,227</ix:nonFraction>&#160;million as of May&#160;10, 2022. This includes goodwill of &#8364;<ix:nonFraction unitRef="eur" contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510" decimals="-6" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0NTQ_b1c49a6e-5c76-4677-83cd-b5ad54f02cf5">164</ix:nonFraction>&#160;million, determined in accordance with IAS&#160;36 (&#8220;Impairment of Assets&#8221;), which was historically allocated to the Pharmaceuticals cash generating unit (CGU), and which for the purposes of the deconsolidation was allocated using an alternative method based on the relative values of goodwill as of the date of consolidation (the &#8220;notional goodwill method&#8221;). That method was considered more appropriate to the capital-intensive nature of EUROAPI operations than the method based on the relative values of EUROAPI operations and the retained portion of the&#160;CGU;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a reduction in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Equity attributable to equity holders </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">of Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> reflecting the distribution in kind, measured at &#8364;<ix:nonFraction unitRef="eur" contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231" decimals="-6" name="sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0NjY_5f4b2acc-6827-4003-b32c-0acf77491343">793</ix:nonFraction>&#160;million based on the weighted average price of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510" decimals="2" name="ifrs-full:WeightedAverageSharePrice2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0OTI_65dfeff8-ff7c-4b8f-b214-1d617ed037d3">14.58</ix:nonFraction> per share as of the date of delivery of the EUROAPI shares to Sanofi shareholders and corresponding to the fair value of the distribution in accordance with IFRIC&#160;17 (Distribution of Non-Cash Assets to Owners);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a cash inflow of &#8364;<ix:nonFraction unitRef="eur" contextRef="i1363015e33be4996b0e8a89139d4895f_D20220617-20220617" decimals="-6" name="sny:ConsiderationTransferredMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0OTY_a1575755-ffa9-47da-afdb-6f4bc7cd67e2">150</ix:nonFraction>&#160;million from the divestment of <ix:nonFraction unitRef="number" contextRef="i50fb7abe554a4e5b9bda9e50cdfd1966_I20220617" decimals="2" name="sny:PercentageOfVotingEquityInterestsDivested" scale="4" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1MDg_05ae8655-a056-4a08-a8b5-95a58147931c">12</ix:nonFraction>% of the share capital of EUROAPI to EPIC Bpifrance as of the settlement date of the shares, i.e. June&#160;17, 2022;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the recognition in the statement of financial position, within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, of the retained <ix:nonFraction unitRef="number" contextRef="id97d7b03002b4aba8b5f84d88ed212ab_D20220510-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInAssociate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1MTI_2ccba3da-50d2-4152-be2f-ca5f04a06ae6">30.1</ix:nonFraction>% equity interest in EUROAPI at an amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="ifc8f06a841e6428180d8121555e73740_I20221231" decimals="-6" name="ifrs-full:InvestmentAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1MTY_2f63d3ee-1b85-408d-b82e-04b476c952e0">413</ix:nonFraction>&#160;million, determined on the basis of the weighted average price of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510" decimals="2" name="ifrs-full:WeightedAverageSharePrice2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1Mjg_33dde466-16dd-48e4-a728-f60429e6bd32">14.58</ix:nonFraction> per share and representing the fair value of the equity interest in accordance with IFRS&#160;10;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the reclassification within the net gain/loss on deconsolidation of unrealized foreign exchange losses amounting to &#8364;<ix:nonFraction unitRef="eur" contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510" decimals="-6" name="ifrs-full:NetForeignExchangeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1MzI_9e87a9d9-9029-449d-80ec-d4f13de95e5a">35</ix:nonFraction>&#160;million arising on EUROAPI subsidiaries, in accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the recognition of transaction-related costs and of the effects of undertakings made under agreements entered into with EUROAPI setting out the principles and terms of the legal reorganization carried out ahead of the date of deconsolidation. The principal undertakings made to EUROAPI relate to compensation for:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">environmental remediation obligations on non-operational chemical sites in France transferred to EUROAPI, amounting to&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i67af3f0fc7dd4b2eaa2a63d60e4251a0_I20220510" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1NDY_cf8e3c2c-3f3e-4085-9ca2-50d6e2934129">14</ix:nonFraction> million, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">regulatory compliance costs relating to certain state-of-the-art active pharmaceutical ingredients of EUROAPI, capped at&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="ieddf1529368346c285a415c5ccebe6b7_I20220510" decimals="-6" name="ifrs-full:OtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1NTg_1375f2d0-51f9-496c-96a8-3b3e90ad1e27">15</ix:nonFraction> million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These elements collectively resulted in a pre-tax loss on deconsolidation of &#8364;<ix:nonFraction unitRef="eur" contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510" decimals="-6" name="sny:OtherGainsLossesAndLitigation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzI2OTM4MDM0OTEyMTIw_bd174f10-ba50-4b1d-995c-75443492b02e">3</ix:nonFraction>&#160;million, presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement. The tax effect of the deconsolidation was a net gain of &#8364;<ix:nonFraction unitRef="eur" contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510" decimals="-6" sign="-" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1ODI_0e57aa25-e39b-4b43-a0a1-5cc5081c0201">111</ix:nonFraction> million, presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the income statement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The cash impact of the deconsolidation of EUROAPI, presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Disposals of consolidated undertakings and investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the statement of cash flows, was a net cash inflow of &#8364;<ix:nonFraction unitRef="eur" contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510" decimals="-6" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1OTQ_6d35a61e-f444-4997-bbbb-7d442b4906fd">101</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has entered into an agreement with EUROAPI for the manufacture and supply of active pharmaceutical ingredients, intermediates and other substances, which took effect on October&#160;1, 2021 and expires <ix:nonNumeric contextRef="i34419df6f45d4271bd03deeb7650e44d_D20211001-20211001" name="sny:CollaborationAgreementPeriodAfterLossOfControl" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzQzNDMwNzA5MzI4Nzc3_780555bd-367c-4420-83b4-38db314a8f78">five years</ix:nonNumeric> after the loss of control. Under the terms of the agreement, Sanofi committed to target annual net sales of approximately &#8364;<ix:nonFraction unitRef="eur" contextRef="i2b3edabed67d4c528f7b9b3aa5532b9e_I20211001" decimals="-6" name="sny:CollaborationAgreementAnnualNetSalesTarget" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM2MTA_e0103040-0fdb-43ae-a8c6-dea069b036e8">300</ix:nonFraction>&#160;million for a list of specified active ingredients until the agreement expires in 2026. As of December&#160;31, 2022, that commitment amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i77db5a6ce6f941378dabe84d0fb99691_I20221231" decimals="-8" name="sny:CollaborationAgreementCommitmentAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM2MjI_1ba7bf8b-9ebf-4648-9d21-f1091d29c214">1.1</ix:nonFraction>&#160;billion.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">With effect from the date of deconsolidation, the <ix:nonFraction unitRef="number" contextRef="id97d7b03002b4aba8b5f84d88ed212ab_D20220510-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInAssociate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM2MzQ_93defab6-944e-45f2-8ec3-40715744e80f">30.1</ix:nonFraction>% equity interest in EUROAPI is accounted for using the equity method in accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), and the share of EUROAPI profits or losses arising from application of the equity method is excluded from &#8220;Business operating income&#8221;, the non-IFRS financial indicator used internally by&#160;Sanofi to measure the performance of its operating segments.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-33</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_595"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ie02d17b66b7a474a99697c1fd5653bea" continuedAt="idcf3f16ecd6143c5a04bc28fdb567497"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.2. Principal changes in the scope of consolidation in 2021 and 2020</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.2.1. Principal changes in the scope of consolidation in 2021</span></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Kymab</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;8, 2021, Sanofi acquired the entire share capital of Kymab for an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="iee572facf17d4fcf8b3895371e7c97f1_I20210408" decimals="-8" name="ifrs-full:CashTransferred" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEwMDIz_8f2c923a-dc45-4224-a67a-a14dc0e15ca9">1.1</ix:nonFraction> billion (&#8364;<ix:nonFraction unitRef="eur" contextRef="iee572facf17d4fcf8b3895371e7c97f1_I20210408" decimals="-6" name="ifrs-full:CashTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEwMDI4_10f13e63-0116-450b-84ca-b37a624c6eca">973</ix:nonFraction> million) and up to&#160;$<ix:nonFraction unitRef="usd" contextRef="iee572facf17d4fcf8b3895371e7c97f1_I20210408" decimals="-6" name="sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEwMDQz_f0b0b282-61ea-4182-941e-c41f21604662">350</ix:nonFraction> million contingent upon reaching certain development milestones.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the KY1005 project, currently in Phase&#160;II clinical development, and relating to the human monoclonal antibody OX40L, an essential regulator of the immune system) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;<ix:nonFraction unitRef="eur" contextRef="iee572facf17d4fcf8b3895371e7c97f1_I20210408" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEwNjAx_52080e36-9af5-4ab5-bb92-86c9c31dcf79">965</ix:nonFraction> million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;<ix:nonFraction unitRef="eur" contextRef="i4b42acc0514d4e10970ac15d3afcb8ad_D20210101-20211231" decimals="-6" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTExMDU3_66654add-78bf-4a28-ab57-7439c94f1327">932</ix:nonFraction> million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Kiadis</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;2, 2020, Sanofi and Kiadis, a biopharmaceutical company developing novel "off-the-shelf" natural killer (NK) cell therapies for patients with life-threatening diseases, entered into a definitive agreement whereby Sanofi was to make a public offer to acquire the entire share capital of Kiadis, i.e. <ix:nonFraction unitRef="shares" contextRef="i11073bbcc0a14c62b570fb898e98d18d_I20201102" decimals="-6" name="sny:BusinessCombinationNumberOfSharesIncludedInPublicOffering" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTExMzk1_df5706a4-64af-4e5d-8f96-98d4b53d8593">61</ix:nonFraction>&#160;million shares, at a cash price of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i11073bbcc0a14c62b570fb898e98d18d_I20201102" decimals="2" name="sny:BusinessCombinationPurchasePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTExNDI3_1c58b627-a7e5-4686-893a-f67ee34d0b19">5.45</ix:nonFraction> per share.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition was approved unanimously by the Boards of Directors of Sanofi and Kiadis, and <ix:nonFraction unitRef="number" contextRef="ifa7ce4e64a0145088c122905f0dc3331_D20210416-20210416" decimals="4" name="sny:BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTExNTM2_6b127592-fa3e-48e4-b10a-6b414f154fba">95.03</ix:nonFraction>% of the share capital of Kiadis had been tendered into the offer as of April&#160;16, 2021. As of the end of the post-closing acceptance period on April&#160;29, 2021, Sanofi held&#160;<ix:nonFraction unitRef="number" contextRef="i3392c86b77ce4ec1ae56d2c26b0f10f0_D20210429-20210429" decimals="4" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTExNzA5_49a4f9cf-176c-4f74-91af-29e4b2880811">97.39</ix:nonFraction>% of the share capital of Kiadis, and proceeded to buy out the remaining non-controlling shareholders. As of&#160;December&#160;31, 2022, Sanofi held <ix:nonFraction unitRef="number" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="2" name="sny:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzgzMDEzMTI3OTI4NDc3_9e205536-7685-4f1f-85e6-a9e69b52a506">100</ix:nonFraction>% of the share capital of Kiadis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the K-NK technology platform) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;<ix:nonFraction unitRef="eur" contextRef="i1e3f5c0fbd854b0887ac60561bc8bbe1_I20210429" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEyMjA1_e1571cf2-9cfe-4078-b35f-2b646a8f74df">339</ix:nonFraction> million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;<ix:nonFraction unitRef="eur" contextRef="ib1ab1eca87aa42b79b79ae7cb8a40079_D20210101-20211231" decimals="-6" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEyNjYx_ce46836b-ea03-408f-a94e-a339845226a0">326</ix:nonFraction> million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Tidal</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;9, 2021, Sanofi acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a unique mRNA-based approach for in vivo reprogramming of immune cells. The new technology platform will expand Sanofi&#8217;s research capabilities in immuno-oncology and inflammatory diseases, and may have applicability to other disease areas as well.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Tidal Therapeutics was acquired for an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i37e52c8c761c4a2c94bcd4c10a298624_I20210409" decimals="-6" name="ifrs-full:CashTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjM1_19cf4c9a-e446-4ad4-a60e-2400bf5babee">160</ix:nonFraction>&#160;million (&#8364;<ix:nonFraction unitRef="eur" contextRef="i37e52c8c761c4a2c94bcd4c10a298624_I20210409" decimals="-6" name="ifrs-full:CashTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjQy_4edbd46e-05b1-4a6d-b03b-dca8d8fbac32">136</ix:nonFraction>&#160;million), and up to $<ix:nonFraction unitRef="usd" contextRef="i91ee802320a44a84b28df3ca02a2a4c6_I20210409" decimals="-6" name="sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjUx_12e8fe2d-fa58-4e8e-b6fe-5f525d4c0c61">310</ix:nonFraction>&#160;million contingent upon reaching certain development milestones.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the unique mRNA-based in vivo reprogramming technology) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;<ix:nonFraction unitRef="eur" contextRef="i91ee802320a44a84b28df3ca02a2a4c6_I20210409" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjYx_a1ae24a5-a040-49da-a51a-f024ab97b9a6">130</ix:nonFraction>&#160;million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;<ix:nonFraction unitRef="eur" contextRef="i50186dc8e2144cf580cb8c90422239bc_D20210101-20211231" decimals="-6" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjgx_5c0cb9df-9975-431e-9486-051ea60e98a1">135</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Translate Bio</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On August&#160;3, 2021, Sanofi entered into a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutics company, under which Sanofi was to acquire all outstanding shares of Translate Bio for $<ix:nonFraction unitRef="usdPerShare" contextRef="i779663ca39724fff9eb372087b37e45b_I20210803" decimals="2" name="sny:BusinessCombinationPurchasePricePerShare" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMTk0_58a98f32-3581-49ce-b782-93f4531544ba">38</ix:nonFraction> per share. The Sanofi and Translate Bio Boards of Directors unanimously approved the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition of Translate Bio by Sanofi was completed on September&#160;14, 2021, with Sanofi holding the entire share capital of Translate&#160;Bio upon expiration of the squeeze-out procedure.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-34</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="idcf3f16ecd6143c5a04bc28fdb567497" continuedAt="i0478e9c1859646dbbce3a8bbfbf2ab7d"><ix:continuation id="ida9b822892b74c69a7184b1430e548a4" continuedAt="iee21ca335bac4cf5b2e9e58972b0d787"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;<ix:nonFraction unitRef="eur" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjAw_9b2fab91-aa10-4c52-86df-14e14d47e832">2,118</ix:nonFraction>&#160;million:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:72.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzEtMS0xLTEtNDQ5Mzg5_9621582e-b9f2-45ed-8b10-e841d0a4e248">396</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="-6" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzItMS0xLTEtNDQ5Mzg5_46e46ae6-dfbf-47e7-9e8b-cd6c1ca887a3">93</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="-6" name="sny:OtherAssetsAndLiabilitiesAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzMtMS0xLTEtNDQ5Mzg5_85840ab3-24cc-447c-adea-42357acb2f13">235</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="-6" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzQtMS0xLTEtNDQ5Mzg5_669ef288-7fc8-4862-9a58-1055fac55b86">247</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shire contingent consideration liability (see Note&#160;D.18.)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzUtMS0xLTEtNDQ5Mzg5_adb05b92-6cbf-489f-93ff-c2310d1f0f04">323</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Translate Bio</span></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="-6" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzctMS0xLTEtNDQ5Mzg5_ff871faf-ce58-4695-a1bb-a412c38c2f5f">462</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzgtMS0xLTEtNDQ5Mzgx_afaca4b7-f970-4563-b54f-fe0a8b8715d5">2,118</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="-6" name="sny:PurchasePrice" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzktMS0xLTEtNDY5NzYx_a7ec53a4-294e-45f1-980a-c70bf0d82ceb">2,580</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The other intangible assets mainly comprise a messenger RNA technological platform applied to the development of vaccines and therapeutic agents.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill mainly represents the effects of expected future synergies and other benefits to be derived from the integration of Translate Bio into the Sanofi group, in particular by accelerating the delivery of development programs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Translate Bio has no commercial operations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;<ix:nonFraction unitRef="eur" contextRef="i0befa4372a524fab81e8c4d403d76062_D20210101-20211231" decimals="-6" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjEz_759b5977-5754-4ebc-86bb-2cdc7e4a78de">2,333</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the terms of the collaboration agreement between Sanofi and Translate Bio as announced on June&#160;23, 2020, Sanofi held an equity interest of approximately <ix:nonFraction unitRef="number" contextRef="i81cc2b2f8e09437a9a99b63d42e7b55e_I20200623" decimals="2" name="sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjIx_815f4766-f73e-47ee-bbd6-ad5454f79056">5</ix:nonFraction>% in Translate Bio. As of the date when Sanofi obtained control of Translate Bio, that interest was remeasured at the purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="2" name="sny:BusinessCombinationPurchasePricePerShare" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjI2_026797ba-f2d2-462b-9e98-aeb53c20c7b1">38</ix:nonFraction> per share. The change in fair value was recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, in accordance</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">with paragraph&#160;42 of IFRS&#160;3 </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(see Note&#160;D.7.).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Kadmon</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;8, 2021, Sanofi entered into a definitive merger agreement with Kadmon, a biopharmaceutical company that discovers, develops and markets transformative therapies for disease areas with significant unmet medical needs. Shareholders of Kadmon common stock received $<ix:nonFraction unitRef="usdPerShare" contextRef="i8bf9f268a35e45dbace519548e4267f3_I20211109" decimals="INF" name="sny:BusinessCombinationPurchasePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNDAw_852d9783-c386-4ffd-a5c3-e423ecc06fbb">9.50</ix:nonFraction> per share in cash, representing a transaction valued at $<ix:nonFraction unitRef="usd" contextRef="i8bf9f268a35e45dbace519548e4267f3_I20211109" decimals="-8" name="sny:BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExMzgw_5ae75765-9540-42c0-b957-e33e10344e1f">1.9</ix:nonFraction>&#160;billion on a fully-diluted basis. The Sanofi and Kadmon Boards of Directors unanimously approved the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition of Kadmon by Sanofi was completed on November&#160;9, 2021, with Sanofi holding the entire share capital of Kadmon upon expiration of the squeeze-out procedure.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was therefore accounted for as an asset acquisition given that the principal asset (belumosudil, commercialized in the United States under the brand name Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;<ix:nonFraction unitRef="eur" contextRef="i8bf9f268a35e45dbace519548e4267f3_I20211109" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNTE5_e3b807fb-f87d-47dd-8078-246bd17c3e4b">1,739</ix:nonFraction>&#160;million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the consolidated statement of cash flows is a net cash outflow of &#8364;<ix:nonFraction unitRef="eur" contextRef="i1e41032ba4984bdcbc1251beafa9fb22_D20211109-20211109" decimals="-6" sign="-" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNDg3_90bc85ee-7a40-442f-94b8-c4eb36100e91">1,575</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Origimm</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;3, 2021, Sanofi acquired the entire share capital of Origimm Biotechnology GmbH, a privately owned Austrian biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria that cause skin diseases such as acne, for an upfront payment of &#8364;<ix:nonFraction unitRef="eur" contextRef="i4ba12f5a779c416ea0550b3a72a82b6c_I20211203" decimals="-6" name="ifrs-full:CashTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNDMy_9dda7ca3-176e-4e9c-9f21-0003060cd991">55</ix:nonFraction>&#160;million and up to &#8364;<ix:nonFraction unitRef="eur" contextRef="i4ba12f5a779c416ea0550b3a72a82b6c_I20211203" decimals="-6" name="sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNDU4_b83a64e4-c71a-4bea-aab9-37d749ccd64a">95</ix:nonFraction>&#160;million contingent upon reaching certain development and regulatory milestones.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was therefore accounted for as an asset acquisition given that the principal asset (the group of Propionibacterium acnes antigens) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Nearly &#8364;<ix:nonFraction unitRef="eur" contextRef="i4ba12f5a779c416ea0550b3a72a82b6c_I20211203" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNTQ4_aeaa83cb-efae-4746-8c80-f3bb8bae1999">55</ix:nonFraction>&#160;million of the acquisition price paid was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the consolidated statement of cash flows for the year ended December&#160;31, 2021 is a net cash outflow of&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="iab5f424031af478da77b305846219403_D20211203-20211203" decimals="-6" sign="-" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExMzIy_9ef62650-eadf-4d2d-9efc-caf917688e87">50</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-35</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i0478e9c1859646dbbce3a8bbfbf2ab7d" continuedAt="ic39910d02b924d569effc89c7e423a7f"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.2.2. Principal changes in the scope of consolidation in 2020</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Principia</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On August&#160;17, 2020, Sanofi and Principia Biopharma&#160;Inc. (&#8220;Principia&#8221;), a late-stage biopharmaceutical company focused on developing treatments for autoimmune diseases, entered into a definitive agreement under which Sanofi was to acquire all the outstanding shares of Principia for $<ix:nonFraction unitRef="usdPerShare" contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928" decimals="INF" name="sny:BusinessCombinationPurchasePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNDEz_377eb56a-d3aa-4c39-a5b9-500d0f9320bc">100</ix:nonFraction> per share. The transaction was approved unanimously by the Boards of Directors of Sanofi and Principia. Sanofi's acquisition of Principia was completed on September&#160;28, 2020, with Sanofi holding the entire share capital of Principia upon expiration of the squeeze-out procedure. <ix:continuation id="iee21ca335bac4cf5b2e9e58972b0d787" continuedAt="id26fd40790eb435a948e4c9220fc43fe">The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;<ix:nonFraction unitRef="eur" contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMDk2OTU0_1e535492-bdef-48c9-acbe-6f7ce25f54c9">912</ix:nonFraction> million:</ix:continuation></span></div><div style="margin-bottom:5pt;text-align:justify"><ix:continuation id="id26fd40790eb435a948e4c9220fc43fe" continuedAt="id9b55a193286440696cceb5ea091404f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:76.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzEtMS0xLTEtNDA0NTE2_235a2fa3-7c57-4244-9456-63196103174c">2,534</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928" decimals="-6" sign="-" name="sny:OtherAssetsAndLiabilitiesAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzQtMS0xLTEtNDA0NTE2_70791c00-8f17-43c8-b5e6-01c1fb77ef22">38</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928" decimals="-6" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzUtMS0xLTEtNDA0NTE2_e3b4f165-e945-4989-9ff5-5f3d36712fe7">186</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net deferred tax position</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928" decimals="-6" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzYtMS0xLTEtNDA0NTE2_7cdf5bc8-1907-415d-84c0-a5072a65c887">436</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Principia</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928" decimals="-6" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzctMS0xLTEtNDA0NTE2_f7f6253a-03a4-409a-8678-8b7a9b11b09b">2,246</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzgtMS0xLTEtNDA0NTE2_7bfc2bbe-2b2a-45cf-80ea-bdbc9bdecaf5">912</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928" decimals="-6" name="sny:PurchasePrice" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzktMS0xLTEtNDUyMTU0_31d537d5-6aee-4b01-a932-25c10a0d82aa">3,158</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The other intangible assets mainly comprise:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">rilzabrutinib (PRN&#160;1008), a molecule undergoing clinical trials for various indications in immuno-inflammatory diseases and rare blood disorders; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">tolebrutinib (PRN&#160;2246/SAR442168), a molecule currently undergoing clinical trials for the treatment of multiple sclerosis and other diseases of the central nervous system.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill represents (i)&#160;the pipeline of future products in pre-clinical research and development; (ii)&#160;the capacity to draw on a specialized structure to refresh the existing product portfolio; and (iii)&#160;the competencies of Principia staff.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No material adjustment was required on completion of the final purchase price allocation.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Synthorx</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;9, 2019, Sanofi and Synthorx&#160;Inc. (&#8220;Synthorx&#8221;), a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, entered into a definitive agreement under which Sanofi was to acquire all of the outstanding shares of Synthorx for $<ix:nonFraction unitRef="usdPerShare" contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123" decimals="INF" name="sny:BusinessCombinationPurchasePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMDk4MTA2_2cd353b1-e3d0-4aa9-81d3-60af2493868e">68</ix:nonFraction> per share. The transaction was unanimously approved by both the Sanofi and Synthorx Boards of Directors. On December&#160;23, 2019, Sanofi launched a public tender offer to acquire all of the outstanding ordinary shares of Synthorx for $<ix:nonFraction unitRef="usdPerShare" contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123" decimals="INF" name="sny:BusinessCombinationPurchasePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMDk4MzQx_ae591721-0bf8-4886-bf9c-558051e31e51">68</ix:nonFraction> per share in cash, without interest and net of any applicable withholding taxes. The acquisition of Synthorx was completed on January&#160;23, 2020, with Sanofi holding the entire share capital of Synthorx upon expiration of the squeeze-out procedure. <ix:continuation id="id9b55a193286440696cceb5ea091404f" continuedAt="i8a4e8c5713134598ae92502b875e8ba6">The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;<ix:nonFraction unitRef="eur" contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI5MTM3MDU4MTY3MTk1_3a149b95-7898-406f-aeb7-24995359d3df">930</ix:nonFraction>&#160;million:</ix:continuation></span></div><div style="margin-bottom:5pt;text-align:justify"><ix:continuation id="i8a4e8c5713134598ae92502b875e8ba6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzEtMS0xLTEtNDQ5NDI4_48b73196-5f85-43e3-a6cd-27d345887d45">1,549</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123" decimals="-6" name="sny:OtherAssetsAndLiabilitiesAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzItMS0xLTEtNDQ5NDI4_99494c61-9fb8-4fda-847b-400e2d8b384f">36</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net deferred tax position</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123" decimals="-6" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzMtMS0xLTEtNDQ5NDI4_bba3fd62-51a2-48ed-a2ac-91e53925f4cc">269</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Synthorx</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123" decimals="-6" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzQtMS0xLTEtNDQ5NDI4_7441df28-0cee-403f-b5ef-daa7bb7dd3a7">1,316</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123" decimals="-6" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzUtMS0xLTEtNDQ5NDI4_e02016ba-cd22-4041-a4d5-b16c4acdcc89">930</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123" decimals="-6" name="sny:PurchasePrice" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzYtMS0xLTEtNDQ5NDI4_8a1c5646-35c8-4e20-9874-911e62a62434">2,246</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The other intangible assets mainly comprise THOR-707, a molecule currently in Phase&#160;I clinical trials that stimulates T&#160;lymphocytes, and as such has potential as a cancer immunotherapy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill represents (i)&#160;the pipeline of future products in pre-clinical research and development; (ii)&#160;the capacity to draw on a specialized structure to refresh the existing product portfolio; (iii)&#160;the competencies of Synthorx staff; (iv)&#160;benefits derived from the creation of new growth platforms; and (v)&#160;expected future synergies and other benefits from the combination of Synthorx and Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No material adjustment was required on completion of the final purchase price allocation.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-36</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ic39910d02b924d569effc89c7e423a7f"><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transaction related to the equity-accounted investment in Regeneron</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">From the beginning of April&#160;2014, Sanofi accounted for its investment in Regeneron using the equity method. As from that date, in accordance with the Investor Agreement as amended in early 2014, Sanofi had the right to designate a member of the Regeneron Board of Directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;29, 2020, Sanofi closed the transaction announced on May&#160;25, 2020 involving the sale of its equity investment in Regeneron (with the exception of <ix:nonFraction unitRef="shares" contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529" decimals="INF" name="sny:NonCurrentFinancialAssetsNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMDk5OTgx_b1899b5b-a606-4d8a-aab2-62839945c45f">400,000</ix:nonFraction>&#160;shares), through (i)&#160;a registered public offering in the United States and internationally and (ii)&#160;a share repurchase by Regeneron. Sanofi divested <ix:nonFraction unitRef="shares" contextRef="id3e2037ecf8e496eaf3ae27c42505f70_D20200529-20200529" decimals="INF" name="sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwMTM0_f8b89553-d6a9-4804-9744-b719ce6da231">13</ix:nonFraction>&#160;million shares of Regeneron common stock (of which&#160;<ix:nonFraction unitRef="shares" contextRef="i502d25752fbb41198b743f7ae7a986d8_D20200529-20200529" decimals="INF" name="sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNTg2_cfd6aa17-dd36-4694-9216-84b1472f7fb2">10.6</ix:nonFraction>&#160;million were sold by Sanofi) through the public offering at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i87164f7d070f43bebcd477c11338759b_I20200529" decimals="INF" name="sny:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwMjQ5_833fc7e9-8a53-4030-8531-2e3963fd22ec">515</ix:nonFraction> per share, raising a total amount of&#160;$<ix:nonFraction unitRef="usd" contextRef="id3e2037ecf8e496eaf3ae27c42505f70_D20200529-20200529" decimals="-6" name="sny:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwMjkw_4dce3a3b-8cf1-497b-8066-a19ac1143a1a">6,703</ix:nonFraction>&#160;million; and Regeneron repurchased <ix:nonFraction unitRef="shares" contextRef="i5e547fa7f10d4ba49513412e133bcd62_I20200529" decimals="INF" name="sny:SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwMzIx_ad8df81a-ba9d-4fcb-8483-e840576c6a58">9.8</ix:nonFraction>&#160;million of its own shares of common stock directly from Sanofi for&#160;$<ix:nonFraction unitRef="usd" contextRef="i169847bcb5da4bf9a458b8021feaeb0c_D20200529-20200529" decimals="-6" name="sny:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwMzg0_0cab1d9d-5486-4eb2-8238-d780757d5487">5,000</ix:nonFraction>&#160;million, at the offer price less a subscription discount ($<ix:nonFraction unitRef="usdPerShare" contextRef="i5e547fa7f10d4ba49513412e133bcd62_I20200529" decimals="INF" name="sny:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwNDM4_86f76ab8-3145-4c5e-8083-5021ef025ffe">509.85</ix:nonFraction> per share). The total sale proceeds (before transaction-related costs) amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529" decimals="-6" name="sny:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwNTI1_3308150f-7bf8-4587-b7f4-be4814ed274f">10,575</ix:nonFraction>&#160;million. At the same time, Sanofi as a result of this transaction lost the right to designate a member of the Regeneron Board of Directors under the amended Investor Agreement. Finally, as of May&#160;29, 2020 Sanofi retained ownership of <ix:nonFraction unitRef="shares" contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529" decimals="INF" name="sny:NonCurrentFinancialAssetsNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwNzU1_36cecce9-6635-43eb-a752-baa5d0b946a4">400,000</ix:nonFraction>&#160;Regeneron shares in order to continue to partially fund its commitments to invest in the development programs for cemiplimab (REGN2810) and dupilumab, in line with the 2018 Letter Agreement under which Sanofi is permitted to sell up to <ix:nonFraction unitRef="shares" contextRef="i755f9def05814a168296cd241a1146d3_I20201231" decimals="-5" name="sny:AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwOTk1_ef31ac62-f95d-4a57-9e4b-544cd471489d">1.4</ix:nonFraction>&#160;million shares through the end of 2020. As of December 31, 2022, Sanofi had sold <ix:nonFraction unitRef="shares" contextRef="i0f42c6e0f02b45889491a52aa65d4c26_I20221231" decimals="INF" name="sny:SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxMDU4_bedbfe75-6f88-4ff1-b247-081a76208d15">779,320</ix:nonFraction>&#160;Regeneron shares under that agreement. The number of Regeneron shares retained by Sanofi is <ix:nonFraction unitRef="shares" contextRef="i7727cfd3e20341039f39e0046c5ed90b_I20211231" decimals="INF" name="sny:NonCurrentFinancialAssetsNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxMTU0_2de8647d-96c7-4c3f-a7cd-2d3481452561">279,766</ix:nonFraction> as of December&#160;31, 2021 (see&#160;Note&#160;C.1.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s equity investment in Regeneron was accounted for by the equity method until May&#160;29, 2020. As of that date, the carrying amount of the investment was &#8364;<ix:nonFraction unitRef="eur" contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529" decimals="-6" name="ifrs-full:InvestmentAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxMzU3_9ab6b756-4ddf-4c76-8f0f-0d5ddc36e952">3,668</ix:nonFraction>&#160;million; that amount was reversed out on closing of the transaction. Before tax effects, the gain on the divestment amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529" decimals="-6" name="ifrs-full:GainsOnDisposalsOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxNDgx_32642316-75cb-46b4-a5bf-3611365d4c32">7,382</ix:nonFraction>&#160;million, including (i)&#160;a gain of &#8364;<ix:nonFraction unitRef="eur" contextRef="ie109280c1ab2461ab5fe2322cf084ae3_D20200529-20200529" decimals="-6" name="ifrs-full:GainsOnDisposalsOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxNTEw_1e5ce08d-369f-475c-aa7f-b6afb2785521">318</ix:nonFraction>&#160;million arising on the currency translation reserve associated with Regeneron, which was taken to profit or loss in accordance with IAS&#160;21; (ii)&#160;the deduction of transaction-related costs of &#8364;<ix:nonFraction unitRef="eur" contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529" decimals="-6" name="sny:SaleOfStockTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxNjk3_97981743-334a-409f-86c0-a089356e0394">64</ix:nonFraction>&#160;million; and&#160;(iii)&#160;a gain of &#8364;<ix:nonFraction unitRef="eur" contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529" decimals="-6" name="ifrs-full:GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxNzIy_9796f7ab-4da6-4246-9f55-f3112af75c50">157</ix:nonFraction>&#160;million on the remeasurement of the <ix:nonFraction unitRef="shares" contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529" decimals="INF" name="sny:NonCurrentFinancialAssetsNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxNzU0_384b16b5-662c-44bb-8f27-b3cc6d07c652">400,000</ix:nonFraction>&#160;retained shares at their quoted market price as of May&#160;29, 2020 ($<ix:nonFraction unitRef="usdPerShare" contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529" decimals="2" name="sny:StockMarketPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxODI0_8d57304e-5c50-4d02-9997-f872a559d33b">612.81</ix:nonFraction>). In accordance with IFRS&#160;9 (Financial Instruments), the retained shares were classified in the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Equity instruments at fair value through other comprehensive income&#8221; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">category on the transaction date, at a value of &#8364;<ix:nonFraction unitRef="eur" contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAyMDQy_26308644-4d34-4581-b360-dd0e0c2fed8e">221</ix:nonFraction>&#160;million (see Note&#160;D.7.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tax charge arising on the transaction was &#8364;<ix:nonFraction unitRef="eur" contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529" decimals="-6" name="sny:TaxExpenseOnDisposalOfInvestment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAyMTEw_b19a0ca2-d982-488f-b99a-37203d750ae1">502</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Given the material impact of this transaction, and to facilitate users&#8217; understanding of the financial statements, the pre-tax gain on this transaction is presented as a separate line item in the consolidated income statement, &#8220;Gain on Regeneron investment arising from the transaction of May&#160;29, 2020&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The net cash inflow from the transaction was &#8364;<ix:nonFraction unitRef="eur" contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529" decimals="-6" name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAyNDYz_d35c058e-41fe-4a38-8070-b6ec06da3216">10,370</ix:nonFraction>&#160;million, which (for the reason cited above) is presented as a separate line item in the consolidated statement of cash flows, &#8220;Net proceeds from sale of Regeneron shares on May&#160;29, 2020&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;27, 2019, Sanofi entered into a definitive agreement to sell Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">to Baxter. The sale was completed on&#160;February&#160;14,&#160;2020. Sanofi recognized a pre-tax gain of &#8364;<ix:nonFraction unitRef="eur" contextRef="i0ae209da62af48d0802dbf6f8ad4a942_D20200214-20200214" decimals="-6" name="ifrs-full:GainsOnDisposalsOfNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAyODQw_b21db766-f934-484a-a152-9dd1c0b2ae15">129</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this sale, reflected in the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">net of tax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> within the consolidated statement of cash flows, was a net cash inflow before tax of&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i0ae209da62af48d0802dbf6f8ad4a942_D20200214-20200214" decimals="-6" name="ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAzMTAw_328acd91-3475-4dad-93b6-9c37ca5a3baa">311</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-37</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_598"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.3. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0MzI_e3e3e60a-23a8-4fdc-a9ab-8889fd14d38e" continuedAt="i56d4a63edaf3495f8eab7662c66e29a8" escape="true">Property, plant and equipment</ix:nonNumeric></span></div><ix:continuation id="i56d4a63edaf3495f8eab7662c66e29a8" continuedAt="ifd26aff1ae094b528df962575d3f376a"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.3.1. Property, plant and equipment owned</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0Mjk_e72a92f1-8b7d-466b-b782-d8234d5e6e9e" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Property, plant and equipment owned by Sanofi is comprised of the following items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:28.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Land</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Buildings</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Machinery<br/>and<br/>equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fixtures,<br/>fittings&#160;and<br/>other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Property,&#160;plant<br/>and&#160;equipment<br/>in process</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8a1fb47c77a7402d896ae4afa489dc32_I20191231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtMS0xLTEtMzY0MDYw_4da496cf-2c04-4e1a-9bc4-6fbdd5419a41">255</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fdd7a020cd743c782be74d0b156d3ff_I20191231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtMi0xLTEtMzY0MDYw_d854734a-14a0-47d8-9638-960f1c4bfabc">7,282</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i44a98fba01634bd9886289ce37e699bd_I20191231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtMy0xLTEtMzY0MDYw_daa88773-4064-4002-8570-35ddce21d16c">11,053</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie6ce85fa444d4547b8275916d66fba2e_I20191231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtNC0xLTEtMzY0MDYw_01dfc3e7-c9d1-4885-9f6e-093ebbcec3e2">2,587</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5025c5e64e0e4238ad981ac8500d4184_I20191231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtNS0xLTEtMzY0MDYw_70b7d39d-fca0-4dca-b37f-2433f8deabbb">2,391</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0a5f73156d8942cc9aff9b90aa0a20d9_I20191231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtNi0xLTEtMzY0MDYw_7f4da517-342f-4f09-bbe5-cc97f77fbce8">23,568</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItMS0xLTEtMzY0MDYw_5320a566-eea0-4482-958b-f65f12bdc02d">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItMi0xLTEtMzY0MDYw_3a1a5dbb-ba49-4285-b27b-4fb086c780b0">6</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItMy0xLTEtMzY0MDYw_b0b5e278-8351-4aad-94cf-19c2c5cd95e8">3</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItNC0xLTEtMzY0MDYw_d202d6f7-90e4-469a-b6ef-7797c53996f4">1</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItNS0xLTEtMzY0MDYw_fdabb729-8747-480f-9a67-2e42ad0a6bde">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItNi0xLTEtMzY0MDYw_1d91a09d-bd44-463a-af39-d7f678a7d439">10</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtMS0xLTEtMzY0MDYw_8318bc79-b136-4cb1-b3ce-b8338e3f1360">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtMi0xLTEtMzY0MDYw_e51506df-bde9-449f-94c5-98871c8eacc9">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtMy0xLTEtMzY0MDYw_25680853-73d0-48f1-8b2e-81cd31b9c245">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtNC0xLTEtMzY0MDYw_5885382e-b10d-44ab-a58d-d385196e8e38">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtNS0xLTEtMzY0MDYw_2d9df0eb-b0d0-4182-8695-d07787ee218a">1,208</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtNi0xLTEtMzY0MDYw_86a78dcd-6953-406e-8bf0-191337c20879">1,310</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtMS0xLTEtMzY0MDYw_c159a07e-e234-4c66-93f1-a790f3df64fd">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtMi0xLTEtMzY0MDYw_25f37730-f043-48c5-8e47-adbc5b450ca6">173</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtMy0xLTEtMzY0MDYw_4a3704e2-e259-42b8-8e51-9b7ee97519f0">177</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtNC0xLTEtMzY0MDYw_a7f7c662-0c70-428b-b645-f9cbedef8a91">123</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtNS0xLTEtMzY0MDYw_fffae85a-40f0-4313-b218-5c7ff3712ff8">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtNi0xLTEtMzY0MDYw_9e3f9e43-bfa7-43d8-b083-d93ca68353e4">487</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtMS0xLTEtMzY0MDYw_946452d0-fed9-4243-85f5-3331ffcd98ca">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtMi0xLTEtMzY0MDYw_519affd0-9c73-4f53-96de-cac0fd08d853">264</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtMy0xLTEtMzY0MDYw_e736ae54-c553-49a5-9b1c-1cf94f6e012d">276</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtNC0xLTEtMzY0MDYw_e6444707-d742-4485-8644-724d740f930f">67</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtNS0xLTEtMzY0MDYw_0b7cfbac-14aa-4e6c-b49b-1d93f1484e4f">91</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtNi0xLTEtMzY0MDYw_ccb15c7c-203d-4090-9fbb-8e6603b659ba">711</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtMS0xLTEtMzY0MDYw_f6d5f156-593d-449c-a4dc-cc5b6cf2d081">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtMi0xLTEtMzY0MDYw_6cac7890-18f7-41fc-8ad8-a54b9ffd84ff">39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtMy0xLTEtMzY0MDYw_5fe7ed59-afaa-48d6-b586-0e3aa57b1f2b">484</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtNC0xLTEtMzY0MDYw_eba5d412-d747-4a6b-9008-370bb2645f02">80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtNS0xLTEtMzY0MDYw_baefcd4c-376f-4e32-8746-5f454c441ce2">1,051</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtNi0xLTEtMzY0MDYw_be352fa3-e725-432d-8c6e-0b0c24c24b73">521</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0206267cac4b43ff9378718b8008875d_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctMS0xLTEtMzY0MDYw_0d8289dd-4ec4-47bb-9451-026dc2ce05d5">236</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaa29c61d6aa54e0c83530917f533df1f_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctMi0xLTEtMzY0MDYw_9ce613dd-f1d9-4ed6-90c2-71be6cec9244">6,828</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibfb17be627054bbcaeb8bb573eb2dabf_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctMy0xLTEtMzY0MDYw_d8b1eedb-f6d4-4112-acab-b158ff9c24f9">11,127</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9fce9fd8a39949fea1857356f2487678_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctNC0xLTEtMzY0MDYw_4e294f9f-6271-4c57-ba8a-e21488393344">2,524</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8e81b12e473e49b5abc85d3e576474fa_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctNS0xLTEtMzY0MDYw_9ca00068-4344-43cf-b77b-6fcca45dec55">2,454</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctNi0xLTEtMzY0MDYw_e4057e6d-9af8-48f5-8ea7-0288b2faa9f1">23,169</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtMS0xLTEtMzY0MDYw_34331169-fd1f-4e08-8c7e-36e89b34176c">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtMi0xLTEtMzY0MDYw_81df6555-f679-4c01-a6cf-34029dd1644c">11</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtMy0xLTEtMzY0MDYw_d43f5d57-701d-4327-adc5-0fb59c1dc0b3">15</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtNC0xLTEtMzY0MDYw_6e87e30c-cb79-43e0-b0cf-18eb0aa9e809">2</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtNS0xLTEtMzY0MDYw_f2bb8380-9c85-4f85-8ba8-ed46a816e886">2</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtNi0xLTEtMzY0MDYw_e0064f2c-a9b2-4eaf-8fa1-750c7c22693c">30</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktMS0xLTEtMzY0MDYw_4ec3caf4-0b47-43c4-8274-0427fffecc3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktMi0xLTEtMzY0MDYw_4e8685b0-0c1a-4dae-b568-6cba1cb9a46e">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktMy0xLTEtMzY0MDYw_057b6693-af5b-4fc7-ac68-9257b805f44e">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktNC0xLTEtMzY0MDYw_a83c7bc3-d8b7-4710-9aa6-b82f51a8d80e">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktNS0xLTEtMzY0MDYw_c0dccb4f-e97c-4691-b007-09e20e74b479">1,404</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktNi0xLTEtMzY0MDYw_5839c9c3-af1e-4eb7-b1ce-33ea0cda7145">1,504</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTEtMS0xLTM2NDA2MA_32dd0b2d-9b90-4274-bc62-1237a3a86235">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTItMS0xLTM2NDA2MA_f244cfcb-2da0-4e6b-8819-6190c870bbeb">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTMtMS0xLTM2NDA2MA_766c49d1-917f-4202-b8c1-6c5f61503593">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTQtMS0xLTM2NDA2MA_29f96b3a-00b2-4fec-808f-3c41c1c70917">80</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTUtMS0xLTM2NDA2MA_e4777174-a0d9-49a0-9cf6-dfe2785ae173">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTYtMS0xLTM2NDA2MA_5ef5bdb3-f15d-4e3e-8d6c-cbf6d9cb39f9">314</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTEtMS0xLTM2NDA2MA_5c27c11a-2bda-41af-9590-9fee9dcaed42">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTItMS0xLTM2NDA2MA_aa571b4e-4741-40ba-a05a-4a92d578dfef">169</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTMtMS0xLTM2NDA2MA_14cb1e02-1b94-46bb-a7db-2e9544050396">155</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTQtMS0xLTM2NDA2MA_b3e399c0-4065-415b-b549-3239a58e46a7">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTUtMS0xLTM2NDA2MA_8c17361c-c1d3-48ce-b32b-2d77b8502aec">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTYtMS0xLTM2NDA2MA_f6e2b6b7-d934-4876-bf38-2068e538c165">443</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTEtMS0xLTM2NDA2MA_c2b9e904-7ddc-4f00-9ed4-1e1049b377d5">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTItMS0xLTM2NDA2MA_3b44edc7-8000-4316-bee8-3d4dcd67e7d8">227</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTMtMS0xLTM2NDA2MA_964c852b-a681-47eb-913a-bec9ab00e6a2">453</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTQtMS0xLTM2NDA2MA_7df18321-e583-4ea3-ad30-a888db527e07">136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTUtMS0xLTM2NDA2MA_29f59a7c-c2a3-4d7f-b2eb-2ce7db94af37">839</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTYtMS0xLTM2NDA2MA_718e7b79-cdde-4078-be62-51cbe34ef62c">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i87d0af8348104bf887f908169ce200b0_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTEtMS0xLTM2NDA2MA_13b0698c-3994-4c55-8807-cbaa1fb268c6">240</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7d6fee5315414ad1a751bc8615b564e4_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTItMS0xLTM2NDA2MA_f350ecc8-56ff-4e84-92b3-7c49cd36ff53">7,170</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i42c95bc466b242eba66c21cf83df94ce_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTMtMS0xLTM2NDA2MA_cfbd6869-236b-4cee-9cd3-7d717ffc5a2d">11,648</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93db76f9896b4f74ba29861299f846f5_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTQtMS0xLTM2NDA2MA_fe2d393c-8e54-48e6-a4cf-f265c4860359">2,655</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i23e8b78ba6e14985bdaf0561022d2fcb_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTUtMS0xLTM2NDA2MA_1333981a-5466-43d8-a23c-87f45cee80ee">3,097</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTYtMS0xLTM2NDA2MA_ff970d05-9d7a-43e0-adea-1c9353476650">24,810</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTEtMS0xLTM2NDA2MA_6743cc59-b77d-4ba4-9350-91b14c4e49eb">17</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTItMS0xLTM2NDA2MA_b8027b1d-7727-4a71-9c22-afd136aef1fa">294</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTMtMS0xLTM2NDA2MA_2a7cbbb9-78cc-4033-a571-59bcc05cc9a7">1,480</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTQtMS0xLTM2NDA2MA_3eb84ef4-2556-4612-b62d-240ee3a52ef3">163</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTUtMS0xLTM2NDA2MA_ddae99a8-ed56-4933-bb29-858ebdddcd43">150</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTYtMS0xLTM2NDA2MA_f6dca72f-59f7-498b-aa41-62c434d56c6b">2,104</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTEtMS0xLTM2NDA2MA_04928677-60ed-40b4-89ec-95fdf1bc9dc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTItMS0xLTM2NDA2MA_2d5d4571-0c35-453c-9f56-68ef5c65a5fa">11</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTMtMS0xLTM2NDA2MA_b9045a50-5a62-4cac-bf26-8c53a95c0ba2">54</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTQtMS0xLTM2NDA2MA_18f2ae3b-f744-4b99-a0f7-92ef8d1b6820">41</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTUtMS0xLTM2NDA2MA_cd3dc8ae-b2ff-4881-9396-68a9e5cf6617">1,642</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTYtMS0xLTM2NDA2MA_0d140fc4-b944-47cc-92fe-97852ff4e3a5">1,748</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTEtMS0xLTM2NDA2MA_08c44645-ea48-4a00-8903-221164a4de32">1</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTItMS0xLTM2NDA2MA_37dddaf3-f129-4919-9401-75cb4f9817a1">161</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTMtMS0xLTM2NDA2MA_d16d1166-9577-4050-a093-538345514243">240</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTQtMS0xLTM2NDA2MA_3fb17c90-fef4-4dc7-a368-d5d017035333">155</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTUtMS0xLTM2NDA2MA_c2e2b97c-7a06-4a7f-b402-d7fa4d46c0de">2</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTYtMS0xLTM2NDA2MA_fe0ebd19-6700-48dc-837c-c4a209eba8e2">559</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTEtMS0xLTM2NDA2MA_21fdf05e-d229-4ecf-8f5b-539f2d74098b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTItMS0xLTM2NDA2MA_4b5435ef-bda5-49f2-9831-f2ee02ece4e2">122</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTMtMS0xLTM2NDA2MA_b5f80075-959a-48b0-9085-cfed3c43715d">144</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTQtMS0xLTM2NDA2MA_baffa1db-c018-40bd-b845-f4db7b1399c3">29</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTUtMS0xLTM2NDA2MA_0c6bdeea-bd1f-4ff3-9427-c254ccaee056">35</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTYtMS0xLTM2NDA2MA_4caa233e-0f8d-4921-9732-146482ef7e56">347</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTEtMS0xLTM2NDA2MA_d734f179-7976-489f-a192-c5d820654aeb">2</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTItMS0xLTM2NDA2MA_9d237119-dfb3-4567-b277-7f90a94d5973">480</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTMtMS0xLTM2NDA2MA_5f54a9f0-e55a-4015-9521-7c2161ebc7e3">722</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTQtMS0xLTM2NDA2MA_51749472-c062-4715-b291-887ccb115040">108</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTUtMS0xLTM2NDA2MA_318463cb-236e-4355-86ea-98b63f3c740f">1,626</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTYtMS0xLTM2NDA2MA_2ca5e56b-dd23-40f9-8be0-57a8d8b8d9db">318</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibd94ddf5b0e84f649ad3f3ba6b5cafb5_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTEtMS0xLTM2NDA2MA_cda2f4b9-bce5-4d40-a432-6c9c4fc18e85">237</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i76a1d3dce1104aa6a7d778f1999c90d9_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTItMS0xLTM2NDA2MA_e077180b-f163-459f-a5d9-d3bb96c18418">7,328</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icb39c23a34044e26bef23d011e133535_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTMtMS0xLTM2NDA2MA_68ccd3fc-bee4-464a-8dd7-46abc143e679">10,848</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia2162c82bdeb4391aa0ecd936cefcc6c_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTQtMS0xLTM2NDA2MA_2cf6fa7b-8188-4b5f-90e9-56ce832b712f">2,515</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifd00cfd5016342eaaea60535f74305b3_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTUtMS0xLTM2NDA2MA_5ce31576-d967-4d16-bbcb-050abc923045">2,996</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTYtMS0xLTM2NDA2MA_91705b79-ea80-4095-8c73-9d461c675c48">23,924</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i476392303b7e4abba1d96716ae9615ab_I20191231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTEtMS0xLTM2NDA2MA_56b9a94e-fe1f-4e8a-a37b-f66aeeedae50">11</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ied331c3fd4b94f45b143e83a62a935f2_I20191231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTItMS0xLTM2NDA2MA_c741cdbb-02c1-48de-ab0a-907d6807b52d">4,065</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1ecc234cc9eb49568130c6b4fc616c68_I20191231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTMtMS0xLTM2NDA2MA_b9e88dfd-f4e5-4d50-a315-9e986aa3228b">7,660</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3f095d969a564ac0a9de8f80291ff734_I20191231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTQtMS0xLTM2NDA2MA_57417325-f18a-4acb-b578-41134afcb0b9">1,984</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0c26e169435e4e9e9fe6193807419216_I20191231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTUtMS0xLTM2NDA2MA_0bf11cea-bbd8-4d8d-9a02-32d483b8a98b">131</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idc8a6784630a4f6dacd4f922e9fdcfda_I20191231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTYtMS0xLTM2NDA2MA_5c69fd58-8ab3-40c9-8371-506544c8b646">13,851</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231" decimals="-6" name="ifrs-full:DepreciationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTEtMS0xLTM2NDA2MA_063aa6cf-3e1b-4c65-9a66-c7d27a1c8285">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231" decimals="-6" name="ifrs-full:DepreciationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTItMS0xLTM2NDA2MA_af8ece7c-b908-40b7-964c-1e980cd4b290">356</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231" decimals="-6" name="ifrs-full:DepreciationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTMtMS0xLTM2NDA2MA_f6b56c5a-7e83-4e97-9944-e0a909dc59c0">605</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i10c25791faca434abad3dcc87c335545_D20200101-20201231" decimals="-6" name="ifrs-full:DepreciationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTQtMS0xLTM2NDA2MA_4e5ed22b-9ff6-41df-a368-f687f0a33e1c">182</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231" decimals="-6" name="ifrs-full:DepreciationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTUtMS0xLTM2NDA2MA_8d7f409a-1fcf-4adc-820b-a3c04a3734ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTYtMS0xLTM2NDA2MA_80de3432-d092-44dc-8937-4b7c40c6b1b4">1,143</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTEtMS0xLTM2NDA2MA_9d2b7bb6-49e3-408e-b72b-524dd03007f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTItMS0xLTM2NDA2MA_6311f764-c9d9-44be-a3dc-bb637360a79b">24</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTMtMS0xLTM2NDA2MA_7ad8c0d6-cfb1-4735-86bb-88f96c3ed4f4">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i10c25791faca434abad3dcc87c335545_D20200101-20201231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTQtMS0xLTM2NDA2MA_9c90655d-766b-4dbf-9132-a5c4b89921a0">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTUtMS0xLTM2NDA2MA_2bfc6fa8-b8ca-4faf-9df6-9f5b7ddb754b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTYtMS0xLTM2NDA2MA_9bcb2e60-9582-4cca-b26b-3367f7d4fea3">43</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTEtMS0xLTM2NDA2MA_41335db2-8d95-4a96-a7ef-6065da0a32a6">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTItMS0xLTM2NDA2MA_2070a8ee-1b1a-4921-b709-0caec072bd8a">168</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTMtMS0xLTM2NDA2MA_961b565b-9b94-49a8-84d4-0e0be6095a17">166</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i10c25791faca434abad3dcc87c335545_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTQtMS0xLTM2NDA2MA_0832775f-f243-4aed-ad99-335a9b1ddc02">117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTUtMS0xLTM2NDA2MA_fb4bf8c5-3732-4fb6-8724-f2fbcf46fce0">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTYtMS0xLTM2NDA2MA_f24d2da7-301f-42da-969f-38f78aa2fef1">460</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTEtMS0xLTM2NDA2MA_90b11200-4813-4636-959d-046106655fc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTItMS0xLTM2NDA2MA_0346ef62-d161-4151-a970-8cc0cf7db3a1">127</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTMtMS0xLTM2NDA2MA_870ee7e2-8940-44d4-b064-152bf020eae7">169</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i10c25791faca434abad3dcc87c335545_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTQtMS0xLTM2NDA2MA_74fec814-c91c-4b69-8a1d-68138f19903d">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTUtMS0xLTM2NDA2MA_c2c3a224-adf8-4888-82b2-0b10e6f039bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTYtMS0xLTM2NDA2MA_a49d385f-32dd-45fd-ae6b-e4b1bff54f65">345</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTEtMS0xLTM2NDA2MA_a1306f01-f166-4945-9af8-88d964538012">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTItMS0xLTM2NDA2MA_4a3bb2cb-b1cb-48bc-b59e-8f28004679fc">252</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTMtMS0xLTM2NDA2MA_627a377a-7266-42c9-9500-dc1821abad5e">150</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i10c25791faca434abad3dcc87c335545_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTQtMS0xLTM2NDA2MA_ba3c166a-7bee-48f4-aea2-96d56da562d7">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTUtMS0xLTM2NDA2MA_3bb8a6b7-f7a6-4bc0-b493-bfd0bd8e4404">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTYtMS0xLTM2NDA2MA_d36f16f0-952c-4619-9f45-11beb80c399b">428</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if76ef11240a9484db66b6a0b5b09f16b_I20201231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTEtMS0xLTM2NDA2MA_767f0538-41fb-4575-b6e3-bfa6868bc3dd">10</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i00ddc700bee94a3ebc732201c1d35de9_I20201231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTItMS0xLTM2NDA2MA_63b5adad-418d-4fe0-8566-e812b6a9060d">3,898</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if2f730ae7e334d48893db2ae20047ece_I20201231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTMtMS0xLTM2NDA2MA_1dc05371-f58d-467a-bc68-decff48bd7c8">7,792</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i472690aecacc4395b411b03484ad169e_I20201231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTQtMS0xLTM2NDA2MA_88952879-c1a0-43c7-9ddb-59aa0e939e99">1,981</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i96cfd3c2e6874abd9afce4c2d4d64ffd_I20201231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTUtMS0xLTM2NDA2MA_2b891024-a427-45da-a629-7333d1471845">123</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd6e4b32cb345028d31ec8dc75abdea_I20201231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTYtMS0xLTM2NDA2MA_f0cf31b8-b743-448e-bfef-c214b04b9740">13,804</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231" decimals="-6" name="ifrs-full:DepreciationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTEtMS0xLTM2NDA2MA_e7a42a26-fb93-41c3-bbad-9975f0cf422e">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i955321bf2dce441dae3876de61625fc6_D20210101-20211231" decimals="-6" name="ifrs-full:DepreciationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTItMS0xLTM2NDA2MA_1849ce5d-7f4e-4ee7-9ae4-bc04aa7db12d">306</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231" decimals="-6" name="ifrs-full:DepreciationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTMtMS0xLTM2NDA2MA_2ada9bde-7af4-439b-8651-efe29733c758">592</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231" decimals="-6" name="ifrs-full:DepreciationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTQtMS0xLTM2NDA2MA_9458697b-dd55-4638-b7f1-11ac47eb4077">167</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231" decimals="-6" name="ifrs-full:DepreciationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTUtMS0xLTM2NDA2MA_c1545a39-b558-49bb-ba23-9b1e9b1faa8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTYtMS0xLTM2NDA2MA_f798e361-6b6d-4cbe-a6bc-12b3f097c785">1,065</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTEtMS0xLTM2NDA2MA_93d26328-7380-4f0e-87ae-76ff9cd21bf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i955321bf2dce441dae3876de61625fc6_D20210101-20211231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTItMS0xLTM2NDA2MA_ffb30e19-54fc-472c-a80c-831e9598669b">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTMtMS0xLTM2NDA2MA_180c31f6-a403-442b-b8a6-222edffad65e">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTQtMS0xLTM2NDA2MA_bd64edd0-d9b2-49fd-9f9d-68853b17e396">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTUtMS0xLTM2NDA2MA_f2ccd079-0788-4a82-8d98-584131b1d4a2">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTYtMS0xLTM2NDA2MA_f5cc62ea-7dac-4e1c-b85b-56c01c947a35">39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTEtMS0xLTM2NDA2MA_86f1975c-7f31-4cdc-8110-2e8817dc7cbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i955321bf2dce441dae3876de61625fc6_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTItMS0xLTM2NDA2MA_c1407297-71fd-4fbc-b4f7-8b106c5f5299">74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTMtMS0xLTM2NDA2MA_dd9f352c-6311-4cdc-9923-f738426877ab">149</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTQtMS0xLTM2NDA2MA_2f359739-1b16-4841-9883-99d6a41f6886">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTUtMS0xLTM2NDA2MA_fbca4d1f-96ad-4632-9e43-2e041c7bd2f1">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTYtMS0xLTM2NDA2MA_8febc712-16e8-4652-b3e8-bcb585464d29">299</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTEtMS0xLTM2NDA2MA_31daf529-6109-4856-b1a6-e5e52a291ac0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i955321bf2dce441dae3876de61625fc6_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTItMS0xLTM2NDA2MA_71e16f2b-52dc-4a3d-82ff-8feabd5db0e0">80</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTMtMS0xLTM2NDA2MA_e72b8b9d-6a1b-4c8e-b800-35e2241d7b8e">99</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTQtMS0xLTM2NDA2MA_2a5498e5-024c-454f-a085-6bc962e53757">29</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTUtMS0xLTM2NDA2MA_277cfccf-dde8-46cf-b606-13baf8fee169">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTYtMS0xLTM2NDA2MA_20fd9fd3-7127-4008-9231-d6cb25fd3eed">208</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTEtMS0xLTM2NDA2MA_d670f4f1-0f89-45df-9cdc-5faf45570eca">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i955321bf2dce441dae3876de61625fc6_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTItMS0xLTM2NDA2MA_7f8e801f-acfc-4082-965d-fa498e411f31">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTMtMS0xLTM2NDA2MA_9ab41ae0-406f-46e1-9b32-67bf91c179dd">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTQtMS0xLTM2NDA2MA_f5906743-98c8-423e-b488-e948390110de">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTUtMS0xLTM2NDA2MA_3c7d1327-b9d3-495e-931d-ab9409177e59">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTYtMS0xLTM2NDA2MA_b439abe0-c1a3-40f0-94de-cd095b1eaddb">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i69399acab7a64ab497728ec8f97b3699_I20211231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTEtMS0xLTM2NDA2MA_78bd68db-db67-4d0e-8c95-1a442f366110">9</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3c7e1a121231436aba2eaeb9b1fe7924_I20211231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTItMS0xLTM2NDA2MA_c60a3d1c-857c-4776-9b12-8a7230cb262d">4,190</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9127d80c07874bffb0988e2f80d522b2_I20211231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTMtMS0xLTM2NDA2MA_c75e62b3-6c42-4389-a546-9540cbc2eac4">8,340</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3c0b39229285466da452d51712d250f6_I20211231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTQtMS0xLTM2NDA2MA_c5ebbf6e-c3f6-45ec-99b9-d129c26c40e9">2,115</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i193fe7806c2641f3b83fb65146f5ee65_I20211231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTUtMS0xLTM2NDA2MA_22ad6adc-9177-4641-9aaa-e79a318aacea">128</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ida5c0c7399ab4f90ab42e89c5e29af71_I20211231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTYtMS0xLTM2NDA2MA_ad1acd31-6103-40f7-8d50-9440d66824a5">14,782</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTEtMS0xLTUwMjA4NQ_e43da565-9843-42a0-9e41-9f92566bdde6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTItMS0xLTUwMjA4NQ_b6ec57c4-b70f-4ea6-b22d-0354c7a86638">201</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTMtMS0xLTUwMjA4NQ_f03f10b1-879b-40fb-9185-cd7aa2172006">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTQtMS0xLTUwMjA4NQ_a03f091e-d063-4cd4-af66-776f54bdb101">130</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTUtMS0xLTUwMjA4NQ_0f3915a7-e34d-484a-aa27-78952b53ae67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTYtMS0xLTUwMjA4NQ_c86e07ec-7a0d-489f-bf42-b2a4e1651932">1,533</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231" decimals="-6" name="ifrs-full:DepreciationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTEtMS0xLTM2NDA2MA_304b82f9-bfed-4ce9-b8c2-bcac1257da69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231" decimals="-6" name="ifrs-full:DepreciationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTItMS0xLTM2NDA2MA_499a2e20-31d1-4d42-8e63-82660f14128c">356</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231" decimals="-6" name="ifrs-full:DepreciationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTMtMS0xLTM2NDA2MA_4010bd48-94f6-4657-9508-7a1b835c9bcb">622</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231" decimals="-6" name="ifrs-full:DepreciationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTQtMS0xLTM2NDA2MA_63dac130-5de1-4e89-8f4f-75b245a06c68">164</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231" decimals="-6" name="ifrs-full:DepreciationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTUtMS0xLTM2NDA2MA_31c10179-ba27-479a-a37c-6249809183c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTYtMS0xLTM2NDA2MA_0539bc57-0a26-4ad6-ada5-160a6dcf778f">1,142</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTEtMS0xLTM2NDA2MA_87c217c3-68a7-4e72-8489-219eb9a09292">1</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTItMS0xLTM2NDA2MA_1214b7c7-ea00-415f-84fa-e51762c844b8">50</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTMtMS0xLTM2NDA2MA_226332cb-6441-492a-a40f-ba9385cfe6e0">58</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTQtMS0xLTM2NDA2MA_9ee89e70-8a96-4efc-9c5e-4caf9b4146e8">2</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTUtMS0xLTM2NDA2MA_466f2f63-5e99-4920-9164-652e13eaf3d2">75</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" name="ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTYtMS0xLTM2NDA2MA_2226c940-b365-42aa-807f-f98ad5131604">186</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTEtMS0xLTM2NDA2MA_eba8a025-6acc-4bef-87ec-97ae62b0bd75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTItMS0xLTM2NDA2MA_0818a9e0-50e2-49f5-b04a-1844b3dabab7">133</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTMtMS0xLTM2NDA2MA_25977e4d-268a-4061-9cac-6b568608e7a8">201</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTQtMS0xLTM2NDA2MA_c2da7e94-d073-4858-9e09-74e6c9c758ce">153</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTUtMS0xLTM2NDA2MA_7830d79c-9fd6-48bd-b88b-2ea49aff9605">31</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTYtMS0xLTM2NDA2MA_1e1ca1aa-fa4b-409f-9368-7f055bb2aa70">518</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTEtMS0xLTM2NDA2MA_ed2ebe1e-7510-4c03-8973-df5b4eac5d75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTItMS0xLTM2NDA2MA_4cc4e6f7-a0ca-44fd-aa10-1165ae8ef30b">52</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTMtMS0xLTM2NDA2MA_99292a26-8202-4b99-abd7-83ca738c778b">69</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTQtMS0xLTM2NDA2MA_0fc02111-9c1c-4495-a6ab-df9a23b82fa8">22</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTUtMS0xLTM2NDA2MA_37a00827-70ab-4680-b987-0f88edebed05">5</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTYtMS0xLTM2NDA2MA_b686f1cd-ec4b-4816-ba13-5d8230eea961">138</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTEtMS0xLTM2NDA2MA_5c80f11c-6b95-48f9-8d57-779adfa5214b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTItMS0xLTM2NDA2MA_bbce6c32-651f-42bc-88db-dd682b3c0f2d">89</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTMtMS0xLTM2NDA2MA_2113bbff-f885-433d-89aa-5db6c39305fb">49</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTQtMS0xLTM2NDA2MA_fc0787d9-06e8-47cd-87cd-2b71083ba054">5</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTUtMS0xLTM2NDA2MA_77896b47-c4a7-4c50-8a5f-1cd534dd4b3c">1</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTYtMS0xLTM2NDA2MA_dcdeb7f5-8ca7-4b0d-8aed-31a36da54d2a">142</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9404661ce5304598a545950eb1e7bf70_I20221231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTEtMS0xLTM2NDA2MA_0352783f-0644-408d-a85f-bf5970bed209">10</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iba41b88a1c3648cbb1015bbea8998f1d_I20221231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTItMS0xLTM2NDA2MA_f4f70720-b7b2-4260-9912-4ae8eaa605cb">4,225</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6fee7647f4f24f3491f03f1226afcc68_I20221231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTMtMS0xLTM2NDA2MA_a9a05cf6-2a6f-4fce-9bdb-db569c0c8997">7,637</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib0f0050d932c48cbad2e4bb3e8838afa_I20221231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTQtMS0xLTM2NDA2MA_9a091e3a-ae30-4e53-b45d-6c63c7120314">2,015</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie6326e3e444e4d0fa59364df7efee398_I20221231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTUtMS0xLTM2NDA2MA_3737293c-01bf-4e06-a625-9709d46071ee">168</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8d73c6b22ae6491dbc37944b398879b4_I20221231" decimals="-6" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTYtMS0xLTM2NDA2MA_f35307bc-bff1-47ab-b49f-5a3fe788b9c5">14,055</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib371a75679dd4f838651914ccd2f7845_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTEtMS0xLTM2NDA2MA_609d6d12-b0fc-423f-9cc4-293b76955da7">226</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d233b94b150441c965315e4c2cdb970_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTItMS0xLTM2NDA2MA_e3b545d5-ace1-459c-8db8-00ea08c606e9">2,930</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i460186f58d964578bb57d83f6b52c068_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTMtMS0xLTM2NDA2MA_546d7cce-3edc-455d-b919-7d2087026040">3,335</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8a427587471c4b43b5afa2d98b323de7_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTQtMS0xLTM2NDA2MA_3817b5af-29ab-4e02-8817-10eafa1c548d">543</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7c53e563aead4f239fdd2a1346eaa2ca_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTUtMS0xLTM2NDA2MA_adc11436-556b-438a-bfea-7583c81ff215">2,331</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTYtMS0xLTM2NDA2MA_d8ab62ad-555d-4f94-b02b-7caadfcbb224">9,365</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i28edbc201159440baec039fe6f9edab4_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTEtMS0xLTM2NDA2MA_4471c65e-9998-42ac-9836-47c36230d829">231</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib0aae04a72c84e138d05a17aa6e4adc6_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTItMS0xLTM2NDA2MA_77fc7201-c3e7-4931-b223-30470945ba94">2,980</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i038f209f31d04ec4baba797bedf7ede2_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTMtMS0xLTM2NDA2MA_9b03e304-2e62-49db-8d93-10d73bd9444b">3,308</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib020c89f73574f31811c48672a7d702a_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTQtMS0xLTM2NDA2MA_709d5f7b-127d-463c-a2d6-ffe668c585fb">540</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie5df9065660c4e1184ba88ea30322027_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTUtMS0xLTM2NDA2MA_9dbde3c0-5b8e-4417-bc65-ec139518fe6b">2,969</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTYtMS0xLTM2NDA2MA_9709295c-ec82-4b5c-b225-aa858df54a81">10,028</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id09d5d649b4446e3a4a10a599d8c7820_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTEtMS0xLTM2NDA2MA_bc42daa6-b9af-4042-9bbc-866f03fbc4f8">227</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib493cbd2620f4ebeb6ea7d83ee096a61_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTItMS0xLTM2NDA2MA_1609c986-dc55-419c-bcba-29c354f4ea16">3,103</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i29b79d594c5948f5abb69e79838735ed_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTMtMS0xLTM2NDA2MA_af5170f4-7d29-4a80-b74f-0e04b8489592">3,211</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2cd5556f3abe48f5a8eab0fd94631f19_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTQtMS0xLTM2NDA2MA_f5a6dc78-d761-4fbb-ae93-4e0ef59d58c5">500</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i15ac112e5ca84ab9a152812eaa4b795c_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTUtMS0xLTM2NDA2MA_9c007f27-27ce-423e-9388-301432337a61">2,828</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTYtMS0xLTM2NDA2MA_013abe6d-aa89-4bed-b487-23b27fbfbffe">9,869</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line includes in particular property, plant and equipment in process brought into service during the period, but also includes the effect of the reclassification of assets to Assets held for sale or exchange.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-38</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ifd26aff1ae094b528df962575d3f376a" continuedAt="i36f85fa5dede4c1f92ba41cb5ee5a873"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0MzA_9c94e656-8015-40bf-90b9-ea91dd9f769e" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth acquisitions and capitalized interest by operating segment for the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzEtMS0xLTEtMzY0MDYw_cd042b01-2996-4531-b5f9-3a720839cc81">1,748</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzEtMi0xLTEtMzY0MDYw_9e2fa8b2-a700-49b3-8ea4-1c099e5a8266">1,504</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzEtMy0xLTEtMzY0MDYw_b7b1a843-ac53-4d59-bdc8-d7315bea89fa">1,310</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibb589cf6b30d4f85b2a6924184520710_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzItMS0xLTEtMzY0MDYw_81598f4d-8935-4a87-bec2-1a47cfbf792f">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb790736d7c44dc0aece34570e7aa9d1_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzItMi0xLTEtMzY0MDYw_3a00b9c0-64cf-4b4c-a9b9-58edb4e0b93b">1,007</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia71d61fb176c44bc85d8a7131e07caca_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzItMy0xLTEtMzY0MDYw_794c5167-42f7-47b4-964b-9a63f0a4fc7c">831</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Industrial facilities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia21cdedb03d541ac8ce4c21e0f09243a_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzMtMS0xLTEtMzY0MDYw_f525bd6b-20a8-4fc6-882a-87353e040d8a">597</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2d87c5192beb4f79a9a215eefde80519_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzMtMi0xLTEtMzY0MDYw_8a8cf781-bbbf-4210-9e98-a70f41c1961f">534</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6e59794b9da94a948e8aa70b12c8ff88_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzMtMy0xLTEtMzY0MDYw_98a9047b-6da9-4384-b885-d36b3f7746d0">634</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Research sites</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if815506776604f328ffbe1f64040e104_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzQtMS0xLTEtMzY0MDYw_83ea8241-cc5c-4cad-b6e4-a32c1bf525cb">153</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7903da3784d448cfb09ae68817994cc1_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzQtMi0xLTEtMzY0MDYw_8929108a-1144-4c19-937d-b7db4e311749">277</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie4dd16005bec44a7bfe5627a199fe9be_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzQtMy0xLTEtMzY0MDYw_85cdf173-f308-4d1a-a69a-494504d8a899">152</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if781d7295c08487ea51c6503613eb526_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzUtMS0xLTEtMzY0MDYw_5fafee69-3971-4f94-9d3c-6bf614754d6f">299</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaf174122818644c48b0a0c91bb27b307_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzUtMi0xLTEtMzY0MDYw_acc14838-2b59-49ee-9382-a51ca32bbc14">199</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifa82abad241d465ebfe6912fd6e39476_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzUtMy0xLTEtMzY0MDYw_fee1dcf9-6c83-4c15-837c-baffe79295ed">45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i50f963fe7eb242389c52c58a27841042_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzYtMS0xLTEtMzY0MDYw_88939c40-1844-42fc-af2f-269d25b46ce2">629</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8ec69c452bde4d2e9c935c00c627ed10_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzYtMi0xLTEtMzY0MDYw_750bbc46-380f-4bc3-b118-d11d1ea3005d">421</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i73d9e784d85c4861808c14effc04b733_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzYtMy0xLTEtMzY0MDYw_bec3163b-50b3-490c-acba-2f1e755d6bda">384</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Consumer Healthcare</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib5d1685308d744b99b0b8ffe90f18bf9_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzctMS0xLTEtMzY0MDYw_b6b2e1a0-3cae-40e8-95d9-2221790f3bce">70</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iec6fc9c2bb8247b2b49f3c157447c542_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzctMi0xLTEtMzY0MDYw_a9c4a2ce-6b3b-4b4e-a74c-9a87e99fc1d0">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib8a4cde136ee4ba6867518e84f629759_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzctMy0xLTEtMzY0MDYw_7e62adc0-6248-42a6-b5d2-fe81eb3bdb4d">95</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capitalized interest</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:InterestCostsCapitalised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzgtMS0xLTEtMzY0MDYw_682f6156-6eea-494a-adb2-c0379db6ce80">17</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:InterestCostsCapitalised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzgtMi0xLTEtMzY0MDYw_b6af0878-3682-4bc5-a79e-bbbe4aa1c033">14</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:InterestCostsCapitalised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzgtMy0xLTEtMzY0MDYw_46dacd4e-245a-45ca-91db-26aba51ef7b2">11</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0MjU_ce848da2-e280-4859-af7a-cda42e02e378" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Off balance sheet commitments relating to property, plant and equipment as of December 31, 2022, 2021 and 2020 are set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Firm orders of property, plant and equipment</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:FirmOrdersOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzEtMS0xLTEtMzY0MDYw_83930a6e-4229-43a5-9fb0-a4fb88d030ee">861</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:FirmOrdersOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzEtMi0xLTEtMzY0MDYw_2e1f1f60-8dfe-4dfd-90f8-e580e32a9306">769</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:FirmOrdersOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzEtMy0xLTEtMzY0MDYw_ccda5be4-23db-4416-a53f-f0f8f7d48b54">708</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Property, plant and equipment pledged as security for liabilities</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzItMS0xLTEtMzY0MDYw_16de73a0-01b7-4f97-a5bc-f0f9fa7f5f3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzItMi0xLTEtMzY0MDYw_1dde16d7-65f5-4d31-9d7a-b8a5ea26d4f8">9</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzItMy0xLTEtMzY0MDYw_2474e40d-29ae-4547-b40c-4ff86fde8bfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0MjE_d7ac26d2-2692-45cd-b462-5ed487c02f36" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth the net impairment losses recognized in each of the last three financial periods:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net impairment losses on property, plant and equipment</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo4NTBiOTlkOGIyZDk0NzI1OWY3MThiNzUxYTBmZDdhYS90YWJsZXJhbmdlOjg1MGI5OWQ4YjJkOTQ3MjU5ZjcxOGI3NTFhMGZkN2FhXzEtMS0xLTEtMzY0MDYw_75c35830-bb95-4a31-a39f-c621caf79084">186</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo4NTBiOTlkOGIyZDk0NzI1OWY3MThiNzUxYTBmZDdhYS90YWJsZXJhbmdlOjg1MGI5OWQ4YjJkOTQ3MjU5ZjcxOGI3NTFhMGZkN2FhXzEtMi0xLTEtMzY0MDYw_bed4c3d5-8c03-4e32-86a4-a98686ec299a">39</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo4NTBiOTlkOGIyZDk0NzI1OWY3MThiNzUxYTBmZDdhYS90YWJsZXJhbmdlOjg1MGI5OWQ4YjJkOTQ3MjU5ZjcxOGI3NTFhMGZkN2FhXzEtMy0xLTEtMzY0MDYw_66952fdb-a6cd-49aa-80ed-62cf587193bd">43</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) For 2022, the amount mainly comprises an impairment loss arising from a decision to discontinue operations at an industrial facility located outside&#160;France.</span></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-39</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i36f85fa5dede4c1f92ba41cb5ee5a873" continuedAt="i85769becaa9b4d8fb955461e123ab2e4"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.3.2. Property, plant and equipment leased &#8211; right-of-use assets</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0Mjg_120e07da-364c-435d-a5e3-8e7563500adc" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Right-of-use assets relating to property, plant and equipment leased by Sanofi are analyzed in the table below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:82.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Right-of-use assets</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0a5f73156d8942cc9aff9b90aa0a20d9_I20191231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzEtMS0xLTEtMzY0MDYw_62f0aa7b-1a38-428e-b2e6-1c0d24bce007">1,583</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" name="sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzItMS0xLTEtMzcxNDIy_7c248326-2f7b-4669-9753-e36367c8e976">15</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" name="sny:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMtMS0xLTEtMzcxNDIy_120d65ca-caf9-4b18-80e4-3791c4edfaba">340</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" name="sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzItMS0xLTEtMzY0MDYw_68e3c346-d4ec-4e49-b97c-1e50c8abcfd2">121</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMtMS0xLTEtMzY0MDYw_1e2268af-9b3a-433d-8c8a-1d730e8cac48">85</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzQtMS0xLTEtMzY0MDYw_c571ed77-b123-4409-8780-a4a692ff841c">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzUtMS0xLTEtMzY0MDYw_c7d8bb25-0627-4782-b2fb-fb815679a09f">1,711</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzYtMS0xLTEtMzY0MDYw_b3c119cc-ba0b-4f7c-9428-5ea8f5547fc0">93</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="sny:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzctMS0xLTEtMzY0MDYw_3df5017d-8a1b-466a-a79e-dbd12e1188a5">963</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzgtMS0xLTEtMzY0MDYw_d709a49c-3d0f-496c-b58f-355e6e67b2b9">91</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzktMS0xLTEtMzY0MDYw_1457ca71-53d6-4583-beca-35a1b19a98e4">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzEwLTEtMS0xLTM2NDA2MA_15ac10ed-328a-47af-bd7d-128946e77f81">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzExLTEtMS0xLTM2NDA2MA_a493ce94-cde1-4b0e-86a8-85c9dc83fc07">2,745</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" sign="-" name="sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzEyLTEtMS0xLTM2NDA2MA_48bf5c5d-3741-45ba-9f81-931edfdcd797">26</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" name="sny:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzEzLTEtMS0xLTM2NDA2MA_cb274697-2dfc-401d-aa3d-c13cb1ca7b6e">292</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" name="sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE0LTEtMS0xLTM2NDA2MA_16d19a1d-65ce-4055-b8eb-7011473a2e6e">232</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE1LTEtMS0xLTM2NDA2MA_e69dcb61-75c0-4c70-a22c-da3352ab3d8e">101</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE2LTEtMS0xLTM2NDA2MA_554a3144-f03c-4289-8c64-07b97508bc63">8</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE3LTEtMS0xLTM2NDA2MA_859b8b76-3249-432a-acd2-a7298da0dc78">2,872</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idc8a6784630a4f6dacd4f922e9fdcfda_I20191231" decimals="-6" sign="-" name="ifrs-full:RightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE4LTEtMS0xLTM2NDA2MA_ad9acaa5-5cc6-4b23-894b-5aec9d3e4beb">283</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and impairment charged in the period</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIyLTEtMS0xLTM3MTQyMg_c5265486-13c8-4137-8680-27432de5a46e">299</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" sign="-" name="sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIzLTEtMS0xLTM3MTQyMg_6a5ecdee-3a31-4dd1-a729-042040f4bdfc">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE5LTEtMS0xLTM2NDA2MA_bb51dc90-06e9-4782-98a6-55df2bfd207b">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIwLTEtMS0xLTM2NDA2MA_c9564eef-2538-4555-bcb0-fd42d392549c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd6e4b32cb345028d31ec8dc75abdea_I20201231" decimals="-6" sign="-" name="ifrs-full:RightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIxLTEtMS0xLTM2NDA2MA_fc398901-ab13-45bf-8d0b-3f1a848d6afd">513</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and impairment charged in the period</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIyLTEtMS0xLTM2NDA2MA_2be94f0e-ddf6-4b86-a86a-a9fefbde56ba">315</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" sign="-" name="sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIzLTEtMS0xLTM2NDA2MA_388786c9-15b2-44d6-8684-e30a07ebc8d4">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI0LTEtMS0xLTM2NDA2MA_8e78dc7f-7256-4ede-b5c5-e6ca9cd53093">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI1LTEtMS0xLTM2NDA2MA_64f46f01-4c44-48e3-a389-99656402e7fc">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ida5c0c7399ab4f90ab42e89c5e29af71_I20211231" decimals="-6" sign="-" name="ifrs-full:RightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI2LTEtMS0xLTM2NDA2MA_d5ac50d3-6985-42e4-988d-8c47656a2308">797</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" name="sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMzLTEtMS0xLTM3MTQyMg_ac868b18-ddc7-4a22-8e31-6d033c05b853">14</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and impairment charged in the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI3LTEtMS0xLTM2NDA2MA_1b38e35c-1327-4a76-bdfc-b3b76a8bb6b0">341</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" sign="-" name="sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI4LTEtMS0xLTM2NDA2MA_449de399-568f-4efe-8794-193264102aed">82</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI5LTEtMS0xLTM2NDA2MA_4c56990c-d030-43fb-9f15-c5e84b13e308">17</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMwLTEtMS0xLTM2NDA2MA_273b2f05-c9fe-4dd7-971b-8f265a3343c1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8d73c6b22ae6491dbc37944b398879b4_I20221231" decimals="-6" sign="-" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMxLTEtMS0xLTM2NDA2MA_212e14bd-abef-414c-80a8-3f19743db289">1,057</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMyLTEtMS0xLTM2NDA2MA_992e0fe5-e96a-4974-af3e-46a8c2cf1da2">1,198</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMzLTEtMS0xLTM2NDA2MA_51997faa-861e-4a1f-b012-b1411f9c1cf0">1,948</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzM0LTEtMS0xLTM2NDA2MA_bf08c373-aa60-4dbf-b241-da6aa4128268">1,815</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line also includes the effect of the reclassification of assets to &#8220;Assets held for sale or exchange&#8221;.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In December&#160;2018, Sanofi signed <ix:nonFraction unitRef="lease" contextRef="ia2a9d85e3600439fa8021956ade9fb27_D20181201-20181231" decimals="INF" name="sny:NumberOfLeaseAgreementsSigned" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzExOTA_93f8956e-3716-439f-97b8-e45092aff0a4">two</ix:nonFraction> leases on real estate assets in the United States (at Cambridge, Massachusetts) for an initial lease term of <ix:nonNumeric contextRef="ia2a9d85e3600439fa8021956ade9fb27_D20181201-20181231" name="sny:InitialLeaseTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzEzMDI_c847bb5f-edc4-415b-ae61-473a1c8d5b49">15</ix:nonNumeric> years. The first lease, relating to office space, began in April&#160;2021; Sanofi recognized a right-of-use asset of &#8364;<ix:nonFraction unitRef="eur" contextRef="idf46653d45ba47878e79284f8a9651fe_I20211231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE0MTI_06c43500-f176-43a3-b9e0-1a201c71ae94"><ix:nonFraction unitRef="eur" contextRef="idf46653d45ba47878e79284f8a9651fe_I20211231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE0MTI_3636b328-499e-485e-b5a9-61207b66884b">320</ix:nonFraction></ix:nonFraction> million, as well as the lease liability. The second lease, relating to laboratory facilities, began on July&#160;1, 2021; Sanofi recognized a right-of-use asset of &#8364;<ix:nonFraction unitRef="eur" contextRef="i521770fd159a444e8b290a2b366d3120_I20211231" decimals="-6" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE1NjY_7a43ea13-b5d6-412c-9a7b-0c5074d25bba"><ix:nonFraction unitRef="eur" contextRef="i521770fd159a444e8b290a2b366d3120_I20211231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE1NjY_84e80aae-ea0d-44f5-88de-b47d16cd2aed">424</ix:nonFraction></ix:nonFraction> million, as well as the lease liability.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Leased assets are mainly comprised of office and industrial premises (<ix:nonFraction unitRef="number" contextRef="i9975866b6f0948c4b2dc3d5202c3a8e7_I20221231" decimals="2" name="sny:LeasedAssetsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE2NzM_cc40e9b7-d382-4809-8240-8b9f17599254">93</ix:nonFraction>%) and the vehicle fleet (<ix:nonFraction unitRef="number" contextRef="ie04ea8d3bc0f4c5ba8c8a671c1dfec8a_I20221231" decimals="2" name="sny:LeasedAssetsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE3MDA_811a5ffe-5e24-4fc9-9857-5ce861f41f53">7</ix:nonFraction>%) as of December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Annual lease costs on short term leases and low value asset leases amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE3OTM_8d09dddc-3887-47e6-a21d-657ce3447b61">26</ix:nonFraction> million in the year ended December 31, 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE4MTg_7b73e03d-ceeb-4ea8-8036-30751d3cc7ba">25</ix:nonFraction> million in the year ended December 31, 2021, and &#8364;<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE4NDc_c89cac2b-4170-40d5-9fc9-8ad18fe5d2a3">27</ix:nonFraction> million in the year ended December 31, 2020. Variable lease payments, sub-leasing activities, and sale-and-leaseback transactions were immaterial.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Total cash outflows on leases (excluding annual lease costs on short term leases and low value asset leases) were &#8364;<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:CashOutflowForLeases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzIwOTU_dfc2ea75-8368-4aa7-9c6f-6db63be2a1c3">389</ix:nonFraction> million in&#160;the year ended December 31, 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:CashOutflowForLeases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzIxMjA_2d99b079-f4c6-4b9d-a0c3-8f5cae9572be">302</ix:nonFraction> million in the year ended December 31, 2021, and &#8364;<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:CashOutflowForLeases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzIxNDk_88540ffe-2840-4d64-9fc7-88f7957e0ed2">269</ix:nonFraction> million in the year ended&#160;December 31, 2020.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-40</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i85769becaa9b4d8fb955461e123ab2e4"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A maturity analysis of the lease liability is disclosed in Note&#160;D.17.2.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Commitments related to short-term leases and low value asset leases, including future payments for lease contracts committed but not yet commenced, are disclosed in Note&#160;D.21.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_601"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.4. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2OTM4MDM0ODkyMTQw_8d5f4c61-b2c9-4dc0-88d7-927c608dbc1e" continuedAt="ie6798a23e28648a59d9fae9a7c2da05d" escape="true">Goodwill and other intangible assets</ix:nonNumeric></span></div><ix:continuation id="ie6798a23e28648a59d9fae9a7c2da05d" continuedAt="i47f6dfd423454277ae9983bda0534525"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzM5NzU_7774da56-e2be-4fc3-b30f-63470ab42d3d" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in goodwill comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:82.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ddd2e8b048c4aceb5e20e5ee54cfd35_I20191231" decimals="-6" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzEtMS0xLTEtMzY0MDYw_15bb4f78-cf63-4cc4-9b62-b2e969fb5833">44,519</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions during the period</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i04c2256e354744d2b996810e1b4ce23b_D20200101-20201231" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzItMS0xLTEtMzY0MDYw_10aa8690-827b-4e5e-a901-5dc4b5bf8046">1,843</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements during the period</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i04c2256e354744d2b996810e1b4ce23b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzMtMS0xLTEtMzY0MDYw_14d51b47-233f-4207-8a53-e7223da8f044">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i04c2256e354744d2b996810e1b4ce23b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzQtMS0xLTEtMzY0MDYw_5e8dd783-ada4-435c-bb73-2a9511fa8108">1,923</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic7d3b42ca90c45d9a60556ebff587fa1_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzUtMS0xLTEtMzY0MDYw_ec53260d-921c-4525-ab49-ab992199b2ba">44,364</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions during the period</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iccfd390288694500897be21beb1f90d6_D20210101-20211231" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzYtMS0xLTEtMzY0MDYw_f70941a5-02f7-4f49-a2a3-6790ca22ded2">2,179</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements during the period</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iccfd390288694500897be21beb1f90d6_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzctMS0xLTEtMzY0MDYw_54e6db24-07eb-420b-9d0a-add014002004">89</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iccfd390288694500897be21beb1f90d6_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzgtMS0xLTEtMzY0MDYw_306d7572-a387-475b-b8fa-ff94b5218384">1,602</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6e1d225964344fc99aa88194ac03758e_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzktMS0xLTEtMzY0MDYw_5bd537b5-f1f8-4960-87e5-dfeb106c3049">48,056</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions during the period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i18beae5325a24e4b91ab73391d713a14_D20220101-20221231" decimals="-6" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzEwLTEtMS0xLTM2NDA2MA_10b4e3bb-b95a-4a09-bb35-6911574bb791">609</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements during the period</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i18beae5325a24e4b91ab73391d713a14_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzExLTEtMS0xLTM2NDA2MA_5f4d0ddd-9b92-4e2b-83eb-dc5bd85d60fc">258</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i18beae5325a24e4b91ab73391d713a14_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzEyLTEtMS0xLTM2NDA2MA_0c3c79a4-dba7-4bda-9f44-2ba0eddab01a">1,485</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i805096a31a54493f98690df2512c4182_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzEzLTEtMS0xLTM2NDA2MA_2e610b1e-4b87-49e6-96db-52cba51fd63c">49,892</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line mainly comprises the amount of goodwill allocated to divested operations in accordance with paragraph&#160;86 of IAS&#160;36, and in 2022 the sale of EUROAPI (see note&#160;D.1.).</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Amunix Pharmaceuticals, Inc. (2022)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation for Amunix Pharmaceuticals, Inc. resulted in the recognition of intangible assets (other than goodwill) o</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">f&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="ice04a6b9957a4d6db37a912faaaaa4fb_I20220208" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzYwNDczMTM5NTc0MTQ_de356b15-f5b9-419e-ac39-1a88606c1ef8">493</ix:nonFraction>&#160;million as of the acquisition date (February&#160;8, 2022), and of goodwill provisionally measured at &#8364;<ix:nonFraction unitRef="eur" contextRef="ice04a6b9957a4d6db37a912faaaaa4fb_I20220208" decimals="-6" name="ifrs-full:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2OTM4MDM0ODkyMTM4_50a36537-84dd-4e0c-8971-fa936669b616">609</ix:nonFraction>&#160;million as of the acquisition date (see Note&#160;D.1.).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Translate Bio (2021)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation for Translate&#160;Bio resulted in the recognition of intangible a</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ssets (other than goodwill) of&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzM3NQ_eb93f39b-a604-499d-8947-c05b79acd879">396</ix:nonFraction>&#160;million as of the acquisition date (September&#160;14, 2021), and of goodwill measured at &#8364;<ix:nonFraction unitRef="eur" contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzQ3OA_cd4a3974-123c-4e67-bc7e-4e2e7dcc7163">2,118</ix:nonFraction>&#160;million as of the</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> acquisition date (see Note&#160;D.2.1.).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Principia (2020)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation for Principia resulted in the recognition of in</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">tangible assets (other than goodwill) of &#8364;<ix:nonFraction unitRef="eur" contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzY4OQ_98928fb7-0f64-428b-a96b-000cdbe856b0">2,534</ix:nonFraction> million as of the acquisition date (September&#160;28, 2020), and of goodwill measured at &#8364;<ix:nonFraction unitRef="eur" contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928" decimals="-6" name="ifrs-full:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzc3MA_5dcdce4a-c559-40a8-9a4f-1fc8d92f9be9">912</ix:nonFraction>&#160;million as of the acquisition date (se</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">e&#160;Note&#160;D.2.2.).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Synthorx (2020)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation for Synthorx resulted in the recognition of intangible a</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ssets (other than goodwill) totaling &#8364;<ix:nonFraction unitRef="eur" contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123" decimals="-6" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzk4Nw_212a5874-0168-4bca-81d4-e8bd58b298c6">1,549</ix:nonFraction> million as of the acquisition date (January&#160;23, 2020), and of goodwill measured at &#8364;<ix:nonFraction unitRef="eur" contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzEwNjU_3058177f-bae7-443a-9f2b-4ddf2ed3c812">930</ix:nonFraction> million as o</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">f the acquisition date (see Note&#160;D.2.2.).</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-41</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i47f6dfd423454277ae9983bda0534525" continuedAt="id76b55679fa544b9b29714a379df71b1"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzM5Nzc_f09607c5-96e9-417f-93fe-5cf9ef22f98e" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in other intangible assets comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.595%"><tr><td style="width:1.0%"></td><td style="width:50.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.235%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.061%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquired R&amp;D</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Products,<br/>trademarks and<br/>other rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Software</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total other<br/>intangible assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at January&#160;1, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i972f543731c343078d24518f433fa726_I20191231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEtMS0xLTEtMzY0MDYw_90cd4c54-c9e9-46ff-ac92-dd1a4d433987">5,730</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i479eecf06f384cd28a6d6234aded995c_I20191231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEtMi0xLTEtMzY0MDYw_cb7b380d-cb56-4329-9c8a-006e11c33453">63,953</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib655a021196d4cdfbe4475108064a5fd_I20191231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEtMy0xLTEtMzY0MDYw_839d4dd7-bdf1-4b91-8596-55eca74f6af3">1,613</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0a5f73156d8942cc9aff9b90aa0a20d9_I20191231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEtNS0xLTEtMzY0MDYw_3b8cfb4b-a000-4de5-9523-313b66250511">71,296</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes&#160;in&#160;scope of&#160;consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzItMS0xLTEtMzY0MDYw_f948768b-f431-4e7f-9e92-13de33ebb687">3,951</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idcc8c91558474195b7619d926905f4a8_D20200101-20201231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzItMi0xLTEtMzY0MDYw_bda135fb-01f4-42b7-85db-7d2f34b969a9">132</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzItMy0xLTEtMzY0MDYw_bab677bc-a243-402f-92a1-f094b868623d">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzItNS0xLTEtMzY0MDYw_2c49a438-5b48-491b-965c-b4887832ed44">4,083</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMtMS0xLTEtMzY0MDYw_37eaf158-be34-4b30-8ac5-876f120aa232">654</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idcc8c91558474195b7619d926905f4a8_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMtMi0xLTEtMzY0MDYw_9009d31b-98ed-4fa7-a948-3023613d012b">58</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMtMy0xLTEtMzY0MDYw_48b3c6b2-36db-4aa3-8814-7183d1c49b4d">106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMtNS0xLTEtMzY0MDYw_2a694e23-a9f8-4975-9f24-8d0acc76fe4b">818</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQtMS0xLTEtMzY0MDYw_eeaf9e56-90c8-4b11-97a0-4262c73ec605">44</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idcc8c91558474195b7619d926905f4a8_D20200101-20201231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQtMi0xLTEtMzY0MDYw_a0153541-27fb-49da-aea0-c09fd39e0712">243</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQtMy0xLTEtMzY0MDYw_62e394b6-8e97-4bfb-bda3-9728f511d92d">46</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQtNS0xLTEtMzY0MDYw_47d715b1-cb6c-4c80-af85-cfc1ae5b5fd3">333</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzUtMS0xLTEtMzY0MDYw_d946e3f1-1f5f-4297-b42b-2a9f3ea62381">593</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idcc8c91558474195b7619d926905f4a8_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzUtMi0xLTEtMzY0MDYw_963e31d1-b7cc-4812-8425-5622631261d3">2,926</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzUtMy0xLTEtMzY0MDYw_6ecebe3d-b25e-439a-ac31-680c262eb6ab">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzUtNS0xLTEtMzY0MDYw_7be7d891-94a8-449b-9615-58a505c8b34f">3,557</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzYtMS0xLTEtMzY0MDYw_ac0db332-c592-4cb4-9b54-dab398d333d4">98</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idcc8c91558474195b7619d926905f4a8_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzYtMi0xLTEtMzY0MDYw_683e6749-c4c8-4ba6-a20b-896cd5102696">100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzYtMy0xLTEtMzY0MDYw_49404a8c-0aef-456b-ac20-ecb67f0ace3f">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzYtNS0xLTEtMzY0MDYw_6db206a0-f47d-48bb-ab15-d643ad6035df">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December&#160;31, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0012231543ff4a8da7fc419bff0a9e67_I20201231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzctMS0xLTEtMzY0MDYw_327af381-070d-408b-9e03-972a361a7e14">9,600</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic2d610536ebf4dbf8b9a88106c67353f_I20201231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzctMi0xLTEtMzY0MDYw_79c33281-8415-47b6-af39-9efd64017e87">61,074</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic16020b4a1554e8a9cf89178c464111a_I20201231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzctMy0xLTEtMzY0MDYw_73dacd03-8a1a-485e-997f-1f4347a2478a">1,633</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzctNS0xLTEtMzY0MDYw_6e49198e-0aae-458d-9546-c974f9f837d6">72,307</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzgtMS0xLTEtMzY0MDYw_80e20218-2d9a-4145-86e3-79abdc7fdb04">1,805</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzgtMi0xLTEtMzY0MDYw_2d7dd2f2-1a98-4e27-97e0-fb6acc6fa79b">1,821</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzgtMy0xLTEtMzY0MDYw_98ffab46-5c9a-4bac-a023-e73b16c4f60e">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzgtNS0xLTEtMzY0MDYw_f1f34ff0-2ae6-49ea-b05a-ca312575c373">3,626</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzktMS0xLTEtMzY0MDYw_60910940-1ef2-4a6a-83e9-368d789265c2">339</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzktMi0xLTEtMzY0MDYw_9bd9bf8a-f761-411b-80ec-063376558285">159</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzktMy0xLTEtMzY0MDYw_0ba10264-3235-4fda-b055-89f71784827a">118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzktNS0xLTEtMzY0MDYw_5097892f-8a76-4f63-b55b-4993ae1bae20">616</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEwLTEtMS0xLTM2NDA2MA_5120710b-19d9-4e07-b5b9-7dea8a010bca">313</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEwLTItMS0xLTM2NDA2MA_972e08a9-6947-4e66-a05c-a800498ed181">173</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEwLTMtMS0xLTM2NDA2MA_a16f94b0-af1f-4347-97d1-9b8d7fcc5e9e">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEwLTUtMS0xLTM2NDA2MA_8f644319-4f30-4bf1-89c2-4d947b70efab">502</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzExLTEtMS0xLTM2NDA2MA_7d485f7c-45ea-4687-878e-d5416910d27d">560</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzExLTItMS0xLTM2NDA2MA_8102bb04-5021-46cc-8806-15e67f72788d">2,234</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzExLTMtMS0xLTM2NDA2MA_de7ff90f-5f06-4405-b8df-80e4abd399f8">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzExLTUtMS0xLTM2NDA2MA_d88ad1e9-675a-4e4c-92eb-cdeff9c9f83a">2,818</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEyLTEtMS0xLTM2NDA2MA_7899ce1c-53b3-4270-b934-dc95fb04dff4">784</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEyLTItMS0xLTM2NDA2MA_5b3722f7-8461-4801-9876-b920c1dd3656">791</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEyLTMtMS0xLTM2NDA2MA_d5bf01e8-8be6-4995-8163-6628cdf66840">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEyLTUtMS0xLTM2NDA2MA_b9703ab7-101e-4792-a542-16573ec61a92">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2021</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7a0da2ecaa04eeb814d811ee982a0af_I20211231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEzLTEtMS0xLTM2NDA2MA_1e892f7c-62a1-4c2c-b254-b0929b37a7ee">11,207</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3f1973ece55247c7bfca1df0959ed390_I20211231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEzLTItMS0xLTM2NDA2MA_20bbdfdb-607b-426c-9290-fda2605f4bb4">65,906</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i738d8bb190154e6885638cf09b03af8a_I20211231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEzLTMtMS0xLTM2NDA2MA_36100dc9-cda3-4e88-9686-c8a7f98e4d37">1,752</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEzLTUtMS0xLTM2NDA2MA_5ac2e5a8-94e0-42df-89ec-7acfcfddbb31">78,865</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE0LTEtMS0xLTM2NDA2MA_c0d77a61-8c65-4204-a84f-e6e38586f0d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i212426e60cf24241b201ace1b0732af7_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE0LTItMS0xLTM2NDA2MA_117ea130-ebfe-48e9-9be6-797151fdcae1">499</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE0LTMtMS0xLTM2NDA2MA_bafa3e30-45e0-4dd9-bc9e-0dda4a90ffe0">35</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE0LTUtMS0xLTM2NDA2MA_511eacc1-990b-4360-aafa-a65dc27f32d6">464</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE1LTEtMS0xLTM2NDA2MA_27ae6585-2250-4536-b091-1c3cb43cca3c">277</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i212426e60cf24241b201ace1b0732af7_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE1LTItMS0xLTM2NDA2MA_ddb101a7-eafa-48ad-8da4-ca33ca370944">195</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE1LTMtMS0xLTM2NDA2MA_513dedac-05c8-4856-b3bc-3f88434b3afe">99</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE1LTUtMS0xLTM2NDA2MA_0888f9ec-9435-4bd8-9c85-c764856f8c38">571</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE2LTEtMS0xLTM2NDA2MA_51ead8ec-f391-47e4-ad22-c8007559b03e">72</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i212426e60cf24241b201ace1b0732af7_D20220101-20221231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE2LTItMS0xLTM2NDA2MA_96feb6fa-716b-4309-9e98-2b5e30486581">423</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE2LTMtMS0xLTM2NDA2MA_11da7be6-d768-4394-bb6c-65df1b9bc6d7">48</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE2LTUtMS0xLTM2NDA2MA_694e1972-b8ae-4136-84f3-fe26e0a2a5a1">543</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE3LTEtMS0xLTM2NDA2MA_b99974ca-47e0-4e23-af5d-906e50c1136d">518</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i212426e60cf24241b201ace1b0732af7_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE3LTItMS0xLTM2NDA2MA_44a3e4c2-0294-4acf-ad37-007ddab1f694">1,994</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE3LTMtMS0xLTM2NDA2MA_877a73a5-b1c9-4f6c-9465-79181a19c855">21</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE3LTUtMS0xLTM2NDA2MA_f2067bce-2fc7-4f24-858f-26712790f54c">2,533</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE4LTEtMS0xLTM2NDA2MA_f8818442-acb0-4018-b519-71c626b8c0fe">1,576</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i212426e60cf24241b201ace1b0732af7_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE4LTItMS0xLTM2NDA2MA_ee72955b-cc31-4f18-b1ca-251242b3e59d">1,408</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE4LTMtMS0xLTM2NDA2MA_b515e084-0b39-492a-8bcb-3f7f13d26a7d">6</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE4LTUtMS0xLTM2NDA2MA_a9c698be-260f-46d0-80e8-fc4174f48e69">174</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6c347307f4a945aeaeb2aa62d4b9c418_I20221231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE5LTEtMS0xLTM2NDA2MA_9155e974-3d8d-4471-9d37-0f16e4fb6da0">10,354</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id4bbdd4e400844a79a5da75e3ae604c9_I20221231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE5LTItMS0xLTM2NDA2MA_f5712864-d914-401c-80d0-53928f93dd44">69,579</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fdd2720629d4afcb9cb4ca0934ff100_I20221231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE5LTMtMS0xLTM2NDA2MA_c86817e6-1ef2-43dc-b088-2faad3c56113">1,783</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE5LTUtMS0xLTM2NDA2MA_8ae6d3c3-9a64-460b-9087-eac25c16eeca">81,716</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at January&#160;1, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id1e50048305543d09b31dcbeb40df282_I20191231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIwLTEtMS0xLTM2NDA2MA_a6be4950-ef2f-4629-a73d-b482936222c5">3,396</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i89f73a7c69a540c59681a9b3cdc360f5_I20191231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIwLTItMS0xLTM2NDA2MA_8ed245fe-d7e7-4f29-8178-4e15b86cb22f">50,314</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4eaa16fcabab488eaa79bd1b746613c6_I20191231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIwLTMtMS0xLTM2NDA2MA_deeb5c21-6468-42cc-af32-7fbb27dde0ed">1,077</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idc8a6784630a4f6dacd4f922e9fdcfda_I20191231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIwLTUtMS0xLTM2NDA2MA_bb2a39ce-d533-4520-b4a3-051e3cfc2e5d">54,787</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIyLTEtMS0xLTM2NDA2MA_c1c599e4-9829-47b4-b5d9-6f8bb1c4cfb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIyLTItMS0xLTM2NDA2MA_5a674c5d-73db-493d-9d9c-75b24ed4b880">1,707</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIyLTMtMS0xLTM2NDA2MA_0f2a0a4f-7f16-4e67-bf0d-5a3cf2ad26ef">112</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIyLTUtMS0xLTM2NDA2MA_3ec56732-2cc8-4e48-8579-25ca4ea4393e">1,819</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIzLTEtMS0xLTM2NDA2MA_dfde0544-d221-40e6-a018-dc10ac482b5a">328</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIzLTItMS0xLTM2NDA2MA_fbc03c23-654c-4585-a407-d9b73d3bb677">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIzLTMtMS0xLTM2NDA2MA_7e493f60-2317-43dd-a67a-41b62e7dec68">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIzLTUtMS0xLTM2NDA2MA_a4b721fc-7404-48c7-a5ee-7741487de04c">330</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI0LTEtMS0xLTM2NDA2MA_f1452a7f-8ff7-45cf-b5af-ed089b8f8592">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI0LTItMS0xLTM2NDA2MA_189d06ab-edc6-41a6-b18f-b19426bb1ff9">232</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI0LTMtMS0xLTM2NDA2MA_85dae13f-32a1-46f5-bf57-1054c2387209">45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI0LTUtMS0xLTM2NDA2MA_7b1f974d-4db5-4d91-9359-a9942831aff4">321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI1LTEtMS0xLTM2NDA2MA_f7e9f87e-7216-4fe9-92eb-0dbd259d0597">158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI1LTItMS0xLTM2NDA2MA_200c8e14-2c0f-4303-adb4-258e9c28b970">2,460</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI1LTMtMS0xLTM2NDA2MA_c41c65f4-9ac7-4130-a360-16cffa989863">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI1LTUtMS0xLTM2NDA2MA_fc070d13-be78-475c-80c4-39675cfde509">2,649</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI2LTEtMS0xLTM2NDA2MA_23db2ce5-b785-46a6-8b1e-d919d93902b2">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI2LTItMS0xLTM2NDA2MA_d67efe6e-6b87-4a45-9376-914bd5f3d407">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI2LTMtMS0xLTM2NDA2MA_afe67313-b4c0-4474-83a1-6773bea6bab0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI2LTUtMS0xLTM2NDA2MA_9e27af3b-c296-4f47-9263-850d10f72fa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at December&#160;31, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i58368e802e1c49819f70d00a80e9b758_I20201231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI3LTEtMS0xLTM2NDA2MA_1985f5b8-a5aa-46c2-87fc-e6de95396189">3,508</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3f5e538c39c74bc1bda08a15d67a3de9_I20201231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI3LTItMS0xLTM2NDA2MA_4006da26-7d92-4953-8e71-dff2abed0791">49,345</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i808e5c06bdd646ccbbe77ddc9e3f1433_I20201231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI3LTMtMS0xLTM2NDA2MA_bea15288-ddbc-4bb2-9e41-ac12886434e3">1,113</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd6e4b32cb345028d31ec8dc75abdea_I20201231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI3LTUtMS0xLTM2NDA2MA_2ad86cb1-ecd8-4b9f-8345-2af017005f79">53,966</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia8053a4d07214c0c8866abb7aa242822_D20210101-20211231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI5LTEtMS0xLTM2NDA2MA_b22d0ea4-0a9d-4696-9236-e08464d8be20">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie4e712c22a384fdf9a6a92f6d8363ca3_D20210101-20211231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI5LTItMS0xLTM2NDA2MA_62f95f71-0561-4a97-a622-4dd48534c7ee">1,621</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic159b371543149fe98e5dbe979df7b29_D20210101-20211231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI5LTMtMS0xLTM2NDA2MA_405e57cb-eeb9-44b1-a33f-6fc448239122">119</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI5LTUtMS0xLTM2NDA2MA_d98767bc-b072-4cb5-a377-90ba442cb224">1,740</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia8053a4d07214c0c8866abb7aa242822_D20210101-20211231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMwLTEtMS0xLTM2NDA2MA_9f9178ed-8d4d-429b-be02-167d394969eb">150</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie4e712c22a384fdf9a6a92f6d8363ca3_D20210101-20211231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMwLTItMS0xLTM2NDA2MA_9d06050a-d785-43a4-ae10-f10e287bb1e6">42</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic159b371543149fe98e5dbe979df7b29_D20210101-20211231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMwLTMtMS0xLTM2NDA2MA_27d632da-bcb3-4955-bd9a-f9d6e7e67c7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMwLTUtMS0xLTM2NDA2MA_022f81bf-a97c-4f02-b6ee-0d54a3f7f038">192</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia8053a4d07214c0c8866abb7aa242822_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMxLTEtMS0xLTM2NDA2MA_84cea413-2bb5-4071-afe5-67086e8ac7fb">313</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie4e712c22a384fdf9a6a92f6d8363ca3_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMxLTItMS0xLTM2NDA2MA_d2f762f7-43d9-4d81-be7e-c116ed2cbeab">133</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic159b371543149fe98e5dbe979df7b29_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMxLTMtMS0xLTM2NDA2MA_20592696-2a4b-4d15-b9f5-1852f3ed42b6">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMxLTUtMS0xLTM2NDA2MA_e8876e43-a7f8-4e6f-b486-7907c1a1857a">462</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia8053a4d07214c0c8866abb7aa242822_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMyLTEtMS0xLTM2NDA2MA_b6c230e2-8801-4eff-8131-cc975bb0c79c">132</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie4e712c22a384fdf9a6a92f6d8363ca3_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMyLTItMS0xLTM2NDA2MA_4b42403a-efe3-45f3-adf8-86a2f35dab87">1,869</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic159b371543149fe98e5dbe979df7b29_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMyLTMtMS0xLTM2NDA2MA_78df9375-2b00-4a7a-b384-a9a66d88a7f8">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMyLTUtMS0xLTM2NDA2MA_26f40618-aa58-4c4b-928b-1f2c84905f46">2,022</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at December&#160;31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i86724a133aba4372861b17fd7cc5dcc4_I20211231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM0LTEtMS0xLTM2NDA2MA_89a4f0b4-0589-4f80-8cfa-19c3dceeffcb">3,477</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6dd35aac58414697b4cc3b232d182e78_I20211231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM0LTItMS0xLTM2NDA2MA_b41bee2e-d813-48c3-8ca2-1d7077904c9b">52,744</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5661f3ac3eb046019a9fd43280b32b15_I20211231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM0LTMtMS0xLTM2NDA2MA_0d3c717b-2b7d-4746-9cb8-dfd343e34905">1,237</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ida5c0c7399ab4f90ab42e89c5e29af71_I20211231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM0LTUtMS0xLTM2NDA2MA_887ff2b2-891e-4b82-9f04-e1a90ccabd45">57,458</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM1LTEtMS0xLTM2NDA2MA_bad1c812-f79a-4592-9b42-3e5e513912a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM1LTItMS0xLTM2NDA2MA_c361422a-7fcf-4d07-ad0c-94198ad2001a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM1LTMtMS0xLTM2NDA2MA_4b8326ff-1325-4ec1-8732-e560468b2c5f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM1LTUtMS0xLTM2NDA2MA_21d2cd9f-c36c-404f-b299-0a9e1429df89">11</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM2LTEtMS0xLTM2NDA2MA_fdcb693b-c44c-4f6a-9e97-04d98325d4b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM2LTItMS0xLTM2NDA2MA_85d59d8f-abec-4462-890c-0449aba3dd81">2,099</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM2LTMtMS0xLTM2NDA2MA_4419d26b-4be5-4db1-b3a1-93a3d6a1bc17">97</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM2LTUtMS0xLTM2NDA2MA_1800e6ae-573e-44c8-a6eb-95c15e38d124">2,196</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM3LTEtMS0xLTM2NDA2MA_e6bd8328-bf6f-4884-b6e6-b4fb0a216ad7">1,107</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM3LTItMS0xLTM2NDA2MA_804ac66d-112a-40de-9be0-a451c39059ce">1,561</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM3LTMtMS0xLTM2NDA2MA_f81a913c-e036-4d92-8832-1909f904b3c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM3LTUtMS0xLTM2NDA2MA_6ac96976-724a-4101-9b23-9061228262d6">454</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM4LTEtMS0xLTM2NDA2MA_8ce920fd-03a2-4965-b654-2458751d4cab">75</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM4LTItMS0xLTM2NDA2MA_4dff4284-84b7-4783-bef1-38f60d325e97">411</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM4LTMtMS0xLTM2NDA2MA_737712ad-06b9-4f27-9e67-12b7e2c3ca86">39</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM4LTUtMS0xLTM2NDA2MA_1ca11e1a-09d9-4402-a7e3-d1dad447bd7b">525</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM5LTEtMS0xLTM2NDA2MA_b5ac6f69-a99c-4c34-a5a9-8f5f38ce929a">7</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM5LTItMS0xLTM2NDA2MA_e35c9fdb-5c4f-4766-ab87-1454393ec188">1,567</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM5LTMtMS0xLTM2NDA2MA_19ad8c7a-d1fe-48c8-a8ed-c70e84a51e1f">17</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM5LTUtMS0xLTM2NDA2MA_a03afb44-c3ff-4744-80a3-4d0c95dc40cc">1,591</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQwLTEtMS0xLTM2NDA2MA_ecd8d9fb-0fbf-48f0-98ad-5e3f16d14e2b">388</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQwLTItMS0xLTM2NDA2MA_f85e793e-e371-4953-9606-0542f93b0b77">214</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQwLTMtMS0xLTM2NDA2MA_5ab88cc9-757d-4959-a2a7-5468c5ca55e6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQwLTUtMS0xLTM2NDA2MA_612df526-b176-4ed1-a8d2-341c982abd46">179</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idddba6af7c6d4af7bbd01c92c017cb84_I20221231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQxLTEtMS0xLTM2NDA2MA_fd6cf54c-9bb7-4c30-bd2b-b78116e320eb">4,128</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5c01ebbf5a814bd68303efe91ff455cc_I20221231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQxLTItMS0xLTM2NDA2MA_ff8443c2-5960-4aff-a8ec-2d8a179e6f85">54,652</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if22620dc4746433ea7ede1e7e434757f_I20221231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQxLTMtMS0xLTM2NDA2MA_2e6d3188-3b04-4286-8dd6-655e0d2fbbe6">1,296</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8d73c6b22ae6491dbc37944b398879b4_I20221231" decimals="-6" sign="-" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQxLTUtMS0xLTM2NDA2MA_05edf979-f166-4789-a9b3-24b27e0fe8ed">60,076</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia4736438590b4561bf1bcf564c1f1016_I20201231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQyLTEtMS0xLTM2NDA2MA_33d92f17-c968-492c-a51c-2c440c3bc85f">6,092</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaa0f7fa9eea84ac4a2c28706473cc2e5_I20201231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQyLTItMS0xLTM2NDA2MA_f95ba211-dc63-46d0-920a-263478804b5f">11,729</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2b534838cd34410bbdd454b2427db95c_I20201231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQyLTMtMS0xLTM2NDA2MA_ae5c886d-2207-4147-95b8-9d89882eae27">520</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQyLTUtMS0xLTM2NDA2MA_315f804f-eb47-492a-8efa-c771b339c57e">18,341</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia2b9c32fec7247f5b6cf4d373a4bdfdc_I20211231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQzLTEtMS0xLTM2NDA2MA_161a92b1-ce19-4d3a-9ebc-fb32bab9c542">7,730</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i83d587327ece400fb1dc4a4ed917f95c_I20211231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQzLTItMS0xLTM2NDA2MA_629bf263-6b39-4a90-bc0b-95f6a402a425">13,162</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief8f9ac9127344e5a1d9e4dc7468661d_I20211231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQzLTMtMS0xLTM2NDA2MA_7e9e5cff-adab-42c9-9b1e-628b89fa98d5">515</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQzLTUtMS0xLTM2NDA2MA_af37197b-cd54-4e67-b1a5-fca859f2daac">21,407</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5633c4724ce148ac9ddfe510b1f65f4e_I20221231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQ0LTEtMS0xLTM2NDA2MA_0001f479-15b4-4b9d-8112-07c147a89f57">6,226</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i958343bdb078497db2b964d690e99d81_I20221231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQ0LTItMS0xLTM2NDA2MA_3e9236f0-b372-4fd8-8837-543714b73a3b">14,927</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaabb9095a1ff42f9a914e504f9b48258_I20221231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQ0LTMtMS0xLTM2NDA2MA_bbdcf47f-ed12-4920-a8a0-c58349558794">487</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:OtherIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQ0LTUtMS0xLTM2NDA2MA_b4beb061-497d-4987-9b3c-717fad92a85e">21,640</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement (see Note&#160;A.2.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) The &#8220;Transfers&#8221; line mainly comprises (i) acquired R&amp;D that came into commercial use during the period and (ii) reclassifications of assets as held for sale or exchange.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) The &#8220;Changes in scope of consolidation&#8221; line corresponds to the fair value of intangible assets recognized in connection with acquisitions made during the period (see Notes&#160;D.1. and&#160;D.2.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) See Note&#160;D.5.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) The amendment to the terms of the IO License and Collaboration Agreement resulted in the recognition of an amortization charge of &#8364;<ix:nonFraction unitRef="eur" contextRef="i425bfebf084d448791653b647ddc68bb_D20220101-20221231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzgxMzYzODYwNDY3ODE3_08c50c64-6e2d-4d47-af15-d1d94234cd84">226</ix:nonFraction>&#160;million (see&#160;Note C.1.).</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-42</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="id76b55679fa544b9b29714a379df71b1"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Products, trademarks and other rights&#8221; mainly comprise:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">&#8220;marketed products&#8221;, with a carrying amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="i09b51cc206164edcae17c3cfc4b8be23_I20221231" decimals="-8" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzE4MjY_c2d127d9-f093-456b-a598-aecdac88d874">12.7</ix:nonFraction> billion as of December 31, 2022 (versus &#8364;<ix:nonFraction unitRef="eur" contextRef="i84439ea7fd4f41189f4efa5cce7f5dee_I20211231" decimals="-8" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzE4NDY_f1f542ec-3909-4be6-afc7-385a23b30dfb">11.7</ix:nonFraction> billion as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="iab92fc7553f84732a53070d96b07d717_I20201231" decimals="-8" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzE4NjI_8bc322ed-f422-46d4-bb8f-907edadc5ee9">11.4</ix:nonFraction> billion as of December 31, 2020) and a weighted average amortization period of approximately <ix:nonNumeric contextRef="if1da231f2f58464e95b73ab82f7a6ea5_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzE5MzU_cd6f409f-172f-4bb8-87e9-c0d1d2e4215e">10</ix:nonNumeric>&#160;years; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">&#8220;technological platforms&#8221;, with a carrying amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="i3cb82f850b314453a6ec5d1921dc1d46_I20221231" decimals="-8" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzE5OTk_91318b90-cd2b-4723-b842-e34e1b271d97">2.2</ix:nonFraction> billion as of December 31, 2022 (versus &#8364;<ix:nonFraction unitRef="eur" contextRef="if35c01a7371643bc9842164b984ee110_I20211231" decimals="-8" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzIwMjA_e3789c20-e571-4f93-8fa7-c0787ef2231c">1.2</ix:nonFraction>&#160;billion as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="iac2d7ed11f724c0ebcd3e81759fc9219_I20201231" decimals="-8" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzIwNDU_fb909aa2-0617-438e-a7f2-548281605920">0.2</ix:nonFraction>&#160;billion as of December 31, 2020) and a weighted average amortization period of approximately <ix:nonNumeric contextRef="i08203211b0d245c4b6d1cc85ee868582_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzIxMjY_7822f91a-201d-41c3-badb-72552a895886">18</ix:nonNumeric>&#160;years.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfPrincipalMarketedProductsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzM5Nzk_9ec75072-98b8-4b7c-85fe-b87a31f8e522" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below provides information about the principal &#8220;marketed products&#8221;, which were recognized in connection with major acquisitions made by Sanofi and represented <ix:nonFraction unitRef="number" contextRef="if1da231f2f58464e95b73ab82f7a6ea5_D20220101-20221231" decimals="2" name="sny:ConcentrationRiskThresholdPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI0Njk_746f7dbe-6787-46c0-8aa4-435558bcc794">92</ix:nonFraction>% of the carrying amount of that item as of December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:20.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>amortization&#160;&amp;<br/>impairment</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortization</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">period</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(years)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Residual</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">amortization</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">period</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(years)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id773f103dc28473da6dce61b97b4599f_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtMS0xLTEtMzY0MDYw_319a125d-7358-41e0-bde8-b931e7328d94">10,490</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i327e5ac314c147afbbac34d3cd5154e6_I20221231" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtMi0xLTEtMzY0MDYw_436fe5f4-c0b9-42af-a300-f4555dc06529">9,869</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie35c53e81e9249b386cd4ca320340845_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtMy0xLTEtMzY0MDYw_f6ca07b5-4461-4558-a234-c6b9789488a6">621</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3d83b887fd184dc780e366b282c56ac1_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtNC0xLTEtMzY0MDYw_ece487c3-1213-4da4-a818-cbbecd8a0369">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3d83b887fd184dc780e366b282c56ac1_D20220101-20221231" name="ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtNS0xLTEtMzY0MDYw_23521890-4df3-480a-a2a8-12a2aee88bbe">2</ix:nonNumeric></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i12436be5245a454fb08492a29387c400_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtNi0xLTEtMzY0MDYw_7d3d36ad-ebb5-4238-92c0-7543361932fe">1,032</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibecbd6a1102148a4b1cdae4692855a35_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtNy0xLTEtMzY0MDYw_8f5f3bd4-6338-4e97-a742-fe3b4381944d">1,485</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Boehringer Ingelheim <br/>Consumer Healthcare</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8df75a742b2b432f8ed86c2c047454fd_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItMS0xLTEtMzY0MDYw_20c5f7f0-9d58-4a1e-819a-1cf36e392f65">3,633</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ide1da35c16a04b58969940528c31dca4_I20221231" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItMi0xLTEtMzY0MDYw_86cdfd73-d1d0-4af1-ae26-e9ea4bec5cff">1,596</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0256bda43a0b401793ad67599d6f854f_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItMy0xLTEtMzY0MDYw_05460c80-e40c-4897-a6c6-d84d15805c35">2,037</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i49fae0c938264bbeade9dbd853b7285a_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItNC0xLTEtMzY0MDYw_a5cbfb2f-b3d6-4e25-96c5-0d98540d2088">17</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i49fae0c938264bbeade9dbd853b7285a_D20220101-20221231" name="ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItNS0xLTEtMzY0MDYw_9f88e682-19e8-4de1-a866-e2d1da00fff0">12</ix:nonNumeric></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i340660daa522440ba21086f7ad5848cd_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItNi0xLTEtMzY0MDYw_9410fb0c-3251-42aa-9db7-60e4116c9ac6">2,213</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie6daac2f7de947078866a970b9af341b_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItNy0xLTEtMzY0MDYw_e31d28a8-4849-4181-af4e-2140d496a6ff">2,489</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib3d27352e1d547bc80849f473b0bc333_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtMS0xLTEtMzY0MDYw_63f19ba7-bbce-4af8-a66f-f970c2900b8b">34,684</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i94646d0f821b41aa99fc727b5160ed48_I20221231" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtMi0xLTEtMzY0MDYw_9369694f-f725-4e6b-a2d8-c1b2dc196c21">34,626</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0c421b52b59042909b5e110415a07634_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtMy0xLTEtMzY0MDYw_1e61d39d-ce30-4844-82d7-e39c6249b3b3">58</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i71c2f33574774918a3d21a0ac64c1257_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtNC0xLTEtMzY0MDYw_fef21846-b9aa-49dc-94f8-2b189170dcd8">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i71c2f33574774918a3d21a0ac64c1257_D20220101-20221231" name="ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtNS0xLTEtMzY0MDYw_4fe57d7a-ce9d-41d1-9ec4-20a1c943c85f">10</ix:nonNumeric></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief7e1240661e4b40847321005295df4b_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtNi0xLTEtMzY0MDYw_85ba2f70-f6a5-4ce7-a1e7-77ae63f13dc3">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63e0783c68d542939a2d058ea87add2d_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtNy0xLTEtMzY0MDYw_d8e0045a-0bfd-4923-805a-35e86a9a21bb">110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chattem</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i25232be32cd74ac0a93373b678e59630_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtMS0xLTEtMzY0MDYw_4f39d7e0-443c-4193-a13a-c7dd83a80ac2">1,360</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3ce30f864e704909a1e2a6e1f5ee8e5e_I20221231" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtMi0xLTEtMzY0MDYw_b495a437-1ec2-4e9c-bb0f-364dd42d6128">786</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b23c81c20fc4794914a0250573bd609_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtMy0xLTEtMzY0MDYw_a1efaf08-855a-44fd-a529-e4784dc97791">574</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia1228690812c49ad88631d95ed6c90e1_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtNC0xLTEtMzY0MDYw_0e3274dc-480a-49d5-9328-b4d3e3b3fbb0">23</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia1228690812c49ad88631d95ed6c90e1_D20220101-20221231" name="ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtNS0xLTEtMzY0MDYw_ce82bf3e-6cdc-424b-a1ac-a5c3ad960128">11</ix:nonNumeric></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i50b0b8ed81ed46e8be5e882078a4d6fa_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtNi0xLTEtMzY0MDYw_96be96f5-8259-46b7-8b93-3539169c69fb">593</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i026e8f42a4b84878bffe5af0996e6fd4_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtNy0xLTEtMzY0MDYw_7dd65d29-9ab3-465e-bf23-df5445c5d5dd">602</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Protein Sciences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icf18b6d1ad6c4d90924bd6cb8c0e44bf_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtMS0xLTEtMzY0MDYw_d9d1ad81-475f-49b0-961d-a6d1bfe5cbf9">857</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0b24fec1ff334b3caffadd87b1917a88_I20221231" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtMi0xLTEtMzY0MDYw_dd15c1bd-04c2-43de-b670-be8bf714cddf">359</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3fe69425172b4ed3b1a78c4b0afa1443_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtMy0xLTEtMzY0MDYw_4cbd97f8-2f64-4834-bcc9-8be7482f581e">498</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf8439c477204ed5bb7b9c50513f4458_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtNC0xLTEtMzY0MDYw_10aca48a-049b-4f79-ab1a-6618854f6159">13</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf8439c477204ed5bb7b9c50513f4458_D20220101-20221231" name="ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtNS0xLTEtMzY0MDYw_aad864a6-9a72-4e78-b05e-8a748ef02952">8</ix:nonNumeric></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i40fb8c5a2d6649cc9bc68e43de8013db_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtNi0xLTEtMzY0MDYw_9234f44c-b730-4097-a7a4-d2696e517fae">532</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idc41e3bc2b9345fc876440577f2e644d_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtNy0xLTEtMzY0MDYw_9de507ed-5a74-4299-9f3b-dd8b4b308feb">554</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ablynx</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i041ab8c4596a46c7bb5f0667d7c6bc14_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtMS0xLTEtMzY0MDYw_cb8ed3c0-8cd4-4dff-a340-c74937a8c6e7">1,966</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3c5e6ecfa9074b3e8f20927944000385_I20221231" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtMi0xLTEtMzY0MDYw_b54d6ee8-3bf3-4386-b778-c12fa299325c">609</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ica7f84b515f546d8bda9c71bbe43ec0e_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtMy0xLTEtMzY0MDYw_b798094d-dc8b-43b7-9dd4-2c80216545be">1,357</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i026473957d65465ea3db2de3e9751210_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtNC0xLTEtMzY0MDYw_f865f4ad-0e18-4208-b18a-60232e77e654">14</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i026473957d65465ea3db2de3e9751210_D20220101-20221231" name="ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtNS0xLTEtMzY0MDYw_8a8c8558-30d0-42fd-8240-87e36d9df2ba">10</ix:nonNumeric></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i792f1cc45ec547c3a499357b17b066ec_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtNi0xLTEtMzY0MDYw_0371c8db-cd9b-43b7-b27d-a14d30109a75">1,494</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5f4deabc2c274c3babd78470045f1453_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtNy0xLTEtMzY0MDYw_e653dc6a-8b68-48e3-93e8-519b2c8368b4">1,861</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i530f7df295184dd9a99b515e6d74ca8d_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctMS0xLTEtMzY0MDYw_f06d8d01-2a79-498b-b264-0026d302a765">7,955</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i296acdd1f99f4541a48fd22b1964d943_I20221231" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctMi0xLTEtMzY0MDYw_7957d3c4-c636-4ccd-9dba-791db650a51b">3,119</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i708d728675864096b68be3e4e5fffa80_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctMy0xLTEtMzY0MDYw_a01c4b32-e508-4a79-984b-38d65a786b3b">4,836</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie8566075f1554143b73513ddf54ad64f_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctNC0xLTEtMzY0MDYw_e2f078e6-02a2-4ec6-99af-480173887687">13</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie8566075f1554143b73513ddf54ad64f_D20220101-20221231" name="ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctNS0xLTEtMzY0MDYw_58913a3e-b2a3-4eb6-9060-7059c6b8ccb5">9</ix:nonNumeric></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i04aac2d172a44ccc919acc1227192e67_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctNi0xLTEtMzY0MDYw_891590ef-9916-479e-8655-7d1bb8094355">3,065</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i637119bb5a7b42f8afb86de0c5d5219f_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctNy0xLTEtMzY0MDYw_a32bc5ee-0d77-4044-9e23-eadbd0f4bdb8">3,240</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kadmon</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dcc5fc52d7a4d7aba03c1b54a2a3571_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtMS0xLTEtMzY0MDYw_a5795b89-1610-4d3e-abdc-445f0a4e5cf3">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iae48efe4b3334259807bafd602c70de7_I20221231" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtMi0xLTEtMzY0MDYw_73bb02da-9d88-4a20-b93e-d55857eea537">180</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaa812a8430e74c7e8e6a760b5a84e493_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtMy0xLTEtMzY0MDYw_3f03d75c-e829-4eb3-b24e-eec23ff78ef4">1,702</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5cc7ce98c2143698b9d193c4906485d_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtNC0xLTEtMzY0MDYw_759cedf7-a136-4813-b7d6-fa1d2d5962fa">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5cc7ce98c2143698b9d193c4906485d_D20220101-20221231" name="ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtNS0xLTEtMzY0MDYw_a0dd2be1-19d7-4051-8017-f2cb8b1e0fe0">11</ix:nonNumeric></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i45f265c078e647a6a3dda117ab01eed7_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtNi0xLTEtMzY0MDYw_5690e2f9-48da-4628-8861-537c7eeb1c5f">1,750</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0dd016314ae6400591f48c4e6f72f4f1_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtNy0xLTEtMzY0MDYw_a5a0322c-f318-497c-b718-9dff93088400">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total: principal marketed products</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iebcd0b91b7444542b0c79aa4c96b7801_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzktMS0xLTEtMzY0MDYw_35bbb34e-32be-4aff-ae54-89717fadeb4e">62,827</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5bc35a3cbc8c4534b90c96bf47118eb5_I20221231" decimals="-6" sign="-" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzktMi0xLTEtMzY0MDYw_291d9c60-2b77-4b91-aeb9-0abe7825ef2e">51,144</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie24b60956389422e8f541e06b844991b_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzktMy0xLTEtMzY0MDYw_29f03bfb-8ede-4223-a2e9-0ce584ac9efe">11,683</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iea694613587d485fa04b5eb768f73f00_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzktNi0xLTEtMzY0MDYw_3650a1bc-cf74-4ff4-8bf6-23532d2fb6fe">10,752</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i293dc949848347408815145576461710_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzktNy0xLTEtMzY0MDYw_e994af00-fb2b-4b66-a6c2-0c57374c41f4">10,341</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Weighted averages. The amortization periods for these products vary between <ix:nonNumeric contextRef="i9ed6aa800df24aecae7a3964ffbedd63_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2MDA_83dbd3d8-9311-4a3d-a36d-ac4dc8498aed">1</ix:nonNumeric>&#160;and <ix:nonNumeric contextRef="i45d75dd4cd4f4947b431c2b6a34e7c1f_D20220101-20221231" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2MDc_44442340-9b03-4ad8-9afc-7aa15212ab23">25</ix:nonNumeric>&#160;years.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Weighted averages.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acquisitions of other intangible assets (excluding software) during 2022 amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="iae3e84046d214495840027e2c3540430_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI3MjQ_4fd11477-a1b1-4806-86e1-443a3428967f">472</ix:nonFraction> million. The main items were upfront and milestone payments within the Specialty Care GBU.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal intangible assets brought into service during 2022 were:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (sutimlimab-jome), a treatment for cold agglutinin disease (gross value &#8364;<ix:nonFraction unitRef="eur" contextRef="iafe00cfe38914facb60fe02e8320fc90_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2OTM4MDM0ODkyMTQz_1d5f048d-51e5-4079-8fb5-7e778045cd1e">854</ix:nonFraction>&#160;million net of impairment of &#8364;<ix:nonFraction unitRef="eur" contextRef="ib7fddf7e73a04c67bd9d437a86bbdabf_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2OTM4MDM0ODkyMTU3_e3b2ba94-754e-4c54-bc26-5ee0a60d50db">363</ix:nonFraction>&#160;million), with effect from the date of marketing approval (February&#160;2022); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">technology platforms (&#8364;<ix:nonFraction unitRef="eur" contextRef="i08203211b0d245c4b6d1cc85ee868582_D20220101-20221231" decimals="-6" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2OTM4MDM0ODkyMTcx_09f91ac0-d79b-4285-a889-c1ac070eebbc">525</ix:nonFraction>&#160;million).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main asset brought into service during 2021 was the Translate Bio mRNA technology platform.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During 2020, some of the acquired research and development came into commercial use, and started being amortized from the date of marketing approval; the main items involved were Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, indicated for the treatment of relapsed refractory multiple myeloma, and the meningococcal vaccine MenQuadfi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amortization of other intangible assets is recognized in the income statement within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Amortization of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, except for amortization of software and other rights of an industrial or operational nature which is recognized in the relevant classification of expense by function. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzM5ODU_1740dfbb-cc69-4433-8061-c9736a00077a" continuedAt="ide7a3c84ff034005b16af4a1cd66660d" escape="true">An analysis of amortization of software is shown in the table below:</ix:nonNumeric></span></div><ix:continuation id="ide7a3c84ff034005b16af4a1cd66660d"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:59.696%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzEtMS0xLTEtMzY0MDYw_9fd719a5-c653-46ae-937a-13cf12a76508">10</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzEtMi0xLTEtMzY0MDYw_99f0bd62-38c0-4213-ad4a-6a769c75c286">18</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzEtNC0xLTEtMzY0MDYw_4674dd1c-0c1d-466c-8372-7d3b7e45036c">19</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzItMS0xLTEtMzY0MDYw_217f9c60-4ceb-484b-83e3-4febebc5ea6d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzItMi0xLTEtMzY0MDYw_eb86d8a6-2b26-45f8-9519-889a4c5c9586">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzItNC0xLTEtMzY0MDYw_7f85dc5f-f1e3-4a29-a2a3-ca9b04b121b1">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzMtMS0xLTEtMzY0MDYw_c4191548-47aa-4a6a-a9e9-de653ca37b7f">82</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzMtMi0xLTEtMzY0MDYw_56489b91-ec04-4466-af4d-4ddb819adf64">98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzMtNC0xLTEtMzY0MDYw_1017b008-57f4-4ed2-a7c5-30fe9769ea51">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzQtMS0xLTEtMzY0MDYw_e32d4697-d74f-47b3-a57a-a32cafc5b26b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzQtMi0xLTEtMzY0MDYw_90a333e1-0723-4b45-be7d-985aa991163f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzQtNC0xLTEtMzY0MDYw_b745722e-8837-4f69-aca3-7443040c2ece">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzUtMS0xLTEtMzY0MDYw_8aa7c397-cdc5-4f54-a021-b1136a9f869d">97</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzUtMi0xLTEtMzY0MDYw_d44af548-5636-4f6d-9695-09dd755bbfc9">119</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231" decimals="-6" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzUtNC0xLTEtMzY0MDYw_f51467a8-67aa-4344-8196-947f99409cd7">112</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement (see Note&#160;A.2.1.).</span></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-43</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_604"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.5. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzU3NzE_f0e7ddf3-dc53-4de4-94fc-659c16928f52" continuedAt="i099439de1e8a463191c83bbab269702d" escape="true">Impairment of intangible assets and property, plant and equipment</ix:nonNumeric></span></div><ix:continuation id="i099439de1e8a463191c83bbab269702d" continuedAt="i2f7e3ebb9764420592677cea8e22050f"><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;36, goodwill is allocated to groups of cash generating units (CGUs) at a level corresponding to the Pharmaceuticals, Consumer Healthcare and Vaccines segments. When testing goodwill annually for impairment, the recoverable amount is determined for each segment on the basis of value in use, determined using discounted estimates of the future cash flows in accordance with the policies described in Note&#160;B.6.1.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzU3NzI_b17464e5-e781-44e1-a416-b58e14d58fbb" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The allocation of goodwill as of December 31, 2022 is shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer Healthcare</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iee7cb4947a1c4854876868c8e2fb82d1_I20221231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZToxYzI2NDc2ZDZiYzU0ZDVlOTc1OWQyOWUxNTcyNzczZS90YWJsZXJhbmdlOjFjMjY0NzZkNmJjNTRkNWU5NzU5ZDI5ZTE1NzI3NzNlXzEtMS0xLTEtMzY0MDYw_04de8e17-138e-4e12-8a39-b9ec19fb4bd7">39,421</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16582892e01c4bb3be453ed03f64b2ae_I20221231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZToxYzI2NDc2ZDZiYzU0ZDVlOTc1OWQyOWUxNTcyNzczZS90YWJsZXJhbmdlOjFjMjY0NzZkNmJjNTRkNWU5NzU5ZDI5ZTE1NzI3NzNlXzEtMi0xLTEtMzY0MDYw_2fe4f157-19f7-434b-9acb-c45f04c77b94">6,690</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5146ddfb19c5499c89ad75916030806b_I20221231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZToxYzI2NDc2ZDZiYzU0ZDVlOTc1OWQyOWUxNTcyNzczZS90YWJsZXJhbmdlOjFjMjY0NzZkNmJjNTRkNWU5NzU5ZDI5ZTE1NzI3NzNlXzEtMy0xLTEtMzY0MDYw_e5b85969-c505-4398-8051-48b57c4a7e43">3,781</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZToxYzI2NDc2ZDZiYzU0ZDVlOTc1OWQyOWUxNTcyNzczZS90YWJsZXJhbmdlOjFjMjY0NzZkNmJjNTRkNWU5NzU5ZDI5ZTE1NzI3NzNlXzEtNC0xLTEtMzY0MDYw_55272030-f228-4a53-8cc0-c5c682d0b255">49,892</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The value in use of each segment was determined by applying an after-tax discount rate to estimated future after-tax cash flows.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A separate discount rate is used for each segment to reflect the specific economic conditions of that segment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The rates used for impairment testing in 2022 were <ix:nonFraction unitRef="number" contextRef="i21d16f2eeeb44e9abc4e0d2fff1623bc_D20220101-20221231" decimals="4" name="sny:ImpairmentTestingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg2Mg_a34e577e-4871-4cdc-b9d2-fb308b613761">7.25</ix:nonFraction>% for the Pharmaceuticals segment, <ix:nonFraction unitRef="number" contextRef="iea1750e2b68b4202b8af152deb123cba_D20220101-20221231" decimals="4" name="sny:ImpairmentTestingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg5OA_88649644-37c8-41a1-87ff-80b8f681acb1">7.00</ix:nonFraction>% for the Consumer Healthcare segment and <ix:nonFraction unitRef="number" contextRef="iacd98ed640914415ae9a8c8cb5f49656_D20220101-20221231" decimals="4" name="sny:ImpairmentTestingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzk0MQ_fb5105b3-002c-4e60-aecf-a4d56dd616d0">7.25</ix:nonFraction>% for the Vaccines segment; an identical value in use for Sanofi as a whole would be obtained by applying a uniform <ix:nonFraction unitRef="number" contextRef="i6291343ad8be4f14b06b056b796a9012_D20220101-20221231" decimals="3" name="sny:UniformImpairmentTestingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzEwNTg_46af8c3e-11d5-4717-9370-76220e4b2125">7.2</ix:nonFraction>% rate to all <ix:nonFraction unitRef="segment" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzEwNzM_7a8da66c-fe00-46f1-a865-120b71e46db1">three</ix:nonFraction> segments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The pre-tax discount rates applied to estimated pre-tax cash flows are calculated by iteration from the previously-determined value in use. Those pre-tax discount rates were <ix:nonFraction unitRef="number" contextRef="i21d16f2eeeb44e9abc4e0d2fff1623bc_D20220101-20221231" decimals="3" name="sny:PretaxDiscountRateAppliedForGoodwill" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzEyNjA_3e2235ac-df3f-4ebb-9114-4a06d6e519cb">9.9</ix:nonFraction>% for the Pharmaceuticals segment, <ix:nonFraction unitRef="number" contextRef="iea1750e2b68b4202b8af152deb123cba_D20220101-20221231" decimals="3" name="sny:PretaxDiscountRateAppliedForGoodwill" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzEyOTY_67ef812f-0dbe-4aad-9cb2-47c074796ef4">9.4</ix:nonFraction>% for the Consumer Healthcare segment and <ix:nonFraction unitRef="number" contextRef="iacd98ed640914415ae9a8c8cb5f49656_D20220101-20221231" decimals="3" name="sny:PretaxDiscountRateAppliedForGoodwill" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzEzMzk_996dc5e9-5409-4818-be7f-025dba7b31b1">9.9</ix:nonFraction>% for the Vaccines segment, and equate to a uniform rate of <ix:nonFraction unitRef="number" contextRef="ib359277c5a6e4155b350cf434d57f618_D20220101-20221231" decimals="3" name="sny:UniformPreTaxDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzE0MDA_c4e7acaf-ce36-4342-9380-7fef01917e5c">9.8</ix:nonFraction>% for Sanofi as a whole.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The assumptions used in testing goodwill for impairment are reviewed annually. Apart from the discount rate, the principal assumptions used in 2022 were as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the perpetual growth rates applied to future cash flows were <ix:nonFraction unitRef="number" contextRef="i5bc6ed2a91ca4c32a13fd8fb9df67c92_I20221231" decimals="INF" name="ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzE2NTE_7f14cec7-2562-4096-9e58-653fcf8ee7a0"><ix:nonFraction unitRef="number" contextRef="ia5ad3f91fb64465ea39c823dc7f679b2_I20221231" decimals="INF" name="ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzE2NTE_d0e71173-3946-483f-8232-6ddf50bdb309">zero</ix:nonFraction></ix:nonFraction> for the Pharmaceuticals and Vaccines segments, and <ix:nonFraction unitRef="number" contextRef="ie4cde3de3d25485abc32561745035697_I20221231" decimals="2" name="ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzE3MDU_decaefac-0d87-4660-a8cb-e713164c70ac">1</ix:nonFraction>% for the Consumer Healthcare segment;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Sanofi also applies assumptions on the probability of success of current research and development projects, and more generally on its ability to renew the product portfolio in the longer term.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Value in use (determined as described above) is compared with the carrying amount, and this comparison is then subjected to sensitivity analyses by reference to the principal parameters, including:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">changes in the discount rate;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">changes in the perpetual growth rate; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">fluctuations in operating margin.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No impairment of goodwill would need to be recognized in the event of a reasonably possible change in the assumptions used in&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A value in use calculation for each of the segments would not result in an impairment loss using:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a discount rate up to <ix:nonFraction unitRef="number" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI0OTQ_5387a2b6-4b85-4437-b45d-73cd5d6b878b">2.6</ix:nonFraction>&#160;percentage points above the rates actually used; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a perpetual growth rate up to <ix:nonFraction unitRef="number" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI1Nzk_f8afd2aa-4208-4be4-95ee-8e9ecd7fef87">4.3</ix:nonFraction>&#160;percentage points below the rates actually used; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">an operating margin up to <ix:nonFraction unitRef="number" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI2NjA_1f2b0a00-ec4b-47c5-9cab-cbb90e9b9645">6.7</ix:nonFraction>&#160;percentage points below the rates actually used.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="INF" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI3MTI_17a4f826-e99f-410c-8ce7-9e36f2f83bbe"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI3MTI_29d48d0c-556d-46df-b67d-a6b5f35c0a0a"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="INF" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI3MTI_cd2a4772-6529-48d6-8aec-df327d641cd6">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment losses were recognized against goodwill in the years ended December 31, 2022, 2021 or 2020.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When there is evidence that an asset may have become impaired, the asset&#8217;s value in use is calculated by applying an after-tax discount rate to the estimated future after-tax cash flows from that asset. For the purposes of impairment testing, the tax cash flows relating to the asset are determined using a notional tax rate incorporating the notional tax benefit that would result from amortizing the asset if its value in use were regarded as its depreciable amount for tax purposes. Applying after-tax discount rates&#160;to after-tax cash flows gives the same values in use as would be obtained by applying pre-tax discount rates to pre-tax cash&#160;flows.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The after-tax discount rates used in 2022 for impairment testing of other intangible assets in the Pharmaceuticals, Consumer Healthcare and Vaccines segments were obtained by adjusting Sanofi&#8217;s weighted average cost of capital to reflect specific country and business risks, giving after-tax discount rates in a range from </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i9ed6aa800df24aecae7a3964ffbedd63_D20220101-20221231" decimals="INF" name="sny:AfterTaxDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzM3OTY_413581e6-fad0-4b08-8f64-12dfbc016ae0">7.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i45d75dd4cd4f4947b431c2b6a34e7c1f_D20220101-20221231" decimals="INF" name="sny:AfterTaxDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzM4MDI_e6492bcb-2700-498b-a534-61126e13aa4e">8.25</ix:nonFraction>%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In most instances, there are no market data that would enable fair value less costs to sell to be determined other than by means of developing a similar estimate based on future cash flows. Consequently, recoverable amount is in substance equal to value in use. The estimates used to determine value in use are sensitive to assumptions specific to the nature of the asset and to Sanofi's activities. Apart from the discount rate, the principal assumptions used in 2022 were as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">mid-term and long-term forecasts;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">perpetual growth or attrition rates, when applicable; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">probability of success of current research and development projects.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The assumptions used in testing intangible assets for impairment are reviewed at least annually.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-44</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i2f7e3ebb9764420592677cea8e22050f"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzU3NzQ_885aa201-b60e-49f0-85cd-0216cc0188d7" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, 2021 and 2020, impairment testing of other intangible assets (excluding software) resulted in the recognition of net impairment losses as shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impairment of other intangible assets, net of reversals  (excluding software)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1b27476d93554df89ad49b3ee11c7c77_D20220101-20221231" decimals="-6" sign="-" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzEtMS0xLTEtMzY0MDYw_96db8429-ba10-4be5-903c-5f9a1bb20d4f">454</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3068d0c640bc435e891dadca47642b8f_D20210101-20211231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzEtMi0xLTEtMzY0MDYw_7f483d2c-56c2-4b05-b7da-d338251ec290">192</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0c54b1010c23469cab4bb3eff3e7d353_D20200101-20201231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzEtMy0xLTEtMzY0MDYw_0b3f4258-fd47-4ff2-96b4-42b2de4b6fcc">330</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Marketed products</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i28d5de7a4fc14b2593071a0d5fdc0a8a_D20220101-20221231" decimals="-6" sign="-" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzItMS0xLTEtMzY0MDYw_4b45dccf-d0ee-4da9-98d0-ad35c059de10">1,561</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2b91f780cb5b4a2ea49c0de8b0410b7b_D20210101-20211231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzItMi0xLTEtMzY0MDYw_4daeb53d-c57e-48d7-9ad2-3fdb9c2f90e6">42</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8a363d9f71a4498e9eb6d77ce4ae1ce1_D20200101-20201231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzItMy0xLTEtMzY0MDYw_8ed141bd-8e23-4a58-ae3d-1d001e0b2852">2</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Pharmaceuticals </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ibe47f0460c6443d7aac34037c1a7776f_D20220101-20221231" decimals="-6" sign="-" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzMtMS0xLTEtMzY0MDYw_4a4d662a-b26d-4e3f-a1fa-4c73e4009f94">1,542</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia20f460d071c4c28a7e9a76758243fbd_D20210101-20211231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzMtMi0xLTEtMzY0MDYw_89bbddf4-e347-4017-94d9-59eb5199bbd8">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5dc0f8a6677d425cbf34a6827f35eec7_D20200101-20201231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzMtMy0xLTEtMzY0MDYw_e92d9a4a-b030-4f7f-894c-dd4bdaf4b732">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Vaccines</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if951db4e148548b0ab33c185a8187b15_D20220101-20221231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzQtMS0xLTEtMzY0MDYw_07becc26-3a55-491d-a90b-33daeed411ec">16</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iccf65087a3c74152a1319c345dad3d4a_D20210101-20211231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzQtMi0xLTEtMzY0MDYw_9c1f789a-6dd6-4d45-9377-54737effc1bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia45e141afabe465e85ec0f96fdaf178a_D20200101-20201231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzQtMy0xLTEtMzY0MDYw_22a05771-0849-42de-851c-e950ed1d5fdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Consumer Healthcare</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i43261e364b9346549b6c2f1839b5914b_D20220101-20221231" decimals="-6" sign="-" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzUtMS0xLTEtMzY0MDYw_75a9866a-54d2-4a9f-aca9-1b1fb19f55cf">35</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaebb948c909c492e932578257e1ad2fc_D20210101-20211231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzUtMi0xLTEtMzY0MDYw_dc6356ff-4459-402c-8a0d-689168640bbd">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibd554b41fcbb47338ebb6b86fee85e2c_D20200101-20201231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzUtMy0xLTEtMzY0MDYw_1ef15eec-910c-473c-9f0c-ed0d4397c296">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development projects </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a) / (b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia8cc913bbe0246f79a657a1446f40d4b_D20220101-20221231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzYtMS0xLTEtMzY0MDYw_231afb34-b6b0-4af5-b904-d1306e3b1d16">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i00ff7bddddd7454291874636f6fcda0c_D20210101-20211231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzYtMi0xLTEtMzY0MDYw_5cf3983d-fcbb-4e48-a1f5-40b0c4ac3f53">150</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic32352d1a6b84884aee10c01c7d2556a_D20200101-20201231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzYtMy0xLTEtMzY0MDYw_96d7e8cc-3fdf-40ad-8176-1f8f6112b4a0">328</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) For 2022, these amounts mainly comprise a reversal of &#8364;<ix:nonFraction unitRef="eur" contextRef="i9b81437bb0bc49abac2a243bae255b03_D20220101-20221231" decimals="-6" name="sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNDYz_0b63a886-0edf-4d1b-be45-6942b18eb9a5">2,154</ix:nonFraction>&#160;million of impairment losses taken against Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> and BIVV001 (assets belonging to the Eloctate franchise), consisting of &#8364;<ix:nonFraction unitRef="eur" contextRef="ib78ba3c2232f4c65ac54a211433313c6_D20220101-20221231" decimals="-6" name="sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNDc5_4a51708c-7e59-4635-ad36-6aa9f1476d76">1,554</ix:nonFraction>&#160;million for marketed products and &#8364;<ix:nonFraction unitRef="eur" contextRef="i75a477cfdbfd407296126150806dc8ac_D20220101-20221231" decimals="-6" name="sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNDk1_fdd07481-065e-48b4-804d-53e401716982">600</ix:nonFraction>&#160;million for research and development projects respectively. In 2019, the launch of competing products for Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> led Sanofi to update its sales forecasts for products belonging to the franchise, as a result of which  impairment losses of &#8364;<ix:nonFraction unitRef="eur" contextRef="i4af100e170394112bab4a52fece35962_D20190101-20191231" decimals="-8" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNTA5_4e69a0b9-d3d1-44b5-b096-c382ebae0f0b">2.8</ix:nonFraction>&#160;billion were recognized against the assets in question. The reversal reflects the approval by the FDA on February 22, 2023 of the marketing authorization application for ALTUVIIIO&#8482; (the commercial name of efanesoctocog alpha, corresponding to the BIVV001 project), which was submitted in 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) For 2022, this amount mainly comprises: </span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.93pt">an impairment loss of &#8364;<ix:nonFraction unitRef="eur" contextRef="i5742d95426994746862eae78944333b8_D20220101-20221231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNTIz_09980f05-7ae4-41d1-b2f8-ba0d855baeec">1,586</ix:nonFraction>&#160;million taken against the development project for SAR444245 (non-alpha interleukin-2), recognized following revised cash flow projections reflecting unfavorable developments in the launch schedule;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.93pt">the &#8364;<ix:nonFraction unitRef="eur" contextRef="i75a477cfdbfd407296126150806dc8ac_D20220101-20221231" decimals="-6" name="sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNTM5_e4dbee23-37f0-4e81-8f24-a55b00ebe3a5">600</ix:nonFraction>m reversal relating to the BIVV001 project (see above). </span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">     For 2021, this line relates to the discontinuation of the development of sutimlimab in the treatment of Immune Thrombocytopenic Purpura (ITP), and to the termination of various research projects in Vaccines. For 2020, this line mainly comprises impairment losses taken against R&amp;D programs within the Specialty Care GBU, and the discontinuation of certain R&amp;D programs and collaboration agreements in Diabetes.</span></div></ix:nonNumeric><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Impairment losses taken against property, plant and equipment are disclosed in Note&#160;D.3.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_607"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.6. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzM1MzM_6f01cc64-bff5-4d28-8d43-79f615f557b1" continuedAt="ieb326f2367004d3fba4e797311be8b19" escape="true">Investments accounted for using the equity method</ix:nonNumeric></span></div><ix:continuation id="ieb326f2367004d3fba4e797311be8b19" continuedAt="i653c1adfbf4c44938c98e2f0e0182f07"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Investments accounted for using the equity method comprise associates and joint ventures (see Note&#160;B.1.), and are set forth below.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzM1MzI_23834684-babd-4f93-9ccd-24cbeb27ab5a" escape="true"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:49.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%&#160;interest</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EUROAPI</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb5a0f3994f84521ab2fd69b67690383_D20220101-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInAssociate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzEtMS0xLTEtMzY0MDYw_524cad5e-069b-48f2-b06d-ce86a37d1894">30.1</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifc8f06a841e6428180d8121555e73740_I20221231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzEtMi0xLTEtMzY0MDYw_ccfae5a9-11e9-4357-b08d-5104a15b8f70">392</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i495abeb0c8ec43bd9a8672fcf415b572_I20211231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzEtMy0xLTEtMzY0MDYw_a54fab54-c519-4874-b197-8b5ef5e94826">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic5f95cfdf0c2482a8e6ae4ea1b83aeed_I20201231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzEtNC0xLTEtMzY0MDYw_9fa03aaa-fb79-4daa-87bf-a9eefe8af117">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i987f61ccd11547579d7e7f53a35371e8_D20220101-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzItMS0xLTEtMzY0MDYw_8e2423f0-42a7-4afe-9373-2f3c8030f2da">31.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaa479340569c4f32a4dccb3228f32e50_I20221231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzItMi0xLTEtMzY0MDYw_8ed02ad7-c6a5-414e-811e-1e91408df931">97</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifeb832a3c66e4a378f24c3a521e9cf5c_I20211231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzItMy0xLTEtMzY0MDYw_b2bfe838-58fa-4fb6-87e9-a9100d17446e">80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0f3efa364fdd42cf927933b24fd4755d_I20201231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzItNC0xLTEtMzY0MDYw_d7691ec4-5800-4b4d-b9a2-dc7f967f118f">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MSP Vaccine Company</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i782f27e42e1d446bb06029d7b6d07d77_D20220101-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzMtMS0xLTEtMzY0MDYw_3628131f-0008-44d4-9d74-7048dee029a1">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i669940f41ad04996a28f45d5787d6ddb_I20221231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzMtMi0xLTEtMzY0MDYw_e732125c-77d5-415b-9b53-f1033747b538">104</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63e035f853e24b69a878f537955ad35a_I20211231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzMtMy0xLTEtMzY0MDYw_86746ed6-3b52-48e0-8453-e23233046f07">88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i82151e9cc3d943a69133a8307efdb603_I20201231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzMtNC0xLTEtMzY0MDYw_8da7d189-3be9-4f14-90c8-f6dad8d75f72">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91ae659ae5f74464822bc2b56b6fbf88_D20220101-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzUtMS0xLTEtMzY0MDYw_78940cd6-82d9-4f0f-99c9-2ee925573abb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i957f812f550347fabcd2ee14c0bc75b0_I20221231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzUtMi0xLTEtMzY0MDYw_694ba275-bf3a-4b2b-a80f-15e66f05ab48">84</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if13d5090e3fb4ebaa88f2f834e7b85d9_I20211231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzUtMy0xLTEtMzY0MDYw_e81b6151-5900-4d7c-851f-dbe1a434c75f">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib5f292fbae704649bdd7f44efd9dc45f_I20201231" decimals="-6" name="ifrs-full:InvestmentsInJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzUtNC0xLTEtMzY0MDYw_2ce3bd12-2423-407d-82a5-261459e42132">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzYtMi0xLTEtMzY0MDYw_1ebfc6e1-96cc-4e9c-97ec-36d1e3f1588b">677</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzYtMy0xLTEtMzY0MDYw_6cddcc95-7063-4e1e-bff0-404084ef17ca">250</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzYtNC0xLTEtMzY0MDYw_cd4221ee-eb5d-4a11-9792-ffacef313132">201</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;Following the distribution in kind and the acquisition of an equity interest by EPIC Bpifrance, Sanofi holds <ix:nonFraction unitRef="number" contextRef="ifb5a0f3994f84521ab2fd69b67690383_D20220101-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInAssociate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzE5NzkxMjA5MzA4Mjc0_6dcd314c-0d64-4267-8197-9781245b6567">30.1</ix:nonFraction>% of the capital of EUROAPI (see Note&#160;B.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Joint venture.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Joint venture. MSP Vaccine Company owns <ix:nonFraction unitRef="number" contextRef="i092bf3d6ba454bcd8193568dd0f4509b_D20220101-20221231" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzY4OA_4dddd127-c1ac-425e-a7b6-77cf4a75a2c2">100</ix:nonFraction>% of MCM Vaccine B.V.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-45</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i653c1adfbf4c44938c98e2f0e0182f07"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzM1MTg_419503d3-17f3-4978-b407-dfcc15db7e86" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows Sanofi&#8217;s overall share of (i)&#160;profit or loss and (ii)&#160;other comprehensive income from investments accounted for using the equity method, showing the split between associates and joint ventures in accordance with IFRS&#160;12 (the amounts for each individual associate or joint venture are not material):</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:28.762%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Joint&#160;ventures</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Associates</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Joint&#160;ventures</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Associates</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Joint&#160;ventures</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Associates</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic49924175296420b805d168c7336e31d_D20220101-20221231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItMS0xLTEtMzY0MDYw_4209a86d-8598-4212-9da9-f5bd54f59d51">74</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i58223acf6fb24980bc8feacdb2bfeae8_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItMi0xLTEtMzY0MDYw_de246952-9758-47e2-bc90-ff8763ec223d">6</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1c41e8bd45074b609022a18dba83404d_D20210101-20211231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItMy0xLTEtMzY0MDYw_991b9af5-a5a0-4e37-a1bc-6a7b73907f63">26</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1d40d00a4f940f4b8c4db3de85057f3_D20210101-20211231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItNC0xLTEtMzY0MDYw_591955f8-edb1-4603-ac00-605884918802">13</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i75f7fd33c99141b0834d8cd0bde8d7e4_D20200101-20201231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItNi0xLTEtMzY0MDYw_419b873d-92b1-4dcd-9cf8-3241610864e2">4</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i116430c7eca24b8ebbfa85cbe5cf6fb8_D20200101-20201231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItNy0xLTEtMzY0MDYw_837908a1-13b9-4028-b7c2-cb0dacd29605">355</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of other comprehensive income from investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic49924175296420b805d168c7336e31d_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtMS0xLTEtMzY0MDYw_fa8cb7e3-ba35-40f3-9e70-59f2b56fdf90">2</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i58223acf6fb24980bc8feacdb2bfeae8_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtMi0xLTEtMzY0MDYw_639a6185-5326-4f2b-b8c1-5c8837a58fe7">3</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1c41e8bd45074b609022a18dba83404d_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtMy0xLTEtMzY0MDYw_3001f552-c9ba-4d32-945c-9830cdfbfc28">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1d40d00a4f940f4b8c4db3de85057f3_D20210101-20211231" decimals="-6" name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtNC0xLTEtMzY0MDYw_559fa731-d7f5-40d9-b724-f6cde39d04df">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i75f7fd33c99141b0834d8cd0bde8d7e4_D20200101-20201231" decimals="-6" name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtNi0xLTEtMzY0MDYw_49f290f1-d5e7-47bb-b874-fcf563f94290">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i116430c7eca24b8ebbfa85cbe5cf6fb8_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtNy0xLTEtMzY0MDYw_14fe17e9-0ee9-4b61-a923-b44b54e229c7">311</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic49924175296420b805d168c7336e31d_D20220101-20221231" decimals="-6" name="sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtMS0xLTEtMzY0MDYw_e807bc78-e132-45e3-90a1-4aeeb7a8de17">72</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i58223acf6fb24980bc8feacdb2bfeae8_D20220101-20221231" decimals="-6" sign="-" name="sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtMi0xLTEtMzY0MDYw_896d8095-f736-4785-a2bc-ffc79a494390">9</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1c41e8bd45074b609022a18dba83404d_D20210101-20211231" decimals="-6" name="sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtMy0xLTEtMzY0MDYw_593d28b9-a0b4-4a6a-8414-33ec5b8c236a">20</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1d40d00a4f940f4b8c4db3de85057f3_D20210101-20211231" decimals="-6" name="sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtNC0xLTEtMzY0MDYw_acd2ff1f-00fe-4045-89b9-bb5b2d514ea7">13</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i75f7fd33c99141b0834d8cd0bde8d7e4_D20200101-20201231" decimals="-6" name="sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtNi0xLTEtMzY0MDYw_f57b357e-cdb5-4b14-8540-7a07e5ecf581">12</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i116430c7eca24b8ebbfa85cbe5cf6fb8_D20200101-20201231" decimals="-6" name="sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtNy0xLTEtMzY0MDYw_00f34ab8-8ca6-4c3c-850a-0cf873ac78da">44</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes &#8364;<ix:nonFraction unitRef="eur" contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzI4MDM3NTQ2NTE0MDg3_0817bb62-ab7d-4846-a3e6-a9c5e306f2c5">343</ix:nonFraction>&#160;million for Sanofi's share of the net income of Regeneron up to and including May&#160;29, 2020 (see Note&#160;D.2.2.).</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The financial statements include arm&#8217;s length commercial transactions between Sanofi and some equity-accounted investments that are classified as related parties. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzM1Mjg_12b12ad3-8e70-4a32-8f3d-9a5b24bb0c41" continuedAt="iba84a1c4dd65430684c3757b596a9b30" escape="true">The principal transactions and balances with related parties are summarized below:</ix:nonNumeric></span></div><ix:continuation id="iba84a1c4dd65430684c3757b596a9b30"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:59.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i147d77d0cdbc43f8a3861edb09fba518_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzEtMS0xLTEtMzY0MDYw_b753e88f-78a2-40d3-b461-9343a26c51f5">131</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife8c65e63c7b45eb9f4a9c39837733fd_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzEtMi0xLTEtMzY0MDYw_cbd1f385-4b26-4367-8649-2c9420d716d5">70</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fab8659aed84831a2579ade0399d130_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzEtMy0xLTEtMzY0MDYw_6a59ef34-a6a2-4ce3-97ce-83b827ae78cb">75</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Royalties and other income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i147d77d0cdbc43f8a3861edb09fba518_D20220101-20221231" decimals="-6" name="sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzItMS0xLTEtMzY0MDYw_5439b33c-fe37-4ad8-b07c-6adb877b93c7">81</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife8c65e63c7b45eb9f4a9c39837733fd_D20210101-20211231" decimals="-6" name="sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzItMi0xLTEtMzY0MDYw_fbc9b612-de07-4e18-8aff-696378c6064b">66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fab8659aed84831a2579ade0399d130_D20200101-20201231" decimals="-6" name="sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzItMy0xLTEtMzY0MDYw_b54a2056-4947-43e7-bbe6-875357401a1c">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable and other receivables</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie5ceb0532e334611ab935fb0364427b6_I20221231" decimals="-6" name="ifrs-full:AmountsReceivableRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzMtMS0xLTEtMzY0MDYw_32f593c5-83e5-48f9-b008-10bf83ce0973">174</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id92cabfe863843afa6b89218300e3c36_I20211231" decimals="-6" name="ifrs-full:AmountsReceivableRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzMtMi0xLTEtMzY0MDYw_ce666fd1-97cd-48f7-9ff6-7560d54833c1">116</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if09b2251983a4669a88b8ff54f8690c0_I20201231" decimals="-6" name="ifrs-full:AmountsReceivableRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzMtMy0xLTEtMzY0MDYw_544a5429-c85d-4858-b7f3-a5fac258b348">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchases and other expenses (including research expenses)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i147d77d0cdbc43f8a3861edb09fba518_D20220101-20221231" decimals="-6" name="ifrs-full:PurchasesOfGoodsRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzQtMS0xLTEtMzY0MDYw_bca8baeb-846d-4d30-b2bb-0d86d38c9030">477</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife8c65e63c7b45eb9f4a9c39837733fd_D20210101-20211231" decimals="-6" name="ifrs-full:PurchasesOfGoodsRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzQtMi0xLTEtMzY0MDYw_f81ae4b3-a103-440a-b6f6-62b5f07dfe90">178</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fab8659aed84831a2579ade0399d130_D20200101-20201231" decimals="-6" name="ifrs-full:PurchasesOfGoodsRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzQtMy0xLTEtMzY0MDYw_f9b398eb-ad86-4bb2-983e-243e42d87157">747</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts payable and other payables</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie5ceb0532e334611ab935fb0364427b6_I20221231" decimals="-6" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzUtMS0xLTEtMzY0MDYw_a3d071db-8198-41ff-b3cf-1b06bdadbec3">132</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id92cabfe863843afa6b89218300e3c36_I20211231" decimals="-6" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzUtMi0xLTEtMzY0MDYw_a0e8d722-53a4-4a9c-9e85-ac77ab617e5c">28</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if09b2251983a4669a88b8ff54f8690c0_I20201231" decimals="-6" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzUtMy0xLTEtMzY0MDYw_0443a01c-ebbb-4d1f-bce0-e95a81a21622">15</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) For 2020, these amounts include transactions between Sanofi and Regeneron for the period from January&#160;1 through May&#160;29, 2020. The table above does not include the repurchase by Regeneron of its own shares from Sanofi (see Note&#160;D.2.2.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In 2022, these items include Sanofi's transactions with EUROAPI from May&#160;10, 2022 (see Note&#160;D.1.).</span></div></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="eur" contextRef="id92cabfe863843afa6b89218300e3c36_I20211231" decimals="INF" name="sny:CommitmentsMadeToJointVenturesAndAssociates" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzIwMDc_378827c3-60b0-4a73-a654-ed7cd87b168a"><ix:nonFraction unitRef="eur" contextRef="ie5ceb0532e334611ab935fb0364427b6_I20221231" decimals="INF" name="sny:CommitmentsMadeToJointVenturesAndAssociates" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzIwMDc_9fd4d7a1-5813-4c9f-8379-7487de4fa757"><ix:nonFraction unitRef="eur" contextRef="if09b2251983a4669a88b8ff54f8690c0_I20201231" decimals="INF" name="sny:CommitmentsMadeToJointVenturesAndAssociates" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzIwMDc_bef6f79c-6073-41f9-9f17-772bfc4c80c0">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> funding commitments to associates and joint ventures as of December 31, 2022, December 31, 2021 or December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For off balance sheet commitments of an operational nature involving joint ventures, see Note&#160;D.21.1.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_610"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.7. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY3NjU_bf0d5c6f-39ce-4659-955b-a2f1d1b81db6" continuedAt="ia5467ab0abe947b997c7ceac32223b67" escape="true">Other non-current assets</ix:nonNumeric></span></div><ix:continuation id="ia5467ab0abe947b997c7ceac32223b67" continuedAt="if6eedbc2e77846688bf536c11abad125"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY3Njc_1df1193c-7cc6-4026-937f-60820a001807" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:49.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity instruments at fair value through other comprehensive income (D.7.1.)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2598979394db469aaf140d5bfe9a797e_I20221231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzMtMS0xLTEtMzY0MDYw_7c02a43a-5166-424b-a708-a23ce83c8cb1">936</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic0b1bc46ffe04f0299592c1fa440af75_I20211231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzMtMi0xLTEtMzY0MDYw_b94404cb-0a4e-43e0-98d1-74d0f2f04b1b">823</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i672c84847c6c48278feb34e54f8c653e_I20201231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzMtMy0xLTEtMzY0MDYw_371177ec-7380-4701-9886-4c39e5cac914">588</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt instruments at fair value through other comprehensive income (D.7.2.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ec71259f6414571a2d78f044395b234_I20221231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzQtMS0xLTEtMzY0MDYw_34ac499c-f03c-4450-be8d-9b92d8714ed7">329</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i18dfacac600544adb63df420cb892c4a_I20211231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzQtMi0xLTEtMzY0MDYw_c0c514e6-0d87-4950-b266-d08580e5abec">447</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i947289ceb8754aafa7862f600d091bb9_I20201231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzQtMy0xLTEtMzY0MDYw_a2713d99-fb0c-4d5a-817e-082348f9507c">426</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other financial assets at fair value through profit or loss (D.7.3.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzUtMS0xLTEtMzY0MDYw_505b0043-8ed4-4acc-beb5-e73a73006783">823</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzUtMi0xLTEtMzY0MDYw_f1d7638b-b605-4d4b-9ae7-5253da74e566">902</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzUtMy0xLTEtMzY0MDYw_8bfcd556-05bc-481f-a810-5b4ffc07eb62">890</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pre-funded pension obligations (Note&#160;D.19.1.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:PreFundedPensionObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzYtMS0xLTEtMzY0MDYw_5c002d40-13c9-4ac9-a295-78e982f1c2a0">269</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:PreFundedPensionObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzYtMi0xLTEtMzY0MDYw_d1f92528-5577-4a29-9d83-5e7d0139760a">408</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:PreFundedPensionObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzYtMy0xLTEtMzY0MDYw_38f38a9e-80b5-4a7e-b06e-099f9831a089">177</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term prepaid expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:LongTermPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzctMS0xLTEtMzY0MDYw_38ca9cb0-a381-4f01-8ba8-e41948d7db4a">286</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:LongTermPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzctMi0xLTEtMzY0MDYw_316796b8-3522-424a-868f-007e4c1bec14">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:LongTermPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzctMy0xLTEtMzY0MDYw_a383904a-3dce-41da-ba08-2c4c74ae3754">92</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term loans and advances and other non-current receivables</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentLoansAndReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzgtMS0xLTEtMzY0MDYw_90c0abe3-2047-4f9d-9f4c-98871d6b7cfc">452</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncurrentLoansAndReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzgtMi0xLTEtMzY0MDYw_02d11a00-a2d2-4f4c-8ed8-72d1c9c4a2ac">485</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncurrentLoansAndReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzgtMy0xLTEtMzY0MDYw_70449306-1f84-4f66-a1c7-3a0a547b280c">537</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derivative financial instruments (Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzktMS0xLTEtMzY0MDYw_a05e3cc9-3160-4536-97b6-db9abd97d095">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzktMi0xLTEtMzY0MDYw_6d748c46-c1cd-49a7-91c4-df3f5e86504f">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzktMy0xLTEtMzY0MDYw_3fb7bee7-b5c0-4961-9479-20a5bee19fe7">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzEwLTEtMS0xLTM2NDA2MA_c6abc20c-da9a-47db-be14-7af2e0f90937">3,095</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzEwLTItMS0xLTM2NDA2MA_d8ac6f40-d472-4002-888e-31fc5e1d2699">3,127</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzEwLTMtMS0xLTM2NDA2MA_4621d40a-7a5a-4980-80a0-2326f151b2b9">2,734</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) The movement in this item mainly comprises (i)&#160;the non-current portion of a $<ix:nonFraction unitRef="usd" contextRef="i35f0fcaaff094ff283b1ab8503932dab_D20220107-20220107" decimals="-6" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzgyNDYzMzcyMTY5OTM_84d4db1a-6877-46d6-943a-c0503bf7fb2f">100</ix:nonFraction>&#160;million upfront payment made on signature of a research agreement with Exscientia on January&#160;7, 2022 to develop a portfolio of precision-engineered medicines using artificial intelligence; and (ii)&#160;the non-current portion of a $<ix:nonFraction unitRef="usd" contextRef="i7d7acd3285a64b18bcadb39dc8467fe9_D20220329-20220329" decimals="-6" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzgyNDYzMzcyMTY5OTk_2f660362-f612-4292-bfb3-ba5108b42f88">150</ix:nonFraction>&#160;million upfront payment made as part of a strategic partnership with IGM Biosciences signed on March&#160;29, 2022, with a view to developing targets in oncology, immunology and inflammation</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) As of December 31, 2022, this item includes a receivable under a sub-lease amounting to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentFinanceLeaseReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzgyNDYzMzcyMTcwMDU_b8bed4cd-e378-419f-a7ab-2a5420955572">164</ix:nonFraction> million, or &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:NonCurrentFinanceLeaseReceivablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzgyNDYzMzcyMTcwMTE_223c1733-43b3-442f-ba07-c99a7549748b">227</ix:nonFraction> million before discounting.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-46</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="if6eedbc2e77846688bf536c11abad125" continuedAt="i19355fcac9de4a7e84f6178ae5c17156"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.7.1. Equity instruments at fair value through other comprehensive income</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quoted equity investments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line &#8220;Equity instruments at fair value through other comprehensive income&#8221; includes equity investments quoted in an active market with a carrying amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="i85d4d256594b464a8880f4ff83e76312_I20221231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzMzMw_d14677d8-cdf8-4e61-a85d-1601f0a68eca">387</ix:nonFraction> million as of December 31, 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i747f411b1b5b4dc38fd872cb94543817_I20211231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzM0Ng_d1827eae-fdb2-4b3c-82b9-3ba2d59613e3">396</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i30ef28538e274977b05fe65db2be8141_I20201231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzM2Mg_0db27619-ba5c-4b74-9d5b-c3d97f21baad">439</ix:nonFraction> million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main changes in quoted equity investments included in the &#8220;Equity instruments at fair value through other comprehensive income&#8221; category in the year ended December 31, 2022 are described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the sale in June&#160;2022 of the residual equity interest in Regeneron (see Note&#160;C.1.). for $<ix:nonFraction unitRef="usd" contextRef="i06d47704541e4ee1a797c39f08654082_D20220601-20220630" decimals="-6" name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNTAyMDY_d839b636-5478-4442-ab19-6be0e98a36d8">174</ix:nonFraction> million, the entire loss on which was recorded within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the acquisition of an equity interest in Innovent Biologics, in connection with a strategic collaboration agreement to intensify&#160;development in oncology medicines signed in August 2022, which had a fair value of &#8364;<ix:nonFraction unitRef="eur" contextRef="i5d0712e20c454b3c96fcf98e68a25960_I20220831" decimals="-6" name="sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNTE0NDg_6ecad852-0e19-4c18-b774-62879d7d3e01">250</ix:nonFraction> million as of that date and &#8364;<ix:nonFraction unitRef="eur" contextRef="ic0d86ac7238f4dd59ab63269350d8d09_I20221231" decimals="-6" name="sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNjEyODY_4d68eb1b-f13e-4a46-8e70-4dd31720dced">228</ix:nonFraction> million as of December&#160;31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main changes in quoted equity investments included in this category in previous years are described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in 2021, following completion of the acquisition of Translate Bio on September&#160;14, 2021 (see Note&#160;D.2.1.), the equity interest of approximately <ix:nonFraction unitRef="number" contextRef="i57ad482a322b4fc0a81c53a3afc3d8d6_I20210914" decimals="2" name="sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY5OQ_80f345fe-420f-4999-b043-65087a2037ed">5</ix:nonFraction>% in Translate Bio previously held by Sanofi ceased to be accounted for as an </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">equity instrument at fair value through other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in 2020:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">following the sale of <ix:nonFraction unitRef="shares" contextRef="i58dc338d3859459eb1381af00a929009_D20200529-20200529" decimals="INF" name="sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzEwODk_2591b0e2-dbe2-4180-a74f-62e69d2301f4">22.8</ix:nonFraction>&#160;million shares of Regeneron common stock on May&#160;29, 2020 (see Note&#160;D.2.2.), Sanofi ceased to exercise significant influence over Regeneron, and this investment ceased to be accounted for using the equity method (see Note&#160;D.6.). In accordance with IFRS&#160;9 (Financial Instruments), the <ix:nonFraction unitRef="shares" contextRef="ib198bd6cc6604c2b9675491c47738ca5_I20200529" decimals="INF" name="sny:NonCurrentFinancialAssetsNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzEzNDk_a51317ac-810d-4913-b2b3-e5458a6f4a5e">400,000</ix:nonFraction>&#160;shares retained by Sanofi were classified in&#160;the &#8220;Equity instruments at fair value through other comprehensive income&#8221; category as of May&#160;29, 2020, at a carrying&#160;amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="ib198bd6cc6604c2b9675491c47738ca5_I20200529" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE1MjQ_83779e7d-125b-4517-922b-5991d4668b55">221</ix:nonFraction>&#160;million. As of&#160;December 31, 2020, Sanofi held <ix:nonFraction unitRef="shares" contextRef="i7488dcfd6c2945918eaf022e244867f7_I20201231" decimals="INF" name="sny:NonCurrentFinancialAssetsNumberOfShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE1NTA_6ff61fcf-e1f5-4bd1-8712-b4760a0ddb83">279,766</ix:nonFraction>&#160;Regeneron shares with a carrying amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="i7488dcfd6c2945918eaf022e244867f7_I20201231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE1OTc_a1907fec-dc95-4da0-ad15-614258ca6bdb">111</ix:nonFraction> million,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">an equity injection was made into Translate&#160;Bio under the terms of the collaboration and license agreement announced on&#160;June&#160;23,&#160;2020, which had a carrying amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="ie64fc8634a414cf0b229f5f5231182b0_I20211231" decimals="-6" name="ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE3NjM_fdd0fb49-151c-4ef8-ba38-79793e060cdc">74</ix:nonFraction> million as of December&#160;31, 2021 and represented an equity interest of approximately&#160;<ix:nonFraction unitRef="number" contextRef="ie64fc8634a414cf0b229f5f5231182b0_I20211231" decimals="2" name="sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE4Mjg_34b78e9a-bfb5-4543-9edb-9891f2047549">8</ix:nonFraction>% of Translate Bio as of that date,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">Sanofi owns equity interests in quoted biotechnology companies. Movements in the quoted market prices of the shares held in those companies generated a net gain of &#8364;<ix:nonFraction unitRef="eur" contextRef="if6436922a2ad48e6aa3486427a648935_I20201231" decimals="-6" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzIwMzA_674e687b-bd21-4d9e-bb9d-fcc4a151ea47">357</ix:nonFraction> million, recognized in &#8220;Equity instruments at fair value through other comprehensive income&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A 10% decline in stock prices of the quoted equity investments included within &#8220;Equity instruments at fair value through&#160;other&#160;comprehensive income&#8221; would have had a pre-tax impact of &#8364;<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzMzMDc_07bcac62-1606-48f5-abbc-bd0fee35f565">39</ix:nonFraction> million on </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as of December 31, 2022.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unquoted equity investments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line item &#8220;Equity instruments at fair value through other comprehensive income&#8221; also includes equity investments not quoted in an active market with a carrying amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="i1cb860a561454a50b32cf9b3ef5bf20a_I20221231" decimals="-6" name="ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzM1NTI_775acdce-9cdd-4d0d-8a6e-8d85869f07a9">549</ix:nonFraction> million as of December 31, 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="if350acb0ea304e1380f8a7daa4bf3d34_I20211231" decimals="-6" name="ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzM1NjU_cb1a1215-b9f1-4281-aafb-93228309fc85">427</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i58761417deb34e4789711c949bf2754c_I20201231" decimals="-6" name="ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzM1ODE_2cf131a4-8ef9-4a7b-acbb-c14d199d253f">149</ix:nonFraction> million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The change in unquoted equity investments included in the &#8220;Equity instruments at fair value through other comprehensive income&#8221; category during the year ended December 31, 2022 was mainly due to various equity stakes acquired through the Sanofi Ventures fund, partly offset by the sale in October&#160;2022 of the <ix:nonFraction unitRef="number" contextRef="i737d6d075cd24a3fa0a94d9a8769b9f8_D20221001-20221031" decimals="2" name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE5NzkxMjA5MzIzMDA5_d14e922d-77b8-4dcd-bd09-704f754abe8a">19</ix:nonFraction>% non-controlling interest in Onduo for $<ix:nonFraction unitRef="eur" contextRef="i4c302b94ca2e4d78b8e9a5e1966760e7_I20221031" decimals="-6" name="sny:DisposalGroupGainOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNjE3NTI_6a64ee1f-322f-4619-bfb8-494f4246e89f">175</ix:nonFraction> million; the entire gain on the disposal was recognised in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.7.2. Debt instruments at fair value through other comprehensive income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The &#8220;Debt instruments at fair value through other comprehensive income&#8221; category includes quoted euro-denominated senior bonds amounting to &#8364;<ix:nonFraction unitRef="eur" contextRef="i58d99ec61b724625ba3cf5fe5d54f353_I20221231" decimals="-6" name="ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzQxOTk_621f0d50-4fea-4ca9-b261-afc5e3a92d47">329</ix:nonFraction> million as of December 31, 2022, including &#8364;<ix:nonFraction unitRef="eur" contextRef="i0316f32ab41848ccaa532657cf32b68f_I20221231" decimals="-6" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzQyMjI_526287c8-6ff0-4de0-abec-604baabd793a">104</ix:nonFraction> million of securities obtained in exchange for financial assets held to meet obligations to employees under post-employment benefit plans.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi held &#8364;<ix:nonFraction unitRef="eur" contextRef="if7bc7c1140af4531b7bb1f0aa3a64394_I20211231" decimals="-6" name="ifrs-full:HeldtomaturityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNjE3NzE_73b61a86-58f4-429f-a78a-718acde8ccce">447</ix:nonFraction> million of quoted senior bonds as of December&#160;31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="idbc81c6777a247f3a55a9409731b937f_I20201231" decimals="-6" name="ifrs-full:HeldtomaturityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzQzNjg_0c4f0cfb-2590-4042-b331-832457daa20b">426</ix:nonFraction> million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As regards debt instruments held to meet obligations to employees under post-employment benefit plans, an increase of 10&#160;basis points in market interest rates as of December 31, 2022 would have had a pre-tax impact of &#8364;<ix:nonFraction unitRef="eur" contextRef="if636e1b1d9c94752b6e7d2f5d093ad9c_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzQ2MjM_ac99ec7d-d780-4ef1-a18d-342430bc6d0a">1</ix:nonFraction> million on </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As regards other quoted debt instruments, an increase of 10&#160;basis points in market interest rates as of December 31, 2022 would have had a pre-tax impact of &#8364;<ix:nonFraction unitRef="eur" contextRef="i2a89cf5df5aa43cd9b53e1ca3064c250_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzQ3OTk_91c70b96-e8ae-49b5-af6b-8229c3a530fc">1</ix:nonFraction> million on </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other comprehensive income recognized in respect of &#8220;Equity instruments at fair value through other comprehensive income&#8221; and &#8220;Debt instruments at fair value through other comprehensive income&#8221; represented unrealized after-tax gains of &#8364;<ix:nonFraction unitRef="eur" contextRef="ib26b365d63504886a705909c700dad19_D20220101-20221231" decimals="-6" name="sny:UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzUwNjk_6837ac19-1b8b-46b8-a5c2-1059097a1fbf">256</ix:nonFraction> million for the year ended December 31, 2022, versus unrealized after-tax gains of &#8364;<ix:nonFraction unitRef="eur" contextRef="i0f1cbd8e523544a09df5288b9e682c8b_D20210101-20211231" decimals="-6" name="sny:UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzUxMzI_352d67c1-cd97-4eff-886d-587118748abc">322</ix:nonFraction> million for the year ended December 31, 2021 and unrealized after-tax losses of &#8364;<ix:nonFraction unitRef="eur" contextRef="i187a52d9d71643088cd196df81c6809f_D20200101-20201231" decimals="-6" sign="-" name="sny:UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzUxOTM_c422270e-f716-4635-ac76-7c0345b4c882">200</ix:nonFraction> million for the year ended December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of the change in gains and losses recognized in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, and of items reclassified to profit or loss, is presented in Note&#160;D.15.7.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-47</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i19355fcac9de4a7e84f6178ae5c17156"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.7.3. Other financial assets at fair value through profit or loss</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The &#8220;Other financial assets at fair value through profit or loss&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">category includes:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">contingent consideration receivable by Sanofi following the dissolution of the Sanofi Pasteur MSD (SPMSD) joint venture, based on a percentage of MSD&#8217;s future sales during the 2017-2024 period of specified products previously distributed by&#160;SPMSD (see Note&#160;D.12.).</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of the MSD contingent consideration was determined by applying the royalty percentage stipulated in the contract to discounted sales projections. A reduction of one percentage point in the discount rate would increase the fair value of the&#160;MSD&#160;contingent consideration by approximately <ix:nonFraction unitRef="number" contextRef="i8b47ba7fd49a4339a1546e28df0f6cc1_I20221231" decimals="2" name="sny:IncreaseInContingentConsideration" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzYxMDA_5f3f649a-b6aa-43fc-883d-71cf78a6f634">1</ix:nonFraction>%.</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in the fair value of this contingent consideration are recognized in the income statement within the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Fair value remeasurement of contingent consideration </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(see Note&#160;B.18.). As of December 31, 2022, the contingent consideration asset amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="ia89ef6966eae49a3b34c0c5c4c087cbc_I20221231" decimals="-6" name="sny:FairValueOfTheContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzYzNTE_ba676f0c-e2dd-468e-89f0-e73b904c9aa7">303</ix:nonFraction> million (including a non-current portion of &#8364;<ix:nonFraction unitRef="eur" contextRef="i545b36dad89549698a7358e61f470fae_I20221231" decimals="-6" name="sny:FairValueOfTheContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzYzOTA_eb8a6312-6232-48ce-994d-64a034acee79">196</ix:nonFraction> million), versus &#8364;<ix:nonFraction unitRef="eur" contextRef="if2790c19603340069463669a1121103c_I20211231" decimals="-6" name="sny:FairValueOfTheContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY0MDI_ed4863c4-733e-44bf-b945-993df47c4efe">378</ix:nonFraction> million (non-current portion: &#8364;<ix:nonFraction unitRef="eur" contextRef="i29f5271fd56c4132b303c64792c7e68b_I20211231" decimals="-6" name="sny:FairValueOfTheContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY0Mjc_62944752-0fff-4b7b-a8ad-70ff7ad8b3fe">275</ix:nonFraction> million) as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i008006b7cc834a49a4178a0fd6d1f590_I20201231" decimals="-6" name="sny:FairValueOfTheContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY0NDQ_fcaa6a56-5fa3-44ee-af2b-db72e71773e0">483</ix:nonFraction> million (non current portion: &#8364;<ix:nonFraction unitRef="eur" contextRef="icd6801a467d04340b8c2bbb32208b916_I20201231" decimals="-6" name="sny:FairValueOfTheContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNjE3OTE_5d122117-88ce-426d-bd46-c4eddcd605b7">374</ix:nonFraction> million) as of December 31, 2020;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a portfolio of financial investments (amounting to &#8364;<ix:nonFraction unitRef="eur" contextRef="i59d2d460cf184fc7aa2916de537a8f07_I20221231" decimals="-6" name="sny:FinancialInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY1MDk_27508308-60e7-422b-8731-94b9970b0a68">512</ix:nonFraction> million as of December 31, 2022) held to fund a deferred compensation plan provided to certain employees (versus &#8364;<ix:nonFraction unitRef="eur" contextRef="ie8b445cb2507415fb152acdc9b875a90_I20211231" decimals="-6" name="sny:FinancialInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY2MDI_744c9b1f-e874-4d99-82f8-c034bb7096d0">549</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i6f597a89a6d040349370742d7e4695ac_I20201231" decimals="-6" name="sny:FinancialInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY2MTg_8570c02b-2f65-42b5-aa26-4f9b79f26be2">453</ix:nonFraction> million as of December 31, 2020);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">unquoted securities not meeting the definition of equity instruments amounting to &#8364;<ix:nonFraction unitRef="eur" contextRef="i0b12ab871b274e9aa1aa68c28cd74514_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY3MTQ_bb876a43-b09a-4b9a-a76b-3d5f4eff9acd">115</ix:nonFraction> million as of December 31, 2022 (versus &#8364;<ix:nonFraction unitRef="eur" contextRef="i8bbf8d410b244301ac8ff091e2c31cd3_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY3MzQ_f08ac728-e37b-400a-b21b-fc44927fa36d">78</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i41f3c0f9515d4e13aa74179f5b5a3840_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY3NTA_0aa1d648-e420-481b-a582-d16e833631a8">63</ix:nonFraction> million as of December 31, 2020).</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_613"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.8. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90ZXh0cmVnaW9uOjIzYzQ2NGI3ZGExYzRlNmZiMjNkNmNhYzAyYjcxNTkyXzY3Mg_abec95f2-ec1a-462b-abcb-ee850dd2069a" continuedAt="iba8a088db66a45f68f7666cfbb923d23" escape="true">Assets held for sale or exchange and liabilities related to&#160;assets held for sale or exchange</ix:nonNumeric></span></div><ix:continuation id="iba8a088db66a45f68f7666cfbb923d23"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90ZXh0cmVnaW9uOjIzYzQ2NGI3ZGExYzRlNmZiMjNkNmNhYzAyYjcxNTkyXzY3MA_78dd802b-a452-48b5-95e2-47329574ba78" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Assets held for sale or exchange, and liabilities related to assets held for sale or exchange, comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:52.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.216%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets held for sale or exchange</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzEtMS0xLTEtMzY0MDYw_3878eb6f-cfd8-40b7-ae97-6c8f2f1975cf">85</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzEtMi0xLTEtMzY0MDYw_6d7b69ae-513d-4f1f-9302-7828ada5efc7">89</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzEtMy0xLTEtMzY0MDYw_2436de90-5f5c-4c35-b1bb-e3c40dead1ac">83</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Liabilities related to assets held for sale or exchange</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzItMS0xLTEtMzY0MDYw_4e0c8005-c07f-4932-8506-c32784886ea5">10</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzItMi0xLTEtMzY0MDYw_301e6d0f-2265-4fe7-ba3d-e2d8e4467cd2">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzItMy0xLTEtMzY0MDYw_81768e65-12be-4acf-855a-6cc155ff341c">32</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, assets held for sale mainly related to items of property, plant and equipment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2021, assets held for sale mainly related to the divestment of a listed equity investments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2020, assets held for sale mainly related to the planned divestment of an industrial facility in North America.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_616"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.9. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfInventoriesExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90ZXh0cmVnaW9uOjNlYTFlYjQ5NjEyZTRkYjU4NGUyOGIyZTJmY2E2Y2YzXzQxNw_830180ac-e7a1-4f8f-a071-84af95bcc47f" continuedAt="i1cb1450387bc421f83048ea645dc16ce" escape="true">Inventories</ix:nonNumeric></span></div><ix:continuation id="i1cb1450387bc421f83048ea645dc16ce"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90ZXh0cmVnaW9uOjNlYTFlYjQ5NjEyZTRkYjU4NGUyOGIyZTJmY2E2Y2YzXzQxNA_9ce76fee-0c53-4901-9a8d-384e45ee7759" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inventories comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.907%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.829%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Allowances</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Allowances</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Allowances</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying<br/>amount</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231" decimals="-6" name="ifrs-full:RawMaterials" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItMS0xLTEtMzY0MDYw_9d2731b3-cb2e-49fc-bc9a-4c8c84957008">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib647a1698a86427cb8d4b97bbad379d5_I20221231" decimals="-6" name="ifrs-full:RawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItMi0xLTEtMzY0MDYw_c21f1c96-912f-4a43-8a06-ad1fb4a63e6e">139</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:RawMaterials" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItMy0xLTEtMzY0MDYw_4545bc30-98aa-44d2-8f8d-aa92644857b9">1,474</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231" decimals="-6" name="ifrs-full:RawMaterials" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItNC0xLTEtMzY0MDYw_e726de21-d857-47d1-8c2f-36d7f0a01d2d">1,344</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iac996783058743dc90c8e8829cd97b94_I20211231" decimals="-6" name="ifrs-full:RawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItNS0xLTEtMzY0MDYw_d9319ef0-9848-42f9-965d-fff42f391035">66</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:RawMaterials" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItNi0xLTEtMzY0MDYw_9e796864-072e-4e9b-9a74-d83345a64908">1,278</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231" decimals="-6" name="ifrs-full:RawMaterials" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItNy0xLTEtMzY0MDYw_46624b20-d558-40b5-82a0-b4b748e865cf">1,051</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1b3cc5ff69f34488be79292aa20b972d_I20201231" decimals="-6" name="ifrs-full:RawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItOC0xLTEtMzY0MDYw_a0a6f703-fd4a-4c4f-b007-72659eedd66c">76</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:RawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItOS0xLTEtMzY0MDYw_3fef5778-35ae-4be8-83db-8159ffbcc0b1">975</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231" decimals="-6" name="ifrs-full:WorkInProgress" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtMS0xLTEtMzY0MDYw_b6339f82-059d-4f00-8f45-22ba06be023d">5,663</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib647a1698a86427cb8d4b97bbad379d5_I20221231" decimals="-6" name="ifrs-full:WorkInProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtMi0xLTEtMzY0MDYw_5788e2f6-c9a1-41da-b444-6bd7677594c5">678</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:WorkInProgress" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtMy0xLTEtMzY0MDYw_4f009353-9c62-420a-ad95-a868b124abaf">4,985</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231" decimals="-6" name="ifrs-full:WorkInProgress" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtNC0xLTEtMzY0MDYw_05aef563-c747-4602-bdf7-62c7fbc60784">5,579</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iac996783058743dc90c8e8829cd97b94_I20211231" decimals="-6" name="ifrs-full:WorkInProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtNS0xLTEtMzY0MDYw_57e65adc-d25e-40a8-a95b-f491bc305ab2">554</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:WorkInProgress" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtNi0xLTEtMzY0MDYw_e46025d4-7399-408a-9ddb-871b2deed3ed">5,025</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231" decimals="-6" name="ifrs-full:WorkInProgress" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtNy0xLTEtMzY0MDYw_8bef61d9-697a-4ffa-a868-c8997a911463">5,398</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1b3cc5ff69f34488be79292aa20b972d_I20201231" decimals="-6" name="ifrs-full:WorkInProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtOC0xLTEtMzY0MDYw_9a97140b-3bc3-4699-a0d3-aedf8773d2e7">542</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:WorkInProgress" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtOS0xLTEtMzY0MDYw_84a197ac-259f-445b-b29c-275173dd9db2">4,856</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231" decimals="-6" name="ifrs-full:FinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtMS0xLTEtMzY0MDYw_008128e1-fe74-4ae5-95c9-aa0f5780219b">2,748</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib647a1698a86427cb8d4b97bbad379d5_I20221231" decimals="-6" name="ifrs-full:FinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtMi0xLTEtMzY0MDYw_fb2bb2e9-12d6-42a1-a165-cc2808998b46">247</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:FinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtMy0xLTEtMzY0MDYw_ef3f5824-28f0-4eaa-abf7-0d3c2744a9aa">2,501</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231" decimals="-6" name="ifrs-full:FinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtNC0xLTEtMzY0MDYw_6567dc9b-8334-4242-96c1-4b362805c27c">2,696</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iac996783058743dc90c8e8829cd97b94_I20211231" decimals="-6" name="ifrs-full:FinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtNS0xLTEtMzY0MDYw_17a3e7b3-4467-4aad-8952-d4f57b947e5d">284</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:FinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtNi0xLTEtMzY0MDYw_b443e2f9-e66b-42de-8071-1dca53034941">2,412</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231" decimals="-6" name="ifrs-full:FinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtNy0xLTEtMzY0MDYw_4d5d1f9f-2a00-4bcf-9be7-8c516dc0471f">2,739</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1b3cc5ff69f34488be79292aa20b972d_I20201231" decimals="-6" name="ifrs-full:FinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtOC0xLTEtMzY0MDYw_6a79adae-1d23-4a01-a067-cd83962542f2">218</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:FinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtOS0xLTEtMzY0MDYw_14ed9e12-d360-4430-8c42-36e89c867748">2,521</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtMS0xLTEtMzY0MDYw_6c610045-fa13-464b-9c7f-8c67506cee12">10,024</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib647a1698a86427cb8d4b97bbad379d5_I20221231" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtMi0xLTEtMzY0MDYw_60fc8a0c-2816-488d-8e7a-6c5f87cf8853">1,064</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtMy0xLTEtMzY0MDYw_7fa67f09-3616-4140-a65e-5f22d871db96">8,960</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtNC0xLTEtMzY0MDYw_a6c37a61-effc-43c6-8aeb-659f1d8212de">9,619</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iac996783058743dc90c8e8829cd97b94_I20211231" decimals="-6" name="ifrs-full:Inventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtNS0xLTEtMzY0MDYw_469b86f1-8ff7-4bdc-a6f3-78eb7b30bd25">904</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtNi0xLTEtMzY0MDYw_7357dd3a-6c9e-4c5d-b0d3-71ad4ac1d454">8,715</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtNy0xLTEtMzY0MDYw_69604a27-5582-4361-806b-bb1e822ad526">9,188</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1b3cc5ff69f34488be79292aa20b972d_I20201231" decimals="-6" name="ifrs-full:Inventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtOC0xLTEtMzY0MDYw_2f3ac7ef-85ec-40e2-8e04-35a7cf6b5588">836</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtOS0xLTEtMzY0MDYw_8ed50d71-adaa-4ca0-96ae-2a8d5b63ecad">8,352</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Allowances include write-downs of products on hand pending marketing approval, except in specific circumstances where it is possible to estimate that recovery of the value of inventories as of the end of the reporting period is highly probable.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inventories pledged as security for liabilities amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:InventoriesPledgedAsSecurityForLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90ZXh0cmVnaW9uOjNlYTFlYjQ5NjEyZTRkYjU4NGUyOGIyZTJmY2E2Y2YzXzM2NQ_077027f8-6159-4028-90f6-7120e133f3dd">3</ix:nonFraction> million as of December 31, 2022 (versus &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:InventoriesPledgedAsSecurityForLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90ZXh0cmVnaW9uOjNlYTFlYjQ5NjEyZTRkYjU4NGUyOGIyZTJmY2E2Y2YzXzM4NQ_850801af-5dfd-46af-948b-9bcf95b36e02">20</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:InventoriesPledgedAsSecurityForLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90ZXh0cmVnaW9uOjNlYTFlYjQ5NjEyZTRkYjU4NGUyOGIyZTJmY2E2Y2YzXzQwMQ_6ec236bc-291f-4f25-be18-bf8ea1c1ab3a">17</ix:nonFraction> million as of December 31, 2020).</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_619"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.10. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfTradeReceivablesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzY3MQ_6262d5ff-dd37-4ebb-8b22-6a9929bac9a0" continuedAt="ibc7523d9d4db4ccd97d3a4efcb2e33db" escape="true">Accounts receivable</ix:nonNumeric></span></div><ix:continuation id="ibc7523d9d4db4ccd97d3a4efcb2e33db" continuedAt="idcfec26dd89b4377941276c9b8bce613"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfCurrentTradeReceivablesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzY3Mw_d0a7fcab-03af-48cb-b592-50b8f21486b0" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Accounts receivable break down as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:52.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.216%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross value</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzEtMS0xLTEtMzY0MDYw_ba485b8f-2e62-4419-abfb-3c5bb49ee5de">8,537</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzEtMi0xLTEtMzY0MDYw_787d46c8-044e-4a07-be4b-1a3077753a1f">7,705</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzEtMy0xLTEtMzY0MDYw_0c4edec7-1db3-48f0-b622-48b0d3747d6f">7,633</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iaa4b63bd7db44ad5911b73e3491dd4a3_I20221231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzItMS0xLTEtMzY0MDYw_926b76eb-7709-4c1c-b452-e51de83c7af2">113</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i05f28cd38d0841ebb218af6930d501eb_I20211231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzItMi0xLTEtMzY0MDYw_92d788cb-a952-440b-b611-74a76a675f1a">137</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i032944e42df3482bbe716ed7bc4d8482_I20201231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzItMy0xLTEtMzY0MDYw_68b4efc5-1376-493d-bc7f-4c427b7a5bc6">142</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzMtMS0xLTEtMzY0MDYw_762dfb53-c866-475f-9d99-2202473c6ded">8,424</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzMtMi0xLTEtMzY0MDYw_47e7c91a-1620-4368-b229-9559d738f0aa">7,568</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzMtMy0xLTEtMzY0MDYw_021e94be-685d-43bf-8cf5-43aea2be501d">7,491</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of allowances against accounts receivable in 2022 was a net amount of less than &#8364;<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzE1Ng_328abd81-326b-4f4d-bd36-ea041991adbc">1</ix:nonFraction> million (versus a net expense of&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzE4NA_4b63ee18-feaa-41a6-855d-55ffeee419a9">12</ix:nonFraction> million in 2021 and a net expense of &#8364;<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzIxMQ_b94e96bb-5449-4429-b4cd-d5b7a79ccad0">30</ix:nonFraction> million in 2020).</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-48</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="idcfec26dd89b4377941276c9b8bce613"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The gross value of overdue receivables was &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:OverdueReceivablesGrossValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzI2Ng_2ec3e5e9-2989-4a40-91f3-c50ce834a3c9">452</ix:nonFraction> million as of December 31, 2022, versus &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:OverdueReceivablesGrossValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzI5NA_dde1bb7b-7d0c-41da-8c19-5d0e9ff21377">455</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:OverdueReceivablesGrossValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzMxMQ_ab4fbeb3-b8e2-4ed0-bce1-9dd5b40f034c">549</ix:nonFraction> million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfOverdueReceivablesGrossValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzY3NQ_e84d8606-119b-4403-9b46-4efcd4038440" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:17.123%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.532%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;accounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">gross value</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&lt;1 month</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to&#160;3&#160;months</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to&#160;6&#160;months</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6&#160;to&#160;12&#160;months</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&gt;&#160;12&#160;months</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItMS0xLTEtMzY0MDYw_2ec3e5e9-2989-4a40-91f3-c50ce834a3c9">452</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib366bca9838a4f858834d488788aa1aa_I20221231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItMi0xLTEtMzY0MDYw_71bd357b-3749-43be-8457-00981420c567">118</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i92676380068543619922d35317997de3_I20221231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItMy0xLTEtMzY0MDYw_ef6f552d-a2b1-4767-b2e8-0de9b275a50c">161</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i51c89819a09a4a869b9cf28d9487e9a0_I20221231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItNC0xLTEtMzY0MDYw_df1f5aa3-cf7b-4c80-a730-380502dc15b7">87</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4ef2f8187cfa4407be68d0b5b25618ad_I20221231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItNS0xLTEtMzY0MDYw_c3ea3436-2ccd-4b24-92d5-d22e25d1f913">35</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i204cf38410c44c62bd596f2773e81a5b_I20221231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItNi0xLTEtMzY0MDYw_2ad1f60a-19bf-4dc4-931e-44dba2574af4">51</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtMS0xLTEtMzY0MDYw_dde1bb7b-7d0c-41da-8c19-5d0e9ff21377">455</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ba3ac339a504f58a90dc11aa1e8caef_I20211231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtMi0xLTEtMzY0MDYw_42dee4a4-c54b-45a1-948c-c0be7b943625">169</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iec0ca9779e2a464985b051e55ada2803_I20211231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtMy0xLTEtMzY0MDYw_b79efcc6-29b5-4968-9619-dc8b6e7a445a">151</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaa0f24f6bcc446849ba76127738f68fb_I20211231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtNC0xLTEtMzY0MDYw_941363d3-990b-493c-8524-d3633bc7a974">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id20ecec6f1584de38800aacb975d6350_I20211231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtNS0xLTEtMzY0MDYw_e00c05c4-95e6-40b1-9095-7274f7343988">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0fe124e0795a41ebac762da9097bb875_I20211231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtNi0xLTEtMzY0MDYw_814865bf-b153-404f-8fe8-0632c0f884c9">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtMS0xLTEtMzY0MDYw_ab4fbeb3-b8e2-4ed0-bce1-9dd5b40f034c">549</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i71a39145bca34b95ae9166213239a5c9_I20201231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtMi0xLTEtMzY0MDYw_bd560c87-9fc2-41fa-9e5b-ea6f5de009e7">271</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifd3ffc9d285a4ee5b56664fc9405500a_I20201231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtMy0xLTEtMzY0MDYw_fc4b24a5-f3ff-42b1-b524-fc6fef886f08">97</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id8bfa977878c49e4801932e083d9a1d9_I20201231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtNC0xLTEtMzY0MDYw_ab96a703-9c32-4c90-9ae9-c189956018e7">52</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0c1337c5561d4086b729fb3b2df1d049_I20201231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtNS0xLTEtMzY0MDYw_0d16cffc-518d-4e97-af14-98d60dc99931">34</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2e7cdf1797e949f6abdf600757d84aa3_I20201231" decimals="-6" name="sny:OverdueReceivablesGrossValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtNi0xLTEtMzY0MDYw_341c01bb-7bd1-44cf-a122-535373e12c64">95</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amounts overdue by more than one month relate mainly to public-sector customers.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Some Sanofi subsidiaries have assigned receivables to factoring companies or banks without recourse. The amount of receivables&#160;derecognized was &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:DerecognizedReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzU1MQ_2c25f668-faa5-495b-b87c-0baf3caa7ab7">131</ix:nonFraction> million as of December 31, 2022 (&#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:DerecognizedReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzU2NA_70eea285-9b15-4254-940e-b010ccfb1d72">3</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:DerecognizedReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzU4MA_2d082f1c-cc58-41c5-a96f-c8a059c13434">18</ix:nonFraction> million as of December 31, 2020). The residual guarantees relating to such transfers were immaterial as of December 31, 2022.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_622"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.11. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90ZXh0cmVnaW9uOmUyNzBjNGI1ODE5YjQwZGRiY2M0ZDEwYzEzZTU3ZGIxXzY4NA_d8ba05f0-fe39-4040-bd2e-826134d704e9" continuedAt="i66c70a9268e94f30b144b6fd20e8a16e" escape="true">Other current assets</ix:nonNumeric></span></div><ix:continuation id="i66c70a9268e94f30b144b6fd20e8a16e"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90ZXh0cmVnaW9uOmUyNzBjNGI1ODE5YjQwZGRiY2M0ZDEwYzEzZTU3ZGIxXzY4Mg_21cb74e8-11a7-4a81-b6f5-44170dd47eea" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Other current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax receivables, other than corporate income taxes</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzEtMS0xLTEtMzY0MDYw_c1cadad4-ec85-4da9-806e-b03dff7a1165">658</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzEtMi0xLTEtMzY0MDYw_b3b58d2f-8d78-40b0-84f0-cd771eff4504">802</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzEtMy0xLTEtMzY0MDYw_e7da15bb-8c97-4ce7-86dd-2a85ee815604">687</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzItMS0xLTEtMzY0MDYw_209bce85-7f0b-4af5-8531-e21e695363fd">714</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzItMi0xLTEtMzY0MDYw_c5f8b754-8ed9-4307-86bb-a6ec51fb8795">615</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzItMy0xLTEtMzY0MDYw_882447e9-16d3-40dd-95e8-f5d4bab811c9">525</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other receivables</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:OtherCurrentReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzMtMS0xLTEtMzY0MDYw_8c85bc85-ae95-48b2-a9da-db72e07b268d">1,290</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:OtherCurrentReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzMtMi0xLTEtMzY0MDYw_403d2fff-8392-4793-bd1d-e7df804852f2">805</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:OtherCurrentReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzMtMy0xLTEtMzY0MDYw_efc9c680-4a42-4dc2-9492-ac947021bca4">567</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate derivatives measured at fair value (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:InterestRateDerivativesMeasuredAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzQtMS0xLTEtMzY0MDYw_a16dc7b5-72b9-4a2d-9de1-6d47fb317d6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:InterestRateDerivativesMeasuredAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzQtMi0xLTEtMzY0MDYw_71a05d12-cfe1-47a2-a99b-69238123bf7e">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:InterestRateDerivativesMeasuredAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzQtMy0xLTEtMzY0MDYw_9508fa6c-b8a0-4690-aaf5-746305001dd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency derivatives measured at fair value (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CurrencyDerivativesMeasuredAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzUtMS0xLTEtMzY0MDYw_ad9f71ff-edf5-4232-a988-5f8d131ff250">206</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CurrencyDerivativesMeasuredAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzUtMi0xLTEtMzY0MDYw_bd688798-8660-4b34-ab7a-6b4a951bba1d">284</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CurrencyDerivativesMeasuredAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzUtMy0xLTEtMzY0MDYw_461cdb6e-e7ab-4c21-a92d-30e8151443aa">58</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current financial assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:OtherCurrentFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzYtMS0xLTEtMzY0MDYw_c737f46f-86f5-407a-a12a-1c0d78e70df2">664</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:OtherCurrentFinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzYtMi0xLTEtMzY0MDYw_d25a2395-814f-44df-acc4-c5458ade7a20">1,054</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:OtherCurrentFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzYtMy0xLTEtMzY0MDYw_edfb4957-094b-4b2d-b55c-ebead607ed0b">900</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:OtherCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzctMS0xLTEtMzY0MDYw_7f945e72-e1ca-4dac-a4e1-9b6a1bb0aed5">3,532</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:OtherCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzctMi0xLTEtMzY0MDYw_ce2d4b93-e715-4249-b5e9-f99ead381cd3">3,571</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:OtherCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzctMy0xLTEtMzY0MDYw_f4abbf97-5248-4ce8-9769-4a7105e5e1d8">2,737</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line mainly comprises advance payments to suppliers, and receivables relating to Sanofi's activities as agent under a transitional services agreement.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) This item includes bank loans and receivables maturing in less than one year with high-grade counterparties. For 2021, this item also includes debt instruments derived from the acquisitions of Translate Bio and Kadmon (carried out in 2021) with maturities of more than 3&#160;months at inception and less than 12&#160;months at December&#160;31, 2021.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;padding-left:13.5pt;text-align:justify"><span><br/></span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_625"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.12. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90ZXh0cmVnaW9uOmNmNzI1N2QyMmRhZjQ4YjRiODM3YjNiN2I3ZDI3ZGZjXzg2MQ_0add67a5-34ab-419e-82d3-d238434755a8" continuedAt="i5963d20c10224f2183a5c914ab1c89d3" escape="true">Financial assets and liabilities measured at fair value</ix:nonNumeric></span></div><ix:continuation id="i5963d20c10224f2183a5c914ab1c89d3" continuedAt="i6c4499fd0e734669841f4b708e953e54"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under IFRS&#160;7 (Financial Instruments: Disclosures), fair value measurements must be classified using a fair value hierarchy with the following levels:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">level&#160;2: quoted prices in active markets for similar assets and liabilities, or valuation techniques in which all important inputs are derived from observable market data;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">level&#160;3: valuation techniques in which not all important inputs are derived from observable market data.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The valuation techniques used are described in Note&#160;B.8.5.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-49</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i6c4499fd0e734669841f4b708e953e54"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90ZXh0cmVnaW9uOmNmNzI1N2QyMmRhZjQ4YjRiODM3YjNiN2I3ZDI3ZGZjXzg2Mg_332610bd-9614-4021-89c5-fe9d68d9b7f3" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the balance sheet amounts of assets and liabilities measured at fair value.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:32.131%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in the fair value</span></div><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">hierarchy</span></div></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in the fair value<br/>hierarchy</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in the fair value<br/>hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial assets measured at fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Quoted equity investments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.1.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5a92ec01ab6f4056bb7dd2fe7b28bbd6_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtMi0xLTEtMzY0MDYw_13c28d8e-aed8-4de5-8fd2-4339277250fb">387</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4d71f901edbb4fc9b19eac52b6dd1c63_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtMy0xLTEtMzY0MDYw_34f1c016-97d1-422b-b9bc-0a5129dc77c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i64bff274bc764511ad68b85e40be4102_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtNC0xLTEtMzY0MDYw_82857db4-0476-4314-b70f-300138763818">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bdbc198b14747a6b443e5f51b4c57c5_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtNS0xLTEtMzY0MDYw_d13c85ec-0c80-4c04-891a-8f854a6a82c7">396</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9f35300ff6594e66a950dbb07f57d751_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtNi0xLTEtMzY0MDYw_84a29bf8-17dd-4da2-be4b-0e6a75aab197">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i68712353db49491990d250cab1dc2b7c_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtNy0xLTEtMzY0MDYw_b2ac1392-6ffb-44f0-b142-bb2ed50b7314">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9902da71fc7c466694af634d0376287c_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtOC0xLTEtMzY0MDYw_ae50b8df-d197-4d77-b441-89c29596b205">439</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie6a2320406ec4131b78807bdb61adf57_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtOS0xLTEtMzY0MDYw_c214b67f-f27a-43a7-a0b1-de3c601878d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i868a0e34292946128d179703085f0318_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtMTAtMS0xLTM2NDA2MA_f43a6c51-e9ae-465e-9b7f-644673cfa92e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unquoted equity investments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.1.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if227ca69b6764bd5aa2743a5eec6c517_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtMi0xLTEtMzY0MDYw_6af5b48a-3e85-4148-b0fe-cedeedd086a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id3e0e6f2fc174daaa294b5fd344eaae5_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtMy0xLTEtMzY0MDYw_6f80feb3-838a-4f66-bc96-92744d19bfac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie1c712a9f5e240d0a223b5fc4d7f3821_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtNC0xLTEtMzY0MDYw_ab2c3b7d-933b-4e8a-9909-827af535b0eb">549</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie034a80e75204f5a86d6d8868b8ca40b_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtNS0xLTEtMzY0MDYw_d042b241-faae-4219-a2e4-ba15ae1165d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57c74edeb8724bff9b4a8ade725f2f63_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtNi0xLTEtMzY0MDYw_edafbd26-9ba8-4ca7-995f-faae13ee408f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57c1816e408f4146980929ba115caa65_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtNy0xLTEtMzY0MDYw_7f23c20c-bb18-4180-a6ae-f794d096e723">427</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id78484142d96470daaa4465a88fd1465_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtOC0xLTEtMzY0MDYw_6efc2a4f-8361-42c6-9964-b9234cd4ee2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idaf554ea45834ed891abe8817a179274_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtOS0xLTEtMzY0MDYw_5eed6e60-8d09-49f1-bb50-861a41f6f5f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic934f45d8eef45ffb86db0dbaebcbbb6_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtMTAtMS0xLTM2NDA2MA_c77f4e76-fac7-4466-afcd-728d99970248">149</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Quoted debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.2.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0e83c9ceee8d4973a9fd9afd3eb6f554_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtMi0xLTEtMzY0MDYw_a2a113b3-b34e-4cb0-bc2c-1f1a19c6fb00">329</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i98d98d655e2840c6a7097e85707ab978_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtMy0xLTEtMzY0MDYw_ec9fb390-0d03-4da2-bac4-ee1a702905ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0725e56c610b4ef8a9c778e1f873a5f5_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtNC0xLTEtMzY0MDYw_02ce0d06-f08b-4e0c-ab0b-cdaf6e3e4d2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b13fd34daea45cb93c23eb68b1d9997_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtNS0xLTEtMzY0MDYw_5a4d6808-74d3-429f-813f-dabf87eb8ec2">447</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i440fc3ad28704a76ac9e4456da1c6091_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtNi0xLTEtMzY0MDYw_acd21c49-dfac-4ad3-b6a6-b51a0b2de1d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifddadc6b0fd44b5e968e11dd8e284db1_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtNy0xLTEtMzY0MDYw_d0c0dc40-f6a5-4da2-95d5-5255815ddc54">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i506eefd0acc64aa98a0ea2812e1edab1_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtOC0xLTEtMzY0MDYw_67fd7eb9-7417-46e7-a5b3-a3ca000fe998">426</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iba6ab0a538b548faafe7034677544b54_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtOS0xLTEtMzY0MDYw_a62d7e92-4649-429a-9249-35ccd27d4c83">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibbdcbc2963214d8c9842c9ab0a7d99f6_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtMTAtMS0xLTM2NDA2MA_e1e7a699-01da-4438-9a9c-94cc347373b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unquoted debt securities not meeting the definition of equity instruments</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.3.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if091001a8a224ba884e81e875ef8f51a_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctMi0xLTEtMzY0MDYw_696f6d4f-eb63-4477-8182-795a4b8e1c9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i29c615a591b8421183c5124409777d8c_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctMy0xLTEtMzY0MDYw_eada40a0-6f72-44a6-a7d7-7f6b94b5e65c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic16171d1dc9b4826902326dab2989ff4_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctNC0xLTEtMzY0MDYw_6420c57d-bdb2-475a-b841-eb0704015f09">115</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idedbd6af27cc45138105bd954312850d_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctNS0xLTEtMzY0MDYw_f2ba9270-7fef-4efe-ba47-339051eef48c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i66f1507ff6024854ab28cb15b8139bb7_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctNi0xLTEtMzY0MDYw_05ced425-921f-4a6b-93fe-763dec741390">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibae8f42e29e44a80a767329003e96b3c_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctNy0xLTEtMzY0MDYw_cad75de7-0bc0-4c01-83ba-4c45f06a9b25">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib4e1f6dffa3f4033a907e381fe585927_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctOC0xLTEtMzY0MDYw_d3593af8-d476-428f-ae3d-02bc985bc6cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icce038f9032149768e955222f2aca120_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctOS0xLTEtMzY0MDYw_630f7f18-d977-406d-bb82-581aa97331c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib63df7edcf044cccad9f0d666c02d417_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctMTAtMS0xLTM2NDA2MA_143f6404-f970-46b0-a7b0-94f05fb49e4a">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration relating to divestments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.3.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6edb24c7b7614f5e8426e248ad8c0012_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtMi0xLTEtMzY0MDYw_ceba465e-1718-40c4-8493-75bd644edbe7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie9e0f64911dd4a9591b9bc586892e8ba_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtMy0xLTEtMzY0MDYw_a6773677-b94d-4cd1-9768-9dc2a6d77545">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia33a4f9a84e44e238ebd55018effc821_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtNC0xLTEtMzY0MDYw_7dc1e6cb-b849-40f0-947f-5974acbe161c">303</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93162a8ef8d44ceca6e6bc7a60a8fc3d_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtNS0xLTEtMzY0MDYw_727cc77a-c5bc-4d84-87ba-29682e3d9ba5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6ee383251d8a4a5db431280d0829da5b_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtNi0xLTEtMzY0MDYw_5b36ec2b-8860-484a-9b57-c1bfe191f5d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i251a1285ee9d49388641e59f23f6241c_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtNy0xLTEtMzY0MDYw_fdd9fa33-1dd8-4d94-9155-f471354cdeed">378</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idbeac9cc516e4ecaa016f7b5a9919939_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtOC0xLTEtMzY0MDYw_8ed6e1ad-4ff6-497a-81f2-979660c94728">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i812479914b214ae5b372315aab8728a9_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtOS0xLTEtMzY0MDYw_5d402828-3e66-4705-9909-0e3ab9ceae31">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if21f555fdb8141dc8dcdbc4a99f03044_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtMTAtMS0xLTM2NDA2MA_6dd6f286-1b39-4d6d-b795-7cca7d365ff9">483</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial assets held to meet obligations under deferred compensation plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.3.  and D.11.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9a5c31a587e4a009e48f3ae090ae3d4_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTItMS0xLTM2NDA2MA_08665703-0bed-4ad7-b920-5d17e673caef">512</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5b50aeecb014f088d04f8708033fed4_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTMtMS0xLTM2NDA2MA_50d95f50-7b87-48a7-9ff4-005b5bff1aa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i865d3e2ccf184a1fa3395fe6567538b9_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTQtMS0xLTM2NDA2MA_04bed21d-a4ec-4869-bc67-fe01189436fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia5e602ade1a84742b797ec53b6d74912_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTUtMS0xLTM2NDA2MA_0ed4e605-dc06-4d48-8e36-fcb500d7035f">549</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibde8b2ab03584ae4a5bca97d80502c95_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTYtMS0xLTM2NDA2MA_f1af5433-6f79-4c51-a922-5ff25d32ff94">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i226f7c29cfb84987a2a9deb701ed1907_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTctMS0xLTM2NDA2MA_d294464c-a354-46f1-bd39-5794d948a0ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i85306855f61b45f28134e4c906e484e2_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTgtMS0xLTM2NDA2MA_5cc88baf-21a7-4165-8a1e-2e6f9740b1b8">454</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6268251951114f5db755d35912bbb195_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTktMS0xLTM2NDA2MA_f2a9cc7e-4567-4036-9e0b-9cfd0d763adc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iefc2bf19aa14458e8c2c9dce268786a8_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTEwLTEtMS0zNjQwNjA_eccd2913-de86-4552-930e-44389ff9c9b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9510f1a95a7b43ac86ee6d4c0b128d24_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTItMS0xLTM2NDA2MA_f1808a89-0b88-4102-afd2-4c1f22b2159f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id2f822898ca84cb8a79415a6cdc45e3d_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTMtMS0xLTM2NDA2MA_12f07d63-8e63-4fd8-a887-895a98b5cf9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a0738d4f3a648699d252a97ba3e6ee4_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTQtMS0xLTM2NDA2MA_64c9b9b0-f1d2-40db-83f1-348fbb6e9917">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i158b44cdb3244768945b39667ddac6f8_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTUtMS0xLTM2NDA2MA_f10fb49e-8658-4fd5-a014-b6908f67f710">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia10bc441f3d34c13ac07f05030c62cf5_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTYtMS0xLTM2NDA2MA_3a657545-7be5-4808-93b3-07a68417224f">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic1d93a2e51b44726bd0f629ca403921b_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTctMS0xLTM2NDA2MA_602902fe-1b76-44f6-b4d7-c613853d0b70">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie8ac539935374b558f669ee77dac8db6_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTgtMS0xLTM2NDA2MA_2bf7e328-d7a7-4812-a520-7dfa592e23c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia936cebd16574ca3b1b0522bc2565698_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTktMS0xLTM2NDA2MA_782d6542-1883-4741-b7d8-47a76cdee126">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3ecabc225dcf456c8163959683eaac2f_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTEwLTEtMS0zNjQwNjA_fdb26c98-0c1f-4ed2-9290-9f974f7336c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.11.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaf455571305f4064b0c27c09d9e0779e_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTItMS0xLTM2NDA2MA_0a647aae-a11a-4cd5-a04c-78a3039fc253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i24ce970c3de542ecacf624dcc54c068f_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTMtMS0xLTM2NDA2MA_90790c44-9ed1-4aa1-83a3-722a419a9a15">206</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7a85f9f5746b442bad900c30146e6957_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTQtMS0xLTM2NDA2MA_9834a0a6-93ee-4691-ba84-9de15cb8d710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6f9513c503d647e5864a3f1b67b93937_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTUtMS0xLTM2NDA2MA_d9ceb6ce-9af2-470a-b653-74e62af3814a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6bf17373c5694449bcc60449faab13ad_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTYtMS0xLTM2NDA2MA_ee0bcd2c-966a-4cdc-a9a4-82563afdec61">295</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6ac92dbfb0dc490aa7026799fe831566_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTctMS0xLTM2NDA2MA_a8bdd122-7b7c-4a8e-bae4-0e6f6ec8d8ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i42bcfaacf8014b70b45f0bc2e3826df0_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTgtMS0xLTM2NDA2MA_ce1fbc73-e6f0-4ea9-8f49-df398994aa65">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic4363d5a964d4bf9a405bbc5ad84d075_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTktMS0xLTM2NDA2MA_d7202889-6ad0-4624-b368-3187f46b569f">58</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5f59a0aed26e461d8f59cef0d6162389_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTEwLTEtMS0zNjQwNjA_43566088-ae41-4afd-9cc5-4c07cd193fb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mutual fund investments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.13.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifa6146ee4dc34054b4f2c8dd934ce7b6_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTItMS0xLTM2NDA2MA_fc8e815c-928c-419c-bcf2-fa56dc8e4427">9,537</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib2a400aeea96455eac5efbbfaac85997_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTMtMS0xLTM2NDA2MA_9eff7090-a27f-4a18-8c05-fb0f705c3454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i414ace804d3948748fb5516ef6e3c93d_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTQtMS0xLTM2NDA2MA_4d98cba2-3c1b-4df7-9048-2c1333747ebd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3dd8126dfa704004be857e04a1d63621_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTUtMS0xLTM2NDA2MA_dede5724-0134-4ab0-a211-6bd8bfdf0500">5,057</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4bce6c62ac7e458790049ac23f730d7b_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTYtMS0xLTM2NDA2MA_40fccc97-af2e-4fc4-a5ba-478c8e9f75f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i55736011d7504217b288feccd10003c3_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTctMS0xLTM2NDA2MA_2c148deb-71ad-44b6-8e13-d9a1d61e8a4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1a742bafd34b4be09b40358da2f7f5c4_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTgtMS0xLTM2NDA2MA_3a30fbff-9bc2-4265-b249-c351e93c9808">8,703</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if0e53d257a5b4cfb9ef9a43db3e18a44_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTktMS0xLTM2NDA2MA_e3c3c2cc-b907-4e7e-b43e-3d30d00ef073">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie3df519902364806b6b4df1fa5fcaecd_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTEwLTEtMS0zNjQwNjA_23679208-dea0-44bd-b5ed-ba536411aba3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total financial assets measured at fair value</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib4cbd6b4a3914b4bb22bc2cb56989463_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTItMS0xLTM2NDA2MA_fd71d711-ec92-4914-9733-ca2108eb3d12">10,765</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i409a2ac80199410c9d2f13738b9c1fc5_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTMtMS0xLTM2NDA2MA_fcaf47de-4bc2-4bbf-82d9-0a37dd81d802">206</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i361a9c2e95a54cbb9685b3e4db0de703_I20221231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTQtMS0xLTM2NDA2MA_237e69a1-a462-4ba1-ac36-607fec210d9e">967</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic2b4a0233a76467f9da9303ec9617568_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTUtMS0xLTM2NDA2MA_7b90cc66-62a4-49c1-8a17-82a0db021235">6,449</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5a4ec58f212240f98494aef951fe0ab2_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTYtMS0xLTM2NDA2MA_4ecb19e1-a612-4be5-a5e0-5677fdd52b16">298</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c5b69a1242e4ce3bbd8d3803a17f77b_I20211231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTctMS0xLTM2NDA2MA_0d4e2b6a-88e9-4dea-9f3b-18183bdcdcf1">883</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id87ff9e380354502a2cc0a654bd50c36_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTgtMS0xLTM2NDA2MA_7f3f5017-89e6-47b4-bc24-fae3f6bdfcb2">10,022</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iba95b079275c4adc847b0cd47a476111_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTktMS0xLTM2NDA2MA_e3287ea4-efa6-4da2-b6b6-a99633390974">82</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic6f8c9f62f344106bee9e868531813a0_I20201231" decimals="-6" name="ifrs-full:FinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTEwLTEtMS0zNjQwNjA_83a39ff3-ecf2-4b31-ac4d-29f13c716336">695</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial liabilities measured at fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bayer contingent purchase consideration arising from the acquisition of Genzyme</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ice8470e3cc6242f0b1b1e15732ab662f_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTItMS0xLTM2NDA2MA_02a563ea-981f-40b1-90fb-7680db9bbece">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0814cdc2bc444fe0a82e40cb939eaf13_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTMtMS0xLTM2NDA2MA_771624fa-92af-41ce-a20d-517079bc57e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6ff19b8f7bc742c39dd5d0c627b6945b_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTQtMS0xLTM2NDA2MA_678b9fca-bc32-44fe-bcb7-5fea5e2362b1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i628eeffca97848fbbca2d84940ef2052_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTUtMS0xLTM2NDA2MA_b8975d1d-1c7d-4356-862a-6f1c040054f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i13bdffd21ca54bcdb0343b795ab7b63f_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTYtMS0xLTM2NDA2MA_d2c63e1e-39d1-452a-9f9b-0a0485cfe138">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iadd128658e52488aa52e2432c171e6ce_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTctMS0xLTM2NDA2MA_ccf0a1ba-8ade-4e1e-8a7b-1ceb98f3e01d">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16e7a672e44841db8d883f1ef6d50e41_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTgtMS0xLTM2NDA2MA_b0257415-381b-474c-8b8d-de1322114588">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb9560b7bb344d8783c8a3d70ed140a3_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTktMS0xLTM2NDA2MA_d7d99c5f-609a-4791-8d85-a6bef25b57b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2f86412d6fcd48e59fdae513888795c1_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTEwLTEtMS0zNjQwNjA_90b82aa5-8b88-407e-b7aa-d9ef3a051ed3">104</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MSD contingent consideration (European vaccines business)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e655abf2eff4f648351419b666b1cce_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTItMS0xLTM2NDA2MA_673bfc22-4258-494c-883f-54236f2befcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie70a21fbce684182b63354cd9500f730_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTMtMS0xLTM2NDA2MA_6270179b-022a-447b-8ffd-437c02f45940">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i777128a1566043dfaae4b53b65022410_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTQtMS0xLTM2NDA2MA_e00e7de9-5b92-47a2-a87a-82cb517da490">204</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id02c995274e4478396f61da8899c1b7a_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTUtMS0xLTM2NDA2MA_85773405-1600-47c6-afc6-51774cf8155b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibb908d2f93ff4a659991e90bcf70ab55_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTYtMS0xLTM2NDA2MA_5aacf577-f5f9-45b3-b5b4-7e1ab1fa28cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i14178e4bb8cb402f92a63d6707574a90_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTctMS0xLTM2NDA2MA_73944095-f6d9-475c-9569-94fb3680de22">269</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia4d269e6493342a1a5a259b8a23aeeaf_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTgtMS0xLTM2NDA2MA_72839751-e814-4af1-bd36-fc556a8761af">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7d4b6ce60161438c8fbc24e68b71336b_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTktMS0xLTM2NDA2MA_44d6e8c7-128b-4c20-bd4f-e421bf552d4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib3234a98630243148d78d87d71b9384a_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTEwLTEtMS0zNjQwNjA_18de8e0d-5394-4c64-b3a0-bae400220526">312</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shire contingent consideration arising from the acquisition of Translate Bio</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5223d477aaa341c6b4d55fe7ea7d4cea_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTItMS0xLTM2NDA2MA_fda5d318-4c8c-4bf9-8889-168bbc95b16b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i080f9c0694bf4d54922bdd4f999a0643_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTMtMS0xLTM2NDA2MA_9a25acc9-10ac-47ac-a9aa-b8d2e1b81a0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i48e7503106404209990dfdc490c457ce_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTQtMS0xLTM2NDA2MA_ef14dcad-1970-49a9-890a-a99dbed8f983">380</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i36ed13ff5ab544e187d2fa000ff3f53a_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTUtMS0xLTM2NDA2MA_37aa6942-fce2-4b0b-8a89-a642c9897319">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3edf6fd8a7cd4c6991b85fa8d8833a29_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTYtMS0xLTM2NDA2MA_83155df6-5d38-4bc8-91d4-8258943fa65d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i80b048bc5e924696bc290cf8e154d08d_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTctMS0xLTM2NDA2MA_11373976-e987-4928-8bae-36123486f648">354</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iadeed4d1a84740f08d7f77eb1d523def_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTgtMS0xLTM2NDA2MA_565efc8d-3e42-4a73-8025-76d0286bec49">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8e6725118f5948a789bfbbbf3550d8f1_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTktMS0xLTM2NDA2MA_9e595b5b-0f1c-43a9-b74b-0c9545152d24">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8f777088d46d4dcd985ba538a27bed29_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTEwLTEtMS0zNjQwNjA_d4e8346d-2cc2-4dd5-bf77-eb15411842ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration arising from acquisition of Amunix</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0baef8b28597402d8adf6cee9aa0d5d6_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTItMS0xLTM5OTU5Ng_9e409116-1471-42ab-aca8-4881e08fc820">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i58e1e7cad9164a70839fa03c11e4a3cb_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTMtMS0xLTM5OTU5Ng_b425e8e6-e1b8-477c-9978-45b504960e9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i66f8461c0f524353bb1ff3afc8b439e3_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTQtMS0xLTM5OTU5Ng_67e4247d-84c8-4635-89a6-70e97abd8ae8">165</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icd997e2d59284fdcbf55f9fc4a2d1a5b_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTUtMS0xLTM5OTU5Ng_1c518434-e33f-424e-bb92-1d67f65c29bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7ab76bd67b74ffc8af89529ba43e4b1_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTYtMS0xLTM5OTU5Ng_f9de913c-4792-4b08-9350-ed6e3c0eeb71">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic727bbbef1ae42deb05bb6a11214c40f_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTctMS0xLTM5OTU5Ng_4583ca49-1354-42c8-94c6-f3585e68e658">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3754841fd7614021b0d3d454afce5cb4_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTgtMS0xLTM5OTU5Ng_82445190-158c-459a-80e3-44a0485bdfb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife3e8160c2604592a96fe70b98af7419_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTktMS0xLTM5OTU5Ng_be5e6e8a-9f97-4b63-94d7-603d822dc37f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2c3722d2c71b40a5b0cd3fbdd62a14fb_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTEwLTEtMS0zOTk1OTY_2b2026c6-f946-41a7-b0cd-c47c43f91c1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other contingent consideration arising from business combinations and acquisitions</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4f77768527954a3ea0a87e7081b338cf_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTItMS0xLTM2NDA2MA_490bd8d3-dfac-4382-87c8-f091173b7896">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic866f02ab74b43c6bbab392d315c36e5_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTMtMS0xLTM2NDA2MA_60220498-f5d1-4a20-9022-b2f6a1d14027">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i980e5c837107458eb2f70d743a451e27_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTQtMS0xLTM2NDA2MA_b601a1a5-7355-46ac-8506-3cc50525ef83">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia48366d62ce64d6e94246e1a6b554bac_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTUtMS0xLTM2NDA2MA_57e54ffc-8418-4734-a72f-487b1ed5cf08">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2363afabce5c46a3b4c953bd0582795e_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTYtMS0xLTM2NDA2MA_02719ac8-2569-4bb7-99b7-1a911f564c03">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77d7a7bdcbff48a69181f857e54c25ee_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTctMS0xLTM2NDA2MA_20328a1b-4aff-41f8-bd09-e8c14e7ac6f5">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8ee0b2e050a04774bbcc876af9b05e2e_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTgtMS0xLTM2NDA2MA_b552154f-146a-4843-9e22-85ae12e5efaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7aebbb6cd5394ffa80a4acb7f23fbc26_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTktMS0xLTM2NDA2MA_ddf4b1e5-2906-4d68-929d-27f0769763ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9edaf00d040343fb95831f3cc2313b2e_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTEwLTEtMS0zNjQwNjA_6629c44d-30cf-44d2-a36e-f71aee69901e">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.19.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i41e7d57ea4de4fb2acde34fb25042f3c_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTItMS0xLTM2NDA2MA_54f930aa-8878-447e-a6bf-6d753d2ab4ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic054a9f7342d452997b69f83837ad01d_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTMtMS0xLTM2NDA2MA_cfad54e1-10f2-4a6b-9c9e-21a00ef0e312">232</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if6c1c44bc60f4d718bf8a08c96042e61_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTQtMS0xLTM2NDA2MA_0055d47f-f21e-4cfc-a0d3-faaf92bf4829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i391e0993fafa4e8194f1cee9bc292cb8_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTUtMS0xLTM2NDA2MA_eb1238ed-54a5-44e4-b194-b7806eea9704">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i98a96a99ad894d939a8ef2cf79d189ca_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTYtMS0xLTM2NDA2MA_4da75b66-d992-48d3-8b1b-e2ff5387e364">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a9ba46c71214fe8bdd739e06a5e2cea_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTctMS0xLTM2NDA2MA_3eb7f162-61cb-4e04-ad29-bf3376e8f2c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b2f10037fac4641824455bcae113474_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTgtMS0xLTM2NDA2MA_4eb950a9-4220-4e65-82a7-40903fbb44b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iea19c792195c46bd9032528e794b669f_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTktMS0xLTM2NDA2MA_cb132576-8ee1-4e9f-aef3-28216ba989e9">92</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4022972c8bde4a9ca3cb288456a68271_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTEwLTEtMS0zNjQwNjA_8b6d325f-ddc6-4ecc-aba5-c919df023713">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.19.5</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i42e844a6d4cb450f9d291a2abe40dd93_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTItMS0xLTM2NDA2MA_c62da4d8-5f62-4126-b5d1-4debeecc5932">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3ac22998c1824a71b163369ba9107fc3_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTMtMS0xLTM2NDA2MA_f50195f5-d1fb-4f16-9df9-e08892e031e2">94</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8e3b3ef271ab427b944675c91e586c90_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTQtMS0xLTM2NDA2MA_32a7013d-194e-4a8e-a4e0-cc414aac084c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i90897d7067434c91a8f8652d33ff01ba_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTUtMS0xLTM2NDA2MA_0947e2fa-f8b8-4701-b299-93329f6b4b47">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9a15ff2465a24f9d8f467e861eace688_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTYtMS0xLTM2NDA2MA_ea774bcc-15d9-43ea-986f-535fb166e062">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaff6099dca9e44fc83c5aa691e056e44_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTctMS0xLTM2NDA2MA_ca1544b8-ca69-4c4c-96e2-bb65d83c44b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i40563d22b6d240b1938338dc3cb44c4d_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTgtMS0xLTM2NDA2MA_304ec7d2-760a-4175-bfc7-ffb8ca4b6987">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1dae2c57e4564bc098cf95f1a6b088e2_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTktMS0xLTM2NDA2MA_cd6a6e2b-d611-4b25-8adc-8e33c8692280">205</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6370e3221d264c9283fc7256385a72e7_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTEwLTEtMS0zNjQwNjA_9fcb5d10-70d7-4206-876f-24e4594ab883">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total financial liabilities measured at fair value</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib4cbd6b4a3914b4bb22bc2cb56989463_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTItMS0xLTM2NDA2MA_55cd3956-9b71-4af8-96b2-50ac771d4135">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i409a2ac80199410c9d2f13738b9c1fc5_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTMtMS0xLTM2NDA2MA_3db5927b-8e15-4a16-bd2a-5cee394f3ed8">326</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i361a9c2e95a54cbb9685b3e4db0de703_I20221231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTQtMS0xLTM2NDA2MA_e7f1129a-7e5f-4332-b472-598fa8e60d74">779</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic2b4a0233a76467f9da9303ec9617568_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTUtMS0xLTM2NDA2MA_65927e9f-a56a-406a-bf10-febe04593acf">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5a4ec58f212240f98494aef951fe0ab2_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTYtMS0xLTM2NDA2MA_6e232a7a-f5f8-4a47-a215-2d2e4d7dbdbc">85</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c5b69a1242e4ce3bbd8d3803a17f77b_I20211231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTctMS0xLTM2NDA2MA_9bd30e49-fb1c-40b7-a510-be4e92fdf895">714</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id87ff9e380354502a2cc0a654bd50c36_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTgtMS0xLTM2NDA2MA_948b0d35-88d4-4bc7-9020-326a1f4bedd2">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iba95b079275c4adc847b0cd47a476111_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTktMS0xLTM2NDA2MA_f1d0f648-3d4b-49ad-962d-f2bbfc88286f">297</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic6f8c9f62f344106bee9e868531813a0_I20201231" decimals="-6" name="ifrs-full:FinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTEwLTEtMS0zNjQwNjA_8a6f59fb-1bc3-40dd-ba0c-3ff032e1ba67">605</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No transfers between the different levels of the fair value hierarchy occurred during 2022.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_628"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.13. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzQzMg_6450ea22-f6cc-4683-9619-1d8bba9c6e04" continuedAt="ibb6fd81d21ed4e368de266a72a5d21d8" escape="true">Cash and cash equivalents</ix:nonNumeric></span></div><ix:continuation id="ibb6fd81d21ed4e368de266a72a5d21d8"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzQzNA_2f0a4428-0812-4654-aba8-38f8a5757007" escape="true"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:Cash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzEtMS0xLTEtMzY0MDYw_ed6f60b5-5f80-4a73-acb1-94c6d2807d2d">1,385</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:Cash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzEtMi0xLTEtMzY0MDYw_b507b2ea-a30f-4c17-99d1-83b2b2bfbe82">1,358</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:Cash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzEtMy0xLTEtMzY0MDYw_2df42c2f-5e42-41c9-a700-2f9b2c4dad52">1,144</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash equivalents</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzItMS0xLTEtMzY0MDYw_12214515-2174-4bf7-b32a-73a9677e1c8b">11,351</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzItMi0xLTEtMzY0MDYw_3884d353-12c0-403a-aa77-abd3568cf897">8,740</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzItMy0xLTEtMzY0MDYw_9b12a380-4ee3-452f-a90b-dbec2c27b7ef">12,771</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzMtMS0xLTEtMzY0MDYw_b6121274-ac30-40e1-bedc-da10ff439c2c">12,736</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzMtMi0xLTEtMzY0MDYw_c31ee7f5-a5b4-4950-8974-3dcc33c33a90">10,098</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzMtMy0xLTEtMzY0MDYw_6d7a6bb6-a7c9-4a1d-8b57-e584b1ecaebc">13,915</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) As of December 31, 2022, cash equivalents mainly comprised the following: (i)&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CashEquivalentsMoneyMarketMutualFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzEwNg_9d95b272-12a9-49f2-867e-2c8c80c333eb">9,537</ix:nonFraction> million invested in euro and US dollar denominated money-market mutual funds (December 31, 2021: &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CashEquivalentsMoneyMarketMutualFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzE4Mw_bd960a59-83e3-4502-b059-d551c842fe48">5,057</ix:nonFraction> million; December 31, 2020: &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CashEquivalentsMoneyMarketMutualFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzE5MQ_e07a5376-e868-4d72-b360-cf93223c152b">8,703</ix:nonFraction> million); (ii)&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzIwMQ_280f896a-9ce3-4cac-9ccc-e858f8d40c8b">1,167</ix:nonFraction> million of term deposits (December 31, 2021: &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzIyNg_260bdbb3-1ed0-4e76-8051-6d6c13437ac6">2,768</ix:nonFraction> million; December 31, 2020: &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzIzNA_83f725fb-3cd9-43a6-b1a2-9f8d2d7463dc">3,259</ix:nonFraction> million) and (iii)&#160;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="INF" name="sny:CashEquivalentsCommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzYwNDczMTM5NTMyNDQ_19e4be7b-79c6-4fcc-a983-778291a43cba">nil</ix:nonFraction> commercial paper (December 31, 2021: &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CashEquivalentsCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzI3Ng_3eb6ee70-c0a4-4fc6-82ae-8c2d7b9eceb7">179</ix:nonFraction> million; December 31, 2020: &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CashEquivalentsCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzI4NA_a674be11-4bf0-4696-b903-9d9988e4f4e1">74</ix:nonFraction> million). Cash equivalents also include &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzMxOQ_ffa90ddd-57a9-4b7e-a67f-6f1f4e3435cd">439</ix:nonFraction> million held by captive insurance and reinsurance companies in accordance with insurance regulations (December 31, 2021: &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzQyMA_3fc2c75f-7132-4c45-81f4-7efa5beee278">427</ix:nonFraction> million; December 31, 2020: &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzQyOA_02a586cc-074c-4d22-a645-bbeacb9b5cb7">425</ix:nonFraction> million).</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-50</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_631"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.14. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfDeferredTaxesExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4NDc_f8e4076f-64c5-4cd3-aff1-702e028e36bc" continuedAt="i558b530785c94c2ea21e5548c2d9cc3d" escape="true">Net deferred tax position</ix:nonNumeric></span></div><ix:continuation id="i558b530785c94c2ea21e5548c2d9cc3d"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4NDQ_7a12724f-2892-4243-87e2-b7d4f68463ca" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of the net deferred tax position is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:54.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred taxes on:</span></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Consolidation adjustments (intragroup margin in inventory)</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5c52f444ed0f4bda84a42b7e930f8420_I20221231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzItMS0xLTEtMzY0MDYw_17f83391-885c-41fd-a5ed-8f445054a296">1,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id11eb7058089436a9aff2a514b26afe8_I20211231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzItMy0xLTEtMzY0MDYw_858305f7-aa9f-446f-bf36-18f4a7976b22">1,292</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i56a5626912de40e39e4a075cd3ebc7bc_I20201231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzItNS0xLTEtMzY0MDYw_6497fd40-38be-4b55-b6cb-a29b439dcae0">1,142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision for pensions and other employee benefits</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iadbc77437f194c4b9714d27bea45d27d_I20221231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzMtMS0xLTEtMzY0MDYw_b62eba11-e83f-4a5f-87d7-546c65d53a82">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7fed9cb1446a49ffa3cc1ec60473ea51_I20211231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzMtMy0xLTEtMzY0MDYw_0855df8d-2784-4ee8-a8ca-8c46a2247f61">1,117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6c1f1c7a87a147aea05b154acab7ecac_I20201231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzMtNS0xLTEtMzY0MDYw_dbd086a2-582c-442e-836b-68caa45f9374">1,156</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of other acquired intangible assets</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if2d0541f761144ae8559c1ccc9e1c928_I20221231" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzQtMS0xLTEtMzY0MDYw_17cfc751-f9a3-475d-83df-489a7723529c">3,269</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if0b71582500946dba2dcb41e5a262822_I20211231" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzQtMy0xLTEtMzY0MDYw_ca06f600-e95c-48ec-b468-acbe49cf8421">3,079</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifad5fc92533e41a7aeaa856fcb32b3ee_I20201231" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzQtNS0xLTEtMzY0MDYw_7fb2074f-aea6-45df-b04b-c9e0925f1bd1">3,083</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognition of acquired property, plant and equipment at fair value</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i812946d6d99c488b913e652bf22c35e2_I20221231" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzUtMS0xLTEtMzY0MDYw_a52875bc-1d29-4536-8739-e5802ab59b62">24</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i592524c5425b4fd687989aa3fa4c2fc6_I20211231" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzUtMy0xLTEtMzY0MDYw_b5360592-2383-4de6-933b-d9734873eaab">26</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia6ac37e52785466095dc8e783f91f5bf_I20201231" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzUtNS0xLTEtMzY0MDYw_10d778a1-25c6-4149-926e-2499c36597b8">27</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity interests in subsidiaries and investments in other entities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6e2dcbba0a064e75ab731959eaa3eb3c_I20221231" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzYtMS0xLTEtMzY0MDYw_20bcfd1d-5310-4579-a244-af6318643f0b">617</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib906ba086bbe4f30abe707134e42e386_I20211231" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzYtMy0xLTEtMzY0MDYw_655f1815-17fe-44f9-9389-166e4d36c70f">590</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie5535831de3647578a867ea9e090f1b9_I20201231" decimals="-6" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzYtNS0xLTEtMzY0MDYw_4f764654-a961-43ca-a71d-474faf22dff9">522</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax losses available for carry-forward</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2cfc74b847364b73b4c2966e30b347c9_I20221231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzctMS0xLTEtMzY0MDYw_ca77588d-1836-4682-a6f4-76720d355212">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if0499e2936c14c57a7abc3de327bb2ba_I20211231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzctMy0xLTEtMzY0MDYw_1ddb940d-c3e8-4e28-918c-f41769fe94d9">1,516</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i079e44824551470ebf2ecdbe82c78c53_I20201231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzctNS0xLTEtMzY0MDYw_913e193a-4396-45c7-8b35-ee37fcc94990">1,327</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock options and other share-based payments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7470aa0bd046445ba5d903e0903f429a_I20221231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzgtMS0xLTEtMzY0MDYw_7b9c479f-d5f8-4a87-a650-1ef31fe30836">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9fdcded8d294930941d9b9619419474_I20211231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzgtMy0xLTEtMzY0MDYw_17fc2c2e-696f-4c9e-88fe-a731ee9bed53">88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaa8eaa248f964dcc9b6c43fc5fe3997b_I20201231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzgtNS0xLTEtMzY0MDYw_2678f55d-8890-42dd-9dba-dac453302eea">89</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued expenses and provisions deductible at the time of payment</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idabd22ffeca842938dbb461d8aeb992f_I20221231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzktMS0xLTEtMzY0MDYw_61004333-7f13-4d74-b28e-69db17402810">1,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20ddd88784fd4401811a5d58a1e0998c_I20211231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzktMy0xLTEtMzY0MDYw_87cebf53-2bb6-40aa-b626-fd4dc006db52">1,585</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9380121dcb2b4c5f96096a046caefe54_I20201231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzktNS0xLTEtMzY0MDYw_248d8165-b9db-47cd-94b9-91597c949213">1,399</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i066e7decba3b4361be385e2553f7c453_I20221231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzEwLTEtMS0xLTM2NDA2MA_7886fb94-811c-407e-ba0c-39d5454c603c">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if38e6ef7aed243b8ac91bf5307d108ff_I20211231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzEwLTMtMS0xLTM2NDA2MA_9fad063e-8eac-459a-abd3-b0b6b66ac59a">1,078</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iec4651d9b55449be9cc5bd98617ca794_I20201231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzEwLTUtMS0xLTM2NDA2MA_f6e96ba8-e1e1-46ea-8e02-63af56fb079c">925</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred tax asset/(liability)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzExLTEtMS0xLTM2NDA2MA_3bfff951-f3cf-4148-945d-8cb37ffad1d9">3,540</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzExLTMtMS0xLTM2NDA2MA_74e92651-66b2-46a2-882a-2b9d24ae5ab4">2,981</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzExLTUtMS0xLTM2NDA2MA_5e4a568b-0337-46b1-8fe6-988f72dceda2">2,406</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) As of December&#160;31, 2022, includes remeasurements of the acquired intangible assets of Bioverativ (&#8364;<ix:nonFraction unitRef="eur" contextRef="i443cce1a00af49c5b31e138daebd4921_I20221231" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIwNg_0c9946cf-68b0-42a6-887e-5c09c6d859b0">1,429</ix:nonFraction> million), Principia (&#8364;<ix:nonFraction unitRef="eur" contextRef="i4b62979a6fe9440786e1d336c8029542_I20221231" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIyMw_07633816-9ef8-4a51-982e-f5c6e55a3d83">625</ix:nonFraction> million), Ablynx (&#8364;<ix:nonFraction unitRef="eur" contextRef="i410ae0b344fc43a3ab2cf3899b851c5e_I20221231" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE3MDQyNDMwMjMzNTQz_943a420e-bd6e-4a35-b4c0-944fe0cb6583">229</ix:nonFraction> million), Genzyme (&#8364;<ix:nonFraction unitRef="eur" contextRef="ia53cda7c749e46b1af9080f7e52833cf_I20221231" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI0NQ_5d197259-e2d9-4312-9099-63c7699b4d21">150</ix:nonFraction> million) and Amunix (&#8364;<ix:nonFraction unitRef="eur" contextRef="id4d4bab9b0aa4d6a9547cfc9fb7b0e8d_I20221231" decimals="-6" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE3MDQyNDMwMjMzNjE2_cd42b59b-e073-45c1-b11b-39a592e144f7">118</ix:nonFraction> million).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In some countries, Sanofi is liable for withholding taxes and other tax charges when dividends are distributed. Consequently, Sanofi recognizes a deferred tax liability on the reserves of French and foreign subsidiaries (approximately &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-8" name="sny:ReservesLikelyToBeDistributedInTheForeseeableFuture" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzUxOA_24d4b7e3-0b10-4c04-9749-acddc700a9d5">59.1</ix:nonFraction> billion) which it regards as likely to be distributed in the foreseeable future. In determining the amount of the deferred tax liability as of December 31, 2022, Sanofi took into account changes in the ownership structure of certain subsidiaries, and the effects of changes in the taxation of dividends in France, following the ruling of the Court of Justice of the European Union in the Steria case and the resulting amendments to the 2015 Finance Act.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Includes deferred tax assets related to restructuring provisions, amounting to &#8364;<ix:nonFraction unitRef="eur" contextRef="i7a265fee43744c58b5ca31c83714d579_I20221231" decimals="-6" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEwMzU_127d7b1e-51a9-414a-9fd3-2afd7e28125a">256</ix:nonFraction> million as of December 31, 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i8f17ae20601144ea9e0f23d12022ca1a_I20211231" decimals="-6" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEwNDg_c3c81a8a-d8f2-445c-a680-e41448d5dacd">307</ix:nonFraction> million as of December 31, 2021, and &#8364;<ix:nonFraction unitRef="eur" contextRef="ib9ca24cbf2ff42778b6960dcc8505438_I20201231" decimals="-6" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEwNjU_568119a2-20db-47e4-ac78-ceeb28273292">259</ix:nonFraction> million as of December 31, 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The reserves of Sanofi subsidiaries that would be taxable if distributed but for which no distribution is planned, and for which no deferred tax liability has therefore been recognized, totaled &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-8" name="ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEyODA_4fc8d0bc-665c-4250-b7bb-8952a036db14">10.6</ix:nonFraction> billion as of December 31, 2022, compared with &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-8" name="ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEzMDc_d9ffab0e-f193-4670-b080-ec40959bd58f">10.0</ix:nonFraction> billion as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-8" name="ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEzMjM_ab6d086d-4352-4a60-a985-0bfa42a53c8d">11.5</ix:nonFraction> billion as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Most of Sanofi&#8217;s tax loss carry-forwards are available indefinitely. For a description of policies on the recognition of deferred tax assets, refer to Note&#160;B.22. For each tax consolidation, the recognition of deferred tax assets is determined on the basis of profit forecasts that are consistent with Sanofi&#8217;s medium-term strategic plan, and taking into consideration the tax consequences of the strategic opportunities available to Sanofi within the period of availability of tax loss carry-forwards and the specific circumstances of each tax consolidation. Deferred tax assets relating to tax loss carry-forwards as of December 31, 2022 amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:TotalDeferredTaxAssetsForTaxLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE5NzI_a7f60a73-6640-47e4-af45-ae6a522a1e9a">2,650</ix:nonFraction> million, of which &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE5ODU_75793b59-1af5-4e88-9155-205ef7c0f997">1,144</ix:nonFraction> million were not recognized (including &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE3MDQyNDMwMjMzNDc2_e7667e04-dac9-4663-aac9-8d4bf35b8050">488</ix:nonFraction>&#160;million in respect of capital losses). This compares with &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:TotalDeferredTaxAssetsForTaxLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIwNzI_bf45bb8f-3d28-4817-b14a-ad9b494e2c85">2,391</ix:nonFraction> million as of December 31, 2021 (of which&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIwOTQ_4f4dc85d-2de6-41fe-a174-96733e715ea1">875</ix:nonFraction> million were not recognized) and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:TotalDeferredTaxAssetsForTaxLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIxMjI_845d574f-39f0-45f3-8836-30d4731215a8">1,658</ix:nonFraction> million as of&#160;December 31, 2020 (of which &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIxNDQ_b30b8b5e-2769-425b-91ab-c51926b280af">331</ix:nonFraction> million were not recognized).</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4NDY_aec5ac0d-41e9-4da9-812f-2a2357f47b02" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows when tax losses available for carry-forward are due to expire:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:70.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Tax&#160;losses&#160;available for carry-forward</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife7c44a9a1e84cb7b6b4f6fe06b1ebab_D20220101-20221231" decimals="-6" name="sny:TaxLossesCarryforwards" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzEtMS0xLTEtMzY0MDYw_59d9c0b6-0e4c-45ea-aeae-2632bce2f2c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8ea79a68514c4efeb70ef0c35a2baf70_D20220101-20221231" decimals="-6" name="sny:TaxLossesCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzItMS0xLTEtMzY0MDYw_fef837b6-54c0-439f-9c6e-83480a80f4ee">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1f94df52faeb4018aac422ffccd0adf5_D20220101-20221231" decimals="-6" name="sny:TaxLossesCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzMtMS0xLTEtMzY0MDYw_462bdcb9-1904-4880-90e0-d24f004325be">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5e29bbd050a542b6994f56c5f2fafee4_D20220101-20221231" decimals="-6" name="sny:TaxLossesCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzQtMS0xLTEtMzY0MDYw_69e0b2db-7dd7-4716-bff2-24b316cc0095">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i26c6820c3ece4e2aad2f35e051f8b181_D20220101-20221231" decimals="-6" name="sny:TaxLossesCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzUtMS0xLTEtMzY0MDYw_199a28d9-6782-4900-9650-8f21a03d3a94">102</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2028 and later</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id75833e7c0144f56ab9eac0ea4d607f3_D20220101-20221231" decimals="-6" name="sny:TaxLossesCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzYtMS0xLTEtMzY0MDYw_d9bbc3e2-6318-45aa-972f-e234595355d7">8,349</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total as of December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:TaxLossesCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzctMS0xLTEtMzY0MDYw_7432df65-1968-4e69-94b0-4d57165e4452">8,503</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total as of December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:TaxLossesCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzgtMS0xLTEtMzY0MDYw_b0d2a4a0-024c-4c73-b1d0-d406246f7a8f">7,644</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total as of December 31, 2020</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:TaxLossesCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzktMS0xLTEtMzY0MDYw_567c46c5-c1d5-40a3-a380-442c9bcd89d2">6,515</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Excluding tax loss carry-forwards on asset disposals. Such carry-forwards amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:TaxLossCarryforwardsOnAssetDisposals" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIzNDY_fd763d99-1f62-4700-aea5-2562098486fe">5</ix:nonFraction> million as of December 31, 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:TaxLossCarryforwardsOnAssetDisposals" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE3MDQyNDMwMjMzNDA2_d9cf247d-3d95-4a5f-8ec9-be28e8ee1f01">5</ix:nonFraction> million as of&#160;December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:TaxLossCarryforwardsOnAssetDisposals" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIzOTA_24cb6d64-ac86-478b-b81d-347ecd474004">6</ix:nonFraction> million as of December 31, 2020.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Use of tax loss carry-forwards is limited to the entity in which they arose. In jurisdictions where tax consolidations are in place, tax losses can be netted against taxable income generated by entities in the same tax consolidation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Deferred tax assets not recognized (primarily because their future recovery was not regarded as probable given the expected results of the entities in question) amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4MTE_064b8ebb-a097-44e7-9dae-714d71dffa89">995</ix:nonFraction> million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4MjE_2524f41a-c4de-44fc-9d7d-0c888ad86243">615</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4MzQ_917085b9-dd83-4ab2-a323-447cb0ad99d6">346</ix:nonFraction> million in 2020.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-51</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_634"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.15. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwOTM_ea7f81ba-646a-4deb-83bf-b81da135674b" continuedAt="i524601e1f46242f6b3457cb86c66ad3e" escape="true">Consolidated shareholders&#8217; equity</ix:nonNumeric></span></div><ix:continuation id="i524601e1f46242f6b3457cb86c66ad3e" continuedAt="i9bcb7321f5bb42fd9d4c7d44612bbc46"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.1. Share capital</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, the share capital w</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="0" name="ifrs-full:IssuedCapital" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3Xzk5_418b552a-dff2-4baf-81fc-da33daa5d8f8">2,521,671,464</ix:nonFraction>, consisting of <ix:nonFraction unitRef="shares" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzExNw_0a5322e3-ee4b-4bae-acae-421b0f0c2a67">1,260,835,732</ix:nonFraction>&#160;shar</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">es with a par value of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="INF" name="ifrs-full:ParValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE0Nw_76c00511-412f-453b-baf5-4033e9af717c">2</ix:nonFraction>. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwODg_e1374ea0-996b-4258-abe2-1449405980dd" continuedAt="ifae7681005414ca6882832de709f461d" escape="true">Treasury shares held by Sanofi are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;text-align:justify"><ix:continuation id="ifae7681005414ca6882832de709f461d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:49.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of&#160;shares </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(million)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%&#160;of&#160;share&#160;capital <br/>for the period</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-4" name="sny:NumberOfSharesHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzEtMS0xLTEtMzY0MDYw_e22c0451-c8e7-4cbe-ad9a-d4c1c9097891">8.20</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="5" name="sny:PercentageOfShareCapitalForThePeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzEtMi0xLTEtMzY0MDYw_63bd5c88-a85c-430a-ab21-af7c55cfbe43">0.650</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="2" style="border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-4" name="sny:NumberOfSharesHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzItMS0xLTEtMzY0MDYw_f8448724-3d86-4241-8891-090081e10ecb">11.02</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="5" name="sny:PercentageOfShareCapitalForThePeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzItMi0xLTEtMzY0MDYw_92aabe91-8e1a-4e66-aa4b-df6c33f43aa7">0.872</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-4" name="sny:NumberOfSharesHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzMtMS0xLTEtMzY0MDYw_ba5b6836-3a42-4e18-b2a6-c405325e78d8">8.28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="5" name="sny:PercentageOfShareCapitalForThePeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzMtMi0xLTEtMzY0MDYw_0adc9624-a007-4fd2-a732-c7b5a86b364b">0.658</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231" decimals="-4" name="sny:NumberOfSharesHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzQtMS0xLTEtMzY0MDYw_aa1a26f0-c614-4fd6-af45-a11ecd28e30b">0.02</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231" decimals="5" name="sny:PercentageOfShareCapitalForThePeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzQtMi0xLTEtMzY0MDYw_710d55f9-e042-4189-8d93-1fb5c0322ca5">0.002</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Treasury shares are deducted from shareholders&#8217; equity. Gains and losses on disposals of treasury shares are recorded directly in equity and are not recognized in net income for the period.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMDA_45dbf072-9d87-49f2-8110-d597b78bcfcd" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in the share capital of the Sanofi parent company over the last three years are set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:33.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d88a2edb81648e6afc4f83c69c424a9_I20191231" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzEtMi0xLTEtMzY0MDYw_92b8355b-6649-474e-bdaa-366d4886272e">1,253,846,111</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital&#160;increase&#160;by&#160;exercise&#160;of stock subscription options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia39e689409964bfa8f99f19cbd6e41c3_D20200101-20201231" decimals="INF" name="sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzItMi0xLTEtMzY0MDYw_4681579c-bb96-49f8-b923-1cc83bf08a30">868,655</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by issuance of restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia39e689409964bfa8f99f19cbd6e41c3_D20200101-20201231" decimals="INF" name="sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzMtMi0xLTEtMzY0MDYw_49cffeb6-4c7e-4383-8121-9b2e4c856774">1,666,256</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of July 28, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase reserved for employees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia196461989f240c08680cf2183a306d3_D20200728-20200728" decimals="INF" name="sny:NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzQtMi0xLTEtMzk1NTAz_d4ea581e-9b45-488a-b50d-644aee5e443a">2,590,716</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36f49e4cf39f434fb5ea2349696ed58f_I20201231" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzQtMi0xLTEtMzY0MDYw_0ef230bb-60b9-4bcc-8bc4-afb8cf4bb99a">1,258,971,738</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by exercise of stock subscription options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib03aa1724e294ec09dd7edb58b1d4e63_D20210101-20211231" decimals="INF" name="sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzUtMi0xLTEtMzY0MDYw_b8d7cd16-bc66-4e11-aec8-8450412607d0">190,076</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by issuance of restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib03aa1724e294ec09dd7edb58b1d4e63_D20210101-20211231" decimals="INF" name="sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzYtMi0xLTEtMzY0MDYw_ce017cef-6072-4871-815a-35e18da63505">1,836,179</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of July 28, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase reserved for employees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7e77578600e4c639e9d27feb554081b_D20210728-20210728" decimals="INF" name="sny:NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzctMi0xLTEtMzY0MDYw_22deb393-2d6f-4485-a568-749ca6b961a6">2,562,702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e9f1e47319c48d5a2202f889bf79fd8_I20211231" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzgtMi0xLTEtMzY0MDYw_bd468d72-d3fb-4250-9653-79b1df0d8c59">1,263,560,695</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by exercise of stock subscription options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85f3af7ddeb746839ba726053d9da1d4_D20220101-20221231" decimals="INF" name="sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzktMi0xLTEtMzY0MDYw_272533e1-8646-45e2-8839-c301c0206613">490,373</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by issuance of restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85f3af7ddeb746839ba726053d9da1d4_D20220101-20221231" decimals="INF" name="sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzEwLTItMS0xLTM2NDA2MA_2a12cbb6-39a6-4b00-b18d-af41020c7114">1,499,987</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of July 27, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase reserved for employees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifcfbe4403ae14242851e1ae3cd6f979c_D20220727-20220727" decimals="INF" name="sny:NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzExLTItMS0xLTM2NDA2MA_bebe9edc-43e5-41ce-a9fc-c13aeaae9a03">2,027,057</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of December 14, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reduction in share capital by cancellation of <br/>treasury shares</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id1f20d3235444723a9c023e3b4339f8d_D20221214-20221214" decimals="INF" name="sny:ReductionOfSharesByCancellationOfTreasuryShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzEzLTItMS0xLTQ3Nzg1MA_80d5af3d-1484-4615-a936-ffbcd847ba5a">6,742,380</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #5064a9;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i515ddb2455da44eaa66b43d874f42983_I20221231" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzEyLTItMS0xLTM2NDA2MA_c940d8e3-1911-4a53-9266-2bf99d2a300f">1,260,835,732</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Shares issued on exercise of Sanofi stock subscription options.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Shares vesting under restricted share plans and issued in the period.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For the disclosures about the management of capital required under IFRS&#160;7, refer to Note&#160;B.27.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-52</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i9bcb7321f5bb42fd9d4c7d44612bbc46" continuedAt="i7def5d13cc274ee2badffd3dda037d0b"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.2. Restricted share plans</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwODU_33394fb6-6f55-4c8a-8f9a-f84f1a3985f4" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restricted share plans are accounted for in accordance with the policies described in Note&#160;B.24.3. The principal characteristics of those plans are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:38.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Type of plan</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Date of Board meeting approving the plan</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 3, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 14, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 27, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 28, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 28, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service period</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib0692613954647719cf5a55f8b2600b8_D20220101-20221231" name="sny:NumberOfYearsServicePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtMS0xLTEtMzY0MDYw_3ce541bd-6a5b-49be-a515-be85c66f2e79">3</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iafa20f1425b74849a9afed9c64bbbccc_D20220101-20221231" name="sny:NumberOfYearsServicePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtMi0xLTEtMzY0MDYw_3484c73c-22ca-471b-b0df-e1141d34eb2f">3</ix:nonNumeric> years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i93f5d73d4345431eb6e2b0feaf16ec74_D20210101-20211231" name="sny:NumberOfYearsServicePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtMy0xLTEtMzY0MDYw_6e79fc16-281d-4425-8771-f823a1e737e8">3</ix:nonNumeric> years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ice0df2b13649423eb9b2868f28d11017_D20210101-20211231" name="sny:NumberOfYearsServicePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtNC0xLTEtMzY0MDYw_8eefed22-3f53-4636-a520-32ade46be827">3</ix:nonNumeric> years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8c3bd86d2c1b44d7a257e61844c2fd3d_D20200101-20201231" name="sny:NumberOfYearsServicePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtNS0xLTEtMzY0MDYw_c7629477-a93b-4478-9b84-83cb2a556b4f">3</ix:nonNumeric> years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id12efe7d6a7346ab84d22f390dff95a3_D20200101-20201231" name="sny:NumberOfYearsServicePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtNi0xLTEtMzY4Mzk3_a92af788-0267-4402-ac92-bdcc293c64d5">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total number of shares awarded </span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0692613954647719cf5a55f8b2600b8_D20220101-20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtMS0xLTEtMzY0MDYw_a5f0d03d-d82d-4a47-8803-87adb401e593">3,344,432</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafa20f1425b74849a9afed9c64bbbccc_D20220101-20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtMi0xLTEtMzY0MDYw_4a7a427f-ed10-436b-847c-033eb32ef124">109,981</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93f5d73d4345431eb6e2b0feaf16ec74_D20210101-20211231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtMy0xLTEtMzY0MDYw_f72411fb-f040-4f8f-9293-56b45e0a4855">3,484,420</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice0df2b13649423eb9b2868f28d11017_D20210101-20211231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtNC0xLTEtMzY0MDYw_b832c117-a40e-4f3e-999e-de8ce3d0605b">13,521</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c3bd86d2c1b44d7a257e61844c2fd3d_D20200101-20201231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtNS0xLTEtMzY0MDYw_ba6bd90c-1934-42d3-85f2-3c0f6036e954">3,340,501</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id12efe7d6a7346ab84d22f390dff95a3_D20200101-20201231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtNi0xLTEtMzY4Mzk3_0a6755a7-685f-4c0a-8cba-8d132f25d866">73,027</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which with no market condition</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc7b7077ef674419ba3fb299aa9d4fd6_D20220101-20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtMS0xLTEtMzY0MDYw_d2661032-190d-4011-adda-86066055f3a2">2,000,627</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f883da95dd949dfb22ee5967a73f21a_D20220101-20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtMi0xLTEtMzY0MDYw_fcfb65b2-bbed-4dec-8479-f01e2e05877f">10,335</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4abe87f00861469a8648dc66935cc3a9_D20210101-20211231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtMy0xLTEtMzY0MDYw_0230508f-f233-4ca7-a475-741195efd7b8">2,209,901</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf17328999f949ebab31efd9a5ca0b93_D20210101-20211231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtNC0xLTEtMzY0MDYw_1d3c6eff-e7e3-4e01-a8c8-03529a71eb04">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91a183f0e6fb407f97a8c1b19774a395_D20200101-20201231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtNS0xLTEtMzY0MDYw_3043abe5-5487-48a6-9848-9966c95f9e83">2,536,893</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4923e9cc73c846eaa19bc82128326804_D20200101-20201231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtNi0xLTEtMzY4NDA0_016bb663-f58c-49e3-b4f8-3a653c45fbed">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="idc7b7077ef674419ba3fb299aa9d4fd6_D20220101-20221231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtMS0xLTEtMzY0MDYw_fb799b27-e987-40d5-9c15-c845d0c1f606">91.19</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i2f883da95dd949dfb22ee5967a73f21a_D20220101-20221231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtMi0xLTEtMzY0MDYw_8219bb3d-71c2-4d09-ba8e-52d52d443db5">79.17</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i4abe87f00861469a8648dc66935cc3a9_D20210101-20211231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtMy0xLTEtMzY0MDYw_9314b56f-835a-4c75-ad84-8d2ae981a886">77.27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="idf17328999f949ebab31efd9a5ca0b93_D20210101-20211231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtNC0xLTEtMzY0MDYw_53cffe01-334f-47cf-874e-713b1c790d8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i91a183f0e6fb407f97a8c1b19774a395_D20200101-20201231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtNS0xLTEtMzY0MDYw_815a9bf5-85b5-42e6-a413-923bd2105476">82.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i4923e9cc73c846eaa19bc82128326804_D20200101-20201231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtNi0xLTEtMzY4NDA0_54f74076-09ef-422c-986f-5e44ecac7b3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which with market condition</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5563efbc666d49d292f620bd6319cea2_D20220101-20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctMS0xLTEtMzY0MDYw_1beffd84-6c21-4538-b9bf-34438576ab4b">1,343,805</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iace7c690ea614bcaac762af51caa6166_D20220101-20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctMi0xLTEtMzY0MDYw_2c15af45-60e4-4865-af31-1641fb8bfafc">99,646</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2be6784fc06342efab44ff95725d2986_D20210101-20211231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctMy0xLTEtMzY0MDYw_3a8d6a65-f4cc-4b68-b76d-7e1e5ee31306">1,274,519</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96dc54b1575f45aa9360b1da2d463ea9_D20210101-20211231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctNC0xLTEtMzY0MDYw_4c6cd786-3c63-4be8-a124-07d88f98c8ae">13,521</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d45edc6cd6941ef9b03d7003f0afd1f_D20200101-20201231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctNS0xLTEtMzY0MDYw_209884da-6a14-43ca-9ab8-07aa51db1b86">803,608</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ad138fe89454c15a781c584d7c0212d_D20200101-20201231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctNi0xLTEtMzY4NDA0_9ad9828d-e451-41b2-be6b-2222866e471f">73,027</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded other than to the Chief Executive Officer</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i5563efbc666d49d292f620bd6319cea2_D20220101-20221231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtMS0xLTEtMzY0MDYw_63991653-b753-437d-a285-7963ad37d8fb">86.65</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="iace7c690ea614bcaac762af51caa6166_D20220101-20221231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtMi0xLTEtMzY0MDYw_74851841-1074-423f-930f-4c5a741965b0">69.60</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i2be6784fc06342efab44ff95725d2986_D20210101-20211231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtMy0xLTEtMzY0MDYw_7e1b6630-0b4e-4540-9af9-fb61fc6c05e5">71.30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i96dc54b1575f45aa9360b1da2d463ea9_D20210101-20211231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtNC0xLTEtMzY0MDYw_c87b1620-a8f4-4e15-a216-6f5f1316f52b">68.45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i0d45edc6cd6941ef9b03d7003f0afd1f_D20200101-20201231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtNS0xLTEtMzY0MDYw_c838eb44-5371-4966-88c1-bc596386c8f7">76.11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i5ad138fe89454c15a781c584d7c0212d_D20200101-20201231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtNi0xLTEtMzY4NDA0_ea90f322-85c9-4062-923e-823f5addbf6c">63.18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded other than to the Chief Executive Officer - additional shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i5563efbc666d49d292f620bd6319cea2_D20220101-20221231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMS0xLTEtMzY4NTc5_e5ea31d1-a533-4dcc-b34f-796b6f6188ef">49.00</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="iace7c690ea614bcaac762af51caa6166_D20220101-20221231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMi0xLTEtMzY4NjQy_9237a9ff-95a6-42c9-8052-0549d6b68e50">54.70</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i2be6784fc06342efab44ff95725d2986_D20210101-20211231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMy0xLTEtMzY4NTkz_c80e901a-7893-4cac-a4b0-7bf25f27ea38">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i96dc54b1575f45aa9360b1da2d463ea9_D20210101-20211231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNC0xLTEtMzY4NTkz_02808123-abee-40b0-9cd5-489dcfadbfa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i0d45edc6cd6941ef9b03d7003f0afd1f_D20200101-20201231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNS0xLTEtMzY4NTkz_212aa8cd-b12b-4d51-be12-38886890bb4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i5ad138fe89454c15a781c584d7c0212d_D20200101-20201231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNi0xLTEtMzY4NTkz_a7920edc-bfd5-417c-9ebb-d370047707b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded to the Chief Executive Officer</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i5563efbc666d49d292f620bd6319cea2_D20220101-20221231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTEtMS0xLTM2ODU3OQ_38d1d2dc-30c7-4253-b9ae-3747b70bcdba">84.46</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="iace7c690ea614bcaac762af51caa6166_D20220101-20221231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTItMS0xLTM2ODY0Mg_5f99d03e-c0f0-4d50-a76e-1f847513cc13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i2be6784fc06342efab44ff95725d2986_D20210101-20211231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTMtMS0xLTM2ODU5Mw_56f8dd48-faa3-4ada-8455-b97e73ece5f6">71.30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i96dc54b1575f45aa9360b1da2d463ea9_D20210101-20211231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTQtMS0xLTM2ODU5Mw_ede11c11-7ce6-4d01-a4c3-0455c891413a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i0d45edc6cd6941ef9b03d7003f0afd1f_D20200101-20201231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTUtMS0xLTM2ODU5Mw_bd828d76-5cb8-439d-9ff6-7f7174c38cfc">76.11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i5ad138fe89454c15a781c584d7c0212d_D20200101-20201231" decimals="2" name="sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTYtMS0xLTM2ODU5Mw_dae5dc3d-b561-408b-ad48-66655a556455">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value of plan at the date of grant (&#8364; million)</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib0692613954647719cf5a55f8b2600b8_D20220101-20221231" decimals="-6" name="sny:FairValueOfPlanAtDateOfGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMS0xLTEtMzY0MDYw_c522ae3c-04dd-41e0-b175-719c3e2a7f67">294</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iafa20f1425b74849a9afed9c64bbbccc_D20220101-20221231" decimals="-6" name="sny:FairValueOfPlanAtDateOfGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMi0xLTEtMzY0MDYw_4aede710-bac9-4da7-bda3-ef561c7cadac">8</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93f5d73d4345431eb6e2b0feaf16ec74_D20210101-20211231" decimals="-6" name="sny:FairValueOfPlanAtDateOfGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMy0xLTEtMzY0MDYw_2a5a8ca0-e4f3-4b94-9751-4736cf891ca3">262</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ice0df2b13649423eb9b2868f28d11017_D20210101-20211231" decimals="-6" name="sny:FairValueOfPlanAtDateOfGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNC0xLTEtMzY0MDYw_1d595479-02e3-4f7b-9d5e-a468d7c34412">1</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c3bd86d2c1b44d7a257e61844c2fd3d_D20200101-20201231" decimals="-6" name="sny:FairValueOfPlanAtDateOfGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNS0xLTEtMzY0MDYw_5efe19b5-3040-41b5-86ea-93d5567129cd">270</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id12efe7d6a7346ab84d22f390dff95a3_D20200101-20201231" decimals="-6" name="sny:FairValueOfPlanAtDateOfGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNi0xLTEtMzY4NDEx_61a71d58-2fcb-4a78-a494-7dc346665444">5</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Additional tranche subject to a higher level of market conditions: <ix:nonFraction unitRef="shares" contextRef="ia5cad4f0687a4cc08c2c4b21b29e7459_D20220501-20220531" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzU0OTc1NTgxNDQ1Mzg_310b9b29-ad97-4a65-a7fb-1312fe528b93">114,874</ix:nonFraction>&#160;additional shares were awarded in May&#160;2022, and <ix:nonFraction unitRef="shares" contextRef="i55ee43f980e74742950602d7ecd1c557_D20221201-20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzU0OTc1NTgxNDU1Njc_d76a2986-5003-487c-998b-a0f9f70aa653">9,066</ix:nonFraction>&#160;additional shares were awarded in December&#160;2022.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMDQ_dd476e77-ca8c-4726-9053-ed10c2084ae3" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The total expense recognized for all restricted share plans, and the number of restricted shares not yet fully vested, are shown in the table below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:58.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total expense for restricted share plans (&#8364; million)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie92c2dbc9c094b098879979d51afa004_D20220101-20221231" decimals="-6" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzEtMS0xLTEtMzY0MDYw_dfeb630a-e68d-48e8-9efd-39705ed1e14c">206</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1cdf739ed9644e06b67f23711ab2839d_D20210101-20211231" decimals="-6" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzEtMi0xLTEtMzY0MDYw_ae8b6cad-281f-441f-8a8a-27e1c9f7b217">193</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6484d0f5c354afc941fe76a527c5cbe_D20200101-20201231" decimals="-6" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzEtMy0xLTEtMzY0MDYw_1d75edfd-03b3-461d-aaca-8695f1da1fa6">222</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Number of shares not yet fully vested</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00edc5105e9f4951893c539899a4e361_I20221231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzItMS0xLTEtMzY0MDYw_c45b2a8f-f3ba-428f-b1ca-569cef0978f9">9,121,573</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8aef65cbc35b4a7bb1424c660441fa25_I20211231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzItMi0xLTEtMzY0MDYw_3db3c469-1bc8-4e1d-a931-0185dc199c08">9,507,849</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib550dc9e8fed49219de32ab81c00e68c_I20201231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzItMy0xLTEtMzY0MDYw_b821e39d-45b1-40ab-a3c2-10e7da22f834">10,546,612</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2022 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d14025c7c424adab3048e4636420277_I20221231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMS0xLTEtMzY5MDQ2_887a7947-d631-45f6-a679-5e3516f108f9">3,206,861</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2efdc68378814672ad2455c0e7526d09_I20211231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMi0xLTEtMzY5MDQ2_3e0413e1-5e2f-49eb-87ac-b912383e59a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if37df78c7cb74666ad31409c6077db06_I20201231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMy0xLTEtMzY5MDQ2_b3627bcf-ae66-4151-a630-155098428a17">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2021 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98e5eb6aef8d43febb13411a27d3bb45_I20221231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMS0xLTEtMzY0MDYw_90e29848-bf1f-49ac-85bd-9a04f0b2e2d9">3,097,531</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i005faca79d6b45eca0b9960a7a8cccf2_I20211231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMi0xLTEtMzY0MDYw_cc60340e-a6ae-4cd9-8f15-9617966b6de3">3,364,895</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4874a200b94b4652b806a566996b1830_I20201231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMy0xLTEtMzY0MDYw_a05d9903-75e3-4f1c-8da3-308ebb246e85">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2020 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia63ef8082fe642f691db7df32a40dac2_I20221231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzQtMS0xLTEtMzY0MDYw_06d6f5e1-e2ee-4037-9834-8c33f1b65717">2,817,181</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i19a68be4db394b5d8547b3806e810a60_I20211231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzQtMi0xLTEtMzY0MDYw_0f24ed48-8e10-46a8-aa9a-f3edcc71da7c">3,014,496</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e0a10794cf6434dac120f4b0fd4e858_I20201231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzQtMy0xLTEtMzY0MDYw_303aa621-afc6-4702-8353-1234c2bf3580">3,284,558</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2019 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i175a0715b16947179dca2850b07e59eb_I20221231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzUtMS0xLTEtMzY0MDYw_47d98ad3-767d-42f6-a7ac-d061242e4112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5952ef337321480da9d9eb91e066f493_I20211231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzUtMi0xLTEtMzY0MDYw_6fc92364-a934-41da-99fc-e43528d0fc6b">3,128,458</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9eebc27712f4a14983ed16a7f0cdc1e_I20201231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzUtMy0xLTEtMzY0MDYw_e8a9d85e-a335-4a66-bb21-0b4c5dbc305a">3,375,717</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2018 plans</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i200a7f91a38845258783cd5f4f247240_I20221231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzYtMS0xLTEtMzY0MDYw_adb98ca5-3327-4bd2-8461-bdd13b73c8d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icd3026e0c94449659a50317d98e7f973_I20211231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzYtMi0xLTEtMzY0MDYw_7416db85-8cfa-492a-a755-d5a3a22edb1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71429c4358e24efc9d002898f6394ae5_I20201231" decimals="INF" name="sny:NumberOfRestrictedSharesNotYetFullyVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzYtMy0xLTEtMzY0MDYw_9a8eb8b7-c7e8-45bd-9123-7eaf1ea9bd1a">3,886,337</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.3. Capital increases</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMTU_d21e47db-afcf-4dcf-81f5-4f7e5c7bad13" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The characteristics of the employee share ownership plans awarded in the form of a capital increase reserved for employees in&#160;2022, 2021 and 2020 are summarized in the table below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:58.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Date of Board meeting approving the plan</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 3, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 4, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 5, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Subscription price (&#8364;)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i7950c585f21f43c9b757252673571f29_I20220203" decimals="2" name="sny:SubscriptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzItMS0xLTEtMzY4MDc3_7370faea-b476-4676-ac1e-2b95ded608fe">80.21</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i79da5b5df5a44ed2819eb15a236aea21_I20210204" decimals="2" name="sny:SubscriptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzItMS0xLTEtMzY0MDYw_bdde49dc-1453-467f-b02e-6f2d3cba0ae9">69.38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i46fda90bd8224cb8aab66c2e4efa5317_I20200205" decimals="2" name="sny:SubscriptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzItMi0xLTEtMzY0MDYw_897e92f6-eb1d-4072-96b4-fd6b291c25d2">70.67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Subscription period</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 9-29, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 7-25, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 8-26, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Number of shares subscribed</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7950c585f21f43c9b757252673571f29_I20220203" decimals="INF" name="sny:NumberOfShareSubscribed" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzQtMS0xLTEtMzY4MDc3_972c6905-1994-4154-a4f9-05f31784c679">1,909,008</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79da5b5df5a44ed2819eb15a236aea21_I20210204" decimals="INF" name="sny:NumberOfShareSubscribed" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzQtMS0xLTEtMzY0MDYw_c2e95562-1719-44fc-893a-d053f4ee54eb">2,438,590</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46fda90bd8224cb8aab66c2e4efa5317_I20200205" decimals="INF" name="sny:NumberOfShareSubscribed" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzQtMi0xLTEtMzY0MDYw_65ffbc29-5921-43d9-8fac-53a0888f6b7f">2,467,101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Number of shares issued immediately as employer&#8217;s contribution</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7950c585f21f43c9b757252673571f29_I20220203" decimals="INF" name="sny:IssuanceOfFurtherSharesAsAnEmployersContribution" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzUtMS0xLTEtMzY4MDc3_53d37f2f-71c1-43a4-980f-117cc66ea690">118,049</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79da5b5df5a44ed2819eb15a236aea21_I20210204" decimals="INF" name="sny:IssuanceOfFurtherSharesAsAnEmployersContribution" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzUtMS0xLTEtMzY0MDYw_d9658c8e-4192-4dc5-9b49-cb82a34e1f96">124,112</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46fda90bd8224cb8aab66c2e4efa5317_I20200205" decimals="INF" name="sny:IssuanceOfFurtherSharesAsAnEmployersContribution" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzUtMi0xLTEtMzY0MDYw_eb60a898-45ed-4848-b1e5-9e68e5a8a41f">123,615</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Subscription price representing <ix:nonFraction unitRef="number" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="2" name="sny:PercentageOfAverageOfQuotedMarketPricesOfShares" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE2OTI_9a0cc83d-a4d9-4500-9884-5db9f13c6023"><ix:nonFraction unitRef="number" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="2" name="sny:PercentageOfAverageOfQuotedMarketPricesOfShares" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE2OTI_a466f3f2-51aa-4740-8ae6-f613ead44bdf"><ix:nonFraction unitRef="number" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="2" name="sny:PercentageOfAverageOfQuotedMarketPricesOfShares" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE2OTI_aa71aacb-6f9f-4207-a2c5-33f2d2ceb79c">80</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the average of the opening quoted market prices of Sanofi shares during the <ix:nonNumeric contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" name="sny:NumberOfTradingDaysPrecedingPlanApproval" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE3NzQ_8e2e2726-220a-4550-86e5-8c8c4139e70a"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:NumberOfTradingDaysPrecedingPlanApproval" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE3NzQ_8f06e9fc-e117-4467-acd4-886bc63928dd"><ix:nonNumeric contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" name="sny:NumberOfTradingDaysPrecedingPlanApproval" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE3NzQ_eea1a3e2-6e54-41df-9df2-3d85e0bca6c6">20</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric>&#160;trading days preceding June&#160;6,&#160;2022, June&#160;3,&#160;2021 and June&#160;2, 2020, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-53</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i7def5d13cc274ee2badffd3dda037d0b" continuedAt="ie6aed59686de4ec7b4a9ce10c5cc208b"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:AdditionalInformationAboutSharebasedPaymentArrangements" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwODc_ebcc1b93-2a7b-4cdc-b89f-b8f8e1fbe735" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth the expense recognized for each plan:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:58.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense recognized</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i66d14f14ca8849fa99dc8c0918792fb1_D20220101-20221231" decimals="-6" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzEtMS0xLTEtMzY4MzM3_7fc5b944-ea46-4664-921a-d24924e984b3">39</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic1516dd6e9d447e8a114d4530d0dc9ef_D20210101-20211231" decimals="-6" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzEtMS0xLTEtMzY0MDYw_0f3c1846-a8af-4cdd-8f74-7fdc0b8a0a59">51</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63eadec211ae4265a25589628b710de1_D20200101-20201231" decimals="-6" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzEtMi0xLTEtMzY0MDYw_2f6abcfe-4544-43b7-968a-1908c6cb2cb1">52</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which employer&#8217;s contribution</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i66d14f14ca8849fa99dc8c0918792fb1_D20220101-20221231" decimals="-6" name="sny:ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzItMS0xLTEtMzY4MzM3_552a7a2b-d2c3-454a-b25d-e9ab77751f33">11</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic1516dd6e9d447e8a114d4530d0dc9ef_D20210101-20211231" decimals="-6" name="sny:ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzItMS0xLTEtMzY0MDYw_85b9b7ed-4d5c-4bcd-a2e0-e066c2bc4bc6">11</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63eadec211ae4265a25589628b710de1_D20200101-20201231" decimals="-6" name="sny:ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzItMi0xLTEtMzY0MDYw_b0fd2f40-fcba-4980-bd65-d2e8518ddc4b">11</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.4. Repurchase of Sanofi shares</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Annual General Meetings of Sanofi shareholders held on May&#160;3, 2022, April&#160;30, 2021 and April&#160;28, 2020 each authorized a share repurchase program for a period of <ix:nonNumeric contextRef="i0bcc53d1b46b433eb833bb6a2091a218_D20210101-20211231" name="sny:PeriodOfShareRepurchaseProgram" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzIxMzA_007ad1ee-b5e3-46d8-8bf3-f2fa195ef6e4"><ix:nonNumeric contextRef="icceb8678190f4fc092c24a26a6eb8a8b_D20220101-20221231" name="sny:PeriodOfShareRepurchaseProgram" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzIxMzA_9ddadcd5-06af-4398-9afe-bd4fca3cdbd1"><ix:nonNumeric contextRef="ib996bb209f3341dea9daa277aacec9ee_D20200101-20201231" name="sny:PeriodOfShareRepurchaseProgram" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzIxMzA_a7958b90-a2b0-4624-9407-c1714d25601b">18</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> months. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMTE_c46cbf0f-9437-4c33-9be9-772c32db90b5" continuedAt="ic174aaba1a424a0ca1a55d4c32b3318e" escape="true">The following repurchases have been made under those programs:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;text-align:justify"><ix:continuation id="ic174aaba1a424a0ca1a55d4c32b3318e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.185%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:29.25pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(in number of shares and &#8364; million)</span></div><div style="padding-right:29.25pt;text-align:justify"><span><br/></span></div><div style="padding-right:29.25pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Year of authorization</span></div></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number <br/>of shares</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number <br/>of shares</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number <br/>of shares</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022 program</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iabf63d973d864585b86699f4855bc32b_D20220101-20221231" decimals="INF" name="sny:NumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzItMS0xLTEtMzY0MDYw_0e81900e-d2f6-404d-80a7-ef0924e276c6">1,510,000</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibcea4ad6a0f44a998a9b40d108e25d03_I20221231" decimals="-6" name="sny:AmountOfSharesRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzItMi0xLTEtMzY0MDYw_31bd78bd-5634-466d-94d1-c2ff72912aaf">137</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021 program</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i133ad2daf2c744769bc88969889d854c_D20220101-20221231" decimals="INF" name="sny:NumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzMtMS0xLTEtMzY0MDYw_3cc9dc4a-a1a4-4386-8ee4-31f5515855c0">3,976,992</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie98122f205404008bf0c4d6ef91f8cd9_I20221231" decimals="-6" name="sny:AmountOfSharesRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzMtMi0xLTEtMzY0MDYw_c445a0db-1c71-43e9-860a-87b0b4cb2939">360</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47de2d9d1a944092a8be630f2ab66718_D20210101-20211231" decimals="INF" name="sny:NumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzMtMy0xLTEtMzY0MDYw_c2610c6d-c5aa-41ad-b57c-7972c16340ae">2,765,388</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7de3c0be32cc48acacb91c4afe0b5475_I20211231" decimals="-6" name="sny:AmountOfSharesRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzMtNC0xLTEtMzY0MDYw_5a35545b-4a9c-45a9-b3d6-564e9f603468">242</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020 program</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id93a545773b04620ac8f01558b1daf08_D20210101-20211231" decimals="INF" name="sny:NumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzQtMy0xLTEtMzY0MDYw_a4966e08-a945-44e1-ab28-30fc2f50ad28">1,758,569</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic1b2461e749440a5bdbb736ccaf68050_I20211231" decimals="-6" name="sny:AmountOfSharesRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzQtNC0xLTEtMzY0MDYw_0caeba7d-c544-4248-a4eb-4d937cf59fb5">140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e27f23597f74a1c9ecae2a85d4ccc94_D20200101-20201231" decimals="INF" name="sny:NumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzQtNS0xLTEtMzY0MDYw_629f9129-fe40-46fa-8e54-747fba5d986a">5,685,426</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i880490f8dfd74492ab0ebb0a198871b8_I20201231" decimals="-6" name="sny:AmountOfSharesRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzQtNi0xLTEtMzY0MDYw_2f1e3d7e-ded3-4451-9869-bc41159c8860">461</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2019 program</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c119e3c395a473f9ea5f13d6ebdde04_D20200101-20201231" decimals="INF" name="sny:NumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzUtNS0xLTEtMzY0MDYw_2fe8c300-74ce-416c-baf4-73b8154810d5">3,982,939</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ieb20c7e9683948fcb26fb328baed1c91_I20201231" decimals="-6" name="sny:AmountOfSharesRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzUtNi0xLTEtMzY0MDYw_6aa9ed20-ee13-4fde-9c0a-80822d67b0f2">361</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.5. Reductions in share capital</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Reductions in share capital for the accounting periods presented are described in the table included at Note&#160;D.15.1. above.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Those reductions have no impact on shareholders&#8217; equity.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.6. Currency translation differences</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwOTY_f485523d-d7ae-4e68-ae47-4bca9e37236a" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Currency translation differences comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.901%"><tr><td style="width:1.0%"></td><td style="width:56.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.283%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.276%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Attributable to equity holders of Sanofi</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id2b3c17bccc5485fa012a841128e0541_I20221231" decimals="-6" name="ifrs-full:EquityAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzEtMS0xLTEtMzY0MDYw_07261486-cc30-4f35-8626-7bf33e28225e">1,499</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i343a67603f674e36a4e9acecfd848af6_I20211231" decimals="-6" sign="-" name="ifrs-full:EquityAttributableToOwnersOfParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzEtMi0xLTEtMzY0MDYw_e75cdad0-30f8-4340-a70d-9970990a6e2c">865</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7b49431edc8942d0a4afa8a40fe26c46_I20201231" decimals="-6" sign="-" name="ifrs-full:EquityAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzEtNC0xLTEtMzY0MDYw_29b6941c-f89e-4a4b-862d-d853ae402f05">3,384</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id2b3c17bccc5485fa012a841128e0541_I20221231" decimals="-6" sign="-" name="ifrs-full:NoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzItMS0xLTEtMzY0MDYw_8d19c363-1c67-4bfb-86a3-8039db4336d6">37</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i343a67603f674e36a4e9acecfd848af6_I20211231" decimals="-6" sign="-" name="ifrs-full:NoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzItMi0xLTEtMzY0MDYw_3f14a047-c356-4e81-9e02-9c2ebb65f56c">42</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7b49431edc8942d0a4afa8a40fe26c46_I20201231" decimals="-6" sign="-" name="ifrs-full:NoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzItNC0xLTEtMzY0MDYw_6e31f648-7a84-4794-be23-b3a35b648a38">55</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id2b3c17bccc5485fa012a841128e0541_I20221231" decimals="-6" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzMtMS0xLTEtMzY0MDYw_9ab3d3d7-5cfd-4fdc-afb4-ce4128a2c6a4">1,462</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i343a67603f674e36a4e9acecfd848af6_I20211231" decimals="-6" sign="-" name="ifrs-full:Equity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzMtMi0xLTEtMzY0MDYw_94af7ca9-7b27-4f89-ac5e-5b3fe6fa4e3a">907</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7b49431edc8942d0a4afa8a40fe26c46_I20201231" decimals="-6" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzMtNC0xLTEtMzY0MDYw_44dcb68d-32f8-45b2-89ef-17408af223df">3,439</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the financial statements for the year ended December&#160;31, 2021.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The balance as of December 31, 2022 includes an after-tax amount of &#8364;(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:HedgesOfNetInvestmentsInForeignOperationsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzI2NTk_68f48a22-dcf3-4d01-a51f-721d4294f1ee">580</ix:nonFraction>) million relating to hedges of net investments in&#160;foreign operations (refer to Note&#160;B.8.3. for a description of the relevant accounting policy), compared with &#8364;(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:HedgesOfNetInvestmentsInForeignOperationsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzI4MDY_b411a196-3749-48fb-b9f1-f507a42a31cb">317</ix:nonFraction>) million as of&#160;December 31, 2021 and&#160;&#8364;(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:HedgesOfNetInvestmentsInForeignOperationsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzI4MjM_7fbcf48b-1a26-4cd5-bda8-807d6e68080c">136</ix:nonFraction>) million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The movement in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Currency translation differences</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is mainly attributable to the US dollar.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-54</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ie6aed59686de4ec7b4a9ce10c5cc208b" continuedAt="i220e1b310d4c49a7bb98f026e311eb6b"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.7. Other comprehensive income</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwOTI_527f51c6-37c3-4acb-a1e8-3bb36ea128d0" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements within other comprehensive income are shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:61.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains/(losses):</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Actuarial gains/(losses) excluding investments accounted for using the equity method (see Note&#160;D.19.1.)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaf9aeb01b7384684be3ef0b4bc47fc8e_D20220101-20221231" decimals="-6" name="sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzMtMS0xLTEtMzY0MDYw_8cedfbad-783a-4912-8771-04f8d7af8dee">650</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i101060c5a55146ab94a8e716c499c73b_D20210101-20211231" decimals="-6" name="sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzMtMi0xLTEtMzY0MDYw_07c3319e-2983-4ef5-897d-986d36309d48">685</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5fbf93c7ecb84b3c99fe4d603cce5cca_D20200101-20201231" decimals="-6" sign="-" name="sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzMtNC0xLTEtMzY0MDYw_39db9822-34ea-41c9-a5b5-df8c03850dda">266</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaf9aeb01b7384684be3ef0b4bc47fc8e_D20220101-20221231" decimals="-6" name="sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzQtMS0xLTEtMzY0MDYw_6541319e-1f68-4b80-914f-be9eec30f5b7">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i101060c5a55146ab94a8e716c499c73b_D20210101-20211231" decimals="-6" name="sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzQtMi0xLTEtMzY0MDYw_b34a1a48-335c-430c-87e1-031f775829f4">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5fbf93c7ecb84b3c99fe4d603cce5cca_D20200101-20201231" decimals="-6" sign="-" name="sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzQtNC0xLTEtMzY0MDYw_e70ac79f-84c8-4c53-a2de-7a5bcd63fbe3">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iaf9aeb01b7384684be3ef0b4bc47fc8e_D20220101-20221231" decimals="-6" name="sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzUtMS0xLTEtMzY0MDYw_509c3275-f5fe-4490-958f-d116b2329976">212</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i101060c5a55146ab94a8e716c499c73b_D20210101-20211231" decimals="-6" name="sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzUtMi0xLTEtMzY0MDYw_ae1db31e-dfc1-4755-bd36-b0dd60c307c3">36</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fbf93c7ecb84b3c99fe4d603cce5cca_D20200101-20201231" decimals="-6" sign="-" name="sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzUtNC0xLTEtMzY0MDYw_a0f66aaf-1510-46cc-8994-b30caf5d3458">45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity instruments included in financial assets and financial liabilities:</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;padding-right:29.25pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (excluding investments accounted for using the equity method)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzctMS0xLTEtMzY0MDYw_739d992e-0906-4f85-b825-c1c87df37081">4</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231" decimals="-6" name="sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzctMi0xLTEtMzY0MDYw_09c9cbed-02c1-41e3-98f2-c846c961317f">154</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231" decimals="-6" name="sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzctNC0xLTEtMzY0MDYw_b1cd2988-a67e-49ef-9765-818418209a84">358</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (investments accounted for using the equity method, net of taxes)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231" decimals="-6" name="sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzgtMS0xLTEtMzY0MDYw_7ebd3ef1-d903-4062-9f13-3b7a563c5586">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231" decimals="-6" name="sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzgtMi0xLTEtMzY0MDYw_3953a8e6-c350-4648-820d-93c2d7225e46">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231" decimals="-6" sign="-" name="sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzgtNC0xLTEtMzY0MDYw_9c317d28-0869-48c9-b01f-c081ecaa91d0">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Equity risk hedging instruments designated as fair value hedges</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231" decimals="-6" name="sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzktMS0xLTEtMzY0MDYw_849d738a-05ff-4a6e-a935-1187fdf4c79c">17</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231" decimals="-6" name="sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzktMi0xLTEtMzY0MDYw_0e902d50-75a3-4e2b-8506-adc22bd8896c">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231" decimals="-6" sign="-" name="sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzktNC0xLTEtMzY0MDYw_2b867f47-f290-4d96-ba75-3c50fa228ee6">24</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231" decimals="-6" name="sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEwLTEtMS0xLTM2NDA2MA_8b391452-7f61-40ea-b282-9ba77cced18d">4</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231" decimals="-6" name="sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEwLTItMS0xLTM2NDA2MA_c70e40d1-e783-4acc-bbde-f017265b287c">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231" decimals="-6" name="sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEwLTQtMS0xLTM2NDA2MA_8835bbea-ac90-4625-9031-0559b425d71d">84</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not subsequently reclassifiable to profit or loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzExLTEtMS0xLTM2NDA2MA_e8224b6d-64e0-4dc3-966c-e277b362aad4">451</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzExLTItMS0xLTM2NDA2MA_e00fff7f-cf1f-4886-8fd9-42c14d427087">797</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzExLTQtMS0xLTM2NDA2MA_8eccda5e-44ae-4de8-a275-76492260088b">14</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt instruments included in financial assets:</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (excluding investments accounted for using the equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iaddc5f29d63d46fabf82586a2abfd3ce_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEzLTEtMS0xLTM2NDA2MA_e849a6cf-e7c1-419f-9cfa-eaac192e6a0e">77</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5642b66a094b41b78ecf737cf0fb29ee_D20210101-20211231" decimals="-6" sign="-" name="sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEzLTItMS0xLTM2NDA2MA_7dd71570-103e-417a-8b5a-f454182836c3">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7c7268343e3c4b149282aaac720d320c_D20200101-20201231" decimals="-6" name="sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEzLTQtMS0xLTM2NDA2MA_101471cf-cafd-4cbc-bf6b-21d42ef47f4f">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaddc5f29d63d46fabf82586a2abfd3ce_D20220101-20221231" decimals="-6" sign="-" name="sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE1LTEtMS0xLTM2NDA2MA_ef82f4e2-eb57-49df-af38-6c88cb11d609">15</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5642b66a094b41b78ecf737cf0fb29ee_D20210101-20211231" decimals="-6" sign="-" name="sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE1LTItMS0xLTM2NDA2MA_556ddd27-1794-4531-810b-92d4980b7625">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7c7268343e3c4b149282aaac720d320c_D20200101-20201231" decimals="-6" name="sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE1LTQtMS0xLTM2NDA2MA_f24faeff-12de-4abe-8c0a-64bc773e8d4f">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash flow and fair value hedges:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (excluding investments accounted for using the equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231" decimals="-6" name="sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE3LTEtMS0xLTM2NDA2MA_66d31765-33da-4091-8fc3-10927f25d4c1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231" decimals="-6" sign="-" name="sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE3LTItMS0xLTM2NDA2MA_bed5f1c1-1bca-46b6-8e1e-c9ab8faecac0">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231" decimals="-6" name="sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE3LTQtMS0xLTM2NDA2MA_ab940607-9505-4269-9018-6cafaee5d7f3">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (investments accounted for using the equity method, net of taxes)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231" decimals="-6" name="sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE4LTEtMS0xLTM2NDA2MA_698c1168-2b9a-4c7d-b00a-4956cc11f793">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231" decimals="-6" name="sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE4LTItMS0xLTM2NDA2MA_609ab456-a33a-4daf-9647-92f8ce727253">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231" decimals="-6" name="sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE4LTQtMS0xLTM2NDA2MA_d8b6264d-d7a0-4e90-b2f1-e631cdd5c248">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#9642;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:9.29pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231" decimals="-6" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE5LTEtMS0xLTM2NDA2MA_753e877d-0588-479f-a21c-f0712cc9b130">1</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE5LTItMS0xLTM2NDA2MA_3bdb327e-9684-4ac6-b0f1-d94039a58779">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231" decimals="-6" name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE5LTQtMS0xLTM2NDA2MA_5849bfca-b109-4c96-b2f1-4cc2fea2b4b1">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in currency translation differences:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231" decimals="-6" name="sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIxLTEtMS0xLTM2NDA2MA_4ba88330-34e4-40eb-8668-f59ed823da27">2,643</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231" decimals="-6" name="sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIxLTItMS0xLTM2NDA2MA_d98cc138-df88-44e9-9bb5-1ad8a8a438a9">2,719</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231" decimals="-6" sign="-" name="sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIxLTQtMS0xLTM2NDA2MA_51553870-e817-4ed6-88ef-5ee69113238b">3,870</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Currency translation differences (investments accounted for using the&#160;equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIyLTEtMS0xLTM2NDA2MA_bd79e645-bfd4-4c97-84f1-f8d0230fb11b">11</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231" decimals="-6" sign="-" name="sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIyLTItMS0xLTM2NDA2MA_cb8a9f0b-02a9-4200-917c-5607519e7de3">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231" decimals="-6" name="sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIyLTQtMS0xLTM2NDA2MA_96289aad-19a1-4b28-83ca-40961b1c76f2">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Currency translation differences related to the investment in Regeneron and&#160;reclassified to profit or loss</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib5f0f8400faf41899e56a9f755aa798b_D20220101-20221231" decimals="-6" name="sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIzLTEtMS0xLTM2NDA2MA_e9dc0283-d456-4257-a339-93989d39a587">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i84e5f74193b24fd0a09abc9140858b91_D20210101-20211231" decimals="-6" name="sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIzLTItMS0xLTM2NDA2MA_a30a1480-37f8-4e13-86fd-0738eb5425ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i01a11c5677794ada9a35a69fc37af36b_D20200101-20201231" decimals="-6" sign="-" name="sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIzLTQtMS0xLTM2NDA2MA_769afd39-a0b7-4de2-921d-c80ecff473c9">318</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Hedges of net investments in foreign operations</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI0LTEtMS0xLTM2NDA2MA_1c937a55-a77d-4b6f-a608-531e6cf13f5e">354</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231" decimals="-6" sign="-" name="sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI0LTItMS0xLTM2NDA2MA_6a156640-136a-496c-ad80-2b8b5a042c6f">254</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231" decimals="-6" name="sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI0LTQtMS0xLTM2NDA2MA_d6faad74-9794-4b7e-9eba-450285b59e5d">180</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231" decimals="-6" sign="-" name="sny:ChangeInCurrencyTranslationOnTaxEffects" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI1LTEtMS0xLTM2NDA2MA_147803d8-0ffb-47dd-9aa5-3606005cbcb7">91</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231" decimals="-6" sign="-" name="sny:ChangeInCurrencyTranslationOnTaxEffects" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI1LTItMS0xLTM2NDA2MA_1fdfc6db-f56a-4524-9d7a-485c92e26939">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231" decimals="-6" name="sny:ChangeInCurrencyTranslationOnTaxEffects" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI1LTQtMS0xLTM2NDA2MA_3594a39d-180f-416d-a8ca-d2095eb3e5ef">59</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items subsequently reclassifiable to profit or loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI2LTEtMS0xLTM2NDA2MA_07065861-fb9c-46e8-ac09-df59e7bc29b6">2,313</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI2LTItMS0xLTM2NDA2MA_1e75fcac-8d14-4695-a46c-85b60770cb48">2,510</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI2LTQtMS0xLTM2NDA2MA_7cdd4d71-8bfd-4284-874f-bebd13e1a1dc">4,021</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Amounts reclassified to profit or loss: <ix:nonFraction unitRef="eur" contextRef="iaddc5f29d63d46fabf82586a2abfd3ce_D20220101-20221231" decimals="INF" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzgzMDEzMTI3OTA4Mzk1_35f82b36-24ee-43e1-aabc-606829314a4b">immaterial</ix:nonFraction> amount in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i5642b66a094b41b78ecf737cf0fb29ee_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzMwODc_67d23729-bed8-4ba8-a3f0-0f66c2e25afd">4</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i7c7268343e3c4b149282aaac720d320c_D20200101-20201231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzU0OTc1NTgxNDQyMDI_2b52e643-e4e2-40f6-ac3c-f1e815a333f3">5</ix:nonFraction> million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Amounts reclassified to profit or loss: &#8364;<ix:nonFraction unitRef="eur" contextRef="i4949eb4dec9442ac85100f908e6972f1_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzMxNTc_8a0d56ba-fe66-4f74-a2b4-df5fc76d730f">2</ix:nonFraction> million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i1f6d2fa7ab6e42599794a051ecd2b89e_D20210101-20211231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzMxNjc_bfb42ea0-aa2b-48c4-8430-b1c6b46f0e82">12</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="icd31d9498df742b0b80e99888ab0fd03_D20200101-20201231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzMxODE_2a38726e-ecc9-4ed6-9140-0304b8ae286b">1</ix:nonFraction> million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Amounts reclassified to profit or loss: &#8364;<ix:nonFraction unitRef="eur" contextRef="ib49080ce7345480abd6e11f6e27bc713_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzU0OTc1NTgxNDk0MTc_cefb9c7d-5734-46d0-a9a6-e6b6d63b7089">40</ix:nonFraction> million in 2022, including &#8364;<ix:nonFraction unitRef="eur" contextRef="i386bf60e102f452f92cd64f880c74114_D20220101-20221231" decimals="-6" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzU0OTc1NTgxNDk5NjU_96585e7b-6d18-4667-b598-a66fbb9a48ce">35</ix:nonFraction> million relating to the deconsolidation of EUROAPI (see note&#160;D.1.). The amounts reclassified to profit and loss were <ix:nonFraction unitRef="eur" contextRef="id5e403b7788e477a853eef59c1c0ea76_D20200101-20201231" decimals="INF" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzgzMDEzMTI3OTA4NDEx_b36d5e85-822e-46ad-ac12-ba566cc512d7"><ix:nonFraction unitRef="eur" contextRef="ibcee24e1452447f784500be45b06d7e8_D20210101-20211231" decimals="INF" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzgzMDEzMTI3OTA4NDEx_e8b7d323-f167-4f89-aa90-bbf13397b112">immaterial</ix:nonFraction></ix:nonFraction> in 2021 and 2020. Currency translation differences arise from the translation into euros of the financial statements of foreign subsidiaries, and are mainly due to the appreciation of the dollar against the euro.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) &#160;&#160;&#160;&#160;The amount recorded for 2020 relates to the translation reserve arising on the investment in Regeneron; the reserve was reclassified to profit or loss in accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates), including &#8364;<ix:nonFraction unitRef="eur" contextRef="i01a11c5677794ada9a35a69fc37af36b_D20200101-20201231" decimals="-6" name="sny:ChangeInCurrencyTranslationOnTaxEffects" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzMzOTg_5a40dd16-c533-457a-871f-9a74c9ed4199">2</ix:nonFraction> million (net of tax) relating to hedges of net investments in foreign operations.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.8. Stock options</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock option plans awarded and measurement of stock option plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No stock options were awarded during 2022, 2021 or 2020.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock subscription option plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Details of the terms of exercise of stock subscription options granted under the various plans are presented below in Sanofi share equivalents. These plans were awarded to certain corporate officers and employees of Sanofi companies.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-55</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i220e1b310d4c49a7bb98f026e311eb6b" continuedAt="id85c2aa8def24c878b697a31864db347"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwOTg_7d50b029-bd26-415c-9965-b7c0810b7273" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table shows all Sanofi stock subscription option plans still outstanding or under which options were exercised in the year ended&#160;December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:18.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Source</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Date of grant</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>options<br/>granted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Start&#160;date&#160;of<br/>exercise<br/>period</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exercise<br/>price (&#8364;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of options outstanding as of 12/31/2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2012</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica78b7fc4ed34047b47a514ea2899e83_D20120305-20120305" decimals="INF" name="ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzItMi0xLTEtMzY0MDYw_7a86eb66-2b21-40ee-b0b3-a4132afbf8b0">814,050</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/06/2016</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2022</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="id7e65738a1c54e028a8f9ed3e5c8f6ab_D20220101-20221231" decimals="2" name="sny:StockBasedCompensationStockOptionsExercisedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzItNS0xLTEtMzY0MDYw_68390af0-9323-46ac-a5c0-a91cb1aa2109">56.44</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9a0dc1e4f1cb4d699ec65237a7102e35_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzItNi0xLTEtMzY0MDYw_b7ec5fe6-57a0-47ae-9fbb-b18c14661154">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2013</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6fdbb4a4b5c641fc830a0a4bf600f878_D20130305-20130305" decimals="INF" name="ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzMtMi0xLTEtMzY0MDYw_8c43a68c-6f3d-479d-ae11-26cb004694a1">788,725</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/06/2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i850f42283b4b45f5af5a9e3cb5bcb9fe_D20220101-20221231" decimals="2" name="sny:StockBasedCompensationStockOptionsExercisedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzMtNS0xLTEtMzY0MDYw_e63beb41-f3ec-47ea-a779-845a4ecd54dc">72.19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib7a863d7a3b84e16ada34b5dd5363074_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzMtNi0xLTEtMzY0MDYw_2fc90ddb-8c6d-41ba-87cf-34c02904e644">78,089</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2014</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70e570beee9247dd9373015a21c81447_D20140305-20140305" decimals="INF" name="ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzQtMi0xLTEtMzY0MDYw_66ee8ac2-1ffd-4ed4-8982-efcf854abe5a">1,009,250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/06/2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i46fad837e04947e195c6de7464520552_D20220101-20221231" decimals="2" name="sny:StockBasedCompensationStockOptionsExercisedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzQtNS0xLTEtMzY0MDYw_4d2acc42-b861-4d98-9684-48dd3537bc46">73.48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8eceb614c7954b4a9e69dda6979655f9_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzQtNi0xLTEtMzY0MDYw_d086f313-867a-41c4-9282-2c6a639dcfcf">506,042</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">06/24/2015</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0423b3f235d249af9b6c602495486f3f_D20150624-20150624" decimals="INF" name="ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzUtMi0xLTEtMzY0MDYw_1bb9a619-d5f7-4b9b-9d4e-44e54ca8e5ef">435,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">06/25/2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">06/24/2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i761f2bdb34ff43adaab4025fbadfd268_D20220101-20221231" decimals="2" name="sny:StockBasedCompensationStockOptionsExercisedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzUtNS0xLTEtMzY0MDYw_a08aa46b-1d86-461e-9118-8c8ad39031ee">89.38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e0102d8ca1542de9dd7e5b5292bff6d_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzUtNi0xLTEtMzY0MDYw_a0b0e043-3b09-4fac-aacb-f735470e48af">338,464</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/04/2016</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9991ac00c4ee4f6795e497369e9998ea_D20160504-20160504" decimals="INF" name="ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzYtMi0xLTEtMzY0MDYw_37ea4cf4-41d1-4d55-af8e-14422bc163b5">402,750</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/05/2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/04/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="ifeac6a9bfcdb48f68a24eab465620944_D20220101-20221231" decimals="2" name="sny:StockBasedCompensationStockOptionsExercisedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzYtNS0xLTEtMzY0MDYw_7cb08dca-86b6-4396-9a43-93275af9f9cf">75.90</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c11a2397029406fb3e60037da96b3b9_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzYtNi0xLTEtMzY0MDYw_1c3b915b-0a10-46a4-91df-99cb1f673f29">264,750</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/10/2017</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb730a8c0b4f4f30bd170f0b73b2ae58_D20170510-20170510" decimals="INF" name="ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzctMi0xLTEtMzY0MDYw_b1b10db6-d827-4408-87a1-fd713ead7a42">378,040</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/11/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/10/2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i123d774d41684985a2a86c269755103e_D20220101-20221231" decimals="2" name="sny:StockBasedCompensationStockOptionsExercisedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzctNS0xLTEtMzY0MDYw_2dbbbe0f-61a9-4575-838b-7eef9b89a5c3">88.97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ff9ac16b7da4a46b910521e9f05b3e2_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzctNi0xLTEtMzY0MDYw_395fdb0c-626c-4e7d-af17-5d0e192d7428">268,440</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/02/2018</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b8cc6b5bfa042099e14b29e8ca19daa_D20180502-20180502" decimals="INF" name="ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzgtMi0xLTEtMzY0MDYw_4cb1ed76-3c4c-4cc6-bfaf-7b018efc387a">220,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/03/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/02/2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="iab81166fd8d041fd9836ffd1e59632a1_D20220101-20221231" decimals="2" name="sny:StockBasedCompensationStockOptionsExercisedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzgtNS0xLTEtMzY0MDYw_073950cb-8037-4c71-8d23-68b044b8ca24">65.84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b3f2d5eb1ab430482c82afc1c357df2_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzgtNi0xLTEtMzY0MDYw_a5a3a897-cde4-4723-bc54-869cbe259d1d">168,784</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">04/30/2019</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e201b70b2444c88a26affb3d73de9ad_D20190430-20190430" decimals="INF" name="ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzktMi0xLTEtMzY0MDYw_7c5b7184-13f4-4264-960e-0cddff9ee604">220,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/02/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">04/30/2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="iac1fbcaf85814c7a9412ccfa10736712_D20220101-20221231" decimals="2" name="sny:StockBasedCompensationStockOptionsExercisedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzktNS0xLTEtMzY0MDYw_3792e7c6-25b2-4ea7-9e6a-edfc58e42646">76.71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ade5b12cb694090a8bb2346378f9880_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzktNi0xLTEtMzY0MDYw_dbbea1a5-9365-43c3-b2b2-49a0bec2e3c8">213,400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7761f45b2c44f4b874bfeb6104744cb_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzEwLTYtMS0xLTM2NDA2MA_22780b32-0256-4d34-9d33-c586be87ac2e">1,837,969</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The exercise of all outstanding stock subscription options would increase shareholders&#8217; equity by approximately &#8364;<ix:nonFraction unitRef="eur" contextRef="ia81dd6015449467683cda683d3e36cf4_D20220101-20221231" decimals="-6" name="sny:ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzQzMjM_24697294-36af-4793-9880-cc335b9c858f">145</ix:nonFraction> million. The exercise of each option results in the issuance of <ix:nonFraction unitRef="shares" contextRef="ia81dd6015449467683cda683d3e36cf4_D20220101-20221231" decimals="INF" name="sny:NumberOfSharesIssuedByExerciceOfEachOption" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzQzODI_9ab2352a-ca75-4ae8-9a6a-01224bb953ec">one</ix:nonFraction> share.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of stock option plans</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwODI_37a32b12-e5be-40dd-870b-6679843389c4" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A summary of stock options outstanding at each balance sheet date, and of movements during the relevant periods, is presented below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:58.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of<br/>options</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted average<br/>exercise&#160;price<br/>per share (&#8364;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>(&#8364;&#160;million)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07c7f8bc45bc439083fadaebe0c772c2_I20191231" decimals="INF" name="sny:NumberOfShareOutstandingInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEtMS0xLTEtMzY0MDYw_a24af7da-5a51-49ff-8599-72992a72dfb3">3,822,020</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i07c7f8bc45bc439083fadaebe0c772c2_I20191231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEtMi0xLTEtMzY0MDYw_acc493e5-7526-4d00-a303-867bcf99f223">70.58</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i07c7f8bc45bc439083fadaebe0c772c2_I20191231" decimals="-6" name="sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEtMy0xLTEtMzY0MDYw_3c0fd04d-4108-4308-a492-43901bd51647">270</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07c7f8bc45bc439083fadaebe0c772c2_I20191231" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzItMS0xLTEtMzY0MDYw_3f74ce6c-3e99-4d8f-a37d-173a8767b7c5">2,650,375</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i07c7f8bc45bc439083fadaebe0c772c2_I20191231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzItMi0xLTEtMzY0MDYw_6c06c9b7-2aea-4996-9fe1-e0b1d6db5ea2">67.14</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i43789de88f2946b3a8bd5af44ea50d3c_D20190101-20191231" decimals="-6" name="sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzItMy0xLTEtMzY0MDYw_6a9008af-44fc-47d6-a23b-22ebc787d830">178</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzQtMS0xLTEtMzY0MDYw_f1bcb20b-fb44-4886-99fe-f435afe5096f">868,655</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzQtMi0xLTEtMzY0MDYw_bda6ae14-d0f2-4760-bd4b-26132b6c3861">59.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231" decimals="-6" name="sny:ValueOfShareOptionsExercisedInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzQtMy0xLTEtMzY0MDYw_63fef895-df11-4613-ad83-cf559fa16f53">52</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options cancelled</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)&#160;</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231" decimals="INF" name="sny:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzUtMS0xLTEtMzY0MDYw_c4352302-ef27-4236-ae75-bcd6013e16f8">91,305</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231" decimals="2" name="sny:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzUtMi0xLTEtMzY0MDYw_00cbe009-f58e-4aaf-8bb9-7e335fe6ca6c">87.73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231" decimals="-6" name="sny:ValueOfShareOptionsCancelledInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzUtMy0xLTEtMzY0MDYw_86215ce1-55bc-4482-8b85-29d36813b8e8">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231" decimals="INF" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzYtMS0xLTEtMzY0MDYw_5d96ff10-e94c-48da-833a-b3294bc45580">282,790</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzYtMi0xLTEtMzY0MDYw_d31b18ec-2c67-4e54-8d01-be7afe96bfbd">54.12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231" decimals="-6" name="sny:ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzYtMy0xLTEtMzY0MDYw_3a488251-ab12-4f86-8239-c4790b6222ca">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdedad23dad54fc796d50896cba79d31_I20201231" decimals="INF" name="sny:NumberOfShareOutstandingInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzctMS0xLTEtMzY0MDYw_21755bab-92cf-4eda-a069-f8c0ccae55c3">2,579,270</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="icdedad23dad54fc796d50896cba79d31_I20201231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzctMi0xLTEtMzY0MDYw_796b065c-f7f3-4770-a4ec-7d72642d35db">75.61</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icdedad23dad54fc796d50896cba79d31_I20201231" decimals="-6" name="sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzctMy0xLTEtMzY0MDYw_583d51fe-668d-40cf-a95a-df271879f0e4">195</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdedad23dad54fc796d50896cba79d31_I20201231" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzgtMS0xLTEtMzY0MDYw_ee110978-727f-4960-ad33-e69743b3cbed">1,845,050</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="icdedad23dad54fc796d50896cba79d31_I20201231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzgtMi0xLTEtMzY0MDYw_60375af8-d1c1-47bf-9cb6-d07959b1c5d8">74.51</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231" decimals="-6" name="sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzgtMy0xLTEtMzY0MDYw_7440778e-4a5d-44cd-be1a-b5f6bebbe028">137</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEwLTEtMS0xLTM2NDA2MA_bd8ee6dd-9389-49d2-9842-85bd1f36c9c8">190,076</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEwLTItMS0xLTM2NDA2MA_e79b1aec-18a1-40a1-a16d-c165c1dac9d1">59.53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231" decimals="-6" name="sny:ValueOfShareOptionsExercisedInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEwLTMtMS0xLTM2NDA2MA_eacac365-3fa9-450a-8d96-9510a3af157e">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options cancelled</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)&#160;</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231" decimals="INF" name="sny:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzExLTEtMS0xLTM2NDA2MA_e568d7f0-f3ce-4208-ab98-cd2dcb67aa83">51,216</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231" decimals="2" name="sny:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzExLTItMS0xLTM2NDA2MA_641131a7-91e4-4398-9f5f-596ffe85fdc7">65.84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231" decimals="-6" name="sny:ValueOfShareOptionsCancelledInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzExLTMtMS0xLTM2NDA2MA_e5bf1407-bb1f-4c24-9ce5-470dbd06a291">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231" decimals="INF" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEyLTEtMS0xLTM2NDA2MA_d3fc7a63-a381-4093-bfa6-c8e3463bfc7c">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEyLTItMS0xLTM2NDA2MA_f772bdf5-a5ff-4d9e-b123-542f35f9186c">50.48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231" decimals="-6" name="sny:ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEyLTMtMS0xLTM2NDA2MA_5fa08cb4-693a-4921-a2f3-79d1c91030e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231" decimals="INF" name="sny:NumberOfShareOutstandingInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEzLTEtMS0xLTM2NDA2MA_18a4da42-335c-42de-817f-f7588a29e0fd">2,337,968</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEzLTItMS0xLTM2NDA2MA_4f7eef6a-6826-48c7-b908-195ef7bc3b17">77.13</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231" decimals="-6" name="sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEzLTMtMS0xLTM2NDA2MA_1d88df0b-8ab2-48a4-9226-502edcd13192">180</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE0LTEtMS0xLTM2NDA2MA_495767e7-c4bb-4658-9aeb-fe856c404804">1,949,184</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE0LTItMS0xLTM2NDA2MA_899e2afb-7010-45f0-b356-298e673c7b02">78.15</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231" decimals="-6" name="sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE0LTMtMS0xLTM2NDA2MA_1ed3a38a-7eb2-44fe-b521-ee93026405f1">152</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE2LTEtMS0xLTM2NDA2MA_618a2a89-48f3-4385-b77c-b173257f4e4d">490,373</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE2LTItMS0xLTM2NDA2MA_6d746b55-e558-4c45-aa60-7db9f3bfbf8a">71.39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231" decimals="-6" name="sny:ValueOfShareOptionsExercisedInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE2LTMtMS0xLTM2NDA2MA_d8f9f26d-f1de-469d-930a-ffb602677edc">35</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options cancelled</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)&#160;</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231" decimals="INF" name="sny:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE3LTEtMS0xLTM2NDA2MA_20dd5356-a91f-446a-9a92-cb5516194872">9,626</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231" decimals="2" name="sny:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE3LTItMS0xLTM2NDA2MA_745c3532-a2e0-4fe5-8dea-e3b928564468">80.56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231" decimals="-6" name="sny:ValueOfShareOptionsCancelledInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE3LTMtMS0xLTM2NDA2MA_56fc5d19-2c04-4ba8-a55c-92fa3b3de3d1">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4927989d9967442c8996bd62b8ad73e2_I20221231" decimals="INF" name="sny:NumberOfShareOutstandingInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE5LTEtMS0xLTM2NDA2MA_b172710b-29b8-4419-9495-ea6b95d73bbe">1,837,969</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i4927989d9967442c8996bd62b8ad73e2_I20221231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE5LTItMS0xLTM2NDA2MA_577f3e8a-089c-4e8d-a3c3-c114df976445">78.64</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4927989d9967442c8996bd62b8ad73e2_I20221231" decimals="-6" name="sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE5LTMtMS0xLTM2NDA2MA_5d6da6d1-ced9-490f-a984-27fe6d5e0317">145</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4927989d9967442c8996bd62b8ad73e2_I20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzIwLTEtMS0xLTM2NDA2MA_6b91dd2c-8208-486d-8b6d-9a64d2f5fbc1">1,624,569</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i4927989d9967442c8996bd62b8ad73e2_I20221231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzIwLTItMS0xLTM2NDA2MA_91b37958-3668-4cac-abb1-bcaa6108ea5f">78.89</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231" decimals="-6" name="sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzIwLTMtMS0xLTM2NDA2MA_56025b1e-2d51-4870-8d3c-2954419f437b">128</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Mainly due to the grantees leaving Sanofi.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMTM_4476738e-2c8f-4c04-acf7-73bec2634989" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below provides summary information about options outstanding and exercisable as of December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Range of exercise prices per share</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>options</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>residual&#160;life<br/>(years)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price per<br/>share (&#8364;)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>options</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price per<br/>share (&#8364;)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">From &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i821889f0ea344561b6b623f1569dcf5a_I20221231" decimals="2" name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZWY3MzBhNjVlNGNmNDEwYmFjOGZlNjJiM2ZjZDRhYzRfOQ_862c8543-d354-41fb-9da5-43b0ae227f3e">60.00</ix:nonFraction> to &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="ib8bf080bbe314c159376eab8228e0259_I20221231" decimals="2" name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZWY3MzBhNjVlNGNmNDEwYmFjOGZlNjJiM2ZjZDRhYzRfMTU_b709f97a-d8f4-4d67-aafe-858daa92d5c2">70.00</ix:nonFraction> per share</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96d625b90bc5415ea3c4f123b942d689_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtMS0xLTEtMzY0MDYw_f7b3e950-65d3-4c13-86e9-cacb2bff28d5">168,784</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i86600d52210546e48c0c267d156433a2_D20220101-20221231" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtMi0xLTEtMzY0MDYw_e1214ba9-2040-40ba-9fdd-4ac78cd7287c">5.34</ix:nonNumeric></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i96d625b90bc5415ea3c4f123b942d689_I20221231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtMy0xLTEtMzY0MDYw_0e1346b4-abed-4782-b115-a5e8e16c08d6">65.84</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96d625b90bc5415ea3c4f123b942d689_I20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtNC0xLTEtMzY0MDYw_321e9346-c229-46a5-b495-c625554228a6">168,784</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i96d625b90bc5415ea3c4f123b942d689_I20221231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtNS0xLTEtMzY0MDYw_3e1aaa70-6833-4ce1-b00c-1563a4ea7d15">65.84</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">From &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i761cd5d2d3af436abebf5b7972feb90e_I20221231" decimals="2" name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246MTdiY2Y5MGEyMDk5NGYyYzk1Y2JjMTcwZGI2ZWRjZmVfOQ_c3c8bff2-ce4e-4495-ae11-15d9451f08b8">70.00</ix:nonFraction> to &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i8ddb1db14dc74affb6c0eddc366fa6ee_I20221231" decimals="2" name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246MTdiY2Y5MGEyMDk5NGYyYzk1Y2JjMTcwZGI2ZWRjZmVfMTU_456cb995-e87f-4cf2-9369-5aab3fb28472">80.00</ix:nonFraction> per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if945729d6a4149c98bb12ede0a766d47_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtMS0xLTEtMzY0MDYw_e5c3ede7-fd6c-43a3-b81f-e7c5facf8a24">1,062,281</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e790c51810745d39c5f898d13e4d429_D20220101-20221231" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtMi0xLTEtMzY0MDYw_ee3f30bc-bb49-4f12-9e45-63f9ab38fcb9">2.68</ix:nonNumeric></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="if945729d6a4149c98bb12ede0a766d47_I20221231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtMy0xLTEtMzY0MDYw_caeca737-8380-46b9-b7c6-b37799bfda06">74.64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if945729d6a4149c98bb12ede0a766d47_I20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtNC0xLTEtMzY0MDYw_5ea6017c-653d-4291-8250-2a6d1c68adae">848,881</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="if945729d6a4149c98bb12ede0a766d47_I20221231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtNS0xLTEtMzY0MDYw_eaf129a1-6bce-41c6-984e-336b7867ecfc">74.12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">From &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i72ed25668eab49c2b6083a9d4b1afed6_I20221231" decimals="2" name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZjQ1MmQ3MmRjNjUzNGU0MGFiYTJhYzc2M2RmZGFkOTBfOQ_5db01ac6-a447-4d36-af18-d5517b0d4c94">80.00</ix:nonFraction> to &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i23039a6ebb6044c893c2b3b14a2e0be0_I20221231" decimals="2" name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZjQ1MmQ3MmRjNjUzNGU0MGFiYTJhYzc2M2RmZGFkOTBfMTU_eecac07c-4bea-4278-b5c5-f799e342de01">90.00</ix:nonFraction> per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c0322302b7940e2b62b4e9d6b0dd997_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtMS0xLTEtMzY0MDYw_548ad9d1-893c-4d7d-8051-28f46529514d">606,904</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifb96c4c54f0e4c9593d667cdb20954ef_D20220101-20221231" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtMi0xLTEtMzY0MDYw_5b628944-f486-4900-8f73-467364e6a119">3.31</ix:nonNumeric></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i6c0322302b7940e2b62b4e9d6b0dd997_I20221231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtMy0xLTEtMzY0MDYw_4dd1784d-b1b0-40c4-a48b-13dd5f562183">89.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c0322302b7940e2b62b4e9d6b0dd997_I20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtNC0xLTEtMzY0MDYw_f339505e-0e64-482a-acb2-34ae1d33c805">606,904</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eurPerShare" contextRef="i6c0322302b7940e2b62b4e9d6b0dd997_I20221231" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtNS0xLTEtMzY0MDYw_befdb047-f8c6-4889-8b83-aa22cd5b8957">89.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica46b5f804e3417dad93336ac31a2ecb_I20221231" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzYtMS0xLTEtMzY0MDYw_44c764f5-5c10-43eb-bbf1-5a8b69391c53">1,837,969</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica46b5f804e3417dad93336ac31a2ecb_I20221231" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzYtNC0xLTEtMzY0MDYw_6e4d6db5-af10-4132-9f31-40bb1d0aba41">1,624,569</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-56</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="id85c2aa8def24c878b697a31864db347"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.9. Number of shares used to compute diluted earnings per share</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Diluted earnings per share is computed using the number of shares outstanding plus stock options with dilutive effect and restricted shares.</span></div><div style="margin-bottom:5pt;text-align:justify"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMTQ_cf693272-00b1-45b5-a4fb-d2e091fe8d29" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.991%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Average number of shares outstanding</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-5" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzEtMS0xLTEtMzY0MDYw_0b152aba-40fd-4f13-8e38-f755c847a167">1,251.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-5" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzEtMi0xLTEtMzY0MDYw_cf294736-0a9d-402e-8494-9ad7fd3e800a">1,252.5</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-5" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzEtMy0xLTEtMzY0MDYw_978caa82-e63e-437d-a77e-a97db2d0da76">1,253.6</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustment for stock options with dilutive effect</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-5" name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzItMS0xLTEtMzY0MDYw_52ff95e0-e2c6-40cb-8b7c-aa4eec4e8764">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-5" name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzItMi0xLTEtMzY0MDYw_5581577e-612f-405f-8a88-85b2d678239b">0.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-5" name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzItMy0xLTEtMzY0MDYw_f46cef83-eebb-459b-9ccf-ebb0ff2793bd">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustment for restricted shares</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-5" name="sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzMtMS0xLTEtMzY0MDYw_65beeafe-8997-405f-bbcb-63f271a970b8">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-5" name="sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzMtMi0xLTEtMzY0MDYw_44c257ed-d142-4441-ae9a-3a31d0b55ab0">5.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-5" name="sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzMtMy0xLTEtMzY0MDYw_0a71d660-bf8a-47e7-96f9-7abd0e5b86f1">6.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average number of shares used to compute diluted earnings per share</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-5" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzQtMS0xLTEtMzY0MDYw_96a1f892-4388-4d76-8268-79571cf56f2b">1,256.9</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-5" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzQtMi0xLTEtMzY0MDYw_13fdfe50-8b53-45e7-a157-d4a0e7817605">1,257.9</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-5" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzQtMy0xLTEtMzY0MDYw_6c9b5752-f453-4898-b3f4-fa0d2d5ed5ec">1,260.1</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, all stock options were taken into account in computing diluted earnings per share because they all had a dilutive effect. In both 2021 and 2020, <ix:nonFraction unitRef="shares" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-5" name="sny:StockOptionsWithNoDilutiveEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwNTg_135319df-eafe-4dbc-ac15-412aaaf3b02e"><ix:nonFraction unitRef="shares" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-5" name="sny:StockOptionsWithNoDilutiveEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwNTg_6278f938-6f62-4b45-aaad-2e8d279670eb">0.6</ix:nonFraction></ix:nonFraction> million&#160;stock options were not taken into account in computing diluted earnings per share because they had no dilutive effect.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_637"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.16. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzcvZnJhZzphZWY0M2FmZThiM2M0NzBmODdlMzE3ZDU4NjYzOTgzNy90ZXh0cmVnaW9uOmFlZjQzYWZlOGIzYzQ3MGY4N2UzMTdkNTg2NjM5ODM3XzE4MA_1bc65263-9950-40e2-9a1b-1fac4222ea70" continuedAt="i2f1cd08d095545708a1c892525f17548" escape="true">Non-controlling interests</ix:nonNumeric></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:continuation id="i2f1cd08d095545708a1c892525f17548">Non-controlling interests did not represent a material component of Sanofi&#8217;s consolidated financial statements in the years ended December 31, 2022, 2021 and 2020</ix:continuation>.</span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_640"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.17. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NDk_7b0bba59-b6bd-47bc-ac2e-3de98c8b53bc" continuedAt="ia5f74d3f00f841a389f697c0644a2ab5" escape="true">Debt, cash and cash equivalents and lease liabilities</ix:nonNumeric></span></div><ix:continuation id="ia5f74d3f00f841a389f697c0644a2ab5" continuedAt="i9f8b5f778dd24943bf0ee167dd0dc834"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.17.1. Debt, cash and cash equivalents</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfChangesInFinancialPositionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NDA_b2206ed3-3554-49c4-8e6f-e9ac0e8e78f7" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in Sanofi's financial position during the period were as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.991%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEtMS0xLTEtMzY0MDYw_9015aba1-9533-41eb-a9f3-5c3b22c4ac05">14,857</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEtMi0xLTEtMzY0MDYw_7cfec027-d23a-4256-8baf-19a13553dee8">17,123</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEtMy0xLTEtMzY0MDYw_393bc6be-91be-40f1-917c-d32209e983ca">19,745</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzItMS0xLTEtMzY0MDYw_0e897f2b-97ad-45e0-831d-00c2045067f1">4,174</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzItMi0xLTEtMzY0MDYw_e9452bee-4ba3-4dc7-9a94-05d48b36dcec">3,183</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzItMy0xLTEtMzY0MDYw_a853510d-71e8-429a-84f9-0203acdc45dc">2,767</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzUtMS0xLTEtMzY0MDYw_bf36b04b-e283-4c81-ba19-2ff93506e1d8">187</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzUtMi0xLTEtMzY0MDYw_90f88140-6c0a-46b7-a111-607e31ffc389">56</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzUtMy0xLTEtMzY0MDYw_ea74365b-5c35-43ae-a1d8-d7873e7202b0">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzYtMS0xLTEtMzY0MDYw_8401dba6-3835-43ef-ba61-6a06c90c045e">19,218</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzYtMi0xLTEtMzY0MDYw_eb01bfbe-4e22-4819-95be-34e16b3c1bda">20,250</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzYtMy0xLTEtMzY0MDYw_aa188621-5c42-4a72-9453-b502da990748">22,631</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzctMS0xLTEtMzY0MDYw_4d7fdc52-7dfa-48c2-87f5-031234999b44">12,736</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzctMi0xLTEtMzY0MDYw_6a92f465-8298-419e-8d8b-ec4d28962034">10,098</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzctMy0xLTEtMzY0MDYw_586efd43-d3a1-4ae3-ac49-deefe927104b">13,915</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEwLTEtMS0xLTM2NDA2MA_226c2bc4-6c0b-4b12-820f-3aede0604a47">45</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEwLTItMS0xLTM2NDA2MA_bad73e32-5814-49de-af8d-1d8ba02e0a8b">169</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEwLTMtMS0xLTM2NDA2MA_73fedef2-f81f-498a-9e09-36ccaf8f886f">74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzExLTEtMS0xLTM2NDA2MA_e7b4c969-bada-4dc2-b5a7-3563672ef7fd">6,437</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzExLTItMS0xLTM2NDA2MA_b3c8c444-001f-47bd-8be8-fde0cd4ebb98">9,983</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzExLTMtMS0xLTM2NDA2MA_76d04335-67d3-497e-a9f6-e10f7d987d31">8,790</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Net debt does not include lease liabilities, which amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzI0OA_b8e77a0b-c18d-4dbc-85e1-81d8f3177f99">2,181</ix:nonFraction> million as of December 31, 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzI3Nw_d1d52ba2-bea1-468f-a41e-38055b097ad9">2,108</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> million as of December 31, 2021, and&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonFraction unitRef="eur" contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzMxOA_3c3d855a-863a-4ea4-ab6d-9f7f955c321c">1,163</ix:nonFraction>&#160;million as of December 31, 2020 </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(see the maturity analysis at Note&#160;D.17.2.).</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Net debt&#8221; is a non-IFRS financial measure used by management and investors to measure Sanofi&#8217;s overall net indebtedness.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MjE_bc83a01d-b676-4d1d-8d88-7f42cc206b5e" escape="true"><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Reconciliation of carrying amount to value on redemption</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:25.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value on redemption</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustment<br/>to debt<br/>measured&#160;at<br/>fair value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItMS0xLTEtMzY0MDYw_553f7409-219d-4d4c-9a63-1427dc1b54e3">14,857</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8cf06b4cc8747228729190e580e0310_I20221231" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItMi0xLTEtMzY0MDYw_ac8f2587-bfa5-4a4b-adfd-afc766b6e85b">51</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231" decimals="-6" name="ifrs-full:LongtermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItMy0xLTEtMzY0MDYw_7dc6aea8-a4a8-4c02-aa8c-3d3380ee1730">235</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItNC0xLTEtMzY0MDYw_b94c615a-fc69-4411-b817-56fb030f1e53">15,143</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItNS0xLTEtMzY0MDYw_33091410-7555-4380-ab5d-876fdd6e1fbd">17,176</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItNi0xLTEtMzY0MDYw_54500de2-ff3c-4ddd-ae7e-6d1375847f36">19,794</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion<br/>of long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtMS0xLTEtMzY0MDYw_d5b15c80-7ac5-46eb-994d-7b055d62f41e">4,174</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8cf06b4cc8747228729190e580e0310_I20221231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtMi0xLTEtMzY0MDYw_c6ec1e94-da64-494a-b062-1490dddd061c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtMy0xLTEtMzY0MDYw_e12c7a01-4893-4e28-82f6-cd9c2a3a0640">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtNC0xLTEtMzY0MDYw_8d5d4781-4c23-43ac-aed9-14af61c3bcd8">4,178</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtNS0xLTEtMzY0MDYw_68029c6a-6e1c-4321-9752-15f68dcfbafd">3,183</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtNi0xLTEtMzY0MDYw_e879decd-e1f6-43ee-9982-38f122ad7889">2,767</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtMS0xLTEtMzY0MDYw_3b175121-4bcd-4586-810e-d1925912fcea">187</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8cf06b4cc8747228729190e580e0310_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtMi0xLTEtMzY0MDYw_d1c46244-bf67-4523-a71a-2d75fd36a1b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtMy0xLTEtMzY0MDYw_cca3ded6-9c0b-43a6-ab34-9c35ca6386e2">235</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtNC0xLTEtMzY0MDYw_6e853cf1-36e2-4b9f-970e-2e782cd5570c">48</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtNS0xLTEtMzY0MDYw_170d94d4-56e2-4e0a-82c7-ef946eb74be8">45</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtNi0xLTEtMzY0MDYw_deff0117-21b9-458c-a358-de267d0c9917">142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtMS0xLTEtMzY0MDYw_3f616b31-31ab-405f-9e82-c93f5d5ef537">19,218</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8cf06b4cc8747228729190e580e0310_I20221231" decimals="-6" name="ifrs-full:Borrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtMi0xLTEtMzY0MDYw_fa7db2b1-de65-4666-8ea6-45dbd286dc8d">51</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231" decimals="-6" name="ifrs-full:Borrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtMy0xLTEtMzY0MDYw_8abd6b66-71b8-4184-92bf-87f9832e87ea">4</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtNC0xLTEtMzY0MDYw_0c7d8518-3593-42a6-b34b-6f0927461f07">19,273</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtNS0xLTEtMzY0MDYw_f7bd72d2-41a5-4f09-ba09-315eebc4581f">20,314</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtNi0xLTEtMzY0MDYw_249538b5-227c-4dbd-a6ba-d0e6702b186f">22,703</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtMS0xLTEtMzY0MDYw_dc50d0f5-ce0d-44c6-8890-fdacd999776a">12,736</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8cf06b4cc8747228729190e580e0310_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtMi0xLTEtMzY0MDYw_630ccf6e-9ec1-485c-82f0-7744f4a5e9f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtMy0xLTEtMzY0MDYw_5acdc92a-6351-44f7-99d8-12b1166e6337">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtNC0xLTEtMzY0MDYw_577371e3-c301-4331-b1ff-6347d63cdb39">12,736</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtNS0xLTEtMzY0MDYw_dac7a3c0-f22a-45d4-8e7c-b296eacb0c3c">10,098</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtNi0xLTEtMzY0MDYw_9d22acf3-0d0d-4b38-8a50-f454393cdf88">13,915</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctMS0xLTEtMzY0MDYw_b9180c1a-6aee-4a24-9c7f-91fa7eed3775">45</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8cf06b4cc8747228729190e580e0310_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctMi0xLTEtMzY0MDYw_30d5bf9e-9b9d-46ac-9d45-f1e9da4007f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctMy0xLTEtMzY0MDYw_785e5e2d-e9e8-4371-9479-f9d72721dfae">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctNC0xLTEtMzY0MDYw_e943e645-af92-4e09-a362-5a73dfa6bf4d">45</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctNS0xLTEtMzY0MDYw_44d5c143-233e-4384-b5da-6bc15655c474">169</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctNi0xLTEtMzY0MDYw_7d7d6dcd-9536-4d31-b05c-71ad52c59139">74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtMS0xLTEtMzY0MDYw_8feaad52-9c4d-4661-8e01-aa6b5b9ee6af">6,437</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8cf06b4cc8747228729190e580e0310_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtMi0xLTEtMzY0MDYw_19653435-e9b9-4739-a8b7-e61e7c352742">51</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtMy0xLTEtMzY0MDYw_a12e3704-f036-4e24-8ac3-8e05a3125a63">4</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtNC0xLTEtMzY0MDYw_eac25ac3-1643-493d-b331-e4406975bab5">6,492</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtNS0xLTEtMzY0MDYw_e3473a9e-d4cc-45c0-b44f-2981ad39250c">10,047</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtNi0xLTEtMzY0MDYw_630992e5-b732-4d76-b4ac-fec6c3c4c960">8,862</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-57</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i9f8b5f778dd24943bf0ee167dd0dc834" continuedAt="i8e8016b6a49f4644a29f344e410d7588"><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a) Principal financing transactions during the year</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MTc_f10b5a11-3a05-4698-b996-41692d680b6a" continuedAt="i998e130359c84ff9828429131b864410" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the movement in total debt during the period:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash&#160;flows&#160;from<br/>financing activities</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-cash items</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repayments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">New<br/>borrowings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>cash<br/>flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">translation</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">differences</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification<br/>from<br/>non-current to<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">items</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i10309ee26b644653875a9ef939afe780_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItMS0xLTEtMzY0MDYw_c6b71bbb-a9e1-4446-bfa3-2b9bc27a5e6b">17,123</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItMi0xLTEtMzY0MDYw_7f970ed1-721f-469d-aec0-3fbfa6ad78e1">11</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItMy0xLTEtMzY0MDYw_61d137e1-e768-4d8e-bd76-01c4ec1e4b57">1,549</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231" decimals="-6" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItNC0xLTEtMzY0MDYw_eb237c39-4c49-4d71-a7d6-0ba2bd2a66b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231" decimals="-6" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItNS0xLTEtMzY0MDYw_c38df5e5-7fd3-45d9-b377-9995699d2487">56</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i821c164ee86d4851828efe3ab80b5250_I20221231" decimals="-6" sign="-" name="sny:ReclassificationFromNonCurrentToCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItNi0xLTEtMzY0MDYw_d8add52c-0cac-4ce6-9b9d-1ca5242951ab">3,632</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItNy0xLTEtMzY0MDYw_0a60828b-866d-4205-b86d-8992c1d87bc2">228</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i821c164ee86d4851828efe3ab80b5250_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItOC0xLTEtMzY0MDYw_6b1b6200-56bf-4093-ad5f-a32b9d48a635">14,857</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib2ad2e7b83694c51aa8ec5759b996a3a_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtMS0xLTEtMzY0MDYw_92f7e6f9-29c3-40de-b212-5a3b6028a976">3,183</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtMi0xLTEtMzY0MDYw_e6282f50-e25c-4482-b443-df46535c08da">2,707</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtMy0xLTEtMzY0MDYw_690fbc3b-42bf-4f02-bd24-f0d88645b406">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231" decimals="-6" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtNC0xLTEtMzY0MDYw_ecce8c1c-2d58-4f3e-bd3c-58729fc302d3">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231" decimals="-6" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtNS0xLTEtMzY0MDYw_b52c86d5-4934-4943-9321-91ed86f60d22">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i610ac40ea4444926b8ca4fc00340297b_I20221231" decimals="-6" name="sny:ReclassificationFromNonCurrentToCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtNi0xLTEtMzY0MDYw_fdde88c7-d3dd-4b13-90f9-466784ecbddf">3,632</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231" decimals="-6" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtNy0xLTEtMzY0MDYw_7e123edd-5fbf-4445-9210-add6955f5b99">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i610ac40ea4444926b8ca4fc00340297b_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtOC0xLTEtMzY0MDYw_ed1e31a9-bb49-40f7-b24e-8b8e5054c5cb">4,174</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7460dad569314917928c609f43188c3e_I20211231" decimals="-6" sign="-" name="ifrs-full:Borrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtMS0xLTEtMzY0MDYw_be1314a0-bdda-40e5-9c23-5640651cd666">56</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtMi0xLTEtMzY0MDYw_a7ae6c84-1cff-4b37-b178-f07f0d2285a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtMy0xLTEtMzY0MDYw_70483524-8abd-4039-a5ea-3d10da6e84dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtNC0xLTEtMzY0MDYw_60d951b4-3133-4fd3-ab06-a8db93d6daae">373</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231" decimals="-6" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtNS0xLTEtMzY0MDYw_036a4712-0ff8-4c22-a909-8c0d5a31e4fd">366</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d1e362d6a2340b88d664b8d7109b86e_I20221231" decimals="-6" name="sny:ReclassificationFromNonCurrentToCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtNi0xLTEtMzY0MDYw_90e98eaf-4892-486c-a3ce-14f0debb777e">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231" decimals="-6" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtNy0xLTEtMzY0MDYw_4325e992-f44e-4e29-9395-d9d89cb5ab8c">243</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d1e362d6a2340b88d664b8d7109b86e_I20221231" decimals="-6" name="ifrs-full:Borrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtOC0xLTEtMzY0MDYw_c1246bd0-ad69-4ea4-92ab-08e673788245">187</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtMS0xLTEtMzY0MDYw_c1f2b1c1-c057-4295-95a7-e1240e97e42a">20,250</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtMi0xLTEtMzY0MDYw_c2464cea-b413-4146-a80f-5d8ca0517c62">2,718</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtMy0xLTEtMzY0MDYw_288328d3-a5c7-4e9e-ab19-1005fda8b28f">1,549</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtNC0xLTEtMzY0MDYw_dff45f31-5d9a-4546-ad60-617a25ea417c">330</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtNS0xLTEtMzY0MDYw_f9f95d60-0785-4b92-a6e2-358f5896c331">442</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:ReclassificationFromNonCurrentToCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtNi0xLTEtMzY0MDYw_c4cbf72d-1861-4acc-89e5-1885e68993b7">7</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtNy0xLTEtMzY0MDYw_cf922671-81ae-42f4-82fe-d7900037d4a5">18</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtOC0xLTEtMzY0MDYw_47567617-764e-4a76-af24-fbbd571cf427">19,218</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These amounts include unrealized gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the Euro zone.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) These amounts include changes in accrued interest balances, and fair value adjustments.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During 2022, Sanofi carried out a bond issue of &#8364;<ix:nonFraction unitRef="eur" contextRef="id2a418ab95d54008afcb49dc0cee1dcb_I20220430" decimals="-8" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMDUx_f0f944ac-14a6-4805-a6bf-bfb84c2f9779">1.5</ix:nonFraction>&#160;billion in April as part of its EMTN (Euro Medium Term Note) program, in <ix:nonFraction unitRef="tranche" contextRef="id2a418ab95d54008afcb49dc0cee1dcb_I20220430" decimals="INF" name="sny:NumberOfTranches" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTY0_75eb8824-e7e9-42f4-a154-68d959b9d04f">two</ix:nonFraction> tranches:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:7.48pt">&#8364;<ix:nonFraction unitRef="eur" contextRef="i9b7d742e8ca14e02bbba4212b5f9df28_I20220430" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMDY5_355208c4-acf4-4832-9412-3ce3758dc5de">850</ix:nonFraction>&#160;million bearing interest at a fixed annual rate of <ix:nonFraction unitRef="number" contextRef="i9b7d742e8ca14e02bbba4212b5f9df28_I20220430" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwNDczMTM5Njg2MzY_43b30086-6865-43cd-8c59-3f8541e839b7">0.875</ix:nonFraction>% and maturing April&#160;2025; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.61pt">&#8364;<ix:nonFraction unitRef="eur" contextRef="i63eaa2695fc84ccdbf9aa943ad509de8_I20220430" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMDg3_f7bd5c80-e512-4681-ad20-a8f9bd1b27f7">650</ix:nonFraction>&#160;million bearing interest at a fixed annual rate of <ix:nonFraction unitRef="number" contextRef="i63eaa2695fc84ccdbf9aa943ad509de8_I20220430" decimals="5" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwNDczMTM5Njg2NDk_01bdf4d3-6b40-40a2-92fc-31cef4178fe0">1.250</ix:nonFraction>% and maturing April&#160;2029; the amount of interest applicable is contingent on the attainment of a sustainability performance objective, i.e.: the cumulative number of patients (subject to a minimum of <ix:nonFraction unitRef="patient" contextRef="i63eaa2695fc84ccdbf9aa943ad509de8_I20220430" decimals="-5" name="sny:PerformanceObjectiveMinimumNumberOfPatients" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMDM0_987fa52c-d6bc-4d2d-8557-eef783fc88e9">1.5</ix:nonFraction>&#160;million) to which Sanofi Global Health has provided essential medicines to treat non-communicable diseases in the <ix:nonFraction unitRef="country" contextRef="i63eaa2695fc84ccdbf9aa943ad509de8_I20220430" decimals="INF" name="sny:PerformanceObjectiveNumberOfCountries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwNDczMTM5Njg2ODQ_dc96e5c7-887a-47bb-8b95-b2e128df1a2f">40</ix:nonFraction>&#160;poorest countries on the planet between 2022 and 2026.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="bond" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:NumberOfBondIssuesRedeemed" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTcy_effe5a0d-72ab-4564-a4a8-96269eeadd9f">Three</ix:nonFraction> bond issues were redeemed in 2022:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:7.48pt">&#8364;<ix:nonFraction unitRef="eur" contextRef="if33294fda4e34c3097e959eb6003c057_I20140930" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTAy_4a838fcd-6484-4cc5-a57b-e65ed8c812a6">1,000</ix:nonFraction>&#160;million issued September&#160;2014 and maturing March&#160;2022, early redeemed on January&#160;10, 2022;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.61pt">&#8364;<ix:nonFraction unitRef="eur" contextRef="ie9fabfa6d35447128880bf4259339f29_I20190331" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTE5_8b2a4fbd-78e8-41f9-8be8-eea4dec5b45f">850</ix:nonFraction>&#160;million issued March&#160;2019 and maturing March&#160;2022, early redeemed on February&#160;21, 2022; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:3.74pt">&#8364;<ix:nonFraction unitRef="eur" contextRef="i119b8f75feb74fbeabff0df24440bb94_I20160930" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTM3_96d3eb21-6693-4df4-b1a9-5f8d4afcbfe1">850</ix:nonFraction>&#160;million issued September&#160;2016 and maturing September&#160;2022, early redeemed on June&#160;13, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 Sanofi had <ix:nonFraction unitRef="credit_facility" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="INF" name="sny:NumberOfCreditFacilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwNDczMTM5Njg2ODI_c13d6d0a-11d4-482b-8a33-2595e8f7f699">two</ix:nonFraction>&#160;syndicated credit facilities of &#8364;<ix:nonFraction unitRef="eur" contextRef="i2d6f40c3d9f341be8626293e79a24136_I20221231" decimals="-9" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTUz_1647124c-739c-4cef-a216-e702780ff746"><ix:nonFraction unitRef="eur" contextRef="i3c67233c3b0e4833a40cd61543f883b4_I20221231" decimals="-9" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTUz_2716150c-fe51-4e05-b156-75c95b64f1ce">4</ix:nonFraction></ix:nonFraction>&#160;billion each to provide liquidity for the purposes of current operations, each of them linked to environmental and social indicators. The maturity of one facility has been extended to&#160;December&#160;3, 2023 following the exercise of an extension option in June&#160;2022, and the maturity of the other has been extended to December&#160;6, 2027 following the exercise of an extension option in September&#160;2022. Sanofi does not have any further extension options available for either facility.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In line with Sanofi's commitment to embed sustainable development in the &#8220;Play to Win&#8221; strategy, the <ix:nonFraction unitRef="credit_facility" contextRef="if95b13db708a44338258d8529b0ec6c2_I20211231" decimals="INF" name="sny:NumberOfCreditFacilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzE4OTg_76d0ff0f-2869-456e-9078-cfb70c5e36f7">two</ix:nonFraction>&#160;revolving credit facilities build in an adjustment mechanism that links the credit spread to the attainment of <ix:nonFraction unitRef="performance_indicator" contextRef="if95b13db708a44338258d8529b0ec6c2_I20211231" decimals="INF" name="sny:NumberOfSustainableDevelopmentPerformanceIndicators" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzIwMTI_bd87b97b-c214-49ea-bf7d-cdf54a45301b">two</ix:nonFraction>&#160;sustainable development performance indicators: Sanofi's contribution to polio eradication, and the reduction in Sanofi's carbon footprint.</span></div><ix:continuation id="i998e130359c84ff9828429131b864410" continuedAt="i4bad8dcd5f354576838b05bd7d3c2b3d"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show the movement in total debt during prior periods:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash&#160;flows&#160;from<br/>financing activities</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-cash items</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repayments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">New<br/>borrowings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>cash<br/>flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">translation</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">differences</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification<br/>from<br/>non-current to<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">items</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63e6bd162fc34a0b91feb5978e757f6a_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItMS0xLTEtMzY0MDYw_e1e6a850-6136-4d67-a052-c1cfccdead76">19,745</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i02963f181d634b7694e608faefff4b63_D20210101-20211231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItMi0xLTEtMzY0MDYw_bc425201-2f0c-4f35-9726-c91fa96eae61">38</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i02963f181d634b7694e608faefff4b63_D20210101-20211231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItMy0xLTEtMzY0MDYw_69ea1178-f52b-4b9b-a84d-afaef137e3c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i02963f181d634b7694e608faefff4b63_D20210101-20211231" decimals="-6" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItNC0xLTEtMzY0MDYw_e7d9abe9-badb-4673-87b3-893f7e2ac83d">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i02963f181d634b7694e608faefff4b63_D20210101-20211231" decimals="-6" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItNS0xLTEtMzY0MDYw_7573906e-8609-44f0-8902-420f20bbb830">124</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i10309ee26b644653875a9ef939afe780_I20211231" decimals="-6" sign="-" name="sny:ReclassificationFromNonCurrentToCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItNi0xLTEtMzY0MDYw_2ee40688-b4dc-4389-92c5-9bb0ed3a5c35">2,704</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i02963f181d634b7694e608faefff4b63_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItNy0xLTEtMzY0MDYw_a2b4c185-768e-4021-bd1b-f31fed06eb7b">4</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i10309ee26b644653875a9ef939afe780_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItOC0xLTEtMzY0MDYw_7a57c320-9da7-4b19-a3c8-7f48945b3cd0">17,123</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5d73cdea800649ee9ff0d7d7f47de6b4_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtMS0xLTEtMzY0MDYw_e77e0337-9594-4ccb-a0a0-63a98632663b">2,767</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtMi0xLTEtMzY0MDYw_1cc7d484-1011-460e-85ee-a80c267d1d53">2,203</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtMy0xLTEtMzY0MDYw_560d44cd-8bed-46cc-9222-187d903841f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtNC0xLTEtMzY0MDYw_548c2574-ab86-447e-b081-7c56d48181b2">615</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231" decimals="-6" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtNS0xLTEtMzY0MDYw_bfcad15c-526b-4412-91f1-25551eddad3b">248</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib2ad2e7b83694c51aa8ec5759b996a3a_I20211231" decimals="-6" name="sny:ReclassificationFromNonCurrentToCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtNi0xLTEtMzY0MDYw_6399bc36-9f91-4406-8a74-c5d3a5ed27f6">2,704</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231" decimals="-6" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtNy0xLTEtMzY0MDYw_9a22af56-8a29-47c6-82ca-6f61c56b9181">282</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib2ad2e7b83694c51aa8ec5759b996a3a_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtOC0xLTEtMzY0MDYw_e78d182e-64ac-4003-aca6-47faabd58466">3,183</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i98ecbb3b780b4531b583aa429548a360_I20201231" decimals="-6" name="ifrs-full:Borrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtMS0xLTEtMzY0MDYw_7779e944-0d36-4ac7-9269-a27efaf63996">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i234aab96cb044325aa2b96beec593299_D20210101-20211231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtMi0xLTEtMzY0MDYw_b96907e7-d4e3-4d06-8ba6-160880dd86af">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i234aab96cb044325aa2b96beec593299_D20210101-20211231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtMy0xLTEtMzY0MDYw_be75bb20-ef92-400e-93ef-731989b3f5ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i234aab96cb044325aa2b96beec593299_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtNC0xLTEtMzY0MDYw_bdf8355a-3ff0-4110-86e1-e23511979676">197</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i234aab96cb044325aa2b96beec593299_D20210101-20211231" decimals="-6" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtNS0xLTEtMzY0MDYw_e54d720e-4438-4ef1-ab21-7097ea651d51">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7460dad569314917928c609f43188c3e_I20211231" decimals="-6" name="sny:ReclassificationFromNonCurrentToCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtNi0xLTEtMzY0MDYw_95cba3ae-110e-4873-8b76-942d3302e189">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i234aab96cb044325aa2b96beec593299_D20210101-20211231" decimals="-6" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtNy0xLTEtMzY0MDYw_d142bbcf-1c46-4c04-9770-58a936528e8d">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7460dad569314917928c609f43188c3e_I20211231" decimals="-6" sign="-" name="ifrs-full:Borrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtOC0xLTEtMzY0MDYw_f2b59f3a-0ae7-4745-bb2f-688a0b89176a">56</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtMS0xLTEtMzY0MDYw_96b3453d-b539-43ef-9d3b-6caec4756657">22,631</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtMi0xLTEtMzY0MDYw_d71ee087-c18b-4a34-b62f-d88e123793ae">2,241</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtMy0xLTEtMzY0MDYw_2a2ea1a3-f98c-4e94-b7ed-9e6c623d8f9b">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtNC0xLTEtMzY0MDYw_1382b20e-d8d0-4123-9216-7518e18b547e">812</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtNS0xLTEtMzY0MDYw_cb72bb50-0899-4bec-bb17-dff1c9359e93">381</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:ReclassificationFromNonCurrentToCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtNi0xLTEtMzY0MDYw_c811f5cf-278a-4d53-bde7-869dcf83ff08">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtNy0xLTEtMzY0MDYw_f324c65e-5569-4c78-9e9e-6e555d24ca54">291</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtOC0xLTEtMzY0MDYw_ad2efe85-565a-40fd-bf98-b7d5521e1ed5">20,250</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-58</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i8e8016b6a49f4644a29f344e410d7588" continuedAt="i0ac1c46d446f405cb4463e8bed0c35dd"><ix:continuation id="i4bad8dcd5f354576838b05bd7d3c2b3d"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash&#160;flows&#160;from<br/>financing activities</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-cash items</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repayments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">New<br/>borrowings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>cash<br/>flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">translation</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">differences </span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification<br/>from<br/>non-current to<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">items</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i655df7026f214593b7b2e1587e041a19_I20191231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItMS0xLTEtMzY0MDYw_f67a17cd-215a-4cdb-87af-d4c23ed5dde7">20,131</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItMi0xLTEtMzY0MDYw_f0155db5-6a0a-40f7-a21c-06d1c9aaf624">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItMy0xLTEtMzY0MDYw_c12b53a9-1d36-4343-959b-674668c7bbd0">2,019</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231" decimals="-6" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItNC0xLTEtMzY0MDYw_684539d6-b814-4165-a20f-442a5bd155b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231" decimals="-6" sign="-" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItNS0xLTEtMzY0MDYw_d205687c-cda5-4805-a82e-68f0988dda45">152</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i63e6bd162fc34a0b91feb5978e757f6a_I20201231" decimals="-6" sign="-" name="sny:ReclassificationFromNonCurrentToCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItNi0xLTEtMzY0MDYw_f01eddab-8b82-4d81-bb8d-b42fee3928ee">2,285</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231" decimals="-6" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItNy0xLTEtMzY0MDYw_c167dacf-61ef-47a1-a6d8-3ecd37c82f59">32</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63e6bd162fc34a0b91feb5978e757f6a_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItOC0xLTEtMzY0MDYw_f125bf33-012e-4250-8b62-38a1cbbb8ff7">19,745</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7c961701531461c8f912e9bbcf2d37f_I20191231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtMS0xLTEtMzY0MDYw_e1a40089-80ce-4735-8d8b-d4b06ea796ca">4,554</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtMi0xLTEtMzY0MDYw_e78baa08-c494-4482-a699-5b70776518b2">3,952</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtMy0xLTEtMzY0MDYw_f08dac6f-51a0-4997-8051-c78786b62115">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231" decimals="-6" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtNC0xLTEtMzY0MDYw_bc294136-de8d-4584-be66-41e137d2d95d">86</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231" decimals="-6" sign="-" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtNS0xLTEtMzY0MDYw_dadaf89b-3a44-41ab-b3b0-22fdbf6571d4">219</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5d73cdea800649ee9ff0d7d7f47de6b4_I20201231" decimals="-6" name="sny:ReclassificationFromNonCurrentToCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtNi0xLTEtMzY0MDYw_9ccc6e55-de20-498f-bdab-e848edf9653d">2,285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231" decimals="-6" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtNy0xLTEtMzY0MDYw_72742048-546a-433f-b26b-d8f7be56f1d3">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5d73cdea800649ee9ff0d7d7f47de6b4_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtOC0xLTEtMzY0MDYw_699f871e-39b0-4b54-8af2-0418e0c27dfe">2,767</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="icf2f817c4f5c4ccb9efc1f90f92e9aac_I20191231" decimals="-6" sign="-" name="ifrs-full:Borrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtMS0xLTEtMzY0MDYw_daece9f0-22bf-46f2-8e10-4c68229aad0c">117</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtMi0xLTEtMzY0MDYw_c3f5518c-27ec-43c6-bfdb-d90642524a8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtMy0xLTEtMzY0MDYw_2344b60c-11ea-4543-9cff-63e81c3bb5d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231" decimals="-6" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtNC0xLTEtMzY0MDYw_5e23db0b-b5c8-4021-a371-38f58af4cf75">196</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231" decimals="-6" sign="-" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtNS0xLTEtMzY0MDYw_40386945-5db6-4a39-a57b-43565b344080">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i98ecbb3b780b4531b583aa429548a360_I20201231" decimals="-6" name="sny:ReclassificationFromNonCurrentToCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtNi0xLTEtMzY0MDYw_8888b535-2348-4821-a5ff-c2d6f22cbca5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231" decimals="-6" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtNy0xLTEtMzY0MDYw_95252c75-63f8-48ea-a405-23c983751a3b">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i98ecbb3b780b4531b583aa429548a360_I20201231" decimals="-6" name="ifrs-full:Borrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtOC0xLTEtMzY0MDYw_b389c8ca-0ea3-464f-943a-ad14ec810ffb">119</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtMS0xLTEtMzY0MDYw_4f428d07-ccdf-4473-82be-84cd68d19a67">24,568</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtMi0xLTEtMzY0MDYw_0fc08320-b098-49d1-ac93-1b03c1bf60fc">3,952</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtMy0xLTEtMzY0MDYw_fe1e2365-d5bb-4aa5-b6d4-1022e5b6e26b">2,019</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtNC0xLTEtMzY0MDYw_9b7bf689-257e-492f-86de-edd45e39dd85">282</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="sny:ForeignCurrencyTranslationDifferences" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtNS0xLTEtMzY0MDYw_a6a34187-c441-473f-9758-b82fe6e1a514">385</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:ReclassificationFromNonCurrentToCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtNi0xLTEtMzY0MDYw_88b4d46b-3e6f-42b6-98f4-c1988b941116">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:OtherAdjustmentsForNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtNy0xLTEtMzY0MDYw_7d3d2a77-0735-4aff-bd41-4a5652934155">99</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtOC0xLTEtMzY0MDYw_4350382e-636f-4918-bada-1fbaf11e2ced">22,631</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These amounts include unrealized gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the&#160;Euro zone.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) These amounts include movements in accrued interest and fair value remeasurements.</span></div></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b) Net debt by type, at value on redemption</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0Mjg_54c430ac-40e2-427b-9c0e-753f4bbaba2e" escape="true"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:14.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.246%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">current </span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current </span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItMS0xLTEtMzY0MDYw_b7c83e4e-3a2a-44c7-b5a0-6f526771cc6d">15,044</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItMi0xLTEtMzY0MDYw_51ab703e-71f7-4fc5-b6b2-5ad3b316a7a5">3,817</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItMy0xLTEtMzY0MDYw_db767b6f-cf5f-4130-9771-23efda8944b6">18,861</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItNC0xLTEtMzY0MDYw_2b052424-5a64-4b9f-9bfc-4983780d8acc">17,118</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItNS0xLTEtMzY0MDYw_fef0604d-ab53-43b0-8c57-54ec72cfc786">2,828</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItNi0xLTEtMzY0MDYw_608c83ea-ae05-47dd-bc1f-c5554745eeb3">19,946</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8aae788d334a48228c148b2c1872c556_I20201231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItNy0xLTEtMzY0MDYw_ffff1c2e-6b1f-4f99-9100-579667a83789">19,698</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItOC0xLTEtMzY0MDYw_f954ad88-a19d-4324-b469-e7108571f10f">2,280</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItOS0xLTEtMzY0MDYw_8d945110-4791-4346-9a6a-4c439550f8d3">21,978</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtMS0xLTEtMzY0MDYw_55846f49-34ef-4605-b871-62ed02f2274a">99</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtMi0xLTEtMzY0MDYw_0a87fcb0-e7f8-46fd-bc3d-9a1424351e39">187</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtMy0xLTEtMzY0MDYw_78eec03e-600e-4425-aadc-a9a669f8f101">286</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtNC0xLTEtMzY0MDYw_5d4cd030-57f4-4768-b8b9-cbeb6c2f08d5">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtNS0xLTEtMzY0MDYw_6bf2926e-2ddf-47bf-97f2-3a8e3d430bea">163</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtNi0xLTEtMzY0MDYw_1d5de94f-b599-4302-9721-96e0aeab6ec7">184</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8aae788d334a48228c148b2c1872c556_I20201231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtNy0xLTEtMzY0MDYw_3cde9e8d-4690-44cf-ad25-cd3e55ee06b0">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtOC0xLTEtMzY0MDYw_917961d6-84c3-4d14-8a68-15fedde78684">200</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtOS0xLTEtMzY0MDYw_ed8da3c2-c5fd-4d31-9463-270582cae86b">296</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtMS0xLTEtMzY0MDYw_b7bacf8a-8b8e-47a2-a93f-80ab95ecf0a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtMi0xLTEtMzY0MDYw_0c111266-0b15-4105-8f58-54a656ce5b1a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtMy0xLTEtMzY0MDYw_72ed17d9-ebcb-4ae2-a598-2e1f4467a12c">6</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtNC0xLTEtMzY0MDYw_57dfb632-05b5-4227-be96-63016b3ad7db">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtNS0xLTEtMzY0MDYw_e13f2d4a-3837-47a5-845b-353623ff9047">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtNi0xLTEtMzY0MDYw_c0bd0000-1fb9-4e62-b7af-b9c8391a7f7b">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8aae788d334a48228c148b2c1872c556_I20201231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtNy0xLTEtMzY0MDYw_e9b964e1-efcb-4535-88af-9881d1ebedbf">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtOC0xLTEtMzY0MDYw_6177f6fb-c5ec-4eba-9ff7-fc53b7908540">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtOS0xLTEtMzY0MDYw_d3b5925d-4340-4675-b195-83eead03c099">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtMS0xLTEtMzY0MDYw_1d3f7429-eabf-4526-86e3-233edf94dac3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtMi0xLTEtMzY0MDYw_caf27dbb-5b32-48ef-8c7c-3825aa0ad350">168</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtMy0xLTEtMzY0MDYw_7ccc4617-95bb-491a-b5c7-82b6f0407f1c">168</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtNC0xLTEtMzY0MDYw_52c0220e-05ac-4a7d-a728-5675ca26cb73">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtNS0xLTEtMzY0MDYw_4641113a-edca-4ecd-960d-17db15fdbda0">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtNi0xLTEtMzY0MDYw_164d8577-989e-48a6-8840-89dd9716fd9f">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8aae788d334a48228c148b2c1872c556_I20201231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtNy0xLTEtMzY0MDYw_6c964dfd-bc28-439f-8bc8-59bd181cd98c">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtOC0xLTEtMzY0MDYw_fd31f6d8-45df-45fd-985c-6cbcc9f36af4">285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtOS0xLTEtMzY0MDYw_fd8a011b-cc82-43fd-b44f-e8d98614d6e8">285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtMS0xLTEtMzY0MDYw_f6f8d778-f8ce-486b-8125-aade0619c5dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtMi0xLTEtMzY0MDYw_3e91093b-8eb2-4a80-97be-c8e05a664622">48</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtMy0xLTEtMzY0MDYw_93fbc22c-2dc3-4e7c-b497-146b81564e66">48</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtNC0xLTEtMzY0MDYw_1697c42a-d8b5-467a-b04f-13c5046459ab">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtNS0xLTEtMzY0MDYw_1a31902f-3a62-4ceb-9bfb-c26565122db5">45</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtNi0xLTEtMzY0MDYw_dfb2b536-efa6-4eae-a792-a8ea3c8430bc">45</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8aae788d334a48228c148b2c1872c556_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtNy0xLTEtMzY0MDYw_c677b9c1-1a9f-4b71-8c48-274937d99e51">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtOC0xLTEtMzY0MDYw_79255d73-2a5a-4dd6-9e5d-d35fee7176a3">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtOS0xLTEtMzY0MDYw_627e1d58-081d-41fa-81d3-2a4f331cfa92">142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctMS0xLTEtMzY0MDYw_17635627-95d6-4a84-b10c-c1ed705da7ef">15,143</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctMi0xLTEtMzY0MDYw_3d657d26-9109-42ce-8e35-7ce55b5fcfb9">4,130</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctMy0xLTEtMzY0MDYw_ae0fd05c-64e1-4ab4-bcf8-bec1fced4382">19,273</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctNC0xLTEtMzY0MDYw_1712cadc-8655-415a-885e-105cbc747636">17,176</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctNS0xLTEtMzY0MDYw_75051dc0-85f9-44a7-a643-19207375a581">3,138</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctNi0xLTEtMzY0MDYw_13699f8d-c2da-41ad-ba57-b26b3a4113c1">20,314</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8aae788d334a48228c148b2c1872c556_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctNy0xLTEtMzY0MDYw_9693f25f-dbd2-4654-a9c2-d498f9aefeb4">19,851</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctOC0xLTEtMzY0MDYw_eb1aa707-91e3-4088-85be-bef684779437">2,852</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctOS0xLTEtMzY0MDYw_85a283db-c9ba-4bf2-a8d9-e325ba03ebe7">22,703</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifdf61719dfa64d609696094dbfb37080_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtMS0xLTEtMzY0MDYw_b1a7be3c-d47d-4f72-9ab4-85fb8548f0a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id85f695673f24baba6ff5f3c480383e8_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtMi0xLTEtMzY0MDYw_2a439fbf-baae-4582-97c1-27bddee16f11">12,736</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtMy0xLTEtMzY0MDYw_b8999b10-5c51-4326-8a37-4191d747db10">12,736</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i00f6bb1b41d7431b8ba45da9f097bcd9_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtNC0xLTEtMzY0MDYw_0f4c85dd-0613-4b63-a885-a675b87822a2">&#8211;</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i607a722971b34cabb5fbb67804411532_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtNS0xLTEtMzY0MDYw_a316c02e-6178-4dd6-aadb-69297dd9c0f1">10,098</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtNi0xLTEtMzY0MDYw_fdee9727-7bd0-498b-af01-8b59ea45c792">10,098</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i023658cb94d842df8f9033585b3df0f2_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtNy0xLTEtMzY0MDYw_f660d87a-c9f1-4f11-8715-e0c6d4f51328">&#8211;</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9db61024b8a64a5b8c29aec2980c480c_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtOC0xLTEtMzY0MDYw_b5e32099-7948-41f4-aa7b-9ce3bfc3135f">13,915</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtOS0xLTEtMzY0MDYw_f1ec94dd-2bdf-45f4-b76d-31474892ffef">13,915</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifdf61719dfa64d609696094dbfb37080_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktMS0xLTEtMzY0MDYw_58b2efe4-4d9b-4381-9eae-1f2c23d6e4cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id85f695673f24baba6ff5f3c480383e8_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktMi0xLTEtMzY0MDYw_a4e674ab-4f29-4b91-9d06-8f308240ecb6">45</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktMy0xLTEtMzY0MDYw_63dfe671-b3f4-46e1-a287-a58a5dcc26c0">45</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i00f6bb1b41d7431b8ba45da9f097bcd9_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktNC0xLTEtMzY0MDYw_d09d70c2-a574-462e-9bde-7e2b5ba3f198">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i607a722971b34cabb5fbb67804411532_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktNS0xLTEtMzY0MDYw_0e01ec02-bb83-4f0d-83cc-e85f7bb56948">169</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktNi0xLTEtMzY0MDYw_f7a9b51e-2203-4a55-a3f5-215758368d2a">169</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i023658cb94d842df8f9033585b3df0f2_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktNy0xLTEtMzY0MDYw_8e7310fb-95da-4dea-9318-ca00704d9e07">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9db61024b8a64a5b8c29aec2980c480c_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktOC0xLTEtMzY0MDYw_0c6b6429-0178-4a83-9687-e4b0760ea5ed">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktOS0xLTEtMzY0MDYw_8996642b-89f1-4d91-a145-e6c32783a9b3">74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifdf61719dfa64d609696094dbfb37080_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTEtMS0xLTM2NDA2MA_4699028a-4ea6-41d3-9f44-6c00665dcea8">15,143</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id85f695673f24baba6ff5f3c480383e8_I20221231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTItMS0xLTM2NDA2MA_fe8b58d7-bbb3-4264-8c15-45c3718af3e2">8,651</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTMtMS0xLTM2NDA2MA_f5b13b10-929b-4807-a40e-a2a0a8a71558">6,492</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i00f6bb1b41d7431b8ba45da9f097bcd9_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTQtMS0xLTM2NDA2MA_2104946c-be3c-476a-8e72-42053bf509a6">17,176</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i607a722971b34cabb5fbb67804411532_I20211231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTUtMS0xLTM2NDA2MA_b2e7ff7b-c0c9-4129-b302-aa46de322a60">7,129</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTYtMS0xLTM2NDA2MA_1de6edc8-2530-4b7c-b0a3-9ec65f6244a5">10,047</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i023658cb94d842df8f9033585b3df0f2_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTctMS0xLTM2NDA2MA_06c889d3-e59f-4b1b-9608-db917f7e0768">19,857</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9db61024b8a64a5b8c29aec2980c480c_I20201231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTgtMS0xLTM2NDA2MA_46876bdf-212e-4856-9359-6150ea7b108d">10,995</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTktMS0xLTM2NDA2MA_47471bee-f96d-43ac-8afd-d82db67eae43">8,862</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Net debt does not include lease liabilities (see the maturity schedule in Note&#160;D.17.2.).</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MzQ_ded9ae65-8825-4404-a16c-420a07523947" continuedAt="i43a5bf39900f4a3d926b98a5507d10f5" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bond issues carried out by Sanofi under the Euro Medium Term Note (EMTN) program are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issuer</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ISIN code</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issue date</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual&#160;interest&#160;rate</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364; million)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0011625433</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 2013</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i04c2510d77e942f4ba7a8de27cabcaff_I20131130" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEtNC0xLTEtMzY0MDYw_bf4da51b-297a-453b-9099-abe144005b4b">2.5</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i04c2510d77e942f4ba7a8de27cabcaff_I20131130" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEtNS0xLTEtMzY0MDYw_457709ca-120f-4915-b766-54b2013c0473">1,000</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0014009KS6</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2469ac21b7364be09f669cb500520319_I20140930" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzItNC0xLTEtMzY0MDYw_767b5af8-cb58-4c95-bb90-6e0cae576fee">0.875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2469ac21b7364be09f669cb500520319_I20140930" decimals="-6" name="ifrs-full:NotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzItNS0xLTEtMzY0MDYw_20e2b9b1-388b-4462-9577-1e88179e727e">850</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0012146801</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i047b177ba24344cb92a1ff94db833558_I20140930" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzMtNC0xLTEtMzY0MDYw_661903f5-e657-4f24-8504-36ef160edc6d">1.75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i047b177ba24344cb92a1ff94db833558_I20140930" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzMtNS0xLTEtMzY0MDYw_fa955846-11f0-4f63-bd1f-323ca7c892da">1,510</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0014009KQ0</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id114c1320b834ff0b585507080df2d3e_I20140930" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzQtNC0xLTEtNTAzNjEw_abfe9091-e639-4e7c-8ce0-b6199ebe60c0">1.25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id114c1320b834ff0b585507080df2d3e_I20140930" decimals="-6" name="ifrs-full:NotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzQtNS0xLTEtNTAzNjEw_cc358cfe-4587-4d19-a831-e86378facc6c">650</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0012969038</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f75dc1fff81450490afa0858e34619f_I20150930" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzQtNC0xLTEtMzY0MDYw_924c2521-f516-4f45-9b06-825f87e8c9d4">1.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7f75dc1fff81450490afa0858e34619f_I20150930" decimals="-6" name="ifrs-full:NotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzQtNS0xLTEtMzY0MDYw_92b5ad22-caea-43dd-a93c-33da7f73afab">750</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013143997</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i199175f15b1046ac837513acb744cede_I20160430" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzUtNC0xLTEtMzY0MDYw_c1e2af42-4369-4cfa-8d8a-8fc75e43ef8f">0.625</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i199175f15b1046ac837513acb744cede_I20160430" decimals="-6" name="ifrs-full:NotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzUtNS0xLTEtMzY0MDYw_3c2c376f-98c6-40cd-a034-c3c8dbec8b51">600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013144003</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6594737bb0244237b737e165845993d7_I20160430" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzYtNC0xLTEtMzY0MDYw_41af32f3-81d8-46fd-ab85-0322fce473d9">1.125</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6594737bb0244237b737e165845993d7_I20160430" decimals="-6" name="ifrs-full:NotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzYtNS0xLTEtMzY0MDYw_5ec23789-3f4c-4054-ab17-2bee3a51876a">700</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013201639</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5205edb0a2ef44219261e0dd5e52acdd_I20160930" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzgtNC0xLTEtMzY0MDYw_ab47b968-7e18-4aac-8149-3271d8e8d1cb">0.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5205edb0a2ef44219261e0dd5e52acdd_I20160930" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzgtNS0xLTEtMzY0MDYw_436d8e70-1bc6-4527-9a1e-d7f3dedfbb16">1,150</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013505104 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if56de4286562416281bd1e12783b1be7_I20200331" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzktNC0xLTEtMzY0MDYw_ed717c5a-70a5-40d6-b652-4a3dbb921b11">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if56de4286562416281bd1e12783b1be7_I20200331" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzktNS0xLTEtMzY0MDYw_e819b782-f864-4800-996a-c34758ca0386">1,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013505112</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2030</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id77eb5dc6f4f42379ad386e2e02634c1_I20200331" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEwLTQtMS0xLTM2NDA2MA_38b98e49-e38e-4114-9f21-a0b4d32a0d65">1.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id77eb5dc6f4f42379ad386e2e02634c1_I20200331" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEwLTUtMS0xLTM2NDA2MA_a97d692c-9f7b-4862-93e9-11c0877905f7">1,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324332</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id10b1bea133a4963a7fdd17e91652506_I20180331" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzExLTQtMS0xLTM2NDA2MA_0f18809b-120c-4c95-a44d-82c822ededc9">0.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id10b1bea133a4963a7fdd17e91652506_I20180331" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzExLTUtMS0xLTM2NDA2MA_e190a718-5f8a-4481-af2b-7da6e8a08e8f">1,750</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324340</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia72c42b97a864e11a83f480f49ccae83_I20180331" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEyLTQtMS0xLTM2NDA2MA_290f9759-1426-461e-87e8-f1ca7d191a93">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia72c42b97a864e11a83f480f49ccae83_I20180331" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEyLTUtMS0xLTM2NDA2MA_32dfe7b1-ae73-40a0-a739-f46e92cc9203">1,500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324357</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2030</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i75cf2627ef3e4b49a60bffdc84713fe3_I20180331" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEzLTQtMS0xLTM2NDA2MA_9ec97e8a-5907-4c64-a0d8-4701f1d88a13">1.375</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i75cf2627ef3e4b49a60bffdc84713fe3_I20180331" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEzLTUtMS0xLTM2NDA2MA_61033d8a-1e7f-4668-91a8-34875392d7d1">2,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324373</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2038</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad984e38fb9c4661b085d5217e565409_I20180331" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE0LTQtMS0xLTM2NDA2MA_83749745-9fdb-4f2c-9a85-1d256db02516">1.875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iad984e38fb9c4661b085d5217e565409_I20180331" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE0LTUtMS0xLTM2NDA2MA_a432ef5f-191c-4a15-ad49-9460d05e5f19">1,250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013409844</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32f8fe30afa14a24ac9c7eaceaaadef0_I20190331" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE2LTQtMS0xLTM2NDA2MA_518f8459-564d-4031-b259-fa906438175b">0.875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i32f8fe30afa14a24ac9c7eaceaaadef0_I20190331" decimals="-6" name="ifrs-full:NotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE2LTUtMS0xLTM2NDA2MA_fffbd1ff-de25-4746-823b-f9321896c405">650</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013409851</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2034</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bd94679eb80436b822cc5a86b620280_I20190331" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE3LTQtMS0xLTM2NDA2MA_c25b494d-7d03-4971-9ebb-b21a3c281f26">1.25</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd94679eb80436b822cc5a86b620280_I20190331" decimals="-6" name="ifrs-full:NotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE3LTUtMS0xLTM2NDA2MA_f9255896-b925-4ab7-b7c5-0b620ac430e3">500</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-59</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i0ac1c46d446f405cb4463e8bed0c35dd" continuedAt="i4f7087b847124eceb1bc4ecf3d58520d"><ix:continuation id="i43a5bf39900f4a3d926b98a5507d10f5"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bond issues carried out by Sanofi under the public bond issue program (shelf registration statement) registered with the US&#160;Securities and Exchange Commission (SEC) comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issuer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ISIN code</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issue&#160;date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual&#160;<br/>interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">($&#160;million)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US801060AC87</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1513a029052410e867702910e46272a_I20180630" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjMzU4N2M2MmUxZDM0Njc0YmM0NzgxYTc3ZDgzMzNjMC90YWJsZXJhbmdlOmMzNTg3YzYyZTFkMzQ2NzRiYzQ3ODFhNzdkODMzM2MwXzItNC0xLTEtMzY0MDYw_11704b27-15df-4786-b5e5-f81a0f5b0464">3.375</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1513a029052410e867702910e46272a_I20180630" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjMzU4N2M2MmUxZDM0Njc0YmM0NzgxYTc3ZDgzMzNjMC90YWJsZXJhbmdlOmMzNTg3YzYyZTFkMzQ2NzRiYzQ3ODFhNzdkODMzM2MwXzItNS0xLTEtMzY0MDYw_131a3922-d78e-4e81-813f-c1cba2d80f65">1,000</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US801060AD60</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2028</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e560b0683e3415f88c8eea18541347e_I20180630" decimals="INF" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjMzU4N2M2MmUxZDM0Njc0YmM0NzgxYTc3ZDgzMzNjMC90YWJsZXJhbmdlOmMzNTg3YzYyZTFkMzQ2NzRiYzQ3ODFhNzdkODMzM2MwXzMtNC0xLTEtMzY0MDYw_56789251-81d0-46f9-8576-c49ce858e8b4">3.625</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e560b0683e3415f88c8eea18541347e_I20180630" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjMzU4N2M2MmUxZDM0Njc0YmM0NzgxYTc3ZDgzMzNjMC90YWJsZXJhbmdlOmMzNTg3YzYyZTFkMzQ2NzRiYzQ3ODFhNzdkODMzM2MwXzMtNS0xLTEtMzY0MDYw_15965ff8-edc7-4ecb-9540-80c5cd329900">1,000</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The &#8220;Other borrowings&#8221; line mainly comprises participating shares issued between 1983 and 1987, of which <ix:nonFraction unitRef="shares" contextRef="i6d556347116c4d7392f113ed4a0ab9d6_I20221231" decimals="INF" name="sny:ParticipatingSharesNumberOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzMwMDk_e18506d3-df73-40ac-834e-ad01876d9fd7">74,996</ix:nonFraction>&#160;remain outstanding, with a nominal amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="i6d556347116c4d7392f113ed4a0ab9d6_I20221231" decimals="-6" name="sny:ParticipatingSharesCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzMwNTc_b9890f27-1433-40e2-89a5-2044532ea966">11</ix:nonFraction> million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order to manage its liquidity needs for current operations, as of December&#160;31, 2022 Sanofi has:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a syndicated credit facility of &#8364;<ix:nonFraction unitRef="eur" contextRef="i04b9380769a449a58e37ee1407a157ae_I20221231" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzMxOTI_058219c8-4edd-4ada-ae83-18995cb242d4">4</ix:nonFraction>&#160;billion, drawable in euros and in US dollars, maturing December&#160;3,&#160;2023 following the exercise of the second extension option in June&#160;2022; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a syndicated credit facility of &#8364;<ix:nonFraction unitRef="eur" contextRef="idee5b77afc724b18b9ed606b041a8f3c_I20221231" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM0NTg_f0d65564-4229-4514-960b-f6dc7b003593">4</ix:nonFraction>&#160;billion, drawable in euros and in US dollars, maturing December&#160;6, 2027 following the exercise of the second extension option in September&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi also has a &#8364;<ix:nonFraction unitRef="eur" contextRef="i584b670205654f298de6bc6c82719f4f_I20221231" decimals="-6" name="ifrs-full:CommercialPapersIssued" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM3MDk_5ec60ed8-9a8f-4629-8af0-4cb077a65245">6</ix:nonFraction>&#160;billion Negotiable European Commercial Paper program in France and a $<ix:nonFraction unitRef="usd" contextRef="ie51595be9dd743b794627696bbc95347_I20221231" decimals="-6" name="ifrs-full:CommercialPapersIssued" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM3NzM_90c67a90-6a3f-47c5-9171-bd99796e32da">10</ix:nonFraction>&#160;billion Commercial Paper program in the United States. During 2022 only the US program was used, with an average drawdown of $<ix:nonFraction unitRef="usd" contextRef="i1d46e42d80ad40f7be7642c3218b547b_D20220101-20221231" decimals="-8" name="sny:BorrowingAverageDrawdown" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM4OTE_23d22a61-0652-4d54-8a1f-8a6081db4dfc">2.3</ix:nonFraction>&#160;billion (versus a maximum of&#160;$<ix:nonFraction unitRef="usd" contextRef="i1d46e42d80ad40f7be7642c3218b547b_D20220101-20221231" decimals="-8" name="sny:BorrowingMaximumDrawdown" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM5MTU_ee54a2c6-b19b-49ca-86d5-6e741716dde3">4.0</ix:nonFraction>&#160;billion). As of December&#160;31, 2022, there were <ix:nonFraction unitRef="usd" contextRef="ie51595be9dd743b794627696bbc95347_I20221231" decimals="INF" name="sny:BorrowingDrawdown" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM5NTY_5a520fab-bfe6-4fad-b127-6283e2d24993">no</ix:nonFraction> drawdowns under any of those programs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The financing in place as of December 31, 2022 at the level of the holding company (which manages most of Sanofi&#8217;s financing needs centrally) is not subject to any financial covenants, and contains no clauses linking spreads or fees to the credit rating.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c) Debt by maturity, at value on redemption</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NTM_de417125-292c-46f2-8c6b-92a0df87a82e" continuedAt="i721c8599f24e4528bddd80b4ddfb202a" escape="true"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:34.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItMS0xLTEtMzY0MDYw_169ec2c4-69a3-4adc-be2e-a93474b392fa">18,861</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9e52293342884ce98adab12df87659e0_I20221231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItMi0xLTEtMzY0MDYw_3c56dd6d-8aa3-4d0d-9aee-726b0d01d7f1">3,817</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231" decimals="-6" name="ifrs-full:BondsIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItMy0xLTEtMzY0MDYw_24c1e071-c61e-4f1e-bf32-59317721a9c2">600</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItNC0xLTEtMzY0MDYw_49d1f67d-3aa6-40ae-88c1-00b3e72fd519">2,600</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItNS0xLTEtMzY0MDYw_e874e246-5335-4a5e-97d8-b4928ad8c06c">4,160</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItNi0xLTEtMzY0MDYw_9f17ee04-9777-46ce-b76c-1feb9ce3a2e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItNy0xLTEtMzY0MDYw_82722205-5303-4f81-aa6f-6f47a5d5a832">7,684</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtMS0xLTEtMzY0MDYw_bfc4b0e4-0932-45eb-8acd-d2a9ae183f88">286</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9e52293342884ce98adab12df87659e0_I20221231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtMi0xLTEtMzY0MDYw_521147a2-c32d-41b9-8265-a2c6c4d19534">187</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtMy0xLTEtMzY0MDYw_6c281604-92f7-41bc-a287-713820b7ae9a">61</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231" decimals="-6" name="sny:OtherBankBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtNC0xLTEtMzY0MDYw_611e342d-ff2c-4c03-a2fc-88b1b32d45e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231" decimals="-6" name="sny:OtherBankBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtNS0xLTEtMzY0MDYw_50bd4921-0018-49c6-8936-28ad1a3f1ee4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231" decimals="-6" name="sny:OtherBankBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtNi0xLTEtMzY0MDYw_aedb30f9-da46-4cf5-99e3-a3ac9505d2d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtNy0xLTEtMzY0MDYw_747ae667-449b-4416-8051-0ac40bcf48e1">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtMS0xLTEtMzY0MDYw_8e4c1192-61f6-4cb9-9b7e-ae39ac600d80">6</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9e52293342884ce98adab12df87659e0_I20221231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtMi0xLTEtMzY0MDYw_641088b0-527e-4854-9881-2ad462db741f">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtMy0xLTEtMzY0MDYw_2a6e6deb-7a42-41eb-a431-88a36dab8558">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtNC0xLTEtMzY0MDYw_d771547d-fdb0-4fe3-9696-5205dea66f4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtNS0xLTEtMzY0MDYw_06126523-0b45-49e9-9c5d-71638f3f7657">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtNi0xLTEtMzY0MDYw_aef46794-21a4-44ee-9ed5-bda1de0ed639">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtNy0xLTEtMzY0MDYw_abc2263b-1e53-4ca9-a3a4-317739acec64">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtMS0xLTEtMzY0MDYw_919745f9-e511-4192-b587-4e4fade7a6e2">168</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9e52293342884ce98adab12df87659e0_I20221231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtMi0xLTEtMzY0MDYw_1182cea1-31d8-4bb8-9583-9e0805315eac">168</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtMy0xLTEtMzY0MDYw_f7b0ec5d-0b39-47e2-a247-e8a4c702a07c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtNC0xLTEtMzY0MDYw_6133453f-982d-464c-a4ea-aed7a8d45145">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtNS0xLTEtMzY0MDYw_9e2c196b-ae96-499c-8e2f-af3413323bb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtNi0xLTEtMzY0MDYw_feed7db5-da5d-4cd0-a8f0-073f0d0a8f40">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtNy0xLTEtMzY0MDYw_8196b72c-d890-4687-9426-60ab78e8a889">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used <br/>to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtMS0xLTEtMzY0MDYw_fed3bd52-8dd4-4bda-b21b-cf22b8b7b473">48</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9e52293342884ce98adab12df87659e0_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtMi0xLTEtMzY0MDYw_51b6a39f-aa68-4c68-937e-216dc7571729">48</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtMy0xLTEtMzY0MDYw_465a4a52-49e6-4f9c-9ee2-e2564aeeb8ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtNC0xLTEtMzY0MDYw_9172e4dd-b760-43c0-9add-7585a2c0f585">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtNS0xLTEtMzY0MDYw_f8202930-adc4-4f28-b7b3-c5e4b1ca39de">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtNi0xLTEtMzY0MDYw_d9eefe3e-6daf-4239-8372-90177bc850ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtNy0xLTEtMzY0MDYw_1aa22722-88fb-411c-9349-022daf73001c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctMS0xLTEtMzY0MDYw_68cd24d3-e7de-4f89-9f9e-824580637e82">19,273</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9e52293342884ce98adab12df87659e0_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctMi0xLTEtMzY0MDYw_fda2f55c-148c-4e98-8ba1-0c2227cfffab">4,130</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231" decimals="-6" name="ifrs-full:Borrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctMy0xLTEtMzY0MDYw_b7e97ac8-107c-4715-a0af-3734f72e073f">661</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctNC0xLTEtMzY0MDYw_6e5ee047-9c5d-4565-a1a2-8ad0c3107ff2">2,600</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctNS0xLTEtMzY0MDYw_417b5794-a0d7-46d4-ba30-48699caccf4b">4,160</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctNi0xLTEtMzY0MDYw_f7eae6c7-36a9-4c41-b310-4df5c420cf77">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctNy0xLTEtMzY0MDYw_00600620-2a36-4969-93f7-3096b6b0dca4">7,722</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtMS0xLTEtMzY0MDYw_e8a6bf73-5343-48f5-8875-4172da6b9a46">12,736</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9e52293342884ce98adab12df87659e0_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtMi0xLTEtMzY0MDYw_f57fb9f8-655a-4ad9-a56b-bdbeb599dd45">12,736</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtMy0xLTEtMzY0MDYw_e66183be-5a55-4b2a-91c1-6fdb00c9bd40">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtNC0xLTEtMzY0MDYw_a9742d81-be13-44ca-a8d6-f83897814b56">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtNS0xLTEtMzY0MDYw_feeae699-cb85-4a56-8d5c-9a49648311c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtNi0xLTEtMzY0MDYw_4ccb6000-7e36-46d4-8a50-41e46e630b2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtNy0xLTEtMzY0MDYw_1078632b-b826-49dd-93d8-539155d21a5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used <br/>to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktMS0xLTEtMzY0MDYw_50345479-9001-4af6-b005-4f9abad9b6c9">45</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9e52293342884ce98adab12df87659e0_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktMi0xLTEtMzY0MDYw_f2791f23-5cbb-4ac5-93ef-b6ed6fcc43d0">45</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktMy0xLTEtMzY0MDYw_3417e534-1934-45ed-9f6c-1c9a0894a112">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktNC0xLTEtMzY0MDYw_751c64ff-47e6-4277-b3d8-ed3e98b540ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktNS0xLTEtMzY0MDYw_db07658c-7d68-4988-8583-b7e6ecd9da72">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktNi0xLTEtMzY0MDYw_f4b27b0e-2ee6-4744-adcd-010ff8dfb379">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktNy0xLTEtMzY0MDYw_848e8678-9d1b-4667-8739-9721ed4deaa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTEtMS0xLTM2NDA2MA_a7749556-3a34-4d33-ac39-ad71fd6ef4af">6,492</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9e52293342884ce98adab12df87659e0_I20221231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTItMS0xLTM2NDA2MA_3e261f56-ba23-418b-bb9b-7ace6e8124d5">8,651</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTMtMS0xLTM2NDA2MA_b1385cf3-e462-4f3b-96ea-be48d3e5f541">661</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTQtMS0xLTM2NDA2MA_79e5eda7-c733-4217-9b52-c544f2ca2e94">2,600</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTUtMS0xLTM2NDA2MA_e2140fd7-541d-4641-9c04-5c8c03e843ea">4,160</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTYtMS0xLTM2NDA2MA_4cb5c432-c274-4af2-9316-bbf1cf824af1">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTctMS0xLTM2NDA2MA_ecd29dc0-8b5c-4fb3-9de8-a04d2cbef563">7,722</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Net debt does not include lease liabilities, which amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzQzNTI_b8e77a0b-c18d-4dbc-85e1-81d8f3177f99">2,181</ix:nonFraction>&#160;million as of December&#160;31, 2022; &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzQ0MTM_d1d52ba2-bea1-468f-a41e-38055b097ad9">2,108</ix:nonFraction>&#160;million as of&#160;December&#160;31, 2021; and&#160;&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonFraction unitRef="eur" contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzQ0NTQ_3c3d855a-863a-4ea4-ab6d-9f7f955c321c">1,163</ix:nonFraction>&#160;million as of December&#160;31, 2020</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> (see the maturity analysis at Note&#160;D.17.2.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, the main undrawn confirmed general-purpose credit facilities at holding company level amounted to&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i21b97dca30ff4878a0d00522d024354b_I20221231" decimals="-9" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzQ2NDI_78fe0718-ed74-4e22-9c59-6f9887d2677f">8</ix:nonFraction> billion, half of which expires in 2023 and the other half of which expires in 2027.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, no single counterparty represented more than 6% of Sanofi&#8217;s undrawn confirmed credit facilities.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:34.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItMS0xLTEtMzY0MDYw_4a358627-fcf4-4c85-ae44-f1876a5d248a">19,946</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9863724d6eed4da18629877e392fd908_I20211231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItMi0xLTEtMzY0MDYw_ab435ab3-c738-4fe8-bab5-d30a2e147024">2,828</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8115851386c448bb86584a094cd62be1_I20211231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItMy0xLTEtMzY0MDYw_76e11d23-b6e1-4ac1-b5b0-05284fad7756">3,629</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231" decimals="-6" name="ifrs-full:BondsIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItNC0xLTEtMzY0MDYw_29dbf800-902c-4ab8-ba91-cd4d49b8da4a">600</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItNS0xLTEtMzY0MDYw_baed3913-da55-4065-b328-491fc374f9fa">1,750</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc5db8aced27474ba3858b0e92719936_I20211231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItNi0xLTEtMzY0MDYw_601b76bc-cd97-438b-94ca-948a0696ee16">4,160</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItNy0xLTEtMzY0MDYw_b1ac13a1-cb54-4b6c-8480-7b1590300da0">6,979</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtMS0xLTEtMzY0MDYw_2df76bad-65f1-42ac-ae9d-b4b14969192e">184</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9863724d6eed4da18629877e392fd908_I20211231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtMi0xLTEtMzY0MDYw_534e6fd2-e97d-4c7e-aa0f-9bedcfe9cf3c">163</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8115851386c448bb86584a094cd62be1_I20211231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtMy0xLTEtMzY0MDYw_917d8330-e9a4-4428-9207-3d50569867d6">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtNC0xLTEtMzY0MDYw_812aead1-4719-4106-87b0-e6909c958404">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtNS0xLTEtMzY0MDYw_945524d1-6212-42f0-98de-0ae31a8c10b5">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc5db8aced27474ba3858b0e92719936_I20211231" decimals="-6" name="sny:OtherBankBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtNi0xLTEtMzY0MDYw_e1b2e8e5-79f7-4f85-8192-eef316b13934">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231" decimals="-6" name="sny:OtherBankBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtNy0xLTEtMzY0MDYw_4129578c-5b1d-44ce-8158-27d5e5e0ff94">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtMS0xLTEtMzY0MDYw_5aa54dbc-65b7-4a9c-a91f-88b51bc2d517">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9863724d6eed4da18629877e392fd908_I20211231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtMi0xLTEtMzY0MDYw_9d8db104-a305-4281-910a-64fcf800fd54">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8115851386c448bb86584a094cd62be1_I20211231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtMy0xLTEtMzY0MDYw_9f7a9790-3b8e-4cd0-8c67-ac93b4b04dee">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtNC0xLTEtMzY0MDYw_993b9516-11f7-429e-b6a7-db20f677215d">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtNS0xLTEtMzY0MDYw_cde3d241-9712-47f5-8500-1cd5e8857591">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc5db8aced27474ba3858b0e92719936_I20211231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtNi0xLTEtMzY0MDYw_26b6ba37-1062-48af-b93b-127dcd007c58">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtNy0xLTEtMzY0MDYw_0cd37399-7313-45a1-abd0-13554a827a32">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtMS0xLTEtMzY0MDYw_98ed9f9f-07aa-4951-8208-2edbaeaefad5">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9863724d6eed4da18629877e392fd908_I20211231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtMi0xLTEtMzY0MDYw_2251c336-46fb-4cce-b317-c2602bbde88b">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8115851386c448bb86584a094cd62be1_I20211231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtMy0xLTEtMzY0MDYw_5ad26c2b-5b79-4f18-bf1c-c7305caa7091">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtNC0xLTEtMzY0MDYw_528f796e-1b2b-4a6a-a23a-505cfb52e1cd">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtNS0xLTEtMzY0MDYw_2520d9a8-fae2-423b-9176-50860298d857">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc5db8aced27474ba3858b0e92719936_I20211231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtNi0xLTEtMzY0MDYw_8df95209-041b-4eff-a9a1-06999cb1fd00">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtNy0xLTEtMzY0MDYw_f4f8ab55-3da9-4cdb-8f85-2d2686fa5990">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtMS0xLTEtMzY0MDYw_24a799d2-9770-483c-ba4c-832951f5f24d">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9863724d6eed4da18629877e392fd908_I20211231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtMi0xLTEtMzY0MDYw_5d2ed8dd-eb5b-4f6c-b987-3ef8149f24a6">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8115851386c448bb86584a094cd62be1_I20211231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtMy0xLTEtMzY0MDYw_9b2dac3d-1de3-4ba6-b7d2-4a46aea122ca">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtNC0xLTEtMzY0MDYw_fc49bb86-25a8-45a3-ba8d-37c02f181de1">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtNS0xLTEtMzY0MDYw_47e84651-2505-42ae-ad49-ab3d07a23540">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc5db8aced27474ba3858b0e92719936_I20211231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtNi0xLTEtMzY0MDYw_56308a0c-2cb9-4f50-913a-e020b05e9935">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtNy0xLTEtMzY0MDYw_253c1605-e262-4c73-990f-702363878e3b">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctMS0xLTEtMzY0MDYw_713cecc3-7e4f-45a4-a9c4-6e3bd84f6fbd">45</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9863724d6eed4da18629877e392fd908_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctMi0xLTEtMzY0MDYw_36f54e48-1fbc-4fae-8552-7428da9fa8c0">45</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8115851386c448bb86584a094cd62be1_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctMy0xLTEtMzY0MDYw_1605ba18-ceff-4b0d-aca7-f5c679fa24a5">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctNC0xLTEtMzY0MDYw_e9745682-aa63-4be6-88e7-5aae2eac6eac">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctNS0xLTEtMzY0MDYw_ac6941b7-6115-4159-a2fc-4e1075ab9d4a">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc5db8aced27474ba3858b0e92719936_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctNi0xLTEtMzY0MDYw_13677760-604e-4cd6-a442-8ccc8e1d2f38">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctNy0xLTEtMzY0MDYw_3896aadd-954c-4df7-afba-fb2a351e1940">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtMS0xLTEtMzY0MDYw_c75b91b1-c66e-4c04-9921-62012cc25513">20,314</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9863724d6eed4da18629877e392fd908_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtMi0xLTEtMzY0MDYw_830a184e-3c79-4096-a04d-7eab9c6926bb">3,138</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8115851386c448bb86584a094cd62be1_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtMy0xLTEtMzY0MDYw_b0489310-f292-41a6-be58-1b95eb3fe516">3,647</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231" decimals="-6" name="ifrs-full:Borrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtNC0xLTEtMzY0MDYw_39000786-0e95-4dd9-9dfe-713b48f1db17">602</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtNS0xLTEtMzY0MDYw_8fd5bfd6-17d8-4c3f-bc1b-59d2213bea18">1,751</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc5db8aced27474ba3858b0e92719936_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtNi0xLTEtMzY0MDYw_7b21667f-b314-45a5-bf0f-f46285df7de0">4,160</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtNy0xLTEtMzY0MDYw_475b1085-f680-46bc-b948-b4df1b1903d3">7,016</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktMS0xLTEtMzY0MDYw_35504233-8a89-403a-9a07-8db51bbf4e35">10,098</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9863724d6eed4da18629877e392fd908_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktMi0xLTEtMzY0MDYw_764a51bf-b168-4c60-9464-4770f0d1520a">10,098</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8115851386c448bb86584a094cd62be1_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktMy0xLTEtMzY0MDYw_5c37a19e-8f53-416f-ab81-cccacd69b732">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktNC0xLTEtMzY0MDYw_cf039ae6-fd74-40ac-af08-c4d2920511cf">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktNS0xLTEtMzY0MDYw_30c392d2-c7b2-4a66-85bf-fb3abe9789ac">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc5db8aced27474ba3858b0e92719936_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktNi0xLTEtMzY0MDYw_cb3a8e96-cd51-4908-ac26-b4a9e2b104a5">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktNy0xLTEtMzY0MDYw_4b86d609-9110-45f2-9c91-60d3c9a8e8cc">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTEtMS0xLTM2NDA2MA_1a5eb32e-efe9-4ab2-aa69-bd36c606f27d">169</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9863724d6eed4da18629877e392fd908_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTItMS0xLTM2NDA2MA_13a633bf-fe26-4b0f-9911-91e3632d2767">169</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8115851386c448bb86584a094cd62be1_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTMtMS0xLTM2NDA2MA_e70c0bff-0e33-4040-9d1c-810a0d71771e">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTQtMS0xLTM2NDA2MA_20a25683-f479-4132-8520-545a9530a459">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTUtMS0xLTM2NDA2MA_14f60a74-f40c-4a25-bf9a-47cf489be129">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc5db8aced27474ba3858b0e92719936_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTYtMS0xLTM2NDA2MA_752451e6-f8d8-4de5-898a-3869837ccd09">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTctMS0xLTM2NDA2MA_dddfebea-4381-4434-a203-7d9e7103da56">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTEtMS0xLTM2NDA2MA_ec77c50c-437e-47d7-9aa0-add1a0f2e9dd">10,047</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9863724d6eed4da18629877e392fd908_I20211231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTItMS0xLTM2NDA2MA_1c063115-c1a9-4522-891c-c5209420076f">7,129</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8115851386c448bb86584a094cd62be1_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTMtMS0xLTM2NDA2MA_5bb2f028-db31-48fd-924c-bbc4029255a7">3,647</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTQtMS0xLTM2NDA2MA_184149b6-deac-469a-874d-969fad0983c0">602</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTUtMS0xLTM2NDA2MA_f086e290-a6c2-4699-a13f-775bacacb5b2">1,751</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc5db8aced27474ba3858b0e92719936_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTYtMS0xLTM2NDA2MA_d4597b9f-e331-42a3-b145-a9befb7da6a6">4,160</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTctMS0xLTM2NDA2MA_18565560-d4e3-4e8d-80de-f5a5554a7eaa">7,016</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-60</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i4f7087b847124eceb1bc4ecf3d58520d" continuedAt="i725b0bb8f4d44dbbad416a7741137df0"><div style="margin-bottom:5pt;text-align:justify"><ix:continuation id="i721c8599f24e4528bddd80b4ddfb202a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:34.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItMS0xLTEtMzY0MDYw_e865051b-43b4-4160-9d94-7fb1d479cdbc">21,978</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItMi0xLTEtMzY0MDYw_46e5e310-03a0-4a7b-89d4-8f3a678446b4">2,280</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItMy0xLTEtMzY0MDYw_6fb639c4-41f5-4586-9252-0b086f1f4fd4">2,700</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a4898d404904d67b54841026f034dd5_I20201231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItNC0xLTEtMzY0MDYw_ca7f1d64-44a7-44e2-84da-96e45ed1d354">3,569</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231" decimals="-6" name="ifrs-full:BondsIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItNS0xLTEtMzY0MDYw_6192bd99-6066-403b-ab24-1f311f3af82b">600</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItNi0xLTEtMzY0MDYw_c15bf1f1-81b6-4b09-81ab-829905797eef">1,750</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231" decimals="-6" name="ifrs-full:BondsIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItNy0xLTEtMzY0MDYw_a49d65cb-9056-4cb4-ae94-d23dc26814bc">11,079</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtMS0xLTEtMzY0MDYw_de3e206a-fa84-467b-b2b7-3e6da4e23a3d">296</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtMi0xLTEtMzY0MDYw_cacaa558-8e8e-4443-a216-67ebe5159b28">200</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtMy0xLTEtMzY0MDYw_6bbdaa3c-0171-4636-8794-f8df432a0510">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a4898d404904d67b54841026f034dd5_I20201231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtNC0xLTEtMzY0MDYw_44d0938e-3550-4818-b48d-32469e8c1f2c">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtNS0xLTEtMzY0MDYw_4d89de60-b14b-4976-9195-3365b8eef4a6">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtNi0xLTEtMzY0MDYw_d08ed7e8-3a1b-4702-9843-542ecba51f2a">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231" decimals="-6" name="sny:OtherBankBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtNy0xLTEtMzY0MDYw_ffb60373-c6ef-4d79-8c8b-12c2f42ca4a1">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtMS0xLTEtMzY0MDYw_d65980b6-e107-4cc9-84d4-e237367aeb2c">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtMi0xLTEtMzY0MDYw_5424fb9e-00ad-43e6-a144-54155dd0c541">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtMy0xLTEtMzY0MDYw_7f0b8f6b-1757-43a3-a47c-6358e3c2f6e1">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a4898d404904d67b54841026f034dd5_I20201231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtNC0xLTEtMzY0MDYw_029aee0b-c67c-4ca8-81a8-efe3c90dadd9">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtNS0xLTEtMzY0MDYw_29cbd171-2013-4687-9388-c409465d4b86">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtNi0xLTEtMzY0MDYw_fd4c1bf0-7191-4bbe-97b1-9d3bc806d23a">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231" decimals="-6" name="sny:FinanceLeaseLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtNy0xLTEtMzY0MDYw_90f5a98f-0c0c-4927-ba56-348912121774">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtMS0xLTEtMzY0MDYw_0b284583-cd50-4c42-9be5-b773f2443d42">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231" decimals="-6" name="ifrs-full:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtMi0xLTEtMzY0MDYw_f942f115-37be-4aba-83c9-a015063e5240">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtMy0xLTEtMzY0MDYw_e6571478-5770-45a1-9010-2acff46cde10">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a4898d404904d67b54841026f034dd5_I20201231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtNC0xLTEtMzY0MDYw_938aa0c2-dde9-45b4-b491-c32ba6807db7">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtNS0xLTEtMzY0MDYw_84af5600-3d0e-4c9a-9328-cd2ffa12a28f">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtNi0xLTEtMzY0MDYw_8c91614f-5935-4ad3-a371-068228411e26">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231" decimals="-6" name="ifrs-full:OtherBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtNy0xLTEtMzY0MDYw_3187ff2a-c4f2-4066-bd13-31e297720619">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtMS0xLTEtMzY0MDYw_e2fdc3c9-456e-4fdd-998b-048bee03f122">285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtMi0xLTEtMzY0MDYw_a0ffbd03-f6c8-40ca-8ca8-fd71ed8fc05a">285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtMy0xLTEtMzY0MDYw_b1cb2d0f-0301-4be4-b467-4de1201ca542">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a4898d404904d67b54841026f034dd5_I20201231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtNC0xLTEtMzY0MDYw_51d6e2a6-ef22-45c2-ae02-bb5a569115ce">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtNS0xLTEtMzY0MDYw_db3f2a5f-7b77-4743-aca7-36f922c4b58b">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtNi0xLTEtMzY0MDYw_aaf84e27-d6cb-45d2-91a7-36fa69a5a2d2">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231" decimals="-6" name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtNy0xLTEtMzY0MDYw_d55bb8d6-8568-43a4-998d-15a51557cc79">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctMS0xLTEtMzY0MDYw_7572af89-1ec0-4e72-bf80-dbd7e32dfc7f">142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctMi0xLTEtMzY0MDYw_43bce636-91f3-4d60-a3b3-81589f53e4d6">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctMy0xLTEtMzY0MDYw_60e2bab6-f0fd-4fa9-8b3e-ec7930abd136">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a4898d404904d67b54841026f034dd5_I20201231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctNC0xLTEtMzY0MDYw_662d5da6-a3d9-4d02-9380-5c766ab791e2">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctNS0xLTEtMzY0MDYw_2a190514-9216-4dff-bcc9-687fa9a86389">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctNi0xLTEtMzY0MDYw_78273028-e1cb-4b35-ae88-4386966734b2">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctNy0xLTEtMzY0MDYw_fb6c7a6c-b66c-4fee-8fce-f019e6710da0">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtMS0xLTEtMzY0MDYw_77ca57d0-851a-4b33-bfae-73e55755bb78">22,703</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtMi0xLTEtMzY0MDYw_f7344dca-a671-437e-a3d7-6666ba15e67d">2,852</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtMy0xLTEtMzY0MDYw_9fe7e43e-53c8-4584-8e45-9cfc5b90aba5">2,830</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a4898d404904d67b54841026f034dd5_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtNC0xLTEtMzY0MDYw_ea144e93-a981-456a-8ff5-fcb08cd77c2d">3,575</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231" decimals="-6" name="ifrs-full:Borrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtNS0xLTEtMzY0MDYw_cbfbcf90-ccb5-4a63-af57-e28446d83447">602</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtNi0xLTEtMzY0MDYw_09b5818b-52e0-463b-9688-73de25630f07">1,756</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtNy0xLTEtMzY0MDYw_c2f9dea7-c3ef-4a30-bd0a-f6121abfd75a">11,088</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktMS0xLTEtMzY0MDYw_07b566b4-c11e-4bb4-a623-b28c71a2ad24">13,915</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktMi0xLTEtMzY0MDYw_15fa7384-8865-496b-857a-716f16ee3a52">13,915</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktMy0xLTEtMzY0MDYw_d2293a68-934e-4cfe-aae9-605f41db0f43">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a4898d404904d67b54841026f034dd5_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktNC0xLTEtMzY0MDYw_18373d8c-30a4-4457-9500-5b93f85f8765">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktNS0xLTEtMzY0MDYw_493c50e9-384d-49e1-a4d2-e87db5f773c9">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktNi0xLTEtMzY0MDYw_cfde3a7c-1d64-4066-9cf0-ba66868060dd">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktNy0xLTEtMzY0MDYw_39469798-c6ba-42e9-bae0-d2114482ee7a">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTEtMS0xLTM2NDA2MA_7890b55b-e24e-403a-a5b3-4a85daf28ecf">74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTItMS0xLTM2NDA2MA_7f6bc09c-3e64-4948-9b56-c2c9c7b4bcc7">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231" decimals="-6" sign="-" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTMtMS0xLTM2NDA2MA_5ccfad3b-ac1c-4180-9667-854db09f7608">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a4898d404904d67b54841026f034dd5_I20201231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTQtMS0xLTM2NDA2MA_7060ecd8-e7bf-4c07-b522-21af9c59661e">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTUtMS0xLTM2NDA2MA_54f0de86-abfe-40de-858b-0bef953f17c4">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTYtMS0xLTM2NDA2MA_93f4a2ab-8bd1-4b34-8459-069e74c521cd">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231" decimals="-6" name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTctMS0xLTM2NDA2MA_a5c81e21-2949-4e99-bbc5-5fa0a884241f">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTEtMS0xLTM2NDA2MA_d1fc4765-72b5-46e3-b3e5-cb243ce522d4">8,862</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTItMS0xLTM2NDA2MA_3bd23d46-e5b1-404d-8a0a-7cfcc32d4840">10,995</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTMtMS0xLTM2NDA2MA_19b18f32-303f-4282-b330-0c277d1bcad3">2,836</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a4898d404904d67b54841026f034dd5_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTQtMS0xLTM2NDA2MA_e392715f-d776-4703-8a10-ded46dbdf586">3,575</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTUtMS0xLTM2NDA2MA_db8d6e20-8fd2-4d7a-97fe-3f354259dd73">602</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTYtMS0xLTM2NDA2MA_dbe7c3a1-afba-4ff0-9685-d21393eac329">1,756</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTctMS0xLTM2NDA2MA_33e1ae4b-2d79-419a-95ac-a437de08ddd7">11,088</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d) Debt by interest rate, at value on redemption</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NTQ_be3b5962-1632-49e7-92a8-15875a282c8f" continuedAt="i19c823b15a344b64b22fd041c0b07a4c" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below splits net debt between fixed and floating rate, and by maturity, as of December 31, 2022. The figures shown are values on redemption, before the effects of derivative instruments:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:34.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixed-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iebd2bcba58ef4b558528913b09bfaea2_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtMS0xLTEtMzY0MDYw_648bae0e-8ad8-4007-9b05-0afcc3a5c87b">18,861</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i540f25e289fc4a81b2b603c1ce544e8e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtMi0xLTEtMzY0MDYw_a70242e3-6190-4cfd-92f4-ad602c17b0a0">3,817</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i75c02dbe746a4f0c8dd0bf49930dcd0f_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtMy0xLTEtMzY0MDYw_8fe3d5e9-7c95-408a-ab80-a1b4f8853149">600</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia7d499e8c9264feb8703281a726ff271_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtNC0xLTEtMzY0MDYw_a2f7c529-398a-45e2-abc7-5c6045ed5da2">2,600</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b6083f115234231b8a9cb18a0d9cf1c_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtNS0xLTEtMzY0MDYw_9a2e816c-d3c1-443e-b557-a6a2856c5a23">4,160</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i00b59f839f7a4230acf9e7674e11930f_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtNi0xLTEtMzY0MDYw_2696504d-afcb-43ba-98e9-544299ef40c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6834ab2b35104783bf996d12d8b5b3be_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtNy0xLTEtMzY0MDYw_18d1a0ee-6c14-4b53-8b27-4d6ea8e5ab08">7,684</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5bae5a0d6a9e4f738590405a5e507f88_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzItMS0xLTEtMzY0MDYw_7ad3a5ee-024f-4cc1-bb0c-8b5858640783">16,993</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icda6c69534d246a48a04830eb613df01_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzMtMS0xLTEtMzY0MDYw_14038f16-ff70-4a2c-ba43-83ea3a21ba23">1,868</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% fixed-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8c3e0f4218054eae8d6f0cd63d414c89_I20221231" decimals="2" name="sny:DebtPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzQtMS0xLTEtMzY0MDYw_5144f6c0-38b7-453f-9459-44cc700afb7c">98</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Floating-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ieffdd3fdeffd433ea7df1b20775e6aad_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtMS0xLTEtMzY0MDYw_623e7b51-cf8d-4808-a131-97f041113f25">460</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7b5db8eab4b64e88973da38da595851d_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtMi0xLTEtMzY0MDYw_d3d3092e-6dbf-46d3-958b-629336d8083f">361</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i01fe7149c70b4165ab567b66b5f5a43e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtMy0xLTEtMzY0MDYw_5a3ea233-2aff-4b67-a265-a9626a910dd5">61</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i689114ca44ed42ee9df9e1c418d03d2e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtNC0xLTEtMzY0MDYw_96d07a67-052b-4aeb-bbf2-fc6da10225bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib102efb6dc8143618a1e6b93d00e10a0_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtNS0xLTEtMzY0MDYw_e820ddcc-c3fb-4818-9dfe-6505eff360bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4fab70a599804fa892e143f5459a87bc_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtNi0xLTEtMzY0MDYw_ef804c31-1a2b-4817-a00d-21c8e0e274cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7670912ed6048a3915926c30a98416b_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtNy0xLTEtMzY0MDYw_7d71ca41-d78d-487f-a239-8883e956c394">38</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic557830f381f4210be0d6833c36f65fc_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzYtMS0xLTEtMzY0MDYw_026c0bf8-71fe-4989-a7f9-7fb021e73301">60</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8041942870dd4730b5723c5dc68d38e9_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzctMS0xLTEtMzY0MDYw_4cdf1f17-8454-4f5e-b041-fdbde2b21826">15</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia21f3e9de40f435e9c254cf2a6cde7d5_I20221231" decimals="2" name="sny:DebtPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzgtMS0xLTEtMzY0MDYw_36080f29-db18-4c40-b02f-89cf46ad336c">2</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i562d7157b7e8481a9b91191e18e64665_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktMS0xLTEtMzY0MDYw_e8690146-1bc3-42f3-b6b3-289315436473">19,321</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ce628e107bf47078ecfcfdb13f3e5cc_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktMi0xLTEtMzY0MDYw_a9d16508-3f7e-43e0-b80c-292d788e1d00">4,178</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iedf903d1811b48a5b959ad28581d7e2e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktMy0xLTEtMzY0MDYw_9d10a7f5-0582-4570-b979-b49aac6147da">661</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i91024893bd7f4842a6956080118265db_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktNC0xLTEtMzY0MDYw_b7b55e07-c9e5-419b-8b72-8fd58199c8de">2,600</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4c93c6fb82d542b198701a104373ae59_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktNS0xLTEtMzY0MDYw_5d7f8ede-4e5e-488f-8943-56eb797ea581">4,160</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ida6442fa725647e9a4886d876f008303_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktNi0xLTEtMzY0MDYw_dc434fbd-0d6f-4996-8a02-1c712a1de151">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie0145a96971e41eda0b8dbf9c0cc4308_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktNy0xLTEtMzY0MDYw_51dc987e-b06f-4d95-9969-0178351fc2c5">7,722</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia21f3e9de40f435e9c254cf2a6cde7d5_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEwLTEtMS0xLTM2NDA2MA_7373dd70-934d-4160-a586-f0481e9eac0b">12,736</ix:nonFraction>)</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1adf194cc771430ba20e49e1d9df2cca_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEwLTItMS0xLTM2NDA2MA_10411ba5-2fbf-4de9-9725-9d34522f5018">12,736</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8e9f3675bc884686b9346c2cc4bc46d0_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzExLTEtMS0xLTM2NDA2MA_f118371b-7d11-4382-b798-ce4441b6a9f1">3,908</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i82de31322c4840e9965d37b0c2de087e_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEyLTEtMS0xLTM2NDA2MA_c020b014-6922-4b7b-8611-53bfa39731cf">8,391</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36278eb71056497db2592c9bb8341cf9_I20221231" decimals="INF" name="sny:DebtPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEzLTEtMS0xLTM2NDA2MA_6274d345-648a-47c2-8a04-aa58424a3fdb">100</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i36278eb71056497db2592c9bb8341cf9_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTEtMS0xLTM2NDA2MA_d449c973-c45f-4035-98f5-d0134fe81621">6,585</ix:nonFraction></span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifda4536c10fc4da7bddd520da0e7f941_I20221231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTItMS0xLTM2NDA2MA_ee01ec3e-2f90-488f-86cc-664f8d52f4dc">8,558</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7fdb3550f04484b8bcc3e27a74136e3_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTMtMS0xLTM2NDA2MA_e4d46faf-184f-4c41-bff4-260e9546ef64">661</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if252267932914e47aa7eb646796d3c93_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTQtMS0xLTM2NDA2MA_0bb5e494-6938-4b5a-bbac-234baeb5ce93">2,600</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i588d16a72b9a43e2ad82c0a0a94a5919_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTUtMS0xLTM2NDA2MA_40bc0a48-207a-4a77-b763-86f1f2d8b18b">4,160</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3fc6504724b94686b7b9c04f189e7e73_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTYtMS0xLTM2NDA2MA_ff59fd42-66d2-47cd-a9c9-94366b2df536">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8cc8bc76c35d41f08399d789a26cfdc6_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTctMS0xLTM2NDA2MA_034a3cb3-6599-486a-ba46-d9367f2546b0">7,722</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi issues debt in <ix:nonFraction unitRef="currency" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="INF" name="sny:NumberOfCurrenciesDebtIsIssuedIn" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzUwNjI_0529f9f4-fb89-4156-89ae-efe5077269f1">two</ix:nonFraction> currencies, the euro and the US dollar, and also invests its cash and cash equivalents in those currencies. Sanofi also operates cash pooling arrangements to manage the surplus cash and short-term liquidity needs of foreign subsidiaries located outside the euro zone.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-61</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i725b0bb8f4d44dbbad416a7741137df0" continuedAt="i6107481cf1b545e0b61b46ccda5e6858"><ix:continuation id="i19c823b15a344b64b22fd041c0b07a4c"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To optimize the cost of debt or reduce the volatility of debt and manage its exposure to financial foreign exchange risk, Sanofi uses derivative instruments (interest rate swaps, currency swaps, foreign exchange swaps and forward contracts) that alter the fixed/floating rate split and the currency split of its net debt:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:34.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixed-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibb27d0c0e23e426ea143647091a7d102_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtMS0xLTEtMzY0MDYw_4bd91f68-724d-4ec9-bc3a-afb5427e5f38">16,386</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i26aaac9784564a11983a342fbd429be1_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtMi0xLTEtMzY0MDYw_94a3ae52-2dd4-4508-b2f3-a6236f548298">1,342</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i891c90b7df6d4e61a27d601eeae750a6_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtMy0xLTEtMzY0MDYw_76605fbe-d408-4b16-92a1-fe09e337786b">600</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9aa711fcb6a40d2b80db74ac171cc0c_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtNC0xLTEtMzY0MDYw_dcb2b79f-d016-4967-8a95-f395fd1bb5df">2,600</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2a0b0e6e459f41638acacc3fc37a42fb_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtNS0xLTEtMzY0MDYw_168a3528-17e8-40c4-a145-caaf58f3cf7f">4,160</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8fd5aa573ef4460cbfad34c55a86f731_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtNi0xLTEtMzY0MDYw_5db5c161-1114-4e25-8df7-ccfe62ec38dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i49b804d9ed614704907b110f70a5cdfb_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtNy0xLTEtMzY0MDYw_c8ef0f8a-3ded-4dc8-b026-adb36c54b243">7,684</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i506dffc0627c41909915d7e8817418b5_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzItMS0xLTEtMzY0MDYw_090a01e3-6dd1-4d46-9c60-b51d82ffbd71">13,944</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57012484148948689f89fea0aa3009eb_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzMtMS0xLTEtMzY0MDYw_9e4c273c-bb56-475b-b9cd-d8046b9596fe">2,443</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% fixed-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id1774eefc6c64ab0af41316d805ee58e_I20221231" decimals="2" name="sny:DebtPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzQtMS0xLTEtMzY0MDYw_fe7aed12-6363-4a13-a970-c197a492fa5f">85</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Floating-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibbcc5028550249b08609aa6bfdc653b1_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtMS0xLTEtMzY0MDYw_98801f3f-40d9-4c30-86f8-6dc8855736ff">2,886</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77fea54f24f24e5daa16b8e9af0ec3ba_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtMi0xLTEtMzY0MDYw_9122b30f-d86f-4e4b-a088-095c5024aaf0">2,787</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5cedacf54d4441efb351a26b12b34b7d_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtMy0xLTEtMzY0MDYw_eb72b39e-d58f-4a7f-bc01-2d928cb565f7">61</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3d7c1443a2d7463e82df2174db1636ee_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtNC0xLTEtMzY0MDYw_172ecff2-ac5d-410b-8308-512eece20ede">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia5c92790c66c4fb89e2306e62a806e24_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtNS0xLTEtMzY0MDYw_c5f7ee3c-140d-437d-9696-8716c4ff4da1">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie769b358c2a7430eaa9c327866a428af_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtNi0xLTEtMzY0MDYw_4e239301-25f2-425f-be42-15e598f8ea7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id275ba29b8e14859b191132d6c2cac69_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtNy0xLTEtMzY0MDYw_a5dffa21-46ee-4079-a305-af249f8d1e46">38</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibee927ede2a140759f0c5c12d11794c0_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzYtMS0xLTEtMzY0MDYw_090d1ef7-de1a-4ca6-9b49-2222c56f20bb">592</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib91f94ba7e664e9a82b38a8746af0b80_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzctMS0xLTEtMzY0MDYw_9b255f82-64a7-43ac-937f-5f7775193e16">950</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i237bae27b00946af9d0b8a11f902a571_I20221231" decimals="2" name="sny:DebtPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzktMS0xLTEtMzY0MDYw_abcfdfd0-9c86-4ad3-85dd-4e5ed3ca3a46">15</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i35a06cbd066c4a6385ffce5cd1bcaa31_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTEtMS0xLTM2NDA2MA_8b5d8dd0-cdc9-406c-b65a-1c19413acca4">19,273</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iab4a2932b5504a659476a2c7ba6d88ef_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTItMS0xLTM2NDA2MA_0a690999-c585-44a5-ac58-9078ce2a6b3c">4,130</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibb312bd23a3443b3bd0d8c41cd9225c2_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTMtMS0xLTM2NDA2MA_039edddf-770b-4c01-aac7-294a85640885">661</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1a1452ac88b47cdba83dde78ded377f_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTQtMS0xLTM2NDA2MA_02f5a02d-73d4-488c-9113-d64dbff57a07">2,600</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57ad0dfa87a84703b12af704a04f6d7d_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTUtMS0xLTM2NDA2MA_d89e4e53-544b-4e6d-aa18-d5439d061a0e">4,160</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibf7e07a4b08c413f97b8d93e97d582ae_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTYtMS0xLTM2NDA2MA_c59a3aff-7629-470b-9fa1-4800e25bb362">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idf8910c273344e81baf6be3ce9cebda0_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTctMS0xLTM2NDA2MA_e08a8a57-6b3c-4225-af6d-3b92f0ca5bf9">7,722</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic9ad47fc844b46bc80ec5166c7202ecf_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzExLTEtMS0xLTM2NDA2MA_ef651a9f-e526-4051-8a0d-5990defe51ef">12,781</ix:nonFraction>)</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i68a66f1fea5a498aa1aa1217323de722_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzExLTItMS0xLTM2NDA2MA_1d3ff2a5-e5ba-42a5-933a-014a2de0e260">12,781</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia9829d8804884a12b2a996bb924f52c1_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEyLTEtMS0xLTM2NDA2MA_330875e7-4af9-492d-b9a7-74ac443700dd">4,046</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2b4aebf768c5437dbb995a69b847a59c_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEzLTEtMS0xLTM2NDA2MA_f4e135da-7273-4d17-8fae-aa0a1dd7b14c">5,797</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i88fe0cc7b26a444897204bd0cd68ce16_I20221231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE0LTEtMS0xLTM2NDA2MA_687cf67e-da4d-4aa6-955f-a624dc4738c6">2,155</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic9ad47fc844b46bc80ec5166c7202ecf_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTEtMS0xLTM2NDA2MA_1f89ffc7-c526-4f47-abd2-dd48ba6fdf17">6,492</ix:nonFraction></span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i68a66f1fea5a498aa1aa1217323de722_I20221231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTItMS0xLTM2NDA2MA_11ef185d-2732-4824-9b1a-2e98007eea02">8,651</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id463ae47153a4acca4d4ce0cd4105e45_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTMtMS0xLTM2NDA2MA_bea3b645-95e7-4f47-a802-e7724d65dc4f">661</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i017628a6bb05492681816fc312f67c17_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTQtMS0xLTM2NDA2MA_69951e8c-d4a0-419f-aa85-7f6fb70aac72">2,600</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idd131014a277431580f16bdaa1cf4dea_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTUtMS0xLTM2NDA2MA_8e7ced6c-5bc9-4a1c-aa3e-06fe35bdf2a3">4,160</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iee3f28b6afc141c89ce5d05cee0c9373_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTYtMS0xLTM2NDA2MA_a8510381-66f0-43c8-8a4a-c80320b7d2ad">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1b2abede0f3b4da6acb6ca1d80672165_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTctMS0xLTM2NDA2MA_ea7cbb41-8dd9-4377-9384-5d2703de3dff">7,722</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MTk_f61095fc-802b-47ae-9a18-9d111bf84998" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the fixed/floating rate split of net debt at value on redemption after taking account of derivative instruments as of&#160;December 31, 2021 and December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:49.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixed-rate debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i76094c0250834f1a85e51ab92e040912_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzEtMS0xLTEtMzY0MDYw_05c507c9-e099-418e-9451-999b575e6829">17,612</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i76094c0250834f1a85e51ab92e040912_I20211231" decimals="2" name="sny:DebtPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzEtMi0xLTEtMzY0MDYw_75a0cee8-7acb-4ac9-8b90-ce88add9e3a9">87</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4fe1d1477b9f4783b9f56a9968687afb_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzEtMy0xLTEtMzY0MDYw_7f4a7f64-112a-44b7-aa29-f42372366012">20,713</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4fe1d1477b9f4783b9f56a9968687afb_I20201231" decimals="2" name="sny:DebtPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzEtNC0xLTEtMzY0MDYw_053a0743-f993-4bfb-9c44-66b63f5ac3f2">91</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Floating-rate debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib2c9b9d646ff44a8a69e68756acb7765_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzItMS0xLTEtMzY0MDYw_d61b5ffc-07e6-4706-aa29-aa96fb18b1e1">2,702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2c9b9d646ff44a8a69e68756acb7765_I20211231" decimals="2" name="sny:DebtPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzItMi0xLTEtMzY0MDYw_b3ff1fc5-04d7-4618-b427-b2b5937b822b">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i44ca61b134c947c4bee18de7bfc7e7ca_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzItMy0xLTEtMzY0MDYw_84651845-7774-44a6-a6fe-4ff9f0f08c3f">1,990</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44ca61b134c947c4bee18de7bfc7e7ca_I20201231" decimals="2" name="sny:DebtPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzItNC0xLTEtMzY0MDYw_4625e2ff-a034-495d-8f69-228addfa3ab0">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia15a0d49ecac416c8e39472c771744ae_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzMtMS0xLTEtMzY0MDYw_2ece6cad-e474-4692-a87a-a6e23a250ab2">20,314</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia15a0d49ecac416c8e39472c771744ae_I20211231" decimals="2" name="sny:DebtPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzMtMi0xLTEtMzY0MDYw_e459241b-a430-4afd-9d34-5c1489110b16">100</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i29b764a8ef7e489b91978a7eb7e69313_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzMtMy0xLTEtMzY0MDYw_25671a01-c8f7-4af7-9f0b-83244ce930a5">22,703</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29b764a8ef7e489b91978a7eb7e69313_I20201231" decimals="2" name="sny:DebtPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzMtNC0xLTEtMzY0MDYw_5472c20b-cc08-44ea-82ae-8c32614f1bd3">100</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia15a0d49ecac416c8e39472c771744ae_I20211231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzQtMS0xLTEtMzY0MDYw_bfa11b8f-1260-4891-8102-d744ad6fce71">10,267</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i29b764a8ef7e489b91978a7eb7e69313_I20201231" decimals="-6" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzQtMy0xLTEtMzY0MDYw_86b7598c-0dcf-416c-a684-fcdf6d8f24f7">13,841</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia15a0d49ecac416c8e39472c771744ae_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzUtMS0xLTEtMzY0MDYw_12bc8cec-392c-4d03-a598-f8859d99ddf0">10,047</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i29b764a8ef7e489b91978a7eb7e69313_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzUtMy0xLTEtMzY0MDYw_1500b85d-593d-427a-80de-c58eb715e7a1">8,862</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The weighted average interest rate on debt as of December 31, 2022 was <ix:nonFraction unitRef="number" contextRef="i460a31d6345a47c1a7b3e2578b9ba86d_I20221231" decimals="3" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzU4Nzk_ec7292da-9a15-46c2-b25f-57924014ff03">1.6</ix:nonFraction>% before derivative instruments and <ix:nonFraction unitRef="number" contextRef="ie2b6d2511d0e4766a94389d42ac8728d_I20221231" decimals="3" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzU5MTY_63ce711d-a588-4222-a9d8-caa762a11684">2.5</ix:nonFraction>% after derivative instruments. Cash and cash equivalents were invested as of December 31, 2022 at an average rate of <ix:nonFraction unitRef="number" contextRef="i460a31d6345a47c1a7b3e2578b9ba86d_I20221231" decimals="3" name="sny:CashAndCashEquivalentsInvestedRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwMjA_3cb0acdd-ec51-4ebb-87b9-8c3c793e511d">3.9</ix:nonFraction>% before derivative instruments and <ix:nonFraction unitRef="number" contextRef="ie2b6d2511d0e4766a94389d42ac8728d_I20221231" decimals="3" name="sny:CashAndCashEquivalentsInvestedRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwNTc_81402b4c-d6b9-4cd3-ba0e-43a6d8c2172b">4.0</ix:nonFraction>% after derivative instruments.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NDg_d915fdbc-c35e-44b9-b932-600785ec6264" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The projected full-year sensitivity of net debt to interest rate fluctuations for 2023 is as&#160;follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:53.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in short-term interest rates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact&#160;on&#160;pre-tax&#160;net<br/>income&#160;(&#8364;&#160;million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact&#160;on&#160;pre-tax<br/>income/(expense)&#160;recognized<br/>directly in equity<br/>(&#8364; million)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+100&#160;bp</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic41f4a5b56624a49a78f6fe5ac261c4d_D20220101-20221231" decimals="-6" name="sny:ImpactOfChangeInInterestRateOnPreTaxIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzEtMS0xLTEtMzY0MDYw_273a688c-cf72-45d8-a9a6-9a2397530ef8">98</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic41f4a5b56624a49a78f6fe5ac261c4d_D20220101-20221231" decimals="-6" name="sny:ImpactOfPreTaxIncomeRecognisedInEquity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzEtMi0xLTEtMzY0MDYw_dd94ee74-d762-4d0f-9029-00ac6772ef3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+25&#160;bp</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5d14a3445818400e945ec968094e1c76_D20220101-20221231" decimals="-6" name="sny:ImpactOfChangeInInterestRateOnPreTaxIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzItMS0xLTEtMzY0MDYw_1bf498be-dd53-4ac9-9c23-5670e2bdea01">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5d14a3445818400e945ec968094e1c76_D20220101-20221231" decimals="-6" name="sny:ImpactOfPreTaxIncomeRecognisedInEquity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzItMi0xLTEtMzY0MDYw_703d9ca3-5203-4aa9-89d0-842f268d7588">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25&#160;bp</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i16680b6fb943448fb282d180578aad71_D20220101-20221231" decimals="-6" sign="-" name="sny:ImpactOfChangeInInterestRateOnPreTaxIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzMtMS0xLTEtMzY0MDYw_5dc4a21b-6c0e-4b40-b0ed-746b3ed56d22">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16680b6fb943448fb282d180578aad71_D20220101-20221231" decimals="-6" name="sny:ImpactOfPreTaxIncomeRecognisedInEquity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzMtMi0xLTEtMzY0MDYw_11110e6b-4153-442f-8c9d-8e89304b6b0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-100&#160;bp</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4bfdac81298541228d40dcfd2166cf4a_D20220101-20221231" decimals="-6" sign="-" name="sny:ImpactOfChangeInInterestRateOnPreTaxIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzQtMS0xLTEtMzY0MDYw_a1847c74-aab8-4dd4-b194-e583f863d4cf">98</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4bfdac81298541228d40dcfd2166cf4a_D20220101-20221231" decimals="-6" name="sny:ImpactOfPreTaxIncomeRecognisedInEquity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzQtMi0xLTEtMzY0MDYw_b23b597a-82e3-41bf-bf48-09dc1e79f5da">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e) Debt by currency, at value on redemption</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MjU_e2231678-b1eb-4017-aea8-8f4552a267f3" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows net debt by currency at December 31, 2022, before and after derivative instruments contracted to convert the foreign-currency net debt of exposed entities into their functional currency:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:53.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Before&#160;derivative&#160;instruments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">After&#160;derivative&#160;instruments</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57bb5023f2b84d4487314592d0f4240a_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzEtMS0xLTEtMzY0MDYw_e8bfc9d4-aecd-44fd-9202-b4cbcbb3b349">13,145</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6cbeba8a8bea4164a2c6d181bd02c2bb_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzEtMi0xLTEtMzY0MDYw_39357a1c-44f7-475d-89a9-826441796b79">10,489</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i986c2ee021b44ce3b4b179b044998da2_I20221231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzItMS0xLTEtMzY0MDYw_5b3e9999-a928-402e-81b9-42a615a47c48">6,508</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9fe5b918c28d40af8499fc1cc0b70c9a_I20221231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzItMi0xLTEtMzY0MDYw_a501bfa6-da68-4b04-855c-84523e2bcc18">2,404</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifdd755aac0fc48e689e14a6274f310fb_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzMtMS0xLTEtMzY0MDYw_6caec28e-5266-4370-9d1c-cd7e02239ef9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i276f12c0b8124b55895020cdb1b4f4c9_I20221231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzMtMi0xLTEtMzY0MDYw_04292484-c4bf-4d69-a0c9-f6a33686a4e0">2,155</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pound sterling</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ice55484dadfb417dadb944cba1425875_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzQtMS0xLTEtMzY0MDYw_6264002d-a449-4d4a-a63e-e55f0fe9a3c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0053ae4d634f454d9610544b49d8cde1_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzQtMi0xLTEtMzY0MDYw_0047723e-985f-4c70-a74c-887ed4ae05fa">359</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexican peso</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8b2c283754f141868e981361c2f48440_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzUtMS0xLTEtMzY0MDYw_60c929a5-bcaa-4433-80a8-296100b94352">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie96001907d3e48d1868c019e1a785aa1_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzUtMi0xLTEtMzY0MDYw_895f1585-31cd-4029-930c-34cbf5e8a61a">98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other currencies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if7e673112a4142d6a878b6f0f4052237_I20221231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzYtMS0xLTEtMzY0MDYw_bb1e417c-8f54-4310-b993-d0629a3b511d">52</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibf44e1ea006f438d8d586516b03c1f93_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzYtMi0xLTEtMzY0MDYw_bdef3f9b-8679-493f-9254-88ad9ba894a4">105</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i36278eb71056497db2592c9bb8341cf9_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzctMS0xLTEtMzY0MDYw_e9c5fa3e-ad6b-4a2c-9402-a67ce14057e0">6,585</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic9ad47fc844b46bc80ec5166c7202ecf_I20221231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzctMi0xLTEtMzY0MDYw_4b14c7d3-14e4-4bd0-9683-ececf84c9079">6,492</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-62</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i6107481cf1b545e0b61b46ccda5e6858" continuedAt="i9c954af7de514bd5b80561afa0ee6303"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MzA_6ecd03fb-21f2-4fac-8fc5-3a6606396c27" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows net debt by currency at December 31, 2021 and 2020, after derivative instruments contracted to convert the foreign currency net debt of exposed entities into their functional currency:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:74.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d361595b981448ab1d50f6b03da6881_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzEtMS0xLTEtMzY0MDYw_5b9fa8a6-1ca1-46c2-adc9-d6db2bca6723">13,129</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i33739fde16464d6e90fb87630cb2feca_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzEtMi0xLTEtMzY0MDYw_a743a2fb-48ba-4a63-8d97-7b04b79d29cf">13,725</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if126614dea4c41a48da8c2ad61a16c94_I20211231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzItMS0xLTEtMzY0MDYw_97c421a1-d346-4828-b8c6-4728ae91a764">669</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9110312ee2f64746a22d9a66d04adf9b_I20201231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzItMi0xLTEtMzY0MDYw_1a416b9c-67d5-4491-8628-8acddcdf42d3">3,304</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other currencies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id9b4ea343f3047468f2f5d10fc5c9122_I20211231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzMtMS0xLTEtMzY0MDYw_a3586376-5733-41b6-99fa-3c3a0ca2d47b">2,413</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i762332be16fa4365b2cc90d3d0037dc0_I20201231" decimals="-6" sign="-" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzMtMi0xLTEtMzY0MDYw_190168ba-6aba-43c1-a299-d883ae37860f">1,559</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia15a0d49ecac416c8e39472c771744ae_I20211231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzQtMS0xLTEtMzY0MDYw_230c58d2-b55b-413e-9fa7-759dac955ad9">10,047</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i29b764a8ef7e489b91978a7eb7e69313_I20201231" decimals="-6" name="sny:DebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzQtMi0xLTEtMzY0MDYw_0306a906-1846-4bb0-a41b-1615ccf963cd">8,862</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">f) Market value of net debt</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfMarketValueOfNetDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MzE_87980e6a-0b98-48f2-9fd0-ed7a5713ff01" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The market value of Sanofi&#8217;s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic291b624a38e421d9afc1f580652e23d_I20221231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzEtMS0xLTEtMzY0MDYw_0af36ffd-4371-4bcf-b60a-7422f319e900">5,227</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9e4e5ad251f94a3f8a8756af248a86b1_I20211231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzEtMi0xLTEtMzY0MDYw_e8d96f1b-e2fd-46ad-84a7-6b3cc33b1e2e">11,024</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iffeccf1af73449d2a5ed59864455f0d9_I20201231" decimals="-6" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzEtMy0xLTEtMzY0MDYw_6c391f3c-5338-4775-9fab-b5a65df0d1b7">10,500</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value on redemption</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1935e628d70046c1966e7d84061601fd_D20220101-20221231" decimals="-6" name="sny:RedemptionOfDebtInstrumentIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzItMS0xLTEtMzY0MDYw_23ad0adc-1a8f-4079-ae7a-201b04389eac">6,492</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifeb107e71e654a8ba62720ba4f39052b_D20210101-20211231" decimals="-6" name="sny:RedemptionOfDebtInstrumentIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzItMi0xLTEtMzY0MDYw_0993b5bc-2f03-4a70-928f-5ca75943fc4b">10,047</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iea4dd6e2c1634f6a8d800a040260a39e_D20200101-20201231" decimals="-6" name="sny:RedemptionOfDebtInstrumentIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzItMy0xLTEtMzY0MDYw_3f686dc6-1ffa-4249-a200-27f64ff3e9e1">8,862</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of debt is determined by reference to quoted market prices at the balance sheet date in the case of quoted instruments (level&#160;1 in the IFRS&#160;7 hierarchy, see Note&#160;D.12.), and by reference to the fair value of interest rate and currency derivatives used to manage net debt (level&#160;2 in the IFRS&#160;7 hierarchy, see Note&#160;D.12.).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">g) Future contractual cash flows relating to debt and related derivatives</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MzI_c28c9f48-48a6-4ce5-bc32-250e084f33b8" continuedAt="i9132c2de2cc34d7ab03e64d4f1ed74b3" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:42.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItMS0xLTEtMzY0MDYw_b5a2e5d0-07d3-4b93-abde-d61c738c7a45">20,408</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItMi0xLTEtMzY0MDYw_a026854c-d938-4f1c-a703-b59e399bac09">4,206</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i280298edcb0840438a14b90d970fec63_I20221231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItMy0xLTEtMzY0MDYw_7d98acf1-28db-48b7-a532-68aff532d153">868</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItNC0xLTEtMzY0MDYw_ec98bc7e-06d3-4b27-9bfd-073949967356">2,803</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItNS0xLTEtMzY0MDYw_9d93e7ec-29b6-4289-9ca9-d659486ceb1e">3,184</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItNi0xLTEtMzY0MDYw_8e2b8214-882e-409f-b86b-0f1209bf04cd">1,283</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItNy0xLTEtMzY0MDYw_05f22478-ccf0-4228-83cf-f223d42f019b">8,064</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principal</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtMS0xLTEtMzY0MDYw_a3a71aef-36b2-448e-903d-ad11a9492309">18,932</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtMi0xLTEtMzY0MDYw_4ce0f98e-c107-4f7b-adcf-b73e540733c0">3,928</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i280298edcb0840438a14b90d970fec63_I20221231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtMy0xLTEtMzY0MDYw_b29dae0a-3f3b-4b3c-9944-e32135427207">661</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtNC0xLTEtMzY0MDYw_643b8878-4142-4d92-b58a-1611b08075f8">2,601</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtNS0xLTEtMzY0MDYw_913e7d25-12f4-4715-9aed-c2d3b4659e66">3,011</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtNi0xLTEtMzY0MDYw_776d33c1-efff-48f1-ab23-2f91e68a8a39">1,151</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtNy0xLTEtMzY0MDYw_99569fe7-351d-44da-aed2-c5f4573c5da4">7,580</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:InterestUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtMS0xLTEtMzY0MDYw_4017cf29-ec23-4297-ac44-2e24c91351c0">1,476</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtMi0xLTEtMzY0MDYw_bcca52d7-9d1d-46c2-ae68-5e690ac2b51f">278</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i280298edcb0840438a14b90d970fec63_I20221231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtMy0xLTEtMzY0MDYw_78a407aa-4403-4232-b536-e4b266d55a46">207</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtNC0xLTEtMzY0MDYw_013d113e-c40d-4d3b-a963-feb2e86f94aa">202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtNS0xLTEtMzY0MDYw_58e93f44-9522-481d-8f43-d88b8990a399">173</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtNi0xLTEtMzY0MDYw_d44e8503-6768-4587-a164-273867769c0c">132</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtNy0xLTEtMzY0MDYw_3b891eeb-c7fe-473d-9e00-539cf6022d92">484</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash flows related to derivative instruments</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtMS0xLTEtMzY0MDYw_8f2edd10-c608-4ecf-bb75-f398f172d01e">209</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtMi0xLTEtMzY0MDYw_1af3c2c0-5bcd-4a6a-8768-ca779abb9cc8">24</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i280298edcb0840438a14b90d970fec63_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtMy0xLTEtMzY0MDYw_be61181e-387a-422b-bc3b-938697546156">60</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtNC0xLTEtMzY0MDYw_fc9bcdcb-3554-42df-9da5-f73a5f3cf450">38</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtNS0xLTEtMzY0MDYw_8ee1c570-57a9-4f3a-95a4-16b6bd3b7c95">31</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtNi0xLTEtMzY0MDYw_df6b589c-637e-469e-b8ec-f5f611f632b2">31</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtNy0xLTEtMzY0MDYw_3f5d1996-497d-4234-8a35-ea55c730d69b">25</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtMS0xLTEtMzY0MDYw_2f768023-a8fe-4ba1-9665-d13b502ee265">20,617</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtMi0xLTEtMzY0MDYw_92ca7aeb-78fc-4061-8408-6dbd2b5f2813">4,230</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i280298edcb0840438a14b90d970fec63_I20221231" decimals="-6" name="sny:TotalUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtMy0xLTEtMzY0MDYw_cd10ed6e-354c-43d4-a340-e99815266380">928</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtNC0xLTEtMzY0MDYw_a4479faf-b797-445e-8510-73fcb70244b7">2,841</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtNS0xLTEtMzY0MDYw_50fff844-b9a1-431e-84db-0908978edd95">3,215</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtNi0xLTEtMzY0MDYw_59e277f5-9d73-4806-bf1e-fe82df533b76">1,314</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtNy0xLTEtMzY0MDYw_34bd24cf-90bf-425f-a110-94b9e1b34a59">8,089</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2022.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Future contractual cash flows are shown on the basis of the carrying amount in the balance sheet at the reporting date, without reference to any subsequent management decision that might materially alter the structure of Sanofi&#8217;s debt or its hedging policy.</span></div><ix:continuation id="i9132c2de2cc34d7ab03e64d4f1ed74b3"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt as of December 31, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:42.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItMS0xLTEtMzY0MDYw_b2298e64-e5a3-4d92-bfe6-9170ba9dc281">21,728</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItMi0xLTEtMzY0MDYw_6ad5fcd3-9293-4c28-8e20-1d7fb76dc0f7">3,330</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id3388b8c97b14858be97adc9fa1bb28f_I20211231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItMy0xLTEtMzY0MDYw_b58e30d7-548d-45bf-8db0-d46b38863645">3,826</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItNC0xLTEtMzY0MDYw_e9948a8b-2a4a-497a-88f7-a44cd2dba85b">791</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i34c7881faa9548c999a9a866d7049120_I20211231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItNS0xLTEtMzY0MDYw_2d3a08e8-48fd-44ea-9b0d-0865065d3ead">1,937</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib80a3cdc90b542b3872bb71805fbced2_I20211231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItNi0xLTEtMzY0MDYw_5d0e54f1-fe50-489f-a068-e10423c189e3">3,176</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItNy0xLTEtMzY0MDYw_f01b8f55-80ae-408d-b46d-4ed6a65155eb">8,668</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principal</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtMS0xLTEtMzY0MDYw_68bb017b-8c9a-4696-90d7-f65afa83fe93">20,086</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtMi0xLTEtMzY0MDYw_4f281383-bc64-46c6-b14e-210730d514d1">3,055</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id3388b8c97b14858be97adc9fa1bb28f_I20211231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtMy0xLTEtMzY0MDYw_c06e47c8-c2c7-4857-885c-939939ee8abc">3,588</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtNC0xLTEtMzY0MDYw_737a7201-08b0-494d-a1cb-aa9761514922">601</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i34c7881faa9548c999a9a866d7049120_I20211231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtNS0xLTEtMzY0MDYw_46e8e701-68e6-497a-a133-56887b69c3db">1,751</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib80a3cdc90b542b3872bb71805fbced2_I20211231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtNi0xLTEtMzY0MDYw_d0d3c434-8391-4b4d-97ea-960ad93794c7">3,011</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtNy0xLTEtMzY0MDYw_9df2feeb-3449-49b6-a2f3-2a334eb0d172">8,080</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:InterestUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtMS0xLTEtMzY0MDYw_23431727-6926-4083-9b09-a1b9a4eba6c7">1,642</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtMi0xLTEtMzY0MDYw_60e55f3d-19ac-46a3-a396-cec0f8cc9098">275</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id3388b8c97b14858be97adc9fa1bb28f_I20211231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtMy0xLTEtMzY0MDYw_f770b6ac-7a81-411f-8b35-4d9ba654f87e">238</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtNC0xLTEtMzY0MDYw_4c34a227-3481-4380-9e55-e007f3bab0ff">190</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i34c7881faa9548c999a9a866d7049120_I20211231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtNS0xLTEtMzY0MDYw_ae0680ce-d7ef-4501-b148-95885f91c66e">186</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib80a3cdc90b542b3872bb71805fbced2_I20211231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtNi0xLTEtMzY0MDYw_4d869f16-bb49-492e-9d3a-525ccf37684b">165</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtNy0xLTEtMzY0MDYw_f63e6123-c388-4b51-a940-4f991a460737">588</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash flows related to derivative instruments</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" sign="-" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtMS0xLTEtMzY0MDYw_48781990-f825-4b29-b04b-e9fdba7274d1">51</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231" decimals="-6" sign="-" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtMi0xLTEtMzY0MDYw_889a943f-0998-403a-b7f5-030339ff7d74">59</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id3388b8c97b14858be97adc9fa1bb28f_I20211231" decimals="-6" sign="-" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtMy0xLTEtMzY0MDYw_4d68863b-577b-46d1-9c48-da78951712d9">1</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtNC0xLTEtMzY0MDYw_63953b4c-e508-4765-85f2-2d4e31d94e97">2</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i34c7881faa9548c999a9a866d7049120_I20211231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtNS0xLTEtMzY0MDYw_328bfca8-f383-4e81-a333-99637203cfa5">2</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib80a3cdc90b542b3872bb71805fbced2_I20211231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtNi0xLTEtMzY0MDYw_33fe1584-1e63-4715-a427-1ebf7d4f274f">2</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtNy0xLTEtMzY0MDYw_1ff4b673-0a63-4f80-9551-8f027620f2b6">3</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtMS0xLTEtMzY0MDYw_0afbdd8a-56fb-45b4-b569-ceb97cfc8180">21,677</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtMi0xLTEtMzY0MDYw_016ad58b-b92d-46bc-8786-a4c94e688b32">3,271</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id3388b8c97b14858be97adc9fa1bb28f_I20211231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtMy0xLTEtMzY0MDYw_4d643e10-03c1-4a09-ba25-b23d1be28a21">3,825</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231" decimals="-6" name="sny:TotalUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtNC0xLTEtMzY0MDYw_8b991661-bd9f-4d60-96c0-26a120032c7c">793</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i34c7881faa9548c999a9a866d7049120_I20211231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtNS0xLTEtMzY0MDYw_bb7a0142-b334-407c-967a-2a4b597ef5f4">1,939</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib80a3cdc90b542b3872bb71805fbced2_I20211231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtNi0xLTEtMzY0MDYw_5322c9a5-400d-453f-b9da-74e01db9ad67">3,178</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtNy0xLTEtMzY0MDYw_93d114b1-b843-4057-a63e-b1771ec142b7">8,671</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:42.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItMS0xLTEtMzY0MDYw_5fd85f8a-4ab8-4d1c-99d5-9086d3f308f1">24,339</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItMi0xLTEtMzY0MDYw_edf647f5-230d-49ac-9bc2-45e1359acd66">2,943</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i36e91efc121046df8f37594a45bf2954_I20201231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItMy0xLTEtMzY0MDYw_e0901b30-fd3e-4f6b-ae2c-d19113a93e5c">3,019</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03200b0530124cf6b744c38cef9f2c64_I20201231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItNC0xLTEtMzY0MDYw_44771a9e-6ba5-40f5-9f4b-3182dd6b7387">3,808</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i82c963ffba184f95b526d153ee99815a_I20201231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItNS0xLTEtMzY0MDYw_d4152568-ebd1-4b15-902e-41202c573330">791</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b10dc3381f24884b9901897b6d650eb_I20201231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItNi0xLTEtMzY0MDYw_883f7d88-b3fc-4ba2-aee2-5ca0937f01a0">1,937</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231" decimals="-6" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItNy0xLTEtMzY0MDYw_6dcd24ec-4e38-4ab9-867a-2d9c75adb549">11,841</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principal</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtMS0xLTEtMzY0MDYw_b05be9e0-c65e-49d1-98a2-01d0b9f1eea5">22,392</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtMi0xLTEtMzY0MDYw_d6f3af33-bf08-4b25-b39b-051d18a938c9">2,622</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i36e91efc121046df8f37594a45bf2954_I20201231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtMy0xLTEtMzY0MDYw_af024a20-3bc6-415a-bddc-bd48264b933b">2,757</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03200b0530124cf6b744c38cef9f2c64_I20201231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtNC0xLTEtMzY0MDYw_8f0e280f-bf28-424f-98b9-0472b31441ec">3,571</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i82c963ffba184f95b526d153ee99815a_I20201231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtNS0xLTEtMzY0MDYw_60278f6d-e28c-4e40-b3c4-a4c3399a3a53">601</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b10dc3381f24884b9901897b6d650eb_I20201231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtNi0xLTEtMzY0MDYw_cad541b2-97c8-4544-8679-d32c2b1dba8a">1,751</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231" decimals="-6" name="sny:PrincipalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtNy0xLTEtMzY0MDYw_75d5742f-7041-4c31-9251-044a8348b816">11,090</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:InterestUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtMS0xLTEtMzY0MDYw_77069e50-efa9-4244-8728-f33df5a24d69">1,947</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtMi0xLTEtMzY0MDYw_e8f2fe82-1dce-4c27-ae24-4db202220f11">321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i36e91efc121046df8f37594a45bf2954_I20201231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtMy0xLTEtMzY0MDYw_c7207367-cf7b-4889-a471-4c344f8aa1cc">262</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03200b0530124cf6b744c38cef9f2c64_I20201231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtNC0xLTEtMzY0MDYw_3f796c4f-346c-4d83-b768-cf7ca9588221">237</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i82c963ffba184f95b526d153ee99815a_I20201231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtNS0xLTEtMzY0MDYw_f49e43b0-f401-4f79-a861-d872fa21ba96">190</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b10dc3381f24884b9901897b6d650eb_I20201231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtNi0xLTEtMzY0MDYw_0c24e3b5-4c34-4ce8-a049-5de8f68ebba4">186</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231" decimals="-6" name="sny:InterestUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtNy0xLTEtMzY0MDYw_d7f6eaaa-94a8-45b2-b8b9-438db62913af">751</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash flows related to derivative instruments</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtMS0xLTEtMzY0MDYw_2fcd766d-71fc-487e-8d53-401b03f95db2">163</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtMi0xLTEtMzY0MDYw_59342d32-a33f-4a3c-bc39-a213c76e653a">135</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i36e91efc121046df8f37594a45bf2954_I20201231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtMy0xLTEtMzY0MDYw_b950facb-047d-4790-b944-f0f4a83afaaa">28</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03200b0530124cf6b744c38cef9f2c64_I20201231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtNC0xLTEtMzY0MDYw_7322b9a9-f9b2-443e-9b99-c3fb0a012f6c">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i82c963ffba184f95b526d153ee99815a_I20201231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtNS0xLTEtMzY0MDYw_fc62d33c-bb76-4bc4-aca5-549708d8b046">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b10dc3381f24884b9901897b6d650eb_I20201231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtNi0xLTEtMzY0MDYw_9b597ce8-5ba1-4981-9a55-7a671e6223d0">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtNy0xLTEtMzY0MDYw_ba452e3b-114e-4da1-ae85-c93122264ae7">&#8211;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtMS0xLTEtMzY0MDYw_1ec8ce94-2d3c-4118-87ef-812077db8b8d">24,502</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtMi0xLTEtMzY0MDYw_93a2babd-a1c1-4d74-a53d-b8a4594fa11c">3,078</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i36e91efc121046df8f37594a45bf2954_I20201231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtMy0xLTEtMzY0MDYw_5c33e404-bb7d-455d-b7d9-67fa690e6622">3,047</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03200b0530124cf6b744c38cef9f2c64_I20201231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtNC0xLTEtMzY0MDYw_93b7f7a2-bcc1-4ef9-b0ab-9de068b02f93">3,808</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i82c963ffba184f95b526d153ee99815a_I20201231" decimals="-6" name="sny:TotalUndiscountedCashFlow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtNS0xLTEtMzY0MDYw_de37c91c-2729-4295-87bc-db619c2d95d5">791</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b10dc3381f24884b9901897b6d650eb_I20201231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtNi0xLTEtMzY0MDYw_c61448be-7685-4b5f-95e7-0fe21b5cc010">1,937</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231" decimals="-6" name="sny:TotalUndiscountedCashFlow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtNy0xLTEtMzY0MDYw_d479f991-4bce-478b-9182-e557467a2624">11,841</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2020.</span></div></ix:continuation></ix:continuation><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-63</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i9c954af7de514bd5b80561afa0ee6303"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.17.2. Lease liabilities</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NDQ_6ca0a21a-ac08-4cfa-8764-19cdaa601757" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A maturity analysis of lease liabilities as of December 31, 2022, 2021 and 2020 is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:41.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Undiscounted future minimum lease payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less than 1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From 1 to 3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From 3 to 5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More than 5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Discounting effect</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total lease liabilities as of December 31, 2022</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItMS0xLTEtMzY0MDYw_b8e77a0b-c18d-4dbc-85e1-81d8f3177f99">2,181</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItMi0xLTEtMzY0MDYw_12f71e1b-3004-4e78-89e5-37763b334dfb">320</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItMy0xLTEtMzY0MDYw_56f77361-6675-4ddc-9f05-5fe5a83ce3f4">515</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItNC0xLTEtMzY0MDYw_4f5a9e42-0aef-42fc-8cdc-1d9e8503ee4c">436</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItNS0xLTEtMzY0MDYw_40c6c0dd-b76b-4652-9a38-2b22ee052183">1,129</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:LeaseLiabilitiesEffectOfDiscounting" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItNi0xLTEtMzY0MDYw_e6d8c852-7a68-41c3-9a0a-a4b41bd4974e">219</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total lease liabilities as of December 31, 2021</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtMS0xLTEtMzY0MDYw_d1d52ba2-bea1-468f-a41e-38055b097ad9">2,108</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtMi0xLTEtMzY0MDYw_27445614-80c7-469c-813e-6677ba104926">314</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie428880947a544b49bb0e7d00760fd8c_I20211231" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtMy0xLTEtMzY0MDYw_afff8fe2-851f-42a7-900a-6421e72c01bd">476</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff9a6cfc0d3c4fb393a0f42915753ff1_I20211231" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtNC0xLTEtMzY0MDYw_2e1079f7-90d5-45b2-b03a-63c59111735a">362</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtNS0xLTEtMzY0MDYw_e17d27b5-7c66-4040-ae06-d8b16db0244f">1,184</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:LeaseLiabilitiesEffectOfDiscounting" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtNi0xLTEtMzY0MDYw_b450820b-6226-4d78-ab78-2dbf7591ddad">228</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total lease liabilities as of December 31, 2020</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231" decimals="-6" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtMS0xLTEtMzY0MDYw_3c3d855a-863a-4ea4-ab6d-9f7f955c321c">1,163</ix:nonFraction></span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtMi0xLTEtMzY0MDYw_262199c3-5aec-4153-b1d8-da3219a3f58a">247</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i597d4960121a42bbb65d0137e78d145a_I20201231" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtMy0xLTEtMzY0MDYw_d0b55ad5-9952-41fc-9bfd-acc784c13b60">357</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0c3121bafadb4e4f8e35a95800cbc2f0_I20201231" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtNC0xLTEtMzY0MDYw_b1ae5f0e-457d-4892-95f2-ca779cc9bafd">225</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231" decimals="-6" name="ifrs-full:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtNS0xLTEtMzY0MDYw_965dfc1e-eed4-44ae-ac64-cfed3328f8ab">482</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:LeaseLiabilitiesEffectOfDiscounting" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtNi0xLTEtMzY0MDYw_1800c3b8-b545-4b8b-87af-d6d4e3b0d5de">148</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Lease liabilities as of December&#160;31, 2022 and December&#160;31, 2021 include leases relating to real estate assets located at Cambridge, MA (United States), as described in Note&#160;D.3., which have a lease term of <ix:nonNumeric contextRef="if4a75584545048bb9fe869e325a3208b_D20220101-20221231" name="sny:InitialLeaseTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MTM_ceeeef49-d5f4-4b3b-afc6-e66481a63653">15</ix:nonNumeric> years.</span></div></ix:nonNumeric></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_643"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.18. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ2OTU_1906634f-ffe1-40c8-85c1-355094cd55c7" continuedAt="i017718dd224e45969630a32b919b292f" escape="true">Liabilities related to business combinations and to non-controlling interests</ix:nonNumeric></span></div><ix:continuation id="i017718dd224e45969630a32b919b292f" continuedAt="if8542dad018648fab70b6296306ce41f"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a description of the nature of the liabilities reported in the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Liabilities related to business combinations and to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, refer to Note&#160;B.8.5. The principal acquisitions are described in Notes&#160;D.1. and&#160;D.2.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The liabilities related to business combinations and to non-controlling interests shown in the table below are level&#160;3 instruments under the IFRS&#160;7 fair value hierarchy (see Note&#160;D.12.).</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ2OTc_389c12a9-4383-4aff-9e38-daf0cff3cbcd" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in liabilities related to business combinations and to non-controlling interests are shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:34.734%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Bayer</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">contingent</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">consideration</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">arising&#160;from&#160;the</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">acquisition of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Genzyme </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MSD<br/>contingent<br/>consideration<br/>(European<br/>Vaccines<br/>business)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shire</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">contingent</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">consideration</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">arising&#160;from&#160;the</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">acquisition of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Translate Bio</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Contingent consideration arising from acquisition of Amunix</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at January 1, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8e622d8cb4934c84ad1e319b2aff140b_I20191231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtMy0xLTEtMzY0MDYw_864f85ba-e6a6-4e6e-ae25-c68028b6a33b">156</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5f5f52dce766446e8aa8c13efb12df1f_I20191231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtNC0xLTEtMzY0MDYw_a074a991-faf0-4808-adc2-6aae956cf571">385</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a26a676a71148dbbed13648e1ad3400_I20191231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtNS0xLTEtMzY0MDYw_da9d7056-b0b2-47b7-8d21-257563e5d50f">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1d472a3e57b147aeb03a38a1c58e1c64_I20191231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtNi0xLTEtMzY4NTUx_4d68a5e7-307d-4e3b-86d6-4eaf37ec60fc">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ida0de68516d145a58b76c93f372cbcc5_I20191231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtNi0xLTEtMzY0MDYw_3d378bb3-f9b8-4616-ada6-0fb37fec1e19">259</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtNy0xLTEtMzY0MDYw_33757cf2-b02b-4f25-82d6-59f5f7e2699e">800</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idf3de6cf917a44899ea3e45a8a4818fc_D20200101-20201231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtMy0xLTEtMzY0MDYw_ac6074a5-5b08-4775-ac0c-f48e39ebd0d6">42</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8e44cd8b091f420abc8a03afa2bb16e2_D20200101-20201231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtNC0xLTEtMzY0MDYw_c478391c-09ee-4de7-bbc8-70191c0e3bd4">78</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i96eb878aad884bb1836b938d8ed8cb7b_D20200101-20201231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtNS0xLTEtMzY0MDYw_5de641bb-3245-4f02-8c43-204db0daafc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1bc6ab03815b40d8abfda40457a31676_D20200101-20201231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtNi0xLTEtMzY4NTUx_a6ae532e-a0f9-4c85-b0ff-20db826b2ae4">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib7a524009bd4455fa39f388d2372d26c_D20200101-20201231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtNi0xLTEtMzY0MDYw_7001e341-7ae8-4139-ac54-700cf019b075">2</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtNy0xLTEtMzY0MDYw_8558c5f3-320f-41f5-9601-cac98a102bcd">122</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idf3de6cf917a44899ea3e45a8a4818fc_D20200101-20201231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtMy0xLTEtMzY0MDYw_9da23b8a-0c81-418d-ac5f-a553919d954e">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8e44cd8b091f420abc8a03afa2bb16e2_D20200101-20201231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtNC0xLTEtMzY0MDYw_7e0e1996-265f-4e16-9fbe-58f2423e6078">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i96eb878aad884bb1836b938d8ed8cb7b_D20200101-20201231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtNS0xLTEtMzY0MDYw_d05daa93-aa77-478a-b44f-3ab105fae92d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1bc6ab03815b40d8abfda40457a31676_D20200101-20201231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtNi0xLTEtMzY4NTUx_2181415d-6ec5-4f14-b511-411490030dad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib7a524009bd4455fa39f388d2372d26c_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtNi0xLTEtMzY0MDYw_3db2d6b7-b346-45b3-8203-2a62d7d47782">53</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtNy0xLTEtMzY0MDYw_caec917a-274e-48f7-8c30-a2796ed70d96">35</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idf3de6cf917a44899ea3e45a8a4818fc_D20200101-20201231" decimals="-6" name="sny:OtherMovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtMy0xLTEtMzY0MDYw_26c7f212-7ab3-4161-a864-f972d56c0ec5">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8e44cd8b091f420abc8a03afa2bb16e2_D20200101-20201231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtNC0xLTEtMzY0MDYw_5ea851d6-18bd-436a-9d5b-601a73f87c0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i96eb878aad884bb1836b938d8ed8cb7b_D20200101-20201231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtNS0xLTEtMzY0MDYw_3e0ddf2d-5fee-4e3e-a9d3-ebdfaee7e82e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1bc6ab03815b40d8abfda40457a31676_D20200101-20201231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtNi0xLTEtMzY4NTUx_6902ef38-e4e6-4c8b-bc92-a7524e971490">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib7a524009bd4455fa39f388d2372d26c_D20200101-20201231" decimals="-6" name="sny:OtherMovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtNi0xLTEtMzY0MDYw_3cb95fcb-ca67-4658-9a44-cb9cd0fdf26a">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:OtherMovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtNy0xLTEtMzY0MDYw_f13964cc-e963-4df3-a783-1eec4334be5b">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idf3de6cf917a44899ea3e45a8a4818fc_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtMy0xLTEtMzY0MDYw_2bb748a4-c0f2-49ba-aea0-f025fc6ac237">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8e44cd8b091f420abc8a03afa2bb16e2_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtNC0xLTEtMzY0MDYw_3b2bd1c1-8c4c-42bb-8e3d-8d8a9ed9caa8">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i96eb878aad884bb1836b938d8ed8cb7b_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtNS0xLTEtMzY0MDYw_49d16387-5a2d-4fa8-befc-8a2b3f6519ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1bc6ab03815b40d8abfda40457a31676_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtNi0xLTEtMzY4NTUx_bc546579-54ba-4235-9369-33b4d162545e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib7a524009bd4455fa39f388d2372d26c_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtNi0xLTEtMzY0MDYw_fcb53924-8fc3-4fda-9287-27c193fdd590">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtNy0xLTEtMzY0MDYw_780f08fa-b88c-4c43-98b5-ba27dbca5ab1">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i86bc2d12cd7842f099841197a912ae1d_I20201231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctMy0xLTEtMzY0MDYw_d5275e43-f4c8-45fc-93f8-dbce4be74b86">104</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0cde6022813d4c0faf7f41e7da37f957_I20201231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctNC0xLTEtMzY0MDYw_016cce6f-5805-42a4-a750-5db266d14a85">312</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i276543f6767c4836beb195c81c4f8a9d_I20201231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctNS0xLTEtMzY0MDYw_29e7c270-6928-4dfb-91d0-9889a4c6852a">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia42d31397cec4401901cafed6f408fdf_I20201231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctNi0xLTEtMzY4NTUx_cad39c42-fce2-40cf-9db5-7edb0b0eaca0">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0b6de6418317488f82c440f54eb0498c_I20201231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctNi0xLTEtMzY0MDYw_27d9cc0c-8769-4a7c-86de-0a842ec36521">189</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctNy0xLTEtMzY0MDYw_09b4966e-8707-40c7-b0b1-6b40188a24fd">605</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New transactions</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtMy0xLTEtMzY0MDYw_eabc2328-ba3a-4ba2-9da2-8ed9f4ff395a">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtNC0xLTEtMzY0MDYw_dcd3e3d1-ae6f-4c0c-b977-1b669a65b779">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtNS0xLTEtMzY0MDYw_117fa85c-1730-4294-9f60-4b2ac3af38ca">323</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtNi0xLTEtMzY4NTUx_f0a0f686-4044-484f-a0ee-49801aa228dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtNi0xLTEtMzY0MDYw_432e37a1-07a3-4dff-adae-6df588fa1b65">37</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtNy0xLTEtMzY0MDYw_20d62c48-9b64-474f-b913-efe03111f905">360</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktMy0xLTEtMzY0MDYw_6d211872-39f9-40dd-9868-6f28545c58ef">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktNC0xLTEtMzY0MDYw_13bdd5df-d01e-4ed9-9920-7cd9742d7a7a">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktNS0xLTEtMzY0MDYw_e69fc51e-e257-4618-b96b-c96b23786d63">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktNi0xLTEtMzY4NTUx_610b497d-47a7-4bc8-83c1-34d92dba9b9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktNi0xLTEtMzY0MDYw_821aff80-76a9-4022-964d-4e48ce16e096">152</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktNy0xLTEtMzY0MDYw_b6a20192-aeb4-45c8-b049-61f250e8f15f">258</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTMtMS0xLTM2NDA2MA_3e3af05f-484c-45e4-a90e-979f92a99f65">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTQtMS0xLTM2NDA2MA_bcc7ca44-e77d-4332-be8c-6722902a6b50">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTUtMS0xLTM2NDA2MA_d06178de-8748-4bf9-86ad-934e85c0f653">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTYtMS0xLTM2ODU1MQ_c8ce024f-36fc-43f1-a98b-54281a806abe">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTYtMS0xLTM2NDA2MA_2bb05acf-788f-4af2-bc2d-10887d4af2c4">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTctMS0xLTM2NDA2MA_3e3b334b-152d-496a-8392-e59cfdc1d447">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTMtMS0xLTM2NDA2MA_b451d8df-ace7-4871-b164-ba190bada6bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTQtMS0xLTM2NDA2MA_48bd68a5-7cd3-43d0-a996-8bc38bf078af">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTUtMS0xLTM2NDA2MA_cf5ddbcb-3d46-4072-88c8-411d72bf0a33">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTYtMS0xLTM2ODU1MQ_8fde67cf-441f-4f2a-bf79-a978cc32230b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231" decimals="-6" name="sny:OtherMovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTYtMS0xLTM2NDA2MA_1b50b038-909d-41d1-8d5f-b70a2d0a1146">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:OtherMovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTctMS0xLTM2NDA2MA_4c8ab710-aec5-41a7-8ead-c51757034b7c">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTMtMS0xLTM2NDA2MA_331b29a0-2474-4f99-aaab-ebe87e65c89a">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTQtMS0xLTM2NDA2MA_bf694492-afdf-4632-a4ae-232f78e7f38a">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTUtMS0xLTM2NDA2MA_315d7b72-01de-4fae-896d-9262d4110979">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTYtMS0xLTM2ODU1MQ_507cf090-cd30-4600-a312-5c050b95f983">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTYtMS0xLTM2NDA2MA_ad5a4788-4959-4225-81ab-6571928835d4">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTctMS0xLTM2NDA2MA_12bdf705-dd49-4b50-8b7d-805e64a33386">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic709e4b4631c4e698a72e76c85ee85b2_I20211231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTMtMS0xLTM2NDA2MA_9fc3bbff-b7cd-47ab-86be-0ec47c1b4c1e">59</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iad675e551ad149f2bef90277d9fc9dfd_I20211231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTQtMS0xLTM2NDA2MA_b8bee069-42dd-4e92-b7aa-678b78ac54f2">269</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5321b815afeb4a57a109cf015f023977_I20211231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTUtMS0xLTM2NDA2MA_fcd7f0be-2095-4734-b99e-f4106e207597">354</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1c1ada8ab8e643c880ed5b7be15fcdd3_I20211231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTYtMS0xLTM2ODU1MQ_382a898d-4b8c-462f-af6a-b92127c09182">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if7c05c49e9a749a280011ae480cc3b0d_I20211231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTYtMS0xLTM2NDA2MA_9741cc09-cb16-4a7b-be98-8883486eb365">32</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTctMS0xLTM2NDA2MA_e8fc4a99-e1a6-4e5c-82c3-d4d60dcebb58">714</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New transactions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTMtMS0xLTM2NDA2MA_69173e29-b782-4068-8795-afb9fa2fb722">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9028475126f24188932b789c9c3a8b88_D20220101-20221231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTQtMS0xLTM2NDA2MA_12651448-6b41-4973-ac2c-7883f1af9118">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4be94d08066947e295889299f946ac89_D20220101-20221231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTUtMS0xLTM2NDA2MA_6e215f5a-7c79-473c-be25-478101386e80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTYtMS0xLTM2ODU1MQ_c27de62b-56f9-437a-842e-6a71745ed83d">156</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTYtMS0xLTM2NDA2MA_c38ae769-c8fe-447f-a701-eec738393cff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTctMS0xLTM2NDA2MA_bf752413-9a60-4aa3-80ac-b90740558115">156</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTMtMS0xLTM2NDA2MA_518a10f0-3a08-4a52-b444-0c787b5522c2">29</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9028475126f24188932b789c9c3a8b88_D20220101-20221231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTQtMS0xLTM2NDA2MA_9b094508-6437-4439-9f90-f383c0f8a4e8">79</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4be94d08066947e295889299f946ac89_D20220101-20221231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTUtMS0xLTM2NDA2MA_1c98d84f-036c-46c3-a98f-2650602f4c24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTYtMS0xLTM2ODU1MQ_5dcda018-1bee-4d3c-82c4-eda34f96dc16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTYtMS0xLTM2NDA2MA_5a8354c8-2468-4fd5-b483-02ba1ede2ea1">28</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTctMS0xLTM2NDA2MA_69eb603b-fce7-4987-a888-2250131d7509">136</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTMtMS0xLTM2NDA2MA_979252e5-c538-4279-b62d-b3cb42e82fcf">9</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9028475126f24188932b789c9c3a8b88_D20220101-20221231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTQtMS0xLTM2NDA2MA_01d4addd-0bb5-488d-8c99-d2d390ebc96c">14</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4be94d08066947e295889299f946ac89_D20220101-20221231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTUtMS0xLTM2NDA2MA_41e9e8be-0f0a-414d-8418-045b263547ea">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTYtMS0xLTM2ODU1MQ_ecbe9757-59f8-435e-9d64-c7446361988b">2</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTYtMS0xLTM2NDA2MA_eb202f53-fd26-4792-847f-06c1dec981a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTctMS0xLTM2NDA2MA_477c9579-11e8-465d-b1b5-baff9c9e43be">5</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTMtMS0xLTM2NDA2MA_d9b77763-44ca-4719-978a-803dff33b2ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9028475126f24188932b789c9c3a8b88_D20220101-20221231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTQtMS0xLTM2NDA2MA_e6eca165-003d-4e2f-a361-db621cac1e6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4be94d08066947e295889299f946ac89_D20220101-20221231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTUtMS0xLTM2NDA2MA_a076f157-4fba-4d56-a6fa-84be28615fb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTYtMS0xLTM2ODU1MQ_f0270c6a-aa11-4a43-b3ae-f5e9ab47528a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTYtMS0xLTM2NDA2MA_db4e7b05-c9dc-4a29-bba3-ffeed29cde0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:OtherMovements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTctMS0xLTM2NDA2MA_f7d7c066-bb38-4edb-bba2-3f8901532d5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTMtMS0xLTM2NDA2MA_d4cb292d-8f0f-4e61-8a19-ae7e8c69a6e7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9028475126f24188932b789c9c3a8b88_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTQtMS0xLTM2NDA2MA_f4eae446-a171-4c4f-8c7c-5ef89722cbb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4be94d08066947e295889299f946ac89_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTUtMS0xLTM2NDA2MA_eb6bcf78-7cfa-4fd7-96db-32d8f79b5b17">24</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTYtMS0xLTM2ODU1MQ_e4ecb6dd-8855-4927-8206-76ceef6c461d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTYtMS0xLTM2NDA2MA_5c99b7e7-532d-4e0c-b809-308068997df2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTctMS0xLTM2NDA2MA_bd4fc3ef-d603-48db-9139-dff7e4518e63">40</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i48e232fbe36749e39b797ba6bb47d688_I20221231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTMtMS0xLTM2NDA2MA_e67951ae-b12b-449a-8b6f-50ca613d16c5">26</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i24d884695eeb435a925fbec2c89281ad_I20221231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTQtMS0xLTM2NDA2MA_a1b15adb-c762-44ab-849c-dd549bd2e7a4">204</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic6840db205a344f3a3a3624ad1fe3d84_I20221231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTUtMS0xLTM2NDA2MA_34031972-d0b6-49ab-bfff-688b6e969805">380</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2ff7c27b940f47dc8db4744efa5751f9_I20221231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTYtMS0xLTM2ODU1MQ_bab830cf-e552-4442-b5f2-8553b9a3102b">165</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibe52215125434d49876df22db77015d8_I20221231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTYtMS0xLTM2NDA2MA_17293478-cbb2-4401-8620-d24071ea43aa">4</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTctMS0xLTM2NDA2MA_67d88858-3eb2-4a4b-8a56-9d0ccca359c3">779</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Portion due after more than one year: &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzEwNTI_401ba9a6-3730-4187-acc0-f087552db9c9">674</ix:nonFraction> million as of December 31, 2022 (&#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzEwNjU_acec6b26-dead-4913-98ab-7388bf7d0d93">577</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzEwODE_1e7e0ac4-a448-4077-98ee-cb916e4ac096">387</ix:nonFraction> million as of December 31, 2020); portion due within less than one year: &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzExMzQ_fc5d8ecc-8843-4a7a-bc40-6e77e8f4027f">105</ix:nonFraction> million as of December 31, 2022 (&#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzExNDc_003b1ea7-ad24-4276-a42e-b3ad303c6a86">137</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzExNjM_f48d7e38-ca4b-4ba3-ae6d-8551688adb9f">218</ix:nonFraction> million as of&#160;December 31, 2020).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Amounts reported within the income statement line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">, and mainly comprising unrealized gains and losses.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Mainly corresponds to the recognition of the Shire Human Genetic Therapies&#160;Inc. (Shire) contingent consideration liability of $<ix:nonFraction unitRef="usd" contextRef="i39a7aeb71d26483d91e0c2fa09f8bace_I20221231" decimals="-6" name="sny:ContingentConsiderationLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzE0NzE_1cf43d24-5e66-4c2b-a562-b6bb54cd272a">382</ix:nonFraction> million resulting from the acquisition of Translate Bio in September&#160;2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The &#8220;Other&#8221; column mainly relates to the contingent consideration liability due to True North Therapeutics as a result of Sanofi's acquisition of Bioverativ which was settled in the first half of 2021.</span></div></ix:nonNumeric><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations and to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> mainly comprised:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the Bayer contingent consideration liability arising from Sanofi's acquisition of Genzyme in 2011. As of December 31, 2022, Bayer was still entitled to receive the following potential payments:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">a percentage of sales of alemtuzumab up to a maximum of $<ix:nonFraction unitRef="usd" contextRef="i61a0d34e548c452b80e7527cff0720d1_D20220101-20221231" decimals="INF" name="sny:PotentialPaymentsRelatedToPercentageOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIwOTE_901c6b35-5427-40ee-8a2e-38261f5b0817">1,250</ix:nonFraction> million or over a maximum period of <ix:nonNumeric contextRef="i59afdb4fc3d74ad98a57783363180e8f_D20220101-20221231" name="sny:PaymentToSaleOfBusinessPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIxMjI_299e0450-e83c-48e9-b6e7-05fe819c306e">10</ix:nonNumeric>&#160;years, whichever is achieved first,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">milestone payments subject to the attainment of specified levels of worldwide sales of alemtuzumab beginning in <ix:nonNumeric contextRef="i59afdb4fc3d74ad98a57783363180e8f_D20220101-20221231" name="sny:MilestonePaymentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIyNzM_e3bc0a4d-b42d-44ec-9713-a4dc51627025">2021</ix:nonNumeric>.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-64</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="if8542dad018648fab70b6296306ce41f" continuedAt="i0fd93592d2264f73953419f465e64b29"><div style="margin-bottom:5pt;padding-left:11.25pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of this liability was measured at &#8364;<ix:nonFraction unitRef="eur" contextRef="iffd5a4bf38dc4532a6905a24f9510e2b_I20221231" decimals="-6" name="sny:FairValueOfContingentConsiderationPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIzMjY_563b059e-54c5-4f2b-8a98-ba05db11225b">26</ix:nonFraction> million as of December 31, 2022, compared with &#8364;<ix:nonFraction unitRef="eur" contextRef="ie797eb00f7304dddbf2cde22a2826442_I20211231" decimals="-6" name="sny:FairValueOfContingentConsiderationPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIzNTM_261462af-b6cf-41c5-9d0f-190ac80f1036">59</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i5f26ac7c041844fa84f5ccaf51563dde_I20201231" decimals="-6" name="sny:FairValueOfContingentConsiderationPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIzNjk_0c05b441-3950-4a13-a8c3-ef3da7a0314b">104</ix:nonFraction> million as of December 31, 2020. The fair value of the Bayer liability is determined by applying the contractual terms to sales projections which have been weighted to reflect the probability of success, and discounted. If the discount rate were to fall by one percentage point, the fair value of the Bayer liability would increase by approximately <ix:nonFraction unitRef="number" contextRef="iffd5a4bf38dc4532a6905a24f9510e2b_I20221231" decimals="2" name="sny:PercentageIncreaseInFairValueLiabilities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzI2OTc_af6290b6-b34e-4fc6-a9db-46b3f8c2f39b">1</ix:nonFraction>%;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the MSD contingent consideration liability arising from the 2016 acquisition of the Sanofi Pasteur activities carried on within the former Sanofi Pasteur MSD joint venture, which amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i24d884695eeb435a925fbec2c89281ad_I20221231" decimals="-6" name="sny:FairValueOfContingentConsiderationPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzI4OTM_efb8ba29-edbe-47ae-a85e-a820a20d353a">204</ix:nonFraction> million as of December 31, 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="iad675e551ad149f2bef90277d9fc9dfd_I20211231" decimals="-6" name="sny:FairValueOfContingentConsiderationPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzI5MDY_d5913984-bd9a-4ec4-9f14-15ec654a0b16">269</ix:nonFraction> million as of&#160;December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0cde6022813d4c0faf7f41e7da37f957_I20201231" decimals="-6" name="sny:FairValueOfContingentConsiderationPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzI5MjI_19dda148-acad-4224-a5c3-7649f2fc17c7">312</ix:nonFraction> million as of December 31, 2020 (see Note&#160;D.12.). The fair value of this contingent consideration is determined by applying the royalty percentage stipulated in the contract to discounted sales projections. If the discount rate were to fall by one percentage point, the fair value of the MSD contingent consideration liability would increase by approximately <ix:nonFraction unitRef="number" contextRef="i24d884695eeb435a925fbec2c89281ad_I20221231" decimals="2" name="sny:PercentageIncreaseInFairValueLiabilities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzMyNjA_edebfb2e-967f-46ac-85be-58db9daa38b7">1</ix:nonFraction>%;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a contingent consideration liability towards Shire Human Genetic Therapies Inc. (Shire) arising from Sanofi's acquisition of Translate&#160;Bio in September&#160;2021. In a December&#160;2016 business combination predating the acquisition of control by Sanofi, Translate Bio (then called Rana Therapeutics, Inc.) acquired from Shire the intellectual property rights relating to the latter's Messenger RNA Therapeutics (MRT) program. As of December 31, 2022, Shire was entitled to receive the following potential payments:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">milestone payments contingent on the launch of products based on MRT technology, and on the attainment of a specified level of sales of those products, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">a percentage of sales of those products.</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-0.01pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of the Shire liability was measured at &#8364;<ix:nonFraction unitRef="eur" contextRef="ic6840db205a344f3a3a3624ad1fe3d84_I20221231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQwMDc_e6c4b39b-17d0-42ca-9e99-09b8d520abce">380</ix:nonFraction> million as of December 31, 2022, compared with &#8364;<ix:nonFraction unitRef="eur" contextRef="i5321b815afeb4a57a109cf015f023977_I20211231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzMwMjM2NTY5NzcwMTU3_d8771181-852e-4b55-b8ee-d34fdf87a205">354</ix:nonFraction> million as of&#160;December 31, 2021; it was determined by applying the contractual terms to development and sales projections which were weighted to reflect the probability of success, and discounted. If the discount rate were to fall by one percentage point, the fair value of the Shire liability would increase by approximately <ix:nonFraction unitRef="number" contextRef="i8794718e5aa14c49a27eea0403dcf813_I20221231" decimals="2" name="sny:PercentageIncreaseInFairValueLiabilities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQzMTM_6e3a6d6b-b558-4d80-95fb-044cbb82aba2">13</ix:nonFraction>%;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the contingent consideration liability arising from the 2022 acquisition of Amunix. The fair value of the liability is determined on&#160;the basis of the nominal value of payments due subject to the attainment of specified</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> development milestones; these&#160;are&#160;weighted to reflect the probability of success, and discounted. The liability was measured at &#8364;<ix:nonFraction unitRef="eur" contextRef="i2ff7c27b940f47dc8db4744efa5751f9_I20221231" decimals="-6" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzEwOTk1MTE2MzMzMTM_1fbe394c-a9d3-40ed-a832-d1abb2861011">165</ix:nonFraction>&#160;million as of December 31, 2022. If the discount rate were to fall by one percentage point, the fair value of the liability would increase by approximately&#160;<ix:nonFraction unitRef="number" contextRef="i2ff7c27b940f47dc8db4744efa5751f9_I20221231" decimals="2" name="sny:PercentageIncreaseInFairValueLiabilities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzEwOTk1MTE2MzMzMTc_787d4943-ee3e-472c-8239-c007bc817457">1</ix:nonFraction>%.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ2OTI_3524b7fc-381b-4edc-892a-ca0f3de459c7" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth the maximum amount of contingent consideration payable in respect of already-marketed products:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From&#160;1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From&#160;3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commitments relating to contingent consideration&#160;in connection with business combinations</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo3MjBkNTU5MmJiZmY0YTg4YWVhZjFlMGMwMTYwYWEyYi90YWJsZXJhbmdlOjcyMGQ1NTkyYmJmZjRhODhhZWFmMWUwYzAxNjBhYTJiXzItMS0xLTEtMzY0MDYw_03d9ca83-c22a-446d-8957-e7ea2979a8b5">604</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo3MjBkNTU5MmJiZmY0YTg4YWVhZjFlMGMwMTYwYWEyYi90YWJsZXJhbmdlOjcyMGQ1NTkyYmJmZjRhODhhZWFmMWUwYzAxNjBhYTJiXzItMi0xLTEtMzY0MDYw_fa90781a-86e4-4593-8786-a5ca73c66aa1">104</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231" decimals="-6" name="sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo3MjBkNTU5MmJiZmY0YTg4YWVhZjFlMGMwMTYwYWEyYi90YWJsZXJhbmdlOjcyMGQ1NTkyYmJmZjRhODhhZWFmMWUwYzAxNjBhYTJiXzItMy0xLTEtMzY0MDYw_9a883b95-7dae-4967-8791-b94be16558c0">145</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231" decimals="-6" name="sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo3MjBkNTU5MmJiZmY0YTg4YWVhZjFlMGMwMTYwYWEyYi90YWJsZXJhbmdlOjcyMGQ1NTkyYmJmZjRhODhhZWFmMWUwYzAxNjBhYTJiXzItNC0xLTEtMzY0MDYw_bcc4baf2-1073-4062-af65-76c7b78ec8bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo3MjBkNTU5MmJiZmY0YTg4YWVhZjFlMGMwMTYwYWEyYi90YWJsZXJhbmdlOjcyMGQ1NTkyYmJmZjRhODhhZWFmMWUwYzAxNjBhYTJiXzItNS0xLTEtMzY0MDYw_5a4168fb-2be4-4ead-a29a-5702f7d42afc">355</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes &#8364;<ix:nonFraction unitRef="eur" contextRef="iffd5a4bf38dc4532a6905a24f9510e2b_I20221231" decimals="-8" name="sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ0MTU_c2200a78-3a62-49ae-ad1f-f6b041cf712d">0.4</ix:nonFraction> billion for the Bayer contingent consideration, &#8364;<ix:nonFraction unitRef="eur" contextRef="i24d884695eeb435a925fbec2c89281ad_I20221231" decimals="-8" name="sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ0NjE_2f40c29b-d956-4f9f-ad8f-126eaebd222a">0.2</ix:nonFraction> billion for the MSD contingent consideration.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:continuation id="i0fd93592d2264f73953419f465e64b29">The nominal amount of contingent consideration was &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ1NTQ_de4d7fcb-e942-4a24-9bcb-cc35c6ae7e55">689</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ1NzA_edc31492-b7a4-408a-a289-20065c3c935d">1,043</ix:nonFraction> million as of December 31, 2020.</ix:continuation> </span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_646"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.19. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfProvisionsAndOtherLiabilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NTA5_f3c99a14-7b90-41d7-a4e8-3e1c1a8a4e8b" continuedAt="ia55039fa055642a6a047385233b12366" escape="true">Provisions, income tax liabilities and other liabilities</ix:nonNumeric></span></div><ix:continuation id="ia55039fa055642a6a047385233b12366" continuedAt="i718190fe3b594106932077f6bcd75ee2"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDkx_5bab8f81-5f0d-4c5f-9992-f75a882bc9b0" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Non current provisions and other non-current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comprises the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:57.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzEtMS0xLTEtMzY0MDYw_eecc902c-32f8-4020-86be-9d56836987b4">5,822</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzEtMi0xLTEtMzY0MDYw_d5d1c1b8-e0c9-44c2-9fd0-e1bb4179b3fc">6,430</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzEtNC0xLTEtMzY0MDYw_3107fec1-0c76-4b9b-aaa3-6fa749c47a5f">6,998</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other non-current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzItMS0xLTEtMzY0MDYw_fd3a1a74-5c33-4d60-a56e-3f93410b5d96">519</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzItMi0xLTEtMzY0MDYw_444c798c-4a84-413f-b38a-99e8e384bc43">291</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzItNC0xLTEtMzY0MDYw_25fd113b-2055-47df-b54f-482513dc3f0f">317</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzQtMS0xLTEtMzY0MDYw_4e70fea6-bf6e-4acd-85c8-361a6b15cd21">6,341</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzQtMi0xLTEtMzY0MDYw_9438c858-24b8-41b1-96cb-f3f67eb83d38">6,721</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzQtNC0xLTEtMzY0MDYw_09619340-c2e5-4677-bfdf-bdaeb8f32cc9">7,315</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (IAS&#160;19, Employee Benefits), </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Includes derivative financial instru</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">ments: &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzM3Mw_57673396-fcfa-4c61-888e-881441994671">232</ix:nonFraction> million as of De</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">cember&#160;31, 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQwMQ_f683d53b-0d67-4c9a-bb8a-483b0ad76f4d">6</ix:nonFraction> million as of December&#160;31, 2021, &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQyOQ_634b2654-9b9c-46fe-8dcc-b6adc2a6f114">92</ix:nonFraction> million as of December&#160;31, 2020.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Non-current income tax liabilities are described in Note&#160;D.19.4., and other current liabilities in Note&#160;D.19.5.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-65</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i718190fe3b594106932077f6bcd75ee2" continuedAt="i9fcd2ba010314f5f8d112070af207c3f"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfNoncurrentProvisionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDcz_e2ee3871-db9d-4dc5-9baa-ef0694f753ac" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth movements in non-current provisions for the reporting periods presented:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"></td><td style="width:33.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.035%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.035%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.035%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Provisions&#160;for<br/>pensions and<br/>other&#160;post-employment<br/>benefits<br/>(D.19.1.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Provisions<br/>for other<br/>long-term<br/>benefits</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Restructuring<br/>provisions<br/>(D.19.2.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>provisions<br/>(D.19.3.)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i532881433aa7423d869b4ec57f911c53_I20191231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEtMS0xLTEtMzY0MDYw_c832c633-c70e-460e-80bd-38a0f82e660c">3,599</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i414d2c248b5a458dae7e76250a0ff9b5_I20191231" decimals="-6" name="ifrs-full:NoncurrentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEtMy0xLTEtMzY0MDYw_721ffca4-2a2e-4964-99fb-49afabb7e298">855</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i43dfdc134bf04195b896b412124e7194_I20191231" decimals="-6" name="ifrs-full:NoncurrentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEtNC0xLTEtMzY0MDYw_87ded9ff-f4e9-4e16-845e-8f9a6be628e8">600</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i31f290bd30874504995867d89e80c3d9_I20191231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEtNS0xLTEtMzY0MDYw_c498582b-924f-44d9-95e0-5bf37d11fb1b">2,071</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEtNy0xLTEtMzY0MDYw_204645dc-fb34-4385-91b2-4b7c8c20e299">7,125</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzItMS0xLTEtMzY0MDYw_f9a0bc30-9336-44dd-84d8-92419481aabd">3</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzItMy0xLTEtMzY0MDYw_6efe33ed-780d-40b1-ad66-3d3361d3860a">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzItNC0xLTEtMzY0MDYw_0fcb36f9-43bd-405c-b47f-dfa01eb56f4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzItNS0xLTEtMzY0MDYw_d41feecd-a67a-444e-93a2-267c47744d17">8</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzItNy0xLTEtMzY0MDYw_ad436c08-f512-424b-9a65-b01ec0c26549">5</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases in provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMtMS0xLTEtMzY0MDYw_80e0a31b-b93f-44e9-b614-119a99786ee7">256</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMtMy0xLTEtMzY0MDYw_42ea2bd7-9e7b-4096-a823-c4160e7caa10">169</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMtNC0xLTEtMzY0MDYw_daa7c230-815f-4b63-8565-7649a2e3eaf9">688</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMtNS0xLTEtMzY0MDYw_20aabc4a-f771-4cc8-9070-2e25e0ae97e4">369</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMtNy0xLTEtMzY0MDYw_682aa1a9-33b3-49a7-946d-11ba78a76a18">1,482</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzQtMS0xLTEtMzY0MDYw_fcbd5b78-a43b-4a35-99d8-535b0f085c94">566</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzQtMy0xLTEtMzY0MDYw_c51cb54d-8c12-4dab-b55b-713a4a7a3e74">109</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzQtNC0xLTEtMzY0MDYw_4edfe764-0a35-4075-8ab6-3c9ee22c148b">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzQtNS0xLTEtMzY0MDYw_eeecf75e-1f81-47df-bc49-919338e63c71">113</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzQtNy0xLTEtMzY0MDYw_83e1a4c4-675a-4e8c-aed8-2e446a5c91d3">793</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reversals of unutilized provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzUtMS0xLTEtMzY0MDYw_6d91acb8-cb4d-40d2-b1c7-e8c9263539ac">226</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzUtMy0xLTEtMzY0MDYw_ccb1d753-7ed2-4dda-afb3-9bd2765e8149">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzUtNC0xLTEtMzY0MDYw_e3b39b45-eee4-4b86-8308-d110f49dc5bb">42</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzUtNS0xLTEtMzY0MDYw_94dad0a1-62f6-4ff7-86a6-9305f3c7d749">245</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzUtNy0xLTEtMzY0MDYw_ae84d9b0-574c-43db-9d4a-a20bbb5d35cb">518</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzYtMS0xLTEtMzY0MDYw_c5adcfff-b545-47a3-8fea-29fe922fb2bd">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzYtMy0xLTEtMzY0MDYw_e8f778f2-94c7-4723-aefb-d7e048cd8551">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzYtNC0xLTEtMzY0MDYw_feef1df7-bbd3-492e-b789-7c9eb7e6dc8e">369</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzYtNS0xLTEtMzY0MDYw_d29798b8-15e3-4368-b13c-dc948638a739">64</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzYtNy0xLTEtMzY0MDYw_ecb9776c-cc62-41fb-a614-0c9657f1b014">421</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest related to employee benefits, and unwinding of discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzctMS0xLTEtMzY0MDYw_23b5838b-a6cd-48d4-8d10-89adcf046493">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzctMy0xLTEtMzY0MDYw_bd2c51b7-09dc-4fec-9ad0-53b16ee86ba0">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzctNC0xLTEtMzY0MDYw_b6f99202-928d-4398-b080-4b387970068f">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzctNS0xLTEtMzY0MDYw_ffeda01c-13da-440e-ba3e-69b7c5cd86a1">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzctNy0xLTEtMzY0MDYw_da484cbf-1ec8-4c9f-84dd-742f48e673b5">66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzktMS0xLTEtMzY0MDYw_6f6f0723-1963-43fd-a1be-edd5063bc1ea">117</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzktMy0xLTEtMzY0MDYw_b8d6b6d3-09b0-4567-b7d3-1e4f1b7d25d2">33</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzktNC0xLTEtMzY0MDYw_6d386825-a19f-4721-b2a4-1c0fe1940a41">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzktNS0xLTEtMzY0MDYw_97ea44d4-e50c-41b5-905a-ac0819dc9b2c">59</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzktNy0xLTEtMzY0MDYw_31f5c6c6-e3a0-4106-958c-1256c4ee4e8b">214</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains and losses on defined-benefit plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231" decimals="-6" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEwLTEtMS0xLTM2NDA2MA_176aa4eb-5dd8-4c63-a365-31db6b5cf5bb">266</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231" decimals="-6" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEwLTMtMS0xLTM2NDA2MA_ee4e7de6-bec2-4077-8036-29d99923ba68">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231" decimals="-6" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEwLTQtMS0xLTM2NDA2MA_83205df8-b295-4507-8d91-f855abfd37be">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231" decimals="-6" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEwLTUtMS0xLTM2NDA2MA_5722e34f-e8ab-4563-85a8-9047c841691a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEwLTctMS0xLTM2NDA2MA_95c7b8c9-bc38-4f6a-8b43-4a829038e26b">266</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ida1b0b7fd59a4db78494bb22968fdd7a_I20201231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzExLTEtMS0xLTM2NDA2MA_8dc9c749-139b-4227-b591-483de3994210">3,276</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie4751a46e76748978b422a63571faf77_I20201231" decimals="-6" name="ifrs-full:NoncurrentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzExLTMtMS0xLTM2NDA2MA_0083b0ba-0936-4d64-9dc7-da488b61c98c">879</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie016f1bfac62464f88ec010a81d0e1ba_I20201231" decimals="-6" name="ifrs-full:NoncurrentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzExLTQtMS0xLTM2NDA2MA_81d518a8-c21b-43e2-b181-217066818e91">868</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2ef08d9911e24c519c5cd052d066245a_I20201231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzExLTUtMS0xLTM2NDA2MA_cc009da1-6745-4e89-b8fc-e156310a4104">1,975</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzExLTctMS0xLTM2NDA2MA_989c3ae2-4402-4025-aeea-3b6b54df3698">6,998</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEyLTEtMS0xLTM2NDA2MA_15d5ba77-1384-4b8b-b4f1-d48932148926">2</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEyLTMtMS0xLTM2NDA2MA_e7300188-c95b-4915-98cd-751fae3aee27">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEyLTQtMS0xLTM2NDA2MA_aa7463f2-a271-4bd4-b367-d12a492403d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEyLTUtMS0xLTM2NDA2MA_088c3da8-c90b-44f0-bdbb-2d084e7eb170">37</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEyLTctMS0xLTM2NDA2MA_821da38a-c1a6-44e7-b237-8c5a3fff72d5">35</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases in provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEzLTEtMS0xLTM2NDA2MA_810e6779-fa05-4375-b941-a0a762e5421c">247</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEzLTMtMS0xLTM2NDA2MA_96732961-4a3f-4489-b8f2-e04f26b9dc66">156</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEzLTQtMS0xLTM2NDA2MA_5bdebb08-436d-4626-86e5-4eebfd061bbb">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEzLTUtMS0xLTM2NDA2MA_a5398270-cec4-44f8-97f4-ef35e7dac0e5">261</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEzLTctMS0xLTM2NDA2MA_e042d544-df23-499e-a011-30c38135b878">731</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE0LTEtMS0xLTM2NDA2MA_969705f6-65dc-4418-a5e1-3d3dccbd54c5">222</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE0LTMtMS0xLTM2NDA2MA_ac0037d1-1dd7-45d7-a3c2-d2e2863281f1">122</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE0LTQtMS0xLTM2NDA2MA_847675ec-bb30-4468-b9bb-fa4f9dadb363">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE0LTUtMS0xLTM2NDA2MA_e436f1b5-ac67-455b-9488-065599fa1740">107</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE0LTctMS0xLTM2NDA2MA_bc5ec9b8-fc0d-4b8d-9e31-800658910359">459</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reversals of unutilized provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE1LTEtMS0xLTM2NDA2MA_b8202c6a-9422-413e-a070-ec422b3a705b">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE1LTMtMS0xLTM2NDA2MA_4eb5dd66-b874-4fdf-8927-3ac8651b7679">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE1LTQtMS0xLTM2NDA2MA_2df43353-9f40-4a1c-bf73-a0e9058b88ed">35</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE1LTUtMS0xLTM2NDA2MA_f60242d2-bede-47d5-b7be-a57e1f1af4de">145</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE1LTctMS0xLTM2NDA2MA_dfe984c2-076c-4dd4-984b-8f81c158511b">200</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE2LTEtMS0xLTM2NDA2MA_59008b37-a870-4cce-b262-7e505bdb986b">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE2LTMtMS0xLTM2NDA2MA_dc027f15-d9c4-494d-86bb-82679183d80b">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE2LTQtMS0xLTM2NDA2MA_4bec4a6f-93bf-450e-b786-148a50898280">370</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE2LTUtMS0xLTM2NDA2MA_1a9460b4-33dc-4602-814e-8af4bfad6b0e">39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE2LTctMS0xLTM2NDA2MA_afe6b7b7-fc62-4a55-a0c7-62826f3994fa">425</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest related to employee benefits, and unwinding of discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE3LTEtMS0xLTM2NDA2MA_427624c6-98b4-4fb4-a754-29c2efe8fc5d">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE3LTMtMS0xLTM2NDA2MA_22bee1a9-64ba-41e0-bacd-11840a5d7583">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE3LTQtMS0xLTM2NDA2MA_49c41768-657e-41bc-b198-4e87de72999c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE3LTUtMS0xLTM2NDA2MA_81574b01-d3b1-4cdc-b364-873ce1688b02">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE3LTctMS0xLTM2NDA2MA_276e22dc-70a2-49a2-b57e-59de049382ba">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE5LTEtMS0xLTM2NDA2MA_e6390930-51e6-48b0-bc18-5ae012ac66ae">80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE5LTMtMS0xLTM2NDA2MA_5c5348ae-96ed-4af2-ad67-4c6f3a51c9e7">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE5LTQtMS0xLTM2NDA2MA_5e92bff8-223e-453c-9813-7a8e4e8975ae">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE5LTUtMS0xLTM2NDA2MA_332ab806-a116-47d6-aba6-4b64bb2c4673">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE5LTctMS0xLTM2NDA2MA_edb29b42-d04e-4df1-b131-adfff40448f1">145</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains and losses on defined-benefit plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231" decimals="-6" sign="-" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIwLTEtMS0xLTM2NDA2MA_9d03d0d0-dab6-44dd-b4db-98265bea65b5">448</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231" decimals="-6" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIwLTMtMS0xLTM2NDA2MA_306963a7-e83f-4394-a61b-2534202fe05f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231" decimals="-6" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIwLTQtMS0xLTM2NDA2MA_d8663bee-0297-441e-aa04-d5073a89f9f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231" decimals="-6" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIwLTUtMS0xLTM2NDA2MA_83f04657-f557-44b1-9921-ecd71610b25f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIwLTctMS0xLTM2NDA2MA_544c960b-f198-4561-aeaf-6e23ebb4045b">448</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6287d4b535a408eaad25228f5b4da0d_I20211231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIxLTEtMS0xLTM2NDA2MA_7e4ca96a-7b43-44fe-9bd0-ce4084f0e231">2,947</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53403a31e97c40538e551d37a2a4daa8_I20211231" decimals="-6" name="ifrs-full:NoncurrentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIxLTMtMS0xLTM2NDA2MA_479003b8-9c2c-4f07-95c9-5eecaea28fe4">935</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i87f7b547836c49bfbc71cc2d0e1e129e_I20211231" decimals="-6" name="ifrs-full:NoncurrentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIxLTQtMS0xLTM2NDA2MA_d4a3abe7-1cc1-4eca-b94b-38afff040dbb">524</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93c8eb824f4249b3bfda0339bc01253c_I20211231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIxLTUtMS0xLTM2NDA2MA_dc7f2487-5e56-4d7b-8540-43c85b65aeed">2,024</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIxLTctMS0xLTM2NDA2MA_3b8ec918-5ee6-4adf-8a8f-a896bc264b21">6,430</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIyLTEtMS0xLTM2NDA2MA_81e35e29-7393-48f4-a3a6-7fc8f16fdff2">96</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIyLTMtMS0xLTM2NDA2MA_4b533926-74ce-4587-a584-d0560ff8e7be">28</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIyLTQtMS0xLTM2NDA2MA_43bca423-e034-4785-bb9b-2f06e81c2eeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIyLTUtMS0xLTM2NDA2MA_7615b53b-0c93-4df9-930d-1ddadb68802b">76</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIyLTctMS0xLTM2NDA2MA_a0c26ae8-ddd6-4b63-a8ef-fc6152cdc3e4">200</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases in provisions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIzLTEtMS0xLTM2NDA2MA_2b9a2d90-1300-4ad2-a389-d008a32dfadd">193</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIzLTMtMS0xLTM2NDA2MA_1d81b0d2-2522-44c9-8fc9-8a83b65cdcd8">40</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIzLTQtMS0xLTM2NDA2MA_87affa8d-cc44-48ba-9783-58f6267b9be9">521</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIzLTUtMS0xLTM2NDA2MA_99d49956-64be-4524-a491-323da4e42151">531</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ChangesInOtherProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIzLTctMS0xLTM2NDA2MA_f214bc1d-5e93-4f5d-bee3-05b3ee9edba0">1,285</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI0LTEtMS0xLTM2NDA2MA_abe5c8e1-a9ae-4f05-bfe7-8ff7fab6fe54">275</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI0LTMtMS0xLTM2NDA2MA_fcaf9ec3-ae93-4ce3-8016-7dc197ceb0fc">119</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI0LTQtMS0xLTM2NDA2MA_df1b151f-d3ae-4360-80cb-3b1f47886539">12</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI0LTUtMS0xLTM2NDA2MA_5cae471b-9dfc-4e7d-9ca7-34565ac77077">122</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI0LTctMS0xLTM2NDA2MA_a70e1a7f-88ca-4f36-b1d1-6a6e233ef534">528</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reversals of unutilized provisions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI1LTEtMS0xLTM2NDA2MA_3fe2a891-c619-4e59-a204-755dc61aefef">66</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI1LTMtMS0xLTM2NDA2MA_aa1b323d-b347-49ae-ae7e-71fef38f2eb3">20</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI1LTQtMS0xLTM2NDA2MA_388cb8be-807d-4783-9794-4f59dc9e4566">11</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI1LTUtMS0xLTM2NDA2MA_1e7a94e0-e231-4a31-83ff-2e239adcfeba">191</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI1LTctMS0xLTM2NDA2MA_9bdf58ea-f8f8-4836-9282-5548a16aedcb">288</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI2LTEtMS0xLTM2NDA2MA_28c76548-6d64-4cbe-a8fc-7f4863a1e555">10</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI2LTMtMS0xLTM2NDA2MA_06d4418c-352e-4600-b189-607d5b884ab9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI2LTQtMS0xLTM2NDA2MA_c6d0a5f9-125f-4b8b-99e2-6e849a140452">265</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI2LTUtMS0xLTM2NDA2MA_f771d09e-b9d3-42a7-b625-5b70dd873156">23</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI2LTctMS0xLTM2NDA2MA_5404cb80-3ef2-4dca-a27c-db0a97483844">274</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest related to employee benefits, and unwinding of discount</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI3LTEtMS0xLTM2NDA2MA_620f1280-6152-43c3-a451-3304510821bd">43</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI3LTMtMS0xLTM2NDA2MA_5b834f77-9761-4583-ae83-7e4055d2077c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI3LTQtMS0xLTM2NDA2MA_7932dce8-b0e1-4576-a84b-125165609e86">5</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI3LTUtMS0xLTM2NDA2MA_667c7c18-077f-43eb-8609-d1b4cfeab136">12</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI3LTctMS0xLTM2NDA2MA_3d367b56-15e9-41d4-9d76-ec661246543f">64</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI5LTEtMS0xLTM2NDA2MA_107f10e3-a0c8-424d-ab08-4bec263aa2b7">63</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI5LTMtMS0xLTM2NDA2MA_6201ee62-7eb8-4068-bbfb-870751cee16d">28</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI5LTQtMS0xLTM2NDA2MA_69da9819-68ad-4c63-aa8f-f25909ff87ae">1</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI5LTUtMS0xLTM2NDA2MA_dab75740-ffdb-4202-a808-78d9e44afd10">23</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI5LTctMS0xLTM2NDA2MA_ff13e7c2-f942-499f-a933-141ba5eb8025">113</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains and losses on defined-benefit plans</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231" decimals="-6" sign="-" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMwLTEtMS0xLTM2NDA2MA_910d106a-b281-40f8-8449-fc10e691d086">780</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231" decimals="-6" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMwLTMtMS0xLTM2NDA2MA_c067cb3d-98bc-4361-b24e-5c8192a339df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231" decimals="-6" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMwLTQtMS0xLTM2NDA2MA_7097aad3-ef13-47d0-b62c-2d64028e5dc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231" decimals="-6" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMwLTUtMS0xLTM2NDA2MA_30705515-1ae6-4898-a01f-cbdc3ceea473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="sny:ActuarialGainsAndLossesOnDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMwLTctMS0xLTM2NDA2MA_944e3dfd-0f36-423f-80c3-1814d26b55bc">780</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i99f14dae6c344820b8cfd29600e3d5a5_I20221231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMxLTEtMS0xLTM2NDA2MA_8a314f38-0efb-47e4-a134-8fcba3121888">2,039</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i166b657852b1433a9e018a31616ff84f_I20221231" decimals="-6" name="ifrs-full:NoncurrentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMxLTMtMS0xLTM2NDA2MA_da868be0-189b-42ad-9b5b-13e70abaebf8">844</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i68ec19e5d4dd47f99a2b91bffaf44998_I20221231" decimals="-6" name="ifrs-full:NoncurrentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMxLTQtMS0xLTM2NDA2MA_3db26947-54b6-458e-a8a9-240955aa9ed2">761</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i38e42cc577a14225b39b09272fa72a61_I20221231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMxLTUtMS0xLTM2NDA2MA_50b356ac-82dc-4f3b-aa69-1ca3c54fa900">2,178</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMxLTctMS0xLTM2NDA2MA_45b14449-45bb-4c50-adf1-e1d940e64eae">5,822</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) In the case of &#8220;Provisions for pensions and other post-employment benefits&#8221;, the &#8220;Increases in provisions&#8221; line corresponds to rights vesting in employees during the period, and past service cost; the &#8220;Provisions utilized&#8221; line corresponds to contributions paid into pension funds and to beneficiaries; and the&#160;&#8220;Reversals of unutilized provisions&#8221; line corresponds to plan curtailments, settlements and amendments.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.19.1. Provisions for pensions and other post-employment benefits</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi offers its employees pension plans and other post-employment benefit plans. The specific features of the plans (benefit formulas, fund investment policy and fund assets held) vary depending on the applicable laws and regulations in each country where the employees work. These employee benefits are accounted for in accordance with IAS&#160;19 (see Note&#160;B.23.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s pension obligations in <ix:nonFraction unitRef="country" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:NumberOfCountriesIncludedInPensionPlans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE5MjE_405d121d-e674-4d60-a36d-ea58eef28d90">four</ix:nonFraction>&#160;major countries represented approximately <ix:nonFraction unitRef="number" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="2" name="sny:PensionObligationPercentageToDefinedBenefitLiability" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE5NjY_420c145b-fe42-4275-8e17-37de9d47e811">89</ix:nonFraction>% of the total value of the defined-benefit obligation and approximately <ix:nonFraction unitRef="number" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="2" name="sny:PensionObligationPercentageToPlanAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzIwNDA_86553942-7972-4b02-a38b-a8ca9039fa34">88</ix:nonFraction>% of the total value of plan assets as of December 31, 2022. The features of the principal defined-benefit plans in each of those four countries are described below.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">France</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Lump-sum retirement benefit plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All employees working for Sanofi in France are entitled on retirement to a lump-sum payment, the amount of which depends both on their length of service and on the rights guaranteed by collective and internal agreements. The employee&#8217;s final salary is used in calculating the amount of these lump-sum retirement benefits. These plans represent approximately <ix:nonFraction unitRef="number" contextRef="ia10e6503fcc842d0a8ec71b5c5ce2538_I20221231" decimals="2" name="sny:PensionObligationPercentageToDefinedBenefitLiability" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzI1OTE_1c0346c5-0fec-49b1-9aed-55d6311b0562">35</ix:nonFraction>% of Sanofi&#8217;s total obligation in France.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-66</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i9fcd2ba010314f5f8d112070af207c3f" continuedAt="i92f4e7fad27a44e991425a51fe2d646b"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Defined-benefit pension plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These plans provide benefits from the date of retirement. Employees must fulfil a number of criteria to be eligible for these benefits. All of these plans are now closed. These plans represent approximately&#160;<ix:nonFraction unitRef="number" contextRef="i1658b22a6e4540a0807eac410291250d_I20221231" decimals="2" name="sny:PensionObligationPercentageToDefinedBenefitLiability" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzI5NDA_f7211e5c-b6f7-48cb-8c26-eb916f4512a9">65</ix:nonFraction>% of Sanofi&#8217;s total obligation in France.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Germany</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Top-up defined-benefit pension plan</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The benefits offered under this pension plan are wholly funded by the employer (there are no employee contributions) via a Contractual Trust Agreement (CTA), under which benefits are estimated on the basis of a career average salary. Employees are entitled to receive an annuity under this plan if their salary exceeds the social security ceiling. The amount of the pension is calculated by reference to a range of vesting rates corresponding to salary bands. The plan also includes disability and death benefits. This plan represents approximately <ix:nonFraction unitRef="number" contextRef="i144ca30e0cf646e2b838836778d7d0b4_I20221231" decimals="2" name="sny:PensionObligationPercentageToDefinedBenefitLiability" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzM1NzY_2880d3c1-05cb-4ce2-9400-17485c162797">62</ix:nonFraction>% of Sanofi&#8217;s total obligation in Germany.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi-Aventis plus (SAV plus)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A top-up pension plan (SAV plus) replaced a previous top-up defined-benefit plan. New entrants joining the plan after April&#160;1,&#160;2015 contribute to a defined-contribution plan that is partially funded via the company&#8217;s CTA.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All employees whose salary exceeds the social security ceiling are automatically covered by the plan. The employer&#8217;s contribution is <ix:nonFraction unitRef="number" contextRef="ief705d2690d74284bfafb92aae683ade_D20220101-20221231" decimals="INF" name="sny:EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQwMDY_cab7c6e4-3604-4f53-88c2-9e3c18bdcd44">15</ix:nonFraction>% of the amount by which the employee&#8217;s salary exceeds the social security ceiling.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Multi-employer plan (Pensionskasse)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This is a defined-benefit plan treated as a defined-contribution plan, in accordance with the accounting policies described in&#160;Note&#160;B.23. Currently, contributions cover the level of annuities. Only the portion relating to the future revaluation of&#160;the&#160;annuities is included in the defined-benefit pension obligation. The obligation relating to this revaluation amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i84d47ba9760945e48ac11bae1f3b3f30_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQ1MDA_81de10b5-3dca-4406-aa19-41b0b0e472b3">652</ix:nonFraction> million as of December 31, 2022, versus&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="ie22c0c0a8b924a2b9eb8114a97aa2197_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQ1MjA_62d43cb9-3679-4ad6-a262-ce450f459377">877</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="iae25acad84cd4329ab2b319e35f1cf11_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQ1MzY_32bc6f2d-ddff-4c35-b1da-214a3c81524a">773</ix:nonFraction> million as of December 31, 2020. This plan represents approximately <ix:nonFraction unitRef="number" contextRef="i84d47ba9760945e48ac11bae1f3b3f30_I20221231" decimals="2" name="sny:PensionObligationPercentageToDefinedBenefitLiability" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQ1ODQ_9db3a088-897b-4d43-bc1c-a7160e80a8b3">24</ix:nonFraction>% of Sanofi&#8217;s total defined-benefit obligation in Germany.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">United States</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Defined-benefit pension plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the United States, there are <ix:nonFraction unitRef="plan" contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231" decimals="INF" name="sny:NumberOfDefinedBenefitPlans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQ3MjA_a5b3cba5-8c73-4b47-8eb9-5d68f62ea76d">two</ix:nonFraction> types of defined-benefit plan:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">&#8220;qualified&#8221; plans within the meaning of the Employee Retirement Income Security Act of 1974 (ERISA), which provide guaranteed benefits to eligible employees during retirement, and in the event of death or disability. Employees can elect to receive a reduced annuity, in exchange for an annuity to be paid in the event of their death to a person designated by them. An annuity is also granted under the plan if the employee dies before retirement age. Eligible employees do not pay any contributions. These plans are closed to new entrants, and the vesting of rights for future service periods is partially frozen. These plans represent approximately <ix:nonFraction unitRef="number" contextRef="i72b834d66c174249a0c347659203c14e_I20221231" decimals="2" name="sny:PensionObligationPercentageToDefinedBenefitLiability" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzU0MDU_f74c9c32-2885-463c-b30b-ca492d3bc5d8">60</ix:nonFraction>% of Sanofi&#8217;s total obligation in the United States;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">&#8220;non-qualified&#8221; plans within the meaning of ERISA provide top-up retirement benefits to some eligible employees depending on the employee&#8217;s level of responsibility and subject to a salary cap. These plans represent approximately <ix:nonFraction unitRef="number" contextRef="ib27399813eb6424abd019f16bfa18111_I20221231" decimals="2" name="sny:PensionObligationPercentageToDefinedBenefitLiability" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzU2ODg_5ddf27a0-e650-4340-bb61-069b84c7f3b5">14</ix:nonFraction>% of Sanofi&#8217;s total obligation in the United States.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare cover and life insurance</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi companies provide some eligible employees with healthcare cover and life insurance during the retirement period (the company&#8217;s contributions are capped at a specified level). These plans represent approximately <ix:nonFraction unitRef="number" contextRef="i07e1ed072e3e438e9fa21f2b6b669c94_I20221231" decimals="2" name="sny:PensionObligationPercentageToDefinedBenefitLiability" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzU5OTY_048a1535-fbdb-4f57-bc26-f3f4f5ab30ab">26</ix:nonFraction>% (or &#8364;<ix:nonFraction unitRef="eur" contextRef="i07e1ed072e3e438e9fa21f2b6b669c94_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzYwMDM_6641327c-d326-4af3-acff-88ccbad9fcd7">409</ix:nonFraction> million) of Sanofi&#8217;s total obligation and&#160;<ix:nonFraction unitRef="number" contextRef="i76c3583de96148c4885a50242b9c6cbd_I20221231" decimals="2" name="sny:PensionObligationPercentageToPlanAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzYwNDA_24720741-59fb-4d60-9b92-68a836e1be78">3</ix:nonFraction>% (or &#8364;<ix:nonFraction unitRef="eur" contextRef="i76c3583de96148c4885a50242b9c6cbd_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzYwNDc_d28e8cc2-0366-44a1-82f9-9e7875cbed51">28</ix:nonFraction> million) of total plan assets in the United States.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">United Kingdom</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Defined-benefit pension plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi operates a number of pension plans in the United Kingdom that reflect past acquisitions. The most significant arrangements are defined-benefit plans that have been closed since October&#160;1, 2015. With effect from that date, employees can no longer pay into these plans.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under these defined-benefit plans, an annuity is paid from the retirement date. This annuity is calculated on the basis of the employee&#8217;s length of service as of September&#160;30, 2015, and of the employee&#8217;s final salary (or salary on the date he or she leaves Sanofi).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The rates used for the vesting of rights vary from member to member. For most members, rights vest at the rate of <ix:nonFraction unitRef="number" contextRef="i6f22c7c899354b0cb94d9107f4fd1d7b_D20220101-20221231" decimals="INF" name="sny:DefinedBenefitPlansVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzY3OTQ_a9f39446-6064-4097-93f6-f781c5d9e88b">1.25</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="idce85fea541d4dca84fd5c265ae2ce3d_D20220101-20221231" decimals="INF" name="sny:DefinedBenefitPlansVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzY4MDE_3b46ce38-3641-44fc-9af5-91252a8a7110">1.50</ix:nonFraction>% of final salary for each qualifying year of service giving entitlement. The notional retirement age varies according to the category to which the member belongs, but in most cases retirement is at age <ix:nonFraction unitRef="age" contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231" decimals="INF" name="sny:RetirementAge" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzcwMDU_82af764c-7c57-4694-8bab-d5159a2f4dcb">65</ix:nonFraction>. Members may choose to retire before or after the notional retirement age (<ix:nonFraction unitRef="age" contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231" decimals="INF" name="sny:NotionalRetirementAge" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzcwODM_b0ee3d9e-84dd-4c8e-a1ce-61a3a335bad2">60</ix:nonFraction>&#160;years), in which case the amount of the annual pension is adjusted to reflect the revised estimate of the length of the retirement phase. Pensions are usually indexed to the Retail Price Index (RPI). Members paid a fixed-percentage contribution into their pension plan (the percentage varied according to the employee category), and the employer topped up the contribution to the required amount. These plans represent approximately <ix:nonFraction unitRef="number" contextRef="iaa0767613c3f411ca54f05839ea4dfcd_I20221231" decimals="INF" name="sny:PensionObligationPercentageToDefinedBenefitLiability" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzc1MTk_20086845-20d7-4e99-af01-19cd805eeb27">100</ix:nonFraction>% of Sanofi&#8217;s total obligation in the United Kingdom.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For service periods subsequent to October&#160;1, 2015, employees belong to a new defined-contribution plan.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-67</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i92f4e7fad27a44e991425a51fe2d646b" continuedAt="if9b603a3ec4f4af1bde010ec80b4f352"><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Actuarial assumptions used to measure Sanofi&#8217;s obligations</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Actuarial valuations of Sanofi&#8217;s benefit obligations were computed by management with assistance from external actuaries as of&#160;December 31, 2022, 2021 and 2020.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfActuarialAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDc0_3f6cfbbe-4389-4e2e-8380-aced9645db89" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Those calculations were based on the following financial and demographic assumptions:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)/(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2fc70c201ea485293d21743a8c878ce_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZmYwMWE5MDQ3OGViNGY2MThiOGQwNGY2MGY5ZmE2OTVfNzY5NjU4MTM5NDQ3OQ_0112498c-1e34-45fb-9c90-3ff61836b321">3.55</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i2161c01fcdb543bf903af67ad7c742bc_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZmYwMWE5MDQ3OGViNGY2MThiOGQwNGY2MGY5ZmE2OTVfNzY5NjU4MTM5NDQ4Nw_119de001-b2b6-4702-9c47-f8dad193287b">3.75</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib109e7b8a7804e8faf5db8da9efa7002_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMi0xLTEtMzY0MDYwL3RleHRyZWdpb246MGIyMzI4OWZiMWZjNGJlMzlhM2QzZTRhMGQwNWNiYTBfNzY5NjU4MTM5NDQ3OQ_d7f45f0c-095b-490b-af47-27ff66cc3ee7">3.55</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="iad383d0b40904aa78c611003295b9f75_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMi0xLTEtMzY0MDYwL3RleHRyZWdpb246MGIyMzI4OWZiMWZjNGJlMzlhM2QzZTRhMGQwNWNiYTBfNzY5NjU4MTM5NDQ4Nw_7ea0f94e-abb2-4f0b-a460-d4cde87486cb">3.75</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItNC0xLTEtMzY0MDYwL3RleHRyZWdpb246NDhiOTAwOTc2ZWY0NDNlOGIzZDU5MjQ5ZmYyY2NjNTFfNzY5NjU4MTM5NDQ1Ng_038a7d83-1328-4700-accc-89e5d8cb73ff">4.90</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37dc156184d44185ad77a05f3d1c8e7d_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItNS0xLTEtMzY0MDYwL3RleHRyZWdpb246NmE4ODczMjg0YmY5NDY5ZGExZmVjYTc4MzI3NWY1MmVfNzY5NjU4MTM5NDQ1OA_425f3ed4-c42d-4519-8657-16cbff406318">4.75</ix:nonFraction>%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7d1dddd9218a466d80295b2cd0ba570a_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItNy0xLTEtMzY0MDYwL3RleHRyZWdpb246MjdlOTdlM2NkMTdlNDRlZDlmYzkyMDM0YzA2YzU4MWFfNzY5NjU4MTM5NDQ3Nw_e7b110bd-5f94-48b4-8df1-03f9c890f2cc">0.10</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ib64132cf06b441e783c6365e8d7e0777_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItNy0xLTEtMzY0MDYwL3RleHRyZWdpb246MjdlOTdlM2NkMTdlNDRlZDlmYzkyMDM0YzA2YzU4MWFfNzY5NjU4MTM5NDQ4NQ_16fc138b-336d-4096-b8cd-afcf5ccd14e4">1.10</ix:nonFraction>%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d969a5687574442a05c8b81a0fdc221_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItOC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZGI5MTZlMzY1ZmNhNGI5ZTg5NjlmMjU5MjMyZTA4OGZfNzY5NjU4MTM5NDQ3Nw_9332e296-f0b3-41f1-814f-6ff82e345ddb">0.10</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i9ead7b007eb34735a7448b53948b4495_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItOC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZGI5MTZlMzY1ZmNhNGI5ZTg5NjlmMjU5MjMyZTA4OGZfNzY5NjU4MTM5NDQ4NQ_2b18660d-d4a9-403b-a554-fec61d891db2">1.10</ix:nonFraction>%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjJkOWE1MDQ3NmE5OTRmN2FiYzA0NDJmMjBkYjAwYTg5Xzc2OTY1ODEzOTQ0NTY_169424cc-b658-44c7-96ce-413ec54f5459">2.70</ix:nonFraction>%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib5ccc5f405134715b9e46b9feb0319b6_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjFlODk1ZmI2NjQ0YTQ3YjRiM2M0YzViZTMzYzVlYjM4Xzc2OTY1ODEzOTQ0NTg_cdb2bf0b-8d45-4854-9376-0b5b4b2c9700">1.90</ix:nonFraction>%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i058d3dfb4d72464288d47993d2264238_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjc2ZjM2ODRiYWYwMDRjMjdiZmNkNjJhYjRmMDUyM2VmXzE5NzkxMjA5MzAwMDUz_297f44f8-b8c4-4d87-a3ba-fd8debe0ef55">0.00</ix:nonFraction>%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">or </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b87b7d69412417d8a10e4771f17da62_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjc2ZjM2ODRiYWYwMDRjMjdiZmNkNjJhYjRmMDUyM2VmXzc2OTY1ODEzOTQ0ODQ_758e38b3-3579-4b09-a07c-6fa46643dbda">0.55</ix:nonFraction>%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i11aa53d3dc864e008f9e1088d764b254_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjE0YTM4MWRiZDA3MDRjYTdhNmYxZDZjYzdhNDkwMmI1XzE5NzkxMjA5MzAwMDUz_61ff054f-eb6d-42f0-bc94-58f9f03859b3">0.00</ix:nonFraction>%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">or </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41bece1da3a74bb9b590430977baca7c_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjE0YTM4MWRiZDA3MDRjYTdhNmYxZDZjYzdhNDkwMmI1Xzc2OTY1ODEzOTQ0ODQ_4def06f3-a522-47c6-92ae-28b9a001cbcc">0.55</ix:nonFraction>%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjA5NWUyYjJkMjU0MjQ0Njk5Y2Q0OTcwMDY5ZDdlNmFkXzc2OTY1ODEzOTQ0NTQ_54ac2428-2c19-4ddb-a7c7-fba2abb2faf9">2.40</ix:nonFraction>%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7848ab0fc3954d42a48de56c4b377354_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmI5NDEwZmI5OTMzYTQyMjBiY2Y1MWY5MDk4NjcxYTA4Xzc2OTY1ODEzOTQ0NTY_7a9db231-889e-49e2-9687-dda26446fc7f">1.35</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">General inflation rate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246MzU0ZGNjZTQ3Y2NiNDg3YTk5YjBjZGI0OTczM2FkZmZfNzY5NjU4MTM5NDQ2Mg_5f2a9d00-d19b-41a0-a09a-0ded83b9f5a8">2.50</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2b8dfeed67443e4a6e31f8a92ee2680_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMi0xLTEtMzY0MDYwL3RleHRyZWdpb246NzQ3MzlmMzZkMzM3NDgxNWJkYTcyOWY5ZTkyNDZlNzBfNzY5NjU4MTM5NDQ1OA_10ff06c4-34be-41ef-be86-f70518077207">2.50</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231" decimals="0" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246OGMwNDY3OTBjNzQzNGY4N2I1ZGQ1NTI5ZmI2M2NmMGRfNzY5NjU4MTM5NDQzOA_54e819e5-c317-43b9-82e8-aedec662e345">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37dc156184d44185ad77a05f3d1c8e7d_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtNS0xLTEtMzY0MDYwL3RleHRyZWdpb246NDRmMzBmMjgyYjlkNDAyNWI0MTJjYWUyNTY2NTQ0NmVfNzY5NjU4MTM5NDQ1OA_1668a450-6f15-4fb1-b892-aeb1e8f545d5">3.25</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtNy0xLTEtMzY0MDYwL3RleHRyZWdpb246NDYyMjVhZTcyNDIyNDZmZThkMWZlMzkzMzM3ZTE5YmNfNzY5NjU4MTM5NDQ2MA_ae44c805-50b5-4d7b-80e8-9284465ed023">1.95</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61f3d4e904be4545a74ce3fa06c1a204_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtOC0xLTEtMzY0MDYwL3RleHRyZWdpb246Y2ZmZjk4ZTYyZGE0NDQ2NWFjN2E5ZWI3MzU2MjhmNTFfNzY5NjU4MTM5NDQ2MA_e7053d7d-482e-449a-98de-e69a696c223b">1.95</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231" decimals="0" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmZiZDM1NTdkODg2ZDQ0ZjE4Nzc1NjNiNTU2ODI3NmFjXzc2OTY1ODEzOTQ0Mzg_c2238722-4a06-44fc-88e6-fe35e0420eb1">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib5ccc5f405134715b9e46b9feb0319b6_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjI5YjM0OTc5M2Q4ZDRkNDM4MTNjZDAwMTE3Y2ViMjA1Xzc2OTY1ODEzOTQ0NTg_8252ada3-3c86-4531-bb5e-9bd797d27790">3.30</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjQ5OTI1YzdlMzU4MjRjNTViNWI2Y2ZmZGZjY2Y5NWNlXzc2OTY1ODEzOTQ0NTg_c8fb3918-ed06-4e80-b45a-f55a29ef344c">1.45</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib07bedf4fd5b4afd80a58bc9cb0aec36_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjM1ZTY2OGZjNjdmZTRmZDQ5MDAyOWQ3OGRmMWIxN2JmXzc2OTY1ODEzOTQ0NTg_1c91789e-f45a-4f36-8354-065e99dc1851">1.45</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231" decimals="0" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjcwN2VjYTIyOTk5YjQwNDA5YjZiZjBhMDMxMmRkMTBhXzc2OTY1ODEzOTQ0NDI_7a229fd0-fa1d-4f5e-afcd-49520aff5538">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7848ab0fc3954d42a48de56c4b377354_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjYzZWY0N2FmYjkxODRhZjhiMTY4NTU1NGY4ZGRlNWUwXzc2OTY1ODEzOTQ0NjA_be35fdd1-a771-417d-9fc2-3848d6b42304">2.95</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pension benefit <br/>indexation</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246NThkYmYxN2QyMjVjNGY0NmEyNDBiNjc0MWY1ZTljYmNfNzY5NjU4MTM5NDQ1Ng_2c58987e-2345-4cee-a6fd-ebf5876561ec">2.50</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2b8dfeed67443e4a6e31f8a92ee2680_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMi0xLTEtMzY0MDYwL3RleHRyZWdpb246N2FhYjFjMWJlYjUwNDViOGJlYmU2ODkzY2MxNTY1YTRfNzY5NjU4MTM5NDQ1OA_22c59fe0-b33b-4d09-8745-02eef5dd99c1">2.50</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231" decimals="0" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246NjE0MTcwZWYwNmY0NGJlNzhlNTFhMzkwMzljZDY1MWZfNzY5NjU4MTM5NDQzOA_452fbf91-cdd2-44bb-9f59-26c4382fd8b7">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37dc156184d44185ad77a05f3d1c8e7d_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtNS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZGI3NzljMDQzZmQ2NDYyNThlYWJjOTEzNWMzODdjZThfNzY5NjU4MTM5NDQ1Ng_e3781d83-535f-4cc8-9719-d4f720ade10f">3.00</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtNy0xLTEtMzY0MDYwL3RleHRyZWdpb246NzY1MzA1NTQ1NTFiNDE0NWE2YjRiZDZiZDA4MzY5MjBfNzY5NjU4MTM5NDQ1Ng_f2921123-f2ea-4876-83e1-baf4011a8b75">1.95</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61f3d4e904be4545a74ce3fa06c1a204_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtOC0xLTEtMzY0MDYwL3RleHRyZWdpb246NmFkZDcwMDAxYzE4NDFhM2EwZTA2ZjAwOTMyNWY1NDdfNzY5NjU4MTM5NDQ2MA_f6f7ad48-5137-43fc-a9eb-b4f2deb95586">1.95</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231" decimals="0" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjJhZjIzYjgzNzcxMDQ4MjhhYzNiZmExMWE1NzU4ZTNmXzc2OTY1ODEzOTQ0Mzg_05efd7b9-8db7-4f61-8b02-939138fad262">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib5ccc5f405134715b9e46b9feb0319b6_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmNkMzZkYjQzNTViNTRmNmM4MDJhM2UwYzdmMzY1MzdiXzc2OTY1ODEzOTQ0NjA_4c3e1d54-8436-4e36-9841-61fb5b42ff41">3.15</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i058d3dfb4d72464288d47993d2264238_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmU4ZDI0NmNhN2NkMjQ3ZjY5MTQwOTk3YWJlZDFiZjQ2Xzc2OTY1ODEzOTQ0NzY_7213dd93-8c45-4ff1-9311-99787290756c">1.45</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib07bedf4fd5b4afd80a58bc9cb0aec36_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjJhZDQ0MTg1MDYzZjQ2NzRiZDM5ZWIyZDY5YzA2YjQ2Xzc2OTY1ODEzOTQ0NTg_602e5949-5be3-4b5d-89f8-424d180bdee2">1.45</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231" decimals="0" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjcxMmQ3YmRjYWI5MTQzZWU5MmQzMjdlNDZkMWE3NGE3Xzc2OTY1ODEzOTQ0Mzg_b10a6de6-e027-433f-9a42-f25a3bb27091">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7848ab0fc3954d42a48de56c4b377354_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjEzYWI4OGQ4OWViZDQ4MmY4MjdmY2IzZDViNmYxNjhmXzc2OTY1ODEzOTQ0NTg_4e72b1f3-5f3e-4db1-b409-d6e1c4b6e26e">2.85</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Healthcare cost </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">inflation rate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231" decimals="0" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246NjkzN2RmYzA4ZDhlNDYxMTgzYzQ3MGJjY2QwNDBhZTZfNzY5NjU4MTM5NDQzOA_0632aa31-b88f-481c-ab40-1973d5c32919">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2b8dfeed67443e4a6e31f8a92ee2680_I20221231" decimals="0" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMi0xLTEtMzY0MDYwL3RleHRyZWdpb246NmY2NzgzNTA1ZGUyNDcxNzhhZTM3NGRhNDI5ODA5YjdfNzY5NjU4MTM5NDQzOA_3877f138-5904-4d2e-a13a-9735911947a1">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a09555de5d2475e921b22b01c4067e0_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDBmMzM4Y2MzOTRmNGVmMmI3ZTdjNTAzZTlkZjFlZDRfNzY5NjU4MTM5NDQ1NQ_1c8e5c2f-64b3-463a-bc68-bc670d705002">3.29</ix:nonFraction>%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb0e67934e9342fe8d11bdef892de277_I20221231" decimals="4" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDBmMzM4Y2MzOTRmNGVmMmI3ZTdjNTAzZTlkZjFlZDRfNzY5NjU4MTM5NDQ2Mw_97359474-be04-4878-89e6-be59d5bcd362">6.56</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37dc156184d44185ad77a05f3d1c8e7d_I20221231" decimals="0" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtNS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZTAwMWExZjVjN2ZjNDIyMzkzOTdkMTNhZDBkMWQ0MTVfNzY5NjU4MTM5NDQzOA_afdfe770-40ec-426b-bc88-40e9398eb3f4">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231" decimals="0" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtNy0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDBiOWM2ZTkzNmQ2NDliMDhhZDM3NTNhZmRjNGZhNGFfNzY5NjU4MTM5NDQzOA_aaba7211-96ab-45fc-9c5c-d948317efd32">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61f3d4e904be4545a74ce3fa06c1a204_I20211231" decimals="0" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtOC0xLTEtMzY0MDYwL3RleHRyZWdpb246OWFjMWRjNjA4OTVjNGZiYjkyMTEzYzFkZDViZjA0ZDJfNzY5NjU4MTM5NDQzOA_b8448b7c-02f9-4749-b565-4a6d92c7ac5a">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia76aa13b727547f4b1f27cd2781c256a_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjdlNWRiNzhmODdhNTRlMWI5YTcxNTA3MThmNDMwMmUwXzQ_00ab34ad-3cf3-4983-8e8f-07c9fff6ac33">3.50</ix:nonFraction>%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4b4ab3d8a6a24c718f4ce304e594594a_I20211231" decimals="4" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjdlNWRiNzhmODdhNTRlMWI5YTcxNTA3MThmNDMwMmUwXzEw_59ff9374-d7fa-4c43-bed1-7a0ea62f3c1c">4.50</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib5ccc5f405134715b9e46b9feb0319b6_I20211231" decimals="0" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjA4YjEyNjZhNTZjODQ5ZDRhNGRiOTg2ZmRmZmM0ZmNmXzc2OTY1ODEzOTQ0Mzg_4432cefa-172d-4436-b57c-d1a457f22f59">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231" decimals="0" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmJlMzUyNDE1ZDFkMDQ0YjdiYjc2YzIxMGVlMDViMGRmXzc2OTY1ODEzOTQ0Mzg_b0f5fb3e-a22f-408c-98f7-b165d7e82bbc">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib07bedf4fd5b4afd80a58bc9cb0aec36_I20201231" decimals="0" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjgyMTgwNzE2YmJjYTQ4MWNiMTYwZThjMzlkYmE2MzU5Xzc2OTY1ODEzOTQ0Mzg_a0a64011-36f6-4a01-a258-31fa698b6f2b">&#8212;</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i389422a893e247e09550b1c3b9924585_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjRhZjBkOGE4YTE4NzRkYjA4MDU4ZWU1MDc5MjVjYTJjXzc2OTY1ODEzOTQ0Njc_f40570d9-1969-4fc0-83b7-daacacbb8f45">3.50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ib2b883217a0b47c1809f32a00d79e510_I20201231" decimals="4" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjRhZjBkOGE4YTE4NzRkYjA4MDU4ZWU1MDc5MjVjYTJjXzc2OTY1ODEzOTQ0NzU_e5db6924-5c1d-44e0-9f49-8c1e941389d3">4.50</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7848ab0fc3954d42a48de56c4b377354_I20201231" decimals="0" name="ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmIyZmEzOGM4ZTZmYTRhMTg4OTQ0MDUyMjk3ODlhZDRiXzc2OTY1ODEzOTQ0Mzg_a0e1be6f-4a38-420a-8569-d9959dcb8394">&#8212;</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retirement age</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231" name="sny:ActuarialAssumptionOfRetirementAgeBottomOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246YWQyMGFlODU4MjViNGE4ZGFiNWQxYmYwOWMyMDA1OGZfNzY5NjU4MTM5NDQ0Ng_fa8e5c68-8a9c-47ea-adf8-c0aa771c4330">62</ix:nonNumeric></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to <ix:nonNumeric contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246YWQyMGFlODU4MjViNGE4ZGFiNWQxYmYwOWMyMDA1OGZfNzY5NjU4MTM5NDQ1MQ_6e5c4722-a3b9-41e7-a60e-479a0fbc2f9f">67</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMi0xLTEtMzY0MDYwL3RleHRyZWdpb246ODUyNmU2Y2Q0YzFkNGNkMDk5MjI3ODgzYWU3MmYyZTFfNzY5NjU4MTM5NDQ0MA_8dac44c0-19d6-4b85-aa98-e09d09c72260">63</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231" name="sny:ActuarialAssumptionOfRetirementAgeBottomOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDBlNjgyNGQ4YTY5NDBmMDhmYzY1MjQ4MTAxYjU4NTBfNzY5NjU4MTM5NDQ1NA_a0929c8d-7741-4db0-94fc-bd8da698b442">55</ix:nonNumeric></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to <ix:nonNumeric contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDBlNjgyNGQ4YTY5NDBmMDhmYzY1MjQ4MTAxYjU4NTBfNzY5NjU4MTM5NDQ1OQ_e47ce5a7-412b-48b7-9aa8-e79a4aa5add5">70</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231" name="sny:ActuarialAssumptionOfRetirementAgeBottomOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNS0xLTEtMzY0MDYwL3RleHRyZWdpb246MDVlNmQ4MTY2MWMyNDQ5ZWEwZGIwMDY0NGQwOGM5MGZfNzY5NjU4MTM5NDQ0Ng_d28d7555-26a9-4f86-995e-d70469114934">60</ix:nonNumeric></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to <ix:nonNumeric contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNS0xLTEtMzY0MDYwL3RleHRyZWdpb246MDVlNmQ4MTY2MWMyNDQ5ZWEwZGIwMDY0NGQwOGM5MGZfNzY5NjU4MTM5NDQ1Mg_afbee218-5f1b-4722-9044-e89f90b902b6">65</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231" name="sny:ActuarialAssumptionOfRetirementAgeBottomOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNy0xLTEtMzY0MDYwL3RleHRyZWdpb246Mjk1MGRhYWE3ZWE0NGI0OGJhYWQ0ZGZjNDllOWMwMjJfNzY5NjU4MTM5NDQ0NQ_547604ec-55c2-4b9f-bd08-964507f90dc1">62</ix:nonNumeric></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to <ix:nonNumeric contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNy0xLTEtMzY0MDYwL3RleHRyZWdpb246Mjk1MGRhYWE3ZWE0NGI0OGJhYWQ0ZGZjNDllOWMwMjJfNzY5NjU4MTM5NDQ0OQ_b56f4dd8-ea4f-41a0-ab8f-63f13e39f9f4">67</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtOC0xLTEtMzY0MDYwL3RleHRyZWdpb246YzU4ZjBkNTFlYTMzNDdjOGI1MDNiY2JmNWZmZTlhOTRfNzY5NjU4MTM5NDQ0OA_a1f2cb3f-f848-439b-be06-efcb4f5ea7c7">62</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231" name="sny:ActuarialAssumptionOfRetirementAgeBottomOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmFjYjYwYTVlY2Y4ZTQ5MTU5ODI3ZmExZTExNGFiZWUwXzc2OTY1ODEzOTQ0NDU_889148f0-4a02-450a-a3b5-8b05a51db378">55</ix:nonNumeric></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to <ix:nonNumeric contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmFjYjYwYTVlY2Y4ZTQ5MTU5ODI3ZmExZTExNGFiZWUwXzc2OTY1ODEzOTQ0NDk_54256b45-7726-4102-a28e-50e31787f263">70</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231" name="sny:ActuarialAssumptionOfRetirementAgeBottomOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjhhM2E4MjZiOGFkMzQzNDk4OGQ0MzdlMzNlYjYyMjBhXzc2OTY1ODEzOTQ0NDU_56910bcb-6977-4c4a-bda3-9389204a1a5f">60</ix:nonNumeric></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to <ix:nonNumeric contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjhhM2E4MjZiOGFkMzQzNDk4OGQ0MzdlMzNlYjYyMjBhXzc2OTY1ODEzOTQ0NDk_4970ca96-6307-4c83-8dc9-51ef8634e82f">65</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231" name="sny:ActuarialAssumptionOfRetirementAgeBottomOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjgxNWM0M2YyNjM5ODRjODU4YzhmYmRmZGM5NDhiYjIxXzc2OTY1ODEzOTQ0NDU_8926fbf1-b00f-4b5d-8c10-035b32200aec">62</ix:nonNumeric></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to <ix:nonNumeric contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjgxNWM0M2YyNjM5ODRjODU4YzhmYmRmZGM5NDhiYjIxXzc2OTY1ODEzOTQ0NDk_4bfdb18d-0252-4985-b8b2-3b1dc6be01c4">67</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjJjNmEwZDQ4NzI5ZDQ5OWQ5MTE0OTEwNjVlMGI0MjNjXzc2OTY1ODEzOTQ0NDg_39d7431f-ee47-4a66-b132-b44ce293e12a">62</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231" name="sny:ActuarialAssumptionOfRetirementAgeBottomOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjZhN2UzMzJkNDA2YTQ1OTM4OTAwMjA5Yzc2NzYzMjg1Xzc2OTY1ODEzOTQ0NDU_f790f46e-cd59-4b40-a14f-9c63f1a70246">55</ix:nonNumeric></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to <ix:nonNumeric contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjZhN2UzMzJkNDA2YTQ1OTM4OTAwMjA5Yzc2NzYzMjg1Xzc2OTY1ODEzOTQ0NDg_243b61df-37dd-42fb-8447-f560731e8ac9">70</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231" name="sny:ActuarialAssumptionOfRetirementAgeBottomOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjVhZmVjN2FmYzA5MzQ3YjA4Y2VkYTYwZTI4YjY1MmZiXzc2OTY1ODEzOTQ0NDU_5e56a837-b99f-486f-b3fb-fb5489878910">60</ix:nonNumeric></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to <ix:nonNumeric contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231" name="sny:ActuarialAssumptionOfRetirementAgeTopOfRange" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjVhZmVjN2FmYzA5MzQ3YjA4Y2VkYTYwZTI4YjY1MmZiXzc2OTY1ODEzOTQ0NDk_6fcb3d00-3386-44ca-b762-a27025419a20">65</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TGH/<br/>TGF<br/>05</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Heubeck<br/>RT<br/>2018 G</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RP2012 Proj.<br/>MP2021 White Collar</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SAPS<br/>S3</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TGH/<br/>TGF<br/>05</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Heubeck<br/>RT<br/>2018 G</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RP2012 Proj.<br/>MP2020 White Collar</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SAPS<br/>S3</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TGH/<br/>TGF<br/>05</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Heubeck<br/>RT<br/>2018 G</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RP2012 Proj.<br/>G.&#160;Scale<br/>MP2019 White Collar</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SAPS<br/>S2</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The discount rates used were based on market rates for high quality corporate bonds with a duration close to that of the expected benefit payments under the plans. The benchmarks used to determine discount rates were the same for all periods presented.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The rate depends on the duration of the plan (<ix:nonNumeric contextRef="i5064ea492ff44ec88d332c35c309d9a2_D20220101-20221231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgyNzQ_52eedd2e-0071-41fb-a6bd-689143ac5ae0">0</ix:nonNumeric>&#160;to <ix:nonNumeric contextRef="ieceff523a9144294a083d40ae6a52b9a_D20220101-20221231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgyODA_7e3e51c7-b964-40bd-a146-40145736f8ab">7</ix:nonNumeric>&#160;years, <ix:nonNumeric contextRef="ie625e49612cb42ce92fe5437d2292431_D20220101-20221231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgyOTA_c427204b-3c8e-4930-bd72-fac9d6937de6">7</ix:nonNumeric> to <ix:nonNumeric contextRef="i9ed6f92d51e8497998956b0d5d310672_D20220101-20221231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgyOTY_2c4e6086-2cb9-45d3-b122-cf8fe0a280e7">10</ix:nonNumeric>&#160;years, or more than <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgzMTk_9b2c70ba-91c4-45c1-8848-886754cd7808">10</ix:nonNumeric>&#160;years).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Inflation for the euro zone is determined using a multi-criterion method.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;No post-employment healthcare benefits are provided in France since 2020, Germany and UK.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted average duration of obligation for pensions and other long-term benefits in principal countries</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDgx_3c490f9f-9fae-41e1-9763-08090a13ed28" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the duration of Sanofi&#8217;s obligations in the principal countries:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:25.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(years)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted average duration</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMS0xLTEtMzY0MDYw_8a287a84-8032-4e2e-a6e1-1b9cb3416e63">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMi0xLTEtMzY0MDYw_2a734250-f61f-425b-8227-077c0ca55470">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMy0xLTEtMzY0MDYw_76231227-3e77-4143-904d-5f0209dc5622">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItNC0xLTEtMzY0MDYw_7e5d32ac-79d1-4a1e-9da2-d648649990bb">13</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItNS0xLTEtMzY0MDYw_8c1091b3-5380-469d-817f-31a21bb6e9a0">12</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItNi0xLTEtMzY0MDYw_aaddc364-8a67-474a-a3a9-40bf545e6612">16</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItNy0xLTEtMzY0MDYw_646ea2ea-6bde-438b-a252-90a0686a6b3d">15</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItOC0xLTEtMzY0MDYw_c3cc7c2c-4100-4590-a402-94d5e5cbca7d">17</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItOS0xLTEtMzY0MDYw_a73e2ffd-908a-4bbf-ad41-f9f44a4f458e">13</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMTAtMS0xLTM2NDA2MA_9d0c1782-0cc7-42c3-9318-743bd3c07718">16</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMTEtMS0xLTM2NDA2MA_e564ebdc-3128-422b-ab01-187ac0567f09">16</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMTItMS0xLTM2NDA2MA_d08e33b9-43cc-422d-99aa-4e75bc0ffc21">18</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sensitivity analysis</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDgy_f5590636-7634-4206-afe7-18f9863d1f86" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the sensitivity of Sanofi&#8217;s obligations for pensions and other post-employment benefits to changes in key actuarial assumptions:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions and other post-employment benefits, <br/>by principal country</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Measurement of defined-benefit obligation</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in<br/>assumption</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-<ix:nonFraction unitRef="number" contextRef="ia7102fede0d146a4b433b8edd4bfc772_I20221231" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzItMS0xLTEtMzY0MDYw_8b1c4d5f-9b7d-4cd5-b484-6745c073be5b">0.50</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="ibb62e344ae904638b2180924543f92ea_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzItMi0xLTEtMzY0MDYw_50f34523-3c98-4250-a9a1-d19595e422cf">72</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="id9847d7e6def4b7581c9458c55a23404_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzItMy0xLTEtMzY0MDYw_2e786f47-915b-446b-ab83-013dbafdba4a">162</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="i2e3c25fe823d4ad6b20f9c54e9bbb046_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzItNC0xLTEtMzY0MDYw_ebc64601-5935-4e2f-9738-c78f64aef9b2">75</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="i9a7882fdbd5e4e05aa9602a3893e9063_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzItNS0xLTEtMzY0MDYw_11de42d4-a8ab-4524-84d5-4d5e96dfd958">136</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">General inflation rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="number" contextRef="i8e44e9528b734db79cc3d65a8189939d_I20221231" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzMtMS0xLTEtMzY0MDYw_71cd65cc-85ee-4f13-80d9-2e54606a7505">0.50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="i9f0a85e9edb0438fafb910e5b162bdb1_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzMtMi0xLTEtMzY0MDYw_7f02f8ad-7ffa-437e-acaf-6fae13a2e773">47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="ic4384e1a2f0a448db27dfc68742b600e_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzMtMy0xLTEtMzY0MDYw_2cc37d18-1936-472c-aaf2-5a3068399244">306</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib4a60f88d3bf4ef7820610f341e5d953_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzMtNC0xLTEtMzY0MDYw_8eaf51d0-e384-4ec2-881c-e70afdde4ee0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="i79da83e967ea4e5e90e0bf72928c2373_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzMtNS0xLTEtMzY0MDYw_29372358-9d69-432a-a466-35ae7fddffca">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pension benefit indexation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="number" contextRef="i4785a07760e04fa78307171b6792c3eb_I20221231" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzQtMS0xLTEtMzY0MDYw_cd5f5a2e-649a-449a-a328-b69e2b5c5e43">0.50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="i869eae3e607c4fe0a4413a6a56efb7f1_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzQtMi0xLTEtMzY0MDYw_9416df45-d20f-4f5c-b2b7-790a2f43b774">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="i328a8d284f6846269cfae2148edfd6c1_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzQtMy0xLTEtMzY0MDYw_0c9f5f34-5dc9-4968-abc4-3108573a09f8">200</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5ccfe837400547adbd518f52980bff84_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzQtNC0xLTEtMzY0MDYw_02b98ab4-5278-4a35-8e11-678e1a25863e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="i3aaf7a0ab28f49108002d2f4290bd493_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzQtNS0xLTEtMzY0MDYw_c1c5e069-fd41-4506-9fd1-5f1ff5165154">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Healthcare cost inflation rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="number" contextRef="ic8f6bcd683c14b17bea138ad1208ab88_I20221231" decimals="INF" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzUtMS0xLTEtMzY0MDYw_874ca71f-198b-4c4b-af62-c068de7e218c">0.50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8332aad05ed4409494a56fb553b8cf48_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzUtMi0xLTEtMzY0MDYw_9b0732a6-7c68-4f9a-8062-d9e12a42e659">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="if40430fe8c9b45feb6dc9b6f4a03573b_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzUtMy0xLTEtMzY0MDYw_60e51618-7544-4ce7-8d38-575513fa39b3">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="i148b4cdc5ea1410fa268363a20cffc49_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzUtNC0xLTEtMzY0MDYw_7fc34155-19be-4fa9-8c5a-baa3dcf097d2">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i58cc77a855b44d93866738bd3c23f42e_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzUtNS0xLTEtMzY0MDYw_07275cdd-9dc4-45e6-955f-bb1ab5c7c9e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">+1 year</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="ie526c1d298584ae8972260efcc9808b6_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzYtMi0xLTEtMzY0MDYw_8bdb10e0-c339-46c5-aced-a78a9f05c269">61</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="i127c8206a4a849dbbb0fd4ceee30d8aa_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzYtMy0xLTEtMzY0MDYw_8b291982-4da2-4b4d-a3fc-eb4d812bc874">51</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="i54a79349271f4e4fb33e85139f76607f_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzYtNC0xLTEtMzY0MDYw_554d976f-7a3e-47be-8233-f28ba56dd076">19</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+<ix:nonFraction unitRef="eur" contextRef="ibaefca5f76804fce8b04f617795c3068_I20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzYtNS0xLTEtMzY0MDYw_a9f6767d-cd3d-4880-927b-b647e062cf95">74</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-68</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="if9b603a3ec4f4af1bde010ec80b4f352" continuedAt="icdff62cdec244cc088d24e362cb82266"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDc1_e0bd3331-8a40-4651-b470-80d7c8f47018" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below reconciles the net obligation in respect of Sanofi&#8217;s pension and other post-employment benefit plans with the amounts recognized in the consolidated financial statements:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:63.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Measurement of the obligation:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning of period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1aeea4ef448d4878b040aca58e59cef7_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMtMS0xLTEtMzY0MDYw_06209289-c303-49e1-a6b9-7a7cd86a1933">12,175</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i46a2a2a21d77490d9398a698d3aec8c0_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMtMi0xLTEtMzY0MDYw_ed6a70c1-b7aa-4ff5-9da1-701319ce30ef">12,456</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0d7223a21f0b4cee97becbcdd1bb2efc_I20191231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMtNC0xLTEtMzY0MDYw_bea8e7b6-a310-4ff7-bcf8-a0902b40bbb8">13,094</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQtMS0xLTEtMzY0MDYw_213c9443-62c3-4d24-b6c3-60ddd643eeec">193</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQtMi0xLTEtMzY0MDYw_189d62f9-14fd-4bdc-8357-4ca159d1fb8f">227</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQtNC0xLTEtMzY0MDYw_24c89d2f-f639-471d-b8f3-0a0b3d38025f">221</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzUtMS0xLTEtMzY0MDYw_380ad16c-9446-4160-b21d-da268368d55b">206</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzUtMi0xLTEtMzY0MDYw_c1346325-0cde-4799-a5ef-b59a8cace873">148</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzUtNC0xLTEtMzY0MDYw_a8709277-9a50-429e-acfb-dae70066bd24">192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial losses/(gains) due to changes in demographic assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzYtMS0xLTEtMzY0MDYw_cbb42974-fceb-4e66-8b1f-f59ebbedcc05">219</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzYtMi0xLTEtMzY0MDYw_e691eca9-13d4-4322-8d0d-9e93d0951a17">162</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzYtNC0xLTEtMzY0MDYw_3c386825-2d3d-4d75-aa33-511b1fef3058">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial losses/(gains) due to changes in financial assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzctMS0xLTEtMzY0MDYw_e5f2fb6f-ae22-4fe0-9f23-50bafac635ca">3,006</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzctMi0xLTEtMzY0MDYw_752b2a83-5d49-4048-8fa9-8a7981f66a71">210</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzctNC0xLTEtMzY0MDYw_40f2aec5-018f-4ce9-850b-aa886cfeb0b0">936</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial losses/(gains) due to experience adjustments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzgtMS0xLTEtMzY0MDYw_838b2955-1c48-42c4-9c8e-85bf5a8d5a6d">177</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzgtMi0xLTEtMzY0MDYw_ffefec78-95dc-48bb-80e3-36280005f8b5">120</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzgtNC0xLTEtMzY0MDYw_715ecd84-fa53-4aba-9f69-86d8ead2cd17">26</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan amendments, curtailments or settlements not specified in the terms of the plan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzktMS0xLTEtMzY0MDYw_3fa7f510-d919-4f06-84d4-bcc6141d5125">229</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzktMi0xLTEtMzY0MDYw_60348bf9-f844-4fb0-b804-61682121cfd3">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzktNC0xLTEtMzY0MDYw_f5aa0464-3887-49e6-8a7a-35db6b92a89d">938</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan settlements specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEwLTEtMS0xLTM2NDA2MA_a5cf4848-e1d4-4b89-8714-0d953bfdc7a7">84</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEwLTItMS0xLTM2NDA2MA_ea33086b-1cac-4a90-869d-38c6a45879a7">66</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEwLTQtMS0xLTM2NDA2MA_5c9d55a5-6524-435a-810f-851076364d08">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231" decimals="-6" name="ifrs-full:BenefitsPaidOrPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzExLTEtMS0xLTM2NDA2MA_26d78a1e-1cb0-494d-9e80-148ed1ba6e2d">463</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231" decimals="-6" name="ifrs-full:BenefitsPaidOrPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzExLTItMS0xLTM2NDA2MA_1dd16a43-5b19-4fa0-9842-28e0ed5aee78">503</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231" decimals="-6" name="ifrs-full:BenefitsPaidOrPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzExLTQtMS0xLTM2NDA2MA_ee51c892-0eae-45da-8449-d231a9f35452">545</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation and transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEyLTEtMS0xLTM2NDA2MA_24815b57-5119-4144-9ac7-1568bae6b278">114</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEyLTItMS0xLTM2NDA2MA_828479d8-4793-44e9-9c47-ed6b831e294e">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEyLTQtMS0xLTM2NDA2MA_5b957ff2-449e-4797-b527-b3a720a9286b">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEzLTEtMS0xLTM2NDA2MA_7279977a-b92c-49b4-9cf1-7c01c9bd6b79">15</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEzLTItMS0xLTM2NDA2MA_6e7cd805-03c9-4944-9cf5-a55cb63cf280">417</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEzLTQtMS0xLTM2NDA2MA_77cc4a60-c44d-481b-9fdc-1269d996b1c3">443</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Obligation at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifda432649e3d4b16b2b65809871ae47a_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE0LTEtMS0xLTM2NDA2MA_976a7b56-faab-45a3-973a-d1e867803012">8,651</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1aeea4ef448d4878b040aca58e59cef7_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE0LTItMS0xLTM2NDA2MA_f0f9a0d9-b715-4a1d-b0ed-586e0de94039">12,175</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i46a2a2a21d77490d9398a698d3aec8c0_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE0LTQtMS0xLTM2NDA2MA_d73227bf-54ff-45f6-9a9f-60e2556b202f">12,456</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value of plan assets:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning of period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i04bc92eea38a43168f452b170f5b5971_I20211231" decimals="-6" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE2LTEtMS0xLTM2NDA2MA_6e558f6d-9033-404f-a6e4-71a4643acfb7">9,651</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7fcfaf4afb0a4150a2e4eb7dcb4551b3_I20201231" decimals="-6" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE2LTItMS0xLTM2NDA2MA_0e746b79-740d-44fd-9c74-a739905e1216">9,358</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5920c792a4ae4e7d86f79510124b3f82_I20191231" decimals="-6" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE2LTQtMS0xLTM2NDA2MA_e121d077-2b85-424e-9811-1e3f8d712697">9,651</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest income on plan assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE3LTEtMS0xLTM2NDA2MA_32e84bff-1114-484c-b751-bdf9fbb73658">163</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE3LTItMS0xLTM2NDA2MA_707f4609-5930-4daf-bb73-d891d2de9db2">106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE3LTQtMS0xLTM2NDA2MA_147a5dd0-4d4a-42fa-b474-12c12bd06805">138</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Difference between actual return and interest income on plan assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE4LTEtMS0xLTM2NDA2MA_660012b6-3413-4ed5-b3e6-86ceb2640ff8">2,398</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231" decimals="-6" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE4LTItMS0xLTM2NDA2MA_77906760-5103-4a70-9226-7d1c2ecfc347">207</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231" decimals="-6" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE4LTQtMS0xLTM2NDA2MA_6b2494fb-c8b8-4309-959d-dac0eea904f5">696</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Administration costs</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE5LTEtMS0xLTM2NDA2MA_5f901a43-63f8-40b3-b6a4-25b5f7420bcb">6</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE5LTItMS0xLTM2NDA2MA_f1eb88aa-8267-4147-a792-781e859f36b8">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE5LTQtMS0xLTM2NDA2MA_eb1e7057-7aed-4918-bfb9-903c9ae26765">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan settlements specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIwLTEtMS0xLTM2NDA2MA_48664848-164f-41fc-bfab-abce69060eff">84</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIwLTItMS0xLTM2NDA2MA_cb650ca7-cb94-4d61-bf8c-f9487a3fbba7">66</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIwLTQtMS0xLTM2NDA2MA_e7fc83d6-d6c1-4953-a932-ce728af41982">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan settlements not specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIxLTEtMS0xLTM2NDA2MA_590a71cd-b0c1-4b72-bbf3-5731337ed44b">161</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIxLTItMS0xLTM2NDA2MA_cf2062bf-df13-4f63-be45-6d17a741c96d">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIxLTQtMS0xLTM2NDA2MA_bbc1f207-56da-419f-8f69-bdf9106609cf">739</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIyLTEtMS0xLTM2NDA2MA_1b979238-de5f-4f5e-bc44-01410440b63f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIyLTItMS0xLTM2NDA2MA_d9949aad-6692-4a2e-9dc2-4a2647af6a1a">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIyLTQtMS0xLTM2NDA2MA_ac08cc1b-0e29-4cfa-bdf7-d8486590dcbc">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer&#8217;s contributions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIzLTEtMS0xLTM2NDA2MA_df951f4a-ad0e-46ae-8671-1d43be56e5bd">238</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIzLTItMS0xLTM2NDA2MA_caf6fc3c-0b7b-41a9-994b-4e2b6b9515ec">176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231" decimals="-6" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIzLTQtMS0xLTM2NDA2MA_d8d567e0-817f-4576-8cee-9771b56301d4">490</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI0LTEtMS0xLTM2NDA2MA_e63c0499-4a11-44b4-aff1-e3423fe91731">426</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI0LTItMS0xLTM2NDA2MA_8414e2a9-ec5d-4d22-a580-d8d2df64de59">458</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI0LTQtMS0xLTM2NDA2MA_7be0e38d-dfab-4ce3-bbea-5a40e3358961">469</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation and transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI1LTEtMS0xLTM2NDA2MA_603d521c-42c5-4f65-bec0-7ce608eeefb3">32</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI1LTItMS0xLTM2NDA2MA_bd4f3f8e-5c3b-4d13-8ec9-cb97aa3e46cb">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI1LTQtMS0xLTM2NDA2MA_f1a65221-3469-44be-9ebc-c15d8f36de91">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI2LTEtMS0xLTM2NDA2MA_0e31c386-75e9-415f-8c8a-d6d3384e67ef">52</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI2LTItMS0xLTM2NDA2MA_0c1a8995-234f-45b6-b1dc-00f9bcf557e8">344</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI2LTQtMS0xLTM2NDA2MA_0843dcec-fdd2-4bf8-b42d-6795ad9dd630">326</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value of plan assets at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i937300c73128444c840c7f1ad48a02a2_I20221231" decimals="-6" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI3LTEtMS0xLTM2NDA2MA_feae442b-c905-4f31-8088-0fc1a951e8e0">6,899</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i04bc92eea38a43168f452b170f5b5971_I20211231" decimals="-6" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI3LTItMS0xLTM2NDA2MA_2252aead-94b2-4338-a7c1-020d885e31ba">9,651</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7fcfaf4afb0a4150a2e4eb7dcb4551b3_I20201231" decimals="-6" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI3LTQtMS0xLTM2NDA2MA_dfcb4a2b-a2aa-40e7-bb07-9ae9c96356e7">9,358</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net obligation</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231" decimals="-6" name="ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI5LTEtMS0xLTM2NDA2MA_258d1c75-eebb-43b6-8af8-376295c3c8e3">1,752</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231" decimals="-6" name="ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI5LTItMS0xLTM2NDA2MA_308ae90c-58b7-4bd4-8b31-5297566930e9">2,524</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231" decimals="-6" name="ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI5LTQtMS0xLTM2NDA2MA_72a8ba96-4e9c-4afd-9487-fbdb717b77da">3,098</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia26a9a0089c24d36a14fba4dc1693ac2_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMwLTEtMS0xLTM2NDA2MA_ecced113-e36f-4c42-92e4-11a3e5b34217">18</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i807618602bfb425397cffdd414a540ad_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMwLTItMS0xLTM2NDA2MA_4674cc50-6e1e-4865-ae53-946d7413e401">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5072e9250f7c4f3d89d1b407dd2508a4_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMwLTQtMS0xLTM2NDA2MA_4da5ecc9-ce3a-4c49-ab61-d8d7e469014d">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMxLTEtMS0xLTM2NDA2MA_67a8dfdd-799f-4922-a032-c4a495a55dc3">1,770</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMxLTItMS0xLTM2NDA2MA_ae5b4e2a-e20e-46ad-8051-97ac77ab603d">2,539</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMxLTQtMS0xLTM2NDA2MA_57316272-5f77-4f1e-adb6-14e97d45eb32">3,099</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amounts recognized in the balance sheet:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pre-funded obligations (see Note D.7.)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231" decimals="-6" name="sny:PreFundedPensionObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMzLTEtMS0xLTM2NDA2MA_ab0255f0-c0e8-4eb8-ae75-bb951b8c94ac">269</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231" decimals="-6" name="sny:PreFundedPensionObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMzLTItMS0xLTM2NDA2MA_c425db18-e1e8-4393-be27-c34b40c248ec">408</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231" decimals="-6" name="sny:PreFundedPensionObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMzLTQtMS0xLTM2NDA2MA_39be06e5-fba7-46da-9f04-91aaf12a9ceb">177</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Obligations provided for</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie3092ea35a054f4882eb46f7d877613d_I20221231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM0LTEtMS0xLTM2NDA2MA_5a129ced-014d-4a3b-948a-680682b5868b">2,039</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7cf90fb83ae431ca29e7217f1d29cc6_I20211231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM0LTItMS0xLTM2NDA2MA_1d04ad3e-aa78-4fe4-a684-b58a63ad71d6">2,947</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74c83face2414740ae5f9026f45db6e2_I20201231" decimals="-6" name="ifrs-full:NoncurrentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM0LTQtMS0xLTM2NDA2MA_fb37a420-f72a-43b5-b8e2-23b4001c51b8">3,276</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount recognized at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM1LTEtMS0xLTM2NDA2MA_04636b69-149a-4e67-9ca2-2779b27dade5">1,770</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM1LTItMS0xLTM2NDA2MA_7b3a2573-ce0c-4620-af67-88d202959521">2,539</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM1LTQtMS0xLTM2NDA2MA_1f12346d-de2f-4789-9895-e0dd0c2751da">3,099</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit cost for the period:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM3LTEtMS0xLTM2NDA2MA_e1a20542-33f5-4b14-b108-99724fd6e6ef">193</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM3LTItMS0xLTM2NDA2MA_886f4645-f6a4-4a0a-8b8e-7f0ab846fce7">227</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM3LTQtMS0xLTM2NDA2MA_93a6c22c-2755-4ee5-9715-37a971fa9d6d">221</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in&#160;the&#160;terms&#160;of the plan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM4LTEtMS0xLTM2NDA2MA_f4c131fd-a24c-4cd2-8948-92584ede4b62">68</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM4LTItMS0xLTM2NDA2MA_cc4f4607-34f8-42cc-aa8f-9a06d819ee02">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM4LTQtMS0xLTM2NDA2MA_067eb1d3-798e-4332-9337-f2bfe6c4183d">199</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest (income)/cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM5LTEtMS0xLTM2NDA2MA_9fcc09a6-0dd6-4c67-a31c-ed99b37bc66c">43</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM5LTItMS0xLTM2NDA2MA_8b270076-bdb7-4641-95a0-29ab5055ad15">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM5LTQtMS0xLTM2NDA2MA_3cf9f52c-f9fc-41a1-bdee-63dae56447ff">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQwLTEtMS0xLTM2NDA2MA_faa5a5a0-3c39-4655-9038-f06b2832676e">6</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQwLTItMS0xLTM2NDA2MA_1e5b7ea2-7b8c-4f68-b5df-b1dbfaea82c6">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQwLTQtMS0xLTM2NDA2MA_4277bcfe-5e24-49c7-9447-e06a2b6ccd71">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Administration costs and taxes paid during the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQxLTEtMS0xLTM2NDA2MA_2c6704e3-cda0-4b69-a949-f059340933a5">6</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQxLTItMS0xLTM2NDA2MA_06cec28f-a941-4edc-93bf-3fb2ebf57ad4">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQxLTQtMS0xLTM2NDA2MA_c8a19af4-5c74-4fd2-9eb3-020ec87b2f4c">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense recognized directly in profit or loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQyLTEtMS0xLTM2NDA2MA_6e3a8adf-e3fb-4ee4-b767-9046dfd083de">168</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQyLTItMS0xLTM2NDA2MA_ef11d54c-8a95-401f-a049-536f3c038d0c">276</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQyLTQtMS0xLTM2NDA2MA_85e7007c-e477-4678-a48a-71dbfdc1dc91">84</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQzLTEtMS0xLTM2NDA2MA_114ac67e-f498-40d7-92b8-05a01c900f1d">650</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQzLTItMS0xLTM2NDA2MA_ce8650db-39ca-4add-9404-2a9d454728ae">685</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQzLTQtMS0xLTM2NDA2MA_13a3b2fb-ddb3-4cf6-bc03-3e6c8a5dea75">266</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" sign="-" name="sny:EmployeeBenefitsExpenseGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQ0LTEtMS0xLTM2NDA2MA_a02199f5-714e-43cf-b196-4a974789e16c">482</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" sign="-" name="sny:EmployeeBenefitsExpenseGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQ0LTItMS0xLTM2NDA2MA_7c06866d-a2f1-4231-8382-d08b363f5c64">409</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="sny:EmployeeBenefitsExpenseGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQ0LTQtMS0xLTM2NDA2MA_4b367d72-2568-41b5-836d-aa9972bc728b">350</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;These amounts include the impact of applying the April&#160;2021 IFRIC agenda decision on the attribution of benefits to periods of service.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For 2020, this line mainly comprises a reduction in post-employment benefit liabilities following the announcement of voluntary redundancy programs, primarily in Europe.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;For 2022, this line includes &#8364;<ix:nonFraction unitRef="eur" contextRef="i39d668fce64249f697434c38ca01ade9_I20221231" decimals="-6" name="sny:PreFundedPensionObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgwODE0MTA0Njc1MjAz_9698621e-de27-4938-82ba-2b6a00d026e8">99</ix:nonFraction>&#160;million of assets in the United Kingdom (versus &#8364;<ix:nonFraction unitRef="eur" contextRef="i196a10f493ab454b9274ca3eb5246334_I20211231" decimals="-6" name="sny:PreFundedPensionObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgwODE0MTA0Njc1MjE2_a7557bd2-883f-4753-a88b-fedc2659e86a">220</ix:nonFraction>&#160;million for 2021); those amounts are not subject to any asset ceiling, in accordance with IFRIC&#160;14.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Amounts recognized in Other comprehensive income (see Note&#160;D.15.7.).</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-69</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="icdff62cdec244cc088d24e362cb82266" continuedAt="i22e61821eab94c2681f64dd241c2a330"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NTA2_20d0b398-2e4a-44ef-8448-301e4e23fdb7" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show Sanofi&#8217;s net liability in respect of pension plans and other post-employment benefits by geographical region:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:25.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Measurement of obligation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia89777d1856946948f3ab287b274b7b3_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItMS0xLTEtMzY0MDYw_70c1ff39-d25b-4c62-a5a7-a880aed9bbce">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7d7547d361d44bc7bc51287f8d63fa39_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItMi0xLTEtMzY0MDYw_64a3096a-0013-4cb8-aa5f-aa5d68a69790">2,730</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i735c553a649d4710a2f06d4ea8c8f3eb_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItMy0xLTEtMzY0MDYw_9f995357-58b5-4084-a5f4-af08b0aa2f22">1,546</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i39d668fce64249f697434c38ca01ade9_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItNC0xLTEtMzY0MDYw_d1ee2a32-dba9-41ad-abfc-3bb02d77b0db">2,080</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9f74e0cfe57246efbeaadd68666dbd3c_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItNS0xLTEtMzY0MDYw_700f09d8-d40f-4d88-a58a-24355de273e9">971</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItNi0xLTEtMzY0MDYw_a2e40eef-304e-4fb6-a706-3cff6b3b2211">8,651</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia89777d1856946948f3ab287b274b7b3_I20221231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtMS0xLTEtMzY0MDYw_ef971d66-5589-4697-a35d-88137c9f6fd0">697</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7d7547d361d44bc7bc51287f8d63fa39_I20221231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtMi0xLTEtMzY0MDYw_b8f44844-5a80-4958-8385-5794cccf991b">2,317</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i735c553a649d4710a2f06d4ea8c8f3eb_I20221231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtMy0xLTEtMzY0MDYw_f63249c8-c6f2-4efd-8644-fefcc1470c58">860</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i39d668fce64249f697434c38ca01ade9_I20221231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtNC0xLTEtMzY0MDYw_85d46873-39c2-4093-a444-e8adc5718728">2,175</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9f74e0cfe57246efbeaadd68666dbd3c_I20221231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtNS0xLTEtMzY0MDYw_16128a7b-2da4-4e9f-99c8-0f517f7eb1a5">850</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtNi0xLTEtMzY0MDYw_e7cc22ae-53e4-4d5a-8ad6-d9928afe1a0d">6,899</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia89777d1856946948f3ab287b274b7b3_I20221231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtMS0xLTEtMzY0MDYw_5a06b6df-beca-4b39-a8f3-0699d274d161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7d7547d361d44bc7bc51287f8d63fa39_I20221231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtMi0xLTEtMzY0MDYw_f8d43fbb-4fb9-4e71-9ce7-91d8dbdd0aa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i735c553a649d4710a2f06d4ea8c8f3eb_I20221231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtMy0xLTEtMzY0MDYw_70ed9df2-c15a-4f29-b703-3d9adb46ddae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i39d668fce64249f697434c38ca01ade9_I20221231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtNC0xLTEtMzY0MDYw_30f06237-9af2-44a4-b5aa-dc2069e8a550">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9f74e0cfe57246efbeaadd68666dbd3c_I20221231" decimals="-6" sign="-" name="sny:PlanAssetsEffectOfAssetCeiling" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtNS0xLTEtMzY0MDYw_fc7e63f7-9c9a-478f-a3c9-3a3e3be77b3c">18</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231" decimals="-6" sign="-" name="sny:PlanAssetsEffectOfAssetCeiling" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtNi0xLTEtMzY0MDYw_8b1d554b-e024-4f87-ae78-8b4e43f6a017">18</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia89777d1856946948f3ab287b274b7b3_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtMS0xLTEtMzY0MDYw_5e6cdf6d-98cc-41d7-8a24-9f0515b2791a">627</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7d7547d361d44bc7bc51287f8d63fa39_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtMi0xLTEtMzY0MDYw_f0165368-efc8-4f38-b133-da3ef2102638">413</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i735c553a649d4710a2f06d4ea8c8f3eb_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtMy0xLTEtMzY0MDYw_8994a0dd-1f97-4119-83e6-5bc25f5f120c">686</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i39d668fce64249f697434c38ca01ade9_I20221231" decimals="-6" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtNC0xLTEtMzY0MDYw_0bffe4b0-6845-4bd5-ab6b-c57f82185dab">95</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9f74e0cfe57246efbeaadd68666dbd3c_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtNS0xLTEtMzY0MDYw_16063033-50a1-4aad-9bbc-1418ee0e6ab4">139</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtNi0xLTEtMzY0MDYw_ee4a4f81-1744-4c46-a56e-d96129c303a2">1,770</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:25.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Measurement of obligation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9658a2abf9a5478fa9e50db338221664_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItMS0xLTEtMzY0MDYw_16f32bad-b6c8-4492-b2f8-0c5177e4b161">1,657</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i625df457bbfd46169d9a20d074aae8b1_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItMi0xLTEtMzY0MDYw_babfa98e-df7e-4c14-9dd0-093e5639742a">3,576</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d15ea0bd3b14ac3b41652e59b0e1991_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItMy0xLTEtMzY0MDYw_35bba39a-d32d-4991-916f-6335af77cba4">2,099</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i196a10f493ab454b9274ca3eb5246334_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItNC0xLTEtMzY0MDYw_8302c802-2289-4401-9c0c-4d5d791dd4af">3,414</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icef5204976824f79a913930fb94f085b_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItNS0xLTEtMzY0MDYw_a35ec3d2-4b93-4747-8f0d-8c883d44da3b">1,429</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItNi0xLTEtMzY0MDYw_13a91501-6780-49aa-af0b-7a25225d2111">12,175</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9658a2abf9a5478fa9e50db338221664_I20211231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtMS0xLTEtMzY0MDYw_d092c0b0-797f-4916-8eaa-88348f67951b">838</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i625df457bbfd46169d9a20d074aae8b1_I20211231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtMi0xLTEtMzY0MDYw_b64c78ec-69d2-4cfb-853a-363f552394d4">2,808</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d15ea0bd3b14ac3b41652e59b0e1991_I20211231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtMy0xLTEtMzY0MDYw_8761f720-2939-4e03-85e4-6fc7402aceca">1,127</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i196a10f493ab454b9274ca3eb5246334_I20211231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtNC0xLTEtMzY0MDYw_d3b715c7-c407-4756-b8f4-1f9ccce136c0">3,629</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icef5204976824f79a913930fb94f085b_I20211231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtNS0xLTEtMzY0MDYw_f2020000-5237-407f-b0f3-2ff76171ede9">1,249</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtNi0xLTEtMzY0MDYw_b5712db8-38f3-4e73-985a-2ef66dbd2d8e">9,651</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9658a2abf9a5478fa9e50db338221664_I20211231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtMS0xLTEtMzY0MDYw_71256e63-a22f-4534-9f1f-f6fb06c11f64">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i625df457bbfd46169d9a20d074aae8b1_I20211231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtMi0xLTEtMzY0MDYw_5c533c21-d44d-4602-b420-7a3c4b610ae8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d15ea0bd3b14ac3b41652e59b0e1991_I20211231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtMy0xLTEtMzY0MDYw_6253127c-60c9-4819-86a9-afa75ba249fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i196a10f493ab454b9274ca3eb5246334_I20211231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtNC0xLTEtMzY0MDYw_4c7f20f1-f11d-4071-8f47-878815c7a900">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="icef5204976824f79a913930fb94f085b_I20211231" decimals="-6" sign="-" name="sny:PlanAssetsEffectOfAssetCeiling" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtNS0xLTEtMzY0MDYw_2a3ac2e7-2355-4bee-9a16-1690e8f40e93">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231" decimals="-6" sign="-" name="sny:PlanAssetsEffectOfAssetCeiling" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtNi0xLTEtMzY0MDYw_7821496c-5c6a-4363-8e15-fc522a6a75f4">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9658a2abf9a5478fa9e50db338221664_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtMS0xLTEtMzY0MDYw_729e98ba-8dda-4995-8860-507dfd67b1d9">819</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i625df457bbfd46169d9a20d074aae8b1_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtMi0xLTEtMzY0MDYw_c5ef01ba-dff4-41ae-b5d5-e9ebe9ec4110">768</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d15ea0bd3b14ac3b41652e59b0e1991_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtMy0xLTEtMzY0MDYw_63d3f69b-b64c-4080-8bea-705f51b624fe">972</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i196a10f493ab454b9274ca3eb5246334_I20211231" decimals="-6" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtNC0xLTEtMzY0MDYw_5cd7dc72-2053-48ee-bcc2-2e325bcbdd15">215</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icef5204976824f79a913930fb94f085b_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtNS0xLTEtMzY0MDYw_cc0b8e39-cf11-4849-bf14-1bea7581c7e0">195</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtNi0xLTEtMzY0MDYw_c435a484-00eb-4c09-a2ff-3161a99bc1e0">2,539</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:25.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Measurement of obligation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i52f9ed0a9cdd406e836a0653d1da4b33_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItMS0xLTEtMzY0MDYw_3b3968ea-8ff6-4b3d-be88-ff811b1bba2a">1,778</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i372ca78f06fe4df388ba26d79d02bc31_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItMi0xLTEtMzY0MDYw_2301c8db-c487-4297-8842-57204414684a">3,580</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6c3bd7580bba402387e084f56f6be553_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItMy0xLTEtMzY0MDYw_dd11161a-ca61-4765-850c-b395509479b1">2,091</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i385f7ed33c244c8f9865082c29418042_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItNC0xLTEtMzY0MDYw_f02069e5-3f96-485c-841f-12e3552f1f04">3,561</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1d9cb083d13740c7ac9847d70e575e46_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItNS0xLTEtMzY0MDYw_d758503b-9784-4f86-a93e-b2255d6dad0a">1,446</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItNi0xLTEtMzY0MDYw_afba1cc7-2e69-4859-9c35-2af45cb7e8ce">12,456</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i52f9ed0a9cdd406e836a0653d1da4b33_I20201231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtMS0xLTEtMzY0MDYw_4b02009d-a2b9-4234-9aab-2ed22e182bef">906</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i372ca78f06fe4df388ba26d79d02bc31_I20201231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtMi0xLTEtMzY0MDYw_b2fa87c9-7bfd-482a-a97c-bf95f0be9832">2,661</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6c3bd7580bba402387e084f56f6be553_I20201231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtMy0xLTEtMzY0MDYw_5a6812e5-ea3f-4964-8795-b866a21d5270">1,077</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i385f7ed33c244c8f9865082c29418042_I20201231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtNC0xLTEtMzY0MDYw_2858eadd-f252-4327-b6ff-f5e51bd7d7cd">3,536</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1d9cb083d13740c7ac9847d70e575e46_I20201231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtNS0xLTEtMzY0MDYw_614e2565-648a-4663-b921-d2037047cdd7">1,178</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231" decimals="-6" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtNi0xLTEtMzY0MDYw_07486100-cdb1-4207-8662-2f25dec7d325">9,358</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i52f9ed0a9cdd406e836a0653d1da4b33_I20201231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtMS0xLTEtMzY0MDYw_54c796f1-13cd-4449-8957-edd2f9db75c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i372ca78f06fe4df388ba26d79d02bc31_I20201231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtMi0xLTEtMzY0MDYw_3043481b-4c66-4938-b2a3-767f69b861d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6c3bd7580bba402387e084f56f6be553_I20201231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtMy0xLTEtMzY0MDYw_62afb695-e70f-404d-b09b-3befd1124637">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i385f7ed33c244c8f9865082c29418042_I20201231" decimals="-6" name="sny:PlanAssetsEffectOfAssetCeiling" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtNC0xLTEtMzY0MDYw_ef81ea41-4d95-4a1f-930e-bb412458e403">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1d9cb083d13740c7ac9847d70e575e46_I20201231" decimals="-6" sign="-" name="sny:PlanAssetsEffectOfAssetCeiling" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtNS0xLTEtMzY0MDYw_77724349-8968-48a5-b767-b2f80ba26b8a">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231" decimals="-6" sign="-" name="sny:PlanAssetsEffectOfAssetCeiling" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtNi0xLTEtMzY0MDYw_4679be78-f0ea-4e5b-9549-f8249c75519d">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i52f9ed0a9cdd406e836a0653d1da4b33_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtMS0xLTEtMzY0MDYw_0a76e5b8-0398-4395-b44c-02e0b3b642fd">872</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i372ca78f06fe4df388ba26d79d02bc31_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtMi0xLTEtMzY0MDYw_28654821-1528-4236-9cb5-ff97942548c9">919</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6c3bd7580bba402387e084f56f6be553_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtMy0xLTEtMzY0MDYw_37480cc5-251e-4df1-b210-4b451ea308bf">1,014</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i385f7ed33c244c8f9865082c29418042_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtNC0xLTEtMzY0MDYw_9ed04fa3-401f-4be7-b281-9e77dface17f">25</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1d9cb083d13740c7ac9847d70e575e46_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtNS0xLTEtMzY0MDYw_1b40ca09-9b10-407a-9e02-2d8bb2312d8d">269</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtNi0xLTEtMzY0MDYw_c1b49d0e-6b1a-480c-aefb-29c05de21d28">3,099</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDg3_bf9b35f9-e523-4e6b-9c9d-2fb77eea6849" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the fair value of plan assets relating to Sanofi&#8217;s pension and other post-employment plans, split by asset category:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Securities quoted in an active market</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEtMS0xLTEtMzY0MDYw_746f6108-2fc1-478f-82a3-48206cb8f55c">84.4</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEtMi0xLTEtMzY0MDYw_5166acc9-3297-42e7-9026-286520c95bd6">86.9</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEtMy0xLTEtMzY0MDYw_f40f21fc-9a6c-4730-958c-e40543f5ac06">94.8</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd245ab0bb874dd9b68d83d0e2a73768_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzItMS0xLTEtMzY0MDYw_7c48db73-f03e-4696-bd74-93ee16eb3877">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i132794e24a974e33a6a21b07c9e18759_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzItMi0xLTEtMzY0MDYw_40f51bb2-defe-4a84-9a63-8ff12f63f15a">0.7</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieceadb4bd3734ed687be7e86ad699c73_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzItMy0xLTEtMzY0MDYw_f293992f-4f2c-439e-b929-158ab8029c1c">3.5</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity instruments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied5cdd7108ef4bde8a190a1fdd725e36_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzMtMS0xLTEtMzY0MDYw_01c34209-d475-4e49-a730-aabc2c4d2a13">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9322df58abf645a38feae4db48a58ebd_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzMtMi0xLTEtMzY0MDYw_74f89b60-2987-44e8-bbb2-99b3c51d4277">25.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9a4f3a465b6f42b98396a6e356f30a9e_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzMtMy0xLTEtMzY0MDYw_515aa140-ecd6-4877-8ced-eba18071e213">24.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bonds and similar instruments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibb517efada3a407d847b0ca69894e99a_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzQtMS0xLTEtMzY0MDYw_92633469-4d40-4943-bd7c-f29fde707745">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e4be19b26a049e1bf1e91bab2e11e5c_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzQtMi0xLTEtMzY0MDYw_d4c2e4ce-bc90-44cb-aaa1-adf42356d5b8">53.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39da8a2d60674ff4ae5c11c70259b5e3_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzQtMy0xLTEtMzY0MDYw_1552f843-eed8-44bd-a096-9238c8783442">59.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a41dc31c3e74eedb023bf10eb8a0e7c_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzUtMS0xLTEtMzY0MDYw_5216744a-79d6-4576-a02e-7e6ae514fa04">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i251e98323a6443539777c4746f73c0a1_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzUtMi0xLTEtMzY0MDYw_2fee1f1b-e18a-4073-85e6-95ec83cabe65">4.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6cf3f0fc2b4e4980a5a3b2ffa0064c5f_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzUtMy0xLTEtMzY0MDYw_c12c9abe-7b34-440e-8e58-fccf4a6a4c2c">3.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ff9752dc8ff4ccda97e1df53f25b146_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMS0xLTEtNTA2MTgy_7f4ae856-9a18-471b-8137-291b3c2f5a9a"><ix:nonFraction unitRef="number" contextRef="i6ff9752dc8ff4ccda97e1df53f25b146_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMS0xLTEtNTA2MTgy_a076ff94-81dc-4eea-ad38-6924a7dea22e">0.1</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad8a1b698baa4703b83d370174975b1c_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMi0xLTEtNTA2MTgy_cff35af6-dd2e-423b-a973-4c544eac4ad6"><ix:nonFraction unitRef="number" contextRef="iad8a1b698baa4703b83d370174975b1c_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMi0xLTEtNTA2MTgy_df4b63a7-e065-4994-9471-de52fdacbbd2">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i312bbd7a70ac416b96b1efb30fc8419b_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMy0xLTEtNTA2MTgy_711e2d7b-2543-4907-83ba-1c019961437a"><ix:nonFraction unitRef="number" contextRef="i312bbd7a70ac416b96b1efb30fc8419b_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMy0xLTEtNTA2MTgy_bbfa285e-3f8a-4fed-abc6-ed4daa48afff">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commodities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15aa7ea7a17149d88f714ad7ee033ef2_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMS0xLTEtMzY0MDYw_a1394c2f-13fa-4bd9-af92-abf81d9f3c5c">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iecbde7dd3ae84c15a00c868d439658cd_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMi0xLTEtMzY0MDYw_2c2f6df0-5976-449e-9b37-d775c13e442f">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ee30b965d34426b8572cbfbe3d99ab5_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMy0xLTEtMzY0MDYw_a4d1cf87-f953-4ba0-a266-eb47dd172074">0.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic2bab82be0a94d3385be51baf05b2e8a_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzgtMS0xLTEtMzY0MDYw_bb290631-e1de-4dd1-aa70-6d90405c8686">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a3027be885242dda3901c2d93f03d2f_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzgtMi0xLTEtMzY0MDYw_8af0a127-8259-4461-be3b-575a969bbaf2">2.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i208f6ffa4b1f4aef954fb58bed015cee_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzgtMy0xLTEtMzY0MDYw_cb4604b2-b560-4f16-af83-d669a692c9f9">2.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzktMS0xLTEtMzY0MDYw_88a4f154-8713-4a51-a740-427beccc6714">15.6</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzktMi0xLTEtMzY0MDYw_e6a97c58-2f8d-4530-8ccd-06a0c0e7659c">13.1</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzktMy0xLTEtMzY0MDYw_4cd4e8d5-2a9b-4151-a2bc-b9cf8e975e70">5.2</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hedge funds</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4072b208f40b416c93f385cd81718d4c_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEwLTEtMS0xLTM2NDA2MA_d348f751-7c2d-42be-81eb-7e3a16ede825">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c9573f4723f496886c9527af11cd414_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEwLTItMS0xLTM2NDA2MA_f7efbc9f-c477-4e5b-accb-cf66a80b92d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib77de26cb736428ea323b4bf71486e1f_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEwLTMtMS0xLTM2NDA2MA_edd3a910-1182-4e8e-b5de-8c363feec768">0.4</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Insurance policies</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45d69c6b976b4b52b4b221ada5523cf3_I20221231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzExLTEtMS0xLTM2NDA2MA_e05f04b7-69ad-4839-99c3-21803fe7df77">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4202392dc954ef699a4858b3b2f3d28_I20211231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzExLTItMS0xLTM2NDA2MA_6db4799e-d520-4dff-b226-35fcf123a087">13.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie7625f2a35e3415980a56f594344ef2c_I20201231" decimals="3" name="sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzExLTMtMS0xLTM2NDA2MA_74aaefae-ffa1-465a-a3e3-e3645d4d47b7">4.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="INF" name="sny:PercentageContributedToFairValueOfPlanAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEyLTEtMS0xLTM2NDA2MA_c211c6f7-1351-4b6d-83d1-1cb04f9862e4">100.0</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="INF" name="sny:PercentageContributedToFairValueOfPlanAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEyLTItMS0xLTM2NDA2MA_341eee2a-1f35-4028-88fa-f1626cc84c65">100.0</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="INF" name="sny:PercentageContributedToFairValueOfPlanAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEyLTMtMS0xLTM2NDA2MA_acfce9c2-07cf-4da2-8efa-93cd3d226cb2">100.0</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has a long-term objective of maintaining or increasing the extent to which its pension obligations are covered by assets. To this end, Sanofi uses an asset-liability management strategy, matching plan assets to its pension obligations. This policy aims to ensure the best fit between the assets held on the one hand, and the associated liabilities and expected future payments to plan members on the other. To meet this aim, Sanofi operates a risk monitoring and management strategy (mainly focused on interest rate risk and inflation risk), while investing a growing proportion of assets in high-quality bonds with comparable maturities to those of the underlying obligations and in contracts entered into with leading insurance companies to fund certain post-employment benefit obligations.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-70</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i22e61821eab94c2681f64dd241c2a330" continuedAt="ie3862ad6750d426192c5abbbe009a0b4"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDc2_04e19dd2-30ca-4d29-9fe4-b7d6caa7cb9b" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show the service cost for Sanofi&#8217;s pension and other post-employment benefit plans, by geographical region:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Service cost for 2022</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItMS0xLTEtMzY0MDYw_e8d9ab9c-6e0d-4b1d-b778-2b8816eba2df">61</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItMi0xLTEtMzY0MDYw_6835c0bb-6868-4708-bdcc-66070ff3a62e">44</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItMy0xLTEtMzY0MDYw_3142d79e-0e1e-40da-99f4-715f69f97665">50</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItNC0xLTEtMzY0MDYw_9a73500b-0a79-4f90-91e7-a7b4cb65dadc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItNS0xLTEtMzY0MDYw_4c99b46f-3fe1-4bdc-bfbb-efe325adf47b">38</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItNi0xLTEtMzY0MDYw_4aca1107-5b8b-46f2-a0a3-5d27dc3feda6">193</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231" decimals="-6" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtMS0xLTEtMzY0MDYw_39e17a8c-b82c-4c13-b578-87ed00e1ae4b">60</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231" decimals="-6" sign="-" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtMi0xLTEtMzY0MDYw_1238e3d7-0653-4419-9495-08c4c3b8aa53">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231" decimals="-6" sign="-" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtMy0xLTEtMzY0MDYw_0a5ad5a8-4f6a-47cb-b390-f70cc734b981">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231" decimals="-6" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtNC0xLTEtMzY0MDYw_25a300f8-2248-4634-a6a1-9b102929ff1c">6</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231" decimals="-6" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtNS0xLTEtMzY0MDYw_3f79e7d1-f072-4195-be41-d558f620c59c">5</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtNi0xLTEtMzY0MDYw_99605f32-8854-44fa-87a4-1a3bacb343fb">68</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost/(income) including administration costs and taxes paid during the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtMS0xLTEtMzY0MDYw_523633dc-14bd-4e64-98cd-d1ab7d4f4448">10</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtMi0xLTEtMzY0MDYw_d0ed0a40-4a0c-4b3f-95f6-a71eebd47176">7</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtMy0xLTEtMzY0MDYw_4d96d421-71a5-4df6-a8f0-68e120ffbc28">30</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231" decimals="-6" sign="-" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtNC0xLTEtMzY0MDYw_c2d98f77-881d-497e-bc57-5e42097df676">7</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtNS0xLTEtMzY0MDYw_4a0e3a5e-4e1b-431a-bb55-2622ff158f4f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtNi0xLTEtMzY0MDYw_799898c1-b28b-43b7-b853-795fa4f10750">49</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtMS0xLTEtMzY0MDYw_f4bb68c2-a038-4cb4-9ead-4f105ce4f92d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtMi0xLTEtMzY0MDYw_c4581fff-a033-40eb-bbd4-85796fcf3216">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtMy0xLTEtMzY0MDYw_5ca1f0fe-3122-4e41-bd42-c73a873220d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtNC0xLTEtMzY0MDYw_3f0f84f6-f6b4-437d-a022-39b423969fc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtNS0xLTEtMzY0MDYw_c6be478d-2123-463f-92d1-0c9d0d5b67a2">6</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtNi0xLTEtMzY0MDYw_0475598d-9d70-4141-950b-3f8c613bcb81">6</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) recognized directly in profit or loss</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtMS0xLTEtMzY0MDYw_11f29e3e-7591-449b-a332-282b7b5dafe4">11</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtMi0xLTEtMzY0MDYw_544350ae-f3fe-4ee6-b406-5bb80f199bf5">53</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtMy0xLTEtMzY0MDYw_fff940ec-e508-44f6-a757-9f91bdf765e9">81</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231" decimals="-6" sign="-" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtNC0xLTEtMzY0MDYw_29dbfa54-453d-4c84-80cb-72120cd6d1e3">13</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtNS0xLTEtMzY0MDYw_a2d1196c-c66b-4389-a873-61da0dd313f8">36</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtNi0xLTEtMzY0MDYw_1d9fde55-5b88-41ae-88b1-aad4ba3cf0d5">168</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctMS0xLTEtMzY0MDYw_bcb2dc5f-b935-4ec5-a25b-bbc1dec0eb6f">156</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctMi0xLTEtMzY0MDYw_7787cd8a-d99b-4263-8c94-633fe01fd7a4">204</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctMy0xLTEtMzY0MDYw_203baa89-49dc-4c8f-935c-b0ad47ae42f9">382</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctNC0xLTEtMzY0MDYw_608fb498-07d4-42f0-b3c0-d529985f9acf">130</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctNS0xLTEtMzY0MDYw_68799654-4875-4486-b703-c543fd185608">38</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctNi0xLTEtMzY0MDYw_7b2e045a-b941-4f02-8310-848a23919aa6">650</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtMS0xLTEtMzY0MDYw_f0e51322-0ab3-424d-8d61-9e60611d4aa5">145</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtMi0xLTEtMzY0MDYw_9697c73d-62fd-47c4-be4b-b7525778daa3">151</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtMy0xLTEtMzY0MDYw_39901f1b-5d7f-4533-bf87-54c3ded074d6">301</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231" decimals="-6" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtNC0xLTEtMzY0MDYw_2dd628a2-737e-4957-b028-846519288970">117</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtNS0xLTEtMzY0MDYw_4c612cfe-8441-441a-984d-7380b9f25dcb">2</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtNi0xLTEtMzY0MDYw_57ca5850-c72a-45a3-bd70-0fde534b0db9">482</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Service cost for 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItMS0xLTEtMzY0MDYw_ce1d0828-815f-4b9b-abee-486467dd3e42">72</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItMi0xLTEtMzY0MDYw_1fcfb2ea-3103-4681-934d-852e42db519a">47</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItMy0xLTEtMzY0MDYw_0b173751-25ce-4c33-95b3-4d045a50fb9d">57</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItNC0xLTEtMzY0MDYw_f46c392e-17ae-4128-8cc5-5a1e836c9a2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItNS0xLTEtMzY0MDYw_99ecb3ce-09b7-406b-9022-11f3aad0ed11">51</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItNi0xLTEtMzY0MDYw_da401f09-b0b6-44ac-b46f-f68a229d8ba1">227</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231" decimals="-6" sign="-" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtMS0xLTEtMzY0MDYw_3959128e-0a8b-40e4-a1f6-0c26b17758f4">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231" decimals="-6" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtMi0xLTEtMzY0MDYw_9101a84b-2587-4635-b8da-69f6e6c15051">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231" decimals="-6" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtMy0xLTEtMzY0MDYw_f02e483b-f907-431d-9c9f-0df722844cf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231" decimals="-6" sign="-" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtNC0xLTEtMzY0MDYw_e7cbca62-e47c-4f4b-896e-e49ddda5ed6b">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231" decimals="-6" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtNS0xLTEtMzY0MDYw_0d8647a5-1ffe-4929-b54e-edd28329cf04">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" sign="-" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtNi0xLTEtMzY0MDYw_fdf4cd65-665a-4576-a675-9f1eea36ab32">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost/(income) including administration costs and taxes paid during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtMS0xLTEtMzY0MDYw_94a8d7f7-7425-4f11-9b84-33e4155e4fb5">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtMi0xLTEtMzY0MDYw_fb26ab72-4821-4095-b7e7-90cc4e3ecf96">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtMy0xLTEtMzY0MDYw_686e4776-fe11-4295-8a66-c45534e67193">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtNC0xLTEtMzY0MDYw_b105ecf6-6b61-4c25-8e48-38081f425ce5">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtNS0xLTEtMzY0MDYw_2dee84ba-46f3-4039-864c-20dd4d9241f6">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtNi0xLTEtMzY0MDYw_ac981142-60a4-4e2c-ac6d-94062e9b1e3c">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtMS0xLTEtMzY0MDYw_f98287e0-0d14-4998-a6a2-701533248edc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtMi0xLTEtMzY0MDYw_b358d448-577c-45e8-9b8b-cb12045df159">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtMy0xLTEtMzY0MDYw_e387c458-2f9d-4f5c-a0c3-5f79ccb2dbe3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtNC0xLTEtMzY0MDYw_e4fc121e-cb79-454d-aa77-df4e99ab1e6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtNS0xLTEtMzY0MDYw_e58c9aa8-a297-4d57-a9da-5f060178580d">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtNi0xLTEtMzY0MDYw_9b80e233-6201-4c63-9c78-1a4c791774a0">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) recognized directly in profit or loss</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtMS0xLTEtMzY0MDYw_b5693b8f-739f-4a8b-9929-621359afaf5a">80</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtMi0xLTEtMzY0MDYw_ccbd56fb-c68a-47a3-88d3-6b5c3e95e2fe">52</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtMy0xLTEtMzY0MDYw_4b95734d-a38a-4571-9d11-78415dd4579b">84</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtNC0xLTEtMzY0MDYw_1ddf01e3-6cdf-4702-ab00-8edb43ec2ea1">6</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtNS0xLTEtMzY0MDYw_9e5c9c4f-e03d-4ea7-a3ef-82d624bb13e5">54</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtNi0xLTEtMzY0MDYw_fe6773a0-eed1-4357-92fe-31417459f9aa">276</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctMS0xLTEtMzY0MDYw_84f700f4-7c49-454f-ad18-1ebbb94b95bd">106</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctMi0xLTEtMzY0MDYw_b90b9cfb-abc2-421b-ae68-db4925fc3e43">113</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctMy0xLTEtMzY0MDYw_3de18229-9020-4018-a3dd-40b706e1b597">157</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctNC0xLTEtMzY0MDYw_df163dab-ccd8-4737-b731-0e82de171674">236</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctNS0xLTEtMzY0MDYw_3eff4f22-c767-4eb4-a889-8efbffc02a96">73</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctNi0xLTEtMzY0MDYw_c4ab98d1-2240-46a9-9c88-7150fffe24cc">685</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtMS0xLTEtMzY0MDYw_53d4c9de-5a34-41ba-a9ec-5e931108f198">26</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtMi0xLTEtMzY0MDYw_496ab505-05d5-4056-b7f8-6436cc3da67e">61</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtMy0xLTEtMzY0MDYw_b187f711-2215-4e86-a295-0236aae11de5">73</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtNC0xLTEtMzY0MDYw_56bc9d2d-7765-425c-8e19-4d7cfbe28861">230</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtNS0xLTEtMzY0MDYw_fd20ecb2-2e1d-4b8a-90d0-4cba53a0c29f">19</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtNi0xLTEtMzY0MDYw_e90da40e-02be-47c0-b170-09fc8d6a248c">409</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Service cost for 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItMS0xLTEtMzY0MDYw_d55aba65-84e3-4d09-8cc5-c54f129e0402">65</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItMi0xLTEtMzY0MDYw_b815884f-328c-4468-a7cc-15eeba9c77e1">49</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItMy0xLTEtMzY0MDYw_45e4ca9e-8ea1-4243-96ba-4c53732265bc">51</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItNC0xLTEtMzY0MDYw_607459f8-f7e3-4605-938f-b8ca5592be6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItNS0xLTEtMzY0MDYw_c7568487-6685-4a07-9535-20429503a2cc">56</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItNi0xLTEtMzY0MDYw_fb2992db-483a-47a1-af88-fab728a3f20d">221</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231" decimals="-6" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtMS0xLTEtMzY0MDYw_b0c9ca2b-4440-46c6-9b63-c33018645d1a">87</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231" decimals="-6" sign="-" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtMi0xLTEtMzY0MDYw_c8fe78ac-b6e8-47b1-b797-abe86cc75539">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231" decimals="-6" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtMy0xLTEtMzY0MDYw_6d6ec3a8-0c3a-48eb-a668-702cc261de29">123</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231" decimals="-6" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtNC0xLTEtMzY0MDYw_f9b1093b-0d7c-4da6-b924-2c60a610112a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231" decimals="-6" sign="-" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtNS0xLTEtMzY0MDYw_4fdda480-3bdd-4726-8399-0bb9a3be0ae4">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtNi0xLTEtMzY0MDYw_e9bebc14-883f-40a9-bc24-92f59fd8adac">199</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost/(income) including administration costs and taxes paid during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtMS0xLTEtMzY0MDYw_c87feee4-7e2f-4e85-95f6-33799efb4736">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtMi0xLTEtMzY0MDYw_2ae37870-60a1-4b12-b77f-48e9747f15ab">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtMy0xLTEtMzY0MDYw_a17fe582-9505-408e-a097-fd8a53f8f39f">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtNC0xLTEtMzY0MDYw_dec336c6-549e-4909-872d-ecd549ff1ceb">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtNS0xLTEtMzY0MDYw_6fb9bfb7-03e7-4a07-8749-f21426b0076d">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtNi0xLTEtMzY0MDYw_a213348c-deb1-4a04-8438-070284102184">69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtMS0xLTEtMzY0MDYw_f16b4d5d-82de-4ab4-a7e3-a65a5e5399a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtMi0xLTEtMzY0MDYw_a44165d8-c82a-49c4-bfcb-4e25b467be2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtMy0xLTEtMzY0MDYw_a6c7055f-b5a7-4a49-84a4-680fce39e7f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtNC0xLTEtMzY0MDYw_5bdad3a6-d39a-470d-9eda-2f8dde7f48ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtNS0xLTEtMzY0MDYw_7d6f3de5-df35-4abf-b130-e9a199976239">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtNi0xLTEtMzY0MDYw_a9a283d7-9b17-43fa-b98d-aed20563a0b2">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) recognized directly in profit or loss</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231" decimals="-6" sign="-" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtMS0xLTEtMzY0MDYw_2337c7b7-c55b-41a2-a04d-f98951f8d195">15</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtMi0xLTEtMzY0MDYw_e5d1f757-10f7-47e0-ab6c-e2025cfda2f5">72</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231" decimals="-6" sign="-" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtMy0xLTEtMzY0MDYw_10d504ef-cc43-4e94-829e-05eea84c876f">38</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtNC0xLTEtMzY0MDYw_bad6570e-93b6-481c-bbf2-8aab2df459c2">5</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtNS0xLTEtMzY0MDYw_ab718552-8beb-4c96-bace-334b9f3a2d6c">60</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtNi0xLTEtMzY0MDYw_9de8d113-b327-471e-b92d-f3dd65f7a52b">84</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctMS0xLTEtMzY0MDYw_08683b12-050c-463e-91ba-bc899227d035">23</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctMi0xLTEtMzY0MDYw_e1c73d87-9d91-4692-b8ca-c52a7203ee6e">121</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctMy0xLTEtMzY0MDYw_03b989d2-db2a-414f-83b4-3907b69e9489">22</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctNC0xLTEtMzY0MDYw_33b94172-f7b6-4694-b2b2-f9f2d93bcbe5">115</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctNS0xLTEtMzY0MDYw_2027ddbe-a833-4b5b-b548-539a4564623a">15</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctNi0xLTEtMzY0MDYw_babd6350-f3b3-4669-a8c2-6e6b2755dd6b">266</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231" decimals="-6" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtMS0xLTEtMzY0MDYw_8d38d507-011a-4c81-b67f-44e46282dfe2">8</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231" decimals="-6" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtMi0xLTEtMzY0MDYw_3c2a7d44-cda7-4ee6-9fa5-f921bab34b16">193</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231" decimals="-6" sign="-" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtMy0xLTEtMzY0MDYw_d0e2e03e-1442-4f0a-b780-14c4c5789c82">16</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231" decimals="-6" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtNC0xLTEtMzY0MDYw_605bbdcb-7bc7-4ad7-9f54-709ae8f6e214">120</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231" decimals="-6" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtNS0xLTEtMzY0MDYw_6d8b884d-6312-4a06-b3f7-5f236ccd64ea">45</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtNi0xLTEtMzY0MDYw_9aefcf06-9246-47e6-a929-c623fb8c2e65">350</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDky_77e09dac-f77e-49a6-97b1-fd3a4744af52" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of the &#8220;Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)&#8221; line in the preceding tables is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:19.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.108%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.108%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.574%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.429%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains/(losses) arising during the period</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMS0xLTEtMzY0MDYw_96d0ff15-c894-40d9-b020-3e3d0b3809e6">156</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMi0xLTEtMzY0MDYw_1779c551-6ec0-4040-bb77-3dd731cc1795">205</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMy0xLTEtMzY0MDYw_839c2b08-e49b-487e-8863-b3b59722ef2e">382</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItNC0xLTEtMzY0MDYw_70eaef3c-4b64-488e-9dbf-9687ed75ebc3">131</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItNS0xLTEtMzY0MDYw_b895bf4c-ed60-4900-ae3d-4221d965197b">106</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItNi0xLTEtMzY0MDYw_7ac8f415-35e1-41de-8153-db4f63572a4a">113</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItNy0xLTEtMzY0MDYw_b357cad6-66b1-4684-8cee-390fa8bdce4d">156</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231" decimals="-6" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItOC0xLTEtMzY0MDYw_53d1d089-ad19-4be2-93ce-0baa915bcb77">237</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItOS0xLTEtMzY0MDYw_6f4deab7-5790-4799-ab93-6ac3528e5108">23</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMTAtMS0xLTM2NDA2MA_9b4a71af-7819-44c1-a4e3-b375ad3f5dff">121</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMTEtMS0xLTM2NDA2MA_1cc35ea3-26c0-474a-9cb4-11bde4be958c">22</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMTItMS0xLTM2NDA2MA_27e00337-500f-4036-bf49-c1026b658050">115</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprising:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">on experience adjustments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMS0xLTEtMzY0MDYw_dec5a405-0829-48c7-ad8e-6193e170495c">120</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMi0xLTEtMzY0MDYw_7e8efe19-b0e3-446f-9151-5c25d4b9514d">620</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMy0xLTEtMzY0MDYw_be64f15a-f870-499d-9072-b7b4995fa7e5">287</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231" decimals="-6" sign="-" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtNC0xLTEtMzY0MDYw_a931a608-3d98-4fa5-aa03-48ab99e2e52c">1,328</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtNS0xLTEtMzY0MDYw_03a79167-6fde-4d53-8b47-0eae7dc1fe6b">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtNi0xLTEtMzY0MDYw_2d7e635b-781f-4d5f-bf66-c083c3c2b39c">182</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtNy0xLTEtMzY0MDYw_f67f9f73-37be-49ac-b3a2-47349f8c36d9">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtOC0xLTEtMzY0MDYw_cc4b7d29-7df8-48e5-9883-8f0b9dca1775">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtOS0xLTEtMzY0MDYw_37c2f726-84ca-4462-a2cc-bc9f8083f342">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMTAtMS0xLTM2NDA2MA_8ada40e4-482d-492f-98b1-0b7ce48bfd74">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMTEtMS0xLTM2NDA2MA_11dd6919-9509-40bd-99fa-7e80be869da8">214</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231" decimals="-6" name="sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMTItMS0xLTM2NDA2MA_16dad7f4-e533-4ed3-b0ae-910676d00d71">341</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) <br/>on demographic assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMS0xLTEtMzY0MDYw_225fb376-e0e6-4725-84b6-8f21fbd7680d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMi0xLTEtMzY0MDYw_24a8d514-6e9d-4512-a8b0-916a9184fa3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMy0xLTEtMzY0MDYw_c42bdabb-76d0-416c-a5a8-dd48b74ad426">129</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtNC0xLTEtMzY0MDYw_8e62956a-65ac-4b1f-822f-cedd334b108b">54</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtNS0xLTEtMzY0MDYw_6e467a58-9370-4e7d-8460-ee0484d09558">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtNi0xLTEtMzY0MDYw_d57cfbaf-da03-453c-84fd-d48fbb7f5c9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtNy0xLTEtMzY0MDYw_8bc2be18-3d9b-4a15-8d95-025e82108c66">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtOC0xLTEtMzY0MDYw_bfc37c06-e1fe-4ae3-b313-eed5dbb5b48a">125</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtOS0xLTEtMzY0MDYw_32bd8a21-0243-483f-ae43-f3843643b345">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMTAtMS0xLTM2NDA2MA_f6f67363-b83e-400a-8d4a-9cf618f2d9db">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMTEtMS0xLTM2NDA2MA_dc3dd56b-f094-4fe6-8f8d-adee3d922e77">42</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMTItMS0xLTM2NDA2MA_7d91731c-c898-4f32-8d7e-cdfdba113cff">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) <br/>on financial assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMS0xLTEtMzY0MDYw_d15d8db3-9670-427e-b172-fb7092b0974a">276</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMi0xLTEtMzY0MDYw_9edbb084-6f0d-4a49-a435-dbb601d8db0f">825</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMy0xLTEtMzY0MDYw_4ee0836e-cdc8-4d6c-95fc-0eae00e6713d">540</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtNC0xLTEtMzY0MDYw_27b867d6-d014-43d5-9a48-59d7f728dc91">1,143</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtNS0xLTEtMzY0MDYw_3e84a49e-8adc-4489-8f3c-84097db7c5c0">46</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtNi0xLTEtMzY0MDYw_e1c6da3a-e8d9-4aae-8421-44ddb76b38a5">69</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtNy0xLTEtMzY0MDYw_17753287-c8fd-4b0a-8f32-225147b47831">82</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231" decimals="-6" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtOC0xLTEtMzY0MDYw_3934bb9c-011b-471b-acab-5ba4c9d7cad1">77</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtOS0xLTEtMzY0MDYw_fccc3733-331c-4370-9529-1c4bdd43cac0">60</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMTAtMS0xLTM2NDA2MA_cdd7a2ab-965b-48b1-bf2e-ac9bd100aa57">197</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMTEtMS0xLTM2NDA2MA_87091a32-95e7-4ef1-94be-d3872df85e14">194</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMTItMS0xLTM2NDA2MA_053dc864-0fc1-4bc7-912f-45937c744827">442</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Experience adjustments are mainly due to the effect of trends in the financial markets on plan assets.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDY5_c3eac020-627d-48e6-942c-9ef3791da5cc" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The net pre-tax actuarial loss (excluding investments accounted for using the equity method) recognized directly in equity is presented below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net pre-tax actuarial loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2NDE5MGM3ZGYwMjA0ZDQxOThlNmRlMjFkMzg0YmE4OS90YWJsZXJhbmdlOjY0MTkwYzdkZjAyMDRkNDE5OGU2ZGUyMWQzODRiYTg5XzEtMS0xLTEtMzY0MDYw_38ee8639-3199-40e9-a2f0-a90d18e810ca">2,090</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2NDE5MGM3ZGYwMjA0ZDQxOThlNmRlMjFkMzg0YmE4OS90YWJsZXJhbmdlOjY0MTkwYzdkZjAyMDRkNDE5OGU2ZGUyMWQzODRiYTg5XzEtMi0xLTEtMzY0MDYw_7c65bb8c-237b-4817-b567-c9fefec9557b">2,738</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2NDE5MGM3ZGYwMjA0ZDQxOThlNmRlMjFkMzg0YmE4OS90YWJsZXJhbmdlOjY0MTkwYzdkZjAyMDRkNDE5OGU2ZGUyMWQzODRiYTg5XzEtMy0xLTEtMzY0MDYw_78bb7caf-c916-452a-9f58-72fdd477afa6">3,423</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-71</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ie3862ad6750d426192c5abbbe009a0b4" continuedAt="id6ff8644d15147d9a3062d1e17943c22"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDcw_9f4f3a6a-e833-4b59-8a65-277bd8d51662" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The present value of Sanofi&#8217;s obligations in respect of pension and other post-employment benefit plans at the end of each reporting period is shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Present value of wholly or partially funded obligations in respect of pension and other post-employment benefit plans</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i083a34cade7349a9809e1628fbacf89d_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzEtMS0xLTEtMzY0MDYw_74d0effd-773b-4a47-8fc1-97cc1ee7bba5">7,463</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia031999e21bb4be09427968a148fae23_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzEtMi0xLTEtMzY0MDYw_b9df7866-e783-4f90-9c4d-2f6eb7da79ac">10,416</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia1b909a4273c42b5a19aef1f040188d4_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzEtMy0xLTEtMzY0MDYw_1d3b55d1-19b6-4385-a08a-78de1aa466ec">10,734</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Present value of unfunded obligations</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie22b5bc62d6a4722a5151ce86a8d9c8b_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzItMS0xLTEtMzY0MDYw_2a4a746c-14bb-4df9-9c65-c4d892d9ec5b">1,188</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i82dd25c00891486492e8fec0de4ec5a3_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzItMi0xLTEtMzY0MDYw_b86d0dca-0bde-4d3c-b2f8-efd17d012c52">1,759</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia75be383078e44f5a715dc5a129e531c_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzItMy0xLTEtMzY0MDYw_b0269547-284f-4daa-b582-7bd6e515dd87">1,722</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifda432649e3d4b16b2b65809871ae47a_I20221231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzMtMS0xLTEtMzY0MDYw_0b78e9ba-4b04-42f0-894d-659f7a52d2b0">8,651</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1aeea4ef448d4878b040aca58e59cef7_I20211231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzMtMi0xLTEtMzY0MDYw_3fdb975e-01b2-4309-8f00-45bc925e5550">12,175</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i46a2a2a21d77490d9398a698d3aec8c0_I20201231" decimals="-6" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzMtMy0xLTEtMzY0MDYw_147cdd19-9836-4c53-a5fc-ca7209f21d26">12,456</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDg4_d2fcc33c-d87e-41ca-ab97-8468bb311e4b" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The total expense for pensions and other post-employment benefits (&#8364;<ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzEyMDQ0_364e8433-a188-4af3-b6ad-ca6efd1f50be">168</ix:nonFraction> million in 2022) is allocated between income statement line items as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzEtMS0xLTEtMzY0MDYw_f09a3a15-51d8-4b1b-8678-48f04308a549">55</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzEtMi0xLTEtMzY0MDYw_93de8606-139e-4ed1-a3e1-d0a9cc66dcd6">77</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzEtMy0xLTEtMzY0MDYw_307aa9a2-9a80-4e13-9c18-d52a015329e7">77</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzItMS0xLTEtMzY0MDYw_e807c59a-234e-436b-9d6b-2054df1f6bc3">52</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzItMi0xLTEtMzY0MDYw_fbe6432a-6b91-4e52-8e9f-484645280292">65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzItMy0xLTEtMzY0MDYw_01fe286f-7ba5-42dc-beeb-0cef7ce2c9b3">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzMtMS0xLTEtMzY0MDYw_929b364c-8a19-490a-9c80-0c0acd2937b7">81</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzMtMi0xLTEtMzY0MDYw_4814c835-be1d-4b32-a8a1-9098dcff978f">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzMtMy0xLTEtMzY0MDYw_dc33a484-6375-4df7-88b6-583cc1bd85b2">88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating (income)/expenses, net</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzQtMS0xLTEtMzY0MDYw_53c3458c-8bb5-4359-a98b-299f25de76c6">2</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzQtMi0xLTEtMzY0MDYw_05a90957-8da3-4c47-86ae-1d97a3eab96f">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzQtMy0xLTEtMzY0MDYw_28cf8047-7e3c-4b7a-96a0-d5bb300b80d0">140</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" sign="-" name="sny:RestructuringCostsReversedAndSimilarItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzUtMS0xLTEtMzY0MDYw_308160e6-ed7f-4fe5-b8d0-d3b9833c2888">61</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="sny:RestructuringCostsReversedAndSimilarItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzUtMi0xLTEtMzY0MDYw_835a7b04-1cd6-4dc6-9773-22cae3299c5b">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" sign="-" name="sny:RestructuringCostsReversedAndSimilarItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzUtMy0xLTEtMzY0MDYw_27b2e7e5-e570-48c0-b504-74357cb99c05">59</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzYtMS0xLTEtMzY0MDYw_6b0b4029-313c-48d4-9544-4129d48f497c">43</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzYtMi0xLTEtMzY0MDYw_a746cc41-f952-4e14-8ebe-39ab86ce71c7">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzYtMy0xLTEtMzY0MDYw_134b0e39-d079-4ebe-84df-0f7856178ebe">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231" decimals="-6" name="sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzctMS0xLTEtMzY0MDYw_a384fa2e-46ca-4d95-bb62-61d4e215200a">168</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231" decimals="-6" name="sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzctMi0xLTEtMzY0MDYw_e6b30f36-4de5-426c-91ca-125f8ca4a68f">276</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231" decimals="-6" name="sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzctMy0xLTEtMzY0MDYw_e0ff83aa-cdd5-47f8-ab8c-5fe5028dec4a">84</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDc4_6093c014-97df-470c-a0f6-4dadcaad04d2" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The estimated amounts of employer&#8217;s contributions to plan assets in 2023 are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employer&#8217;s contributions in 2023 (estimate):</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4fe5b990d9de45b49b7bf7c02a4be68c_D20220101-20221231" decimals="-6" name="ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItMS0xLTEtMzY0MDYw_a546fa73-a3c1-4cac-971b-4226d4f31ad6">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idf679ad39d3c42948615b8c3d8c06913_D20220101-20221231" decimals="-6" name="ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItMi0xLTEtMzY0MDYw_229ffb37-d555-4959-80e6-61c9f77c4b51">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idbdcdcb4253747a694c0b2a3d28a086b_D20220101-20221231" decimals="-6" name="ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItMy0xLTEtMzY0MDYw_36d86b68-0782-4aaf-8bbc-3c692cf0bb31">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie76d9750fed74c6ab5c5827885cabb66_D20220101-20221231" decimals="-6" name="ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItNC0xLTEtMzY0MDYw_62096114-6c6d-4fec-b502-38771ff498ea">4</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i972b0ef516064ace86f839ae7759f600_D20220101-20221231" decimals="-6" name="ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItNS0xLTEtMzY0MDYw_170fc918-4d22-4fb2-9d19-26b6d2779ef7">34</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife7c44a9a1e84cb7b6b4f6fe06b1ebab_D20220101-20221231" decimals="-6" name="ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItNi0xLTEtMzY0MDYw_a093cd2a-6e92-4972-a658-830ce0519fb7">38</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NTAw_872bc6dc-1af9-49b6-95a2-e36fce33b863" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the expected timing of benefit payments under pension and other post-employment benefit plans for future years:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated future benefit payments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fbc3ff0245c49bca7590dacfde5337a_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItMS0xLTEtMzY0MDYw_038d603e-87e9-48a2-aba3-a975e0693a7b">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idc226cab822a45fa830781a2276243b5_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItMi0xLTEtMzY0MDYw_beca77d0-db23-4614-8a0b-3332585ec305">195</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia144a9826d65474fa13a4d6d05757814_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItMy0xLTEtMzY0MDYw_e26da371-5069-4819-bf29-4290df35bd21">118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3f42213a78854baf93af23eb78fbfbfa_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItNC0xLTEtMzY0MDYw_bd0a049b-b400-454d-b3f0-d569f9d90799">125</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia6a2ab1329f9438bb6a95f98aaf0e3f3_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItNS0xLTEtMzY0MDYw_bcfd4305-425f-4f3b-a7aa-a3465e220ca2">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItNi0xLTEtMzY0MDYw_8b1d432c-4cab-43e1-b463-00c6b1ce6627">596</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i73bcd0e9416b405280b71184e77d390e_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtMS0xLTEtMzY0MDYw_d8705b7d-e356-4b7e-ba1b-8bd8031bbdf4">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03a64532928a45bea416e80a24fbb2e0_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtMi0xLTEtMzY0MDYw_765a4d30-8223-4b23-9dc3-8320590801d3">203</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ieb0eb02549864f8ea6aea2b8ba55c46d_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtMy0xLTEtMzY0MDYw_0cbba03c-3577-4139-a2a8-4a43b35c10d7">106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2d19463a7a444bcd984e9d3b9d49979e_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtNC0xLTEtMzY0MDYw_b7885495-643c-4519-ad9d-bb240d3cfa7e">129</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4105798cd2d14971b1fec1fe37a7bd83_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtNS0xLTEtMzY0MDYw_26a60672-cfe3-40a7-bb95-6537765150bd">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i280298edcb0840438a14b90d970fec63_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtNi0xLTEtMzY0MDYw_afafece7-da03-4ec8-8221-0f3b4ab60c60">558</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib06b988b7e3c4c2e94ff11744b627571_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtMS0xLTEtMzY0MDYw_f1a27323-1883-4f7f-abc0-5b932addf8d8">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3dbde64047a84c3ca07ea93b5743b0e4_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtMi0xLTEtMzY0MDYw_03cd517f-a50b-4f2a-a5e2-49b6128eb344">209</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib3fae2f714c94f67af54f0be875a5384_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtMy0xLTEtMzY0MDYw_9ba7ead8-2643-4cf1-b07c-745a3a37c735">107</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia2f17bc572b546a0b59fd7c5297ae445_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtNC0xLTEtMzY0MDYw_72aaf5c4-89b2-4ff9-aff2-dd17c9eee0dc">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i47dfa2f710b1453fb0ad595e495e2a09_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtNS0xLTEtMzY0MDYw_8d6f75d8-cf39-4637-adf8-a742e5820192">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtNi0xLTEtMzY0MDYw_88373036-eece-4d02-add0-18873383749a">575</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9deef6d5e7a4bcfbd422deaf4dc5fa4_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtMS0xLTEtMzY0MDYw_79369f53-55de-436a-b02c-2aff8fd2d3d8">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i09a717365a084772ae035c13b5a5f7f3_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtMi0xLTEtMzY0MDYw_92840b0e-e288-4840-b8fd-38de3f88e996">212</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22228827eb244f83a0287d5644da5318_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtMy0xLTEtMzY0MDYw_3df068db-b484-4246-9247-b70981045bbe">110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie01edb6a55dd423487fb757d28bf4ea0_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtNC0xLTEtMzY0MDYw_9db96e10-7a64-4303-9255-2edc671a0617">138</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib2194e5d4a094d0582dcc78661f5b256_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtNS0xLTEtMzY0MDYw_0210c794-10ef-44df-bf0e-88ab2886a29a">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtNi0xLTEtMzY0MDYw_dce5121a-98ae-4d78-984a-72b2a295babc">592</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3de22f04eb7e4c70949d28adf82e0abf_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtMS0xLTEtMzY0MDYw_58b0118a-ce48-4df9-bf04-c33eb53f20b7">94</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie18cdcaf451b4e6a822ac250b33acd0a_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtMi0xLTEtMzY0MDYw_95f0b22d-b5fc-46d2-900e-1dbef890da3a">219</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idf005e09f52c4e098f1b0faabc27a76e_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtMy0xLTEtMzY0MDYw_46abbe63-97bf-4786-b288-b83eb4eb4aea">100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8f2fa5376a74486b8e858119d96d0922_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtNC0xLTEtMzY0MDYw_c1ae3a4c-5551-4b92-b6a1-f0b168f36aab">142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i078b4c1ea24c4f69852b61428b6e2fdb_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtNS0xLTEtMzY0MDYw_7770d1f3-17d8-48e6-aeab-d96307b549ba">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtNi0xLTEtMzY0MDYw_db73d532-2455-4d89-afa1-5ca210c0dc60">614</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2028 to 2032</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8b5e5589175949ed969ff4a1ccb121bb_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctMS0xLTEtMzY0MDYw_40166270-734a-443b-bb65-8b9d8e4c1325">505</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1d087e9dddd44337a0f1832768419409_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctMi0xLTEtMzY0MDYw_f074fab1-1648-4c6f-ac2d-f76d5d85f772">1,135</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iec7a123c92024f24b8e10eced658e625_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctMy0xLTEtMzY0MDYw_468de13d-fbfd-442f-ad71-4a848166ce69">499</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i475f28cce8a2420887453fd4e83fb711_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctNC0xLTEtMzY0MDYw_09fcb59d-aa7d-4242-8a96-458cfbc745fb">784</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iab4710282aa04343af3461b3a5005198_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctNS0xLTEtMzY0MDYw_8a0127af-8942-4210-b9fa-129f5f4ad578">323</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief42aa8c7cfe4ac888627eeabf185c37_I20221231" decimals="-6" name="sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctNi0xLTEtMzY0MDYw_55f4e277-06cb-4723-841d-03b22d708cee">3,246</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDg0_a6edd403-5ce2-4140-a1c8-aa0bc530b632" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows estimates as of December 31, 2022 for the timing of future payments in respect of unfunded pension and other post-employment benefit plans:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than 1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to <br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to <br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated payments</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjNjhkMTM3NzQ1NzQ0ZjYwYjdkZWJmMGRjZmE0YjBmZC90YWJsZXJhbmdlOmM2OGQxMzc3NDU3NDRmNjBiN2RlYmYwZGNmYTRiMGZkXzItMS0xLTEtMzY0MDYw_3ab7d573-849e-4889-898e-1be3dbd2fbd8">1,188</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ife7c44a9a1e84cb7b6b4f6fe06b1ebab_D20220101-20221231" decimals="-6" name="sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjNjhkMTM3NzQ1NzQ0ZjYwYjdkZWJmMGRjZmE0YjBmZC90YWJsZXJhbmdlOmM2OGQxMzc3NDU3NDRmNjBiN2RlYmYwZGNmYTRiMGZkXzItMi0xLTEtMzY0MDYw_cc622f84-b2a7-4f8b-bb51-3fe9ef4a1654">74</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i64534b6ebaf2429c9abcfa76a80980aa_D20220101-20221231" decimals="-6" name="sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjNjhkMTM3NzQ1NzQ0ZjYwYjdkZWJmMGRjZmE0YjBmZC90YWJsZXJhbmdlOmM2OGQxMzc3NDU3NDRmNjBiN2RlYmYwZGNmYTRiMGZkXzItMy0xLTEtMzY0MDYw_4bbce661-a028-43c8-95db-8dd6acb52f51">116</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8672ddeb9f334dfaa7ff3d1ce467ff9c_D20220101-20221231" decimals="-6" name="sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjNjhkMTM3NzQ1NzQ0ZjYwYjdkZWJmMGRjZmE0YjBmZC90YWJsZXJhbmdlOmM2OGQxMzc3NDU3NDRmNjBiN2RlYmYwZGNmYTRiMGZkXzItNC0xLTEtMzY0MDYw_b997430f-d5bf-4d6e-9ccd-d515ddba2560">139</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id75833e7c0144f56ab9eac0ea4d607f3_D20220101-20221231" decimals="-6" name="sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjNjhkMTM3NzQ1NzQ0ZjYwYjdkZWJmMGRjZmE0YjBmZC90YWJsZXJhbmdlOmM2OGQxMzc3NDU3NDRmNjBiN2RlYmYwZGNmYTRiMGZkXzItNS0xLTEtMzY0MDYw_b859242d-a0c8-4b5a-b8dc-3bf9f4686933">859</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-72</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="id6ff8644d15147d9a3062d1e17943c22" continuedAt="i8cd663f3bc7642edbb1fa51a81434cf1"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.19.2. Restructuring provisions</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfRestructuringProvisionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDcx_a045b86e-6f96-4371-be9c-2ecb904ca424" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows movements in restructuring provisions classified in non-current and current liabilities:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEtMS0xLTEtMzY0MDYw_279863d8-64ee-4328-a81d-490c6cdb71a2">1,118</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5afebb992674818a78a7834ac446ae9_I20201231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEtMi0xLTEtMzY0MDYw_5c03b1cb-e643-4365-87ac-441a7c17db5e">1,499</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icb5f9e7c6185477aa7f9a156dc214f20_I20191231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEtMy0xLTEtMzY0MDYw_2dd4d0c5-ec54-448b-a5d9-44e3bf5d6eee">1,390</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in non-current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231" decimals="-6" name="ifrs-full:LongtermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzMtMS0xLTEtMzY0MDYw_f5286cb0-2cd8-4000-b10a-ae7fbbad3537">524</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5afebb992674818a78a7834ac446ae9_I20201231" decimals="-6" name="ifrs-full:LongtermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzMtMi0xLTEtMzY0MDYw_d116c766-522c-4ac0-b375-24670976e8fa">868</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icb5f9e7c6185477aa7f9a156dc214f20_I20191231" decimals="-6" name="ifrs-full:LongtermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzMtMy0xLTEtMzY0MDYw_82796eeb-0ea2-4940-84c0-a6295a6b16d8">600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231" decimals="-6" name="ifrs-full:ShorttermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzQtMS0xLTEtMzY0MDYw_e371a4f8-5ea9-4fd3-9f13-16d288bb3622">594</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5afebb992674818a78a7834ac446ae9_I20201231" decimals="-6" name="ifrs-full:ShorttermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzQtMi0xLTEtMzY0MDYw_82b8eda8-b675-4291-a53a-421770da7e48">631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icb5f9e7c6185477aa7f9a156dc214f20_I20191231" decimals="-6" name="ifrs-full:ShorttermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzQtMy0xLTEtMzY0MDYw_29e8895c-6cac-4f70-8bf2-c34772c3fd69">790</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in provisions recognized in profit or loss for the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i845514465d3444229b0025c52ed9385a_D20220101-20221231" decimals="-6" name="sny:ChangeInProvisionsRecognizedInProfitOrLossForThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzUtMS0xLTEtMzY0MDYw_f7797baa-fde3-4513-8cb9-d6fa072ed1ad">636</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231" decimals="-6" name="sny:ChangeInProvisionsRecognizedInProfitOrLossForThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzUtMi0xLTEtMzY0MDYw_335accc7-b955-491a-994a-92707dbe8867">183</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231" decimals="-6" name="sny:ChangeInProvisionsRecognizedInProfitOrLossForThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzUtMy0xLTEtMzY0MDYw_f23136d1-c0eb-4812-83ad-f2f5ea3fa735">767</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i845514465d3444229b0025c52ed9385a_D20220101-20221231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzYtMS0xLTEtMzY0MDYw_3c3982dd-4af7-4ae6-a662-fd7133ab2cc1">522</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzYtMi0xLTEtMzY0MDYw_90b9995c-42e7-425b-8467-66292d7f66be">571</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231" decimals="-6" name="ifrs-full:ProvisionUsedOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzYtMy0xLTEtMzY0MDYw_51c54cee-e378-471a-acbe-0c704960cf55">663</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i845514465d3444229b0025c52ed9385a_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzctMS0xLTEtMzY0MDYw_39d6170d-dcaa-4c65-9500-134479d289d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzctMi0xLTEtMzY0MDYw_f14227f7-a2c6-43c3-8bfb-f1e9a4098042">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzctMy0xLTEtMzY0MDYw_7d257689-b6f3-4754-b928-b36e3c755a48">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unwinding of discount</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i845514465d3444229b0025c52ed9385a_D20220101-20221231" decimals="-6" name="sny:UnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzgtMS0xLTEtMzY0MDYw_08c7b0c7-31f0-4597-bc8c-9955355ca014">5</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231" decimals="-6" name="sny:UnwindingOfDiscount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzgtMi0xLTEtMzY0MDYw_c4400605-80cb-4f24-8259-027a442e1f37">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231" decimals="-6" name="sny:UnwindingOfDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzgtMy0xLTEtMzY0MDYw_ae2edede-33a7-4b51-b914-568e4035717e">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i845514465d3444229b0025c52ed9385a_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzktMS0xLTEtMzY0MDYw_d5aa977c-e52a-41a2-99bf-5a3503ccd853">4</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231" decimals="-6" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzktMi0xLTEtMzY0MDYw_3ab9014c-d073-42c5-b837-e91f18935c92">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzktMy0xLTEtMzY0MDYw_b6a04c0a-9485-48e3-832f-3faab0b3f65c">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if7b1f1d64d014db48f48a68a6832b64a_I20221231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEwLTEtMS0xLTM2NDA2MA_6662044c-b039-4ab8-9757-db336d6272fe">1,233</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEwLTItMS0xLTM2NDA2MA_51030fc4-70dc-4ab3-a93f-092230b813e0">1,118</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5afebb992674818a78a7834ac446ae9_I20201231" decimals="-6" name="sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEwLTMtMS0xLTM2NDA2MA_82497fd9-7244-47b2-b3d5-d33a5ad14467">1,499</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in non-current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if7b1f1d64d014db48f48a68a6832b64a_I20221231" decimals="-6" name="ifrs-full:LongtermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEyLTEtMS0xLTM2NDA2MA_de41c0e6-6330-4a2c-a55a-4d749e0600ca">761</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231" decimals="-6" name="ifrs-full:LongtermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEyLTItMS0xLTM2NDA2MA_2b34a08d-73d7-45be-bf8b-285466fc71f3">524</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5afebb992674818a78a7834ac446ae9_I20201231" decimals="-6" name="ifrs-full:LongtermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEyLTMtMS0xLTM2NDA2MA_b058f4c3-bcc1-44d0-ace7-8be1f429135b">868</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if7b1f1d64d014db48f48a68a6832b64a_I20221231" decimals="-6" name="ifrs-full:ShorttermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEzLTEtMS0xLTM2NDA2MA_ccb6f6fb-a41f-43d3-9ffe-4a484566140d">472</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231" decimals="-6" name="ifrs-full:ShorttermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEzLTItMS0xLTM2NDA2MA_d52cae02-3e07-4b8d-a4d7-1b492025ea59">594</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5afebb992674818a78a7834ac446ae9_I20201231" decimals="-6" name="ifrs-full:ShorttermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEzLTMtMS0xLTM2NDA2MA_a468852a-cd3f-4a39-9e0c-9d26f865092b">631</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Provisions utilized mainly correspond to payments related to employees affected by separation programs.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Provisions for employee termination benefits as of December 31, 2022 amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzEyNzAz_f2701bc5-7621-4d15-aaec-5ce735919baf">1,039</ix:nonFraction> million (compared with &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzEyNzIy_28230593-7625-4126-b399-fa5cd086a9f7">943</ix:nonFraction>&#160;million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzEyNzQ2_2af8f237-8868-42fc-bbdf-2f117084efde">1,260</ix:nonFraction> million as of December 31, 2020).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The provisions apply mainly to France, and relate to various voluntary redundancy programs:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">agreement under the Job Management and Career Paths (&#8220;GEPP&#8221;) scheme affecting several French legal entities, signed on&#160;February&#160;28, 2022 and announced in April&#160;2022 as part of the &#8220;Play to Win&#8221; strategy. The agreement provides internal transfer and outplacement opportunities for employees whose jobs are undergoing transformation, and also includes an end-of-career paid leave program and an external retraining program. The majority of the provisions charged in 2022 relate to this plan, which was implemented during 2022;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">collectively-agreed separation programs involving a number of legal entities were announced at the end of June&#160;2020 as part of the rollout of the &#8220;Play to Win&#8221; strategy; these include an end-of-career paid leave plan and an external retraining program, and were still ongoing during 2022. In addition, Sanofi-Aventis Recherche &amp;&#160;D&#233;veloppement (i)&#160;announced a voluntary redundancy program in&#160;2020 in connection with the reorganization of R&amp;D operations in France, which was implemented in&#160;2021, and (ii)&#160;signed a collectively-agreed termination program in&#160;2021 as part of the rollout of the &#8220;Play to Win&#8221; strategy; these programs, which cover support functions, include an end-of-career paid leave plan and an end-of-career transition plan;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">programs were announced in 2019 relating to (i)&#160;R&amp;D (Sanofi-Aventis Recherche &amp;&#160;D&#233;veloppement), and (ii)&#160;sales forces (the&#160;&#8220;SAF&#160;2019&#8221; plan implemented by Sanofi-Aventis France); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">collectively-agreed separation programs were announced in 2018 relating to the reorganization of support functions (&#8220;Horizon&#160;2020&#8221; plan).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The remainder of the provision for France comprises termination benefits associated with previously-announced programs (early retirement plans and end-of-career transition plans).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The provision includes the present values of:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">gross annuities for self-funded plans;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">employer&#8217;s social security charges on early retirement annuities for all plans (outsourced and self-funded); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the levy charged on those annuities under the &#8220;Fillon&#8221;&#160;law (only for plans with termination of employment contracts).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The average residual holding periods under these plans were <ix:nonNumeric contextRef="ie3a804cc972b46818508faabd25873f4_D20221231-20221231" name="sny:AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE0NjE1_3f565ab0-ed0c-4c33-bb8c-4fa94f22b1e7">2.60</ix:nonNumeric>&#160;years, <ix:nonNumeric contextRef="i0f39e329592f4ecf907cc503dcb00e16_D20211231-20211231" name="sny:AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE0NjI1_51ed3385-df47-46fc-9931-a0cc3e190208">1.94</ix:nonNumeric>&#160;year and <ix:nonNumeric contextRef="i76c0ea6a3dee45298522d8ae0b039615_D20201231-20201231" name="sny:AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE0NjM4_ae0e2e02-8d17-490b-83a6-b983b19d5dcc">1.99</ix:nonNumeric>&#160;year as of December 31, 2022, 2021 and&#160;2020, respectively.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main other countries covered by restructuring provisions are Germany, Japan and the United States.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-73</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i8cd663f3bc7642edbb1fa51a81434cf1" continuedAt="i40295b4f1d3341ff8e18d86c6f9cafed"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NTAy_ee7e0837-06ad-4dc7-8a6c-774c8f315520" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The timing of future termination benefit payments is as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit payments by period</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employee termination benefits</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">France</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzMtMS0xLTEtMzY0MDYw_0eedf25a-0d86-45d5-94e4-6be3baf2c4d1">804</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fbc3ff0245c49bca7590dacfde5337a_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzMtMi0xLTEtMzY0MDYw_0bdad2d8-e9f3-47a9-8f8e-07738bde6201">185</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib3ede158a1804cc89e2cbf56a9146440_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzMtMy0xLTEtMzY0MDYw_5e831766-e154-451e-94af-f536c177961b">412</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief8448635aed42ec8bd010e6d8d33e6f_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzMtNC0xLTEtMzY0MDYw_1be2ac9a-c657-40f3-ba3c-55d9c7199099">207</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i733d9f9b2b73442f8f3ee6d411efc319_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzMtNS0xLTEtMzY0MDYw_6e280b3d-fb37-4ddf-bbeb-bbbc6b34be68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other countries</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i727bd67c94b846ec879e26bf1451a28b_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzQtMS0xLTEtMzY0MDYw_0b37cb09-4047-40d8-ac71-ff4d82bd3294">235</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia6a2ab1329f9438bb6a95f98aaf0e3f3_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzQtMi0xLTEtMzY0MDYw_9bbde57a-4347-4d54-bf1b-20616ca9edba">189</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib5abb9e9b2d645b687214ebf5e5b917b_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzQtMy0xLTEtMzY0MDYw_a05de612-258d-4d5f-bb4b-0e6ba0cfb834">36</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4217022461624166b066799e52ed0ae2_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzQtNC0xLTEtMzY0MDYw_4c040117-8775-4622-adcf-2abde7600c47">8</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia0b14f40a60345cfbb888ce3b1583ed8_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzQtNS0xLTEtMzY0MDYw_ae5d3d95-7710-4d79-a537-0c5d12ce2995">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzUtMS0xLTEtMzY0MDYw_f2701bc5-7621-4d15-aaec-5ce735919baf">1,039</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzUtMi0xLTEtMzY0MDYw_74544c8f-0079-43ab-8daf-bf7cf7b5f79a">374</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzUtMy0xLTEtMzY0MDYw_dcddeb96-e4e0-4725-8331-4265f8f50fcb">448</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzUtNC0xLTEtMzY0MDYw_797dbc01-aea3-493a-9668-95a4d63b1a7f">215</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzUtNS0xLTEtMzY0MDYw_9c90cae9-5569-43e3-816c-75cb5d1daafa">2</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit payments by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employee termination benefits</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">France</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzMtMS0xLTEtMzY0MDYw_73d808f2-ca0e-4e51-bf58-784ecf230752">614</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idf14e75b5e984c98bc6e960753b80f31_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzMtMi0xLTEtMzY0MDYw_2ebf0132-05c0-4e38-9a75-1cc1be299634">269</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i66df5d0d41d6428d9debc9c4c2f80889_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzMtMy0xLTEtMzY0MDYw_1a5e4a4f-ba58-435c-ae2e-67ce56e418e9">288</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i54ab42bc5dab418284d3709b3f894736_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzMtNC0xLTEtMzY0MDYw_2bad719b-9154-4dae-bdca-c757b327ae1e">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i836df9a1ca87450a9ed9f75118770f04_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzMtNS0xLTEtMzY0MDYw_e6decf4d-8f6d-4361-bae6-cd0e0f823216">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other countries</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i688e526d505647cca548bad7d372816f_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzQtMS0xLTEtMzY0MDYw_5603a17f-2eb9-4d72-9e3d-2b3a5c7c9f98">329</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6d8865e8b32416f920b803df1461469_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzQtMi0xLTEtMzY0MDYw_5734dcdc-19a8-4629-87ca-3258cc5bee8f">207</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2f7f02d43ee94a4280406be5c3292239_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzQtMy0xLTEtMzY0MDYw_276aec8d-bec1-4713-a576-5abd31bf41a3">106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic901448a78764b3c9b5def1dfdd7fbee_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzQtNC0xLTEtMzY0MDYw_0e898bfd-2b26-4936-a47c-ba58d37de4b2">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ide13b51197a24ee9b4038dac78c62afc_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzQtNS0xLTEtMzY0MDYw_77651c21-d6f0-4c2a-a10f-c4e7599d96a2">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzUtMS0xLTEtMzY0MDYw_28230593-7625-4126-b399-fa5cd086a9f7">943</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzUtMi0xLTEtMzY0MDYw_d04c204d-82d5-4d43-8036-e878769b9eae">476</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie428880947a544b49bb0e7d00760fd8c_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzUtMy0xLTEtMzY0MDYw_1b38e344-f40f-4d18-8961-9a325c383aad">394</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff9a6cfc0d3c4fb393a0f42915753ff1_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzUtNC0xLTEtMzY0MDYw_33189e31-2afd-450d-9f40-ea65d3d04082">67</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzUtNS0xLTEtMzY0MDYw_54124d99-1f2b-4ef4-9523-967eb4ec65cd">6</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit payments by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employee termination benefits</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">France</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzMtMS0xLTEtMzY0MDYw_3776a788-962c-4eb6-a8aa-8b7fe1745362">889</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i158f70bc52794d319fedf9a855b45b25_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzMtMi0xLTEtMzY0MDYw_dfe27176-304c-4028-b967-a9111c1f13e2">295</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i21e0cbf5e58a47feb6bd62e37f9b2bb2_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzMtMy0xLTEtMzY0MDYw_55e8cc12-d0f6-48c2-94f6-b640a4693137">457</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2f92b31b598b40a7b5f13a153bfbadba_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzMtNC0xLTEtMzY0MDYw_20e752fd-06ec-4fb1-ab86-67219fd79a49">124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i46f2414fec014acf824049d7ef8a26af_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzMtNS0xLTEtMzY0MDYw_783562ec-d635-4d00-b3df-489187c5c285">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other countries</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0593a502ce6b4cd49c8af7a40f39e801_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzQtMS0xLTEtMzY0MDYw_bd9b5272-eea4-47e9-b7d2-10db7a1ec502">371</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3c31592c4cfa491e9223f6491673f1a2_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzQtMi0xLTEtMzY0MDYw_09c34b3e-717d-4afa-b3f3-b813f673fc3a">195</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff57e235495f4a5589b5d11d2537313e_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzQtMy0xLTEtMzY0MDYw_c7255553-56e7-4ee3-90cd-f7bb6605d0f7">149</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i370f9ca08eec4c64933f63c4154c6168_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzQtNC0xLTEtMzY0MDYw_4a34b7a6-ff11-4e37-87e7-c004616c3fde">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idcc9f8081cf140aba4e01d0be09d50e5_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzQtNS0xLTEtMzY0MDYw_3def6656-1959-4c26-b4aa-a42578b84342">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzUtMS0xLTEtMzY0MDYw_2af8f237-8868-42fc-bbdf-2f117084efde">1,260</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzUtMi0xLTEtMzY0MDYw_3f400685-e8e7-4d78-bb72-d01524db3b6d">490</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i597d4960121a42bbb65d0137e78d145a_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzUtMy0xLTEtMzY0MDYw_37ffe98b-6b30-4575-9836-6dc63c5b9bed">606</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0c3121bafadb4e4f8e35a95800cbc2f0_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzUtNC0xLTEtMzY0MDYw_d6bdd2b2-a53a-432a-a6ce-dafee0573cc8">142</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231" decimals="-6" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzUtNS0xLTEtMzY0MDYw_f2b2bd5e-d0d0-4cdc-a9cd-79554ae2ca1a">22</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.19.3. Other provisions</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfOtherLongTermProvisionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDg5_0c8f5d4f-0301-4e66-9b2b-d726ac73c2ab" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other provisions</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> include provisions for risks and litigation relating to environmental, tax, commercial and product liability matters.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Environmental risks</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:NonCurrentProvisionForEnvironmentRisks" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzEtMS0xLTEtMzY0MDYw_eee19e01-7706-48aa-b28e-a68adf913fcd">526</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:NonCurrentProvisionForEnvironmentRisks" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzEtMi0xLTEtMzY0MDYw_07f08726-9a4f-40b9-bb74-ee22c8f0ba6d">650</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:NonCurrentProvisionForEnvironmentRisks" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzEtMy0xLTEtMzY0MDYw_c3ae2f77-7c2e-4456-99d7-6a8c900b720c">713</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product liability risks, litigation and other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzItMS0xLTEtMzY0MDYw_72d66f83-a30c-4d63-84a1-7c83733bdacb">1,652</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzItMi0xLTEtMzY0MDYw_9b3c2333-e14d-40dc-9ea8-ae8bbec8eb75">1,374</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzItMy0xLTEtMzY0MDYw_8fe2631c-0c21-4a11-b185-e836184da4e5">1,262</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:OtherLongtermProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzMtMS0xLTEtMzY0MDYw_b4e4cdc9-c0b1-4583-a9f8-f2521af0b93b">2,178</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:OtherLongtermProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzMtMi0xLTEtMzY0MDYw_999f0a96-4505-4167-8122-1fac91582534">2,024</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:OtherLongtermProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzMtMy0xLTEtMzY0MDYw_9e0234ea-37a3-4e4e-b7a9-b301d80c8fc8">1,975</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Provisions for environmental risks relate primarily to contingencies arising from business divestitures, and include remediation costs relating to such environmental risks.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Identified environmental risks are covered by provisions estimated on the basis of the costs Sanofi believes it will be obliged to meet over a period not exceeding (other than in exceptional cases) <ix:nonNumeric contextRef="idb626ed9d7754d599f6dcb43cd6f78a7_D20220101-20221231" name="sny:IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE1Nzkw_448c641c-3ec8-45be-80fb-881e374c511f">30</ix:nonNumeric>&#160;years. Sanofi expects that &#8364;<ix:nonFraction unitRef="eur" contextRef="idb626ed9d7754d599f6dcb43cd6f78a7_D20220101-20221231" decimals="-6" name="sny:IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE1ODIw_83786039-c90f-4078-b919-f4ab41dcbdb4">96</ix:nonFraction> million of those provisions will be utilized in&#160;2023, and &#8364;<ix:nonFraction unitRef="eur" contextRef="idb626ed9d7754d599f6dcb43cd6f78a7_D20220101-20221231" decimals="-6" name="sny:IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE1ODcx_97045856-8595-4c7d-b111-2fd97fd2c634">201</ix:nonFraction> million over the period from 2024 through 2027.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Product liability risks, litigation and other&#8221; mainly comprises provisions for risks relating to product liability (including IBNR provisions as described in Note&#160;B.12.), government investigations, regulatory or antitrust law claims, contingencies arising from business divestitures (other than environmental risks), and remediation costs related to leases.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main pending legal and arbitral proceedings and government investigations are described in Note&#160;D.22.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A full risk and litigation assessment is performed with the assistance of Sanofi&#8217;s legal advisers, and provisions are recorded as required by circumstances in accordance with the principles described in Note&#160;B.12.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.19.4. Non-current income tax liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Non-current income tax liabilities </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2Njgw_e4f510ed-55e3-4f7a-97f0-8cd86614b244">1,979</ix:nonFraction> million as of December 31, 2022 (versus &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2NzAx_0351b7a0-d048-4586-aa3c-58e6f1fa8104">2,039</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2NzE4_434e824d-7efd-4872-891e-4d7b636aeadb">1,733</ix:nonFraction> million as of December 31, 2020).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The estimated tax charge on deemed repatriation attributable to the accumulated earnings of non-US operations and payable over <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2ODU5_6ba3c51b-afb1-47d0-b63f-d92d65ec4d8e">8</ix:nonNumeric>&#160;years is recognized as a liability, and amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:LiabilityRecognizedRepresentingEstimatedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2OTE0_0801ef6a-9f92-49fb-900e-e3588fcb4a67">1,020</ix:nonFraction> million in 2022 versus &#8364;<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:LiabilityRecognizedRepresentingEstimatedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2OTMw_4ec2f0f0-ea60-4e85-8b09-338336fb071f">960</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:LiabilityRecognizedRepresentingEstimatedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2OTQ0_eb965910-16b9-448b-b76a-6d49aa76b65f">894</ix:nonFraction> million in&#160;2020. The resulting residual tax charge generated a non-current liability of &#8364;<ix:nonFraction unitRef="eur" contextRef="i204cf38410c44c62bd596f2773e81a5b_I20221231" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3MDI1_431c4cf1-936f-41ce-b23b-b0dbdbddedfc">459</ix:nonFraction> million as of December 31, 2022, versus &#8364;<ix:nonFraction unitRef="eur" contextRef="i0fe124e0795a41ebac762da9097bb875_I20211231" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3MDQ1_ba235c91-5670-4bb8-b0f9-b5fab927a721">576</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i2e7cdf1797e949f6abdf600757d84aa3_I20201231" decimals="-6" name="ifrs-full:OtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3MDU4_15efc7d9-8eb2-4d4b-9631-1986525bd930">569</ix:nonFraction> million in 2020. In accordance with Sanofi accounting policies, this non-current liability is not discounted.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Non-current income tax liabilities include uncertainties over income tax treatments amounting to &#8364;<ix:nonFraction unitRef="eur" contextRef="i1f1c485ac1cf4f59b3dec0c221bf9747_I20221231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3MjU4_1e938802-1baa-44be-8a44-797ca9ead20d">1,520</ix:nonFraction> million as of December 31, 2022, versus &#8364;<ix:nonFraction unitRef="eur" contextRef="i0067e056654b438e962ebd27feb406c1_I20211231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3Mjc4_c781b469-786f-4da6-8538-25f23f0a9c34">1,463</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="if40304953a534c06a43b1715cc0c7ffa_I20201231" decimals="-6" name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3Mjk0_cbf415dc-4ee8-43c8-9d9b-316398189b9e">1,164</ix:nonFraction> million as of December 31, 2020.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-74</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i40295b4f1d3341ff8e18d86c6f9cafed"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A US legal restructuring resulted in a capital loss of &#8364;<ix:nonFraction unitRef="eur" contextRef="i7182e8a5acb84acb81eb76efa4a859af_I20211231" decimals="-8" name="sny:UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3MzYz_35b3b670-99fe-4221-a83b-7a27291e08bc">2.9</ix:nonFraction>&#160;billion recognized in the 2020 final tax filing. One-third of the capital loss has been used against 2020 capital gains and the remaining balance will be eligible to carry back for <ix:nonNumeric contextRef="i3b16a68d75504188ac3d7a2cb2687840_D20210101-20211231" name="sny:CapitalLossesCarryBackPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3NTQ3_d6100ff0-7e50-430c-9552-03a64a931a20">three years</ix:nonNumeric>. Due to management&#8217;s judgement about potential alternative interpretations of the prevailing tax law, no tax benefit has been recognized on this transaction in accordance with IFRIC&#160;23.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.19.5. Current provisions and other current liabilities</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NTA4_a58d39b9-9190-4e76-8699-9f00e55224d7" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Current provisions and other current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes payable, other than corporate income taxes</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEtMS0xLTEtMzY0MDYw_35e81fe9-8b7c-4212-9ba3-33ba57664fb3">420</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEtMi0xLTEtMzY0MDYw_ff3b0075-0af6-421a-bf36-73009292d719">428</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEtMy0xLTEtMzY0MDYw_8386b0fe-922c-4248-ba89-3b8992160a98">347</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee-related liabilities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzItMS0xLTEtMzY0MDYw_8c7d4973-96ad-40ef-95e7-9b79d9666759">2,158</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzItMi0xLTEtMzY0MDYw_66c7140f-0005-4eb4-b043-75b92f104cbe">2,126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzItMy0xLTEtMzY0MDYw_3fade880-0454-4a81-9e02-577607a996ed">2,042</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring provisions (see Note&#160;D.19.2.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:ShorttermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzMtMS0xLTEtMzY0MDYw_2f563ec7-83be-4c98-aecf-b557e69e7bd2">472</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:ShorttermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzMtMi0xLTEtMzY0MDYw_7d601789-8ef7-45f2-bc9c-214a6b87d66e">594</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:ShorttermRestructuringProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzMtMy0xLTEtMzY0MDYw_d4f1c130-6a11-49f7-b140-8f0bc7361a66">631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate derivatives (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CurrentInterestRateDerivativesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzQtMS0xLTEtMzY0MDYw_0b1844d0-17ca-4ac8-ba25-1445e870d9f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CurrentInterestRateDerivativesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzQtMi0xLTEtMzY0MDYw_ca5f2962-e72c-4102-ae33-ff820ac69cfd">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CurrentInterestRateDerivativesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzQtMy0xLTEtMzY0MDYw_30946100-172e-451a-80a6-7d9a10f40bfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency derivatives (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CurrentCurrencyDerivativesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzUtMS0xLTEtMzY0MDYw_1912ac6e-567d-4ece-8535-e5d616ff191c">94</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CurrentCurrencyDerivativesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzUtMi0xLTEtMzY0MDYw_9798a2f6-208f-47f5-9f23-1703b36898a1">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CurrentCurrencyDerivativesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzUtMy0xLTEtMzY0MDYw_fb71ad32-f15c-48eb-882d-f13a901d7964">205</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity derivatives (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CurrentEquityDerivativesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzYtMS0xLTEtMzY0MDYw_d28e4822-40a7-4bf1-975e-90844616f4fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CurrentEquityDerivativesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzYtMi0xLTEtMzY0MDYw_2b693102-fcd7-4995-a748-edbbb5f2c2ef">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CurrentEquityDerivativesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzYtMy0xLTEtMzY0MDYw_0651660d-00b3-4d43-bd42-8396d6b5d4e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts payable for acquisitions of non-current assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:AmountsPayableForAcquisitionOfNonCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzctMS0xLTEtMzY0MDYw_78dac1f7-2ad5-4ab1-908c-55ff40bf2d7c">714</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:AmountsPayableForAcquisitionOfNonCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzctMi0xLTEtMzY0MDYw_adc4526d-4081-459f-a42f-00a3ff2696a0">559</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:AmountsPayableForAcquisitionOfNonCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzctMy0xLTEtMzY0MDYw_f291f243-535a-4a0d-8915-a2bd96e9742d">467</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer contract liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentContractLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzgtMS0xLTEtMzY0MDYw_44980c80-8f71-4fc7-9642-68dfb56700ac">264</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:CurrentContractLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzgtMi0xLTEtMzY0MDYw_9679bcb4-1851-4bdc-8a88-5fd53c894211">319</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:CurrentContractLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzgtMy0xLTEtMzY0MDYw_a61ee222-bb66-4ffb-a4e6-fd548575bdfe">252</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:OtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzktMS0xLTEtMzY0MDYw_df337933-e9c4-47a9-a069-da78a5c4d668">7,899</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:OtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzktMi0xLTEtMzY0MDYw_a382f895-053d-4966-83d7-24f46f6a9f0d">7,112</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:OtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzktMy0xLTEtMzY0MDYw_3f0d28c8-fcb6-4079-a035-053ad5700d2b">6,188</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CurrentProvisionsAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEwLTEtMS0xLTM2NDA2MA_ca5600d7-89a8-4dfe-b8df-c48fed798a2f">12,021</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CurrentProvisionsAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEwLTItMS0xLTM2NDA2MA_270e80dc-4e0b-4e53-b6e9-85fbf11c4cfb">11,217</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:CurrentProvisionsAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEwLTMtMS0xLTM2NDA2MA_2a0bc318-9cfe-403d-ad7e-bad5e4f8c5a1">10,132</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">See Note&#160;A.5.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">, &#8220;Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">. The year-on-year change in this item includes revenue of &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:ContractLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE5NzkxMjA5MzI1NTI4_e30c2949-05f2-486e-93da-248dc2cdb0e9">85</ix:nonFraction>&#160;million recognized in profit or loss during 2022 that was included in the customer contract liabilities balance as of December&#160;31, 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) &#8220;Other current liabilities&#8221; mainly comprises provisions for customer rebates and returns; provisions for discounts and rebates granted to healthcare authorities and governmental programs (see Note&#160;D.23.); and the liability payable at each reporting date under the Monoclonal Antibody Alliance with Regeneron.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_652"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.20. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MjQ_710c5d95-74a8-4a71-9003-85bef9e110b9" continuedAt="i2d7ba6090eae44138faf4572317301d6" escape="true">Derivative financial instruments and market risks</ix:nonNumeric></span></div><ix:continuation id="i2d7ba6090eae44138faf4572317301d6" continuedAt="icdbeab8535a64f24af400e578e0a9a6e"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MTI_60599b81-97d8-4e88-9f20-83220cef8070" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the fair value of derivative instruments as of December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">assets</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current<br/>assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current<br/>liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current<br/>liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>liabilities</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market value at December 31, 2022 (net)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market value at December 31, 2021 (net)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market value at December 31, 2020 (net)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency derivatives</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtMS0xLTEtMzY0MDYw_d0e5fe5e-5b93-4086-be34-575ca47b9213">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtMi0xLTEtMzY0MDYw_bdb5fa81-9a31-4581-ab4d-d7095e980d37">206</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtMy0xLTEtMzY0MDYw_1cd7ab1e-3f5b-4539-ae90-60462b9442f4">206</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtNC0xLTEtMzY0MDYw_4b92781f-376b-4015-a680-42441794dffe">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtNS0xLTEtMzY0MDYw_6530e223-2093-4e7f-8ad2-e9e4f99de3cc">94</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtNi0xLTEtMzY0MDYw_d7128bec-3458-490f-91e2-4489b07dae5b">94</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231" decimals="-6" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtNy0xLTEtMzY0MDYw_e4953e57-4407-4b07-a5f7-5f5cb66f9003">112</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6f34920cef9945fd969c11ea4e857b12_I20211231" decimals="-6" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtOC0xLTEtMzY0MDYw_57b15a0a-cd47-42eb-9297-204ae9986827">222</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ifb00596e224b4b3eb3c4df739ff52cc1_I20201231" decimals="-6" sign="-" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtOS0xLTEtMzY0MDYw_645bfa2e-ebb5-4c22-a912-21f498acc75e">209</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">operating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItMS0xLTEtMzY0MDYw_d4accf9e-30e3-49dd-a88e-3caef5f2bbd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItMi0xLTEtMzY0MDYw_9615722f-2655-47a3-b8a0-dab9de005c9c">88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItMy0xLTEtMzY0MDYw_a2f0308c-973d-4d6a-9a23-8021c04e5117">88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItNC0xLTEtMzY0MDYw_9e6eea81-9d98-4f84-82a3-52843d9c1781">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItNS0xLTEtMzY0MDYw_0421354e-7728-40b3-aeb8-29dd9868acf1">66</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItNi0xLTEtMzY0MDYw_8b0ed034-bd59-4aad-8470-236b0dd68dcb">66</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231" decimals="-6" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItNy0xLTEtMzY0MDYw_baf68674-a4b1-458f-bf45-0b3a7eada100">22</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icb368c61c98d4f5f804fb045a97d08e4_I20211231" decimals="-6" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItOC0xLTEtMzY0MDYw_3f22f5d2-fc96-4703-a687-03c9594d6048">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifeca42fd3faa45ae94e5c1bb85088c87_I20201231" decimals="-6" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItOS0xLTEtMzY0MDYw_2c8306c1-6f3e-49cc-902c-e4e6c29140a2">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">financial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtMS0xLTEtMzY0MDYw_0eaaf037-26cb-41fc-8ae9-00b7538fde2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtMi0xLTEtMzY0MDYw_07c93871-a1f6-4ef4-9a9a-9627942eca66">118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtMy0xLTEtMzY0MDYw_2909acce-bc10-4041-97a8-d80f08a41421">118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtNC0xLTEtMzY0MDYw_cb21b8ca-969f-4f07-a299-0f70b139685e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtNS0xLTEtMzY0MDYw_ab87accb-57a3-41f3-ae42-04bc7b5e9dae">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtNi0xLTEtMzY0MDYw_8ce2756b-9c33-42d6-ad74-dd206a0df9df">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231" decimals="-6" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtNy0xLTEtMzY0MDYw_be7f5e49-8c22-4f72-a212-f3057027d400">90</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie9bce47aac6f476b9ddd183a1b48c82a_I20211231" decimals="-6" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtOC0xLTEtMzY0MDYw_d7623634-205e-46d5-872a-2d4741d08fe3">212</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i77add1a06a69418dab94e867b2a86d41_I20201231" decimals="-6" sign="-" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtOS0xLTEtMzY0MDYw_866d627e-8c32-4516-86e0-5d5aac1fbce5">216</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtMS0xLTEtMzY0MDYw_a32b773c-ecbc-4269-ac79-3b0c2dcc8402">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtMi0xLTEtMzY0MDYw_4361f526-0c7e-4986-8c52-4fbcd778f727">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtMy0xLTEtMzY0MDYw_23ee5341-0644-479f-ac71-9234c3ca7c42">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtNC0xLTEtMzY0MDYw_fcf38aaf-50f1-4569-ab52-68b6551dab92">232</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtNS0xLTEtMzY0MDYw_f6d5aa9e-a62d-4e37-8a81-3e67fe698b68">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtNi0xLTEtMzY0MDYw_02af7f1b-0ae1-407c-8efe-9c912444d118">232</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231" decimals="-6" sign="-" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtNy0xLTEtMzY0MDYw_fd05f50d-5380-4f61-8433-4551bffb06a4">232</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i01f241b2e7334652930d2a5f3bcae23d_I20211231" decimals="-6" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtOC0xLTEtMzY0MDYw_94734b79-0f2b-4c32-ba80-0510249f6781">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idd6f6afab5064092a3ab474b0a93921f_I20201231" decimals="-6" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtOS0xLTEtMzY0MDYw_a0ce1199-5ad4-4968-9014-c5cdd191a3a3">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iad5d34f9d74d4248b507d41261086914_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtMS0xLTEtMzY0MDYw_2f886ec0-cc1a-4eaf-9c2e-016f18fc346b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iad5d34f9d74d4248b507d41261086914_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtMi0xLTEtMzY0MDYw_4144e595-302a-46ef-87f9-199b23ebbc56">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iad5d34f9d74d4248b507d41261086914_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtMy0xLTEtMzY0MDYw_8d3acf6b-6515-4c37-9388-353413212c56">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iad5d34f9d74d4248b507d41261086914_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtNC0xLTEtMzY0MDYw_595e0139-b461-4d4f-8fa6-f413e9d51256">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iad5d34f9d74d4248b507d41261086914_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtNS0xLTEtMzY0MDYw_a189ebd8-c6f6-4fc7-8f1d-538f305e82f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iad5d34f9d74d4248b507d41261086914_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtNi0xLTEtMzY0MDYw_42ffe352-bc08-496c-80e1-5abc4487dbdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iad5d34f9d74d4248b507d41261086914_I20221231" decimals="-6" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtNy0xLTEtMzY0MDYw_acf820f0-e23e-4dd4-b25f-0c95a4c53213">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic3c4833a597b445e8ac99a4bbe634506_I20211231" decimals="-6" sign="-" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtOC0xLTEtMzY0MDYw_6a73e091-3d7a-4b6a-adc2-9bb3cfeb3306">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i579725acb4414ac980d9c04bf21d1baa_I20201231" decimals="-6" sign="-" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtOS0xLTEtMzY0MDYw_29aa9c95-8d8a-4553-8462-82842afc232d">26</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtMS0xLTEtMzY0MDYw_8bde0361-7a26-4177-b9c2-03a5ea2412da">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtMi0xLTEtMzY0MDYw_6aaa09b8-c831-4fa3-aa0e-d16059d765f0">206</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtMy0xLTEtMzY0MDYw_1980a7e3-ad69-491c-81eb-ca9e98eaeb01">206</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( <ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtNC0xLTEtMzY0MDYw_3de40d4e-d971-40c5-b3c6-cf0de47f1380">232</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( <ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:CurrentDerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtNS0xLTEtMzY0MDYw_d63a1899-6339-4ce2-980d-394bf55372c3">94</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( <ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtNi0xLTEtMzY0MDYw_846802c8-e9b1-4ade-8817-6664dcfff03b">326</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( <ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" sign="-" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtNy0xLTEtMzY0MDYw_9fbc0d2a-2225-4f15-a1ad-19b9125c71da">120</ix:nonFraction>)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtOC0xLTEtMzY0MDYw_3b185e4c-a2e7-426b-aadb-be560a0857ec">213</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( <ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" sign="-" name="ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtOS0xLTEtMzY0MDYw_81e16cdf-382f-4566-8b41-135d15a9b9dc">215</ix:nonFraction>)</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Objectives of the use of derivative financial instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi uses derivative instruments to manage operating exposure to movements in exchange rates, and financial exposure to movements in interest rates and exchange rates (where the debt or receivable is not contracted in the functional currency of the borrower or lender entity). On occasion, Sanofi uses equity derivatives in connection with the management of its portfolio of equity investments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi performs periodic reviews of its transactions and contractual agreements in order to identify any embedded derivatives, which are accounted for separately from the host contract in accordance with IFRS&#160;9. Sanofi had no material embedded derivatives as of December 31, 2022, 2021 or 2020.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-75</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="icdbeab8535a64f24af400e578e0a9a6e" continuedAt="i267a088d83ba4187a33b96b3f84a120c"><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Counterparty risk</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a description of counterparty risk, refer to &#8220;Item&#160;11. &#8212; Quantitative and Qualitative Disclosures about Market Risk&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">a) Currency derivatives used to manage operating risk exposures</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a description of Sanofi's objectives, policies and procedures for the management of operating foreign exchange risk, refer to &#8220;Item&#160;11. &#8212; Quantitative and Qualitative Disclosures about Market Risk&#8221;.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MTM_3fdf7a64-77ae-4210-a75a-bd084dac6f7b" continuedAt="i36eb0b2bee6e4955a0de564a8cec2246" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows operating currency hedging instruments in place as of December 31, 2022, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which derivatives designated as<br/>cash flow hedges</span></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which&#160;derivatives&#160;not<br/>eligible&#160;for&#160;hedge&#160;accounting</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which<br/>recognized&#160;in&#160;equity</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2c02fd8df4a441dcb9995176d3a629bf_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItMS0xLTEtMzY0MDYw_0c11a5db-8808-42e5-8a5b-cc72ab67d456">5,403</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i72c3586a9fd0496ba3bc0f02039968e7_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItMi0xLTEtMzY0MDYw_64dd074f-db48-40fc-a4f0-e2ed9809219e">49</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5c9d5d1deb134833b4e2036bf3f18d5a_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItMy0xLTEtMzY0MDYw_be48beda-601b-40bb-8a6f-2e97493e6e11">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i10922d814e24467cb216f9da5b9d4241_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItNC0xLTEtMzY0MDYw_2e0a6888-54dd-4a8a-b7c0-477e3b2aee83">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie786e671f2514434bb2cc23e067013a6_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItNS0xLTEtMzY0MDYw_a5d7ae3c-7681-49ed-891b-d5a97226d1c0">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id08df1158473419092d42e5efbd09182_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItNi0xLTEtMzY0MDYw_60bbf029-7126-443c-a85d-db80c1253ec5">5,403</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3077a750c45649c4b6777546b6550f85_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItNy0xLTEtMzY0MDYw_e21a0288-81d0-464e-b41f-7274355b08fe">49</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i670bfd8fbb1f496cb197f8a8d7aead50_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtMS0xLTEtMzY0MDYw_c104684c-756c-46b3-a247-9a56b7e8df42">2,732</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib47972465c6744dbb2af277f58822cc3_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtMi0xLTEtMzY0MDYw_158ae203-5e9b-41d3-8e6b-8d11de336248">56</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1515e825367145dab2111f5b97ac20ff_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtMy0xLTEtMzY0MDYw_e1f45f7c-a4e6-4f62-abf6-52a344820fb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id9a877b2db5f4ef5a898f9ab4cd8c3bb_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtNC0xLTEtMzY0MDYw_a2254856-1e56-4673-adc5-1c9daef415f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5f0d14b4b851424096254509ca5ce614_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtNS0xLTEtMzY0MDYw_da8b2f79-2112-4564-b0bc-b0ccf9e7ac3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib0b930fe86134a789ba869c99ac6922a_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtNi0xLTEtMzY0MDYw_eb74a006-b2be-4b85-b967-7685ab91a557">2,732</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53b2dc71058f462a964f7f92010a94f8_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtNy0xLTEtMzY0MDYw_d3384851-4749-4375-8b48-66e777a93b01">56</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6369626ceda6440e9ae77971eb0af8ce_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtMS0xLTEtMzY0MDYw_5fdf6448-65a0-4a48-bd67-abaea4d96460">576</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i31b628cae9e04ffc99774dc92b5b02b7_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtMi0xLTEtMzY0MDYw_b8fced98-b7ea-4499-a380-d6c9d9dd5102">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1ed9108e10a7437da4ce7e1145d235d2_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtMy0xLTEtMzY0MDYw_7c910789-c111-44ee-8cb1-765238217f4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i844c3e2c764c42c38c639fff0e73a5d9_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtNC0xLTEtMzY0MDYw_e6083e14-f7e4-4ec1-8b18-271df11268eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i616809455ece420c96191218acbd4402_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtNS0xLTEtMzY0MDYw_53cd5252-4c9f-406d-a5dc-cb2d948ff700">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2600795f42b14e488938c37089a03fdc_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtNi0xLTEtMzY0MDYw_626fdf2d-9992-4bd0-b50b-180ddb78d2ba">576</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i72fe87984bc64e35af0fdf8b4f5b3af7_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtNy0xLTEtMzY0MDYw_500475f5-aaa1-404f-9dd3-609624563637">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i023e473680f74d54a9e6f6b0424ff693_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtMS0xLTEtMzY0MDYw_28ad8575-cff2-4bde-8d7a-14adb76064d3">240</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2d190f1e3f654825a7689ee2a7e9ed59_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtMi0xLTEtMzY0MDYw_86aabbbb-ee99-4851-aad9-378540c1d1e6">5</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9ea0c8b9510b4cdd91fa96778338156d_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtMy0xLTEtMzY0MDYw_9b2018c7-f83d-4799-b894-2bef3e91eb53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icd085483ffc4410e9d0c190b8c42df88_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtNC0xLTEtMzY0MDYw_66400ddd-0e0e-41a7-9cbc-f201135f8e0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i386b0ada740d403b80ec57b202d9925f_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtNS0xLTEtMzY0MDYw_ad12712c-388e-4ca7-8e3f-ff8b3025ce07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8e328aedd84b49a29a910cbaa90fbe33_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtNi0xLTEtMzY0MDYw_89c81acf-2127-441b-b187-1ea3ac18d6f8">240</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4781504261424f1e922ae06f843e805b_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtNy0xLTEtMzY0MDYw_b0defa29-0673-4b5b-ab88-03dbaddd84c2">5</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i34e173a6429643fbb1fc2fe0c4485b3e_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtMS0xLTEtMzY0MDYw_f2332907-c946-42e2-8881-b2cafd83e148">180</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic08ec36e888244fc9d534271f013c502_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtMi0xLTEtMzY0MDYw_0cea637f-1786-44b1-892d-f30a1410af50">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id22287e14b1647b7b35da64ef2a0bcd0_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtMy0xLTEtMzY0MDYw_ba584c9b-fd12-45a0-829e-a3dd91412ddc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i554177ec4f184e20b73e2d228590a9f5_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtNC0xLTEtMzY0MDYw_f038ca30-e768-4599-a9f7-b431dad8cdbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2bbeb6793ff24719922e66a138d80cb6_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtNS0xLTEtMzY0MDYw_3349b646-6cd2-42fc-9278-4263fd8e200e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7f8fdd2d956b482b956d8f11d789446d_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtNi0xLTEtMzY0MDYw_7e4321ba-4c6c-4925-8cce-22d8efe8f53b">180</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i490e720986f8468298889ed58d2712f6_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtNy0xLTEtMzY0MDYw_180613bd-f649-44f4-ba3b-2a1781d6ad7b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Korean won</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i736a15874177466a8cdf1da7d0053f24_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctMS0xLTEtMzY0MDYw_b92d7c54-508d-4eb1-8538-da76bbdf3791">179</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3a7f408bac704d3190ff4e36dacdffd1_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctMi0xLTEtMzY0MDYw_c415844c-fcac-4e56-9152-05adfb4242a1">14</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0ff96e7abe6440fa939c031c8fda0ea9_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctMy0xLTEtMzY0MDYw_07fc7cd6-5a3a-41d7-b5e4-84496b5c87cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i833ebae90f784a20b1d78388fc99a799_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctNC0xLTEtMzY0MDYw_f1b5a810-8233-4eed-9ae0-6a37f3758b6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i55b54f75fd784f738ba0c199ae6088a1_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctNS0xLTEtMzY0MDYw_b8850004-3675-44f5-9c9d-29769095bf7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc588cc6b9f54f1d963f8d24ad61d2ac_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctNi0xLTEtMzY0MDYw_3815cab6-503c-438e-907a-4ff965c7bfee">179</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i255506009ec44c939308e99a6b52e9f1_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctNy0xLTEtMzY0MDYw_65c24928-2c27-4e27-9f21-606728407bc3">14</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7d7af22b9f714cb2ac911c16230f1007_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtMS0xLTEtMzY0MDYw_ddfb059b-bd58-492b-9da5-8a1b2e0e120c">3,459</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id027bcc05cc942509383921729fab6a8_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtMi0xLTEtMzY0MDYw_44533952-40d2-4088-af20-3246326fb781">27</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i876113a89cb44346a3da543cb98fe7ae_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtMy0xLTEtMzY0MDYw_ce07cc35-a54e-4931-96f3-90724d66df16">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i34bc3f2e19ed40ab8850869c31eaaf6c_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtNC0xLTEtMzY0MDYw_5e7b6d16-44ed-4a74-9909-0340d228d7e7">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9e0dfe2b1623470f91db3c18ce68dcc4_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtNS0xLTEtMzY0MDYw_b01de91f-f484-4299-8615-f74d1d719c78">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8ba2fcfafbe54bd7bf7de2bb6f55eaba_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtNi0xLTEtMzY0MDYw_5eb31ea8-5337-4c9f-a644-65e09f097cd7">3,459</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i22da51d7b0254bd880ea050847a615f1_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtNy0xLTEtMzY0MDYw_b51e7741-38d3-4ec9-b4d5-6315209eb339">27</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idaf9617caf734e5585971e11ab4b6606_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktMS0xLTEtMzY0MDYw_33550caa-3129-4258-8ab7-1ea1ea727153">2,047</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i35ea3b55ed754a60a864ed8442dc2c4e_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktMi0xLTEtMzY0MDYw_0268def0-9960-442b-a149-6938d669204a">21</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia8566044ec104b54875bbc56afc2d6c6_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktMy0xLTEtMzY0MDYw_06bb3d11-d912-415f-9db7-fdf5467519e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia61ae8b4b03e49bba08e79f0b7a8f8c3_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktNC0xLTEtMzY0MDYw_2a1f0bfa-49b0-477a-a635-2fcfad65938f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c24dfa0a78b4e9d9bc86d6f52203580_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktNS0xLTEtMzY0MDYw_5d02db16-e0cf-4545-93f4-f66f5696131a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i548e00dab5dc4ee7bdbfe1756bcb7839_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktNi0xLTEtMzY0MDYw_3e62940a-c900-460c-bbfe-eed8a4f2764d">2,047</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia0c5b59aa68d49298a45a2a610f5c5e0_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktNy0xLTEtMzY0MDYw_83f18dbf-227c-4f42-a0f3-bdab6925d278">21</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic9668fa019664db492a7ff6c75a6318d_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTEtMS0xLTM2NDA2MA_57673d05-8dce-48e2-8a13-e9ba18f28ad1">375</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i97148636de194a33893bec4aee4aa41c_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTItMS0xLTM2NDA2MA_2193c325-874f-4c90-b346-9d1b6e66975f">7</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iecc031691818425087e6d05be7c7c9bf_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTMtMS0xLTM2NDA2MA_0ba37539-da0c-49d9-bdca-c90127a8a4b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ieff7a0389c9140eb879d380758dff38a_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTQtMS0xLTM2NDA2MA_9bd0c6e6-77ff-40e8-81c1-2bc2f77517b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1d0dcd53f94b45319eafd4558d70f360_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTUtMS0xLTM2NDA2MA_d6d8dcfe-e3bb-4f6f-9837-3c0be7c37fc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a186c3f32f5484f8ac45bfb18dc2330_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTYtMS0xLTM2NDA2MA_75ebf7a3-3a9d-46a8-acaa-c0f320576095">375</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1ea8e0414ea34508ab58fd08342971ae_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTctMS0xLTM2NDA2MA_11412cfe-1711-4c39-9f2e-be3b7b7bf1a2">7</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iee6addbe47a440138b52bf3611a17ceb_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTEtMS0xLTM2NDA2MA_c55f6b0b-dbed-4078-8f4d-ce2858066b1c">142</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb5f65eb694a459d87948dc73311f144_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTItMS0xLTM2NDA2MA_414a236f-7ec0-4786-a96c-cbd55f69cd79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icab460a6e7e941308427a83c3d253601_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTMtMS0xLTM2NDA2MA_eabc7b42-c9cb-4ee9-be57-b988584de3a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9e4cadaf5b0845cba7f9cde445b6c92a_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTQtMS0xLTM2NDA2MA_0c719e44-63be-4b90-98c5-bc536e09ce01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i900cd87f4c904d21a069da0f48a921a7_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTUtMS0xLTM2NDA2MA_ece14a2f-9a49-48c5-9f45-7659ab83559c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8e3485983e3542ef8b9c5940a6e4d2cc_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTYtMS0xLTM2NDA2MA_a3f4728f-6d94-4afe-8804-0dbc5e68faa3">142</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2bd90408fdb848f4a168d4d2dcbc0549_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTctMS0xLTM2NDA2MA_22c7be0f-2d01-476b-9251-ae2103ceac71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Korean won</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i614be5021c604d959a144279ba0b4526_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTEtMS0xLTM2NDA2MA_51f8425f-4ebd-4cdd-b4d7-39e88c3728a4">130</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5bae6aad36b1448fa535c41175f48601_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTItMS0xLTM2NDA2MA_182c69f7-b9d6-49f3-834f-8eac227113b2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7276b76a402b473f9e7c127ecbf662be_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTMtMS0xLTM2NDA2MA_0b05cf09-109e-4117-a6f2-4b8d63d86a20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i93c37d30370944a2826ff37e9d34e8a0_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTQtMS0xLTM2NDA2MA_0cb07e7f-f71d-49be-88c3-1903fd46a5e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i589c2dbf17b348879dc721a9525fc177_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTUtMS0xLTM2NDA2MA_7c2667bd-813f-4ab4-98fb-458c0e70e9b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i50449c405d664c4dbd84b341ea3b257a_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTYtMS0xLTM2NDA2MA_2840739d-6f90-4650-b6a9-bbcefddd8332">130</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5ab17fcfc4d84fa99bdf75244c2ebf9a_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTctMS0xLTM2NDA2MA_d1acc2bb-6bf2-447c-bd61-578ca6663afb">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Taiwan dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iad4ce0de849d4cbab8c710e2aed2c4b2_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTEtMS0xLTM2NDA2MA_4f35967d-8ecd-47cc-a457-8dddda3f6f32">84</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0d052a4d832444a98b95347523810eae_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTItMS0xLTM2NDA2MA_ccbc00d5-71c6-412f-b5b0-3c0d22b3b518">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaf8f1eeaa8714aa7be4e39be402dcc41_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTMtMS0xLTM2NDA2MA_22ebfbb3-a0c6-46a3-b462-27508b6c2468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2cfdfea2209d4ccbbc523a777b090e42_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTQtMS0xLTM2NDA2MA_e823b13b-994a-4e98-bb71-5a7fb7a3e0ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i90a937537aa44ba09a3f7643066da725_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTUtMS0xLTM2NDA2MA_37521cc5-08ed-480c-80af-1f606c3b763b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i48b4da387756465aa5c44aacdc958949_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTYtMS0xLTM2NDA2MA_31310fbf-a2eb-4875-a768-939e9368631d">84</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i38fc2554622a4d10a204d1c010febc3f_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTctMS0xLTM2NDA2MA_820f6036-2c8f-48c3-bfa5-c45fe398a357">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i48e2f84695a246b1b0d8229ae8e26267_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTEtMS0xLTM2NDA2MA_f9ee8548-3515-4cf9-9191-d22ae09bed1f">8,862</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i922eeb9c64b04920a294d8178d09fe8b_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTItMS0xLTM2NDA2MA_c1e14887-407f-444e-8075-2c183a7d4437">22</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i73a34cffa66544deb36e7732558b3762_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTMtMS0xLTM2NDA2MA_be4cda09-52ec-44d8-b328-5b28324aa435">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i97c8f085dafb45a2992095d4c7dae629_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTQtMS0xLTM2NDA2MA_6c0e237b-9c42-4ecb-bcac-15caeb4362c4">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i682f1cd2c61447218a7903da70602a00_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTUtMS0xLTM2NDA2MA_3780ec94-8ec1-4bf1-a330-09fd6a8abdfe">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16bad98d4d934e91a14f1d7988740778_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTYtMS0xLTM2NDA2MA_9417c64c-81dc-4085-96d2-b22cd27fbaa3">8,862</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ideb5cf2c7c144e379dcc2ea51539478a_I20221231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTctMS0xLTM2NDA2MA_997d2e8d-57a4-423c-ad6f-9b96f58de2ad">22</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows operating currency hedging instruments in place as of December 31, 2021, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.907%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which derivatives designated as<br/>cash flow hedges</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which&#160;derivatives&#160;not<br/>eligible&#160;for&#160;hedge&#160;accounting</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which<br/>recognized&#160;in&#160;equity</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iee1024eeb9314f339e519f511c666ea0_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItMS0xLTEtMzY0MDYw_b1cbc8b9-a752-41f3-b6b8-3f6a90793327">3,912</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5a170b12241f484083d21f6e5794807e_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItMi0xLTEtMzY0MDYw_18f2d657-73c1-41e2-9a5e-53cc0d2cfbf0">4</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1f9c05daae0d40f886aa6ba7000ba3ff_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItMy0xLTEtMzY0MDYw_eb281d51-0b17-47eb-a229-fa8a62bb0b43">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i64087778cca74bc4a526a10b569636b2_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItNC0xLTEtMzY0MDYw_4d5cd652-4886-498e-80f9-bd6ee8953d02">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i20618940d10145199825568865ca8d66_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItNS0xLTEtMzY0MDYw_0b2822a5-bc20-4ae6-b7d3-c2be35e22b34">&#8211;</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i854bab973a0144a9aea65d7db2440733_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItNi0xLTEtMzY0MDYw_70bb02f4-cec3-42bf-a5b5-ed09ae4801e1">3,912</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iffcabbbf635b4fd992b8a41b9510b915_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItNy0xLTEtMzY0MDYw_dc285cff-3df5-409b-be0e-8b08ba969170">4</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4f2ea65d6c9a47f6814f3d31cd2df80c_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtMS0xLTEtMzY0MDYw_15b7e78f-bdb2-43cc-ae3d-87980c44df8e">1,392</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0a1f01f9052d425aa69dcfe3b06dc17c_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtMi0xLTEtMzY0MDYw_0fcf9673-fe58-4ddb-a3a7-bb870f501f40">5</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i183f0ed5ed164cb5b4ea5ee09dc73278_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtMy0xLTEtMzY0MDYw_1e797b30-4c34-4f2a-aef5-504ace6769be">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idaf0eceeae6d4eeebbc0e8defaee5b65_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtNC0xLTEtMzY0MDYw_395029d8-61a1-45ba-b532-63b3a8fb324d">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie2fe78b5e0fa46828e0f0ab6e8f5bd07_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtNS0xLTEtMzY0MDYw_1f8f08cd-2e01-4b2b-a0a4-0f965517d00d">&#8211;</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0dc453015c43417f8a310403dafbf8fe_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtNi0xLTEtMzY0MDYw_ebcd3854-a485-407c-bfbf-95ac9e4f2d4f">1,392</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i07769fdb0fe34d908e96c647c0db6d12_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtNy0xLTEtMzY0MDYw_3328280a-e608-4cfa-a51c-7f8116eda95b">5</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if36d1070ee9d4489a4cade29dd0771b2_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtMS0xLTEtMzY0MDYw_3d25df61-f925-411c-bb0e-707504babc82">665</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i384079b1f8bd40cca5b521eecc67173d_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtMi0xLTEtMzY0MDYw_f2cbdfe6-6bcb-4d37-a0b2-4f3aa34ca178">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id7d3fc2dde0f4fc1bd61c1025d30ee5a_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtMy0xLTEtMzY0MDYw_d4219776-16d1-4dba-a8ed-85403e346c00">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2e1a8164b01f454a9ef85a1f93c00105_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtNC0xLTEtMzY0MDYw_1e0390b9-a7c8-4e43-ac0f-438573a80908">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i35ccacb194c94c69b5d085bc5ff5e589_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtNS0xLTEtMzY0MDYw_ab15fb6d-2d2f-48de-b089-3d771f97fc1d">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if4fc30d0563c4651b04f28750beea307_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtNi0xLTEtMzY0MDYw_1ffcd02f-6947-40b7-bd0f-cd3ce3ec37ec">665</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="icc51c3a8b7fc41a092d0d1730df7f963_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtNy0xLTEtMzY0MDYw_0bdfafcd-2714-4498-949c-f26ba6ae12ff">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7a90a0ef0ed4c3b8eb42178924b637d_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtMS0xLTEtMzY0MDYw_6bc34a48-16e5-44ff-a2ba-bc1de485b959">355</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i471fcc10e8564dd98a67fb349fdc3a8e_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtMi0xLTEtMzY0MDYw_036cc176-807d-4339-8798-a0a19449a9ab">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i18559c6c0cb3430ca0132b84801f9e99_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtMy0xLTEtMzY0MDYw_722d2143-137e-47be-81fa-3e84bc4d9830">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iac26642cffbd4b2999baeeb3a1685db5_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtNC0xLTEtMzY0MDYw_9b8d0817-11cf-46eb-bd90-4dd01ca76b4b">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib23b2da676d5492e802ac4c812a506f2_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtNS0xLTEtMzY0MDYw_9c0c79ea-7bd9-4904-a944-f811726e602e">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5da383083c0c4afda0ee7c969ad8b27f_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtNi0xLTEtMzY0MDYw_b5d79e8e-f134-426a-81df-d2a98d17f1ad">355</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6dada3962cd44c1da2ef4a630f6b1ed1_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtNy0xLTEtMzY0MDYw_33a2a508-308d-4f1e-ad4e-90a2649008ca">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i434e5e043aa94881a6a3e2eedff9adc9_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtMS0xLTEtMzY0MDYw_e109d0f3-71e6-4305-9660-8927dc6169ad">199</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if34f2b53c7d045a18844b31f4a900e41_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtMi0xLTEtMzY0MDYw_74e71daa-622c-49cb-84af-ad581cc3cd06">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i894a76d0d7de48e58253294db3627dac_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtMy0xLTEtMzY0MDYw_01f98019-4887-4405-bb0a-482615c47cae">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id9c39b6d14e84ae4b1b24e007a9e3786_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtNC0xLTEtMzY0MDYw_ba80d230-03aa-4710-ad07-88c3aec792b4">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc12122f258749a5bd2e6732f1d304f7_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtNS0xLTEtMzY0MDYw_5be5407d-7234-4891-a126-ebd28d04c8c7">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ida1a51f00f9f43e2addea3cff1a8fe07_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtNi0xLTEtMzY0MDYw_5407fc5b-4c6e-45a2-ae0a-701e21bb493b">199</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5281a2a2dd074a66a4481d353042fc10_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtNy0xLTEtMzY0MDYw_416ec122-783f-45ae-a2ce-5b79a5d0db99">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Taiwan dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="twd" contextRef="i930fc256127049c79f51ecf59663a752_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctMS0xLTEtMzY0MDYw_8ca0aa18-26c9-4cc9-936b-9e646d5eb66f">122</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="twd" contextRef="id5f5c206bbe041ae839e26cfe2a55dd9_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctMi0xLTEtMzY0MDYw_202c5923-f380-4037-931d-e7321d625675">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="twd" contextRef="i837cfe78d2b645d98705c95b25994752_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctMy0xLTEtMzY0MDYw_07f6d2c3-f149-4cb9-97ef-e92db5573d1a">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="twd" contextRef="i7ab3ed6ee531495f95aea44cf44b1526_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctNC0xLTEtMzY0MDYw_4d43a1ad-f848-4b92-988e-fc05f5272ad4">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="twd" contextRef="i6e0e7ef8f62a445ab7615b93e8c6e5b5_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctNS0xLTEtMzY0MDYw_ee5dff43-55df-406a-9e10-051e0e4ae088">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="twd" contextRef="i3ebf4555124a4b54be1588e86a3da403_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctNi0xLTEtMzY0MDYw_358825be-26c0-4fe9-bff4-13f29a0c5d97">122</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="twd" contextRef="i193a8989856645a48abe7f92509a5f9e_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctNy0xLTEtMzY0MDYw_242bd023-7ba6-45a9-a9e5-3a59012891dd">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic80c137f25e045a9822774580063fe84_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtMS0xLTEtMzY0MDYw_2e8e6778-077e-42db-87d2-db86cab97522">2,374</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia18a712428304812b70e53d9693ee063_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtMi0xLTEtMzY0MDYw_9d405723-19ea-4195-b49e-db87c748bbcc">6</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7109eb1c65b04a438909883fca4c7d28_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtMy0xLTEtMzY0MDYw_5c6da555-937d-41be-873c-872f8930f7ac">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic5f09375512f4606be23527c48462237_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtNC0xLTEtMzY0MDYw_5bc38de3-9d66-4fd0-9fde-15b022d39242">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if2cbb135c3a0433ca0c3b69c5501968f_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtNS0xLTEtMzY0MDYw_619126c6-da6b-45e6-a141-f0c967afdcca">&#8211;</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2a0830338f724cbdb4b9b9bfd6adeda3_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtNi0xLTEtMzY0MDYw_8bd86792-ad47-4ae8-9cda-b329530e76aa">2,374</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia56a7d86f76a4d05b6d08eae7ee6f6bd_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtNy0xLTEtMzY0MDYw_067cc671-d4e3-4d26-88eb-d3eefad9698b">6</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if71d9bd7d43e496e93db1925af2e1b60_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktMS0xLTEtMzY0MDYw_46d39f2c-6f0b-4b10-9c0f-446d77735a13">833</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic2a16b777ba940a4ac181e8a001d2faf_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktMi0xLTEtMzY0MDYw_122165cc-4476-4fef-8781-6b87c76a1729">2</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4903495579f44e64ac57f0cc1e2d7ad9_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktMy0xLTEtMzY0MDYw_4a7f37c9-0f30-46c6-8fd0-a66a0bb1ba62">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if2c01ed8a41d4db787af4ee204db1fdc_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktNC0xLTEtMzY0MDYw_1e3a16ed-0f35-451c-bd84-ef732d00464d">&#8211;</ix:nonFraction></span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iec6eb2436d6e40a0a872d2bbf400d795_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktNS0xLTEtMzY0MDYw_e45b82f8-9497-4222-b3ad-a2ddb1caebeb">&#8211;</ix:nonFraction></span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8106356ac1984ab9be68b54b74eb94cb_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktNi0xLTEtMzY0MDYw_5f76e0eb-fb04-45ff-9a00-08f791b251f2">833</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ica7586eadbbc44c880e8d163aad962c9_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktNy0xLTEtMzY0MDYw_23fe358e-f669-4c3f-b9e0-95e6a0bbf824">2</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i044093d165864adcae409f5f0044ffbf_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTEtMS0xLTM2NDA2MA_147a067c-8329-4b72-8d11-da68a6bd8ad4">696</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i51dd419d2cd9485bae987d880a7bcdf0_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTItMS0xLTM2NDA2MA_8a9efba9-605b-4b0f-9eb5-17ecb3fb2b3c">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia5324129041d4c7a8cffd51b410c8dff_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTMtMS0xLTM2NDA2MA_ca84f517-12e7-47a8-b6d1-9379daa7cca9">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i302a876c87b44ee3a7af953022d71a40_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTQtMS0xLTM2NDA2MA_961b6ad8-51f3-4d79-bb55-383732406636">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3825d70a3a964b628a2d61ffeb07d222_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTUtMS0xLTM2NDA2MA_ef3cfacb-6cd7-4073-a54b-9a745a659473">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i10d98c3b5e3140ec951a12de228261fc_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTYtMS0xLTM2NDA2MA_24556685-c5e7-466d-b050-b64c7aa787f4">696</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibacaf6d36f6a46e6b159f5aa7231b80f_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTctMS0xLTM2NDA2MA_5db95563-a05a-4301-8990-6f30373356f5">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i36c63ba9c19349b1b82e245f1b2c64d8_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTEtMS0xLTM2NDA2MA_870c8315-2ade-44bb-b678-fdb00fee230d">255</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id0abd8e7f1e841f7ada74773a2015b61_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTItMS0xLTM2NDA2MA_fff29a34-9b77-4080-8d19-3232e3272f09">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie1c9d16b1d5543db83b717cb805a3054_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTMtMS0xLTM2NDA2MA_e0f5c36c-3cb0-46e6-aa81-5c33373145e2">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie53d539627af4726a35780f1cc08e507_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTQtMS0xLTM2NDA2MA_ad1dde83-4d3a-42ca-924e-f41c109e8423">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id73c46ce75c74139a8bcba359c49f997_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTUtMS0xLTM2NDA2MA_33b2952a-8230-490c-a268-06b69843c784">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i456a2daa913c419c8e6c1a03257e474e_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTYtMS0xLTM2NDA2MA_58ae4ede-95a8-4787-8836-cfba94bf39a9">255</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifbca91ac9abf4c87a69b47abbd03d727_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTctMS0xLTM2NDA2MA_74a3dd69-3906-4bcf-9be9-f7c1d8cec4a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Hungarian forint</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e4f8aee86404215976b9646e9d9edb6_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTEtMS0xLTM2NDA2MA_308daaf9-9029-4d5b-b14d-25fd2ca9691e">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9d14b72ec254084ba3095230da92d21_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTItMS0xLTM2NDA2MA_65539509-fa37-436a-915c-d630077e43aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4f99799f7a8d4e2d84ecd1fff82653b5_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTMtMS0xLTM2NDA2MA_3c46a1d2-c2d4-4eb4-be34-07408f5c911b">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibd3753fbe0a74c589d523cfd5c6b89fc_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTQtMS0xLTM2NDA2MA_54ce0978-aa9a-4c2d-88ed-7f2281431650">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i054783a0dd0a4f84aa2d451d39159d7d_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTUtMS0xLTM2NDA2MA_b432b6f6-c481-4b10-9a48-cc9ca69ccf23">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icad712c978144c3084e0faa45a0c85ef_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTYtMS0xLTM2NDA2MA_ed8a8be0-e983-4182-ab0f-9dbac495a965">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b8b8a03c8b14a00b47b0e84291b29d7_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTctMS0xLTM2NDA2MA_057df03b-e4ad-4610-af6d-628c25d46bfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Russian rouble</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9928943949d54771ad5e72bd36d1e3ff_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTEtMS0xLTM2NDA2MA_6eb966cf-d40d-49bf-b56d-6fa7f1efed4f">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6586fee6173645e78e13348b13791844_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTItMS0xLTM2NDA2MA_6f1dda37-5be5-4c55-a70d-fe0d8b9d912d">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i545bd8a737bf4fb3af3076a7c330b2c0_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTMtMS0xLTM2NDA2MA_c083adc2-f633-4d4a-94d1-17e9a7c217e9">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i602ce8f41d414b48b5a84661a31d706c_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTQtMS0xLTM2NDA2MA_7cc6a5db-d5f6-4fe9-b077-a654c6487683">&#8211;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i027058e0a496449eaf197cdfafc45b2c_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTUtMS0xLTM2NDA2MA_f9c1f160-f239-46af-961e-81ecdad89238">&#8211;</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i34b226c1622a45528a50ce7d8f2d8fb5_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTYtMS0xLTM2NDA2MA_2f352d43-2ae6-489b-847d-ea188042f009">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i73141eca736d4bc5afd3a96cdac8bbef_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTctMS0xLTM2NDA2MA_25d6211d-154f-4a9d-a213-deee9a3095f8">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i56bcc4da86dc4c3e9d1f700ddb1fbd10_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTEtMS0xLTM2NDA2MA_a1d9cf27-c10d-496e-a71c-4c225c80707a">6,286</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic6fbda346e6a493cb16800f488f83cc2_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTItMS0xLTM2NDA2MA_0a983f28-2576-4b90-bcd3-5b8c40cf30c3">10</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib6ea9e1f7b784baea9d9e983ef781098_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTMtMS0xLTM2NDA2MA_2f0478fd-f63d-42fa-8b6b-a58e11d13636">&#8211;</ix:nonFraction></span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0872c944abfa45428950a1bd06308fb9_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTQtMS0xLTM2NDA2MA_a5e87aea-b23f-4de0-9a4c-1603c85390f1">&#8211;</ix:nonFraction></span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if75a6d9165a94a1cbf4f47aa2183cdaa_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTUtMS0xLTM2NDA2MA_c447af7a-e383-438a-926e-6a9bb478af55">&#8211;</ix:nonFraction></span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia6b4d5b53fda43ea851ebdc43262033d_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTYtMS0xLTM2NDA2MA_2daa2880-db3f-4847-ba08-26f51452a523">6,286</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i95d0c7bc51184d8e8639aa78338ad663_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTctMS0xLTM2NDA2MA_3013f870-b639-492d-95c2-9c7548ff4709">10</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-76</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i267a088d83ba4187a33b96b3f84a120c" continuedAt="iacf444cbd038439697e37244b5bc5541"><ix:continuation id="i36eb0b2bee6e4955a0de564a8cec2246"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows operating currency hedging instruments in place as of December 31, 2020, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:20.339%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.921%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which derivatives<br/>designated&#160;as&#160;cash&#160;flow&#160;hedges</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which&#160;derivatives&#160;not</span></div><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">eligible&#160;for&#160;hedge&#160;accounting </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which<br/>recognized<br/>in&#160;equity</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4c5ef4bfd1f14291bfa73144e9052516_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItMS0xLTEtMzY0MDYw_2266e871-d443-49a4-b708-178ad48eb90e">3,477</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i486d9cec4cb24d9da261820e6f2216cd_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItMi0xLTEtMzY0MDYw_2ab0ee7b-de8d-47b8-b5cb-fc9991309222">7</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib51cb586079a4e04bbd72dcec69da0bd_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItMy0xLTEtMzY0MDYw_b0a8648c-3c93-4220-acda-9b633f1acfc5">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5697cb7cf4d04dfc8add48c1c94cbbaa_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItNC0xLTEtMzY0MDYw_ce743d45-e0ee-444f-a711-4c40b8cbc1ff">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i34aa0682772c44b4a0ff76dc79d28958_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItNS0xLTEtMzY0MDYw_167cf99b-e7e6-4b64-a000-760bc271f9ea">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0a8cb6cb5af547b28dce285b9c653502_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItNi0xLTEtMzY0MDYw_13392a45-8936-47fa-bc3b-39a948a9e2be">3,477</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e76f8051bde43d3a56dc6270370a1b2_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItNy0xLTEtMzY0MDYw_5bda88c1-1294-4743-9720-0dfae47f0760">7</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i147b071b30a142d6810201f12247d61b_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtMS0xLTEtMzY0MDYw_defa79d7-339c-4b26-9720-3542f5165be4">1,367</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9f071c0f18bd445eacee2517362cdc08_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtMi0xLTEtMzY0MDYw_8fd5327b-4ab5-44b8-8f6d-16098d9780de">10</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i181e7ef5bdff4cf6876e51eea6ca820c_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtMy0xLTEtMzY0MDYw_34bdd684-8c94-4247-8966-134bd7062a63">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibf14d2129bc34c2bb2bdb6c97085b4d8_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtNC0xLTEtMzY0MDYw_288a6228-24c0-4b14-b7a4-400bcfe4d9b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3db42c94517e4705b4da1eed3d57e340_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtNS0xLTEtMzY0MDYw_0b178518-a45a-4b53-97f2-2afbfdcca55a">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i252c5890b2344a738c0f89c1f5f5c87a_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtNi0xLTEtMzY0MDYw_43f52bc1-b91c-494a-85f0-fab31a19edeb">1,367</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4346d9e3152d432bb116ca1410c35048_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtNy0xLTEtMzY0MDYw_f3019df0-39c2-42c4-9eff-5cd1ca10f862">10</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2a69b4b219ce4e26a3a79c96b68b5c95_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtMS0xLTEtMzY0MDYw_01012951-b434-415d-b54e-768a15c5a621">521</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id227c1ffc144495b9c6a929875311feb_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtMi0xLTEtMzY0MDYw_f0541911-d20f-4acc-bc56-a01a5927f137">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2257aad4e93045328f47a96258ab2005_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtMy0xLTEtMzY0MDYw_129be358-7ef6-45b3-85d0-341a95967711">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4037de80178a4bd687c7efac29bc15d5_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtNC0xLTEtMzY0MDYw_79949615-cb7c-4463-8fd5-dd27912746da">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia4f7f8938c7042c39938f0852b1bca3a_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtNS0xLTEtMzY0MDYw_0bcd07d2-c9fd-4686-bd55-c6ecd14bd329">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89025c2ce61749fe87850d73eded6ec2_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtNi0xLTEtMzY0MDYw_e083c84b-3137-44e3-883d-9c422e474015">521</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9be9642933af42f8b0cd6d23298b5018_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtNy0xLTEtMzY0MDYw_8a7622f8-b12d-41f9-832c-2918bff56042">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4ae1d237af784d4f8fa137d708f60517_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtMS0xLTEtMzY0MDYw_ae393912-0414-4665-b084-9320cddf8c4a">287</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1ffbb59d6cc44d84854b689b538ed0ce_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtMi0xLTEtMzY0MDYw_48832345-8279-42e9-a024-aa285f092779">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibae1a4d3dba24ffba6d892dbaa92e78a_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtMy0xLTEtMzY0MDYw_bf16c9a6-2766-481e-b6a1-3da49587467c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2d0474adac6b45b1a78fc524e09f71de_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtNC0xLTEtMzY0MDYw_1c062039-5962-4906-96c6-78f504e3cd95">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibc5ec7415a4f46fd80b575baa7648a15_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtNS0xLTEtMzY0MDYw_098ed3b7-0562-4bdb-a1a5-6c5fe4645551">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief09a86e6cd4415eb08a6914a33e295b_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtNi0xLTEtMzY0MDYw_1f10bb6d-03aa-4395-8334-4774d4e41fd9">287</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if4ccb84c532546b9b5869e4d9f81c989_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtNy0xLTEtMzY0MDYw_7b87bf72-d55d-4e9d-a0e4-f6d491b6e3b7">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic7b4d7c8c509402c8eca5e791875f3c9_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtMS0xLTEtMzY0MDYw_b64219f2-99bf-426c-8211-c3ce75340d12">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic3431bfe1daa41098f327267164dd835_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtMi0xLTEtMzY0MDYw_a102bc23-bae3-4a31-ba1d-147e5b15a77f">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia9e5de3ab1f64c9ab3bdcb2c553d1039_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtMy0xLTEtMzY0MDYw_c6e7995e-e1cb-4678-bf0e-cc8df8a8aa8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27152c3f2bae46278e43f8d1a81dd8f1_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtNC0xLTEtMzY0MDYw_9f550ccf-e088-42bb-8bb7-ac630c0385b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i840dda0508654caba7f51026ebdafdd4_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtNS0xLTEtMzY0MDYw_ec6f9527-f0c5-4fa1-b78a-73b79fee5ac6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d0481cacd274b2fa681c5bf9890a2b7_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtNi0xLTEtMzY0MDYw_54fad63d-93b7-447b-8309-1c5b591a599f">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3906596ab71d4692bfd9c38d60ea6188_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtNy0xLTEtMzY0MDYw_cdb6d7ad-7194-40ea-97ca-614823fc6ed2">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Mexican peso</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i58183268ba544f91b20e9bc30b6797b1_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctMS0xLTEtMzY0MDYw_5e53268d-0d76-45b2-9821-89ec43061812">121</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1f96ec8ab49a456fb96eb444552e80b7_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctMi0xLTEtMzY0MDYw_751e9c53-a222-4d88-921b-3f54ec025441">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia344078238f4464196932e8c0a5ab334_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctMy0xLTEtMzY0MDYw_f3406888-3228-4f8a-b485-e08cfeb78dfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i68cf8057519245799cdf12687b2a6f93_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctNC0xLTEtMzY0MDYw_25a20743-5dc5-41fb-9208-814a3be55317">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i37726d73b17249feaa902d38b48653b8_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctNS0xLTEtMzY0MDYw_287c9197-14c2-44f8-8187-1ec15bd86bac">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2c91d2ed118d4954bc375ef4b66d5e48_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctNi0xLTEtMzY0MDYw_a0250001-e75d-4fff-b306-683a4506d037">121</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7e1cdda7b2be454db539353df19db57c_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctNy0xLTEtMzY0MDYw_4aa0cd72-80c2-4899-8296-8696bfbae461">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5bc3cb9493e1444f82f06a80cb7a29d5_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtMS0xLTEtMzY0MDYw_d5ced4b5-f7b5-4594-b7a6-a7d34369245c">1,932</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idf56910613674139b60ad8c9e882447b_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtMi0xLTEtMzY0MDYw_33a71c5a-ceaa-4c44-a771-e3fdffb6d6a0">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id7a02300cd2f47f99a98237e0dd5a58f_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtMy0xLTEtMzY0MDYw_5c39f8c3-23a3-4dd7-9d28-5392ce7954eb">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i07e6a5b18f544c01aaa9836f457f7bd1_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtNC0xLTEtMzY0MDYw_4d90c5df-98fa-4270-aa22-da2a54a8c222">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1195cba0e9c94a3699b59f45259287a5_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtNS0xLTEtMzY0MDYw_7610cc37-ee46-424b-b589-b403646e2355">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6dda0ea5c90b4325865f424eeb8327d3_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtNi0xLTEtMzY0MDYw_8e9cd712-ab7c-4b92-9fe2-8604d2929049">1,932</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia8e6703b549e47efa32fac9619c9ae51_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtNy0xLTEtMzY0MDYw_e439df81-fb0f-47b3-821b-ffc9e200e3f2">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6bdf7cf5cfbc4d09bc7c7ce7da7a3262_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktMS0xLTEtMzY0MDYw_b04554be-998e-413d-8b92-e27c3ac1684b">580</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id0415e276f844457af7bd49394e36866_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktMi0xLTEtMzY0MDYw_9daa001b-0a21-4f42-83a8-ae4f3c0795a5">1</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i99eef181a9e24ffc834f4feda4476a7a_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktMy0xLTEtMzY0MDYw_6633d993-706a-48ce-abe5-cffa9ca95372">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1c698af52bd241a89b377b3e2aa21704_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktNC0xLTEtMzY0MDYw_58df45a8-7527-43c3-8cff-759abde8efef">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iba0b876a446f49b586a44a97e9d18648_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktNS0xLTEtMzY0MDYw_c4dfd284-bfa5-4df9-994e-0de8fa40447c">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iace2c7895f8f48599dab84606e9dce17_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktNi0xLTEtMzY0MDYw_1ecfc684-526d-40e6-ae28-bc2e4c1fe137">580</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic5e4d74fde564a0c9ea5bbbc53197031_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktNy0xLTEtMzY0MDYw_8a7690e8-0571-4f29-85ea-3c5ed81f3f8d">1</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7921f1ac6904419daeff3fe087f5224d_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTEtMS0xLTM2NDA2MA_844c1248-fcdc-44c5-8c32-dbef052abe26">571</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i88dee4ccc2704017b2c902c331437292_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTItMS0xLTM2NDA2MA_04f52af3-45cd-4866-9b3e-8cd723132735">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8d6d099311ed413981c361852e147d39_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTMtMS0xLTM2NDA2MA_ef8e2c9e-83a3-4a26-a5fe-d3096f045230">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i47fd53236cf54f4f82c3f29a86f18f6c_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTQtMS0xLTM2NDA2MA_1d53dce9-2ae9-4756-a712-4fa08d8e5a6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3d03c5a45fb74275ad0ddab937a7a0c9_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTUtMS0xLTM2NDA2MA_ed1092e7-d81a-4fb1-89b5-087699186a43">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i03f818d2869744ecb3692c1dfa0777b2_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTYtMS0xLTM2NDA2MA_66b03b94-34d8-4081-9b06-30aced9329f4">571</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i87c7d8e2747146e2801b216c717facb7_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTctMS0xLTM2NDA2MA_43864e9a-8455-47e9-9680-dd5c6611a387">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib05e9a15a2a54bceb63e80175a9eb481_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTEtMS0xLTM2NDA2MA_35eb77f2-59e4-435d-a96e-e69b96012217">286</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib2acba41953a4a5780da364938d0473f_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTItMS0xLTM2NDA2MA_6eb0ff43-a368-4497-9f5f-b2aba8166a6c">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i82128cfb81e44472a2b78b3caf2eeef5_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTMtMS0xLTM2NDA2MA_64590731-7b1e-42c3-8f4f-7b91ca0c5519">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7e05b379fae4bec9455bd5a1185a73b_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTQtMS0xLTM2NDA2MA_5f1e5b85-c26e-4920-9919-fa924f8e7f61">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5f9e8576bdae4d2f82d0d3347ee01107_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTUtMS0xLTM2NDA2MA_917ddcfd-0e9a-4326-abb9-a511e309b4ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i050b28520fab4a6f9bc88d51dfbef06a_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTYtMS0xLTM2NDA2MA_1e5b92c7-7a21-4b7a-844a-7d5ae3fdd8e1">286</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3ab71783130b4442bcae86e594469499_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTctMS0xLTM2NDA2MA_835c10c9-5bda-4d47-985a-4d36180857f0">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Russian rouble</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i15ed755082ec489cb3e55190fe799c9e_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTEtMS0xLTM2NDA2MA_033ccdc6-1f2a-45c2-ad7d-18b4b6464824">61</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2cb3114c2cfc4748bb24e171ddf88d3f_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTItMS0xLTM2NDA2MA_d4759c1d-80b6-48df-a835-7b1bbdb238c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib3fce9cf02c444aeaedf9dbb530518b4_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTMtMS0xLTM2NDA2MA_ff96b6f7-35ea-4dbb-819c-3a480dbaf655">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib880c2e4796e464d9fd6ca3f922f0c21_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTQtMS0xLTM2NDA2MA_6a43fb6b-9024-4858-8b4d-4119afad0167">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6dc8281e891142dc8ce362dd453c8adb_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTUtMS0xLTM2NDA2MA_a2ce5bb3-7b8d-4c3b-96d4-0d9c9fadb073">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6854f04e5b34f0a90f6a8809433364b_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTYtMS0xLTM2NDA2MA_7947d3c7-b142-49f3-8e14-0b87f2d5709a">61</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ide85e2c1b3c54f9b982f9dbd2e31dc36_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTctMS0xLTM2NDA2MA_a7750089-4231-4fae-9ed6-1e775d063cf8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2c053f5646db456cb456a7f6cab34418_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTEtMS0xLTM2NDA2MA_43f17dd7-6113-40ea-8422-0b33a48184a3">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i256e776c3ef949d8a602d77944076c95_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTItMS0xLTM2NDA2MA_b452a82f-a347-4b33-b7b2-8394743a96a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i669dc41a3e9d430285a05154e6987cfe_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTMtMS0xLTM2NDA2MA_3fa7db3a-ff61-422e-996d-83e26c4f655d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9f760561a25c455ca863173bc85ba050_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTQtMS0xLTM2NDA2MA_1530ab67-13ef-4457-aa28-822376384e2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1f736a955d6d426fa14bccb7f20423fd_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTUtMS0xLTM2NDA2MA_783601f9-815b-4a4e-9a42-dae01655d4c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27e3afc8cd9a466b85b73154f1fcc426_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTYtMS0xLTM2NDA2MA_2a96f860-1ac7-4430-957f-7a5aa0eff95f">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id8b931a3e7974af8baab435cd83f842c_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTctMS0xLTM2NDA2MA_07e92dba-a12c-4ffe-b344-d23d9239ab33">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6ee14014d724beba49280ee27bd0579_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTEtMS0xLTM2NDA2MA_dd029795-767a-4427-8508-cd0b6dfab56f">5,409</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i079d026d077e4c1ca6b37005c231329a_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTItMS0xLTM2NDA2MA_055c9a93-0e6c-4c90-8f66-7aca45cfe4e7">7</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6bf8f4e0a00a442d95a5b6f57d0965db_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTMtMS0xLTM2NDA2MA_1470878b-15d9-484c-b167-e7f0eef1b16f">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8dbfe93bcc924f1db627a13c4e7d0036_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTQtMS0xLTM2NDA2MA_158fa0b1-c423-4606-a98e-94aab68bb686">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5129bf60276249ea8a7084e5aa6f5c82_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTUtMS0xLTM2NDA2MA_6eb47db2-bbe9-4b7d-8a5e-66349634510f">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i98b58c7d8626470da2fc804347bb6886_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTYtMS0xLTM2NDA2MA_b9c1a386-7d66-4c61-a210-907e3a7ca7f4">5,409</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2960e5bbc9504987a45ca0885c28f42e_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTctMS0xLTM2NDA2MA_5a49cf8f-2cfb-4de9-9ac1-c9cf6fd0f5eb">7</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">b) Currency and interest rate derivatives used to manage financial exposure</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a description of Sanofi's objectives, policies and procedures for the management of financial foreign exchange risk and interest rate risk, refer to &#8220;Item&#160;11. &#8212; Quantitative and Qualitative Disclosures about Market Risk&#8221;.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MTQ_8603fb9e-3f3e-47e1-aa42-f8b17cab2dbf" continuedAt="iac0261e28bd44999b274cdad396c01ce" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows financial currency hedging instruments in place, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:22.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.178%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.178%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.178%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.249%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2c02fd8df4a441dcb9995176d3a629bf_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItMS0xLTEtMzY0MDYw_0853c04e-4ae0-4385-b032-6d0d7236bde9">7,559</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i72c3586a9fd0496ba3bc0f02039968e7_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItMy0xLTEtMzY0MDYw_7537530a-8c94-4b7f-bdc5-69be8eb53b43">66</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iee1024eeb9314f339e519f511c666ea0_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItNS0xLTEtMzY0MDYw_4d986e78-cce8-477e-ad06-c1fe907cddb7">7,655</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5a170b12241f484083d21f6e5794807e_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItNi0xLTEtMzY0MDYw_6b0b5916-b207-4bff-a543-27abb0f9cace">15</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4c5ef4bfd1f14291bfa73144e9052516_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItOC0xLTEtMzY0MDYw_dd7a881a-3808-4dec-bc86-ac029ed3784f">5,064</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i486d9cec4cb24d9da261820e6f2216cd_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItOS0xLTEtMzY0MDYw_d27f4099-082e-40cc-83e9-a90b5dcd8349">10</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bbbfeca962641258e5e78ffca35be1c_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtMS0xLTEtMzY0MDYw_a4b59e0d-e19e-4648-9aea-c8ca774c4644">6,114</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2efe7553ba0c46a08b7712adb8057d20_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtMy0xLTEtMzY0MDYw_fabaa311-955f-4975-bc47-edcec02c650a">59</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8ea8eeea954c47c9a00eb5c671577819_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtNS0xLTEtMzY0MDYw_a6868c96-0b99-4e12-a2e7-9b5665e7efae">5,384</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id972eac7d0f34a4a884e97419ab42e7b_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtNi0xLTEtMzY0MDYw_349bb58e-d49b-49a1-8c9d-46fc2df85517">23</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if037f28f69f94e49ae8653fe85139f4f_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtOC0xLTEtMzY0MDYw_ae2e7580-2e54-4b98-a542-f33aa1cfdaf4">3,721</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib1df7d3e3f334428885ea11342334450_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtOS0xLTEtMzY0MDYw_645786f6-dde5-48c4-9e7e-3ad9fc9423b7">20</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Pound sterling</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a8231394bbe4689b1cbffe0f2e8bd63_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtMS0xLTEtMzY0MDYw_2cd38e3f-f532-472e-b178-ba2c37f37427">384</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1ca8b2205d5e44f28738ffac6b5a6556_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtMy0xLTEtMzY0MDYw_94b46dcb-02d2-47e6-afc2-7caf2c3fd706">7</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i004c9565807d44089939621542e2100f_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtNS0xLTEtMzY0MDYw_da8d8cf9-0d45-4f37-8cb9-38189ed9b888">309</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ica05527dd8e340a49bb52e01b20aa348_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtNi0xLTEtMzY0MDYw_895166c1-49e9-4733-8858-79ef8be97fa1">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie6009351116f4a2c9676eee17f694438_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtOC0xLTEtMzY0MDYw_612ba90c-2436-4f42-8d77-13c86b52af3d">257</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i861fbccf765e48598186ff8685f2297a_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtOS0xLTEtMzY0MDYw_28fcbfab-2c85-4f01-926c-8f1ec995a9c5">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic28b8006d92e44a99432611f84570817_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtMS0xLTEtMzY0MDYw_02d94db3-2758-4b9a-a86a-b04ea7cfab3d">203</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8eaa77b9d15142e09240ccba86255414_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtMy0xLTEtMzY0MDYw_efb5cb7e-0ea9-41b3-8787-4325129784f1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i64c5dbb2401d4d34a576efb6df99ddf8_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtNS0xLTEtMzY0MDYw_141fd8b5-8ab6-4664-9996-a6acc035e269">70</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6ecb8839526441e789fcc73987406208_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtNi0xLTEtMzY0MDYw_95499462-8990-4251-b604-a4667181ae18">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i94437cc84d09476a840a8eb6ec207dae_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtOC0xLTEtMzY0MDYw_ff668bb1-57d4-48d3-b9b6-f2c624de6309">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic79ef551074942af9ecbdc5716db6ce2_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtOS0xLTEtMzY0MDYw_2600052d-32d3-470a-a914-aee575c49fd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7d7af22b9f714cb2ac911c16230f1007_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtMS0xLTEtMzY0MDYw_6b77bcf5-ff5e-43fe-a918-0b03050e4d23">4,997</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id027bcc05cc942509383921729fab6a8_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtMy0xLTEtMzY0MDYw_b3be0f1c-d1ca-4629-a0fe-4737017ffa12">24</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic80c137f25e045a9822774580063fe84_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtNS0xLTEtMzY0MDYw_7670dc1e-d157-4405-932e-4f318d2f5d60">9,293</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia18a712428304812b70e53d9693ee063_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtNi0xLTEtMzY0MDYw_6f12f799-bb03-4505-8e5b-0ad97b195c4a">197</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5bc3cb9493e1444f82f06a80cb7a29d5_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtOC0xLTEtMzY0MDYw_d0af4cd4-be2c-4f37-880a-6ce3d1bd1a0e">9,004</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idf56910613674139b60ad8c9e882447b_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtOS0xLTEtMzY0MDYw_e79af7a2-6bf0-4ce0-8dd4-52a39b07159a">226</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ieb40125de23e47f4b691beb3f8caaf8a_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctMS0xLTEtMzY0MDYw_bf758038-7d0c-455e-a927-a2aed24202f7">2,011</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(b) (c)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic710cde7f07241878fb45bc80807b33e_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctMy0xLTEtMzY0MDYw_13ea73ca-fdd7-4290-bd32-2ee1ec458d24">4</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie43506936ad84ce5a6554679ac752b3c_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctNS0xLTEtMzY0MDYw_126fa42a-5d13-43c1-b900-b01be1fc61d3">4,816</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i09d9373e22c04796932fe109e2e7e74a_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctNi0xLTEtMzY0MDYw_e0291ea9-37bd-453d-96b9-1a864c415f8b">128</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie5ccc85c23444dce9bae65bbd26a864a_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctOC0xLTEtMzY0MDYw_fa207fb0-c335-4833-b361-98bbba27e4a4">6,068</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9e84a1e2fa8d414cab3bdca6d9e37a42_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctOS0xLTEtMzY0MDYw_aa937e54-bd29-42bc-941c-ee977b63d17a">200</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i85aaa6f19d1c4e41892f9efb28e339cb_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtMS0xLTEtMzY0MDYw_ba777cab-deda-4f34-8314-4c4447e702fa">2,154</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(d)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i55b98a7738694729859cf1f701a3036c_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtMy0xLTEtMzY0MDYw_cd429bb1-38c8-42aa-8c12-5b0c4f4576cb">22</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9cfed40ed16b475a994112d539fb98df_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtNS0xLTEtMzY0MDYw_458f6ed5-03c6-4285-84c0-5bc55cb40074">2,910</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7e141872c7da4fd0a0923c8056541885_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtNi0xLTEtMzY0MDYw_d9697297-551b-48c7-af9a-66c7b30bb44e">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id35af5750eb94d1194ede73371ab7443_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtOC0xLTEtMzY0MDYw_a69f4689-36eb-4381-b38b-7f9bf3c0b356">2,250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i227270b1fc19499f93797d6f9434612c_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtOS0xLTEtMzY0MDYw_aa5b10e1-7dae-4223-8f04-06ca757c0bf1">27</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie029e1cca2a447a4a3a3fab3f837ab58_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktMS0xLTEtMzY0MDYw_4e472ef4-cb1d-4936-81d4-906efbb8b771">205</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id4f729e37a504044b70b5df154cba02c_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktMy0xLTEtMzY0MDYw_8de6d4e2-39dd-41e6-8789-05edd947c919">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7e5347dec1084a829aea7d78ec58effa_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktNS0xLTEtMzY0MDYw_fbca9e15-9b09-4dd6-9e3d-fc0b6a194954">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i44dc35f3195448b4a394aa1a99ee422d_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktNi0xLTEtMzY0MDYw_57af6035-298d-4f36-b97c-63dbc100fcff">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ied6aa1c882654c8f9b00c1a4695ec3e0_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktOC0xLTEtMzY0MDYw_bd97c3ca-3e4d-42f3-855f-ce4342fee9f5">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic171ffaf34c443418e622acadcc523a5_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktOS0xLTEtMzY0MDYw_052f3d2e-af55-4e21-93f0-31ad71dc0db0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i48e2f84695a246b1b0d8229ae8e26267_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTEtMS0xLTM2NDA2MA_dc35abed-13d4-4f31-9f13-1fafd03b9077">12,556</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i922eeb9c64b04920a294d8178d09fe8b_I20221231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTMtMS0xLTM2NDA2MA_5c618631-6205-4fdb-bf6e-6ed38002baac">90</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i56bcc4da86dc4c3e9d1f700ddb1fbd10_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTUtMS0xLTM2NDA2MA_e93b6090-254c-4f2e-a8fa-f065eddb8515">16,948</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic6fbda346e6a493cb16800f488f83cc2_I20211231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTYtMS0xLTM2NDA2MA_491106aa-e272-4c58-b095-abbcde6adcc3">212</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6ee14014d724beba49280ee27bd0579_I20201231" decimals="-6" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTgtMS0xLTM2NDA2MA_69652966-829f-44c5-b928-e0d5d8f9b182">14,068</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i079d026d077e4c1ca6b37005c231329a_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTktMS0xLTM2NDA2MA_5f01f3ae-9fe5-436f-896d-ef281486032e">216</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes forward sales with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="ifbad1a772c8243ff9be90c4d20a4e525_I20221231" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzIzMDc_f2948394-323e-42eb-8dd1-2d025bb851df">3,615</ix:nonFraction> million expiring in 2023, designated as a hedge of Sanofi&#8217;s net investment in Bioverativ. As of December 31, 2022, the fair value of these forward contracts represented an asset of &#8364;<ix:nonFraction unitRef="eur" contextRef="ifbad1a772c8243ff9be90c4d20a4e525_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzI0NjY_f10d64e6-9dfa-4723-b9cd-fd4400752c03">38</ix:nonFraction> million; the opposite entry was recognized in "Other comprehensive income", with the impact on financial income and expense being immaterial.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Includes forward purchases with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="ie0ec4b8e46114ca2b35eaca06a75d8c3_I20221231" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM0MDI_096ca510-c685-4292-9d6d-f763cab38c5a">1,000</ix:nonFraction> million expiring in 2023, designated as a fair value hedge of the exposure of $<ix:nonFraction unitRef="usd" contextRef="ie0ec4b8e46114ca2b35eaca06a75d8c3_I20221231" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM0NzQ_096ca510-c685-4292-9d6d-f763cab38c5a">1,000</ix:nonFraction> million of bond issues to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of &#8364;<ix:nonFraction unitRef="eur" contextRef="ie0ec4b8e46114ca2b35eaca06a75d8c3_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM1OTM_7d1275d7-7bee-4852-8795-5f489e2b1b55">3</ix:nonFraction> million, the opposite entry for &#8364;<ix:nonFraction unitRef="eur" contextRef="if6f16cedceff4ae3b093541f0395f25f_D20220101-20221231" decimals="-5" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzgwODE0MTA0NjUxMDE3_1bee202e-996d-4923-8991-f0202719b3d2">0.6</ix:nonFraction>&#160;million of which was debited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting treatment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Includes receiver currency swaps with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="if49ca5a45afd4b6290deff09c0f6bc9b_I20221231" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM3ODA_2be33d06-2a7c-4d21-9d95-ba1248b19cbe">1,000</ix:nonFraction> million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the swaps was a liability of &#8364;<ix:nonFraction unitRef="eur" contextRef="if49ca5a45afd4b6290deff09c0f6bc9b_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM5MzQ_4e2d9292-cbe1-4185-b17d-4e029b996978">2</ix:nonFraction> million, the opposite entry for &#8364;<ix:nonFraction unitRef="eur" contextRef="i06dc5a5dfd664b289378fb47e3556afb_D20220101-20221231" decimals="-5" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzE5NzkxMjA5MzA3MTM2_9402f37b-895f-4745-b5f1-41c44027c931">1.4</ix:nonFraction>&#160;million of which was credited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting treatment.</span></div></ix:nonNumeric><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="iac0261e28bd44999b274cdad396c01ce">(d) Includes forward purchases with a notional amount of SGD<ix:nonFraction unitRef="sgd" contextRef="i661e3141aef34374bc5a4c2b0282a005_I20221231" decimals="-6" name="ifrs-full:NotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM5OTg_8c814ac9-1b6b-4f43-b835-05ae21d91e3b">1,500</ix:nonFraction> million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/SGD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i661e3141aef34374bc5a4c2b0282a005_I20221231" decimals="-6" name="ifrs-full:DerivativeFinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzQyMjI_ad1955fb-2b65-4339-b4fd-c577bcd7e37e">33</ix:nonFraction> million, the opposite entry for &#8364;<ix:nonFraction unitRef="eur" contextRef="i11d47edbce414914a613eb9ba3ddd387_D20220101-20221231" decimals="-5" name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzE5NzkxMjA5MzA3MTUw_60df2c78-9362-40fd-a8cf-8cc4aa859239">2.5</ix:nonFraction>&#160;million of which was credited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting treatment</ix:continuation>.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-77</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="iacf444cbd038439697e37244b5bc5541" continuedAt="i2af20d3102a54eabb6cd1a83ee0dc08b"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MTA_f2dec5a5-9b1e-4f5b-8ab9-b74bed31c28b" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows interest rate hedging instruments in place as of December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:17.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amounts by expiry date as of December 31, 2022</span></td><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"></td><td colspan="6" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>designated as<br/>fair value<br/>hedges</span></td><td colspan="9" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which designated as<br/>cash flow hedges</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>recognized<br/>in equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive <ix:nonFraction unitRef="number" contextRef="i15aff7b3369844169fb17236f6500876_I20221231" decimals="4" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246NjcxYTRlNzZjM2E5NDI0NDhjMWU0YzQ5ZThkZjg3OTZfMTk3OTEyMDkzMDAwNjY_b82dccda-2b64-40a1-957a-fe4623d263aa">1.03</ix:nonFraction>%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i18a2fd58cbc9469c87f4b9177e7354bb_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMS0xLTEtMzY0MDYw_ccc98bf2-6a7e-4769-95b4-25f4b1dfa4fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i895f035f5ef54ff6a621aa415748dd18_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMi0xLTEtMzY0MDYw_f04c5c9d-6d94-4cdd-9d6b-c002b0ae2e67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i069619337dbc4ccc847e26e6b2556b7c_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMy0xLTEtMzY0MDYw_2a2796ac-1a9f-4e45-8601-d7312c405180">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i893adc22890b4055af537741a376b6f4_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtNC0xLTEtMzY0MDYw_ee32c9a4-2497-4515-8eb8-c1d0239b0fb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i04a837a3f9b545248b617c5023b8eca8_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtNS0xLTEtMzY0MDYw_6ffca81c-6a1a-4328-ad6d-bb92ac668ec8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if03b358d41cb407d8e96408c4edd4151_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtNi0xLTEtMzY0MDYw_cd745a89-042f-4ef6-a756-8b757eefb2fb">467</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iee9d3e0b60fa489ba2e1a59ccd300754_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtNy0xLTEtMzY0MDYw_ff59c573-e243-449a-b58f-60372f08266e">467</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idb30bf0b28ef4c6eb5494ffbe2ef90b3_I20221231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtOC0xLTEtMzY0MDYw_244efd3e-698d-4b96-9475-a851b105e208">62</ix:nonFraction>)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5ac4648736544d5be682b0545f039b8_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtOS0xLTEtMzY0MDYw_f502674c-554b-4805-943c-3ba4d21fdbc8">467</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7b24d6ead4f44d549106fd85b92a18ba_I20221231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMTAtMS0xLTM2NDA2MA_a6dc809f-a7fe-453e-bc8c-55e319211214">62</ix:nonFraction>)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i67dfb600319c4c0e8957725369f434bf_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMTEtMS0xLTM2NDA2MA_60698be4-eaeb-4d3a-acc8-dc70eff3270c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie9cb8f93e1b846d58430281df87402c1_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMTItMS0xLTM2NDA2MA_4e467aeb-d844-4b7d-bc75-3668aa256e78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0486b9ddaf8740c29301347caa547205_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMTMtMS0xLTM2NDA2MA_66cb1137-b680-49bb-b420-8664bd361dbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive <ix:nonFraction unitRef="number" contextRef="i436fb0a145f24198b631657a4b307c84_I20221231" decimals="4" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ODM1M2UxNzlkMjNhNGI0M2FmZTdiZGI0NDYzZDE0MzFfMTk3OTEyMDkzMDAwNjg_1d1a39d8-dbe8-4518-99fb-4d6e2058da87">1.32</ix:nonFraction>%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia0cea86ea6bc459e9837c24b4130bdd6_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMS0xLTEtMzY0MDYw_372c18d6-340b-4724-bfad-096bba7e1a9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i44734cb0c2064272a0ad777ee49ce42c_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMi0xLTEtMzY0MDYw_a29ed738-7f6a-4080-bc61-072676a87e5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0622cdaa9da64461a96fb0292ec0eea0_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMy0xLTEtMzY0MDYw_86005fd4-f227-4e52-bea7-e198cede15bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i34c19e263a4b4b1081b0aff21bbca864_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtNC0xLTEtMzY0MDYw_3ff0783a-297c-4a0b-b9c1-478161ab69c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i426ef0ef517c427a8af20107114ef8ca_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtNS0xLTEtMzY0MDYw_4c713d47-0415-4d7f-9ae0-5156725bd89a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i191f61c5f38f4bf69380a073349229ea_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtNi0xLTEtMzY0MDYw_5ef33e35-6005-40e2-aa33-dd852f96eefa">467</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8474639b23494b81bb367f15d980ea45_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtNy0xLTEtMzY0MDYw_d91f9897-7690-4068-a51b-da2aeffacfd9">467</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id5d1a7773b0f41d5865caf10d0769e53_I20221231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtOC0xLTEtMzY0MDYw_382ca98b-e499-4805-9efb-5e4dc4cb312c">56</ix:nonFraction>)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8899ba6d4f7742d8bef35ffd6e411f61_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtOS0xLTEtMzY0MDYw_b775ae1d-0a01-4e2c-ae67-fb1491263156">467</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i487c7bae36874cfa83dd6d27aeaaf611_I20221231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMTAtMS0xLTM2NDA2MA_2f850134-46c1-4c15-be02-787901e7a81a">56</ix:nonFraction>)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7c78a322e0c7481982834bec3a307bfd_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMTEtMS0xLTM2NDA2MA_a84d0772-418a-48d9-9683-ddaf960bc7b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bef3049f3174f4daeeb2b280ca9d62a_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMTItMS0xLTM2NDA2MA_a69e3087-9ee0-4973-a529-f459c06c8f5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i968d0b61e3c442b8a646491f66efac4e_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMTMtMS0xLTM2NDA2MA_bb4d0d20-a813-4fb0-8666-b4f7e4f21554">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized Ester/receive <ix:nonFraction unitRef="number" contextRef="i9adf3d9fad074a0c935d684bd36535ec_I20221231" decimals="4" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246NjRmY2QwMDc0MWQ3NDNmYmEwOTY5M2U3M2Y0Njc1NGVfMTk3OTEyMDkzMDAwNDA_1dd5aee9-df0b-4c35-bd1a-3a161cf624bb">0.69</ix:nonFraction>%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i271929f8b0414f61a36fcd512a84ce24_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMS0xLTEtMzY0MDYw_b6233f52-612f-4f71-8bd3-59c0553bbfe3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1b3b4a9f07684b9fad388a8d3257b3a6_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMi0xLTEtMzY0MDYw_caf395c4-b257-4a3e-a23d-8f4986bcdb03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7006a90210804b1eba413146a647967f_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMy0xLTEtMzY0MDYw_190607b8-c594-4633-ba5b-b0abc236b381">850</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8aa5a36243114d7492f0b3b84690ce01_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtNC0xLTEtMzY0MDYw_a992b980-8f0d-43dc-a6ed-f83fa8d7489d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i784bdfbab14c473da1d2cac7e203f118_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtNS0xLTEtMzY0MDYw_066803f8-2785-4f56-a473-1911d78b3bff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia97eb1a29ddb48e3ac11be4d8af016e5_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtNi0xLTEtMzY0MDYw_491acc6b-bbbc-4b12-a86f-f4f73b7fa95c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i480a5ccfaf0a4d619969b512824c1c9e_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtNy0xLTEtMzY0MDYw_b7edca09-ab36-4a8a-8c02-effd7f59fa7a">850</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3446baf8e2ff432d9469238fb5dc3fb8_I20221231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtOC0xLTEtMzY0MDYw_6087f393-b9f9-4e45-b609-a05f8581873b">43</ix:nonFraction>)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8e35d2d09ed94351a8a81acaa3338261_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtOS0xLTEtMzY0MDYw_c810db6c-cd9f-4950-b2fe-3631c00b118a">850</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idc8c65ed2128473a8828f847b40cab4e_I20221231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMTAtMS0xLTM2NDA2MA_946cfc40-8cb1-479d-b599-a6c829be37df">43</ix:nonFraction>)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i60f42132b5024da096b34e23a312678e_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMTEtMS0xLTM2NDA2MA_b5721471-c0ea-409a-a953-2eebb8233a8e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89aae2d2b1504df39f88a1146257c96d_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMTItMS0xLTM2NDA2MA_cc8d19f6-722f-4d53-acd4-5089101d66d6">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8ebe9e98e9c944fa9ac489f3e3801729_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMTMtMS0xLTM2NDA2MA_6a05d4ce-3fc5-41a5-a842-3144b30fa6ea">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized Ester/receive <ix:nonFraction unitRef="number" contextRef="i6c18a7ae7ef14a598a9312096c25ded0_I20221231" decimals="4" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246Y2YxZDI5NzJjZGZkNDdkNzhiZDgyOWU5NDE2YTlhMWRfMTk3OTEyMDkzMDAwNDM_926622af-e382-42f2-b587-a0b57955c87f">0.92</ix:nonFraction>%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9fef17ad4b784d198f1d2c810f5555ca_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMS0xLTEtMzY0MDYw_936995ad-b957-4728-b9ca-91283620f301">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6852770d10664fa7aa7420995a79c7df_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMi0xLTEtMzY0MDYw_34b2ffb2-b406-4df1-b43d-e93d6baca667">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3b22da99f8e242f988414e346bbea953_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMy0xLTEtMzY0MDYw_22b743e1-28c5-43d0-8250-1550b4d8b5d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i24369237e6074efaa812824f17d04b81_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtNC0xLTEtMzY0MDYw_f695d599-150e-4677-8b4b-6361042ee4be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8911505211274ebb8c960de64bb8c7f8_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtNS0xLTEtMzY0MDYw_2ddd15de-67b6-437e-84b4-7e6af0b2b3d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i415ddbc400be4e558c1b1cb09d9eae83_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtNi0xLTEtMzY0MDYw_4b4db35f-138b-4d6e-8a73-583502543f48">650</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib13971669f0845ea9bb525a15a7c1309_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtNy0xLTEtMzY0MDYw_4dd12a05-d707-4d35-b24c-b9a0006e36c5">650</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i406525a21a61478ea46cc93649d471dc_I20221231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtOC0xLTEtMzY0MDYw_e12eecdb-928f-4343-89a0-3562a91c5823">71</ix:nonFraction>)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if93b383d587447b1baa059cdf91afb22_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtOS0xLTEtMzY0MDYw_da085b75-a2ec-4265-a732-d9eba0e6ef28">650</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3bcbc6f1c89a4aee8b4962d00160fb87_I20221231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMTAtMS0xLTM2NDA2MA_e7c83bfb-ea1a-45e9-b2fd-f6c599b602fd">71</ix:nonFraction>)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4bb05a8539e2427eadb812e81fdc182b_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMTEtMS0xLTM2NDA2MA_e452ce98-189f-4a22-9280-624cc1e24b97">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c645944814e426cb0a58e0b62656c9a_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMTItMS0xLTM2NDA2MA_2cb2e67c-c6f3-49b7-8ec2-a38d74162c12">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id99d44b83ffb41fbb20bd144d592090a_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMTMtMS0xLTM2NDA2MA_5354f10a-0e96-406e-b9f9-48e6372d2a6e">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6978d30ff20b420296da0d92dac7a1e2_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMS0xLTEtMzY0MDYw_2ccf7c64-12eb-4892-8d6f-669fb20fa6b3">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5762f0e8002b4b5abe902947c5d662e6_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMi0xLTEtMzY0MDYw_1c7cba19-a17d-4cf5-914f-2e368521ed67">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic26bcbc2c757485d8d5a38c334f0d541_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMy0xLTEtMzY0MDYw_4c9cd14d-9c82-4758-bc63-e756719dce56">850</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i689b9e821d364e81a6228480dd2479ff_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtNC0xLTEtMzY0MDYw_8d85662b-b4ea-42e2-97a5-10c46a6f6bdb">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i252e89fda19345c083603752e6118f19_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtNS0xLTEtMzY0MDYw_62497395-bae1-412b-bb86-e4264f06834c">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib17a33966126400e9c099f5178ff7db3_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtNi0xLTEtMzY0MDYw_b475faf3-eb65-4918-8189-e2f069551584">1,584</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i48e2f84695a246b1b0d8229ae8e26267_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtNy0xLTEtMzY0MDYw_7ba968e5-5ddc-4472-8efe-c8aeb692dedf">2,434</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i922eeb9c64b04920a294d8178d09fe8b_I20221231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtOC0xLTEtMzY0MDYw_96882a58-4e38-4ead-916c-1847a2f235dd">232</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6c2f529934674b7699d9daf02407ed9d_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtOS0xLTEtMzY0MDYw_3fb8a811-3227-4cbb-ae2e-af4e4d03859c">2,434</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3bda9484385f4811a6cb4397402bad3c_I20221231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMTAtMS0xLTM2NDA2MA_ac3a4a2c-ebbe-4b33-a279-91e04f66865a">232</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i73a34cffa66544deb36e7732558b3762_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMTEtMS0xLTM2NDA2MA_4423e6ba-88f5-4e0b-be7f-dcb492a673c3">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i97c8f085dafb45a2992095d4c7dae629_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMTItMS0xLTM2NDA2MA_42ba49d6-e29c-4bb4-aeb3-b7cc4173a0d7">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i682f1cd2c61447218a7903da70602a00_I20221231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMTMtMS0xLTM2NDA2MA_80b58ba2-5f09-4770-a10b-af441daaa9b0">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows interest rate hedging instruments in place as of December 31, 2021:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:17.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amounts by expiry date as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>designated as<br/>fair value<br/>hedges</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which designated as<br/>cash flow hedges</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027 and later</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>recognized<br/>in equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized EONIA/receive <ix:nonFraction unitRef="number" contextRef="i1aea5e7d1f14480c9b4c2b380e13a8ad_I20211231" decimals="4" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246Y2Y1OGM4MDVjMTQzNDBkYjhhY2NkMWVjM2FhZGUzYWRfMTk3OTEyMDkzMDAwNzA_d16f40c8-5175-4c14-9822-0268f6a218f3">0.06</ix:nonFraction>%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9e1181b5e1f94eb0afab79e5ead12d84_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMS0xLTEtMzY0MDYw_ab30d9d4-79e9-4ea7-a0e2-72334f9a1f23">2,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8da9f53c8b5e4025909bce39297919f7_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMi0xLTEtMzY0MDYw_78bc0648-9f7b-4d33-b959-1d61e011376b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9237a2fe49694802969f89c436b00934_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMy0xLTEtMzY0MDYw_d801555b-bbda-465f-bcd9-f450acb254a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8d5f45eab86f43429c18bcd68ccecdec_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtNC0xLTEtMzY0MDYw_447f3250-dc35-4ff0-ad39-30ec22d33f02">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iae24cf8f5b9643f9ba49fa85b263ed29_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtNS0xLTEtMzY0MDYw_bad0f580-350e-4151-9add-ab4db1c18b62">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic1cf833a38674b19a98ce0b07e1f2fbb_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtNi0xLTEtMzY0MDYw_5ac8f1ae-bb85-4c09-b009-6bd32c01356b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i892f75e2092f4191a9eb1d67b804e93d_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtNy0xLTEtMzY0MDYw_4188efd9-612b-4d95-9ca6-0edb43de4b99">2,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i81056da6811b49d2aeff4320c2d985f8_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtOC0xLTEtMzY0MDYw_0c327da9-b4ae-4cf1-9b05-158944679507">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i231c93471cd24cd9a8425c657a55b8d0_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtOS0xLTEtMzY0MDYw_3e31bcc3-3960-496c-af4b-ec13a47732d1">2,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a751e5dfe154e47bebcd411a4556b5f_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMTAtMS0xLTM2NDA2MA_61b81499-d8bd-4071-9e40-a335aef5a30c">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8ed3a0382bac4c6dbb4f81fb8b4510c5_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMTEtMS0xLTM2NDA2MA_315f0399-50a9-443e-952a-0273af253d9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bf5b26909214f5c88e018a134323460_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMTItMS0xLTM2NDA2MA_9ab0a6e2-c593-420f-9a04-91429b4738f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie2dd4c1e5ce840daaa3939c67f591aaf_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMTMtMS0xLTM2NDA2MA_ebc79425-6f36-43b3-a4a7-a876e78c5097">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay -<ix:nonFraction unitRef="number" contextRef="i6d113eb1ff7649b097238d0d21ee6615_I20211231" decimals="4" sign="-" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMC0xLTEtNDc1OTE3L3RleHRyZWdpb246OGRmNmQ0MTE2ZWIwNDY1YTk1Y2U1ODM2ZDQzZjljMWRfMTk3OTEyMDkzMDAwMTY_d7853de8-c4d5-4762-b9ba-fd566e77977d">0.57</ix:nonFraction>%/receive capitalized EONIA</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i07fca8f6f83a40b588dc84ee11762d60_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMS0xLTEtNDUzODcz_b9416b92-0bc5-456c-82cc-3c2a43bd256b">600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia99138c4d7234b91b3fea8b6e94fa8c6_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMi0xLTEtNDUzODcz_43ea24ec-e4e3-47a9-98e5-c3bf6bf4db56">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i60b7bade7cce4c9b8fd2a07220556816_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMy0xLTEtNDUzODcz_23289a0b-885b-4436-8fec-d1968e732db6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i65eb896f1a3d432eae2f406e8163f8a6_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNC0xLTEtNDUzODcz_6fc3494e-a32d-48da-92d1-e93652f2ccc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i842ef60079fb4a788eb441c59eb01957_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNS0xLTEtNDUzODcz_205a2f14-e357-4386-bba2-5d63ba3627f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d02dedf5e2f40de9a94dc76b5057ee4_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNi0xLTEtNDUzODcz_951a9a44-432a-4f6e-add2-73dc63d934bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9f0e19dd29ee4a76a46262c50b166cf6_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNy0xLTEtNDUzODcz_9610d743-84ed-4904-810c-d95be3552641">600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i41c13ab9329b48849e3517bc4d5a7a56_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtOC0xLTEtNDUzODcz_5c10a270-ed5f-4195-97f4-678dab6f1b3b">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a6c75ffdef646cb8b9bc85acee5c836_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtOS0xLTEtNDUzODcz_e65c33af-aa95-4401-8c66-d980d0e19d02">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0e04aa67c1b64442af65cb51690fb931_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTAtMS0xLTQ1Mzg3Mw_d5cff796-1782-40e8-8a81-1233f70518e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0628e92d1cdb49db881f08e4556161e4_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTEtMS0xLTQ1Mzg3Mw_f6f269de-14f6-48fe-9f5d-7a5778c1f923">600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd23edce11d47f08572dcd6cef1c475_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTItMS0xLTQ1Mzg3Mw_eb164489-2a3c-45f8-9cab-c5837f773d40">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1160917297df4a258637aeea6cbc8408_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTMtMS0xLTQ1Mzg3Mw_bc02cfcc-1f5f-45fd-be09-865014dd51f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive <ix:nonFraction unitRef="number" contextRef="i513d59d537cf409284ea93c1d7ee3074_I20211231" decimals="4" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMC0xLTEtNDc1OTI0L3RleHRyZWdpb246MzAzNmZiNjZjZDliNGIxZjhkZTVmMjljM2NjNDVmNmNfMTk3OTEyMDkzMDAwMDU_2e12dd20-3c80-4bce-a67e-e60e1e3433f5">1.03</ix:nonFraction>%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia0be4069af744d4ebb72262d1c49c6c6_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMS0xLTEtNDUzOTg2_e454afc5-c8f5-42b1-b39a-3d4be318d4b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7406e8367d044ac6a93b02c7fd8d0d7f_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMi0xLTEtNDUzOTg2_03dc1aac-5912-41b9-aa5b-13da166db72f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic3406477180b408291805ed68b070663_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMy0xLTEtNDUzOTg2_74f4415c-e5d1-4f1d-a7f1-dff7fbb690df">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibb7e6bf403b141899b31d01fc7aad5cd_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNC0xLTEtNDUzOTg2_840db47f-7b4b-4080-87dc-c7a1c7206633">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia21c8f6607e84aeba3d97b89e5ac81a7_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNS0xLTEtNDUzOTg2_112a4f18-e788-4688-87d2-4d4214657f5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i344ad243d07147ce8a36b8ded9882056_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNi0xLTEtNDUzOTg2_5315b4d7-2f59-46ae-ae1b-db5144fbcdc4">440</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i02be206b72714d4db901c0a669d074ed_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNy0xLTEtNDUzOTg2_e62b03c0-f576-4fc0-bb0d-35974eeae619">440</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3670c40f29fa41288dc623d89f7afdda_I20211231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtOC0xLTEtNDUzOTg2_046d3eb0-d8b0-4d1a-b45f-1cba039763b4">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6287e5395dae4c4ab46cabbec24ae24c_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtOS0xLTEtNDUzOTg2_fc6edc6f-b249-49c9-9a71-11f07b2335a4">440</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic9542809101c47f08405adbf19df6a9d_I20211231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTAtMS0xLTQ1Mzk4Ng_95e71008-0e1f-4d22-bfe4-aade4e88d13e">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iba70f10f62eb4b97a7aa7d41726b6a9f_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTEtMS0xLTQ1Mzk4Ng_8f972299-a257-4bdb-93ff-861e0924bc55">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6ff7d79feeaa43ff8fea8ebcd34aaf25_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTItMS0xLTQ1Mzk4Ng_8f7c8c1e-b52b-4ad1-b0f6-e77a17acf5d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i29f59bc216884949bafcb1d15976757a_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTMtMS0xLTQ1Mzk4Ng_348343ae-9310-45fc-a014-422b773392ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive <ix:nonFraction unitRef="number" contextRef="ic2c068ebbb0a4c8c9fe94deb9daad677_I20211231" decimals="4" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246YTQ4MzY3Yzk3MDI0NGJlYTg1NmE2YjhiOWY3MzY1MTJfMTk3OTEyMDkzMDAwNjE_e3d37d1a-14c2-4fed-8250-d08bb25b06d8">1.32</ix:nonFraction>%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibef5d40bf8ab462bbc8e1f854f2fc952_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMS0xLTEtMzY0MDYw_93134084-6f76-444b-a32a-fabaa1a7c0cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaadc8f4f98bd4e31ba053344ae90a5a2_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMi0xLTEtMzY0MDYw_66f69a38-3887-48b7-9a01-5321da5b295b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ida69b1ffd6a1453b8602532bc630b384_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMy0xLTEtMzY0MDYw_bdd1f043-b9f6-4381-9b5e-226eef1c6e87">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia316589e705d4589bf786b0a1fa58345_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNC0xLTEtMzY0MDYw_84e05611-cb69-4870-abbf-7072937cefb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i83bd333ecc5a45689ebc96365daf83a8_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNS0xLTEtMzY0MDYw_0221c9ce-4373-4f5b-93b6-c85c0252897b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i14841d0962de4dcd830a6e6ec232552e_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNi0xLTEtMzY0MDYw_af955210-6f1e-472d-ba3b-eec1a8d57104">440</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib0959357ae6d442db6998d16a60afb3b_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNy0xLTEtMzY0MDYw_ebc83329-364a-4be7-a7b8-90c4aad309ad">440</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if90289f503234a0eb212cd627281795b_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtOC0xLTEtMzY0MDYw_05712e9c-2e88-4044-b57e-6d88f757c42e">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib0b2b67ce2434e4c9bb4553d177ba27d_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtOS0xLTEtMzY0MDYw_266c6825-46f1-4d52-8495-a2f1ff2fde45">440</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i696be015b6144d53970810bcddd34f8a_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTAtMS0xLTM2NDA2MA_9d1d3b54-fc6e-42ad-ae2a-4bfd2d0181fc">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idf406a436f8543afa2b07724b0e77498_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTEtMS0xLTM2NDA2MA_f190a789-be94-4e48-82c6-2ecf9d82e711">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5c3d82ed507848a7bee6b5dcfc4b9add_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTItMS0xLTM2NDA2MA_4c08e0f0-fb2d-4183-a3bc-9c7b40cfa9f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9fa0165dae10416f9360d8ef68751988_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTMtMS0xLTM2NDA2MA_7d35b50c-aa2e-406d-961c-248585e44ce1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">receive capitalized EONIA/pay <ix:nonFraction unitRef="number" contextRef="i3005470a09144e07b9520bf27a0e096c_I20211231" decimals="4" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZjA0NjcxMDRjYTYwNDdlOTk3OWQ4ZDIwMTRhOTY3MmFfMTk3OTEyMDkzMDAwMTg_7b4eda44-eab8-4970-b00a-7ee8d8d89c60">1.48</ix:nonFraction>%</span><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie3448b7dc78d4dcba65212215c69d18e_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMS0xLTEtMzY0MDYw_db6c779f-ac81-42cb-99b6-4d3afcd6a78f">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iccff00d7889c450492a7d84bcb6cd980_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMi0xLTEtMzY0MDYw_62c01ec6-91c3-4c73-a17c-f1cf7ba0183c">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i089150e0dfc24a74b7f19849daad27ef_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMy0xLTEtMzY0MDYw_75647770-4f3b-4203-b6ea-f0d4788526c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7500ac1bc0c9434c9d072c80aa083d52_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNC0xLTEtMzY0MDYw_4abdddaf-9b05-4cff-a5e8-2097810572b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63d81c82ce534a6cbe657f9d4db19639_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNS0xLTEtMzY0MDYw_f19c9a61-0d2e-46a3-93a9-39a3a1560c47">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i75edfd05889740488fd52f90caf59de4_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNi0xLTEtMzY0MDYw_ec5559bf-ffec-41f3-bf2c-d6a596456c8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0da07b9b35de4e45b2743100b13eaa31_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNy0xLTEtMzY0MDYw_bb40069d-cf98-4f49-a06d-23c005e9a6cb">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2cf262c93d024154b2d0d308743e547d_I20211231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtOC0xLTEtMzY0MDYw_128ecd26-1f9c-495b-ac35-7a44d07cc4b3">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib80b97abcc214e64a591648c1c81e225_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtOS0xLTEtMzY0MDYw_d16e4774-9f88-486d-abe8-b83b943a15c3">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i30c163ec956f41df837a5eca1f6f6b37_I20211231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTAtMS0xLTM2NDA2MA_02aee0f2-ff84-4f6d-8dc4-0e5ba3883d79">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i799cd607a2c24cbf8ce1dd45a6e411e8_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTEtMS0xLTM2NDA2MA_b14a3fbf-ac06-460b-9327-2bbc754bba01">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib09d73f6dafe467f9a1acd771011bef5_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTItMS0xLTM2NDA2MA_69a6bd47-cafc-4c01-9770-a26b5104c1b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i23f76b64e1e34fc6961e70aa8b9920f5_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTMtMS0xLTM2NDA2MA_4416f910-4589-40ae-b9fe-0f5bccb3f2a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia03794f3843a4cf3aca9226c900a741a_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMS0xLTEtMzY0MDYw_86de4f1a-6c8e-49fb-8d70-1850cc0b6b51">2,642</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie16c564bf48f4da9a2d1edd6359a8bd6_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMi0xLTEtMzY0MDYw_873fde71-c2fa-4a2d-833e-d91a93234105">57</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i704b08a911a149928d59f0fe5f3da5dd_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMy0xLTEtMzY0MDYw_5abd82b7-1208-4957-823e-7b27ae4176a8">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i84049923ad77487f9fa811c3372a7764_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtNC0xLTEtMzY0MDYw_3d40a69f-54ac-4605-804f-12431d0ce4ae">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3c40cd1979af4ea2be50a3ad38051006_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtNS0xLTEtMzY0MDYw_05e79b34-8360-4925-b26e-a316d04d6626">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1646cc36612494a895c40df0cbfdcd5_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtNi0xLTEtMzY0MDYw_59d3afe2-cec2-4033-a269-b403c03d037a">880</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i56bcc4da86dc4c3e9d1f700ddb1fbd10_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtNy0xLTEtMzY0MDYw_53fb8874-e61e-4b9d-ae5a-9df928583065">3,579</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic6fbda346e6a493cb16800f488f83cc2_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtOC0xLTEtMzY0MDYw_22437664-8e2e-48a1-8140-3838c0874985">7</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i47848bc2a7334009b78e12456fc26c7d_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtOS0xLTEtMzY0MDYw_ae58770b-f661-4e65-896e-5dfc1bc1124a">2,979</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibaa88d67818d446c976af2e5fbbe22d4_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMTAtMS0xLTM2NDA2MA_e3792463-3c2e-4696-81cd-fb7ffce86834">6</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib6ea9e1f7b784baea9d9e983ef781098_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMTEtMS0xLTM2NDA2MA_dbdb0fe0-c0bd-4862-8dd6-d77abbbee787">600</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0872c944abfa45428950a1bd06308fb9_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMTItMS0xLTM2NDA2MA_fadcbe96-cf82-4fda-92a6-e6370164795d">1</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if75a6d9165a94a1cbf4f47aa2183cdaa_I20211231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMTMtMS0xLTM2NDA2MA_f91ec6a6-ff09-4a05-9de4-3b83d51e8bb4">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These interest rate swaps hedge fixed-rate bonds with a nominal of &#8364;<ix:nonFraction unitRef="eur" contextRef="i0da07b9b35de4e45b2743100b13eaa31_I20211231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzQ4MTM_fd1fb8b1-1779-4f23-81b3-83604d8317f8">99</ix:nonFraction> million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within &#8220;Loans, advances and other long-term receivables&#8221; (see Note D.7.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows interest rate hedging instruments in place as of December 31, 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:17.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amounts by expiry date as of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>designated as<br/>fair value<br/>hedges</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which designated as<br/>cash flow hedges</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026 and later</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>recognized<br/>in equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized EONIA/receive <ix:nonFraction unitRef="number" contextRef="ic631820a8c0641ac9e9f460890aaec85_I20201231" decimals="4" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZGQ0OTNmYzMxNDQ0NGE1OGE2ZTZiOWJmMDg2NTdjY2JfMTk3OTEyMDkzMDAwMzQ_262061eb-b499-41c3-a277-1cbb72499632">0.06</ix:nonFraction>%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53cfa96ea5124d07b04df526798c7f66_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMS0xLTEtMzY0MDYw_fa21fa6e-8ec4-43f2-8bc7-eaee3588daed">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i513c01d3044b4f8abd4b146fe577810d_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMi0xLTEtMzY0MDYw_82308659-fab1-4cfb-bf1d-f312131fbd65">2,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5fa3a9c279d04c76a24fbd4bca5acf08_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMy0xLTEtMzY0MDYw_da1eb69f-8b50-43e3-904f-365c919709bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8b48e75f4c634efc8eb26e95ef3cc591_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtNC0xLTEtMzY0MDYw_ef756d96-719a-456f-a66f-d8f5f0e7df8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i063b1dc5829c4e8cb5617293416976a0_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtNS0xLTEtMzY0MDYw_f55bb0cf-c5b4-4c2d-b492-24e73c32e5b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5add9211f40f403aaf54c1ee281839d6_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtNi0xLTEtMzY0MDYw_babdf979-9a31-4426-ab60-ac8994a48759">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ieec97775a7de49ffb1a9c4cf02b086de_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtNy0xLTEtMzY0MDYw_5ca2ffcb-ec2b-43a8-bf77-943519928096">2,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i10ed642e6d39458d841e67fd6d9e99cf_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtOC0xLTEtMzY0MDYw_7d86fbfe-6114-41b6-8d7d-23aba3760179">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iebbcbd554d974218a72b9914fce1e919_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtOS0xLTEtMzY0MDYw_f67247b9-5873-45a5-8b11-c39e811337f8">2,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia9a04df3d2ef496d98b3c993e83e59f8_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMTAtMS0xLTM2NDA2MA_ca6b4b8c-3cab-4c70-895f-f92a8dcccb37">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idcac06c155c046cb8bab14fc84e911ed_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMTEtMS0xLTM2NDA2MA_52e690de-be3f-4030-863c-9516c6e14d28">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if2c043c8ca5b4070a8a9a79320cf0244_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMTItMS0xLTM2NDA2MA_463399c2-8429-4bce-9987-ca5a440c622c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7974fd34e2524ff8b37923a5ebcf26a2_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMTMtMS0xLTM2NDA2MA_122ed4e4-8aa5-4a93-8912-714c046caa17">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay -<ix:nonFraction unitRef="number" contextRef="i9039d5a648d44eb6a6285e7a8f3ed6f5_I20201231" decimals="4" sign="-" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246OTNjYjkxZTZmNTcyNDgyMWFjZTJkY2VkMzk2MGM4NGNfMTk3OTEyMDkzMDAwNjA_2b047e5b-a0dd-4947-b899-fa0bf09ffb4c">0.57</ix:nonFraction>%/receive capitalized EONIA</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5623b04048b44838b80378f94f84c892_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMS0xLTEtMzY0MDYw_952ed1d7-73b3-475f-826b-ff88f3f13929">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia6c8f8b2dc504670a6689c9e6cb5a9c9_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMi0xLTEtMzY0MDYw_b486bb81-3e58-4dfb-ab7e-fe762020d9ea">600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib968055f931a4052831d81f2d009e0dd_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMy0xLTEtMzY0MDYw_e4ea7dd8-3978-4bdb-8ba9-0c0fd0e1aa92">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4b23561502b7467e8dedcaa04bf23cac_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtNC0xLTEtMzY0MDYw_5f69cc46-3956-4ae8-8489-31e9a1b7392a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idbd6d8c2ec6646ddab12eb846faa1e2e_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtNS0xLTEtMzY0MDYw_ae8ccc68-d2a1-4d8d-98e5-19091b5f4521">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i11fe8f6851654698a4c3c1314f4cdb7e_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtNi0xLTEtMzY0MDYw_fbb0eae1-d412-4241-b135-56a9db5b174c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i74afaf7dd9d34e35b425f2ad9ab6c04c_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtNy0xLTEtMzY0MDYw_e87c3549-b67d-4f38-839f-e4f244038ff6">600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i30a27053b6e14def8c033d7349e920eb_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtOC0xLTEtMzY0MDYw_b4d894b3-8125-43c6-919c-00f235252029">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie69dcce667cd4fea93c09d624bf405e8_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtOS0xLTEtMzY0MDYw_fcee3c44-b002-43f4-8a41-66db2feb7c74">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icc9a867ba32c4f5188edd4f852728ef7_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMTAtMS0xLTM2NDA2MA_766bfab7-d629-4fdb-8911-1b6d9dca795e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if11a192ecef44797abf4e8a5c1ee30a1_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMTEtMS0xLTM2NDA2MA_e2512480-a9a7-495b-89a4-1cd2108d5b9b">600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i952a1cded8a74815937ca15f2edabb80_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMTItMS0xLTM2NDA2MA_656318dc-fd2e-4bb6-965e-a087ee0123a1">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i88a1b5f415cf464e89d9ca13ca302777_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMTMtMS0xLTM2NDA2MA_9d518329-94ff-415e-a026-f8d2bd304653">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">receive capitalized Eonia/pay <ix:nonFraction unitRef="number" contextRef="i1467f4d4b42140c2abf929b4d833c3fb_I20201231" decimals="4" name="sny:InterestRateSwapsInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMC0xLTEtMzY0MDYwL3RleHRyZWdpb246OGYwNjFmYjUxYTU2NDU5MGEyN2ZmY2Q0YzY3YTg1MTNfMTk3OTEyMDkzMDAwMTA_bf04b65a-525e-4a7e-af70-b19686e80697">1.48</ix:nonFraction>%</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5e4f05d47add459ab8040ffae65ac2ba_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMS0xLTEtMzY0MDYw_20b3af42-1e84-4631-bedf-1ac1e0bd4ff2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie62d1f5008e247f0a3ea8b6ca9f80dbb_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMi0xLTEtMzY0MDYw_c53826ad-828b-403e-a77d-d82d0e71f0b1">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i708d051a58c54e20b95d3176a3c77084_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMy0xLTEtMzY0MDYw_0fce17c8-eafd-4724-83bd-bae17ff1292b">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7b68e46221cb423b913a0db767409942_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctNC0xLTEtMzY0MDYw_ea783484-b098-45ac-be6b-fbcdb25ca806">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b9836c97a3149258a9dcf5b0cd2ffc0_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctNS0xLTEtMzY0MDYw_5472b657-8b39-4cc6-b4e4-9f9fe7cea8ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i799d40fa5c78466998a48db7ad50c332_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctNi0xLTEtMzY0MDYw_1d436331-3259-419f-8756-ae0bec8844a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i68a6cd0be59b4416bebc0edff829e3cd_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctNy0xLTEtMzY0MDYw_a8eaf688-47e0-40bc-9e41-43ee3ae96453">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id6efc8e80c8341db96a4ea42fb92ea80_I20201231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctOC0xLTEtMzY0MDYw_45db9431-0142-4a45-a265-2d3f3a9c3085">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e72356c5a114d11bd9759a87e0029e7_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctOS0xLTEtMzY0MDYw_ded89375-c61f-49ac-9bb0-bc27057ffeb4">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="idd430971a28b4ea0b9e3b9a41d1c2ec7_I20201231" decimals="-6" sign="-" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMTAtMS0xLTM2NDA2MA_0563c772-f646-4fb6-9659-71cacbfd0400">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8d96c431df54470d96145e5b8c4a4e5d_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMTEtMS0xLTM2NDA2MA_f9a89278-5832-4d5f-8e3b-143311556fda">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7f30a6b3626548d68f342ca8d454fe33_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMTItMS0xLTM2NDA2MA_367f62fb-5947-453a-8fe3-3a7cd56e3a88">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i874556ffc208487cae49386049753a72_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMTMtMS0xLTM2NDA2MA_efd4511e-3dfa-4b11-a845-c4fff26250fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id2bb50c6933e41bfb10adb4d6e458270_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMS0xLTEtMzY0MDYw_87dc511c-65ca-4f9f-8c02-38444ef98549">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8387da968c3a4fec95af79eb735152fd_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMi0xLTEtMzY0MDYw_61168d49-7575-4a3b-a076-ca1db97b4319">2,642</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib8ed54d04df74d759a8be7cbf83b103a_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMy0xLTEtMzY0MDYw_f9bb65e6-2318-4d5c-9530-1af690bb7dfe">57</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i273afa0ec4ce4433806daee6d20d5529_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtNC0xLTEtMzY0MDYw_417e7b0b-de20-4aa9-9320-1570a71b0ea2">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5f6050765a2747e59fe7bf091298355d_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtNS0xLTEtMzY0MDYw_6d2c77a4-95ab-47cb-ac83-b106b71c4c27">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7964ee5305d44c3802adf3c53126d12_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtNi0xLTEtMzY0MDYw_61c29638-4cd7-4c00-8778-adaa4c5bf42f">&#8212;</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id6ee14014d724beba49280ee27bd0579_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtNy0xLTEtMzY0MDYw_f42f53c2-1c9a-47b7-a73d-b95603d4d1ce">2,699</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i079d026d077e4c1ca6b37005c231329a_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtOC0xLTEtMzY0MDYw_b4f8f548-2336-4a58-b0b6-e8fe2ab160f4">20</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1076d751ef0a41919289d3a7fd81eb08_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtOS0xLTEtMzY0MDYw_eca79f5c-f106-4dee-9a91-e5c841625be7">2,099</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i631031048a414305b2d327250a95741d_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMTAtMS0xLTM2NDA2MA_3f6aedd4-b5cc-4900-a05a-229bcd352889">19</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6bf8f4e0a00a442d95a5b6f57d0965db_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMTEtMS0xLTM2NDA2MA_3c36a38a-1ca2-4d58-9cda-60909485132f">600</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8dbfe93bcc924f1db627a13c4e7d0036_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMTItMS0xLTM2NDA2MA_7f81cfaa-8f24-4dc8-9fbc-62ae7ccb9efb">1</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5129bf60276249ea8a7084e5aa6f5c82_I20201231" decimals="-6" name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMTMtMS0xLTM2NDA2MA_dc697623-9a03-454c-b054-46c5fe154659">1</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These interest rate swaps hedge fixed-rate bonds with a nominal of &#8364;<ix:nonFraction unitRef="eur" contextRef="i68a6cd0be59b4416bebc0edff829e3cd_I20201231" decimals="-6" name="sny:DerivativeFinancialInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzQ5Njc_7234f045-d95f-427d-8ddf-4eb4c2e35347">99</ix:nonFraction> million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within &#8220;Loans, advances and other long-term receivables&#8221; (see Note D.7.).</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-78</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i2af20d3102a54eabb6cd1a83ee0dc08b"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">c) Actual or potential effects of netting arrangements</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MjU_4aed4753-e824-4910-803b-8760c33245f5" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below is prepared in accordance with the accounting policies described in Note&#160;B.8.3.:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:31.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.081%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:26pt"><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>assets</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>liabilities</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross carrying amounts before offset (a)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i237b42e7bb904d21a79f9880001b2ae2_I20221231" decimals="-6" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItMS0xLTEtMzY0MDYw_b2e6cd0e-d513-42b8-abbc-0fd5ac9aed13">206</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iba962d9e6d694d2b8779612e3b767372_I20221231" decimals="-6" sign="-" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItMi0xLTEtMzY0MDYw_fe4aef89-ccd4-4474-bed9-c34aa757620f">326</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i155d49744d8747b49c962b6edeeeb4e5_I20211231" decimals="-6" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItMy0xLTEtMzY0MDYw_f05ffade-abb5-47f0-a03c-df2544982f8d">298</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ied2d4b521a314246803eecd8ae01786c_I20211231" decimals="-6" sign="-" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItNC0xLTEtMzY0MDYw_5d44e913-0397-4287-916a-8405b0100851">85</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id3db7e4575054274b9fb7995816583e5_I20201231" decimals="-6" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItNS0xLTEtMzY0MDYw_84489ebf-6e3e-4b78-8799-ec28af907c9e">82</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="icad7c8faf49747ac89ffe01efbd20b55_I20201231" decimals="-6" sign="-" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItNi0xLTEtMzY0MDYw_4a596ddb-7670-47bc-b336-817ff37c3627">297</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross amounts offset (in accordance with IAS&#160;32)&#160;(b)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i237b42e7bb904d21a79f9880001b2ae2_I20221231" decimals="-6" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtMS0xLTEtMzY0MDYw_dc2c6a10-3fc4-4ebf-aca1-2432bd7d3aa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iba962d9e6d694d2b8779612e3b767372_I20221231" decimals="-6" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtMi0xLTEtMzY0MDYw_1843ee26-8b7e-49d2-8a12-b14eeca9a25e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i155d49744d8747b49c962b6edeeeb4e5_I20211231" decimals="-6" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtMy0xLTEtMzY0MDYw_faf2ebd2-88e8-452b-9e77-6c1c9fd6d078">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ied2d4b521a314246803eecd8ae01786c_I20211231" decimals="-6" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtNC0xLTEtMzY0MDYw_40856321-1b96-418c-bb8a-a576203ca7d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id3db7e4575054274b9fb7995816583e5_I20201231" decimals="-6" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtNS0xLTEtMzY0MDYw_7ab2ca67-3149-44ad-9c9d-9545bd410bea">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icad7c8faf49747ac89ffe01efbd20b55_I20201231" decimals="-6" name="sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtNi0xLTEtMzY0MDYw_7e15f64f-e1a0-4d48-9eea-15a6707f96c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amounts as reported in the balance sheet (a) -&#160;(b) =&#160;(c)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i237b42e7bb904d21a79f9880001b2ae2_I20221231" decimals="-6" name="sny:NetAmountsAsReportedInTheBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtMS0xLTEtMzY0MDYw_be3cd153-d70a-4355-b159-bf25663e706c">206</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iba962d9e6d694d2b8779612e3b767372_I20221231" decimals="-6" sign="-" name="sny:NetAmountsAsReportedInTheBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtMi0xLTEtMzY0MDYw_2db27cd0-b25b-4f0b-b0eb-aef1579b3355">326</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i155d49744d8747b49c962b6edeeeb4e5_I20211231" decimals="-6" name="sny:NetAmountsAsReportedInTheBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtMy0xLTEtMzY0MDYw_a4a3beff-3ddf-41f8-80fc-e6e2c19a4608">298</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ied2d4b521a314246803eecd8ae01786c_I20211231" decimals="-6" sign="-" name="sny:NetAmountsAsReportedInTheBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtNC0xLTEtMzY0MDYw_899e694e-523a-4164-9c16-04b0f27d6ace">85</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id3db7e4575054274b9fb7995816583e5_I20201231" decimals="-6" name="sny:NetAmountsAsReportedInTheBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtNS0xLTEtMzY0MDYw_28a1f243-783f-4c21-afbd-7ad3a55ea883">82</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="icad7c8faf49747ac89ffe01efbd20b55_I20201231" decimals="-6" sign="-" name="sny:NetAmountsAsReportedInTheBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtNi0xLTEtMzY0MDYw_624ac1d5-22fc-40e7-88e4-80fcef4d997c">297</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effects of other netting arrangements (not fulfilling the IAS&#160;32 criteria for offsetting) (d)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib697f784925f45fb87aef20924b4c88b_I20221231" decimals="-6" name="sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzUtMS0xLTEtMzY0MDYw_60526792-479a-45c5-a349-c6ce1329d8dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i21c5524f40ae4628ac06cf82feac300d_I20221231" decimals="-6" name="sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzUtMi0xLTEtMzY0MDYw_d8150d80-85c3-4d89-a658-e6b5fcad6288">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial instruments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib697f784925f45fb87aef20924b4c88b_I20221231" decimals="-6" sign="-" name="sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtMS0xLTEtMzY0MDYw_e501b49f-affd-44df-ba2f-1bf343b5e7c1">160</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i21c5524f40ae4628ac06cf82feac300d_I20221231" decimals="-6" name="sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtMi0xLTEtMzY0MDYw_76101cd9-c529-4671-bad7-0402d79d2a04">160</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if160fc4f51bb485d81d5f05461afea9a_I20211231" decimals="-6" sign="-" name="sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtMy0xLTEtMzY0MDYw_166be067-b7cb-46a8-a1ff-a15576e2731e">67</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i32163ab576b64e3a95bbb62ebcbdb9cc_I20211231" decimals="-6" name="sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtNC0xLTEtMzY0MDYw_f8610a9e-2605-4b6b-8e35-b8d0cb03e516">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia952b3d7417849c8ab7c1fd9d194c90e_I20201231" decimals="-6" sign="-" name="sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtNS0xLTEtMzY0MDYw_71a4a876-8ff1-4e63-a53b-153be399f79c">81</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0d8db00ca8a8449db76cc5c3d45ca76d_I20201231" decimals="-6" name="sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtNi0xLTEtMzY0MDYw_07c1e8e2-a0ec-4821-befd-65b6342c8bb8">81</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of financial collateral</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net exposure (c) + (d)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i237b42e7bb904d21a79f9880001b2ae2_I20221231" decimals="-6" name="sny:NetExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtMS0xLTEtMzY0MDYw_a2f19d9a-d878-46ee-98c0-a700645fa16c">46</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iba962d9e6d694d2b8779612e3b767372_I20221231" decimals="-6" sign="-" name="sny:NetExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtMi0xLTEtMzY0MDYw_0812a9fd-fb62-48ef-afba-cd7db3455ef8">166</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i155d49744d8747b49c962b6edeeeb4e5_I20211231" decimals="-6" name="sny:NetExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtMy0xLTEtMzY0MDYw_4889ec13-edea-49d2-8b32-d5ed04d06f7e">231</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ied2d4b521a314246803eecd8ae01786c_I20211231" decimals="-6" sign="-" name="sny:NetExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtNC0xLTEtMzY0MDYw_b455cd05-2e44-4e48-bbce-7242d5d888ea">18</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id3db7e4575054274b9fb7995816583e5_I20201231" decimals="-6" name="sny:NetExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtNS0xLTEtMzY0MDYw_f17f72d7-b633-48e4-88b7-b4052af4d6e5">1</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="icad7c8faf49747ac89ffe01efbd20b55_I20201231" decimals="-6" sign="-" name="sny:NetExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtNi0xLTEtMzY0MDYw_10c64c6d-1619-4023-ab8e-29b6039aeadd">216</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_655"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.21. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEzODYy_eda640d8-d0dc-483b-b9ca-b6b7641814fd" continuedAt="i1b1e0fbdd393489393f1e1c89ab28eb1" escape="true">Off balance sheet commitments</ix:nonNumeric></span></div><ix:continuation id="i1b1e0fbdd393489393f1e1c89ab28eb1" continuedAt="i3da96df8446f40d584c41980682cc204"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The off balance sheet commitments presented below are shown at their nominal value.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.21.1. Off balance sheet commitments relating to operating activities</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEzODU1_abebb698-837d-4c73-9022-58f480e89e2f" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Off balance sheet commitments relating to Sanofi&#8217;s operating activities comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:48.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.008%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzItMS0xLTEtMzY0MDYw_432ddc24-6dfb-4bd4-9549-cf20e7b3c9ac">38</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzItMi0xLTEtMzY0MDYw_78781de7-f64a-4dd3-8644-3641c60933ab">26</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231" decimals="-6" name="sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzItMy0xLTEtMzY0MDYw_f6a3e99c-e082-4637-9b9d-6622ab2e6265">4</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231" decimals="-6" name="sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzItNC0xLTEtMzY0MDYw_899b6cde-3fe9-4a7e-a3b4-1ce3bdf8215c">3</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzItNS0xLTEtMzY0MDYw_cc9acf4d-7fa1-473d-b3de-b221963d0241">5</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Irrevocable purchase commitments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">given</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsGiven" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzQtMS0xLTEtMzY0MDYw_32436e75-be44-4fa5-ad85-8852c50b4679">10,921</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsGiven" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzQtMi0xLTEtMzY0MDYw_1d43a0ba-104d-4c8f-9258-8563ed2cb4b3">5,957</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsGiven" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzQtMy0xLTEtMzY0MDYw_a6a7d5a6-c17a-468f-969c-01881ea68920">2,922</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsGiven" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzQtNC0xLTEtMzY0MDYw_f77a26cf-48c6-47c3-a014-17c1893e0a3c">1,062</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsGiven" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzQtNS0xLTEtMzY0MDYw_bc7718bd-fdf5-4de9-af80-a5bb2d944567">980</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">received</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzUtMS0xLTEtMzY0MDYw_e38b36af-c918-4234-b6c9-c86914f93f81">1,025</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzUtMi0xLTEtMzY0MDYw_c7d05510-c877-4c45-8e9b-0a030ba5ae48">482</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzUtMy0xLTEtMzY0MDYw_d1a60b93-d4a3-4a87-8251-ed18f27be50c">335</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzUtNC0xLTEtMzY0MDYw_3f6d179b-b5f7-41c8-9589-6699a1a8fc79">86</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzUtNS0xLTEtMzY0MDYw_b278cd63-9501-44b2-952b-3a89c75a4b76">122</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development license agreements - commitments given</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">commitments related to R&amp;D and other commitments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzctMS0xLTEtMzY0MDYw_ed0aa7e5-02c8-4bbd-a14e-05a353c1272f">259</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzctMi0xLTEtMzY0MDYw_81bab1ac-f85f-4ef4-8bfc-9db2a467926f">197</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzctMy0xLTEtMzY0MDYw_139b8ede-7214-4322-b2aa-5a2eef99310a">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzctNC0xLTEtMzY0MDYw_dd4365fc-4927-408b-b069-07e931a799fa">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzctNS0xLTEtMzY0MDYw_5dc89916-2ffc-41b5-8e1d-84fb1a392773">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">contingent milestone payments in connection with development programs in progress</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzgtMS0xLTEtMzY0MDYw_7a1bcfd4-837d-4b4b-8863-b8bad45adc97">2,919</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzgtMi0xLTEtMzY0MDYw_720c98d4-ef02-43e2-b7f1-60d8b4d4b5e6">203</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzgtMy0xLTEtMzY0MDYw_b132bfca-4469-4c18-aa1e-a34a2d092c11">875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzgtNC0xLTEtMzY0MDYw_997e844b-2ad7-4186-9a4d-8b3e8110b20e">889</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzgtNS0xLTEtMzY0MDYw_b87f8852-9b42-4ec5-995c-894478a0d000">952</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total - net commitments given</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:TotalOffBalanceSheetCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzktMS0xLTEtMzY0MDYw_e8da3516-1ce3-475a-952b-78d753d83572">13,112</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="sny:TotalOffBalanceSheetCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzktMi0xLTEtMzY0MDYw_6461ebf3-57a9-4713-8563-7496907a4690">5,901</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231" decimals="-6" name="sny:TotalOffBalanceSheetCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzktMy0xLTEtMzY0MDYw_f8441ea6-c10f-4727-94e3-8407e406ebc8">3,505</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231" decimals="-6" name="sny:TotalOffBalanceSheetCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzktNC0xLTEtMzY0MDYw_04f26e1a-ffb6-4ef7-b65f-3145619cca86">1,878</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="sny:TotalOffBalanceSheetCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzktNS0xLTEtMzY0MDYw_26afa4de-8748-417d-8568-f1f941e53a6a">1,828</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the variable portion of future lease payments not recognized as lease liabilities as of December 31, 2022; the equivalent amount of these commitments as of December&#160;31, 2021 was &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI5Njg2ODEzOTc4Njc4_2fe92697-161b-4766-909b-ebbe16a0e050">109</ix:nonFraction>&#160;million.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) These comprise irrevocable commitments to suppliers of (i)&#160;property, plant and equipment, net of down-payments (see Note&#160;D.3.) and (ii)&#160;goods and services. As of December 31, 2021, irrevocable commitments amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="ifee9283d0d0f4705bf8cdb52374c5add_I20211231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsGiven" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2Xzg1Mw_c42f92bf-eadb-41e7-8a6a-67927d5ca9e3">8,901</ix:nonFraction> million given and &#8364;<ix:nonFraction unitRef="eur" contextRef="ifee9283d0d0f4705bf8cdb52374c5add_I20211231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2Xzg2Nw_1171beae-6dd9-412b-9528-b629f3307941">1,124</ix:nonFraction> million received.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Irrevocable purchase commitments given as of December 31, 2022 include &#8364;<ix:nonFraction unitRef="eur" contextRef="ida98673a0c314cbbb23bda8debf1c3a2_I20221231" decimals="-6" name="sny:IrrevocablePurchaseCommitmentsGiven" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2Xzk0MQ_1261ce8d-3029-4406-ae9a-1704896aa6ab">871</ix:nonFraction> million of commitments to joint ventures, and the commitment to EUROAPI as described in Note&#160;D.1.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Commitments related to R&amp;D, and other commitments, amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwNDY_69af29da-7485-4e4f-b0be-2698d825cd6d">536</ix:nonFraction> million as of December 31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) This line includes only contingent milestone payments on development projects in progress. The equivalent amount as of December 31, 2021 was &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyMTM_0d36fd4b-610b-48a9-beb2-34ffae11ce28">2,892</ix:nonFraction> million.</span></div></ix:nonNumeric><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In pursuance of its strategy, Sanofi may acquire technologies and rights to products. Such acquisitions may be made in various contractual forms: acquisitions of shares, loans, license agreements, joint development, and co-marketing. These arrangements generally involve upfront payments on signature of the agreement, development milestone payments, and royalties. Some of these complex agreements include undertakings to fund research programs in future years and payments contingent upon achieving specified development milestones, the granting of approvals or licenses, or the attainment of sales targets once a product is commercialized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The &#8220;Research and development license agreements&#8221; line comprises future service commitments to fund research and development or technology, and probable contingent milestone payments regarded as reasonably achievable (i.e. all potential milestone payments relating to projects in the development phase, for which the future financial consequences are known or probable and for which there is a sufficiently reliable estimate). This line excludes:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">commitments given relating to projects in the research phase for &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-8" name="sny:CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMTg1Mjg_ec79ef45-8b5b-4555-bc50-525e2192994d">18.0</ix:nonFraction> billion as of December&#160;31, 2022 (&#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-8" name="sny:CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMTg1NDA_867c77a5-9eb1-4f1e-827c-041ebbf68b07">6.7</ix:nonFraction> billion as of December&#160;31, 2021) and commitments given relating to contingent payments upon the attainment of sales targets once a product is commercialized for &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-8" name="sny:CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMTg2NDc_4076bb57-5625-4d78-8bed-f227623e19ab">18.5</ix:nonFraction> billion as of December&#160;31, 2022 (&#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-8" name="sny:CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMTg2NTk_91e3a305-78ca-4e64-91fe-92a87281a47b">8.1</ix:nonFraction> billion as of December&#160;31, 2021);</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-79</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i3da96df8446f40d584c41980682cc204" continuedAt="i6405410dec674c749a1825bab12d98d1"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">commitments received amounting to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-8" name="sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjIxNjM_f06bc195-2ce5-4d8e-b201-d9f628035586">8.8</ix:nonFraction> billion as of December&#160;31, 2022 (&#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-8" name="sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjIxOTE_7cf00a3a-d4ab-480b-aed4-ddc8ef58114c">5.8</ix:nonFraction> billion as of December&#160;31, 2021), mainly&#160;comprising research, development and commercialization agreements with partners further to the acquisitions of Ablynx&#160;for&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i1aecb43ad25f41bf8dc1c5d72a0787bb_I20221231" decimals="-8" name="sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjIzNDc_6660a8fe-8c8b-4e79-b801-a534a423250e">1.0</ix:nonFraction> billion as of December 31, 2022 (&#8364;<ix:nonFraction unitRef="eur" contextRef="i34de2d5f0d404fe8b61b41f862084aa5_I20211231" decimals="-8" name="sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjIzNjI_a02895cb-f24f-44c1-a12a-78cb5f1d74f2">1.0</ix:nonFraction> billion as of December&#160;31, 2021) and of Kymab for &#8364;<ix:nonFraction unitRef="eur" contextRef="i1db7d23934de4ddd846d982ab6ddd48e_I20221231" decimals="-8" name="sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjI0MDU_eb28093e-c813-43db-937e-bf374d4d78ef">0.2</ix:nonFraction>&#160;billion as of December 31, 2022 (&#8364;<ix:nonFraction unitRef="eur" contextRef="i51d7f3d541c8470e916d2b51d66890f0_I20211231" decimals="-8" name="sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjI0Mjk_cd66f872-e732-4154-8e8b-f5974f80e0dd">0.5</ix:nonFraction> billion as of December&#160;31, 2021), plus contingent consideration receivable based on attainment of regulatory and&#160;sales milestones for commercialized products under the terms of licenses or rights assignment agreements amounting to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-8" name="sny:CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjI2NjU_c218884e-1e98-4c3e-92be-5f1f12a53672">7.6</ix:nonFraction>&#160;billion as of December&#160;31, 2022 (&#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-8" name="sny:CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjI3MDY_bf14a477-3d65-4d55-8751-bdc8d9bfd95b">4.2</ix:nonFraction>&#160;billion as of December&#160;31, 2021).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The major agreements entered into by Sanofi in 2022 are described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on January&#160;7, 2022, Sanofi entered into an innovative license agreement and research collaboration with Exscientia to develop up to <ix:nonFraction unitRef="molecule" contextRef="i9a347be5f1b14fadbc39a77db3c13573_I20220107" decimals="INF" name="sny:NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI5MTM3MDU4MTcwNTYz_4b71c851-5078-4b94-8d58-bfdc79179b24">15</ix:nonFraction>&#160;novel small molecule candidates across oncology and immunology, leveraging Exscientia&#8217;s end-to-end AI-driven platform utilizing actual patient samples. Under the terms of the agreement, Sanofi made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i35f0fcaaff094ff283b1ab8503932dab_D20220107-20220107" decimals="-6" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4MDE_84d4db1a-6877-46d6-943a-c0503bf7fb2f">100</ix:nonFraction>&#160;million and could pay up to $<ix:nonFraction unitRef="usd" contextRef="i9a347be5f1b14fadbc39a77db3c13573_I20220107" decimals="-8" name="sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4MDc_c098a23a-3720-46b4-8bd3-c6b01b0178c2">5.2</ix:nonFraction>&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on January&#160;12, 2022, Sanofi entered into a licensing and collaboration agreement with ABL Bio for the development of ABL301, a bispecific antibody targeting alpha-synuclein and intended as a treatment for alpha-synucleinopathies. Under the terms of the agreement, Sanofi paid ABL Bio $<ix:nonFraction unitRef="usd" contextRef="i2ee3b5635d9a4570b0eaa9262220df54_D20220111-20220111" decimals="-6" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4MTM_c282dedc-aad1-4a97-871c-d6544031f1bb">75</ix:nonFraction>&#160;million upfront, and could make potential milestone payments of up to approximately $<ix:nonFraction unitRef="usd" contextRef="ia237d1ef26b2453a9066a2c6db45411a_I20220111" decimals="-6" name="sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4MTk_dfc13684-c18e-44ad-860e-2019b95103c7">985</ix:nonFraction>&#160;million contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on March&#160;2, 2022, Sanofi entered into a collaboration and exclusive license agreement with Adagene Inc., a company transforming the discovery and development of antibody-based therapies. Under the terms of the agreement, Sanofi made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i5bf703c7b65f49509efae3ab1093a037_D20220302-20220302" decimals="-5" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4Mjc_480d3159-f400-41dc-add4-822fcd9d32a6">17.5</ix:nonFraction>&#160;million&#160;and could pay up to $<ix:nonFraction unitRef="usd" contextRef="i8577ba8bcc2641bd8f3f948974bf77da_I20220302" decimals="-8" name="sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4MzM_98fc8a53-13f6-43d4-8b5d-dc90eda2a32d">2.5</ix:nonFraction>&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on March&#160;15, 2022, Sanofi entered into a strategic risk-sharing collaboration with Blackstone under which funds managed by Blackstone Life Sciences (BXLS) will contribute up to &#8364;<ix:nonFraction unitRef="eur" contextRef="i4e5b18318ed54f3eb42bb7d6fc7b7b2f_D20220315-20220315" decimals="-6" name="sny:CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4NDA_61e58b73-eed9-4bb9-977a-7497f808a4a0">300</ix:nonFraction>&#160;million to accelerate the global pivotal studies and clinical development program for the subcutaneous formulation and delivery of the anti-CD38 antibody Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, to treat patients with multiple myeloma. That amount will be paid to Sanofi on the basis of development expenses incurred. In addition, Sanofi may pay royalties on future sales of this solution;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on March&#160;29, 2022, Sanofi entered into an exclusive collaboration agreement with IGM Biosciences, Inc. to create, develop, manufacture and commercialize IgM antibody agonists against <ix:nonFraction unitRef="target" contextRef="iee6d0db9a6b14019a9f01106b4265553_I20220329" decimals="INF" name="sny:NumberOfOncologyTargetsUnderCollaborationAgreement" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzQwNjgxOTMwMjUzNjEw_c889bbb7-4f8b-404f-ad42-7144e2532e76">three</ix:nonFraction> oncology targets and <ix:nonFraction unitRef="target" contextRef="iee6d0db9a6b14019a9f01106b4265553_I20220329" decimals="0" name="sny:NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzgwODE0MTA0NjgwNTEw_9a84af18-b284-451a-910b-10f93cef8b92">three</ix:nonFraction> immunology/inflammation targets. Under the terms of the agreement, IGM received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i7d7acd3285a64b18bcadb39dc8467fe9_D20220329-20220329" decimals="-6" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4NDc_2f660362-f612-4292-bfb3-ba5108b42f88">150</ix:nonFraction>&#160;million and could receive up to $<ix:nonFraction unitRef="eur" contextRef="iee6d0db9a6b14019a9f01106b4265553_I20220329" decimals="-8" name="sny:ContingentConsiderationCollaborationAgreements" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4NTM_28bff37f-3ce6-432e-9c1a-dceb78734ea7">6.0</ix:nonFraction>&#160;billion for milestones in the development, regulatory approval and sales of each target;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on July&#160;5, 2022, Sanofi entered into a collaboration agreement with Skyhawk Therapeutics, Inc. to discover and develop novel small molecules that modulate RNA splicing to address challenging oncology and immunology targets. Under the terms of the agreement, Skyhawk received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i44fe2a71b5884068beea16755e096330_D20220705-20220705" decimals="-6" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTA0Nzk_51459437-9b27-47ed-9313-c5db5edaa058">54</ix:nonFraction>&#160;million and could receive more than $<ix:nonFraction unitRef="usd" contextRef="iabdcdf0ea9e54926bd844b49811591f2_I20220705" decimals="-8" name="sny:ContingentConsiderationCollaborationAgreements" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTA1MzA_53cee153-4432-4f31-bbf5-104ba95c111f">2.0</ix:nonFraction>&#160;billion&#160;contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on August&#160;17, 2022, Sanofi entered into a strategic research collaboration with Atomwise, that will leverage its AtomNet</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> platform to identify and synthesize up to five drug targets. Under the terms of the agreement, Atomwise received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i4412024b1ca64ec595944d1b8a39c157_D20220817-20220817" decimals="-6" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTk0Nzk_c8030514-c2e6-4cf1-80ef-4328d9926127">20</ix:nonFraction>&#160;million and could receive up to $<ix:nonFraction unitRef="usd" contextRef="iefe35c5798714318b57d812dd4c261dc_I20220817" decimals="-8" name="sny:ContingentConsiderationCollaborationAgreements" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTk1MzA_1cfc4a9f-86b2-46ef-9042-d0657059c03b">1.0</ix:nonFraction>&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on September&#160;27, 2022, Sanofi entered into a research collaboration with Scribe Therapeutics, to leverage its CRISPR by&#160;Design&#8482; platform and to obtain a non-exclusive license to genome editing CasX-Editor(XE) technology for multiple oncology targets. Under the terms of the agreement, Scribe Therapeutics received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i4ce31d589886460a8d3fa4ad454d29e9_D20220927-20220927" decimals="-6" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTk5NTc_2f4169b0-30c6-40a4-aad1-3fb4140c0b41">25</ix:nonFraction>&#160;million and could receive more than $<ix:nonFraction unitRef="usd" contextRef="i2e57da6edcd64cc0855f5deeb43a3a3e_I20220927" decimals="-8" name="sny:ContingentConsiderationCollaborationAgreements" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NjAwMDg_97b03108-0165-4ed1-b4c2-baac32767ebe">1.0</ix:nonFraction>&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on October&#160;4, 2022, Sanofi entered into a strategic collaboration with miRecule to accelerate the discovery and development of a Best-in-Class Antibody-RNA conjugate to treat Facioscapulohumeral Muscular Dystrophy (FSHD). Under the terms of the agreement, miRecule received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i3acc15b07f7340ec878d66dfd3f468d7_D20221004-20221004" decimals="-6" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTE3NTM_d67cc577-9fb2-41c7-b8ee-9356fa457cce">20</ix:nonFraction>&#160;million and could receive up to $<ix:nonFraction unitRef="usd" contextRef="i28364fce90bf409d98323009a8de319e_I20221004" decimals="-6" name="sny:ContingentConsiderationCollaborationAgreements" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTE4MDQ_5c5d6a6d-eff1-4fbc-9434-9311c98b0363">0.4</ix:nonFraction>&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on November&#160;8, 2022, Sanofi entered into a strategic research collaboration with Insilico Medicine to leverage Insilico Medicine's AI platform, Pharma.AI, to advance drug development candidates for up to six new targets. Under the terms of the agreement, Insilico Medicine received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i69e8fa7b0e3e42d4a5776c81a67f605c_D20221108-20221108" decimals="-5" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NjEzNzU_31bfc390-0ffa-4c1e-ae82-8954031440f5">12.5</ix:nonFraction>&#160;million and could receive up to $<ix:nonFraction unitRef="usd" contextRef="i627c20e57c964355b8bcb250eb638da3_I20221108" decimals="-8" name="sny:ContingentConsiderationCollaborationAgreements" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NjE0MjY_7520241e-a326-4215-bc46-c23c91293d73">1.2</ix:nonFraction>&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on December&#160;19 2022, Sanofi and Innate Pharma SA announced an expansion of their collaboration, with Sanofi licensing a natural killer (NK) cell engager program targeting B7H3 from Innate's ANKET</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Antibody-based NK Cell Engager Therapeutics) platform. Innate received an upfront payment of &#8364;<ix:nonFraction unitRef="usd" contextRef="i466e422ce31947d2b1f05591f8974461_D20221219-20221219" decimals="-6" name="sny:UpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTQxMDg_79b98536-265b-4f0e-bd97-a238c2492551">25</ix:nonFraction>&#160;million and could receive up to &#8364;<ix:nonFraction unitRef="usd" contextRef="i1b248f6ef872486e91c5718d675cc163_I20221219" decimals="-7" name="sny:ContingentConsiderationCollaborationAgreements" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTQxNTY_a00a3d8d-2a93-4108-bdc2-925e748142a6">1.4</ix:nonFraction>&#160;billion contingent on the attainment of certain objectives.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of commitments as of December&#160;31, 2022 also includes commitments under agreements entered into by Sanofi in prior years, the principal ones of which are described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Biond Biologics (2021): license agreement for the development and commercialization of BND-22 (a humanized IgG4 antagonist antibody targeting the Ig-like transcript&#160;2 (ILT2) receptor, in development for the treatment of solid tumors);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Eureka Therapeutics and Memorial Sloan Kettering Cancer Center (MSK) (2021): license agreement with for the treatment of multiple myeloma;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Kymera (2020): agreement to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Nurix Therapeutics (2020): collaboration to develop novel targeted protein degradation therapies;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Denali Therapeutics&#160;Inc. (2018): collaboration agreement on the development of multiple molecules with the potential to treat a range of neurological and systemic inflammatory diseases. The two lead molecules are DNL747 in multiple sclerosis and amyotrophic lateral sclerosis, and DNL758 in systemic inflammatory diseases such as rheumatoid arthritis and psoriasis;</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-80</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i6405410dec674c749a1825bab12d98d1" continuedAt="i06e04c8a829842b9bd7de13dbfe10f2b"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">MedImmune (a division of AstraZeneca) (2017): agreement to develop and commercialize a monoclonal antibody (MEDI8897) for the prevention of Respiratory Syncytial Virus (RSV) associated illness in newborns and infants;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Innate Pharma (2016): collaboration and licensing agreement to apply Innate Pharma&#8217;s new proprietary technology to the development of innovative bispecific antibody formats engaging natural killer (NK) cells to kill tumor cells through the activating receptor NKp46;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Eli Lilly and Company (2014): agreement to pursue regulatory approval for non-prescription Cialis</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (tadalafil).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and its alliance partners have decided to terminate the following agreements (the related commitments are no longer included in Sanofi&#8217;s off balance sheet disclosures as of December 31, 2022):</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in October&#160;2022, Sanofi and DiCE Molecules ended their global collaboration to discover potential new therapeutics for up to&#160;<ix:nonFraction unitRef="target" contextRef="if937d6453c6841d8b3e41feedb2e553c_D20160101-20161231" decimals="0" name="sny:NumberOfTargetsThatEncompassAllDiseasesAreas" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDg5NzA_d6b51964-1096-4c7c-a161-6b9751c187e8">12</ix:nonFraction>&#160;targets that encompass all disease areas of strategic interest to Sanofi; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in December&#160;2022, Sanofi and Revolution Medicines agreed, after a transitional phase, to end their partnership agreement in oncology signed in 2018.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, under the collaboration agreement with Regeneron on monoclonal antibodies (see Note&#160;C.1.), Sanofi is entitled to receive an additional share of quarterly profits (capped at <ix:nonFraction unitRef="number" contextRef="ia86bd221eba9446a8f9f749cb46b9a8a_D20220101-20220331" decimals="2" name="sny:PercentageOfProfitShareOnCounterpartiesProfit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzgwODE0MTA0NzQ4ODAx_d36a7bd8-7e2b-4bcf-9b78-7da0235c2537">10</ix:nonFraction>% of Regeneron&#8217;s share of quarterly profits until March&#160;31, 2022, and thereafter at <ix:nonFraction unitRef="number" contextRef="ibf593c1decbc4ca188f74599b1b99ff6_D20220401-20221231" decimals="2" name="sny:PercentageOfProfitShareOnCounterpartiesProfit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzgwODE0MTA0NzQ4ODEx_fff19d15-7c72-42f0-8aa2-c5b98d6531e1">20</ix:nonFraction>%), until Regeneron has paid <ix:nonFraction unitRef="number" contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231" decimals="2" name="sny:PercentageOfCumulativeDevelopmentCostsReimbursed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzgwODE0MTA0NzQ4ODA2_fed51c52-1a00-47fb-857c-bb23f0bae766">50</ix:nonFraction>% of the cumulative development costs incurred by the parties to the alliance. As of December&#160;31, 2022 this represented total commitments received of &#8364;<ix:nonFraction unitRef="eur" contextRef="i3ecee33decbb47918bc45c5d39b6e2d8_I20221231" decimals="-8" name="sny:CommitmentsReceivedForDevelopmentCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjM4Mzg_45bd72c3-09a0-431f-8ff4-6fd4ca49e814">2.7</ix:nonFraction> billion (versus &#8364;<ix:nonFraction unitRef="eur" contextRef="if08a539d4d40455d827bc164ddb96d57_I20211231" decimals="-8" name="sny:CommitmentsReceivedForDevelopmentCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjM4NTE_fca51858-5835-42ba-82d7-b54ea9c4d61f">2.9</ix:nonFraction> billion as of December&#160;31, 2021), against cumulative development costs of &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-8" name="sny:CumulativeDevelopmentCostsIncurred" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjM5MTQ_753daca0-e9dd-4136-b593-41ba7f2e422a">8.4</ix:nonFraction> billion.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi entered into an agreement with Royalty Pharma in December&#160;2014 relating to development programs under which Royalty Pharma bears a portion of the remaining development costs of the project on a quarterly basis in return for royalties on future sales. This transaction is a co-investment, whereby the partner acquires an interest in the jointly-developed product by providing funding towards the development program. Consequently, the amounts received by Sanofi are recorded as a reduction in development costs, to the extent that the development costs incurred by Sanofi are recognized in profit or loss in accordance with the policies described in Note&#160;B.4.1. The products in development under the December&#160;2014 agreement with Royalty Pharma have been launched in the United States and Europe, marking the end of the joint development programs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;27, 2017, Sanofi and Lonza announced a strategic partnership in the form of a joint venture (BioAtrium AG) to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. An initial investment of approximately &#8364;<ix:nonFraction unitRef="eur" contextRef="ib16cb21631ad4c40a1073da4e54006b2_I20170227" decimals="-8" name="ifrs-full:InvestmentsInJointVentures" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzExNzE3_f75066b9-cdb4-4639-8662-a355f9a00737">0.3</ix:nonFraction> billion to finance construction of the facility, split <ix:nonFraction unitRef="number" contextRef="ie9a55e06161b4bc6ab47f39f7831c794_D20170227-20170227" decimals="INF" name="sny:PercentageOfFutureDevelopmentExpenseFundedByCompany" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzExNzY3_b69d7826-27e2-4d86-810b-1b86e574edce">50</ix:nonFraction>/<ix:nonFraction unitRef="number" contextRef="if77c8aea29ef447792cb9de0a457cec9_D20170227-20170227" decimals="INF" name="sny:PercentageOfFutureDevelopmentExpenseFundedByOtherParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzExNzcw_815ce034-ccc3-471f-9dcb-ee99bf94374a">50</ix:nonFraction> between the two partners, has now been made in full. In addition, Sanofi could pay BioAtrium AG in the region of &#8364;<ix:nonFraction unitRef="eur" contextRef="ib16cb21631ad4c40a1073da4e54006b2_I20170227" decimals="-8" name="sny:AmountsPayablePartnersInCollaborationAgreements" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzExODc5_383f2ad1-cc29-467d-b79b-11c7172f9336">0.6</ix:nonFraction> billion over the next <ix:nonNumeric contextRef="ie9a55e06161b4bc6ab47f39f7831c794_D20170227-20170227" name="sny:ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzExODk2_9572e5d0-2774-4c14-8963-327704f43da6">fifteen years</ix:nonNumeric> as its share of operating expenses and the cost of producing future batches.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2014, pursuant to the &#8220;Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits&#8221; (still effective as of December 31, 2022), Sanofi Pasteur and the World Health Organization (WHO) signed a bilateral &#8220;Standard Material Transfer Agreement&#8221; (SMTA&#160;2). This agreement stipulates that Sanofi Pasteur will, during declared pandemic periods, (i)&#160;donate <ix:nonFraction unitRef="number" contextRef="i7297bd667dcc407e9d3a685feb63aa85_I20140228" decimals="3" name="sny:TransferPercentageOfPandemicVaccines" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyMzg4_8b4c308e-9fcf-41d0-8f1b-dcf8368e9e7a">7.5</ix:nonFraction>% of its real-time production of pandemic vaccines against any strain with potential to cause a pandemic, and (ii)&#160;reserve a further <ix:nonFraction unitRef="number" contextRef="i7297bd667dcc407e9d3a685feb63aa85_I20140228" decimals="3" name="sny:ReservePercentageOfPandemicVaccines" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyNTIy_c2440964-c278-481a-ad56-4870b98b750d">7.5</ix:nonFraction>% of such production on affordable terms. The agreement cancels and replaces all preceding commitments to donate pandemic vaccines to the WHO.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.21.2. Off balance sheet commitments relating to financing activities</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit facilities</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEzODU4_58c53636-bee3-4692-814b-c2d64b938ed1" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Undrawn credit facilities are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:37.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">General-purpose credit facilities</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToxZmM5YjhmY2IzYTc0ZWViYjU2NjkwZTE3NDI3MDc1YS90YWJsZXJhbmdlOjFmYzliOGZjYjNhNzRlZWJiNTY2OTBlMTc0MjcwNzVhXzItMS0xLTEtMzY0MDYw_9e7134af-4669-455a-a507-107ae33e6be7">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231" decimals="-6" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToxZmM5YjhmY2IzYTc0ZWViYjU2NjkwZTE3NDI3MDc1YS90YWJsZXJhbmdlOjFmYzliOGZjYjNhNzRlZWJiNTY2OTBlMTc0MjcwNzVhXzItMi0xLTEtMzY0MDYw_de6714a5-1eb6-4981-b10b-0688c4430982">4,000</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231" decimals="-6" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToxZmM5YjhmY2IzYTc0ZWViYjU2NjkwZTE3NDI3MDc1YS90YWJsZXJhbmdlOjFmYzliOGZjYjNhNzRlZWJiNTY2OTBlMTc0MjcwNzVhXzItMy0xLTEtMzY0MDYw_dae89307-754a-419a-95ea-e9ebaf2d24ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231" decimals="-6" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToxZmM5YjhmY2IzYTc0ZWViYjU2NjkwZTE3NDI3MDc1YS90YWJsZXJhbmdlOjFmYzliOGZjYjNhNzRlZWJiNTY2OTBlMTc0MjcwNzVhXzItNC0xLTEtMzY0MDYw_c5945dec-0f80-4fbd-9e62-b8baf18a2738">4,000</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fda103b354c454696639116746e4ce6_I20221231" decimals="-6" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToxZmM5YjhmY2IzYTc0ZWViYjU2NjkwZTE3NDI3MDc1YS90YWJsZXJhbmdlOjFmYzliOGZjYjNhNzRlZWJiNTY2OTBlMTc0MjcwNzVhXzItNS0xLTEtMzY0MDYw_de8ffea5-9e74-4e45-b0e7-1272b68d6052">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, total credit facilities amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyODQ1_ce47020d-3760-4f44-aead-2b253269910e">8,000</ix:nonFraction> million (versus &#8364;<ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyODU2_d6f5af07-0cc7-475b-bc40-24e7be4c05f9">8,000</ix:nonFraction> million as of December 31, 2021 and&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="ifrs-full:UndrawnBorrowingFacilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyODcy_ec4cff75-dee7-4761-856a-8722d8f58efc">8,000</ix:nonFraction> million as of December 31, 2020).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEzODY3_95ebbf2d-b2dd-4bec-a196-78fb1969c0a7" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the amount of guarantees given and received:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Guarantees given:</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibf03bba2a0f04d1188d25f148f36a72d_I20221231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzEtMS0xLTEtMzY0MDYw_5dbb1e2f-d7b8-4a1c-99e7-3fdf25b6c713">3,815</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i939fa095546f44a393ce805aaaade10d_I20211231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzEtMi0xLTEtMzY0MDYw_a54e6a48-1f48-4e99-8d2e-43f510a20e8d">3,794</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7d70051b63048b482c6e8dc47988e25_I20201231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzEtMy0xLTEtMzY0MDYw_190ef15f-6984-4ea1-9b43-98f37bf664a5">3,291</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Guarantees provided to banks in connection with credit facilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if1de0a6f85434a9b9e97775863357700_I20221231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzItMS0xLTEtMzY0MDYw_2b7d625d-3356-4f40-8e81-95e578008ad0">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1b027a016e14cfe88b71b1c3fb15eca_I20211231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzItMi0xLTEtMzY0MDYw_ff4f4e31-0d3a-4def-b22a-954d28aea9a5">1,042</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8bc3ba5245904e0a90bb4d29a9cc145e_I20201231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzItMy0xLTEtMzY0MDYw_f9536780-3e10-4325-a188-a9e7f8f14159">695</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other guarantees given</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia0d813bb627146f2ad3035a585e98181_I20221231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzMtMS0xLTEtMzY0MDYw_0be7929f-f486-4d94-b6fb-491f3dfc1c14">2,808</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i044e8ccf5872470daae5e14174d0c4c0_I20211231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzMtMi0xLTEtMzY0MDYw_6bee93d2-b8e1-4e33-b793-7b79b672c3e9">2,752</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ieeeb99efde1d442fa44fecb8bdbed1f6_I20201231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzMtMy0xLTEtMzY0MDYw_bdf8f012-7fbf-44b2-8e62-d26f711d82e7">2,596</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Guarantees received</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2ee6a60b930541f79b2560c7e63bdae3_I20221231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzQtMS0xLTEtMzY0MDYw_e3d8dbcc-5857-4e48-ba45-155bfd2f5ec2">1,229</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i214032b872604476b3988af269c27156_I20211231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzQtMi0xLTEtMzY0MDYw_8994e359-4e65-47f7-9b4d-2c3b69669908">1,149</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6a28592851c14211acba46221b993eb6_I20201231" decimals="-6" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzQtMy0xLTEtMzY0MDYw_34f72064-73a9-465a-82c1-521df9c1f55a">964</ix:nonFraction>)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-81</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i06e04c8a829842b9bd7de13dbfe10f2b"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.21.3. Off balance sheet commitments relating to asset acquisitions and divestments, and to changes in the scope of consolidation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, Sanofi had received commitments amounting in aggregate to &#8364;<ix:nonFraction unitRef="usd" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-8" name="sny:OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI5Njg2ODE0MDQ5MDA3_55a84cea-4aa6-4b1e-b5d9-92b34386b046">1.0</ix:nonFraction>&#160;billion in respect of (i)&#160;divestments of assets relating to transactions not yet finalized as of that date and (ii)&#160;contingent consideration arising under past agreements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Off balance sheet commitments of a financing nature with associates and joint ventures are disclosed in N</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ote&#160;D.6.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The maximum amount of contingent consideration relating to business combinations is disclosed in Note&#160;D.18.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_658"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.22. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfLegalAndArbitralProceedingsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzM3MDE5_f65db3d1-b56e-4f8c-88e2-66fa81fb65e3" continuedAt="ic52c54949d60423891d0dcb35080a2e8" escape="true">Legal and arbitral proceedings</ix:nonNumeric></span></div><ix:continuation id="ic52c54949d60423891d0dcb35080a2e8" continuedAt="ifaba268c382844e78464738e5f5ed843"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and its affiliates are involved in litigation, arbitration and other legal proceedings. These proceedings typically are related to product liability claims, intellectual property rights (particularly claims against generic companies seeking to limit the patent protection of Sanofi&#160;products), competition law and trade practices, commercial claims, employment and wrongful discharge claims, tax assessment claims, waste disposal and pollution claims, and claims under warranties or indemnification arrangements relating to business divestitures. Provisions related to legal and arbitral proceedings are recorded in accordance with the principles described in Note&#160;B.12.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Most of the issues raised by these claims are highly complex and subject to substantial uncertainties; therefore, the probability of loss and an estimation of damages are difficult to ascertain. Contingent liabilities are cases for which either we are unable to make a reasonable estimate of the expected financial effect that will result from ultimate resolution of the proceeding, or a cash outflow is not probable. In either case, a brief description of the nature of the contingent liability is disclosed and, where practicable, an estimate of its financial effect, an indication of the uncertainties relating to the amount and timing of any outflow, and the possibility of any reimbursement are provided in application of paragraph&#160;86 of IAS&#160;37.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the cases that have been settled or adjudicated, or where quantifiable fines and penalties have been assessed, we have indicated our losses or the amount of provision accrued that is the estimate of the probable loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In a limited number of ongoing cases, while we are able to make a reasonable estimate of the expected loss or range of the possible loss and have accrued a provision for such loss, we believe that publication of this information on a case-by-case basis or by class would seriously prejudice the Company&#8217;s position in the ongoing legal proceedings or in any related settlement discussions. Accordingly, in those cases, we have disclosed information with respect to the nature of the contingency but have not disclosed our estimate of the range of potential loss, in accordance with paragraph&#160;92 of IAS&#160;37.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These assessments can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. Our assessments are based on estimates and assumptions that have been deemed reasonable by management. We believe that the aggregate provisions recorded for the above matters are adequate based upon currently available information. However, given the inherent uncertainties related to these cases and involved in estimating contingent liabilities, we could in the future incur judgments that could have a material adverse effect on our net income in any particular period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Long term provisions are disclosed in Note&#160;D.19. They include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">provisions for product liability risks, litigation and other amount to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzMwMzU_72d66f83-a30c-4d63-84a1-7c83733bdacb">1,652</ix:nonFraction> million in 2022. These provisions are mainly related to product liabilities, government investigations, competition law, regulatory claims, warranties in connection with certain contingent liabilities arising from business divestitures other than environmental matters and other claims;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">provisions for environmental risks and remediation amount to &#8364;<ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:NonCurrentProvisionForEnvironmentRisks" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzMzNzY_eee19e01-7706-48aa-b28e-a68adf913fcd">526</ix:nonFraction> million in 2022, the majority of which are related to contingencies that have arisen from business divestitures.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">a) Products</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sanofi Pasteur Hepatitis&#160;B Vaccine Product Litigation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since 1996, more than <ix:nonFraction unitRef="lawsuit" contextRef="ia2d901acae514e5e8280c783c251f450_I20221231" decimals="INF" name="sny:NumberOfCivilIndividualActions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzM1NzA_d8ec0ae3-0711-42af-947a-b40b9c565628">180</ix:nonFraction>&#160;lawsuits have been filed in various French civil courts against Sanofi Pasteur and/or Sanofi Pasteur&#160;MSD&#160;S.N.C., the former French subsidiary of Sanofi, and the latter a joint venture company with Merck&#160;&amp; Co.,&#160;Inc. now terminated, for which past ongoing litigation is now managed by the originating party. In such lawsuits, the plaintiffs allege that they suffer from a variety of neurological disorders and autoimmune diseases, including multiple sclerosis and Guillain-Barr&#233; syndrome as a result of receiving the hepatitis&#160;B vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In January&#160;2018, the Appeal Court of Bordeaux found a causal link between hepatitis&#160;B vaccine and multiple sclerosis. In&#160;July&#160;2019, the French Supreme Court </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Cour de cassation)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> cancelled the&#160;judgment&#160;of the Appeal Court of Bordeaux and referred the&#160;case back to the Appeal Court of Toulouse. On March&#160;30, 2022, the Appeal Court of Toulouse dismissed all the plaintiff&#8217;s claims.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there were <ix:nonFraction unitRef="lawsuit" contextRef="ia2d901acae514e5e8280c783c251f450_I20221231" decimals="INF" name="sny:NumberOfOngoingLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzQ1MzI_f7fda773-380e-4621-b80d-f0396ca365df">49</ix:nonFraction>&#160;ongoing lawsuits related to Sanofi Pasteur hepatitis&#160;B vaccine.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-82</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ifaba268c382844e78464738e5f5ed843" continuedAt="ib863b8eeb9c9474c96fe4335efdb0e04"><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxotere</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Product Litigation in the US</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, there were approximately <ix:nonFraction unitRef="plaintiff" contextRef="ide8e1ec806db4932b7eba982cc52419e_D20211231-20211231" decimals="0" name="sny:NumberOfPlaintiffs" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzQ2NzM_d8f6c213-4369-42fb-bb68-840ec6ef1ee0">8,300</ix:nonFraction>&#160;plaintiffs in courts across the country, with approximately <ix:nonFraction unitRef="plaintiff" contextRef="ide8e1ec806db4932b7eba982cc52419e_D20211231-20211231" decimals="0" name="sny:NumberOfLossConsortiumPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzQ3MzY_c66b99ea-03c8-4340-97c2-1b45a7282893">700</ix:nonFraction>&#160;of those plaintiffs being spouses who have filed loss of consortium claims.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Lawsuits have been filed against affiliates of Sanofi under US state law for personal injuries allegedly sustained in connection with&#160;the use of Taxotere</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The actions are held in several jurisdictions, including the federal and/or state courts of Louisiana, New&#160;Jersey, California, and Delaware. To date, there have been <ix:nonFraction unitRef="trial" contextRef="i9812f0f2ab434fd5b26f297a36264169_I20221231" decimals="0" name="sny:NumberOfBellweatherTrialsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzUxMzc_ff62b064-bd1f-456e-98b6-f4fff8065ccf">two</ix:nonFraction>&#160;bellwether trials as part of a federal multi-district litigation in the Eastern District of Louisiana both resulting in jury verdicts in Sanofi's favor.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to reliably assess the outcome of these lawsuits or the potential financial impact on the Company.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxotere</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8211; Mississippi Attorney General Litigation in the US</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In October&#160;2018, the Attorney General for the State of Mississippi filed a civil action in Hinds County, Mississippi, Chancery Court against various Sanofi Defendants related to Taxotere</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The State asserts one cause of action based on the Mississippi Consumer Protection Act (&#8220;MCPA&#8221;) and seeks a permanent injunction prohibiting Defendants&#8217; conduct and civil penalties of up to $<ix:nonFraction unitRef="usd" contextRef="i3c1b80392c24483ea3270088e8c3d341_D20181001-20181031" decimals="INF" name="sny:MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzU4Njg_51ef3a19-0ebc-4755-b832-85dc5d82a3f9">10,000</ix:nonFraction> for each violation. Sanofi filed a motion to dismiss the entire action in Hinds County, Mississippi, Chancery Court, which is currently pending.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to assess reliably the outcome of this lawsuit or the potential financial impact on the Company.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Litigation in the US</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2019, the US Food and Drug Administration (&#8220;FDA&#8221;) announced it was investigating the claims of an online pharmacy&#8217;s Citizen Petition that the medication Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (the brand name for ranitidine) used for stomach heartburn contains or can generate the chemical N-Nitrosodimethylamine (&#8220;NDMA&#8221;), an alleged human carcinogen. As a precautionary measure, Sanofi initiated a voluntary recall of branded over-the-counter Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in October&#160;2019. Concurrent with FDA&#8217;s investigation, multiple personal injury lawsuits and class actions alleging that Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> causes various cancers and seeking damages for either alleged personal injuries or alleged economic injuries were filed. Most of those cases have been coordinated into a Multi-District Litigation (&#8220;MDL&#8221;) in the Southern District of Florida.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On June&#160;30 and July&#160;8, 2021, the Federal MDL Court entered orders granting in part and denying in part Defendants&#8217; motions to dismiss various aspects of Plaintiffs&#8217; amended complaints. The rulings narrowed the scope of plaintiffs&#8217; complaints and saw the dismissal of all retailers and generic manufacturers from the MDL, leaving branded manufacturers GSK, Pfizer, Boehringer Ingelheim, and Sanofi as the defendants.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;6, 2022, the MDL Court granted Sanofi and the other defendants&#8217; Daubert and Summary Judgment motions. As a result, the Court will dismiss approximately <ix:nonFraction unitRef="case" contextRef="id03ce38671d242c5b423a1d25f8c6f7e_I20221206" decimals="0" name="sny:NumberOfCasesDismissed" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzA5_e35cb0b7-dec8-4251-8d4f-0e8ef8d23838">50,000</ix:nonFraction>&#160;cases involving plaintiffs&#8217; <ix:nonFraction unitRef="cancer" contextRef="id03ce38671d242c5b423a1d25f8c6f7e_I20221206" decimals="0" name="sny:NumberOfCancersAssociatedWithDismissedCases" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzE2_dae3b78c-36a8-4547-91c8-1e27e725ee96">five</ix:nonFraction> designated cancers. We expect those plaintiffs to appeal the MDL's Court's decision.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other cases are pending in various state courts. These state court cases still include numerous retail and generics manufacturing defendants in addition to branded manufacturers.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, in November&#160;2019, Sanofi received a Civil Investigative Demand (&#8220;CID&#8221;) related to this issue from the Arizona Attorney General.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;2020, the New Mexico Attorney General filed a complaint against Sanofi, the previous marketing authorization holders for branded Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a dozen generic manufacturers, and several retailers. The complaint brings claims for alleged violations of the New Mexico Unfair Practices Act, violations of the New Mexico False Advertising Act, violations of the New Mexico Public Nuisance Statute, common law public nuisance, and negligence.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;2020, Sanofi received a notice from the US Department of Justice Civil Division and US Attorney&#8217;s Office for the Eastern District of Pennsylvania of an investigation into allegations that pharmaceutical manufacturers violated the False Claims Act,&#160;31&#160;U.S.C. &#167;&#160;3729, in relation to the drug Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and ranitidine hydrochloride through alleged failure to disclose to the federal government information about the potential presence of NDMA. The notice requests information and documents from Sanofi including applications and communications with&#160;FDA.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In November&#160;2020, the Mayor and City Council of Baltimore filed a complaint against Sanofi, the previous marketing authorization holders for branded Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, generic manufacturers, and several retailers. The complaint alleges violations of the Maryland Consumer Protection statute, public nuisance, and negligence.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In January&#160;2021, Sanofi was served with the Center for Environmental Health&#8217;s Second Amended Complaint alleging Proposition&#160;65&#160;violations. The case, which also names generic manufacturers and retailers, is pending in California Superior Court&#160;in Alameda County.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Overall between State and federal filings, there are currently <ix:nonFraction unitRef="complaint" contextRef="iacdab6e288ea48229984fd6fdc5f672d_D20211231-20211231" decimals="INF" name="sny:NumberOfComplaintsFiled" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzk2OTM_295e5e1e-6b5c-4867-8ec0-966ef87ee859">3,486</ix:nonFraction>&#160;product liability &#8220;complaints&#8221; filed. These complaints encompass&#160;<ix:nonFraction unitRef="plaintiff" contextRef="iacdab6e288ea48229984fd6fdc5f672d_D20211231-20211231" decimals="INF" name="sny:NumberOfPlaintiffs" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzk3NjE_beb9bcce-1ec8-406c-92cf-80ce7a32a780">68,355</ix:nonFraction>&#160;individual product liability &#8220;plaintiffs&#8221; who have all filed against Sanofi. The vast majority of these plaintiffs participated in the MDL Court&#8217;s census registry program, allege cancers that the plaintiffs&#8217; leadership decided not to designate and pursue in the MDL, and have since filed their complaints in state courts. Additional cases may be filed.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to assess reliably the outcome of these lawsuits or the potential financial impact on Sanofi.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-83</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ib863b8eeb9c9474c96fe4335efdb0e04" continuedAt="iba2c165b01eb40be9f7eaee9eb4b97b9"><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Litigation in Canada</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Between 2019 and 2022, <ix:nonFraction unitRef="action" contextRef="ife35047b3efb48d49565a8abefe87bdd_D20190101-20211231" decimals="INF" name="sny:NumberOfClassActionLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzEwMDUz_7eb700dd-c3b5-46ae-bb5d-fd7719901f86">7</ix:nonFraction>&#160;proposed class actions naming notably Sanofi Consumer Health&#160;Inc., Sanofi-Aventis Canada Inc., Chattem (Canada)&#160;Inc., Sanofi and Sanofi Pasteur Limited as Defendants, relating to ranitidine were filed in various Canadian States court on behalf of all Canadian provinces alleging they suffered personal injury, including cancer, from the ingestion of ranitidine and are seeking general special, statutory, punitive and aggravated damages in an unspecified amount as well as disgorgement of profits. Additionally, some plaintiffs seek restitution for unjust enrichment in an amount equivalent to the purchase price of Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and subrogated damages on behalf of provincial health insurers for health care costs related to ranitidine use. These actions are pending before the courts of Alberta, British Columbia, Quebec and Ontario. A Certification hearing was held in the British Columbia action in October&#160;2022 and the certification decision is under review of the Court.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to assess reliably the outcome of these lawsuits or the potential financial impact on Sanofi.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depakine</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Product Litigation in France</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Civil proceedings</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, <ix:nonFraction unitRef="claim" contextRef="i69ade77d4014436cb24fe9c6b800b42c_I20221231" decimals="INF" name="sny:NumberOfCivilIndividualActions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzExMDgy_83f465fb-249e-46a3-be77-26a544625355">78</ix:nonFraction>&#160;families brought a civil claim involving <ix:nonFraction unitRef="person" contextRef="i69ade77d4014436cb24fe9c6b800b42c_I20221231" decimals="INF" name="sny:NumberOfPeopleExposed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzExMTI2_30870ad4-3c1e-4ec7-9603-e0817fc82b48">131</ix:nonFraction>&#160;people exposed in utero to sodium valproate against a French affiliate of Sanofi seeking indemnification under French law for personal injuries allegedly suffered by children in connection with the use of sodium valproate by their mothers during pregnancy to treat their epilepsy (Depakine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">). These actions are held in several jurisdictions in&#160;France.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="lawsuit" contextRef="i69ade77d4014436cb24fe9c6b800b42c_I20221231" decimals="INF" name="sny:NumberOfLawsuitsRuledOnMerit" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzExNDgx_146e2002-caec-4734-bc5b-13279a1f95e6">Twenty-nine</ix:nonFraction> lawsuits are proceedings on the merits, the most advanced was tried at the French Supreme Court level which issued in November&#160;2019 a ruling sending the case before the Paris Appeal Court to rule on Sanofi&#8217;s argument on the compliance of the product with mandatory regulations, as well as on the question of defectiveness of the product and the assessment of damages. In January&#160;2023, the Paris Appeal Court ordered a stay in the proceedings until the second expert opinion report is handed down in the criminal investigation (see below). </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="ruling" contextRef="ifd9713c0f3b84a2087189ac6adf31e26_I20220820" decimals="INF" name="sny:NumberOfFirstInstanceRulings" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzI2_067d7bb6-073f-4ef3-9b88-4351469f7ade"><ix:nonFraction unitRef="ruling" contextRef="id0a6ca82125c4345addbd9134859f4dc_I20220512" decimals="INF" name="sny:NumberOfFirstInstanceRulings" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzI2_4a0ec77e-46c2-4d00-9f05-ab9e21888d1b">Seven</ix:nonFraction></ix:nonFraction> first instance rulings on the merits were handed down in 2022 by the Judicial Tribunal of Nanterre. In <ix:nonFraction unitRef="case" contextRef="i9a57a25d53544b7bbc8e58ad797964d3_I20221231" decimals="INF" name="sny:NumberOfFirstInstanceRulings" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzI3_fb50fd6f-7ce0-4ae7-beb7-a029ab49c5b2">three</ix:nonFraction> cases, the Court declared the judicial expert report null and void and the Court dismissed one claim in another case.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Concerning <ix:nonFraction unitRef="case" contextRef="i9a57a25d53544b7bbc8e58ad797964d3_I20221231" decimals="INF" name="sny:NumberOfFirstInstanceRulings" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzI1_55580f9c-6e01-49bb-9394-6d704e632689">three</ix:nonFraction> other cases relating to births that occurred between 2005 and 2009, the Court held, on the basis of a non-fault liability, that Sanofi was liable in light of the wording of the patient information leaflet. Provisional compensation amounts were set in the range of &#8364;<ix:nonFraction unitRef="eur" contextRef="i1a12953bef7249c18a068db579937b2f_I20221231" decimals="-5" name="sny:LitigationAmountPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4Mzc4_55698535-d39a-4571-b75c-4b642b66ca61">0.1</ix:nonFraction>&#160;million to &#8364;<ix:nonFraction unitRef="eur" contextRef="iaff1b7c5dd354bbca260343d8976c984_I20221231" decimals="-5" name="sny:LitigationAmountPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzMw_952f6ccc-b1ee-4ee8-b150-af15888693ff">0.5</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All the judgments have been appealed.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the class action lawsuit filed in May&#160;2017 by the APESAC </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Association des Parents d&#8217;Enfants souffrant du Syndrome de l&#8217;Anti-Convulsivant)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> against the French affiliate, the Judicial Tribunal of Paris ruled on January&#160;5, 2022 that a class is admissible, retaining Sanofi&#8217;s liability between 1984 and January&#160;2006 for malformations and between 2001 and January&#160;2006 for neuro-developmental disorders (NDD). This decision is based on the conclusions of a criminal expert report within the frame of ongoing criminal proceeding, for which the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Chambre de l&#8217;Instruction</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> of the Appeal Court of Paris had ordered a counter-expertise (see&#160;below). Sanofi and its insurers appealed the Judicial Tribunal of Paris' ruling related to the class action.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On July&#160;21, 2021, a Judicial Tribunal in France dismissed a claim for damages brought against Sanofi regarding a child born in&#160;1995. The Judicial Tribunal considered that the risk of occurrence of NDD in children born to mother exposed to sodium valproate during pregnancy was not demonstrated by the state of scientific knowledge at the time of her pregnancy. This decision was appealed and the proceeding is now pending before the Appeal Court of Paris, which had ordered a stay in the proceeding until the end of the criminal investigation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In July&#160;2020, a collective redress against the French affiliate was filed by</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="family" contextRef="id8fbf1dee4e248d398715fa56ef2544a_I20200731" decimals="INF" name="sny:NumberOfFamiliesWhoFiledACivilClaim" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzEzOTg2_4f0387d6-9f7a-472f-a9ce-78dd041bb38e">63</ix:nonFraction>&#160;f</span><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">amilies, seeking indemnification for a</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> prejudice of anxiety</span><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">There is no date set for the hearing on the merits in this case yet.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Criminal investigation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A criminal investigation was initiated in May&#160;2015 before the Paris Civil Court. In January&#160;2020, the French affiliate of Sanofi was indicted for aggravated deception and involuntary injuries and in July&#160;2020 for involuntary manslaughter. In July&#160;2020, a judicial supervision of the affiliate was ordered, together with the implementation of financial guarantees. In November&#160;2020, the Health Authority (</span><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ANSM) was similarly indicted for involuntary injuries and involuntary manslaughters.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On March&#160;9, 2022, the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Chambre de l&#8217;Instruction</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> of the Appeal Court of Paris ruled that certain complaints for involuntary manslaughter and several others for aggravated deception and involuntary injuries were time-barred. The Public Prosecutor, as well as the civil parties, have brought the matter before the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Chambre Criminelle </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">of the Supreme Court. </span><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2022, the investigating judges appointed <ix:nonFraction unitRef="expert" contextRef="iea2e083a765b4ce7902705ed5cd966e7_D20220901-20220930" decimals="INF" name="sny:NumberOfCounterExpertiseExperts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4Mzg0_46ca6c25-e1da-499e-b030-6438c40bdf02">2</ix:nonFraction>&#160;experts for a counter-expertise following the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Chambre de l&#8217;Instruction&#8217;s</span><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> ruling handed down end of 2021 and in October&#160;2022 ordered <ix:nonFraction unitRef="medical_assessment" contextRef="i5b0489fbbf76442ab038901380310b9f_D20221001-20221031" decimals="INF" name="sny:NumberOfMedicalAssessments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4Mzkz_1d40247b-7374-4e7f-814b-eba9f5a26595">6</ix:nonFraction>&#160;individual medical assessments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Public compensation scheme</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2017, the French government set up a public compensation scheme to indemnify patients for damages suffered in connection with the prescription of sodium valproate and its derivatives. The scheme was further amended through the 2020 Finance Law, with notably the introduction of presumptions of default for lack of information of the mother since 1982 for malformations and since 1984 for NDD. The scheme was amended again through the&#160;2021 Finance Law in order to increase the maximum premium applicable in case of refusal to make an offer (or insufficient offer) which would be deemed unjustified by a court ruling.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-84</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="iba2c165b01eb40be9f7eaee9eb4b97b9" continuedAt="ifca4c6616f114fdea9f593ab878eafa4"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The committee of the compensation scheme has issued several final opinions holding the French affiliate liable for damages either in full or in part along with the French State, and, in some cases, healthcare practitioners. The French affiliate disagreed with the committee&#8217;s conclusions and has accordingly not offered indemnification to the claimants who have received compensation from the ONIAM </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Office National d'Indemnisation des Accidents M&#233;dicaux)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The ONIAM is now seeking reimbursement from Sanofi who has filed legal actions to oppose ONIAM&#8217;s payment orders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has also been notified of <ix:nonFraction unitRef="person" contextRef="i69ade77d4014436cb24fe9c6b800b42c_I20221231" decimals="INF" name="sny:NumberOfPeopleExposedWhoFiledARequestForIndemnification" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE2MzUx_6fa6f2e5-92a3-4d80-a4dd-1e1c615ed984">63</ix:nonFraction>&#160;exposed persons who have filed a request for indemnification before the public compensation scheme and who are also claimants against Sanofi in individual judicial proceedings (summary proceedings or actions on the&#160;merits).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Administrative Actions</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In July&#160;2020, March and June&#160;2021, the Montreuil Administrative Court had held the French State liable in <ix:nonFraction unitRef="proceeding" contextRef="i82f5b65dd97e478faf4feebb1a461d65_D20200701-20210331" decimals="INF" name="sny:NumberOfAdministrativeProceedings" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE2NjM3_dd2df685-7202-4c73-b533-507080c70180">5</ix:nonFraction>&#160;administrative proceedings initiated by families against the State. In March&#160;2021, the Administrative Court did not retain any lack of information of the mother regarding the risk of neurodevelopmental disorders for births in 1999 and in 2002, based on the state of scientific knowledge at the time. However, regarding the risk of malformations, liabilities were retained against the State, the healthcare professionals and Sanofi, notably for discrepancy between the SmPC (Summary of the Product Characteristics) and the patient leaflet. In other cases involving births in 2005-2008, the liability of the State was retained for both malformations and neurodevelopmental disorders, and partially exonerated, taking into account the roles of healthcare practitioners and Sanofi. Given that the French affiliate was not a party to these administrative proceedings, its arguments (i.e. notably several requests from the French affiliate to the Health Authorities to reinforce warnings to healthcare professionals and patients in relation to Depakine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) were not considered. All rulings were appealed by the claimants. Sanofi has filed requests for voluntary intervention in these proceedings to present its arguments before the Administrative Court of Appeal. In one proceeding, the claimants decided to withdraw their claims.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to assess reliably the outcome of these cases or the potential financial impact on the Company.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depakine</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Product Litigation in other EU countries and in the UK</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Switzerland, <ix:nonFraction unitRef="family" contextRef="i38c648e7e3d449e7a4ef085d255a725f_I20221231" decimals="INF" name="sny:NumberOfFamiliesWhoFiledACivilClaim" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE3ODI2_f3a898f9-6e22-4779-8251-04578a45f909">10</ix:nonFraction>&#160;families have filed a civil claim for damages concerning <ix:nonFraction unitRef="person" contextRef="i38c648e7e3d449e7a4ef085d255a725f_I20221231" decimals="INF" name="sny:NumberOfPeopleExposed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE3ODg2_b476b047-3dd0-4fb9-b22d-5933806637e6">16</ix:nonFraction>&#160;people exposed in utero. Some of them also involve the claimants&#8217; physicians. In November&#160;2022, one action was declared time-barred by the judge. The claimant appealed this court decision on the merit. The appeal is on-going.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Spain, there are <ix:nonFraction unitRef="trial" contextRef="i5914be30840a424e9ba15aac06bfd84a_I20221231" decimals="INF" name="sny:NumberOfOngoingTrials" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE3OTg3_f52c78a5-899b-48ee-bf65-64b4747b3685">4</ix:nonFraction>&#160;trials ongoing relating to <ix:nonFraction unitRef="children" contextRef="i5914be30840a424e9ba15aac06bfd84a_I20221231" decimals="INF" name="sny:NumberOfPeopleExposed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE4MDE3_b4650236-0ae0-460c-8ee8-081f48b785d0">10</ix:nonFraction>&#160;children. In March&#160;2022, in one of the trials, the Court condemned Sanofi to indemnify 4&#160;patients. Sanofi appealed this decision. In January&#160;2023, in another trial filed by one patient, the Appeal Court confirmed the first instance's decision and dismissed the claim. The other actions are still at a preliminary stage.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Belgium, there are <ix:nonFraction unitRef="complaint" contextRef="ie3099953088a4d92b74521a460c6296a_I20221231" decimals="INF" name="sny:NumberOfCivilIndividualActions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE4MDUy_15c6026d-2ec7-4780-acb1-81255c25463f">2</ix:nonFraction>&#160;civil proceedings (currently on hold) and a criminal complaint against X and against Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Germany, there is <ix:nonFraction unitRef="lawsuit" contextRef="i3d1a1e91d76a423db829d84274c18752_I20221231" decimals="INF" name="sny:NumberOfCivilIndividualActions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE4MTY5_5713effc-7a33-44b6-b575-dfe181534cd0">one</ix:nonFraction> civil lawsuit before the Berlin Regional Court, relating to <ix:nonFraction unitRef="children" contextRef="i3d1a1e91d76a423db829d84274c18752_I20221231" decimals="INF" name="sny:NumberOfPeopleExposed" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE4MjMy_721a3c98-fa9c-407c-81dc-ac18cc1421cd">one</ix:nonFraction> child exposed </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">in utero</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to valproate taken by the mother during pregnancy for bipolar disorder.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Ireland, there are <ix:nonFraction unitRef="case" contextRef="i31d63c85f8e441c7807a6e955b15559f_I20221231" decimals="INF" name="sny:NumberOfPreActionProtocolCases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4Mzk2_b68e0a01-1336-42b1-84f5-8a3b6339db45">2</ix:nonFraction>&#160;Pre-Action Protocol cases and <ix:nonFraction unitRef="claim" contextRef="i31d63c85f8e441c7807a6e955b15559f_I20221231" decimals="INF" name="sny:NumberOfCivilClaimsOnGoing" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4Mzk5_060f4c9e-09fc-4dd4-b38f-89de3420afdd">2</ix:nonFraction>&#160;civil claims on-going.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the United Kingdom, there are <ix:nonFraction unitRef="case" contextRef="icc705712fa1947ae879577c168f3f666_I20221231" decimals="INF" name="sny:NumberOfPreActionProtocolCases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDAy_f28866a5-0c37-4c90-a987-671439a1f4ab">3</ix:nonFraction>&#160;Pre-Action Protocol cases in Great Britain and <ix:nonFraction unitRef="case" contextRef="ifd45fd1ec3c449df97cba0f45eef2ae9_I20221231" decimals="INF" name="sny:NumberOfPreActionProtocolCases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDA1_3e5674bd-0651-4290-95b2-bb89760b7fd0">1</ix:nonFraction>&#160;Pre-Action Protocol case in Northern Ireland on-going.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to assess reliably the outcome of these cases or the potential financial impact on the Company.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dengvaxia</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (Philippines)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since early 2018 up to present date, several claims were filed in the Philippines by parents of deceased children whose deaths were allegedly due to vaccination with Dengvaxia</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Early March&#160;2019, 2020 and 2022, the Philippine Department of Justice (DOJ) prosecution panel announced it had found probable cause to indict several Sanofi employees/former employees and former Government officials for &#8220;reckless imprudence&#8221; resulting in homicides. Since then, several criminal actions have been filed in court as a result of this finding. Petitions for Review to the DOJ Secretary have been filed and the said petitions remain pending. Meanwhile, the majority of the respondents have challenged the jurisdiction of the lower court where the first&#160;<ix:nonFraction unitRef="case" contextRef="ia799047f91fb498c88944dff7dc04fd0_D20180101-20221231" decimals="INF" name="sny:NumberOfCases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE5MzU5_ed11e9e2-a957-45f4-8e2f-8133ecb2ba72">8</ix:nonFraction>&#160;cases had been assigned and this issue is now filed with the Supreme Court. There are several claims that have not yet been filed in any court despite resolutions by the DOJ that there is probable cause.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">b) Patents</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ramipril Canada Patent Litigation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi was involved in a number of legal proceedings involving companies which market generic Altace</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (ramipril) in Canada. In&#160;2004, Sanofi unsuccessfully brought Notice of Compliance proceedings (NOC proceedings) at the end of which <ix:nonFraction unitRef="manufacturer" contextRef="i0f6eba28b15e4c47a8864e9a6806f73c_I20221231" decimals="INF" name="sny:NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE5ODEy_b2a740c7-af64-40b4-95fb-7d8def6a15c1">eight</ix:nonFraction> manufacturers obtained marketing authorizations from the Canadian Minister of Health for generic versions of ramipril in Canada. Sanofi filed unsuccessful patent infringement actions against all those companies and ultimately Sanofi was liable for damages under Section&#160;8. Sanofi made payment in complete satisfaction of those awards.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;2011, Apotex commenced an action in the Ontario Superior Court of Justice asserting damages under the Ontario Statute of Monopolies, the UK Statute of Monopolies, and the Trade-marks Act (the &#8220;Ontario Action&#8221;). </span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-85</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ifca4c6616f114fdea9f593ab878eafa4" continuedAt="i760db5ddd7644efda66320fc1cc3f4b9"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At the request of the parties, in June&#160;2021, the Court ordered that the action be stayed in view of the lower court's decision in March in the Apotex vs. Lilly case. In the Lilly case, the Court dismissed Apotex's Statute of Monopolies claim by way of summary judgment. If upheld on appeal, this decision may end Apotex's claim against Sanofi, also based on the Statute of Monopolies. In November&#160;2022, Apotex filed an application for leave to appeal the Ontario Court of Appeal decision in the Lilly case with the Supreme Court of Canada. The Court will decide whether to grant the leave application in late Q1&#160;2023. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Praluent</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (alirocumab)-related Amgen Patent Litigation in the US</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2014, Amgen filed <ix:nonFraction unitRef="complaint" contextRef="iad588bc5db4440fa968e52c2f65ca474_I20141231" decimals="INF" name="sny:NumberOfPatentActionsInitiallyFiled" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzIxMjI0_fc929289-f0bd-48d7-92b3-806b66c48674">four</ix:nonFraction> separate complaints against Sanofi and Regeneron in the US District Court for the District of Delaware (&#8220;District Court&#8221;) asserting patent infringement relating to Sanofi and Regeneron&#8217;s Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> product. Together these complaints alleged that Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> infringed <ix:nonFraction unitRef="patent" contextRef="i0d714fe0593a4f539299e40038a0ff5d_I20141118" decimals="INF" name="sny:NumberOfPatentsAllegedlyInfringed" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzIxNDky_e4870e5a-a486-4c9b-8f9d-8ee3f87e2e37">seven</ix:nonFraction> patents for antibodies targeting PCSK9 and sought injunctive relief and unspecified damages.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2021, the Federal Circuit affirmed the District Court&#8217;s ruling invalidating the Amgen asserted patent claims. In November&#160;2021, Amgen filed a petition with the US&#160;Supreme Court, asking it to overturn the Federal Circuit decision. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;4, 2022, the US Supreme Court granted Amgen&#8217;s petition for review. Proceedings before the US Supreme Court are now underway.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dupixent</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (dupilumab)-related Amgen Patent Opposition and Revocation&#160;in Europe</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Immunex Corporation, an Amgen affiliate, is the registered proprietor of European Patent&#160;EP2292665. The claims of this patent relate to, among other things, human monoclonal antibodies that are capable of inhibiting IL-4 induced biological activity and which compete with one of four reference antibodies for binding to a cell that expresses human IL-4R. In April&#160;2016, Sanofi and Regeneron each filed an opposition in the European Patent Office (EPO) against EP2292665, seeking its revocation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The EPO rendered its decision in November&#160;2017 and revoked the patent in its entirety. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2017, Sanofi and Regeneron filed oppositions in the EPO against Amgen&#8217;s European Patent EP2990420, which is a divisional of the EP2292665 Patent discussed above.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In March&#160;2022, the European Patent Office Technical Board of Appeals (&#8220;TBA&#8221;) ruled in Sanofi and Regeneron&#8217;s favor and affirmed the invalidation of Amgen/Immunex&#8217;s EP2990420 patent. In December&#160;2022, the TBA issued its written decision in favor of Sanofi and Regeneron. Amgen/Immunex may seek review of this decision by the Enlarged Board of Appeals.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In March&#160;2022, Amgen/Immunex withdrew its appeal to the TBA for its EP2292665 patent.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jevtana</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (cabazitaxel)-related patent litigation in the US</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently covered by <ix:nonFraction unitRef="patent" contextRef="i7b37c3673570484dbdc61b7e2c0bf6bd_D20220101-20221231" decimals="INF" name="sny:NumberOfPatentsCoveringProduct" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI0NTA1_42c2a90a-1c4f-4a41-9171-f702e2197b48">four</ix:nonFraction> Orange Book listed patents US&#160;7,241,907, US&#160;8,927,592, US&#160;10,583,110 and US&#160;10,716,777. In&#160;May&#160;to July&#160;2020, Sanofi filed patent infringement suits under Hatch-Waxman against <ix:nonFraction unitRef="claim" contextRef="i1591035a52b44bfb8ab033baa46f80a7_I20200731" decimals="INF" name="sny:NumberOfPatentsAllegedlyInfringed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI0Njgz_64272a63-5d8f-44ec-a6d0-c0f7229c4c53">12</ix:nonFraction>&#160;generic filers asserting the &#8216;110&#160;patent and the&#160;&#8216;777&#160;patent in the US District Court for the District of Delaware. The '592&#160;patent was added to the suits after its amended claims issued in August&#160;2021. In January&#160;2021 and August&#160;2022, the District Court issued <ix:nonFraction unitRef="decision" contextRef="i53507d8a67164c8eb8d2fec1ab5c2dca_D20220801-20220831" decimals="INF" name="sny:NumberOfDecisionsIssuedByTheDistrictCourt" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDA3_4ae50562-05b7-4cd7-ac8e-d93ba990408e"><ix:nonFraction unitRef="decision" contextRef="i9e06dd78a2cc45e8b38a451ebfd53f19_D20210101-20210131" decimals="INF" name="sny:NumberOfDecisionsIssuedByTheDistrictCourt" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDA3_5e9166ad-929d-4489-bf90-4435133f4417">two</ix:nonFraction></ix:nonFraction> claim construction decisions in favor of the defendants. In September&#160;2022, the district court issued a decision that granted the defendants&#8217; motion to dismiss in part related to the &#8216;592&#160;patent but denied the motion to dismiss in part related to the &#8216;777 and &#8216;110&#160;patents. Sanofi has reached settlement agreements with most of the defendants and the suit against the remaining defendant Sandoz is ongoing. Sanofi has voluntarily withdrawn the &#8216;110&#160;patent from the suit and a <ix:nonNumeric contextRef="i9a496f537a8d429ba5d2f470f546b3d4_D20230101-20230131" name="sny:LengthOfTrial" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDM0_af699e82-8f8d-42b5-a215-1848c7cd19a7">3-day</ix:nonNumeric> trial on the &#8216;777&#160;patent was held in January&#160;2023. Sandoz has&#160;agreed not to launch any generic cabazitaxel product until the earlier of a district court decision in favor of the defendants or&#160;<ix:nonNumeric contextRef="i7b37c3673570484dbdc61b7e2c0bf6bd_D20220101-20221231" name="sny:NumberOfDaysAfterCompletionOfPostTrailBriefing" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDEx_28e4abc2-e42f-4aec-a355-e477a73ef254">120</ix:nonNumeric> days after the completion of the post-trial briefing.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Litigation (Commonwealth) in Australia</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In August&#160;2007, GenRX (a subsidiary of Apotex) obtained registration of a generic clopidogrel bisulfate product on the Australian Register of Therapeutic Goods. At the same time, GenRX filed a patent invalidation action with the Federal Court of Australia, seeking revocation of Sanofi&#8217;s Australian enantiomer patent claiming clopidogrel salts (a &#8220;nullity action&#8221;). In September&#160;2007, Sanofi obtained a preliminary injunction from the Federal Court preventing commercial launch of this generic clopidogrel bisulfate product until judgment on the substantive issues of patent validity and infringement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In August&#160;2008, the Australian Federal Court confirmed that the claim in Sanofi&#8217;s Australian enantiomer patent directed to clopidogrel bisulfate (the salt form in Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) was valid and the patent infringed. On appeal, the Full Federal Court of Australia held in&#160;September&#160;2009 that all claims in the patent are invalid. Sanofi&#8217;s appeal to the Australia High Court was denied in&#160;March&#160;2010.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In April&#160;2013, the Australian Department of Health and Ageing (&#8220;Commonwealth&#8221;) filed an application before the Federal Court&#160;of&#160;Australia seeking payment of damages from Sanofi related to the Apotex preliminary injunction of up to AUD<ix:nonFraction unitRef="aud" contextRef="i91c653975b734c3bbbb90a324b0a9e43_I20130430" decimals="-6" name="sny:PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI2OTc1_906e73c7-6209-4bf5-b4bd-61a2cdade5ff">449</ix:nonFraction> million (&#8364;<ix:nonFraction unitRef="eur" contextRef="idc6e5447243c412aa0be53b3fe522c2b_I20221231" decimals="-6" name="sny:PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI2OTc5_c6710569-f6ea-4e97-bfe3-3d6f86efff2d">286</ix:nonFraction> million as of December 31, 2022), plus interest.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and BMS settled the patent litigation with Apotex in November&#160;2014. In April&#160;2020, the Commonwealth&#8217;s claim was dismissed. In&#160;May&#160;2020, the Commonwealth filed a Notice of Appeal to the Full Court of the Federal Court. On appeal, the Commonwealth reduced its claim to a range of AUD<ix:nonFraction unitRef="aud" contextRef="i4fa9734152fe42adafe9a6457b51a172_I20221231" decimals="-5" name="sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mjkz_099d1cf3-ed39-4f07-8a8b-0aad8ade72a7">223.3</ix:nonFraction>&#160;million (&#8364;<ix:nonFraction unitRef="eur" contextRef="i4fa9734152fe42adafe9a6457b51a172_I20221231" decimals="-5" name="sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mjk3_04efd6ff-923e-47ce-88d8-1ddb3403d45b">142.1</ix:nonFraction>&#160;million) to AUD<ix:nonFraction unitRef="aud" contextRef="i94f85a2e1aab46aab17b13a49d52aa0e_I20221231" decimals="-5" name="sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3MzA0_c861fd3e-3220-4ee2-916a-ab80b40134bf">280.2</ix:nonFraction>&#160;million (&#8364;<ix:nonFraction unitRef="eur" contextRef="i94f85a2e1aab46aab17b13a49d52aa0e_I20221231" decimals="-5" name="sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3MzA4_9af0a169-0c8e-4ec1-946c-d60e4f9a679b">178.4</ix:nonFraction>&#160;million) which, inclusive of interest to&#160;December&#160;31,&#160;2022, ranges from AUD<ix:nonFraction unitRef="aud" contextRef="i4fa9734152fe42adafe9a6457b51a172_I20221231" decimals="-5" name="sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mzc1_0ad4e017-5924-443d-801f-de60b4774cce">343.4</ix:nonFraction>&#160;million (&#8364;<ix:nonFraction unitRef="eur" contextRef="i4fa9734152fe42adafe9a6457b51a172_I20221231" decimals="-5" name="sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mzc5_b6555416-8f40-469a-90ac-e3b3856e1b4f">218.6</ix:nonFraction>&#160;million) to AUD<ix:nonFraction unitRef="aud" contextRef="i94f85a2e1aab46aab17b13a49d52aa0e_I20221231" decimals="-5" name="sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mzg2_e3c50c51-53f4-4448-b7e4-d7f0cb443ca3">463.6</ix:nonFraction>&#160;million (&#8364;<ix:nonFraction unitRef="eur" contextRef="i94f85a2e1aab46aab17b13a49d52aa0e_I20221231" decimals="-5" name="sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mzkw_2e856eee-4a6f-49c5-99bf-1fea2804c17d">295.1</ix:nonFraction>&#160;million) depending on whether interest accrues from the date the Commonwealth claims the Apotex products would have been listed on the Government reimbursement scheme in the absence of the injunction (i.e. April&#160;1, 2008) or the date the Commonwealth filed its claim (i.e. April&#160;1, 2013). Appeal hearing took place in February&#160;2021 before the Full Court of the Federal Court. The ruling is expected in 2023.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-86</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i760db5ddd7644efda66320fc1cc3f4b9" continuedAt="i87a6551511034bd29addbf27c1b51886"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">c) Other litigation</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aubagio</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (teriflunomide)-related litigation in Europe</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In October&#160;2020, Mylan Ireland&#160;Ltd (&#8220;Mylan&#8221;) brought an action before the General Court of the European Union requesting the annulment of the August&#160;18, 2020 decision of the European Medicines Agency (&#8220;EMA&#8221;) refusing to validate Mylan&#8217;s marketing authorization application for a generic version of Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (teriflunomide). Sanofi has intervened in this court case between Mylan and the EMA in order to defend Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8217;s regulatory exclusivity. Mylan submitted a request for discontinuance of the proceedings in December&#160;2022. The case is over.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (clopidogrel) &#8211; Attorney General Action in Hawaii</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In March&#160;2014, the Hawaii Attorney General (AG) filed a complaint that sets forth allegations related to the sale and marketing of and variability of response to Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The Hawaii AG specifically alleged that Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> had a diminished effect in patients of certain genetic backgrounds and that Sanofi and BMS had failed to make an earlier disclosure of this information.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2021, the Court issued its decision, imposing penalties in the total amount of $<ix:nonFraction unitRef="usd" contextRef="ic9db8ac12dc644388e59ef5e31d39357_D20210201-20210228" decimals="0" name="sny:GlobalPenaltyFeeIncurredByDefendants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI4ODkx_1c635ed0-3f71-456a-bb05-8423d9a23f71">834,012,000</ix:nonFraction> against both Sanofi and Bristol Myers Squibb (BMS), with $<ix:nonFraction unitRef="usd" contextRef="ic9db8ac12dc644388e59ef5e31d39357_D20210201-20210228" decimals="0" name="sny:PenaltyFeeIncurred" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI4OTUx_6479b466-2033-4b4b-b387-e0c11d495700">417,006,000</ix:nonFraction> being apportioned to each company. In June&#160;2021, Sanofi and BMS appealed this judgment. To the extent this judgment or possibly a reduced judgment remains after the appeal, the judgment would be split evenly with BMS. On May&#160;3, 2022, the Hawaii Supreme Court granted a request to transfer the appeal directly to the Hawaii Supreme Court, thereby eliminating review by the Hawaii intermediate Court of Appeals. The Hawaii Supreme Court had oral argument in December&#160;2022 and a decision is expected in or around March&#160;2023.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(clopidogrel) - Attorney General Action in New Mexico</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2016, the New Mexico Attorney General (AG) filed a complaint, claiming that Sanofi and Bristol Meyers Squibb (BMS) engaged in unfair and deceptive practices related to the marketing and labelling of Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The New Mexico AG specifically alleged that Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> had a diminished effect in patients of certain genetic backgrounds and that the Companies failed to make an earlier disclosure of this information. This matter has been concluded and dismissed by way of a settlement by all parties that was finalized in Q4&#160;2022.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (clopidogrel)-related litigation in France</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In France, in the claim concerning allegations that Sanofi&#8217;s communication and promotional practices inhibited the entry on the&#160;market of generics of clopidogrel (the active ingredient of Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), the French Antitrust Authority issued its decision on May&#160;14,&#160;2013, imposing on Sanofi a fine of &#8364;<ix:nonFraction unitRef="eur" contextRef="ia9903703ab204fe0a894254df0aaa506_D20130514-20130514" decimals="-5" name="sny:PenaltyFeeIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzMwMDI1_a2ed6326-04cb-4b00-b503-b3815ca161f7">40.6</ix:nonFraction>&#160;million. In December&#160;2014, the Paris Court of Appeals rejected Sanofi&#8217;s appeal and confirmed in totality the decision. As a consequence of the May&#160;2013 ruling, claims were filed by Sandoz and by Teva in 2014 before the Commercial Court of Paris for compensation of their alleged damages: loss of margin and other ancillary damages (legal fees to external counsel, image and reputation). In June&#160;and November&#160;2016 respectively, settlement agreements were entered into with Sandoz and Teva. Consequently, they subsequently withdrew their civil claims, jointly and severally. On October&#160;18, 2016, the Supreme Court confirmed the Court of Appeals&#8217; decision. Therefore, the Court of Appeals&#8217; decision became definitive. In September&#160;2017, Sanofi and its French affiliate received a summons before the Paris Commercial Court from the French</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> Caisse Nationale d&#8217;Assurance Maladie &#8211; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">CNAM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(French Social Security) claiming &#8364;<ix:nonFraction unitRef="eur" contextRef="if5016791206545f1a8de98c53126c448_D20170901-20170930" decimals="-5" name="sny:PaymentOfDamagesClaimedByCounterparty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzMwOTMz_8d44a837-e7bd-418c-9e29-8b3aaee6ec63">115.8</ix:nonFraction>&#160;million for their alleged damages. On October&#160;1, 2019, the Paris Commercial Court dismissed the CNAM&#8217;s action as time barred. On February&#160;9, 2022, the Paris Court of Appeals overturned the Paris Commercial Court's ruling, finding the&#160;French</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> Caisse Nationale d'Assurance Maladie - </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">CNAM (French Social Security)'s action as not time-barred and designated an expert to determine the amount of damages. The expertise is on-going.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">340B Drug Pricing Program in the United States</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is currently involved in several matters relating to the 340B&#160;program in the US (a federal program that requires drug manufacturers to supply certain products to certain &#8220;covered entities&#8221; at reduced prices). In 2021, Sanofi filed a lawsuit against the Department of Health and Human Services (&#8220;HHS&#8221;), the Health Resources and Services Administration (&#8220;HRSA&#8221;), and certain of their administrators in the&#160;US&#160;District Court for the District of New Jersey challenging (i)&#160;HHS&#8217;s December 2020 Advisory Opinion (the &#8220;AO&#8221;) stating that drug manufacturers are legally obligated to deliver discounts under the 340B&#160;program to an unlimited number of contract pharmacies; (ii)&#160;HHS&#8217;s December&#160;2020 Administrative Dispute Resolution (&#8220;ADR&#8221;) Rule; and (iii)&#160;HRSA&#8217;s May&#160;2021 letter to Sanofi concluding that Sanofi&#8217;s 340B integrity initiative (under which Sanofi collects limited, de-identified, claims data on 340B-priced drugs dispensed by contract pharmacies) violates section&#160;340B and that Sanofi has therefore &#8220;overcharged&#8221; certain covered entities. The court issued its opinion in November&#160;2021, upholding HRSA&#8217;s conclusion in the May&#160;2021 letter, but did not impose any fines, penalties or refund obligations against Sanofi for any &#8220;overcharges&#8221;. The court also rejected Sanofi&#8217;s challenge to the ADR Rule and dismissed its challenge to the AO as moot. Sanofi appealed the court&#8217;s decision to the Third Circuit Court of Appeals and the government filed a cross-appeal. The Third Circuit issued its opinion on&#160;January&#160;30, 2023. It held that Sanofi&#8217;s restrictions on delivery to contract pharmacies do not violate Section&#160;340B. It also enjoined HHS from enforcing against Sanofi its reading of Section&#160;340B in the AO and the May&#160;2021 violation letter. As to Sanofi&#8217;s challenge to the ADR Rule, the Third Circuit held that HHS did not violate the Administrative Procedure Act&#8217;s notice-and-comment requirement in promulgating the ADR Rule.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In January&#160;2021, the National Association of Community Health Centers (&#8220;NACHC&#8221;) filed an ADR proceeding before HRSA on behalf of a number of covered entities, seeking to require Sanofi and AstraZeneca to supply contract pharmacies with 340B discounts without conditions. On August&#160;10, 2022, the ADR panel granted the motions to dismiss filed both by Sanofi and AstraZeneca, holding that the Delaware district court&#8217;s decision granting AstraZeneca&#8217;s motion for summary judgment precluded NACHC&#8217;s ADR claims against both AstraZeneca and Sanofi. </span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-87</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i87a6551511034bd29addbf27c1b51886"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2021, HRSA referred Sanofi (as well as other manufacturers) to the HHS Office of the Inspector General (OIG) in accordance with the 340B Program Ceiling Price and Civil Monetary Penalties Final Rule.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2021, the Vermont Attorney General issued a Civil Investigative Subpoena seeking certain information about Sanofi&#8217;s participation in the 340B Drug Pricing Program. Sanofi continues to cooperate with this investigation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, in July&#160;2021, Mosaic Health Inc. and Central Virginia Health Services (covered entities) filed a nationwide antitrust class action complaint against Sanofi and <ix:nonFraction unitRef="manufacturer" contextRef="if95f17244f744589bad8e963d5814997_D20210701-20210731" decimals="INF" name="sny:NumberOfOtherManufacturersInvolvedInProceedings" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzMzNjQ3_ca6a8577-8352-4296-a298-18deee45dcaa">three</ix:nonFraction> other manufacturers in the United States District Court for the Western District of New York. Plaintiffs allege that Sanofi and the other defendants conspired to eliminate favorable 340B pricing, particularly with&#160;respect to diabetes therapies. On September&#160;2, 2022, the court granted Defendants&#8217; motion to dismiss the complaint. On&#160;October&#160;3, 2022, plaintiff filed a motion for leave to file a second amended complaint. A motion to dismiss the second amended complaint is fully briefed and pending before the court.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">d) Contingencies arising from certain mergers &amp; acquisitions transactions</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As a result of divestitures, the Company is subject to a number of ongoing contractual and legal obligations regarding the state of the sold businesses, their assets, and their liabilities, some of which may be subject to dispute.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aventis CropScience Retained Liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The sale by Aventis Agriculture S.A. and Hoechst GmbH (both legacy companies of Sanofi) of their aggregate <ix:nonFraction unitRef="number" contextRef="i3575a00a4d2941dbb8f4491a3d7966d1_D20220101-20221231" decimals="2" name="sny:EquityInvestmentSoldPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzM0NTMw_9a9196a8-b42f-43c5-9b30-e1bc15bcd810">76</ix:nonFraction>% participation in Aventis CropScience Holding (ACS) to Bayer and Bayer CropScience AG (BCS), the wholly owned subsidiary of Bayer which holds the ACS shares, was effective on June&#160;3, 2002. The Stock Purchase Agreement (SPA) dated October&#160;2, 2001, contained customary representations and warranties with respect to the sold business, as well as a number of indemnifications subject to limitation periods and caps, in particular with respect to environmental liabilities for which some outstanding claims from Bayer remain unresolved.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infraserv Hoechst Retained Liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">By the Asset Contribution Agreement dated December&#160;19/20, 1996, as amended in 1997, Hoechst contributed all lands, buildings, and related assets of the Hoechst site at Frankfurt Hoechst to Infraserv GmbH &amp; Co. Hoechst KG. Infraserv Hoechst undertook to indemnify Hoechst against environmental liabilities at the Hoechst site and with respect to certain landfills. As consideration for the indemnification undertaking, Hoechst transferred to Infraserv Hoechst approximately &#8364;<ix:nonFraction unitRef="eur" contextRef="i14c2910d62e54d579f8a84cb7af92bab_I19971231" decimals="-6" name="sny:ConsiderationTransferredToFundReserveForIndemnificationUndertaking" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzM1NTc3_4fc210d4-8353-4b4d-8ac8-dcaac1eeca75">57</ix:nonFraction>&#160;million to fund reserves. In 1997, Hoechst also agreed it would reimburse current and future Infraserv Hoechst environmental expenses up to &#8364;<ix:nonFraction unitRef="eur" contextRef="i14c2910d62e54d579f8a84cb7af92bab_I19971231" decimals="-6" name="sny:MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzM1NzEy_e189a25e-cc5a-4785-8310-ac9f1eba1cf6">143</ix:nonFraction>&#160;million. As a former operator of the land and as a former user of the landfills, Hoechst may ultimately be liable for costs of remedial action in excess of this amount.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Boehringer Ingelheim (BI) Consumer Healthcare Liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and Boehringer Ingelheim (BI) are involved in an ICC (International Chamber of Commerce) arbitration regarding their respective indemnification obligations for liabilities connected to ongoing US court proceedings regarding Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> manufactured by BI (see above - Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Litigation in the US). The dispute arises from indemnification obligations agreed between Sanofi and BI as part of the swap of Sanofi&#8217;s Animal Health (AH) business for BI&#8217;s Consumer Health Care (CHC) business in January&#160;2017 and under a Global Settlement Agreement concluded in September&#160;2019 regarding notably the offset of respective AH and CHC claims notified under the SPAs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2020, BI initiated an arbitration against Sanofi seeking indemnification for losses it could incur as a result of the Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> litigation in the US. Sanofi is disputing BI&#8217;s claim for indemnification and has asserted several counterclaims under relevant agreements, including a counterclaim for indemnification of losses Sanofi and its affiliates have incurred and may incur in connection with the same US court proceedings involving Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The arbitration is expected to conclude at the earliest in&#160;March&#160;2023.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-88</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_661"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.23. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzY3NA_87e2a09b-3db9-410b-ab9c-2587b8089d75" continuedAt="i9f1fe7e82db94cfda71e63cab0b49eda" escape="true">Provisions for discounts, rebates and sales returns</ix:nonNumeric></span></div><ix:continuation id="i9f1fe7e82db94cfda71e63cab0b49eda"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Adjustments between gross sales and net sales, as described in Note&#160;B.13., are recognized either as provisions or as reductions in accounts receivable, depending on their nature.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzY3NQ_8c4707b5-20ae-4e65-8ac6-fcd5c748c0ad" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows movements in these items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:28.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Government</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and State</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">programs</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Managed&#160;care</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and&#160;GPO</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">programs</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chargeback<br/>incentives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rebates<br/>and<br/>discounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sales<br/>returns</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>deductions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1b692bdf75f2434fb133bc7a3bb3fdb5_I20191231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtMi0xLTEtMzY0MDYw_ed553d6c-bab8-4061-87ce-2c1af2e93144">2,178</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2bca265b5de846a49ff7d66d365cd3f5_I20191231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtMy0xLTEtMzY0MDYw_2cef449f-4e23-4fc8-88f7-826dd74c0f3b">726</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4c7d49c8079f45a984607afd055f6141_I20191231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtNC0xLTEtMzY0MDYw_66134d41-7593-4eaf-9743-568ca5916e67">312</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9a5e4694eeae43cb9ed974f712d64133_I20191231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtNS0xLTEtMzY0MDYw_76b0a5b5-7393-4fa6-8395-7b7fb14dbe3c">1,330</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i616d5f0474774329bb2e1a83718aa3db_I20191231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtNi0xLTEtMzY0MDYw_fe05c9be-436e-4f24-a1fc-bd2efd3acb55">621</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0581727a37ae4f2d83f10871f2fa2679_I20191231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtNy0xLTEtMzY0MDYw_d64e4bd1-36c0-4e27-9d8f-3cd7b30f9b54">51</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtOC0xLTEtMzY0MDYw_db3361e4-a4c8-4abf-b96a-76ccd7882055">5,218</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision related to current period sales</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3ed9f546c418470cba11c23974e26f46_D20200101-20201231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtMi0xLTEtMzY0MDYw_23ecaabe-f07a-4157-abac-63e1b9c1fc28">5,970</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9769bd55d48b434eb6a92677ad1f68f5_D20200101-20201231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtMy0xLTEtMzY0MDYw_c6227033-7956-40c6-8719-db8977df57df">2,752</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibd15f26a3ce6450ca2aca80db285ee51_D20200101-20201231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtNC0xLTEtMzY0MDYw_d9b5cb11-1b1a-419b-bbc6-8e1b877d2b4c">4,633</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0b61014391a14c5fb1683b9dc341e3d0_D20200101-20201231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtNS0xLTEtMzY0MDYw_be2fe26b-7e24-46a5-bbb0-b7bd14de27b2">6,221</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic01ffee4e6cd43d784f593303e505e23_D20200101-20201231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtNi0xLTEtMzY0MDYw_e61e26fa-9452-4127-897e-fcb3b9ceba70">628</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0b84d1d2c5a14568bc00a2d9f3f9825d_D20200101-20201231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtNy0xLTEtMzY0MDYw_a3c9b5c3-fd7c-41a8-a4b2-336230c14bd2">110</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtOC0xLTEtMzY0MDYw_49cd1bd5-e7f3-493b-afbd-0b7bb22f6ff2">20,314</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in provision related to prior period sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3ed9f546c418470cba11c23974e26f46_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtMi0xLTEtMzY0MDYw_19d21a7f-b729-4e59-bb43-0590679bb468">54</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9769bd55d48b434eb6a92677ad1f68f5_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtMy0xLTEtMzY0MDYw_caf596d3-d26a-4c12-8ef7-dab401ba87b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibd15f26a3ce6450ca2aca80db285ee51_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtNC0xLTEtMzY0MDYw_338eae15-a1dc-4ef0-8493-3e7e63c1ff12">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0b61014391a14c5fb1683b9dc341e3d0_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtNS0xLTEtMzY0MDYw_5579a0c1-2b33-418b-952f-61a486e7435c">113</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic01ffee4e6cd43d784f593303e505e23_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtNi0xLTEtMzY0MDYw_642b47c6-0bc1-44f1-8181-33a2d7d42b63">34</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0b84d1d2c5a14568bc00a2d9f3f9825d_D20200101-20201231" decimals="-6" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtNy0xLTEtMzY0MDYw_ad876468-80cd-44ba-a0b9-b9ee226c7c53">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtOC0xLTEtMzY0MDYw_4f3e1e31-cb1a-473f-bd4f-5ce7e077616c">201</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3ed9f546c418470cba11c23974e26f46_D20200101-20201231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtMi0xLTEtMzY0MDYw_ac67d305-ae7c-4b3d-bf51-fb09e189f828">5,552</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9769bd55d48b434eb6a92677ad1f68f5_D20200101-20201231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtMy0xLTEtMzY0MDYw_4a6c4a21-1145-4cca-95f7-2254d9325c23">2,556</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ibd15f26a3ce6450ca2aca80db285ee51_D20200101-20201231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtNC0xLTEtMzY0MDYw_be1f4597-9d71-4c90-a7a7-7f5b7db473f6">4,604</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0b61014391a14c5fb1683b9dc341e3d0_D20200101-20201231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtNS0xLTEtMzY0MDYw_3f0d0d65-2fb5-46cb-88ca-3d6507d2b6e6">5,838</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic01ffee4e6cd43d784f593303e505e23_D20200101-20201231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtNi0xLTEtMzY0MDYw_1fbd49a0-11ed-408c-9ad5-3653e18d0b2f">512</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0b84d1d2c5a14568bc00a2d9f3f9825d_D20200101-20201231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtNy0xLTEtMzY0MDYw_b1dabb49-0e9a-4760-8332-236366b5f628">112</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtOC0xLTEtMzY0MDYw_fcd048ec-b216-48a3-b8e1-e17c08542861">19,174</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3ed9f546c418470cba11c23974e26f46_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtMi0xLTEtMzY0MDYw_319a4583-e79e-4e00-88eb-e986a2b6fbfa">35</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9769bd55d48b434eb6a92677ad1f68f5_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtMy0xLTEtMzY0MDYw_3a7544af-e77a-479f-a4f7-88b82401d6f8">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ibd15f26a3ce6450ca2aca80db285ee51_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtNC0xLTEtMzY0MDYw_337e2441-b7f7-4e9f-b6cd-1ed1c0c3dd69">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0b61014391a14c5fb1683b9dc341e3d0_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtNS0xLTEtMzY0MDYw_ea34a3ee-c186-4017-9d8e-a0d517dbbf26">43</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic01ffee4e6cd43d784f593303e505e23_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtNi0xLTEtMzY0MDYw_f76570b7-2de6-4710-9737-cd14ed37897e">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0b84d1d2c5a14568bc00a2d9f3f9825d_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtNy0xLTEtMzY0MDYw_cfa3d1a3-ef22-4beb-aeb1-4ea81f306fe4">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtOC0xLTEtMzY0MDYw_0bff03c3-2344-4da9-bb20-4a6bc4c94757">118</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i85baff112a0f450580f65baeb088ac0e_I20201231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctMi0xLTEtMzY0MDYw_6349913f-a4a3-4432-b697-480565dca664">2,507</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic3e70d031c364b549f2725ec8740c482_I20201231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctMy0xLTEtMzY0MDYw_54e1c3ce-756f-40c6-b789-a66278a08393">908</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i344fce21336047d085f98ba60b6a24d1_I20201231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctNC0xLTEtMzY0MDYw_bdeb6fa3-6e74-4e23-bc34-b1d839da88f9">333</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4ccd90377a634c1ba0858901f0b24074_I20201231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctNS0xLTEtMzY0MDYw_b5d0196c-0fee-4e43-aca1-ffec6bd3061f">1,557</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie3b2786a0eee40519674a931fd7e4b4f_I20201231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctNi0xLTEtMzY0MDYw_8a35bf82-5190-44cd-b2f1-ccd6d8b13321">688</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63ca5f593dcd4e829883dd52c4e652e1_I20201231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctNy0xLTEtMzY0MDYw_db7bd200-1ee1-490c-aa4f-f16602a87999">46</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctOC0xLTEtMzY0MDYw_118b62fd-706e-4e93-9e8a-0eeb887ee61c">6,039</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtMi0xLTEtNDkyMTA5_cc3cf844-8720-430f-9e53-10bc7f650b0d">3</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtMy0xLTEtNDkyMTA5_9fa02d6b-1c85-45a1-98c2-b7b1a044aa7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNC0xLTEtNDkyMTA5_b409f6b5-b117-4e58-9fde-b3abb7901479">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNS0xLTEtNDkyMTA5_2b1546ef-10b8-49ac-ad20-94306a0737ba">2</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNi0xLTEtNDkyMTA5_619a6a08-1a0b-48df-9814-60e068f18176">1</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNy0xLTEtNDkyMTA5_9e5e160a-ca22-4478-9efb-96e164d95d3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtOC0xLTEtNDkyMTA5_5f02edee-8b35-4e24-afff-d639fa3be398">2</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision related to current period sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtMi0xLTEtMzY0MDYw_31335799-cbdb-4887-aaf8-fd1b7817947c">5,855</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtMy0xLTEtMzY0MDYw_b6c2d3aa-7050-4794-832b-e452ec7df61e">3,037</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNC0xLTEtMzY0MDYw_3dd55cf5-3b5d-4651-9c27-65f02473b88b">3,813</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNS0xLTEtMzY0MDYw_3f9b014f-3092-47f3-a57c-b0d0b09b9e4c">6,330</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNi0xLTEtMzY0MDYw_17a098d2-902c-47bf-9157-00b6bc29d962">582</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNy0xLTEtMzY0MDYw_8952a83c-f74e-4af1-91d0-51bd94446ac1">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtOC0xLTEtMzY0MDYw_0c25a4f0-8b90-4236-b91c-6a1355a2a7b1">19,714</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in provision related to prior period sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktMi0xLTEtMzY0MDYw_d885624a-61ca-42e2-884b-d5fec672491a">136</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktMy0xLTEtMzY0MDYw_5fac7d07-1018-404d-a48a-460fadb76990">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktNC0xLTEtMzY0MDYw_2f61a305-f543-45cf-84d4-dce998abaf9f">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktNS0xLTEtMzY0MDYw_7ce32378-bac8-485d-b5fe-c573c6107257">152</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231" decimals="-6" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktNi0xLTEtMzY0MDYw_b69c4469-0c90-40a5-8f77-53df5a2b52cd">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktNy0xLTEtMzY0MDYw_69f4b88a-d8d2-4c33-83c2-fbe175b3b6da">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktOC0xLTEtMzY0MDYw_0b37fa06-5f54-4e9a-b08e-c4c4f580a8d8">242</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTItMS0xLTM2NDA2MA_484aedee-7267-446c-b678-a2d45d6afbcb">5,561</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTMtMS0xLTM2NDA2MA_9b74ea78-ad71-4678-836b-13c000847e18">2,979</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTQtMS0xLTM2NDA2MA_5993ca24-4258-4d38-beb9-8f13938c1998">3,828</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTUtMS0xLTM2NDA2MA_e9be9634-fe00-45cb-99e0-7f2af927a115">6,291</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTYtMS0xLTM2NDA2MA_efb42f58-7a28-4c9c-81b9-cefef692ed99">697</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTctMS0xLTM2NDA2MA_baecd370-8f89-4f2f-8e0a-ab1767277ad0">105</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTgtMS0xLTM2NDA2MA_ece9fd54-c62b-4a7c-b0c4-01dc62093921">19,461</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTItMS0xLTM2NDA2MA_26f6f36e-3966-4e6b-8359-61cb5f0a446c">72</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTMtMS0xLTM2NDA2MA_6104fd5a-ab83-4ea0-9b4a-bb791674795e">32</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTQtMS0xLTM2NDA2MA_4dcb5851-b6ef-43b0-b5ab-8b2b97eec0b1">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTUtMS0xLTM2NDA2MA_f18051ad-afb8-445b-943b-b6f5d3535be5">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTYtMS0xLTM2NDA2MA_cd76afe9-2068-4eba-aaaf-c0dc2b110bbe">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTctMS0xLTM2NDA2MA_f95e8b60-5474-4fb5-83e5-ac42c2869839">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTgtMS0xLTM2NDA2MA_f6cafbb7-e1e2-40f5-8ec6-8816482571a2">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i64d9d93ffb0648ffbad6d150cda752c8_I20211231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTItMS0xLTM2NDA2MA_91f76e43-1483-4d90-9a3b-92b7447bf290">2,596</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibded5a5821924d39b6d1c07b0695c6d9_I20211231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTMtMS0xLTM2NDA2MA_f47fb9de-ab8a-4aa8-9fa6-2ed0fddb0610">931</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i99b5e4f93c1a49cd8ea204607473a1ec_I20211231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTQtMS0xLTM2NDA2MA_3603996b-509f-4a3a-bbd0-13452b97be7e">303</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia3210673a6874b43b966528be2cf0794_I20211231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTUtMS0xLTM2NDA2MA_7e85b44a-4fa3-4c82-bedf-fa78813bba33">1,425</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i233e41249a394b40b74263dc10afafe5_I20211231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTYtMS0xLTM2NDA2MA_0886c12c-7cd8-4b09-aaae-88f77df033da">610</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b9aaaedaaea4f29a759d257cad38085_I20211231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTctMS0xLTM2NDA2MA_e28fe6a7-c16b-4944-963e-e0008705b7ec">34</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTgtMS0xLTM2NDA2MA_84b6fa95-80ef-4393-b3c2-3162981c5d72">5,899</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision related to current period sales</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib46e8377d3f94800bd25709bd341fc00_D20220101-20221231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTItMS0xLTM2NDA2MA_c050d3fb-ff4a-47cc-80e5-4d91c7768235">6,744</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib22a0224790241248f93cd93a45b1232_D20220101-20221231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTMtMS0xLTM2NDA2MA_feacab69-9821-454e-8f48-08955eecade6">3,246</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8f228d50520f41bc92115db7843c0ad7_D20220101-20221231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTQtMS0xLTM2NDA2MA_6c9942cc-5129-4212-be61-746683ecaf23">4,147</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4116d4bfc3b743c3a4f8f2de755afa63_D20220101-20221231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTUtMS0xLTM2NDA2MA_c1c7569a-c718-493e-b951-d63a05202f9f">7,244</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie16e60a90d774109bacdee057e8bca89_D20220101-20221231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTYtMS0xLTM2NDA2MA_8261af9f-a889-4528-a8dd-453af32c3ea7">578</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0f6bf0d8ac1b4edb9f472e86394d3706_D20220101-20221231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTctMS0xLTM2NDA2MA_97b37c7a-fb45-4c47-8b2b-3ef1071cf202">182</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTgtMS0xLTM2NDA2MA_5ca409dd-037a-40d4-baaa-86dcd57c4aa0">22,141</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in provision related to prior period sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib46e8377d3f94800bd25709bd341fc00_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTItMS0xLTM2NDA2MA_caaf661d-99a5-4c93-909f-33f3750546e5">120</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib22a0224790241248f93cd93a45b1232_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTMtMS0xLTM2NDA2MA_c2fa035b-180f-4425-b088-96fabdcc2d48">47</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8f228d50520f41bc92115db7843c0ad7_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTQtMS0xLTM2NDA2MA_e85dcad0-9e38-4c88-b496-63469839b9ed">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4116d4bfc3b743c3a4f8f2de755afa63_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTUtMS0xLTM2NDA2MA_7c516330-b739-44e0-a45c-9257713cece3">138</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie16e60a90d774109bacdee057e8bca89_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTYtMS0xLTM2NDA2MA_07ae8d94-91bc-4188-b592-1e79d8b85530">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0f6bf0d8ac1b4edb9f472e86394d3706_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTctMS0xLTM2NDA2MA_3aba5625-39fa-4ab0-9048-0e54e69f0957">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTgtMS0xLTM2NDA2MA_d90b4d6e-10fb-4c1e-8e65-a8e1492d566b">315</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib46e8377d3f94800bd25709bd341fc00_D20220101-20221231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTItMS0xLTM2NDA2MA_91381890-f70a-4591-8d3d-014e233b8a15">6,824</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib22a0224790241248f93cd93a45b1232_D20220101-20221231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTMtMS0xLTM2NDA2MA_2fdbd6ef-0364-48d8-8155-508393681c28">3,208</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8f228d50520f41bc92115db7843c0ad7_D20220101-20221231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTQtMS0xLTM2NDA2MA_044e173c-5be4-4b4b-afd5-ff151fd00727">4,093</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4116d4bfc3b743c3a4f8f2de755afa63_D20220101-20221231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTUtMS0xLTM2NDA2MA_f860af74-7a49-4c64-b80c-00b2d487f45c">6,809</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie16e60a90d774109bacdee057e8bca89_D20220101-20221231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTYtMS0xLTM2NDA2MA_b8dc0af1-2c16-4ff4-bc48-b296466c5d5d">599</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i0f6bf0d8ac1b4edb9f472e86394d3706_D20220101-20221231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTctMS0xLTM2NDA2MA_742acaae-c58b-42ee-b3fc-f7cf3d061a2e">166</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTgtMS0xLTM2NDA2MA_193527e4-5f5f-4b1a-b365-9c22c687f7f2">21,699</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib46e8377d3f94800bd25709bd341fc00_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTItMS0xLTM2NDA2MA_811cbb81-0daf-4811-8ba6-70fe942e4b82">207</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib22a0224790241248f93cd93a45b1232_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTMtMS0xLTM2NDA2MA_e6482af2-c92d-4796-a1f8-f98fc150e899">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8f228d50520f41bc92115db7843c0ad7_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTQtMS0xLTM2NDA2MA_d1a1d52e-63ec-4693-b455-f9a9c5777c2a">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4116d4bfc3b743c3a4f8f2de755afa63_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTUtMS0xLTM2NDA2MA_ee3a27f0-1644-4df0-80a6-dc59b822d906">83</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie16e60a90d774109bacdee057e8bca89_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTYtMS0xLTM2NDA2MA_059200a9-28da-43b9-bab3-abd8297005e8">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0f6bf0d8ac1b4edb9f472e86394d3706_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTctMS0xLTM2NDA2MA_da0b5977-5f45-417e-9fbb-a67300a41f6c">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTgtMS0xLTM2NDA2MA_b686b791-aec0-4312-a005-7121c77c3ede">464</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2022</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i72900069921b42fea99c263ebf35ef00_I20221231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTItMS0xLTM2NDA2MA_4f6938d4-31a2-4ed8-be8f-3d8e6ae60128">2,603</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4cca6f8175204ac1bc6a07e79e2ef411_I20221231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTMtMS0xLTM2NDA2MA_4e7ce593-6f55-45a9-b58a-04e2c8503679">1,021</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4cdb48ddcab543e797bec062453e8560_I20221231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTQtMS0xLTM2NDA2MA_32fe24ca-cec3-4614-9bb0-9c2ca835319c">362</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic7d6e7f31f0449ad8c055ca0af7ee098_I20221231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTUtMS0xLTM2NDA2MA_f5a27ac0-a91d-4c9a-92ce-df2e9a24e8f8">1,805</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iff9f3b36e4cf420295883612ede99cca_I20221231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTYtMS0xLTM2NDA2MA_32926516-a797-439d-819c-c324735b01aa">629</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7f9eac0c1cdb4f5c83bcb43211427c90_I20221231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTctMS0xLTM2NDA2MA_b92cf2e3-5817-40cb-99b7-80831099cbea">70</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTgtMS0xLTM2NDA2MA_dd9e953b-b469-4866-9ff9-44af3314204b">6,490</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Primarily US government programs: Medicaid (&#8364;<ix:nonFraction unitRef="eur" contextRef="i290ce668686b44a794845d7477734f86_I20221231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzM0MA_403be3f5-119c-400d-89a3-7990366f4893">1,307</ix:nonFraction> million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i6c1eb476973a44889e6ab4746c231250_I20211231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzM1MA_e8394013-426e-4cc8-8b14-652f8c38e8da">1,244</ix:nonFraction> million in 2021, &#8364;<ix:nonFraction unitRef="eur" contextRef="i85bcc857ce00463eac390d699613b102_I20201231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzM2MA_c498f4a8-3161-48e9-aea3-8370b5fbaaa7">1,015</ix:nonFraction> million in 2020) and Medicare (&#8364;<ix:nonFraction unitRef="eur" contextRef="ib426e8d70a6d4415bc4d1dad51db673f_I20221231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzM4NA_c7e96dfb-b737-4b4c-b21c-bb7a6b5cad62">775</ix:nonFraction> million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i90191c61996943178db939f24e430160_I20211231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzM5NA_1e241076-9989-41f7-abfe-f8c72f1a3310">941</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i5007c17b33544991b3dbdb064cc3f736_I20201231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzQwOQ_58cb6ad2-7483-4d38-9e1e-bb73a0b522b2">726</ix:nonFraction> million in 2020).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Mainly rebates and other price reductions granted to healthcare authorities in the United States (including Managed Care: &#8364;<ix:nonFraction unitRef="eur" contextRef="if8af58300a9146fc82e82e9c13c202cc_I20221231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzU0Ng_3093252e-e425-4502-858d-2cfe7d04c486">934</ix:nonFraction> million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i852b799422a14eaba1c477f4f3c8a31d_I20211231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzU1Ng_151f57c2-ed92-476b-bffe-d0777b800207">896</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="iebbc786d5e4e406c8d9fb17fb74e7b2b_I20201231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzU3MA_8081b180-2e3d-499d-bcc8-0f5b180ef9e0">692</ix:nonFraction> million in 2020).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Provisions related to US net sales amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzYzMg_2e00136c-8024-467b-aedb-20ad4021175c">4,270</ix:nonFraction> million as of December 31, 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzY0NQ_5db7eb89-11e6-413e-93c2-662869bf2135">4,057</ix:nonFraction> million as of December 31, 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231" decimals="-6" name="sny:ProvisionsForDiscountsRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzY2MQ_6eb16252-b5e7-4fe4-9165-eafbcfdcb81a">3,982</ix:nonFraction> million as of&#160;December 31, 2020.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_664"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.24. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90ZXh0cmVnaW9uOjYwMDIwZjE3ZGE1YTQxNjE4NGVkYTI0YTRmNjM4YTJiXzM3Mg_c5852b7a-48d2-44c6-be16-e8724012d605" continuedAt="i6dd573a0cdb94fa493761db4a710e61a" escape="true">Personnel costs</ix:nonNumeric></span></div><ix:continuation id="i6dd573a0cdb94fa493761db4a710e61a"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfPersonnelCostsDetailsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90ZXh0cmVnaW9uOjYwMDIwZjE3ZGE1YTQxNjE4NGVkYTI0YTRmNjM4YTJiXzM3NA_e14d46ed-2acb-43d7-917a-41cc2663c102" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Total personnel costs (other than termination benefits, presented in Note&#160;D.27.) include the following items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Salaries</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:WagesAndSalaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzEtMS0xLTEtMzY0MDYw_8c76f2f6-2c85-4078-be6a-f0fa12f7ae0c">7,145</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:WagesAndSalaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzEtMi0xLTEtMzY0MDYw_60c7f908-691f-4146-809d-c9b7816d5309">6,625</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:WagesAndSalaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzEtMy0xLTEtMzY0MDYw_0edb5767-83cc-4196-bf77-94f76ae5cd41">6,508</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Social security charges (including defined-contribution pension plans)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:SocialSecurityContributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzItMS0xLTEtMzY0MDYw_d0a58a40-36ad-4757-aed4-72f3b228730e">2,098</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:SocialSecurityContributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzItMi0xLTEtMzY0MDYw_277386b3-e39e-4b37-816a-dc0b70c80b8d">1,929</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:SocialSecurityContributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzItMy0xLTEtMzY0MDYw_2680ed88-2585-4ebe-b132-b7d2a311fa08">1,874</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock options and other share-based payment expense</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzMtMS0xLTEtMzY0MDYw_2ca28ad5-feb6-411d-a700-d13d3b967d43">245</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzMtMi0xLTEtMzY0MDYw_cac2a9cb-8424-44de-968e-383859f27ee2">244</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzMtMy0xLTEtMzY0MDYw_43dcaec8-8c8e-4158-b8bf-431fc8979a37">274</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Defined-benefit plans</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzQtMS0xLTEtMzY0MDYw_93371163-079d-47df-9b23-9a29fdbd91b5">236</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzQtMi0xLTEtMzY0MDYw_1e69dd88-3854-438f-9b0f-57628860bf6d">273</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzQtMy0xLTEtMzY0MDYw_74459905-6a9b-494b-8358-56c96e214a55">162</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other employee benefits</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:OtherEmployeeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzUtMS0xLTEtMzY0MDYw_3b3d11cc-fa31-45e3-ab78-1b545e124fce">267</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:OtherEmployeeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzUtMi0xLTEtMzY0MDYw_40d1aa0b-756a-4afd-8a68-62dc5dde294d">269</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:OtherEmployeeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzUtMy0xLTEtMzY0MDYw_1067d848-fffc-4941-abbb-52dd4ae5d907">261</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzYtMS0xLTEtMzY0MDYw_b1658044-d85d-462d-9885-29390fcf5f9d">9,991</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzYtMi0xLTEtMzY0MDYw_fc16bfce-0401-43fd-acd9-a329546a64f3">9,340</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:EmployeeBenefitsExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzYtMy0xLTEtMzY0MDYw_3c90f967-5fe1-4e9b-88b7-30d61ff92530">9,079</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The total number of registered employees was <ix:nonFraction unitRef="employee" contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231" decimals="INF" name="ifrs-full:NumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90ZXh0cmVnaW9uOjYwMDIwZjE3ZGE1YTQxNjE4NGVkYTI0YTRmNjM4YTJiXzMxNw_acff51a6-7c32-4126-9288-21faa50dc1cc">91,573</ix:nonFraction> as of December 31, 2022, compared with <ix:nonFraction unitRef="employee" contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231" decimals="INF" name="ifrs-full:NumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90ZXh0cmVnaW9uOjYwMDIwZjE3ZGE1YTQxNjE4NGVkYTI0YTRmNjM4YTJiXzM0NA_9f293b5d-a448-495f-bd63-24dc56d70a63">95,442</ix:nonFraction> as of December 31, 2021 and&#160;<ix:nonFraction unitRef="employee" contextRef="i0566192b2355417fa9d42170481d811a_I20201231" decimals="INF" name="ifrs-full:NumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90ZXh0cmVnaW9uOjYwMDIwZjE3ZGE1YTQxNjE4NGVkYTI0YTRmNjM4YTJiXzM2MA_a29de26d-20eb-408b-9aba-0cef95d6a83e">99,412</ix:nonFraction> as of December 31, 2020.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_667"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.25.&#160;<ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzY5MA_bf4df5d6-fffd-46b3-8e6f-40c12a644eb9" continuedAt="ie1957697f96e481f9ad7eaf7d4e2ec87" escape="true">Other operating income</ix:nonNumeric></span></div><div style="margin-bottom:5pt;text-align:justify"><ix:continuation id="ie1957697f96e481f9ad7eaf7d4e2ec87" continuedAt="i254d0d7143a44a9eb5d0c9249c716528"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">totaled &#8364;<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzY1_b191e594-33fb-4884-a292-fe8b76af4d2f">1,969</ix:nonFraction> million in 2022, versus &#8364;<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzgy_9903c0ed-2563-4c6e-97fc-a40e1ca46c63">859</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzk1_bcf60734-3181-499e-b4fe-85fded705b9a">697</ix:nonFraction> million in 2020.</span></ix:continuation></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:continuation id="i254d0d7143a44a9eb5d0c9249c716528">Other operating income includes (i)&#160;gains from asset divestments, amounting to &#8364;<ix:nonFraction unitRef="eur" contextRef="i91602956c5a04e7d8e221b1a2b3c3fd3_D20220101-20221231" decimals="-6" name="sny:GainsOnDivestmentOfProducts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzE4NQ_bd64b51a-1d7a-4f4e-8218-39e32d12843b">655</ix:nonFraction>&#160;million in 2022 (versus &#8364;<ix:nonFraction unitRef="eur" contextRef="ie12b73fd2da74dce969b70268e0ff95e_D20210101-20211231" decimals="-6" name="sny:GainsOnDivestmentOfProducts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzIxMQ_8b6b28a7-f5b8-449d-9e9c-308bb49019fc">418</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="iaa3510029eb8449b898dcffcb36596d8_D20200101-20201231" decimals="-6" name="sny:GainsOnDivestmentOfProducts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzIyNQ_f016af0d-991a-4642-b571-392ee2538582">307</ix:nonFraction> million in 2020); and (ii)&#160;income from Sanofi&#8217;s pharmaceutical partners, amounting to &#8364;<ix:nonFraction unitRef="eur" contextRef="iff607e4176ca4b068613990b2582eabf_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzMwMQ_714ffda2-059b-4bcc-922a-b3e356ce86a9">1,178</ix:nonFraction> million in 2022 (including &#8364;<ix:nonFraction unitRef="eur" contextRef="i5f958208733644e1aae6fda659400f4e_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzMyMg_e7f15133-9139-4c01-b904-4b5195704129">1,147</ix:nonFraction> million from Regeneron, see Note&#160;D.26. below and Note C.1.), compared with &#8364;<ix:nonFraction unitRef="eur" contextRef="iaa10c8ec5cac4f29a0a9183bbd94bd99_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzM3OQ_26284c0c-5831-49e7-a8a9-45d78c708b5f">245</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i6e57a41f946d4ff4a313d21852bdba8b_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzM5Mw_4c68b7b2-5e1d-4e19-891c-35276ce233ab">199</ix:nonFraction> million in 2020. For 2021, it includes a payment of &#8364;<ix:nonFraction unitRef="eur" contextRef="i970b0685e8954a3aa5ddf4a490518870_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzQ1OA_58dbaea8-ac41-4fee-a215-63ad47699c44">119</ix:nonFraction>&#160;million from Daiichi Sankyo relating to the termination of a vaccines collaboration agreement in Japan</ix:continuation>.</span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-89</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_670"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.26.&#160;<ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzM4NQ_c3755847-14f3-49cf-99b4-9e92667e5773" continuedAt="i251d0eca1fab41408a163ba5eb984d6b" escape="true">Other operating expenses</ix:nonNumeric></span></div><ix:continuation id="i251d0eca1fab41408a163ba5eb984d6b"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> totaled &#8364;<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzY5_a35b8fe1-a495-4c29-a9f8-cc1f021f28cb">2,531</ix:nonFraction> million in 2022, compared with &#8364;<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4Xzkz_2abf9cca-162b-4e3c-ae56-9a4420f1a290">1,805</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzEwNg_46b1a524-4dc1-49a5-84e1-9ce493db541c">1,415</ix:nonFraction> million in 2020.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:OtherOperatingExpensesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzM4Ng_f329ca90-1a8c-4136-8e88-91c3706b640d" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2022, this line item includes &#8364;<ix:nonFraction unitRef="eur" contextRef="ie13a4afd7b1b4e79b6db10af437058d8_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzE0OA_d7fd3e11-73c1-4c92-982a-26d6168c72a0">2,378</ix:nonFraction> million of expenses relating to the alliance with Regeneron (see Note&#160;C.1.), compared with&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i018625c9ec8b468a9ff0873e7d03260a_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzIyNw_3c8f0334-f6f7-4480-a1c0-21f97c95d3dc">1,568</ix:nonFraction> million for 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i17591b56caee4f43b8f0bbb8ca58a6f4_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzI0MQ_4aca79f6-b9ab-401c-bfb6-8bd82c15323a">1,090</ix:nonFraction> million for 2020 (as shown in the table below):</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income &amp; expense related to sharing of (profits)/losses under the Monoclonal Antibody Alliance</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i52bffdb81007440da92ed6b97e6d9231_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzEtMS0xLTEtMzY0MDYw_b0a77f30-9b43-4e97-9d5f-144d0e1b4075">2,325</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5c405e8e7d324c77bfd2af173dcbb932_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzEtMi0xLTEtMzY0MDYw_cbc9452b-90c6-4d8d-b9c6-fa24fb745eb5">1,253</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i62fee9f3c5744551bbe06227b0c173fa_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzEtMy0xLTEtMzY0MDYw_424a90e7-9fb6-4213-a551-a017845a4a6b">727</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional share of profit paid by Regeneron towards development costs </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6fd5132ee30d4c7493ae9545f5714b73_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzItMS0xLTEtMzY0MDYw_133f210e-f9cf-4bd2-b94b-e9a58f341455">434</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d08b9ad0c254c1e8eeeba6476b35c2e_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzItMi0xLTEtMzY0MDYw_521200b5-dee9-4e23-9a2b-f3a3c0d25e05">127</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if958d5b745e54738bf294167a5124ac7_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzItMy0xLTEtMzY0MDYw_a2927634-3e39-4623-aefc-0adfda5b0722">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reimbursement to Regeneron of selling expenses incurred</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i171827e88bc74a668b2a39c3176ab65f_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzMtMS0xLTEtMzY0MDYw_8cbfac5b-5e88-45af-8274-9fb5b451066e">476</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i8348d8dee22140afbaa6845ac4456f2b_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzMtMi0xLTEtMzY0MDYw_c01499dd-78b8-4248-b4d1-f8d97dbc27e4">303</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6bcd495e13694c26aed02fa8a7200ca9_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzMtMy0xLTEtMzY0MDYw_a656e90c-df55-4f73-81da-9f7c8e77bb36">349</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total - Monoclonal Antibody Alliance</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i7a34f2d952b641fa9a97150c939ad0be_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzQtMS0xLTEtMzY0MDYw_c5c752c0-aa2a-422f-9022-8ac17f96629d">2,367</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i55a8693d305047af919fadebbfac7084_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzQtMi0xLTEtMzY0MDYw_b3199a1a-36ae-43d8-b49b-442882535e13">1,429</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic2326a92e2034921aa2a51bf11bc0d93_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzQtMy0xLTEtMzY0MDYw_779d9ead-b13e-4f77-a796-6cac98c72eed">1,001</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Immuno-Oncology Alliance</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ce30596c49c4242b0c04b915f6f7e57_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzUtMS0xLTEtMzY0MDYw_874b544a-ad3a-4c7f-aa94-8d7d8edb0f83">16</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i717efcfa32c548de8e23d8e05d058bc2_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzUtMi0xLTEtMzY0MDYw_b1c6dc83-9be3-413e-83f1-5a2aaf18a9f9">68</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia56a9ae0556147629310bbf5d7bcda1a_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzUtMy0xLTEtMzY0MDYw_ecbeeb72-be36-4c45-84a6-5980ea44d57b">89</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other (mainly Zaltrap</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"> and Libtayo</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i622bf4fa192846ca9f1f1cdce02e4c83_D20220101-20221231" decimals="-6" name="sny:MiscellaneousOtherOperatingIncomeExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzYtMS0xLTEtMzY0MDYw_9af87101-4db0-4a6f-b66c-bc4b31b19b00">1,120</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib7937d433de14ca7932134a404b27d2f_D20210101-20211231" decimals="-6" sign="-" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzYtMi0xLTEtMzY0MDYw_4c2134ed-705f-495a-ab20-0383a5511f11">12</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib79d267fb5b34f5cbd786c75b48c5759_D20200101-20201231" decimals="-6" sign="-" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzYtMy0xLTEtMzY0MDYw_589d4b12-1bf8-4e75-9ad2-28e392c55bfd">14</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other operating income/(expenses), net related to the Regeneron Alliance</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:OtherOperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzctMS0xLTEtMzY0MDYw_9d6936ba-4ea8-45cb-8738-60808ba8bf77">1,231</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:OtherOperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzctMi0xLTEtMzY0MDYw_c8be0fe8-b442-4b40-b5b0-d166129d2f94">1,373</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzctMy0xLTEtMzY0MDYw_bde7f6df-9cf4-4964-96d6-163c79378855">926</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which amount presented in</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"> Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"> (Note&#160;D.25.)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5f958208733644e1aae6fda659400f4e_D20220101-20221231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzgtMS0xLTEtMzY0MDYw_e7f15133-9139-4c01-b904-4b5195704129">1,147</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i088be89f9d1b4730a785c0f6445acec8_D20210101-20211231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzgtMi0xLTEtMzY0MDYw_cda29c72-9c77-4e32-a5e7-d44d071fb8d5">195</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib4a2186378404e3987bb8fd7e88f511f_D20200101-20201231" decimals="-6" name="ifrs-full:MiscellaneousOtherOperatingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzgtMy0xLTEtMzY0MDYw_6a6881f6-08ca-42e0-9ebc-d90adbc8b796">164</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Following the restructuring of the Immuno-Oncology agreement between Sanofi and Regeneron, applicable from July&#160;1, 2022 (see Note&#160;C.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) As of December 31, 2022, the commitment received by Sanofi in respect of the additional profit share payable by Regeneron towards development costs amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i3ecee33decbb47918bc45c5d39b6e2d8_I20221231" decimals="-8" name="sny:CommitmentsReceivedForDevelopmentCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzQyODgwOTUzNDg1MDY5_fd23bae1-f6dc-4b39-a120-cea15d90ac47">2.7</ix:nonFraction> billion, compared with &#8364;<ix:nonFraction unitRef="eur" contextRef="if08a539d4d40455d827bc164ddb96d57_I20211231" decimals="-8" name="sny:CommitmentsReceivedForDevelopmentCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzQyODgwOTUzNDg1MDI2_656acfd2-5e80-4b22-91f7-71e6c9c3ac40">2.9</ix:nonFraction>&#160;billion as of December 31, 2021 (see note D.21).</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Charges to provisions for litigation and environmental risks are also recorded within this line item.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_673"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.27. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfRestructuringCostsAndSimilarItemsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzEyMjg_e304e081-f3ad-4039-bfb5-499776d69f1a" continuedAt="i6e3375e272344db399d9c764fd5da908" escape="true">Restructuring costs and similar items</ix:nonNumeric></span></div><ix:continuation id="i6e3375e272344db399d9c764fd5da908"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfRestructuringCostsDetailsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzEyMzE_7f062f66-ae41-4570-8a4d-21d48e1046b0" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restructuring costs and similar items amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzEwMA_cea2a219-23b6-4ba9-9009-496db4e59314">1,336</ix:nonFraction> million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzExOQ_537ab77f-3b4f-4619-9f98-5803e1ae8863">820</ix:nonFraction> million in 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzE0MQ_31075019-f6f8-48ac-8e0a-d5a0a6947249">1,089</ix:nonFraction> million in 2020, and were comprised of the following items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:59.696%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee-related expenses</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzEtMS0xLTEtMzY0MDYw_10c1aff9-cf99-406f-b3b1-e5670c2539d0">507</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzEtMi0xLTEtMzY0MDYw_0f4ef0a6-8084-47a5-81ba-99cccadcc45e">193</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzEtNC0xLTEtMzY0MDYw_969df51b-7962-4389-a4e5-879b882a7e88">697</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Charges, gains or losses on assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzItMS0xLTEtMzY0MDYw_ec0217d7-0ac2-4db9-906d-74d0fd724492">261</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzItMi0xLTEtMzY0MDYw_73547244-178a-4958-82a0-15fa3fffa679">110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzItNC0xLTEtMzY0MDYw_6cb42d54-5a9e-4322-b8e8-109962da6388">149</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compensation for early termination of contracts (other than contracts of employment)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzMtMS0xLTEtMzY0MDYw_7fdce263-eed4-4f8f-b667-04a7a010f3ba">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzMtMi0xLTEtMzY0MDYw_d5f60b61-9c08-490b-beea-1c4fc829a031">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzMtNC0xLTEtMzY0MDYw_2dfee850-7e93-4b30-b045-e96a70f07e7e">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transformation programs costs</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzUtMS0xLTEtMzY0MDYw_37e824dd-79a5-4ac1-a757-fa9d991d7389">547</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzUtMi0xLTEtMzY0MDYw_b725c0b8-68d6-41e2-b2d4-a1aef562e05e">463</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzUtNC0xLTEtMzY0MDYw_8ef8f2fc-9b59-44a4-aa4c-34522f8e5885">191</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzYtMS0xLTEtMzY0MDYw_ea2167b6-72bf-403e-9baa-f356579d0027">20</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzYtMi0xLTEtMzY0MDYw_972eca47-e939-4f33-856c-f5a2ec82ab78">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzYtNC0xLTEtMzY0MDYw_66d4f4e4-b006-4b16-a840-e2c83e533adc">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzctMS0xLTEtMzY0MDYw_cea2a219-23b6-4ba9-9009-496db4e59314">1,336</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzctMi0xLTEtMzY0MDYw_537ab77f-3b4f-4619-9f98-5803e1ae8863">820</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzctNC0xLTEtMzY0MDYw_31075019-f6f8-48ac-8e0a-d5a0a6947249">1,089</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;This line consists of impairment losses and accelerated depreciation charges related to site closures (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the employee-related expenses of &#8364;<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzgwODE0MTA0NjQ4NjM3_282609b1-37c5-44eb-8bfb-ef2a42c480bd">507</ix:nonFraction>&#160;million related to termination benefits further to announcements made during the year, and the line &#8220;Charges, gains or losses on assets&#8221; related mainly to a strategic decision to close an industrial facility outside France. The costs of Sanofi's transformation program (as defined in Note&#160;B.19.) relate mainly to the ongoing creation of the new standalone Consumer Healthcare entity, and to the implementation of Sanofi&#8217;s new digital strategy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2021, the costs of Sanofi's transformation program were mainly related to the creation of the new standalone Consumer Healthcare entity and of EUROAPI (the new European market leader in active pharmaceutical ingredients), and to the implementation of Sanofi&#8217;s new digital strategy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2020, employee-related expenses amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzc2OTY1ODEzOTc5Mjk_66b130f6-b9c3-4344-aa32-c2d2f3e4b54c">697</ix:nonFraction>&#160;million, and consisted of termination benefits further to the announcement of plans to adapt Sanofi&#8217;s organization (primarily in Europe) in line with the new &#8220;Play to Win&#8221; strategy announced in December&#160;2019.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_676"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.28. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzYvZnJhZzowMTNiOWZlNGE3YWE0NjYxOTBmNWUxYTU2MDc3M2M3MS90ZXh0cmVnaW9uOjAxM2I5ZmU0YTdhYTQ2NjE5MGY1ZTFhNTYwNzczYzcxXzMzNg_e7e79bcd-be7e-4678-b2e7-9b456a8090b4" continuedAt="i2652695d2eda436190792c4b5c707970" escape="true">Other gains and losses, and litigation</ix:nonNumeric></span></div><ix:continuation id="i2652695d2eda436190792c4b5c707970"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">for </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2022 represent a charge of &#8364;<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="sny:OtherGainsLossesAndLitigation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzYvZnJhZzowMTNiOWZlNGE3YWE0NjYxOTBmNWUxYTU2MDc3M2M3MS90ZXh0cmVnaW9uOjAxM2I5ZmU0YTdhYTQ2NjE5MGY1ZTFhNTYwNzczYzcxXzI5Njg2ODEzOTUwNjA0_a01bf90d-26b5-4002-980c-87ba8c60c072">370</ix:nonFraction>&#160;million, </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">including the pre-tax loss arising on the deconsolidation of EUROAPI (see Note&#160;D.1.) and costs related to major litigation, including the estimated future defense costs which Sanofi may be exposed in connection with the Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> litigation</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2021, this line item represented a charge of &#8364;<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="sny:OtherGainsLossesAndLitigation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzYvZnJhZzowMTNiOWZlNGE3YWE0NjYxOTBmNWUxYTU2MDc3M2M3MS90ZXh0cmVnaW9uOjAxM2I5ZmU0YTdhYTQ2NjE5MGY1ZTFhNTYwNzczYzcxXzE3Ng_54232797-b400-4cb8-870b-694fe08fd1df">5</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2020, this line item represented a net gain of &#8364;<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:OtherGainsLossesAndLitigation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzYvZnJhZzowMTNiOWZlNGE3YWE0NjYxOTBmNWUxYTU2MDc3M2M3MS90ZXh0cmVnaW9uOjAxM2I5ZmU0YTdhYTQ2NjE5MGY1ZTFhNTYwNzczYzcxXzI3OA_9b0bfbe3-b435-4094-abec-45bb11801f2a">136</ix:nonFraction> million, mainly relating to the sale of Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-90</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_679"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.29. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2Xzc0Nw_ca03df23-1c20-4a4c-ae5d-08be5e4657b2" continuedAt="i9ac89faf57a74efea5f1ec3b779887f5" escape="true">Financial expenses and income</ix:nonNumeric></span></div><ix:continuation id="i9ac89faf57a74efea5f1ec3b779887f5"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2Xzc0OQ_568987f4-6917-4329-a040-6a2a553e1131" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:57.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of debt</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEtMS0xLTEtMzY0MDYw_aee91495-4cb0-49a7-b72f-417dfab0ec9e">365</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEtMi0xLTEtMzY0MDYw_f385b02e-e05d-4ff1-b140-400fe4cee5fe">313</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:InterestExpenseOnBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEtNC0xLTEtMzY0MDYw_bcd15c76-07fb-4c7c-83fc-09905889f43c">328</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:InterestIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzItMS0xLTEtMzY0MDYw_0ce3655b-db09-4666-8f81-5cc788f92d40">241</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:InterestIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzItMi0xLTEtMzY0MDYw_1de8cd58-a407-4626-822f-3348314e87ed">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:InterestIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzItNC0xLTEtMzY0MDYw_9979f8a1-9b51-4fe9-ae4b-f134a198f762">103</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cost of net debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:CostOfDebtNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzMtMS0xLTEtMzY0MDYw_b1fe12af-c957-487e-8c9e-d93874e857bd">124</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:CostOfDebtNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzMtMi0xLTEtMzY0MDYw_36aa0586-358b-412f-883d-9e7e042712c0">259</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:CostOfDebtNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzMtNC0xLTEtMzY0MDYw_795ac924-1edb-45f5-8326-2da07fc552e3">225</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-operating foreign exchange gains/(losses)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="sny:NonOperatingForeignExchangeGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzQtMS0xLTEtMzY0MDYw_041d795c-d44c-4866-87a6-747011c55677">4</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:NonOperatingForeignExchangeGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzQtMi0xLTEtMzY0MDYw_19a70c5e-be35-400e-b811-3dc70fc67e91">2</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="sny:NonOperatingForeignExchangeGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzQtNC0xLTEtMzY0MDYw_8e3bdd44-296f-4835-96f4-c63cc0ca64eb">6</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unwinding of discounting of provisions</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzUtMS0xLTEtMzY0MDYw_03ecd5ec-52f0-4898-9371-59d630a6b1b0">20</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzUtMi0xLTEtMzY0MDYw_0a441d1a-9f65-4003-a99f-2497b7cd6f5f">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzUtNC0xLTEtMzY0MDYw_cd07c76e-90a5-43b0-ab4a-6ac851acc1d1">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost related to employee benefits</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:NetInterestCostRelatedToEmployeeBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzYtMS0xLTEtMzY0MDYw_a47a0b09-0fec-47e4-a797-b63c749bfe34">47</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:NetInterestCostRelatedToEmployeeBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzYtMi0xLTEtMzY0MDYw_ad44dce5-6115-4c56-a526-3e85afc086c6">44</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:NetInterestCostRelatedToEmployeeBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzYtNC0xLTEtMzY0MDYw_93c48a91-94f5-4907-8df7-203b2958cefe">57</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) on disposals of financial assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:GainsLossesOnAvailableforsaleFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzctMS0xLTEtMzY0MDYw_82a66839-b7fa-4fa5-82b1-cd41fc5caa4c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:GainsLossesOnAvailableforsaleFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzctMi0xLTEtMzY0MDYw_20bacd78-6a59-4302-aa18-657c47d40830">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:GainsLossesOnAvailableforsaleFinancialAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzctNC0xLTEtMzY0MDYw_8d8bd101-debc-45c7-8e25-89f8d670bf58">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest expense on lease liabilities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzktMS0xLTEtMzY0MDYw_b0638f7c-5186-4959-a597-f23411ac9f47">40</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzktMi0xLTEtMzY0MDYw_74f21294-6762-443b-b5c4-2c20c89f346d">35</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzktNC0xLTEtMzY0MDYw_9de96676-bef7-4f22-b3d0-ea2afa92820d">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:OtherFinanceIncomeCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEwLTEtMS0xLTM2NDA2MA_cdc3de45-67b7-49fb-ae05-e15229a20078">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:OtherFinanceIncomeCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEwLTItMS0xLTM2NDA2MA_5a9718fc-31a4-441d-9c67-e992285b8fd2">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:OtherFinanceIncomeCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEwLTQtMS0xLTM2NDA2MA_26e79b81-2463-4345-ab84-0abef96aaa24">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net financial income/(expenses)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:FinanceIncomeCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzExLTEtMS0xLTM2NDA2MA_6fc7e2fc-2e4f-40d6-be3f-96a6049a47dd">234</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:FinanceIncomeCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzExLTItMS0xLTM2NDA2MA_5e263f4a-9891-4765-b3ce-6016e72fe5cd">328</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:FinanceIncomeCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzExLTQtMS0xLTM2NDA2MA_0d645955-b426-4186-a5b8-7a41b17954f4">335</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">comprising: Financial expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEyLTEtMS0xLTM2NDA2MA_d65c8421-37de-46a8-9f0f-6f86e86aa882">440</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEyLTItMS0xLTM2NDA2MA_18db40b5-9e82-41bb-9518-43c54708c003">368</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEyLTQtMS0xLTM2NDA2MA_ff2e696b-5c56-41cc-b889-bae1bd32ebb0">388</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial income</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEzLTEtMS0xLTM2NDA2MA_b545b726-dfef-4ddd-a394-7afdc59267d3">206</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEzLTItMS0xLTM2NDA2MA_eb5770b9-cdde-409d-8904-9c0c1eced34c">40</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEzLTQtMS0xLTM2NDA2MA_9a616d49-a647-4b1f-86b5-35afb5ef2ff2">53</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Includes net gains/(losses) on interest rate and currency derivatives used to manage debt: &#8364;(<ix:nonFraction unitRef="eur" contextRef="i552611be812d4cebb9f4bf048999a643_D20220101-20221231" decimals="-6" sign="-" name="sny:GainOnDerivativesUsedToManageDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzIwNA_da6833b2-fb8c-467c-a01f-1362e255c727">11</ix:nonFraction>) million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i7ace254a2ef1455c83c5985dd96fa2cb_D20210101-20211231" decimals="-6" name="sny:GainOnDerivativesUsedToManageDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzIxNA_9230e99c-c4a4-471f-9689-30fb3cb4ac39">14</ix:nonFraction> million in 2021, &#8364;<ix:nonFraction unitRef="eur" contextRef="ie87ee93c6896489f80ceecb2f2e91ea3_D20200101-20201231" decimals="-6" name="sny:GainOnDerivativesUsedToManageDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzIyNw_74c266fa-abfe-4aa2-a324-fd87464848fe">93</ix:nonFraction> million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Includes net gains on interest rate and currency derivatives used to manage cash and cash equivalents: &#8364;<ix:nonFraction unitRef="eur" contextRef="i552611be812d4cebb9f4bf048999a643_D20220101-20221231" decimals="-6" name="sny:GainOnDerivativesUsedToManageCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzM0NA_1866e69a-17fa-445c-88b0-b98d90ce2ddb">68</ix:nonFraction> million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i7ace254a2ef1455c83c5985dd96fa2cb_D20210101-20211231" decimals="-6" name="sny:GainOnDerivativesUsedToManageCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzM1NA_9765a032-5f82-4ca1-ac20-eca7d9f67b3f">51</ix:nonFraction> million in 2021, &#8364;<ix:nonFraction unitRef="eur" contextRef="ie87ee93c6896489f80ceecb2f2e91ea3_D20200101-20201231" decimals="-6" name="sny:GainOnDerivativesUsedToManageCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzM2Nw_20c2de5e-f78d-4efa-bd93-4ea7eb913f3d">66</ix:nonFraction> million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note&#160;D.19.).</span></div></ix:nonNumeric><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, 2021 and 2020, the impact of the ineffective portion of hedging relationships was not material.</span></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_682"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.30. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90ZXh0cmVnaW9uOjljZjRiNTI0NjQ4MzQ4N2JhZjQ4MmQyYzFmZWNkM2JhXzEyODc_d1ca08fb-e669-4287-b2e3-b38eec7531c7" continuedAt="i9ce2b25cc6844d6dbb373e7dd88f1acb" escape="true">Income tax expense</ix:nonNumeric></span></div><ix:continuation id="i9ce2b25cc6844d6dbb373e7dd88f1acb"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has elected for tax consolidations in a number of countries, principally France, Germany, the United Kingdom and the United States.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90ZXh0cmVnaW9uOjljZjRiNTI0NjQ4MzQ4N2JhZjQ4MmQyYzFmZWNkM2JhXzEyODg_1b199f1f-07f5-4bfa-9cc1-07781b9e8799" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the allocation of income tax expense between current and deferred taxes:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:57.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current taxes</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzEtMS0xLTEtMzY0MDYw_3a5deadc-eaf1-460e-9e0f-bf30fcdc614f">2,774</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzEtMi0xLTEtMzY0MDYw_c5893c05-73f0-4ad5-8f7e-d18183dd17a2">1,908</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:CurrentTaxExpenseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzEtNC0xLTEtMzY0MDYw_dfbee5de-e634-4211-8130-f943a64af90c">1,913</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzItMS0xLTEtMzY0MDYw_3ce2ee0b-954e-49ce-8dc1-8facfb66d9b8">768</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzItMi0xLTEtMzY0MDYw_9ec94c23-2156-4aef-8682-a4ac12685514">350</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:DeferredTaxExpenseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzItNC0xLTEtMzY0MDYw_6781424f-117e-42e0-9cea-fcab769782d0">106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzMtMS0xLTEtMzY0MDYw_3a96d870-3425-42ea-90d8-fe603f43de1f">2,006</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzMtMi0xLTEtMzY0MDYw_1d6d3705-6a85-40c5-9bd8-25cf11ae54bd">1,558</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzMtNC0xLTEtMzY0MDYw_7fe1df2c-5b7b-4f2b-9ba8-20651967fee9">1,807</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income before tax and investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzQtMS0xLTEtMzY0MDYw_c0b3c9bd-37a6-48ee-bd86-5400f1b4aba4">10,422</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzQtMi0xLTEtMzY0MDYw_3e0fbc47-c8c8-4ae1-a5fb-8af4331ab86e">7,798</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#23004c;padding:0 1pt"></td><td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzQtNC0xLTEtMzY0MDYw_7ba2f528-3f1f-4786-a2d6-ae9f56a684af">13,778</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#23004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90ZXh0cmVnaW9uOjljZjRiNTI0NjQ4MzQ4N2JhZjQ4MmQyYzFmZWNkM2JhXzEyODU_b1fd8024-a54f-4d3a-b748-10a08ab8980c" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the standard corporate income tax rate applicable in France is explained as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(as a percentage)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Standard tax rate applicable in France</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="3" name="ifrs-full:ApplicableTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzEtMS0xLTEtMzY0MDYw_8aedf0fd-f8ab-403c-b1fb-e9a23cfe7c43">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="3" name="ifrs-full:ApplicableTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzEtMi0xLTEtMzY0MDYw_494adf40-4f02-469c-9fd1-641adf5ab8fa">28.4</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="3" name="ifrs-full:ApplicableTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzEtMy0xLTEtMzY0MDYw_5f0822d9-230a-4fd9-a097-86b1c554776c">32.0</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Difference between the standard French tax rate and the rates applicable to Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="3" sign="-" name="ifrs-full:TaxRateEffectOfForeignTaxRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzItMS0xLTEtMzY0MDYw_5b5ec54d-34d1-461f-b570-c2038351ead6">6.5</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="3" sign="-" name="ifrs-full:TaxRateEffectOfForeignTaxRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzItMi0xLTEtMzY0MDYw_f3a4a992-587c-406f-bee1-8067afd8dff9">9.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="3" sign="-" name="ifrs-full:TaxRateEffectOfForeignTaxRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzItMy0xLTEtMzY0MDYw_acc731f1-112c-41d9-8c0e-68d9bec7a312">18.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Revisions to tax exposures and settlements of tax disputes</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="3" sign="-" name="sny:TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzMtMS0xLTEtMzY0MDYw_d93e32be-7f5f-4a1d-8815-f90197b209a4">0.8</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="3" name="sny:TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzMtMi0xLTEtMzY0MDYw_1cfcbf3b-827d-43e0-93fd-20b3f399dda3">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="3" name="sny:TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzMtMy0xLTEtMzY0MDYw_aae2df70-a261-489e-b923-3e72f74ea8f2">0.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="3" sign="-" name="sny:TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzUtMS0xLTEtMzY0MDYw_93b42ca7-a311-4da2-af8f-599d273ceb24">0.2</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="3" name="sny:TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzUtMi0xLTEtMzY0MDYw_c08374a1-7eaf-469d-a9d1-a2d2f058f325">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="3" name="sny:TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzUtMy0xLTEtMzY0MDYw_8cc65213-874f-4b88-9d01-56ead0ef3933">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other items</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="3" name="ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzYtMS0xLTEtMzY0MDYw_b556105d-f3f4-4e2a-a1ea-040510f1e056">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="3" name="ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzYtMi0xLTEtMzY0MDYw_9d1a3ad5-1402-46fd-8391-247a0cf7720b">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="3" sign="-" name="ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzYtMy0xLTEtMzY0MDYw_97a270ba-5299-4c7c-beba-e6ce2cd07ced">1.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="3" name="ifrs-full:AverageEffectiveTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzctMS0xLTEtMzY0MDYw_8dde86a0-5c46-4ea4-bbec-932262eee8bd">19.2</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="3" name="ifrs-full:AverageEffectiveTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzctMi0xLTEtMzY0MDYw_cf16c9cb-baac-4271-ab14-10c65abe1c3b">20.0</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="3" name="ifrs-full:AverageEffectiveTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzctMy0xLTEtMzY0MDYw_4f32887e-fbef-4b6f-b6de-6eaba5544e42">13.1</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France. For 2020, this line includes the difference between the standard French tax rate and the tax rate applicable to the gain on divestment of Regeneron shares.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In determining the amount of the deferred tax liability for 2022, 2021 and 2020, Sanofi took into account changes in the ownership structure of certain subsidiaries.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For the periods presented, the amount of deferred tax assets recognized in profit or loss that were initially subject to impairment losses at the time of a business combination is immaterial.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-91</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_685"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.31. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODUvZnJhZzphMGZiZTc2NjM4NDQ0NjZjODc3MGZkMTZjNGIyZDU2Mi90ZXh0cmVnaW9uOmEwZmJlNzY2Mzg0NDQ2NmM4NzcwZmQxNmM0YjJkNTYyXzg2Nw_4c9d7ebe-563c-490c-9b7d-c6598aa49a20" continuedAt="ida380b14ca2c4123a23e3520f076a5ed" escape="true">Share of profit/loss from investments accounted for using the equity method</ix:nonNumeric></span></div><div style="margin-bottom:5pt;text-align:justify"><ix:continuation id="ida380b14ca2c4123a23e3520f076a5ed"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Share of profit/(loss) from investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">amounted to &#8364;<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODUvZnJhZzphMGZiZTc2NjM4NDQ0NjZjODc3MGZkMTZjNGIyZDU2Mi90ZXh0cmVnaW9uOmEwZmJlNzY2Mzg0NDQ2NmM4NzcwZmQxNmM0YjJkNTYyXzIxNDQwNDc2NzQ1MDkx_9bad1c50-bf0f-4d13-909f-8b8c5fdcb538">68</ix:nonFraction>&#160;million for 2022, compared with &#8364;<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODUvZnJhZzphMGZiZTc2NjM4NDQ0NjZjODc3MGZkMTZjNGIyZDU2Mi90ZXh0cmVnaW9uOmEwZmJlNzY2Mzg0NDQ2NmM4NzcwZmQxNmM0YjJkNTYyXzIxNDQwNDc2NzQ1MDg2_0efb3c11-1922-4efc-b0f7-9f2de3c112e5">39</ix:nonFraction>&#160;million for 2021 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODUvZnJhZzphMGZiZTc2NjM4NDQ0NjZjODc3MGZkMTZjNGIyZDU2Mi90ZXh0cmVnaW9uOmEwZmJlNzY2Mzg0NDQ2NmM4NzcwZmQxNmM0YjJkNTYyXzIxNDQwNDc2NzQ1MDgx_23f25e7e-34c4-457e-acbf-c1c23e8a990d">359</ix:nonFraction>&#160;million for 2020 (including &#8364;<ix:nonFraction unitRef="eur" contextRef="i17591b56caee4f43b8f0bbb8ca58a6f4_D20200101-20201231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODUvZnJhZzphMGZiZTc2NjM4NDQ0NjZjODc3MGZkMTZjNGIyZDU2Mi90ZXh0cmVnaW9uOmEwZmJlNzY2Mzg0NDQ2NmM4NzcwZmQxNmM0YjJkNTYyXzgwODE0MTA0NjQ0OTk5_2dbff976-f10b-4e9b-8948-502da2f3f8de">343</ix:nonFraction>&#160;million for the share of Regeneron profits up to and including May&#160;29, 2020, the date on which Sanofi ceased to exercise significant influence over Regeneron: see Note&#160;D.2.).</span></ix:continuation></div><div id="i52f57172a9d7443580346c2d8f39cd2b_688"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.32. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90ZXh0cmVnaW9uOjFmYmI2YzY5OWVjMjRhYmZiYjdiYWZhMGY4N2Y4YzBkXzE3Nw_13c4481f-4efa-4bb3-8ea8-a377706d7aee" continuedAt="i19a36e027c0e44eaacdd37a3aea89e19" escape="true">Net income attributable to non-controlling interests</ix:nonNumeric></span></div><ix:continuation id="i19a36e027c0e44eaacdd37a3aea89e19"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90ZXh0cmVnaW9uOjFmYmI2YzY5OWVjMjRhYmZiYjdiYWZhMGY4N2Y4YzBkXzE3OQ_dc97f678-1e40-46c9-b4d5-ba4330b20ef3" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the reporting periods presented:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:62.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of net income attributable to other non-controlling interests</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id4e374af20434124bd68044ee5c3132d_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzItMS0xLTEtMzY0MDYw_d3152081-2519-484c-9454-4533674d4cd9">113</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibed5e5583149430ea92a3d05d5060125_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzItMi0xLTEtMzY0MDYw_cc326dec-7a4f-4fee-bdb7-d13ec73339ea">56</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i45a01c0bbd2d41d7b151eaf603f54f9d_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzItMy0xLTEtMzY0MDYw_942a5ad9-f136-449e-8e88-1ca3fe93a2f3">36</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzMtMS0xLTEtMzY0MDYw_5f493780-c56c-470c-b26b-5a05ec2490e6">113</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzMtMi0xLTEtMzY0MDYw_9a352a25-3531-4ef1-a4bf-e2e0dd31a334">56</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzMtMy0xLTEtMzY0MDYw_87582a4d-896c-4918-a9e2-4983f2bda3ab">36</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_691"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.33.&#160;<ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5XzE4ODQ_27192e19-36fb-4281-b294-11f50dffa050" continuedAt="i74f40fdeeef643fd97ba25584932a216" escape="true">Related party transactions</ix:nonNumeric></span></div><ix:continuation id="i74f40fdeeef643fd97ba25584932a216"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal related parties are companies over which Sanofi has control or significant influence, joint ventures, key management personnel, and principal shareholders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has not entered into any material transactions with any key management personnel. Financial relations with Sanofi&#8217;s principal shareholders fall within the ordinary course of business and were immaterial in the years ended December 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Note&#160;F.1. lists the principal companies controlled by Sanofi; those companies are fully consolidated, as described in Note&#160;B.1. Transactions between those companies, and between the parent company and its subsidiaries, are eliminated when preparing the consolidated financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Transactions with companies over which Sanofi has significant influence, and with joint ventures, are presented in Note&#160;D.6.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Key management personnel include corporate officers and the members of the Executive Committee (an a</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">verage of <ix:nonFraction unitRef="executives" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="0" name="sny:NumberOfExecutiveCommitteeMembers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5Xzk3NQ_a047d7eb-404d-4537-9a09-2cffd41de250"><ix:nonFraction unitRef="executives" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="0" name="sny:NumberOfExecutiveCommitteeMembers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5Xzk3NQ_d156f4f2-5448-42ff-9165-57f04a10571a"><ix:nonFraction unitRef="executives" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="0" name="sny:NumberOfExecutiveCommitteeMembers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5Xzk3NQ_f1ab576b-c6f0-472f-b9de-d5a07c526c94">11</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">members in 2022, in 2021 and in 2020).</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5XzE4ODc_97dcbe14-4e9e-4a79-951d-c497f06ba61f" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows, by type, the compensation paid to key management personnel:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:57.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term benefits</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzEtMS0xLTEtMzY0MDYw_db3c9225-57e3-4967-8648-f9a67101506f">31</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzEtMi0xLTEtMzY0MDYw_43e4009b-ce87-48a0-b6f1-be9edd093de2">33</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzEtNC0xLTEtMzY0MDYw_53779d61-7ee4-4b38-9488-1468b5c8ad60">36</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Post-employment benefits</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzItMS0xLTEtMzY0MDYw_40b72c78-651b-4285-a0f8-b72db18d8fff">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzItMi0xLTEtMzY0MDYw_1ee99e38-3cc8-435b-ba51-2eaba3d94bee">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzItNC0xLTEtMzY0MDYw_f0f10380-3b3e-4410-a18b-ebbb84bce745">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based payment</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzMtMS0xLTEtMzY0MDYw_e6f3c4c3-735a-4c8a-9cc9-db084c1375b2">19</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzMtMi0xLTEtMzY0MDYw_87bd132f-e4b3-4cba-9e2f-053234f7042d">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzMtNC0xLTEtMzY0MDYw_73f8cdd7-eed7-45ff-b5d5-f05402887164">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in profit or loss</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzQtMS0xLTEtMzY0MDYw_12ebe864-272c-4484-b282-cac8dfb185f8">52</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzQtMi0xLTEtMzY0MDYw_f7ace87c-992d-44cb-bb48-f5a965bc14f8">55</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:KeyManagementPersonnelCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzQtNC0xLTEtMzY0MDYw_cc173227-6705-4314-82ef-790225360013">57</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Compensation, employer&#8217;s social security contributions, directors&#8217; attendance fees, and any termination benefits (net of reversals of termination benefit obligations).</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5XzE4ODg_4eb27318-1c0c-4a1c-8e70-7cfce7126eb8" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the aggregate obligation as of December&#160;31 for each period presented for individuals who hold or have held executive positions within Sanofi during that period.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:60.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate top-up pension obligation in favor of certain corporate officers and of Executive Committee members</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzEtMS0xLTEtMzY0MDYw_7a9befbd-f111-4d8b-a485-11308f2a74a1">10</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzEtMi0xLTEtMzY0MDYw_4e80ca10-f33d-4ba1-9690-a3919d009129">28</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzEtNC0xLTEtMzY0MDYw_f86ea3c2-b1bf-4edc-96e0-3c4008acd29f">32</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate termination benefits and lump-sum retirement benefits in favor of key management personnel</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzItMS0xLTEtMzY0MDYw_7fa72954-90eb-4521-8326-242e6e260679">5</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzItMi0xLTEtMzY0MDYw_1c24f363-8ab9-45c9-895e-6c596280e8c0">7</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzItNC0xLTEtMzY0MDYw_c0608a2e-dc03-4e23-8415-9cb10bbba85a">5</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021).</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div id="i52f57172a9d7443580346c2d8f39cd2b_694"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.34. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfCreditRiskExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2XzkzNA_1e436275-5fa9-4eed-9095-dc53eb19e309" continuedAt="ie9a9adf966494080b69542e7b3e77404" escape="true">Disclosures about major customers and credit risk</ix:nonNumeric></span></div><ix:continuation id="ie9a9adf966494080b69542e7b3e77404"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Credit risk is the risk that customers (wholesalers, distributors, pharmacies, hospitals, clinics or government agencies) may fail to pay their debts; for Sanofi, that risk is mainly concentrated on amounts receivable from wholesalers in the United States. Sanofi manages credit risk by vetting customers in order to set credit limits and risk levels, and asking for guarantees or insurance where necessary; performing controls; and monitoring qualitative and quantitative indicators of accounts receivable balances, such as the period of credit taken and overdue payments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sales generated by Sanofi with its biggest customers, in particular certain wholesalers in the United States, represented </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i1dd1a6b04c6b4be9b142d30598f7a4f6_D20220101-20221231" decimals="2" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzc1Nw_2bcef9b9-4ecf-4a2e-ad32-de4feee8544b">27</ix:nonFraction>% of net sales in </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The three largest customers respectively accounted for approximately <ix:nonFraction unitRef="number" contextRef="i5945bf292aba43d3b3933ee4fa267f48_D20220101-20221231" decimals="2" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzg0OQ_eea8950c-25ba-4103-9f1a-d9072840506f">12</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i54f0c3f56ec94246b15c17488b0f280b_D20220101-20221231" decimals="2" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzg1Mw_bb05483e-daa9-4074-973f-a0e1644eb5fd">8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i043c68f74cf54dd3b12ca0cbc0859d62_D20220101-20221231" decimals="2" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzg2MA_36135593-d434-4bf3-b28d-5b40c6c2d89d">7</ix:nonFraction>% of Sanofi's net sales in&#160;2022 (<ix:nonFraction unitRef="number" contextRef="icf706ed1467c4a3396b7c74584527eea_D20210101-20211231" decimals="2" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzg5Mg_324c7319-855f-4475-a9b4-49b01bb289d4">10</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i3f723776de7640daa8cd4b9421bfd338_D20210101-20211231" decimals="2" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzg5Ng_ca521d10-79e8-4153-a87f-c4dc1cb7b89f">7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1cada9bee6d546aa93544736eadd46de_D20210101-20211231" decimals="2" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2XzkwMw_fe120e47-b01f-4b36-9d40-b09bdbd574f1">6</ix:nonFraction>% in 2021; <ix:nonFraction unitRef="number" contextRef="i18e5dd1b4b0649eeb4cae77cc5f1744f_D20200101-20201231" decimals="2" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2XzkxMw_1d8420e2-b612-44aa-bf5b-9d5e2848aba5">10</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i56aabda8aa634a87b93f96b0ae541185_D20200101-20201231" decimals="2" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2XzkxNw_34dd29e5-34f9-4d31-b462-8eba15746ac5">6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="2" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2XzkyNA_e9f32b12-8e62-4086-b74c-7330f434eb6e">5</ix:nonFraction>% in 2020).</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-92</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_697"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.35. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDUw_3da0b584-b344-4f2b-995a-e3c8402d173e" continuedAt="ia0e82f14aa75445cab19872bcf2f6301" escape="true">Segment information</ix:nonNumeric></span></div><ix:continuation id="ia0e82f14aa75445cab19872bcf2f6301" continuedAt="idc5c83ff337a44a6ad038a094dc3a581"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As indicated in Note&#160;B.26., Sanofi has <ix:nonFraction unitRef="segment" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="INF" name="sny:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzcw_31ee15d4-cfda-429f-b4f8-a51f2f5f62a0">three</ix:nonFraction> operating segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Pharmaceuticals segment comprises, for all geographical territories, the commercial operations of the following global franchises: Specialty Care (Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Neurology &amp; Immunology, Rare Diseases, Oncology, and Rare Blood Disorders) and General Medicines (Core and Non-Core Assets), together with research, development and production activities dedicated to the Pharmaceuticals segment. This segment also includes associates whose activities are related to pharmaceuticals. Following the transaction of May&#160;29, 2020, Regeneron is no longer an associate of Sanofi (see Note&#160;D.2.). Consequently, the Pharmaceuticals segment no longer includes Sanofi&#8217;s equity-accounted share of Regeneron&#8217;s profits for the periods presented.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Vaccines segment comprises, for all geographical territories, the commercial operations of Vaccines, together with research, development and production activities dedicated to vaccines.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for Sanofi&#8217;s Consumer Healthcare products, together with research, development and production activities dedicated to those products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inter-segment transactions are not material.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The costs of Sanofi's global support functions (Corporate Affairs, Finance, People &amp; Culture, Legal, Ethics &amp; Business Integrity, Information Solutions &amp;&#160;Technologies, Sanofi Business Services,&#160;etc.) are primarily managed centrally at the group-wide level. The costs of those functions are presented within the &#8220;Other&#8221; category. That category also includes other reconciling items such as retained commitments in respect of divested activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Following the Capital Markets Day in February&#160;2021, Sanofi changed the presentation of the net sales of the General Medicines and Consumer Healthcare GBUs, and also reallocated certain expenses. In particular, IT costs relating to Sanofi's new digital organization &#8211; previously allocated to the Pharmaceuticals, Vaccines, and Consumer Healthcare segments &#8211; are now included within the &#8220;Other&#8221; segment. The 2020 segment results presented below have been amended for comparative purposes in order to reflect those adjustments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;8, Sanofi treated the first-time application of the IFRIC agenda decisions on (i)&#160;the calculation of provisions for pensions and other post-employment benefits under IAS&#160;19 and (ii)&#160;accounting for costs of configuring or customizing a supplier&#8217;s application software in a Software as a Service (SaaS) arrangement as retrospective changes in&#160;accounting policy. The impacts are described in Note&#160;A.2.1 to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-93</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="idc5c83ff337a44a6ad038a094dc3a581" continuedAt="icf3ae30afa4b4987b4ec265c3a5db7c6"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.35.1. Segment results</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.35.1.1. Analysis of net sales </span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDUx_823eda64-f8e7-4aaa-901a-f9e51b6e0371" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth Sanofi&#8217;s net sales for the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:7.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.178%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.178%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.491%"></td><td style="width:0.1%"></td></tr><tr style="height:8pt"><td colspan="6" rowspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.5pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Other<br/>countries</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</span></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Other<br/>countries</span></td><td colspan="3" rowspan="2" style="border-right:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</span></div></td><td colspan="3" rowspan="2" style="border-left:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Other<br/>countries</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2020</span></div></td></tr><tr style="height:9pt"><td colspan="42" style="display:none"></td></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if3906e38c7744d118e2d80ee3ff3beb4_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMi0xLTEtMzY0MDYw_b97e8a32-dfd4-416a-b80f-6de885bbe998">7,157</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib75c6578c3a84cb08fa98e7e6b8a4a4e_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMy0xLTEtMzY0MDYw_4a305407-45b3-4bca-ba53-41aa54322f75">13,694</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia960f25762194eed8ba9198f645620cf_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItNC0xLTEtMzY0MDYw_a8f33037-57de-4817-b519-8b059dccfa99">9,837</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItNS0xLTEtMzY0MDYw_82279507-94e9-4849-bebb-2e2b96edcb9a">30,688</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i388b2e8292964dd488b8e5822ff441b9_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItNi0xLTEtMzY0MDYw_0bb830f2-3965-4f4c-90cf-3992af5beb54">7,201</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i703eee8c3cf4450398c63faaf2b2713f_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItNy0xLTEtMzY0MDYw_8fb9c14c-69be-4b2d-9e39-8e8c7f0f6c4a">10,484</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icb6ec4264f7b41eeb79ce7df60d9b024_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItOC0xLTEtMzY0MDYw_2192236b-19e0-4eb8-b0eb-753334648af2">9,285</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItOS0xLTEtMzY0MDYw_f9b19460-9e75-4abc-9d9c-b70867bad2d3">26,970</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3cc915a3e8304b36b9aaea6a3b1e923a_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMTAtMS0xLTM2NDA2MA_0d66ecda-720b-4517-af43-d5dc44fb0932">6,819</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1a0eef0b887c463b978e082705e53ff2_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMTEtMS0xLTM2NDA2MA_60ddb69d-57c4-4514-b1bb-05a7503d2bed">9,635</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibf8fcf146c8248ec9b16d57552fb0679_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMTItMS0xLTM2NDA2MA_bf6cd19d-eb1d-4390-8472-71b460d3b305">9,220</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMTMtMS0xLTM2NDA2MA_fcb5abbb-b2ea-4351-8e3b-ead11370f811">25,674</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Dupixent</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.22pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if1b32034d89d4c5492894716caf75760_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMi0xLTEtMzY0MDYw_9f83357c-aec1-4d9f-a81a-9bbc581f506b">940</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie001d812cbaa42849ff65fc0f25fc9df_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMy0xLTEtMzY0MDYw_353e0400-eac8-4bec-88d0-acbc63995555">6,346</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaf451e85e36d430f80d3e0dea3554d74_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtNC0xLTEtMzY0MDYw_0ae76523-66a2-4f09-9f9d-85eac3aa4164">1,007</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6966a3cdac584a90877a12600daac3a9_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtNS0xLTEtMzY0MDYw_0ab6862e-1371-44b4-b422-746504d5ebcd">8,293</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i97ab9118674344ae90b1ec5cdd6d8dc7_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtNi0xLTEtMzY0MDYw_4f274ee2-c0ac-4b67-ba6d-bfa0a7803928">649</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3fddbef245ff4118abb1ece0065f767a_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtNy0xLTEtMzY0MDYw_9dce022d-d76e-4027-a115-ec4404f82bda">3,971</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0eb99c9f11e04cc6a1c3cc09537ceea1_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtOC0xLTEtMzY0MDYw_f5fd5a11-aef0-4fb4-969f-373d16242254">629</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ice90a87f313444cda4f67ec7f33659da_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtOS0xLTEtMzY0MDYw_d01c89ef-c496-4af0-843e-c47b9e25aab3">5,249</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia60703fcf4f34ef79aa5696b24dc5b76_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMTAtMS0xLTM2NDA2MA_1380bd74-d7c2-40b6-bea7-c2d60fb6844a">386</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if7d5b31e23b846449b9dc6aca6c543d1_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMTEtMS0xLTM2NDA2MA_662c6759-f6bf-4dcb-8dc3-560507171ab7">2,808</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1bf14ecb83e341a28f96acd5106c6361_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMTItMS0xLTM2NDA2MA_83829967-d4f7-457e-8972-f0a6f3d9eff2">340</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i38f46c66004f45f79c7d14d33e786167_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMTMtMS0xLTM2NDA2MA_a98edb63-5e7f-4c17-bc84-54f1da756da1">3,534</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Neurology &amp; Immunology</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0cb348a72bfd43a8ae3327734c1b4a43_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMi0xLTEtNDYyMDYy_4b816aad-0f02-4d27-95d7-eaf36579abcc">639</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i497f9ba9e48b486f9aabba34acb6dda3_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMy0xLTEtNDYyMDY5_ea5109b0-c704-4d86-99a4-fb40136da09e">1,637</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d31cf6a543b41fd88ed835cb7b080e1_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNC0xLTEtNDYyMDc0_748ce22b-8300-4671-88bd-abe0330bd1b9">174</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4dd47a8ee94b4ecba12d3409c2d6307e_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNS0xLTEtNDYyMDc5_450ecac6-c13a-44fa-a86f-09ef8619404d">2,450</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib4c50ff163de4a81822ecca972401b9d_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNi0xLTEtNDYyNDQ1_440309ef-f250-4040-bc3c-a98dded21cd8">638</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7aee59f02c404957a63d2c6a84ac1bc7_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNy0xLTEtNDYyNDUz_4ba7b878-e8f6-4e19-81b3-1627e3e9d17a">1,482</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7da96c92143e4cfe87cbc8ec12bb9393_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtOC0xLTEtNDYyNDYx_926bb249-af14-4a4d-9743-f0a1e778177e">204</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i63350fb6564e4bfab92644debffad89e_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtOS0xLTEtNDYyNDY5_89a521f4-e0fd-4da1-b9b2-7578ff530802">2,324</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if7d1991136ac485ca3f17d7bf6664386_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTAtMS0xLTQ2MjQ3Nw_881e86ea-6514-42c2-9cff-6a5af16a5318">578</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic536b741856d496fbbc9ceb07260b2bd_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTEtMS0xLTQ2MjQ4NQ_6814985c-3e31-4eb9-bfdd-1e53869e85f5">1,631</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifd98da43cc404ca08771230fbf198841_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTItMS0xLTQ2MjQ5Mw_1a842320-7e80-4236-8ada-0b8d469c077e">185</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i275946a1cae9496ca4567cbb23511dc8_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTMtMS0xLTQ2MjUwNw_0b518fde-1da4-4446-880a-023988113362">2,394</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i925d323dd481457dbb437525932095e7_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMi0xLTEtMzY0MDYw_175fb1cf-cce9-45f3-a9dd-a90e6639781d">511</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic1297a94f7ed45e493c05001e0b81533_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMy0xLTEtMzY0MDYw_18840608-004e-444c-b98f-cc187f7efaf8">1,420</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e35850252ee49c29e37a747602844b1_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNC0xLTEtMzY0MDYw_3138a40f-30f1-4104-a0d9-0044c87418ed">100</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia65102e90b134f118e220863c8b48f53_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNS0xLTEtMzY0MDYw_a0937d1a-fe3e-44bc-b47e-5916bac10263">2,031</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if7e375fc233a4357934b4c0cff27f093_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNi0xLTEtMzY0MDYw_283f55bc-1492-42d4-9351-d0b1643981f5">512</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i356311f03967464ebffc32cc1749c915_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNy0xLTEtMzY0MDYw_ca0607eb-2d8f-411c-a276-87aafa7ff7f2">1,312</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3ce1b6e300ae49b8975bcd687f09500b_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtOC0xLTEtMzY0MDYw_7f419d66-9556-4397-9cd0-6f5e7ace7ff5">131</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie8632a72e1dc41958e1a40418be2dcdf_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtOS0xLTEtMzY0MDYw_50aad779-70cb-4732-a08f-cc9d172e734f">1,955</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i86bfa094225f4f33bf2caa26f75ea5df_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTAtMS0xLTM2NDA2MA_d2f59a9c-98fb-4d1a-8dd0-3c6ae0d8f22b">473</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i05e5dbe4e5c6497f9fd313a217ef2eba_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTEtMS0xLTM2NDA2MA_24f867b3-0d15-4429-a16d-984148359412">1,448</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i51d60da5814d4da3b4582525b5ea5de6_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTItMS0xLTM2NDA2MA_5a8457a0-4089-4a12-b713-e33b90e3ff26">124</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i39dae50c59ff444589960d8b83241824_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTMtMS0xLTM2NDA2MA_2938c5f6-a323-4801-a220-9082af7bb2d9">2,045</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Rare Diseases</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id26f8eb73c594a90a9c4cd301b065133_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMi0xLTEtNDYyMTA1_f03da9d3-be7d-49fc-8adf-9d282efe53f4">1,104</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9fc91d54abbf41ea870eb45075d2c54f_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMy0xLTEtNDYyMTEw_57c72fc1-ec0c-45c8-8f8c-0a2b45bc96de">1,367</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3331011dc076449c99047a7dc1945e0e_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNC0xLTEtNDYyMTE4_c62d89c1-0a11-4065-b9ea-fb0871c7c814">974</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib6399fd1af9d411d8a47300f12f1d9b3_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNS0xLTEtNDYyMTI2_9574377f-3e7e-4b39-88de-659bad7f7e37">3,445</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1ba80ab3e00743088ed870250562c4c3_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNi0xLTEtNDYyNTE1_e5474ddb-ecf6-4644-b40c-b3a29e3e72e8">1,069</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if5351a9412414364a48f29bc495d1b51_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNy0xLTEtNDYyNTIz_6099d859-f774-4bd0-8676-0e9873aa9b90">1,142</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5755c87fa7584572873b015a8e208548_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOC0xLTEtNDYyNTMx_ee04f904-acd0-419b-a45f-fe411d42518b">915</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if5a6dbcefd8a4ab68267b53708933123_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOS0xLTEtNDYyNTM5_68e4ecdc-e743-4b60-bff2-edf55ce98c94">3,126</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i833eb11d63f9442f9f7f72021922e8f5_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTAtMS0xLTQ2MjU1Mg_75226293-ef23-48ce-9340-7de3665744b3">1,010</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iadb9c19bb94841d2a79288d7aadecaa2_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTEtMS0xLTQ2MjU2MA_1ed01b24-296b-4376-824d-802a1cb9f072">1,122</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i42ab938545594eb992053504011e4252_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTItMS0xLTQ2MjU2OA_ab3b3803-5c5e-47e7-87de-00802314e45c">879</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5726d6cac7a14f3ca1568529807b8c90_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTMtMS0xLTQ2MjU3Ng_6f7b294e-f53c-41b9-a870-48444ce30648">3,011</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cerezyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib2664f2da4914ced8cdc3fc6e2aaabcc_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMi0xLTEtNDYxNzMx_8c538481-a3f3-4b0a-b47a-e2199de0d32d">239</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if6654ba9bc13481fb4f6e2d9755a7d57_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMy0xLTEtNDYxNzMx_bcfc2aee-6e97-48e8-87fb-e5cc9bbb3071">194</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i27e8629a7974464c91e36e4aecb175e6_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNC0xLTEtNDYxNzMx_6ffb4969-916b-4318-ad38-be1e65d54bb9">274</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c4ada02638b4ae29081e603d6b495da_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNS0xLTEtNDYxNzMx_a6a585d0-16e1-423c-b249-d7f06de3bb4e">707</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4f851b224ec6401c881a9da5f983599a_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNi0xLTEtNDYxNzMx_a89db706-ccfd-4b13-8df7-882e8c0c9845">244</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i009300f656604097800d9b7ea2a83bb6_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNy0xLTEtNDYxNzMx_46dbc7aa-8460-42fa-ae93-1a857f3e8916">173</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c3c8fc92f834ca0afc1d103c341e47c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOC0xLTEtNDYxNzMx_6ecc6c51-0d14-4352-8050-bb47beb91e1e">266</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i36ab119d8f59472ca95eacef7ad659cc_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOS0xLTEtNDYxNzMx_0417ca65-467c-45d6-b22e-adea1a04dc34">683</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id739f18cd5204257b8c191b419d8e59b_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTAtMS0xLTQ2MTczMQ_e6c9432d-9738-4737-8941-5ee315d3b3c6">249</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7e37e052f4f34e379c2230b24e177d6e_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTEtMS0xLTQ2MTczMQ_45d19d80-b2c8-47f4-aad7-849371193507">177</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i02995abbcb574be98f1b4b8903dd790d_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTItMS0xLTQ2MTczMQ_03583e47-9848-4c94-8153-e060bc7174b3">264</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i66ebcdcc275242988ca39be9aeed1808_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTMtMS0xLTQ2MTczMQ_1b838af8-2114-4f1f-8744-6a6de4cfb002">690</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fabrazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i59f7875640d940d4be71548d2d02155c_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMi0xLTEtNDYxNzY2_7a46477f-7aed-45e2-b33f-70ad6c4587e3">228</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i679a528164774d5291f5852f0e21e383_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMy0xLTEtNDYxNzY2_290f8e09-4cb5-4ab7-b087-33dd03db82da">471</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i008880cfdcf84137bd2c2e9958802471_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNC0xLTEtNDYxNzY2_80886a74-1f44-4bd3-a736-4ba42a7ccea1">239</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic75317c2c30b470f935f8f50ca516dcc_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNS0xLTEtNDYxNzY2_caed303f-e325-4c13-92fb-e36166c0c15a">938</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9e2f07f1f1914db2861375b158d6e829_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNi0xLTEtNDYxNzY2_f194d220-a1e5-4a80-9efe-a55faa056634">223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if482478107224ecfa98b4d25e9684b0c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNy0xLTEtNDYxNzY2_2209de95-3a98-4965-adbb-94a647f20ed0">395</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5e50d845481a46298dce1596b91bb672_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctOC0xLTEtNDYxNzY2_11e783d4-90e1-42f1-88e9-8edfe4739f20">226</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i19d85e03aecd4441bc80d278e7bbeff9_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctOS0xLTEtNDYxNzY2_063bb02f-b528-447f-8c2d-00356569df54">844</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bb0c08a9b19417e99fceb3e2de828cf_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTAtMS0xLTQ2MTc2Ng_bf4f91be-1f77-4ed6-9d5b-6f8223fce1f8">200</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ice3ea0298e5348ebb9595f08b6d49ff5_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTEtMS0xLTQ2MTc2Ng_ff7b434d-25eb-4fd7-aeeb-d1cc95550729">406</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7c1dd865175f445a94c92d1bf48727a9_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTItMS0xLTQ2MTc2Ng_a0e20b31-ba38-4d3d-b6ef-606b4cebfa80">211</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3d009dcb0eb04ef3a021faa9a7402b4f_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTMtMS0xLTQ2MTc2Ng_607f875b-6ece-4a52-a76d-5b5b57a5c9c9">817</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Myozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">/</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lumizyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i12bd9173dbaf4c49aa86481e27892395_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMi0xLTEtNDYxNzk1_54b5cb80-7cda-43ec-9537-162d4b70bad7">408</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ied76f2bed5094e9699ba62ae5eddf190_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMy0xLTEtNDYxNzk1_ddf46d0e-9533-4745-bfa1-bcdf9cadc8f9">318</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i530dfd00d80842dbafce7ae5cb9655ad_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNC0xLTEtNDYxNzk1_8ec2cf1d-d97c-4de4-acb3-6044b6ac00f9">232</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia1e5d0b8029b4a8a8b1f4ac574af7ad1_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNS0xLTEtNDYxNzk1_197889b8-a0ba-4ec5-81c7-2043e47dbbfc">958</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icb8ac8a0ccce4b5a934f205497b715e0_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNi0xLTEtNDYxNzk1_ff793b6e-9852-43c9-92a4-1615cbe74d71">410</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i24e00e485b8e45618986356e620c908c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNy0xLTEtNDYxNzk1_31dda82b-f4d5-4d95-8cf8-ab2f84f7c68b">373</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i885a178675c5451191389ab0cef8985d_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtOC0xLTEtNDYxNzk1_ba98fc0c-2572-4a36-9efa-ccf1d0efccd5">220</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i434b726907294409b29412431a7c19bb_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtOS0xLTEtNDYxNzk1_b7314644-cdb5-4b34-9356-be6121fe6dcd">1,003</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i83a9ef0ccd5b487fbb118b7e76ceb612_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTAtMS0xLTQ2MTc5NQ_7ecee8df-8710-48d0-9760-f569e932af9c">389</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7205b4923fa543c7813a6878b9485c35_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTEtMS0xLTQ2MTc5NQ_efb207bc-5331-4a62-afe3-f41d48b1d1d5">359</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i86f4b2048c414e2e9c5eb44cc0eaedcf_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTItMS0xLTQ2MTc5NQ_6493c6c3-6b4f-4145-8fdd-3106af38156c">200</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2ee1d4e1116f4243b99c352e87d1d74c_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTMtMS0xLTQ2MTc5NQ_477b581e-c4f5-4cde-92ca-c26c679112b3">948</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Oncology</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b9df25140174f39b8d25fa4bbda653b_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTItMS0xLTQ2MjE4MQ_6e4488fa-01c9-4882-be9b-b062cfde31f1">239</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c86f2f0b2854fcba45877b8058bd8e8_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTMtMS0xLTQ2MjE3Mw_acb16ae4-e517-4f14-85a7-e3f964a101c9">515</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4c53ce511bba449da99749a8e4ce6d4d_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTQtMS0xLTQ2MjIxNA_4b8b46ec-1ed7-4a0d-be94-19fde8655180">198</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id9f8b9f4a590449496b876034d80b8e8_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTUtMS0xLTQ2MjIxOA_4eeec340-01dc-4c34-8279-da1c62e0a462">952</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ice20f96fb0cf4de0b3ca3965e622ae3a_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTYtMS0xLTQ2MjU4NA_da596d62-21f0-40db-8cce-ea84a0b23cde">327</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0b81cb6976ea4348881ae7d19e9b64be_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTctMS0xLTQ2MjU5Mg_976fe8aa-440c-4188-8d3a-415beff7334f">410</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5cc0ccf1590e4affab7ef2e75874f65e_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTgtMS0xLTQ2MjYwMA_3c57861f-cfa1-4b3f-a454-7685e5fd2dd4">175</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i17ab8be945b245c6ab4bcad11716698c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTktMS0xLTQ2MjYwOQ_7139ba3b-6b61-4e3d-ba6e-952e91a6578b">912</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9ab393d2fde64052a23ce4a484c207d8_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTEwLTEtMS00NjI2MjI_a0e05552-1042-4363-b41e-30040a50e1b9">299</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="icee2e75239b54a6691515f6280082f01_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTExLTEtMS00NjI2MzA_f988b2c1-b5b0-41b2-9191-c16e78373451">368</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7818bd4346ec4748b6753e13dc4eb6e9_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTEyLTEtMS00NjI2Mzg_d0b07ddc-0d27-46ad-8645-2ffe62e79603">131</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i07c0978e52b444298d8618c3d2159678_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTEzLTEtMS00NjI2NDY_6e9b590f-0dd3-4a5e-b211-5ba5c041bdf7">798</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia9a280e56f3a41af88aba2bd4cb1d48c_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTItMS0xLTQ2MjIyOQ_fef55e52-d397-4454-9885-891b67230e34">33</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4288c1aa9dc6416cb56c247f3a5ea4ba_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTMtMS0xLTQ2MjIzMw_3050d05a-e55c-44d6-8375-7a991604ce64">275</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i30c4fc1b2d404bcaa190fa35d3838578_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTQtMS0xLTQ2MjIzNw_82ad148a-13a4-4e40-b3dd-41948f0b7edd">83</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6ef47532b8bd443d92c96e9744f3c55c_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTUtMS0xLTQ2MjI0MQ_87ffae6b-c66e-4e9f-86c2-5de20b6635d2">391</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i117b2d1cc5d346c9877ebace612c1ed6_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTYtMS0xLTQ2MjY1NA_a92dc3a2-1d88-46e8-9ad4-9df88fcdbd25">112</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i657d3f930d0d4905af0b5e1b5dbefe0c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTctMS0xLTQ2MjY1OA_fea4049b-15c8-4fdb-a38f-b069caf458ea">253</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7b3ebdaa8d354f83993ea4311de0e5ca_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTgtMS0xLTQ2MjY2Mw_212956c3-4470-4a5f-918f-3cdbe9b72495">90</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i85143d1ef2a047ef8d1509cff1b4eb35_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTktMS0xLTQ2MjY2OA_3ead38a1-8a66-48ef-a375-071a9cb5790f">455</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie090a33d5f6e4860a9db0e69a9cdb4df_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTEwLTEtMS00NjI2NzI_75cbcd43-e490-433a-8677-01e64d4cab20">187</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia8d7968a46b648a4b7ca0e2438afd8aa_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTExLTEtMS00NjI2NzY_46cf8734-c4f0-4a59-9a4b-f1a146bf9a0e">246</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i381585a218bc4a21bc9dbccd82b92f3c_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTEyLTEtMS00NjI2ODA_239c5dfd-67a0-466f-9ba5-f1858c63864b">103</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i296a8f4baeea42e78a0dd8f1a3fd6a56_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTEzLTEtMS00NjI2ODU_7bdd8455-3a24-432d-9145-71e5a119656b">536</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Rare Blood Disorders</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i51bdb13aba434060a597a9097458c3a0_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTItMS0xLTQ2MjI0NQ_8794e66c-8f89-4ba1-9227-d8d09ea0f91d">94</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0f792c072bf54f60b88192d56f584272_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTMtMS0xLTQ2MjI1NQ_748b6b9c-609a-4772-b03d-c97619e77027">983</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id67bfe76694f4de1839334ce8b69a261_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTQtMS0xLTQ2MjI2Mw_a3a2e02a-de6f-416f-91b5-51be57b25161">240</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i474ddfd1c7664510913a9d53823fe524_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTUtMS0xLTQ2MjI3Mg_c5466c30-fdf8-4cf3-a2c0-3116ddf09afd">1,317</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iecd790138e5f4caeb22913e385a783c6_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTYtMS0xLTQ2MjY4OQ_11c54b3a-e8df-42b9-948c-0590ffdacfcb">81</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3bbac3b89df045bca004b76f88dbfb78_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTctMS0xLTQ2MjY5Nw_e2270855-6d10-4e44-bc2c-0410ee67e1ab">842</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if58bda7003d64454ae0b3769c32c45bc_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTgtMS0xLTQ2MjcwNw_96e8fc40-d677-4a79-b94e-ca5c35bdd7ee">218</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i07798b22999e4551bc98330cd328ac58_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTktMS0xLTQ2MjcxNQ_632dd5ef-f6bc-4fd8-8eab-4be7696464c5">1,141</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i808feb017bbb47b2a5990030172ae9e9_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTEwLTEtMS00NjI3MjQ_b9c4c489-6389-49db-9df5-7f9a0483e025">41</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ide523dbe8589413aabe48647cf02a037_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTExLTEtMS00NjI3MzM_7fbabb6b-c645-429a-ab1e-7f4de611dbc4">837</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1ac7e39036e4bb5b0a39b7b97512708_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTEyLTEtMS00NjI3NDU_7d2a6643-8cae-4999-9cf6-d56dce0d5fcf">339</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i58eaa30a28f4407f804608f379faab0d_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTEzLTEtMS00NjI3NTQ_2ee60c7c-f8d1-44ef-a5fc-fcb0915996f9">1,217</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if17af11c5d8a41feb31c45c868fe9eae_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTItMS0xLTQ2MjI4Mg_3cb4b592-10a3-4081-9260-156c7ecadc18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib70be66dcfd54b8fa1967dc6ba0bb5eb_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTMtMS0xLTQ2MjI4OQ_be7a236a-ec33-4550-ac8d-b47c8c72bc59">406</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaf5a3b324da94b91b08eaac503473be5_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTQtMS0xLTQ2MjI5NQ_1c35793c-49bc-4a99-8ff3-2e2332ed81df">98</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7cb49f4f811244b596cd629fe1ff04e0_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTUtMS0xLTQ2MjMwMA_35aff350-eb2a-49f2-bdc2-3e0aaea9dc7a">504</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1b3b532d87ee4f92b20b6eca2f77a81c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTYtMS0xLTQ2MzU1OA_15dbb682-b1bf-4f8e-9d36-f79bc37b3181">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4d67cad1157445109898fc8120f7683d_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTctMS0xLTQ2MzU3MQ_792bf262-0ead-4cef-b91d-3ebbef3b67f8">332</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9e64c845eeb246f59dfd656899a27837_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTgtMS0xLTQ2MzU4Mg_d68f64a5-e4a6-42dc-9aec-d59670558d71">82</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i35c6e946c3624b76905a8cbf979857ba_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTktMS0xLTQ2MzU5MA_3b453a32-36ac-4a44-82cd-3c9d7fc1f7b2">414</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8a4839221a9b478a8e315985b0c6c6c9_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTEwLTEtMS00NjM2MDQ_9010250e-61ea-4d73-87b1-e991224e5ee7">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4aac4d6ed7044a869f2ab2a402ed6891_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTExLTEtMS00NjM2MzQ_f627d2e1-c252-4648-8968-060d1faa9f0d">320</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie188b535c20b4152b071cec5896f8a8e_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTEyLTEtMS00NjM2NTU_850bd83f-f26c-409b-981f-ea8bd7cc4378">146</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5193ccd45f664a6e87c2cd7ffebea135_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTEzLTEtMS00NjM2Njk_1d10efbc-fbfb-4836-b59a-8cb6532b1b53">466</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7242f99862ee418daa94f18ea3004d14_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTItMS0xLTQ2MjMxNQ_d4c1ab46-1b0f-4123-8e10-5b1272793cef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i42189e03c07c4dc89544b5314ae6fa7f_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTMtMS0xLTQ2MjMyNA_5ad3b986-c796-40b7-8cf6-69665f0eeaea">450</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2343ab2aad5e4a75bc999c5ed10f2dc8_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTQtMS0xLTQ2MjMzMg_1aba6845-2d40-44db-9a82-4f7f3db67cc4">130</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb2d3cf6268242e1a113cb343e29cbe1_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTUtMS0xLTQ2MjM0Mg_274fbee2-78f1-4717-bab2-82865f7153e8">580</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id3bbdee34574428b81d52395573a7a50_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTYtMS0xLTQ2MzY4OQ_5a84598f-6489-42c2-b009-a7ffd7c1027f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i89bbec019eba4315ac544fc5b16a8ee1_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTctMS0xLTQ2MzcwNQ_587ba7aa-0861-48a9-83aa-fdc36a06f70e">429</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if7b892ef3d1141339a371a9d6ee5b705_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTgtMS0xLTQ2MzcxMA_44821602-17f4-4ee3-9401-1b27d88646d9">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1d9408eb958d47f9970a1477c454e52b_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTktMS0xLTQ2MzcxNg_ac59cd5a-65a6-42f5-8407-cdfa0b6ad114">563</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1cefce5d6bf34ac6b51f91739b702fb3_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTEwLTEtMS00NjM3MjM_5ed6c1b3-b5c2-4cac-b014-f715ac7a2d6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bc5e144c1a04076b51456626e9cd1fe_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTExLTEtMS00NjM3MzY_2d51173c-c8a1-4a41-8096-1536f4566547">445</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i758a45c283f3434ca1c881ffb264058b_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTEyLTEtMS00NjM3NDA_17ab8a40-6b8e-4670-80e0-e08a0de579fa">193</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idd17ee78068b4d03a01620b3f9a48899_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTEzLTEtMS00NjM3NDQ_b6aea295-c4ce-4760-813c-a18633dec312">638</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Core Assets</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7534c54d521e42bfa11f4ec26a7237df_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTItMS0xLTQ2MjM2MA_9240fba2-426c-44ed-b952-90d0158cd6c8">1,917</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d735f3d6a394c9cb978c28c14f66ec5_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTMtMS0xLTQ2MjM3NA_058d4c04-d669-4c5b-b054-7dfaf1ce37fe">1,653</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6780792481f84d549561c3ae8139f8fe_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTQtMS0xLTQ2MjM3OA_b8a33333-bd27-47e4-be6d-ae7c516ed1c6">2,819</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c8ed8009e0749b5ab9de034c8837959_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTUtMS0xLTQ2MjM4Mw_6cd93b46-e6ec-4243-a1c1-85cea26c7a4f">6,389</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1ffc44bf8e0f41e781b7e2ebbb1e69d2_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTYtMS0xLTQ2Mzc1OA_61fdd937-11c5-41f4-9f19-46e9a3cde5f9">1,868</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id3a725010cd94a3c834bc25a5093a46c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTctMS0xLTQ2Mzc3Mg_c7ddeead-0582-4785-a840-64863051b8c0">1,315</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ied5995be0e4745d280c9b295e1a23e20_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTgtMS0xLTQ2Mzc4NQ_f6c1b0ec-5b35-484f-a2fd-3e908b0fd81c">2,585</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i90de959467104871a3e22682cf4131f8_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTktMS0xLTQ2Mzc5MQ_022ba761-737e-4bc6-a19f-5ce1ab7d40b3">5,768</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22138736e8ca42b38ff8c48941f38409_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEwLTEtMS00NjM3OTY_29185188-f7de-40c9-a959-9a0a748e9d90">1,759</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i69f76298218f4254bc305200c960f426_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTExLTEtMS00NjM4MDU_430f8edf-f1b1-4156-b0f4-4b49eaab405c">1,413</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i52cf9837e6ed40aa85632eec92ba6f45_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEyLTEtMS00NjM4MTc_9088bf6d-d34b-43e5-bd3d-7b9eca518fac">2,409</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i727e0782da3d46ec8fe5ab5e632fc070_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEzLTEtMS00NjM4MjU_e501eb26-9071-4263-80c8-0a35146b80ba">5,581</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic44928021d4f4236870f0bf6d6fd1311_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTItMS0xLTQ2MTg5MA_7c48f438-a4a5-4ae2-8614-2ced81514154">658</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib0e28c706e6d4bf18081e809b52dd3f7_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTMtMS0xLTQ2MTg5MA_cf638c9f-6f9a-41db-9cc1-5f0d02557ce6">17</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id861d9b153c74477a49abd477eddc226_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTQtMS0xLTQ2MTg5MA_d73dd7d4-208c-44f2-a014-dfbe74c3a1dd">635</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i357469340a86491ab237157cde1612d1_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTUtMS0xLTQ2MTg5MA_d7b6a502-c1a9-4092-b67d-7143b3f88422">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i60d25e37a08049dcb2fb97d0a8b25b0a_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTYtMS0xLTQ2MTg5MA_e4032fb6-5b04-41bd-9591-e4074eecfdbf">703</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57dd079515644fe69b73d21d94ac3e9d_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTctMS0xLTQ2MTg5MA_9cba9f71-41a2-4547-8f86-faa82fe175b8">29</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7a1a5c473c9b4cce9650d795bfaece4c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTgtMS0xLTQ2MTg5MA_60e4023e-1bcd-4e82-a6bd-d1d8ea3a7061">754</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0e76cbde32b54813adf63f05934bec59_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTktMS0xLTQ2MTg5MA_3e69c75e-bb95-4e13-8cee-4c3e951b24fd">1,486</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib446fc017cbe473c8fee4d2dad31e01b_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEwLTEtMS00NjE4OTA_89167ad7-cc04-4920-bdc7-f4e59b34cb3a">656</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i370d5592a1da444699977335ae0d6aa4_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTExLTEtMS00NjE4OTA_29bf8062-5137-4917-8535-56f9daea0a7c">30</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3025efe993694823a88967c4a6ddda1c_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEyLTEtMS00NjE4OTA_f9413eb4-9670-4fc8-b655-ef3f77213ea6">665</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie718eb6f98704abebab8e41cf0bb433d_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEzLTEtMS00NjE4OTA_6b742ea7-b380-495f-aba8-55d3d4b058b1">1,351</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i30c5ee5de6db4c66bc2a5def80cb3630_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMi0xLTEtMzY0MDYw_1d715b42-d115-4da1-b753-82f4c9a3557c">421</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i17834d1f197042f1a682ebdde3f1bfb1_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMy0xLTEtMzY0MDYw_38585ed6-09bc-489f-be9f-2ef30b9f1a7d">283</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i998de8ae593247f495156ca0fd001bbf_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtNC0xLTEtMzY0MDYw_6b6f1ec3-abd0-42e3-b8a1-eeb9cb4defbb">413</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0977ba6fd2084d8ca30b097662a249d1_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtNS0xLTEtMzY0MDYw_827d400e-4e79-437f-90b7-190ae7966117">1,117</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b17aab75c004d718993f2b67a67ff5c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtNi0xLTEtMzY0MDYw_38f7a98a-5650-4c18-891a-7ef37101d4f0">394</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i740678f4087c45798717797b54332317_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtNy0xLTEtMzY0MDYw_870b597d-8db0-461c-8201-a15c9cd8fd16">259</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i49540aeddfb1476badc6b4db7a86037c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtOC0xLTEtMzY0MDYw_e56cf475-cd32-4087-bbf2-01fe4c0724ed">316</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53367ae84f81438ea1f7429170ac4341_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtOS0xLTEtMzY0MDYw_725d0584-4857-4466-92ee-73d1c5439d4d">969</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie9d5c0a2194149e9829332b644e91e78_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMTAtMS0xLTM2NDA2MA_f739e2e3-d14a-4366-b6f8-5ed4955b83ca">374</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16768b64d8324f648ba3dcd8ea1743bc_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMTEtMS0xLTM2NDA2MA_c563b137-0fe8-4d81-acfa-f9ddb04e362f">267</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i95951b5818aa458b8d05be95e32f6f29_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMTItMS0xLTM2NDA2MA_7a73415a-2630-4187-94aa-1139f003b089">292</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib93e54f78f854e94acd0d345f631c76f_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMTMtMS0xLTM2NDA2MA_49b9d7e2-e732-40f6-9e08-8e0ed5d002bb">933</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i92984c0d697e42b69afe6d9913419c61_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMi0xLTEtMzY0MDYw_c671ff36-6d6d-434a-847a-1c7082d5d70d">101</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i997357ba5e0d4103a854138682dbad0c_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMy0xLTEtMzY0MDYw_cc4ebd98-26b1-48a5-a5a6-4da5e6e4e57c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i97f55be8ce6645d5a550bfa46ae5aefa_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNC0xLTEtMzY0MDYw_67dc1afe-adaf-40b9-960e-f07894bc6813">873</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib18bf96fce9840e79199255e69961a1a_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNS0xLTEtMzY0MDYw_e2a0c96f-1229-4d52-8cdd-ccf592a11950">983</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i16b5d5a19be44034bdb35c036e33c369_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNi0xLTEtMzY0MDYw_3a885f74-210e-4284-b314-c6ec34e324e1">115</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i48989f71da6140a4beb9df8f40518550_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNy0xLTEtMzY0MDYw_ff29adac-be89-47f6-b220-6c43f4cc14d9">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i343f9ebee6b943a7bf2931dd320e3aa0_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOC0xLTEtMzY0MDYw_216fb187-6868-4c74-aff2-5f89b0f09bc5">805</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i167b4765e010409db6a9ef1c2724d107_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOS0xLTEtMzY0MDYw_6e5e0ef5-19ec-469b-bbfe-022b19511dcf">929</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i628fcb0013224533ae759b38ed4a9e8b_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTAtMS0xLTM2NDA2MA_52c60ae0-51fc-4a3b-8fdf-1a7347ecb9d9">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i37db7c2f8d7b469997221d1aa218fe6f_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTEtMS0xLTM2NDA2MA_01a8a55b-cc46-4ef8-b267-b001d74e399c">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i925f6b2d5b5d40a58aa0860a22c1fbea_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTItMS0xLTM2NDA2MA_a4c48339-402e-459d-8123-878efb342760">777</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0aa66e4f08254a8eb5827d9da0511d7d_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTMtMS0xLTM2NDA2MA_f4d156c9-1e71-4b19-a80a-4ca5a732e1f5">913</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Non-Core Assets</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib6918b42287543ffae67f45e89689571_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTItMS0xLTQ2MjM4Nw_53b1539c-81d6-409b-99f1-7c11af1aaf8f">1,637</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i83b5b2fcccc6496684aa6cb171a11b8e_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTMtMS0xLTQ2MjM5MQ_c093a846-ea2a-4834-8b5d-0bc41a31e13d">1,176</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iae87558939404363b5fccfefd97a00fd_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTQtMS0xLTQ2MjM5NQ_61b489fd-7a9b-4889-9f8b-4df12b686558">4,409</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i40fa65e1893444b2b1d53b7ce6e4f2ca_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTUtMS0xLTQ2MjM5OQ_9606c3d7-1b8c-4df8-b5e8-10d8297dc98f">7,222</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic8eac199a2aa4dea9ca5e52b9f0bba8a_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTYtMS0xLTQ2MzgzNA_c294d4c1-4fe0-42fb-a638-3da7b63de3a3">1,846</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if706c3f3b7c64218b54c47278fdff29b_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTctMS0xLTQ2MzgzOA_8e435b0d-9270-4178-a7fd-00940d86ee72">1,281</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i902260c2fc46471c9838a41c2d4ee190_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTgtMS0xLTQ2Mzg0NQ_47896fda-7fde-42e7-8069-f67cc0e324f8">4,515</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8fa99407fd0d465dad206a1e0d6e807e_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTktMS0xLTQ2Mzg1MA_77935b2f-7813-488f-950b-54e8c1295086">7,642</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iad567579f11c4396ad1e56f97b7462ee_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEwLTEtMS00NjM4NTk_2df6779b-49f8-4d72-ba40-ee38f8ad923d">2,088</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb3ceb86dd6c4368b68c2adc32c3298f_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTExLTEtMS00NjM4NjM_ab2f9574-92c2-4eec-82be-ffab6e501d73">1,389</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if613bbe5c0594318b016b497ee91c597_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEyLTEtMS00NjM4Njc_800e3597-e098-4c66-acbf-26694e6f7ff0">4,849</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3b001a8470a941d89da632e7bc9daf72_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEzLTEtMS00NjM4ODM_2cc1bfad-c7c3-4ef5-a6fa-d7e3dd93360e">8,326</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22153967fac6428b833321479fdb1306_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMi0xLTEtMzY0MDYw_501e6a8a-f576-4c95-9c71-fde571623d0e">426</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5594aa252dab4309b3116b07f116ccac_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMy0xLTEtMzY0MDYw_3684b8a9-39bf-4ce1-bc95-5f2e62330e0a">757</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iea483c0a6b6e49a5b4641fed43699ded_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNC0xLTEtMzY0MDYw_df73d29c-2a2e-4676-8e2e-2e7bd63f584a">1,076</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i312af4a1d5294779ba7c9a2e218b6b4b_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNS0xLTEtMzY0MDYw_a5843817-5555-4923-8075-2b6efdaeca35">2,259</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i578a1693685b4648b843c7591f102024_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNi0xLTEtMzY0MDYw_7043517e-c431-4937-9ccc-07c5d4e8fed9">474</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic943869cbe084442b9752f3125562eba_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNy0xLTEtMzY0MDYw_32ada888-77ad-4066-aa7c-40f591f852cd">861</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i59b03d0aa3374a76a09ad675f12ec5fd_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctOC0xLTEtMzY0MDYw_4a16bfed-fcde-485a-b8b4-a977094722ea">1,159</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i45eb32fbd1db4afe99ef24b30301d967_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctOS0xLTEtMzY0MDYw_b288210f-736f-4db4-9e18-26c42d2015ee">2,494</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8f63b529f1744fbc83d583f5b12c35e2_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTAtMS0xLTM2NDA2MA_5ae21775-e8d6-452e-9f8e-986bbff314e2">537</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i866a97436e854d82a86d47a3f7c2e9cd_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTEtMS0xLTM2NDA2MA_17c52c40-77f5-4d61-a5cf-3682f983b42f">929</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idf055ce7cd0d4b41b0974d84a4828176_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTItMS0xLTM2NDA2MA_c4844dfe-c41a-4e78-aefe-2fceaebc024c">1,195</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1c2f60a295184259a5e98824572dc354_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTMtMS0xLTM2NDA2MA_cf0a91fb-c152-4c17-9273-503d8a6c748d">2,661</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Other non-core assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7161276da0fb46c8a7f757ed66cd6b74_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMi0xLTEtMzY0MDYw_14bfad69-5805-4e9a-91fa-a7d557f17d90">1,129</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i75a5f2ec92a94a89b3aae509e3a5cae0_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMy0xLTEtMzY0MDYw_b388f720-0008-4b4e-a444-f2e8dc55d70f">412</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i73a08d51def1454d9443a2bc8b6580e2_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNC0xLTEtMzY0MDYw_020645af-048b-4c3e-b612-40d0ae324dc7">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iadb91c4ffea14a4c86b46fa219e8e8e9_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNS0xLTEtMzY0MDYw_b39d7e13-b53b-405d-8f90-1526ac95217c">4,485</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic496482793684b30af908ea4b53e6237_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNi0xLTEtMzY0MDYw_5e5f328a-9ca5-4d24-b047-3151da9a8da8">1,285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i34ae4ee5253743af84111345f0f31775_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNy0xLTEtMzY0MDYw_643803cf-26de-4590-9614-b47052b55bc7">410</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i466ea9984a9746c1b1788273a8e951fe_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtOC0xLTEtMzY0MDYw_aff30f27-e70f-4dba-aa39-ade6d01e844b">3,034</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i77618a8613ca4289b3b3a2b779826d72_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtOS0xLTEtMzY0MDYw_f1009bac-4ce9-4ed0-b838-1bc051cb3858">4,729</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id9552a01052c443f87d515d5c3a5020e_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTAtMS0xLTM2NDA2MA_68c64e56-1554-45db-84cf-b84cb0d03f6b">1,451</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i912066ccddd243118e3de68640de9dcf_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTEtMS0xLTM2NDA2MA_47837a1d-a3fb-4e4d-945e-67775d666d8b">438</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7c5c4713cc814bd7ab49ed66efb4c628_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTItMS0xLTM2NDA2MA_3959f33d-3942-4875-887f-bbc20c938816">3,222</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0a90a9627ee244f28f6e326030e8fb04_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTMtMS0xLTM2NDA2MA_c2db954c-97b5-4de1-bff8-23596d49300a">5,111</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Industrial sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i202bd69ea7354e44a25c96c53391e267_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTItMS0xLTM2NDA2MA_8be88853-ceae-424b-b603-1d3180e982e9">587</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i46f1f42e50b94bfb85ebce0b53ffcb95_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTMtMS0xLTM2NDA2MA_56549dc5-7a4b-48d9-a1d8-33b7eeb891ae">17</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5269963529c04271bdd98254675e07ba_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTQtMS0xLTM2NDA2MA_17897731-46b4-4d2f-bd75-551890dd89b9">16</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i95373a070bcb4ebc8e62a097d81bc07b_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTUtMS0xLTM2NDA2MA_0be1f62a-eaa7-4834-9371-74140e0359e4">620</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2f756c850c4f43a6aa9a408f9b93eb20_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTYtMS0xLTM2NDA2MA_43c8359b-0a05-4d2e-a6ff-8c9a0096f95c">723</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i60f2bf9e9e914ea3872005fd530433e3_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTctMS0xLTM2NDA2MA_ea905a63-88fa-4419-b72e-232e1e34cf06">41</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if6decca1f9a94e3caad98da2fcdc75d0_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTgtMS0xLTM2NDA2MA_7072de35-7dc0-4525-873a-ef1d5bbf8b8c">44</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i085e1c70e50641f2962c6964513071a1_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTktMS0xLTM2NDA2MA_e4d961e8-fcd0-4db3-a420-957b7adfb612">808</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5ce62b370fd24f39a199e1d375dfb6d3_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEwLTEtMS0zNjQwNjA_f095989f-1406-4e48-982e-aa0d1e42350c">658</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i093e51cb9252485a94109d38a8fa4702_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTExLTEtMS0zNjQwNjA_f8e256ba-0a06-4c65-b5a1-5ab464dbfe3e">67</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i53c5d7935c7b4937a7191d5857435346_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEyLTEtMS0zNjQwNjA_961b7293-a616-43f2-a68b-5cb3bd72af88">88</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i66e48178e270445b9442f66c6b94104d_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEzLTEtMS0zNjQwNjA_23c4e482-eed2-4662-ae94-95ff1eac331f">813</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id543945583c840488898c47cb6f44f8a_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTItMS0xLTM2NDA2MA_17882816-5d1b-4089-875a-3e6f35488519">1,341</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i52bb756b60e14df9a45298f4b3784a0e_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTMtMS0xLTM2NDA2MA_c0ec759a-ebcc-405a-8c51-e54983a55593">3,291</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i24cc0a91048b4fdebadcb26d0ef92277_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTQtMS0xLTM2NDA2MA_c3f13f66-e67e-4084-9634-8460f4d910a9">2,597</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTUtMS0xLTM2NDA2MA_dc5134ac-a426-4875-bc62-f0e5720e93a3">7,229</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i86187c82c19c4cb9a375fa90f77d5b4a_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTYtMS0xLTM2NDA2MA_b716f14e-446e-4e4c-8111-b8b8662466a1">1,225</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4d424d7a10774447a1a4b8b5e0ae7689_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTctMS0xLTM2NDA2MA_eb8f4f0e-a95e-4d67-89e4-66f14e1b2de0">2,762</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib056f7eee5db49e6ad47e9f71e8c6ed8_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTgtMS0xLTM2NDA2MA_2b7c8b06-1856-418e-9068-7f7ad4ee47c4">2,336</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTktMS0xLTM2NDA2MA_57eeabd1-5ba1-428c-8c5e-6c747050ebbd">6,323</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7ae926d85669499cb9afa33c7d9241d8_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTEwLTEtMS0zNjQwNjA_fbbe973d-8c0b-4480-b062-3449fcd9537f">973</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4e6ac042ac204ffa91527696c60c97e4_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTExLTEtMS0zNjQwNjA_b12ee929-6a65-4626-afcf-7553c13703c1">2,759</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8467dbc5770446939551b7a699d503f2_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTEyLTEtMS0zNjQwNjA_a2dc9e01-94e2-4d3c-8e5a-e08ca4725e1a">2,241</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTEzLTEtMS0zNjQwNjA_8deb9e40-2f4d-4682-95de-cd922547f851">5,973</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Polio/Pertussis/<br/>Hib Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifd94df2c80d743d8a13502c39a73b7ed_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTItMS0xLTM2NDA2MA_2c8e6708-e29c-4b58-a10b-d4eee1666873">325</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i566185ab6e264c6a8db7216893997e35_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTMtMS0xLTM2NDA2MA_432de92d-8b21-4d04-953e-3a0553a0fb2b">456</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i28a1069b3bb642b693c980f6b28c3e84_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTQtMS0xLTM2NDA2MA_a8570d6c-c01b-4944-92c3-a6261eabfc7f">1,504</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4df972df975b43f0ba3ed94f3ac9b0f0_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTUtMS0xLTM2NDA2MA_6e861720-8ae4-4f01-b4ac-19c840ff16d6">2,285</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if9c5ed55783540d9aa5ba29544a1b58e_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTYtMS0xLTM2NDA2MA_aa9ef3a6-646e-48b8-9f4a-5980d4a09f73">306</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i88db9dd7ec104b49aa9f5cad7c6b5d8f_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTctMS0xLTM2NDA2MA_57805d4c-5ef5-48fb-b4af-c5d0e7e01482">470</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7e5b7dc49ebf4382a4ae26de2ebc180f_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTgtMS0xLTM2NDA2MA_bdbd3514-8597-4e5a-ba80-3407cce22836">1,383</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5531b6cfd28445d29737a2bfa6bc7241_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTktMS0xLTM2NDA2MA_33dd0c91-4305-4520-99f1-430e26f4847e">2,159</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1f061cdc8a4049e298e7ce678ecba5fe_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTEwLTEtMS0zNjQwNjA_88038089-2339-432d-8bd6-9edd3e67114d">331</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if9421508acd14db08ec0028a7eef9bb4_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTExLTEtMS0zNjQwNjA_68f82b94-a577-4282-b4ae-699fc8923f7e">412</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib7092d8f4e2046b9860885a474a6d5db_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTEyLTEtMS0zNjQwNjA_132a982b-09c9-48ce-9970-0ae8119329ff">1,363</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i90cb244705d34e58b4ef04e3600b013d_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTEzLTEtMS0zNjQwNjA_32390585-31a5-409e-92c7-c25379cfd021">2,106</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Influenza Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i456fa2153dc446f5bce91beff992d477_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTItMS0xLTM2NDA2MA_6f14a330-ac60-4d22-9834-052aa32deb59">681</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0bfa10bd76b546309489629a22ee1f6d_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTMtMS0xLTM2NDA2MA_59aa4702-6ebb-4b57-a551-4fcc32c92284">1,737</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2bed6a217a124ce2832a0c652eb14a8f_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTQtMS0xLTM2NDA2MA_82a17500-42f2-4ee5-88f9-6ffa9c863800">559</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iacff9073d13f4103810361e59ee490ad_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTUtMS0xLTM2NDA2MA_2cbb3625-08a8-4074-96ad-08a4dc69da7e">2,977</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib25f8d53a5414fe19f6ae1ed1c367b75_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTYtMS0xLTM2NDA2MA_2c0d245a-0fcf-42e7-9ea5-1028a8bc065b">729</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic25e96d4bc874fc5a518e3a62b557388_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTctMS0xLTM2NDA2MA_2919d59f-9c61-4979-98e9-f9e45e0f55d9">1,366</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i66b75c69b5de4e3d8a0d43182fa87920_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTgtMS0xLTM2NDA2MA_bfe03901-0254-446f-a60a-fa7bab398a3a">533</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i336524d5d81f4a39bf61ca920af300b4_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTktMS0xLTM2NDA2MA_0aaa6bc6-9aa3-4f4b-8624-b3bb199610c8">2,628</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3ee49f3c004543aaa32444ea5f031578_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTEwLTEtMS0zNjQwNjA_452069a4-c548-476f-995c-ee3a8fa79152">441</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie898ae59a55b46f0bd8bd709eb4f822a_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTExLTEtMS0zNjQwNjA_9f7d40cd-f1cb-4c1f-91ad-1cbe7b03da63">1,575</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifdd8d6dad55c4232b49ae3d7899b823e_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTEyLTEtMS0zNjQwNjA_bced7836-beb2-41ea-a93b-4a58eb02a4bb">456</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if882abae01c8491aa97cc0f3708f8398_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTEzLTEtMS0zNjQwNjA_1bc8bed1-d144-4c9a-95fe-e378ec7526c5">2,472</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer Healthcare</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7b09c85efa64008a5815fa2c2c3a477_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTItMS0xLTM2NDA2MA_3f425707-1e86-4e6a-b2a9-80f529abc09d">1,501</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id8f643c30d914f8ab4e03c092efb3091_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTMtMS0xLTM2NDA2MA_200c56dd-9775-4e6e-9479-21993c96f584">1,290</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5e5094b910954c5f8c2098e2be4c991a_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTQtMS0xLTM2NDA2MA_461b22f0-b286-4891-a928-810359bc188c">2,289</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTUtMS0xLTM2NDA2MA_6f67d165-10c7-43cc-9f2b-f9fa291fc3a6">5,080</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i500abf386db74b7f9515899bb2358a6d_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTYtMS0xLTM2NDA2MA_49f74b39-4c4c-4132-9c70-97635e24f0ef">1,333</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia8336020a29448de861074ef317b627f_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTctMS0xLTM2NDA2MA_73170083-0587-4e32-881d-76b9efc54730">1,139</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3d97b9f2b2384d5fb8b3e7b0afa2a5a1_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTgtMS0xLTM2NDA2MA_06f68d1a-c7e2-46d2-ac09-23e1307fd7af">1,996</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTktMS0xLTM2NDA2MA_43984402-6685-49a8-9fb6-4ff9cc74562b">4,468</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d653af939404c578466f638984d2422_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTEwLTEtMS0zNjQwNjA_9d094161-b5fb-4013-b6fb-972641fd6720">1,359</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0407751659c54020a63e3b5e93476585_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTExLTEtMS0zNjQwNjA_ec128ea3-e0ac-400c-8d3d-1381a130371c">1,071</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i66d6c454ffb244d98228a677f46b2fac_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTEyLTEtMS0zNjQwNjA_dc576981-f767-49df-93a6-8efe50496bed">1,964</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTEzLTEtMS0zNjQwNjA_15bc771f-6f5d-41f6-8772-a85cafb76b2c">4,394</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Allergy</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6bda1c567b1c49029b875aa4febc16bc_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTItMS0xLTM2NDA2MA_9aa847e6-8675-4e32-8651-c83491db1bf4">55</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9c22a1098e3e46b3b86d47b9cf5ba970_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTMtMS0xLTM2NDA2MA_98e517d2-c0ed-4200-b682-17d8c836fce8">439</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i156e9e8a21b449018c4bd18d3570d698_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTQtMS0xLTM2NDA2MA_80dbd5d6-574d-48c2-8b71-54269154afb1">240</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id5cdd431c5ae43a593b7cfa1f7bdbfd9_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTUtMS0xLTM2NDA2MA_053390ca-26e5-4d88-9e9d-dacabc7bd8e6">734</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9a2f8c0d377e4c1283f5b111722e1ba9_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTYtMS0xLTM2NDA2MA_30ae4b3e-b919-4567-bc4f-6a523b2d545f">49</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9082ca4896f544149c5fa993fc76e11a_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTctMS0xLTM2NDA2MA_0d5e248b-9d19-4587-a669-8649181cf100">371</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i255d9fe68622490197bffdba2a258f3f_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTgtMS0xLTM2NDA2MA_d0e54343-5bde-433e-8b27-644122df39f2">192</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a047d0a5c8a445f9834ff3fbe6bb785_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTktMS0xLTM2NDA2MA_8d3cf92c-2837-4aa5-8412-9eb9ab5b81fe">612</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib9b0bb905111472f9a11100558b1571c_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTEwLTEtMS0zNjQwNjA_8503e47a-50ec-4ecd-931e-1b4501dd8f75">51</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5c459d45e7794c9597c5651cd4ef947b_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTExLTEtMS0zNjQwNjA_fa78812f-c188-4d59-8c5a-1ebbe4e60cb9">361</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i84d4767234f44fd1b5d3a8968daa3946_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTEyLTEtMS0zNjQwNjA_f6cf35fc-bc43-4b64-9049-2f986f9d3191">205</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia50a50591809469c9fb3b18d4811f6c6_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTEzLTEtMS0zNjQwNjA_7c70ef2c-1f0a-4f68-9a4b-6fe7e96fbb14">617</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Pain Care</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i214d7e38fa714fa9b73acc2b9f341911_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTItMS0xLTM2NDA2MA_5fd9589e-b231-4d60-a09f-012040ba31ec">555</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia473b953f05b4b35b5b13789c70d761c_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTMtMS0xLTM2NDA2MA_89b4f2c4-a930-484e-ab11-88ecfd04c057">212</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic6e4519162104b64a22cc688d15044cd_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTQtMS0xLTM2NDA2MA_703b96fc-0610-45fd-a88e-84da36639bff">446</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iacefe436e3af422292acb5714b1bb8b4_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTUtMS0xLTM2NDA2MA_93295a7c-9567-46b1-801d-37b6630570fe">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i259f4b387d9c42eb93ef585b678f7f77_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTYtMS0xLTM2NDA2MA_0414d2bc-5942-46f6-82a1-fb51bc1dba2a">515</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id551965a5ec24ec7b5833702fead3db8_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTctMS0xLTM2NDA2MA_488945f5-e9ac-4ed3-96c1-4e1c9c2708f2">196</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i116a1c4972304262b4654d3e3720dd45_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTgtMS0xLTM2NDA2MA_7e9021ad-592f-4c58-a661-3535df9c3cf2">382</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i78407570f0dd4b788e9539bca72b8480_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTktMS0xLTM2NDA2MA_d7f38d03-e791-4640-afed-1a5735d7ed24">1,093</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9539a37f5b634f80a45b018298a7e6bf_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTEwLTEtMS0zNjQwNjA_c07d9e79-1f4d-4071-90ef-64f7b249cec8">481</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1a60f0418a2945d6816d55ba2ee00395_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTExLTEtMS0zNjQwNjA_d65e040d-e3f0-4389-b1bf-8ea049edd420">181</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3637ba1108d64738a99a8947658367e5_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTEyLTEtMS0zNjQwNjA_846d1a9c-e266-4bc1-97cd-ae9520882233">389</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4cb20a306adc460d867ea28b00dea2fc_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTEzLTEtMS0zNjQwNjA_a2743b46-e692-4d60-b13d-24fdcdb06256">1,051</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Digestive Wellness</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i756f63fcc9aa4b528eaafce6b9d10810_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTItMS0xLTM2NDA2MA_de870741-0c7f-41b0-b052-2c4fd7fffcc7">432</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1680427a219746dd8d52e2b51d87bbeb_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTMtMS0xLTM2NDA2MA_5ff179e9-65a5-4e4e-a8ce-5b59f1646d86">144</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia572af328eb04f15a08f4b4be0b3c642_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTQtMS0xLTM2NDA2MA_9fecec74-a157-40de-abab-40a66de210e7">742</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i122e1cf42c504ef281c0148bcb08bfa4_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTUtMS0xLTM2NDA2MA_ee093325-8ad3-4a24-bdb7-75ead3909bba">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i90e43d267391440f976deaffa7f1ee2c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTYtMS0xLTM2NDA2MA_8be36a96-da86-44b5-a387-1233f22d63f3">389</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia15f03b10746440791e34cb56493eec6_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTctMS0xLTM2NDA2MA_00bf775d-aac0-47ae-909d-d80011daa126">124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22e0e6e055ed470d9bf214946d58ab2d_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTgtMS0xLTM2NDA2MA_5443c9c2-c688-478a-9c4f-c933aebddbdb">618</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia8ac8b1054ed482a8e8960303293a8d7_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTktMS0xLTM2NDA2MA_8451a1c1-cf96-4627-9553-dd35f4512373">1,131</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i329b514f506f477d9329c03ae9d60a33_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTEwLTEtMS0zNjQwNjA_3c81612e-f84d-409f-816a-3e898cab732b">371</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i60bd3898aea54bd1923c045dc3905730_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTExLTEtMS0zNjQwNjA_e5c2ad31-1f11-43e2-8529-50e063b54bf1">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i01fe34367f704a4d9280d0e481946add_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTEyLTEtMS0zNjQwNjA_d7245dff-2b61-4fdc-9dd4-88419e7827a3">532</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i48f608014a524624a2b5d9789797f352_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTEzLTEtMS0zNjQwNjA_3ae0a806-d1e4-4264-906e-3554b942d9ed">988</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6e829ee2f99a465ab88b9472b399fb82_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTItMS0xLTM2NDA2MA_75378073-89a8-4475-8236-c594ccf4217b">9,999</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTMtMS0xLTM2NDA2MA_f2c0cd6c-e60d-4f5d-ba61-5a8381d2d8bc">18,275</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i1d62960d62de4d168f734a97be14a478_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTQtMS0xLTM2NDA2MA_a51da84c-d8ea-401b-af4a-4ebff1f2ff59">14,723</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTUtMS0xLTM2NDA2MA_996427fa-d5ac-4dbe-82d8-e91f43f9ae54">42,997</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibf60334e241640fe96a7903ed2e9b3ad_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTYtMS0xLTM2NDA2MA_b30340b1-ad54-47c5-a033-fa7c18c08a55">9,759</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTctMS0xLTM2NDA2MA_c45bb618-e953-4a57-8c4f-c0775f7ce441">14,385</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2f77a621c718482c8212f4c353b4d1b7_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTgtMS0xLTM2NDA2MA_2ff1d6ed-15bb-4870-8cc5-8bad0fe52ef3">13,617</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTktMS0xLTM2NDA2MA_513a695b-2342-419b-aeb0-1249364dc542">37,761</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;border-left:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id0034d62b9984b9c819c9089b17c9dff_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTEwLTEtMS0zNjQwNjA_eab9b3d6-044a-4bd4-81ec-50c09c3b8fa8">9,151</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTExLTEtMS0zNjQwNjA_2a8a9c97-4957-4dba-91cd-4061118237da">13,465</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6a8f83aca4714f6ab0e8c9bb8b1a50a2_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTEyLTEtMS0zNjQwNjA_c0d4f3b2-c809-441e-8837-829d458a15b0">13,425</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTEzLTEtMS0zNjQwNjA_1abd459e-e8d7-441b-bcaf-5e7137029f7b">36,041</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160; For the Consumer Healthcare GBU, Sanofi has since 2021 adopted a more granular presentation by introducing new sub-categories that reflect consumer trends and the strengths and opportunities of the portfolio.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.35.1.2. Business operating income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi reports segment results on the basis of &#8220;Business operating income&#8221;. This indicator is used internally by Sanofi&#8217;s chief operating decision maker to measure the performance of each operating segment and to allocate resources.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Business operating income&#8221; is derived from </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, adjusted as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amounts reported in the line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Restructuring costs and similar items</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> relating to business combinations (IFRS&#160;3) and </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (gains and losses on major disposals of assets, asset groups ore operations, and costs related to major litigation) are eliminated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">expenses arising from the remeasurement of inventories following a business combination (IFRS&#160;3) are eliminated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">amortization and impairment losses charged against intangible assets (other than software and other rights of an industrial or operational nature) are eliminated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">upfront payments and regulatory milestone payments recognized within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and related to transactions outside the ordinary activities of Sanofi are eliminated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the share of profits/losses from investments accounted for using the equity method is added, to the extent that this relates to&#160;joint ventures and associates with which Sanofi has a strategic alliance (for 2020, excludes Regeneron up to and including&#160;May&#160;29, 2020; see Note&#160;D.2.);</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-94</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="icf3ae30afa4b4987b4ec265c3a5db7c6" continuedAt="ia33c60eba140409fbcbe3d9b77b77ea6"><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">acquisition-related effects and restructuring costs relating to investments accounted for using the equity method (joint ventures and associates with which Sanofi has a strategic alliance) are eliminated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">net income attributable to non-controlling interests is deducted; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">for 2020, the gain on the divestment of Regeneron shares on May&#160;29, 2020 is eliminated. This elimination does not include the gain on the remeasurement of the <ix:nonFraction unitRef="shares" contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529" decimals="INF" name="sny:NonCurrentFinancialAssetsNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzYxMDg_651fa2c9-5787-4f81-961d-09b98e016c80">400,000</ix:nonFraction>&#160;retained shares at market value as of that date.</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfOperatingSegmentsExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDU5_e5a958b4-db1f-4a94-a56a-4e98d11a252e" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows Sanofi&#8217;s segment results for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:35.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Sanofi</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzItMS0xLTEtMzY0MDYw_daf4398d-4775-4c8e-ac92-26a1bf60d45a">30,688</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzItMi0xLTEtMzY0MDYw_4a6513ef-6957-4184-a15c-4f794095c073">7,229</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzItMy0xLTEtMzY0MDYw_796abecd-0da9-47c6-bc2e-2f1236ee537d">5,080</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzItNC0xLTEtMzY0MDYw_7db22e56-2de3-4295-9ce4-8ca1ef9c62b6">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzItNS0xLTEtMzY0MDYw_ed0de674-2607-486f-9dda-f17cdda760b8">42,997</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231" decimals="-6" name="ifrs-full:OtherRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzMtMS0xLTEtMzY0MDYw_1173e3f8-da66-4026-88ca-c26504162f6c">657</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231" decimals="-6" name="ifrs-full:OtherRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzMtMi0xLTEtMzY0MDYw_033dee1f-62ab-4c37-a9dd-cdea918f1df3">1,666</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" name="ifrs-full:OtherRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzMtMy0xLTEtMzY0MDYw_73c1cf8f-3a1e-42b9-ac2e-a10e7e8a524d">62</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231" decimals="-6" name="ifrs-full:OtherRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzMtNC0xLTEtMzY0MDYw_d7764683-48d3-4087-b614-90f264699d3c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231" decimals="-6" name="ifrs-full:OtherRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzMtNS0xLTEtMzY0MDYw_c501555f-940c-4391-9c23-1ce0082eae8d">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzQtMS0xLTEtMzY0MDYw_64e81359-dfd8-4a0f-9339-2925daa30580">7,511</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzQtMi0xLTEtMzY0MDYw_3fa2d7cd-ef35-4ffe-a937-f29c5d92682d">4,101</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzQtMy0xLTEtMzY0MDYw_7660f46e-8866-4215-8879-4060ca21a687">1,827</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzQtNC0xLTEtMzY0MDYw_fdbb9e13-8510-41e9-b454-0778276d78ed">253</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzQtNS0xLTEtMzY0MDYw_270a8e40-57f6-45a1-9294-1f196cd91116">13,692</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzUtMS0xLTEtMzY0MDYw_3eb03316-e4c3-4ad6-aeef-07ff3f451438">5,067</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzUtMi0xLTEtMzY0MDYw_41987df5-f681-4202-ae47-b2044804126e">936</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzUtMy0xLTEtMzY0MDYw_5070edaf-b256-4e46-9964-0ac64dacc90d">187</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzUtNC0xLTEtMzY0MDYw_278de198-c574-46cc-99d0-108e64f7cac9">516</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzUtNS0xLTEtMzY0MDYw_568f617a-f3fc-40b9-bca8-13ed6cdd79e7">6,706</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzYtMS0xLTEtMzY0MDYw_2871905b-3ba2-4123-a14f-ed4582e88899">5,923</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzYtMi0xLTEtMzY0MDYw_ffd5b6e6-25cb-4add-a311-aff4b6aadb23">870</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzYtMy0xLTEtMzY0MDYw_ee80536f-1199-4591-814c-05d1f5436045">1,478</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzYtNC0xLTEtMzY0MDYw_cf619c5b-b70e-46a4-a1e3-21803a02271e">2,221</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzYtNS0xLTEtMzY0MDYw_bca4fa10-a24e-4118-ab9e-2551de1e7761">10,492</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income and expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231" decimals="-6" sign="-" name="sny:MiscellaneousOtherOperatingIncomeExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzctMS0xLTEtMzY0MDYw_f56cefe6-b7e6-4f00-ba08-36005483e543">1,800</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231" decimals="-6" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzctMi0xLTEtMzY0MDYw_eeca744a-a5f0-4759-972b-f7a3ec5eec0b">132</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzctMy0xLTEtMzY0MDYw_d7a5ec4e-8761-4ff5-a0b2-dbd99d7baf96">152</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231" decimals="-6" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzctNC0xLTEtMzY0MDYw_bcaea117-f09f-4ba3-abd1-1932882a6325">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231" decimals="-6" sign="-" name="sny:MiscellaneousOtherOperatingIncomeExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzctNS0xLTEtMzY0MDYw_dfaa0a19-8196-47cf-abd7-24c0aeb24cfd">1,514</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzgtMS0xLTEtMzY0MDYw_10b0fab6-fe7f-428e-be4b-c4c29187658d">28</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzgtMi0xLTEtMzY0MDYw_93747d48-ea92-451a-a8ce-c259f9a42d98">48</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzgtMy0xLTEtMzY0MDYw_d27e0966-a06c-4e3c-8534-e0c354b21626">12</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzgtNC0xLTEtMzY0MDYw_8a29a972-69db-4995-8643-b604a7272894">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzgtNS0xLTEtMzY0MDYw_52277fe5-6f3c-4f46-a9e9-2217f0ae8095">88</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzktMS0xLTEtMzY0MDYw_a59dfdec-a5ca-4f0f-bfe9-b8867504f6ba">29</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzktMi0xLTEtMzY0MDYw_776f5fb5-8755-49f2-a2b0-795fc88847f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzktMy0xLTEtMzY0MDYw_da4b950c-f8e0-4157-9b44-71a8eb68e670">4</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzktNC0xLTEtMzY0MDYw_afd9894f-122f-4a4f-bbf1-211d0c66032d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzktNS0xLTEtMzY0MDYw_29de6495-cc68-4ee2-a785-3f69d8354f37">33</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzEwLTEtMS0xLTM2NDA2MA_2f0d549b-6571-4548-a5b5-28ceb031b161">11,043</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzEwLTItMS0xLTM2NDA2MA_2e669a06-33c8-4af9-83c0-4963b822f535">3,168</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzEwLTMtMS0xLTM2NDA2MA_102210b0-c308-469a-b91d-543b03642c2f">1,810</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231" decimals="-6" sign="-" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzEwLTQtMS0xLTM2NDA2MA_d9501d51-667e-48ec-96f0-81b7d44b3210">2,981</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzEwLTUtMS0xLTM2NDA2MA_edb3a615-66da-4e3a-91e8-4e9f7d4c39b3">13,040</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">a) This caption reconciles segment financial information to total consolidated financial information.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:35.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Sanofi</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzItMS0xLTEtMzY0MDYw_722683e4-c937-446c-8444-a2712e971112">26,970</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzItMi0xLTEtMzY0MDYw_9967ab85-b928-4af8-9c10-17c58f023dc8">6,323</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzItMy0xLTEtMzY0MDYw_daa0aa1c-f3ec-4fa7-9956-1b839f8b0c2f">4,468</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzItNC0xLTEtMzY0MDYw_5254a5e6-a867-488b-9c5e-815e20ddfa6d">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzItNS0xLTEtMzY0MDYw_3e561c49-09c0-470a-ba6f-be44ed11540b">37,761</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231" decimals="-6" name="ifrs-full:OtherRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzMtMS0xLTEtMzY0MDYw_03dca851-9864-4a08-b516-9234303f2c90">264</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231" decimals="-6" name="ifrs-full:OtherRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzMtMi0xLTEtMzY0MDYw_a5fa83c8-aa7e-4199-92f8-a92200f2e696">1,095</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" name="ifrs-full:OtherRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzMtMy0xLTEtMzY0MDYw_1a0345af-f5e0-4ed5-a303-dad4af9cc08a">55</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231" decimals="-6" name="ifrs-full:OtherRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzMtNC0xLTEtMzY0MDYw_efdabf40-6224-4391-b35b-503335cbec16">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231" decimals="-6" name="ifrs-full:OtherRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzMtNS0xLTEtMzY0MDYw_b9a7ec3a-5e63-4f89-b95b-5f87c67e7813">1,414</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzQtMS0xLTEtMzY0MDYw_d95b92cd-24c4-4d8c-af99-1539b423234d">6,965</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzQtMi0xLTEtMzY0MDYw_be56f4f3-fcb4-443f-9278-a7ca7f2962a9">3,430</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzQtMy0xLTEtMzY0MDYw_e4bd7265-fddb-4cc1-a364-d92bd7168d2d">1,606</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzQtNC0xLTEtMzY0MDYw_4730fa24-e060-4267-89d6-b94735d9c14c">250</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzQtNS0xLTEtMzY0MDYw_d80fa903-57a9-4058-8051-3efab3897a2a">12,251</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzUtMS0xLTEtMzY0MDYw_07834c5b-a2cb-4705-af08-56824f44cdee">4,330</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzUtMi0xLTEtMzY0MDYw_cb9f5eee-8e06-4706-8a83-d0480a320138">712</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzUtMy0xLTEtMzY0MDYw_15c3a473-3864-4849-96a7-187092b5669b">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzUtNC0xLTEtMzY0MDYw_16015e3a-057b-4419-b627-450096a6b2bb">497</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzUtNS0xLTEtMzY0MDYw_5f9f9a9b-54e6-445a-ae2d-6c1401ac05fc">5,692</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzYtMS0xLTEtMzY0MDYw_a0e85aa6-ee2f-4a4d-b32c-9f6269f7a949">5,326</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzYtMi0xLTEtMzY0MDYw_2fa7102c-548d-4de4-ab20-e19aa789bdfd">805</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzYtMy0xLTEtMzY0MDYw_100780e8-cc39-4b3c-87cd-6579ccbb1d43">1,388</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzYtNC0xLTEtMzY0MDYw_6c19fa01-7960-489f-8f66-80b90c0ce068">2,036</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzYtNS0xLTEtMzY0MDYw_8145dae8-41d7-4f6b-bffa-3cf4c0841676">9,555</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income and expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231" decimals="-6" sign="-" name="sny:MiscellaneousOtherOperatingIncomeExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzctMS0xLTEtMzY0MDYw_dc6d1699-c042-44a9-bfec-518e34756faf">1,172</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231" decimals="-6" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzctMi0xLTEtMzY0MDYw_da314ea3-da27-4d05-9eae-f238c73e1158">128</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzctMy0xLTEtMzY0MDYw_4168934f-7a6c-4685-a290-40dcd7e74dde">111</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231" decimals="-6" sign="-" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzctNC0xLTEtMzY0MDYw_53ee4fd7-12bc-4c0b-9042-4722edadd36e">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231" decimals="-6" sign="-" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzctNS0xLTEtMzY0MDYw_2f03848d-3e2b-4738-bc80-f9824b48452b">946</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzgtMS0xLTEtMzY0MDYw_d6d8e2cc-c2b3-4830-8714-320afeb05c67">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzgtMi0xLTEtMzY0MDYw_40f94fbb-2bef-4f56-9881-128bf23d6199">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzgtMy0xLTEtMzY0MDYw_8d241f9b-1597-40d9-aa38-f1a43a253252">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzgtNC0xLTEtMzY0MDYw_00c6844c-ed7a-455a-a0c0-36090ec256a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzgtNS0xLTEtMzY0MDYw_4dea8a8a-37b6-4d29-8382-a96fde10b2b1">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzktMS0xLTEtMzY0MDYw_2f5341bd-477e-46d7-825e-24997cd69fb5">49</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzktMi0xLTEtMzY0MDYw_5e024f6a-20e5-4fc6-b0f0-1f6d41060412">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzktMy0xLTEtMzY0MDYw_e027e0ca-30e2-4725-8f42-ba39f0cc43a6">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzktNC0xLTEtMzY0MDYw_63cabbdb-c752-4da1-8291-9a60ef658506">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzktNS0xLTEtMzY0MDYw_9e340624-7770-489a-8c32-f467d0e9ac2c">56</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzEwLTEtMS0xLTM2NDA2MA_d3fae6af-9b22-4c1f-9880-4114a2e4c119">9,409</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzEwLTItMS0xLTM2NDA2MA_b3c3d801-86c1-4525-a9df-d1801217ba0c">2,609</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzEwLTMtMS0xLTM2NDA2MA_4ce35214-8354-491e-aaaf-f045ce36b062">1,493</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231" decimals="-6" sign="-" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzEwLTQtMS0xLTM2NDA2MA_8276c4c1-1522-4a2e-abaa-e9156f4e6c0b">2,797</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzEwLTUtMS0xLTM2NDA2MA_738c98a8-8563-4f02-b654-bc19ccc2ac0e">10,714</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">This caption reconciles segment financial information to total consolidated financial information.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:36.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Sanofi</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzItMS0xLTEtMzY0MDYw_fc0baa6d-7fc4-4027-9a74-434212b14893">25,674</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzItMi0xLTEtMzY0MDYw_46cda69b-53ce-4a93-9242-8bf31cdde069">5,973</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzItMy0xLTEtMzY0MDYw_774aef60-0b28-4fef-aee5-20a6425fdec4">4,394</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzItNC0xLTEtMzY0MDYw_aefd9867-2e92-474c-aff0-ec1327574caf">&#8212;</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzItNS0xLTEtMzY0MDYw_593dee01-210b-4ad2-9f93-1c6a9861f8ce">36,041</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231" decimals="-6" name="ifrs-full:OtherRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzMtMS0xLTEtMzY0MDYw_7e71cff7-0252-4475-893f-f3c46ac95253">128</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231" decimals="-6" name="ifrs-full:OtherRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzMtMi0xLTEtMzY0MDYw_6aa53a96-9f71-420a-ae82-3793cfddc69e">1,141</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" name="ifrs-full:OtherRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzMtMy0xLTEtMzY0MDYw_608dc93e-2d9f-467f-bd1f-76d9a1601505">59</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231" decimals="-6" name="ifrs-full:OtherRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzMtNC0xLTEtMzY0MDYw_4a6bfb59-a593-421c-8317-20b25d6dd3be">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231" decimals="-6" name="ifrs-full:OtherRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzMtNS0xLTEtMzY0MDYw_1bbe6b9d-6b0c-45f6-b512-e42ab5d8c345">1,328</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzQtMS0xLTEtMzY0MDYw_a1483f78-9f36-42a1-b5d7-7771a2bcb8da">6,982</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzQtMi0xLTEtMzY0MDYw_2109ee5e-31cb-46e7-9b83-ea58b55f5894">3,312</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzQtMy0xLTEtMzY0MDYw_913b76cb-da03-465d-8eb6-e3af163f5da9">1,528</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231" decimals="-6" name="ifrs-full:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzQtNC0xLTEtMzY0MDYw_36c7de2d-fdc5-4a96-bd3e-ca04af947da9">284</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231" decimals="-6" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzQtNS0xLTEtMzY0MDYw_2f663c60-8e03-4755-8559-dfc0cc10f6b7">12,106</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzUtMS0xLTEtMzY0MDYw_c6b78802-f713-44ce-9367-04881d55ee26">4,171</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzUtMi0xLTEtMzY0MDYw_5684ecda-d65b-4e54-b110-cee63a3e9305">682</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzUtMy0xLTEtMzY0MDYw_44812421-c3f4-47fb-bf05-493c370dd23e">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzUtNC0xLTEtMzY0MDYw_541d7668-a28c-47e6-8de6-5a4d3b4dce77">524</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231" decimals="-6" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzUtNS0xLTEtMzY0MDYw_7d465ccf-76e2-4aa9-84ad-b95988d2ff1c">5,530</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzYtMS0xLTEtMzY0MDYw_5bfcc1d1-7e02-4f7d-b930-55a2da2fc772">4,927</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzYtMi0xLTEtMzY0MDYw_bb67ccf7-d6d4-4230-b3d9-48aefe05c026">789</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzYtMy0xLTEtMzY0MDYw_b524df3a-ea54-4f48-bee0-817b0754d7c2">1,419</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzYtNC0xLTEtMzY0MDYw_0cbf6db5-7560-4b9d-a30c-e5b02edd14f7">2,256</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231" decimals="-6" name="ifrs-full:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzYtNS0xLTEtMzY0MDYw_f23137aa-1f13-4d57-85b8-89e556cf1638">9,391</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income and expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231" decimals="-6" sign="-" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzctMS0xLTEtMzY0MDYw_36d20614-7dc6-4b70-b3b1-e61a5eb4cb66">487</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231" decimals="-6" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzctMi0xLTEtMzY0MDYw_a099af1e-36a4-45d6-8a6f-0b1255f8f65a">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzctMy0xLTEtMzY0MDYw_caaff323-956f-47e1-84fd-659b7c8194a4">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231" decimals="-6" sign="-" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzctNC0xLTEtMzY0MDYw_80484aa4-d0fb-4c01-b764-7ad23fa623f3">130</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231" decimals="-6" sign="-" name="sny:MiscellaneousOtherOperatingIncomeExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzctNS0xLTEtMzY0MDYw_90e6c902-15e0-495a-911b-f1c35606219e">561</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzgtMS0xLTEtMzY0MDYw_81448c33-cd29-4e2f-b684-7e8911e6e170">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzgtMi0xLTEtMzY0MDYw_539a39cd-588d-41a1-aee3-c6cacecef19f">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzgtMy0xLTEtMzY0MDYw_d566bc8f-ba6d-4990-bafa-73070857611e">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzgtNC0xLTEtMzY0MDYw_70b84172-0271-4691-b857-a02c02080d9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231" decimals="-6" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzgtNS0xLTEtMzY0MDYw_591eb7d7-86bd-4e18-ba54-9874247a7c1b">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzktMS0xLTEtMzY0MDYw_45635301-25bc-41aa-b469-34dda2880462">33</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzktMi0xLTEtMzY0MDYw_80570e53-62ad-47c6-8b9d-81e0283a0e93">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzktMy0xLTEtMzY0MDYw_7b83e069-c7c0-45f8-ba3d-05ed6f09e83a">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzktNC0xLTEtMzY0MDYw_0f29a7e3-cda5-4e62-ab0e-f0055040c1a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzktNS0xLTEtMzY0MDYw_780ad07f-895e-406d-9569-a60854389cd9">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzEwLTEtMS0xLTM2NDA2MA_82a350d8-5229-42d8-9b41-c8b0816a7164">9,207</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzEwLTItMS0xLTM2NDA2MA_67a2930b-921f-423d-971f-e46c952fac54">2,336</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzEwLTMtMS0xLTM2NDA2MA_43eaf992-22bc-4d66-8804-66755b71ceac">1,410</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231" decimals="-6" sign="-" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzEwLTQtMS0xLTM2NDA2MA_40fd3c2b-6944-4069-84ba-70bb7fd10d96">3,194</ix:nonFraction>)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzEwLTUtMS0xLTM2NDA2MA_b6dd9495-6876-47b1-8a5f-3f0d0395d8b3">9,759</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">2020 figures have been adjusted to take account of the reallocation of certain expenses (in particular IT costs related to Sanofi&#8217;s new digital organization) from the Pharmaceuticals, Vaccines and Consumer Healthcare operating segments to the &#8220;Other&#8221; segment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) This caption reconciles segment financial information to total consolidated financial information.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-95</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="ia33c60eba140409fbcbe3d9b77b77ea6" continuedAt="i217f7eb938654da89ef2269cae731af0"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDU0_f48b2bd0-d7b2-4bbb-8ce9-c5ffb2247d71" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below, presented in compliance with IFRS&#160;8, shows a reconciliation between aggregated &#8220;Business operating income&#8221; for the segments and</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Income before tax and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.676%"><tr><td style="width:1.0%"></td><td style="width:58.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.152%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(h)</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i013162020a33403bb8ab3a5b4d6acf5b_D20220101-20221231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEtMS0xLTEtMzY0MDYw_3a8d6eb1-8890-4286-b3bf-7f3bb7977849">13,040</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i86bdcc50c470440b9f04a89cc25fc25e_D20210101-20211231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEtMi0xLTEtMzY0MDYw_db4c0258-50f9-4efc-a8ab-bd0ce71b71c8">10,714</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i10a2eadc160a461e8aa95a317634efc4_D20200101-20201231" decimals="-6" name="sny:BusinessOperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEtNC0xLTEtMzY0MDYw_3f383401-851f-43e0-8b83-f5dcac27d942">9,759</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzItMS0xLTEtMzY0MDYw_2720d3cb-f6bd-4ed1-854f-bec48a6e5791">88</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzItMi0xLTEtMzY0MDYw_5e4126e2-11a1-459b-b7a7-1734e1e04c1e">39</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231" decimals="-6" sign="-" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzItNC0xLTEtMzY0MDYw_91f1e052-f0a0-4cd6-a105-d57456e0e2f6">16</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzMtMS0xLTEtMzY0MDYw_9a1424c5-b300-4b87-9f1b-255b8bb5c71a">33</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzMtMi0xLTEtMzY0MDYw_ac1fca66-0366-48c1-8674-1aa0a194c6f6">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzMtNC0xLTEtMzY0MDYw_71dea521-721b-4e98-bdad-adf2df295a4b">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization and impairment of intangible assets </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231" decimals="-6" name="sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzQtMS0xLTEtMzY0MDYw_f3698bad-331f-4905-8a07-b3904f8792cb">1,599</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231" decimals="-6" name="sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzQtMi0xLTEtMzY0MDYw_dd5d947c-2cb3-414e-be03-965fc38babf8">1,772</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231" decimals="-6" name="sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzQtNC0xLTEtMzY0MDYw_4ad5657a-ac1d-4aaf-a628-ef222aaaae17">2,011</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231" decimals="-6" name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzUtMS0xLTEtMzY0MDYw_ffd332fb-09e3-4ab1-b8b3-81c88fe45781">27</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231" decimals="-6" sign="-" name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzUtMi0xLTEtMzY0MDYw_110495ec-116d-496a-b69d-84f3ebc4ed45">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231" decimals="-6" name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzUtNC0xLTEtMzY0MDYw_feeca2c3-c6d6-4de2-b717-2f0a176995dd">124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expenses arising from the impact of acquisitions on inventories</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231" decimals="-6" name="sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzYtMS0xLTEtMzY0MDYw_a4bfa685-64ee-4e81-a0fa-1c508c6dedb3">3</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231" decimals="-6" name="sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzYtMi0xLTEtMzY0MDYw_03f298d9-8520-4f8f-90fa-c8816303ae53">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231" decimals="-6" name="sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzYtNC0xLTEtMzY0MDYw_9ef15954-d8ac-480e-9ab3-c791a33d0a8a">53</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzctMS0xLTEtMzY0MDYw_ea7b8733-1919-4d64-9e15-afd5c5e77ef4">1,336</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzctMi0xLTEtMzY0MDYw_dd0af69a-e284-4dca-8c3e-42a2cde5145b">820</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231" decimals="-6" name="ifrs-full:ExpenseOfRestructuringActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzctNC0xLTEtMzY0MDYw_2960f8d1-17b8-4d70-886d-0da17abab1c0">1,089</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231" decimals="-6" sign="-" name="sny:OtherGainsLossesAndLitigation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzktMS0xLTEtMzY0MDYw_32eda327-8dae-4df0-9bad-7e36e06a0283">370</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231" decimals="-6" sign="-" name="sny:OtherGainsLossesAndLitigation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzktMi0xLTEtMzY0MDYw_56b273c4-5153-494f-8328-54a1e7f96452">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231" decimals="-6" name="sny:OtherGainsLossesAndLitigation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzktNC0xLTEtMzY0MDYw_25a1452f-953c-4a2b-8d7c-dedda92ec7eb">136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gain on divestment of Regeneron shares on May&#160;29, 2020</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231" decimals="-6" name="sny:GainOnRegeneronInvestmentSold" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEwLTEtMS0xLTM2NDA2MA_e42a20ce-0253-4a7f-b5e0-c84d4fafcc8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231" decimals="-6" name="sny:GainOnRegeneronInvestmentSold" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEwLTItMS0xLTM2NDA2MA_daee5277-47d6-4bed-9f1b-298fd2393464">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231" decimals="-6" name="sny:GainOnRegeneronInvestmentSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEwLTQtMS0xLTM2NDA2MA_79cce99f-e962-48af-b57e-f827847f9d15">7,225</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income from out-licensing</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231" decimals="-6" name="sny:IncomeResultingFromOutLicensing" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTEtMS0xLTQ0NzkwOA_76c8981a-8eb6-4fa8-b698-e0d6d3d1fb57">952</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231" decimals="-6" name="sny:IncomeResultingFromOutLicensing" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTItMS0xLTQ0NzkwOA_fbb12f5a-b8a6-4243-98da-5a3167f9d6d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231" decimals="-6" name="sny:IncomeResultingFromOutLicensing" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTQtMS0xLTQ0NzkxNg_980e21af-44a5-4f43-af5d-0b34276f50e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTEtMS0xLTM2NDA2MA_99498100-fc0b-4375-862f-849e9c29e184">10,656</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTItMS0xLTM2NDA2MA_b58d4478-534e-451f-a3d4-0e37d34e8ba1">8,126</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTQtMS0xLTM2NDA2MA_e5374ccc-2d88-49cf-9981-17c21b8f6b01">14,113</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial expenses</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEyLTEtMS0xLTM2NDA2MA_7a406d8a-594e-442b-8b6d-9d5528bee57f">440</ix:nonFraction>)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEyLTItMS0xLTM2NDA2MA_2128e605-50e8-419f-a501-1c0e3f378d18">368</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:FinanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEyLTQtMS0xLTM2NDA2MA_a8392b1a-9940-4b5c-85f6-43da1ccd5946">388</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEzLTEtMS0xLTM2NDA2MA_a60a5950-7f61-4746-b594-13e97cff0d91">206</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEzLTItMS0xLTM2NDA2MA_d86a2cf4-ad14-472a-b436-d909039011ab">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="ifrs-full:FinanceIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEzLTQtMS0xLTM2NDA2MA_69a16d2d-08bd-463d-9f14-13e5a197d647">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income before tax and investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" decimals="-6" name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzE0LTEtMS0xLTM2NDA2MA_1557d4c8-31da-4675-a490-f386f8fb734b">10,422</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231" decimals="-6" name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzE0LTItMS0xLTM2NDA2MA_dd8bd87a-8c5d-47fb-86e0-f3a53a00568c">7,798</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231" decimals="-6" name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzE0LTQtMS0xLTM2NDA2MA_441554ba-9109-4313-9428-397598f7123b">13,778</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Excludes restructuring costs relating to investments accounted for using the equity method and expenses arising from the impact of acquisitions on investments accounted for using the equity method. For the first two quarters of 2020, this line has been restated to exclude any effect of equity method accounting for the investment in Regeneron following the divestment of Sanofi's entire equity interest (with the exception of the <ix:nonFraction unitRef="shares" contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529" decimals="INF" name="sny:NonCurrentFinancialAssetsNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzc3NTg_0b8cffe7-cefc-4d16-85be-35b1551a23c0">400,000</ix:nonFraction>&#160;shares retained by Sanofi) on May&#160;29, 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to non-controlling interests.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) For 2022, this line includes a reversal of &#8364;<ix:nonFraction unitRef="eur" contextRef="i9b81437bb0bc49abac2a243bae255b03_D20220101-20221231" decimals="-6" name="sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEyMzY5NTA1ODE1Mzg1OQ_4ae5ea8a-913b-45b3-8fd9-79b15ff7fbde">2,154</ix:nonFraction>&#160;million on Eloctate franchise products following FDA approval of ALTUVIIIO </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">dated February 22, 2023, partially offset by an impairment of &#8364;<ix:nonFraction unitRef="eur" contextRef="i5742d95426994746862eae78944333b8_D20220101-20221231" decimals="-6" name="sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEyMzY5NTA1ODE1Mzg3NQ_436b699c-711a-4a9b-8e3c-43f2a099a52e">1,586</ix:nonFraction>&#160;million relating to the development project for SAR444245 (non-alpha interleukin-2).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) For 2020, this line mainly comprises the gain on the sale of operations related to the Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> activity to Baxter.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(f) This line includes the gain on the sale of (i)&#160;<ix:nonFraction unitRef="shares" contextRef="id3e2037ecf8e496eaf3ae27c42505f70_D20200529-20200529" decimals="-6" name="sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzgyOTQ_d5c046e3-6f1c-4259-901b-8b549aa0285a">13</ix:nonFraction>&#160;million shares of Regeneron common stock in the registered public offering and (ii)&#160;the <ix:nonFraction unitRef="shares" contextRef="i5e547fa7f10d4ba49513412e133bcd62_I20200529" decimals="-5" name="sny:SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzgzODU_31db2bfc-7133-4e0a-9c71-a902ff7215f1">9.8</ix:nonFraction>&#160;million shares repurchased by Regeneron, but does not include the gain arising from the remeasurement of the <ix:nonFraction unitRef="shares" contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529" decimals="INF" name="sny:NonCurrentFinancialAssetsNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzg0OTc_353373fa-0310-4c4e-bb9a-2fe027e893c1">400,000</ix:nonFraction>&#160;retained shares at market value as of&#160;May&#160;29,&#160;2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">)&#160;&#160;&#160;&#160;For 2022, this line includes an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i49530103426b457c9644701cc0be276d_D20220101-20221231" decimals="-6" name="sny:UpfrontPaymentsForProjectsUnderCollaborationAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzE5NzkxMjA5MzE0MTE3_456a88dc-12f8-4a53-a24d-a0f5570aa6eb">900</ix:nonFraction> million and a regulatory milestone payment of $<ix:nonFraction unitRef="usd" contextRef="i49530103426b457c9644701cc0be276d_D20220101-20221231" decimals="-6" name="sny:RegularMilestonePaymentsForProjectsUnderCollaborationAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzE5NzkxMjA5MzE0MTI2_296f92c4-803b-4ffd-89b8-f13a2aee5f80">100</ix:nonFraction> million related to the out-licensing of Libtayo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> following the restructuring of the Immuno-Oncology Collaboration and License Agreement with Regeneron (see Note&#160;C.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(h) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.35.2. Other segment information</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show the split by operating segment of (i)&#160;the carrying amount of investments accounted for using the equity method, (ii)&#160;acquisitions of property, plant and equipment, and (iii)&#160;acquisitions of intangible assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal investments accounted for using the equity method in the Pharmaceuticals segment are entities majority owned by EUROAPI, MSP Vaccine Company, and Infraserv GmbH &amp; Co. H&#246;chst&#160;KG (see Note&#160;D.6.).</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDYx_ae277f57-5771-477a-a8eb-f57f34c448b5" continuedAt="ibf006f02dc424866ab52c6e361b9367f" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acquisitions of intangible assets and property, plant and equipment correspond to acquisitions paid for during the period.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:48.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iee7cb4947a1c4854876868c8e2fb82d1_I20221231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzItMS0xLTEtMzY0MDYw_c43b7916-74c8-41fe-b747-cae73b7ece7f">536</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5146ddfb19c5499c89ad75916030806b_I20221231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzItMi0xLTEtMzY0MDYw_8de2bd3b-7873-419c-aea8-f0fe6c36b17a">104</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i029d1d8f14bf48ff95eda3b544a4736b_I20221231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzItMy0xLTEtMzY0MDYw_4d974c37-a7b8-4a85-88c7-8e6ee45c2eee">37</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3e9e1a94b89044af91d3720935c6c41b_I20221231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzItNC0xLTEtMzY0MDYw_85172159-f761-41e9-890d-b34d0d1ac7d2">677</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibb589cf6b30d4f85b2a6924184520710_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzMtMS0xLTEtMzY0MDYw_fcf08fc6-85e8-407d-8626-98715d59b2e1">1,025</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i50f963fe7eb242389c52c58a27841042_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzMtMi0xLTEtMzY0MDYw_48ad60e5-e956-4eba-958c-a0221cd5bf07">504</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzMtMy0xLTEtMzY0MDYw_f5f9f2e4-4c1e-4891-b7d2-ea024074dfe8">77</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzMtNC0xLTEtMzY0MDYw_e0f822a2-f978-4181-b7d9-dfa132664d92">1,606</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of other intangible assets</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibb589cf6b30d4f85b2a6924184520710_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzQtMS0xLTEtMzY0MDYw_c9609d00-e3a1-4ce3-9969-7b5768355af5">463</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i50f963fe7eb242389c52c58a27841042_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzQtMi0xLTEtMzY0MDYw_503cab0a-0b01-4b28-9975-fed901dd2464">111</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzQtMy0xLTEtMzY0MDYw_9115d069-a4ac-40ec-aa84-48a2c8a87ec3">21</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzQtNC0xLTEtMzY0MDYw_b01a1ec6-7ff8-435f-8be7-5db0213aabe5">595</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:48.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investments accounted for using the equity method</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib6b0b143fa7e4ffd8648c6d67f7caaa0_I20211231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzItMS0xLTEtMzY0MDYw_572db3c4-60ce-4b57-a534-b7832472ed34">159</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2a2427f9f19e4111a878f552385abb20_I20211231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzItMi0xLTEtMzY0MDYw_3b6c6f22-cdbb-4f74-9c62-7a6a3a43ffb5">91</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if3776772d55d454e9e161ef283add8c7_I20211231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzItMy0xLTEtMzY0MDYw_6b46391f-8b61-4b12-bcee-be341c00fe72">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id755af668f8b430fbfe6cc864db69bba_I20211231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzItNC0xLTEtMzY0MDYw_9c315893-134d-4594-8c3d-da478d5026cd">250</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb790736d7c44dc0aece34570e7aa9d1_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzMtMS0xLTEtMzY0MDYw_8bbb39ee-af92-41ad-87aa-a275065fa902">1,024</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8ec69c452bde4d2e9c935c00c627ed10_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzMtMi0xLTEtMzY0MDYw_b43050ea-5693-4813-a79a-37013803bbcc">382</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzMtMy0xLTEtMzY0MDYw_5b021c05-7c7d-42c2-89a5-8a797aa2a858">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzMtNC0xLTEtMzY0MDYw_18cd10f6-036c-462f-bc6d-e212be5a27b4">1,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb790736d7c44dc0aece34570e7aa9d1_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzQtMS0xLTEtMzY0MDYw_29741985-2e92-47d1-9db6-f289c8a85cf7">450</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8ec69c452bde4d2e9c935c00c627ed10_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzQtMi0xLTEtMzY0MDYw_6505e110-754f-484c-a390-93823bae4713">108</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzQtMy0xLTEtMzY0MDYw_cbeba79a-2a02-44cf-998a-b101fbbff928">6</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzQtNC0xLTEtMzY0MDYw_86beaa86-0d54-4834-99c1-ea3558b54fb5">564</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-96</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="i217f7eb938654da89ef2269cae731af0"><ix:continuation id="ibf006f02dc424866ab52c6e361b9367f"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:48.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investments accounted for using the equity method</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8feda8bd457f4a26b64959caa430dd5e_I20201231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzItMS0xLTEtMzY0MDYw_59127c34-65b6-4849-8743-e754cd1a770e">154</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2d0c0e35669c4d7aae59762151215c68_I20201231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzItMi0xLTEtMzY0MDYw_1d480def-e76d-4bc8-a099-bd5ca8ca21f2">47</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5ccf1608d43245e99567d6f375c33201_I20201231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzItMy0xLTEtMzY0MDYw_7861f038-13ea-4b00-a6f3-33c7565d76d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i556d066cc252454daf37eb98b7987866_I20201231" decimals="-6" name="sny:InvestmentsInAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzItNC0xLTEtMzY0MDYw_a89c8a33-3eb6-4676-a34b-522979901f1a">201</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia71d61fb176c44bc85d8a7131e07caca_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzMtMS0xLTEtMzY0MDYw_c138eec0-dc40-45db-b496-1c74f76406d5">755</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i73d9e784d85c4861808c14effc04b733_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzMtMi0xLTEtMzY0MDYw_cb79ec92-37fb-41b1-9f17-c0156e7e55cb">404</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzMtMy0xLTEtMzY0MDYw_7b4c34de-8009-434a-ad34-041b5fb6705d">95</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzMtNC0xLTEtMzY0MDYw_c8431713-f5bf-4b5d-ab0c-2899da4280e9">1,254</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia71d61fb176c44bc85d8a7131e07caca_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzQtMS0xLTEtMzY0MDYw_11305a88-3265-4f0a-b26c-f6ab0e755612">501</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i73d9e784d85c4861808c14effc04b733_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzQtMi0xLTEtMzY0MDYw_b80231c5-d0cc-41df-9a85-88b4532ecb1f">322</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzQtMy0xLTEtMzY0MDYw_68250a8c-a622-4a86-8a36-eb84ccb6728b">6</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231" decimals="-6" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzQtNC0xLTEtMzY0MDYw_271ccb50-5999-4e7d-859e-88f2b76c0374">829</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div></ix:continuation><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.35.3. Information by geographical region</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfGeographicalAreasExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDU2_c2a538fa-7bb9-4d3f-ac0d-483920564df1" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The geographical information on net sales provided below is based on the geographical location of the customer. In accordance with&#160;IFRS&#160;8, the non-current assets reported below exclude right-of-use assets relating to leases as determined under IFRS&#160;16, investments accounted for using the equity method, other non-current assets, non-current income tax assets, and deferred tax assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:26.311%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.999%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">North<br/>America</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>United&#160;States</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>countries</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i26e900f47f5a43c1af34c00b6fbd86f1_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItMS0xLTEtMzY0MDYw_943563e0-729a-4b0e-a757-bc113a350684">42,997</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6e829ee2f99a465ab88b9472b399fb82_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItMi0xLTEtMzY0MDYw_ef2c8e51-db52-4a80-b443-387831cbc0b6">9,999</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItMy0xLTEtMzY0MDYw_e15fc2ff-7d61-4aa3-a333-13f26ed8001b">2,296</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifa27b1484913467086d8717268468676_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItNC0xLTEtMzY0MDYw_eea6a661-b930-4be0-9ae2-b76c0aafca9c">18,984</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItNS0xLTEtMzY0MDYw_0d136949-1f82-4766-a16f-9eecc638be54">18,275</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3f6aa7c2c0a940db95a9895599a8e561_D20220101-20221231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItNi0xLTEtMzY0MDYw_b968b8b2-5284-469c-981a-0feeedbbc76a">14,014</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">property, plant and equipment owned</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib54fed9458034a4eac2a4487edc9c09e_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtMS0xLTEtMzY0MDYw_77f56a30-55c8-4efa-8b35-1147c511d6a4">9,869</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3abc51abaff14a808a53308dacb0555b_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtMi0xLTEtMzY0MDYw_d64bedae-e4ee-4238-ab09-c8ca37c9c14a">5,365</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtMy0xLTEtMzY0MDYw_7b30aac9-307f-4fd6-bf76-092a1c5d1d4b">2,875</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0c05f2b9a58842bf9131e7d74f48ec7e_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtNC0xLTEtMzY0MDYw_9407c50f-119a-4398-998a-e26bc4db4e2e">3,284</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtNS0xLTEtMzY0MDYw_7102aa47-b287-4643-b423-6d2fa24bea79">2,457</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i727bd67c94b846ec879e26bf1451a28b_I20221231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtNi0xLTEtMzY0MDYw_8dc00d94-0048-420c-bf05-0fe24a9e38ae">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">goodwill</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib54fed9458034a4eac2a4487edc9c09e_I20221231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtMS0xLTEtMzY0MDYw_1db10087-5c48-40de-bb48-5e4897c69257">49,892</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3abc51abaff14a808a53308dacb0555b_I20221231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtMi0xLTEtMzY0MDYw_97c9801f-66ab-4932-82f1-b8db1389d4ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtMy0xLTEtMzY0MDYw_eee0776a-05bc-4753-8c60-38a0560e4c55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0c05f2b9a58842bf9131e7d74f48ec7e_I20221231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtNC0xLTEtMzY0MDYw_a01d01f0-6352-4e21-af63-7d74d707b838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtNS0xLTEtMzY0MDYw_119e9e2d-4f7e-47c5-b40f-796e9b8c7365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i727bd67c94b846ec879e26bf1451a28b_I20221231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtNi0xLTEtMzY0MDYw_43a61532-d9f3-4363-b320-e603ae6c0e30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#9642;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:9.29pt">other intangible assets</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib54fed9458034a4eac2a4487edc9c09e_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtMS0xLTEtMzY0MDYw_df162ec4-bf68-4d49-b8ca-930a651ee844">21,640</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3abc51abaff14a808a53308dacb0555b_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtMi0xLTEtMzY0MDYw_f9d28ed6-9d10-467a-a346-14a1f92ddc37">6,257</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtMy0xLTEtMzY0MDYw_cbb71be9-a51c-4f0d-b35a-2c338c1fd62c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0c05f2b9a58842bf9131e7d74f48ec7e_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtNC0xLTEtMzY0MDYw_0a517cdc-163f-42d9-b1cb-7d0449c96d83">14,178</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtNS0xLTEtMzY0MDYw_8ceff476-05ae-4063-bdee-95e8c9f33bd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i727bd67c94b846ec879e26bf1451a28b_I20221231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtNi0xLTEtMzY0MDYw_4f006701-40ac-4468-8425-32c8a2bafa76">1,205</ix:nonFraction>&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:26.311%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.999%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></div></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">North<br/>America</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>United&#160;States</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>countries</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5f4f45d36c37402780501202da882836_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItMS0xLTEtMzY0MDYw_cb0ceed1-bf41-4d50-aa07-8a7183bb6111">37,761</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibf60334e241640fe96a7903ed2e9b3ad_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItMi0xLTEtMzY0MDYw_caafbfd9-06e0-4adb-9c87-127501047b9e">9,759</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItMy0xLTEtMzY0MDYw_95d6c1bd-b0b9-41b6-8bb1-78565e93e161">2,256</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i68c4deea6e6b470da44d7eb61f99c2c4_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItNC0xLTEtMzY0MDYw_333ec188-76b8-4a2e-a8f4-7eba4119e678">15,075</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItNS0xLTEtMzY0MDYw_ed62f046-1966-4d79-8b5f-55f1a7b2f355">14,385</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie7997885ee5a421a93ddf5ffca11ea96_D20210101-20211231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItNi0xLTEtMzY0MDYw_a954c580-317e-4847-b2a8-1868f6f2559a">12,927</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">property, plant and equipment owned</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i54e8e37c74a24991b87c1d67d7375882_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtMS0xLTEtMzY0MDYw_82fdf7b6-baab-495f-b0e2-be2af0889266">10,028</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibff824acb702445385e0da9d25b4b793_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtMi0xLTEtMzY0MDYw_877da7e5-ac40-4fbe-8c19-b72218919114">5,959</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtMy0xLTEtMzY0MDYw_be7d61d1-d890-417b-b236-06ef7735fb81">3,253</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i26f8ec3e990b4a519b49cf861ce481c7_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtNC0xLTEtMzY0MDYw_4726be24-05e2-439c-9ab4-76e07ba590e5">2,998</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtNS0xLTEtMzY0MDYw_4da80c93-5a85-448b-a701-52afff545cc2">2,234</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i688e526d505647cca548bad7d372816f_I20211231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtNi0xLTEtMzY0MDYw_ec34ab25-d026-4411-a026-93315c2d8561">1,071</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">goodwill</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i54e8e37c74a24991b87c1d67d7375882_I20211231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtMS0xLTEtMzY0MDYw_05d9e189-fcd2-41d9-a552-3369017c1694">48,056</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibff824acb702445385e0da9d25b4b793_I20211231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtMi0xLTEtMzY0MDYw_285ca39d-b3c4-4e2f-b050-64f67d750c93">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtMy0xLTEtMzY0MDYw_ae3573b1-c78d-4ecd-9c05-f47caefe10dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i26f8ec3e990b4a519b49cf861ce481c7_I20211231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtNC0xLTEtMzY0MDYw_bccb12b2-7b84-471f-9f97-bfac4d9fd489">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtNS0xLTEtMzY0MDYw_1baf56f4-63a0-4320-97e5-e2bc269b5e9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i688e526d505647cca548bad7d372816f_I20211231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtNi0xLTEtMzY0MDYw_8c2c810b-ca25-4c93-adc7-dcc4d719518b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i54e8e37c74a24991b87c1d67d7375882_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtMS0xLTEtMzY0MDYw_bf436342-82ce-44cc-a209-28b9166beb14">21,407</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibff824acb702445385e0da9d25b4b793_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtMi0xLTEtMzY0MDYw_8e2f321d-86b2-4c6d-8e45-e29b50f79779">7,059</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtMy0xLTEtMzY0MDYw_f3868593-dae5-400a-b198-eaf62ace8874">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i26f8ec3e990b4a519b49cf861ce481c7_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtNC0xLTEtMzY0MDYw_22fc7eb1-ee78-48fc-9274-d0ee2b17aed5">13,187</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtNS0xLTEtMzY0MDYw_667d4d04-2bd4-4112-865f-7cd998e3d4cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i688e526d505647cca548bad7d372816f_I20211231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtNi0xLTEtMzY0MDYw_f2843d9c-e205-4c8c-b766-8d03b6823ea1">1,161</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:26.311%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.999%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></div></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">North<br/>America</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>United&#160;States</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>countries</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i2a967f1a2afd4c4aa4177d1e5ef46e32_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItMS0xLTEtMzY0MDYw_8412e481-cd3c-40d8-8766-e72ac27d08de">36,041</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id0034d62b9984b9c819c9089b17c9dff_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItMi0xLTEtMzY0MDYw_f7007cf0-197a-4e88-a02f-592bc16b1a90">9,151</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItMy0xLTEtMzY0MDYw_b849d3d8-9a58-4f66-845d-ab6b4b8595ed">2,223</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idc6d783c6be84509bbd905f3377753b0_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItNC0xLTEtMzY0MDYw_ad9c02c4-58d1-419d-bee1-992b9bf21faa">14,060</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItNS0xLTEtMzY0MDYw_1aace4d6-6e72-434d-95b0-89f9101abbde">13,465</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="idd3e8e0424b04715b821e32eeb629ba6_D20200101-20201231" decimals="-6" name="ifrs-full:RevenueFromSaleOfGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItNi0xLTEtMzY0MDYw_512358e6-a208-485b-b41f-44f2d2866184">12,830</ix:nonFraction></span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">property, plant and equipment owned</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id92a273efd0e45db9787db6e8508d895_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtMS0xLTEtMzY0MDYw_68ef52cf-bdc1-48ac-a915-893cd97ab5d5">9,365</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4c09e143fbea445f8efdabebb4865bc8_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtMi0xLTEtMzY0MDYw_5c74c652-c09e-48ae-a918-f211b50167f2">5,895</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtMy0xLTEtMzY0MDYw_c2ea144a-31a0-40ed-b6d2-ef9f915340f1">3,189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic65c1b0f25e14bc0a163de986a44369b_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtNC0xLTEtMzY0MDYw_580379a0-100d-4347-9a5b-e868e022944d">2,542</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtNS0xLTEtMzY0MDYw_9c729f81-1832-471f-870e-913b7e2b7c00">1,899</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0593a502ce6b4cd49c8af7a40f39e801_I20201231" decimals="-6" name="ifrs-full:PropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtNi0xLTEtMzY0MDYw_f282965c-b93f-4391-acf7-0a3ec5709df0">928</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">goodwill</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id92a273efd0e45db9787db6e8508d895_I20201231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtMS0xLTEtMzY0MDYw_1b264649-1f17-40bd-8253-e7018e501275">44,364</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4c09e143fbea445f8efdabebb4865bc8_I20201231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtMi0xLTEtMzY0MDYw_42b2f66f-9d92-4abd-b123-82c77e90b045">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtMy0xLTEtMzY0MDYw_e4b77d01-b775-475e-9c8b-83cc57e9bd06">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic65c1b0f25e14bc0a163de986a44369b_I20201231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtNC0xLTEtMzY0MDYw_a901b492-b08a-477c-acba-91fff14c1226">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtNS0xLTEtMzY0MDYw_c271b896-b952-4d12-80e4-1e74ad402b5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0593a502ce6b4cd49c8af7a40f39e801_I20201231" decimals="-6" name="ifrs-full:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtNi0xLTEtMzY0MDYw_0edf24a3-4f1d-47f5-8353-961b80b2fdd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id92a273efd0e45db9787db6e8508d895_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtMS0xLTEtMzY0MDYw_bdfde6d5-09f2-4a72-8eae-cab5483704b9">18,341</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i4c09e143fbea445f8efdabebb4865bc8_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtMi0xLTEtMzY0MDYw_46debe73-6d76-4c25-ba64-7f100f84e027">6,208</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtMy0xLTEtMzY0MDYw_fab00b47-6817-4827-85f9-2b96123fa138">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ic65c1b0f25e14bc0a163de986a44369b_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtNC0xLTEtMzY0MDYw_2732fe9c-bb56-4a75-add3-fe21a2a9ae8d">10,665</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtNS0xLTEtMzY0MDYw_9748f979-abe3-4707-aaed-04df36316e3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0593a502ce6b4cd49c8af7a40f39e801_I20201231" decimals="-6" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtNi0xLTEtMzY0MDYw_3e34189b-f8e7-49c4-82e0-4406eafdd298">1,468</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As stated in Note&#160;D.5., goodwill is not allocated by geographical region.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-97</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_700"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">E/ <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfAuditorsRemunerationExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzIyMjQ_38c38042-c314-4ad9-80a8-d933bd747860" continuedAt="i9632db0b15094a88b4e8593b0a54f0b4" escape="true">Principal accountants&#8217; fees and services</ix:nonNumeric></span></div><ix:continuation id="i9632db0b15094a88b4e8593b0a54f0b4"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">PricewaterhouseCoopers Audit and Ernst&#160;&amp; Young et Autres served as independent auditors of Sanofi for the year ended December 31, 2022 and for all other reporting periods presented. <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:AuditorsRemunerationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzIyMjc_496f62df-2e26-47a0-a7c0-2149be1a2434" continuedAt="i31b0492e59974f10b6ca401aa988d041" escape="true">The table below shows fees charged by those firms and member firms of their networks to Sanofi and consolidated subsidiaries in the years ended December 31, 2022 and 2021.</ix:nonNumeric></span></div><ix:continuation id="i31b0492e59974f10b6ca401aa988d041"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:29.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ernst&#160;&amp;&#160;Young</span></td><td colspan="12" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PricewaterhouseCoopers</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Audit:</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> Statutory audit of separate and consolidated financial statements</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtMS0xLTEtMzY0MDYw_8701bbb0-41f4-4178-b846-9ae633d10488">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231" decimals="2" name="sny:PercentageOfAuditorRemunerationForStatutoryAudit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtMi0xLTEtMzY0MDYw_33667420-99f7-4b6a-bcee-dd91d570c6c1">89</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtMy0xLTEtMzY0MDYw_fc226134-ea56-461e-b141-70d196ebc2d9">13.9</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231" decimals="2" name="sny:PercentageOfAuditorRemunerationForStatutoryAudit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtNC0xLTEtMzY0MDYw_674722c4-d8a7-41d9-b55b-c8644e67eac0">82</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtNS0xLTEtMzY0MDYw_59f30fff-1cdc-4605-b07e-624d4e1523a1">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231" decimals="2" name="sny:PercentageOfAuditorRemunerationForStatutoryAudit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtNi0xLTEtMzY0MDYw_7b429ca8-aecd-4850-a3e6-bd058be58969">97</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231" decimals="-5" name="ifrs-full:AuditorsRemunerationForAuditServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtNy0xLTEtMzY0MDYw_d8f98a3e-5ac7-432c-864e-a091cbae727e">13.8</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231" decimals="2" name="sny:PercentageOfAuditorRemunerationForStatutoryAudit" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtOC0xLTEtMzY0MDYw_b199d46d-6d39-49aa-bc14-21ed9b18859a">97</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Services other than statutory audit</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231" decimals="-5" name="sny:ServicesOtherThanStatutoryAudit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtMS0xLTEtMzY0MDYw_527be519-353a-4c7f-9e57-3da5da63dfaf">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231" decimals="2" name="sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtMi0xLTEtMzY0MDYw_5c5d94da-af9d-4c73-b9e4-75e8b989c7d5">11</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231" decimals="-5" name="sny:ServicesOtherThanStatutoryAudit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtMy0xLTEtMzY0MDYw_d65843bf-6b9d-4745-9b81-ef594600b2d9">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231" decimals="2" name="sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtNC0xLTEtMzY0MDYw_84e15b0b-b1c8-45e8-b59b-914be9f2d996">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231" decimals="-5" name="sny:ServicesOtherThanStatutoryAudit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtNS0xLTEtMzY0MDYw_bcd58b35-9b2b-4bdd-b23c-d8921719a6d6">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231" decimals="2" name="sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtNi0xLTEtMzY0MDYw_9e59d9c1-0f24-46a8-9217-16cb73efd748">3</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231" decimals="-5" name="sny:ServicesOtherThanStatutoryAudit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtNy0xLTEtMzY0MDYw_c2c80ab4-4007-4ca8-960c-eebb4c59403a">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231" decimals="2" name="sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtOC0xLTEtMzY0MDYw_cc8737df-e4a0-471d-b330-c8286e3f4685">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Audit-related services</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231" decimals="-5" name="sny:AuditorsRemunerationForAuditRelatedServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzYtMS0xLTEtMzY0MDYw_379fc932-316a-40be-8ead-b73321948b7f">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231" decimals="-5" name="sny:AuditorsRemunerationForAuditRelatedServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzYtMy0xLTEtMzY0MDYw_c9c6da4f-c7fe-4d18-abe9-3ce0cf8cd3ba">2.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231" decimals="-5" name="sny:AuditorsRemunerationForAuditRelatedServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzYtNS0xLTEtMzY0MDYw_fbb63151-6fe8-47fa-a777-70aa093e01d9">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231" decimals="-5" name="sny:AuditorsRemunerationForAuditRelatedServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzYtNy0xLTEtMzY0MDYw_44c96965-3e19-4051-beb9-7aaf9f4edd07">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231" decimals="-5" name="ifrs-full:AuditorsRemunerationForTaxServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzctMS0xLTEtMzY0MDYw_b10ab91a-ea85-4f53-a5c5-a5abc3639143">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231" decimals="-5" name="ifrs-full:AuditorsRemunerationForTaxServices" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzctMy0xLTEtMzY0MDYw_05d31709-2af7-4519-b29a-b4fac75ed959">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231" decimals="-5" name="ifrs-full:AuditorsRemunerationForTaxServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzctNS0xLTEtMzY0MDYw_aebe8f8f-6bf8-4650-8e87-069c7cc42e64">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231" decimals="-5" name="ifrs-full:AuditorsRemunerationForTaxServices" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzctNy0xLTEtMzY0MDYw_3df24d20-f114-4260-a1ef-0d9f691b245b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231" decimals="-5" name="ifrs-full:AuditorsRemunerationForOtherServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzgtMS0xLTEtMzY0MDYw_4cab4e23-cc8d-4dd5-9770-cc1144f2f568">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231" decimals="-5" name="ifrs-full:AuditorsRemunerationForOtherServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzgtMy0xLTEtMzY0MDYw_6e5bd2f2-fb73-49af-a307-4493906bd339">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231" decimals="-5" name="ifrs-full:AuditorsRemunerationForOtherServices" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzgtNS0xLTEtMzY0MDYw_7108ef10-a870-45ac-a938-5c8200a902bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231" decimals="-5" name="ifrs-full:AuditorsRemunerationForOtherServices" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzgtNy0xLTEtMzY0MDYw_59e5c237-3795-4736-83f7-e0477554b829">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231" decimals="-5" name="ifrs-full:AuditorsRemuneration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktMS0xLTEtMzY0MDYw_25d968cf-175b-4e1c-90a1-0f7c4ecf8f6a">16.0</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231" decimals="INF" name="sny:PercentageOfAuditorsRemuneration" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktMi0xLTEtMzY0MDYw_6070cec2-c658-4a25-9a25-9b5b5c91853d">100</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231" decimals="-5" name="ifrs-full:AuditorsRemuneration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktMy0xLTEtMzY0MDYw_cbe0b0fc-c655-4590-be2e-c031b0ed6550">16.9</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231" decimals="INF" name="sny:PercentageOfAuditorsRemuneration" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktNC0xLTEtMzY0MDYw_f37a2161-7dfc-4fa9-8bcb-0fb6f387f2ae">100</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231" decimals="-5" name="ifrs-full:AuditorsRemuneration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktNS0xLTEtMzY0MDYw_3edcaa4e-e5b3-4b34-bf5a-210b8a2af30a">14.6</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231" decimals="INF" name="sny:PercentageOfAuditorsRemuneration" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktNi0xLTEtMzY0MDYw_6bf38a97-b78c-4383-aca0-a59dbc5886b7">100</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231" decimals="-5" name="ifrs-full:AuditorsRemuneration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktNy0xLTEtMzY0MDYw_3f3238bd-09c9-40ce-9595-fa5bcf0d5e8d">14.2</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231" decimals="INF" name="sny:PercentageOfAuditorsRemuneration" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktOC0xLTEtMzY0MDYw_62dc9d15-2a4f-4e88-8a13-b6e38a826289">100</ix:nonFraction></span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes services provided by the independent auditors of the parent company and French subsidiaries: Ernst&#160;&amp; Young &#8364;<ix:nonFraction unitRef="eur" contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231" decimals="-5" name="sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzQ5Mw_861bd31b-dafb-430b-8190-d48749f02011">7.3</ix:nonFraction> million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231" decimals="-5" name="sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzUwMw_3b1de4da-3f7d-49fe-a25d-3e818d06d29f">7.2</ix:nonFraction> million in&#160;2021; PricewaterhouseCoopers &#8364;<ix:nonFraction unitRef="eur" contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231" decimals="-5" name="sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzUzNg_fc64dd08-a2c7-48f3-a8c0-a93ca7581362">7.7</ix:nonFraction> million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231" decimals="-5" name="sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzU0Ng_0c99ce6b-3592-4f19-9609-e6ee4807e615">7.7</ix:nonFraction> million in 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Services other than statutory audit provided by Ernst&#160;&amp; Young et Autres during 2022 comprised:</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - work on share capital transactions and securities issues submitted to the Annual General Meeting (in extraordinary business) for approval;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - additional procedures to enable reports previously signed by the firm to be incorporated by reference;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - agreed-upon and audit procedures in connection with a proposed divestment; and</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - issuance of the Independent third party&#8217;s report on the consolidated statement of extra-financial performance.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      Services other than statutory audit provided by PricewaterhouseCoopers Audit during 2022 comprised:</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - work on share capital transactions and securities issues submitted to the Annual General Meeting (in extraordinary business) for approval;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - additional procedures to enable reports previously signed by the firm to be incorporated by reference;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - contractual audits, assurance engagements, agreed-upon procedures, tax compliance work, and technical consultancy.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Includes services provided by the independent auditors of the parent company and French subsidiaries: Ernst&#160;&amp; Young: &#8364;<ix:nonFraction unitRef="eur" contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231" decimals="-5" name="sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzE3MDE_dbbebaa7-945d-45dc-b921-2c8452de870e">1.4</ix:nonFraction> million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231" decimals="-5" name="sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzE3MTE_7bf0ce04-7c90-4433-a099-924b76a3aaec">2.7</ix:nonFraction> million in&#160;2021; PricewaterhouseCoopers &#8364;<ix:nonFraction unitRef="eur" contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231" decimals="-5" name="sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzE3NDQ_861f93b7-4a74-436e-b800-c14731dabd97">0.3</ix:nonFraction> million in 2022, &#8364;<ix:nonFraction unitRef="eur" contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231" decimals="-5" name="sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzE3NTQ_1278e474-1584-4762-80da-713d47d39e83">0.3</ix:nonFraction> million in 2021.</span></div></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee pre-approval and procedures</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Audit Committee of Sanofi has adopted a policy and established certain procedures for the approval of audit services and for the pre-approval of other services to be provided by the independent auditors. In 2022, the Audit Committee established a limit for permitted audit-related and other services (i.e. services other than statutory audit) that can be provided by the independent auditors, and the related fees.</span></div></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-98</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_703"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">F/ <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90ZXh0cmVnaW9uOjgzZjJjZTY0YWFkNDQyOWNiMzA3OTYwMjc5MWEzZDQ1XzI4Ng_d95792da-ca4d-4f57-b8ad-09a427373851" continuedAt="i66a6249f3ad240dab81b40f5126a64d7" escape="true">List of principal companies included in the scope of&#160;consolidation during&#160;2022</ix:nonNumeric></span></div><ix:continuation id="i66a6249f3ad240dab81b40f5126a64d7" continuedAt="if423b6cae6084302bf9dab6a9b6731f9"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">F.1. Principal fully consolidated companies</span></div><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90ZXh0cmVnaW9uOjgzZjJjZTY0YWFkNDQyOWNiMzA3OTYwMjc5MWEzZDQ1XzI4OA_e5a7a44a-69ba-4711-a547-80796fdf0db5" continuedAt="ia4a675c93e4f41e5acc28326a994d8ce" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows Sanofi's principal subsidiaries and their country of incorporation:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:60.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hoechst GmbH</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i498c1591947b45fdadb2bb6778e0ea74_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzEtMi0xLTEtMzY0MDYw_a1bdc4f1-b1f3-4320-b823-f55be80e19a8">100.0</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Deutschland GmbH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5ae387e2cbe47c3912417d8623bf900_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzItMi0xLTEtMzY0MDYw_dcdf7343-b82b-4151-b6fa-516f75b38c64">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">A. Nattermann &amp; Cie. GmbH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4adfb7da9ccb448d9ad8c9e69d0b3cc1_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzMtMi0xLTEtMzY0MDYw_8ea9677b-5a15-4b69-86e8-66d0ea4ca827">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis GmbH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idebf15d680cb4a1184f7f35728f60030_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzUtMi0xLTEtMzY0MDYw_fa5fe58c-0e51-43f7-862c-f8441e25a1f3">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Belgium</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1051a7b1a8d549b19efe21164afc8517_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYtMi0xLTEtMzY0MDYw_0f144380-693c-4a66-a31f-5821b7b3060d">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ablynx N.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63571a41cac6407491245bad0632cf43_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzctMi0xLTEtMzY0MDYw_eae7724f-121e-4a32-bc11-1b373271d406">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Flanders BVBA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica986457aa234217a2fac7fc80955729_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzgtMi0xLTEtMzY0MDYw_0961db18-8ed1-4bbd-a10f-fc6134680f38">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi A/S</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9b7192d1177f41e6939a7a9bad74bf5a_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzktMi0xLTEtMzY0MDYw_2389afa0-626d-431f-be46-453dc253ba8b">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i285cbecf53934809bfc57407935033d4_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzEwLTItMS0xLTM2NDA2MA_ef30e111-1b73-4d21-bc85-5b9145642525">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Spain, S.L.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24ec77a85f5e48ed937a7403fd09b34b_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzEwLTItMS0xLTQyNjQwOA_ad96454b-fcd6-4207-990a-54841909fbc6">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Oy</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic074678a420e47758b62873cc4d859f6_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzExLTItMS0xLTM2NDA2MA_170c7078-a900-44d5-bbf7-29553feb962c">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic74f613c0cb646968c6021eb3f15c61c_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzEyLTItMS0xLTM2NDA2MA_776c41c0-c122-4e0c-ba52-24205ead7e92">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis France</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibb45d02df4dc419e8ddda8153ae34b79_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzEzLTItMS0xLTM2NDA2MA_d27c038c-2c7b-4630-98e3-913274852f6a">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Winthrop Industrie</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2205f57d9c8449cb0e0f24d60269bc5_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzE0LTItMS0xLTM2NDA2MA_837fa627-c16e-4806-9d44-710acd00b729">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Recherche &amp; D&#233;veloppement</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2121a047ee3e4de3bdbdc5ce00e809ba_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzE1LTItMS0xLTM2NDA2MA_ad419e0e-eb9f-41b8-a9b8-da7ef19528a3">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Groupe</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i080fdac6aa0d43588960255f9f17f975_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzE2LTItMS0xLTM2NDA2MA_9422e1ef-f35d-4901-8d65-75c30b4081a3">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Chimie</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16069c2bafd44ad0bea3a6b3957889c1_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzE3LTItMS0xLTM2NDA2MA_34c395d1-8d14-4498-aaac-c56e8a9235a1">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Participations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i79acb16ef6f74dfd8a5afee5b7eaaf0b_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzE5LTItMS0xLTM2NDA2MA_850dc33f-7604-4400-afdd-5a4b33290fc6">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id75e41a2a8d44456a85dddcb895d6379_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzIxLTItMS0xLTM2NDA2MA_40694094-4a95-4544-b8e9-d8b7c33db519">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia1564bffc0f94330a56e53eb941e410c_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzIyLTItMS0xLTM2NDA2MA_76d706c7-e457-4725-95b5-c3d1ce390a48">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Biotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13936cffe69644268b73faa1e0f1222c_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzIzLTItMS0xLTM2NDA2MA_7f432ff9-9088-4810-8853-2589f02a1e0d">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Mature IP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4e1d630778d4bdf98e7975d7d41370e_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzI0LTItMS0xLTM2NDA2MA_709076be-eeea-44c1-ae6c-c575783aa644">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur NVL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i351193f373d14cfba556201ad238e512_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzI1LTItMS0xLTM2NDA2MA_a6bbce61-6afd-4384-8415-002b27fd7bea">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Europe</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13a2d009465c4ed2b62b3c4ce7bedf35_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzI3LTItMS0xLTM2NDA2MA_bdcae1a5-cd07-424c-a7d8-e43032af7134">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SECIPE SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c5bc0d0654d49e484d5bda422c95c96_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzI4LTItMS0xLTM2NDA2MA_fd21e103-3133-432f-bfcb-7fd3d05906e7">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Merieux S.A.S.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0538adb5d86145d8b2614a4783bcd071_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzI5LTItMS0xLTM2NDA2MA_680fd991-2761-4359-8e8e-b9069745202c">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi 2015 D SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib51944e0d29846a1b0a6665d934c0d7a_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzMwLTItMS0xLTM2NDA2MA_d961bfd5-255d-4701-ae72-67203b360590">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare International SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaa2e5413dd9a4c5c8f7d90b8a94df128_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzMxLTItMS0xLTM2NDA2MA_2f33d593-6b21-458b-a986-09de8f274cf3">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare France SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ca8f4e855884896957fe5976fc46f0b_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzMyLTItMS0xLTM2NDA2MA_d29a643c-863f-485d-a2f3-1c6a9919499b">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Group SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i325731cb5882403b849f26ad9d4954b9_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzMxLTItMS0xLTQ2NjA1OA_91f0cbde-6ffa-486e-9bc7-9e6f319efe0e">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis A.E.B.E.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Greece</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e5219940fdd4088915a6be208a8c941_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzM1LTItMS0xLTM2NDA2MA_740bdf41-4fb4-48cc-bc99-9a0c917230bc">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Private Co, Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibaaa67301b32448ea984ea8286dd1dd8_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzM2LTItMS0xLTM2NDA2MA_9f9797ea-b961-4793-ba79-74665f7f53a5">99.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chinoin Private Co. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4631c1fb362a4507ad8496f0043f8818_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzM3LTItMS0xLTM2NDA2MA_2730666d-d90c-4255-9340-9652008ec653">99.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Hungary Commercial K.F.T</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc230f3aa6da4dc1830276e62e498a05_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzM1LTItMS0xLTM3MDEyNQ_5589e406-f27c-4ddb-be91-316853a059ba">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carraig Insurance DAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i589ccb194ca14fd289b658aeea655731_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQwLTItMS0xLTM2NDA2MA_7cb22c93-f010-45fa-b366-91ba8049ee54">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Ireland Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0941b5e1401244aeb011299f6b18762c_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQyLTItMS0xLTM2NDA2MA_ac0c710f-076c-455d-a2f9-c8215f59bcc1">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Holdings (Ireland) Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4dfafa70e252425495ec4aa84c0b3462_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ0LTItMS0xLTM2NDA2MA_08d0ca98-3880-4620-bb10-b679809d1d84">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi S.R.L.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5c98b61ee6a49c6bbe6745fbe8903f0_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ1LTItMS0xLTM2NDA2MA_1d2bcda3-a90d-47ce-8a5a-335406b799c6">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Italy S.R.L.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4db465cfb48243f681f6c69e00a03120_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQyLTItMS0xLTM3MDEzNA_fa1e9ae6-3a02-4849-bfb6-8857aa080fd7">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Global Sarl</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa21535e233747e191e1efe06e939f24_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ3LTItMS0xLTM2NDA2MA_8565c2d4-aebc-4f58-91b5-efeb9e8de770">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Luxembourg Sarl</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id9be7cc0cfdc4c01bd3cdefbc2db8865_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ4LTItMS0xLTM2NDA2MA_2b62dfdd-01f7-4ff6-9efe-4c65268ea7fa">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Norge AS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Norway</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic4a729e9da034ba9ba366e137ead0039_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ3LTItMS0xLTQyNjQ1Nw_942431bc-505a-47f2-8cd0-827c47a6630b">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Europe B.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0fd91674dc3f4546ab4d9ec18c77344c_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ5LTItMS0xLTM2NDA2MA_84e1bffd-317f-42bd-ab5b-4f02cda77eb1">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Foreign Participations B.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iefa5c464887543849754b364afb61226_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzUwLTItMS0xLTM2NDA2MA_9796034b-8ed0-4482-9455-ad0cb463371e">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Sp. z.o.o.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i806cb8bde2da41fa864ebe59f6439f93_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzUzLTItMS0xLTM2NDA2MA_0d2a2709-cb1c-4634-8765-04ca7e201680">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Poland sp.Z.O.O</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5677045852f43c3b14b4e3424e84806_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzUxLTItMS0xLTM3MDE2Ng_b384d50f-175e-465b-a389-b2161f878f3e">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Sp. z.o.o.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i07d862e00e454435ba5778981fdd8d86_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzUwLTItMS0xLTQ2NjIyMA_06057847-6c79-4143-b5ce-ad290481c767">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Produtos Farmaceuticos Lda</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Portugal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d8c1c94ceb5454aaa207f9ba7d1e1d4_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU0LTItMS0xLTM2NDA2MA_975386ab-acc8-4985-8782-710de279cf0e">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis, s.r.o.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a16e6db8221468eb5b3b7969c6b0832_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU1LTItMS0xLTM2NDA2MA_cbb8137c-70aa-408b-b801-a8a00119b892">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Czech s.r.o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id426e598bb94421cb6e62308d8f1efee_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU1LTItMS0xLTQyNjQ3OQ_affb8c49-d188-4dbc-aa39-099e0a4bf86b">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Romania SRL</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d8b86bfb5a2496495c7585dc69b8b27_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU2LTItMS0xLTM2NDA2MA_b9d23717-5cc4-493b-a235-e08b7def395e">100.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-99</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="if423b6cae6084302bf9dab6a9b6731f9" continuedAt="icaf365e65d8f454cb4b1d6d9002a399c"><ix:continuation id="ia4a675c93e4f41e5acc28326a994d8ce" continuedAt="if42c99d802d2474dad195f97813bbe21"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:60.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Romania S.R.L.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iecc505bcb14d4f708a5e5b413b0da850_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU1LTItMS0xLTM3MDE4Mg_599ff3c3-efa0-4315-8960-b9fb96cadcb1">100.0</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis UK Holdings Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58ff366114fa423c816fd9c7d12c6ee5_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU3LTItMS0xLTM2NDA2MA_c4ddefed-621a-4bc8-9a9a-8d782de05b96">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5935a593578b42bd992125d84fde4c2b_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU5LTItMS0xLTM2NDA2MA_d8af0b96-17be-456b-8d53-323692229df9">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Synthelabo UK Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ab8aa458b2e4741896b715f331173c5_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYwLTItMS0xLTM2NDA2MA_f17ac460-85e8-44fe-a3fe-bee0de3b9df3">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma Holdings Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea8d1294ee8a48b2acfe1c079ae36761_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYyLTItMS0xLTM2NDA2MA_799b0d82-ce5f-4442-9b29-5eb44c04fd2e">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare UK Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7457f5f4052d410aada699fd4a19b6f6_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYzLTItMS0xLTQyNjUyMw_cc70251f-3b65-4f44-b8bc-7edce6fdace8">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">AO Sanofi Russia</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba8eb10b04bf4f299d1a467e30b4255c_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYzLTItMS0xLTM2NDA2MA_f869f91c-0925-4f25-9d79-568e87f65841">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd6d3494d7da437f8fd0c9e1b7dcbdda_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYzLTItMS0xLTM3MDE5OA_fb5e3a55-0d22-45d2-9383-6f8acc940a18">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi AB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i57aa1c00eabf4f6f995aa00fe1f4cad3_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzY2LTItMS0xLTM2NDA2MA_cd17a42a-62aa-4fb9-9bbf-bdbdc3f61ac1">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis (Suisse) SA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52f9faf9cfa44dc0a653f6ac823bbff6_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzY3LTItMS0xLTM2NDA2MA_f542694f-4d13-40e3-bceb-f5c0b9ab09fe">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Global Sarl Baar Intellectual Property Branch</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5770860577043ba89757912c7144758_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzY4LTItMS0xLTM2NDA2MA_7eb2a706-63c6-4b49-b976-b8874008dc0a">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Ilac Sanayi ve Ticaret A.S.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88db3e6c62364ad8b70611ef3579c3e0_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzY5LTItMS0xLTM2NDA2MA_570db97a-c173-474e-a8c4-ced68e9e45db">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Asi Ticaret A.S.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i516dd1cd29b84843b7e8aab3e5a4c6e7_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzcwLTItMS0xLTM2NDA2MA_46ec5b00-9aa4-47b7-93ec-c9ec850ba021">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Saglik Urunleri Limited Sirketi</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i005b6ed2aeb1435ea08d3315ae40197b_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzcxLTItMS0xLTM2NDA2MA_edf86d24-0343-4811-8de6-6bc72de75c38">100.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:60.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Therapeutic Products Limited Partnership</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic41db69eadcd4e9c982ed089e1167d58_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzEtMi0xLTEtMzY0MDYw_0b5d1132-57e8-4aea-816e-f3a80beeee78">100.0</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f0515138f7c418c9bcbb13c636c695c_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzItMi0xLTEtMzY0MDYw_4198d1bc-42b6-4e89-ac68-93fa7c059e98">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi US Services Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i08e2f2cccd464d70abbd1e5f42eed60f_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzMtMi0xLTEtMzY0MDYw_b8537a54-7210-4f1f-9189-f2541db8e4ce">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis U.S. LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60b9857f92eb49a8a8c2d24791c3ce46_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzQtMi0xLTEtMzY0MDYw_124bf1a5-e2d5-40d0-bdb0-7447c81380ee">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chattem, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4d77d7546954bb39c5739590d22ed90_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzUtMi0xLTEtMzY0MDYw_8879d4ab-ae1b-4532-87bb-492c449169c3">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventisub LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icdfce984527840aa9096f39e4c594c81_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzYtMi0xLTEtMzY0MDYw_cefccf46-c51a-4eeb-b9b1-c418239a407c">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Corporation</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idcba81032cc44b6d96e7841acb4c6f8e_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzctMi0xLTEtMzY0MDYw_23a54c31-85f5-4f71-8324-11a0f1596825">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia84f6147917444bc85ac41f1fe48a282_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzgtMi0xLTEtMzY0MDYw_f4a7787b-778c-4c4a-abe3-b577d838a2eb">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">VaxServe, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa9d541bb2af4c559dbbaf5d6692d189_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzktMi0xLTEtMzY0MDYw_ee7d808f-02d4-4960-91c4-25f5480bdd23">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5307b0935b94772a58f8ea12f188818_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzEwLTItMS0xLTM2NDA2MA_197544fa-4999-4c88-8817-f30e1ba42932">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ U.S. LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i08d853212613473facfe866d69b99234_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzExLTItMS0xLTM2NDA2MA_c06315d4-60ef-49df-9aa7-3793711819a4">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ Therapeutics Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1bbdc75c43824eb8a3de899e259da76c_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzEyLTItMS0xLTM2NDA2MA_2a2a952f-d342-400f-9b43-3d9d3381d71b">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principia Biopharma Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb9a553ac7e54b47a1eaa3597816db8e_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzEzLTItMS0xLTM2NDA2MA_235a9436-449d-4c66-b249-cb95426dfe1f">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Research Invest LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37c82d3e1df445788ff372833849ae27_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzE0LTItMS0xLTM2NDA2MA_5f6876f1-4c33-4473-adc7-43b10161928c">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Bioverativ Holdings LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87693c70bb4c4820b200f85cae0c40fe_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzE3LTItMS0xLTM2NDA2MA_78b06525-4d0d-4eaa-91bc-5408fbf98482">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RPR US Ltd.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8482c94334704ac2a9f5d46f5b538414_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzE4LTItMS0xLTM2NDA2MA_0f5052ea-5657-4df9-bead-44a3740d0964">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kadmon Holdings, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibcf097d2e4454d87b7c58b76251a2385_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzE5LTItMS0xLTM2NDA2MA_c6105b99-c00c-43fc-9c4a-892d9390d8d0">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kadmon Corporation, LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b8053816d6a4e6c9e20fc4c30f781aa_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzIwLTItMS0xLTM2NDA2MA_b2725efc-c45b-4d3f-8692-e9b93303d85e">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amunix</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide7f7e63784f41a183803f0ac8a137e7_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzIxLTItMS0xLTM3MDIyMA_82cd595b-f2b0-4a5f-a598-365220f4912f">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Synthorx, Inc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i718def90f99b44c1ace694608132b059_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzIyLTItMS0xLTQyNjUzNQ_746d77df-06bd-42b9-a229-777197af5d3c">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Translate Bio, Inc</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i983da08a0b754be2b43b04b0c13ea843_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzIzLTItMS0xLTQyNjUzNQ_2bf38286-6fc1-4eee-8c75-8a4deadce2fd">100.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-100</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:5pt;text-align:justify"><ix:continuation id="icaf365e65d8f454cb4b1d6d9002a399c" continuedAt="id72882e3dfdb4ad7a74827ac9b9cfea8"><ix:continuation id="if42c99d802d2474dad195f97813bbe21"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:57.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.311%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Countries</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis South Africa (Pty) Ltd</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Africa</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34818f54408849b78b0de1673856f0f8_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzEtMi0xLTEtMzY0MDYw_755bcaf1-97a5-4ccb-9d35-2e5fbddcac05">100.0</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Alg&#233;rie</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Algeria</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i825c57dbd8964e30b031dee0899ee99f_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzItMi0xLTEtMzY0MDYw_8cb8190e-32af-4c35-9021-5440b7f69c97">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Arabia Trading Company Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Saudi Arabia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5e42794c886e4988b9410e7875fa4ea3_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzMtMi0xLTEtMzY0MDYw_aee6f569-ee5b-4a83-9622-8905b00b3210">75.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Argentina S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41868f27b25346e1b0eebd1483e1fc50_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQtMi0xLTEtMzY0MDYw_5cb1c123-9543-4e9b-9a6c-31d4cf2a0d29">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme de Argentina S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica13971ef10f4193b4a67e7c1af3ebf7_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzUtMi0xLTEtMzY0MDYw_d57986c8-09d7-4953-b950-328f62d9ce39">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Argentina S.A.U.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i493a9c684cd24c618768ad51fe4c99b0_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzgtMi0xLTEtMzcwMjcw_043aa1f4-8dab-4b31-860c-6b3dcc001978">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Healthcare Pty Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifeb9cb68f7eb4fca8a15ce101f73ec2d_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzYtMi0xLTEtMzY0MDYw_0b84dc98-895b-4e75-a57c-c5efb41eb0a5">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Australia Pty Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8be1a4c0cf864ca580eeff34de647013_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzctMi0xLTEtMzY0MDYw_f93a854b-38cc-46ca-95f0-43d0babce02a">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Medley Farmaceutica Ltda</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id38ab6ac3a3140ee8c774a6c879777f4_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzgtMi0xLTEtMzY0MDYw_99ae46cf-3787-4844-95f7-65d6aea1f346">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Canada Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42d8188e7be34beb9c79c609575725ce_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzktMi0xLTEtMzY0MDYw_3a17a2a6-54ad-47ed-9d71-793ee6bb5521">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if7703f57c8434b53a13de4396f59696f_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzEwLTItMS0xLTM2NDA2MA_c8b9b5ec-932d-4796-a561-c36b3433a1a1">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Merieux Canada Holdings ULC (Canada)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7d8105546d9a43eba6a5ba0d273ef35d_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE0LTItMS0xLTM3MDI4Ng_a06bd14b-d03a-4177-889a-5711b481b26d">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Chile S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic71d57fdeec447afb3b584aff6e7e598_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzExLTItMS0xLTM2NDA2MA_b48a5359-9942-49b2-8614-82aca7d4efa4">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi (Hangzhou) Pharmaceuticals Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61fc86f2e0d54b88a9ae5af651e73bbf_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzEyLTItMS0xLTM2NDA2MA_59b771c7-074b-4cb6-b955-d69f7eb9b56e">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi (China) Investment Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5762c3305eac419d9d4d578ae3517cec_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzEzLTItMS0xLTM2NDA2MA_230829ff-2f95-4f5c-9e58-89e3d50330be">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi (Beijing) Pharmaceuticals Co.Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if523ef2e47944973b93e0232412ed5db_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE0LTItMS0xLTM2NDA2MA_a8eb0cba-d0ea-475e-b048-6dcd5c03ed35">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Biologies Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i319f41b8a18c4cf6b5f956ed40fbfa70_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE1LTItMS0xLTM2NDA2MA_7112c9dc-dd35-4c18-bd1f-9379f68bb682">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shenzhen Sanofi pasteur Biological Products Co, Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i72b45e8b7e194f42be530027f55dbd36_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE2LTItMS0xLTM2NDA2MA_be0ade73-6948-46ee-ae82-9b22f4ee7d7d">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shanghai Rongheng Pharmaceutical Co, Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic82939cbfa4e4308b5c954a528b904b3_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE3LTItMS0xLTM2NDA2MA_40131075-4610-48c6-a13d-33baa44001ca">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genfar S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i21ea9e0d97b84ea8bed89d96c90b4a4c_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE4LTItMS0xLTM2NDA2MA_8799e3eb-2db8-483a-83f9-c17314ef3f3d">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Colombia S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a61deb6118546cca9152a3d19ca7ded_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE5LTItMS0xLTM2NDA2MA_d1cbd4f7-c82a-425c-98cf-0e9b458bead2">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Korea Co. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b77c884d5cf4c459d41322e688941e2_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzIwLTItMS0xLTM2NDA2MA_70494314-f76a-4e56-8973-c4cdea9348c7">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d8c63a1688f487f8f48b66b144d7b14_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzIxLTItMS0xLTM2NDA2MA_e8a64329-09c7-47e1-a186-9797726a46c4">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella healthcare Korea Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i235e682ab77a4e1b83eb628a686cb67d_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI2LTItMS0xLTQ2NjMwMw_b76f96d5-903e-490f-a435-76cfdf83dd72">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Gulf FZE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Arab Emirates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94cfec9a31f2484bbf3be22fda030c95_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzIyLTItMS0xLTM2NDA2MA_d9208233-2448-49ac-b52b-7c53ef50f288">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Egypt</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Egypt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9265b4b9635b4f268661bb9af41d4910_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzIzLTItMS0xLTM2NDA2MA_faf82cdc-ba55-4d11-b312-ba324f2a0f6b">99.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Egypt LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Egypt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ac69def9695452fa8056d9a9cf37f80_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI5LTItMS0xLTQ2NjM0OQ_9bfc8b80-2783-4f8e-b661-21817044b18f">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Hong-Kong Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie7215e66652242c888d9188932de83ef_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI0LTItMS0xLTM2NDA2MA_3be12934-cfc9-4750-b70a-e7051f8897dc">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi India Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">India</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd902f48e4e0470789302c7c306a7226_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI1LTItMS0xLTM2NDA2MA_80ee68e0-58fa-4a3b-b598-ec59217c23f5">60.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Healthcare India Private Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">India</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3427ee82661045e69654d0f7f3c81b5f_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI2LTItMS0xLTM2NDA2MA_67f1133a-06c7-4c3e-b04e-bca9ccb7dad6">99.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Isra&#235;l Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i931de8c63c0a4132b7dc27fd739de9ee_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI4LTItMS0xLTM2NDA2MA_f48c33dc-2d85-490a-8cfc-6b2f27e181a2">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi K.K.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if83f0c24152340948edc3fce389f90bc_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI5LTItMS0xLTM2NDA2MA_66ea2f32-5858-4b2b-9157-6771ff4203b0">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SSP Co.,Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia183f27f20164e5db33ab876c94506f6_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzMwLTItMS0xLTM2NDA2MA_dc7e7c25-c57c-4d41-953d-6da1bbf45184">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis (Malaysia) SDN. BHD.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Malaysia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4658ecaa90e474bbf5ced2fcc7ac5a2_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzMyLTItMS0xLTM2NDA2MA_1cc52738-6d0a-411a-afc9-39a5779f6cec">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Maroc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Morocco</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id812b34881814260a4fde8dbd44c51c6_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzMzLTItMS0xLTM2NDA2MA_02825bb4-9a57-4002-a13f-1241fcb5aeae">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Mexico S.A. de C.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic471ab2e84ae4923a1e2dd798a44a353_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzM0LTItMS0xLTM2NDA2MA_bc81fd7a-58ed-4cad-8271-4dbc7f93e5a3">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur S.A. de C.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i05626dc1fd684848a779e5531a41d341_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzM2LTItMS0xLTM2NDA2MA_b99ee4e9-5522-44a9-b9f2-2db4be78ad4b">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Azteca Vacunas, S.A. de C.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i18812706bbaf4fcd8256d1807ae64a5c_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzM3LTItMS0xLTM2NDA2MA_7ddf1a36-869a-4c4c-8e37-18ce11dfce5a">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Pakistan Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pakistan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2dfc1df9889e46c0a941ac9f24266a01_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzM4LTItMS0xLTM2NDA2MA_fa9ec489-414e-4fde-99c6-fd2ef81d0d2e">52.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Panama S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Panama</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id621d1155a9144f2a85532c3bfa7cd75_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzM5LTItMS0xLTM2NDA2MA_d7c056aa-c16e-4bb0-b252-57931df1e2f6">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis del Peru S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Peru</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i81604c6ae3a740b7ab7f5a449eff82c5_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ0LTItMS0xLTM3MDMzMQ_49112d14-c93a-4b1f-b270-df3d05d82a98">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Puerto Rico Inc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f0dab49c934466b9cc002391f7bc3f0_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQwLTItMS0xLTM2NDA2MA_1d9067af-f1fe-4bfb-9f9f-88ff6567bea9">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Philippines Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d7249e960a449009edd04541ebb0a9a_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQxLTItMS0xLTM2NDA2MA_b9bebf58-f16d-4e0c-ac3a-e22824b622fc">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Philippines Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5941a7f40b04bed9aab3ca1870c53f3_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ4LTItMS0xLTM3MDM1NQ_fd52d311-12c3-4641-8aae-19eef67e7eb3">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Singapore Pte. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3aa25010b3d247be8ea308b7d38e3498_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQzLTItMS0xLTM2NDA2MA_ae8aec65-90a9-46f2-8341-a928f8b40e14">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma (Manufacturing) Pte. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4036a3cf2bd8487cabda1ea457bd5fcf_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ0LTItMS0xLTM2NDA2MA_802fec89-731c-447d-90f5-2f426b1ff698">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Manufacturing Pte Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1d6ea91a03cb4a04ba283518cfb3a3b8_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzUxLTItMS0xLTM3MDQ1NA_6e5c07ad-e391-4c5c-850d-a06e7a6b4efd">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Taiwan Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie8ba60949d764ee68bd5fa3cae3fd182_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ1LTItMS0xLTM2NDA2MA_f355e0de-d824-4312-84e8-630fd3b1a12a">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis (Thailand) Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ad82677839649138379e9cf405edc11_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ2LTItMS0xLTM2NDA2MA_4c2ab2b2-04a7-4507-823b-562992fe2cc3">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Venezuela S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Venezuela</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d616d9fdf31436c85f6dd196bbba8da_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ3LTItMS0xLTM2NDA2MA_54e6a954-60dd-4f29-83f2-71c18c2b3ca9">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Vietnam Company Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vietnam</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic3ab1d4e7a0b42c08245f856927cb942_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ4LTItMS0xLTM2NDA2MA_0b04c542-67c4-48dd-9884-52032ca6f09b">100.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Vietnam Shareholding Company Limited</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vietnam</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfc5328cd614aacab6fbc5dcd73b515_D20220101-20221231" decimals="INF" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ5LTItMS0xLTM2NDA2MA_aa69c3f0-76e1-4a87-86b8-ab68c7c743bb">85.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-101</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center;text-indent:-8.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.225%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><ix:continuation id="id72882e3dfdb4ad7a74827ac9b9cfea8"><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">F.2. Principal investments accounted for using the equity method</span></div><div style="margin-bottom:5pt;text-align:justify"><ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="sny:DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90ZXh0cmVnaW9uOjgzZjJjZTY0YWFkNDQyOWNiMzA3OTYwMjc5MWEzZDQ1XzI5MA_cdc5ea8e-93f0-4dea-b5db-b74e23856158" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"></td><td style="width:62.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.214%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">GlaxoSmithKline Consumer Healthcare, L.P.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8a871b1ed6b455f8d1c0cea30f525e8_D20220101-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInJointOperation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzItMi0xLTEtMzY0MDYw_051ec10e-65ba-4ae6-a181-e9489aa0ba3a">11.7</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52895c33c77b401c852cf418dd101085_D20220101-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInJointOperation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzMtMi0xLTEtMzY0MDYw_755f7172-639e-4787-826e-0a8d00349d4b">31.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maphar</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Morocco</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7effbd9d99be4fa09eb11d6a24112790_D20220101-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInJointOperation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzQtMi0xLTEtMzY0MDYw_f49bf7fc-33a3-46ab-9270-c1d905af36f4">48.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MCM Vaccine B.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9db2167110a34e338dda46b7b37c973b_D20220101-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInJointOperation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzUtMi0xLTEtMzY0MDYw_b7a8c548-e9c1-48dd-9919-f454af64f2b3">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MSP Vaccine Company (formerly MCM company)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i57640986aa3c447c9a69578a8c50672a_D20220101-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInJointOperation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzYtMi0xLTEtMzY0MDYw_3485eaaf-4cbf-4ad7-bd43-6bc5fe065577">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EUROAPI</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i634adddc2f7149a6b915f960673b1b38_D20220101-20221231" decimals="3" name="ifrs-full:ProportionOfOwnershipInterestInJointOperation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzctMi0xLTEtMzcwNDQx_1989f73e-ca4e-41a7-85da-d288802b5c81">30.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i52f57172a9d7443580346c2d8f39cd2b_706"></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">G/ <ix:nonNumeric contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDYvZnJhZzoxNTVhYzA5MWUzODA0MTYwODRhODJmNTgyZTM5M2Y2Zi90ZXh0cmVnaW9uOjE1NWFjMDkxZTM4MDQxNjA4NGE4MmY1ODJlMzkzZjZmXzExNDA_c0c08821-8a32-46fe-bfc5-6739efdbfba1" continuedAt="i02af1be43cf14850ac9e624426913189" escape="true">Events subsequent to December 31, 2022</ix:nonNumeric></span></div><div style="margin-bottom:5pt;text-align:justify"><ix:continuation id="i02af1be43cf14850ac9e624426913189"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February 22, 2023, the US Food and Drug Administration (FDA) approved ALTUVIIIO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. That decision resulted in the reversal, in 2022 books, of &#8364;<ix:nonFraction unitRef="eur" contextRef="i9b81437bb0bc49abac2a243bae255b03_D20220101-20221231" decimals="-6" name="sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDYvZnJhZzoxNTVhYzA5MWUzODA0MTYwODRhODJmNTgyZTM5M2Y2Zi90ZXh0cmVnaW9uOjE1NWFjMDkxZTM4MDQxNjA4NGE4MmY1ODJlMzkzZjZmXzg1NzYxOTA2OTcyNjc2_4534771f-739f-4e27-9528-6fbfec58880a">2,154</ix:nonFraction>&#160;million of impairment losses against the intangible assets associated with the Eloctate franchise, in accordance with IAS 36 (Impairment of Assets); the asset had been partially written down in 2019. For more information please refer to Note D.5. to the financial statements of the present annual report. The adjustment is presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Impairment of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated income statement; the net impact after tax is &#8364;<ix:nonFraction unitRef="eur" contextRef="i9b81437bb0bc49abac2a243bae255b03_D20220101-20221231" decimals="-6" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDYvZnJhZzoxNTVhYzA5MWUzODA0MTYwODRhODJmNTgyZTM5M2Y2Zi90ZXh0cmVnaW9uOjE1NWFjMDkxZTM4MDQxNjA4NGE4MmY1ODJlMzkzZjZmXzg1NzYxOTA2OTcyNjky_9d05fb3d-f939-47a9-bb91-3e909cc364b1">1,651</ix:nonFraction>&#160;million.</span></ix:continuation></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-102</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_709"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Notes</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:92.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-103</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Notes</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.................................................................................................................................................................................................................................................................</span></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:4.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F-104</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI   </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">FORM 20-F</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%">2022</span></div></td></tr></table></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_712"></div><hr style="page-break-after:always"/><div style="min-height:107.72pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.686%"><tr><td style="width:1.0%"></td><td style="width:2.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.580%"></td><td style="width:0.1%"></td></tr><tr style="height:563pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:4.25pt;padding-right:4.25pt;text-align:center"><img src="sny-20221231_g27.jpg" alt="sny-20221231_g27.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:90px"/></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.5pt;padding-right:8.5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">English translation and language consultancy: Stephen Reynolds &amp; Jane Lambert.</span></div><div style="padding-left:8.5pt;padding-right:8.5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Photo credits: Front cover: &#169; Akos Stiller/Capa Pictures &#8211; Key Figures : &#169; Vincent Fournier -  p. 92 : &#169; Yann Audic - p. 93 : &#169; Jean Chiscano - p. 94 : &#169; Alain BUU - p. 95 : &#169; GE China - p. 96 : &#169; Christel Sasso/Capa Pictures - p. 97 : &#169; Lisbeth Holten, Denmark - </span></div><div style="padding-left:8.5pt;padding-right:8.5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">p. 98 : Christel Sasso/Capa Pictures - p. 99 :  &#169; Julien LUTT/Capa Pictures - p. 100 : &#169; Pierre-Olivier / Capa Pictures - p. 101 : &#169; Marie Etchegoyen/Capa Pictures - p. 102 : &#169; Legrand - p. 103 : &#169; Franck Parisot - p. 104 : &#169; Augustin Detienne/Capa Pictures - p. 106 : &#169; Julien LUTT/Capa Pictures - p.107 : &#169;Oscar Timmers/Capa Pictures &#8211; p. 108 : &#169; Jennifer Altman/Capa Pictures - p. 109 : &#169; Jean-Marie Cras</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="sny-20221231_g28.jpg" alt="sny-20221231_g28.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div></div><div id="i52f57172a9d7443580346c2d8f39cd2b_715"></div><hr style="page-break-after:always"/><div style="min-height:0pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:0pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>a2022-exhibit11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6740201499e9489b92db889f2dc2abe1_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SANOFI</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Limited liability company</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Soci&#233;t&#233; Anonyme &#224; conseil d&#8217;administration)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Registered capital &#58; &#8364;2,521,494,572</font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Registered office &#58; 46 avenue de la Grande Arm&#233;e &#8211; 75017 Paris</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Registration number &#58; PARIS 395 030 844</font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ARTICLES OF ASSOCIATION</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">This text is a free translation from the French language and is supplied solely for information purposes. Only the original version in the</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">French language has legal force.</font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div id="i6740201499e9489b92db889f2dc2abe1_4"></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART I </font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">GENERAL PROVISIONS</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 1 &#8211; FORM OF COMPANY</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company, in the form of a limited liability company (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">soci&#233;t&#233; anonyme</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">), is governed by applicable laws and regulations as well as by these articles of association (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">statuts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 2 &#8211; CORPORATE NAME</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The corporate name shall be&#58; Sanofi.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 3 &#8211; CORPORATE PURPOSE</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company&#8217;s corporate purpose, in France and abroad, is&#58;</font></div><div style="padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Acquiring interests and holdings, in any form whatsoever, in any company or enterprise, in existence or to be created, connected directly or indirectly with the health and fine chemistry sectors, human and animal therapeutics, nutrition and bio-industry&#59;</font></div><div style="padding-left:27pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in the following areas&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Purchase and sale of all raw materials and products necessary for these activities</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Research, study, and development of new products, techniques and processes&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Manufacture and sale of all chemical, biological, dietary and hygienic products&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Obtaining or acquiring all intellectual property rights related to results obtained and, in particular, filing all patents, trademarks and models, processes or inventions&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Operating directly or indirectly, purchasing, and transferring &#8211; for free or for consideration &#8211; pledging or securing all intellectual property rights, particularly all patents, trademarks and models, processes or inventions&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Obtaining, operating, holding and granting all licenses&#59;</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Within the framework of a group-wide policy and subject to compliance with the relevant legislation, participating in treasury management transactions, whether as lead company or otherwise, in the form of centralized currency risk management or intragroup netting, or any other form permitted under the relevant laws and regulations&#59;</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">And, more generally&#58;</font></div><div style="padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;All commercial, industrial, real or personal, property financial or other transactions, connected directly or indirectly, totally or partially, with the activities described above and with all similar or related activities and even with any other purposes likely to encourage or develop the company's activities.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 4 &#8211; REGISTERED OFFICE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The registered office is located at&#58; 46, avenue de la Grande Arm&#233;e, PARIS 75017.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Should a transfer of the registered office be decided upon by the Board of Directors </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(conseil d&#8217;administration)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, the Board is authorised to modify the statutes accordingly.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 5 &#8211; TERM OF COMPANY</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The term of the company will expire on May 18, 2093 unless dissolved prior to that date or extended by a decision of the Shareholders&#8217; Extraordinary General Meeting. </font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="i6740201499e9489b92db889f2dc2abe1_7"></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART II SHARE</font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CAPITAL</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 6 &#8211; REGISTERED CAPITAL</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The share capital is &#8364;2,521,494,572 (two billion five hundred twenty-one million four hundred ninety-four thousand five hundred seventy-two euros).</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">It is divided into 1,260,747,286 shares each having a par value of &#8364;2, of the same class, fully paid.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 7 &#8211; FORM OF SHARES</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The shares are registered or bearer shares, according to the shareholder&#8217;s choice, under the conditions established by applicable legal provisions.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company may apply legislative and regulatory provisions concerning the identification of holders of securities giving them the immediate or future right to vote.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any individual or entity, acting individually or jointly, who acquires a number of shares representing a proportion of the capital or of voting rights equal to or exceeding 1% of the share capital, or any multiple of this percentage, even beyond the minimum declaration limits laid down by the legal and regulatory provisions, must inform the company of the total number of shares and voting rights held by the individual or entity and also of any securities giving future access to the  capital or voting rights which may potentially be attached. Notification is to be made by registered mail, return receipt requested, within five stock exchange days of the date on which the threshold was reached.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The obligation to notify the company also applies when the shareholder's holding of the capital or voting rights falls to a level below each of those thresholds described in the third paragraph of this article.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The legal penalties applicable to failure to declare the crossing of a statutory threshold apply equally to a failure to declare the crossing of any threshold stipulated in the articles of association and recorded in the minutes of the shareholders&#8217; meeting at the request of one or more shareholders holding at least 5% of the company&#8217;s share capital or voting rights.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 8 &#8211; CONVEYANCE AND TRANSFER OF SHARES</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The shares are freely negotiable.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The transfer of shares occurs by transfer from one account to another in accordance with the conditions laid down by law and regulations.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 9 &#8211; RIGHTS AND OBLIGATIONS ATTACHED TO EACH SHARE</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1)&#160;&#160;&#160;&#160;With regard to ownership of the corporate assets, sharing of profits and the liquidation surplus, each share entitles its owner to an amount in proportion to the number of existing shares.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2)&#160;&#160;&#160;&#160;Whenever it is necessary to possess a certain number of shares to exercise a right, the owners who do not possess that number of shares are responsible for taking any steps to combine the number required.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3)&#160;&#160;&#160;&#160;Each shareholder has as many votes as the number of shares he owns or represents subject to the provisions below.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">       A double voting right is assigned to each registered share that is paid for in full and that has been registered in the name of the same shareholder for at least two years.</font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">       The double vote ceases automatically for any share converted into a bearer share or transferred from one owner to another, subject to exceptions laid down by law. Bonus shares arising from an increase of share capital by incorporation of reserves, profits or share premiums receive the benefit of the double vote as from the time of their issue in so far as they have been assigned on the basis of shares already benefiting from this right.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 10 &#8211; PAYING-UP (LIB&#201;RATION) OF SHARES</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sums that are due on shares to be paid for in cash are requested by the Board of Directors which determines the dates and extent of the calls for funds.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shareholders who do not make the payments due on the shares they hold automatically owe the company default interest calculated on a daily basis starting from the due date, at the legal rate in business matters increased by three points, without prejudice to the compulsory enforcement measures provided by law.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="i6740201499e9489b92db889f2dc2abe1_10"></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART III MANAGEMENT OF THE</font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">COMPANY</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 11 &#8211; BOARD OF DIRECTORS</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1)&#160;&#160;&#160;&#160;The Company shall be administered by a Board of Directors of which the minimum and maximum number of members is set by current legislation. </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A natural person cannot be appointed or reappointed as a director once he or she reaches the age of 70. As soon as the number of directors aged over 70 represents more than one-third of the directors in office, the oldest director shall be deemed to have resigned&#59; his or her term of office shall end at the date of the next shareholders&#8217; Ordinary General Meeting.</font></div><div style="padding-left:27pt;text-align:justify"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each director appointed by a Shareholders&#8217; Ordinary General Meeting must own at least five hundred shares throughout his term of office.</font></div><div style="padding-left:27pt;text-align:justify"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The term of office of directors shall be four years. Directors shall be required to seek reappointment by rotation, such that members of the Board are required to seek reappointment on a regular basis in the most equal proportions possible. Exceptionally, the Shareholders&#8217; Ordinary General Meeting may appoint a director to serve for a term of one, two or three years, in order to ensure adequate rotation of Board members.</font></div><div style="padding-left:27pt;text-align:justify"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each director standing down shall be eligible for reappointment. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2)       Directors representing employees</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In accordance with the law, one employee representative director shall be designated by the trade union body which is the most representative, within the meaning of the applicable legislation, in the Company and those of its direct or indirect subsidiaries that have their registered office in French territory, and one director shall be designated by the European Works Council.</font></div><div style="padding-left:27pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An employee representative director shall hold office for a term of four years. His term of office shall end at the close of the Shareholders&#8217; General Meeting held during the calendar year in which his term of office expires to approve the financial statements for the previous financial year.</font></div><div style="padding-left:27pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If the Company is no longer subject to an obligation to appoint one or more employee representatives to the Board of Directors, the term of office of the employee representative(s) shall end automatically with no other formalities at the close of the meeting of the Board of Directors which formally notes that the Company no longer falls within the scope of such obligation.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 12 &#8211; CHAIRMAN AND VICE-CHAIRMAN OF THE BOARD OF DIRECTORS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall appoint from among its members a Chairman, who must be a natural person. Except in the circumstances specified in article 16 when he or she also assumes the function of Chief Executive Officer, the Chairman may hold office for the duration of his or her term of office as director, under the conditions laid down in article 11.1 paragraph 2 above.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board may appoint from among its members a Vice-Chairman, who must be a natural person less than 70 years of age.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">They may be appointed for their entire term of office as directors.</font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the event of the temporary incapacity, resignation, death or non-reappointment of the Chairman, the Board of Directors may delegate another director to act as chairman. In the event of temporary incapacity, such delegation shall be given for a limited period and shall be renewable. In other cases, it shall be valid until a new Chairman is appointed.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chairman shall organise and direct the work of the Board, and be accountable for this to the Shareholders&#8217; General Meeting.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">He shall ensure that the company's organs of management operate properly and in particular that the directors are capable of fulfilling their duties.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 13 &#8211; DELIBERATIONS OF THE BOARD</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall meet as often as required by the interests of the company, either at the registered office or at any other place indicated in the notice of the meeting. The Chairman may notify the directors of meetings of the Board of Directors by any means, even orally.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Meetings of the Board of Directors shall be chaired by the Chairman of the Board of Directors or in his absence by the Vice-Chairman. If the Chairman and Vice-Chairman are both absent, the Board of Directors shall appoint, for each meeting, a member who will chair the meeting.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Decisions shall be taken on the quorum and majority conditions stipulated by law.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The secretary of the Board of Directors shall be authorised to certify copies of and extracts from minutes of Board meetings as a true record.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors may take decisions by written consultation with the directors on the terms set forth in law. The arrangements for such written consultations shall be specified in the Board Charter.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 14 &#8211; BOARD POWERS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall determine the strategic orientations of the company&#8217;s business and ensure they are implemented, in accordance with the corporate interest and taking account of the social and environmental issues relating to its operations.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subject to powers expressly granted to shareholders' meetings and within the limits of the corporate objects, the Board shall address any issue of relevance to the proper functioning of the company, and shall by its deliberations settle all matters that concern it.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board shall perform controls and tests as it sees fit. Each director shall receive all the information necessary for the fulfilment of his duties, and may have disclosed to him all documents that he judges to be useful.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 15 &#8211; COMMITTEES</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board shall appoint a Committee, accountable to the Board, to oversee issues relating to the preparation and audit of financial and accounting information, in accordance with the law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board may appoint one or more other Committees to examine issues referred to them by the Board or the Chairman.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 16 &#8211; MANAGEMENT</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In accordance with the law, the executive management of the company shall be conducted under the responsibility of the Chairman of the Board of Directors, either by himself or by another natural person appointed by the Board of Directors and bearing the title of Chief Executive Officer.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall decide which of these two methods of executive management to adopt on a majority of directors present or represented.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall appoint from among its members, or from outside the Board, the Chief Executive Officer, who shall be a physical person aged less than 65. The Chief Executive Officer shall have the broadest powers to act in all circumstances in the name of the company, within the limits of the corporate objects and subject to powers expressly reserved by law for shareholders&#8217; meetings and the Board of Directors. He shall represent the company in its dealings with third parties.</font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If the executive management of the company is conducted by the Chairman, the provisions contained in the law and regulations and in the articles of association relating to the Chief Executive Officer shall apply to him except those relating to the age limit. He shall take the title of Chairman and Chief Executive Officer and shall hold office until the Ordinary General Meeting called to approve the financial statements of the immediately preceding financial year and held in the calendar year in which he reaches the age of 68.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On a proposal by the Chief Executive Officer, whether this function be assumed by the Chairman of the Board or by another person, the Board of Directors may appoint from one to five persons in charge of assisting the Chief Executive Officer, with the title of Deputy Chief Executive Officer.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In agreement with the Chief Executive Officer, the Board of Directors shall determine the scope and duration of the powers granted to the Deputy Chief Executive Officers.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In dealings with third parties, the Deputy Chief Executive Officers shall have the same powers as the Chief Executive Officer.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 17 &#8211; OBSERVERS (CENSEURS)</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On the Chairman's proposal, the Board may appoint up to two observers (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">censeurs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">). Observers are chosen from amongst the shareholders and are appointed for a period of five years. The observers may be re-appointed. They may be dismissed at any time by decision of the Board of Directors.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">They are responsible for ensuring that the articles of association are strictly observed. They are invited to attend Board meetings in a consultative capacity&#59; however, their absence from such meetings is not detrimental to the validity of the proceedings.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">They examine the annual accounts and address comments to the members of the Shareholders&#8217; Ordinary General Meeting as they deem necessary.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board may remunerate the observers by allocating sums from the amount of annual compensation allotted by the general shareholders&#8217; meeting to Board members.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="i6740201499e9489b92db889f2dc2abe1_13"></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART IV STATUTORY</font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">AUDITORS</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 18 &#8211; STATUTORY AUDITORS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">One or several principal auditors are appointed and carry out their audit assignment in compliance with the law.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="i6740201499e9489b92db889f2dc2abe1_16"></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART V </font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">GENERAL SHAREHOLDERS&#8217; MEETINGS</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 19 &#8211; RIGHT OF ACCESS &#8211; REPRESENTATION</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1)    All shareholders shall be entitled to attend personally or by proxy, in the form and at the places indicated in the notice of the meeting, on presentation of proof of identity and of ownership of the shares held in an account before the legal limit of accounting registration.  </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2)    Any shareholder may be represented or vote by mail on the conditions stipulated by law.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3)    Any shareholder may also, if the Board of Directors so decides on convening the meeting, participate and vote at meetings by video-</font></div><div style="padding-left:20.16pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">conference or by any other means of telecommunication including the Internet that enables him or her to be identified on the conditions and accordance to the methods laid down by applicable legislation. Such decision will be notified in accordance with the law.</font></div><div style="padding-left:20.16pt"><font><br></font></div><div style="padding-left:20.16pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Those shareholders who use for this purpose, and within the time limits, the electronic form provided on the website of the General Meeting centralizer shall be deemed to be among the shareholders present or represented.  The electronic form may be completed and signed directly on this site through a user code and a password</font></div><div style="padding-left:20.16pt"><font><br></font></div><div style="padding-left:20.16pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The proxy or the vote provided by electronic means prior to the General Meeting, as well as the evidence of receipt which is provided, shall be deemed irrevocable and may be asserted against all persons, it being specified that in the event of a transfer of share ownership occurring before the legal limit of accounting registration of the shares, the Company will invalidate or revise, depending on the situation, the proxy or the vote provided before this date and this hour.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 20 &#8211; NOTICE OF GENERAL SHAREHOLDERS&#8217; MEETINGS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The meetings are convened by the Board of Directors under the conditions and within the time limits prescribed by law. They are held at the registered office or at in any other place indicated in the convening letter or notice.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 21 &#8211; MEETING COMMITTEE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shareholders&#8217; General Meetings  are presided over by the Chairman of the Board of Directors or, in his absence, by a director appointed by the Board.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The duties of examiner (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">scrutateur</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) are fulfilled by the two shareholders, present and willing, who hold the greatest number of votes both in their own name and in their capacity as authorised agents.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The committee appoints a secretary who need not be a member of the general meeting.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 22 &#8211; GENERAL SHAREHOLDERS&#8217; MEETINGS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ordinary and Extraordinary General Shareholders&#8217; Meetings, acting under the conditions of quorum and majority laid down by law, exercise the powers assigned to them in compliance with the law.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="i6740201499e9489b92db889f2dc2abe1_19"></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART VI </font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ALLOCATION OF PROFITS</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 23 &#8211; FINANCIAL YEAR</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each financial year starts on January 1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and ends on December 31</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 24 &#8211; ALLOCATION OF PROFITS</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1)    The profit or loss of the financial year is the difference between the income and expenses of the financial year, after deduction of depreciation, amortization and provisions, as shown in the income statement.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2)    From the profit of the financial year, less any prior losses, a deduction of at least five per cent is made, this deduction being allocated for the creation of a reserve fund known as the &#34;legal reserve&#34;. This deduction is no longer compulsory when the amount of the legal reserve reaches one-tenth of the registered capital. The deduction begins again if, for any reason whatsoever, the legal reserve falls to a level below the said fraction.</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The remaining balance, plus any profit carried forward, constitutes the distributable profit.On the Board&#8217;s proposal, the Shareholders&#8217; General Meeting may decide that the distributable profit may, totally or partially, be carried forward or assigned to one or several general or special reserve funds.</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 25 &#8211; DIVIDENDS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Shareholders&#8217; General Meeting that votes on the financial statements for the financial year may allow each shareholder the option, for all or some of the dividend or interim dividend distributed, to receive payment of the dividend or interim dividend either in cash or in shares.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, the Shareholders&#8217; General Meeting may decide, for all or some of the dividend, interim dividend, reserves or additional paid-in capital that are distributed, that the distribution of such dividends, interim dividends, reserves, additional paid-in capital will be made in kind by the delivery of assets of the Company, including financial securities, with or without cash option.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Shareholders&#8217; General Meeting may decide that fractional rights will be neither negotiable nor transferable notwithstanding the provisions of Article 9-2&#176;) of the Articles of Association. The Shareholders&#8217; General Meeting may in particular decide that, when the proportion of the distribution to which a shareholder is entitled does not correspond to a whole number of the unit of measurement used for the distribution, that shareholder will receive the next lowest whole number of shares plus a cash payment for the balance.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="i6740201499e9489b92db889f2dc2abe1_22"></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART VII </font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DISSOLUTION &#8211; LIQUIDATION</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE 26</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On the expiry of the term of the company or in case of dissolution prior to that date, the Shareholders&#8217; General Meeting rules on the mode of liquidation and appoints one or several liquidators whose powers it determines and who carry out their duties, in compliance with the law.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The liquidation proceeds are first used to pay liabilities. Subsequent to this payment and after payment of liquidation costs, the surplus is used to reimburse the nominal value of the shares&#59; the balance is distributed amongst the shareholders in the same proportions as their participation in the share capital.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="i6740201499e9489b92db889f2dc2abe1_25"></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART VIII </font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DISPUTES</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE  27</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any disputes that may arise during the life of the company or its liquidation, either between the shareholders and the company or between the shareholders themselves, concerning the interpretation or enforcement of these statutes or generally regarding corporate business, are subject to the jurisdiction of the competent courts.</font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>3
<FILENAME>a2022-exhibit12.htm
<DESCRIPTION>EX-1.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie178793b38b448e8ac8e6dc4b6e17522_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 1.2</font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font><br></font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">This text is a free translation from the French language and is supplied solely for information purposes. Only the original version in the French language has legal force.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SANOFI BOARD CHARTER</font></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Approved by the Board of Directors on July 28, 2021</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">This text is a free translation from the French language and is supplied solely for information purposes. Only the original version in the French language has legal force.</font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_4"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">LIST OF CONTENTS</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.733%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">I &#8211; Composition of the Board of Directors and term of office</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_7" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">3</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;I</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">ndependent Directors</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_10" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">3</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Directors representing employees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_13" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">3</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8194;&#8201;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Outside speakers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_16" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">3</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">D.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8194;&#8201;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Term of office and reappointment by rotation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_19" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">3</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">II &#8211; Ethical duties of Sanofi Directors</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_22" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Information provided to new Directors</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_25" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Training of Directors</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_28" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8194;&#8201;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Holding of shares in the Company</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_31" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">D.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8194;&#8201;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Corporate interests</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_34" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">E.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Preparation for meetings &#8211; Attendance</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_37" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">F.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#8202;Confidentiality</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_40" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">G</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.&#8194;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#8201;Holding of multiple offices</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_43" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">H.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8194;&#8201;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Prevention of conflicts of interest</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_46" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">I.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#8201;Privileged information</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_49" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">III &#8211; Remit and powers of the Board of Directors</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_52" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">IV &#8211; Operating procedures of the Board of Directors</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_55" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Meetings</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_58" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Secretary to the Board</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_61" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8194;&#8201;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Evaluation of the Board and its Committees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_64" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">D.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8194;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#8201;Provision of information to Directors</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_67" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">E.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Attendance fees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_70" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">V &#8211; Roles and powers of the Chairman and the Chief Executive Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_73" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Chairman of the Board of Directors</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_76" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Chief Executive Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_79" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">VI &#8211; Committees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_82" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Provisions common to all Committees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_85" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Specific provisions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_88" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:58.5pt;padding-right:2.25pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%;text-decoration:underline">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%">&#8195;&#8201;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%;text-decoration:underline">Audit Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_91" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:58.5pt;padding-right:2.25pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%;text-decoration:underline">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%">&#8195;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%;text-decoration:underline">Compensation Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_94" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">13</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:58.5pt;padding-right:2.25pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%;text-decoration:underline">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%">&#8195;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%;text-decoration:underline">Appointments, Governance and CSR Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_97" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">13</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:58.5pt;padding-right:2.25pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%;text-decoration:underline">iv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%">&#8194;&#8201;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%;text-decoration:underline">Strategy Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_100" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:58.5pt;padding-right:2.25pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%;text-decoration:underline">v.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%">&#8195;&#8201;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%;text-decoration:underline">Scientific Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_103" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">15</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:159%;text-decoration:underline">VII &#8211; Amendment of the Board Charter</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a href="#ie178793b38b448e8ac8e6dc4b6e17522_106" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none">15</a></font></div></td></tr></table></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_7"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board Charter (the &#8220;Charter&#8221;) describes the rights and obligations of Board members&#59; the composition, role and operating procedures of the Board of Directors and Board Committees&#59; and the roles and powers of the Chairman and the Chief Executive Officer. It is prepared in accordance with the French Commercial Code and the Company&#8217;s Articles of Association.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Charter shall be binding on all members of the Board of Directors. All members of the Board shall on assuming office be deemed to adhere to the Charter and shall comply with it in full.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors refers to the corporate governance principles contained in the Code de gouvernement d&#8217;entreprise des soci&#233;t&#233;s cot&#233;es (Corporate Governance Code of Listed Companies) applicable as of the date of the presents (the &#8220;AFEP-MEDEF Code&#8221;).</font></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">I &#8211; Composition of the Board of Directors and term of office</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall seek to establish an appropriate balance among its members and among members of its Committees, in particular in terms of diversity (representation of men and women, nationalities, ages and competencies), while taking the necessary measures to provide shareholders the market and stakeholders with assurance that it is fulfilling its remit with the requisite independence and objectivity. The Board shall disclose publicly in the Annual Report a description of its policy in this area, covering the objectives, procedures and outcomes of that policy.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_10"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Independent Directors</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At least half of the members of the Board of Directors shall be independent Directors.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A Director shall be independent when they have no relationship of any kind with the Company, its subsidiaries or its senior management that may color their judgment. Accordingly, an independent Director shall be understood to be any non-executive Director of the Company or of a subsidiary who has no particular bonds of interest (significant shareholder, employee, other) with either the Company or its subsidiaries.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">It shall be the responsibility of the Board of Directors, acting on proposals from the Appointments, Governance and CSR Committee, to assess the independence of each of its members with reference to the recommendations and guidelines of the AFEP-MEDEF code.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The independence of Directors shall be discussed by the Appointments, Governance and CSR Committee and determined by the Board whenever a Director is appointed, and annually for all Directors. The shareholders shall be informed of such assessments.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_13"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Directors representing employees</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall include two Directors representing employees, designated in accordance with the arrangements specified in the Articles of Association.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subject to any legal provisions specific to them, the Directors representing employees shall have the same rights and be subject to the same obligations as the other members of the Board, in particular as regards confidentiality, and shall bear the same responsibility.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors representing employees shall not count towards the proportion of independent or female members of the Board of Directors.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_16"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Outside speakers</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If the agenda so dictates, the Chairman of the Board of Directors may, especially if a Director so requests, invite any person (whether or not an employee of the Company) that he or she sees fit to make a presentation or provide clarification as part of preparatory discussions for Board deliberations.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_19"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Term of office and reappointment by rotation</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The term of office of Directors shall be four years.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors shall be required to seek reappointment by rotation, such that members of the Board are required to seek reappointment on a regular basis in the most equal proportions possible. Exceptionally, a Shareholders&#8217; Ordinary General Meeting may appoint a Director to serve for a term of one, two or three years in order to ensure adequate rotation of Board members.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_22"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">II &#8211; Ethical duties of Sanofi Directors</font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_25"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Information provided to new Directors</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When Directors assume office, the Secretary to the Board shall provide them with an information pack, to include the Articles of Association and the Charter. Directors shall ensure that they are aware of and comply with the obligations placed upon them by the relevant laws and regulations, the Articles of Association, the Charter, and such other internal rules and procedures of the Company as apply to them.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_28"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Training of Directors</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors may, at the time of their appointment and throughout their term of office, request such training as they regard as necessary to discharge their duties as Directors, and in particular training about the specific characteristics of the Company&#59; its business lines&#59; the sector in which it operates&#59; and its social and environmental responsibilities. Such training shall be organized and offered by the Company at its expense.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_31"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Holding of shares in the Company</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to their obligations under the Articles of Association, each Director must be a shareholder in their own right and must within no more than two years from their appointment hold at least 1,000 Sanofi shares in their own name, which must be retained until they cease to hold office. Any Director who does not hold such shares on assuming office shall use their attendance fees to finance the acquisition thereof.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors shall be required to convert into registered form any financial instruments of the Company they hold when they assume office and any that they acquire during their term of office.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In accordance with legislation, that obligation of holding shares shall not apply to Directors representing employees.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_34"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Corporate interests</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors is a collegiate body acting in Sanofi&#8217;s corporate interests and representing the shareholders collectively. Directors shall discharge collectively, jointly and severally the responsibilities and obligations incumbent by law on the Board of Directors.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_37"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Preparation for meetings &#8211; Attendance</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In preparing for meetings of the Board and Committees on which they sit, Directors shall devote the time and attention necessary to examining the supporting documentation sent to them.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors representing employees shall be allowed sufficient time to properly discharge their duties as Directors.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unless they inform the Chairman in advance of their absence, Directors shall participate in all meetings of the Board and of the Committees on which they sit, as well as in Shareholders&#8217; General Meetings.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_40"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Confidentiality</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Files for Board meetings, and information received prior to or during Board meetings, shall be treated as confidential by Directors, who shall be bound by this strict duty of confidentiality vis-&#224;-vis not only persons external to the Company but also persons within the Company who do not need to know such information by reason of their duties.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If a third party who is not a Director is invited to a Board meeting or to a preparatory session of such a meeting, the Chairman shall remind them of their duty of confidentiality in relation to information provided before or during such meeting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As regards information not in the public domain obtained in the course of their duties, Directors shall regard themselves as bound by an obligation of professional secrecy that goes beyond the mere duty of discretion contained in the relevant laws and regulations.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Only the Chairman and the Chief Executive Officer of the Company shall be entitled to provide third parties and the public with information on the Company&#8217;s policy, strategies, activities and performance.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the event of a proven breach of the duty of confidentiality by a Director or any person attending a Board meeting, the Chairman of the Board, after consulting the Legal Department, shall inform the Board of Directors of the action he or she intends to take in respect of such breach, including any legal proceedings.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_43"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">G.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Holding of multiple offices</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An executive Officer shall not hold more than two other directorships in listed companies outside the Company and its subsidiaries, including foreign companies. He or she must also seek the opinion of the Board of Directors before accepting a new office in a listed company.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A Director shall not hold directorships in more than four listed companies outside the Company and its subsidiaries, including foreign companies. This recommendation shall apply on their initial appointment as Director or on their next reappointment.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors shall keep the Board informed of offices held in other French or foreign companies, including membership of those companies&#8217; board committees.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_46"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">H.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Prevention of conflicts of interest</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A Director may not use their title or office as Director to obtain for themselves or for a third party any pecuniary or non-pecuniary benefit.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors undertake to inform the Board of Directors of any actual or potential conflict of interest between their duties to the Company and their private interests and&#47;or other duties. They shall also abstain from voting and participating in debate on any such matter.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A Director who is involved in a transaction in which Sanofi has a direct interest or of which they became aware in their capacity as Director shall inform the Board thereof prior to entering into such transaction.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No Director, and no permanent representative of a Director that is a corporate entity, may be involved in a personal capacity in any business or activity in competition with those of Sanofi without having previously informed the Board of Directors and obtained its consent.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During their entire term of office, Directors (or permanent representatives of a Director that is a corporate entity) undertake not to seek and&#47;or accept a directorship in any business or activity in competition with those of Sanofi and&#47;or in businesses in which Sanofi holds a significant equity interest or more generally in businesses with which Sanofi is in significant collaboration without previously seeking the opinion of the Chairman of the Board of Directors. If the Chairman regards the holding of such a directorship as contrary to the corporate interests of the Company or as liable to create a conflict of interest, he or she may require the Director to resign from or refuse to accept said directorship.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the end of their term of office, Directors (or permanent representatives of a Director that is corporate entity) shall allow a reasonable period of time to elapse before seeking and&#47;or accepting a directorship in businesses carrying on activities in competition with those of Sanofi and&#47;or in businesses in which Sanofi holds an equity interest.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In any event, Directors shall fulfill their commitment to confidentiality and loyalty vis-&#224;-vis the Company.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors undertake to tender their resignation to the Board of Directors in the event that their other activities and directorships change significantly.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors who believe they are no longer capable of fulfilling their duties within the Board or a Committee of which they are a member shall resign.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors who abstain from voting on a Board motion due to a conflict of interest shall not count towards quorum.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_49"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">I.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Privileged information</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with their duties, Directors receive much confidential information, some of which may be privileged information on the Company within the meaning of securities law.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors who are in possession of privileged information must, for as long as that information is not in the public domain, refrain from directly or indirectly entering into (or recommending others to enter into or refrain from) any transaction involving the financial instruments of the Company (shares, ADRs, CVRs, bonds, futures, etc.) and from disclosing such information to third parties.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors shall also refrain from trading in financial instruments of the Company during closed periods determined and communicated to them by the Company.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors shall refrain from entering into speculative or hedging transactions, in particular derivatives transactions and short selling. Directors and persons closely associated with Directors shall, on the terms specified in the relevant regulations, notify transactions in financial instruments of the Company to the Company itself and to the Autorit&#233; des march&#233;s financiers, which discloses such transactions to the public.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors shall send written notification informing persons closely associated with them of their obligations to declare transactions, and shall retain a copy of that notification.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_52"></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">III &#8211; Remit and powers of the Board of Directors</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board shall deliberate on issues that are within its competence by law or under the Articles of Association.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall lay down the orientations of the Company&#8217;s activities and ensure that they are implemented, paying due consideration to social and environmental issues. Subject to those powers expressly attributed to Shareholders&#8217; General Meetings and within the limits set by the corporate purpose, the Board of Directors shall address any issue of relevance to the proper conduct of the Company&#8217;s affairs and shall, through its deliberations, settle matters concerning the Company. It shall in all circumstances act in the corporate interests of the Company, seeking to promote long-term value creation in all aspects of the Company&#8217;s operations.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall carry out such inspections and verifications as it deems fit. It shall conduct an annual review of the key points in the Management Report and other reports submitted to the shareholders, and of the resolutions submitted to the Shareholders&#8217; General Meeting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As part of its remit, the Board shall have inter alia the following powers&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to be kept informed of any important event affecting the affairs of the Company, and more generally of trends in the markets, in the competitive environment, and in the main challenges faced by the Company, including its social and environmental responsibilities&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to determine the strategic orientations of the Company and the Group, based on advice from the Strategy Committee&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to appoint corporate officers responsible for managing the business and decide on the governance rules for corporate officers (separation or combination of the offices of Chairman and Chief Executive Officer)&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to establish an Audit Committee on the terms specified by law, and assess the appropriateness of establishing other specialist Committees on a permanent or temporary basis&#59; to determine the composition of such Committees with regard to the issues they will examine, and ensure they function properly&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to examine on a regular basis, consistently with the strategy determined by the Board and in liaison with the Audit Committee, the opportunities and risks (in particular of a financial, legal, operational, social or environmental nature) to which the Company and its subsidiaries are exposed, and the measures taken in response&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to ensure that the necessary systems are in place to prevent and detect corruption and influence trafficking, and obtain all necessary information to that effect&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to set the compensation payable to the Company Officers, acting on proposals from the Compensation Committee. The Board shall give reasons for decisions taken on such matters&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to determine, upon the Chief Executive Officer's proposal and, in conjunction with the Compensation Committee and the Appointments, Governance and CSR Committee, targets in terms of gender balance within the executive bodies and ensure that the Chief Executive Officer implements global non-discrimination and diversity policy within the Company&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to exercise control over management and oversee the quality of information provided to shareholders and to the markets, in particular via the financial statements or on the occasion of major corporate actions&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to establish the Company&#8217;s financial communication policy&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to be kept regularly informed by the Audit Committee of the financial position, cash position and commitments of the Company&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to call and prepare the agenda for Shareholders&#8217; General Meetings.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, without prejudice to those transactions for which Board approval is legally required (regulated agreements, divestments of equity interests or real estate, etc.), the following shall specifically require the prior consent of the Board&#58;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;any significant transaction outside the scope of the Company&#8217;s declared strategy (see also the limitations on the powers of the Chief Executive Officer mentioned below)&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;commitments in respect of investments, acquisitions and divestments that exceed the limitations on the powers of the Chief Executive Officer&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;authorizations given to the Chief Executive Officer to grant guarantees in the name of the Company, including to the tax and customs authorities.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_55"></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">IV &#8211; Operating procedures of the Board of Directors</font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_58"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Meetings</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall meet at least four times a year, and whenever the interests of the Company require. Meetings may be called by any means, including orally, by the Chairman or by the Secretary to the Board at the Chairman&#8217;s request.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Meetings shall take place at the registered office or at any other place indicated in the notice of the meeting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chairman shall chair Board meetings and organize the work done at meetings. If the Chairman is unable to chair a meeting, he or she shall be replaced by the Chief Executive Officer (provided the two offices are separated and that the Chief Executive Officer is also a Director), or otherwise by another Director chosen by the Board at the start of the meeting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall organize at least two meetings a year without the executive Officers being present. Such meetings may also be held without Directors representing employees or any other Group employee being present. These meetings shall inter alia evaluate the performance and determine the compensation of the Chief Executive Officer.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The agenda for meetings shall be established by the Chairman. Directors may request the Chairman to add to the agenda an item that they wish to be discussed at the meeting, provided such request is made in reasonable time.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chairman shall ensure that the Company provides all relevant information and documents to the Directors on a timely basis in advance of each meeting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors may choose to be represented by another Director at meetings of the Board of Directors. Each Director may represent no more than one other Director at any Board meeting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors who participate in a Board meeting by video-conference and&#47;or tele-conference links that enable them to be identified and effectively participate in the meeting and that comply with the technical specifications stipulated in the regulations applicable as of the date of the meeting shall be deemed present for the purposes of determining quorum and majority at such meetings. By law, such methods cannot be used for certain decisions, including when the Board deliberates on the individual company and consolidated financial statements of the Company and on the management report.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If the Chairman of the Board becomes aware of a malfunction in the video-conference or tele- conference system, the Board of Directors may validly deliberate and&#47;or continue with only those Directors attending in person, provided that the quorum requirements are met. The occurrence of any technical problem affecting the course of the meeting shall be recorded in the minutes, including the interruption and restoration of the remote attendance links.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors may at the Company&#8217;s expense have recourse to external experts and commission external technical research on issues within its sphere of competence, on condition that a report is provided to the Board itself thereon. The Board must obtain assurance as to the objectivity of any external experts retained.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_61"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Secretary to the Board</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board, acting on a proposal from the Chairman, shall appoint a Secretary. All members of the Board may consult the Secretary and make use of his or her services. The Secretary shall ensure that the Board&#8217;s operating procedures are complied with and shall establish minutes of its meetings, which shall include a summary of the discussions and the motions submitted for its approval. The minutes shall mention questions put and reservations expressed by those attending.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Secretary&#8217;s responsibilities shall include sending working papers to the Directors and dealing with any request from them for information about their rights and responsibilities, the operating procedures of the Board or the Company&#8217;s affairs.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_64"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Evaluation of the Board and its Committees</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall evaluate its ability to meet the expectations of the Shareholders who have mandated the Board to administer the Company, by performing periodic reviews of the Board&#8217;s composition, organization and operating procedures, to include by extension a review of the Board Committees.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board shall consider what is an appropriate balance for its composition, and periodically reassess whether the way in which the Board is organized and operates is appropriate to fulfill its remit.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The evaluation shall have two principal objectives&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;assess the way in which the Board operates&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;check that the important issues are properly prepared and discussed. The arrangements for the Board evaluation are as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the Board discusses its own operating procedures once a year&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;at least once every three years there is a formal evaluation, which may be conducted with assistance from an external consultant under the direction of the Appointments, Governance and CSR Committee&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;shareholders are informed each year in the annual report about the evaluation, and any follow-up action.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_67"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Provision of information to Directors</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other than in exceptional circumstances, Directors shall within a reasonable period in advance of each Board meeting receive the agenda for that meeting and necessary information for their consideration.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">They shall also be provided with information at any time between Board meetings if necessary.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors shall in addition keep themselves informed at all times of developments affecting the Company and the market. To that end, a Director must request on a timely basis such information as they regard as essential for making a useful contribution on the issues included on the agenda from the Chairman or the Secretary to the Board.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors must be able to meet the Company&#8217;s principal executives, and may do so without the executive Officers being present provided that the executive officers are given prior notice.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_70"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Attendance fees</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acting on a proposal from the Compensation Committee, the Board shall allocate the annual attendance fee budget authorized by the Shareholders&#8217; General Meeting.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Members of the Board shall be entitled to a fixed fee to compensate their role as Director and any role as member or Chairman of one or more Committees, and to a preponderant variable fee reflecting effective attendance at meetings of the Board and of any Committees to which they belong.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board may also allocate additional attendance fees to Directors living outside France to reflect the necessity of their traveling to attend meetings.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors who simultaneously hold office as Chairman of the Board, Chief Executive Officer or Deputy Chief Executive Officer shall not receive attendance fees.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A Director participating in a meeting of the Board or of a Committee by tele-conference or video-conference shall receive the equivalent of the attendance fee paid to a Director residing in France who attends in person. Committee Chairs retain their usual compensation for committees they chair.</font></div><div><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As an exception, in certain cases two meetings held on the same day shall give entitlement to a single attendance fee&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;if on the day of the Shareholders&#8217; General Meeting, the Board of Directors meets both before and after that meeting, only one attendance fee shall be paid for the two meetings&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;if on the same day a Director participates in one meeting of the Compensation Committee and one meeting of the Appointments, Governance and CSR Committee, only the higher of the two fees shall be paid to cover both meetings.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors representing employees shall receive attendance fees in accordance with the rules described above.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Directors shall also be entitled to be reimbursed for travel expenses they incur in the exercise of their duties on presentation of supporting documentation.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_73"></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">V &#8211; Roles and powers of the Chairman and the Chief Executive Officer</font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_76"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Chairman of the Board of Directors</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chairman shall organize and direct the work of the Board of Directors, on which he or she shall report to the Shareholders&#8217; General Meeting. The Chairman shall also be responsible for ensuring the proper functioning of the corporate decision-making bodies in compliance with good governance principles. The Chairman shall coordinate the work of the Board of Directors with that of its Committees.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">He or she shall ensure that Directors have access on a timely basis to information required for the performance of their duties, in a clear and appropriate form.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chairman shall, in coordination with the Chief Executive Officer, liaise between the Board of Directors and the Shareholders. The Chairman of the Board of Directors shall have sole authority to speak in the name of the Board. The role of the Chairman of the Board of Directors shall include&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;explaining previously-disclosed positions taken by the Board within its areas of competence&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;ensuring that shareholders receive the information they expect about the Company.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chairman shall report to the Board on the fulfilment of his or her remit in the event that the offices of Chairman and Chief Executive Officer are separated, and shall develop and maintain a proper relationship of trust between the Board and the Chief Executive Officer, so as to ensure that the latter consistently and continuously implements the orientations determined by the Board.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chairman shall be kept regularly informed by the Chief Executive Officer of significant events and situations affecting the affairs of the Company, especially in the areas of strategy, organization, financial reporting, major investment and divestment proposals, and major corporate actions. The Chairman may request from the Chief Executive Officer any information useful to the Board of Directors.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In close collaboration with the Chief Executive Officer, the Chairman may represent the Company in high-level dealings with governmental bodies and with key partners of the Company and&#47;or of its subsidiaries, both nationally and internationally.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As required by law and by the Charter, the Chairman shall seek to prevent any conflict of interest and manage any situation that might give rise to a conflict of interest. He or she shall also give rulings, in the name of the Board, on requests to take up external directorships of which he or she may become aware or that may be submitted to him or her by a Director.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chairman shall strive to promote in all circumstances the values and the image of the Company.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">He or she may interview the statutory auditors in preparation for the work of the Board of Directors and the Audit Committee.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In fulfilling his remit, the Chairman may meet with any individual, including senior executives of the Company, while avoiding any involvement in directing the Company or managing its operations, which are exclusively the responsibility of the Chief Executive Officer.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_79"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Chief Executive Officer</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chief Executive Officer shall assume responsibility for the general management of the Company. He or she shall chair the Executive Committee. He or she shall have sole responsibility for directing the Company and managing its operations.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">He or she shall have the broadest powers to act in the name of the Company in all circumstances, subject to powers attributed by law to the Board of Directors or to the Shareholders&#8217; General Meeting and subject to the limitations on powers described below.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prior approval from the Board of Directors shall be required for transactions or decisions resulting in an investment or divestment, or an expenditure or guarantee commitment, made by the Company and its subsidiaries, in excess of&#58;</font></div><div style="margin-bottom:9pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;a cap of &#8364;500 million (per transaction) for transactions, decisions or commitments pertaining to a previously approved strategy&#59; and</font></div><div style="margin-bottom:9pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;a cap of &#8364;150 million (per transaction) for transactions, decisions or commitments not pertaining to a previously approved strategy.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When such transactions, decisions or commitments give rise to installment payments to the contracting third party (or parties) that are contingent upon future results or objectives, such as the registration of one or more products, attainment of the caps shall be calculated by </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">aggregating the various payments due from signature of the contract until (and including) filing of the first application for marketing authorization in the United States or in Europe.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Attainment of the above caps shall also be assessed after taking into account all commitments to make payments on exercise of a firm or conditional option with immediate or deferred effect, and all guarantees or collateral to be provided to third parties over the duration of such commitments.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The prior approval procedure shall not apply to transactions and decisions that result in the signature of agreements that solely involve subsidiaries and the Company itself.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At each Board meeting, the Chief Executive Officer shall present a report on significant events affecting the Company&#8217;s affairs</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_82"></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">VI &#8211; Committees</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To fulfill its remit in a spirit of good governance and in accordance with legal requirements, the Board of Directors has established five permanent Committees, the members of which shall be chosen by the Board from among its own members&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the Audit Committee&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the Compensation Committee&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the Appointments, Governance and CSR Committee&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the Strategy Committee&#59; and</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the Scientific Committee.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In accordance with the law, the existence of those five Committees shall not preclude any other Committees that the Board may decide to establish on a temporary or ad hoc basis.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_85"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Provisions common to all Committees</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">General remit of the Committees</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The remit of the Committees shall be to conduct analysis and in-depth thinking ahead of Board discussions, and to help prepare decisions to be taken by the Board. The Committees shall have no decision-making powers and the opinions, proposals and recommendations submitted by the Committees to the Board shall in no way be binding on the Board.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The operating procedures of each Committee shall be set by the Charter, in line with the principle of collegiality that governs the Board of Directors. The specialist Committees shall therefore carry on their activities under the responsibility of the Board of Directors and within the limits of the Board&#8217;s powers. They shall report regularly to the Board on their remit. The annual report shall include a description of the work of the Committees during the past financial year.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Committee members shall be subject to the same civil and criminal liability as the other Directors.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any member of a Committee may inform the Chairman of the Board at any time of any aspect of that Committee&#8217;s remit of which he or she feels the Board should be made aware.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Resources provided to the Committees</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company shall provide members of the Committees with all relevant information and documents.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committees may at the Company&#8217;s expense have recourse to external experts and commission external technical research on issues within their sphere of competence, on condition that (i) the Committee has previously informed the Chairman of the Board or the Board of Directors and (ii) a report is provided to the Board thereon. The Committees must obtain assurance as to the objectivity of any external experts retained.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any person invited to attend Committee meetings shall be bound by an obligation of non-disclosure with respect to any information not in the public domain, and by a general obligation of discretion in respect of all matters relating to the Committee and the Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Appointment of Committee members</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors shall appoint the members and Chairman of the Appointments, Governance and CSR Committee. It shall then, acting upon proposals from that Committee, appoint the members and Chairman of each Committee established by the Board.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board shall have discretion to allow a period of time to elapse between the date on which a Director is first appointed to serve on the Board and the appointment of that Director to a Committee, in particular to give the new Director time to assimilate, to understand how the Company operates and the issues facing its business, or to complete any training programs.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Members of each Committee shall serve on that Committee for a period concurrent with their term of office as Director, and may be reappointed at the time of their reappointment as a Director.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board may summarily remove any member of a Committee without having to give reasons.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Committees shall avoid having any member who holds cross-directorships within the meaning of the AFEP-MEDEF code.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Quorum and majority</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Committee meetings may take place with members physically present or participating via video-conference and&#47;or tele-conference links that enable a list of participants to be established and enable the members to discuss and arrive at recommendations, conclusions and observations.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Committees may only deliberate validly if at least half of their members participate in the meeting&#59; members who participate in Committee meetings via video-conference or tele-conference links shall be deemed present on the same conditions as stipulated for meetings of the Board of Directors. No member of a Committee may be represented thereon by another person.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proposals made by Committees shall be decided on a simple majority. In the event of a tied vote, the Chairman of the Committee shall have a casting vote.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Committee meetings</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Committee meetings shall be called by the Chairman of the Committee whenever he or she sees fit. Other than the Audit Committee, which shall meet at least four times a year, Committees shall meet at least twice a year.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chairman of each Committee shall designate a secretary, who may or may not be chosen from among its members. Committee deliberations shall be recorded in minutes validated by its Chairman and the secretary or another Committee member, and shall be sent to Committee members by any means of communication.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_88"></div><div style="margin-bottom:9pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Specific provisions</font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_91"></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">i.&#160;&#160;&#160;&#160;Audit Committee</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Composition of the Audit Committee</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee shall have at least three members, appointed by the Board from among the Directors.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At least two-thirds of its members shall be independent Directors and no executive Officer may sit on the Committee.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The members of the Committee must be competent in financial or accounting matters. At least one member must qualify as a financial expert within the meaning of U.S. securities legislation and of French legislation.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On appointment to the Audit Committee, members shall be provided with specific information about the accounting, financial and operational characteristics of the Company.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When the Governance and CSR Committee proposes the appointment or reappointment of the Chairman of the Audit Committee, such proposal must be specifically examined by the Board.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Remit of the Audit Committee</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The principal remit of the Audit Committee shall be to monitor matters relating to the preparation and audit of accounting, financial and extra-financial information. Without prejudice to the powers of the Board of Directors, the Committee shall inter alia be responsible for monitoring&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the process of preparing the annual and half-year financial statements, and financial information more generally. The Committee shall formulate any recommendations to ensure the integrity thereof&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the implementation and effectiveness of internal control and risk management systems, and if appropriate of internal audit as regards procedures for preparing and processing accounting, financial and extra-financial information, but without undermining the independence of internal audit&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the audit of the individual company financial statements and consolidated financial statements by the statutory auditors.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The role of the Committee shall be not so much to examine the financial statements in detail as to monitor the process of preparing them and to assess the validity of elective accounting treatments used for significant transactions.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Audit Committee must obtain assurance that the Chief Executive Officer has sufficient resources to identify and manage the risks, and in particular risks of an economic, financial and legal nature, to which the Company and its subsidiaries are exposed in the course of routine and exceptional transactions.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, the Committee shall&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;direct the selection process for the statutory auditors, submit the results of this process to the Board of Directors, and issue a recommendation concerning the statutory auditors proposed for appointment by the Shareholders&#8217; General Meeting. It shall supervise any call for tenders, and approve the terms of reference and the panel of firms invited to tender&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;be informed every year of the fees paid to the statutory auditors of the Company, and be provided with their attestation of independence&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;monitor the independence of the statutory auditors, and examine with them any risks to such independence and protective measures to mitigate those risks. The Committee shall obtain assurance that the statutory auditors comply with the legal and regulatory requirements relating to incompatibility of interests within the auditing profession. In that regard, the Committee shall monitor compliance with auditor rotation requirements&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;approve in advance any request to the statutory auditors to provide services that are ancillary or directly complementary to the audit of the financial statements and rule on requests to&#47;from the statutory auditors to supply services other than audit of the financial statements, in compliance with the relevant laws&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;examine risk exposures and significant off balance sheet commitments, assess the materiality of deficiencies or weaknesses reported to it and, where appropriate, inform the Board thereof&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;examine the scope of consolidation and, if applicable, the reasons for an entity&#8217;s inclusion or exclusion from that scope&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;obtain assurance that the Company&#8217;s internal audit function has sufficient resources to fulfill its remit&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;obtain assurance that the Company&#8217;s accounting policies are relevant, consistent and reliable, and examine any changes in those policies&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;ensure that internal whistle-blowing procedures relating to accounting, internal accounting controls and audit are in place and applied&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;oversee compliance with ethical standards within the Company and in its dealings with third parties&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;ensure that independent Directors receive no compensation other than attendance fees. The Committee shall be kept informed of projects and&#47;or significant financial decisions.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee shall report regularly to the Board of Directors. Such reports shall cover fulfillment of the Committee&#8217;s remit, outcomes of the statutory audit engagement, how that engagement contributed to the integrity of financial information, and the role played by the Committee in that process. The Committee shall inform the Board immediately of any difficulties encountered.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Organization of the work of the Audit Committee</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On appointment to the Audit Committee, members must be provided with information about the accounting, financial and operational characteristics of the Company.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In furtherance of its remit, the Committee shall have access to all documents and interview the statutory auditors and the officers responsible for finance, accounting, and treasury management. It shall be possible for such interviews to take place without the Chief Executive Officer being present if the Committee sees fit. The Committee may also visit or interview managers of operational entities in furtherance of its remit, having given prior notice to the Chairman of the Board and to the Chief Executive Officer.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee shall interview the person responsible for internal audit and give its opinion on the organization of the internal audit function. The Committee shall be notified of the internal audit program and shall be sent internal audit reports or a periodic summary of such reports.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sufficient time shall be allowed for the financial statements to be examined. The examination of the financial statements by the Audit Committee shall be accompanied by a presentation by the statutory auditors highlighting key issues raised by the statutory audit (including audit adjustments and significant internal control weaknesses identified during the audit) and the elective accounting treatments adopted. It shall also be accompanied by a presentation by the Chief Financial Officer describing the Company&#8217;s exposure to risks and significant off balance sheet commitments.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_94"></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">ii.&#160;&#160;&#160;&#160;Compensation Committee</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Composition of the Compensation Committee</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee shall have at least three members, appointed by the Board from among the Directors.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A majority of its members shall be independent Directors, and no executive Officer may sit on the Committee. The Committee shall be chaired by an independent Director. The Board may also decide to appoint a Director representing employees to sit on this Committee.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Remit of the Compensation Committee</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The remit of the Committee shall be to&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;make recommendations and proposals to the Board allowing the latter to define the Company Officers' compensation policy, which includes compensation, pension and welfare plans, top-up pension plans, benefits in kind, miscellaneous pecuniary benefits, and awards of restricted or performance shares or stock options to the executive officers of Sanofi (it being stipulated that when the Committee&#8217;s report on those topics is presented, the Board shall deliberate without the executive officers present)&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;define the methods used to set the variable portion of the compensation of the Chairman and the Chief Executive Officer, and check that those methods are applied&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;formulate general policy on the granting of restricted and performance shares and stock options, and determine the frequency of grants for each category of grantee&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;issue recommendations on the Directors' compensation policy (total amount of attendance fees and how those fees are to be allocated between Directors)&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;consider ethical issues that the Board, the Chairman or the Audit Committee may decide to refer to it&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;examine human resources policy, especially as regards industrial relations, recruitment, diversity, talent management, pay equality and building staff loyalty&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;advise the Chief Executive Officer on the compensation of key senior executives.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Compensation Committee shall also assist in the preparation of the sections of the annual report dealing with the Company Officers' compensation policy and compensation report. The Committee shall also check that the amount of fixed, variable and exceptional compensation paid or awarded to the Company Officers in respect of the previous financial year is consistent with the policy approved by the shareholders.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee shall also be kept informed of the compensation policy in place for the principal executive managers who are not Company Officers. On such occasions, the Committee shall meet with the executive Officers present.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_97"></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">iii.&#160;&#160;&#160;&#160;Appointments, Governance and CSR Committee</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Composition of the Appointments, Governance and CSR Committee</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee shall not include any executive Officer and shall include a majority of independent Directors. The Chief Executive Officer shall take part in the work of the Appointments, Governance and CSR Committee. In the event that the offices of Chairman of the Board and Chief Executive Officer are separated, the non-executive Chairman may be a member of the Committee.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Remit of the Appointments, Governance and CSR Committee</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The remit of the Committee shall be to&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;assess and recommend suitable candidates to the Board of Directors for appointment as Directors taking into account the target balance of the composition of the Board and its Committees in light of the composition of and changes in the Company&#8217;s shareholder base, the skills and expertise needed for the Board to fulfill its remit, and the gender balance of the Board&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;assess and make recommendations to the Board of Directors as necessary regarding the reappointment of individuals whose terms of office are due to expire, in particular those of the Chairman and Chief Executive Officer&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;propose methods for evaluating the operating procedures of the Board of Directors and its Committees, and monitor the application of those methods&#59;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;determine whether each Director qualifies as being independent, both on initial appointment and annually prior to publication of the annual report, and report its conclusions to the Board of Directors. The Board may at its discretion set independence criteria with reference to those set forth in the AFEP-MEDEF Code&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;establish corporate governance rules for the Company and monitor application of those rules&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;consider ethical issues that the Board, the Chairman or the Audit Committee may decide to refer to it&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;ensure that there is adequate succession planning for the Company&#8217;s executive bodies, in particular through the establishment of a succession plan for the Company Officers so that replacement solutions may be proposed to the Board in the event of unplanned vacancies&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;establish a procedure for the selection of future independent Directors and carry out research on potential candidates prior to any contact with them&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;debate the skills and&#47;or financial expertise of Directors nominated to the Audit Committee and report its conclusions to the Board of Directors&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;examine and monitor the Company&#8217;s commitments and policy orientations in terms of social, environmental and societal responsibility (collectively referred to as Corporate Social Responsibility or &#8220;CSR&#8221;) and the extent to which they meet stakeholder expectations, and more generally ensure that CSR issues are taken into account in developing and implementing corporate strategy&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;examine draft reports by the Company on governance and CSR matters, and more generally ensure that all information required by applicable legislation on such matters is prepared&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;ensure that regular exchanges take place with shareholders on corporate governance and CSR issues and determine how such exchanges take place, while making sure that the principles of equal treatment of all shareholders and the collegiate nature of the Board are not undermined&#59; and</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;identify and discuss emerging trends in governance and CSR, and ensure that the Company is preparing as well as possible to deal with those trends in light of issues specific to its operations and objectives.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Appointments, Governance and CSR Committee shall also assist in the preparation of the sections of the annual report dealing with the diversity policy applied to members of the Board.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_100"></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">iv.&#160;&#160;&#160;&#160;Strategy Committee</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Composition of the Strategy Committee</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee shall consist of at least three Directors, including the Chairman of the Board of Directors and the Chief Executive Officer. It shall be chaired by the Chairman of the Board of Directors unless that office is combined with that of Chief Executive Officer.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chairman of the Committee may invite some or all Directors who are not members of the Committee to attend meetings at which strategic development priorities and initiatives are discussed with the Chief Executive Officer and senior executives.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Remit of the Strategy Committee</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee&#8217;s remit shall be to identify, investigate, propose, support, assess and monitor strategic development priorities and initiatives relating to the Company and its operations. It may address any significant question relating to such matters.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">It shall brief the Board of Directors on issues of major strategic interest, such as&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;external growth opportunities&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;divestment opportunities&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;development priorities&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;financial and stock market strategies, and compliance with key financial ratios&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;determining the appropriate level of diversification&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;strategic alliances and major corporate actions outside the Company&#8217;s declared strategy&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;and more generally, any course of action judged essential to the Company&#8217;s future.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_103"></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">v.&#160;&#160;&#160;&#160;Scientific Committee</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Composition of the Scientific Committee</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Committee shall have at least three members, appointed by the Board from among the Directors. At least two of those members must be judged by the Appointments, Governance and CSR Committee to have scientific expertise and in-depth knowledge of issued related to R&#38;D. The Committee shall be chaired by an independent Director.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chairman of the Committee may invite Directors who are not members of the Committee &#8211; and more generally any person he or she sees fit, whether or not employed by the Company &#8211; to attend Committee meetings in order to present a dossier or provide explanations to inform the Committee&#8217;s deliberations.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Remit of the Scientific Committee</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The principal remit of the Committee shall be to assist the Board in setting strategic orientations in the field of Research and Development. It may address any significant question relating to such matters.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">More specifically, the Committee shall be responsible for&#58;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;assisting the Board in scrutinizing strategic orientations, in particular the quality and competitiveness of R&#38;D programs, and investments proposed by the Chief Executive Officer in that area&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;identifying and discussing emerging trends in science and technology, and ensuring that Sanofi is preparing for them as effectively as possible&#59;</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;obtaining assurance that processes are in place to enable optimal decision-making on investments in R&#38;D, consistent with the strategy determined by the Board&#59; and</font></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;reviewing and evaluating the quality of Sanofi&#8217;s scientific expertise, and advising the Board accordingly.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div id="ie178793b38b448e8ac8e6dc4b6e17522_106"></div><div style="margin-bottom:9pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">VII &#8211; Amendment of the Board Charter</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Charter may be amended by a Board decision approved by a majority of the Directors present or represented at that Board meeting, except that provisions of the Charter that replicate certain provisions of the Articles of Association may only be amended insofar as the corresponding provisions of the Articles of Association have been previously amended by an Extraordinary General Meeting of the Company&#8217;s Shareholders.</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">******</font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>4
<FILENAME>a2022-exhibit22.htm
<DESCRIPTION>EX-2.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8b5d4566e0e242fa966856b284687036_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 2.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF SECURITIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Introduction</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022, Sanofi (&#8220;Sanofi,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) had the following series of securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Title of Each Class</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Trading Symbol</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Name of each exchange on which registered</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">American Depositary Shares, each representing one half of one ordinary share, par value &#8364;2 per share</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">SNY</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">NASDAQ Global Select Market</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ordinary shares, par value &#8364;2 per share*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">NASDAQ Global Select Market*</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not for trading, but only in connection with the registration of American Depositary Shares representing such ordinary shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have one class of shares, which trade on Compartment A of the regulated market of Euronext Paris under the symbol SAN. American Depositary Shares (&#8220;ADSs&#8221;), each representing one-half of one ordinary share, par value &#8364;2 per share of Sanofi, have been available in the United States through an American Depositary Receipt (&#8220;ADR&#8221;) program established pursuant to the Second Amended and Restated Deposit Agreement between Sanofi and JPMorgan Chase Bank, N.A. (&#8220;JPMorgan&#8221;), as amended by Amendment No. 1 dated July 23, 2020 (&#8220;Amendment No. 1&#8221;), and as may be further amended from time to time (together, the &#8220;deposit agreement&#8221;). Our ADSs trade on the NASDAQ Global Select Market, or NASDAQ under the symbol SNY and are evidenced by American Depositary Receipts, or ADRs, which are issued by JPMorgan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This exhibit contains a description of the rights of (i) the holders of ordinary shares and (ii) ADS holders. Shares underlying the ADSs are held by JPMorgan, the depositary, and holders of ADSs will not be treated as holders of the shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following summaries are not intended to be exhaustive and, in the case of our ordinary shares, such summary is subject to, and qualified in its entirety by, Sanofi&#8217;s Articles of Association (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">statuts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), an English translation of which has been filed as an exhibit to Sanofi&#8217;s annual report on Form 20-F for which this exhibit is provided and by French law and in the case of our ADSs, such summary is subject to, and qualified in its entirety by the terms of the deposit agreement. Such summaries do not address all of the provisions of the Articles of Association or French law or of the deposit agreement, and do not purport to be complete. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized terms not otherwise defined in this exhibit have the meanings given to them in Sanofi&#8217;s annual report on Form 20-F for which this exhibit is provided.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ORDINARY SHARES</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The description below reflects certain terms of our Articles of Association, and summarizes the material rights of holders of our ordinary shares under French law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Share capital </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2022, our share capital amounted to &#8364;2,521,671,464, divided into 1,260,835,732&#160;outstanding shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with a par value of &#8364;2&#160;per share. All of our outstanding shares are of the same class and are fully paid. Of these shares, we or entities controlled by us held&#160;8,195,266 shares (or&#160;0.65% of our outstanding share capital), as treasury shares as of such date. As of December&#160;31, 2022, the carrying amount of such shares was &#8364;692&#160;million.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At a combined general meeting held on April&#160;30, 2021, our shareholders authorized our Board of Directors to increase our share capital, through the issuance of shares or other securities giving access to the share capital with or without preemptive rights, by an aggregate maximum nominal amount of &#8364;997&#160;million. See &#8220;&#8212;&#160;Ordinary Shares&#8212;&#160;Changes in Share Capital in 2022 &#8212;&#160;Increases in Share Capital&#8221;, below.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The maximum total number of authorized but unissued shares as of December&#160;31, 2022 was 130.96&#160;million, reflecting the unused part of the April&#160;30, 2021 shareholder authorizations to issue shares without preemptive rights, outstanding options to subscribe for shares, and awards of&#160;shares. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock options </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Types of stock options</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have two types of stock options outstanding&#58; options to subscribe for shares </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(options de souscription d&#8217;actions)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and options to purchase shares </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(options d&#8217;achat d&#8217;actions)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Upon exercise of an option to subscribe for shares, we issue new shares, whereas upon exercise of an option to purchase shares, the option holder receives existing shares. We purchase our shares on the market prior to the vesting of the options to purchase in order to provide the option holder with shares upon&#160;exercise.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Because the exercise of options to purchase shares will be satisfied with existing shares repurchased on the market or held in treasury, the exercise of options to purchase shares has no impact on the amount of our share&#160;capital.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Stock option plans </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our combined general meeting held on April&#160;30, 2019 authorized our Board of Directors for a period of 38&#160;months, i.e. effective until&#160;July&#160;30, 2022, to grant, on one or more occasions, options to subscribe for shares and options to purchase shares in favor of persons to be chosen by the Board of Directors from among the salaried employees and corporate officers of our Company or of companies or groupings of economic interest of the Group in accordance with Article&#160;L.&#160;225-180 of the French Commercial&#160;Code. The shareholders have not reviewed this authorization.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The aggregate number of options to subscribe for shares and options to purchase shares that may be granted under this authorization may not give entitlement to a total number of shares exceeding 0.5% of the share capital as of the date of the decision by the Board of Directors to grant such&#160;options.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Board of Directors sets the exercise price of options to subscribe for shares and options to purchase shares. However, the exercise price never incorporates a discount and must be at least equal (i)&#160;in the case of a grant of options to subscribe for shares, to the average of the quoted market prices of Sanofi's shares on the 20&#160;trading sessions preceding the date of grant by the Board of&#160;Directors and (ii)&#160;in the case of a grant of options to purchase shares, either (a)&#160;the price indicated in (i) or (b)&#160;the average purchase price of shares held by Sanofi under Articles&#160;L.&#160;225-208 and L.&#160;22-10-62 of the French Commercial Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option plans generally provide for a lock-up period of four years and have a duration of ten&#160;years.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under such authorization the shareholders expressly waived, in favor of the grantees of options to subscribe for shares, their preemptive rights in respect of shares that are to be issued as and when options are exercised.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Board of Directors was granted full power to implement this authorization and to set the terms and conditions on which options were granted and the arrangements with respect to the dividend entitlement of the&#160;shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With effect from June&#160;2019, the Chief Executive Officer can only be awarded performance shares. As a result, in 2022 the Board of Directors did not grant any stock-options.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See &#8220;Item&#160;6. Directors, Senior Management and Employees &#8212;&#160;E.&#160;Share Ownership&#8221; for a description of our option plans currently in force and &#8220;Item&#160;6. Directors, Senior Management and Employees &#8212;&#160;D.&#160;Employees&#8221; for a description of profit-sharing schemes.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards of shares</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our combined general meeting held on April&#160;30, 2021 authorized our Board of Directors for a period of 38&#160;months to allot, on one or more occasions, existing or new restricted shares in favor of persons to be chosen by the Board of Directors from among the salaried employees and corporate officers of our Company or of companies or economic interest groupings of the Group in accordance with Articles&#160;L.&#160;225-197-1 et seq. of the French Commercial&#160;Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The existing or new shares allotted under this authorization may not represent more than 1.5% of our share capital as of the date of the decision by the Board of Directors to allot such&#160;shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The authorization provides that allotment of shares to the allottees will become irrevocable at the end of a minimum vesting period of three years.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the case of newly issued shares, the authorization entails the express waiver by the shareholders, in favor of the allottees of restricted shares, of their preemptive rights in respect of shares that are to be issued as and when restricted shares&#160;vest.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Board of Directors sets the terms on which restricted shares are granted and the arrangements with respect to the dividend entitlement of the&#160;shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See &#8220;Item&#160;6. Directors, Senior Management and Employees &#8212;&#160;E.&#160;Share Ownership&#8221; for a description of our restricted shares plans currently in force.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rights, preferences and restrictions attaching to ordinary shares </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Dividends</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We may only distribute dividends out of our &#8220;distributable profits,&#8221; plus any amounts held in our reserves that the shareholders decide to make available for distribution, other than those reserves that are specifically required bylaw or our Articles of Association. &#8220;Distributable profits&#8221; consist of our unconsolidated net profit in each fiscal year, as increased or reduced by any profit or loss carried forward from prior years, less any contributions to the reserve accounts pursuant to law or our Articles of Association.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Legal reserve</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The French Commercial Code requires us to allocate 5% of our unconsolidated net profit for each year to our legal reserve fund before dividends may be paid with respect to that year. Funds must be allocated until the amount in the legal reserve is equal to 10% of the aggregate par value of the issued and outstanding share capital. This restriction on the payment of dividends also applies to each of our French subsidiaries on an unconsolidated basis. At December&#160;31, 2022, our legal reserve amounted to &#8364;282,280,863.40, representing&#160;11.19% of the aggregate par value of our issued and outstanding share capital as of that date. The legal reserve of any company subject to this requirement may serve to allocate losses that may not be allocated to other reserves, or may be distributed to shareholders upon liquidation of the&#160;company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Approval of dividends</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">According to the French Commercial Code, our Board of Directors may propose a dividend for approval by shareholders at the annual general shareholders&#8217; meeting. If we have earned distributable profits since the end of the preceding fiscal year, as reflected in an interim income statement certified by our independent auditors, our Board of Directors may distribute interim dividends to the extent of the distributable profits for the period covered by the interim income statement. Our Board of Directors exercises this authority subject to French law and regulations and may do so without obtaining shareholder approval.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Distribution of dividends</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends are distributed to shareholders pro rata according to their respective holdings of shares. In the case of interim dividends, distributions are made to shareholders on the date set by our Board of Directors during the meeting in which the distribution of interim dividends is approved. The actual dividend payment date is decided by the shareholders at an ordinary general shareholders&#8217; meeting or by our Board of Directors in the absence of such a decision by the shareholders. Shareholders that own shares on the actual payment date are entitled to the dividend.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends may be paid in cash or, if the shareholders&#8217; meeting so decides, in kind, provided that all shareholders receive a whole number of assets of the same nature paid in lieu of cash. Our Articles of Association provide that a decision of the shareholders&#8217; meeting taken by ordinary resolution may give each shareholder the option to receive payment of their dividend in cash, in shares, or in kind by delivery of assets including financial securities with or without an option to receive cash. In the case of a dividend payment resulting in the payment of a right that is a fraction of a given unit of measurement, the shareholders&#8217; meeting may decide that the shareholder will not receive any such fraction of a unit and will instead receive the next lowest whole number of such unit plus a cash payment for the balance.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Timing of payment</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">According to the French Commercial Code, we must pay any existing dividends within nine months of the end of our fiscal year, unless otherwise authorized by court order. Dividends on shares that are not claimed within five years of the date of declared payment revert to the French State.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Voting rights </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In general, each shareholder is entitled to one vote per share at any shareholders&#8217; general meeting. Our Articles of Association do not provide for cumulative voting rights. However, our Articles of Association provide that any fully paid-up shares that have been held in registered form under the name of the same shareholder for at least two years acquire double voting rights. The double voting rights cease automatically for any share converted into bearer form or transferred from one owner to another, subject to certain exceptions permitted by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022, there were 157,662,985 shares that were entitled to double voting rights, representing 12,5% of our total share capital, and approximately 11,18&#160;% of the voting rights which can be cast at our shareholders&#8217; general meeting as of that date. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Double voting rights are not taken into account in determining whether a quorum exists.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the French Commercial Code, treasury shares or shares held by entities controlled by that company are not entitled to voting rights and do not count for quorum purposes.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our Articles of Association allow us to obtain from Euroclear France the name, nationality, address and number of shares held by holders of our securities that have, or may in the future have, voting rights. If we have reason to believe that a person on any list provided by Euroclear France holds securities on behalf of another person, our Articles of Association allow us to request information regarding beneficial ownership directly from such person. See &#8220;&#8212; Ordinary Shares &#8212; Form, Holding and Transfer of Shares&#8221;, below.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our Articles of Association provide that Board members are elected on a rolling basis for a maximum tenure of four years.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Shareholders&#8217; agreement </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are not aware of any shareholder&#8217;s agreement currently in force concerning our&#160;shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Liquidation rights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If we are liquidated, any assets remaining after payment of our debts, liquidation expenses and all of our remaining obligations will first be distributed to repay in full the par value of our shares. Any surplus will be distributed pro rata among shareholders in proportion to the par value of their shareholdings.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sinking fund provisions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our Articles of Association do not provide for any sinking fund provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Redemption of shares</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under French law, our Board of Directors is entitled to redeem a set number of shares as authorized by the extraordinary shareholders&#8217; meeting. In the case of such an authorization, the shares redeemed must be cancelled within one month after the end of the offer to purchase such shares from shareholders. However, shares redeemed on the open market do not need to be cancelled if the company redeeming the shares grants options on or awards those shares to its employees within one year following the acquisition. See also &#8220;&#8212; Trading in Our Own Shares&#8221; below.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Liability for further capital calls</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders are liable for corporate liabilities only up to the par value of the shares they hold&#59; they are not liable for further capital calls.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Requirements for holdings exceeding certain percentages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The French Commercial Code and AMF regulations provide that any individual or entity, acting alone or in concert with others, that becomes the owner, directly or indirectly, of more than 5%, 10%, 15%, 20%, 25%, 30%, 331&#47;3%, 50%, 662&#47;3%, 90% or 95% of the outstanding shares or voting rights of a listed company in France, such as our Company, or that increases or decreases its shareholding or voting rights above or below any of those percentages, must notify the company, before the end of the fourth trading day following the date it crosses the threshold, of the number of shares it holds and their voting rights. The individual or entity must also notify the AMF before the end of the fourth trading day following the date it crosses any such threshold. The AMF makes the notice public.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to the French Commercial Code and the AMF General Regulation, the participation thresholds shall be calculated on the basis of the shares and voting rights owned, and shall take into account the shares and voting rights which are deemed to be shares and voting rights owned, even if the individual or entity does not itself hold shares or voting rights. In accordance with this deemed ownership principle, the individual or entity must take into account specific situations where shares and voting rights are deemed to be shares and voting rights owned when calculating the number of shares owned to be disclosed in the notifications to the Company and to the AMF. It includes among others situations where an individual or entity is entitled to acquire issued shares at its own initiative, immediately or at the end of a maturity period, under an agreement or a financial instrument, without set-off against the number of shares that this individual or entity is entitled to sell under another agreement or financial instrument. The individual or entity required to make such notification shall also take into account issued shares covered by an agreement or cash-settled financial instrument and having an economic effect for said individual or entity that is equivalent to owning such shares. In the cases of deemed ownership described above, the notification shall mention the type of deemed ownership and include a description of the main characteristics of the financial instrument or agreement with specific details required by the AMF General Regulation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The AMF General Regulation provides that shares and voting rights subject to multiple cases of deemed ownership shall only be counted&#160;once.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">When an individual or entity modifies the allocation between the shares it owns and its financial instruments or agreements deemed to be owned shares, it must disclose that change in a new notification. However, the change must only be disclosed if the acquisition of owned shares due to the settlement of the financial instruments or agreements causes the investor to cross a&#160;threshold.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to certain limited exceptions, French law and AMF regulations impose additional reporting requirements on persons who acquire more than 10%, 15%, 20%, or 25% of the outstanding shares or voting rights of a company listed in France. These persons must file&#160;a report with the company and the AMF before the end of the fifth trading day following the date they cross any such&#160;threshold.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the report, the acquirer will have to specify its intentions for the following six months including&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">whether it acts alone or in concert with others&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the means of financing of the acquisition (the notifying party shall indicate in particular whether the acquisition is being financed with equity or debt, the main features of that debt, and, where applicable, the main guarantees given or received by the notifying party. The notifying party shall also indicate what portion of its holding, if any, it obtained through securities loans)&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">whether or not it intends to continue its purchases&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">whether or not it intends to acquire control of the company in question&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the strategy it contemplates vis-&#224;-vis the issuer&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the way it intends to implement its strategy, including&#58; (i)&#160;any plans for a merger, reorganization, liquidation, or partial transfer of a substantial part of the assets of the issuer or of any other entity it controls within the meaning of Article&#160;L.&#160;233-3 of the French Commercial Code, (ii)&#160;any plans to modify the business of the issuer, (iii)&#160;any plans to modify articles of association of the issuer, (iv)&#160;any plans to delist a category of the issuer&#8217;s financial instruments, and (v)&#160;any plans to issue the issuer&#8217;s financial instruments&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any agreement for the temporary transfer of shares or voting rights of the issuer&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the way it intends to settle its agreements or instruments on the shares or voting rights of the issuer mentioned in Article&#160;L.&#160;233-9,&#160;para. 4&#160;and para. 4&#160;bis of the French Commercial Code&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">whether it seeks representation on the Board of Directors.</font></div><div style="padding-left:11.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The AMF makes the report public. Upon any change of intention within the six-month period following the filing of the report, it will have to file&#160;a new report for the following six-month period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In order to enable shareholders to give the required notice, we must each month publish on our website and send the AMF a written notice setting forth the total number of our shares and voting rights (including treasury shares) whenever they vary from the figures previously published.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If any shareholder fails to comply with an applicable legal notification requirement, the shares in excess of the relevant threshold will be deprived of voting rights for all shareholders&#8217; meetings until the end of a two-year period following the date on which the owner complies with the notification requirements. In addition, any shareholder who fails to comply with these requirements may have all or part of its voting rights suspended for up to five years by the Commercial Court at the request of our Chairman, any shareholder or the AMF, and may be subject to criminal&#160;fines.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under AMF regulations, and subject to limited exemptions granted by the AMF, any person or entity, acting alone or in concert, that crosses the threshold of 30% of the share capital or voting rights of a French listed company must initiate a public tender offer for the balance of the shares and securities giving access to the share capital or voting rights of such company. Cash-settled derivative instruments or agreements mentioned in Article&#160;L.&#160;233-9, 4&#176;&#160;bis of the French Commercial Code are not included in the calculation of the number of shares related to the mandatory public tender&#160;offer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, our Articles of Association provide that any person or entity, acting alone or in concert with others, who becomes the owner of 1%, or any multiple of 1% of our share capital or our voting rights, even beyond the minimum declaration limits permitted by the legal and regulatory provisions, must notify us by certified mail, return receipt requested, within five trading days, of the total number of shares and securities giving access to our share capital and voting rights that such person then owns. The same provisions of our Articles of Association apply whenever such owner increases or decreases its ownership of our share capital or our voting rights to such extent that it goes above or below one of the thresholds described in the preceding sentence. Any person or entity that fails to comply with such notification requirement will, upon the request of one or more shareholders holding at least 5% of our share capital or of our voting rights made at the general shareholders&#8217; meeting, be deprived of voting rights with respect to the shares in excess of the relevant threshold for all shareholders&#8217; meetings until the end of a two-year period following the date on which such person or entity complies with the notification requirements.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; meetings</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">General</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In accordance with the provisions of the French Commercial Code, there are three types of shareholders&#8217; meetings&#58; ordinary, extraordinary and&#160;special.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary general meetings of shareholders are required for matters such as&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">electing, replacing and removing Directors&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">appointing independent auditors&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">approving the annual financial statements&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">declaring dividends or authorizing dividends to be paid in shares, provided the Articles of Association contain a provision to that effect&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">approving share repurchase programs.</font></div><div style="padding-left:11.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extraordinary general meetings of shareholders are required for approval of matters such as amendments to our Articles of Association, including any amendment required in connection with extraordinary corporate actions. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extraordinary corporate actions include&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">changing our Company&#8217;s name or corporate purpose&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">increasing or decreasing our share capital&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">creating a new class of equity securities&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">authorizing the issuance of&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.44pt">shares giving access to our share capital or giving the right to receive debt instruments, or</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.44pt">other securities giving access to our share capital&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">establishing any other rights to equity securities&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">selling or transferring substantially all of our assets&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the voluntary liquidation of our Company.</font></div><div style="padding-left:11.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special meetings of shareholders of a certain category of shares or shares with certain specific rights (such as shares with double voting rights) are required for any modification of the rights derived from that category of shares. The resolutions of the shareholders&#8217; general meeting affecting these rights are effective only after approval by the relevant special meeting.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Annual ordinary meetings</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The French Commercial Code requires the Board of Directors to convene an annual ordinary general shareholders&#8217; meeting to approve the annual financial statements. This meeting must be held within six months of the end of each fiscal year. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Board of Directors may also convene an ordinary or extraordinary general shareholders&#8217; meeting upon proper notice at any time during the year. If the Board of Directors fails to convene a shareholders&#8217; meeting, our independent auditors may call the meeting. In case of bankruptcy, the liquidator or court-appointed agent may also call a shareholders&#8217; meeting in some instances. In addition, any of the following may request the court to appoint an agent for the purpose of calling a shareholders&#8217; meeting&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">one or several shareholders holding at least 5% of our share capital&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">duly qualified associations of shareholders who have held their shares in registered form for at least two years and who together hold at least 1% of our voting rights&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the works council in cases of urgency&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any interested party in cases of urgency.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under our Articles of Association, the Board of Directors may take decisions by written consultation under the conditions permitted by law and as specified in the Board Charter (an English language version of which is reproduced in full as Exhibit&#160;1.2 to the annual report on Form&#160;20-F for which this exhibit is provided), including the possibility to convene an ordinary or extraordinary general meeting,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Notice of shareholders&#8217; meetings</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All prior notice periods provided for below are minimum periods required by French law and cannot be shortened, except in case of a public tender offer for our&#160;shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We must announce general meetings at least thirty-five days in advance by means of a preliminary notice </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(avis de r&#233;union)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, which is published in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Bulletin des Annonces L&#233;gales Obligatoires</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BALO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The preliminary notice must first be sent to the French Financial markets authority (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Autorit&#233; des march&#233;s financiers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, the &#8220;AMF&#8221;), with an indication of the date on which it will be published in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BALO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. It must be published on our website at least twenty-one days prior to the general meeting. The preliminary notice must contain, among other things, the agenda, a draft of the resolutions to be submitted to the shareholders for consideration at the general meeting and a detailed description of the voting procedures (proxy voting, electronic voting or voting by mail), the procedures permitting shareholders to submit additional resolutions or items to the agenda and to ask written </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">questions to the Board of Directors. The AMF also recommends that, prior to or simultaneously with the publication of the preliminary notice, we publish a summary of the notice indicating the date, time and place of the meeting in a newspaper of national circulation in France and on our&#160;website.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At least fifteen days prior to the date set for a first convening, and at least ten days prior to any second convening, we must send a final notice </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(avis de convocation)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> containing the final agenda, the date, time and place of the meeting and other information related to the meeting. Such final notice must be sent by mail to all registered shareholders who have held shares in registered form for more than one month prior to the date of the final notice and by registered mail, if shareholders have asked for it and paid the corresponding charges. The final notice must also be published in a newspaper authorized to publish legal announcements in the local administrative department </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(d&#233;partement)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> in which our Company is registered as well as in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BALO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, with prior notice having been given to the AMF for informational purposes. Even if there are no proposals for new resolutions or items to be submitted to the shareholders at the meeting, we must publish a final notice in a newspaper authorized to publish legal announcements in the local administrative department </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(d&#233;partement)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> in which our Company is registered as well as in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BALO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other issues</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In general, shareholders can only take action at shareholders&#8217; meetings on matters listed on the agenda. As an exception to this rule, shareholders may take action with respect to the appointment and dismissal of directors even if this action has not been included on the&#160;agenda.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional resolutions to be submitted for approval by the shareholders at the shareholders&#8217; meeting may be proposed to the Board of Directors, for recommendation to the shareholders at any time from the publication of the preliminary notice in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BALO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> until twenty-five days prior to the general meeting and in any case no later than twenty days following the publication of the preliminary notice in the&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BALO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;by&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">one or several shareholders together holding a specified percentage of shares&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">a duly qualified association of shareholders who have held their shares in registered form for at least two years and who together hold at least 1% of our voting rights&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the works council.</font></div><div style="padding-left:11.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within the same period, the shareholders may also propose additional items (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">points</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) to be submitted and discussed during the shareholders&#8217; meeting, without a shareholders&#8217; vote. The shareholders must substantiate the reasons for their proposals of additional items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The resolutions and the list of items added to the agenda of the shareholders&#8217; meeting must be promptly published on our&#160;website.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Board of Directors must submit the resolutions to a vote of the shareholders after having made a recommendation thereon. The Board of Directors may also comment on the items that are submitted to the shareholders&#8217; meeting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Following the date on which documents must be made available to the shareholders (including documents to be submitted to the shareholders&#8217; meeting and resolutions proposed by the Board of Directors, which must be published on our website at least twenty-one days prior to the general meeting), shareholders may submit written questions to the Board of Directors relating to the agenda for the meeting until the fourth business day prior to the general meeting. The Board of Directors must respond to these questions during the meeting or may refer to a Q&#38;A section located on our website in which the question submitted by a shareholder has already been&#160;answered.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Attendance at shareholders&#8217; meetings&#59; proxies and votes by mail</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In general, all shareholders may participate in general meetings either in person or by proxy. Shareholders may vote in person, by proxy or by&#160;mail.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The right of shareholders to participate in general meetings is subject to the recording </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(inscription en compte)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> of their shares on the second business day, 12&#58;00&#160;a.m. (Paris time), preceding the general meeting&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">for holders of registered shares&#58; in the registered shareholder account held by the Company or on its behalf by an agent appointed by&#160;it&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">for holders of bearer shares&#58; in the bearer shareholder account held by the accredited financial intermediary with whom such holders have deposited their shares&#59; such financial intermediaries shall deliver to holders of bearer shares a shareholding certificate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(attestation de participation)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> enabling them to participate in the general meeting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Attendance in person</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any shareholder may attend ordinary general meetings and extraordinary general meetings and exercise its voting rights subject to the conditions specified in the French Commercial Code, the French Civil Code and our Articles of&#160;Association.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An attendance sheet and written minutes are established for each shareholders' meeting&#59; failure to do so could lead to cancellation of the decisions at the shareholders' meeting.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Proxies and votes by mail</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proxies are sent to any shareholder upon a request received between the publication of the final notice of meeting and six days before the general meeting and must be made available on our website at least twenty-one days before the general meeting. In order to be counted, such proxies must be received at our registered office, or at any other address indicated on the notice of the meeting or by any electronic mail indicated on the notice of the meeting, prior to the date of the meeting (in&#160;practice, we request that shareholders return proxies at least three business days prior to the meeting&#59; electronic proxies must be returned before 3&#160;p.m. Paris time, on the day prior to the general meeting). A shareholder may grant proxies to any natural person or legal entity. The agent may be required to disclose certain information to the shareholder or to the&#160;public.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A proxy is only valid for one meeting (or by way of exception for two meetings, one being ordinary and the other extraordinary, held on the same day or within a single 15-day period)&#59; it remains valid in the event such meeting is convened multiple times for the same agenda, and may be revoked by written statement of the shareholder granting the proxy.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternatively, the shareholder may send us a blank proxy without nominating any representative. In this case, the chairman of the meeting will vote the blank proxies in favor of all resolutions proposed or approved by the Board of Directors and against all&#160;others.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With respect to votes by mail, we must send shareholders a voting form upon request or must make available a voting form on our website at least twenty-one days before the general meeting. The completed form must be returned to us at least three days prior to the date of the shareholders&#8217; meeting. For holders of registered shares, in addition to traditional voting by mail, instructions may also be given via the&#160;internet.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quorum</font></div><div><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The French Commercial Code requires that shareholders holding in the aggregate at least 20% of the shares entitled to vote must be present in person, or vote by mail or by proxy, in order to fulfill the quorum requirement&#160;for&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">an ordinary general meeting&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">an extraordinary general meeting where the only resolutions pertain to either (a)&#160;a proposed increase in our share capital through incorporation of reserves, profits or share premium, or (b)&#160;the potential issuance of free share warrants in the event of a public tender offer for our shares (Article&#160;L.&#160;233-32 of the French Commercial Code).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For any other extraordinary general meeting the quorum requirement is at least 25% of the shares entitled to vote, held by shareholders present in person, voting by mail or by&#160;proxy.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For a special meeting of holders of a certain category of shares, the quorum requirement is one third of the shares entitled to vote in that category, held by shareholders present in person, voting by mail or by&#160;proxy.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If a quorum is not present at a meeting, the meeting is adjourned. However, only questions that were on the agenda of the adjourned meeting may be discussed and voted upon once the meeting resumes.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">When an adjourned meeting is resumed, there is no quorum requirement for meetings cited in the first paragraph of this &#8220;Quorum&#8221; section. In the case of any other reconvened extraordinary general meeting or special meeting, the quorum requirement is 20% of the shares entitled to vote (or&#160;voting shares belonging to the relevant category for special meetings of holders of shares of such specific category), held by shareholders present in person or voting by mail or by proxy. If a quorum is not met, the reconvened meeting may be adjourned for a maximum of two months with the same quorum requirement. No deliberation or action by the shareholders may take place without a&#160;quorum.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes required for shareholder action</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The affirmative vote of a simple majority of the votes cast may pass a resolution at either an ordinary general meeting or an extraordinary general meeting where the only resolution(s) pertain(s) to either (a)&#160;a proposed increase in our share capital through incorporation of reserves, profits or share premium, or (b)&#160;the potential issuance of free share warrants in the event of a public tender offer for our shares (Article&#160;L.&#160;233-32 of the French Commercial Code). At any other extraordinary general shareholders&#8217; meeting and at any special meeting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of holders of a specific category of shares, the affirmative vote of two-thirds of the votes cast by those present or those represented by proxy or voting by mail is&#160;required.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstention from voting, blank votes and null votes by those present or those represented by proxy or voting by mail are not counted as votes cast, i.e. they are not counted as votes against the resolution submitted to a shareholder vote at any of the three types of meetings.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes to shareholders&#8217; rights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under French law, the affirmative vote of two-thirds of the votes cast at an extraordinary shareholders&#8217; meeting is required to change our Articles of Association, which set out the rights attached to our shares, except for capital increases through incorporation of reserves, profits or share premium, or through the issuance of free share warrants in the event of a public tender offer for our shares (Article L. 233-32 of the French Commercial Code).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The rights of a class of shareholders can be amended only after a special meeting of the class of shareholders affected has taken place. The voting requirements applicable to this type of special meeting are the same as those applicable to an extraordinary general shareholders&#8217; meeting. The quorum requirements for a special meeting are one-third of the voting shares, or 20% upon resumption of an adjourned meeting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A unanimous shareholders&#8217; vote is required to increase the liabilities of shareholders.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial statements and other communications with shareholders</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In connection with any shareholders&#8217; meeting, we must provide a set of documents which includes our annual&#160;report on Form 20-F for which this exhibit is provided.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We must also provide on our website at least twenty-one days before a shareholders&#8217; meeting certain information and a set of documents that includes the preliminary notice, the proxies and voting forms, the resolutions proposed by the Board of Directors, and the documents to be submitted to the shareholders&#8217; meeting pursuant to Articles&#160;L.&#160;225-115 and R.&#160;225-83 of the French Commercial Code, etc. The resolutions and the list of items added to the agenda of the shareholders&#8217; meeting must be promptly published on our&#160;website.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading in our own shares</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under French law, Sanofi may not issue shares to itself. However, we may, either directly or through a financial intermediary acting on our behalf, acquire up to 10% of our issued share capital within a maximum period of 18&#160;months, provided our shares are listed on a regulated market. Prior to acquiring our shares, we must publish a description of the share repurchase program </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(descriptif du programme de rachat d&#8217;actions)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We may not cancel more than 10% of our issued share capital over any 24-month period. Our repurchase of shares must not result in our Company holding, directly or through a person acting on our behalf, more than 10% of our issued share capital. We must hold any shares that we repurchase in registered form. These shares must be fully paid up. Shares repurchased by us continue to be deemed &#8220;issued&#8221; under French law but are not entitled to dividends or voting rights so long as we hold them directly or indirectly, and we may not exercise the preemptive rights attached to&#160;them.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The shareholders, at an extraordinary general shareholders meeting, may decide not to take these shares into account in determining the preemptive rights attached to the other shares. However, if the shareholders decide to take them into account, we must either sell the rights attached to the shares we hold on the market before the end of the subscription period or distribute them to the other shareholders on a pro&#160;rata&#160;basis.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On May 3, 2022, our shareholders approved a resolution authorizing us to repurchase up to 10% of our shares over an 18-month period. Under this authorization, the purchase price for each Sanofi ordinary share may not be</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">greater than &#8364;150.00 and the maximum amount that Sanofi may pay for the repurchases is &#8364;18&#160;953&#160;410&#160;350&#160;. This authorization cancelled and replaced the authorization granted to the Board of Directors by the combined general meeting held on April&#160;30, 2021. A description of this share repurchase program as adopted by the ordinary general meeting held on May 3, 2022 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(descriptif du programme de rachat d&#8217;actions)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> was published on February 23, 2022. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purposes of share repurchase programs</font></div><div><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Regulation&#160;596&#47;2014 of the European Parliament and of the Counsel, dated April&#160;16, 2014 on market abuse and its Delegated Regulation 2016&#47;1052 on repurchase programs and stabilization measures, dated March&#160;8, 2016 (which we refer to in this section as the &#8220;Regulation&#8221;), an issuer will benefit from a safe harbor for share transactions that comply with certain conditions relating in particular to the pricing, volume and timing of transactions (see&#160;below) and that are made in connection with a share repurchase program authorized by the shareholders the purpose of which&#160;is&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to reduce the share capital through the cancellation of treasury shares&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to meet obligations arising from debt financial instruments that are exchangeable into equity instruments&#59; and&#47;or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to meet obligations arising from share option programs or other allocations of shares to employees or to members of the administrative, management or supervisory bodies of the issuer or of an associate company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Safe harbor transactions will by definition not be considered market abuses under the Regulation. Transactions that are carried out for other purposes than those mentioned above do not qualify for the safe harbor.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">However, as permitted by the Regulation, which provides for a presumption of legitimacy for existing market practices that do not constitute market manipulation and that conform with certain criteria, the AMF has established as a French accepted market practice, which therefore benefits from a presumption of legitimacy, the use of liquidity agreements for share purchases that are entered into with a financial services intermediary and that comply with the criteria set out by the AMF.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The AMF confirmed that all transactions directed at maintaining the liquidity of an issuer&#8217;s shares must be conducted pursuant to a liquidity agreement with a financial services intermediary acting independently.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of July&#160;3, 2016, the purchase of shares that are subsequently used as acquisition currency in a business combination transaction, which the AMF previously permitted as an accepted market practice, is no longer considered as such, although such practice, while not benefiting from the presumption of legitimacy, is not prohibited under the Regulation.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pricing, volume and other restrictions</font></div><div><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In order to qualify for the safe harbor described above, the issuer must generally comply with the following pricing and volume restrictions&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">a share purchase must not be made at a price higher than the higher of the price of the last independent trade and the highest current independent bid on the trading venues where the purchase is carried out&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">subject to certain exceptions for illiquid securities, the issuer must not purchase on any trading day more than 25% of the average daily volume of the shares on the regulated market on which the purchase is carried out. The average daily volume figure must be based on the average daily volume traded in the month preceding the month of public disclosure of the share repurchase program and fixed on that basis for the authorized period of that program. If the program does not make reference to this volume, the average daily volume figure must be based on the average daily volume traded in the 20&#160;trading days preceding the date of purchase.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, unless the issuer has in place a time-scheduled repurchase program or the repurchase program is lead-managed by an investment firm or a credit institution which makes its trading decisions concerning the timing of the purchase of the issuer&#8217;s shares independently of the issuer, the issuer must not, for the duration of the repurchase program, engage in the following activities&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">selling its own shares&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">effecting any transaction during a closed period imposed by the applicable law of the Member State in which the transaction occurs (i.e.&#160;under French law, during the period between the date on which the company has knowledge of insider information and the date on which such information is made public, during the 30&#160;calendar day period before the announcement of an interim financial report or a year-end report which the issuer is obliged to make public, and during the 15&#160;calendar day period before the publication of the quarterly results)&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">effecting any transaction in securities with respect to which the issuer has decided to delay the public disclosure of inside information, in accordance with applicable rules.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Use of share repurchase programs</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to the AMF rules, issuers must immediately allocate the repurchased shares to one of the purposes provided for in the Regulation and must not subsequently use the shares for a different purpose. As an exception to the foregoing, shares repurchased with a view to covering stock option plans may, if no longer needed for this purpose, be re-allocated for cancellation or sold in compliance with AMF requirements relating in particular to blackout periods. Shares repurchased in connection with one of the market practices authorized by the AMF (see&#160;above) may also be re-allocated to one of the purposes contemplated by the Regulation or sold in compliance with AMF requirements. Shares repurchased with a view to their cancellation must be cancelled within 24&#160;months following their acquisition.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During the year ended December&#160;31, 2022, we used the authority delegated by our shareholders to repurchase our shares on the stock&#160;market.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to our share repurchase programs authorized by our shareholders on April&#160;30, 2021 and on May 3, 2022, we repurchased 5,486,992&#160;of our shares for a weighted average price of &#8364;90.32, i.e. a total cost of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;496&#160;million. Brokerage fees, financial transaction taxes and the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMF contribution (net of income taxes) amounted to &#8364;1.40&#160;million. Our Company did not resort to derivatives to repurchase our own shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On December 14, 2022, the Board of Directors cancelled 6,742,380 treasury shares repurchased between December 2021 and January 2022 pursuant to the share repurchase program of the Company. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During 2022, we did not use a liquidity contract.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During 2022, we did not allocate any shares to stock purchase option plans. </font></div><div style="padding-left:11.35pt;text-align:justify;text-indent:-11.35pt"><font><br></font></div><div style="margin-bottom:5pt;padding-left:11.35pt;text-align:justify;text-indent:-11.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In 2022, in addition to the 8,252,573 shares allocated to performance share plans outstanding at December&#160;31, 2021, Sanofi&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">purchased 1,510,000 of its shares at an average weighted price of &#8364;90.62 for a total amount of &#8364;136,836,345&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">transferred 1,566,038&#160; of its shares to beneficiaries of performance shares at an average weighted price of &#8364;83.09 for a total amount of 130&#160;125&#160;141&#160;.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2022, the 8,195,266&#160;treasury shares held under our share repurchase program were allocated to covering performance share plans.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2022, all the shares created under the Action 2022 employee share ownership plan were allocated to employees.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In 2022, Sanofi purchased </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,976,992</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shares at an average weighted price of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;90.21 </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for a total amount of &#8364;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358,753,199</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, which were allocated to a cancellation objective.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, no shares were held to cover stock option plans or for liquidity purposes.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2022, we directly owned 8,195,266 Sanofi shares with a par value of &#8364;2&#160;representing around 0.65% of our share capital and with an estimated value of &#8364;692&#160;million, based on the share price at the time of&#160;purchase. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reporting obligations</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to the Regulation, the AMF Regulation and the French Commercial Code, issuers trading in their own shares are subject to the following reporting obligations&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">issuers must report all transactions in their own shares to the competent authority of each trading venue on which the shares are admitted to trading or are traded within seven trading days of the transaction in a prescribed format, unless such transactions are carried out pursuant to a liquidity agreement that complies with the ethical code approved by the AMF&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">issuers must declare to the AMF on a monthly basis all transactions completed under the share repurchase program unless they provide the same information on a weekly basis&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">post on its website the transactions disclosed and keep that information available to the public for at least a 5-year period from the date of public disclosure.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ownership of shares by non-French persons</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The French Commercial Code and our Articles of Association currently do not limit the right of non-residents of France or non-French persons to own or, where applicable, to vote our securities. However, pursuant to the provisions of the French Monetary and Financial Code (CMF), any investment by any non-French citizen, any French citizen not residing in France, any non-French entity or any French entity controlled by such persons or entities that will result in the relevant investor (a) acquiring control of an entity registered in France, (b) acquiring all or part of a business line of an entity registered in France, or (c) for non-EU or non-EEA investors crossing, directly or indirectly, alone or in concert, a 25% threshold of voting rights in an entity registered in France, in each case, where all or part of the target&#8217;s business and activity relate to a strategic sector, is subject to the prior authorization of the French Minister of the Economy. Under existing administrative rulings, ownership of 331&#47;3% or more of our share capital or voting rights is regarded as a controlling interest, but a lower percentage might be held to be a controlling interest in certain circumstances depending upon factors such as&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the acquiring party&#8217;s intentions&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the acquiring party&#8217;s ability to elect directors&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">financial reliance by the company on the acquiring party.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Such strategic sectors include (a)&#160;activities likely to prejudice national defense interests, participating in the exercise of official authority or likely to prejudice public order and public security (including activities related to weapons, dual-use goods and technologies, IT systems, cryptology, data capturing devices, gambling, toxic agents or data storage), (b)&#160;activities relating to essential infrastructure, goods or services (including energy, water, transportation, space, public health, telecommunications, farm products or media), (c)&#160;research and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">development activities related to critical technologies (including biotechnology, cybersecurity, artificial intelligence, robotics, additive manufacturing, semiconductors, quantum technologies, energy storage and technologies related to generation of renewable energy) or dual-use goods and technologies.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This request for prior authorization must be filed with the French Ministry of Economy, which has 30&#160;business days from receipt of the complete file to provide a first decision which may (i)&#160;unconditionally authorize the investment or (ii)&#160;indicate that further examination is required. In the latter case, the French Ministry of the Economy must make a second decision within 45&#160;business days from its first decision. In the event of a lack of response from the French Ministry of the Economy within the above mentioned timeframe, the authorization will be deemed refused. If the authorization is granted, it may be subject to the signature of a letter of undertakings aimed at protecting French national interests. If an investment requiring the prior authorization of the French Minister of the Economy is completed without such authorization having been granted, the French Minister of the Economy might direct the relevant investor to (i)&#160;submit a request for authorization, (ii)&#160;have the previous situation restored at its own expense, or (iii)&#160;amend the investment. The relevant investor might also be found criminally liable and might be sanctioned with a fine which cannot exceed the greater of&#58; (i)&#160;twice the amount of the relevant investment, (ii)&#160;10% of the annual turnover before tax of the target company and (iii)&#160;&#8364;5&#160;million (for a company) or &#8364;1&#160;million (for an individual).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the context of the ongoing COVID-19 pandemic, a decree dated July&#160;22, 2020, as amended on December 22, 2021, added a new 10% threshold with respect to investments in and ownership of voting rights of companies organized under the laws of France whose shares are admitted to trading on a regulated market, in addition to the 25% threshold mentioned above. A &#8220;fast track&#8221; procedure is available for investors whose holdings exceed the 10% threshold but are less than the 25% threshold mentioned above. Such measures remained in force until December&#160;31, 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The CMF provides for statistical reporting requirements. Transactions by which non-French residents acquire at least 10% of the share capital or voting rights, or cross the 10% threshold, of a French resident company, are considered as foreign direct investments in France and are subject to statistical reporting requirements (Articles&#160;R.&#160;152-1&#59; R.&#160;152-3 and&#160;R.&#160;152-11 of the CMF). When the investment exceeds&#160;&#8364;125,500,000, companies must declare foreign transactions directly to the Banque de France within 20&#160;business days following the date of certain direct foreign investments in us, including any purchase of ADSs. Failure to comply with such statistical reporting requirement may be sanctioned by five years&#8217; imprisonment and a fine of a maximum amount equal to twice the amount which should have been reported, in accordance with Article&#160;L.&#160;165-1 of the CMF. This amount may be increased fivefold if the violation is made by a legal entity.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in control &#47; Anti-takeover</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There are no provisions in our Articles of Association that would have the effect of delaying, deferring or preventing a change in control of our Company or that would operate only with respect to a merger, acquisition or corporate restructuring involving our Company or any of our subsidiaries. Further, there are no provisions in our Articles of Association that allow the issuance of preferred stock upon the occurrence of a takeover attempt or the addition of other &#8220;anti-takeover&#8221; measures without a shareholder vote.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our Articles of Association do not include any provisions discriminating against any existing or prospective holder of our securities as a result of such shareholder owning a substantial number of shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See above additional information in relation to foreign direct investments under &#8220;&#8212; Ownership of Shares by Non-French Persons&#8221;. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in capital in 2022</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See Note&#160;D.15.1. to&#160;our consolidated financial statements, included at Item&#160;18. of the annual&#160;report on Form 20-F for which this exhibit is provided.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Increases in share capital</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As provided for by the French Commercial Code, our share capital may be increased only with shareholders&#8217; approval at an extraordinary general shareholders&#8217; meeting following the recommendation of our Board of Directors. The shareholders may delegate to our Board of Directors either the authority (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d&#233;l&#233;gation de comp&#233;tence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) or the power (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d&#233;l&#233;gation de pouvoir</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) to carry out any increase in share capital. Our Board of Directors may further delegate this power to our Chief Executive Officer or, subject to our Chief Executive Officer&#8217;s approval, to his delegates (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">directeurs g&#233;n&#233;raux d&#233;l&#233;gu&#233;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases in our share capital may be effected by&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">issuing additional shares&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">increasing the par value of existing shares&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">creating a new class of equity securities&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">exercising the rights attached to securities giving access to the share capital.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases in share capital by issuing additional securities may be effected through one or a combination of the following&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">in consideration for cash&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">in consideration for assets contributed in kind&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">through an exchange offer&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">by conversion of previously issued debt instruments&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">by capitalization of profits, reserves or share premium&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">subject to various conditions, in satisfaction of debt incurred by our Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decisions to increase the share capital through the capitalization of reserves, profits and&#47;or share premium or through the issuance of free share warrants in the event of a public tender offer for our shares (Article L. 233-32 of the French Commercial Code) require shareholders&#8217; approval at an extraordinary general shareholders&#8217; meeting, acting under the quorum and majority requirements applicable to ordinary shareholders&#8217; meetings. Increases effected by an increase in the par value of shares require unanimous approval of the shareholders, unless effected by capitalization of reserves, profits or share premium. All other capital increases require shareholders&#8217; approval at an extraordinary general shareholders&#8217; meeting acting under the regular quorum and majority requirements for such meetings. See &#8220;&#8212; Quorum&#8221; and &#8220;&#8212; Votes Required for Shareholder Action&#8221; above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On April 30, 2021, our shareholders approved various resolutions delegating to the Board of Directors the authority to increase our share capital through the issuance of shares or securities giving access to the share capital, subject to an overall cap set at &#8364;997 million. This cap applies to all the resolutions whereby the extraordinary shareholders&#8217; meeting delegated to the Board of Directors the authority to increase the share capital, it being also specified that&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the maximum aggregate par value of capital increases that may be carried out with preemptive rights maintained was set at &#8364;997 million&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the maximum aggregate par value of capital increases that may be carried out by public offering (other than of the type specified in Article L. 411-2, 1&#176; of the French Monetary and Financial Code) without preemptive rights was set at &#8364;240 million&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the maximum aggregate par value of capital increases that may be carried out in connection with an offering of the type specified in Article L. 411-2, 1&#176; of the French Monetary and Financial Code (i.e. an offer addressed exclusively to a limited number of investors) without preemptive rights was set at &#8364;240 million&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">capital increases resulting in the issuance of securities to members of employee savings plans are limited to 1% of the share capital as computed on the date of the Board of Directors&#8217; decision to issue such securities, and such issuances may be made at a discount of 30% (or 40%) if certain French law restrictions on resales were to apply, i.e. a lock up period of five years (or 10 years).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022, the shares held by the company's current employees or by employees of affiliated companies in the Group savings programs represented 1,16% of the share capital.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At its February 2022 meeting, our Board of Directors decided to delegate to the Chief Executive Officer the powers necessary to carry out a capital increase reserved for members of the Group savings program. Every employee subscribing for at least five shares received one additional new share as an employer&#8217;s top-up contribution. Beyond the first twenty shares there was no entitlement to any further shares by way of employer&#8217;s top-up contribution (every employee subscribing for twenty shares received four additional shares as an employer&#8217;s top-up contribution). The subscription period was open during June 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During the subscription period, 32,854 employees from nearly 58 countries subscribed for a total of </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909,008</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> shares. Of these, 1 106 304 shares were subscribed via FCPE Actions Sanofi, the dedicated employee share ownership fund for employees of our French subsidiaries&#59; 387,264 shares via FCPE Sanofi Shares, the dedicated employee share ownership fund for employees of our foreign subsidiaries&#59; and </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,440</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> shares directly by employees who were eligible for the employee share ownership plan but were in countries where local regulations did not allow the use of a dedicated employee share ownership fund.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A total of </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,049</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> shares were issued by way of employer&#8217;s top-up contribution. Of these, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,105</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> were issued to FCPE Actions Sanofi&#59; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,905</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to FCPE Sanofi Shares&#59; and </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> 29 039</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> directly to employees who were eligible for the employee share ownership plan but were in countries where local regulations did not allow the use of a dedicated employee share ownership fund.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Voting rights attached to shares held by FCPE Actions Sanofi are exercised individually by the employees who hold units in the fund&#59; fractional rights are exercised by the fund&#8217;s supervisory board.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Voting rights attached to shares held by FCPE Sanofi Shares are also exercised individually by the employees who hold units in the fund&#59; any rights not exercised by them are exercised by the fund&#8217;s supervisory board.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In each case, the supervisory board includes an equal number of representatives of employees and of Sanofi management.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On April 30, 2021, our shareholders also approved resolutions delegating to the Board of Directors the authority to increase the share capital by granting existing or new restricted shares to our employees and&#47;or corporate officers, subject to the overall cap mentioned above and under the following terms and conditions&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the authorization is valid for a period of 38 months, and is subject to a limit of 1.5% of the share capital as computed on the date of the decision of the Board of Directors to allot such shares&#59; see &#8220;&#8212; Awards of Shares&#8221; above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Since June 30, 2022 i.e., the expiration of the prior delegation of power that had been authorized by the shareholders, the Board of Directors no longer has the authority to increase the Company&#8217;s share capital by granting options to our employees or corporate officers.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See also &#8220;Item 6. Directors, Senior Management and Employees &#8212; E. Share Ownership&#8221;.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Decreases in share capital</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In accordance with the provisions of the French Commercial Code, any decrease in our share capital requires approval by the shareholders entitled to vote at an extraordinary general meeting. The share capital may be reduced either by decreasing the par value of the outstanding shares or by reducing the number of outstanding shares. The number of outstanding shares may be reduced either by an exchange of shares or by the repurchase and cancellation of shares. Holders of each class of shares must be treated equally unless each affected shareholder agrees otherwise.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">merc</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, specific rules exist to permit the cancellation of treasury shares, by which the shareholders&#8217; meeting may authorize the cancellation of up to a maximum of 10% of a company&#8217;s share capital within any 24-month period. On April 30, 2021, our shareholders delegated to our Board of Directors for 26 months (i.e. until June 30, 2023) the right to reduce our share capital by cancelling our own shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On December 14, 2022, the Board of Directors cancelled 6,742,380 treasury shares repurchased between December 2021 and January 2022 pursuant to the share repurchase program of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preemptive rights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">According to the French Commercial Code, if we issue additional securities to be paid in cash, current shareholders will have preemptive rights to these securities on a pro&#160;rata basis. These preemptive rights require us to give priority treatment to current shareholders. The rights entitle the individual or entity that holds them to subscribe to the issuance of any securities that may increase the share capital of our Company by means of a cash payment or a set-off of cash debts. Preemptive rights are transferable during the subscription period relating to a particular offering. These rights may also be listed on Euronext Paris Stock Exchange.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preemptive rights with respect to any particular offering may be waived by the affirmative vote of shareholders holding two-thirds of the shares entitled to vote at an extraordinary general meeting. Our Board of Directors and our independent auditors are required by French law to present reports that specifically address any proposal to waive preemptive rights. In the event of a waiver, the issuance of securities must be completed within the period prescribed by law. Shareholders may also notify us that they wish to waive their own preemptive rights with respect to any particular offering if they so&#160;choose.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The shareholders may decide at extraordinary general meetings to give the existing shareholders a non-transferable priority right to subscribe to the new securities, for a limited period of time.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of a capital increase without preemptive rights to existing shareholders, French law requires that (i)&#160;the capital increase be made at a price determined by an extraordinary general meeting after submission of a report by the Board of Directors and (ii)&#160;the amount of a capital increase carried out each year in connection with an offering of the type specified in Article&#160;L.&#160;411-2-1 of the French Monetary and Financial Code must be limited to 20% of a company&#8217;s share capital.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form, holding and transfer of shares</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Form of shares</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our Articles of Association provide that the shares may be held in either bearer form or registered form at the option of the&#160;holder.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Holding of shares</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In accordance with French law relating to the dematerialization of securities, shareholders&#8217; ownership rights are represented by book entries instead of share certificates. We maintain a share account with Euroclear France (a&#160;French clearing system, which holds securities for its participants) for all shares in registered form, which is administered by Uptevia. In addition, we maintain separate accounts in the name of each shareholder either directly or, at a shareholder&#8217;s request, through the shareholder&#8217;s accredited intermediary. Each shareholder </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">account shows the name of the holder and the number of shares held. Uptevia issues confirmations </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(attestations d&#8217;inscription en compte)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to each registered shareholder as to shares registered in the shareholder&#8217;s account, but these confirmations are not documents of&#160;title.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of a listed company may also be issued in bearer form. Shares held in bearer form are held and registered on the shareholder&#8217;s behalf in an account maintained by an accredited financial intermediary and are credited to an account at Euroclear France maintained by such intermediary. Each accredited financial intermediary maintains a record of shares held through it and provides the account holder with a securities account statement. Transfers of shares held in bearer form may only be made through accredited financial intermediaries and Euroclear France.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares held by persons who are not domiciled in France may be registered in the name of intermediaries who act on behalf of one or more investors. When shares are so held, we are entitled to request from such intermediaries the names of the investors. Also, we may request any legal entity </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(personne morale)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> which holds more than 2.5% of our shares or voting rights to disclose the name of any person who owns, directly or indirectly, more than one-third of its share capital or of its voting rights. A person not providing the complete requested information in time, or who provides incomplete or false information, will be deprived of its voting rights at shareholders&#8217; meetings and will have its payment of dividends withheld until it has provided the requested information in strict compliance with French law. If such person acted willfully, the person may be deprived by a French court of either its voting rights or its dividends or both for a period of up to five&#160;years.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Transfer of shares</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our Articles of Association do not contain any restrictions relating to the transfer of&#160;shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registered shares must be converted into bearer form before being transferred on the Euronext Paris Stock Exchange on the shareholders&#8217; behalf and, accordingly, must be registered in an account maintained by an accredited financial intermediary on the shareholders&#8217; behalf. A shareholder may initiate a transfer by giving instructions to the relevant accredited financial intermediary.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A fee or commission is payable to the broker involved in the transaction, regardless of whether the transaction occurs within or outside France. Registration duty is currently payable in France if a written deed of sale and purchase (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">acte</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) is executed in France or outside France with respect to the shares of the&#160;Company.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Enforceability of civil liabilities</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are a limited liability company (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">soci&#233;t&#233; anonyme</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) organized under the laws of France, and most of our officers and directors reside outside the United&#160;States. In addition, a substantial portion of our assets is located outside of the United States.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a result, it may be difficult for investors&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to obtain jurisdiction over us or our non-US resident officers and directors in US&#160;courts, or obtain evidence in France or from French citizen or any individual being resident in France or any officer, representative, agent or employee of a legal person having its registered office or an establishment in a territory of France, in connection with those actions in actions predicated on the civil liability provisions of the US&#160;federal securities laws&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to enforce in US courts judgments obtained in such actions against us or our non-US resident officers and directors&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to bring an original action in a French court to enforce liabilities based upon the US federal securities laws against us or our non-US resident officers or directors&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to enforce in US courts against us or our directors in non-US courts, including French courts, judgments of US&#160;courts predicated upon the civil liability provisions of the US&#160;federal securities laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevertheless, a final judgment for the payment of money rendered by any federal or state court in the United&#160;States based on civil liability, whether or not predicated solely upon the US&#160;federal securities laws, would be recognized and enforced in France provided that a French judge considers that this judgment meets the French legal requirement concerning the recognition and the enforcement of foreign judgments and is capable of being immediately enforced in the United States. A French court is therefore likely to grant the enforcement of a foreign judgment without a review of the merits of the underlying claim, only if (1)&#160;that judgment was rendered by a court having jurisdiction over the matter as the dispute is clearly connected to the jurisdiction of such court, the choice of the US court was not fraudulent and the French courts did not have exclusive jurisdiction over the matter, (2)&#160;the judgment does not contravene international public policy rules, both pertaining to the merits and to the procedure of the case, including the defense rights, (3)&#160;the judgment is not tainted with fraud and (4)&#160;the judgment does not conflict with a French or foreign judgment (or an arbitral award) which has become effective in France.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, French law guarantees full compensation for the harm suffered but is limited to the actual damages, so the victim does not suffer or benefit from the situation, it being specified that under French law, the principle </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of awarding punitive damages is not, per se, contrary to public order, provided the amount awarded is not disproportionate to the harm suffered and the defendant&#8217;s breach.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a result, the enforcement, by US investors, of any judgments obtained in US courts in civil and commercial matters, including judgments under the US federal securities law against us or members of our Board of Directors, officers or certain experts named herein who are residents of France or countries other than the United States would be subject to the above conditions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finally, there may be doubt as to whether a French court would impose civil liability on us, the members of our Board of Directors, our officers or certain experts named herein in an original action predicated solely upon the US federal securities laws brought in a court of competent jurisdiction in France against us or such members, officers or experts, respectively.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF AMERICAN DEPOSITARY SHARES</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The description below reflects certain terms of the deposit agreement, and summarizes the material rights of holders of our ADSs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JPMorgan Chase Bank, N.A. (&#8220;JPMorgan&#8221;), as depositary, issues Sanofi ADSs in certificated form (evidenced by an ADR) or book-entry form. Each ADR is a certificate evidencing a specific number of Sanofi ADSs. Each Sanofi ADS represents one-half of one Sanofi ordinary share (or&#160;the right to receive one-half of one Sanofi ordinary share) deposited with the Paris, France office of BNP Paribas, as custodian. Each Sanofi ADS also represents an interest in any other securities, cash or other property that may be held by the depositary under Second Amended and Restated Deposit Agreement between Sanofi and JPMorgan dated February 13, 2015, as amended by Amendment No. 1 dated July 23, 2020 (&#8220;Amendment No. 1&#8221;), and as may be further amended from time to time (together, the &#8220;deposit agreement&#8221;). The depositary&#8217;s principal executive office is located at 383&#160;Madison Avenue, 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Floor, New&#160;York, New&#160;York&#160;10179. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A holder may hold Sanofi ADSs either directly or indirectly through his or her broker or other financial institution. The following description assumes holders hold their Sanofi ADSs directly, in certificated form evidenced by ADRs. Holders who hold the Sanofi ADSs indirectly must rely on the procedures of their broker or other financial institution to assert the rights of ADR holders described in this section. Holders should consult with their broker or financial institution to find out what those procedures are.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holders of Sanofi ADSs do not have the same rights as holders of Sanofi shares. French law governs shareholder rights. The rights of holders of Sanofi ADSs are set forth in the deposit agreement and in the ADR. New York law governs the deposit agreement and the ADRs. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following is a summary of certain terms of the deposit agreement, as in effect at the date of filing of this document. Our form of second amended and restated deposit agreement was filed with the SEC as an exhibit to our Post-Effective Amendment No. 1 to Form F-6 filed on February 13, 2015. The form of Amendment No. 1 was filed as an exhibit to our Post-Effective Amendment No. 2 to Form F-6 filed with the SEC on August 4, 2020. To the extent any portion of any amendments and restatement would prejudice any substantial existing right of holders of ADSs under previous versions of the first amended and restated deposit agreement, such portion shall not become effective as to such holders until 30 days after holders have received notice thereof. For more complete information, holders should read the entire second amended and restated deposit agreement, Amendment No. 1 and the ADR itself. Holders may also inspect a copy of the second amended and restated current deposit agreement, and Amendment No. 1 and the ADR itself at the depositary&#8217;s office. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deposit, withdrawal and cancellation</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Delivery of ADRs </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary will deliver ADRs if the holder or his or her broker deposit shares or evidence of rights to receive shares with the custodian. Upon payment of its fees and expenses and any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of Sanofi ADSs in the names the holder requests and will deliver the ADRs to the persons the holder requests at its office.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Obtaining Sanofi ordinary shares</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A holder may turn in his or her ADRs at the depositary&#8217;s office. Upon payment of its fees and expenses and any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will deliver (1) the underlying shares to an account designated by the holder and (2) any other deposited securities underlying the ADR at the office of a custodian or, at the holder&#8217;s request, risk and expense, the depositary will deliver the deposited securities at its office.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Voting rights </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A holder may instruct the depositary to vote the Sanofi ordinary shares underlying his or her Sanofi ADSs at any meeting of Sanofi shareholders, but only if we request that the depositary ask for holder instructions. Otherwise, holders will not be able to exercise their right to vote unless they withdraw the underlying ordinary shares from the ADR program and vote as an ordinary shareholder. However, holders may not know about the meeting sufficiently in advance to timely withdraw the underlying ordinary shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If we ask for holder instructions in connection with a meeting of Sanofi shareholders, the depositary will provide materials to holders of Sanofi ADSs in the manner described under the heading &#8220;Notices and reports&#59; rights of holders to inspect books&#8221; below. For any instructions to be valid, the depositary must receive them on or before the date specified in the materials distributed by the depositary. The depositary will endeavor, in so far as practical, subject to French law and the provisions of our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">statuts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, to vote or to have its agents vote the shares or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other deposited securities as holders may validly instruct. The depositary will only vote or attempt to vote shares as holders validly instruct.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We cannot guarantee holders that they will receive the voting materials with sufficient time to enable them to return any voting instructions to the depositary in a timely manner to vote their shares. As long as they act in good faith, neither the depositary nor its agents will be responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">This means that holders may not be able to exercise their right to vote and there may be nothing holders can do if the shares represented by their ADSs are not voted as they requested.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Similar to our shares, Sanofi ADSs evidenced by ADRs that are registered in the name of the same owner for at least two (2) years are eligible for double voting rights so long as certain procedures are followed, as set out in the deposit agreement. For additional information regarding double voting rights, see &#8220;&#8212;&#160;Ordinary Shares &#8212;&#160;Rights, preferences and restrictions attaching to ordinary shares &#8212; Voting Rights&#8221; above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The deposit agreement allows the depositary and Sanofi to change the voting procedures or require additional voting procedures in addition to the ones described above if necessary or appropriate. For example, holders might be required to arrange to have their Sanofi ADSs deposited in a blocked account for a specified period of time prior to a shareholders&#8217; meeting in order to be allowed to give voting instructions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share dividends and other distributions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Receipt of dividends and other distributions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary has agreed to pay to holders of Sanofi ADSs the cash dividends or other distributions that it or the custodian receives on the deposited Sanofi ordinary shares and other deposited securities after deducting its fees, charges and expenses and taxes withheld. Holders of Sanofi ADSs will receive these distributions in proportion to the number of Sanofi ADSs that they&#160;hold. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Distribution of cash</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary will convert any cash dividend or other cash distribution paid on the shares into US&#160;dollars if, in its judgment, it can do so on a reasonable basis and can transfer the US&#160;dollars to the United&#160;States. If the depositary determines that such a conversion and transfer is not possible, or if any approval from the French government is needed and cannot be obtained within a reasonable period, then the depositary may (1)&#160;distribute the foreign currency received by it to the holders of Sanofi ADSs or (2)&#160;hold the foreign currency distribution (uninvested and without liability for any interest) for the account of holders of Sanofi&#160;ADSs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, if any conversion of foreign currency, in whole or in part, cannot be effected to some holders of Sanofi ADSs, the deposit agreement allows the depositary to distribute the dividends only to those ADR holders to whom it is possible to do so. It will hold the foreign currency it cannot convert into US&#160;dollars for the account of the ADR holders who have not been paid. It will not invest the funds it holds and it will not be liable for any&#160;interest.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Before making a distribution, any withholding taxes that must be paid under French law will be deducted. The depositary will distribute only whole US&#160;dollars and cents and will round fractional cents down to the nearest whole cent. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Exchange rate fluctuations during a period when the depositary cannot convert euros into US&#160;dollars may result in holders losing some or all of the value of a&#160;distribution.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Distribution of shares</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary may, and at our request will, distribute new ADRs representing any shares we distribute as a dividend or free distribution, if we furnish it promptly with satisfactory evidence that it is legal to do so. At its option, the depositary may distribute fractional Sanofi ADSs. If the depositary does not distribute additional Sanofi ADSs, the outstanding ADRs will also represent the new shares. The depositary may withhold any tax or other governmental charges, or require the payment of any required fees and expenses, prior to making any distribution of additional Sanofi&#160;ADSs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rights to receive additional shares</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If we offer holders of Sanofi ordinary shares any rights to subscribe for additional shares or any other rights, the depositary, after consultation with us, will, in its discretion, either (1)&#160;make these rights available to holders or (2)&#160;dispose of such rights on behalf of ADR holders and make the net proceeds available to holders. The depositary may make rights available to certain holders but not others if it determines it is lawful and feasible to do so. However, if, under the terms of the offering or for any other reason, the depositary may not make such rights available or dispose of such rights and make the net proceeds available, it will allow the rights to lapse. In that case, holders of Sanofi ADSs will receive no value for&#160;them.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In circumstances where rights would not otherwise be distributed by the depositary to holders of Sanofi ADSs, a holder of Sanofi ADSs may nonetheless request, and will receive from the depositary, any instruments or other documents necessary to exercise the rights allocable to that holder if the depositary first receives written notice from Sanofi that (1)&#160;Sanofi has elected, in its sole discretion, to permit the rights to be exercised and (2)&#160;such holder has executed the documents Sanofi has determined, in its sole discretion, are reasonably required under applicable&#160;law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the depositary makes rights available to holders of Sanofi ADSs, upon instruction from such holders, it will exercise the rights and purchase the shares on such holder&#8217;s behalf. The depositary will then deposit the shares and deliver ADRs to such holders. It will only exercise rights if holders of Sanofi ADSs pay it the exercise price and any other charges the rights require such holders to&#160;pay.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US&#160;securities laws may restrict the sale, deposit, cancellation or transfer of ADRs issued upon exercise of rights. For example, holders of Sanofi ADSs may not be able to trade such Sanofi ADSs freely in the United&#160;States. In this case, the depositary may deliver Sanofi ADSs under a separate restricted deposit agreement that will contain the same provisions as the deposit agreement, except for changes needed to implement the required restrictions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other distributions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary will distribute to holders of Sanofi ADSs anything else we may distribute on deposited securities (after deduction or upon payment of fees and expenses or any taxes or other governmental charges) by any means it thinks is legal, equitable and practical. If, for any reason, it cannot make the distribution in that way, the depositary may sell what we distributed and distribute the net proceeds of the sale in the same way it distributes cash dividends, or it may choose any other method to distribute the property it deems equitable and practicable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any holders of Sanofi ADSs. We have no obligation to register Sanofi ADSs, shares, rights or other securities under the US&#160;Securities Act of 1933, as amended. We also have no obligation to take any other action to permit the distribution of ADRs, shares, rights or anything else to holders of Sanofi ADSs. This means that holders may not receive the distribution we make on our shares or any value for them if it is illegal or impractical for the depositary to make them available to such&#160;holders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Elective distributions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whenever we intend to distribute a dividend payable at the election of shareholders either in cash or in additional shares, we will give prior notice thereof to the depositary and will indicate whether we wish the elective distribution to be made available to holders of Sanofi ADSs. In that case, we will assist the depositary in determining whether that distribution is lawful and reasonably practicable. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary will make the election available to holders of Sanofi ADSs only if it is reasonably practicable and if we have provided all the documentation contemplated in the deposit agreement. In that case, the depositary will establish procedures to enable holders of Sanofi ADSs to elect to receive either cash or additional ADSs, in each case as described in the deposit agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the election is not made available to holders of Sanofi ADSs, such holders will receive either cash or additional Sanofi ADSs, depending on what a shareholder in France would receive for failing to make an election, as more fully described in the deposit agreement.</font></div><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notices and reports, rights of holders to inspect books</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On or before the first date on which we give notice, by publication or otherwise, of any meeting of holders of shares or other deposited securities, or of any adjourned meeting of such holders, or of the taking of any action in respect of any cash or other distributions or the offering of any rights, we will transmit to the depositary a copy of the&#160;notice.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon notice of any meeting of holders of shares or other deposited securities, if requested in writing by Sanofi, the depositary will, as soon as practicable, mail to the holders of Sanofi ADSs a notice, the form of which is in the discretion of the depositary, containing (1)&#160;a summary in English of the information contained in the notice of meeting provided by Sanofi to the depositary, (2)&#160;a statement that the holders as of the close of business on a specified record date will be entitled, subject to any applicable provision of French law and of our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">statuts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, to instruct the depositary as to the exercise of the voting rights, if any, pertaining to the amount of shares or other deposited securities represented by their respective ADSs and (3)&#160;a statement as to the manner in which such instructions may be given. Notwithstanding the above, the depositary may, to the extent not prohibited by law or regulations, or by the requirements of NASDAQ, in lieu of distribution of the materials provided to the depositary as described above, distribute to the holders a notice that provides holders with, or otherwise publicizes to holders, instructions on how to retrieve such materials or receive such materials upon request (i.e.,&#160;by reference to a website containing the materials for retrieval or a contact for requesting copies of the&#160;materials). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary will make available for inspection by ADS holders at the depositary&#8217;s office any reports and communications, including any proxy soliciting material, received from us that are both (1) received by the depositary as the holder of the deposited securities and (2) made generally available to the holders of such deposited securities by us. The depositary will also, upon written request, send to ADS holders copies of such reports when furnished by us pursuant to the deposit agreement. Any such reports and communications, including any such proxy soliciting material, furnished to the depositary by us will be furnished in English to the extent such materials are required to be translated into English pursuant to any regulations of the SEC.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary will keep books for the registration of ADRs and transfers of ADRs that at all reasonable times will be open for inspection by the holders provided that such inspection is not for the purpose of communicating with holders in the interest of a business or object other than our business or a matter related to the deposit agreement or the ADRs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sale or exercising of rights and right to receive the shares underlying the Sanofi ADSs </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Requirements for depositary actions</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Before the depositary will deliver or register the transfer of Sanofi ADSs, make a distribution on Sanofi ADSs or process a withdrawal of shares, the depositary may&#160;require&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any shares or other deposited securities&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">production of satisfactory proof of the identity and genuineness of any signature or other information it deems necessary&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">compliance with regulations it may establish, from time to time, consistent with the deposit agreement, including presentation of transfer documents.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary may refuse to deliver Sanofi ADSs, register transfers of Sanofi ADSs or permit withdrawals of shares when the transfer books of the depositary or our transfer books are closed, or at any time if the depositary or we think it advisable to do&#160;so.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Right to receive the shares underlying the Sanofi ADSs</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holders have the right to cancel their Sanofi ADSs and withdraw the underlying Sanofi ordinary shares at any time&#160;except&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">when temporary delays arise when we or the depositary have closed our transfer books or the deposit of shares in connection with voting at a shareholders&#8217; meeting, or the payment of dividends&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">when the holder or other holders of Sanofi ADSs seeking to withdraw shares owe money to pay fees, taxes and similar charges&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to Sanofi ADSs or to the withdrawal of shares or other deposited securities.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This right of withdrawal may not be limited by any other provision of the deposit agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pre-release of Sanofi ADSs</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The provisions of our form of second amended and restated deposit agreement, as amended, do not permit the pre-release of the Sanofi ADSs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deposit or sale of securities resulting from dividends, splits or plans of reorganization </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Changes affecting deposited securities</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If we&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">change the nominal or par value of our Sanofi ordinary shares&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">recapitalize, reorganize, merge or consolidate, liquidate, sell assets, or take any similar action&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">reclassify, split up or consolidate any of the deposited securities&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">distribute securities on the deposited securities that are not distributed to holders&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">then either&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the cash, shares or other securities received by the depositary will become deposited securities and each Sanofi ADS will automatically represent its equal share of the new deposited securities&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the depositary may, and will if we ask it to, distribute some or all of the cash, shares or other securities it receives. It may also deliver new ADRs or ask holders to surrender their outstanding ADRs in exchange for new ADRs identifying the new deposited securities.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Disclosure of interests</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The obligation of a holder or other person with an interest in our shares to disclose information under French law and under our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">statuts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> also applies to holders and any other persons, other than the depositary, who have an interest in the Sanofi ADSs. The consequences for failing to comply with these provisions are the same for holders and any other persons with an interest as a holder of our ordinary shares. For additional information regarding these obligations, see &#8220;&#8212;&#160;Ordinary Shares &#8212;&#160;Rights, preferences and restrictions attaching to ordinary shares &#8212;&#160;Requirements for holdings exceeding certain percentages&#8221; above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amendment and termination</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We may agree with the depositary to amend the deposit agreement and the ADRs without the consent of the ADS holders for any reason. If the amendment adds or increases fees or charges, except for taxes and other governmental charges or registration fees, cable, telex or facsimile transmission costs, delivery costs or other such expenses, or prejudices a substantial right of holders of Sanofi ADSs, it will only become effective 30&#160;days after the depositary notifies such holders of the amendment. However, we may not be able to provide holders of Sanofi ADSs with prior notice of the effectiveness of any modifications or supplements that are required to accommodate compliance with applicable provisions of law, whether or not those modifications or supplements could be considered to be materially prejudicial to the substantial rights of holders of Sanofi ADSs. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">At the time an amendment becomes effective, such holders will be considered, by continuing to hold their ADR, to have agreed to the amendment and to be bound by the ADR and the deposit agreement as&#160;amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary will terminate the agreement if we ask it to do so. The depositary may also terminate the agreement if the depositary has told us that it would like to resign and we have not appointed a new depositary bank within 90&#160;days. In both cases, the depositary must notify holders of Sanofi ADSs at least 30&#160;days before termination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After termination, the depositary and its agents will be required to do only the following under the deposit agreement&#58; (1)&#160;collect distributions on the deposited securities, (2)&#160;sell rights and other property as provided in the deposit agreement and (3)&#160;deliver shares and other deposited securities upon cancellation of ADRs. Six months or more after termination, the depositary may sell any remaining deposited securities by public or private sale. After that, the depositary will hold the money it receives on the sale, as well as any other cash it is holding under the deposit agreement, for the pro&#160;rata benefit of the holders of Sanofi ADSs that have not surrendered their Sanofi ADSs. It will have no liability for interest. Upon termination of the deposit agreement, the depositary&#8217;s only obligations will be to account for the proceeds of the sale and other cash and with respect to indemnification. After termination, our only obligation will be with respect to indemnification and to pay certain amounts to the&#160;depositary.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Limitations on obligations and liability to holders of Sanofi ADSs</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The deposit agreement expressly limits our obligations and the obligations of the depositary, and it limits our liability and the liability of the depositary. In particular, please note the following&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">we and the depositary are obligated only to take the actions specifically set forth in the deposit agreement without gross negligence or bad faith&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">we and the depositary are not liable if either is prevented or delayed by law or circumstances beyond its control from performing its obligations under the deposit agreement&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">we and the depositary are not liable if either exercises, or fails to exercise, any discretion permitted under the deposit agreement&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">we and the depositary have no obligation to become involved in a lawsuit or other proceeding related to the Sanofi ADSs or the deposit agreement on holders&#8217; behalf or on behalf of any other party, unless indemnity satisfactory to it against all expense and liability is furnished as often as may be required&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">we and the depositary are not liable for the acts or omissions made by, or the insolvency of, any securities depository, clearing agency or settlement system or the custodian, subject to certain exceptions and to the extent the custodian is not a branch or affiliate of JPMorgan&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the depositary is not liable for the price received in connection with any sale of securities, the timing thereof or any delays, acts, omissions to act, errors, defaults or negligence on the part of the party so retained in connection with any such sale or proposed sale&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">we and the depositary may rely without any liability upon any written notice, request, direction, instruction or other document believed by either of us to be genuine and to have been signed or presented by the proper parties&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">we and the depositary are not liable for any action or nonaction taken in reliance upon the advice of or information from legal counsel, accountants, any person presenting ordinary shares for deposit, any ADS holder, or any other person believed in good faith to be competent to give such advice or information. </font></div><div style="padding-left:11.35pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, the depositary will not be liable for any acts or omissions made by a successor depositary. Moreover, neither we nor the depositary nor any of our respective agents will be liable to any holder of Sanofi ADSs for any indirect, special, punitive or consequential damages.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to the terms of the deposit agreement, we and the depositary have agreed to indemnify each other under certain circumstances.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">EUI-1214624659v7</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>5
<FILENAME>a2022-exhibit121.htm
<DESCRIPTION>EX-12.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2bca5a7c380244c68eed679060d5a24b_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 12.1</font></div></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Paul Hudson, certify that&#58;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 20-F of Sanofi&#59;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the Audit Committee of the company&#8217;s Board of Directors&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; February 24, 2023</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.967%"><tr><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.494%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Paul Hudson</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Paul Hudson</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:232%">Title&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:232%">Chief Executive Officer (1)</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:12.601%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Principal executive officer.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>6
<FILENAME>a2022-exhibit122.htm
<DESCRIPTION>EX-12.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6bf5616e60af45bea975e366f14c3662_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 12.2</font></div><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Jean-Baptiste Chasseloup de Chatillon, certify that&#58;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 20-F of Sanofi&#59;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the Audit Committee of the company&#8217;s Board of Directors&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; February 24, 2023</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.967%"><tr><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.494%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Jean-Baptiste Chasseloup de Chatillon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jean-Baptiste Chasseloup de Chatillon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:232%">Title&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:232%">Executive Vice President Chief Financial Officer (1)</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:12.601%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Principal financial officer.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>7
<FILENAME>a2022-exhibit131.htm
<DESCRIPTION>EX-13.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8b0fe6f968554ee9bc71f7005546641c_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 13.1</font></div><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Sanofi, a French soci&#233;t&#233; anonyme (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The annual report on Form 20-F for the year ended December 31, 2022 (the &#8220;Form 20-F&#8221;) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; February 24, 2023</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.967%"><tr><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.494%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">&#47;s&#47; Paul Hudson</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">Paul Hudson</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:103%">Chief Executive Officer (1)</font></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to Sanofi and will be retained by Sanofi and furnished to the Securities and Exchange Commission or its staff upon request.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:12.601%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Principal executive officer.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>8
<FILENAME>a2022-exhibit132.htm
<DESCRIPTION>EX-13.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic0142698cc7f45e9805f12acb3398e35_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 13.2</font></div><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Sanofi, a French soci&#233;t&#233; anonyme (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The annual report on Form 20-F for the year ended December 31, 2022 (the &#8220;Form 20-F&#8221;) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; February 24, 2023</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.967%"><tr><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.494%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">&#47;s&#47; Jean-Baptiste Chasseloup de Chatillon</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">Jean-Baptiste Chasseloup de Chatillon</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:103%">Executive Vice President Chief Financial Officer (1)</font></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to Sanofi and will be retained by Sanofi and furnished to the Securities and Exchange Commission or its staff upon request</font></div><div style="margin-bottom:9pt;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:12.601%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Principal financial officer.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>9
<FILENAME>a2022-exhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7bee7b751d4a49b69b8b0b67d4b41bb6_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements on Form S-8 Nos. 333-256208, 333-238686 and 333-225522 and on Form F-3 No. 333-258327 of Sanofi of our reports dated February 24, 2023, with respect to the consolidated financial statements of Sanofi and its subsidiaries, and the effectiveness of internal control over financial reporting of Sanofi and its subsidiaries, included in this Annual Report (Form 20-F) for the year ended December 31, 2022.</font></div><div style="margin-bottom:9pt;text-indent:27pt"><font><br></font></div><div style="margin-bottom:9pt;padding-left:45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young et Autres</font></div><div style="margin-bottom:9pt;padding-left:45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Paris-La D&#233;fense, France</font></div><div style="margin-bottom:9pt;padding-left:45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February 24, 2023</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>10
<FILENAME>a2022-exhibit232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6b485124e1504c2884b3481a9c6e3bf7_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 23.2</font></div></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-256208, 333-238686 and 333-225522) and on Form F-3 (No. 333-258327) of Sanofi of our reports dated February 24, 2023 relating to the financial statements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and the effectiveness of internal control over financial reporting, which appear in this Form 20-F.</font></div><div><font><br></font></div><div style="text-indent:10.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Neuilly-sur-Seine, France</font></div><div style="text-indent:10.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> February 24, 2023</font></div><div><font><br></font></div><div style="text-indent:10.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#47;s&#47; PricewaterhouseCoopers Audit</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>11
<FILENAME>a2022-exhibit233.htm
<DESCRIPTION>EX-23.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4fd508eeceb54fe18bbada0b039ae3da_33"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 23.3</font></div></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EY CHANGE IN AUDITORS 16F ITEM LETTER</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities and Exchange Commission</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100 F Street, N.E.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Washington, DC 20549</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ladies and Gentlemen</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have read Item 16F. Change in Registrant&#8217;s Certifying Accountant on page 171 of Form 20-F dated February 24, 2023 of Sanofi and are in agreement with the statements contained in paragraphs one and four. We have no basis to agree or disagree with other statements of the registrant contained therein.</font></div><div style="margin-bottom:9pt;text-indent:27pt"><font><br></font></div><div style="margin-bottom:9pt;padding-left:45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young et Autres</font></div><div style="margin-bottom:9pt;padding-left:45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Paris-La D&#233;fense, France</font></div><div style="margin-bottom:9pt;padding-left:45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February 24, 2023</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>sny-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:89d6bfca-a5b4-4bcd-ad12-f1718d876f14,g:8278f0b1-e8dc-472d-9868-3f575a842a56-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sny="http://www.sanofi.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.sanofi.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sny-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sny-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sny-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sny-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Coverpage" roleURI="http://www.sanofi.com/role/Coverpage">
        <link:definition>0000001 - Document - Cover page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.sanofi.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedbalancesheets" roleURI="http://www.sanofi.com/role/Consolidatedbalancesheets">
        <link:definition>0000003 - Statement - Consolidated balance sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedincomestatements" roleURI="http://www.sanofi.com/role/Consolidatedincomestatements">
        <link:definition>0000004 - Statement - Consolidated income statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedincomestatements_1" roleURI="http://www.sanofi.com/role/Consolidatedincomestatements_1">
        <link:definition>0000004 - Statement - Consolidated income statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedstatementsofcomprehensiveincome" roleURI="http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome">
        <link:definition>0000005 - Statement - Consolidated statements of comprehensive income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedstatementsofcomprehensiveincome_1" roleURI="http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome_1">
        <link:definition>0000005 - Statement - Consolidated statements of comprehensive income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedstatementsofchangesinequity" roleURI="http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity">
        <link:definition>0000006 - Statement - Consolidated statements of changes in equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedstatementsofchangesinequityParenthetical" roleURI="http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical">
        <link:definition>0000007 - Statement - Consolidated statements of changes in equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedstatementsofcashflows" roleURI="http://www.sanofi.com/role/Consolidatedstatementsofcashflows">
        <link:definition>0000008 - Statement - Consolidated statements of cash flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedstatementsofcashflowsParenthetical" roleURI="http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical">
        <link:definition>0000009 - Statement - Consolidated statements of cash flows (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Introduction" roleURI="http://www.sanofi.com/role/Introduction">
        <link:definition>0000010 - Disclosure - Introduction</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Basisofpreparation" roleURI="http://www.sanofi.com/role/Basisofpreparation">
        <link:definition>0000011 - Disclosure - Basis of preparation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Summaryofsignificantaccountingpolicies" roleURI="http://www.sanofi.com/role/Summaryofsignificantaccountingpolicies">
        <link:definition>0000012 - Disclosure - Summary of significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Principalalliances" roleURI="http://www.sanofi.com/role/Principalalliances">
        <link:definition>0000013 - Disclosure - Principal alliances</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Principalchangesinthescopeofconsolidationin2022" roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022">
        <link:definition>0000014 - Disclosure - Principal changes in the scope of consolidation in 2022</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Principalchangesinthescopeofconsolidationin2021and2020" roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020">
        <link:definition>0000015 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Propertyplantandequipment" roleURI="http://www.sanofi.com/role/Propertyplantandequipment">
        <link:definition>0000016 - Disclosure - Property, plant and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwillandotherintangibleassets" roleURI="http://www.sanofi.com/role/Goodwillandotherintangibleassets">
        <link:definition>0000017 - Disclosure - Goodwill and other intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Impairmentofintangibleassetsandpropertyplantandequipment" roleURI="http://www.sanofi.com/role/Impairmentofintangibleassetsandpropertyplantandequipment">
        <link:definition>0000018 - Disclosure - Impairment of intangible assets and property, plant and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investmentsaccountedforusingtheequitymethod" roleURI="http://www.sanofi.com/role/Investmentsaccountedforusingtheequitymethod">
        <link:definition>0000019 - Disclosure - Investments accounted for using the equity method</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Othernoncurrentassets" roleURI="http://www.sanofi.com/role/Othernoncurrentassets">
        <link:definition>0000020 - Disclosure - Other non-current assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Assetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchange" roleURI="http://www.sanofi.com/role/Assetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchange">
        <link:definition>0000021 - Disclosure - Assets held for sale or exchange and liabilities related to assets held for sale or exchange</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.sanofi.com/role/Inventories">
        <link:definition>0000022 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accountsreceivable" roleURI="http://www.sanofi.com/role/Accountsreceivable">
        <link:definition>0000023 - Disclosure - Accounts receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Othercurrentassets" roleURI="http://www.sanofi.com/role/Othercurrentassets">
        <link:definition>0000024 - Disclosure - Other current assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Financialassetsandliabilitiesmeasuredatfairvalue" roleURI="http://www.sanofi.com/role/Financialassetsandliabilitiesmeasuredatfairvalue">
        <link:definition>0000025 - Disclosure - Financial assets and liabilities measured at fair value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Cashandcashequivalents" roleURI="http://www.sanofi.com/role/Cashandcashequivalents">
        <link:definition>0000026 - Disclosure - Cash and cash equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Netdeferredtaxposition" roleURI="http://www.sanofi.com/role/Netdeferredtaxposition">
        <link:definition>0000027 - Disclosure - Net deferred tax position</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Consolidatedshareholdersequity" roleURI="http://www.sanofi.com/role/Consolidatedshareholdersequity">
        <link:definition>0000028 - Disclosure - Consolidated shareholders&#8217; equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Noncontrollinginterests" roleURI="http://www.sanofi.com/role/Noncontrollinginterests">
        <link:definition>0000029 - Disclosure - Non-controlling interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debtcashandcashequivalentsandleaseliabilities" roleURI="http://www.sanofi.com/role/Debtcashandcashequivalentsandleaseliabilities">
        <link:definition>0000030 - Disclosure - Debt, cash and cash equivalents and lease liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Liabilitiesrelatedtobusinesscombinationsandtononcontrollinginterests" roleURI="http://www.sanofi.com/role/Liabilitiesrelatedtobusinesscombinationsandtononcontrollinginterests">
        <link:definition>0000031 - Disclosure - Liabilities related to business combinations and to non-controlling interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Provisionsincometaxliabilitiesandotherliabilities" roleURI="http://www.sanofi.com/role/Provisionsincometaxliabilitiesandotherliabilities">
        <link:definition>0000032 - Disclosure - Provisions, income tax liabilities and other liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivativefinancialinstrumentsandmarketrisks" roleURI="http://www.sanofi.com/role/Derivativefinancialinstrumentsandmarketrisks">
        <link:definition>0000033 - Disclosure - Derivative financial instruments and market risks</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Offbalancesheetcommitments" roleURI="http://www.sanofi.com/role/Offbalancesheetcommitments">
        <link:definition>0000034 - Disclosure - Off balance sheet commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Legalandarbitralproceedings" roleURI="http://www.sanofi.com/role/Legalandarbitralproceedings">
        <link:definition>0000035 - Disclosure - Legal and arbitral proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Provisionsfordiscountsrebatesandsalesreturns" roleURI="http://www.sanofi.com/role/Provisionsfordiscountsrebatesandsalesreturns">
        <link:definition>0000036 - Disclosure - Provisions for discounts, rebates and sales returns</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Personnelcosts" roleURI="http://www.sanofi.com/role/Personnelcosts">
        <link:definition>0000037 - Disclosure - Personnel costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Otheroperatingincome" roleURI="http://www.sanofi.com/role/Otheroperatingincome">
        <link:definition>0000038 - Disclosure - Other operating income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Otheroperatingexpenses" roleURI="http://www.sanofi.com/role/Otheroperatingexpenses">
        <link:definition>0000039 - Disclosure - Other operating expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuringcostsandsimilaritems" roleURI="http://www.sanofi.com/role/Restructuringcostsandsimilaritems">
        <link:definition>0000040 - Disclosure - Restructuring costs and similar items</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Othergainsandlossesandlitigation" roleURI="http://www.sanofi.com/role/Othergainsandlossesandlitigation">
        <link:definition>0000041 - Disclosure - Other gains and losses, and litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Financialexpensesandincome" roleURI="http://www.sanofi.com/role/Financialexpensesandincome">
        <link:definition>0000042 - Disclosure - Financial expenses and income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Incometaxexpense" roleURI="http://www.sanofi.com/role/Incometaxexpense">
        <link:definition>0000043 - Disclosure - Income tax expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Shareofprofitlossfrominvestmentsaccountedforusingtheequitymethod" roleURI="http://www.sanofi.com/role/Shareofprofitlossfrominvestmentsaccountedforusingtheequitymethod">
        <link:definition>0000044 - Disclosure - Share of profit/loss from investments accounted for using the equity method</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Netincomeattributabletononcontrollinginterests" roleURI="http://www.sanofi.com/role/Netincomeattributabletononcontrollinginterests">
        <link:definition>0000045 - Disclosure - Net income attributable to non-controlling interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Relatedpartytransactions" roleURI="http://www.sanofi.com/role/Relatedpartytransactions">
        <link:definition>0000046 - Disclosure - Related party transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Disclosuresaboutmajorcustomersandcreditrisk" roleURI="http://www.sanofi.com/role/Disclosuresaboutmajorcustomersandcreditrisk">
        <link:definition>0000047 - Disclosure - Disclosures about major customers and credit risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segmentinformation" roleURI="http://www.sanofi.com/role/Segmentinformation">
        <link:definition>0000048 - Disclosure - Segment information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Principalaccountantsfeesandservices" roleURI="http://www.sanofi.com/role/Principalaccountantsfeesandservices">
        <link:definition>0000049 - Disclosure - Principal accountants' fees and services</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022" roleURI="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022">
        <link:definition>0000050 - Disclosure - List of principal companies included in the scope of consolidation during&#160;2022</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EventssubsequenttoDecember312022" roleURI="http://www.sanofi.com/role/EventssubsequenttoDecember312022">
        <link:definition>0000051 - Disclosure - Events subsequent to December 31, 2022</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesPolicies" roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies">
        <link:definition>0000052 - Disclosure - Summary of significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesTables" roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTables">
        <link:definition>0000053 - Disclosure - Summary of significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Principalchangesinthescopeofconsolidationin2022Tables" roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022Tables">
        <link:definition>0000054 - Disclosure - Principal changes in the scope of consolidation in 2022 (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Principalchangesinthescopeofconsolidationin2021and2020Tables" roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020Tables">
        <link:definition>0000055 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020 (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentTables" roleURI="http://www.sanofi.com/role/PropertyplantandequipmentTables">
        <link:definition>0000056 - Disclosure - Property, plant and equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandotherintangibleassetsTables" roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsTables">
        <link:definition>0000057 - Disclosure - Goodwill and other intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ImpairmentofintangibleassetsandpropertyplantandequipmentTables" roleURI="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentTables">
        <link:definition>0000058 - Disclosure - Impairment of intangible assets and property, plant and equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsaccountedforusingtheequitymethodTables" roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodTables">
        <link:definition>0000059 - Disclosure - Investments accounted for using the equity method (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OthernoncurrentassetsTables" roleURI="http://www.sanofi.com/role/OthernoncurrentassetsTables">
        <link:definition>0000060 - Disclosure - Other non-current assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeTables" roleURI="http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeTables">
        <link:definition>0000061 - Disclosure - Assets held for sale or exchange and liabilities related to assets held for sale or exchange (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.sanofi.com/role/InventoriesTables">
        <link:definition>0000062 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableTables" roleURI="http://www.sanofi.com/role/AccountsreceivableTables">
        <link:definition>0000063 - Disclosure - Accounts receivable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OthercurrentassetsTables" roleURI="http://www.sanofi.com/role/OthercurrentassetsTables">
        <link:definition>0000064 - Disclosure - Other current assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialassetsandliabilitiesmeasuredatfairvalueTables" roleURI="http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueTables">
        <link:definition>0000065 - Disclosure - Financial assets and liabilities measured at fair value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandcashequivalentsTables" roleURI="http://www.sanofi.com/role/CashandcashequivalentsTables">
        <link:definition>0000066 - Disclosure - Cash and cash equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetdeferredtaxpositionTables" roleURI="http://www.sanofi.com/role/NetdeferredtaxpositionTables">
        <link:definition>0000067 - Disclosure - Net deferred tax position (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequityTables" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequityTables">
        <link:definition>0000068 - Disclosure - Consolidated shareholders&#8217; equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesTables" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables">
        <link:definition>0000069 - Disclosure - Debt, cash and cash equivalents and lease liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsTables" roleURI="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsTables">
        <link:definition>0000070 - Disclosure - Liabilities related to business combinations and to non-controlling interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesTables" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables">
        <link:definition>0000071 - Disclosure - Provisions, income tax liabilities and other liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativefinancialinstrumentsandmarketrisksTables" roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksTables">
        <link:definition>0000072 - Disclosure - Derivative financial instruments and market risks (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OffbalancesheetcommitmentsTables" roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsTables">
        <link:definition>0000073 - Disclosure - Off balance sheet commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsfordiscountsrebatesandsalesreturnsTables" roleURI="http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsTables">
        <link:definition>0000074 - Disclosure - Provisions for discounts, rebates and sales returns (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PersonnelcostsTables" roleURI="http://www.sanofi.com/role/PersonnelcostsTables">
        <link:definition>0000075 - Disclosure - Personnel costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtheroperatingexpensesTables" roleURI="http://www.sanofi.com/role/OtheroperatingexpensesTables">
        <link:definition>0000076 - Disclosure - Other operating expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringcostsandsimilaritemsTables" roleURI="http://www.sanofi.com/role/RestructuringcostsandsimilaritemsTables">
        <link:definition>0000077 - Disclosure - Restructuring costs and similar items (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialexpensesandincomeTables" roleURI="http://www.sanofi.com/role/FinancialexpensesandincomeTables">
        <link:definition>0000078 - Disclosure - Financial expenses and income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxexpenseTables" roleURI="http://www.sanofi.com/role/IncometaxexpenseTables">
        <link:definition>0000079 - Disclosure - Income tax expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetincomeattributabletononcontrollinginterestsTables" roleURI="http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsTables">
        <link:definition>0000080 - Disclosure - Net income attributable to non-controlling interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartytransactionsTables" roleURI="http://www.sanofi.com/role/RelatedpartytransactionsTables">
        <link:definition>0000081 - Disclosure - Related party transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationTables" roleURI="http://www.sanofi.com/role/SegmentinformationTables">
        <link:definition>0000082 - Disclosure - Segment information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrincipalaccountantsfeesandservicesTables" roleURI="http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesTables">
        <link:definition>0000083 - Disclosure - Principal accountants' fees and services (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022Tables" roleURI="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022Tables">
        <link:definition>0000084 - Disclosure - List of principal companies included in the scope of consolidation during&#160;2022 (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofpreparationAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails">
        <link:definition>0000085 - Disclosure - Basis of preparation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails" roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails">
        <link:definition>0000086 - Disclosure - Summary of significant accounting policies - Other Intangible Assets not Acquired in Business Combination (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails" roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails">
        <link:definition>0000087 - Disclosure - Summary of significant accounting policies - Summary of Useful Lives of Property Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesTreasurySharesDetails" roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTreasurySharesDetails">
        <link:definition>0000088 - Disclosure - Summary of significant accounting policies - Treasury Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesProvisionforRisksDetails" roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesProvisionforRisksDetails">
        <link:definition>0000089 - Disclosure - Summary of significant accounting policies - Provision for Risks (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails" roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails">
        <link:definition>0000090 - Disclosure - Summary of significant accounting policies - Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails" roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails">
        <link:definition>0000091 - Disclosure - Summary of significant accounting policies - Share-Based Payment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesSegmentInformationDetails" roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSegmentInformationDetails">
        <link:definition>0000092 - Disclosure - Summary of significant accounting policies - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails" roleURI="http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails">
        <link:definition>0000093 - Disclosure - Principal alliances -Collaboration agreements on human therapeutic antibodies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails" roleURI="http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails">
        <link:definition>0000094 - Disclosure - Principal alliances - Immuno-Oncology Agreement with Regeneron Pharmaceuticals, Inc. (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails" roleURI="http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails">
        <link:definition>0000095 - Disclosure - Principal alliances - Investor Agreement with Regeneron Pharmaceuticals, Inc. (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails" roleURI="http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails">
        <link:definition>0000096 - Disclosure - Principal alliances - Alliance Arrangements with Bristol-Myers Squibb (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails" roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails">
        <link:definition>0000097 - Disclosure - Principal changes in the scope of consolidation in 2022 - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails" roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails">
        <link:definition>0000098 - Disclosure - Principal changes in the scope of consolidation in 2022 - Summary of Provisional Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails" roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails">
        <link:definition>0000099 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020 - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails" roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails">
        <link:definition>0000100 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020 - Summary of Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails" roleURI="http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails">
        <link:definition>0000101 - Disclosure - Property, plant and equipment - Schedule of Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails" roleURI="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails">
        <link:definition>0000102 - Disclosure - Property, plant and equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentSummaryofOffBalanceSheetCommitmentsRelatingtoPropertyPlantandEquipmentDetails" roleURI="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofOffBalanceSheetCommitmentsRelatingtoPropertyPlantandEquipmentDetails">
        <link:definition>0000103 - Disclosure - Property, plant and equipment - Summary of Off Balance Sheet Commitments Relating to Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentSummaryofImpairmentLossesRecognisedinPropertyPlantandEquipmentDetails" roleURI="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofImpairmentLossesRecognisedinPropertyPlantandEquipmentDetails">
        <link:definition>0000104 - Disclosure - Property, plant and equipment - Summary of Impairment Losses Recognised in Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails" roleURI="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails">
        <link:definition>0000105 - Disclosure - Property, plant and equipment - Summary of Property, Plant and Equipment Leased (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails">
        <link:definition>0000106 - Disclosure - Property, plant and equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails" roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails">
        <link:definition>0000107 - Disclosure - Goodwill and other intangible assets - Schedule of Movements in Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandotherintangibleassetsAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails">
        <link:definition>0000108 - Disclosure - Goodwill and other intangible assets - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails" roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails">
        <link:definition>0000109 - Disclosure - Goodwill and other intangible assets - Schedule of Movements in Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails" roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails">
        <link:definition>0000110 - Disclosure - Goodwill and other intangible assets - Detailed Information for Principal Marketed Products (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails" roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails">
        <link:definition>0000111 - Disclosure - Goodwill and other intangible assets - Amortization of Softwares Recognized in Income Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails" roleURI="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails">
        <link:definition>0000112 - Disclosure - Impairment of intangible assets and property, plant and equipment - Schedule of Allocation of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails">
        <link:definition>0000113 - Disclosure - Impairment of intangible assets and property, plant and equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails" roleURI="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails">
        <link:definition>0000114 - Disclosure - Impairment of intangible assets and property, plant and equipment - Summary of Net Impairment Losses of Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails" roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails">
        <link:definition>0000115 - Disclosure - Investments accounted for using the equity method - Summary of Investments in Associates and Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails" roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails">
        <link:definition>0000116 - Disclosure - Investments accounted for using the equity method - Summary of Share of Profit or Loss and Other Comprehensive Income of Associates and Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails" roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails">
        <link:definition>0000117 - Disclosure - Investments accounted for using the equity method - Summary of Principal Transactions and Balances with Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails">
        <link:definition>0000118 - Disclosure - Investments accounted for using the equity method - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails" roleURI="http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails">
        <link:definition>0000119 - Disclosure - Other non-current assets - Summary of Other Non-current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OthernoncurrentassetsAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails">
        <link:definition>0000120 - Disclosure - Other non-current assets - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeSummaryofAssetsHeldforSaleorExchangeandLiabilitiesRelatedtoAssetsHeldforSaleorExchangeDetails" roleURI="http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeSummaryofAssetsHeldforSaleorExchangeandLiabilitiesRelatedtoAssetsHeldforSaleorExchangeDetails">
        <link:definition>0000121 - Disclosure - Assets held for sale or exchange and liabilities related to assets held for sale or exchange - Summary of Assets Held for Sale or Exchange, and Liabilities Related to Assets Held for Sale or Exchange (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesScheduleofInventoriesDetails" roleURI="http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails">
        <link:definition>0000122 - Disclosure - Inventories - Schedule of Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/InventoriesAdditionalInformationDetails">
        <link:definition>0000123 - Disclosure - Inventories - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableSummaryofAccountsReceivableDetails" roleURI="http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails">
        <link:definition>0000124 - Disclosure - Accounts receivable - Summary of Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/AccountsreceivableAdditionalInformationDetails">
        <link:definition>0000125 - Disclosure - Accounts receivable - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails" roleURI="http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails">
        <link:definition>0000126 - Disclosure - Accounts receivable - Summary of Gross Value of Overdue Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OthercurrentassetsDetails" roleURI="http://www.sanofi.com/role/OthercurrentassetsDetails">
        <link:definition>0000127 - Disclosure - Other current assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" roleURI="http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails">
        <link:definition>0000128 - Disclosure - Financial assets and liabilities measured at fair value - Summary of Assets and Liabilities Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandcashequivalentsDetails" roleURI="http://www.sanofi.com/role/CashandcashequivalentsDetails">
        <link:definition>0000129 - Disclosure - Cash and cash equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails" roleURI="http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails">
        <link:definition>0000130 - Disclosure - Net deferred tax position - Summary of Net Deferred Tax Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetdeferredtaxpositionAdditionalinformationDetails" roleURI="http://www.sanofi.com/role/NetdeferredtaxpositionAdditionalinformationDetails">
        <link:definition>0000131 - Disclosure - Net deferred tax position - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails" roleURI="http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails">
        <link:definition>0000132 - Disclosure - Net deferred tax position - Summary of Tax Losses Available for Carry-forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequityAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails">
        <link:definition>0000133 - Disclosure - Consolidated shareholders&#8217; equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequitySummaryofTreasurySharesHeldDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofTreasurySharesHeldDetails">
        <link:definition>0000134 - Disclosure - Consolidated shareholders&#8217; equity - Summary of Treasury Shares Held (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails">
        <link:definition>0000135 - Disclosure - Consolidated shareholders&#8217; equity - Summary of Movements Share Capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails">
        <link:definition>0000136 - Disclosure - Consolidated shareholders&#8217; equity - Principal Characteristics of Restricted Share Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails">
        <link:definition>0000137 - Disclosure - Consolidated shareholders&#8217; equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails">
        <link:definition>0000138 - Disclosure - Consolidated shareholders&#8217; equity - Summary of Characteristics of Employee Share Ownership Plans Awarded (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequitySummaryofExpensesDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails">
        <link:definition>0000139 - Disclosure - Consolidated shareholders&#8217; equity - Summary of Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails">
        <link:definition>0000140 - Disclosure - Consolidated shareholders&#8217; equity - Summary of Repurchases Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails">
        <link:definition>0000141 - Disclosure - Consolidated shareholders&#8217; equity - Summary of Currency Translation Differences (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails">
        <link:definition>0000142 - Disclosure - Consolidated shareholders&#8217; equity - Summary of Movements within Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails">
        <link:definition>0000143 - Disclosure - Consolidated shareholders&#8217; equity - Disclosure of Stock Subscription Option Plan Outstanding and Option Exercised (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails">
        <link:definition>0000144 - Disclosure - Consolidated shareholders&#8217; equity - Summary of Stock Options Outstanding at Each Balance Sheet Date (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails">
        <link:definition>0000145 - Disclosure - Consolidated shareholders&#8217; equity - Summary of Options Outstanding and Exercisable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails" roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails">
        <link:definition>0000146 - Disclosure - Consolidated shareholders&#8217; equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails">
        <link:definition>0000147 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Changes in Financial Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails">
        <link:definition>0000148 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails">
        <link:definition>0000149 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Disclosure of Movement In Total Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails">
        <link:definition>0000150 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails">
        <link:definition>0000151 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Net Debt by Type Valuation of Redemption (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails">
        <link:definition>0000152 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Bond Issues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails">
        <link:definition>0000153 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Maturity at Value on Redemption (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails">
        <link:definition>0000154 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Interest Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails">
        <link:definition>0000155 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate of Net Debt at Value on Redemption (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails">
        <link:definition>0000156 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails">
        <link:definition>0000157 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Currency (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails">
        <link:definition>0000158 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Market Value of Net Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails">
        <link:definition>0000159 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails" roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails">
        <link:definition>0000160 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails" roleURI="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails">
        <link:definition>0000161 - Disclosure - Liabilities related to business combinations and to non-controlling interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails">
        <link:definition>0000162 - Disclosure - Liabilities related to business combinations and to non-controlling interests - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails" roleURI="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails">
        <link:definition>0000163 - Disclosure - Liabilities related to business combinations and to non-controlling interests - Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails">
        <link:definition>0000164 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Non Current Provisions and Other Non-current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails">
        <link:definition>0000165 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Movements in Non-current Provisions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails">
        <link:definition>0000166 - Disclosure - Provisions, income tax liabilities and other liabilities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails">
        <link:definition>0000167 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Financial and Demographic Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails">
        <link:definition>0000168 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Weighted Average Duration of Obligation for Pensions and Other Long-term Benefits in Principal Countries (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails">
        <link:definition>0000169 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Sensitivity for Pensions and Other Post-Employment Benefits to Changes in Key Actuarial Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails">
        <link:definition>0000170 - Disclosure - Provisions, income tax liabilities and other liabilities - Reconciliation of Net Amount Recognized in Respect of Pension and Other Post-employment Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails">
        <link:definition>0000171 - Disclosure - Provisions, income tax liabilities and other liabilities - Net Liability in Respect of Pension Plans and Other Post-employment Benefits by Geographical Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails">
        <link:definition>0000172 - Disclosure - Provisions, income tax liabilities and other liabilities - Fair Value of Plans Assets relating to Pension Plans and Other Post-employment Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails">
        <link:definition>0000173 - Disclosure - Provisions, income tax liabilities and other liabilities - Service Cost for Pension and Other post-employment Benefit Plans, by Geographical Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails">
        <link:definition>0000174 - Disclosure - Provisions, income tax liabilities and other liabilities - Remeasurement of Net Defined-benefit (Asset)/Liability (Actuarial Gains and Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNetPretaxActuarialLossDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNetPretaxActuarialLossDetails">
        <link:definition>0000175 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Net Pre-tax Actuarial Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails">
        <link:definition>0000176 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Present Value of Pension and Other Post Employment Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails">
        <link:definition>0000177 - Disclosure - Provisions, income tax liabilities and other liabilities - Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails">
        <link:definition>0000178 - Disclosure - Provisions, income tax liabilities and other liabilities - Estimated Amounts of Employer's Contributions to Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails">
        <link:definition>0000179 - Disclosure - Provisions, income tax liabilities and other liabilities - Expected Timing of Benefit Payments under Pension and Other Post-employment Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails">
        <link:definition>0000180 - Disclosure - Provisions, income tax liabilities and other liabilities - Timing of Future Payments in Respect of Unfunded Pension and Other Post-employment Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails">
        <link:definition>0000181 - Disclosure - Provisions, income tax liabilities and other liabilities - Movements in Restructuring Provisions Classified in Non-current and Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails">
        <link:definition>0000182 - Disclosure - Provisions, income tax liabilities and other liabilities - Timing of Future Termination Benefit Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails">
        <link:definition>0000183 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Other Provisions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails" roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails">
        <link:definition>0000184 - Disclosure - Provisions, income tax liabilities and other liabilities - Current Provisions and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails" roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails">
        <link:definition>0000185 - Disclosure - Derivative financial instruments and market risks - Summary of Fair Value of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails" roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails">
        <link:definition>0000186 - Disclosure - Derivative financial instruments and market risks - Summary of Operating Currency Hedging Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails" roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails">
        <link:definition>0000187 - Disclosure - Derivative financial instruments and market risks - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails" roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails">
        <link:definition>0000188 - Disclosure - Derivative financial instruments and market risks - Disclosure of Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails" roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails">
        <link:definition>0000189 - Disclosure - Derivative financial instruments and market risks - Disclosure of Actual or Potential Effects of Netting Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails" roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails">
        <link:definition>0000190 - Disclosure - Off balance sheet commitments - Summary of Off Balance Sheet Commitments Relating to Operating Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OffbalancesheetcommitmentsAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails">
        <link:definition>0000191 - Disclosure - Off balance sheet commitments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails" roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails">
        <link:definition>0000192 - Disclosure - Off balance sheet commitments - Summary of Undrawn Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails" roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails">
        <link:definition>0000193 - Disclosure - Off balance sheet commitments - Summary of Amount of Guarantees Given and Received (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalandarbitralproceedingsDetails" roleURI="http://www.sanofi.com/role/LegalandarbitralproceedingsDetails">
        <link:definition>0000194 - Disclosure - Legal and arbitral proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails" roleURI="http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails">
        <link:definition>0000195 - Disclosure - Provisions for discounts, rebates and sales returns - Summary of Movement in Provisions for Discounts, Rebates and Sales Returns (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PersonnelcostsSummaryofPersonalCostsDetails" roleURI="http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails">
        <link:definition>0000196 - Disclosure - Personnel costs - Summary of Personal Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PersonnelcostsAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/PersonnelcostsAdditionalInformationDetails">
        <link:definition>0000197 - Disclosure - Personnel costs - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtheroperatingincomeDetails" roleURI="http://www.sanofi.com/role/OtheroperatingincomeDetails">
        <link:definition>0000198 - Disclosure - Other operating income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtheroperatingexpensesAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/OtheroperatingexpensesAdditionalInformationDetails">
        <link:definition>0000199 - Disclosure - Other operating expenses - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtheroperatingexpensesOtherIncomeandExpenseDetails" roleURI="http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails">
        <link:definition>0000200 - Disclosure - Other operating expenses - Other Income and Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails" roleURI="http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails">
        <link:definition>0000201 - Disclosure - Restructuring costs and similar items - Summary of Restructuring Costs and Similar Items (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringcostsandsimilaritemsAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/RestructuringcostsandsimilaritemsAdditionalInformationDetails">
        <link:definition>0000202 - Disclosure - Restructuring costs and similar items - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OthergainsandlossesandlitigationDetails" roleURI="http://www.sanofi.com/role/OthergainsandlossesandlitigationDetails">
        <link:definition>0000203 - Disclosure - Other gains and losses, and litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialexpensesandincomeDetails" roleURI="http://www.sanofi.com/role/FinancialexpensesandincomeDetails">
        <link:definition>0000204 - Disclosure - Financial expenses and income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialexpensesandincomeDetails_1" roleURI="http://www.sanofi.com/role/FinancialexpensesandincomeDetails_1">
        <link:definition>0000204 - Disclosure - Financial expenses and income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails" roleURI="http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails">
        <link:definition>0000205 - Disclosure - Income tax expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails" roleURI="http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails">
        <link:definition>0000206 - Disclosure - Income tax expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails" roleURI="http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails">
        <link:definition>0000207 - Disclosure - Share of profit/loss from investments accounted for using the equity method (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetincomeattributabletononcontrollinginterestsDetails" roleURI="http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails">
        <link:definition>0000208 - Disclosure - Net income attributable to non-controlling interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartytransactionsAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/RelatedpartytransactionsAdditionalInformationDetails">
        <link:definition>0000209 - Disclosure - Related party transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails" roleURI="http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails">
        <link:definition>0000210 - Disclosure - Related party transactions - Schedule of Compensation Paid to Key Management Personnel (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartytransactionsSummaryofaggregateamountsPayabletoKeyManagementPersonnelDetails" roleURI="http://www.sanofi.com/role/RelatedpartytransactionsSummaryofaggregateamountsPayabletoKeyManagementPersonnelDetails">
        <link:definition>0000211 - Disclosure - Related party transactions - Summary of aggregate amounts Payable to Key Management Personnel (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisclosuresaboutmajorcustomersandcreditriskDetails" roleURI="http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails">
        <link:definition>0000212 - Disclosure - Disclosures about major customers and credit risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationAdditionalInformationDetails" roleURI="http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails">
        <link:definition>0000213 - Disclosure - Segment information - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails" roleURI="http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails">
        <link:definition>0000214 - Disclosure - Segment information - Summary of Net Sales by Segment and Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationScheduleofSegmentResultsDetails" roleURI="http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails">
        <link:definition>0000215 - Disclosure - Segment information - Schedule of Segment Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails" roleURI="http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails">
        <link:definition>0000216 - Disclosure - Segment information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails" roleURI="http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails">
        <link:definition>0000217 - Disclosure - Segment information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails" roleURI="http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails">
        <link:definition>0000218 - Disclosure - Segment information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrincipalaccountantsfeesandservicesDetails" roleURI="http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails">
        <link:definition>0000219 - Disclosure - Principal accountants' fees and services (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails" roleURI="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails">
        <link:definition>0000220 - Disclosure - List of principal companies included in the scope of consolidation during&#160;2022 - Summary of Principal Companies and their Country of Incorporation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails" roleURI="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails">
        <link:definition>0000221 - Disclosure - List of principal companies included in the scope of consolidation during&#160;2022 - Summary of Principal Investments Accounted for Using the Equity Method (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EventssubsequenttoDecember312022Details" roleURI="http://www.sanofi.com/role/EventssubsequenttoDecember312022Details">
        <link:definition>0000222 - Disclosure - Events subsequent to December 31, 2022 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sny_DisclosureOfRestructuringProvisionsTableTextBlock" abstract="false" name="DisclosureOfRestructuringProvisionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_NumberOfVaccineDosesToBeSupplied" abstract="false" name="NumberOfVaccineDosesToBeSupplied" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_ImpairmentOfAssetsAbstract" abstract="true" name="ImpairmentOfAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_SpecialDistributionSharesReceivedPerConversionOfParentShares" abstract="false" name="SpecialDistributionSharesReceivedPerConversionOfParentShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_SanofiAventisArgentinaSAMember" abstract="true" name="SanofiAventisArgentinaSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable" abstract="true" name="DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_SanofiAventisSingaporePteLtdMember" abstract="true" name="SanofiAventisSingaporePteLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions" abstract="false" name="ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_WithMarketConditionMember" abstract="true" name="WithMarketConditionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" abstract="false" name="DisclosureOfRestructuringCostsDetailsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock" abstract="false" name="DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SanofiAventisMalaysiaSDNBHDMember" abstract="true" name="SanofiAventisMalaysiaSDNBHDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember" abstract="true" name="PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member" abstract="true" name="InterestRateSwapsPayCapitalizedEoniaReceive006Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PensionObligationPercentageToPlanAssets" abstract="false" name="PensionObligationPercentageToPlanAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_NonCurrentFinanceLeaseReceivablesGross" abstract="false" name="NonCurrentFinanceLeaseReceivablesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NotionalRetirementAge" abstract="false" name="NotionalRetirementAge" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_DigestiveWellnessMember" abstract="true" name="DigestiveWellnessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PensionsAndOtherPostEmploymentBenefitsMember" abstract="true" name="PensionsAndOtherPostEmploymentBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_TotalOffBalanceSheetCommitments" abstract="false" name="TotalOffBalanceSheetCommitments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_RepurchaseFromTheCounterpartMember" abstract="true" name="RepurchaseFromTheCounterpartMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ConcentrationRiskThresholdPercentage" abstract="false" name="ConcentrationRiskThresholdPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_DisclosureOfPersonnelCostsDetailsTableTextBlock" abstract="false" name="DisclosureOfPersonnelCostsDetailsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember" abstract="true" name="TaxotereMississippiAttorneyGeneralLitigationInTheUSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DefendantAxis" abstract="true" name="DefendantAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_RareBloodDisordersMember" abstract="true" name="RareBloodDisordersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_EuroapiMember" abstract="true" name="EuroapiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" abstract="false" name="IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DepakineProductLitigationInBelgiumMember" abstract="true" name="DepakineProductLitigationInBelgiumMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments" abstract="false" name="OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ParticipatingSharesCarryingAmount" abstract="false" name="ParticipatingSharesCarryingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiAventisUSLLCMember" abstract="true" name="SanofiAventisUSLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock" abstract="false" name="DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_AuditorsRemunerationForAuditRelatedServices" abstract="false" name="AuditorsRemunerationForAuditRelatedServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_InterestRateAndCurrencyDerivativesMember" abstract="true" name="InterestRateAndCurrencyDerivativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DerivativeInstrumentAxis" abstract="true" name="DerivativeInstrumentAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_AventisPharmaLimitedMember" abstract="true" name="AventisPharmaLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ShireHumanGeneticTherapiesIncMember" abstract="true" name="ShireHumanGeneticTherapiesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiAventisSouthAfricaPtyLtdMember" abstract="true" name="SanofiAventisSouthAfricaPtyLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_EPICBPIFranceMember" abstract="true" name="EPICBPIFranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiPasteurHepatitisBVaccineMember" abstract="true" name="SanofiPasteurHepatitisBVaccineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ActionForWhichWeArePlaintiffMember" abstract="true" name="ActionForWhichWeArePlaintiffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sny_PrincipalMarketedProductsBioverativMember" abstract="true" name="PrincipalMarketedProductsBioverativMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CustomerThreeMember" abstract="true" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PercentageOfAuditorsRemuneration" abstract="false" name="PercentageOfAuditorsRemuneration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_NumberOfFirstInstanceRulings" abstract="false" name="NumberOfFirstInstanceRulings" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_MiReculeMember" abstract="true" name="MiReculeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ShareBasedPaymentPlansAbstract" abstract="true" name="ShareBasedPaymentPlansAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock" abstract="false" name="DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems" abstract="true" name="DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_DefinedBenefitPlansVestingRightsPercentage" abstract="false" name="DefinedBenefitPlansVestingRightsPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" abstract="false" name="DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PlusHundredBasisPointsMember" abstract="true" name="PlusHundredBasisPointsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DengvaxiaProductLitigationInThePhilippinesMember" abstract="true" name="DengvaxiaProductLitigationInThePhilippinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_OtherCountriesInSegmentResultsMember" abstract="true" name="OtherCountriesInSegmentResultsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems" abstract="true" name="DisclosureOfDetailedInformationAboutIncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod" abstract="false" name="TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_OptionVestingPeriod" abstract="false" name="OptionVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_TranslateBioIncMember" abstract="true" name="TranslateBioIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_VaccinesMember" abstract="true" name="VaccinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OtherOperatingExpensesTableTextBlock" abstract="false" name="OtherOperatingExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_StockBasedCompensationStockOptionsExercisedPricePerShare" abstract="false" name="StockBasedCompensationStockOptionsExercisedPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="sny_IncomeTaxesAbstract" abstract="true" name="IncomeTaxesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_SpecialDistributionPercentageOfShareCapitalDistributed" abstract="false" name="SpecialDistributionPercentageOfShareCapitalDistributed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock" abstract="false" name="DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" abstract="false" name="NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_IndustrialSalesMember" abstract="true" name="IndustrialSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock" abstract="false" name="DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_LengthOfTrial" abstract="false" name="LengthOfTrial" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" abstract="false" name="AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_OperatingSegmentsAbstract" abstract="true" name="OperatingSegmentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_BioverativUSLLCMember" abstract="true" name="BioverativUSLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PlavixLitigationCommonwealthInAustraliaMember" abstract="true" name="PlavixLitigationCommonwealthInAustraliaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" abstract="false" name="DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" abstract="false" name="IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" abstract="false" name="IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_PharmaceuticalsSegmentMember" abstract="true" name="PharmaceuticalsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_LumpSumRetirementBenefitPlansMember" abstract="true" name="LumpSumRetirementBenefitPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ExercisePriceRangeTwoMember" abstract="true" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax" abstract="false" name="HedgesOfNetInvestmentsInForeignOperationsAfterTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiAventisDeVenezuelaSAMember" abstract="true" name="SanofiAventisDeVenezuelaSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_TidalTherapeuticsMember" abstract="true" name="TidalTherapeuticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfLegalAndArbitralProceedingsTable" abstract="true" name="DisclosureOfLegalAndArbitralProceedingsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock" abstract="false" name="DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SanofiPasteurAsiTicaretASMember" abstract="true" name="SanofiPasteurAsiTicaretASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PrincipalAlliancesAxis" abstract="true" name="PrincipalAlliancesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_NetExposure" abstract="false" name="NetExposure" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_EquityInstrumentsIncludedInFinancialAssetMember" abstract="true" name="EquityInstrumentsIncludedInFinancialAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CurrentInterestRateDerivativesPayable" abstract="false" name="CurrentInterestRateDerivativesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_CashFlowAndFairValueHedgeMember" abstract="true" name="CashFlowAndFairValueHedgeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_OpellaHealthcareKoreaIncMember" abstract="true" name="OpellaHealthcareKoreaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_StockSubscriptionOptionPlanSixMember" abstract="true" name="StockSubscriptionOptionPlanSixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfOtherOperatingIncomeTable" abstract="true" name="DisclosureOfOtherOperatingIncomeTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_RestrictedSharePlansMember" abstract="true" name="RestrictedSharePlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" abstract="false" name="DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" abstract="false" name="CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ChangeInCurrencyTranslationOnTaxEffects" abstract="false" name="ChangeInCurrencyTranslationOnTaxEffects" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ProductLiabilitiesMember" abstract="true" name="ProductLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CollaborationAgreementWithGSKMember" abstract="true" name="CollaborationAgreementWithGSKMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" abstract="false" name="ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_InsilicoMedicineMember" abstract="true" name="InsilicoMedicineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" abstract="false" name="IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PercentageOfCumulativeDevelopmentCostsReimbursed" abstract="false" name="PercentageOfCumulativeDevelopmentCostsReimbursed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" abstract="false" name="ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member" abstract="true" name="EightHundredFiftyMillionBondsMaturingFebruary2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DepakineProductLitigationInSwitzerlandMember" abstract="true" name="DepakineProductLitigationInSwitzerlandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_CashInflowsFromExchangeOfBusinessInvestingActivities" abstract="false" name="CashInflowsFromExchangeOfBusinessInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ProvisionsRecordedForFutureOperatingLosses" abstract="false" name="ProvisionsRecordedForFutureOperatingLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" abstract="false" name="ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_CommoditiesMember" abstract="true" name="CommoditiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PaymentToSaleOfBusinessPeriod" abstract="false" name="PaymentToSaleOfBusinessPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" abstract="false" name="ExpenseOfRestructuringActivitiesTransformationProgramsCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement" abstract="false" name="SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_CurrentAssetsMember" abstract="true" name="CurrentAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PropertyPlantAndEquipmentInProcessMember" abstract="true" name="PropertyPlantAndEquipmentInProcessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_GeneralInformationAboutFinancialStatementsAbstract" abstract="true" name="GeneralInformationAboutFinancialStatementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock" abstract="false" name="DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_NonQualifiedDefinedBenefitPensionPlansMember" abstract="true" name="NonQualifiedDefinedBenefitPensionPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfOtherManufacturersInvolvedInProceedings" abstract="false" name="NumberOfOtherManufacturersInvolvedInProceedings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_September2015EMTNISINFR0012969038Member" abstract="true" name="September2015EMTNISINFR0012969038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock" abstract="false" name="DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SanofiAventisThailandLtdMember" abstract="true" name="SanofiAventisThailandLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits" abstract="false" name="KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_RPRUSLtdMember" abstract="true" name="RPRUSLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ResearchSitesMember" abstract="true" name="ResearchSitesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CerezymeMember" abstract="true" name="CerezymeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_USLegalRestructuringMember" abstract="true" name="USLegalRestructuringMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NetChangeInOtherNonCurrentAssets" abstract="false" name="NetChangeInOtherNonCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" abstract="false" name="ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiAventisCanadaIncMember" abstract="true" name="SanofiAventisCanadaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ManagedCareMember" abstract="true" name="ManagedCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" abstract="false" name="DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" abstract="false" name="AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_OneBillionBondsMaturingJanuary2022Member" abstract="true" name="OneBillionBondsMaturingJanuary2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod" abstract="false" name="ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_TaxExpenseOnDisposalOfInvestment" abstract="false" name="TaxExpenseOnDisposalOfInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PricewaterhousecoopersMember" abstract="true" name="PricewaterhousecoopersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OtherRestructuringCosts" abstract="false" name="OtherRestructuringCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_ResearchAndDevelopmentMember" abstract="true" name="ResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss" abstract="false" name="PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_MachineryAndEquipmentMember" abstract="true" name="MachineryAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" abstract="false" name="ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiForeignParticipationsB.V.Member" abstract="true" name="SanofiForeignParticipationsB.V.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ErnstYoungEtAutresMember" abstract="true" name="ErnstYoungEtAutresMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiPasteurBiologiesCo.LtdMember" abstract="true" name="SanofiPasteurBiologiesCo.LtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements" abstract="false" name="RegularMilestonePaymentsForProjectsUnderCollaborationAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_TransferPercentageOfPandemicVaccines" abstract="false" name="TransferPercentageOfPandemicVaccines" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_MarketedProductsTrademarksAndOtherRightsMember" abstract="true" name="MarketedProductsTrademarksAndOtherRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_RestrictedSharePlan2019Member" abstract="true" name="RestrictedSharePlan2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfLossConsortiumPlaintiffs" abstract="false" name="NumberOfLossConsortiumPlaintiffs" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_MinimumPlan2Member" abstract="true" name="MinimumPlan2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable" abstract="true" name="DisclosureOfNetIncomeAttributableToNonControllingInterestsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_ChinoinPrivateCoLtdMember" abstract="true" name="ChinoinPrivateCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PrincipalMarketedProductsChattemMember" abstract="true" name="PrincipalMarketedProductsChattemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ShareRepurchase2021ProgramMember" abstract="true" name="ShareRepurchase2021ProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering" abstract="false" name="BusinessCombinationNumberOfSharesIncludedInPublicOffering" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_JevtanaMember" abstract="true" name="JevtanaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NetInterestCostRelatedToEmployeeBenefits" abstract="false" name="NetInterestCostRelatedToEmployeeBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiABMember" abstract="true" name="SanofiABMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock" abstract="false" name="AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_PercentageOfProfitShareOnCounterpartiesProfit" abstract="false" name="PercentageOfProfitShareOnCounterpartiesProfit" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_KadmonHoldingsIncMember" abstract="true" name="KadmonHoldingsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ForwardCurrencySalesInChineseYuanRenminbiMember" abstract="true" name="ForwardCurrencySalesInChineseYuanRenminbiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_StockSubscriptionOptionPlanFiveMember" abstract="true" name="StockSubscriptionOptionPlanFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo" abstract="false" name="PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_FinancialInstrumentsAbstract" abstract="true" name="FinancialInstrumentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_PharmaceuticalsMember" abstract="true" name="PharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfProductsJointlyDeveloped" abstract="false" name="NumberOfProductsJointlyDeveloped" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" abstract="false" name="DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ReservePercentageOfPandemicVaccines" abstract="false" name="ReservePercentageOfPandemicVaccines" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_AllergyMember" abstract="true" name="AllergyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_RestrictedSharePlan2020Member" abstract="true" name="RestrictedSharePlan2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfOtherOperatingIncomeExpensesTable" abstract="true" name="DisclosureOfOtherOperatingIncomeExpensesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_PretaxDiscountRateAppliedForGoodwill" abstract="false" name="PretaxDiscountRateAppliedForGoodwill" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty" abstract="false" name="PercentageOfFutureDevelopmentExpenseFundedByOtherParty" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember" abstract="true" name="EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts" abstract="false" name="CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_March2020EMTNISINFR0013505112Member" abstract="true" name="March2020EMTNISINFR0013505112Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_April282020Member" abstract="true" name="April282020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember" abstract="true" name="GenzymeGlobalSarlBaarIntellectualPropertyBranchMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember" abstract="true" name="MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_EquityInstrumentsMember" abstract="true" name="EquityInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiPasteurMerieuxSASMember" abstract="true" name="SanofiPasteurMerieuxSASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_AmunixMember" abstract="true" name="AmunixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_RestrictedSharesMember" abstract="true" name="RestrictedSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PercentageIncreaseInFairValueLiabilities" abstract="false" name="PercentageIncreaseInFairValueLiabilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember" abstract="true" name="OtherContingentConsiderationArisingFromBusinessCombinationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CorporateInformationAndStatementOfIFRSComplianceAbstract" abstract="true" name="CorporateInformationAndStatementOfIFRSComplianceAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_InterestIncome" abstract="false" name="InterestIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NeurologyImmunologyMember" abstract="true" name="NeurologyImmunologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable" abstract="true" name="DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_AdjustmentToDebtMeasuredAtFairValueMember" abstract="true" name="AdjustmentToDebtMeasuredAtFairValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PerformanceObjectiveMinimumNumberOfPatients" abstract="false" name="PerformanceObjectiveMinimumNumberOfPatients" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_DepakineProductLitigationInFranceMember" abstract="true" name="DepakineProductLitigationInFranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_GuaranteesReceivedMember" abstract="true" name="GuaranteesReceivedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OfficeSpaceCambridgeMassachusettsMember" abstract="true" name="OfficeSpaceCambridgeMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_PotentialPaymentsRelatedToPercentageOfSales" abstract="false" name="PotentialPaymentsRelatedToPercentageOfSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_March2018EMTNISINFR0013324340Member" abstract="true" name="March2018EMTNISINFR0013324340Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisIsraelLtdMember" abstract="true" name="SanofiAventisIsraelLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_March2020EMTNISINFR0013505104Member" abstract="true" name="March2020EMTNISINFR0013505104Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OpellaHealthcareLLCMember" abstract="true" name="OpellaHealthcareLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiProdutosFarmaceuticosLdaMember" abstract="true" name="SanofiProdutosFarmaceuticosLdaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity" abstract="false" name="NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_InfraservHoechstRetainedLiabilitiesMember" abstract="true" name="InfraservHoechstRetainedLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfAccountsReceivableTable" abstract="true" name="DisclosureOfAccountsReceivableTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD" abstract="false" name="CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfTaxLossesAvailableForCarryforwardTable" abstract="true" name="DisclosureOfTaxLossesAvailableForCarryforwardTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_PlavixAttorneyGeneralActionInHawaiiMember" abstract="true" name="PlavixAttorneyGeneralActionInHawaiiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_BorrowingAverageDrawdown" abstract="false" name="BorrowingAverageDrawdown" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember" abstract="true" name="PraluentAlirocumabRelatedEpoPatentOppositionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IGMBiosciencesIncMember" abstract="true" name="IGMBiosciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ContingentConsiderationLiabilities" abstract="false" name="ContingentConsiderationLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ProvisionsAndOtherNonCurrentLiabilitiesTable" abstract="true" name="ProvisionsAndOtherNonCurrentLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_OrdinarySharesNASDAQGlobalSelectMarketMember" abstract="true" name="OrdinarySharesNASDAQGlobalSelectMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_TaxLossesCarryforwards" abstract="false" name="TaxLossesCarryforwards" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ExpenseCategoriesAxis" abstract="true" name="ExpenseCategoriesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock" abstract="false" name="DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_LongTermPrepaidExpenses" abstract="false" name="LongTermPrepaidExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ManagedCareAndGPOProgramsMember" abstract="true" name="ManagedCareAndGPOProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OthersCounterpartyMember" abstract="true" name="OthersCounterpartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities" abstract="false" name="DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_CashEquivalentsMoneyMarketMutualFunds" abstract="false" name="CashEquivalentsMoneyMarketMutualFunds" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ParticipatingSharesMember" abstract="true" name="ParticipatingSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ActuarialGainsAndLossesOnDefinedBenefitPlans" abstract="false" name="ActuarialGainsAndLossesOnDefinedBenefitPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" abstract="false" name="IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_June2018SNFISINUS801060AC87Member" abstract="true" name="June2018SNFISINUS801060AC87Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_QuotedDebtInstrumentsMember" abstract="true" name="QuotedDebtInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisPhilippinesIncMember" abstract="true" name="SanofiAventisPhilippinesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IncreaseInContingentConsideration" abstract="false" name="IncreaseInContingentConsideration" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_SalesOfAntibodiesThirdAchievementMember" abstract="true" name="SalesOfAntibodiesThirdAchievementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember" abstract="true" name="ChangeInEuroAndUSDollarShortTermInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_TwoThousandEighteenLetterAgreementMember" abstract="true" name="TwoThousandEighteenLetterAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ForwardCurrencySalesInJapaneseYenMember" abstract="true" name="ForwardCurrencySalesInJapaneseYenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisNorgeASMember" abstract="true" name="SanofiAventisNorgeASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_WriteDownMember" abstract="true" name="WriteDownMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AventisPharmaSAFranceMember" abstract="true" name="AventisPharmaSAFranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiChimieMember" abstract="true" name="SanofiChimieMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems" abstract="true" name="DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_ShareRepurchase2020ProgramMember" abstract="true" name="ShareRepurchase2020ProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking" abstract="false" name="ConsiderationTransferredToFundReserveForIndemnificationUndertaking" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock" abstract="false" name="DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_UnquotedEquityInvestmentsMember" abstract="true" name="UnquotedEquityInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DerivativeFinancialInstruments" abstract="false" name="DerivativeFinancialInstruments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_CollaborationAgreementCommitmentAmount" abstract="false" name="CollaborationAgreementCommitmentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_BusinessCombinationPurchasePricePerShare" abstract="false" name="BusinessCombinationPurchasePricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="sny_DerivativeFinancialInstrumentsToManageFinancialExposure" abstract="false" name="DerivativeFinancialInstrumentsToManageFinancialExposure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" abstract="false" name="CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NetAmountsAsReportedInTheBalanceSheet" abstract="false" name="NetAmountsAsReportedInTheBalanceSheet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" abstract="false" name="ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NewBusinessModelRolloutInVariousGeographiesMember" abstract="true" name="NewBusinessModelRolloutInVariousGeographiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NumberOfBondIssuesRedeemed" abstract="false" name="NumberOfBondIssuesRedeemed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" abstract="false" name="WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="sny_USGovernmentMember" abstract="true" name="USGovernmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ConsumerHealthcareMember" abstract="true" name="ConsumerHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SalesOfAntibodiesFirstAchievementMember" abstract="true" name="SalesOfAntibodiesFirstAchievementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NewAgreementMember" abstract="true" name="NewAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive" abstract="false" name="IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock" abstract="false" name="DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" abstract="false" name="IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" abstract="true" name="ShareOfProfitOrLossFromCommercializationOfZaltrapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ForeignCurrencyTranslationMember" abstract="true" name="ForeignCurrencyTranslationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ShelfRegistrationStatementProgramMember" abstract="true" name="ShelfRegistrationStatementProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PrincipalMarketedProductsAventisMember" abstract="true" name="PrincipalMarketedProductsAventisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ImpairmentTestingPercentage" abstract="false" name="ImpairmentTestingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_ExceptionalSupplementaryDividendPercentageOfShareCapital" abstract="false" name="ExceptionalSupplementaryDividendPercentageOfShareCapital" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" abstract="false" name="ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ForwardCurrencyPurchasedInRussianRoubleMember" abstract="true" name="ForwardCurrencyPurchasedInRussianRoubleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CurrentCurrencyDerivativesPayable" abstract="false" name="CurrentCurrencyDerivativesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_OtherNonCoreAssetsMember" abstract="true" name="OtherNonCoreAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" abstract="false" name="IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" abstract="true" name="DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_NumberOfCases" abstract="false" name="NumberOfCases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember" abstract="true" name="AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_UnquotedDebtSecuritiesMember" abstract="true" name="UnquotedDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" abstract="false" name="DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" abstract="false" name="FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="sny_KadmonMember" abstract="true" name="KadmonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_WorldHealthOrganizationMember" abstract="true" name="WorldHealthOrganizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AmountsPayableForAcquisitionOfNonCurrentAssets" abstract="false" name="AmountsPayableForAcquisitionOfNonCurrentAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_RareDiseasesMember" abstract="true" name="RareDiseasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees" abstract="false" name="NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_OpellaHealthcareEgyptLLCMember" abstract="true" name="OpellaHealthcareEgyptLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NumberOfRestrictedSharesNotYetFullyVested" abstract="false" name="NumberOfRestrictedSharesNotYetFullyVested" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_OtherMovements" abstract="false" name="OtherMovements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_StockSubscriptionOptionPlanMember" abstract="true" name="StockSubscriptionOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiMember" abstract="true" name="SanofiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_GovernmentAndStateProgramsMember" abstract="true" name="GovernmentAndStateProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CashAndCashEquivalentsMember" abstract="true" name="CashAndCashEquivalentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_LovenoxMember" abstract="true" name="LovenoxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ActionForWhichWeAreDefendantMember" abstract="true" name="ActionForWhichWeAreDefendantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ChattemIncMember" abstract="true" name="ChattemIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DebtInstrumentsMember" abstract="true" name="DebtInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ContingenciesArisingFromCertainBusinessDivestituresMember" abstract="true" name="ContingenciesArisingFromCertainBusinessDivestituresMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" abstract="false" name="DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfDebtByCurrencyTable" abstract="true" name="DisclosureOfDebtByCurrencyTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock" abstract="false" name="DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SanofiaventisAEBEMember" abstract="true" name="SanofiaventisAEBEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_TaxLossCarryforwardsOnAssetDisposals" abstract="false" name="TaxLossCarryforwardsOnAssetDisposals" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_KymabMember" abstract="true" name="KymabMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_QuotedEquityInvestmentsMember" abstract="true" name="QuotedEquityInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised" abstract="false" name="UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_InsurancePoliciesMember" abstract="true" name="InsurancePoliciesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PublicOfferingMember" abstract="true" name="PublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" abstract="false" name="ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PreFundedPensionObligations" abstract="false" name="PreFundedPensionObligations" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" abstract="false" name="DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_BusinessOperatingIncome" abstract="false" name="BusinessOperatingIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock" abstract="false" name="DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_CurrencyDerivativesOperatingMember" abstract="true" name="CurrencyDerivativesOperatingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PrincipalMarketedProductsGenzymeMember" abstract="true" name="PrincipalMarketedProductsGenzymeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation" abstract="false" name="MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" abstract="false" name="IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_TranslateBioMember" abstract="true" name="TranslateBioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_QuotedEuroDenominatedSeniorBondsMember" abstract="true" name="QuotedEuroDenominatedSeniorBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiIlacSanayiVeTicaretASMember" abstract="true" name="SanofiIlacSanayiVeTicaretASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfPayments" abstract="false" name="NumberOfPayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate" abstract="false" name="OtherAssetsAndLiabilitiesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock" abstract="false" name="DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_PerformanceObjectiveNumberOfCountries" abstract="false" name="PerformanceObjectiveNumberOfCountries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_NumberOfCurrenciesDebtIsIssuedIn" abstract="false" name="NumberOfCurrenciesDebtIsIssuedIn" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" abstract="false" name="AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiTaiwanCoLtdMember" abstract="true" name="SanofiTaiwanCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_RoyaltyIncomePercentage" abstract="false" name="RoyaltyIncomePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_ExscientiaMember" abstract="true" name="ExscientiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable" abstract="true" name="DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_LiabilityRecognizedRepresentingEstimatedCost" abstract="false" name="LiabilityRecognizedRepresentingEstimatedCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AmountsPayablePartnersInCollaborationAgreements" abstract="false" name="AmountsPayablePartnersInCollaborationAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ABLBioMember" abstract="true" name="ABLBioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems" abstract="true" name="DisclosureOfTaxLossesAvailableForCarryforwardLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_StockSubscriptionOptionPlanTenMember" abstract="true" name="StockSubscriptionOptionPlanTenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiPasteurSpZooMember" abstract="true" name="SanofiPasteurSpZooMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory" abstract="false" name="DescriptionOfAccountingPolicyForCostOfSalesExplanatory" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember" abstract="true" name="AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfPeopleExposed" abstract="false" name="NumberOfPeopleExposed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock" abstract="false" name="DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" abstract="false" name="TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SAR444245Member" abstract="true" name="SAR444245Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_CommitmentsReceivedForDevelopmentCosts" abstract="false" name="CommitmentsReceivedForDevelopmentCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfCivilIndividualActions" abstract="false" name="NumberOfCivilIndividualActions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement" abstract="false" name="CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiEgyptSAEMember" abstract="true" name="SanofiEgyptSAEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ManufactureAndSupplyCollaborationAgreementMember" abstract="true" name="ManufactureAndSupplyCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiASMember" abstract="true" name="SanofiASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ForeignCurrencyTranslationDifferences" abstract="false" name="ForeignCurrencyTranslationDifferences" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_FabrazymeMember" abstract="true" name="FabrazymeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems" abstract="true" name="ProvisionsAndOtherNonCurrentLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_PercentageOfProfitsArisingFromCommercialOperations" abstract="false" name="PercentageOfProfitsArisingFromCommercialOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_PriorDevelopmentBudget" abstract="false" name="PriorDevelopmentBudget" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfDaysAfterCompletionOfPostTrailBriefing" abstract="false" name="NumberOfDaysAfterCompletionOfPostTrailBriefing" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member" abstract="true" name="OneBillionFiveHundredMillionBondsIssuedInApril2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SalesOfAntibodiesSecondAchievementMember" abstract="true" name="SalesOfAntibodiesSecondAchievementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_PrincipalAlliancesDomain" abstract="true" name="PrincipalAlliancesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember" abstract="true" name="ConsolidationAdjustmentsIntragroupMarginInInventoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DerecognizedReceivables" abstract="false" name="DerecognizedReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_RestrictedSharePlan2022Member" abstract="true" name="RestrictedSharePlan2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NumberOfPatentsAllegedlyInfringed" abstract="false" name="NumberOfPatentsAllegedlyInfringed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" abstract="false" name="IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" abstract="false" name="ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ForwardCurrencySalesInKoreanWonMember" abstract="true" name="ForwardCurrencySalesInKoreanWonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiVietnamShareholdingCompanyLimitedMember" abstract="true" name="SanofiVietnamShareholdingCompanyLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OtherBankBorrowings" abstract="false" name="OtherBankBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfNoncurrentProvisionsLineItems" abstract="true" name="DisclosureOfNoncurrentProvisionsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_KadmonCorporationLLCMember" abstract="true" name="KadmonCorporationLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_MilestoneTypesDomain" abstract="true" name="MilestoneTypesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember" abstract="true" name="GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" abstract="false" name="DisclosureOfLegalAndArbitralProceedingsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_IrrevocablePurchaseCommitmentsGiven" abstract="false" name="IrrevocablePurchaseCommitmentsGiven" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_BorrowingMaximumDrawdown" abstract="false" name="BorrowingMaximumDrawdown" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_IOLicenseAndCollaborationAgreementMember" abstract="true" name="IOLicenseAndCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" abstract="false" name="AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_April2022EMTNISINFR0014009KS6Member" abstract="true" name="April2022EMTNISINFR0014009KS6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember" abstract="true" name="ShortTermDebtAndCurrentPortionOfLongTermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" abstract="false" name="DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_GainOnDerivativesUsedToManageDebt" abstract="false" name="GainOnDerivativesUsedToManageDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PerformanceSharePlanTwoMember" abstract="true" name="PerformanceSharePlanTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" abstract="false" name="IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" abstract="false" name="PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_SanofiPasteurNVLMember" abstract="true" name="SanofiPasteurNVLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock" abstract="false" name="DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" abstract="false" name="NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfOtherNoncurrentAssetsTable" abstract="true" name="DisclosureOfOtherNoncurrentAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures" abstract="false" name="IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_MilestonePaymentTerm" abstract="false" name="MilestonePaymentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:gYearItemType"/>
  <xs:element id="sny_ForwardCurrencyPurchasedInHungarianForintMember" abstract="true" name="ForwardCurrencyPurchasedInHungarianForintMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OutsideUnitedStatesMember" abstract="true" name="OutsideUnitedStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement" abstract="false" name="NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired" abstract="false" name="BusinessAcquisitionPercentageOfVotingInterestsAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="sny_CurrentEquityDerivativesPayable" abstract="false" name="CurrentEquityDerivativesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiAventisSAMember" abstract="true" name="SanofiAventisSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_JevtanaRelatedPatentLitigationInTheUSMember" abstract="true" name="JevtanaRelatedPatentLitigationInTheUSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_BlackstoneLifeSciencesMember" abstract="true" name="BlackstoneLifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NonCurrentRestructuringProvisionMember" abstract="true" name="NonCurrentRestructuringProvisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_FairValueOfSPMSDContingentConsiderationMember" abstract="true" name="FairValueOfSPMSDContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement" abstract="false" name="NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_NumberOfSharesHeld" abstract="false" name="NumberOfSharesHeld" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_April2016EMTNISINFR0013143997Member" abstract="true" name="April2016EMTNISINFR0013143997Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_GenfarSAMember" abstract="true" name="GenfarSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss" abstract="false" name="PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_OpellaHealthcareSpainSLMember" abstract="true" name="OpellaHealthcareSpainSLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_WithoutMarketConditionMember" abstract="true" name="WithoutMarketConditionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_March2019EMTNISINFR0013409844Member" abstract="true" name="March2019EMTNISINFR0013409844Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PlaintiffMember" abstract="true" name="PlaintiffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfPrincipalMarketedProductsTableTextBlock" abstract="false" name="DisclosureOfPrincipalMarketedProductsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ZantacLitigationInTheUSMDLCourtMember" abstract="true" name="ZantacLitigationInTheUSMDLCourtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiAventisAustraliaPtyLtdMember" abstract="true" name="SanofiAventisAustraliaPtyLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CustomerOneMember" abstract="true" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" abstract="false" name="DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_NumberOfCountriesIncludedInPensionPlans" abstract="false" name="NumberOfCountriesIncludedInPensionPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="sny_GenzymeMember" abstract="true" name="GenzymeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfAccountsReceivableLineItems" abstract="true" name="DisclosureOfAccountsReceivableLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_HealthcareCoverAndLifeInsuranceMember" abstract="true" name="HealthcareCoverAndLifeInsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_StockOptionsAndShareBasedPaymentsMember" abstract="true" name="StockOptionsAndShareBasedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PenaltyFeeIncurred" abstract="false" name="PenaltyFeeIncurred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfOtherOperatingIncomeLineItems" abstract="true" name="DisclosureOfOtherOperatingIncomeLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_GenzymeGlobalSarlMember" abstract="true" name="GenzymeGlobalSarlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty" abstract="false" name="PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" abstract="false" name="IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SeprafilmMember" abstract="true" name="SeprafilmMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisHoldingsIrelandLtdMember" abstract="true" name="SanofiAventisHoldingsIrelandLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_EnjaymoMember" abstract="true" name="EnjaymoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_KiadisMember" abstract="true" name="KiadisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_GenzymeLuxembourgSarlMember" abstract="true" name="GenzymeLuxembourgSarlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiPasteurLimitedMember" abstract="true" name="SanofiPasteurLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfOffBalanceSheetCommitmentsTable" abstract="true" name="DisclosureOfOffBalanceSheetCommitmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems" abstract="true" name="DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_GenzymeEuropeBVMember" abstract="true" name="GenzymeEuropeBVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" abstract="false" name="CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_InitialLeaseTerm" abstract="false" name="InitialLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_ReclassificationFromNonCurrentToCurrent" abstract="false" name="ReclassificationFromNonCurrentToCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfTargetsThatEncompassAllDiseasesAreas" abstract="false" name="NumberOfTargetsThatEncompassAllDiseasesAreas" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_SaleOfStockAxis" abstract="true" name="SaleOfStockAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_SyndicatedCreditFacilityTwoMember" abstract="true" name="SyndicatedCreditFacilityTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CommitmentsMadeToJointVenturesAndAssociates" abstract="false" name="CommitmentsMadeToJointVenturesAndAssociates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AventisCropScienceRetainedLiabilitiesMember" abstract="true" name="AventisCropScienceRetainedLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" abstract="false" name="DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfGuaranteesTable" abstract="true" name="DisclosureOfGuaranteesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_ShareRepurchase2022ProgramMember" abstract="true" name="ShareRepurchase2022ProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_GlaxoSmithKlineConsumerHealthcareLPMember" abstract="true" name="GlaxoSmithKlineConsumerHealthcareLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock" abstract="false" name="DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SanofiAventisPakistanLtdMember" abstract="true" name="SanofiAventisPakistanLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisHealthcarePtyLtdMember" abstract="true" name="SanofiAventisHealthcarePtyLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IncomeStatementLocationAxis" abstract="true" name="IncomeStatementLocationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfAuditFeesAndOtherServicesLineItems" abstract="true" name="DisclosureOfAuditFeesAndOtherServicesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember" abstract="true" name="AmericanDepositorySharesNASDAQGlobalSelectMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_StockSubscriptionOptionPlanEightMember" abstract="true" name="StockSubscriptionOptionPlanEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member" abstract="true" name="InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities" abstract="false" name="PercentageContributedToFairValueOfPlanAssetsOtherSecurities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_PercentageOfAuditorRemunerationForStatutoryAudit" abstract="false" name="PercentageOfAuditorRemunerationForStatutoryAudit" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_SaleOfStockDomain" abstract="true" name="SaleOfStockDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_HoechstGmbHMember" abstract="true" name="HoechstGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" abstract="false" name="DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DebtNetOfCashAndCashEquivalents" abstract="false" name="DebtNetOfCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ExercisePriceRangeFourMember" abstract="true" name="ExercisePriceRangeFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisGulfFZEMember" abstract="true" name="SanofiAventisGulfFZEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ConsiderationTransferredMaximumAmount" abstract="false" name="ConsiderationTransferredMaximumAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiIndiaLimitedMember" abstract="true" name="SanofiIndiaLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement" abstract="false" name="ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_MapharMember" abstract="true" name="MapharMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_MinimumPlan1Member" abstract="true" name="MinimumPlan1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" abstract="false" name="DisclosureOfCurrentTradeReceivablesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember" abstract="true" name="SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ScribeTherapeuticsMember" abstract="true" name="ScribeTherapeuticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" abstract="false" name="DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AubagioMember" abstract="true" name="AubagioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_RegulatoryComplianceCostsMember" abstract="true" name="RegulatoryComplianceCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock" abstract="false" name="DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_EquityDerivativesMember" abstract="true" name="EquityDerivativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_RoyaltyExpensePercentage" abstract="false" name="RoyaltyExpensePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_SaleOfStockTransactionCosts" abstract="false" name="SaleOfStockTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember" abstract="true" name="EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_StockOptionsWithNoDilutiveEffect" abstract="false" name="StockOptionsWithNoDilutiveEffect" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_March2018EMTNISINFR0013324373Member" abstract="true" name="March2018EMTNISINFR0013324373Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_TotalDeferredTaxAssetsForTaxLossCarryforwards" abstract="false" name="TotalDeferredTaxAssetsForTaxLossCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets" abstract="false" name="AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember" abstract="true" name="RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AventisubLLCMember" abstract="true" name="AventisubLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification" abstract="false" name="NumberOfPeopleExposedWhoFiledARequestForIndemnification" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_NonCurrentProvisionForEnvironmentRisks" abstract="false" name="NonCurrentProvisionForEnvironmentRisks" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfAdministrativeProceedings" abstract="false" name="NumberOfAdministrativeProceedings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_CommercialPaperProgramInUSAMember" abstract="true" name="CommercialPaperProgramInUSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiBiotechnologyMember" abstract="true" name="SanofiBiotechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ShareCapitalReservesAndOtherEquityInterestAbstract" abstract="true" name="ShareCapitalReservesAndOtherEquityInterestAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_OpellaHealthcareItalySRLMember" abstract="true" name="OpellaHealthcareItalySRLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_BioverativTherapeuticsIncMember" abstract="true" name="BioverativTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember" abstract="true" name="IncreaseOfTenPercentBasisPointInMarketInterestRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OtherGuaranteesGivenMember" abstract="true" name="OtherGuaranteesGivenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ForwardCurrencyPurchasedInJapaneseYenMember" abstract="true" name="ForwardCurrencyPurchasedInJapaneseYenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_GuaranteesGivenMember" abstract="true" name="GuaranteesGivenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" abstract="false" name="DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared" abstract="false" name="PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_SanofiPasteurLtdMember" abstract="true" name="SanofiPasteurLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ContingentConsiderationRelatingToDivestmentsMember" abstract="true" name="ContingentConsiderationRelatingToDivestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" abstract="false" name="ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_FairValuePerShareAwardedForThreeYearServicePeriod" abstract="false" name="FairValuePerShareAwardedForThreeYearServicePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember" abstract="true" name="InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember" abstract="true" name="RemeasurementOfOtherAcquiredIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfShareSubscribed" abstract="false" name="NumberOfShareSubscribed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment" abstract="false" name="AntiProgrammedCellDeathProtein1SalesMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiPasteurIncMember" abstract="true" name="SanofiPasteurIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfTradeReceivablesTextBlock" abstract="false" name="DisclosureOfTradeReceivablesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable" abstract="false" name="DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NoncurrentLiabilitiesMember" abstract="true" name="NoncurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfYearsServicePeriod" abstract="false" name="NumberOfYearsServicePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_AtNotionalAmountMember" abstract="true" name="AtNotionalAmountMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_EquityInvestmentSoldPercentage" abstract="false" name="EquityInvestmentSoldPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_September2014EMTNISINFR0012146801Member" abstract="true" name="September2014EMTNISINFR0012146801Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfBellweatherTrialsHeld" abstract="false" name="NumberOfBellweatherTrialsHeld" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_PaymentOfDamagesClaimedByCounterparty" abstract="false" name="PaymentOfDamagesClaimedByCounterparty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies" abstract="false" name="CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_MaximumPlan2Member" abstract="true" name="MaximumPlan2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiResearchInvestLLCMember" abstract="true" name="SanofiResearchInvestLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_EvotecMember" abstract="true" name="EvotecMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember" abstract="true" name="ShenzhenSanofiPasteurBiologicalProductsCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_InterestRateDerivativesMeasuredAtFairValue" abstract="false" name="InterestRateDerivativesMeasuredAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_LargestCustomersMember" abstract="true" name="LargestCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisDeColombiaSAMember" abstract="true" name="SanofiAventisDeColombiaSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisGmbHMember" abstract="true" name="SanofiAventisGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" abstract="false" name="NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod" abstract="false" name="ChangeInProvisionsRecognizedInProfitOrLossForThePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock" abstract="false" name="DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ServicesOtherThanStatutoryAudit" abstract="false" name="ServicesOtherThanStatutoryAudit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NonCurrentDerivativesMember" abstract="true" name="NonCurrentDerivativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DeferredTaxRelatingToRestructuringProvisionsMember" abstract="true" name="DeferredTaxRelatingToRestructuringProvisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_MerieuxCanadaHoldingsULCCanadaMember" abstract="true" name="MerieuxCanadaHoldingsULCCanadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ProceedsFromCollaborationAgreements" abstract="false" name="ProceedsFromCollaborationAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_MyozymeOrLumizymeMember" abstract="true" name="MyozymeOrLumizymeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ValueOnRedemptionMember" abstract="true" name="ValueOnRedemptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems" abstract="true" name="DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_NumberOfDecisionsIssuedByTheDistrictCourt" abstract="false" name="NumberOfDecisionsIssuedByTheDistrictCourt" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_CumulativeConsumerPriceInflationOverTheLastThreeYears" abstract="false" name="CumulativeConsumerPriceInflationOverTheLastThreeYears" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount" abstract="false" name="InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_TechnologicalPlatformsMember" abstract="true" name="TechnologicalPlatformsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock" abstract="false" name="DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_CommercializationRelatedExpensesMember" abstract="true" name="CommercializationRelatedExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_RoyaltiesPaymentsMadeBySanofi" abstract="false" name="RoyaltiesPaymentsMadeBySanofi" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" abstract="false" name="DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" abstract="false" name="AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiManufacturingPteLtdMember" abstract="true" name="SanofiManufacturingPteLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NonCoreAssetsMember" abstract="true" name="NonCoreAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ExercisePriceRangeThreeMember" abstract="true" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_BorrowingDrawdown" abstract="false" name="BorrowingDrawdown" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ForwardCurrencySalesInChineseYuanMember" abstract="true" name="ForwardCurrencySalesInChineseYuanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_PrincipalMarketedProductsProteinSciencesMember" abstract="true" name="PrincipalMarketedProductsProteinSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable" abstract="true" name="DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_LonzaMember" abstract="true" name="LonzaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ChargebackIncentivesMember" abstract="true" name="ChargebackIncentivesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OpellaHealthcareUKLimitedMember" abstract="true" name="OpellaHealthcareUKLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock" abstract="false" name="DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" abstract="true" name="DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_QuotedEquitySecuritiesMember" abstract="true" name="QuotedEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfAgreementsSigned" abstract="false" name="NumberOfAgreementsSigned" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_InnoventBiologicsMember" abstract="true" name="InnoventBiologicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_CoreAssetsMember" abstract="true" name="CoreAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ValueOfHedgeRecognizedInEquityMember" abstract="true" name="ValueOfHedgeRecognizedInEquityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_MarketConditionDomain" abstract="true" name="MarketConditionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ShareRepurchase2019ProgramMember" abstract="true" name="ShareRepurchase2019ProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiMatureIPMember" abstract="true" name="SanofiMatureIPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CarraigInsuranceDACMember" abstract="true" name="CarraigInsuranceDACMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations" abstract="false" name="TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_PriorAgreementMember" abstract="true" name="PriorAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiAventisDeMexicoSADeCVMember" abstract="true" name="SanofiAventisDeMexicoSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" abstract="false" name="DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock" abstract="false" name="DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfActuarialAssumptionsTableTextBlock" abstract="false" name="DisclosureOfActuarialAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_MCMVaccineBVMember" abstract="true" name="MCMVaccineBVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ProvisionsForDiscountsRebatesAndSalesReturns" abstract="false" name="ProvisionsForDiscountsRebatesAndSalesReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_LantusMember" abstract="true" name="LantusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable" abstract="true" name="DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_ShanghaiRonghengPharmaceuticalCoLtdMember" abstract="true" name="ShanghaiRonghengPharmaceuticalCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_TotalStockOptionPlansMember" abstract="true" name="TotalStockOptionPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets" abstract="false" name="CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiAventisGroupeMember" abstract="true" name="SanofiAventisGroupeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfCounterExpertiseExperts" abstract="false" name="NumberOfCounterExpertiseExperts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_NumberOfOperatingSegments" abstract="false" name="NumberOfOperatingSegments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_RetirementAge" abstract="false" name="RetirementAge" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_BioverativMember" abstract="true" name="BioverativMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems" abstract="true" name="DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfPrincipalAlliancesLineItems" abstract="true" name="DisclosureOfPrincipalAlliancesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_AntibodiesAllianceMember" abstract="true" name="AntibodiesAllianceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_A.NattermannCie.GmbHMember" abstract="true" name="A.NattermannCie.GmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_RamiprilCanadaPatentLitigationMember" abstract="true" name="RamiprilCanadaPatentLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" abstract="false" name="AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AdageneIncMember" abstract="true" name="AdageneIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ValueOnRedemptionAfterDerivativeInstrumentsMember" abstract="true" name="ValueOnRedemptionAfterDerivativeInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CurrentLiabilitiesMember" abstract="true" name="CurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" abstract="false" name="DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SanofiArabiaTradingCompanyLimitedMember" abstract="true" name="SanofiArabiaTradingCompanyLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock" abstract="false" name="DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ContingentConsiderationTranslateBioMember" abstract="true" name="ContingentConsiderationTranslateBioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_FirmOrdersOfPropertyPlantAndEquipment" abstract="false" name="FirmOrdersOfPropertyPlantAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" abstract="false" name="CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NotEligibleForHedgeAccountingMember" abstract="true" name="NotEligibleForHedgeAccountingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IssuanceOfFurtherSharesAsAnEmployersContribution" abstract="false" name="IssuanceOfFurtherSharesAsAnEmployersContribution" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_IrrevocablePurchaseCommitmentsReceived" abstract="false" name="IrrevocablePurchaseCommitmentsReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_OpellaHealthcareRomaniaSRLMember" abstract="true" name="OpellaHealthcareRomaniaSRLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NumberOfOngoingTrials" abstract="false" name="NumberOfOngoingTrials" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_GainsOnDivestmentOfProducts" abstract="false" name="GainsOnDivestmentOfProducts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" abstract="false" name="DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ErnstAndYoungMember" abstract="true" name="ErnstAndYoungMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_March2019EMTNISINFR0013409851Member" abstract="true" name="March2019EMTNISINFR0013409851Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" abstract="true" name="DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss" abstract="false" name="PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_GainOnDerivativesUsedToManageCashAndCashEquivalents" abstract="false" name="GainOnDerivativesUsedToManageCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ZantacLitigationInTheUSMember" abstract="true" name="ZantacLitigationInTheUSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" abstract="false" name="DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses" abstract="false" name="GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PrincipalMarketedProductsMember" abstract="true" name="PrincipalMarketedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense" abstract="false" name="MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ExpenseCategoriesDomain" abstract="true" name="ExpenseCategoriesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AmountOfSharesRepurchased" abstract="false" name="AmountOfSharesRepurchased" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DefinedBenefitPensionPlansMember" abstract="true" name="DefinedBenefitPensionPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax" abstract="false" name="AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ForwardCurrencyPurchasedInKoreanWonMember" abstract="true" name="ForwardCurrencyPurchasedInKoreanWonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" abstract="false" name="IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_GainOnRegeneronInvestmentSold" abstract="false" name="GainOnRegeneronInvestmentSold" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PeriodOfShareRepurchaseProgram" abstract="false" name="PeriodOfShareRepurchaseProgram" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" abstract="false" name="CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" abstract="true" name="ItemsSubsequentlyReclassifiableToProfitOrLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ForwardCurrencyPurchasedInSingaporeDollarMember" abstract="true" name="ForwardCurrencyPurchasedInSingaporeDollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember" abstract="true" name="LaterThanFiveYearsAndNotLaterThanEightYearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral" abstract="false" name="EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfLawsuitsRuledOnMerit" abstract="false" name="NumberOfLawsuitsRuledOnMerit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock" abstract="false" name="DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DepakineProductLitigationInSpainMember" abstract="true" name="DepakineProductLitigationInSpainMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_LitigationAmountPayable" abstract="false" name="LitigationAmountPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock" abstract="false" name="DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember" abstract="true" name="ValueOnRedemptionBeforeDerivativeInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" abstract="false" name="DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfNoncurrentProvisionsTable" abstract="true" name="DisclosureOfNoncurrentProvisionsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_GenzymeTherapeuticProductsLimitedPartnershipMember" abstract="true" name="GenzymeTherapeuticProductsLimitedPartnershipMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" abstract="false" name="InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ForwardCurrencyPurchasedInTaiwanDollarMember" abstract="true" name="ForwardCurrencyPurchasedInTaiwanDollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_PatentsMember" abstract="true" name="PatentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets" abstract="false" name="DecreaseThroughLossOfControlOfSubsidiaryNetAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_InterestRateDerivativesMember" abstract="true" name="InterestRateDerivativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CurrencySwapsInUSDToEURMember" abstract="true" name="CurrencySwapsInUSDToEURMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock" abstract="false" name="DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember" abstract="true" name="FinancialAssetsHeldToFundDeferredCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OpellaHealthcareCzechSroMember" abstract="true" name="OpellaHealthcareCzechSroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" abstract="false" name="ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SalesReturnMember" abstract="true" name="SalesReturnMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" abstract="false" name="ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment" abstract="false" name="IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount" abstract="false" name="EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_CurrentProvisionsAndOtherCurrentLiabilities" abstract="false" name="CurrentProvisionsAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PurchasePrice" abstract="false" name="PurchasePrice" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" abstract="false" name="DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" abstract="false" name="BasicEarningsLossPerShareAttributableToOwnersOfParent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="sny_CurrencyDerivativesFinancialMember" abstract="true" name="CurrencyDerivativesFinancialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts" abstract="false" name="ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock" abstract="false" name="DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock" abstract="false" name="DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths" abstract="false" name="IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ForwardCurrencySalesMember" abstract="true" name="ForwardCurrencySalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OtherOperatingExpensesRelatedToBusinessCombinations" abstract="false" name="OtherOperatingExpensesRelatedToBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" abstract="false" name="NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_LegalAndArbitralProceedingsAxis" abstract="true" name="LegalAndArbitralProceedingsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_PainCareMember" abstract="true" name="PainCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CashGeneratingUnitsMember" abstract="true" name="CashGeneratingUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment" abstract="false" name="MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AventisIncMember" abstract="true" name="AventisIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" abstract="false" name="DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_CashEquivalentsCommercialPaper" abstract="false" name="CashEquivalentsCommercialPaper" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" abstract="false" name="EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfOtherNonCurrentAssetsLineItems" abstract="true" name="DisclosureOfOtherNonCurrentAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_April2022EMTNISINFR0014009KQ0Member" abstract="true" name="April2022EMTNISINFR0014009KQ0Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" abstract="false" name="NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_GainLossOnSaleOfTreasuryShares" abstract="false" name="GainLossOnSaleOfTreasuryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_StockOptionPlansMember" abstract="true" name="StockOptionPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfCreditFacilities" abstract="false" name="NumberOfCreditFacilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_PlavixMember" abstract="true" name="PlavixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CollaborationAgreementAnnualNetSalesTarget" abstract="false" name="CollaborationAgreementAnnualNetSalesTarget" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfShareOutstandingInShareBasedPaymentArrangement" abstract="false" name="NumberOfShareOutstandingInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="sny_SanofiAventisUkHoldingsLimitedMember" abstract="true" name="SanofiAventisUkHoldingsLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisposalGroupNameAxis" abstract="true" name="DisposalGroupNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_ReportableGeographicalZonesMember" abstract="true" name="ReportableGeographicalZonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal" abstract="false" name="SaleOfStockNumberOfSharesIssuedInTransactionTotal" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_FairValueOfTheContingentConsideration" abstract="false" name="FairValueOfTheContingentConsideration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember" abstract="true" name="PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" abstract="false" name="InterestRateAndCurrencyDerivativesUsedToManageDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AventisPharmaManufacturingPTELTDMember" abstract="true" name="AventisPharmaManufacturingPTELTDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock" abstract="false" name="DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_AcquiredRDMember" abstract="true" name="AcquiredRDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisDeChileSAMember" abstract="true" name="SanofiAventisDeChileSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiAventisDePanamaSAMember" abstract="true" name="SanofiAventisDePanamaSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_GenzymeFlandersBVBAMember" abstract="true" name="GenzymeFlandersBVBAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" abstract="false" name="NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_IncomeResultingFromOutLicensing" abstract="false" name="IncomeResultingFromOutLicensing" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" abstract="true" name="MSDContingentConsiderationEuropeanVaccinesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember" abstract="true" name="ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SubscriptionPricePerShare" abstract="false" name="SubscriptionPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="sny_PercentageOfVotingEquityInterestsDivested" abstract="false" name="PercentageOfVotingEquityInterestsDivested" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_PaymentRelatedToAttainmentOfGoal" abstract="false" name="PaymentRelatedToAttainmentOfGoal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" abstract="false" name="ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_CurrencyDerivativesMeasuredAtFairValue" abstract="false" name="CurrencyDerivativesMeasuredAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_March2018EMTNISINFR0013324332Member" abstract="true" name="March2018EMTNISINFR0013324332Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfNoncurrentProvisionsTableTextBlock" abstract="false" name="DisclosureOfNoncurrentProvisionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_AuditorsNameMember" abstract="true" name="AuditorsNameMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock" abstract="false" name="DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_GenzymeIrelandLimitedMember" abstract="true" name="GenzymeIrelandLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PlavixRelatedLitigationInFranceMember" abstract="true" name="PlavixRelatedLitigationInFranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SPMSDContingentConsiderationAssetMember" abstract="true" name="SPMSDContingentConsiderationAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SeniorBondMember" abstract="true" name="SeniorBondMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_GlobalPenaltyFeeIncurredByDefendants" abstract="false" name="GlobalPenaltyFeeIncurredByDefendants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sny_RebatesAndDiscountsMember" abstract="true" name="RebatesAndDiscountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiPasteurEuropeMember" abstract="true" name="SanofiPasteurEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts" abstract="false" name="AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_SanofiAventisPrivateCoLtdMember" abstract="true" name="SanofiAventisPrivateCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiPasteurFranceSAMember" abstract="true" name="SanofiPasteurFranceSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiHealthcareIndiaPrivateLimitedMember" abstract="true" name="SanofiHealthcareIndiaPrivateLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_InfraservGmbhAndCoHochstKGMember" abstract="true" name="InfraservGmbhAndCoHochstKGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements" abstract="false" name="UpfrontPaymentsForProjectsUnderCollaborationAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfTranches" abstract="false" name="NumberOfTranches" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_LegalAndArbitralProceedingsDomain" abstract="true" name="LegalAndArbitralProceedingsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PrincipalUndiscountedCashFlow" abstract="false" name="PrincipalUndiscountedCashFlow" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans" abstract="false" name="AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_LeasedAssetsPercentage" abstract="false" name="LeasedAssetsPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_VaccinesSegmentMember" abstract="true" name="VaccinesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" abstract="true" name="DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_InfluenzaVaccinesMember" abstract="true" name="InfluenzaVaccinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisSuisseSAMember" abstract="true" name="SanofiAventisSuisseSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AntibodiesCollaborationAgreementMember" abstract="true" name="AntibodiesCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PossibleIncreaseInMortalityTableInYears" abstract="false" name="PossibleIncreaseInMortalityTableInYears" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_TypesOfAgreementAxis" abstract="true" name="TypesOfAgreementAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_SuppliersMember" abstract="true" name="SuppliersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" abstract="false" name="DisclosureOfMarketValueOfNetDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfChangesInFinancialPositionTableTextBlock" abstract="false" name="DisclosureOfChangesInFinancialPositionTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SanofiAventisVietnamCompanyLimitedMember" abstract="true" name="SanofiAventisVietnamCompanyLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfPrincipalAlliancesTextBlock" abstract="false" name="DisclosureOfPrincipalAlliancesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_AwardsDateDomain" abstract="true" name="AwardsDateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" abstract="false" name="EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_FairValueMeasurementAbstract" abstract="true" name="FairValueMeasurementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_NonCurrentAssetsMember" abstract="true" name="NonCurrentAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock" abstract="false" name="DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock" abstract="false" name="DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock" abstract="false" name="DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_OrigimmBiotechnologyGmbHMember" abstract="true" name="OrigimmBiotechnologyGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SynthorxMember" abstract="true" name="SynthorxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember" abstract="true" name="IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AwardsDateAxis" abstract="true" name="AwardsDateAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_CurrentDerivativesMember" abstract="true" name="CurrentDerivativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" abstract="false" name="TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ForwardCurrencySalesInTaiwanDollarMember" abstract="true" name="ForwardCurrencySalesInTaiwanDollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis" abstract="false" name="BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_OtherLiabilitiesMember" abstract="true" name="OtherLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisposalGroupGainOnDisposal" abstract="false" name="DisposalGroupGainOnDisposal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfSharesRepurchased" abstract="false" name="NumberOfSharesRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_EmployeeBenefitsAbstract" abstract="true" name="EmployeeBenefitsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_EightHundredFiftyMillionBondsMaturingJune2022Member" abstract="true" name="EightHundredFiftyMillionBondsMaturingJune2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_GenzymeCorporationMember" abstract="true" name="GenzymeCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfDefinedBenefitPlans" abstract="false" name="NumberOfDefinedBenefitPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" abstract="false" name="DilutedEarningsLossPerShareAttributableToOwnersOfParent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="sny_DisclosureOfInventoriesLineItems" abstract="true" name="DisclosureOfInventoriesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_PrincipalMarketedProductsAblynxMember" abstract="true" name="PrincipalMarketedProductsAblynxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember" abstract="true" name="EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_PlusTwentyFiveBasisPointsMember" abstract="true" name="PlusTwentyFiveBasisPointsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" abstract="false" name="IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AventisPharmaHoldingsLtdMember" abstract="true" name="AventisPharmaHoldingsLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_MilestoneTypesAxis" abstract="true" name="MilestoneTypesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member" abstract="true" name="InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember" abstract="true" name="EntitiesAndCompaniesManagedByBristolMyersSquibbMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfAuditFeesAndOtherServicesTable" abstract="true" name="DisclosureOfAuditFeesAndOtherServicesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock" abstract="false" name="DisclosureOfRestructuringCostsAndSimilarItemsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" abstract="false" name="DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" abstract="false" name="DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AztecaVacunasSADeCVMember" abstract="true" name="AztecaVacunasSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_RegeneronPharmaceuticalsIncMember" abstract="true" name="RegeneronPharmaceuticalsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ImpactOfChangeInInterestRateOnPreTaxIncome" abstract="false" name="ImpactOfChangeInInterestRateOnPreTaxIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SECIPESASMember" abstract="true" name="SECIPESASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock" abstract="false" name="DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ConsumerHealthcareSegmentMember" abstract="true" name="ConsumerHealthcareSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CollaborationAgreementPeriodAfterLossOfControl" abstract="false" name="CollaborationAgreementPeriodAfterLossOfControl" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_CaissePrimaireDassuranceMaladieMember" abstract="true" name="CaissePrimaireDassuranceMaladieMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ImmunooncologyAllianceMember" abstract="true" name="ImmunooncologyAllianceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CumulativeDevelopmentCostsIncurred" abstract="false" name="CumulativeDevelopmentCostsIncurred" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiAventisAlgerieMember" abstract="true" name="SanofiAventisAlgerieMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisRomaniaSRLMember" abstract="true" name="SanofiAventisRomaniaSRLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CommercialPaperProgramInFranceMember" abstract="true" name="CommercialPaperProgramInFranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity" abstract="false" name="UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ForwardCurrencySalesInSingaporeDollarMember" abstract="true" name="ForwardCurrencySalesInSingaporeDollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfCasesDismissed" abstract="false" name="NumberOfCasesDismissed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_SanofiSRLMember" abstract="true" name="SanofiSRLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PensionObligationPercentageToDefinedBenefitLiability" abstract="false" name="PensionObligationPercentageToDefinedBenefitLiability" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_DisclosureOfRestructuringProvisionsLineItems" abstract="true" name="DisclosureOfRestructuringProvisionsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_DividendsPaidAbstract" abstract="true" name="DividendsPaidAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_MarketConditionAxis" abstract="true" name="MarketConditionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" abstract="false" name="DisclosureOfOverdueReceivablesGrossValueTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DepakineProductLitigationInNorthernIrelandMember" abstract="true" name="DepakineProductLitigationInNorthernIrelandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_BayerScheringPharmaAGMember" abstract="true" name="BayerScheringPharmaAGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OtherOperatingIncomeExpenseMember" abstract="true" name="OtherOperatingIncomeExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IncreaseDecreaseOfBorrowings" abstract="false" name="IncreaseDecreaseOfBorrowings" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_HedgeFundsMember" abstract="true" name="HedgeFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OtherGainsLossesAndLitigation" abstract="false" name="OtherGainsLossesAndLitigation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_IncomeStatementLocationDomain" abstract="true" name="IncomeStatementLocationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" abstract="false" name="InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_GenzymeDeArgentinaSAMember" abstract="true" name="GenzymeDeArgentinaSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DebtInstrumentDomain" abstract="true" name="DebtInstrumentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfOngoingLawsuits" abstract="false" name="NumberOfOngoingLawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_MSPVaccineCompanyMember" abstract="true" name="MSPVaccineCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock" abstract="false" name="DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SpecialDistributionNumberOfSharesConverted" abstract="false" name="SpecialDistributionNumberOfSharesConverted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_RegeneronMember" abstract="true" name="RegeneronMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember" abstract="true" name="ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NumberOfOncologyTargetsUnderCollaborationAgreement" abstract="false" name="NumberOfOncologyTargetsUnderCollaborationAgreement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_SanofiAventisPuertoRicoIncMember" abstract="true" name="SanofiAventisPuertoRicoIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ForwardCurrencyPurchasesMember" abstract="true" name="ForwardCurrencyPurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" abstract="false" name="CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfOtherLongTermProvisionsTableTextBlock" abstract="false" name="DisclosureOfOtherLongTermProvisionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock" abstract="false" name="DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" abstract="false" name="DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_NumberOfFamiliesWhoFiledACivilClaim" abstract="false" name="NumberOfFamiliesWhoFiledACivilClaim" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_NumberOfMedicalAssessments" abstract="false" name="NumberOfMedicalAssessments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" abstract="false" name="NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_OverdueReceivablesGrossValue" abstract="false" name="OverdueReceivablesGrossValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_VaxServeIncMember" abstract="true" name="VaxServeIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CapitalLossesCarryBackPeriod" abstract="false" name="CapitalLossesCarryBackPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_SynthorxIncMember" abstract="true" name="SynthorxIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_BioverativIncMember" abstract="true" name="BioverativIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug" abstract="false" name="NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember" abstract="true" name="BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" abstract="false" name="IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_OtherIntangibleAssetsExcludingSoftwareMember" abstract="true" name="OtherIntangibleAssetsExcludingSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ProvisionsForOtherLongTermBenefitsMember" abstract="true" name="ProvisionsForOtherLongTermBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" abstract="false" name="ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SspCoLtdMember" abstract="true" name="SspCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AfterTaxDiscountRates" abstract="false" name="AfterTaxDiscountRates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_TopUpDefinedBenefitPensionPlanMember" abstract="true" name="TopUpDefinedBenefitPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AmunixPharmaceuticalsIncMember" abstract="true" name="AmunixPharmaceuticalsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" abstract="false" name="EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" abstract="false" name="FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" abstract="false" name="DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_CostOfDebtNet" abstract="false" name="CostOfDebtNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock" abstract="false" name="DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering" abstract="false" name="BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_April302021Member" abstract="true" name="April302021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_IndustrialFacilitiesMember" abstract="true" name="IndustrialFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfDebtByCurrencyLineItems" abstract="true" name="DisclosureOfDebtByCurrencyLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_FinancialInvestments" abstract="false" name="FinancialInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_InvestmentsInAssociatesAndJointVentures" abstract="false" name="InvestmentsInAssociatesAndJointVentures" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SaleOfStockPricePerShare" abstract="false" name="SaleOfStockPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="sny_RestructuringCostsReversedAndSimilarItems" abstract="false" name="RestructuringCostsReversedAndSimilarItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_OpellaHealthcareHungaryCommercialKFTMember" abstract="true" name="OpellaHealthcareHungaryCommercialKFTMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfInventoriesTable" abstract="true" name="DisclosureOfInventoriesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_SanofiaventisSpZooMember" abstract="true" name="SanofiaventisSpZooMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" abstract="false" name="ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiMedleyFarmaceuticaLtdaMember" abstract="true" name="SanofiMedleyFarmaceuticaLtdaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" abstract="false" name="DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_UpfrontPayments" abstract="false" name="UpfrontPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" abstract="false" name="DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PercentageOfLossesArisingFromCommercialOperations" abstract="false" name="PercentageOfLossesArisingFromCommercialOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_AmortizedCostMember" abstract="true" name="AmortizedCostMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems" abstract="true" name="DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_NumberOfLeaseAgreementsSigned" abstract="false" name="NumberOfLeaseAgreementsSigned" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_OtherDeductionsMember" abstract="true" name="OtherDeductionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_FairValueOfPlanAtDateOfGrant" abstract="false" name="FairValueOfPlanAtDateOfGrant" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" abstract="true" name="DisclosureOfOtherOperatingIncomeExpensesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_SanofiOyMember" abstract="true" name="SanofiOyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AtMarketValueMember" abstract="true" name="AtMarketValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock" abstract="false" name="DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_PercentageOfShareCapitalForThePeriod" abstract="false" name="PercentageOfShareCapitalForThePeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_SanofiWinthropIndustriesMember" abstract="true" name="SanofiWinthropIndustriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfGuaranteesLineItems" abstract="true" name="DisclosureOfGuaranteesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_DerivativeInstrumentDomain" abstract="true" name="DerivativeInstrumentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ActuarialAssumptionOfRetirementAgeBottomOfRange" abstract="false" name="ActuarialAssumptionOfRetirementAgeBottomOfRange" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_NumberOfSharesIssuedByExerciceOfEachOption" abstract="false" name="NumberOfSharesIssuedByExerciceOfEachOption" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_PrincipalMarketedProductsKadmonMember" abstract="true" name="PrincipalMarketedProductsKadmonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DevelopmentOfCemiplimabREGN2810Member" abstract="true" name="DevelopmentOfCemiplimabREGN2810Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" abstract="false" name="ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiHongKongLimitedMember" abstract="true" name="SanofiHongKongLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ForwardCurrencySalesInPoundSterlingMember" abstract="true" name="ForwardCurrencySalesInPoundSterlingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_OpellaHealthcareInternationalSASMember" abstract="true" name="OpellaHealthcareInternationalSASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_OncologyMember" abstract="true" name="OncologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock" abstract="false" name="DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" abstract="true" name="OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_SanofiEuroMediumTermNotesMember" abstract="true" name="SanofiEuroMediumTermNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_InterestRateSwapsPayCapitalizedEsterReceive069Member" abstract="true" name="InterestRateSwapsPayCapitalizedEsterReceive069Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems" abstract="true" name="DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_RelatedPartyAbstract" abstract="true" name="RelatedPartyAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction" abstract="false" name="SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_SanofiAventisParticipationsSASMember" abstract="true" name="SanofiAventisParticipationsSASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisDelPeruSAMember" abstract="true" name="SanofiAventisDelPeruSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DisclosureOfLineOfCreditFacilityTable" abstract="true" name="DisclosureOfLineOfCreditFacilityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock" abstract="false" name="DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DerivativeFinancialAssetsMember" abstract="true" name="DerivativeFinancialAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ForwardCurrencyPurchasedInUSDollarMember" abstract="true" name="ForwardCurrencyPurchasedInUSDollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfSustainableDevelopmentPerformanceIndicators" abstract="false" name="NumberOfSustainableDevelopmentPerformanceIndicators" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_StockSubscriptionOptionPlanSevenMember" abstract="true" name="StockSubscriptionOptionPlanSevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_GainLossOnCancellationOfTreasuryShares" abstract="false" name="GainLossOnCancellationOfTreasuryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_CashAndCashEquivalentsInvestedRate" abstract="false" name="CashAndCashEquivalentsInvestedRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_FinanceLeaseLiabilities" abstract="false" name="FinanceLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer" abstract="false" name="CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock" abstract="false" name="DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_LaboratoryFacilitiesCambridgeMassachusettsMember" abstract="true" name="LaboratoryFacilitiesCambridgeMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_April2016EMTNISINFR0013144003Member" abstract="true" name="April2016EMTNISINFR0013144003Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_June2018SNFISINUS801060AD60Member" abstract="true" name="June2018SNFISINUS801060AD60Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" abstract="false" name="IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" abstract="true" name="ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_StockOptionPlanMember" abstract="true" name="StockOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DupixentMember" abstract="true" name="DupixentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OpellaHealthcareGroupSASMember" abstract="true" name="OpellaHealthcareGroupSASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ConsiderationTransferredValuationPeriod" abstract="false" name="ConsiderationTransferredValuationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_NumberOfComplaintsFiled" abstract="false" name="NumberOfComplaintsFiled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_MaximumOwnershipPercentageAllowedToAcquire" abstract="false" name="MaximumOwnershipPercentageAllowedToAcquire" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate" abstract="false" name="OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_InterestUndiscountedCashFlow" abstract="false" name="InterestUndiscountedCashFlow" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NonCurrentAssetMember" abstract="true" name="NonCurrentAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs" abstract="false" name="ReducedAmountOfCompensationClaimedByFilledPlaintiffs" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_MajorCollaborationAgreementMember" abstract="true" name="MajorCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NumberOfPlaintiffs" abstract="false" name="NumberOfPlaintiffs" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_UnwindingOfDiscount" abstract="false" name="UnwindingOfDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" abstract="false" name="ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_InnatePharmaSAMember" abstract="true" name="InnatePharmaSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" abstract="false" name="ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfCivilClaimsOnGoing" abstract="false" name="NumberOfCivilClaimsOnGoing" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_ReservesLikelyToBeDistributedInTheForeseeableFuture" abstract="false" name="ReservesLikelyToBeDistributedInTheForeseeableFuture" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PrincipiaBiopharmaIncMember" abstract="true" name="PrincipiaBiopharmaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ForwardCurrencySalesInUSDollarMember" abstract="true" name="ForwardCurrencySalesInUSDollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NonOperatingForeignExchangeGainsLosses" abstract="false" name="NonOperatingForeignExchangeGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member" abstract="true" name="InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_NumberOfCancersAssociatedWithDismissedCases" abstract="false" name="NumberOfCancersAssociatedWithDismissedCases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock" abstract="false" name="DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_RedemptionOfDebtInstrumentIssued" abstract="false" name="RedemptionOfDebtInstrumentIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" abstract="false" name="DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod" abstract="false" name="IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_DisclosureOfInformationOnIncomeStatementLineItems" abstract="true" name="DisclosureOfInformationOnIncomeStatementLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_AblynxMember" abstract="true" name="AblynxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase" abstract="false" name="CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ActuarialAssumptionOfMortalityTableMember" abstract="true" name="ActuarialAssumptionOfMortalityTableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock" abstract="false" name="DisclosureOfProvisionsAndOtherLiabilitiesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ContractualAgreementForAntiProgrammedCellDeathProtein1" abstract="false" name="ContractualAgreementForAntiProgrammedCellDeathProtein1" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_RestrictedSharePlan2018Member" abstract="true" name="RestrictedSharePlan2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock" abstract="false" name="DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_PolioPertussisHibVaccinesMember" abstract="true" name="PolioPertussisHibVaccinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NonCurrentFinancialAssetsNumberOfShares" abstract="false" name="NonCurrentFinancialAssetsNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_GainLossOnImpairmentOfTreasuryShares" abstract="false" name="GainLossOnImpairmentOfTreasuryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SyndicatedCreditFacilityOneMember" abstract="true" name="SyndicatedCreditFacilityOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember" abstract="true" name="InterestRateSwapsPay057ReceiveCapitalizedEoniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember" abstract="true" name="FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage" abstract="false" name="InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_AlprolixMember" abstract="true" name="AlprolixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiHangzhouPharmaceuticalsCoLtdMember" abstract="true" name="SanofiHangzhouPharmaceuticalsCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" abstract="false" name="DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SanofiAventisMarocMember" abstract="true" name="SanofiAventisMarocMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisposalGroupNameDomain" abstract="true" name="DisposalGroupNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ParticipatingSharesNumberOutstanding" abstract="false" name="ParticipatingSharesNumberOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_BusinessCombinationsAbstract" abstract="true" name="BusinessCombinationsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_MedicareMember" abstract="true" name="MedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" abstract="true" name="DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_CurrencyDerivativesMember" abstract="true" name="CurrencyDerivativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_UncertaintiesOverIncomeTaxTreatmentsMember" abstract="true" name="UncertaintiesOverIncomeTaxTreatmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember" abstract="true" name="ForwardCurrencyPurchasedInChineseYuanRenminbiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AnticipatedDurationOfAppealsProcess" abstract="false" name="AnticipatedDurationOfAppealsProcess" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_CambridgeMassachusettsMember" abstract="true" name="CambridgeMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_StockSubscriptionOptionPlanNineMember" abstract="true" name="StockSubscriptionOptionPlanNineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PercentageOfFutureDevelopmentExpenseFundedByCompany" abstract="false" name="PercentageOfFutureDevelopmentExpenseFundedByCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember" abstract="true" name="WeightedAverageInterestRateBeforeDerivativeInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling" abstract="false" name="EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_AuditorsNameAxis" abstract="true" name="AuditorsNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_ZantacLitigationInCanadaMember" abstract="true" name="ZantacLitigationInCanadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisKoreaCoLtdMember" abstract="true" name="SanofiAventisKoreaCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfDebtLineItems" abstract="true" name="DisclosureOfDebtLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_QuotedDebtSecuritiesMember" abstract="true" name="QuotedDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiSynthelaboUKLtdMember" abstract="true" name="SanofiSynthelaboUKLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiPasteurS.A.deC.V.Member" abstract="true" name="SanofiPasteurS.A.deC.V.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" abstract="false" name="RoyaltiesAndOtherIncomeRelatedPartyTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" abstract="false" name="ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" abstract="true" name="DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_TaxotereProductLitigationInTheUSMember" abstract="true" name="TaxotereProductLitigationInTheUSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_MiscellaneousOtherOperatingIncomeExpenses" abstract="false" name="MiscellaneousOtherOperatingIncomeExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfPatentsCoveringProduct" abstract="false" name="NumberOfPatentsCoveringProduct" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock" abstract="false" name="DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_AOSanofiRussiaMember" abstract="true" name="AOSanofiRussiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SkyhawkTherapeuticsIncMember" abstract="true" name="SkyhawkTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_MaximumPlan1Member" abstract="true" name="MaximumPlan1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_PercentageOfSecondPartOfDevelopmentCostsFunded" abstract="false" name="PercentageOfSecondPartOfDevelopmentCostsFunded" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_November2013EMTNISINFR0011625433Member" abstract="true" name="November2013EMTNISINFR0011625433Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiAventisRechercheEtDeveloppementMember" abstract="true" name="SanofiAventisRechercheEtDeveloppementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" abstract="false" name="TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts" abstract="false" name="ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_RestrictedSharePlan2021Member" abstract="true" name="RestrictedSharePlan2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ReductionOfSharesByCancellationOfTreasuryShares" abstract="false" name="ReductionOfSharesByCancellationOfTreasuryShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sny_ToujeoMember" abstract="true" name="ToujeoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_PerformanceSharePlanOneMember" abstract="true" name="PerformanceSharePlanOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_BristolMyersSquibbMember" abstract="true" name="BristolMyersSquibbMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_MutualFundInvestmentsMember" abstract="true" name="MutualFundInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities" abstract="false" name="NonCurrentProvisionsAndOtherNoncurrentLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems" abstract="true" name="DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_DisclosureOfLegalAndArbitralProceedingsLineItems" abstract="true" name="DisclosureOfLegalAndArbitralProceedingsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" abstract="false" name="IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_OpellaHealthcareFranceSASMember" abstract="true" name="OpellaHealthcareFranceSASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_May32022Member" abstract="true" name="May32022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_MarketedProductsMember" abstract="true" name="MarketedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_InterestsInOtherEntitiesAbstract" abstract="true" name="InterestsInOtherEntitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_OtherCurrenciesMember" abstract="true" name="OtherCurrenciesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" abstract="false" name="ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" abstract="true" name="DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_EmployeesShareOwnershipPlanMember" abstract="true" name="EmployeesShareOwnershipPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_EmployeeBenefitsExpenseGain" abstract="false" name="EmployeeBenefitsExpenseGain" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee" abstract="false" name="AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_OnduoMember" abstract="true" name="OnduoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_MinusTwentyFiveBasisPointsMember" abstract="true" name="MinusTwentyFiveBasisPointsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DerivativeFinancialLiabilitiesMember" abstract="true" name="DerivativeFinancialLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement" abstract="false" name="ValueOfShareOptionsExercisedInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable" abstract="true" name="DisclosureOfDetailedInformationAboutIncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes" abstract="false" name="TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations" abstract="false" name="PercentageOfProfitsAndLossesArisingFromCommercialOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_GainLossOnPurchaseOfTreasuryShares" abstract="false" name="GainLossOnPurchaseOfTreasuryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AtomwiseMember" abstract="true" name="AtomwiseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital" abstract="false" name="ExceptionalSupplementaryDividendProposedPercentageOfShareCapital" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember" abstract="true" name="ProvisionForPensionsAndOtherEmployeeBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiBelgiumMember" abstract="true" name="SanofiBelgiumMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" abstract="false" name="DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_NumberOfClassActionLawsuits" abstract="false" name="NumberOfClassActionLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_InterestRateSwapsInterestRate" abstract="false" name="InterestRateSwapsInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_SanofiBioverativHoldingsLLCMember" abstract="true" name="SanofiBioverativHoldingsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_EloctateMember" abstract="true" name="EloctateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_TotalUndiscountedCashFlow" abstract="false" name="TotalUndiscountedCashFlow" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DiceMoleculesMember" abstract="true" name="DiceMoleculesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfDebtTable" abstract="true" name="DisclosureOfDebtTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" abstract="false" name="GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DebtPercent" abstract="false" name="DebtPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_ActuarialAssumptionOfRetirementAgeTopOfRange" abstract="false" name="ActuarialAssumptionOfRetirementAgeTopOfRange" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_March2018EMTNISINFR0013324357Member" abstract="true" name="March2018EMTNISINFR0013324357Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" abstract="false" name="IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" abstract="false" name="DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SanofiAventisDeutschlandGmbHMember" abstract="true" name="SanofiAventisDeutschlandGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod" abstract="false" name="OwnershipInterestInSubsidiaryMinimumHoldingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement" abstract="false" name="ValueOfShareOptionsCancelledInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DefendantsMember" abstract="true" name="DefendantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_UniformPreTaxDiscountRates" abstract="false" name="UniformPreTaxDiscountRates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_CustomerTwoMember" abstract="true" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable" abstract="true" name="DisclosureOfDetailedInformationAboutShareBasedPaymentTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_OpellaHealthcarePhilippinesIncMember" abstract="true" name="OpellaHealthcarePhilippinesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiSustainabilityLinkedCreditFacilitiesMember" abstract="true" name="SanofiSustainabilityLinkedCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" abstract="false" name="ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PercentageOfAverageOfQuotedMarketPricesOfShares" abstract="false" name="PercentageOfAverageOfQuotedMarketPricesOfShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_DepakineProductLitigationInGermanyMember" abstract="true" name="DepakineProductLitigationInGermanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiAventisSROMember" abstract="true" name="SanofiAventisSROMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock" abstract="false" name="DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" abstract="false" name="ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_A340BDrugPricingProgramInTheUnitedStatesMember" abstract="true" name="A340BDrugPricingProgramInTheUnitedStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiAventisFranceMember" abstract="true" name="SanofiAventisFranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_UniformImpairmentTestingPercentage" abstract="false" name="UniformImpairmentTestingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" abstract="false" name="ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfExecutiveCommitteeMembers" abstract="false" name="NumberOfExecutiveCommitteeMembers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_SanofiUSServicesIncMember" abstract="true" name="SanofiUSServicesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations" abstract="false" name="CommitmentsRelatedToMilestonePaymentsBusinessCombinations" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_September2016EMTNISINFR0013201639Member" abstract="true" name="September2016EMTNISINFR0013201639Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiBeijingPharmaceuticalsCoLtdMember" abstract="true" name="SanofiBeijingPharmaceuticalsCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution" abstract="false" name="ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" abstract="true" name="DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_RealEstateMember" abstract="true" name="RealEstateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" abstract="false" name="CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" abstract="false" name="ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_LeaseLiabilitiesEffectOfDiscounting" abstract="false" name="LeaseLiabilitiesEffectOfDiscounting" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfPatentActionsInitiallyFiled" abstract="false" name="NumberOfPatentActionsInitiallyFiled" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_ContingentConsiderationCollaborationAgreements" abstract="false" name="ContingentConsiderationCollaborationAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" abstract="false" name="PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember" abstract="true" name="ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" abstract="false" name="CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_SanofiChinaInvestmentCoLtdMember" abstract="true" name="SanofiChinaInvestmentCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_BondsAndSimilarInstrumentsMember" abstract="true" name="BondsAndSimilarInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfRestructuringProvisionsTable" abstract="true" name="DisclosureOfRestructuringProvisionsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_ImmunoOncologyCollaborationAgreementMember" abstract="true" name="ImmunoOncologyCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SanofiSaglikUrunleriLimitedSirketiMember" abstract="true" name="SanofiSaglikUrunleriLimitedSirketiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" abstract="false" name="DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_SanofiaventisPlusPensionPlanMember" abstract="true" name="SanofiaventisPlusPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfTradingDaysPrecedingPlanApproval" abstract="false" name="NumberOfTradingDaysPrecedingPlanApproval" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sny_TypesOfAgreementDomain" abstract="true" name="TypesOfAgreementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_SanofiKKMember" abstract="true" name="SanofiKKMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" abstract="false" name="ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfLineOfCreditFacilityLineItems" abstract="true" name="DisclosureOfLineOfCreditFacilityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember" abstract="true" name="TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_StockMarketPricePerShare" abstract="false" name="StockMarketPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="sny_DepakineProductLitigationInGreatBritainMember" abstract="true" name="DepakineProductLitigationInGreatBritainMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ImpactOfPreTaxIncomeRecognisedInEquity" abstract="false" name="ImpactOfPreTaxIncomeRecognisedInEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DepakineProductLitigationInIrelandMember" abstract="true" name="DepakineProductLitigationInIrelandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" abstract="false" name="ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_PercentageContributedToFairValueOfPlanAssets" abstract="false" name="PercentageContributedToFairValueOfPlanAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock" abstract="false" name="DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_PlanAssetsEffectOfAssetCeiling" abstract="false" name="PlanAssetsEffectOfAssetCeiling" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_AssociatesAndJointVenturesMember" abstract="true" name="AssociatesAndJointVenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" abstract="true" name="DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_TwoThousandFourteenAmendedInvestmentAgreementMember" abstract="true" name="TwoThousandFourteenAmendedInvestmentAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_MinusHundredBasisPointsMember" abstract="true" name="MinusHundredBasisPointsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_CapitalLossesUsedAgainstCapitalGainsPercentage" abstract="false" name="CapitalLossesUsedAgainstCapitalGainsPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" abstract="false" name="DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_OpellaHealthcareArgentinaSAUMember" abstract="true" name="OpellaHealthcareArgentinaSAUMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_SanofiSAMember" abstract="true" name="SanofiSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_Sanofi2015DSASMember" abstract="true" name="Sanofi2015DSASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_OpellaHealthcarePolandSpZOOMember" abstract="true" name="OpellaHealthcarePolandSpZOOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_USFDAApprovalMember" abstract="true" name="USFDAApprovalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_DebtInstrumentAxis" abstract="true" name="DebtInstrumentAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany" abstract="false" name="MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_DisclosureOfOffBalanceSheetCommitmentsLineItems" abstract="true" name="DisclosureOfOffBalanceSheetCommitmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" abstract="false" name="IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_QualifiedDefinedBenefitPensionPlansMember" abstract="true" name="QualifiedDefinedBenefitPensionPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember" abstract="true" name="WeightedAverageInterestRateAfterDerivativeInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_MedicaidMember" abstract="true" name="MedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" abstract="true" name="ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_StockSubscriptionOptionPlanThreeMember" abstract="true" name="StockSubscriptionOptionPlanThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_ForwardCurrencySalesInMexicanPesoMember" abstract="true" name="ForwardCurrencySalesInMexicanPesoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_NumberOfPreActionProtocolCases" abstract="false" name="NumberOfPreActionProtocolCases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_StockSubscriptionOptionPlanFourMember" abstract="true" name="StockSubscriptionOptionPlanFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="sny_AntibodiesMember" abstract="true" name="AntibodiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sny_FairValueOfContingentConsiderationPayable" abstract="false" name="FairValueOfContingentConsiderationPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" abstract="false" name="GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sny_NumberOfClaimsInvalid" abstract="false" name="NumberOfClaimsInvalid" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sny_AuditorsRemunerationTableTextBlock" abstract="false" name="AuditorsRemunerationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="sny_DaiichiSankyoMember" abstract="true" name="DaiichiSankyoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>sny-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:89d6bfca-a5b4-4bcd-ad12-f1718d876f14,g:8278f0b1-e8dc-472d-9868-3f575a842a56-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedbalancesheets" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedbalancesheets"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/Consolidatedbalancesheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1523d695-8843-46d6-adcf-b480ac8bb631" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentAssets_f16cac96-d44c-4149-92c5-c3ceb35e5910" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1523d695-8843-46d6-adcf-b480ac8bb631" xlink:to="loc_ifrs-full_OtherCurrentAssets_f16cac96-d44c-4149-92c5-c3ceb35e5910" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxAssetsCurrent_ec4814dd-8304-4692-b4db-a98dc7594ca9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1523d695-8843-46d6-adcf-b480ac8bb631" xlink:to="loc_ifrs-full_CurrentTaxAssetsCurrent_ec4814dd-8304-4692-b4db-a98dc7594ca9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_38c707e3-323c-4a14-9777-af9851c8c7d1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1523d695-8843-46d6-adcf-b480ac8bb631" xlink:to="loc_ifrs-full_Inventories_38c707e3-323c-4a14-9777-af9851c8c7d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTradeReceivables_13b7f4a2-8af4-4003-8ce2-3477aa0ecb63" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1523d695-8843-46d6-adcf-b480ac8bb631" xlink:to="loc_ifrs-full_CurrentTradeReceivables_13b7f4a2-8af4-4003-8ce2-3477aa0ecb63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_a43f9532-414f-4d22-b018-96fc4009a002" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1523d695-8843-46d6-adcf-b480ac8bb631" xlink:to="loc_ifrs-full_CashAndCashEquivalents_a43f9532-414f-4d22-b018-96fc4009a002" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_c82ebe58-40e4-45e3-a532-127b81d8cadc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_cf81255c-3e9f-43fa-b953-71512ec1d145" xlink:href="sny-20221231.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_c82ebe58-40e4-45e3-a532-127b81d8cadc" xlink:to="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_cf81255c-3e9f-43fa-b953-71512ec1d145" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_2eca7675-a255-4fdf-a11a-b2edc026a085" xlink:href="sny-20221231.xsd#sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_c82ebe58-40e4-45e3-a532-127b81d8cadc" xlink:to="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_2eca7675-a255-4fdf-a11a-b2edc026a085" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_dbddf498-bd03-42f5-b605-b58d4d8756d1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_c82ebe58-40e4-45e3-a532-127b81d8cadc" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_dbddf498-bd03-42f5-b605-b58d4d8756d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_6423fa27-b985-4828-90b6-ac1e0ad57d0f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_c82ebe58-40e4-45e3-a532-127b81d8cadc" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_6423fa27-b985-4828-90b6-ac1e0ad57d0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_ee46a739-ebb2-4238-a379-c79b21e8bdc4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_c82ebe58-40e4-45e3-a532-127b81d8cadc" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_ee46a739-ebb2-4238-a379-c79b21e8bdc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_77e29718-2969-46b7-a758-bc4a7494c360" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_c82ebe58-40e4-45e3-a532-127b81d8cadc" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_77e29718-2969-46b7-a758-bc4a7494c360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_9c0772d9-74a8-449f-ad01-08f262188b62" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_f6ba2d2f-284c-480d-805e-5c7d2835fe71" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_9c0772d9-74a8-449f-ad01-08f262188b62" xlink:to="loc_ifrs-full_DeferredTaxAssets_f6ba2d2f-284c-480d-805e-5c7d2835fe71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_9fca6dcc-d7a5-4366-88af-d207200904c8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_9c0772d9-74a8-449f-ad01-08f262188b62" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_9fca6dcc-d7a5-4366-88af-d207200904c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxAssetsNoncurrent_0ccfdc33-63ac-4c96-81ce-6be8a0806440" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_9c0772d9-74a8-449f-ad01-08f262188b62" xlink:to="loc_ifrs-full_CurrentTaxAssetsNoncurrent_0ccfdc33-63ac-4c96-81ce-6be8a0806440" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_1d3a7566-2f4e-4f51-a78a-bb0009d71a4f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_9c0772d9-74a8-449f-ad01-08f262188b62" xlink:to="loc_ifrs-full_Goodwill_1d3a7566-2f4e-4f51-a78a-bb0009d71a4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_ee29eb4a-a0bf-43cf-ab54-0895c43998ed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_9c0772d9-74a8-449f-ad01-08f262188b62" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_ee29eb4a-a0bf-43cf-ab54-0895c43998ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_dfeeef00-837c-4338-acde-ffbbc3fdd27c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_9c0772d9-74a8-449f-ad01-08f262188b62" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_dfeeef00-837c-4338-acde-ffbbc3fdd27c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_97fe8f51-dd6c-4588-b12e-e1272e98e7ae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_9c0772d9-74a8-449f-ad01-08f262188b62" xlink:to="loc_ifrs-full_RightofuseAssets_97fe8f51-dd6c-4588-b12e-e1272e98e7ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_1aa6a9f0-2892-4d3d-adaa-1de74af2d9ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_9c0772d9-74a8-449f-ad01-08f262188b62" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_1aa6a9f0-2892-4d3d-adaa-1de74af2d9ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_79cafacb-45a1-4239-8093-375dc8ddfeb5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_62e91751-a07d-49f2-a70a-830c02a49a75" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_79cafacb-45a1-4239-8093-375dc8ddfeb5" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_62e91751-a07d-49f2-a70a-830c02a49a75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_4b31466f-0b0f-438a-9e7b-e21b4ae68180" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_79cafacb-45a1-4239-8093-375dc8ddfeb5" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_4b31466f-0b0f-438a-9e7b-e21b4ae68180" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_a49ec7ae-b24a-4d1d-9ab2-8ffecade3cac" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_79cafacb-45a1-4239-8093-375dc8ddfeb5" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_a49ec7ae-b24a-4d1d-9ab2-8ffecade3cac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_91fbf297-315e-45f9-b3d4-4877fe1d367a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_79cafacb-45a1-4239-8093-375dc8ddfeb5" xlink:to="loc_ifrs-full_LongtermBorrowings_91fbf297-315e-45f9-b3d4-4877fe1d367a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_dafe8265-092f-457a-9b5a-ad3a533a73eb" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_79cafacb-45a1-4239-8093-375dc8ddfeb5" xlink:to="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_dafe8265-092f-457a-9b5a-ad3a533a73eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_a41d0a8b-6c79-4cf7-9e07-8eb856f162b5" xlink:href="sny-20221231.xsd#sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_79cafacb-45a1-4239-8093-375dc8ddfeb5" xlink:to="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_a41d0a8b-6c79-4cf7-9e07-8eb856f162b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_db523d27-c9dc-4866-83e2-4ac42ed43330" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_bdc32a50-d9b0-4fc9-bf4c-eed25427facd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_db523d27-c9dc-4866-83e2-4ac42ed43330" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParent_bdc32a50-d9b0-4fc9-bf4c-eed25427facd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterests_ff9ac084-eaa6-4f93-94ea-d6da5a1cf56a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_db523d27-c9dc-4866-83e2-4ac42ed43330" xlink:to="loc_ifrs-full_NoncontrollingInterests_ff9ac084-eaa6-4f93-94ea-d6da5a1cf56a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities_bb89fe1e-023e-4210-889e-e03db4d34174" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_9ea829e2-83cb-409c-b63d-57021e3aaba7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_bb89fe1e-023e-4210-889e-e03db4d34174" xlink:to="loc_ifrs-full_Equity_9ea829e2-83cb-409c-b63d-57021e3aaba7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_6034168a-823c-458b-9d22-7eda2dfb7687" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_bb89fe1e-023e-4210-889e-e03db4d34174" xlink:to="loc_ifrs-full_NoncurrentLiabilities_6034168a-823c-458b-9d22-7eda2dfb7687" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_753fc056-772e-4372-82a1-413160e57c82" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_bb89fe1e-023e-4210-889e-e03db4d34174" xlink:to="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_753fc056-772e-4372-82a1-413160e57c82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_1fa8c689-e77f-4f26-8c83-ca47f79bc961" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_bb89fe1e-023e-4210-889e-e03db4d34174" xlink:to="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_1fa8c689-e77f-4f26-8c83-ca47f79bc961" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_a268d26f-ded8-4579-b29e-c0f434d25e58" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_2c8fd96b-cb96-4de5-a104-48358d8dc784" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_a268d26f-ded8-4579-b29e-c0f434d25e58" xlink:to="loc_ifrs-full_NoncurrentAssets_2c8fd96b-cb96-4de5-a104-48358d8dc784" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_b6bd2348-ab86-4bdd-83ee-9e71016922eb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_a268d26f-ded8-4579-b29e-c0f434d25e58" xlink:to="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_b6bd2348-ab86-4bdd-83ee-9e71016922eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_b26e2190-4df6-406f-b2f1-38d7767ec6ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_a268d26f-ded8-4579-b29e-c0f434d25e58" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_b26e2190-4df6-406f-b2f1-38d7767ec6ca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedincomestatements" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedincomestatements"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/Consolidatedincomestatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_d9e5371c-ed59-4b18-a254-900292ec7cd7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:to="loc_ifrs-full_GrossProfit_d9e5371c-ed59-4b18-a254-900292ec7cd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGainsLossesAndLitigation_5cff516a-151f-44f6-9346-d2450d936ab0" xlink:href="sny-20221231.xsd#sny_OtherGainsLossesAndLitigation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:to="loc_sny_OtherGainsLossesAndLitigation_5cff516a-151f-44f6-9346-d2450d936ab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_8758fe63-5164-4710-8c3b-2ee0009cc70f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_8758fe63-5164-4710-8c3b-2ee0009cc70f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_d57a42e9-5917-45a2-94fd-c388d7d341e4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_d57a42e9-5917-45a2-94fd-c388d7d341e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_b265d99b-6680-4442-bf72-a77c8cc2ca1c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_b265d99b-6680-4442-bf72-a77c8cc2ca1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_a3b05e35-5e4c-43c4-80d1-6d867e709cfc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_a3b05e35-5e4c-43c4-80d1-6d867e709cfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e58d70ad-a56a-4fc6-920f-a64bc6f08cb2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e58d70ad-a56a-4fc6-920f-a64bc6f08cb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_cda5ae25-a847-4a75-8c0e-bc3f005efff9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseOfRestructuringActivities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_cda5ae25-a847-4a75-8c0e-bc3f005efff9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnDisposalsOfInvestments_522a6fa7-1829-4992-b610-3b1ce6823138" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestments"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:to="loc_ifrs-full_GainsOnDisposalsOfInvestments_522a6fa7-1829-4992-b610-3b1ce6823138" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_f8b0d123-ce09-4d47-96ae-4a5a04c29cd9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingIncome"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_f8b0d123-ce09-4d47-96ae-4a5a04c29cd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_2c5702e9-5744-4799-9efe-e7c2b133a50c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1f4d0438-5917-4233-873a-b587689beaa6" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_2c5702e9-5744-4799-9efe-e7c2b133a50c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_65ce2c72-8d83-4335-b288-b12be693840a" xlink:href="sny-20221231.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_40d07260-3ff7-492f-b30e-b8f8d33f4e95" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_65ce2c72-8d83-4335-b288-b12be693840a" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_40d07260-3ff7-492f-b30e-b8f8d33f4e95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_370e9068-a7ae-450e-9875-7fcde57cfed1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_65ce2c72-8d83-4335-b288-b12be693840a" xlink:to="loc_ifrs-full_FinanceCosts_370e9068-a7ae-450e-9875-7fcde57cfed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_9e90f381-2fa8-4c3d-865f-900979e3a674" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_65ce2c72-8d83-4335-b288-b12be693840a" xlink:to="loc_ifrs-full_FinanceIncome_9e90f381-2fa8-4c3d-865f-900979e3a674" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_78935302-bd1b-417b-84ac-65ab09a189a0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_260e99ba-d3cd-4ff4-b1ee-790316a614f7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_78935302-bd1b-417b-84ac-65ab09a189a0" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_260e99ba-d3cd-4ff4-b1ee-790316a614f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_a199892b-5693-4c9b-8a24-5b5a47d41556" xlink:href="sny-20221231.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_78935302-bd1b-417b-84ac-65ab09a189a0" xlink:to="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_a199892b-5693-4c9b-8a24-5b5a47d41556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_153b5cad-b2d7-48a8-be0f-992fe9f3db30" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_78935302-bd1b-417b-84ac-65ab09a189a0" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_153b5cad-b2d7-48a8-be0f-992fe9f3db30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_63351419-0748-45af-b40a-e980d9a240e8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_d8b5ed55-93a3-45c5-8b4e-256fa09a25dd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_63351419-0748-45af-b40a-e980d9a240e8" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_d8b5ed55-93a3-45c5-8b4e-256fa09a25dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherRevenue_171f779f-369a-4475-ad7b-c9eb3f5eddcc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_63351419-0748-45af-b40a-e980d9a240e8" xlink:to="loc_ifrs-full_OtherRevenue_171f779f-369a-4475-ad7b-c9eb3f5eddcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_81f4a776-f2ac-4a90-9b09-c5c2dde1a4e8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_63351419-0748-45af-b40a-e980d9a240e8" xlink:to="loc_ifrs-full_CostOfSales_81f4a776-f2ac-4a90-9b09-c5c2dde1a4e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedincomestatements_1" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedincomestatements_1"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/Consolidatedincomestatements_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_fb863438-11c4-40e3-b28a-05d42bb92f2f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_224ad9af-66e2-41c1-9102-f3e6e6879dad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_fb863438-11c4-40e3-b28a-05d42bb92f2f" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_224ad9af-66e2-41c1-9102-f3e6e6879dad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_4d360ebd-db24-4504-829b-51f62c87d5e5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_fb863438-11c4-40e3-b28a-05d42bb92f2f" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_4d360ebd-db24-4504-829b-51f62c87d5e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedstatementsofcomprehensiveincome"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_2c617cfd-0715-4d56-851c-eb61bc03c771" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_f3f25f13-ff15-4c8f-b452-674c8f6e74a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_2c617cfd-0715-4d56-851c-eb61bc03c771" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_f3f25f13-ff15-4c8f-b452-674c8f6e74a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_c01799b4-fdb9-4f9a-9fbb-8c4e0d14b0aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_2c617cfd-0715-4d56-851c-eb61bc03c771" xlink:to="loc_ifrs-full_ProfitLoss_c01799b4-fdb9-4f9a-9fbb-8c4e0d14b0aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_38bffdb9-474c-4bed-a8ae-8def4b26fa4f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss_1dcca258-f502-4554-b2d4-5d8a7299df5f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_38bffdb9-474c-4bed-a8ae-8def4b26fa4f" xlink:to="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss_1dcca258-f502-4554-b2d4-5d8a7299df5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_ea9ac67f-a814-4915-a411-21245e2a06a5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_38bffdb9-474c-4bed-a8ae-8def4b26fa4f" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_ea9ac67f-a814-4915-a411-21245e2a06a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments_0b24b804-9b25-48e4-a891-f77505751800" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_38bffdb9-474c-4bed-a8ae-8def4b26fa4f" xlink:to="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments_0b24b804-9b25-48e4-a891-f77505751800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_6b9f8e74-f792-4829-b003-399b793114c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_1a111f13-177f-420e-a5c9-65a81e487266" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_6b9f8e74-f792-4829-b003-399b793114c2" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_1a111f13-177f-420e-a5c9-65a81e487266" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_6e814f1e-ecc6-4994-b3ec-72f09314aba2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_6b9f8e74-f792-4829-b003-399b793114c2" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_6e814f1e-ecc6-4994-b3ec-72f09314aba2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_2c385d3a-36bf-41f2-9a13-3fddc3793012" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax_8f4ffbbb-078b-4054-98de-77bc5962e738" xlink:href="sny-20221231.xsd#sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_2c385d3a-36bf-41f2-9a13-3fddc3793012" xlink:to="loc_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax_8f4ffbbb-078b-4054-98de-77bc5962e738" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_d3055561-fa68-4f48-bda3-6c47338ec220" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_2c385d3a-36bf-41f2-9a13-3fddc3793012" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_d3055561-fa68-4f48-bda3-6c47338ec220" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_60497ad1-8600-48b7-8d02-474db7c47f86" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_2c385d3a-36bf-41f2-9a13-3fddc3793012" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_60497ad1-8600-48b7-8d02-474db7c47f86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss_3d52b0ba-4a78-495c-95d4-b17dcc5ef8dc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_2c385d3a-36bf-41f2-9a13-3fddc3793012" xlink:to="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss_3d52b0ba-4a78-495c-95d4-b17dcc5ef8dc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome_1" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedstatementsofcomprehensiveincome_1"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_17fd9584-11a0-4edc-8658-204f0ac9a060" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_dffafeb7-b839-4d9d-b008-f01f9e682e75" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_17fd9584-11a0-4edc-8658-204f0ac9a060" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_dffafeb7-b839-4d9d-b008-f01f9e682e75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_c84d4ad4-4e93-4407-9dc1-0005ec342987" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_17fd9584-11a0-4edc-8658-204f0ac9a060" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_c84d4ad4-4e93-4407-9dc1-0005ec342987" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedstatementsofcashflows" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedstatementsofcashflows"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/Consolidatedstatementsofcashflows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_f23d4c3f-a77f-4fc6-99f0-1933a8b0289d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_7cd0b8d2-3988-4f69-a876-cf520c9dbadc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_f23d4c3f-a77f-4fc6-99f0-1933a8b0289d" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_7cd0b8d2-3988-4f69-a876-cf520c9dbadc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_0756f9eb-9031-41e5-96b1-6af338e8857b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_f23d4c3f-a77f-4fc6-99f0-1933a8b0289d" xlink:to="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_0756f9eb-9031-41e5-96b1-6af338e8857b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_9aa98d9e-effc-4743-9441-a9330e94ddfc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_f23d4c3f-a77f-4fc6-99f0-1933a8b0289d" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_9aa98d9e-effc-4743-9441-a9330e94ddfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_35da5727-7e8a-407d-b768-6765e3a0394c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_f23d4c3f-a77f-4fc6-99f0-1933a8b0289d" xlink:to="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_35da5727-7e8a-407d-b768-6765e3a0394c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_a1057f54-b80e-4551-8aeb-0cfa3dbafb50" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_f23d4c3f-a77f-4fc6-99f0-1933a8b0289d" xlink:to="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_a1057f54-b80e-4551-8aeb-0cfa3dbafb50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetChangeInOtherNonCurrentAssets_57b7f31b-c2c4-4821-9dd3-79fa50a410a0" xlink:href="sny-20221231.xsd#sny_NetChangeInOtherNonCurrentAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_f23d4c3f-a77f-4fc6-99f0-1933a8b0289d" xlink:to="loc_sny_NetChangeInOtherNonCurrentAssets_57b7f31b-c2c4-4821-9dd3-79fa50a410a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_aaf0ddda-4e59-4a3d-baab-156e1726073b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_f23d4c3f-a77f-4fc6-99f0-1933a8b0289d" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_aaf0ddda-4e59-4a3d-baab-156e1726073b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities_8dd726a9-8252-4627-b8e1-972808385f35" xlink:href="sny-20221231.xsd#sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:to="loc_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities_8dd726a9-8252-4627-b8e1-972808385f35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c2df723a-e44c-4a1f-911b-40727020d421" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:to="loc_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c2df723a-e44c-4a1f-911b-40727020d421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_37ab05e2-38ad-4432-a41a-94a0db3f90a4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:to="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_37ab05e2-38ad-4432-a41a-94a0db3f90a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_f60f20f8-36bb-4d82-88cb-2dced97928e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:to="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_f60f20f8-36bb-4d82-88cb-2dced97928e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset_2198632a-c0f0-4352-b43c-44eead61657e" xlink:href="sny-20221231.xsd#sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:to="loc_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset_2198632a-c0f0-4352-b43c-44eead61657e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_c8cb6173-61e6-43f8-890d-1ec7709d114c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:to="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_c8cb6173-61e6-43f8-890d-1ec7709d114c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_010776f4-97ca-4bc2-b4f9-a357a7e15f8a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_010776f4-97ca-4bc2-b4f9-a357a7e15f8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_1de1452e-4e49-4c00-af2b-065965e9f67e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_1de1452e-4e49-4c00-af2b-065965e9f67e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod_1c0dfc73-c765-4252-aef9-255935a9e9a0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:to="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod_1c0dfc73-c765-4252-aef9-255935a9e9a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue_b3550852-cf9a-4879-9d25-20e8358a828b" xlink:href="sny-20221231.xsd#sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:to="loc_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue_b3550852-cf9a-4879-9d25-20e8358a828b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_d00eb41f-7e00-4038-acf7-d78402c2588b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_ab69e555-a2c0-4a2f-872f-3ddebd39db1b" xlink:to="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_d00eb41f-7e00-4038-acf7-d78402c2588b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_164ba52a-52f7-4f41-bfd6-e88e0ecfe6b2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_59e7ee62-acee-41fa-b740-d30648ad036f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_164ba52a-52f7-4f41-bfd6-e88e0ecfe6b2" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_59e7ee62-acee-41fa-b740-d30648ad036f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_458c88c7-09e4-4e76-90ee-29f8f60a4167" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_164ba52a-52f7-4f41-bfd6-e88e0ecfe6b2" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_458c88c7-09e4-4e76-90ee-29f8f60a4167" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_8fe812b5-b90d-4b00-bc77-8fbdb0055522" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_164ba52a-52f7-4f41-bfd6-e88e0ecfe6b2" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_8fe812b5-b90d-4b00-bc77-8fbdb0055522" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities_96500ca0-bc35-422b-8c8e-60592a49c3c6" xlink:href="sny-20221231.xsd#sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_164ba52a-52f7-4f41-bfd6-e88e0ecfe6b2" xlink:to="loc_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities_96500ca0-bc35-422b-8c8e-60592a49c3c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_4f043296-7ff8-423b-95c8-d9cd783d736c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_164ba52a-52f7-4f41-bfd6-e88e0ecfe6b2" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_4f043296-7ff8-423b-95c8-d9cd783d736c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_f9600114-543a-4bc9-b358-73fb652c69c6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_9f6cb841-4b33-4c51-a3a8-26c9de6654f6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_f9600114-543a-4bc9-b358-73fb652c69c6" xlink:to="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_9f6cb841-4b33-4c51-a3a8-26c9de6654f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_6c4211c9-0ec5-4cf0-9b68-3a9785bc1c62" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_f9600114-543a-4bc9-b358-73fb652c69c6" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_6c4211c9-0ec5-4cf0-9b68-3a9785bc1c62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_3ec0df31-8071-4975-bf41-bb99f3271e8e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_f9600114-543a-4bc9-b358-73fb652c69c6" xlink:to="loc_ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_3ec0df31-8071-4975-bf41-bb99f3271e8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_071975b4-e62f-4f7a-b83f-8dc0915c16e5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_f9600114-543a-4bc9-b358-73fb652c69c6" xlink:to="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_071975b4-e62f-4f7a-b83f-8dc0915c16e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_00bab5a1-87ce-4f9a-b665-7fe4fcdff7f5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_f9600114-543a-4bc9-b358-73fb652c69c6" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_00bab5a1-87ce-4f9a-b665-7fe4fcdff7f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_ba6ecaa3-c493-46fd-a032-e0b38a97b2a5" xlink:href="sny-20221231.xsd#sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_f9600114-543a-4bc9-b358-73fb652c69c6" xlink:to="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_ba6ecaa3-c493-46fd-a032-e0b38a97b2a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_e65ae9f0-a54a-4ecf-a0a7-2feea801694d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_f9600114-543a-4bc9-b358-73fb652c69c6" xlink:to="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_e65ae9f0-a54a-4ecf-a0a7-2feea801694d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_1c80e376-8786-40d7-b153-c0546cbbe9b1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_f9600114-543a-4bc9-b358-73fb652c69c6" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_1c80e376-8786-40d7-b153-c0546cbbe9b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_365903df-23c4-4861-bcff-41255afabe3f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_f9600114-543a-4bc9-b358-73fb652c69c6" xlink:to="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_365903df-23c4-4861-bcff-41255afabe3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_9c9b3d1c-2b95-4491-86c1-e4a4f6986f6f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_3c87e22b-8130-43f1-9dc0-701b2d989da8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_9c9b3d1c-2b95-4491-86c1-e4a4f6986f6f" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_3c87e22b-8130-43f1-9dc0-701b2d989da8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_9b700c56-202e-4c4d-bfbe-b117b3e2391b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_9c9b3d1c-2b95-4491-86c1-e4a4f6986f6f" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_9b700c56-202e-4c4d-bfbe-b117b3e2391b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashInflowsFromExchangeOfBusinessInvestingActivities_7757a3d5-d258-4a2a-9f58-941830e8db8c" xlink:href="sny-20221231.xsd#sny_CashInflowsFromExchangeOfBusinessInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_9c9b3d1c-2b95-4491-86c1-e4a4f6986f6f" xlink:to="loc_sny_CashInflowsFromExchangeOfBusinessInvestingActivities_7757a3d5-d258-4a2a-9f58-941830e8db8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_60a6df9b-089d-4724-bbf0-32949fde3946" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_9c9b3d1c-2b95-4491-86c1-e4a4f6986f6f" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_60a6df9b-089d-4724-bbf0-32949fde3946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_e0a0bdc4-d10f-4497-9b58-20484c30632c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_9c9b3d1c-2b95-4491-86c1-e4a4f6986f6f" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_e0a0bdc4-d10f-4497-9b58-20484c30632c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_86d00cce-bfb1-4e5a-9f0b-c47bd4f3b079" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_26101e52-f2b9-4c17-9799-8d6eefd5cb8d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_86d00cce-bfb1-4e5a-9f0b-c47bd4f3b079" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_26101e52-f2b9-4c17-9799-8d6eefd5cb8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_37fd6fdb-593d-4881-802b-2027802cc76c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_86d00cce-bfb1-4e5a-9f0b-c47bd4f3b079" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_37fd6fdb-593d-4881-802b-2027802cc76c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate_c1317ee2-2a80-4291-9230-5bea49031366" xlink:href="sny-20221231.xsd#sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_86d00cce-bfb1-4e5a-9f0b-c47bd4f3b079" xlink:to="loc_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate_c1317ee2-2a80-4291-9230-5bea49031366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_9a381406-43bb-405c-9c64-7a9e0d68abe3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_86d00cce-bfb1-4e5a-9f0b-c47bd4f3b079" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_9a381406-43bb-405c-9c64-7a9e0d68abe3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_9f085424-4a5b-4ad4-aa1d-7d3d7d6d7fdb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_86d00cce-bfb1-4e5a-9f0b-c47bd4f3b079" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_9f085424-4a5b-4ad4-aa1d-7d3d7d6d7fdb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures_36e47582-4ab7-4507-a6bb-ea2bae829aa0" xlink:href="sny-20221231.xsd#sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_5bfd6a67-a864-4a71-8864-80718a78c0b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures_36e47582-4ab7-4507-a6bb-ea2bae829aa0" xlink:to="loc_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_5bfd6a67-a864-4a71-8864-80718a78c0b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax_f5ca144d-2bc1-4938-95e1-9e7ee5c56bbc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures_36e47582-4ab7-4507-a6bb-ea2bae829aa0" xlink:to="loc_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax_f5ca144d-2bc1-4938-95e1-9e7ee5c56bbc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InventoriesScheduleofInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_0a6743a0-d4b1-4c7b-b8ed-f23279798053" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RawMaterials_63780831-7d85-4947-b572-42cec1df94e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_0a6743a0-d4b1-4c7b-b8ed-f23279798053" xlink:to="loc_ifrs-full_RawMaterials_63780831-7d85-4947-b572-42cec1df94e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WorkInProgress_526efb0d-dcab-4efa-8e57-41d790553086" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WorkInProgress"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_0a6743a0-d4b1-4c7b-b8ed-f23279798053" xlink:to="loc_ifrs-full_WorkInProgress_526efb0d-dcab-4efa-8e57-41d790553086" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinishedGoods_62124718-4a0e-43d1-bd77-9f3ac5664da7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_0a6743a0-d4b1-4c7b-b8ed-f23279798053" xlink:to="loc_ifrs-full_FinishedGoods_62124718-4a0e-43d1-bd77-9f3ac5664da7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OthercurrentassetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OthercurrentassetsDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/OthercurrentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentAssets_0998278d-ce13-42c2-bf33-49fe0899b784" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesMeasuredAtFairValue_9f6b7c0b-29cf-4bfe-9c1a-3eb5bcdbce13" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesMeasuredAtFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets_0998278d-ce13-42c2-bf33-49fe0899b784" xlink:to="loc_sny_CurrencyDerivativesMeasuredAtFairValue_9f6b7c0b-29cf-4bfe-9c1a-3eb5bcdbce13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets_5c7c829e-86ab-4afa-86e1-c31938a712b3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets_0998278d-ce13-42c2-bf33-49fe0899b784" xlink:to="loc_ifrs-full_OtherCurrentFinancialAssets_5c7c829e-86ab-4afa-86e1-c31938a712b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_abfbedb9-89cd-4b8b-bcf3-86915259d890" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets_0998278d-ce13-42c2-bf33-49fe0899b784" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_abfbedb9-89cd-4b8b-bcf3-86915259d890" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentReceivables_174aaf83-1498-44b5-b9f1-caf975dcf67f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets_0998278d-ce13-42c2-bf33-49fe0899b784" xlink:to="loc_ifrs-full_OtherCurrentReceivables_174aaf83-1498-44b5-b9f1-caf975dcf67f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax_f9977e37-cac5-43b5-b336-d0c8737ec2aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets_0998278d-ce13-42c2-bf33-49fe0899b784" xlink:to="loc_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax_f9977e37-cac5-43b5-b336-d0c8737ec2aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateDerivativesMeasuredAtFairValue_5667e1ec-adab-4cef-8c30-8ba727b4dc81" xlink:href="sny-20221231.xsd#sny_InterestRateDerivativesMeasuredAtFairValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets_0998278d-ce13-42c2-bf33-49fe0899b784" xlink:to="loc_sny_InterestRateDerivativesMeasuredAtFairValue_5667e1ec-adab-4cef-8c30-8ba727b4dc81" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/CashandcashequivalentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#CashandcashequivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/CashandcashequivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1ccae6be-c822-46b6-8cd8-72f674461a99" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash_5c58c56a-49e1-4f46-b7cd-22f04295e2e2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Cash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_1ccae6be-c822-46b6-8cd8-72f674461a99" xlink:to="loc_ifrs-full_Cash_5c58c56a-49e1-4f46-b7cd-22f04295e2e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents_a8e3cd52-f6c8-4921-862a-7bd895232ad8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_1ccae6be-c822-46b6-8cd8-72f674461a99" xlink:to="loc_ifrs-full_CashEquivalents_a8e3cd52-f6c8-4921-862a-7bd895232ad8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d7c3c10c-0089-44fe-b822-c9788ce0b4ce" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_7d6da26a-fb61-4c23-b8db-d5eb715a69d1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d7c3c10c-0089-44fe-b822-c9788ce0b4ce" xlink:to="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_7d6da26a-fb61-4c23-b8db-d5eb715a69d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_8b98c13d-1057-4ed6-bde1-9c15cab436d4" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d7c3c10c-0089-44fe-b822-c9788ce0b4ce" xlink:to="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_8b98c13d-1057-4ed6-bde1-9c15cab436d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_af695a9c-a31a-4b21-b49d-9097bbc1faa1" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d7c3c10c-0089-44fe-b822-c9788ce0b4ce" xlink:to="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_af695a9c-a31a-4b21-b49d-9097bbc1faa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_6f1037c1-19df-4ce3-8c56-370b85121956" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d7c3c10c-0089-44fe-b822-c9788ce0b4ce" xlink:to="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_6f1037c1-19df-4ce3-8c56-370b85121956" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationOnTaxEffects_d719b2cd-7a99-4aa3-95a2-dc4414ed0719" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationOnTaxEffects"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d7c3c10c-0089-44fe-b822-c9788ce0b4ce" xlink:to="loc_sny_ChangeInCurrencyTranslationOnTaxEffects_d719b2cd-7a99-4aa3-95a2-dc4414ed0719" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_45af7209-d0e4-4aea-8468-a529254729cd" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d7c3c10c-0089-44fe-b822-c9788ce0b4ce" xlink:to="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_45af7209-d0e4-4aea-8468-a529254729cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures_d362a867-95f6-4b42-8132-179e35303565" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d7c3c10c-0089-44fe-b822-c9788ce0b4ce" xlink:to="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures_d362a867-95f6-4b42-8132-179e35303565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_f0164f1c-6d9c-49db-aa1a-f6becefb7117" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d7c3c10c-0089-44fe-b822-c9788ce0b4ce" xlink:to="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_f0164f1c-6d9c-49db-aa1a-f6becefb7117" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_0e3c41d8-20be-4559-b3bb-0bb7ebae19ae" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d7c3c10c-0089-44fe-b822-c9788ce0b4ce" xlink:to="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_0e3c41d8-20be-4559-b3bb-0bb7ebae19ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_407b402d-cec8-49e2-b15f-db4aad8a153a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_4938b61e-c64e-4b64-86bc-09527bd543dd" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_407b402d-cec8-49e2-b15f-db4aad8a153a" xlink:to="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_4938b61e-c64e-4b64-86bc-09527bd543dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_15e4980e-f0a0-47d7-a3a7-d21b3217b421" xlink:href="sny-20221231.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_407b402d-cec8-49e2-b15f-db4aad8a153a" xlink:to="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_15e4980e-f0a0-47d7-a3a7-d21b3217b421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_ec446915-33e3-4b6e-a2a1-1be4bd823a5b" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_407b402d-cec8-49e2-b15f-db4aad8a153a" xlink:to="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_ec446915-33e3-4b6e-a2a1-1be4bd823a5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_e8430047-e26d-4586-a016-5b664ca37382" xlink:href="sny-20221231.xsd#sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_407b402d-cec8-49e2-b15f-db4aad8a153a" xlink:to="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_e8430047-e26d-4586-a016-5b664ca37382" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_221909a2-dc0a-4bd8-b11a-685beba615f4" xlink:href="sny-20221231.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_407b402d-cec8-49e2-b15f-db4aad8a153a" xlink:to="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_221909a2-dc0a-4bd8-b11a-685beba615f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_a5b1faf8-361a-4dc7-9b50-3a2df7787932" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_407b402d-cec8-49e2-b15f-db4aad8a153a" xlink:to="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_a5b1faf8-361a-4dc7-9b50-3a2df7787932" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_554eaa01-96a9-45a1-9e64-45ad959a95d1" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_407b402d-cec8-49e2-b15f-db4aad8a153a" xlink:to="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_554eaa01-96a9-45a1-9e64-45ad959a95d1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_5f431232-d2f3-4544-bc37-ed44f01fe424" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares_78db6819-938b-4cb5-8b68-257cf6576c0a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_5f431232-d2f3-4544-bc37-ed44f01fe424" xlink:to="loc_ifrs-full_WeightedAverageShares_78db6819-938b-4cb5-8b68-257cf6576c0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_b612d68b-475f-48d0-8e9f-3665d2cbb265" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_5f431232-d2f3-4544-bc37-ed44f01fe424" xlink:to="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_b612d68b-475f-48d0-8e9f-3665d2cbb265" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares_2736a48c-81fe-49f6-81a8-854e3f17558b" xlink:href="sny-20221231.xsd#sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_5f431232-d2f3-4544-bc37-ed44f01fe424" xlink:to="loc_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares_2736a48c-81fe-49f6-81a8-854e3f17558b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_18cc80b3-0bf9-401f-8627-009180e38c77" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_321bb229-f62d-451c-ab7d-d8d03275ef61" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings_18cc80b3-0bf9-401f-8627-009180e38c77" xlink:to="loc_ifrs-full_LongtermBorrowings_321bb229-f62d-451c-ab7d-d8d03275ef61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_765da5e1-df5c-42f9-9c39-003266e3b6fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings_18cc80b3-0bf9-401f-8627-009180e38c77" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_765da5e1-df5c-42f9-9c39-003266e3b6fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_f132f88d-ac2d-4dc7-b5e0-35af5d6d48eb" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings_18cc80b3-0bf9-401f-8627-009180e38c77" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_f132f88d-ac2d-4dc7-b5e0-35af5d6d48eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_b95288c6-66fe-4f27-a5b3-dbb234f97fa9" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_368651bb-5318-4c64-96bb-26e8fc4870dc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_DebtNetOfCashAndCashEquivalents_b95288c6-66fe-4f27-a5b3-dbb234f97fa9" xlink:to="loc_ifrs-full_Borrowings_368651bb-5318-4c64-96bb-26e8fc4870dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_30af44ad-4719-449d-8fce-b8bfc170d8e5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_DebtNetOfCashAndCashEquivalents_b95288c6-66fe-4f27-a5b3-dbb234f97fa9" xlink:to="loc_ifrs-full_CashAndCashEquivalents_30af44ad-4719-449d-8fce-b8bfc170d8e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_2ad8044e-215e-4ec8-a477-85dee6b96afa" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_DebtNetOfCashAndCashEquivalents_b95288c6-66fe-4f27-a5b3-dbb234f97fa9" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_2ad8044e-215e-4ec8-a477-85dee6b96afa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_f3a232c1-454d-403a-be26-86e6a311feae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherBorrowings_44723ba4-4adf-42a3-8ffb-a35153be59c4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings_f3a232c1-454d-403a-be26-86e6a311feae" xlink:to="loc_ifrs-full_OtherBorrowings_44723ba4-4adf-42a3-8ffb-a35153be59c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BondsIssued_329318ca-55e8-472d-896a-8f5e10a11309" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BondsIssued"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings_f3a232c1-454d-403a-be26-86e6a311feae" xlink:to="loc_ifrs-full_BondsIssued_329318ca-55e8-472d-896a-8f5e10a11309" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_28cfd02b-2956-4201-a761-9904bf50099e" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings_f3a232c1-454d-403a-be26-86e6a311feae" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_28cfd02b-2956-4201-a761-9904bf50099e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_08d5393e-aa4f-46f0-964f-b860e3a543e1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings_f3a232c1-454d-403a-be26-86e6a311feae" xlink:to="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_08d5393e-aa4f-46f0-964f-b860e3a543e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherBankBorrowings_e666acb9-1694-423b-b33a-3145029a11a6" xlink:href="sny-20221231.xsd#sny_OtherBankBorrowings"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings_f3a232c1-454d-403a-be26-86e6a311feae" xlink:to="loc_sny_OtherBankBorrowings_e666acb9-1694-423b-b33a-3145029a11a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_3fdd294c-5cd1-49d7-bf53-46b442735edf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalUndiscountedCashFlow_ea82301d-0858-4c72-b20a-e685c6eab717" xlink:href="sny-20221231.xsd#sny_PrincipalUndiscountedCashFlow"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_3fdd294c-5cd1-49d7-bf53-46b442735edf" xlink:to="loc_sny_PrincipalUndiscountedCashFlow_ea82301d-0858-4c72-b20a-e685c6eab717" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestUndiscountedCashFlow_59b88a47-ff2c-4240-b814-ae597e850ece" xlink:href="sny-20221231.xsd#sny_InterestUndiscountedCashFlow"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_3fdd294c-5cd1-49d7-bf53-46b442735edf" xlink:to="loc_sny_InterestUndiscountedCashFlow_59b88a47-ff2c-4240-b814-ae597e850ece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalUndiscountedCashFlow_8befced6-b67b-464a-8b43-dece379d23c1" xlink:href="sny-20221231.xsd#sny_TotalUndiscountedCashFlow"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_d74b7857-3b49-4417-9638-380fa0ba186c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_TotalUndiscountedCashFlow_8befced6-b67b-464a-8b43-dece379d23c1" xlink:to="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_d74b7857-3b49-4417-9638-380fa0ba186c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_c2a58e3a-68aa-4dc5-bf1a-664ac7b77808" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_TotalUndiscountedCashFlow_8befced6-b67b-464a-8b43-dece379d23c1" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_c2a58e3a-68aa-4dc5-bf1a-664ac7b77808" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_de3f7508-8fd4-4112-be3f-78beabfaf4aa" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions_fe47963c-35a5-4acd-9d2f-53d90f0c1bac" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_de3f7508-8fd4-4112-be3f-78beabfaf4aa" xlink:to="loc_ifrs-full_NoncurrentProvisions_fe47963c-35a5-4acd-9d2f-53d90f0c1bac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_098794cd-e35f-4cf4-8306-8df6430f0ae4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_de3f7508-8fd4-4112-be3f-78beabfaf4aa" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_098794cd-e35f-4cf4-8306-8df6430f0ae4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_805da518-e6cd-4b89-9afe-69d7da2f576d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlanAssetsEffectOfAssetCeiling_8c4cfc80-c214-4ca7-9db0-1c7b99c0d95c" xlink:href="sny-20221231.xsd#sny_PlanAssetsEffectOfAssetCeiling"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_805da518-e6cd-4b89-9afe-69d7da2f576d" xlink:to="loc_sny_PlanAssetsEffectOfAssetCeiling_8c4cfc80-c214-4ca7-9db0-1c7b99c0d95c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_4bd15a36-e3aa-4350-85a8-3ec2352b2236" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_805da518-e6cd-4b89-9afe-69d7da2f576d" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_4bd15a36-e3aa-4350-85a8-3ec2352b2236" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_71afe772-3fe7-445b-a530-c35389d9e339" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_805da518-e6cd-4b89-9afe-69d7da2f576d" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_71afe772-3fe7-445b-a530-c35389d9e339" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssets_de22e963-05c8-4468-83c5-f9d3bb9b1ab4" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket_ead91ed1-c7f4-461a-9fc9-e3fd194e9aaa" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_PercentageContributedToFairValueOfPlanAssets_de22e963-05c8-4468-83c5-f9d3bb9b1ab4" xlink:to="loc_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket_ead91ed1-c7f4-461a-9fc9-e3fd194e9aaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities_3e3bb739-1ae5-4609-95c4-7da650fc843a" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_PercentageContributedToFairValueOfPlanAssets_de22e963-05c8-4468-83c5-f9d3bb9b1ab4" xlink:to="loc_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities_3e3bb739-1ae5-4609-95c4-7da650fc843a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset_8fa56e1d-31c5-4298-a767-b41bacd2fa9e" xlink:href="sny-20221231.xsd#sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_5bb96ccf-73c0-41a9-b371-c38904f5082a" xlink:href="sny-20221231.xsd#sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset_8fa56e1d-31c5-4298-a767-b41bacd2fa9e" xlink:to="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_5bb96ccf-73c0-41a9-b371-c38904f5082a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_d3cd8a4b-8d9e-472a-a42d-9c6c74d1c3fa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset_8fa56e1d-31c5-4298-a767-b41bacd2fa9e" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_d3cd8a4b-8d9e-472a-a42d-9c6c74d1c3fa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_10fca3e9-ea26-491c-9398-3e58088707c0" xlink:href="sny-20221231.xsd#sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_930b1b74-d362-4f0b-93a3-a3de9fab069d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_10fca3e9-ea26-491c-9398-3e58088707c0" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_930b1b74-d362-4f0b-93a3-a3de9fab069d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_bae69b5d-e634-4acd-aea6-2da149bfa5aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_10fca3e9-ea26-491c-9398-3e58088707c0" xlink:to="loc_ifrs-full_FinanceCosts_bae69b5d-e634-4acd-aea6-2da149bfa5aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_7398d5c0-d4bf-480a-808e-b957ef0e7264" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_10fca3e9-ea26-491c-9398-3e58088707c0" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_7398d5c0-d4bf-480a-808e-b957ef0e7264" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_e8547896-d955-4df5-b55b-96e25392e622" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_10fca3e9-ea26-491c-9398-3e58088707c0" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_e8547896-d955-4df5-b55b-96e25392e622" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_1b597110-ad19-49ad-98ce-40d37ee16cf1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_10fca3e9-ea26-491c-9398-3e58088707c0" xlink:to="loc_ifrs-full_CostOfSales_1b597110-ad19-49ad-98ce-40d37ee16cf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestructuringCostsReversedAndSimilarItems_b7789a93-cf51-452b-9c35-6833382bab08" xlink:href="sny-20221231.xsd#sny_RestructuringCostsReversedAndSimilarItems"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_10fca3e9-ea26-491c-9398-3e58088707c0" xlink:to="loc_sny_RestructuringCostsReversedAndSimilarItems_b7789a93-cf51-452b-9c35-6833382bab08" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherLongtermProvisions_a5bfee6a-1c72-4f87-bf91-7f0f97bf91c8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherLongtermProvisions"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionForEnvironmentRisks_12220773-d750-40d2-b683-8aae3ab44c44" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionForEnvironmentRisks"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherLongtermProvisions_a5bfee6a-1c72-4f87-bf91-7f0f97bf91c8" xlink:to="loc_sny_NonCurrentProvisionForEnvironmentRisks_12220773-d750-40d2-b683-8aae3ab44c44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_d28da911-a7a6-4abd-bd10-578f9aa41f3d" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherLongtermProvisions_a5bfee6a-1c72-4f87-bf91-7f0f97bf91c8" xlink:to="loc_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_d28da911-a7a6-4abd-bd10-578f9aa41f3d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_702df339-9f91-4ebd-bae5-62f8924de18b" xlink:href="sny-20221231.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c2cfaf22-e5fe-4f8b-948f-1e7727af927a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_702df339-9f91-4ebd-bae5-62f8924de18b" xlink:to="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c2cfaf22-e5fe-4f8b-948f-1e7727af927a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentInterestRateDerivativesPayable_3fac8905-e9a3-4734-9a47-d62cb0423f6c" xlink:href="sny-20221231.xsd#sny_CurrentInterestRateDerivativesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_702df339-9f91-4ebd-bae5-62f8924de18b" xlink:to="loc_sny_CurrentInterestRateDerivativesPayable_3fac8905-e9a3-4734-9a47-d62cb0423f6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentLiabilities_663e5abb-6903-4909-a433-e66a6fff1d1a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_702df339-9f91-4ebd-bae5-62f8924de18b" xlink:to="loc_ifrs-full_OtherCurrentLiabilities_663e5abb-6903-4909-a433-e66a6fff1d1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentCurrencyDerivativesPayable_fa120b05-fac5-4518-ba92-2168df91fa42" xlink:href="sny-20221231.xsd#sny_CurrentCurrencyDerivativesPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_702df339-9f91-4ebd-bae5-62f8924de18b" xlink:to="loc_sny_CurrentCurrencyDerivativesPayable_fa120b05-fac5-4518-ba92-2168df91fa42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermRestructuringProvision_0e8e2358-0f70-420b-addd-c7b2d13b39ce" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermRestructuringProvision"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_702df339-9f91-4ebd-bae5-62f8924de18b" xlink:to="loc_ifrs-full_ShorttermRestructuringProvision_0e8e2358-0f70-420b-addd-c7b2d13b39ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilities_73c5d0d9-9691-4ef7-a2c3-485be8a6c886" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentContractLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_702df339-9f91-4ebd-bae5-62f8924de18b" xlink:to="loc_ifrs-full_CurrentContractLiabilities_73c5d0d9-9691-4ef7-a2c3-485be8a6c886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_2679a02b-d234-44b0-a06c-0ee6e0bbec77" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_702df339-9f91-4ebd-bae5-62f8924de18b" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_2679a02b-d234-44b0-a06c-0ee6e0bbec77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmountsPayableForAcquisitionOfNonCurrentAssets_edfbac42-f8af-4764-937a-fa1bda983937" xlink:href="sny-20221231.xsd#sny_AmountsPayableForAcquisitionOfNonCurrentAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_702df339-9f91-4ebd-bae5-62f8924de18b" xlink:to="loc_sny_AmountsPayableForAcquisitionOfNonCurrentAssets_edfbac42-f8af-4764-937a-fa1bda983937" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentEquityDerivativesPayable_7c526d11-2ec4-4e7c-bfc4-09773f7c03ac" xlink:href="sny-20221231.xsd#sny_CurrentEquityDerivativesPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_702df339-9f91-4ebd-bae5-62f8924de18b" xlink:to="loc_sny_CurrentEquityDerivativesPayable_7c526d11-2ec4-4e7c-bfc4-09773f7c03ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_16ba556d-ecf2-4c03-a0c5-7a31514df7d2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_a04975fe-6606-4f94-b46b-278d4b70dedd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilities_16ba556d-ecf2-4c03-a0c5-7a31514df7d2" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_a04975fe-6606-4f94-b46b-278d4b70dedd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_091adb5f-015d-4004-8b3d-5b4581fc2b0d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilities_16ba556d-ecf2-4c03-a0c5-7a31514df7d2" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_091adb5f-015d-4004-8b3d-5b4581fc2b0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_72f29dd8-cbc7-4dc6-95e2-821ccd504031" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_0357e222-ed53-42b1-9d3d-38f5a9a04f4e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DerivativeFinancialAssets_72f29dd8-cbc7-4dc6-95e2-821ccd504031" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_0357e222-ed53-42b1-9d3d-38f5a9a04f4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialAssets_d0dabe54-415b-45f2-9733-87ae1168c055" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDerivativeFinancialAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DerivativeFinancialAssets_72f29dd8-cbc7-4dc6-95e2-821ccd504031" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialAssets_d0dabe54-415b-45f2-9733-87ae1168c055" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_5bc77acc-d6a1-4f68-9a90-4306d75cf920" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_8974f939-2548-42e3-b4ed-f2472a2c7f60" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_5bc77acc-d6a1-4f68-9a90-4306d75cf920" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_8974f939-2548-42e3-b4ed-f2472a2c7f60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_599a1214-15f5-4834-b0f3-f59121b02c7c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_5bc77acc-d6a1-4f68-9a90-4306d75cf920" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_599a1214-15f5-4834-b0f3-f59121b02c7c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetAmountsAsReportedInTheBalanceSheet_037ff5d4-f8c4-4f85-bea3-67db77b3f05c" xlink:href="sny-20221231.xsd#sny_NetAmountsAsReportedInTheBalanceSheet"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset_9ab6e967-fab3-4e8c-9ded-9c98eddce37e" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_NetAmountsAsReportedInTheBalanceSheet_037ff5d4-f8c4-4f85-bea3-67db77b3f05c" xlink:to="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset_9ab6e967-fab3-4e8c-9ded-9c98eddce37e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32_7861164f-93fb-40ff-8f9b-db22fe9489a6" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_NetAmountsAsReportedInTheBalanceSheet_037ff5d4-f8c4-4f85-bea3-67db77b3f05c" xlink:to="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32_7861164f-93fb-40ff-8f9b-db22fe9489a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetExposure_18b54df3-78a3-42c3-b729-fea45ebc74ee" xlink:href="sny-20221231.xsd#sny_NetExposure"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments_e72a3884-ff06-4d8e-8410-7bb6331f90ce" xlink:href="sny-20221231.xsd#sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_NetExposure_18b54df3-78a3-42c3-b729-fea45ebc74ee" xlink:to="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments_e72a3884-ff06-4d8e-8410-7bb6331f90ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral_2bd6ae0c-1525-4a3a-9b74-3084caf8c305" xlink:href="sny-20221231.xsd#sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_NetExposure_18b54df3-78a3-42c3-b729-fea45ebc74ee" xlink:to="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral_2bd6ae0c-1525-4a3a-9b74-3084caf8c305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetAmountsAsReportedInTheBalanceSheet_b08de366-810d-4d9f-ae15-f15430a99ccd" xlink:href="sny-20221231.xsd#sny_NetAmountsAsReportedInTheBalanceSheet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_NetExposure_18b54df3-78a3-42c3-b729-fea45ebc74ee" xlink:to="loc_sny_NetAmountsAsReportedInTheBalanceSheet_b08de366-810d-4d9f-ae15-f15430a99ccd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PersonnelcostsSummaryofPersonalCostsDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_414f7ac1-f57b-41cb-a97f-b18f0e7160d4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WagesAndSalaries_b86bdedf-0d71-4a8b-9165-d2ce38d6114c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WagesAndSalaries"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_414f7ac1-f57b-41cb-a97f-b18f0e7160d4" xlink:to="loc_ifrs-full_WagesAndSalaries_b86bdedf-0d71-4a8b-9165-d2ce38d6114c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SocialSecurityContributions_59f514ac-5f3a-4c83-bd8c-2e19df7689f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SocialSecurityContributions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_414f7ac1-f57b-41cb-a97f-b18f0e7160d4" xlink:to="loc_ifrs-full_SocialSecurityContributions_59f514ac-5f3a-4c83-bd8c-2e19df7689f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_b8f377f0-84bd-467a-ad60-51c2a41cc6a2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_414f7ac1-f57b-41cb-a97f-b18f0e7160d4" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_b8f377f0-84bd-467a-ad60-51c2a41cc6a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_182edc7b-9734-4518-9b43-0614609c26fc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_414f7ac1-f57b-41cb-a97f-b18f0e7160d4" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_182edc7b-9734-4518-9b43-0614609c26fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherEmployeeExpense_636b6a0c-406b-41c7-b45f-141c33195875" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherEmployeeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_414f7ac1-f57b-41cb-a97f-b18f0e7160d4" xlink:to="loc_ifrs-full_OtherEmployeeExpense_636b6a0c-406b-41c7-b45f-141c33195875" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_b72b25ec-bda0-4411-b51f-ed4eca8e30c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseOfRestructuringActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherRestructuringCosts_15edb828-9659-4717-a101-e0356e8e44ff" xlink:href="sny-20221231.xsd#sny_OtherRestructuringCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities_b72b25ec-bda0-4411-b51f-ed4eca8e30c2" xlink:to="loc_sny_OtherRestructuringCosts_15edb828-9659-4717-a101-e0356e8e44ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories_d981147d-a15b-4216-84de-66bb86a386a5" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities_b72b25ec-bda0-4411-b51f-ed4eca8e30c2" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories_d981147d-a15b-4216-84de-66bb86a386a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts_9f3d6e3f-b133-4d3e-9ac2-4ef0cab154a9" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities_b72b25ec-bda0-4411-b51f-ed4eca8e30c2" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts_9f3d6e3f-b133-4d3e-9ac2-4ef0cab154a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts_82cb66e3-3624-4bbd-8a67-5ae7e0666ff5" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities_b72b25ec-bda0-4411-b51f-ed4eca8e30c2" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts_82cb66e3-3624-4bbd-8a67-5ae7e0666ff5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_b543d9f5-e1de-4d10-b458-d9b6b346e4d3" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities_b72b25ec-bda0-4411-b51f-ed4eca8e30c2" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_b543d9f5-e1de-4d10-b458-d9b6b346e4d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/FinancialexpensesandincomeDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#FinancialexpensesandincomeDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/FinancialexpensesandincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CostOfDebtNet_0c12e663-67db-4fef-9e49-0ab1163b0b7e" xlink:href="sny-20221231.xsd#sny_CostOfDebtNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_4a623f64-47d4-4295-a6ee-aa99b12ddc01" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_CostOfDebtNet_0c12e663-67db-4fef-9e49-0ab1163b0b7e" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_4a623f64-47d4-4295-a6ee-aa99b12ddc01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestIncome_4588b8eb-30c6-41e9-99f5-091abe230be7" xlink:href="sny-20221231.xsd#sny_InterestIncome"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_CostOfDebtNet_0c12e663-67db-4fef-9e49-0ab1163b0b7e" xlink:to="loc_sny_InterestIncome_4588b8eb-30c6-41e9-99f5-091abe230be7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_ca15ebda-11d2-4a2f-ae21-14576c194121" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CostOfDebtNet_c364c4d9-02bd-470c-af93-60c764f4ead9" xlink:href="sny-20221231.xsd#sny_CostOfDebtNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_ca15ebda-11d2-4a2f-ae21-14576c194121" xlink:to="loc_sny_CostOfDebtNet_c364c4d9-02bd-470c-af93-60c764f4ead9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonOperatingForeignExchangeGainsLosses_0eeca10f-7a7a-4d7e-a195-9ec261f50167" xlink:href="sny-20221231.xsd#sny_NonOperatingForeignExchangeGainsLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_ca15ebda-11d2-4a2f-ae21-14576c194121" xlink:to="loc_sny_NonOperatingForeignExchangeGainsLosses_0eeca10f-7a7a-4d7e-a195-9ec261f50167" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_2642cac4-6a11-4f7e-b856-53d4cfb1758e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_ca15ebda-11d2-4a2f-ae21-14576c194121" xlink:to="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_2642cac4-6a11-4f7e-b856-53d4cfb1758e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetInterestCostRelatedToEmployeeBenefits_be94632b-f15e-423a-8d09-72d706c9c12c" xlink:href="sny-20221231.xsd#sny_NetInterestCostRelatedToEmployeeBenefits"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_ca15ebda-11d2-4a2f-ae21-14576c194121" xlink:to="loc_sny_NetInterestCostRelatedToEmployeeBenefits_be94632b-f15e-423a-8d09-72d706c9c12c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets_e36e0d2c-1250-4564-9c41-eaf11bfc7791" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_ca15ebda-11d2-4a2f-ae21-14576c194121" xlink:to="loc_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets_e36e0d2c-1250-4564-9c41-eaf11bfc7791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_ad37107e-ff61-4022-9729-88947636f875" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_ca15ebda-11d2-4a2f-ae21-14576c194121" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_ad37107e-ff61-4022-9729-88947636f875" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceIncomeCost_0c9fcc17-8dec-4e8c-977f-4cb64e44493c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_ca15ebda-11d2-4a2f-ae21-14576c194121" xlink:to="loc_ifrs-full_OtherFinanceIncomeCost_0c9fcc17-8dec-4e8c-977f-4cb64e44493c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/FinancialexpensesandincomeDetails_1" xlink:type="simple" xlink:href="sny-20221231.xsd#FinancialexpensesandincomeDetails_1"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/FinancialexpensesandincomeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_9b979794-27f3-43bb-969d-e4afe3a61a12" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_b12d4fd9-1a21-4b03-be29-379504d5c9c8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_9b979794-27f3-43bb-969d-e4afe3a61a12" xlink:to="loc_ifrs-full_FinanceCosts_b12d4fd9-1a21-4b03-be29-379504d5c9c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_fbaa9243-e49f-4e70-8514-de0abafa593e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_9b979794-27f3-43bb-969d-e4afe3a61a12" xlink:to="loc_ifrs-full_FinanceIncome_fbaa9243-e49f-4e70-8514-de0abafa593e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_156c5db4-40c8-4427-b6ac-15f2f47ff5fd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_337f6a3d-70d0-47de-b65c-5d6e6a544b21" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_156c5db4-40c8-4427-b6ac-15f2f47ff5fd" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_337f6a3d-70d0-47de-b65c-5d6e6a544b21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_c959754b-c8e6-41d3-a65b-4e69202e80ff" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_156c5db4-40c8-4427-b6ac-15f2f47ff5fd" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_c959754b-c8e6-41d3-a65b-4e69202e80ff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate_ea966f96-0f14-49f9-b101-c14e3bdf7664" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AverageEffectiveTaxRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_b512dbcf-2840-474c-9bee-139c6b7dccdf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_ea966f96-0f14-49f9-b101-c14e3bdf7664" xlink:to="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_b512dbcf-2840-474c-9bee-139c6b7dccdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes_eef21649-bd77-4bb2-81ec-f1c0ef485c90" xlink:href="sny-20221231.xsd#sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_ea966f96-0f14-49f9-b101-c14e3bdf7664" xlink:to="loc_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes_eef21649-bd77-4bb2-81ec-f1c0ef485c90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_fe133215-442d-465f-baba-0b4ae8ef4f30" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_ea966f96-0f14-49f9-b101-c14e3bdf7664" xlink:to="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_fe133215-442d-465f-baba-0b4ae8ef4f30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations_b193ba8d-87e0-480a-a88c-29eeb5ef65dd" xlink:href="sny-20221231.xsd#sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_ea966f96-0f14-49f9-b101-c14e3bdf7664" xlink:to="loc_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations_b193ba8d-87e0-480a-a88c-29eeb5ef65dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ApplicableTaxRate_32b726b2-3242-40cc-9ebe-ad1ba8045741" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_ea966f96-0f14-49f9-b101-c14e3bdf7664" xlink:to="loc_ifrs-full_ApplicableTaxRate_32b726b2-3242-40cc-9ebe-ad1ba8045741" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_f1b13425-63c4-493c-8fd8-4fc6b6f42315" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_d27e6cf3-2492-45b4-b9e5-057d393d66b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_f1b13425-63c4-493c-8fd8-4fc6b6f42315" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_d27e6cf3-2492-45b4-b9e5-057d393d66b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_433a55aa-4339-43eb-acaf-743d62d713d8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_f1b13425-63c4-493c-8fd8-4fc6b6f42315" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_433a55aa-4339-43eb-acaf-743d62d713d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_7f9c323d-c1a4-4809-999f-8bb00dabb8c6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_f1b13425-63c4-493c-8fd8-4fc6b6f42315" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_7f9c323d-c1a4-4809-999f-8bb00dabb8c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationScheduleofSegmentResultsDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessOperatingIncome_ae6fac1f-1e85-46e9-9ddf-5dcf747f034e" xlink:href="sny-20221231.xsd#sny_BusinessOperatingIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_f6d29400-30ec-47a1-a626-a3d1b188decf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_BusinessOperatingIncome_ae6fac1f-1e85-46e9-9ddf-5dcf747f034e" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_f6d29400-30ec-47a1-a626-a3d1b188decf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherRevenue_0fb18604-d768-4928-ba4b-ac5472650e5e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_BusinessOperatingIncome_ae6fac1f-1e85-46e9-9ddf-5dcf747f034e" xlink:to="loc_ifrs-full_OtherRevenue_0fb18604-d768-4928-ba4b-ac5472650e5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_06b3a3ea-8159-4c38-b59c-e5845563c601" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_BusinessOperatingIncome_ae6fac1f-1e85-46e9-9ddf-5dcf747f034e" xlink:to="loc_ifrs-full_CostOfSales_06b3a3ea-8159-4c38-b59c-e5845563c601" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_0e0a1b04-6bac-43cf-abd8-510e3ea2dd51" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_BusinessOperatingIncome_ae6fac1f-1e85-46e9-9ddf-5dcf747f034e" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_0e0a1b04-6bac-43cf-abd8-510e3ea2dd51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_ad22846d-895c-4890-a227-9483c5fe08ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_BusinessOperatingIncome_ae6fac1f-1e85-46e9-9ddf-5dcf747f034e" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_ad22846d-895c-4890-a227-9483c5fe08ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_0194e88b-51f2-45b3-82f0-c6cc548cb82f" xlink:href="sny-20221231.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_BusinessOperatingIncome_ae6fac1f-1e85-46e9-9ddf-5dcf747f034e" xlink:to="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_0194e88b-51f2-45b3-82f0-c6cc548cb82f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_37ed2279-dcb9-4149-9bec-a16277580b8a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_BusinessOperatingIncome_ae6fac1f-1e85-46e9-9ddf-5dcf747f034e" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_37ed2279-dcb9-4149-9bec-a16277580b8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_a0ff2b34-718f-40f7-93e6-9ae480d1c3cc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_BusinessOperatingIncome_ae6fac1f-1e85-46e9-9ddf-5dcf747f034e" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_a0ff2b34-718f-40f7-93e6-9ae480d1c3cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessOperatingIncome_a8d2698f-6bfe-452e-b45b-02e3220fc0de" xlink:href="sny-20221231.xsd#sny_BusinessOperatingIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:to="loc_sny_BusinessOperatingIncome_a8d2698f-6bfe-452e-b45b-02e3220fc0de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_9000b383-dd75-4897-9bcf-ea497d12115d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_9000b383-dd75-4897-9bcf-ea497d12115d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherOperatingExpensesRelatedToBusinessCombinations_3ba91db5-40ff-48ca-ae96-c4d7fc37d16a" xlink:href="sny-20221231.xsd#sny_OtherOperatingExpensesRelatedToBusinessCombinations"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:to="loc_sny_OtherOperatingExpensesRelatedToBusinessCombinations_3ba91db5-40ff-48ca-ae96-c4d7fc37d16a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainOnRegeneronInvestmentSold_59ff4aee-8592-44e3-89b3-d62f53576213" xlink:href="sny-20221231.xsd#sny_GainOnRegeneronInvestmentSold"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:to="loc_sny_GainOnRegeneronInvestmentSold_59ff4aee-8592-44e3-89b3-d62f53576213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeResultingFromOutLicensing_5bb81de3-e521-4e32-965c-07c61b2e77f6" xlink:href="sny-20221231.xsd#sny_IncomeResultingFromOutLicensing"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:to="loc_sny_IncomeResultingFromOutLicensing_5bb81de3-e521-4e32-965c-07c61b2e77f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_7748f595-9a49-41e6-9f87-029649984197" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseOfRestructuringActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_7748f595-9a49-41e6-9f87-029649984197" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_a4f2ff8b-de5c-4297-935c-e516a5150c64" xlink:href="sny-20221231.xsd#sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:to="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_a4f2ff8b-de5c-4297-935c-e516a5150c64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_38376ed8-9f77-4e57-bbfc-4b45809f3e8f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_38376ed8-9f77-4e57-bbfc-4b45809f3e8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGainsLossesAndLitigation_ba2d7ef1-2462-4c16-9cc1-5b04c95f1827" xlink:href="sny-20221231.xsd#sny_OtherGainsLossesAndLitigation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:to="loc_sny_OtherGainsLossesAndLitigation_ba2d7ef1-2462-4c16-9cc1-5b04c95f1827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_643d36fb-8f19-43a4-83e6-708489b2158c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_643d36fb-8f19-43a4-83e6-708489b2158c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_85d15317-adf2-4e52-9769-bf0282f1d62b" xlink:href="sny-20221231.xsd#sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_017a979f-dd5d-4273-a1ad-29d9512dd55f" xlink:to="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_85d15317-adf2-4e52-9769-bf0282f1d62b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalaccountantsfeesandservicesDetails"/>
  <link:calculationLink xlink:role="http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemuneration_9e8f696b-24c5-4aa0-b765-88d77f86adc9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemuneration"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForAuditServices_13052bbd-8cc9-4c49-9406-275f58c5d3ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForAuditServices"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AuditorsRemuneration_9e8f696b-24c5-4aa0-b765-88d77f86adc9" xlink:to="loc_ifrs-full_AuditorsRemunerationForAuditServices_13052bbd-8cc9-4c49-9406-275f58c5d3ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ServicesOtherThanStatutoryAudit_ef937df6-155b-4652-91ae-27a78cedbb53" xlink:href="sny-20221231.xsd#sny_ServicesOtherThanStatutoryAudit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AuditorsRemuneration_9e8f696b-24c5-4aa0-b765-88d77f86adc9" xlink:to="loc_sny_ServicesOtherThanStatutoryAudit_ef937df6-155b-4652-91ae-27a78cedbb53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorsRemuneration_8a089825-d12d-44c0-931f-d8e4b437467b" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorsRemuneration"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorRemunerationForStatutoryAudit_eef38ffb-a5d3-4631-84a4-0ca10d3b933a" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorRemunerationForStatutoryAudit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_PercentageOfAuditorsRemuneration_8a089825-d12d-44c0-931f-d8e4b437467b" xlink:to="loc_sny_PercentageOfAuditorRemunerationForStatutoryAudit_eef38ffb-a5d3-4631-84a4-0ca10d3b933a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements_da9312d8-a7ea-4e31-aaa8-65a255cb3ad8" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_PercentageOfAuditorsRemuneration_8a089825-d12d-44c0-931f-d8e4b437467b" xlink:to="loc_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements_da9312d8-a7ea-4e31-aaa8-65a255cb3ad8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ServicesOtherThanStatutoryAudit_b4739618-cb22-4fed-a68b-fa318ad75b8a" xlink:href="sny-20221231.xsd#sny_ServicesOtherThanStatutoryAudit"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsRemunerationForAuditRelatedServices_56da5561-345e-400c-8bd4-10eb454683e3" xlink:href="sny-20221231.xsd#sny_AuditorsRemunerationForAuditRelatedServices"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_ServicesOtherThanStatutoryAudit_b4739618-cb22-4fed-a68b-fa318ad75b8a" xlink:to="loc_sny_AuditorsRemunerationForAuditRelatedServices_56da5561-345e-400c-8bd4-10eb454683e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForTaxServices_0662354b-98f1-43a0-b639-15bf8403c208" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForTaxServices"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_ServicesOtherThanStatutoryAudit_b4739618-cb22-4fed-a68b-fa318ad75b8a" xlink:to="loc_ifrs-full_AuditorsRemunerationForTaxServices_0662354b-98f1-43a0-b639-15bf8403c208" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices_21e34ced-83a9-45c8-8bb6-2081ee6d7717" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForOtherServices"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sny_ServicesOtherThanStatutoryAudit_b4739618-cb22-4fed-a68b-fa318ad75b8a" xlink:to="loc_ifrs-full_AuditorsRemunerationForOtherServices_21e34ced-83a9-45c8-8bb6-2081ee6d7717" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>sny-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:89d6bfca-a5b4-4bcd-ad12-f1718d876f14,g:8278f0b1-e8dc-472d-9868-3f575a842a56-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.sanofi.com/role/Coverpage" xlink:type="simple" xlink:href="sny-20221231.xsd#Coverpage"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/Coverpage" xlink:type="extended" id="ia800db27fcd840beaf7ee63cc41fd31a_Coverpage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_529f5f1c-342a-43c9-ba23-08a295a2cf95" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentType_529f5f1c-342a-43c9-ba23-08a295a2cf95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_243349d0-f52b-4b72-b7d6-94b3c469e502" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentRegistrationStatement_243349d0-f52b-4b72-b7d6-94b3c469e502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_0e02f9b2-b512-42b1-9a9f-172226249bd8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentAnnualReport_0e02f9b2-b512-42b1-9a9f-172226249bd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f641740a-07b2-465d-a3e9-3e322c6cda83" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_CurrentFiscalYearEndDate_f641740a-07b2-465d-a3e9-3e322c6cda83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_aea99c0f-ab40-4429-a09a-b454c6318349" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentPeriodEndDate_aea99c0f-ab40-4429-a09a-b454c6318349" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b0039123-5958-4804-a976-271132822a2d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentTransitionReport_b0039123-5958-4804-a976-271132822a2d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_ce8650e1-137a-4f55-8a2a-6b3a4cc5c2d0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentShellCompanyReport_ce8650e1-137a-4f55-8a2a-6b3a4cc5c2d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_31ca8a00-f0b3-4e0d-b004-797e58eb82fd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityFileNumber_31ca8a00-f0b3-4e0d-b004-797e58eb82fd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e1b22984-7bad-4c81-ac20-135dcc0eafb0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityRegistrantName_e1b22984-7bad-4c81-ac20-135dcc0eafb0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b36aab4a-77a3-4143-b917-45a5d36b4da2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b36aab4a-77a3-4143-b917-45a5d36b4da2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7bca2cdb-c29c-4271-8758-519fbc64b87a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityAddressAddressLine1_7bca2cdb-c29c-4271-8758-519fbc64b87a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_572e43e7-01d2-468c-a5bc-f319c6dce856" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityAddressPostalZipCode_572e43e7-01d2-468c-a5bc-f319c6dce856" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8563cfae-114d-4297-a3d5-a749fc61146f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityAddressCityOrTown_8563cfae-114d-4297-a3d5-a749fc61146f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_c6f20a75-1e8c-49df-baa3-1648e2c9b6c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityAddressCountry_c6f20a75-1e8c-49df-baa3-1648e2c9b6c4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_bd020b61-b367-4eea-aa04-04313b414890" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_ContactPersonnelName_bd020b61-b367-4eea-aa04-04313b414890" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelFaxNumber_6acf2657-4cd5-4f03-acda-ad1d80c5b01c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelFaxNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_ContactPersonnelFaxNumber_6acf2657-4cd5-4f03-acda-ad1d80c5b01c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4c8814a0-2bac-4eef-a7db-5de8336b9af9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_CityAreaCode_4c8814a0-2bac-4eef-a7db-5de8336b9af9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f6393694-5190-4483-9d50-b512be2badc8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_LocalPhoneNumber_f6393694-5190-4483-9d50-b512be2badc8" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_acc9fd1c-9fc1-4cb2-8704-82f59e3beaa2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_Security12bTitle_acc9fd1c-9fc1-4cb2-8704-82f59e3beaa2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_685a6187-64af-4d1d-aa17-a489c1fe4c0e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_TradingSymbol_685a6187-64af-4d1d-aa17-a489c1fe4c0e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_14079a00-1a0a-4cf9-bdbd-62b681a7d534" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_SecurityExchangeName_14079a00-1a0a-4cf9-bdbd-62b681a7d534" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a20e6267-ddcc-4222-a9be-f7d57a8eaa18" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a20e6267-ddcc-4222-a9be-f7d57a8eaa18" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_82c22d02-9d49-4a68-93ce-511437d1c468" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_82c22d02-9d49-4a68-93ce-511437d1c468" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_5a080330-6267-46d4-8e4e-ceaea19e4022" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityVoluntaryFilers_5a080330-6267-46d4-8e4e-ceaea19e4022" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_591752c4-f115-45ee-988a-1bab4854cd94" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityCurrentReportingStatus_591752c4-f115-45ee-988a-1bab4854cd94" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_76d11622-85b1-4016-afd8-a45c683ddbdc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityInteractiveDataCurrent_76d11622-85b1-4016-afd8-a45c683ddbdc" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e42d40a4-b23e-47e4-bd02-2c81fca15a93" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityFilerCategory_e42d40a4-b23e-47e4-bd02-2c81fca15a93" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5b4e8075-0e6c-4459-8c04-4217c7bc2d5e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityEmergingGrowthCompany_5b4e8075-0e6c-4459-8c04-4217c7bc2d5e" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_6bf01b8e-28db-413e-bb6f-55f7d9bf80ed" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_IcfrAuditorAttestationFlag_6bf01b8e-28db-413e-bb6f-55f7d9bf80ed" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_9e09335e-26c8-4a60-9857-bec57d1df985" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentAccountingStandard_9e09335e-26c8-4a60-9857-bec57d1df985" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a7f60ad9-43e1-48be-b0f3-55a5a9af9997" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityShellCompany_a7f60ad9-43e1-48be-b0f3-55a5a9af9997" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b039a9a1-f0f1-4973-9737-eb5649093915" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_AmendmentFlag_b039a9a1-f0f1-4973-9737-eb5649093915" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_2034b215-4a96-4104-a8e1-bc892c355cf8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentFiscalYearFocus_2034b215-4a96-4104-a8e1-bc892c355cf8" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_436cbbcb-1e77-4524-95c2-685bc2cc3adf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_436cbbcb-1e77-4524-95c2-685bc2cc3adf" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_842c614f-96d2-4b6e-a188-88e9b78019cc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityCentralIndexKey_842c614f-96d2-4b6e-a188-88e9b78019cc" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_9a4f7623-68a8-4e1a-bd88-83a95f0a7e8b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntitiesTable_9a4f7623-68a8-4e1a-bd88-83a95f0a7e8b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_bee4769c-20c6-4351-a968-b6c152072937" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_9a4f7623-68a8-4e1a-bd88-83a95f0a7e8b" xlink:to="loc_dei_EntityListingsExchangeAxis_bee4769c-20c6-4351-a968-b6c152072937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_bee4769c-20c6-4351-a968-b6c152072937_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_bee4769c-20c6-4351-a968-b6c152072937" xlink:to="loc_dei_ExchangeDomain_bee4769c-20c6-4351-a968-b6c152072937_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_9b0e9151-ddc4-4f82-a1f0-360fa695edf4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_bee4769c-20c6-4351-a968-b6c152072937" xlink:to="loc_dei_ExchangeDomain_9b0e9151-ddc4-4f82-a1f0-360fa695edf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember_4bff1cfa-512a-4354-b79e-be25a5fbf11f" xlink:href="sny-20221231.xsd#sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_9b0e9151-ddc4-4f82-a1f0-360fa695edf4" xlink:to="loc_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember_4bff1cfa-512a-4354-b79e-be25a5fbf11f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OrdinarySharesNASDAQGlobalSelectMarketMember_3f51b6ef-ea5c-4187-b695-8efe11f084a7" xlink:href="sny-20221231.xsd#sny_OrdinarySharesNASDAQGlobalSelectMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_9b0e9151-ddc4-4f82-a1f0-360fa695edf4" xlink:to="loc_sny_OrdinarySharesNASDAQGlobalSelectMarketMember_3f51b6ef-ea5c-4187-b695-8efe11f084a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_8834e814-e21d-4093-956d-8235ef6d8264" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_9a4f7623-68a8-4e1a-bd88-83a95f0a7e8b" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_8834e814-e21d-4093-956d-8235ef6d8264" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_8834e814-e21d-4093-956d-8235ef6d8264_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_8834e814-e21d-4093-956d-8235ef6d8264" xlink:to="loc_dei_AddressTypeDomain_8834e814-e21d-4093-956d-8235ef6d8264_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_7b3da21b-1b49-4744-be0d-e9f14e72a6ff" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_8834e814-e21d-4093-956d-8235ef6d8264" xlink:to="loc_dei_AddressTypeDomain_7b3da21b-1b49-4744-be0d-e9f14e72a6ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_d49a0285-0bc7-4ef7-b581-6f6983be2121" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_7b3da21b-1b49-4744-be0d-e9f14e72a6ff" xlink:to="loc_dei_BusinessContactMember_d49a0285-0bc7-4ef7-b581-6f6983be2121" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/AuditInformation" xlink:type="simple" xlink:href="sny-20221231.xsd#AuditInformation"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/AuditInformation" xlink:type="extended" id="i663534200f054f82b68064fedc0ba6b1_AuditInformation">
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLineItems_ccb16560-f991-42ce-84d5-6a75e0c5c161" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_f2596976-2f2d-4079-b658-d79aa1d83b0b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AuditorLineItems_ccb16560-f991-42ce-84d5-6a75e0c5c161" xlink:to="loc_dei_AuditorName_f2596976-2f2d-4079-b658-d79aa1d83b0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_1e703cbe-95a5-44d5-90a9-75a904bc55bc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AuditorLineItems_ccb16560-f991-42ce-84d5-6a75e0c5c161" xlink:to="loc_dei_AuditorLocation_1e703cbe-95a5-44d5-90a9-75a904bc55bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_74fd520b-779f-4e08-8b55-c4730298bc72" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AuditorLineItems_ccb16560-f991-42ce-84d5-6a75e0c5c161" xlink:to="loc_dei_AuditorFirmId_74fd520b-779f-4e08-8b55-c4730298bc72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorTable_be0d0919-cef2-495e-b111-33110039f688" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_AuditorLineItems_ccb16560-f991-42ce-84d5-6a75e0c5c161" xlink:to="loc_dei_AuditorTable_be0d0919-cef2-495e-b111-33110039f688" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e86f849b-6f2d-4bf2-b1c8-7995de4d3889" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_AuditorTable_be0d0919-cef2-495e-b111-33110039f688" xlink:to="loc_srt_CounterpartyNameAxis_e86f849b-6f2d-4bf2-b1c8-7995de4d3889" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e86f849b-6f2d-4bf2-b1c8-7995de4d3889_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e86f849b-6f2d-4bf2-b1c8-7995de4d3889" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e86f849b-6f2d-4bf2-b1c8-7995de4d3889_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_abaff4d0-ba92-4313-a9d2-855021a7c7ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e86f849b-6f2d-4bf2-b1c8-7995de4d3889" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_abaff4d0-ba92-4313-a9d2-855021a7c7ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ErnstYoungEtAutresMember_73e85d8b-b979-493c-8bdf-9ff2bee87816" xlink:href="sny-20221231.xsd#sny_ErnstYoungEtAutresMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_abaff4d0-ba92-4313-a9d2-855021a7c7ed" xlink:to="loc_sny_ErnstYoungEtAutresMember_73e85d8b-b979-493c-8bdf-9ff2bee87816" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedstatementsofchangesinequity"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity" xlink:type="extended" id="ic554f9810a3041e0aa614b086774c277_Consolidatedstatementsofchangesinequity">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_35dfc4b2-80b9-427e-9211-ab826399643b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_Equity_35dfc4b2-80b9-427e-9211-ab826399643b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_2466268d-6d0a-4d14-a2c3-a08372da93ec" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_2466268d-6d0a-4d14-a2c3-a08372da93ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_8792ccd5-a9d4-47e8-90e3-212f81aad691" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_ProfitLoss_8792ccd5-a9d4-47e8-90e3-212f81aad691" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_f1b6e73f-1010-4fa7-b730-a1661bd26bf9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_ComprehensiveIncome_f1b6e73f-1010-4fa7-b730-a1661bd26bf9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent_ce1d338b-328a-4d1c-960d-21e9b17315ea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent_ce1d338b-328a-4d1c-960d-21e9b17315ea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_bddd4f81-42e7-4aef-98c1-316f1925dad7" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_bddd4f81-42e7-4aef-98c1-316f1925dad7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_73c3eab5-deb6-4321-9d0f-ba8f638e389c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_73c3eab5-deb6-4321-9d0f-ba8f638e389c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_ceb496c2-781a-41e2-bfbd-1c4588daa577" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfTreasuryShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_PurchaseOfTreasuryShares_ceb496c2-781a-41e2-bfbd-1c4588daa577" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReductionOfIssuedCapital_acaf149f-32e3-4295-b1f9-e61b76407ca0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReductionOfIssuedCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_ReductionOfIssuedCapital_acaf149f-32e3-4295-b1f9-e61b76407ca0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:href="sny-20221231.xsd#sny_ShareBasedPaymentPlansAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_b07d18f5-5c89-40e3-89f8-a65b6702b827" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_b07d18f5-5c89-40e3-89f8-a65b6702b827" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares_943a51e9-1fdb-41ee-8b28-90c3c3a46043" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares_943a51e9-1fdb-41ee-8b28-90c3c3a46043" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans_9d47f2d0-aae2-4cf6-ad29-2f2250d1fefc" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans_9d47f2d0-aae2-4cf6-ad29-2f2250d1fefc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees_fe914619-5d2d-4787-9d78-f24220d2a2ab" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees_fe914619-5d2d-4787-9d78-f24220d2a2ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions_66a8f83a-7075-4512-9424-0df5aace515e" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions_66a8f83a-7075-4512-9424-0df5aace515e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity_03b506af-94c7-4bf9-9af6-658e9b1c0145" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity_03b506af-94c7-4bf9-9af6-658e9b1c0145" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity_53121711-a54c-449f-8bdb-64801e31048e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity_53121711-a54c-449f-8bdb-64801e31048e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment_9bc351a8-93c8-4a9e-9f3a-a65327d5051f" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment_9bc351a8-93c8-4a9e-9f3a-a65327d5051f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_b116710f-d132-4c55-9cff-e1bc1e2198d5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_3b551846-c7dd-42a1-ae0b-3db6f67eea98" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_3b551846-c7dd-42a1-ae0b-3db6f67eea98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_09c7a031-da2d-4359-8965-5ff22416a27d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_3b551846-c7dd-42a1-ae0b-3db6f67eea98" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_09c7a031-da2d-4359-8965-5ff22416a27d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_09c7a031-da2d-4359-8965-5ff22416a27d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_09c7a031-da2d-4359-8965-5ff22416a27d" xlink:to="loc_ifrs-full_EquityMember_09c7a031-da2d-4359-8965-5ff22416a27d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_d266956a-33e2-4182-a0fb-8f7e57838515" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_09c7a031-da2d-4359-8965-5ff22416a27d" xlink:to="loc_ifrs-full_EquityMember_d266956a-33e2-4182-a0fb-8f7e57838515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_d266956a-33e2-4182-a0fb-8f7e57838515" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_4b00b8c2-6323-4e0c-8f1d-06553c20918c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_IssuedCapitalMember_4b00b8c2-6323-4e0c-8f1d-06553c20918c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionalPaidinCapitalMember_2d82cccd-ea79-4bb0-917d-b1f626701134" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalPaidinCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_AdditionalPaidinCapitalMember_2d82cccd-ea79-4bb0-917d-b1f626701134" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasurySharesMember_28a090d1-e7bb-4e80-a20e-2e188ad3fadb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_TreasurySharesMember_28a090d1-e7bb-4e80-a20e-2e188ad3fadb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember_3dc8d3af-ef35-4f2a-b702-26115e7f591e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_RetainedEarningsMember_3dc8d3af-ef35-4f2a-b702-26115e7f591e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_66ff9fd7-2bfc-4f5f-9cec-0f8d4fc4c316" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_66ff9fd7-2bfc-4f5f-9cec-0f8d4fc4c316" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_9a113a37-bb86-4e79-b9ff-2b0a16e8a4a9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_9a113a37-bb86-4e79-b9ff-2b0a16e8a4a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_f9719c75-be5a-40b5-8bf7-28b08db8a8a3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_d266956a-33e2-4182-a0fb-8f7e57838515" xlink:to="loc_ifrs-full_NoncontrollingInterestsMember_f9719c75-be5a-40b5-8bf7-28b08db8a8a3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedstatementsofchangesinequityParenthetical"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical" xlink:type="extended" id="i8d1629c945aa4ac6b33f954519e72859_ConsolidatedstatementsofchangesinequityParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_30d73e70-0b86-4d33-b491-3d993ab8da5c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare_f9517305-c4c8-42e6-b587-b040862cd568" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_30d73e70-0b86-4d33-b491-3d993ab8da5c" xlink:to="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare_f9517305-c4c8-42e6-b587-b040862cd568" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital_fb76be0f-2d3e-4fda-b4e8-453198e71e81" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendPercentageOfShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_30d73e70-0b86-4d33-b491-3d993ab8da5c" xlink:to="loc_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital_fb76be0f-2d3e-4fda-b4e8-453198e71e81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_e517da76-d7fb-4107-89f2-3f36b9cd922f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_30d73e70-0b86-4d33-b491-3d993ab8da5c" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_e517da76-d7fb-4107-89f2-3f36b9cd922f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_f91cffed-2578-4ffb-be7b-52881b9d8867" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_30d73e70-0b86-4d33-b491-3d993ab8da5c" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_f91cffed-2578-4ffb-be7b-52881b9d8867" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7da8b6cf-976d-4401-b5ed-157c58bc9900" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_f91cffed-2578-4ffb-be7b-52881b9d8867" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7da8b6cf-976d-4401-b5ed-157c58bc9900" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_7da8b6cf-976d-4401-b5ed-157c58bc9900_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7da8b6cf-976d-4401-b5ed-157c58bc9900" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_7da8b6cf-976d-4401-b5ed-157c58bc9900_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_14c1a128-ab2f-42b1-9771-599e78c147b3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7da8b6cf-976d-4401-b5ed-157c58bc9900" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_14c1a128-ab2f-42b1-9771-599e78c147b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_5b35cc12-560c-4387-bd2f-9320b2c821d7" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_14c1a128-ab2f-42b1-9771-599e78c147b3" xlink:to="loc_sny_EuroapiMember_5b35cc12-560c-4387-bd2f-9320b2c821d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1c868d05-9384-4cb9-9b00-187fdf10c4c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_f91cffed-2578-4ffb-be7b-52881b9d8867" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1c868d05-9384-4cb9-9b00-187fdf10c4c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_1c868d05-9384-4cb9-9b00-187fdf10c4c3_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1c868d05-9384-4cb9-9b00-187fdf10c4c3" xlink:to="loc_ifrs-full_EquityMember_1c868d05-9384-4cb9-9b00-187fdf10c4c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_e3f2dae7-4873-4988-9755-279242b18e37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1c868d05-9384-4cb9-9b00-187fdf10c4c3" xlink:to="loc_ifrs-full_EquityMember_e3f2dae7-4873-4988-9755-279242b18e37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember_4a9bf2b2-ad76-4af4-8493-f1828b36906e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_e3f2dae7-4873-4988-9755-279242b18e37" xlink:to="loc_ifrs-full_RetainedEarningsMember_4a9bf2b2-ad76-4af4-8493-f1828b36906e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_4f92762a-a537-4d22-af04-26064deee5f9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_e3f2dae7-4873-4988-9755-279242b18e37" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_4f92762a-a537-4d22-af04-26064deee5f9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedstatementsofcashflowsParenthetical"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical" xlink:type="extended" id="i35c84c52d2724a1e893fd3f723ea84ed_ConsolidatedstatementsofcashflowsParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax_8a87a5e3-87b7-4799-a16c-23810797a4c1" xlink:href="sny-20221231.xsd#sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax_8a87a5e3-87b7-4799-a16c-23810797a4c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_47c6800d-1b74-494a-8e68-3050d81e2cc5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_47c6800d-1b74-494a-8e68-3050d81e2cc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_35945a68-2595-4560-8f7e-1d8e568ed460" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_35945a68-2595-4560-8f7e-1d8e568ed460" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_36bbc175-2d1c-4ae0-acb6-6832cb80ffe4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_36bbc175-2d1c-4ae0-acb6-6832cb80ffe4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities_82bd0c49-8bf9-4b57-815f-96d1ea8b50bd" xlink:href="sny-20221231.xsd#sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities_82bd0c49-8bf9-4b57-815f-96d1ea8b50bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_cb24c486-0509-46e5-8d77-c75b4fb88583" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_cb24c486-0509-46e5-8d77-c75b4fb88583" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_6a90c5dd-2c4d-469a-b7cb-5b06861753c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_6a90c5dd-2c4d-469a-b7cb-5b06861753c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedCashFlowStatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1fdba80e-5a2d-474a-a2dd-7d1dca1f3c1a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1fdba80e-5a2d-474a-a2dd-7d1dca1f3c1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_1fdba80e-5a2d-474a-a2dd-7d1dca1f3c1a_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1fdba80e-5a2d-474a-a2dd-7d1dca1f3c1a" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_1fdba80e-5a2d-474a-a2dd-7d1dca1f3c1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_4550b102-b864-4f3e-a4a2-a059f2dc395f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1fdba80e-5a2d-474a-a2dd-7d1dca1f3c1a" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_4550b102-b864-4f3e-a4a2-a059f2dc395f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_705e0bcb-3410-42a2-ac1c-e7d8281669e9" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_4550b102-b864-4f3e-a4a2-a059f2dc395f" xlink:to="loc_sny_RegeneronMember_705e0bcb-3410-42a2-ac1c-e7d8281669e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_60e95382-6489-40a8-8304-73a1664d086b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_60e95382-6489-40a8-8304-73a1664d086b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_60e95382-6489-40a8-8304-73a1664d086b_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_60e95382-6489-40a8-8304-73a1664d086b" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_60e95382-6489-40a8-8304-73a1664d086b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_5b55a256-9872-487f-8a03-4d371b276a7f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_60e95382-6489-40a8-8304-73a1664d086b" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_5b55a256-9872-487f-8a03-4d371b276a7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationRelatingToDivestmentsMember_21b5c876-a67f-4004-b587-1bb7528b4966" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationRelatingToDivestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_5b55a256-9872-487f-8a03-4d371b276a7f" xlink:to="loc_sny_ContingentConsiderationRelatingToDivestmentsMember_21b5c876-a67f-4004-b587-1bb7528b4966" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_76f0f339-1be2-4bcb-906a-4158c8bd0339" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:to="loc_srt_ProductOrServiceAxis_76f0f339-1be2-4bcb-906a-4158c8bd0339" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_76f0f339-1be2-4bcb-906a-4158c8bd0339_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_76f0f339-1be2-4bcb-906a-4158c8bd0339" xlink:to="loc_srt_ProductsAndServicesDomain_76f0f339-1be2-4bcb-906a-4158c8bd0339_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8af27df2-44ed-4b98-95ff-3d872c424bdd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_76f0f339-1be2-4bcb-906a-4158c8bd0339" xlink:to="loc_srt_ProductsAndServicesDomain_8af27df2-44ed-4b98-95ff-3d872c424bdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsMember_bb6497f6-616a-4b0f-acf1-705160dfd4de" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8af27df2-44ed-4b98-95ff-3d872c424bdd" xlink:to="loc_sny_PharmaceuticalsMember_bb6497f6-616a-4b0f-acf1-705160dfd4de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareMember_e7cd9a20-318d-4660-b6cb-1c291eeba09c" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8af27df2-44ed-4b98-95ff-3d872c424bdd" xlink:to="loc_sny_ConsumerHealthcareMember_e7cd9a20-318d-4660-b6cb-1c291eeba09c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SeprafilmMember_db4c0a63-73aa-489b-bba6-af5569a11d8d" xlink:href="sny-20221231.xsd#sny_SeprafilmMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8af27df2-44ed-4b98-95ff-3d872c424bdd" xlink:to="loc_sny_SeprafilmMember_db4c0a63-73aa-489b-bba6-af5569a11d8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7c46b619-6ca4-432f-87c7-72c3b4a4bc04" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7c46b619-6ca4-432f-87c7-72c3b4a4bc04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_7c46b619-6ca4-432f-87c7-72c3b4a4bc04_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7c46b619-6ca4-432f-87c7-72c3b4a4bc04" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_7c46b619-6ca4-432f-87c7-72c3b4a4bc04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1487d627-86b4-4639-bde8-dc0b87bce7d1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7c46b619-6ca4-432f-87c7-72c3b4a4bc04" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1487d627-86b4-4639-bde8-dc0b87bce7d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_c462eba3-3463-404c-a508-038bfbc1078e" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1487d627-86b4-4639-bde8-dc0b87bce7d1" xlink:to="loc_sny_EuroapiMember_c462eba3-3463-404c-a508-038bfbc1078e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#BasisofpreparationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails" xlink:type="extended" id="iff7fe67db6d84a1dabb1eda2c873dbe1_BasisofpreparationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears_4ca535d8-8125-4c94-ad85-8a6b60fe48d3" xlink:href="sny-20221231.xsd#sny_CumulativeConsumerPriceInflationOverTheLastThreeYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears_4ca535d8-8125-4c94-ad85-8a6b60fe48d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfVaccineDosesToBeSupplied_93c6f2e0-1741-4be3-802d-ca66c8bdee92" xlink:href="sny-20221231.xsd#sny_NumberOfVaccineDosesToBeSupplied"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_sny_NumberOfVaccineDosesToBeSupplied_93c6f2e0-1741-4be3-802d-ca66c8bdee92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses_6f6b9aef-e8eb-4e69-ae98-4745cc92df04" xlink:href="sny-20221231.xsd#sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses_6f6b9aef-e8eb-4e69-ae98-4745cc92df04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilities_9a6d76a3-5ba7-404b-aff7-0d437865f75f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentContractLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_ifrs-full_CurrentContractLiabilities_9a6d76a3-5ba7-404b-aff7-0d437865f75f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_8709754e-8405-4919-adf8-5468960dfed0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_ifrs-full_ContractLiabilities_8709754e-8405-4919-adf8-5468960dfed0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_0afc2f90-3d3b-4cb7-a622-b046f886dd7b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_0afc2f90-3d3b-4cb7-a622-b046f886dd7b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue_3642928e-8144-4346-a0af-f803b6b7f662" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_ifrs-full_PercentageOfEntitysRevenue_3642928e-8144-4346-a0af-f803b6b7f662" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_0bf1d7ca-0263-4824-91ba-ba28bc493301" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_0bf1d7ca-0263-4824-91ba-ba28bc493301" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_4e55ad2e-a92c-4b4f-8a2d-afed5a3b15bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_0bf1d7ca-0263-4824-91ba-ba28bc493301" xlink:to="loc_ifrs-full_GeographicalAreasAxis_4e55ad2e-a92c-4b4f-8a2d-afed5a3b15bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_4e55ad2e-a92c-4b4f-8a2d-afed5a3b15bd_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_4e55ad2e-a92c-4b4f-8a2d-afed5a3b15bd" xlink:to="loc_ifrs-full_GeographicalAreasMember_4e55ad2e-a92c-4b4f-8a2d-afed5a3b15bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_98fca8e9-2e8d-4e27-95cf-88e76d1cc4f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_4e55ad2e-a92c-4b4f-8a2d-afed5a3b15bd" xlink:to="loc_ifrs-full_GeographicalAreasMember_98fca8e9-2e8d-4e27-95cf-88e76d1cc4f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AR_460b5820-abab-4cfb-88b3-9ce133ab2dab" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_98fca8e9-2e8d-4e27-95cf-88e76d1cc4f0" xlink:to="loc_country_AR_460b5820-abab-4cfb-88b3-9ce133ab2dab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TR_21f3d38a-aef5-4ac1-a246-dc30badf1026" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_TR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_98fca8e9-2e8d-4e27-95cf-88e76d1cc4f0" xlink:to="loc_country_TR_21f3d38a-aef5-4ac1-a246-dc30badf1026" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_RU_9cead612-02be-4dd3-be62-9069ab5d3e6d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_RU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_98fca8e9-2e8d-4e27-95cf-88e76d1cc4f0" xlink:to="loc_country_RU_9cead612-02be-4dd3-be62-9069ab5d3e6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementAxis_89da3dc9-2b83-4b11-bc61-03da3b0e4770" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_0bf1d7ca-0263-4824-91ba-ba28bc493301" xlink:to="loc_sny_TypesOfAgreementAxis_89da3dc9-2b83-4b11-bc61-03da3b0e4770" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_89da3dc9-2b83-4b11-bc61-03da3b0e4770_default" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_TypesOfAgreementAxis_89da3dc9-2b83-4b11-bc61-03da3b0e4770" xlink:to="loc_sny_TypesOfAgreementDomain_89da3dc9-2b83-4b11-bc61-03da3b0e4770_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_d41dc86e-dcec-4b68-be18-3e115b770e21" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_TypesOfAgreementAxis_89da3dc9-2b83-4b11-bc61-03da3b0e4770" xlink:to="loc_sny_TypesOfAgreementDomain_d41dc86e-dcec-4b68-be18-3e115b770e21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementWithGSKMember_948da269-6a3b-4f45-be9b-ffbe12c50b05" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementWithGSKMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_TypesOfAgreementDomain_d41dc86e-dcec-4b68-be18-3e115b770e21" xlink:to="loc_sny_CollaborationAgreementWithGSKMember_948da269-6a3b-4f45-be9b-ffbe12c50b05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_71af67cc-b458-41be-8caf-2b25488a7293" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_0bf1d7ca-0263-4824-91ba-ba28bc493301" xlink:to="loc_ifrs-full_CounterpartiesAxis_71af67cc-b458-41be-8caf-2b25488a7293" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_71af67cc-b458-41be-8caf-2b25488a7293_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_71af67cc-b458-41be-8caf-2b25488a7293" xlink:to="loc_ifrs-full_CounterpartiesMember_71af67cc-b458-41be-8caf-2b25488a7293_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_985b2cf0-7cf3-4a3c-a946-b2560a90b219" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_71af67cc-b458-41be-8caf-2b25488a7293" xlink:to="loc_ifrs-full_CounterpartiesMember_985b2cf0-7cf3-4a3c-a946-b2560a90b219" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_USGovernmentMember_ca4906dc-bd39-4c67-a8f0-6a420e9feb84" xlink:href="sny-20221231.xsd#sny_USGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_985b2cf0-7cf3-4a3c-a946-b2560a90b219" xlink:to="loc_sny_USGovernmentMember_ca4906dc-bd39-4c67-a8f0-6a420e9feb84" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails" xlink:type="extended" id="ibeaae606086d477fbcf05cd5e3c5bdc7_SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_64106510-5424-43f9-b483-68d27809e41a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_b12c6692-e97d-4719-8ef9-0fb478bb49e0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_64106510-5424-43f9-b483-68d27809e41a" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_b12c6692-e97d-4719-8ef9-0fb478bb49e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_7a387e0b-490c-4c11-b689-c6d4d48aa826" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_64106510-5424-43f9-b483-68d27809e41a" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_7a387e0b-490c-4c11-b689-c6d4d48aa826" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_e4712b66-3b9a-451a-880d-18934d60b562" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_7a387e0b-490c-4c11-b689-c6d4d48aa826" xlink:to="loc_ifrs-full_RangeAxis_e4712b66-3b9a-451a-880d-18934d60b562" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_e4712b66-3b9a-451a-880d-18934d60b562_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_e4712b66-3b9a-451a-880d-18934d60b562" xlink:to="loc_ifrs-full_RangesMember_e4712b66-3b9a-451a-880d-18934d60b562_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_82cfc647-97ae-4356-a833-e6f7fe59529d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_e4712b66-3b9a-451a-880d-18934d60b562" xlink:to="loc_ifrs-full_RangesMember_82cfc647-97ae-4356-a833-e6f7fe59529d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_02b2f145-dd56-4e39-9f7b-1f8ff1037c48" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_82cfc647-97ae-4356-a833-e6f7fe59529d" xlink:to="loc_ifrs-full_BottomOfRangeMember_02b2f145-dd56-4e39-9f7b-1f8ff1037c48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_ce1e5cc9-e7cf-4d5e-9b3e-699732306ca1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_82cfc647-97ae-4356-a833-e6f7fe59529d" xlink:to="loc_ifrs-full_TopOfRangeMember_ce1e5cc9-e7cf-4d5e-9b3e-699732306ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_3e39e2f7-f0f9-435f-b061-919337de735a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_7a387e0b-490c-4c11-b689-c6d4d48aa826" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_3e39e2f7-f0f9-435f-b061-919337de735a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_3e39e2f7-f0f9-435f-b061-919337de735a_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_3e39e2f7-f0f9-435f-b061-919337de735a" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_3e39e2f7-f0f9-435f-b061-919337de735a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7823a9b9-c59d-449a-bc72-8464099e72fa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_3e39e2f7-f0f9-435f-b061-919337de735a" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7823a9b9-c59d-449a-bc72-8464099e72fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_4ba55cec-5a70-4428-8ac2-9ccf118b57db" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7823a9b9-c59d-449a-bc72-8464099e72fa" xlink:to="loc_ifrs-full_ComputerSoftwareMember_4ba55cec-5a70-4428-8ac2-9ccf118b57db" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="extended" id="i50a0a17dc19f4954b29ca6ee3dd4eff2_SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_d44eeb1e-5db3-49f1-92b0-438b77b8942e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_f6de8784-ac6b-4586-a826-c152b1c2c3dc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_d44eeb1e-5db3-49f1-92b0-438b77b8942e" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_f6de8784-ac6b-4586-a826-c152b1c2c3dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_eee04038-24ab-460b-b974-10c4d9bc50fc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_d44eeb1e-5db3-49f1-92b0-438b77b8942e" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_eee04038-24ab-460b-b974-10c4d9bc50fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_ba7974c6-996f-4117-b7c7-7e32f7ad6b4b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_eee04038-24ab-460b-b974-10c4d9bc50fc" xlink:to="loc_ifrs-full_RangeAxis_ba7974c6-996f-4117-b7c7-7e32f7ad6b4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_ba7974c6-996f-4117-b7c7-7e32f7ad6b4b_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_ba7974c6-996f-4117-b7c7-7e32f7ad6b4b" xlink:to="loc_ifrs-full_RangesMember_ba7974c6-996f-4117-b7c7-7e32f7ad6b4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_d3082cd9-9485-4630-8410-bb9bc5fc0291" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_ba7974c6-996f-4117-b7c7-7e32f7ad6b4b" xlink:to="loc_ifrs-full_RangesMember_d3082cd9-9485-4630-8410-bb9bc5fc0291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_3a1b31d0-d1e5-4922-9afc-cab68dab4bea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_d3082cd9-9485-4630-8410-bb9bc5fc0291" xlink:to="loc_ifrs-full_BottomOfRangeMember_3a1b31d0-d1e5-4922-9afc-cab68dab4bea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_e0a1b46f-6437-4a05-8c8c-71f752fe8045" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_d3082cd9-9485-4630-8410-bb9bc5fc0291" xlink:to="loc_ifrs-full_TopOfRangeMember_e0a1b46f-6437-4a05-8c8c-71f752fe8045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ec738a51-39c5-440c-a659-6aea1a5d838f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_eee04038-24ab-460b-b974-10c4d9bc50fc" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ec738a51-39c5-440c-a659-6aea1a5d838f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_ec738a51-39c5-440c-a659-6aea1a5d838f_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ec738a51-39c5-440c-a659-6aea1a5d838f" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_ec738a51-39c5-440c-a659-6aea1a5d838f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ec738a51-39c5-440c-a659-6aea1a5d838f" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BuildingsMember_731c2ca2-fdaf-42d8-8aba-95f219bdf149" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:to="loc_ifrs-full_BuildingsMember_731c2ca2-fdaf-42d8-8aba-95f219bdf149" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_0e57ddf3-b471-4791-ac25-d9a7f7de7c42" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_0e57ddf3-b471-4791-ac25-d9a7f7de7c42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MachineryAndEquipmentMember_7cd69791-be35-4a99-95d2-64b50594e730" xlink:href="sny-20221231.xsd#sny_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:to="loc_sny_MachineryAndEquipmentMember_7cd69791-be35-4a99-95d2-64b50594e730" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_80059548-c836-4031-a1ef-5171d88156fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_80059548-c836-4031-a1ef-5171d88156fb" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails" xlink:type="extended" id="i097405be0ebd4bb39d566faa3273063a_SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems_db3c571b-77e2-4a37-bd09-10d9e125699c" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_6d36db59-d8a0-4375-a6d2-1aaa99a6db4a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems_db3c571b-77e2-4a37-bd09-10d9e125699c" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_6d36db59-d8a0-4375-a6d2-1aaa99a6db4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_b4591fd7-3e94-420e-9594-80503018793a" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems_db3c571b-77e2-4a37-bd09-10d9e125699c" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_b4591fd7-3e94-420e-9594-80503018793a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_12001036-2fcb-4717-bc93-ca4b39d32dfb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_b4591fd7-3e94-420e-9594-80503018793a" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_12001036-2fcb-4717-bc93-ca4b39d32dfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_12001036-2fcb-4717-bc93-ca4b39d32dfb_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_12001036-2fcb-4717-bc93-ca4b39d32dfb" xlink:to="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_12001036-2fcb-4717-bc93-ca4b39d32dfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_576aa834-6ffe-4bf9-a87d-05cc56705f90" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_12001036-2fcb-4717-bc93-ca4b39d32dfb" xlink:to="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_576aa834-6ffe-4bf9-a87d-05cc56705f90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_54996e6f-9306-48ed-86a8-cc8d0eca4fac" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EliminationOfIntersegmentAmountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_576aa834-6ffe-4bf9-a87d-05cc56705f90" xlink:to="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_54996e6f-9306-48ed-86a8-cc8d0eca4fac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_03130206-55d5-46aa-a2ec-e70caf095633" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_b4591fd7-3e94-420e-9594-80503018793a" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_03130206-55d5-46aa-a2ec-e70caf095633" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_03130206-55d5-46aa-a2ec-e70caf095633_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_03130206-55d5-46aa-a2ec-e70caf095633" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_03130206-55d5-46aa-a2ec-e70caf095633_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_86657648-89e2-496a-b6d5-e2e214f7e938" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_03130206-55d5-46aa-a2ec-e70caf095633" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_86657648-89e2-496a-b6d5-e2e214f7e938" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember_6981c1a7-9928-4913-93a8-d7cd4a40e234" xlink:href="sny-20221231.xsd#sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_86657648-89e2-496a-b6d5-e2e214f7e938" xlink:to="loc_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember_6981c1a7-9928-4913-93a8-d7cd4a40e234" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails" xlink:type="extended" id="i4b938c6c23f44e2e96c77846c1a209d3_SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems_33de09ba-3d7b-492d-b5b8-27c84d70c525" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OptionVestingPeriod_18c57019-996f-48ee-b95c-7c39e3eeaf79" xlink:href="sny-20221231.xsd#sny_OptionVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems_33de09ba-3d7b-492d-b5b8-27c84d70c525" xlink:to="loc_sny_OptionVestingPeriod_18c57019-996f-48ee-b95c-7c39e3eeaf79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_6e6f3c03-35b6-496e-a278-de65c13e91e4" xlink:href="sny-20221231.xsd#sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems_33de09ba-3d7b-492d-b5b8-27c84d70c525" xlink:to="loc_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_6e6f3c03-35b6-496e-a278-de65c13e91e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable_383b282f-de64-4b43-bd72-42e1399663c6" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems_33de09ba-3d7b-492d-b5b8-27c84d70c525" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable_383b282f-de64-4b43-bd72-42e1399663c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7027486d-680c-46bf-b0e8-6a5042a0f315" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable_383b282f-de64-4b43-bd72-42e1399663c6" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7027486d-680c-46bf-b0e8-6a5042a0f315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_7027486d-680c-46bf-b0e8-6a5042a0f315_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7027486d-680c-46bf-b0e8-6a5042a0f315" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_7027486d-680c-46bf-b0e8-6a5042a0f315_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_915a2775-33a3-4a5e-8c50-8967f900c025" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7027486d-680c-46bf-b0e8-6a5042a0f315" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_915a2775-33a3-4a5e-8c50-8967f900c025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionPlansMember_e63f31e6-5785-4441-a857-75510c7b2a61" xlink:href="sny-20221231.xsd#sny_StockOptionPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_915a2775-33a3-4a5e-8c50-8967f900c025" xlink:to="loc_sny_StockOptionPlansMember_e63f31e6-5785-4441-a857-75510c7b2a61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlansMember_25f5c100-3a4c-4baa-a233-976b686adb6c" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_915a2775-33a3-4a5e-8c50-8967f900c025" xlink:to="loc_sny_RestrictedSharePlansMember_25f5c100-3a4c-4baa-a233-976b686adb6c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails" xlink:type="extended" id="i649f3c057b644bbdb3eed9b4499f3c3b_PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfAgreementsSigned_2bc85993-86db-4868-9274-603977cbda83" xlink:href="sny-20221231.xsd#sny_NumberOfAgreementsSigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_NumberOfAgreementsSigned_2bc85993-86db-4868-9274-603977cbda83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFunded_a47d9109-c244-4378-acdb-6c524c3f3941" xlink:href="sny-20221231.xsd#sny_PercentageOfSecondPartOfDevelopmentCostsFunded"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFunded_a47d9109-c244-4378-acdb-6c524c3f3941" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty_88793e7e-293c-491d-bde6-29a6b43081d2" xlink:href="sny-20221231.xsd#sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty_88793e7e-293c-491d-bde6-29a6b43081d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_f24f2400-7fc3-446f-9203-3d29ebda6e93" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitShareOnCounterpartiesProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_f24f2400-7fc3-446f-9203-3d29ebda6e93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_50ea40d1-fd13-4912-a940-7a2bbc8d39ef" xlink:href="sny-20221231.xsd#sny_PercentageOfCumulativeDevelopmentCostsReimbursed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_50ea40d1-fd13-4912-a940-7a2bbc8d39ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared_4d26751a-6ac0-4ab9-9085-4050963b6ca8" xlink:href="sny-20221231.xsd#sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared_4d26751a-6ac0-4ab9-9085-4050963b6ca8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations_885ce88a-b2c1-46d7-962f-ec7bb1c80a48" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations_885ce88a-b2c1-46d7-962f-ec7bb1c80a48" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitsArisingFromCommercialOperations_bd9c71f4-3c66-4477-903f-c49c0db5ecb5" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitsArisingFromCommercialOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfProfitsArisingFromCommercialOperations_bd9c71f4-3c66-4477-903f-c49c0db5ecb5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfLossesArisingFromCommercialOperations_57b16a2e-1b27-4938-8df3-978054f1ac4c" xlink:href="sny-20221231.xsd#sny_PercentageOfLossesArisingFromCommercialOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfLossesArisingFromCommercialOperations_57b16a2e-1b27-4938-8df3-978054f1ac4c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPayments_96a9ada7-5eb4-4bc4-9fd5-e2714beec4b2" xlink:href="sny-20221231.xsd#sny_NumberOfPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_NumberOfPayments_96a9ada7-5eb4-4bc4-9fd5-e2714beec4b2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentRelatedToAttainmentOfGoal_bea2bfd6-ef6f-4d21-a2ce-3afba21efbcd" xlink:href="sny-20221231.xsd#sny_PaymentRelatedToAttainmentOfGoal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PaymentRelatedToAttainmentOfGoal_bea2bfd6-ef6f-4d21-a2ce-3afba21efbcd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_cec277fe-bfda-4dfb-a384-3fc486004184" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_cec277fe-bfda-4dfb-a384-3fc486004184" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltyExpensePercentage_7ba9c988-da44-4dd4-b0ca-87852ea63411" xlink:href="sny-20221231.xsd#sny_RoyaltyExpensePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_RoyaltyExpensePercentage_7ba9c988-da44-4dd4-b0ca-87852ea63411" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_eb78ad14-fc90-44c9-84b8-73fe5b15ca9d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_ifrs-full_CounterpartiesAxis_eb78ad14-fc90-44c9-84b8-73fe5b15ca9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_eb78ad14-fc90-44c9-84b8-73fe5b15ca9d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_eb78ad14-fc90-44c9-84b8-73fe5b15ca9d" xlink:to="loc_ifrs-full_CounterpartiesMember_eb78ad14-fc90-44c9-84b8-73fe5b15ca9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_a7af9141-d16c-42df-9952-5c3070cf1449" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_eb78ad14-fc90-44c9-84b8-73fe5b15ca9d" xlink:to="loc_ifrs-full_CounterpartiesMember_a7af9141-d16c-42df-9952-5c3070cf1449" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_44be4d81-5445-4283-90de-0def18bb7a73" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_a7af9141-d16c-42df-9952-5c3070cf1449" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_44be4d81-5445-4283-90de-0def18bb7a73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_3758e43c-e3f7-46ed-84d1-77190f382022" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_sny_PrincipalAlliancesAxis_3758e43c-e3f7-46ed-84d1-77190f382022" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_3758e43c-e3f7-46ed-84d1-77190f382022_default" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_PrincipalAlliancesAxis_3758e43c-e3f7-46ed-84d1-77190f382022" xlink:to="loc_sny_PrincipalAlliancesDomain_3758e43c-e3f7-46ed-84d1-77190f382022_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_b288af3e-1adf-4ba2-8e80-f6d1d52d3cd8" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_PrincipalAlliancesAxis_3758e43c-e3f7-46ed-84d1-77190f382022" xlink:to="loc_sny_PrincipalAlliancesDomain_b288af3e-1adf-4ba2-8e80-f6d1d52d3cd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember_ccf8a6df-7523-4174-b4d5-1fd1fb3f86bf" xlink:href="sny-20221231.xsd#sny_AntibodiesCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalAlliancesDomain_b288af3e-1adf-4ba2-8e80-f6d1d52d3cd8" xlink:to="loc_sny_AntibodiesCollaborationAgreementMember_ccf8a6df-7523-4174-b4d5-1fd1fb3f86bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImmunoOncologyCollaborationAgreementMember_3b16aee8-ecd3-4fdd-b3aa-6309ff273537" xlink:href="sny-20221231.xsd#sny_ImmunoOncologyCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalAlliancesDomain_b288af3e-1adf-4ba2-8e80-f6d1d52d3cd8" xlink:to="loc_sny_ImmunoOncologyCollaborationAgreementMember_3b16aee8-ecd3-4fdd-b3aa-6309ff273537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesMember_360b7fb8-e59f-4e62-9201-75e9068b013e" xlink:href="sny-20221231.xsd#sny_AntibodiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalAlliancesDomain_b288af3e-1adf-4ba2-8e80-f6d1d52d3cd8" xlink:to="loc_sny_AntibodiesMember_360b7fb8-e59f-4e62-9201-75e9068b013e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1eced509-0124-489a-87b8-5c6c4d99edcb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1eced509-0124-489a-87b8-5c6c4d99edcb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_1eced509-0124-489a-87b8-5c6c4d99edcb_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1eced509-0124-489a-87b8-5c6c4d99edcb" xlink:to="loc_ifrs-full_GeographicalAreasMember_1eced509-0124-489a-87b8-5c6c4d99edcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_3f2ec264-4a06-427b-9954-e60d6a161dcf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1eced509-0124-489a-87b8-5c6c4d99edcb" xlink:to="loc_ifrs-full_GeographicalAreasMember_3f2ec264-4a06-427b-9954-e60d6a161dcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eca94dbb-a3ba-420c-941e-b1971a904230" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_3f2ec264-4a06-427b-9954-e60d6a161dcf" xlink:to="loc_country_US_eca94dbb-a3ba-420c-941e-b1971a904230" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OutsideUnitedStatesMember_5929d648-7f9d-4b0e-8f78-9224590fcf98" xlink:href="sny-20221231.xsd#sny_OutsideUnitedStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_3f2ec264-4a06-427b-9954-e60d6a161dcf" xlink:to="loc_sny_OutsideUnitedStatesMember_5929d648-7f9d-4b0e-8f78-9224590fcf98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_8e89d77f-8276-49fe-b05b-2ae0ae6d1b2e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_ifrs-full_RangeAxis_8e89d77f-8276-49fe-b05b-2ae0ae6d1b2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_8e89d77f-8276-49fe-b05b-2ae0ae6d1b2e_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_8e89d77f-8276-49fe-b05b-2ae0ae6d1b2e" xlink:to="loc_ifrs-full_RangesMember_8e89d77f-8276-49fe-b05b-2ae0ae6d1b2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_f1162a31-a104-442b-99d9-d220c0166739" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_8e89d77f-8276-49fe-b05b-2ae0ae6d1b2e" xlink:to="loc_ifrs-full_RangesMember_f1162a31-a104-442b-99d9-d220c0166739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_f3054c53-4eef-4cd8-b719-01fcf8675ba9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_f1162a31-a104-442b-99d9-d220c0166739" xlink:to="loc_ifrs-full_BottomOfRangeMember_f3054c53-4eef-4cd8-b719-01fcf8675ba9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_c9442100-0e75-47ad-9c20-ce0bafdab0ad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_f1162a31-a104-442b-99d9-d220c0166739" xlink:to="loc_ifrs-full_TopOfRangeMember_c9442100-0e75-47ad-9c20-ce0bafdab0ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementAxis_878a246a-60ed-403d-8fb0-ff754da7626a" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_sny_TypesOfAgreementAxis_878a246a-60ed-403d-8fb0-ff754da7626a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_878a246a-60ed-403d-8fb0-ff754da7626a_default" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_TypesOfAgreementAxis_878a246a-60ed-403d-8fb0-ff754da7626a" xlink:to="loc_sny_TypesOfAgreementDomain_878a246a-60ed-403d-8fb0-ff754da7626a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_TypesOfAgreementAxis_878a246a-60ed-403d-8fb0-ff754da7626a" xlink:to="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesOfAntibodiesFirstAchievementMember_eba3b9b0-b625-48f9-a65b-049e081bc926" xlink:href="sny-20221231.xsd#sny_SalesOfAntibodiesFirstAchievementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:to="loc_sny_SalesOfAntibodiesFirstAchievementMember_eba3b9b0-b625-48f9-a65b-049e081bc926" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesOfAntibodiesSecondAchievementMember_efcab50e-d355-490c-9f6c-6a563801295d" xlink:href="sny-20221231.xsd#sny_SalesOfAntibodiesSecondAchievementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:to="loc_sny_SalesOfAntibodiesSecondAchievementMember_efcab50e-d355-490c-9f6c-6a563801295d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PriorAgreementMember_58293ae7-5367-46e4-b830-3fe5bfc97174" xlink:href="sny-20221231.xsd#sny_PriorAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:to="loc_sny_PriorAgreementMember_58293ae7-5367-46e4-b830-3fe5bfc97174" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NewAgreementMember_50297cd1-9b95-4ccb-8fc0-a9a512669d02" xlink:href="sny-20221231.xsd#sny_NewAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:to="loc_sny_NewAgreementMember_50297cd1-9b95-4ccb-8fc0-a9a512669d02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesOfAntibodiesThirdAchievementMember_f4119c12-2fc1-410b-b807-a802aabff235" xlink:href="sny-20221231.xsd#sny_SalesOfAntibodiesThirdAchievementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:to="loc_sny_SalesOfAntibodiesThirdAchievementMember_f4119c12-2fc1-410b-b807-a802aabff235" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a6e9eba4-4268-4ea9-9067-dc3291b7cbc5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_srt_ProductOrServiceAxis_a6e9eba4-4268-4ea9-9067-dc3291b7cbc5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a6e9eba4-4268-4ea9-9067-dc3291b7cbc5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a6e9eba4-4268-4ea9-9067-dc3291b7cbc5" xlink:to="loc_srt_ProductsAndServicesDomain_a6e9eba4-4268-4ea9-9067-dc3291b7cbc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_65411acf-8093-4c13-aa83-f7c1ce0fc7db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a6e9eba4-4268-4ea9-9067-dc3291b7cbc5" xlink:to="loc_srt_ProductsAndServicesDomain_65411acf-8093-4c13-aa83-f7c1ce0fc7db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesAllianceMember_d408631f-1b5c-4ffc-a6b0-d961a68bca17" xlink:href="sny-20221231.xsd#sny_AntibodiesAllianceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_65411acf-8093-4c13-aa83-f7c1ce0fc7db" xlink:to="loc_sny_AntibodiesAllianceMember_d408631f-1b5c-4ffc-a6b0-d961a68bca17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesMember_7bb7807f-5a2e-45fc-b2e8-309ab870acc9" xlink:href="sny-20221231.xsd#sny_AntibodiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_65411acf-8093-4c13-aa83-f7c1ce0fc7db" xlink:to="loc_sny_AntibodiesMember_7bb7807f-5a2e-45fc-b2e8-309ab870acc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_76fa4235-5325-4fee-8964-121daf0e1b42" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_76fa4235-5325-4fee-8964-121daf0e1b42" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsMember_76fa4235-5325-4fee-8964-121daf0e1b42_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_76fa4235-5325-4fee-8964-121daf0e1b42" xlink:to="loc_ifrs-full_NonadjustingEventsMember_76fa4235-5325-4fee-8964-121daf0e1b42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsMember_ebe9ca96-f05f-4cd2-949f-5a6433ad2a6d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_76fa4235-5325-4fee-8964-121daf0e1b42" xlink:to="loc_ifrs-full_NonadjustingEventsMember_ebe9ca96-f05f-4cd2-949f-5a6433ad2a6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MajorCollaborationAgreementMember_4b1b6c07-0503-49b6-9450-b441b9da5e79" xlink:href="sny-20221231.xsd#sny_MajorCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_ebe9ca96-f05f-4cd2-949f-5a6433ad2a6d" xlink:to="loc_sny_MajorCollaborationAgreementMember_4b1b6c07-0503-49b6-9450-b441b9da5e79" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails" xlink:type="extended" id="i864d98eff0ec4a2485085932831ff1e7_PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:href="sny-20221231.xsd#sny_DisclosureOfPrincipalAlliancesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfAgreementsSigned_6c8c9c8b-c736-4023-9565-fd789c5dc58d" xlink:href="sny-20221231.xsd#sny_NumberOfAgreementsSigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_NumberOfAgreementsSigned_6c8c9c8b-c736-4023-9565-fd789c5dc58d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PriorDevelopmentBudget_afd34683-c14b-483f-8297-fcfa17fdafa9" xlink:href="sny-20221231.xsd#sny_PriorDevelopmentBudget"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_PriorDevelopmentBudget_afd34683-c14b-483f-8297-fcfa17fdafa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1_e5bcd005-9105-409c-98ce-57721ee581fa" xlink:href="sny-20221231.xsd#sny_ContractualAgreementForAntiProgrammedCellDeathProtein1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1_e5bcd005-9105-409c-98ce-57721ee581fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany_d556cf85-6fe3-4f82-852b-668d5721ae6b" xlink:href="sny-20221231.xsd#sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany_d556cf85-6fe3-4f82-852b-668d5721ae6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment_88a6ee9e-9fd2-4100-9958-bab57f781104" xlink:href="sny-20221231.xsd#sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment_88a6ee9e-9fd2-4100-9958-bab57f781104" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment_22f253a5-cedb-4b8e-b2bc-dd5144491f2c" xlink:href="sny-20221231.xsd#sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment_22f253a5-cedb-4b8e-b2bc-dd5144491f2c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_54064b10-3000-43d5-8058-acf73fd220d1" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitShareOnCounterpartiesProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_54064b10-3000-43d5-8058-acf73fd220d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_2f4a79c6-7b3a-4e77-9f51-9db4595da515" xlink:href="sny-20221231.xsd#sny_PercentageOfCumulativeDevelopmentCostsReimbursed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_2f4a79c6-7b3a-4e77-9f51-9db4595da515" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements_4fc9c4da-e6a4-4026-be1f-0e8d87be7bb9" xlink:href="sny-20221231.xsd#sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements_4fc9c4da-e6a4-4026-be1f-0e8d87be7bb9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements_6585d029-e6df-42fb-ab1a-fa2baeee85cc" xlink:href="sny-20221231.xsd#sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements_6585d029-e6df-42fb-ab1a-fa2baeee85cc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltyIncomePercentage_9d86720f-7070-4e5c-a72c-c58d7d8ce8a9" xlink:href="sny-20221231.xsd#sny_RoyaltyIncomePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_RoyaltyIncomePercentage_9d86720f-7070-4e5c-a72c-c58d7d8ce8a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_4f3ab12c-78eb-4a0a-86a0-2333440ef835" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_4f3ab12c-78eb-4a0a-86a0-2333440ef835" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProceedsFromCollaborationAgreements_cbf061e2-0404-4f6e-97ae-b55aefb2c435" xlink:href="sny-20221231.xsd#sny_ProceedsFromCollaborationAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_ProceedsFromCollaborationAgreements_cbf061e2-0404-4f6e-97ae-b55aefb2c435" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_e1ae25d9-35c5-4562-811b-55dd44e097c7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_e1ae25d9-35c5-4562-811b-55dd44e097c7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_677d8945-3c1a-41d9-a52d-3a5d83e07075" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_ifrs-full_CounterpartiesAxis_677d8945-3c1a-41d9-a52d-3a5d83e07075" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_677d8945-3c1a-41d9-a52d-3a5d83e07075_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_677d8945-3c1a-41d9-a52d-3a5d83e07075" xlink:to="loc_ifrs-full_CounterpartiesMember_677d8945-3c1a-41d9-a52d-3a5d83e07075_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_0d05d440-e7eb-4174-b22b-dc1cfa3ced92" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_677d8945-3c1a-41d9-a52d-3a5d83e07075" xlink:to="loc_ifrs-full_CounterpartiesMember_0d05d440-e7eb-4174-b22b-dc1cfa3ced92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_92bc7ecb-bfe7-4177-8a38-304495480f2b" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_0d05d440-e7eb-4174-b22b-dc1cfa3ced92" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_92bc7ecb-bfe7-4177-8a38-304495480f2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_fcefdce6-e6a1-40bc-9a93-e6ffb90202f2" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_sny_PrincipalAlliancesAxis_fcefdce6-e6a1-40bc-9a93-e6ffb90202f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_fcefdce6-e6a1-40bc-9a93-e6ffb90202f2_default" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_PrincipalAlliancesAxis_fcefdce6-e6a1-40bc-9a93-e6ffb90202f2" xlink:to="loc_sny_PrincipalAlliancesDomain_fcefdce6-e6a1-40bc-9a93-e6ffb90202f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_0beba9e0-081b-4475-9afd-1e3f8c974cdf" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_PrincipalAlliancesAxis_fcefdce6-e6a1-40bc-9a93-e6ffb90202f2" xlink:to="loc_sny_PrincipalAlliancesDomain_0beba9e0-081b-4475-9afd-1e3f8c974cdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImmunoOncologyCollaborationAgreementMember_f34d578e-eae0-40d8-9d73-026f9a3d5b60" xlink:href="sny-20221231.xsd#sny_ImmunoOncologyCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalAlliancesDomain_0beba9e0-081b-4475-9afd-1e3f8c974cdf" xlink:to="loc_sny_ImmunoOncologyCollaborationAgreementMember_f34d578e-eae0-40d8-9d73-026f9a3d5b60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementAxis_f46bffc4-882d-4abd-b784-4321973dbdc0" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_sny_TypesOfAgreementAxis_f46bffc4-882d-4abd-b784-4321973dbdc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_f46bffc4-882d-4abd-b784-4321973dbdc0_default" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_TypesOfAgreementAxis_f46bffc4-882d-4abd-b784-4321973dbdc0" xlink:to="loc_sny_TypesOfAgreementDomain_f46bffc4-882d-4abd-b784-4321973dbdc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_dd842930-319b-454d-9911-1eeb72740edf" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_TypesOfAgreementAxis_f46bffc4-882d-4abd-b784-4321973dbdc0" xlink:to="loc_sny_TypesOfAgreementDomain_dd842930-319b-454d-9911-1eeb72740edf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DevelopmentOfCemiplimabREGN2810Member_02e0786f-7b7b-4687-90f1-b476a807d7c1" xlink:href="sny-20221231.xsd#sny_DevelopmentOfCemiplimabREGN2810Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_TypesOfAgreementDomain_dd842930-319b-454d-9911-1eeb72740edf" xlink:to="loc_sny_DevelopmentOfCemiplimabREGN2810Member_02e0786f-7b7b-4687-90f1-b476a807d7c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MilestoneTypesAxis_fb1abca5-50ac-400c-aecc-d631399294d6" xlink:href="sny-20221231.xsd#sny_MilestoneTypesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_sny_MilestoneTypesAxis_fb1abca5-50ac-400c-aecc-d631399294d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MilestoneTypesDomain_fb1abca5-50ac-400c-aecc-d631399294d6_default" xlink:href="sny-20221231.xsd#sny_MilestoneTypesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_MilestoneTypesAxis_fb1abca5-50ac-400c-aecc-d631399294d6" xlink:to="loc_sny_MilestoneTypesDomain_fb1abca5-50ac-400c-aecc-d631399294d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MilestoneTypesDomain_aea610b2-d306-41b7-8f0c-5e536bf0eb6b" xlink:href="sny-20221231.xsd#sny_MilestoneTypesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_MilestoneTypesAxis_fb1abca5-50ac-400c-aecc-d631399294d6" xlink:to="loc_sny_MilestoneTypesDomain_aea610b2-d306-41b7-8f0c-5e536bf0eb6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_USFDAApprovalMember_dd61f7a0-4fcb-4db2-b22a-00252a6e658e" xlink:href="sny-20221231.xsd#sny_USFDAApprovalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_MilestoneTypesDomain_aea610b2-d306-41b7-8f0c-5e536bf0eb6b" xlink:to="loc_sny_USFDAApprovalMember_dd61f7a0-4fcb-4db2-b22a-00252a6e658e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ecb431b5-921d-4801-96a1-1e9054621a0c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ecb431b5-921d-4801-96a1-1e9054621a0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsMember_ecb431b5-921d-4801-96a1-1e9054621a0c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ecb431b5-921d-4801-96a1-1e9054621a0c" xlink:to="loc_ifrs-full_NonadjustingEventsMember_ecb431b5-921d-4801-96a1-1e9054621a0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsMember_e5a52ff3-9fed-4907-b9cf-9e39d4262026" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ecb431b5-921d-4801-96a1-1e9054621a0c" xlink:to="loc_ifrs-full_NonadjustingEventsMember_e5a52ff3-9fed-4907-b9cf-9e39d4262026" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MajorCollaborationAgreementMember_a1a33b6d-0952-42f7-880b-c3158cfae782" xlink:href="sny-20221231.xsd#sny_MajorCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_e5a52ff3-9fed-4907-b9cf-9e39d4262026" xlink:to="loc_sny_MajorCollaborationAgreementMember_a1a33b6d-0952-42f7-880b-c3158cfae782" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ce9b0a64-4343-4dca-b17d-82479ed12db3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ce9b0a64-4343-4dca-b17d-82479ed12db3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_ce9b0a64-4343-4dca-b17d-82479ed12db3_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ce9b0a64-4343-4dca-b17d-82479ed12db3" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_ce9b0a64-4343-4dca-b17d-82479ed12db3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_9fe48bc6-bbb0-4e7c-9e21-175babd060ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ce9b0a64-4343-4dca-b17d-82479ed12db3" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_9fe48bc6-bbb0-4e7c-9e21-175babd060ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_5e800797-7cbf-4907-8a0c-80a181f80c12" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_9fe48bc6-bbb0-4e7c-9e21-175babd060ef" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_5e800797-7cbf-4907-8a0c-80a181f80c12" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails" xlink:type="extended" id="i1509f2dcd9a5425ab6f9f247b1a0c4fa_PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_8caf460e-e14d-4107-af71-db9cd5d6a6e4" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumOwnershipPercentageAllowedToAcquire_5f1b5d47-678b-4837-be68-2b612b29d002" xlink:href="sny-20221231.xsd#sny_MaximumOwnershipPercentageAllowedToAcquire"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_8caf460e-e14d-4107-af71-db9cd5d6a6e4" xlink:to="loc_sny_MaximumOwnershipPercentageAllowedToAcquire_5f1b5d47-678b-4837-be68-2b612b29d002" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_c2aebb55-a35f-4f13-8556-410b64dfc4e0" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_8caf460e-e14d-4107-af71-db9cd5d6a6e4" xlink:to="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_c2aebb55-a35f-4f13-8556-410b64dfc4e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_8caf460e-e14d-4107-af71-db9cd5d6a6e4" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_53116828-9dff-4b78-b9e8-db0d1938d4d9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:to="loc_ifrs-full_CounterpartiesAxis_53116828-9dff-4b78-b9e8-db0d1938d4d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_53116828-9dff-4b78-b9e8-db0d1938d4d9_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_53116828-9dff-4b78-b9e8-db0d1938d4d9" xlink:to="loc_ifrs-full_CounterpartiesMember_53116828-9dff-4b78-b9e8-db0d1938d4d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_112b7958-829f-4816-93d8-0bcd8e4c70d2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_53116828-9dff-4b78-b9e8-db0d1938d4d9" xlink:to="loc_ifrs-full_CounterpartiesMember_112b7958-829f-4816-93d8-0bcd8e4c70d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_4493e050-ca54-4759-8452-a2b04fe0737c" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_112b7958-829f-4816-93d8-0bcd8e4c70d2" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_4493e050-ca54-4759-8452-a2b04fe0737c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_d4fcff7f-88c5-4b94-8c69-134bcf515e3a" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:to="loc_sny_PrincipalAlliancesAxis_d4fcff7f-88c5-4b94-8c69-134bcf515e3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_d4fcff7f-88c5-4b94-8c69-134bcf515e3a_default" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_PrincipalAlliancesAxis_d4fcff7f-88c5-4b94-8c69-134bcf515e3a" xlink:to="loc_sny_PrincipalAlliancesDomain_d4fcff7f-88c5-4b94-8c69-134bcf515e3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_6e333bff-e60b-423c-968b-faf31d72a89c" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_PrincipalAlliancesAxis_d4fcff7f-88c5-4b94-8c69-134bcf515e3a" xlink:to="loc_sny_PrincipalAlliancesDomain_6e333bff-e60b-423c-968b-faf31d72a89c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TwoThousandFourteenAmendedInvestmentAgreementMember_4dd5cc64-bb19-4468-b3e7-da9b33ab0ecf" xlink:href="sny-20221231.xsd#sny_TwoThousandFourteenAmendedInvestmentAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalAlliancesDomain_6e333bff-e60b-423c-968b-faf31d72a89c" xlink:to="loc_sny_TwoThousandFourteenAmendedInvestmentAgreementMember_4dd5cc64-bb19-4468-b3e7-da9b33ab0ecf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockAxis_2c8e4321-3d85-496a-80d0-b499d989b20f" xlink:href="sny-20221231.xsd#sny_SaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:to="loc_sny_SaleOfStockAxis_2c8e4321-3d85-496a-80d0-b499d989b20f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockDomain_2c8e4321-3d85-496a-80d0-b499d989b20f_default" xlink:href="sny-20221231.xsd#sny_SaleOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_SaleOfStockAxis_2c8e4321-3d85-496a-80d0-b499d989b20f" xlink:to="loc_sny_SaleOfStockDomain_2c8e4321-3d85-496a-80d0-b499d989b20f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockDomain_12e24449-d9df-4b79-aaf5-2a1e51a5f569" xlink:href="sny-20221231.xsd#sny_SaleOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_SaleOfStockAxis_2c8e4321-3d85-496a-80d0-b499d989b20f" xlink:to="loc_sny_SaleOfStockDomain_12e24449-d9df-4b79-aaf5-2a1e51a5f569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PublicOfferingMember_405acf95-b024-42e3-ab8c-e7c4e014b138" xlink:href="sny-20221231.xsd#sny_PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_SaleOfStockDomain_12e24449-d9df-4b79-aaf5-2a1e51a5f569" xlink:to="loc_sny_PublicOfferingMember_405acf95-b024-42e3-ab8c-e7c4e014b138" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_00eb16c8-02d7-454d-944f-31287bea58a0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_00eb16c8-02d7-454d-944f-31287bea58a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_00eb16c8-02d7-454d-944f-31287bea58a0_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_00eb16c8-02d7-454d-944f-31287bea58a0" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_00eb16c8-02d7-454d-944f-31287bea58a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_db60da77-8f4f-4294-af04-044f42d64568" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_00eb16c8-02d7-454d-944f-31287bea58a0" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_db60da77-8f4f-4294-af04-044f42d64568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_b70f8c33-a9ab-4718-9abe-c970abcd8216" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_db60da77-8f4f-4294-af04-044f42d64568" xlink:to="loc_sny_RegeneronMember_b70f8c33-a9ab-4718-9abe-c970abcd8216" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails" xlink:type="extended" id="i6cb2b107d60e4460966345b0bd675aab_PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:href="sny-20221231.xsd#sny_DisclosureOfPrincipalAlliancesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfProductsJointlyDeveloped_7008b85e-cb14-46af-969b-02c9ed68d923" xlink:href="sny-20221231.xsd#sny_NumberOfProductsJointlyDeveloped"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:to="loc_sny_NumberOfProductsJointlyDeveloped_7008b85e-cb14-46af-969b-02c9ed68d923" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltiesPaymentsMadeBySanofi_98f56b2f-1c09-4ef5-abe2-b5e4494f5c0d" xlink:href="sny-20221231.xsd#sny_RoyaltiesPaymentsMadeBySanofi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:to="loc_sny_RoyaltiesPaymentsMadeBySanofi_98f56b2f-1c09-4ef5-abe2-b5e4494f5c0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_2c8e70a4-cd07-49b0-90b1-831dee8114d6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_2c8e70a4-cd07-49b0-90b1-831dee8114d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_0cfca452-db10-4cfc-b035-c272df7eb1a5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:to="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_0cfca452-db10-4cfc-b035-c272df7eb1a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_ee8d3fd4-aee4-4fbf-9ec9-cb843a95edd1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:to="loc_ifrs-full_CounterpartiesAxis_ee8d3fd4-aee4-4fbf-9ec9-cb843a95edd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_ee8d3fd4-aee4-4fbf-9ec9-cb843a95edd1_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_ee8d3fd4-aee4-4fbf-9ec9-cb843a95edd1" xlink:to="loc_ifrs-full_CounterpartiesMember_ee8d3fd4-aee4-4fbf-9ec9-cb843a95edd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_33287893-e31d-4dba-ae31-7980b2906294" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_ee8d3fd4-aee4-4fbf-9ec9-cb843a95edd1" xlink:to="loc_ifrs-full_CounterpartiesMember_33287893-e31d-4dba-ae31-7980b2906294" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BristolMyersSquibbMember_27756cf2-6659-4c4b-acf2-4972815ecf6e" xlink:href="sny-20221231.xsd#sny_BristolMyersSquibbMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_33287893-e31d-4dba-ae31-7980b2906294" xlink:to="loc_sny_BristolMyersSquibbMember_27756cf2-6659-4c4b-acf2-4972815ecf6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_941bf14e-0c74-4e89-a74c-8a667aecb884" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_33287893-e31d-4dba-ae31-7980b2906294" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_941bf14e-0c74-4e89-a74c-8a667aecb884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_18dbd8cf-ab53-41dd-9cf9-777124bcefaf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_18dbd8cf-ab53-41dd-9cf9-777124bcefaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_18dbd8cf-ab53-41dd-9cf9-777124bcefaf_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_18dbd8cf-ab53-41dd-9cf9-777124bcefaf" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_18dbd8cf-ab53-41dd-9cf9-777124bcefaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_669b8f86-a9c9-4f6c-821c-d99567c7e081" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_18dbd8cf-ab53-41dd-9cf9-777124bcefaf" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_669b8f86-a9c9-4f6c-821c-d99567c7e081" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember_249b572f-04c2-4d9b-8994-38dad2155ae8" xlink:href="sny-20221231.xsd#sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_669b8f86-a9c9-4f6c-821c-d99567c7e081" xlink:to="loc_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember_249b572f-04c2-4d9b-8994-38dad2155ae8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementAxis_aeb5ead3-c9b1-42ee-a48b-3e35fe64fb06" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:to="loc_sny_TypesOfAgreementAxis_aeb5ead3-c9b1-42ee-a48b-3e35fe64fb06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_aeb5ead3-c9b1-42ee-a48b-3e35fe64fb06_default" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_TypesOfAgreementAxis_aeb5ead3-c9b1-42ee-a48b-3e35fe64fb06" xlink:to="loc_sny_TypesOfAgreementDomain_aeb5ead3-c9b1-42ee-a48b-3e35fe64fb06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_28920645-7684-4600-9564-0c05fe8e815b" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_TypesOfAgreementAxis_aeb5ead3-c9b1-42ee-a48b-3e35fe64fb06" xlink:to="loc_sny_TypesOfAgreementDomain_28920645-7684-4600-9564-0c05fe8e815b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NewAgreementMember_ff709602-2c6a-47ff-9c54-74b066858918" xlink:href="sny-20221231.xsd#sny_NewAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_TypesOfAgreementDomain_28920645-7684-4600-9564-0c05fe8e815b" xlink:to="loc_sny_NewAgreementMember_ff709602-2c6a-47ff-9c54-74b066858918" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PriorAgreementMember_58e21c71-530a-4194-a692-11fe70dd509a" xlink:href="sny-20221231.xsd#sny_PriorAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_TypesOfAgreementDomain_28920645-7684-4600-9564-0c05fe8e815b" xlink:to="loc_sny_PriorAgreementMember_58e21c71-530a-4194-a692-11fe70dd509a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_d2ab0358-48e4-4cd5-97ec-146e46a0c9c2" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:to="loc_sny_PrincipalAlliancesAxis_d2ab0358-48e4-4cd5-97ec-146e46a0c9c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_d2ab0358-48e4-4cd5-97ec-146e46a0c9c2_default" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_PrincipalAlliancesAxis_d2ab0358-48e4-4cd5-97ec-146e46a0c9c2" xlink:to="loc_sny_PrincipalAlliancesDomain_d2ab0358-48e4-4cd5-97ec-146e46a0c9c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_6313d7f3-cd3e-4723-83bb-34a267466823" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_PrincipalAlliancesAxis_d2ab0358-48e4-4cd5-97ec-146e46a0c9c2" xlink:to="loc_sny_PrincipalAlliancesDomain_6313d7f3-cd3e-4723-83bb-34a267466823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember_b6cd0faf-0b92-488c-9e83-fc40b6d0405e" xlink:href="sny-20221231.xsd#sny_AntibodiesCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalAlliancesDomain_6313d7f3-cd3e-4723-83bb-34a267466823" xlink:to="loc_sny_AntibodiesCollaborationAgreementMember_b6cd0faf-0b92-488c-9e83-fc40b6d0405e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails" xlink:type="extended" id="i517bbaa7e76b45d4b16e386b831d7cc6_Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashTransferred_fbb1d75a-bd2a-4145-b68c-6303ba3e0eed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_CashTransferred_fbb1d75a-bd2a-4145-b68c-6303ba3e0eed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations_9b498a20-341d-4ca9-9280-103533513883" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations_9b498a20-341d-4ca9-9280-103533513883" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_9caf768d-3ac1-41dd-8cfa-10c2d03d009c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_9caf768d-3ac1-41dd-8cfa-10c2d03d009c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_5ac39ce2-6f6d-4ec9-92d0-e824a525e4c5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_5ac39ce2-6f6d-4ec9-92d0-e824a525e4c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossOfAcquiree_a75fe09b-d74a-4e8a-b8d9-0c61f95cc0da" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossOfAcquiree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_ProfitLossOfAcquiree_a75fe09b-d74a-4e8a-b8d9-0c61f95cc0da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_80006592-75e8-4612-ab5a-c0df4a72e9c7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_80006592-75e8-4612-ab5a-c0df4a72e9c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital_471421c9-0b80-4b69-b9b9-545ac6cf353d" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital_471421c9-0b80-4b69-b9b9-545ac6cf353d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfVotingEquityInterestsDivested_ed08d4af-db0b-4eb8-a322-a9f3c7ac5e27" xlink:href="sny-20221231.xsd#sny_PercentageOfVotingEquityInterestsDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_PercentageOfVotingEquityInterestsDivested_ed08d4af-db0b-4eb8-a322-a9f3c7ac5e27" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsiderationTransferredMaximumAmount_2f29562c-02a2-4d28-b2ff-7648ed56cc8d" xlink:href="sny-20221231.xsd#sny_ConsiderationTransferredMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_ConsiderationTransferredMaximumAmount_2f29562c-02a2-4d28-b2ff-7648ed56cc8d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsiderationTransferredValuationPeriod_58c46c8c-ac69-4b2b-890f-89fff4e57661" xlink:href="sny-20221231.xsd#sny_ConsiderationTransferredValuationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_ConsiderationTransferredValuationPeriod_58c46c8c-ac69-4b2b-890f-89fff4e57661" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_ad1dbd12-8884-4600-9c5c-1f1ffb66450f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_ad1dbd12-8884-4600-9c5c-1f1ffb66450f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod_227c9850-1b9d-4266-81a1-59a8552fb947" xlink:href="sny-20221231.xsd#sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod_227c9850-1b9d-4266-81a1-59a8552fb947" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital_e0f788c0-8d27-43a3-a68e-1885d87aa510" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendPercentageOfShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital_e0f788c0-8d27-43a3-a68e-1885d87aa510" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares_d618151b-d4c3-4379-8b16-9812476d06fd" xlink:href="sny-20221231.xsd#sny_SpecialDistributionSharesReceivedPerConversionOfParentShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares_d618151b-d4c3-4379-8b16-9812476d06fd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SpecialDistributionNumberOfSharesConverted_1072b1c0-822b-4cd2-95e7-7caa3e681140" xlink:href="sny-20221231.xsd#sny_SpecialDistributionNumberOfSharesConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_SpecialDistributionNumberOfSharesConverted_1072b1c0-822b-4cd2-95e7-7caa3e681140" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SpecialDistributionPercentageOfShareCapitalDistributed_d16126c7-e9c6-41f8-aaca-930e1e4652d4" xlink:href="sny-20221231.xsd#sny_SpecialDistributionPercentageOfShareCapitalDistributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_SpecialDistributionPercentageOfShareCapitalDistributed_d16126c7-e9c6-41f8-aaca-930e1e4652d4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_b9213092-0d2c-4500-9352-1184924f15a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_b9213092-0d2c-4500-9352-1184924f15a1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets_ff585952-fc4c-47b9-8d64-b185dd14d817" xlink:href="sny-20221231.xsd#sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets_ff585952-fc4c-47b9-8d64-b185dd14d817" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill_7b189a0c-d129-4078-a4cf-93b63e9b8561" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill_7b189a0c-d129-4078-a4cf-93b63e9b8561" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_0bd0eb4b-d9da-46c9-b67e-825b2e3e7249" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_0bd0eb4b-d9da-46c9-b67e-825b2e3e7249" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_1ff9712b-4d07-4e2e-ae4b-ed22a8a7d1fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_1ff9712b-4d07-4e2e-ae4b-ed22a8a7d1fb" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_6e704405-20d8-479a-8356-3dc0a75237a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_6e704405-20d8-479a-8356-3dc0a75237a8" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_86d61ae5-628e-48eb-bf09-734558386611" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_NetForeignExchangeLoss_86d61ae5-628e-48eb-bf09-734558386611" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisions_a85c50a1-bf37-48e8-aff2-fb1b7b875c7e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_OtherProvisions_a85c50a1-bf37-48e8-aff2-fb1b7b875c7e" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGainsLossesAndLitigation_69ea2296-f8df-4485-b238-420640eb4896" xlink:href="sny-20221231.xsd#sny_OtherGainsLossesAndLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_OtherGainsLossesAndLitigation_69ea2296-f8df-4485-b238-420640eb4896" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_3960793b-c45b-411f-95b5-b8d25976cdaa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_3960793b-c45b-411f-95b5-b8d25976cdaa" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_10d24523-5669-41b9-9f0a-3c445257bfe9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_10d24523-5669-41b9-9f0a-3c445257bfe9" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementPeriodAfterLossOfControl_3e7eeb0f-dd3f-4426-8e10-291fe4ab0458" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementPeriodAfterLossOfControl"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_CollaborationAgreementPeriodAfterLossOfControl_3e7eeb0f-dd3f-4426-8e10-291fe4ab0458" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementAnnualNetSalesTarget_f71a6f99-29ba-4857-a60e-1c41b2f12f7f" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementAnnualNetSalesTarget"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_CollaborationAgreementAnnualNetSalesTarget_f71a6f99-29ba-4857-a60e-1c41b2f12f7f" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementCommitmentAmount_24beb297-72f3-4879-9a65-e0c78dc59420" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementCommitmentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_CollaborationAgreementCommitmentAmount_24beb297-72f3-4879-9a65-e0c78dc59420" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_49ab173d-14ae-4836-aa77-585f29065129" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_49ab173d-14ae-4836-aa77-585f29065129" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_49ab173d-14ae-4836-aa77-585f29065129_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_49ab173d-14ae-4836-aa77-585f29065129" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_49ab173d-14ae-4836-aa77-585f29065129_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_b8473af6-e22c-4091-8593-e18763411e87" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_49ab173d-14ae-4836-aa77-585f29065129" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_b8473af6-e22c-4091-8593-e18763411e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixPharmaceuticalsIncMember_acbe6ad4-2292-4269-8335-826fc8e3817f" xlink:href="sny-20221231.xsd#sny_AmunixPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_b8473af6-e22c-4091-8593-e18763411e87" xlink:to="loc_sny_AmunixPharmaceuticalsIncMember_acbe6ad4-2292-4269-8335-826fc8e3817f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_30b2537f-c773-4f8c-a573-00b10b7b9ed5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_30b2537f-c773-4f8c-a573-00b10b7b9ed5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_30b2537f-c773-4f8c-a573-00b10b7b9ed5_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_30b2537f-c773-4f8c-a573-00b10b7b9ed5" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_30b2537f-c773-4f8c-a573-00b10b7b9ed5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_84ed9c86-4205-4d76-aa64-1b5f90e3501f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_30b2537f-c773-4f8c-a573-00b10b7b9ed5" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_84ed9c86-4205-4d76-aa64-1b5f90e3501f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_a0e66c7a-6a00-4a3a-bc94-ad1f9e262a2b" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_84ed9c86-4205-4d76-aa64-1b5f90e3501f" xlink:to="loc_sny_EuroapiMember_a0e66c7a-6a00-4a3a-bc94-ad1f9e262a2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_28ff25d6-bafd-43cb-8755-64e098611cad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_CounterpartiesAxis_28ff25d6-bafd-43cb-8755-64e098611cad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_28ff25d6-bafd-43cb-8755-64e098611cad_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_28ff25d6-bafd-43cb-8755-64e098611cad" xlink:to="loc_ifrs-full_CounterpartiesMember_28ff25d6-bafd-43cb-8755-64e098611cad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_fdec2bc4-8b12-4fbd-92f7-8779a41ee840" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_28ff25d6-bafd-43cb-8755-64e098611cad" xlink:to="loc_ifrs-full_CounterpartiesMember_fdec2bc4-8b12-4fbd-92f7-8779a41ee840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EPICBPIFranceMember_1141a219-6acf-4b5e-a255-96141c872db1" xlink:href="sny-20221231.xsd#sny_EPICBPIFranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_fdec2bc4-8b12-4fbd-92f7-8779a41ee840" xlink:to="loc_sny_EPICBPIFranceMember_1141a219-6acf-4b5e-a255-96141c872db1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_9d52ea92-c56c-4cdf-a185-b57a411bb495" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_9d52ea92-c56c-4cdf-a185-b57a411bb495" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_9d52ea92-c56c-4cdf-a185-b57a411bb495_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_9d52ea92-c56c-4cdf-a185-b57a411bb495" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_9d52ea92-c56c-4cdf-a185-b57a411bb495_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_4eef640b-ed90-4c5a-9a8f-26163c18fc18" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_9d52ea92-c56c-4cdf-a185-b57a411bb495" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_4eef640b-ed90-4c5a-9a8f-26163c18fc18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_9a9c9ee2-5b8e-40cd-a5dd-96bd7e5106c4" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_4eef640b-ed90-4c5a-9a8f-26163c18fc18" xlink:to="loc_sny_EuroapiMember_9a9c9ee2-5b8e-40cd-a5dd-96bd7e5106c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_9d610565-94d0-46b1-ad32-d848a92d2542" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_9d610565-94d0-46b1-ad32-d848a92d2542" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_9d610565-94d0-46b1-ad32-d848a92d2542_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_9d610565-94d0-46b1-ad32-d848a92d2542" xlink:to="loc_ifrs-full_EquityMember_9d610565-94d0-46b1-ad32-d848a92d2542_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_f32e2937-77be-4ef8-906b-b7713bbe9387" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_9d610565-94d0-46b1-ad32-d848a92d2542" xlink:to="loc_ifrs-full_EquityMember_f32e2937-77be-4ef8-906b-b7713bbe9387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_cfc02497-6fbe-4def-a686-c6be9ce65fae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_f32e2937-77be-4ef8-906b-b7713bbe9387" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_cfc02497-6fbe-4def-a686-c6be9ce65fae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_08380f56-f904-429b-910e-b84f06e2cfa9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_08380f56-f904-429b-910e-b84f06e2cfa9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_08380f56-f904-429b-910e-b84f06e2cfa9_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_08380f56-f904-429b-910e-b84f06e2cfa9" xlink:to="loc_ifrs-full_OtherProvisionsMember_08380f56-f904-429b-910e-b84f06e2cfa9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_7afc9ae0-a76d-491a-9980-e1a4de113035" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_08380f56-f904-429b-910e-b84f06e2cfa9" xlink:to="loc_ifrs-full_OtherProvisionsMember_7afc9ae0-a76d-491a-9980-e1a4de113035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember_876cb4a3-486f-437d-9a71-2796853de830" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_7afc9ae0-a76d-491a-9980-e1a4de113035" xlink:to="loc_ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember_876cb4a3-486f-437d-9a71-2796853de830" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegulatoryComplianceCostsMember_ca43d428-c840-4103-bb97-813979a9985e" xlink:href="sny-20221231.xsd#sny_RegulatoryComplianceCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_7afc9ae0-a76d-491a-9980-e1a4de113035" xlink:to="loc_sny_RegulatoryComplianceCostsMember_ca43d428-c840-4103-bb97-813979a9985e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementAxis_8deb3085-cfd5-4e7b-8eaa-e1d8afd56bb7" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_sny_TypesOfAgreementAxis_8deb3085-cfd5-4e7b-8eaa-e1d8afd56bb7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_8deb3085-cfd5-4e7b-8eaa-e1d8afd56bb7_default" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_TypesOfAgreementAxis_8deb3085-cfd5-4e7b-8eaa-e1d8afd56bb7" xlink:to="loc_sny_TypesOfAgreementDomain_8deb3085-cfd5-4e7b-8eaa-e1d8afd56bb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_ad89b03f-eb1e-494c-94e5-16a96c5a0e08" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_TypesOfAgreementAxis_8deb3085-cfd5-4e7b-8eaa-e1d8afd56bb7" xlink:to="loc_sny_TypesOfAgreementDomain_ad89b03f-eb1e-494c-94e5-16a96c5a0e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ManufactureAndSupplyCollaborationAgreementMember_bf5e5cbb-dcf3-40fd-a96e-752977faf98e" xlink:href="sny-20221231.xsd#sny_ManufactureAndSupplyCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_TypesOfAgreementDomain_ad89b03f-eb1e-494c-94e5-16a96c5a0e08" xlink:to="loc_sny_ManufactureAndSupplyCollaborationAgreementMember_bf5e5cbb-dcf3-40fd-a96e-752977faf98e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails" xlink:type="extended" id="i86c78971f9774d2081924a75062a4f36_Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_5dab3bf5-86c5-49c5-84c5-eb8fb82d0576" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_5dab3bf5-86c5-49c5-84c5-eb8fb82d0576" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate_fbf1a1da-fc59-4f32-8540-37e18d931da9" xlink:href="sny-20221231.xsd#sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate_fbf1a1da-fc59-4f32-8540-37e18d931da9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_7b957c27-ab7b-4cc4-a46b-2dee45227a1d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_7b957c27-ab7b-4cc4-a46b-2dee45227a1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_258a0a8e-30bb-4098-bdfc-204ed803b5f6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_258a0a8e-30bb-4098-bdfc-204ed803b5f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_3f23ec9c-3b05-44cd-8f43-eb23cd8f9041" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_3f23ec9c-3b05-44cd-8f43-eb23cd8f9041" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_4b151c50-d6e2-485d-a19b-bd8eca8a27d5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_4b151c50-d6e2-485d-a19b-bd8eca8a27d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_93c6cdf6-edb1-4b1f-a88b-ab999e2a7440" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_93c6cdf6-edb1-4b1f-a88b-ab999e2a7440" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_8b890cfd-75d9-42b2-9cee-f552916c4a49" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_8b890cfd-75d9-42b2-9cee-f552916c4a49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_12022ea0-5a2d-47ba-ae92-6b214aaa867f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_8b890cfd-75d9-42b2-9cee-f552916c4a49" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_12022ea0-5a2d-47ba-ae92-6b214aaa867f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_12022ea0-5a2d-47ba-ae92-6b214aaa867f_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_12022ea0-5a2d-47ba-ae92-6b214aaa867f" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_12022ea0-5a2d-47ba-ae92-6b214aaa867f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5abfbb29-f76d-4463-84da-bd83bfcbb7a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_12022ea0-5a2d-47ba-ae92-6b214aaa867f" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5abfbb29-f76d-4463-84da-bd83bfcbb7a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixPharmaceuticalsIncMember_0de220ba-d26f-4dda-af2c-12e88c53a617" xlink:href="sny-20221231.xsd#sny_AmunixPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5abfbb29-f76d-4463-84da-bd83bfcbb7a8" xlink:to="loc_sny_AmunixPharmaceuticalsIncMember_0de220ba-d26f-4dda-af2c-12e88c53a617" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails" xlink:type="extended" id="i9a2896aef94a4b6998668dcd82f7d297_Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashTransferred_d32ee78b-06a8-480e-a4e1-5ded780ea1bf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_CashTransferred_d32ee78b-06a8-480e-a4e1-5ded780ea1bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements_b77b78af-8446-4b0d-ab70-cc81e711243c" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements_b77b78af-8446-4b0d-ab70-cc81e711243c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_8dfae46c-be05-4401-a70d-ddcf8a775301" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_8dfae46c-be05-4401-a70d-ddcf8a775301" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_46a4b781-7734-4291-9cf4-2e68790165d9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_46a4b781-7734-4291-9cf4-2e68790165d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering_05fea828-6f68-4788-811d-9b2bab13da69" xlink:href="sny-20221231.xsd#sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering_05fea828-6f68-4788-811d-9b2bab13da69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationPurchasePricePerShare_1bbf420e-b8bc-495b-96fa-4c210e0953ce" xlink:href="sny-20221231.xsd#sny_BusinessCombinationPurchasePricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_BusinessCombinationPurchasePricePerShare_1bbf420e-b8bc-495b-96fa-4c210e0953ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering_879bda90-4951-4e79-b32c-9de540b7d98e" xlink:href="sny-20221231.xsd#sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering_879bda90-4951-4e79-b32c-9de540b7d98e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_56cd78ad-5d78-40df-8b2c-06ba5e32b53a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_56cd78ad-5d78-40df-8b2c-06ba5e32b53a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired_0835c2c0-f660-4d4a-bc14-3064bded58d6" xlink:href="sny-20221231.xsd#sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired_0835c2c0-f660-4d4a-bc14-3064bded58d6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_c61eaac9-604a-4aa9-959f-64a8df9e4fb6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_c61eaac9-604a-4aa9-959f-64a8df9e4fb6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage_4869b5e7-e175-4b3e-b104-0b4a8d0a0efb" xlink:href="sny-20221231.xsd#sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage_4869b5e7-e175-4b3e-b104-0b4a8d0a0efb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis_2bb597b6-9170-490e-8f77-1a306031765c" xlink:href="sny-20221231.xsd#sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis_2bb597b6-9170-490e-8f77-1a306031765c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinancialAssetsNumberOfShares_987f1ba5-4a39-458b-8654-e0549db702a1" xlink:href="sny-20221231.xsd#sny_NonCurrentFinancialAssetsNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_NonCurrentFinancialAssetsNumberOfShares_987f1ba5-4a39-458b-8654-e0549db702a1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_65f9401f-54fe-461a-aace-e4c49a5c79c8" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_65f9401f-54fe-461a-aace-e4c49a5c79c8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockPricePerShare_625ed69f-09ac-428a-9c30-9d9245d2b19a" xlink:href="sny-20221231.xsd#sny_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_SaleOfStockPricePerShare_625ed69f-09ac-428a-9c30-9d9245d2b19a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts_d29305fb-29e9-4a9c-b989-4290f1eb8556" xlink:href="sny-20221231.xsd#sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts_d29305fb-29e9-4a9c-b989-4290f1eb8556" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction_30ddc650-31d5-47a9-8bfc-840a5719a9b0" xlink:href="sny-20221231.xsd#sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction_30ddc650-31d5-47a9-8bfc-840a5719a9b0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts_4f28bfaf-99cb-4986-a402-f8cecbe916ee" xlink:href="sny-20221231.xsd#sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts_4f28bfaf-99cb-4986-a402-f8cecbe916ee" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement_eaba18dc-c6d4-446b-a8e2-174f0ce5fcd4" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement_eaba18dc-c6d4-446b-a8e2-174f0ce5fcd4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_68875964-692c-41c3-b3a6-c8a6cd735078" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_68875964-692c-41c3-b3a6-c8a6cd735078" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnDisposalsOfInvestments_836c2686-0532-4bda-8275-56881fdd5412" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_GainsOnDisposalsOfInvestments_836c2686-0532-4bda-8275-56881fdd5412" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockTransactionCosts_37010fb6-64bd-420b-905a-c7c09731e0c0" xlink:href="sny-20221231.xsd#sny_SaleOfStockTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_SaleOfStockTransactionCosts_37010fb6-64bd-420b-905a-c7c09731e0c0" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax_54c3e0fd-3a57-4589-8146-e0c31ad45bea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax_54c3e0fd-3a57-4589-8146-e0c31ad45bea" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockMarketPricePerShare_2f4558e8-62b8-4181-97c4-cd9980ebfcda" xlink:href="sny-20221231.xsd#sny_StockMarketPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_StockMarketPricePerShare_2f4558e8-62b8-4181-97c4-cd9980ebfcda" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_11243142-9a76-4b90-8ddb-2d8dda705325" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_11243142-9a76-4b90-8ddb-2d8dda705325" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxExpenseOnDisposalOfInvestment_b3979d12-5732-431e-bb9d-dc45440309e0" xlink:href="sny-20221231.xsd#sny_TaxExpenseOnDisposalOfInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_TaxExpenseOnDisposalOfInvestment_b3979d12-5732-431e-bb9d-dc45440309e0" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_d2fb730a-0f0f-4b01-8ebe-3c730fb4ee3b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_d2fb730a-0f0f-4b01-8ebe-3c730fb4ee3b" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnDisposalsOfNoncurrentAssets_d2fa10df-7fcb-46d5-8bb3-fb1c2a25ef21" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_GainsOnDisposalsOfNoncurrentAssets_d2fa10df-7fcb-46d5-8bb3-fb1c2a25ef21" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_60e309c3-44b7-4bc6-a434-eca601f80e57" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_60e309c3-44b7-4bc6-a434-eca601f80e57" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_04d5059b-21c1-49eb-b5a3-4229801656e9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_04d5059b-21c1-49eb-b5a3-4229801656e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_04d5059b-21c1-49eb-b5a3-4229801656e9_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_04d5059b-21c1-49eb-b5a3-4229801656e9" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_04d5059b-21c1-49eb-b5a3-4229801656e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_04d5059b-21c1-49eb-b5a3-4229801656e9" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KymabMember_df9ad208-4dc2-40d3-974c-5b6c2f1df1f0" xlink:href="sny-20221231.xsd#sny_KymabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_KymabMember_df9ad208-4dc2-40d3-974c-5b6c2f1df1f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KiadisMember_f5f39089-d645-4502-b566-fd26b1e9b469" xlink:href="sny-20221231.xsd#sny_KiadisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_KiadisMember_f5f39089-d645-4502-b566-fd26b1e9b469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TidalTherapeuticsMember_bea47390-155e-4a8e-8de3-2105607826fd" xlink:href="sny-20221231.xsd#sny_TidalTherapeuticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_TidalTherapeuticsMember_bea47390-155e-4a8e-8de3-2105607826fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_844a185f-76f9-4cdc-8363-0d0a47ef7f9e" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_TranslateBioMember_844a185f-76f9-4cdc-8363-0d0a47ef7f9e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KadmonMember_521db566-4cae-4024-90bb-eada9e0991f9" xlink:href="sny-20221231.xsd#sny_KadmonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_KadmonMember_521db566-4cae-4024-90bb-eada9e0991f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OrigimmBiotechnologyGmbHMember_e098338c-efd2-4b3e-8ff7-c083b8931263" xlink:href="sny-20221231.xsd#sny_OrigimmBiotechnologyGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_OrigimmBiotechnologyGmbHMember_e098338c-efd2-4b3e-8ff7-c083b8931263" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipiaBiopharmaIncMember_0eb2c624-c188-4b7a-b408-7273ae515970" xlink:href="sny-20221231.xsd#sny_PrincipiaBiopharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_PrincipiaBiopharmaIncMember_0eb2c624-c188-4b7a-b408-7273ae515970" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxMember_1f98da54-2747-4102-a6f0-6c92cf66f233" xlink:href="sny-20221231.xsd#sny_SynthorxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_SynthorxMember_1f98da54-2747-4102-a6f0-6c92cf66f233" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_35a96c41-ede7-44f1-98ff-cb60a7f0e49c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_35a96c41-ede7-44f1-98ff-cb60a7f0e49c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_35a96c41-ede7-44f1-98ff-cb60a7f0e49c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_35a96c41-ede7-44f1-98ff-cb60a7f0e49c" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_35a96c41-ede7-44f1-98ff-cb60a7f0e49c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_af60fd2e-bbc5-4c17-950e-c468901858d3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_35a96c41-ede7-44f1-98ff-cb60a7f0e49c" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_af60fd2e-bbc5-4c17-950e-c468901858d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_be6c1c33-fcca-4992-9b95-02ced07dd33b" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_af60fd2e-bbc5-4c17-950e-c468901858d3" xlink:to="loc_sny_RegeneronMember_be6c1c33-fcca-4992-9b95-02ced07dd33b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockAxis_69fad9bf-8a5a-4d0b-8b0f-2b68d7b99b8d" xlink:href="sny-20221231.xsd#sny_SaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_sny_SaleOfStockAxis_69fad9bf-8a5a-4d0b-8b0f-2b68d7b99b8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockDomain_69fad9bf-8a5a-4d0b-8b0f-2b68d7b99b8d_default" xlink:href="sny-20221231.xsd#sny_SaleOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_SaleOfStockAxis_69fad9bf-8a5a-4d0b-8b0f-2b68d7b99b8d" xlink:to="loc_sny_SaleOfStockDomain_69fad9bf-8a5a-4d0b-8b0f-2b68d7b99b8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockDomain_0dd8b27e-b38f-4a26-b32e-9f63506ae6a9" xlink:href="sny-20221231.xsd#sny_SaleOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_SaleOfStockAxis_69fad9bf-8a5a-4d0b-8b0f-2b68d7b99b8d" xlink:to="loc_sny_SaleOfStockDomain_0dd8b27e-b38f-4a26-b32e-9f63506ae6a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PublicOfferingMember_c36f28fd-aa9d-4299-85b3-3078f543047b" xlink:href="sny-20221231.xsd#sny_PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_SaleOfStockDomain_0dd8b27e-b38f-4a26-b32e-9f63506ae6a9" xlink:to="loc_sny_PublicOfferingMember_c36f28fd-aa9d-4299-85b3-3078f543047b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RepurchaseFromTheCounterpartMember_a0c72dca-4c8d-4f3a-9873-fda909c1deec" xlink:href="sny-20221231.xsd#sny_RepurchaseFromTheCounterpartMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_SaleOfStockDomain_0dd8b27e-b38f-4a26-b32e-9f63506ae6a9" xlink:to="loc_sny_RepurchaseFromTheCounterpartMember_a0c72dca-4c8d-4f3a-9873-fda909c1deec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fc458865-ac59-4553-aa85-255d7e41b8b4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_dei_LegalEntityAxis_fc458865-ac59-4553-aa85-255d7e41b8b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fc458865-ac59-4553-aa85-255d7e41b8b4_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_fc458865-ac59-4553-aa85-255d7e41b8b4" xlink:to="loc_dei_EntityDomain_fc458865-ac59-4553-aa85-255d7e41b8b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a232b2f8-5ccf-4873-9abc-8e193a3b5a8e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_fc458865-ac59-4553-aa85-255d7e41b8b4" xlink:to="loc_dei_EntityDomain_a232b2f8-5ccf-4873-9abc-8e193a3b5a8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSAMember_43504b8d-6d09-43d9-9d1c-1b8f5bfbfd6f" xlink:href="sny-20221231.xsd#sny_SanofiSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a232b2f8-5ccf-4873-9abc-8e193a3b5a8e" xlink:to="loc_sny_SanofiSAMember_43504b8d-6d09-43d9-9d1c-1b8f5bfbfd6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_edab48e8-8e6c-49e6-a69d-fcae2670e94f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_ifrs-full_CounterpartiesAxis_edab48e8-8e6c-49e6-a69d-fcae2670e94f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_edab48e8-8e6c-49e6-a69d-fcae2670e94f_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_edab48e8-8e6c-49e6-a69d-fcae2670e94f" xlink:to="loc_ifrs-full_CounterpartiesMember_edab48e8-8e6c-49e6-a69d-fcae2670e94f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_77d97b6e-99ca-4a2c-905e-7ac92aacd815" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_edab48e8-8e6c-49e6-a69d-fcae2670e94f" xlink:to="loc_ifrs-full_CounterpartiesMember_77d97b6e-99ca-4a2c-905e-7ac92aacd815" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_f230af35-3eee-4bef-8e77-f4eae844951b" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_77d97b6e-99ca-4a2c-905e-7ac92aacd815" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_f230af35-3eee-4bef-8e77-f4eae844951b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_5c3fe232-0f6b-4604-ba4e-db31fb767bd9" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_sny_PrincipalAlliancesAxis_5c3fe232-0f6b-4604-ba4e-db31fb767bd9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_5c3fe232-0f6b-4604-ba4e-db31fb767bd9_default" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_PrincipalAlliancesAxis_5c3fe232-0f6b-4604-ba4e-db31fb767bd9" xlink:to="loc_sny_PrincipalAlliancesDomain_5c3fe232-0f6b-4604-ba4e-db31fb767bd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_24184b52-8c73-4a8f-9eed-738d1021815e" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_PrincipalAlliancesAxis_5c3fe232-0f6b-4604-ba4e-db31fb767bd9" xlink:to="loc_sny_PrincipalAlliancesDomain_24184b52-8c73-4a8f-9eed-738d1021815e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TwoThousandEighteenLetterAgreementMember_bdf4537d-39d7-4f75-82ae-b4e1c03270b3" xlink:href="sny-20221231.xsd#sny_TwoThousandEighteenLetterAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalAlliancesDomain_24184b52-8c73-4a8f-9eed-738d1021815e" xlink:to="loc_sny_TwoThousandEighteenLetterAgreementMember_bdf4537d-39d7-4f75-82ae-b4e1c03270b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_429cf89b-2ec4-4911-8568-c607f98156ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_429cf89b-2ec4-4911-8568-c607f98156ab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_429cf89b-2ec4-4911-8568-c607f98156ab_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_429cf89b-2ec4-4911-8568-c607f98156ab" xlink:to="loc_ifrs-full_EquityMember_429cf89b-2ec4-4911-8568-c607f98156ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_5bb1b1f6-379b-43fa-87a9-8711fd80b78a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_429cf89b-2ec4-4911-8568-c607f98156ab" xlink:to="loc_ifrs-full_EquityMember_5bb1b1f6-379b-43fa-87a9-8711fd80b78a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_805491cf-845a-4c9e-90d7-977d5cea82d8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_5bb1b1f6-379b-43fa-87a9-8711fd80b78a" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_805491cf-845a-4c9e-90d7-977d5cea82d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_0377d39b-c293-4fde-951b-84e62a3eb96d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_0377d39b-c293-4fde-951b-84e62a3eb96d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_0377d39b-c293-4fde-951b-84e62a3eb96d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_0377d39b-c293-4fde-951b-84e62a3eb96d" xlink:to="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_0377d39b-c293-4fde-951b-84e62a3eb96d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_a238c655-676d-4216-a911-78b16c6b9268" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_0377d39b-c293-4fde-951b-84e62a3eb96d" xlink:to="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_a238c655-676d-4216-a911-78b16c6b9268" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_6fddb4db-eeba-4118-a09c-97dfc339fc9a" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_a238c655-676d-4216-a911-78b16c6b9268" xlink:to="loc_sny_TranslateBioMember_6fddb4db-eeba-4118-a09c-97dfc339fc9a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails" xlink:type="extended" id="i26a7734c53c24570ad3d9cdfc1306a14_Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2858abb0-1590-4f94-a2cc-bd15a8da6c71" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2858abb0-1590-4f94-a2cc-bd15a8da6c71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_97b75965-51c3-4433-80f0-08ca15239ad9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_97b75965-51c3-4433-80f0-08ca15239ad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate_19f1cf94-5630-4515-84a4-13191f079a91" xlink:href="sny-20221231.xsd#sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate_19f1cf94-5630-4515-84a4-13191f079a91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_98c7e6cd-11df-4fec-b921-3d7325cffa13" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_98c7e6cd-11df-4fec-b921-3d7325cffa13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_3c78b0fc-5b0b-4f06-b10c-7cd0b5fd1874" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_3c78b0fc-5b0b-4f06-b10c-7cd0b5fd1874" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_06997f5d-6f4f-493f-bfc7-d6d7645c304d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_06997f5d-6f4f-493f-bfc7-d6d7645c304d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_154e44d3-62e7-4aea-bad1-2d26d5b58c2b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_154e44d3-62e7-4aea-bad1-2d26d5b58c2b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PurchasePrice_ba14cc6d-5500-486a-b955-ebc2a5a92792" xlink:href="sny-20221231.xsd#sny_PurchasePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_sny_PurchasePrice_ba14cc6d-5500-486a-b955-ebc2a5a92792" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_9f6d8513-d20d-4590-90a7-848354007b59" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_9f6d8513-d20d-4590-90a7-848354007b59" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_621ce884-5e2b-4a38-b0b8-427ab95aced2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_9f6d8513-d20d-4590-90a7-848354007b59" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_621ce884-5e2b-4a38-b0b8-427ab95aced2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_621ce884-5e2b-4a38-b0b8-427ab95aced2_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_621ce884-5e2b-4a38-b0b8-427ab95aced2" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_621ce884-5e2b-4a38-b0b8-427ab95aced2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_edc5bf57-adae-4a33-9729-9c1fae50daff" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_621ce884-5e2b-4a38-b0b8-427ab95aced2" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_edc5bf57-adae-4a33-9729-9c1fae50daff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_8da01a63-74b6-484c-a23e-1d2da2f32e7f" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_edc5bf57-adae-4a33-9729-9c1fae50daff" xlink:to="loc_sny_TranslateBioMember_8da01a63-74b6-484c-a23e-1d2da2f32e7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipiaBiopharmaIncMember_88e63ce9-bb3e-481e-b40c-439b2683e239" xlink:href="sny-20221231.xsd#sny_PrincipiaBiopharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_edc5bf57-adae-4a33-9729-9c1fae50daff" xlink:to="loc_sny_PrincipiaBiopharmaIncMember_88e63ce9-bb3e-481e-b40c-439b2683e239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxMember_e3293511-b5b8-424f-9dd4-7eae322eb27d" xlink:href="sny-20221231.xsd#sny_SynthorxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_edc5bf57-adae-4a33-9729-9c1fae50daff" xlink:to="loc_sny_SynthorxMember_e3293511-b5b8-424f-9dd4-7eae322eb27d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended" id="ie6d345771d64480f8e9e255e9b33ff14_PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_d752ffe2-b4e3-4e5a-a33b-c1cbaf783af5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_d752ffe2-b4e3-4e5a-a33b-c1cbaf783af5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment_43be3b09-aa77-4840-922c-03c259323257" xlink:href="sny-20221231.xsd#sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment_43be3b09-aa77-4840-922c-03c259323257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_cd3c9cd4-aaeb-4cf7-85e0-d99021371994" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_cd3c9cd4-aaeb-4cf7-85e0-d99021371994" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_606b7fdf-c3c1-4283-84d0-9394b988f2a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_606b7fdf-c3c1-4283-84d0-9394b988f2a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_7da14198-8cfd-41de-adb0-a962730f2bcf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_7da14198-8cfd-41de-adb0-a962730f2bcf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_f3664fcf-cfca-4f0b-bf86-37f7cdf9fc37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_f3664fcf-cfca-4f0b-bf86-37f7cdf9fc37" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationExpense_c5b50625-fe6d-4b7d-8a8a-a4bbbdf5cf8c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_DepreciationExpense_c5b50625-fe6d-4b7d-8a8a-a4bbbdf5cf8c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_11691149-fcc9-44da-bf51-0c8afacb1746" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_11691149-fcc9-44da-bf51-0c8afacb1746" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_7d450e50-6179-444b-9b21-ce6e5540dd6c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_3101ad9a-9598-4095-9bef-ea42ada346aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_3101ad9a-9598-4095-9bef-ea42ada346aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a692625-c1fd-4955-8656-588adf1e40da" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_3101ad9a-9598-4095-9bef-ea42ada346aa" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a692625-c1fd-4955-8656-588adf1e40da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_7a692625-c1fd-4955-8656-588adf1e40da_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a692625-c1fd-4955-8656-588adf1e40da" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_7a692625-c1fd-4955-8656-588adf1e40da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a692625-c1fd-4955-8656-588adf1e40da" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LandMember_9b3456dc-9681-4906-93e8-35728ace85c0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:to="loc_ifrs-full_LandMember_9b3456dc-9681-4906-93e8-35728ace85c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BuildingsMember_4ce2b078-53de-4bbc-97ea-4bf82574a9a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:to="loc_ifrs-full_BuildingsMember_4ce2b078-53de-4bbc-97ea-4bf82574a9a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MachineryAndEquipmentMember_fc81e777-024d-44b7-ada4-e8e8b625a0ec" xlink:href="sny-20221231.xsd#sny_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:to="loc_sny_MachineryAndEquipmentMember_fc81e777-024d-44b7-ada4-e8e8b625a0ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_ed81a8a6-2384-4926-94a7-427f1fc42520" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_ed81a8a6-2384-4926-94a7-427f1fc42520" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PropertyPlantAndEquipmentInProcessMember_c965fb96-3dda-4531-9451-c02de33af0b6" xlink:href="sny-20221231.xsd#sny_PropertyPlantAndEquipmentInProcessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:to="loc_sny_PropertyPlantAndEquipmentInProcessMember_c965fb96-3dda-4531-9451-c02de33af0b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7c2a2f65-1a66-4105-b28f-bce6a75e41ad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_3101ad9a-9598-4095-9bef-ea42ada346aa" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7c2a2f65-1a66-4105-b28f-bce6a75e41ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_7c2a2f65-1a66-4105-b28f-bce6a75e41ad_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7c2a2f65-1a66-4105-b28f-bce6a75e41ad" xlink:to="loc_ifrs-full_CarryingAmountMember_7c2a2f65-1a66-4105-b28f-bce6a75e41ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_d6a005d0-1e6e-4084-b4c8-edacc4230111" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7c2a2f65-1a66-4105-b28f-bce6a75e41ad" xlink:to="loc_ifrs-full_CarryingAmountMember_d6a005d0-1e6e-4084-b4c8-edacc4230111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_de004744-e237-43fb-a159-c9859e5c5811" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_d6a005d0-1e6e-4084-b4c8-edacc4230111" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_de004744-e237-43fb-a159-c9859e5c5811" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_5d078352-7d88-45f7-a80a-82f97dfe543a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_d6a005d0-1e6e-4084-b4c8-edacc4230111" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_5d078352-7d88-45f7-a80a-82f97dfe543a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails" xlink:type="extended" id="i2744e18e3bf743e6b6b98db3f79acdb5_PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems_59c0145c-5b83-4d6c-b7db-f87a1d08a155" xlink:href="sny-20221231.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_b6a916be-1650-4b4b-8cf7-5a4e31cedff6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems_59c0145c-5b83-4d6c-b7db-f87a1d08a155" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_b6a916be-1650-4b4b-8cf7-5a4e31cedff6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestCostsCapitalised_6e9f4c2f-9e60-44f6-8e14-0dfeb1fc68ec" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestCostsCapitalised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems_59c0145c-5b83-4d6c-b7db-f87a1d08a155" xlink:to="loc_ifrs-full_InterestCostsCapitalised_6e9f4c2f-9e60-44f6-8e14-0dfeb1fc68ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_08f22b6b-a134-4418-8ac7-3ba782f6654a" xlink:href="sny-20221231.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems_59c0145c-5b83-4d6c-b7db-f87a1d08a155" xlink:to="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_08f22b6b-a134-4418-8ac7-3ba782f6654a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_b5381d1d-c126-4101-aea0-d61164d98dff" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_08f22b6b-a134-4418-8ac7-3ba782f6654a" xlink:to="loc_ifrs-full_SegmentsAxis_b5381d1d-c126-4101-aea0-d61164d98dff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_b5381d1d-c126-4101-aea0-d61164d98dff_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_b5381d1d-c126-4101-aea0-d61164d98dff" xlink:to="loc_ifrs-full_SegmentsMember_b5381d1d-c126-4101-aea0-d61164d98dff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_e7f71c65-3ba4-4a90-8372-068edcfdb52a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_b5381d1d-c126-4101-aea0-d61164d98dff" xlink:to="loc_ifrs-full_SegmentsMember_e7f71c65-3ba4-4a90-8372-068edcfdb52a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsMember_0ecf3293-1cb7-4759-a530-65027a0ea4e4" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_e7f71c65-3ba4-4a90-8372-068edcfdb52a" xlink:to="loc_sny_PharmaceuticalsMember_0ecf3293-1cb7-4759-a530-65027a0ea4e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesMember_16568a31-cd4c-4c4d-ad0c-f78ac6fedd5b" xlink:href="sny-20221231.xsd#sny_VaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_e7f71c65-3ba4-4a90-8372-068edcfdb52a" xlink:to="loc_sny_VaccinesMember_16568a31-cd4c-4c4d-ad0c-f78ac6fedd5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareMember_f6fcb371-592f-4940-b6f4-144c8b338e2b" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_e7f71c65-3ba4-4a90-8372-068edcfdb52a" xlink:to="loc_sny_ConsumerHealthcareMember_f6fcb371-592f-4940-b6f4-144c8b338e2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5f3038f5-2010-48d7-8226-3688cd626768" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_08f22b6b-a134-4418-8ac7-3ba782f6654a" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5f3038f5-2010-48d7-8226-3688cd626768" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_5f3038f5-2010-48d7-8226-3688cd626768_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5f3038f5-2010-48d7-8226-3688cd626768" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_5f3038f5-2010-48d7-8226-3688cd626768_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1f6fb5ad-2806-4a05-8395-e62880e52bb5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5f3038f5-2010-48d7-8226-3688cd626768" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1f6fb5ad-2806-4a05-8395-e62880e52bb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IndustrialFacilitiesMember_ddb10ed8-a8c3-49cf-bef1-4d3de17297af" xlink:href="sny-20221231.xsd#sny_IndustrialFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1f6fb5ad-2806-4a05-8395-e62880e52bb5" xlink:to="loc_sny_IndustrialFacilitiesMember_ddb10ed8-a8c3-49cf-bef1-4d3de17297af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ResearchSitesMember_03a5ed0b-87cc-4ca5-8615-588c0e43fb79" xlink:href="sny-20221231.xsd#sny_ResearchSitesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1f6fb5ad-2806-4a05-8395-e62880e52bb5" xlink:to="loc_sny_ResearchSitesMember_03a5ed0b-87cc-4ca5-8615-588c0e43fb79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherMember_22e15ab1-5e35-4c7c-95f3-10db058ba896" xlink:href="sny-20221231.xsd#sny_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1f6fb5ad-2806-4a05-8395-e62880e52bb5" xlink:to="loc_sny_OtherMember_22e15ab1-5e35-4c7c-95f3-10db058ba896" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails" xlink:type="extended" id="i2a239d96961d44aebb6b625707ee65f2_PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_11c8ce9e-c6a3-4352-b5f4-aa1dc19cd684" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_ifrs-full_RightofuseAssets_11c8ce9e-c6a3-4352-b5f4-aa1dc19cd684" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets_1414a4c6-b867-4272-9dcf-df2f486fa532" xlink:href="sny-20221231.xsd#sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets_1414a4c6-b867-4272-9dcf-df2f486fa532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets_ffa1a0ae-cf90-43a3-8a0b-57bde582814a" xlink:href="sny-20221231.xsd#sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets_ffa1a0ae-cf90-43a3-8a0b-57bde582814a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets_c42be7cf-aa09-4951-9a41-64214b38755c" xlink:href="sny-20221231.xsd#sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets_c42be7cf-aa09-4951-9a41-64214b38755c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets_1f1563d9-4a4b-46aa-af45-de3c79db30d3" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets_1f1563d9-4a4b-46aa-af45-de3c79db30d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets_8f6b33de-13fb-490a-b7dd-1eb365b443f9" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets_8f6b33de-13fb-490a-b7dd-1eb365b443f9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_be14eaa5-80cf-4819-9809-604731ea705e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_be14eaa5-80cf-4819-9809-604731ea705e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_fecb8e11-92a5-4b00-8285-c0889484d7a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfLeaseAgreementsSigned_d043ccd8-0fee-494d-8782-7a0dde505f62" xlink:href="sny-20221231.xsd#sny_NumberOfLeaseAgreementsSigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_NumberOfLeaseAgreementsSigned_d043ccd8-0fee-494d-8782-7a0dde505f62" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InitialLeaseTerm_736e2d44-bd95-44be-981c-1eadf2338001" xlink:href="sny-20221231.xsd#sny_InitialLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_InitialLeaseTerm_736e2d44-bd95-44be-981c-1eadf2338001" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_40678219-1dcc-425c-bb88-6db358a86179" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_40405424-0e59-4c51-a633-1237448cd3f2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_ifrs-full_LeaseLiabilities_40405424-0e59-4c51-a633-1237448cd3f2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c801071b-a1e5-4ec1-b41f-fa74291dcfd1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c801071b-a1e5-4ec1-b41f-fa74291dcfd1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1329a160-2a55-4b87-8303-614f40949558" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c801071b-a1e5-4ec1-b41f-fa74291dcfd1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1329a160-2a55-4b87-8303-614f40949558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_1329a160-2a55-4b87-8303-614f40949558_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1329a160-2a55-4b87-8303-614f40949558" xlink:to="loc_ifrs-full_CarryingAmountMember_1329a160-2a55-4b87-8303-614f40949558_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_e832122c-1da4-4c82-a672-76b225202ac1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1329a160-2a55-4b87-8303-614f40949558" xlink:to="loc_ifrs-full_CarryingAmountMember_e832122c-1da4-4c82-a672-76b225202ac1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_386e3695-8cd0-4c65-b87c-92d8435a3ac6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_e832122c-1da4-4c82-a672-76b225202ac1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_386e3695-8cd0-4c65-b87c-92d8435a3ac6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_65dc3c4c-861e-432b-9b93-a57e170f89ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_e832122c-1da4-4c82-a672-76b225202ac1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_65dc3c4c-861e-432b-9b93-a57e170f89ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_702211c3-86de-4b70-acce-a1d6ca2de9b0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c801071b-a1e5-4ec1-b41f-fa74291dcfd1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_702211c3-86de-4b70-acce-a1d6ca2de9b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_702211c3-86de-4b70-acce-a1d6ca2de9b0_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_702211c3-86de-4b70-acce-a1d6ca2de9b0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_702211c3-86de-4b70-acce-a1d6ca2de9b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_5691266f-b653-442c-b11a-48453257b001" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_702211c3-86de-4b70-acce-a1d6ca2de9b0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_5691266f-b653-442c-b11a-48453257b001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CambridgeMassachusettsMember_ff178682-5b98-4e76-82df-783b30e83ef4" xlink:href="sny-20221231.xsd#sny_CambridgeMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5691266f-b653-442c-b11a-48453257b001" xlink:to="loc_sny_CambridgeMassachusettsMember_ff178682-5b98-4e76-82df-783b30e83ef4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OfficeSpaceCambridgeMassachusettsMember_f2f2fcaa-e83f-4e96-986a-c2b50ddd91cf" xlink:href="sny-20221231.xsd#sny_OfficeSpaceCambridgeMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5691266f-b653-442c-b11a-48453257b001" xlink:to="loc_sny_OfficeSpaceCambridgeMassachusettsMember_f2f2fcaa-e83f-4e96-986a-c2b50ddd91cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LaboratoryFacilitiesCambridgeMassachusettsMember_6de8eb9c-66d1-4707-8687-a48116383820" xlink:href="sny-20221231.xsd#sny_LaboratoryFacilitiesCambridgeMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5691266f-b653-442c-b11a-48453257b001" xlink:to="loc_sny_LaboratoryFacilitiesCambridgeMassachusettsMember_6de8eb9c-66d1-4707-8687-a48116383820" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PropertyplantandequipmentAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails" xlink:type="extended" id="i1f5c7704a138454db5ce12da03a36c50_PropertyplantandequipmentAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_60e7bf26-8dfd-4c7d-9746-95379fc078c7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LeasedAssetsPercentage_f47a8675-760c-47b9-b08d-3100c365184a" xlink:href="sny-20221231.xsd#sny_LeasedAssetsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_60e7bf26-8dfd-4c7d-9746-95379fc078c7" xlink:to="loc_sny_LeasedAssetsPercentage_f47a8675-760c-47b9-b08d-3100c365184a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_dc68d49c-3412-4500-bf6d-56441ca67855" xlink:href="sny-20221231.xsd#sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_60e7bf26-8dfd-4c7d-9746-95379fc078c7" xlink:to="loc_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_dc68d49c-3412-4500-bf6d-56441ca67855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashOutflowForLeases_e8a371f9-161f-42d7-8bf6-f10712182b6f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashOutflowForLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_60e7bf26-8dfd-4c7d-9746-95379fc078c7" xlink:to="loc_ifrs-full_CashOutflowForLeases_e8a371f9-161f-42d7-8bf6-f10712182b6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6eaa5794-ccac-42d3-8abc-6f1fccf88475" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_60e7bf26-8dfd-4c7d-9746-95379fc078c7" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6eaa5794-ccac-42d3-8abc-6f1fccf88475" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_6168eb57-6da3-47e2-ae55-0adb76f9bf05" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6eaa5794-ccac-42d3-8abc-6f1fccf88475" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_6168eb57-6da3-47e2-ae55-0adb76f9bf05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_6168eb57-6da3-47e2-ae55-0adb76f9bf05_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_6168eb57-6da3-47e2-ae55-0adb76f9bf05" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_6168eb57-6da3-47e2-ae55-0adb76f9bf05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_d99beb7f-5cb0-4a1f-92b1-7ab57429b427" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_6168eb57-6da3-47e2-ae55-0adb76f9bf05" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_d99beb7f-5cb0-4a1f-92b1-7ab57429b427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LandAndBuildingsMember_c70d18de-4dcc-41b8-ba2f-84f6c8aed39f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandAndBuildingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_d99beb7f-5cb0-4a1f-92b1-7ab57429b427" xlink:to="loc_ifrs-full_LandAndBuildingsMember_c70d18de-4dcc-41b8-ba2f-84f6c8aed39f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_VehiclesMember_466d2cce-b6a5-45e7-b152-b015a8da0a8e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_d99beb7f-5cb0-4a1f-92b1-7ab57429b427" xlink:to="loc_ifrs-full_VehiclesMember_466d2cce-b6a5-45e7-b152-b015a8da0a8e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails" xlink:type="extended" id="i02cc6cd987074bd3ace4e91d7a5aabc8_GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_4650436f-6488-423c-bbf2-07b8fd54117c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_4650436f-6488-423c-bbf2-07b8fd54117c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_72afe4f4-17eb-4e06-b86f-400cdc8e19b6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_72afe4f4-17eb-4e06-b86f-400cdc8e19b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill_e2a3e6f4-ec82-4658-81ec-8d28817932c5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill_e2a3e6f4-ec82-4658-81ec-8d28817932c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_594bad91-6783-4bee-b88f-e73e8b567322" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_594bad91-6783-4bee-b88f-e73e8b567322" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_c0608e71-a9d7-4a49-89f2-e4ae9ffd109f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_3f906aee-2773-4617-a06d-094ea41f1cfc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_3f906aee-2773-4617-a06d-094ea41f1cfc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_76e4c1af-dcc8-4c13-8f41-339595b38076" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_3f906aee-2773-4617-a06d-094ea41f1cfc" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_76e4c1af-dcc8-4c13-8f41-339595b38076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_76e4c1af-dcc8-4c13-8f41-339595b38076_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_76e4c1af-dcc8-4c13-8f41-339595b38076" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_76e4c1af-dcc8-4c13-8f41-339595b38076_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_94eb2b6f-c995-4a01-97d7-5c1df6532034" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_76e4c1af-dcc8-4c13-8f41-339595b38076" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_94eb2b6f-c995-4a01-97d7-5c1df6532034" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillMember_213ecafb-6fdc-4b4b-accf-faf4b4ed91ac" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_94eb2b6f-c995-4a01-97d7-5c1df6532034" xlink:to="loc_ifrs-full_GoodwillMember_213ecafb-6fdc-4b4b-accf-faf4b4ed91ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#GoodwillandotherintangibleassetsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails" xlink:type="extended" id="i9224504a69394edd81b10fe4826b7548_GoodwillandotherintangibleassetsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_02b6765e-deaf-41ea-8f7e-fb87c0512cf9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_02b6765e-deaf-41ea-8f7e-fb87c0512cf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_6816a137-5712-4469-a59e-6a6a6e48d1c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:to="loc_ifrs-full_Goodwill_6816a137-5712-4469-a59e-6a6a6e48d1c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_0d0e8bed-940c-4541-9499-b330eb735724" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_0d0e8bed-940c-4541-9499-b330eb735724" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1869be25-75e8-4f9d-8a4c-0337fc5008d7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1869be25-75e8-4f9d-8a4c-0337fc5008d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_efc4fee4-b55b-4221-9399-e26433934edf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_efc4fee4-b55b-4221-9399-e26433934edf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_f0c6f4bd-c542-43e8-9a3e-de09bc0b51c4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_f0c6f4bd-c542-43e8-9a3e-de09bc0b51c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_14c21834-b3f5-415b-b229-6b789a3d6a68" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_f0c6f4bd-c542-43e8-9a3e-de09bc0b51c4" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_14c21834-b3f5-415b-b229-6b789a3d6a68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_14c21834-b3f5-415b-b229-6b789a3d6a68_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_14c21834-b3f5-415b-b229-6b789a3d6a68" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_14c21834-b3f5-415b-b229-6b789a3d6a68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_14c21834-b3f5-415b-b229-6b789a3d6a68" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixMember_46211f36-9242-41fe-aa42-42827f4c8329" xlink:href="sny-20221231.xsd#sny_AmunixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:to="loc_sny_AmunixMember_46211f36-9242-41fe-aa42-42827f4c8329" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_d733f45b-3d6b-4e38-945a-e77355731019" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:to="loc_sny_TranslateBioMember_d733f45b-3d6b-4e38-945a-e77355731019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipiaBiopharmaIncMember_ed6a6c48-4303-46b6-bebe-7a31f317d0bb" xlink:href="sny-20221231.xsd#sny_PrincipiaBiopharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:to="loc_sny_PrincipiaBiopharmaIncMember_ed6a6c48-4303-46b6-bebe-7a31f317d0bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxMember_9db956a0-d16e-4a8d-8975-fdc6e15efd51" xlink:href="sny-20221231.xsd#sny_SynthorxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:to="loc_sny_SynthorxMember_9db956a0-d16e-4a8d-8975-fdc6e15efd51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_77854710-e0f7-43b2-93d1-a88db8b69de4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_f0c6f4bd-c542-43e8-9a3e-de09bc0b51c4" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_77854710-e0f7-43b2-93d1-a88db8b69de4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_77854710-e0f7-43b2-93d1-a88db8b69de4_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_77854710-e0f7-43b2-93d1-a88db8b69de4" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_77854710-e0f7-43b2-93d1-a88db8b69de4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_77854710-e0f7-43b2-93d1-a88db8b69de4" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketedProductsMember_feb910f4-6eee-4929-9e5f-056e971f628f" xlink:href="sny-20221231.xsd#sny_MarketedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:to="loc_sny_MarketedProductsMember_feb910f4-6eee-4929-9e5f-056e971f628f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TechnologicalPlatformsMember_c0094b8f-09bf-4e30-92e9-f3ae41d2120c" xlink:href="sny-20221231.xsd#sny_TechnologicalPlatformsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:to="loc_sny_TechnologicalPlatformsMember_c0094b8f-09bf-4e30-92e9-f3ae41d2120c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherIntangibleAssetsExcludingSoftwareMember_a0337369-47f1-4972-8d52-c84fec6caf1f" xlink:href="sny-20221231.xsd#sny_OtherIntangibleAssetsExcludingSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:to="loc_sny_OtherIntangibleAssetsExcludingSoftwareMember_a0337369-47f1-4972-8d52-c84fec6caf1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EnjaymoMember_f81dfa55-cae6-4b46-aae0-7ae6eaeaa422" xlink:href="sny-20221231.xsd#sny_EnjaymoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:to="loc_sny_EnjaymoMember_f81dfa55-cae6-4b46-aae0-7ae6eaeaa422" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_314aadbe-db35-45ad-9d81-eaba069143e6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_f0c6f4bd-c542-43e8-9a3e-de09bc0b51c4" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_314aadbe-db35-45ad-9d81-eaba069143e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_314aadbe-db35-45ad-9d81-eaba069143e6_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_314aadbe-db35-45ad-9d81-eaba069143e6" xlink:to="loc_ifrs-full_CarryingAmountMember_314aadbe-db35-45ad-9d81-eaba069143e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_c8273d2c-3877-4a86-b48f-177b6c169de4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_314aadbe-db35-45ad-9d81-eaba069143e6" xlink:to="loc_ifrs-full_CarryingAmountMember_c8273d2c-3877-4a86-b48f-177b6c169de4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_2ca6ece2-be31-4244-8474-8f8faffd30c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_c8273d2c-3877-4a86-b48f-177b6c169de4" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_2ca6ece2-be31-4244-8474-8f8faffd30c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_be86c6c2-054f-44d1-892d-09ff0c0f88bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_c8273d2c-3877-4a86-b48f-177b6c169de4" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_be86c6c2-054f-44d1-892d-09ff0c0f88bd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails" xlink:type="extended" id="i943121187de5405baf763e104719c1ce_GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssets_85149216-cec5-475d-9105-c9f0b1277072" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_OtherIntangibleAssets_85149216-cec5-475d-9105-c9f0b1277072" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets_60d3f2ff-a981-4a0e-9094-ced1ed22a178" xlink:href="sny-20221231.xsd#sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets_60d3f2ff-a981-4a0e-9094-ced1ed22a178" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_8bd0d742-6067-485a-a17f-eb8f9fde9c36" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_8bd0d742-6067-485a-a17f-eb8f9fde9c36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_87698b4e-00df-46cb-8915-1734d5dedfc5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_87698b4e-00df-46cb-8915-1734d5dedfc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_75ba157e-2bea-4710-af39-610d7d3974f9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_75ba157e-2bea-4710-af39-610d7d3974f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_bc296425-71ab-4d63-9350-a238ea3fd0ac" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_bc296425-71ab-4d63-9350-a238ea3fd0ac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_cf145461-b0b5-47cd-97ee-4b8c08d4bb94" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_cf145461-b0b5-47cd-97ee-4b8c08d4bb94" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_d4b2f426-8b7d-4c18-be8d-e75525d6d07c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_d4b2f426-8b7d-4c18-be8d-e75525d6d07c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssets_7229a300-7970-4a70-b6e9-e574f36106cc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e6b477ff-38db-46ba-8db9-b0a4f306671e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e6b477ff-38db-46ba-8db9-b0a4f306671e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_280b5903-e565-4f1b-8f60-17e721f76427" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e6b477ff-38db-46ba-8db9-b0a4f306671e" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_280b5903-e565-4f1b-8f60-17e721f76427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_280b5903-e565-4f1b-8f60-17e721f76427_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_280b5903-e565-4f1b-8f60-17e721f76427" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_280b5903-e565-4f1b-8f60-17e721f76427_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_280b5903-e565-4f1b-8f60-17e721f76427" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AcquiredRDMember_be8a7479-30a3-4d3b-8f8a-fc6d76e5ad07" xlink:href="sny-20221231.xsd#sny_AcquiredRDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:to="loc_sny_AcquiredRDMember_be8a7479-30a3-4d3b-8f8a-fc6d76e5ad07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketedProductsTrademarksAndOtherRightsMember_5c68a305-3301-4ea5-bbc7-43b8cf9ff2e8" xlink:href="sny-20221231.xsd#sny_MarketedProductsTrademarksAndOtherRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:to="loc_sny_MarketedProductsTrademarksAndOtherRightsMember_5c68a305-3301-4ea5-bbc7-43b8cf9ff2e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_bc95217d-771c-4340-8fd6-8b7cc7a6bddd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:to="loc_ifrs-full_ComputerSoftwareMember_bc95217d-771c-4340-8fd6-8b7cc7a6bddd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IOLicenseAndCollaborationAgreementMember_0bb5d409-e708-41c4-a0fe-abc8e4c3aab5" xlink:href="sny-20221231.xsd#sny_IOLicenseAndCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:to="loc_sny_IOLicenseAndCollaborationAgreementMember_0bb5d409-e708-41c4-a0fe-abc8e4c3aab5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8567c6ed-8897-4b9c-a42f-c368bf61caad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e6b477ff-38db-46ba-8db9-b0a4f306671e" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8567c6ed-8897-4b9c-a42f-c368bf61caad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_8567c6ed-8897-4b9c-a42f-c368bf61caad_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8567c6ed-8897-4b9c-a42f-c368bf61caad" xlink:to="loc_ifrs-full_CarryingAmountMember_8567c6ed-8897-4b9c-a42f-c368bf61caad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_332439a5-db78-4927-a641-5cb07ddda8c9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8567c6ed-8897-4b9c-a42f-c368bf61caad" xlink:to="loc_ifrs-full_CarryingAmountMember_332439a5-db78-4927-a641-5cb07ddda8c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_559495e8-0a73-4f14-b84a-9254c6f2451a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_332439a5-db78-4927-a641-5cb07ddda8c9" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_559495e8-0a73-4f14-b84a-9254c6f2451a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_86b4f806-e8e1-409c-8727-d3cf8aa188b2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_332439a5-db78-4927-a641-5cb07ddda8c9" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_86b4f806-e8e1-409c-8727-d3cf8aa188b2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails" xlink:type="extended" id="id151cd9006b34c77afa9e7ed2c4ac55c_GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConcentrationRiskThresholdPercentage_b2063620-adb6-475d-b979-def2afb7bb66" xlink:href="sny-20221231.xsd#sny_ConcentrationRiskThresholdPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:to="loc_sny_ConcentrationRiskThresholdPercentage_b2063620-adb6-475d-b979-def2afb7bb66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_a9041406-81c0-4eae-8c1f-0f3b30f11c45" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_a9041406-81c0-4eae-8c1f-0f3b30f11c45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_ef1718da-bb6a-48c6-9b21-aecd85d3baf6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_ef1718da-bb6a-48c6-9b21-aecd85d3baf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_a6d09f69-6d42-417d-a871-2aae7dda742d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:to="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_a6d09f69-6d42-417d-a871-2aae7dda742d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_3164cc73-5c96-423d-bb79-376367ad7917" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_3164cc73-5c96-423d-bb79-376367ad7917" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_196b5db6-17cb-4c77-a334-43ab5a81564e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_3164cc73-5c96-423d-bb79-376367ad7917" xlink:to="loc_ifrs-full_RangeAxis_196b5db6-17cb-4c77-a334-43ab5a81564e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_196b5db6-17cb-4c77-a334-43ab5a81564e_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_196b5db6-17cb-4c77-a334-43ab5a81564e" xlink:to="loc_ifrs-full_RangesMember_196b5db6-17cb-4c77-a334-43ab5a81564e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_4a15fc0c-50f8-4925-bc3e-e5beea8ab7f5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_196b5db6-17cb-4c77-a334-43ab5a81564e" xlink:to="loc_ifrs-full_RangesMember_4a15fc0c-50f8-4925-bc3e-e5beea8ab7f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_c14f8f6e-58a3-4fe0-ae78-1c1f2b791626" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_4a15fc0c-50f8-4925-bc3e-e5beea8ab7f5" xlink:to="loc_ifrs-full_BottomOfRangeMember_c14f8f6e-58a3-4fe0-ae78-1c1f2b791626" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_879f643a-57a7-44d0-bed9-293dbe32c154" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_4a15fc0c-50f8-4925-bc3e-e5beea8ab7f5" xlink:to="loc_ifrs-full_TopOfRangeMember_879f643a-57a7-44d0-bed9-293dbe32c154" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_507a1bc9-6eb5-43b9-b03e-a79296eb4912" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_3164cc73-5c96-423d-bb79-376367ad7917" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_507a1bc9-6eb5-43b9-b03e-a79296eb4912" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_507a1bc9-6eb5-43b9-b03e-a79296eb4912_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_507a1bc9-6eb5-43b9-b03e-a79296eb4912" xlink:to="loc_ifrs-full_CarryingAmountMember_507a1bc9-6eb5-43b9-b03e-a79296eb4912_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_e12a7c82-e413-455a-83ae-b135cdaddfed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_507a1bc9-6eb5-43b9-b03e-a79296eb4912" xlink:to="loc_ifrs-full_CarryingAmountMember_e12a7c82-e413-455a-83ae-b135cdaddfed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_336a09be-3e7d-45b3-9e5e-b802799024d2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_e12a7c82-e413-455a-83ae-b135cdaddfed" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_336a09be-3e7d-45b3-9e5e-b802799024d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_f5a3180e-eeb9-4a90-9487-2e88ead8e14b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_e12a7c82-e413-455a-83ae-b135cdaddfed" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_f5a3180e-eeb9-4a90-9487-2e88ead8e14b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_2b7dcd92-7b10-4804-8e50-5d90bdf1a54d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_3164cc73-5c96-423d-bb79-376367ad7917" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_2b7dcd92-7b10-4804-8e50-5d90bdf1a54d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_2b7dcd92-7b10-4804-8e50-5d90bdf1a54d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_2b7dcd92-7b10-4804-8e50-5d90bdf1a54d" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_2b7dcd92-7b10-4804-8e50-5d90bdf1a54d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_fbc39b2d-1ce8-426b-a395-fc0bc9030eba" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_2b7dcd92-7b10-4804-8e50-5d90bdf1a54d" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_fbc39b2d-1ce8-426b-a395-fc0bc9030eba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketedProductsMember_35744456-d51a-48ef-8e55-029c87518597" xlink:href="sny-20221231.xsd#sny_MarketedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_fbc39b2d-1ce8-426b-a395-fc0bc9030eba" xlink:to="loc_sny_MarketedProductsMember_35744456-d51a-48ef-8e55-029c87518597" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_fbc39b2d-1ce8-426b-a395-fc0bc9030eba" xlink:to="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsGenzymeMember_4696f510-c905-41fc-8a18-dc6784c589ae" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsGenzymeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsGenzymeMember_4696f510-c905-41fc-8a18-dc6784c589ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember_1d03151a-e7f7-493a-a1a5-8ec3e3c7e0de" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember_1d03151a-e7f7-493a-a1a5-8ec3e3c7e0de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsAventisMember_7025e3f8-3926-41d2-ad52-d116a13e3ed2" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsAventisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsAventisMember_7025e3f8-3926-41d2-ad52-d116a13e3ed2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsChattemMember_9e100618-b4e7-41b8-8613-5bb9fabc684f" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsChattemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsChattemMember_9e100618-b4e7-41b8-8613-5bb9fabc684f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsProteinSciencesMember_54533fe6-4f2b-42f3-b6b2-239facae81fe" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsProteinSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsProteinSciencesMember_54533fe6-4f2b-42f3-b6b2-239facae81fe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsAblynxMember_e9e70596-20c6-40b2-9b25-44a2225a7bb5" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsAblynxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsAblynxMember_e9e70596-20c6-40b2-9b25-44a2225a7bb5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsBioverativMember_04c59ff1-f1f8-4102-ac97-9f61f2177212" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsBioverativMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsBioverativMember_04c59ff1-f1f8-4102-ac97-9f61f2177212" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsKadmonMember_1dc4f3b0-f057-4e25-8f1f-062793f4030f" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsKadmonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsKadmonMember_1dc4f3b0-f057-4e25-8f1f-062793f4030f" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails" xlink:type="extended" id="i9fdef10a6ae4420c9688a33f7cd7148b_GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_273fa078-6a45-492c-b41f-51a11691701e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:to="loc_ifrs-full_CostOfSales_273fa078-6a45-492c-b41f-51a11691701e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_d37728a7-ffd1-48b3-83ce-1d1d98d8ec50" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_d37728a7-ffd1-48b3-83ce-1d1d98d8ec50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_f9f55f32-7e57-4f0d-938a-a9a02b984ec3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_f9f55f32-7e57-4f0d-938a-a9a02b984ec3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_2f8a4e39-f193-4aa9-a61e-a10673029086" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_2f8a4e39-f193-4aa9-a61e-a10673029086" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_be9795f1-60c5-4b8c-9567-492c9a579922" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_be9795f1-60c5-4b8c-9567-492c9a579922" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_13c4d8e1-73e8-47d1-acd4-56e9bb4d73bc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_13c4d8e1-73e8-47d1-acd4-56e9bb4d73bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseCategoriesAxis_0934f9be-a9e7-45d3-8626-7fd6647cf75b" xlink:href="sny-20221231.xsd#sny_ExpenseCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_13c4d8e1-73e8-47d1-acd4-56e9bb4d73bc" xlink:to="loc_sny_ExpenseCategoriesAxis_0934f9be-a9e7-45d3-8626-7fd6647cf75b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseCategoriesDomain_0934f9be-a9e7-45d3-8626-7fd6647cf75b_default" xlink:href="sny-20221231.xsd#sny_ExpenseCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_ExpenseCategoriesAxis_0934f9be-a9e7-45d3-8626-7fd6647cf75b" xlink:to="loc_sny_ExpenseCategoriesDomain_0934f9be-a9e7-45d3-8626-7fd6647cf75b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseCategoriesDomain_c528413b-907d-440b-8cca-15958c45464f" xlink:href="sny-20221231.xsd#sny_ExpenseCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_ExpenseCategoriesAxis_0934f9be-a9e7-45d3-8626-7fd6647cf75b" xlink:to="loc_sny_ExpenseCategoriesDomain_c528413b-907d-440b-8cca-15958c45464f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember_ea2e26ee-ce44-497c-88bf-11e85e48c1e7" xlink:href="sny-20221231.xsd#sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ExpenseCategoriesDomain_c528413b-907d-440b-8cca-15958c45464f" xlink:to="loc_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember_ea2e26ee-ce44-497c-88bf-11e85e48c1e7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails" xlink:type="extended" id="ie7eaea48968a4a559d0f9f24cd6253b1_ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_2b61e3a5-b885-4f18-a436-33bc5c59da33" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_5a0775a0-ce83-451f-8ba2-9e605bcccff8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_2b61e3a5-b885-4f18-a436-33bc5c59da33" xlink:to="loc_ifrs-full_Goodwill_5a0775a0-ce83-451f-8ba2-9e605bcccff8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_95a0415a-2f18-40a1-b774-c6265fc8be2c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_2b61e3a5-b885-4f18-a436-33bc5c59da33" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_95a0415a-2f18-40a1-b774-c6265fc8be2c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_fc1f3a9b-74c3-4067-8b7f-16ee283e9b25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_95a0415a-2f18-40a1-b774-c6265fc8be2c" xlink:to="loc_ifrs-full_SegmentsAxis_fc1f3a9b-74c3-4067-8b7f-16ee283e9b25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_fc1f3a9b-74c3-4067-8b7f-16ee283e9b25_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_fc1f3a9b-74c3-4067-8b7f-16ee283e9b25" xlink:to="loc_ifrs-full_SegmentsMember_fc1f3a9b-74c3-4067-8b7f-16ee283e9b25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_c9b0449b-d2d5-44e8-8bd0-64c9d5adc7b0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_fc1f3a9b-74c3-4067-8b7f-16ee283e9b25" xlink:to="loc_ifrs-full_SegmentsMember_c9b0449b-d2d5-44e8-8bd0-64c9d5adc7b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsMember_dce041d8-d4d4-47e7-9f43-4a1a63a19a70" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_c9b0449b-d2d5-44e8-8bd0-64c9d5adc7b0" xlink:to="loc_sny_PharmaceuticalsMember_dce041d8-d4d4-47e7-9f43-4a1a63a19a70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareMember_0fd63aa5-7176-4a4e-bd92-e3c3dd2669c1" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_c9b0449b-d2d5-44e8-8bd0-64c9d5adc7b0" xlink:to="loc_sny_ConsumerHealthcareMember_0fd63aa5-7176-4a4e-bd92-e3c3dd2669c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesMember_7d241b4e-9997-4115-bd2c-2846b9779cb7" xlink:href="sny-20221231.xsd#sny_VaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_c9b0449b-d2d5-44e8-8bd0-64c9d5adc7b0" xlink:to="loc_sny_VaccinesMember_7d241b4e-9997-4115-bd2c-2846b9779cb7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails" xlink:type="extended" id="i7c7fc4b53afd41d0951bce91d95557bd_ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentTestingPercentage_2b2b6569-06b7-4b8c-96ea-2f97c043f963" xlink:href="sny-20221231.xsd#sny_ImpairmentTestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_ImpairmentTestingPercentage_2b2b6569-06b7-4b8c-96ea-2f97c043f963" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UniformImpairmentTestingPercentage_ef33cbc5-219f-435a-89c5-b6c65454d223" xlink:href="sny-20221231.xsd#sny_UniformImpairmentTestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_UniformImpairmentTestingPercentage_ef33cbc5-219f-435a-89c5-b6c65454d223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOperatingSegments_337fa719-2406-4dae-b2ed-106e95e1d2b2" xlink:href="sny-20221231.xsd#sny_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_NumberOfOperatingSegments_337fa719-2406-4dae-b2ed-106e95e1d2b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PretaxDiscountRateAppliedForGoodwill_a104cd94-7eda-4a2f-b6a6-ee28cff3c83f" xlink:href="sny-20221231.xsd#sny_PretaxDiscountRateAppliedForGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_PretaxDiscountRateAppliedForGoodwill_a104cd94-7eda-4a2f-b6a6-ee28cff3c83f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UniformPreTaxDiscountRates_1b8f00ab-c975-4576-8322-41285bd51448" xlink:href="sny-20221231.xsd#sny_UniformPreTaxDiscountRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_UniformPreTaxDiscountRates_1b8f00ab-c975-4576-8322-41285bd51448" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_eae84fe7-8e67-44f0-b963-bec774ddb03d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_eae84fe7-8e67-44f0-b963-bec774ddb03d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss_6b5e4561-b57f-42d3-8fa2-4a180dd9c9ee" xlink:href="sny-20221231.xsd#sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss_6b5e4561-b57f-42d3-8fa2-4a180dd9c9ee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss_a89ba49e-e555-4314-aa5b-228f6979bc7a" xlink:href="sny-20221231.xsd#sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss_a89ba49e-e555-4314-aa5b-228f6979bc7a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss_6bb50840-ca3c-43ae-be6d-c5c1ae3211b0" xlink:href="sny-20221231.xsd#sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss_6bb50840-ca3c-43ae-be6d-c5c1ae3211b0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_5fbc427b-3030-4830-a137-7de21618a9c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_5fbc427b-3030-4830-a137-7de21618a9c3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AfterTaxDiscountRates_d02a47ea-ee73-450d-8ef7-0da529483602" xlink:href="sny-20221231.xsd#sny_AfterTaxDiscountRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_AfterTaxDiscountRates_d02a47ea-ee73-450d-8ef7-0da529483602" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_43f781d0-e46d-468c-ae64-108cf70f704d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:to="loc_ifrs-full_SegmentsAxis_43f781d0-e46d-468c-ae64-108cf70f704d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_43f781d0-e46d-468c-ae64-108cf70f704d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_43f781d0-e46d-468c-ae64-108cf70f704d" xlink:to="loc_ifrs-full_SegmentsMember_43f781d0-e46d-468c-ae64-108cf70f704d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_af0bc29b-3dbe-4308-971b-162df4bfdf2e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_43f781d0-e46d-468c-ae64-108cf70f704d" xlink:to="loc_ifrs-full_SegmentsMember_af0bc29b-3dbe-4308-971b-162df4bfdf2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsSegmentMember_a74299a3-67ef-4984-8ece-a67776665cdd" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_af0bc29b-3dbe-4308-971b-162df4bfdf2e" xlink:to="loc_sny_PharmaceuticalsSegmentMember_a74299a3-67ef-4984-8ece-a67776665cdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareMember_f27f90a6-49b4-4ce5-a1f8-698905e93058" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_af0bc29b-3dbe-4308-971b-162df4bfdf2e" xlink:to="loc_sny_ConsumerHealthcareMember_f27f90a6-49b4-4ce5-a1f8-698905e93058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesMember_bbd4f876-bd17-4828-b13a-782dec164fcb" xlink:href="sny-20221231.xsd#sny_VaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_af0bc29b-3dbe-4308-971b-162df4bfdf2e" xlink:to="loc_sny_VaccinesMember_bbd4f876-bd17-4828-b13a-782dec164fcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_280aaa46-fa8e-4d86-8906-d84bc95c93c9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_280aaa46-fa8e-4d86-8906-d84bc95c93c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForCashgeneratingUnitsMember_280aaa46-fa8e-4d86-8906-d84bc95c93c9_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForCashgeneratingUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_280aaa46-fa8e-4d86-8906-d84bc95c93c9" xlink:to="loc_ifrs-full_EntitysTotalForCashgeneratingUnitsMember_280aaa46-fa8e-4d86-8906-d84bc95c93c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForCashgeneratingUnitsMember_bb3fa78f-35a9-4253-b041-2d7266610300" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForCashgeneratingUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_280aaa46-fa8e-4d86-8906-d84bc95c93c9" xlink:to="loc_ifrs-full_EntitysTotalForCashgeneratingUnitsMember_bb3fa78f-35a9-4253-b041-2d7266610300" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember_6985ff1c-1266-4430-b10b-0a2bae9d59de" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForCashgeneratingUnitsMember_bb3fa78f-35a9-4253-b041-2d7266610300" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember_6985ff1c-1266-4430-b10b-0a2bae9d59de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_1f36add1-1638-4c3e-9624-d3d87b7b5175" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_1f36add1-1638-4c3e-9624-d3d87b7b5175" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_1f36add1-1638-4c3e-9624-d3d87b7b5175_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1f36add1-1638-4c3e-9624-d3d87b7b5175" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_1f36add1-1638-4c3e-9624-d3d87b7b5175_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_86b17e80-80ad-4876-a333-b48a2c22da37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1f36add1-1638-4c3e-9624-d3d87b7b5175" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_86b17e80-80ad-4876-a333-b48a2c22da37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashGeneratingUnitsMember_19323049-bf49-4321-9301-4e9c7dc54a78" xlink:href="sny-20221231.xsd#sny_CashGeneratingUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_86b17e80-80ad-4876-a333-b48a2c22da37" xlink:to="loc_sny_CashGeneratingUnitsMember_19323049-bf49-4321-9301-4e9c7dc54a78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_2cf196ee-16b4-4df6-bdfa-bc3e24cbaf5a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_2cf196ee-16b4-4df6-bdfa-bc3e24cbaf5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_2cf196ee-16b4-4df6-bdfa-bc3e24cbaf5a_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_2cf196ee-16b4-4df6-bdfa-bc3e24cbaf5a" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_2cf196ee-16b4-4df6-bdfa-bc3e24cbaf5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_72dcb089-5fca-4c11-92c7-aa9642447ef8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_2cf196ee-16b4-4df6-bdfa-bc3e24cbaf5a" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_72dcb089-5fca-4c11-92c7-aa9642447ef8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillMember_d22e9175-d9dc-4ce1-ba3c-4f7f0c196508" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_72dcb089-5fca-4c11-92c7-aa9642447ef8" xlink:to="loc_ifrs-full_GoodwillMember_d22e9175-d9dc-4ce1-ba3c-4f7f0c196508" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_a8e221b0-8765-40b0-8213-c424d033223a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_72dcb089-5fca-4c11-92c7-aa9642447ef8" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_a8e221b0-8765-40b0-8213-c424d033223a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_b6a0ff65-ad02-4c28-b97f-cb42ebb47596" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:to="loc_ifrs-full_RangeAxis_b6a0ff65-ad02-4c28-b97f-cb42ebb47596" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_b6a0ff65-ad02-4c28-b97f-cb42ebb47596_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_b6a0ff65-ad02-4c28-b97f-cb42ebb47596" xlink:to="loc_ifrs-full_RangesMember_b6a0ff65-ad02-4c28-b97f-cb42ebb47596_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_91a7c177-eae9-471a-b92b-3a670dc9a31c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_b6a0ff65-ad02-4c28-b97f-cb42ebb47596" xlink:to="loc_ifrs-full_RangesMember_91a7c177-eae9-471a-b92b-3a670dc9a31c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_b7f89a72-43f4-43f8-92a8-ef434d21c8f9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_91a7c177-eae9-471a-b92b-3a670dc9a31c" xlink:to="loc_ifrs-full_BottomOfRangeMember_b7f89a72-43f4-43f8-92a8-ef434d21c8f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_be6da27f-0a6c-4bce-8260-c37f9578888e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_91a7c177-eae9-471a-b92b-3a670dc9a31c" xlink:to="loc_ifrs-full_TopOfRangeMember_be6da27f-0a6c-4bce-8260-c37f9578888e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails" xlink:type="extended" id="ia39955a4d7b34590aac2702a227b11fe_ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_a591b402-ee0d-46a8-951a-82511c340d56" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill_28a5fd48-8608-4969-bd84-8c7184fb5196" xlink:href="sny-20221231.xsd#sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_a591b402-ee0d-46a8-951a-82511c340d56" xlink:to="loc_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill_28a5fd48-8608-4969-bd84-8c7184fb5196" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_39d523d9-dac8-48ac-931b-9a9e7cf4c947" xlink:href="sny-20221231.xsd#sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_a591b402-ee0d-46a8-951a-82511c340d56" xlink:to="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_39d523d9-dac8-48ac-931b-9a9e7cf4c947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_4b0870e5-676e-4c33-9572-5dd665616e9e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_a591b402-ee0d-46a8-951a-82511c340d56" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_4b0870e5-676e-4c33-9572-5dd665616e9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_a591b402-ee0d-46a8-951a-82511c340d56" xlink:to="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_5df393d6-4ebd-412d-bb03-ac6ede0cd00a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:to="loc_ifrs-full_SegmentsAxis_5df393d6-4ebd-412d-bb03-ac6ede0cd00a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_5df393d6-4ebd-412d-bb03-ac6ede0cd00a_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_5df393d6-4ebd-412d-bb03-ac6ede0cd00a" xlink:to="loc_ifrs-full_SegmentsMember_5df393d6-4ebd-412d-bb03-ac6ede0cd00a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_60294081-0f5a-435d-86ff-cf2e64b082f3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_5df393d6-4ebd-412d-bb03-ac6ede0cd00a" xlink:to="loc_ifrs-full_SegmentsMember_60294081-0f5a-435d-86ff-cf2e64b082f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsSegmentMember_07fa49d8-6861-4fef-924c-833753554ee8" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_60294081-0f5a-435d-86ff-cf2e64b082f3" xlink:to="loc_sny_PharmaceuticalsSegmentMember_07fa49d8-6861-4fef-924c-833753554ee8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareSegmentMember_b209816f-9fa2-444f-88c0-93898badedbf" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_60294081-0f5a-435d-86ff-cf2e64b082f3" xlink:to="loc_sny_ConsumerHealthcareSegmentMember_b209816f-9fa2-444f-88c0-93898badedbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesSegmentMember_0be59ed2-09bc-4824-b9ce-f83c36e037ae" xlink:href="sny-20221231.xsd#sny_VaccinesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_60294081-0f5a-435d-86ff-cf2e64b082f3" xlink:to="loc_sny_VaccinesSegmentMember_0be59ed2-09bc-4824-b9ce-f83c36e037ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7dd7f48e-ee39-4edc-a5f2-edbb26a08189" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7dd7f48e-ee39-4edc-a5f2-edbb26a08189" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7dd7f48e-ee39-4edc-a5f2-edbb26a08189_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7dd7f48e-ee39-4edc-a5f2-edbb26a08189" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7dd7f48e-ee39-4edc-a5f2-edbb26a08189_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1f137596-3525-4439-a41f-3934ffaffb7a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7dd7f48e-ee39-4edc-a5f2-edbb26a08189" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1f137596-3525-4439-a41f-3934ffaffb7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_cec584f0-f957-4bb7-9b9b-47afc9133da4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1f137596-3525-4439-a41f-3934ffaffb7a" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_cec584f0-f957-4bb7-9b9b-47afc9133da4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_3b0d4518-14f0-4116-8d96-93d10aaa32aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_3b0d4518-14f0-4116-8d96-93d10aaa32aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesMember_3b0d4518-14f0-4116-8d96-93d10aaa32aa_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_3b0d4518-14f0-4116-8d96-93d10aaa32aa" xlink:to="loc_ifrs-full_ProductsAndServicesMember_3b0d4518-14f0-4116-8d96-93d10aaa32aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesMember_4996dd7f-ea66-4083-a855-37fdaeb018ea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_3b0d4518-14f0-4116-8d96-93d10aaa32aa" xlink:to="loc_ifrs-full_ProductsAndServicesMember_4996dd7f-ea66-4083-a855-37fdaeb018ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketedProductsMember_2a18117f-1b4a-4735-a715-69b51ade006f" xlink:href="sny-20221231.xsd#sny_MarketedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_4996dd7f-ea66-4083-a855-37fdaeb018ea" xlink:to="loc_sny_MarketedProductsMember_2a18117f-1b4a-4735-a715-69b51ade006f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ResearchAndDevelopmentMember_ce7152f1-5c3f-41a6-9760-cf901029e992" xlink:href="sny-20221231.xsd#sny_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_4996dd7f-ea66-4083-a855-37fdaeb018ea" xlink:to="loc_sny_ResearchAndDevelopmentMember_ce7152f1-5c3f-41a6-9760-cf901029e992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SAR444245Member_efa4cf4e-af2b-4c0f-bb0a-666e758740b3" xlink:href="sny-20221231.xsd#sny_SAR444245Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_4996dd7f-ea66-4083-a855-37fdaeb018ea" xlink:to="loc_sny_SAR444245Member_efa4cf4e-af2b-4c0f-bb0a-666e758740b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_da985085-5dce-42f2-aeac-11eae6f8da93" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:to="loc_srt_ProductOrServiceAxis_da985085-5dce-42f2-aeac-11eae6f8da93" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_da985085-5dce-42f2-aeac-11eae6f8da93_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_da985085-5dce-42f2-aeac-11eae6f8da93" xlink:to="loc_srt_ProductsAndServicesDomain_da985085-5dce-42f2-aeac-11eae6f8da93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_418911d8-09f2-4823-afdc-cc32c4ab4b2a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_da985085-5dce-42f2-aeac-11eae6f8da93" xlink:to="loc_srt_ProductsAndServicesDomain_418911d8-09f2-4823-afdc-cc32c4ab4b2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EloctateMember_e67d7b88-4e44-469e-ad75-2b752a87a002" xlink:href="sny-20221231.xsd#sny_EloctateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_418911d8-09f2-4823-afdc-cc32c4ab4b2a" xlink:to="loc_sny_EloctateMember_e67d7b88-4e44-469e-ad75-2b752a87a002" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_98112ea5-8d42-40a0-af21-3762448817d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_98112ea5-8d42-40a0-af21-3762448817d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_98112ea5-8d42-40a0-af21-3762448817d0_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_98112ea5-8d42-40a0-af21-3762448817d0" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_98112ea5-8d42-40a0-af21-3762448817d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_7767641a-9b97-4cfc-bf8a-433d87f4d6e8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_98112ea5-8d42-40a0-af21-3762448817d0" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_7767641a-9b97-4cfc-bf8a-433d87f4d6e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_132b22f0-90f3-482b-b549-9ed7c7c02774" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_7767641a-9b97-4cfc-bf8a-433d87f4d6e8" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_132b22f0-90f3-482b-b549-9ed7c7c02774" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails" xlink:type="extended" id="i2ed79aad457b470196d8890e84f34c08_InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_2329ed6f-6bad-4f09-80ea-c632431da9db" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_2329ed6f-6bad-4f09-80ea-c632431da9db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture_c10493c2-ba82-496d-9d1a-b96475c779d7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture_c10493c2-ba82-496d-9d1a-b96475c779d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInJointVentures_3cc028a5-9855-41cd-908f-3495c42598d4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:to="loc_ifrs-full_InvestmentsInJointVentures_3cc028a5-9855-41cd-908f-3495c42598d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_81b61e73-b055-48b1-afd2-13c715756815" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:to="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_81b61e73-b055-48b1-afd2-13c715756815" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_a18c734c-c41e-4a40-af67-1374938a939f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_a18c734c-c41e-4a40-af67-1374938a939f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_53055414-0174-4290-b448-4130722101a4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_a18c734c-c41e-4a40-af67-1374938a939f" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_53055414-0174-4290-b448-4130722101a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_53055414-0174-4290-b448-4130722101a4_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_53055414-0174-4290-b448-4130722101a4" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_53055414-0174-4290-b448-4130722101a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_fceedead-5f87-4fd4-a458-96df59dc24aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_53055414-0174-4290-b448-4130722101a4" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_fceedead-5f87-4fd4-a458-96df59dc24aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_792e7280-1ae3-4c4a-bbe1-f44af21fcea2" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_fceedead-5f87-4fd4-a458-96df59dc24aa" xlink:to="loc_sny_EuroapiMember_792e7280-1ae3-4c4a-bbe1-f44af21fcea2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MCMVaccineBVMember_52985c99-3c37-467c-aa0c-272c9561695a" xlink:href="sny-20221231.xsd#sny_MCMVaccineBVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_fceedead-5f87-4fd4-a458-96df59dc24aa" xlink:to="loc_sny_MCMVaccineBVMember_52985c99-3c37-467c-aa0c-272c9561695a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_4ea1550e-f3d5-4d3e-ab7f-754f1b5aea7b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_a18c734c-c41e-4a40-af67-1374938a939f" xlink:to="loc_ifrs-full_JointVenturesAxis_4ea1550e-f3d5-4d3e-ab7f-754f1b5aea7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_4ea1550e-f3d5-4d3e-ab7f-754f1b5aea7b_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointVenturesAxis_4ea1550e-f3d5-4d3e-ab7f-754f1b5aea7b" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_4ea1550e-f3d5-4d3e-ab7f-754f1b5aea7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_d9406c73-55c5-4e66-8d58-cc3e0112a9e4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointVenturesAxis_4ea1550e-f3d5-4d3e-ab7f-754f1b5aea7b" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_d9406c73-55c5-4e66-8d58-cc3e0112a9e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InfraservGmbhAndCoHochstKGMember_e10eeae3-bfb9-492e-8bdd-c1819c6243a7" xlink:href="sny-20221231.xsd#sny_InfraservGmbhAndCoHochstKGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_d9406c73-55c5-4e66-8d58-cc3e0112a9e4" xlink:to="loc_sny_InfraservGmbhAndCoHochstKGMember_e10eeae3-bfb9-492e-8bdd-c1819c6243a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSPVaccineCompanyMember_6d21d936-05de-44c7-973c-2301c2b6d509" xlink:href="sny-20221231.xsd#sny_MSPVaccineCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_d9406c73-55c5-4e66-8d58-cc3e0112a9e4" xlink:to="loc_sny_MSPVaccineCompanyMember_6d21d936-05de-44c7-973c-2301c2b6d509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_80ec66ec-f6cb-45d1-8ecd-34982cd8d5e2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_d9406c73-55c5-4e66-8d58-cc3e0112a9e4" xlink:to="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_80ec66ec-f6cb-45d1-8ecd-34982cd8d5e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_79e49347-e9d5-41ef-8f94-a5a744cf7b07" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_a18c734c-c41e-4a40-af67-1374938a939f" xlink:to="loc_dei_LegalEntityAxis_79e49347-e9d5-41ef-8f94-a5a744cf7b07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_79e49347-e9d5-41ef-8f94-a5a744cf7b07_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_79e49347-e9d5-41ef-8f94-a5a744cf7b07" xlink:to="loc_dei_EntityDomain_79e49347-e9d5-41ef-8f94-a5a744cf7b07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4173cd3e-bf26-4d4e-815c-5c1556609579" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_79e49347-e9d5-41ef-8f94-a5a744cf7b07" xlink:to="loc_dei_EntityDomain_4173cd3e-bf26-4d4e-815c-5c1556609579" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSPVaccineCompanyMember_32fbb505-f47c-4d71-870d-39955576671e" xlink:href="sny-20221231.xsd#sny_MSPVaccineCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4173cd3e-bf26-4d4e-815c-5c1556609579" xlink:to="loc_sny_MSPVaccineCompanyMember_32fbb505-f47c-4d71-870d-39955576671e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails" xlink:type="extended" id="i48d0d90f4cb347afbc959f616f13b8c4_InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_5e1b334e-160e-4a90-ad90-d222a5164acb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:to="loc_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_5e1b334e-160e-4a90-ad90-d222a5164acb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax_1d27a963-916c-429c-a183-806cccd806d7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:to="loc_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax_1d27a963-916c-429c-a183-806cccd806d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures_6dbb0384-e091-4fbe-abb1-f893ea544cbd" xlink:href="sny-20221231.xsd#sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:to="loc_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures_6dbb0384-e091-4fbe-abb1-f893ea544cbd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_d72a7229-7568-43e3-98c8-131198324814" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_d72a7229-7568-43e3-98c8-131198324814" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_e61119c3-3332-4653-a71a-94e48102fc1f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_e61119c3-3332-4653-a71a-94e48102fc1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ddd9f0-d2e7-43fd-b2e3-a2136b2c3a21" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_e61119c3-3332-4653-a71a-94e48102fc1f" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ddd9f0-d2e7-43fd-b2e3-a2136b2c3a21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_85ddd9f0-d2e7-43fd-b2e3-a2136b2c3a21_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ddd9f0-d2e7-43fd-b2e3-a2136b2c3a21" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_85ddd9f0-d2e7-43fd-b2e3-a2136b2c3a21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_a32abb41-fc8b-40ef-9291-36e579a797e3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ddd9f0-d2e7-43fd-b2e3-a2136b2c3a21" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_a32abb41-fc8b-40ef-9291-36e579a797e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssociatesMember_8ec9fb3a-5ae6-4953-a1bc-bbe286594d20" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_a32abb41-fc8b-40ef-9291-36e579a797e3" xlink:to="loc_ifrs-full_AssociatesMember_8ec9fb3a-5ae6-4953-a1bc-bbe286594d20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_89ed00ea-067b-4b68-a4f1-bf57512839ba" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_a32abb41-fc8b-40ef-9291-36e579a797e3" xlink:to="loc_sny_RegeneronMember_89ed00ea-067b-4b68-a4f1-bf57512839ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_01d2b4c5-3554-4ae9-a293-e3b923abe7e2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_e61119c3-3332-4653-a71a-94e48102fc1f" xlink:to="loc_ifrs-full_JointVenturesAxis_01d2b4c5-3554-4ae9-a293-e3b923abe7e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_01d2b4c5-3554-4ae9-a293-e3b923abe7e2_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointVenturesAxis_01d2b4c5-3554-4ae9-a293-e3b923abe7e2" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_01d2b4c5-3554-4ae9-a293-e3b923abe7e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_45bde043-2f3b-4bd2-803f-54c3c9c12f9b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointVenturesAxis_01d2b4c5-3554-4ae9-a293-e3b923abe7e2" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_45bde043-2f3b-4bd2-803f-54c3c9c12f9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesMember_6691c8f6-4a2a-4368-aed9-f0a0e0abf72c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_45bde043-2f3b-4bd2-803f-54c3c9c12f9b" xlink:to="loc_ifrs-full_JointVenturesMember_6691c8f6-4a2a-4368-aed9-f0a0e0abf72c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails" xlink:type="extended" id="ibd9abf46f5514b3aa93fb72407d2736a_InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_970673bb-59d6-4b05-949a-64fc967867a9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_970673bb-59d6-4b05-949a-64fc967867a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions_a1cb8eb0-fb93-4f57-a8be-71c3d568718d" xlink:href="sny-20221231.xsd#sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:to="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions_a1cb8eb0-fb93-4f57-a8be-71c3d568718d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_d4c9eec9-6f29-4b07-96ef-e6f049d23781" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:to="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_d4c9eec9-6f29-4b07-96ef-e6f049d23781" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions_cdb754af-90d4-4c79-9ea2-3b9de85c1e4f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchasesOfGoodsRelatedPartyTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:to="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions_cdb754af-90d4-4c79-9ea2-3b9de85c1e4f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_f2f241e5-d77d-4ad5-8b48-9e53e9950472" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_f2f241e5-d77d-4ad5-8b48-9e53e9950472" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_84ba22ea-faaf-49b5-b284-f0fa07b2e65c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_84ba22ea-faaf-49b5-b284-f0fa07b2e65c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7bfe54cd-4287-4476-bd5b-2f69ec256acd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_84ba22ea-faaf-49b5-b284-f0fa07b2e65c" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7bfe54cd-4287-4476-bd5b-2f69ec256acd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_7bfe54cd-4287-4476-bd5b-2f69ec256acd_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7bfe54cd-4287-4476-bd5b-2f69ec256acd" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_7bfe54cd-4287-4476-bd5b-2f69ec256acd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_a7e065cd-87c7-4619-a59b-137d35337861" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7bfe54cd-4287-4476-bd5b-2f69ec256acd" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_a7e065cd-87c7-4619-a59b-137d35337861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AssociatesAndJointVenturesMember_4db28631-672a-48f8-9d00-f3dd4ae664f2" xlink:href="sny-20221231.xsd#sny_AssociatesAndJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_a7e065cd-87c7-4619-a59b-137d35337861" xlink:to="loc_sny_AssociatesAndJointVenturesMember_4db28631-672a-48f8-9d00-f3dd4ae664f2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails" xlink:type="extended" id="i5ea4787a3b044145a2b42fe60929ad0e_InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_a5e11ac4-e708-4df5-83eb-7e14328454de" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsMadeToJointVenturesAndAssociates_25701ed3-9f82-41d5-81a5-f402b4c510d7" xlink:href="sny-20221231.xsd#sny_CommitmentsMadeToJointVenturesAndAssociates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_a5e11ac4-e708-4df5-83eb-7e14328454de" xlink:to="loc_sny_CommitmentsMadeToJointVenturesAndAssociates_25701ed3-9f82-41d5-81a5-f402b4c510d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_297df12c-a1c6-4fd4-9246-ea64bca0d60a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_a5e11ac4-e708-4df5-83eb-7e14328454de" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_297df12c-a1c6-4fd4-9246-ea64bca0d60a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_e02618b4-7119-4f90-9d82-68b616920193" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_297df12c-a1c6-4fd4-9246-ea64bca0d60a" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_e02618b4-7119-4f90-9d82-68b616920193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_e02618b4-7119-4f90-9d82-68b616920193_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_e02618b4-7119-4f90-9d82-68b616920193" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_e02618b4-7119-4f90-9d82-68b616920193_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_e1ea62b2-07be-4edd-9ed0-b574f9eba10a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_e02618b4-7119-4f90-9d82-68b616920193" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_e1ea62b2-07be-4edd-9ed0-b574f9eba10a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AssociatesAndJointVenturesMember_70a43fc3-032a-44cc-ab73-45cbc80bbfe2" xlink:href="sny-20221231.xsd#sny_AssociatesAndJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_e1ea62b2-07be-4edd-9ed0-b574f9eba10a" xlink:to="loc_sny_AssociatesAndJointVenturesMember_70a43fc3-032a-44cc-ab73-45cbc80bbfe2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_17e22aca-f857-45f9-9276-c52ef5c9f4c4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_297df12c-a1c6-4fd4-9246-ea64bca0d60a" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_17e22aca-f857-45f9-9276-c52ef5c9f4c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_17e22aca-f857-45f9-9276-c52ef5c9f4c4_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_17e22aca-f857-45f9-9276-c52ef5c9f4c4" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_17e22aca-f857-45f9-9276-c52ef5c9f4c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_efe3ee94-18b9-49eb-ad7f-cbdeb9e237e5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_17e22aca-f857-45f9-9276-c52ef5c9f4c4" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_efe3ee94-18b9-49eb-ad7f-cbdeb9e237e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_4c9c6973-3376-409e-9970-3af2932859c1" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_efe3ee94-18b9-49eb-ad7f-cbdeb9e237e5" xlink:to="loc_sny_RegeneronMember_4c9c6973-3376-409e-9970-3af2932859c1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails" xlink:type="extended" id="i6c8b106fdd7d4f919f51035f75ef605c_OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherNonCurrentAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_8eb22d92-4044-4d57-8bf7-b203d3d73f91" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_8eb22d92-4044-4d57-8bf7-b203d3d73f91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_34e6d336-b3fd-4c22-9607-f5a82953fb21" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_34e6d336-b3fd-4c22-9607-f5a82953fb21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PreFundedPensionObligations_0c7fc9c4-36d0-4c77-8f4e-a49ad65e9ea2" xlink:href="sny-20221231.xsd#sny_PreFundedPensionObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_sny_PreFundedPensionObligations_0c7fc9c4-36d0-4c77-8f4e-a49ad65e9ea2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LongTermPrepaidExpenses_b76b2124-3aac-4973-b5a0-4f9c3ff8bcf0" xlink:href="sny-20221231.xsd#sny_LongTermPrepaidExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_sny_LongTermPrepaidExpenses_b76b2124-3aac-4973-b5a0-4f9c3ff8bcf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLoansAndReceivables_11c35af1-ca64-47f4-8012-82af05cdb7a4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLoansAndReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_NoncurrentLoansAndReceivables_11c35af1-ca64-47f4-8012-82af05cdb7a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_18af2510-651f-4766-95a5-fbb9ca863a94" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_18af2510-651f-4766-95a5-fbb9ca863a94" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_305faf82-584f-47a2-8f85-7f44aa42887b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_305faf82-584f-47a2-8f85-7f44aa42887b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UpfrontPayments_eb5577bd-2131-48b1-8508-de36466a65c6" xlink:href="sny-20221231.xsd#sny_UpfrontPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_sny_UpfrontPayments_eb5577bd-2131-48b1-8508-de36466a65c6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_e919ead8-b828-4ab1-9e17-3504b0b20097" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinanceLeaseReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_e919ead8-b828-4ab1-9e17-3504b0b20097" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinanceLeaseReceivablesGross_feb566d9-3f4d-48ec-9bcf-9432fc55a255" xlink:href="sny-20221231.xsd#sny_NonCurrentFinanceLeaseReceivablesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_sny_NonCurrentFinanceLeaseReceivablesGross_feb566d9-3f4d-48ec-9bcf-9432fc55a255" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_fb795fba-134f-4d63-aec6-fba3202cfa68" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherNoncurrentAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_fb795fba-134f-4d63-aec6-fba3202cfa68" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_aada3497-a9db-4154-9270-1265e3e4d8c5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_fb795fba-134f-4d63-aec6-fba3202cfa68" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_aada3497-a9db-4154-9270-1265e3e4d8c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_aada3497-a9db-4154-9270-1265e3e4d8c5_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_aada3497-a9db-4154-9270-1265e3e4d8c5" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_aada3497-a9db-4154-9270-1265e3e4d8c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_e9e42c60-e4d5-471b-8fdd-e6d60f73202c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_aada3497-a9db-4154-9270-1265e3e4d8c5" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_e9e42c60-e4d5-471b-8fdd-e6d60f73202c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradingEquitySecuritiesMember_0587fdf5-2f60-4e5b-b1b1-9ef140f30e8c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradingEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e9e42c60-e4d5-471b-8fdd-e6d60f73202c" xlink:to="loc_ifrs-full_TradingEquitySecuritiesMember_0587fdf5-2f60-4e5b-b1b1-9ef140f30e8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DebtSecuritiesMember_d04ee1c1-82b8-43f5-9fb1-433a272b7111" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e9e42c60-e4d5-471b-8fdd-e6d60f73202c" xlink:to="loc_ifrs-full_DebtSecuritiesMember_d04ee1c1-82b8-43f5-9fb1-433a272b7111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_3efb3eb5-a10e-473c-935a-91c829cf3710" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_fb795fba-134f-4d63-aec6-fba3202cfa68" xlink:to="loc_ifrs-full_CounterpartiesAxis_3efb3eb5-a10e-473c-935a-91c829cf3710" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_3efb3eb5-a10e-473c-935a-91c829cf3710_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_3efb3eb5-a10e-473c-935a-91c829cf3710" xlink:to="loc_ifrs-full_CounterpartiesMember_3efb3eb5-a10e-473c-935a-91c829cf3710_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_e04a1fdb-0b1c-4dc9-be6e-88d5b59268b2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_3efb3eb5-a10e-473c-935a-91c829cf3710" xlink:to="loc_ifrs-full_CounterpartiesMember_e04a1fdb-0b1c-4dc9-be6e-88d5b59268b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExscientiaMember_d11cfcc7-b03d-43ba-aeaf-52e33d91bb6e" xlink:href="sny-20221231.xsd#sny_ExscientiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_e04a1fdb-0b1c-4dc9-be6e-88d5b59268b2" xlink:to="loc_sny_ExscientiaMember_d11cfcc7-b03d-43ba-aeaf-52e33d91bb6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IGMBiosciencesIncMember_419d6551-16d7-4063-af20-1d72f1ee62b8" xlink:href="sny-20221231.xsd#sny_IGMBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_e04a1fdb-0b1c-4dc9-be6e-88d5b59268b2" xlink:to="loc_sny_IGMBiosciencesIncMember_419d6551-16d7-4063-af20-1d72f1ee62b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OthernoncurrentassetsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails" xlink:type="extended" id="i4afed93f91e24871bf2e4ac1c1455130_OthernoncurrentassetsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherNonCurrentAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_dbf97c8b-47db-43de-96bf-5b109eeda73a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_dbf97c8b-47db-43de-96bf-5b109eeda73a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_e15b1ca8-8a56-4a68-a887-a606319d7e81" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_e15b1ca8-8a56-4a68-a887-a606319d7e81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount_085d7e41-b126-4f49-a95d-a20852e93b2a" xlink:href="sny-20221231.xsd#sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount_085d7e41-b126-4f49-a95d-a20852e93b2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage_57b2810e-bf15-4119-b6a8-31d9c8cdc77c" xlink:href="sny-20221231.xsd#sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage_57b2810e-bf15-4119-b6a8-31d9c8cdc77c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_f2e2ac66-ce2d-4418-b6b8-f4d16ceedf0e" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_f2e2ac66-ce2d-4418-b6b8-f4d16ceedf0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinancialAssetsNumberOfShares_5dde6370-95f9-4930-996e-4aace06e0cac" xlink:href="sny-20221231.xsd#sny_NonCurrentFinancialAssetsNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_NonCurrentFinancialAssetsNumberOfShares_5dde6370-95f9-4930-996e-4aace06e0cac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_0c83a5b1-770e-44aa-8e71-b38fcbd5c439" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_0c83a5b1-770e-44aa-8e71-b38fcbd5c439" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount_345ccef1-8f9f-426c-89ef-d01d132bb3b1" xlink:href="sny-20221231.xsd#sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount_345ccef1-8f9f-426c-89ef-d01d132bb3b1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome_82bc0874-1113-44bf-9a7d-d6e7a9f55733" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome_82bc0874-1113-44bf-9a7d-d6e7a9f55733" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_5aa69dda-0e8b-4077-ba44-887dce8d9c81" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_5aa69dda-0e8b-4077-ba44-887dce8d9c81" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HeldtomaturityInvestments_e4e29293-1132-4612-8227-f47e8f553917" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HeldtomaturityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_HeldtomaturityInvestments_e4e29293-1132-4612-8227-f47e8f553917" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeBeforeTax_dce395b0-ada9-4ba9-bed9-b57efb17f02e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeBeforeTax_dce395b0-ada9-4ba9-bed9-b57efb17f02e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity_c25bad3f-0383-47db-8a7e-2cc06b3d7c73" xlink:href="sny-20221231.xsd#sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity_c25bad3f-0383-47db-8a7e-2cc06b3d7c73" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseInContingentConsideration_e065198b-d352-42d3-a259-cb7acf1bb29a" xlink:href="sny-20221231.xsd#sny_IncreaseInContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_IncreaseInContingentConsideration_e065198b-d352-42d3-a259-cb7acf1bb29a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfTheContingentConsideration_7d9e5288-2739-45d2-8c5d-6deefa75a56e" xlink:href="sny-20221231.xsd#sny_FairValueOfTheContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_FairValueOfTheContingentConsideration_7d9e5288-2739-45d2-8c5d-6deefa75a56e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInvestments_e807b42e-c3a5-470d-b376-f6f876ea8415" xlink:href="sny-20221231.xsd#sny_FinancialInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_FinancialInvestments_e807b42e-c3a5-470d-b376-f6f876ea8415" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_a170a844-97cb-4e64-b116-3fa442af815e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_FinancialAssets_a170a844-97cb-4e64-b116-3fa442af815e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_699fd325-1785-48f1-8aa2-f6d9272de008" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_699fd325-1785-48f1-8aa2-f6d9272de008" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalGroupGainOnDisposal_53276f56-c9d6-494c-b6fc-4e8ae3c22bd1" xlink:href="sny-20221231.xsd#sny_DisposalGroupGainOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_DisposalGroupGainOnDisposal_53276f56-c9d6-494c-b6fc-4e8ae3c22bd1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherNoncurrentAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_4764099f-5d4a-4831-8c44-69f96e8aec7a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_4764099f-5d4a-4831-8c44-69f96e8aec7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_4764099f-5d4a-4831-8c44-69f96e8aec7a_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_4764099f-5d4a-4831-8c44-69f96e8aec7a" xlink:to="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_4764099f-5d4a-4831-8c44-69f96e8aec7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_4764099f-5d4a-4831-8c44-69f96e8aec7a" xlink:to="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_a0b4de84-5c8f-454c-85e7-4963f805de84" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:to="loc_sny_TranslateBioMember_a0b4de84-5c8f-454c-85e7-4963f805de84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_c6724348-8790-4f27-b6f8-2475bff28fda" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:to="loc_sny_RegeneronMember_c6724348-8790-4f27-b6f8-2475bff28fda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InnoventBiologicsMember_8b43e218-349e-47dc-900e-57bcb74603a3" xlink:href="sny-20221231.xsd#sny_InnoventBiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:to="loc_sny_InnoventBiologicsMember_8b43e218-349e-47dc-900e-57bcb74603a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssociatesMember_70c3b67e-0ade-4f2c-9556-6ece3e368df6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:to="loc_ifrs-full_AssociatesMember_70c3b67e-0ade-4f2c-9556-6ece3e368df6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_9650ca02-9f3e-4f33-ade4-d755adb1d306" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_9650ca02-9f3e-4f33-ade4-d755adb1d306" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_9650ca02-9f3e-4f33-ade4-d755adb1d306_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_9650ca02-9f3e-4f33-ade4-d755adb1d306" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_9650ca02-9f3e-4f33-ade4-d755adb1d306_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_87bafe4a-470d-4959-baea-f9e7e1bfb01c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_9650ca02-9f3e-4f33-ade4-d755adb1d306" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_87bafe4a-470d-4959-baea-f9e7e1bfb01c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_ceb7f705-f525-443a-8104-bbdd3fed56f6" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_87bafe4a-470d-4959-baea-f9e7e1bfb01c" xlink:to="loc_sny_TranslateBioMember_ceb7f705-f525-443a-8104-bbdd3fed56f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_f7e7c6a2-c9cb-46e3-ae9c-48d202eb6b90" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_MeasurementAxis_f7e7c6a2-c9cb-46e3-ae9c-48d202eb6b90" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_f7e7c6a2-c9cb-46e3-ae9c-48d202eb6b90_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_f7e7c6a2-c9cb-46e3-ae9c-48d202eb6b90" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_f7e7c6a2-c9cb-46e3-ae9c-48d202eb6b90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_bca1901a-81e0-4b3d-9e94-a75cf46c8c40" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_f7e7c6a2-c9cb-46e3-ae9c-48d202eb6b90" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_bca1901a-81e0-4b3d-9e94-a75cf46c8c40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember_4df90258-cff7-4c2f-85bc-b31b12673887" xlink:href="sny-20221231.xsd#sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_bca1901a-81e0-4b3d-9e94-a75cf46c8c40" xlink:to="loc_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember_4df90258-cff7-4c2f-85bc-b31b12673887" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_09bb5290-7a7f-4d37-b42f-03da35fbfa96" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_09bb5290-7a7f-4d37-b42f-03da35fbfa96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_09bb5290-7a7f-4d37-b42f-03da35fbfa96_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_09bb5290-7a7f-4d37-b42f-03da35fbfa96" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_09bb5290-7a7f-4d37-b42f-03da35fbfa96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_09bb5290-7a7f-4d37-b42f-03da35fbfa96" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradingEquitySecuritiesMember_ac18c564-bcda-4404-88b8-d8badc69454b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradingEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_ifrs-full_TradingEquitySecuritiesMember_ac18c564-bcda-4404-88b8-d8badc69454b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnquotedEquityInvestmentsMember_40bd1f93-9712-4f72-a219-8a615773ac53" xlink:href="sny-20221231.xsd#sny_UnquotedEquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_UnquotedEquityInvestmentsMember_40bd1f93-9712-4f72-a219-8a615773ac53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentsMember_ee499cd8-a7ff-457a-9db8-621b8452f270" xlink:href="sny-20221231.xsd#sny_DebtInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_DebtInstrumentsMember_ee499cd8-a7ff-457a-9db8-621b8452f270" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedDebtInstrumentsMember_2d9cbb92-17e2-4227-a1ba-66385ee37cfa" xlink:href="sny-20221231.xsd#sny_QuotedDebtInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_QuotedDebtInstrumentsMember_2d9cbb92-17e2-4227-a1ba-66385ee37cfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedEquitySecuritiesMember_8d57b9a9-2bdb-4bc8-88d8-270b7a07d584" xlink:href="sny-20221231.xsd#sny_QuotedEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_QuotedEquitySecuritiesMember_8d57b9a9-2bdb-4bc8-88d8-270b7a07d584" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SPMSDContingentConsiderationAssetMember_29b06553-71b7-41b6-94a3-b6eaadaa5d6a" xlink:href="sny-20221231.xsd#sny_SPMSDContingentConsiderationAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_SPMSDContingentConsiderationAssetMember_29b06553-71b7-41b6-94a3-b6eaadaa5d6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentAssetMember_eadeedbf-7b3b-4cab-a1ca-0ad609f684ec" xlink:href="sny-20221231.xsd#sny_NonCurrentAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_NonCurrentAssetMember_eadeedbf-7b3b-4cab-a1ca-0ad609f684ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnquotedDebtSecuritiesMember_1c8ba04a-49bb-4676-a2ed-83d6055fa7e7" xlink:href="sny-20221231.xsd#sny_UnquotedDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_UnquotedDebtSecuritiesMember_1c8ba04a-49bb-4676-a2ed-83d6055fa7e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e1297835-45c2-4f3b-965a-41e1062269dc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e1297835-45c2-4f3b-965a-41e1062269dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_e1297835-45c2-4f3b-965a-41e1062269dc_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e1297835-45c2-4f3b-965a-41e1062269dc" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_e1297835-45c2-4f3b-965a-41e1062269dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_b0c48d81-d1c3-40e1-a36d-73e7a67bd93c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e1297835-45c2-4f3b-965a-41e1062269dc" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_b0c48d81-d1c3-40e1-a36d-73e7a67bd93c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedEuroDenominatedSeniorBondsMember_f29e4800-8508-4fe7-ba6f-149194020fb1" xlink:href="sny-20221231.xsd#sny_QuotedEuroDenominatedSeniorBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_b0c48d81-d1c3-40e1-a36d-73e7a67bd93c" xlink:to="loc_sny_QuotedEuroDenominatedSeniorBondsMember_f29e4800-8508-4fe7-ba6f-149194020fb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SeniorBondMember_c8f593e6-dfb6-4fef-baee-abeb251df48e" xlink:href="sny-20221231.xsd#sny_SeniorBondMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_b0c48d81-d1c3-40e1-a36d-73e7a67bd93c" xlink:to="loc_sny_SeniorBondMember_c8f593e6-dfb6-4fef-baee-abeb251df48e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember_018e6782-cc78-4e59-89ea-5ec40726842f" xlink:href="sny-20221231.xsd#sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_b0c48d81-d1c3-40e1-a36d-73e7a67bd93c" xlink:to="loc_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember_018e6782-cc78-4e59-89ea-5ec40726842f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_fab303b6-d972-4b0e-8810-39c4bc07b11f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_fab303b6-d972-4b0e-8810-39c4bc07b11f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_fab303b6-d972-4b0e-8810-39c4bc07b11f_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_fab303b6-d972-4b0e-8810-39c4bc07b11f" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_fab303b6-d972-4b0e-8810-39c4bc07b11f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_d0dea960-fae7-4f31-9d55-00eac327854b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_fab303b6-d972-4b0e-8810-39c4bc07b11f" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_d0dea960-fae7-4f31-9d55-00eac327854b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_bc19ac43-6a75-4609-b987-538681607915" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_d0dea960-fae7-4f31-9d55-00eac327854b" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_bc19ac43-6a75-4609-b987-538681607915" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis_60ffb441-b6d6-45a3-ae06-fe3bada27515" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis_60ffb441-b6d6-45a3-ae06-fe3bada27515" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember_60ffb441-b6d6-45a3-ae06-fe3bada27515_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis_60ffb441-b6d6-45a3-ae06-fe3bada27515" xlink:to="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember_60ffb441-b6d6-45a3-ae06-fe3bada27515_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember_50e18a80-e3ee-42a8-a50d-52f739ab4ad8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis_60ffb441-b6d6-45a3-ae06-fe3bada27515" xlink:to="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember_50e18a80-e3ee-42a8-a50d-52f739ab4ad8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfSPMSDContingentConsiderationMember_e066e06e-403e-4645-9cdd-50e5096322d5" xlink:href="sny-20221231.xsd#sny_FairValueOfSPMSDContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember_50e18a80-e3ee-42a8-a50d-52f739ab4ad8" xlink:to="loc_sny_FairValueOfSPMSDContingentConsiderationMember_e066e06e-403e-4645-9cdd-50e5096322d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalGroupNameAxis_6e844b95-d7ee-4f63-b07a-5875229e9c29" xlink:href="sny-20221231.xsd#sny_DisposalGroupNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_sny_DisposalGroupNameAxis_6e844b95-d7ee-4f63-b07a-5875229e9c29" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalGroupNameDomain_6e844b95-d7ee-4f63-b07a-5875229e9c29_default" xlink:href="sny-20221231.xsd#sny_DisposalGroupNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_DisposalGroupNameAxis_6e844b95-d7ee-4f63-b07a-5875229e9c29" xlink:to="loc_sny_DisposalGroupNameDomain_6e844b95-d7ee-4f63-b07a-5875229e9c29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalGroupNameDomain_ea40158b-f963-4536-9e65-b8df79f6be16" xlink:href="sny-20221231.xsd#sny_DisposalGroupNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_DisposalGroupNameAxis_6e844b95-d7ee-4f63-b07a-5875229e9c29" xlink:to="loc_sny_DisposalGroupNameDomain_ea40158b-f963-4536-9e65-b8df79f6be16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OnduoMember_29e3a38f-6ae3-40da-abb1-994d426fa794" xlink:href="sny-20221231.xsd#sny_OnduoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisposalGroupNameDomain_ea40158b-f963-4536-9e65-b8df79f6be16" xlink:to="loc_sny_OnduoMember_29e3a38f-6ae3-40da-abb1-994d426fa794" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InventoriesScheduleofInventoriesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="extended" id="id727a462a9d746169f21cf4d3e0c33bd_InventoriesScheduleofInventoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:href="sny-20221231.xsd#sny_DisclosureOfInventoriesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RawMaterials_f1440e43-7a33-4e95-9574-47ec073225f6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RawMaterials"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:to="loc_ifrs-full_RawMaterials_f1440e43-7a33-4e95-9574-47ec073225f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WorkInProgress_5624e384-e65e-4d96-bd60-ac80c75b1d53" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WorkInProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:to="loc_ifrs-full_WorkInProgress_5624e384-e65e-4d96-bd60-ac80c75b1d53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinishedGoods_c2d35c30-f5a4-40ab-82c3-c4dea9944f51" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinishedGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:to="loc_ifrs-full_FinishedGoods_c2d35c30-f5a4-40ab-82c3-c4dea9944f51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_731363b8-4976-4e81-a03c-eaf77616ad7d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:to="loc_ifrs-full_Inventories_731363b8-4976-4e81-a03c-eaf77616ad7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInventoriesTable_8855169a-2c2a-49de-86ed-e176f468f16b" xlink:href="sny-20221231.xsd#sny_DisclosureOfInventoriesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:to="loc_sny_DisclosureOfInventoriesTable_8855169a-2c2a-49de-86ed-e176f468f16b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_fc47f4bd-7ca4-4681-852b-c6af34d8618c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfInventoriesTable_8855169a-2c2a-49de-86ed-e176f468f16b" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_fc47f4bd-7ca4-4681-852b-c6af34d8618c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_fc47f4bd-7ca4-4681-852b-c6af34d8618c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_fc47f4bd-7ca4-4681-852b-c6af34d8618c" xlink:to="loc_ifrs-full_CarryingAmountMember_fc47f4bd-7ca4-4681-852b-c6af34d8618c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_c8942f00-0117-4b2c-9207-0e4bf6cdc9ed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_fc47f4bd-7ca4-4681-852b-c6af34d8618c" xlink:to="loc_ifrs-full_CarryingAmountMember_c8942f00-0117-4b2c-9207-0e4bf6cdc9ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_88856198-1d2e-4eaa-9c45-12bf409d60ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_c8942f00-0117-4b2c-9207-0e4bf6cdc9ed" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_88856198-1d2e-4eaa-9c45-12bf409d60ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WriteDownMember_d2754e44-e211-48d3-bce9-667b0b9d6fed" xlink:href="sny-20221231.xsd#sny_WriteDownMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_c8942f00-0117-4b2c-9207-0e4bf6cdc9ed" xlink:to="loc_sny_WriteDownMember_d2754e44-e211-48d3-bce9-667b0b9d6fed" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#AccountsreceivableSummaryofAccountsReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails" xlink:type="extended" id="iaf9ec1bce6f0425682e5f9076bfcf423_AccountsreceivableSummaryofAccountsReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAccountsReceivableLineItems_6b98e41d-629c-4ae8-baa7-bc25c942d18d" xlink:href="sny-20221231.xsd#sny_DisclosureOfAccountsReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTradeReceivables_2d5c6da2-c0f1-40d9-9db4-e5ad7432ba43" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAccountsReceivableLineItems_6b98e41d-629c-4ae8-baa7-bc25c942d18d" xlink:to="loc_ifrs-full_CurrentTradeReceivables_2d5c6da2-c0f1-40d9-9db4-e5ad7432ba43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAccountsReceivableTable_84d40e94-8fc0-4626-b4da-af6e333bf293" xlink:href="sny-20221231.xsd#sny_DisclosureOfAccountsReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfAccountsReceivableLineItems_6b98e41d-629c-4ae8-baa7-bc25c942d18d" xlink:to="loc_sny_DisclosureOfAccountsReceivableTable_84d40e94-8fc0-4626-b4da-af6e333bf293" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_39c31169-f499-429a-8eed-afb6d3b6c79d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfAccountsReceivableTable_84d40e94-8fc0-4626-b4da-af6e333bf293" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_39c31169-f499-429a-8eed-afb6d3b6c79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_39c31169-f499-429a-8eed-afb6d3b6c79d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_39c31169-f499-429a-8eed-afb6d3b6c79d" xlink:to="loc_ifrs-full_CarryingAmountMember_39c31169-f499-429a-8eed-afb6d3b6c79d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_604a3b51-0688-4f0f-9887-f8a625f29387" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_39c31169-f499-429a-8eed-afb6d3b6c79d" xlink:to="loc_ifrs-full_CarryingAmountMember_604a3b51-0688-4f0f-9887-f8a625f29387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_833250da-231b-4ef9-8f2d-521056b65293" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_604a3b51-0688-4f0f-9887-f8a625f29387" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_833250da-231b-4ef9-8f2d-521056b65293" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllowanceForCreditLossesMember_f0d35f3f-dbe8-42af-9d6a-2e376c2c08a7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllowanceForCreditLossesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_604a3b51-0688-4f0f-9887-f8a625f29387" xlink:to="loc_ifrs-full_AllowanceForCreditLossesMember_f0d35f3f-dbe8-42af-9d6a-2e376c2c08a7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails" xlink:type="extended" id="i8208a1e2e2de4c9fab4877fa955741d5_AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_369d2d3a-3164-49de-94c8-63ac81ab11d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OverdueReceivablesGrossValue_8af8f64f-d020-4712-95c1-84fb2234ca41" xlink:href="sny-20221231.xsd#sny_OverdueReceivablesGrossValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_369d2d3a-3164-49de-94c8-63ac81ab11d0" xlink:to="loc_sny_OverdueReceivablesGrossValue_8af8f64f-d020-4712-95c1-84fb2234ca41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_aa1a9373-b620-4b5a-9c84-2b1a27f9989a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_369d2d3a-3164-49de-94c8-63ac81ab11d0" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_aa1a9373-b620-4b5a-9c84-2b1a27f9989a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_94d1f8ce-0186-4a63-a497-364a52cbea62" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_aa1a9373-b620-4b5a-9c84-2b1a27f9989a" xlink:to="loc_ifrs-full_MaturityAxis_94d1f8ce-0186-4a63-a497-364a52cbea62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_94d1f8ce-0186-4a63-a497-364a52cbea62_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_94d1f8ce-0186-4a63-a497-364a52cbea62" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_94d1f8ce-0186-4a63-a497-364a52cbea62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_94d1f8ce-0186-4a63-a497-364a52cbea62" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneMonthMember_1b9e9c57-a7cd-478c-8b65-3e4851972da6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneMonthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:to="loc_ifrs-full_NotLaterThanOneMonthMember_1b9e9c57-a7cd-478c-8b65-3e4851972da6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_39ff0485-83d7-4328-b15e-17437b1cc536" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:to="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_39ff0485-83d7-4328-b15e-17437b1cc536" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_af94bc80-2076-486a-9da2-001764093e90" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:to="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_af94bc80-2076-486a-9da2-001764093e90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_a2966216-12a4-4f71-8a91-ab0162b16b7a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:to="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_a2966216-12a4-4f71-8a91-ab0162b16b7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearMember_32bdc2fb-86d7-452f-9bc7-865ea5c50acb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:to="loc_ifrs-full_LaterThanOneYearMember_32bdc2fb-86d7-452f-9bc7-865ea5c50acb" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended" id="iaab2edfb0f8d45989e70d7c9664e3fea_FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInformationOnIncomeStatementLineItems_6d6ddab8-060d-43da-92c4-1af288b0d4e3" xlink:href="sny-20221231.xsd#sny_DisclosureOfInformationOnIncomeStatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_1bb35890-a182-4ce8-8337-60ecb187218f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInformationOnIncomeStatementLineItems_6d6ddab8-060d-43da-92c4-1af288b0d4e3" xlink:to="loc_ifrs-full_FinancialAssets_1bb35890-a182-4ce8-8337-60ecb187218f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_57a0b665-3b74-468e-9854-9371bc0f4a39" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInformationOnIncomeStatementLineItems_6d6ddab8-060d-43da-92c4-1af288b0d4e3" xlink:to="loc_ifrs-full_FinancialLiabilities_57a0b665-3b74-468e-9854-9371bc0f4a39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_485264d8-682a-4872-a863-15f4d1dc6e8e" xlink:href="sny-20221231.xsd#sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfInformationOnIncomeStatementLineItems_6d6ddab8-060d-43da-92c4-1af288b0d4e3" xlink:to="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_485264d8-682a-4872-a863-15f4d1dc6e8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_55e06c5c-da61-4cd4-b606-230d59e2206c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_485264d8-682a-4872-a863-15f4d1dc6e8e" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_55e06c5c-da61-4cd4-b606-230d59e2206c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_55e06c5c-da61-4cd4-b606-230d59e2206c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_55e06c5c-da61-4cd4-b606-230d59e2206c" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_55e06c5c-da61-4cd4-b606-230d59e2206c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_ff5f8307-a334-400f-8f24-f0f6014cb9bb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_55e06c5c-da61-4cd4-b606-230d59e2206c" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_ff5f8307-a334-400f-8f24-f0f6014cb9bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_b6be3135-ce5a-4b0d-b410-ca29a263651d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_ff5f8307-a334-400f-8f24-f0f6014cb9bb" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_b6be3135-ce5a-4b0d-b410-ca29a263651d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_6fcce768-5d0a-4c1e-b3d2-de308497a0f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_ff5f8307-a334-400f-8f24-f0f6014cb9bb" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_6fcce768-5d0a-4c1e-b3d2-de308497a0f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_7dbc3a82-6f57-4abc-8a72-7d1ba1b16b47" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_ff5f8307-a334-400f-8f24-f0f6014cb9bb" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_7dbc3a82-6f57-4abc-8a72-7d1ba1b16b47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_7efde3df-d2f7-43c1-a0aa-0068416a72b5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_485264d8-682a-4872-a863-15f4d1dc6e8e" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_7efde3df-d2f7-43c1-a0aa-0068416a72b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_7efde3df-d2f7-43c1-a0aa-0068416a72b5_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_7efde3df-d2f7-43c1-a0aa-0068416a72b5" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_7efde3df-d2f7-43c1-a0aa-0068416a72b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_7efde3df-d2f7-43c1-a0aa-0068416a72b5" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedEquityInvestmentsMember_71863415-bc69-424d-a11d-ee3d0b158906" xlink:href="sny-20221231.xsd#sny_QuotedEquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_QuotedEquityInvestmentsMember_71863415-bc69-424d-a11d-ee3d0b158906" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnquotedEquityInvestmentsMember_430a4fad-db37-4ce8-9683-32593489d058" xlink:href="sny-20221231.xsd#sny_UnquotedEquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_UnquotedEquityInvestmentsMember_430a4fad-db37-4ce8-9683-32593489d058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedDebtSecuritiesMember_f2e696f4-a0c1-4908-833b-e29128b0f5f9" xlink:href="sny-20221231.xsd#sny_QuotedDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_QuotedDebtSecuritiesMember_f2e696f4-a0c1-4908-833b-e29128b0f5f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnquotedDebtSecuritiesMember_2e2b1ae3-8ab2-4bc1-a45c-c18acd5601fa" xlink:href="sny-20221231.xsd#sny_UnquotedDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_UnquotedDebtSecuritiesMember_2e2b1ae3-8ab2-4bc1-a45c-c18acd5601fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationRelatingToDivestmentsMember_60868a05-5feb-4def-a2fb-11d20f9a830c" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationRelatingToDivestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_ContingentConsiderationRelatingToDivestmentsMember_60868a05-5feb-4def-a2fb-11d20f9a830c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember_f5e9b4a7-e2c0-4144-a7bc-c983785f353a" xlink:href="sny-20221231.xsd#sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember_f5e9b4a7-e2c0-4144-a7bc-c983785f353a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentDerivativesMember_4fa43b37-fbda-435f-b3d6-fdbe4f7c5851" xlink:href="sny-20221231.xsd#sny_NonCurrentDerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_NonCurrentDerivativesMember_4fa43b37-fbda-435f-b3d6-fdbe4f7c5851" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentDerivativesMember_9a5f8590-ca1b-439f-b65b-b10b58090930" xlink:href="sny-20221231.xsd#sny_CurrentDerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_CurrentDerivativesMember_9a5f8590-ca1b-439f-b65b-b10b58090930" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MutualFundInvestmentsMember_631b1477-b456-4f49-9f27-ebf87d675e62" xlink:href="sny-20221231.xsd#sny_MutualFundInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_MutualFundInvestmentsMember_631b1477-b456-4f49-9f27-ebf87d675e62" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_72b3d47a-cd84-498f-a5c5-cd7e517eccf2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_485264d8-682a-4872-a863-15f4d1dc6e8e" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_72b3d47a-cd84-498f-a5c5-cd7e517eccf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesMember_72b3d47a-cd84-498f-a5c5-cd7e517eccf2_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_72b3d47a-cd84-498f-a5c5-cd7e517eccf2" xlink:to="loc_ifrs-full_LiabilitiesMember_72b3d47a-cd84-498f-a5c5-cd7e517eccf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_72b3d47a-cd84-498f-a5c5-cd7e517eccf2" xlink:to="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember_ce493eed-3a7c-4f1c-9cc1-b067369b92d1" xlink:href="sny-20221231.xsd#sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember_ce493eed-3a7c-4f1c-9cc1-b067369b92d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_355be190-6ce9-40e2-8b74-b68c04c25987" xlink:href="sny-20221231.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_355be190-6ce9-40e2-8b74-b68c04c25987" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationTranslateBioMember_19ce7295-0c05-4a61-b702-1dab5ccb8e9c" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationTranslateBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_ContingentConsiderationTranslateBioMember_19ce7295-0c05-4a61-b702-1dab5ccb8e9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember_dda7637c-bf92-4a8d-9108-47cd08cf8be2" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember_dda7637c-bf92-4a8d-9108-47cd08cf8be2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember_0509f4f6-27d1-47ca-aad6-8fa6a585b229" xlink:href="sny-20221231.xsd#sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember_0509f4f6-27d1-47ca-aad6-8fa6a585b229" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentDerivativesMember_73fbed56-3bbf-488e-ae75-8081e47c5d31" xlink:href="sny-20221231.xsd#sny_NonCurrentDerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_NonCurrentDerivativesMember_73fbed56-3bbf-488e-ae75-8081e47c5d31" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentDerivativesMember_34cf0087-ba1b-4cbf-8760-8692e9953d01" xlink:href="sny-20221231.xsd#sny_CurrentDerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_CurrentDerivativesMember_34cf0087-ba1b-4cbf-8760-8692e9953d01" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails" xlink:type="extended" id="i7522c53938aa40aab392e2ff0182ad30_NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_c6f414b3-735a-43fb-b91c-362251a53cfc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_c6f414b3-735a-43fb-b91c-362251a53cfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_9eb0e111-75ce-4df3-be88-574daccd762f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_9eb0e111-75ce-4df3-be88-574daccd762f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture_4889935c-4e43-4504-9707-7772d28e8229" xlink:href="sny-20221231.xsd#sny_ReservesLikelyToBeDistributedInTheForeseeableFuture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:to="loc_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture_4889935c-4e43-4504-9707-7772d28e8229" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_779f39b3-e1fa-4ce5-bc49-cb24496cfc62" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:to="loc_ifrs-full_DeferredTaxAssets_779f39b3-e1fa-4ce5-bc49-cb24496cfc62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1772c355-e836-4978-9976-94adf0d2468a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1772c355-e836-4978-9976-94adf0d2468a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_eae1dcae-7ab9-4a5a-a269-d0ba22cb5e7e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1772c355-e836-4978-9976-94adf0d2468a" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_eae1dcae-7ab9-4a5a-a269-d0ba22cb5e7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_eae1dcae-7ab9-4a5a-a269-d0ba22cb5e7e_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_eae1dcae-7ab9-4a5a-a269-d0ba22cb5e7e" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_eae1dcae-7ab9-4a5a-a269-d0ba22cb5e7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_eae1dcae-7ab9-4a5a-a269-d0ba22cb5e7e" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember_78ed4079-919d-478d-8199-f39fb79aa422" xlink:href="sny-20221231.xsd#sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember_78ed4079-919d-478d-8199-f39fb79aa422" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember_f4b6b1da-e9fc-47ce-93e7-32cb29edb567" xlink:href="sny-20221231.xsd#sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember_f4b6b1da-e9fc-47ce-93e7-32cb29edb567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember_4079e7f9-0883-4b0b-82ca-629d2e234663" xlink:href="sny-20221231.xsd#sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember_4079e7f9-0883-4b0b-82ca-629d2e234663" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember_d961151a-da34-4db7-a82e-306c10278887" xlink:href="sny-20221231.xsd#sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember_d961151a-da34-4db7-a82e-306c10278887" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember_d644e2fd-2dba-4871-b5b5-72b4ec46b0f7" xlink:href="sny-20221231.xsd#sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember_d644e2fd-2dba-4871-b5b5-72b4ec46b0f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_89e6c545-9ed9-4411-a7ec-ab8f6534e665" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_89e6c545-9ed9-4411-a7ec-ab8f6534e665" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionsAndShareBasedPaymentsMember_fd10f3c5-638f-4ff9-975b-9d0f99dc80b5" xlink:href="sny-20221231.xsd#sny_StockOptionsAndShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_StockOptionsAndShareBasedPaymentsMember_fd10f3c5-638f-4ff9-975b-9d0f99dc80b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember_e3aeab71-5397-4864-8aaa-4cd5c8b8ff70" xlink:href="sny-20221231.xsd#sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember_e3aeab71-5397-4864-8aaa-4cd5c8b8ff70" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_f1d8b6f3-0847-4248-a944-9de8c1722803" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_ifrs-full_OtherTemporaryDifferencesMember_f1d8b6f3-0847-4248-a944-9de8c1722803" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DeferredTaxRelatingToRestructuringProvisionsMember_e72848d3-b512-4167-8d08-009288912906" xlink:href="sny-20221231.xsd#sny_DeferredTaxRelatingToRestructuringProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_DeferredTaxRelatingToRestructuringProvisionsMember_e72848d3-b512-4167-8d08-009288912906" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d57c58ef-74e8-46cd-b21c-912516e7a7e1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1772c355-e836-4978-9976-94adf0d2468a" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d57c58ef-74e8-46cd-b21c-912516e7a7e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_d57c58ef-74e8-46cd-b21c-912516e7a7e1_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d57c58ef-74e8-46cd-b21c-912516e7a7e1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_d57c58ef-74e8-46cd-b21c-912516e7a7e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d57c58ef-74e8-46cd-b21c-912516e7a7e1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativMember_bb86e530-d045-4c64-b28b-0f49ccf3e644" xlink:href="sny-20221231.xsd#sny_BioverativMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_BioverativMember_bb86e530-d045-4c64-b28b-0f49ccf3e644" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipiaBiopharmaIncMember_4bf1134c-0117-4681-8d7d-e77ff69400af" xlink:href="sny-20221231.xsd#sny_PrincipiaBiopharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_PrincipiaBiopharmaIncMember_4bf1134c-0117-4681-8d7d-e77ff69400af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxMember_8c0231d5-665b-4bb8-b241-31c693be8dfb" xlink:href="sny-20221231.xsd#sny_SynthorxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_SynthorxMember_8c0231d5-665b-4bb8-b241-31c693be8dfb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeMember_fcc06918-2c2e-4c90-bfd3-5d567a1e7b5b" xlink:href="sny-20221231.xsd#sny_GenzymeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_GenzymeMember_fcc06918-2c2e-4c90-bfd3-5d567a1e7b5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AblynxMember_6b15a9c9-b9b2-4070-82f0-548792ee85d2" xlink:href="sny-20221231.xsd#sny_AblynxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_AblynxMember_6b15a9c9-b9b2-4070-82f0-548792ee85d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixMember_9e1482de-67a5-4cb2-9e2d-2efe1c4e7165" xlink:href="sny-20221231.xsd#sny_AmunixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_AmunixMember_9e1482de-67a5-4cb2-9e2d-2efe1c4e7165" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails" xlink:type="extended" id="i1ebf0243d70a48fe9b9fd0e62a4b61b7_NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems_84b01f14-25b2-43d4-b71b-ed92e63e416d" xlink:href="sny-20221231.xsd#sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxLossesCarryforwards_5ba4b9ea-e446-4e4c-a51b-4e23d949b3f3" xlink:href="sny-20221231.xsd#sny_TaxLossesCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems_84b01f14-25b2-43d4-b71b-ed92e63e416d" xlink:to="loc_sny_TaxLossesCarryforwards_5ba4b9ea-e446-4e4c-a51b-4e23d949b3f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxLossCarryforwardsOnAssetDisposals_247c10ea-8267-4ebb-a965-66db7fd5c449" xlink:href="sny-20221231.xsd#sny_TaxLossCarryforwardsOnAssetDisposals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems_84b01f14-25b2-43d4-b71b-ed92e63e416d" xlink:to="loc_sny_TaxLossCarryforwardsOnAssetDisposals_247c10ea-8267-4ebb-a965-66db7fd5c449" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable_59918120-0d8a-44e1-8068-e79f637d2e1d" xlink:href="sny-20221231.xsd#sny_DisclosureOfTaxLossesAvailableForCarryforwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems_84b01f14-25b2-43d4-b71b-ed92e63e416d" xlink:to="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable_59918120-0d8a-44e1-8068-e79f637d2e1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_449006c5-1526-463c-90f3-6fd8a25f3cd7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable_59918120-0d8a-44e1-8068-e79f637d2e1d" xlink:to="loc_ifrs-full_MaturityAxis_449006c5-1526-463c-90f3-6fd8a25f3cd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_449006c5-1526-463c-90f3-6fd8a25f3cd7_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_449006c5-1526-463c-90f3-6fd8a25f3cd7" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_449006c5-1526-463c-90f3-6fd8a25f3cd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_449006c5-1526-463c-90f3-6fd8a25f3cd7" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_86c1ca5c-09d6-4e40-82c7-dc8ef6683371" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_86c1ca5c-09d6-4e40-82c7-dc8ef6683371" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_8228e935-6778-4804-a57d-694cbc43cfae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_8228e935-6778-4804-a57d-694cbc43cfae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_e25236fa-da58-499c-83f7-66c82bba78db" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_e25236fa-da58-499c-83f7-66c82bba78db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_cb8c5e73-c261-494e-ae2f-bfcda31e2a5d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_cb8c5e73-c261-494e-ae2f-bfcda31e2a5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_05a3a598-e901-42d8-a91c-2dcd5fc0305a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_05a3a598-e901-42d8-a91c-2dcd5fc0305a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_4ad0b658-7db6-4861-9589-49c41904b525" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_4ad0b658-7db6-4861-9589-49c41904b525" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails" xlink:type="extended" id="i804d6791fb2448a1b50742dd49276ba1_ConsolidatedshareholdersequityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_f4fb0e87-0af7-48d2-be46-2d12ef8ecd40" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_ifrs-full_IssuedCapital_f4fb0e87-0af7-48d2-be46-2d12ef8ecd40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_8626d802-0088-4b1f-b1ab-24c02859b7e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_ifrs-full_NumberOfSharesIssued_8626d802-0088-4b1f-b1ab-24c02859b7e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_de23cc21-4085-4c87-a715-5ee216b67909" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_ifrs-full_ParValuePerShare_de23cc21-4085-4c87-a715-5ee216b67909" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PeriodOfShareRepurchaseProgram_ebcc114c-9f35-45a4-8e5e-dd3eb0b614c7" xlink:href="sny-20221231.xsd#sny_PeriodOfShareRepurchaseProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_sny_PeriodOfShareRepurchaseProgram_ebcc114c-9f35-45a4-8e5e-dd3eb0b614c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax_f7f55d6b-747c-479b-94ce-2b6824322593" xlink:href="sny-20221231.xsd#sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax_f7f55d6b-747c-479b-94ce-2b6824322593" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions_43722fec-93ca-4445-813d-984766a6a9f1" xlink:href="sny-20221231.xsd#sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions_43722fec-93ca-4445-813d-984766a6a9f1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSharesIssuedByExerciceOfEachOption_6f7b4e76-ea4e-4d82-a7a7-d753962a5c7c" xlink:href="sny-20221231.xsd#sny_NumberOfSharesIssuedByExerciceOfEachOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_sny_NumberOfSharesIssuedByExerciceOfEachOption_6f7b4e76-ea4e-4d82-a7a7-d753962a5c7c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionsWithNoDilutiveEffect_1bbe9185-5bf7-4d8d-aad0-2b4a3d96edd9" xlink:href="sny-20221231.xsd#sny_StockOptionsWithNoDilutiveEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_sny_StockOptionsWithNoDilutiveEffect_1bbe9185-5bf7-4d8d-aad0-2b4a3d96edd9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a7f265fe-f821-43cc-8959-01842b19ab28" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a7f265fe-f821-43cc-8959-01842b19ab28" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_9ebd2949-1895-4446-99b1-2ddbdf3e35cb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a7f265fe-f821-43cc-8959-01842b19ab28" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_9ebd2949-1895-4446-99b1-2ddbdf3e35cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_9ebd2949-1895-4446-99b1-2ddbdf3e35cb_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_9ebd2949-1895-4446-99b1-2ddbdf3e35cb" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_9ebd2949-1895-4446-99b1-2ddbdf3e35cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_444e4d58-27c2-4d79-a04a-04291ee5e9ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_9ebd2949-1895-4446-99b1-2ddbdf3e35cb" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_444e4d58-27c2-4d79-a04a-04291ee5e9ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanMember_581a7ca1-d061-4c44-9aec-ded1aec47956" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_444e4d58-27c2-4d79-a04a-04291ee5e9ab" xlink:to="loc_sny_StockSubscriptionOptionPlanMember_581a7ca1-d061-4c44-9aec-ded1aec47956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateAxis_fa37317d-f725-461f-8fe9-b060b74225a0" xlink:href="sny-20221231.xsd#sny_AwardsDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a7f265fe-f821-43cc-8959-01842b19ab28" xlink:to="loc_sny_AwardsDateAxis_fa37317d-f725-461f-8fe9-b060b74225a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateDomain_fa37317d-f725-461f-8fe9-b060b74225a0_default" xlink:href="sny-20221231.xsd#sny_AwardsDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_AwardsDateAxis_fa37317d-f725-461f-8fe9-b060b74225a0" xlink:to="loc_sny_AwardsDateDomain_fa37317d-f725-461f-8fe9-b060b74225a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateDomain_36745988-5835-4de3-9f03-7ef17e9a342a" xlink:href="sny-20221231.xsd#sny_AwardsDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_AwardsDateAxis_fa37317d-f725-461f-8fe9-b060b74225a0" xlink:to="loc_sny_AwardsDateDomain_36745988-5835-4de3-9f03-7ef17e9a342a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April302021Member_5a369c6f-56f8-46e6-9ff8-fa38626af516" xlink:href="sny-20221231.xsd#sny_April302021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AwardsDateDomain_36745988-5835-4de3-9f03-7ef17e9a342a" xlink:to="loc_sny_April302021Member_5a369c6f-56f8-46e6-9ff8-fa38626af516" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April282020Member_f2a1c486-c6da-4bd3-9b98-83ac129e82e2" xlink:href="sny-20221231.xsd#sny_April282020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AwardsDateDomain_36745988-5835-4de3-9f03-7ef17e9a342a" xlink:to="loc_sny_April282020Member_f2a1c486-c6da-4bd3-9b98-83ac129e82e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_May32022Member_c41830e0-1d04-404f-abbb-b45629efe64f" xlink:href="sny-20221231.xsd#sny_May32022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AwardsDateDomain_36745988-5835-4de3-9f03-7ef17e9a342a" xlink:to="loc_sny_May32022Member_c41830e0-1d04-404f-abbb-b45629efe64f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails" xlink:type="extended" id="i06ab6ee6473f4eb7bb6865c0989d750a_ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_8e401a9c-0da4-4611-a8b3-ff234ae73a99" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_ifrs-full_NumberOfSharesIssued_8e401a9c-0da4-4611-a8b3-ff234ae73a99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions_b3ccd8c7-bb8a-4c2e-93c2-be252ed48e29" xlink:href="sny-20221231.xsd#sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions_b3ccd8c7-bb8a-4c2e-93c2-be252ed48e29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease_e729d8a5-b45b-485a-9beb-fbaabd811150" xlink:href="sny-20221231.xsd#sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease_e729d8a5-b45b-485a-9beb-fbaabd811150" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees_4a5991d5-9ecf-477a-b286-afd812fc2151" xlink:href="sny-20221231.xsd#sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees_4a5991d5-9ecf-477a-b286-afd812fc2151" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReductionOfSharesByCancellationOfTreasuryShares_ba19300b-d25c-4616-8852-db827ec5ce53" xlink:href="sny-20221231.xsd#sny_ReductionOfSharesByCancellationOfTreasuryShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_sny_ReductionOfSharesByCancellationOfTreasuryShares_ba19300b-d25c-4616-8852-db827ec5ce53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_f30ba522-6263-4a0c-a4c8-24c23e687510" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a72d450b-c2b0-48a4-afbc-762aa55848aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a72d450b-c2b0-48a4-afbc-762aa55848aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_c1077fe9-38ac-48cd-9b16-7b11d01c6a17" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a72d450b-c2b0-48a4-afbc-762aa55848aa" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_c1077fe9-38ac-48cd-9b16-7b11d01c6a17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_c1077fe9-38ac-48cd-9b16-7b11d01c6a17_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_c1077fe9-38ac-48cd-9b16-7b11d01c6a17" xlink:to="loc_ifrs-full_EquityMember_c1077fe9-38ac-48cd-9b16-7b11d01c6a17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_c925e72d-79f9-41a8-9963-921bde4a04ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_c1077fe9-38ac-48cd-9b16-7b11d01c6a17" xlink:to="loc_ifrs-full_EquityMember_c925e72d-79f9-41a8-9963-921bde4a04ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_4f984b5e-801b-4808-a79a-3fdddd83e017" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_c925e72d-79f9-41a8-9963-921bde4a04ef" xlink:to="loc_ifrs-full_IssuedCapitalMember_4f984b5e-801b-4808-a79a-3fdddd83e017" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e7b8fc33-ad73-46f6-a0db-ee70227dec24" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a72d450b-c2b0-48a4-afbc-762aa55848aa" xlink:to="loc_dei_LegalEntityAxis_e7b8fc33-ad73-46f6-a0db-ee70227dec24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e7b8fc33-ad73-46f6-a0db-ee70227dec24_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e7b8fc33-ad73-46f6-a0db-ee70227dec24" xlink:to="loc_dei_EntityDomain_e7b8fc33-ad73-46f6-a0db-ee70227dec24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_84079e9f-17e4-4fc1-bc8e-c2b8056c9751" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e7b8fc33-ad73-46f6-a0db-ee70227dec24" xlink:to="loc_dei_EntityDomain_84079e9f-17e4-4fc1-bc8e-c2b8056c9751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiMember_27a2cebc-999d-4efd-b616-8ba4ee9a3c14" xlink:href="sny-20221231.xsd#sny_SanofiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_84079e9f-17e4-4fc1-bc8e-c2b8056c9751" xlink:to="loc_sny_SanofiMember_27a2cebc-999d-4efd-b616-8ba4ee9a3c14" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails" xlink:type="extended" id="i4566a026c7c641feb573a19fa4592a5f_ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfYearsServicePeriod_736fdb6d-d9dd-42e0-bfa6-dfdf0e82d82e" xlink:href="sny-20221231.xsd#sny_NumberOfYearsServicePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_sny_NumberOfYearsServicePeriod_736fdb6d-d9dd-42e0-bfa6-dfdf0e82d82e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_7f33c2ac-50fc-4a64-8af1-8895db4f008f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_7f33c2ac-50fc-4a64-8af1-8895db4f008f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod_e975edd8-6a37-4ba9-b8a4-8a98372c8eba" xlink:href="sny-20221231.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod_e975edd8-6a37-4ba9-b8a4-8a98372c8eba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares_78df4063-01cc-492f-963d-8a5fea28e6d6" xlink:href="sny-20221231.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares_78df4063-01cc-492f-963d-8a5fea28e6d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer_f3b68879-20e4-4425-bb4f-c80e7fa139d8" xlink:href="sny-20221231.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer_f3b68879-20e4-4425-bb4f-c80e7fa139d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfPlanAtDateOfGrant_57d5d337-bc7b-4349-b566-b854a05e237f" xlink:href="sny-20221231.xsd#sny_FairValueOfPlanAtDateOfGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_sny_FairValueOfPlanAtDateOfGrant_57d5d337-bc7b-4349-b566-b854a05e237f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_d3d78da8-3797-40d8-9e7e-0c4d1eef76e8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_d3d78da8-3797-40d8-9e7e-0c4d1eef76e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10a05814-d65e-4c08-8a1f-d412d7f42e7d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_d3d78da8-3797-40d8-9e7e-0c4d1eef76e8" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10a05814-d65e-4c08-8a1f-d412d7f42e7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_10a05814-d65e-4c08-8a1f-d412d7f42e7d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10a05814-d65e-4c08-8a1f-d412d7f42e7d" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_10a05814-d65e-4c08-8a1f-d412d7f42e7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_4ee194ce-3e91-4f2e-bf74-3e7835b77add" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10a05814-d65e-4c08-8a1f-d412d7f42e7d" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_4ee194ce-3e91-4f2e-bf74-3e7835b77add" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2022Member_2d20852a-93a1-4b3d-8090-1289a294c144" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_4ee194ce-3e91-4f2e-bf74-3e7835b77add" xlink:to="loc_sny_RestrictedSharePlan2022Member_2d20852a-93a1-4b3d-8090-1289a294c144" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2021Member_6cbdc46f-51af-4193-ad59-1a7f583b2559" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_4ee194ce-3e91-4f2e-bf74-3e7835b77add" xlink:to="loc_sny_RestrictedSharePlan2021Member_6cbdc46f-51af-4193-ad59-1a7f583b2559" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2020Member_81471a52-c533-4238-bd53-372d1b5ecb5d" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_4ee194ce-3e91-4f2e-bf74-3e7835b77add" xlink:to="loc_sny_RestrictedSharePlan2020Member_81471a52-c533-4238-bd53-372d1b5ecb5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_bfe74056-0682-4140-aaf1-76f4fa173a08" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_d3d78da8-3797-40d8-9e7e-0c4d1eef76e8" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_bfe74056-0682-4140-aaf1-76f4fa173a08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_bfe74056-0682-4140-aaf1-76f4fa173a08_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_bfe74056-0682-4140-aaf1-76f4fa173a08" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_bfe74056-0682-4140-aaf1-76f4fa173a08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_bcf192bf-15a9-4321-b39f-12779e8e07b0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_bfe74056-0682-4140-aaf1-76f4fa173a08" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_bcf192bf-15a9-4321-b39f-12779e8e07b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceSharePlanOneMember_69dee6ac-7f21-4c43-9d5f-f0be83df9bcd" xlink:href="sny-20221231.xsd#sny_PerformanceSharePlanOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_bcf192bf-15a9-4321-b39f-12779e8e07b0" xlink:to="loc_sny_PerformanceSharePlanOneMember_69dee6ac-7f21-4c43-9d5f-f0be83df9bcd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceSharePlanTwoMember_788c9156-a469-4fd1-ba16-e6bf14a70a4c" xlink:href="sny-20221231.xsd#sny_PerformanceSharePlanTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_bcf192bf-15a9-4321-b39f-12779e8e07b0" xlink:to="loc_sny_PerformanceSharePlanTwoMember_788c9156-a469-4fd1-ba16-e6bf14a70a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketConditionAxis_3e5e0be9-4f70-441a-b7bc-2dac80a4baec" xlink:href="sny-20221231.xsd#sny_MarketConditionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_d3d78da8-3797-40d8-9e7e-0c4d1eef76e8" xlink:to="loc_sny_MarketConditionAxis_3e5e0be9-4f70-441a-b7bc-2dac80a4baec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketConditionDomain_3e5e0be9-4f70-441a-b7bc-2dac80a4baec_default" xlink:href="sny-20221231.xsd#sny_MarketConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_MarketConditionAxis_3e5e0be9-4f70-441a-b7bc-2dac80a4baec" xlink:to="loc_sny_MarketConditionDomain_3e5e0be9-4f70-441a-b7bc-2dac80a4baec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketConditionDomain_6feaf742-59b8-4c03-9005-061dc97b264a" xlink:href="sny-20221231.xsd#sny_MarketConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_MarketConditionAxis_3e5e0be9-4f70-441a-b7bc-2dac80a4baec" xlink:to="loc_sny_MarketConditionDomain_6feaf742-59b8-4c03-9005-061dc97b264a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WithoutMarketConditionMember_bed064e4-2516-4ed0-aa35-689a819ed634" xlink:href="sny-20221231.xsd#sny_WithoutMarketConditionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_MarketConditionDomain_6feaf742-59b8-4c03-9005-061dc97b264a" xlink:to="loc_sny_WithoutMarketConditionMember_bed064e4-2516-4ed0-aa35-689a819ed634" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WithMarketConditionMember_6b946014-e0fc-401f-bd62-aabc6d7acbc0" xlink:href="sny-20221231.xsd#sny_WithMarketConditionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_MarketConditionDomain_6feaf742-59b8-4c03-9005-061dc97b264a" xlink:to="loc_sny_WithMarketConditionMember_6b946014-e0fc-401f-bd62-aabc6d7acbc0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails" xlink:type="extended" id="i3d2683b8e01c49108ec4d501d767e07d_ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_03207b63-c597-43a1-b668-7d9d0f5f0a0b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_83d92b81-5abe-433e-aca1-82b3436d81c9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_03207b63-c597-43a1-b668-7d9d0f5f0a0b" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_83d92b81-5abe-433e-aca1-82b3436d81c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfRestrictedSharesNotYetFullyVested_f2de938f-ed24-4ba2-b337-5411caf0a263" xlink:href="sny-20221231.xsd#sny_NumberOfRestrictedSharesNotYetFullyVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_03207b63-c597-43a1-b668-7d9d0f5f0a0b" xlink:to="loc_sny_NumberOfRestrictedSharesNotYetFullyVested_f2de938f-ed24-4ba2-b337-5411caf0a263" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_dfb25342-4533-4aa8-b1d7-fe5b88a6f58e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_03207b63-c597-43a1-b668-7d9d0f5f0a0b" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_dfb25342-4533-4aa8-b1d7-fe5b88a6f58e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_b54628ce-c696-4d54-9bfb-5850cfc9c999" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_dfb25342-4533-4aa8-b1d7-fe5b88a6f58e" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_b54628ce-c696-4d54-9bfb-5850cfc9c999" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_b54628ce-c696-4d54-9bfb-5850cfc9c999_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_b54628ce-c696-4d54-9bfb-5850cfc9c999" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_b54628ce-c696-4d54-9bfb-5850cfc9c999_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_9a924803-8c29-4e48-95bc-34363ce8280a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_b54628ce-c696-4d54-9bfb-5850cfc9c999" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_9a924803-8c29-4e48-95bc-34363ce8280a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:href="sny-20221231.xsd#sny_RestrictedSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_9a924803-8c29-4e48-95bc-34363ce8280a" xlink:to="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2022Member_28433b93-c225-4340-8a5d-426c53641b8b" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:to="loc_sny_RestrictedSharePlan2022Member_28433b93-c225-4340-8a5d-426c53641b8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2021Member_72820a94-5b76-4e2f-a2e5-a2a92298755d" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:to="loc_sny_RestrictedSharePlan2021Member_72820a94-5b76-4e2f-a2e5-a2a92298755d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2020Member_cdf997f6-1786-479b-9778-3d3ae8173d56" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:to="loc_sny_RestrictedSharePlan2020Member_cdf997f6-1786-479b-9778-3d3ae8173d56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2019Member_0701312d-ce53-45c9-9c8a-842e23257d82" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:to="loc_sny_RestrictedSharePlan2019Member_0701312d-ce53-45c9-9c8a-842e23257d82" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2018Member_f8d534da-7e7b-4782-9a2a-929d20534574" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:to="loc_sny_RestrictedSharePlan2018Member_f8d534da-7e7b-4782-9a2a-929d20534574" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails" xlink:type="extended" id="i7f67e05836bf43f8b219588d8cbb3386_ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SubscriptionPricePerShare_591eca63-6f24-4033-a589-03851be0a76b" xlink:href="sny-20221231.xsd#sny_SubscriptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:to="loc_sny_SubscriptionPricePerShare_591eca63-6f24-4033-a589-03851be0a76b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareSubscribed_ee9b0082-3127-4192-9eb9-c91a8eb226f3" xlink:href="sny-20221231.xsd#sny_NumberOfShareSubscribed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:to="loc_sny_NumberOfShareSubscribed_ee9b0082-3127-4192-9eb9-c91a8eb226f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution_8a644914-1035-4047-b99e-85656d5359a7" xlink:href="sny-20221231.xsd#sny_IssuanceOfFurtherSharesAsAnEmployersContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:to="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution_8a644914-1035-4047-b99e-85656d5359a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAverageOfQuotedMarketPricesOfShares_7c4dab6e-6f21-4784-8a13-d500c50c762e" xlink:href="sny-20221231.xsd#sny_PercentageOfAverageOfQuotedMarketPricesOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:to="loc_sny_PercentageOfAverageOfQuotedMarketPricesOfShares_7c4dab6e-6f21-4784-8a13-d500c50c762e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfTradingDaysPrecedingPlanApproval_341a39ab-342b-4a57-8d21-e943d3e4eb2b" xlink:href="sny-20221231.xsd#sny_NumberOfTradingDaysPrecedingPlanApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:to="loc_sny_NumberOfTradingDaysPrecedingPlanApproval_341a39ab-342b-4a57-8d21-e943d3e4eb2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_4322f5f3-20ad-4b8e-8b7c-013d6db2cc93" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_4322f5f3-20ad-4b8e-8b7c-013d6db2cc93" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e1cbf43d-2d07-4444-9017-60cbc07d9c26" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_4322f5f3-20ad-4b8e-8b7c-013d6db2cc93" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e1cbf43d-2d07-4444-9017-60cbc07d9c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_e1cbf43d-2d07-4444-9017-60cbc07d9c26_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e1cbf43d-2d07-4444-9017-60cbc07d9c26" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_e1cbf43d-2d07-4444-9017-60cbc07d9c26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_07fcbee7-aac6-40c1-8aad-73834a94a987" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e1cbf43d-2d07-4444-9017-60cbc07d9c26" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_07fcbee7-aac6-40c1-8aad-73834a94a987" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeesShareOwnershipPlanMember_c4b5232b-06f7-4a11-b8ad-a9a164be3bda" xlink:href="sny-20221231.xsd#sny_EmployeesShareOwnershipPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_07fcbee7-aac6-40c1-8aad-73834a94a987" xlink:to="loc_sny_EmployeesShareOwnershipPlanMember_c4b5232b-06f7-4a11-b8ad-a9a164be3bda" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails" xlink:type="extended" id="i78585c8e433b47d8b5e35961523dc79f_ConsolidatedshareholdersequitySummaryofExpensesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_2df6b06d-05fa-4b3f-b77a-2aa2fb867135" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_8f34549e-b8b2-485e-bcf4-86d7a00ef243" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_2df6b06d-05fa-4b3f-b77a-2aa2fb867135" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_8f34549e-b8b2-485e-bcf4-86d7a00ef243" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution_3ea861a5-c93f-4183-90cf-a251f4c8d32f" xlink:href="sny-20221231.xsd#sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_2df6b06d-05fa-4b3f-b77a-2aa2fb867135" xlink:to="loc_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution_3ea861a5-c93f-4183-90cf-a251f4c8d32f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_83d4dee3-17eb-4053-8ca2-563eeb308c1a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_2df6b06d-05fa-4b3f-b77a-2aa2fb867135" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_83d4dee3-17eb-4053-8ca2-563eeb308c1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_688ce994-39b9-4f6f-8880-c343d27a5373" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_83d4dee3-17eb-4053-8ca2-563eeb308c1a" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_688ce994-39b9-4f6f-8880-c343d27a5373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_688ce994-39b9-4f6f-8880-c343d27a5373_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_688ce994-39b9-4f6f-8880-c343d27a5373" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_688ce994-39b9-4f6f-8880-c343d27a5373_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_3feb63a5-9d77-4c5b-9b2f-5d963c83a820" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_688ce994-39b9-4f6f-8880-c343d27a5373" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_3feb63a5-9d77-4c5b-9b2f-5d963c83a820" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeesShareOwnershipPlanMember_898b4b04-c9b4-4e00-8e10-47bc87bca80c" xlink:href="sny-20221231.xsd#sny_EmployeesShareOwnershipPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_3feb63a5-9d77-4c5b-9b2f-5d963c83a820" xlink:to="loc_sny_EmployeesShareOwnershipPlanMember_898b4b04-c9b4-4e00-8e10-47bc87bca80c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails" xlink:type="extended" id="i5bddf1d65c1c4564afcb1675138574e8_ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_1e83483f-1c79-4e48-8b70-884d8abad596" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSharesRepurchased_33bf6034-8097-4042-b0b8-8da18d514a77" xlink:href="sny-20221231.xsd#sny_NumberOfSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_1e83483f-1c79-4e48-8b70-884d8abad596" xlink:to="loc_sny_NumberOfSharesRepurchased_33bf6034-8097-4042-b0b8-8da18d514a77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmountOfSharesRepurchased_705d5130-9eed-4c04-ac14-373f05e00fd9" xlink:href="sny-20221231.xsd#sny_AmountOfSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_1e83483f-1c79-4e48-8b70-884d8abad596" xlink:to="loc_sny_AmountOfSharesRepurchased_705d5130-9eed-4c04-ac14-373f05e00fd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_98f34f3e-0384-4b8c-8994-592054657f1b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_1e83483f-1c79-4e48-8b70-884d8abad596" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_98f34f3e-0384-4b8c-8994-592054657f1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateAxis_5492748f-2af8-4852-99dc-c15d331447ad" xlink:href="sny-20221231.xsd#sny_AwardsDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_98f34f3e-0384-4b8c-8994-592054657f1b" xlink:to="loc_sny_AwardsDateAxis_5492748f-2af8-4852-99dc-c15d331447ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateDomain_5492748f-2af8-4852-99dc-c15d331447ad_default" xlink:href="sny-20221231.xsd#sny_AwardsDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_AwardsDateAxis_5492748f-2af8-4852-99dc-c15d331447ad" xlink:to="loc_sny_AwardsDateDomain_5492748f-2af8-4852-99dc-c15d331447ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:href="sny-20221231.xsd#sny_AwardsDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_AwardsDateAxis_5492748f-2af8-4852-99dc-c15d331447ad" xlink:to="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2022ProgramMember_448702f4-d7d9-42f7-879e-2fc1ac80b288" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2022ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:to="loc_sny_ShareRepurchase2022ProgramMember_448702f4-d7d9-42f7-879e-2fc1ac80b288" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2021ProgramMember_edf1831c-ef1b-4a5e-a726-537da3b51019" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2021ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:to="loc_sny_ShareRepurchase2021ProgramMember_edf1831c-ef1b-4a5e-a726-537da3b51019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2020ProgramMember_872be1d4-b03a-4df8-bc0f-7cfbed9ac715" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2020ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:to="loc_sny_ShareRepurchase2020ProgramMember_872be1d4-b03a-4df8-bc0f-7cfbed9ac715" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2019ProgramMember_602cfcfd-12ef-4e20-bbb2-b7a7372630f1" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2019ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:to="loc_sny_ShareRepurchase2019ProgramMember_602cfcfd-12ef-4e20-bbb2-b7a7372630f1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails" xlink:type="extended" id="i4faa74f062d94fdeb659294fa921152b_ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_c830c2f1-3a36-4caa-9d6a-7558dcfa42a7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_7feb68fe-47a5-4d20-afbe-e55cefa431fc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_c830c2f1-3a36-4caa-9d6a-7558dcfa42a7" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParent_7feb68fe-47a5-4d20-afbe-e55cefa431fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterests_90d7656f-87dd-448a-a66f-9b50e75d8fd5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_c830c2f1-3a36-4caa-9d6a-7558dcfa42a7" xlink:to="loc_ifrs-full_NoncontrollingInterests_90d7656f-87dd-448a-a66f-9b50e75d8fd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_5823d76f-26a4-4373-af39-90297175c766" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_c830c2f1-3a36-4caa-9d6a-7558dcfa42a7" xlink:to="loc_ifrs-full_Equity_5823d76f-26a4-4373-af39-90297175c766" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_2d7ef388-30a3-4901-9e59-054ff17e3189" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_c830c2f1-3a36-4caa-9d6a-7558dcfa42a7" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_2d7ef388-30a3-4901-9e59-054ff17e3189" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_dc40bb54-e618-4b72-967f-4f6d08b16a0d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_2d7ef388-30a3-4901-9e59-054ff17e3189" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_dc40bb54-e618-4b72-967f-4f6d08b16a0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_dc40bb54-e618-4b72-967f-4f6d08b16a0d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_dc40bb54-e618-4b72-967f-4f6d08b16a0d" xlink:to="loc_ifrs-full_EquityMember_dc40bb54-e618-4b72-967f-4f6d08b16a0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_d5d4d67d-28ed-49ba-9e14-5567628c28ae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_dc40bb54-e618-4b72-967f-4f6d08b16a0d" xlink:to="loc_ifrs-full_EquityMember_d5d4d67d-28ed-49ba-9e14-5567628c28ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_55bc52bb-f621-408a-9915-e5f9792737ce" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_d5d4d67d-28ed-49ba-9e14-5567628c28ae" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_55bc52bb-f621-408a-9915-e5f9792737ce" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails" xlink:type="extended" id="i67273c45756943ccaf6a8d6d310d19d5_ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_52cde75a-1613-4d6f-a7a8-02aee02f33f3" xlink:href="sny-20221231.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_52cde75a-1613-4d6f-a7a8-02aee02f33f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_0421ce94-31b4-408b-941d-feb8b8cc5ccb" xlink:href="sny-20221231.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_0421ce94-31b4-408b-941d-feb8b8cc5ccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_791690d9-1724-4ef5-81b5-c70bd4c35bf6" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_791690d9-1724-4ef5-81b5-c70bd4c35bf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_1d18ebab-661f-45f1-8ff9-7fb30a57d12f" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_1d18ebab-661f-45f1-8ff9-7fb30a57d12f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_7cea3df2-6cbc-4937-ad37-da008911624d" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_7cea3df2-6cbc-4937-ad37-da008911624d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_37e21a4d-e31a-445a-adbb-cc825a63cfba" xlink:href="sny-20221231.xsd#sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_37e21a4d-e31a-445a-adbb-cc825a63cfba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_7e8e7989-7976-4033-9a51-4b7507f8d887" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_7e8e7989-7976-4033-9a51-4b7507f8d887" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_14152da6-766d-4a9d-b2ba-a5a5d213bcdc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_14152da6-766d-4a9d-b2ba-a5a5d213bcdc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_caa34f04-a354-4e76-bdc8-7ba18543a8f5" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_caa34f04-a354-4e76-bdc8-7ba18543a8f5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures_842ce631-0722-426b-9787-e56ae2c58af4" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures_842ce631-0722-426b-9787-e56ae2c58af4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_3499e97c-525b-4cd0-bd11-f10dfa71e637" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_3499e97c-525b-4cd0-bd11-f10dfa71e637" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_c11271dd-0e67-4bff-85ea-5495382095b7" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_c11271dd-0e67-4bff-85ea-5495382095b7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_4cb1cd1d-5193-4c2c-9929-94b54343b485" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_4cb1cd1d-5193-4c2c-9929-94b54343b485" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_ab8eed26-5503-4888-9d7e-cca35eef8842" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_ab8eed26-5503-4888-9d7e-cca35eef8842" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_2bd18a85-e8bf-440b-9952-ed86b318f401" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_2bd18a85-e8bf-440b-9952-ed86b318f401" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_69a6882e-8ef8-4160-a0b8-a1cac647ca85" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_69a6882e-8ef8-4160-a0b8-a1cac647ca85" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationOnTaxEffects_df82d2da-cfff-4628-8d93-ee943e13eeae" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationOnTaxEffects"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInCurrencyTranslationOnTaxEffects_df82d2da-cfff-4628-8d93-ee943e13eeae" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_325fa8fc-05e7-4043-a4d3-d3d79f812940" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_325fa8fc-05e7-4043-a4d3-d3d79f812940" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_6037959a-472f-4037-b961-c38221db2607" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_6037959a-472f-4037-b961-c38221db2607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_6037959a-472f-4037-b961-c38221db2607_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_6037959a-472f-4037-b961-c38221db2607" xlink:to="loc_ifrs-full_EquityMember_6037959a-472f-4037-b961-c38221db2607_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_9596e7c7-9906-4a44-ad72-50eb4250aedc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_6037959a-472f-4037-b961-c38221db2607" xlink:to="loc_ifrs-full_EquityMember_9596e7c7-9906-4a44-ad72-50eb4250aedc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_53583496-0f1e-4147-bff5-95220c4bbd13" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_9596e7c7-9906-4a44-ad72-50eb4250aedc" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_53583496-0f1e-4147-bff5-95220c4bbd13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassifiedItemsAxis_f5ca92fc-c84f-44f9-abcf-6f0915cfc8c1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReclassifiedItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:to="loc_ifrs-full_ReclassifiedItemsAxis_f5ca92fc-c84f-44f9-abcf-6f0915cfc8c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassifiedItemsMember_f5ca92fc-c84f-44f9-abcf-6f0915cfc8c1_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReclassifiedItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ReclassifiedItemsAxis_f5ca92fc-c84f-44f9-abcf-6f0915cfc8c1" xlink:to="loc_ifrs-full_ReclassifiedItemsMember_f5ca92fc-c84f-44f9-abcf-6f0915cfc8c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassifiedItemsMember_ebdc80d3-edd4-43b8-8e3e-8258d99de1ed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReclassifiedItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ReclassifiedItemsAxis_f5ca92fc-c84f-44f9-abcf-6f0915cfc8c1" xlink:to="loc_ifrs-full_ReclassifiedItemsMember_ebdc80d3-edd4-43b8-8e3e-8258d99de1ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember_8d83e07a-26ce-4b83-9acd-d9a7be312630" xlink:href="sny-20221231.xsd#sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReclassifiedItemsMember_ebdc80d3-edd4-43b8-8e3e-8258d99de1ed" xlink:to="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember_8d83e07a-26ce-4b83-9acd-d9a7be312630" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_4f5d9661-1faf-465d-9cb5-b54b6ce65166" xlink:href="sny-20221231.xsd#sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReclassifiedItemsMember_ebdc80d3-edd4-43b8-8e3e-8258d99de1ed" xlink:to="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_4f5d9661-1faf-465d-9cb5-b54b6ce65166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_dc432d53-1bb4-42f4-b746-b37f93175db7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_dc432d53-1bb4-42f4-b746-b37f93175db7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsMember_dc432d53-1bb4-42f4-b746-b37f93175db7_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_dc432d53-1bb4-42f4-b746-b37f93175db7" xlink:to="loc_ifrs-full_FinancialAssetsMember_dc432d53-1bb4-42f4-b746-b37f93175db7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_dc432d53-1bb4-42f4-b746-b37f93175db7" xlink:to="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInstrumentsIncludedInFinancialAssetMember_edb7ea59-f02f-4aeb-b019-610adc44da99" xlink:href="sny-20221231.xsd#sny_EquityInstrumentsIncludedInFinancialAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:to="loc_sny_EquityInstrumentsIncludedInFinancialAssetMember_edb7ea59-f02f-4aeb-b019-610adc44da99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentsMember_4fb14a8c-6381-4060-91d1-b47e9bb68481" xlink:href="sny-20221231.xsd#sny_DebtInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:to="loc_sny_DebtInstrumentsMember_4fb14a8c-6381-4060-91d1-b47e9bb68481" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember_cfca1d7a-4bae-4835-b884-09a72990f8e9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:to="loc_ifrs-full_EquityInvestmentsMember_cfca1d7a-4bae-4835-b884-09a72990f8e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashFlowAndFairValueHedgeMember_becae682-1c03-4b2d-aeea-41b445e75bb6" xlink:href="sny-20221231.xsd#sny_CashFlowAndFairValueHedgeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:to="loc_sny_CashFlowAndFairValueHedgeMember_becae682-1c03-4b2d-aeea-41b445e75bb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForeignCurrencyTranslationMember_066a45ee-8cf9-456c-8156-566739c6ace2" xlink:href="sny-20221231.xsd#sny_ForeignCurrencyTranslationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:to="loc_sny_ForeignCurrencyTranslationMember_066a45ee-8cf9-456c-8156-566739c6ace2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_eb4a845a-41c8-410d-85d3-161760e3da93" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_eb4a845a-41c8-410d-85d3-161760e3da93" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_eb4a845a-41c8-410d-85d3-161760e3da93_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_eb4a845a-41c8-410d-85d3-161760e3da93" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_eb4a845a-41c8-410d-85d3-161760e3da93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_26b339c3-abef-408e-993f-2a4ffcf211a2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_eb4a845a-41c8-410d-85d3-161760e3da93" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_26b339c3-abef-408e-993f-2a4ffcf211a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_8662807b-a151-4cb9-9d00-d72ce8bb31dd" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_26b339c3-abef-408e-993f-2a4ffcf211a2" xlink:to="loc_sny_RegeneronMember_8662807b-a151-4cb9-9d00-d72ce8bb31dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_9b3d34df-c2e7-46d6-86ea-004081a083b1" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_26b339c3-abef-408e-993f-2a4ffcf211a2" xlink:to="loc_sny_EuroapiMember_9b3d34df-c2e7-46d6-86ea-004081a083b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails" xlink:type="extended" id="i9c974cc52b2c4110b8df9f6d3fa32d56_ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_48415428-a80e-4fd3-8d93-ab77d770f531" xlink:href="sny-20221231.xsd#sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_8da8956d-1be5-46a9-a368-7de70fade463" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_48415428-a80e-4fd3-8d93-ab77d770f531" xlink:to="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_8da8956d-1be5-46a9-a368-7de70fade463" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockBasedCompensationStockOptionsExercisedPricePerShare_601222ec-6487-4dc1-ac42-ee95fb4e4a8f" xlink:href="sny-20221231.xsd#sny_StockBasedCompensationStockOptionsExercisedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_48415428-a80e-4fd3-8d93-ab77d770f531" xlink:to="loc_sny_StockBasedCompensationStockOptionsExercisedPricePerShare_601222ec-6487-4dc1-ac42-ee95fb4e4a8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_b28cb736-93b6-4bfb-8b8f-7856b48bb46c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_48415428-a80e-4fd3-8d93-ab77d770f531" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_b28cb736-93b6-4bfb-8b8f-7856b48bb46c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable_858ed988-dd49-4e37-adc5-5984bb5dce1b" xlink:href="sny-20221231.xsd#sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_48415428-a80e-4fd3-8d93-ab77d770f531" xlink:to="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable_858ed988-dd49-4e37-adc5-5984bb5dce1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_6c86b30d-6f36-48ee-8a20-7c643095d234" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable_858ed988-dd49-4e37-adc5-5984bb5dce1b" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_6c86b30d-6f36-48ee-8a20-7c643095d234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_6c86b30d-6f36-48ee-8a20-7c643095d234_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_6c86b30d-6f36-48ee-8a20-7c643095d234" xlink:to="loc_ifrs-full_EquityMember_6c86b30d-6f36-48ee-8a20-7c643095d234_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_37f3c47a-bb36-44d5-8cf4-ffe6601a5e59" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_6c86b30d-6f36-48ee-8a20-7c643095d234" xlink:to="loc_ifrs-full_EquityMember_37f3c47a-bb36-44d5-8cf4-ffe6601a5e59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_37f3c47a-bb36-44d5-8cf4-ffe6601a5e59" xlink:to="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanThreeMember_3f854cc7-934c-422d-a35b-609a24eebcc3" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanThreeMember_3f854cc7-934c-422d-a35b-609a24eebcc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanFourMember_fa9e4565-3193-4be7-9fe3-bbb8e0ab827b" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanFourMember_fa9e4565-3193-4be7-9fe3-bbb8e0ab827b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanFiveMember_ee557194-8fc5-4dcd-b084-19b4abae842f" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanFiveMember_ee557194-8fc5-4dcd-b084-19b4abae842f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanSixMember_30e4c7d9-69fd-4ebf-adbc-748b59091cf9" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanSixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanSixMember_30e4c7d9-69fd-4ebf-adbc-748b59091cf9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanSevenMember_cdb59547-0078-4692-add6-b040cc9b8e56" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanSevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanSevenMember_cdb59547-0078-4692-add6-b040cc9b8e56" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanEightMember_4d4779aa-e121-4432-9fa9-99d684631870" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanEightMember_4d4779aa-e121-4432-9fa9-99d684631870" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanNineMember_520b225f-6a13-45a2-951b-85bd1f998553" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanNineMember_520b225f-6a13-45a2-951b-85bd1f998553" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanTenMember_b04fb556-c4fa-4482-8894-5d5018e33f42" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanTenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanTenMember_b04fb556-c4fa-4482-8894-5d5018e33f42" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails" xlink:type="extended" id="ia8ee14a6884043e3a8029c5c00410693_ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement_02c29060-92a4-491b-bd37-fa885335f14f" xlink:href="sny-20221231.xsd#sny_NumberOfShareOutstandingInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement_02c29060-92a4-491b-bd37-fa885335f14f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_8185683d-e610-4a77-a67f-defa239ee314" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_8185683d-e610-4a77-a67f-defa239ee314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3ae8da84-7090-4669-83ad-e83309fdb0dd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3ae8da84-7090-4669-83ad-e83309fdb0dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_41a81439-3388-498d-8cc4-ad8682aed85d" xlink:href="sny-20221231.xsd#sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_41a81439-3388-498d-8cc4-ad8682aed85d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_3ae4d27c-478f-4379-843e-fd6b6d77b28f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_3ae4d27c-478f-4379-843e-fd6b6d77b28f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement_1e264f1a-7739-4a8e-ba95-1339a71aa205" xlink:href="sny-20221231.xsd#sny_NumberOfShareOutstandingInShareBasedPaymentArrangement"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_946b691b-021f-431a-ab1b-bab6fd1d678a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_946b691b-021f-431a-ab1b-bab6fd1d678a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_66efbd9c-9ff9-4b97-9dac-d0183ec913b6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_66efbd9c-9ff9-4b97-9dac-d0183ec913b6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_4af49ead-c5d1-4b42-9c34-2eb68fd67b8c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_4af49ead-c5d1-4b42-9c34-2eb68fd67b8c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_0cf4384b-cfb9-4b1f-96da-6d30f6a7a751" xlink:href="sny-20221231.xsd#sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_0cf4384b-cfb9-4b1f-96da-6d30f6a7a751" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_79da223e-43ae-48a5-a8f4-da4cb7bee5f9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_79da223e-43ae-48a5-a8f4-da4cb7bee5f9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_4f4a441d-5d8c-4c32-b012-e716a821c503" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement_9d16e91b-8847-43ad-9ce0-749b6ed17221" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement_9d16e91b-8847-43ad-9ce0-749b6ed17221" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement_f537c5cc-23e7-41a7-90db-7134a8901013" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement_f537c5cc-23e7-41a7-90db-7134a8901013" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement_9d202201-f5c0-4010-9a37-747e6088ef30" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement_9d202201-f5c0-4010-9a37-747e6088ef30" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement_01025d0a-9141-422a-8baa-6d25455a2088" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement_01025d0a-9141-422a-8baa-6d25455a2088" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement_e4f1ac99-44d7-4cb3-9ed7-68d6962b507e" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement_e4f1ac99-44d7-4cb3-9ed7-68d6962b507e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement_7874a0aa-7a55-4142-ac68-eb06855c87aa" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e19b9579-192d-4b02-b425-d71a0191ffa6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e19b9579-192d-4b02-b425-d71a0191ffa6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1bf85f61-1cb7-40de-bc05-6e4610a6d7ae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e19b9579-192d-4b02-b425-d71a0191ffa6" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1bf85f61-1cb7-40de-bc05-6e4610a6d7ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1bf85f61-1cb7-40de-bc05-6e4610a6d7ae_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1bf85f61-1cb7-40de-bc05-6e4610a6d7ae" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1bf85f61-1cb7-40de-bc05-6e4610a6d7ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_02732a86-a9a8-4fd3-aa70-071e60792f4d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1bf85f61-1cb7-40de-bc05-6e4610a6d7ae" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_02732a86-a9a8-4fd3-aa70-071e60792f4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalStockOptionPlansMember_60efadd5-f2d4-47c2-911f-db31c991939c" xlink:href="sny-20221231.xsd#sny_TotalStockOptionPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_02732a86-a9a8-4fd3-aa70-071e60792f4d" xlink:to="loc_sny_TotalStockOptionPlansMember_60efadd5-f2d4-47c2-911f-db31c991939c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails" xlink:type="extended" id="ia668971d6d8840608d2f49c0a34c6ace_ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_e6f88a65-dd3e-4fc7-93a4-8b692e5bdd4f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_e6f88a65-dd3e-4fc7-93a4-8b692e5bdd4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_a44a4160-0eb5-4bcb-a7ba-4218cb2fa010" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_a44a4160-0eb5-4bcb-a7ba-4218cb2fa010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_7f72d6cc-44a3-4246-89ac-9aa1941a2f65" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_7f72d6cc-44a3-4246-89ac-9aa1941a2f65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1ce83d24-9495-4d23-b020-211ac4b97620" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1ce83d24-9495-4d23-b020-211ac4b97620" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_c23f11ee-9865-48fd-9735-30ddb1306dce" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_c23f11ee-9865-48fd-9735-30ddb1306dce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1ca19719-cee9-4373-94bd-2c31ee5acee6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1ca19719-cee9-4373-94bd-2c31ee5acee6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_98018f9b-67ad-42dd-ac61-b2d48ae455c8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_98018f9b-67ad-42dd-ac61-b2d48ae455c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_cdf3ab44-6e83-41d8-b0d7-a6fb7e7f5eed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_98018f9b-67ad-42dd-ac61-b2d48ae455c8" xlink:to="loc_ifrs-full_RangeAxis_cdf3ab44-6e83-41d8-b0d7-a6fb7e7f5eed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_cdf3ab44-6e83-41d8-b0d7-a6fb7e7f5eed_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_cdf3ab44-6e83-41d8-b0d7-a6fb7e7f5eed" xlink:to="loc_ifrs-full_RangesMember_cdf3ab44-6e83-41d8-b0d7-a6fb7e7f5eed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_5f674af3-75c2-467c-adec-15a9b432922a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_cdf3ab44-6e83-41d8-b0d7-a6fb7e7f5eed" xlink:to="loc_ifrs-full_RangesMember_5f674af3-75c2-467c-adec-15a9b432922a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_ecf65a7c-969e-4906-934f-0e1aed953bb7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_5f674af3-75c2-467c-adec-15a9b432922a" xlink:to="loc_ifrs-full_BottomOfRangeMember_ecf65a7c-969e-4906-934f-0e1aed953bb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_6503a684-f3d4-4b84-b6e7-4fe2c7aee7d5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_5f674af3-75c2-467c-adec-15a9b432922a" xlink:to="loc_ifrs-full_TopOfRangeMember_6503a684-f3d4-4b84-b6e7-4fe2c7aee7d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_047f4c44-c826-499e-9542-98802b02328f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_98018f9b-67ad-42dd-ac61-b2d48ae455c8" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_047f4c44-c826-499e-9542-98802b02328f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_047f4c44-c826-499e-9542-98802b02328f_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_047f4c44-c826-499e-9542-98802b02328f" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_047f4c44-c826-499e-9542-98802b02328f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_8fb716a6-a073-4828-8ecb-3831b735002c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_047f4c44-c826-499e-9542-98802b02328f" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_8fb716a6-a073-4828-8ecb-3831b735002c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExercisePriceRangeTwoMember_bcd8219f-e403-489e-a6bf-85ed2689a63d" xlink:href="sny-20221231.xsd#sny_ExercisePriceRangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_8fb716a6-a073-4828-8ecb-3831b735002c" xlink:to="loc_sny_ExercisePriceRangeTwoMember_bcd8219f-e403-489e-a6bf-85ed2689a63d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExercisePriceRangeThreeMember_5a784a24-875a-41c3-bdf9-54e8491003dd" xlink:href="sny-20221231.xsd#sny_ExercisePriceRangeThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_8fb716a6-a073-4828-8ecb-3831b735002c" xlink:to="loc_sny_ExercisePriceRangeThreeMember_5a784a24-875a-41c3-bdf9-54e8491003dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExercisePriceRangeFourMember_137adffb-fb89-4fbf-ace3-f880a3736661" xlink:href="sny-20221231.xsd#sny_ExercisePriceRangeFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_8fb716a6-a073-4828-8ecb-3831b735002c" xlink:to="loc_sny_ExercisePriceRangeFourMember_137adffb-fb89-4fbf-ace3-f880a3736661" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_0e6ea46e-562b-4c3f-b8c1-ab3343b7e53b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_98018f9b-67ad-42dd-ac61-b2d48ae455c8" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_0e6ea46e-562b-4c3f-b8c1-ab3343b7e53b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_0e6ea46e-562b-4c3f-b8c1-ab3343b7e53b_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_0e6ea46e-562b-4c3f-b8c1-ab3343b7e53b" xlink:to="loc_ifrs-full_EquityMember_0e6ea46e-562b-4c3f-b8c1-ab3343b7e53b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_c76b5367-9ac5-44db-bff6-2c18c5d9db41" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_0e6ea46e-562b-4c3f-b8c1-ab3343b7e53b" xlink:to="loc_ifrs-full_EquityMember_c76b5367-9ac5-44db-bff6-2c18c5d9db41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionPlanMember_6bbe0b87-c049-4feb-b50e-3e376dc1f5f7" xlink:href="sny-20221231.xsd#sny_StockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_c76b5367-9ac5-44db-bff6-2c18c5d9db41" xlink:to="loc_sny_StockOptionPlanMember_6bbe0b87-c049-4feb-b50e-3e376dc1f5f7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails" xlink:type="extended" id="i4bc39a6d97954a4ebd3dbaafeb424463_DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_98def5f9-408c-46fc-a9ab-c06dfa5998bb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_ifrs-full_LongtermBorrowings_98def5f9-408c-46fc-a9ab-c06dfa5998bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_20b14524-38fb-47c1-9fac-1343f1324cf2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_20b14524-38fb-47c1-9fac-1343f1324cf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_3552cfbd-4b9c-4fdc-a6f2-62e510b5a054" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_3552cfbd-4b9c-4fdc-a6f2-62e510b5a054" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_e47eab92-43be-4e42-9edf-d41e180fde6f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_ifrs-full_Borrowings_e47eab92-43be-4e42-9edf-d41e180fde6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_8dae2a54-c6d3-45da-8da2-e1b9ee3805bb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_ifrs-full_CashAndCashEquivalents_8dae2a54-c6d3-45da-8da2-e1b9ee3805bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_b88ae286-8e89-47df-90a7-546d4c4f18a4" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_b88ae286-8e89-47df-90a7-546d4c4f18a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_7d502c9a-f68d-4d69-9dd4-87a0399195aa" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_7d502c9a-f68d-4d69-9dd4-87a0399195aa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_145ee0db-0d9b-4690-8e43-0dbf4c80c3a6" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_145ee0db-0d9b-4690-8e43-0dbf4c80c3a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_e969be33-3db3-40e1-9852-bf55cace9e9c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_145ee0db-0d9b-4690-8e43-0dbf4c80c3a6" xlink:to="loc_ifrs-full_MeasurementAxis_e969be33-3db3-40e1-9852-bf55cace9e9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_e969be33-3db3-40e1-9852-bf55cace9e9c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_e969be33-3db3-40e1-9852-bf55cace9e9c" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_e969be33-3db3-40e1-9852-bf55cace9e9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_5fce37fd-6f71-4377-a31c-dddbbbae67df" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_e969be33-3db3-40e1-9852-bf55cace9e9c" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_5fce37fd-6f71-4377-a31c-dddbbbae67df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmortizedCostMember_220a0e9a-2023-4969-b614-b29ae86ef229" xlink:href="sny-20221231.xsd#sny_AmortizedCostMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_5fce37fd-6f71-4377-a31c-dddbbbae67df" xlink:to="loc_sny_AmortizedCostMember_220a0e9a-2023-4969-b614-b29ae86ef229" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember_d3b9b5f8-bebe-440d-b20e-7d024f6db910" xlink:href="sny-20221231.xsd#sny_AdjustmentToDebtMeasuredAtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_5fce37fd-6f71-4377-a31c-dddbbbae67df" xlink:to="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember_d3b9b5f8-bebe-440d-b20e-7d024f6db910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionMember_f046edad-4206-40f9-ac6f-d60cc70bf296" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_5fce37fd-6f71-4377-a31c-dddbbbae67df" xlink:to="loc_sny_ValueOnRedemptionMember_f046edad-4206-40f9-ac6f-d60cc70bf296" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails" xlink:type="extended" id="i559e38e45742466f9caede2623b6a89e_DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_10e146ca-7763-4efa-984c-11f15f397f70" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_ifrs-full_Borrowings_10e146ca-7763-4efa-984c-11f15f397f70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_c3c7acc1-6ab6-48a9-b9a1-d46cda68e0a0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_c3c7acc1-6ab6-48a9-b9a1-d46cda68e0a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_53684b61-24e1-4e4a-a0d0-fe5e5dc90518" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_53684b61-24e1-4e4a-a0d0-fe5e5dc90518" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_dce67046-f4f9-4b3a-81e8-e1bfdf243c1e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_dce67046-f4f9-4b3a-81e8-e1bfdf243c1e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForeignCurrencyTranslationDifferences_43e3cb8c-f42a-422f-be2c-3bf01d0c7f2f" xlink:href="sny-20221231.xsd#sny_ForeignCurrencyTranslationDifferences"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_sny_ForeignCurrencyTranslationDifferences_43e3cb8c-f42a-422f-be2c-3bf01d0c7f2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReclassificationFromNonCurrentToCurrent_e1e0f648-444c-473a-9c70-7e8c894ea0f4" xlink:href="sny-20221231.xsd#sny_ReclassificationFromNonCurrentToCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_sny_ReclassificationFromNonCurrentToCurrent_e1e0f648-444c-473a-9c70-7e8c894ea0f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsForNoncashItems_3a2ec0d4-63b1-4436-a6ca-c7011a722174" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsForNoncashItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_ifrs-full_OtherAdjustmentsForNoncashItems_3a2ec0d4-63b1-4436-a6ca-c7011a722174" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_a8a7a227-2ffa-4784-a7be-f1746380a770" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtTable_523361a1-73b7-4dc9-a86d-2e6af64a6652" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_sny_DisclosureOfDebtTable_523361a1-73b7-4dc9-a86d-2e6af64a6652" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_ed9b2625-d2c6-4a87-8fc6-a4940544ad30" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfDebtTable_523361a1-73b7-4dc9-a86d-2e6af64a6652" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_ed9b2625-d2c6-4a87-8fc6-a4940544ad30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_ed9b2625-d2c6-4a87-8fc6-a4940544ad30_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_ed9b2625-d2c6-4a87-8fc6-a4940544ad30" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_ed9b2625-d2c6-4a87-8fc6-a4940544ad30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_693efef5-dd8d-4d63-9f89-581f6745aa20" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_ed9b2625-d2c6-4a87-8fc6-a4940544ad30" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_693efef5-dd8d-4d63-9f89-581f6745aa20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowingsMember_a72baf27-023b-4147-9c64-4623d197ad15" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_693efef5-dd8d-4d63-9f89-581f6745aa20" xlink:to="loc_ifrs-full_LongtermBorrowingsMember_a72baf27-023b-4147-9c64-4623d197ad15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember_028dc3b1-9eb9-40ff-a8f0-fad593fbd02c" xlink:href="sny-20221231.xsd#sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_693efef5-dd8d-4d63-9f89-581f6745aa20" xlink:to="loc_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember_028dc3b1-9eb9-40ff-a8f0-fad593fbd02c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember_44a8036d-9f14-4863-85e0-5435deb7fdb1" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_693efef5-dd8d-4d63-9f89-581f6745aa20" xlink:to="loc_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember_44a8036d-9f14-4863-85e0-5435deb7fdb1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails" xlink:type="extended" id="i76de8adf69e24ac1995a7f113579af5b_DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_e80781b9-2658-4042-8d89-f8b2cf7ca684" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_ifrs-full_NotionalAmount_e80781b9-2658-4042-8d89-f8b2cf7ca684" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfTranches_c038017a-638b-4b8b-a983-d13368f63e6a" xlink:href="sny-20221231.xsd#sny_NumberOfTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_NumberOfTranches_c038017a-638b-4b8b-a983-d13368f63e6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_1655129f-41cc-4c9e-ad72-ec8a4035f6f7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_ifrs-full_BorrowingsInterestRate_1655129f-41cc-4c9e-ad72-ec8a4035f6f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceObjectiveMinimumNumberOfPatients_0ba5f28c-1eb9-45f1-a30a-89ecb4269dd5" xlink:href="sny-20221231.xsd#sny_PerformanceObjectiveMinimumNumberOfPatients"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_PerformanceObjectiveMinimumNumberOfPatients_0ba5f28c-1eb9-45f1-a30a-89ecb4269dd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceObjectiveNumberOfCountries_1ffbb835-837e-44c7-b1a0-4eb72b7457b3" xlink:href="sny-20221231.xsd#sny_PerformanceObjectiveNumberOfCountries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_PerformanceObjectiveNumberOfCountries_1ffbb835-837e-44c7-b1a0-4eb72b7457b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfBondIssuesRedeemed_dda38bb8-9df7-4b1d-b6dc-437ce83a865f" xlink:href="sny-20221231.xsd#sny_NumberOfBondIssuesRedeemed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_NumberOfBondIssuesRedeemed_dda38bb8-9df7-4b1d-b6dc-437ce83a865f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCreditFacilities_32422c27-9ef4-425f-b1f2-530aeb9f348b" xlink:href="sny-20221231.xsd#sny_NumberOfCreditFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_NumberOfCreditFacilities_32422c27-9ef4-425f-b1f2-530aeb9f348b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSustainableDevelopmentPerformanceIndicators_12dde9ef-27bb-4c2d-a2ce-e1b23b188413" xlink:href="sny-20221231.xsd#sny_NumberOfSustainableDevelopmentPerformanceIndicators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_NumberOfSustainableDevelopmentPerformanceIndicators_12dde9ef-27bb-4c2d-a2ce-e1b23b188413" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ParticipatingSharesNumberOutstanding_e207b12c-70c0-4723-8a39-ce45ee4c24fa" xlink:href="sny-20221231.xsd#sny_ParticipatingSharesNumberOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_ParticipatingSharesNumberOutstanding_e207b12c-70c0-4723-8a39-ce45ee4c24fa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ParticipatingSharesCarryingAmount_94d39f2e-09af-411b-8656-d9af6d2feb1e" xlink:href="sny-20221231.xsd#sny_ParticipatingSharesCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_ParticipatingSharesCarryingAmount_94d39f2e-09af-411b-8656-d9af6d2feb1e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommercialPapersIssued_11ed0b35-5667-4e83-b804-7a6d2c61ae9c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CommercialPapersIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_ifrs-full_CommercialPapersIssued_11ed0b35-5667-4e83-b804-7a6d2c61ae9c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BorrowingAverageDrawdown_009b4867-a3e3-43b0-a9e7-53957e48a1b9" xlink:href="sny-20221231.xsd#sny_BorrowingAverageDrawdown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_BorrowingAverageDrawdown_009b4867-a3e3-43b0-a9e7-53957e48a1b9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BorrowingMaximumDrawdown_779cdf10-abe3-4ddb-9169-974c070b3719" xlink:href="sny-20221231.xsd#sny_BorrowingMaximumDrawdown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_BorrowingMaximumDrawdown_779cdf10-abe3-4ddb-9169-974c070b3719" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BorrowingDrawdown_fe264031-869f-40d0-a96b-cf19fda7dd25" xlink:href="sny-20221231.xsd#sny_BorrowingDrawdown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_BorrowingDrawdown_fe264031-869f-40d0-a96b-cf19fda7dd25" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCurrenciesDebtIsIssuedIn_83aa54a7-b5f7-4326-a221-7c5b5381c8fe" xlink:href="sny-20221231.xsd#sny_NumberOfCurrenciesDebtIsIssuedIn"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_NumberOfCurrenciesDebtIsIssuedIn_83aa54a7-b5f7-4326-a221-7c5b5381c8fe" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashAndCashEquivalentsInvestedRate_ffaa34d4-5220-4129-8754-6a0f9f09f7ed" xlink:href="sny-20221231.xsd#sny_CashAndCashEquivalentsInvestedRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_CashAndCashEquivalentsInvestedRate_ffaa34d4-5220-4129-8754-6a0f9f09f7ed" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_03a92eef-6fdc-47e9-9c48-c4fca0905efc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_03a92eef-6fdc-47e9-9c48-c4fca0905efc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_4e402e00-9662-4a00-83d8-3eb9f5be8531" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_03a92eef-6fdc-47e9-9c48-c4fca0905efc" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_4e402e00-9662-4a00-83d8-3eb9f5be8531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameMember_4e402e00-9662-4a00-83d8-3eb9f5be8531_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_4e402e00-9662-4a00-83d8-3eb9f5be8531" xlink:to="loc_ifrs-full_BorrowingsByNameMember_4e402e00-9662-4a00-83d8-3eb9f5be8531_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_4e402e00-9662-4a00-83d8-3eb9f5be8531" xlink:to="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSustainabilityLinkedCreditFacilitiesMember_8afe27d0-c18d-468f-8510-30792b7fc21f" xlink:href="sny-20221231.xsd#sny_SanofiSustainabilityLinkedCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_SanofiSustainabilityLinkedCreditFacilitiesMember_8afe27d0-c18d-468f-8510-30792b7fc21f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ParticipatingSharesMember_af65659b-baf0-4f6d-89ab-555ca3c78b6a" xlink:href="sny-20221231.xsd#sny_ParticipatingSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_ParticipatingSharesMember_af65659b-baf0-4f6d-89ab-555ca3c78b6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SyndicatedCreditFacilityOneMember_38fc3e41-e13b-4aac-94ec-4bb77f9a90ad" xlink:href="sny-20221231.xsd#sny_SyndicatedCreditFacilityOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_SyndicatedCreditFacilityOneMember_38fc3e41-e13b-4aac-94ec-4bb77f9a90ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SyndicatedCreditFacilityTwoMember_413eba50-8163-43d7-b753-d3a3769343b5" xlink:href="sny-20221231.xsd#sny_SyndicatedCreditFacilityTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_SyndicatedCreditFacilityTwoMember_413eba50-8163-43d7-b753-d3a3769343b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommercialPaperProgramInFranceMember_569202b4-c111-4c03-ba7e-09b025669662" xlink:href="sny-20221231.xsd#sny_CommercialPaperProgramInFranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_CommercialPaperProgramInFranceMember_569202b4-c111-4c03-ba7e-09b025669662" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommercialPaperProgramInUSAMember_48216f94-baf7-4fe3-adf6-e4c7ce541118" xlink:href="sny-20221231.xsd#sny_CommercialPaperProgramInUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_CommercialPaperProgramInUSAMember_48216f94-baf7-4fe3-adf6-e4c7ce541118" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember_3fcfaecb-ee21-4750-9df5-8e457531b42c" xlink:href="sny-20221231.xsd#sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember_3fcfaecb-ee21-4750-9df5-8e457531b42c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member_d7ceb784-e2ce-4e47-840e-9ad5cc510460" xlink:href="sny-20221231.xsd#sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member_d7ceb784-e2ce-4e47-840e-9ad5cc510460" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember_7ae9b35f-d7ba-4c25-84db-fa5cc4c6bdf0" xlink:href="sny-20221231.xsd#sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember_7ae9b35f-d7ba-4c25-84db-fa5cc4c6bdf0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember_91c0b413-18a4-489e-b7a6-5de36693f0f5" xlink:href="sny-20221231.xsd#sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember_91c0b413-18a4-489e-b7a6-5de36693f0f5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OneBillionBondsMaturingJanuary2022Member_c62697ee-0fe3-4525-b005-0833532ff942" xlink:href="sny-20221231.xsd#sny_OneBillionBondsMaturingJanuary2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_OneBillionBondsMaturingJanuary2022Member_c62697ee-0fe3-4525-b005-0833532ff942" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member_1861ad3a-3a05-4797-90fb-0f0709e5201d" xlink:href="sny-20221231.xsd#sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member_1861ad3a-3a05-4797-90fb-0f0709e5201d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EightHundredFiftyMillionBondsMaturingJune2022Member_6d7731c8-79da-441f-9532-bf669e7aba5d" xlink:href="sny-20221231.xsd#sny_EightHundredFiftyMillionBondsMaturingJune2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_EightHundredFiftyMillionBondsMaturingJune2022Member_6d7731c8-79da-441f-9532-bf669e7aba5d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentAxis_8e33b36a-cae7-4175-bba3-74de96156b11" xlink:href="sny-20221231.xsd#sny_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_03a92eef-6fdc-47e9-9c48-c4fca0905efc" xlink:to="loc_sny_DebtInstrumentAxis_8e33b36a-cae7-4175-bba3-74de96156b11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentDomain_8e33b36a-cae7-4175-bba3-74de96156b11_default" xlink:href="sny-20221231.xsd#sny_DebtInstrumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_DebtInstrumentAxis_8e33b36a-cae7-4175-bba3-74de96156b11" xlink:to="loc_sny_DebtInstrumentDomain_8e33b36a-cae7-4175-bba3-74de96156b11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentDomain_f2f8fd64-4c7c-4eda-9189-f79a1342b0dc" xlink:href="sny-20221231.xsd#sny_DebtInstrumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_DebtInstrumentAxis_8e33b36a-cae7-4175-bba3-74de96156b11" xlink:to="loc_sny_DebtInstrumentDomain_f2f8fd64-4c7c-4eda-9189-f79a1342b0dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiEuroMediumTermNotesMember_29012419-20c7-42ee-90b7-12b2a9999a8c" xlink:href="sny-20221231.xsd#sny_SanofiEuroMediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DebtInstrumentDomain_f2f8fd64-4c7c-4eda-9189-f79a1342b0dc" xlink:to="loc_sny_SanofiEuroMediumTermNotesMember_29012419-20c7-42ee-90b7-12b2a9999a8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_ca92ccf9-5610-4895-b849-d48d2d1beca1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_03a92eef-6fdc-47e9-9c48-c4fca0905efc" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_ca92ccf9-5610-4895-b849-d48d2d1beca1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_ca92ccf9-5610-4895-b849-d48d2d1beca1_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_ca92ccf9-5610-4895-b849-d48d2d1beca1" xlink:to="loc_ifrs-full_InterestRateTypesMember_ca92ccf9-5610-4895-b849-d48d2d1beca1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_8067ac79-39f0-4a1e-bba0-2793013b7707" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_ca92ccf9-5610-4895-b849-d48d2d1beca1" xlink:to="loc_ifrs-full_InterestRateTypesMember_8067ac79-39f0-4a1e-bba0-2793013b7707" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember_8bfb44b0-3653-4a6c-97a9-28c63947ce60" xlink:href="sny-20221231.xsd#sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_8067ac79-39f0-4a1e-bba0-2793013b7707" xlink:to="loc_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember_8bfb44b0-3653-4a6c-97a9-28c63947ce60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember_864d2fdf-5c94-49bd-8b86-bc193c498b9c" xlink:href="sny-20221231.xsd#sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_8067ac79-39f0-4a1e-bba0-2793013b7707" xlink:to="loc_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember_864d2fdf-5c94-49bd-8b86-bc193c498b9c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails" xlink:type="extended" id="ifd31433f13b64f2fb584d73147d6bd7f_DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BondsIssued_9eb9a5cc-5014-4305-a478-6a7b5f413bf9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BondsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_ifrs-full_BondsIssued_9eb9a5cc-5014-4305-a478-6a7b5f413bf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherBankBorrowings_1589061d-f32e-487e-b15b-a89317c72935" xlink:href="sny-20221231.xsd#sny_OtherBankBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_sny_OtherBankBorrowings_1589061d-f32e-487e-b15b-a89317c72935" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinanceLeaseLiabilities_f04a3190-ed17-4ca4-95c5-71ea8111cf1a" xlink:href="sny-20221231.xsd#sny_FinanceLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_sny_FinanceLeaseLiabilities_f04a3190-ed17-4ca4-95c5-71ea8111cf1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherBorrowings_824e4eb7-6c16-44fc-9677-ba5a964766b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_ifrs-full_OtherBorrowings_824e4eb7-6c16-44fc-9677-ba5a964766b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_e0585f6c-04db-4dc9-a51b-e8ede3242d6f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_e0585f6c-04db-4dc9-a51b-e8ede3242d6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_e6dd93bc-fc74-42e1-b7e6-a75cec85cf83" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_e6dd93bc-fc74-42e1-b7e6-a75cec85cf83" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_0b0769f4-be14-4453-9e78-e4a1cf36187d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_ifrs-full_Borrowings_0b0769f4-be14-4453-9e78-e4a1cf36187d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_cbdae267-7664-4008-89c1-1b02680c7255" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_ifrs-full_CashAndCashEquivalents_cbdae267-7664-4008-89c1-1b02680c7255" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_cd78d58d-2f4c-42cf-ac5e-378181650ba4" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_cd78d58d-2f4c-42cf-ac5e-378181650ba4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_1ec0c6c0-4105-4674-aa05-041ba7a1901d" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_1ec0c6c0-4105-4674-aa05-041ba7a1901d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_f6f5570b-31cb-462e-9366-cbf62787ef25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:to="loc_ifrs-full_MeasurementAxis_f6f5570b-31cb-462e-9366-cbf62787ef25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_f6f5570b-31cb-462e-9366-cbf62787ef25_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_f6f5570b-31cb-462e-9366-cbf62787ef25" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_f6f5570b-31cb-462e-9366-cbf62787ef25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_1a63ab4f-884e-4961-abd5-e3d7a4bf0e4e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_f6f5570b-31cb-462e-9366-cbf62787ef25" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_1a63ab4f-884e-4961-abd5-e3d7a4bf0e4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionMember_42be2544-55ad-4dce-8fc2-54acab03a3c8" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_1a63ab4f-884e-4961-abd5-e3d7a4bf0e4e" xlink:to="loc_sny_ValueOnRedemptionMember_42be2544-55ad-4dce-8fc2-54acab03a3c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_460f5507-6196-4781-a2cb-2b14e9760578" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_460f5507-6196-4781-a2cb-2b14e9760578" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesMember_460f5507-6196-4781-a2cb-2b14e9760578_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_460f5507-6196-4781-a2cb-2b14e9760578" xlink:to="loc_ifrs-full_LiabilitiesMember_460f5507-6196-4781-a2cb-2b14e9760578_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesMember_77e5251f-0d5a-47e4-96ca-8636adaa0ae8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_460f5507-6196-4781-a2cb-2b14e9760578" xlink:to="loc_ifrs-full_LiabilitiesMember_77e5251f-0d5a-47e4-96ca-8636adaa0ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NoncurrentLiabilitiesMember_0fa28fee-272c-46fa-aa65-f284079ee641" xlink:href="sny-20221231.xsd#sny_NoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesMember_77e5251f-0d5a-47e4-96ca-8636adaa0ae8" xlink:to="loc_sny_NoncurrentLiabilitiesMember_0fa28fee-272c-46fa-aa65-f284079ee641" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentLiabilitiesMember_1a93d5a5-5702-445c-9bf4-b05a9f0ff74f" xlink:href="sny-20221231.xsd#sny_CurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesMember_77e5251f-0d5a-47e4-96ca-8636adaa0ae8" xlink:to="loc_sny_CurrentLiabilitiesMember_1a93d5a5-5702-445c-9bf4-b05a9f0ff74f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_b122112f-e05d-45ac-aa9f-4c12bb020760" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_b122112f-e05d-45ac-aa9f-4c12bb020760" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_b122112f-e05d-45ac-aa9f-4c12bb020760_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_b122112f-e05d-45ac-aa9f-4c12bb020760" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_b122112f-e05d-45ac-aa9f-4c12bb020760_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_b1800911-857c-4c09-90ed-ca5778e7e7c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_b122112f-e05d-45ac-aa9f-4c12bb020760" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_b1800911-857c-4c09-90ed-ca5778e7e7c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentAssetsMember_30d07ead-3591-4795-96f8-44e612d80b6d" xlink:href="sny-20221231.xsd#sny_NonCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_b1800911-857c-4c09-90ed-ca5778e7e7c3" xlink:to="loc_sny_NonCurrentAssetsMember_30d07ead-3591-4795-96f8-44e612d80b6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentAssetsMember_063f1779-1c91-4027-8e54-16fff8ec5a76" xlink:href="sny-20221231.xsd#sny_CurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_b1800911-857c-4c09-90ed-ca5778e7e7c3" xlink:to="loc_sny_CurrentAssetsMember_063f1779-1c91-4027-8e54-16fff8ec5a76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_723ff351-b5d6-4c4a-ad6b-ea1cd2008439" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:to="loc_ifrs-full_MaturityAxis_723ff351-b5d6-4c4a-ad6b-ea1cd2008439" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_723ff351-b5d6-4c4a-ad6b-ea1cd2008439_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_723ff351-b5d6-4c4a-ad6b-ea1cd2008439" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_723ff351-b5d6-4c4a-ad6b-ea1cd2008439_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_723ff351-b5d6-4c4a-ad6b-ea1cd2008439" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_09f36489-fa85-4338-b718-0e74ffcc1d0b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_09f36489-fa85-4338-b718-0e74ffcc1d0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_18ccaf61-59da-4cae-b56a-5c328019de60" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_18ccaf61-59da-4cae-b56a-5c328019de60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_9d1ff411-2368-467d-9399-a492311bb8dd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_9d1ff411-2368-467d-9399-a492311bb8dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_ddc67d2f-8db4-4e10-abd7-f6409fbba89e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_ddc67d2f-8db4-4e10-abd7-f6409fbba89e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_dd2f51ec-8981-4cae-ae63-ab0827dec5b3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_dd2f51ec-8981-4cae-ae63-ab0827dec5b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_db97d7cf-d331-469b-aace-bda94df21735" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_db97d7cf-d331-469b-aace-bda94df21735" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails" xlink:type="extended" id="i77befde07db24139b73ee54387419e36_DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_e6bd5e96-c332-40ac-990e-9a41659c471b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_9c40f334-d41e-41ca-b973-2b32e24e7343" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_e6bd5e96-c332-40ac-990e-9a41659c471b" xlink:to="loc_ifrs-full_BorrowingsInterestRate_9c40f334-d41e-41ca-b973-2b32e24e7343" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_038a07c8-7c25-4e3d-b1d6-b36695a6b9c1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_e6bd5e96-c332-40ac-990e-9a41659c471b" xlink:to="loc_ifrs-full_NotionalAmount_038a07c8-7c25-4e3d-b1d6-b36695a6b9c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_738e9b0f-3e82-4a3e-9284-fcf2abf1115d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_e6bd5e96-c332-40ac-990e-9a41659c471b" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_738e9b0f-3e82-4a3e-9284-fcf2abf1115d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentAxis_ef476e48-7ac1-4d31-9bf8-c5595d6f9ece" xlink:href="sny-20221231.xsd#sny_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_738e9b0f-3e82-4a3e-9284-fcf2abf1115d" xlink:to="loc_sny_DebtInstrumentAxis_ef476e48-7ac1-4d31-9bf8-c5595d6f9ece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentDomain_ef476e48-7ac1-4d31-9bf8-c5595d6f9ece_default" xlink:href="sny-20221231.xsd#sny_DebtInstrumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_DebtInstrumentAxis_ef476e48-7ac1-4d31-9bf8-c5595d6f9ece" xlink:to="loc_sny_DebtInstrumentDomain_ef476e48-7ac1-4d31-9bf8-c5595d6f9ece_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentDomain_1b6ad518-c9b9-49dc-bda0-591bbcca0ebe" xlink:href="sny-20221231.xsd#sny_DebtInstrumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_DebtInstrumentAxis_ef476e48-7ac1-4d31-9bf8-c5595d6f9ece" xlink:to="loc_sny_DebtInstrumentDomain_1b6ad518-c9b9-49dc-bda0-591bbcca0ebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiEuroMediumTermNotesMember_6b78c36c-07f8-4ff1-9dfc-cbad88a83989" xlink:href="sny-20221231.xsd#sny_SanofiEuroMediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DebtInstrumentDomain_1b6ad518-c9b9-49dc-bda0-591bbcca0ebe" xlink:to="loc_sny_SanofiEuroMediumTermNotesMember_6b78c36c-07f8-4ff1-9dfc-cbad88a83989" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShelfRegistrationStatementProgramMember_49804bd8-c712-45e2-b291-76256b71533c" xlink:href="sny-20221231.xsd#sny_ShelfRegistrationStatementProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DebtInstrumentDomain_1b6ad518-c9b9-49dc-bda0-591bbcca0ebe" xlink:to="loc_sny_ShelfRegistrationStatementProgramMember_49804bd8-c712-45e2-b291-76256b71533c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_ebf6b629-5f51-426b-a73f-a6ea4a543c93" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_738e9b0f-3e82-4a3e-9284-fcf2abf1115d" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_ebf6b629-5f51-426b-a73f-a6ea4a543c93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameMember_ebf6b629-5f51-426b-a73f-a6ea4a543c93_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_ebf6b629-5f51-426b-a73f-a6ea4a543c93" xlink:to="loc_ifrs-full_BorrowingsByNameMember_ebf6b629-5f51-426b-a73f-a6ea4a543c93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_ebf6b629-5f51-426b-a73f-a6ea4a543c93" xlink:to="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_November2013EMTNISINFR0011625433Member_b2a541f6-f1bc-4b1d-ab4d-9ad0d696fe56" xlink:href="sny-20221231.xsd#sny_November2013EMTNISINFR0011625433Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_November2013EMTNISINFR0011625433Member_b2a541f6-f1bc-4b1d-ab4d-9ad0d696fe56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2022EMTNISINFR0014009KS6Member_2a31197f-e460-4adc-952f-baea22e7d8aa" xlink:href="sny-20221231.xsd#sny_April2022EMTNISINFR0014009KS6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_April2022EMTNISINFR0014009KS6Member_2a31197f-e460-4adc-952f-baea22e7d8aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_September2014EMTNISINFR0012146801Member_22bb3c50-6314-4ade-aa3a-f051e949ffb6" xlink:href="sny-20221231.xsd#sny_September2014EMTNISINFR0012146801Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_September2014EMTNISINFR0012146801Member_22bb3c50-6314-4ade-aa3a-f051e949ffb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2022EMTNISINFR0014009KQ0Member_2f6d363f-7c2c-49e3-9844-fc550ea3bde9" xlink:href="sny-20221231.xsd#sny_April2022EMTNISINFR0014009KQ0Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_April2022EMTNISINFR0014009KQ0Member_2f6d363f-7c2c-49e3-9844-fc550ea3bde9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_September2015EMTNISINFR0012969038Member_2cbc6057-6368-4516-bbc1-88be2e15030b" xlink:href="sny-20221231.xsd#sny_September2015EMTNISINFR0012969038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_September2015EMTNISINFR0012969038Member_2cbc6057-6368-4516-bbc1-88be2e15030b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2016EMTNISINFR0013143997Member_98816913-3364-4d0c-b6eb-10a528a1c803" xlink:href="sny-20221231.xsd#sny_April2016EMTNISINFR0013143997Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_April2016EMTNISINFR0013143997Member_98816913-3364-4d0c-b6eb-10a528a1c803" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2016EMTNISINFR0013144003Member_94304fa1-f39f-4e91-a64d-9cd6c0641a8d" xlink:href="sny-20221231.xsd#sny_April2016EMTNISINFR0013144003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_April2016EMTNISINFR0013144003Member_94304fa1-f39f-4e91-a64d-9cd6c0641a8d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_September2016EMTNISINFR0013201639Member_713887a6-4634-4b89-bf3e-058d558c50d5" xlink:href="sny-20221231.xsd#sny_September2016EMTNISINFR0013201639Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_September2016EMTNISINFR0013201639Member_713887a6-4634-4b89-bf3e-058d558c50d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2020EMTNISINFR0013505104Member_7a8b1979-31be-4655-99e9-4f05d4fd3b37" xlink:href="sny-20221231.xsd#sny_March2020EMTNISINFR0013505104Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2020EMTNISINFR0013505104Member_7a8b1979-31be-4655-99e9-4f05d4fd3b37" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2020EMTNISINFR0013505112Member_b63d3fef-f8fe-44f7-9730-02c70daab5e4" xlink:href="sny-20221231.xsd#sny_March2020EMTNISINFR0013505112Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2020EMTNISINFR0013505112Member_b63d3fef-f8fe-44f7-9730-02c70daab5e4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324332Member_3d4d3b32-50c7-4dc5-a935-27450d7749ff" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324332Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2018EMTNISINFR0013324332Member_3d4d3b32-50c7-4dc5-a935-27450d7749ff" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324340Member_01da1648-419e-4c66-8119-fb5dbfe231f9" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324340Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2018EMTNISINFR0013324340Member_01da1648-419e-4c66-8119-fb5dbfe231f9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324357Member_8b4c8c4c-9e4e-4348-8ee8-d46fc72abadf" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324357Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2018EMTNISINFR0013324357Member_8b4c8c4c-9e4e-4348-8ee8-d46fc72abadf" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324373Member_9db2f599-ce53-4293-b66d-f08550aab9f5" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324373Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2018EMTNISINFR0013324373Member_9db2f599-ce53-4293-b66d-f08550aab9f5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2019EMTNISINFR0013409844Member_798d5a68-97af-4cf3-951d-645abe13f6b3" xlink:href="sny-20221231.xsd#sny_March2019EMTNISINFR0013409844Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2019EMTNISINFR0013409844Member_798d5a68-97af-4cf3-951d-645abe13f6b3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2019EMTNISINFR0013409851Member_03116176-daaa-44b5-8a1e-570c21e89b17" xlink:href="sny-20221231.xsd#sny_March2019EMTNISINFR0013409851Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2019EMTNISINFR0013409851Member_03116176-daaa-44b5-8a1e-570c21e89b17" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_June2018SNFISINUS801060AC87Member_1f389434-d581-40e3-bd05-e86cc61a2bf6" xlink:href="sny-20221231.xsd#sny_June2018SNFISINUS801060AC87Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_June2018SNFISINUS801060AC87Member_1f389434-d581-40e3-bd05-e86cc61a2bf6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_June2018SNFISINUS801060AD60Member_ce5f37f7-6174-4d66-a0c2-e6aaabd0d5f1" xlink:href="sny-20221231.xsd#sny_June2018SNFISINUS801060AD60Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_June2018SNFISINUS801060AD60Member_ce5f37f7-6174-4d66-a0c2-e6aaabd0d5f1" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails" xlink:type="extended" id="i31e2155a2f4143079ada66e7a9b30580_DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BondsIssued_a4ef6597-3c7e-40c0-bb38-c2e843d95d1a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BondsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_BondsIssued_a4ef6597-3c7e-40c0-bb38-c2e843d95d1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherBankBorrowings_248e6ba3-fc5b-44c6-ba6f-d0661281c936" xlink:href="sny-20221231.xsd#sny_OtherBankBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_sny_OtherBankBorrowings_248e6ba3-fc5b-44c6-ba6f-d0661281c936" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherBorrowings_76e3ac77-698e-41cd-bbb2-58a85c0ba77b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_OtherBorrowings_76e3ac77-698e-41cd-bbb2-58a85c0ba77b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_f7c93f26-88cb-44ae-92d1-55553b1d162e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_f7c93f26-88cb-44ae-92d1-55553b1d162e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_99bdb71d-c849-4885-8175-8f95d45ebdd4" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_99bdb71d-c849-4885-8175-8f95d45ebdd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_b59e7c0b-95c4-4ce9-9680-4ec2ad296145" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_Borrowings_b59e7c0b-95c4-4ce9-9680-4ec2ad296145" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_8b9b85d5-ceb4-44a6-85be-eb041380f16e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_CashAndCashEquivalents_8b9b85d5-ceb4-44a6-85be-eb041380f16e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_ced43268-da3d-4aef-825e-9bed0e1db46d" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_ced43268-da3d-4aef-825e-9bed0e1db46d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_41e613e6-0f09-40eb-a84b-5149cea69ae6" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_41e613e6-0f09-40eb-a84b-5149cea69ae6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_227d670a-ae0f-43fd-9332-7a3dd98ac72a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_LeaseLiabilities_227d670a-ae0f-43fd-9332-7a3dd98ac72a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_19f9e936-f992-474a-b12c-ba180699180a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_19f9e936-f992-474a-b12c-ba180699180a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_a8f54ec1-dacd-428f-ab1a-12892c128e71" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_19f9e936-f992-474a-b12c-ba180699180a" xlink:to="loc_ifrs-full_MeasurementAxis_a8f54ec1-dacd-428f-ab1a-12892c128e71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_a8f54ec1-dacd-428f-ab1a-12892c128e71_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_a8f54ec1-dacd-428f-ab1a-12892c128e71" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_a8f54ec1-dacd-428f-ab1a-12892c128e71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_bfa62e43-fab1-41d7-9cb3-1fe787f5893f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_a8f54ec1-dacd-428f-ab1a-12892c128e71" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_bfa62e43-fab1-41d7-9cb3-1fe787f5893f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionMember_57ac0724-3da0-4e29-b331-f3c49d0b3949" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_bfa62e43-fab1-41d7-9cb3-1fe787f5893f" xlink:to="loc_sny_ValueOnRedemptionMember_57ac0724-3da0-4e29-b331-f3c49d0b3949" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_9fda3b56-e309-40d7-b68e-e05cdb7710c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_19f9e936-f992-474a-b12c-ba180699180a" xlink:to="loc_ifrs-full_MaturityAxis_9fda3b56-e309-40d7-b68e-e05cdb7710c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_9fda3b56-e309-40d7-b68e-e05cdb7710c3_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_9fda3b56-e309-40d7-b68e-e05cdb7710c3" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_9fda3b56-e309-40d7-b68e-e05cdb7710c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_9fda3b56-e309-40d7-b68e-e05cdb7710c3" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_e008a2ba-e8e3-48da-9bac-3a8366107738" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_e008a2ba-e8e3-48da-9bac-3a8366107738" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_ce2d0a40-d1a8-420d-b499-d0039807f98e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_ce2d0a40-d1a8-420d-b499-d0039807f98e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_9653c021-8439-41d9-b7a3-1a6139239521" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_9653c021-8439-41d9-b7a3-1a6139239521" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2cbeb7db-222b-46f8-8509-63cf71263533" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2cbeb7db-222b-46f8-8509-63cf71263533" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_0073606b-f971-4bb0-9d3d-be006e2cf9e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_0073606b-f971-4bb0-9d3d-be006e2cf9e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_4ed7ecc5-7aa3-4787-9820-980aaa69ac5d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_4ed7ecc5-7aa3-4787-9820-980aaa69ac5d" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails" xlink:type="extended" id="i4363aa3945a3414cb4f860d4b8fb0f25_DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseOfBorrowings_735fca47-4d84-4392-9ead-4392a84e5807" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:to="loc_sny_IncreaseDecreaseOfBorrowings_735fca47-4d84-4392-9ead-4392a84e5807" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtPercent_ef0b910c-c41c-497b-b888-257cd4a4d1d4" xlink:href="sny-20221231.xsd#sny_DebtPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:to="loc_sny_DebtPercent_ef0b910c-c41c-497b-b888-257cd4a4d1d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_172eee10-ddef-403f-b3d5-c012965d2534" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:to="loc_ifrs-full_CashAndCashEquivalents_172eee10-ddef-403f-b3d5-c012965d2534" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_38d23dd4-4b6a-49fd-b4f7-ba509040f69f" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_38d23dd4-4b6a-49fd-b4f7-ba509040f69f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_9c9b3bf1-0f2b-4d7c-9e00-b51f5116de0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:to="loc_srt_CurrencyAxis_9c9b3bf1-0f2b-4d7c-9e00-b51f5116de0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_9c9b3bf1-0f2b-4d7c-9e00-b51f5116de0c_default" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_9c9b3bf1-0f2b-4d7c-9e00-b51f5116de0c" xlink:to="loc_currency_AllCurrenciesDomain_9c9b3bf1-0f2b-4d7c-9e00-b51f5116de0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_418bf5e1-31a9-4af0-8316-0862a1df7ca8" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_9c9b3bf1-0f2b-4d7c-9e00-b51f5116de0c" xlink:to="loc_currency_AllCurrenciesDomain_418bf5e1-31a9-4af0-8316-0862a1df7ca8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_7e837ed4-759e-4507-ab23-e1afbb9241fe" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_418bf5e1-31a9-4af0-8316-0862a1df7ca8" xlink:to="loc_currency_EUR_7e837ed4-759e-4507-ab23-e1afbb9241fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_7a5ffa53-a226-465a-9203-fd0649fe9cca" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_418bf5e1-31a9-4af0-8316-0862a1df7ca8" xlink:to="loc_currency_USD_7a5ffa53-a226-465a-9203-fd0649fe9cca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_830aba18-0596-40df-b146-9c258ec9e696" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_418bf5e1-31a9-4af0-8316-0862a1df7ca8" xlink:to="loc_currency_SGD_830aba18-0596-40df-b146-9c258ec9e696" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_16cd602b-72e1-4cb6-a9b0-4b5f7dcd1f6e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:to="loc_ifrs-full_MaturityAxis_16cd602b-72e1-4cb6-a9b0-4b5f7dcd1f6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_16cd602b-72e1-4cb6-a9b0-4b5f7dcd1f6e_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_16cd602b-72e1-4cb6-a9b0-4b5f7dcd1f6e" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_16cd602b-72e1-4cb6-a9b0-4b5f7dcd1f6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_16cd602b-72e1-4cb6-a9b0-4b5f7dcd1f6e" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_cf4645e0-24f1-49d8-80e1-bafebffab3f8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_cf4645e0-24f1-49d8-80e1-bafebffab3f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_7cbded75-a183-4dac-b0f9-643c6585a028" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_7cbded75-a183-4dac-b0f9-643c6585a028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_c96bd4bf-15fd-46bf-a77c-aa9395e8e824" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_c96bd4bf-15fd-46bf-a77c-aa9395e8e824" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_52974857-f203-43f5-8be8-da244589640a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_52974857-f203-43f5-8be8-da244589640a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_f75c7be2-d083-476f-9b78-522c08cd88b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_f75c7be2-d083-476f-9b78-522c08cd88b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_aaee8a44-d586-4421-99ff-8932ed4adb8b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_aaee8a44-d586-4421-99ff-8932ed4adb8b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_a104ec1f-50ba-4319-ba34-890c03600c09" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:to="loc_ifrs-full_MeasurementAxis_a104ec1f-50ba-4319-ba34-890c03600c09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_a104ec1f-50ba-4319-ba34-890c03600c09_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_a104ec1f-50ba-4319-ba34-890c03600c09" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_a104ec1f-50ba-4319-ba34-890c03600c09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_455ccb86-1072-4b08-b1a6-60495555fd37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_a104ec1f-50ba-4319-ba34-890c03600c09" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_455ccb86-1072-4b08-b1a6-60495555fd37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember_c4998f6d-8157-483d-b886-f161fbeb345f" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_455ccb86-1072-4b08-b1a6-60495555fd37" xlink:to="loc_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember_c4998f6d-8157-483d-b886-f161fbeb345f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_065bc906-03c7-4c7b-abd0-3c94d51d7bc0" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionAfterDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_455ccb86-1072-4b08-b1a6-60495555fd37" xlink:to="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_065bc906-03c7-4c7b-abd0-3c94d51d7bc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_dcf5f86f-982a-4576-9240-787b96b7fd24" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_dcf5f86f-982a-4576-9240-787b96b7fd24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_dcf5f86f-982a-4576-9240-787b96b7fd24_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_dcf5f86f-982a-4576-9240-787b96b7fd24" xlink:to="loc_ifrs-full_InterestRateTypesMember_dcf5f86f-982a-4576-9240-787b96b7fd24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_73a2ffbc-07f5-43b6-ac4e-ee2879056e64" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_dcf5f86f-982a-4576-9240-787b96b7fd24" xlink:to="loc_ifrs-full_InterestRateTypesMember_73a2ffbc-07f5-43b6-ac4e-ee2879056e64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixedInterestRateMember_96cf155b-0dd2-48da-8425-c56ca46d7eed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixedInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_73a2ffbc-07f5-43b6-ac4e-ee2879056e64" xlink:to="loc_ifrs-full_FixedInterestRateMember_96cf155b-0dd2-48da-8425-c56ca46d7eed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FloatingInterestRateMember_59349e8f-02fc-4e86-b691-f07c81dd511e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FloatingInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_73a2ffbc-07f5-43b6-ac4e-ee2879056e64" xlink:to="loc_ifrs-full_FloatingInterestRateMember_59349e8f-02fc-4e86-b691-f07c81dd511e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails" xlink:type="extended" id="id6fd6dbeebe84fcbab817a65ba1efd6e_DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_42208ff2-cf99-4e4d-b30a-0b10b876e43e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:to="loc_ifrs-full_Borrowings_42208ff2-cf99-4e4d-b30a-0b10b876e43e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_212cc86a-3060-44d4-8f32-d761e7bcaa58" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:to="loc_ifrs-full_CashAndCashEquivalents_212cc86a-3060-44d4-8f32-d761e7bcaa58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_e682d15a-99ed-4209-acec-88f62861f27c" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_e682d15a-99ed-4209-acec-88f62861f27c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtPercent_5c1f1f7f-e9b2-424e-bce8-a00de1e51d6a" xlink:href="sny-20221231.xsd#sny_DebtPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:to="loc_sny_DebtPercent_5c1f1f7f-e9b2-424e-bce8-a00de1e51d6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_855166e9-7e27-410b-8027-ba6b60f2c6a6" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:to="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_855166e9-7e27-410b-8027-ba6b60f2c6a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_ffa451ab-3497-4e3e-8450-e13609af35a2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_855166e9-7e27-410b-8027-ba6b60f2c6a6" xlink:to="loc_ifrs-full_MeasurementAxis_ffa451ab-3497-4e3e-8450-e13609af35a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_ffa451ab-3497-4e3e-8450-e13609af35a2_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_ffa451ab-3497-4e3e-8450-e13609af35a2" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_ffa451ab-3497-4e3e-8450-e13609af35a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_35b44708-34ff-4e03-b85d-80a5513504e5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_ffa451ab-3497-4e3e-8450-e13609af35a2" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_35b44708-34ff-4e03-b85d-80a5513504e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_3726c3c1-3f5d-4fb0-8978-36b5a8beb92a" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionAfterDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_35b44708-34ff-4e03-b85d-80a5513504e5" xlink:to="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_3726c3c1-3f5d-4fb0-8978-36b5a8beb92a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_e4b47385-3751-47eb-9103-d09a5b175f75" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_855166e9-7e27-410b-8027-ba6b60f2c6a6" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_e4b47385-3751-47eb-9103-d09a5b175f75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_e4b47385-3751-47eb-9103-d09a5b175f75_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_e4b47385-3751-47eb-9103-d09a5b175f75" xlink:to="loc_ifrs-full_InterestRateTypesMember_e4b47385-3751-47eb-9103-d09a5b175f75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_c3dce2f7-a6de-4374-84bf-e9afe7564d53" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_e4b47385-3751-47eb-9103-d09a5b175f75" xlink:to="loc_ifrs-full_InterestRateTypesMember_c3dce2f7-a6de-4374-84bf-e9afe7564d53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixedInterestRateMember_ef42266c-faff-4339-acc5-b0a28b752e68" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixedInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_c3dce2f7-a6de-4374-84bf-e9afe7564d53" xlink:to="loc_ifrs-full_FixedInterestRateMember_ef42266c-faff-4339-acc5-b0a28b752e68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FloatingInterestRateMember_dd15c2d9-c73a-49bf-bec0-b9de72b5dd81" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FloatingInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_c3dce2f7-a6de-4374-84bf-e9afe7564d53" xlink:to="loc_ifrs-full_FloatingInterestRateMember_dd15c2d9-c73a-49bf-bec0-b9de72b5dd81" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails" xlink:type="extended" id="i648f45b5485749de8af297fafddca15b_DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_8323db79-80be-4cb5-8ddc-4f904f98606a" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpactOfChangeInInterestRateOnPreTaxIncome_ce6d8c24-4f83-4016-92f5-fc9956dfc757" xlink:href="sny-20221231.xsd#sny_ImpactOfChangeInInterestRateOnPreTaxIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_8323db79-80be-4cb5-8ddc-4f904f98606a" xlink:to="loc_sny_ImpactOfChangeInInterestRateOnPreTaxIncome_ce6d8c24-4f83-4016-92f5-fc9956dfc757" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpactOfPreTaxIncomeRecognisedInEquity_bb71d718-32db-40c9-a1ac-222c6d3a0be9" xlink:href="sny-20221231.xsd#sny_ImpactOfPreTaxIncomeRecognisedInEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_8323db79-80be-4cb5-8ddc-4f904f98606a" xlink:to="loc_sny_ImpactOfPreTaxIncomeRecognisedInEquity_bb71d718-32db-40c9-a1ac-222c6d3a0be9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_381de7ba-c2da-4e48-8c5d-e649e43d7156" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_8323db79-80be-4cb5-8ddc-4f904f98606a" xlink:to="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_381de7ba-c2da-4e48-8c5d-e649e43d7156" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_fcf71530-8fce-4ac2-8842-58ce17773538" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_381de7ba-c2da-4e48-8c5d-e649e43d7156" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_fcf71530-8fce-4ac2-8842-58ce17773538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_fcf71530-8fce-4ac2-8842-58ce17773538_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_fcf71530-8fce-4ac2-8842-58ce17773538" xlink:to="loc_ifrs-full_InterestRateTypesMember_fcf71530-8fce-4ac2-8842-58ce17773538_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_fcf71530-8fce-4ac2-8842-58ce17773538" xlink:to="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlusHundredBasisPointsMember_f2b88aac-e9b7-482b-b534-64b9a835cc91" xlink:href="sny-20221231.xsd#sny_PlusHundredBasisPointsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:to="loc_sny_PlusHundredBasisPointsMember_f2b88aac-e9b7-482b-b534-64b9a835cc91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlusTwentyFiveBasisPointsMember_d45dc6b9-8865-4c5b-b8d8-15913e4464ac" xlink:href="sny-20221231.xsd#sny_PlusTwentyFiveBasisPointsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:to="loc_sny_PlusTwentyFiveBasisPointsMember_d45dc6b9-8865-4c5b-b8d8-15913e4464ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinusTwentyFiveBasisPointsMember_ddd610a1-08b7-4863-ae4e-a040f9de8f12" xlink:href="sny-20221231.xsd#sny_MinusTwentyFiveBasisPointsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:to="loc_sny_MinusTwentyFiveBasisPointsMember_ddd610a1-08b7-4863-ae4e-a040f9de8f12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinusHundredBasisPointsMember_34b21580-4dac-49d3-9ca9-8887e91fbb3e" xlink:href="sny-20221231.xsd#sny_MinusHundredBasisPointsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:to="loc_sny_MinusHundredBasisPointsMember_34b21580-4dac-49d3-9ca9-8887e91fbb3e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_a99c964b-5973-4b18-9f09-3dbf590a5b66" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_381de7ba-c2da-4e48-8c5d-e649e43d7156" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_a99c964b-5973-4b18-9f09-3dbf590a5b66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameMember_a99c964b-5973-4b18-9f09-3dbf590a5b66_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_a99c964b-5973-4b18-9f09-3dbf590a5b66" xlink:to="loc_ifrs-full_BorrowingsByNameMember_a99c964b-5973-4b18-9f09-3dbf590a5b66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameMember_9d28d7f4-b2d6-4f7f-8bc5-1a03c809f494" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_a99c964b-5973-4b18-9f09-3dbf590a5b66" xlink:to="loc_ifrs-full_BorrowingsByNameMember_9d28d7f4-b2d6-4f7f-8bc5-1a03c809f494" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember_1d317498-5cf9-4e74-9f2a-e48418438580" xlink:href="sny-20221231.xsd#sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_9d28d7f4-b2d6-4f7f-8bc5-1a03c809f494" xlink:to="loc_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember_1d317498-5cf9-4e74-9f2a-e48418438580" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails" xlink:type="extended" id="icfc07a2240d546ada65259ee1f896df5_DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByCurrencyLineItems_bc3c5f9a-6018-45d4-bcdc-b5298eed0a96" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByCurrencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_cd9557dc-bf6a-4abf-a998-991f3673104e" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDebtByCurrencyLineItems_bc3c5f9a-6018-45d4-bcdc-b5298eed0a96" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_cd9557dc-bf6a-4abf-a998-991f3673104e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByCurrencyTable_ba3db0a5-e2bf-46d1-96ca-57a6654aee1f" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByCurrencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfDebtByCurrencyLineItems_bc3c5f9a-6018-45d4-bcdc-b5298eed0a96" xlink:to="loc_sny_DisclosureOfDebtByCurrencyTable_ba3db0a5-e2bf-46d1-96ca-57a6654aee1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_5f15d74f-7325-4c16-85e0-58eb39f73146" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfDebtByCurrencyTable_ba3db0a5-e2bf-46d1-96ca-57a6654aee1f" xlink:to="loc_srt_CurrencyAxis_5f15d74f-7325-4c16-85e0-58eb39f73146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_5f15d74f-7325-4c16-85e0-58eb39f73146_default" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_5f15d74f-7325-4c16-85e0-58eb39f73146" xlink:to="loc_currency_AllCurrenciesDomain_5f15d74f-7325-4c16-85e0-58eb39f73146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_5f15d74f-7325-4c16-85e0-58eb39f73146" xlink:to="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_da464f02-91e3-48f6-8dc4-3d5e00834341" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_currency_EUR_da464f02-91e3-48f6-8dc4-3d5e00834341" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_61513dcf-6b88-4eee-8e1f-1d6970136ccd" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_currency_USD_61513dcf-6b88-4eee-8e1f-1d6970136ccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_dd6db9fc-4331-4cd2-8e08-4c97e91d34df" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_currency_SGD_dd6db9fc-4331-4cd2-8e08-4c97e91d34df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_7e489dcd-2930-4016-a6b7-1411fbad7f12" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_GBP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_currency_GBP_7e489dcd-2930-4016-a6b7-1411fbad7f12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_b6c66559-95a3-4108-ba2e-0de94f35eda0" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MXN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_currency_MXN_b6c66559-95a3-4108-ba2e-0de94f35eda0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCurrenciesMember_e4858b09-bc8a-4ef5-9686-8a26a4951e98" xlink:href="sny-20221231.xsd#sny_OtherCurrenciesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_sny_OtherCurrenciesMember_e4858b09-bc8a-4ef5-9686-8a26a4951e98" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_3168af2d-f4e5-4294-a994-28a905f3c191" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfDebtByCurrencyTable_ba3db0a5-e2bf-46d1-96ca-57a6654aee1f" xlink:to="loc_ifrs-full_MeasurementAxis_3168af2d-f4e5-4294-a994-28a905f3c191" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_3168af2d-f4e5-4294-a994-28a905f3c191_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_3168af2d-f4e5-4294-a994-28a905f3c191" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_3168af2d-f4e5-4294-a994-28a905f3c191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_d6b49151-696c-4604-b3ed-0c53f3fe9cdd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_3168af2d-f4e5-4294-a994-28a905f3c191" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_d6b49151-696c-4604-b3ed-0c53f3fe9cdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember_eddc013a-41fb-41b8-b4a9-aae4708bc474" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_d6b49151-696c-4604-b3ed-0c53f3fe9cdd" xlink:to="loc_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember_eddc013a-41fb-41b8-b4a9-aae4708bc474" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_36e55a21-78c0-47b8-b4eb-e8155fdcab46" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionAfterDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_d6b49151-696c-4604-b3ed-0c53f3fe9cdd" xlink:to="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_36e55a21-78c0-47b8-b4eb-e8155fdcab46" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails" xlink:type="extended" id="i4c08f1b646e0443184e5da380f36366b_DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6d47861a-3d40-4b70-a673-f1728c940302" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_71e7c4cf-71fb-47a2-8d33-c341b4875924" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6d47861a-3d40-4b70-a673-f1728c940302" xlink:to="loc_ifrs-full_Borrowings_71e7c4cf-71fb-47a2-8d33-c341b4875924" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RedemptionOfDebtInstrumentIssued_f04866f8-159c-4e8b-9a93-ea26bf6d96c6" xlink:href="sny-20221231.xsd#sny_RedemptionOfDebtInstrumentIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6d47861a-3d40-4b70-a673-f1728c940302" xlink:to="loc_sny_RedemptionOfDebtInstrumentIssued_f04866f8-159c-4e8b-9a93-ea26bf6d96c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_88d8832a-865f-4ca0-8e39-ccb2ecf85970" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6d47861a-3d40-4b70-a673-f1728c940302" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_88d8832a-865f-4ca0-8e39-ccb2ecf85970" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_37705566-5c2d-4768-abb9-2e6d422ac749" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_88d8832a-865f-4ca0-8e39-ccb2ecf85970" xlink:to="loc_ifrs-full_MeasurementAxis_37705566-5c2d-4768-abb9-2e6d422ac749" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_37705566-5c2d-4768-abb9-2e6d422ac749_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_37705566-5c2d-4768-abb9-2e6d422ac749" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_37705566-5c2d-4768-abb9-2e6d422ac749_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_9d2d9dff-aa04-407c-930e-0e82be891d65" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_37705566-5c2d-4768-abb9-2e6d422ac749" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_9d2d9dff-aa04-407c-930e-0e82be891d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtMarketValueMember_23b2b7ca-66a1-4abb-8c02-deef1c146148" xlink:href="sny-20221231.xsd#sny_AtMarketValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_9d2d9dff-aa04-407c-930e-0e82be891d65" xlink:to="loc_sny_AtMarketValueMember_23b2b7ca-66a1-4abb-8c02-deef1c146148" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionMember_9a14713e-c6f5-487f-b0c9-de613cb5cd45" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_9d2d9dff-aa04-407c-930e-0e82be891d65" xlink:to="loc_sny_ValueOnRedemptionMember_9a14713e-c6f5-487f-b0c9-de613cb5cd45" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails" xlink:type="extended" id="i66f788691048492491d595861a049d8c_DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_5f0a5dac-3bb7-48a8-8c61-88889be35c11" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:to="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_5f0a5dac-3bb7-48a8-8c61-88889be35c11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalUndiscountedCashFlow_aef1a273-1572-4db6-b738-06f8f94fef71" xlink:href="sny-20221231.xsd#sny_PrincipalUndiscountedCashFlow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:to="loc_sny_PrincipalUndiscountedCashFlow_aef1a273-1572-4db6-b738-06f8f94fef71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestUndiscountedCashFlow_625eb835-7f81-4da6-abb8-d9aba672571d" xlink:href="sny-20221231.xsd#sny_InterestUndiscountedCashFlow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:to="loc_sny_InterestUndiscountedCashFlow_625eb835-7f81-4da6-abb8-d9aba672571d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_5969b5da-92d8-4521-8958-9e990cf8c8d4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_5969b5da-92d8-4521-8958-9e990cf8c8d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalUndiscountedCashFlow_8f5aef91-e09e-4c41-b65b-44a5ace0fc35" xlink:href="sny-20221231.xsd#sny_TotalUndiscountedCashFlow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:to="loc_sny_TotalUndiscountedCashFlow_8f5aef91-e09e-4c41-b65b-44a5ace0fc35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_ff2b6e91-fadd-4984-8c81-116222fe1e6e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_ff2b6e91-fadd-4984-8c81-116222fe1e6e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_26842d30-a783-41c3-b7a0-c9eb88107f53" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_ff2b6e91-fadd-4984-8c81-116222fe1e6e" xlink:to="loc_ifrs-full_MaturityAxis_26842d30-a783-41c3-b7a0-c9eb88107f53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_26842d30-a783-41c3-b7a0-c9eb88107f53_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_26842d30-a783-41c3-b7a0-c9eb88107f53" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_26842d30-a783-41c3-b7a0-c9eb88107f53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_26842d30-a783-41c3-b7a0-c9eb88107f53" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_8e70c2d1-c1a8-4447-8702-5248a3d0b5f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_8e70c2d1-c1a8-4447-8702-5248a3d0b5f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1455f704-d3f3-4393-b24f-4a5c31ae06dc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1455f704-d3f3-4393-b24f-4a5c31ae06dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_641b614b-7153-4802-b4ad-65f871e7ee83" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_641b614b-7153-4802-b4ad-65f871e7ee83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_272d359a-df8d-401c-aace-bfbc1ba8c9b2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_272d359a-df8d-401c-aace-bfbc1ba8c9b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_d5e810ea-78fe-4514-b427-be0f898453bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_d5e810ea-78fe-4514-b427-be0f898453bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_badc3661-b07b-4686-967c-e63b46198365" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_badc3661-b07b-4686-967c-e63b46198365" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails" xlink:type="extended" id="ibd33fe08713b4b22b8cb606af43914e0_DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_568696fd-7b8a-47b9-87f8-875f55df111c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_4aaa6237-05a5-445e-8284-4bf6269dc826" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_568696fd-7b8a-47b9-87f8-875f55df111c" xlink:to="loc_ifrs-full_LeaseLiabilities_4aaa6237-05a5-445e-8284-4bf6269dc826" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LeaseLiabilitiesEffectOfDiscounting_457d0873-4d90-4c99-98e0-f7c958571638" xlink:href="sny-20221231.xsd#sny_LeaseLiabilitiesEffectOfDiscounting"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_568696fd-7b8a-47b9-87f8-875f55df111c" xlink:to="loc_sny_LeaseLiabilitiesEffectOfDiscounting_457d0873-4d90-4c99-98e0-f7c958571638" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InitialLeaseTerm_b37bcc19-bfe1-498a-a124-0ea707df107b" xlink:href="sny-20221231.xsd#sny_InitialLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_568696fd-7b8a-47b9-87f8-875f55df111c" xlink:to="loc_sny_InitialLeaseTerm_b37bcc19-bfe1-498a-a124-0ea707df107b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_ca256244-22a1-4441-a5d1-ab2e9d123745" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_568696fd-7b8a-47b9-87f8-875f55df111c" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_ca256244-22a1-4441-a5d1-ab2e9d123745" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_3bdb1dc3-21a1-4c23-8350-f42d3d6633fc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_ca256244-22a1-4441-a5d1-ab2e9d123745" xlink:to="loc_ifrs-full_MaturityAxis_3bdb1dc3-21a1-4c23-8350-f42d3d6633fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_3bdb1dc3-21a1-4c23-8350-f42d3d6633fc_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_3bdb1dc3-21a1-4c23-8350-f42d3d6633fc" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_3bdb1dc3-21a1-4c23-8350-f42d3d6633fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_3bdb1dc3-21a1-4c23-8350-f42d3d6633fc" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_79fe36ab-1848-4919-8dd3-bb14095f2a2f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_79fe36ab-1848-4919-8dd3-bb14095f2a2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_865be04f-8d4f-4911-a665-1b221f75efe4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_865be04f-8d4f-4911-a665-1b221f75efe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_bdc97227-a3bd-4287-9c93-feb2199461e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_bdc97227-a3bd-4287-9c93-feb2199461e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_e16eddbd-4259-418f-bf7f-a498c593e3ec" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_e16eddbd-4259-418f-bf7f-a498c593e3ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a54f843-3c38-4bb8-822b-45d4e7c0e8fc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_ca256244-22a1-4441-a5d1-ab2e9d123745" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a54f843-3c38-4bb8-822b-45d4e7c0e8fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_7a54f843-3c38-4bb8-822b-45d4e7c0e8fc_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a54f843-3c38-4bb8-822b-45d4e7c0e8fc" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_7a54f843-3c38-4bb8-822b-45d4e7c0e8fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_4488ca4d-43d3-44dd-a1d3-18e8aad45e7d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a54f843-3c38-4bb8-822b-45d4e7c0e8fc" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_4488ca4d-43d3-44dd-a1d3-18e8aad45e7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CambridgeMassachusettsMember_1372645f-7d2c-40bd-9bd0-7e9c5d2828c3" xlink:href="sny-20221231.xsd#sny_CambridgeMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4488ca4d-43d3-44dd-a1d3-18e8aad45e7d" xlink:to="loc_sny_CambridgeMassachusettsMember_1372645f-7d2c-40bd-9bd0-7e9c5d2828c3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails" xlink:type="extended" id="idb073468bbe04b94b9dbeafe8401f4f1_LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_0d522727-57a4-456e-b1d9-6b5210faf26c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_0d522727-57a4-456e-b1d9-6b5210faf26c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_ed600871-135e-4ca5-83f5-c0d2f4a650b1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_ed600871-135e-4ca5-83f5-c0d2f4a650b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_a2c28092-7f74-4acf-a7a9-5867fe54041d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_a2c28092-7f74-4acf-a7a9-5867fe54041d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherMovements_ea03d99d-979e-4138-8a67-e2fc8bac9b79" xlink:href="sny-20221231.xsd#sny_OtherMovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_sny_OtherMovements_ea03d99d-979e-4138-8a67-e2fc8bac9b79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests_a7973f18-6743-4f43-bead-f2a77efe0236" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests_a7973f18-6743-4f43-bead-f2a77efe0236" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_63e30d73-ad2d-487c-baa2-487dde49930a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_63e30d73-ad2d-487c-baa2-487dde49930a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_ea17197f-7534-429c-94e8-4ad094a76038" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_fd220062-b9fe-4e7f-831c-c3c9ce235f67" xlink:href="sny-20221231.xsd#sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_fd220062-b9fe-4e7f-831c-c3c9ce235f67" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_8c296b99-8dd4-4676-a7a4-47eb14887777" xlink:href="sny-20221231.xsd#sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_8c296b99-8dd4-4676-a7a4-47eb14887777" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationLiabilities_b7e2920b-42fb-4d00-b8b6-6967d4771228" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_sny_ContingentConsiderationLiabilities_b7e2920b-42fb-4d00-b8b6-6967d4771228" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_021cf22e-2886-4c0f-b079-3846981ca9a3" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_021cf22e-2886-4c0f-b079-3846981ca9a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_513251e6-dcbb-4114-8125-ed55b79ca777" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_021cf22e-2886-4c0f-b079-3846981ca9a3" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_513251e6-dcbb-4114-8125-ed55b79ca777" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_513251e6-dcbb-4114-8125-ed55b79ca777_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_513251e6-dcbb-4114-8125-ed55b79ca777" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_513251e6-dcbb-4114-8125-ed55b79ca777_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_513251e6-dcbb-4114-8125-ed55b79ca777" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember_5d69ee84-1a72-4a84-af5d-3218becc58e4" xlink:href="sny-20221231.xsd#sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember_5d69ee84-1a72-4a84-af5d-3218becc58e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_0c9e1347-4cfc-4fcd-8aa8-1675db434c55" xlink:href="sny-20221231.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_0c9e1347-4cfc-4fcd-8aa8-1675db434c55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember_6600217e-6c3e-4644-9784-947a2945c4c5" xlink:href="sny-20221231.xsd#sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember_6600217e-6c3e-4644-9784-947a2945c4c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixMember_49bcd906-fb4e-498d-8f2b-6865cdbfeffe" xlink:href="sny-20221231.xsd#sny_AmunixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_AmunixMember_49bcd906-fb4e-498d-8f2b-6865cdbfeffe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherLiabilitiesMember_76f6f684-87ac-4fa5-ba94-a2c5d8082647" xlink:href="sny-20221231.xsd#sny_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_OtherLiabilitiesMember_76f6f684-87ac-4fa5-ba94-a2c5d8082647" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_21809d8e-190d-4a87-bd26-e1dc85c9111b" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_TranslateBioMember_21809d8e-190d-4a87-bd26-e1dc85c9111b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails" xlink:type="extended" id="i44fbfa5ed4bf4501a6125cd33c7d791f_LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PotentialPaymentsRelatedToPercentageOfSales_ba5dc26f-a102-462b-953b-73130884e19d" xlink:href="sny-20221231.xsd#sny_PotentialPaymentsRelatedToPercentageOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_PotentialPaymentsRelatedToPercentageOfSales_ba5dc26f-a102-462b-953b-73130884e19d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentToSaleOfBusinessPeriod_ed32b768-88af-4f58-a46c-1a56d42ab8b6" xlink:href="sny-20221231.xsd#sny_PaymentToSaleOfBusinessPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_PaymentToSaleOfBusinessPeriod_ed32b768-88af-4f58-a46c-1a56d42ab8b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MilestonePaymentTerm_88c59af0-c669-41a9-b410-9114d1cf8e11" xlink:href="sny-20221231.xsd#sny_MilestonePaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_MilestonePaymentTerm_88c59af0-c669-41a9-b410-9114d1cf8e11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfContingentConsiderationPayable_8e08f16a-224f-4eda-a3d1-2ca3220b9cfa" xlink:href="sny-20221231.xsd#sny_FairValueOfContingentConsiderationPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_FairValueOfContingentConsiderationPayable_8e08f16a-224f-4eda-a3d1-2ca3220b9cfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageIncreaseInFairValueLiabilities_920b0971-33c7-446e-9b07-dbc9046583cb" xlink:href="sny-20221231.xsd#sny_PercentageIncreaseInFairValueLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_PercentageIncreaseInFairValueLiabilities_920b0971-33c7-446e-9b07-dbc9046583cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_e7f9645d-993e-4aab-983b-3073aecb52e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_e7f9645d-993e-4aab-983b-3073aecb52e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations_6a12eb48-a48b-4757-a5c8-febddc388fce" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations_6a12eb48-a48b-4757-a5c8-febddc388fce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_c87ffdff-7c71-422f-b85c-21caa5498e7a" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_c87ffdff-7c71-422f-b85c-21caa5498e7a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_2e9c7509-ab7e-42aa-b0b4-519bcfa305c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_c87ffdff-7c71-422f-b85c-21caa5498e7a" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_2e9c7509-ab7e-42aa-b0b4-519bcfa305c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_2e9c7509-ab7e-42aa-b0b4-519bcfa305c3_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_2e9c7509-ab7e-42aa-b0b4-519bcfa305c3" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_2e9c7509-ab7e-42aa-b0b4-519bcfa305c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_2e9c7509-ab7e-42aa-b0b4-519bcfa305c3" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BayerScheringPharmaAGMember_8daa98e4-3970-4f61-b159-eb4652b24ab5" xlink:href="sny-20221231.xsd#sny_BayerScheringPharmaAGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:to="loc_sny_BayerScheringPharmaAGMember_8daa98e4-3970-4f61-b159-eb4652b24ab5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_a2de50b4-6247-4545-b5d5-94de3c8bba61" xlink:href="sny-20221231.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:to="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_a2de50b4-6247-4545-b5d5-94de3c8bba61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShireHumanGeneticTherapiesIncMember_2aab0fc3-c183-4dab-96a0-474cd6282070" xlink:href="sny-20221231.xsd#sny_ShireHumanGeneticTherapiesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:to="loc_sny_ShireHumanGeneticTherapiesIncMember_2aab0fc3-c183-4dab-96a0-474cd6282070" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixMember_d31f63c6-cfcd-4598-a26b-e731cd3a4952" xlink:href="sny-20221231.xsd#sny_AmunixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:to="loc_sny_AmunixMember_d31f63c6-cfcd-4598-a26b-e731cd3a4952" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_f806c207-4e0d-43aa-8653-31875f16bc1c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_c87ffdff-7c71-422f-b85c-21caa5498e7a" xlink:to="loc_ifrs-full_RangeAxis_f806c207-4e0d-43aa-8653-31875f16bc1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_f806c207-4e0d-43aa-8653-31875f16bc1c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_f806c207-4e0d-43aa-8653-31875f16bc1c" xlink:to="loc_ifrs-full_RangesMember_f806c207-4e0d-43aa-8653-31875f16bc1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_45efd171-2de9-45d9-ba57-d88ab22380d8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_f806c207-4e0d-43aa-8653-31875f16bc1c" xlink:to="loc_ifrs-full_RangesMember_45efd171-2de9-45d9-ba57-d88ab22380d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_7696c410-9e0c-4aaf-8e01-eb855f3bd3b4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_45efd171-2de9-45d9-ba57-d88ab22380d8" xlink:to="loc_ifrs-full_TopOfRangeMember_7696c410-9e0c-4aaf-8e01-eb855f3bd3b4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails" xlink:type="extended" id="i7d54d80188d84609bfa19606d54329ba_LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_f4e74538-e9fc-4902-9eea-9bf9f9a2c270" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations_f676b2b4-ed47-47b1-b35a-db196378331c" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_f4e74538-e9fc-4902-9eea-9bf9f9a2c270" xlink:to="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations_f676b2b4-ed47-47b1-b35a-db196378331c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer_275f5a28-5f3c-47d4-a313-7f5af6286a1b" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_f4e74538-e9fc-4902-9eea-9bf9f9a2c270" xlink:to="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer_275f5a28-5f3c-47d4-a313-7f5af6286a1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD_b5dd8061-0d68-4358-a65f-18c355aeea08" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_f4e74538-e9fc-4902-9eea-9bf9f9a2c270" xlink:to="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD_b5dd8061-0d68-4358-a65f-18c355aeea08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_6a14bcc7-4c2d-4b83-ba93-26cff4a07e20" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_f4e74538-e9fc-4902-9eea-9bf9f9a2c270" xlink:to="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_6a14bcc7-4c2d-4b83-ba93-26cff4a07e20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_58a8e5a1-4ee1-4a6a-ab7c-b7ba79adb7d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_6a14bcc7-4c2d-4b83-ba93-26cff4a07e20" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_58a8e5a1-4ee1-4a6a-ab7c-b7ba79adb7d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_58a8e5a1-4ee1-4a6a-ab7c-b7ba79adb7d0_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_58a8e5a1-4ee1-4a6a-ab7c-b7ba79adb7d0" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_58a8e5a1-4ee1-4a6a-ab7c-b7ba79adb7d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34441daf-7642-4745-8dea-c90e8284af25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_58a8e5a1-4ee1-4a6a-ab7c-b7ba79adb7d0" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34441daf-7642-4745-8dea-c90e8284af25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BayerScheringPharmaAGMember_26dc30bf-e517-45b3-8604-3d19bd8c5f41" xlink:href="sny-20221231.xsd#sny_BayerScheringPharmaAGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34441daf-7642-4745-8dea-c90e8284af25" xlink:to="loc_sny_BayerScheringPharmaAGMember_26dc30bf-e517-45b3-8604-3d19bd8c5f41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_2f11518c-3810-4c87-ad20-8e6c2eedfe55" xlink:href="sny-20221231.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34441daf-7642-4745-8dea-c90e8284af25" xlink:to="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_2f11518c-3810-4c87-ad20-8e6c2eedfe55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_25791e79-5772-44b8-a43f-aa41a267425e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_6a14bcc7-4c2d-4b83-ba93-26cff4a07e20" xlink:to="loc_ifrs-full_MaturityAxis_25791e79-5772-44b8-a43f-aa41a267425e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_25791e79-5772-44b8-a43f-aa41a267425e_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_25791e79-5772-44b8-a43f-aa41a267425e" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_25791e79-5772-44b8-a43f-aa41a267425e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_25791e79-5772-44b8-a43f-aa41a267425e" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_da99bb81-0c37-46c5-aada-4572d2014ac5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_da99bb81-0c37-46c5-aada-4572d2014ac5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_0a25ca48-527d-42b0-a38a-189cc94efbd0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_0a25ca48-527d-42b0-a38a-189cc94efbd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_d217434b-1bff-43bc-87f3-db0796ca27ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_d217434b-1bff-43bc-87f3-db0796ca27ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_883eaec1-08ba-4a40-9f84-5ce98a407418" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_883eaec1-08ba-4a40-9f84-5ce98a407418" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails" xlink:type="extended" id="ia01eb717070a4f8c9ae2aa9def2d177b_ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNoncurrentProvisionsLineItems_4a943fc6-49e0-48e4-bbb8-c2d7e1943a32" xlink:href="sny-20221231.xsd#sny_DisclosureOfNoncurrentProvisionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfNoncurrentProvisionsLineItems_4a943fc6-49e0-48e4-bbb8-c2d7e1943a32" xlink:to="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions_2881bfa9-d05a-46a0-ba7a-8f2cd6f61a51" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_ifrs-full_NoncurrentProvisions_2881bfa9-d05a-46a0-ba7a-8f2cd6f61a51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions_59b9bb0f-73f3-4a8f-af24-793fc618423e" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions_59b9bb0f-73f3-4a8f-af24-793fc618423e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInOtherProvisions_602bb728-081e-45e9-bb27-bee5eb9e9731" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_ifrs-full_ChangesInOtherProvisions_602bb728-081e-45e9-bb27-bee5eb9e9731" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions_b74daed3-051e-409a-a89c-af732560820c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProvisionUsedOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_ifrs-full_ProvisionUsedOtherProvisions_b74daed3-051e-409a-a89c-af732560820c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions_d4d2d33d-d7d2-4e55-a5b7-58e8d2acff54" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions_d4d2d33d-d7d2-4e55-a5b7-58e8d2acff54" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_3872c99e-797c-4210-a733-3f16b5cbabe5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_3872c99e-797c-4210-a733-3f16b5cbabe5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount_0027d0a4-3b07-4ba0-8311-07651ce54a2e" xlink:href="sny-20221231.xsd#sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount_0027d0a4-3b07-4ba0-8311-07651ce54a2e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_51be5018-91df-4f7f-877a-4360abe025a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_51be5018-91df-4f7f-877a-4360abe025a8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans_218943ec-90d6-45a3-a53c-c7e92d13b661" xlink:href="sny-20221231.xsd#sny_ActuarialGainsAndLossesOnDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans_218943ec-90d6-45a3-a53c-c7e92d13b661" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions_751d192a-8237-4888-9f98-9213857cd3cb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNoncurrentProvisionsTable_ab28e98e-5713-41d0-b65b-6399de3797c8" xlink:href="sny-20221231.xsd#sny_DisclosureOfNoncurrentProvisionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfNoncurrentProvisionsLineItems_4a943fc6-49e0-48e4-bbb8-c2d7e1943a32" xlink:to="loc_sny_DisclosureOfNoncurrentProvisionsTable_ab28e98e-5713-41d0-b65b-6399de3797c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_a9017c23-469d-4333-a1ef-d72fe94cf48c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfNoncurrentProvisionsTable_ab28e98e-5713-41d0-b65b-6399de3797c8" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_a9017c23-469d-4333-a1ef-d72fe94cf48c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_a9017c23-469d-4333-a1ef-d72fe94cf48c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_a9017c23-469d-4333-a1ef-d72fe94cf48c" xlink:to="loc_ifrs-full_OtherProvisionsMember_a9017c23-469d-4333-a1ef-d72fe94cf48c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_a9017c23-469d-4333-a1ef-d72fe94cf48c" xlink:to="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember_b5e8b796-16d9-4307-a91d-47603a8ff631" xlink:href="sny-20221231.xsd#sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:to="loc_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember_b5e8b796-16d9-4307-a91d-47603a8ff631" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForOtherLongTermBenefitsMember_b11173ca-67a7-49f2-99f7-5b00f3ae862d" xlink:href="sny-20221231.xsd#sny_ProvisionsForOtherLongTermBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:to="loc_sny_ProvisionsForOtherLongTermBenefitsMember_b11173ca-67a7-49f2-99f7-5b00f3ae862d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentRestructuringProvisionMember_c8a98b68-4a9d-4c45-aed3-4bcac522a3e6" xlink:href="sny-20221231.xsd#sny_NonCurrentRestructuringProvisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:to="loc_sny_NonCurrentRestructuringProvisionMember_c8a98b68-4a9d-4c45-aed3-4bcac522a3e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherProvisionsMember_71b4c84e-6934-4221-81dc-77377e7f6539" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:to="loc_ifrs-full_MiscellaneousOtherProvisionsMember_71b4c84e-6934-4221-81dc-77377e7f6539" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails" xlink:type="extended" id="if6758cbcf68e4326be309e66448c545b_ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:href="sny-20221231.xsd#sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCountriesIncludedInPensionPlans_ea0f1517-6047-4b26-abe8-3066feec7ce7" xlink:href="sny-20221231.xsd#sny_NumberOfCountriesIncludedInPensionPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_NumberOfCountriesIncludedInPensionPlans_ea0f1517-6047-4b26-abe8-3066feec7ce7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionObligationPercentageToDefinedBenefitLiability_8142a284-5bcf-4f0c-b9f0-834a8f652c44" xlink:href="sny-20221231.xsd#sny_PensionObligationPercentageToDefinedBenefitLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_PensionObligationPercentageToDefinedBenefitLiability_8142a284-5bcf-4f0c-b9f0-834a8f652c44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionObligationPercentageToPlanAssets_3748aa06-5d53-4cc0-afbd-f6ead9011e50" xlink:href="sny-20221231.xsd#sny_PensionObligationPercentageToPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_PensionObligationPercentageToPlanAssets_3748aa06-5d53-4cc0-afbd-f6ead9011e50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling_eab7b5f5-4da3-4ac9-bc75-3a2bfb52288c" xlink:href="sny-20221231.xsd#sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling_eab7b5f5-4da3-4ac9-bc75-3a2bfb52288c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_74f6f5f4-261a-467f-9dcc-1cfdcdba126b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_74f6f5f4-261a-467f-9dcc-1cfdcdba126b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfDefinedBenefitPlans_a6fc5ab3-ab1b-4394-bb4c-9e93b6175c09" xlink:href="sny-20221231.xsd#sny_NumberOfDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_NumberOfDefinedBenefitPlans_a6fc5ab3-ab1b-4394-bb4c-9e93b6175c09" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_5cf9bea2-ca2f-42dc-adc1-a9fc911b2d20" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_5cf9bea2-ca2f-42dc-adc1-a9fc911b2d20" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefinedBenefitPlansVestingRightsPercentage_cf103393-7981-4131-9a6a-9195ec4e14ba" xlink:href="sny-20221231.xsd#sny_DefinedBenefitPlansVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_DefinedBenefitPlansVestingRightsPercentage_cf103393-7981-4131-9a6a-9195ec4e14ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RetirementAge_8fb5d91a-9413-4b44-b2b7-930561b542d5" xlink:href="sny-20221231.xsd#sny_RetirementAge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_RetirementAge_8fb5d91a-9413-4b44-b2b7-930561b542d5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NotionalRetirementAge_3c43a8d2-578b-4076-84d9-8c3e946b8f49" xlink:href="sny-20221231.xsd#sny_NotionalRetirementAge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_NotionalRetirementAge_3c43a8d2-578b-4076-84d9-8c3e946b8f49" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans_42f39342-8d75-44ca-850b-d248404ed0d5" xlink:href="sny-20221231.xsd#sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans_42f39342-8d75-44ca-850b-d248404ed0d5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod_2025cb63-69a6-4575-a1ea-46697d86fced" xlink:href="sny-20221231.xsd#sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod_2025cb63-69a6-4575-a1ea-46697d86fced" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths_32ef2021-c649-4ded-ab88-c1be70b26b76" xlink:href="sny-20221231.xsd#sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths_32ef2021-c649-4ded-ab88-c1be70b26b76" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive_0c485deb-43b8-43be-97ed-a07c751e2d3d" xlink:href="sny-20221231.xsd#sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive_0c485deb-43b8-43be-97ed-a07c751e2d3d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_2da36488-5106-434b-a32b-0bf072ec6e2f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_2da36488-5106-434b-a32b-0bf072ec6e2f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod_cca9773f-7789-4010-928b-ade9d93a6470" xlink:href="sny-20221231.xsd#sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod_cca9773f-7789-4010-928b-ade9d93a6470" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LiabilityRecognizedRepresentingEstimatedCost_106ebe33-59e6-450e-bb6a-6c2bc652c8ee" xlink:href="sny-20221231.xsd#sny_LiabilityRecognizedRepresentingEstimatedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_LiabilityRecognizedRepresentingEstimatedCost_106ebe33-59e6-450e-bb6a-6c2bc652c8ee" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_d0197d44-e0fe-42f9-b2ac-e6a63c7721b5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_d0197d44-e0fe-42f9-b2ac-e6a63c7721b5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised_7710e668-abda-40d1-8d8a-3057a9558142" xlink:href="sny-20221231.xsd#sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised_7710e668-abda-40d1-8d8a-3057a9558142" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CapitalLossesCarryBackPeriod_5d3c0781-e71b-4381-b9a2-5936fe652ae7" xlink:href="sny-20221231.xsd#sny_CapitalLossesCarryBackPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_CapitalLossesCarryBackPeriod_5d3c0781-e71b-4381-b9a2-5936fe652ae7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CapitalLossesUsedAgainstCapitalGainsPercentage_900c6636-a359-4bf8-bd1d-dca8833a4feb" xlink:href="sny-20221231.xsd#sny_CapitalLossesUsedAgainstCapitalGainsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_CapitalLossesUsedAgainstCapitalGainsPercentage_900c6636-a359-4bf8-bd1d-dca8833a4feb" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:href="sny-20221231.xsd#sny_ProvisionsAndOtherNonCurrentLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_d17becb2-7606-4507-9397-d4c3ddbfc7d3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_d17becb2-7606-4507-9397-d4c3ddbfc7d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_d17becb2-7606-4507-9397-d4c3ddbfc7d3_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_d17becb2-7606-4507-9397-d4c3ddbfc7d3" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_d17becb2-7606-4507-9397-d4c3ddbfc7d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_d17becb2-7606-4507-9397-d4c3ddbfc7d3" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LumpSumRetirementBenefitPlansMember_240d9eee-0066-413b-bee1-4c9117588346" xlink:href="sny-20221231.xsd#sny_LumpSumRetirementBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_sny_LumpSumRetirementBenefitPlansMember_240d9eee-0066-413b-bee1-4c9117588346" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefinedBenefitPensionPlansMember_bc216d86-b2db-468c-b87d-31d4fc260c16" xlink:href="sny-20221231.xsd#sny_DefinedBenefitPensionPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_sny_DefinedBenefitPensionPlansMember_bc216d86-b2db-468c-b87d-31d4fc260c16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TopUpDefinedBenefitPensionPlanMember_6b3e1ec2-0e48-490d-868a-f2ba9153d0c6" xlink:href="sny-20221231.xsd#sny_TopUpDefinedBenefitPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_sny_TopUpDefinedBenefitPensionPlanMember_6b3e1ec2-0e48-490d-868a-f2ba9153d0c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiaventisPlusPensionPlanMember_7b24ab30-dbed-4418-b324-00ecc7a5fab4" xlink:href="sny-20221231.xsd#sny_SanofiaventisPlusPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_sny_SanofiaventisPlusPensionPlanMember_7b24ab30-dbed-4418-b324-00ecc7a5fab4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MultiemployerDefinedBenefitPlansMember_f55bd040-c433-46b5-a184-ee82f3c29822" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MultiemployerDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_ifrs-full_MultiemployerDefinedBenefitPlansMember_f55bd040-c433-46b5-a184-ee82f3c29822" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HealthcareCoverAndLifeInsuranceMember_1e2a1ecc-3f61-49db-9b65-6cc9e02bf502" xlink:href="sny-20221231.xsd#sny_HealthcareCoverAndLifeInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_sny_HealthcareCoverAndLifeInsuranceMember_1e2a1ecc-3f61-49db-9b65-6cc9e02bf502" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_6c9ccf3f-ec35-4087-9431-5c9e6d506820" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_GeographicalAreasAxis_6c9ccf3f-ec35-4087-9431-5c9e6d506820" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_6c9ccf3f-ec35-4087-9431-5c9e6d506820_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_6c9ccf3f-ec35-4087-9431-5c9e6d506820" xlink:to="loc_ifrs-full_GeographicalAreasMember_6c9ccf3f-ec35-4087-9431-5c9e6d506820_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_6c9ccf3f-ec35-4087-9431-5c9e6d506820" xlink:to="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_f496f051-d89b-478d-a782-cf30f66f688d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:to="loc_country_FR_f496f051-d89b-478d-a782-cf30f66f688d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_9d3dcb35-210e-41d4-af9f-81d8b61e4f6b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:to="loc_country_DE_9d3dcb35-210e-41d4-af9f-81d8b61e4f6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5f8d8c9f-5169-447b-8ef5-3c5d0a2fb2ab" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:to="loc_country_US_5f8d8c9f-5169-447b-8ef5-3c5d0a2fb2ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_0503b6fa-ef98-4969-bf55-9b04ed11f431" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:to="loc_country_GB_0503b6fa-ef98-4969-bf55-9b04ed11f431" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_9ebd668e-5a6a-445c-9a23-fe70ca4b32ea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_RangeAxis_9ebd668e-5a6a-445c-9a23-fe70ca4b32ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_9ebd668e-5a6a-445c-9a23-fe70ca4b32ea_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_9ebd668e-5a6a-445c-9a23-fe70ca4b32ea" xlink:to="loc_ifrs-full_RangesMember_9ebd668e-5a6a-445c-9a23-fe70ca4b32ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_06030ae4-ffa4-4ab2-a7f1-3014d63bad17" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_9ebd668e-5a6a-445c-9a23-fe70ca4b32ea" xlink:to="loc_ifrs-full_RangesMember_06030ae4-ffa4-4ab2-a7f1-3014d63bad17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_e8c4bbbd-9484-402e-9ded-2639532269ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_06030ae4-ffa4-4ab2-a7f1-3014d63bad17" xlink:to="loc_ifrs-full_BottomOfRangeMember_e8c4bbbd-9484-402e-9ded-2639532269ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_d185d0e0-59e7-4cee-bf6e-5a1137497bff" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_06030ae4-ffa4-4ab2-a7f1-3014d63bad17" xlink:to="loc_ifrs-full_TopOfRangeMember_d185d0e0-59e7-4cee-bf6e-5a1137497bff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_4eda634a-e418-4da9-882d-2cc295a72ea3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_4eda634a-e418-4da9-882d-2cc295a72ea3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_4eda634a-e418-4da9-882d-2cc295a72ea3_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_4eda634a-e418-4da9-882d-2cc295a72ea3" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_4eda634a-e418-4da9-882d-2cc295a72ea3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_4eda634a-e418-4da9-882d-2cc295a72ea3" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QualifiedDefinedBenefitPensionPlansMember_7a03853f-0bb7-402a-ab80-5a6a92a0b717" xlink:href="sny-20221231.xsd#sny_QualifiedDefinedBenefitPensionPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:to="loc_sny_QualifiedDefinedBenefitPensionPlansMember_7a03853f-0bb7-402a-ab80-5a6a92a0b717" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonQualifiedDefinedBenefitPensionPlansMember_67dd4171-79b5-44fd-b0ae-af772d3d8a63" xlink:href="sny-20221231.xsd#sny_NonQualifiedDefinedBenefitPensionPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:to="loc_sny_NonQualifiedDefinedBenefitPensionPlansMember_67dd4171-79b5-44fd-b0ae-af772d3d8a63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsMember_a05b3516-f34e-4939-873e-96600675be01" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:to="loc_ifrs-full_PlanAssetsMember_a05b3516-f34e-4939-873e-96600675be01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UncertaintiesOverIncomeTaxTreatmentsMember_db95bb40-62bd-4906-bffe-e792cd0a447a" xlink:href="sny-20221231.xsd#sny_UncertaintiesOverIncomeTaxTreatmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:to="loc_sny_UncertaintiesOverIncomeTaxTreatmentsMember_db95bb40-62bd-4906-bffe-e792cd0a447a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_5f1d022f-bcbc-4777-ab52-1e823bc61411" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_5f1d022f-bcbc-4777-ab52-1e823bc61411" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_5f1d022f-bcbc-4777-ab52-1e823bc61411_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_5f1d022f-bcbc-4777-ab52-1e823bc61411" xlink:to="loc_ifrs-full_OtherProvisionsMember_5f1d022f-bcbc-4777-ab52-1e823bc61411_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_1d799e11-7b00-4eab-88c9-9a96e1791537" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_5f1d022f-bcbc-4777-ab52-1e823bc61411" xlink:to="loc_ifrs-full_OtherProvisionsMember_1d799e11-7b00-4eab-88c9-9a96e1791537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NewBusinessModelRolloutInVariousGeographiesMember_69dacef5-9afb-4ad3-825f-b312ae4b10f6" xlink:href="sny-20221231.xsd#sny_NewBusinessModelRolloutInVariousGeographiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_1d799e11-7b00-4eab-88c9-9a96e1791537" xlink:to="loc_sny_NewBusinessModelRolloutInVariousGeographiesMember_69dacef5-9afb-4ad3-825f-b312ae4b10f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherEnvironmentRelatedProvisionMember_843d9ced-b83c-4299-95c5-8508838277bc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherEnvironmentRelatedProvisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_1d799e11-7b00-4eab-88c9-9a96e1791537" xlink:to="loc_ifrs-full_OtherEnvironmentRelatedProvisionMember_843d9ced-b83c-4299-95c5-8508838277bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_a21c5666-4f4d-4adb-8903-28bdd83ca722" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_a21c5666-4f4d-4adb-8903-28bdd83ca722" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_a21c5666-4f4d-4adb-8903-28bdd83ca722_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_a21c5666-4f4d-4adb-8903-28bdd83ca722" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_a21c5666-4f4d-4adb-8903-28bdd83ca722_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_9e333b61-1517-4e45-a2ef-a92848ce037e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_a21c5666-4f4d-4adb-8903-28bdd83ca722" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_9e333b61-1517-4e45-a2ef-a92848ce037e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EvotecMember_08f727a9-7d64-4d2d-a4de-2224a20997ed" xlink:href="sny-20221231.xsd#sny_EvotecMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_9e333b61-1517-4e45-a2ef-a92848ce037e" xlink:to="loc_sny_EvotecMember_08f727a9-7d64-4d2d-a4de-2224a20997ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_f2b1c005-66f6-40a6-b967-da1009c43ee2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_MaturityAxis_f2b1c005-66f6-40a6-b967-da1009c43ee2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_f2b1c005-66f6-40a6-b967-da1009c43ee2_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_f2b1c005-66f6-40a6-b967-da1009c43ee2" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_f2b1c005-66f6-40a6-b967-da1009c43ee2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_fe814282-8ea7-4c65-a464-70cb5cd55d2d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_f2b1c005-66f6-40a6-b967-da1009c43ee2" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_fe814282-8ea7-4c65-a464-70cb5cd55d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearMember_c1454241-e51d-41f9-b859-e0388c50c39f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_fe814282-8ea7-4c65-a464-70cb5cd55d2d" xlink:to="loc_ifrs-full_LaterThanOneYearMember_c1454241-e51d-41f9-b859-e0388c50c39f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_b33bbddd-5d17-43e9-887b-56c31b8235c7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_b33bbddd-5d17-43e9-887b-56c31b8235c7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_b33bbddd-5d17-43e9-887b-56c31b8235c7_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_b33bbddd-5d17-43e9-887b-56c31b8235c7" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_b33bbddd-5d17-43e9-887b-56c31b8235c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_27235a40-04cb-45a7-914f-13428ffe939a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_b33bbddd-5d17-43e9-887b-56c31b8235c7" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_27235a40-04cb-45a7-914f-13428ffe939a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_USLegalRestructuringMember_8e3df5f2-e342-41d9-8624-bfcaeea48ff6" xlink:href="sny-20221231.xsd#sny_USLegalRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_27235a40-04cb-45a7-914f-13428ffe939a" xlink:to="loc_sny_USLegalRestructuringMember_8e3df5f2-e342-41d9-8624-bfcaeea48ff6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails" xlink:type="extended" id="i4f81327e4bdc4cb2b3597586221e5f10_ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_9aaa1b3a-5007-4d7a-acf5-deb22c60f402" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_9aaa1b3a-5007-4d7a-acf5-deb22c60f402" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_f9fb74a5-f903-4b13-b50e-ab1214e6cbf6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_f9fb74a5-f903-4b13-b50e-ab1214e6cbf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_18a0c3fd-f3e5-4d83-bac3-d89938c6a42d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_18a0c3fd-f3e5-4d83-bac3-d89938c6a42d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates_98990ea6-c15b-422c-8e43-59391b7796f2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates_98990ea6-c15b-422c-8e43-59391b7796f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange_3598600e-f810-44e4-a0be-cce9d0e3e6b2" xlink:href="sny-20221231.xsd#sny_ActuarialAssumptionOfRetirementAgeBottomOfRange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange_3598600e-f810-44e4-a0be-cce9d0e3e6b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialAssumptionOfRetirementAgeTopOfRange_8ece1789-578b-4796-9491-fd34435c4856" xlink:href="sny-20221231.xsd#sny_ActuarialAssumptionOfRetirementAgeTopOfRange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_sny_ActuarialAssumptionOfRetirementAgeTopOfRange_8ece1789-578b-4796-9491-fd34435c4856" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_90324afa-db7b-4ded-8c2b-23e3e15cd368" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_90324afa-db7b-4ded-8c2b-23e3e15cd368" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_00efd1b5-a6b1-483e-897a-cdf55df32c7c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_00efd1b5-a6b1-483e-897a-cdf55df32c7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_a6fc76c3-815a-4279-bdeb-b0e4c2bd2d67" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_00efd1b5-a6b1-483e-897a-cdf55df32c7c" xlink:to="loc_ifrs-full_GeographicalAreasAxis_a6fc76c3-815a-4279-bdeb-b0e4c2bd2d67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_a6fc76c3-815a-4279-bdeb-b0e4c2bd2d67_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_a6fc76c3-815a-4279-bdeb-b0e4c2bd2d67" xlink:to="loc_ifrs-full_GeographicalAreasMember_a6fc76c3-815a-4279-bdeb-b0e4c2bd2d67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_a6fc76c3-815a-4279-bdeb-b0e4c2bd2d67" xlink:to="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_9c034e78-572d-42d0-9af2-c8d5a3192744" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:to="loc_country_FR_9c034e78-572d-42d0-9af2-c8d5a3192744" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_087cd224-1867-4ffe-b123-cd2a52799f2a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:to="loc_country_DE_087cd224-1867-4ffe-b123-cd2a52799f2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_370b2968-6cec-45bc-9239-40af8c0d081a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:to="loc_country_US_370b2968-6cec-45bc-9239-40af8c0d081a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_37fc1b8a-fcbf-4ba9-abf1-f18c44664712" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:to="loc_country_GB_37fc1b8a-fcbf-4ba9-abf1-f18c44664712" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_1d307ac0-86a4-44b0-886c-1b28fca2eb25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_00efd1b5-a6b1-483e-897a-cdf55df32c7c" xlink:to="loc_ifrs-full_RangeAxis_1d307ac0-86a4-44b0-886c-1b28fca2eb25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_1d307ac0-86a4-44b0-886c-1b28fca2eb25_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_1d307ac0-86a4-44b0-886c-1b28fca2eb25" xlink:to="loc_ifrs-full_RangesMember_1d307ac0-86a4-44b0-886c-1b28fca2eb25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_1d307ac0-86a4-44b0-886c-1b28fca2eb25" xlink:to="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_e18e6cfc-c52a-4d39-b1de-9c64cf1f7c57" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_ifrs-full_BottomOfRangeMember_e18e6cfc-c52a-4d39-b1de-9c64cf1f7c57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_641f554d-817c-4065-81a3-82eef638796d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_ifrs-full_TopOfRangeMember_641f554d-817c-4065-81a3-82eef638796d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinimumPlan1Member_7aced359-e6e0-4884-9cd5-61d3479c943e" xlink:href="sny-20221231.xsd#sny_MinimumPlan1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_sny_MinimumPlan1Member_7aced359-e6e0-4884-9cd5-61d3479c943e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumPlan1Member_36e303fa-2c6e-49a1-9934-a369608dcf39" xlink:href="sny-20221231.xsd#sny_MaximumPlan1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_sny_MaximumPlan1Member_36e303fa-2c6e-49a1-9934-a369608dcf39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinimumPlan2Member_df4e527e-c8b9-44a2-9ddc-140d2d177518" xlink:href="sny-20221231.xsd#sny_MinimumPlan2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_sny_MinimumPlan2Member_df4e527e-c8b9-44a2-9ddc-140d2d177518" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumPlan2Member_585ee70e-8775-4e27-8e7d-a211ce944399" xlink:href="sny-20221231.xsd#sny_MaximumPlan2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_sny_MaximumPlan2Member_585ee70e-8775-4e27-8e7d-a211ce944399" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails" xlink:type="extended" id="i086421fbf78e4964a6476b3c0bbc5cb4_ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_74ce87d4-9854-4644-98c3-3b0a3ab03727" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_4f0ee3a3-e1a2-47a0-a1a2-c58ce233faf8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_74ce87d4-9854-4644-98c3-3b0a3ab03727" xlink:to="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_4f0ee3a3-e1a2-47a0-a1a2-c58ce233faf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_cfb86bb2-1e79-498c-b950-42f27c08cd84" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_74ce87d4-9854-4644-98c3-3b0a3ab03727" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_cfb86bb2-1e79-498c-b950-42f27c08cd84" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_fc9c7526-4ff1-433f-8714-954022b9ca6c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_cfb86bb2-1e79-498c-b950-42f27c08cd84" xlink:to="loc_ifrs-full_GeographicalAreasAxis_fc9c7526-4ff1-433f-8714-954022b9ca6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_fc9c7526-4ff1-433f-8714-954022b9ca6c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_fc9c7526-4ff1-433f-8714-954022b9ca6c" xlink:to="loc_ifrs-full_GeographicalAreasMember_fc9c7526-4ff1-433f-8714-954022b9ca6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_fc9c7526-4ff1-433f-8714-954022b9ca6c" xlink:to="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_081f3381-1b0f-4558-81fe-4f29b03d593c" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:to="loc_country_FR_081f3381-1b0f-4558-81fe-4f29b03d593c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_8becaea5-91bc-436b-ba58-c79e6b2c99fa" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:to="loc_country_DE_8becaea5-91bc-436b-ba58-c79e6b2c99fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_52ff9997-b61e-4c2a-9d94-cd7652879da4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:to="loc_country_US_52ff9997-b61e-4c2a-9d94-cd7652879da4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_73ea2580-b091-48b8-8b93-eca809e8ad05" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:to="loc_country_GB_73ea2580-b091-48b8-8b93-eca809e8ad05" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails" xlink:type="extended" id="i617fe622ed43445b95f0e16212faefa2_ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_1ced9c31-758c-40cf-baf7-c36a849e3672" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_1ced9c31-758c-40cf-baf7-c36a849e3672" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_b0afcfe9-615a-4065-b1bd-6da0b3a526d4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_b0afcfe9-615a-4065-b1bd-6da0b3a526d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_35d7bc7b-e8f5-4c90-9cb2-9d10dee059f7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_35d7bc7b-e8f5-4c90-9cb2-9d10dee059f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PossibleIncreaseInMortalityTableInYears_c0915316-ff26-4f4d-9e5f-f29c34286558" xlink:href="sny-20221231.xsd#sny_PossibleIncreaseInMortalityTableInYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:to="loc_sny_PossibleIncreaseInMortalityTableInYears_c0915316-ff26-4f4d-9e5f-f29c34286558" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_5ed73301-f66c-4bf3-a8cb-06dc63c01593" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_5ed73301-f66c-4bf3-a8cb-06dc63c01593" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_cb271761-07a2-4131-aedf-c2a26088fbea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_5ed73301-f66c-4bf3-a8cb-06dc63c01593" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_cb271761-07a2-4131-aedf-c2a26088fbea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_cb271761-07a2-4131-aedf-c2a26088fbea_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_cb271761-07a2-4131-aedf-c2a26088fbea" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_cb271761-07a2-4131-aedf-c2a26088fbea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_cb271761-07a2-4131-aedf-c2a26088fbea" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_fff9e774-0bf0-41b8-8b89-b54c80c8c205" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:to="loc_country_FR_fff9e774-0bf0-41b8-8b89-b54c80c8c205" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_b574c252-77e2-4dac-8259-bc7c3fe864cc" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:to="loc_country_DE_b574c252-77e2-4dac-8259-bc7c3fe864cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d2658667-8620-43fd-b7dc-d59e07187908" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:to="loc_country_US_d2658667-8620-43fd-b7dc-d59e07187908" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_fd9bb928-0728-4475-9067-84444fc119d4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:to="loc_country_GB_fd9bb928-0728-4475-9067-84444fc119d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis_357e1f2c-33b6-4c92-b501-627763ba2b6d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_5ed73301-f66c-4bf3-a8cb-06dc63c01593" xlink:to="loc_ifrs-full_ActuarialAssumptionsAxis_357e1f2c-33b6-4c92-b501-627763ba2b6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsMember_357e1f2c-33b6-4c92-b501-627763ba2b6d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_357e1f2c-33b6-4c92-b501-627763ba2b6d" xlink:to="loc_ifrs-full_ActuarialAssumptionsMember_357e1f2c-33b6-4c92-b501-627763ba2b6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_357e1f2c-33b6-4c92-b501-627763ba2b6d" xlink:to="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_52486c28-d847-489e-9037-01edbedebd5f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_52486c28-d847-489e-9037-01edbedebd5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_a88e1bfb-5be7-4b16-80fd-3a6f0b6c98ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_a88e1bfb-5be7-4b16-80fd-3a6f0b6c98ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_808854b4-9949-4e8b-8a0a-69cecb858cd6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_808854b4-9949-4e8b-8a0a-69cecb858cd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember_cbc26c96-8364-4bcf-acc2-f11c04c1539d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:to="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember_cbc26c96-8364-4bcf-acc2-f11c04c1539d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialAssumptionOfMortalityTableMember_e7b3bd4c-4fe0-4352-97ec-e322c20e466d" xlink:href="sny-20221231.xsd#sny_ActuarialAssumptionOfMortalityTableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:to="loc_sny_ActuarialAssumptionOfMortalityTableMember_e7b3bd4c-4fe0-4352-97ec-e322c20e466d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="extended" id="i7622a7a78b5e45d9b349b7205e43ad1c_ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_0c4e2d91-9b00-4c33-a1b1-d8cf50906266" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_0c4e2d91-9b00-4c33-a1b1-d8cf50906266" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_6b8d5880-618f-40b2-a8ee-6ec0c9d0e22a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_6b8d5880-618f-40b2-a8ee-6ec0c9d0e22a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_e8c8c007-9a0b-4f28-bed0-fc991319472b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_e8c8c007-9a0b-4f28-bed0-fc991319472b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_55015121-69e6-4e68-80dc-40f8fd7fd656" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_55015121-69e6-4e68-80dc-40f8fd7fd656" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_6db6c496-8e37-4977-bbcb-96832de6574c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_6db6c496-8e37-4977-bbcb-96832de6574c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_2a9388bd-6588-47b1-9da8-d4ab74c687fe" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_2a9388bd-6588-47b1-9da8-d4ab74c687fe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan_44f25bde-88c2-46b5-9173-f4872f6ba010" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan_44f25bde-88c2-46b5-9173-f4872f6ba010" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset_65240598-b557-46cf-bb48-22cfaa562f82" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset_65240598-b557-46cf-bb48-22cfaa562f82" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BenefitsPaidOrPayable_80fbb06a-819d-4213-a0f0-582e792cfc7f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BenefitsPaidOrPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_BenefitsPaidOrPayable_80fbb06a-819d-4213-a0f0-582e792cfc7f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset_53d58f13-c70a-4d83-bd61-f2087da92a1e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset_53d58f13-c70a-4d83-bd61-f2087da92a1e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_bdf2cb1f-91be-41fe-9d7d-bebbe269163e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_bdf2cb1f-91be-41fe-9d7d-bebbe269163e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_4bd8f19d-c963-428f-bd20-3777315dad81" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_4bd8f19d-c963-428f-bd20-3777315dad81" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod_2fbc9046-17b4-4997-a16c-a3a43982ea3b" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod_2fbc9046-17b4-4997-a16c-a3a43982ea3b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_47d39579-b256-4149-a17c-21268cd9d51c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_47d39579-b256-4149-a17c-21268cd9d51c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_c96e88f4-f9ad-4b0b-a000-905372721d47" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_c96e88f4-f9ad-4b0b-a000-905372721d47" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_b705c691-9f84-4348-a994-4397f35cbfdb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_b705c691-9f84-4348-a994-4397f35cbfdb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_c781939e-ce01-4623-8fa4-3e4fa5a7fa01" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_c781939e-ce01-4623-8fa4-3e4fa5a7fa01" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PreFundedPensionObligations_3c7b72e8-9cb4-48b0-bbc1-28c44cce41d7" xlink:href="sny-20221231.xsd#sny_PreFundedPensionObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_PreFundedPensionObligations_3c7b72e8-9cb4-48b0-bbc1-28c44cce41d7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions_d597f63c-98b4-475a-b3f6-af9964c91e6d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_NoncurrentProvisions_d597f63c-98b4-475a-b3f6-af9964c91e6d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_1262a557-72cf-4ca6-8baf-0719731d4794" xlink:href="sny-20221231.xsd#sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_1262a557-72cf-4ca6-8baf-0719731d4794" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_40191547-fd24-44f3-b631-faaa790903c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_071f7d7c-3264-4b6c-ba88-94d3fffb592a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_071f7d7c-3264-4b6c-ba88-94d3fffb592a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeeBenefitsExpenseGain_79c0da97-9889-4ec6-8337-1e258e14f0c7" xlink:href="sny-20221231.xsd#sny_EmployeeBenefitsExpenseGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_EmployeeBenefitsExpenseGain_79c0da97-9889-4ec6-8337-1e258e14f0c7" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_ea93c465-0322-4348-b5d3-d8aba829a26a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_ea93c465-0322-4348-b5d3-d8aba829a26a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_ea93c465-0322-4348-b5d3-d8aba829a26a_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_ea93c465-0322-4348-b5d3-d8aba829a26a" xlink:to="loc_ifrs-full_OtherProvisionsMember_ea93c465-0322-4348-b5d3-d8aba829a26a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_32db38cb-3ed3-4d15-b986-5591bdc27262" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_ea93c465-0322-4348-b5d3-d8aba829a26a" xlink:to="loc_ifrs-full_OtherProvisionsMember_32db38cb-3ed3-4d15-b986-5591bdc27262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember_fcbdb788-ecb2-4fcc-bb3c-074169646b98" xlink:href="sny-20221231.xsd#sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_32db38cb-3ed3-4d15-b986-5591bdc27262" xlink:to="loc_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember_fcbdb788-ecb2-4fcc-bb3c-074169646b98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_86610256-167c-4fbc-84d0-8629131dfe5c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_86610256-167c-4fbc-84d0-8629131dfe5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_86610256-167c-4fbc-84d0-8629131dfe5c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_86610256-167c-4fbc-84d0-8629131dfe5c" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_86610256-167c-4fbc-84d0-8629131dfe5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_36028c8e-c379-4908-807e-9f44641a44c1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_86610256-167c-4fbc-84d0-8629131dfe5c" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_36028c8e-c379-4908-807e-9f44641a44c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_c2b7b27b-1d39-48af-8722-af8556937d37" xlink:href="sny-20221231.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_36028c8e-c379-4908-807e-9f44641a44c1" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_c2b7b27b-1d39-48af-8722-af8556937d37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_c1cc2119-f9ab-46d5-8934-f003676f097a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_c1cc2119-f9ab-46d5-8934-f003676f097a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_c1cc2119-f9ab-46d5-8934-f003676f097a_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_c1cc2119-f9ab-46d5-8934-f003676f097a" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_c1cc2119-f9ab-46d5-8934-f003676f097a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_45bd11fe-db64-4400-bdb0-bf2768c803ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_c1cc2119-f9ab-46d5-8934-f003676f097a" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_45bd11fe-db64-4400-bdb0-bf2768c803ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_3d6069a6-5870-4c3f-be0b-723c41e3037c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_45bd11fe-db64-4400-bdb0-bf2768c803ef" xlink:to="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_3d6069a6-5870-4c3f-be0b-723c41e3037c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsMember_23e49292-432d-42ae-9826-3440603fbe18" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_45bd11fe-db64-4400-bdb0-bf2768c803ef" xlink:to="loc_ifrs-full_PlanAssetsMember_23e49292-432d-42ae-9826-3440603fbe18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfAssetCeilingMember_276b49d5-2356-4c3c-a726-d94717fdc95f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfAssetCeilingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_45bd11fe-db64-4400-bdb0-bf2768c803ef" xlink:to="loc_ifrs-full_EffectOfAssetCeilingMember_276b49d5-2356-4c3c-a726-d94717fdc95f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_e5f471ca-90c4-4e4f-8312-b6d0b43bd0db" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:to="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_e5f471ca-90c4-4e4f-8312-b6d0b43bd0db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_e5f471ca-90c4-4e4f-8312-b6d0b43bd0db_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_e5f471ca-90c4-4e4f-8312-b6d0b43bd0db" xlink:to="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_e5f471ca-90c4-4e4f-8312-b6d0b43bd0db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_c1a000a9-dcf2-403a-9172-bd43ee6411e1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_e5f471ca-90c4-4e4f-8312-b6d0b43bd0db" xlink:to="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_c1a000a9-dcf2-403a-9172-bd43ee6411e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember_cd166355-7667-427a-95b5-87fe07e46a8f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_c1a000a9-dcf2-403a-9172-bd43ee6411e1" xlink:to="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember_cd166355-7667-427a-95b5-87fe07e46a8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_de2b184e-8fc9-4eac-8728-4cfbd1a54625" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_de2b184e-8fc9-4eac-8728-4cfbd1a54625" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_de2b184e-8fc9-4eac-8728-4cfbd1a54625_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_de2b184e-8fc9-4eac-8728-4cfbd1a54625" xlink:to="loc_ifrs-full_GeographicalAreasMember_de2b184e-8fc9-4eac-8728-4cfbd1a54625_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_4c8fcda1-bad2-4182-87db-cee7837b5344" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_de2b184e-8fc9-4eac-8728-4cfbd1a54625" xlink:to="loc_ifrs-full_GeographicalAreasMember_4c8fcda1-bad2-4182-87db-cee7837b5344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_ecaf12be-7027-485d-b83e-1b0bc33e113a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_4c8fcda1-bad2-4182-87db-cee7837b5344" xlink:to="loc_country_GB_ecaf12be-7027-485d-b83e-1b0bc33e113a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails" xlink:type="extended" id="if425349fda174b7d8c5eea2ebe80ace6_ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_d265d183-ff0a-431a-84d6-ec588b3e22a6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_d265d183-ff0a-431a-84d6-ec588b3e22a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_a2e98ba2-4f42-4a54-bf7e-7a48f408e5e5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_a2e98ba2-4f42-4a54-bf7e-7a48f408e5e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlanAssetsEffectOfAssetCeiling_5abb4943-a531-424f-8b10-dc2b5509197a" xlink:href="sny-20221231.xsd#sny_PlanAssetsEffectOfAssetCeiling"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:to="loc_sny_PlanAssetsEffectOfAssetCeiling_5abb4943-a531-424f-8b10-dc2b5509197a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_7c052601-98a1-4c7e-9576-8ffd85aa9f48" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_7c052601-98a1-4c7e-9576-8ffd85aa9f48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_01a08aa3-0271-4ac3-9223-e63f808d970c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_01a08aa3-0271-4ac3-9223-e63f808d970c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_3cbe9058-f3ae-4fc6-9fc9-9e5aae5da216" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_01a08aa3-0271-4ac3-9223-e63f808d970c" xlink:to="loc_ifrs-full_GeographicalAreasAxis_3cbe9058-f3ae-4fc6-9fc9-9e5aae5da216" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_3cbe9058-f3ae-4fc6-9fc9-9e5aae5da216_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_3cbe9058-f3ae-4fc6-9fc9-9e5aae5da216" xlink:to="loc_ifrs-full_GeographicalAreasMember_3cbe9058-f3ae-4fc6-9fc9-9e5aae5da216_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_3cbe9058-f3ae-4fc6-9fc9-9e5aae5da216" xlink:to="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_00a7371a-a7cf-4e80-b7db-c9541e15118e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:to="loc_country_FR_00a7371a-a7cf-4e80-b7db-c9541e15118e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_994035c8-c511-42e9-a749-b65defae4236" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:to="loc_country_DE_994035c8-c511-42e9-a749-b65defae4236" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_231cff0e-7fe7-4d3c-b00a-070d2f29beda" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:to="loc_country_US_231cff0e-7fe7-4d3c-b00a-070d2f29beda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_254e0dd0-9417-4f58-b138-2ba74eb7b5da" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:to="loc_country_GB_254e0dd0-9417-4f58-b138-2ba74eb7b5da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_0941630f-881c-4954-b7f0-20b8a2205413" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:to="loc_sny_OtherCountriesMember_0941630f-881c-4954-b7f0-20b8a2205413" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_6ec01ed6-3e5d-48d1-9293-bc231bd4070b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_01a08aa3-0271-4ac3-9223-e63f808d970c" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_6ec01ed6-3e5d-48d1-9293-bc231bd4070b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_6ec01ed6-3e5d-48d1-9293-bc231bd4070b_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_6ec01ed6-3e5d-48d1-9293-bc231bd4070b" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_6ec01ed6-3e5d-48d1-9293-bc231bd4070b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_7693b71f-d019-4302-9902-f0de685c59d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_6ec01ed6-3e5d-48d1-9293-bc231bd4070b" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_7693b71f-d019-4302-9902-f0de685c59d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_be7a4f11-5fcc-4e9a-8261-11c7acc6fbf3" xlink:href="sny-20221231.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_7693b71f-d019-4302-9902-f0de685c59d0" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_be7a4f11-5fcc-4e9a-8261-11c7acc6fbf3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails" xlink:type="extended" id="ib11985b29b0346199225ba49e5396bef_ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_bce7093d-5095-46fd-b38b-ea42a832eb25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket_bd70f479-4745-4a92-b8a7-d929424ed501" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_bce7093d-5095-46fd-b38b-ea42a832eb25" xlink:to="loc_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket_bd70f479-4745-4a92-b8a7-d929424ed501" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities_b7c6af37-7389-4561-ba56-2f4189a1d288" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_bce7093d-5095-46fd-b38b-ea42a832eb25" xlink:to="loc_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities_b7c6af37-7389-4561-ba56-2f4189a1d288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssets_08d8f6b8-350c-4e0e-86e8-22a24d1781aa" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_bce7093d-5095-46fd-b38b-ea42a832eb25" xlink:to="loc_sny_PercentageContributedToFairValueOfPlanAssets_08d8f6b8-350c-4e0e-86e8-22a24d1781aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_6a5435ed-d88a-427d-ab17-323368f7e800" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_bce7093d-5095-46fd-b38b-ea42a832eb25" xlink:to="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_6a5435ed-d88a-427d-ab17-323368f7e800" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_e2e43bca-2fab-4ac0-b455-bf9f06c1ccf0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_6a5435ed-d88a-427d-ab17-323368f7e800" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_e2e43bca-2fab-4ac0-b455-bf9f06c1ccf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_e2e43bca-2fab-4ac0-b455-bf9f06c1ccf0_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_e2e43bca-2fab-4ac0-b455-bf9f06c1ccf0" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_e2e43bca-2fab-4ac0-b455-bf9f06c1ccf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_e2e43bca-2fab-4ac0-b455-bf9f06c1ccf0" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashAndCashEquivalentsMember_849a4d9e-8cd7-4177-88b0-60ec08ebc070" xlink:href="sny-20221231.xsd#sny_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_CashAndCashEquivalentsMember_849a4d9e-8cd7-4177-88b0-60ec08ebc070" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInstrumentsMember_17d6a1c8-964e-4458-8866-a2752d69a235" xlink:href="sny-20221231.xsd#sny_EquityInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_EquityInstrumentsMember_17d6a1c8-964e-4458-8866-a2752d69a235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BondsAndSimilarInstrumentsMember_ceb72cdd-5c8d-442d-a010-daffd5736f0b" xlink:href="sny-20221231.xsd#sny_BondsAndSimilarInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_BondsAndSimilarInstrumentsMember_ceb72cdd-5c8d-442d-a010-daffd5736f0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RealEstateMember_2746e415-9e2a-4408-a132-30c237b63838" xlink:href="sny-20221231.xsd#sny_RealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_RealEstateMember_2746e415-9e2a-4408-a132-30c237b63838" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativesMember_a3de2377-5be5-411e-bdae-cacb01dbd0cd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_ifrs-full_DerivativesMember_a3de2377-5be5-411e-bdae-cacb01dbd0cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommoditiesMember_6da30f9d-a6a2-45ed-bb73-aca7f574631f" xlink:href="sny-20221231.xsd#sny_CommoditiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_CommoditiesMember_6da30f9d-a6a2-45ed-bb73-aca7f574631f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAssetsMember_13e27b80-cbec-4431-94cf-d0222a829ed6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_ifrs-full_OtherAssetsMember_13e27b80-cbec-4431-94cf-d0222a829ed6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HedgeFundsMember_3c5f9f3b-9c59-4d46-8b8d-a23769602fd8" xlink:href="sny-20221231.xsd#sny_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_HedgeFundsMember_3c5f9f3b-9c59-4d46-8b8d-a23769602fd8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InsurancePoliciesMember_58572f42-5bbd-4a68-a4d2-2ade8d23a3ff" xlink:href="sny-20221231.xsd#sny_InsurancePoliciesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_InsurancePoliciesMember_58572f42-5bbd-4a68-a4d2-2ade8d23a3ff" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails" xlink:type="extended" id="iad243a3a021049fdb9bfe5e44f9f6776_ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_de810da9-e77b-4051-838c-1e74a21350f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_de810da9-e77b-4051-838c-1e74a21350f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement_4741fe7c-cbfd-4e7a-a287-2bdb789acdc5" xlink:href="sny-20221231.xsd#sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement_4741fe7c-cbfd-4e7a-a287-2bdb789acdc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset_921e69a1-ac4e-495c-a436-fb74d36d0365" xlink:href="sny-20221231.xsd#sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset_921e69a1-ac4e-495c-a436-fb74d36d0365" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_8334f96a-3b35-4e11-be93-98e1d17e772b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_8334f96a-3b35-4e11-be93-98e1d17e772b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_79106108-026f-4561-962c-237b9cb3f9eb" xlink:href="sny-20221231.xsd#sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_79106108-026f-4561-962c-237b9cb3f9eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_153b8c0a-ecc5-45b8-9129-aad104c292e9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_153b8c0a-ecc5-45b8-9129-aad104c292e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset_1ddf6181-d98f-4ff9-a1b4-4e550a720bed" xlink:href="sny-20221231.xsd#sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset_1ddf6181-d98f-4ff9-a1b4-4e550a720bed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_69f172ee-717e-48b7-bdd4-5fff2e8ec205" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_69f172ee-717e-48b7-bdd4-5fff2e8ec205" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_4e193c2f-bb0c-4b51-8fe2-772bf52c31b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_69f172ee-717e-48b7-bdd4-5fff2e8ec205" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_4e193c2f-bb0c-4b51-8fe2-772bf52c31b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_4e193c2f-bb0c-4b51-8fe2-772bf52c31b8_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_4e193c2f-bb0c-4b51-8fe2-772bf52c31b8" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_4e193c2f-bb0c-4b51-8fe2-772bf52c31b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_85f51fdf-15c5-493d-815a-b691f42be464" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_4e193c2f-bb0c-4b51-8fe2-772bf52c31b8" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_85f51fdf-15c5-493d-815a-b691f42be464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_9ff4697e-41cb-4a22-8bc3-f4b0531532c1" xlink:href="sny-20221231.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_85f51fdf-15c5-493d-815a-b691f42be464" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_9ff4697e-41cb-4a22-8bc3-f4b0531532c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_d0ecbe3c-60e5-4a8d-9bba-e1c565a4878c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_69f172ee-717e-48b7-bdd4-5fff2e8ec205" xlink:to="loc_ifrs-full_GeographicalAreasAxis_d0ecbe3c-60e5-4a8d-9bba-e1c565a4878c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_d0ecbe3c-60e5-4a8d-9bba-e1c565a4878c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_d0ecbe3c-60e5-4a8d-9bba-e1c565a4878c" xlink:to="loc_ifrs-full_GeographicalAreasMember_d0ecbe3c-60e5-4a8d-9bba-e1c565a4878c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_d0ecbe3c-60e5-4a8d-9bba-e1c565a4878c" xlink:to="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_d801568f-a84c-4b66-b888-9ef67257e405" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:to="loc_country_FR_d801568f-a84c-4b66-b888-9ef67257e405" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_d33103d8-e489-41a4-a2c8-577d8c248f49" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:to="loc_country_DE_d33103d8-e489-41a4-a2c8-577d8c248f49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_30e1ca4d-806f-4e0e-bd09-a4dfe965ec34" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:to="loc_country_US_30e1ca4d-806f-4e0e-bd09-a4dfe965ec34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_7eecb800-56d5-458c-b3be-e830e1d4c8a1" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:to="loc_country_GB_7eecb800-56d5-458c-b3be-e830e1d4c8a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_3d2dffeb-3c29-4dfc-81a7-2866e36194e6" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:to="loc_sny_OtherCountriesMember_3d2dffeb-3c29-4dfc-81a7-2866e36194e6" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails" xlink:type="extended" id="ibea1bce156d64a288f4ea03d7d060141_ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_16cc47dd-48c6-437c-a706-269561cde616" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_16cc47dd-48c6-437c-a706-269561cde616" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments_09a13f10-092d-4f4c-a39c-608de1d44a8e" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:to="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments_09a13f10-092d-4f4c-a39c-608de1d44a8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_66416f0a-d609-4c2d-b744-20e6e5398d51" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_66416f0a-d609-4c2d-b744-20e6e5398d51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_75b9d660-0e7a-41b5-8155-f9fa70fa252b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_75b9d660-0e7a-41b5-8155-f9fa70fa252b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_eafde9b0-27d5-4309-be48-039677bcc194" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_eafde9b0-27d5-4309-be48-039677bcc194" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_176b9a72-0fb3-4d4c-af9c-67929de61989" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_eafde9b0-27d5-4309-be48-039677bcc194" xlink:to="loc_ifrs-full_GeographicalAreasAxis_176b9a72-0fb3-4d4c-af9c-67929de61989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_176b9a72-0fb3-4d4c-af9c-67929de61989_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_176b9a72-0fb3-4d4c-af9c-67929de61989" xlink:to="loc_ifrs-full_GeographicalAreasMember_176b9a72-0fb3-4d4c-af9c-67929de61989_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_176b9a72-0fb3-4d4c-af9c-67929de61989" xlink:to="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_f4f27a46-2b49-4c5e-8db2-0dc9343490e7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:to="loc_country_FR_f4f27a46-2b49-4c5e-8db2-0dc9343490e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_5975236f-5bd8-4f8f-a516-077b6c33cd09" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:to="loc_country_DE_5975236f-5bd8-4f8f-a516-077b6c33cd09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_65ac12c4-52dd-43a2-81e7-05be8ebcc07a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:to="loc_country_US_65ac12c4-52dd-43a2-81e7-05be8ebcc07a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_5b2ec49f-c073-43fb-b240-36d046f4e3bb" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:to="loc_country_GB_5b2ec49f-c073-43fb-b240-36d046f4e3bb" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails" xlink:type="extended" id="i6fa31c0d06b2453c93a2de8ecc1ec388_ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_fd66c71d-c20a-44e7-859b-b417d65d526a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_2890f3b8-2c86-43a1-b475-b82631043311" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_fd66c71d-c20a-44e7-859b-b417d65d526a" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_2890f3b8-2c86-43a1-b475-b82631043311" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_e258db30-785c-4661-b541-51d8433c3c76" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_fd66c71d-c20a-44e7-859b-b417d65d526a" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_e258db30-785c-4661-b541-51d8433c3c76" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_37ca10af-0e0a-41ea-b4a9-31d880343b1e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_e258db30-785c-4661-b541-51d8433c3c76" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_37ca10af-0e0a-41ea-b4a9-31d880343b1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_37ca10af-0e0a-41ea-b4a9-31d880343b1e_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_37ca10af-0e0a-41ea-b4a9-31d880343b1e" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_37ca10af-0e0a-41ea-b4a9-31d880343b1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_82f2bb17-b0d2-4169-a8c9-ce8d271da2d1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_37ca10af-0e0a-41ea-b4a9-31d880343b1e" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_82f2bb17-b0d2-4169-a8c9-ce8d271da2d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_a7c01065-73b8-453d-80e5-e3b2ce1d7a43" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_82f2bb17-b0d2-4169-a8c9-ce8d271da2d1" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_a7c01065-73b8-453d-80e5-e3b2ce1d7a43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_74da1634-98ad-45a0-8e6b-92be973b2c54" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_82f2bb17-b0d2-4169-a8c9-ce8d271da2d1" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_74da1634-98ad-45a0-8e6b-92be973b2c54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_fecb05b2-0491-4661-ab5e-63a25745347b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_e258db30-785c-4661-b541-51d8433c3c76" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_fecb05b2-0491-4661-ab5e-63a25745347b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_fecb05b2-0491-4661-ab5e-63a25745347b_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_fecb05b2-0491-4661-ab5e-63a25745347b" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_fecb05b2-0491-4661-ab5e-63a25745347b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_1d06b4bb-8503-4f78-bad5-9ce38a6e9602" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_fecb05b2-0491-4661-ab5e-63a25745347b" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_1d06b4bb-8503-4f78-bad5-9ce38a6e9602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_3da4a288-9b81-4e21-a4eb-7f1d72fc8750" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_1d06b4bb-8503-4f78-bad5-9ce38a6e9602" xlink:to="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_3da4a288-9b81-4e21-a4eb-7f1d72fc8750" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_8cdc95dd-125b-49b3-a3ac-e749649e786d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_e258db30-785c-4661-b541-51d8433c3c76" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_8cdc95dd-125b-49b3-a3ac-e749649e786d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_8cdc95dd-125b-49b3-a3ac-e749649e786d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_8cdc95dd-125b-49b3-a3ac-e749649e786d" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_8cdc95dd-125b-49b3-a3ac-e749649e786d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_f6721200-ac81-4d4b-bda1-ef53724e795a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_8cdc95dd-125b-49b3-a3ac-e749649e786d" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_f6721200-ac81-4d4b-bda1-ef53724e795a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_26fa8fb9-94f2-48d6-a297-5b548db5b6de" xlink:href="sny-20221231.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_f6721200-ac81-4d4b-bda1-ef53724e795a" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_26fa8fb9-94f2-48d6-a297-5b548db5b6de" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails" xlink:type="extended" id="iff7817dbf787405ca54cdc572ee37bb5_ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_32f4d0d3-d1bd-4f47-80fd-7b6c6d1f21c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_ifrs-full_CostOfSales_32f4d0d3-d1bd-4f47-80fd-7b6c6d1f21c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_eb210d37-4835-4ceb-a8ac-ba4261bcc0ec" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_eb210d37-4835-4ceb-a8ac-ba4261bcc0ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_7c5f1df9-e46d-4cf9-9131-1327864eb91f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_7c5f1df9-e46d-4cf9-9131-1327864eb91f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_3d3a5e66-dc06-49bc-9314-550c9df7c294" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_3d3a5e66-dc06-49bc-9314-550c9df7c294" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestructuringCostsReversedAndSimilarItems_157e5f63-3054-4a46-a57d-92287d5a0578" xlink:href="sny-20221231.xsd#sny_RestructuringCostsReversedAndSimilarItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_sny_RestructuringCostsReversedAndSimilarItems_157e5f63-3054-4a46-a57d-92287d5a0578" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_e53e73cb-3f77-4c8d-abde-d9f14adcdaa7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_ifrs-full_FinanceCosts_e53e73cb-3f77-4c8d-abde-d9f14adcdaa7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_83174792-ccc2-4aa4-b0af-77f2d89326bb" xlink:href="sny-20221231.xsd#sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_83174792-ccc2-4aa4-b0af-77f2d89326bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_edbdea08-0f34-41cf-80a3-b76bbda65f03" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_edbdea08-0f34-41cf-80a3-b76bbda65f03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_4fb79044-2c45-467a-a07a-fec9fd98a02b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_edbdea08-0f34-41cf-80a3-b76bbda65f03" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_4fb79044-2c45-467a-a07a-fec9fd98a02b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_4fb79044-2c45-467a-a07a-fec9fd98a02b_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_4fb79044-2c45-467a-a07a-fec9fd98a02b" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_4fb79044-2c45-467a-a07a-fec9fd98a02b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_ca0e7567-8f20-476e-bf0e-c474ddb33d1a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_4fb79044-2c45-467a-a07a-fec9fd98a02b" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_ca0e7567-8f20-476e-bf0e-c474ddb33d1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_5c3d29c3-e6c8-43e9-b242-7b9c825b7d5e" xlink:href="sny-20221231.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_ca0e7567-8f20-476e-bf0e-c474ddb33d1a" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_5c3d29c3-e6c8-43e9-b242-7b9c825b7d5e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails" xlink:type="extended" id="i7f96bd48435c44068dc4f7bd27af7f6b_ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_7bdd0735-c227-4a8e-a304-b52e63282979" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_2bc515cb-f14d-4df5-8f14-f7e61d14acc7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_7bdd0735-c227-4a8e-a304-b52e63282979" xlink:to="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_2bc515cb-f14d-4df5-8f14-f7e61d14acc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_7c949e9f-2176-4ed4-b996-cbc28099caf2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_7bdd0735-c227-4a8e-a304-b52e63282979" xlink:to="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_7c949e9f-2176-4ed4-b996-cbc28099caf2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_1ac98a73-af1d-4c79-96bd-f2f3ee764ea8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_7c949e9f-2176-4ed4-b996-cbc28099caf2" xlink:to="loc_ifrs-full_MaturityAxis_1ac98a73-af1d-4c79-96bd-f2f3ee764ea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1ac98a73-af1d-4c79-96bd-f2f3ee764ea8_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1ac98a73-af1d-4c79-96bd-f2f3ee764ea8" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1ac98a73-af1d-4c79-96bd-f2f3ee764ea8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_4784ddd4-c04c-40df-93ec-2ad54058e2a0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1ac98a73-af1d-4c79-96bd-f2f3ee764ea8" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_4784ddd4-c04c-40df-93ec-2ad54058e2a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1246bb44-7a56-4413-a597-f169cca083c1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_4784ddd4-c04c-40df-93ec-2ad54058e2a0" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1246bb44-7a56-4413-a597-f169cca083c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_7601698f-e492-4c61-b84e-5f7c30dcf1af" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_7c949e9f-2176-4ed4-b996-cbc28099caf2" xlink:to="loc_ifrs-full_GeographicalAreasAxis_7601698f-e492-4c61-b84e-5f7c30dcf1af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_7601698f-e492-4c61-b84e-5f7c30dcf1af_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_7601698f-e492-4c61-b84e-5f7c30dcf1af" xlink:to="loc_ifrs-full_GeographicalAreasMember_7601698f-e492-4c61-b84e-5f7c30dcf1af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_7601698f-e492-4c61-b84e-5f7c30dcf1af" xlink:to="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_506ff827-4a4d-4ed8-824e-7811aa4d19a2" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:to="loc_country_FR_506ff827-4a4d-4ed8-824e-7811aa4d19a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_08ccb6e7-49c9-42a7-9306-f8682ecc06bc" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:to="loc_country_DE_08ccb6e7-49c9-42a7-9306-f8682ecc06bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_067cf2c1-32eb-4955-9fce-5c76bf5ebb8e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:to="loc_country_US_067cf2c1-32eb-4955-9fce-5c76bf5ebb8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_0d4aa447-e969-4876-b7b2-774b90ae361a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:to="loc_country_GB_0d4aa447-e969-4876-b7b2-774b90ae361a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_a6911e70-0d4e-492b-b108-7842e094938e" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:to="loc_sny_OtherCountriesMember_a6911e70-0d4e-492b-b108-7842e094938e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="extended" id="icbd263ee07be448596b456207a011ee3_ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_682ed4d7-d95e-4f02-819c-176662f8b338" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans_cfa2c89f-f16f-4fc9-8911-c26d043bbbb1" xlink:href="sny-20221231.xsd#sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_682ed4d7-d95e-4f02-819c-176662f8b338" xlink:to="loc_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans_cfa2c89f-f16f-4fc9-8911-c26d043bbbb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7745c565-804e-4663-87f3-eccadb74d371" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_682ed4d7-d95e-4f02-819c-176662f8b338" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7745c565-804e-4663-87f3-eccadb74d371" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_066d93dc-0187-4640-97dc-0fa34878e2fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7745c565-804e-4663-87f3-eccadb74d371" xlink:to="loc_ifrs-full_GeographicalAreasAxis_066d93dc-0187-4640-97dc-0fa34878e2fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_066d93dc-0187-4640-97dc-0fa34878e2fb_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_066d93dc-0187-4640-97dc-0fa34878e2fb" xlink:to="loc_ifrs-full_GeographicalAreasMember_066d93dc-0187-4640-97dc-0fa34878e2fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_066d93dc-0187-4640-97dc-0fa34878e2fb" xlink:to="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_d3f5273e-a33d-4a7f-97fe-41b2e8773bd3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:to="loc_country_FR_d3f5273e-a33d-4a7f-97fe-41b2e8773bd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_852c7c9e-e826-4582-aedc-5c26d61f8a05" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:to="loc_country_DE_852c7c9e-e826-4582-aedc-5c26d61f8a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3503a368-92d1-41a3-8d83-a1c7de7e0500" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:to="loc_country_US_3503a368-92d1-41a3-8d83-a1c7de7e0500" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_7ce51c67-4423-4b68-bdf9-e6e1611940e4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:to="loc_country_GB_7ce51c67-4423-4b68-bdf9-e6e1611940e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_7e29d10e-2ef6-43fc-a0a5-083df9ea8269" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:to="loc_sny_OtherCountriesMember_7e29d10e-2ef6-43fc-a0a5-083df9ea8269" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_d5964443-fc38-4da9-8dad-f2f3a18d2546" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7745c565-804e-4663-87f3-eccadb74d371" xlink:to="loc_ifrs-full_MaturityAxis_d5964443-fc38-4da9-8dad-f2f3a18d2546" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_d5964443-fc38-4da9-8dad-f2f3a18d2546_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_d5964443-fc38-4da9-8dad-f2f3a18d2546" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_d5964443-fc38-4da9-8dad-f2f3a18d2546_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_d5964443-fc38-4da9-8dad-f2f3a18d2546" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_9e9d39da-5639-4297-b664-3f4d8e9eea68" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_9e9d39da-5639-4297-b664-3f4d8e9eea68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0b35cdc4-229b-438e-9883-c3a54a8f6e82" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0b35cdc4-229b-438e-9883-c3a54a8f6e82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_bf64394c-6dff-41df-abd8-2fde8f321211" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_bf64394c-6dff-41df-abd8-2fde8f321211" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_a7d93fa0-7616-4508-afa0-199b2da6ae46" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_a7d93fa0-7616-4508-afa0-199b2da6ae46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_bfff070f-e96b-4766-b965-625302edd2a9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_bfff070f-e96b-4766-b965-625302edd2a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember_95db2740-1cf0-4c8e-9d0f-0951949621f0" xlink:href="sny-20221231.xsd#sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember_95db2740-1cf0-4c8e-9d0f-0951949621f0" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="extended" id="i739f46ef99a940f0a314dff86c21dbbb_ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_e53fea17-3135-4849-88b3-0c471f7165f9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans_8d3b620e-a662-4796-87b3-9d605b1833ac" xlink:href="sny-20221231.xsd#sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_e53fea17-3135-4849-88b3-0c471f7165f9" xlink:to="loc_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans_8d3b620e-a662-4796-87b3-9d605b1833ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_e851d647-dc38-418e-8bb9-89d92af1c9c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_e53fea17-3135-4849-88b3-0c471f7165f9" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_e851d647-dc38-418e-8bb9-89d92af1c9c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_7a46211b-fd3d-4f33-be9e-b26f83ac121c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_e851d647-dc38-418e-8bb9-89d92af1c9c2" xlink:to="loc_ifrs-full_MaturityAxis_7a46211b-fd3d-4f33-be9e-b26f83ac121c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_7a46211b-fd3d-4f33-be9e-b26f83ac121c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_7a46211b-fd3d-4f33-be9e-b26f83ac121c" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_7a46211b-fd3d-4f33-be9e-b26f83ac121c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_7a46211b-fd3d-4f33-be9e-b26f83ac121c" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_060142cf-8692-4441-a44b-bcbb57c85d14" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_060142cf-8692-4441-a44b-bcbb57c85d14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_35c5b656-f29d-453e-af38-54803995116b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_35c5b656-f29d-453e-af38-54803995116b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_96908cb4-8e76-4529-92ce-353163d15f71" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_96908cb4-8e76-4529-92ce-353163d15f71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_5fdeb9ec-b274-4843-986d-ffb5fbdd18a2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_5fdeb9ec-b274-4843-986d-ffb5fbdd18a2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails" xlink:type="extended" id="i4beb2524d2d44220b5e332ebebd7062e_ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringProvisionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_431a71ef-ead8-411a-9006-3d55ad70ce8c" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_431a71ef-ead8-411a-9006-3d55ad70ce8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestructuringProvisionAbstract_c9ee52bb-1fd9-400a-ab05-1732e999ac96" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RestructuringProvisionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_ifrs-full_RestructuringProvisionAbstract_c9ee52bb-1fd9-400a-ab05-1732e999ac96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermRestructuringProvision_d8d4e35a-eb48-490f-b667-5154f3703dc1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermRestructuringProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RestructuringProvisionAbstract_c9ee52bb-1fd9-400a-ab05-1732e999ac96" xlink:to="loc_ifrs-full_LongtermRestructuringProvision_d8d4e35a-eb48-490f-b667-5154f3703dc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermRestructuringProvision_d27823e8-378a-424a-b942-4c24952956e2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermRestructuringProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RestructuringProvisionAbstract_c9ee52bb-1fd9-400a-ab05-1732e999ac96" xlink:to="loc_ifrs-full_ShorttermRestructuringProvision_d27823e8-378a-424a-b942-4c24952956e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod_39eca69d-bcba-4e3b-a2ea-2df5b48c79e1" xlink:href="sny-20221231.xsd#sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod_39eca69d-bcba-4e3b-a2ea-2df5b48c79e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions_0b1b1ee7-e6d1-4957-92bd-74d106b5c227" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProvisionUsedOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_ifrs-full_ProvisionUsedOtherProvisions_0b1b1ee7-e6d1-4957-92bd-74d106b5c227" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_776b7b60-544f-41c7-9ed6-1eaf2042053f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_776b7b60-544f-41c7-9ed6-1eaf2042053f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnwindingOfDiscount_62dc3867-2599-405c-a450-b6c7d90a0fe2" xlink:href="sny-20221231.xsd#sny_UnwindingOfDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_sny_UnwindingOfDiscount_62dc3867-2599-405c-a450-b6c7d90a0fe2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_fe507da7-1bb1-4344-910b-46c182965c41" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_fe507da7-1bb1-4344-910b-46c182965c41" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_a93f0ef6-10cc-4286-b842-7e2a931f3c70" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringProvisionsTable_5461ce1c-399d-4df1-bc2f-605382e68e33" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringProvisionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_sny_DisclosureOfRestructuringProvisionsTable_5461ce1c-399d-4df1-bc2f-605382e68e33" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_5e1b76f7-a4ef-4303-9891-fafa9124bc81" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsTable_5461ce1c-399d-4df1-bc2f-605382e68e33" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_5e1b76f7-a4ef-4303-9891-fafa9124bc81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_5e1b76f7-a4ef-4303-9891-fafa9124bc81_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_5e1b76f7-a4ef-4303-9891-fafa9124bc81" xlink:to="loc_ifrs-full_OtherProvisionsMember_5e1b76f7-a4ef-4303-9891-fafa9124bc81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_92a9c261-bb73-4d66-9eb8-22c3dfe8bdbf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_5e1b76f7-a4ef-4303-9891-fafa9124bc81" xlink:to="loc_ifrs-full_OtherProvisionsMember_92a9c261-bb73-4d66-9eb8-22c3dfe8bdbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestructuringProvisionMember_b61caf38-9eeb-4cca-ab03-5e7f8316149f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RestructuringProvisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_92a9c261-bb73-4d66-9eb8-22c3dfe8bdbf" xlink:to="loc_ifrs-full_RestructuringProvisionMember_b61caf38-9eeb-4cca-ab03-5e7f8316149f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails" xlink:type="extended" id="i53fce8c058ec481a8fd007f4dc62a89d_ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_02571359-3b1d-4aba-8d2a-4d98c110a812" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_6a2bacdd-3385-46ec-b2e2-50068dce2079" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_02571359-3b1d-4aba-8d2a-4d98c110a812" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_6a2bacdd-3385-46ec-b2e2-50068dce2079" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_5bcc23c0-76a5-441e-90e8-faf14ff0e356" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_02571359-3b1d-4aba-8d2a-4d98c110a812" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_5bcc23c0-76a5-441e-90e8-faf14ff0e356" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_19dd80b6-aa95-4ae7-a9cb-a35170cfe23c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_5bcc23c0-76a5-441e-90e8-faf14ff0e356" xlink:to="loc_ifrs-full_GeographicalAreasAxis_19dd80b6-aa95-4ae7-a9cb-a35170cfe23c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_19dd80b6-aa95-4ae7-a9cb-a35170cfe23c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_19dd80b6-aa95-4ae7-a9cb-a35170cfe23c" xlink:to="loc_ifrs-full_GeographicalAreasMember_19dd80b6-aa95-4ae7-a9cb-a35170cfe23c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_cf9f51ac-0ffb-4062-b205-be3b3efc2d16" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_19dd80b6-aa95-4ae7-a9cb-a35170cfe23c" xlink:to="loc_ifrs-full_GeographicalAreasMember_cf9f51ac-0ffb-4062-b205-be3b3efc2d16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_1c248eff-fd38-443f-a0a0-279422acd13a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_cf9f51ac-0ffb-4062-b205-be3b3efc2d16" xlink:to="loc_country_FR_1c248eff-fd38-443f-a0a0-279422acd13a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_84ca4617-6493-4ae0-a841-dd19ee1de08d" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_cf9f51ac-0ffb-4062-b205-be3b3efc2d16" xlink:to="loc_sny_OtherCountriesMember_84ca4617-6493-4ae0-a841-dd19ee1de08d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_ad2b4845-b134-412f-ba6b-a2ee2dbfd6e1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_5bcc23c0-76a5-441e-90e8-faf14ff0e356" xlink:to="loc_ifrs-full_MaturityAxis_ad2b4845-b134-412f-ba6b-a2ee2dbfd6e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_ad2b4845-b134-412f-ba6b-a2ee2dbfd6e1_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_ad2b4845-b134-412f-ba6b-a2ee2dbfd6e1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_ad2b4845-b134-412f-ba6b-a2ee2dbfd6e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_ad2b4845-b134-412f-ba6b-a2ee2dbfd6e1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_86838806-c9f5-4b7d-b39e-7bb4f485fea6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_86838806-c9f5-4b7d-b39e-7bb4f485fea6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_1623644a-2413-4192-85c7-9ba51effa75f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_1623644a-2413-4192-85c7-9ba51effa75f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_3b307f28-f7cd-488a-9f0e-164da652ac87" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_3b307f28-f7cd-488a-9f0e-164da652ac87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_d212e820-9404-43d2-b43d-cd7dd9fd6144" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_d212e820-9404-43d2-b43d-cd7dd9fd6144" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails" xlink:type="extended" id="i8b80c56b7929417daf0d5e6520a8eb27_DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_7cca82be-b976-48de-95fe-12c6d9f1f797" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_7cca82be-b976-48de-95fe-12c6d9f1f797" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialAssets_085f20bc-77f2-4170-a7ae-5ea4b43515ac" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDerivativeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialAssets_085f20bc-77f2-4170-a7ae-5ea4b43515ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_369edde5-6c78-4a77-887e-a7833cefc6ae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_369edde5-6c78-4a77-887e-a7833cefc6ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_a4716640-9cb1-45de-9db5-fa495e48bd72" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_a4716640-9cb1-45de-9db5-fa495e48bd72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_a26a2e79-b3f4-4061-b4c0-c9f0421e8f70" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_a26a2e79-b3f4-4061-b4c0-c9f0421e8f70" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_5f6836f9-54f6-4c6d-827c-cf5d441cac6b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_5f6836f9-54f6-4c6d-827c-cf5d441cac6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_146f2aa7-594c-423e-a7b6-68e4fc38baf7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_146f2aa7-594c-423e-a7b6-68e4fc38baf7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_3577d988-4506-44e1-b53d-e5bd0b3cae34" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCreditRiskExposureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_3577d988-4506-44e1-b53d-e5bd0b3cae34" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_04998d15-4e49-479f-9088-b53d129f784b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_3577d988-4506-44e1-b53d-e5bd0b3cae34" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_04998d15-4e49-479f-9088-b53d129f784b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_04998d15-4e49-479f-9088-b53d129f784b_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_04998d15-4e49-479f-9088-b53d129f784b" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_04998d15-4e49-479f-9088-b53d129f784b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_04998d15-4e49-479f-9088-b53d129f784b" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesMember_24276e95-4ea6-4332-be63-804f5a048fd4" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:to="loc_sny_CurrencyDerivativesMember_24276e95-4ea6-4332-be63-804f5a048fd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesOperatingMember_2d222ff4-0573-40aa-8c42-446c035cc9fc" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesOperatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:to="loc_sny_CurrencyDerivativesOperatingMember_2d222ff4-0573-40aa-8c42-446c035cc9fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesFinancialMember_35ab92ee-3f3b-421a-bdc0-91cfbc262fbf" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesFinancialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:to="loc_sny_CurrencyDerivativesFinancialMember_35ab92ee-3f3b-421a-bdc0-91cfbc262fbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateDerivativesMember_0fe749f9-13b1-4e9c-845e-47d7863d9688" xlink:href="sny-20221231.xsd#sny_InterestRateDerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:to="loc_sny_InterestRateDerivativesMember_0fe749f9-13b1-4e9c-845e-47d7863d9688" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityDerivativesMember_1b063748-44e1-4675-8fee-5f221345a18f" xlink:href="sny-20221231.xsd#sny_EquityDerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:to="loc_sny_EquityDerivativesMember_1b063748-44e1-4675-8fee-5f221345a18f" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails" xlink:type="extended" id="i85ac9dbe8a924ab59297425a48f4db91_DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_8d51c95c-3ce4-4fe8-ad90-c2be40dda3e9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialInstruments_8a47a39f-a173-4e80-a1a2-909146195b73" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_8d51c95c-3ce4-4fe8-ad90-c2be40dda3e9" xlink:to="loc_sny_DerivativeFinancialInstruments_8a47a39f-a173-4e80-a1a2-909146195b73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_0a8eb863-6bb6-4b1f-81b9-7c52c4078836" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_8d51c95c-3ce4-4fe8-ad90-c2be40dda3e9" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_0a8eb863-6bb6-4b1f-81b9-7c52c4078836" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_fad87a0f-47d9-46c4-b147-0656595e9627" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_0a8eb863-6bb6-4b1f-81b9-7c52c4078836" xlink:to="loc_ifrs-full_MeasurementAxis_fad87a0f-47d9-46c4-b147-0656595e9627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_fad87a0f-47d9-46c4-b147-0656595e9627_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_fad87a0f-47d9-46c4-b147-0656595e9627" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_fad87a0f-47d9-46c4-b147-0656595e9627_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_9ff9b38e-274d-435d-8df1-d52a7256f149" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_fad87a0f-47d9-46c4-b147-0656595e9627" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_9ff9b38e-274d-435d-8df1-d52a7256f149" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtNotionalAmountMember_bc69ae38-909b-4ccb-b42f-81accf736c2a" xlink:href="sny-20221231.xsd#sny_AtNotionalAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_9ff9b38e-274d-435d-8df1-d52a7256f149" xlink:to="loc_sny_AtNotionalAmountMember_bc69ae38-909b-4ccb-b42f-81accf736c2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AtFairValueMember_26e431f4-0288-4423-8594-1a5705b45089" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_9ff9b38e-274d-435d-8df1-d52a7256f149" xlink:to="loc_ifrs-full_AtFairValueMember_26e431f4-0288-4423-8594-1a5705b45089" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfHedgeRecognizedInEquityMember_4c4a659c-ad0b-42fe-8f5e-0e2fb41465ba" xlink:href="sny-20221231.xsd#sny_ValueOfHedgeRecognizedInEquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_9ff9b38e-274d-435d-8df1-d52a7256f149" xlink:to="loc_sny_ValueOfHedgeRecognizedInEquityMember_4c4a659c-ad0b-42fe-8f5e-0e2fb41465ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_5c75b8ae-5779-405c-9c03-7e5fe329526b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_0a8eb863-6bb6-4b1f-81b9-7c52c4078836" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_5c75b8ae-5779-405c-9c03-7e5fe329526b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesMember_5c75b8ae-5779-405c-9c03-7e5fe329526b_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_5c75b8ae-5779-405c-9c03-7e5fe329526b" xlink:to="loc_ifrs-full_TypesOfHedgesMember_5c75b8ae-5779-405c-9c03-7e5fe329526b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesMember_970a7859-27e4-4746-9654-390cab03dc6c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_5c75b8ae-5779-405c-9c03-7e5fe329526b" xlink:to="loc_ifrs-full_TypesOfHedgesMember_970a7859-27e4-4746-9654-390cab03dc6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowHedgesMember_4059c3ed-86b2-4d7e-b571-df431d1da052" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesMember_970a7859-27e4-4746-9654-390cab03dc6c" xlink:to="loc_ifrs-full_CashFlowHedgesMember_4059c3ed-86b2-4d7e-b571-df431d1da052" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NotEligibleForHedgeAccountingMember_df90d907-01eb-4b5c-99b0-6b4d68fce51c" xlink:href="sny-20221231.xsd#sny_NotEligibleForHedgeAccountingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesMember_970a7859-27e4-4746-9654-390cab03dc6c" xlink:to="loc_sny_NotEligibleForHedgeAccountingMember_df90d907-01eb-4b5c-99b0-6b4d68fce51c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_fcc739ef-38a8-46bc-a54b-0ab23f9d0223" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_0a8eb863-6bb6-4b1f-81b9-7c52c4078836" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_fcc739ef-38a8-46bc-a54b-0ab23f9d0223" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_fcc739ef-38a8-46bc-a54b-0ab23f9d0223_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_fcc739ef-38a8-46bc-a54b-0ab23f9d0223" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_fcc739ef-38a8-46bc-a54b-0ab23f9d0223_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_40c22908-f10f-4079-bd8e-5df99408c291" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_fcc739ef-38a8-46bc-a54b-0ab23f9d0223" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_40c22908-f10f-4079-bd8e-5df99408c291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_40c22908-f10f-4079-bd8e-5df99408c291" xlink:to="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInUSDollarMember_ec01ecbd-0474-4efc-a2be-447cfbe7f776" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInUSDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInUSDollarMember_ec01ecbd-0474-4efc-a2be-447cfbe7f776" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember_eeb15a7d-5e3d-4923-8274-3e9b168f235f" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInChineseYuanRenminbiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember_eeb15a7d-5e3d-4923-8274-3e9b168f235f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInJapaneseYenMember_5f791a42-ca6b-4d3a-9d1d-8c204ab8d53b" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInJapaneseYenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInJapaneseYenMember_5f791a42-ca6b-4d3a-9d1d-8c204ab8d53b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInSingaporeDollarMember_3c9d39ec-fae8-4216-9e35-a80e29d11bb4" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInSingaporeDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInSingaporeDollarMember_3c9d39ec-fae8-4216-9e35-a80e29d11bb4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInKoreanWonMember_21019995-4acd-44cc-8753-e53f22248802" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInKoreanWonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInKoreanWonMember_21019995-4acd-44cc-8753-e53f22248802" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInTaiwanDollarMember_35e6a433-2a1e-4aa4-bbda-656e6c0dbfeb" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInTaiwanDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInTaiwanDollarMember_35e6a433-2a1e-4aa4-bbda-656e6c0dbfeb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInMexicanPesoMember_8ce79c85-cb93-4f59-a5a9-a0ea2454df71" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInMexicanPesoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInMexicanPesoMember_8ce79c85-cb93-4f59-a5a9-a0ea2454df71" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_40c22908-f10f-4079-bd8e-5df99408c291" xlink:to="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInUSDollarMember_0911f82b-32e6-4431-90b9-0c1a4ac13c59" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInUSDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInUSDollarMember_0911f82b-32e6-4431-90b9-0c1a4ac13c59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInSingaporeDollarMember_bb1dbd07-ca9b-4f8a-82f2-62f84d8fc55d" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInSingaporeDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInSingaporeDollarMember_bb1dbd07-ca9b-4f8a-82f2-62f84d8fc55d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember_f5767738-30a1-4db1-abe0-7af2ef7a53e9" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember_f5767738-30a1-4db1-abe0-7af2ef7a53e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInKoreanWonMember_5520cc28-47c9-4004-b292-66d3a7de5292" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInKoreanWonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInKoreanWonMember_5520cc28-47c9-4004-b292-66d3a7de5292" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInHungarianForintMember_89922387-ac90-431e-850c-4e2c6ca479da" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInHungarianForintMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInHungarianForintMember_89922387-ac90-431e-850c-4e2c6ca479da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInTaiwanDollarMember_a3df6d83-5c4d-4827-81f0-4385e2cb5d69" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInTaiwanDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInTaiwanDollarMember_a3df6d83-5c4d-4827-81f0-4385e2cb5d69" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInRussianRoubleMember_b5dde2cc-6344-4d6f-9ac6-8e797c0bba1d" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInRussianRoubleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInRussianRoubleMember_b5dde2cc-6344-4d6f-9ac6-8e797c0bba1d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInJapaneseYenMember_9bcd1ab7-214e-4c09-b938-3bc769556c57" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInJapaneseYenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInJapaneseYenMember_9bcd1ab7-214e-4c09-b938-3bc769556c57" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails" xlink:type="extended" id="i841d1f75f7ae4914ba902d6211abc638_DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure_101e9d74-777e-473a-a8d4-fdb7c646f0c6" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialInstrumentsToManageFinancialExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:to="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure_101e9d74-777e-473a-a8d4-fdb7c646f0c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_785eea4e-b9cd-4ac1-98d7-7f66f52561e4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:to="loc_ifrs-full_NotionalAmount_785eea4e-b9cd-4ac1-98d7-7f66f52561e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_abf2a05f-22bc-4db8-a1f3-26356d7787cc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_abf2a05f-22bc-4db8-a1f3-26356d7787cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_5e497381-04c5-43a8-9c1d-5efe8aa7555f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_5e497381-04c5-43a8-9c1d-5efe8aa7555f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_12304a20-9f7b-4dfa-a010-f654ba095d2c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_12304a20-9f7b-4dfa-a010-f654ba095d2c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_6c69e95e-e215-4564-8a2e-a6423ad85596" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_12304a20-9f7b-4dfa-a010-f654ba095d2c" xlink:to="loc_ifrs-full_MeasurementAxis_6c69e95e-e215-4564-8a2e-a6423ad85596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_6c69e95e-e215-4564-8a2e-a6423ad85596_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_6c69e95e-e215-4564-8a2e-a6423ad85596" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_6c69e95e-e215-4564-8a2e-a6423ad85596_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_86b703e9-c2c3-45e2-b524-e51c88153530" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_6c69e95e-e215-4564-8a2e-a6423ad85596" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_86b703e9-c2c3-45e2-b524-e51c88153530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtNotionalAmountMember_439f180c-96fd-450f-a11e-ac0776efd1a6" xlink:href="sny-20221231.xsd#sny_AtNotionalAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_86b703e9-c2c3-45e2-b524-e51c88153530" xlink:to="loc_sny_AtNotionalAmountMember_439f180c-96fd-450f-a11e-ac0776efd1a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AtFairValueMember_af1fe89e-97c1-4792-b664-4030b3315ea3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_86b703e9-c2c3-45e2-b524-e51c88153530" xlink:to="loc_ifrs-full_AtFairValueMember_af1fe89e-97c1-4792-b664-4030b3315ea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_f7624de4-5d5c-4155-bc53-f10b7e516b1c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_12304a20-9f7b-4dfa-a010-f654ba095d2c" xlink:to="loc_ifrs-full_MaturityAxis_f7624de4-5d5c-4155-bc53-f10b7e516b1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_f7624de4-5d5c-4155-bc53-f10b7e516b1c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_f7624de4-5d5c-4155-bc53-f10b7e516b1c" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_f7624de4-5d5c-4155-bc53-f10b7e516b1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_d701f750-6307-4bfd-842f-e162dd87ba23" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_f7624de4-5d5c-4155-bc53-f10b7e516b1c" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_d701f750-6307-4bfd-842f-e162dd87ba23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_fa423711-d1f4-468c-88e2-7d0b19f84904" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_d701f750-6307-4bfd-842f-e162dd87ba23" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_fa423711-d1f4-468c-88e2-7d0b19f84904" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_d27e369e-faa3-42c8-8c59-a7b6e3bad358" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_12304a20-9f7b-4dfa-a010-f654ba095d2c" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_d27e369e-faa3-42c8-8c59-a7b6e3bad358" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_d27e369e-faa3-42c8-8c59-a7b6e3bad358_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_d27e369e-faa3-42c8-8c59-a7b6e3bad358" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_d27e369e-faa3-42c8-8c59-a7b6e3bad358_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_0a8e7b19-a2bd-47ef-9b05-7945bbd885f3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_d27e369e-faa3-42c8-8c59-a7b6e3bad358" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_0a8e7b19-a2bd-47ef-9b05-7945bbd885f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesMember_473dcc83-bcaf-4437-8cdd-7c72b24ab8bc" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_0a8e7b19-a2bd-47ef-9b05-7945bbd885f3" xlink:to="loc_sny_ForwardCurrencySalesMember_473dcc83-bcaf-4437-8cdd-7c72b24ab8bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInUSDollarMember_5b2547e4-995a-4b9a-884a-15b3f53dabbb" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInUSDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_473dcc83-bcaf-4437-8cdd-7c72b24ab8bc" xlink:to="loc_sny_ForwardCurrencySalesInUSDollarMember_5b2547e4-995a-4b9a-884a-15b3f53dabbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInPoundSterlingMember_51f37ff4-c24d-4ff7-9dc4-3e831dd0eb39" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInPoundSterlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_473dcc83-bcaf-4437-8cdd-7c72b24ab8bc" xlink:to="loc_sny_ForwardCurrencySalesInPoundSterlingMember_51f37ff4-c24d-4ff7-9dc4-3e831dd0eb39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInChineseYuanMember_4a2617c4-0503-4f5f-b166-b5c974289858" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInChineseYuanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_473dcc83-bcaf-4437-8cdd-7c72b24ab8bc" xlink:to="loc_sny_ForwardCurrencySalesInChineseYuanMember_4a2617c4-0503-4f5f-b166-b5c974289858" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasesMember_e99d79f0-77ca-4731-ac32-89516cf22dc5" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_0a8e7b19-a2bd-47ef-9b05-7945bbd885f3" xlink:to="loc_sny_ForwardCurrencyPurchasesMember_e99d79f0-77ca-4731-ac32-89516cf22dc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInUSDollarMember_fdcd44bc-e5fc-464c-9599-01d1821b1c48" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInUSDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_e99d79f0-77ca-4731-ac32-89516cf22dc5" xlink:to="loc_sny_ForwardCurrencyPurchasedInUSDollarMember_fdcd44bc-e5fc-464c-9599-01d1821b1c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInSingaporeDollarMember_1733976c-6455-4aa6-b1a7-131d5bc98db0" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInSingaporeDollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_e99d79f0-77ca-4731-ac32-89516cf22dc5" xlink:to="loc_sny_ForwardCurrencyPurchasedInSingaporeDollarMember_1733976c-6455-4aa6-b1a7-131d5bc98db0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInJapaneseYenMember_bef64f34-f49c-4d4e-95c8-b6cb1177c457" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInJapaneseYenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_e99d79f0-77ca-4731-ac32-89516cf22dc5" xlink:to="loc_sny_ForwardCurrencyPurchasedInJapaneseYenMember_bef64f34-f49c-4d4e-95c8-b6cb1177c457" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencySwapsInUSDToEURMember_bee969d7-b3d4-4a2a-af3a-fe5bf79992cd" xlink:href="sny-20221231.xsd#sny_CurrencySwapsInUSDToEURMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_0a8e7b19-a2bd-47ef-9b05-7945bbd885f3" xlink:to="loc_sny_CurrencySwapsInUSDToEURMember_bee969d7-b3d4-4a2a-af3a-fe5bf79992cd" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails" xlink:type="extended" id="ieec14fd40a6345f388acf86eb456c8cf_DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7bbdd7f4-c92c-411f-9866-b75595ec6402" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsInterestRate_4d057e1d-c6fd-484b-a134-a2a9b4868d40" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7bbdd7f4-c92c-411f-9866-b75595ec6402" xlink:to="loc_sny_InterestRateSwapsInterestRate_4d057e1d-c6fd-484b-a134-a2a9b4868d40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents_39232b17-868e-44d3-aa43-56f8374b1319" xlink:href="sny-20221231.xsd#sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7bbdd7f4-c92c-411f-9866-b75595ec6402" xlink:to="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents_39232b17-868e-44d3-aa43-56f8374b1319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialInstruments_ec2e8110-9a9b-4789-9db9-e5bb1ba5d952" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7bbdd7f4-c92c-411f-9866-b75595ec6402" xlink:to="loc_sny_DerivativeFinancialInstruments_ec2e8110-9a9b-4789-9db9-e5bb1ba5d952" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7bbdd7f4-c92c-411f-9866-b75595ec6402" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_b8deaf1e-df93-4dc6-b6ac-d2ef82b4f7d8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_b8deaf1e-df93-4dc6-b6ac-d2ef82b4f7d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_b8deaf1e-df93-4dc6-b6ac-d2ef82b4f7d8_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_b8deaf1e-df93-4dc6-b6ac-d2ef82b4f7d8" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_b8deaf1e-df93-4dc6-b6ac-d2ef82b4f7d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_b8deaf1e-df93-4dc6-b6ac-d2ef82b4f7d8" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member_c63940e3-81bd-4810-992c-b4c0409eb40c" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member_c63940e3-81bd-4810-992c-b4c0409eb40c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member_38cf341f-0753-4f68-9efc-bf81c814a429" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member_38cf341f-0753-4f68-9efc-bf81c814a429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member_010b6087-7db0-4bd3-b60f-765a979aab1f" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedEsterReceive069Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member_010b6087-7db0-4bd3-b60f-765a979aab1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member_cb880321-7fc0-4d6a-8e05-3790308d6ddd" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member_cb880321-7fc0-4d6a-8e05-3790308d6ddd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember_ff084853-a483-4d3d-a8bf-bfa837d2cdb5" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember_ff084853-a483-4d3d-a8bf-bfa837d2cdb5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member_40ff82cd-1461-4f1f-9865-1fedf6957599" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member_40ff82cd-1461-4f1f-9865-1fedf6957599" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember_e77fc5c2-c4d7-4161-85fa-59064ac81368" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember_e77fc5c2-c4d7-4161-85fa-59064ac81368" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_079d4621-0bfb-4387-8caf-8d49858ac41f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:to="loc_ifrs-full_MeasurementAxis_079d4621-0bfb-4387-8caf-8d49858ac41f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_079d4621-0bfb-4387-8caf-8d49858ac41f_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_079d4621-0bfb-4387-8caf-8d49858ac41f" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_079d4621-0bfb-4387-8caf-8d49858ac41f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_911d2ef6-4ed9-4ffc-aa77-ccd142b2d7ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_079d4621-0bfb-4387-8caf-8d49858ac41f" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_911d2ef6-4ed9-4ffc-aa77-ccd142b2d7ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtNotionalAmountMember_bba95202-009a-4f15-9a71-3d76c0d9c030" xlink:href="sny-20221231.xsd#sny_AtNotionalAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_911d2ef6-4ed9-4ffc-aa77-ccd142b2d7ab" xlink:to="loc_sny_AtNotionalAmountMember_bba95202-009a-4f15-9a71-3d76c0d9c030" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AtFairValueMember_4880679f-2524-4b33-938c-e1e180df93ee" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AtFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_911d2ef6-4ed9-4ffc-aa77-ccd142b2d7ab" xlink:to="loc_ifrs-full_AtFairValueMember_4880679f-2524-4b33-938c-e1e180df93ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfHedgeRecognizedInEquityMember_f7a4feef-d971-4f4b-9b57-0f951713c4f2" xlink:href="sny-20221231.xsd#sny_ValueOfHedgeRecognizedInEquityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_911d2ef6-4ed9-4ffc-aa77-ccd142b2d7ab" xlink:to="loc_sny_ValueOfHedgeRecognizedInEquityMember_f7a4feef-d971-4f4b-9b57-0f951713c4f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_21afab94-b0ec-4752-b729-00cea1538db7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:to="loc_ifrs-full_MaturityAxis_21afab94-b0ec-4752-b729-00cea1538db7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_21afab94-b0ec-4752-b729-00cea1538db7_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_21afab94-b0ec-4752-b729-00cea1538db7" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_21afab94-b0ec-4752-b729-00cea1538db7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_21afab94-b0ec-4752-b729-00cea1538db7" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_53a79416-a1cd-4c72-9db7-bb485c76797d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_53a79416-a1cd-4c72-9db7-bb485c76797d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_cf359405-35bf-4e1f-9831-2aa83433dbe3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_cf359405-35bf-4e1f-9831-2aa83433dbe3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_c1f57616-78d1-4342-b060-ed2c461553ea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_c1f57616-78d1-4342-b060-ed2c461553ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_95a1fcfc-2078-4731-9a2f-00bef215cc18" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_95a1fcfc-2078-4731-9a2f-00bef215cc18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_d0f03dd2-e49d-469c-b3f7-09d61b925516" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_d0f03dd2-e49d-469c-b3f7-09d61b925516" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_afbe8161-c7ce-4ba0-8823-9f1f00379459" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_afbe8161-c7ce-4ba0-8823-9f1f00379459" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_38acb254-5d28-48b3-afda-1926d8c9c5b0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_38acb254-5d28-48b3-afda-1926d8c9c5b0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesMember_38acb254-5d28-48b3-afda-1926d8c9c5b0_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_38acb254-5d28-48b3-afda-1926d8c9c5b0" xlink:to="loc_ifrs-full_TypesOfHedgesMember_38acb254-5d28-48b3-afda-1926d8c9c5b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesMember_8e9ed0b1-4f22-4f32-b91d-c066fc507984" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_38acb254-5d28-48b3-afda-1926d8c9c5b0" xlink:to="loc_ifrs-full_TypesOfHedgesMember_8e9ed0b1-4f22-4f32-b91d-c066fc507984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FairValueHedgesMember_513914ea-8368-42f4-9910-a1a211566bfd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FairValueHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesMember_8e9ed0b1-4f22-4f32-b91d-c066fc507984" xlink:to="loc_ifrs-full_FairValueHedgesMember_513914ea-8368-42f4-9910-a1a211566bfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowHedgesMember_3ef3e82a-3aad-4d6f-b88e-36881d57aad9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesMember_8e9ed0b1-4f22-4f32-b91d-c066fc507984" xlink:to="loc_ifrs-full_CashFlowHedgesMember_3ef3e82a-3aad-4d6f-b88e-36881d57aad9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails" xlink:type="extended" id="if411671c0163489680b88716148dcd32_DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset_71690203-1b9e-4c2b-8fa3-c7c4d741f45f" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset_71690203-1b9e-4c2b-8fa3-c7c4d741f45f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32_7b6ebc1e-a019-45b5-af43-63f873915eb2" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32_7b6ebc1e-a019-45b5-af43-63f873915eb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetAmountsAsReportedInTheBalanceSheet_125c0471-c4c0-4a1e-9a15-515b2bcd514d" xlink:href="sny-20221231.xsd#sny_NetAmountsAsReportedInTheBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_NetAmountsAsReportedInTheBalanceSheet_125c0471-c4c0-4a1e-9a15-515b2bcd514d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral_7ea3c723-bc39-4705-aa96-938658f3bfea" xlink:href="sny-20221231.xsd#sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral_7ea3c723-bc39-4705-aa96-938658f3bfea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments_e2e12af5-a184-4522-b9f1-0b17ff639f0b" xlink:href="sny-20221231.xsd#sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments_e2e12af5-a184-4522-b9f1-0b17ff639f0b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetExposure_3c429fb3-6957-45ee-a05e-2a50c1a65e88" xlink:href="sny-20221231.xsd#sny_NetExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_NetExposure_3c429fb3-6957-45ee-a05e-2a50c1a65e88" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_f889a7a6-4b01-4210-a9c5-04e75634f175" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_f889a7a6-4b01-4210-a9c5-04e75634f175" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_3a9374ef-0bc2-44aa-8ab6-62962a4d223a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_f889a7a6-4b01-4210-a9c5-04e75634f175" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_3a9374ef-0bc2-44aa-8ab6-62962a4d223a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_3a9374ef-0bc2-44aa-8ab6-62962a4d223a_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_3a9374ef-0bc2-44aa-8ab6-62962a4d223a" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_3a9374ef-0bc2-44aa-8ab6-62962a4d223a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_36f11143-a539-4582-93fd-1fd496e27cb1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_3a9374ef-0bc2-44aa-8ab6-62962a4d223a" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_36f11143-a539-4582-93fd-1fd496e27cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialAssetsMember_4d44213f-4379-4cab-acac-ad801f23e2bf" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_36f11143-a539-4582-93fd-1fd496e27cb1" xlink:to="loc_sny_DerivativeFinancialAssetsMember_4d44213f-4379-4cab-acac-ad801f23e2bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialLiabilitiesMember_4c1523d5-7252-4538-916d-9327e1a09eef" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_36f11143-a539-4582-93fd-1fd496e27cb1" xlink:to="loc_sny_DerivativeFinancialLiabilitiesMember_4c1523d5-7252-4538-916d-9327e1a09eef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeInstrumentAxis_13edef7b-d6e1-427b-a180-8cf72c8c624a" xlink:href="sny-20221231.xsd#sny_DerivativeInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_f889a7a6-4b01-4210-a9c5-04e75634f175" xlink:to="loc_sny_DerivativeInstrumentAxis_13edef7b-d6e1-427b-a180-8cf72c8c624a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeInstrumentDomain_13edef7b-d6e1-427b-a180-8cf72c8c624a_default" xlink:href="sny-20221231.xsd#sny_DerivativeInstrumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_DerivativeInstrumentAxis_13edef7b-d6e1-427b-a180-8cf72c8c624a" xlink:to="loc_sny_DerivativeInstrumentDomain_13edef7b-d6e1-427b-a180-8cf72c8c624a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeInstrumentDomain_cb3c3a47-2021-4d87-bf47-869a65120e5f" xlink:href="sny-20221231.xsd#sny_DerivativeInstrumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_DerivativeInstrumentAxis_13edef7b-d6e1-427b-a180-8cf72c8c624a" xlink:to="loc_sny_DerivativeInstrumentDomain_cb3c3a47-2021-4d87-bf47-869a65120e5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember_184a2dea-8b52-468e-bf9e-c96769b7e625" xlink:href="sny-20221231.xsd#sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DerivativeInstrumentDomain_cb3c3a47-2021-4d87-bf47-869a65120e5f" xlink:to="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember_184a2dea-8b52-468e-bf9e-c96769b7e625" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails" xlink:type="extended" id="ic42c36cbda5a4038b2c5274f79131f64_OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet_5f308b48-8219-46ff-ba04-54b6777a66d1" xlink:href="sny-20221231.xsd#sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet_5f308b48-8219-46ff-ba04-54b6777a66d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IrrevocablePurchaseCommitmentsGiven_8636201e-dc59-4bd6-b7e4-22e3b895836e" xlink:href="sny-20221231.xsd#sny_IrrevocablePurchaseCommitmentsGiven"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_IrrevocablePurchaseCommitmentsGiven_8636201e-dc59-4bd6-b7e4-22e3b895836e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IrrevocablePurchaseCommitmentsReceived_e67fd0d0-281b-4418-9d1d-0c5a5da14172" xlink:href="sny-20221231.xsd#sny_IrrevocablePurchaseCommitmentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_IrrevocablePurchaseCommitmentsReceived_e67fd0d0-281b-4418-9d1d-0c5a5da14172" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments_21ce3cc0-0aa2-4a96-b70e-e0d0504493ea" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments_21ce3cc0-0aa2-4a96-b70e-e0d0504493ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress_426b4793-34cb-4057-bf4c-e23259fc7f0a" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress_426b4793-34cb-4057-bf4c-e23259fc7f0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalOffBalanceSheetCommitments_115d0579-3391-4c9a-bb7a-5bc4a09fba4d" xlink:href="sny-20221231.xsd#sny_TotalOffBalanceSheetCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_TotalOffBalanceSheetCommitments_115d0579-3391-4c9a-bb7a-5bc4a09fba4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable_123cb28c-5743-4073-b0bf-5b57501d16a4" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable_123cb28c-5743-4073-b0bf-5b57501d16a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_748037bc-4882-4071-898c-01381476f5b4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable_123cb28c-5743-4073-b0bf-5b57501d16a4" xlink:to="loc_ifrs-full_JointVenturesAxis_748037bc-4882-4071-898c-01381476f5b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_748037bc-4882-4071-898c-01381476f5b4_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointVenturesAxis_748037bc-4882-4071-898c-01381476f5b4" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_748037bc-4882-4071-898c-01381476f5b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_b28b364d-0f44-4671-a114-d71c4b09cb8b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointVenturesAxis_748037bc-4882-4071-898c-01381476f5b4" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_b28b364d-0f44-4671-a114-d71c4b09cb8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesMember_ab79c307-0a19-4a61-a14e-469fb48e2fe5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_b28b364d-0f44-4671-a114-d71c4b09cb8b" xlink:to="loc_ifrs-full_JointVenturesMember_ab79c307-0a19-4a61-a14e-469fb48e2fe5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6b9acf1c-8900-41aa-ac98-4d355d5da44a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable_123cb28c-5743-4073-b0bf-5b57501d16a4" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6b9acf1c-8900-41aa-ac98-4d355d5da44a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6b9acf1c-8900-41aa-ac98-4d355d5da44a_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6b9acf1c-8900-41aa-ac98-4d355d5da44a" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6b9acf1c-8900-41aa-ac98-4d355d5da44a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_ba3ed54f-e5eb-42a1-9b1d-a6ee45887ba9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6b9acf1c-8900-41aa-ac98-4d355d5da44a" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_ba3ed54f-e5eb-42a1-9b1d-a6ee45887ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SuppliersMember_720fd6aa-13d5-4e65-ad67-5db630e41f12" xlink:href="sny-20221231.xsd#sny_SuppliersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_ba3ed54f-e5eb-42a1-9b1d-a6ee45887ba9" xlink:to="loc_sny_SuppliersMember_720fd6aa-13d5-4e65-ad67-5db630e41f12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_a3abce63-07cd-4746-a76e-003a89078073" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable_123cb28c-5743-4073-b0bf-5b57501d16a4" xlink:to="loc_ifrs-full_MaturityAxis_a3abce63-07cd-4746-a76e-003a89078073" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_a3abce63-07cd-4746-a76e-003a89078073_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_a3abce63-07cd-4746-a76e-003a89078073" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_a3abce63-07cd-4746-a76e-003a89078073_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_a3abce63-07cd-4746-a76e-003a89078073" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_17ae33c0-585e-4617-8d99-b9e1ec9e8c3b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_17ae33c0-585e-4617-8d99-b9e1ec9e8c3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_57af3b38-17e8-4d32-947d-f8a33869ec5e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_57af3b38-17e8-4d32-947d-f8a33869ec5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_dd5439cd-8299-47f0-98a6-e4a4e31ac1a3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_dd5439cd-8299-47f0-98a6-e4a4e31ac1a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_9114b505-ed92-46a4-a8ed-4c190f131a99" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_9114b505-ed92-46a4-a8ed-4c190f131a99" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OffbalancesheetcommitmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails" xlink:type="extended" id="ib5334da96090475f85648bf16e7696eb_OffbalancesheetcommitmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:href="sny-20221231.xsd#sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase_69d10515-3720-4fd7-9d51-5f1ceea41ffe" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase_69d10515-3720-4fd7-9d51-5f1ceea41ffe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets_7354967b-22ae-45ab-845e-bc8c0b1c4494" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets_7354967b-22ae-45ab-845e-bc8c0b1c4494" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements_d7db0be1-3b35-4d0b-a2fb-d806951bc5e3" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements_d7db0be1-3b35-4d0b-a2fb-d806951bc5e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts_e915f83f-1f51-40e7-815f-d374b13a1153" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts_e915f83f-1f51-40e7-815f-d374b13a1153" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement_e7dbb6d6-7be0-41ee-b29e-ab1d20057cca" xlink:href="sny-20221231.xsd#sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement_e7dbb6d6-7be0-41ee-b29e-ab1d20057cca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UpfrontPayments_9bbc86c0-f0aa-42e6-933a-b234cb772fc3" xlink:href="sny-20221231.xsd#sny_UpfrontPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_UpfrontPayments_9bbc86c0-f0aa-42e6-933a-b234cb772fc3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements_69bebc17-cb0d-4587-abe7-51e30229bc53" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements_69bebc17-cb0d-4587-abe7-51e30229bc53" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement_dc0037d2-0e44-4761-94a0-a1f5802dccac" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement_dc0037d2-0e44-4761-94a0-a1f5802dccac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOncologyTargetsUnderCollaborationAgreement_84a8b39c-b51b-483e-9d40-1e8e2d45548b" xlink:href="sny-20221231.xsd#sny_NumberOfOncologyTargetsUnderCollaborationAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_NumberOfOncologyTargetsUnderCollaborationAgreement_84a8b39c-b51b-483e-9d40-1e8e2d45548b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement_8e38bbf2-7659-456c-bd44-80161314ba9c" xlink:href="sny-20221231.xsd#sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement_8e38bbf2-7659-456c-bd44-80161314ba9c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationCollaborationAgreements_2cd87fbb-44f3-43e8-b1b7-b86188da0433" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationCollaborationAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_ContingentConsiderationCollaborationAgreements_2cd87fbb-44f3-43e8-b1b7-b86188da0433" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfTargetsThatEncompassAllDiseasesAreas_006d74c0-0c4f-4773-a843-3db74024ae0a" xlink:href="sny-20221231.xsd#sny_NumberOfTargetsThatEncompassAllDiseasesAreas"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_NumberOfTargetsThatEncompassAllDiseasesAreas_006d74c0-0c4f-4773-a843-3db74024ae0a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsReceivedForDevelopmentCosts_f6ac19e2-880e-4c02-8f93-a9a6d7eb2a1e" xlink:href="sny-20221231.xsd#sny_CommitmentsReceivedForDevelopmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsReceivedForDevelopmentCosts_f6ac19e2-880e-4c02-8f93-a9a6d7eb2a1e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CumulativeDevelopmentCostsIncurred_4d3ef61f-04a8-426e-81ec-eb2df7f5562f" xlink:href="sny-20221231.xsd#sny_CumulativeDevelopmentCostsIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CumulativeDevelopmentCostsIncurred_4d3ef61f-04a8-426e-81ec-eb2df7f5562f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInJointVentures_172b059b-ae0d-46d1-bbfa-7d509922b4f8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_ifrs-full_InvestmentsInJointVentures_172b059b-ae0d-46d1-bbfa-7d509922b4f8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany_a4feeedd-803a-4040-af8e-92757b143212" xlink:href="sny-20221231.xsd#sny_PercentageOfFutureDevelopmentExpenseFundedByCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany_a4feeedd-803a-4040-af8e-92757b143212" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty_45556e30-b8e2-4116-874b-79de95525c3b" xlink:href="sny-20221231.xsd#sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty_45556e30-b8e2-4116-874b-79de95525c3b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmountsPayablePartnersInCollaborationAgreements_0a519e19-77b5-4d03-b8fb-db46633aa49c" xlink:href="sny-20221231.xsd#sny_AmountsPayablePartnersInCollaborationAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_AmountsPayablePartnersInCollaborationAgreements_0a519e19-77b5-4d03-b8fb-db46633aa49c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod_d7d1c9f9-0708-4169-b1b2-54e70a269e43" xlink:href="sny-20221231.xsd#sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod_d7d1c9f9-0708-4169-b1b2-54e70a269e43" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TransferPercentageOfPandemicVaccines_03398a62-8b43-4ae6-951a-39578413c453" xlink:href="sny-20221231.xsd#sny_TransferPercentageOfPandemicVaccines"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_TransferPercentageOfPandemicVaccines_03398a62-8b43-4ae6-951a-39578413c453" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReservePercentageOfPandemicVaccines_ea83181b-c8c6-464e-bb08-8816e5ef4f4a" xlink:href="sny-20221231.xsd#sny_ReservePercentageOfPandemicVaccines"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_ReservePercentageOfPandemicVaccines_ea83181b-c8c6-464e-bb08-8816e5ef4f4a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_beb894a9-a77f-4d3e-95a3-b89c84c43e5e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UndrawnBorrowingFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_beb894a9-a77f-4d3e-95a3-b89c84c43e5e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments_0fb8a20e-3bdb-4180-9b68-e4b2251dfd0a" xlink:href="sny-20221231.xsd#sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments_0fb8a20e-3bdb-4180-9b68-e4b2251dfd0a" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_88a5181b-7f75-49eb-9bc8-929fc2b9ab5a" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitShareOnCounterpartiesProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_88a5181b-7f75-49eb-9bc8-929fc2b9ab5a" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_a030bace-452e-41c8-868e-a77686a307bb" xlink:href="sny-20221231.xsd#sny_PercentageOfCumulativeDevelopmentCostsReimbursed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_a030bace-452e-41c8-868e-a77686a307bb" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:href="sny-20221231.xsd#sny_ProvisionsAndOtherNonCurrentLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_5ab9ecee-0ca3-412b-9450-fb62b9065af2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_ifrs-full_CounterpartiesAxis_5ab9ecee-0ca3-412b-9450-fb62b9065af2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_5ab9ecee-0ca3-412b-9450-fb62b9065af2_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_5ab9ecee-0ca3-412b-9450-fb62b9065af2" xlink:to="loc_ifrs-full_CounterpartiesMember_5ab9ecee-0ca3-412b-9450-fb62b9065af2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_5ab9ecee-0ca3-412b-9450-fb62b9065af2" xlink:to="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DiceMoleculesMember_993d624c-8acb-46b0-87af-a52ee0855604" xlink:href="sny-20221231.xsd#sny_DiceMoleculesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_DiceMoleculesMember_993d624c-8acb-46b0-87af-a52ee0855604" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LonzaMember_366bff7f-6f55-4608-ac14-3576ee8c2582" xlink:href="sny-20221231.xsd#sny_LonzaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_LonzaMember_366bff7f-6f55-4608-ac14-3576ee8c2582" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ABLBioMember_60d18873-6b55-4e32-8a51-63d62e1597be" xlink:href="sny-20221231.xsd#sny_ABLBioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_ABLBioMember_60d18873-6b55-4e32-8a51-63d62e1597be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdageneIncMember_93a8f845-8b62-4ffd-97eb-f1fe5021ee15" xlink:href="sny-20221231.xsd#sny_AdageneIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_AdageneIncMember_93a8f845-8b62-4ffd-97eb-f1fe5021ee15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BlackstoneLifeSciencesMember_13b1b5eb-9264-4f0d-85e8-271aaca19a1a" xlink:href="sny-20221231.xsd#sny_BlackstoneLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_BlackstoneLifeSciencesMember_13b1b5eb-9264-4f0d-85e8-271aaca19a1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IGMBiosciencesIncMember_4f25c3dd-c3e5-4b24-bf41-4d760e5de2c5" xlink:href="sny-20221231.xsd#sny_IGMBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_IGMBiosciencesIncMember_4f25c3dd-c3e5-4b24-bf41-4d760e5de2c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SkyhawkTherapeuticsIncMember_0957c298-6c1b-435d-85df-076f627ab953" xlink:href="sny-20221231.xsd#sny_SkyhawkTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_SkyhawkTherapeuticsIncMember_0957c298-6c1b-435d-85df-076f627ab953" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InnoventBiologicsMember_6f9d4390-f88a-480e-8dde-13315648567f" xlink:href="sny-20221231.xsd#sny_InnoventBiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_InnoventBiologicsMember_6f9d4390-f88a-480e-8dde-13315648567f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MiReculeMember_7a45c75f-4719-434a-8e30-a03db6763fd8" xlink:href="sny-20221231.xsd#sny_MiReculeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_MiReculeMember_7a45c75f-4719-434a-8e30-a03db6763fd8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InnatePharmaSAMember_8497212d-deda-4cd4-abda-4d3bfc69bc46" xlink:href="sny-20221231.xsd#sny_InnatePharmaSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_InnatePharmaSAMember_8497212d-deda-4cd4-abda-4d3bfc69bc46" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExscientiaMember_1fcfb780-dd15-4681-9b3d-343456e3c0ad" xlink:href="sny-20221231.xsd#sny_ExscientiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_ExscientiaMember_1fcfb780-dd15-4681-9b3d-343456e3c0ad" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtomwiseMember_bdafb5e3-8654-4d67-99b6-add398918589" xlink:href="sny-20221231.xsd#sny_AtomwiseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_AtomwiseMember_bdafb5e3-8654-4d67-99b6-add398918589" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ScribeTherapeuticsMember_07f8186b-074f-4d6b-8e22-3e6929af17df" xlink:href="sny-20221231.xsd#sny_ScribeTherapeuticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_ScribeTherapeuticsMember_07f8186b-074f-4d6b-8e22-3e6929af17df" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InsilicoMedicineMember_1b1df0a7-3b60-4d4f-957b-9b68fa1c2f1b" xlink:href="sny-20221231.xsd#sny_InsilicoMedicineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_InsilicoMedicineMember_1b1df0a7-3b60-4d4f-957b-9b68fa1c2f1b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_69b8b577-4f52-4c0d-beb8-b4598796bc3c" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_69b8b577-4f52-4c0d-beb8-b4598796bc3c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_2c9578db-0301-49b4-bc83-c81c362f047c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_ifrs-full_JointVenturesAxis_2c9578db-0301-49b4-bc83-c81c362f047c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_2c9578db-0301-49b4-bc83-c81c362f047c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointVenturesAxis_2c9578db-0301-49b4-bc83-c81c362f047c" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_2c9578db-0301-49b4-bc83-c81c362f047c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_de496ed9-00f4-4a74-83f1-96b7a6429f37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointVenturesAxis_2c9578db-0301-49b4-bc83-c81c362f047c" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_de496ed9-00f4-4a74-83f1-96b7a6429f37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesMember_528dccad-853c-45a3-9d0e-827102bf0a90" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_de496ed9-00f4-4a74-83f1-96b7a6429f37" xlink:to="loc_ifrs-full_JointVenturesMember_528dccad-853c-45a3-9d0e-827102bf0a90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_974b01c3-2546-4c7e-8192-7eb3c135f226" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_974b01c3-2546-4c7e-8192-7eb3c135f226" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_974b01c3-2546-4c7e-8192-7eb3c135f226_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_974b01c3-2546-4c7e-8192-7eb3c135f226" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_974b01c3-2546-4c7e-8192-7eb3c135f226_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_bd96e910-c750-4ac4-ac37-f8856cf44cb1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_974b01c3-2546-4c7e-8192-7eb3c135f226" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_bd96e910-c750-4ac4-ac37-f8856cf44cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WorldHealthOrganizationMember_a4e56706-e490-42e6-aa4e-d45699889de3" xlink:href="sny-20221231.xsd#sny_WorldHealthOrganizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_bd96e910-c750-4ac4-ac37-f8856cf44cb1" xlink:to="loc_sny_WorldHealthOrganizationMember_a4e56706-e490-42e6-aa4e-d45699889de3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_9edda23f-07bb-4005-ba39-7de3ed676642" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_ifrs-full_RangeAxis_9edda23f-07bb-4005-ba39-7de3ed676642" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_9edda23f-07bb-4005-ba39-7de3ed676642_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_9edda23f-07bb-4005-ba39-7de3ed676642" xlink:to="loc_ifrs-full_RangesMember_9edda23f-07bb-4005-ba39-7de3ed676642_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_ec725424-1c2d-4e87-becb-2b76e773b57a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_9edda23f-07bb-4005-ba39-7de3ed676642" xlink:to="loc_ifrs-full_RangesMember_ec725424-1c2d-4e87-becb-2b76e773b57a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_55a67060-2351-4d0d-8fa3-a2033e2b71c1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_ec725424-1c2d-4e87-becb-2b76e773b57a" xlink:to="loc_srt_MaximumMember_55a67060-2351-4d0d-8fa3-a2033e2b71c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_cffa954e-6585-4b26-bcb9-b7cbaa3806fa" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_sny_PrincipalAlliancesAxis_cffa954e-6585-4b26-bcb9-b7cbaa3806fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_cffa954e-6585-4b26-bcb9-b7cbaa3806fa_default" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_PrincipalAlliancesAxis_cffa954e-6585-4b26-bcb9-b7cbaa3806fa" xlink:to="loc_sny_PrincipalAlliancesDomain_cffa954e-6585-4b26-bcb9-b7cbaa3806fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_3cefd8af-77e0-4eb7-9a1c-a279d52ec91e" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_PrincipalAlliancesAxis_cffa954e-6585-4b26-bcb9-b7cbaa3806fa" xlink:to="loc_sny_PrincipalAlliancesDomain_3cefd8af-77e0-4eb7-9a1c-a279d52ec91e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember_f05f6e27-3a4e-4d3e-bdd0-3e886625fec2" xlink:href="sny-20221231.xsd#sny_AntibodiesCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalAlliancesDomain_3cefd8af-77e0-4eb7-9a1c-a279d52ec91e" xlink:to="loc_sny_AntibodiesCollaborationAgreementMember_f05f6e27-3a4e-4d3e-bdd0-3e886625fec2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_7d4fba40-913f-4baa-bc80-518bde10e1e3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_7d4fba40-913f-4baa-bc80-518bde10e1e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_7d4fba40-913f-4baa-bc80-518bde10e1e3_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_7d4fba40-913f-4baa-bc80-518bde10e1e3" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_7d4fba40-913f-4baa-bc80-518bde10e1e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_73e76d54-f861-4d35-b997-ae58aa948538" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_7d4fba40-913f-4baa-bc80-518bde10e1e3" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_73e76d54-f861-4d35-b997-ae58aa948538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AblynxMember_32eef557-359b-4ae6-bb3f-88c248487a36" xlink:href="sny-20221231.xsd#sny_AblynxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_73e76d54-f861-4d35-b997-ae58aa948538" xlink:to="loc_sny_AblynxMember_32eef557-359b-4ae6-bb3f-88c248487a36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KymabMember_3d63e8c4-7478-4ade-a5c6-4c41994d65f6" xlink:href="sny-20221231.xsd#sny_KymabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_73e76d54-f861-4d35-b997-ae58aa948538" xlink:to="loc_sny_KymabMember_3d63e8c4-7478-4ade-a5c6-4c41994d65f6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails" xlink:type="extended" id="ic70e10ed9ce048a98fa0596885b2800c_OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLineOfCreditFacilityLineItems_bf90b150-5a2b-4b9a-921c-f08eb79ab2d7" xlink:href="sny-20221231.xsd#sny_DisclosureOfLineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_9c2030b6-fc19-4b9b-8338-8603cf503adf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UndrawnBorrowingFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLineOfCreditFacilityLineItems_bf90b150-5a2b-4b9a-921c-f08eb79ab2d7" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_9c2030b6-fc19-4b9b-8338-8603cf503adf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLineOfCreditFacilityTable_94de03d2-d06e-4563-8f74-791cbe7b6741" xlink:href="sny-20221231.xsd#sny_DisclosureOfLineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfLineOfCreditFacilityLineItems_bf90b150-5a2b-4b9a-921c-f08eb79ab2d7" xlink:to="loc_sny_DisclosureOfLineOfCreditFacilityTable_94de03d2-d06e-4563-8f74-791cbe7b6741" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_bd70c8c7-551f-4bb8-9f60-aa12f3dd65aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLineOfCreditFacilityTable_94de03d2-d06e-4563-8f74-791cbe7b6741" xlink:to="loc_ifrs-full_MaturityAxis_bd70c8c7-551f-4bb8-9f60-aa12f3dd65aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_bd70c8c7-551f-4bb8-9f60-aa12f3dd65aa_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_bd70c8c7-551f-4bb8-9f60-aa12f3dd65aa" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_bd70c8c7-551f-4bb8-9f60-aa12f3dd65aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_bd70c8c7-551f-4bb8-9f60-aa12f3dd65aa" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_6a2057b5-5ea7-49dd-9d1d-ada1b21f520c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_6a2057b5-5ea7-49dd-9d1d-ada1b21f520c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_91fab54b-3db5-4819-9438-95f1413eefe4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_91fab54b-3db5-4819-9438-95f1413eefe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_39cd34e6-5196-49f3-94b7-8612a1784e55" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_39cd34e6-5196-49f3-94b7-8612a1784e55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_1510dc47-e8ca-472c-83a4-48d753b7cdf2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_1510dc47-e8ca-472c-83a4-48d753b7cdf2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails" xlink:type="extended" id="i7f7380e94b1a486ca6b48007a2050681_OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfGuaranteesLineItems_aea4c83c-7aeb-494a-9e85-b164c8a6f613" xlink:href="sny-20221231.xsd#sny_DisclosureOfGuaranteesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_d3ace4fb-b399-405e-8aca-64c2a442c535" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfGuaranteesLineItems_aea4c83c-7aeb-494a-9e85-b164c8a6f613" xlink:to="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_d3ace4fb-b399-405e-8aca-64c2a442c535" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfGuaranteesTable_7ef3e51e-99de-4419-813f-650a65577afb" xlink:href="sny-20221231.xsd#sny_DisclosureOfGuaranteesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfGuaranteesLineItems_aea4c83c-7aeb-494a-9e85-b164c8a6f613" xlink:to="loc_sny_DisclosureOfGuaranteesTable_7ef3e51e-99de-4419-813f-650a65577afb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_95165234-c805-4be2-ad8e-916863eef5a7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfGuaranteesTable_7ef3e51e-99de-4419-813f-650a65577afb" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_95165234-c805-4be2-ad8e-916863eef5a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_95165234-c805-4be2-ad8e-916863eef5a7_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_95165234-c805-4be2-ad8e-916863eef5a7" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_95165234-c805-4be2-ad8e-916863eef5a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_b0a1cd10-84fa-4c77-aaca-e77f044a5515" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_95165234-c805-4be2-ad8e-916863eef5a7" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_b0a1cd10-84fa-4c77-aaca-e77f044a5515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GuaranteesReceivedMember_d2b45c7b-5e5d-47db-bd05-bb1c6e778016" xlink:href="sny-20221231.xsd#sny_GuaranteesReceivedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_b0a1cd10-84fa-4c77-aaca-e77f044a5515" xlink:to="loc_sny_GuaranteesReceivedMember_d2b45c7b-5e5d-47db-bd05-bb1c6e778016" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GuaranteesGivenMember_804315f4-ebbc-44c9-8ab4-c2f48e758830" xlink:href="sny-20221231.xsd#sny_GuaranteesGivenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_GuaranteesReceivedMember_d2b45c7b-5e5d-47db-bd05-bb1c6e778016" xlink:to="loc_sny_GuaranteesGivenMember_804315f4-ebbc-44c9-8ab4-c2f48e758830" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember_b877a0ec-4ca1-4b2d-9e65-c8b2da4f8878" xlink:href="sny-20221231.xsd#sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_GuaranteesReceivedMember_d2b45c7b-5e5d-47db-bd05-bb1c6e778016" xlink:to="loc_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember_b877a0ec-4ca1-4b2d-9e65-c8b2da4f8878" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGuaranteesGivenMember_1c2df828-8878-4edb-89cf-60e69ff76e0d" xlink:href="sny-20221231.xsd#sny_OtherGuaranteesGivenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_GuaranteesReceivedMember_d2b45c7b-5e5d-47db-bd05-bb1c6e778016" xlink:to="loc_sny_OtherGuaranteesGivenMember_1c2df828-8878-4edb-89cf-60e69ff76e0d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/LegalandarbitralproceedingsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#LegalandarbitralproceedingsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/LegalandarbitralproceedingsDetails" xlink:type="extended" id="i8d0c7d2287c1436da54947ed6bb7b91d_LegalandarbitralproceedingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:href="sny-20221231.xsd#sny_DisclosureOfLegalAndArbitralProceedingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_d2c37c0e-dbbe-43a6-9bbd-7b43d77234ad" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_d2c37c0e-dbbe-43a6-9bbd-7b43d77234ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionForEnvironmentRisks_cd2a6221-34ac-4393-a03b-6baba2cbe7d6" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionForEnvironmentRisks"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NonCurrentProvisionForEnvironmentRisks_cd2a6221-34ac-4393-a03b-6baba2cbe7d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCivilIndividualActions_9af8d3af-f6ab-417e-b9e5-8bb986392ece" xlink:href="sny-20221231.xsd#sny_NumberOfCivilIndividualActions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCivilIndividualActions_9af8d3af-f6ab-417e-b9e5-8bb986392ece" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOngoingLawsuits_a7729917-9dd0-49b4-a998-ff692fdbe185" xlink:href="sny-20221231.xsd#sny_NumberOfOngoingLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfOngoingLawsuits_a7729917-9dd0-49b4-a998-ff692fdbe185" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPlaintiffs_2d0800e3-62ae-455c-87cb-907779453f1d" xlink:href="sny-20221231.xsd#sny_NumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPlaintiffs_2d0800e3-62ae-455c-87cb-907779453f1d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfLossConsortiumPlaintiffs_7298eba4-a1e6-463a-bea2-18746b45702c" xlink:href="sny-20221231.xsd#sny_NumberOfLossConsortiumPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfLossConsortiumPlaintiffs_7298eba4-a1e6-463a-bea2-18746b45702c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfBellweatherTrialsHeld_11541a68-9c14-44fb-8d48-85ab04a82d50" xlink:href="sny-20221231.xsd#sny_NumberOfBellweatherTrialsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfBellweatherTrialsHeld_11541a68-9c14-44fb-8d48-85ab04a82d50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation_0ca05042-9f7f-4fcf-b50e-df83134003bf" xlink:href="sny-20221231.xsd#sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation_0ca05042-9f7f-4fcf-b50e-df83134003bf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCasesDismissed_98f73319-5383-4b48-9201-bce100a1fef1" xlink:href="sny-20221231.xsd#sny_NumberOfCasesDismissed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCasesDismissed_98f73319-5383-4b48-9201-bce100a1fef1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCancersAssociatedWithDismissedCases_bf3e4fc8-d577-4749-951d-cb9f83af3041" xlink:href="sny-20221231.xsd#sny_NumberOfCancersAssociatedWithDismissedCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCancersAssociatedWithDismissedCases_bf3e4fc8-d577-4749-951d-cb9f83af3041" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfComplaintsFiled_af53ad8f-ccfa-4b80-a742-ee428dfb7046" xlink:href="sny-20221231.xsd#sny_NumberOfComplaintsFiled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfComplaintsFiled_af53ad8f-ccfa-4b80-a742-ee428dfb7046" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfClassActionLawsuits_d4fe835c-2066-4205-953b-cb7211ae82bf" xlink:href="sny-20221231.xsd#sny_NumberOfClassActionLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfClassActionLawsuits_d4fe835c-2066-4205-953b-cb7211ae82bf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPeopleExposed_61e75d3f-ae5a-467f-b674-6ee754cdda45" xlink:href="sny-20221231.xsd#sny_NumberOfPeopleExposed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPeopleExposed_61e75d3f-ae5a-467f-b674-6ee754cdda45" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfLawsuitsRuledOnMerit_38b74521-9da3-4d1a-ab87-ec12206b9e5d" xlink:href="sny-20221231.xsd#sny_NumberOfLawsuitsRuledOnMerit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfLawsuitsRuledOnMerit_38b74521-9da3-4d1a-ab87-ec12206b9e5d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfFirstInstanceRulings_03c97bab-617c-4152-a473-b111f58b4873" xlink:href="sny-20221231.xsd#sny_NumberOfFirstInstanceRulings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfFirstInstanceRulings_03c97bab-617c-4152-a473-b111f58b4873" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LitigationAmountPayable_a7eb19ca-cc31-4f8a-94b7-90686d853068" xlink:href="sny-20221231.xsd#sny_LitigationAmountPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_LitigationAmountPayable_a7eb19ca-cc31-4f8a-94b7-90686d853068" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfFamiliesWhoFiledACivilClaim_e414047e-6e29-4096-a1ac-a13efb3259c8" xlink:href="sny-20221231.xsd#sny_NumberOfFamiliesWhoFiledACivilClaim"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfFamiliesWhoFiledACivilClaim_e414047e-6e29-4096-a1ac-a13efb3259c8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCounterExpertiseExperts_af015254-b20b-4dc6-9d19-5033d45b7c44" xlink:href="sny-20221231.xsd#sny_NumberOfCounterExpertiseExperts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCounterExpertiseExperts_af015254-b20b-4dc6-9d19-5033d45b7c44" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfMedicalAssessments_dc1ef185-fd86-4526-9c4f-ef643f2aaeec" xlink:href="sny-20221231.xsd#sny_NumberOfMedicalAssessments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfMedicalAssessments_dc1ef185-fd86-4526-9c4f-ef643f2aaeec" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification_d8483ef7-5b3f-425a-8b80-27b9bfa01d78" xlink:href="sny-20221231.xsd#sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification_d8483ef7-5b3f-425a-8b80-27b9bfa01d78" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfAdministrativeProceedings_61c0ff0b-4b4d-4b6c-be0e-6611d584b36b" xlink:href="sny-20221231.xsd#sny_NumberOfAdministrativeProceedings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfAdministrativeProceedings_61c0ff0b-4b4d-4b6c-be0e-6611d584b36b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOngoingTrials_d047861c-d668-4f66-9824-27c6b1fcf949" xlink:href="sny-20221231.xsd#sny_NumberOfOngoingTrials"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfOngoingTrials_d047861c-d668-4f66-9824-27c6b1fcf949" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPreActionProtocolCases_4e598166-f0e8-475c-b113-e5becd31c4c9" xlink:href="sny-20221231.xsd#sny_NumberOfPreActionProtocolCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPreActionProtocolCases_4e598166-f0e8-475c-b113-e5becd31c4c9" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCases_a2dca97a-b415-42b3-b96a-e8269f2fc009" xlink:href="sny-20221231.xsd#sny_NumberOfCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCases_a2dca97a-b415-42b3-b96a-e8269f2fc009" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCivilClaimsOnGoing_f34f104d-a70b-42e2-8012-350c9c1e1769" xlink:href="sny-20221231.xsd#sny_NumberOfCivilClaimsOnGoing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCivilClaimsOnGoing_f34f104d-a70b-42e2-8012-350c9c1e1769" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug_dbd8a103-8f49-494b-8ad0-9a7aaf9df3c3" xlink:href="sny-20221231.xsd#sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug_dbd8a103-8f49-494b-8ad0-9a7aaf9df3c3" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AnticipatedDurationOfAppealsProcess_ad7b40d8-20fe-4550-8594-15670f57408c" xlink:href="sny-20221231.xsd#sny_AnticipatedDurationOfAppealsProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_AnticipatedDurationOfAppealsProcess_ad7b40d8-20fe-4550-8594-15670f57408c" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPatentActionsInitiallyFiled_254e0333-61bb-49f6-83d2-9e104bfb7a4a" xlink:href="sny-20221231.xsd#sny_NumberOfPatentActionsInitiallyFiled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPatentActionsInitiallyFiled_254e0333-61bb-49f6-83d2-9e104bfb7a4a" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPatentsAllegedlyInfringed_6221ab95-f476-42b6-a4db-008b02719edc" xlink:href="sny-20221231.xsd#sny_NumberOfPatentsAllegedlyInfringed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPatentsAllegedlyInfringed_6221ab95-f476-42b6-a4db-008b02719edc" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfClaimsInvalid_caedd130-358e-4840-af61-cc4f528b6432" xlink:href="sny-20221231.xsd#sny_NumberOfClaimsInvalid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfClaimsInvalid_caedd130-358e-4840-af61-cc4f528b6432" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPatentsCoveringProduct_2d14b9da-4438-43c4-83d2-602f8392b3ec" xlink:href="sny-20221231.xsd#sny_NumberOfPatentsCoveringProduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPatentsCoveringProduct_2d14b9da-4438-43c4-83d2-602f8392b3ec" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfDecisionsIssuedByTheDistrictCourt_53aee082-8409-4eeb-9de6-c21600387287" xlink:href="sny-20221231.xsd#sny_NumberOfDecisionsIssuedByTheDistrictCourt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfDecisionsIssuedByTheDistrictCourt_53aee082-8409-4eeb-9de6-c21600387287" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LengthOfTrial_bebe4e04-0651-4f03-a5be-8ea9da7c2a9a" xlink:href="sny-20221231.xsd#sny_LengthOfTrial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_LengthOfTrial_bebe4e04-0651-4f03-a5be-8ea9da7c2a9a" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing_bc6f35ed-e53f-451f-b5e6-02687020035c" xlink:href="sny-20221231.xsd#sny_NumberOfDaysAfterCompletionOfPostTrailBriefing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing_bc6f35ed-e53f-451f-b5e6-02687020035c" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo_106c9599-02d7-40e6-9a6a-dc334191f282" xlink:href="sny-20221231.xsd#sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo_106c9599-02d7-40e6-9a6a-dc334191f282" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs_8b27fa42-cdf6-41c8-8fdc-685aef0a8c98" xlink:href="sny-20221231.xsd#sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs_8b27fa42-cdf6-41c8-8fdc-685aef0a8c98" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded_578f6760-bb01-40c8-935c-a11c31826c6c" xlink:href="sny-20221231.xsd#sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded_578f6760-bb01-40c8-935c-a11c31826c6c" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GlobalPenaltyFeeIncurredByDefendants_6d3a634f-f5a1-47d3-ab6e-ff05746202e6" xlink:href="sny-20221231.xsd#sny_GlobalPenaltyFeeIncurredByDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_GlobalPenaltyFeeIncurredByDefendants_6d3a634f-f5a1-47d3-ab6e-ff05746202e6" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PenaltyFeeIncurred_1400b8fb-84d6-44db-86c9-455687380a5c" xlink:href="sny-20221231.xsd#sny_PenaltyFeeIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_PenaltyFeeIncurred_1400b8fb-84d6-44db-86c9-455687380a5c" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentOfDamagesClaimedByCounterparty_526bdb67-5e8f-4a43-9394-a8df24f9cc46" xlink:href="sny-20221231.xsd#sny_PaymentOfDamagesClaimedByCounterparty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_PaymentOfDamagesClaimedByCounterparty_526bdb67-5e8f-4a43-9394-a8df24f9cc46" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOtherManufacturersInvolvedInProceedings_b81f6b6a-e7ca-4027-9ab7-e7a245297fcd" xlink:href="sny-20221231.xsd#sny_NumberOfOtherManufacturersInvolvedInProceedings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfOtherManufacturersInvolvedInProceedings_b81f6b6a-e7ca-4027-9ab7-e7a245297fcd" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInvestmentSoldPercentage_06712db6-ced0-4df7-a118-f00834028ded" xlink:href="sny-20221231.xsd#sny_EquityInvestmentSoldPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_EquityInvestmentSoldPercentage_06712db6-ced0-4df7-a118-f00834028ded" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking_59961510-92b9-4f80-a339-cf0e19fce866" xlink:href="sny-20221231.xsd#sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking_59961510-92b9-4f80-a339-cf0e19fce866" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense_6d6d9172-18a9-418a-b3c3-7e15db042f50" xlink:href="sny-20221231.xsd#sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense_6d6d9172-18a9-418a-b3c3-7e15db042f50" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:href="sny-20221231.xsd#sny_DisclosureOfLegalAndArbitralProceedingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LegalAndArbitralProceedingsAxis_51003b17-4000-4e52-b26f-8537f544e8fe" xlink:href="sny-20221231.xsd#sny_LegalAndArbitralProceedingsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_sny_LegalAndArbitralProceedingsAxis_51003b17-4000-4e52-b26f-8537f544e8fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LegalAndArbitralProceedingsDomain_51003b17-4000-4e52-b26f-8537f544e8fe_default" xlink:href="sny-20221231.xsd#sny_LegalAndArbitralProceedingsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_LegalAndArbitralProceedingsAxis_51003b17-4000-4e52-b26f-8537f544e8fe" xlink:to="loc_sny_LegalAndArbitralProceedingsDomain_51003b17-4000-4e52-b26f-8537f544e8fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:href="sny-20221231.xsd#sny_LegalAndArbitralProceedingsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_LegalAndArbitralProceedingsAxis_51003b17-4000-4e52-b26f-8537f544e8fe" xlink:to="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurHepatitisBVaccineMember_dc10e5e1-24c9-4e5e-800d-2283b5d6a455" xlink:href="sny-20221231.xsd#sny_SanofiPasteurHepatitisBVaccineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_SanofiPasteurHepatitisBVaccineMember_dc10e5e1-24c9-4e5e-800d-2283b5d6a455" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxotereProductLitigationInTheUSMember_272ffc96-9b3d-4bf6-a2c7-9b86cb861875" xlink:href="sny-20221231.xsd#sny_TaxotereProductLitigationInTheUSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_TaxotereProductLitigationInTheUSMember_272ffc96-9b3d-4bf6-a2c7-9b86cb861875" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember_717671dc-0b9c-4527-8fc6-4852b54b8a11" xlink:href="sny-20221231.xsd#sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember_717671dc-0b9c-4527-8fc6-4852b54b8a11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ZantacLitigationInTheUSMDLCourtMember_8e06fa49-1a4a-445d-bd42-9714b10f250d" xlink:href="sny-20221231.xsd#sny_ZantacLitigationInTheUSMDLCourtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_ZantacLitigationInTheUSMDLCourtMember_8e06fa49-1a4a-445d-bd42-9714b10f250d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ZantacLitigationInTheUSMember_c766e55d-22e2-4ddc-a127-dcb3fad2c695" xlink:href="sny-20221231.xsd#sny_ZantacLitigationInTheUSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_ZantacLitigationInTheUSMember_c766e55d-22e2-4ddc-a127-dcb3fad2c695" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ZantacLitigationInCanadaMember_057b45ff-01d1-4ff7-bd26-a9e53311eeee" xlink:href="sny-20221231.xsd#sny_ZantacLitigationInCanadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_ZantacLitigationInCanadaMember_057b45ff-01d1-4ff7-bd26-a9e53311eeee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInFranceMember_8f3d9afb-896d-4a9b-83cb-2d65e083b314" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInFranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInFranceMember_8f3d9afb-896d-4a9b-83cb-2d65e083b314" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInSwitzerlandMember_6aed192c-4daf-47c0-a14c-8c7d81acd79c" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInSwitzerlandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInSwitzerlandMember_6aed192c-4daf-47c0-a14c-8c7d81acd79c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInSpainMember_450bb731-40a1-4ebd-bd8a-c105beaeeecb" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInSpainMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInSpainMember_450bb731-40a1-4ebd-bd8a-c105beaeeecb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInBelgiumMember_7bac548b-7adf-4be8-8f6b-62b556465a96" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInBelgiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInBelgiumMember_7bac548b-7adf-4be8-8f6b-62b556465a96" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInGermanyMember_7c2e9d14-9475-4ca4-a853-4a8fdfbaf3bb" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInGermanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInGermanyMember_7c2e9d14-9475-4ca4-a853-4a8fdfbaf3bb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DengvaxiaProductLitigationInThePhilippinesMember_2c4b371c-9c53-4e1d-b87d-23b777e1e849" xlink:href="sny-20221231.xsd#sny_DengvaxiaProductLitigationInThePhilippinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DengvaxiaProductLitigationInThePhilippinesMember_2c4b371c-9c53-4e1d-b87d-23b777e1e849" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RamiprilCanadaPatentLitigationMember_963638c3-5b57-4c6b-80fc-0f319a714e4d" xlink:href="sny-20221231.xsd#sny_RamiprilCanadaPatentLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_RamiprilCanadaPatentLitigationMember_963638c3-5b57-4c6b-80fc-0f319a714e4d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember_cb802529-9187-45b8-91cd-ca657cfa38ad" xlink:href="sny-20221231.xsd#sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember_cb802529-9187-45b8-91cd-ca657cfa38ad" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember_76102651-50f0-46a9-add4-066fe96ddfe9" xlink:href="sny-20221231.xsd#sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember_76102651-50f0-46a9-add4-066fe96ddfe9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_JevtanaRelatedPatentLitigationInTheUSMember_360f44c6-eafa-48e3-9cbb-f6e2203d5de8" xlink:href="sny-20221231.xsd#sny_JevtanaRelatedPatentLitigationInTheUSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_JevtanaRelatedPatentLitigationInTheUSMember_360f44c6-eafa-48e3-9cbb-f6e2203d5de8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixLitigationCommonwealthInAustraliaMember_62b081e1-6abf-4b35-afe4-778101940bf8" xlink:href="sny-20221231.xsd#sny_PlavixLitigationCommonwealthInAustraliaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_PlavixLitigationCommonwealthInAustraliaMember_62b081e1-6abf-4b35-afe4-778101940bf8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember_b744fc48-1b7d-43df-95f0-aa806a8fd918" xlink:href="sny-20221231.xsd#sny_PlavixAttorneyGeneralActionInHawaiiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember_b744fc48-1b7d-43df-95f0-aa806a8fd918" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixRelatedLitigationInFranceMember_dfb77e51-be7b-46a8-92a4-730b3f627ac7" xlink:href="sny-20221231.xsd#sny_PlavixRelatedLitigationInFranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_PlavixRelatedLitigationInFranceMember_dfb77e51-be7b-46a8-92a4-730b3f627ac7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_A340BDrugPricingProgramInTheUnitedStatesMember_e5934454-12c1-48a9-885d-83f0e120802f" xlink:href="sny-20221231.xsd#sny_A340BDrugPricingProgramInTheUnitedStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_A340BDrugPricingProgramInTheUnitedStatesMember_e5934454-12c1-48a9-885d-83f0e120802f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisCropScienceRetainedLiabilitiesMember_82ff9f58-b6ca-4cfd-a0df-5d22182d51b0" xlink:href="sny-20221231.xsd#sny_AventisCropScienceRetainedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_AventisCropScienceRetainedLiabilitiesMember_82ff9f58-b6ca-4cfd-a0df-5d22182d51b0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InfraservHoechstRetainedLiabilitiesMember_665cf263-2047-4c1b-be4c-a97a8ecc2a49" xlink:href="sny-20221231.xsd#sny_InfraservHoechstRetainedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_InfraservHoechstRetainedLiabilitiesMember_665cf263-2047-4c1b-be4c-a97a8ecc2a49" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInIrelandMember_4f5a3de4-240d-4d66-ac16-d16e172a167e" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInIrelandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInIrelandMember_4f5a3de4-240d-4d66-ac16-d16e172a167e" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInGreatBritainMember_7103e6a8-fdf9-4ef5-b809-8793d7ccb9cd" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInGreatBritainMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInGreatBritainMember_7103e6a8-fdf9-4ef5-b809-8793d7ccb9cd" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInNorthernIrelandMember_c72396e6-24b1-464e-b175-d2262fa250eb" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInNorthernIrelandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInNorthernIrelandMember_c72396e6-24b1-464e-b175-d2262fa250eb" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefendantAxis_2562e67c-75a2-4833-a4e0-d26d99d0054b" xlink:href="sny-20221231.xsd#sny_DefendantAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_sny_DefendantAxis_2562e67c-75a2-4833-a4e0-d26d99d0054b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefendantsMember_2562e67c-75a2-4833-a4e0-d26d99d0054b_default" xlink:href="sny-20221231.xsd#sny_DefendantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_DefendantAxis_2562e67c-75a2-4833-a4e0-d26d99d0054b" xlink:to="loc_sny_DefendantsMember_2562e67c-75a2-4833-a4e0-d26d99d0054b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefendantsMember_3e076f0c-1a99-4b6d-9442-dc91f2898672" xlink:href="sny-20221231.xsd#sny_DefendantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_DefendantAxis_2562e67c-75a2-4833-a4e0-d26d99d0054b" xlink:to="loc_sny_DefendantsMember_3e076f0c-1a99-4b6d-9442-dc91f2898672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActionForWhichWeAreDefendantMember_7935e105-6f0f-4ab4-b226-d4936cc77b44" xlink:href="sny-20221231.xsd#sny_ActionForWhichWeAreDefendantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DefendantsMember_3e076f0c-1a99-4b6d-9442-dc91f2898672" xlink:to="loc_sny_ActionForWhichWeAreDefendantMember_7935e105-6f0f-4ab4-b226-d4936cc77b44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActionForWhichWeArePlaintiffMember_488de598-4015-44aa-a4c6-56608097d5d4" xlink:href="sny-20221231.xsd#sny_ActionForWhichWeArePlaintiffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DefendantsMember_3e076f0c-1a99-4b6d-9442-dc91f2898672" xlink:to="loc_sny_ActionForWhichWeArePlaintiffMember_488de598-4015-44aa-a4c6-56608097d5d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_1664b533-d7d8-4544-adbd-5a2fe22a873d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_CounterpartiesAxis_1664b533-d7d8-4544-adbd-5a2fe22a873d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_1664b533-d7d8-4544-adbd-5a2fe22a873d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_1664b533-d7d8-4544-adbd-5a2fe22a873d" xlink:to="loc_ifrs-full_CounterpartiesMember_1664b533-d7d8-4544-adbd-5a2fe22a873d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_f4b084a7-ab9c-4f58-988c-284f64504c5b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_1664b533-d7d8-4544-adbd-5a2fe22a873d" xlink:to="loc_ifrs-full_CounterpartiesMember_f4b084a7-ab9c-4f58-988c-284f64504c5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlaintiffMember_3bede628-6c64-4b9c-be70-15bc2bb8e4ec" xlink:href="sny-20221231.xsd#sny_PlaintiffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_f4b084a7-ab9c-4f58-988c-284f64504c5b" xlink:to="loc_sny_PlaintiffMember_3bede628-6c64-4b9c-be70-15bc2bb8e4ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CaissePrimaireDassuranceMaladieMember_6247d856-d441-4e85-b4bf-3e5cb37c161a" xlink:href="sny-20221231.xsd#sny_CaissePrimaireDassuranceMaladieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_f4b084a7-ab9c-4f58-988c-284f64504c5b" xlink:to="loc_sny_CaissePrimaireDassuranceMaladieMember_6247d856-d441-4e85-b4bf-3e5cb37c161a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_a548777c-9b7a-473c-87a4-b4857b569216" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_a548777c-9b7a-473c-87a4-b4857b569216" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_a548777c-9b7a-473c-87a4-b4857b569216_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_a548777c-9b7a-473c-87a4-b4857b569216" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_a548777c-9b7a-473c-87a4-b4857b569216_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_741da41d-a782-471b-8ee0-f8eec22edbba" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_a548777c-9b7a-473c-87a4-b4857b569216" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_741da41d-a782-471b-8ee0-f8eec22edbba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingenciesArisingFromCertainBusinessDivestituresMember_b0402e4b-8ca4-4977-a6b8-517bd0c1e50d" xlink:href="sny-20221231.xsd#sny_ContingenciesArisingFromCertainBusinessDivestituresMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_741da41d-a782-471b-8ee0-f8eec22edbba" xlink:to="loc_sny_ContingenciesArisingFromCertainBusinessDivestituresMember_b0402e4b-8ca4-4977-a6b8-517bd0c1e50d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_7dbe57db-607f-4d2b-9cb1-84c5856711bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_7dbe57db-607f-4d2b-9cb1-84c5856711bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_7dbe57db-607f-4d2b-9cb1-84c5856711bd_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_7dbe57db-607f-4d2b-9cb1-84c5856711bd" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_7dbe57db-607f-4d2b-9cb1-84c5856711bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_4dd9cf28-2f3b-4ba0-bfcb-dd9ef0bcfed9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_7dbe57db-607f-4d2b-9cb1-84c5856711bd" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_4dd9cf28-2f3b-4ba0-bfcb-dd9ef0bcfed9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProductLiabilitiesMember_6a19fd30-2ed5-454d-9c20-6d6c7f20bff5" xlink:href="sny-20221231.xsd#sny_ProductLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_4dd9cf28-2f3b-4ba0-bfcb-dd9ef0bcfed9" xlink:to="loc_sny_ProductLiabilitiesMember_6a19fd30-2ed5-454d-9c20-6d6c7f20bff5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_d90be8eb-b470-4125-a6b1-3ff0e2fe52b6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_d90be8eb-b470-4125-a6b1-3ff0e2fe52b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_d90be8eb-b470-4125-a6b1-3ff0e2fe52b6_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_d90be8eb-b470-4125-a6b1-3ff0e2fe52b6" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_d90be8eb-b470-4125-a6b1-3ff0e2fe52b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_398d3921-d6f2-409c-b9da-1a7bd7c393f1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_d90be8eb-b470-4125-a6b1-3ff0e2fe52b6" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_398d3921-d6f2-409c-b9da-1a7bd7c393f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PatentsMember_eee025d5-fb40-43ad-a0a0-c86652134a5c" xlink:href="sny-20221231.xsd#sny_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_398d3921-d6f2-409c-b9da-1a7bd7c393f1" xlink:to="loc_sny_PatentsMember_eee025d5-fb40-43ad-a0a0-c86652134a5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_d2a0f56f-a864-4cf5-b8ba-58eb87957c03" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_RangeAxis_d2a0f56f-a864-4cf5-b8ba-58eb87957c03" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_d2a0f56f-a864-4cf5-b8ba-58eb87957c03_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_d2a0f56f-a864-4cf5-b8ba-58eb87957c03" xlink:to="loc_ifrs-full_RangesMember_d2a0f56f-a864-4cf5-b8ba-58eb87957c03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_d89281ea-d773-4ddd-b2c1-9ff195a06203" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_d2a0f56f-a864-4cf5-b8ba-58eb87957c03" xlink:to="loc_ifrs-full_RangesMember_d89281ea-d773-4ddd-b2c1-9ff195a06203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f56dd3ee-8bac-4870-a001-6fda8c7153d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_d89281ea-d773-4ddd-b2c1-9ff195a06203" xlink:to="loc_srt_MinimumMember_f56dd3ee-8bac-4870-a001-6fda8c7153d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cf73d06a-af2c-4346-98ea-5658c81fad2c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_d89281ea-d773-4ddd-b2c1-9ff195a06203" xlink:to="loc_srt_MaximumMember_cf73d06a-af2c-4346-98ea-5658c81fad2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8700662a-0c5a-408c-be83-b548d3e366fc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8700662a-0c5a-408c-be83-b548d3e366fc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsMember_8700662a-0c5a-408c-be83-b548d3e366fc_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8700662a-0c5a-408c-be83-b548d3e366fc" xlink:to="loc_ifrs-full_NonadjustingEventsMember_8700662a-0c5a-408c-be83-b548d3e366fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsMember_c4a9f69a-b01f-44c8-b8b8-72c8bd99f6f4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8700662a-0c5a-408c-be83-b548d3e366fc" xlink:to="loc_ifrs-full_NonadjustingEventsMember_c4a9f69a-b01f-44c8-b8b8-72c8bd99f6f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommencementOfMajorLitigationMember_ce60da9d-ac94-4ae8-8b49-77cd2575fbfa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CommencementOfMajorLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_c4a9f69a-b01f-44c8-b8b8-72c8bd99f6f4" xlink:to="loc_ifrs-full_CommencementOfMajorLitigationMember_ce60da9d-ac94-4ae8-8b49-77cd2575fbfa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails" xlink:type="extended" id="i88010e1d5b914c8ab4a48faa30204b3d_ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForDiscountsRebatesAndSalesReturns_4c6ef939-c4a2-4710-8669-86461ce6aae3" xlink:href="sny-20221231.xsd#sny_ProvisionsForDiscountsRebatesAndSalesReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_ProvisionsForDiscountsRebatesAndSalesReturns_4c6ef939-c4a2-4710-8669-86461ce6aae3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns_28869307-174f-4a90-87e9-bf42cb7a2142" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns_28869307-174f-4a90-87e9-bf42cb7a2142" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales_07a0fe49-a624-4ba4-a473-2444523c59c9" xlink:href="sny-20221231.xsd#sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales_07a0fe49-a624-4ba4-a473-2444523c59c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales_e5702b06-4a7e-4f12-b9fa-958482a6acf6" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales_e5702b06-4a7e-4f12-b9fa-958482a6acf6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns_bb1c9d39-0af4-4e08-b2d9-cf4263955219" xlink:href="sny-20221231.xsd#sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns_bb1c9d39-0af4-4e08-b2d9-cf4263955219" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns_e3fe7baa-d999-4649-8a43-ec09dd0b9d6e" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns_e3fe7baa-d999-4649-8a43-ec09dd0b9d6e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForDiscountsRebatesAndSalesReturns_db5e5c7d-ef8c-4158-884f-ea8afc8b61ee" xlink:href="sny-20221231.xsd#sny_ProvisionsForDiscountsRebatesAndSalesReturns"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable_f5fe7644-077b-4d6b-9dd0-35426069072b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherProvisionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsTable_f5fe7644-077b-4d6b-9dd0-35426069072b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_87a2d511-989f-483c-98ba-5a433a8f2d33" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_f5fe7644-077b-4d6b-9dd0-35426069072b" xlink:to="loc_srt_CounterpartyNameAxis_87a2d511-989f-483c-98ba-5a433a8f2d33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_87a2d511-989f-483c-98ba-5a433a8f2d33_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_87a2d511-989f-483c-98ba-5a433a8f2d33" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_87a2d511-989f-483c-98ba-5a433a8f2d33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_35dceae1-6f84-4e3a-92f4-e73b3b9ba41b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_87a2d511-989f-483c-98ba-5a433a8f2d33" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_35dceae1-6f84-4e3a-92f4-e73b3b9ba41b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MedicaidMember_53dd8f9c-fb93-45c7-91fb-839b2b456132" xlink:href="sny-20221231.xsd#sny_MedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_35dceae1-6f84-4e3a-92f4-e73b3b9ba41b" xlink:to="loc_sny_MedicaidMember_53dd8f9c-fb93-45c7-91fb-839b2b456132" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MedicareMember_c52ac651-c36a-4782-bb4a-217bf2adb7bf" xlink:href="sny-20221231.xsd#sny_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_35dceae1-6f84-4e3a-92f4-e73b3b9ba41b" xlink:to="loc_sny_MedicareMember_c52ac651-c36a-4782-bb4a-217bf2adb7bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_f5fd86e2-3390-433c-b6d3-43ee4ccbe17c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_f5fe7644-077b-4d6b-9dd0-35426069072b" xlink:to="loc_ifrs-full_GeographicalAreasAxis_f5fd86e2-3390-433c-b6d3-43ee4ccbe17c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_f5fd86e2-3390-433c-b6d3-43ee4ccbe17c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_f5fd86e2-3390-433c-b6d3-43ee4ccbe17c" xlink:to="loc_ifrs-full_GeographicalAreasMember_f5fd86e2-3390-433c-b6d3-43ee4ccbe17c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_7b216010-5879-42ae-8cce-5c10a18fed26" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_f5fd86e2-3390-433c-b6d3-43ee4ccbe17c" xlink:to="loc_ifrs-full_GeographicalAreasMember_7b216010-5879-42ae-8cce-5c10a18fed26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_99d983ab-91e8-46d6-adfc-f161e8408603" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_7b216010-5879-42ae-8cce-5c10a18fed26" xlink:to="loc_country_US_99d983ab-91e8-46d6-adfc-f161e8408603" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_de9f01ef-ed15-46d1-af05-3e067556e170" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_f5fe7644-077b-4d6b-9dd0-35426069072b" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_de9f01ef-ed15-46d1-af05-3e067556e170" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_de9f01ef-ed15-46d1-af05-3e067556e170_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_de9f01ef-ed15-46d1-af05-3e067556e170" xlink:to="loc_ifrs-full_OtherProvisionsMember_de9f01ef-ed15-46d1-af05-3e067556e170_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_de9f01ef-ed15-46d1-af05-3e067556e170" xlink:to="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GovernmentAndStateProgramsMember_5029481f-b11d-4df5-9f7b-e39b4e1d5fe3" xlink:href="sny-20221231.xsd#sny_GovernmentAndStateProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_GovernmentAndStateProgramsMember_5029481f-b11d-4df5-9f7b-e39b4e1d5fe3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ManagedCareAndGPOProgramsMember_ecdfc119-82b7-41e2-bab0-eff245885d96" xlink:href="sny-20221231.xsd#sny_ManagedCareAndGPOProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_ManagedCareAndGPOProgramsMember_ecdfc119-82b7-41e2-bab0-eff245885d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChargebackIncentivesMember_b8fab536-4589-422b-bf81-0227ee4e2c23" xlink:href="sny-20221231.xsd#sny_ChargebackIncentivesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_ChargebackIncentivesMember_b8fab536-4589-422b-bf81-0227ee4e2c23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RebatesAndDiscountsMember_96b82661-4d0f-4ae3-b5ef-687471a4bebf" xlink:href="sny-20221231.xsd#sny_RebatesAndDiscountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_RebatesAndDiscountsMember_96b82661-4d0f-4ae3-b5ef-687471a4bebf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesReturnMember_51c7327c-63d0-4d91-93ac-e5984e1957e9" xlink:href="sny-20221231.xsd#sny_SalesReturnMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_SalesReturnMember_51c7327c-63d0-4d91-93ac-e5984e1957e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherDeductionsMember_5110138b-567c-4b84-877e-674282e58bd5" xlink:href="sny-20221231.xsd#sny_OtherDeductionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_OtherDeductionsMember_5110138b-567c-4b84-877e-674282e58bd5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ManagedCareMember_dd0cc5b1-ecc5-4a2a-b7fe-5562a8e0a8bf" xlink:href="sny-20221231.xsd#sny_ManagedCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_ManagedCareMember_dd0cc5b1-ecc5-4a2a-b7fe-5562a8e0a8bf" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OtheroperatingincomeDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OtheroperatingincomeDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/OtheroperatingincomeDetails" xlink:type="extended" id="id67022396e0c4eaaa0a03ff15974a306_OtheroperatingincomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeLineItems_4deb78cf-2d69-42e5-a7db-0c9527aa70b5" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_6b02f596-e652-47aa-a211-6bd19461a6e6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeLineItems_4deb78cf-2d69-42e5-a7db-0c9527aa70b5" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_6b02f596-e652-47aa-a211-6bd19461a6e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainsOnDivestmentOfProducts_e0889453-92cc-4431-9e56-4c2077678cc6" xlink:href="sny-20221231.xsd#sny_GainsOnDivestmentOfProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeLineItems_4deb78cf-2d69-42e5-a7db-0c9527aa70b5" xlink:to="loc_sny_GainsOnDivestmentOfProducts_e0889453-92cc-4431-9e56-4c2077678cc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeTable_858f8c2a-cf62-4e5c-a335-0b2505abf526" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeLineItems_4deb78cf-2d69-42e5-a7db-0c9527aa70b5" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeTable_858f8c2a-cf62-4e5c-a335-0b2505abf526" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_547e71f5-8f23-46b9-b62e-b549892f2ec1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeTable_858f8c2a-cf62-4e5c-a335-0b2505abf526" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_547e71f5-8f23-46b9-b62e-b549892f2ec1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_547e71f5-8f23-46b9-b62e-b549892f2ec1_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_547e71f5-8f23-46b9-b62e-b549892f2ec1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_547e71f5-8f23-46b9-b62e-b549892f2ec1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_c7ec2641-c88f-41d0-aa40-78a45eaca6ad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_547e71f5-8f23-46b9-b62e-b549892f2ec1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_c7ec2641-c88f-41d0-aa40-78a45eaca6ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember_77b0be16-1544-4928-82e8-7a3f9c4d7a16" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_c7ec2641-c88f-41d0-aa40-78a45eaca6ad" xlink:to="loc_ifrs-full_OtherRelatedPartiesMember_77b0be16-1544-4928-82e8-7a3f9c4d7a16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DaiichiSankyoMember_afccb819-4d5f-4f82-a14c-83738bc65d19" xlink:href="sny-20221231.xsd#sny_DaiichiSankyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_c7ec2641-c88f-41d0-aa40-78a45eaca6ad" xlink:to="loc_sny_DaiichiSankyoMember_afccb819-4d5f-4f82-a14c-83738bc65d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ecfda4-e49f-4892-929e-356a1c5e6382" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeTable_858f8c2a-cf62-4e5c-a335-0b2505abf526" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ecfda4-e49f-4892-929e-356a1c5e6382" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_85ecfda4-e49f-4892-929e-356a1c5e6382_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ecfda4-e49f-4892-929e-356a1c5e6382" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_85ecfda4-e49f-4892-929e-356a1c5e6382_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_fc2bab2d-d2b4-4b29-a1ed-484abb7baa35" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ecfda4-e49f-4892-929e-356a1c5e6382" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_fc2bab2d-d2b4-4b29-a1ed-484abb7baa35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_3fed98b2-b7ea-4af5-a003-28f454117525" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_fc2bab2d-d2b4-4b29-a1ed-484abb7baa35" xlink:to="loc_sny_RegeneronMember_3fed98b2-b7ea-4af5-a003-28f454117525" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationAxis_321eaf1a-1530-48d3-b83e-71d4eff52c6f" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeTable_858f8c2a-cf62-4e5c-a335-0b2505abf526" xlink:to="loc_sny_IncomeStatementLocationAxis_321eaf1a-1530-48d3-b83e-71d4eff52c6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationDomain_321eaf1a-1530-48d3-b83e-71d4eff52c6f_default" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_IncomeStatementLocationAxis_321eaf1a-1530-48d3-b83e-71d4eff52c6f" xlink:to="loc_sny_IncomeStatementLocationDomain_321eaf1a-1530-48d3-b83e-71d4eff52c6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationDomain_ccad6032-35c6-421f-bbc0-4f7d9331c62e" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_IncomeStatementLocationAxis_321eaf1a-1530-48d3-b83e-71d4eff52c6f" xlink:to="loc_sny_IncomeStatementLocationDomain_ccad6032-35c6-421f-bbc0-4f7d9331c62e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherOperatingIncomeExpenseMember_febc2f86-cb3c-4ede-aede-c0edb4a1b1d2" xlink:href="sny-20221231.xsd#sny_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_IncomeStatementLocationDomain_ccad6032-35c6-421f-bbc0-4f7d9331c62e" xlink:to="loc_sny_OtherOperatingIncomeExpenseMember_febc2f86-cb3c-4ede-aede-c0edb4a1b1d2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OtheroperatingexpensesOtherIncomeandExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails" xlink:type="extended" id="i28fc9c343e714f8fb69a2939ef789446_OtheroperatingexpensesOtherIncomeandExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_ce550650-0516-473e-8db0-5d22d0f3ca3f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_ce550650-0516-473e-8db0-5d22d0f3ca3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_7679f4ad-c81e-47d5-b102-1886a04874bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_7679f4ad-c81e-47d5-b102-1886a04874bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_39e7d641-e52c-47e7-9cae-45bc9a562608" xlink:href="sny-20221231.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:to="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_39e7d641-e52c-47e7-9cae-45bc9a562608" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_98dc7371-1e5f-4d3e-910b-44bfff7eff2b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_98dc7371-1e5f-4d3e-910b-44bfff7eff2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsReceivedForDevelopmentCosts_d9f812ec-0556-406c-84cf-7b6345bf28c7" xlink:href="sny-20221231.xsd#sny_CommitmentsReceivedForDevelopmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:to="loc_sny_CommitmentsReceivedForDevelopmentCosts_d9f812ec-0556-406c-84cf-7b6345bf28c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c977f893-141c-4b88-afc8-0adc12e5676e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:to="loc_srt_CounterpartyNameAxis_c977f893-141c-4b88-afc8-0adc12e5676e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c977f893-141c-4b88-afc8-0adc12e5676e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_c977f893-141c-4b88-afc8-0adc12e5676e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c977f893-141c-4b88-afc8-0adc12e5676e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46ba4884-cd27-4a2b-b058-1f9bb41f33cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_c977f893-141c-4b88-afc8-0adc12e5676e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46ba4884-cd27-4a2b-b058-1f9bb41f33cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesAllianceMember_5934143c-603b-4a2c-9310-116555454de0" xlink:href="sny-20221231.xsd#sny_AntibodiesAllianceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46ba4884-cd27-4a2b-b058-1f9bb41f33cc" xlink:to="loc_sny_AntibodiesAllianceMember_5934143c-603b-4a2c-9310-116555454de0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImmunooncologyAllianceMember_db8ffafe-33c6-4fb9-a59b-3636a42de9f3" xlink:href="sny-20221231.xsd#sny_ImmunooncologyAllianceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46ba4884-cd27-4a2b-b058-1f9bb41f33cc" xlink:to="loc_sny_ImmunooncologyAllianceMember_db8ffafe-33c6-4fb9-a59b-3636a42de9f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OthersCounterpartyMember_571e65d6-6c72-460b-82f4-f6c4581770a2" xlink:href="sny-20221231.xsd#sny_OthersCounterpartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46ba4884-cd27-4a2b-b058-1f9bb41f33cc" xlink:to="loc_sny_OthersCounterpartyMember_571e65d6-6c72-460b-82f4-f6c4581770a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationAxis_4d96396e-d6ea-4a80-b6d0-40a78215f183" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:to="loc_sny_IncomeStatementLocationAxis_4d96396e-d6ea-4a80-b6d0-40a78215f183" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationDomain_4d96396e-d6ea-4a80-b6d0-40a78215f183_default" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_IncomeStatementLocationAxis_4d96396e-d6ea-4a80-b6d0-40a78215f183" xlink:to="loc_sny_IncomeStatementLocationDomain_4d96396e-d6ea-4a80-b6d0-40a78215f183_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_IncomeStatementLocationAxis_4d96396e-d6ea-4a80-b6d0-40a78215f183" xlink:to="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember_3f9a682d-b198-437d-b070-b6158eba654b" xlink:href="sny-20221231.xsd#sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:to="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember_3f9a682d-b198-437d-b070-b6158eba654b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember_ce7e4688-d3af-419d-ab59-9aaffba5d45b" xlink:href="sny-20221231.xsd#sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:to="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember_ce7e4688-d3af-419d-ab59-9aaffba5d45b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommercializationRelatedExpensesMember_4dd94c8f-e294-4014-b6b8-aa18de0627de" xlink:href="sny-20221231.xsd#sny_CommercializationRelatedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:to="loc_sny_CommercializationRelatedExpensesMember_4dd94c8f-e294-4014-b6b8-aa18de0627de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherOperatingIncomeExpenseMember_d9dd36ae-0b1f-4f63-9c70-35b9794c8a24" xlink:href="sny-20221231.xsd#sny_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:to="loc_sny_OtherOperatingIncomeExpenseMember_d9dd36ae-0b1f-4f63-9c70-35b9794c8a24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_c71e4077-e257-4a78-9dc1-45d2dc51bdf0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_c71e4077-e257-4a78-9dc1-45d2dc51bdf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_c71e4077-e257-4a78-9dc1-45d2dc51bdf0_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_c71e4077-e257-4a78-9dc1-45d2dc51bdf0" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_c71e4077-e257-4a78-9dc1-45d2dc51bdf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_16d95220-6072-495d-ab78-c7e0e083308b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_c71e4077-e257-4a78-9dc1-45d2dc51bdf0" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_16d95220-6072-495d-ab78-c7e0e083308b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_f8a90eb8-8af6-495d-b6be-f4b0410462ee" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_16d95220-6072-495d-ab78-c7e0e083308b" xlink:to="loc_sny_RegeneronMember_f8a90eb8-8af6-495d-b6be-f4b0410462ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_4ece2edc-0b00-4163-b92f-61f5833341c7" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:to="loc_sny_PrincipalAlliancesAxis_4ece2edc-0b00-4163-b92f-61f5833341c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_4ece2edc-0b00-4163-b92f-61f5833341c7_default" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_PrincipalAlliancesAxis_4ece2edc-0b00-4163-b92f-61f5833341c7" xlink:to="loc_sny_PrincipalAlliancesDomain_4ece2edc-0b00-4163-b92f-61f5833341c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_fada925f-8d19-4ce7-8251-b0d0e6d839a0" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_PrincipalAlliancesAxis_4ece2edc-0b00-4163-b92f-61f5833341c7" xlink:to="loc_sny_PrincipalAlliancesDomain_fada925f-8d19-4ce7-8251-b0d0e6d839a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember_bcafc5b3-0e60-4b53-bbf5-0c88dfe96d5e" xlink:href="sny-20221231.xsd#sny_AntibodiesCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalAlliancesDomain_fada925f-8d19-4ce7-8251-b0d0e6d839a0" xlink:to="loc_sny_AntibodiesCollaborationAgreementMember_bcafc5b3-0e60-4b53-bbf5-0c88dfe96d5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_ff92457b-918c-4448-a269-ce188c253399" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:to="loc_ifrs-full_CounterpartiesAxis_ff92457b-918c-4448-a269-ce188c253399" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_ff92457b-918c-4448-a269-ce188c253399_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_ff92457b-918c-4448-a269-ce188c253399" xlink:to="loc_ifrs-full_CounterpartiesMember_ff92457b-918c-4448-a269-ce188c253399_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_e20d22aa-1ccb-4491-b4fd-5949077d3b52" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_ff92457b-918c-4448-a269-ce188c253399" xlink:to="loc_ifrs-full_CounterpartiesMember_e20d22aa-1ccb-4491-b4fd-5949077d3b52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_2b982a49-f862-4365-8d39-da245b6f43f5" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_e20d22aa-1ccb-4491-b4fd-5949077d3b52" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_2b982a49-f862-4365-8d39-da245b6f43f5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/FinancialexpensesandincomeDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#FinancialexpensesandincomeDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/FinancialexpensesandincomeDetails" xlink:type="extended" id="ie6c650389ec8430880b2440598dba6bd_FinancialexpensesandincomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_222a3643-0be8-4b3d-b4db-20a091e420b4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_222a3643-0be8-4b3d-b4db-20a091e420b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestIncome_59202a47-8969-4995-9d69-247cf3628fd6" xlink:href="sny-20221231.xsd#sny_InterestIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_InterestIncome_59202a47-8969-4995-9d69-247cf3628fd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CostOfDebtNet_2dacb047-9532-4868-8c15-9ff5c3d4e119" xlink:href="sny-20221231.xsd#sny_CostOfDebtNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_CostOfDebtNet_2dacb047-9532-4868-8c15-9ff5c3d4e119" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonOperatingForeignExchangeGainsLosses_28fb8158-897a-4a52-be68-e62d502f70e4" xlink:href="sny-20221231.xsd#sny_NonOperatingForeignExchangeGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_NonOperatingForeignExchangeGainsLosses_28fb8158-897a-4a52-be68-e62d502f70e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_dfa6b1b9-0b23-4d04-a3d1-d637f6b0ce57" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_dfa6b1b9-0b23-4d04-a3d1-d637f6b0ce57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetInterestCostRelatedToEmployeeBenefits_79c95d46-4089-4600-8373-b1399e928768" xlink:href="sny-20221231.xsd#sny_NetInterestCostRelatedToEmployeeBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_NetInterestCostRelatedToEmployeeBenefits_79c95d46-4089-4600-8373-b1399e928768" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets_64c1ade2-b942-43b0-bbf1-ecea64db4e60" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets_64c1ade2-b942-43b0-bbf1-ecea64db4e60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_c46e6a9d-fa09-4212-a94f-4f4904800948" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_c46e6a9d-fa09-4212-a94f-4f4904800948" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceIncomeCost_7e89d265-f610-45c9-b3e2-bfaa1328bfe0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_OtherFinanceIncomeCost_7e89d265-f610-45c9-b3e2-bfaa1328bfe0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_a89d585a-285e-46ec-b91b-d4b1e95c290e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_FinanceIncomeCost_a89d585a-285e-46ec-b91b-d4b1e95c290e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_b2384a74-0c51-46cf-b9fc-1bdaab9d80a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_FinanceCosts_b2384a74-0c51-46cf-b9fc-1bdaab9d80a8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_8bf10358-1e23-4a06-be47-882d6664ece5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_FinanceIncome_8bf10358-1e23-4a06-be47-882d6664ece5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainOnDerivativesUsedToManageDebt_38162398-e707-4639-a438-60aa7668187c" xlink:href="sny-20221231.xsd#sny_GainOnDerivativesUsedToManageDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_GainOnDerivativesUsedToManageDebt_38162398-e707-4639-a438-60aa7668187c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents_c30d981a-242d-4e0d-b041-022b50e20614" xlink:href="sny-20221231.xsd#sny_GainOnDerivativesUsedToManageCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents_c30d981a-242d-4e0d-b041-022b50e20614" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_ccaba45a-a28b-45ac-8f91-61bf35a5824e" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_ccaba45a-a28b-45ac-8f91-61bf35a5824e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsAxis_cf77badd-bc1f-48ea-aca2-bfe04bb2b321" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgedItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_ccaba45a-a28b-45ac-8f91-61bf35a5824e" xlink:to="loc_ifrs-full_HedgedItemsAxis_cf77badd-bc1f-48ea-aca2-bfe04bb2b321" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsMember_cf77badd-bc1f-48ea-aca2-bfe04bb2b321_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgedItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgedItemsAxis_cf77badd-bc1f-48ea-aca2-bfe04bb2b321" xlink:to="loc_ifrs-full_HedgedItemsMember_cf77badd-bc1f-48ea-aca2-bfe04bb2b321_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsMember_47013754-345c-462a-9f19-a7929f622635" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgedItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgedItemsAxis_cf77badd-bc1f-48ea-aca2-bfe04bb2b321" xlink:to="loc_ifrs-full_HedgedItemsMember_47013754-345c-462a-9f19-a7929f622635" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesMember_755ad189-e865-4095-8add-96234be684b7" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsMember_47013754-345c-462a-9f19-a7929f622635" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesMember_755ad189-e865-4095-8add-96234be684b7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails" xlink:type="extended" id="i0f4a33aec96041f7a498819d64158b5e_ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_a93e507e-351a-402e-b36a-66f37674d7e9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_e6778ac1-a19d-466e-a21c-70d84b3ffbf8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_a93e507e-351a-402e-b36a-66f37674d7e9" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_e6778ac1-a19d-466e-a21c-70d84b3ffbf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_ced6d247-b3e4-4bfb-9055-08cf78dee931" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_a93e507e-351a-402e-b36a-66f37674d7e9" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_ced6d247-b3e4-4bfb-9055-08cf78dee931" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4fc4e1c7-e16f-4f4b-a92c-f08e923cf7ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_ced6d247-b3e4-4bfb-9055-08cf78dee931" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4fc4e1c7-e16f-4f4b-a92c-f08e923cf7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_4fc4e1c7-e16f-4f4b-a92c-f08e923cf7ef_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4fc4e1c7-e16f-4f4b-a92c-f08e923cf7ef" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_4fc4e1c7-e16f-4f4b-a92c-f08e923cf7ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_8cea4651-5a8f-4237-b257-822241ccc9b2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4fc4e1c7-e16f-4f4b-a92c-f08e923cf7ef" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_8cea4651-5a8f-4237-b257-822241ccc9b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_b8af2c92-433e-470e-91c1-8f7d53d9978a" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_8cea4651-5a8f-4237-b257-822241ccc9b2" xlink:to="loc_sny_RegeneronMember_b8af2c92-433e-470e-91c1-8f7d53d9978a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#NetincomeattributabletononcontrollinginterestsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails" xlink:type="extended" id="ib4c4a3eda4b14f22a2a8053c63d6b813_NetincomeattributabletononcontrollinginterestsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems_914e4ae2-d06f-4603-a360-03c4a77309e9" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_8fc85175-6e8d-49ba-86ec-7c902f5493a3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems_914e4ae2-d06f-4603-a360-03c4a77309e9" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_8fc85175-6e8d-49ba-86ec-7c902f5493a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable_90b961f2-4d67-4883-9647-3ced1e2a83a8" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems_914e4ae2-d06f-4603-a360-03c4a77309e9" xlink:to="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable_90b961f2-4d67-4883-9647-3ced1e2a83a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_3922ae9f-35b4-462c-90d1-29f23aed5b70" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable_90b961f2-4d67-4883-9647-3ced1e2a83a8" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_3922ae9f-35b4-462c-90d1-29f23aed5b70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_3922ae9f-35b4-462c-90d1-29f23aed5b70_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_3922ae9f-35b4-462c-90d1-29f23aed5b70" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_3922ae9f-35b4-462c-90d1-29f23aed5b70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_25faedca-caad-4c8c-a290-59c8a61a68df" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_3922ae9f-35b4-462c-90d1-29f23aed5b70" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_25faedca-caad-4c8c-a290-59c8a61a68df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_1130b1b2-8d0e-4a78-879a-99822fc3585b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_25faedca-caad-4c8c-a290-59c8a61a68df" xlink:to="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_1130b1b2-8d0e-4a78-879a-99822fc3585b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DisclosuresaboutmajorcustomersandcreditriskDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails" xlink:type="extended" id="i6f7975bb9c324677ae89f159d9f8e187_DisclosuresaboutmajorcustomersandcreditriskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_9d60e78f-a578-484f-9a9a-a0bc9540ee33" xlink:href="sny-20221231.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue_0a59145c-ec2f-4080-82eb-c5fceac4ca16" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_9d60e78f-a578-484f-9a9a-a0bc9540ee33" xlink:to="loc_ifrs-full_PercentageOfEntitysRevenue_0a59145c-ec2f-4080-82eb-c5fceac4ca16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_1c2e3298-0e61-4653-8031-48d86bbf8f26" xlink:href="sny-20221231.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_9d60e78f-a578-484f-9a9a-a0bc9540ee33" xlink:to="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_1c2e3298-0e61-4653-8031-48d86bbf8f26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersAxis_27a9ac4b-039d-4582-84e3-2f0007a29671" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_1c2e3298-0e61-4653-8031-48d86bbf8f26" xlink:to="loc_ifrs-full_MajorCustomersAxis_27a9ac4b-039d-4582-84e3-2f0007a29671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersMember_27a9ac4b-039d-4582-84e3-2f0007a29671_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MajorCustomersAxis_27a9ac4b-039d-4582-84e3-2f0007a29671" xlink:to="loc_ifrs-full_MajorCustomersMember_27a9ac4b-039d-4582-84e3-2f0007a29671_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MajorCustomersAxis_27a9ac4b-039d-4582-84e3-2f0007a29671" xlink:to="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LargestCustomersMember_90667d62-3ff1-4edf-a601-7d8908e56717" xlink:href="sny-20221231.xsd#sny_LargestCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:to="loc_sny_LargestCustomersMember_90667d62-3ff1-4edf-a601-7d8908e56717" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CustomerOneMember_2a180ebd-08c8-4b3c-b776-0531d4a7112a" xlink:href="sny-20221231.xsd#sny_CustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:to="loc_sny_CustomerOneMember_2a180ebd-08c8-4b3c-b776-0531d4a7112a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CustomerTwoMember_fdad0101-a76e-4975-9deb-18bcdf02a594" xlink:href="sny-20221231.xsd#sny_CustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:to="loc_sny_CustomerTwoMember_fdad0101-a76e-4975-9deb-18bcdf02a594" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CustomerThreeMember_c73d07fc-2f7f-4637-b52b-6094c88f8980" xlink:href="sny-20221231.xsd#sny_CustomerThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:to="loc_sny_CustomerThreeMember_c73d07fc-2f7f-4637-b52b-6094c88f8980" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails" xlink:type="extended" id="i041373a2339c4a6fb37ba32e5d06964f_SegmentinformationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_9f2cf379-ce25-4437-a3d1-fabf6879252f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOperatingSegments_39d07bd6-12c6-45df-aea7-0d489f3a5e79" xlink:href="sny-20221231.xsd#sny_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_9f2cf379-ce25-4437-a3d1-fabf6879252f" xlink:to="loc_sny_NumberOfOperatingSegments_39d07bd6-12c6-45df-aea7-0d489f3a5e79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinancialAssetsNumberOfShares_d848f644-697e-431f-984c-1cdf2523461f" xlink:href="sny-20221231.xsd#sny_NonCurrentFinancialAssetsNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_9f2cf379-ce25-4437-a3d1-fabf6879252f" xlink:to="loc_sny_NonCurrentFinancialAssetsNumberOfShares_d848f644-697e-431f-984c-1cdf2523461f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_c0cc4e96-d367-4d0b-991b-0f70a00234b2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_9f2cf379-ce25-4437-a3d1-fabf6879252f" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_c0cc4e96-d367-4d0b-991b-0f70a00234b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ed0b1b10-cc93-48a7-b97e-b85e089c963d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_c0cc4e96-d367-4d0b-991b-0f70a00234b2" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ed0b1b10-cc93-48a7-b97e-b85e089c963d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_ed0b1b10-cc93-48a7-b97e-b85e089c963d_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ed0b1b10-cc93-48a7-b97e-b85e089c963d" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_ed0b1b10-cc93-48a7-b97e-b85e089c963d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_55ceda31-b655-4714-afb6-5bb32840ab85" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ed0b1b10-cc93-48a7-b97e-b85e089c963d" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_55ceda31-b655-4714-afb6-5bb32840ab85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_ecd47ada-b064-4886-9232-9d6fb900dcd3" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_55ceda31-b655-4714-afb6-5bb32840ab85" xlink:to="loc_sny_RegeneronMember_ecd47ada-b064-4886-9232-9d6fb900dcd3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails" xlink:type="extended" id="i52134aa5e8f641f086b3dab9e0e9f348_SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_d8c4ac2e-da6c-43af-8859-3807bef76ae9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_035f9297-ebab-4881-b67c-7552e41ede18" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_d8c4ac2e-da6c-43af-8859-3807bef76ae9" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_035f9297-ebab-4881-b67c-7552e41ede18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4c39923e-692a-43b4-87a1-45fb9bd7cdc5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_d8c4ac2e-da6c-43af-8859-3807bef76ae9" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4c39923e-692a-43b4-87a1-45fb9bd7cdc5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_191ca006-58c9-460f-b843-6b62747495ff" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4c39923e-692a-43b4-87a1-45fb9bd7cdc5" xlink:to="loc_ifrs-full_GeographicalAreasAxis_191ca006-58c9-460f-b843-6b62747495ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_191ca006-58c9-460f-b843-6b62747495ff_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_191ca006-58c9-460f-b843-6b62747495ff" xlink:to="loc_ifrs-full_GeographicalAreasMember_191ca006-58c9-460f-b843-6b62747495ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_22a4b58c-8703-4ff4-8be9-15cf5e4378f8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_191ca006-58c9-460f-b843-6b62747495ff" xlink:to="loc_ifrs-full_GeographicalAreasMember_22a4b58c-8703-4ff4-8be9-15cf5e4378f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0cf4e5fd-18fc-429d-8cf6-27f0c5a719c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_22a4b58c-8703-4ff4-8be9-15cf5e4378f8" xlink:to="loc_srt_EuropeMember_0cf4e5fd-18fc-429d-8cf6-27f0c5a719c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_740d550b-9842-4cb7-8cf8-7f613dd9c680" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_22a4b58c-8703-4ff4-8be9-15cf5e4378f8" xlink:to="loc_country_US_740d550b-9842-4cb7-8cf8-7f613dd9c680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesInSegmentResultsMember_7a9be312-ebd4-4d05-acdb-9854d5351a63" xlink:href="sny-20221231.xsd#sny_OtherCountriesInSegmentResultsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_22a4b58c-8703-4ff4-8be9-15cf5e4378f8" xlink:to="loc_sny_OtherCountriesInSegmentResultsMember_7a9be312-ebd4-4d05-acdb-9854d5351a63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_79833c56-fc62-4ac7-a41c-e1b3c4a4a61c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4c39923e-692a-43b4-87a1-45fb9bd7cdc5" xlink:to="loc_ifrs-full_SegmentsAxis_79833c56-fc62-4ac7-a41c-e1b3c4a4a61c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_79833c56-fc62-4ac7-a41c-e1b3c4a4a61c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_79833c56-fc62-4ac7-a41c-e1b3c4a4a61c" xlink:to="loc_ifrs-full_SegmentsMember_79833c56-fc62-4ac7-a41c-e1b3c4a4a61c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_028cdc09-fea2-4fda-8835-2cee69c4e0ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_79833c56-fc62-4ac7-a41c-e1b3c4a4a61c" xlink:to="loc_ifrs-full_SegmentsMember_028cdc09-fea2-4fda-8835-2cee69c4e0ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsSegmentMember_1569f7a9-cd25-4ede-ad01-2b72f8908935" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_028cdc09-fea2-4fda-8835-2cee69c4e0ef" xlink:to="loc_sny_PharmaceuticalsSegmentMember_1569f7a9-cd25-4ede-ad01-2b72f8908935" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesSegmentMember_1e8c0fcb-a145-4069-9482-b7370658d5a7" xlink:href="sny-20221231.xsd#sny_VaccinesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_028cdc09-fea2-4fda-8835-2cee69c4e0ef" xlink:to="loc_sny_VaccinesSegmentMember_1e8c0fcb-a145-4069-9482-b7370658d5a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareSegmentMember_62246092-9f73-4921-80e9-7a498ae2495a" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_028cdc09-fea2-4fda-8835-2cee69c4e0ef" xlink:to="loc_sny_ConsumerHealthcareSegmentMember_62246092-9f73-4921-80e9-7a498ae2495a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_754ce55c-ea91-4ecc-9d58-3254ba1cd2c1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4c39923e-692a-43b4-87a1-45fb9bd7cdc5" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_754ce55c-ea91-4ecc-9d58-3254ba1cd2c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesMember_754ce55c-ea91-4ecc-9d58-3254ba1cd2c1_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_754ce55c-ea91-4ecc-9d58-3254ba1cd2c1" xlink:to="loc_ifrs-full_ProductsAndServicesMember_754ce55c-ea91-4ecc-9d58-3254ba1cd2c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_754ce55c-ea91-4ecc-9d58-3254ba1cd2c1" xlink:to="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DupixentMember_8ba397b9-56e6-4ef9-bd56-dc6499bc1270" xlink:href="sny-20221231.xsd#sny_DupixentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_DupixentMember_8ba397b9-56e6-4ef9-bd56-dc6499bc1270" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NeurologyImmunologyMember_07a4e42f-3063-4ed2-94b7-2e0f8a5f4056" xlink:href="sny-20221231.xsd#sny_NeurologyImmunologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_NeurologyImmunologyMember_07a4e42f-3063-4ed2-94b7-2e0f8a5f4056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AubagioMember_d290b8d8-702c-4efe-a01e-9851be973d65" xlink:href="sny-20221231.xsd#sny_AubagioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_NeurologyImmunologyMember_07a4e42f-3063-4ed2-94b7-2e0f8a5f4056" xlink:to="loc_sny_AubagioMember_d290b8d8-702c-4efe-a01e-9851be973d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RareDiseasesMember_3b973703-184a-4cfa-abd9-0056720bbbba" xlink:href="sny-20221231.xsd#sny_RareDiseasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_RareDiseasesMember_3b973703-184a-4cfa-abd9-0056720bbbba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CerezymeMember_c6ebddc9-7405-400e-b4e7-a642b7423ca9" xlink:href="sny-20221231.xsd#sny_CerezymeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_RareDiseasesMember_3b973703-184a-4cfa-abd9-0056720bbbba" xlink:to="loc_sny_CerezymeMember_c6ebddc9-7405-400e-b4e7-a642b7423ca9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FabrazymeMember_d7d9a2ba-24c6-4aca-8f14-53f08b970bb2" xlink:href="sny-20221231.xsd#sny_FabrazymeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_RareDiseasesMember_3b973703-184a-4cfa-abd9-0056720bbbba" xlink:to="loc_sny_FabrazymeMember_d7d9a2ba-24c6-4aca-8f14-53f08b970bb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MyozymeOrLumizymeMember_0780dec4-f7ff-403c-9228-acdc42abc4a6" xlink:href="sny-20221231.xsd#sny_MyozymeOrLumizymeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_RareDiseasesMember_3b973703-184a-4cfa-abd9-0056720bbbba" xlink:to="loc_sny_MyozymeOrLumizymeMember_0780dec4-f7ff-403c-9228-acdc42abc4a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OncologyMember_549508ce-6c69-4891-858c-5a25c6468385" xlink:href="sny-20221231.xsd#sny_OncologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_OncologyMember_549508ce-6c69-4891-858c-5a25c6468385" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_JevtanaMember_2555da3d-21a8-43bf-89c5-01560bcabecc" xlink:href="sny-20221231.xsd#sny_JevtanaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_OncologyMember_549508ce-6c69-4891-858c-5a25c6468385" xlink:to="loc_sny_JevtanaMember_2555da3d-21a8-43bf-89c5-01560bcabecc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RareBloodDisordersMember_4f3cbfe7-29ec-493b-918e-89e33b116176" xlink:href="sny-20221231.xsd#sny_RareBloodDisordersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_RareBloodDisordersMember_4f3cbfe7-29ec-493b-918e-89e33b116176" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AlprolixMember_b7bf77db-45cf-4ade-90b0-e48c7a0d56f6" xlink:href="sny-20221231.xsd#sny_AlprolixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_RareBloodDisordersMember_4f3cbfe7-29ec-493b-918e-89e33b116176" xlink:to="loc_sny_AlprolixMember_b7bf77db-45cf-4ade-90b0-e48c7a0d56f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EloctateMember_7ca03afb-e9f1-4940-9c27-3fed693ac855" xlink:href="sny-20221231.xsd#sny_EloctateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_RareBloodDisordersMember_4f3cbfe7-29ec-493b-918e-89e33b116176" xlink:to="loc_sny_EloctateMember_7ca03afb-e9f1-4940-9c27-3fed693ac855" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CoreAssetsMember_719e6bb2-df06-496b-b0c7-18914489d274" xlink:href="sny-20221231.xsd#sny_CoreAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_CoreAssetsMember_719e6bb2-df06-496b-b0c7-18914489d274" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LovenoxMember_605cc56f-4664-4ae7-a15f-998a421df653" xlink:href="sny-20221231.xsd#sny_LovenoxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_CoreAssetsMember_719e6bb2-df06-496b-b0c7-18914489d274" xlink:to="loc_sny_LovenoxMember_605cc56f-4664-4ae7-a15f-998a421df653" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ToujeoMember_d30ec3de-396b-4672-80dc-e3e765da1a7e" xlink:href="sny-20221231.xsd#sny_ToujeoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_CoreAssetsMember_719e6bb2-df06-496b-b0c7-18914489d274" xlink:to="loc_sny_ToujeoMember_d30ec3de-396b-4672-80dc-e3e765da1a7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixMember_da74bb54-865c-4783-ad5d-de1163ce2ad6" xlink:href="sny-20221231.xsd#sny_PlavixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_CoreAssetsMember_719e6bb2-df06-496b-b0c7-18914489d274" xlink:to="loc_sny_PlavixMember_da74bb54-865c-4783-ad5d-de1163ce2ad6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCoreAssetsMember_76c79eaa-baff-4178-aa0a-f56c3b4f1e1c" xlink:href="sny-20221231.xsd#sny_NonCoreAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_NonCoreAssetsMember_76c79eaa-baff-4178-aa0a-f56c3b4f1e1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LantusMember_4d735199-c5ce-43ac-8940-6ec999a7ae24" xlink:href="sny-20221231.xsd#sny_LantusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_NonCoreAssetsMember_76c79eaa-baff-4178-aa0a-f56c3b4f1e1c" xlink:to="loc_sny_LantusMember_4d735199-c5ce-43ac-8940-6ec999a7ae24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherNonCoreAssetsMember_05cd0a14-4ecc-4541-8347-6821881746bf" xlink:href="sny-20221231.xsd#sny_OtherNonCoreAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_NonCoreAssetsMember_76c79eaa-baff-4178-aa0a-f56c3b4f1e1c" xlink:to="loc_sny_OtherNonCoreAssetsMember_05cd0a14-4ecc-4541-8347-6821881746bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IndustrialSalesMember_d255898f-080c-4e18-aff1-f132964b46f4" xlink:href="sny-20221231.xsd#sny_IndustrialSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_IndustrialSalesMember_d255898f-080c-4e18-aff1-f132964b46f4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PolioPertussisHibVaccinesMember_ca1f2629-5da8-479d-bb7c-794682749627" xlink:href="sny-20221231.xsd#sny_PolioPertussisHibVaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_PolioPertussisHibVaccinesMember_ca1f2629-5da8-479d-bb7c-794682749627" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InfluenzaVaccinesMember_79e1c5d6-082d-41cc-905f-feaafeb90588" xlink:href="sny-20221231.xsd#sny_InfluenzaVaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_InfluenzaVaccinesMember_79e1c5d6-082d-41cc-905f-feaafeb90588" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AllergyMember_e3191faf-c79f-4e73-9bb1-4388d97d106c" xlink:href="sny-20221231.xsd#sny_AllergyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_AllergyMember_e3191faf-c79f-4e73-9bb1-4388d97d106c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PainCareMember_33378a77-1f3c-4329-ac45-4a745b5add1b" xlink:href="sny-20221231.xsd#sny_PainCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_PainCareMember_33378a77-1f3c-4329-ac45-4a745b5add1b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DigestiveWellnessMember_13794e6a-b7af-48ce-828e-87ce959734a3" xlink:href="sny-20221231.xsd#sny_DigestiveWellnessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_DigestiveWellnessMember_13794e6a-b7af-48ce-828e-87ce959734a3" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationScheduleofSegmentResultsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails" xlink:type="extended" id="i8c7fb660633d4d46850205d2d548a354_SegmentinformationScheduleofSegmentResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_4868bf64-8815-45f8-9e74-59f9ab284bb9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_4868bf64-8815-45f8-9e74-59f9ab284bb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherRevenue_e8e3d10d-63b5-4cf1-8968-a618b4e5a200" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_OtherRevenue_e8e3d10d-63b5-4cf1-8968-a618b4e5a200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_8207a10e-2694-4efe-94f0-3b6baad309a6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_CostOfSales_8207a10e-2694-4efe-94f0-3b6baad309a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_7ff15747-00da-491c-8eaf-8517dfc238b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_7ff15747-00da-491c-8eaf-8517dfc238b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_6addbd0c-3ba5-4611-a18a-378838830801" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_6addbd0c-3ba5-4611-a18a-378838830801" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_7c641c1d-9dd7-4b0d-b9c3-caf9204249ab" xlink:href="sny-20221231.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_7c641c1d-9dd7-4b0d-b9c3-caf9204249ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_d783f267-3a68-4ef9-bbb0-62bef90564ce" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_d783f267-3a68-4ef9-bbb0-62bef90564ce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_44114a32-7143-4d3d-8e16-806ef7599d56" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_44114a32-7143-4d3d-8e16-806ef7599d56" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessOperatingIncome_9ff9aad4-a53e-4f87-8e57-91340f52f715" xlink:href="sny-20221231.xsd#sny_BusinessOperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_sny_BusinessOperatingIncome_9ff9aad4-a53e-4f87-8e57-91340f52f715" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_7bee15cb-2de1-4cb4-9e38-924d9191a3a7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_7bee15cb-2de1-4cb4-9e38-924d9191a3a7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_4b5dbbb3-b69e-46b2-9ad4-4d2768d5dda7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_7bee15cb-2de1-4cb4-9e38-924d9191a3a7" xlink:to="loc_ifrs-full_SegmentsAxis_4b5dbbb3-b69e-46b2-9ad4-4d2768d5dda7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_4b5dbbb3-b69e-46b2-9ad4-4d2768d5dda7_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_4b5dbbb3-b69e-46b2-9ad4-4d2768d5dda7" xlink:to="loc_ifrs-full_SegmentsMember_4b5dbbb3-b69e-46b2-9ad4-4d2768d5dda7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_4b5dbbb3-b69e-46b2-9ad4-4d2768d5dda7" xlink:to="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsSegmentMember_d18d4be7-945d-44d7-b813-7b9e1d583345" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:to="loc_sny_PharmaceuticalsSegmentMember_d18d4be7-945d-44d7-b813-7b9e1d583345" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesSegmentMember_df4747c1-0b3c-48ca-ac7c-f290289649b2" xlink:href="sny-20221231.xsd#sny_VaccinesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:to="loc_sny_VaccinesSegmentMember_df4747c1-0b3c-48ca-ac7c-f290289649b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareSegmentMember_7d3d3e89-bf2e-4ef1-85e2-07943650f63f" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:to="loc_sny_ConsumerHealthcareSegmentMember_7d3d3e89-bf2e-4ef1-85e2-07943650f63f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllOtherSegmentsMember_1e0a1eff-80ba-4b14-884d-37aafc448065" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:to="loc_ifrs-full_AllOtherSegmentsMember_1e0a1eff-80ba-4b14-884d-37aafc448065" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReportableSegmentsMember_e4144221-0e4c-40ad-9821-1b12a0724c15" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:to="loc_ifrs-full_ReportableSegmentsMember_e4144221-0e4c-40ad-9821-1b12a0724c15" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails" xlink:type="extended" id="i3003469c86c844d790364666293b22e8_SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessOperatingIncome_fc9dbd12-d48d-47a4-a589-3254a6fcb92b" xlink:href="sny-20221231.xsd#sny_BusinessOperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_BusinessOperatingIncome_fc9dbd12-d48d-47a4-a589-3254a6fcb92b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_638b0924-b2aa-4f26-95b4-53a219f76d35" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_638b0924-b2aa-4f26-95b4-53a219f76d35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_bf6af6d8-528f-449b-afa0-6b9f478d2b1b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_bf6af6d8-528f-449b-afa0-6b9f478d2b1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_a3f5a938-2d95-492b-8293-b8eb3b872d91" xlink:href="sny-20221231.xsd#sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_a3f5a938-2d95-492b-8293-b8eb3b872d91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_0fb71128-d0df-4fef-a16d-b16327752fb3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_0fb71128-d0df-4fef-a16d-b16327752fb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_cef3de49-c676-4925-8c15-b767a18e419c" xlink:href="sny-20221231.xsd#sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_cef3de49-c676-4925-8c15-b767a18e419c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_11be1547-5549-4080-aa14-d1df2a6a1aff" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseOfRestructuringActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_11be1547-5549-4080-aa14-d1df2a6a1aff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGainsLossesAndLitigation_87eac66f-53cf-4c15-8dde-f85e276bb66e" xlink:href="sny-20221231.xsd#sny_OtherGainsLossesAndLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_OtherGainsLossesAndLitigation_87eac66f-53cf-4c15-8dde-f85e276bb66e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainOnRegeneronInvestmentSold_f032fd13-358e-46a9-8ed8-9c30bde82a61" xlink:href="sny-20221231.xsd#sny_GainOnRegeneronInvestmentSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_GainOnRegeneronInvestmentSold_f032fd13-358e-46a9-8ed8-9c30bde82a61" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeResultingFromOutLicensing_ab483696-a92d-4360-8b20-4e503bd84f2e" xlink:href="sny-20221231.xsd#sny_IncomeResultingFromOutLicensing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_IncomeResultingFromOutLicensing_ab483696-a92d-4360-8b20-4e503bd84f2e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_2bb2a1ed-b980-4787-bf5c-d22c8443319f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_2bb2a1ed-b980-4787-bf5c-d22c8443319f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_b8c189d2-b43c-449d-a7ab-cc3dfde367ad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_FinanceCosts_b8c189d2-b43c-449d-a7ab-cc3dfde367ad" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_a0710ebe-8594-44d5-b989-6cceb485a1df" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_FinanceIncome_a0710ebe-8594-44d5-b989-6cceb485a1df" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_70ede18b-38ed-4a71-8726-e32e89a29c5d" xlink:href="sny-20221231.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_70ede18b-38ed-4a71-8726-e32e89a29c5d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinancialAssetsNumberOfShares_c005dc46-ce25-44ee-9151-c22e8aa11727" xlink:href="sny-20221231.xsd#sny_NonCurrentFinancialAssetsNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_NonCurrentFinancialAssetsNumberOfShares_c005dc46-ce25-44ee-9151-c22e8aa11727" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_65ad5155-5bc3-4bbb-8058-91fc3effda5b" xlink:href="sny-20221231.xsd#sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_65ad5155-5bc3-4bbb-8058-91fc3effda5b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill_c5c138a3-8918-45d5-b4f1-950bc7e01ab7" xlink:href="sny-20221231.xsd#sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill_c5c138a3-8918-45d5-b4f1-950bc7e01ab7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_82aa8876-d336-4393-9145-e97a29edaf5c" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_82aa8876-d336-4393-9145-e97a29edaf5c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction_0b968495-b561-436c-8e51-15635de60790" xlink:href="sny-20221231.xsd#sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction_0b968495-b561-436c-8e51-15635de60790" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements_4e261df2-4c99-4976-b11e-9a6e8d78e819" xlink:href="sny-20221231.xsd#sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements_4e261df2-4c99-4976-b11e-9a6e8d78e819" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements_314ec6f8-e687-4fb3-b1b4-062d48233e06" xlink:href="sny-20221231.xsd#sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements_314ec6f8-e687-4fb3-b1b4-062d48233e06" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_0fc54895-ccbf-4558-805c-218cc7feca59" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_0fc54895-ccbf-4558-805c-218cc7feca59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_0fc54895-ccbf-4558-805c-218cc7feca59_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_0fc54895-ccbf-4558-805c-218cc7feca59" xlink:to="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_0fc54895-ccbf-4558-805c-218cc7feca59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_4bcfcd26-18ca-4343-8b71-d3ef2e3b12b9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_0fc54895-ccbf-4558-805c-218cc7feca59" xlink:to="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_4bcfcd26-18ca-4343-8b71-d3ef2e3b12b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingSegmentsMember_8d8505c9-1506-44c5-9de9-514538c95fa7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_4bcfcd26-18ca-4343-8b71-d3ef2e3b12b9" xlink:to="loc_ifrs-full_OperatingSegmentsMember_8d8505c9-1506-44c5-9de9-514538c95fa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember_db1dd850-b8a3-4bd3-bb32-6e19a4f55ad9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_4bcfcd26-18ca-4343-8b71-d3ef2e3b12b9" xlink:to="loc_ifrs-full_MaterialReconcilingItemsMember_db1dd850-b8a3-4bd3-bb32-6e19a4f55ad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_b6793ce8-6e83-4da8-aff9-3b82ea49dd3e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_b6793ce8-6e83-4da8-aff9-3b82ea49dd3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_b6793ce8-6e83-4da8-aff9-3b82ea49dd3e_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_b6793ce8-6e83-4da8-aff9-3b82ea49dd3e" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_b6793ce8-6e83-4da8-aff9-3b82ea49dd3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_dbefeee4-43d2-44c0-bce0-9d430aaddff3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_b6793ce8-6e83-4da8-aff9-3b82ea49dd3e" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_dbefeee4-43d2-44c0-bce0-9d430aaddff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_ec6fe16a-e6d7-4cd7-8a07-27374c1f7ef1" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_dbefeee4-43d2-44c0-bce0-9d430aaddff3" xlink:to="loc_sny_RegeneronMember_ec6fe16a-e6d7-4cd7-8a07-27374c1f7ef1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockAxis_96a4bd43-67f7-4df0-bfa4-95a47367eaba" xlink:href="sny-20221231.xsd#sny_SaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_sny_SaleOfStockAxis_96a4bd43-67f7-4df0-bfa4-95a47367eaba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockDomain_96a4bd43-67f7-4df0-bfa4-95a47367eaba_default" xlink:href="sny-20221231.xsd#sny_SaleOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_SaleOfStockAxis_96a4bd43-67f7-4df0-bfa4-95a47367eaba" xlink:to="loc_sny_SaleOfStockDomain_96a4bd43-67f7-4df0-bfa4-95a47367eaba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockDomain_fd185597-a634-480a-a65a-53dba3117056" xlink:href="sny-20221231.xsd#sny_SaleOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_SaleOfStockAxis_96a4bd43-67f7-4df0-bfa4-95a47367eaba" xlink:to="loc_sny_SaleOfStockDomain_fd185597-a634-480a-a65a-53dba3117056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PublicOfferingMember_c8b70a90-8c53-4728-ab2e-ddff298dde20" xlink:href="sny-20221231.xsd#sny_PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_SaleOfStockDomain_fd185597-a634-480a-a65a-53dba3117056" xlink:to="loc_sny_PublicOfferingMember_c8b70a90-8c53-4728-ab2e-ddff298dde20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RepurchaseFromTheCounterpartMember_8d0b7064-273f-4c56-99fa-af3c064db765" xlink:href="sny-20221231.xsd#sny_RepurchaseFromTheCounterpartMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_SaleOfStockDomain_fd185597-a634-480a-a65a-53dba3117056" xlink:to="loc_sny_RepurchaseFromTheCounterpartMember_8d0b7064-273f-4c56-99fa-af3c064db765" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_ce72a5d4-3453-48e9-b31d-2516e0d2f3d1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_ifrs-full_CounterpartiesAxis_ce72a5d4-3453-48e9-b31d-2516e0d2f3d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_ce72a5d4-3453-48e9-b31d-2516e0d2f3d1_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_ce72a5d4-3453-48e9-b31d-2516e0d2f3d1" xlink:to="loc_ifrs-full_CounterpartiesMember_ce72a5d4-3453-48e9-b31d-2516e0d2f3d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_43fdb6de-eb1f-43da-bc0e-d99402b4c7fe" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_ce72a5d4-3453-48e9-b31d-2516e0d2f3d1" xlink:to="loc_ifrs-full_CounterpartiesMember_43fdb6de-eb1f-43da-bc0e-d99402b4c7fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_d619d39d-a3b8-47f9-ab5e-4a3a4cea06f4" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_43fdb6de-eb1f-43da-bc0e-d99402b4c7fe" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_d619d39d-a3b8-47f9-ab5e-4a3a4cea06f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_d94432c2-3327-45bf-9e69-813467bb182f" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_sny_PrincipalAlliancesAxis_d94432c2-3327-45bf-9e69-813467bb182f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_d94432c2-3327-45bf-9e69-813467bb182f_default" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_PrincipalAlliancesAxis_d94432c2-3327-45bf-9e69-813467bb182f" xlink:to="loc_sny_PrincipalAlliancesDomain_d94432c2-3327-45bf-9e69-813467bb182f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_2d97f25d-d6af-4596-b100-e3277713b544" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_PrincipalAlliancesAxis_d94432c2-3327-45bf-9e69-813467bb182f" xlink:to="loc_sny_PrincipalAlliancesDomain_2d97f25d-d6af-4596-b100-e3277713b544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImmunoOncologyCollaborationAgreementMember_6613b46d-f688-4ccb-8747-8ab6deb8a86d" xlink:href="sny-20221231.xsd#sny_ImmunoOncologyCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalAlliancesDomain_2d97f25d-d6af-4596-b100-e3277713b544" xlink:to="loc_sny_ImmunoOncologyCollaborationAgreementMember_6613b46d-f688-4ccb-8747-8ab6deb8a86d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_28169b7e-71af-42f7-9543-b0acb39a4c1f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_srt_ProductOrServiceAxis_28169b7e-71af-42f7-9543-b0acb39a4c1f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_28169b7e-71af-42f7-9543-b0acb39a4c1f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_28169b7e-71af-42f7-9543-b0acb39a4c1f" xlink:to="loc_srt_ProductsAndServicesDomain_28169b7e-71af-42f7-9543-b0acb39a4c1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c06dfcbb-b784-4fbd-9a99-cc89abc5713e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_28169b7e-71af-42f7-9543-b0acb39a4c1f" xlink:to="loc_srt_ProductsAndServicesDomain_c06dfcbb-b784-4fbd-9a99-cc89abc5713e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EloctateMember_11cd4bc7-fb82-4be4-8dac-c30c151298d2" xlink:href="sny-20221231.xsd#sny_EloctateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c06dfcbb-b784-4fbd-9a99-cc89abc5713e" xlink:to="loc_sny_EloctateMember_11cd4bc7-fb82-4be4-8dac-c30c151298d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_9019047e-c8b1-46de-9ab6-6fa7cda813d2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_9019047e-c8b1-46de-9ab6-6fa7cda813d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_9019047e-c8b1-46de-9ab6-6fa7cda813d2_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_9019047e-c8b1-46de-9ab6-6fa7cda813d2" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_9019047e-c8b1-46de-9ab6-6fa7cda813d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_8a1d8cef-9b60-430c-923d-5133c2263346" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_9019047e-c8b1-46de-9ab6-6fa7cda813d2" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_8a1d8cef-9b60-430c-923d-5133c2263346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_8792be6b-0517-4a93-a1cc-ba03c089fa0d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_8a1d8cef-9b60-430c-923d-5133c2263346" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_8792be6b-0517-4a93-a1cc-ba03c089fa0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_8e27ce10-5aff-4cd5-b814-38c01256d3a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_8e27ce10-5aff-4cd5-b814-38c01256d3a8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesMember_8e27ce10-5aff-4cd5-b814-38c01256d3a8_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_8e27ce10-5aff-4cd5-b814-38c01256d3a8" xlink:to="loc_ifrs-full_ProductsAndServicesMember_8e27ce10-5aff-4cd5-b814-38c01256d3a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesMember_c86a4fc0-7bfc-4d11-aa49-0d9c185a3e3e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_8e27ce10-5aff-4cd5-b814-38c01256d3a8" xlink:to="loc_ifrs-full_ProductsAndServicesMember_c86a4fc0-7bfc-4d11-aa49-0d9c185a3e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SAR444245Member_a111332a-2c4e-48b3-b40e-489c19ab26d4" xlink:href="sny-20221231.xsd#sny_SAR444245Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesMember_c86a4fc0-7bfc-4d11-aa49-0d9c185a3e3e" xlink:to="loc_sny_SAR444245Member_a111332a-2c4e-48b3-b40e-489c19ab26d4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails" xlink:type="extended" id="i1f990e5dfa2a4252a013b273ff3c6953_SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_f74ebfd5-d88c-4e6c-90c2-6fa88cc13402" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InvestmentsInAssociatesAndJointVentures_6b747124-6117-44fd-9618-85ddf14f4573" xlink:href="sny-20221231.xsd#sny_InvestmentsInAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_f74ebfd5-d88c-4e6c-90c2-6fa88cc13402" xlink:to="loc_sny_InvestmentsInAssociatesAndJointVentures_6b747124-6117-44fd-9618-85ddf14f4573" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_8ef3c053-aecf-4af5-8644-d2d2bb8d74fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_f74ebfd5-d88c-4e6c-90c2-6fa88cc13402" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_8ef3c053-aecf-4af5-8644-d2d2bb8d74fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_ca6b7c78-f7aa-4934-a3e3-5e75a0ba131a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_f74ebfd5-d88c-4e6c-90c2-6fa88cc13402" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_ca6b7c78-f7aa-4934-a3e3-5e75a0ba131a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_8a33c67b-555b-47e8-9422-6696120df3ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_f74ebfd5-d88c-4e6c-90c2-6fa88cc13402" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_8a33c67b-555b-47e8-9422-6696120df3ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_ab6bc01a-fac3-491d-8dfe-9f861b0add1c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_8a33c67b-555b-47e8-9422-6696120df3ca" xlink:to="loc_ifrs-full_SegmentsAxis_ab6bc01a-fac3-491d-8dfe-9f861b0add1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_ab6bc01a-fac3-491d-8dfe-9f861b0add1c_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_ab6bc01a-fac3-491d-8dfe-9f861b0add1c" xlink:to="loc_ifrs-full_SegmentsMember_ab6bc01a-fac3-491d-8dfe-9f861b0add1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_ab6bc01a-fac3-491d-8dfe-9f861b0add1c" xlink:to="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsMember_119e5ee7-da94-4270-9183-ba23737e8c5a" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:to="loc_sny_PharmaceuticalsMember_119e5ee7-da94-4270-9183-ba23737e8c5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesMember_e9a79cd2-671b-44b4-8563-1fa4234a360a" xlink:href="sny-20221231.xsd#sny_VaccinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:to="loc_sny_VaccinesMember_e9a79cd2-671b-44b4-8563-1fa4234a360a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareSegmentMember_a26770c0-2d0f-4347-87af-de3463227897" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:to="loc_sny_ConsumerHealthcareSegmentMember_a26770c0-2d0f-4347-87af-de3463227897" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReportableSegmentsMember_3e6c893a-b158-4a57-b8a5-ab0aa0f322c8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:to="loc_ifrs-full_ReportableSegmentsMember_3e6c893a-b158-4a57-b8a5-ab0aa0f322c8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails" xlink:type="extended" id="i757902b4312548a682a6030797bdfe4e_SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_265ffd22-ab5d-4af3-95e9-daa05440ee9e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_265ffd22-ab5d-4af3-95e9-daa05440ee9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_7a29f80e-ec3b-4e72-a648-1a6b6918d9a2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_7a29f80e-ec3b-4e72-a648-1a6b6918d9a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_08398261-4b03-48e5-a03b-009df6af2c61" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:to="loc_ifrs-full_Goodwill_08398261-4b03-48e5-a03b-009df6af2c61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_38e39a14-ad4c-4a7c-bfa7-46adaec4e871" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_38e39a14-ad4c-4a7c-bfa7-46adaec4e871" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4e25e519-23ad-45ca-b5ff-58a5dc1fecbd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4e25e519-23ad-45ca-b5ff-58a5dc1fecbd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_06841405-0816-4cca-bfa6-09485f598f12" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4e25e519-23ad-45ca-b5ff-58a5dc1fecbd" xlink:to="loc_ifrs-full_GeographicalAreasAxis_06841405-0816-4cca-bfa6-09485f598f12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_06841405-0816-4cca-bfa6-09485f598f12_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_06841405-0816-4cca-bfa6-09485f598f12" xlink:to="loc_ifrs-full_GeographicalAreasMember_06841405-0816-4cca-bfa6-09485f598f12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_046524f3-204b-45c3-ab0b-753888a9b4a9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_06841405-0816-4cca-bfa6-09485f598f12" xlink:to="loc_ifrs-full_GeographicalAreasMember_046524f3-204b-45c3-ab0b-753888a9b4a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReportableGeographicalZonesMember_ebc15e08-9f65-4126-8178-822f30caa15b" xlink:href="sny-20221231.xsd#sny_ReportableGeographicalZonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_046524f3-204b-45c3-ab0b-753888a9b4a9" xlink:to="loc_sny_ReportableGeographicalZonesMember_ebc15e08-9f65-4126-8178-822f30caa15b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_661d6e3a-c3b9-4959-b6cc-323210fda877" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ReportableGeographicalZonesMember_ebc15e08-9f65-4126-8178-822f30caa15b" xlink:to="loc_srt_EuropeMember_661d6e3a-c3b9-4959-b6cc-323210fda877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_53eae7b3-caaa-485b-a225-af85129bb79b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EuropeMember_661d6e3a-c3b9-4959-b6cc-323210fda877" xlink:to="loc_country_FR_53eae7b3-caaa-485b-a225-af85129bb79b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_1a30d78c-94e9-4c0f-921d-f78c34b325e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ReportableGeographicalZonesMember_ebc15e08-9f65-4126-8178-822f30caa15b" xlink:to="loc_srt_NorthAmericaMember_1a30d78c-94e9-4c0f-921d-f78c34b325e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_42f579d1-1980-4da1-9c43-fe26a8caee92" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NorthAmericaMember_1a30d78c-94e9-4c0f-921d-f78c34b325e8" xlink:to="loc_country_US_42f579d1-1980-4da1-9c43-fe26a8caee92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_04eda3a3-89ca-47ba-9347-3a6e3efb55c9" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ReportableGeographicalZonesMember_ebc15e08-9f65-4126-8178-822f30caa15b" xlink:to="loc_sny_OtherCountriesMember_04eda3a3-89ca-47ba-9347-3a6e3efb55c9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalaccountantsfeesandservicesDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails" xlink:type="extended" id="icb3489afe27d45c28b309098f0e4a0bf_PrincipalaccountantsfeesandservicesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:href="sny-20221231.xsd#sny_DisclosureOfAuditFeesAndOtherServicesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForAuditServices_5b0941b7-0d63-4f05-9add-94a5e2e5a903" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForAuditServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_ifrs-full_AuditorsRemunerationForAuditServices_5b0941b7-0d63-4f05-9add-94a5e2e5a903" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ServicesOtherThanStatutoryAudit_7c21f8ef-d21d-480c-923d-8512112ac40f" xlink:href="sny-20221231.xsd#sny_ServicesOtherThanStatutoryAudit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_ServicesOtherThanStatutoryAudit_7c21f8ef-d21d-480c-923d-8512112ac40f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsRemunerationForAuditRelatedServices_8e89689c-245f-49a4-a543-ed8bed5becfc" xlink:href="sny-20221231.xsd#sny_AuditorsRemunerationForAuditRelatedServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_AuditorsRemunerationForAuditRelatedServices_8e89689c-245f-49a4-a543-ed8bed5becfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForTaxServices_cd1d95a6-6f99-4f4b-a8db-b6b43f6218a7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForTaxServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_ifrs-full_AuditorsRemunerationForTaxServices_cd1d95a6-6f99-4f4b-a8db-b6b43f6218a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices_e80f1a8e-f59f-4c31-9af7-78e9672d33f1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForOtherServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_ifrs-full_AuditorsRemunerationForOtherServices_e80f1a8e-f59f-4c31-9af7-78e9672d33f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemuneration_92e92f22-6c4f-4542-a79f-c2c4a585f572" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemuneration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_ifrs-full_AuditorsRemuneration_92e92f22-6c4f-4542-a79f-c2c4a585f572" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorRemunerationForStatutoryAudit_ba37d97a-2ada-45bc-b71d-7a40e36da423" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorRemunerationForStatutoryAudit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_PercentageOfAuditorRemunerationForStatutoryAudit_ba37d97a-2ada-45bc-b71d-7a40e36da423" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements_d357fa2a-0a27-436b-8b9a-960debcf1130" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements_d357fa2a-0a27-436b-8b9a-960debcf1130" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorsRemuneration_0e6610f4-e355-47d8-9c7d-d9a5447893bf" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorsRemuneration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_PercentageOfAuditorsRemuneration_0e6610f4-e355-47d8-9c7d-d9a5447893bf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries_e71b872e-c268-4008-bdd6-005b71ad1ee4" xlink:href="sny-20221231.xsd#sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries_e71b872e-c268-4008-bdd6-005b71ad1ee4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries_d6ce96d5-c1bc-489c-871c-d72eadbbd1c0" xlink:href="sny-20221231.xsd#sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries_d6ce96d5-c1bc-489c-871c-d72eadbbd1c0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAuditFeesAndOtherServicesTable_29915be1-319e-4ee6-9d44-01176a42f16d" xlink:href="sny-20221231.xsd#sny_DisclosureOfAuditFeesAndOtherServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_DisclosureOfAuditFeesAndOtherServicesTable_29915be1-319e-4ee6-9d44-01176a42f16d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsNameAxis_3c9997dc-0e0f-4cb9-8141-add4c2f04c26" xlink:href="sny-20221231.xsd#sny_AuditorsNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesTable_29915be1-319e-4ee6-9d44-01176a42f16d" xlink:to="loc_sny_AuditorsNameAxis_3c9997dc-0e0f-4cb9-8141-add4c2f04c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsNameMember_3c9997dc-0e0f-4cb9-8141-add4c2f04c26_default" xlink:href="sny-20221231.xsd#sny_AuditorsNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_AuditorsNameAxis_3c9997dc-0e0f-4cb9-8141-add4c2f04c26" xlink:to="loc_sny_AuditorsNameMember_3c9997dc-0e0f-4cb9-8141-add4c2f04c26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsNameMember_cc0bcd6a-b9ca-4edf-b7db-7b2511462d11" xlink:href="sny-20221231.xsd#sny_AuditorsNameMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_AuditorsNameAxis_3c9997dc-0e0f-4cb9-8141-add4c2f04c26" xlink:to="loc_sny_AuditorsNameMember_cc0bcd6a-b9ca-4edf-b7db-7b2511462d11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ErnstAndYoungMember_4102a071-7d1a-418d-b878-6b424c3b6a30" xlink:href="sny-20221231.xsd#sny_ErnstAndYoungMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AuditorsNameMember_cc0bcd6a-b9ca-4edf-b7db-7b2511462d11" xlink:to="loc_sny_ErnstAndYoungMember_4102a071-7d1a-418d-b878-6b424c3b6a30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PricewaterhousecoopersMember_9d5d7a72-6954-4a57-8255-7ac28e9347f1" xlink:href="sny-20221231.xsd#sny_PricewaterhousecoopersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AuditorsNameMember_cc0bcd6a-b9ca-4edf-b7db-7b2511462d11" xlink:to="loc_sny_PricewaterhousecoopersMember_9d5d7a72-6954-4a57-8255-7ac28e9347f1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails" xlink:type="extended" id="i1ce2a2048d6345b7a289064445c3daa1_Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_8784ff25-1e36-4459-9a03-331ff606998a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_5ab0dec5-7dcf-4657-9ade-989d4d5f9fc5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_8784ff25-1e36-4459-9a03-331ff606998a" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_5ab0dec5-7dcf-4657-9ade-989d4d5f9fc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_cfbe9ce3-903e-4d07-8e8e-38e303ba9010" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_8784ff25-1e36-4459-9a03-331ff606998a" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_cfbe9ce3-903e-4d07-8e8e-38e303ba9010" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_4daa189f-8ed7-47d3-8c9d-eda653a06b0b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_cfbe9ce3-903e-4d07-8e8e-38e303ba9010" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_4daa189f-8ed7-47d3-8c9d-eda653a06b0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4daa189f-8ed7-47d3-8c9d-eda653a06b0b_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_4daa189f-8ed7-47d3-8c9d-eda653a06b0b" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4daa189f-8ed7-47d3-8c9d-eda653a06b0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_4daa189f-8ed7-47d3-8c9d-eda653a06b0b" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HoechstGmbHMember_756578a8-923a-41e0-bc67-0fbeb1423606" xlink:href="sny-20221231.xsd#sny_HoechstGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_HoechstGmbHMember_756578a8-923a-41e0-bc67-0fbeb1423606" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeutschlandGmbHMember_6b290362-89cb-40bc-86cb-a5abe0a03d9b" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeutschlandGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDeutschlandGmbHMember_6b290362-89cb-40bc-86cb-a5abe0a03d9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_A.NattermannCie.GmbHMember_7dd89f66-9c1c-4767-9290-530e09971cce" xlink:href="sny-20221231.xsd#sny_A.NattermannCie.GmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_A.NattermannCie.GmbHMember_7dd89f66-9c1c-4767-9290-530e09971cce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisGmbHMember_a92bb7e7-ab69-4bd6-8da9-bce613e208d3" xlink:href="sny-20221231.xsd#sny_SanofiAventisGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisGmbHMember_a92bb7e7-ab69-4bd6-8da9-bce613e208d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBelgiumMember_2a82c84a-26db-4292-a29c-4aa49fc02bb1" xlink:href="sny-20221231.xsd#sny_SanofiBelgiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiBelgiumMember_2a82c84a-26db-4292-a29c-4aa49fc02bb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AblynxMember_b33ea5a7-8a09-4b07-8ee4-549d5f794228" xlink:href="sny-20221231.xsd#sny_AblynxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AblynxMember_b33ea5a7-8a09-4b07-8ee4-549d5f794228" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeFlandersBVBAMember_99bf8456-bd64-4b05-8900-62bd7df87a54" xlink:href="sny-20221231.xsd#sny_GenzymeFlandersBVBAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeFlandersBVBAMember_99bf8456-bd64-4b05-8900-62bd7df87a54" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiASMember_ab0430cc-d1fe-4220-becc-a9c0fc6378dd" xlink:href="sny-20221231.xsd#sny_SanofiASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiASMember_ab0430cc-d1fe-4220-becc-a9c0fc6378dd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSAMember_2e0644f6-89fb-489a-baff-c13458d23eb0" xlink:href="sny-20221231.xsd#sny_SanofiAventisSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisSAMember_2e0644f6-89fb-489a-baff-c13458d23eb0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareSpainSLMember_7e9c2433-479a-42d5-90eb-b0b899721f95" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareSpainSLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareSpainSLMember_7e9c2433-479a-42d5-90eb-b0b899721f95" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiOyMember_2e1dd3cc-1187-4fdc-b55f-3862ffe9f681" xlink:href="sny-20221231.xsd#sny_SanofiOyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiOyMember_2e1dd3cc-1187-4fdc-b55f-3862ffe9f681" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiMember_7ec92afd-e72c-4599-b862-a294e7347375" xlink:href="sny-20221231.xsd#sny_SanofiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiMember_7ec92afd-e72c-4599-b862-a294e7347375" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisFranceMember_18e09193-3b7a-4542-b9ba-6fd37c6d93fb" xlink:href="sny-20221231.xsd#sny_SanofiAventisFranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisFranceMember_18e09193-3b7a-4542-b9ba-6fd37c6d93fb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiWinthropIndustriesMember_e1fd6b5a-8f37-4ac6-969c-c94bb77d5b0e" xlink:href="sny-20221231.xsd#sny_SanofiWinthropIndustriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiWinthropIndustriesMember_e1fd6b5a-8f37-4ac6-969c-c94bb77d5b0e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisRechercheEtDeveloppementMember_4982d52d-3afd-4f3b-8cfa-45c3c6fbf4ce" xlink:href="sny-20221231.xsd#sny_SanofiAventisRechercheEtDeveloppementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisRechercheEtDeveloppementMember_4982d52d-3afd-4f3b-8cfa-45c3c6fbf4ce" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisGroupeMember_33dbfd43-3cc8-4d4f-bdff-a71fc9564582" xlink:href="sny-20221231.xsd#sny_SanofiAventisGroupeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisGroupeMember_33dbfd43-3cc8-4d4f-bdff-a71fc9564582" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiChimieMember_ec1c3bbf-d11f-41cf-bb5e-9e8b3c15db8b" xlink:href="sny-20221231.xsd#sny_SanofiChimieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiChimieMember_ec1c3bbf-d11f-41cf-bb5e-9e8b3c15db8b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisParticipationsSASMember_007d7273-e919-420b-ab3d-79f7e708a6d1" xlink:href="sny-20221231.xsd#sny_SanofiAventisParticipationsSASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisParticipationsSASMember_007d7273-e919-420b-ab3d-79f7e708a6d1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurFranceSAMember_8a1e8180-60d2-45b5-aa87-91fe3286fea9" xlink:href="sny-20221231.xsd#sny_SanofiPasteurFranceSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurFranceSAMember_8a1e8180-60d2-45b5-aa87-91fe3286fea9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaSAFranceMember_5a5c047a-9c99-468d-9ba5-e60623daf1d8" xlink:href="sny-20221231.xsd#sny_AventisPharmaSAFranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisPharmaSAFranceMember_5a5c047a-9c99-468d-9ba5-e60623daf1d8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBiotechnologyMember_8b6335b6-34a8-4ce3-8a09-73c5c0049323" xlink:href="sny-20221231.xsd#sny_SanofiBiotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiBiotechnologyMember_8b6335b6-34a8-4ce3-8a09-73c5c0049323" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiMatureIPMember_8030a443-c513-4ab7-bdd7-a3d33d52f121" xlink:href="sny-20221231.xsd#sny_SanofiMatureIPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiMatureIPMember_8030a443-c513-4ab7-bdd7-a3d33d52f121" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurNVLMember_a491c3ba-0508-4b2d-ba11-7debe9658685" xlink:href="sny-20221231.xsd#sny_SanofiPasteurNVLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurNVLMember_a491c3ba-0508-4b2d-ba11-7debe9658685" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurEuropeMember_0c1cb5ad-3da0-42d5-a0b5-b6ae78a595be" xlink:href="sny-20221231.xsd#sny_SanofiPasteurEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurEuropeMember_0c1cb5ad-3da0-42d5-a0b5-b6ae78a595be" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SECIPESASMember_634a85d9-7ed2-4525-9e6d-56083d750958" xlink:href="sny-20221231.xsd#sny_SECIPESASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SECIPESASMember_634a85d9-7ed2-4525-9e6d-56083d750958" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurMerieuxSASMember_05d1aa14-9d87-4568-8f86-fdd77e72d162" xlink:href="sny-20221231.xsd#sny_SanofiPasteurMerieuxSASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurMerieuxSASMember_05d1aa14-9d87-4568-8f86-fdd77e72d162" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_Sanofi2015DSASMember_565547cb-3347-43fb-b9d1-04da266e7286" xlink:href="sny-20221231.xsd#sny_Sanofi2015DSASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_Sanofi2015DSASMember_565547cb-3347-43fb-b9d1-04da266e7286" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareInternationalSASMember_e89a3a40-b5ff-428f-9e01-fb07f59c55e3" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareInternationalSASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareInternationalSASMember_e89a3a40-b5ff-428f-9e01-fb07f59c55e3" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareFranceSASMember_afdcd88c-509c-499b-88ce-4990e3465a64" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareFranceSASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareFranceSASMember_afdcd88c-509c-499b-88ce-4990e3465a64" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareGroupSASMember_a5080135-5f28-4669-983f-b157e72b6b4e" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareGroupSASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareGroupSASMember_a5080135-5f28-4669-983f-b157e72b6b4e" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiaventisAEBEMember_41e17606-e488-41e2-bc9b-081e3ecfa2bc" xlink:href="sny-20221231.xsd#sny_SanofiaventisAEBEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiaventisAEBEMember_41e17606-e488-41e2-bc9b-081e3ecfa2bc" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPrivateCoLtdMember_ba630ae1-77fd-48d6-96bd-e2644c136ec5" xlink:href="sny-20221231.xsd#sny_SanofiAventisPrivateCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisPrivateCoLtdMember_ba630ae1-77fd-48d6-96bd-e2644c136ec5" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChinoinPrivateCoLtdMember_8423125d-3c16-4d07-9d5d-49b66f356f5b" xlink:href="sny-20221231.xsd#sny_ChinoinPrivateCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_ChinoinPrivateCoLtdMember_8423125d-3c16-4d07-9d5d-49b66f356f5b" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareHungaryCommercialKFTMember_4fe67075-0939-4896-962c-f276b03dbdac" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareHungaryCommercialKFTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareHungaryCommercialKFTMember_4fe67075-0939-4896-962c-f276b03dbdac" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CarraigInsuranceDACMember_783f93eb-f8fc-44b9-becc-c79854e9e187" xlink:href="sny-20221231.xsd#sny_CarraigInsuranceDACMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_CarraigInsuranceDACMember_783f93eb-f8fc-44b9-becc-c79854e9e187" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeIrelandLimitedMember_311cf65b-6dc7-4772-8b68-bd1b2ea245e8" xlink:href="sny-20221231.xsd#sny_GenzymeIrelandLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeIrelandLimitedMember_311cf65b-6dc7-4772-8b68-bd1b2ea245e8" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisHoldingsIrelandLtdMember_ca8b550a-5345-44df-86ae-f2b579f3b671" xlink:href="sny-20221231.xsd#sny_SanofiAventisHoldingsIrelandLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisHoldingsIrelandLtdMember_ca8b550a-5345-44df-86ae-f2b579f3b671" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSRLMember_b9bcdf6b-a0a2-415a-8c1f-0b37c5915650" xlink:href="sny-20221231.xsd#sny_SanofiSRLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiSRLMember_b9bcdf6b-a0a2-415a-8c1f-0b37c5915650" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareItalySRLMember_82f7ed04-5f48-4ee6-a812-fee17e9dcdb0" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareItalySRLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareItalySRLMember_82f7ed04-5f48-4ee6-a812-fee17e9dcdb0" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeGlobalSarlMember_b4ee6b3e-8a3b-48af-bc86-26e6ac732e67" xlink:href="sny-20221231.xsd#sny_GenzymeGlobalSarlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeGlobalSarlMember_b4ee6b3e-8a3b-48af-bc86-26e6ac732e67" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeLuxembourgSarlMember_10c7a780-3d30-43d0-a545-d933aa49deb2" xlink:href="sny-20221231.xsd#sny_GenzymeLuxembourgSarlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeLuxembourgSarlMember_10c7a780-3d30-43d0-a545-d933aa49deb2" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisNorgeASMember_4f7d27cd-360b-47b5-b021-2c4f6b05dce2" xlink:href="sny-20221231.xsd#sny_SanofiAventisNorgeASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisNorgeASMember_4f7d27cd-360b-47b5-b021-2c4f6b05dce2" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeEuropeBVMember_5ee2feba-16a3-4df9-93d5-35f916e351e2" xlink:href="sny-20221231.xsd#sny_GenzymeEuropeBVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeEuropeBVMember_5ee2feba-16a3-4df9-93d5-35f916e351e2" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiForeignParticipationsB.V.Member_51a08a4c-b0b4-4ff0-919f-dcc95b78395d" xlink:href="sny-20221231.xsd#sny_SanofiForeignParticipationsB.V.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiForeignParticipationsB.V.Member_51a08a4c-b0b4-4ff0-919f-dcc95b78395d" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiaventisSpZooMember_b6c9cb76-984e-43d7-9123-a981386923b9" xlink:href="sny-20221231.xsd#sny_SanofiaventisSpZooMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiaventisSpZooMember_b6c9cb76-984e-43d7-9123-a981386923b9" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcarePolandSpZOOMember_314414f3-eca6-4504-95ab-8ca78b698ae9" xlink:href="sny-20221231.xsd#sny_OpellaHealthcarePolandSpZOOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcarePolandSpZOOMember_314414f3-eca6-4504-95ab-8ca78b698ae9" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurSpZooMember_112d58d1-1990-438d-b5c7-cfff2b14e207" xlink:href="sny-20221231.xsd#sny_SanofiPasteurSpZooMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurSpZooMember_112d58d1-1990-438d-b5c7-cfff2b14e207" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiProdutosFarmaceuticosLdaMember_6a487e32-cbcd-45d3-a4c0-1ef5a6996c04" xlink:href="sny-20221231.xsd#sny_SanofiProdutosFarmaceuticosLdaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiProdutosFarmaceuticosLdaMember_6a487e32-cbcd-45d3-a4c0-1ef5a6996c04" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSROMember_7a281c6f-920b-4aa7-85fa-08cc98cc3539" xlink:href="sny-20221231.xsd#sny_SanofiAventisSROMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisSROMember_7a281c6f-920b-4aa7-85fa-08cc98cc3539" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareCzechSroMember_34e2f53e-7143-45bc-b094-1934a4dfb5d6" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareCzechSroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareCzechSroMember_34e2f53e-7143-45bc-b094-1934a4dfb5d6" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisRomaniaSRLMember_c93c9d1f-040d-4e9c-bce9-c5afcbaa743d" xlink:href="sny-20221231.xsd#sny_SanofiAventisRomaniaSRLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisRomaniaSRLMember_c93c9d1f-040d-4e9c-bce9-c5afcbaa743d" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareRomaniaSRLMember_8e43e5c3-3496-4216-a292-0debefdcbfa4" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareRomaniaSRLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareRomaniaSRLMember_8e43e5c3-3496-4216-a292-0debefdcbfa4" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisUkHoldingsLimitedMember_a22a739a-0af9-4c68-a9df-134ac8192f1d" xlink:href="sny-20221231.xsd#sny_SanofiAventisUkHoldingsLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisUkHoldingsLimitedMember_a22a739a-0af9-4c68-a9df-134ac8192f1d" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaLimitedMember_9a48789b-1a02-45cf-a614-377e0c145501" xlink:href="sny-20221231.xsd#sny_AventisPharmaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisPharmaLimitedMember_9a48789b-1a02-45cf-a614-377e0c145501" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSynthelaboUKLtdMember_2b8613bd-29be-4785-b02a-cfd7f37b01e2" xlink:href="sny-20221231.xsd#sny_SanofiSynthelaboUKLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiSynthelaboUKLtdMember_2b8613bd-29be-4785-b02a-cfd7f37b01e2" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaHoldingsLtdMember_00667c0e-c34b-469e-aa3a-6e47d4e0d497" xlink:href="sny-20221231.xsd#sny_AventisPharmaHoldingsLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisPharmaHoldingsLtdMember_00667c0e-c34b-469e-aa3a-6e47d4e0d497" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareUKLimitedMember_6c0db3b9-36a4-4f2a-ba62-3236afee72d0" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareUKLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareUKLimitedMember_6c0db3b9-36a4-4f2a-ba62-3236afee72d0" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AOSanofiRussiaMember_6da3f780-1900-4388-8335-344f4f5fcba8" xlink:href="sny-20221231.xsd#sny_AOSanofiRussiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AOSanofiRussiaMember_6da3f780-1900-4388-8335-344f4f5fcba8" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareLLCMember_e890bd08-46ba-460f-b95f-9c556f0e5bd8" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareLLCMember_e890bd08-46ba-460f-b95f-9c556f0e5bd8" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiABMember_78776015-e939-4064-ac5e-5412ec0f3934" xlink:href="sny-20221231.xsd#sny_SanofiABMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiABMember_78776015-e939-4064-ac5e-5412ec0f3934" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSuisseSAMember_f2e76baa-4f77-46d1-a7a9-6c748205297e" xlink:href="sny-20221231.xsd#sny_SanofiAventisSuisseSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisSuisseSAMember_f2e76baa-4f77-46d1-a7a9-6c748205297e" xlink:type="arc" order="60"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember_bc634e88-b897-454e-8f56-87d0e08f88a7" xlink:href="sny-20221231.xsd#sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember_bc634e88-b897-454e-8f56-87d0e08f88a7" xlink:type="arc" order="61"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiIlacSanayiVeTicaretASMember_8d0d12d1-358f-40ae-9bb7-171c6b7addab" xlink:href="sny-20221231.xsd#sny_SanofiIlacSanayiVeTicaretASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiIlacSanayiVeTicaretASMember_8d0d12d1-358f-40ae-9bb7-171c6b7addab" xlink:type="arc" order="62"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurAsiTicaretASMember_aae1a87e-6d20-48b4-9446-393c5758e431" xlink:href="sny-20221231.xsd#sny_SanofiPasteurAsiTicaretASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurAsiTicaretASMember_aae1a87e-6d20-48b4-9446-393c5758e431" xlink:type="arc" order="63"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSaglikUrunleriLimitedSirketiMember_2bd9c2e5-05e7-4832-9ca4-7659d71678dd" xlink:href="sny-20221231.xsd#sny_SanofiSaglikUrunleriLimitedSirketiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiSaglikUrunleriLimitedSirketiMember_2bd9c2e5-05e7-4832-9ca4-7659d71678dd" xlink:type="arc" order="64"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeTherapeuticProductsLimitedPartnershipMember_309abc42-8c12-4585-872d-cef2ede46a61" xlink:href="sny-20221231.xsd#sny_GenzymeTherapeuticProductsLimitedPartnershipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeTherapeuticProductsLimitedPartnershipMember_309abc42-8c12-4585-872d-cef2ede46a61" xlink:type="arc" order="65"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisIncMember_09abb589-e685-4323-8ec6-0aa2b5ceff59" xlink:href="sny-20221231.xsd#sny_AventisIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisIncMember_09abb589-e685-4323-8ec6-0aa2b5ceff59" xlink:type="arc" order="66"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiUSServicesIncMember_15c9a928-1d30-4686-9e15-b609e91d7c0e" xlink:href="sny-20221231.xsd#sny_SanofiUSServicesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiUSServicesIncMember_15c9a928-1d30-4686-9e15-b609e91d7c0e" xlink:type="arc" order="67"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisUSLLCMember_8a10017a-eeca-4d85-bdf6-4728fe37376a" xlink:href="sny-20221231.xsd#sny_SanofiAventisUSLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisUSLLCMember_8a10017a-eeca-4d85-bdf6-4728fe37376a" xlink:type="arc" order="68"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChattemIncMember_3db4944a-984f-4e8a-8c58-1517e82702ce" xlink:href="sny-20221231.xsd#sny_ChattemIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_ChattemIncMember_3db4944a-984f-4e8a-8c58-1517e82702ce" xlink:type="arc" order="69"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisubLLCMember_765cb8e4-15ce-4d9d-bb92-4e4679512906" xlink:href="sny-20221231.xsd#sny_AventisubLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisubLLCMember_765cb8e4-15ce-4d9d-bb92-4e4679512906" xlink:type="arc" order="70"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeCorporationMember_e2f4a17d-2363-49db-9950-0c3850527492" xlink:href="sny-20221231.xsd#sny_GenzymeCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeCorporationMember_e2f4a17d-2363-49db-9950-0c3850527492" xlink:type="arc" order="71"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurIncMember_fe9e45fb-cdf1-4405-9f7d-7d92e654773e" xlink:href="sny-20221231.xsd#sny_SanofiPasteurIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurIncMember_fe9e45fb-cdf1-4405-9f7d-7d92e654773e" xlink:type="arc" order="72"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaxServeIncMember_df892708-a4a1-4981-9033-c75f786c606e" xlink:href="sny-20221231.xsd#sny_VaxServeIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_VaxServeIncMember_df892708-a4a1-4981-9033-c75f786c606e" xlink:type="arc" order="73"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativIncMember_eb263cf9-e683-46f0-b81d-fc34a4610abb" xlink:href="sny-20221231.xsd#sny_BioverativIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_BioverativIncMember_eb263cf9-e683-46f0-b81d-fc34a4610abb" xlink:type="arc" order="74"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativUSLLCMember_7d8c71d4-20c7-4f8a-a203-bd56523c8abc" xlink:href="sny-20221231.xsd#sny_BioverativUSLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_BioverativUSLLCMember_7d8c71d4-20c7-4f8a-a203-bd56523c8abc" xlink:type="arc" order="75"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativTherapeuticsIncMember_4d00c465-1672-4f21-b612-5950eefb1b15" xlink:href="sny-20221231.xsd#sny_BioverativTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_BioverativTherapeuticsIncMember_4d00c465-1672-4f21-b612-5950eefb1b15" xlink:type="arc" order="76"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipiaBiopharmaIncMember_b594e842-5d7c-4a97-8529-49a51d6425c1" xlink:href="sny-20221231.xsd#sny_PrincipiaBiopharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_PrincipiaBiopharmaIncMember_b594e842-5d7c-4a97-8529-49a51d6425c1" xlink:type="arc" order="77"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiResearchInvestLLCMember_d760d09a-ab01-4639-9b1d-62bca4c18f5b" xlink:href="sny-20221231.xsd#sny_SanofiResearchInvestLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiResearchInvestLLCMember_d760d09a-ab01-4639-9b1d-62bca4c18f5b" xlink:type="arc" order="78"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBioverativHoldingsLLCMember_750222e5-a301-4c60-90f6-213be79d5a06" xlink:href="sny-20221231.xsd#sny_SanofiBioverativHoldingsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiBioverativHoldingsLLCMember_750222e5-a301-4c60-90f6-213be79d5a06" xlink:type="arc" order="79"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RPRUSLtdMember_a71122b6-2f60-4a7a-a91e-a103afad80e9" xlink:href="sny-20221231.xsd#sny_RPRUSLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_RPRUSLtdMember_a71122b6-2f60-4a7a-a91e-a103afad80e9" xlink:type="arc" order="80"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KadmonHoldingsIncMember_506efdfe-b401-41d7-ba81-5c08bf7298fa" xlink:href="sny-20221231.xsd#sny_KadmonHoldingsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_KadmonHoldingsIncMember_506efdfe-b401-41d7-ba81-5c08bf7298fa" xlink:type="arc" order="81"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KadmonCorporationLLCMember_07842b14-c479-4789-b441-82ad4c50e90b" xlink:href="sny-20221231.xsd#sny_KadmonCorporationLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_KadmonCorporationLLCMember_07842b14-c479-4789-b441-82ad4c50e90b" xlink:type="arc" order="82"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixMember_74313dad-13ba-4408-a4bc-db1f80173e1a" xlink:href="sny-20221231.xsd#sny_AmunixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AmunixMember_74313dad-13ba-4408-a4bc-db1f80173e1a" xlink:type="arc" order="83"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxIncMember_fa7b1975-78fe-46ab-b566-cb4ae7ec3ec1" xlink:href="sny-20221231.xsd#sny_SynthorxIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SynthorxIncMember_fa7b1975-78fe-46ab-b566-cb4ae7ec3ec1" xlink:type="arc" order="84"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioIncMember_a03e6a4e-4653-48a3-97cd-2dbc9ae1d835" xlink:href="sny-20221231.xsd#sny_TranslateBioIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_TranslateBioIncMember_a03e6a4e-4653-48a3-97cd-2dbc9ae1d835" xlink:type="arc" order="85"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSouthAfricaPtyLtdMember_1b2797ff-8c9a-462e-a480-1e2827460600" xlink:href="sny-20221231.xsd#sny_SanofiAventisSouthAfricaPtyLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisSouthAfricaPtyLtdMember_1b2797ff-8c9a-462e-a480-1e2827460600" xlink:type="arc" order="86"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisAlgerieMember_d7efa076-dd45-420d-bd3f-f6ee65f5bc73" xlink:href="sny-20221231.xsd#sny_SanofiAventisAlgerieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisAlgerieMember_d7efa076-dd45-420d-bd3f-f6ee65f5bc73" xlink:type="arc" order="87"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiArabiaTradingCompanyLimitedMember_59e9e202-e7dc-45a0-8036-eed210047f7e" xlink:href="sny-20221231.xsd#sny_SanofiArabiaTradingCompanyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiArabiaTradingCompanyLimitedMember_59e9e202-e7dc-45a0-8036-eed210047f7e" xlink:type="arc" order="88"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisArgentinaSAMember_b9c7325f-0836-4cd5-a625-e5d8baf213b3" xlink:href="sny-20221231.xsd#sny_SanofiAventisArgentinaSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisArgentinaSAMember_b9c7325f-0836-4cd5-a625-e5d8baf213b3" xlink:type="arc" order="89"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeDeArgentinaSAMember_b0d54d3d-7fc8-42d6-ac9e-ed3a7da9c0ab" xlink:href="sny-20221231.xsd#sny_GenzymeDeArgentinaSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeDeArgentinaSAMember_b0d54d3d-7fc8-42d6-ac9e-ed3a7da9c0ab" xlink:type="arc" order="90"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareArgentinaSAUMember_d55dc291-a8a7-4d4d-b87c-05a557935338" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareArgentinaSAUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareArgentinaSAUMember_d55dc291-a8a7-4d4d-b87c-05a557935338" xlink:type="arc" order="91"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisHealthcarePtyLtdMember_5e468c3f-4ac1-4e89-ba62-c5d195020093" xlink:href="sny-20221231.xsd#sny_SanofiAventisHealthcarePtyLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisHealthcarePtyLtdMember_5e468c3f-4ac1-4e89-ba62-c5d195020093" xlink:type="arc" order="92"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisAustraliaPtyLtdMember_18868cd2-5ba2-47a8-98e9-6b61a784d34f" xlink:href="sny-20221231.xsd#sny_SanofiAventisAustraliaPtyLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisAustraliaPtyLtdMember_18868cd2-5ba2-47a8-98e9-6b61a784d34f" xlink:type="arc" order="93"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiMedleyFarmaceuticaLtdaMember_11d40435-ba3c-4406-97af-8c63c07b9235" xlink:href="sny-20221231.xsd#sny_SanofiMedleyFarmaceuticaLtdaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiMedleyFarmaceuticaLtdaMember_11d40435-ba3c-4406-97af-8c63c07b9235" xlink:type="arc" order="94"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisCanadaIncMember_1d0e37a9-4e7b-4038-9729-1611f3054258" xlink:href="sny-20221231.xsd#sny_SanofiAventisCanadaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisCanadaIncMember_1d0e37a9-4e7b-4038-9729-1611f3054258" xlink:type="arc" order="95"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurLimitedMember_af0ec8ea-5995-410d-8767-1ae52b430d87" xlink:href="sny-20221231.xsd#sny_SanofiPasteurLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurLimitedMember_af0ec8ea-5995-410d-8767-1ae52b430d87" xlink:type="arc" order="96"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MerieuxCanadaHoldingsULCCanadaMember_700a1596-6fa3-4f32-a924-3872b0de9776" xlink:href="sny-20221231.xsd#sny_MerieuxCanadaHoldingsULCCanadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_MerieuxCanadaHoldingsULCCanadaMember_700a1596-6fa3-4f32-a924-3872b0de9776" xlink:type="arc" order="97"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeChileSAMember_b832075e-a823-4dd0-84cf-78ee3cf41287" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeChileSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDeChileSAMember_b832075e-a823-4dd0-84cf-78ee3cf41287" xlink:type="arc" order="98"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiHangzhouPharmaceuticalsCoLtdMember_a0c7f739-1064-4fd7-a117-fb650a33af8c" xlink:href="sny-20221231.xsd#sny_SanofiHangzhouPharmaceuticalsCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiHangzhouPharmaceuticalsCoLtdMember_a0c7f739-1064-4fd7-a117-fb650a33af8c" xlink:type="arc" order="99"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiChinaInvestmentCoLtdMember_23101bdf-273f-40ad-8bc3-ba5b69a6f896" xlink:href="sny-20221231.xsd#sny_SanofiChinaInvestmentCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiChinaInvestmentCoLtdMember_23101bdf-273f-40ad-8bc3-ba5b69a6f896" xlink:type="arc" order="100"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBeijingPharmaceuticalsCoLtdMember_ccf0367b-ab75-44fc-a946-069f63e1fbc6" xlink:href="sny-20221231.xsd#sny_SanofiBeijingPharmaceuticalsCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiBeijingPharmaceuticalsCoLtdMember_ccf0367b-ab75-44fc-a946-069f63e1fbc6" xlink:type="arc" order="101"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurBiologiesCo.LtdMember_e6648846-bb19-4858-9d07-cbb9cdd4b29e" xlink:href="sny-20221231.xsd#sny_SanofiPasteurBiologiesCo.LtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurBiologiesCo.LtdMember_e6648846-bb19-4858-9d07-cbb9cdd4b29e" xlink:type="arc" order="102"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember_8f278e84-61ef-4880-a9e3-916606f4afd2" xlink:href="sny-20221231.xsd#sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember_8f278e84-61ef-4880-a9e3-916606f4afd2" xlink:type="arc" order="103"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShanghaiRonghengPharmaceuticalCoLtdMember_2b0b378f-82f3-4f3e-be5a-76434a12ef0c" xlink:href="sny-20221231.xsd#sny_ShanghaiRonghengPharmaceuticalCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_ShanghaiRonghengPharmaceuticalCoLtdMember_2b0b378f-82f3-4f3e-be5a-76434a12ef0c" xlink:type="arc" order="104"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenfarSAMember_373ad26f-d6cc-4c8f-8a52-f2fdbfc0ef70" xlink:href="sny-20221231.xsd#sny_GenfarSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenfarSAMember_373ad26f-d6cc-4c8f-8a52-f2fdbfc0ef70" xlink:type="arc" order="105"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeColombiaSAMember_1e806a9f-bf30-475b-acd2-04d97959d5a8" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeColombiaSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDeColombiaSAMember_1e806a9f-bf30-475b-acd2-04d97959d5a8" xlink:type="arc" order="106"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisKoreaCoLtdMember_c0374002-93d6-4785-9a47-392793b121d7" xlink:href="sny-20221231.xsd#sny_SanofiAventisKoreaCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisKoreaCoLtdMember_c0374002-93d6-4785-9a47-392793b121d7" xlink:type="arc" order="107"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurLtdMember_ca5d90ea-06ec-454d-8927-44c76d9ac2e3" xlink:href="sny-20221231.xsd#sny_SanofiPasteurLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurLtdMember_ca5d90ea-06ec-454d-8927-44c76d9ac2e3" xlink:type="arc" order="108"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareKoreaIncMember_f66f54f6-0dc9-42ed-b523-9abb92bdf413" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareKoreaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareKoreaIncMember_f66f54f6-0dc9-42ed-b523-9abb92bdf413" xlink:type="arc" order="109"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisGulfFZEMember_78d3da20-3170-41bb-a5bc-7448edb8c5ad" xlink:href="sny-20221231.xsd#sny_SanofiAventisGulfFZEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisGulfFZEMember_78d3da20-3170-41bb-a5bc-7448edb8c5ad" xlink:type="arc" order="110"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiEgyptSAEMember_f5a77756-e14e-46df-90ea-f07db7b6e5e2" xlink:href="sny-20221231.xsd#sny_SanofiEgyptSAEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiEgyptSAEMember_f5a77756-e14e-46df-90ea-f07db7b6e5e2" xlink:type="arc" order="111"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareEgyptLLCMember_e529be3a-f4ff-4865-98ab-da7c7b54b535" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareEgyptLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareEgyptLLCMember_e529be3a-f4ff-4865-98ab-da7c7b54b535" xlink:type="arc" order="112"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiHongKongLimitedMember_29368bc6-a18b-4ef5-9376-b18f27b54b8c" xlink:href="sny-20221231.xsd#sny_SanofiHongKongLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiHongKongLimitedMember_29368bc6-a18b-4ef5-9376-b18f27b54b8c" xlink:type="arc" order="113"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiIndiaLimitedMember_57f48911-3b1a-4892-9316-5ab5d5edb2a2" xlink:href="sny-20221231.xsd#sny_SanofiIndiaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiIndiaLimitedMember_57f48911-3b1a-4892-9316-5ab5d5edb2a2" xlink:type="arc" order="114"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiHealthcareIndiaPrivateLimitedMember_deda407f-0028-4ebd-ac4a-6ffeee56df23" xlink:href="sny-20221231.xsd#sny_SanofiHealthcareIndiaPrivateLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiHealthcareIndiaPrivateLimitedMember_deda407f-0028-4ebd-ac4a-6ffeee56df23" xlink:type="arc" order="115"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisIsraelLtdMember_24da811d-7fd4-4d11-97ce-a9b9c1835c4b" xlink:href="sny-20221231.xsd#sny_SanofiAventisIsraelLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisIsraelLtdMember_24da811d-7fd4-4d11-97ce-a9b9c1835c4b" xlink:type="arc" order="116"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiKKMember_fee8c90e-a44e-4042-a97c-5645c6379945" xlink:href="sny-20221231.xsd#sny_SanofiKKMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiKKMember_fee8c90e-a44e-4042-a97c-5645c6379945" xlink:type="arc" order="117"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SspCoLtdMember_0eb5a64f-e5ae-4831-b483-3735a83d6efb" xlink:href="sny-20221231.xsd#sny_SspCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SspCoLtdMember_0eb5a64f-e5ae-4831-b483-3735a83d6efb" xlink:type="arc" order="118"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisMalaysiaSDNBHDMember_13bba46d-7f22-46b3-874f-4d2ab238c523" xlink:href="sny-20221231.xsd#sny_SanofiAventisMalaysiaSDNBHDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisMalaysiaSDNBHDMember_13bba46d-7f22-46b3-874f-4d2ab238c523" xlink:type="arc" order="119"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisMarocMember_b7b442d1-dfa5-47e1-b1c0-caac4f4b4c2f" xlink:href="sny-20221231.xsd#sny_SanofiAventisMarocMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisMarocMember_b7b442d1-dfa5-47e1-b1c0-caac4f4b4c2f" xlink:type="arc" order="120"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeMexicoSADeCVMember_ffd07e85-303c-4353-b9c1-12d71256438b" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeMexicoSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDeMexicoSADeCVMember_ffd07e85-303c-4353-b9c1-12d71256438b" xlink:type="arc" order="121"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurS.A.deC.V.Member_1b012a36-b9e9-4d9e-bd16-05fe1244855f" xlink:href="sny-20221231.xsd#sny_SanofiPasteurS.A.deC.V.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurS.A.deC.V.Member_1b012a36-b9e9-4d9e-bd16-05fe1244855f" xlink:type="arc" order="122"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AztecaVacunasSADeCVMember_e25b92bb-8f40-409c-8056-62d27ecf41fa" xlink:href="sny-20221231.xsd#sny_AztecaVacunasSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AztecaVacunasSADeCVMember_e25b92bb-8f40-409c-8056-62d27ecf41fa" xlink:type="arc" order="123"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPakistanLtdMember_e6b96d7c-2988-4095-9d41-e26939cb6d14" xlink:href="sny-20221231.xsd#sny_SanofiAventisPakistanLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisPakistanLtdMember_e6b96d7c-2988-4095-9d41-e26939cb6d14" xlink:type="arc" order="124"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDePanamaSAMember_4a9b9771-8858-473c-b533-022abe840340" xlink:href="sny-20221231.xsd#sny_SanofiAventisDePanamaSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDePanamaSAMember_4a9b9771-8858-473c-b533-022abe840340" xlink:type="arc" order="125"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDelPeruSAMember_bef72d1f-554a-4a50-a09a-f1568edb6f19" xlink:href="sny-20221231.xsd#sny_SanofiAventisDelPeruSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDelPeruSAMember_bef72d1f-554a-4a50-a09a-f1568edb6f19" xlink:type="arc" order="126"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPuertoRicoIncMember_03b035ab-a705-42ca-8465-505729e98c3e" xlink:href="sny-20221231.xsd#sny_SanofiAventisPuertoRicoIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisPuertoRicoIncMember_03b035ab-a705-42ca-8465-505729e98c3e" xlink:type="arc" order="127"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPhilippinesIncMember_cbe4ac4e-1d16-4230-9815-960135f88b97" xlink:href="sny-20221231.xsd#sny_SanofiAventisPhilippinesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisPhilippinesIncMember_cbe4ac4e-1d16-4230-9815-960135f88b97" xlink:type="arc" order="128"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcarePhilippinesIncMember_749506c3-2b0a-4e00-9ef7-8992e68ea76d" xlink:href="sny-20221231.xsd#sny_OpellaHealthcarePhilippinesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcarePhilippinesIncMember_749506c3-2b0a-4e00-9ef7-8992e68ea76d" xlink:type="arc" order="129"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSingaporePteLtdMember_827588ad-765b-429c-95fe-36cdfab3554e" xlink:href="sny-20221231.xsd#sny_SanofiAventisSingaporePteLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisSingaporePteLtdMember_827588ad-765b-429c-95fe-36cdfab3554e" xlink:type="arc" order="130"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaManufacturingPTELTDMember_cd89368b-004e-4a02-85f9-ecfbf35e6558" xlink:href="sny-20221231.xsd#sny_AventisPharmaManufacturingPTELTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisPharmaManufacturingPTELTDMember_cd89368b-004e-4a02-85f9-ecfbf35e6558" xlink:type="arc" order="131"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiManufacturingPteLtdMember_07b6460e-6b03-4129-a62f-16b60ecbeccf" xlink:href="sny-20221231.xsd#sny_SanofiManufacturingPteLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiManufacturingPteLtdMember_07b6460e-6b03-4129-a62f-16b60ecbeccf" xlink:type="arc" order="132"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiTaiwanCoLtdMember_b51d492f-0be6-4e40-8c35-f6967c436b42" xlink:href="sny-20221231.xsd#sny_SanofiTaiwanCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiTaiwanCoLtdMember_b51d492f-0be6-4e40-8c35-f6967c436b42" xlink:type="arc" order="133"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisThailandLtdMember_8cde104f-20a8-446e-a115-c6210f7c539b" xlink:href="sny-20221231.xsd#sny_SanofiAventisThailandLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisThailandLtdMember_8cde104f-20a8-446e-a115-c6210f7c539b" xlink:type="arc" order="134"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeVenezuelaSAMember_55b4cc2d-b442-43f4-8227-7a6cfee1fea8" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeVenezuelaSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDeVenezuelaSAMember_55b4cc2d-b442-43f4-8227-7a6cfee1fea8" xlink:type="arc" order="135"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisVietnamCompanyLimitedMember_db501cad-04b3-4a2e-8138-1ef39fe8b70c" xlink:href="sny-20221231.xsd#sny_SanofiAventisVietnamCompanyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisVietnamCompanyLimitedMember_db501cad-04b3-4a2e-8138-1ef39fe8b70c" xlink:type="arc" order="136"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiVietnamShareholdingCompanyLimitedMember_12846ee8-65cc-4654-8ab2-d18b461a914b" xlink:href="sny-20221231.xsd#sny_SanofiVietnamShareholdingCompanyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiVietnamShareholdingCompanyLimitedMember_12846ee8-65cc-4654-8ab2-d18b461a914b" xlink:type="arc" order="137"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_5f107b3b-92dd-4372-b607-9f7ff51243a5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_cfbe9ce3-903e-4d07-8e8e-38e303ba9010" xlink:to="loc_ifrs-full_GeographicalAreasAxis_5f107b3b-92dd-4372-b607-9f7ff51243a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_5f107b3b-92dd-4372-b607-9f7ff51243a5_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5f107b3b-92dd-4372-b607-9f7ff51243a5" xlink:to="loc_ifrs-full_GeographicalAreasMember_5f107b3b-92dd-4372-b607-9f7ff51243a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_b9983984-5cbb-4541-ac61-eb4175170033" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5f107b3b-92dd-4372-b607-9f7ff51243a5" xlink:to="loc_ifrs-full_GeographicalAreasMember_b9983984-5cbb-4541-ac61-eb4175170033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_068fa7a9-9117-4dea-9c05-7f1e12106f30" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_b9983984-5cbb-4541-ac61-eb4175170033" xlink:to="loc_srt_EuropeMember_068fa7a9-9117-4dea-9c05-7f1e12106f30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_95534b92-03f7-47c7-922b-9e920d851e49" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_b9983984-5cbb-4541-ac61-eb4175170033" xlink:to="loc_country_US_95534b92-03f7-47c7-922b-9e920d851e49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_45d5b684-1abf-4e7f-a207-eecd14a88095" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_b9983984-5cbb-4541-ac61-eb4175170033" xlink:to="loc_sny_OtherCountriesMember_45d5b684-1abf-4e7f-a207-eecd14a88095" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails" xlink:type="extended" id="iec4ea15ae75d4e6dbce9cebc7e88f733_Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfJointOperationsLineItems_b4ed2d5b-b8d8-4d31-a4c8-bc2646b8d0be" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfJointOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInJointOperation_7c1ecbcf-5051-4716-9628-61afdc7c55d5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInJointOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfJointOperationsLineItems_b4ed2d5b-b8d8-4d31-a4c8-bc2646b8d0be" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInJointOperation_7c1ecbcf-5051-4716-9628-61afdc7c55d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfJointOperationsTable_480fb899-68d5-4423-8b5d-953b63cfb46b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfJointOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfJointOperationsLineItems_b4ed2d5b-b8d8-4d31-a4c8-bc2646b8d0be" xlink:to="loc_ifrs-full_DisclosureOfJointOperationsTable_480fb899-68d5-4423-8b5d-953b63cfb46b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointOperationsAxis_4c49037f-29d9-4ead-87dd-87e136fef148" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfJointOperationsTable_480fb899-68d5-4423-8b5d-953b63cfb46b" xlink:to="loc_ifrs-full_JointOperationsAxis_4c49037f-29d9-4ead-87dd-87e136fef148" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointOperationsMember_4c49037f-29d9-4ead-87dd-87e136fef148_default" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointOperationsAxis_4c49037f-29d9-4ead-87dd-87e136fef148" xlink:to="loc_ifrs-full_EntitysTotalForJointOperationsMember_4c49037f-29d9-4ead-87dd-87e136fef148_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointOperationsAxis_4c49037f-29d9-4ead-87dd-87e136fef148" xlink:to="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GlaxoSmithKlineConsumerHealthcareLPMember_db08df4f-aab3-4954-a3d2-36a339d225e0" xlink:href="sny-20221231.xsd#sny_GlaxoSmithKlineConsumerHealthcareLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_GlaxoSmithKlineConsumerHealthcareLPMember_db08df4f-aab3-4954-a3d2-36a339d225e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InfraservGmbhAndCoHochstKGMember_6fe8543b-118a-4d8e-b68a-88f970f325f5" xlink:href="sny-20221231.xsd#sny_InfraservGmbhAndCoHochstKGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_InfraservGmbhAndCoHochstKGMember_6fe8543b-118a-4d8e-b68a-88f970f325f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MapharMember_3f4d3f58-5a31-42c2-a423-15f795e678a0" xlink:href="sny-20221231.xsd#sny_MapharMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_MapharMember_3f4d3f58-5a31-42c2-a423-15f795e678a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MCMVaccineBVMember_fcd2a2dd-7fdc-4c1f-ba4d-fae32c5d09e8" xlink:href="sny-20221231.xsd#sny_MCMVaccineBVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_MCMVaccineBVMember_fcd2a2dd-7fdc-4c1f-ba4d-fae32c5d09e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSPVaccineCompanyMember_84ca335e-058a-4762-aa80-db5736a6e060" xlink:href="sny-20221231.xsd#sny_MSPVaccineCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_MSPVaccineCompanyMember_84ca335e-058a-4762-aa80-db5736a6e060" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_afe833ff-bd2f-4de9-a2e7-5e4fe680cd09" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_EuroapiMember_afe833ff-bd2f-4de9-a2e7-5e4fe680cd09" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/EventssubsequenttoDecember312022Details" xlink:type="simple" xlink:href="sny-20221231.xsd#EventssubsequenttoDecember312022Details"/>
  <link:definitionLink xlink:role="http://www.sanofi.com/role/EventssubsequenttoDecember312022Details" xlink:type="extended" id="i33b8b91870614b04a7c9f04fcb96f4cf_EventssubsequenttoDecember312022Details">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_136fe0a7-02ed-4af1-a1d0-3ad2e8b82a84" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_36abf569-e901-44bf-8a5c-e5c25a4ab588" xlink:href="sny-20221231.xsd#sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_136fe0a7-02ed-4af1-a1d0-3ad2e8b82a84" xlink:to="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_36abf569-e901-44bf-8a5c-e5c25a4ab588" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e8d2bfa9-4cb5-4f8a-83c7-51494cdf8d7d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_136fe0a7-02ed-4af1-a1d0-3ad2e8b82a84" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e8d2bfa9-4cb5-4f8a-83c7-51494cdf8d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_6db6d7a0-fda3-41dd-8b4c-99bfd29283f2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_136fe0a7-02ed-4af1-a1d0-3ad2e8b82a84" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_6db6d7a0-fda3-41dd-8b4c-99bfd29283f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c78948fe-c549-42eb-91c7-05d56ca73e3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_6db6d7a0-fda3-41dd-8b4c-99bfd29283f2" xlink:to="loc_srt_ProductOrServiceAxis_c78948fe-c549-42eb-91c7-05d56ca73e3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c78948fe-c549-42eb-91c7-05d56ca73e3a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c78948fe-c549-42eb-91c7-05d56ca73e3a" xlink:to="loc_srt_ProductsAndServicesDomain_c78948fe-c549-42eb-91c7-05d56ca73e3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_14f4060e-76ce-4a71-b2c7-8430c2eaf6b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c78948fe-c549-42eb-91c7-05d56ca73e3a" xlink:to="loc_srt_ProductsAndServicesDomain_14f4060e-76ce-4a71-b2c7-8430c2eaf6b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EloctateMember_7101d852-e0ce-498c-808f-2cde27f3f986" xlink:href="sny-20221231.xsd#sny_EloctateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_14f4060e-76ce-4a71-b2c7-8430c2eaf6b8" xlink:to="loc_sny_EloctateMember_7101d852-e0ce-498c-808f-2cde27f3f986" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>sny-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:89d6bfca-a5b4-4bcd-ad12-f1718d876f14,g:8278f0b1-e8dc-472d-9868-3f575a842a56-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity_bd9cd841-b44b-43e5-a622-cf84819e7ad2_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other changes arising from issuance of restricted shares</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Issuance Of Restricted Shares, Equity</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through issuance of restricted shares, equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xlink:to="lab_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_957c2380-e782-487e-a728-206538ba7f6b_negatedLabel_en-US" xlink:label="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals and other decreases</link:label>
    <link:label id="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals and retirements, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DebtInstrumentAxis_aa6ee6a5-c40c-4f56-97c0-0613e69877c6_terseLabel_en-US" xlink:label="lab_sny_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_sny_DebtInstrumentAxis_label_en-US" xlink:label="lab_sny_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_sny_DebtInstrumentAxis_documentation_en-US" xlink:label="lab_sny_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument 1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentAxis" xlink:href="sny-20221231.xsd#sny_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DebtInstrumentAxis" xlink:to="lab_sny_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IOLicenseAndCollaborationAgreementMember_2fe3efda-9c39-481c-a335-f8097b97b9e6_terseLabel_en-US" xlink:label="lab_sny_IOLicenseAndCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IO License And Collaboration Agreement</link:label>
    <link:label id="lab_sny_IOLicenseAndCollaborationAgreementMember_label_en-US" xlink:label="lab_sny_IOLicenseAndCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IO License And Collaboration Agreement [Member]</link:label>
    <link:label id="lab_sny_IOLicenseAndCollaborationAgreementMember_documentation_en-US" xlink:label="lab_sny_IOLicenseAndCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IO License And Collaboration Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IOLicenseAndCollaborationAgreementMember" xlink:href="sny-20221231.xsd#sny_IOLicenseAndCollaborationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IOLicenseAndCollaborationAgreementMember" xlink:to="lab_sny_IOLicenseAndCollaborationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AventisPharmaManufacturingPTELTDMember_73c3c1da-0257-4d69-bcae-a2951522024c_terseLabel_en-US" xlink:label="lab_sny_AventisPharmaManufacturingPTELTDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma (Manufacturing) Pte. Ltd</link:label>
    <link:label id="lab_sny_AventisPharmaManufacturingPTELTDMember_label_en-US" xlink:label="lab_sny_AventisPharmaManufacturingPTELTDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma Manufacturing PTE LTD [Member]</link:label>
    <link:label id="lab_sny_AventisPharmaManufacturingPTELTDMember_documentation_en-US" xlink:label="lab_sny_AventisPharmaManufacturingPTELTDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma (Manufacturing) PTE LTD.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaManufacturingPTELTDMember" xlink:href="sny-20221231.xsd#sny_AventisPharmaManufacturingPTELTDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AventisPharmaManufacturingPTELTDMember" xlink:to="lab_sny_AventisPharmaManufacturingPTELTDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DebtSecuritiesMember_78291a54-261d-4296-b9dc-254302c8d64c_terseLabel_en-US" xlink:label="lab_ifrs-full_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_ifrs-full_DebtSecuritiesMember_label_en-US" xlink:label="lab_ifrs-full_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DebtSecuritiesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DebtSecuritiesMember" xlink:to="lab_ifrs-full_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b042a0d1-f428-498f-9f93-431b86f02f93_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PeriodOfShareRepurchaseProgram_7a01a1e4-6bde-419c-a845-1d7d4b586b08_terseLabel_en-US" xlink:label="lab_sny_PeriodOfShareRepurchaseProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of share repurchase program</link:label>
    <link:label id="lab_sny_PeriodOfShareRepurchaseProgram_label_en-US" xlink:label="lab_sny_PeriodOfShareRepurchaseProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Of Share Repurchase Program</link:label>
    <link:label id="lab_sny_PeriodOfShareRepurchaseProgram_documentation_en-US" xlink:label="lab_sny_PeriodOfShareRepurchaseProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of share repurchase program.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PeriodOfShareRepurchaseProgram" xlink:href="sny-20221231.xsd#sny_PeriodOfShareRepurchaseProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PeriodOfShareRepurchaseProgram" xlink:to="lab_sny_PeriodOfShareRepurchaseProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Goodwill_2b4032e6-d30f-4426-b305-b76716df77fa_terseLabel_en-US" xlink:label="lab_ifrs-full_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_ifrs-full_Goodwill_label_en-US" xlink:label="lab_ifrs-full_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Goodwill" xlink:to="lab_ifrs-full_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaturityAxis_085a24dc-1a37-459f-aab0-bfd669824bfb_terseLabel_en-US" xlink:label="lab_ifrs-full_MaturityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity [axis]</link:label>
    <link:label id="lab_ifrs-full_MaturityAxis_label_en-US" xlink:label="lab_ifrs-full_MaturityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis" xlink:to="lab_ifrs-full_MaturityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_aabbf058-52e6-45e0-b79c-b0b19a26c15b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of financial assets that are either past due or impaired [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of financial assets that are either past due or impaired [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GenzymeEuropeBVMember_e34984ca-e2a1-4ee8-a921-ca79f4c21709_terseLabel_en-US" xlink:label="lab_sny_GenzymeEuropeBVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Europe B.V.</link:label>
    <link:label id="lab_sny_GenzymeEuropeBVMember_label_en-US" xlink:label="lab_sny_GenzymeEuropeBVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Europe BV [member]</link:label>
    <link:label id="lab_sny_GenzymeEuropeBVMember_documentation_en-US" xlink:label="lab_sny_GenzymeEuropeBVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Europe BV.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeEuropeBVMember" xlink:href="sny-20221231.xsd#sny_GenzymeEuropeBVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GenzymeEuropeBVMember" xlink:to="lab_sny_GenzymeEuropeBVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalMarketedProductsMember_2c4d8b68-3bbc-4345-93ed-b2ebd31745b2_terseLabel_en-US" xlink:label="lab_sny_PrincipalMarketedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total: principal marketed products</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsMember_label_en-US" xlink:label="lab_sny_PrincipalMarketedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products [member]</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsMember_documentation_en-US" xlink:label="lab_sny_PrincipalMarketedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal marketed products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsMember" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalMarketedProductsMember" xlink:to="lab_sny_PrincipalMarketedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LiabilityRecognizedRepresentingEstimatedCost_3b65fbf1-da85-4306-a1fc-6e3d2651b046_terseLabel_en-US" xlink:label="lab_sny_LiabilityRecognizedRepresentingEstimatedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability recognized representing the estimated cost</link:label>
    <link:label id="lab_sny_LiabilityRecognizedRepresentingEstimatedCost_label_en-US" xlink:label="lab_sny_LiabilityRecognizedRepresentingEstimatedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Recognized Representing Estimated Cost</link:label>
    <link:label id="lab_sny_LiabilityRecognizedRepresentingEstimatedCost_documentation_en-US" xlink:label="lab_sny_LiabilityRecognizedRepresentingEstimatedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability recognized representing estimated cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LiabilityRecognizedRepresentingEstimatedCost" xlink:href="sny-20221231.xsd#sny_LiabilityRecognizedRepresentingEstimatedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LiabilityRecognizedRepresentingEstimatedCost" xlink:to="lab_sny_LiabilityRecognizedRepresentingEstimatedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember_78ec38fe-f2c5-4892-bf1f-d86a6ae25b36_terseLabel_en-US" xlink:label="lab_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities and companies managed by Bristol Mayers Squibb</link:label>
    <link:label id="lab_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember_label_en-US" xlink:label="lab_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities And Companies Managed By Bristol Myers Squibb [Member]</link:label>
    <link:label id="lab_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember_documentation_en-US" xlink:label="lab_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities and companies managed by bristol myers squibb.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember" xlink:href="sny-20221231.xsd#sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember" xlink:to="lab_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalUndiscountedCashFlow_97c9a01b-b820-4123-ada3-6d161a3b5842_terseLabel_en-US" xlink:label="lab_sny_PrincipalUndiscountedCashFlow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal</link:label>
    <link:label id="lab_sny_PrincipalUndiscountedCashFlow_label_en-US" xlink:label="lab_sny_PrincipalUndiscountedCashFlow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Undiscounted Cash Flow</link:label>
    <link:label id="lab_sny_PrincipalUndiscountedCashFlow_documentation_en-US" xlink:label="lab_sny_PrincipalUndiscountedCashFlow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal undiscounted cash flow.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalUndiscountedCashFlow" xlink:href="sny-20221231.xsd#sny_PrincipalUndiscountedCashFlow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalUndiscountedCashFlow" xlink:to="lab_sny_PrincipalUndiscountedCashFlow" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ReductionOfSharesByCancellationOfTreasuryShares_20d11e26-8960-4b45-af3e-3608c687f570_negatedTerseLabel_en-US" xlink:label="lab_sny_ReductionOfSharesByCancellationOfTreasuryShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in share capital by cancellation of treasury shares (in shares)</link:label>
    <link:label id="lab_sny_ReductionOfSharesByCancellationOfTreasuryShares_label_en-US" xlink:label="lab_sny_ReductionOfSharesByCancellationOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction Of Shares By Cancellation Of Treasury Shares</link:label>
    <link:label id="lab_sny_ReductionOfSharesByCancellationOfTreasuryShares_documentation_en-US" xlink:label="lab_sny_ReductionOfSharesByCancellationOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction Of Shares By Cancellation Of Treasury Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReductionOfSharesByCancellationOfTreasuryShares" xlink:href="sny-20221231.xsd#sny_ReductionOfSharesByCancellationOfTreasuryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ReductionOfSharesByCancellationOfTreasuryShares" xlink:to="lab_sny_ReductionOfSharesByCancellationOfTreasuryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfVotingEquityInterestsDivested_7552aa19-f53e-404d-8730-0763e2989ada_terseLabel_en-US" xlink:label="lab_sny_PercentageOfVotingEquityInterestsDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting equity interests divested</link:label>
    <link:label id="lab_sny_PercentageOfVotingEquityInterestsDivested_label_en-US" xlink:label="lab_sny_PercentageOfVotingEquityInterestsDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Voting Equity Interests Divested</link:label>
    <link:label id="lab_sny_PercentageOfVotingEquityInterestsDivested_documentation_en-US" xlink:label="lab_sny_PercentageOfVotingEquityInterestsDivested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Voting Equity Interests Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfVotingEquityInterestsDivested" xlink:href="sny-20221231.xsd#sny_PercentageOfVotingEquityInterestsDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfVotingEquityInterestsDivested" xlink:to="lab_sny_PercentageOfVotingEquityInterestsDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PenaltyFeeIncurred_aecb169e-3310-4d61-8a34-eb0cc2b46968_terseLabel_en-US" xlink:label="lab_sny_PenaltyFeeIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Penalty fee incurred by Sanofi</link:label>
    <link:label id="lab_sny_PenaltyFeeIncurred_label_en-US" xlink:label="lab_sny_PenaltyFeeIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Penalty Fee Incurred</link:label>
    <link:label id="lab_sny_PenaltyFeeIncurred_documentation_en-US" xlink:label="lab_sny_PenaltyFeeIncurred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Penalty Fee Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PenaltyFeeIncurred" xlink:href="sny-20221231.xsd#sny_PenaltyFeeIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PenaltyFeeIncurred" xlink:to="lab_sny_PenaltyFeeIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_70edc5b0-4293-4c9b-8fa6-8114157a013c_terseLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee termination benefits</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_083575c0-2d9f-473b-925a-bf1474d47d7c_verboseLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement of obligation</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_label_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit obligation, at present value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:to="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OperatingSegmentsAbstract_eff24122-ba19-4f17-83fa-7f5ea4f361bf_terseLabel_en-US" xlink:label="lab_sny_OperatingSegmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Abstract]</link:label>
    <link:label id="lab_sny_OperatingSegmentsAbstract_label_en-US" xlink:label="lab_sny_OperatingSegmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Abstract]</link:label>
    <link:label id="lab_sny_OperatingSegmentsAbstract_documentation_en-US" xlink:label="lab_sny_OperatingSegmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OperatingSegmentsAbstract" xlink:href="sny-20221231.xsd#sny_OperatingSegmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OperatingSegmentsAbstract" xlink:to="lab_sny_OperatingSegmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TotalOffBalanceSheetCommitments_9fd6a740-e66b-4e11-a8b5-a53b47435bc6_terseLabel_en-US" xlink:label="lab_sny_TotalOffBalanceSheetCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total - net contributions given</link:label>
    <link:label id="lab_sny_TotalOffBalanceSheetCommitments_label_en-US" xlink:label="lab_sny_TotalOffBalanceSheetCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Off Balance Sheet Commitments</link:label>
    <link:label id="lab_sny_TotalOffBalanceSheetCommitments_documentation_en-US" xlink:label="lab_sny_TotalOffBalanceSheetCommitments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalOffBalanceSheetCommitments" xlink:href="sny-20221231.xsd#sny_TotalOffBalanceSheetCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TotalOffBalanceSheetCommitments" xlink:to="lab_sny_TotalOffBalanceSheetCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_da6d87ad-7cfa-4b5d-9e5c-1c5a6689181c_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale or exchange</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets or disposal groups classified as held for sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:to="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsMember_d5110064-9d15-467c-80d5-8b29de722d24_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial instruments, class [member]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsMember_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial instruments, class [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDebtTable_73db002e-af87-498c-b0eb-b81174cf7e8e_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtTable_label_en-US" xlink:label="lab_sny_DisclosureOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtTable" xlink:to="lab_sny_DisclosureOfDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears_12f1c179-7bb5-474e-9c2d-e95a6fc97298_terseLabel_en-US" xlink:label="lab_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative inflation rate over three years</link:label>
    <link:label id="lab_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears_label_en-US" xlink:label="lab_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Consumer Price Inflation Over The Last Three Years</link:label>
    <link:label id="lab_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears_documentation_en-US" xlink:label="lab_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative consumer price inflation rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears" xlink:href="sny-20221231.xsd#sny_CumulativeConsumerPriceInflationOverTheLastThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears" xlink:to="lab_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_6829b216-0365-48ec-b496-bf5c664ce69c_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipiaBiopharmaIncMember_fc468fe2-a1cb-42d0-b03b-7a1360d31342_terseLabel_en-US" xlink:label="lab_sny_PrincipiaBiopharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principia</link:label>
    <link:label id="lab_sny_PrincipiaBiopharmaIncMember_d733bdf5-8bdd-4abc-bdba-d6747f9b3b00_verboseLabel_en-US" xlink:label="lab_sny_PrincipiaBiopharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principia Biopharma Inc.</link:label>
    <link:label id="lab_sny_PrincipiaBiopharmaIncMember_label_en-US" xlink:label="lab_sny_PrincipiaBiopharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principia Biopharma Inc. [Member]</link:label>
    <link:label id="lab_sny_PrincipiaBiopharmaIncMember_documentation_en-US" xlink:label="lab_sny_PrincipiaBiopharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principia Biopharma Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipiaBiopharmaIncMember" xlink:href="sny-20221231.xsd#sny_PrincipiaBiopharmaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipiaBiopharmaIncMember" xlink:to="lab_sny_PrincipiaBiopharmaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GainsOnDivestmentOfProducts_abf79d70-8734-413a-b4be-144bf3be45c3_terseLabel_en-US" xlink:label="lab_sny_GainsOnDivestmentOfProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on divestment of some mature products</link:label>
    <link:label id="lab_sny_GainsOnDivestmentOfProducts_label_en-US" xlink:label="lab_sny_GainsOnDivestmentOfProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains On Divestment Of Products</link:label>
    <link:label id="lab_sny_GainsOnDivestmentOfProducts_documentation_en-US" xlink:label="lab_sny_GainsOnDivestmentOfProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on divestment of products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainsOnDivestmentOfProducts" xlink:href="sny-20221231.xsd#sny_GainsOnDivestmentOfProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainsOnDivestmentOfProducts" xlink:to="lab_sny_GainsOnDivestmentOfProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_3f644d0b-c880-4aa7-b675-3b35f3b60487_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment owned and leased</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0d96bfac-0e2b-4e1a-b4fd-211b097add6f_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of lease liabilities</link:label>
    <link:label id="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InsilicoMedicineMember_812278c7-5d19-4f9b-9ba4-9860a47d7ca1_terseLabel_en-US" xlink:label="lab_sny_InsilicoMedicineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insilico Medicine</link:label>
    <link:label id="lab_sny_InsilicoMedicineMember_label_en-US" xlink:label="lab_sny_InsilicoMedicineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insilico Medicine [Member]</link:label>
    <link:label id="lab_sny_InsilicoMedicineMember_documentation_en-US" xlink:label="lab_sny_InsilicoMedicineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insilico Medicine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InsilicoMedicineMember" xlink:href="sny-20221231.xsd#sny_InsilicoMedicineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InsilicoMedicineMember" xlink:to="lab_sny_InsilicoMedicineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AcquiredRDMember_05fa932a-7e85-4c13-aff2-891961b7f706_terseLabel_en-US" xlink:label="lab_sny_AcquiredRDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired R&amp;D</link:label>
    <link:label id="lab_sny_AcquiredRDMember_label_en-US" xlink:label="lab_sny_AcquiredRDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired R&amp;D [Member]</link:label>
    <link:label id="lab_sny_AcquiredRDMember_documentation_en-US" xlink:label="lab_sny_AcquiredRDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired R&amp;D</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AcquiredRDMember" xlink:href="sny-20221231.xsd#sny_AcquiredRDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AcquiredRDMember" xlink:to="lab_sny_AcquiredRDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_March2020EMTNISINFR0013505104Member_68c13cd9-2d3c-4505-ba48-89a0a4061a0b_terseLabel_en-US" xlink:label="lab_sny_March2020EMTNISINFR0013505104Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2020 EMTN ISIN FR0013505104</link:label>
    <link:label id="lab_sny_March2020EMTNISINFR0013505104Member_label_en-US" xlink:label="lab_sny_March2020EMTNISINFR0013505104Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2020 EMTNISINFR0013505104 [Member]</link:label>
    <link:label id="lab_sny_March2020EMTNISINFR0013505104Member_documentation_en-US" xlink:label="lab_sny_March2020EMTNISINFR0013505104Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2020 EMTNISINFR0013505104</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2020EMTNISINFR0013505104Member" xlink:href="sny-20221231.xsd#sny_March2020EMTNISINFR0013505104Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_March2020EMTNISINFR0013505104Member" xlink:to="lab_sny_March2020EMTNISINFR0013505104Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock_9702ecfd-d551-419f-8e29-46b19b2e67a9_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests</link:label>
    <link:label id="lab_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Changes In Liabilities Related To Business Combinations And To Noncontrolling Interests [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of changes in liabilities related to business combinations and to non-controlling interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xlink:to="lab_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock_3a6467f8-1908-4454-a208-7f6d6ddcbe27_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions, income tax liabilities and other liabilities</link:label>
    <link:label id="lab_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Provisions And Other Liabilities [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure of provisions and other liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock" xlink:to="lab_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_JointVenturesMember_f8a74c60-f104-4144-81a2-4b354d90cd08_terseLabel_en-US" xlink:label="lab_ifrs-full_JointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint ventures</link:label>
    <link:label id="lab_ifrs-full_JointVenturesMember_label_en-US" xlink:label="lab_ifrs-full_JointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint ventures [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_JointVenturesMember" xlink:to="lab_ifrs-full_JointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock_6b853014-a2e3-4d50-b0d5-73381dee8e0c_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Amount of Guarantees Given and Received</link:label>
    <link:label id="lab_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Guarantees Given And Received Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of guarantees given and received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_4cf24a0e-8d19-4524-810b-65c76e51f38f_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for earnings per share [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssets_0cdd8555-3c98-4486-9e43-fac7e6e9c56e_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total financial assets measured at fair value</link:label>
    <link:label id="lab_ifrs-full_FinancialAssets_label_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssets" xlink:to="lab_ifrs-full_FinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange_79e91f91-2a54-489f-b7c4-79d28186fed2_terseLabel_en-US" xlink:label="lab_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement age, bottom of range</link:label>
    <link:label id="lab_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange_label_en-US" xlink:label="lab_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial Assumption Of Retirement Age Bottom Of Range</link:label>
    <link:label id="lab_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange_documentation_en-US" xlink:label="lab_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement age, bottom of range.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange" xlink:href="sny-20221231.xsd#sny_ActuarialAssumptionOfRetirementAgeBottomOfRange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange" xlink:to="lab_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_0902d21e-5600-4659-a9b5-830a2994241f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_82d2866a-fb30-4d41-86b6-c63a885d4fb2_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of stock subscription option plan outstanding and option exercised [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Stock Subscription Option Plan Outstanding And Option Exercised [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of stock subscription option plan outstanding and option exercised [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems" xlink:to="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RestrictedSharePlan2018Member_31da7b1b-5b69-4c23-84fa-9557c782ec00_terseLabel_en-US" xlink:label="lab_sny_RestrictedSharePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted share plan 2018</link:label>
    <link:label id="lab_sny_RestrictedSharePlan2018Member_label_en-US" xlink:label="lab_sny_RestrictedSharePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plan 2018 [member]</link:label>
    <link:label id="lab_sny_RestrictedSharePlan2018Member_documentation_en-US" xlink:label="lab_sny_RestrictedSharePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plan 2018.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2018Member" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharePlan2018Member" xlink:to="lab_sny_RestrictedSharePlan2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock_70cc1068-6e78-4162-8e0e-b749d7079b53_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Future Payments in Respect of Unfunded Pension and Other Post-employment Benefit Plans</link:label>
    <link:label id="lab_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Expected Timing Of Payments In Respect Of Unfunded Pension And Other Post Employment Benefit Plans Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of expected timing of payments in respect of unfunded pension and other post employment benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GainLossOnCancellationOfTreasuryShares_ceb72da5-fec8-4e86-96ad-60201e541470_terseLabel_en-US" xlink:label="lab_sny_GainLossOnCancellationOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized on cancellation of treasury shares</link:label>
    <link:label id="lab_sny_GainLossOnCancellationOfTreasuryShares_label_en-US" xlink:label="lab_sny_GainLossOnCancellationOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Cancellation Of Treasury Shares</link:label>
    <link:label id="lab_sny_GainLossOnCancellationOfTreasuryShares_documentation_en-US" xlink:label="lab_sny_GainLossOnCancellationOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on cancellation of treasury shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainLossOnCancellationOfTreasuryShares" xlink:href="sny-20221231.xsd#sny_GainLossOnCancellationOfTreasuryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainLossOnCancellationOfTreasuryShares" xlink:to="lab_sny_GainLossOnCancellationOfTreasuryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_QualifiedDefinedBenefitPensionPlansMember_cd341200-11a7-4190-a6d1-dcb72bf1b4c4_terseLabel_en-US" xlink:label="lab_sny_QualifiedDefinedBenefitPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified defined benefit pension plans</link:label>
    <link:label id="lab_sny_QualifiedDefinedBenefitPensionPlansMember_label_en-US" xlink:label="lab_sny_QualifiedDefinedBenefitPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Defined Benefit Pension Plans [member]</link:label>
    <link:label id="lab_sny_QualifiedDefinedBenefitPensionPlansMember_documentation_en-US" xlink:label="lab_sny_QualifiedDefinedBenefitPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified defined benefit pension plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QualifiedDefinedBenefitPensionPlansMember" xlink:href="sny-20221231.xsd#sny_QualifiedDefinedBenefitPensionPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_QualifiedDefinedBenefitPensionPlansMember" xlink:to="lab_sny_QualifiedDefinedBenefitPensionPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_7ab0ffc3-31ac-4c51-9ca6-7bfabc60c775_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange for financial assets held to meet obligations to employees under post-employment benefit plans</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:to="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember_23d408bb-234b-4d36-a63c-6dab6d6a6015_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases in Chinese Yuan Renminbi</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember_label_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Chinese Yuan Renminbi [member]</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases in Chinese Yuan Renminbi.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember" xlink:to="lab_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_b75ad04b-611a-4031-80c0-439c086dc9fa_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key management personnel compensation, share-based payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_5b474d9f-2055-4465-a29e-007e6aa73adc_terseLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_label_en-US" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from sale of goods, related party transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:to="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAuditFeesAndOtherServicesTable_14fe7d12-c548-45fb-b184-892af01fe32a_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAuditFeesAndOtherServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of audit fees and other services [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfAuditFeesAndOtherServicesTable_label_en-US" xlink:label="lab_sny_DisclosureOfAuditFeesAndOtherServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Audit Fees And Other Services [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfAuditFeesAndOtherServicesTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfAuditFeesAndOtherServicesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of audit fees and other services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAuditFeesAndOtherServicesTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfAuditFeesAndOtherServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesTable" xlink:to="lab_sny_DisclosureOfAuditFeesAndOtherServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember_3476933b-a557-4e02-818c-9883236a5dc3_terseLabel_en-US" xlink:label="lab_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Main undrawn confirmed general purpose credit facilities</link:label>
    <link:label id="lab_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember_label_en-US" xlink:label="lab_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Main Undrawn Confirmed General Purpose Credit Facilities [member]</link:label>
    <link:label id="lab_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember_documentation_en-US" xlink:label="lab_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Main undrawn confirmed general purpose credit facilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember" xlink:href="sny-20221231.xsd#sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember" xlink:to="lab_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityInvestmentsMember_4af2cef6-860a-40bd-8b7b-4fe798ce9976_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_ifrs-full_EquityInvestmentsMember_label_en-US" xlink:label="lab_ifrs-full_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInvestmentsMember" xlink:to="lab_ifrs-full_EquityInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfPrincipalAlliancesLineItems_dc79b504-79bd-4fe0-bc72-dad9ddf290f9_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfPrincipalAlliancesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Principal Alliances [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfPrincipalAlliancesLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfPrincipalAlliancesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Principal Alliances [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfPrincipalAlliancesLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfPrincipalAlliancesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Principal Alliances [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPrincipalAlliancesLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfPrincipalAlliancesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems" xlink:to="lab_sny_DisclosureOfPrincipalAlliancesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalMarketedProductsProteinSciencesMember_342ab74a-6a13-43b5-9a33-7a3e8da763a4_terseLabel_en-US" xlink:label="lab_sny_PrincipalMarketedProductsProteinSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Protein Sciences</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsProteinSciencesMember_label_en-US" xlink:label="lab_sny_PrincipalMarketedProductsProteinSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products Protein Sciences [member]</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsProteinSciencesMember_documentation_en-US" xlink:label="lab_sny_PrincipalMarketedProductsProteinSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal marketed products Protein Sciences.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsProteinSciencesMember" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsProteinSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalMarketedProductsProteinSciencesMember" xlink:to="lab_sny_PrincipalMarketedProductsProteinSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeExpensesTable_cc3eafd6-b67d-401c-b6c7-a9eb63cd6997_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Other Operating Income Expenses [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeExpensesTable_label_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Operating Income Expenses [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeExpensesTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other operating income expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:to="lab_sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_e753d3c7-5c70-4b93-821f-49c05bb63897_terseLabel_en-US" xlink:label="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in subsidiaries, joint ventures and associates</link:label>
    <link:label id="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_label_en-US" xlink:label="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in subsidiaries, joint ventures and associates reported in separate financial statements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="lab_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock_81b7f530-a28d-42e5-ab96-a99c0d1e0258_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Liability in Respect of Pension Plans and Other Post-employment Benefits by Geographical Region</link:label>
    <link:label id="lab_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Net Liability In Respect Of Pension Plans And Other Post-employment Benefits By Geographical Region [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of net liability in respect of pension plans and other post-employment benefits by geographical region.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock" xlink:to="lab_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateAndCurrencyDerivativesMember_fe8f66fb-2122-4c12-8cfa-155240c86344_terseLabel_en-US" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate and currency derivatives used to hedge debt</link:label>
    <link:label id="lab_sny_InterestRateAndCurrencyDerivativesMember_label_en-US" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate And Currency Derivatives [Member]</link:label>
    <link:label id="lab_sny_InterestRateAndCurrencyDerivativesMember_documentation_en-US" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate and currency derivatives used to hedge debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesMember" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateAndCurrencyDerivativesMember" xlink:to="lab_sny_InterestRateAndCurrencyDerivativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PlusHundredBasisPointsMember_5c92a376-0e2a-41b6-aa59-7fc12af731b1_terseLabel_en-US" xlink:label="lab_sny_PlusHundredBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">+100&#160;bp</link:label>
    <link:label id="lab_sny_PlusHundredBasisPointsMember_label_en-US" xlink:label="lab_sny_PlusHundredBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus Hundred Basis Points [Member]</link:label>
    <link:label id="lab_sny_PlusHundredBasisPointsMember_documentation_en-US" xlink:label="lab_sny_PlusHundredBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus hundred basis points.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlusHundredBasisPointsMember" xlink:href="sny-20221231.xsd#sny_PlusHundredBasisPointsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PlusHundredBasisPointsMember" xlink:to="lab_sny_PlusHundredBasisPointsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock_3cbd79a3-bc41-48fb-95fd-96dba065e034_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Principal Investments Accounted for Using the Equity Method</link:label>
    <link:label id="lab_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Investments In Subsidiaries Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Investments In Subsidiaries Explanatory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CumulativeDevelopmentCostsIncurred_75c75750-3316-4c39-8b90-9930b5c8a28c_terseLabel_en-US" xlink:label="lab_sny_CumulativeDevelopmentCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative development costs incurred</link:label>
    <link:label id="lab_sny_CumulativeDevelopmentCostsIncurred_label_en-US" xlink:label="lab_sny_CumulativeDevelopmentCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Development Costs Incurred</link:label>
    <link:label id="lab_sny_CumulativeDevelopmentCostsIncurred_documentation_en-US" xlink:label="lab_sny_CumulativeDevelopmentCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Development Costs Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CumulativeDevelopmentCostsIncurred" xlink:href="sny-20221231.xsd#sny_CumulativeDevelopmentCostsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CumulativeDevelopmentCostsIncurred" xlink:to="lab_sny_CumulativeDevelopmentCostsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_e7349cab-830a-4347-b238-3a9f8b69731c_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories of Financial Assets [Axis]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories of financial assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_c9c02eed-6e8e-4dce-a7a7-a094bd99eccb_terseLabel_en-US" xlink:label="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of outstanding options (in euros per share)</link:label>
    <link:label id="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_label_en-US" xlink:label="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of outstanding share options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:to="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_ba584004-0932-4702-89e9-11d86a1a9135_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shire contingent consideration liability (see Note&#160;D.18.)</link:label>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset_7e39c60b-4bbd-4d72-b59c-dbc82471809a_terseLabel_en-US" xlink:label="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross carrying amounts before offset</link:label>
    <link:label id="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset_label_en-US" xlink:label="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Assets And Liabilities, Gross Carrying Amounts Before Offset</link:label>
    <link:label id="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset_documentation_en-US" xlink:label="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial assets and liabilities gross carrying amounts before offset.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" xlink:to="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInRussianRoubleMember_2677c827-832c-405b-a475-58fd3031b048_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInRussianRoubleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases In Russian Rouble</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInRussianRoubleMember_label_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInRussianRoubleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Russian Rouble [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInRussianRoubleMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInRussianRoubleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Russian Rouble [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInRussianRoubleMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInRussianRoubleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasedInRussianRoubleMember" xlink:to="lab_sny_ForwardCurrencyPurchasedInRussianRoubleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_6cb41049-ea0e-46a3-8e4b-0ab4ab8d2731_negatedLabel_en-US" xlink:label="lab_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and impairment of intangible assets (c)</link:label>
    <link:label id="lab_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization And Impairment Of Intangible Assets Other Than Goodwill</link:label>
    <link:label id="lab_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_documentation_en-US" xlink:label="lab_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and impairment of intangible assets other than goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xlink:href="sny-20221231.xsd#sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xlink:to="lab_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_4c2616cb-7ae3-465e-8862-5b4a3171b641_negatedLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses/(gains) due to changes in demographic assumptions</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_e9ad2566-e686-4c58-97ed-d0c1787c11a0_verboseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains/(losses) on demographic assumptions</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_275db4a0-e69d-44fa-a19e-a79adfdd5123_periodStartLabel_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_c261175d-fa73-462e-b8e5-158403400ab5_periodEndLabel_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_166fbc80-d3c7-442f-a87c-c5b0e1f41f6e_terseLabel_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent consideration payable</link:label>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_label_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities recognised in business combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:to="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_March2018EMTNISINFR0013324332Member_db49159e-f5fa-467e-881d-474e7e26adaf_terseLabel_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324332Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR0013324332</link:label>
    <link:label id="lab_sny_March2018EMTNISINFR0013324332Member_label_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324332Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR0013324332 [Member]</link:label>
    <link:label id="lab_sny_March2018EMTNISINFR0013324332Member_documentation_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324332Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR 0013324332.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324332Member" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324332Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_March2018EMTNISINFR0013324332Member" xlink:to="lab_sny_March2018EMTNISINFR0013324332Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_b6317704-3003-4552-882f-e89f7ef1ecba_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial instruments and market risks</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of derivative financial instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock_1e403d64-f3ba-41a6-9826-3544036fc902_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal and arbitral proceedings</link:label>
    <link:label id="lab_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Legal And Arbitral Proceedings [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Legal And Arbitral Proceedings [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfLegalAndArbitralProceedingsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xlink:to="lab_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems_d65ba887-6cc7-4d3b-9d8f-e3b325f5cd8a_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Income Taxes [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Income Taxes [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems" xlink:to="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital_a705f5e8-fd76-494d-9d78-d2f88e702279_terseLabel_en-US" xlink:label="lab_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exceptional supplementary dividend, percentage of share capital</link:label>
    <link:label id="lab_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital_label_en-US" xlink:label="lab_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exceptional Supplementary Dividend, Percentage Of Share Capital</link:label>
    <link:label id="lab_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital_documentation_en-US" xlink:label="lab_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exceptional Supplementary Dividend, Percentage Of Share Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendPercentageOfShareCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital" xlink:to="lab_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PensionObligationPercentageToDefinedBenefitLiability_cad6193a-01a6-4a37-8310-e1d1aa979580_terseLabel_en-US" xlink:label="lab_sny_PensionObligationPercentageToDefinedBenefitLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension obligation, percentage to defined benefit liability</link:label>
    <link:label id="lab_sny_PensionObligationPercentageToDefinedBenefitLiability_label_en-US" xlink:label="lab_sny_PensionObligationPercentageToDefinedBenefitLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Obligation, Percentage To Defined Benefit Liability</link:label>
    <link:label id="lab_sny_PensionObligationPercentageToDefinedBenefitLiability_documentation_en-US" xlink:label="lab_sny_PensionObligationPercentageToDefinedBenefitLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension obligation percentage to defined benefit liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionObligationPercentageToDefinedBenefitLiability" xlink:href="sny-20221231.xsd#sny_PensionObligationPercentageToDefinedBenefitLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PensionObligationPercentageToDefinedBenefitLiability" xlink:to="lab_sny_PensionObligationPercentageToDefinedBenefitLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BuildingsMember_692d2d5f-fdbf-4acf-9a99-2f37f03ab897_terseLabel_en-US" xlink:label="lab_ifrs-full_BuildingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_ifrs-full_BuildingsMember_label_en-US" xlink:label="lab_ifrs-full_BuildingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BuildingsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember" xlink:to="lab_ifrs-full_BuildingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiForeignParticipationsB.V.Member_cb020e2e-2fc1-404f-a2f4-f4d96e2e674a_terseLabel_en-US" xlink:label="lab_sny_SanofiForeignParticipationsB.V.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Foreign Participations B.V.</link:label>
    <link:label id="lab_sny_SanofiForeignParticipationsB.V.Member_label_en-US" xlink:label="lab_sny_SanofiForeignParticipationsB.V.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Foreign Participations B.V. [Member]</link:label>
    <link:label id="lab_sny_SanofiForeignParticipationsB.V.Member_documentation_en-US" xlink:label="lab_sny_SanofiForeignParticipationsB.V.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Foreign Participations B.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiForeignParticipationsB.V.Member" xlink:href="sny-20221231.xsd#sny_SanofiForeignParticipationsB.V.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiForeignParticipationsB.V.Member" xlink:to="lab_sny_SanofiForeignParticipationsB.V.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsByNameMember_678fc23b-9fd4-42b3-a761-7eaa9d616f2c_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings by name [member]</link:label>
    <link:label id="lab_ifrs-full_BorrowingsByNameMember_label_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings by name [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameMember" xlink:to="lab_ifrs-full_BorrowingsByNameMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MapharMember_48dfd6b8-202c-4aff-832a-46bb883592fa_terseLabel_en-US" xlink:label="lab_sny_MapharMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maphar</link:label>
    <link:label id="lab_sny_MapharMember_label_en-US" xlink:label="lab_sny_MapharMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maphar [Member]</link:label>
    <link:label id="lab_sny_MapharMember_documentation_en-US" xlink:label="lab_sny_MapharMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maphar.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MapharMember" xlink:href="sny-20221231.xsd#sny_MapharMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MapharMember" xlink:to="lab_sny_MapharMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember_8b345282-ae1d-43e5-b450-0344ef14e5b6_terseLabel_en-US" xlink:label="lab_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase of ten percent basis point in market interest rate</link:label>
    <link:label id="lab_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember_label_en-US" xlink:label="lab_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Of Ten Percent Basis Point In Market Interest Rate [Member]</link:label>
    <link:label id="lab_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember_documentation_en-US" xlink:label="lab_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of ten percent basis point in market interest rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember" xlink:href="sny-20221231.xsd#sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember" xlink:to="lab_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiIlacSanayiVeTicaretASMember_4f16a593-24e3-4228-9075-0fdd14145b7b_terseLabel_en-US" xlink:label="lab_sny_SanofiIlacSanayiVeTicaretASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Ilac Sanayi ve Ticaret A.S.</link:label>
    <link:label id="lab_sny_SanofiIlacSanayiVeTicaretASMember_label_en-US" xlink:label="lab_sny_SanofiIlacSanayiVeTicaretASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Ilac Sanayi ve Ticaret A.S. [member]</link:label>
    <link:label id="lab_sny_SanofiIlacSanayiVeTicaretASMember_documentation_en-US" xlink:label="lab_sny_SanofiIlacSanayiVeTicaretASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Ilac Sanayi ve Ticaret A.S.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiIlacSanayiVeTicaretASMember" xlink:href="sny-20221231.xsd#sny_SanofiIlacSanayiVeTicaretASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiIlacSanayiVeTicaretASMember" xlink:to="lab_sny_SanofiIlacSanayiVeTicaretASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_97e66ea8-5727-4e88-8452-b0ceb7b965be_terseLabel_en-US" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains/(losses) excluding investments accounted for using the equity method (see Note&#160;D.19.1.)</link:label>
    <link:label id="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Excluding Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset excluding associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xlink:to="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestIncome_6e6ff3ba-18df-4a45-a446-fa3566cfb41f_terseLabel_en-US" xlink:label="lab_sny_InterestIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_sny_InterestIncome_label_en-US" xlink:label="lab_sny_InterestIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income</link:label>
    <link:label id="lab_sny_InterestIncome_documentation_en-US" xlink:label="lab_sny_InterestIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestIncome" xlink:href="sny-20221231.xsd#sny_InterestIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestIncome" xlink:to="lab_sny_InterestIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_a234268e-880c-4f4c-97cb-619b208da090_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional long-term debt contracted</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from non-current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:to="lab_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_55471094-96f1-4f1d-b838-c95a90b0c1da_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about finance income expense [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Finance Income Expense [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line items represent detailed information about finance income expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xlink:to="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_5bda1015-7754-4de5-bed5-378c9a88e98b_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ImpairmentOfAssetsAbstract_db3b800d-c787-4e0a-a82e-4ce77c27a039_terseLabel_en-US" xlink:label="lab_sny_ImpairmentOfAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Assets [Abstract]</link:label>
    <link:label id="lab_sny_ImpairmentOfAssetsAbstract_label_en-US" xlink:label="lab_sny_ImpairmentOfAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Assets [Abstract]</link:label>
    <link:label id="lab_sny_ImpairmentOfAssetsAbstract_documentation_en-US" xlink:label="lab_sny_ImpairmentOfAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentOfAssetsAbstract" xlink:href="sny-20221231.xsd#sny_ImpairmentOfAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ImpairmentOfAssetsAbstract" xlink:to="lab_sny_ImpairmentOfAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards_6c1e1b02-153a-4cca-841a-e516f27e7468_terseLabel_en-US" xlink:label="lab_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets for tax loss carryforwards</link:label>
    <link:label id="lab_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards_label_en-US" xlink:label="lab_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred Tax Assets For Tax Loss Carryforwards</link:label>
    <link:label id="lab_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards_documentation_en-US" xlink:label="lab_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets for tax loss carryforwards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards" xlink:href="sny-20221231.xsd#sny_TotalDeferredTaxAssetsForTaxLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards" xlink:to="lab_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_25e95285-33fa-4190-bf96-0d7dea86168d_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Income Taxes [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_label_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Income Taxes [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable" xlink:to="lab_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts_12155cc2-bdd5-4a3f-a196-e3a9450d8bc9_terseLabel_en-US" xlink:label="lab_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate number of Regeneron shares that could be sold for cemiplimab and dupilimab funding costs (in shares)</link:label>
    <link:label id="lab_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts_label_en-US" xlink:label="lab_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Number Of Regeneron Shares That Could Be Sold For Cemiplimab And Dupilumab Funding Costs</link:label>
    <link:label id="lab_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts_documentation_en-US" xlink:label="lab_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate number of regeneron shares that could be sold for cemiplimab and dupilumab funding costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts" xlink:href="sny-20221231.xsd#sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts" xlink:to="lab_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities_e0a1140c-b29f-4b6d-959f-98c41b7b597a_terseLabel_en-US" xlink:label="lab_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in other current assets and other current liabilities</link:label>
    <link:label id="lab_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Change In Other Current Assets And Other Current Liabilities</link:label>
    <link:label id="lab_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for decrease (increase) in other current assets and increase (decrease) in other current liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xlink:href="sny-20221231.xsd#sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xlink:to="lab_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialAssets_c30a0810-d9bb-4a25-9611-42c0a24555c0_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current derivative financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDerivativeFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDerivativeFinancialAssets" xlink:to="lab_ifrs-full_CurrentDerivativeFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_cb49d373-8508-483a-9f4d-d3d41a4010e3_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock_725392c0-6570-4702-863e-2dd8fe463d7a_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Trends in Net Income Attributable to Non-Controlling Interests</link:label>
    <link:label id="lab_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Information About The Amounts Attributable To Non Controlling Interests Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Information About The Amounts Attributable To Non Controlling Interests Explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensation_eceb0766-2359-433a-9460-e1718200c57e_totalLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in profit or loss</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensation_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key management personnel compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_9142347d-8e38-4cd4-b90c-16701cd8733f_terseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss recognised in profit or loss, trade receivables</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss recognised in profit or loss, trade receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TwoThousandFourteenAmendedInvestmentAgreementMember_f96d60a4-40b3-40ea-b537-36ce9c0916d6_terseLabel_en-US" xlink:label="lab_sny_TwoThousandFourteenAmendedInvestmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Amended Investment Agreement</link:label>
    <link:label id="lab_sny_TwoThousandFourteenAmendedInvestmentAgreementMember_label_en-US" xlink:label="lab_sny_TwoThousandFourteenAmendedInvestmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Amended Investment Agreement [member]</link:label>
    <link:label id="lab_sny_TwoThousandFourteenAmendedInvestmentAgreementMember_documentation_en-US" xlink:label="lab_sny_TwoThousandFourteenAmendedInvestmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand fourteen amended investment agreement,</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TwoThousandFourteenAmendedInvestmentAgreementMember" xlink:href="sny-20221231.xsd#sny_TwoThousandFourteenAmendedInvestmentAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TwoThousandFourteenAmendedInvestmentAgreementMember" xlink:to="lab_sny_TwoThousandFourteenAmendedInvestmentAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurLimitedMember_47706d22-1f20-4048-92b8-bb44480280f3_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Limited</link:label>
    <link:label id="lab_sny_SanofiPasteurLimitedMember_label_en-US" xlink:label="lab_sny_SanofiPasteurLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Limited [Member]</link:label>
    <link:label id="lab_sny_SanofiPasteurLimitedMember_documentation_en-US" xlink:label="lab_sny_SanofiPasteurLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurLimitedMember" xlink:href="sny-20221231.xsd#sny_SanofiPasteurLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurLimitedMember" xlink:to="lab_sny_SanofiPasteurLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_4a5f42fe-3704-478a-b9da-fe6c5e782f3a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements_7c9695eb-fc55-402a-8502-423fb71077ca_terseLabel_en-US" xlink:label="lab_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regular milestone payments for projects under collaboration agreements</link:label>
    <link:label id="lab_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements_label_en-US" xlink:label="lab_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regular Milestone Payments For Projects Under Collaboration Agreements</link:label>
    <link:label id="lab_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements_documentation_en-US" xlink:label="lab_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regular Milestone Payments For Projects Under Collaboration Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:href="sny-20221231.xsd#sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:to="lab_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions_ea5951d2-343b-4d76-9415-a006421547a3_terseLabel_en-US" xlink:label="lab_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and other expenses (including research expenses)</link:label>
    <link:label id="lab_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions_label_en-US" xlink:label="lab_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of goods, related party transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchasesOfGoodsRelatedPartyTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" xlink:to="lab_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BioverativUSLLCMember_decf590d-8591-417b-b241-35d847a2fca5_terseLabel_en-US" xlink:label="lab_sny_BioverativUSLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ U.S. LLC</link:label>
    <link:label id="lab_sny_BioverativUSLLCMember_label_en-US" xlink:label="lab_sny_BioverativUSLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ US LLC [member]</link:label>
    <link:label id="lab_sny_BioverativUSLLCMember_documentation_en-US" xlink:label="lab_sny_BioverativUSLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ US LLC.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativUSLLCMember" xlink:href="sny-20221231.xsd#sny_BioverativUSLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BioverativUSLLCMember" xlink:to="lab_sny_BioverativUSLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAttributableToOwnersOfParentMember_d3d32636-77f1-4ddf-ad30-b4e6dd1f9e0b_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Attributable to&#160;equity holders of Sanofi&#160;</link:label>
    <link:label id="lab_ifrs-full_EquityAttributableToOwnersOfParentMember_label_en-US" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity attributable to owners of parent [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="lab_ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock_2e7bb3ab-fc9f-4964-87e9-bbcff0e26728_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Changes In Property, Plant And Equipment [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of changes in property, plant and equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock" xlink:to="lab_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths_73198fb0-b3a7-4694-8caf-9961fb6d84cb_terseLabel_en-US" xlink:label="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other provisions, expected utilized amount in 2022</link:label>
    <link:label id="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths_label_en-US" xlink:label="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identified Environmental Risks Provisions Expected Utilized Amount Next Twelve Months</link:label>
    <link:label id="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths_documentation_en-US" xlink:label="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identified environmental risks provisions expected utilized amount next twelve months.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths" xlink:href="sny-20221231.xsd#sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths" xlink:to="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseOfBorrowings_7218e2f0-4b22-4f97-b7ff-606e5220d8a2_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_sny_IncreaseDecreaseOfBorrowings_label_en-US" xlink:label="lab_sny_IncreaseDecreaseOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Of Borrowings</link:label>
    <link:label id="lab_sny_IncreaseDecreaseOfBorrowings_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Of Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseOfBorrowings" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseOfBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseOfBorrowings" xlink:to="lab_sny_IncreaseDecreaseOfBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_5ac6991b-905b-4782-9f67-42fb109c7b88_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MinimumPlan2Member_1ab6b541-9d44-49bb-bddf-8262bc4cc9c7_terseLabel_en-US" xlink:label="lab_sny_MinimumPlan2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum plan 2</link:label>
    <link:label id="lab_sny_MinimumPlan2Member_label_en-US" xlink:label="lab_sny_MinimumPlan2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Plan 2 [Member]</link:label>
    <link:label id="lab_sny_MinimumPlan2Member_documentation_en-US" xlink:label="lab_sny_MinimumPlan2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Plan 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinimumPlan2Member" xlink:href="sny-20221231.xsd#sny_MinimumPlan2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MinimumPlan2Member" xlink:to="lab_sny_MinimumPlan2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PlusTwentyFiveBasisPointsMember_6e9ee67b-76fa-465a-baa4-442430782bfe_terseLabel_en-US" xlink:label="lab_sny_PlusTwentyFiveBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">+25&#160;bp</link:label>
    <link:label id="lab_sny_PlusTwentyFiveBasisPointsMember_label_en-US" xlink:label="lab_sny_PlusTwentyFiveBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus Twenty Five Basis Points [Member]</link:label>
    <link:label id="lab_sny_PlusTwentyFiveBasisPointsMember_documentation_en-US" xlink:label="lab_sny_PlusTwentyFiveBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus twenty five basis points.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlusTwentyFiveBasisPointsMember" xlink:href="sny-20221231.xsd#sny_PlusTwentyFiveBasisPointsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PlusTwentyFiveBasisPointsMember" xlink:to="lab_sny_PlusTwentyFiveBasisPointsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MinusHundredBasisPointsMember_ea123d3e-f3eb-4b02-8cd2-726cabec5db5_terseLabel_en-US" xlink:label="lab_sny_MinusHundredBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-100&#160;bp</link:label>
    <link:label id="lab_sny_MinusHundredBasisPointsMember_label_en-US" xlink:label="lab_sny_MinusHundredBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minus Hundred Basis Points [Member]</link:label>
    <link:label id="lab_sny_MinusHundredBasisPointsMember_documentation_en-US" xlink:label="lab_sny_MinusHundredBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minus hundred basis points.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinusHundredBasisPointsMember" xlink:href="sny-20221231.xsd#sny_MinusHundredBasisPointsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MinusHundredBasisPointsMember" xlink:to="lab_sny_MinusHundredBasisPointsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EvotecMember_59ec63f4-572a-40fe-8191-b5ddecb45e1a_terseLabel_en-US" xlink:label="lab_sny_EvotecMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evotec</link:label>
    <link:label id="lab_sny_EvotecMember_label_en-US" xlink:label="lab_sny_EvotecMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evotec [Member]</link:label>
    <link:label id="lab_sny_EvotecMember_documentation_en-US" xlink:label="lab_sny_EvotecMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evotec.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EvotecMember" xlink:href="sny-20221231.xsd#sny_EvotecMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EvotecMember" xlink:to="lab_sny_EvotecMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_084b9d62-3a63-4ee0-9d17-66c2b5c0081d_negatedLabel_en-US" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and general expenses</link:label>
    <link:label id="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_4bda2a41-c3a9-4630-97aa-b567950ca885_terseLabel_en-US" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and general expenses</link:label>
    <link:label id="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets_97b643a1-d442-40cf-b8f5-1d1f9c50bbc1_terseLabel_en-US" xlink:label="lab_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and other increases</link:label>
    <link:label id="lab_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets_label_en-US" xlink:label="lab_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions Other Than Through Business Combinations, Property, Plant and Equipment, Right Of Use Assets</link:label>
    <link:label id="lab_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets_documentation_en-US" xlink:label="lab_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions Other Than Through Business Combinations, Property, Plant and Equipment, Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets" xlink:href="sny-20221231.xsd#sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets" xlink:to="lab_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_4d3443d2-299e-4221-8359-e9d0c0132a9b_terseLabel_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial interest in principal fully consolidated companies</link:label>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_label_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of ownership interest in subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_bc3aa309-88e5-40b0-b72d-60ee6be32fa6_terseLabel_en-US" xlink:label="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recognised as of acquisition date</link:label>
    <link:label id="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NeurologyImmunologyMember_e8092cb0-1e02-4ef1-952b-e20cd66dda46_terseLabel_en-US" xlink:label="lab_sny_NeurologyImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurology &amp; Immunology</link:label>
    <link:label id="lab_sny_NeurologyImmunologyMember_label_en-US" xlink:label="lab_sny_NeurologyImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurology &amp; Immunology [Member]</link:label>
    <link:label id="lab_sny_NeurologyImmunologyMember_documentation_en-US" xlink:label="lab_sny_NeurologyImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurology &amp; Immunology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NeurologyImmunologyMember" xlink:href="sny-20221231.xsd#sny_NeurologyImmunologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NeurologyImmunologyMember" xlink:to="lab_sny_NeurologyImmunologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SuppliersMember_6fb803f3-3ad9-4687-adfc-7151f142ba4e_terseLabel_en-US" xlink:label="lab_sny_SuppliersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Suppliers</link:label>
    <link:label id="lab_sny_SuppliersMember_label_en-US" xlink:label="lab_sny_SuppliersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Suppliers [Member]</link:label>
    <link:label id="lab_sny_SuppliersMember_documentation_en-US" xlink:label="lab_sny_SuppliersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Suppliers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SuppliersMember" xlink:href="sny-20221231.xsd#sny_SuppliersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SuppliersMember" xlink:to="lab_sny_SuppliersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_JevtanaMember_00325e97-6ae5-42cb-9c11-7421a89a2d33_terseLabel_en-US" xlink:label="lab_sny_JevtanaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jevtana</link:label>
    <link:label id="lab_sny_JevtanaMember_label_en-US" xlink:label="lab_sny_JevtanaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jevtana [Member]</link:label>
    <link:label id="lab_sny_JevtanaMember_documentation_en-US" xlink:label="lab_sny_JevtanaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jevtana.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_JevtanaMember" xlink:href="sny-20221231.xsd#sny_JevtanaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_JevtanaMember" xlink:to="lab_sny_JevtanaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement_e8b426a6-698a-4c96-86bf-23e6f05ef58d_negatedLabel_en-US" xlink:label="lab_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, options cancelled</link:label>
    <link:label id="lab_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Share Options Cancelled In Share Based Payment Arrangement</link:label>
    <link:label id="lab_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Share Options Cancelled In Share Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:to="lab_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiWinthropIndustriesMember_9359f47d-d5ca-4746-8863-53efd6ea2aa3_terseLabel_en-US" xlink:label="lab_sny_SanofiWinthropIndustriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Winthrop Industrie</link:label>
    <link:label id="lab_sny_SanofiWinthropIndustriesMember_label_en-US" xlink:label="lab_sny_SanofiWinthropIndustriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Winthrop Industries [member]</link:label>
    <link:label id="lab_sny_SanofiWinthropIndustriesMember_documentation_en-US" xlink:label="lab_sny_SanofiWinthropIndustriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Winthrop Industries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiWinthropIndustriesMember" xlink:href="sny-20221231.xsd#sny_SanofiWinthropIndustriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiWinthropIndustriesMember" xlink:to="lab_sny_SanofiWinthropIndustriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_e24136ed-a994-47d8-9a9e-cc2e388844ae_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries_97ef997c-06c2-4174-a457-9c574972c978_terseLabel_en-US" xlink:label="lab_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit of the financial statements of the parent company and its French subsidiaries</link:label>
    <link:label id="lab_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries_label_en-US" xlink:label="lab_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Of The Financial Statements Of The Parent Company And Its French Subsidiaries</link:label>
    <link:label id="lab_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries_documentation_en-US" xlink:label="lab_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit of the financial statements of the parent company and its French subsidiaries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" xlink:href="sny-20221231.xsd#sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" xlink:to="lab_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SegmentsAxis_57a0007a-034e-4425-ab29-dbb80118f2c2_terseLabel_en-US" xlink:label="lab_ifrs-full_SegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [axis]</link:label>
    <link:label id="lab_ifrs-full_SegmentsAxis_label_en-US" xlink:label="lab_ifrs-full_SegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentsAxis" xlink:to="lab_ifrs-full_SegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BusinessCombinationsAbstract_120e0749-2a2f-4afc-b7fb-f3fe97e425a9_terseLabel_en-US" xlink:label="lab_sny_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations 1 [Abstract]</link:label>
    <link:label id="lab_sny_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_sny_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_sny_BusinessCombinationsAbstract_documentation_en-US" xlink:label="lab_sny_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BusinessCombinationsAbstract" xlink:to="lab_sny_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GoodwillMember_c1e6263c-5413-4aac-8eda-e144c0af64fe_terseLabel_en-US" xlink:label="lab_ifrs-full_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_ifrs-full_GoodwillMember_label_en-US" xlink:label="lab_ifrs-full_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillMember" xlink:to="lab_ifrs-full_GoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock_184fae1d-4a17-4fa3-8a1a-10030589fce4_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Net Obligation in Respect of Sanofi's Pension and Other Post-Employment Benefit Plans</link:label>
    <link:label id="lab_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Net Defined Benefit Liability Assets Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of net defined benefit liability assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_2a1f0c8e-d287-46e1-9ac9-da969f7e2c08_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial instruments</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for financial instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CommencementOfMajorLitigationMember_e0546c74-40cf-4796-adf4-a042795d7394_terseLabel_en-US" xlink:label="lab_ifrs-full_CommencementOfMajorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commencement of major litigation [member]</link:label>
    <link:label id="lab_ifrs-full_CommencementOfMajorLitigationMember_label_en-US" xlink:label="lab_ifrs-full_CommencementOfMajorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commencement of major litigation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommencementOfMajorLitigationMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CommencementOfMajorLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CommencementOfMajorLitigationMember" xlink:to="lab_ifrs-full_CommencementOfMajorLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RestrictedSharePlan2022Member_65726a79-d65e-421a-bb54-2bdec527d1ba_terseLabel_en-US" xlink:label="lab_sny_RestrictedSharePlan2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plan 2022</link:label>
    <link:label id="lab_sny_RestrictedSharePlan2022Member_label_en-US" xlink:label="lab_sny_RestrictedSharePlan2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plan 2022 [Member]</link:label>
    <link:label id="lab_sny_RestrictedSharePlan2022Member_documentation_en-US" xlink:label="lab_sny_RestrictedSharePlan2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plan 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2022Member" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharePlan2022Member" xlink:to="lab_sny_RestrictedSharePlan2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OthersCounterpartyMember_a6142751-f8eb-47df-a9b0-7f734ab9b677_terseLabel_en-US" xlink:label="lab_sny_OthersCounterpartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others</link:label>
    <link:label id="lab_sny_OthersCounterpartyMember_label_en-US" xlink:label="lab_sny_OthersCounterpartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others Counterparty [Member]</link:label>
    <link:label id="lab_sny_OthersCounterpartyMember_documentation_en-US" xlink:label="lab_sny_OthersCounterpartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others Counterparty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OthersCounterpartyMember" xlink:href="sny-20221231.xsd#sny_OthersCounterpartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OthersCounterpartyMember" xlink:to="lab_sny_OthersCounterpartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencySalesMember_df6ee0a7-ae2e-46a5-9ca3-25fb6b296f5d_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencySalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesMember_label_en-US" xlink:label="lab_sny_ForwardCurrencySalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencySalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesMember" xlink:to="lab_sny_ForwardCurrencySalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AtNotionalAmountMember_a7c5aece-2100-4c77-a95c-52ae1aef1118_terseLabel_en-US" xlink:label="lab_sny_AtNotionalAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_sny_AtNotionalAmountMember_label_en-US" xlink:label="lab_sny_AtNotionalAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At Notional Amount [member]</link:label>
    <link:label id="lab_sny_AtNotionalAmountMember_documentation_en-US" xlink:label="lab_sny_AtNotionalAmountMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At notional amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtNotionalAmountMember" xlink:href="sny-20221231.xsd#sny_AtNotionalAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AtNotionalAmountMember" xlink:to="lab_sny_AtNotionalAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_a789aa91-bd3c-4aea-9655-10f56604b08b_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options granted (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of instruments granted in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity_a269f20b-fb52-46c4-aa26-7d37bc583f86_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through other changes, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinanceCosts_c668b94a-5f74-46d1-b736-463150aeeb32_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_FinanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial expenses</link:label>
    <link:label id="lab_ifrs-full_FinanceCosts_1af97830-ddf1-4fe7-8247-0f397965da4b_terseLabel_en-US" xlink:label="lab_ifrs-full_FinanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial expenses</link:label>
    <link:label id="lab_ifrs-full_FinanceCosts_8e89d423-91dc-4129-bfb4-31f360821435_negatedLabel_en-US" xlink:label="lab_ifrs-full_FinanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">comprising: Financial expenses</link:label>
    <link:label id="lab_ifrs-full_FinanceCosts_label_en-US" xlink:label="lab_ifrs-full_FinanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts" xlink:to="lab_ifrs-full_FinanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_fd486416-bf35-4a4d-b45d-db772cbce04a_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3&#160;to&#160;6&#160;months</link:label>
    <link:label id="lab_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than three months and not later than six months [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:to="lab_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiManufacturingPteLtdMember_1ac339a0-40cc-4c56-9be2-bef04458ea76_terseLabel_en-US" xlink:label="lab_sny_SanofiManufacturingPteLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Manufacturing Pte Ltd</link:label>
    <link:label id="lab_sny_SanofiManufacturingPteLtdMember_label_en-US" xlink:label="lab_sny_SanofiManufacturingPteLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Manufacturing Pte Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiManufacturingPteLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiManufacturingPteLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Manufacturing Pte Ltd</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiManufacturingPteLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiManufacturingPteLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiManufacturingPteLtdMember" xlink:to="lab_sny_SanofiManufacturingPteLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals_fbeeca0c-5e32-445c-bec5-395ae16a48b2_terseLabel_en-US" xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related liabilities</link:label>
    <link:label id="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals_label_en-US" xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term employee benefits accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:to="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities_d093425d-66e5-4e5f-8609-935612fe46dc_verboseLabel_en-US" xlink:label="lab_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends received from non-consolidated entities</link:label>
    <link:label id="lab_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities_label_en-US" xlink:label="lab_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Received from Non-consolidated Entities Classified As Operating Activities</link:label>
    <link:label id="lab_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities_documentation_en-US" xlink:label="lab_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends received from non-consolidated entities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities" xlink:href="sny-20221231.xsd#sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities" xlink:to="lab_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_74cb8846-c1e4-4dd3-a9e5-969e7638c95e_negatedLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax position</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_58d1c9f3-d953-469b-b16b-f4a14187e65f_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherMovements_1298eaae-3c76-4f3f-ab10-6c4e147ddbf9_negatedTerseLabel_en-US" xlink:label="lab_sny_OtherMovements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other movements</link:label>
    <link:label id="lab_sny_OtherMovements_label_en-US" xlink:label="lab_sny_OtherMovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Movements</link:label>
    <link:label id="lab_sny_OtherMovements_documentation_en-US" xlink:label="lab_sny_OtherMovements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other movements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherMovements" xlink:href="sny-20221231.xsd#sny_OtherMovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherMovements" xlink:to="lab_sny_OtherMovements" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PlanAssetsMember_b312730d-d546-4bf8-baf4-d680381e7482_terseLabel_en-US" xlink:label="lab_ifrs-full_PlanAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets</link:label>
    <link:label id="lab_ifrs-full_PlanAssetsMember_label_en-US" xlink:label="lab_ifrs-full_PlanAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlanAssetsMember" xlink:to="lab_ifrs-full_PlanAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_59847f85-cf20-4b9d-826a-d5a9a7d9397b_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 5</link:label>
    <link:label id="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_71110f3a-99b4-4db8-8ecb-c874dc1d0156_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4 to 5 years</link:label>
    <link:label id="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than four years and not later than five years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_e6666da7-8761-4c1e-8c91-05140346ba5b_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FabrazymeMember_6cecbc59-2840-4575-9c41-5ace5cd416d4_terseLabel_en-US" xlink:label="lab_sny_FabrazymeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fabrazyme</link:label>
    <link:label id="lab_sny_FabrazymeMember_label_en-US" xlink:label="lab_sny_FabrazymeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fabrazyme [Member]</link:label>
    <link:label id="lab_sny_FabrazymeMember_documentation_en-US" xlink:label="lab_sny_FabrazymeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fabrazyme [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FabrazymeMember" xlink:href="sny-20221231.xsd#sny_FabrazymeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FabrazymeMember" xlink:to="lab_sny_FabrazymeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_4fe91f99-1bff-4d74-98b0-7bffcabcc903_terseLabel_en-US" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value (excluding investments accounted for using the equity method)</link:label>
    <link:label id="lab_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value On Equity Instruments Excluding Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value On Equity Instruments Excluding Associates And Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SaleOfStockPricePerShare_bb9715c6-cc37-4c4e-b86a-f7b74b49dce8_terseLabel_en-US" xlink:label="lab_sny_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, price per share (in USD per share)</link:label>
    <link:label id="lab_sny_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_sny_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Price Per Share</link:label>
    <link:label id="lab_sny_SaleOfStockPricePerShare_documentation_en-US" xlink:label="lab_sny_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockPricePerShare" xlink:href="sny-20221231.xsd#sny_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SaleOfStockPricePerShare" xlink:to="lab_sny_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfInventoriesTable_5ae4926d-2413-4f77-9c29-524f5ecc2de6_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfInventoriesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of inventories [table]</link:label>
    <link:label id="lab_sny_DisclosureOfInventoriesTable_label_en-US" xlink:label="lab_sny_DisclosureOfInventoriesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Inventories [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfInventoriesTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfInventoriesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of inventories.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInventoriesTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfInventoriesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInventoriesTable" xlink:to="lab_sny_DisclosureOfInventoriesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockSubscriptionOptionPlanTenMember_910a5656-52df-4aff-9ddb-b7754c7197cd_terseLabel_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanTenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan ten</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanTenMember_label_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanTenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Subscription Option Plan Ten [Member]</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanTenMember_documentation_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanTenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan ten.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanTenMember" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanTenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockSubscriptionOptionPlanTenMember" xlink:to="lab_sny_StockSubscriptionOptionPlanTenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock_94ff8117-05a9-4cb2-bccc-6573909ce11b_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Movements Share Capital</link:label>
    <link:label id="lab_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Statement Of Changes In Equity Of Parent [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of statement of changes in equity of parent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock" xlink:to="lab_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c6bc14be-6078-469d-ab65-f4f8f7fec19e_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations_2c21097a-b651-4223-af09-753492ed34ea_terseLabel_en-US" xlink:label="lab_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of profits and losses arising from commercial operations</link:label>
    <link:label id="lab_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations_label_en-US" xlink:label="lab_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Profits And Losses Arising From Commercial Operations</link:label>
    <link:label id="lab_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations_documentation_en-US" xlink:label="lab_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of profits and losses arising from commercial operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations" xlink:to="lab_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FinancialInvestments_ca37aeee-8f27-4a17-b442-ec5f7ef9d60c_terseLabel_en-US" xlink:label="lab_sny_FinancialInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial investments</link:label>
    <link:label id="lab_sny_FinancialInvestments_label_en-US" xlink:label="lab_sny_FinancialInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Investments</link:label>
    <link:label id="lab_sny_FinancialInvestments_documentation_en-US" xlink:label="lab_sny_FinancialInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of financial assets that are classified as financial assets available-for-sale, held-to-maturity investments or loans and receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInvestments" xlink:href="sny-20221231.xsd#sny_FinancialInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FinancialInvestments" xlink:to="lab_sny_FinancialInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_91b23e55-972e-4e78-8c31-4cd10188e205_terseLabel_en-US" xlink:label="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of contributions expected to be paid to plan for next annual reporting period</link:label>
    <link:label id="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_label_en-US" xlink:label="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of contributions expected to be paid to plan for next annual reporting period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:to="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_bfab104a-703f-400b-b89c-f9ce6724b148_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumption of discount rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:to="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareUKLimitedMember_c1806aab-bd19-4dea-9406-c2dfdf934821_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareUKLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare UK Limited</link:label>
    <link:label id="lab_sny_OpellaHealthcareUKLimitedMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareUKLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare UK Limited [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareUKLimitedMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareUKLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare UK Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareUKLimitedMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareUKLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareUKLimitedMember" xlink:to="lab_sny_OpellaHealthcareUKLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_WriteDownMember_3984561c-6e58-4e85-8772-f6566ff4dde0_terseLabel_en-US" xlink:label="lab_sny_WriteDownMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances</link:label>
    <link:label id="lab_sny_WriteDownMember_label_en-US" xlink:label="lab_sny_WriteDownMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-down [member]</link:label>
    <link:label id="lab_sny_WriteDownMember_documentation_en-US" xlink:label="lab_sny_WriteDownMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write down.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WriteDownMember" xlink:href="sny-20221231.xsd#sny_WriteDownMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_WriteDownMember" xlink:to="lab_sny_WriteDownMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DepreciationExpense_477e42e9-6f02-446d-9098-a5bca0882f77_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_DepreciationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_ifrs-full_DepreciationExpense_label_en-US" xlink:label="lab_ifrs-full_DepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationExpense" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationExpense" xlink:to="lab_ifrs-full_DepreciationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MajorCustomersAxis_0c50f9e0-6e77-4d77-8ce9-38cbc2b09473_terseLabel_en-US" xlink:label="lab_ifrs-full_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customers [axis]</link:label>
    <link:label id="lab_ifrs-full_MajorCustomersAxis_label_en-US" xlink:label="lab_ifrs-full_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customers [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorCustomersAxis" xlink:to="lab_ifrs-full_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisRechercheEtDeveloppementMember_ad7ea9c5-c2fa-4d0a-a03f-21ff1e579a2f_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisRechercheEtDeveloppementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Recherche &amp; D&#233;veloppement</link:label>
    <link:label id="lab_sny_SanofiAventisRechercheEtDeveloppementMember_label_en-US" xlink:label="lab_sny_SanofiAventisRechercheEtDeveloppementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Recherche Et Developpement [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisRechercheEtDeveloppementMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisRechercheEtDeveloppementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi aventis Recherche et Developpement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisRechercheEtDeveloppementMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisRechercheEtDeveloppementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisRechercheEtDeveloppementMember" xlink:to="lab_sny_SanofiAventisRechercheEtDeveloppementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_b52c3311-0613-4b15-9e6f-4214bda8060c_negatedLabel_en-US" xlink:label="lab_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments made</link:label>
    <link:label id="lab_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_label_en-US" xlink:label="lab_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled liabilities, contingent liabilities recognised in business combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:to="lab_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PaymentRelatedToAttainmentOfGoal_0044804f-e9bb-4993-a2e2-d2b1fa314c36_terseLabel_en-US" xlink:label="lab_sny_PaymentRelatedToAttainmentOfGoal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment related to attainment of goal</link:label>
    <link:label id="lab_sny_PaymentRelatedToAttainmentOfGoal_label_en-US" xlink:label="lab_sny_PaymentRelatedToAttainmentOfGoal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Related To Attainment Of Goal</link:label>
    <link:label id="lab_sny_PaymentRelatedToAttainmentOfGoal_documentation_en-US" xlink:label="lab_sny_PaymentRelatedToAttainmentOfGoal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Related To Attainment Of Goal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentRelatedToAttainmentOfGoal" xlink:href="sny-20221231.xsd#sny_PaymentRelatedToAttainmentOfGoal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PaymentRelatedToAttainmentOfGoal" xlink:to="lab_sny_PaymentRelatedToAttainmentOfGoal" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityAbstract_d92bfce7-014e-4701-add4-77f3815d1be2_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of changes in equity [abstract]</link:label>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of changes in equity [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_GBP_53568b3a-f8fb-4bec-a009-5c87af8e9b2d_terseLabel_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pound sterling</link:label>
    <link:label id="lab_currency_GBP_label_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_GBP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP" xlink:to="lab_currency_GBP" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsOnDisposalsOfNoncurrentAssets_dfe0ec28-9a1e-4af8-bea3-e3504a97ca6d_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsOnDisposalsOfNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on disposal of non-current assets, net of tax</link:label>
    <link:label id="lab_ifrs-full_GainsOnDisposalsOfNoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_GainsOnDisposalsOfNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on disposals of non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnDisposalsOfNoncurrentAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsOnDisposalsOfNoncurrentAssets" xlink:to="lab_ifrs-full_GainsOnDisposalsOfNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MiscellaneousOtherOperatingIncome_b977c97b-a923-46c7-849e-a37e618ab4cd_terseLabel_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income</link:label>
    <link:label id="lab_ifrs-full_MiscellaneousOtherOperatingIncome_label_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous other operating income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousOtherOperatingIncome" xlink:to="lab_ifrs-full_MiscellaneousOtherOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeLineItems_41e2c966-4709-4338-934a-4d136134ad64_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Operating Income [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Operating Income [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Operating Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeLineItems" xlink:to="lab_sny_DisclosureOfOtherOperatingIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod_bfbc541f-3d24-4e7f-bc1f-68aedfed8edf_terseLabel_en-US" xlink:label="lab_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in provisions recognized in profit or loss for the period</link:label>
    <link:label id="lab_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod_label_en-US" xlink:label="lab_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Provisions Recognized In Profit Or Loss For The Period</link:label>
    <link:label id="lab_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod_documentation_en-US" xlink:label="lab_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in provisions recognized in profit or loss for the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod" xlink:href="sny-20221231.xsd#sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod" xlink:to="lab_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentLiabilities_8b7822a5-65c7-4437-9023-936d3eb6feb5_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentLiabilities_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities" xlink:to="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PaymentToSaleOfBusinessPeriod_7fdb7a9d-1df4-4151-91cb-3b993fa39034_terseLabel_en-US" xlink:label="lab_sny_PaymentToSaleOfBusinessPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to sale of business period</link:label>
    <link:label id="lab_sny_PaymentToSaleOfBusinessPeriod_label_en-US" xlink:label="lab_sny_PaymentToSaleOfBusinessPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment To Sale Of Business Period</link:label>
    <link:label id="lab_sny_PaymentToSaleOfBusinessPeriod_documentation_en-US" xlink:label="lab_sny_PaymentToSaleOfBusinessPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to sale of business period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentToSaleOfBusinessPeriod" xlink:href="sny-20221231.xsd#sny_PaymentToSaleOfBusinessPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PaymentToSaleOfBusinessPeriod" xlink:to="lab_sny_PaymentToSaleOfBusinessPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_391851ee-a95d-44eb-80e7-a781628a76d4_terseLabel_en-US" xlink:label="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from payments from plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax_054f225d-6249-4067-8210-ec3ac799cd02_terseLabel_en-US" xlink:label="lab_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of debt instruments included in financial assets</link:label>
    <link:label id="lab_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax_label_en-US" xlink:label="lab_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) On Remeasuring Debt Instruments, Before Tax</link:label>
    <link:label id="lab_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax_documentation_en-US" xlink:label="lab_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) On Remeasuring Debt Instruments, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xlink:href="sny-20221231.xsd#sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xlink:to="lab_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs_bab0d1a3-c85c-4d13-b64d-26f4783a2134_terseLabel_en-US" xlink:label="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduced amount of compensation claimed</link:label>
    <link:label id="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs_label_en-US" xlink:label="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduced Amount Of Compensation Claimed By Filled Plaintiffs</link:label>
    <link:label id="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs_documentation_en-US" xlink:label="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduced Amount Of Compensation Claimed By Filled Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs" xlink:href="sny-20221231.xsd#sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs" xlink:to="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty_a4b7ca2a-46d0-478e-80db-db2c1fac3160_terseLabel_en-US" xlink:label="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase III costs, responsibility percentage for Regeneron</link:label>
    <link:label id="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty_label_en-US" xlink:label="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Second Part Of Development Costs Funded By Other Party</link:label>
    <link:label id="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty_documentation_en-US" xlink:label="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of second part of development costs funded by other party.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty" xlink:href="sny-20221231.xsd#sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty" xlink:to="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CarraigInsuranceDACMember_3970ab03-545b-465d-bdec-01b144493694_terseLabel_en-US" xlink:label="lab_sny_CarraigInsuranceDACMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carraig Insurance DAC</link:label>
    <link:label id="lab_sny_CarraigInsuranceDACMember_label_en-US" xlink:label="lab_sny_CarraigInsuranceDACMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carraig Insurance DAC [member]</link:label>
    <link:label id="lab_sny_CarraigInsuranceDACMember_documentation_en-US" xlink:label="lab_sny_CarraigInsuranceDACMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carraig Insurance DAC.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CarraigInsuranceDACMember" xlink:href="sny-20221231.xsd#sny_CarraigInsuranceDACMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CarraigInsuranceDACMember" xlink:to="lab_sny_CarraigInsuranceDACMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalMarketedProductsBioverativMember_703d37dc-2539-4acf-96ec-20118239db4d_terseLabel_en-US" xlink:label="lab_sny_PrincipalMarketedProductsBioverativMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsBioverativMember_label_en-US" xlink:label="lab_sny_PrincipalMarketedProductsBioverativMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products Bioverativ [Member]</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsBioverativMember_documentation_en-US" xlink:label="lab_sny_PrincipalMarketedProductsBioverativMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products Bioverativ</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsBioverativMember" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsBioverativMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalMarketedProductsBioverativMember" xlink:to="lab_sny_PrincipalMarketedProductsBioverativMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems_495ea704-d4b6-4ed3-a546-e5a49d26d5a9_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other provisions [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other provisions [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EntitysTotalForJointVenturesMember_ce4d996a-f9ea-41fd-92f2-0fa13c959ac4_terseLabel_en-US" xlink:label="lab_ifrs-full_EntitysTotalForJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for joint ventures</link:label>
    <link:label id="lab_ifrs-full_EntitysTotalForJointVenturesMember_label_en-US" xlink:label="lab_ifrs-full_EntitysTotalForJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for joint ventures [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember" xlink:to="lab_ifrs-full_EntitysTotalForJointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_2d794186-43f8-457a-85d8-701d1a3f6b48_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1832ddac-c4ee-46f3-aaee-03fe9567066a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Results</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of operating segments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RoyaltyIncomePercentage_d0792a35-7b3b-4e62-8e0c-b4d98c5f8c26_terseLabel_en-US" xlink:label="lab_sny_RoyaltyIncomePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty income percentage (percentage)</link:label>
    <link:label id="lab_sny_RoyaltyIncomePercentage_label_en-US" xlink:label="lab_sny_RoyaltyIncomePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Income, Percentage</link:label>
    <link:label id="lab_sny_RoyaltyIncomePercentage_documentation_en-US" xlink:label="lab_sny_RoyaltyIncomePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Income, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltyIncomePercentage" xlink:href="sny-20221231.xsd#sny_RoyaltyIncomePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RoyaltyIncomePercentage" xlink:to="lab_sny_RoyaltyIncomePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfComplaintsFiled_85e7668a-fe32-4188-a148-76d77e885442_terseLabel_en-US" xlink:label="lab_sny_NumberOfComplaintsFiled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of complaints filed</link:label>
    <link:label id="lab_sny_NumberOfComplaintsFiled_label_en-US" xlink:label="lab_sny_NumberOfComplaintsFiled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Complaints Filed</link:label>
    <link:label id="lab_sny_NumberOfComplaintsFiled_documentation_en-US" xlink:label="lab_sny_NumberOfComplaintsFiled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Complaints Filed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfComplaintsFiled" xlink:href="sny-20221231.xsd#sny_NumberOfComplaintsFiled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfComplaintsFiled" xlink:to="lab_sny_NumberOfComplaintsFiled" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome_4c310fed-8928-475b-99be-994b54488422_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instruments at fair value through other comprehensive income</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets at fair value through other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_cfccc254-65c3-465e-bd97-6943c0b8a8a2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other operating expense [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod_d9a0006e-22eb-4397-8fdf-95bdf0bba30a_terseLabel_en-US" xlink:label="lab_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of operating expenses and cost of production to joint partner payable period</link:label>
    <link:label id="lab_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod_label_en-US" xlink:label="lab_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Of Operating Expenses And Cost Of Production To Joint Partner Payable Period</link:label>
    <link:label id="lab_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod_documentation_en-US" xlink:label="lab_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of operating expenses and cost of producion to joint partner payable period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod" xlink:href="sny-20221231.xsd#sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod" xlink:to="lab_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember_4090f35b-f425-49a6-b8cf-9146f959c282_terseLabel_en-US" xlink:label="lab_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Euro and US dollar short-term interest rates</link:label>
    <link:label id="lab_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember_label_en-US" xlink:label="lab_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Euro And US Dollar Short-term Interest Rates [Member]</link:label>
    <link:label id="lab_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember_documentation_en-US" xlink:label="lab_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Euro and US dollar short-term interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember" xlink:href="sny-20221231.xsd#sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember" xlink:to="lab_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DefendantsMember_e52f3b65-edb5-4876-a4eb-26b56480e4ff_terseLabel_en-US" xlink:label="lab_sny_DefendantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defendants [Member]</link:label>
    <link:label id="lab_sny_DefendantsMember_label_en-US" xlink:label="lab_sny_DefendantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defendants [Member]</link:label>
    <link:label id="lab_sny_DefendantsMember_documentation_en-US" xlink:label="lab_sny_DefendantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defendant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefendantsMember" xlink:href="sny-20221231.xsd#sny_DefendantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DefendantsMember" xlink:to="lab_sny_DefendantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_846c0b63-a82f-4875-bc95-8df12f23ec6a_terseLabel_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined-benefit plans</link:label>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-employment benefit expense in profit or loss, defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisCanadaIncMember_e649bb49-0d09-443f-a0aa-3af0b119630e_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisCanadaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Canada Inc.</link:label>
    <link:label id="lab_sny_SanofiAventisCanadaIncMember_label_en-US" xlink:label="lab_sny_SanofiAventisCanadaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Canada Inc [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisCanadaIncMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisCanadaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Canada Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisCanadaIncMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisCanadaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisCanadaIncMember" xlink:to="lab_sny_SanofiAventisCanadaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SalesOfAntibodiesFirstAchievementMember_748c84d9-b2cc-4f56-8e92-afc604fb0afd_terseLabel_en-US" xlink:label="lab_sny_SalesOfAntibodiesFirstAchievementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of antibodies, first achievement</link:label>
    <link:label id="lab_sny_SalesOfAntibodiesFirstAchievementMember_label_en-US" xlink:label="lab_sny_SalesOfAntibodiesFirstAchievementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Of Antibodies, First Achievement [Member]</link:label>
    <link:label id="lab_sny_SalesOfAntibodiesFirstAchievementMember_documentation_en-US" xlink:label="lab_sny_SalesOfAntibodiesFirstAchievementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Of Antibodies, First Achievement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesOfAntibodiesFirstAchievementMember" xlink:href="sny-20221231.xsd#sny_SalesOfAntibodiesFirstAchievementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SalesOfAntibodiesFirstAchievementMember" xlink:to="lab_sny_SalesOfAntibodiesFirstAchievementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CambridgeMassachusettsMember_d7ea8708-e691-4bfe-90ab-6c51755866f4_terseLabel_en-US" xlink:label="lab_sny_CambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cambridge, Massachusetts</link:label>
    <link:label id="lab_sny_CambridgeMassachusettsMember_label_en-US" xlink:label="lab_sny_CambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cambridge, Massachusetts [Member]</link:label>
    <link:label id="lab_sny_CambridgeMassachusettsMember_documentation_en-US" xlink:label="lab_sny_CambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cambridge, Massachusetts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CambridgeMassachusettsMember" xlink:href="sny-20221231.xsd#sny_CambridgeMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CambridgeMassachusettsMember" xlink:to="lab_sny_CambridgeMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NotEligibleForHedgeAccountingMember_bec26258-022c-4024-a49c-0a9802ee3470_terseLabel_en-US" xlink:label="lab_sny_NotEligibleForHedgeAccountingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not eligible for hedge accounting</link:label>
    <link:label id="lab_sny_NotEligibleForHedgeAccountingMember_label_en-US" xlink:label="lab_sny_NotEligibleForHedgeAccountingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Eligible For Hedge Accounting [Member]</link:label>
    <link:label id="lab_sny_NotEligibleForHedgeAccountingMember_documentation_en-US" xlink:label="lab_sny_NotEligibleForHedgeAccountingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not eligible for hedge accounting.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NotEligibleForHedgeAccountingMember" xlink:href="sny-20221231.xsd#sny_NotEligibleForHedgeAccountingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NotEligibleForHedgeAccountingMember" xlink:to="lab_sny_NotEligibleForHedgeAccountingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_99cae4ac-1e58-478f-bf05-71a13c084abb_terseLabel_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible increase in actuarial assumption</link:label>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_label_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of reasonably possible increase in actuarial assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1_b4a94441-ef07-4c35-810c-f6a573a8de9b_terseLabel_en-US" xlink:label="lab_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual agreement for anti-programmed cell death protein</link:label>
    <link:label id="lab_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1_label_en-US" xlink:label="lab_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Agreement For Anti-programmed Cell Death Protein1</link:label>
    <link:label id="lab_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1_documentation_en-US" xlink:label="lab_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Agreement For Anti-programmed Cell Death Protein1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1" xlink:href="sny-20221231.xsd#sny_ContractualAgreementForAntiProgrammedCellDeathProtein1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1" xlink:to="lab_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfLegalAndArbitralProceedingsTable_4fdafbaa-0dd2-453d-94d7-e6c9370d964f_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Legal and Arbitral Proceedings [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfLegalAndArbitralProceedingsTable_label_en-US" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Legal And Arbitral Proceedings [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfLegalAndArbitralProceedingsTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of legal and arbitral proceedings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfLegalAndArbitralProceedingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable" xlink:to="lab_sny_DisclosureOfLegalAndArbitralProceedingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CashAndCashEquivalentsMember_d22b34f9-551f-45b3-be09-c0b2b9142b35_terseLabel_en-US" xlink:label="lab_sny_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_sny_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_sny_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents [Member]</link:label>
    <link:label id="lab_sny_CashAndCashEquivalentsMember_documentation_en-US" xlink:label="lab_sny_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashAndCashEquivalentsMember" xlink:href="sny-20221231.xsd#sny_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CashAndCashEquivalentsMember" xlink:to="lab_sny_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_QuotedEuroDenominatedSeniorBondsMember_9c786337-2bc1-416d-b2d2-72c7d09b62f9_terseLabel_en-US" xlink:label="lab_sny_QuotedEuroDenominatedSeniorBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted euro denominated senior bonds</link:label>
    <link:label id="lab_sny_QuotedEuroDenominatedSeniorBondsMember_label_en-US" xlink:label="lab_sny_QuotedEuroDenominatedSeniorBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Euro Denominated Senior Bonds [Member]</link:label>
    <link:label id="lab_sny_QuotedEuroDenominatedSeniorBondsMember_documentation_en-US" xlink:label="lab_sny_QuotedEuroDenominatedSeniorBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted euro denominated senior bonds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedEuroDenominatedSeniorBondsMember" xlink:href="sny-20221231.xsd#sny_QuotedEuroDenominatedSeniorBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_QuotedEuroDenominatedSeniorBondsMember" xlink:to="lab_sny_QuotedEuroDenominatedSeniorBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncome_dcca6c90-4a38-4802-adac-740d87d97827_terseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax expense</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncome_779ec7ef-7c98-462a-bc76-1513848b1cb3_negatedLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncome_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowHedgesMember_d5619592-a982-4973-b72f-f1eb321fd954_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges</link:label>
    <link:label id="lab_ifrs-full_CashFlowHedgesMember_label_en-US" xlink:label="lab_ifrs-full_CashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowHedgesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowHedgesMember" xlink:to="lab_ifrs-full_CashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates_01670f12-07b5-4f9b-9ee4-c4fe1802c085_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare cost inflation rate(d)</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumption of medical cost trend rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates" xlink:to="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_4e91149d-e72c-4914-afb3-b616f74059d8_terseLabel_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused tax losses for which no deferred tax asset recognised</link:label>
    <link:label id="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_label_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused tax losses for which no deferred tax asset recognised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:to="lab_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock_a83fcd4a-4122-4366-b205-cd7a10a378ca_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes</link:label>
    <link:label id="lab_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Allocation Of Income Tax Between Current And Deferred Taxes [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of allocation of income tax between current and deferred taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xlink:to="lab_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LegalAndArbitralProceedingsDomain_b8aa845b-fa8a-40f1-b35d-1c0d94976776_terseLabel_en-US" xlink:label="lab_sny_LegalAndArbitralProceedingsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal And Arbitral Proceedings [Domain]</link:label>
    <link:label id="lab_sny_LegalAndArbitralProceedingsDomain_label_en-US" xlink:label="lab_sny_LegalAndArbitralProceedingsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal And Arbitral Proceedings [Domain]</link:label>
    <link:label id="lab_sny_LegalAndArbitralProceedingsDomain_documentation_en-US" xlink:label="lab_sny_LegalAndArbitralProceedingsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Legal And Arbitral Proceedings [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LegalAndArbitralProceedingsDomain" xlink:href="sny-20221231.xsd#sny_LegalAndArbitralProceedingsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain" xlink:to="lab_sny_LegalAndArbitralProceedingsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommercialPaperProgramInUSAMember_03225eae-f941-4520-9a15-301fb769a259_terseLabel_en-US" xlink:label="lab_sny_CommercialPaperProgramInUSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper program in USA</link:label>
    <link:label id="lab_sny_CommercialPaperProgramInUSAMember_label_en-US" xlink:label="lab_sny_CommercialPaperProgramInUSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program In USA [Member]</link:label>
    <link:label id="lab_sny_CommercialPaperProgramInUSAMember_documentation_en-US" xlink:label="lab_sny_CommercialPaperProgramInUSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper program in USA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommercialPaperProgramInUSAMember" xlink:href="sny-20221231.xsd#sny_CommercialPaperProgramInUSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommercialPaperProgramInUSAMember" xlink:to="lab_sny_CommercialPaperProgramInUSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrencyDerivativesMeasuredAtFairValue_1e6ef40f-c7e0-4233-b998-1c0a49e35b88_terseLabel_en-US" xlink:label="lab_sny_CurrencyDerivativesMeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency derivatives measured at fair value (see Note&#160;D.20.)</link:label>
    <link:label id="lab_sny_CurrencyDerivativesMeasuredAtFairValue_label_en-US" xlink:label="lab_sny_CurrencyDerivativesMeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Derivatives Measured At Fair Value</link:label>
    <link:label id="lab_sny_CurrencyDerivativesMeasuredAtFairValue_documentation_en-US" xlink:label="lab_sny_CurrencyDerivativesMeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency derivatives measured at fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesMeasuredAtFairValue" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesMeasuredAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrencyDerivativesMeasuredAtFairValue" xlink:to="lab_sny_CurrencyDerivativesMeasuredAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember_2e96fa31-d827-4108-b3d0-a37116784f1c_terseLabel_en-US" xlink:label="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for business combinations</link:label>
    <link:label id="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember_label_en-US" xlink:label="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for business combinations [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:to="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares_7b92b140-7997-457a-afb0-71915899066b_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted shares and vesting of existing restricted shares</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Share-Based Payment Plans Issuance Of Restricted Shares And Vesting Of Existing Restricted Shares</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through share-based payment plans issuance of restricted shares and vesting of existing restricted shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xlink:to="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_a23cab62-fc30-4b1d-bcf3-3bd81659da0b_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CerezymeMember_33b8c269-f5db-4d98-b712-5035dc007d5f_terseLabel_en-US" xlink:label="lab_sny_CerezymeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cerezyme</link:label>
    <link:label id="lab_sny_CerezymeMember_label_en-US" xlink:label="lab_sny_CerezymeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cerezyme [Member]</link:label>
    <link:label id="lab_sny_CerezymeMember_documentation_en-US" xlink:label="lab_sny_CerezymeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cerezyme.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CerezymeMember" xlink:href="sny-20221231.xsd#sny_CerezymeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CerezymeMember" xlink:to="lab_sny_CerezymeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember_46db3801-e82f-42dc-bd19-2559da979881_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate and currency derivatives used to manage debt</link:label>
    <link:label id="lab_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember_label_en-US" xlink:label="lab_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Interest Rate And Currency Derivatives Used To Manage Debt [Member]</link:label>
    <link:label id="lab_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate and currency derivatives used to manage debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember" xlink:to="lab_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FinancialInstrumentsAbstract_6fbb501a-3c74-4667-91ed-ad9b3d140787_terseLabel_en-US" xlink:label="lab_sny_FinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Abstract]</link:label>
    <link:label id="lab_sny_FinancialInstrumentsAbstract_label_en-US" xlink:label="lab_sny_FinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Abstract]</link:label>
    <link:label id="lab_sny_FinancialInstrumentsAbstract_documentation_en-US" xlink:label="lab_sny_FinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FinancialInstrumentsAbstract" xlink:to="lab_sny_FinancialInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PossibleIncreaseInMortalityTableInYears_d53cb9ca-f85c-4e72-af69-5f72296ab21a_terseLabel_en-US" xlink:label="lab_sny_PossibleIncreaseInMortalityTableInYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible increase in mortality table (in years)</link:label>
    <link:label id="lab_sny_PossibleIncreaseInMortalityTableInYears_label_en-US" xlink:label="lab_sny_PossibleIncreaseInMortalityTableInYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible Increase In Mortality Table In Years</link:label>
    <link:label id="lab_sny_PossibleIncreaseInMortalityTableInYears_documentation_en-US" xlink:label="lab_sny_PossibleIncreaseInMortalityTableInYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible increase in mortality table in years.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PossibleIncreaseInMortalityTableInYears" xlink:href="sny-20221231.xsd#sny_PossibleIncreaseInMortalityTableInYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PossibleIncreaseInMortalityTableInYears" xlink:to="lab_sny_PossibleIncreaseInMortalityTableInYears" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PaymentOfDamagesClaimedByCounterparty_752a280a-84c0-42b7-b3e0-c5c2e04cede2_terseLabel_en-US" xlink:label="lab_sny_PaymentOfDamagesClaimedByCounterparty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of damages claimed by the French CNAM (French Social Security)</link:label>
    <link:label id="lab_sny_PaymentOfDamagesClaimedByCounterparty_label_en-US" xlink:label="lab_sny_PaymentOfDamagesClaimedByCounterparty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Damages Claimed By Counterparty</link:label>
    <link:label id="lab_sny_PaymentOfDamagesClaimedByCounterparty_documentation_en-US" xlink:label="lab_sny_PaymentOfDamagesClaimedByCounterparty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Damages Claimed By Counterparty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentOfDamagesClaimedByCounterparty" xlink:href="sny-20221231.xsd#sny_PaymentOfDamagesClaimedByCounterparty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PaymentOfDamagesClaimedByCounterparty" xlink:to="lab_sny_PaymentOfDamagesClaimedByCounterparty" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CollaborationAgreementCommitmentAmount_9f8d30ae-f566-4f14-b104-b2372a474985_terseLabel_en-US" xlink:label="lab_sny_CollaborationAgreementCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, commitment amount</link:label>
    <link:label id="lab_sny_CollaborationAgreementCommitmentAmount_label_en-US" xlink:label="lab_sny_CollaborationAgreementCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Commitment Amount</link:label>
    <link:label id="lab_sny_CollaborationAgreementCommitmentAmount_documentation_en-US" xlink:label="lab_sny_CollaborationAgreementCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Commitment Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementCommitmentAmount" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementCommitmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CollaborationAgreementCommitmentAmount" xlink:to="lab_sny_CollaborationAgreementCommitmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock_5d2602a6-a8dd-4592-a361-e599da39b031_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method</link:label>
    <link:label id="lab_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Operating Segments Reconciling Items [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of operating segments reconciling items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xlink:to="lab_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PharmaceuticalsMember_f8c69298-0a0c-48a1-bfc1-feec55272ac8_terseLabel_en-US" xlink:label="lab_sny_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals</link:label>
    <link:label id="lab_sny_PharmaceuticalsMember_label_en-US" xlink:label="lab_sny_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals [Member]</link:label>
    <link:label id="lab_sny_PharmaceuticalsMember_documentation_en-US" xlink:label="lab_sny_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsMember" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PharmaceuticalsMember" xlink:to="lab_sny_PharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember_b9ab0afb-7bd2-4df3-88e4-24fc49007208_terseLabel_en-US" xlink:label="lab_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American&#160;Depositary&#160;Shares,&#160;each&#160;representing one half of one ordinary share, par value &#8364;2&#160;per&#160;share</link:label>
    <link:label id="lab_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember_label_en-US" xlink:label="lab_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depository Shares, NASDAQ Global Select Market [Member]</link:label>
    <link:label id="lab_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember_documentation_en-US" xlink:label="lab_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depository Shares, NASDAQ Global Select Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember" xlink:href="sny-20221231.xsd#sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember" xlink:to="lab_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DepakineProductLitigationInGermanyMember_743af9ef-61fb-45d7-96c5-a3d68ce3abe6_terseLabel_en-US" xlink:label="lab_sny_DepakineProductLitigationInGermanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine product litigation in Germany</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInGermanyMember_label_en-US" xlink:label="lab_sny_DepakineProductLitigationInGermanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Germany [Member]</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInGermanyMember_documentation_en-US" xlink:label="lab_sny_DepakineProductLitigationInGermanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Germany</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInGermanyMember" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInGermanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DepakineProductLitigationInGermanyMember" xlink:to="lab_sny_DepakineProductLitigationInGermanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock_4365923e-2041-4aea-a2b0-d0950b4283b6_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment</link:label>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Acquisitions Of Property Plant And Equipment And Other Intangible Assets And Carrying Amount Of Investments In Associates And Joint Ventures By Operating Segment [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of acquisitions of property plant and equipment and other intangible assets and carrying amount of investments in associates and joint ventures by operating segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xlink:to="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NewAgreementMember_18fda7c1-d8d7-491b-b75e-44d5db945037_terseLabel_en-US" xlink:label="lab_sny_NewAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New agreement</link:label>
    <link:label id="lab_sny_NewAgreementMember_label_en-US" xlink:label="lab_sny_NewAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Agreement [Member]</link:label>
    <link:label id="lab_sny_NewAgreementMember_documentation_en-US" xlink:label="lab_sny_NewAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NewAgreementMember" xlink:href="sny-20221231.xsd#sny_NewAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NewAgreementMember" xlink:to="lab_sny_NewAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_bca95b37-300c-46ef-a429-6483ea89c083_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements_ca468ab8-2079-4f62-b8e5-8a63bea48945_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments related to collaboration, discovery, development and commercialization agreements</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements_label_en-US" xlink:label="lab_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Collaboration, Discovery, Development And Commercialization Agreements</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Collaboration, Discovery, Development And Commercialization Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" xlink:to="lab_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfJointOperationsTable_d43d5049-2de4-4ba7-a561-f7c00c8a38ce_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfJointOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Joint Operations [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfJointOperationsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfJointOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of joint operations [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfJointOperationsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfJointOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfJointOperationsTable" xlink:to="lab_ifrs-full_DisclosureOfJointOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements_9e6a0f1d-58b0-4260-9370-159c2e3ea0d4_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments related to milestone payments for projects under collaboration agreements</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements_label_en-US" xlink:label="lab_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Milestone Payments For Projects Under Collaboration Agreements</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Milestone Payments For Projects Under Collaboration Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:to="lab_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisHoldingsIrelandLtdMember_92f11d87-f362-4b97-96fc-91ecdbd1eb6d_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisHoldingsIrelandLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Holdings (Ireland) Ltd</link:label>
    <link:label id="lab_sny_SanofiAventisHoldingsIrelandLtdMember_label_en-US" xlink:label="lab_sny_SanofiAventisHoldingsIrelandLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Holdings (Ireland) Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisHoldingsIrelandLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisHoldingsIrelandLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Holdings (Ireland) Ltd</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisHoldingsIrelandLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisHoldingsIrelandLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisHoldingsIrelandLtdMember" xlink:to="lab_sny_SanofiAventisHoldingsIrelandLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare_1d81a275-c2d6-4646-8654-c68dd6875f93_terseLabel_en-US" xlink:label="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid, ordinary shares per share (in EUR per share)</link:label>
    <link:label id="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare_label_en-US" xlink:label="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid, ordinary shares per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:to="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_11c4fe1e-5629-484f-a2dc-722c6fe54a74_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off Balance Sheet Commitments [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off Balance Sheet Commitments [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Disclosure Of Off Balance Sheet Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:to="lab_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherIntangibleAssetsMember_5930ccbb-ffd7-40aa-bf49-6c9dd0e788a7_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_ifrs-full_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssetsMember" xlink:to="lab_ifrs-full_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiEuroMediumTermNotesMember_77ec41dd-bb45-4f84-a3b3-244f45c0213b_terseLabel_en-US" xlink:label="lab_sny_SanofiEuroMediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Euro Medium Term Notes (EMTN) bonds</link:label>
    <link:label id="lab_sny_SanofiEuroMediumTermNotesMember_label_en-US" xlink:label="lab_sny_SanofiEuroMediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Euro Medium Term Notes [Member]</link:label>
    <link:label id="lab_sny_SanofiEuroMediumTermNotesMember_documentation_en-US" xlink:label="lab_sny_SanofiEuroMediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Euro Medium Term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiEuroMediumTermNotesMember" xlink:href="sny-20221231.xsd#sny_SanofiEuroMediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiEuroMediumTermNotesMember" xlink:to="lab_sny_SanofiEuroMediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TranslateBioMember_9f87bfb5-664c-4b7b-9545-2980e9e7689b_terseLabel_en-US" xlink:label="lab_sny_TranslateBioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translate Bio</link:label>
    <link:label id="lab_sny_TranslateBioMember_label_en-US" xlink:label="lab_sny_TranslateBioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translate Bio [Member]</link:label>
    <link:label id="lab_sny_TranslateBioMember_documentation_en-US" xlink:label="lab_sny_TranslateBioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translate Bio.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TranslateBioMember" xlink:to="lab_sny_TranslateBioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax_e146685a-f0b6-4084-9b76-28015f20533d_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax receivables, other than corporate income taxes</link:label>
    <link:label id="lab_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax_label_en-US" xlink:label="lab_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current receivables from taxes other than income tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax" xlink:to="lab_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BlackstoneLifeSciencesMember_b6a04755-eb95-42f9-a350-e9fd65b4eb79_terseLabel_en-US" xlink:label="lab_sny_BlackstoneLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blackstone Life Sciences</link:label>
    <link:label id="lab_sny_BlackstoneLifeSciencesMember_label_en-US" xlink:label="lab_sny_BlackstoneLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blackstone Life Sciences [Member]</link:label>
    <link:label id="lab_sny_BlackstoneLifeSciencesMember_documentation_en-US" xlink:label="lab_sny_BlackstoneLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blackstone Life Sciences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BlackstoneLifeSciencesMember" xlink:href="sny-20221231.xsd#sny_BlackstoneLifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BlackstoneLifeSciencesMember" xlink:to="lab_sny_BlackstoneLifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockSubscriptionOptionPlanMember_378e3d86-dbce-4b7d-8ab1-d4a70ef3bd29_terseLabel_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanMember_label_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Subscription Option Plan [Member]</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanMember_documentation_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanMember" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockSubscriptionOptionPlanMember" xlink:to="lab_sny_StockSubscriptionOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_76af8fd6-c002-4290-9683-2a40d8f345e6_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedges</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on cash flow hedges, before tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:to="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_21d1798e-a6a3-447c-b7b2-bd41f48670e5_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile profit (loss) [abstract]</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile profit (loss) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EquityInvestmentSoldPercentage_258350dc-61cb-4d26-91dd-1e129c91438a_terseLabel_en-US" xlink:label="lab_sny_EquityInvestmentSoldPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate participation percentage of legacy companies in ACS</link:label>
    <link:label id="lab_sny_EquityInvestmentSoldPercentage_label_en-US" xlink:label="lab_sny_EquityInvestmentSoldPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment Sold Percentage</link:label>
    <link:label id="lab_sny_EquityInvestmentSoldPercentage_documentation_en-US" xlink:label="lab_sny_EquityInvestmentSoldPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment sold percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInvestmentSoldPercentage" xlink:href="sny-20221231.xsd#sny_EquityInvestmentSoldPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityInvestmentSoldPercentage" xlink:to="lab_sny_EquityInvestmentSoldPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_3c41132b-4540-40cf-bd3f-39d6dfc4e299_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through transfers, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_978d9e17-8726-42cf-8086-43d98cf50268_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through transfers and other changes, other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_bd886d69-fed1-4d94-8906-2b1feae747cb_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for measuring inventories [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable_dfe001d3-b808-48c9-824b-e4909ae7b0a4_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Share-Based Payment [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable_label_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Share-Based Payment [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Share-Based Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable" xlink:to="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_HedgingInstrumentsMember_4673e691-6980-4a18-903f-a66b2428fc03_terseLabel_en-US" xlink:label="lab_ifrs-full_HedgingInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging instruments [member]</link:label>
    <link:label id="lab_ifrs-full_HedgingInstrumentsMember_label_en-US" xlink:label="lab_ifrs-full_HedgingInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging instruments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgingInstrumentsMember" xlink:to="lab_ifrs-full_HedgingInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_HoechstGmbHMember_7c5bd98e-0f22-43d5-985d-e7dc9b5828e7_terseLabel_en-US" xlink:label="lab_sny_HoechstGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hoechst GmbH</link:label>
    <link:label id="lab_sny_HoechstGmbHMember_label_en-US" xlink:label="lab_sny_HoechstGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hoechst Gmbh [member]</link:label>
    <link:label id="lab_sny_HoechstGmbHMember_documentation_en-US" xlink:label="lab_sny_HoechstGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hoechst GmbH.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HoechstGmbHMember" xlink:href="sny-20221231.xsd#sny_HoechstGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_HoechstGmbHMember" xlink:to="lab_sny_HoechstGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativeFinancialAssets_2209f4ca-b56d-4f12-83e3-d567fb7cb19d_totalLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialAssets_15c1cb38-f1db-40e7-a7bd-30ce520978a9_terseLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial assets</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialAssets" xlink:to="lab_ifrs-full_DerivativeFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage_94cbf3d6-941e-4a1e-a03a-7c6832b3cf8a_terseLabel_en-US" xlink:label="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity instruments designated at fair value through OCI, ownership percentage</link:label>
    <link:label id="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage_label_en-US" xlink:label="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income, Ownership Percentage</link:label>
    <link:label id="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage_documentation_en-US" xlink:label="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage" xlink:href="sny-20221231.xsd#sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage" xlink:to="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember_a05d1869-09ed-4259-968b-8b5d8aca8c84_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of applying IFRIC agenda decision on IAS 19</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) due to changes in accounting policy required by IFRSs, cumulative effect at date of initial application [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember" xlink:to="lab_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ProductLiabilitiesMember_5653fe75-4b5c-407b-ab94-f7324ae2467a_terseLabel_en-US" xlink:label="lab_sny_ProductLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liabilities</link:label>
    <link:label id="lab_sny_ProductLiabilitiesMember_label_en-US" xlink:label="lab_sny_ProductLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liabilities [Member]</link:label>
    <link:label id="lab_sny_ProductLiabilitiesMember_documentation_en-US" xlink:label="lab_sny_ProductLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProductLiabilitiesMember" xlink:href="sny-20221231.xsd#sny_ProductLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProductLiabilitiesMember" xlink:to="lab_sny_ProductLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherCountriesInSegmentResultsMember_0cff3055-4e87-4851-b08f-b42bd7b87e56_terseLabel_en-US" xlink:label="lab_sny_OtherCountriesInSegmentResultsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries</link:label>
    <link:label id="lab_sny_OtherCountriesInSegmentResultsMember_label_en-US" xlink:label="lab_sny_OtherCountriesInSegmentResultsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries In Segment Results [Member]</link:label>
    <link:label id="lab_sny_OtherCountriesInSegmentResultsMember_documentation_en-US" xlink:label="lab_sny_OtherCountriesInSegmentResultsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries in segement results.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesInSegmentResultsMember" xlink:href="sny-20221231.xsd#sny_OtherCountriesInSegmentResultsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherCountriesInSegmentResultsMember" xlink:to="lab_sny_OtherCountriesInSegmentResultsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInJointOperation_e2c3fbee-e9b7-4e90-a863-42667de1538e_terseLabel_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInJointOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial interest in principal investments accounted for using the equity method</link:label>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInJointOperation_label_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInJointOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of ownership interest in joint operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInJointOperation" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInJointOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInJointOperation" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInJointOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive_bed6daff-4ea1-4390-a454-734321716f6f_terseLabel_en-US" xlink:label="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other provisions, expected utilized amount in 2023 through 2026</link:label>
    <link:label id="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive_label_en-US" xlink:label="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identified Environmental Risks Provisions Expected Utilized Amount Year Two To Five</link:label>
    <link:label id="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive_documentation_en-US" xlink:label="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identified environmental risks provisions expected utilized amount year two to five.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive" xlink:href="sny-20221231.xsd#sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive" xlink:to="lab_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock_47375e9b-a773-4599-9873-5412c2428b1e_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Off balance sheet commitments</link:label>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off-Balance Sheet Commitments Explanatory [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of off-balance sheet commitments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xlink:to="lab_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PlanAssetsEffectOfAssetCeiling_daec7e0d-a3ef-4df0-a671-927822acf834_terseLabel_en-US" xlink:label="lab_sny_PlanAssetsEffectOfAssetCeiling" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of asset ceiling</link:label>
    <link:label id="lab_sny_PlanAssetsEffectOfAssetCeiling_label_en-US" xlink:label="lab_sny_PlanAssetsEffectOfAssetCeiling" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Assets, Effect Of Asset Ceiling</link:label>
    <link:label id="lab_sny_PlanAssetsEffectOfAssetCeiling_documentation_en-US" xlink:label="lab_sny_PlanAssetsEffectOfAssetCeiling" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Assets, Effect Of Asset Ceiling</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlanAssetsEffectOfAssetCeiling" xlink:href="sny-20221231.xsd#sny_PlanAssetsEffectOfAssetCeiling"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PlanAssetsEffectOfAssetCeiling" xlink:to="lab_sny_PlanAssetsEffectOfAssetCeiling" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FixedInterestRateMember_56f3b787-55a8-497b-b607-83cf3773a0f0_terseLabel_en-US" xlink:label="lab_ifrs-full_FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed-rate debt</link:label>
    <link:label id="lab_ifrs-full_FixedInterestRateMember_label_en-US" xlink:label="lab_ifrs-full_FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed interest rate [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixedInterestRateMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixedInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixedInterestRateMember" xlink:to="lab_ifrs-full_FixedInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFunded_55d44023-08c1-43ad-8e6d-5f4f1721ab04_terseLabel_en-US" xlink:label="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFunded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase III costs, responsibility percentage</link:label>
    <link:label id="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFunded_label_en-US" xlink:label="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFunded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Second Part Of Development Costs Funded</link:label>
    <link:label id="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFunded_documentation_en-US" xlink:label="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFunded" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Second Part Of Development Costs Funded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFunded" xlink:href="sny-20221231.xsd#sny_PercentageOfSecondPartOfDevelopmentCostsFunded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFunded" xlink:to="lab_sny_PercentageOfSecondPartOfDevelopmentCostsFunded" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock_1ef335cb-037b-40c0-999c-2605c9b9a76c_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Cost for Pension and Other post-employment Benefit Plans, by Geographical Region</link:label>
    <link:label id="lab_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Service Costs Of Net Defined Benefits By Country [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of service costs of net defined benefits by country.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock" xlink:to="lab_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_April2022EMTNISINFR0014009KQ0Member_2c551449-80c1-41cc-9888-4422af617987_terseLabel_en-US" xlink:label="lab_sny_April2022EMTNISINFR0014009KQ0Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2022 EMTN ISIN FR0014009KQ0</link:label>
    <link:label id="lab_sny_April2022EMTNISINFR0014009KQ0Member_label_en-US" xlink:label="lab_sny_April2022EMTNISINFR0014009KQ0Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2022 EMTN ISIN FR0014009KQ0 [Member]</link:label>
    <link:label id="lab_sny_April2022EMTNISINFR0014009KQ0Member_documentation_en-US" xlink:label="lab_sny_April2022EMTNISINFR0014009KQ0Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2022 EMTN ISIN FR0014009KQ0</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2022EMTNISINFR0014009KQ0Member" xlink:href="sny-20221231.xsd#sny_April2022EMTNISINFR0014009KQ0Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_April2022EMTNISINFR0014009KQ0Member" xlink:to="lab_sny_April2022EMTNISINFR0014009KQ0Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MultiemployerDefinedBenefitPlansMember_0c98084d-fa3c-4ddb-a6db-2594e08b2ae3_terseLabel_en-US" xlink:label="lab_ifrs-full_MultiemployerDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi-employer plan (Pensionskasses)</link:label>
    <link:label id="lab_ifrs-full_MultiemployerDefinedBenefitPlansMember_label_en-US" xlink:label="lab_ifrs-full_MultiemployerDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi-employer defined benefit plans [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MultiemployerDefinedBenefitPlansMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MultiemployerDefinedBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MultiemployerDefinedBenefitPlansMember" xlink:to="lab_ifrs-full_MultiemployerDefinedBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BenefitsPaidOrPayable_f121caac-de1e-49ab-ac54-414371f47bc1_negatedLabel_en-US" xlink:label="lab_ifrs-full_BenefitsPaidOrPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_ifrs-full_BenefitsPaidOrPayable_label_en-US" xlink:label="lab_ifrs-full_BenefitsPaidOrPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid or payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BenefitsPaidOrPayable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BenefitsPaidOrPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BenefitsPaidOrPayable" xlink:to="lab_ifrs-full_BenefitsPaidOrPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AuditorsRemunerationForAuditRelatedServices_1edeac15-a79a-41b2-aff7-36c1a64fa484_terseLabel_en-US" xlink:label="lab_sny_AuditorsRemunerationForAuditRelatedServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit-related services</link:label>
    <link:label id="lab_sny_AuditorsRemunerationForAuditRelatedServices_label_en-US" xlink:label="lab_sny_AuditorsRemunerationForAuditRelatedServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor's Remuneration For Audit Related Services</link:label>
    <link:label id="lab_sny_AuditorsRemunerationForAuditRelatedServices_documentation_en-US" xlink:label="lab_sny_AuditorsRemunerationForAuditRelatedServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor's remuneration for audit related services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsRemunerationForAuditRelatedServices" xlink:href="sny-20221231.xsd#sny_AuditorsRemunerationForAuditRelatedServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AuditorsRemunerationForAuditRelatedServices" xlink:to="lab_sny_AuditorsRemunerationForAuditRelatedServices" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GenzymeTherapeuticProductsLimitedPartnershipMember_17594444-ed32-4a65-b41f-01cabf298491_terseLabel_en-US" xlink:label="lab_sny_GenzymeTherapeuticProductsLimitedPartnershipMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Therapeutic Products Limited Partnership</link:label>
    <link:label id="lab_sny_GenzymeTherapeuticProductsLimitedPartnershipMember_label_en-US" xlink:label="lab_sny_GenzymeTherapeuticProductsLimitedPartnershipMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Therapeutic Products Limited Partnership [Member]</link:label>
    <link:label id="lab_sny_GenzymeTherapeuticProductsLimitedPartnershipMember_documentation_en-US" xlink:label="lab_sny_GenzymeTherapeuticProductsLimitedPartnershipMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Therapeutic Products Limited Partnership [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeTherapeuticProductsLimitedPartnershipMember" xlink:href="sny-20221231.xsd#sny_GenzymeTherapeuticProductsLimitedPartnershipMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GenzymeTherapeuticProductsLimitedPartnershipMember" xlink:to="lab_sny_GenzymeTherapeuticProductsLimitedPartnershipMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_27060e2c-2ffc-4afd-8a50-83b0ca0d911d_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combinations and transactions with non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for business combinations and goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsAbstract_67849ea1-3a3d-4b7d-b0c6-816384178c3e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other provisions [abstract]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other provisions [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherProvisionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsAbstract" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_f535d282-1ac0-4fa1-958b-e92a9274e1a8_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of impairment loss and reversal of impairment loss [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of impairment loss and reversal of impairment loss [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable" xlink:to="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InsurancePoliciesMember_d1d347b3-6dca-43ea-ac91-527b7b666287_terseLabel_en-US" xlink:label="lab_sny_InsurancePoliciesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance policies</link:label>
    <link:label id="lab_sny_InsurancePoliciesMember_label_en-US" xlink:label="lab_sny_InsurancePoliciesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Policies [Member]</link:label>
    <link:label id="lab_sny_InsurancePoliciesMember_documentation_en-US" xlink:label="lab_sny_InsurancePoliciesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InsurancePoliciesMember" xlink:href="sny-20221231.xsd#sny_InsurancePoliciesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InsurancePoliciesMember" xlink:to="lab_sny_InsurancePoliciesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TechnologicalPlatformsMember_5a547026-ed01-455e-8fd2-685f0bdf7219_terseLabel_en-US" xlink:label="lab_sny_TechnologicalPlatformsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technological Platforms</link:label>
    <link:label id="lab_sny_TechnologicalPlatformsMember_label_en-US" xlink:label="lab_sny_TechnologicalPlatformsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technological Platforms [Member]</link:label>
    <link:label id="lab_sny_TechnologicalPlatformsMember_documentation_en-US" xlink:label="lab_sny_TechnologicalPlatformsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technological Platforms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TechnologicalPlatformsMember" xlink:href="sny-20221231.xsd#sny_TechnologicalPlatformsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TechnologicalPlatformsMember" xlink:to="lab_sny_TechnologicalPlatformsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShorttermRestructuringProvision_0e590a19-55a1-42e4-8324-c95f743df4dd_verboseLabel_en-US" xlink:label="lab_ifrs-full_ShorttermRestructuringProvision" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classified in current liabilities</link:label>
    <link:label id="lab_ifrs-full_ShorttermRestructuringProvision_1268f397-acbd-4085-ae50-00e89df00666_terseLabel_en-US" xlink:label="lab_ifrs-full_ShorttermRestructuringProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring provisions (see Note&#160;D.19.2.)</link:label>
    <link:label id="lab_ifrs-full_ShorttermRestructuringProvision_label_en-US" xlink:label="lab_ifrs-full_ShorttermRestructuringProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current restructuring provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermRestructuringProvision" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermRestructuringProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermRestructuringProvision" xlink:to="lab_ifrs-full_ShorttermRestructuringProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsInterestRate_09b8d90a-4c05-4ac6-97e8-e50e65dc4bba_verboseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bonds, interest rate (in percent)</link:label>
    <link:label id="lab_ifrs-full_BorrowingsInterestRate_fcd9c7f9-ca17-4ecb-a640-7cfa0a654fa4_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual&#160;interest&#160;rate</link:label>
    <link:label id="lab_ifrs-full_BorrowingsInterestRate_label_en-US" xlink:label="lab_ifrs-full_BorrowingsInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings, interest rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate" xlink:to="lab_ifrs-full_BorrowingsInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock_b999217b-93e2-459e-a989-d6ca4bd34f53_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Personal Costs</link:label>
    <link:label id="lab_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Personnel Costs Details [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of personnel costs details.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfPersonnelCostsDetailsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock" xlink:to="lab_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember_2bbe4453-c081-40b8-acd6-6e32a36199b1_terseLabel_en-US" xlink:label="lab_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Items not subsequently reclassifiable to profit or loss</link:label>
    <link:label id="lab_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember_label_en-US" xlink:label="lab_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Items Not Subsequently Reclassifiable To Profit Or Loss [Member]</link:label>
    <link:label id="lab_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember_documentation_en-US" xlink:label="lab_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Items not subsequently reclassifiable to profit or loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xlink:href="sny-20221231.xsd#sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xlink:to="lab_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_QuotedDebtSecuritiesMember_ba413f38-b02f-42ff-b60e-a238532f2b1d_terseLabel_en-US" xlink:label="lab_sny_QuotedDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted debt securities</link:label>
    <link:label id="lab_sny_QuotedDebtSecuritiesMember_label_en-US" xlink:label="lab_sny_QuotedDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Debt Securities [Member]</link:label>
    <link:label id="lab_sny_QuotedDebtSecuritiesMember_documentation_en-US" xlink:label="lab_sny_QuotedDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted debt securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedDebtSecuritiesMember" xlink:href="sny-20221231.xsd#sny_QuotedDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_QuotedDebtSecuritiesMember" xlink:to="lab_sny_QuotedDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LeasedAssetsPercentage_31af3ec2-0e4c-45bf-87b7-600814d6aad7_terseLabel_en-US" xlink:label="lab_sny_LeasedAssetsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets, percentage</link:label>
    <link:label id="lab_sny_LeasedAssetsPercentage_label_en-US" xlink:label="lab_sny_LeasedAssetsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased Assets, Percentage</link:label>
    <link:label id="lab_sny_LeasedAssetsPercentage_documentation_en-US" xlink:label="lab_sny_LeasedAssetsPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased Assets, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LeasedAssetsPercentage" xlink:href="sny-20221231.xsd#sny_LeasedAssetsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LeasedAssetsPercentage" xlink:to="lab_sny_LeasedAssetsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems_31d158e5-806b-4fa3-8db7-3a55bc505fb3_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of net income attributable to non-controlling interests [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Net Income Attributable To Non-controlling Interests [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of net income attributable to noncontrolling interests [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems" xlink:to="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OperatingSegmentsMember_7e26ba28-8f96-4c55-9314-4068173303cc_terseLabel_en-US" xlink:label="lab_ifrs-full_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating segments</link:label>
    <link:label id="lab_ifrs-full_OperatingSegmentsMember_label_en-US" xlink:label="lab_ifrs-full_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating segments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingSegmentsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingSegmentsMember" xlink:to="lab_ifrs-full_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral_cbb82f8f-b05e-41e3-8360-ce71c87f29e1_terseLabel_en-US" xlink:label="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial collateral</link:label>
    <link:label id="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral_label_en-US" xlink:label="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects Of Other Netting Arrangements Not Fulfilling The IAS 32 Criteria For Offsetting Fair Value Of Financial Collateral</link:label>
    <link:label id="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral_documentation_en-US" xlink:label="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of other netting arrangements not fulfilling the IAS32 criteria for offsetting fair value of financial collateral.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral" xlink:href="sny-20221231.xsd#sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral" xlink:to="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue_29b11a66-4eb6-45c8-95eb-87dfd883be1e_verboseLabel_en-US" xlink:label="lab_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of the workdown of acquired inventories remeasured at fair value</link:label>
    <link:label id="lab_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue_label_en-US" xlink:label="lab_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact Of The Workdown Of Acquired Inventories Remeasured At Fair Value</link:label>
    <link:label id="lab_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue_documentation_en-US" xlink:label="lab_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of the workdown of acquired inventories remeasured at fair value arising from business combination in accordance with IFRS 3.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xlink:href="sny-20221231.xsd#sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xlink:to="lab_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_13046154-5594-4014-a9c6-ec5e796e8d02_terseLabel_en-US" xlink:label="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities related to business combinations and to non-controlling interests</link:label>
    <link:label id="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_label_en-US" xlink:label="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Liabilities Related To Business Combinations And To Non-controlling Interests</link:label>
    <link:label id="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_documentation_en-US" xlink:label="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This account includes non-current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes non-current portion of liabilities related to non-controlling interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:href="sny-20221231.xsd#sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:to="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_May32022Member_79f5783a-0b1d-4c14-93b7-f1f65a5394da_verboseLabel_en-US" xlink:label="lab_sny_May32022Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 3, 2022</link:label>
    <link:label id="lab_sny_May32022Member_label_en-US" xlink:label="lab_sny_May32022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 3, 2022 [Member]</link:label>
    <link:label id="lab_sny_May32022Member_documentation_en-US" xlink:label="lab_sny_May32022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2, 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_May32022Member" xlink:href="sny-20221231.xsd#sny_May32022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_May32022Member" xlink:to="lab_sny_May32022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract_ab90d89e-ffcd-4f30-9ee4-e59a8b176f68_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of comprehensive income [abstract]</link:label>
    <link:label id="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of comprehensive income [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock_d48173a2-37e0-4028-85ad-8ed78c7c360f_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information Of Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of detailed information of other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_f80cf082-0bd0-4e72-8b07-799504cc38f2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Subsidiaries [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of subsidiaries [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_278e51a1-fc7f-4d14-a089-1c1f6769411d_terseLabel_en-US" xlink:label="lab_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity instruments designated at fair value through OCI</link:label>
    <link:label id="lab_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity instruments designated at fair value through other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:to="lab_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_4a36c97f-228a-4d4d-a7d1-72308f6d401b_negatedLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options, options exercised (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory_0d448510-4c06-484b-9dd6-4b81d5347b56_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal accountants' fees and services</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of auditors' remuneration [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAuditorsRemunerationExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetMember_eb540627-3c6b-4fca-a2eb-cdd64a51cbf0_terseLabel_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit liability (asset) [member]</link:label>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetMember_label_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit liability (asset) [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:to="lab_ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SalesOfAntibodiesThirdAchievementMember_07dd2b3b-c2db-4105-926f-f74f375f4479_terseLabel_en-US" xlink:label="lab_sny_SalesOfAntibodiesThirdAchievementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Of Antibodies, Third Achievement</link:label>
    <link:label id="lab_sny_SalesOfAntibodiesThirdAchievementMember_label_en-US" xlink:label="lab_sny_SalesOfAntibodiesThirdAchievementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Of Antibodies, Third Achievement [Member]</link:label>
    <link:label id="lab_sny_SalesOfAntibodiesThirdAchievementMember_documentation_en-US" xlink:label="lab_sny_SalesOfAntibodiesThirdAchievementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Of Antibodies, Third Achievement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesOfAntibodiesThirdAchievementMember" xlink:href="sny-20221231.xsd#sny_SalesOfAntibodiesThirdAchievementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SalesOfAntibodiesThirdAchievementMember" xlink:to="lab_sny_SalesOfAntibodiesThirdAchievementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SynthorxIncMember_679d379c-9652-43e2-8a4e-3477f29bf5a2_terseLabel_en-US" xlink:label="lab_sny_SynthorxIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Synthorx, Inc</link:label>
    <link:label id="lab_sny_SynthorxIncMember_label_en-US" xlink:label="lab_sny_SynthorxIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Synthorx, Inc [Member]</link:label>
    <link:label id="lab_sny_SynthorxIncMember_documentation_en-US" xlink:label="lab_sny_SynthorxIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Synthorx, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxIncMember" xlink:href="sny-20221231.xsd#sny_SynthorxIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SynthorxIncMember" xlink:to="lab_sny_SynthorxIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherGainsLossesAndLitigation_70f47433-6944-4c5c-9cc8-28ff907d3716_verboseLabel_en-US" xlink:label="lab_sny_OtherGainsLossesAndLitigation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other gains and losses, and litigation</link:label>
    <link:label id="lab_sny_OtherGainsLossesAndLitigation_2aaa0883-af66-46fa-af68-5f5c1e1f88e4_terseLabel_en-US" xlink:label="lab_sny_OtherGainsLossesAndLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other gains, (losses) and litigation</link:label>
    <link:label id="lab_sny_OtherGainsLossesAndLitigation_1f1a00f7-648d-4c8b-8aa8-6fb664e6ff0f_negatedTerseLabel_en-US" xlink:label="lab_sny_OtherGainsLossesAndLitigation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other gains, (losses) and litigation</link:label>
    <link:label id="lab_sny_OtherGainsLossesAndLitigation_label_en-US" xlink:label="lab_sny_OtherGainsLossesAndLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Gains, (Losses) And Litigation</link:label>
    <link:label id="lab_sny_OtherGainsLossesAndLitigation_documentation_en-US" xlink:label="lab_sny_OtherGainsLossesAndLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The line item other gains and losses, and litigation includes the impact of material transactions of an unusual nature or amount. [note B.20.2.]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGainsLossesAndLitigation" xlink:href="sny-20221231.xsd#sny_OtherGainsLossesAndLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherGainsLossesAndLitigation" xlink:to="lab_sny_OtherGainsLossesAndLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_c44cda1a-bc38-449b-b876-52cd1eb93d2c_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_September2014EMTNISINFR0012146801Member_f19407bd-bd3f-4af1-89ed-b47655076115_terseLabel_en-US" xlink:label="lab_sny_September2014EMTNISINFR0012146801Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2014 EMTN ISIN FR0012146801</link:label>
    <link:label id="lab_sny_September2014EMTNISINFR0012146801Member_label_en-US" xlink:label="lab_sny_September2014EMTNISINFR0012146801Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2014 EMTNISINFR0012146801 [Member]</link:label>
    <link:label id="lab_sny_September2014EMTNISINFR0012146801Member_documentation_en-US" xlink:label="lab_sny_September2014EMTNISINFR0012146801Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2014 EMTN ISIN FR0012146801.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_September2014EMTNISINFR0012146801Member" xlink:href="sny-20221231.xsd#sny_September2014EMTNISINFR0012146801Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_September2014EMTNISINFR0012146801Member" xlink:to="lab_sny_September2014EMTNISINFR0012146801Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember_027d88ce-badd-4667-8a73-3f300a86327e_terseLabel_en-US" xlink:label="lab_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and provisions deductible at time of payments</link:label>
    <link:label id="lab_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember_label_en-US" xlink:label="lab_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Provisions Deductible At Time Of Payments [member]</link:label>
    <link:label id="lab_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember_documentation_en-US" xlink:label="lab_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and provisions deductible at time of payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember" xlink:href="sny-20221231.xsd#sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember" xlink:to="lab_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MerieuxCanadaHoldingsULCCanadaMember_d8f614fa-b4c4-4b6a-9dd8-e5157cfe2ead_terseLabel_en-US" xlink:label="lab_sny_MerieuxCanadaHoldingsULCCanadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merieux Canada Holdings ULC (Canada)</link:label>
    <link:label id="lab_sny_MerieuxCanadaHoldingsULCCanadaMember_label_en-US" xlink:label="lab_sny_MerieuxCanadaHoldingsULCCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merieux Canada Holdings ULC (Canada) [Member]</link:label>
    <link:label id="lab_sny_MerieuxCanadaHoldingsULCCanadaMember_documentation_en-US" xlink:label="lab_sny_MerieuxCanadaHoldingsULCCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merieux Canada Holdings ULC (Canada)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MerieuxCanadaHoldingsULCCanadaMember" xlink:href="sny-20221231.xsd#sny_MerieuxCanadaHoldingsULCCanadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MerieuxCanadaHoldingsULCCanadaMember" xlink:to="lab_sny_MerieuxCanadaHoldingsULCCanadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChattemIncMember_6a7b914a-509a-434d-a448-a93fc897224f_terseLabel_en-US" xlink:label="lab_sny_ChattemIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chattem, Inc.</link:label>
    <link:label id="lab_sny_ChattemIncMember_label_en-US" xlink:label="lab_sny_ChattemIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chattem Inc [member]</link:label>
    <link:label id="lab_sny_ChattemIncMember_documentation_en-US" xlink:label="lab_sny_ChattemIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chattem, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChattemIncMember" xlink:href="sny-20221231.xsd#sny_ChattemIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChattemIncMember" xlink:to="lab_sny_ChattemIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AlprolixMember_ddf33fa8-6aa1-422e-8667-e0577fc26c81_terseLabel_en-US" xlink:label="lab_sny_AlprolixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alprolix</link:label>
    <link:label id="lab_sny_AlprolixMember_label_en-US" xlink:label="lab_sny_AlprolixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alprolix [Member]</link:label>
    <link:label id="lab_sny_AlprolixMember_documentation_en-US" xlink:label="lab_sny_AlprolixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alprolix</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AlprolixMember" xlink:href="sny-20221231.xsd#sny_AlprolixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AlprolixMember" xlink:to="lab_sny_AlprolixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonCurrentProvisionForEnvironmentRisks_47ffa0cf-bca9-4e5a-ba9a-e6a80e01e257_terseLabel_en-US" xlink:label="lab_sny_NonCurrentProvisionForEnvironmentRisks" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental risks</link:label>
    <link:label id="lab_sny_NonCurrentProvisionForEnvironmentRisks_label_en-US" xlink:label="lab_sny_NonCurrentProvisionForEnvironmentRisks" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Provision For Environment Risks</link:label>
    <link:label id="lab_sny_NonCurrentProvisionForEnvironmentRisks_documentation_en-US" xlink:label="lab_sny_NonCurrentProvisionForEnvironmentRisks" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environment risks.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionForEnvironmentRisks" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionForEnvironmentRisks"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentProvisionForEnvironmentRisks" xlink:to="lab_sny_NonCurrentProvisionForEnvironmentRisks" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FairValueOfContingentConsiderationPayable_ca33f7b4-5330-43e1-9716-9657fb315412_terseLabel_en-US" xlink:label="lab_sny_FairValueOfContingentConsiderationPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent consideration payable</link:label>
    <link:label id="lab_sny_FairValueOfContingentConsiderationPayable_label_en-US" xlink:label="lab_sny_FairValueOfContingentConsiderationPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Contingent Consideration Payable</link:label>
    <link:label id="lab_sny_FairValueOfContingentConsiderationPayable_documentation_en-US" xlink:label="lab_sny_FairValueOfContingentConsiderationPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the contingent consideration payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfContingentConsiderationPayable" xlink:href="sny-20221231.xsd#sny_FairValueOfContingentConsiderationPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FairValueOfContingentConsiderationPayable" xlink:to="lab_sny_FairValueOfContingentConsiderationPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurEuropeMember_bc2b4931-5253-4f59-bb88-cc6b130a49e0_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Europe</link:label>
    <link:label id="lab_sny_SanofiPasteurEuropeMember_label_en-US" xlink:label="lab_sny_SanofiPasteurEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Europe [Member]</link:label>
    <link:label id="lab_sny_SanofiPasteurEuropeMember_documentation_en-US" xlink:label="lab_sny_SanofiPasteurEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurEuropeMember" xlink:href="sny-20221231.xsd#sny_SanofiPasteurEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurEuropeMember" xlink:to="lab_sny_SanofiPasteurEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_5d903bef-ff25-457d-a831-97fc67a8058b_terseLabel_en-US" xlink:label="lab_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wholly unfunded defined benefit plans</link:label>
    <link:label id="lab_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_label_en-US" xlink:label="lab_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wholly unfunded defined benefit plans [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember" xlink:to="lab_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FairValueOfTheContingentConsideration_404a45e8-4f48-4def-a690-1cd535a19967_terseLabel_en-US" xlink:label="lab_sny_FairValueOfTheContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the contingent consideration</link:label>
    <link:label id="lab_sny_FairValueOfTheContingentConsideration_label_en-US" xlink:label="lab_sny_FairValueOfTheContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of The Contingent Consideration</link:label>
    <link:label id="lab_sny_FairValueOfTheContingentConsideration_documentation_en-US" xlink:label="lab_sny_FairValueOfTheContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfTheContingentConsideration" xlink:href="sny-20221231.xsd#sny_FairValueOfTheContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FairValueOfTheContingentConsideration" xlink:to="lab_sny_FairValueOfTheContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ManagedCareAndGPOProgramsMember_3569fa71-5b7e-4247-842d-50bccbe6420e_terseLabel_en-US" xlink:label="lab_sny_ManagedCareAndGPOProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed care and GPO Programs</link:label>
    <link:label id="lab_sny_ManagedCareAndGPOProgramsMember_label_en-US" xlink:label="lab_sny_ManagedCareAndGPOProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care And GPO Programs [Member]</link:label>
    <link:label id="lab_sny_ManagedCareAndGPOProgramsMember_documentation_en-US" xlink:label="lab_sny_ManagedCareAndGPOProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care And GPO Programs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ManagedCareAndGPOProgramsMember" xlink:href="sny-20221231.xsd#sny_ManagedCareAndGPOProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ManagedCareAndGPOProgramsMember" xlink:to="lab_sny_ManagedCareAndGPOProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7c320705-81fe-41b0-99f7-e330e5669add_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of defined benefit plans [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of defined benefit plans [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_6a2c0716-9c38-4d6b-8349-e90741f77a78_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Deferred Tax Position</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrentDerivativesMember_ad373c70-0b02-4ead-9f7d-b79bd1bfdd11_terseLabel_en-US" xlink:label="lab_sny_CurrentDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current derivatives</link:label>
    <link:label id="lab_sny_CurrentDerivativesMember_d5d6d49a-1c9e-4654-ac1d-ba2704b35cef_verboseLabel_en-US" xlink:label="lab_sny_CurrentDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current derivatives</link:label>
    <link:label id="lab_sny_CurrentDerivativesMember_label_en-US" xlink:label="lab_sny_CurrentDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Derivatives [Member]</link:label>
    <link:label id="lab_sny_CurrentDerivativesMember_documentation_en-US" xlink:label="lab_sny_CurrentDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current derivatives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentDerivativesMember" xlink:href="sny-20221231.xsd#sny_CurrentDerivativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentDerivativesMember" xlink:to="lab_sny_CurrentDerivativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents_c17978fd-5dbb-400e-b368-36081a8880a2_terseLabel_en-US" xlink:label="lab_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on derivatives used to manage cash and cash equivalents</link:label>
    <link:label id="lab_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents_label_en-US" xlink:label="lab_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain On Derivatives Used To Manage Cash And Cash Equivalents</link:label>
    <link:label id="lab_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents_documentation_en-US" xlink:label="lab_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on derivatives used to manage cash and cash equivalents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents" xlink:href="sny-20221231.xsd#sny_GainOnDerivativesUsedToManageCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents" xlink:to="lab_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockSubscriptionOptionPlanFourMember_bf15ae6b-15d2-419d-9fbc-75aefe549b48_terseLabel_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan four</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanFourMember_label_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Subscription Option Plan Four [Member]</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanFourMember_documentation_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan four.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanFourMember" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockSubscriptionOptionPlanFourMember" xlink:to="lab_sny_StockSubscriptionOptionPlanFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradingEquitySecuritiesMember_ad25dea1-2c41-4a65-ba27-f23556d76d97_terseLabel_en-US" xlink:label="lab_ifrs-full_TradingEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading equity securities</link:label>
    <link:label id="lab_ifrs-full_TradingEquitySecuritiesMember_label_en-US" xlink:label="lab_ifrs-full_TradingEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading equity securities [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradingEquitySecuritiesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradingEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradingEquitySecuritiesMember" xlink:to="lab_ifrs-full_TradingEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset_aeb16d37-081c-49a5-a574-4981084ea13e_verboseLabel_en-US" xlink:label="lab_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, amortization and impairment of property, plant and equipment, right-of-use assets and intangible assets</link:label>
    <link:label id="lab_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset_label_en-US" xlink:label="lab_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments For Depreciation And Amortisation Expense And Impairment Loss Reversal Of Impairment Loss Of Property Plant And Equipment Right-of Use Assets And Intangible Asset</link:label>
    <link:label id="lab_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset_documentation_en-US" xlink:label="lab_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, amortization and impairment of property, plant and equipment, right-of use assets and intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xlink:href="sny-20221231.xsd#sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xlink:to="lab_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d2e4f913-f2ae-41b1-a3dc-552a86763867_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisKoreaCoLtdMember_0e6a9b7e-8131-4c0b-83a1-cc5e0c051ce9_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisKoreaCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Korea Co. Ltd</link:label>
    <link:label id="lab_sny_SanofiAventisKoreaCoLtdMember_label_en-US" xlink:label="lab_sny_SanofiAventisKoreaCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Korea Co Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisKoreaCoLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisKoreaCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Korea Co. Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisKoreaCoLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisKoreaCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisKoreaCoLtdMember" xlink:to="lab_sny_SanofiAventisKoreaCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurNVLMember_f885697b-0b77-471c-84ef-02558b5eb381_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurNVLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur NVL</link:label>
    <link:label id="lab_sny_SanofiPasteurNVLMember_label_en-US" xlink:label="lab_sny_SanofiPasteurNVLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur NVL [Member]</link:label>
    <link:label id="lab_sny_SanofiPasteurNVLMember_documentation_en-US" xlink:label="lab_sny_SanofiPasteurNVLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur NVL [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurNVLMember" xlink:href="sny-20221231.xsd#sny_SanofiPasteurNVLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurNVLMember" xlink:to="lab_sny_SanofiPasteurNVLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_April2016EMTNISINFR0013144003Member_d59cdf6a-f621-411f-9ee6-6dc0f6a38330_terseLabel_en-US" xlink:label="lab_sny_April2016EMTNISINFR0013144003Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2016 EMTN ISIN FR0013144003</link:label>
    <link:label id="lab_sny_April2016EMTNISINFR0013144003Member_label_en-US" xlink:label="lab_sny_April2016EMTNISINFR0013144003Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2016 EMTNISINFR0013144003 [Member]</link:label>
    <link:label id="lab_sny_April2016EMTNISINFR0013144003Member_documentation_en-US" xlink:label="lab_sny_April2016EMTNISINFR0013144003Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2016 EMTN ISIN FR0013144003.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2016EMTNISINFR0013144003Member" xlink:href="sny-20221231.xsd#sny_April2016EMTNISINFR0013144003Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_April2016EMTNISINFR0013144003Member" xlink:to="lab_sny_April2016EMTNISINFR0013144003Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_5a19739f-fcf2-407e-b0c1-ef7933fd9f8f_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AggregatedMeasurementMember_c5e91e21-b2bd-4fdf-b33e-62373f3d7f97_terseLabel_en-US" xlink:label="lab_ifrs-full_AggregatedMeasurementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregated measurement</link:label>
    <link:label id="lab_ifrs-full_AggregatedMeasurementMember_label_en-US" xlink:label="lab_ifrs-full_AggregatedMeasurementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregated measurement [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedMeasurementMember" xlink:to="lab_ifrs-full_AggregatedMeasurementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfIFRSCompliance_bc89cf8d-7287-4270-8888-657ba01a2e4d_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfIFRSCompliance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International financial reporting standards (IFRS)</link:label>
    <link:label id="lab_ifrs-full_StatementOfIFRSCompliance_label_en-US" xlink:label="lab_ifrs-full_StatementOfIFRSCompliance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of IFRS compliance [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfIFRSCompliance" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfIFRSCompliance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfIFRSCompliance" xlink:to="lab_ifrs-full_StatementOfIFRSCompliance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_BusinessContactMember_14cbe36e-d31d-4d50-948f-f858839f8ba0_terseLabel_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Contact</link:label>
    <link:label id="lab_dei_BusinessContactMember_label_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Contact [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonCurrentAssetMember_35a0712b-a719-4418-972e-15a385bee288_terseLabel_en-US" xlink:label="lab_sny_NonCurrentAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non current asset</link:label>
    <link:label id="lab_sny_NonCurrentAssetMember_label_en-US" xlink:label="lab_sny_NonCurrentAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Current Asset [Member]</link:label>
    <link:label id="lab_sny_NonCurrentAssetMember_documentation_en-US" xlink:label="lab_sny_NonCurrentAssetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current asset.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentAssetMember" xlink:href="sny-20221231.xsd#sny_NonCurrentAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentAssetMember" xlink:to="lab_sny_NonCurrentAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents_6ec43ab2-62e8-4163-8451-8aa553e457d1_terseLabel_en-US" xlink:label="lab_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency and interest rate derivatives</link:label>
    <link:label id="lab_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents_label_en-US" xlink:label="lab_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency And Interest Rate Derivatives Used To Manage Debt Net Of Cash And Cash Equivalents</link:label>
    <link:label id="lab_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents_documentation_en-US" xlink:label="lab_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency and interest rate derivatives used to manage debt, net of cash and cash equivalents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xlink:href="sny-20221231.xsd#sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xlink:to="lab_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BusinessCombinationPurchasePricePerShare_add2d08f-f7f3-4dc5-ad7f-9f01c96ecbbc_terseLabel_en-US" xlink:label="lab_sny_BusinessCombinationPurchasePricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price (in EUR/USD per share)</link:label>
    <link:label id="lab_sny_BusinessCombinationPurchasePricePerShare_label_en-US" xlink:label="lab_sny_BusinessCombinationPurchasePricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Per Share</link:label>
    <link:label id="lab_sny_BusinessCombinationPurchasePricePerShare_documentation_en-US" xlink:label="lab_sny_BusinessCombinationPurchasePricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationPurchasePricePerShare" xlink:href="sny-20221231.xsd#sny_BusinessCombinationPurchasePricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BusinessCombinationPurchasePricePerShare" xlink:to="lab_sny_BusinessCombinationPurchasePricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ZantacLitigationInCanadaMember_1c83f2c6-55cb-4d7e-833a-5647e469da91_terseLabel_en-US" xlink:label="lab_sny_ZantacLitigationInCanadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zantac litigation in Canada</link:label>
    <link:label id="lab_sny_ZantacLitigationInCanadaMember_label_en-US" xlink:label="lab_sny_ZantacLitigationInCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zantac Litigation In Canada [Member]</link:label>
    <link:label id="lab_sny_ZantacLitigationInCanadaMember_documentation_en-US" xlink:label="lab_sny_ZantacLitigationInCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zantac Litigation In Canada</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ZantacLitigationInCanadaMember" xlink:href="sny-20221231.xsd#sny_ZantacLitigationInCanadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ZantacLitigationInCanadaMember" xlink:to="lab_sny_ZantacLitigationInCanadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember_20f2782b-f6c2-433b-9512-f718001f2e80_terseLabel_en-US" xlink:label="lab_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees provided to banks in connection with credit facilities</link:label>
    <link:label id="lab_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember_label_en-US" xlink:label="lab_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees Provided To Banks In Connection With Credit Facilities [Member]</link:label>
    <link:label id="lab_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember_documentation_en-US" xlink:label="lab_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees provided to banks in connection with credit facilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember" xlink:href="sny-20221231.xsd#sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember" xlink:to="lab_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_dda0f388-90aa-43d9-a2c5-9e3d658381df_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other cash flows</link:label>
    <link:label id="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other inflows (outflows) of cash, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherAdjustmentsForNoncashItems_7f4c28a2-54fa-474c-bfea-ff019b44e246_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherAdjustmentsForNoncashItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other items</link:label>
    <link:label id="lab_ifrs-full_OtherAdjustmentsForNoncashItems_label_en-US" xlink:label="lab_ifrs-full_OtherAdjustmentsForNoncashItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments for non-cash items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsForNoncashItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsForNoncashItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAdjustmentsForNoncashItems" xlink:to="lab_ifrs-full_OtherAdjustmentsForNoncashItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ActuarialAssumptionOfMortalityTableMember_45a05eb2-e09d-48af-a22a-3f0ef50777e6_terseLabel_en-US" xlink:label="lab_sny_ActuarialAssumptionOfMortalityTableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortality table</link:label>
    <link:label id="lab_sny_ActuarialAssumptionOfMortalityTableMember_label_en-US" xlink:label="lab_sny_ActuarialAssumptionOfMortalityTableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial Assumption Of Mortality Table [Member]</link:label>
    <link:label id="lab_sny_ActuarialAssumptionOfMortalityTableMember_documentation_en-US" xlink:label="lab_sny_ActuarialAssumptionOfMortalityTableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumption of mortality table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialAssumptionOfMortalityTableMember" xlink:href="sny-20221231.xsd#sny_ActuarialAssumptionOfMortalityTableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActuarialAssumptionOfMortalityTableMember" xlink:to="lab_sny_ActuarialAssumptionOfMortalityTableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_3db61740-eaa3-47e1-b838-3b601347ef68_negatedLabel_en-US" xlink:label="lab_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options, options cancelled (in shares)</link:label>
    <link:label id="lab_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Share Options Cancelled In Share-Based Payment Arrangement</link:label>
    <link:label id="lab_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Share Options Cancelled In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:href="sny-20221231.xsd#sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:to="lab_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReclassifiedItemsAxis_f9efd002-1ead-424a-a4de-f2a9f46ab444_terseLabel_en-US" xlink:label="lab_ifrs-full_ReclassifiedItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified items [axis]</link:label>
    <link:label id="lab_ifrs-full_ReclassifiedItemsAxis_label_en-US" xlink:label="lab_ifrs-full_ReclassifiedItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified items [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassifiedItemsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReclassifiedItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassifiedItemsAxis" xlink:to="lab_ifrs-full_ReclassifiedItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherOperatingIncomeExpense_c63714ed-2171-4fb6-9b85-85f76ce1aaa1_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income/(expenses), net related to the Regeneron Alliance</link:label>
    <link:label id="lab_ifrs-full_OtherOperatingIncomeExpense_b2618ca2-41d3-42a0-ad74-546af8571ccd_negatedLabel_en-US" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating (income)/expenses, net</link:label>
    <link:label id="lab_ifrs-full_OtherOperatingIncomeExpense_label_en-US" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income (expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_KadmonHoldingsIncMember_526525a9-7e8f-4921-ad9b-6af4efc8ebc6_terseLabel_en-US" xlink:label="lab_sny_KadmonHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kadmon Holdings, Inc.</link:label>
    <link:label id="lab_sny_KadmonHoldingsIncMember_label_en-US" xlink:label="lab_sny_KadmonHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kadmon Holdings, Inc [Member]</link:label>
    <link:label id="lab_sny_KadmonHoldingsIncMember_documentation_en-US" xlink:label="lab_sny_KadmonHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kadmon Holdings, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KadmonHoldingsIncMember" xlink:href="sny-20221231.xsd#sny_KadmonHoldingsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_KadmonHoldingsIncMember" xlink:to="lab_sny_KadmonHoldingsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_1a97ffeb-e28b-42c3-bd6c-4d0a6ada6ef9_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PercentageOfEntitysRevenue_75f01de6-8d99-4605-a609-5fa614079f29_terseLabel_en-US" xlink:label="lab_ifrs-full_PercentageOfEntitysRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of entity's revenue (in percent)</link:label>
    <link:label id="lab_ifrs-full_PercentageOfEntitysRevenue_label_en-US" xlink:label="lab_ifrs-full_PercentageOfEntitysRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of entity's revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfEntitysRevenue" xlink:to="lab_ifrs-full_PercentageOfEntitysRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock_26ac3507-5a09-4b06-9934-a21382a66762_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Useful Lives of Property, Plant and Equipment</link:label>
    <link:label id="lab_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Estimated Useful Lives Of Property Plant And Equipment Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of estimated useful lives of property plant and equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_2d4f3ca0-fc29-4d0e-b2b1-4cba714bed47_terseLabel_en-US" xlink:label="lab_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities related to assets held for sale or exchange</link:label>
    <link:label id="lab_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_label_en-US" xlink:label="lab_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities included in disposal groups classified as held for sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="lab_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_6e809382-cd04-4995-8973-e241f3fafdd0_terseLabel_en-US" xlink:label="lab_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Items subsequently reclassifiable to profit or loss</link:label>
    <link:label id="lab_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_label_en-US" xlink:label="lab_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Items Subsequently Reclassifiable To Profit Or Loss [Member]</link:label>
    <link:label id="lab_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_documentation_en-US" xlink:label="lab_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Items subsequently reclassifiable to profit or loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:href="sny-20221231.xsd#sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:to="lab_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock_6e7d97bd-b2e3-414e-b7a9-75e1e10d8d67_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Impairment Losses Recognised in Property, Plant and Equipment</link:label>
    <link:label id="lab_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Impairment Losses of Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Impairment Losses of Property, Plant and Equipment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock" xlink:to="lab_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_e44710b6-cfeb-40e1-879f-233984f69fbc_negatedLabel_en-US" xlink:label="lab_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">to shareholders of Sanofi</link:label>
    <link:label id="lab_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid to equity holders of parent, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug_392b8c32-53ca-46ed-94e6-cbb8908d1e96_terseLabel_en-US" xlink:label="lab_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of manufacturers with marketing authorization for generic version of drug</link:label>
    <link:label id="lab_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug_label_en-US" xlink:label="lab_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Manufacturers With Marketing Authorization For Generic Version Of Drug</link:label>
    <link:label id="lab_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug_documentation_en-US" xlink:label="lab_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Manufacturers With Marketing Authorization For Generic Version Of Drug</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug" xlink:href="sny-20221231.xsd#sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug" xlink:to="lab_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Cash_a2bc8a8c-fddf-4bc0-918f-e167f7c64216_terseLabel_en-US" xlink:label="lab_ifrs-full_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_ifrs-full_Cash_label_en-US" xlink:label="lab_ifrs-full_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash" xlink:to="lab_ifrs-full_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PerformanceObjectiveNumberOfCountries_f73fbed5-69b2-4156-86bc-abaa0fde6344_terseLabel_en-US" xlink:label="lab_sny_PerformanceObjectiveNumberOfCountries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries</link:label>
    <link:label id="lab_sny_PerformanceObjectiveNumberOfCountries_label_en-US" xlink:label="lab_sny_PerformanceObjectiveNumberOfCountries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Objective, Number Of Countries</link:label>
    <link:label id="lab_sny_PerformanceObjectiveNumberOfCountries_documentation_en-US" xlink:label="lab_sny_PerformanceObjectiveNumberOfCountries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Objective, Number Of Countries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceObjectiveNumberOfCountries" xlink:href="sny-20221231.xsd#sny_PerformanceObjectiveNumberOfCountries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PerformanceObjectiveNumberOfCountries" xlink:to="lab_sny_PerformanceObjectiveNumberOfCountries" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LengthOfTrial_8fe0de50-9cfb-4bfe-968e-db2368bc319c_terseLabel_en-US" xlink:label="lab_sny_LengthOfTrial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Length of trial (in days)</link:label>
    <link:label id="lab_sny_LengthOfTrial_label_en-US" xlink:label="lab_sny_LengthOfTrial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Length Of Trial</link:label>
    <link:label id="lab_sny_LengthOfTrial_documentation_en-US" xlink:label="lab_sny_LengthOfTrial" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Length Of Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LengthOfTrial" xlink:href="sny-20221231.xsd#sny_LengthOfTrial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LengthOfTrial" xlink:to="lab_sny_LengthOfTrial" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherCurrentReceivables_591f7729-84af-4af7-992e-58acc3c4e6bc_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherCurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_ifrs-full_OtherCurrentReceivables_label_en-US" xlink:label="lab_ifrs-full_OtherCurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentReceivables" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentReceivables" xlink:to="lab_ifrs-full_OtherCurrentReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GeographicalAreasMember_0abd5f01-fed1-4dd4-bc1a-3f9718e5f0c4_terseLabel_en-US" xlink:label="lab_ifrs-full_GeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical areas [member]</link:label>
    <link:label id="lab_ifrs-full_GeographicalAreasMember_label_en-US" xlink:label="lab_ifrs-full_GeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical areas [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasMember" xlink:to="lab_ifrs-full_GeographicalAreasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfProvisionsAxis_b9789d2c-dc6a-4f9e-a63c-40ce5c489559_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfProvisionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of other provisions [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfProvisionsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfProvisionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of other provisions [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis" xlink:to="lab_ifrs-full_ClassesOfProvisionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForTaxServices_8d6c8785-873b-467a-9b1b-c2765f20a8f0_terseLabel_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForTaxServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax</link:label>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForTaxServices_label_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForTaxServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor's remuneration for tax services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForTaxServices" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForTaxServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemunerationForTaxServices" xlink:to="lab_ifrs-full_AuditorsRemunerationForTaxServices" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems_425eb914-b674-4703-839f-0651fec7f1d6_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of operating segments [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of operating segments [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SGD_11ceb01d-84cf-4617-83d8-8ab70a47902c_terseLabel_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore dollar</link:label>
    <link:label id="lab_currency_SGD_label_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_SGD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SGD" xlink:to="lab_currency_SGD" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GainLossOnPurchaseOfTreasuryShares_0549f668-f889-4d4c-9330-1464a1389117_terseLabel_en-US" xlink:label="lab_sny_GainLossOnPurchaseOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized on purchase of treasury shares</link:label>
    <link:label id="lab_sny_GainLossOnPurchaseOfTreasuryShares_label_en-US" xlink:label="lab_sny_GainLossOnPurchaseOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Purchase Of Treasury Shares</link:label>
    <link:label id="lab_sny_GainLossOnPurchaseOfTreasuryShares_documentation_en-US" xlink:label="lab_sny_GainLossOnPurchaseOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on purchase of treasury shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainLossOnPurchaseOfTreasuryShares" xlink:href="sny-20221231.xsd#sny_GainLossOnPurchaseOfTreasuryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainLossOnPurchaseOfTreasuryShares" xlink:to="lab_sny_GainLossOnPurchaseOfTreasuryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_bb563d41-6250-4d27-b7ad-657d7416695d_verboseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to equity holders of Sanofi</link:label>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_c3999823-a426-4861-b011-4bbe912cea1f_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Attributable to equity holders of Sanofi</link:label>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_label_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit (loss), attributable to owners of parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfNoncurrentProvisionsTable_4df10f91-9f48-475f-b5fe-9b3b5c98eb89_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfNoncurrentProvisionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Noncurrent Provisions [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfNoncurrentProvisionsTable_label_en-US" xlink:label="lab_sny_DisclosureOfNoncurrentProvisionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Noncurrent Provisions [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfNoncurrentProvisionsTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfNoncurrentProvisionsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Noncurrent Provisions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNoncurrentProvisionsTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfNoncurrentProvisionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNoncurrentProvisionsTable" xlink:to="lab_sny_DisclosureOfNoncurrentProvisionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_12c3115a-8444-46d3-b980-cb3cf3b5e493_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets_bf5861a5-6935-476f-a6b0-66798971a744_terseLabel_en-US" xlink:label="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes&#160;in&#160;scope of&#160;consolidation</link:label>
    <link:label id="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets_label_en-US" xlink:label="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Scope Of Consolidation Through Business Combination, Intangible Assets</link:label>
    <link:label id="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets_documentation_en-US" xlink:label="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Scope Of Consolidation Through Business Combination, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xlink:href="sny-20221231.xsd#sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xlink:to="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1c93c347-8e29-4a5e-b287-b9c7bcce9bf1_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_a532aced-a173-4d6f-bfb9-a22c62827810_verboseLabel_en-US" xlink:label="lab_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt and current portion of long-term debt</link:label>
    <link:label id="lab_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_label_en-US" xlink:label="lab_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current borrowings and current portion of non-current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:to="lab_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NotLaterThanOneMonthMember_c84dabd5-3aee-4dfa-828b-e7652e5903a7_terseLabel_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneMonthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 1 month</link:label>
    <link:label id="lab_ifrs-full_NotLaterThanOneMonthMember_label_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneMonthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not later than one month [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneMonthMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneMonthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneMonthMember" xlink:to="lab_ifrs-full_NotLaterThanOneMonthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_b74370c4-1da2-4ed4-838e-58a1c4e01612_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financial assets at fair value through profit or loss</link:label>
    <link:label id="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current financial assets at fair value through profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock_9a9ee6d4-9630-4d9a-9d3e-e073b52b5d03_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets and liabilities measured at fair value</link:label>
    <link:label id="lab_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Financial Assets And Liabilities At Fair Value Explanatory [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of financial assets and liabilities at fair value explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock" xlink:to="lab_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTradeReceivables_b94ceb6f-8cbf-4919-9320-c4e53eb462bd_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTradeReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_ifrs-full_CurrentTradeReceivables_label_en-US" xlink:label="lab_ifrs-full_CurrentTradeReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current trade receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTradeReceivables" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables" xlink:to="lab_ifrs-full_CurrentTradeReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment_456c7882-d8ff-4986-a2b4-17d7227b6ab8_terseLabel_en-US" xlink:label="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in scope of consolidation</link:label>
    <link:label id="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Scope Of Consolidation Through Business Combinations, Property, Plant And Equipment</link:label>
    <link:label id="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment_documentation_en-US" xlink:label="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Scope Of Consolidation Through Business Combinations, Property, Plant And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="sny-20221231.xsd#sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_00d31b0d-8936-4c9a-b587-471183ec9eaf_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LeaseLiabilities_7f09ee96-ce60-49f8-bf35-1af6b72b57db_terseLabel_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_ifrs-full_LeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities" xlink:to="lab_ifrs-full_LeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EliminationOfIntersegmentAmountsMember_0b50b2e8-a336-459f-869f-9301c1c73275_terseLabel_en-US" xlink:label="lab_ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elimination of inter-segment amounts</link:label>
    <link:label id="lab_ifrs-full_EliminationOfIntersegmentAmountsMember_label_en-US" xlink:label="lab_ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elimination of intersegment amounts [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EliminationOfIntersegmentAmountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:to="lab_ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfAssetsMember_e052aede-d638-4612-8336-44eef07dfd94_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_ifrs-full_ClassesOfAssetsMember_label_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsMember" xlink:to="lab_ifrs-full_ClassesOfAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CoreAssetsMember_2b91b5dd-00bf-42a1-8c2f-01a1fa1ae0a3_terseLabel_en-US" xlink:label="lab_sny_CoreAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core Assets</link:label>
    <link:label id="lab_sny_CoreAssetsMember_label_en-US" xlink:label="lab_sny_CoreAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core Assets [Member]</link:label>
    <link:label id="lab_sny_CoreAssetsMember_documentation_en-US" xlink:label="lab_sny_CoreAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CoreAssetsMember" xlink:href="sny-20221231.xsd#sny_CoreAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CoreAssetsMember" xlink:to="lab_sny_CoreAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncontrollingInterestsMember_76fcfd45-071e-408d-98a2-75385d9a634e_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Attributable to&#160;non- controlling interests</link:label>
    <link:label id="lab_ifrs-full_NoncontrollingInterestsMember_label_en-US" xlink:label="lab_ifrs-full_NoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterestsMember" xlink:to="lab_ifrs-full_NoncontrollingInterestsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember_7acd2b4c-3bed-4c37-a9e2-9c701d8740db_terseLabel_en-US" xlink:label="lab_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration arising from acquisition of Amunix</link:label>
    <link:label id="lab_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember_label_en-US" xlink:label="lab_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Arising From The Acquisition Of Amunix [Member]</link:label>
    <link:label id="lab_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember_documentation_en-US" xlink:label="lab_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Arising From The Acquisition Of Amunix</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember" xlink:to="lab_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_af6bdcf2-8fe7-4c24-b816-6e07868a8181_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_8272c1da-173e-4eb3-acad-6b7b960a3c60_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains/(losses)</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_706d89a3-7f7c-4555-956a-fec5f9c5cc61_negatedLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses/(gains) due to changes in financial assumptions</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_b52c9e4a-c1e0-463a-abfa-e72643f1ce0e_verboseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains/(losses) on financial assumptions</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiIndiaLimitedMember_10f126c0-2272-4ae1-8ed1-f58fee06cae0_terseLabel_en-US" xlink:label="lab_sny_SanofiIndiaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi India Limited</link:label>
    <link:label id="lab_sny_SanofiIndiaLimitedMember_label_en-US" xlink:label="lab_sny_SanofiIndiaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi India Limited [Member]</link:label>
    <link:label id="lab_sny_SanofiIndiaLimitedMember_documentation_en-US" xlink:label="lab_sny_SanofiIndiaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi India Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiIndiaLimitedMember" xlink:href="sny-20221231.xsd#sny_SanofiIndiaLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiIndiaLimitedMember" xlink:to="lab_sny_SanofiIndiaLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AventisIncMember_eaedbac1-b9f0-42ba-9fa7-e8aec78f5b97_terseLabel_en-US" xlink:label="lab_sny_AventisIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Inc.</link:label>
    <link:label id="lab_sny_AventisIncMember_label_en-US" xlink:label="lab_sny_AventisIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Inc [member]</link:label>
    <link:label id="lab_sny_AventisIncMember_documentation_en-US" xlink:label="lab_sny_AventisIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisIncMember" xlink:href="sny-20221231.xsd#sny_AventisIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AventisIncMember" xlink:to="lab_sny_AventisIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ApplicableTaxRate_5eb49274-a640-4a81-a4f5-874af2509eb8_terseLabel_en-US" xlink:label="lab_ifrs-full_ApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard tax rate applicable in France</link:label>
    <link:label id="lab_ifrs-full_ApplicableTaxRate_label_en-US" xlink:label="lab_ifrs-full_ApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable tax rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ApplicableTaxRate" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate" xlink:to="lab_ifrs-full_ApplicableTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ResearchSitesMember_8b7cda84-ae6b-4c29-bddc-a453bf19e7b5_terseLabel_en-US" xlink:label="lab_sny_ResearchSitesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research sites</link:label>
    <link:label id="lab_sny_ResearchSitesMember_label_en-US" xlink:label="lab_sny_ResearchSitesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Sites [Member]</link:label>
    <link:label id="lab_sny_ResearchSitesMember_documentation_en-US" xlink:label="lab_sny_ResearchSitesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research sites.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ResearchSitesMember" xlink:href="sny-20221231.xsd#sny_ResearchSitesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ResearchSitesMember" xlink:to="lab_sny_ResearchSitesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GuaranteesReceivedMember_e40c33ef-8934-4108-9fd4-bbdee0f01db6_terseLabel_en-US" xlink:label="lab_sny_GuaranteesReceivedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees received</link:label>
    <link:label id="lab_sny_GuaranteesReceivedMember_label_en-US" xlink:label="lab_sny_GuaranteesReceivedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees Received [Member]</link:label>
    <link:label id="lab_sny_GuaranteesReceivedMember_documentation_en-US" xlink:label="lab_sny_GuaranteesReceivedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GuaranteesReceivedMember" xlink:href="sny-20221231.xsd#sny_GuaranteesReceivedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GuaranteesReceivedMember" xlink:to="lab_sny_GuaranteesReceivedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ConsumerHealthcareMember_394bef0c-ae73-4c28-b5d0-a0aeed1652af_terseLabel_en-US" xlink:label="lab_sny_ConsumerHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Healthcare</link:label>
    <link:label id="lab_sny_ConsumerHealthcareMember_label_en-US" xlink:label="lab_sny_ConsumerHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Healthcare [Member]</link:label>
    <link:label id="lab_sny_ConsumerHealthcareMember_documentation_en-US" xlink:label="lab_sny_ConsumerHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Healthcare.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareMember" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ConsumerHealthcareMember" xlink:to="lab_sny_ConsumerHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_d29dd459-3bcd-482a-a2a6-7f5dae89cd89_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from sale of Regeneron shares on May&#160;29, 2020</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_80d5ba25-201b-4689-a259-88bb520a2502_verboseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of investments accounted for using equity method</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of investments accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentContractLiabilities_f1c90ae7-9972-4a29-a9a4-db08698bb0e0_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contract liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentContractLiabilities_d4ad1d7a-b7fd-4630-8f9e-be30696dc5c4_verboseLabel_en-US" xlink:label="lab_ifrs-full_CurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contract liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentContractLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contract liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentContractLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentContractLiabilities" xlink:to="lab_ifrs-full_CurrentContractLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock_6e6d7bbd-9eb3-40ed-b156-b979a946abe0_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents</link:label>
    <link:label id="lab_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of sensitivity Analysis On Long-term Borrowings And Debt Securities Assuming A 1% Increase And Decrease In Interest Rates [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of sensitivity analysis on long-term borrowings and debt securities assuming a 1% increase and decrease in interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock" xlink:to="lab_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ParticipatingSharesMember_6cd77c84-15dd-4c7b-8870-9ad9b696fcad_terseLabel_en-US" xlink:label="lab_sny_ParticipatingSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1983 to 1987 participating shares issued</link:label>
    <link:label id="lab_sny_ParticipatingSharesMember_label_en-US" xlink:label="lab_sny_ParticipatingSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Shares [Member]</link:label>
    <link:label id="lab_sny_ParticipatingSharesMember_documentation_en-US" xlink:label="lab_sny_ParticipatingSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ParticipatingSharesMember" xlink:href="sny-20221231.xsd#sny_ParticipatingSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ParticipatingSharesMember" xlink:to="lab_sny_ParticipatingSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_ffefc287-ff7f-4856-a365-0afd489bb8bb_terseLabel_en-US" xlink:label="lab_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amortisation period of intangible assets material to entity</link:label>
    <link:label id="lab_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_label_en-US" xlink:label="lab_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amortisation period of intangible assets material to entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" xlink:to="lab_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MiscellaneousOtherOperatingIncomeExpenses_cc6a3bba-8b3c-4ccb-bec7-356760d9b5e5_terseLabel_en-US" xlink:label="lab_sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income and expenses</link:label>
    <link:label id="lab_sny_MiscellaneousOtherOperatingIncomeExpenses_label_en-US" xlink:label="lab_sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous Other Operating Income (Expenses)</link:label>
    <link:label id="lab_sny_MiscellaneousOtherOperatingIncomeExpenses_documentation_en-US" xlink:label="lab_sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income and expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:href="sny-20221231.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:to="lab_sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanOneYearMember_2c8c3c61-4c62-4f28-96e3-58361aa6eecd_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than 12 months</link:label>
    <link:label id="lab_ifrs-full_LaterThanOneYearMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than one year [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearMember" xlink:to="lab_ifrs-full_LaterThanOneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossCarryingAmountMember_df51210c-64db-4b7d-b765-611209b9e57f_terseLabel_en-US" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross value</link:label>
    <link:label id="lab_ifrs-full_GrossCarryingAmountMember_label_en-US" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross carrying amount [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember" xlink:to="lab_ifrs-full_GrossCarryingAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShanghaiRonghengPharmaceuticalCoLtdMember_bbf0e044-ad77-467e-be73-a845406cadbe_terseLabel_en-US" xlink:label="lab_sny_ShanghaiRonghengPharmaceuticalCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shanghai Rongheng Pharmaceutical Co, Ltd</link:label>
    <link:label id="lab_sny_ShanghaiRonghengPharmaceuticalCoLtdMember_label_en-US" xlink:label="lab_sny_ShanghaiRonghengPharmaceuticalCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shanghai Rongheng Pharmaceutical Co. Ltd [Member]</link:label>
    <link:label id="lab_sny_ShanghaiRonghengPharmaceuticalCoLtdMember_documentation_en-US" xlink:label="lab_sny_ShanghaiRonghengPharmaceuticalCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shanghai Rongheng Pharmaceutical Co. Ltd</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShanghaiRonghengPharmaceuticalCoLtdMember" xlink:href="sny-20221231.xsd#sny_ShanghaiRonghengPharmaceuticalCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShanghaiRonghengPharmaceuticalCoLtdMember" xlink:to="lab_sny_ShanghaiRonghengPharmaceuticalCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems_e16b0069-1301-448b-bd6e-ba7949f829ab_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of acquisitions of property plant and equipment by operating segments [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Acquisitions Of Property Plant And Equipment By Operating Segments [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of acquisitions of property plant and equipment by operating segments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems" xlink:to="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_f98d601d-ac13-4f76-bd31-cd7ea742dcc2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Events subsequent to December 31, 2022</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of events after reporting period [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InnoventBiologicsMember_d4035c06-9910-422a-8d40-8e21a632868b_terseLabel_en-US" xlink:label="lab_sny_InnoventBiologicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Innovent Biologics</link:label>
    <link:label id="lab_sny_InnoventBiologicsMember_label_en-US" xlink:label="lab_sny_InnoventBiologicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Innovent Biologics [Member]</link:label>
    <link:label id="lab_sny_InnoventBiologicsMember_documentation_en-US" xlink:label="lab_sny_InnoventBiologicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Innovent Biologics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InnoventBiologicsMember" xlink:href="sny-20221231.xsd#sny_InnoventBiologicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InnoventBiologicsMember" xlink:to="lab_sny_InnoventBiologicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_80f1d9bc-75cc-4aef-9f9b-39c4eb51def4_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets and goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_ea532ada-640f-4632-9708-0dd72d176cb5_terseLabel_en-US" xlink:label="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities related to business combinations and to non-controlling interests</link:label>
    <link:label id="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_label_en-US" xlink:label="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities Related To Business Combinations And To Non-Controlling Interests</link:label>
    <link:label id="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_documentation_en-US" xlink:label="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This account includes current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes current portion of liabilities related to non-controlling interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:href="sny-20221231.xsd#sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:to="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember_95df8cd9-6307-4398-af51-d18232ba963b_terseLabel_en-US" xlink:label="lab_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interests in subsidiaries and investments in other entities</link:label>
    <link:label id="lab_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember_label_en-US" xlink:label="lab_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interests In Subsidiaries And Investments In Other Entities [member]</link:label>
    <link:label id="lab_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember_documentation_en-US" xlink:label="lab_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interests in subsidiaries and investments in other entities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember" xlink:href="sny-20221231.xsd#sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember" xlink:to="lab_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_ab61b732-91d3-48c7-9480-5fb5ceb819bc_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures_c90dce84-12c2-4c71-9526-e124659e080a_totalLabel_en-US" xlink:label="lab_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Share Of Profit And Comprehensive Income Of Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" xlink:to="lab_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_784c8452-7d7b-4176-95b6-22ae80b5ef4f_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAuditFeesAndOtherServicesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of audit fees and other services [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfAuditFeesAndOtherServicesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Audit Fees And Other Services [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfAuditFeesAndOtherServicesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of audit fees and other services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfAuditFeesAndOtherServicesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems" xlink:to="lab_sny_DisclosureOfAuditFeesAndOtherServicesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_8debeea1-19cc-49b8-9fbf-ac0dd154f74b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RelatedPartyAbstract_8079a57d-24ee-45da-b745-1fc67d1afc6a_terseLabel_en-US" xlink:label="lab_sny_RelatedPartyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Abstract]</link:label>
    <link:label id="lab_sny_RelatedPartyAbstract_label_en-US" xlink:label="lab_sny_RelatedPartyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Abstract]</link:label>
    <link:label id="lab_sny_RelatedPartyAbstract_documentation_en-US" xlink:label="lab_sny_RelatedPartyAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RelatedPartyAbstract" xlink:href="sny-20221231.xsd#sny_RelatedPartyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RelatedPartyAbstract" xlink:to="lab_sny_RelatedPartyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GainLossOnSaleOfTreasuryShares_a86e96fa-1a5f-40c2-97da-9d51abbee968_terseLabel_en-US" xlink:label="lab_sny_GainLossOnSaleOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized on sale of treasury shares</link:label>
    <link:label id="lab_sny_GainLossOnSaleOfTreasuryShares_label_en-US" xlink:label="lab_sny_GainLossOnSaleOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Sale Of Treasury Shares</link:label>
    <link:label id="lab_sny_GainLossOnSaleOfTreasuryShares_documentation_en-US" xlink:label="lab_sny_GainLossOnSaleOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sale of treasury shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainLossOnSaleOfTreasuryShares" xlink:href="sny-20221231.xsd#sny_GainLossOnSaleOfTreasuryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainLossOnSaleOfTreasuryShares" xlink:to="lab_sny_GainLossOnSaleOfTreasuryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock_5a9e5869-9444-423f-b6cb-67fae8b625bf_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement Line Items</link:label>
    <link:label id="lab_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Expense For Pensions And Other Post Employment Benefits By Income Statement Line Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of expense for pensions and other post employment benefits by income statement line.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DerivativeFinancialLiabilitiesMember_eabc911a-fcfb-4758-9da1-a0800f395550_terseLabel_en-US" xlink:label="lab_sny_DerivativeFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial liabilities</link:label>
    <link:label id="lab_sny_DerivativeFinancialLiabilitiesMember_label_en-US" xlink:label="lab_sny_DerivativeFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Liabilities [Member]</link:label>
    <link:label id="lab_sny_DerivativeFinancialLiabilitiesMember_documentation_en-US" xlink:label="lab_sny_DerivativeFinancialLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialLiabilitiesMember" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerivativeFinancialLiabilitiesMember" xlink:to="lab_sny_DerivativeFinancialLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfCivilClaimsOnGoing_045d28b3-577d-4eba-8304-99769123e78b_terseLabel_en-US" xlink:label="lab_sny_NumberOfCivilClaimsOnGoing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of civil claims on-going</link:label>
    <link:label id="lab_sny_NumberOfCivilClaimsOnGoing_label_en-US" xlink:label="lab_sny_NumberOfCivilClaimsOnGoing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Civil Claims On-Going</link:label>
    <link:label id="lab_sny_NumberOfCivilClaimsOnGoing_documentation_en-US" xlink:label="lab_sny_NumberOfCivilClaimsOnGoing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Civil Claims On-Going</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCivilClaimsOnGoing" xlink:href="sny-20221231.xsd#sny_NumberOfCivilClaimsOnGoing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfCivilClaimsOnGoing" xlink:to="lab_sny_NumberOfCivilClaimsOnGoing" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket_c4b9dc44-272b-4241-abdc-543a17d6b809_terseLabel_en-US" xlink:label="lab_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities quoted in an active market</link:label>
    <link:label id="lab_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket_label_en-US" xlink:label="lab_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Contributed To Fair Value Of Plan Assets, Securities Quoted In An Active Market</link:label>
    <link:label id="lab_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket_documentation_en-US" xlink:label="lab_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Contributed To Fair Value Of Plan Assets, Securities Quoted In An Active Market</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" xlink:to="lab_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod_0088edaf-b54b-4ed3-8285-7fbbab39fa02_terseLabel_en-US" xlink:label="lab_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest in subsidiary, minimum holding period</link:label>
    <link:label id="lab_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod_label_en-US" xlink:label="lab_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership Interest In Subsidiary, Minimum Holding Period</link:label>
    <link:label id="lab_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod_documentation_en-US" xlink:label="lab_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership Interest In Subsidiary, Minimum Holding Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod" xlink:href="sny-20221231.xsd#sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod" xlink:to="lab_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_2f306b60-6d01-4c79-b5c5-6441177fd9a4_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_March2019EMTNISINFR0013409844Member_e5ba073b-8dd7-4dde-9afe-dbef2f3976c5_terseLabel_en-US" xlink:label="lab_sny_March2019EMTNISINFR0013409844Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2019 EMTN ISIN FR0013409844</link:label>
    <link:label id="lab_sny_March2019EMTNISINFR0013409844Member_label_en-US" xlink:label="lab_sny_March2019EMTNISINFR0013409844Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2019 EMTN ISIN FR0013409844 [Member]</link:label>
    <link:label id="lab_sny_March2019EMTNISINFR0013409844Member_documentation_en-US" xlink:label="lab_sny_March2019EMTNISINFR0013409844Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2019 EMTN ISIN FR0013409844 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2019EMTNISINFR0013409844Member" xlink:href="sny-20221231.xsd#sny_March2019EMTNISINFR0013409844Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_March2019EMTNISINFR0013409844Member" xlink:to="lab_sny_March2019EMTNISINFR0013409844Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AventisCropScienceRetainedLiabilitiesMember_f3523232-6bf7-4fae-8345-3d15abec4aba_terseLabel_en-US" xlink:label="lab_sny_AventisCropScienceRetainedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Crop Science retained liabilities</link:label>
    <link:label id="lab_sny_AventisCropScienceRetainedLiabilitiesMember_label_en-US" xlink:label="lab_sny_AventisCropScienceRetainedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Crop Science Retained Liabilities [member]</link:label>
    <link:label id="lab_sny_AventisCropScienceRetainedLiabilitiesMember_documentation_en-US" xlink:label="lab_sny_AventisCropScienceRetainedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis crop science retained liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisCropScienceRetainedLiabilitiesMember" xlink:href="sny-20221231.xsd#sny_AventisCropScienceRetainedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AventisCropScienceRetainedLiabilitiesMember" xlink:to="lab_sny_AventisCropScienceRetainedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MilestoneTypesAxis_dc339348-1d7f-4c1c-91fe-94338c4f39ac_terseLabel_en-US" xlink:label="lab_sny_MilestoneTypesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Types [Axis]</link:label>
    <link:label id="lab_sny_MilestoneTypesAxis_label_en-US" xlink:label="lab_sny_MilestoneTypesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Types [Axis]</link:label>
    <link:label id="lab_sny_MilestoneTypesAxis_documentation_en-US" xlink:label="lab_sny_MilestoneTypesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Types</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MilestoneTypesAxis" xlink:href="sny-20221231.xsd#sny_MilestoneTypesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MilestoneTypesAxis" xlink:to="lab_sny_MilestoneTypesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_52de71c2-5221-47b0-8d4e-ecd1a67bd203_verboseLabel_en-US" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current provisions and other non-current liabilities</link:label>
    <link:label id="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_cb324205-0713-4094-afe2-e201975a7e72_totalLabel_en-US" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_84e08d76-6516-497e-8616-9c811aaa6d8d_periodStartLabel_en-US" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period</link:label>
    <link:label id="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_58556f15-5dfc-48a1-b339-509f61f9ba9d_periodEndLabel_en-US" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period</link:label>
    <link:label id="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Provisions And Other Noncurrent Liabilities</link:label>
    <link:label id="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_documentation_en-US" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of non-current provisions and non-current other liabilities that the entity does not separately disclose in the same statement or note.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities" xlink:to="lab_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ErnstYoungEtAutresMember_437d5b9b-d19e-4e51-8ece-d43e3ea9a248_terseLabel_en-US" xlink:label="lab_sny_ErnstYoungEtAutresMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ernst &amp; Young et Autres</link:label>
    <link:label id="lab_sny_ErnstYoungEtAutresMember_label_en-US" xlink:label="lab_sny_ErnstYoungEtAutresMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ernst &amp; Young Et Autres [Member]</link:label>
    <link:label id="lab_sny_ErnstYoungEtAutresMember_documentation_en-US" xlink:label="lab_sny_ErnstYoungEtAutresMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ernst &amp; Young Et Autres</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ErnstYoungEtAutresMember" xlink:href="sny-20221231.xsd#sny_ErnstYoungEtAutresMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ErnstYoungEtAutresMember" xlink:to="lab_sny_ErnstYoungEtAutresMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TopOfRangeMember_54b58c62-1a07-4086-a743-0d6d5c6dcbcb_terseLabel_en-US" xlink:label="lab_ifrs-full_TopOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top of range</link:label>
    <link:label id="lab_ifrs-full_TopOfRangeMember_label_en-US" xlink:label="lab_ifrs-full_TopOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top of range [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember" xlink:to="lab_ifrs-full_TopOfRangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_31c2d91e-635a-4e4d-8667-cb9123359bcb_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by/(used in) investing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used in) investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisHealthcarePtyLtdMember_baf47883-27c7-4118-8aa8-6883207e6526_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisHealthcarePtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Healthcare Pty Ltd</link:label>
    <link:label id="lab_sny_SanofiAventisHealthcarePtyLtdMember_label_en-US" xlink:label="lab_sny_SanofiAventisHealthcarePtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Healthcare Pty Ltd [member]</link:label>
    <link:label id="lab_sny_SanofiAventisHealthcarePtyLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisHealthcarePtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Healthcare Pty Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisHealthcarePtyLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisHealthcarePtyLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisHealthcarePtyLtdMember" xlink:to="lab_sny_SanofiAventisHealthcarePtyLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_e2e0832a-bf61-412c-911b-d1c31071b3a0_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New pronouncements issued by IASB and applicable from 2023 or later</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember_17f9b843-4bb1-4ee4-9c3a-c4c319b95ea7_terseLabel_en-US" xlink:label="lab_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value on redemption before derivative instruments</link:label>
    <link:label id="lab_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember_label_en-US" xlink:label="lab_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value On Redemption Before Derivative Instruments [Member]</link:label>
    <link:label id="lab_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember_documentation_en-US" xlink:label="lab_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value on redemption before derivative instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember" xlink:to="lab_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OutsideUnitedStatesMember_b4a7277a-4be2-45d7-97e5-f5721a4166c0_terseLabel_en-US" xlink:label="lab_sny_OutsideUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside the United States</link:label>
    <link:label id="lab_sny_OutsideUnitedStatesMember_label_en-US" xlink:label="lab_sny_OutsideUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside United States [member]</link:label>
    <link:label id="lab_sny_OutsideUnitedStatesMember_documentation_en-US" xlink:label="lab_sny_OutsideUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside United States.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OutsideUnitedStatesMember" xlink:href="sny-20221231.xsd#sny_OutsideUnitedStatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OutsideUnitedStatesMember" xlink:to="lab_sny_OutsideUnitedStatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncomeResultingFromOutLicensing_b4271bb5-49ac-45e7-b9c3-4b1de30bbcbd_terseLabel_en-US" xlink:label="lab_sny_IncomeResultingFromOutLicensing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from out-licensing</link:label>
    <link:label id="lab_sny_IncomeResultingFromOutLicensing_label_en-US" xlink:label="lab_sny_IncomeResultingFromOutLicensing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Resulting From Out-Licensing</link:label>
    <link:label id="lab_sny_IncomeResultingFromOutLicensing_documentation_en-US" xlink:label="lab_sny_IncomeResultingFromOutLicensing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Resulting From Out-Licensing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeResultingFromOutLicensing" xlink:href="sny-20221231.xsd#sny_IncomeResultingFromOutLicensing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeResultingFromOutLicensing" xlink:to="lab_sny_IncomeResultingFromOutLicensing" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember_03b5d5b2-190a-4468-94d4-b5437e7a1d0c_terseLabel_en-US" xlink:label="lab_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxotere mississippi attorney general litigation in the US</link:label>
    <link:label id="lab_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember_label_en-US" xlink:label="lab_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxotere Mississippi Attorney General Litigation In The US [Member]</link:label>
    <link:label id="lab_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember_documentation_en-US" xlink:label="lab_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxotere mississippi attorney general litigation in the US.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember" xlink:href="sny-20221231.xsd#sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember" xlink:to="lab_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_c7292fb3-d764-4d85-9dfd-f8f740ab1a81_totalLabel_en-US" xlink:label="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before tax and investments accounted for using the equity method</link:label>
    <link:label id="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_9af46570-645c-4841-905a-07f771e6d345_terseLabel_en-US" xlink:label="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before tax and investments accounted for using the equity method</link:label>
    <link:label id="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_label_en-US" xlink:label="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Before Tax And Investments Accounted For Equity Method Investments</link:label>
    <link:label id="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_documentation_en-US" xlink:label="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before tax and investments accounted for equity method investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:href="sny-20221231.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:to="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member_a31abb99-6f4f-45b2-8550-621f8474f54c_verboseLabel_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03%</link:label>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member_label_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% [Member]</link:label>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member_documentation_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member" xlink:to="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GeneralInformationAboutFinancialStatementsAbstract_7c622b45-f952-4f42-a256-fd798a994b7b_terseLabel_en-US" xlink:label="lab_sny_GeneralInformationAboutFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Information About Financial Statements [Abstract]</link:label>
    <link:label id="lab_sny_GeneralInformationAboutFinancialStatementsAbstract_label_en-US" xlink:label="lab_sny_GeneralInformationAboutFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Information About Financial Statements [Abstract]</link:label>
    <link:label id="lab_sny_GeneralInformationAboutFinancialStatementsAbstract_documentation_en-US" xlink:label="lab_sny_GeneralInformationAboutFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Information About Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GeneralInformationAboutFinancialStatementsAbstract" xlink:href="sny-20221231.xsd#sny_GeneralInformationAboutFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GeneralInformationAboutFinancialStatementsAbstract" xlink:to="lab_sny_GeneralInformationAboutFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MiReculeMember_4436950f-758a-4f2d-b0c3-b0ad90984f6c_terseLabel_en-US" xlink:label="lab_sny_MiReculeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">miRecule</link:label>
    <link:label id="lab_sny_MiReculeMember_label_en-US" xlink:label="lab_sny_MiReculeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">miRecule [Member]</link:label>
    <link:label id="lab_sny_MiReculeMember_documentation_en-US" xlink:label="lab_sny_MiReculeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">miRecule</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MiReculeMember" xlink:href="sny-20221231.xsd#sny_MiReculeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MiReculeMember" xlink:to="lab_sny_MiReculeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TotalUndiscountedCashFlow_11e6f071-f42d-495d-8573-8514b7e98113_totalLabel_en-US" xlink:label="lab_sny_TotalUndiscountedCashFlow" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_sny_TotalUndiscountedCashFlow_label_en-US" xlink:label="lab_sny_TotalUndiscountedCashFlow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Undiscounted Cash Flow</link:label>
    <link:label id="lab_sny_TotalUndiscountedCashFlow_documentation_en-US" xlink:label="lab_sny_TotalUndiscountedCashFlow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted cash flow.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalUndiscountedCashFlow" xlink:href="sny-20221231.xsd#sny_TotalUndiscountedCashFlow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TotalUndiscountedCashFlow" xlink:to="lab_sny_TotalUndiscountedCashFlow" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BioverativTherapeuticsIncMember_882a66e1-b0e4-46e6-b39d-044755a1da94_terseLabel_en-US" xlink:label="lab_sny_BioverativTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ Therapeutics Inc.</link:label>
    <link:label id="lab_sny_BioverativTherapeuticsIncMember_label_en-US" xlink:label="lab_sny_BioverativTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ Therapeutics Inc. [member]</link:label>
    <link:label id="lab_sny_BioverativTherapeuticsIncMember_documentation_en-US" xlink:label="lab_sny_BioverativTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ Therapeutics Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativTherapeuticsIncMember" xlink:href="sny-20221231.xsd#sny_BioverativTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BioverativTherapeuticsIncMember" xlink:to="lab_sny_BioverativTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisIsraelLtdMember_d8ef1d84-f285-42c0-997e-8b73e386c5e7_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisIsraelLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Isra&#235;l Ltd</link:label>
    <link:label id="lab_sny_SanofiAventisIsraelLtdMember_label_en-US" xlink:label="lab_sny_SanofiAventisIsraelLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Israel Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisIsraelLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisIsraelLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Israel Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisIsraelLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisIsraelLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisIsraelLtdMember" xlink:to="lab_sny_SanofiAventisIsraelLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherAssetsMember_2f05f796-3fda-47b7-af33-5f61046ae441_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_OtherAssetsMember_label_en-US" xlink:label="lab_ifrs-full_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAssetsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAssetsMember" xlink:to="lab_ifrs-full_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_90e9a6f9-887b-47ca-a68f-8e6be02557b3_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax paid</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid (refund), classified as operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ConsiderationTransferredValuationPeriod_a0b0d0e4-254c-4e4e-9aad-3862f6c2b462_terseLabel_en-US" xlink:label="lab_sny_ConsiderationTransferredValuationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, valuation period</link:label>
    <link:label id="lab_sny_ConsiderationTransferredValuationPeriod_label_en-US" xlink:label="lab_sny_ConsiderationTransferredValuationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration Transferred, Valuation Period</link:label>
    <link:label id="lab_sny_ConsiderationTransferredValuationPeriod_documentation_en-US" xlink:label="lab_sny_ConsiderationTransferredValuationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration Transferred, Valuation Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsiderationTransferredValuationPeriod" xlink:href="sny-20221231.xsd#sny_ConsiderationTransferredValuationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ConsiderationTransferredValuationPeriod" xlink:to="lab_sny_ConsiderationTransferredValuationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_3bcef63a-3d08-42dc-9c83-164625bfa720_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Items subsequently reclassifiable to profit or loss</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d1a9588d-3908-4390-80ff-d6aa798a88ba_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_a4eea6a0-dd3d-4a5a-ada1-082335e549c2_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average duration of defined benefit obligation</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_39951894-e983-44ee-a304-5102e672a997_verboseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average duration in main countries</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average duration of defined benefit obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:to="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_8a84a868-481f-4b5d-a88d-c37ba0c14c7c_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effects</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax relating to cash flow hedges included in other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:to="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReductionOfIssuedCapital_7b4f36e7-2537-425d-af5c-d3cc4b62ff73_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ReductionOfIssuedCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in share capital</link:label>
    <link:label id="lab_ifrs-full_ReductionOfIssuedCapital_label_en-US" xlink:label="lab_ifrs-full_ReductionOfIssuedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of issued capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReductionOfIssuedCapital" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReductionOfIssuedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReductionOfIssuedCapital" xlink:to="lab_ifrs-full_ReductionOfIssuedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencySalesInKoreanWonMember_17bf17a4-151b-4630-b525-11eeaf9bfc1e_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencySalesInKoreanWonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Korean Won</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInKoreanWonMember_label_en-US" xlink:label="lab_sny_ForwardCurrencySalesInKoreanWonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Korean Won [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInKoreanWonMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencySalesInKoreanWonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Korean Won</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInKoreanWonMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInKoreanWonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInKoreanWonMember" xlink:to="lab_sny_ForwardCurrencySalesInKoreanWonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiArabiaTradingCompanyLimitedMember_6f103720-23f8-4206-aecb-bbdda907997a_terseLabel_en-US" xlink:label="lab_sny_SanofiArabiaTradingCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Arabia Trading Company Limited</link:label>
    <link:label id="lab_sny_SanofiArabiaTradingCompanyLimitedMember_label_en-US" xlink:label="lab_sny_SanofiArabiaTradingCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Arabia Trading Company Limited [Member]</link:label>
    <link:label id="lab_sny_SanofiArabiaTradingCompanyLimitedMember_documentation_en-US" xlink:label="lab_sny_SanofiArabiaTradingCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Arabia Trading Company Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiArabiaTradingCompanyLimitedMember" xlink:href="sny-20221231.xsd#sny_SanofiArabiaTradingCompanyLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiArabiaTradingCompanyLimitedMember" xlink:to="lab_sny_SanofiArabiaTradingCompanyLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ChangesInOtherProvisions_99470e25-4498-4b61-86c6-24fafd3136e4_terseLabel_en-US" xlink:label="lab_ifrs-full_ChangesInOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases in provisions</link:label>
    <link:label id="lab_ifrs-full_ChangesInOtherProvisions_label_en-US" xlink:label="lab_ifrs-full_ChangesInOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInOtherProvisions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInOtherProvisions" xlink:to="lab_ifrs-full_ChangesInOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_a34094a8-7dda-4739-9ed8-e03abdbb1dff_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2</link:label>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_fff62bde-83e1-4ae9-96c3-2bc217ef2b3a_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1&#160;to&#160;2 years</link:label>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than one year and not later than two years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AmunixMember_1726cf65-0467-4774-9887-0eeabc8f5113_terseLabel_en-US" xlink:label="lab_sny_AmunixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amunix</link:label>
    <link:label id="lab_sny_AmunixMember_label_en-US" xlink:label="lab_sny_AmunixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amunix [Member]</link:label>
    <link:label id="lab_sny_AmunixMember_documentation_en-US" xlink:label="lab_sny_AmunixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amunix</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixMember" xlink:href="sny-20221231.xsd#sny_AmunixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmunixMember" xlink:to="lab_sny_AmunixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DeferredTaxRelatingToRestructuringProvisionsMember_0c02461d-4b3a-41c5-9c45-a5e450527069_terseLabel_en-US" xlink:label="lab_sny_DeferredTaxRelatingToRestructuringProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax relating to restructuring provisions</link:label>
    <link:label id="lab_sny_DeferredTaxRelatingToRestructuringProvisionsMember_label_en-US" xlink:label="lab_sny_DeferredTaxRelatingToRestructuringProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Relating To Restructuring Provisions [member]</link:label>
    <link:label id="lab_sny_DeferredTaxRelatingToRestructuringProvisionsMember_documentation_en-US" xlink:label="lab_sny_DeferredTaxRelatingToRestructuringProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax relating to restructuring provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DeferredTaxRelatingToRestructuringProvisionsMember" xlink:href="sny-20221231.xsd#sny_DeferredTaxRelatingToRestructuringProvisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DeferredTaxRelatingToRestructuringProvisionsMember" xlink:to="lab_sny_DeferredTaxRelatingToRestructuringProvisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_401ae41e-fdd9-442e-aa4d-7cf806cb2807_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Fair Value Measurement of Assets and Liabilities [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_label_en-US" xlink:label="lab_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of fair value measurement of assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:to="lab_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareKoreaIncMember_9adc4184-c8f4-4a8b-a2c6-4bee830d7d6e_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareKoreaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella healthcare Korea Inc.</link:label>
    <link:label id="lab_sny_OpellaHealthcareKoreaIncMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareKoreaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella healthcare Korea Inc. [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareKoreaIncMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareKoreaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella healthcare Korea Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareKoreaIncMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareKoreaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareKoreaIncMember" xlink:to="lab_sny_OpellaHealthcareKoreaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LonzaMember_589d7256-7be6-4c01-9c73-bc905ea86129_terseLabel_en-US" xlink:label="lab_sny_LonzaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lonza</link:label>
    <link:label id="lab_sny_LonzaMember_label_en-US" xlink:label="lab_sny_LonzaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lonza [member]</link:label>
    <link:label id="lab_sny_LonzaMember_documentation_en-US" xlink:label="lab_sny_LonzaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lonza.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LonzaMember" xlink:href="sny-20221231.xsd#sny_LonzaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LonzaMember" xlink:to="lab_sny_LonzaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AuditorsRemunerationTableTextBlock_1ac4320e-536b-4a8c-8e3f-87fa8e1d1c11_terseLabel_en-US" xlink:label="lab_sny_AuditorsRemunerationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Accountants' Fees and Services</link:label>
    <link:label id="lab_sny_AuditorsRemunerationTableTextBlock_label_en-US" xlink:label="lab_sny_AuditorsRemunerationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditors Remuneration [Table Text Block]</link:label>
    <link:label id="lab_sny_AuditorsRemunerationTableTextBlock_documentation_en-US" xlink:label="lab_sny_AuditorsRemunerationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditors remuneration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsRemunerationTableTextBlock" xlink:href="sny-20221231.xsd#sny_AuditorsRemunerationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AuditorsRemunerationTableTextBlock" xlink:to="lab_sny_AuditorsRemunerationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales_90a88671-0106-4e81-b240-9738454fa16f_terseLabel_en-US" xlink:label="lab_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision related to current period sales</link:label>
    <link:label id="lab_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales_label_en-US" xlink:label="lab_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Through New Provision Related To Current Period Sales</link:label>
    <link:label id="lab_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales_documentation_en-US" xlink:label="lab_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision related to current period sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" xlink:href="sny-20221231.xsd#sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" xlink:to="lab_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_eff1f408-57ea-4a0a-af5a-fd06990d17ba_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest (income)/cost</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_8d8fe0fd-2c34-4a66-89cd-36f2b6cf4101_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of income tax [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisDeVenezuelaSAMember_cb2902f0-ea3b-4550-a261-a39913d12c9a_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisDeVenezuelaSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis de Venezuela S.A.</link:label>
    <link:label id="lab_sny_SanofiAventisDeVenezuelaSAMember_label_en-US" xlink:label="lab_sny_SanofiAventisDeVenezuelaSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis De Venezuela SA [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisDeVenezuelaSAMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisDeVenezuelaSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis de Venezuela SA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeVenezuelaSAMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeVenezuelaSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisDeVenezuelaSAMember" xlink:to="lab_sny_SanofiAventisDeVenezuelaSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfLineOfCreditFacilityLineItems_0663b168-dfe0-4178-86ad-58d819f0dd76_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfLineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfLineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfLineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Line Of Credit Facility [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfLineOfCreditFacilityLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfLineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of line of credit facility table line items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLineOfCreditFacilityLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfLineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLineOfCreditFacilityLineItems" xlink:to="lab_sny_DisclosureOfLineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockSubscriptionOptionPlanFiveMember_fd91750d-31db-4615-9c72-6190c235149f_terseLabel_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan five</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanFiveMember_label_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Subscription Option Plan Five [Member]</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanFiveMember_documentation_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan five.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanFiveMember" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockSubscriptionOptionPlanFiveMember" xlink:to="lab_sny_StockSubscriptionOptionPlanFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock_be158fed-9429-4f37-b862-41e8493b1208_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Stock Subscription Option Plan Outstanding and Option Exercised</link:label>
    <link:label id="lab_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Stock Subscription Option Plans Under Which Options Were Exercised In The Year [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of stock subscription option plans under which options were exercised in the year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock" xlink:to="lab_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiMedleyFarmaceuticaLtdaMember_dbaa9b85-b863-419b-8e77-76d4201ba69d_terseLabel_en-US" xlink:label="lab_sny_SanofiMedleyFarmaceuticaLtdaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Medley Farmaceutica Ltda</link:label>
    <link:label id="lab_sny_SanofiMedleyFarmaceuticaLtdaMember_label_en-US" xlink:label="lab_sny_SanofiMedleyFarmaceuticaLtdaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Medley Farmaceutica Ltda [Member]</link:label>
    <link:label id="lab_sny_SanofiMedleyFarmaceuticaLtdaMember_documentation_en-US" xlink:label="lab_sny_SanofiMedleyFarmaceuticaLtdaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Medley Farmaceutica Ltda [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiMedleyFarmaceuticaLtdaMember" xlink:href="sny-20221231.xsd#sny_SanofiMedleyFarmaceuticaLtdaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiMedleyFarmaceuticaLtdaMember" xlink:to="lab_sny_SanofiMedleyFarmaceuticaLtdaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EntitysTotalForJointOperationsMember_1bf35a1c-9b8d-4abd-8659-bd7b3b1a832f_terseLabel_en-US" xlink:label="lab_ifrs-full_EntitysTotalForJointOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's Total for Joint Operations [Member]</link:label>
    <link:label id="lab_ifrs-full_EntitysTotalForJointOperationsMember_label_en-US" xlink:label="lab_ifrs-full_EntitysTotalForJointOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for joint operations [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointOperationsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember" xlink:to="lab_ifrs-full_EntitysTotalForJointOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_4aec2167-a418-4128-9fd7-824a5b41a659_terseLabel_en-US" xlink:label="lab_sny_PercentageOfCumulativeDevelopmentCostsReimbursed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of cumulative development costs reimbursed</link:label>
    <link:label id="lab_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_label_en-US" xlink:label="lab_sny_PercentageOfCumulativeDevelopmentCostsReimbursed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Cumulative Development Costs Reimbursed</link:label>
    <link:label id="lab_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_documentation_en-US" xlink:label="lab_sny_PercentageOfCumulativeDevelopmentCostsReimbursed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of cumulative development costs reimbursed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed" xlink:href="sny-20221231.xsd#sny_PercentageOfCumulativeDevelopmentCostsReimbursed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed" xlink:to="lab_sny_PercentageOfCumulativeDevelopmentCostsReimbursed" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinanceIncomeCost_2e3940d6-3736-4c1a-8dbb-9227eea33300_totalLabel_en-US" xlink:label="lab_ifrs-full_FinanceIncomeCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net financial income/(expenses)</link:label>
    <link:label id="lab_ifrs-full_FinanceIncomeCost_label_en-US" xlink:label="lab_ifrs-full_FinanceIncomeCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance income (cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="lab_ifrs-full_FinanceIncomeCost" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember_b2c7fe6f-09de-4213-ac22-3f374a889c8c_terseLabel_en-US" xlink:label="lab_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate before derivative instruments</link:label>
    <link:label id="lab_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember_label_en-US" xlink:label="lab_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Interest Rate Before Derivative Instruments [Member]</link:label>
    <link:label id="lab_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember_documentation_en-US" xlink:label="lab_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate before derivative instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember" xlink:href="sny-20221231.xsd#sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember" xlink:to="lab_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisRomaniaSRLMember_e924148e-99d1-4f48-8f33-9bfa8109a9f6_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisRomaniaSRLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Romania SRL</link:label>
    <link:label id="lab_sny_SanofiAventisRomaniaSRLMember_label_en-US" xlink:label="lab_sny_SanofiAventisRomaniaSRLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Romania SRL [member]</link:label>
    <link:label id="lab_sny_SanofiAventisRomaniaSRLMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisRomaniaSRLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Romania SRL.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisRomaniaSRLMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisRomaniaSRLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisRomaniaSRLMember" xlink:to="lab_sny_SanofiAventisRomaniaSRLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherRelatedPartiesMember_fc30c92d-ddc7-4816-a359-f5dffbbc0285_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherRelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other related parties</link:label>
    <link:label id="lab_ifrs-full_OtherRelatedPartiesMember_label_en-US" xlink:label="lab_ifrs-full_OtherRelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other related parties [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRelatedPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherRelatedPartiesMember" xlink:to="lab_ifrs-full_OtherRelatedPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MutualFundInvestmentsMember_343c43bc-deaa-47d2-a4b3-c53e7e67d910_terseLabel_en-US" xlink:label="lab_sny_MutualFundInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual fund investments</link:label>
    <link:label id="lab_sny_MutualFundInvestmentsMember_label_en-US" xlink:label="lab_sny_MutualFundInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund Investments [Member]</link:label>
    <link:label id="lab_sny_MutualFundInvestmentsMember_documentation_en-US" xlink:label="lab_sny_MutualFundInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual fund investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MutualFundInvestmentsMember" xlink:href="sny-20221231.xsd#sny_MutualFundInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MutualFundInvestmentsMember" xlink:to="lab_sny_MutualFundInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NotionalRetirementAge_39a2594b-a976-43c2-bc9e-c65980acc6ce_terseLabel_en-US" xlink:label="lab_sny_NotionalRetirementAge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional retirement age</link:label>
    <link:label id="lab_sny_NotionalRetirementAge_label_en-US" xlink:label="lab_sny_NotionalRetirementAge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Retirement Age</link:label>
    <link:label id="lab_sny_NotionalRetirementAge_documentation_en-US" xlink:label="lab_sny_NotionalRetirementAge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional retirement age.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NotionalRetirementAge" xlink:href="sny-20221231.xsd#sny_NotionalRetirementAge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NotionalRetirementAge" xlink:to="lab_sny_NotionalRetirementAge" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets_4562e5eb-72ff-4c29-8766-440f81c90707_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Net Exchange Differences, Property, Plant and Equipment, Right Of Use Assets</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Net Exchange Differences, Property, Plant and Equipment, Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" xlink:to="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_1c269b56-1136-4071-8388-190a8efa541c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_b9b1fbc4-3380-4bbb-91c6-2f2b27681ecd_negatedLabel_en-US" xlink:label="lab_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">to non-controlling interests, excluding BMS</link:label>
    <link:label id="lab_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid to non-controlling interests, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ABLBioMember_d3dac648-87b2-4f1d-8e0f-aacbdde1c842_terseLabel_en-US" xlink:label="lab_sny_ABLBioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Bio</link:label>
    <link:label id="lab_sny_ABLBioMember_label_en-US" xlink:label="lab_sny_ABLBioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Bio [Member]</link:label>
    <link:label id="lab_sny_ABLBioMember_documentation_en-US" xlink:label="lab_sny_ABLBioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Bio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ABLBioMember" xlink:href="sny-20221231.xsd#sny_ABLBioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ABLBioMember" xlink:to="lab_sny_ABLBioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_0e4f8e07-9032-473a-9bbb-71cab98c6c5a_terseLabel_en-US" xlink:label="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net obligation</link:label>
    <link:label id="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_label_en-US" xlink:label="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:to="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_55977c3f-28f2-47be-9902-f7442a7dd519_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average exercise&#160;price per share, options forfeited (in euros per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of share options forfeited in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ConsiderationTransferredMaximumAmount_d94d1835-d360-4c8b-be9d-3634852d61b6_terseLabel_en-US" xlink:label="lab_sny_ConsiderationTransferredMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, maximum amount</link:label>
    <link:label id="lab_sny_ConsiderationTransferredMaximumAmount_label_en-US" xlink:label="lab_sny_ConsiderationTransferredMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration Transferred, Maximum Amount</link:label>
    <link:label id="lab_sny_ConsiderationTransferredMaximumAmount_documentation_en-US" xlink:label="lab_sny_ConsiderationTransferredMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration Transferred, Maximum Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsiderationTransferredMaximumAmount" xlink:href="sny-20221231.xsd#sny_ConsiderationTransferredMaximumAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ConsiderationTransferredMaximumAmount" xlink:to="lab_sny_ConsiderationTransferredMaximumAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AventisPharmaHoldingsLtdMember_00373e59-c751-4bf3-8b71-493ace39266d_terseLabel_en-US" xlink:label="lab_sny_AventisPharmaHoldingsLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma Holdings Ltd</link:label>
    <link:label id="lab_sny_AventisPharmaHoldingsLtdMember_label_en-US" xlink:label="lab_sny_AventisPharmaHoldingsLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma Holdings Ltd [Member]</link:label>
    <link:label id="lab_sny_AventisPharmaHoldingsLtdMember_documentation_en-US" xlink:label="lab_sny_AventisPharmaHoldingsLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma Holdings Ltd</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaHoldingsLtdMember" xlink:href="sny-20221231.xsd#sny_AventisPharmaHoldingsLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AventisPharmaHoldingsLtdMember" xlink:to="lab_sny_AventisPharmaHoldingsLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ContingentConsiderationCollaborationAgreements_2377d7bf-d08d-4f25-b62e-816dd8469fd4_terseLabel_en-US" xlink:label="lab_sny_ContingentConsiderationCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration collaboration agreements</link:label>
    <link:label id="lab_sny_ContingentConsiderationCollaborationAgreements_label_en-US" xlink:label="lab_sny_ContingentConsiderationCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Collaboration Agreements</link:label>
    <link:label id="lab_sny_ContingentConsiderationCollaborationAgreements_documentation_en-US" xlink:label="lab_sny_ContingentConsiderationCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Collaboration Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationCollaborationAgreements" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationCollaborationAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ContingentConsiderationCollaborationAgreements" xlink:to="lab_sny_ContingentConsiderationCollaborationAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisNorgeASMember_7f4ad879-87c5-4bb8-8e7d-d6046e8892a7_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisNorgeASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Norge AS</link:label>
    <link:label id="lab_sny_SanofiAventisNorgeASMember_label_en-US" xlink:label="lab_sny_SanofiAventisNorgeASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-aventis Norge AS [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisNorgeASMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisNorgeASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-aventis Norge AS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisNorgeASMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisNorgeASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisNorgeASMember" xlink:to="lab_sny_SanofiAventisNorgeASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ParticipatingSharesCarryingAmount_9a7a8d6d-0c3d-4b52-b076-98250d983060_terseLabel_en-US" xlink:label="lab_sny_ParticipatingSharesCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating shares carrying amount</link:label>
    <link:label id="lab_sny_ParticipatingSharesCarryingAmount_label_en-US" xlink:label="lab_sny_ParticipatingSharesCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Shares Carrying Amount</link:label>
    <link:label id="lab_sny_ParticipatingSharesCarryingAmount_documentation_en-US" xlink:label="lab_sny_ParticipatingSharesCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating shares carrying amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ParticipatingSharesCarryingAmount" xlink:href="sny-20221231.xsd#sny_ParticipatingSharesCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ParticipatingSharesCarryingAmount" xlink:to="lab_sny_ParticipatingSharesCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_efa53ed9-b9a4-4202-be30-474d84cd52bf_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [text block]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BottomOfRangeMember_f7573570-6974-4f8c-b6a2-5a5063e730e2_terseLabel_en-US" xlink:label="lab_ifrs-full_BottomOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bottom of range</link:label>
    <link:label id="lab_ifrs-full_BottomOfRangeMember_label_en-US" xlink:label="lab_ifrs-full_BottomOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bottom of range [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember" xlink:to="lab_ifrs-full_BottomOfRangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_5cb85e7e-66da-489f-b7a2-57524a39984b_terseLabel_en-US" xlink:label="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment for stock options with dilutive effect (in shares)</link:label>
    <link:label id="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_label_en-US" xlink:label="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share options on number of ordinary shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:to="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NorthAmericaMember_501b5eac-6f4f-4408-b999-d502548d711f_terseLabel_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America</link:label>
    <link:label id="lab_srt_NorthAmericaMember_label_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NorthAmericaMember" xlink:to="lab_srt_NorthAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill_a3c8358a-50ca-4215-9828-1b809e1aafc8_terseLabel_en-US" xlink:label="lab_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease through loss of control of subsidiary, intangible assets and goodwill</link:label>
    <link:label id="lab_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill_label_en-US" xlink:label="lab_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease through loss of control of subsidiary, intangible assets and goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill" xlink:to="lab_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification_6afb14e8-f885-4756-90c9-423bf44e14c9_terseLabel_en-US" xlink:label="lab_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of people exposed who filed a request for indemnification</link:label>
    <link:label id="lab_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification_label_en-US" xlink:label="lab_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Exposed Who Filed A Request For Indemnification</link:label>
    <link:label id="lab_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification_documentation_en-US" xlink:label="lab_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Exposed Who Filed A Request For Indemnification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification" xlink:href="sny-20221231.xsd#sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification" xlink:to="lab_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_950a5629-7d7d-438d-9177-7e4a60d3fd88_terseLabel_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and other increases</link:label>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill_f29e5fca-3f6d-4121-9bad-2feb0bad670b_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other movements during the period</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through other changes, intangible assets and goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilities_4983c52d-4385-4e94-9dc4-7b840df47b88_terseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilities_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities" xlink:to="lab_ifrs-full_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisDeMexicoSADeCVMember_2434780f-2ef4-41f7-aa6a-755d93d5f30a_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisDeMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis de Mexico S.A. de C.V.</link:label>
    <link:label id="lab_sny_SanofiAventisDeMexicoSADeCVMember_label_en-US" xlink:label="lab_sny_SanofiAventisDeMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis De Mexico S.A. De C.V. [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisDeMexicoSADeCVMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisDeMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis de Mexico S.A. de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeMexicoSADeCVMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeMexicoSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisDeMexicoSADeCVMember" xlink:to="lab_sny_SanofiAventisDeMexicoSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_878f05ac-8003-4bf9-b15f-24a341da1b69_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Interest Rate Of Debt Net Of Cash And Cash Equivalent [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_label_en-US" xlink:label="lab_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Interest Rate Of Debt NetOf Cash And Cash Equivalent [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of interest rate of debt net of cash and cash equivalent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable" xlink:to="lab_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense_ada8730f-4c3c-4d13-957c-875fc1d62aa3_terseLabel_en-US" xlink:label="lab_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum amount to be reimbursed for current and future environmental expense</link:label>
    <link:label id="lab_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense_label_en-US" xlink:label="lab_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Amount To Be Reimbursed For Current And Future Environmental Expense</link:label>
    <link:label id="lab_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense_documentation_en-US" xlink:label="lab_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Amount To Be Reimbursed For Current And Future Environmental Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense" xlink:href="sny-20221231.xsd#sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense" xlink:to="lab_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_USFDAApprovalMember_88eccb40-557b-4dd0-b7a1-dff4e5dd7fa2_terseLabel_en-US" xlink:label="lab_sny_USFDAApprovalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US FDA Approval</link:label>
    <link:label id="lab_sny_USFDAApprovalMember_label_en-US" xlink:label="lab_sny_USFDAApprovalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US FDA Approval [Member]</link:label>
    <link:label id="lab_sny_USFDAApprovalMember_documentation_en-US" xlink:label="lab_sny_USFDAApprovalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US FDA Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_USFDAApprovalMember" xlink:href="sny-20221231.xsd#sny_USFDAApprovalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_USFDAApprovalMember" xlink:to="lab_sny_USFDAApprovalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EnjaymoMember_0d74f899-65bb-4d03-8fc4-a345e994706c_terseLabel_en-US" xlink:label="lab_sny_EnjaymoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enjaymo</link:label>
    <link:label id="lab_sny_EnjaymoMember_label_en-US" xlink:label="lab_sny_EnjaymoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enjaymo [Member]</link:label>
    <link:label id="lab_sny_EnjaymoMember_documentation_en-US" xlink:label="lab_sny_EnjaymoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enjaymo</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EnjaymoMember" xlink:href="sny-20221231.xsd#sny_EnjaymoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EnjaymoMember" xlink:to="lab_sny_EnjaymoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans_e1a782a1-666b-4cb3-80c8-89d047209e67_terseLabel_en-US" xlink:label="lab_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated payments</link:label>
    <link:label id="lab_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans_label_en-US" xlink:label="lab_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Timing Of Payments In Respect Of Unfunded Pension And Other Post-employment Benefit Plans</link:label>
    <link:label id="lab_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans_documentation_en-US" xlink:label="lab_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected timing of payments in respect of unfunded pension and other post-employment benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" xlink:href="sny-20221231.xsd#sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" xlink:to="lab_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfOperatingSegments_723024a0-76af-45ae-a5c6-1bf6055a9475_terseLabel_en-US" xlink:label="lab_sny_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_sny_NumberOfOperatingSegments_label_en-US" xlink:label="lab_sny_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Operating Segments</link:label>
    <link:label id="lab_sny_NumberOfOperatingSegments_documentation_en-US" xlink:label="lab_sny_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOperatingSegments" xlink:href="sny-20221231.xsd#sny_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfOperatingSegments" xlink:to="lab_sny_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EffectOfAssetCeilingMember_4aceebcc-d0c6-404d-b52b-d011b816a776_terseLabel_en-US" xlink:label="lab_ifrs-full_EffectOfAssetCeilingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of asset ceiling</link:label>
    <link:label id="lab_ifrs-full_EffectOfAssetCeilingMember_label_en-US" xlink:label="lab_ifrs-full_EffectOfAssetCeilingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of asset ceiling [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfAssetCeilingMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfAssetCeilingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfAssetCeilingMember" xlink:to="lab_ifrs-full_EffectOfAssetCeilingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedCashFlowStatementsCaptionsLineItems_44d009b7-6738-4741-adcd-f74ac4c1eeba_terseLabel_en-US" xlink:label="lab_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedCashFlowStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent_c909f5a9-ea8f-4233-86d3-f6b23ac4eeea_negatedLabel_en-US" xlink:label="lab_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend paid out of earnings</link:label>
    <link:label id="lab_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent_label_en-US" xlink:label="lab_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends recognised as distributions to owners of parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:to="lab_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RangeAxis_bdb21438-8f8c-4e15-809f-9ecf734c9eae_terseLabel_en-US" xlink:label="lab_ifrs-full_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [axis]</link:label>
    <link:label id="lab_ifrs-full_RangeAxis_label_en-US" xlink:label="lab_ifrs-full_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis" xlink:to="lab_ifrs-full_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_dc45ad5d-a818-4f2f-b849-4ca1f93ecbd5_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6&#160;to&#160;12&#160;months</link:label>
    <link:label id="lab_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than six months and not later than one year [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:to="lab_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales_5ae88d1c-c7a6-40f8-8ac5-3c1a5c5196d2_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in provision related to prior period sales</link:label>
    <link:label id="lab_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales_label_en-US" xlink:label="lab_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Provisions Related To Prior Period Sales</link:label>
    <link:label id="lab_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in provisions related to prior period sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" xlink:to="lab_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesMember_79e8e463-2556-4509-b27f-d05913e08ea6_terseLabel_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities [member]</link:label>
    <link:label id="lab_ifrs-full_ContingentLiabilitiesMember_label_en-US" xlink:label="lab_ifrs-full_ContingentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember" xlink:to="lab_ifrs-full_ContingentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiMember_a5d2bee7-c602-420c-8545-45b081bc4f1e_verboseLabel_en-US" xlink:label="lab_sny_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi</link:label>
    <link:label id="lab_sny_SanofiMember_e04daadf-6c23-4a37-b450-d7cb0b53cc64_terseLabel_en-US" xlink:label="lab_sny_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi</link:label>
    <link:label id="lab_sny_SanofiMember_label_en-US" xlink:label="lab_sny_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi [member]</link:label>
    <link:label id="lab_sny_SanofiMember_documentation_en-US" xlink:label="lab_sny_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiMember" xlink:href="sny-20221231.xsd#sny_SanofiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiMember" xlink:to="lab_sny_SanofiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements_caa7acee-cc5e-4e0c-b58a-1982a70cc83a_terseLabel_en-US" xlink:label="lab_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services other than statutory audit, percentage</link:label>
    <link:label id="lab_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements_label_en-US" xlink:label="lab_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Auditors Remuneration For Services Other Than Audit Of Financial Statements</link:label>
    <link:label id="lab_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements_documentation_en-US" xlink:label="lab_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services other than audit of financial statements, percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" xlink:to="lab_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_6af6466d-5428-4bef-aa81-09ee7d760122_terseLabel_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding arrangements of defined benefit plans [axis]</link:label>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_label_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding arrangements of defined benefit plans [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:to="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherRestructuringCosts_36d463ef-a7e2-4bcd-bf35-b099363fc2ca_terseLabel_en-US" xlink:label="lab_sny_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others</link:label>
    <link:label id="lab_sny_OtherRestructuringCosts_label_en-US" xlink:label="lab_sny_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:label id="lab_sny_OtherRestructuringCosts_documentation_en-US" xlink:label="lab_sny_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other restructuring costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherRestructuringCosts" xlink:href="sny-20221231.xsd#sny_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherRestructuringCosts" xlink:to="lab_sny_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SaleOfStockAxis_36c88788-19e2-483c-bf5f-9f804e250b27_terseLabel_en-US" xlink:label="lab_sny_SaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock [Axis]</link:label>
    <link:label id="lab_sny_SaleOfStockAxis_label_en-US" xlink:label="lab_sny_SaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock [Axis]</link:label>
    <link:label id="lab_sny_SaleOfStockAxis_documentation_en-US" xlink:label="lab_sny_SaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockAxis" xlink:href="sny-20221231.xsd#sny_SaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SaleOfStockAxis" xlink:to="lab_sny_SaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_ed29ccb4-87f0-45d1-86a1-915c0307ab41_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax position</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of deferred taxes [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock_3fb20a97-a139-43b1-84eb-941475ee3a90_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Off Balance Sheet Commitments Relating to Property, Plant and Equipment</link:label>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off-Balance Sheet Commitments Of Property Plant And Equipment [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Off-Balance Sheet Commitments of Property Plant and Equipment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock" xlink:to="lab_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssetsAbstract_a513b8f3-3fa9-4ead-a84e-a9913416ee30_terseLabel_en-US" xlink:label="lab_ifrs-full_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_ifrs-full_AssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract" xlink:to="lab_ifrs-full_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations_65425549-374a-4e80-9db6-b7e93fa5b759_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments related to milestone payments, business combinations</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations_label_en-US" xlink:label="lab_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Milestone Payments, Business Combinations</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Milestone Payments, Business Combinations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations" xlink:to="lab_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TopUpDefinedBenefitPensionPlanMember_70d6a204-5c3a-4734-95f7-1ba8b9609e12_terseLabel_en-US" xlink:label="lab_sny_TopUpDefinedBenefitPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up defined-benefit pension plan</link:label>
    <link:label id="lab_sny_TopUpDefinedBenefitPensionPlanMember_label_en-US" xlink:label="lab_sny_TopUpDefinedBenefitPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-Up Defined-Benefit Pension Plan [Member]</link:label>
    <link:label id="lab_sny_TopUpDefinedBenefitPensionPlanMember_documentation_en-US" xlink:label="lab_sny_TopUpDefinedBenefitPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up defined-benefit pension plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TopUpDefinedBenefitPensionPlanMember" xlink:href="sny-20221231.xsd#sny_TopUpDefinedBenefitPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TopUpDefinedBenefitPensionPlanMember" xlink:to="lab_sny_TopUpDefinedBenefitPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations_3b119cf0-66ee-4104-b7d7-cf034cc28971_terseLabel_en-US" xlink:label="lab_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurement of contingent considerations</link:label>
    <link:label id="lab_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations_label_en-US" xlink:label="lab_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate Effect Of Fair Value Remeasurement Of Contingent Considerations</link:label>
    <link:label id="lab_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations_documentation_en-US" xlink:label="lab_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate Effect Of Fair Value Remeasurement Of Contingent Considerations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations" xlink:href="sny-20221231.xsd#sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations" xlink:to="lab_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember_02d4cc8d-1537-4eaa-a822-821aa75e44be_terseLabel_en-US" xlink:label="lab_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eight Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Five</link:label>
    <link:label id="lab_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember_label_en-US" xlink:label="lab_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eight Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Five [Member]</link:label>
    <link:label id="lab_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember_documentation_en-US" xlink:label="lab_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eight Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember" xlink:href="sny-20221231.xsd#sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember" xlink:to="lab_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfYearsServicePeriod_8111304c-0901-4c2d-8f99-123a3a91819d_terseLabel_en-US" xlink:label="lab_sny_NumberOfYearsServicePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service period</link:label>
    <link:label id="lab_sny_NumberOfYearsServicePeriod_label_en-US" xlink:label="lab_sny_NumberOfYearsServicePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Years, Service Period</link:label>
    <link:label id="lab_sny_NumberOfYearsServicePeriod_documentation_en-US" xlink:label="lab_sny_NumberOfYearsServicePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Years, Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfYearsServicePeriod" xlink:href="sny-20221231.xsd#sny_NumberOfYearsServicePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfYearsServicePeriod" xlink:to="lab_sny_NumberOfYearsServicePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SaleOfStockTransactionCosts_993b3176-b04b-49e4-a1de-05727d4d1f3d_terseLabel_en-US" xlink:label="lab_sny_SaleOfStockTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction-related costs</link:label>
    <link:label id="lab_sny_SaleOfStockTransactionCosts_label_en-US" xlink:label="lab_sny_SaleOfStockTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Transaction Costs</link:label>
    <link:label id="lab_sny_SaleOfStockTransactionCosts_documentation_en-US" xlink:label="lab_sny_SaleOfStockTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockTransactionCosts" xlink:href="sny-20221231.xsd#sny_SaleOfStockTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SaleOfStockTransactionCosts" xlink:to="lab_sny_SaleOfStockTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfRestrictedSharesNotYetFullyVested_7a26ab05-ad28-43b0-ae58-4ab6b9cc9f0e_terseLabel_en-US" xlink:label="lab_sny_NumberOfRestrictedSharesNotYetFullyVested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares not yet fully vested (in shares)</link:label>
    <link:label id="lab_sny_NumberOfRestrictedSharesNotYetFullyVested_label_en-US" xlink:label="lab_sny_NumberOfRestrictedSharesNotYetFullyVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Restricted Shares Not Yet Fully Vested</link:label>
    <link:label id="lab_sny_NumberOfRestrictedSharesNotYetFullyVested_documentation_en-US" xlink:label="lab_sny_NumberOfRestrictedSharesNotYetFullyVested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted shares not yet fully vested.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfRestrictedSharesNotYetFullyVested" xlink:href="sny-20221231.xsd#sny_NumberOfRestrictedSharesNotYetFullyVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfRestrictedSharesNotYetFullyVested" xlink:to="lab_sny_NumberOfRestrictedSharesNotYetFullyVested" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AtFairValueMember_a78ebd7c-c66f-41ec-a0e1-5d0710d55473_terseLabel_en-US" xlink:label="lab_ifrs-full_AtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_ifrs-full_AtFairValueMember_label_en-US" xlink:label="lab_ifrs-full_AtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At fair value [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AtFairValueMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AtFairValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AtFairValueMember" xlink:to="lab_ifrs-full_AtFairValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b029d36d-e67b-45de-a263-d66c3a9bf3ab_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MajorCustomersMember_35ccd5f4-aa70-40da-b880-33cf248a4110_terseLabel_en-US" xlink:label="lab_ifrs-full_MajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customers [member]</link:label>
    <link:label id="lab_ifrs-full_MajorCustomersMember_label_en-US" xlink:label="lab_ifrs-full_MajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customers [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorCustomersMember" xlink:to="lab_ifrs-full_MajorCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_f36a8478-d861-4b2a-95bd-d3b7e1e36463_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement of defined-benefit obligation</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfProductsJointlyDeveloped_d87da551-157c-4b81-b801-6080c2ffc162_terseLabel_en-US" xlink:label="lab_sny_NumberOfProductsJointlyDeveloped" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of leading products jointly developed</link:label>
    <link:label id="lab_sny_NumberOfProductsJointlyDeveloped_label_en-US" xlink:label="lab_sny_NumberOfProductsJointlyDeveloped" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products Jointly Developed</link:label>
    <link:label id="lab_sny_NumberOfProductsJointlyDeveloped_documentation_en-US" xlink:label="lab_sny_NumberOfProductsJointlyDeveloped" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of products jointly developed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfProductsJointlyDeveloped" xlink:href="sny-20221231.xsd#sny_NumberOfProductsJointlyDeveloped"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfProductsJointlyDeveloped" xlink:to="lab_sny_NumberOfProductsJointlyDeveloped" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate_8cae0d71-3a29-4596-99c4-f689a06eda9d_terseLabel_en-US" xlink:label="lab_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current and non-current assets and liabilities</link:label>
    <link:label id="lab_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate_label_en-US" xlink:label="lab_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets And Liabilities As Of Acquisition Date</link:label>
    <link:label id="lab_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate_documentation_en-US" xlink:label="lab_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities as of acquisition date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate" xlink:href="sny-20221231.xsd#sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate" xlink:to="lab_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossOfAcquiree_16e1d2bd-4351-487c-84d1-753f5bcef26a_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossOfAcquiree" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit (loss) of acquiree since acquisition date</link:label>
    <link:label id="lab_ifrs-full_ProfitLossOfAcquiree_label_en-US" xlink:label="lab_ifrs-full_ProfitLossOfAcquiree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit (loss) of acquiree since acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossOfAcquiree" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossOfAcquiree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossOfAcquiree" xlink:to="lab_ifrs-full_ProfitLossOfAcquiree" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PainCareMember_743f3096-15ae-4bb7-9a99-15b72b6e52d8_terseLabel_en-US" xlink:label="lab_sny_PainCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pain Care</link:label>
    <link:label id="lab_sny_PainCareMember_label_en-US" xlink:label="lab_sny_PainCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pain Care [Member]</link:label>
    <link:label id="lab_sny_PainCareMember_documentation_en-US" xlink:label="lab_sny_PainCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pain Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PainCareMember" xlink:href="sny-20221231.xsd#sny_PainCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PainCareMember" xlink:to="lab_sny_PainCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_118f9262-4780-4264-ad5d-11f7ed74b581_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information about major customers and credit risk [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Information About Major Customers And Credit Risk [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information about major customers and credit risk.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xlink:to="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisUkHoldingsLimitedMember_c4ba1dad-8a9a-4bf2-9759-d8b2ede79a77_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisUkHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis UK Holdings Limited</link:label>
    <link:label id="lab_sny_SanofiAventisUkHoldingsLimitedMember_label_en-US" xlink:label="lab_sny_SanofiAventisUkHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis UK Holdings Limited [member]</link:label>
    <link:label id="lab_sny_SanofiAventisUkHoldingsLimitedMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisUkHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis UK Holdings Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisUkHoldingsLimitedMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisUkHoldingsLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisUkHoldingsLimitedMember" xlink:to="lab_sny_SanofiAventisUkHoldingsLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelName_12f0b706-b4d8-4533-90b6-f2b0a4d7d5c8_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:label id="lab_dei_ContactPersonnelName_label_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_1e2e0333-5a7d-4a74-9532-d356c2d7a598_terseLabel_en-US" xlink:label="lab_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New transactions</link:label>
    <link:label id="lab_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_label_en-US" xlink:label="lab_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New liabilities, contingent liabilities recognised in business combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:to="lab_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AmountsPayableForAcquisitionOfNonCurrentAssets_a2c3506a-8586-47fc-9a79-4f365f917de8_terseLabel_en-US" xlink:label="lab_sny_AmountsPayableForAcquisitionOfNonCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts payable for acquisitions of non-current assets</link:label>
    <link:label id="lab_sny_AmountsPayableForAcquisitionOfNonCurrentAssets_label_en-US" xlink:label="lab_sny_AmountsPayableForAcquisitionOfNonCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Payable For Acquisition Of Non-current Assets</link:label>
    <link:label id="lab_sny_AmountsPayableForAcquisitionOfNonCurrentAssets_documentation_en-US" xlink:label="lab_sny_AmountsPayableForAcquisitionOfNonCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts payable for acquisitions of non-current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmountsPayableForAcquisitionOfNonCurrentAssets" xlink:href="sny-20221231.xsd#sny_AmountsPayableForAcquisitionOfNonCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmountsPayableForAcquisitionOfNonCurrentAssets" xlink:to="lab_sny_AmountsPayableForAcquisitionOfNonCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInHungarianForintMember_1000a6a7-860b-4310-949d-2d4bf570a1b1_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInHungarianForintMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases in Hungarian Forint</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInHungarianForintMember_label_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInHungarianForintMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Hungarian Forint [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInHungarianForintMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInHungarianForintMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases in Hungarian Forint.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInHungarianForintMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInHungarianForintMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasedInHungarianForintMember" xlink:to="lab_sny_ForwardCurrencyPurchasedInHungarianForintMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_6e8bc816-c081-4237-92c8-98258bfb4deb_terseLabel_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method)</link:label>
    <link:label id="lab_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Currency Translation Before Tax Excluding Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in currency translation before tax excluding associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_87845670-a581-431c-b706-b485637addd9_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Movements in Goodwill</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock_e47f6138-79a9-4266-bd9d-0947072bbcce_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and property, plant and equipment</link:label>
    <link:label id="lab_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Impairment Of Intangible Assets And Property Plant And Equipment Explanatory [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for impairment of intangible assets and property, plant and equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xlink:to="lab_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_efd7a1d2-162a-45e4-bf4e-888c7314443d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personnel costs</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information about employees [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax_baed92b9-85b2-4f41-bf43-86be00240d58_terseLabel_en-US" xlink:label="lab_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of other comprehensive income from investments accounted for using the equity method</link:label>
    <link:label id="lab_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax_label_en-US" xlink:label="lab_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of other comprehensive income of associates and joint ventures accounted for using equity method, before tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax" xlink:to="lab_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod_cc9befca-1095-4439-92bf-adb375fc3011_negatedLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of undistributed earnings from investments accounted for using the&#160;equity method</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for undistributed profits of investments accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IrrevocablePurchaseCommitmentsReceived_f2c16e5a-0187-4675-b4c1-25fc8d777885_negatedLabel_en-US" xlink:label="lab_sny_IrrevocablePurchaseCommitmentsReceived" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Irrevocable purchase commitments received</link:label>
    <link:label id="lab_sny_IrrevocablePurchaseCommitmentsReceived_label_en-US" xlink:label="lab_sny_IrrevocablePurchaseCommitmentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Irrevocable Purchase Commitments Received</link:label>
    <link:label id="lab_sny_IrrevocablePurchaseCommitmentsReceived_documentation_en-US" xlink:label="lab_sny_IrrevocablePurchaseCommitmentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Irrevocable purchase commitments received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IrrevocablePurchaseCommitmentsReceived" xlink:href="sny-20221231.xsd#sny_IrrevocablePurchaseCommitmentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IrrevocablePurchaseCommitmentsReceived" xlink:to="lab_sny_IrrevocablePurchaseCommitmentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NetAmountsAsReportedInTheBalanceSheet_ddeba9f9-2d50-4cc8-ab37-6a829bdc227b_totalLabel_en-US" xlink:label="lab_sny_NetAmountsAsReportedInTheBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amounts as reported in the balance sheet</link:label>
    <link:label id="lab_sny_NetAmountsAsReportedInTheBalanceSheet_label_en-US" xlink:label="lab_sny_NetAmountsAsReportedInTheBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amounts As Reported In The Balance Sheet</link:label>
    <link:label id="lab_sny_NetAmountsAsReportedInTheBalanceSheet_documentation_en-US" xlink:label="lab_sny_NetAmountsAsReportedInTheBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amounts as reported in the balance sheet.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetAmountsAsReportedInTheBalanceSheet" xlink:href="sny-20221231.xsd#sny_NetAmountsAsReportedInTheBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetAmountsAsReportedInTheBalanceSheet" xlink:to="lab_sny_NetAmountsAsReportedInTheBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MarketedProductsMember_3ed126e3-4765-420d-ac33-25f488fe1555_terseLabel_en-US" xlink:label="lab_sny_MarketedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketed products</link:label>
    <link:label id="lab_sny_MarketedProductsMember_label_en-US" xlink:label="lab_sny_MarketedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketed Products [Member]</link:label>
    <link:label id="lab_sny_MarketedProductsMember_documentation_en-US" xlink:label="lab_sny_MarketedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketed products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketedProductsMember" xlink:href="sny-20221231.xsd#sny_MarketedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MarketedProductsMember" xlink:to="lab_sny_MarketedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember_7f65cbc0-56cc-411f-8a8d-36b25d153439_terseLabel_en-US" xlink:label="lab_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of acquired property, plant and equipment at fair value</link:label>
    <link:label id="lab_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember_label_en-US" xlink:label="lab_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition Of Acquired Property Plant And Equipment At Fair Value [member]</link:label>
    <link:label id="lab_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember_documentation_en-US" xlink:label="lab_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of acquired property plant and equipment at fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember" xlink:href="sny-20221231.xsd#sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember" xlink:to="lab_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount_5aac47b6-ce9c-4ed9-98f1-ef6c6e7207c5_terseLabel_en-US" xlink:label="lab_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net interest related to employee benefits, and unwinding of discount</link:label>
    <link:label id="lab_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount_label_en-US" xlink:label="lab_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Interest Related To Employees Benefits And Unwinding Of Discount</link:label>
    <link:label id="lab_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount_documentation_en-US" xlink:label="lab_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net interest related to employees benefits and unwinding of discount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" xlink:href="sny-20221231.xsd#sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" xlink:to="lab_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AdjustmentToDebtMeasuredAtFairValueMember_5c33c9d0-b87e-496a-9ab5-dd7f73f4d0e8_terseLabel_en-US" xlink:label="lab_sny_AdjustmentToDebtMeasuredAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to debt measured&#160;at fair value</link:label>
    <link:label id="lab_sny_AdjustmentToDebtMeasuredAtFairValueMember_label_en-US" xlink:label="lab_sny_AdjustmentToDebtMeasuredAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To Debt Measured At Fair Value [Member]</link:label>
    <link:label id="lab_sny_AdjustmentToDebtMeasuredAtFairValueMember_documentation_en-US" xlink:label="lab_sny_AdjustmentToDebtMeasuredAtFairValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to debt measured at fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember" xlink:href="sny-20221231.xsd#sny_AdjustmentToDebtMeasuredAtFairValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember" xlink:to="lab_sny_AdjustmentToDebtMeasuredAtFairValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RetainedEarningsMember_bbcca271-a715-4c91-a6c0-aecf750996c6_terseLabel_en-US" xlink:label="lab_ifrs-full_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves and retained earnings</link:label>
    <link:label id="lab_ifrs-full_RetainedEarningsMember_label_en-US" xlink:label="lab_ifrs-full_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember" xlink:to="lab_ifrs-full_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LantusMember_5a0f76cb-111c-40f0-8c3a-6f8b5f6453a8_terseLabel_en-US" xlink:label="lab_sny_LantusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lantus</link:label>
    <link:label id="lab_sny_LantusMember_label_en-US" xlink:label="lab_sny_LantusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lantus [Member]</link:label>
    <link:label id="lab_sny_LantusMember_documentation_en-US" xlink:label="lab_sny_LantusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lantus.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LantusMember" xlink:href="sny-20221231.xsd#sny_LantusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LantusMember" xlink:to="lab_sny_LantusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanFiveYearsMember_875a5d1f-b836-4d88-b350-e9c5e5def141_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 5 and later</link:label>
    <link:label id="lab_ifrs-full_LaterThanFiveYearsMember_ac666716-effe-4547-8974-83934d3e3281_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">More&#160;than 5&#160;years</link:label>
    <link:label id="lab_ifrs-full_LaterThanFiveYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than five years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent_32446a64-5f14-4e7a-86ac-90b4a1eba8b9_verboseLabel_en-US" xlink:label="lab_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share (in euros per share)</link:label>
    <link:label id="lab_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent_label_en-US" xlink:label="lab_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic Earnings (Loss) Per Share, Attributable To Owners Of Parent</link:label>
    <link:label id="lab_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent_documentation_en-US" xlink:label="lab_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic Earnings (Loss) Per Share, Attributable To Owners Of Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xlink:href="sny-20221231.xsd#sny_BasicEarningsLossPerShareAttributableToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xlink:to="lab_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis_0a7dc635-f140-4687-b67f-ab3718110c6f_terseLabel_en-US" xlink:label="lab_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated purchase price on a fully-diluted basis</link:label>
    <link:label id="lab_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis_label_en-US" xlink:label="lab_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Estimated Purchase Price On A Fully-Diluted Basis</link:label>
    <link:label id="lab_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis_documentation_en-US" xlink:label="lab_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Estimated Purchase Price On A Fully-Diluted Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis" xlink:href="sny-20221231.xsd#sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis" xlink:to="lab_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencySalesInMexicanPesoMember_72c8584f-f8fb-451c-ab43-3fc1f73aee67_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencySalesInMexicanPesoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales In Mexican Peso</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInMexicanPesoMember_label_en-US" xlink:label="lab_sny_ForwardCurrencySalesInMexicanPesoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Mexican Peso [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInMexicanPesoMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencySalesInMexicanPesoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Mexican Peso</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInMexicanPesoMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInMexicanPesoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInMexicanPesoMember" xlink:to="lab_sny_ForwardCurrencySalesInMexicanPesoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets_b93a9178-f06d-46c1-a222-d7b263497e5e_terseLabel_en-US" xlink:label="lab_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease through loss of control of subsidiary, net assets</link:label>
    <link:label id="lab_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets_label_en-US" xlink:label="lab_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease Through Loss Of Control Of Subsidiary, Net Assets</link:label>
    <link:label id="lab_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets_documentation_en-US" xlink:label="lab_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease Through Loss Of Control Of Subsidiary, Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets" xlink:href="sny-20221231.xsd#sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets" xlink:to="lab_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfOncologyTargetsUnderCollaborationAgreement_d18350d8-722b-4748-ad3f-fa7e769b7184_terseLabel_en-US" xlink:label="lab_sny_NumberOfOncologyTargetsUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of oncology targets under collaboration agreement</link:label>
    <link:label id="lab_sny_NumberOfOncologyTargetsUnderCollaborationAgreement_label_en-US" xlink:label="lab_sny_NumberOfOncologyTargetsUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Oncology Targets Under Collaboration Agreement</link:label>
    <link:label id="lab_sny_NumberOfOncologyTargetsUnderCollaborationAgreement_documentation_en-US" xlink:label="lab_sny_NumberOfOncologyTargetsUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Oncology Targets Under Collaboration Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOncologyTargetsUnderCollaborationAgreement" xlink:href="sny-20221231.xsd#sny_NumberOfOncologyTargetsUnderCollaborationAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfOncologyTargetsUnderCollaborationAgreement" xlink:to="lab_sny_NumberOfOncologyTargetsUnderCollaborationAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RegeneronPharmaceuticalsIncMember_846667a4-8dd2-48b7-9c75-413e972fcc20_terseLabel_en-US" xlink:label="lab_sny_RegeneronPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regeneron Pharmaceuticals, INC</link:label>
    <link:label id="lab_sny_RegeneronPharmaceuticalsIncMember_label_en-US" xlink:label="lab_sny_RegeneronPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regeneron Pharmaceuticals, INC [Member]</link:label>
    <link:label id="lab_sny_RegeneronPharmaceuticalsIncMember_documentation_en-US" xlink:label="lab_sny_RegeneronPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regeneron Pharmaceuticals, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RegeneronPharmaceuticalsIncMember" xlink:to="lab_sny_RegeneronPharmaceuticalsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherCurrentLiabilities_a9c1bd45-0318-4ff2-8225-a790ac39c982_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_ifrs-full_OtherCurrentLiabilities_label_en-US" xlink:label="lab_ifrs-full_OtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentLiabilities" xlink:to="lab_ifrs-full_OtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss_664cbb9d-e039-467a-a217-e83027da91c3_negatedLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effects</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax relating to components of other comprehensive income that will be reclassified to profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" xlink:to="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareHungaryCommercialKFTMember_61a04ce2-a4d5-4e7e-bf90-2c42efad64de_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareHungaryCommercialKFTMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Hungary Commercial K.F.T</link:label>
    <link:label id="lab_sny_OpellaHealthcareHungaryCommercialKFTMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareHungaryCommercialKFTMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Hungary Commercial K.F.T [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareHungaryCommercialKFTMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareHungaryCommercialKFTMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Hungary Commercial K.F.T</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareHungaryCommercialKFTMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareHungaryCommercialKFTMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareHungaryCommercialKFTMember" xlink:to="lab_sny_OpellaHealthcareHungaryCommercialKFTMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisSAMember_9a118e04-d80d-4b24-b393-c34eadc8d64c_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis S.A.</link:label>
    <link:label id="lab_sny_SanofiAventisSAMember_label_en-US" xlink:label="lab_sny_SanofiAventisSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis SA [member]</link:label>
    <link:label id="lab_sny_SanofiAventisSAMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis SA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSAMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisSAMember" xlink:to="lab_sny_SanofiAventisSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_ffd562f7-70c3-4d5e-b2c6-956a3c2c0d4b_terseLabel_en-US" xlink:label="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity instruments designated at fair value through other comprehensive income [axis]</link:label>
    <link:label id="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity instruments designated at fair value through other comprehensive income [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:to="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_2f03aa2b-a67a-4d2d-899c-e7c6eee04450_terseLabel_en-US" xlink:label="lab_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period (in years)</link:label>
    <link:label id="lab_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_label_en-US" xlink:label="lab_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period</link:label>
    <link:label id="lab_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_documentation_en-US" xlink:label="lab_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:href="sny-20221231.xsd#sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:to="lab_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfAssetsAxis_24fc334c-cca4-491f-a166-76e208dae635_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of assets [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UndrawnBorrowingFacilities_3abe32b9-5df8-4317-833b-8ff3454383ee_verboseLabel_en-US" xlink:label="lab_ifrs-full_UndrawnBorrowingFacilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total credit facilities</link:label>
    <link:label id="lab_ifrs-full_UndrawnBorrowingFacilities_3fc3b3ec-c5a6-4d83-b735-302da27e5b7d_terseLabel_en-US" xlink:label="lab_ifrs-full_UndrawnBorrowingFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General-purpose credit facilities</link:label>
    <link:label id="lab_ifrs-full_UndrawnBorrowingFacilities_label_en-US" xlink:label="lab_ifrs-full_UndrawnBorrowingFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undrawn borrowing facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UndrawnBorrowingFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UndrawnBorrowingFacilities" xlink:to="lab_ifrs-full_UndrawnBorrowingFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_0a24009e-a250-4e7d-b3ed-9ae09cdd72b7_verboseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_089192bf-ec7a-41ae-8689-96b90698bde2_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Attributable to non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit (loss), attributable to non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member_e5ab4d1c-a94e-48d2-924e-c31203448dc8_verboseLabel_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06%</link:label>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member_label_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% [Member]</link:label>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member_documentation_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps pay capitalized Eonia / receive 0.06%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member" xlink:to="lab_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_VaccinesMember_5651bfa8-9af3-4ee2-9223-22e3330cb723_terseLabel_en-US" xlink:label="lab_sny_VaccinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vaccines</link:label>
    <link:label id="lab_sny_VaccinesMember_label_en-US" xlink:label="lab_sny_VaccinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vaccines [Member]</link:label>
    <link:label id="lab_sny_VaccinesMember_documentation_en-US" xlink:label="lab_sny_VaccinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vaccines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesMember" xlink:href="sny-20221231.xsd#sny_VaccinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_VaccinesMember" xlink:to="lab_sny_VaccinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityLineItems_12e992b4-1cfb-4a09-8a95-1224aa73d62b_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of changes in equity [line items]</link:label>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityLineItems_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of changes in equity [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_ba38feac-e599-4ca2-87dd-6c9dfc891592_negatedLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses/(gains) due to experience adjustments</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GenzymeDeArgentinaSAMember_2d2bb7f8-79d6-4993-87e3-0aa9ad4cdcf7_terseLabel_en-US" xlink:label="lab_sny_GenzymeDeArgentinaSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme de Argentina S.A.</link:label>
    <link:label id="lab_sny_GenzymeDeArgentinaSAMember_label_en-US" xlink:label="lab_sny_GenzymeDeArgentinaSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme De Argentina SA [Member]</link:label>
    <link:label id="lab_sny_GenzymeDeArgentinaSAMember_documentation_en-US" xlink:label="lab_sny_GenzymeDeArgentinaSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme de Argentina SA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeDeArgentinaSAMember" xlink:href="sny-20221231.xsd#sny_GenzymeDeArgentinaSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GenzymeDeArgentinaSAMember" xlink:to="lab_sny_GenzymeDeArgentinaSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking_26c7ac48-ae01-4991-a4d0-537e27723bdc_terseLabel_en-US" xlink:label="lab_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fund reserves transferred</link:label>
    <link:label id="lab_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking_label_en-US" xlink:label="lab_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration Transferred To Fund Reserve For Indemnification Undertaking</link:label>
    <link:label id="lab_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking_documentation_en-US" xlink:label="lab_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration Transferred To Fund Reserve For Indemnification Undertaking</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking" xlink:href="sny-20221231.xsd#sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking" xlink:to="lab_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiSustainabilityLinkedCreditFacilitiesMember_8ff9378c-414b-4504-8cc1-f21d0816e0be_terseLabel_en-US" xlink:label="lab_sny_SanofiSustainabilityLinkedCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi sustainability-linked credit facilities</link:label>
    <link:label id="lab_sny_SanofiSustainabilityLinkedCreditFacilitiesMember_label_en-US" xlink:label="lab_sny_SanofiSustainabilityLinkedCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Sustainability-Linked Credit Facilities [Member]</link:label>
    <link:label id="lab_sny_SanofiSustainabilityLinkedCreditFacilitiesMember_documentation_en-US" xlink:label="lab_sny_SanofiSustainabilityLinkedCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Sustainability-Linked Credit Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSustainabilityLinkedCreditFacilitiesMember" xlink:href="sny-20221231.xsd#sny_SanofiSustainabilityLinkedCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiSustainabilityLinkedCreditFacilitiesMember" xlink:to="lab_sny_SanofiSustainabilityLinkedCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_6662e8a9-90cb-4876-8c9d-9222dc25e3e5_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Offsetting of Financial Assets and Liabilities [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off Setting Of Financial Assets And Liabilities [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of offsetting of financial assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems" xlink:to="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Inventories_7fffb453-45cc-46bb-8c15-3f455388ee1a_terseLabel_en-US" xlink:label="lab_ifrs-full_Inventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_ifrs-full_Inventories_4cad4612-8e57-4913-a564-a3b6b2d3d6af_totalLabel_en-US" xlink:label="lab_ifrs-full_Inventories" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_Inventories_label_en-US" xlink:label="lab_ifrs-full_Inventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories" xlink:to="lab_ifrs-full_Inventories" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisGmbHMember_b2a5d48f-e123-48d9-adca-6726476ca650_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis GmbH</link:label>
    <link:label id="lab_sny_SanofiAventisGmbHMember_label_en-US" xlink:label="lab_sny_SanofiAventisGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis GmbH [member]</link:label>
    <link:label id="lab_sny_SanofiAventisGmbHMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis GmbH.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisGmbHMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisGmbHMember" xlink:to="lab_sny_SanofiAventisGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ImpactOfChangeInInterestRateOnPreTaxIncome_8e39751d-847d-4b04-a9af-feb6cf4fc0f5_terseLabel_en-US" xlink:label="lab_sny_ImpactOfChangeInInterestRateOnPreTaxIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact on pre-tax net income</link:label>
    <link:label id="lab_sny_ImpactOfChangeInInterestRateOnPreTaxIncome_label_en-US" xlink:label="lab_sny_ImpactOfChangeInInterestRateOnPreTaxIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact Of Change In Interest Rate On Pre Tax Income</link:label>
    <link:label id="lab_sny_ImpactOfChangeInInterestRateOnPreTaxIncome_documentation_en-US" xlink:label="lab_sny_ImpactOfChangeInInterestRateOnPreTaxIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of change in interest rate on pre tax income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpactOfChangeInInterestRateOnPreTaxIncome" xlink:href="sny-20221231.xsd#sny_ImpactOfChangeInInterestRateOnPreTaxIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ImpactOfChangeInInterestRateOnPreTaxIncome" xlink:to="lab_sny_ImpactOfChangeInInterestRateOnPreTaxIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_4c618dcc-d425-42b5-9c72-15a11a36e5ec_terseLabel_en-US" xlink:label="lab_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in short-term debt and other financial instruments</link:label>
    <link:label id="lab_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_label_en-US" xlink:label="lab_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From (Used In) Increase (Decrease) In Current Borrowings And Other Financial Instruments</link:label>
    <link:label id="lab_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_documentation_en-US" xlink:label="lab_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From (Used In) Increase (Decrease) In Current Borrowings And Other Financial Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:href="sny-20221231.xsd#sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:to="lab_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_25e36501-c22e-4f53-8a4d-ce01f689fa2e_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Finance Income Expense [table]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_label_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Finance Income Expense [table]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule disclosing information related to details of finance income (expense).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xlink:to="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_909a3bfb-6108-46b6-95e2-89265f355473_terseLabel_en-US" xlink:label="lab_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for segment consolidation items [member]</link:label>
    <link:label id="lab_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_label_en-US" xlink:label="lab_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for segment consolidation items [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lab_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfGuaranteesTable_cbf316e4-437b-4cdc-bbab-9620045f4de8_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfGuaranteesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Guarantees [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfGuaranteesTable_label_en-US" xlink:label="lab_sny_DisclosureOfGuaranteesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Guarantees [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfGuaranteesTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfGuaranteesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Guarantees [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfGuaranteesTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfGuaranteesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfGuaranteesTable" xlink:to="lab_sny_DisclosureOfGuaranteesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CustomerTwoMember_ad7a5185-d7f4-4c40-9a3a-38e7d1813ce4_terseLabel_en-US" xlink:label="lab_sny_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer two</link:label>
    <link:label id="lab_sny_CustomerTwoMember_label_en-US" xlink:label="lab_sny_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two [member]</link:label>
    <link:label id="lab_sny_CustomerTwoMember_documentation_en-US" xlink:label="lab_sny_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CustomerTwoMember" xlink:href="sny-20221231.xsd#sny_CustomerTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CustomerTwoMember" xlink:to="lab_sny_CustomerTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CaissePrimaireDassuranceMaladieMember_6f156b24-a679-4488-a10c-2c2052d5bb1b_terseLabel_en-US" xlink:label="lab_sny_CaissePrimaireDassuranceMaladieMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Caisse Primaire D Assurance Maladie</link:label>
    <link:label id="lab_sny_CaissePrimaireDassuranceMaladieMember_label_en-US" xlink:label="lab_sny_CaissePrimaireDassuranceMaladieMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Caisse Primaire DAssurance Maladie [Member]</link:label>
    <link:label id="lab_sny_CaissePrimaireDassuranceMaladieMember_documentation_en-US" xlink:label="lab_sny_CaissePrimaireDassuranceMaladieMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Caisse Primaire D Assurance Maladie.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CaissePrimaireDassuranceMaladieMember" xlink:href="sny-20221231.xsd#sny_CaissePrimaireDassuranceMaladieMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CaissePrimaireDassuranceMaladieMember" xlink:to="lab_sny_CaissePrimaireDassuranceMaladieMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_97c8f548-7fb2-4fd0-b9fa-4cedbf473a17_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ContingenciesArisingFromCertainBusinessDivestituresMember_7a49cc01-f45e-4a40-aa13-aeafdb8b9676_terseLabel_en-US" xlink:label="lab_sny_ContingenciesArisingFromCertainBusinessDivestituresMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies arising from certain business divestitures</link:label>
    <link:label id="lab_sny_ContingenciesArisingFromCertainBusinessDivestituresMember_label_en-US" xlink:label="lab_sny_ContingenciesArisingFromCertainBusinessDivestituresMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Arising From Certain Business Divestitures [Member]</link:label>
    <link:label id="lab_sny_ContingenciesArisingFromCertainBusinessDivestituresMember_documentation_en-US" xlink:label="lab_sny_ContingenciesArisingFromCertainBusinessDivestituresMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Arising From Certain Business Divestitures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingenciesArisingFromCertainBusinessDivestituresMember" xlink:href="sny-20221231.xsd#sny_ContingenciesArisingFromCertainBusinessDivestituresMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ContingenciesArisingFromCertainBusinessDivestituresMember" xlink:to="lab_sny_ContingenciesArisingFromCertainBusinessDivestituresMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_WithMarketConditionMember_f5a9787f-fb82-472b-8864-7324c6ce7087_terseLabel_en-US" xlink:label="lab_sny_WithMarketConditionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">With market condition</link:label>
    <link:label id="lab_sny_WithMarketConditionMember_label_en-US" xlink:label="lab_sny_WithMarketConditionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">With Market Condition [Member]</link:label>
    <link:label id="lab_sny_WithMarketConditionMember_documentation_en-US" xlink:label="lab_sny_WithMarketConditionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">With Market Condition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WithMarketConditionMember" xlink:href="sny-20221231.xsd#sny_WithMarketConditionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_WithMarketConditionMember" xlink:to="lab_sny_WithMarketConditionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilities_475786ea-2870-4b82-bdd8-a96df3a8ae5c_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilities" xlink:to="lab_ifrs-full_DerivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareFranceSASMember_ac869a01-1857-498e-9ac6-1d6b50fbbc09_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareFranceSASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare France SAS</link:label>
    <link:label id="lab_sny_OpellaHealthcareFranceSASMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareFranceSASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare France SAS [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareFranceSASMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareFranceSASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare France SAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareFranceSASMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareFranceSASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareFranceSASMember" xlink:to="lab_sny_OpellaHealthcareFranceSASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RoyaltyExpensePercentage_868ed6d7-310f-436d-b162-674a462c7e5b_terseLabel_en-US" xlink:label="lab_sny_RoyaltyExpensePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty expense, percentage (percentage)</link:label>
    <link:label id="lab_sny_RoyaltyExpensePercentage_label_en-US" xlink:label="lab_sny_RoyaltyExpensePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense, Percentage</link:label>
    <link:label id="lab_sny_RoyaltyExpensePercentage_documentation_en-US" xlink:label="lab_sny_RoyaltyExpensePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltyExpensePercentage" xlink:href="sny-20221231.xsd#sny_RoyaltyExpensePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RoyaltyExpensePercentage" xlink:to="lab_sny_RoyaltyExpensePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares_8f7fafdf-70fc-4a1d-86c0-4d4ddc264377_terseLabel_en-US" xlink:label="lab_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares received (in shares)</link:label>
    <link:label id="lab_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares_label_en-US" xlink:label="lab_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Distribution, Shares Received Per Conversion Of Parent Shares</link:label>
    <link:label id="lab_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares_documentation_en-US" xlink:label="lab_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Distribution, Shares Received Per Conversion Of Parent Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares" xlink:href="sny-20221231.xsd#sny_SpecialDistributionSharesReceivedPerConversionOfParentShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares" xlink:to="lab_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurSpZooMember_c3d4d9d6-9f93-4fc4-bed1-15c3fa3dd341_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurSpZooMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Sp. z.o.o.</link:label>
    <link:label id="lab_sny_SanofiPasteurSpZooMember_label_en-US" xlink:label="lab_sny_SanofiPasteurSpZooMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Sp z.o.o. [Member]</link:label>
    <link:label id="lab_sny_SanofiPasteurSpZooMember_documentation_en-US" xlink:label="lab_sny_SanofiPasteurSpZooMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Sp z.o.o.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurSpZooMember" xlink:href="sny-20221231.xsd#sny_SanofiPasteurSpZooMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurSpZooMember" xlink:to="lab_sny_SanofiPasteurSpZooMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentLeaseLiabilities_388bf60e-cef1-4014-b265-ee6c45239798_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentLeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ServicesOtherThanStatutoryAudit_d42e70f2-011a-4b0f-bad0-3c137861bd01_totalLabel_en-US" xlink:label="lab_sny_ServicesOtherThanStatutoryAudit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services other than statutory audit</link:label>
    <link:label id="lab_sny_ServicesOtherThanStatutoryAudit_label_en-US" xlink:label="lab_sny_ServicesOtherThanStatutoryAudit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Other Than Statutory Audit</link:label>
    <link:label id="lab_sny_ServicesOtherThanStatutoryAudit_documentation_en-US" xlink:label="lab_sny_ServicesOtherThanStatutoryAudit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services other than statutory audit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ServicesOtherThanStatutoryAudit" xlink:href="sny-20221231.xsd#sny_ServicesOtherThanStatutoryAudit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ServicesOtherThanStatutoryAudit" xlink:to="lab_sny_ServicesOtherThanStatutoryAudit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOutstandingShareOptions_e614cc5a-d352-4d13-b35e-5acccfa44514_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options outstanding (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOutstandingShareOptions_ad96a623-5b4c-423e-9cab-e7a24437305e_verboseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Number&#160;of options (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOutstandingShareOptions_label_en-US" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossProfit_e8ddad59-8bc3-471c-91b2-e44f4ce7216b_totalLabel_en-US" xlink:label="lab_ifrs-full_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_ifrs-full_GrossProfit_label_en-US" xlink:label="lab_ifrs-full_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit" xlink:to="lab_ifrs-full_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CounterpartiesAxis_e1ab09aa-2e49-4cc0-a24e-a138208e9b87_terseLabel_en-US" xlink:label="lab_ifrs-full_CounterpartiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparties [axis]</link:label>
    <link:label id="lab_ifrs-full_CounterpartiesAxis_label_en-US" xlink:label="lab_ifrs-full_CounterpartiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparties [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesAxis" xlink:to="lab_ifrs-full_CounterpartiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits_6e878917-db79-48e6-aaeb-70bd398aa6ef_terseLabel_en-US" xlink:label="lab_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate termination benefits and lump-sum retirement benefits in favor of key management personnel</link:label>
    <link:label id="lab_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits_label_en-US" xlink:label="lab_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key Management Personnel Compensation Termination Benefits And LumpSum Retirement Benefits</link:label>
    <link:label id="lab_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits_documentation_en-US" xlink:label="lab_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key management personnel compensation, termination benefits and lump sum retirement benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits" xlink:href="sny-20221231.xsd#sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits" xlink:to="lab_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AuditorsNameAxis_02f8fed3-b501-42bc-b092-abc8567a66e9_terseLabel_en-US" xlink:label="lab_sny_AuditorsNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditors Name [Axis]</link:label>
    <link:label id="lab_sny_AuditorsNameAxis_label_en-US" xlink:label="lab_sny_AuditorsNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditors Name [Axis]</link:label>
    <link:label id="lab_sny_AuditorsNameAxis_documentation_en-US" xlink:label="lab_sny_AuditorsNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditors Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsNameAxis" xlink:href="sny-20221231.xsd#sny_AuditorsNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AuditorsNameAxis" xlink:to="lab_sny_AuditorsNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions_0beddec1-59f4-4396-9cc6-08d0606c1aad_terseLabel_en-US" xlink:label="lab_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties and other income</link:label>
    <link:label id="lab_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions_label_en-US" xlink:label="lab_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties And Other Income, Related Party Transactions</link:label>
    <link:label id="lab_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions_documentation_en-US" xlink:label="lab_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties and other income, related party transactions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xlink:href="sny-20221231.xsd#sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xlink:to="lab_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfShareCapitalForThePeriod_c56adad3-ed6a-4dd9-9183-85a1710c24f2_terseLabel_en-US" xlink:label="lab_sny_PercentageOfShareCapitalForThePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">%&#160;of&#160;share&#160;capital for the period</link:label>
    <link:label id="lab_sny_PercentageOfShareCapitalForThePeriod_label_en-US" xlink:label="lab_sny_PercentageOfShareCapitalForThePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Share Capital For The Period</link:label>
    <link:label id="lab_sny_PercentageOfShareCapitalForThePeriod_documentation_en-US" xlink:label="lab_sny_PercentageOfShareCapitalForThePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of share capital for the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfShareCapitalForThePeriod" xlink:href="sny-20221231.xsd#sny_PercentageOfShareCapitalForThePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfShareCapitalForThePeriod" xlink:to="lab_sny_PercentageOfShareCapitalForThePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_d296aad8-9de0-4db9-8a96-c570bd76edcd_periodStartLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average exercise&#160;price per share, beginning balance (in euros per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_fa945d71-e971-4fb6-b76d-73c35deafeda_periodEndLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average exercise&#160;price per share, ending balance (in euros per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_f8b60576-e89f-4707-ad5c-90cde3dd4877_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement (in euros per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockBasedCompensationStockOptionsExercisedPricePerShare_d5a25d5e-b12c-4250-9f7e-82b89f937ee1_terseLabel_en-US" xlink:label="lab_sny_StockBasedCompensationStockOptionsExercisedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in euros per share)</link:label>
    <link:label id="lab_sny_StockBasedCompensationStockOptionsExercisedPricePerShare_label_en-US" xlink:label="lab_sny_StockBasedCompensationStockOptionsExercisedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Based Compensation Stock Options Exercised Price Per Share</link:label>
    <link:label id="lab_sny_StockBasedCompensationStockOptionsExercisedPricePerShare_documentation_en-US" xlink:label="lab_sny_StockBasedCompensationStockOptionsExercisedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation stock options exercised price per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockBasedCompensationStockOptionsExercisedPricePerShare" xlink:href="sny-20221231.xsd#sny_StockBasedCompensationStockOptionsExercisedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockBasedCompensationStockOptionsExercisedPricePerShare" xlink:to="lab_sny_StockBasedCompensationStockOptionsExercisedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InfluenzaVaccinesMember_f2368283-30d5-4246-b689-412a42fcb251_terseLabel_en-US" xlink:label="lab_sny_InfluenzaVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Influenza Vaccines</link:label>
    <link:label id="lab_sny_InfluenzaVaccinesMember_label_en-US" xlink:label="lab_sny_InfluenzaVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Influenza Vaccines [Member]</link:label>
    <link:label id="lab_sny_InfluenzaVaccinesMember_documentation_en-US" xlink:label="lab_sny_InfluenzaVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Influenza Vaccines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InfluenzaVaccinesMember" xlink:href="sny-20221231.xsd#sny_InfluenzaVaccinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InfluenzaVaccinesMember" xlink:to="lab_sny_InfluenzaVaccinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities_728d8e27-f875-4431-a9b4-ac0d7edcd950_terseLabel_en-US" xlink:label="lab_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in non-current provisions and other non-current liabilities</link:label>
    <link:label id="lab_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities_label_en-US" xlink:label="lab_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments For Non-current Provisions And Other Non-current Liabilities</link:label>
    <link:label id="lab_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities_documentation_en-US" xlink:label="lab_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for noncurrent provisions and other noncurrent liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:href="sny-20221231.xsd#sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:to="lab_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisAustraliaPtyLtdMember_bb51eaa8-6cfa-4677-adc2-f07e9a134711_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisAustraliaPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Australia Pty Ltd</link:label>
    <link:label id="lab_sny_SanofiAventisAustraliaPtyLtdMember_label_en-US" xlink:label="lab_sny_SanofiAventisAustraliaPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Australia Pty Ltd [member]</link:label>
    <link:label id="lab_sny_SanofiAventisAustraliaPtyLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisAustraliaPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Australia Pty Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisAustraliaPtyLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisAustraliaPtyLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisAustraliaPtyLtdMember" xlink:to="lab_sny_SanofiAventisAustraliaPtyLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RareBloodDisordersMember_b8743ca8-310c-4ff3-bd63-d9e872c49078_terseLabel_en-US" xlink:label="lab_sny_RareBloodDisordersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rare Blood Disorders</link:label>
    <link:label id="lab_sny_RareBloodDisordersMember_label_en-US" xlink:label="lab_sny_RareBloodDisordersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rare Blood Disorders [Member]</link:label>
    <link:label id="lab_sny_RareBloodDisordersMember_documentation_en-US" xlink:label="lab_sny_RareBloodDisordersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rare Blood Disorders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RareBloodDisordersMember" xlink:href="sny-20221231.xsd#sny_RareBloodDisordersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RareBloodDisordersMember" xlink:to="lab_sny_RareBloodDisordersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet_2669d08b-b400-41bc-9333-0d926da94bdf_terseLabel_en-US" xlink:label="lab_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced</link:label>
    <link:label id="lab_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet_label_en-US" xlink:label="lab_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Leases, Low Value Asset Leases And Lease Contracts Committed But Not Started Yet</link:label>
    <link:label id="lab_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet_documentation_en-US" xlink:label="lab_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Leases, Low Value Asset Leases And Lease Contracts Committed But Not Started Yet</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" xlink:href="sny-20221231.xsd#sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" xlink:to="lab_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ParValuePerShare_e8ccc60c-d1e9-48cf-8a2d-f8fe5e2ab094_terseLabel_en-US" xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par value per share (in euros per share)</link:label>
    <link:label id="lab_ifrs-full_ParValuePerShare_label_en-US" xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par value per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare" xlink:to="lab_ifrs-full_ParValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_2dca53f3-a411-4728-a530-cca263147339_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal of consolidated undertakings and investments accounted for using the equity method, net of tax</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from losing control of subsidiaries or other businesses, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AllowanceForCreditLossesMember_4f858a57-291c-4746-bc9b-70736394917b_terseLabel_en-US" xlink:label="lab_ifrs-full_AllowanceForCreditLossesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances</link:label>
    <link:label id="lab_ifrs-full_AllowanceForCreditLossesMember_label_en-US" xlink:label="lab_ifrs-full_AllowanceForCreditLossesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllowanceForCreditLossesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllowanceForCreditLossesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AllowanceForCreditLossesMember" xlink:to="lab_ifrs-full_AllowanceForCreditLossesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilities_f315597c-a686-494a-ab4b-05afda8ebb75_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total financial liabilities measured at fair value</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilities" xlink:to="lab_ifrs-full_FinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_36f9ddeb-6d0c-4c08-990a-db90db582889_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other profit or loss items with no cash effect on cash flows generated by operating activities</link:label>
    <link:label id="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_label_en-US" xlink:label="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments to reconcile profit (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:to="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DigestiveWellnessMember_83e4979b-629a-4206-b0bd-b2620633b510_terseLabel_en-US" xlink:label="lab_sny_DigestiveWellnessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive Wellness</link:label>
    <link:label id="lab_sny_DigestiveWellnessMember_label_en-US" xlink:label="lab_sny_DigestiveWellnessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive Wellness [Member]</link:label>
    <link:label id="lab_sny_DigestiveWellnessMember_documentation_en-US" xlink:label="lab_sny_DigestiveWellnessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DigestiveWellnessMember" xlink:href="sny-20221231.xsd#sny_DigestiveWellnessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DigestiveWellnessMember" xlink:to="lab_sny_DigestiveWellnessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MachineryAndEquipmentMember_da2bbb0b-c8be-41fe-9e36-b21e41841d2b_terseLabel_en-US" xlink:label="lab_sny_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_sny_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_sny_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery And Equipment [Member]</link:label>
    <link:label id="lab_sny_MachineryAndEquipmentMember_documentation_en-US" xlink:label="lab_sny_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MachineryAndEquipmentMember" xlink:href="sny-20221231.xsd#sny_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MachineryAndEquipmentMember" xlink:to="lab_sny_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalMarketedProductsAventisMember_483e575d-1dc2-4e37-b466-fc458e7883b9_terseLabel_en-US" xlink:label="lab_sny_PrincipalMarketedProductsAventisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsAventisMember_label_en-US" xlink:label="lab_sny_PrincipalMarketedProductsAventisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products Aventis [member]</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsAventisMember_documentation_en-US" xlink:label="lab_sny_PrincipalMarketedProductsAventisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal marketed products aventis.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsAventisMember" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsAventisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalMarketedProductsAventisMember" xlink:to="lab_sny_PrincipalMarketedProductsAventisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock_a7467431-20f7-49fd-8ac4-2ddd070d3551_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Other Provisions</link:label>
    <link:label id="lab_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Long Term Provisions [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of other long term provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherLongTermProvisionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock" xlink:to="lab_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyLineItems_249bb5f2-52c1-43d0-93e1-a9af71f405b1_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt By Currency [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt By Currency [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt By Currency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByCurrencyLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByCurrencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtByCurrencyLineItems" xlink:to="lab_sny_DisclosureOfDebtByCurrencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SynthorxMember_097369d4-b749-43be-97a3-7305fb0dafed_terseLabel_en-US" xlink:label="lab_sny_SynthorxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Synthorx</link:label>
    <link:label id="lab_sny_SynthorxMember_label_en-US" xlink:label="lab_sny_SynthorxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Synthorx [Member]</link:label>
    <link:label id="lab_sny_SynthorxMember_documentation_en-US" xlink:label="lab_sny_SynthorxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Synthorx [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxMember" xlink:href="sny-20221231.xsd#sny_SynthorxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SynthorxMember" xlink:to="lab_sny_SynthorxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossFromOperatingActivities_c0ac6e84-9439-43b6-88d7-6f9a17d7d182_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_ifrs-full_ProfitLossFromOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit (loss) from operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_HedgingInstrumentsAxis_bca1828c-65d9-42ee-a1f0-96eb0552267c_terseLabel_en-US" xlink:label="lab_ifrs-full_HedgingInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging instruments [axis]</link:label>
    <link:label id="lab_ifrs-full_HedgingInstrumentsAxis_label_en-US" xlink:label="lab_ifrs-full_HedgingInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging instruments [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis" xlink:to="lab_ifrs-full_HedgingInstrumentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_b8fb0ad4-f218-456b-b1a8-b9b1750f5646_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Items not subsequently reclassifiable to profit or loss</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income that will not be reclassified to profit or loss, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ResearchAndDevelopmentExpense_43f0b321-3ed4-4963-a386-b6805b9b79e3_negatedLabel_en-US" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_ifrs-full_ResearchAndDevelopmentExpense_495136bf-c660-4351-a737-7ebb99d0eec6_terseLabel_en-US" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_ifrs-full_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MilestonePaymentTerm_9d2acff3-2a6c-4306-806b-8c9920c29d65_terseLabel_en-US" xlink:label="lab_sny_MilestonePaymentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payment period</link:label>
    <link:label id="lab_sny_MilestonePaymentTerm_label_en-US" xlink:label="lab_sny_MilestonePaymentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Term</link:label>
    <link:label id="lab_sny_MilestonePaymentTerm_documentation_en-US" xlink:label="lab_sny_MilestonePaymentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payment term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MilestonePaymentTerm" xlink:href="sny-20221231.xsd#sny_MilestonePaymentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MilestonePaymentTerm" xlink:to="lab_sny_MilestonePaymentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod_e027a9e5-06be-4372-a6a7-6988ae7ad6cc_terseLabel_en-US" xlink:label="lab_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax charge on deemed repatriation attributable to accumulated earnings payable period</link:label>
    <link:label id="lab_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod_label_en-US" xlink:label="lab_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Charge On Deemed Repatriation Attributable To Accumulated Earnings Payable Period</link:label>
    <link:label id="lab_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod_documentation_en-US" xlink:label="lab_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax charge on deemed repatriation attributable to accumulated earnings payable period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod" xlink:href="sny-20221231.xsd#sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod" xlink:to="lab_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_49b22630-6219-43da-9138-5ca6d18585bb_terseLabel_en-US" xlink:label="lab_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect at date of initial application [axis]</link:label>
    <link:label id="lab_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_label_en-US" xlink:label="lab_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect at date of initial application [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis" xlink:to="lab_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_ac9e7a74-699b-4ba0-aa5f-e2771e0f713b_negatedLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of other equity investments</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of financial instruments, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EntitysTotalForCashgeneratingUnitsMember_9cb23446-377e-4797-8062-13b01fcab535_terseLabel_en-US" xlink:label="lab_ifrs-full_EntitysTotalForCashgeneratingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for cash-generating units [member]</link:label>
    <link:label id="lab_ifrs-full_EntitysTotalForCashgeneratingUnitsMember_label_en-US" xlink:label="lab_ifrs-full_EntitysTotalForCashgeneratingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for cash-generating units [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForCashgeneratingUnitsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForCashgeneratingUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForCashgeneratingUnitsMember" xlink:to="lab_ifrs-full_EntitysTotalForCashgeneratingUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_db595640-44b9-4c15-9b3e-f8cacb9d9319_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of maturity analysis of finance lease payments receivable [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of maturity analysis of finance lease payments receivable [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IrrevocablePurchaseCommitmentsGiven_e710c112-0d4a-40f7-9c0f-8c2e047ebf00_terseLabel_en-US" xlink:label="lab_sny_IrrevocablePurchaseCommitmentsGiven" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Irrevocable purchase commitments given</link:label>
    <link:label id="lab_sny_IrrevocablePurchaseCommitmentsGiven_label_en-US" xlink:label="lab_sny_IrrevocablePurchaseCommitmentsGiven" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Irrevocable Purchase Commitments Given</link:label>
    <link:label id="lab_sny_IrrevocablePurchaseCommitmentsGiven_documentation_en-US" xlink:label="lab_sny_IrrevocablePurchaseCommitmentsGiven" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Irrevocable purchase commitments given.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IrrevocablePurchaseCommitmentsGiven" xlink:href="sny-20221231.xsd#sny_IrrevocablePurchaseCommitmentsGiven"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IrrevocablePurchaseCommitmentsGiven" xlink:to="lab_sny_IrrevocablePurchaseCommitmentsGiven" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PerformanceSharePlanOneMember_3543fc7d-6d5c-4248-a309-0b19adef2c25_terseLabel_en-US" xlink:label="lab_sny_PerformanceSharePlanOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share plan one</link:label>
    <link:label id="lab_sny_PerformanceSharePlanOneMember_label_en-US" xlink:label="lab_sny_PerformanceSharePlanOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Plan One [member]</link:label>
    <link:label id="lab_sny_PerformanceSharePlanOneMember_documentation_en-US" xlink:label="lab_sny_PerformanceSharePlanOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Plan One.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceSharePlanOneMember" xlink:href="sny-20221231.xsd#sny_PerformanceSharePlanOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PerformanceSharePlanOneMember" xlink:to="lab_sny_PerformanceSharePlanOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiSynthelaboUKLtdMember_c4516c1d-4123-4301-9014-69970505eb1a_terseLabel_en-US" xlink:label="lab_sny_SanofiSynthelaboUKLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Synthelabo UK Ltd</link:label>
    <link:label id="lab_sny_SanofiSynthelaboUKLtdMember_label_en-US" xlink:label="lab_sny_SanofiSynthelaboUKLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Synthelabo UK Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiSynthelaboUKLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiSynthelaboUKLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Synthelabo UK Ltd</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSynthelaboUKLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiSynthelaboUKLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiSynthelaboUKLtdMember" xlink:to="lab_sny_SanofiSynthelaboUKLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfFinancialPositionAbstract_8f9f16e3-6128-478f-94e7-c821dc1bb864_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of financial position [abstract]</link:label>
    <link:label id="lab_ifrs-full_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of financial position [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NonadjustingEventsMember_7e2522f4-d97c-4525-97bb-c1310cce5616_terseLabel_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-adjusting events after reporting period [member]</link:label>
    <link:label id="lab_ifrs-full_NonadjustingEventsMember_label_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-adjusting events after reporting period [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsMember" xlink:to="lab_ifrs-full_NonadjustingEventsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInSingaporeDollarMember_9566af8e-2118-4c0b-ab36-def7f2364ef8_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInSingaporeDollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases in Singapore Dollar</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInSingaporeDollarMember_label_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInSingaporeDollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Singapore Dollar [member]</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInSingaporeDollarMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInSingaporeDollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases in Singapore Dollar.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInSingaporeDollarMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInSingaporeDollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasedInSingaporeDollarMember" xlink:to="lab_sny_ForwardCurrencyPurchasedInSingaporeDollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfActuarialAssumptionsTableTextBlock_2bf4a7d9-6df7-4df3-b26d-5219d842ddf0_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfActuarialAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial and Demographic Assumptions</link:label>
    <link:label id="lab_sny_DisclosureOfActuarialAssumptionsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfActuarialAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Actuarial Assumptions [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfActuarialAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfActuarialAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Actuarial Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfActuarialAssumptionsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfActuarialAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfActuarialAssumptionsTableTextBlock" xlink:to="lab_sny_DisclosureOfActuarialAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock_aaf044da-c3d3-436f-aa61-df8646bc8402_terseLabel_en-US" xlink:label="lab_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK</link:label>
    <link:label id="lab_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock_label_en-US" xlink:label="lab_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreements Relating To The Recombinant Covid-19 Vaccine Candidate Developed By Sanofi In Collaboration With GSK [Policy Text Block]</link:label>
    <link:label id="lab_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock_documentation_en-US" xlink:label="lab_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreements Relating To The Recombinant Covid-19 Vaccine Candidate Developed By Sanofi In Collaboration With GSK</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock" xlink:href="sny-20221231.xsd#sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock" xlink:to="lab_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_40bd4ccb-20df-4dd1-beaf-0de3700f6fdd_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension benefit indexation</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumption of expected rates of pension increases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SpecialDistributionPercentageOfShareCapitalDistributed_1310369b-d672-49b7-b7ca-eb130a607f09_terseLabel_en-US" xlink:label="lab_sny_SpecialDistributionPercentageOfShareCapitalDistributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special distribution, percentage of share capital distributed</link:label>
    <link:label id="lab_sny_SpecialDistributionPercentageOfShareCapitalDistributed_label_en-US" xlink:label="lab_sny_SpecialDistributionPercentageOfShareCapitalDistributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Distribution, Percentage Of Share Capital Distributed</link:label>
    <link:label id="lab_sny_SpecialDistributionPercentageOfShareCapitalDistributed_documentation_en-US" xlink:label="lab_sny_SpecialDistributionPercentageOfShareCapitalDistributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Distribution, Percentage Of Share Capital Distributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SpecialDistributionPercentageOfShareCapitalDistributed" xlink:href="sny-20221231.xsd#sny_SpecialDistributionPercentageOfShareCapitalDistributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SpecialDistributionPercentageOfShareCapitalDistributed" xlink:to="lab_sny_SpecialDistributionPercentageOfShareCapitalDistributed" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateSwapsInterestRate_ba03b1a1-c954-438b-9cfe-1cad37f66449_terseLabel_en-US" xlink:label="lab_sny_InterestRateSwapsInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_sny_InterestRateSwapsInterestRate_label_en-US" xlink:label="lab_sny_InterestRateSwapsInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps, Interest Rate</link:label>
    <link:label id="lab_sny_InterestRateSwapsInterestRate_documentation_en-US" xlink:label="lab_sny_InterestRateSwapsInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps, Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsInterestRate" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateSwapsInterestRate" xlink:to="lab_sny_InterestRateSwapsInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember_90043e0b-0ccd-482e-b890-0cf5079a6add_terseLabel_en-US" xlink:label="lab_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation adjustments (intragroup margin in inventory)</link:label>
    <link:label id="lab_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember_label_en-US" xlink:label="lab_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Adjustments Intragroup Margin In Inventory [Member]</link:label>
    <link:label id="lab_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember_documentation_en-US" xlink:label="lab_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation adjustments intragroup margin In Inventory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember" xlink:href="sny-20221231.xsd#sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember" xlink:to="lab_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_dd7fb60e-7736-4078-b19e-fb34fe2ee6be_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General inflation rate</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumption of expected rates of inflation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_cd5a5acc-8413-4bf9-8fa9-9db0ef172fd9_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of property, plant and equipment, intangible assets, and investments accounted for using the equity method</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for impairment of assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfLossesArisingFromCommercialOperations_455f1e56-e952-476a-8159-40d432be3eb6_terseLabel_en-US" xlink:label="lab_sny_PercentageOfLossesArisingFromCommercialOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of losses arising from commercial operations</link:label>
    <link:label id="lab_sny_PercentageOfLossesArisingFromCommercialOperations_label_en-US" xlink:label="lab_sny_PercentageOfLossesArisingFromCommercialOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Losses Arising From Commercial Operations</link:label>
    <link:label id="lab_sny_PercentageOfLossesArisingFromCommercialOperations_documentation_en-US" xlink:label="lab_sny_PercentageOfLossesArisingFromCommercialOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Losses Arising From Commercial Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfLossesArisingFromCommercialOperations" xlink:href="sny-20221231.xsd#sny_PercentageOfLossesArisingFromCommercialOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfLossesArisingFromCommercialOperations" xlink:to="lab_sny_PercentageOfLossesArisingFromCommercialOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_7a593d31-b8e0-4fd9-a23a-446f24119b67_terseLabel_en-US" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of profit/(loss) from investments accounted for using the equity method</link:label>
    <link:label id="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of profit (loss) of associates accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisSingaporePteLtdMember_44485bbc-7ddc-402e-9ce4-6637756ff1ae_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisSingaporePteLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Singapore Pte. Ltd</link:label>
    <link:label id="lab_sny_SanofiAventisSingaporePteLtdMember_label_en-US" xlink:label="lab_sny_SanofiAventisSingaporePteLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Singapore Pte Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisSingaporePteLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisSingaporePteLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Singapore Pte Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSingaporePteLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisSingaporePteLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisSingaporePteLtdMember" xlink:to="lab_sny_SanofiAventisSingaporePteLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_b0f113f4-060e-4785-802d-2cd733c8bffb_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of financial instruments by type of interest rate [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of financial instruments by type of interest rate [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_c8ebd0e0-54c6-4861-a990-41e64f920417_negatedLabel_en-US" xlink:label="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of dividends to non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends recognised as distributions to non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:to="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RightofuseAssets_be71867f-6b1c-4b1d-9cbd-fe8b56bd3872_terseLabel_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_ifrs-full_RightofuseAssets_add985dd-951c-4b3f-8ebb-85feec60ab5e_periodStartLabel_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets at beginning of period</link:label>
    <link:label id="lab_ifrs-full_RightofuseAssets_e4d8c8be-f9f9-493a-9786-29b42fd2b3ea_periodEndLabel_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets at end of period</link:label>
    <link:label id="lab_ifrs-full_RightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets" xlink:to="lab_ifrs-full_RightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities_22074956-e1f4-4313-ac48-d30b704ce15b_terseLabel_en-US" xlink:label="lab_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other securities</link:label>
    <link:label id="lab_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities_label_en-US" xlink:label="lab_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Contributed To Fair Value Of Plan Assets, Other Securities</link:label>
    <link:label id="lab_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities_documentation_en-US" xlink:label="lab_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Contributed To Fair Value Of Plan Assets, Other Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities" xlink:to="lab_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_March2018EMTNISINFR0013324373Member_87ba9f2b-45f5-4012-a2cb-544b5cd7f1de_terseLabel_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324373Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR0013324373</link:label>
    <link:label id="lab_sny_March2018EMTNISINFR0013324373Member_label_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324373Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR0013324373 [Member]</link:label>
    <link:label id="lab_sny_March2018EMTNISINFR0013324373Member_documentation_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324373Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR 0013324373.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324373Member" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324373Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_March2018EMTNISINFR0013324373Member" xlink:to="lab_sny_March2018EMTNISINFR0013324373Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments_068577c4-028f-49d2-84b8-72ce9d841801_terseLabel_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains/(losses) on experience adjustments</link:label>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments_label_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Actuarial Gains (Losses) On Experience Adjustments</link:label>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments_documentation_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains/(losses) on experience adjustments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" xlink:to="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ProvisionsForOtherLongTermBenefitsMember_87378254-4788-452c-934e-319bb324cb8a_terseLabel_en-US" xlink:label="lab_sny_ProvisionsForOtherLongTermBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for other long-term benefits</link:label>
    <link:label id="lab_sny_ProvisionsForOtherLongTermBenefitsMember_label_en-US" xlink:label="lab_sny_ProvisionsForOtherLongTermBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions For Other Long Term Benefits [member]</link:label>
    <link:label id="lab_sny_ProvisionsForOtherLongTermBenefitsMember_documentation_en-US" xlink:label="lab_sny_ProvisionsForOtherLongTermBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for other long term benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForOtherLongTermBenefitsMember" xlink:href="sny-20221231.xsd#sny_ProvisionsForOtherLongTermBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProvisionsForOtherLongTermBenefitsMember" xlink:to="lab_sny_ProvisionsForOtherLongTermBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock_3191517d-30a2-4675-8407-a19e54516a32_terseLabel_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs and similar items</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock_label_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Accounting Policy For Restructuring Costs And Similar Items [Policy Text Block]</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock_documentation_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The description of the entity's accounting policy for restructuring costs and similar items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock" xlink:to="lab_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommercializationRelatedExpensesMember_9594d761-af15-44c6-b3c5-6c10fab6caab_terseLabel_en-US" xlink:label="lab_sny_CommercializationRelatedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercialization related expenses</link:label>
    <link:label id="lab_sny_CommercializationRelatedExpensesMember_label_en-US" xlink:label="lab_sny_CommercializationRelatedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercialization Related Expenses [Member]</link:label>
    <link:label id="lab_sny_CommercializationRelatedExpensesMember_documentation_en-US" xlink:label="lab_sny_CommercializationRelatedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercialization related expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommercializationRelatedExpensesMember" xlink:href="sny-20221231.xsd#sny_CommercializationRelatedExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommercializationRelatedExpensesMember" xlink:to="lab_sny_CommercializationRelatedExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfProfitShareOnCounterpartiesProfit_f78c3c66-eb23-493e-a382-2e87b44ff183_terseLabel_en-US" xlink:label="lab_sny_PercentageOfProfitShareOnCounterpartiesProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum additional profit-share, in percentage of Regeneron's quarterly profit (in percent)</link:label>
    <link:label id="lab_sny_PercentageOfProfitShareOnCounterpartiesProfit_label_en-US" xlink:label="lab_sny_PercentageOfProfitShareOnCounterpartiesProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Profit Share On Counterparties Profit</link:label>
    <link:label id="lab_sny_PercentageOfProfitShareOnCounterpartiesProfit_documentation_en-US" xlink:label="lab_sny_PercentageOfProfitShareOnCounterpartiesProfit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of profit share on counter parties profit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitShareOnCounterpartiesProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit" xlink:to="lab_sny_PercentageOfProfitShareOnCounterpartiesProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AmountsPayablePartnersInCollaborationAgreements_5cc99371-55a1-4ea7-a604-9895d82055f3_terseLabel_en-US" xlink:label="lab_sny_AmountsPayablePartnersInCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts payable partners in collaboration agreements</link:label>
    <link:label id="lab_sny_AmountsPayablePartnersInCollaborationAgreements_label_en-US" xlink:label="lab_sny_AmountsPayablePartnersInCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Payable Partners In Collaboration Agreements</link:label>
    <link:label id="lab_sny_AmountsPayablePartnersInCollaborationAgreements_documentation_en-US" xlink:label="lab_sny_AmountsPayablePartnersInCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts payable partners in collaboration agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmountsPayablePartnersInCollaborationAgreements" xlink:href="sny-20221231.xsd#sny_AmountsPayablePartnersInCollaborationAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmountsPayablePartnersInCollaborationAgreements" xlink:to="lab_sny_AmountsPayablePartnersInCollaborationAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_173943d6-1767-4b69-b95e-c194d8415c2f_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_A340BDrugPricingProgramInTheUnitedStatesMember_5841d5b9-a0eb-45c3-9493-922e0060f673_terseLabel_en-US" xlink:label="lab_sny_A340BDrugPricingProgramInTheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">340B Drug Pricing Program in the United States</link:label>
    <link:label id="lab_sny_A340BDrugPricingProgramInTheUnitedStatesMember_label_en-US" xlink:label="lab_sny_A340BDrugPricingProgramInTheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">340B Drug Pricing Program In The United States [Member]</link:label>
    <link:label id="lab_sny_A340BDrugPricingProgramInTheUnitedStatesMember_documentation_en-US" xlink:label="lab_sny_A340BDrugPricingProgramInTheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">340B Drug Pricing Program In The United States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_A340BDrugPricingProgramInTheUnitedStatesMember" xlink:href="sny-20221231.xsd#sny_A340BDrugPricingProgramInTheUnitedStatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_A340BDrugPricingProgramInTheUnitedStatesMember" xlink:to="lab_sny_A340BDrugPricingProgramInTheUnitedStatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfFirstInstanceRulings_3b6b49c4-1c9b-4c37-b947-9a351c31406e_terseLabel_en-US" xlink:label="lab_sny_NumberOfFirstInstanceRulings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of first instance rulings</link:label>
    <link:label id="lab_sny_NumberOfFirstInstanceRulings_label_en-US" xlink:label="lab_sny_NumberOfFirstInstanceRulings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of First Instance Rulings</link:label>
    <link:label id="lab_sny_NumberOfFirstInstanceRulings_documentation_en-US" xlink:label="lab_sny_NumberOfFirstInstanceRulings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of First Instance Rulings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfFirstInstanceRulings" xlink:href="sny-20221231.xsd#sny_NumberOfFirstInstanceRulings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfFirstInstanceRulings" xlink:to="lab_sny_NumberOfFirstInstanceRulings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AggregatedTimeBandsMember_b079982d-12b3-4188-8e94-004ae15a6b8f_terseLabel_en-US" xlink:label="lab_ifrs-full_AggregatedTimeBandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregated time bands</link:label>
    <link:label id="lab_ifrs-full_AggregatedTimeBandsMember_label_en-US" xlink:label="lab_ifrs-full_AggregatedTimeBandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregated time bands [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember" xlink:to="lab_ifrs-full_AggregatedTimeBandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NewBusinessModelRolloutInVariousGeographiesMember_7f20758f-ed75-48f4-99a2-4f0bc7fc4cc7_terseLabel_en-US" xlink:label="lab_sny_NewBusinessModelRolloutInVariousGeographiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New business model, rollout in various geographies</link:label>
    <link:label id="lab_sny_NewBusinessModelRolloutInVariousGeographiesMember_label_en-US" xlink:label="lab_sny_NewBusinessModelRolloutInVariousGeographiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Business Model, Rollout In Various Geographies [Member]</link:label>
    <link:label id="lab_sny_NewBusinessModelRolloutInVariousGeographiesMember_documentation_en-US" xlink:label="lab_sny_NewBusinessModelRolloutInVariousGeographiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Business Model, Rollout In Various Geographies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NewBusinessModelRolloutInVariousGeographiesMember" xlink:href="sny-20221231.xsd#sny_NewBusinessModelRolloutInVariousGeographiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NewBusinessModelRolloutInVariousGeographiesMember" xlink:to="lab_sny_NewBusinessModelRolloutInVariousGeographiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_0865106c-e64c-4c3e-a10c-13472774c9a2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of associates [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of associates [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_6b9228ca-d3c9-4954-b822-b67b571da497_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of transactions between related parties [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of transactions between related parties [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock_a689cb0b-1b76-4770-97a9-d3afcff13fb3_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Share of Profit or Loss and Other Comprehensive Income of Associates and Joint Ventures</link:label>
    <link:label id="lab_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Profit Or Loss And Other Comprehensive Income Of Associates And Joint Ventures [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of profit or loss and other comprehensive income of associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock" xlink:to="lab_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DebtInstrumentsMember_22888332-2e08-4818-b7c0-ea45dfe0f519_terseLabel_en-US" xlink:label="lab_sny_DebtInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instruments</link:label>
    <link:label id="lab_sny_DebtInstrumentsMember_label_en-US" xlink:label="lab_sny_DebtInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Member]</link:label>
    <link:label id="lab_sny_DebtInstrumentsMember_documentation_en-US" xlink:label="lab_sny_DebtInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentsMember" xlink:href="sny-20221231.xsd#sny_DebtInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DebtInstrumentsMember" xlink:to="lab_sny_DebtInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssociatesMember_ee3ddba8-b0d3-4c9a-8f1a-0f66274942ed_terseLabel_en-US" xlink:label="lab_ifrs-full_AssociatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associates</link:label>
    <link:label id="lab_ifrs-full_AssociatesMember_label_en-US" xlink:label="lab_ifrs-full_AssociatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associates [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssociatesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssociatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssociatesMember" xlink:to="lab_ifrs-full_AssociatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfPeopleExposed_8de40f43-80d3-4448-afd6-7715a38064eb_terseLabel_en-US" xlink:label="lab_sny_NumberOfPeopleExposed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of people exposed</link:label>
    <link:label id="lab_sny_NumberOfPeopleExposed_label_en-US" xlink:label="lab_sny_NumberOfPeopleExposed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Exposed</link:label>
    <link:label id="lab_sny_NumberOfPeopleExposed_documentation_en-US" xlink:label="lab_sny_NumberOfPeopleExposed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Exposed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPeopleExposed" xlink:href="sny-20221231.xsd#sny_NumberOfPeopleExposed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfPeopleExposed" xlink:to="lab_sny_NumberOfPeopleExposed" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EightHundredFiftyMillionBondsMaturingJune2022Member_f9353a1d-2438-42b7-b23b-ed3d342b4f53_terseLabel_en-US" xlink:label="lab_sny_EightHundredFiftyMillionBondsMaturingJune2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eight Hundred Fifty Million Bonds Maturing June 2022</link:label>
    <link:label id="lab_sny_EightHundredFiftyMillionBondsMaturingJune2022Member_label_en-US" xlink:label="lab_sny_EightHundredFiftyMillionBondsMaturingJune2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eight Hundred Fifty Million Bonds Maturing June 2022 [Member]</link:label>
    <link:label id="lab_sny_EightHundredFiftyMillionBondsMaturingJune2022Member_documentation_en-US" xlink:label="lab_sny_EightHundredFiftyMillionBondsMaturingJune2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eight Hundred Fifty Million Bonds Maturing June 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EightHundredFiftyMillionBondsMaturingJune2022Member" xlink:href="sny-20221231.xsd#sny_EightHundredFiftyMillionBondsMaturingJune2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EightHundredFiftyMillionBondsMaturingJune2022Member" xlink:to="lab_sny_EightHundredFiftyMillionBondsMaturingJune2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfCancersAssociatedWithDismissedCases_f4e819ea-89e8-4734-a794-575b9b7384fd_terseLabel_en-US" xlink:label="lab_sny_NumberOfCancersAssociatedWithDismissedCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cancers associated with dismissed cases</link:label>
    <link:label id="lab_sny_NumberOfCancersAssociatedWithDismissedCases_label_en-US" xlink:label="lab_sny_NumberOfCancersAssociatedWithDismissedCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Cancers Associated With Dismissed Cases</link:label>
    <link:label id="lab_sny_NumberOfCancersAssociatedWithDismissedCases_documentation_en-US" xlink:label="lab_sny_NumberOfCancersAssociatedWithDismissedCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Cancers Associated With Dismissed Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCancersAssociatedWithDismissedCases" xlink:href="sny-20221231.xsd#sny_NumberOfCancersAssociatedWithDismissedCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfCancersAssociatedWithDismissedCases" xlink:to="lab_sny_NumberOfCancersAssociatedWithDismissedCases" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RawMaterials_39edd2a2-759c-4e98-bac3-68fa84bb9a33_terseLabel_en-US" xlink:label="lab_ifrs-full_RawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_ifrs-full_RawMaterials_label_en-US" xlink:label="lab_ifrs-full_RawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current raw materials</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RawMaterials" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RawMaterials" xlink:to="lab_ifrs-full_RawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock_d76f7e3d-02a8-44b0-bca9-7d4706de9c5c_verboseLabel_en-US" xlink:label="lab_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal changes in the scope of consolidation in 2021 and 2020</link:label>
    <link:label id="lab_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Impact Of Changes In The Scope Of Consolidation Due To Acquisitions And Divestments Explanatory [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for impact of changes in the scope of consolidation due to acquisitions and divestments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xlink:to="lab_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock_c4d4e034-d9c9-4fb2-9963-0267226c1ea9_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Operating Currency Hedging Instruments</link:label>
    <link:label id="lab_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Operating Currency Hedging Instruments With Notional Amount Translated In To Euros At Closing Exchange Rate [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of operating currency hedging instruments with notional amount translated in to euros at closing exchange rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xlink:to="lab_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee_6b20d319-e52d-4789-bf41-25183de69f14_terseLabel_en-US" xlink:label="lab_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate top-up pension obligation in favor of certain corporate officers and of Executive Committee members</link:label>
    <link:label id="lab_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee_label_en-US" xlink:label="lab_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Pension Obligation In Favor Of Certain Corporate Officers And Of Members Of The Executive Committee</link:label>
    <link:label id="lab_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee_documentation_en-US" xlink:label="lab_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate pension obligation in favor of certain corporate officers and of members of the executive committee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee" xlink:href="sny-20221231.xsd#sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee" xlink:to="lab_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MeasurementAxis_5062afcb-e8b9-4023-a006-2a462bebb923_terseLabel_en-US" xlink:label="lab_ifrs-full_MeasurementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement [axis]</link:label>
    <link:label id="lab_ifrs-full_MeasurementAxis_label_en-US" xlink:label="lab_ifrs-full_MeasurementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementAxis" xlink:to="lab_ifrs-full_MeasurementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RareDiseasesMember_728f6f59-4be1-4976-95ea-3ff5025fa27d_terseLabel_en-US" xlink:label="lab_sny_RareDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rare Diseases</link:label>
    <link:label id="lab_sny_RareDiseasesMember_label_en-US" xlink:label="lab_sny_RareDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rare Diseases [Member]</link:label>
    <link:label id="lab_sny_RareDiseasesMember_documentation_en-US" xlink:label="lab_sny_RareDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rare Diseases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RareDiseasesMember" xlink:href="sny-20221231.xsd#sny_RareDiseasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RareDiseasesMember" xlink:to="lab_sny_RareDiseasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1214320e-35e8-4ced-bcc7-2f64fcd6cf25_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentAssets_635c85f7-cc3f-4c4f-89b2-7ec1b30a9231_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="lab_ifrs-full_OtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MiscellaneousOtherOperatingExpense_154412a8-0703-4e0f-9eaf-187817351228_negatedLabel_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_ifrs-full_MiscellaneousOtherOperatingExpense_b063d532-1cb9-4885-ac01-e546f39487bf_verboseLabel_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_ifrs-full_MiscellaneousOtherOperatingExpense_19d20b95-f4b8-42c6-a381-c05be87388a9_terseLabel_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense</link:label>
    <link:label id="lab_ifrs-full_MiscellaneousOtherOperatingExpense_label_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous other operating expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:to="lab_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_UnquotedDebtSecuritiesMember_c537ccb5-58d1-40f8-842e-2f04fd3bf649_terseLabel_en-US" xlink:label="lab_sny_UnquotedDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unquoted debt securities not meeting the definition of equity instruments</link:label>
    <link:label id="lab_sny_UnquotedDebtSecuritiesMember_label_en-US" xlink:label="lab_sny_UnquotedDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unquoted Debt Securities [Member]</link:label>
    <link:label id="lab_sny_UnquotedDebtSecuritiesMember_documentation_en-US" xlink:label="lab_sny_UnquotedDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unquoted debt securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnquotedDebtSecuritiesMember" xlink:href="sny-20221231.xsd#sny_UnquotedDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UnquotedDebtSecuritiesMember" xlink:to="lab_sny_UnquotedDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AmunixPharmaceuticalsIncMember_2ec0eade-e138-4766-8c86-f5c208ff4feb_terseLabel_en-US" xlink:label="lab_sny_AmunixPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amunix Pharmaceuticals, Inc</link:label>
    <link:label id="lab_sny_AmunixPharmaceuticalsIncMember_label_en-US" xlink:label="lab_sny_AmunixPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amunix Pharmaceuticals, Inc [Member]</link:label>
    <link:label id="lab_sny_AmunixPharmaceuticalsIncMember_documentation_en-US" xlink:label="lab_sny_AmunixPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amunix Pharmaceuticals, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixPharmaceuticalsIncMember" xlink:href="sny-20221231.xsd#sny_AmunixPharmaceuticalsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmunixPharmaceuticalsIncMember" xlink:to="lab_sny_AmunixPharmaceuticalsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxAssets_e07e651b-528a-4195-be74-5c43d1ebbc38_terseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxAssets_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets" xlink:to="lab_ifrs-full_DeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfExecutiveCommitteeMembers_7b7c02a9-419e-43db-9b6d-b124dba3e3e4_terseLabel_en-US" xlink:label="lab_sny_NumberOfExecutiveCommitteeMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average number of members of executive committee</link:label>
    <link:label id="lab_sny_NumberOfExecutiveCommitteeMembers_label_en-US" xlink:label="lab_sny_NumberOfExecutiveCommitteeMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Executive Committee Members</link:label>
    <link:label id="lab_sny_NumberOfExecutiveCommitteeMembers_documentation_en-US" xlink:label="lab_sny_NumberOfExecutiveCommitteeMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of executive committee members.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfExecutiveCommitteeMembers" xlink:href="sny-20221231.xsd#sny_NumberOfExecutiveCommitteeMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfExecutiveCommitteeMembers" xlink:to="lab_sny_NumberOfExecutiveCommitteeMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees_a3d580d6-a568-4a27-bb4e-90ebb1cb6312_terseLabel_en-US" xlink:label="lab_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital increase reserved for employees (in shares)</link:label>
    <link:label id="lab_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees_label_en-US" xlink:label="lab_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Share Issues In Regards To Capital increase Reserved For Employees</link:label>
    <link:label id="lab_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees_documentation_en-US" xlink:label="lab_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Share Issues In Regards To Capital increase Reserved For Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees" xlink:href="sny-20221231.xsd#sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees" xlink:to="lab_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LongtermBorrowingsMember_4c3e955b-6e18-4ee8-b6b5-44fa4887d3df_terseLabel_en-US" xlink:label="lab_ifrs-full_LongtermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_ifrs-full_LongtermBorrowingsMember_label_en-US" xlink:label="lab_ifrs-full_LongtermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term borrowings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowingsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowingsMember" xlink:to="lab_ifrs-full_LongtermBorrowingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_0109f64d-a93c-4987-a98c-34333d5ae0bb_terseLabel_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer&#8217;s contributions</link:label>
    <link:label id="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InfraservGmbhAndCoHochstKGMember_657befb0-bdc4-4790-8a22-10233f54259b_verboseLabel_en-US" xlink:label="lab_sny_InfraservGmbhAndCoHochstKGMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG</link:label>
    <link:label id="lab_sny_InfraservGmbhAndCoHochstKGMember_label_en-US" xlink:label="lab_sny_InfraservGmbhAndCoHochstKGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infraserv Gmbh And Co Hochst KG [member]</link:label>
    <link:label id="lab_sny_InfraservGmbhAndCoHochstKGMember_documentation_en-US" xlink:label="lab_sny_InfraservGmbhAndCoHochstKGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infraserv GmbH and Co. Hochst KG.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InfraservGmbhAndCoHochstKGMember" xlink:href="sny-20221231.xsd#sny_InfraservGmbhAndCoHochstKGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InfraservGmbhAndCoHochstKGMember" xlink:to="lab_sny_InfraservGmbhAndCoHochstKGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_8227fdd5-72f8-4fee-8aa6-9c210bbc002e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of analysis of other comprehensive income by item [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of analysis of other comprehensive income by item [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" xlink:to="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_3caeff8e-40e6-47f0-93d4-329b393a4955_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average exercise&#160;price per share, options exercised (in euros per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorTable_c7808b22-fcdb-4d72-9dc1-51d1d260c04f_terseLabel_en-US" xlink:label="lab_dei_AuditorTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor [Table]</link:label>
    <link:label id="lab_dei_AuditorTable_label_en-US" xlink:label="lab_dei_AuditorTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorTable" xlink:to="lab_dei_AuditorTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_f4c70722-c1a7-4324-abd0-b871ebc95853_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_9f0e6a7c-7f9f-477a-a0e7-5eec9108b060_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current derivative financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:to="lab_ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansMember_b9179312-f964-4c33-8694-f9ebe1663e18_terseLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans [member]</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansMember_label_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember" xlink:to="lab_ifrs-full_DefinedBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_QuotedDebtInstrumentsMember_d7628035-fe6a-4f0e-834f-5b2f41688111_terseLabel_en-US" xlink:label="lab_sny_QuotedDebtInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted debt instruments</link:label>
    <link:label id="lab_sny_QuotedDebtInstrumentsMember_label_en-US" xlink:label="lab_sny_QuotedDebtInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Debt Instruments [Member]</link:label>
    <link:label id="lab_sny_QuotedDebtInstrumentsMember_documentation_en-US" xlink:label="lab_sny_QuotedDebtInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted equity securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedDebtInstrumentsMember" xlink:href="sny-20221231.xsd#sny_QuotedDebtInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_QuotedDebtInstrumentsMember" xlink:to="lab_sny_QuotedDebtInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Level2OfFairValueHierarchyMember_e3efe2ac-8690-4fa5-aa0d-beb44b869c4e_terseLabel_en-US" xlink:label="lab_ifrs-full_Level2OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_ifrs-full_Level2OfFairValueHierarchyMember_label_en-US" xlink:label="lab_ifrs-full_Level2OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2 of fair value hierarchy [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level2OfFairValueHierarchyMember" xlink:to="lab_ifrs-full_Level2OfFairValueHierarchyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentsInJointVentures_afaccee1-f7f2-4691-ba74-2587320ba8a4_terseLabel_en-US" xlink:label="lab_ifrs-full_InvestmentsInJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in joint ventures</link:label>
    <link:label id="lab_ifrs-full_InvestmentsInJointVentures_label_en-US" xlink:label="lab_ifrs-full_InvestmentsInJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in joint ventures reported in separate financial statements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInJointVentures" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInJointVentures" xlink:to="lab_ifrs-full_InvestmentsInJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock_0d79d658-559f-4eec-b8a7-1680fb428ac3_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Debt by Maturity at Value on Redemption</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt By Maturity At Value Of Redemption Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of debt by maturity at value of redemption.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GuaranteesGivenMember_220de998-f399-452b-8ed3-bf68c4334485_terseLabel_en-US" xlink:label="lab_sny_GuaranteesGivenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees given</link:label>
    <link:label id="lab_sny_GuaranteesGivenMember_label_en-US" xlink:label="lab_sny_GuaranteesGivenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees Given [member]</link:label>
    <link:label id="lab_sny_GuaranteesGivenMember_documentation_en-US" xlink:label="lab_sny_GuaranteesGivenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees given.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GuaranteesGivenMember" xlink:href="sny-20221231.xsd#sny_GuaranteesGivenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GuaranteesGivenMember" xlink:to="lab_sny_GuaranteesGivenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForAuditServices_7294e8de-e4c4-4642-bdd2-9e0782a93970_terseLabel_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForAuditServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory audit of separate and consolidated financial statements</link:label>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForAuditServices_label_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForAuditServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor's remuneration for audit services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForAuditServices" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForAuditServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemunerationForAuditServices" xlink:to="lab_ifrs-full_AuditorsRemunerationForAuditServices" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BioverativIncMember_6e06a2ee-5f3f-4b7b-8e69-aebcf3ef32e9_terseLabel_en-US" xlink:label="lab_sny_BioverativIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ Inc.</link:label>
    <link:label id="lab_sny_BioverativIncMember_label_en-US" xlink:label="lab_sny_BioverativIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ Inc. [member]</link:label>
    <link:label id="lab_sny_BioverativIncMember_documentation_en-US" xlink:label="lab_sny_BioverativIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativIncMember" xlink:href="sny-20221231.xsd#sny_BioverativIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BioverativIncMember" xlink:to="lab_sny_BioverativIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativesMember_1c92c06f-f818-4c7f-ba9c-f560a734372d_terseLabel_en-US" xlink:label="lab_ifrs-full_DerivativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_ifrs-full_DerivativesMember_label_en-US" xlink:label="lab_ifrs-full_DerivativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativesMember" xlink:to="lab_ifrs-full_DerivativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonCurrentAssetsMember_11c75295-8918-4346-bcd2-aee143dc1700_terseLabel_en-US" xlink:label="lab_sny_NonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current</link:label>
    <link:label id="lab_sny_NonCurrentAssetsMember_label_en-US" xlink:label="lab_sny_NonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Assets [Member]</link:label>
    <link:label id="lab_sny_NonCurrentAssetsMember_documentation_en-US" xlink:label="lab_sny_NonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentAssetsMember" xlink:href="sny-20221231.xsd#sny_NonCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentAssetsMember" xlink:to="lab_sny_NonCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DepakineProductLitigationInIrelandMember_8d75c5e0-3d00-4a98-adb5-d85b84afd4d1_terseLabel_en-US" xlink:label="lab_sny_DepakineProductLitigationInIrelandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Ireland</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInIrelandMember_label_en-US" xlink:label="lab_sny_DepakineProductLitigationInIrelandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Ireland [Member]</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInIrelandMember_documentation_en-US" xlink:label="lab_sny_DepakineProductLitigationInIrelandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Ireland</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInIrelandMember" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInIrelandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DepakineProductLitigationInIrelandMember" xlink:to="lab_sny_DepakineProductLitigationInIrelandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_89aedc19-6472-482b-b6ab-048aa20ecf5b_negatedLabel_en-US" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments</link:label>
    <link:label id="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of borrowings, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForeignCurrencyTranslationDifferences_3b083cad-6698-4b05-8bd2-3bc881d9c656_terseLabel_en-US" xlink:label="lab_sny_ForeignCurrencyTranslationDifferences" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_sny_ForeignCurrencyTranslationDifferences_label_en-US" xlink:label="lab_sny_ForeignCurrencyTranslationDifferences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Differences</link:label>
    <link:label id="lab_sny_ForeignCurrencyTranslationDifferences_documentation_en-US" xlink:label="lab_sny_ForeignCurrencyTranslationDifferences" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Differences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForeignCurrencyTranslationDifferences" xlink:href="sny-20221231.xsd#sny_ForeignCurrencyTranslationDifferences"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForeignCurrencyTranslationDifferences" xlink:to="lab_sny_ForeignCurrencyTranslationDifferences" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareGroupSASMember_9aeb5300-c6f5-45e1-aa37-57cb45062668_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareGroupSASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Group SAS</link:label>
    <link:label id="lab_sny_OpellaHealthcareGroupSASMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareGroupSASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Group SAS [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareGroupSASMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareGroupSASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Group SAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareGroupSASMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareGroupSASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareGroupSASMember" xlink:to="lab_sny_OpellaHealthcareGroupSASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FloatingInterestRateMember_a874bb94-3432-4395-a653-e2b6bf16377d_terseLabel_en-US" xlink:label="lab_ifrs-full_FloatingInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating-rate debt</link:label>
    <link:label id="lab_ifrs-full_FloatingInterestRateMember_label_en-US" xlink:label="lab_ifrs-full_FloatingInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating interest rate [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FloatingInterestRateMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FloatingInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FloatingInterestRateMember" xlink:to="lab_ifrs-full_FloatingInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentPrepaidExpenses_6f4bb459-cacb-4a34-8eb6-2ba177ad76c2_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_ifrs-full_CurrentPrepaidExpenses_label_en-US" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current prepaid expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_bd6ea208-13eb-4e50-898c-87cc0c0a74a5_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about business combination [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about business combination [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_940b5ee9-8b3f-4f38-acd2-71db5c099636_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_024633ee-70a1-44f1-9ec7-813a71f07113_periodStartLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_e4cb8a3d-6234-4d08-878f-979d624ac114_periodEndLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_6da4bf49-3c04-4465-b47e-37b11be1681c_totalLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_74886344-c627-4a5b-8a17-c5313357f86d_negatedLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents" xlink:to="lab_ifrs-full_CashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiSRLMember_b54898b7-3969-4e2d-aad6-f07d955ed670_terseLabel_en-US" xlink:label="lab_sny_SanofiSRLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi S.R.L.</link:label>
    <link:label id="lab_sny_SanofiSRLMember_label_en-US" xlink:label="lab_sny_SanofiSRLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi SRL [Member]</link:label>
    <link:label id="lab_sny_SanofiSRLMember_documentation_en-US" xlink:label="lab_sny_SanofiSRLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Spa.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSRLMember" xlink:href="sny-20221231.xsd#sny_SanofiSRLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiSRLMember" xlink:to="lab_sny_SanofiSRLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RestructuringProvisionMember_c8cbd811-9eda-4af3-8ca4-8b0c0c02ce37_terseLabel_en-US" xlink:label="lab_ifrs-full_RestructuringProvisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Provision</link:label>
    <link:label id="lab_ifrs-full_RestructuringProvisionMember_label_en-US" xlink:label="lab_ifrs-full_RestructuringProvisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring provision [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestructuringProvisionMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RestructuringProvisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestructuringProvisionMember" xlink:to="lab_ifrs-full_RestructuringProvisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_979f6159-46bb-4c9b-81ef-20aecfefec26_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets_6f5926a0-de94-4709-860e-8d451f250a87_terseLabel_en-US" xlink:label="lab_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in scope of consolidation</link:label>
    <link:label id="lab_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets_label_en-US" xlink:label="lab_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Through Business Combinations, Property, Plant and Equipment, Right Of Use Assets</link:label>
    <link:label id="lab_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets_documentation_en-US" xlink:label="lab_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Through Business Combinations, Property, Plant and Equipment, Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" xlink:href="sny-20221231.xsd#sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" xlink:to="lab_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable_46a77f8d-f280-4605-aa70-627071378ee2_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Tax Losses Available For Carryforward [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable_label_en-US" xlink:label="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Tax Losses Available For Carryforward [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Tax Losses Available For Carryforward [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfTaxLossesAvailableForCarryforwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable" xlink:to="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentProvisions_13d9c24a-59cb-47c4-86ad-029e16c49377_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_ifrs-full_NoncurrentProvisions_6acfb98b-062c-4a25-a68f-2d417d25d495_periodStartLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentProvisions" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_ifrs-full_NoncurrentProvisions_a7cb0862-b4bd-4102-a435-8cf3d937524e_periodEndLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentProvisions" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_ifrs-full_NoncurrentProvisions_90e114f3-2195-4f0b-a5a0-49f82553a635_verboseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentProvisions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations provided for</link:label>
    <link:label id="lab_ifrs-full_NoncurrentProvisions_label_en-US" xlink:label="lab_ifrs-full_NoncurrentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentProvisions" xlink:to="lab_ifrs-full_NoncurrentProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember_dd8fd955-b87a-469f-a518-14a6b67f9ef0_terseLabel_en-US" xlink:label="lab_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets held to meet obligations under deferred compensation plans</link:label>
    <link:label id="lab_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember_label_en-US" xlink:label="lab_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets Held To Meet Obligations Under Deferred Compensation Plans [Member]</link:label>
    <link:label id="lab_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember_documentation_en-US" xlink:label="lab_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets held to meet obligations under deferred compensation plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember" xlink:href="sny-20221231.xsd#sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember" xlink:to="lab_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WorkInProgress_95093d21-c80a-4c43-b8fa-2720418062e3_terseLabel_en-US" xlink:label="lab_ifrs-full_WorkInProgress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_ifrs-full_WorkInProgress_label_en-US" xlink:label="lab_ifrs-full_WorkInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current work in progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WorkInProgress" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WorkInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WorkInProgress" xlink:to="lab_ifrs-full_WorkInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_1c63a0e6-5558-4c8a-8ecf-93f2228ac185_terseLabel_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of changes in other provisions [abstract]</link:label>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_label_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of changes in other provisions [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" xlink:to="lab_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_e5ce2f5e-b0d8-46d7-b3a3-72c342da61d3_terseLabel_en-US" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_label_en-US" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, acquisition-date fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_cd6d122d-0ed0-4025-894f-36b7ff2916ed_terseLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_f26d0c15-98b5-4ef4-a40e-07e32388ee66_periodStartLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, beginning balance</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_5e301b12-4e72-4979-a851-e204985fd678_periodEndLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, ending balance</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_3f0619b1-7d5e-4f7e-84f0-d9157b4f1ab6_verboseLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment owned</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForOtherServices_655c8607-fd97-4b24-8f08-a37e28cccf38_terseLabel_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForOtherServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_AuditorsRemunerationForOtherServices_label_en-US" xlink:label="lab_ifrs-full_AuditorsRemunerationForOtherServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor's remuneration for other services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForOtherServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemunerationForOtherServices" xlink:to="lab_ifrs-full_AuditorsRemunerationForOtherServices" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FirmOrdersOfPropertyPlantAndEquipment_72aff82f-25c6-4388-a7bf-0af550a12d20_terseLabel_en-US" xlink:label="lab_sny_FirmOrdersOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Firm orders of property, plant and equipment</link:label>
    <link:label id="lab_sny_FirmOrdersOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_sny_FirmOrdersOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Firm Orders Of Property Plant And Equipment</link:label>
    <link:label id="lab_sny_FirmOrdersOfPropertyPlantAndEquipment_documentation_en-US" xlink:label="lab_sny_FirmOrdersOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Firm orders of property plant and equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FirmOrdersOfPropertyPlantAndEquipment" xlink:href="sny-20221231.xsd#sny_FirmOrdersOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FirmOrdersOfPropertyPlantAndEquipment" xlink:to="lab_sny_FirmOrdersOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcarePhilippinesIncMember_d2c4618c-3094-44a3-9d5a-1026975536be_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcarePhilippinesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Philippines Inc.</link:label>
    <link:label id="lab_sny_OpellaHealthcarePhilippinesIncMember_label_en-US" xlink:label="lab_sny_OpellaHealthcarePhilippinesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Philippines Inc. [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcarePhilippinesIncMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcarePhilippinesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Philippines Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcarePhilippinesIncMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcarePhilippinesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcarePhilippinesIncMember" xlink:to="lab_sny_OpellaHealthcarePhilippinesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_443ef6ec-ec5e-4729-b0c1-66aa2f06ca12_totalLabel_en-US" xlink:label="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_label_en-US" xlink:label="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-derivative financial liabilities, undiscounted cash flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:to="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations_8d6fa363-8b2f-47a6-a784-07135142cb91_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments relating to contingent consideration in connection with business combinations</link:label>
    <link:label id="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations_label_en-US" xlink:label="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Relating To Contingent Consideration In Connection With Business Combinations</link:label>
    <link:label id="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Relating To Contingent Consideration In Connection With Business Combinations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" xlink:to="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAccountsReceivableTable_f8d38d91-1996-4f47-9aa9-ff3f0516228d_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAccountsReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounts receivable [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfAccountsReceivableTable_label_en-US" xlink:label="lab_sny_DisclosureOfAccountsReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Accounts Receivable [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfAccountsReceivableTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfAccountsReceivableTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Accounts receivable Table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAccountsReceivableTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfAccountsReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAccountsReceivableTable" xlink:to="lab_sny_DisclosureOfAccountsReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfInformationOnIncomeStatementLineItems_ade528d2-8c44-4188-ba8b-1e535ed902e0_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfInformationOnIncomeStatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information on income statement [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfInformationOnIncomeStatementLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfInformationOnIncomeStatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Information On Income Statement [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfInformationOnIncomeStatementLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfInformationOnIncomeStatementLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information on income statement line items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInformationOnIncomeStatementLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfInformationOnIncomeStatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInformationOnIncomeStatementLineItems" xlink:to="lab_sny_DisclosureOfInformationOnIncomeStatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiHongKongLimitedMember_38ae39ea-59ec-4243-81fe-35d92b54ede3_terseLabel_en-US" xlink:label="lab_sny_SanofiHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Hong-Kong Limited</link:label>
    <link:label id="lab_sny_SanofiHongKongLimitedMember_label_en-US" xlink:label="lab_sny_SanofiHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Hong-Kong Limited [Member]</link:label>
    <link:label id="lab_sny_SanofiHongKongLimitedMember_documentation_en-US" xlink:label="lab_sny_SanofiHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Hong-Kong Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiHongKongLimitedMember" xlink:href="sny-20221231.xsd#sny_SanofiHongKongLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiHongKongLimitedMember" xlink:to="lab_sny_SanofiHongKongLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareCzechSroMember_76e065bf-1b55-4ddb-ae87-d56660930bfd_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareCzechSroMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Czech s.r.o</link:label>
    <link:label id="lab_sny_OpellaHealthcareCzechSroMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareCzechSroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Czech s.r.o [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareCzechSroMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareCzechSroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Czech s.r.o</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareCzechSroMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareCzechSroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareCzechSroMember" xlink:to="lab_sny_OpellaHealthcareCzechSroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement_8e7a08df-b7a2-4102-b374-02fa76e65ca0_negatedTerseLabel_en-US" xlink:label="lab_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</link:label>
    <link:label id="lab_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement_label_en-US" xlink:label="lab_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gains) Losses Related To Plan Amendments, Curtailments Or Settlement</link:label>
    <link:label id="lab_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement_documentation_en-US" xlink:label="lab_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gains) Losses Related To Plan Amendments, Curtailments Or Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" xlink:href="sny-20221231.xsd#sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" xlink:to="lab_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SegmentConsolidationItemsAxis_72262686-6b53-4e7d-94ac-964a53e700cb_terseLabel_en-US" xlink:label="lab_ifrs-full_SegmentConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment consolidation items [axis]</link:label>
    <link:label id="lab_ifrs-full_SegmentConsolidationItemsAxis_label_en-US" xlink:label="lab_ifrs-full_SegmentConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment consolidation items [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis" xlink:to="lab_ifrs-full_SegmentConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems_e43ed7b7-51aa-4c9e-aafa-4999895825ed_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Credit Risk Exposure [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of credit risk exposure [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_4441c33a-4cf4-4cf7-aeff-78ea4adec8a4_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by/(used in) financing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used in) financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiVietnamShareholdingCompanyLimitedMember_f646a3ce-d799-446b-9398-ca9f927b04ea_terseLabel_en-US" xlink:label="lab_sny_SanofiVietnamShareholdingCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Vietnam Shareholding Company Limited</link:label>
    <link:label id="lab_sny_SanofiVietnamShareholdingCompanyLimitedMember_label_en-US" xlink:label="lab_sny_SanofiVietnamShareholdingCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Vietnam Shareholding Company Limited [Member]</link:label>
    <link:label id="lab_sny_SanofiVietnamShareholdingCompanyLimitedMember_documentation_en-US" xlink:label="lab_sny_SanofiVietnamShareholdingCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Vietnam Shareholding Company Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiVietnamShareholdingCompanyLimitedMember" xlink:href="sny-20221231.xsd#sny_SanofiVietnamShareholdingCompanyLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiVietnamShareholdingCompanyLimitedMember" xlink:to="lab_sny_SanofiVietnamShareholdingCompanyLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiOyMember_edc59d1e-064d-4056-8b30-be0b2a08faca_terseLabel_en-US" xlink:label="lab_sny_SanofiOyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Oy</link:label>
    <link:label id="lab_sny_SanofiOyMember_label_en-US" xlink:label="lab_sny_SanofiOyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Oy [member]</link:label>
    <link:label id="lab_sny_SanofiOyMember_documentation_en-US" xlink:label="lab_sny_SanofiOyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Oy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiOyMember" xlink:href="sny-20221231.xsd#sny_SanofiOyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiOyMember" xlink:to="lab_sny_SanofiOyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_73dfd84c-c1d5-4fdf-8762-3608f32b7577_negatedTerseLabel_en-US" xlink:label="lab_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of the distribution of an exceptional supplementary dividend of 58% of the shares of EUROAPI to the equity holders of Sanofi</link:label>
    <link:label id="lab_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_311e07b3-8889-475d-bc96-055cd7a04811_terseLabel_en-US" xlink:label="lab_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exceptional supplementary dividends recognised as distributions to owners of parent</link:label>
    <link:label id="lab_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_label_en-US" xlink:label="lab_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exceptional Supplementary Dividends Recognised As Distributions To Owners Of Parent</link:label>
    <link:label id="lab_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_documentation_en-US" xlink:label="lab_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exceptional Supplementary Dividends Recognised As Distributions To Owners Of Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" xlink:to="lab_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AwardsDateAxis_ded5fbc7-db22-41bb-a376-638d0355821b_terseLabel_en-US" xlink:label="lab_sny_AwardsDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Date [Axis]</link:label>
    <link:label id="lab_sny_AwardsDateAxis_label_en-US" xlink:label="lab_sny_AwardsDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Date [Axis]</link:label>
    <link:label id="lab_sny_AwardsDateAxis_documentation_en-US" xlink:label="lab_sny_AwardsDateAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Date 1 [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateAxis" xlink:href="sny-20221231.xsd#sny_AwardsDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AwardsDateAxis" xlink:to="lab_sny_AwardsDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock_812c2b5b-88fe-47de-9ef3-2edde4f2c731_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Acquisitions and Capitalized Interest by Operating Segment</link:label>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Acquisitions Of Property Plant And Equipment By Operating Segments Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of acquisitions of property plant and equipment by operating segments explanatory [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_9fbc2a45-9892-47ab-877c-2268dd70d97a_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through transfers, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_90537fe3-f710-4150-bb3f-c338bd2463f7_terseLabel_en-US" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value (excluding investments accounted for using the equity method)</link:label>
    <link:label id="lab_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value On Cash Flow Hedges Excluding Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value on cash flow hedges excluding associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock_a9fa68a9-9938-4e47-b410-56c74317f85c_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Interest Rate of Net Debt at Value on Redemption</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt By Interest Rate At Value Of Redemption After Taking Account Of Derivative Instruments N1N2 [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of debt by interest rate at value of redemption after taking account of derivative instruments N1 N2.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock" xlink:to="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherProvisionsMember_ab7d0e78-382b-4225-b3e7-d70337e31bf9_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other provisions [member]</link:label>
    <link:label id="lab_ifrs-full_OtherProvisionsMember_label_en-US" xlink:label="lab_ifrs-full_OtherProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other provisions [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherProvisionsMember" xlink:to="lab_ifrs-full_OtherProvisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember_d8bda1e2-0797-495e-8971-104a7a51d58b_terseLabel_en-US" xlink:label="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All levels of fair value hierarchy [member]</link:label>
    <link:label id="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember_label_en-US" xlink:label="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All levels of fair value hierarchy [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:to="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AuditorInformationAbstract_label_en-US" xlink:label="lab_sny_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_sny_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_sny_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorInformationAbstract" xlink:href="sny-20221231.xsd#sny_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AuditorInformationAbstract" xlink:to="lab_sny_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShareRepurchase2022ProgramMember_ed16d786-54bf-4cf6-b663-240cf79d515e_terseLabel_en-US" xlink:label="lab_sny_ShareRepurchase2022ProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_sny_ShareRepurchase2022ProgramMember_label_en-US" xlink:label="lab_sny_ShareRepurchase2022ProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase 2022 Program [Member]</link:label>
    <link:label id="lab_sny_ShareRepurchase2022ProgramMember_documentation_en-US" xlink:label="lab_sny_ShareRepurchase2022ProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase 2022 Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2022ProgramMember" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2022ProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareRepurchase2022ProgramMember" xlink:to="lab_sny_ShareRepurchase2022ProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EquityDerivativesMember_46e52f67-b21a-4fea-a571-a6309b9f0f2d_terseLabel_en-US" xlink:label="lab_sny_EquityDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity derivatives</link:label>
    <link:label id="lab_sny_EquityDerivativesMember_label_en-US" xlink:label="lab_sny_EquityDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Derivatives [Member]</link:label>
    <link:label id="lab_sny_EquityDerivativesMember_documentation_en-US" xlink:label="lab_sny_EquityDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Derivatives [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityDerivativesMember" xlink:href="sny-20221231.xsd#sny_EquityDerivativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityDerivativesMember" xlink:to="lab_sny_EquityDerivativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_098ef140-0df3-4ed3-bb87-4f3b209ac78f_totalLabel_en-US" xlink:label="lab_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_label_en-US" xlink:label="lab_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Expense For Pension And Other Post-employment Benefits Recognized Directly In Profit Or Loss</link:label>
    <link:label id="lab_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_documentation_en-US" xlink:label="lab_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense recognized directly in profit or loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:href="sny-20221231.xsd#sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:to="lab_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IssuedCapitalMember_836f06d3-bfc8-40e2-86dd-3cb848a744da_terseLabel_en-US" xlink:label="lab_ifrs-full_IssuedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share capital</link:label>
    <link:label id="lab_ifrs-full_IssuedCapitalMember_label_en-US" xlink:label="lab_ifrs-full_IssuedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued capital [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember" xlink:to="lab_ifrs-full_IssuedCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock_09b25128-dd25-4e75-827c-512fe0bc7c84_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Compensation Paid to Key Management Personnel</link:label>
    <link:label id="lab_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Compensation Paid To Key Management Personnel [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of compensation paid to key management personnel.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock" xlink:to="lab_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShareBasedPaymentPlansAbstract_8e5162f2-0186-4334-8719-1630bd23c0ed_terseLabel_en-US" xlink:label="lab_sny_ShareBasedPaymentPlansAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment plans:</link:label>
    <link:label id="lab_sny_ShareBasedPaymentPlansAbstract_label_en-US" xlink:label="lab_sny_ShareBasedPaymentPlansAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Payment Plans [abstract]</link:label>
    <link:label id="lab_sny_ShareBasedPaymentPlansAbstract_documentation_en-US" xlink:label="lab_sny_ShareBasedPaymentPlansAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based payment plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareBasedPaymentPlansAbstract" xlink:href="sny-20221231.xsd#sny_ShareBasedPaymentPlansAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract" xlink:to="lab_sny_ShareBasedPaymentPlansAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_f35bedeb-0b5d-4072-8792-63277c4279cc_terseLabel_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences (investments accounted for using the equity method)</link:label>
    <link:label id="lab_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Currency Translation Net Of Tax On Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in currency translation net of tax on associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DiceMoleculesMember_8af67a9c-2230-4bc9-8620-2ffbf46a9387_terseLabel_en-US" xlink:label="lab_sny_DiceMoleculesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dice Molecules</link:label>
    <link:label id="lab_sny_DiceMoleculesMember_label_en-US" xlink:label="lab_sny_DiceMoleculesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DiCE Molecules [Member]</link:label>
    <link:label id="lab_sny_DiceMoleculesMember_documentation_en-US" xlink:label="lab_sny_DiceMoleculesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dice molecules.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DiceMoleculesMember" xlink:href="sny-20221231.xsd#sny_DiceMoleculesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DiceMoleculesMember" xlink:to="lab_sny_DiceMoleculesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation_be469e94-17fb-4d8f-beae-36225061b23b_terseLabel_en-US" xlink:label="lab_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum penalty amount sought by plaintiffs for each violation</link:label>
    <link:label id="lab_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation_label_en-US" xlink:label="lab_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Penalty Amount Sought By Plaintiffs For Each Violation</link:label>
    <link:label id="lab_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation_documentation_en-US" xlink:label="lab_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum penalty amount sought by plaintiffs for each violation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation" xlink:href="sny-20221231.xsd#sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation" xlink:to="lab_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember_35860430-4472-49e4-9842-23692aea4243_terseLabel_en-US" xlink:label="lab_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Boehringer Ingelheim Consumer Healthcare</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember_label_en-US" xlink:label="lab_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products Boehringer Ingelheim Consumer Healthcare [member]</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember_documentation_en-US" xlink:label="lab_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal marketed products Boehringer Ingelheim Consumer Healthcare.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember" xlink:to="lab_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ZantacLitigationInTheUSMDLCourtMember_1a110aa1-f4fc-448b-8297-0dca4c7de763_terseLabel_en-US" xlink:label="lab_sny_ZantacLitigationInTheUSMDLCourtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zantac litigation in the US, MDL Court</link:label>
    <link:label id="lab_sny_ZantacLitigationInTheUSMDLCourtMember_label_en-US" xlink:label="lab_sny_ZantacLitigationInTheUSMDLCourtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zantac Litigation In the US, MDL Court [Member]</link:label>
    <link:label id="lab_sny_ZantacLitigationInTheUSMDLCourtMember_documentation_en-US" xlink:label="lab_sny_ZantacLitigationInTheUSMDLCourtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zantac Litigation In the US, MDL Court</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ZantacLitigationInTheUSMDLCourtMember" xlink:href="sny-20221231.xsd#sny_ZantacLitigationInTheUSMDLCourtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ZantacLitigationInTheUSMDLCourtMember" xlink:to="lab_sny_ZantacLitigationInTheUSMDLCourtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts_dce07c9f-2887-49c4-9afe-a76896e9cdb0_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments related to attainment of regulatory and sales milestones for commercialized products</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts_label_en-US" xlink:label="lab_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Attainment Of Regulatory And Sales Milestones For Commercialized Products</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Attainment Of Regulatory And Sales Milestones For Commercialized Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts" xlink:to="lab_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisDelPeruSAMember_e8325197-df42-41a9-bee1-78ce5276566b_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisDelPeruSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis del Peru S.A.</link:label>
    <link:label id="lab_sny_SanofiAventisDelPeruSAMember_label_en-US" xlink:label="lab_sny_SanofiAventisDelPeruSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis del Peru S.A. [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisDelPeruSAMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisDelPeruSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis del Peru S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDelPeruSAMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisDelPeruSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisDelPeruSAMember" xlink:to="lab_sny_SanofiAventisDelPeruSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock_9bd00ef3-7e3c-45bb-ab32-338a266e4992_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Movements in Other Intangible Assets</link:label>
    <link:label id="lab_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Reconciliation Of Changes In Other Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of reconciliation of changes in other intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xlink:to="lab_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IssuanceOfFurtherSharesAsAnEmployersContribution_1ef11d30-2572-4301-af36-3a447296facf_terseLabel_en-US" xlink:label="lab_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued immediately as employer's contribution (in shares)</link:label>
    <link:label id="lab_sny_IssuanceOfFurtherSharesAsAnEmployersContribution_label_en-US" xlink:label="lab_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance Of Further Shares As An Employers Contribution</link:label>
    <link:label id="lab_sny_IssuanceOfFurtherSharesAsAnEmployersContribution_documentation_en-US" xlink:label="lab_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Further shares as an employers contribution.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xlink:href="sny-20221231.xsd#sny_IssuanceOfFurtherSharesAsAnEmployersContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xlink:to="lab_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CashEquivalentsMoneyMarketMutualFunds_d0502a5c-48bc-496c-8cb0-bb78e4a4a5d8_terseLabel_en-US" xlink:label="lab_sny_CashEquivalentsMoneyMarketMutualFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, money market mutual funds</link:label>
    <link:label id="lab_sny_CashEquivalentsMoneyMarketMutualFunds_label_en-US" xlink:label="lab_sny_CashEquivalentsMoneyMarketMutualFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, Money Market Mutual Funds</link:label>
    <link:label id="lab_sny_CashEquivalentsMoneyMarketMutualFunds_documentation_en-US" xlink:label="lab_sny_CashEquivalentsMoneyMarketMutualFunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalent money market mutual funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashEquivalentsMoneyMarketMutualFunds" xlink:href="sny-20221231.xsd#sny_CashEquivalentsMoneyMarketMutualFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CashEquivalentsMoneyMarketMutualFunds" xlink:to="lab_sny_CashEquivalentsMoneyMarketMutualFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement_08e4275c-eb8a-4200-8423-9a747ce4f293_negatedLabel_en-US" xlink:label="lab_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, options forfeited</link:label>
    <link:label id="lab_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Share Options Forfeited In Share Based Payment Arrangement</link:label>
    <link:label id="lab_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of share options forfeited in share based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement" xlink:to="lab_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiChinaInvestmentCoLtdMember_ce562852-fca0-448b-8b51-64aa22782b6d_terseLabel_en-US" xlink:label="lab_sny_SanofiChinaInvestmentCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi (China) Investment Co., Ltd</link:label>
    <link:label id="lab_sny_SanofiChinaInvestmentCoLtdMember_label_en-US" xlink:label="lab_sny_SanofiChinaInvestmentCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi China Investment Co Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiChinaInvestmentCoLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiChinaInvestmentCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi (China) Investment Co., Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiChinaInvestmentCoLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiChinaInvestmentCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiChinaInvestmentCoLtdMember" xlink:to="lab_sny_SanofiChinaInvestmentCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_352d5cbf-e6fa-4320-9f53-f5ad2af3f44a_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for treasury shares [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_UnquotedEquityInvestmentsMember_edf7f1c8-7d91-419c-ad0d-6436a6875941_terseLabel_en-US" xlink:label="lab_sny_UnquotedEquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unquoted equity investments</link:label>
    <link:label id="lab_sny_UnquotedEquityInvestmentsMember_label_en-US" xlink:label="lab_sny_UnquotedEquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unquoted Equity Investments [Member]</link:label>
    <link:label id="lab_sny_UnquotedEquityInvestmentsMember_documentation_en-US" xlink:label="lab_sny_UnquotedEquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unquoted equity investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnquotedEquityInvestmentsMember" xlink:href="sny-20221231.xsd#sny_UnquotedEquityInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UnquotedEquityInvestmentsMember" xlink:to="lab_sny_UnquotedEquityInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SspCoLtdMember_5dc3a6ba-8fde-46ef-9a8b-6168768fb0d0_terseLabel_en-US" xlink:label="lab_sny_SspCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SSP Co.,Ltd</link:label>
    <link:label id="lab_sny_SspCoLtdMember_label_en-US" xlink:label="lab_sny_SspCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SSP Co Ltd [member]</link:label>
    <link:label id="lab_sny_SspCoLtdMember_documentation_en-US" xlink:label="lab_sny_SspCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SSP Co., Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SspCoLtdMember" xlink:href="sny-20221231.xsd#sny_SspCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SspCoLtdMember" xlink:to="lab_sny_SspCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsOnDisposalsOfInvestments_55f43803-db52-4f31-b611-ccf626266c66_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsOnDisposalsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Regeneron investment arising from transaction of&#160;May&#160;29, 2020</link:label>
    <link:label id="lab_ifrs-full_GainsOnDisposalsOfInvestments_label_en-US" xlink:label="lab_ifrs-full_GainsOnDisposalsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on disposals of investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnDisposalsOfInvestments" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsOnDisposalsOfInvestments" xlink:to="lab_ifrs-full_GainsOnDisposalsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_April2022EMTNISINFR0014009KS6Member_d8afc194-8e20-4467-a5e3-08d1ade332a3_verboseLabel_en-US" xlink:label="lab_sny_April2022EMTNISINFR0014009KS6Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2022 EMTN ISIN FR0014009KS6</link:label>
    <link:label id="lab_sny_April2022EMTNISINFR0014009KS6Member_label_en-US" xlink:label="lab_sny_April2022EMTNISINFR0014009KS6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2022 EMTN ISIN FR0014009KS6 [Member]</link:label>
    <link:label id="lab_sny_April2022EMTNISINFR0014009KS6Member_documentation_en-US" xlink:label="lab_sny_April2022EMTNISINFR0014009KS6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2014 EMTN ISIN FR0012146777.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2022EMTNISINFR0014009KS6Member" xlink:href="sny-20221231.xsd#sny_April2022EMTNISINFR0014009KS6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_April2022EMTNISINFR0014009KS6Member" xlink:to="lab_sny_April2022EMTNISINFR0014009KS6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ContingentConsiderationTranslateBioMember_156139e5-7c7c-4ba4-a8c8-e219519f0e5f_terseLabel_en-US" xlink:label="lab_sny_ContingentConsiderationTranslateBioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shire contingent consideration arising from the acquisition of Translate Bio</link:label>
    <link:label id="lab_sny_ContingentConsiderationTranslateBioMember_label_en-US" xlink:label="lab_sny_ContingentConsiderationTranslateBioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Translate Bio [Member]</link:label>
    <link:label id="lab_sny_ContingentConsiderationTranslateBioMember_documentation_en-US" xlink:label="lab_sny_ContingentConsiderationTranslateBioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Translate Bio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationTranslateBioMember" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationTranslateBioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ContingentConsiderationTranslateBioMember" xlink:to="lab_sny_ContingentConsiderationTranslateBioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BusinessCombinationsAxis_57666e9b-3f5a-47e3-9e2b-8c59a82196c5_terseLabel_en-US" xlink:label="lab_ifrs-full_BusinessCombinationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Axis]</link:label>
    <link:label id="lab_ifrs-full_BusinessCombinationsAxis_label_en-US" xlink:label="lab_ifrs-full_BusinessCombinationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combinations [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis" xlink:to="lab_ifrs-full_BusinessCombinationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress_0f37c954-1f44-4b15-8fea-377751204cac_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development license agreements - contingent milestone payments in connection with development programs in progress</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress_label_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Research And Development License Agreements, Contingent Milestone Payments In Connection With Development Programs In Progress</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Research And Development License Agreements, Contingent Milestone Payments In Connection With Development Programs In Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" xlink:to="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies_289432f1-48f5-45ac-b5de-6a32ff2bfa31_terseLabel_en-US" xlink:label="lab_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, captive insurance and reinsurance companies</link:label>
    <link:label id="lab_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies_label_en-US" xlink:label="lab_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, Captive Insurance And Reinsurance Companies</link:label>
    <link:label id="lab_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies_documentation_en-US" xlink:label="lab_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents captive insurance and reinsurance companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies" xlink:href="sny-20221231.xsd#sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies" xlink:to="lab_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement_7974b8e0-2436-40eb-a4cd-dedeb679c08b_terseLabel_en-US" xlink:label="lab_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of novel small molecule candidates developed</link:label>
    <link:label id="lab_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement_label_en-US" xlink:label="lab_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Novel Small Molecule Candidates To Be Developed Under Collaboration Agreement</link:label>
    <link:label id="lab_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement_documentation_en-US" xlink:label="lab_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Novel Small Molecule Candidates To Be Developed Under Collaboration Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement" xlink:href="sny-20221231.xsd#sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement" xlink:to="lab_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock_37150658-150c-4024-ac64-8de670a6dc92_terseLabel_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">War in Ukraine</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock_label_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Accounting Policy For International Conflicts [Policy Text Block]</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock_documentation_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Accounting Policy For International Conflicts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock" xlink:to="lab_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_b835bdc2-508c-4649-bae7-50863b2afd61_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in deferred taxes</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for deferred tax expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:to="lab_ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SubscriptionPricePerShare_bf22a06f-8306-48b5-9ae7-a54c91b3b5d1_terseLabel_en-US" xlink:label="lab_sny_SubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription price (in euros per share)</link:label>
    <link:label id="lab_sny_SubscriptionPricePerShare_label_en-US" xlink:label="lab_sny_SubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription Price Per Share</link:label>
    <link:label id="lab_sny_SubscriptionPricePerShare_documentation_en-US" xlink:label="lab_sny_SubscriptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription price per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SubscriptionPricePerShare" xlink:href="sny-20221231.xsd#sny_SubscriptionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SubscriptionPricePerShare" xlink:to="lab_sny_SubscriptionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfProfitsArisingFromCommercialOperations_7762d7b5-4de3-4dcc-9f46-d20c7dd2797c_terseLabel_en-US" xlink:label="lab_sny_PercentageOfProfitsArisingFromCommercialOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of profits arising from commercial operations</link:label>
    <link:label id="lab_sny_PercentageOfProfitsArisingFromCommercialOperations_label_en-US" xlink:label="lab_sny_PercentageOfProfitsArisingFromCommercialOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Profits Arising From Commercial Operations</link:label>
    <link:label id="lab_sny_PercentageOfProfitsArisingFromCommercialOperations_documentation_en-US" xlink:label="lab_sny_PercentageOfProfitsArisingFromCommercialOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Profits Arising From Commercial Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitsArisingFromCommercialOperations" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitsArisingFromCommercialOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfProfitsArisingFromCommercialOperations" xlink:to="lab_sny_PercentageOfProfitsArisingFromCommercialOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock_30602355-6c78-4dc5-bdbe-50d7179463b6_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Weighted Average Duration of Obligation for Pensions and Other Long-term Benefits in Principal Countries</link:label>
    <link:label id="lab_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Weighted Average Duration Of Defined Benefit Obligation [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of weighted average duration of defined benefit obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock" xlink:to="lab_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate_ce88840f-bf59-49a8-b4be-4024e3dcfb20_terseLabel_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of ownership interest in associate (in percent)</link:label>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate_3e2a8ab4-0c25-4b76-88a0-08385a980143_verboseLabel_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of ownership interest in associate (in percent)</link:label>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate_label_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of ownership interest in associate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_2e23f4ae-c4af-40f2-882c-b62925c3704b_negatedLabel_en-US" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate and currency derivatives used to manage debt</link:label>
    <link:label id="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_label_en-US" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate And Currency Derivatives Used To Manage Debt</link:label>
    <link:label id="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_documentation_en-US" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate and currency derivatives used to manage debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:to="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DengvaxiaProductLitigationInThePhilippinesMember_180af349-93cc-415f-9f37-dc356a3506c1_terseLabel_en-US" xlink:label="lab_sny_DengvaxiaProductLitigationInThePhilippinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dengvaxia product litigation in the Philippines</link:label>
    <link:label id="lab_sny_DengvaxiaProductLitigationInThePhilippinesMember_label_en-US" xlink:label="lab_sny_DengvaxiaProductLitigationInThePhilippinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dengvaxia Product Litigation In The Philippines [Member]</link:label>
    <link:label id="lab_sny_DengvaxiaProductLitigationInThePhilippinesMember_documentation_en-US" xlink:label="lab_sny_DengvaxiaProductLitigationInThePhilippinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dengvaxia Product Litigation In The Philippines</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DengvaxiaProductLitigationInThePhilippinesMember" xlink:href="sny-20221231.xsd#sny_DengvaxiaProductLitigationInThePhilippinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DengvaxiaProductLitigationInThePhilippinesMember" xlink:to="lab_sny_DengvaxiaProductLitigationInThePhilippinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_d89d913c-942a-4ef9-97a0-87659e8a7ef7_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General inflation rate</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumption of expected rates of inflation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_USLegalRestructuringMember_ae3fd1be-3442-4db9-ba85-8f034f446aa8_terseLabel_en-US" xlink:label="lab_sny_USLegalRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US legal restructuring</link:label>
    <link:label id="lab_sny_USLegalRestructuringMember_label_en-US" xlink:label="lab_sny_USLegalRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Legal Restructuring [Member]</link:label>
    <link:label id="lab_sny_USLegalRestructuringMember_documentation_en-US" xlink:label="lab_sny_USLegalRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Legal Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_USLegalRestructuringMember" xlink:href="sny-20221231.xsd#sny_USLegalRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_USLegalRestructuringMember" xlink:to="lab_sny_USLegalRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaterialReconcilingItemsMember_2555282d-816d-4b78-9940-1782e294ccb3_terseLabel_en-US" xlink:label="lab_ifrs-full_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material reconciling items</link:label>
    <link:label id="lab_ifrs-full_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_ifrs-full_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material reconciling items [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaterialReconcilingItemsMember" xlink:to="lab_ifrs-full_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShareRepurchase2019ProgramMember_35b9d59f-ba2f-44b3-b128-b7ea3ae841d8_terseLabel_en-US" xlink:label="lab_sny_ShareRepurchase2019ProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_sny_ShareRepurchase2019ProgramMember_label_en-US" xlink:label="lab_sny_ShareRepurchase2019ProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase 2019 Program [Member]</link:label>
    <link:label id="lab_sny_ShareRepurchase2019ProgramMember_documentation_en-US" xlink:label="lab_sny_ShareRepurchase2019ProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase 2019 program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2019ProgramMember" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2019ProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareRepurchase2019ProgramMember" xlink:to="lab_sny_ShareRepurchase2019ProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions_88d60293-79e0-4919-aedb-70b7e231098b_negatedLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversals of unutilized provisions</link:label>
    <link:label id="lab_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions_label_en-US" xlink:label="lab_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Of Unused Provision Reversed, Other Provisions</link:label>
    <link:label id="lab_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease of unused provision reversed, other provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xlink:to="lab_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAccountsReceivableLineItems_f952bad0-92ed-4551-8146-af2daa654ef2_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAccountsReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounts receivable [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfAccountsReceivableLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfAccountsReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Accounts Receivable [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfAccountsReceivableLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfAccountsReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Accounts Receivable [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAccountsReceivableLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfAccountsReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAccountsReceivableLineItems" xlink:to="lab_sny_DisclosureOfAccountsReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_5c233181-8aa6-4062-b1d6-14683463d157_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AuditorsRemuneration_7dbb19c9-a0a3-49bc-9dce-8f8e7f12b0af_totalLabel_en-US" xlink:label="lab_ifrs-full_AuditorsRemuneration" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_AuditorsRemuneration_label_en-US" xlink:label="lab_ifrs-full_AuditorsRemuneration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor's remuneration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemuneration" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemuneration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemuneration" xlink:to="lab_ifrs-full_AuditorsRemuneration" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisGroupeMember_465a2817-1a69-46d0-9845-e508441acb83_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisGroupeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Groupe</link:label>
    <link:label id="lab_sny_SanofiAventisGroupeMember_label_en-US" xlink:label="lab_sny_SanofiAventisGroupeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Groupe [member]</link:label>
    <link:label id="lab_sny_SanofiAventisGroupeMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisGroupeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Groupe.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisGroupeMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisGroupeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisGroupeMember" xlink:to="lab_sny_SanofiAventisGroupeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_June2018SNFISINUS801060AD60Member_153a12cb-7e0a-469b-b9f5-1ce3c46ef537_terseLabel_en-US" xlink:label="lab_sny_June2018SNFISINUS801060AD60Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2018 SNF ISIN US801060AD60</link:label>
    <link:label id="lab_sny_June2018SNFISINUS801060AD60Member_label_en-US" xlink:label="lab_sny_June2018SNFISINUS801060AD60Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2018 SNFISINUS801060AD60 [member]</link:label>
    <link:label id="lab_sny_June2018SNFISINUS801060AD60Member_documentation_en-US" xlink:label="lab_sny_June2018SNFISINUS801060AD60Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2018SNFISINUS801060AD60.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_June2018SNFISINUS801060AD60Member" xlink:href="sny-20221231.xsd#sny_June2018SNFISINUS801060AD60Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_June2018SNFISINUS801060AD60Member" xlink:to="lab_sny_June2018SNFISINUS801060AD60Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4f737f7f-a139-485a-8ae6-2841385f1e93_terseLabel_en-US" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranges of exercise prices for outstanding share options [member]</link:label>
    <link:label id="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_label_en-US" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranges of exercise prices for outstanding share options [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CustomerOneMember_3d5d5a69-0400-4541-b807-2c039f2d6140_terseLabel_en-US" xlink:label="lab_sny_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer one</link:label>
    <link:label id="lab_sny_CustomerOneMember_label_en-US" xlink:label="lab_sny_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One [member]</link:label>
    <link:label id="lab_sny_CustomerOneMember_documentation_en-US" xlink:label="lab_sny_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CustomerOneMember" xlink:href="sny-20221231.xsd#sny_CustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CustomerOneMember" xlink:to="lab_sny_CustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_0ecbc221-56d2-4f35-9d3c-10a228bc239a_terseLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Attributable to non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income, attributable to non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_9649d85d-26c8-4ba4-8222-7b3b9ced4e21_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions_5594a33c-8cd4-4462-b1eb-9d5060c9aa5d_terseLabel_en-US" xlink:label="lab_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in shareholders equity due to exercise of stock purchase option</link:label>
    <link:label id="lab_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions_label_en-US" xlink:label="lab_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder's Equity Increase Due To The Exercise Of All Stock Subscription Options</link:label>
    <link:label id="lab_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions_documentation_en-US" xlink:label="lab_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder's equity increase due to the exercise of all stock subscription options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions" xlink:href="sny-20221231.xsd#sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions" xlink:to="lab_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock_633e98f6-e502-427a-953d-513fded906a5_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for discounts, rebates and sales returns</link:label>
    <link:label id="lab_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Provisions For Discounts Rebates And Sales Returns [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for provisions for discounts rebates and sales returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock" xlink:to="lab_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PurchasePrice_7fd10141-d2f6-4a22-9023-c95685b59ae1_totalLabel_en-US" xlink:label="lab_sny_PurchasePrice" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_sny_PurchasePrice_label_en-US" xlink:label="lab_sny_PurchasePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_sny_PurchasePrice_documentation_en-US" xlink:label="lab_sny_PurchasePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PurchasePrice" xlink:href="sny-20221231.xsd#sny_PurchasePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PurchasePrice" xlink:to="lab_sny_PurchasePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock_280160d8-474c-4b02-8b18-64087468804a_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restructuring Costs and Similar Items</link:label>
    <link:label id="lab_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Restructuring Costs Details [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of restructuring costs details.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringCostsDetailsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xlink:to="lab_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock_5b68f13c-91d5-47f8-b5b9-c36a91dd2efd_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, cash and cash equivalents and lease liabilities</link:label>
    <link:label id="lab_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt Instruments Issued Explanatory [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of debt instruments issued explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xlink:to="lab_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing_f35b7b0a-244d-471b-8767-e3a3643cc5f1_terseLabel_en-US" xlink:label="lab_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of days after the completion of the post-trial briefing (in days)</link:label>
    <link:label id="lab_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing_label_en-US" xlink:label="lab_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Days After Completion Of Post-Trail Briefing</link:label>
    <link:label id="lab_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing_documentation_en-US" xlink:label="lab_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Days After Completion Of Post-Trail Briefing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing" xlink:href="sny-20221231.xsd#sny_NumberOfDaysAfterCompletionOfPostTrailBriefing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing" xlink:to="lab_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_UniformPreTaxDiscountRates_588ecca4-447c-47ca-b846-82901a2f4ea2_terseLabel_en-US" xlink:label="lab_sny_UniformPreTaxDiscountRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform pre-tax discount rates</link:label>
    <link:label id="lab_sny_UniformPreTaxDiscountRates_label_en-US" xlink:label="lab_sny_UniformPreTaxDiscountRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform Pre-Tax Discount Rates</link:label>
    <link:label id="lab_sny_UniformPreTaxDiscountRates_documentation_en-US" xlink:label="lab_sny_UniformPreTaxDiscountRates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform pre-tax discount rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UniformPreTaxDiscountRates" xlink:href="sny-20221231.xsd#sny_UniformPreTaxDiscountRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UniformPreTaxDiscountRates" xlink:to="lab_sny_UniformPreTaxDiscountRates" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock_96e308aa-cf3b-4a13-a20a-5c90947a3a94_terseLabel_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurement of contingent consideration</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock_label_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Accounting Policy For Fair Value Remeasurement Of Contingent Consideration Liabilities Explanatory [Policy Text Block]</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock_documentation_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The description of the entity's accounting policy for fair value remeasurement of contingent consideration liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock" xlink:to="lab_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_8e6b0a61-67d4-4b05-bb23-7bad4fcaba5b_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and losses on disposals of non-current assets, net of tax</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for losses (gains) on disposal of non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:to="lab_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseOfRestructuringActivities_0506f8e1-c35d-4b69-beeb-931540416eb7_negatedLabel_en-US" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs and similar items</link:label>
    <link:label id="lab_ifrs-full_ExpenseOfRestructuringActivities_1f4e3c67-d155-403c-9305-af15c1878292_totalLabel_en-US" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_ExpenseOfRestructuringActivities_label_en-US" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense of restructuring activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseOfRestructuringActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities" xlink:to="lab_ifrs-full_ExpenseOfRestructuringActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RPRUSLtdMember_faea6087-cd19-433a-94d4-24f88448f9a5_terseLabel_en-US" xlink:label="lab_sny_RPRUSLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RPR US Ltd.</link:label>
    <link:label id="lab_sny_RPRUSLtdMember_label_en-US" xlink:label="lab_sny_RPRUSLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RPR US Ltd [Member]</link:label>
    <link:label id="lab_sny_RPRUSLtdMember_documentation_en-US" xlink:label="lab_sny_RPRUSLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RPR US Ltd</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RPRUSLtdMember" xlink:href="sny-20221231.xsd#sny_RPRUSLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RPRUSLtdMember" xlink:to="lab_sny_RPRUSLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInCurrencyTranslationOnTaxEffects_29a2dc7a-074c-4cde-8e1b-99ab38ed7ed0_negatedLabel_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationOnTaxEffects" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effects</link:label>
    <link:label id="lab_sny_ChangeInCurrencyTranslationOnTaxEffects_label_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationOnTaxEffects" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Currency Translation On Tax Effects</link:label>
    <link:label id="lab_sny_ChangeInCurrencyTranslationOnTaxEffects_documentation_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationOnTaxEffects" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in currency translation on tax effects.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationOnTaxEffects" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationOnTaxEffects"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInCurrencyTranslationOnTaxEffects" xlink:to="lab_sny_ChangeInCurrencyTranslationOnTaxEffects" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement_921271fa-7504-4bf2-bb0e-38d5f72f7f4e_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments related to maximum payments for projects under collaboration agreement</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement_label_en-US" xlink:label="lab_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Maximum Payments For Projects Under Collaboration Agreement</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Maximum Payments For Projects Under Collaboration Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement" xlink:to="lab_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReclassifiedItemsMember_c2195384-4ac0-4dde-b44c-b6fa30b3a0e3_terseLabel_en-US" xlink:label="lab_ifrs-full_ReclassifiedItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified items</link:label>
    <link:label id="lab_ifrs-full_ReclassifiedItemsMember_label_en-US" xlink:label="lab_ifrs-full_ReclassifiedItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified items [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassifiedItemsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReclassifiedItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassifiedItemsMember" xlink:to="lab_ifrs-full_ReclassifiedItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_78c2faad-7dcc-4ccb-b7d5-91778942c9cf_terseLabel_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of ownership interests held by non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of ownership interests held by non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DerivativeFinancialInstrumentsToManageFinancialExposure_be2e4bfd-1d76-48ba-ad81-a73d1d42d805_terseLabel_en-US" xlink:label="lab_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial currency hedging instruments in place</link:label>
    <link:label id="lab_sny_DerivativeFinancialInstrumentsToManageFinancialExposure_label_en-US" xlink:label="lab_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments To Manage Financial Exposure</link:label>
    <link:label id="lab_sny_DerivativeFinancialInstrumentsToManageFinancialExposure_documentation_en-US" xlink:label="lab_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial instruments to manage financial exposure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialInstrumentsToManageFinancialExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xlink:to="lab_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfInventoriesLineItems_6a293ea8-90fd-481d-89a6-9a9f0b88fa24_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfInventoriesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of inventories [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfInventoriesLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfInventoriesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Inventories [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfInventoriesLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfInventoriesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of inventories.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInventoriesLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfInventoriesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInventoriesLineItems" xlink:to="lab_sny_DisclosureOfInventoriesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfCases_dcaac449-2d2b-4f93-88dd-6b5074bea6aa_terseLabel_en-US" xlink:label="lab_sny_NumberOfCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_sny_NumberOfCases_label_en-US" xlink:label="lab_sny_NumberOfCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Cases</link:label>
    <link:label id="lab_sny_NumberOfCases_documentation_en-US" xlink:label="lab_sny_NumberOfCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCases" xlink:href="sny-20221231.xsd#sny_NumberOfCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfCases" xlink:to="lab_sny_NumberOfCases" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_b557865f-b9af-42de-8ddf-416b99cb1364_terseLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of other intangible assets</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_a3ec1e3f-42af-4099-ad6d-d4bea01d9048_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Perpetual growth rates applied to future cash flows</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Growth rate used to extrapolate cash flow projections</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:to="lab_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MajorCollaborationAgreementMember_2add6c33-4cb9-49eb-86ab-b738e5c3852f_terseLabel_en-US" xlink:label="lab_sny_MajorCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Collaboration Agreement</link:label>
    <link:label id="lab_sny_MajorCollaborationAgreementMember_label_en-US" xlink:label="lab_sny_MajorCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Collaboration Agreement [Member]</link:label>
    <link:label id="lab_sny_MajorCollaborationAgreementMember_documentation_en-US" xlink:label="lab_sny_MajorCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Collaboration Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MajorCollaborationAgreementMember" xlink:href="sny-20221231.xsd#sny_MajorCollaborationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MajorCollaborationAgreementMember" xlink:to="lab_sny_MajorCollaborationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_f64f30a6-92dd-40f1-a7ab-4d1b9ce6922e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment information</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of entity's operating segments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChinoinPrivateCoLtdMember_46ab0cdf-2361-43df-b46c-e61206061219_terseLabel_en-US" xlink:label="lab_sny_ChinoinPrivateCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chinoin Private Co. Ltd</link:label>
    <link:label id="lab_sny_ChinoinPrivateCoLtdMember_label_en-US" xlink:label="lab_sny_ChinoinPrivateCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chinoin Private Co. Ltd [member]</link:label>
    <link:label id="lab_sny_ChinoinPrivateCoLtdMember_documentation_en-US" xlink:label="lab_sny_ChinoinPrivateCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chinoin Private Co. Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChinoinPrivateCoLtdMember" xlink:href="sny-20221231.xsd#sny_ChinoinPrivateCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChinoinPrivateCoLtdMember" xlink:to="lab_sny_ChinoinPrivateCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment_ef443424-ff8c-4b4e-9629-1e387939ed65_terseLabel_en-US" xlink:label="lab_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PD1 sales milestone payment from Sanofi</link:label>
    <link:label id="lab_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment_label_en-US" xlink:label="lab_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti Programmed Cell Death Protein 1 Sales Milestone Payment</link:label>
    <link:label id="lab_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment_documentation_en-US" xlink:label="lab_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti programmed cell death protein 1 sales milestone payment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment" xlink:href="sny-20221231.xsd#sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment" xlink:to="lab_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock_f8bec395-9499-48c4-bdd9-566935fed8cc_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Timing of Benefit Payments under Pension and Other Post-employment Benefit Plans</link:label>
    <link:label id="lab_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Expected Timing Of Payments Under Pension And Other Post Employment Benefit Plans [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of expected timing of payments under pension and other post employment benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock" xlink:to="lab_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock_8e716850-37c6-4218-8ac5-418a071c23f8_terseLabel_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of consolidation</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Accounting Policy For Basis Of Consolidation [Policy Text Block]</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock_documentation_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The description of the entity's accounting policy for basis of consolidation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:to="lab_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfRestructuringProvisionsTableTextBlock_9e0b8c3d-2bbf-46f4-8cd9-cd288375415c_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfRestructuringProvisionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movements in Restructuring Provisions Classified in Non-current and Current Liabilities</link:label>
    <link:label id="lab_sny_DisclosureOfRestructuringProvisionsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfRestructuringProvisionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Restructuring Provisions [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfRestructuringProvisionsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfRestructuringProvisionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of restructuring provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringProvisionsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringProvisionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsTableTextBlock" xlink:to="lab_sny_DisclosureOfRestructuringProvisionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_07571ec1-9f3a-47f8-9c74-cc9a69b134a5_terseLabel_en-US" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)</link:label>
    <link:label id="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_0ec025a9-75ab-4ed6-a97c-094c60fdc499_negatedLabel_en-US" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</link:label>
    <link:label id="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_db47785e-ae7b-4efe-9ab7-b55c020193a0_verboseLabel_en-US" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains/(losses) arising during the period</link:label>
    <link:label id="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EmployeesShareOwnershipPlanMember_10c7941f-08c6-4c09-afba-36112781154e_terseLabel_en-US" xlink:label="lab_sny_EmployeesShareOwnershipPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees share ownership plan</link:label>
    <link:label id="lab_sny_EmployeesShareOwnershipPlanMember_label_en-US" xlink:label="lab_sny_EmployeesShareOwnershipPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees Share Ownership Plan [member]</link:label>
    <link:label id="lab_sny_EmployeesShareOwnershipPlanMember_documentation_en-US" xlink:label="lab_sny_EmployeesShareOwnershipPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees share ownership plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeesShareOwnershipPlanMember" xlink:href="sny-20221231.xsd#sny_EmployeesShareOwnershipPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EmployeesShareOwnershipPlanMember" xlink:to="lab_sny_EmployeesShareOwnershipPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurHepatitisBVaccineMember_8f178cc4-9d8a-47e1-8ec0-3763fc46fc13_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurHepatitisBVaccineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Hepatitis B Vaccine product litigation</link:label>
    <link:label id="lab_sny_SanofiPasteurHepatitisBVaccineMember_label_en-US" xlink:label="lab_sny_SanofiPasteurHepatitisBVaccineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Hepatitis B Vaccine [Member]</link:label>
    <link:label id="lab_sny_SanofiPasteurHepatitisBVaccineMember_documentation_en-US" xlink:label="lab_sny_SanofiPasteurHepatitisBVaccineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Hepatitis B Vaccine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurHepatitisBVaccineMember" xlink:href="sny-20221231.xsd#sny_SanofiPasteurHepatitisBVaccineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurHepatitisBVaccineMember" xlink:to="lab_sny_SanofiPasteurHepatitisBVaccineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ImpairmentTestingPercentage_2fb01ae4-fa4a-41c2-9213-fac744a531bb_terseLabel_en-US" xlink:label="lab_sny_ImpairmentTestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate used for Impairment of goodwill</link:label>
    <link:label id="lab_sny_ImpairmentTestingPercentage_label_en-US" xlink:label="lab_sny_ImpairmentTestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Testing Percentage</link:label>
    <link:label id="lab_sny_ImpairmentTestingPercentage_documentation_en-US" xlink:label="lab_sny_ImpairmentTestingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Testing Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentTestingPercentage" xlink:href="sny-20221231.xsd#sny_ImpairmentTestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ImpairmentTestingPercentage" xlink:to="lab_sny_ImpairmentTestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction_7b4b004d-0e14-41b0-bc19-07c3ccb9577d_terseLabel_en-US" xlink:label="lab_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares agreement, sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Agreement Sale Of Stock, Number Of Shares Issued In Transaction</link:label>
    <link:label id="lab_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction_documentation_en-US" xlink:label="lab_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Agreement Sale Of Stock, Number Of Shares Issued In Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="sny-20221231.xsd#sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock_aa920ba4-6c5f-4845-b042-3a490eb3fbea_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Actual or Potential Effects of Netting Arrangements</link:label>
    <link:label id="lab_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Actual Or Potential Effects Of Netting Arrangements [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of actual or potential effects of netting arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock" xlink:to="lab_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_b79101b6-4ceb-4b4c-b971-f2ee0d41d473_terseLabel_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related expenses</link:label>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_label_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Of Restructuring Activities, Employee Related Expenses</link:label>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_documentation_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee related expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:to="lab_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SegmentsMember_eb78da32-32b0-4534-9406-25e1cf6c6923_terseLabel_en-US" xlink:label="lab_ifrs-full_SegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [member]</link:label>
    <link:label id="lab_ifrs-full_SegmentsMember_label_en-US" xlink:label="lab_ifrs-full_SegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentsMember" xlink:to="lab_ifrs-full_SegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ImmunoOncologyCollaborationAgreementMember_9a9ddf16-1abe-4b0a-81d7-44773241d772_terseLabel_en-US" xlink:label="lab_sny_ImmunoOncologyCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immuno-oncology collaboration agreement</link:label>
    <link:label id="lab_sny_ImmunoOncologyCollaborationAgreementMember_label_en-US" xlink:label="lab_sny_ImmunoOncologyCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immuno Oncology Collaboration Agreement [Member]</link:label>
    <link:label id="lab_sny_ImmunoOncologyCollaborationAgreementMember_documentation_en-US" xlink:label="lab_sny_ImmunoOncologyCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immuno oncology collaboration agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImmunoOncologyCollaborationAgreementMember" xlink:href="sny-20221231.xsd#sny_ImmunoOncologyCollaborationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ImmunoOncologyCollaborationAgreementMember" xlink:to="lab_sny_ImmunoOncologyCollaborationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_HedgedItemsMember_a1afc0ad-3345-4740-a56a-c4cf75c861a8_terseLabel_en-US" xlink:label="lab_ifrs-full_HedgedItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged items [member]</link:label>
    <link:label id="lab_ifrs-full_HedgedItemsMember_label_en-US" xlink:label="lab_ifrs-full_HedgedItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged items [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgedItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgedItemsMember" xlink:to="lab_ifrs-full_HedgedItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_02ce3161-1904-4e1a-9d76-7eaa91cfdd32_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current service cost</link:label>
    <link:label id="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in net defined benefit liability (asset) resulting from current service cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencySalesInJapaneseYenMember_7d2dfd34-1510-4124-99c5-7b73f4db8dd9_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencySalesInJapaneseYenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales in Japanese Yen</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInJapaneseYenMember_label_en-US" xlink:label="lab_sny_ForwardCurrencySalesInJapaneseYenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Japanese Yen [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInJapaneseYenMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencySalesInJapaneseYenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales in Japanese Yen.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInJapaneseYenMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInJapaneseYenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInJapaneseYenMember" xlink:to="lab_sny_ForwardCurrencySalesInJapaneseYenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_JointVenturesAxis_fa53366c-fd05-44f7-aa27-eaf6e10ae49c_terseLabel_en-US" xlink:label="lab_ifrs-full_JointVenturesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint ventures [axis]</link:label>
    <link:label id="lab_ifrs-full_JointVenturesAxis_label_en-US" xlink:label="lab_ifrs-full_JointVenturesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint ventures [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_JointVenturesAxis" xlink:to="lab_ifrs-full_JointVenturesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_e181efb2-4325-4548-b50f-ee2d994437e8_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfLawsuitsRuledOnMerit_627525c4-ee63-4b64-b11f-1bf34a0551c7_terseLabel_en-US" xlink:label="lab_sny_NumberOfLawsuitsRuledOnMerit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lawsuits ruled on merits</link:label>
    <link:label id="lab_sny_NumberOfLawsuitsRuledOnMerit_label_en-US" xlink:label="lab_sny_NumberOfLawsuitsRuledOnMerit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Lawsuits Ruled On Merit</link:label>
    <link:label id="lab_sny_NumberOfLawsuitsRuledOnMerit_documentation_en-US" xlink:label="lab_sny_NumberOfLawsuitsRuledOnMerit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Lawsuits Ruled On Merit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfLawsuitsRuledOnMerit" xlink:href="sny-20221231.xsd#sny_NumberOfLawsuitsRuledOnMerit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfLawsuitsRuledOnMerit" xlink:to="lab_sny_NumberOfLawsuitsRuledOnMerit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LandMember_66d0bcf8-9fbd-4f84-9c58-ae0617f5e9eb_terseLabel_en-US" xlink:label="lab_ifrs-full_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_ifrs-full_LandMember_label_en-US" xlink:label="lab_ifrs-full_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LandMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandMember" xlink:to="lab_ifrs-full_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BorrowingDrawdown_1e7348a6-fab1-457f-9084-4e4173456519_terseLabel_en-US" xlink:label="lab_sny_BorrowingDrawdown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing, drawdown</link:label>
    <link:label id="lab_sny_BorrowingDrawdown_label_en-US" xlink:label="lab_sny_BorrowingDrawdown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing, Drawdown</link:label>
    <link:label id="lab_sny_BorrowingDrawdown_documentation_en-US" xlink:label="lab_sny_BorrowingDrawdown" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing, Drawdown</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BorrowingDrawdown" xlink:href="sny-20221231.xsd#sny_BorrowingDrawdown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BorrowingDrawdown" xlink:to="lab_sny_BorrowingDrawdown" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherRevenue_6dee52b1-d784-4a20-9044-33849b9760da_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_ifrs-full_OtherRevenue_label_en-US" xlink:label="lab_ifrs-full_OtherRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherRevenue" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherRevenue" xlink:to="lab_ifrs-full_OtherRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RangesMember_07173bc5-7062-4b18-8c18-ad20f286fdd4_terseLabel_en-US" xlink:label="lab_ifrs-full_RangesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranges</link:label>
    <link:label id="lab_ifrs-full_RangesMember_label_en-US" xlink:label="lab_ifrs-full_RangesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranges [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesMember" xlink:to="lab_ifrs-full_RangesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelFaxNumber_a81d4eac-febd-4275-9099-3ce1c18bf8ca_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelFaxNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Fax Number</link:label>
    <link:label id="lab_dei_ContactPersonnelFaxNumber_label_en-US" xlink:label="lab_dei_ContactPersonnelFaxNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Fax Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelFaxNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelFaxNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelFaxNumber" xlink:to="lab_dei_ContactPersonnelFaxNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiaventisSpZooMember_98a16fb5-17ed-4553-9952-ff05c472ba0a_terseLabel_en-US" xlink:label="lab_sny_SanofiaventisSpZooMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Sp. z.o.o.</link:label>
    <link:label id="lab_sny_SanofiaventisSpZooMember_label_en-US" xlink:label="lab_sny_SanofiaventisSpZooMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Sp. zoo [member]</link:label>
    <link:label id="lab_sny_SanofiaventisSpZooMember_documentation_en-US" xlink:label="lab_sny_SanofiaventisSpZooMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Sp. z.o.o.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiaventisSpZooMember" xlink:href="sny-20221231.xsd#sny_SanofiaventisSpZooMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiaventisSpZooMember" xlink:to="lab_sny_SanofiaventisSpZooMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BioverativMember_9a1f992e-58f2-4726-9943-663b759a96cd_terseLabel_en-US" xlink:label="lab_sny_BioverativMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ</link:label>
    <link:label id="lab_sny_BioverativMember_label_en-US" xlink:label="lab_sny_BioverativMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ [member]</link:label>
    <link:label id="lab_sny_BioverativMember_documentation_en-US" xlink:label="lab_sny_BioverativMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bioverativ.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativMember" xlink:href="sny-20221231.xsd#sny_BioverativMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BioverativMember" xlink:to="lab_sny_BioverativMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_0544bde5-f6e0-4401-acc3-18d3a0576f1f_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New standards, amendments and interpretations</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of initial application of standards or interpretations [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:to="lab_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Borrowings_88dfa4ad-e63b-4a67-b942-3889c022b36a_totalLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_ifrs-full_Borrowings_decfe860-2e46-407c-b29c-2c576a37da3f_periodStartLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings at beginning of period</link:label>
    <link:label id="lab_ifrs-full_Borrowings_4ea38c41-05a2-436d-807c-287efc1152c5_periodEndLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings at end of period</link:label>
    <link:label id="lab_ifrs-full_Borrowings_2a3f0e99-fa03-4455-8534-40de5ecf941b_terseLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_ifrs-full_Borrowings_ddb7c573-4901-479e-8a1d-6d4f461eda4b_verboseLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_ifrs-full_Borrowings_label_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings" xlink:to="lab_ifrs-full_Borrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareEgyptLLCMember_8d564724-9c67-4145-984c-471a99ab882c_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareEgyptLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Egypt LLC</link:label>
    <link:label id="lab_sny_OpellaHealthcareEgyptLLCMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareEgyptLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Egypt LLC [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareEgyptLLCMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareEgyptLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Egypt LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareEgyptLLCMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareEgyptLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareEgyptLLCMember" xlink:to="lab_sny_OpellaHealthcareEgyptLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TidalTherapeuticsMember_74c7d886-e9d8-4790-9be8-31e15f9a8d98_terseLabel_en-US" xlink:label="lab_sny_TidalTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tidal Therapeutics</link:label>
    <link:label id="lab_sny_TidalTherapeuticsMember_label_en-US" xlink:label="lab_sny_TidalTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tidal Therapeutics [Member]</link:label>
    <link:label id="lab_sny_TidalTherapeuticsMember_documentation_en-US" xlink:label="lab_sny_TidalTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tidal Therapeutics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TidalTherapeuticsMember" xlink:href="sny-20221231.xsd#sny_TidalTherapeuticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TidalTherapeuticsMember" xlink:to="lab_sny_TidalTherapeuticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_aa045a4e-2ea1-4937-afad-db882d57e71d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information about credit exposures designated as measured at fair value through profit or loss [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisSouthAfricaPtyLtdMember_eae01235-5bef-4cfa-8acd-7332e4888ec5_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisSouthAfricaPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis South Africa (Pty) Ltd</link:label>
    <link:label id="lab_sny_SanofiAventisSouthAfricaPtyLtdMember_label_en-US" xlink:label="lab_sny_SanofiAventisSouthAfricaPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis South Africa (Pty) Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisSouthAfricaPtyLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisSouthAfricaPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis South Africa (Pty) Ltd</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSouthAfricaPtyLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisSouthAfricaPtyLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisSouthAfricaPtyLtdMember" xlink:to="lab_sny_SanofiAventisSouthAfricaPtyLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_47a17499-3141-4674-907d-380bcceb9ba0_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments accounted for using the equity method</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of investments accounted for using equity method [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax_77b985c0-d390-483e-a380-01352f350500_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on remeasuring available-for-sale financial assets, net of tax</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on remeasuring available-for-sale financial assets, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax" xlink:to="lab_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfVaccineDosesToBeSupplied_5878b2e0-1942-4dbb-a87e-121297b3de70_terseLabel_en-US" xlink:label="lab_sny_NumberOfVaccineDosesToBeSupplied" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vaccine doses to be supplied</link:label>
    <link:label id="lab_sny_NumberOfVaccineDosesToBeSupplied_label_en-US" xlink:label="lab_sny_NumberOfVaccineDosesToBeSupplied" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Vaccine Doses To Be Supplied</link:label>
    <link:label id="lab_sny_NumberOfVaccineDosesToBeSupplied_documentation_en-US" xlink:label="lab_sny_NumberOfVaccineDosesToBeSupplied" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Vaccine Doses To Be Supplied</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfVaccineDosesToBeSupplied" xlink:href="sny-20221231.xsd#sny_NumberOfVaccineDosesToBeSupplied"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfVaccineDosesToBeSupplied" xlink:to="lab_sny_NumberOfVaccineDosesToBeSupplied" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AventisPharmaSAFranceMember_4469ec27-66c6-4060-80dc-2117d08c8683_terseLabel_en-US" xlink:label="lab_sny_AventisPharmaSAFranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma S.A.</link:label>
    <link:label id="lab_sny_AventisPharmaSAFranceMember_label_en-US" xlink:label="lab_sny_AventisPharmaSAFranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma S.A. France [member]</link:label>
    <link:label id="lab_sny_AventisPharmaSAFranceMember_documentation_en-US" xlink:label="lab_sny_AventisPharmaSAFranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma S.A. France.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaSAFranceMember" xlink:href="sny-20221231.xsd#sny_AventisPharmaSAFranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AventisPharmaSAFranceMember" xlink:to="lab_sny_AventisPharmaSAFranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfNoncurrentProvisionsTableTextBlock_38212177-f6c0-4248-b351-7c24bd0c70fa_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfNoncurrentProvisionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Movements in Non-current Provisions</link:label>
    <link:label id="lab_sny_DisclosureOfNoncurrentProvisionsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfNoncurrentProvisionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Noncurrent Provisions [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfNoncurrentProvisionsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfNoncurrentProvisionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of noncurrent provisions explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNoncurrentProvisionsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfNoncurrentProvisionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNoncurrentProvisionsTableTextBlock" xlink:to="lab_sny_DisclosureOfNoncurrentProvisionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_d89e4afe-33ea-4ec2-82bf-a8b13a8f3469_terseLabel_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from plan members</link:label>
    <link:label id="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_96ab372b-5317-4c20-93fa-9a2374e4a7a0_negatedLabel_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from plan members</link:label>
    <link:label id="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_8f626821-0291-4bd2-97a7-2dc7482d77c1_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefit obligations</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for employee benefits [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiTaiwanCoLtdMember_5b5acc40-3972-4fe0-8bc5-86c88d17f326_terseLabel_en-US" xlink:label="lab_sny_SanofiTaiwanCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Taiwan Co., Ltd</link:label>
    <link:label id="lab_sny_SanofiTaiwanCoLtdMember_label_en-US" xlink:label="lab_sny_SanofiTaiwanCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Taiwan Co Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiTaiwanCoLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiTaiwanCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Taiwan Co Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiTaiwanCoLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiTaiwanCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiTaiwanCoLtdMember" xlink:to="lab_sny_SanofiTaiwanCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_31426b1d-00c9-4109-b083-8f1fbef230d1_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for foreign currency translation [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestsInOtherEntitiesAbstract_72a50c97-f2cc-44fc-bd31-d095300096d0_terseLabel_en-US" xlink:label="lab_sny_InterestsInOtherEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interests In Other Entities [Abstract]</link:label>
    <link:label id="lab_sny_InterestsInOtherEntitiesAbstract_label_en-US" xlink:label="lab_sny_InterestsInOtherEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interests In Other Entities [Abstract]</link:label>
    <link:label id="lab_sny_InterestsInOtherEntitiesAbstract_documentation_en-US" xlink:label="lab_sny_InterestsInOtherEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interests In Other Entities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract" xlink:to="lab_sny_InterestsInOtherEntitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurFranceSAMember_e57fb5dd-f884-40cb-9fb5-316e66288771_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurFranceSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur</link:label>
    <link:label id="lab_sny_SanofiPasteurFranceSAMember_label_en-US" xlink:label="lab_sny_SanofiPasteurFranceSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur (France) SA [member]</link:label>
    <link:label id="lab_sny_SanofiPasteurFranceSAMember_documentation_en-US" xlink:label="lab_sny_SanofiPasteurFranceSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur (France) SA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurFranceSAMember" xlink:href="sny-20221231.xsd#sny_SanofiPasteurFranceSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurFranceSAMember" xlink:to="lab_sny_SanofiPasteurFranceSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentFinanceLeaseReceivables_f69c465f-5063-49d9-9a4e-5f1e9511b719_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current finance lease receivables</link:label>
    <link:label id="lab_ifrs-full_NoncurrentFinanceLeaseReceivables_label_en-US" xlink:label="lab_ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current finance lease receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinanceLeaseReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:to="lab_ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement_e8ac8b51-aa63-47f5-8c5e-0a15c3f14605_negatedLabel_en-US" xlink:label="lab_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, options exercised</link:label>
    <link:label id="lab_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Share Options Exercised In Share Based Payment Arrangement</link:label>
    <link:label id="lab_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of share options exercised in share based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement" xlink:to="lab_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EuroapiMember_7965014b-c1cf-47fd-9b0d-c64aecb11392_terseLabel_en-US" xlink:label="lab_sny_EuroapiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EUROAPI</link:label>
    <link:label id="lab_sny_EuroapiMember_label_en-US" xlink:label="lab_sny_EuroapiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euroapi [Member]</link:label>
    <link:label id="lab_sny_EuroapiMember_documentation_en-US" xlink:label="lab_sny_EuroapiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euroapi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EuroapiMember" xlink:to="lab_sny_EuroapiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AztecaVacunasSADeCVMember_ac89f813-8af6-4b88-9733-c3904aea977e_terseLabel_en-US" xlink:label="lab_sny_AztecaVacunasSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Azteca Vacunas, S.A. de C.V.</link:label>
    <link:label id="lab_sny_AztecaVacunasSADeCVMember_label_en-US" xlink:label="lab_sny_AztecaVacunasSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Azteca Vacunas, S.A. De C.V [Member]</link:label>
    <link:label id="lab_sny_AztecaVacunasSADeCVMember_documentation_en-US" xlink:label="lab_sny_AztecaVacunasSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Azteca Vacunas, S.A. De C.V</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AztecaVacunasSADeCVMember" xlink:href="sny-20221231.xsd#sny_AztecaVacunasSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AztecaVacunasSADeCVMember" xlink:to="lab_sny_AztecaVacunasSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InitialLeaseTerm_877ace61-b838-4926-81be-ebd11621b978_terseLabel_en-US" xlink:label="lab_sny_InitialLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial lease term</link:label>
    <link:label id="lab_sny_InitialLeaseTerm_label_en-US" xlink:label="lab_sny_InitialLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Lease Term</link:label>
    <link:label id="lab_sny_InitialLeaseTerm_documentation_en-US" xlink:label="lab_sny_InitialLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InitialLeaseTerm" xlink:href="sny-20221231.xsd#sny_InitialLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InitialLeaseTerm" xlink:to="lab_sny_InitialLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdditionalPaidinCapitalMember_5bdb571c-dfce-4daf-848c-1af5e91563be_terseLabel_en-US" xlink:label="lab_ifrs-full_AdditionalPaidinCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_ifrs-full_AdditionalPaidinCapitalMember_label_en-US" xlink:label="lab_ifrs-full_AdditionalPaidinCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionalPaidinCapitalMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalPaidinCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionalPaidinCapitalMember" xlink:to="lab_ifrs-full_AdditionalPaidinCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChargebackIncentivesMember_ef1e1edb-3a23-4182-9596-35db4a779554_terseLabel_en-US" xlink:label="lab_sny_ChargebackIncentivesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargeback incentives</link:label>
    <link:label id="lab_sny_ChargebackIncentivesMember_label_en-US" xlink:label="lab_sny_ChargebackIncentivesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargeback Incentives [Member]</link:label>
    <link:label id="lab_sny_ChargebackIncentivesMember_documentation_en-US" xlink:label="lab_sny_ChargebackIncentivesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargeback incentives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChargebackIncentivesMember" xlink:href="sny-20221231.xsd#sny_ChargebackIncentivesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChargebackIncentivesMember" xlink:to="lab_sny_ChargebackIncentivesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_343055fd-3ea5-46f5-87f2-610b7b688a6c_negatedLabel_en-US" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2d666ea8-1046-49c0-b4fd-5e121f0b64c4_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_06440115-03f9-4606-9dc2-6e4c4786b73d_terseLabel_en-US" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortisation, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b2e8aaf6-f574-43ac-8ffa-f090698ae68c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of analysis of other comprehensive income by item [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of analysis of other comprehensive income by item [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" xlink:to="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_65c734c2-d023-4b4d-99f1-e1860148d009_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfInterestRatesAxis_1e5898f9-504f-42e1-bdbf-5254b08c76b9_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfInterestRatesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types of interest rates [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfInterestRatesAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfInterestRatesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types of interest rates [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis" xlink:to="lab_ifrs-full_TypesOfInterestRatesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MaximumPlan1Member_d88bccc8-2824-49ea-9a72-99fb72e1a965_terseLabel_en-US" xlink:label="lab_sny_MaximumPlan1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Plan 1</link:label>
    <link:label id="lab_sny_MaximumPlan1Member_label_en-US" xlink:label="lab_sny_MaximumPlan1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Plan 1 [Member]</link:label>
    <link:label id="lab_sny_MaximumPlan1Member_documentation_en-US" xlink:label="lab_sny_MaximumPlan1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Plan 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumPlan1Member" xlink:href="sny-20221231.xsd#sny_MaximumPlan1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MaximumPlan1Member" xlink:to="lab_sny_MaximumPlan1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GenzymeLuxembourgSarlMember_b2f2858e-6f22-43a8-953b-193edabb3a7a_terseLabel_en-US" xlink:label="lab_sny_GenzymeLuxembourgSarlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Luxembourg Sarl</link:label>
    <link:label id="lab_sny_GenzymeLuxembourgSarlMember_label_en-US" xlink:label="lab_sny_GenzymeLuxembourgSarlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Luxembourg Sarl [Member]</link:label>
    <link:label id="lab_sny_GenzymeLuxembourgSarlMember_documentation_en-US" xlink:label="lab_sny_GenzymeLuxembourgSarlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Luxembourg Sarl</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeLuxembourgSarlMember" xlink:href="sny-20221231.xsd#sny_GenzymeLuxembourgSarlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GenzymeLuxembourgSarlMember" xlink:to="lab_sny_GenzymeLuxembourgSarlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ManufactureAndSupplyCollaborationAgreementMember_6bad1e48-5464-4547-9f64-fa67b693de66_terseLabel_en-US" xlink:label="lab_sny_ManufactureAndSupplyCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacture and supply collaboration agreement</link:label>
    <link:label id="lab_sny_ManufactureAndSupplyCollaborationAgreementMember_label_en-US" xlink:label="lab_sny_ManufactureAndSupplyCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacture And Supply Collaboration Agreement [Member]</link:label>
    <link:label id="lab_sny_ManufactureAndSupplyCollaborationAgreementMember_documentation_en-US" xlink:label="lab_sny_ManufactureAndSupplyCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacture And Supply Collaboration Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ManufactureAndSupplyCollaborationAgreementMember" xlink:href="sny-20221231.xsd#sny_ManufactureAndSupplyCollaborationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ManufactureAndSupplyCollaborationAgreementMember" xlink:to="lab_sny_ManufactureAndSupplyCollaborationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock_7b6c476b-5c18-4798-8410-d1bdfdb37e4e_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Amounts of Employer's Contributions to Plan Assets</link:label>
    <link:label id="lab_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Estimated Amounts Of Employer's Contributions To Plan Assets [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of estimated amounts of employer's contributions to plan assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock" xlink:to="lab_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_907ffdde-f960-418b-99aa-ce34cabe786e_terseLabel_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows related to derivative instruments</link:label>
    <link:label id="lab_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_label_en-US" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial liabilities, undiscounted cash flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:to="lab_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments_7e98e7d9-1e19-4b15-8932-e9de8f743d90_verboseLabel_en-US" xlink:label="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial instruments</link:label>
    <link:label id="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments_label_en-US" xlink:label="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects Of Other Netting Arrangements Not Fulfilling The IAS 32 Criteria For Offsetting Financial Instruments</link:label>
    <link:label id="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments_documentation_en-US" xlink:label="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of other netting arrangements not fulfilling the IAS32 criteria for offsetting financial instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" xlink:href="sny-20221231.xsd#sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" xlink:to="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_a4d5935c-ef69-4442-874b-575f0d5bb677_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockMarketPricePerShare_262d5a46-ea6b-4822-9733-77aa27b576f0_terseLabel_en-US" xlink:label="lab_sny_StockMarketPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted stock market price per share (in USD per share)</link:label>
    <link:label id="lab_sny_StockMarketPricePerShare_label_en-US" xlink:label="lab_sny_StockMarketPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Market Price Per Share</link:label>
    <link:label id="lab_sny_StockMarketPricePerShare_documentation_en-US" xlink:label="lab_sny_StockMarketPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock market price per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockMarketPricePerShare" xlink:href="sny-20221231.xsd#sny_StockMarketPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockMarketPricePerShare" xlink:to="lab_sny_StockMarketPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock_2dbe683f-5efd-492d-a3c2-140a69a49dc2_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of profit/loss from investments accounted for using the equity method</link:label>
    <link:label id="lab_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of share of profit loss of associates and joint ventures accounted for using equity method explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock" xlink:to="lab_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AtMarketValueMember_24a69748-7486-4bee-aafe-93129782b193_terseLabel_en-US" xlink:label="lab_sny_AtMarketValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market value</link:label>
    <link:label id="lab_sny_AtMarketValueMember_label_en-US" xlink:label="lab_sny_AtMarketValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At Market Value [member]</link:label>
    <link:label id="lab_sny_AtMarketValueMember_documentation_en-US" xlink:label="lab_sny_AtMarketValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At market value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtMarketValueMember" xlink:href="sny-20221231.xsd#sny_AtMarketValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AtMarketValueMember" xlink:to="lab_sny_AtMarketValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2b0dc0c5-8f77-4440-ad37-9256c1b9108d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_aa9ab5e1-846b-44ab-a61f-b6ac848e20dc_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transactions</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of related party [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TaxLossCarryforwardsOnAssetDisposals_037dffbe-8155-4713-855e-f87c2d69adf8_terseLabel_en-US" xlink:label="lab_sny_TaxLossCarryforwardsOnAssetDisposals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax loss carry-forwards on asset disposals</link:label>
    <link:label id="lab_sny_TaxLossCarryforwardsOnAssetDisposals_label_en-US" xlink:label="lab_sny_TaxLossCarryforwardsOnAssetDisposals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Loss Carryforwards On Asset Disposals</link:label>
    <link:label id="lab_sny_TaxLossCarryforwardsOnAssetDisposals_documentation_en-US" xlink:label="lab_sny_TaxLossCarryforwardsOnAssetDisposals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax loss carryforwards on asset disposals.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxLossCarryforwardsOnAssetDisposals" xlink:href="sny-20221231.xsd#sny_TaxLossCarryforwardsOnAssetDisposals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TaxLossCarryforwardsOnAssetDisposals" xlink:to="lab_sny_TaxLossCarryforwardsOnAssetDisposals" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestCostsCapitalised_26b2bf05-25cf-4655-9645-ebe268aa635f_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestCostsCapitalised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_ifrs-full_InterestCostsCapitalised_label_en-US" xlink:label="lab_ifrs-full_InterestCostsCapitalised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest costs capitalised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestCostsCapitalised" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestCostsCapitalised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestCostsCapitalised" xlink:to="lab_ifrs-full_InterestCostsCapitalised" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss_2b9b57d2-5af4-4b6c-8ec2-d17b22b5f4ec_terseLabel_en-US" xlink:label="lab_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss_label_en-US" xlink:label="lab_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Discount Rate Above Rate Actually Used Would Not Cause Impairment Loss</link:label>
    <link:label id="lab_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss_documentation_en-US" xlink:label="lab_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of discount rate above rate actually used would not cause impairment loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss" xlink:href="sny-20221231.xsd#sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss" xlink:to="lab_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NotionalAmount_da0e16c7-8085-4a45-b4e1-96e303242066_terseLabel_en-US" xlink:label="lab_ifrs-full_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facilities, amount drawable</link:label>
    <link:label id="lab_ifrs-full_NotionalAmount_6c22ac8e-05f2-4cd6-9e13-840d9fe77a38_verboseLabel_en-US" xlink:label="lab_ifrs-full_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount</link:label>
    <link:label id="lab_ifrs-full_NotionalAmount_d6f32e68-f750-4b48-8a7a-f42b68c830c8_netLabel_en-US" xlink:label="lab_ifrs-full_NotionalAmount" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of forward sales</link:label>
    <link:label id="lab_ifrs-full_NotionalAmount_label_en-US" xlink:label="lab_ifrs-full_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotionalAmount" xlink:to="lab_ifrs-full_NotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockSubscriptionOptionPlanThreeMember_4f19ed60-1c53-45cd-9564-85f4a7757bff_terseLabel_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan three</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanThreeMember_label_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Subscription Option Plan Three [Member]</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanThreeMember_documentation_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan three.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanThreeMember" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockSubscriptionOptionPlanThreeMember" xlink:to="lab_sny_StockSubscriptionOptionPlanThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfAdministrativeProceedings_af3c8d66-7538-4fde-abe7-a68454769bd3_terseLabel_en-US" xlink:label="lab_sny_NumberOfAdministrativeProceedings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of administrative proceedings</link:label>
    <link:label id="lab_sny_NumberOfAdministrativeProceedings_label_en-US" xlink:label="lab_sny_NumberOfAdministrativeProceedings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Administrative Proceedings</link:label>
    <link:label id="lab_sny_NumberOfAdministrativeProceedings_documentation_en-US" xlink:label="lab_sny_NumberOfAdministrativeProceedings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Administrative Proceedings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfAdministrativeProceedings" xlink:href="sny-20221231.xsd#sny_NumberOfAdministrativeProceedings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfAdministrativeProceedings" xlink:to="lab_sny_NumberOfAdministrativeProceedings" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrencySwapsInUSDToEURMember_cd7d4147-2da9-4bcd-9490-889b0d279c45_terseLabel_en-US" xlink:label="lab_sny_CurrencySwapsInUSDToEURMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency swaps in USD to EUR</link:label>
    <link:label id="lab_sny_CurrencySwapsInUSDToEURMember_label_en-US" xlink:label="lab_sny_CurrencySwapsInUSDToEURMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swaps In USD to EUR [Member]</link:label>
    <link:label id="lab_sny_CurrencySwapsInUSDToEURMember_documentation_en-US" xlink:label="lab_sny_CurrencySwapsInUSDToEURMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swaps In USD to EUR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencySwapsInUSDToEURMember" xlink:href="sny-20221231.xsd#sny_CurrencySwapsInUSDToEURMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrencySwapsInUSDToEURMember" xlink:to="lab_sny_CurrencySwapsInUSDToEURMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestUndiscountedCashFlow_cdb08198-2a4c-4a33-999f-397c64576c6b_terseLabel_en-US" xlink:label="lab_sny_InterestUndiscountedCashFlow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_sny_InterestUndiscountedCashFlow_label_en-US" xlink:label="lab_sny_InterestUndiscountedCashFlow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Undiscounted Cash Flow</link:label>
    <link:label id="lab_sny_InterestUndiscountedCashFlow_documentation_en-US" xlink:label="lab_sny_InterestUndiscountedCashFlow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest undiscounted cash flow.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestUndiscountedCashFlow" xlink:href="sny-20221231.xsd#sny_InterestUndiscountedCashFlow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestUndiscountedCashFlow" xlink:to="lab_sny_InterestUndiscountedCashFlow" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5894363e-aef9-49cf-b9bd-ed288b24804c_terseLabel_en-US" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</link:label>
    <link:label id="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_label_en-US" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_March2018EMTNISINFR0013324340Member_d5fa02ba-207c-4328-8ad2-97d6e4393a3c_terseLabel_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324340Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR0013324340</link:label>
    <link:label id="lab_sny_March2018EMTNISINFR0013324340Member_label_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324340Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR0013324340 [Member]</link:label>
    <link:label id="lab_sny_March2018EMTNISINFR0013324340Member_documentation_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324340Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR 0013324340.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324340Member" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324340Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_March2018EMTNISINFR0013324340Member" xlink:to="lab_sny_March2018EMTNISINFR0013324340Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageContributedToFairValueOfPlanAssets_96979459-06ac-4347-9ba4-5ffc5e8d6722_totalLabel_en-US" xlink:label="lab_sny_PercentageContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_sny_PercentageContributedToFairValueOfPlanAssets_label_en-US" xlink:label="lab_sny_PercentageContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Contributed To Fair Value Of Plan Assets</link:label>
    <link:label id="lab_sny_PercentageContributedToFairValueOfPlanAssets_documentation_en-US" xlink:label="lab_sny_PercentageContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage contributed to fair value of plan assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssets" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageContributedToFairValueOfPlanAssets" xlink:to="lab_sny_PercentageContributedToFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageIncreaseInFairValueLiabilities_ccbe0ca3-6e89-489c-bf01-b2dcb4861cc2_terseLabel_en-US" xlink:label="lab_sny_PercentageIncreaseInFairValueLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in fair value of liability</link:label>
    <link:label id="lab_sny_PercentageIncreaseInFairValueLiabilities_label_en-US" xlink:label="lab_sny_PercentageIncreaseInFairValueLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Increase In Fair Value Liabilities</link:label>
    <link:label id="lab_sny_PercentageIncreaseInFairValueLiabilities_documentation_en-US" xlink:label="lab_sny_PercentageIncreaseInFairValueLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage increase in fair value liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageIncreaseInFairValueLiabilities" xlink:href="sny-20221231.xsd#sny_PercentageIncreaseInFairValueLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageIncreaseInFairValueLiabilities" xlink:to="lab_sny_PercentageIncreaseInFairValueLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForSharebasedPayments_d3e9be01-07ed-4ff3-b169-61a767fcd4e3_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of employee benefits (stock options and other share-based payments)</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForSharebasedPayments_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for share-based payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_172a1971-19ef-408d-8a10-76262a3f06d8_terseLabel_en-US" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments accounted for using the equity method</link:label>
    <link:label id="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinanceIncome_6d02cc33-68af-4af9-b554-2b5a27b4f459_verboseLabel_en-US" xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial income</link:label>
    <link:label id="lab_ifrs-full_FinanceIncome_907992bf-f4e5-44c8-99a0-2b454db2211c_terseLabel_en-US" xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">comprising: financial income</link:label>
    <link:label id="lab_ifrs-full_FinanceIncome_label_en-US" xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome" xlink:to="lab_ifrs-full_FinanceIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_43e7ad9e-395d-4e26-8b3b-c4e730e23f64_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">From&#160;1&#160;to 3&#160;years</link:label>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than one year and not later than three years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PlanAssetsAtFairValue_664d4eae-c417-415c-ac61-0485ace248ca_terseLabel_en-US" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_ifrs-full_PlanAssetsAtFairValue_label_en-US" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets, at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlanAssetsAtFairValue" xlink:to="lab_ifrs-full_PlanAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_4828b7bc-c90d-440d-b05d-2454d12281b9_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management of capital</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for issued capital [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DefendantAxis_990e8234-9c12-4c26-87f6-761675423a14_terseLabel_en-US" xlink:label="lab_sny_DefendantAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defendant [Axis]</link:label>
    <link:label id="lab_sny_DefendantAxis_label_en-US" xlink:label="lab_sny_DefendantAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defendant [Axis]</link:label>
    <link:label id="lab_sny_DefendantAxis_documentation_en-US" xlink:label="lab_sny_DefendantAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defendant [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefendantAxis" xlink:href="sny-20221231.xsd#sny_DefendantAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DefendantAxis" xlink:to="lab_sny_DefendantAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AmountOfSharesRepurchased_7787ca63-2463-4f20-af82-d33d4d944d98_terseLabel_en-US" xlink:label="lab_sny_AmountOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value</link:label>
    <link:label id="lab_sny_AmountOfSharesRepurchased_label_en-US" xlink:label="lab_sny_AmountOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Of Shares Repurchased</link:label>
    <link:label id="lab_sny_AmountOfSharesRepurchased_documentation_en-US" xlink:label="lab_sny_AmountOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of shares repurchased.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmountOfSharesRepurchased" xlink:href="sny-20221231.xsd#sny_AmountOfSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmountOfSharesRepurchased" xlink:to="lab_sny_AmountOfSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns_0b954962-0c94-49cf-9d84-25301465a6c5_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Net Exchange Differences Provisions For Discounts Rebates And Sales Returns</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" xlink:to="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfCashFlowsAbstract_9c305c7d-a1b0-4e47-9ac7-343c0abe7da4_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of cash flows [abstract]</link:label>
    <link:label id="lab_ifrs-full_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of cash flows [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiMatureIPMember_49d8102a-76ed-4f23-8a1b-3359eb38f76a_terseLabel_en-US" xlink:label="lab_sny_SanofiMatureIPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Mature IP</link:label>
    <link:label id="lab_sny_SanofiMatureIPMember_label_en-US" xlink:label="lab_sny_SanofiMatureIPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Mature IP [Member]</link:label>
    <link:label id="lab_sny_SanofiMatureIPMember_documentation_en-US" xlink:label="lab_sny_SanofiMatureIPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Mature IP [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiMatureIPMember" xlink:href="sny-20221231.xsd#sny_SanofiMatureIPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiMatureIPMember" xlink:to="lab_sny_SanofiMatureIPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfPatentsAllegedlyInfringed_2e026a0c-19b5-48d7-8b63-7b9b6634774d_terseLabel_en-US" xlink:label="lab_sny_NumberOfPatentsAllegedlyInfringed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents allegedly infringed</link:label>
    <link:label id="lab_sny_NumberOfPatentsAllegedlyInfringed_label_en-US" xlink:label="lab_sny_NumberOfPatentsAllegedlyInfringed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Patents Allegedly Infringed</link:label>
    <link:label id="lab_sny_NumberOfPatentsAllegedlyInfringed_documentation_en-US" xlink:label="lab_sny_NumberOfPatentsAllegedlyInfringed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents allegedly infringed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPatentsAllegedlyInfringed" xlink:href="sny-20221231.xsd#sny_NumberOfPatentsAllegedlyInfringed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfPatentsAllegedlyInfringed" xlink:to="lab_sny_NumberOfPatentsAllegedlyInfringed" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DerivativeInstrumentAxis_9908a487-518b-47b9-b812-f816e3465596_terseLabel_en-US" xlink:label="lab_sny_DerivativeInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_sny_DerivativeInstrumentAxis_label_en-US" xlink:label="lab_sny_DerivativeInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_sny_DerivativeInstrumentAxis_documentation_en-US" xlink:label="lab_sny_DerivativeInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeInstrumentAxis" xlink:href="sny-20221231.xsd#sny_DerivativeInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerivativeInstrumentAxis" xlink:to="lab_sny_DerivativeInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MSPVaccineCompanyMember_0efead92-aa5f-47e7-8ba8-644e899dadf2_terseLabel_en-US" xlink:label="lab_sny_MSPVaccineCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MSP Vaccine Company (formerly MCM company)</link:label>
    <link:label id="lab_sny_MSPVaccineCompanyMember_label_en-US" xlink:label="lab_sny_MSPVaccineCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MSP Vaccine Company [Member]</link:label>
    <link:label id="lab_sny_MSPVaccineCompanyMember_documentation_en-US" xlink:label="lab_sny_MSPVaccineCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MSP Vaccine Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSPVaccineCompanyMember" xlink:href="sny-20221231.xsd#sny_MSPVaccineCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MSPVaccineCompanyMember" xlink:to="lab_sny_MSPVaccineCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiProdutosFarmaceuticosLdaMember_2bfbce9c-14c1-4f74-b9cf-9fd2d393afde_terseLabel_en-US" xlink:label="lab_sny_SanofiProdutosFarmaceuticosLdaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Produtos Farmaceuticos Lda</link:label>
    <link:label id="lab_sny_SanofiProdutosFarmaceuticosLdaMember_label_en-US" xlink:label="lab_sny_SanofiProdutosFarmaceuticosLdaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Produtos Farmaceuticos Lda [member]</link:label>
    <link:label id="lab_sny_SanofiProdutosFarmaceuticosLdaMember_documentation_en-US" xlink:label="lab_sny_SanofiProdutosFarmaceuticosLdaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Produtos Farmaceuticos Lda.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiProdutosFarmaceuticosLdaMember" xlink:href="sny-20221231.xsd#sny_SanofiProdutosFarmaceuticosLdaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiProdutosFarmaceuticosLdaMember" xlink:to="lab_sny_SanofiProdutosFarmaceuticosLdaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised_3f630ebe-f9ff-4516-a01f-c480938a068d_terseLabel_en-US" xlink:label="lab_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capital losses for which no deferred tax asset recognised</link:label>
    <link:label id="lab_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised_label_en-US" xlink:label="lab_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused Capital Losses For Which No Deferred Tax Asset Recognised</link:label>
    <link:label id="lab_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised_documentation_en-US" xlink:label="lab_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused Capital Losses For Which No Deferred Tax Asset Recognised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised" xlink:href="sny-20221231.xsd#sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised" xlink:to="lab_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories_cf105403-121b-4aa7-a9fe-bfe423b96886_terseLabel_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges, gains or losses on assets</link:label>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories_label_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Of Restructuring Activities, Related To Property Plant And Equipment And To Inventories</link:label>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories_documentation_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense of restructuring activities related to property plant and equipment to inventories.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xlink:to="lab_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_7aab862f-4562-476f-bfc3-04cd70443a18_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of subsidiaries [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of subsidiaries [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_HealthcareCoverAndLifeInsuranceMember_b52df035-92c7-4f97-853b-40484134d3f1_terseLabel_en-US" xlink:label="lab_sny_HealthcareCoverAndLifeInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Cover And Life Insurance</link:label>
    <link:label id="lab_sny_HealthcareCoverAndLifeInsuranceMember_label_en-US" xlink:label="lab_sny_HealthcareCoverAndLifeInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Cover And Life Insurance [Member]</link:label>
    <link:label id="lab_sny_HealthcareCoverAndLifeInsuranceMember_documentation_en-US" xlink:label="lab_sny_HealthcareCoverAndLifeInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Cover And Life Insurance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HealthcareCoverAndLifeInsuranceMember" xlink:href="sny-20221231.xsd#sny_HealthcareCoverAndLifeInsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_HealthcareCoverAndLifeInsuranceMember" xlink:to="lab_sny_HealthcareCoverAndLifeInsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfNoncurrentProvisionsLineItems_da640452-fb33-4265-b29e-77f1a00ba26d_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfNoncurrentProvisionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Non-current Provisions [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfNoncurrentProvisionsLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfNoncurrentProvisionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Noncurrent Provisions [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfNoncurrentProvisionsLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfNoncurrentProvisionsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Non-current Provisions [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNoncurrentProvisionsLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfNoncurrentProvisionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNoncurrentProvisionsLineItems" xlink:to="lab_sny_DisclosureOfNoncurrentProvisionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_22de5c9a-4a53-480c-aa81-3080bac1680d_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories of Related Parties [Axis]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories of related parties [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InfraservHoechstRetainedLiabilitiesMember_24f2ea64-2232-436f-8448-0509d07184ab_terseLabel_en-US" xlink:label="lab_sny_InfraservHoechstRetainedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infraserv Hoechst retained liabilities</link:label>
    <link:label id="lab_sny_InfraservHoechstRetainedLiabilitiesMember_label_en-US" xlink:label="lab_sny_InfraservHoechstRetainedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infraserv Hoechst Retained Liabilities [member]</link:label>
    <link:label id="lab_sny_InfraservHoechstRetainedLiabilitiesMember_documentation_en-US" xlink:label="lab_sny_InfraservHoechstRetainedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infraserv Hoechst retained liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InfraservHoechstRetainedLiabilitiesMember" xlink:href="sny-20221231.xsd#sny_InfraservHoechstRetainedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InfraservHoechstRetainedLiabilitiesMember" xlink:to="lab_sny_InfraservHoechstRetainedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfTradeReceivablesTextBlock_5970fac3-d3f9-470a-979a-bb0fc6093edb_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfTradeReceivablesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_sny_DisclosureOfTradeReceivablesTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfTradeReceivablesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Trade Receivables [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfTradeReceivablesTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfTradeReceivablesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of trade receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfTradeReceivablesTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfTradeReceivablesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfTradeReceivablesTextBlock" xlink:to="lab_sny_DisclosureOfTradeReceivablesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_7c8c3364-24cc-4d1c-b77d-59f4c4af5c28_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">From&#160;3&#160;to 5&#160;years</link:label>
    <link:label id="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than three years and not later than five years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyTable_52f0595f-6333-4d52-9eb0-3104b783a368_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt By Currency [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyTable_label_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt By Currency [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt By Currency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByCurrencyTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByCurrencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtByCurrencyTable" xlink:to="lab_sny_DisclosureOfDebtByCurrencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurLtdMember_6a04c672-f4a2-4378-95a6-221521c0752b_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Ltd</link:label>
    <link:label id="lab_sny_SanofiPasteurLtdMember_label_en-US" xlink:label="lab_sny_SanofiPasteurLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiPasteurLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiPasteurLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Ltd [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiPasteurLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurLtdMember" xlink:to="lab_sny_SanofiPasteurLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisUSLLCMember_99d01dee-14a3-42d6-a293-d1bef9c51f8b_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisUSLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis U.S. LLC</link:label>
    <link:label id="lab_sny_SanofiAventisUSLLCMember_label_en-US" xlink:label="lab_sny_SanofiAventisUSLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis US LLC [member]</link:label>
    <link:label id="lab_sny_SanofiAventisUSLLCMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisUSLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis US LLC.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisUSLLCMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisUSLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisUSLLCMember" xlink:to="lab_sny_SanofiAventisUSLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_236870ab-5001-4204-b943-910a70f530e4_terseLabel_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</link:label>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_label_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageShares_55f88c56-af91-4882-a0b4-1dbe90c9e71b_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average number of shares outstanding (in shares)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageShares_d7cc4e24-76e4-4c6d-8c15-6b738eaafb02_verboseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average number of shares outstanding (in shares)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageShares_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares used in calculating basic earnings per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares" xlink:to="lab_ifrs-full_WeightedAverageShares" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DepakineProductLitigationInSwitzerlandMember_ed953e4e-0f2f-415a-8ec2-27047286fbac_terseLabel_en-US" xlink:label="lab_sny_DepakineProductLitigationInSwitzerlandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine product litigation in Switzerland</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInSwitzerlandMember_label_en-US" xlink:label="lab_sny_DepakineProductLitigationInSwitzerlandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Switzerland [Member]</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInSwitzerlandMember_documentation_en-US" xlink:label="lab_sny_DepakineProductLitigationInSwitzerlandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Switzerland</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInSwitzerlandMember" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInSwitzerlandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DepakineProductLitigationInSwitzerlandMember" xlink:to="lab_sny_DepakineProductLitigationInSwitzerlandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfShareSubscribed_aab61c83-6883-424d-9ac4-a0dbd5513936_terseLabel_en-US" xlink:label="lab_sny_NumberOfShareSubscribed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares subscribed (in shares)</link:label>
    <link:label id="lab_sny_NumberOfShareSubscribed_label_en-US" xlink:label="lab_sny_NumberOfShareSubscribed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Share Subscribed</link:label>
    <link:label id="lab_sny_NumberOfShareSubscribed_documentation_en-US" xlink:label="lab_sny_NumberOfShareSubscribed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares subscribed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareSubscribed" xlink:href="sny-20221231.xsd#sny_NumberOfShareSubscribed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfShareSubscribed" xlink:to="lab_sny_NumberOfShareSubscribed" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShelfRegistrationStatementProgramMember_a0e0681c-bfa6-4ea2-badc-90f1d4167a8b_terseLabel_en-US" xlink:label="lab_sny_ShelfRegistrationStatementProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shelf registration statement program</link:label>
    <link:label id="lab_sny_ShelfRegistrationStatementProgramMember_label_en-US" xlink:label="lab_sny_ShelfRegistrationStatementProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shelf Registration Statement Program [Member]</link:label>
    <link:label id="lab_sny_ShelfRegistrationStatementProgramMember_documentation_en-US" xlink:label="lab_sny_ShelfRegistrationStatementProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shelf registration statement program.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShelfRegistrationStatementProgramMember" xlink:href="sny-20221231.xsd#sny_ShelfRegistrationStatementProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShelfRegistrationStatementProgramMember" xlink:to="lab_sny_ShelfRegistrationStatementProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AuditorsNameMember_e782c694-9252-4306-8283-ad9a4a47b3bc_terseLabel_en-US" xlink:label="lab_sny_AuditorsNameMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditors Name [Member]</link:label>
    <link:label id="lab_sny_AuditorsNameMember_label_en-US" xlink:label="lab_sny_AuditorsNameMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditors Name [Member]</link:label>
    <link:label id="lab_sny_AuditorsNameMember_documentation_en-US" xlink:label="lab_sny_AuditorsNameMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditors Name [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsNameMember" xlink:href="sny-20221231.xsd#sny_AuditorsNameMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AuditorsNameMember" xlink:to="lab_sny_AuditorsNameMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo_6fafe596-d482-44fe-9d67-06db27d2be79_terseLabel_en-US" xlink:label="lab_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of damages sought by Australian Department of Health related to the Apotex preliminary injunction, up to</link:label>
    <link:label id="lab_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo_label_en-US" xlink:label="lab_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Damages Sought By Australian Department Of Health Related To The Apotex Preliminary Injunction Up To</link:label>
    <link:label id="lab_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo_documentation_en-US" xlink:label="lab_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of damages sought by australian department of health related to the apotex preliminary injunction up to.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo" xlink:href="sny-20221231.xsd#sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo" xlink:to="lab_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_c5893307-e35a-4cce-8bd4-9956e5799929_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_f1be8a6c-18ee-4a0d-b706-87936dba37fc_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and impairment of intangible assets</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for intangible assets and goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees_292c6dff-93f9-4c35-87c3-2b6c5f9e7567_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of services obtained from employees</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Share-Based Payment Plans Value Of Services Obtained From Employees</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of services obtained from employees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xlink:to="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution_4bfa17c8-bfad-4334-a979-906a39ea93af_terseLabel_en-US" xlink:label="lab_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense recognized of which employers' contribution</link:label>
    <link:label id="lab_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution_label_en-US" xlink:label="lab_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense From Equity-Settled Share-Based Payment Transactions Of Which Goods Or Services Received Did Not Qualify For Recognition As Assets Employer Contribution</link:label>
    <link:label id="lab_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution_documentation_en-US" xlink:label="lab_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense recognized in equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution" xlink:href="sny-20221231.xsd#sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution" xlink:to="lab_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SalesOfAntibodiesSecondAchievementMember_af3ac833-b7b8-4144-a0fc-82c7eacc69a5_terseLabel_en-US" xlink:label="lab_sny_SalesOfAntibodiesSecondAchievementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of antibodies, second achievement</link:label>
    <link:label id="lab_sny_SalesOfAntibodiesSecondAchievementMember_label_en-US" xlink:label="lab_sny_SalesOfAntibodiesSecondAchievementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Of Antibodies, Second Achievement [Member]</link:label>
    <link:label id="lab_sny_SalesOfAntibodiesSecondAchievementMember_documentation_en-US" xlink:label="lab_sny_SalesOfAntibodiesSecondAchievementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Of Antibodies, Second Achievement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesOfAntibodiesSecondAchievementMember" xlink:href="sny-20221231.xsd#sny_SalesOfAntibodiesSecondAchievementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SalesOfAntibodiesSecondAchievementMember" xlink:to="lab_sny_SalesOfAntibodiesSecondAchievementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockSubscriptionOptionPlanEightMember_31686af7-3ee0-459e-aeb2-8db1a7981c49_terseLabel_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan eight</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanEightMember_label_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Subscription Option Plan Eight [Member]</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanEightMember_documentation_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan eight.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanEightMember" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockSubscriptionOptionPlanEightMember" xlink:to="lab_sny_StockSubscriptionOptionPlanEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions_3d246d9a-9efd-4040-a69a-7385abe05e65_terseLabel_en-US" xlink:label="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable and other receivables</link:label>
    <link:label id="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions_label_en-US" xlink:label="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts receivable, related party transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:to="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExscientiaMember_c79f9d34-3635-4421-a291-cbf27f4caa16_terseLabel_en-US" xlink:label="lab_sny_ExscientiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exscientia</link:label>
    <link:label id="lab_sny_ExscientiaMember_label_en-US" xlink:label="lab_sny_ExscientiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exscientia [Member]</link:label>
    <link:label id="lab_sny_ExscientiaMember_documentation_en-US" xlink:label="lab_sny_ExscientiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exscientia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExscientiaMember" xlink:href="sny-20221231.xsd#sny_ExscientiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExscientiaMember" xlink:to="lab_sny_ExscientiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AfterTaxDiscountRates_ea534233-804c-42c8-bdf7-95b9bcd61e59_terseLabel_en-US" xlink:label="lab_sny_AfterTaxDiscountRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After tax discount rates</link:label>
    <link:label id="lab_sny_AfterTaxDiscountRates_label_en-US" xlink:label="lab_sny_AfterTaxDiscountRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After Tax Discount Rates</link:label>
    <link:label id="lab_sny_AfterTaxDiscountRates_documentation_en-US" xlink:label="lab_sny_AfterTaxDiscountRates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After tax discount rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AfterTaxDiscountRates" xlink:href="sny-20221231.xsd#sny_AfterTaxDiscountRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AfterTaxDiscountRates" xlink:to="lab_sny_AfterTaxDiscountRates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CostOfSales_d8be7285-3fce-4cb8-94d0-1079241b757f_negatedLabel_en-US" xlink:label="lab_ifrs-full_CostOfSales" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_ifrs-full_CostOfSales_dd15a5d5-aeb3-4e6a-8ec9-1c292b5c1bc9_terseLabel_en-US" xlink:label="lab_ifrs-full_CostOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_ifrs-full_CostOfSales_label_en-US" xlink:label="lab_ifrs-full_CostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales" xlink:to="lab_ifrs-full_CostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MaximumPlan2Member_36483f12-bc5f-476c-beaa-3bb501a85e9f_terseLabel_en-US" xlink:label="lab_sny_MaximumPlan2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum plan 2</link:label>
    <link:label id="lab_sny_MaximumPlan2Member_label_en-US" xlink:label="lab_sny_MaximumPlan2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Plan 2 [Member]</link:label>
    <link:label id="lab_sny_MaximumPlan2Member_documentation_en-US" xlink:label="lab_sny_MaximumPlan2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Plan 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumPlan2Member" xlink:href="sny-20221231.xsd#sny_MaximumPlan2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MaximumPlan2Member" xlink:to="lab_sny_MaximumPlan2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AdageneIncMember_60cb6efa-65a0-46cd-b601-57c4929f510f_terseLabel_en-US" xlink:label="lab_sny_AdageneIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adagene, Inc</link:label>
    <link:label id="lab_sny_AdageneIncMember_label_en-US" xlink:label="lab_sny_AdageneIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adagene, Inc [Member]</link:label>
    <link:label id="lab_sny_AdageneIncMember_documentation_en-US" xlink:label="lab_sny_AdageneIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adagene, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdageneIncMember" xlink:href="sny-20221231.xsd#sny_AdageneIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AdageneIncMember" xlink:to="lab_sny_AdageneIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnusedTaxLossesMember_1b38b2bd-9772-4722-bb93-220f0602b505_terseLabel_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax losses available for carry-forward</link:label>
    <link:label id="lab_ifrs-full_UnusedTaxLossesMember_label_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused tax losses [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnusedTaxLossesMember" xlink:to="lab_ifrs-full_UnusedTaxLossesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_8cb1e769-e7de-4eca-8872-01ea2c3a96fa_terseLabel_en-US" xlink:label="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wholly or partly funded defined benefit plans</link:label>
    <link:label id="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_label_en-US" xlink:label="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wholly or partly funded defined benefit plans [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:to="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_e007b416-ff7c-43ed-8052-e5b9d62c9898_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of impairment loss and reversal of impairment loss [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of impairment loss and reversal of impairment loss [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems" xlink:to="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComponentsOfEquityAxis_3917f67a-8334-483a-a438-4a1b8a39e643_terseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of equity [axis]</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfEquityAxis_label_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of equity [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_ff8df32f-2fd6-4a09-8c63-8bf2a4ed30a6_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of reconciliation of carrying amount to value on redemption [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of reconciliation of carrying amount to value on redemption.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:to="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_06ce78d6-11d1-4249-9b95-b5607024bc71_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for income tax [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_31f08a12-745b-4bf0-aabc-850e42e0da91_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of associates [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of associates [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ContingentConsiderationRelatingToDivestmentsMember_db687327-ec51-47be-94bb-1a61ac949f04_terseLabel_en-US" xlink:label="lab_sny_ContingentConsiderationRelatingToDivestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration relating to divestments</link:label>
    <link:label id="lab_sny_ContingentConsiderationRelatingToDivestmentsMember_label_en-US" xlink:label="lab_sny_ContingentConsiderationRelatingToDivestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Relating To Divestments [Member]</link:label>
    <link:label id="lab_sny_ContingentConsiderationRelatingToDivestmentsMember_documentation_en-US" xlink:label="lab_sny_ContingentConsiderationRelatingToDivestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration relating to divestments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationRelatingToDivestmentsMember" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationRelatingToDivestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ContingentConsiderationRelatingToDivestmentsMember" xlink:to="lab_sny_ContingentConsiderationRelatingToDivestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_4c0e954e-e9a5-4aa1-a0ac-4ad3ad177bf7_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of nature of non-adjusting event after reporting period</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_42d358f2-0e57-47d2-8b94-ad9ddd725703_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of non-controlling interests [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PotentialPaymentsRelatedToPercentageOfSales_6ed1fcfb-11f1-464b-82e9-da1aad828d26_terseLabel_en-US" xlink:label="lab_sny_PotentialPaymentsRelatedToPercentageOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentiel payments related to percentage of sales of alemtuzumab</link:label>
    <link:label id="lab_sny_PotentialPaymentsRelatedToPercentageOfSales_label_en-US" xlink:label="lab_sny_PotentialPaymentsRelatedToPercentageOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Payments Related To Percentage Of Sales</link:label>
    <link:label id="lab_sny_PotentialPaymentsRelatedToPercentageOfSales_documentation_en-US" xlink:label="lab_sny_PotentialPaymentsRelatedToPercentageOfSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentiel payments related to percentage of sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PotentialPaymentsRelatedToPercentageOfSales" xlink:href="sny-20221231.xsd#sny_PotentialPaymentsRelatedToPercentageOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PotentialPaymentsRelatedToPercentageOfSales" xlink:to="lab_sny_PotentialPaymentsRelatedToPercentageOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_April2016EMTNISINFR0013143997Member_ffd29a26-cc65-47c1-8faf-f7817633cd34_terseLabel_en-US" xlink:label="lab_sny_April2016EMTNISINFR0013143997Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2016 EMTN ISIN FR0013143997</link:label>
    <link:label id="lab_sny_April2016EMTNISINFR0013143997Member_label_en-US" xlink:label="lab_sny_April2016EMTNISINFR0013143997Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2016 EMTNISINFR0013143997 [Member]</link:label>
    <link:label id="lab_sny_April2016EMTNISINFR0013143997Member_documentation_en-US" xlink:label="lab_sny_April2016EMTNISINFR0013143997Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2016 EMTN ISIN FR0013143997.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2016EMTNISINFR0013143997Member" xlink:href="sny-20221231.xsd#sny_April2016EMTNISINFR0013143997Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_April2016EMTNISINFR0013143997Member" xlink:to="lab_sny_April2016EMTNISINFR0013143997Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_KymabMember_18c89832-0b25-4d37-a21c-07d24a4d4d2e_terseLabel_en-US" xlink:label="lab_sny_KymabMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kymab</link:label>
    <link:label id="lab_sny_KymabMember_label_en-US" xlink:label="lab_sny_KymabMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kymab [Member]</link:label>
    <link:label id="lab_sny_KymabMember_documentation_en-US" xlink:label="lab_sny_KymabMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kymab</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KymabMember" xlink:href="sny-20221231.xsd#sny_KymabMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_KymabMember" xlink:to="lab_sny_KymabMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_f6069751-ff6a-440f-81ff-0c7326fa2655_terseLabel_en-US" xlink:label="lab_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MSD contingent consideration (European vaccines business)</link:label>
    <link:label id="lab_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_label_en-US" xlink:label="lab_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MSD Contingent Consideration (European Vaccines Business) [Member]</link:label>
    <link:label id="lab_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_documentation_en-US" xlink:label="lab_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MSD contingent consideration European vaccines business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xlink:href="sny-20221231.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xlink:to="lab_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PensionObligationPercentageToPlanAssets_f1d12db0-4b7c-49f8-915f-77e5a43b273f_terseLabel_en-US" xlink:label="lab_sny_PensionObligationPercentageToPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension obligations, percentage to plan assets</link:label>
    <link:label id="lab_sny_PensionObligationPercentageToPlanAssets_label_en-US" xlink:label="lab_sny_PensionObligationPercentageToPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Obligation, Percentage To Plan Assets</link:label>
    <link:label id="lab_sny_PensionObligationPercentageToPlanAssets_documentation_en-US" xlink:label="lab_sny_PensionObligationPercentageToPlanAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension obligation percentage to plan assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionObligationPercentageToPlanAssets" xlink:href="sny-20221231.xsd#sny_PensionObligationPercentageToPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PensionObligationPercentageToPlanAssets" xlink:to="lab_sny_PensionObligationPercentageToPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment_8ef89093-8baf-4176-8d76-bc736982dbbc_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other changes in non-controlling interests</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Changes In Non-controlling Interests Arising From Divestment</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease through changes in non-controlling interests arising from divestment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment" xlink:to="lab_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_e6cb1b94-6225-4360-93b2-838691983eaf_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Principal Companies and their Country of Incorporation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of interests in subsidiaries [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GenfarSAMember_2124efb6-3228-4b60-9297-e90998b0c4c5_terseLabel_en-US" xlink:label="lab_sny_GenfarSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genfar S.A.</link:label>
    <link:label id="lab_sny_GenfarSAMember_label_en-US" xlink:label="lab_sny_GenfarSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genfar S A [Member]</link:label>
    <link:label id="lab_sny_GenfarSAMember_documentation_en-US" xlink:label="lab_sny_GenfarSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genfar S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenfarSAMember" xlink:href="sny-20221231.xsd#sny_GenfarSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GenfarSAMember" xlink:to="lab_sny_GenfarSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxLiabilitiesNoncurrent_7db1bce1-1dd0-4543-94df-f63644ce153a_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current income tax liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxLiabilitiesNoncurrent_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax liabilities, non-current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent" xlink:to="lab_ifrs-full_CurrentTaxLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_3181f841-021a-4101-b470-7200de0c5980_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets other than goodwill</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets other than goodwill [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RebatesAndDiscountsMember_3968c117-a888-4d99-9062-5895118f343b_terseLabel_en-US" xlink:label="lab_sny_RebatesAndDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates and discounts</link:label>
    <link:label id="lab_sny_RebatesAndDiscountsMember_label_en-US" xlink:label="lab_sny_RebatesAndDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates And Discounts [Member]</link:label>
    <link:label id="lab_sny_RebatesAndDiscountsMember_documentation_en-US" xlink:label="lab_sny_RebatesAndDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates and discounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RebatesAndDiscountsMember" xlink:href="sny-20221231.xsd#sny_RebatesAndDiscountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RebatesAndDiscountsMember" xlink:to="lab_sny_RebatesAndDiscountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_a37e5bc8-09e3-4901-a0fd-791632ebba5c_terseLabel_en-US" xlink:label="lab_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense recognized directly in profit or loss</link:label>
    <link:label id="lab_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_b4de88f3-b1c0-470b-ac75-34ef30f17b56_verboseLabel_en-US" xlink:label="lab_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense/(gain) recognized directly in profit or loss</link:label>
    <link:label id="lab_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_label_en-US" xlink:label="lab_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Expense For Pensions And Other Post-employment Benefits Recognized Directly In Profit Or Loss</link:label>
    <link:label id="lab_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_documentation_en-US" xlink:label="lab_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expense for pensions and other post-employment benefits recognized directly in profit or loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:href="sny-20221231.xsd#sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:to="lab_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_a426f4eb-664c-478a-b17f-09322c983351_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale or exchange and liabilities related to assets held for sale or exchange</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of non-current assets or disposal groups classified as held for sale [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DepakineProductLitigationInFranceMember_8247f9b6-6a5c-446e-90da-a2bc487d335a_terseLabel_en-US" xlink:label="lab_sny_DepakineProductLitigationInFranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine product litigation In France</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInFranceMember_label_en-US" xlink:label="lab_sny_DepakineProductLitigationInFranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In France [Member]</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInFranceMember_documentation_en-US" xlink:label="lab_sny_DepakineProductLitigationInFranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In France</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInFranceMember" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInFranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DepakineProductLitigationInFranceMember" xlink:to="lab_sny_DepakineProductLitigationInFranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember_41ec3a4d-ac95-4de5-950d-d76dd2dc7579_terseLabel_en-US" xlink:label="lab_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Nine</link:label>
    <link:label id="lab_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember_label_en-US" xlink:label="lab_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Nine [Member]</link:label>
    <link:label id="lab_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember_documentation_en-US" xlink:label="lab_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Nine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember" xlink:href="sny-20221231.xsd#sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember" xlink:to="lab_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock_4a4fb4f5-fec1-4d8a-9948-06ae247272aa_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of Net Defined-benefit (Asset)/Liability (Actuarial Gains and Losses)</link:label>
    <link:label id="lab_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Remeasurement Of Net Defined Benefit Liability Asset By Country [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of remeasuresment of net defined benefit liability asset by country.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock" xlink:to="lab_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_fff12768-336c-4b02-ad34-4de7e643d4e8_terseLabel_en-US" xlink:label="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank credit balances</link:label>
    <link:label id="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank overdrafts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:to="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AtomwiseMember_c36fb002-11d9-416e-80ab-088324c21960_terseLabel_en-US" xlink:label="lab_sny_AtomwiseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Atomwise</link:label>
    <link:label id="lab_sny_AtomwiseMember_label_en-US" xlink:label="lab_sny_AtomwiseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Atomwise [Member]</link:label>
    <link:label id="lab_sny_AtomwiseMember_documentation_en-US" xlink:label="lab_sny_AtomwiseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Atomwise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtomwiseMember" xlink:href="sny-20221231.xsd#sny_AtomwiseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AtomwiseMember" xlink:to="lab_sny_AtomwiseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalMarketedProductsChattemMember_d4794742-d7a9-4deb-b1a8-127249853b22_terseLabel_en-US" xlink:label="lab_sny_PrincipalMarketedProductsChattemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chattem</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsChattemMember_label_en-US" xlink:label="lab_sny_PrincipalMarketedProductsChattemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products Chattem [member]</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsChattemMember_documentation_en-US" xlink:label="lab_sny_PrincipalMarketedProductsChattemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal marketed products chattem.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsChattemMember" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsChattemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalMarketedProductsChattemMember" xlink:to="lab_sny_PrincipalMarketedProductsChattemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisSROMember_cb2a0424-2ade-4bfd-ab74-cf7910ac933b_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisSROMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis, s.r.o.</link:label>
    <link:label id="lab_sny_SanofiAventisSROMember_label_en-US" xlink:label="lab_sny_SanofiAventisSROMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis, S.R.O. [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisSROMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisSROMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis, s.r.o.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSROMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisSROMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisSROMember" xlink:to="lab_sny_SanofiAventisSROMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FairValueHedgesMember_6329c2e6-d01b-46fa-8d9e-b0d8dbed46c1_terseLabel_en-US" xlink:label="lab_ifrs-full_FairValueHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as fair value hedges</link:label>
    <link:label id="lab_ifrs-full_FairValueHedgesMember_label_en-US" xlink:label="lab_ifrs-full_FairValueHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value hedges [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FairValueHedgesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FairValueHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FairValueHedgesMember" xlink:to="lab_ifrs-full_FairValueHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_9da05ae9-4411-4dd9-957a-84c2cba4c550_negatedLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of consolidated undertakings and investments accounted for using the equity method</link:label>
    <link:label id="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_b82bc009-808e-4fb6-a576-7ff3acc4dfe7_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow on acquisition</link:label>
    <link:label id="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares_267e96ec-378e-4dbb-8139-350afa4c87c7_terseLabel_en-US" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value per share awarded for three year service period, additional shares (in euros per share)</link:label>
    <link:label id="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares_label_en-US" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Per Share Awarded For Three Year Service Period, Additional Shares</link:label>
    <link:label id="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares_documentation_en-US" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Per Share Awarded For Three Year Service Period, Additional Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" xlink:href="sny-20221231.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" xlink:to="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OverdueReceivablesGrossValue_ea7cecfc-8093-41dc-aad6-c6ab32907f7d_terseLabel_en-US" xlink:label="lab_sny_OverdueReceivablesGrossValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross value of overdue receivables</link:label>
    <link:label id="lab_sny_OverdueReceivablesGrossValue_1fdbe5df-7c9f-497d-8f8b-1c883d441c5e_verboseLabel_en-US" xlink:label="lab_sny_OverdueReceivablesGrossValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overdue receivables gross value</link:label>
    <link:label id="lab_sny_OverdueReceivablesGrossValue_label_en-US" xlink:label="lab_sny_OverdueReceivablesGrossValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overdue Receivables Gross Value</link:label>
    <link:label id="lab_sny_OverdueReceivablesGrossValue_documentation_en-US" xlink:label="lab_sny_OverdueReceivablesGrossValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overdue receivables gross value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OverdueReceivablesGrossValue" xlink:href="sny-20221231.xsd#sny_OverdueReceivablesGrossValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OverdueReceivablesGrossValue" xlink:to="lab_sny_OverdueReceivablesGrossValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_44425669-ba47-4579-9d12-814515a37494_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Characteristics of Restricted Share Plans</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForeignCurrencyTranslationMember_634ab0ce-1f84-42d9-a012-1fc53695d695_terseLabel_en-US" xlink:label="lab_sny_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_sny_ForeignCurrencyTranslationMember_label_en-US" xlink:label="lab_sny_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation [Member]</link:label>
    <link:label id="lab_sny_ForeignCurrencyTranslationMember_documentation_en-US" xlink:label="lab_sny_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForeignCurrencyTranslationMember" xlink:href="sny-20221231.xsd#sny_ForeignCurrencyTranslationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForeignCurrencyTranslationMember" xlink:to="lab_sny_ForeignCurrencyTranslationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement_8bfb12e0-e47d-4583-8379-efeb16cf7117_terseLabel_en-US" xlink:label="lab_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, options exercisable</link:label>
    <link:label id="lab_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Share Options Exercisable In Share Based Payment Arrangement</link:label>
    <link:label id="lab_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of share options exercisable in share based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" xlink:to="lab_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1e54fe2e-5009-4c8e-9b84-0e1052a034de_terseLabel_en-US" xlink:label="lab_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of share capital owned (in percent)</link:label>
    <link:label id="lab_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage Of Voting Interests Acquired</link:label>
    <link:label id="lab_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired_documentation_en-US" xlink:label="lab_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage Of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="sny-20221231.xsd#sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember_fe196c79-4abd-4c05-8d9c-4a1602ccd680_terseLabel_en-US" xlink:label="lab_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other contingent consideration arising from business combinations and acquisitions</link:label>
    <link:label id="lab_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember_label_en-US" xlink:label="lab_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contingent Consideration Arising From Business Combinations [Member]</link:label>
    <link:label id="lab_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember_documentation_en-US" xlink:label="lab_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other contingent consideration arising from business combinations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember" xlink:href="sny-20221231.xsd#sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember" xlink:to="lab_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ScribeTherapeuticsMember_6a53d2d6-86ba-4f28-89f2-b824770af282_terseLabel_en-US" xlink:label="lab_sny_ScribeTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scribe Therapeutics</link:label>
    <link:label id="lab_sny_ScribeTherapeuticsMember_label_en-US" xlink:label="lab_sny_ScribeTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scribe Therapeutics [Member]</link:label>
    <link:label id="lab_sny_ScribeTherapeuticsMember_documentation_en-US" xlink:label="lab_sny_ScribeTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scribe Therapeutics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ScribeTherapeuticsMember" xlink:href="sny-20221231.xsd#sny_ScribeTherapeuticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ScribeTherapeuticsMember" xlink:to="lab_sny_ScribeTherapeuticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfEmployees_5813ac68-8d5b-457d-a1a5-9e14743a1134_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of employees</link:label>
    <link:label id="lab_ifrs-full_NumberOfEmployees_label_en-US" xlink:label="lab_ifrs-full_NumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfEmployees" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfEmployees" xlink:to="lab_ifrs-full_NumberOfEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareInternationalSASMember_d7b33d77-a39d-44f0-8077-b89e3cd656c6_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareInternationalSASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare International SAS</link:label>
    <link:label id="lab_sny_OpellaHealthcareInternationalSASMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareInternationalSASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare International SAS [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareInternationalSASMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareInternationalSASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare International SAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareInternationalSASMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareInternationalSASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareInternationalSASMember" xlink:to="lab_sny_OpellaHealthcareInternationalSASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock_becea9db-354b-44d8-9d57-e8085418a106_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt</link:label>
    <link:label id="lab_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Maturity Analysis Of Future Undiscounted Cash Flows Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of maturity analysis of future undiscounted cash flows.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_e60cce14-6861-4059-9b64-ede4c02387ea_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_VaxServeIncMember_c714e51e-2747-4f84-94f4-65fdaa40b972_terseLabel_en-US" xlink:label="lab_sny_VaxServeIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VaxServe, Inc.</link:label>
    <link:label id="lab_sny_VaxServeIncMember_label_en-US" xlink:label="lab_sny_VaxServeIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VaxServe Inc [member]</link:label>
    <link:label id="lab_sny_VaxServeIncMember_documentation_en-US" xlink:label="lab_sny_VaxServeIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VaxServe, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaxServeIncMember" xlink:href="sny-20221231.xsd#sny_VaxServeIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_VaxServeIncMember" xlink:to="lab_sny_VaxServeIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SyndicatedCreditFacilityOneMember_53918fbd-bc76-4749-9338-f83c6d909a04_terseLabel_en-US" xlink:label="lab_sny_SyndicatedCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated credit facility, expires in 2022</link:label>
    <link:label id="lab_sny_SyndicatedCreditFacilityOneMember_label_en-US" xlink:label="lab_sny_SyndicatedCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated Credit Facility One [Member]</link:label>
    <link:label id="lab_sny_SyndicatedCreditFacilityOneMember_documentation_en-US" xlink:label="lab_sny_SyndicatedCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated credit facility one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SyndicatedCreditFacilityOneMember" xlink:href="sny-20221231.xsd#sny_SyndicatedCreditFacilityOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SyndicatedCreditFacilityOneMember" xlink:to="lab_sny_SyndicatedCreditFacilityOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_6e42aa0a-6500-41d1-b48f-9c8e2f68d127_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock_1a7ca6ee-48ee-42a0-957e-fe1dc9f89ec8_terseLabel_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of climate change</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock_label_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Accounting Policy For Effects Of Climate Change [Policy Text Block]</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock_documentation_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Accounting Policy For Effects Of Climate Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock" xlink:to="lab_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockSubscriptionOptionPlanSixMember_8390cbc4-9865-4232-9d12-fd53bc5934ea_terseLabel_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanSixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan six</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanSixMember_label_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanSixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Subscription Option Plan Six [Member]</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanSixMember_documentation_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanSixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan six.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanSixMember" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanSixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockSubscriptionOptionPlanSixMember" xlink:to="lab_sny_StockSubscriptionOptionPlanSixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PatentsMember_c550cb57-8f48-4705-9a5d-04fab1cc66c7_terseLabel_en-US" xlink:label="lab_sny_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_sny_PatentsMember_label_en-US" xlink:label="lab_sny_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_sny_PatentsMember_documentation_en-US" xlink:label="lab_sny_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PatentsMember" xlink:href="sny-20221231.xsd#sny_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PatentsMember" xlink:to="lab_sny_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_64f2f0f6-c83d-4f73-991d-6d34dbac3765_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashOutflowForLeases_f33dfefc-a382-4316-9b19-036f5ffd9793_terseLabel_en-US" xlink:label="lab_ifrs-full_CashOutflowForLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outflow for leases, excluding short-term leases</link:label>
    <link:label id="lab_ifrs-full_CashOutflowForLeases_label_en-US" xlink:label="lab_ifrs-full_CashOutflowForLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outflow for leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashOutflowForLeases" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashOutflowForLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases" xlink:to="lab_ifrs-full_CashOutflowForLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherEmployeeExpense_676ed548-6e52-4038-9600-98f05ba3e962_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherEmployeeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other employee benefits</link:label>
    <link:label id="lab_ifrs-full_OtherEmployeeExpense_label_en-US" xlink:label="lab_ifrs-full_OtherEmployeeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other employee expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherEmployeeExpense" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherEmployeeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherEmployeeExpense" xlink:to="lab_ifrs-full_OtherEmployeeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CashFlowAndFairValueHedgeMember_755f9543-8afc-4803-916c-55b9a0ac61ee_terseLabel_en-US" xlink:label="lab_sny_CashFlowAndFairValueHedgeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow And Fair Value Hedge</link:label>
    <link:label id="lab_sny_CashFlowAndFairValueHedgeMember_label_en-US" xlink:label="lab_sny_CashFlowAndFairValueHedgeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow And Fair Value Hedge [Member]</link:label>
    <link:label id="lab_sny_CashFlowAndFairValueHedgeMember_documentation_en-US" xlink:label="lab_sny_CashFlowAndFairValueHedgeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow And Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashFlowAndFairValueHedgeMember" xlink:href="sny-20221231.xsd#sny_CashFlowAndFairValueHedgeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CashFlowAndFairValueHedgeMember" xlink:to="lab_sny_CashFlowAndFairValueHedgeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_3652659c-b592-486e-9ed1-c11376af5b95_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfHedgesMember_a793c415-ec5d-4b5c-b342-1744a2d34881_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedges [member]</link:label>
    <link:label id="lab_ifrs-full_TypesOfHedgesMember_label_en-US" xlink:label="lab_ifrs-full_TypesOfHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedges [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfHedgesMember" xlink:to="lab_ifrs-full_TypesOfHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_a3858df6-4503-4a6a-902a-2e888aea6082_terseLabel_en-US" xlink:label="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, term deposits</link:label>
    <link:label id="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term deposits, classified as cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:to="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NetInterestCostRelatedToEmployeeBenefits_0dec75c7-5357-488b-b744-07df41d9c9bb_negatedLabel_en-US" xlink:label="lab_sny_NetInterestCostRelatedToEmployeeBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net interest cost related to employee benefits</link:label>
    <link:label id="lab_sny_NetInterestCostRelatedToEmployeeBenefits_label_en-US" xlink:label="lab_sny_NetInterestCostRelatedToEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Interest Cost Related To Employee Benefits</link:label>
    <link:label id="lab_sny_NetInterestCostRelatedToEmployeeBenefits_documentation_en-US" xlink:label="lab_sny_NetInterestCostRelatedToEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net interest cost related to employee benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetInterestCostRelatedToEmployeeBenefits" xlink:href="sny-20221231.xsd#sny_NetInterestCostRelatedToEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetInterestCostRelatedToEmployeeBenefits" xlink:to="lab_sny_NetInterestCostRelatedToEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_A.NattermannCie.GmbHMember_a1b86576-5168-45a2-922b-99531b95f93e_terseLabel_en-US" xlink:label="lab_sny_A.NattermannCie.GmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A. Nattermann &amp; Cie. GmbH</link:label>
    <link:label id="lab_sny_A.NattermannCie.GmbHMember_label_en-US" xlink:label="lab_sny_A.NattermannCie.GmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A. Nattermann &amp; Cie. GmbH [Member]</link:label>
    <link:label id="lab_sny_A.NattermannCie.GmbHMember_documentation_en-US" xlink:label="lab_sny_A.NattermannCie.GmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A. Nattermann &amp; Cie. GmbH [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_A.NattermannCie.GmbHMember" xlink:href="sny-20221231.xsd#sny_A.NattermannCie.GmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_A.NattermannCie.GmbHMember" xlink:to="lab_sny_A.NattermannCie.GmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember_fcb12b19-5f26-4caf-9c88-8c14c29b506b_terseLabel_en-US" xlink:label="lab_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Praluent (Alirocumab)-related EPO patent oppositions</link:label>
    <link:label id="lab_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember_label_en-US" xlink:label="lab_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Praluent Alirocumab Related Epo Patent Oppositions [member]</link:label>
    <link:label id="lab_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember_documentation_en-US" xlink:label="lab_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Praluent (alirocumab)-related EPO patent oppositions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember" xlink:href="sny-20221231.xsd#sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember" xlink:to="lab_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BorrowingAverageDrawdown_55e2b853-3b64-4b56-8510-9915e2d11186_terseLabel_en-US" xlink:label="lab_sny_BorrowingAverageDrawdown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing, average drawdown</link:label>
    <link:label id="lab_sny_BorrowingAverageDrawdown_label_en-US" xlink:label="lab_sny_BorrowingAverageDrawdown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing, Average Drawdown</link:label>
    <link:label id="lab_sny_BorrowingAverageDrawdown_documentation_en-US" xlink:label="lab_sny_BorrowingAverageDrawdown" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing, Average Drawdown</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BorrowingAverageDrawdown" xlink:href="sny-20221231.xsd#sny_BorrowingAverageDrawdown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BorrowingAverageDrawdown" xlink:to="lab_sny_BorrowingAverageDrawdown" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_c549e9d4-15bf-40e6-8597-5011009dee8e_terseLabel_en-US" xlink:label="lab_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subclassifications of assets, liabilities and equities [abstract]</link:label>
    <link:label id="lab_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subclassifications of assets, liabilities and equities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:to="lab_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_14b29de7-f461-4b3d-96b9-fc2c057cb259_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value through other comprehensive income</link:label>
    <link:label id="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current financial assets at fair value through other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:to="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock_2873ab4d-8246-4d1c-bf12-39f08ce8abfe_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Analysis of Financial Income and Expenses</link:label>
    <link:label id="lab_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Financial Income And Expenses Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for financial income and expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SalesReturnMember_482e3cd8-6e87-4d0a-92fd-8d95cd0a64f9_terseLabel_en-US" xlink:label="lab_sny_SalesReturnMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales returns</link:label>
    <link:label id="lab_sny_SalesReturnMember_label_en-US" xlink:label="lab_sny_SalesReturnMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Return [Member]</link:label>
    <link:label id="lab_sny_SalesReturnMember_documentation_en-US" xlink:label="lab_sny_SalesReturnMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales return.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesReturnMember" xlink:href="sny-20221231.xsd#sny_SalesReturnMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SalesReturnMember" xlink:to="lab_sny_SalesReturnMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock_6249834c-838e-4116-96ca-20d2db4c191d_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Undrawn Credit Facilities</link:label>
    <link:label id="lab_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Undrawn Borrowing Facilities [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of undrawn borrowing facilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock" xlink:to="lab_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember_68d8619f-fa6f-4847-aa5d-e51a5d26827f_terseLabel_en-US" xlink:label="lab_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for pensions and other post-employment benefits</link:label>
    <link:label id="lab_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember_label_en-US" xlink:label="lab_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions For Pensions And Other Post-Employment Benefits [Member]</link:label>
    <link:label id="lab_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember_documentation_en-US" xlink:label="lab_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for pensions and other post-employment benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember" xlink:href="sny-20221231.xsd#sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember" xlink:to="lab_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ActuarialAssumptionOfRetirementAgeTopOfRange_2d0bbbf6-9805-4ab4-a8c3-e31f2ebbfb3b_terseLabel_en-US" xlink:label="lab_sny_ActuarialAssumptionOfRetirementAgeTopOfRange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement age, top of range</link:label>
    <link:label id="lab_sny_ActuarialAssumptionOfRetirementAgeTopOfRange_label_en-US" xlink:label="lab_sny_ActuarialAssumptionOfRetirementAgeTopOfRange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial Assumption Of Retirement Age Top Of Range</link:label>
    <link:label id="lab_sny_ActuarialAssumptionOfRetirementAgeTopOfRange_documentation_en-US" xlink:label="lab_sny_ActuarialAssumptionOfRetirementAgeTopOfRange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumption of retirement age top of range.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialAssumptionOfRetirementAgeTopOfRange" xlink:href="sny-20221231.xsd#sny_ActuarialAssumptionOfRetirementAgeTopOfRange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActuarialAssumptionOfRetirementAgeTopOfRange" xlink:to="lab_sny_ActuarialAssumptionOfRetirementAgeTopOfRange" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember_b61c849e-1933-4784-834a-2cd70dd19d9b_verboseLabel_en-US" xlink:label="lab_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent</link:label>
    <link:label id="lab_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember_label_en-US" xlink:label="lab_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent [Member]</link:label>
    <link:label id="lab_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember_documentation_en-US" xlink:label="lab_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps receive capitalized Eonia / pay 1.48%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember" xlink:to="lab_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfCreditFacilities_9c1a4470-afa8-48e8-8b16-f140abddd211_terseLabel_en-US" xlink:label="lab_sny_NumberOfCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of credit facilities</link:label>
    <link:label id="lab_sny_NumberOfCreditFacilities_label_en-US" xlink:label="lab_sny_NumberOfCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Credit Facilities</link:label>
    <link:label id="lab_sny_NumberOfCreditFacilities_documentation_en-US" xlink:label="lab_sny_NumberOfCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Credit Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCreditFacilities" xlink:href="sny-20221231.xsd#sny_NumberOfCreditFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfCreditFacilities" xlink:to="lab_sny_NumberOfCreditFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FinanceLeaseLiabilities_4c237ddb-87b0-4062-8f7f-881ace44b66f_terseLabel_en-US" xlink:label="lab_sny_FinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_sny_FinanceLeaseLiabilities_label_en-US" xlink:label="lab_sny_FinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liabilities</link:label>
    <link:label id="lab_sny_FinanceLeaseLiabilities_documentation_en-US" xlink:label="lab_sny_FinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinanceLeaseLiabilities" xlink:href="sny-20221231.xsd#sny_FinanceLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FinanceLeaseLiabilities" xlink:to="lab_sny_FinanceLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock_4e9b02f1-3d61-46b2-87a0-196922a614ef_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Lease Liabilities</link:label>
    <link:label id="lab_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Maturity Analysis Of Lease Payments [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Maturity Analysis Of Lease Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock" xlink:to="lab_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_baa77aa7-b29c-4aba-9b39-76932c1a2761_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of significant accounting policies</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of significant accounting policies [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IndustrialSalesMember_3005b0d9-5aa4-4d9a-acad-51890bc07204_terseLabel_en-US" xlink:label="lab_sny_IndustrialSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial sales</link:label>
    <link:label id="lab_sny_IndustrialSalesMember_label_en-US" xlink:label="lab_sny_IndustrialSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial Sales [Member]</link:label>
    <link:label id="lab_sny_IndustrialSalesMember_documentation_en-US" xlink:label="lab_sny_IndustrialSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IndustrialSalesMember" xlink:href="sny-20221231.xsd#sny_IndustrialSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IndustrialSalesMember" xlink:to="lab_sny_IndustrialSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember_50bf5298-cbfe-4e5d-b8fb-15736a8490ab_verboseLabel_en-US" xlink:label="lab_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia</link:label>
    <link:label id="lab_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember_label_en-US" xlink:label="lab_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia [Member]</link:label>
    <link:label id="lab_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember_documentation_en-US" xlink:label="lab_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps pay -0.57% / receivecapitalized Eonia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember" xlink:to="lab_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_6c1ca2fd-2953-4457-8ffb-6c973d62d2ba_terseLabel_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful lives or depreciation rates, property, plant and equipment (in years)</link:label>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life measured as period of time, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IssuedCapital_f92cf1af-bc71-4978-9c9b-be17414bc87b_terseLabel_en-US" xlink:label="lab_ifrs-full_IssuedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share capital</link:label>
    <link:label id="lab_ifrs-full_IssuedCapital_label_en-US" xlink:label="lab_ifrs-full_IssuedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital" xlink:to="lab_ifrs-full_IssuedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_bf0cdd21-efe1-42b5-95eb-fb75be342773_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Detailed Information about Financial Instruments</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about financial instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedCashFlowStatementTable_007645a0-9c25-44a0-a8ff-332de654c707_terseLabel_en-US" xlink:label="lab_srt_CondensedCashFlowStatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statement [Table]</link:label>
    <link:label id="lab_srt_CondensedCashFlowStatementTable_label_en-US" xlink:label="lab_srt_CondensedCashFlowStatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedCashFlowStatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedCashFlowStatementTable" xlink:to="lab_srt_CondensedCashFlowStatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_8acda329-6b17-4aea-a288-cb6a432e91ed_terseLabel_en-US" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of exchange rates on cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_bf0e3f16-485c-4735-b027-6ed9e1bb67fd_terseLabel_en-US" xlink:label="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions And Other Noncurrent Liabilities [Table]</link:label>
    <link:label id="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_label_en-US" xlink:label="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions And Other Non-current Liabilities [Table]</link:label>
    <link:label id="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_documentation_en-US" xlink:label="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions and other noncurrent liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable" xlink:href="sny-20221231.xsd#sny_ProvisionsAndOtherNonCurrentLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable" xlink:to="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_65228c32-fc0f-46ff-8e77-b70538ccf869_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Movement In Total Debt</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about borrowings [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes_6b056ccf-8e25-4801-8e75-e1c457a3c6e2_terseLabel_en-US" xlink:label="lab_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revisions to tax exposures and settlements of tax disputes</link:label>
    <link:label id="lab_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes_label_en-US" xlink:label="lab_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate Effect Of Revisions To Tax Exposures And Settlements Of Tax Disputes</link:label>
    <link:label id="lab_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes_documentation_en-US" xlink:label="lab_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate Effect Of Revisions To Tax Exposures And Settlements Of Tax Disputes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xlink:href="sny-20221231.xsd#sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xlink:to="lab_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MinusTwentyFiveBasisPointsMember_250ad1f9-a146-444a-b1a7-10f3c9552c21_terseLabel_en-US" xlink:label="lab_sny_MinusTwentyFiveBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-25&#160;bp</link:label>
    <link:label id="lab_sny_MinusTwentyFiveBasisPointsMember_label_en-US" xlink:label="lab_sny_MinusTwentyFiveBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minus Twenty Five Basis Points [Member]</link:label>
    <link:label id="lab_sny_MinusTwentyFiveBasisPointsMember_documentation_en-US" xlink:label="lab_sny_MinusTwentyFiveBasisPointsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minus twenty five basis points.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinusTwentyFiveBasisPointsMember" xlink:href="sny-20221231.xsd#sny_MinusTwentyFiveBasisPointsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MinusTwentyFiveBasisPointsMember" xlink:to="lab_sny_MinusTwentyFiveBasisPointsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ProceedsFromCollaborationAgreements_d6de2c85-246c-4357-9877-e0489e62813b_terseLabel_en-US" xlink:label="lab_sny_ProceedsFromCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from collaboration agreements</link:label>
    <link:label id="lab_sny_ProceedsFromCollaborationAgreements_label_en-US" xlink:label="lab_sny_ProceedsFromCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Collaboration Agreements</link:label>
    <link:label id="lab_sny_ProceedsFromCollaborationAgreements_documentation_en-US" xlink:label="lab_sny_ProceedsFromCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Collaboration Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProceedsFromCollaborationAgreements" xlink:href="sny-20221231.xsd#sny_ProceedsFromCollaborationAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProceedsFromCollaborationAgreements" xlink:to="lab_sny_ProceedsFromCollaborationAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ReservePercentageOfPandemicVaccines_a2f39e2e-8326-4c9b-a146-70fbcd4d37d3_terseLabel_en-US" xlink:label="lab_sny_ReservePercentageOfPandemicVaccines" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of pandemic vaccines agreed to reserve</link:label>
    <link:label id="lab_sny_ReservePercentageOfPandemicVaccines_label_en-US" xlink:label="lab_sny_ReservePercentageOfPandemicVaccines" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve Percentage of Pandemic Vaccines</link:label>
    <link:label id="lab_sny_ReservePercentageOfPandemicVaccines_documentation_en-US" xlink:label="lab_sny_ReservePercentageOfPandemicVaccines" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve percentage of pandemic vaccines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReservePercentageOfPandemicVaccines" xlink:href="sny-20221231.xsd#sny_ReservePercentageOfPandemicVaccines"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ReservePercentageOfPandemicVaccines" xlink:to="lab_sny_ReservePercentageOfPandemicVaccines" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis_b0d8ebb8-b9a4-48e9-943f-91ca8b9986be_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [axis]</link:label>
    <link:label id="lab_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis_label_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis" xlink:to="lab_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity_5b624147-2b4d-43b4-814e-2e70129b89bd_terseLabel_en-US" xlink:label="lab_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net pre-tax actuarial loss</link:label>
    <link:label id="lab_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity_label_en-US" xlink:label="lab_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Pretax Actuarial Loss Excluding Associates And Joint Ventures Recognized Directly In Equity</link:label>
    <link:label id="lab_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity_documentation_en-US" xlink:label="lab_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net pretax actuarial loss excluding associates and joint ventures recognized directly in equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity" xlink:href="sny-20221231.xsd#sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity" xlink:to="lab_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AventisPharmaLimitedMember_fd0b3c50-a971-4ef0-b97d-0a8cf9ed59c7_terseLabel_en-US" xlink:label="lab_sny_AventisPharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma Limited</link:label>
    <link:label id="lab_sny_AventisPharmaLimitedMember_label_en-US" xlink:label="lab_sny_AventisPharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma Limited [member]</link:label>
    <link:label id="lab_sny_AventisPharmaLimitedMember_documentation_en-US" xlink:label="lab_sny_AventisPharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventis Pharma Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaLimitedMember" xlink:href="sny-20221231.xsd#sny_AventisPharmaLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AventisPharmaLimitedMember" xlink:to="lab_sny_AventisPharmaLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EPICBPIFranceMember_325cd446-c173-48d7-ab81-a00e933a89b1_terseLabel_en-US" xlink:label="lab_sny_EPICBPIFranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPIC BPIFrance</link:label>
    <link:label id="lab_sny_EPICBPIFranceMember_label_en-US" xlink:label="lab_sny_EPICBPIFranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPIC BPIFrance [Member]</link:label>
    <link:label id="lab_sny_EPICBPIFranceMember_documentation_en-US" xlink:label="lab_sny_EPICBPIFranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPIC BPIFrance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EPICBPIFranceMember" xlink:href="sny-20221231.xsd#sny_EPICBPIFranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EPICBPIFranceMember" xlink:to="lab_sny_EPICBPIFranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_54ccc938-e79e-408a-bf0e-f44ab46a4a10_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis_7f8f0d71-c424-4aa3-bac3-68ee7c00f4eb_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associates [axis]</link:label>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis_label_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associates [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:to="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_8cb501bc-044a-4a40-b119-d539b5ab670a_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase/(decrease) in accounts payable</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for increase (decrease) in trade accounts payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_March2020EMTNISINFR0013505112Member_3fc63af8-2b62-40a5-b316-14a2cf7e937e_terseLabel_en-US" xlink:label="lab_sny_March2020EMTNISINFR0013505112Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2020 EMTN ISIN FR0013505112</link:label>
    <link:label id="lab_sny_March2020EMTNISINFR0013505112Member_label_en-US" xlink:label="lab_sny_March2020EMTNISINFR0013505112Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2020 EMTNISINFR0013505112 [Member]</link:label>
    <link:label id="lab_sny_March2020EMTNISINFR0013505112Member_documentation_en-US" xlink:label="lab_sny_March2020EMTNISINFR0013505112Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2020 EMTNISINFR0013505112</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2020EMTNISINFR0013505112Member" xlink:href="sny-20221231.xsd#sny_March2020EMTNISINFR0013505112Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_March2020EMTNISINFR0013505112Member" xlink:to="lab_sny_March2020EMTNISINFR0013505112Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BondsAndSimilarInstrumentsMember_45834c14-1846-4486-8f25-e900fc578dd8_terseLabel_en-US" xlink:label="lab_sny_BondsAndSimilarInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bonds and similar instruments</link:label>
    <link:label id="lab_sny_BondsAndSimilarInstrumentsMember_label_en-US" xlink:label="lab_sny_BondsAndSimilarInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bonds And Similar Instruments [member]</link:label>
    <link:label id="lab_sny_BondsAndSimilarInstrumentsMember_documentation_en-US" xlink:label="lab_sny_BondsAndSimilarInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bonds and similar instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BondsAndSimilarInstrumentsMember" xlink:href="sny-20221231.xsd#sny_BondsAndSimilarInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BondsAndSimilarInstrumentsMember" xlink:to="lab_sny_BondsAndSimilarInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember_e3398596-c03f-4826-b825-52a06108fc6c_terseLabel_en-US" xlink:label="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of other netting arrangements not fulfilling the IAS 32 criteria for offsetting</link:label>
    <link:label id="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember_label_en-US" xlink:label="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects Of Other Netting Arrangements Not Fulfilling The IAS 32 Criteria For Offsetting [Member]</link:label>
    <link:label id="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember_documentation_en-US" xlink:label="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of other netting arrangements not fulfilling the IAS 32 criteria for offsetting.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember" xlink:href="sny-20221231.xsd#sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember" xlink:to="lab_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NoncurrentLiabilitiesMember_f6b6bcb1-f126-4444-a679-a98b0a950486_terseLabel_en-US" xlink:label="lab_sny_NoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current</link:label>
    <link:label id="lab_sny_NoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_sny_NoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Liabilities [member]</link:label>
    <link:label id="lab_sny_NoncurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_sny_NoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NoncurrentLiabilitiesMember" xlink:href="sny-20221231.xsd#sny_NoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NoncurrentLiabilitiesMember" xlink:to="lab_sny_NoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_3db04eca-ee24-4a68-bd20-443f90cf36ac_terseLabel_en-US" xlink:label="lab_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Information And Statement Of IFRS Compliance [Abstract]</link:label>
    <link:label id="lab_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_label_en-US" xlink:label="lab_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Information And Statement Of IFRS Compliance [Abstract]</link:label>
    <link:label id="lab_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_documentation_en-US" xlink:label="lab_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Information And Statement Of IFRS Compliance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="lab_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_f2b8c32e-c4a8-4007-9ab0-ec12fcdb447d_terseLabel_en-US" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value (investments accounted for using the equity method, net of taxes)</link:label>
    <link:label id="lab_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_label_en-US" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value On Equity Instruments For Investments Accounted For Using The Equity Method Net Of Tax</link:label>
    <link:label id="lab_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_documentation_en-US" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value On Equity Instruments For Investments Accounted For Using The Equity Method Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xlink:to="lab_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GainOnDerivativesUsedToManageDebt_015e6a2a-2fac-4647-b874-01ea328e6538_terseLabel_en-US" xlink:label="lab_sny_GainOnDerivativesUsedToManageDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on derivatives used to manage debt</link:label>
    <link:label id="lab_sny_GainOnDerivativesUsedToManageDebt_label_en-US" xlink:label="lab_sny_GainOnDerivativesUsedToManageDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain On Derivatives Used To Manage Debt</link:label>
    <link:label id="lab_sny_GainOnDerivativesUsedToManageDebt_documentation_en-US" xlink:label="lab_sny_GainOnDerivativesUsedToManageDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain derivatives used to manage debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainOnDerivativesUsedToManageDebt" xlink:href="sny-20221231.xsd#sny_GainOnDerivativesUsedToManageDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainOnDerivativesUsedToManageDebt" xlink:to="lab_sny_GainOnDerivativesUsedToManageDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member_6cd1f37f-60ca-4f01-9f04-6d0edfbca5c8_terseLabel_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32%</link:label>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member_label_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% [Member]</link:label>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member_documentation_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member" xlink:to="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DE_f0dc456c-b098-4951-b06f-51eaee3c4996_terseLabel_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Germany</link:label>
    <link:label id="lab_country_DE_label_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE" xlink:to="lab_country_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_cdd152f5-cdc5-47e8-886e-3aca192ac9f2_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems_4814339f-1256-4705-a044-c7199b8bf11d_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Share-Based Payment [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Share-Based Payment [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Share-Based Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems" xlink:to="lab_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_bbdcef80-e71a-431e-a159-20e06d22518b_terseLabel_en-US" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_8f84bab0-8499-4e9e-89de-5b1fb2bb7a22_netLabel_en-US" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</link:label>
    <link:label id="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements_69269f35-9d16-45a0-964c-3d4e393a6ca9_terseLabel_en-US" xlink:label="lab_ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Expenses</link:label>
    <link:label id="lab_ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements_label_en-US" xlink:label="lab_ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional information about share-based payment arrangements [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements" xlink:to="lab_ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded_7b7c5f0e-ab76-481b-b6f9-b59a3a5eefb6_terseLabel_en-US" xlink:label="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduced amount of compensation claimed, interest included</link:label>
    <link:label id="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded_label_en-US" xlink:label="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduced Amount Of Compensation Claimed By Filled Plaintiffs, Interest Included</link:label>
    <link:label id="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded_documentation_en-US" xlink:label="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduced Amount Of Compensation Claimed By Filled Plaintiffs, Interest Included</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" xlink:href="sny-20221231.xsd#sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" xlink:to="lab_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisDeutschlandGmbHMember_1bebd3c3-d618-4036-bfe8-ff55a46bb471_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisDeutschlandGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Deutschland GmbH</link:label>
    <link:label id="lab_sny_SanofiAventisDeutschlandGmbHMember_label_en-US" xlink:label="lab_sny_SanofiAventisDeutschlandGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Deutschland Gmbh [member]</link:label>
    <link:label id="lab_sny_SanofiAventisDeutschlandGmbHMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisDeutschlandGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Deutschland GmbH.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeutschlandGmbHMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeutschlandGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisDeutschlandGmbHMember" xlink:to="lab_sny_SanofiAventisDeutschlandGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonCurrentFinanceLeaseReceivablesGross_7c0ad15c-f4c5-4f3c-b772-3d119d3ec82c_terseLabel_en-US" xlink:label="lab_sny_NonCurrentFinanceLeaseReceivablesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current finance lease receivables, gross</link:label>
    <link:label id="lab_sny_NonCurrentFinanceLeaseReceivablesGross_label_en-US" xlink:label="lab_sny_NonCurrentFinanceLeaseReceivablesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Finance Lease Receivables, Gross</link:label>
    <link:label id="lab_sny_NonCurrentFinanceLeaseReceivablesGross_documentation_en-US" xlink:label="lab_sny_NonCurrentFinanceLeaseReceivablesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Finance Lease Receivables, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinanceLeaseReceivablesGross" xlink:href="sny-20221231.xsd#sny_NonCurrentFinanceLeaseReceivablesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentFinanceLeaseReceivablesGross" xlink:to="lab_sny_NonCurrentFinanceLeaseReceivablesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOtherNonCurrentAssetsLineItems_031f134d-0275-42a4-957a-e4535fb2d171_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Non Current Assets [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherNonCurrentAssetsLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Non Current Assets [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherNonCurrentAssetsLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other non-current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherNonCurrentAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:to="lab_sny_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrentEquityDerivativesPayable_c510d077-dfa2-4b86-8542-ec5b476ef9a5_verboseLabel_en-US" xlink:label="lab_sny_CurrentEquityDerivativesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity derivatives (see Note&#160;D.20.)</link:label>
    <link:label id="lab_sny_CurrentEquityDerivativesPayable_label_en-US" xlink:label="lab_sny_CurrentEquityDerivativesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Equity Derivatives Payable</link:label>
    <link:label id="lab_sny_CurrentEquityDerivativesPayable_documentation_en-US" xlink:label="lab_sny_CurrentEquityDerivativesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Equity Derivatives Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentEquityDerivativesPayable" xlink:href="sny-20221231.xsd#sny_CurrentEquityDerivativesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentEquityDerivativesPayable" xlink:to="lab_sny_CurrentEquityDerivativesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BristolMyersSquibbMember_24001d50-844f-43ed-ab4b-eefcd8bbee73_terseLabel_en-US" xlink:label="lab_sny_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb</link:label>
    <link:label id="lab_sny_BristolMyersSquibbMember_label_en-US" xlink:label="lab_sny_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb [Member]</link:label>
    <link:label id="lab_sny_BristolMyersSquibbMember_documentation_en-US" xlink:label="lab_sny_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BristolMyersSquibbMember" xlink:href="sny-20221231.xsd#sny_BristolMyersSquibbMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BristolMyersSquibbMember" xlink:to="lab_sny_BristolMyersSquibbMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LumpSumRetirementBenefitPlansMember_7a278cc2-d836-48a9-8543-f3c6117a6dc1_terseLabel_en-US" xlink:label="lab_sny_LumpSumRetirementBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lump-sum retirement benefit plans</link:label>
    <link:label id="lab_sny_LumpSumRetirementBenefitPlansMember_label_en-US" xlink:label="lab_sny_LumpSumRetirementBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lump-sum Retirement Benefit Plans [Member]</link:label>
    <link:label id="lab_sny_LumpSumRetirementBenefitPlansMember_documentation_en-US" xlink:label="lab_sny_LumpSumRetirementBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lump-sum retirement benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LumpSumRetirementBenefitPlansMember" xlink:href="sny-20221231.xsd#sny_LumpSumRetirementBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LumpSumRetirementBenefitPlansMember" xlink:to="lab_sny_LumpSumRetirementBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GeographicalAreasAxis_e07507cd-d6da-4178-afae-d49661b5e86f_terseLabel_en-US" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical areas [axis]</link:label>
    <link:label id="lab_ifrs-full_GeographicalAreasAxis_label_en-US" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical areas [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasAxis" xlink:to="lab_ifrs-full_GeographicalAreasAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_ed06af11-6979-4ccf-ba82-17060a165dcb_terseLabel_en-US" xlink:label="lab_sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Capital, Reserves And Other Equity Interest [Abstract]</link:label>
    <link:label id="lab_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_label_en-US" xlink:label="lab_sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Capital, Reserves And Other Equity Interest [Abstract]</link:label>
    <link:label id="lab_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_documentation_en-US" xlink:label="lab_sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Capital, Reserves And Other Equity Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:to="lab_sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TreasurySharesMember_3a621d75-a873-436a-9c89-7ac6bc8b9d6f_terseLabel_en-US" xlink:label="lab_ifrs-full_TreasurySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares</link:label>
    <link:label id="lab_ifrs-full_TreasurySharesMember_label_en-US" xlink:label="lab_ifrs-full_TreasurySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasurySharesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasurySharesMember" xlink:to="lab_ifrs-full_TreasurySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisPuertoRicoIncMember_bb353ca0-2b42-4f8b-8932-16ea0f9e6bb3_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisPuertoRicoIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Puerto Rico Inc</link:label>
    <link:label id="lab_sny_SanofiAventisPuertoRicoIncMember_label_en-US" xlink:label="lab_sny_SanofiAventisPuertoRicoIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Puerto Rico Inc [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisPuertoRicoIncMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisPuertoRicoIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Puerto Rico Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPuertoRicoIncMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisPuertoRicoIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisPuertoRicoIncMember" xlink:to="lab_sny_SanofiAventisPuertoRicoIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_d44cb0b2-a314-41c3-824b-cba7d3974d8c_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net interest expense on lease liabilities</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GenzymeCorporationMember_e1e2d470-dc41-4b53-9333-788bd45c8be4_terseLabel_en-US" xlink:label="lab_sny_GenzymeCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Corporation</link:label>
    <link:label id="lab_sny_GenzymeCorporationMember_label_en-US" xlink:label="lab_sny_GenzymeCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Corporation [Member]</link:label>
    <link:label id="lab_sny_GenzymeCorporationMember_documentation_en-US" xlink:label="lab_sny_GenzymeCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Corporation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeCorporationMember" xlink:href="sny-20221231.xsd#sny_GenzymeCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GenzymeCorporationMember" xlink:to="lab_sny_GenzymeCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesAxis_bc84b92c-9953-4d2a-a5a0-58cd9ab264e2_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of liabilities [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of liabilities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_d73a5479-f607-4ebc-9511-6708161fe0e6_negatedTerseLabel_en-US" xlink:label="lab_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effects</link:label>
    <link:label id="lab_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Relating To Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Net Of Tax On Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Relating To Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Net Of Tax On Associates And Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:to="lab_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MarketConditionDomain_16fb7236-642b-4e0d-9116-e0bca4c8c0ab_terseLabel_en-US" xlink:label="lab_sny_MarketConditionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition [Domain]</link:label>
    <link:label id="lab_sny_MarketConditionDomain_label_en-US" xlink:label="lab_sny_MarketConditionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition [Domain]</link:label>
    <link:label id="lab_sny_MarketConditionDomain_documentation_en-US" xlink:label="lab_sny_MarketConditionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketConditionDomain" xlink:href="sny-20221231.xsd#sny_MarketConditionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MarketConditionDomain" xlink:to="lab_sny_MarketConditionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TypesOfAgreementAxis_02e5dc2c-7f19-4bca-8049-5fa5f04afd39_terseLabel_en-US" xlink:label="lab_sny_TypesOfAgreementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types Of Agreement [Axis]</link:label>
    <link:label id="lab_sny_TypesOfAgreementAxis_label_en-US" xlink:label="lab_sny_TypesOfAgreementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types Of Agreement [Axis]</link:label>
    <link:label id="lab_sny_TypesOfAgreementAxis_documentation_en-US" xlink:label="lab_sny_TypesOfAgreementAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types Of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementAxis" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TypesOfAgreementAxis" xlink:to="lab_sny_TypesOfAgreementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AllergyMember_48ee5811-2fb8-40e6-9d6d-aaccfd7a7bdd_terseLabel_en-US" xlink:label="lab_sny_AllergyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allergy</link:label>
    <link:label id="lab_sny_AllergyMember_label_en-US" xlink:label="lab_sny_AllergyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allergy [Member]</link:label>
    <link:label id="lab_sny_AllergyMember_documentation_en-US" xlink:label="lab_sny_AllergyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allergy, Cough And Cold [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AllergyMember" xlink:href="sny-20221231.xsd#sny_AllergyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AllergyMember" xlink:to="lab_sny_AllergyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RetirementAge_5336247f-7807-4228-b0aa-32db9504ff28_terseLabel_en-US" xlink:label="lab_sny_RetirementAge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement age</link:label>
    <link:label id="lab_sny_RetirementAge_label_en-US" xlink:label="lab_sny_RetirementAge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Age</link:label>
    <link:label id="lab_sny_RetirementAge_documentation_en-US" xlink:label="lab_sny_RetirementAge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement age.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RetirementAge" xlink:href="sny-20221231.xsd#sny_RetirementAge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RetirementAge" xlink:to="lab_sny_RetirementAge" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_April282020Member_2e59fde4-826b-4dbb-a889-5d4466966b06_terseLabel_en-US" xlink:label="lab_sny_April282020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 28, 2020</link:label>
    <link:label id="lab_sny_April282020Member_label_en-US" xlink:label="lab_sny_April282020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 28, 2020 [Member]</link:label>
    <link:label id="lab_sny_April282020Member_documentation_en-US" xlink:label="lab_sny_April282020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 28, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April282020Member" xlink:href="sny-20221231.xsd#sny_April282020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_April282020Member" xlink:to="lab_sny_April282020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember_ffa04964-33c0-484a-8aee-2189828f9ea1_terseLabel_en-US" xlink:label="lab_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt and current portion of long-term debt</link:label>
    <link:label id="lab_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember_label_en-US" xlink:label="lab_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt And Current Portion Of Long-Term Debt [Member]</link:label>
    <link:label id="lab_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember_documentation_en-US" xlink:label="lab_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt and current portion of long term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember" xlink:href="sny-20221231.xsd#sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember" xlink:to="lab_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_AR_08290f75-a756-4417-ab32-353ddbd7e2c8_terseLabel_en-US" xlink:label="lab_country_AR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Argentina</link:label>
    <link:label id="lab_country_AR_label_en-US" xlink:label="lab_country_AR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ARGENTINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_AR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_AR" xlink:to="lab_country_AR" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherBankBorrowings_3d51b0d7-b941-4770-9536-d6c6513d4c9f_terseLabel_en-US" xlink:label="lab_sny_OtherBankBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other bank borrowings</link:label>
    <link:label id="lab_sny_OtherBankBorrowings_label_en-US" xlink:label="lab_sny_OtherBankBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Bank Borrowings</link:label>
    <link:label id="lab_sny_OtherBankBorrowings_documentation_en-US" xlink:label="lab_sny_OtherBankBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other bank borrowings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherBankBorrowings" xlink:href="sny-20221231.xsd#sny_OtherBankBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherBankBorrowings" xlink:to="lab_sny_OtherBankBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherDeductionsMember_84ebf1aa-3ddf-4dbc-a042-daa0c600487a_terseLabel_en-US" xlink:label="lab_sny_OtherDeductionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deductions</link:label>
    <link:label id="lab_sny_OtherDeductionsMember_label_en-US" xlink:label="lab_sny_OtherDeductionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Deductions [Member]</link:label>
    <link:label id="lab_sny_OtherDeductionsMember_documentation_en-US" xlink:label="lab_sny_OtherDeductionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deductions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherDeductionsMember" xlink:href="sny-20221231.xsd#sny_OtherDeductionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherDeductionsMember" xlink:to="lab_sny_OtherDeductionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns_0d39e38c-ef35-4208-aeed-99c06a32002e_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in scope of consolidation</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Change In Scope Of Consolidation In Provision For Discounts Rebates And Sales Returns</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in scope of consolidation in provision for discounts rebates and sales returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" xlink:to="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_f7a9b341-60ef-44b6-84e6-59b2a834aa4c_verboseLabel_en-US" xlink:label="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other property, plant and equipment [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:to="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_a5dc4f86-f571-4181-b5fe-e33ce9005757_terseLabel_en-US" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
    <link:label id="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_label_en-US" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfTradingDaysPrecedingPlanApproval_4adcf868-dc48-4adc-b296-081249d758ef_terseLabel_en-US" xlink:label="lab_sny_NumberOfTradingDaysPrecedingPlanApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of trading days preceding plan approval</link:label>
    <link:label id="lab_sny_NumberOfTradingDaysPrecedingPlanApproval_label_en-US" xlink:label="lab_sny_NumberOfTradingDaysPrecedingPlanApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Trading Days Preceding Plan Approval</link:label>
    <link:label id="lab_sny_NumberOfTradingDaysPrecedingPlanApproval_documentation_en-US" xlink:label="lab_sny_NumberOfTradingDaysPrecedingPlanApproval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Trading Days Preceding Plan Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfTradingDaysPrecedingPlanApproval" xlink:href="sny-20221231.xsd#sny_NumberOfTradingDaysPrecedingPlanApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfTradingDaysPrecedingPlanApproval" xlink:to="lab_sny_NumberOfTradingDaysPrecedingPlanApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfOngoingTrials_9e11be5e-bee0-4cb5-9058-5345ad8e1622_terseLabel_en-US" xlink:label="lab_sny_NumberOfOngoingTrials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ongoing trials</link:label>
    <link:label id="lab_sny_NumberOfOngoingTrials_label_en-US" xlink:label="lab_sny_NumberOfOngoingTrials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Ongoing Trials</link:label>
    <link:label id="lab_sny_NumberOfOngoingTrials_documentation_en-US" xlink:label="lab_sny_NumberOfOngoingTrials" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Ongoing Trials</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOngoingTrials" xlink:href="sny-20221231.xsd#sny_NumberOfOngoingTrials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfOngoingTrials" xlink:to="lab_sny_NumberOfOngoingTrials" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DupixentMember_03d7fc20-48b2-46d0-a9c5-10cc9619e21a_terseLabel_en-US" xlink:label="lab_sny_DupixentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dupixent</link:label>
    <link:label id="lab_sny_DupixentMember_label_en-US" xlink:label="lab_sny_DupixentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dupixent [Member]</link:label>
    <link:label id="lab_sny_DupixentMember_documentation_en-US" xlink:label="lab_sny_DupixentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dupixent [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DupixentMember" xlink:href="sny-20221231.xsd#sny_DupixentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DupixentMember" xlink:to="lab_sny_DupixentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MarketedProductsTrademarksAndOtherRightsMember_3489c49d-13c3-4356-a8d1-80d31026d14e_terseLabel_en-US" xlink:label="lab_sny_MarketedProductsTrademarksAndOtherRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products, trademarks and other rights</link:label>
    <link:label id="lab_sny_MarketedProductsTrademarksAndOtherRightsMember_label_en-US" xlink:label="lab_sny_MarketedProductsTrademarksAndOtherRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketed Products Trademarks And Other Rights [Member]</link:label>
    <link:label id="lab_sny_MarketedProductsTrademarksAndOtherRightsMember_documentation_en-US" xlink:label="lab_sny_MarketedProductsTrademarksAndOtherRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketed products trademarks and other rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketedProductsTrademarksAndOtherRightsMember" xlink:href="sny-20221231.xsd#sny_MarketedProductsTrademarksAndOtherRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MarketedProductsTrademarksAndOtherRightsMember" xlink:to="lab_sny_MarketedProductsTrademarksAndOtherRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_c1df6cb2-ad91-4865-993a-2171542e3f9c_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Maximum Amount Of Contingent Consideration Payable And Firm Commitments To Buy Out Non-controlling Interests [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems" xlink:to="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_f0453468-2525-4de4-9ebd-d6c298243f1a_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New borrowings</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember_3ae67cc2-4ecc-4618-9405-9f4587ffb681_terseLabel_en-US" xlink:label="lab_ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for decommissioning, restoration and rehabilitation costs</link:label>
    <link:label id="lab_ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember_label_en-US" xlink:label="lab_ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for decommissioning, restoration and rehabilitation costs [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember" xlink:to="lab_ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WagesAndSalaries_543e7c6a-e642-4a27-b2e4-a101b7c6f24d_terseLabel_en-US" xlink:label="lab_ifrs-full_WagesAndSalaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries</link:label>
    <link:label id="lab_ifrs-full_WagesAndSalaries_label_en-US" xlink:label="lab_ifrs-full_WagesAndSalaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wages and salaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WagesAndSalaries" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WagesAndSalaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries" xlink:to="lab_ifrs-full_WagesAndSalaries" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_472aba23-757a-4130-8451-959f02a7b3b7_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average residual&#160;life (years)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EmployeeBenefitsExpense_de758b4c-5c9f-4c51-9639-d3a9a2ccec24_totalLabel_en-US" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_EmployeeBenefitsExpense_label_en-US" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefits expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense" xlink:to="lab_ifrs-full_EmployeeBenefitsExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_0c104bbf-c8d1-4097-8309-5c70f57a39a9_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Operating Income Expenses [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Operating Income Expenses [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other operating income (expenses).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:to="lab_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ZantacLitigationInTheUSMember_887860b9-2d16-4180-b5ea-22c3170aea65_terseLabel_en-US" xlink:label="lab_sny_ZantacLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zantac litigation in the US</link:label>
    <link:label id="lab_sny_ZantacLitigationInTheUSMember_label_en-US" xlink:label="lab_sny_ZantacLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zantac Litigation In the US [Member]</link:label>
    <link:label id="lab_sny_ZantacLitigationInTheUSMember_documentation_en-US" xlink:label="lab_sny_ZantacLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zantac Litigation In the US</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ZantacLitigationInTheUSMember" xlink:href="sny-20221231.xsd#sny_ZantacLitigationInTheUSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ZantacLitigationInTheUSMember" xlink:to="lab_sny_ZantacLitigationInTheUSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiEgyptSAEMember_d708570b-944d-49f4-89d8-76f1cf1b9815_terseLabel_en-US" xlink:label="lab_sny_SanofiEgyptSAEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Egypt</link:label>
    <link:label id="lab_sny_SanofiEgyptSAEMember_label_en-US" xlink:label="lab_sny_SanofiEgyptSAEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Egypt S.A.E [Member]</link:label>
    <link:label id="lab_sny_SanofiEgyptSAEMember_documentation_en-US" xlink:label="lab_sny_SanofiEgyptSAEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Egypt S.A.E.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiEgyptSAEMember" xlink:href="sny-20221231.xsd#sny_SanofiEgyptSAEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiEgyptSAEMember" xlink:to="lab_sny_SanofiEgyptSAEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember_633d5bc7-7b8a-4354-a057-085101e09639_terseLabel_en-US" xlink:label="lab_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate after derivative instruments</link:label>
    <link:label id="lab_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember_label_en-US" xlink:label="lab_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Interest Rate After Derivative Instruments [Member]</link:label>
    <link:label id="lab_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember_documentation_en-US" xlink:label="lab_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate after derivative instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember" xlink:href="sny-20221231.xsd#sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember" xlink:to="lab_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss_ac512bf4-fb12-4176-894d-3541af5c9e57_negatedLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effects</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" xlink:to="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IndustrialFacilitiesMember_22beafb0-c93b-4015-809f-cfdc28febb6e_terseLabel_en-US" xlink:label="lab_sny_IndustrialFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial facilities</link:label>
    <link:label id="lab_sny_IndustrialFacilitiesMember_label_en-US" xlink:label="lab_sny_IndustrialFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial Facilities [Member]</link:label>
    <link:label id="lab_sny_IndustrialFacilitiesMember_documentation_en-US" xlink:label="lab_sny_IndustrialFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial facilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IndustrialFacilitiesMember" xlink:href="sny-20221231.xsd#sny_IndustrialFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IndustrialFacilitiesMember" xlink:to="lab_sny_IndustrialFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GenzymeFlandersBVBAMember_84792fbf-44d0-407d-8378-783045b91add_terseLabel_en-US" xlink:label="lab_sny_GenzymeFlandersBVBAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Flanders BVBA</link:label>
    <link:label id="lab_sny_GenzymeFlandersBVBAMember_label_en-US" xlink:label="lab_sny_GenzymeFlandersBVBAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Flanders BVBA [member]</link:label>
    <link:label id="lab_sny_GenzymeFlandersBVBAMember_documentation_en-US" xlink:label="lab_sny_GenzymeFlandersBVBAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Flanders BVBA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeFlandersBVBAMember" xlink:href="sny-20221231.xsd#sny_GenzymeFlandersBVBAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GenzymeFlandersBVBAMember" xlink:to="lab_sny_GenzymeFlandersBVBAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_cc074117-8526-43ff-bac9-3540f6b56dfd_terseLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Attributable to equity holders of Sanofi</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income, attributable to owners of parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ToujeoMember_42a34f37-3ff9-4819-b484-51e5001de66e_terseLabel_en-US" xlink:label="lab_sny_ToujeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toujeo</link:label>
    <link:label id="lab_sny_ToujeoMember_label_en-US" xlink:label="lab_sny_ToujeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toujeo [Member]</link:label>
    <link:label id="lab_sny_ToujeoMember_documentation_en-US" xlink:label="lab_sny_ToujeoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toujeo.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ToujeoMember" xlink:href="sny-20221231.xsd#sny_ToujeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ToujeoMember" xlink:to="lab_sny_ToujeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RestrictedSharePlansMember_f38e49a5-f630-437f-87e7-7a60dedb0934_terseLabel_en-US" xlink:label="lab_sny_RestrictedSharePlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted share plans</link:label>
    <link:label id="lab_sny_RestrictedSharePlansMember_label_en-US" xlink:label="lab_sny_RestrictedSharePlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plans [Member]</link:label>
    <link:label id="lab_sny_RestrictedSharePlansMember_documentation_en-US" xlink:label="lab_sny_RestrictedSharePlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlansMember" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharePlansMember" xlink:to="lab_sny_RestrictedSharePlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_WithoutMarketConditionMember_80b48f07-cce8-4d8e-9db9-0f72e8ead15b_terseLabel_en-US" xlink:label="lab_sny_WithoutMarketConditionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Without market condition</link:label>
    <link:label id="lab_sny_WithoutMarketConditionMember_label_en-US" xlink:label="lab_sny_WithoutMarketConditionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Without Market Condition [Member]</link:label>
    <link:label id="lab_sny_WithoutMarketConditionMember_documentation_en-US" xlink:label="lab_sny_WithoutMarketConditionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Without Market Condition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WithoutMarketConditionMember" xlink:href="sny-20221231.xsd#sny_WithoutMarketConditionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_WithoutMarketConditionMember" xlink:to="lab_sny_WithoutMarketConditionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock_51e8d3ba-02d9-494c-8e4f-686c325d70a0_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Fair Value of Derivative Instruments</link:label>
    <link:label id="lab_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Fair Value Of Derivative Instruments [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of fair value of derivative instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock" xlink:to="lab_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentMember_ffd0c283-ab96-4ef6-ace3-b8a0d8b88f75_terseLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment [member]</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments_25555daf-81f4-47a8-af67-58a985bd6e52_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development license agreements - commitments related to R&amp;D and other commitments</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments_label_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Research And Development License Agreements, Other Commitments</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments related to R&amp; D licence agreements and other commitments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" xlink:to="lab_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_d6ee2346-2e99-41d8-8cc2-377486d61b72_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets, net of tax</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_b8cf9dae-b207-4f02-8102-89b4ec51351b_netLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposals of investments</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:to="lab_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiHangzhouPharmaceuticalsCoLtdMember_146f1780-a632-4cdd-9eaa-a326ddddae62_terseLabel_en-US" xlink:label="lab_sny_SanofiHangzhouPharmaceuticalsCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi (Hangzhou) Pharmaceuticals Co., Ltd</link:label>
    <link:label id="lab_sny_SanofiHangzhouPharmaceuticalsCoLtdMember_label_en-US" xlink:label="lab_sny_SanofiHangzhouPharmaceuticalsCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Hangzhou Pharmaceuticals Co Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiHangzhouPharmaceuticalsCoLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiHangzhouPharmaceuticalsCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi (Hangzhou) Pharmaceuticals Co., Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiHangzhouPharmaceuticalsCoLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiHangzhouPharmaceuticalsCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiHangzhouPharmaceuticalsCoLtdMember" xlink:to="lab_sny_SanofiHangzhouPharmaceuticalsCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock_3c692568-d2b6-42e6-9a9d-74385e7275a5_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Fair Value Of Financial Assets And Liabilities Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of fair value of financial assets and liabilities explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_November2013EMTNISINFR0011625433Member_a16d6077-74bb-403e-ab9b-edcb227e0222_terseLabel_en-US" xlink:label="lab_sny_November2013EMTNISINFR0011625433Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2013 EMTN ISIN FR0011625433</link:label>
    <link:label id="lab_sny_November2013EMTNISINFR0011625433Member_label_en-US" xlink:label="lab_sny_November2013EMTNISINFR0011625433Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2013 EMTNISINFR0011625433 [Member]</link:label>
    <link:label id="lab_sny_November2013EMTNISINFR0011625433Member_documentation_en-US" xlink:label="lab_sny_November2013EMTNISINFR0011625433Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2013 EMTN ISIN FR0011625433.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_November2013EMTNISINFR0011625433Member" xlink:href="sny-20221231.xsd#sny_November2013EMTNISINFR0011625433Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_November2013EMTNISINFR0011625433Member" xlink:to="lab_sny_November2013EMTNISINFR0011625433Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared_4cf361b3-0709-453f-8342-4669c0b2149b_terseLabel_en-US" xlink:label="lab_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period before scheduled launch date</link:label>
    <link:label id="lab_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared_label_en-US" xlink:label="lab_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Before Launch Date During Which Commercial Expenses Of Antibodies Co-Developed Under License Agreement Are Shared</link:label>
    <link:label id="lab_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared_documentation_en-US" xlink:label="lab_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Before Launch Date During Which Commercial Expenses Of Antibodies Co-Developed Under License Agreement Are Shared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared" xlink:href="sny-20221231.xsd#sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared" xlink:to="lab_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock_3e6b8626-a3c5-4aa5-8376-94979d7680c3_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Cash and Cash Equivalents</link:label>
    <link:label id="lab_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Cash And Cash Equivalents Details [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of cash and cash equivalents details.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock" xlink:to="lab_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_KadmonCorporationLLCMember_ae52e4ae-1f5f-4ace-aff1-d00533d1d04b_terseLabel_en-US" xlink:label="lab_sny_KadmonCorporationLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kadmon Corporation, LLC</link:label>
    <link:label id="lab_sny_KadmonCorporationLLCMember_label_en-US" xlink:label="lab_sny_KadmonCorporationLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kadmon Corporation, LLC [Member]</link:label>
    <link:label id="lab_sny_KadmonCorporationLLCMember_documentation_en-US" xlink:label="lab_sny_KadmonCorporationLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kadmon Corporation, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KadmonCorporationLLCMember" xlink:href="sny-20221231.xsd#sny_KadmonCorporationLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_KadmonCorporationLLCMember" xlink:to="lab_sny_KadmonCorporationLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_6e7f4685-e220-4516-aec5-604c7afe0c36_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">France</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherNonCoreAssetsMember_e08c6980-613c-41bf-802b-3b71405d97a5_terseLabel_en-US" xlink:label="lab_sny_OtherNonCoreAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-core assets</link:label>
    <link:label id="lab_sny_OtherNonCoreAssetsMember_label_en-US" xlink:label="lab_sny_OtherNonCoreAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Core Assets [Member]</link:label>
    <link:label id="lab_sny_OtherNonCoreAssetsMember_documentation_en-US" xlink:label="lab_sny_OtherNonCoreAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Core Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherNonCoreAssetsMember" xlink:href="sny-20221231.xsd#sny_OtherNonCoreAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherNonCoreAssetsMember" xlink:to="lab_sny_OtherNonCoreAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisDeColombiaSAMember_2e8772f2-5c02-4fbe-ad26-1f529f7f7b40_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisDeColombiaSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis de Colombia S.A.</link:label>
    <link:label id="lab_sny_SanofiAventisDeColombiaSAMember_label_en-US" xlink:label="lab_sny_SanofiAventisDeColombiaSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis De Colombia S A [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisDeColombiaSAMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisDeColombiaSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis de Colombia S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeColombiaSAMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeColombiaSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisDeColombiaSAMember" xlink:to="lab_sny_SanofiAventisDeColombiaSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BayerScheringPharmaAGMember_89897ec1-2cee-461f-a6de-06bee363a07a_terseLabel_en-US" xlink:label="lab_sny_BayerScheringPharmaAGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer contingent consideration</link:label>
    <link:label id="lab_sny_BayerScheringPharmaAGMember_label_en-US" xlink:label="lab_sny_BayerScheringPharmaAGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer Schering Pharma AG [member]</link:label>
    <link:label id="lab_sny_BayerScheringPharmaAGMember_documentation_en-US" xlink:label="lab_sny_BayerScheringPharmaAGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer Schering Pharma AG.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BayerScheringPharmaAGMember" xlink:href="sny-20221231.xsd#sny_BayerScheringPharmaAGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BayerScheringPharmaAGMember" xlink:to="lab_sny_BayerScheringPharmaAGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInKoreanWonMember_a3ae203a-9a83-4611-ab11-229cd845f8ce_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInKoreanWonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Korean Won</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInKoreanWonMember_label_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInKoreanWonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Korean Won [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInKoreanWonMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInKoreanWonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Korean Won</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInKoreanWonMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInKoreanWonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasedInKoreanWonMember" xlink:to="lab_sny_ForwardCurrencyPurchasedInKoreanWonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TotalStockOptionPlansMember_cf19c24f-7bf6-4b11-87ba-b28028f1e5d6_terseLabel_en-US" xlink:label="lab_sny_TotalStockOptionPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock option plans</link:label>
    <link:label id="lab_sny_TotalStockOptionPlansMember_label_en-US" xlink:label="lab_sny_TotalStockOptionPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stock Option Plans [Member]</link:label>
    <link:label id="lab_sny_TotalStockOptionPlansMember_documentation_en-US" xlink:label="lab_sny_TotalStockOptionPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock option plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalStockOptionPlansMember" xlink:href="sny-20221231.xsd#sny_TotalStockOptionPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TotalStockOptionPlansMember" xlink:to="lab_sny_TotalStockOptionPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_e7529443-e42e-4b34-b9ae-32850e83e187_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UK</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock_0ba9687e-7f3f-46a6-8179-59367cec3372_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Debt by Interest Rate</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt By Interest Rate At Value Of Redemption And By Maturity Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of debt by interest rate at value of redemption and by maturity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_aa09b1f5-b970-4079-80f0-b824285b3248_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Legal and Arbitral Proceedings [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Legal And Arbitral Proceedings [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of legal and arbitral proceedings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfLegalAndArbitralProceedingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xlink:to="lab_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PriorDevelopmentBudget_23ff3304-3725-4df4-994e-a4f6265b67e0_terseLabel_en-US" xlink:label="lab_sny_PriorDevelopmentBudget" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior development budget in total</link:label>
    <link:label id="lab_sny_PriorDevelopmentBudget_label_en-US" xlink:label="lab_sny_PriorDevelopmentBudget" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Development Budget</link:label>
    <link:label id="lab_sny_PriorDevelopmentBudget_documentation_en-US" xlink:label="lab_sny_PriorDevelopmentBudget" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior development budget.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PriorDevelopmentBudget" xlink:href="sny-20221231.xsd#sny_PriorDevelopmentBudget"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PriorDevelopmentBudget" xlink:to="lab_sny_PriorDevelopmentBudget" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfSharesHeld_505bdc9b-ac71-406f-807c-d994a605e998_terseLabel_en-US" xlink:label="lab_sny_NumberOfSharesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares (in shares)</link:label>
    <link:label id="lab_sny_NumberOfSharesHeld_label_en-US" xlink:label="lab_sny_NumberOfSharesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Shares Held</link:label>
    <link:label id="lab_sny_NumberOfSharesHeld_documentation_en-US" xlink:label="lab_sny_NumberOfSharesHeld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares held.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSharesHeld" xlink:href="sny-20221231.xsd#sny_NumberOfSharesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfSharesHeld" xlink:to="lab_sny_NumberOfSharesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_b8c9ca41-10c4-49f6-a3c0-11efd2a4d42d_verboseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_ef3aacc6-caa8-446a-a2b2-5084f64f03c1_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets other than goodwill</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9ade130f-e5f0-48e9-83b3-ebb64584afe5_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_08000c4f-a4d4-4494-b2d6-85bd3a594c59_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of classes of share capital [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of classes of share capital [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock_fec6c813-1ca9-4d3c-a093-e88bf653f132_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Instruments</link:label>
    <link:label id="lab_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Interest Rates Hedging Instruments With Notional Amount By Expiry Date Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of interest rates hedging instruments with notional amount by expiry date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PerformanceObjectiveMinimumNumberOfPatients_a9a045aa-fa45-4ce0-91d3-ade638c5a383_terseLabel_en-US" xlink:label="lab_sny_PerformanceObjectiveMinimumNumberOfPatients" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance objective, minimum number of patients</link:label>
    <link:label id="lab_sny_PerformanceObjectiveMinimumNumberOfPatients_label_en-US" xlink:label="lab_sny_PerformanceObjectiveMinimumNumberOfPatients" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Objective, Minimum Number Of Patients</link:label>
    <link:label id="lab_sny_PerformanceObjectiveMinimumNumberOfPatients_documentation_en-US" xlink:label="lab_sny_PerformanceObjectiveMinimumNumberOfPatients" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Objective, Minimum Number Of Patients</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceObjectiveMinimumNumberOfPatients" xlink:href="sny-20221231.xsd#sny_PerformanceObjectiveMinimumNumberOfPatients"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PerformanceObjectiveMinimumNumberOfPatients" xlink:to="lab_sny_PerformanceObjectiveMinimumNumberOfPatients" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_a3cb453d-0a6b-4afb-80c1-de23817d6a49_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase)/decrease in inventories</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for decrease (increase) in inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture_8a0949b4-1475-43eb-b49a-f5c671a4fa85_terseLabel_en-US" xlink:label="lab_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves likely to be distributed in the foreseeable future</link:label>
    <link:label id="lab_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture_label_en-US" xlink:label="lab_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves Likely To Be Distributed In The Foreseeable Future</link:label>
    <link:label id="lab_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture_documentation_en-US" xlink:label="lab_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves likely to be distributed in the foreseeable future.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture" xlink:href="sny-20221231.xsd#sny_ReservesLikelyToBeDistributedInTheForeseeableFuture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture" xlink:to="lab_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock_0fd4c062-9784-4c3b-a976-a321ccf47471_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Pre-tax Actuarial Loss</link:label>
    <link:label id="lab_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Pre Tax Actuarial Loss Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Pre Tax Actuarial Loss Explanatory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_f98597e6-4222-4d35-9f6a-a2dda221502e_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through net exchange differences, other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock_e9c16891-5308-4e93-add5-e890c491c331_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Accounts Receivable</link:label>
    <link:label id="lab_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Current Trade Receivables [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of current trade receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfCurrentTradeReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xlink:to="lab_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansAxis_f1e63915-268f-4e6e-8281-ac56a3c3de0f_terseLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans [axis]</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansAxis_label_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis" xlink:to="lab_ifrs-full_DefinedBenefitPlansAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfSustainableDevelopmentPerformanceIndicators_058c6413-4765-46b3-9ba9-f8a029a505f5_terseLabel_en-US" xlink:label="lab_sny_NumberOfSustainableDevelopmentPerformanceIndicators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sustainable development performance indicators</link:label>
    <link:label id="lab_sny_NumberOfSustainableDevelopmentPerformanceIndicators_label_en-US" xlink:label="lab_sny_NumberOfSustainableDevelopmentPerformanceIndicators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Sustainable Development Performance Indicators</link:label>
    <link:label id="lab_sny_NumberOfSustainableDevelopmentPerformanceIndicators_documentation_en-US" xlink:label="lab_sny_NumberOfSustainableDevelopmentPerformanceIndicators" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Sustainable Development Performance Indicators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSustainableDevelopmentPerformanceIndicators" xlink:href="sny-20221231.xsd#sny_NumberOfSustainableDevelopmentPerformanceIndicators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfSustainableDevelopmentPerformanceIndicators" xlink:to="lab_sny_NumberOfSustainableDevelopmentPerformanceIndicators" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_e554b1b5-c168-489b-b801-2dfa12e7d6f2_verboseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net impairment losses on property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss recognised in profit or loss, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_ed2a6d0e-7c1c-4042-8e1d-a2dd781b2c88_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Provisional Purchase Price Allocation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_53f296f5-b96a-4d34-a731-f2cb0e3f0b31_verboseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Final Purchase Price Allocation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about business combination [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InventoriesPledgedAsSecurityForLiabilities_33782311-ec9a-4f0c-a3f2-e074caaa7160_terseLabel_en-US" xlink:label="lab_ifrs-full_InventoriesPledgedAsSecurityForLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories pledged as security for liabilities</link:label>
    <link:label id="lab_ifrs-full_InventoriesPledgedAsSecurityForLiabilities_label_en-US" xlink:label="lab_ifrs-full_InventoriesPledgedAsSecurityForLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories pledged as security for liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InventoriesPledgedAsSecurityForLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoriesPledgedAsSecurityForLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoriesPledgedAsSecurityForLiabilities" xlink:to="lab_ifrs-full_InventoriesPledgedAsSecurityForLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherProvisions_530161d1-de8f-4fa4-9fce-4ce1ade508ea_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other provisions</link:label>
    <link:label id="lab_ifrs-full_OtherProvisions_label_en-US" xlink:label="lab_ifrs-full_OtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherProvisions" xlink:to="lab_ifrs-full_OtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EntitysTotalForAssociatesMember_11578ebe-c8db-4ab2-95a5-566c1abf3805_terseLabel_en-US" xlink:label="lab_ifrs-full_EntitysTotalForAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for associates</link:label>
    <link:label id="lab_ifrs-full_EntitysTotalForAssociatesMember_label_en-US" xlink:label="lab_ifrs-full_EntitysTotalForAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for associates [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember" xlink:to="lab_ifrs-full_EntitysTotalForAssociatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_b1169796-16ac-40a7-a7eb-452baa6f4922_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLineItems_b48b97b0-1a9c-4e4d-9808-85e5560eb9b2_terseLabel_en-US" xlink:label="lab_dei_AuditorLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor [Line Items]</link:label>
    <link:label id="lab_dei_AuditorLineItems_label_en-US" xlink:label="lab_dei_AuditorLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLineItems" xlink:to="lab_dei_AuditorLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities_bf0baa4f-8a4c-40c1-b86e-f1408e738b32_negatedLabel_en-US" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid, classified as operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisVietnamCompanyLimitedMember_4c460fbd-af8b-4325-82d3-3d7ced6e42bf_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisVietnamCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Vietnam Company Limited</link:label>
    <link:label id="lab_sny_SanofiAventisVietnamCompanyLimitedMember_label_en-US" xlink:label="lab_sny_SanofiAventisVietnamCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Vietnam Company Limited [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisVietnamCompanyLimitedMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisVietnamCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Vietnam Company Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisVietnamCompanyLimitedMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisVietnamCompanyLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisVietnamCompanyLimitedMember" xlink:to="lab_sny_SanofiAventisVietnamCompanyLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencySalesInSingaporeDollarMember_4af197b3-e804-46c6-9806-7cb62edcf7b8_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencySalesInSingaporeDollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales in Singapore Dollar</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInSingaporeDollarMember_label_en-US" xlink:label="lab_sny_ForwardCurrencySalesInSingaporeDollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Singapore Dollar [member]</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInSingaporeDollarMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencySalesInSingaporeDollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales in Singapore Dollar.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInSingaporeDollarMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInSingaporeDollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInSingaporeDollarMember" xlink:to="lab_sny_ForwardCurrencySalesInSingaporeDollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExercisePriceRangeTwoMember_80f6dd14-5d0b-4829-b676-b4288623dac5_terseLabel_en-US" xlink:label="lab_sny_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price range two</link:label>
    <link:label id="lab_sny_ExercisePriceRangeTwoMember_label_en-US" xlink:label="lab_sny_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
    <link:label id="lab_sny_ExercisePriceRangeTwoMember_documentation_en-US" xlink:label="lab_sny_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExercisePriceRangeTwoMember" xlink:href="sny-20221231.xsd#sny_ExercisePriceRangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExercisePriceRangeTwoMember" xlink:to="lab_sny_ExercisePriceRangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AventisubLLCMember_80ebcfa0-4d57-44fc-a748-3211d18e4582_terseLabel_en-US" xlink:label="lab_sny_AventisubLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventisub LLC</link:label>
    <link:label id="lab_sny_AventisubLLCMember_label_en-US" xlink:label="lab_sny_AventisubLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventisub LLC [Member]</link:label>
    <link:label id="lab_sny_AventisubLLCMember_documentation_en-US" xlink:label="lab_sny_AventisubLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aventisub LLC.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisubLLCMember" xlink:href="sny-20221231.xsd#sny_AventisubLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AventisubLLCMember" xlink:to="lab_sny_AventisubLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_6aa32dde-c00c-412e-904e-b8b112cdc1e9_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_JointOperationsAxis_b94e83e2-bd70-49a7-a523-d63b2fca4ca7_terseLabel_en-US" xlink:label="lab_ifrs-full_JointOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Operations [Axis]</link:label>
    <link:label id="lab_ifrs-full_JointOperationsAxis_label_en-US" xlink:label="lab_ifrs-full_JointOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint operations [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointOperationsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_JointOperationsAxis" xlink:to="lab_ifrs-full_JointOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisPakistanLtdMember_5e3593c0-c10c-475b-a802-ac4630016f99_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisPakistanLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Pakistan Limited</link:label>
    <link:label id="lab_sny_SanofiAventisPakistanLtdMember_label_en-US" xlink:label="lab_sny_SanofiAventisPakistanLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Pakistan Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisPakistanLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisPakistanLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Pakistan Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPakistanLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisPakistanLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisPakistanLtdMember" xlink:to="lab_sny_SanofiAventisPakistanLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MinimumPlan1Member_ae1f553e-254e-4040-a112-15ce0815dcef_terseLabel_en-US" xlink:label="lab_sny_MinimumPlan1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Plan 1</link:label>
    <link:label id="lab_sny_MinimumPlan1Member_label_en-US" xlink:label="lab_sny_MinimumPlan1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Plan 1 [Member]</link:label>
    <link:label id="lab_sny_MinimumPlan1Member_documentation_en-US" xlink:label="lab_sny_MinimumPlan1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Plan 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinimumPlan1Member" xlink:href="sny-20221231.xsd#sny_MinimumPlan1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MinimumPlan1Member" xlink:to="lab_sny_MinimumPlan1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseOnBorrowings_33d829af-0a85-49a0-93e0-44b011aaffad_negatedLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of debt</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnBorrowings_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnBorrowings" xlink:to="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentShellCompanyReport_994ee9f1-8d68-4fb7-992e-1a432d91327e_terseLabel_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:label id="lab_dei_DocumentShellCompanyReport_label_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport" xlink:to="lab_dei_DocumentShellCompanyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MCMVaccineBVMember_f6007bdd-2c9c-4175-bae5-8f6fbe43970c_terseLabel_en-US" xlink:label="lab_sny_MCMVaccineBVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MCM Vaccine B.V.</link:label>
    <link:label id="lab_sny_MCMVaccineBVMember_label_en-US" xlink:label="lab_sny_MCMVaccineBVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MCM Vaccine BV [Member]</link:label>
    <link:label id="lab_sny_MCMVaccineBVMember_documentation_en-US" xlink:label="lab_sny_MCMVaccineBVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MCM Vaccine BV.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MCMVaccineBVMember" xlink:href="sny-20221231.xsd#sny_MCMVaccineBVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MCMVaccineBVMember" xlink:to="lab_sny_MCMVaccineBVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ConcentrationRiskThresholdPercentage_ca884f59-f3e0-429e-a5c2-601860f75ec3_terseLabel_en-US" xlink:label="lab_sny_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_sny_ConcentrationRiskThresholdPercentage_label_en-US" xlink:label="lab_sny_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Threshold Percentage</link:label>
    <link:label id="lab_sny_ConcentrationRiskThresholdPercentage_documentation_en-US" xlink:label="lab_sny_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk threshold percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConcentrationRiskThresholdPercentage" xlink:href="sny-20221231.xsd#sny_ConcentrationRiskThresholdPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ConcentrationRiskThresholdPercentage" xlink:to="lab_sny_ConcentrationRiskThresholdPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill_d36e1445-c1f6-4815-823a-3b762827e29d_terseLabel_en-US" xlink:label="lab_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of other intangible assets, net of reversals (excluding software)</link:label>
    <link:label id="lab_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Loss On Intangible Assets Other Than Goodwill</link:label>
    <link:label id="lab_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill_documentation_en-US" xlink:label="lab_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss on intangible assets other than goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" xlink:href="sny-20221231.xsd#sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" xlink:to="lab_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcarePolandSpZOOMember_9b09d916-f005-4f35-809d-a9909cb7cf3b_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcarePolandSpZOOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Poland sp.Z.O.O</link:label>
    <link:label id="lab_sny_OpellaHealthcarePolandSpZOOMember_label_en-US" xlink:label="lab_sny_OpellaHealthcarePolandSpZOOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Poland sp.Z.O.O [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcarePolandSpZOOMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcarePolandSpZOOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Poland sp.Z.O.O</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcarePolandSpZOOMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcarePolandSpZOOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcarePolandSpZOOMember" xlink:to="lab_sny_OpellaHealthcarePolandSpZOOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock_65243f37-96f2-492d-a371-16a23acc3578_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Inventories [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of detailed information about inventories.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:to="lab_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_UniformImpairmentTestingPercentage_ca2eb05f-7a4a-4969-99b2-920f2dcff110_terseLabel_en-US" xlink:label="lab_sny_UniformImpairmentTestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform impairment testing percentage</link:label>
    <link:label id="lab_sny_UniformImpairmentTestingPercentage_label_en-US" xlink:label="lab_sny_UniformImpairmentTestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform Impairment Testing Percentage</link:label>
    <link:label id="lab_sny_UniformImpairmentTestingPercentage_documentation_en-US" xlink:label="lab_sny_UniformImpairmentTestingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform impairment testing percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UniformImpairmentTestingPercentage" xlink:href="sny-20221231.xsd#sny_UniformImpairmentTestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UniformImpairmentTestingPercentage" xlink:to="lab_sny_UniformImpairmentTestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_442f7b6f-af24-4e89-87a1-2d7638443f6b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of cash and cash equivalents [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ContingentConsiderationLiabilities_4c240d35-7e9f-4bf0-9cc6-a56bb1b01633_terseLabel_en-US" xlink:label="lab_sny_ContingentConsiderationLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_sny_ContingentConsiderationLiabilities_label_en-US" xlink:label="lab_sny_ContingentConsiderationLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liabilities</link:label>
    <link:label id="lab_sny_ContingentConsiderationLiabilities_documentation_en-US" xlink:label="lab_sny_ContingentConsiderationLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationLiabilities" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ContingentConsiderationLiabilities" xlink:to="lab_sny_ContingentConsiderationLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeTable_e87ae7ec-5d66-4558-baee-0b7b3ff4d3ef_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Operating Income [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeTable_label_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Operating Income [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherOperatingIncomeTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Operating Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeTable" xlink:to="lab_sny_DisclosureOfOtherOperatingIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InnatePharmaSAMember_9a41d4d2-0c47-4c03-9739-59d4efbf4e59_terseLabel_en-US" xlink:label="lab_sny_InnatePharmaSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Innate Pharma SA</link:label>
    <link:label id="lab_sny_InnatePharmaSAMember_label_en-US" xlink:label="lab_sny_InnatePharmaSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Innate Pharma SA [Member]</link:label>
    <link:label id="lab_sny_InnatePharmaSAMember_documentation_en-US" xlink:label="lab_sny_InnatePharmaSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Innate Pharma SA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InnatePharmaSAMember" xlink:href="sny-20221231.xsd#sny_InnatePharmaSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InnatePharmaSAMember" xlink:to="lab_sny_InnatePharmaSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_174690a9-9ebf-405d-97f9-176fc41ff53e_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_WorldHealthOrganizationMember_0a426052-984c-4a3f-91e4-f50773ecde73_terseLabel_en-US" xlink:label="lab_sny_WorldHealthOrganizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">World Health Organization</link:label>
    <link:label id="lab_sny_WorldHealthOrganizationMember_label_en-US" xlink:label="lab_sny_WorldHealthOrganizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">World Health Organization [member]</link:label>
    <link:label id="lab_sny_WorldHealthOrganizationMember_documentation_en-US" xlink:label="lab_sny_WorldHealthOrganizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">World Health Organization.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WorldHealthOrganizationMember" xlink:href="sny-20221231.xsd#sny_WorldHealthOrganizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_WorldHealthOrganizationMember" xlink:to="lab_sny_WorldHealthOrganizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SpecialDistributionNumberOfSharesConverted_2b341794-1832-407b-af17-042896de90e2_terseLabel_en-US" xlink:label="lab_sny_SpecialDistributionNumberOfSharesConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Distribution, Number Of Shares Converted</link:label>
    <link:label id="lab_sny_SpecialDistributionNumberOfSharesConverted_label_en-US" xlink:label="lab_sny_SpecialDistributionNumberOfSharesConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Distribution, Number Of Shares Converted</link:label>
    <link:label id="lab_sny_SpecialDistributionNumberOfSharesConverted_documentation_en-US" xlink:label="lab_sny_SpecialDistributionNumberOfSharesConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Distribution, Number Of Shares Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SpecialDistributionNumberOfSharesConverted" xlink:href="sny-20221231.xsd#sny_SpecialDistributionNumberOfSharesConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SpecialDistributionNumberOfSharesConverted" xlink:to="lab_sny_SpecialDistributionNumberOfSharesConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BusinessOperatingIncome_df5d3d57-3564-40b9-bcbe-7aecfaca4f08_totalLabel_en-US" xlink:label="lab_sny_BusinessOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business operating income</link:label>
    <link:label id="lab_sny_BusinessOperatingIncome_a0f6f0ff-c70e-4e48-9122-39a6f822e0e4_terseLabel_en-US" xlink:label="lab_sny_BusinessOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business operating income</link:label>
    <link:label id="lab_sny_BusinessOperatingIncome_label_en-US" xlink:label="lab_sny_BusinessOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Operating Income</link:label>
    <link:label id="lab_sny_BusinessOperatingIncome_documentation_en-US" xlink:label="lab_sny_BusinessOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business operating income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessOperatingIncome" xlink:href="sny-20221231.xsd#sny_BusinessOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BusinessOperatingIncome" xlink:to="lab_sny_BusinessOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock_1b941499-4fde-4a65-a2b5-f14a152bd195_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets Held for Sale or Exchange, and Liabilities Related to Assets Held for Sale or Exchange</link:label>
    <link:label id="lab_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Assets Held For Sale Or Exchange And Related Liabilities [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of assets held for sale or exchange and related liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock" xlink:to="lab_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RestrictedSharePlan2021Member_41b70289-8cc7-4249-8f91-d89c96b6716f_terseLabel_en-US" xlink:label="lab_sny_RestrictedSharePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted share plan 2021</link:label>
    <link:label id="lab_sny_RestrictedSharePlan2021Member_label_en-US" xlink:label="lab_sny_RestrictedSharePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plan 2021 [Member]</link:label>
    <link:label id="lab_sny_RestrictedSharePlan2021Member_documentation_en-US" xlink:label="lab_sny_RestrictedSharePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plan 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2021Member" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharePlan2021Member" xlink:to="lab_sny_RestrictedSharePlan2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncomeStatementLocationAxis_4083004a-03fc-4201-91a7-78a93c3ba648_terseLabel_en-US" xlink:label="lab_sny_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_sny_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_sny_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_sny_IncomeStatementLocationAxis_documentation_en-US" xlink:label="lab_sny_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationAxis" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeStatementLocationAxis" xlink:to="lab_sny_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_a42949f3-fb44-4f75-a337-b3f7fa8e64ad_terseLabel_en-US" xlink:label="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference between actual return and interest income on plan assets</link:label>
    <link:label id="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherTemporaryDifferencesMember_423c5582-8f01-4eff-8f34-a28f2cda8bb4_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_OtherTemporaryDifferencesMember_label_en-US" xlink:label="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other temporary differences [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTemporaryDifferencesMember" xlink:to="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_4f1f038d-5bc6-4d26-ac2a-767e8f9e6754_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about Principal Alliances [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Principal Alliances [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about Principal Alliances [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems" xlink:to="lab_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiHealthcareIndiaPrivateLimitedMember_28741984-de86-453d-a46f-343cc74ae43b_terseLabel_en-US" xlink:label="lab_sny_SanofiHealthcareIndiaPrivateLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Healthcare India Private Limited</link:label>
    <link:label id="lab_sny_SanofiHealthcareIndiaPrivateLimitedMember_label_en-US" xlink:label="lab_sny_SanofiHealthcareIndiaPrivateLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Healthcare India Private Limited [Member]</link:label>
    <link:label id="lab_sny_SanofiHealthcareIndiaPrivateLimitedMember_documentation_en-US" xlink:label="lab_sny_SanofiHealthcareIndiaPrivateLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Healthcare India Private Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiHealthcareIndiaPrivateLimitedMember" xlink:href="sny-20221231.xsd#sny_SanofiHealthcareIndiaPrivateLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiHealthcareIndiaPrivateLimitedMember" xlink:to="lab_sny_SanofiHealthcareIndiaPrivateLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_29103c6d-af4b-4100-8c98-980d0c63d8ff_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_5bde479f-b124-4116-a9a1-1a6c530e738b_verboseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current derivative financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_c0773bdd-4939-4bc9-b07e-b09ae0b915e7_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial expenses and income</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for finance income and costs [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32_72afc5fb-49d8-46be-9eeb-924b665785ea_terseLabel_en-US" xlink:label="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amounts offset (in accordance with IAS 32)</link:label>
    <link:label id="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32_label_en-US" xlink:label="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Assets And Liabilities, Gross Amounts Offset In Accordance With IAS 32</link:label>
    <link:label id="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32_documentation_en-US" xlink:label="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial assets and liabilities gross amounts offset in accordance with IAS 32.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" xlink:to="lab_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProductsAndServicesMember_0c90d7eb-87e0-4acb-9e64-1f55afb845e1_terseLabel_en-US" xlink:label="lab_ifrs-full_ProductsAndServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and services [member]</link:label>
    <link:label id="lab_ifrs-full_ProductsAndServicesMember_label_en-US" xlink:label="lab_ifrs-full_ProductsAndServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and services [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductsAndServicesMember" xlink:to="lab_ifrs-full_ProductsAndServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisposalGroupNameDomain_846983c7-b270-4215-af39-a52d5c91a354_terseLabel_en-US" xlink:label="lab_sny_DisposalGroupNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_sny_DisposalGroupNameDomain_label_en-US" xlink:label="lab_sny_DisposalGroupNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_sny_DisposalGroupNameDomain_documentation_en-US" xlink:label="lab_sny_DisposalGroupNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalGroupNameDomain" xlink:href="sny-20221231.xsd#sny_DisposalGroupNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisposalGroupNameDomain" xlink:to="lab_sny_DisposalGroupNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_111ff762-9a80-421d-b31b-87e5624bed56_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_8f896114-5071-44ee-8be3-b277b9014f0f_terseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and other share-based payment expense</link:label>
    <link:label id="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_label_en-US" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense from share-based payment transactions with employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherIntangibleAssets_4221a189-3c02-4392-88a1-93a13f2657e5_periodStartLabel_en-US" xlink:label="lab_ifrs-full_OtherIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, beginning balance</link:label>
    <link:label id="lab_ifrs-full_OtherIntangibleAssets_9ddec363-a1e8-4b5e-b94a-6d6636ab6995_periodEndLabel_en-US" xlink:label="lab_ifrs-full_OtherIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, ending balance</link:label>
    <link:label id="lab_ifrs-full_OtherIntangibleAssets_label_en-US" xlink:label="lab_ifrs-full_OtherIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssets" xlink:to="lab_ifrs-full_OtherIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RegeneronMember_78a08496-4161-4f08-a6ce-01b89d3ee828_terseLabel_en-US" xlink:label="lab_sny_RegeneronMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regeneron</link:label>
    <link:label id="lab_sny_RegeneronMember_label_en-US" xlink:label="lab_sny_RegeneronMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regeneron [Member]</link:label>
    <link:label id="lab_sny_RegeneronMember_documentation_en-US" xlink:label="lab_sny_RegeneronMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regeneron</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RegeneronMember" xlink:to="lab_sny_RegeneronMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset_38e8af7d-6163-4d23-8aa8-1c14dbfedd21_totalLabel_en-US" xlink:label="lab_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense/(gain) for the period</link:label>
    <link:label id="lab_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Gain For The Period Net Defined Benefit Liability Asset</link:label>
    <link:label id="lab_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset_documentation_en-US" xlink:label="lab_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense/(gain) for the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" xlink:href="sny-20221231.xsd#sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" xlink:to="lab_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsReceivedForDevelopmentCosts_d97c8ff1-6761-4e7c-b4e7-b63721989059_terseLabel_en-US" xlink:label="lab_sny_CommitmentsReceivedForDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments received for development costs</link:label>
    <link:label id="lab_sny_CommitmentsReceivedForDevelopmentCosts_label_en-US" xlink:label="lab_sny_CommitmentsReceivedForDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Received For Development Costs</link:label>
    <link:label id="lab_sny_CommitmentsReceivedForDevelopmentCosts_documentation_en-US" xlink:label="lab_sny_CommitmentsReceivedForDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Received For Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsReceivedForDevelopmentCosts" xlink:href="sny-20221231.xsd#sny_CommitmentsReceivedForDevelopmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsReceivedForDevelopmentCosts" xlink:to="lab_sny_CommitmentsReceivedForDevelopmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LongtermBorrowings_eb6e2a5b-4a37-4fee-8be6-6a72da7a0439_terseLabel_en-US" xlink:label="lab_ifrs-full_LongtermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_ifrs-full_LongtermBorrowings_label_en-US" xlink:label="lab_ifrs-full_LongtermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion of non-current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings" xlink:to="lab_ifrs-full_LongtermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock_37bd106f-0192-476b-9cd9-3478b03abc2e_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Detailed Information for Principal Marketed Products</link:label>
    <link:label id="lab_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Principal Marketed Products [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of principal marketed products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfPrincipalMarketedProductsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock" xlink:to="lab_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock_588593a1-aca1-41cc-a4ae-d56194fa96c8_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities related to business combinations and to non-controlling interests</link:label>
    <link:label id="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests Explanatory [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for liabilities related to business combination and to non-controlling interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xlink:to="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_94a138a0-020d-4bb0-a874-ddfd7e6d11cd_negatedLabel_en-US" xlink:label="lab_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of treasury shares</link:label>
    <link:label id="lab_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_label_en-US" xlink:label="lab_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire or redeem entity's shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:to="lab_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember_fb565fe3-3c27-43f0-be68-993f1d6e03d2_terseLabel_en-US" xlink:label="lab_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shenzhen Sanofi pasteur Biological Products Co, Ltd</link:label>
    <link:label id="lab_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember_label_en-US" xlink:label="lab_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shenzhen Sanofi Pasteur Biological Products Co Ltd [Member]</link:label>
    <link:label id="lab_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember_documentation_en-US" xlink:label="lab_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shenzhen Sanofi Pasteur Biological Products Co, Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember" xlink:href="sny-20221231.xsd#sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember" xlink:to="lab_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DefinedBenefitPensionPlansMember_f8f8c04c-2ebc-4522-9c1e-59bb244f63cf_terseLabel_en-US" xlink:label="lab_sny_DefinedBenefitPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension plans</link:label>
    <link:label id="lab_sny_DefinedBenefitPensionPlansMember_label_en-US" xlink:label="lab_sny_DefinedBenefitPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Pension Plans [Member]</link:label>
    <link:label id="lab_sny_DefinedBenefitPensionPlansMember_documentation_en-US" xlink:label="lab_sny_DefinedBenefitPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefinedBenefitPensionPlansMember" xlink:href="sny-20221231.xsd#sny_DefinedBenefitPensionPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DefinedBenefitPensionPlansMember" xlink:to="lab_sny_DefinedBenefitPensionPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_6093073b-7a37-48eb-b7d2-7504ba6d7acf_terseLabel_en-US" xlink:label="lab_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal amount</link:label>
    <link:label id="lab_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_label_en-US" xlink:label="lab_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Loss Recognised In Profit Or Loss, Intangible Assets Other Than Goodwill, Reversal Amount</link:label>
    <link:label id="lab_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_documentation_en-US" xlink:label="lab_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Loss Recognised In Profit Or Loss, Intangible Assets Other Than Goodwill, Reversal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" xlink:href="sny-20221231.xsd#sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" xlink:to="lab_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory_bf20c7e6-5890-4c20-8f90-879c9c28520e_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale or exchange and liabilities related to assets held for sale or exchange</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for non-current assets or disposal groups classified as held for sale and discontinued operations [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_b53bdcf7-68ac-46f1-a43a-6bab22ebe4af_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OfficeSpaceCambridgeMassachusettsMember_cc4dffe0-8f7c-49e4-b440-6f8d7bdb2137_terseLabel_en-US" xlink:label="lab_sny_OfficeSpaceCambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office space, Cambridge, Massachusetts</link:label>
    <link:label id="lab_sny_OfficeSpaceCambridgeMassachusettsMember_label_en-US" xlink:label="lab_sny_OfficeSpaceCambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Space, Cambridge, Massachusetts [Member]</link:label>
    <link:label id="lab_sny_OfficeSpaceCambridgeMassachusettsMember_documentation_en-US" xlink:label="lab_sny_OfficeSpaceCambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Space, Cambridge, Massachusetts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OfficeSpaceCambridgeMassachusettsMember" xlink:href="sny-20221231.xsd#sny_OfficeSpaceCambridgeMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OfficeSpaceCambridgeMassachusettsMember" xlink:to="lab_sny_OfficeSpaceCambridgeMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_78153b28-2cd7-4e56-b675-137b73855c9c_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisFranceMember_f13f06b2-6264-4cb8-a544-da89cd797df9_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisFranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis France</link:label>
    <link:label id="lab_sny_SanofiAventisFranceMember_label_en-US" xlink:label="lab_sny_SanofiAventisFranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis France [member]</link:label>
    <link:label id="lab_sny_SanofiAventisFranceMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisFranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis France.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisFranceMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisFranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisFranceMember" xlink:to="lab_sny_SanofiAventisFranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_34c45c97-deb2-44dc-942b-7425491ba669_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Regeneron investment arising from transaction of May 29, 2020, net&#160;of tax</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="lab_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurBiologiesCo.LtdMember_367f546d-af93-4234-8869-470158f48140_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurBiologiesCo.LtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Biologies Co., Ltd</link:label>
    <link:label id="lab_sny_SanofiPasteurBiologiesCo.LtdMember_label_en-US" xlink:label="lab_sny_SanofiPasteurBiologiesCo.LtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Biologies Co., Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiPasteurBiologiesCo.LtdMember_documentation_en-US" xlink:label="lab_sny_SanofiPasteurBiologiesCo.LtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Biologies Co., Ltd [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurBiologiesCo.LtdMember" xlink:href="sny-20221231.xsd#sny_SanofiPasteurBiologiesCo.LtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurBiologiesCo.LtdMember" xlink:to="lab_sny_SanofiPasteurBiologiesCo.LtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GovernmentAndStateProgramsMember_83779daf-f9f2-4f13-9f3c-de30ab14e0b7_terseLabel_en-US" xlink:label="lab_sny_GovernmentAndStateProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government and State Programs</link:label>
    <link:label id="lab_sny_GovernmentAndStateProgramsMember_label_en-US" xlink:label="lab_sny_GovernmentAndStateProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government And State Programs [Member]</link:label>
    <link:label id="lab_sny_GovernmentAndStateProgramsMember_documentation_en-US" xlink:label="lab_sny_GovernmentAndStateProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government and state programs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GovernmentAndStateProgramsMember" xlink:href="sny-20221231.xsd#sny_GovernmentAndStateProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GovernmentAndStateProgramsMember" xlink:to="lab_sny_GovernmentAndStateProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_a66d8f97-b898-4054-a84f-c3cdf3bb5f4f_terseLabel_en-US" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of profit/(loss) from investments accounted for using the equity method</link:label>
    <link:label id="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of profit (loss) of associates and joint ventures accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisposalGroupNameAxis_6b795318-9227-484f-8b4c-2b84f5f9fa87_terseLabel_en-US" xlink:label="lab_sny_DisposalGroupNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_sny_DisposalGroupNameAxis_label_en-US" xlink:label="lab_sny_DisposalGroupNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_sny_DisposalGroupNameAxis_documentation_en-US" xlink:label="lab_sny_DisposalGroupNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalGroupNameAxis" xlink:href="sny-20221231.xsd#sny_DisposalGroupNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisposalGroupNameAxis" xlink:to="lab_sny_DisposalGroupNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CostOfDebtNet_53cb8c1c-096e-469b-907b-140c2ee19511_negatedTotalLabel_en-US" xlink:label="lab_sny_CostOfDebtNet" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of net debt</link:label>
    <link:label id="lab_sny_CostOfDebtNet_label_en-US" xlink:label="lab_sny_CostOfDebtNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Debt Net</link:label>
    <link:label id="lab_sny_CostOfDebtNet_documentation_en-US" xlink:label="lab_sny_CostOfDebtNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of debt net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CostOfDebtNet" xlink:href="sny-20221231.xsd#sny_CostOfDebtNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CostOfDebtNet" xlink:to="lab_sny_CostOfDebtNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_50013d11-b4b8-405e-98df-d8ac8e9f593a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Plans Assets relating to Pension Plans and Other Post-employment Plans</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of fair value of plan assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentAbstract_27de381d-acc8-4cd2-a95f-0fbaea3c77f6_terseLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment [abstract]</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MiscellaneousOtherProvisionsMember_6b0daad6-581a-48a8-9a02-11b03696f7bf_terseLabel_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other provisions</link:label>
    <link:label id="lab_ifrs-full_MiscellaneousOtherProvisionsMember_label_en-US" xlink:label="lab_ifrs-full_MiscellaneousOtherProvisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous other provisions [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherProvisionsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherProvisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousOtherProvisionsMember" xlink:to="lab_ifrs-full_MiscellaneousOtherProvisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CollaborationAgreementWithGSKMember_9d74574d-37b9-41d1-a1ca-a88aca9b86b9_terseLabel_en-US" xlink:label="lab_sny_CollaborationAgreementWithGSKMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement with GSK</link:label>
    <link:label id="lab_sny_CollaborationAgreementWithGSKMember_label_en-US" xlink:label="lab_sny_CollaborationAgreementWithGSKMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement With GSK [Member]</link:label>
    <link:label id="lab_sny_CollaborationAgreementWithGSKMember_documentation_en-US" xlink:label="lab_sny_CollaborationAgreementWithGSKMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement With GSK</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementWithGSKMember" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementWithGSKMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CollaborationAgreementWithGSKMember" xlink:to="lab_sny_CollaborationAgreementWithGSKMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock_2b8ce77a-5bd2-4e98-801b-4d7fc80388b2_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Currency Translation Differences</link:label>
    <link:label id="lab_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Reserve Of Exchange Differences On Translation [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of reserve of exchange differences on translation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock" xlink:to="lab_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RedemptionOfDebtInstrumentIssued_4cad369a-fcb8-4fe8-a2dd-3303d800dc9b_terseLabel_en-US" xlink:label="lab_sny_RedemptionOfDebtInstrumentIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt at redemption</link:label>
    <link:label id="lab_sny_RedemptionOfDebtInstrumentIssued_label_en-US" xlink:label="lab_sny_RedemptionOfDebtInstrumentIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption Of Debt Instrument Issued</link:label>
    <link:label id="lab_sny_RedemptionOfDebtInstrumentIssued_documentation_en-US" xlink:label="lab_sny_RedemptionOfDebtInstrumentIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption of debt instrument issued.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RedemptionOfDebtInstrumentIssued" xlink:href="sny-20221231.xsd#sny_RedemptionOfDebtInstrumentIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RedemptionOfDebtInstrumentIssued" xlink:to="lab_sny_RedemptionOfDebtInstrumentIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_f19f18a8-39e0-4639-99e7-04b10cb28646_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information about credit exposures designated as measured at fair value through profit or loss [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PlavixMember_eaee85c5-390e-49ae-b9fa-01e9107ae7d0_terseLabel_en-US" xlink:label="lab_sny_PlavixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix</link:label>
    <link:label id="lab_sny_PlavixMember_label_en-US" xlink:label="lab_sny_PlavixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix [Member]</link:label>
    <link:label id="lab_sny_PlavixMember_documentation_en-US" xlink:label="lab_sny_PlavixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixMember" xlink:href="sny-20221231.xsd#sny_PlavixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PlavixMember" xlink:to="lab_sny_PlavixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_June2018SNFISINUS801060AC87Member_4d7c397f-eadf-41b5-b8dc-a9ae33c6f9c3_terseLabel_en-US" xlink:label="lab_sny_June2018SNFISINUS801060AC87Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2018 SNF ISIN US801060AC87</link:label>
    <link:label id="lab_sny_June2018SNFISINUS801060AC87Member_label_en-US" xlink:label="lab_sny_June2018SNFISINUS801060AC87Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2018 SNFISINUS801060AC87 [member]</link:label>
    <link:label id="lab_sny_June2018SNFISINUS801060AC87Member_documentation_en-US" xlink:label="lab_sny_June2018SNFISINUS801060AC87Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2018SNFISINUS801060AC87.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_June2018SNFISINUS801060AC87Member" xlink:href="sny-20221231.xsd#sny_June2018SNFISINUS801060AC87Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_June2018SNFISINUS801060AC87Member" xlink:to="lab_sny_June2018SNFISINUS801060AC87Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_KiadisMember_bc3e0f6d-c47a-40f8-83e6-02f58796742b_terseLabel_en-US" xlink:label="lab_sny_KiadisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kiadis</link:label>
    <link:label id="lab_sny_KiadisMember_label_en-US" xlink:label="lab_sny_KiadisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kiadis [Member]</link:label>
    <link:label id="lab_sny_KiadisMember_documentation_en-US" xlink:label="lab_sny_KiadisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kiadis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KiadisMember" xlink:href="sny-20221231.xsd#sny_KiadisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_KiadisMember" xlink:to="lab_sny_KiadisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfPatentsCoveringProduct_b78bc53d-53e7-4ff2-9de8-2f61cbca7dd4_terseLabel_en-US" xlink:label="lab_sny_NumberOfPatentsCoveringProduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents covering product</link:label>
    <link:label id="lab_sny_NumberOfPatentsCoveringProduct_label_en-US" xlink:label="lab_sny_NumberOfPatentsCoveringProduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Patents Covering Product</link:label>
    <link:label id="lab_sny_NumberOfPatentsCoveringProduct_documentation_en-US" xlink:label="lab_sny_NumberOfPatentsCoveringProduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Patents Covering Product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPatentsCoveringProduct" xlink:href="sny-20221231.xsd#sny_NumberOfPatentsCoveringProduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfPatentsCoveringProduct" xlink:to="lab_sny_NumberOfPatentsCoveringProduct" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LegalAndArbitralProceedingsAxis_2d506f26-5354-4ed1-bc44-68bf0059f7bb_terseLabel_en-US" xlink:label="lab_sny_LegalAndArbitralProceedingsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal And Arbitral Proceedings [Axis]</link:label>
    <link:label id="lab_sny_LegalAndArbitralProceedingsAxis_label_en-US" xlink:label="lab_sny_LegalAndArbitralProceedingsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal And Arbitral Proceedings [Axis]</link:label>
    <link:label id="lab_sny_LegalAndArbitralProceedingsAxis_documentation_en-US" xlink:label="lab_sny_LegalAndArbitralProceedingsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal And Arbitral Proceedings [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LegalAndArbitralProceedingsAxis" xlink:href="sny-20221231.xsd#sny_LegalAndArbitralProceedingsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LegalAndArbitralProceedingsAxis" xlink:to="lab_sny_LegalAndArbitralProceedingsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities_816dc514-5c12-4920-ac7e-b7dea1b7180a_terseLabel_en-US" xlink:label="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current provisions and other current liabilities</link:label>
    <link:label id="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities_7ea028e5-4610-40a7-83a0-94ca1e43af8d_totalLabel_en-US" xlink:label="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Provisions And Other Current Liabilities</link:label>
    <link:label id="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of current provisions and current other liabilities that the entity does not separately disclose in the same statement or note.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities" xlink:href="sny-20221231.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities" xlink:to="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember_c39b6159-775a-4b42-b6b6-c03b09fbfea3_verboseLabel_en-US" xlink:label="lab_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 6 - Year 10</link:label>
    <link:label id="lab_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember_label_en-US" xlink:label="lab_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later Than Five Years And Not Later Than Eight Years [Member]</link:label>
    <link:label id="lab_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember_documentation_en-US" xlink:label="lab_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later Than Five Years And Not Later Than Eight Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember" xlink:href="sny-20221231.xsd#sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember" xlink:to="lab_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriod_ab63865f-0158-4223-a56b-161ff12ab13e_terseLabel_en-US" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value per share awarded (in euros per share)</link:label>
    <link:label id="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriod_label_en-US" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Per Share Awarded For Three Year Service Period</link:label>
    <link:label id="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriod_documentation_en-US" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value per share awarded to a three year service period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod" xlink:href="sny-20221231.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod" xlink:to="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiBeijingPharmaceuticalsCoLtdMember_628402e2-37cc-462c-abd8-6009f243c49a_terseLabel_en-US" xlink:label="lab_sny_SanofiBeijingPharmaceuticalsCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi (Beijing) Pharmaceuticals Co.Ltd</link:label>
    <link:label id="lab_sny_SanofiBeijingPharmaceuticalsCoLtdMember_label_en-US" xlink:label="lab_sny_SanofiBeijingPharmaceuticalsCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Beijing Pharmaceuticals Co Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiBeijingPharmaceuticalsCoLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiBeijingPharmaceuticalsCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Beijing Pharmaceuticals Co.Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBeijingPharmaceuticalsCoLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiBeijingPharmaceuticalsCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiBeijingPharmaceuticalsCoLtdMember" xlink:to="lab_sny_SanofiBeijingPharmaceuticalsCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAttributableToOwnersOfParent_8c5506e9-c876-4083-9af5-a9e05c512acc_verboseLabel_en-US" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity attributable to equity holders of Sanofi</link:label>
    <link:label id="lab_ifrs-full_EquityAttributableToOwnersOfParent_1cc55bdf-429b-4d09-8396-18e7e5be7048_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Attributable to equity holders of Sanofi</link:label>
    <link:label id="lab_ifrs-full_EquityAttributableToOwnersOfParent_label_en-US" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity attributable to owners of parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_EquityAttributableToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_bb16114e-3511-456b-b111-637926213ed6_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of financial instruments by type of interest rate [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of financial instruments by type of interest rate [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0b1db925-a82a-4106-b733-72fd59393618_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of transactions between related parties [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of transactions between related parties [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_ea116f99-9dd1-4986-8f77-a1d4fdfbd11b_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to equity holders of Sanofi</link:label>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_label_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:to="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember_991e610e-0e3e-47e7-a5f4-eefdb70956d4_terseLabel_en-US" xlink:label="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-generating units</link:label>
    <link:label id="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember_label_en-US" xlink:label="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-generating units [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember" xlink:to="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_2dc81c8f-617b-4026-91f8-6dd50f04895d_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off Setting Of Financial Assets And Liabilities [table]</link:label>
    <link:label id="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_label_en-US" xlink:label="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off Setting Of Financial Assets And Liabilities [table]</link:label>
    <link:label id="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off Setting Of Financial Assets And Liabilities [table].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable" xlink:to="lab_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_d73b557b-2b4d-4efb-aecf-bba4891a27e7_verboseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average exercise&#160;price per share, options exercisable (in euros per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_417ac096-6b99-4a85-8a81-0825eaf2c173_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise&#160;price per share, Options exercisable (in euros per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ImmunooncologyAllianceMember_3c8d7c87-3fea-4518-81f6-bc292380a491_terseLabel_en-US" xlink:label="lab_sny_ImmunooncologyAllianceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immuno-Oncology Alliance</link:label>
    <link:label id="lab_sny_ImmunooncologyAllianceMember_label_en-US" xlink:label="lab_sny_ImmunooncologyAllianceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immuno-oncology Alliance [Member]</link:label>
    <link:label id="lab_sny_ImmunooncologyAllianceMember_documentation_en-US" xlink:label="lab_sny_ImmunooncologyAllianceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immuno-oncology Alliance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImmunooncologyAllianceMember" xlink:href="sny-20221231.xsd#sny_ImmunooncologyAllianceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ImmunooncologyAllianceMember" xlink:to="lab_sny_ImmunooncologyAllianceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_580a0a13-7574-43c8-a4ed-abd59ddd4aaf_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of maturity analysis of finance lease payments receivable [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of maturity analysis of finance lease payments receivable [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans_70b53d9c-b51a-427f-922f-5017c3a1fe73_terseLabel_en-US" xlink:label="lab_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains and losses on defined-benefit plans</link:label>
    <link:label id="lab_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans_label_en-US" xlink:label="lab_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial Gains And Losses On Defined Benefit Plans</link:label>
    <link:label id="lab_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans_documentation_en-US" xlink:label="lab_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains and losses on defined-benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans" xlink:href="sny-20221231.xsd#sny_ActuarialGainsAndLossesOnDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans" xlink:to="lab_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_97ffec82-150e-4088-b9ce-02cb7e3dc487_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of financial instruments [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of financial instruments [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_821644b8-1284-40b9-81b5-6bb9982e3a08_terseLabel_en-US" xlink:label="lab_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability risks, litigation and other</link:label>
    <link:label id="lab_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_b2acd70d-f937-4c45-a812-9836554b83a5_verboseLabel_en-US" xlink:label="lab_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for product liability risks, litigation and other</link:label>
    <link:label id="lab_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_label_en-US" xlink:label="lab_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Provision For Product Liability Risks Litigation And Other</link:label>
    <link:label id="lab_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_documentation_en-US" xlink:label="lab_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability risks litigation and other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" xlink:to="lab_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PublicOfferingMember_d3cea6e3-1002-4568-9129-0248e3f8dc32_terseLabel_en-US" xlink:label="lab_sny_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public offering</link:label>
    <link:label id="lab_sny_PublicOfferingMember_label_en-US" xlink:label="lab_sny_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Offering [Member]</link:label>
    <link:label id="lab_sny_PublicOfferingMember_documentation_en-US" xlink:label="lab_sny_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PublicOfferingMember" xlink:href="sny-20221231.xsd#sny_PublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PublicOfferingMember" xlink:to="lab_sny_PublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_6e26fb6f-2334-48df-bb2f-30f0b4e8b954_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of initial application of standards or interpretations [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of initial application of standards or interpretations [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock_bd07e001-9555-4d4e-a948-c6e392add5c0_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Characteristics of Employee Share Ownership Plans Awarded</link:label>
    <link:label id="lab_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Employee Stock Ownership Plan Awarded In Capital Increase Reserved Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of employee stock ownership plan awarded in capital increase reserved explanatory [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_535b689f-3d20-4ef6-aa6c-578d320fa6bf_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ValueOnRedemptionMember_c3dacf82-cf67-4e5b-abca-dc9e120bbd7a_terseLabel_en-US" xlink:label="lab_sny_ValueOnRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value on redemption</link:label>
    <link:label id="lab_sny_ValueOnRedemptionMember_label_en-US" xlink:label="lab_sny_ValueOnRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value On Redemption [Member]</link:label>
    <link:label id="lab_sny_ValueOnRedemptionMember_documentation_en-US" xlink:label="lab_sny_ValueOnRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value on redemption.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionMember" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ValueOnRedemptionMember" xlink:to="lab_sny_ValueOnRedemptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CollaborationAgreementAnnualNetSalesTarget_0eb3e4e1-445b-4a55-a382-c5c8e880031d_terseLabel_en-US" xlink:label="lab_sny_CollaborationAgreementAnnualNetSalesTarget" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, annual net sales target</link:label>
    <link:label id="lab_sny_CollaborationAgreementAnnualNetSalesTarget_label_en-US" xlink:label="lab_sny_CollaborationAgreementAnnualNetSalesTarget" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Annual Net Sales Target</link:label>
    <link:label id="lab_sny_CollaborationAgreementAnnualNetSalesTarget_documentation_en-US" xlink:label="lab_sny_CollaborationAgreementAnnualNetSalesTarget" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Annual Net Sales Target</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementAnnualNetSalesTarget" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementAnnualNetSalesTarget"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CollaborationAgreementAnnualNetSalesTarget" xlink:to="lab_sny_CollaborationAgreementAnnualNetSalesTarget" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9808fc12-47ea-4267-b18d-7194b07e9b9e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ProvisionsRecordedForFutureOperatingLosses_1a33b478-3a18-4c6a-8fa1-bf592a1ff2ae_terseLabel_en-US" xlink:label="lab_sny_ProvisionsRecordedForFutureOperatingLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions recorded for future operating losses</link:label>
    <link:label id="lab_sny_ProvisionsRecordedForFutureOperatingLosses_label_en-US" xlink:label="lab_sny_ProvisionsRecordedForFutureOperatingLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions Recorded For Future Operating Losses</link:label>
    <link:label id="lab_sny_ProvisionsRecordedForFutureOperatingLosses_documentation_en-US" xlink:label="lab_sny_ProvisionsRecordedForFutureOperatingLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions recorded for future operating losses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsRecordedForFutureOperatingLosses" xlink:href="sny-20221231.xsd#sny_ProvisionsRecordedForFutureOperatingLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProvisionsRecordedForFutureOperatingLosses" xlink:to="lab_sny_ProvisionsRecordedForFutureOperatingLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MedicareMember_d4b76a1c-79f7-48f1-a2a0-1b76d9985636_terseLabel_en-US" xlink:label="lab_sny_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_sny_MedicareMember_label_en-US" xlink:label="lab_sny_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:label id="lab_sny_MedicareMember_documentation_en-US" xlink:label="lab_sny_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MedicareMember" xlink:href="sny-20221231.xsd#sny_MedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MedicareMember" xlink:to="lab_sny_MedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount_b14f6c67-c8f3-4db0-899f-253af0a1eafd_terseLabel_en-US" xlink:label="lab_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax impact on other comprehensive income</link:label>
    <link:label id="lab_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount_label_en-US" xlink:label="lab_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Instruments At Fair Value Through Other Comprehensive Income (Loss), 10% Decline In Credit Prices, Pre-tax Amount</link:label>
    <link:label id="lab_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount_documentation_en-US" xlink:label="lab_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Instruments At Fair Value Through Other Comprehensive Income (Loss), 10% Decline In Credit Prices, Pre-tax Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount" xlink:href="sny-20221231.xsd#sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount" xlink:to="lab_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_c70607bd-2960-4ca1-8c78-070203b1c629_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_September2015EMTNISINFR0012969038Member_38e11d83-6f83-47a6-91ad-efdc55f4904d_terseLabel_en-US" xlink:label="lab_sny_September2015EMTNISINFR0012969038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2015 EMTN ISIN FR0012969038</link:label>
    <link:label id="lab_sny_September2015EMTNISINFR0012969038Member_label_en-US" xlink:label="lab_sny_September2015EMTNISINFR0012969038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2015 EMTNISINFR0012969038 [Member]</link:label>
    <link:label id="lab_sny_September2015EMTNISINFR0012969038Member_documentation_en-US" xlink:label="lab_sny_September2015EMTNISINFR0012969038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2015 EMTN ISIN FR0012969038.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_September2015EMTNISINFR0012969038Member" xlink:href="sny-20221231.xsd#sny_September2015EMTNISINFR0012969038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_September2015EMTNISINFR0012969038Member" xlink:to="lab_sny_September2015EMTNISINFR0012969038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseInContingentConsideration_38503ea0-90d7-4e8b-ac61-5b2be4d1cf37_terseLabel_en-US" xlink:label="lab_sny_IncreaseInContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in contingent consideration</link:label>
    <link:label id="lab_sny_IncreaseInContingentConsideration_label_en-US" xlink:label="lab_sny_IncreaseInContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Contingent Consideration</link:label>
    <link:label id="lab_sny_IncreaseInContingentConsideration_documentation_en-US" xlink:label="lab_sny_IncreaseInContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseInContingentConsideration" xlink:href="sny-20221231.xsd#sny_IncreaseInContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseInContingentConsideration" xlink:to="lab_sny_IncreaseInContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_75d2725d-6bfd-4766-9940-cd3adf6b8e9d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of compensation paid to key management personnel [abstract]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of transactions between related parties [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock_6c7aec04-49ae-4289-8c24-0cab9bb9ae40_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to non-controlling interests</link:label>
    <link:label id="lab_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Profit Loss Attributable To Noncontrolling Interests [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for net income attributable to non-controlling interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock" xlink:to="lab_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts_e48cd545-8168-4bea-bcbd-a6b33bc93d54_terseLabel_en-US" xlink:label="lab_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of investments accounted for using equity method, before transaction costs</link:label>
    <link:label id="lab_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts_label_en-US" xlink:label="lab_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sales Of Investments Accounted For Using Equity Method, Before Transaction Costs</link:label>
    <link:label id="lab_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts_documentation_en-US" xlink:label="lab_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sales Of Investments Accounted For Using Equity Method, Before Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts" xlink:href="sny-20221231.xsd#sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts" xlink:to="lab_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_7c2a5e1b-f4e9-49b1-bd7e-b1fe93b0fd8a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase_0a0c4c1c-08aa-454a-8f48-d8d0d07f310e_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments related to research and development relating to projects in research phase</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase_label_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Research And Development Relating To Projects In Research Phase</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Research And Development Relating To Projects In Research Phase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase" xlink:to="lab_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrentAssetsMember_36a90b9d-c942-4acf-81c1-4ca07cb271d5_terseLabel_en-US" xlink:label="lab_sny_CurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_sny_CurrentAssetsMember_label_en-US" xlink:label="lab_sny_CurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets [Member]</link:label>
    <link:label id="lab_sny_CurrentAssetsMember_documentation_en-US" xlink:label="lab_sny_CurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentAssetsMember" xlink:href="sny-20221231.xsd#sny_CurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentAssetsMember" xlink:to="lab_sny_CurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilityAsset_017189bb-29e0-4a7a-9342-1794cc90c8bc_negatedLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax asset/(liability)</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TransferPercentageOfPandemicVaccines_f2f4cf80-2b14-4f0a-95a0-2581cbd7a979_terseLabel_en-US" xlink:label="lab_sny_TransferPercentageOfPandemicVaccines" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of pandemic vaccines agreed to transfer</link:label>
    <link:label id="lab_sny_TransferPercentageOfPandemicVaccines_label_en-US" xlink:label="lab_sny_TransferPercentageOfPandemicVaccines" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Percentage Of Pandemic Vaccines</link:label>
    <link:label id="lab_sny_TransferPercentageOfPandemicVaccines_documentation_en-US" xlink:label="lab_sny_TransferPercentageOfPandemicVaccines" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer percentage of pandemic vaccines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TransferPercentageOfPandemicVaccines" xlink:href="sny-20221231.xsd#sny_TransferPercentageOfPandemicVaccines"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TransferPercentageOfPandemicVaccines" xlink:to="lab_sny_TransferPercentageOfPandemicVaccines" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CapitalLossesCarryBackPeriod_cf39ddca-6049-4d59-8b51-014e02afdf3f_terseLabel_en-US" xlink:label="lab_sny_CapitalLossesCarryBackPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital losses, carry back period</link:label>
    <link:label id="lab_sny_CapitalLossesCarryBackPeriod_label_en-US" xlink:label="lab_sny_CapitalLossesCarryBackPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Losses, Carry Back Period</link:label>
    <link:label id="lab_sny_CapitalLossesCarryBackPeriod_documentation_en-US" xlink:label="lab_sny_CapitalLossesCarryBackPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Losses, Carry Back Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CapitalLossesCarryBackPeriod" xlink:href="sny-20221231.xsd#sny_CapitalLossesCarryBackPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CapitalLossesCarryBackPeriod" xlink:to="lab_sny_CapitalLossesCarryBackPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiASMember_c44a81be-db9a-4978-9a96-a51080758c51_terseLabel_en-US" xlink:label="lab_sny_SanofiASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi A/S</link:label>
    <link:label id="lab_sny_SanofiASMember_label_en-US" xlink:label="lab_sny_SanofiASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi A/S [Member]</link:label>
    <link:label id="lab_sny_SanofiASMember_documentation_en-US" xlink:label="lab_sny_SanofiASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi A/S [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiASMember" xlink:href="sny-20221231.xsd#sny_SanofiASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiASMember" xlink:to="lab_sny_SanofiASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DepakineProductLitigationInNorthernIrelandMember_6a07b9d4-1b69-46c9-b76b-f4d8e8676d09_terseLabel_en-US" xlink:label="lab_sny_DepakineProductLitigationInNorthernIrelandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Northern Ireland</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInNorthernIrelandMember_label_en-US" xlink:label="lab_sny_DepakineProductLitigationInNorthernIrelandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Northern Ireland [Member]</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInNorthernIrelandMember_documentation_en-US" xlink:label="lab_sny_DepakineProductLitigationInNorthernIrelandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Northern Ireland</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInNorthernIrelandMember" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInNorthernIrelandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DepakineProductLitigationInNorthernIrelandMember" xlink:to="lab_sny_DepakineProductLitigationInNorthernIrelandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfDecisionsIssuedByTheDistrictCourt_4429cf70-c55c-4553-b222-b692b34c26a8_terseLabel_en-US" xlink:label="lab_sny_NumberOfDecisionsIssuedByTheDistrictCourt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of decisions issued by the District Court</link:label>
    <link:label id="lab_sny_NumberOfDecisionsIssuedByTheDistrictCourt_label_en-US" xlink:label="lab_sny_NumberOfDecisionsIssuedByTheDistrictCourt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Decisions Issued By The District Court</link:label>
    <link:label id="lab_sny_NumberOfDecisionsIssuedByTheDistrictCourt_documentation_en-US" xlink:label="lab_sny_NumberOfDecisionsIssuedByTheDistrictCourt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Decisions Issued By The District Court</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfDecisionsIssuedByTheDistrictCourt" xlink:href="sny-20221231.xsd#sny_NumberOfDecisionsIssuedByTheDistrictCourt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfDecisionsIssuedByTheDistrictCourt" xlink:to="lab_sny_NumberOfDecisionsIssuedByTheDistrictCourt" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfTargetsThatEncompassAllDiseasesAreas_9ce9a257-d956-40d6-8ca9-dca2a1963d9c_terseLabel_en-US" xlink:label="lab_sny_NumberOfTargetsThatEncompassAllDiseasesAreas" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Targets that encompass all diseases areas</link:label>
    <link:label id="lab_sny_NumberOfTargetsThatEncompassAllDiseasesAreas_label_en-US" xlink:label="lab_sny_NumberOfTargetsThatEncompassAllDiseasesAreas" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Targets That Encompass All Diseases Areas</link:label>
    <link:label id="lab_sny_NumberOfTargetsThatEncompassAllDiseasesAreas_documentation_en-US" xlink:label="lab_sny_NumberOfTargetsThatEncompassAllDiseasesAreas" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Targets That Encompass All Diseases Areas</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfTargetsThatEncompassAllDiseasesAreas" xlink:href="sny-20221231.xsd#sny_NumberOfTargetsThatEncompassAllDiseasesAreas"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfTargetsThatEncompassAllDiseasesAreas" xlink:to="lab_sny_NumberOfTargetsThatEncompassAllDiseasesAreas" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockOptionPlanMember_e2fd578e-7a0f-40e5-9b2a-e10aa589a85f_terseLabel_en-US" xlink:label="lab_sny_StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Plan</link:label>
    <link:label id="lab_sny_StockOptionPlanMember_label_en-US" xlink:label="lab_sny_StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Plan [member]</link:label>
    <link:label id="lab_sny_StockOptionPlanMember_documentation_en-US" xlink:label="lab_sny_StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Plan [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionPlanMember" xlink:href="sny-20221231.xsd#sny_StockOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockOptionPlanMember" xlink:to="lab_sny_StockOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DepakineProductLitigationInGreatBritainMember_608dcc48-fddb-4552-8b1f-f62847b58c2a_verboseLabel_en-US" xlink:label="lab_sny_DepakineProductLitigationInGreatBritainMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Great Britain</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInGreatBritainMember_label_en-US" xlink:label="lab_sny_DepakineProductLitigationInGreatBritainMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Great Britain [Member]</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInGreatBritainMember_documentation_en-US" xlink:label="lab_sny_DepakineProductLitigationInGreatBritainMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Great Britain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInGreatBritainMember" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInGreatBritainMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DepakineProductLitigationInGreatBritainMember" xlink:to="lab_sny_DepakineProductLitigationInGreatBritainMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_77030fc7-7788-4750-83a7-76d14ac6120b_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term benefits</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key management personnel compensation, short-term employee benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering_d72181b3-ca9f-4b65-8f8b-99d77c958e19_terseLabel_en-US" xlink:label="lab_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of issued and outstanding share capital tendered into the public offer</link:label>
    <link:label id="lab_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering_label_en-US" xlink:label="lab_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Proportion Of Issued And Outstanding Share Capital Tendered Into The Offering</link:label>
    <link:label id="lab_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering_documentation_en-US" xlink:label="lab_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Proportion Of Issued And Outstanding Share Capital Tendered Into The Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering" xlink:href="sny-20221231.xsd#sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering" xlink:to="lab_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock_7deda56f-fd89-4dd6-8e1f-4ec1a40a0da5_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Options Outstanding at Each Balance Sheet Date</link:label>
    <link:label id="lab_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Stock Options Outstanding At Each Balance Sheet Date And Of Changes During The Relevant Periods [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of stock options outstanding at each balance sheet date and of changes during the relevant periods.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock" xlink:to="lab_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests_f4b53861-1644-4fce-9756-77ba8636ed50_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Net Exchange Differences Business Combinations And Noncontrolling Interests</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease through net exchange differences business combinations and noncontrolling interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xlink:to="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member_e0e10da6-1ae3-45ed-b502-1c105cabc9d0_terseLabel_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69%</link:label>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member_label_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% [Member]</link:label>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member_documentation_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedEsterReceive069Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member" xlink:to="lab_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ErnstAndYoungMember_d981aec1-ec8e-4912-a0b3-16acd829b786_terseLabel_en-US" xlink:label="lab_sny_ErnstAndYoungMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ernst&#160;&amp;&#160;Young</link:label>
    <link:label id="lab_sny_ErnstAndYoungMember_label_en-US" xlink:label="lab_sny_ErnstAndYoungMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ernst And Young [Member]</link:label>
    <link:label id="lab_sny_ErnstAndYoungMember_documentation_en-US" xlink:label="lab_sny_ErnstAndYoungMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ernst And Young.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ErnstAndYoungMember" xlink:href="sny-20221231.xsd#sny_ErnstAndYoungMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ErnstAndYoungMember" xlink:to="lab_sny_ErnstAndYoungMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SPMSDContingentConsiderationAssetMember_519ca2fd-d111-4ec0-964d-995d93a4c012_terseLabel_en-US" xlink:label="lab_sny_SPMSDContingentConsiderationAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPMSD contingent consideration asset</link:label>
    <link:label id="lab_sny_SPMSDContingentConsiderationAssetMember_label_en-US" xlink:label="lab_sny_SPMSDContingentConsiderationAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPMSD Contingent Consideration Asset [Member]</link:label>
    <link:label id="lab_sny_SPMSDContingentConsiderationAssetMember_documentation_en-US" xlink:label="lab_sny_SPMSDContingentConsiderationAssetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPMSD contingent consideration asset.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SPMSDContingentConsiderationAssetMember" xlink:href="sny-20221231.xsd#sny_SPMSDContingentConsiderationAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SPMSDContingentConsiderationAssetMember" xlink:to="lab_sny_SPMSDContingentConsiderationAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_March2018EMTNISINFR0013324357Member_12c05672-ada2-469f-9a3e-89dbd572686f_terseLabel_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324357Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR0013324357</link:label>
    <link:label id="lab_sny_March2018EMTNISINFR0013324357Member_label_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324357Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR0013324357 [Member]</link:label>
    <link:label id="lab_sny_March2018EMTNISINFR0013324357Member_documentation_en-US" xlink:label="lab_sny_March2018EMTNISINFR0013324357Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2018 EMTN ISIN FR 0013324357.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324357Member" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324357Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_March2018EMTNISINFR0013324357Member" xlink:to="lab_sny_March2018EMTNISINFR0013324357Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisParticipationsSASMember_a73f8272-6f52-4a92-a557-2aa9a14532fa_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisParticipationsSASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Participations</link:label>
    <link:label id="lab_sny_SanofiAventisParticipationsSASMember_label_en-US" xlink:label="lab_sny_SanofiAventisParticipationsSASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Participations SAS [member]</link:label>
    <link:label id="lab_sny_SanofiAventisParticipationsSASMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisParticipationsSASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Participations SAS.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisParticipationsSASMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisParticipationsSASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisParticipationsSASMember" xlink:to="lab_sny_SanofiAventisParticipationsSASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_76a88c71-32c0-44c0-a07c-df78e657f5de_terseLabel_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedges of net investments in foreign operations</link:label>
    <link:label id="lab_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_label_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Currency Translation On Hedges Of Net Investments In Foreign Operations</link:label>
    <link:label id="lab_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_documentation_en-US" xlink:label="lab_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in currency translation on hedges of net investments in foreign operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xlink:to="lab_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock_9594cfa1-8e69-4661-b624-5259491487a8_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Market Value of Net Debt</link:label>
    <link:label id="lab_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Market Value Of Net Debt [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of market value of net debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfMarketValueOfNetDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xlink:to="lab_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfCasesDismissed_cbaf04cd-0a48-492e-abdc-dd0fc11d2651_terseLabel_en-US" xlink:label="lab_sny_NumberOfCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases dismissed</link:label>
    <link:label id="lab_sny_NumberOfCasesDismissed_label_en-US" xlink:label="lab_sny_NumberOfCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Cases Dismissed</link:label>
    <link:label id="lab_sny_NumberOfCasesDismissed_documentation_en-US" xlink:label="lab_sny_NumberOfCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Cases Dismissed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCasesDismissed" xlink:href="sny-20221231.xsd#sny_NumberOfCasesDismissed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfCasesDismissed" xlink:to="lab_sny_NumberOfCasesDismissed" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfJointOperationsLineItems_6fd37ab6-8813-48c4-ad81-20d9cc37d351_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfJointOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of joint operations [line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfJointOperationsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfJointOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of joint operations [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfJointOperationsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfJointOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfJointOperationsLineItems" xlink:to="lab_ifrs-full_DisclosureOfJointOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GlaxoSmithKlineConsumerHealthcareLPMember_ad389711-6292-47b6-b49e-af1d9ff267b6_terseLabel_en-US" xlink:label="lab_sny_GlaxoSmithKlineConsumerHealthcareLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GlaxoSmithKline Consumer Healthcare, L.P.</link:label>
    <link:label id="lab_sny_GlaxoSmithKlineConsumerHealthcareLPMember_label_en-US" xlink:label="lab_sny_GlaxoSmithKlineConsumerHealthcareLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glaxo Smith Kline Consumer Healthcare L P [Member]</link:label>
    <link:label id="lab_sny_GlaxoSmithKlineConsumerHealthcareLPMember_documentation_en-US" xlink:label="lab_sny_GlaxoSmithKlineConsumerHealthcareLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glaxo Smith Kline Consumer Health Care L P.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GlaxoSmithKlineConsumerHealthcareLPMember" xlink:href="sny-20221231.xsd#sny_GlaxoSmithKlineConsumerHealthcareLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GlaxoSmithKlineConsumerHealthcareLPMember" xlink:to="lab_sny_GlaxoSmithKlineConsumerHealthcareLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PolioPertussisHibVaccinesMember_fd53afab-ac02-461b-9e32-c34b28c77a99_terseLabel_en-US" xlink:label="lab_sny_PolioPertussisHibVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polio/Pertussis/ Hib Vaccines</link:label>
    <link:label id="lab_sny_PolioPertussisHibVaccinesMember_label_en-US" xlink:label="lab_sny_PolioPertussisHibVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polio Pertussis Hib Vaccines [Member]</link:label>
    <link:label id="lab_sny_PolioPertussisHibVaccinesMember_documentation_en-US" xlink:label="lab_sny_PolioPertussisHibVaccinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polio Pertussis Hib Vaccines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PolioPertussisHibVaccinesMember" xlink:href="sny-20221231.xsd#sny_PolioPertussisHibVaccinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PolioPertussisHibVaccinesMember" xlink:to="lab_sny_PolioPertussisHibVaccinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LovenoxMember_de86a524-3147-401c-8ab2-95f13614cb3b_terseLabel_en-US" xlink:label="lab_sny_LovenoxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lovenox</link:label>
    <link:label id="lab_sny_LovenoxMember_label_en-US" xlink:label="lab_sny_LovenoxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lovenox [Member]</link:label>
    <link:label id="lab_sny_LovenoxMember_documentation_en-US" xlink:label="lab_sny_LovenoxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lovenox.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LovenoxMember" xlink:href="sny-20221231.xsd#sny_LovenoxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LovenoxMember" xlink:to="lab_sny_LovenoxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsTable_7d128beb-6687-465c-b8da-1d04aeaecef2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of operating segments [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of operating segments [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SyndicatedCreditFacilityTwoMember_55a0dac0-317a-4012-b788-196fef3d8e78_terseLabel_en-US" xlink:label="lab_sny_SyndicatedCreditFacilityTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated credit facility, expires in December 2025</link:label>
    <link:label id="lab_sny_SyndicatedCreditFacilityTwoMember_label_en-US" xlink:label="lab_sny_SyndicatedCreditFacilityTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated Credit Facility Two [Member]</link:label>
    <link:label id="lab_sny_SyndicatedCreditFacilityTwoMember_documentation_en-US" xlink:label="lab_sny_SyndicatedCreditFacilityTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated credit facility two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SyndicatedCreditFacilityTwoMember" xlink:href="sny-20221231.xsd#sny_SyndicatedCreditFacilityTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SyndicatedCreditFacilityTwoMember" xlink:to="lab_sny_SyndicatedCreditFacilityTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement_450eeab8-259f-428f-a242-59e758a7f174_terseLabel_en-US" xlink:label="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, number of shares issued in transaction, shares agreement (in shares)</link:label>
    <link:label id="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement_label_en-US" xlink:label="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Number Of Shares Issued In Transaction, Shares Agreement</link:label>
    <link:label id="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement_documentation_en-US" xlink:label="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Number Of Shares Issued In Transaction, Shares Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement" xlink:to="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FixturesAndFittingsMember_373dfb5c-7ccc-4311-b41d-71c016394dd8_verboseLabel_en-US" xlink:label="lab_ifrs-full_FixturesAndFittingsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures</link:label>
    <link:label id="lab_ifrs-full_FixturesAndFittingsMember_20302a24-fdc7-4eee-9c65-3da99f52a6d9_terseLabel_en-US" xlink:label="lab_ifrs-full_FixturesAndFittingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures, fittings&#160;and other</link:label>
    <link:label id="lab_ifrs-full_FixturesAndFittingsMember_label_en-US" xlink:label="lab_ifrs-full_FixturesAndFittingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures and fittings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixturesAndFittingsMember" xlink:to="lab_ifrs-full_FixturesAndFittingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentRegistrationStatement_16f1716e-6848-410a-8d90-0f2f8859aa8e_terseLabel_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Registration Statement</link:label>
    <link:label id="lab_dei_DocumentRegistrationStatement_label_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement" xlink:to="lab_dei_DocumentRegistrationStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_c707470c-6ccb-4ed7-970f-ea52394a23d6_terseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_8eb3bf6d-9c3f-44fd-9e8c-951c93ce1809_verboseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxLiabilitiesCurrent_0706683e-839e-4e04-a5dc-35aea62b190a_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxLiabilitiesCurrent_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax liabilities, current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:to="lab_ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SECIPESASMember_b92c6da9-74d0-45e1-8796-88153500546e_terseLabel_en-US" xlink:label="lab_sny_SECIPESASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SECIPE SAS</link:label>
    <link:label id="lab_sny_SECIPESASMember_label_en-US" xlink:label="lab_sny_SECIPESASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SECIPE SAS [Member]</link:label>
    <link:label id="lab_sny_SECIPESASMember_documentation_en-US" xlink:label="lab_sny_SECIPESASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SECIPE SAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SECIPESASMember" xlink:href="sny-20221231.xsd#sny_SECIPESASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SECIPESASMember" xlink:to="lab_sny_SECIPESASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsMember_96d31147-4888-4280-87cf-8c6f5fb6cc45_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets, class</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsMember_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets, class [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsMember" xlink:to="lab_ifrs-full_FinancialAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiChimieMember_2d6b5923-6f78-42ba-b01c-7136ce4cbbc2_terseLabel_en-US" xlink:label="lab_sny_SanofiChimieMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Chimie</link:label>
    <link:label id="lab_sny_SanofiChimieMember_label_en-US" xlink:label="lab_sny_SanofiChimieMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Chimie [member]</link:label>
    <link:label id="lab_sny_SanofiChimieMember_documentation_en-US" xlink:label="lab_sny_SanofiChimieMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Chimie.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiChimieMember" xlink:href="sny-20221231.xsd#sny_SanofiChimieMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiChimieMember" xlink:to="lab_sny_SanofiChimieMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity_8a13f4f6-af3c-437b-bd76-a103390634c9_negatedTerseLabel_en-US" xlink:label="lab_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized after-tax losses</link:label>
    <link:label id="lab_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity_label_en-US" xlink:label="lab_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) On Securities Measured At Fair Value Through Other Comprehensive Income That Will Be Reclassified To Profit And Loss Recognized In Equity</link:label>
    <link:label id="lab_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity_documentation_en-US" xlink:label="lab_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity instruments at fair value through other comprehensive income and Debt instruments at fair value through other comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity" xlink:href="sny-20221231.xsd#sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity" xlink:to="lab_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_961d30c9-58ee-4974-8f78-5c0e7d1a2311_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock_c684d8af-65a0-41f0-8284-d29998d88bd2_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Softwares Recognized in Income Statement</link:label>
    <link:label id="lab_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Amortization Of Software And Other Rights By Income Statement Line [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of amortization of software and other rights by income statement line.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock" xlink:to="lab_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_ff6eb767-0ef9-486f-9e0a-a6e93b041c2a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of classes of share capital [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of classes of share capital [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherLongtermProvisions_0f32370c-82fb-4c4c-a4e2-d527d696bb93_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherLongtermProvisions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_OtherLongtermProvisions_label_en-US" xlink:label="lab_ifrs-full_OtherLongtermProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherLongtermProvisions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherLongtermProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherLongtermProvisions" xlink:to="lab_ifrs-full_OtherLongtermProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashTransferred_66c3b3bd-4c60-4fcc-94f9-4763e17d20b8_terseLabel_en-US" xlink:label="lab_ifrs-full_CashTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash transferred</link:label>
    <link:label id="lab_ifrs-full_CashTransferred_label_en-US" xlink:label="lab_ifrs-full_CashTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashTransferred" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashTransferred" xlink:to="lab_ifrs-full_CashTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_country_TR_25fb4d9b-8b82-4a88-82ce-6a2a3a95e328_terseLabel_en-US" xlink:label="lab_country_TR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turkey</link:label>
    <link:label id="lab_country_TR_label_en-US" xlink:label="lab_country_TR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TURKEY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_TR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_TR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_TR" xlink:to="lab_country_TR" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember_1a92558b-3432-46d3-8ca9-8394ef0d3f20_terseLabel_en-US" xlink:label="lab_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for pensions and other employee benefits</link:label>
    <link:label id="lab_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember_label_en-US" xlink:label="lab_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision For Pensions And Other Employee Benefits [member]</link:label>
    <link:label id="lab_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember_documentation_en-US" xlink:label="lab_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for pensions and other employee benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember" xlink:href="sny-20221231.xsd#sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember" xlink:to="lab_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisposalGroupGainOnDisposal_d0f5f00b-3355-4f6f-b52e-187830fcf4e6_terseLabel_en-US" xlink:label="lab_sny_DisposalGroupGainOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal</link:label>
    <link:label id="lab_sny_DisposalGroupGainOnDisposal_label_en-US" xlink:label="lab_sny_DisposalGroupGainOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Gain On Disposal</link:label>
    <link:label id="lab_sny_DisposalGroupGainOnDisposal_documentation_en-US" xlink:label="lab_sny_DisposalGroupGainOnDisposal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Gain On Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalGroupGainOnDisposal" xlink:href="sny-20221231.xsd#sny_DisposalGroupGainOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisposalGroupGainOnDisposal" xlink:to="lab_sny_DisposalGroupGainOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Equity_3b57e7fa-bd4f-4b09-9aba-b9735cd8bd83_totalLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_ifrs-full_Equity_2dab0973-eae4-4bc7-963d-1c21635ea9b2_periodStartLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_ifrs-full_Equity_3b19e52e-4a92-4d09-8825-c2377e3c4093_periodEndLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_ifrs-full_Equity_label_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity" xlink:to="lab_ifrs-full_Equity" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfFamiliesWhoFiledACivilClaim_f1570caa-9e94-41eb-a371-827438939727_terseLabel_en-US" xlink:label="lab_sny_NumberOfFamiliesWhoFiledACivilClaim" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of families who filed a civil claim</link:label>
    <link:label id="lab_sny_NumberOfFamiliesWhoFiledACivilClaim_label_en-US" xlink:label="lab_sny_NumberOfFamiliesWhoFiledACivilClaim" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Families Who Filed A Civil Claim</link:label>
    <link:label id="lab_sny_NumberOfFamiliesWhoFiledACivilClaim_documentation_en-US" xlink:label="lab_sny_NumberOfFamiliesWhoFiledACivilClaim" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Families Who Filed A Civil Claim</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfFamiliesWhoFiledACivilClaim" xlink:href="sny-20221231.xsd#sny_NumberOfFamiliesWhoFiledACivilClaim"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfFamiliesWhoFiledACivilClaim" xlink:to="lab_sny_NumberOfFamiliesWhoFiledACivilClaim" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_53b585b0-d8fc-4036-be57-e6d9d5284735_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BorrowingMaximumDrawdown_54c8ddf5-2993-4e81-9b7c-73bfffd0fdd4_terseLabel_en-US" xlink:label="lab_sny_BorrowingMaximumDrawdown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing, maximum drawdown</link:label>
    <link:label id="lab_sny_BorrowingMaximumDrawdown_label_en-US" xlink:label="lab_sny_BorrowingMaximumDrawdown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing, Maximum Drawdown</link:label>
    <link:label id="lab_sny_BorrowingMaximumDrawdown_documentation_en-US" xlink:label="lab_sny_BorrowingMaximumDrawdown" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum drawdown.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BorrowingMaximumDrawdown" xlink:href="sny-20221231.xsd#sny_BorrowingMaximumDrawdown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BorrowingMaximumDrawdown" xlink:to="lab_sny_BorrowingMaximumDrawdown" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccumulatedImpairmentMember_8865f897-aa38-4c5b-a902-5a4b49d4a656_terseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment</link:label>
    <link:label id="lab_ifrs-full_AccumulatedImpairmentMember_label_en-US" xlink:label="lab_ifrs-full_AccumulatedImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedImpairmentMember" xlink:to="lab_ifrs-full_AccumulatedImpairmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_UnwindingOfDiscount_3618752c-fe39-4394-9ef0-89d7d9448bca_terseLabel_en-US" xlink:label="lab_sny_UnwindingOfDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unwinding of discount</link:label>
    <link:label id="lab_sny_UnwindingOfDiscount_label_en-US" xlink:label="lab_sny_UnwindingOfDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unwinding Of Discount</link:label>
    <link:label id="lab_sny_UnwindingOfDiscount_documentation_en-US" xlink:label="lab_sny_UnwindingOfDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unwinding Of Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnwindingOfDiscount" xlink:href="sny-20221231.xsd#sny_UnwindingOfDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UnwindingOfDiscount" xlink:to="lab_sny_UnwindingOfDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares_f64ab46b-4214-4b3d-9de9-4e3094dfff8c_terseLabel_en-US" xlink:label="lab_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment for restricted shares (in shares)</link:label>
    <link:label id="lab_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares_label_en-US" xlink:label="lab_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Effect Of Share Options On Number Of Restricted Shares</link:label>
    <link:label id="lab_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares_documentation_en-US" xlink:label="lab_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share options on number of restricted shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xlink:href="sny-20221231.xsd#sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xlink:to="lab_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_6661cf46-8589-41bd-a6b4-8274ae68b7ac_terseLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options&#160;and other&#160;share- based payments</link:label>
    <link:label id="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_label_en-US" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve of share-based payments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:to="lab_ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis_db1e5d16-b376-42bb-9069-99b3ae84114d_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of Contingent Liabilities [Axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of contingent liabilities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable_2acc8bf7-df3c-4caa-9e58-beb97ea06377_terseLabel_en-US" xlink:label="lab_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets not recognized as future recovery not probable</link:label>
    <link:label id="lab_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable_label_en-US" xlink:label="lab_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Not Recognized As Future Recovery Not Probable</link:label>
    <link:label id="lab_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable_documentation_en-US" xlink:label="lab_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets not recognized as future recovery not probable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable" xlink:href="sny-20221231.xsd#sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable" xlink:to="lab_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax_5f61fef7-4b85-4858-8fc0-f81e26f2cd42_terseLabel_en-US" xlink:label="lab_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax on disposal of investments</link:label>
    <link:label id="lab_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax_label_en-US" xlink:label="lab_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments For Gain (Loss) On Disposal Of Investments In Subsidiaries, Joint Ventures And Associates, Deferred Income Tax</link:label>
    <link:label id="lab_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax_documentation_en-US" xlink:label="lab_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments For Gain (Loss) On Disposal Of Investments In Subsidiaries, Joint Ventures And Associates, Deferred Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax" xlink:href="sny-20221231.xsd#sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax" xlink:to="lab_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfClaimsInvalid_d7d07dba-7ed5-4b65-b592-3d705a12ad14_terseLabel_en-US" xlink:label="lab_sny_NumberOfClaimsInvalid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims invalid</link:label>
    <link:label id="lab_sny_NumberOfClaimsInvalid_label_en-US" xlink:label="lab_sny_NumberOfClaimsInvalid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Claims Invalid</link:label>
    <link:label id="lab_sny_NumberOfClaimsInvalid_documentation_en-US" xlink:label="lab_sny_NumberOfClaimsInvalid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Claims Invalid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfClaimsInvalid" xlink:href="sny-20221231.xsd#sny_NumberOfClaimsInvalid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfClaimsInvalid" xlink:to="lab_sny_NumberOfClaimsInvalid" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_5cfa9fc6-f9ba-4cc9-9949-ee96349858f6_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable, other than corporate income taxes</link:label>
    <link:label id="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_label_en-US" xlink:label="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current payables on social security and taxes other than income tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:to="lab_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiABMember_10477ac6-3c74-4267-89d9-5d65c9bbc940_terseLabel_en-US" xlink:label="lab_sny_SanofiABMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi AB</link:label>
    <link:label id="lab_sny_SanofiABMember_label_en-US" xlink:label="lab_sny_SanofiABMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi AB [member]</link:label>
    <link:label id="lab_sny_SanofiABMember_documentation_en-US" xlink:label="lab_sny_SanofiABMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi AB.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiABMember" xlink:href="sny-20221231.xsd#sny_SanofiABMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiABMember" xlink:to="lab_sny_SanofiABMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ConsumerHealthcareSegmentMember_c78d69f8-9732-4015-b71f-96fb16153fa7_terseLabel_en-US" xlink:label="lab_sny_ConsumerHealthcareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Healthcare</link:label>
    <link:label id="lab_sny_ConsumerHealthcareSegmentMember_label_en-US" xlink:label="lab_sny_ConsumerHealthcareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Healthcare Segment [Member]</link:label>
    <link:label id="lab_sny_ConsumerHealthcareSegmentMember_documentation_en-US" xlink:label="lab_sny_ConsumerHealthcareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Healthcare segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareSegmentMember" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ConsumerHealthcareSegmentMember" xlink:to="lab_sny_ConsumerHealthcareSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PriorAgreementMember_03359d8a-516e-4c7a-964d-07634205e8f6_terseLabel_en-US" xlink:label="lab_sny_PriorAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior agreement</link:label>
    <link:label id="lab_sny_PriorAgreementMember_label_en-US" xlink:label="lab_sny_PriorAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Agreement [Member]</link:label>
    <link:label id="lab_sny_PriorAgreementMember_documentation_en-US" xlink:label="lab_sny_PriorAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PriorAgreementMember" xlink:href="sny-20221231.xsd#sny_PriorAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PriorAgreementMember" xlink:to="lab_sny_PriorAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ResearchAndDevelopmentMember_9d32c702-2552-43af-a588-f231f7afb080_terseLabel_en-US" xlink:label="lab_sny_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development projects</link:label>
    <link:label id="lab_sny_ResearchAndDevelopmentMember_label_en-US" xlink:label="lab_sny_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development [Member]</link:label>
    <link:label id="lab_sny_ResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_sny_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ResearchAndDevelopmentMember" xlink:href="sny-20221231.xsd#sny_ResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ResearchAndDevelopmentMember" xlink:to="lab_sny_ResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DaiichiSankyoMember_9863fbda-2ec9-4b69-b188-d2e505d62e5e_terseLabel_en-US" xlink:label="lab_sny_DaiichiSankyoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daiichi Sankyo</link:label>
    <link:label id="lab_sny_DaiichiSankyoMember_label_en-US" xlink:label="lab_sny_DaiichiSankyoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daiichi Sankyo [Member]</link:label>
    <link:label id="lab_sny_DaiichiSankyoMember_documentation_en-US" xlink:label="lab_sny_DaiichiSankyoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daiichi Sankyo</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DaiichiSankyoMember" xlink:href="sny-20221231.xsd#sny_DaiichiSankyoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DaiichiSankyoMember" xlink:to="lab_sny_DaiichiSankyoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInTaiwanDollarMember_27a3d6f5-2dad-4ddd-aef8-2fe66b3199d4_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInTaiwanDollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Taiwan Dollar</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInTaiwanDollarMember_label_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInTaiwanDollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Taiwan Dollar [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInTaiwanDollarMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInTaiwanDollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Taiwan Dollar</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInTaiwanDollarMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInTaiwanDollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasedInTaiwanDollarMember" xlink:to="lab_sny_ForwardCurrencyPurchasedInTaiwanDollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_RU_7282bad4-26c9-4938-89d3-59a79a56e5dc_terseLabel_en-US" xlink:label="lab_country_RU" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RUSSIAN FEDERATION</link:label>
    <link:label id="lab_country_RU_label_en-US" xlink:label="lab_country_RU" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RUSSIAN FEDERATION</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_RU" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_RU"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_RU" xlink:to="lab_country_RU" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAndLiabilitiesAbstract_2711b02b-0a33-4509-ad80-746a4bd55c77_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and liabilities</link:label>
    <link:label id="lab_ifrs-full_EquityAndLiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsTable_f29640f0-8ed0-4c12-a814-63f2a60d13ac_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other provisions [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherProvisionsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other provisions [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherProvisionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonCurrentDerivativesMember_0eb1a8ba-ff4f-439f-b41a-26a3111db012_terseLabel_en-US" xlink:label="lab_sny_NonCurrentDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current derivatives</link:label>
    <link:label id="lab_sny_NonCurrentDerivativesMember_0bc430ec-6c2f-4f54-9aaf-b3f5794e97b0_verboseLabel_en-US" xlink:label="lab_sny_NonCurrentDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current derivatives</link:label>
    <link:label id="lab_sny_NonCurrentDerivativesMember_label_en-US" xlink:label="lab_sny_NonCurrentDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Derivatives [Member]</link:label>
    <link:label id="lab_sny_NonCurrentDerivativesMember_documentation_en-US" xlink:label="lab_sny_NonCurrentDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current derivatives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentDerivativesMember" xlink:href="sny-20221231.xsd#sny_NonCurrentDerivativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentDerivativesMember" xlink:to="lab_sny_NonCurrentDerivativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate_3c0e5cbb-5873-4f89-a852-118242a4b3d4_terseLabel_en-US" xlink:label="lab_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current and non-current assets and liabilities</link:label>
    <link:label id="lab_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate_label_en-US" xlink:label="lab_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets And Current Liabilities As Of Acquisition Date</link:label>
    <link:label id="lab_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate_documentation_en-US" xlink:label="lab_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities as of acquisition date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate" xlink:href="sny-20221231.xsd#sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate" xlink:to="lab_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PlavixRelatedLitigationInFranceMember_6b8ac588-3132-4ffd-a862-5f3d2a9a855e_terseLabel_en-US" xlink:label="lab_sny_PlavixRelatedLitigationInFranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix related litigation in France</link:label>
    <link:label id="lab_sny_PlavixRelatedLitigationInFranceMember_label_en-US" xlink:label="lab_sny_PlavixRelatedLitigationInFranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Related Litigation In France [Member]</link:label>
    <link:label id="lab_sny_PlavixRelatedLitigationInFranceMember_documentation_en-US" xlink:label="lab_sny_PlavixRelatedLitigationInFranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Related Litigation In France</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixRelatedLitigationInFranceMember" xlink:href="sny-20221231.xsd#sny_PlavixRelatedLitigationInFranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PlavixRelatedLitigationInFranceMember" xlink:to="lab_sny_PlavixRelatedLitigationInFranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_2e0dc750-469f-436b-950d-b247731f27f0_negatedLabel_en-US" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate and currency derivatives used to manage cash and cash equivalents</link:label>
    <link:label id="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_label_en-US" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate And Currency Derivatives Used To Manage Cash And Cash Equivalent</link:label>
    <link:label id="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_documentation_en-US" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate and currency derivatives used to manage cash and cash equivalent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:to="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherCountriesMember_b5c645df-f373-45a0-9320-0bce0f55d894_terseLabel_en-US" xlink:label="lab_sny_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_sny_OtherCountriesMember_24c1122d-c5a1-4f21-9ce4-80c3be5cd089_verboseLabel_en-US" xlink:label="lab_sny_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries</link:label>
    <link:label id="lab_sny_OtherCountriesMember_label_en-US" xlink:label="lab_sny_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [member]</link:label>
    <link:label id="lab_sny_OtherCountriesMember_documentation_en-US" xlink:label="lab_sny_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherCountriesMember" xlink:to="lab_sny_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_ddfc4918-3005-47e4-af90-c60217ca15cf_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Aggregate Amounts Payable to Key Management Personnel</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans_dcb864a5-9543-46a3-b269-cdc6c6c67f45_terseLabel_en-US" xlink:label="lab_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future benefit payments under pension and other post-employment benefit plans</link:label>
    <link:label id="lab_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans_label_en-US" xlink:label="lab_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Future Benefit Payments Under Pension And Other Postemployment Benefit Plans</link:label>
    <link:label id="lab_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans_documentation_en-US" xlink:label="lab_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future benefit payments under pension and other post-employment benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" xlink:href="sny-20221231.xsd#sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" xlink:to="lab_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_d3278b37-d8e8-40d0-93da-d997aeeb7ee5_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of preparation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromIssuingShares_00276c15-b98e-4cfc-b272-7b8653254b2d_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Sanofi shares</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromIssuingShares_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuing shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement_2ea2ad29-146b-40e9-9738-6015098d731e_periodStartLabel_en-US" xlink:label="lab_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, beginning balance</link:label>
    <link:label id="lab_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement_d47e9f10-9f99-4f61-b56d-279020da3e11_periodEndLabel_en-US" xlink:label="lab_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, ending balance</link:label>
    <link:label id="lab_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Share Options Outstanding In Share Based Payment Arrangement</link:label>
    <link:label id="lab_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of share options outstanding in share based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" xlink:to="lab_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_9cbc4635-0e70-4301-a593-3ee3584b38b7_terseLabel_en-US" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Levels of fair value hierarchy [axis]</link:label>
    <link:label id="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_label_en-US" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Levels of fair value hierarchy [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrentInterestRateDerivativesPayable_b39ee11c-6eb0-4ec3-ab47-a29a7d645946_terseLabel_en-US" xlink:label="lab_sny_CurrentInterestRateDerivativesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate derivatives (see Note&#160;D.20.)</link:label>
    <link:label id="lab_sny_CurrentInterestRateDerivativesPayable_label_en-US" xlink:label="lab_sny_CurrentInterestRateDerivativesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Interest Rate Derivatives Payable</link:label>
    <link:label id="lab_sny_CurrentInterestRateDerivativesPayable_documentation_en-US" xlink:label="lab_sny_CurrentInterestRateDerivativesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current interest rate derivatives payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentInterestRateDerivativesPayable" xlink:href="sny-20221231.xsd#sny_CurrentInterestRateDerivativesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentInterestRateDerivativesPayable" xlink:to="lab_sny_CurrentInterestRateDerivativesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AwardsDateDomain_7dcea014-a955-4034-bd3d-d505021d5312_terseLabel_en-US" xlink:label="lab_sny_AwardsDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Date [Domain]</link:label>
    <link:label id="lab_sny_AwardsDateDomain_label_en-US" xlink:label="lab_sny_AwardsDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Date [Domain]</link:label>
    <link:label id="lab_sny_AwardsDateDomain_documentation_en-US" xlink:label="lab_sny_AwardsDateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateDomain" xlink:href="sny-20221231.xsd#sny_AwardsDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AwardsDateDomain" xlink:to="lab_sny_AwardsDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_September2016EMTNISINFR0013201639Member_937c55bb-687e-4531-90e7-f51200b6e151_terseLabel_en-US" xlink:label="lab_sny_September2016EMTNISINFR0013201639Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2016 EMTN ISIN FR0013201639</link:label>
    <link:label id="lab_sny_September2016EMTNISINFR0013201639Member_label_en-US" xlink:label="lab_sny_September2016EMTNISINFR0013201639Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2016 EMTNISINFR0013201639 [Member]</link:label>
    <link:label id="lab_sny_September2016EMTNISINFR0013201639Member_documentation_en-US" xlink:label="lab_sny_September2016EMTNISINFR0013201639Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2016 EMTN ISIN FR 0013201639.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_September2016EMTNISINFR0013201639Member" xlink:href="sny-20221231.xsd#sny_September2016EMTNISINFR0013201639Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_September2016EMTNISINFR0013201639Member" xlink:to="lab_sny_September2016EMTNISINFR0013201639Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_5128b6b9-fd3f-4539-bb51-6d038287065b_terseLabel_en-US" xlink:label="lab_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average exercise&#160;price per share, options cancelled (in euros per share)</link:label>
    <link:label id="lab_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price Of Share Options Cancelled In Share-Based Payment Arrangement</link:label>
    <link:label id="lab_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price Of Share Options Cancelled In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:href="sny-20221231.xsd#sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:to="lab_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member_106c9a11-ae09-407b-b089-2a1911efd6e7_terseLabel_en-US" xlink:label="lab_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Billion Five Hundred Million Bonds, Issued In April 2022</link:label>
    <link:label id="lab_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member_label_en-US" xlink:label="lab_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Billion Five Hundred Million Bonds, Issued In April 2022 [Member]</link:label>
    <link:label id="lab_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member_documentation_en-US" xlink:label="lab_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Billion Five Hundred Million Bonds, Issued In April 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member" xlink:href="sny-20221231.xsd#sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member" xlink:to="lab_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_f1857bc2-fdaf-4136-aad3-7bb6d214b645_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 3</link:label>
    <link:label id="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_c0492ea1-203b-408a-a3ad-ddd618a730ab_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2 to 3 years</link:label>
    <link:label id="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than two years and not later than three years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SeprafilmMember_ffe85c07-432d-4bff-8d50-748b6c687243_terseLabel_en-US" xlink:label="lab_sny_SeprafilmMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seprafilm</link:label>
    <link:label id="lab_sny_SeprafilmMember_label_en-US" xlink:label="lab_sny_SeprafilmMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seprafilm [Member]</link:label>
    <link:label id="lab_sny_SeprafilmMember_documentation_en-US" xlink:label="lab_sny_SeprafilmMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seprafilm</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SeprafilmMember" xlink:href="sny-20221231.xsd#sny_SeprafilmMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SeprafilmMember" xlink:to="lab_sny_SeprafilmMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrencyDerivativesOperatingMember_a63abcac-ff29-4bd3-b54f-dce36557f7c5_terseLabel_en-US" xlink:label="lab_sny_CurrencyDerivativesOperatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">operating</link:label>
    <link:label id="lab_sny_CurrencyDerivativesOperatingMember_label_en-US" xlink:label="lab_sny_CurrencyDerivativesOperatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Derivatives Operating [Member]</link:label>
    <link:label id="lab_sny_CurrencyDerivativesOperatingMember_documentation_en-US" xlink:label="lab_sny_CurrencyDerivativesOperatingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency derivatives, operating.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesOperatingMember" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesOperatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrencyDerivativesOperatingMember" xlink:to="lab_sny_CurrencyDerivativesOperatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_87e53c83-e337-4823-8295-b3d1c6d8f256_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Information About Major Customers and Credit Risk [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_label_en-US" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Information About Major Customers And Credit Risk [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information about major customers and credit risk.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xlink:to="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfAuditorRemunerationForStatutoryAudit_f416a7d6-1d97-4a68-bd41-db8af4d957e8_terseLabel_en-US" xlink:label="lab_sny_PercentageOfAuditorRemunerationForStatutoryAudit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory audit of separate and consolidated financial statements, percentage</link:label>
    <link:label id="lab_sny_PercentageOfAuditorRemunerationForStatutoryAudit_label_en-US" xlink:label="lab_sny_PercentageOfAuditorRemunerationForStatutoryAudit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Auditor Remuneration For Statutory Audit</link:label>
    <link:label id="lab_sny_PercentageOfAuditorRemunerationForStatutoryAudit_documentation_en-US" xlink:label="lab_sny_PercentageOfAuditorRemunerationForStatutoryAudit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of auditor remuneration for statutory audit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorRemunerationForStatutoryAudit" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorRemunerationForStatutoryAudit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfAuditorRemunerationForStatutoryAudit" xlink:to="lab_sny_PercentageOfAuditorRemunerationForStatutoryAudit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_55aeec96-11c7-41c3-a872-20a08dc6cc9e_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by/(used in) operating activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used in) operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommoditiesMember_6ae6d01e-efca-4eb3-834f-e9381a9cc5eb_terseLabel_en-US" xlink:label="lab_sny_CommoditiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodities</link:label>
    <link:label id="lab_sny_CommoditiesMember_label_en-US" xlink:label="lab_sny_CommoditiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodities [Member]</link:label>
    <link:label id="lab_sny_CommoditiesMember_documentation_en-US" xlink:label="lab_sny_CommoditiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommoditiesMember" xlink:href="sny-20221231.xsd#sny_CommoditiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommoditiesMember" xlink:to="lab_sny_CommoditiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfAuditorsRemuneration_1ef60711-0a96-4984-b3db-a41ef690f9d9_totalLabel_en-US" xlink:label="lab_sny_PercentageOfAuditorsRemuneration" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, percentage</link:label>
    <link:label id="lab_sny_PercentageOfAuditorsRemuneration_label_en-US" xlink:label="lab_sny_PercentageOfAuditorsRemuneration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Auditors Remuneration</link:label>
    <link:label id="lab_sny_PercentageOfAuditorsRemuneration_documentation_en-US" xlink:label="lab_sny_PercentageOfAuditorsRemuneration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor's remuneration, Total Percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorsRemuneration" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorsRemuneration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfAuditorsRemuneration" xlink:to="lab_sny_PercentageOfAuditorsRemuneration" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_HedgeFundsMember_f262f667-c6b1-4acd-939f-d0f6f952aaa1_terseLabel_en-US" xlink:label="lab_sny_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge funds</link:label>
    <link:label id="lab_sny_HedgeFundsMember_label_en-US" xlink:label="lab_sny_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds [Member]</link:label>
    <link:label id="lab_sny_HedgeFundsMember_documentation_en-US" xlink:label="lab_sny_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HedgeFundsMember" xlink:href="sny-20221231.xsd#sny_HedgeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_HedgeFundsMember" xlink:to="lab_sny_HedgeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e47f86ab-3520-4e19-bb99-aee37d9ca590_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SaleOfStockDomain_02b30ce9-f196-4037-bed1-1d485df43ea5_terseLabel_en-US" xlink:label="lab_sny_SaleOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock [Domain]</link:label>
    <link:label id="lab_sny_SaleOfStockDomain_label_en-US" xlink:label="lab_sny_SaleOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock [Domain]</link:label>
    <link:label id="lab_sny_SaleOfStockDomain_documentation_en-US" xlink:label="lab_sny_SaleOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockDomain" xlink:href="sny-20221231.xsd#sny_SaleOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SaleOfStockDomain" xlink:to="lab_sny_SaleOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SocialSecurityContributions_29b7a456-018f-4954-8dab-1311dc371e9e_terseLabel_en-US" xlink:label="lab_ifrs-full_SocialSecurityContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social security charges (including defined-contribution pension plans)</link:label>
    <link:label id="lab_ifrs-full_SocialSecurityContributions_label_en-US" xlink:label="lab_ifrs-full_SocialSecurityContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social security contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SocialSecurityContributions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SocialSecurityContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SocialSecurityContributions" xlink:to="lab_ifrs-full_SocialSecurityContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInJapaneseYenMember_09d6ab53-a79a-4db5-a57b-926ab470299f_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInJapaneseYenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases In Japanese yen</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInJapaneseYenMember_label_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInJapaneseYenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Japanese yen [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInJapaneseYenMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInJapaneseYenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In Japanese yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInJapaneseYenMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInJapaneseYenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasedInJapaneseYenMember" xlink:to="lab_sny_ForwardCurrencyPurchasedInJapaneseYenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_e6555a4b-d2dd-4385-98e0-7368d15b1ae3_terseLabel_en-US" xlink:label="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_label_en-US" xlink:label="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill recognised as of acquisition date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityTable_2a0210b0-dbda-48ca-afb8-87731e0dcaf9_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of changes in equity [table]</link:label>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityTable_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of changes in equity [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossAbstract_31c9ff3a-2c6e-4c67-8f51-3d11a0559603_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit (loss) [abstract]</link:label>
    <link:label id="lab_ifrs-full_ProfitLossAbstract_label_en-US" xlink:label="lab_ifrs-full_ProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit (loss) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAbstract" xlink:to="lab_ifrs-full_ProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProductsAndServicesAxis_8a68c811-c4eb-48a4-955c-7388f19a971e_terseLabel_en-US" xlink:label="lab_ifrs-full_ProductsAndServicesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and services [axis]</link:label>
    <link:label id="lab_ifrs-full_ProductsAndServicesAxis_label_en-US" xlink:label="lab_ifrs-full_ProductsAndServicesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and services [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductsAndServicesAxis" xlink:to="lab_ifrs-full_ProductsAndServicesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TaxLossesCarryforwards_b11c60b7-81f3-4205-945f-689b59c15e59_terseLabel_en-US" xlink:label="lab_sny_TaxLossesCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax losses available for carry-forward</link:label>
    <link:label id="lab_sny_TaxLossesCarryforwards_label_en-US" xlink:label="lab_sny_TaxLossesCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Losses Carryforwards</link:label>
    <link:label id="lab_sny_TaxLossesCarryforwards_documentation_en-US" xlink:label="lab_sny_TaxLossesCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax losses carryforwards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxLossesCarryforwards" xlink:href="sny-20221231.xsd#sny_TaxLossesCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TaxLossesCarryforwards" xlink:to="lab_sny_TaxLossesCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax_9447c2ee-b80f-495f-bdf2-f83290db02c7_negatedTerseLabel_en-US" xlink:label="lab_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedges of net investments in foreign operations</link:label>
    <link:label id="lab_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax_label_en-US" xlink:label="lab_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedges Of Net Investments In Foreign Operations After Tax</link:label>
    <link:label id="lab_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax_documentation_en-US" xlink:label="lab_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedges of net investments in foreign operations after tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax" xlink:href="sny-20221231.xsd#sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax" xlink:to="lab_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OrigimmBiotechnologyGmbHMember_dd9b5cff-d53a-4df6-bb42-5a3054e027f5_terseLabel_en-US" xlink:label="lab_sny_OrigimmBiotechnologyGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Origimm Biotechnology GmbH</link:label>
    <link:label id="lab_sny_OrigimmBiotechnologyGmbHMember_label_en-US" xlink:label="lab_sny_OrigimmBiotechnologyGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Origimm Biotechnology GmbH [Member]</link:label>
    <link:label id="lab_sny_OrigimmBiotechnologyGmbHMember_documentation_en-US" xlink:label="lab_sny_OrigimmBiotechnologyGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Origimm Biotechnology GmbH</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OrigimmBiotechnologyGmbHMember" xlink:href="sny-20221231.xsd#sny_OrigimmBiotechnologyGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OrigimmBiotechnologyGmbHMember" xlink:to="lab_sny_OrigimmBiotechnologyGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateDerivativesMeasuredAtFairValue_7b7c9cf9-4da7-4d46-bbf1-1f75ca19ef9d_terseLabel_en-US" xlink:label="lab_sny_InterestRateDerivativesMeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate derivatives measured at fair value (see Note&#160;D.20.)</link:label>
    <link:label id="lab_sny_InterestRateDerivativesMeasuredAtFairValue_label_en-US" xlink:label="lab_sny_InterestRateDerivativesMeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivatives Measured At Fair Value</link:label>
    <link:label id="lab_sny_InterestRateDerivativesMeasuredAtFairValue_documentation_en-US" xlink:label="lab_sny_InterestRateDerivativesMeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate derivatives measured at fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateDerivativesMeasuredAtFairValue" xlink:href="sny-20221231.xsd#sny_InterestRateDerivativesMeasuredAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateDerivativesMeasuredAtFairValue" xlink:to="lab_sny_InterestRateDerivativesMeasuredAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_092cc0a6-b1ec-4d5d-8dda-fabd56bc9c9c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember_7ae64e0f-03ad-4cc7-a424-d0f83c2b5158_terseLabel_en-US" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of profit or loss from commercialization of Zaltrap</link:label>
    <link:label id="lab_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember_label_en-US" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Of Profit Or Loss From Commercialization Of Zaltrap [Member]</link:label>
    <link:label id="lab_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember_documentation_en-US" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of profit or loss from commercialization of Zaltrap.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xlink:href="sny-20221231.xsd#sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xlink:to="lab_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LongTermPrepaidExpenses_fe8001ae-3512-4b69-911e-2c80a4ed2a3e_terseLabel_en-US" xlink:label="lab_sny_LongTermPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term prepaid expenses</link:label>
    <link:label id="lab_sny_LongTermPrepaidExpenses_label_en-US" xlink:label="lab_sny_LongTermPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Prepaid Expenses</link:label>
    <link:label id="lab_sny_LongTermPrepaidExpenses_documentation_en-US" xlink:label="lab_sny_LongTermPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term prepaid expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LongTermPrepaidExpenses" xlink:href="sny-20221231.xsd#sny_LongTermPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LongTermPrepaidExpenses" xlink:to="lab_sny_LongTermPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember_4beee3d7-fb1e-4423-92bd-6cd47f7d7b3b_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [member]</link:label>
    <link:label id="lab_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember_label_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember" xlink:to="lab_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_c479c88f-a79f-4ffe-a2dc-3999dd20df68_terseLabel_en-US" xlink:label="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-generating units [axis]</link:label>
    <link:label id="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_label_en-US" xlink:label="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-generating units [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis" xlink:to="lab_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CashAndCashEquivalentsInvestedRate_82ab4a56-f545-497b-8304-16320d0644f1_terseLabel_en-US" xlink:label="lab_sny_CashAndCashEquivalentsInvestedRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, invested rate</link:label>
    <link:label id="lab_sny_CashAndCashEquivalentsInvestedRate_label_en-US" xlink:label="lab_sny_CashAndCashEquivalentsInvestedRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Invested Rate</link:label>
    <link:label id="lab_sny_CashAndCashEquivalentsInvestedRate_documentation_en-US" xlink:label="lab_sny_CashAndCashEquivalentsInvestedRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents invested rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashAndCashEquivalentsInvestedRate" xlink:href="sny-20221231.xsd#sny_CashAndCashEquivalentsInvestedRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CashAndCashEquivalentsInvestedRate" xlink:to="lab_sny_CashAndCashEquivalentsInvestedRate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DebtPercent_c379e4c2-6d65-49b7-bfa5-f893bd8d0cee_terseLabel_en-US" xlink:label="lab_sny_DebtPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, percent</link:label>
    <link:label id="lab_sny_DebtPercent_label_en-US" xlink:label="lab_sny_DebtPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Percent</link:label>
    <link:label id="lab_sny_DebtPercent_documentation_en-US" xlink:label="lab_sny_DebtPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt percent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtPercent" xlink:href="sny-20221231.xsd#sny_DebtPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DebtPercent" xlink:to="lab_sny_DebtPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EloctateMember_9f706691-974d-4ec6-8fc2-f8a9318de13f_terseLabel_en-US" xlink:label="lab_sny_EloctateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eloctate</link:label>
    <link:label id="lab_sny_EloctateMember_label_en-US" xlink:label="lab_sny_EloctateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eloctate [Member]</link:label>
    <link:label id="lab_sny_EloctateMember_documentation_en-US" xlink:label="lab_sny_EloctateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eloctate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EloctateMember" xlink:href="sny-20221231.xsd#sny_EloctateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EloctateMember" xlink:to="lab_sny_EloctateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GenzymeMember_cb0ff633-b634-48a7-b8c5-f146d4d017f9_terseLabel_en-US" xlink:label="lab_sny_GenzymeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme</link:label>
    <link:label id="lab_sny_GenzymeMember_label_en-US" xlink:label="lab_sny_GenzymeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme [Member]</link:label>
    <link:label id="lab_sny_GenzymeMember_documentation_en-US" xlink:label="lab_sny_GenzymeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeMember" xlink:href="sny-20221231.xsd#sny_GenzymeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GenzymeMember" xlink:to="lab_sny_GenzymeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_b7d324f3-579a-4179-86f1-392b4ccbfe77_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other operating income [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_c90084dc-7026-4531-8b45-78a1ae849396_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RevenueFromSaleOfGoods_d2faadf6-81b4-40ef-af4e-236e37ff6bf9_terseLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_ifrs-full_RevenueFromSaleOfGoods_label_en-US" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from sale of goods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromSaleOfGoods" xlink:to="lab_ifrs-full_RevenueFromSaleOfGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncomeStatementLocationDomain_daabfe6b-7ae0-47b5-9827-42f7d4de7753_terseLabel_en-US" xlink:label="lab_sny_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_sny_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_sny_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_sny_IncomeStatementLocationDomain_documentation_en-US" xlink:label="lab_sny_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationDomain" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeStatementLocationDomain" xlink:to="lab_sny_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EquityInstrumentsIncludedInFinancialAssetMember_dbafbdf0-78a5-4725-ae41-c28f38f71aa7_terseLabel_en-US" xlink:label="lab_sny_EquityInstrumentsIncludedInFinancialAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity instruments included in financial assets</link:label>
    <link:label id="lab_sny_EquityInstrumentsIncludedInFinancialAssetMember_label_en-US" xlink:label="lab_sny_EquityInstrumentsIncludedInFinancialAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Instruments Included In Financial Asset [Member]</link:label>
    <link:label id="lab_sny_EquityInstrumentsIncludedInFinancialAssetMember_documentation_en-US" xlink:label="lab_sny_EquityInstrumentsIncludedInFinancialAssetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Instruments Included In Financial Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInstrumentsIncludedInFinancialAssetMember" xlink:href="sny-20221231.xsd#sny_EquityInstrumentsIncludedInFinancialAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityInstrumentsIncludedInFinancialAssetMember" xlink:to="lab_sny_EquityInstrumentsIncludedInFinancialAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering_69f0fa11-494b-4981-b728-6fc7f17b62c0_terseLabel_en-US" xlink:label="lab_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares included in public offer (in shares)</link:label>
    <link:label id="lab_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering_label_en-US" xlink:label="lab_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number Of Shares Included In Public Offering</link:label>
    <link:label id="lab_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering_documentation_en-US" xlink:label="lab_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number Of Shares Included In Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering" xlink:href="sny-20221231.xsd#sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering" xlink:to="lab_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasTable_d046b06c-3453-4450-932a-a08a4758b643_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of geographical areas [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of geographical areas [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_96bca1fc-36b1-4eb1-851a-50aa061bee7e_terseLabel_en-US" xlink:label="lab_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_140b0182-9ec4-417b-8a4b-7697712c5628_verboseLabel_en-US" xlink:label="lab_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of net income attributable to other non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_label_en-US" xlink:label="lab_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregated individually immaterial associates [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xlink:to="lab_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MilestoneTypesDomain_e3f42ea0-6ab8-4952-a385-398540a9e765_terseLabel_en-US" xlink:label="lab_sny_MilestoneTypesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Types [Domain]</link:label>
    <link:label id="lab_sny_MilestoneTypesDomain_label_en-US" xlink:label="lab_sny_MilestoneTypesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Types [Domain]</link:label>
    <link:label id="lab_sny_MilestoneTypesDomain_documentation_en-US" xlink:label="lab_sny_MilestoneTypesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Types [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MilestoneTypesDomain" xlink:href="sny-20221231.xsd#sny_MilestoneTypesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MilestoneTypesDomain" xlink:to="lab_sny_MilestoneTypesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencySalesInChineseYuanMember_048f37dc-11da-45bc-a2b0-83e454021317_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencySalesInChineseYuanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Chinese Yuan</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInChineseYuanMember_label_en-US" xlink:label="lab_sny_ForwardCurrencySalesInChineseYuanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Chinese Yuan [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInChineseYuanMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencySalesInChineseYuanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Chinese Yuan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInChineseYuanMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInChineseYuanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInChineseYuanMember" xlink:to="lab_sny_ForwardCurrencySalesInChineseYuanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ActionForWhichWeArePlaintiffMember_92bd3785-60ff-439c-b971-4ad9907f0931_terseLabel_en-US" xlink:label="lab_sny_ActionForWhichWeArePlaintiffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Action for which we are a plaintiff</link:label>
    <link:label id="lab_sny_ActionForWhichWeArePlaintiffMember_label_en-US" xlink:label="lab_sny_ActionForWhichWeArePlaintiffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Action For Which We Are a Plaintiff [member]</link:label>
    <link:label id="lab_sny_ActionForWhichWeArePlaintiffMember_documentation_en-US" xlink:label="lab_sny_ActionForWhichWeArePlaintiffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Action For Which We Are a Plaintiff.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActionForWhichWeArePlaintiffMember" xlink:href="sny-20221231.xsd#sny_ActionForWhichWeArePlaintiffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActionForWhichWeArePlaintiffMember" xlink:to="lab_sny_ActionForWhichWeArePlaintiffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RealEstateMember_a7856138-89a1-434b-8ccf-cac0ccfd154f_terseLabel_en-US" xlink:label="lab_sny_RealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate</link:label>
    <link:label id="lab_sny_RealEstateMember_label_en-US" xlink:label="lab_sny_RealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Member]</link:label>
    <link:label id="lab_sny_RealEstateMember_documentation_en-US" xlink:label="lab_sny_RealEstateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RealEstateMember" xlink:href="sny-20221231.xsd#sny_RealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RealEstateMember" xlink:to="lab_sny_RealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAndLiabilities_becfff2d-092f-4c4c-900b-326de58c54ee_totalLabel_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity and liabilities</link:label>
    <link:label id="lab_ifrs-full_EquityAndLiabilities_label_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="lab_ifrs-full_EquityAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EmployeeBenefitsAbstract_076d3a34-65d4-4e01-9d7f-f382e12749ce_terseLabel_en-US" xlink:label="lab_sny_EmployeeBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits [Abstract]</link:label>
    <link:label id="lab_sny_EmployeeBenefitsAbstract_label_en-US" xlink:label="lab_sny_EmployeeBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits [Abstract]</link:label>
    <link:label id="lab_sny_EmployeeBenefitsAbstract_documentation_en-US" xlink:label="lab_sny_EmployeeBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeeBenefitsAbstract" xlink:href="sny-20221231.xsd#sny_EmployeeBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EmployeeBenefitsAbstract" xlink:to="lab_sny_EmployeeBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EquityInstrumentsMember_5925c365-2955-4c9c-80e9-023ffaf797de_terseLabel_en-US" xlink:label="lab_sny_EquityInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity instruments</link:label>
    <link:label id="lab_sny_EquityInstrumentsMember_label_en-US" xlink:label="lab_sny_EquityInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Instruments [Member]</link:label>
    <link:label id="lab_sny_EquityInstrumentsMember_documentation_en-US" xlink:label="lab_sny_EquityInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInstrumentsMember" xlink:href="sny-20221231.xsd#sny_EquityInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityInstrumentsMember" xlink:to="lab_sny_EquityInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CapitalLossesUsedAgainstCapitalGainsPercentage_b089a233-af82-4cdd-8a5a-f29faf15bff4_terseLabel_en-US" xlink:label="lab_sny_CapitalLossesUsedAgainstCapitalGainsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of capital losses used</link:label>
    <link:label id="lab_sny_CapitalLossesUsedAgainstCapitalGainsPercentage_label_en-US" xlink:label="lab_sny_CapitalLossesUsedAgainstCapitalGainsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Losses Used Against Capital Gains, Percentage</link:label>
    <link:label id="lab_sny_CapitalLossesUsedAgainstCapitalGainsPercentage_documentation_en-US" xlink:label="lab_sny_CapitalLossesUsedAgainstCapitalGainsPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Losses Used Against Capital Gains, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CapitalLossesUsedAgainstCapitalGainsPercentage" xlink:href="sny-20221231.xsd#sny_CapitalLossesUsedAgainstCapitalGainsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CapitalLossesUsedAgainstCapitalGainsPercentage" xlink:to="lab_sny_CapitalLossesUsedAgainstCapitalGainsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment_7dc6b208-ec0f-4f6a-8ea0-dd6ad3627d22_terseLabel_en-US" xlink:label="lab_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum sales of PD1 in 12-month period to be achieved for milestone payment</link:label>
    <link:label id="lab_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment_label_en-US" xlink:label="lab_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Sales Of Anti Programmed Cell Death Protein 1 In Twelve Month Period To Be Achieved For Milestone Payment</link:label>
    <link:label id="lab_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment_documentation_en-US" xlink:label="lab_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum sales of anti programmed cell death protein 1 in twelve month period to be achieved for milestone payment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment" xlink:href="sny-20221231.xsd#sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment" xlink:to="lab_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_2a4d7109-b120-43fb-b9cb-3a89673bd17c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Sensitivity for Pensions and Other Post-employment Benefits to Changes in Key Actuarial Assumptions</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CollaborationAgreementPeriodAfterLossOfControl_c59184ca-14e7-4043-a23d-3603147dcb77_terseLabel_en-US" xlink:label="lab_sny_CollaborationAgreementPeriodAfterLossOfControl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, period after loss of control</link:label>
    <link:label id="lab_sny_CollaborationAgreementPeriodAfterLossOfControl_label_en-US" xlink:label="lab_sny_CollaborationAgreementPeriodAfterLossOfControl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Period After Loss Of Control</link:label>
    <link:label id="lab_sny_CollaborationAgreementPeriodAfterLossOfControl_documentation_en-US" xlink:label="lab_sny_CollaborationAgreementPeriodAfterLossOfControl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Period After Loss Of Control</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementPeriodAfterLossOfControl" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementPeriodAfterLossOfControl"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CollaborationAgreementPeriodAfterLossOfControl" xlink:to="lab_sny_CollaborationAgreementPeriodAfterLossOfControl" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ProvisionsForDiscountsRebatesAndSalesReturns_e65d0f90-855a-49be-9586-eaccb24af702_periodStartLabel_en-US" xlink:label="lab_sny_ProvisionsForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for discounts, rebates and sales returns, beginning balance</link:label>
    <link:label id="lab_sny_ProvisionsForDiscountsRebatesAndSalesReturns_19a6c2a1-f676-4f47-a36f-a76fee8b4a3a_periodEndLabel_en-US" xlink:label="lab_sny_ProvisionsForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for discounts, rebates and sales returns, ending balance</link:label>
    <link:label id="lab_sny_ProvisionsForDiscountsRebatesAndSalesReturns_label_en-US" xlink:label="lab_sny_ProvisionsForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions For Discounts Rebates And Sales Returns</link:label>
    <link:label id="lab_sny_ProvisionsForDiscountsRebatesAndSalesReturns_documentation_en-US" xlink:label="lab_sny_ProvisionsForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for discounts, rebates and sales returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForDiscountsRebatesAndSalesReturns" xlink:href="sny-20221231.xsd#sny_ProvisionsForDiscountsRebatesAndSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProvisionsForDiscountsRebatesAndSalesReturns" xlink:to="lab_sny_ProvisionsForDiscountsRebatesAndSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInventoriesExplanatory_79c787e9-6fe3-4614-86a3-65c438e8c0f6_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInventoriesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of inventories [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_897b8c8d-15b9-4bdb-bb4a-184775f5184f_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAccountingStandard_6f5acc50-f6a6-4898-98f3-41cb6784ea22_terseLabel_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:label id="lab_dei_DocumentAccountingStandard_label_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard" xlink:to="lab_dei_DocumentAccountingStandard" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_871036d1-eb77-489e-b4ab-4efcc9ad1d95_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of reconciliation of carrying amount to value on redemption [table]</link:label>
    <link:label id="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_label_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:to="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_f1829eb9-be7f-4bae-a04b-3be7f56f24fd_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans_621f5b40-3b2c-4ddd-86b3-fb5292ca7d49_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee share ownership plan</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Share-Based Payment Plans Employee Share Ownership Plans</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee share ownership plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xlink:to="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2b7db3f5-7773-4e92-8dd2-093bee6b68f2_terseLabel_en-US" xlink:label="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of defined benefit obligation</link:label>
    <link:label id="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember_label_en-US" xlink:label="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of defined benefit obligation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:to="lab_ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_719c499e-2c8a-471a-945e-f90489fbb4af_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US</link:label>
    <link:label id="lab_country_US_e299fdf4-2750-42a1-b55a-b11a52e3882f_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_5f87b3dd-0a75-4a23-a77f-7ddbeb4f566c_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible decrease in actuarial assumption</link:label>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_label_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of reasonably possible decrease in actuarial assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_8c4d0316-72ea-4850-af9b-ed62441902c8_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial expenses and income</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of finance income (cost) [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_eb456f3b-a00f-4dee-91d2-ed5f307fe29b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsByNameAxis_bef0d341-413f-4b99-8cf7-80ccaf95c0f4_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings by name [axis]</link:label>
    <link:label id="lab_ifrs-full_BorrowingsByNameAxis_label_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings by name [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis" xlink:to="lab_ifrs-full_BorrowingsByNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalMarketedProductsAblynxMember_e55c708b-5c0d-4ad4-b05f-8252570a71fe_terseLabel_en-US" xlink:label="lab_sny_PrincipalMarketedProductsAblynxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ablynx</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsAblynxMember_label_en-US" xlink:label="lab_sny_PrincipalMarketedProductsAblynxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products Ablynx [Member]</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsAblynxMember_documentation_en-US" xlink:label="lab_sny_PrincipalMarketedProductsAblynxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products Ablynx [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsAblynxMember" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsAblynxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalMarketedProductsAblynxMember" xlink:to="lab_sny_PrincipalMarketedProductsAblynxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_d05e3558-5798-4558-9a8b-8033016e5698_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c5dada22-130e-4d42-bbca-cdbd1056145b_netLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of shares awarded (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share options granted in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_8a587e6f-ed62-425a-b2cc-1c81eb031bdf_terseLabel_en-US" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value (investments accounted for using the equity method, net of taxes)</link:label>
    <link:label id="lab_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value On Cash Flow Hedges Net Of Tax On Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value on cash flow hedges net of tax on associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_54325de2-3421-42db-b267-e296fd84f42d_totalLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LeaseLiabilitiesEffectOfDiscounting_823cb30f-2570-4f0f-8820-a58a25d521db_negatedTerseLabel_en-US" xlink:label="lab_sny_LeaseLiabilitiesEffectOfDiscounting" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounting effect</link:label>
    <link:label id="lab_sny_LeaseLiabilitiesEffectOfDiscounting_label_en-US" xlink:label="lab_sny_LeaseLiabilitiesEffectOfDiscounting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities, Effect Of Discounting</link:label>
    <link:label id="lab_sny_LeaseLiabilitiesEffectOfDiscounting_documentation_en-US" xlink:label="lab_sny_LeaseLiabilitiesEffectOfDiscounting" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities, Effect Of Discounting</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LeaseLiabilitiesEffectOfDiscounting" xlink:href="sny-20221231.xsd#sny_LeaseLiabilitiesEffectOfDiscounting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LeaseLiabilitiesEffectOfDiscounting" xlink:to="lab_sny_LeaseLiabilitiesEffectOfDiscounting" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfLossConsortiumPlaintiffs_66c549e8-d219-4e25-87d8-2895761b3d46_terseLabel_en-US" xlink:label="lab_sny_NumberOfLossConsortiumPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of loss consortium plaintiffs</link:label>
    <link:label id="lab_sny_NumberOfLossConsortiumPlaintiffs_label_en-US" xlink:label="lab_sny_NumberOfLossConsortiumPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Loss Consortium Plaintiffs</link:label>
    <link:label id="lab_sny_NumberOfLossConsortiumPlaintiffs_documentation_en-US" xlink:label="lab_sny_NumberOfLossConsortiumPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of loss consortium plaintiffs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfLossConsortiumPlaintiffs" xlink:href="sny-20221231.xsd#sny_NumberOfLossConsortiumPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfLossConsortiumPlaintiffs" xlink:to="lab_sny_NumberOfLossConsortiumPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets_6b1e325c-767a-4dcd-a7f2-9637ae910dfb_negatedTerseLabel_en-US" xlink:label="lab_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals and other decreases</link:label>
    <link:label id="lab_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets_label_en-US" xlink:label="lab_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals And Retirements, Property, Plant And Equipment, Right Of Use Assets</link:label>
    <link:label id="lab_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets_documentation_en-US" xlink:label="lab_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals And Retirements, Property, Plant And Equipment, Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" xlink:href="sny-20221231.xsd#sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" xlink:to="lab_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock_a867e29c-5cb2-4efc-bce8-a86adeb5f691_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investments in Associates and Joint Ventures</link:label>
    <link:label id="lab_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Investments In Associates And Joint Ventures [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure of investments in associates and joint ventures explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:to="lab_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember_1ade9c6f-02fc-4b69-b65e-129de7822a17_terseLabel_en-US" xlink:label="lab_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer contingent purchase consideration arising from the acquisition of Genzyme</link:label>
    <link:label id="lab_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember_label_en-US" xlink:label="lab_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer Contingent Consideration Arising From The Acquisition Of Genzyme [Member]</link:label>
    <link:label id="lab_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember_documentation_en-US" xlink:label="lab_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer contingent purchase consideration arising from the acquisition of Genzyme.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember" xlink:href="sny-20221231.xsd#sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember" xlink:to="lab_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0b7ed683-bd70-47da-bb6b-ab75dfff4c4e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisArgentinaSAMember_dd5e2489-890c-409f-bac8-63ae85ccb901_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisArgentinaSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Argentina S.A.</link:label>
    <link:label id="lab_sny_SanofiAventisArgentinaSAMember_label_en-US" xlink:label="lab_sny_SanofiAventisArgentinaSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Argentina S A [member]</link:label>
    <link:label id="lab_sny_SanofiAventisArgentinaSAMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisArgentinaSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Argentina S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisArgentinaSAMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisArgentinaSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisArgentinaSAMember" xlink:to="lab_sny_SanofiAventisArgentinaSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisPrivateCoLtdMember_ba465e27-4ac8-41e3-82c9-783823c7b564_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisPrivateCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Private Co, Ltd</link:label>
    <link:label id="lab_sny_SanofiAventisPrivateCoLtdMember_label_en-US" xlink:label="lab_sny_SanofiAventisPrivateCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Private Co, Ltd [member]</link:label>
    <link:label id="lab_sny_SanofiAventisPrivateCoLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisPrivateCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Private Co, Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPrivateCoLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisPrivateCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisPrivateCoLtdMember" xlink:to="lab_sny_SanofiAventisPrivateCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer_b9da98b0-28b8-4aef-a687-aaba00896eaa_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments relating to contingent consideration in connection with business combinations Bayer</link:label>
    <link:label id="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer_label_en-US" xlink:label="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Relating To Contingent Consideration In Connection With Business Combinations Bayer</link:label>
    <link:label id="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments relating to contingent consideration in connection with business combinations bayer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer" xlink:to="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ad96c6e8-5f4c-4e4d-bb56-f0e6513df1e5_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital_943357d8-1c28-4bf9-a96e-f48153280bff_terseLabel_en-US" xlink:label="lab_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exceptional supplementary dividend proposed, percentage of share capital</link:label>
    <link:label id="lab_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital_label_en-US" xlink:label="lab_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exceptional Supplementary Dividend Proposed, Percentage Of Share Capital</link:label>
    <link:label id="lab_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital_documentation_en-US" xlink:label="lab_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exceptional Supplementary Dividend Proposed, Percentage Of Share Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital" xlink:to="lab_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfTreasuryShares_961a3295-972b-4e84-ad38-53079034d614_negatedLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfTreasuryShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfTreasuryShares_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfTreasuryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfTreasuryShares" xlink:to="lab_ifrs-full_PurchaseOfTreasuryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfPreActionProtocolCases_ddf76ac0-5465-43f5-9e32-39e269856197_terseLabel_en-US" xlink:label="lab_sny_NumberOfPreActionProtocolCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pre-action protocol cases</link:label>
    <link:label id="lab_sny_NumberOfPreActionProtocolCases_label_en-US" xlink:label="lab_sny_NumberOfPreActionProtocolCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Pre-Action Protocol Cases</link:label>
    <link:label id="lab_sny_NumberOfPreActionProtocolCases_documentation_en-US" xlink:label="lab_sny_NumberOfPreActionProtocolCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Pre-Action Protocol Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPreActionProtocolCases" xlink:href="sny-20221231.xsd#sny_NumberOfPreActionProtocolCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfPreActionProtocolCases" xlink:to="lab_sny_NumberOfPreActionProtocolCases" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AmortizedCostMember_955bf311-2ada-47a6-a65a-a4b228c0ba6b_terseLabel_en-US" xlink:label="lab_sny_AmortizedCostMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_sny_AmortizedCostMember_label_en-US" xlink:label="lab_sny_AmortizedCostMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost Member [member]</link:label>
    <link:label id="lab_sny_AmortizedCostMember_documentation_en-US" xlink:label="lab_sny_AmortizedCostMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmortizedCostMember" xlink:href="sny-20221231.xsd#sny_AmortizedCostMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmortizedCostMember" xlink:to="lab_sny_AmortizedCostMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock_ff7be0c9-aa9b-4abb-a61e-b233bea7582c_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Options Outstanding and Exercisable</link:label>
    <link:label id="lab_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of share based compensation shares authorized under stock option plans by exercise price range.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xlink:to="lab_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember_3dc6b53b-8932-4e9d-87dd-12c410689128_terseLabel_en-US" xlink:label="lab_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of computer software and other rights of an industrial or operational nature</link:label>
    <link:label id="lab_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember_label_en-US" xlink:label="lab_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Computer Software And Other Rights Of An Industrial Or Operational Nature [member]</link:label>
    <link:label id="lab_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember_documentation_en-US" xlink:label="lab_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of computer software and other rights of an industrial or operational nature.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember" xlink:href="sny-20221231.xsd#sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember" xlink:to="lab_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContractLiabilities_ec92edbd-d2f6-4894-9108-65353e5db1cd_terseLabel_en-US" xlink:label="lab_ifrs-full_ContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_ifrs-full_ContractLiabilities_label_en-US" xlink:label="lab_ifrs-full_ContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractLiabilities" xlink:to="lab_ifrs-full_ContractLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock_872312a2-595b-43ca-b23d-96bd008fd892_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Gross Value of Overdue Receivables</link:label>
    <link:label id="lab_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Overdue Receivables Gross Value [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of overdue receivables gross value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xlink:to="lab_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_74993529-3bb2-4eee-9d96-398b64b2b42b_negatedLabel_en-US" xlink:label="lab_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses arising from the impact of acquisitions on inventories</link:label>
    <link:label id="lab_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_label_en-US" xlink:label="lab_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Arising From The Impact Of Acquisitions On Inventories</link:label>
    <link:label id="lab_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_documentation_en-US" xlink:label="lab_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses arising from the impact of acquisitions on inventories.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xlink:href="sny-20221231.xsd#sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xlink:to="lab_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TaxExpenseOnDisposalOfInvestment_3ad6de93-2865-47dc-bf5e-5a13d96e20a2_terseLabel_en-US" xlink:label="lab_sny_TaxExpenseOnDisposalOfInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense on disposal of investment</link:label>
    <link:label id="lab_sny_TaxExpenseOnDisposalOfInvestment_label_en-US" xlink:label="lab_sny_TaxExpenseOnDisposalOfInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Expense On Disposal Of Investment</link:label>
    <link:label id="lab_sny_TaxExpenseOnDisposalOfInvestment_documentation_en-US" xlink:label="lab_sny_TaxExpenseOnDisposalOfInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Expense On Disposal Of Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxExpenseOnDisposalOfInvestment" xlink:href="sny-20221231.xsd#sny_TaxExpenseOnDisposalOfInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TaxExpenseOnDisposalOfInvestment" xlink:to="lab_sny_TaxExpenseOnDisposalOfInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssets_7a5f13d4-5ed1-4095-af18-c1a690f69a51_totalLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="lab_ifrs-full_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_4016e665-fa14-492e-94ff-86513efd26de_negatedLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options, options forfeited (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_17611264-0e30-4fef-8839-8af3e7182a9f_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_label_en-US" xlink:label="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Maximum Amount Of Contingent Consideration Payable And Firm Commitments To Buy Out Non-controlling Interests [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable" xlink:to="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer_414f09a7-3eca-4f34-bf15-718849729e82_terseLabel_en-US" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value per share awarded for three year service period, to chief executive officer (in euros per share)</link:label>
    <link:label id="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer_label_en-US" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Per Share Awarded For Three Year Service Period, To Chief Executive Officer</link:label>
    <link:label id="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer_documentation_en-US" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Per Share Awarded For Three Year Service Period, To Chief Executive Officer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" xlink:href="sny-20221231.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" xlink:to="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInUSDollarMember_15e429b8-2c71-4f89-b256-c0bd387f4619_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInUSDollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases in US Dollar</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInUSDollarMember_label_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInUSDollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchased In US Dollar [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasedInUSDollarMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasedInUSDollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases in USD.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInUSDollarMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInUSDollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasedInUSDollarMember" xlink:to="lab_sny_ForwardCurrencyPurchasedInUSDollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory_7c3716dd-f12c-4cf2-b352-ac4d6351ec22_terseLabel_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory_label_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Accounting Policy For Cost Of Sales [Policy Text Block]</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory_documentation_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for cost of sales explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory" xlink:to="lab_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_QuotedEquityInvestmentsMember_b0d7aac6-6324-43cf-9486-b2d8b97d3c07_terseLabel_en-US" xlink:label="lab_sny_QuotedEquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted equity investments</link:label>
    <link:label id="lab_sny_QuotedEquityInvestmentsMember_label_en-US" xlink:label="lab_sny_QuotedEquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Equity Investments [Member]</link:label>
    <link:label id="lab_sny_QuotedEquityInvestmentsMember_documentation_en-US" xlink:label="lab_sny_QuotedEquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted equity investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedEquityInvestmentsMember" xlink:href="sny-20221231.xsd#sny_QuotedEquityInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_QuotedEquityInvestmentsMember" xlink:to="lab_sny_QuotedEquityInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions_f9ada5b3-0a8a-4858-a310-eff909fa7487_terseLabel_en-US" xlink:label="lab_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital&#160;increase&#160;by&#160;exercise&#160;of stock subscription options (in shares)</link:label>
    <link:label id="lab_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions_label_en-US" xlink:label="lab_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Shares Issued In Regards Of Capital Increase By Exercise Of Stock Subscription Options</link:label>
    <link:label id="lab_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions_documentation_en-US" xlink:label="lab_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued in regards of capital increase by exercise of stock subscription options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xlink:href="sny-20221231.xsd#sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xlink:to="lab_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisDeChileSAMember_2516767b-d29b-49a1-a911-378e16b0da5d_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisDeChileSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis de Chile S.A.</link:label>
    <link:label id="lab_sny_SanofiAventisDeChileSAMember_label_en-US" xlink:label="lab_sny_SanofiAventisDeChileSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis de Chile S.A. [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisDeChileSAMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisDeChileSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis de Chile S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeChileSAMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeChileSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisDeChileSAMember" xlink:to="lab_sny_SanofiAventisDeChileSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareSpainSLMember_69dd4b4d-078a-4e8e-96b8-749185d88306_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareSpainSLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Spain, S.L.</link:label>
    <link:label id="lab_sny_OpellaHealthcareSpainSLMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareSpainSLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Spain, S.L. [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareSpainSLMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareSpainSLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Spain, S.L.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareSpainSLMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareSpainSLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareSpainSLMember" xlink:to="lab_sny_OpellaHealthcareSpainSLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SkyhawkTherapeuticsIncMember_c3816484-17e2-4a0c-aac2-87b388e5a7ee_terseLabel_en-US" xlink:label="lab_sny_SkyhawkTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skyhawk Therapeutics, Inc</link:label>
    <link:label id="lab_sny_SkyhawkTherapeuticsIncMember_label_en-US" xlink:label="lab_sny_SkyhawkTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skyhawk Therapeutics, Inc [Member]</link:label>
    <link:label id="lab_sny_SkyhawkTherapeuticsIncMember_documentation_en-US" xlink:label="lab_sny_SkyhawkTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skyhawk Therapeutics, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SkyhawkTherapeuticsIncMember" xlink:href="sny-20221231.xsd#sny_SkyhawkTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SkyhawkTherapeuticsIncMember" xlink:to="lab_sny_SkyhawkTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_7bf8121b-44e1-46f8-bf5d-9fb48b822995_terseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill recognized</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss recognised in profit or loss, goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiKKMember_774ebe7a-c3a0-4ca8-b5f6-9636860da83c_terseLabel_en-US" xlink:label="lab_sny_SanofiKKMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi K.K.</link:label>
    <link:label id="lab_sny_SanofiKKMember_label_en-US" xlink:label="lab_sny_SanofiKKMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi K.K [Member]</link:label>
    <link:label id="lab_sny_SanofiKKMember_documentation_en-US" xlink:label="lab_sny_SanofiKKMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi K.K.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiKKMember" xlink:href="sny-20221231.xsd#sny_SanofiKKMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiKKMember" xlink:to="lab_sny_SanofiKKMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member_9cdd836f-e5d0-429d-ac13-2941f153254d_terseLabel_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92%</link:label>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member_label_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% [Member]</link:label>
    <link:label id="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member_documentation_en-US" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member" xlink:to="lab_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfAgreementsSigned_da82f587-e491-4baf-b624-ab4f663dd9ba_terseLabel_en-US" xlink:label="lab_sny_NumberOfAgreementsSigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of agreements signed</link:label>
    <link:label id="lab_sny_NumberOfAgreementsSigned_label_en-US" xlink:label="lab_sny_NumberOfAgreementsSigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Agreements Signed</link:label>
    <link:label id="lab_sny_NumberOfAgreementsSigned_documentation_en-US" xlink:label="lab_sny_NumberOfAgreementsSigned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Agreements Signed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfAgreementsSigned" xlink:href="sny-20221231.xsd#sny_NumberOfAgreementsSigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfAgreementsSigned" xlink:to="lab_sny_NumberOfAgreementsSigned" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencySalesInTaiwanDollarMember_c883192e-1cd8-4215-9b49-8bd9b5a4628c_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencySalesInTaiwanDollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales in Taiwan Dollar</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInTaiwanDollarMember_label_en-US" xlink:label="lab_sny_ForwardCurrencySalesInTaiwanDollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Taiwan Dollar [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInTaiwanDollarMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencySalesInTaiwanDollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Taiwan Dollar</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInTaiwanDollarMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInTaiwanDollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInTaiwanDollarMember" xlink:to="lab_sny_ForwardCurrencySalesInTaiwanDollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_eccc8cd6-d15e-4c8d-af7c-292d37c2d8d4_totalLabel_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market value</link:label>
    <link:label id="lab_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_label_en-US" xlink:label="lab_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial instruments designated as hedging instruments, at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" xlink:to="lab_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_9954d046-7852-4da9-9caf-048de72c971f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of defined benefit plans [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of defined benefit plans [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_868add68-40b9-42fb-8321-4c93c726f7d1_terseLabel_en-US" xlink:label="lab_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense relating to short-term leases and low value assets</link:label>
    <link:label id="lab_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_label_en-US" xlink:label="lab_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Relating To Short-term Leases And Low Value Assets For Which Recognition Exemption Has Been Used</link:label>
    <link:label id="lab_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_documentation_en-US" xlink:label="lab_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Relating To Short-term Leases And Low Value Assets For Which Recognition Exemption Has Been Used</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:href="sny-20221231.xsd#sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:to="lab_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_0efcbfa9-1ba2-49ed-ba7d-4ab94b8773bd_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US dollar</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DevelopmentOfCemiplimabREGN2810Member_69297563-635d-4d7f-973d-f93f9d3f9d05_terseLabel_en-US" xlink:label="lab_sny_DevelopmentOfCemiplimabREGN2810Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development of cemiplimab (REGN2810)</link:label>
    <link:label id="lab_sny_DevelopmentOfCemiplimabREGN2810Member_label_en-US" xlink:label="lab_sny_DevelopmentOfCemiplimabREGN2810Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Of Cemiplimab (REGN2810) [Member]</link:label>
    <link:label id="lab_sny_DevelopmentOfCemiplimabREGN2810Member_documentation_en-US" xlink:label="lab_sny_DevelopmentOfCemiplimabREGN2810Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development of cemiplimab (REGN2810).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DevelopmentOfCemiplimabREGN2810Member" xlink:href="sny-20221231.xsd#sny_DevelopmentOfCemiplimabREGN2810Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DevelopmentOfCemiplimabREGN2810Member" xlink:to="lab_sny_DevelopmentOfCemiplimabREGN2810Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareLLCMember_f2f98324-2749-40f0-99b8-ce3df8d8c795_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare LLC</link:label>
    <link:label id="lab_sny_OpellaHealthcareLLCMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare LLC [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareLLCMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareLLCMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareLLCMember" xlink:to="lab_sny_OpellaHealthcareLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_ea1b67f8-7054-480c-866f-53530469f50d_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in currency translation differences</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on exchange differences on translation of foreign operations, before tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_1daf568c-287c-4a90-b938-4484b5e96415_negatedLabel_en-US" xlink:label="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unwinding of discounting of provisions</link:label>
    <link:label id="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_label_en-US" xlink:label="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense arising from passage of time on other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:to="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans_ed7d02d3-1211-4298-9ab8-53ae1948de1d_terseLabel_en-US" xlink:label="lab_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average residual holding periods</link:label>
    <link:label id="lab_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans_label_en-US" xlink:label="lab_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Residual Holding Periods Under Various Early Retirement Plans</link:label>
    <link:label id="lab_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans_documentation_en-US" xlink:label="lab_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average residual holding periods under various early retirement plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans" xlink:href="sny-20221231.xsd#sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans" xlink:to="lab_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDebtLineItems_6dced883-b9df-4354-acab-bfe77f6fca19_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of debt [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtLineItems" xlink:to="lab_sny_DisclosureOfDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityMember_5686e645-ad34-48ec-b50d-5a8c44757776_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_ifrs-full_EquityMember_label_en-US" xlink:label="lab_ifrs-full_EquityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityMember" xlink:to="lab_ifrs-full_EquityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiResearchInvestLLCMember_5e618f54-87a0-4455-bd1b-7f649387fc56_terseLabel_en-US" xlink:label="lab_sny_SanofiResearchInvestLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Research Invest LLC</link:label>
    <link:label id="lab_sny_SanofiResearchInvestLLCMember_label_en-US" xlink:label="lab_sny_SanofiResearchInvestLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Research Invest LLC [Member]</link:label>
    <link:label id="lab_sny_SanofiResearchInvestLLCMember_documentation_en-US" xlink:label="lab_sny_SanofiResearchInvestLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Research Invest LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiResearchInvestLLCMember" xlink:href="sny-20221231.xsd#sny_SanofiResearchInvestLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiResearchInvestLLCMember" xlink:to="lab_sny_SanofiResearchInvestLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_807a786e-68e0-4e7b-b771-ca56ee1ade76_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</link:label>
    <link:label id="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_label_en-US" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:to="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisPhilippinesIncMember_f3b7c01f-7945-4688-aa47-8d6e44564eb8_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisPhilippinesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Philippines Inc.</link:label>
    <link:label id="lab_sny_SanofiAventisPhilippinesIncMember_label_en-US" xlink:label="lab_sny_SanofiAventisPhilippinesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Philippines Inc [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisPhilippinesIncMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisPhilippinesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Philippines Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPhilippinesIncMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisPhilippinesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisPhilippinesIncMember" xlink:to="lab_sny_SanofiAventisPhilippinesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherGuaranteesGivenMember_f8ca26a8-7b78-4058-b4d7-30507580e528_terseLabel_en-US" xlink:label="lab_sny_OtherGuaranteesGivenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other guarantees given</link:label>
    <link:label id="lab_sny_OtherGuaranteesGivenMember_label_en-US" xlink:label="lab_sny_OtherGuaranteesGivenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Guarantees Given [Member]</link:label>
    <link:label id="lab_sny_OtherGuaranteesGivenMember_documentation_en-US" xlink:label="lab_sny_OtherGuaranteesGivenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Guarantees Given</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGuaranteesGivenMember" xlink:href="sny-20221231.xsd#sny_OtherGuaranteesGivenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherGuaranteesGivenMember" xlink:to="lab_sny_OtherGuaranteesGivenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilitiesMember_69a78ba8-258a-4c83-8294-99a83aa3e38c_terseLabel_en-US" xlink:label="lab_ifrs-full_LiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_ifrs-full_LiabilitiesMember_label_en-US" xlink:label="lab_ifrs-full_LiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesMember" xlink:to="lab_ifrs-full_LiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FairValueMeasurementAbstract_88499787-0ac8-4d45-b31c-fe5757a25e78_terseLabel_en-US" xlink:label="lab_sny_FairValueMeasurementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Abstract]</link:label>
    <link:label id="lab_sny_FairValueMeasurementAbstract_label_en-US" xlink:label="lab_sny_FairValueMeasurementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Abstract]</link:label>
    <link:label id="lab_sny_FairValueMeasurementAbstract_documentation_en-US" xlink:label="lab_sny_FairValueMeasurementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueMeasurementAbstract" xlink:href="sny-20221231.xsd#sny_FairValueMeasurementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FairValueMeasurementAbstract" xlink:to="lab_sny_FairValueMeasurementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockOptionsAndShareBasedPaymentsMember_18bfa1b1-ce21-4861-b3bc-e28b4666e127_terseLabel_en-US" xlink:label="lab_sny_StockOptionsAndShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and other share-based payments</link:label>
    <link:label id="lab_sny_StockOptionsAndShareBasedPaymentsMember_label_en-US" xlink:label="lab_sny_StockOptionsAndShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options And Share Based Payments [Member]</link:label>
    <link:label id="lab_sny_StockOptionsAndShareBasedPaymentsMember_documentation_en-US" xlink:label="lab_sny_StockOptionsAndShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and share based payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionsAndShareBasedPaymentsMember" xlink:href="sny-20221231.xsd#sny_StockOptionsAndShareBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockOptionsAndShareBasedPaymentsMember" xlink:to="lab_sny_StockOptionsAndShareBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MyozymeOrLumizymeMember_b946d8e8-9a41-457e-a906-65f4e13aa786_terseLabel_en-US" xlink:label="lab_sny_MyozymeOrLumizymeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myozyme/Lumizyme</link:label>
    <link:label id="lab_sny_MyozymeOrLumizymeMember_label_en-US" xlink:label="lab_sny_MyozymeOrLumizymeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myozyme Or Lumizyme [Member]</link:label>
    <link:label id="lab_sny_MyozymeOrLumizymeMember_documentation_en-US" xlink:label="lab_sny_MyozymeOrLumizymeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myozyme or Lumizyme [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MyozymeOrLumizymeMember" xlink:href="sny-20221231.xsd#sny_MyozymeOrLumizymeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MyozymeOrLumizymeMember" xlink:to="lab_sny_MyozymeOrLumizymeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RestructuringCostsReversedAndSimilarItems_cf54ed22-6de0-4e71-84c8-f4ae85db2057_verboseLabel_en-US" xlink:label="lab_sny_RestructuringCostsReversedAndSimilarItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_sny_RestructuringCostsReversedAndSimilarItems_label_en-US" xlink:label="lab_sny_RestructuringCostsReversedAndSimilarItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs (Reversed) And Similar Items</link:label>
    <link:label id="lab_sny_RestructuringCostsReversedAndSimilarItems_documentation_en-US" xlink:label="lab_sny_RestructuringCostsReversedAndSimilarItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs (Reversed) And Similar Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestructuringCostsReversedAndSimilarItems" xlink:href="sny-20221231.xsd#sny_RestructuringCostsReversedAndSimilarItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestructuringCostsReversedAndSimilarItems" xlink:to="lab_sny_RestructuringCostsReversedAndSimilarItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherOperatingExpensesTableTextBlock_fa53e059-b4ae-4258-bc6c-601e77690b55_terseLabel_en-US" xlink:label="lab_sny_OtherOperatingExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Other Operating Expenses</link:label>
    <link:label id="lab_sny_OtherOperatingExpensesTableTextBlock_label_en-US" xlink:label="lab_sny_OtherOperatingExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Expenses [Table Text Block]</link:label>
    <link:label id="lab_sny_OtherOperatingExpensesTableTextBlock_documentation_en-US" xlink:label="lab_sny_OtherOperatingExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Expenses [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherOperatingExpensesTableTextBlock" xlink:href="sny-20221231.xsd#sny_OtherOperatingExpensesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherOperatingExpensesTableTextBlock" xlink:to="lab_sny_OtherOperatingExpensesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_73729220-fbd8-4fcf-8e5c-448f1cdb2505_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_e3dc80fb-5757-4605-a3ad-56b82ee7ec89_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [axis]</link:label>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_label_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsAndGoodwillMember_8591f67e-7f38-4b52-b6ab-871b5e8811e3_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets and goodwill [member]</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsAndGoodwillMember_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets and goodwill [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ParticipatingSharesNumberOutstanding_2a290a9c-e293-430f-aafe-b8daddee5c42_terseLabel_en-US" xlink:label="lab_sny_ParticipatingSharesNumberOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of participating shares outstanding (in shares)</link:label>
    <link:label id="lab_sny_ParticipatingSharesNumberOutstanding_label_en-US" xlink:label="lab_sny_ParticipatingSharesNumberOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Shares Number Outstanding</link:label>
    <link:label id="lab_sny_ParticipatingSharesNumberOutstanding_documentation_en-US" xlink:label="lab_sny_ParticipatingSharesNumberOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating shares number outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ParticipatingSharesNumberOutstanding" xlink:href="sny-20221231.xsd#sny_ParticipatingSharesNumberOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ParticipatingSharesNumberOutstanding" xlink:to="lab_sny_ParticipatingSharesNumberOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencySalesInUSDollarMember_f75f5927-8ebd-4297-beda-62fc664c4ebc_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencySalesInUSDollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales in US Dollar</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInUSDollarMember_label_en-US" xlink:label="lab_sny_ForwardCurrencySalesInUSDollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In US Dollar [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInUSDollarMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencySalesInUSDollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales in USD.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInUSDollarMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInUSDollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInUSDollarMember" xlink:to="lab_sny_ForwardCurrencySalesInUSDollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_34422970-6ddd-481f-a12e-ea645ef44773_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfBellweatherTrialsHeld_1cc1ce70-7b9d-4335-9b84-56e29d96212a_terseLabel_en-US" xlink:label="lab_sny_NumberOfBellweatherTrialsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of bellweather trial held</link:label>
    <link:label id="lab_sny_NumberOfBellweatherTrialsHeld_label_en-US" xlink:label="lab_sny_NumberOfBellweatherTrialsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Bellweather Trials Held</link:label>
    <link:label id="lab_sny_NumberOfBellweatherTrialsHeld_documentation_en-US" xlink:label="lab_sny_NumberOfBellweatherTrialsHeld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Bellweather Trials Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfBellweatherTrialsHeld" xlink:href="sny-20221231.xsd#sny_NumberOfBellweatherTrialsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfBellweatherTrialsHeld" xlink:to="lab_sny_NumberOfBellweatherTrialsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SAR444245Member_b59301fc-b068-4bbf-bf0e-f9aa98fe1bb0_terseLabel_en-US" xlink:label="lab_sny_SAR444245Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAR444245</link:label>
    <link:label id="lab_sny_SAR444245Member_label_en-US" xlink:label="lab_sny_SAR444245Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAR444245 [Member]</link:label>
    <link:label id="lab_sny_SAR444245Member_documentation_en-US" xlink:label="lab_sny_SAR444245Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAR444245</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SAR444245Member" xlink:href="sny-20221231.xsd#sny_SAR444245Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SAR444245Member" xlink:to="lab_sny_SAR444245Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4802a1dd-16dd-4945-8386-06098752f3fa_verboseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 4</link:label>
    <link:label id="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4aed4b90-7a07-411a-b4a8-cdc62505fd7c_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3 to 4 years</link:label>
    <link:label id="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than three years and not later than four years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AntibodiesAllianceMember_ab1e5885-d530-456f-8383-9ee1ab11a118_terseLabel_en-US" xlink:label="lab_sny_AntibodiesAllianceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monoclonal Antibody Alliance</link:label>
    <link:label id="lab_sny_AntibodiesAllianceMember_label_en-US" xlink:label="lab_sny_AntibodiesAllianceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antibodies Alliance [Member]</link:label>
    <link:label id="lab_sny_AntibodiesAllianceMember_documentation_en-US" xlink:label="lab_sny_AntibodiesAllianceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antibodies Alliance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesAllianceMember" xlink:href="sny-20221231.xsd#sny_AntibodiesAllianceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AntibodiesAllianceMember" xlink:to="lab_sny_AntibodiesAllianceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan_898bc77b-8908-49ef-827f-bbe4f86c07ae_negatedLabel_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan amendments, curtailments or settlements not specified in the terms of the plan</link:label>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan_label_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Plan Amendments, Curtailments Or Settlements Not Specified In The Terms Of The Plan</link:label>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan_documentation_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Plan Amendments, Curtailments Or Settlements Not Specified In The Terms Of The Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" xlink:to="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ValueOfHedgeRecognizedInEquityMember_3ccf6662-1e4d-4f2c-b507-5d581d2ee569_terseLabel_en-US" xlink:label="lab_sny_ValueOfHedgeRecognizedInEquityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Of&#160;which recognized&#160;in&#160;equity</link:label>
    <link:label id="lab_sny_ValueOfHedgeRecognizedInEquityMember_label_en-US" xlink:label="lab_sny_ValueOfHedgeRecognizedInEquityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Hedge Recognized In Equity [Member]</link:label>
    <link:label id="lab_sny_ValueOfHedgeRecognizedInEquityMember_documentation_en-US" xlink:label="lab_sny_ValueOfHedgeRecognizedInEquityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Hedge Recognized In Equity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfHedgeRecognizedInEquityMember" xlink:href="sny-20221231.xsd#sny_ValueOfHedgeRecognizedInEquityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ValueOfHedgeRecognizedInEquityMember" xlink:to="lab_sny_ValueOfHedgeRecognizedInEquityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareArgentinaSAUMember_f51f4fe2-6568-4ef2-ab47-1c7bb0c2ac7b_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareArgentinaSAUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Argentina S.A.U.</link:label>
    <link:label id="lab_sny_OpellaHealthcareArgentinaSAUMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareArgentinaSAUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Argentina S.A.U. [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareArgentinaSAUMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareArgentinaSAUMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Argentina S.A.U.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareArgentinaSAUMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareArgentinaSAUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareArgentinaSAUMember" xlink:to="lab_sny_OpellaHealthcareArgentinaSAUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfOngoingLawsuits_dcfd5632-f66c-4d6a-9bc1-99d70afba309_terseLabel_en-US" xlink:label="lab_sny_NumberOfOngoingLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ongoing lawsuits</link:label>
    <link:label id="lab_sny_NumberOfOngoingLawsuits_label_en-US" xlink:label="lab_sny_NumberOfOngoingLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Ongoing Lawsuits</link:label>
    <link:label id="lab_sny_NumberOfOngoingLawsuits_documentation_en-US" xlink:label="lab_sny_NumberOfOngoingLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Ongoing Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOngoingLawsuits" xlink:href="sny-20221231.xsd#sny_NumberOfOngoingLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfOngoingLawsuits" xlink:to="lab_sny_NumberOfOngoingLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_babb6975-d90d-4983-870f-aaf966cc6dce_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1&#160;to&#160;3&#160;months</link:label>
    <link:label id="lab_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Later than one month and not later than three months [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:to="lab_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod_7f1a31be-f2b7-4172-ab91-a176131464d9_terseLabel_en-US" xlink:label="lab_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identified environmental risks provisions estimated obligation period</link:label>
    <link:label id="lab_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod_label_en-US" xlink:label="lab_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identified Environmental Risks Provisions Estimated Obligation Period</link:label>
    <link:label id="lab_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod_documentation_en-US" xlink:label="lab_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identified environmental risks provisions estimated obligation period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod" xlink:href="sny-20221231.xsd#sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod" xlink:to="lab_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember_b6a27319-c7d6-4ebe-b117-a87ec10cefc1_terseLabel_en-US" xlink:label="lab_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of other acquired intangible assets</link:label>
    <link:label id="lab_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember_label_en-US" xlink:label="lab_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement Of Other Acquired Intangible Assets [Member]</link:label>
    <link:label id="lab_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember_documentation_en-US" xlink:label="lab_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of other acquired intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember" xlink:href="sny-20221231.xsd#sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember" xlink:to="lab_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CommercialPapersIssued_72034d50-ca30-441d-b6a2-0c24a6434700_terseLabel_en-US" xlink:label="lab_ifrs-full_CommercialPapersIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper programs</link:label>
    <link:label id="lab_ifrs-full_CommercialPapersIssued_label_en-US" xlink:label="lab_ifrs-full_CommercialPapersIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial papers issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommercialPapersIssued" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CommercialPapersIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CommercialPapersIssued" xlink:to="lab_ifrs-full_CommercialPapersIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PharmaceuticalsSegmentMember_d09e5789-90cc-4d41-bb83-93d6909c1646_terseLabel_en-US" xlink:label="lab_sny_PharmaceuticalsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals</link:label>
    <link:label id="lab_sny_PharmaceuticalsSegmentMember_label_en-US" xlink:label="lab_sny_PharmaceuticalsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals Segment [member]</link:label>
    <link:label id="lab_sny_PharmaceuticalsSegmentMember_documentation_en-US" xlink:label="lab_sny_PharmaceuticalsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsSegmentMember" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PharmaceuticalsSegmentMember" xlink:to="lab_sny_PharmaceuticalsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_22214eb9-1bc3-4431-ac94-1a7dce40d19c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember_61105638-1f2f-45fe-ba36-734fe4d9d776_terseLabel_en-US" xlink:label="lab_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial instruments held to fund deferred compensation plan</link:label>
    <link:label id="lab_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember_label_en-US" xlink:label="lab_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets Held To Fund Deferred Compensation Plan [Member]</link:label>
    <link:label id="lab_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember_documentation_en-US" xlink:label="lab_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets Held To Fund Deferred Compensation Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember" xlink:href="sny-20221231.xsd#sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember" xlink:to="lab_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_551ebfde-7367-4a0c-99e5-6e5102055a9a_terseLabel_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit liability (asset) [axis]</link:label>
    <link:label id="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_label_en-US" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit liability (asset) [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:to="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_5b5c36e3-772c-4995-9264-88add7ba9df9_terseLabel_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and other increases</link:label>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_461de8ef-4d7b-4099-ba09-451ee2ab7202_verboseLabel_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Level3OfFairValueHierarchyMember_9a0513ca-33b8-4a79-8692-7d3adb4b2cf7_terseLabel_en-US" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_ifrs-full_Level3OfFairValueHierarchyMember_label_en-US" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 of fair value hierarchy [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level3OfFairValueHierarchyMember" xlink:to="lab_ifrs-full_Level3OfFairValueHierarchyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_b0d71840-8588-49f3-bfec-93c9c36d5f08_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Introduction</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of general information about financial statements [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries_22260624-9dfd-4cf6-9e4f-d0b7f6f58543_terseLabel_en-US" xlink:label="lab_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit-related services charged to the parent company and its French subsidiaries</link:label>
    <link:label id="lab_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries_label_en-US" xlink:label="lab_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Related Services Charged To The Parent Company And Its French Subsidiaries</link:label>
    <link:label id="lab_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries_documentation_en-US" xlink:label="lab_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit-related services charged to the parent company and its French subsidiaries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" xlink:href="sny-20221231.xsd#sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" xlink:to="lab_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencyPurchasesMember_db16958e-ab91-4ea7-a3b0-cf72ac029e12_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasesMember_label_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Purchases [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencyPurchasesMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencyPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency purchases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasesMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasesMember" xlink:to="lab_sny_ForwardCurrencyPurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherCurrenciesMember_76e6af31-f60c-4f34-83ac-d93c9923c775_terseLabel_en-US" xlink:label="lab_sny_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other currencies</link:label>
    <link:label id="lab_sny_OtherCurrenciesMember_label_en-US" xlink:label="lab_sny_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Currencies [Member]</link:label>
    <link:label id="lab_sny_OtherCurrenciesMember_documentation_en-US" xlink:label="lab_sny_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Currencies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCurrenciesMember" xlink:href="sny-20221231.xsd#sny_OtherCurrenciesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherCurrenciesMember" xlink:to="lab_sny_OtherCurrenciesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherIntangibleAssetsExcludingSoftwareMember_cfb92176-e16e-4947-92fc-1f51a609af16_terseLabel_en-US" xlink:label="lab_sny_OtherIntangibleAssetsExcludingSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets excluding software</link:label>
    <link:label id="lab_sny_OtherIntangibleAssetsExcludingSoftwareMember_label_en-US" xlink:label="lab_sny_OtherIntangibleAssetsExcludingSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets Excluding Software [Member]</link:label>
    <link:label id="lab_sny_OtherIntangibleAssetsExcludingSoftwareMember_documentation_en-US" xlink:label="lab_sny_OtherIntangibleAssetsExcludingSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets Excluding Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherIntangibleAssetsExcludingSoftwareMember" xlink:href="sny-20221231.xsd#sny_OtherIntangibleAssetsExcludingSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherIntangibleAssetsExcludingSoftwareMember" xlink:to="lab_sny_OtherIntangibleAssetsExcludingSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InvestmentsInAssociatesAndJointVentures_9104cf44-73aa-4526-9b97-732e3318b68b_terseLabel_en-US" xlink:label="lab_sny_InvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments accounted for using the equity method</link:label>
    <link:label id="lab_sny_InvestmentsInAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_InvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_InvestmentsInAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_InvestmentsInAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of investments, joint ventures and associates in an entity's separate financial statements. Long term equity interest, significant influence.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InvestmentsInAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_InvestmentsInAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InvestmentsInAssociatesAndJointVentures" xlink:to="lab_sny_InvestmentsInAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExercisePriceRangeFourMember_838e09fb-db55-4a97-ab04-45ba56fabc13_terseLabel_en-US" xlink:label="lab_sny_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price range four</link:label>
    <link:label id="lab_sny_ExercisePriceRangeFourMember_label_en-US" xlink:label="lab_sny_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
    <link:label id="lab_sny_ExercisePriceRangeFourMember_documentation_en-US" xlink:label="lab_sny_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExercisePriceRangeFourMember" xlink:href="sny-20221231.xsd#sny_ExercisePriceRangeFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExercisePriceRangeFourMember" xlink:to="lab_sny_ExercisePriceRangeFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MaximumOwnershipPercentageAllowedToAcquire_e057afbc-31fb-45f8-bcf7-47e217cddef5_terseLabel_en-US" xlink:label="lab_sny_MaximumOwnershipPercentageAllowedToAcquire" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum ownership percentage allowed to acquire</link:label>
    <link:label id="lab_sny_MaximumOwnershipPercentageAllowedToAcquire_label_en-US" xlink:label="lab_sny_MaximumOwnershipPercentageAllowedToAcquire" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Ownership Percentage Allowed To Acquire</link:label>
    <link:label id="lab_sny_MaximumOwnershipPercentageAllowedToAcquire_documentation_en-US" xlink:label="lab_sny_MaximumOwnershipPercentageAllowedToAcquire" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum ownership percentage allowed to acquire.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumOwnershipPercentageAllowedToAcquire" xlink:href="sny-20221231.xsd#sny_MaximumOwnershipPercentageAllowedToAcquire"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MaximumOwnershipPercentageAllowedToAcquire" xlink:to="lab_sny_MaximumOwnershipPercentageAllowedToAcquire" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonCurrentFinancialAssetsNumberOfShares_b6a54396-8e54-46a5-b897-d4081d545473_terseLabel_en-US" xlink:label="lab_sny_NonCurrentFinancialAssetsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current financial assets, number of shares (in shares)</link:label>
    <link:label id="lab_sny_NonCurrentFinancialAssetsNumberOfShares_label_en-US" xlink:label="lab_sny_NonCurrentFinancialAssetsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Financial Assets, Number Of Shares</link:label>
    <link:label id="lab_sny_NonCurrentFinancialAssetsNumberOfShares_documentation_en-US" xlink:label="lab_sny_NonCurrentFinancialAssetsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Financial Assets, Number Of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinancialAssetsNumberOfShares" xlink:href="sny-20221231.xsd#sny_NonCurrentFinancialAssetsNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentFinancialAssetsNumberOfShares" xlink:to="lab_sny_NonCurrentFinancialAssetsNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_0df5a5ac-912c-4239-9fa2-4641e0190206_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumption of discount rates [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExpenseCategoriesDomain_adb18c00-c347-4fda-8b37-24a66daa3d8f_terseLabel_en-US" xlink:label="lab_sny_ExpenseCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Categories [Domain]</link:label>
    <link:label id="lab_sny_ExpenseCategoriesDomain_label_en-US" xlink:label="lab_sny_ExpenseCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Categories [Domain]</link:label>
    <link:label id="lab_sny_ExpenseCategoriesDomain_documentation_en-US" xlink:label="lab_sny_ExpenseCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Categories [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseCategoriesDomain" xlink:href="sny-20221231.xsd#sny_ExpenseCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseCategoriesDomain" xlink:to="lab_sny_ExpenseCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_f7c8fd64-ba78-4eb9-a89f-b3d084a95540_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfCountriesIncludedInPensionPlans_30568ec2-8563-43d0-9f94-55ec33391c86_terseLabel_en-US" xlink:label="lab_sny_NumberOfCountriesIncludedInPensionPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of major countries included in pension obligations</link:label>
    <link:label id="lab_sny_NumberOfCountriesIncludedInPensionPlans_label_en-US" xlink:label="lab_sny_NumberOfCountriesIncludedInPensionPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Countries Included In Pension Plans</link:label>
    <link:label id="lab_sny_NumberOfCountriesIncludedInPensionPlans_documentation_en-US" xlink:label="lab_sny_NumberOfCountriesIncludedInPensionPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries included in pension plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCountriesIncludedInPensionPlans" xlink:href="sny-20221231.xsd#sny_NumberOfCountriesIncludedInPensionPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfCountriesIncludedInPensionPlans" xlink:to="lab_sny_NumberOfCountriesIncludedInPensionPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany_0e54e2eb-4ed6-45cd-8ce5-69385ed2a757_verboseLabel_en-US" xlink:label="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of future development expense funded by company</link:label>
    <link:label id="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany_label_en-US" xlink:label="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Future Development Expense Funded By Company</link:label>
    <link:label id="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany_documentation_en-US" xlink:label="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of future development expense funded by company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany" xlink:href="sny-20221231.xsd#sny_PercentageOfFutureDevelopmentExpenseFundedByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany" xlink:to="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_501ab369-6613-41fe-8d6d-dc0395d8240d_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through net exchange differences, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherLiabilitiesMember_8f3f5c9c-3336-4d14-ab5e-1dbc6f96e6f2_terseLabel_en-US" xlink:label="lab_sny_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_sny_OtherLiabilitiesMember_label_en-US" xlink:label="lab_sny_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:label id="lab_sny_OtherLiabilitiesMember_documentation_en-US" xlink:label="lab_sny_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherLiabilitiesMember" xlink:href="sny-20221231.xsd#sny_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherLiabilitiesMember" xlink:to="lab_sny_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock_805ab91e-8a86-41b4-b53e-828a2426c0a1_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs and similar items</link:label>
    <link:label id="lab_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Restructuring Costs And Similar Items [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure of restructuring costs and similar items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock" xlink:to="lab_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShareRepurchase2021ProgramMember_2f944d68-b184-4060-afc0-8f0244883f12_terseLabel_en-US" xlink:label="lab_sny_ShareRepurchase2021ProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_sny_ShareRepurchase2021ProgramMember_label_en-US" xlink:label="lab_sny_ShareRepurchase2021ProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase 2021 Program [Member]</link:label>
    <link:label id="lab_sny_ShareRepurchase2021ProgramMember_documentation_en-US" xlink:label="lab_sny_ShareRepurchase2021ProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase 2021 Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2021ProgramMember" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2021ProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareRepurchase2021ProgramMember" xlink:to="lab_sny_ShareRepurchase2021ProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_Sanofi2015DSASMember_38772435-b374-40a4-bc68-1e3fc1576ae1_terseLabel_en-US" xlink:label="lab_sny_Sanofi2015DSASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi 2015 D SAS</link:label>
    <link:label id="lab_sny_Sanofi2015DSASMember_label_en-US" xlink:label="lab_sny_Sanofi2015DSASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi 2015 D SAS [Member]</link:label>
    <link:label id="lab_sny_Sanofi2015DSASMember_documentation_en-US" xlink:label="lab_sny_Sanofi2015DSASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi 2015 D SAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_Sanofi2015DSASMember" xlink:href="sny-20221231.xsd#sny_Sanofi2015DSASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_Sanofi2015DSASMember" xlink:to="lab_sny_Sanofi2015DSASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod_c1bb2574-7359-425d-9c9f-662d1700784f_terseLabel_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administration costs and taxes paid during the period</link:label>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod_label_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Administration Costs And Taxes Paid During The Period</link:label>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod_documentation_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Administration Costs And Taxes Paid During The Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" xlink:to="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock_057fad9a-037b-48df-b2f9-18ff1d68d970_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated</link:label>
    <link:label id="lab_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Financial Currency Hedging Instruments With Notional Amount Translated In To Euros At Closing Exchange Rate Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of financial currency hedging instruments with notional amount translated in to euros at closing exchange rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DividendsPaidAbstract_e8652d58-2d15-4c13-b4e0-cf9d3c85d3c8_terseLabel_en-US" xlink:label="lab_sny_DividendsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid:</link:label>
    <link:label id="lab_sny_DividendsPaidAbstract_label_en-US" xlink:label="lab_sny_DividendsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Paid [Abstract]</link:label>
    <link:label id="lab_sny_DividendsPaidAbstract_documentation_en-US" xlink:label="lab_sny_DividendsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DividendsPaidAbstract" xlink:href="sny-20221231.xsd#sny_DividendsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DividendsPaidAbstract" xlink:to="lab_sny_DividendsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsAxis_66c82bc5-4f37-4221-a7fa-0683a12dd792_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumptions [axis]</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsAxis_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumptions [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis" xlink:to="lab_ifrs-full_ActuarialAssumptionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures_83e8d771-d79c-40d3-8d73-3a5f3d441542_negatedTerseLabel_en-US" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effects</link:label>
    <link:label id="lab_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Relating To Change In Fair Value Of Debt Instrument Excluding Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Relating To Change In Fair Value Of Debt Instrument Excluding Associates And Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures" xlink:to="lab_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_7cb41ab0-be77-4c5d-ac01-12b719cdead9_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for risks</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for provisions [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfCurrenciesDebtIsIssuedIn_27475d21-5a91-4fc9-be81-dba8dcdf4cc1_terseLabel_en-US" xlink:label="lab_sny_NumberOfCurrenciesDebtIsIssuedIn" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of currencies debt is issued in</link:label>
    <link:label id="lab_sny_NumberOfCurrenciesDebtIsIssuedIn_label_en-US" xlink:label="lab_sny_NumberOfCurrenciesDebtIsIssuedIn" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Currencies Debt Is Issued In</link:label>
    <link:label id="lab_sny_NumberOfCurrenciesDebtIsIssuedIn_documentation_en-US" xlink:label="lab_sny_NumberOfCurrenciesDebtIsIssuedIn" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Currencies Debt Is Issued In</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCurrenciesDebtIsIssuedIn" xlink:href="sny-20221231.xsd#sny_NumberOfCurrenciesDebtIsIssuedIn"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfCurrenciesDebtIsIssuedIn" xlink:to="lab_sny_NumberOfCurrenciesDebtIsIssuedIn" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GainLossOnImpairmentOfTreasuryShares_3c9a4c86-f600-4217-a0f9-680ffae1806d_terseLabel_en-US" xlink:label="lab_sny_GainLossOnImpairmentOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized on impairment of treasury shares</link:label>
    <link:label id="lab_sny_GainLossOnImpairmentOfTreasuryShares_label_en-US" xlink:label="lab_sny_GainLossOnImpairmentOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Impairment Of Treasury Shares</link:label>
    <link:label id="lab_sny_GainLossOnImpairmentOfTreasuryShares_documentation_en-US" xlink:label="lab_sny_GainLossOnImpairmentOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on impairment of treasury shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainLossOnImpairmentOfTreasuryShares" xlink:href="sny-20221231.xsd#sny_GainLossOnImpairmentOfTreasuryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainLossOnImpairmentOfTreasuryShares" xlink:to="lab_sny_GainLossOnImpairmentOfTreasuryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_d2ac4c26-4115-48c7-a747-b3a325856238_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Geographical Information on Net Sales and Non-Current Assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of geographical areas [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock_b285ee56-01ea-4bc8-94cb-2a9e05bc81d0_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Repurchases program</link:label>
    <link:label id="lab_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Share Repurchase Program Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of share repurchase program explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiSaglikUrunleriLimitedSirketiMember_c7b352da-65dc-4d1a-8a55-dcad15d453d1_terseLabel_en-US" xlink:label="lab_sny_SanofiSaglikUrunleriLimitedSirketiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Saglik Urunleri Limited Sirketi</link:label>
    <link:label id="lab_sny_SanofiSaglikUrunleriLimitedSirketiMember_label_en-US" xlink:label="lab_sny_SanofiSaglikUrunleriLimitedSirketiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Saglik Urunleri Limited Sirketi [Member]</link:label>
    <link:label id="lab_sny_SanofiSaglikUrunleriLimitedSirketiMember_documentation_en-US" xlink:label="lab_sny_SanofiSaglikUrunleriLimitedSirketiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Saglik Urunleri Limited Sirketi [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSaglikUrunleriLimitedSirketiMember" xlink:href="sny-20221231.xsd#sny_SanofiSaglikUrunleriLimitedSirketiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiSaglikUrunleriLimitedSirketiMember" xlink:to="lab_sny_SanofiSaglikUrunleriLimitedSirketiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentLeaseLiabilities_4f2e467b-0e6d-4ff8-a869-9a9d0be56e3d_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current lease liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncomeTaxesAbstract_cd69d8db-514d-4889-a9bf-a556a1f1a44b_terseLabel_en-US" xlink:label="lab_sny_IncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Abstract]</link:label>
    <link:label id="lab_sny_IncomeTaxesAbstract_label_en-US" xlink:label="lab_sny_IncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Abstract]</link:label>
    <link:label id="lab_sny_IncomeTaxesAbstract_documentation_en-US" xlink:label="lab_sny_IncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxesAbstract" xlink:href="sny-20221231.xsd#sny_IncomeTaxesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeTaxesAbstract" xlink:to="lab_sny_IncomeTaxesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfRestructuringProvisionsLineItems_eacf7a65-fd07-4208-a01e-2d39222b6d04_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfRestructuringProvisionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Restructuring Provisions [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfRestructuringProvisionsLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfRestructuringProvisionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Restructuring Provisions [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfRestructuringProvisionsLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfRestructuringProvisionsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of restructuring provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringProvisionsLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringProvisionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems" xlink:to="lab_sny_DisclosureOfRestructuringProvisionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrentCurrencyDerivativesPayable_cbf38553-0d81-43e6-8a8e-0bc96c582c74_terseLabel_en-US" xlink:label="lab_sny_CurrentCurrencyDerivativesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency derivatives (see Note&#160;D.20.)</link:label>
    <link:label id="lab_sny_CurrentCurrencyDerivativesPayable_label_en-US" xlink:label="lab_sny_CurrentCurrencyDerivativesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Currency Derivatives Payable</link:label>
    <link:label id="lab_sny_CurrentCurrencyDerivativesPayable_documentation_en-US" xlink:label="lab_sny_CurrentCurrencyDerivativesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency derivatives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentCurrencyDerivativesPayable" xlink:href="sny-20221231.xsd#sny_CurrentCurrencyDerivativesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentCurrencyDerivativesPayable" xlink:to="lab_sny_CurrentCurrencyDerivativesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_11ac6bee-0954-4025-b6f0-2fe0092be608_terseLabel_en-US" xlink:label="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity instruments designated at fair value through other comprehensive income [member]</link:label>
    <link:label id="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity instruments designated at fair value through other comprehensive income [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:to="lab_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RegulatoryComplianceCostsMember_72707174-957c-47d5-8c42-73b1d2aef4b2_terseLabel_en-US" xlink:label="lab_sny_RegulatoryComplianceCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory compliance costs</link:label>
    <link:label id="lab_sny_RegulatoryComplianceCostsMember_label_en-US" xlink:label="lab_sny_RegulatoryComplianceCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Compliance Costs [Member]</link:label>
    <link:label id="lab_sny_RegulatoryComplianceCostsMember_documentation_en-US" xlink:label="lab_sny_RegulatoryComplianceCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Compliance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegulatoryComplianceCostsMember" xlink:href="sny-20221231.xsd#sny_RegulatoryComplianceCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RegulatoryComplianceCostsMember" xlink:to="lab_sny_RegulatoryComplianceCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalAlliancesAxis_a1a3134e-c53b-437b-a7a3-76b9f8de0eb2_terseLabel_en-US" xlink:label="lab_sny_PrincipalAlliancesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal alliances [axis]</link:label>
    <link:label id="lab_sny_PrincipalAlliancesAxis_label_en-US" xlink:label="lab_sny_PrincipalAlliancesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Alliances [Axis]</link:label>
    <link:label id="lab_sny_PrincipalAlliancesAxis_documentation_en-US" xlink:label="lab_sny_PrincipalAlliancesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Alliances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalAlliancesAxis" xlink:to="lab_sny_PrincipalAlliancesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ActionForWhichWeAreDefendantMember_ea9de337-719f-4483-a4f7-14c85fd719e5_terseLabel_en-US" xlink:label="lab_sny_ActionForWhichWeAreDefendantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Action for which we are defendant</link:label>
    <link:label id="lab_sny_ActionForWhichWeAreDefendantMember_label_en-US" xlink:label="lab_sny_ActionForWhichWeAreDefendantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Action For Which We Are Defendant [member]</link:label>
    <link:label id="lab_sny_ActionForWhichWeAreDefendantMember_documentation_en-US" xlink:label="lab_sny_ActionForWhichWeAreDefendantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Action for which we are defendant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActionForWhichWeAreDefendantMember" xlink:href="sny-20221231.xsd#sny_ActionForWhichWeAreDefendantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActionForWhichWeAreDefendantMember" xlink:to="lab_sny_ActionForWhichWeAreDefendantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsMadeToJointVenturesAndAssociates_a05b923c-69c9-493d-96fb-3ae50929f9d1_terseLabel_en-US" xlink:label="lab_sny_CommitmentsMadeToJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding commitments to associates and joint ventures</link:label>
    <link:label id="lab_sny_CommitmentsMadeToJointVenturesAndAssociates_label_en-US" xlink:label="lab_sny_CommitmentsMadeToJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Made To Joint Ventures And Associates</link:label>
    <link:label id="lab_sny_CommitmentsMadeToJointVenturesAndAssociates_documentation_en-US" xlink:label="lab_sny_CommitmentsMadeToJointVenturesAndAssociates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments made to joint ventures and associates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsMadeToJointVenturesAndAssociates" xlink:href="sny-20221231.xsd#sny_CommitmentsMadeToJointVenturesAndAssociates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsMadeToJointVenturesAndAssociates" xlink:to="lab_sny_CommitmentsMadeToJointVenturesAndAssociates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_b761e1fe-41fc-4534-9180-b4491e74bb44_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flow before changes in working capital</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used in) operations before changes in working capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentLoansAndReceivables_cf8dc7c3-f329-4fb9-94a2-a9550c26ba7d_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLoansAndReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term loans and advances and other non-current receivables</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLoansAndReceivables_label_en-US" xlink:label="lab_ifrs-full_NoncurrentLoansAndReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current loans and receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLoansAndReceivables" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLoansAndReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLoansAndReceivables" xlink:to="lab_ifrs-full_NoncurrentLoansAndReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PricewaterhousecoopersMember_f99d9de0-cdf5-43c1-af61-cb16d6b8d553_terseLabel_en-US" xlink:label="lab_sny_PricewaterhousecoopersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PricewaterhouseCoopers</link:label>
    <link:label id="lab_sny_PricewaterhousecoopersMember_label_en-US" xlink:label="lab_sny_PricewaterhousecoopersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PricewaterhouseCoopers [Member]</link:label>
    <link:label id="lab_sny_PricewaterhousecoopersMember_documentation_en-US" xlink:label="lab_sny_PricewaterhousecoopersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PricewaterhouseCoopers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PricewaterhousecoopersMember" xlink:href="sny-20221231.xsd#sny_PricewaterhousecoopersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PricewaterhousecoopersMember" xlink:to="lab_sny_PricewaterhousecoopersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss_cf4fc5e6-620e-41fc-a68d-51ed0b0fed12_terseLabel_en-US" xlink:label="lab_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Perpetual growth rate</link:label>
    <link:label id="lab_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss_label_en-US" xlink:label="lab_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Perpetuity Growth Rate Below The Rates Actually Used Would Not Cause Impairment Loss</link:label>
    <link:label id="lab_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss_documentation_en-US" xlink:label="lab_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of perpetuity growth rate below the rates actually used would not cause impairment loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:href="sny-20221231.xsd#sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:to="lab_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_fe7d5e02-97c2-4712-8953-c76bff4bf22a_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other items</link:label>
    <link:label id="lab_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_label_en-US" xlink:label="lab_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other tax rate effects for reconciliation between accounting profit and tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:to="lab_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_a3871b05-2c3b-4f21-9193-618475fd0e0a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about borrowings [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about borrowings [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ImpactOfPreTaxIncomeRecognisedInEquity_7fa0b837-8152-4355-b136-365ab6b43798_terseLabel_en-US" xlink:label="lab_sny_ImpactOfPreTaxIncomeRecognisedInEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact on pre-tax income/(expense) recognized directly in equity</link:label>
    <link:label id="lab_sny_ImpactOfPreTaxIncomeRecognisedInEquity_label_en-US" xlink:label="lab_sny_ImpactOfPreTaxIncomeRecognisedInEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact Of Pre Tax Income Recognised In Equity</link:label>
    <link:label id="lab_sny_ImpactOfPreTaxIncomeRecognisedInEquity_documentation_en-US" xlink:label="lab_sny_ImpactOfPreTaxIncomeRecognisedInEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of pre tax income recognised in equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpactOfPreTaxIncomeRecognisedInEquity" xlink:href="sny-20221231.xsd#sny_ImpactOfPreTaxIncomeRecognisedInEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ImpactOfPreTaxIncomeRecognisedInEquity" xlink:to="lab_sny_ImpactOfPreTaxIncomeRecognisedInEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_9281971d-df2f-4dfc-aa35-8908e75802bd_terseLabel_en-US" xlink:label="lab_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity risk hedging instruments designated as fair value hedges</link:label>
    <link:label id="lab_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_label_en-US" xlink:label="lab_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Risk Hedging Instruments Designated At Fair Value Hedges</link:label>
    <link:label id="lab_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_documentation_en-US" xlink:label="lab_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Risk Hedging Instruments Designated At Fair Value Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xlink:href="sny-20221231.xsd#sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xlink:to="lab_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_e17d1c19-b0e6-4c5f-a87c-2f3122fe30e9_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member_fc58af01-7278-4579-9829-88ade7d60204_terseLabel_en-US" xlink:label="lab_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eight Hundred Fifty Million Bonds Maturing February 2022</link:label>
    <link:label id="lab_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member_label_en-US" xlink:label="lab_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eight Hundred Fifty Million Bonds Maturing February 2022 [Member]</link:label>
    <link:label id="lab_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member_documentation_en-US" xlink:label="lab_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eight Hundred Fifty Million Bonds Maturing February 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member" xlink:href="sny-20221231.xsd#sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member" xlink:to="lab_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_5e072011-17a8-4fde-9185-52864bbd6a62_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income for the period, net of taxes</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_5b81bbb4-1cc0-48c6-a5d6-49480aed97bd_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income for&#160;the period</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome" xlink:to="lab_ifrs-full_OtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherBorrowings_92217522-9276-4966-8b38-d47b8135cc3d_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other borrowings</link:label>
    <link:label id="lab_ifrs-full_OtherBorrowings_label_en-US" xlink:label="lab_ifrs-full_OtherBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherBorrowings" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherBorrowings" xlink:to="lab_ifrs-full_OtherBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity_d2b267cc-8ad9-4ede-a1f2-4438e3a9916d_terseLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment pledged as security for liabilities</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity_label_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, pledged as security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent_90dd8501-be1e-45a4-b6b7-5feef5ac0163_terseLabel_en-US" xlink:label="lab_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share (in euros per share)</link:label>
    <link:label id="lab_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent_label_en-US" xlink:label="lab_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted Earnings (Loss) Per Share, Attributable To Owners Of Parent</link:label>
    <link:label id="lab_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent_documentation_en-US" xlink:label="lab_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted Earnings (Loss) Per Share, Attributable To Owners Of Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xlink:href="sny-20221231.xsd#sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xlink:to="lab_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfGuaranteesLineItems_6cd0369d-2a88-4145-a7cb-4a0ec5a88cd7_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfGuaranteesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Guarantees [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfGuaranteesLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfGuaranteesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Guarantees [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfGuaranteesLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfGuaranteesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of guarantees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfGuaranteesLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfGuaranteesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfGuaranteesLineItems" xlink:to="lab_sny_DisclosureOfGuaranteesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestRateTypesMember_6dd8d195-bbb3-48eb-8436-5e1de1e55692_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestRateTypesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate types [member]</link:label>
    <link:label id="lab_ifrs-full_InterestRateTypesMember_label_en-US" xlink:label="lab_ifrs-full_InterestRateTypesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate types [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestRateTypesMember" xlink:to="lab_ifrs-full_InterestRateTypesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfChangesInFinancialPositionTableTextBlock_efc051d5-5702-4c7d-b06f-998420714766_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Financial Position</link:label>
    <link:label id="lab_sny_DisclosureOfChangesInFinancialPositionTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Changes In Financial Position [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfChangesInFinancialPositionTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of changes in financial position [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfChangesInFinancialPositionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xlink:to="lab_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AverageEffectiveTaxRate_56567802-3030-4405-869b-06e134403724_totalLabel_en-US" xlink:label="lab_ifrs-full_AverageEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_ifrs-full_AverageEffectiveTaxRate_label_en-US" xlink:label="lab_ifrs-full_AverageEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average effective tax rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AverageEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate" xlink:to="lab_ifrs-full_AverageEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OptionVestingPeriod_a47ee918-1371-470c-be8d-b6509fa4f45c_terseLabel_en-US" xlink:label="lab_sny_OptionVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option vesting period (in years)</link:label>
    <link:label id="lab_sny_OptionVestingPeriod_label_en-US" xlink:label="lab_sny_OptionVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Vesting Period</link:label>
    <link:label id="lab_sny_OptionVestingPeriod_documentation_en-US" xlink:label="lab_sny_OptionVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option vesting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OptionVestingPeriod" xlink:href="sny-20221231.xsd#sny_OptionVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OptionVestingPeriod" xlink:to="lab_sny_OptionVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RepurchaseFromTheCounterpartMember_1456d8bb-9773-47aa-88c9-08e611334850_terseLabel_en-US" xlink:label="lab_sny_RepurchaseFromTheCounterpartMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase from the counterpart</link:label>
    <link:label id="lab_sny_RepurchaseFromTheCounterpartMember_label_en-US" xlink:label="lab_sny_RepurchaseFromTheCounterpartMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase From The Counterpart [Member]</link:label>
    <link:label id="lab_sny_RepurchaseFromTheCounterpartMember_documentation_en-US" xlink:label="lab_sny_RepurchaseFromTheCounterpartMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase From The Counterpart</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RepurchaseFromTheCounterpartMember" xlink:href="sny-20221231.xsd#sny_RepurchaseFromTheCounterpartMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RepurchaseFromTheCounterpartMember" xlink:to="lab_sny_RepurchaseFromTheCounterpartMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_36b619b5-0b7c-48e7-8b95-7ba78efb0e4a_terseLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of property, plant and equipment</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset_f8708767-8505-491c-9ae5-923ab18e2194_negatedLabel_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan settlements specified in the terms of the plan</link:label>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Payments In Respect Of Settlements Specified In The Terms Of The Plan Net Defined Benefit Liability (Asset)</link:label>
    <link:label id="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset_documentation_en-US" xlink:label="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Payments In Respect Of Settlements Specified In The Terms Of The Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" xlink:to="lab_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_7688571b-6881-4b31-b235-8c4c04e7f012_terseLabel_en-US" xlink:label="lab_ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other payables</link:label>
    <link:label id="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_label_en-US" xlink:label="lab_ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts payable, related party transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="lab_ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_5a7bc70e-c928-431b-a3ed-9e1e59082bd3_terseLabel_en-US" xlink:label="lab_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of profit/(loss) from investments accounted for using the equity method</link:label>
    <link:label id="lab_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of profit (loss) of joint ventures accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisGulfFZEMember_9cf8806e-2831-43fb-b01b-8ffb8afeb8ad_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisGulfFZEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Gulf FZE</link:label>
    <link:label id="lab_sny_SanofiAventisGulfFZEMember_label_en-US" xlink:label="lab_sny_SanofiAventisGulfFZEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Gulf FZE [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisGulfFZEMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisGulfFZEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Gulf FZE.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisGulfFZEMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisGulfFZEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisGulfFZEMember" xlink:to="lab_sny_SanofiAventisGulfFZEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReportableSegmentsMember_776e54fc-5e20-45c6-aa9a-c9c47a5f3883_verboseLabel_en-US" xlink:label="lab_ifrs-full_ReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Sanofi</link:label>
    <link:label id="lab_ifrs-full_ReportableSegmentsMember_80e5fa7b-91ec-404f-b8da-5465f9aa8e24_terseLabel_en-US" xlink:label="lab_ifrs-full_ReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable segments</link:label>
    <link:label id="lab_ifrs-full_ReportableSegmentsMember_label_en-US" xlink:label="lab_ifrs-full_ReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable segments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReportableSegmentsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReportableSegmentsMember" xlink:to="lab_ifrs-full_ReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ManagedCareMember_4666e9f4-274a-41a0-9bc2-7a92e3ced525_terseLabel_en-US" xlink:label="lab_sny_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed care</link:label>
    <link:label id="lab_sny_ManagedCareMember_label_en-US" xlink:label="lab_sny_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care [Member]</link:label>
    <link:label id="lab_sny_ManagedCareMember_documentation_en-US" xlink:label="lab_sny_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ManagedCareMember" xlink:href="sny-20221231.xsd#sny_ManagedCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ManagedCareMember" xlink:to="lab_sny_ManagedCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NotLaterThanOneYearMember_4fe2a551-88e1-4f54-a656-c5138a8ef2c3_verboseLabel_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 1</link:label>
    <link:label id="lab_ifrs-full_NotLaterThanOneYearMember_9ad992e2-f9a3-4453-9a20-938f9241eaab_terseLabel_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less&#160;than 1&#160;year</link:label>
    <link:label id="lab_ifrs-full_NotLaterThanOneYearMember_label_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not later than one year [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_8a79388c-96d6-4f24-a67b-dfcf75e98430_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-employment benefits</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key management personnel compensation, post-employment benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestRateDerivativesMember_38f8d8c5-5529-474e-be5e-83387cde5720_terseLabel_en-US" xlink:label="lab_sny_InterestRateDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate derivatives</link:label>
    <link:label id="lab_sny_InterestRateDerivativesMember_label_en-US" xlink:label="lab_sny_InterestRateDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivatives [Member]</link:label>
    <link:label id="lab_sny_InterestRateDerivativesMember_documentation_en-US" xlink:label="lab_sny_InterestRateDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate derivatives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateDerivativesMember" xlink:href="sny-20221231.xsd#sny_InterestRateDerivativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateDerivativesMember" xlink:to="lab_sny_InterestRateDerivativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_5b79f78d-02dc-4e5e-8198-988009a6446d_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension benefit indexation</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumption of expected rates of pension increases [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Assets_5831de6e-990e-4030-a5c1-bb127be00706_totalLabel_en-US" xlink:label="lab_ifrs-full_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_ifrs-full_Assets_label_en-US" xlink:label="lab_ifrs-full_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets" xlink:to="lab_ifrs-full_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_710d2469-89cd-4ab8-95b6-f7dae40375d0_terseLabel_en-US" xlink:label="lab_ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for related parties</link:label>
    <link:label id="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_label_en-US" xlink:label="lab_ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for related parties [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="lab_ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_686e2a4f-e4ec-4b19-a4d8-5c7956f54873_terseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation &amp; impairment</link:label>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_99c444d0-6618-4415-945d-007dc0616295_verboseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization&#160;&amp; impairment</link:label>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_label_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation, amortisation and impairment [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:to="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_UncertaintiesOverIncomeTaxTreatmentsMember_f0bc3793-8df2-43fc-914e-31e3874252b7_terseLabel_en-US" xlink:label="lab_sny_UncertaintiesOverIncomeTaxTreatmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertainties over income tax treatments</link:label>
    <link:label id="lab_sny_UncertaintiesOverIncomeTaxTreatmentsMember_label_en-US" xlink:label="lab_sny_UncertaintiesOverIncomeTaxTreatmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertainties Over Income Tax Treatments [Member]</link:label>
    <link:label id="lab_sny_UncertaintiesOverIncomeTaxTreatmentsMember_documentation_en-US" xlink:label="lab_sny_UncertaintiesOverIncomeTaxTreatmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertainties Over Income Tax Treatments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UncertaintiesOverIncomeTaxTreatmentsMember" xlink:href="sny-20221231.xsd#sny_UncertaintiesOverIncomeTaxTreatmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UncertaintiesOverIncomeTaxTreatmentsMember" xlink:to="lab_sny_UncertaintiesOverIncomeTaxTreatmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProvisionUsedOtherProvisions_3714f141-1550-4d0a-a932-0a11388a8f8c_negatedLabel_en-US" xlink:label="lab_ifrs-full_ProvisionUsedOtherProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions utilized</link:label>
    <link:label id="lab_ifrs-full_ProvisionUsedOtherProvisions_label_en-US" xlink:label="lab_ifrs-full_ProvisionUsedOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision used, other provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProvisionUsedOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProvisionUsedOtherProvisions" xlink:to="lab_ifrs-full_ProvisionUsedOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShareRepurchase2020ProgramMember_29c13556-9593-4b59-82f5-7a9933722be8_terseLabel_en-US" xlink:label="lab_sny_ShareRepurchase2020ProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_sny_ShareRepurchase2020ProgramMember_label_en-US" xlink:label="lab_sny_ShareRepurchase2020ProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase 2020 Program [Member]</link:label>
    <link:label id="lab_sny_ShareRepurchase2020ProgramMember_documentation_en-US" xlink:label="lab_sny_ShareRepurchase2020ProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase 2020 Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2020ProgramMember" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2020ProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareRepurchase2020ProgramMember" xlink:to="lab_sny_ShareRepurchase2020ProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_28d75892-7024-4e41-9954-f25bfeb6cb3f_terseLabel_en-US" xlink:label="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated financial effect of contingent liabilities</link:label>
    <link:label id="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_label_en-US" xlink:label="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated financial effect of contingent liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:to="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PlavixLitigationCommonwealthInAustraliaMember_c8d9e773-2a29-4dda-a1af-01daa07e9876_terseLabel_en-US" xlink:label="lab_sny_PlavixLitigationCommonwealthInAustraliaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix litigation (Commonwealth) in Australia</link:label>
    <link:label id="lab_sny_PlavixLitigationCommonwealthInAustraliaMember_label_en-US" xlink:label="lab_sny_PlavixLitigationCommonwealthInAustraliaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Litigation (Commonwealth) In Australia [Member]</link:label>
    <link:label id="lab_sny_PlavixLitigationCommonwealthInAustraliaMember_documentation_en-US" xlink:label="lab_sny_PlavixLitigationCommonwealthInAustraliaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix litigation (commonwealth) In Australia.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixLitigationCommonwealthInAustraliaMember" xlink:href="sny-20221231.xsd#sny_PlavixLitigationCommonwealthInAustraliaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PlavixLitigationCommonwealthInAustraliaMember" xlink:to="lab_sny_PlavixLitigationCommonwealthInAustraliaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfLineOfCreditFacilityTable_f4b1d51f-f9bf-4711-be18-ccb0125bc1ba_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfLineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Line of Credit Facility [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfLineOfCreditFacilityTable_label_en-US" xlink:label="lab_sny_DisclosureOfLineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Line Of Credit Facility [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfLineOfCreditFacilityTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfLineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of line of credit facility table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLineOfCreditFacilityTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfLineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLineOfCreditFacilityTable" xlink:to="lab_sny_DisclosureOfLineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrentLiabilitiesMember_110a7f41-d0c4-4dca-b7e6-1d4d5b43fe00_terseLabel_en-US" xlink:label="lab_sny_CurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_sny_CurrentLiabilitiesMember_label_en-US" xlink:label="lab_sny_CurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities [Member]</link:label>
    <link:label id="lab_sny_CurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_sny_CurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentLiabilitiesMember" xlink:href="sny-20221231.xsd#sny_CurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentLiabilitiesMember" xlink:to="lab_sny_CurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_April302021Member_cd8cca2d-7b21-469a-8890-5abfb75b5c54_terseLabel_en-US" xlink:label="lab_sny_April302021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 30, 2021</link:label>
    <link:label id="lab_sny_April302021Member_label_en-US" xlink:label="lab_sny_April302021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 30, 2021 [Member]</link:label>
    <link:label id="lab_sny_April302021Member_documentation_en-US" xlink:label="lab_sny_April302021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 30, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April302021Member" xlink:href="sny-20221231.xsd#sny_April302021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_April302021Member" xlink:to="lab_sny_April302021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DerecognizedReceivables_24323eff-7aad-4540-a0cc-a092a2f3f25e_terseLabel_en-US" xlink:label="lab_sny_DerecognizedReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derecognized receivables</link:label>
    <link:label id="lab_sny_DerecognizedReceivables_label_en-US" xlink:label="lab_sny_DerecognizedReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derecognized Receivables</link:label>
    <link:label id="lab_sny_DerecognizedReceivables_documentation_en-US" xlink:label="lab_sny_DerecognizedReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derecognized receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerecognizedReceivables" xlink:href="sny-20221231.xsd#sny_DerecognizedReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerecognizedReceivables" xlink:to="lab_sny_DerecognizedReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock_d4a0d971-1eed-4a8d-bd19-d851a8916016_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Number of Restricted Shares Not Yet Fully Vested</link:label>
    <link:label id="lab_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Number Of Restricted Share Plans Not Yet Fully Vested [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of number of restricted share plans Not yet fully vested.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xlink:to="lab_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonCoreAssetsMember_ffffc74c-2907-43eb-88b8-070129ceb057_terseLabel_en-US" xlink:label="lab_sny_NonCoreAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Core Assets</link:label>
    <link:label id="lab_sny_NonCoreAssetsMember_label_en-US" xlink:label="lab_sny_NonCoreAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Core Assets [Member]</link:label>
    <link:label id="lab_sny_NonCoreAssetsMember_documentation_en-US" xlink:label="lab_sny_NonCoreAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Core Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCoreAssetsMember" xlink:href="sny-20221231.xsd#sny_NonCoreAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCoreAssetsMember" xlink:to="lab_sny_NonCoreAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_UpfrontPayments_21954210-020f-4a2e-95e3-f100fe6446f4_terseLabel_en-US" xlink:label="lab_sny_UpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment</link:label>
    <link:label id="lab_sny_UpfrontPayments_label_en-US" xlink:label="lab_sny_UpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payments</link:label>
    <link:label id="lab_sny_UpfrontPayments_documentation_en-US" xlink:label="lab_sny_UpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UpfrontPayments" xlink:href="sny-20221231.xsd#sny_UpfrontPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UpfrontPayments" xlink:to="lab_sny_UpfrontPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock_6e524721-e1de-4d5b-a2d3-731b1b5f4db0_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Movements within Other Comprehensive Income</link:label>
    <link:label id="lab_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Accumulated Other Comprehensive Income Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information of accumulated other comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_1b9529a0-156d-4a31-8d24-36fda90e2338_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_HedgedItemsAxis_5efb99f1-d1f7-4477-b0af-febe66fdc1df_terseLabel_en-US" xlink:label="lab_ifrs-full_HedgedItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged items [axis]</link:label>
    <link:label id="lab_ifrs-full_HedgedItemsAxis_label_en-US" xlink:label="lab_ifrs-full_HedgedItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged items [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgedItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgedItemsAxis" xlink:to="lab_ifrs-full_HedgedItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AntibodiesMember_0743638d-64ee-4a44-9cd6-8cd5a14f224f_terseLabel_en-US" xlink:label="lab_sny_AntibodiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antibodies</link:label>
    <link:label id="lab_sny_AntibodiesMember_label_en-US" xlink:label="lab_sny_AntibodiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antibodies [Member]</link:label>
    <link:label id="lab_sny_AntibodiesMember_documentation_en-US" xlink:label="lab_sny_AntibodiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antibodies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesMember" xlink:href="sny-20221231.xsd#sny_AntibodiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AntibodiesMember" xlink:to="lab_sny_AntibodiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock_3892f7c0-fe6e-4411-8cb4-02ef2f570210_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Debt by Currency After Derivative Instruments</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt By Currency At Value Of Redemption After Derivative Instruments [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of debt by currency at value of redemption after derivative instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock" xlink:to="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockOptionsWithNoDilutiveEffect_f7ed701d-7529-4dbf-b7a6-967491da801b_terseLabel_en-US" xlink:label="lab_sny_StockOptionsWithNoDilutiveEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stock option not taken for computing diluted earning per share (in shares)</link:label>
    <link:label id="lab_sny_StockOptionsWithNoDilutiveEffect_label_en-US" xlink:label="lab_sny_StockOptionsWithNoDilutiveEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options With No Dilutive Effect</link:label>
    <link:label id="lab_sny_StockOptionsWithNoDilutiveEffect_documentation_en-US" xlink:label="lab_sny_StockOptionsWithNoDilutiveEffect" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options with no dilutive effect.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionsWithNoDilutiveEffect" xlink:href="sny-20221231.xsd#sny_StockOptionsWithNoDilutiveEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockOptionsWithNoDilutiveEffect" xlink:to="lab_sny_StockOptionsWithNoDilutiveEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialAssetsAxis_7d84cb58-4276-49b9-85da-0120e66fb099_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of financial assets [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of financial assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalAlliancesDomain_a7d8c7df-eaaf-47a4-a2db-018658f391a9_terseLabel_en-US" xlink:label="lab_sny_PrincipalAlliancesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal alliances [domain]</link:label>
    <link:label id="lab_sny_PrincipalAlliancesDomain_label_en-US" xlink:label="lab_sny_PrincipalAlliancesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Alliances [Domain]</link:label>
    <link:label id="lab_sny_PrincipalAlliancesDomain_documentation_en-US" xlink:label="lab_sny_PrincipalAlliancesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Alliances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalAlliancesDomain" xlink:to="lab_sny_PrincipalAlliancesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember_552fc5f0-a0f3-4456-8e4c-f4abd2100b43_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare cost inflation rate</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumption of medical cost trend rates [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LandAndBuildingsMember_5014c6ce-c3d7-412a-b694-b209b5c2157c_terseLabel_en-US" xlink:label="lab_ifrs-full_LandAndBuildingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office and industrial premises</link:label>
    <link:label id="lab_ifrs-full_LandAndBuildingsMember_label_en-US" xlink:label="lab_ifrs-full_LandAndBuildingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and buildings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LandAndBuildingsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandAndBuildingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandAndBuildingsMember" xlink:to="lab_ifrs-full_LandAndBuildingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInJointVenture_910e00f2-1c8c-4b59-85a1-2cb8b9dfec8f_terseLabel_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of ownership interest in joint venture (in percent)</link:label>
    <link:label id="lab_ifrs-full_ProportionOfOwnershipInterestInJointVenture_label_en-US" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of ownership interest in joint venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommercialPaperProgramInFranceMember_bbb76d54-5d4e-40b3-b0a1-e43732edcbbf_terseLabel_en-US" xlink:label="lab_sny_CommercialPaperProgramInFranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper program in France</link:label>
    <link:label id="lab_sny_CommercialPaperProgramInFranceMember_label_en-US" xlink:label="lab_sny_CommercialPaperProgramInFranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program In France [Member]</link:label>
    <link:label id="lab_sny_CommercialPaperProgramInFranceMember_documentation_en-US" xlink:label="lab_sny_CommercialPaperProgramInFranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper program In France.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommercialPaperProgramInFranceMember" xlink:href="sny-20221231.xsd#sny_CommercialPaperProgramInFranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommercialPaperProgramInFranceMember" xlink:to="lab_sny_CommercialPaperProgramInFranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FairValueOfPlanAtDateOfGrant_e94c0f5a-126f-4944-a5b4-eada5e5e1172_terseLabel_en-US" xlink:label="lab_sny_FairValueOfPlanAtDateOfGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan at the date of grant</link:label>
    <link:label id="lab_sny_FairValueOfPlanAtDateOfGrant_label_en-US" xlink:label="lab_sny_FairValueOfPlanAtDateOfGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Plan At Date Of Grant</link:label>
    <link:label id="lab_sny_FairValueOfPlanAtDateOfGrant_documentation_en-US" xlink:label="lab_sny_FairValueOfPlanAtDateOfGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan at the date of grant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfPlanAtDateOfGrant" xlink:href="sny-20221231.xsd#sny_FairValueOfPlanAtDateOfGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FairValueOfPlanAtDateOfGrant" xlink:to="lab_sny_FairValueOfPlanAtDateOfGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_2662949a-326a-40b7-924e-67ed87cc1c2f_terseLabel_en-US" xlink:label="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_label_en-US" xlink:label="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Number Of Shares Issued In Transaction, Total</link:label>
    <link:label id="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_documentation_en-US" xlink:label="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Number Of Shares Issued In Transaction, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal" xlink:to="lab_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CustomerThreeMember_e34c5348-a68c-4e7f-9369-405b3230d32c_terseLabel_en-US" xlink:label="lab_sny_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer three</link:label>
    <link:label id="lab_sny_CustomerThreeMember_label_en-US" xlink:label="lab_sny_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three [member]</link:label>
    <link:label id="lab_sny_CustomerThreeMember_documentation_en-US" xlink:label="lab_sny_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer three.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CustomerThreeMember" xlink:href="sny-20221231.xsd#sny_CustomerThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CustomerThreeMember" xlink:to="lab_sny_CustomerThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_edae935a-a6eb-460f-8b88-0d83bd7543d2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated shareholders' equity</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_JevtanaRelatedPatentLitigationInTheUSMember_ee8be830-233a-4327-9396-326b5703cbdd_terseLabel_en-US" xlink:label="lab_sny_JevtanaRelatedPatentLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jevtana related patent litigation in the US</link:label>
    <link:label id="lab_sny_JevtanaRelatedPatentLitigationInTheUSMember_label_en-US" xlink:label="lab_sny_JevtanaRelatedPatentLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jevtana Related Patent Litigation In The US [Member]</link:label>
    <link:label id="lab_sny_JevtanaRelatedPatentLitigationInTheUSMember_documentation_en-US" xlink:label="lab_sny_JevtanaRelatedPatentLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jevtana Related Patent Litigation In The US</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_JevtanaRelatedPatentLitigationInTheUSMember" xlink:href="sny-20221231.xsd#sny_JevtanaRelatedPatentLitigationInTheUSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_JevtanaRelatedPatentLitigationInTheUSMember" xlink:to="lab_sny_JevtanaRelatedPatentLitigationInTheUSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock_d0aeb4a6-7364-4f9b-9c67-0c37e58d4ff7_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Bond Issues</link:label>
    <link:label id="lab_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detail Of Bonds Issued Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detail Of Bonds Issued Explanatory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems_2d614bb4-0ec6-461a-a93e-6c7d5c33c006_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of tax losses available for carryforward [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Tax Losses Available For Carryforward [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of tax losses available for carryforward.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems" xlink:to="lab_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PropertyPlantAndEquipmentInProcessMember_79abd5bd-a6a0-4de6-9f25-fdf8b3dcc961_terseLabel_en-US" xlink:label="lab_sny_PropertyPlantAndEquipmentInProcessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property,&#160;plant and&#160;equipment in process</link:label>
    <link:label id="lab_sny_PropertyPlantAndEquipmentInProcessMember_label_en-US" xlink:label="lab_sny_PropertyPlantAndEquipmentInProcessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant And Equipment In Process [Member]</link:label>
    <link:label id="lab_sny_PropertyPlantAndEquipmentInProcessMember_documentation_en-US" xlink:label="lab_sny_PropertyPlantAndEquipmentInProcessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment in process.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PropertyPlantAndEquipmentInProcessMember" xlink:href="sny-20221231.xsd#sny_PropertyPlantAndEquipmentInProcessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PropertyPlantAndEquipmentInProcessMember" xlink:to="lab_sny_PropertyPlantAndEquipmentInProcessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiBelgiumMember_46da5848-349e-4279-a71e-6e7e1b8c170a_terseLabel_en-US" xlink:label="lab_sny_SanofiBelgiumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Belgium</link:label>
    <link:label id="lab_sny_SanofiBelgiumMember_label_en-US" xlink:label="lab_sny_SanofiBelgiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Belgium [member]</link:label>
    <link:label id="lab_sny_SanofiBelgiumMember_documentation_en-US" xlink:label="lab_sny_SanofiBelgiumMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Belgium.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBelgiumMember" xlink:href="sny-20221231.xsd#sny_SanofiBelgiumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiBelgiumMember" xlink:to="lab_sny_SanofiBelgiumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty_3381753a-248e-4d8e-8838-37502c65736f_verboseLabel_en-US" xlink:label="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of future development expense funded by other party</link:label>
    <link:label id="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty_label_en-US" xlink:label="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Future Development Expense Funded By Other Party</link:label>
    <link:label id="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty_documentation_en-US" xlink:label="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of future development expense funded by other party.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty" xlink:href="sny-20221231.xsd#sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty" xlink:to="lab_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TaxotereProductLitigationInTheUSMember_508b6dea-31c2-454f-aa0d-62a774821064_terseLabel_en-US" xlink:label="lab_sny_TaxotereProductLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxotere product litigation in the US</link:label>
    <link:label id="lab_sny_TaxotereProductLitigationInTheUSMember_label_en-US" xlink:label="lab_sny_TaxotereProductLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxotere Product Litigation In The US [Member]</link:label>
    <link:label id="lab_sny_TaxotereProductLitigationInTheUSMember_documentation_en-US" xlink:label="lab_sny_TaxotereProductLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxotere product litigation in the US.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxotereProductLitigationInTheUSMember" xlink:href="sny-20221231.xsd#sny_TaxotereProductLitigationInTheUSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TaxotereProductLitigationInTheUSMember" xlink:to="lab_sny_TaxotereProductLitigationInTheUSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfBondIssuesRedeemed_2240cedb-c27c-44c7-b546-6bcd662035f3_terseLabel_en-US" xlink:label="lab_sny_NumberOfBondIssuesRedeemed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of bond issues redeemed</link:label>
    <link:label id="lab_sny_NumberOfBondIssuesRedeemed_label_en-US" xlink:label="lab_sny_NumberOfBondIssuesRedeemed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Bond Issues Redeemed</link:label>
    <link:label id="lab_sny_NumberOfBondIssuesRedeemed_documentation_en-US" xlink:label="lab_sny_NumberOfBondIssuesRedeemed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Bond Issues Redeemed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfBondIssuesRedeemed" xlink:href="sny-20221231.xsd#sny_NumberOfBondIssuesRedeemed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfBondIssuesRedeemed" xlink:to="lab_sny_NumberOfBondIssuesRedeemed" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsAndGoodwillAbstract_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets and goodwill [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RamiprilCanadaPatentLitigationMember_f08f683a-e8fb-41a4-94ea-f78c7d65d012_terseLabel_en-US" xlink:label="lab_sny_RamiprilCanadaPatentLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramipril Canada Patent Litigation</link:label>
    <link:label id="lab_sny_RamiprilCanadaPatentLitigationMember_label_en-US" xlink:label="lab_sny_RamiprilCanadaPatentLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramipril Canada Patent Litigation [Member]</link:label>
    <link:label id="lab_sny_RamiprilCanadaPatentLitigationMember_documentation_en-US" xlink:label="lab_sny_RamiprilCanadaPatentLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramipril canada patent litigation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RamiprilCanadaPatentLitigationMember" xlink:href="sny-20221231.xsd#sny_RamiprilCanadaPatentLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RamiprilCanadaPatentLitigationMember" xlink:to="lab_sny_RamiprilCanadaPatentLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_00cccf42-61ce-4f9c-a26e-1a2c29460b08_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TranslateBioIncMember_89159a74-40f1-4a34-a481-b2a8046ec408_terseLabel_en-US" xlink:label="lab_sny_TranslateBioIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translate Bio, Inc</link:label>
    <link:label id="lab_sny_TranslateBioIncMember_label_en-US" xlink:label="lab_sny_TranslateBioIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translate Bio, Inc [Member]</link:label>
    <link:label id="lab_sny_TranslateBioIncMember_documentation_en-US" xlink:label="lab_sny_TranslateBioIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translate Bio, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioIncMember" xlink:href="sny-20221231.xsd#sny_TranslateBioIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TranslateBioIncMember" xlink:to="lab_sny_TranslateBioIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_VaccinesSegmentMember_08e409c0-b687-4558-bbb3-f104c5fd857e_terseLabel_en-US" xlink:label="lab_sny_VaccinesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vaccines</link:label>
    <link:label id="lab_sny_VaccinesSegmentMember_label_en-US" xlink:label="lab_sny_VaccinesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vaccines Segment [member]</link:label>
    <link:label id="lab_sny_VaccinesSegmentMember_documentation_en-US" xlink:label="lab_sny_VaccinesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vaccines segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesSegmentMember" xlink:href="sny-20221231.xsd#sny_VaccinesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_VaccinesSegmentMember" xlink:to="lab_sny_VaccinesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfDefinedBenefitPlans_202e1c15-ddf2-457b-8c78-e77c20a94f22_terseLabel_en-US" xlink:label="lab_sny_NumberOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of types of defined-benefit plan</link:label>
    <link:label id="lab_sny_NumberOfDefinedBenefitPlans_label_en-US" xlink:label="lab_sny_NumberOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Defined Benefit Plans</link:label>
    <link:label id="lab_sny_NumberOfDefinedBenefitPlans_documentation_en-US" xlink:label="lab_sny_NumberOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of defined benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfDefinedBenefitPlans" xlink:href="sny-20221231.xsd#sny_NumberOfDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfDefinedBenefitPlans" xlink:to="lab_sny_NumberOfDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfTranches_a5ccf82c-c828-429a-9485-8aa44c60cd3e_terseLabel_en-US" xlink:label="lab_sny_NumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of tranches</link:label>
    <link:label id="lab_sny_NumberOfTranches_label_en-US" xlink:label="lab_sny_NumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Tranches</link:label>
    <link:label id="lab_sny_NumberOfTranches_documentation_en-US" xlink:label="lab_sny_NumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfTranches" xlink:href="sny-20221231.xsd#sny_NumberOfTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfTranches" xlink:to="lab_sny_NumberOfTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory_d5959528-bd3c-4416-b0a6-967925517229_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hyperinflation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of hyperinflationary reporting [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" xlink:to="lab_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_0d6daa14-b725-4b18-b6f0-265060a3ebae_negatedLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_d879bda0-c955-4877-ba62-db4c6f260c3a_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense (income)</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_2996785b-0e80-426d-aa6d-698d6fa02e96_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock_258ace07-a248-4687-af71-51e5596ab568_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Goodwill</link:label>
    <link:label id="lab_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Goodwill By Operating Segments Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of goodwill by operating segments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiBioverativHoldingsLLCMember_2fc75a7f-4f2f-4c38-9096-ec753c595745_terseLabel_en-US" xlink:label="lab_sny_SanofiBioverativHoldingsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Bioverativ Holdings LLC</link:label>
    <link:label id="lab_sny_SanofiBioverativHoldingsLLCMember_label_en-US" xlink:label="lab_sny_SanofiBioverativHoldingsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Bioverativ Holdings LLC [Member]</link:label>
    <link:label id="lab_sny_SanofiBioverativHoldingsLLCMember_documentation_en-US" xlink:label="lab_sny_SanofiBioverativHoldingsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Bioverativ Holdings LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBioverativHoldingsLLCMember" xlink:href="sny-20221231.xsd#sny_SanofiBioverativHoldingsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiBioverativHoldingsLLCMember" xlink:to="lab_sny_SanofiBioverativHoldingsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AnticipatedDurationOfAppealsProcess_2495e6ca-ef16-49ce-99f4-a9270014c05f_terseLabel_en-US" xlink:label="lab_sny_AnticipatedDurationOfAppealsProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticipated duration of appeals process</link:label>
    <link:label id="lab_sny_AnticipatedDurationOfAppealsProcess_label_en-US" xlink:label="lab_sny_AnticipatedDurationOfAppealsProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticipated Duration Of Appeals Process</link:label>
    <link:label id="lab_sny_AnticipatedDurationOfAppealsProcess_documentation_en-US" xlink:label="lab_sny_AnticipatedDurationOfAppealsProcess" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticipated Duration Of Appeals Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AnticipatedDurationOfAppealsProcess" xlink:href="sny-20221231.xsd#sny_AnticipatedDurationOfAppealsProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AnticipatedDurationOfAppealsProcess" xlink:to="lab_sny_AnticipatedDurationOfAppealsProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_f104fd7a-2afd-4ad8-8ebd-baa685573f0a_negatedLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_17da996d-1960-48e0-be6b-c578c80a8fd3_terseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss recognised in profit or loss, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d1fe5640-5899-4139-b9a3-7c928fa46707_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfSharesRepurchased_3896893a-529b-4088-95e0-7dbad1c99f99_terseLabel_en-US" xlink:label="lab_sny_NumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares (in shares)</link:label>
    <link:label id="lab_sny_NumberOfSharesRepurchased_label_en-US" xlink:label="lab_sny_NumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Shares Repurchased</link:label>
    <link:label id="lab_sny_NumberOfSharesRepurchased_documentation_en-US" xlink:label="lab_sny_NumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares repurchased.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSharesRepurchased" xlink:href="sny-20221231.xsd#sny_NumberOfSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfSharesRepurchased" xlink:to="lab_sny_NumberOfSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses_6a776159-994a-4e10-b069-68639c36de57_terseLabel_en-US" xlink:label="lab_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grant recognised as deduction from development expenses</link:label>
    <link:label id="lab_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses_label_en-US" xlink:label="lab_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Recognised As Deduction From Development Expenses</link:label>
    <link:label id="lab_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses_documentation_en-US" xlink:label="lab_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Recognised As Deduction From Development Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses" xlink:href="sny-20221231.xsd#sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses" xlink:to="lab_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets_97553c3d-14f1-470a-8c42-4dc3f5ca77fc_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains/(losses) on disposals of financial assets</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on available-for-sale financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets" xlink:to="lab_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AssociatesAndJointVenturesMember_f44c6c01-3052-47e0-ac9c-1bd5958e799f_terseLabel_en-US" xlink:label="lab_sny_AssociatesAndJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associates and joint ventures</link:label>
    <link:label id="lab_sny_AssociatesAndJointVenturesMember_label_en-US" xlink:label="lab_sny_AssociatesAndJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associates And Joint Ventures [Member]</link:label>
    <link:label id="lab_sny_AssociatesAndJointVenturesMember_documentation_en-US" xlink:label="lab_sny_AssociatesAndJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associates and Joint Ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AssociatesAndJointVenturesMember" xlink:href="sny-20221231.xsd#sny_AssociatesAndJointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AssociatesAndJointVenturesMember" xlink:to="lab_sny_AssociatesAndJointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetForeignExchangeLoss_2e3e4202-2bcb-4255-bee4-1d7d105d7b6b_terseLabel_en-US" xlink:label="lab_ifrs-full_NetForeignExchangeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net foreign exchange loss</link:label>
    <link:label id="lab_ifrs-full_NetForeignExchangeLoss_label_en-US" xlink:label="lab_ifrs-full_NetForeignExchangeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net foreign exchange loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetForeignExchangeLoss" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeLoss" xlink:to="lab_ifrs-full_NetForeignExchangeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AblynxMember_a2d74fba-f3de-4bb8-a7a7-341025bac2ef_verboseLabel_en-US" xlink:label="lab_sny_AblynxMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ablynx N.V.</link:label>
    <link:label id="lab_sny_AblynxMember_528a6d58-70ba-4ab7-821f-0c7510b07fb8_terseLabel_en-US" xlink:label="lab_sny_AblynxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Belgium</link:label>
    <link:label id="lab_sny_AblynxMember_label_en-US" xlink:label="lab_sny_AblynxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ablynx [member]</link:label>
    <link:label id="lab_sny_AblynxMember_documentation_en-US" xlink:label="lab_sny_AblynxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ablynx.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AblynxMember" xlink:href="sny-20221231.xsd#sny_AblynxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AblynxMember" xlink:to="lab_sny_AblynxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfPlaintiffs_131bc8f3-c11c-48aa-88ef-fe7a7c153895_terseLabel_en-US" xlink:label="lab_sny_NumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_sny_NumberOfPlaintiffs_label_en-US" xlink:label="lab_sny_NumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Plaintiffs</link:label>
    <link:label id="lab_sny_NumberOfPlaintiffs_documentation_en-US" xlink:label="lab_sny_NumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Plaintiffs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPlaintiffs" xlink:href="sny-20221231.xsd#sny_NumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfPlaintiffs" xlink:to="lab_sny_NumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExpenseCategoriesAxis_e2d1f8ce-5472-4ae9-85c1-d3145d8d4c2d_terseLabel_en-US" xlink:label="lab_sny_ExpenseCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Categories [Axis]</link:label>
    <link:label id="lab_sny_ExpenseCategoriesAxis_label_en-US" xlink:label="lab_sny_ExpenseCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Categories [Axis]</link:label>
    <link:label id="lab_sny_ExpenseCategoriesAxis_documentation_en-US" xlink:label="lab_sny_ExpenseCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Categories [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseCategoriesAxis" xlink:href="sny-20221231.xsd#sny_ExpenseCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseCategoriesAxis" xlink:to="lab_sny_ExpenseCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfHedgesAxis_ac896978-8721-4ec7-b68e-f18a7e7088a1_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfHedgesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types of Hedges [Axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfHedgesAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfHedgesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types of hedges [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfHedgesAxis" xlink:to="lab_ifrs-full_TypesOfHedgesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GenzymeIrelandLimitedMember_c413d02f-f0a3-4ac4-b642-de508b013b7a_terseLabel_en-US" xlink:label="lab_sny_GenzymeIrelandLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Ireland Limited</link:label>
    <link:label id="lab_sny_GenzymeIrelandLimitedMember_label_en-US" xlink:label="lab_sny_GenzymeIrelandLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Ireland Limited [member]</link:label>
    <link:label id="lab_sny_GenzymeIrelandLimitedMember_documentation_en-US" xlink:label="lab_sny_GenzymeIrelandLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Ireland Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeIrelandLimitedMember" xlink:href="sny-20221231.xsd#sny_GenzymeIrelandLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GenzymeIrelandLimitedMember" xlink:to="lab_sny_GenzymeIrelandLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock_0b3d2d13-8800-47d4-9508-2e82bdc838f3_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Provisions and Other Current Liabilities</link:label>
    <link:label id="lab_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Current Provisions And Other Current Liabilities [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of current provisions and other current liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonCurrentRestructuringProvisionMember_94a7cd01-22ae-426c-b5ec-7b5dc516fee4_terseLabel_en-US" xlink:label="lab_sny_NonCurrentRestructuringProvisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring provisions</link:label>
    <link:label id="lab_sny_NonCurrentRestructuringProvisionMember_label_en-US" xlink:label="lab_sny_NonCurrentRestructuringProvisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Restructuring Provision [Member]</link:label>
    <link:label id="lab_sny_NonCurrentRestructuringProvisionMember_documentation_en-US" xlink:label="lab_sny_NonCurrentRestructuringProvisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentRestructuringProvisionMember" xlink:href="sny-20221231.xsd#sny_NonCurrentRestructuringProvisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentRestructuringProvisionMember" xlink:to="lab_sny_NonCurrentRestructuringProvisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisMarocMember_c7aae6e1-b67e-4df6-bb97-fb06d49b8eea_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisMarocMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Maroc</link:label>
    <link:label id="lab_sny_SanofiAventisMarocMember_label_en-US" xlink:label="lab_sny_SanofiAventisMarocMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Maroc [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisMarocMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisMarocMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Maroc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisMarocMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisMarocMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisMarocMember" xlink:to="lab_sny_SanofiAventisMarocMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_bd47c562-36a9-43a9-8a7f-43c9b140dcd4_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_314de57b-d165-480b-9c4e-36fa2589b151_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory_a6a1322f-d6ac-4c5f-8ab3-da1cbac71536_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other current assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_eaeaa759-aae3-460d-b648-00dc533ed3a0_terseLabel_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount shown in the balance sheet at end of period</link:label>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_bcaed116-2ef5-4288-862f-0ec9e5ed2c29_periodStartLabel_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_e076261d-8785-4fb7-833f-8fdf19e9abcc_periodEndLabel_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_b81c275c-aaa6-4200-be52-9ab8dda8a4af_totalLabel_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount shown in the balance sheet at end of period</link:label>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_7d2b6d01-835b-4caf-81f1-bc3e67ed5453_verboseLabel_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit liability (asset)</link:label>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:to="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures_088b469e-6df8-4d83-8ff4-a048d2a846f9_terseLabel_en-US" xlink:label="lab_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax liabilities have not been recognised</link:label>
    <link:label id="lab_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures_label_en-US" xlink:label="lab_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax liabilities have not been recognised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" xlink:to="lab_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_79e78e42-f7f7-4554-83a5-56be0339b248_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangible assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of intangible assets and goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_11eb1fca-fa52-4d11-9b03-0b6669058687_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_KadmonMember_23097e57-3b7d-47fa-98ef-9f7ea085f729_terseLabel_en-US" xlink:label="lab_sny_KadmonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kadmon</link:label>
    <link:label id="lab_sny_KadmonMember_label_en-US" xlink:label="lab_sny_KadmonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kadmon [Member]</link:label>
    <link:label id="lab_sny_KadmonMember_documentation_en-US" xlink:label="lab_sny_KadmonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kadmon</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KadmonMember" xlink:href="sny-20221231.xsd#sny_KadmonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_KadmonMember" xlink:to="lab_sny_KadmonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember_ab5c211e-adfa-4585-b6ce-d8351a2d884b_terseLabel_en-US" xlink:label="lab_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary differences subject to GILTI</link:label>
    <link:label id="lab_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember_label_en-US" xlink:label="lab_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Differences Subject To US Global Intangible Low Taxed Income [Member]</link:label>
    <link:label id="lab_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember_documentation_en-US" xlink:label="lab_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Differences Subject To US Global Intangible Low Taxed Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember" xlink:href="sny-20221231.xsd#sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember" xlink:to="lab_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock_b439b919-2191-464b-b50e-8d2404482c62_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Number of Shares Used to Compute Diluted Earnings Per Share</link:label>
    <link:label id="lab_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Shares Used To Compute Diluted Earnings Per Share [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of shares used to compute diluted earnings per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xlink:to="lab_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiaventisPlusPensionPlanMember_7e865003-c163-4a7f-b995-67ffbccafc06_terseLabel_en-US" xlink:label="lab_sny_SanofiaventisPlusPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Plus</link:label>
    <link:label id="lab_sny_SanofiaventisPlusPensionPlanMember_label_en-US" xlink:label="lab_sny_SanofiaventisPlusPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis plus [member]</link:label>
    <link:label id="lab_sny_SanofiaventisPlusPensionPlanMember_documentation_en-US" xlink:label="lab_sny_SanofiaventisPlusPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Plus.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiaventisPlusPensionPlanMember" xlink:href="sny-20221231.xsd#sny_SanofiaventisPlusPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiaventisPlusPensionPlanMember" xlink:to="lab_sny_SanofiaventisPlusPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EntitysTotalForSubsidiariesMember_59091c8b-259a-4d0d-9c7f-cac0eea39876_terseLabel_en-US" xlink:label="lab_ifrs-full_EntitysTotalForSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for subsidiaries</link:label>
    <link:label id="lab_ifrs-full_EntitysTotalForSubsidiariesMember_label_en-US" xlink:label="lab_ifrs-full_EntitysTotalForSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's total for subsidiaries [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="lab_ifrs-full_EntitysTotalForSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PretaxDiscountRateAppliedForGoodwill_cef99eac-055d-476f-84b7-51e1e98caccd_terseLabel_en-US" xlink:label="lab_sny_PretaxDiscountRateAppliedForGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax discount rates</link:label>
    <link:label id="lab_sny_PretaxDiscountRateAppliedForGoodwill_label_en-US" xlink:label="lab_sny_PretaxDiscountRateAppliedForGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pretax Discount Rate Applied For Goodwill</link:label>
    <link:label id="lab_sny_PretaxDiscountRateAppliedForGoodwill_documentation_en-US" xlink:label="lab_sny_PretaxDiscountRateAppliedForGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax discount rate applied for goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PretaxDiscountRateAppliedForGoodwill" xlink:href="sny-20221231.xsd#sny_PretaxDiscountRateAppliedForGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PretaxDiscountRateAppliedForGoodwill" xlink:to="lab_sny_PretaxDiscountRateAppliedForGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherOperatingIncomeExpenseMember_2665f618-a151-4b96-9b28-a0fb8a576c7f_terseLabel_en-US" xlink:label="lab_sny_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income (expense)</link:label>
    <link:label id="lab_sny_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_sny_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:label id="lab_sny_OtherOperatingIncomeExpenseMember_documentation_en-US" xlink:label="lab_sny_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherOperatingIncomeExpenseMember" xlink:href="sny-20221231.xsd#sny_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherOperatingIncomeExpenseMember" xlink:to="lab_sny_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MedicaidMember_17901a29-b68a-410b-87c9-4db69b296797_terseLabel_en-US" xlink:label="lab_sny_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_sny_MedicaidMember_label_en-US" xlink:label="lab_sny_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:label id="lab_sny_MedicaidMember_documentation_en-US" xlink:label="lab_sny_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MedicaidMember" xlink:href="sny-20221231.xsd#sny_MedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MedicaidMember" xlink:to="lab_sny_MedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RestructuringProvisionAbstract_c3838c02-493e-4371-b7be-414f19812cc2_terseLabel_en-US" xlink:label="lab_ifrs-full_RestructuringProvisionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Of which:</link:label>
    <link:label id="lab_ifrs-full_RestructuringProvisionAbstract_label_en-US" xlink:label="lab_ifrs-full_RestructuringProvisionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring provision [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestructuringProvisionAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RestructuringProvisionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestructuringProvisionAbstract" xlink:to="lab_ifrs-full_RestructuringProvisionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_be61a7a8-aec2-424b-b66b-905ee00b59b2_negatedLabel_en-US" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_label_en-US" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of non-current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GainOnRegeneronInvestmentSold_f3c1fa6f-e99d-48d1-bcf1-16acb953ee25_terseLabel_en-US" xlink:label="lab_sny_GainOnRegeneronInvestmentSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on divestment of Regeneron shares on May 29, 2020</link:label>
    <link:label id="lab_sny_GainOnRegeneronInvestmentSold_label_en-US" xlink:label="lab_sny_GainOnRegeneronInvestmentSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain On Regeneron Investment Sold</link:label>
    <link:label id="lab_sny_GainOnRegeneronInvestmentSold_documentation_en-US" xlink:label="lab_sny_GainOnRegeneronInvestmentSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain On Regeneron Investment Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainOnRegeneronInvestmentSold" xlink:href="sny-20221231.xsd#sny_GainOnRegeneronInvestmentSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainOnRegeneronInvestmentSold" xlink:to="lab_sny_GainOnRegeneronInvestmentSold" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_a2e9ed07-f010-4383-af5c-30c71ee7774c_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) through exercise of options, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock_64bcab5c-7564-414f-9859-86d16c99750c_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Off Balance Sheet Commitments Relating to Operating Activities</link:label>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off Balance Sheet Commitments Relating To Operating Activities [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of off balance sheet commitments relating to operating activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock" xlink:to="lab_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount_8a55872a-60f3-45f1-84ec-963451092f66_terseLabel_en-US" xlink:label="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity instruments designated at fair value through other comprehensive income, transaction amount</link:label>
    <link:label id="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount_label_en-US" xlink:label="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income, Transaction Amount</link:label>
    <link:label id="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount_documentation_en-US" xlink:label="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income, Transaction Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount" xlink:href="sny-20221231.xsd#sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount" xlink:to="lab_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_ce5e639c-d4c0-4cb0-bfbe-7e0d9729789d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of other non-current assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RestrictedSharesMember_ca29d683-f270-4a72-925f-899ed32553b4_terseLabel_en-US" xlink:label="lab_sny_RestrictedSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted shares</link:label>
    <link:label id="lab_sny_RestrictedSharesMember_label_en-US" xlink:label="lab_sny_RestrictedSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Shares [Member]</link:label>
    <link:label id="lab_sny_RestrictedSharesMember_documentation_en-US" xlink:label="lab_sny_RestrictedSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharesMember" xlink:href="sny-20221231.xsd#sny_RestrictedSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharesMember" xlink:to="lab_sny_RestrictedSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherFinanceIncomeCost_d61244ec-0396-41cd-bf9b-50b795a3f2c4_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherFinanceIncomeCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_OtherFinanceIncomeCost_label_en-US" xlink:label="lab_ifrs-full_OtherFinanceIncomeCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other finance income (cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceIncomeCost" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinanceIncomeCost" xlink:to="lab_ifrs-full_OtherFinanceIncomeCost" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DefinedBenefitPlansVestingRightsPercentage_236c6441-cb9e-4574-86cb-464c214bfbbc_terseLabel_en-US" xlink:label="lab_sny_DefinedBenefitPlansVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting right percentage</link:label>
    <link:label id="lab_sny_DefinedBenefitPlansVestingRightsPercentage_label_en-US" xlink:label="lab_sny_DefinedBenefitPlansVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans Vesting Rights Percentage</link:label>
    <link:label id="lab_sny_DefinedBenefitPlansVestingRightsPercentage_documentation_en-US" xlink:label="lab_sny_DefinedBenefitPlansVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans vesting rights percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefinedBenefitPlansVestingRightsPercentage" xlink:href="sny-20221231.xsd#sny_DefinedBenefitPlansVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DefinedBenefitPlansVestingRightsPercentage" xlink:to="lab_sny_DefinedBenefitPlansVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RestrictedSharePlan2020Member_3bd8a0a7-55b5-4169-890e-bafc50992d05_terseLabel_en-US" xlink:label="lab_sny_RestrictedSharePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted share plan 2020</link:label>
    <link:label id="lab_sny_RestrictedSharePlan2020Member_label_en-US" xlink:label="lab_sny_RestrictedSharePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plan 2020 [Member]</link:label>
    <link:label id="lab_sny_RestrictedSharePlan2020Member_documentation_en-US" xlink:label="lab_sny_RestrictedSharePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plan 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2020Member" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharePlan2020Member" xlink:to="lab_sny_RestrictedSharePlan2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalMarketedProductsGenzymeMember_9c341f80-2a5c-48f0-bb1d-4c50ad8f817d_terseLabel_en-US" xlink:label="lab_sny_PrincipalMarketedProductsGenzymeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsGenzymeMember_label_en-US" xlink:label="lab_sny_PrincipalMarketedProductsGenzymeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products Genzyme [member]</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsGenzymeMember_documentation_en-US" xlink:label="lab_sny_PrincipalMarketedProductsGenzymeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal marketed products genzyme.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsGenzymeMember" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsGenzymeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalMarketedProductsGenzymeMember" xlink:to="lab_sny_PrincipalMarketedProductsGenzymeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_5ad9acb7-1520-4602-9c89-17f8ee028c23_negatedLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of property, plant and equipment and intangible assets</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_8dc0caf5-f01b-44aa-9f17-fab67e72996a_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of acquisitions of property plant and equipment by operating segments [table]</link:label>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_label_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Acquisitions Of Property Plant And Equipment By Operating Segments [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Acquisitions Of Property Plant And Equipment By Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable" xlink:to="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_0940e80b-4704-40f3-8575-69895b68d689_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase)/decrease in accounts receivable</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SeniorBondMember_a2dc83fd-e259-4274-b361-103778928231_terseLabel_en-US" xlink:label="lab_sny_SeniorBondMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior bond</link:label>
    <link:label id="lab_sny_SeniorBondMember_label_en-US" xlink:label="lab_sny_SeniorBondMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Bond [Member]</link:label>
    <link:label id="lab_sny_SeniorBondMember_documentation_en-US" xlink:label="lab_sny_SeniorBondMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior bond.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SeniorBondMember" xlink:href="sny-20221231.xsd#sny_SeniorBondMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SeniorBondMember" xlink:to="lab_sny_SeniorBondMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PerformanceSharePlanTwoMember_5b6e867a-eb8d-448f-b3af-1fba49240981_terseLabel_en-US" xlink:label="lab_sny_PerformanceSharePlanTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share plan two</link:label>
    <link:label id="lab_sny_PerformanceSharePlanTwoMember_label_en-US" xlink:label="lab_sny_PerformanceSharePlanTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Plan Two [member]</link:label>
    <link:label id="lab_sny_PerformanceSharePlanTwoMember_documentation_en-US" xlink:label="lab_sny_PerformanceSharePlanTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share plan two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceSharePlanTwoMember" xlink:href="sny-20221231.xsd#sny_PerformanceSharePlanTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PerformanceSharePlanTwoMember" xlink:to="lab_sny_PerformanceSharePlanTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfPatentActionsInitiallyFiled_4b916169-6466-433a-9ba0-c45647a87bd0_terseLabel_en-US" xlink:label="lab_sny_NumberOfPatentActionsInitiallyFiled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patent actions initially filed</link:label>
    <link:label id="lab_sny_NumberOfPatentActionsInitiallyFiled_label_en-US" xlink:label="lab_sny_NumberOfPatentActionsInitiallyFiled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Patent Actions Initially Filed</link:label>
    <link:label id="lab_sny_NumberOfPatentActionsInitiallyFiled_documentation_en-US" xlink:label="lab_sny_NumberOfPatentActionsInitiallyFiled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patent actions initially filed .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPatentActionsInitiallyFiled" xlink:href="sny-20221231.xsd#sny_NumberOfPatentActionsInitiallyFiled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfPatentActionsInitiallyFiled" xlink:to="lab_sny_NumberOfPatentActionsInitiallyFiled" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustedWeightedAverageShares_0dca8b6b-e871-464b-8674-2b180befc1b7_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average number of shares after dilution (in shares)</link:label>
    <link:label id="lab_ifrs-full_AdjustedWeightedAverageShares_024c3ff2-dfc9-4fc0-813a-6eabbd5ec7c8_totalLabel_en-US" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average number of shares used to compute diluted earnings per share (in shares)</link:label>
    <link:label id="lab_ifrs-full_AdjustedWeightedAverageShares_label_en-US" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares used in calculating diluted earnings per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_a95cec29-7103-4af1-8b26-c5779c56709c_terseLabel_en-US" xlink:label="lab_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</link:label>
    <link:label id="lab_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_label_en-US" xlink:label="lab_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</link:label>
    <link:label id="lab_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_documentation_en-US" xlink:label="lab_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xlink:to="lab_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfPayments_c9fd3f3d-9ca9-4e2a-a205-7a229362561c_terseLabel_en-US" xlink:label="lab_sny_NumberOfPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of payments</link:label>
    <link:label id="lab_sny_NumberOfPayments_label_en-US" xlink:label="lab_sny_NumberOfPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Payments</link:label>
    <link:label id="lab_sny_NumberOfPayments_documentation_en-US" xlink:label="lab_sny_NumberOfPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPayments" xlink:href="sny-20221231.xsd#sny_NumberOfPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfPayments" xlink:to="lab_sny_NumberOfPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock_23335205-83bb-48f5-8784-50299afd1d27_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate</link:label>
    <link:label id="lab_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Reconciliation Of Average Effective Tax Rate And Applicable Tax Rate Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of reconciliation of average effective tax rate and applicable tax rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DerivativeInstrumentDomain_b8a67366-fef4-428d-bc78-810a73b0f0fe_terseLabel_en-US" xlink:label="lab_sny_DerivativeInstrumentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Domain]</link:label>
    <link:label id="lab_sny_DerivativeInstrumentDomain_label_en-US" xlink:label="lab_sny_DerivativeInstrumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Domain]</link:label>
    <link:label id="lab_sny_DerivativeInstrumentDomain_documentation_en-US" xlink:label="lab_sny_DerivativeInstrumentDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of derivative instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeInstrumentDomain" xlink:href="sny-20221231.xsd#sny_DerivativeInstrumentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerivativeInstrumentDomain" xlink:to="lab_sny_DerivativeInstrumentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_d5d1c606-2906-430b-9746-6bfbd87f7837_terseLabel_en-US" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes</link:label>
    <link:label id="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Net Of Tax On Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset net of tax on associates and joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:to="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CashGeneratingUnitsMember_949cdbd7-1e30-48f2-9c50-1868fc77ace0_terseLabel_en-US" xlink:label="lab_sny_CashGeneratingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CGUs</link:label>
    <link:label id="lab_sny_CashGeneratingUnitsMember_label_en-US" xlink:label="lab_sny_CashGeneratingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Generating Units [member]</link:label>
    <link:label id="lab_sny_CashGeneratingUnitsMember_documentation_en-US" xlink:label="lab_sny_CashGeneratingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Generating Units [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashGeneratingUnitsMember" xlink:href="sny-20221231.xsd#sny_CashGeneratingUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CashGeneratingUnitsMember" xlink:to="lab_sny_CashGeneratingUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncontrollingInterests_a28dca62-51dd-4c5d-a8ed-16d3dcef37c7_verboseLabel_en-US" xlink:label="lab_ifrs-full_NoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity attributable to non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_NoncontrollingInterests_75d54903-5543-4f60-adc0-8ee63ddfb251_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Attributable to non-controlling interests</link:label>
    <link:label id="lab_ifrs-full_NoncontrollingInterests_label_en-US" xlink:label="lab_ifrs-full_NoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterests" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterests" xlink:to="lab_ifrs-full_NoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonOperatingForeignExchangeGainsLosses_e656179f-be52-4bd8-9595-efd06e2c930c_terseLabel_en-US" xlink:label="lab_sny_NonOperatingForeignExchangeGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating foreign exchange gains/(losses)</link:label>
    <link:label id="lab_sny_NonOperatingForeignExchangeGainsLosses_label_en-US" xlink:label="lab_sny_NonOperatingForeignExchangeGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Operating Foreign Exchange Gains (Losses)</link:label>
    <link:label id="lab_sny_NonOperatingForeignExchangeGainsLosses_documentation_en-US" xlink:label="lab_sny_NonOperatingForeignExchangeGainsLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating foreign exchange gains/(losses).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonOperatingForeignExchangeGainsLosses" xlink:href="sny-20221231.xsd#sny_NonOperatingForeignExchangeGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonOperatingForeignExchangeGainsLosses" xlink:to="lab_sny_NonOperatingForeignExchangeGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_a2966199-28b7-4bed-a3ef-ce43dcb648f8_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_f934724f-a8cc-474d-80ec-8a9e3d7ff7c4_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current derivative financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_bb480e72-2006-4639-a0d8-820bfe5d8f75_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in employee-related expenses</link:label>
    <link:label id="lab_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_label_en-US" xlink:label="lab_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Expense Of Restructuring Activities, Employee Related Expenses</link:label>
    <link:label id="lab_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Expense Of Restructuring Activities, Employee Related Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:to="lab_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0146877f-46aa-450e-b9de-bb7db378afbc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfOtherManufacturersInvolvedInProceedings_7e7aa10c-4d3b-4e63-a28e-aa7858e754f7_terseLabel_en-US" xlink:label="lab_sny_NumberOfOtherManufacturersInvolvedInProceedings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of other manufacturers involved in proceedings</link:label>
    <link:label id="lab_sny_NumberOfOtherManufacturersInvolvedInProceedings_label_en-US" xlink:label="lab_sny_NumberOfOtherManufacturersInvolvedInProceedings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Other Manufacturers Involved In Proceedings</link:label>
    <link:label id="lab_sny_NumberOfOtherManufacturersInvolvedInProceedings_documentation_en-US" xlink:label="lab_sny_NumberOfOtherManufacturersInvolvedInProceedings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Other Manufacturers Involved In Proceedings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOtherManufacturersInvolvedInProceedings" xlink:href="sny-20221231.xsd#sny_NumberOfOtherManufacturersInvolvedInProceedings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfOtherManufacturersInvolvedInProceedings" xlink:to="lab_sny_NumberOfOtherManufacturersInvolvedInProceedings" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_00108271-e713-462d-98e4-18d654422e6f_terseLabel_en-US" xlink:label="lab_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value (excluding investments accounted for using the equity method)</link:label>
    <link:label id="lab_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_label_en-US" xlink:label="lab_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value On Debt Instrument Excluding Associates And Joint Ventures</link:label>
    <link:label id="lab_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_documentation_en-US" xlink:label="lab_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value On Debt Instrument Excluding Associates And Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_b483d929-8451-4b3b-af00-54b59c7dfaa5_terseLabel_en-US" xlink:label="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions and other non-current liabilities [Line Items]</link:label>
    <link:label id="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_label_en-US" xlink:label="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions And Other Non-current Liabilities [Line Items]</link:label>
    <link:label id="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_documentation_en-US" xlink:label="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions and other non-current liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems" xlink:href="sny-20221231.xsd#sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems" xlink:to="lab_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherEnvironmentRelatedProvisionMember_6d662c83-d176-4cad-94c2-883b1fa35918_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherEnvironmentRelatedProvisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other environment related provision</link:label>
    <link:label id="lab_ifrs-full_OtherEnvironmentRelatedProvisionMember_label_en-US" xlink:label="lab_ifrs-full_OtherEnvironmentRelatedProvisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other environment related provision [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherEnvironmentRelatedProvisionMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherEnvironmentRelatedProvisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherEnvironmentRelatedProvisionMember" xlink:to="lab_ifrs-full_OtherEnvironmentRelatedProvisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock_720ba58f-6e09-4e6c-a9cf-07490d379f4e_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Present Value of Pension and Other Post Employement Benefits</link:label>
    <link:label id="lab_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Pension And Other Post Employment Benefit Expense [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of pension and other post employment benefit expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock" xlink:to="lab_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockOptionPlansMember_22bf88b9-6594-44d0-a470-e90a5f7303bf_terseLabel_en-US" xlink:label="lab_sny_StockOptionPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option plans</link:label>
    <link:label id="lab_sny_StockOptionPlansMember_label_en-US" xlink:label="lab_sny_StockOptionPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Plans [Member]</link:label>
    <link:label id="lab_sny_StockOptionPlansMember_documentation_en-US" xlink:label="lab_sny_StockOptionPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionPlansMember" xlink:href="sny-20221231.xsd#sny_StockOptionPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockOptionPlansMember" xlink:to="lab_sny_StockOptionPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiaventisAEBEMember_c49ec249-03c3-4f41-9d13-50956b74feb5_terseLabel_en-US" xlink:label="lab_sny_SanofiaventisAEBEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis A.E.B.E.</link:label>
    <link:label id="lab_sny_SanofiaventisAEBEMember_label_en-US" xlink:label="lab_sny_SanofiaventisAEBEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis A.E.B.E. [member]</link:label>
    <link:label id="lab_sny_SanofiaventisAEBEMember_documentation_en-US" xlink:label="lab_sny_SanofiaventisAEBEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis A.E.B.E.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiaventisAEBEMember" xlink:href="sny-20221231.xsd#sny_SanofiaventisAEBEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiaventisAEBEMember" xlink:to="lab_sny_SanofiaventisAEBEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset_bdc48e81-8dfa-4c36-b58e-f0a5aaa16a6a_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in scope of consolidation and transfers</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in net defined benefit liability (asset) resulting from business combinations and disposals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_ff348665-a695-4719-bf4d-d21cefc50773_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</link:label>
    <link:label id="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:to="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxAssetsCurrent_f8317bcf-8a23-4fa6-a8ce-d0b639aa59a1_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax assets</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxAssetsCurrent_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax assets, current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxAssetsCurrent" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxAssetsCurrent" xlink:to="lab_ifrs-full_CurrentTaxAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_a40a6594-be19-4e2c-98eb-1c7517aa6b5c_terseLabel_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [member]</link:label>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_label_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LitigationAmountPayable_0771e25c-cf76-4911-ad3a-9ccc66e3f7b2_terseLabel_en-US" xlink:label="lab_sny_LitigationAmountPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation amount payable</link:label>
    <link:label id="lab_sny_LitigationAmountPayable_label_en-US" xlink:label="lab_sny_LitigationAmountPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Amount Payable</link:label>
    <link:label id="lab_sny_LitigationAmountPayable_documentation_en-US" xlink:label="lab_sny_LitigationAmountPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Amount Payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LitigationAmountPayable" xlink:href="sny-20221231.xsd#sny_LitigationAmountPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LitigationAmountPayable" xlink:to="lab_sny_LitigationAmountPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OtherMember_21252d25-9f0d-458c-86b1-e1f8aa2125ef_terseLabel_en-US" xlink:label="lab_sny_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_sny_OtherMember_label_en-US" xlink:label="lab_sny_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_sny_OtherMember_documentation_en-US" xlink:label="lab_sny_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherMember" xlink:href="sny-20221231.xsd#sny_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherMember" xlink:to="lab_sny_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLoss_bbb7b8de-4f7d-4e35-9869-a156eed2aaab_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_ifrs-full_ProfitLoss_e9a1d302-a849-403f-84eb-e35e933fa36a_verboseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income for the period</link:label>
    <link:label id="lab_ifrs-full_ProfitLoss_label_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="lab_ifrs-full_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CounterpartiesMember_eeb11a4b-8eff-410e-8e9a-eb061b80f8bd_terseLabel_en-US" xlink:label="lab_ifrs-full_CounterpartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparties</link:label>
    <link:label id="lab_ifrs-full_CounterpartiesMember_label_en-US" xlink:label="lab_ifrs-full_CounterpartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparties [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesMember" xlink:to="lab_ifrs-full_CounterpartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurIncMember_9887d8f4-54fc-42e2-a129-33fd0267cc39_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Inc.</link:label>
    <link:label id="lab_sny_SanofiPasteurIncMember_label_en-US" xlink:label="lab_sny_SanofiPasteurIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Inc [member]</link:label>
    <link:label id="lab_sny_SanofiPasteurIncMember_documentation_en-US" xlink:label="lab_sny_SanofiPasteurIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurIncMember" xlink:href="sny-20221231.xsd#sny_SanofiPasteurIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurIncMember" xlink:to="lab_sny_SanofiPasteurIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DepakineProductLitigationInSpainMember_23456224-6458-4228-bef1-83ba364eb437_terseLabel_en-US" xlink:label="lab_sny_DepakineProductLitigationInSpainMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine product litigation in Spain</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInSpainMember_label_en-US" xlink:label="lab_sny_DepakineProductLitigationInSpainMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Spain [Member]</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInSpainMember_documentation_en-US" xlink:label="lab_sny_DepakineProductLitigationInSpainMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Spain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInSpainMember" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInSpainMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DepakineProductLitigationInSpainMember" xlink:to="lab_sny_DepakineProductLitigationInSpainMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OrdinarySharesNASDAQGlobalSelectMarketMember_97e4d477-1417-41c1-a0fa-d2bae4722885_terseLabel_en-US" xlink:label="lab_sny_OrdinarySharesNASDAQGlobalSelectMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value &#8364;2&#160;per share</link:label>
    <link:label id="lab_sny_OrdinarySharesNASDAQGlobalSelectMarketMember_label_en-US" xlink:label="lab_sny_OrdinarySharesNASDAQGlobalSelectMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares, NASDAQ Global Select Market [Member]</link:label>
    <link:label id="lab_sny_OrdinarySharesNASDAQGlobalSelectMarketMember_documentation_en-US" xlink:label="lab_sny_OrdinarySharesNASDAQGlobalSelectMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares, NASDAQ Global Select Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OrdinarySharesNASDAQGlobalSelectMarketMember" xlink:href="sny-20221231.xsd#sny_OrdinarySharesNASDAQGlobalSelectMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OrdinarySharesNASDAQGlobalSelectMarketMember" xlink:to="lab_sny_OrdinarySharesNASDAQGlobalSelectMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock_dab7724e-c278-4f82-bbd4-860f5cd9c7ea_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Debt by Type Valuation of Redemption</link:label>
    <link:label id="lab_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt Net Of Cash And Cash Equivalents By Type At Value On Redemption Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of debt net of cash and cash equivalents by type at value on redemption.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_4e112410-1e0f-4279-a951-7fead6015cda_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisDePanamaSAMember_36db0eea-d95b-4ff0-aaea-9e82e4dbc47f_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisDePanamaSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis de Panama S.A.</link:label>
    <link:label id="lab_sny_SanofiAventisDePanamaSAMember_label_en-US" xlink:label="lab_sny_SanofiAventisDePanamaSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis De Panama S A [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisDePanamaSAMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisDePanamaSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis de Panama S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDePanamaSAMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisDePanamaSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisDePanamaSAMember" xlink:to="lab_sny_SanofiAventisDePanamaSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareRomaniaSRLMember_db145303-f531-4fc6-a8f4-64c38e8da9e9_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareRomaniaSRLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Romania S.R.L.</link:label>
    <link:label id="lab_sny_OpellaHealthcareRomaniaSRLMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareRomaniaSRLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Romania S.R.L. [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareRomaniaSRLMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareRomaniaSRLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Romania S.R.L.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareRomaniaSRLMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareRomaniaSRLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareRomaniaSRLMember" xlink:to="lab_sny_OpellaHealthcareRomaniaSRLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock_6bd7aaf5-f7e8-4993-84c5-c08a514169e5_terseLabel_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other gains and losses, and litigation</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock_label_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Accounting Policy For Other Gains And Losses And Litigation Explanatory [Policy Text Block]</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock_documentation_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for other gains and losses, and litigation explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock" xlink:to="lab_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany_e1873f29-05c1-4d2c-81da-a7bbb1314ab1_terseLabel_en-US" xlink:label="lab_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum additional funding for PD1 - part of each company</link:label>
    <link:label id="lab_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany_label_en-US" xlink:label="lab_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Additional Funding For Anti Programmed Cell Death Protein 1 Part Of Each Company</link:label>
    <link:label id="lab_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany_documentation_en-US" xlink:label="lab_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum additional funding for anti programmed cell death protein 1 part of each company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany" xlink:href="sny-20221231.xsd#sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany" xlink:to="lab_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GlobalPenaltyFeeIncurredByDefendants_4e3b40f6-ed45-4398-9b1a-3899f35169d0_terseLabel_en-US" xlink:label="lab_sny_GlobalPenaltyFeeIncurredByDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total penalty fee incurred by defendants</link:label>
    <link:label id="lab_sny_GlobalPenaltyFeeIncurredByDefendants_label_en-US" xlink:label="lab_sny_GlobalPenaltyFeeIncurredByDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Penalty Fee Incurred By Defendants</link:label>
    <link:label id="lab_sny_GlobalPenaltyFeeIncurredByDefendants_documentation_en-US" xlink:label="lab_sny_GlobalPenaltyFeeIncurredByDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Penalty Fee Incurred By Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GlobalPenaltyFeeIncurredByDefendants" xlink:href="sny-20221231.xsd#sny_GlobalPenaltyFeeIncurredByDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GlobalPenaltyFeeIncurredByDefendants" xlink:to="lab_sny_GlobalPenaltyFeeIncurredByDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencySalesInPoundSterlingMember_e0ee5375-31bc-4bce-924e-9c3d9bb8989e_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencySalesInPoundSterlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Pound Sterling</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInPoundSterlingMember_label_en-US" xlink:label="lab_sny_ForwardCurrencySalesInPoundSterlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Pound Sterling [Member]</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInPoundSterlingMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencySalesInPoundSterlingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Pound Sterling</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInPoundSterlingMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInPoundSterlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInPoundSterlingMember" xlink:to="lab_sny_ForwardCurrencySalesInPoundSterlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_2e372877-7d26-4c94-8d84-5706ac70ec98_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Property, Plant and Equipment Leased</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PlaintiffMember_9c5bdce0-640e-4951-bb69-8bcdcd4774d7_terseLabel_en-US" xlink:label="lab_sny_PlaintiffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff</link:label>
    <link:label id="lab_sny_PlaintiffMember_label_en-US" xlink:label="lab_sny_PlaintiffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff [Member]</link:label>
    <link:label id="lab_sny_PlaintiffMember_documentation_en-US" xlink:label="lab_sny_PlaintiffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlaintiffMember" xlink:href="sny-20221231.xsd#sny_PlaintiffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PlaintiffMember" xlink:to="lab_sny_PlaintiffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts_4aabc02c-87c3-4644-9878-e9ab94236bf7_terseLabel_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation for early termination of contracts (other than contracts of employment)</link:label>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts_label_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Of Restructuring Activities, Compensation For Early Termination Of Contracts</link:label>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts_documentation_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation for early termination of contracts (other than contracts of employment).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts" xlink:to="lab_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SharebasedPaymentArrangementsMember_c4595b10-dd62-4072-8da2-bc5a6715fc8d_terseLabel_en-US" xlink:label="lab_ifrs-full_SharebasedPaymentArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and other share-based payment [Member]</link:label>
    <link:label id="lab_ifrs-full_SharebasedPaymentArrangementsMember_label_en-US" xlink:label="lab_ifrs-full_SharebasedPaymentArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment arrangements [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="lab_ifrs-full_SharebasedPaymentArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_249d72f5-1ea2-4cca-998b-390532e3e238_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DebtNetOfCashAndCashEquivalents_e9782c7c-e5f3-4aaf-a7f2-08b602f2658e_totalLabel_en-US" xlink:label="lab_sny_DebtNetOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net debt</link:label>
    <link:label id="lab_sny_DebtNetOfCashAndCashEquivalents_8161b210-2fd8-4827-9575-5398e12f8942_terseLabel_en-US" xlink:label="lab_sny_DebtNetOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net debt</link:label>
    <link:label id="lab_sny_DebtNetOfCashAndCashEquivalents_label_en-US" xlink:label="lab_sny_DebtNetOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Net Of Cash And Cash Equivalents</link:label>
    <link:label id="lab_sny_DebtNetOfCashAndCashEquivalents_documentation_en-US" xlink:label="lab_sny_DebtNetOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt net of cash and cash equivalents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DebtNetOfCashAndCashEquivalents" xlink:to="lab_sny_DebtNetOfCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisSuisseSAMember_81012ae8-e270-4118-a7ba-c1d132950551_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisSuisseSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis (Suisse) SA</link:label>
    <link:label id="lab_sny_SanofiAventisSuisseSAMember_label_en-US" xlink:label="lab_sny_SanofiAventisSuisseSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis (Suisse) SA [member]</link:label>
    <link:label id="lab_sny_SanofiAventisSuisseSAMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisSuisseSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis (Suisse) SA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSuisseSAMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisSuisseSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisSuisseSAMember" xlink:to="lab_sny_SanofiAventisSuisseSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments_03af4600-b50c-4d05-aad7-2bb09d732aa8_terseLabel_en-US" xlink:label="lab_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments received in respect of disposals proceeds receivable and contingent consideration on divestments</link:label>
    <link:label id="lab_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments_label_en-US" xlink:label="lab_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Off Balance Sheet Commitments Received In Respect Of Disposals Proceeds Receivable And Contingent Consideration On Divestments</link:label>
    <link:label id="lab_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments_documentation_en-US" xlink:label="lab_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Off Balance Sheet Commitments Received In Respect Of Disposals Proceeds Receivable And Contingent Consideration On Divestments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments" xlink:href="sny-20221231.xsd#sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments" xlink:to="lab_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock_88bfb7ed-9726-4cd2-a4c3-5ffece08a581_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Debt by Currency Before and After Derivative Instrument</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Debt By Currency At Value Of Redemption Before And After Derivative Instruments [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of debt by currency at value of redemption before and after derivative instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock" xlink:to="lab_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DepreciationRightofuseAssets_d5d26b61-048a-4ec3-b1bd-0d2d5389ff82_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and impairment charged in the period</link:label>
    <link:label id="lab_ifrs-full_DepreciationRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PreFundedPensionObligations_2b075ad1-7065-42fd-8f97-86af8effb090_terseLabel_en-US" xlink:label="lab_sny_PreFundedPensionObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-funded pension obligations</link:label>
    <link:label id="lab_sny_PreFundedPensionObligations_d3bc32eb-c6cc-42d3-a55a-4c93342d9d73_verboseLabel_en-US" xlink:label="lab_sny_PreFundedPensionObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-funded pension obligations</link:label>
    <link:label id="lab_sny_PreFundedPensionObligations_label_en-US" xlink:label="lab_sny_PreFundedPensionObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Funded Pension Obligations</link:label>
    <link:label id="lab_sny_PreFundedPensionObligations_documentation_en-US" xlink:label="lab_sny_PreFundedPensionObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-funded pension obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PreFundedPensionObligations" xlink:href="sny-20221231.xsd#sny_PreFundedPensionObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PreFundedPensionObligations" xlink:to="lab_sny_PreFundedPensionObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_MXN_256becf3-8026-4306-8928-47dd818b36a1_terseLabel_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexican peso</link:label>
    <link:label id="lab_currency_MXN_label_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico, Pesos</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MXN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_MXN" xlink:to="lab_currency_MXN" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ba04ee7e-59d7-40f3-81a8-12967bbbc795_terseLabel_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-adjusting events after reporting period [axis]</link:label>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_label_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-adjusting events after reporting period [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TypesOfAgreementDomain_2c37745e-8abf-4ff7-8df3-077d84d8ab8a_terseLabel_en-US" xlink:label="lab_sny_TypesOfAgreementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types Of Agreement [Domain]</link:label>
    <link:label id="lab_sny_TypesOfAgreementDomain_label_en-US" xlink:label="lab_sny_TypesOfAgreementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types Of Agreement [Domain]</link:label>
    <link:label id="lab_sny_TypesOfAgreementDomain_documentation_en-US" xlink:label="lab_sny_TypesOfAgreementDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types Of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TypesOfAgreementDomain" xlink:to="lab_sny_TypesOfAgreementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncome_4994eb38-0e14-4b28-bff6-c1aa360b614d_negatedLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current taxes</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncome_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncome" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GenzymeGlobalSarlMember_7923eeeb-9e44-4c31-8612-3af6ab574ec8_terseLabel_en-US" xlink:label="lab_sny_GenzymeGlobalSarlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Global Sarl</link:label>
    <link:label id="lab_sny_GenzymeGlobalSarlMember_label_en-US" xlink:label="lab_sny_GenzymeGlobalSarlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Global Sarl [member]</link:label>
    <link:label id="lab_sny_GenzymeGlobalSarlMember_documentation_en-US" xlink:label="lab_sny_GenzymeGlobalSarlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Global Sarl.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeGlobalSarlMember" xlink:href="sny-20221231.xsd#sny_GenzymeGlobalSarlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GenzymeGlobalSarlMember" xlink:to="lab_sny_GenzymeGlobalSarlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_048a1f5b-93d7-4247-aefb-c72a6e1f7301_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_e46e3949-1da7-4608-9fe3-9fd8ebef31a4_periodStartLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_b1a810b9-155f-4e3b-81c2-0f873a6e78cb_periodEndLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_label_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued" xlink:to="lab_ifrs-full_NumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageSharePrice2019_1b1e828e-50a8-47fa-be2c-606ab4513d0b_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageSharePrice2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average share price (in EUR per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageSharePrice2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageSharePrice2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average share price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePrice2019" xlink:to="lab_ifrs-full_WeightedAverageSharePrice2019" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_743dc9e8-aca8-4fe7-b6d4-2f9cdea26629_totalLabel_en-US" xlink:label="lab_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_label_en-US" xlink:label="lab_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities other than liabilities included in disposal groups classified as held for sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="lab_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_7d8da19f-dbe9-4620-ac44-2d526f6606b6_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_96280f81-9799-4cd0-9968-199cca6b47e1_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of estimates and judgments</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockSubscriptionOptionPlanNineMember_b1b213a8-77c9-43d2-8736-f3c088d0b065_terseLabel_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanNineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan nine</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanNineMember_label_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanNineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Subscription Option Plan Nine [Member]</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanNineMember_documentation_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanNineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan nine.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanNineMember" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanNineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockSubscriptionOptionPlanNineMember" xlink:to="lab_sny_StockSubscriptionOptionPlanNineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinishedGoods_ad956bd4-d09c-41ac-b6a2-457cd62bfe40_terseLabel_en-US" xlink:label="lab_ifrs-full_FinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_ifrs-full_FinishedGoods_label_en-US" xlink:label="lab_ifrs-full_FinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current finished goods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinishedGoods" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinishedGoods" xlink:to="lab_ifrs-full_FinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeBeforeTax_72461cc8-b71f-42cd-bd3c-1001f906f256_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income before tax</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, before tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeBeforeTax" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeBeforeTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_5b50d04c-f9f8-41f3-adca-13f93f1948e5_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest received</link:label>
    <link:label id="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest received, classified as operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurAsiTicaretASMember_7efb76ac-0c2b-486e-ab71-df218d04e04b_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurAsiTicaretASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Asi Ticaret A.S.</link:label>
    <link:label id="lab_sny_SanofiPasteurAsiTicaretASMember_label_en-US" xlink:label="lab_sny_SanofiPasteurAsiTicaretASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Asi Ticaret A.S [member]</link:label>
    <link:label id="lab_sny_SanofiPasteurAsiTicaretASMember_documentation_en-US" xlink:label="lab_sny_SanofiPasteurAsiTicaretASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Asi Ticaret A.S.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurAsiTicaretASMember" xlink:href="sny-20221231.xsd#sny_SanofiPasteurAsiTicaretASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurAsiTicaretASMember" xlink:to="lab_sny_SanofiPasteurAsiTicaretASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_VehiclesMember_2aa616ab-fbe1-4883-9ae6-1943c051353a_terseLabel_en-US" xlink:label="lab_ifrs-full_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicle fleet</link:label>
    <link:label id="lab_ifrs-full_VehiclesMember_label_en-US" xlink:label="lab_ifrs-full_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_VehiclesMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_VehiclesMember" xlink:to="lab_ifrs-full_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_84de318c-58d1-44ce-9cb0-8cc94c9da488_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Treasury Shares Held</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of classes of share capital [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentLiabilities_475c70bc-44e6-4606-92b3-e96448cff678_totalLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLiabilities_label_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="lab_ifrs-full_NoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_4b07f284-d554-4c98-82c6-c399a6e7ebd2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Principal Transactions and Balances with Related Parties</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of transactions between related parties [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DerivativeFinancialInstruments_46cde82f-765d-433d-a76c-71193cf5d1ea_terseLabel_en-US" xlink:label="lab_sny_DerivativeFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating currency hedging instruments in place</link:label>
    <link:label id="lab_sny_DerivativeFinancialInstruments_c4446d5b-c500-4911-a7bc-930379ee8666_verboseLabel_en-US" xlink:label="lab_sny_DerivativeFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nominal value of interest rate swaps hedge fixed-rate bonds</link:label>
    <link:label id="lab_sny_DerivativeFinancialInstruments_label_en-US" xlink:label="lab_sny_DerivativeFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_sny_DerivativeFinancialInstruments_documentation_en-US" xlink:label="lab_sny_DerivativeFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial instrument</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialInstruments" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerivativeFinancialInstruments" xlink:to="lab_sny_DerivativeFinancialInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_USGovernmentMember_ad4aef12-9393-4c64-87af-0b3eb9b67171_terseLabel_en-US" xlink:label="lab_sny_USGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government</link:label>
    <link:label id="lab_sny_USGovernmentMember_label_en-US" xlink:label="lab_sny_USGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government [Member]</link:label>
    <link:label id="lab_sny_USGovernmentMember_documentation_en-US" xlink:label="lab_sny_USGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_USGovernmentMember" xlink:href="sny-20221231.xsd#sny_USGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_USGovernmentMember" xlink:to="lab_sny_USGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_09f003aa-4745-43f5-9074-990f969daaa9_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of financial assets that are either past due or impaired [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of financial assets that are either past due or impaired [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember_e0ad16cd-70a7-44e8-bfcf-54d6ca3c1da5_terseLabel_en-US" xlink:label="lab_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Praluent (Alirocumab)-related amgen patent litigation in the US</link:label>
    <link:label id="lab_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember_label_en-US" xlink:label="lab_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Praluent (Alirocumab)-Related Amgen Patent Litigation In The US [Member]</link:label>
    <link:label id="lab_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember_documentation_en-US" xlink:label="lab_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Praluent (Alirocumab)-Related Amgen Patent Litigation In The US</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember" xlink:href="sny-20221231.xsd#sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember" xlink:to="lab_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AntibodiesCollaborationAgreementMember_189bd8bb-a885-4e03-a7ba-661a5f345328_terseLabel_en-US" xlink:label="lab_sny_AntibodiesCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antibodies collaboration agreement</link:label>
    <link:label id="lab_sny_AntibodiesCollaborationAgreementMember_label_en-US" xlink:label="lab_sny_AntibodiesCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antibodies Collaboration Agreement [Member]</link:label>
    <link:label id="lab_sny_AntibodiesCollaborationAgreementMember_documentation_en-US" xlink:label="lab_sny_AntibodiesCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antibodies collaboration agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember" xlink:href="sny-20221231.xsd#sny_AntibodiesCollaborationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AntibodiesCollaborationAgreementMember" xlink:to="lab_sny_AntibodiesCollaborationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AOSanofiRussiaMember_318d6353-4dc7-4aee-ac3c-61b6612dc761_terseLabel_en-US" xlink:label="lab_sny_AOSanofiRussiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AO Sanofi Russia</link:label>
    <link:label id="lab_sny_AOSanofiRussiaMember_label_en-US" xlink:label="lab_sny_AOSanofiRussiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AO Sanofi Russia [member]</link:label>
    <link:label id="lab_sny_AOSanofiRussiaMember_documentation_en-US" xlink:label="lab_sny_AOSanofiRussiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AO Sanofi Russia.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AOSanofiRussiaMember" xlink:href="sny-20221231.xsd#sny_AOSanofiRussiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AOSanofiRussiaMember" xlink:to="lab_sny_AOSanofiRussiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock_57485f6b-de5b-4653-84e9-eee26f3a7d1a_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests</link:label>
    <link:label id="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Maximum Amount Of Contingent Consideration Payable And Firm Commitments To Buy Out Non-controlling Interests Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OneBillionBondsMaturingJanuary2022Member_53ff56ed-4bbc-4f6d-8032-f010af1c6898_terseLabel_en-US" xlink:label="lab_sny_OneBillionBondsMaturingJanuary2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Billion Bonds Maturing January 2022</link:label>
    <link:label id="lab_sny_OneBillionBondsMaturingJanuary2022Member_label_en-US" xlink:label="lab_sny_OneBillionBondsMaturingJanuary2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Billion Bonds Maturing January 2022 [Member]</link:label>
    <link:label id="lab_sny_OneBillionBondsMaturingJanuary2022Member_documentation_en-US" xlink:label="lab_sny_OneBillionBondsMaturingJanuary2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Billion Bonds Maturing January 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OneBillionBondsMaturingJanuary2022Member" xlink:href="sny-20221231.xsd#sny_OneBillionBondsMaturingJanuary2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OneBillionBondsMaturingJanuary2022Member" xlink:to="lab_sny_OneBillionBondsMaturingJanuary2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeAbstract_0546576a-faa2-42cd-a5b5-572f0a546615_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income:</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RestrictedSharePlan2019Member_214ed96e-3eed-4404-bbb7-8974d573f9a4_terseLabel_en-US" xlink:label="lab_sny_RestrictedSharePlan2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted share plan 2019</link:label>
    <link:label id="lab_sny_RestrictedSharePlan2019Member_label_en-US" xlink:label="lab_sny_RestrictedSharePlan2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plan 2019 [Member]</link:label>
    <link:label id="lab_sny_RestrictedSharePlan2019Member_documentation_en-US" xlink:label="lab_sny_RestrictedSharePlan2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Plan 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2019Member" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharePlan2019Member" xlink:to="lab_sny_RestrictedSharePlan2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_c6784f9f-92fb-4791-bf6d-bbc09464154f_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisThailandLtdMember_871fcbf3-f8b2-49ee-acb9-3a0e5eddbd3b_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisThailandLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis (Thailand) Ltd</link:label>
    <link:label id="lab_sny_SanofiAventisThailandLtdMember_label_en-US" xlink:label="lab_sny_SanofiAventisThailandLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Thailand Ltd [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisThailandLtdMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisThailandLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Thailand Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisThailandLtdMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisThailandLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisThailandLtdMember" xlink:to="lab_sny_SanofiAventisThailandLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NetChangeInOtherNonCurrentAssets_29baf431-c1f5-4eb9-bb6a-942bbd6b8a73_verboseLabel_en-US" xlink:label="lab_sny_NetChangeInOtherNonCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in other non-current assets</link:label>
    <link:label id="lab_sny_NetChangeInOtherNonCurrentAssets_label_en-US" xlink:label="lab_sny_NetChangeInOtherNonCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Change In Other Non-current Assets</link:label>
    <link:label id="lab_sny_NetChangeInOtherNonCurrentAssets_documentation_en-US" xlink:label="lab_sny_NetChangeInOtherNonCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in other non-current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetChangeInOtherNonCurrentAssets" xlink:href="sny-20221231.xsd#sny_NetChangeInOtherNonCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetChangeInOtherNonCurrentAssets" xlink:to="lab_sny_NetChangeInOtherNonCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments_1c01aaaf-cd94-4101-b01f-b3e14bb5392d_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of equity instruments included in&#160;financial assets and financial liabilities</link:label>
    <link:label id="lab_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments_label_en-US" xlink:label="lab_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) recognised in other comprehensive income including exchange differences, fair value measurement, entity's own equity instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" xlink:to="lab_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets_7083728d-7f6f-4981-a61e-3552cddf4692_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments related to research and development payments contingent upon attainment of sales targets</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets_label_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Related To Research And Development Payments Contingent Upon Attainment Of Sales Targets</link:label>
    <link:label id="lab_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments related to r and d payments contingent upon attainment of sales targets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets" xlink:to="lab_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurMerieuxSASMember_2dbb1ccb-2fe8-4524-8379-c9adf8c9e05a_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurMerieuxSASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Merieux S.A.S.</link:label>
    <link:label id="lab_sny_SanofiPasteurMerieuxSASMember_label_en-US" xlink:label="lab_sny_SanofiPasteurMerieuxSASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Merieux S.A.S [Member]</link:label>
    <link:label id="lab_sny_SanofiPasteurMerieuxSASMember_documentation_en-US" xlink:label="lab_sny_SanofiPasteurMerieuxSASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur Merieux S.A.S</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurMerieuxSASMember" xlink:href="sny-20221231.xsd#sny_SanofiPasteurMerieuxSASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurMerieuxSASMember" xlink:to="lab_sny_SanofiPasteurMerieuxSASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_42a34323-d449-42c9-8895-2d09c50dd3ca_terseLabel_en-US" xlink:label="lab_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value on redemption after derivative instruments</link:label>
    <link:label id="lab_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_label_en-US" xlink:label="lab_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value On Redemption After Derivative Instruments [Member]</link:label>
    <link:label id="lab_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_documentation_en-US" xlink:label="lab_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value on redemption after derivative instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionAfterDerivativeInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember" xlink:to="lab_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IGMBiosciencesIncMember_8d0fd53d-cd2f-4418-b9bb-aca9e85bc109_terseLabel_en-US" xlink:label="lab_sny_IGMBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IGM Biosciences, Inc</link:label>
    <link:label id="lab_sny_IGMBiosciencesIncMember_label_en-US" xlink:label="lab_sny_IGMBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IGM Biosciences, Inc [Member]</link:label>
    <link:label id="lab_sny_IGMBiosciencesIncMember_documentation_en-US" xlink:label="lab_sny_IGMBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IGM Biosciences, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IGMBiosciencesIncMember" xlink:href="sny-20221231.xsd#sny_IGMBiosciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IGMBiosciencesIncMember" xlink:to="lab_sny_IGMBiosciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_27edce75-c8b1-4ab7-923d-a0ea1eb0677d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of fair value of plan assets [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of fair value of plan assets [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable" xlink:to="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_269c794d-954a-4175-b95a-c7fc048dd663_terseLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of interests in investments accounted for using equity method</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of interests in investments accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock_d9c659f5-dcb2-49ca-9b0b-7883cbf7971b_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Impairment Losses of Other Intangible Assets</link:label>
    <link:label id="lab_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Impairment Losses Of Other Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Impairment Losses Of Other Intangible Assets [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock" xlink:to="lab_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TaxRateEffectOfForeignTaxRates_0e24347a-4f19-46a7-8526-f2be89d1ee35_terseLabel_en-US" xlink:label="lab_ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference between the standard French tax rate and the rates applicable to the Sanofi</link:label>
    <link:label id="lab_ifrs-full_TaxRateEffectOfForeignTaxRates_label_en-US" xlink:label="lab_ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax rate effect of foreign tax rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:to="lab_ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_d1b5ef13-1bf9-4fde-adb9-9011c1b5f4b3_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment information</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for segment reporting [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrencyDerivativesMember_70b659a6-65cf-404c-8d86-f3d727554a58_terseLabel_en-US" xlink:label="lab_sny_CurrencyDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency derivatives</link:label>
    <link:label id="lab_sny_CurrencyDerivativesMember_label_en-US" xlink:label="lab_sny_CurrencyDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Derivatives [member]</link:label>
    <link:label id="lab_sny_CurrencyDerivativesMember_documentation_en-US" xlink:label="lab_sny_CurrencyDerivativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency derivatives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesMember" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrencyDerivativesMember" xlink:to="lab_sny_CurrencyDerivativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OnduoMember_979d7fe6-e5ae-443e-89e5-61a8f90cdb43_terseLabel_en-US" xlink:label="lab_sny_OnduoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onduo</link:label>
    <link:label id="lab_sny_OnduoMember_label_en-US" xlink:label="lab_sny_OnduoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onduo [Member]</link:label>
    <link:label id="lab_sny_OnduoMember_documentation_en-US" xlink:label="lab_sny_OnduoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onduo</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OnduoMember" xlink:href="sny-20221231.xsd#sny_OnduoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OnduoMember" xlink:to="lab_sny_OnduoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_dd552077-0558-4442-b31b-4a99fa48e821_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current trade payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExposureTable_85991e18-2a7d-4e4b-a2e6-d3a46636cbb5_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Credit Risk Exposure [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExposureTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of credit risk exposure [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCreditRiskExposureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement_d4ecac5f-a692-4ea0-a068-65876796a6ef_terseLabel_en-US" xlink:label="lab_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of immunology or inflammation targets under collaboration agreement</link:label>
    <link:label id="lab_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement_label_en-US" xlink:label="lab_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Immunology Or Inflammation Targets Under Collaboration Agreement</link:label>
    <link:label id="lab_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement_documentation_en-US" xlink:label="lab_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Immunology Or Inflammation Targets Under Collaboration Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement" xlink:href="sny-20221231.xsd#sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement" xlink:to="lab_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_QuotedEquitySecuritiesMember_b9ebc304-c431-4c76-9c6e-569ba0230db2_terseLabel_en-US" xlink:label="lab_sny_QuotedEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted equity securities</link:label>
    <link:label id="lab_sny_QuotedEquitySecuritiesMember_label_en-US" xlink:label="lab_sny_QuotedEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Equity Securities [member]</link:label>
    <link:label id="lab_sny_QuotedEquitySecuritiesMember_documentation_en-US" xlink:label="lab_sny_QuotedEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted equity securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedEquitySecuritiesMember" xlink:href="sny-20221231.xsd#sny_QuotedEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_QuotedEquitySecuritiesMember" xlink:to="lab_sny_QuotedEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfSharesIssuedByExerciceOfEachOption_dbdde00a-1dae-46e6-816a-3a22559d819a_terseLabel_en-US" xlink:label="lab_sny_NumberOfSharesIssuedByExerciceOfEachOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued by exercice of each option (in shares)</link:label>
    <link:label id="lab_sny_NumberOfSharesIssuedByExerciceOfEachOption_label_en-US" xlink:label="lab_sny_NumberOfSharesIssuedByExerciceOfEachOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Shares Issued By Exercice Of Each Option</link:label>
    <link:label id="lab_sny_NumberOfSharesIssuedByExerciceOfEachOption_documentation_en-US" xlink:label="lab_sny_NumberOfSharesIssuedByExerciceOfEachOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Shares Issued By Exercice Of Each Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSharesIssuedByExerciceOfEachOption" xlink:href="sny-20221231.xsd#sny_NumberOfSharesIssuedByExerciceOfEachOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfSharesIssuedByExerciceOfEachOption" xlink:to="lab_sny_NumberOfSharesIssuedByExerciceOfEachOption" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherCurrentAssets_5304cf58-15db-4170-b41b-2ddf8eb5373d_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_ifrs-full_OtherCurrentAssets_c0669e66-6749-44ba-a611-30b9a90e234b_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_OtherCurrentAssets_label_en-US" xlink:label="lab_ifrs-full_OtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentAssets" xlink:to="lab_ifrs-full_OtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_b484c1ea-f992-4be9-9cd5-5dc4d5f9758a_terseLabel_en-US" xlink:label="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Analysis of income and expense [abstract]</link:label>
    <link:label id="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_label_en-US" xlink:label="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Analysis of income and expense [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsCategoryMember_8634972b-4b7a-4ec7-a2b5-4e79fc16472f_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets, category [member]</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_c7037c99-5320-46b5-b461-ab54f0a87185_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of initial application of standards or interpretations [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of initial application of standards or interpretations [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" xlink:to="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LargestCustomersMember_530a577e-6a75-4e03-ada0-d801048cfadf_terseLabel_en-US" xlink:label="lab_sny_LargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest customers</link:label>
    <link:label id="lab_sny_LargestCustomersMember_label_en-US" xlink:label="lab_sny_LargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Customers [Member]</link:label>
    <link:label id="lab_sny_LargestCustomersMember_documentation_en-US" xlink:label="lab_sny_LargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LargestCustomersMember" xlink:href="sny-20221231.xsd#sny_LargestCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LargestCustomersMember" xlink:to="lab_sny_LargestCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_2c201156-df72-48c0-af07-89299349950e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of fair value of plan assets [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of fair value of plan assets [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems" xlink:to="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_d1d7f215-5a50-41c8-9ef4-d7dede77364b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LongtermRestructuringProvision_4cd0ed69-9716-48af-9d43-1957e8a2e3a8_terseLabel_en-US" xlink:label="lab_ifrs-full_LongtermRestructuringProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classified in non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_LongtermRestructuringProvision_label_en-US" xlink:label="lab_ifrs-full_LongtermRestructuringProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current restructuring provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermRestructuringProvision" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermRestructuringProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermRestructuringProvision" xlink:to="lab_ifrs-full_LongtermRestructuringProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_RoyaltiesPaymentsMadeBySanofi_411019f2-97a3-4776-9693-95a96df88bf1_terseLabel_en-US" xlink:label="lab_sny_RoyaltiesPaymentsMadeBySanofi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty payment to be paid by Sanofi</link:label>
    <link:label id="lab_sny_RoyaltiesPaymentsMadeBySanofi_label_en-US" xlink:label="lab_sny_RoyaltiesPaymentsMadeBySanofi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties Payments Made By Sanofi</link:label>
    <link:label id="lab_sny_RoyaltiesPaymentsMadeBySanofi_documentation_en-US" xlink:label="lab_sny_RoyaltiesPaymentsMadeBySanofi" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties payments made by sanofi.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltiesPaymentsMadeBySanofi" xlink:href="sny-20221231.xsd#sny_RoyaltiesPaymentsMadeBySanofi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RoyaltiesPaymentsMadeBySanofi" xlink:to="lab_sny_RoyaltiesPaymentsMadeBySanofi" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncome_1ef033dc-49db-4ef6-be98-4d5daa52c1c3_totalLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="lab_ifrs-full_ComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_52e19392-4579-4821-b97e-fc30f2c89d59_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_label_en-US" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:to="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_StockSubscriptionOptionPlanSevenMember_1468e5f2-868e-44c0-a408-3169b4cf156c_terseLabel_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanSevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan seven</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanSevenMember_label_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanSevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Subscription Option Plan Seven [Member]</link:label>
    <link:label id="lab_sny_StockSubscriptionOptionPlanSevenMember_documentation_en-US" xlink:label="lab_sny_StockSubscriptionOptionPlanSevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock subscription option plan seven.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanSevenMember" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanSevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockSubscriptionOptionPlanSevenMember" xlink:to="lab_sny_StockSubscriptionOptionPlanSevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PlavixAttorneyGeneralActionInHawaiiMember_051f93f8-605c-4b62-b90c-c352aea20cec_terseLabel_en-US" xlink:label="lab_sny_PlavixAttorneyGeneralActionInHawaiiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Attorney General Action in Hawaii</link:label>
    <link:label id="lab_sny_PlavixAttorneyGeneralActionInHawaiiMember_label_en-US" xlink:label="lab_sny_PlavixAttorneyGeneralActionInHawaiiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Attorney General Action In Hawaii [Member]</link:label>
    <link:label id="lab_sny_PlavixAttorneyGeneralActionInHawaiiMember_documentation_en-US" xlink:label="lab_sny_PlavixAttorneyGeneralActionInHawaiiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Attorney General Action In Hawaii</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember" xlink:href="sny-20221231.xsd#sny_PlavixAttorneyGeneralActionInHawaiiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember" xlink:to="lab_sny_PlavixAttorneyGeneralActionInHawaiiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease_fccbcc08-f8fa-4195-b3da-9abbf14cb87f_terseLabel_en-US" xlink:label="lab_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital increase by issuance of restricted shares (in shares)</link:label>
    <link:label id="lab_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease_label_en-US" xlink:label="lab_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Restricted Shares Issued In Regards Of Capital Increase</link:label>
    <link:label id="lab_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease_documentation_en-US" xlink:label="lab_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted shares issued in regards of capital increase.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xlink:href="sny-20221231.xsd#sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xlink:to="lab_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable_bb767cce-ef4f-447c-aa0a-cbaafce4935a_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of net income attributable to Non-controlling Interests [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable_label_en-US" xlink:label="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Net Income Attributable To Non-controlling Interests [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of net income attributable to Non-controlling Interests [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable" xlink:to="lab_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_b044a89c-4e3e-4ea9-9bf7-72bd9efb8a01_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment losses, net of reversals</link:label>
    <link:label id="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-downs (reversals of write-downs) of property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock_75df99cf-e81f-4748-9324-c6962375e3f8_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Sales by Segment and Geographical Area</link:label>
    <link:label id="lab_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Net Sales By Segment And Geographical Area [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of net sales by segment and geographical area.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock" xlink:to="lab_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable_c48c44b7-1170-40ab-8f99-c47c968ec7a7_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of stock subscription option plan outstanding and option exercised [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable_label_en-US" xlink:label="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Stock Subscription Option Plan Outstanding And Option Exercised [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of stock subscription option plan outstanding and option exercised [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable" xlink:to="lab_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_23705676-2695-4a34-96f0-86877ab6ad29_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3f21da50-03e4-4872-8d0a-557a986bc499_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns_8d863810-c942-44a5-90dd-9a8f61693494_negatedTerseLabel_en-US" xlink:label="lab_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments made</link:label>
    <link:label id="lab_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns_label_en-US" xlink:label="lab_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease Through Payments Made Provisions For Discounts Rebates And Sales Returns</link:label>
    <link:label id="lab_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns_documentation_en-US" xlink:label="lab_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments made for discounts, rebates and sales returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" xlink:href="sny-20221231.xsd#sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" xlink:to="lab_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Level1OfFairValueHierarchyMember_e3c6bd57-18ba-423e-a125-cb2a09dc5ae9_terseLabel_en-US" xlink:label="lab_ifrs-full_Level1OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_ifrs-full_Level1OfFairValueHierarchyMember_label_en-US" xlink:label="lab_ifrs-full_Level1OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1 of fair value hierarchy [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level1OfFairValueHierarchyMember" xlink:to="lab_ifrs-full_Level1OfFairValueHierarchyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock_806426b6-e92b-46fc-a107-52ca69392228_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Movement in Provisions for Discounts, Rebates and Sales Returns</link:label>
    <link:label id="lab_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Changes In Provisions For Discounts Rebates And Sales Returns [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of changes in provisions for discounts rebates and sales returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock" xlink:to="lab_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfAverageOfQuotedMarketPricesOfShares_5d5bf941-82d3-4b8d-9422-2e6f373be613_verboseLabel_en-US" xlink:label="lab_sny_PercentageOfAverageOfQuotedMarketPricesOfShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription price (as a percent)</link:label>
    <link:label id="lab_sny_PercentageOfAverageOfQuotedMarketPricesOfShares_label_en-US" xlink:label="lab_sny_PercentageOfAverageOfQuotedMarketPricesOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Average Of Quoted Market Prices Of Shares</link:label>
    <link:label id="lab_sny_PercentageOfAverageOfQuotedMarketPricesOfShares_documentation_en-US" xlink:label="lab_sny_PercentageOfAverageOfQuotedMarketPricesOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of average of quoted market prices of shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAverageOfQuotedMarketPricesOfShares" xlink:href="sny-20221231.xsd#sny_PercentageOfAverageOfQuotedMarketPricesOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfAverageOfQuotedMarketPricesOfShares" xlink:to="lab_sny_PercentageOfAverageOfQuotedMarketPricesOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfPrincipalAlliancesTextBlock_b98a6eaa-c66d-4d73-9faa-c1764661d3a1_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfPrincipalAlliancesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal alliances</link:label>
    <link:label id="lab_sny_DisclosureOfPrincipalAlliancesTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfPrincipalAlliancesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Principal Alliances [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfPrincipalAlliancesTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfPrincipalAlliancesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for principal alliances.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPrincipalAlliancesTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfPrincipalAlliancesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesTextBlock" xlink:to="lab_sny_DisclosureOfPrincipalAlliancesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_TwoThousandEighteenLetterAgreementMember_90dbba7f-a8a5-4c5e-ae3b-28083e96e611_terseLabel_en-US" xlink:label="lab_sny_TwoThousandEighteenLetterAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Letter Agreement</link:label>
    <link:label id="lab_sny_TwoThousandEighteenLetterAgreementMember_label_en-US" xlink:label="lab_sny_TwoThousandEighteenLetterAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen Letter Agreement [Member]</link:label>
    <link:label id="lab_sny_TwoThousandEighteenLetterAgreementMember_documentation_en-US" xlink:label="lab_sny_TwoThousandEighteenLetterAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Letter Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TwoThousandEighteenLetterAgreementMember" xlink:href="sny-20221231.xsd#sny_TwoThousandEighteenLetterAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TwoThousandEighteenLetterAgreementMember" xlink:to="lab_sny_TwoThousandEighteenLetterAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NonQualifiedDefinedBenefitPensionPlansMember_7a104ad8-1dd9-4634-9e12-50558c941afd_terseLabel_en-US" xlink:label="lab_sny_NonQualifiedDefinedBenefitPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non qualified defined benefit pension plans</link:label>
    <link:label id="lab_sny_NonQualifiedDefinedBenefitPensionPlansMember_label_en-US" xlink:label="lab_sny_NonQualifiedDefinedBenefitPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Qualified Defined Benefit Pension Plans [member]</link:label>
    <link:label id="lab_sny_NonQualifiedDefinedBenefitPensionPlansMember_documentation_en-US" xlink:label="lab_sny_NonQualifiedDefinedBenefitPensionPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non qualified defined benefit pension plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonQualifiedDefinedBenefitPensionPlansMember" xlink:href="sny-20221231.xsd#sny_NonQualifiedDefinedBenefitPensionPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonQualifiedDefinedBenefitPensionPlansMember" xlink:to="lab_sny_NonQualifiedDefinedBenefitPensionPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfMedicalAssessments_bd5c253a-b5b0-4406-a9aa-0cd18ffbb79e_terseLabel_en-US" xlink:label="lab_sny_NumberOfMedicalAssessments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of medical assessments</link:label>
    <link:label id="lab_sny_NumberOfMedicalAssessments_label_en-US" xlink:label="lab_sny_NumberOfMedicalAssessments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Medical Assessments</link:label>
    <link:label id="lab_sny_NumberOfMedicalAssessments_documentation_en-US" xlink:label="lab_sny_NumberOfMedicalAssessments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Medical Assessments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfMedicalAssessments" xlink:href="sny-20221231.xsd#sny_NumberOfMedicalAssessments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfMedicalAssessments" xlink:to="lab_sny_NumberOfMedicalAssessments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_09596f5a-95ea-422f-bff6-aae97d6804fa_netLabel_en-US" xlink:label="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expense for restricted share plans</link:label>
    <link:label id="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_df397b79-62a1-44e3-a27f-d7107ed8693f_terseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense recognized</link:label>
    <link:label id="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_label_en-US" xlink:label="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense from equity-settled share-based payment transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShireHumanGeneticTherapiesIncMember_856529f1-3857-4926-afa0-774077a21a78_terseLabel_en-US" xlink:label="lab_sny_ShireHumanGeneticTherapiesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shire contingent consideration</link:label>
    <link:label id="lab_sny_ShireHumanGeneticTherapiesIncMember_label_en-US" xlink:label="lab_sny_ShireHumanGeneticTherapiesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shire Human Genetic Therapies Inc. [Member]</link:label>
    <link:label id="lab_sny_ShireHumanGeneticTherapiesIncMember_documentation_en-US" xlink:label="lab_sny_ShireHumanGeneticTherapiesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shire Human Genetic Therapies Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShireHumanGeneticTherapiesIncMember" xlink:href="sny-20221231.xsd#sny_ShireHumanGeneticTherapiesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShireHumanGeneticTherapiesIncMember" xlink:to="lab_sny_ShireHumanGeneticTherapiesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement_c42a9487-aa23-4127-87d1-738e26e0ac31_periodStartLabel_en-US" xlink:label="lab_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options, beginning balance (in shares)</link:label>
    <link:label id="lab_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement_f3d80619-1713-4bfe-830c-d29fbbc927d3_periodEndLabel_en-US" xlink:label="lab_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options, ending balance (in shares)</link:label>
    <link:label id="lab_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Share Outstanding In Share Based Payment Arrangement</link:label>
    <link:label id="lab_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share outstanding in share based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement" xlink:href="sny-20221231.xsd#sny_NumberOfShareOutstandingInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement" xlink:to="lab_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsAndGoodwill_6a03aad3-3a0f-4c9c-bfdd-4686b3202ed7_periodStartLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsAndGoodwill_6a9d69c4-58d2-4193-bca4-cf0b98f5a8ef_periodEndLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsAndGoodwill_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets and goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember_e6b9961e-1bed-4e74-bbdc-c641fbcbc759_terseLabel_en-US" xlink:label="lab_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shire contingent consideration arising&#160;from&#160;the acquisition of Translate Bio</link:label>
    <link:label id="lab_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember_label_en-US" xlink:label="lab_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shire Contingent Consideration Arising From The Acquisition Of Translate Bio [Member]</link:label>
    <link:label id="lab_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember_documentation_en-US" xlink:label="lab_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shire Contingent Consideration Arising From The Acquisition Of Translate Bio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember" xlink:href="sny-20221231.xsd#sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember" xlink:to="lab_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember_6bf0c230-952f-4291-8e0c-989548803389_terseLabel_en-US" xlink:label="lab_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Global Sarl Baar Intellectual Property Branch</link:label>
    <link:label id="lab_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember_label_en-US" xlink:label="lab_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Global Sarl Baar Intellectual Property Branch [Member]</link:label>
    <link:label id="lab_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember_documentation_en-US" xlink:label="lab_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genzyme Global Sarl Baar Intellectual Property Branch</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember" xlink:href="sny-20221231.xsd#sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember" xlink:to="lab_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OncologyMember_0030cf1d-23fe-485d-a628-d6555569b72f_terseLabel_en-US" xlink:label="lab_sny_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology</link:label>
    <link:label id="lab_sny_OncologyMember_label_en-US" xlink:label="lab_sny_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology [Member]</link:label>
    <link:label id="lab_sny_OncologyMember_documentation_en-US" xlink:label="lab_sny_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OncologyMember" xlink:href="sny-20221231.xsd#sny_OncologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OncologyMember" xlink:to="lab_sny_OncologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PensionsAndOtherPostEmploymentBenefitsMember_08a7981f-8ea8-4cd4-a1ab-904e1e1dcdb3_terseLabel_en-US" xlink:label="lab_sny_PensionsAndOtherPostEmploymentBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pensions and other post-employment benefits</link:label>
    <link:label id="lab_sny_PensionsAndOtherPostEmploymentBenefitsMember_label_en-US" xlink:label="lab_sny_PensionsAndOtherPostEmploymentBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pensions And Other Post-Employment Benefits [Member]</link:label>
    <link:label id="lab_sny_PensionsAndOtherPostEmploymentBenefitsMember_documentation_en-US" xlink:label="lab_sny_PensionsAndOtherPostEmploymentBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pensions and other post-employment benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember" xlink:href="sny-20221231.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember" xlink:to="lab_sny_PensionsAndOtherPostEmploymentBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD_29d97e1f-82d7-49cd-ac45-1ac2b9bfa06b_terseLabel_en-US" xlink:label="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments relating to contingent consideration in connection with business combinations MSD</link:label>
    <link:label id="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD_label_en-US" xlink:label="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Relating To Contingent Consideration In Connection With Business Combinations MSD</link:label>
    <link:label id="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD_documentation_en-US" xlink:label="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Relating To Contingent Consideration In Connection With Business Combinations MSD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD" xlink:to="lab_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiSAMember_63d8bfb4-792f-4a1f-9c65-6862de178b67_terseLabel_en-US" xlink:label="lab_sny_SanofiSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi SA</link:label>
    <link:label id="lab_sny_SanofiSAMember_label_en-US" xlink:label="lab_sny_SanofiSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi SA [Member]</link:label>
    <link:label id="lab_sny_SanofiSAMember_documentation_en-US" xlink:label="lab_sny_SanofiSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi SA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSAMember" xlink:href="sny-20221231.xsd#sny_SanofiSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiSAMember" xlink:to="lab_sny_SanofiSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock_63bd6744-317f-46e1-a97b-8a94936b6dbf_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Non Current Provisions and Other Non-current Liabilities</link:label>
    <link:label id="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Provisions And Other Non Current Liabilities Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of provisions and other non current liabilities explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_6a7ea290-6a23-48da-8c4f-414491d56793_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals and other decreases</link:label>
    <link:label id="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals and retirements, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_99acbc28-499f-4e1f-b3aa-4959562f4f38_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of accounting policy for research and development expense [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ForwardCurrencySalesInChineseYuanRenminbiMember_8c7a72a5-9f62-4567-a9cc-b06b3c714d43_terseLabel_en-US" xlink:label="lab_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales in Chinese Yuan Renminbi</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInChineseYuanRenminbiMember_label_en-US" xlink:label="lab_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Sales In Chinese Yuan Renminbi [member]</link:label>
    <link:label id="lab_sny_ForwardCurrencySalesInChineseYuanRenminbiMember_documentation_en-US" xlink:label="lab_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward currency sales in Chinese Yuan Renminbi.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInChineseYuanRenminbiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xlink:to="lab_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_6384c9c3-74b2-4da3-ad59-4d455377df09_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosures about major customers and credit risk</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of credit risk [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCreditRiskExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_AubagioMember_e2827e93-ea79-4323-b289-7e4724dba6f2_terseLabel_en-US" xlink:label="lab_sny_AubagioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aubagio</link:label>
    <link:label id="lab_sny_AubagioMember_label_en-US" xlink:label="lab_sny_AubagioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aubagio [Member]</link:label>
    <link:label id="lab_sny_AubagioMember_documentation_en-US" xlink:label="lab_sny_AubagioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aubagio.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AubagioMember" xlink:href="sny-20221231.xsd#sny_AubagioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AubagioMember" xlink:to="lab_sny_AubagioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfCivilIndividualActions_01b8ed20-4a01-4f5b-a980-3f742417d343_terseLabel_en-US" xlink:label="lab_sny_NumberOfCivilIndividualActions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of civil individual actions</link:label>
    <link:label id="lab_sny_NumberOfCivilIndividualActions_label_en-US" xlink:label="lab_sny_NumberOfCivilIndividualActions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Civil Individual Actions</link:label>
    <link:label id="lab_sny_NumberOfCivilIndividualActions_documentation_en-US" xlink:label="lab_sny_NumberOfCivilIndividualActions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Civil Individual Actions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCivilIndividualActions" xlink:href="sny-20221231.xsd#sny_NumberOfCivilIndividualActions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfCivilIndividualActions" xlink:to="lab_sny_NumberOfCivilIndividualActions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfRestructuringProvisionsTable_d80194c0-6237-4bb7-891a-de91cdcaf5cc_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfRestructuringProvisionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Restructuring provisions [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfRestructuringProvisionsTable_label_en-US" xlink:label="lab_sny_DisclosureOfRestructuringProvisionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Restructuring Provisions [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfRestructuringProvisionsTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfRestructuringProvisionsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Restructuring provisions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringProvisionsTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringProvisionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsTable" xlink:to="lab_sny_DisclosureOfRestructuringProvisionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsMember_19683485-b170-4c8f-8bfd-aef5f2043615_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumptions [member]</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial assumptions [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionsMember" xlink:to="lab_ifrs-full_ActuarialAssumptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BondsIssued_10343984-a9b4-4507-91e2-c3798ad7f6cb_terseLabel_en-US" xlink:label="lab_ifrs-full_BondsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond issues</link:label>
    <link:label id="lab_ifrs-full_BondsIssued_label_en-US" xlink:label="lab_ifrs-full_BondsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bonds issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BondsIssued" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BondsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BondsIssued" xlink:to="lab_ifrs-full_BondsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_d72f16dd-2e49-42fd-9255-037ab697152b_negatedLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurement of contingent consideration</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_cb93525c-2cf1-499f-a24a-09f85e4e8d0e_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurement of contingent consideration</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in contingent consideration asset (liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:to="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_13989ab1-918e-4a1e-9e91-532d819cdc27_terseLabel_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding arrangements of defined benefit plans [member]</link:label>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_label_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding arrangements of defined benefit plans [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember" xlink:to="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_a9ad315d-2614-4071-9dea-5aa1749d0843_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock_4f792e5e-ff71-4066-8402-9606bee846a1_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Future Termination Benefit Payments</link:label>
    <link:label id="lab_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Future Benefit Payments Explanatory [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of future benefit payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss_e3507ded-ca5b-43d4-af53-3161a8deb277_terseLabel_en-US" xlink:label="lab_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating margin rate</link:label>
    <link:label id="lab_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss_label_en-US" xlink:label="lab_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Operating Margin Rate Below Rates Actually Used Would Not Cause Impairment Loss</link:label>
    <link:label id="lab_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss_documentation_en-US" xlink:label="lab_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of operating margin rate below rates actually used would not cause impairment loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:href="sny-20221231.xsd#sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:to="lab_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CarryingAmountMember_3332b923-1595-4226-bf20-019b6ad76c55_terseLabel_en-US" xlink:label="lab_ifrs-full_CarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount</link:label>
    <link:label id="lab_ifrs-full_CarryingAmountMember_label_en-US" xlink:label="lab_ifrs-full_CarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember" xlink:to="lab_ifrs-full_CarryingAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisMalaysiaSDNBHDMember_aa65a946-31c7-4007-8505-9f33c1d63b44_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisMalaysiaSDNBHDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis (Malaysia) SDN. BHD.</link:label>
    <link:label id="lab_sny_SanofiAventisMalaysiaSDNBHDMember_label_en-US" xlink:label="lab_sny_SanofiAventisMalaysiaSDNBHDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Malaysia SDN. BHD [Member]</link:label>
    <link:label id="lab_sny_SanofiAventisMalaysiaSDNBHDMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisMalaysiaSDNBHDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis (Malaysia) SDN. BHD.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisMalaysiaSDNBHDMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisMalaysiaSDNBHDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisMalaysiaSDNBHDMember" xlink:to="lab_sny_SanofiAventisMalaysiaSDNBHDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_fd529746-dab7-4775-ab5f-0d02c8c81a36_terseLabel_en-US" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions during the period</link:label>
    <link:label id="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_label_en-US" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions through business combinations, intangible assets and goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiBiotechnologyMember_d0ae96b7-6568-4611-a934-6350da3e84e0_terseLabel_en-US" xlink:label="lab_sny_SanofiBiotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Biotechnology</link:label>
    <link:label id="lab_sny_SanofiBiotechnologyMember_label_en-US" xlink:label="lab_sny_SanofiBiotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Biotechnology [Member]</link:label>
    <link:label id="lab_sny_SanofiBiotechnologyMember_documentation_en-US" xlink:label="lab_sny_SanofiBiotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Biotechnology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBiotechnologyMember" xlink:href="sny-20221231.xsd#sny_SanofiBiotechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiBiotechnologyMember" xlink:to="lab_sny_SanofiBiotechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_LaboratoryFacilitiesCambridgeMassachusettsMember_295d1a3e-534b-499f-9702-1265af3b5b0f_terseLabel_en-US" xlink:label="lab_sny_LaboratoryFacilitiesCambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory facilities, Cambridge, Massachusetts</link:label>
    <link:label id="lab_sny_LaboratoryFacilitiesCambridgeMassachusettsMember_label_en-US" xlink:label="lab_sny_LaboratoryFacilitiesCambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Facilities, Cambridge, Massachusetts [Member]</link:label>
    <link:label id="lab_sny_LaboratoryFacilitiesCambridgeMassachusettsMember_documentation_en-US" xlink:label="lab_sny_LaboratoryFacilitiesCambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Facilities, Cambridge, Massachusetts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LaboratoryFacilitiesCambridgeMassachusettsMember" xlink:href="sny-20221231.xsd#sny_LaboratoryFacilitiesCambridgeMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LaboratoryFacilitiesCambridgeMassachusettsMember" xlink:to="lab_sny_LaboratoryFacilitiesCambridgeMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfCounterExpertiseExperts_52ac88a9-6b9c-44b1-bf2b-1d8decfd2f9f_terseLabel_en-US" xlink:label="lab_sny_NumberOfCounterExpertiseExperts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of experts</link:label>
    <link:label id="lab_sny_NumberOfCounterExpertiseExperts_label_en-US" xlink:label="lab_sny_NumberOfCounterExpertiseExperts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Counter-Expertise Experts</link:label>
    <link:label id="lab_sny_NumberOfCounterExpertiseExperts_documentation_en-US" xlink:label="lab_sny_NumberOfCounterExpertiseExperts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Counter-Expertise Experts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCounterExpertiseExperts" xlink:href="sny-20221231.xsd#sny_NumberOfCounterExpertiseExperts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfCounterExpertiseExperts" xlink:to="lab_sny_NumberOfCounterExpertiseExperts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2a5db08d-b6a8-44b4-85dc-0cfc915d6637_verboseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options, options exercisable (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_6a5a88a8-0433-4f3d-bc1e-be017a065751_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, number of options (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiUSServicesIncMember_bf1b6ff0-c94c-4b38-9346-36cf327e36ff_terseLabel_en-US" xlink:label="lab_sny_SanofiUSServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi US Services Inc.</link:label>
    <link:label id="lab_sny_SanofiUSServicesIncMember_label_en-US" xlink:label="lab_sny_SanofiUSServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi US Services Inc [member]</link:label>
    <link:label id="lab_sny_SanofiUSServicesIncMember_documentation_en-US" xlink:label="lab_sny_SanofiUSServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi US Services Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiUSServicesIncMember" xlink:href="sny-20221231.xsd#sny_SanofiUSServicesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiUSServicesIncMember" xlink:to="lab_sny_SanofiUSServicesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CashEquivalentsCommercialPaper_a1d2ad42-a2b5-49d7-b49d-89f20586d938_terseLabel_en-US" xlink:label="lab_sny_CashEquivalentsCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, commercial paper</link:label>
    <link:label id="lab_sny_CashEquivalentsCommercialPaper_label_en-US" xlink:label="lab_sny_CashEquivalentsCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, Commercial Paper</link:label>
    <link:label id="lab_sny_CashEquivalentsCommercialPaper_documentation_en-US" xlink:label="lab_sny_CashEquivalentsCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalent commercial paper.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashEquivalentsCommercialPaper" xlink:href="sny-20221231.xsd#sny_CashEquivalentsCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CashEquivalentsCommercialPaper" xlink:to="lab_sny_CashEquivalentsCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_701bfa9b-6831-4a82-8ddd-a142188c5884_terseLabel_en-US" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting equity interests acquired</link:label>
    <link:label id="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_label_en-US" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting equity interests acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_61d784e3-01cb-471b-8937-9af49820c2c7_terseLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve of exchange differences on translation</link:label>
    <link:label id="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_label_en-US" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve of exchange differences on translation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling_f407f5b9-91e4-4b59-9d13-62b24df88ef6_terseLabel_en-US" xlink:label="lab_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer's contribution percentage</link:label>
    <link:label id="lab_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling_label_en-US" xlink:label="lab_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contribute Percentage On Amounts Exceeding The Social Security Ceiling</link:label>
    <link:label id="lab_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling_documentation_en-US" xlink:label="lab_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribute percentage on amounts exceeding the social security ceiling.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling" xlink:href="sny-20221231.xsd#sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling" xlink:to="lab_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts_5f303b52-872b-4679-a160-eb5a7f776a9a_terseLabel_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transformation programs costs</link:label>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts_label_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Of Restructuring Activities, Transformation Programs Costs</link:label>
    <link:label id="lab_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts_documentation_en-US" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense Of Restructuring Activities, Transformation Programs Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xlink:to="lab_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOtherNoncurrentAssetsTable_c61a8f67-1004-40d9-84f3-2b1cc7476561_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOtherNoncurrentAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Non-current Assets [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherNoncurrentAssetsTable_label_en-US" xlink:label="lab_sny_DisclosureOfOtherNoncurrentAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Non-current Assets [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherNoncurrentAssetsTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfOtherNoncurrentAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule disclosing information related to other non-current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherNoncurrentAssetsTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherNoncurrentAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable" xlink:to="lab_sny_DisclosureOfOtherNoncurrentAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxAssetsNoncurrent_0c405f01-933d-4fbc-b8fb-d3a2d0501d09_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current income tax assets</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxAssetsNoncurrent_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax assets, non-current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxAssetsNoncurrent" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxAssetsNoncurrent" xlink:to="lab_ifrs-full_CurrentTaxAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems_bbc495d8-6c18-4744-a628-38356cd5cde9_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of geographical areas [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of geographical areas [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset_15419e67-eee9-444c-92b4-78411cfd04b9_terseLabel_en-US" xlink:label="lab_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net interest cost/(income) including administration costs and taxes paid during the period</link:label>
    <link:label id="lab_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense (Income) Including Administration Costs And Taxes Paid, Net Defined Benefit Liability (Asset)</link:label>
    <link:label id="lab_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset_documentation_en-US" xlink:label="lab_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense (Income) Including Administration Costs And Taxes Paid, Net Defined Benefit Liability (Asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" xlink:href="sny-20221231.xsd#sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" xlink:to="lab_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NetExposure_5fc065c2-219b-4b96-b1bf-a6daf1e23bdf_totalLabel_en-US" xlink:label="lab_sny_NetExposure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net exposure</link:label>
    <link:label id="lab_sny_NetExposure_label_en-US" xlink:label="lab_sny_NetExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Exposure</link:label>
    <link:label id="lab_sny_NetExposure_documentation_en-US" xlink:label="lab_sny_NetExposure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net exposure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetExposure" xlink:href="sny-20221231.xsd#sny_NetExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetExposure" xlink:to="lab_sny_NetExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComputerSoftwareMember_b87d5116-2712-4878-83c1-2e9a274f64b4_terseLabel_en-US" xlink:label="lab_ifrs-full_ComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_ifrs-full_ComputerSoftwareMember_label_en-US" xlink:label="lab_ifrs-full_ComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer software [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerSoftwareMember" xlink:to="lab_ifrs-full_ComputerSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions_2f733987-3209-40b8-a0e2-91e7e363a82c_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in scope of consolidation</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Change In Scope Of Consolidation, Other Provisions</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Change In Scope Of Consolidation, Other Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" xlink:to="lab_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DebtInstrumentDomain_baac799e-7642-4ad9-8877-dfb764ea8dcf_terseLabel_en-US" xlink:label="lab_sny_DebtInstrumentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Domain]</link:label>
    <link:label id="lab_sny_DebtInstrumentDomain_label_en-US" xlink:label="lab_sny_DebtInstrumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Domain]</link:label>
    <link:label id="lab_sny_DebtInstrumentDomain_documentation_en-US" xlink:label="lab_sny_DebtInstrumentDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentDomain" xlink:href="sny-20221231.xsd#sny_DebtInstrumentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DebtInstrumentDomain" xlink:to="lab_sny_DebtInstrumentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_9b4de0a1-d210-4a4d-822c-7681bcdd02b4_terseLabel_en-US" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets of Translate Bio</link:label>
    <link:label id="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_8f56d30b-d072-4f01-ac8d-2af172d7f82e_totalLabel_en-US" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets of Translate Bio</link:label>
    <link:label id="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_label_en-US" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_62d9cdd4-ed40-4d90-8b7c-fb907a18c49d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions_f76c1fe6-6071-41a6-8a1b-dacb7f2cb573_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effects of the exercise of&#160;stock options</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Share-Based Payment Plans Tax Effects Of The Exercise Of Stock Options</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effects of the exercise of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xlink:to="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_5eb18326-03bf-4389-998c-c1af4f13514b_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_486a9ff4-374b-430c-851f-109e5e4e4a8b_totalLabel_en-US" xlink:label="lab_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_label_en-US" xlink:label="lab_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:to="lab_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfClassActionLawsuits_3a3f4a11-03d3-409b-8178-709073e73c83_terseLabel_en-US" xlink:label="lab_sny_NumberOfClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of class actions</link:label>
    <link:label id="lab_sny_NumberOfClassActionLawsuits_label_en-US" xlink:label="lab_sny_NumberOfClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Class Action Lawsuits</link:label>
    <link:label id="lab_sny_NumberOfClassActionLawsuits_documentation_en-US" xlink:label="lab_sny_NumberOfClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Class Action Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfClassActionLawsuits" xlink:href="sny-20221231.xsd#sny_NumberOfClassActionLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfClassActionLawsuits" xlink:to="lab_sny_NumberOfClassActionLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ExercisePriceRangeThreeMember_fecee76d-51a4-4036-abb7-19493bfe0288_terseLabel_en-US" xlink:label="lab_sny_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price range three</link:label>
    <link:label id="lab_sny_ExercisePriceRangeThreeMember_label_en-US" xlink:label="lab_sny_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
    <link:label id="lab_sny_ExercisePriceRangeThreeMember_documentation_en-US" xlink:label="lab_sny_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExercisePriceRangeThreeMember" xlink:href="sny-20221231.xsd#sny_ExercisePriceRangeThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExercisePriceRangeThreeMember" xlink:to="lab_sny_ExercisePriceRangeThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements_3c8cf1ce-33b5-4039-b46f-31a31dd7c2ca_terseLabel_en-US" xlink:label="lab_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payments for projects under collaboration agreements</link:label>
    <link:label id="lab_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements_label_en-US" xlink:label="lab_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payments For Projects Under Collaboration Agreements</link:label>
    <link:label id="lab_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements_documentation_en-US" xlink:label="lab_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payments For Projects Under Collaboration Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements" xlink:href="sny-20221231.xsd#sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements" xlink:to="lab_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsTable_02a97650-84c4-4948-9590-3f67dcf4378c_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off Balance Sheet Commitments [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsTable_label_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off Balance Sheet Commitments [Table]</link:label>
    <link:label id="lab_sny_DisclosureOfOffBalanceSheetCommitmentsTable_documentation_en-US" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Off Balance Sheet Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:to="lab_sny_DisclosureOfOffBalanceSheetCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_33caceac-05d6-430a-876a-aa5b92ad4642_negatedTerseLabel_en-US" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effects</link:label>
    <link:label id="lab_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_label_en-US" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Relating To Change In Fair Value Of Equity Instruments Excluding Equity Method</link:label>
    <link:label id="lab_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_documentation_en-US" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Relating To Change In Fair Value Of Equity Instruments Excluding Equity Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xlink:to="lab_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ReportableGeographicalZonesMember_13fd0e0a-2ed4-45ea-ae20-b6a3b1e29385_terseLabel_en-US" xlink:label="lab_sny_ReportableGeographicalZonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable geographical zones</link:label>
    <link:label id="lab_sny_ReportableGeographicalZonesMember_label_en-US" xlink:label="lab_sny_ReportableGeographicalZonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable Geographical Zones [Member]</link:label>
    <link:label id="lab_sny_ReportableGeographicalZonesMember_documentation_en-US" xlink:label="lab_sny_ReportableGeographicalZonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable geographical zones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReportableGeographicalZonesMember" xlink:href="sny-20221231.xsd#sny_ReportableGeographicalZonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ReportableGeographicalZonesMember" xlink:to="lab_sny_ReportableGeographicalZonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_HeldtomaturityInvestments_e51a5da8-0f1a-4fee-bbc6-ca6beeccb905_terseLabel_en-US" xlink:label="lab_ifrs-full_HeldtomaturityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets held for investments</link:label>
    <link:label id="lab_ifrs-full_HeldtomaturityInvestments_label_en-US" xlink:label="lab_ifrs-full_HeldtomaturityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HeldtomaturityInvestments" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HeldtomaturityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HeldtomaturityInvestments" xlink:to="lab_ifrs-full_HeldtomaturityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_3e960dee-1ed8-4fbc-9695-04237a605643_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment losses, net of reversals</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock_d3edffff-28ca-4d45-b9f2-ce3138c5dcf1_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Tax Losses Available for Carry-forward</link:label>
    <link:label id="lab_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Availability Of Tax Losses Carry Forwards [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of availability of tax losses carry forwards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock" xlink:to="lab_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_NumberOfLeaseAgreementsSigned_dd145055-27ed-47b8-8a54-530bd58ac5bc_terseLabel_en-US" xlink:label="lab_sny_NumberOfLeaseAgreementsSigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lease agreements signed</link:label>
    <link:label id="lab_sny_NumberOfLeaseAgreementsSigned_label_en-US" xlink:label="lab_sny_NumberOfLeaseAgreementsSigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Lease Agreements Signed</link:label>
    <link:label id="lab_sny_NumberOfLeaseAgreementsSigned_documentation_en-US" xlink:label="lab_sny_NumberOfLeaseAgreementsSigned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Lease Agreements Signed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfLeaseAgreementsSigned" xlink:href="sny-20221231.xsd#sny_NumberOfLeaseAgreementsSigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfLeaseAgreementsSigned" xlink:to="lab_sny_NumberOfLeaseAgreementsSigned" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DerivativeFinancialAssetsMember_8a10d153-2b47-4f3c-b13f-07cfe2f00652_terseLabel_en-US" xlink:label="lab_sny_DerivativeFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial assets</link:label>
    <link:label id="lab_sny_DerivativeFinancialAssetsMember_label_en-US" xlink:label="lab_sny_DerivativeFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Assets [member]</link:label>
    <link:label id="lab_sny_DerivativeFinancialAssetsMember_documentation_en-US" xlink:label="lab_sny_DerivativeFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialAssetsMember" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerivativeFinancialAssetsMember" xlink:to="lab_sny_DerivativeFinancialAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_March2019EMTNISINFR0013409851Member_c2bd9283-d305-495d-b91e-640bbab1eb6c_terseLabel_en-US" xlink:label="lab_sny_March2019EMTNISINFR0013409851Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2019 EMTN ISIN FR0013409851</link:label>
    <link:label id="lab_sny_March2019EMTNISINFR0013409851Member_label_en-US" xlink:label="lab_sny_March2019EMTNISINFR0013409851Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2019 EMTN ISIN FR0013409851 [Member]</link:label>
    <link:label id="lab_sny_March2019EMTNISINFR0013409851Member_documentation_en-US" xlink:label="lab_sny_March2019EMTNISINFR0013409851Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2019 EMTN ISIN FR0013409851 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2019EMTNISINFR0013409851Member" xlink:href="sny-20221231.xsd#sny_March2019EMTNISINFR0013409851Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_March2019EMTNISINFR0013409851Member" xlink:to="lab_sny_March2019EMTNISINFR0013409851Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DepakineProductLitigationInBelgiumMember_6cfe6fc3-a504-4268-b73e-f26c63234f23_terseLabel_en-US" xlink:label="lab_sny_DepakineProductLitigationInBelgiumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine product litigation in Belgium</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInBelgiumMember_label_en-US" xlink:label="lab_sny_DepakineProductLitigationInBelgiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Belgium [Member]</link:label>
    <link:label id="lab_sny_DepakineProductLitigationInBelgiumMember_documentation_en-US" xlink:label="lab_sny_DepakineProductLitigationInBelgiumMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depakine Product Litigation In Belgium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInBelgiumMember" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInBelgiumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DepakineProductLitigationInBelgiumMember" xlink:to="lab_sny_DepakineProductLitigationInBelgiumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7ce282f3-0b6b-44ee-aeaf-8bf148977f04_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_056cae49-d5fc-4025-bccc-c3500699affa_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">List of principal companies included in the scope of consolidation during&#160;2022</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of subsidiaries [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets_94ab4c55-026e-453c-ab62-222009e30dbd_terseLabel_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets_label_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Transfers, Property, Plant and Equipment, Right Of Use Assets</link:label>
    <link:label id="lab_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets_documentation_en-US" xlink:label="lab_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Through Transfers, Property, Plant and Equipment, Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" xlink:to="lab_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ReclassificationFromNonCurrentToCurrent_edcf2337-8b73-46b8-befd-5f39502ed4e1_terseLabel_en-US" xlink:label="lab_sny_ReclassificationFromNonCurrentToCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from non-current to current</link:label>
    <link:label id="lab_sny_ReclassificationFromNonCurrentToCurrent_label_en-US" xlink:label="lab_sny_ReclassificationFromNonCurrentToCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification From Non Current To Current</link:label>
    <link:label id="lab_sny_ReclassificationFromNonCurrentToCurrent_documentation_en-US" xlink:label="lab_sny_ReclassificationFromNonCurrentToCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from non current to current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReclassificationFromNonCurrentToCurrent" xlink:href="sny-20221231.xsd#sny_ReclassificationFromNonCurrentToCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ReclassificationFromNonCurrentToCurrent" xlink:to="lab_sny_ReclassificationFromNonCurrentToCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiAventisAlgerieMember_6b89613f-fa23-4b4e-a9ef-e13cc38be3a0_terseLabel_en-US" xlink:label="lab_sny_SanofiAventisAlgerieMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Alg&#233;rie</link:label>
    <link:label id="lab_sny_SanofiAventisAlgerieMember_label_en-US" xlink:label="lab_sny_SanofiAventisAlgerieMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Aventis Algerie [member]</link:label>
    <link:label id="lab_sny_SanofiAventisAlgerieMember_documentation_en-US" xlink:label="lab_sny_SanofiAventisAlgerieMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi-Aventis Algerie.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisAlgerieMember" xlink:href="sny-20221231.xsd#sny_SanofiAventisAlgerieMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiAventisAlgerieMember" xlink:to="lab_sny_SanofiAventisAlgerieMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_2f7d322b-0d85-4c70-aec7-b1e4d3fdf0e4_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_label_en-US" xlink:label="lab_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Interest Rate Of Debt Net of Cash And Cash Equivalent [Line Items]</link:label>
    <link:label id="lab_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_documentation_en-US" xlink:label="lab_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of interest rate of debt net of cash and cash equivalents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems" xlink:to="lab_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashEquivalents_9a50a482-1904-4f67-9008-0fd71ad202bb_terseLabel_en-US" xlink:label="lab_ifrs-full_CashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashEquivalents_label_en-US" xlink:label="lab_ifrs-full_CashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashEquivalents" xlink:to="lab_ifrs-full_CashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_PrincipalMarketedProductsKadmonMember_12beee93-aa45-4efe-b913-18e984b1c28c_terseLabel_en-US" xlink:label="lab_sny_PrincipalMarketedProductsKadmonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kadmon</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsKadmonMember_label_en-US" xlink:label="lab_sny_PrincipalMarketedProductsKadmonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products Kadmon [Member]</link:label>
    <link:label id="lab_sny_PrincipalMarketedProductsKadmonMember_documentation_en-US" xlink:label="lab_sny_PrincipalMarketedProductsKadmonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Marketed Products Kadmon</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsKadmonMember" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsKadmonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalMarketedProductsKadmonMember" xlink:to="lab_sny_PrincipalMarketedProductsKadmonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_OpellaHealthcareItalySRLMember_8e73ab06-f442-4ef2-81f4-ac09f5b85a36_terseLabel_en-US" xlink:label="lab_sny_OpellaHealthcareItalySRLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Italy S.R.L.</link:label>
    <link:label id="lab_sny_OpellaHealthcareItalySRLMember_label_en-US" xlink:label="lab_sny_OpellaHealthcareItalySRLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Italy S.R.L. [Member]</link:label>
    <link:label id="lab_sny_OpellaHealthcareItalySRLMember_documentation_en-US" xlink:label="lab_sny_OpellaHealthcareItalySRLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opella Healthcare Italy S.R.L.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareItalySRLMember" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareItalySRLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaHealthcareItalySRLMember" xlink:to="lab_sny_OpellaHealthcareItalySRLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherCurrentFinancialAssets_8b6bca4f-bc28-40f3-9afc-37c5ebea3eab_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherCurrentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current financial assets</link:label>
    <link:label id="lab_ifrs-full_OtherCurrentFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_OtherCurrentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentFinancialAssets" xlink:to="lab_ifrs-full_OtherCurrentFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AllOtherSegmentsMember_7487f8ee-efb4-4969-8f48-420485deac76_verboseLabel_en-US" xlink:label="lab_ifrs-full_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_AllOtherSegmentsMember_label_en-US" xlink:label="lab_ifrs-full_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other segments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllOtherSegmentsMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AllOtherSegmentsMember" xlink:to="lab_ifrs-full_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember_764f352b-10e5-4b9b-b5bc-8e1a1d4cd954_terseLabel_en-US" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of profit or loss from commercialization of monoclonal antibodies</link:label>
    <link:label id="lab_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember_label_en-US" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Of Profit Or Loss From Commercialization Of Monoclonal Antibodies [Member]</link:label>
    <link:label id="lab_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember_documentation_en-US" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of profit or loss from commercialization of monoclonal antibodies member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xlink:href="sny-20221231.xsd#sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xlink:to="lab_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_8de37c03-9693-4cab-86d3-f55c994647d1_terseLabel_en-US" xlink:label="lab_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening balance before adjustment, cumulative effect at date of initial application [member]</link:label>
    <link:label id="lab_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_label_en-US" xlink:label="lab_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening balance before adjustment, cumulative effect at date of initial application [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember" xlink:to="lab_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock_7eeba66d-9b8b-4c90-824c-a99a28d551be_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Other Non-current Assets</link:label>
    <link:label id="lab_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Components Of Other Noncurrent Assets [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of components of other noncurrent assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock" xlink:to="lab_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock_38078926-02ef-4168-8289-d3e7ae7fe00b_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Reconciliation of Carrying Amount to Value on Redemption</link:label>
    <link:label id="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Table Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of reconciliation of carrying amount to value on redemption [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xlink:to="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_SanofiPasteurS.A.deC.V.Member_7662d115-ff29-479c-a5a0-7d7e3af9cc2f_terseLabel_en-US" xlink:label="lab_sny_SanofiPasteurS.A.deC.V.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur S.A. de C.V.</link:label>
    <link:label id="lab_sny_SanofiPasteurS.A.deC.V.Member_label_en-US" xlink:label="lab_sny_SanofiPasteurS.A.deC.V.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur S.A. de C.V. [Member]</link:label>
    <link:label id="lab_sny_SanofiPasteurS.A.deC.V.Member_documentation_en-US" xlink:label="lab_sny_SanofiPasteurS.A.deC.V.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Pasteur S.A. de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurS.A.deC.V.Member" xlink:href="sny-20221231.xsd#sny_SanofiPasteurS.A.deC.V.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiPasteurS.A.deC.V.Member" xlink:to="lab_sny_SanofiPasteurS.A.deC.V.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_MarketConditionAxis_00139160-d287-4eb0-9eae-f847bd08955a_terseLabel_en-US" xlink:label="lab_sny_MarketConditionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition [Axis]</link:label>
    <link:label id="lab_sny_MarketConditionAxis_label_en-US" xlink:label="lab_sny_MarketConditionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition [Axis]</link:label>
    <link:label id="lab_sny_MarketConditionAxis_documentation_en-US" xlink:label="lab_sny_MarketConditionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketConditionAxis" xlink:href="sny-20221231.xsd#sny_MarketConditionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MarketConditionAxis" xlink:to="lab_sny_MarketConditionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock_aa32e88c-42fc-4182-aca6-7f0033ced278_terseLabel_en-US" xlink:label="lab_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other gains and losses, and litigation</link:label>
    <link:label id="lab_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock_label_en-US" xlink:label="lab_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Other Gains And Losses, And Litigation [Text Block]</link:label>
    <link:label id="lab_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock_documentation_en-US" xlink:label="lab_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure of other gains and losses, and litigation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xlink:to="lab_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_CurrencyDerivativesFinancialMember_1bea5a2e-eba8-4ef2-9b72-fce657d6dec8_terseLabel_en-US" xlink:label="lab_sny_CurrencyDerivativesFinancialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">financial</link:label>
    <link:label id="lab_sny_CurrencyDerivativesFinancialMember_label_en-US" xlink:label="lab_sny_CurrencyDerivativesFinancialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Derivatives Financial [Member]</link:label>
    <link:label id="lab_sny_CurrencyDerivativesFinancialMember_documentation_en-US" xlink:label="lab_sny_CurrencyDerivativesFinancialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency derivatives, financial.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesFinancialMember" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesFinancialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrencyDerivativesFinancialMember" xlink:to="lab_sny_CurrencyDerivativesFinancialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_EmployeeBenefitsExpenseGain_78115c03-d0a8-4776-bc0a-8b54f95a46eb_terseLabel_en-US" xlink:label="lab_sny_EmployeeBenefitsExpenseGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense/(gain) for the period</link:label>
    <link:label id="lab_sny_EmployeeBenefitsExpenseGain_label_en-US" xlink:label="lab_sny_EmployeeBenefitsExpenseGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits Expense / (Gain)</link:label>
    <link:label id="lab_sny_EmployeeBenefitsExpenseGain_documentation_en-US" xlink:label="lab_sny_EmployeeBenefitsExpenseGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits Expense / (Gain)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeeBenefitsExpenseGain" xlink:href="sny-20221231.xsd#sny_EmployeeBenefitsExpenseGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EmployeeBenefitsExpenseGain" xlink:to="lab_sny_EmployeeBenefitsExpenseGain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_17586b15-bcf6-4019-8b98-1e4e74f3360d_terseLabel_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life, intangible assets other than goodwill (in years)</link:label>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock_39c87b3f-9850-44c5-83a9-dd3b0f4bf7d6_terseLabel_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income and expenses</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock_label_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Accounting Policy For Other Operating Income And Expenses Explanatory [Policy Text Block]</link:label>
    <link:label id="lab_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock_documentation_en-US" xlink:label="lab_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The description of the entity's accounting policy for other operating income and expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock" xlink:to="lab_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sny_FairValueOfSPMSDContingentConsiderationMember_f1d03d75-61b0-4060-bd84-ba37f445f0f0_terseLabel_en-US" xlink:label="lab_sny_FairValueOfSPMSDContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of SPMSD contingent consideration</link:label>
    <link:label id="lab_sny_FairValueOfSPMSDContingentConsiderationMember_label_en-US" xlink:label="lab_sny_FairValueOfSPMSDContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of SPMSD Contingent Consideration [Member]</link:label>
    <link:label id="lab_sny_FairValueOfSPMSDContingentConsiderationMember_documentation_en-US" xlink:label="lab_sny_FairValueOfSPMSDContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of SPMSD contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfSPMSDContingentConsiderationMember" xlink:href="sny-20221231.xsd#sny_FairValueOfSPMSDContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FairValueOfSPMSDContingentConsiderationMember" xlink:to="lab_sny_FairValueOfSPMSDContingentConsiderationMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>sny-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:89d6bfca-a5b4-4bcd-ad12-f1718d876f14,g:8278f0b1-e8dc-472d-9868-3f575a842a56-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sanofi.com/role/Coverpage" xlink:type="simple" xlink:href="sny-20221231.xsd#Coverpage"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Coverpage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f7136474-63dc-4185-9e72-604692854792" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_9a4f7623-68a8-4e1a-bd88-83a95f0a7e8b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f7136474-63dc-4185-9e72-604692854792" xlink:to="loc_dei_EntitiesTable_9a4f7623-68a8-4e1a-bd88-83a95f0a7e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_bee4769c-20c6-4351-a968-b6c152072937" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_9a4f7623-68a8-4e1a-bd88-83a95f0a7e8b" xlink:to="loc_dei_EntityListingsExchangeAxis_bee4769c-20c6-4351-a968-b6c152072937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_9b0e9151-ddc4-4f82-a1f0-360fa695edf4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_bee4769c-20c6-4351-a968-b6c152072937" xlink:to="loc_dei_ExchangeDomain_9b0e9151-ddc4-4f82-a1f0-360fa695edf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember_4bff1cfa-512a-4354-b79e-be25a5fbf11f" xlink:href="sny-20221231.xsd#sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_9b0e9151-ddc4-4f82-a1f0-360fa695edf4" xlink:to="loc_sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember_4bff1cfa-512a-4354-b79e-be25a5fbf11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OrdinarySharesNASDAQGlobalSelectMarketMember_3f51b6ef-ea5c-4187-b695-8efe11f084a7" xlink:href="sny-20221231.xsd#sny_OrdinarySharesNASDAQGlobalSelectMarketMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_9b0e9151-ddc4-4f82-a1f0-360fa695edf4" xlink:to="loc_sny_OrdinarySharesNASDAQGlobalSelectMarketMember_3f51b6ef-ea5c-4187-b695-8efe11f084a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_8834e814-e21d-4093-956d-8235ef6d8264" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_9a4f7623-68a8-4e1a-bd88-83a95f0a7e8b" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_8834e814-e21d-4093-956d-8235ef6d8264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_7b3da21b-1b49-4744-be0d-e9f14e72a6ff" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_8834e814-e21d-4093-956d-8235ef6d8264" xlink:to="loc_dei_AddressTypeDomain_7b3da21b-1b49-4744-be0d-e9f14e72a6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_d49a0285-0bc7-4ef7-b581-6f6983be2121" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_7b3da21b-1b49-4744-be0d-e9f14e72a6ff" xlink:to="loc_dei_BusinessContactMember_d49a0285-0bc7-4ef7-b581-6f6983be2121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_9a4f7623-68a8-4e1a-bd88-83a95f0a7e8b" xlink:to="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_529f5f1c-342a-43c9-ba23-08a295a2cf95" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentType_529f5f1c-342a-43c9-ba23-08a295a2cf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_243349d0-f52b-4b72-b7d6-94b3c469e502" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentRegistrationStatement_243349d0-f52b-4b72-b7d6-94b3c469e502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_0e02f9b2-b512-42b1-9a9f-172226249bd8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentAnnualReport_0e02f9b2-b512-42b1-9a9f-172226249bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f641740a-07b2-465d-a3e9-3e322c6cda83" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_CurrentFiscalYearEndDate_f641740a-07b2-465d-a3e9-3e322c6cda83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_aea99c0f-ab40-4429-a09a-b454c6318349" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentPeriodEndDate_aea99c0f-ab40-4429-a09a-b454c6318349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b0039123-5958-4804-a976-271132822a2d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentTransitionReport_b0039123-5958-4804-a976-271132822a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_ce8650e1-137a-4f55-8a2a-6b3a4cc5c2d0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentShellCompanyReport_ce8650e1-137a-4f55-8a2a-6b3a4cc5c2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_31ca8a00-f0b3-4e0d-b004-797e58eb82fd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityFileNumber_31ca8a00-f0b3-4e0d-b004-797e58eb82fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e1b22984-7bad-4c81-ac20-135dcc0eafb0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityRegistrantName_e1b22984-7bad-4c81-ac20-135dcc0eafb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b36aab4a-77a3-4143-b917-45a5d36b4da2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b36aab4a-77a3-4143-b917-45a5d36b4da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7bca2cdb-c29c-4271-8758-519fbc64b87a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityAddressAddressLine1_7bca2cdb-c29c-4271-8758-519fbc64b87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_572e43e7-01d2-468c-a5bc-f319c6dce856" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityAddressPostalZipCode_572e43e7-01d2-468c-a5bc-f319c6dce856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8563cfae-114d-4297-a3d5-a749fc61146f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityAddressCityOrTown_8563cfae-114d-4297-a3d5-a749fc61146f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_c6f20a75-1e8c-49df-baa3-1648e2c9b6c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityAddressCountry_c6f20a75-1e8c-49df-baa3-1648e2c9b6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_bd020b61-b367-4eea-aa04-04313b414890" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_ContactPersonnelName_bd020b61-b367-4eea-aa04-04313b414890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelFaxNumber_6acf2657-4cd5-4f03-acda-ad1d80c5b01c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelFaxNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_ContactPersonnelFaxNumber_6acf2657-4cd5-4f03-acda-ad1d80c5b01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4c8814a0-2bac-4eef-a7db-5de8336b9af9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_CityAreaCode_4c8814a0-2bac-4eef-a7db-5de8336b9af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f6393694-5190-4483-9d50-b512be2badc8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_LocalPhoneNumber_f6393694-5190-4483-9d50-b512be2badc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_acc9fd1c-9fc1-4cb2-8704-82f59e3beaa2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_Security12bTitle_acc9fd1c-9fc1-4cb2-8704-82f59e3beaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_685a6187-64af-4d1d-aa17-a489c1fe4c0e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_TradingSymbol_685a6187-64af-4d1d-aa17-a489c1fe4c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_14079a00-1a0a-4cf9-bdbd-62b681a7d534" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_SecurityExchangeName_14079a00-1a0a-4cf9-bdbd-62b681a7d534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a20e6267-ddcc-4222-a9be-f7d57a8eaa18" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a20e6267-ddcc-4222-a9be-f7d57a8eaa18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_82c22d02-9d49-4a68-93ce-511437d1c468" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_82c22d02-9d49-4a68-93ce-511437d1c468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_5a080330-6267-46d4-8e4e-ceaea19e4022" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityVoluntaryFilers_5a080330-6267-46d4-8e4e-ceaea19e4022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_591752c4-f115-45ee-988a-1bab4854cd94" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityCurrentReportingStatus_591752c4-f115-45ee-988a-1bab4854cd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_76d11622-85b1-4016-afd8-a45c683ddbdc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityInteractiveDataCurrent_76d11622-85b1-4016-afd8-a45c683ddbdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e42d40a4-b23e-47e4-bd02-2c81fca15a93" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityFilerCategory_e42d40a4-b23e-47e4-bd02-2c81fca15a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5b4e8075-0e6c-4459-8c04-4217c7bc2d5e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityEmergingGrowthCompany_5b4e8075-0e6c-4459-8c04-4217c7bc2d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_6bf01b8e-28db-413e-bb6f-55f7d9bf80ed" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_IcfrAuditorAttestationFlag_6bf01b8e-28db-413e-bb6f-55f7d9bf80ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_9e09335e-26c8-4a60-9857-bec57d1df985" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentAccountingStandard_9e09335e-26c8-4a60-9857-bec57d1df985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a7f60ad9-43e1-48be-b0f3-55a5a9af9997" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityShellCompany_a7f60ad9-43e1-48be-b0f3-55a5a9af9997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b039a9a1-f0f1-4973-9737-eb5649093915" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_AmendmentFlag_b039a9a1-f0f1-4973-9737-eb5649093915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_2034b215-4a96-4104-a8e1-bc892c355cf8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentFiscalYearFocus_2034b215-4a96-4104-a8e1-bc892c355cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_436cbbcb-1e77-4524-95c2-685bc2cc3adf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_436cbbcb-1e77-4524-95c2-685bc2cc3adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_842c614f-96d2-4b6e-a188-88e9b78019cc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc605770-d0cc-4a53-9e03-dd45c52e50e7" xlink:to="loc_dei_EntityCentralIndexKey_842c614f-96d2-4b6e-a188-88e9b78019cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/AuditInformation" xlink:type="simple" xlink:href="sny-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorInformationAbstract_9a5fc9ba-43ef-4aee-98cd-fa032a215c0c" xlink:href="sny-20221231.xsd#sny_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorTable_be0d0919-cef2-495e-b111-33110039f688" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AuditorInformationAbstract_9a5fc9ba-43ef-4aee-98cd-fa032a215c0c" xlink:to="loc_dei_AuditorTable_be0d0919-cef2-495e-b111-33110039f688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e86f849b-6f2d-4bf2-b1c8-7995de4d3889" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorTable_be0d0919-cef2-495e-b111-33110039f688" xlink:to="loc_srt_CounterpartyNameAxis_e86f849b-6f2d-4bf2-b1c8-7995de4d3889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_abaff4d0-ba92-4313-a9d2-855021a7c7ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e86f849b-6f2d-4bf2-b1c8-7995de4d3889" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_abaff4d0-ba92-4313-a9d2-855021a7c7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ErnstYoungEtAutresMember_73e85d8b-b979-493c-8bdf-9ff2bee87816" xlink:href="sny-20221231.xsd#sny_ErnstYoungEtAutresMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_abaff4d0-ba92-4313-a9d2-855021a7c7ed" xlink:to="loc_sny_ErnstYoungEtAutresMember_73e85d8b-b979-493c-8bdf-9ff2bee87816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLineItems_ccb16560-f991-42ce-84d5-6a75e0c5c161" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorTable_be0d0919-cef2-495e-b111-33110039f688" xlink:to="loc_dei_AuditorLineItems_ccb16560-f991-42ce-84d5-6a75e0c5c161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_f2596976-2f2d-4079-b658-d79aa1d83b0b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_ccb16560-f991-42ce-84d5-6a75e0c5c161" xlink:to="loc_dei_AuditorName_f2596976-2f2d-4079-b658-d79aa1d83b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_1e703cbe-95a5-44d5-90a9-75a904bc55bc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_ccb16560-f991-42ce-84d5-6a75e0c5c161" xlink:to="loc_dei_AuditorLocation_1e703cbe-95a5-44d5-90a9-75a904bc55bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_74fd520b-779f-4e08-8b55-c4730298bc72" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_ccb16560-f991-42ce-84d5-6a75e0c5c161" xlink:to="loc_dei_AuditorFirmId_74fd520b-779f-4e08-8b55-c4730298bc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedbalancesheets" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedbalancesheets"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Consolidatedbalancesheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_b12db690-e4f3-473d-9830-d45929821bfe" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_b12db690-e4f3-473d-9830-d45929821bfe" xlink:to="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_da2d37fa-80bf-4b72-a179-e03a75d0093c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_da2d37fa-80bf-4b72-a179-e03a75d0093c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_73321cf1-923a-4501-8915-6c40077668aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_RightofuseAssets_73321cf1-923a-4501-8915-6c40077668aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_6a2ef21d-9e26-4b44-b9e1-1385f56ded85" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_Goodwill_6a2ef21d-9e26-4b44-b9e1-1385f56ded85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_bd1b5237-dfd5-4126-861e-7e162c5c0db8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_bd1b5237-dfd5-4126-861e-7e162c5c0db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_3d61bafb-34bf-42dd-8b90-fd84136be033" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_3d61bafb-34bf-42dd-8b90-fd84136be033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_1c1eaaa0-9565-4314-93f5-13cac2ae7786" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_1c1eaaa0-9565-4314-93f5-13cac2ae7786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxAssetsNoncurrent_8850a392-696f-4ab1-8796-8f60424e745d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_CurrentTaxAssetsNoncurrent_8850a392-696f-4ab1-8796-8f60424e745d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_5d0cdf77-a03d-4262-9823-23e8da9bdac3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_DeferredTaxAssets_5d0cdf77-a03d-4262-9823-23e8da9bdac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_94e912e9-def9-452a-a7da-f08b876d282b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_NoncurrentAssets_94e912e9-def9-452a-a7da-f08b876d282b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_2d323f10-6f5d-4f0e-bca7-17d4bba1ec5b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_Inventories_2d323f10-6f5d-4f0e-bca7-17d4bba1ec5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTradeReceivables_2d5fc1f9-2421-47a7-9f43-25db7c54f89c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_CurrentTradeReceivables_2d5fc1f9-2421-47a7-9f43-25db7c54f89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentAssets_67307680-9b55-4d52-bf8d-bfb4ca4bea37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_OtherCurrentAssets_67307680-9b55-4d52-bf8d-bfb4ca4bea37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxAssetsCurrent_9594d046-ba3b-419a-a10b-4adf22fb08f5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxAssetsCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_CurrentTaxAssetsCurrent_9594d046-ba3b-419a-a10b-4adf22fb08f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_a2294e38-e372-4710-b522-163711718667" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_CashAndCashEquivalents_a2294e38-e372-4710-b522-163711718667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_fc1b43f9-d069-4fe3-bfb3-678271d60c96" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_fc1b43f9-d069-4fe3-bfb3-678271d60c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_544908d6-7a5c-4840-8472-5f82b679f5c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_544908d6-7a5c-4840-8472-5f82b679f5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_a03a1641-57a6-41f6-990d-d3bbda6ad117" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_a196c96d-4185-4346-8169-e5a1b202186f" xlink:to="loc_ifrs-full_Assets_a03a1641-57a6-41f6-990d-d3bbda6ad117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_b12db690-e4f3-473d-9830-d45929821bfe" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_9ac53319-3428-494a-a218-3e2b104191fd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParent_9ac53319-3428-494a-a218-3e2b104191fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterests_dca1b1ff-afec-441c-94d9-82149ca8e1b9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_NoncontrollingInterests_dca1b1ff-afec-441c-94d9-82149ca8e1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_44440630-ce51-4829-841c-a42c04f39ec8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_Equity_44440630-ce51-4829-841c-a42c04f39ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_2373eafb-ef9b-4e58-b96f-49b5ddb191b3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_LongtermBorrowings_2373eafb-ef9b-4e58-b96f-49b5ddb191b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_59137d80-fd6d-4cdc-80e6-50b5f72fa758" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_59137d80-fd6d-4cdc-80e6-50b5f72fa758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_8c590cff-ae7b-43a6-87ba-79c9d74b245a" xlink:href="sny-20221231.xsd#sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_8c590cff-ae7b-43a6-87ba-79c9d74b245a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_b65d9e73-2780-4916-8217-066bb68a98b1" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_b65d9e73-2780-4916-8217-066bb68a98b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_636c0318-7239-4594-9eba-3136a96a9f58" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_636c0318-7239-4594-9eba-3136a96a9f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_d2f0519e-6acf-4d3b-9642-e2a2b0c4596b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_d2f0519e-6acf-4d3b-9642-e2a2b0c4596b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_663d3f34-fec4-40f4-b147-b72d4bbeac6c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_NoncurrentLiabilities_663d3f34-fec4-40f4-b147-b72d4bbeac6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_37b4b02d-994d-458d-9570-cc12beee65cf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_37b4b02d-994d-458d-9570-cc12beee65cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_165ec963-d522-47d9-81ca-19817b8ddaf9" xlink:href="sny-20221231.xsd#sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_165ec963-d522-47d9-81ca-19817b8ddaf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_96227ad9-337f-4479-bec3-59780b3d5aed" xlink:href="sny-20221231.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_96227ad9-337f-4479-bec3-59780b3d5aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_898f34a2-8ee6-44e4-b237-dcf9272b1a1f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_898f34a2-8ee6-44e4-b237-dcf9272b1a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_d7155153-b478-45a4-9016-b14e9c7cd10b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_d7155153-b478-45a4-9016-b14e9c7cd10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_af41bf3a-fa30-4bed-b1ec-b97b087dbd69" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_af41bf3a-fa30-4bed-b1ec-b97b087dbd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_3b94c0ab-2345-4026-80bb-942a6d172c10" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_3b94c0ab-2345-4026-80bb-942a6d172c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_39ee728a-bd09-4580-a527-692ddc2d7ac6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_39ee728a-bd09-4580-a527-692ddc2d7ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities_a7806dac-300e-48ce-b851-e399e9228507" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_6823a103-c5e5-4389-9e99-c132b5caff1d" xlink:to="loc_ifrs-full_EquityAndLiabilities_a7806dac-300e-48ce-b851-e399e9228507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedincomestatements" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedincomestatements"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Consolidatedincomestatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_17aa21fb-5168-419d-a479-9c64214cc1f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_17aa21fb-5168-419d-a479-9c64214cc1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherRevenue_aafbbb8d-078b-4666-b24a-722d3dcd336e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_OtherRevenue_aafbbb8d-078b-4666-b24a-722d3dcd336e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_9cf00411-e489-4148-ac76-1135304a06ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_CostOfSales_9cf00411-e489-4148-ac76-1135304a06ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_977b31a7-039e-43b0-981a-f3e58c00185c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_GrossProfit_977b31a7-039e-43b0-981a-f3e58c00185c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_39929291-98c3-4d85-9b3f-a3badce6eb94" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_39929291-98c3-4d85-9b3f-a3badce6eb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_6169724c-a17a-4c60-9936-8fe94b8de251" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_6169724c-a17a-4c60-9936-8fe94b8de251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_0e0b65e3-9a62-414b-82c9-e8d18a72a6c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_0e0b65e3-9a62-414b-82c9-e8d18a72a6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_399b79e0-f676-47f1-b1aa-232f0e7241de" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_399b79e0-f676-47f1-b1aa-232f0e7241de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_154bc263-3cee-4fcb-8e60-2e1080765871" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_154bc263-3cee-4fcb-8e60-2e1080765871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_0cb65517-aa79-4c51-af17-7723012bdf7c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_0cb65517-aa79-4c51-af17-7723012bdf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_d88ed18c-af30-4cf7-a20e-f53092f82234" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_d88ed18c-af30-4cf7-a20e-f53092f82234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_1856ff31-afc1-49c2-834e-73ec365cab9c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseOfRestructuringActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_1856ff31-afc1-49c2-834e-73ec365cab9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGainsLossesAndLitigation_d26f66fa-5f78-4e95-8a61-22587dbeec0d" xlink:href="sny-20221231.xsd#sny_OtherGainsLossesAndLitigation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_sny_OtherGainsLossesAndLitigation_d26f66fa-5f78-4e95-8a61-22587dbeec0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnDisposalsOfInvestments_f9989d16-9294-4b11-9b78-2130eb3fbdf8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_GainsOnDisposalsOfInvestments_f9989d16-9294-4b11-9b78-2130eb3fbdf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_750ef857-acea-4e29-9376-da368cfc9299" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_750ef857-acea-4e29-9376-da368cfc9299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_823d12ef-8c4b-496d-b1ae-1ffb5de0d0ed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_FinanceCosts_823d12ef-8c4b-496d-b1ae-1ffb5de0d0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_990aadc9-baef-40a0-b977-c1e424187479" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_FinanceIncome_990aadc9-baef-40a0-b977-c1e424187479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_ce2f43c7-2004-4d33-b8b6-2610719b957a" xlink:href="sny-20221231.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_ce2f43c7-2004-4d33-b8b6-2610719b957a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_780f1d48-2133-4016-a3e7-d13d41dcef6d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_780f1d48-2133-4016-a3e7-d13d41dcef6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_6202b05f-2c7b-4d84-8639-daa7014301be" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_6202b05f-2c7b-4d84-8639-daa7014301be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_d924e165-ee29-4e2b-b40d-add21bf14ce9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_ProfitLoss_d924e165-ee29-4e2b-b40d-add21bf14ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_8b52f8c9-4c70-4b79-83d0-a7811380f35f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_8b52f8c9-4c70-4b79-83d0-a7811380f35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_58628ec4-bba8-4bb7-b758-9f1b132f0559" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_58628ec4-bba8-4bb7-b758-9f1b132f0559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares_465bcbc8-11ef-45d1-a6b7-9e987cd069b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_WeightedAverageShares_465bcbc8-11ef-45d1-a6b7-9e987cd069b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_2f952c5d-38e3-4757-9577-ce37b16a7601" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_2f952c5d-38e3-4757-9577-ce37b16a7601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent_f82cb1be-1056-475e-8212-7350682da6eb" xlink:href="sny-20221231.xsd#sny_BasicEarningsLossPerShareAttributableToOwnersOfParent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent_f82cb1be-1056-475e-8212-7350682da6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent_66ca0d26-07d1-4874-8650-a43245cf0137" xlink:href="sny-20221231.xsd#sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_78464227-86ea-4ca8-8933-8b7cec085437" xlink:to="loc_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent_66ca0d26-07d1-4874-8650-a43245cf0137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedincomestatements_1" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedincomestatements_1"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Consolidatedincomestatements_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedstatementsofcomprehensiveincome"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_9c0d6a93-e6a8-49f0-b02b-8e7895b361a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_2f42c04b-ce9c-4c51-9885-5908169c260f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_9c0d6a93-e6a8-49f0-b02b-8e7895b361a1" xlink:to="loc_ifrs-full_ProfitLoss_2f42c04b-ce9c-4c51-9885-5908169c260f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_831c1869-c1ac-4c45-b8bb-20321faaa3f8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_9c0d6a93-e6a8-49f0-b02b-8e7895b361a1" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_831c1869-c1ac-4c45-b8bb-20321faaa3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_fef5b26b-d438-4092-8432-cf48465270a0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_9c0d6a93-e6a8-49f0-b02b-8e7895b361a1" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_fef5b26b-d438-4092-8432-cf48465270a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_9c0d6a93-e6a8-49f0-b02b-8e7895b361a1" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_547ad9c5-3683-4071-b426-cb58cdaf616b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_547ad9c5-3683-4071-b426-cb58cdaf616b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments_b59e3890-30b8-4d0a-b467-70bbc169f0a5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:to="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments_b59e3890-30b8-4d0a-b467-70bbc169f0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss_3a936b0a-b3e7-4f37-bd1e-99e653254249" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:to="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss_3a936b0a-b3e7-4f37-bd1e-99e653254249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_1bbc34a7-fab0-46d9-9cee-bf4861fc7dea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_1bbc34a7-fab0-46d9-9cee-bf4861fc7dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax_50f1058d-6498-4048-b08d-3ae2bf42bd70" xlink:href="sny-20221231.xsd#sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:to="loc_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax_50f1058d-6498-4048-b08d-3ae2bf42bd70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_64704a8f-ddb6-49e2-b83f-253d50e518f5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_64704a8f-ddb6-49e2-b83f-253d50e518f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_66508404-a8cc-4934-a5d8-ced003daf8e4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_66508404-a8cc-4934-a5d8-ced003daf8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss_8b9f54d6-a319-4c16-bab4-bcfa4c3ce527" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:to="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss_8b9f54d6-a319-4c16-bab4-bcfa4c3ce527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_c9aa1899-8305-42a1-93e3-125e88a69c23" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_c9aa1899-8305-42a1-93e3-125e88a69c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_808aa427-cb42-4eb8-b93b-dcef5e550dd2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_b21dabfc-ce85-4da8-97d7-427387068648" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_808aa427-cb42-4eb8-b93b-dcef5e550dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_224350e7-ed07-4dc9-9ccc-3deb36f24edd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_9c0d6a93-e6a8-49f0-b02b-8e7895b361a1" xlink:to="loc_ifrs-full_ComprehensiveIncome_224350e7-ed07-4dc9-9ccc-3deb36f24edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_2f9d0e69-cd93-4a87-ae58-0647344f64d8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_9c0d6a93-e6a8-49f0-b02b-8e7895b361a1" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_2f9d0e69-cd93-4a87-ae58-0647344f64d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_edf9a176-964f-4e85-b2c7-f30eed7de14c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_9c0d6a93-e6a8-49f0-b02b-8e7895b361a1" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_edf9a176-964f-4e85-b2c7-f30eed7de14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome_1" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedstatementsofcomprehensiveincome_1"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedstatementsofchangesinequity"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_10e366df-d0cd-4b83-9b06-8964ef5f9728" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_3b551846-c7dd-42a1-ae0b-3db6f67eea98" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_10e366df-d0cd-4b83-9b06-8964ef5f9728" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_3b551846-c7dd-42a1-ae0b-3db6f67eea98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_09c7a031-da2d-4359-8965-5ff22416a27d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_3b551846-c7dd-42a1-ae0b-3db6f67eea98" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_09c7a031-da2d-4359-8965-5ff22416a27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_d266956a-33e2-4182-a0fb-8f7e57838515" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_09c7a031-da2d-4359-8965-5ff22416a27d" xlink:to="loc_ifrs-full_EquityMember_d266956a-33e2-4182-a0fb-8f7e57838515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_d266956a-33e2-4182-a0fb-8f7e57838515" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_4b00b8c2-6323-4e0c-8f1d-06553c20918c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_IssuedCapitalMember_4b00b8c2-6323-4e0c-8f1d-06553c20918c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionalPaidinCapitalMember_2d82cccd-ea79-4bb0-917d-b1f626701134" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalPaidinCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_AdditionalPaidinCapitalMember_2d82cccd-ea79-4bb0-917d-b1f626701134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasurySharesMember_28a090d1-e7bb-4e80-a20e-2e188ad3fadb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_TreasurySharesMember_28a090d1-e7bb-4e80-a20e-2e188ad3fadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember_3dc8d3af-ef35-4f2a-b702-26115e7f591e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_RetainedEarningsMember_3dc8d3af-ef35-4f2a-b702-26115e7f591e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_66ff9fd7-2bfc-4f5f-9cec-0f8d4fc4c316" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_66ff9fd7-2bfc-4f5f-9cec-0f8d4fc4c316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_9a113a37-bb86-4e79-b9ff-2b0a16e8a4a9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_d5c254fb-61a5-42ac-bf97-b560028375c9" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_9a113a37-bb86-4e79-b9ff-2b0a16e8a4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_f9719c75-be5a-40b5-8bf7-28b08db8a8a3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_d266956a-33e2-4182-a0fb-8f7e57838515" xlink:to="loc_ifrs-full_NoncontrollingInterestsMember_f9719c75-be5a-40b5-8bf7-28b08db8a8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_3b551846-c7dd-42a1-ae0b-3db6f67eea98" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_35dfc4b2-80b9-427e-9211-ab826399643b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_Equity_35dfc4b2-80b9-427e-9211-ab826399643b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_2466268d-6d0a-4d14-a2c3-a08372da93ec" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_2466268d-6d0a-4d14-a2c3-a08372da93ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_8792ccd5-a9d4-47e8-90e3-212f81aad691" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_ProfitLoss_8792ccd5-a9d4-47e8-90e3-212f81aad691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_f1b6e73f-1010-4fa7-b730-a1661bd26bf9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_ComprehensiveIncome_f1b6e73f-1010-4fa7-b730-a1661bd26bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent_ce1d338b-328a-4d1c-960d-21e9b17315ea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent_ce1d338b-328a-4d1c-960d-21e9b17315ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_bddd4f81-42e7-4aef-98c1-316f1925dad7" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_bddd4f81-42e7-4aef-98c1-316f1925dad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_73c3eab5-deb6-4321-9d0f-ba8f638e389c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_73c3eab5-deb6-4321-9d0f-ba8f638e389c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_ceb496c2-781a-41e2-bfbd-1c4588daa577" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfTreasuryShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_PurchaseOfTreasuryShares_ceb496c2-781a-41e2-bfbd-1c4588daa577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReductionOfIssuedCapital_acaf149f-32e3-4295-b1f9-e61b76407ca0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReductionOfIssuedCapital"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_ReductionOfIssuedCapital_acaf149f-32e3-4295-b1f9-e61b76407ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:href="sny-20221231.xsd#sny_ShareBasedPaymentPlansAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_b07d18f5-5c89-40e3-89f8-a65b6702b827" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_b07d18f5-5c89-40e3-89f8-a65b6702b827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares_943a51e9-1fdb-41ee-8b28-90c3c3a46043" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares_943a51e9-1fdb-41ee-8b28-90c3c3a46043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans_9d47f2d0-aae2-4cf6-ad29-2f2250d1fefc" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans_9d47f2d0-aae2-4cf6-ad29-2f2250d1fefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees_fe914619-5d2d-4787-9d78-f24220d2a2ab" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees_fe914619-5d2d-4787-9d78-f24220d2a2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions_66a8f83a-7075-4512-9424-0df5aace515e" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_8d3645a7-545a-42b1-a618-5a70bcc176b7" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions_66a8f83a-7075-4512-9424-0df5aace515e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity_03b506af-94c7-4bf9-9af6-658e9b1c0145" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity_03b506af-94c7-4bf9-9af6-658e9b1c0145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity_53121711-a54c-449f-8bdb-64801e31048e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity_53121711-a54c-449f-8bdb-64801e31048e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment_9bc351a8-93c8-4a9e-9f3a-a65327d5051f" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment_9bc351a8-93c8-4a9e-9f3a-a65327d5051f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_b116710f-d132-4c55-9cff-e1bc1e2198d5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_ac9eec24-ace1-4490-b76a-b6e88083a64b" xlink:to="loc_ifrs-full_Equity_b116710f-d132-4c55-9cff-e1bc1e2198d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedstatementsofchangesinequityParenthetical"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_d32e9169-5f27-49fe-90be-cb8fe5ce4810" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_f91cffed-2578-4ffb-be7b-52881b9d8867" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_d32e9169-5f27-49fe-90be-cb8fe5ce4810" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_f91cffed-2578-4ffb-be7b-52881b9d8867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7da8b6cf-976d-4401-b5ed-157c58bc9900" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_f91cffed-2578-4ffb-be7b-52881b9d8867" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7da8b6cf-976d-4401-b5ed-157c58bc9900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_14c1a128-ab2f-42b1-9771-599e78c147b3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7da8b6cf-976d-4401-b5ed-157c58bc9900" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_14c1a128-ab2f-42b1-9771-599e78c147b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_5b35cc12-560c-4387-bd2f-9320b2c821d7" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_14c1a128-ab2f-42b1-9771-599e78c147b3" xlink:to="loc_sny_EuroapiMember_5b35cc12-560c-4387-bd2f-9320b2c821d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1c868d05-9384-4cb9-9b00-187fdf10c4c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_f91cffed-2578-4ffb-be7b-52881b9d8867" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1c868d05-9384-4cb9-9b00-187fdf10c4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_e3f2dae7-4873-4988-9755-279242b18e37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1c868d05-9384-4cb9-9b00-187fdf10c4c3" xlink:to="loc_ifrs-full_EquityMember_e3f2dae7-4873-4988-9755-279242b18e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember_4a9bf2b2-ad76-4af4-8493-f1828b36906e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_e3f2dae7-4873-4988-9755-279242b18e37" xlink:to="loc_ifrs-full_RetainedEarningsMember_4a9bf2b2-ad76-4af4-8493-f1828b36906e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_4f92762a-a537-4d22-af04-26064deee5f9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_e3f2dae7-4873-4988-9755-279242b18e37" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_4f92762a-a537-4d22-af04-26064deee5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_30d73e70-0b86-4d33-b491-3d993ab8da5c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_f91cffed-2578-4ffb-be7b-52881b9d8867" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_30d73e70-0b86-4d33-b491-3d993ab8da5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare_f9517305-c4c8-42e6-b587-b040862cd568" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_30d73e70-0b86-4d33-b491-3d993ab8da5c" xlink:to="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare_f9517305-c4c8-42e6-b587-b040862cd568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital_fb76be0f-2d3e-4fda-b4e8-453198e71e81" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendPercentageOfShareCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_30d73e70-0b86-4d33-b491-3d993ab8da5c" xlink:to="loc_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital_fb76be0f-2d3e-4fda-b4e8-453198e71e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_e517da76-d7fb-4107-89f2-3f36b9cd922f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_30d73e70-0b86-4d33-b491-3d993ab8da5c" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_e517da76-d7fb-4107-89f2-3f36b9cd922f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedstatementsofcashflows" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedstatementsofcashflows"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Consolidatedstatementsofcashflows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_0e98b611-7b2d-4c07-8216-405aabc705a3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0e98b611-7b2d-4c07-8216-405aabc705a3" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_fb970061-78cf-488f-8784-3faa913ed911" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_fb970061-78cf-488f-8784-3faa913ed911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_65b05a7a-2b17-4994-ab0a-536308bdd2ba" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_65b05a7a-2b17-4994-ab0a-536308bdd2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod_c89efc05-c2e1-4a5c-8417-66fae9d7c175" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod_c89efc05-c2e1-4a5c-8417-66fae9d7c175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset_91fed9e7-5b7b-49a5-8149-5aca85a15ea2" xlink:href="sny-20221231.xsd#sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset_91fed9e7-5b7b-49a5-8149-5aca85a15ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_4a2b73f2-4580-426a-992c-af0c0ac36cb3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_4a2b73f2-4580-426a-992c-af0c0ac36cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_e5166eff-8b3d-41fd-8497-da434297b707" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_e5166eff-8b3d-41fd-8497-da434297b707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_43a92acd-976b-4bd1-a834-134afe2691d2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_43a92acd-976b-4bd1-a834-134afe2691d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities_5412bcef-e609-428b-8367-23f3d11e212a" xlink:href="sny-20221231.xsd#sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities_5412bcef-e609-428b-8367-23f3d11e212a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_07393383-385b-4918-8e91-ff49f8c4f8d2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_07393383-385b-4918-8e91-ff49f8c4f8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue_3a26b87c-1ad4-4142-93cc-ea3d52dbe6df" xlink:href="sny-20221231.xsd#sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue_3a26b87c-1ad4-4142-93cc-ea3d52dbe6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_b41c5f8d-30aa-4f35-9cfa-1ee5c4f74593" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_b41c5f8d-30aa-4f35-9cfa-1ee5c4f74593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_9b2dbaad-8815-4626-ad09-8135e56d85e0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_7e94d15a-448f-48e5-9929-4f292eb5672c" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_9b2dbaad-8815-4626-ad09-8135e56d85e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2b49a862-77c6-45cf-9946-dd086c0f0c37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0e98b611-7b2d-4c07-8216-405aabc705a3" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2b49a862-77c6-45cf-9946-dd086c0f0c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_3d15fa33-ff5f-410e-8561-1c54cb694fb8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2b49a862-77c6-45cf-9946-dd086c0f0c37" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_3d15fa33-ff5f-410e-8561-1c54cb694fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_c2f32926-5a5b-4af9-a9fa-e79d4be1fa6e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2b49a862-77c6-45cf-9946-dd086c0f0c37" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_c2f32926-5a5b-4af9-a9fa-e79d4be1fa6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_0395847b-f77c-43da-b847-a67508a69a96" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2b49a862-77c6-45cf-9946-dd086c0f0c37" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_0395847b-f77c-43da-b847-a67508a69a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities_380cd656-2ba1-4e25-9c2c-730fa989dfab" xlink:href="sny-20221231.xsd#sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2b49a862-77c6-45cf-9946-dd086c0f0c37" xlink:to="loc_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities_380cd656-2ba1-4e25-9c2c-730fa989dfab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_fad7313e-6302-4e7e-a595-1f124420ae26" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2b49a862-77c6-45cf-9946-dd086c0f0c37" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_fad7313e-6302-4e7e-a595-1f124420ae26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_e7c25e56-9547-46d4-a6c1-95928668162d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0e98b611-7b2d-4c07-8216-405aabc705a3" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_e7c25e56-9547-46d4-a6c1-95928668162d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_9a6159e4-c783-4389-8625-3a1bda5bf8fa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_e7c25e56-9547-46d4-a6c1-95928668162d" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_9a6159e4-c783-4389-8625-3a1bda5bf8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_d7ab32ff-127a-4447-93e9-ad9c001b32f3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_e7c25e56-9547-46d4-a6c1-95928668162d" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_d7ab32ff-127a-4447-93e9-ad9c001b32f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_ec31442c-295d-49e4-9813-e12a46862a58" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_e7c25e56-9547-46d4-a6c1-95928668162d" xlink:to="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_ec31442c-295d-49e4-9813-e12a46862a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_9fb68199-415e-44f1-8bd4-8b7fe2814742" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_e7c25e56-9547-46d4-a6c1-95928668162d" xlink:to="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_9fb68199-415e-44f1-8bd4-8b7fe2814742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_96aaf61a-5e8e-41a7-9e2c-fa76818fbed7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_e7c25e56-9547-46d4-a6c1-95928668162d" xlink:to="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_96aaf61a-5e8e-41a7-9e2c-fa76818fbed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_b6a0ff2e-ae18-4288-a721-3adb5893a5a4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_e7c25e56-9547-46d4-a6c1-95928668162d" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_b6a0ff2e-ae18-4288-a721-3adb5893a5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetChangeInOtherNonCurrentAssets_8c591ec4-b003-4445-8803-f12dd6b2c3c3" xlink:href="sny-20221231.xsd#sny_NetChangeInOtherNonCurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_e7c25e56-9547-46d4-a6c1-95928668162d" xlink:to="loc_sny_NetChangeInOtherNonCurrentAssets_8c591ec4-b003-4445-8803-f12dd6b2c3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_3921e152-bf0d-48b3-96e7-7ea8acebae4f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_e7c25e56-9547-46d4-a6c1-95928668162d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_3921e152-bf0d-48b3-96e7-7ea8acebae4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1a40a838-6dbf-42e9-b8c2-925c8585db07" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0e98b611-7b2d-4c07-8216-405aabc705a3" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1a40a838-6dbf-42e9-b8c2-925c8585db07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_5d9dd4f6-29a0-4c1a-89dd-1bfd230620d1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1a40a838-6dbf-42e9-b8c2-925c8585db07" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_5d9dd4f6-29a0-4c1a-89dd-1bfd230620d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DividendsPaidAbstract_1c5e775a-592a-4cd9-8161-c7b2aa8a933d" xlink:href="sny-20221231.xsd#sny_DividendsPaidAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1a40a838-6dbf-42e9-b8c2-925c8585db07" xlink:to="loc_sny_DividendsPaidAbstract_1c5e775a-592a-4cd9-8161-c7b2aa8a933d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_519b33c1-467b-4f40-89a2-c4023c5ed66e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DividendsPaidAbstract_1c5e775a-592a-4cd9-8161-c7b2aa8a933d" xlink:to="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_519b33c1-467b-4f40-89a2-c4023c5ed66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_1425c418-9260-4b89-bd6b-91f100ba0739" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DividendsPaidAbstract_1c5e775a-592a-4cd9-8161-c7b2aa8a933d" xlink:to="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_1425c418-9260-4b89-bd6b-91f100ba0739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_f0cdce7f-694c-4a1d-b7e7-ec78fe5cdc71" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1a40a838-6dbf-42e9-b8c2-925c8585db07" xlink:to="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_f0cdce7f-694c-4a1d-b7e7-ec78fe5cdc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_5988c1ba-7f68-45d7-b2a3-094695b57221" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1a40a838-6dbf-42e9-b8c2-925c8585db07" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_5988c1ba-7f68-45d7-b2a3-094695b57221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_8a73c3c5-d39a-4558-95c9-5a571755df09" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1a40a838-6dbf-42e9-b8c2-925c8585db07" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_8a73c3c5-d39a-4558-95c9-5a571755df09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_20536900-ef54-4986-b221-d4e58240211b" xlink:href="sny-20221231.xsd#sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1a40a838-6dbf-42e9-b8c2-925c8585db07" xlink:to="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_20536900-ef54-4986-b221-d4e58240211b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_5b45da69-d25f-480b-9b6e-fa6c450427ad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1a40a838-6dbf-42e9-b8c2-925c8585db07" xlink:to="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_5b45da69-d25f-480b-9b6e-fa6c450427ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_0cf72c39-f758-429b-bf0b-b591fb00239e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1a40a838-6dbf-42e9-b8c2-925c8585db07" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_0cf72c39-f758-429b-bf0b-b591fb00239e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_7e38d627-edf7-4b84-a621-ddbb1fda8cef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0e98b611-7b2d-4c07-8216-405aabc705a3" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_7e38d627-edf7-4b84-a621-ddbb1fda8cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_22a97c07-7580-47ca-96dd-458f86307ff3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0e98b611-7b2d-4c07-8216-405aabc705a3" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_22a97c07-7580-47ca-96dd-458f86307ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_8a5f2aaa-86b8-4e0d-84a0-549b749fb983" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0e98b611-7b2d-4c07-8216-405aabc705a3" xlink:to="loc_ifrs-full_CashAndCashEquivalents_8a5f2aaa-86b8-4e0d-84a0-549b749fb983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_2ecd2827-bfdc-4305-9690-5173407c45ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0e98b611-7b2d-4c07-8216-405aabc705a3" xlink:to="loc_ifrs-full_CashAndCashEquivalents_2ecd2827-bfdc-4305-9690-5173407c45ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedstatementsofcashflowsParenthetical"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_faec1748-f894-4c53-86c0-c11e1cec596e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedCashFlowStatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_faec1748-f894-4c53-86c0-c11e1cec596e" xlink:to="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1fdba80e-5a2d-474a-a2dd-7d1dca1f3c1a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1fdba80e-5a2d-474a-a2dd-7d1dca1f3c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_4550b102-b864-4f3e-a4a2-a059f2dc395f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_1fdba80e-5a2d-474a-a2dd-7d1dca1f3c1a" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_4550b102-b864-4f3e-a4a2-a059f2dc395f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_705e0bcb-3410-42a2-ac1c-e7d8281669e9" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_4550b102-b864-4f3e-a4a2-a059f2dc395f" xlink:to="loc_sny_RegeneronMember_705e0bcb-3410-42a2-ac1c-e7d8281669e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_60e95382-6489-40a8-8304-73a1664d086b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_60e95382-6489-40a8-8304-73a1664d086b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_5b55a256-9872-487f-8a03-4d371b276a7f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_60e95382-6489-40a8-8304-73a1664d086b" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_5b55a256-9872-487f-8a03-4d371b276a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationRelatingToDivestmentsMember_21b5c876-a67f-4004-b587-1bb7528b4966" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationRelatingToDivestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_5b55a256-9872-487f-8a03-4d371b276a7f" xlink:to="loc_sny_ContingentConsiderationRelatingToDivestmentsMember_21b5c876-a67f-4004-b587-1bb7528b4966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_76f0f339-1be2-4bcb-906a-4158c8bd0339" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:to="loc_srt_ProductOrServiceAxis_76f0f339-1be2-4bcb-906a-4158c8bd0339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8af27df2-44ed-4b98-95ff-3d872c424bdd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_76f0f339-1be2-4bcb-906a-4158c8bd0339" xlink:to="loc_srt_ProductsAndServicesDomain_8af27df2-44ed-4b98-95ff-3d872c424bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsMember_bb6497f6-616a-4b0f-acf1-705160dfd4de" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8af27df2-44ed-4b98-95ff-3d872c424bdd" xlink:to="loc_sny_PharmaceuticalsMember_bb6497f6-616a-4b0f-acf1-705160dfd4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareMember_e7cd9a20-318d-4660-b6cb-1c291eeba09c" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8af27df2-44ed-4b98-95ff-3d872c424bdd" xlink:to="loc_sny_ConsumerHealthcareMember_e7cd9a20-318d-4660-b6cb-1c291eeba09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SeprafilmMember_db4c0a63-73aa-489b-bba6-af5569a11d8d" xlink:href="sny-20221231.xsd#sny_SeprafilmMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8af27df2-44ed-4b98-95ff-3d872c424bdd" xlink:to="loc_sny_SeprafilmMember_db4c0a63-73aa-489b-bba6-af5569a11d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7c46b619-6ca4-432f-87c7-72c3b4a4bc04" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7c46b619-6ca4-432f-87c7-72c3b4a4bc04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1487d627-86b4-4639-bde8-dc0b87bce7d1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_7c46b619-6ca4-432f-87c7-72c3b4a4bc04" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1487d627-86b4-4639-bde8-dc0b87bce7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_c462eba3-3463-404c-a508-038bfbc1078e" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1487d627-86b4-4639-bde8-dc0b87bce7d1" xlink:to="loc_sny_EuroapiMember_c462eba3-3463-404c-a508-038bfbc1078e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_a5ab0947-cb3d-49a9-9c76-08fd6964de42" xlink:to="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax_8a87a5e3-87b7-4799-a16c-23810797a4c1" xlink:href="sny-20221231.xsd#sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax_8a87a5e3-87b7-4799-a16c-23810797a4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_47c6800d-1b74-494a-8e68-3050d81e2cc5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_47c6800d-1b74-494a-8e68-3050d81e2cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_35945a68-2595-4560-8f7e-1d8e568ed460" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_35945a68-2595-4560-8f7e-1d8e568ed460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_36bbc175-2d1c-4ae0-acb6-6832cb80ffe4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_36bbc175-2d1c-4ae0-acb6-6832cb80ffe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities_82bd0c49-8bf9-4b57-815f-96d1ea8b50bd" xlink:href="sny-20221231.xsd#sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities_82bd0c49-8bf9-4b57-815f-96d1ea8b50bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_cb24c486-0509-46e5-8d77-c75b4fb88583" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_cb24c486-0509-46e5-8d77-c75b4fb88583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_6a90c5dd-2c4d-469a-b7cb-5b06861753c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_4e6e99df-f005-49de-9850-95423c789be5" xlink:to="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_6a90c5dd-2c4d-469a-b7cb-5b06861753c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Introduction" xlink:type="simple" xlink:href="sny-20221231.xsd#Introduction"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Introduction" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_GeneralInformationAboutFinancialStatementsAbstract_6227620a-407d-4f27-8950-56e71e6628f6" xlink:href="sny-20221231.xsd#sny_GeneralInformationAboutFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1f6cd446-fd54-454d-b9a6-01c29a67b0c0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_GeneralInformationAboutFinancialStatementsAbstract_6227620a-407d-4f27-8950-56e71e6628f6" xlink:to="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1f6cd446-fd54-454d-b9a6-01c29a67b0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Basisofpreparation" xlink:type="simple" xlink:href="sny-20221231.xsd#Basisofpreparation"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Basisofpreparation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_37d61e4e-0ad2-438f-be08-8f9eb8bda2b3" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_d02941dd-5ad0-4dbf-838e-476f461acab6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_37d61e4e-0ad2-438f-be08-8f9eb8bda2b3" xlink:to="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_d02941dd-5ad0-4dbf-838e-476f461acab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Summaryofsignificantaccountingpolicies" xlink:type="simple" xlink:href="sny-20221231.xsd#Summaryofsignificantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Summaryofsignificantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_68ac4508-75de-4915-95cf-4f777ab34061" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_128348ce-6bb5-46a9-83af-2a25592fb93a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_68ac4508-75de-4915-95cf-4f777ab34061" xlink:to="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_128348ce-6bb5-46a9-83af-2a25592fb93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalalliances" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalalliances"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Principalalliances" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_RelatedPartyAbstract_eb51833a-5080-4441-8dd0-0e78bb038db2" xlink:href="sny-20221231.xsd#sny_RelatedPartyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPrincipalAlliancesTextBlock_5030d0f4-506d-46c0-96b7-bc13ccf38bf4" xlink:href="sny-20221231.xsd#sny_DisclosureOfPrincipalAlliancesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_eb51833a-5080-4441-8dd0-0e78bb038db2" xlink:to="loc_sny_DisclosureOfPrincipalAlliancesTextBlock_5030d0f4-506d-46c0-96b7-bc13ccf38bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2022"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_426bad18-96a1-4a1d-a4ee-ea7c34a12f08" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock_20bfd06d-7ca5-44c3-87c6-abcc8ffc6858" xlink:href="sny-20221231.xsd#sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_426bad18-96a1-4a1d-a4ee-ea7c34a12f08" xlink:to="loc_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock_20bfd06d-7ca5-44c3-87c6-abcc8ffc6858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2021and2020"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_b324ed51-99f6-4f1d-a015-abb79385e28c" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock_1b4df3ef-74dc-4b73-b61b-33ec1322e862" xlink:href="sny-20221231.xsd#sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_b324ed51-99f6-4f1d-a015-abb79385e28c" xlink:to="loc_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock_1b4df3ef-74dc-4b73-b61b-33ec1322e862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Propertyplantandequipment" xlink:type="simple" xlink:href="sny-20221231.xsd#Propertyplantandequipment"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Propertyplantandequipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_ca2457d8-7f6c-47d3-a8ad-8722914a5835" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_cf7c7a53-33fc-4e90-8d30-c4a8671e2b29" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_ca2457d8-7f6c-47d3-a8ad-8722914a5835" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_cf7c7a53-33fc-4e90-8d30-c4a8671e2b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Goodwillandotherintangibleassets" xlink:type="simple" xlink:href="sny-20221231.xsd#Goodwillandotherintangibleassets"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Goodwillandotherintangibleassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_f450f4cf-1e1a-4eae-a2b5-734d16bc914b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_d9498050-11a6-46d5-bd82-5d9ceaf24315" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_f450f4cf-1e1a-4eae-a2b5-734d16bc914b" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_d9498050-11a6-46d5-bd82-5d9ceaf24315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Impairmentofintangibleassetsandpropertyplantandequipment" xlink:type="simple" xlink:href="sny-20221231.xsd#Impairmentofintangibleassetsandpropertyplantandequipment"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Impairmentofintangibleassetsandpropertyplantandequipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentOfAssetsAbstract_b58e38f1-3800-4507-bf6f-b717b3833323" xlink:href="sny-20221231.xsd#sny_ImpairmentOfAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock_a2a80816-84bc-4daa-99b7-a3bfc10e3d3c" xlink:href="sny-20221231.xsd#sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ImpairmentOfAssetsAbstract_b58e38f1-3800-4507-bf6f-b717b3833323" xlink:to="loc_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock_a2a80816-84bc-4daa-99b7-a3bfc10e3d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Investmentsaccountedforusingtheequitymethod" xlink:type="simple" xlink:href="sny-20221231.xsd#Investmentsaccountedforusingtheequitymethod"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Investmentsaccountedforusingtheequitymethod" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_bee687f5-f695-4f48-83e2-d202f19b0b39" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_b0fae707-5f87-4591-bfc4-96a330dd322e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_bee687f5-f695-4f48-83e2-d202f19b0b39" xlink:to="loc_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_b0fae707-5f87-4591-bfc4-96a330dd322e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Othernoncurrentassets" xlink:type="simple" xlink:href="sny-20221231.xsd#Othernoncurrentassets"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Othernoncurrentassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_2cb0cb24-2991-4e44-a7a5-eed3f25b1f43" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_2bdf871d-9ed1-4781-b609-4bdf65489e14" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_2cb0cb24-2991-4e44-a7a5-eed3f25b1f43" xlink:to="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_2bdf871d-9ed1-4781-b609-4bdf65489e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Assetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchange" xlink:type="simple" xlink:href="sny-20221231.xsd#Assetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchange"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Assetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchange" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_f9feecb7-30df-4622-8b50-7b73da123e80" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_6bb4b025-210f-4a76-8d60-7f003e7c81db" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_f9feecb7-30df-4622-8b50-7b73da123e80" xlink:to="loc_ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_6bb4b025-210f-4a76-8d60-7f003e7c81db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Inventories" xlink:type="simple" xlink:href="sny-20221231.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_504d74eb-6764-4df8-89b2-644e4f898ae9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_21e09c6e-36c7-45e6-a2e3-3efcfa598087" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_504d74eb-6764-4df8-89b2-644e4f898ae9" xlink:to="loc_ifrs-full_DisclosureOfInventoriesExplanatory_21e09c6e-36c7-45e6-a2e3-3efcfa598087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Accountsreceivable" xlink:type="simple" xlink:href="sny-20221231.xsd#Accountsreceivable"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Accountsreceivable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_232a8de1-c2f4-4a7b-a98b-6aee633c2e5d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfTradeReceivablesTextBlock_358bae8f-efb2-4637-90fc-64c74cd39abd" xlink:href="sny-20221231.xsd#sny_DisclosureOfTradeReceivablesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_232a8de1-c2f4-4a7b-a98b-6aee633c2e5d" xlink:to="loc_sny_DisclosureOfTradeReceivablesTextBlock_358bae8f-efb2-4637-90fc-64c74cd39abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Othercurrentassets" xlink:type="simple" xlink:href="sny-20221231.xsd#Othercurrentassets"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Othercurrentassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8855906f-1f73-4745-9f42-9acacb407800" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory_8fadcf9e-7f5d-436c-b312-489ec052adae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8855906f-1f73-4745-9f42-9acacb407800" xlink:to="loc_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory_8fadcf9e-7f5d-436c-b312-489ec052adae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Financialassetsandliabilitiesmeasuredatfairvalue" xlink:type="simple" xlink:href="sny-20221231.xsd#Financialassetsandliabilitiesmeasuredatfairvalue"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Financialassetsandliabilitiesmeasuredatfairvalue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueMeasurementAbstract_4a8dbdcd-a0c3-4c58-8937-f21fabef33dd" xlink:href="sny-20221231.xsd#sny_FairValueMeasurementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock_e608faef-57bb-48be-8702-1a7504880441" xlink:href="sny-20221231.xsd#sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FairValueMeasurementAbstract_4a8dbdcd-a0c3-4c58-8937-f21fabef33dd" xlink:to="loc_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock_e608faef-57bb-48be-8702-1a7504880441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Cashandcashequivalents" xlink:type="simple" xlink:href="sny-20221231.xsd#Cashandcashequivalents"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Cashandcashequivalents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_36f0e5bf-5b56-4309-8198-1f06cb7229b9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_b8439a29-9cf4-4919-ab14-e8896071f9b6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_36f0e5bf-5b56-4309-8198-1f06cb7229b9" xlink:to="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_b8439a29-9cf4-4919-ab14-e8896071f9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Netdeferredtaxposition" xlink:type="simple" xlink:href="sny-20221231.xsd#Netdeferredtaxposition"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Netdeferredtaxposition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxesAbstract_97bdd02a-393d-4172-b25a-5d7a2fba00d5" xlink:href="sny-20221231.xsd#sny_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_709bb278-54a9-4536-80b3-1946bf9a5f63" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_97bdd02a-393d-4172-b25a-5d7a2fba00d5" xlink:to="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_709bb278-54a9-4536-80b3-1946bf9a5f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Consolidatedshareholdersequity" xlink:type="simple" xlink:href="sny-20221231.xsd#Consolidatedshareholdersequity"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Consolidatedshareholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5a19e6cb-2874-4a76-8b0a-80f22e93fa3f" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_6ca7ffa9-890f-49a3-ab1a-6259732a9407" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5a19e6cb-2874-4a76-8b0a-80f22e93fa3f" xlink:to="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_6ca7ffa9-890f-49a3-ab1a-6259732a9407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Noncontrollinginterests" xlink:type="simple" xlink:href="sny-20221231.xsd#Noncontrollinginterests"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Noncontrollinginterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_00b8de88-5e70-4685-a91f-53744c5d6517" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_59b24a04-c562-45c4-a820-c4cb21b7ae41" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_00b8de88-5e70-4685-a91f-53744c5d6517" xlink:to="loc_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_59b24a04-c562-45c4-a820-c4cb21b7ae41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Debtcashandcashequivalentsandleaseliabilities" xlink:type="simple" xlink:href="sny-20221231.xsd#Debtcashandcashequivalentsandleaseliabilities"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Debtcashandcashequivalentsandleaseliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_89516450-2518-4ff9-b6f1-ddf8993da7b0" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock_c33e68e1-cc12-45a9-8d17-c221cf961db3" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_89516450-2518-4ff9-b6f1-ddf8993da7b0" xlink:to="loc_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock_c33e68e1-cc12-45a9-8d17-c221cf961db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Liabilitiesrelatedtobusinesscombinationsandtononcontrollinginterests" xlink:type="simple" xlink:href="sny-20221231.xsd#Liabilitiesrelatedtobusinesscombinationsandtononcontrollinginterests"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Liabilitiesrelatedtobusinesscombinationsandtononcontrollinginterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_a90707be-edcc-4a60-8f40-cdb510b4f76b" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock_3e281c7f-70f3-4cf3-9189-e83e65a914c8" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_a90707be-edcc-4a60-8f40-cdb510b4f76b" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock_3e281c7f-70f3-4cf3-9189-e83e65a914c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Provisionsincometaxliabilitiesandotherliabilities" xlink:type="simple" xlink:href="sny-20221231.xsd#Provisionsincometaxliabilitiesandotherliabilities"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Provisionsincometaxliabilitiesandotherliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_bf308ab7-b81c-4937-a3a6-35bfaf3afc8c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock_19f5f65f-51f3-4281-81c7-291ea45d6725" xlink:href="sny-20221231.xsd#sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_bf308ab7-b81c-4937-a3a6-35bfaf3afc8c" xlink:to="loc_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock_19f5f65f-51f3-4281-81c7-291ea45d6725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Derivativefinancialinstrumentsandmarketrisks" xlink:type="simple" xlink:href="sny-20221231.xsd#Derivativefinancialinstrumentsandmarketrisks"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Derivativefinancialinstrumentsandmarketrisks" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_fc3b7689-e320-40a6-a067-ceb9109a3bce" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_bb0f0a59-3b5b-4873-948c-20465014561a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_fc3b7689-e320-40a6-a067-ceb9109a3bce" xlink:to="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_bb0f0a59-3b5b-4873-948c-20465014561a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Offbalancesheetcommitments" xlink:type="simple" xlink:href="sny-20221231.xsd#Offbalancesheetcommitments"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Offbalancesheetcommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_bec8b08c-9d8a-4c06-be76-8bb766a00589" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock_decf2d49-0495-483a-bdee-ced0363af304" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_bec8b08c-9d8a-4c06-be76-8bb766a00589" xlink:to="loc_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock_decf2d49-0495-483a-bdee-ced0363af304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Legalandarbitralproceedings" xlink:type="simple" xlink:href="sny-20221231.xsd#Legalandarbitralproceedings"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Legalandarbitralproceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_5a9752fc-7ace-4ca1-b18b-61c065f7112c" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock_240b1940-476a-423c-8ed6-61dc82e10dae" xlink:href="sny-20221231.xsd#sny_DisclosureOfLegalAndArbitralProceedingsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_5a9752fc-7ace-4ca1-b18b-61c065f7112c" xlink:to="loc_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock_240b1940-476a-423c-8ed6-61dc82e10dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Provisionsfordiscountsrebatesandsalesreturns" xlink:type="simple" xlink:href="sny-20221231.xsd#Provisionsfordiscountsrebatesandsalesreturns"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Provisionsfordiscountsrebatesandsalesreturns" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_ce4170c4-68fa-4538-b0aa-b9492f61d80b" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock_4c867bed-b78d-42e2-8ddc-aa4d1b7d6114" xlink:href="sny-20221231.xsd#sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_ce4170c4-68fa-4538-b0aa-b9492f61d80b" xlink:to="loc_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock_4c867bed-b78d-42e2-8ddc-aa4d1b7d6114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Personnelcosts" xlink:type="simple" xlink:href="sny-20221231.xsd#Personnelcosts"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Personnelcosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeeBenefitsAbstract_cc58694e-8de5-4d87-8f4d-73959bfde9bd" xlink:href="sny-20221231.xsd#sny_EmployeeBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_c72395ff-921f-403c-b2c2-7e5fe9d279c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_EmployeeBenefitsAbstract_cc58694e-8de5-4d87-8f4d-73959bfde9bd" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_c72395ff-921f-403c-b2c2-7e5fe9d279c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Otheroperatingincome" xlink:type="simple" xlink:href="sny-20221231.xsd#Otheroperatingincome"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Otheroperatingincome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_a40c7980-b5da-4b4b-9980-7d26e7dea9a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_e1015ea0-d428-43ce-8d52-047d1b473b17" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_a40c7980-b5da-4b4b-9980-7d26e7dea9a8" xlink:to="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_e1015ea0-d428-43ce-8d52-047d1b473b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Otheroperatingexpenses" xlink:type="simple" xlink:href="sny-20221231.xsd#Otheroperatingexpenses"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Otheroperatingexpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_ec5f1be1-5afb-416a-a49b-42d921b47f2a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_daaf929d-d19b-4a76-9172-c4f05e31c1f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_ec5f1be1-5afb-416a-a49b-42d921b47f2a" xlink:to="loc_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_daaf929d-d19b-4a76-9172-c4f05e31c1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Restructuringcostsandsimilaritems" xlink:type="simple" xlink:href="sny-20221231.xsd#Restructuringcostsandsimilaritems"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Restructuringcostsandsimilaritems" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_3858a574-9273-4507-a041-08b45268287b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock_50e48a48-ef9b-4eec-8970-c7223116715a" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_3858a574-9273-4507-a041-08b45268287b" xlink:to="loc_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock_50e48a48-ef9b-4eec-8970-c7223116715a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Othergainsandlossesandlitigation" xlink:type="simple" xlink:href="sny-20221231.xsd#Othergainsandlossesandlitigation"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Othergainsandlossesandlitigation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_74e37f50-447d-4f3a-8436-c7aa1be771e3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock_a35017bd-30ac-4031-ab2f-367bed5e6835" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_74e37f50-447d-4f3a-8436-c7aa1be771e3" xlink:to="loc_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock_a35017bd-30ac-4031-ab2f-367bed5e6835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Financialexpensesandincome" xlink:type="simple" xlink:href="sny-20221231.xsd#Financialexpensesandincome"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Financialexpensesandincome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_fc7fc6f1-18b8-4f8c-95fd-2af5557c6887" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_14a31f2c-e148-4795-abe6-bb65387a129b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_fc7fc6f1-18b8-4f8c-95fd-2af5557c6887" xlink:to="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_14a31f2c-e148-4795-abe6-bb65387a129b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Incometaxexpense" xlink:type="simple" xlink:href="sny-20221231.xsd#Incometaxexpense"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Incometaxexpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxesAbstract_03ea8fd3-660b-407a-a801-4eed90a8d893" xlink:href="sny-20221231.xsd#sny_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_26f699ed-84b7-4d46-b783-9364f684d1d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_03ea8fd3-660b-407a-a801-4eed90a8d893" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_26f699ed-84b7-4d46-b783-9364f684d1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Shareofprofitlossfrominvestmentsaccountedforusingtheequitymethod" xlink:type="simple" xlink:href="sny-20221231.xsd#Shareofprofitlossfrominvestmentsaccountedforusingtheequitymethod"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Shareofprofitlossfrominvestmentsaccountedforusingtheequitymethod" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_ddcbbb68-8097-439d-a04c-7b5d3b885c30" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock_6444c018-9b29-41b3-8162-680dcd2b03a3" xlink:href="sny-20221231.xsd#sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_ddcbbb68-8097-439d-a04c-7b5d3b885c30" xlink:to="loc_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock_6444c018-9b29-41b3-8162-680dcd2b03a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Netincomeattributabletononcontrollinginterests" xlink:type="simple" xlink:href="sny-20221231.xsd#Netincomeattributabletononcontrollinginterests"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Netincomeattributabletononcontrollinginterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f83681c5-0c0b-4a1b-bc91-294445bf0482" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock_7c994cea-c1dd-4cb4-9e76-6b287bf30487" xlink:href="sny-20221231.xsd#sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f83681c5-0c0b-4a1b-bc91-294445bf0482" xlink:to="loc_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock_7c994cea-c1dd-4cb4-9e76-6b287bf30487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Relatedpartytransactions" xlink:type="simple" xlink:href="sny-20221231.xsd#Relatedpartytransactions"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Relatedpartytransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_RelatedPartyAbstract_dc570ec6-87f3-482a-9870-00f0120f273d" xlink:href="sny-20221231.xsd#sny_RelatedPartyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_d37203c8-8b10-4def-abc2-1f6980d1d55a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_dc570ec6-87f3-482a-9870-00f0120f273d" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_d37203c8-8b10-4def-abc2-1f6980d1d55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Disclosuresaboutmajorcustomersandcreditrisk" xlink:type="simple" xlink:href="sny-20221231.xsd#Disclosuresaboutmajorcustomersandcreditrisk"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Disclosuresaboutmajorcustomersandcreditrisk" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_3cf5df42-bb3c-4d00-9b1c-daecc7400b0c" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_3a25d60b-66d6-4825-9cfb-d5ec4bd16d1b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCreditRiskExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_3cf5df42-bb3c-4d00-9b1c-daecc7400b0c" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_3a25d60b-66d6-4825-9cfb-d5ec4bd16d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Segmentinformation" xlink:type="simple" xlink:href="sny-20221231.xsd#Segmentinformation"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Segmentinformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OperatingSegmentsAbstract_dc65b1fa-dba9-4c84-95a7-e48636aab0b9" xlink:href="sny-20221231.xsd#sny_OperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_4f916bbe-ac9a-4681-a6b4-8f1d9dd09823" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_dc65b1fa-dba9-4c84-95a7-e48636aab0b9" xlink:to="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_4f916bbe-ac9a-4681-a6b4-8f1d9dd09823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalaccountantsfeesandservices" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalaccountantsfeesandservices"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Principalaccountantsfeesandservices" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f5ccd2f4-bcf9-4cd7-a482-3bd4bb200dbd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory_6f5a6c73-72d1-406d-a46b-c9d6f6af9e37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAuditorsRemunerationExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f5ccd2f4-bcf9-4cd7-a482-3bd4bb200dbd" xlink:to="loc_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory_6f5a6c73-72d1-406d-a46b-c9d6f6af9e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022" xlink:type="simple" xlink:href="sny-20221231.xsd#Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_33d42375-d2fd-4784-8cf0-13abe5540622" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_67c87529-6dad-4d5e-934c-fddd22bcdcce" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_33d42375-d2fd-4784-8cf0-13abe5540622" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_67c87529-6dad-4d5e-934c-fddd22bcdcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/EventssubsequenttoDecember312022" xlink:type="simple" xlink:href="sny-20221231.xsd#EventssubsequenttoDecember312022"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/EventssubsequenttoDecember312022" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_4ca3c267-35e7-47b0-9e37-1b9634260ea3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_962f6a7f-8881-44e9-8fb3-77bd8becefbd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_4ca3c267-35e7-47b0-9e37-1b9634260ea3" xlink:to="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_962f6a7f-8881-44e9-8fb3-77bd8becefbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfIFRSCompliance_61a6d7ec-fe65-46dc-a852-1eb64c0fe98a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfIFRSCompliance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_StatementOfIFRSCompliance_61a6d7ec-fe65-46dc-a852-1eb64c0fe98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_46453cf6-4df8-4c95-b746-cd0a3ea57ecc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_46453cf6-4df8-4c95-b746-cd0a3ea57ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_e7ccc8fb-26d1-4cb3-88f9-555759955c68" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_e7ccc8fb-26d1-4cb3-88f9-555759955c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_f25d20b1-ef4c-4b07-bc5f-9ce36fb97fd3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_f25d20b1-ef4c-4b07-bc5f-9ce36fb97fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory_7fa4f25f-6cf7-496c-9546-28408179198a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory_7fa4f25f-6cf7-496c-9546-28408179198a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock_5567f282-85ea-4de6-95c2-6068d32be375" xlink:href="sny-20221231.xsd#sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock_5567f282-85ea-4de6-95c2-6068d32be375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock_3d684e25-4e57-47f3-ad56-8c52fe6ac256" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock_3d684e25-4e57-47f3-ad56-8c52fe6ac256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock_502ba31a-4cc8-459e-b179-48ef912f290c" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock_502ba31a-4cc8-459e-b179-48ef912f290c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock_95a1da0a-b16a-40b6-97fa-b76103beaabd" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock_95a1da0a-b16a-40b6-97fa-b76103beaabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_8589a6a9-f840-41fc-80b9-5b46b3732d5a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_8589a6a9-f840-41fc-80b9-5b46b3732d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_8d804970-68f3-4a81-8c7d-30a8c4e85955" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_8d804970-68f3-4a81-8c7d-30a8c4e85955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_f4672707-ec1d-4a7b-9b19-33866b06ad50" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_f4672707-ec1d-4a7b-9b19-33866b06ad50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_111e94b4-d702-4224-a327-242c0d2e00e2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_111e94b4-d702-4224-a327-242c0d2e00e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_d473e225-5841-4341-aaa6-9b1e8208fb8a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_d473e225-5841-4341-aaa6-9b1e8208fb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory_300d763b-41b6-4390-a689-80d3791ff599" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory_300d763b-41b6-4390-a689-80d3791ff599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_6895f82e-4e43-4dc2-9f32-cc322f3ffd44" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_6895f82e-4e43-4dc2-9f32-cc322f3ffd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_81122caa-d795-4da6-8c7d-abbe233937fd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_81122caa-d795-4da6-8c7d-abbe233937fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_34b0315c-56d9-4f6d-979d-23123ba3ed51" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_34b0315c-56d9-4f6d-979d-23123ba3ed51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_a878494a-3209-470b-a47a-999cc5bcfa58" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_a878494a-3209-470b-a47a-999cc5bcfa58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_f161fae7-8e55-482d-85ff-a0039f84ea9b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_f161fae7-8e55-482d-85ff-a0039f84ea9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_2e6a03ea-8e35-40c5-be95-ffd5d938a7e9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_2e6a03ea-8e35-40c5-be95-ffd5d938a7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory_00dd1963-4697-42b3-aea5-467f5e5f8aa3" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory_00dd1963-4697-42b3-aea5-467f5e5f8aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_b3cccdc7-cdf7-44d0-aa9f-c7454042763d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_b3cccdc7-cdf7-44d0-aa9f-c7454042763d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock_d553d9a1-9317-4e5d-8561-ece7a7644981" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock_d553d9a1-9317-4e5d-8561-ece7a7644981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_ae922c29-f4e9-4c9e-ac74-43dbc6afc6fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_ae922c29-f4e9-4c9e-ac74-43dbc6afc6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock_5708a3a4-ef67-4fe3-a461-ac1951beda5f" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock_5708a3a4-ef67-4fe3-a461-ac1951beda5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock_d3fb9060-6135-4d42-97f6-ed451133358d" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock_d3fb9060-6135-4d42-97f6-ed451133358d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock_bb5c3bd7-aa36-43fc-ad0b-c03af19bfcbd" xlink:href="sny-20221231.xsd#sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock_bb5c3bd7-aa36-43fc-ad0b-c03af19bfcbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_465ae8d3-ab26-4311-8d1c-105a0e681501" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_465ae8d3-ab26-4311-8d1c-105a0e681501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_218275a8-c41f-42b3-a3b5-fa724abcddd8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_218275a8-c41f-42b3-a3b5-fa724abcddd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_f314e71a-6cde-4a06-a651-4c775d86dd48" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_f314e71a-6cde-4a06-a651-4c775d86dd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_c13413ff-3728-4d1b-9c01-60fe96e96e00" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_c13413ff-3728-4d1b-9c01-60fe96e96e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_79c317ec-6142-436a-a3d5-471ce4ae013b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_79c317ec-6142-436a-a3d5-471ce4ae013b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_3fb5ff32-15f8-451e-8e0f-99dc196175b6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_3fb5ff32-15f8-451e-8e0f-99dc196175b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_b33c5c35-1e9d-452f-b7d8-49e04d485842" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_c48c6788-f044-4b2c-8989-e6ffa15f3ab9" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_b33c5c35-1e9d-452f-b7d8-49e04d485842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_d2babfb3-dae6-4358-ad36-aa00f1f47db8" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock_0b4a8be5-d8d5-491b-ae40-60cef81272d2" xlink:href="sny-20221231.xsd#sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_d2babfb3-dae6-4358-ad36-aa00f1f47db8" xlink:to="loc_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock_0b4a8be5-d8d5-491b-ae40-60cef81272d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_0571dc35-0e5d-48d5-8cc6-6c6defdb8143" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_d2babfb3-dae6-4358-ad36-aa00f1f47db8" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_0571dc35-0e5d-48d5-8cc6-6c6defdb8143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022Tables" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2022Tables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022Tables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_7f5d7150-94c7-4add-a2e0-815c389e8258" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_7d37462b-36bd-405c-8645-639ebb5f615a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_7f5d7150-94c7-4add-a2e0-815c389e8258" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_7d37462b-36bd-405c-8645-639ebb5f615a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020Tables" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2021and2020Tables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020Tables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_b281ae1c-aaf9-40c1-b4c6-1ad57e5c5740" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_47f639b5-a0df-4cbd-a538-fa9a199c7bc7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_b281ae1c-aaf9-40c1-b4c6-1ad57e5c5740" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_47f639b5-a0df-4cbd-a538-fa9a199c7bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PropertyplantandequipmentTables" xlink:type="simple" xlink:href="sny-20221231.xsd#PropertyplantandequipmentTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PropertyplantandequipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_ed970985-5455-492a-bd26-87442f370b17" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock_d180db16-6b2b-48e4-9137-b5d47f5ce742" xlink:href="sny-20221231.xsd#sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_ed970985-5455-492a-bd26-87442f370b17" xlink:to="loc_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock_d180db16-6b2b-48e4-9137-b5d47f5ce742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock_c531f814-cf23-43ff-acf5-8e722f18f045" xlink:href="sny-20221231.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_ed970985-5455-492a-bd26-87442f370b17" xlink:to="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock_c531f814-cf23-43ff-acf5-8e722f18f045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock_734661c3-ba36-4988-a581-b6f59d0844f3" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_ed970985-5455-492a-bd26-87442f370b17" xlink:to="loc_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock_734661c3-ba36-4988-a581-b6f59d0844f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock_a480bab3-85c8-4f14-8854-0a3d198e8451" xlink:href="sny-20221231.xsd#sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_ed970985-5455-492a-bd26-87442f370b17" xlink:to="loc_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock_a480bab3-85c8-4f14-8854-0a3d198e8451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_375ff38d-c2f7-4fa1-a852-a3a8decd6507" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_ed970985-5455-492a-bd26-87442f370b17" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_375ff38d-c2f7-4fa1-a852-a3a8decd6507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsTables" xlink:type="simple" xlink:href="sny-20221231.xsd#GoodwillandotherintangibleassetsTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/GoodwillandotherintangibleassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_e28a1d3f-d3bf-4b83-84ba-cb3426f2e069" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_a535fb90-bfcc-48e1-837e-dd381415c318" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_e28a1d3f-d3bf-4b83-84ba-cb3426f2e069" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_a535fb90-bfcc-48e1-837e-dd381415c318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock_8debe9dc-27fd-45b9-bdd3-b4c692dc94ae" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_e28a1d3f-d3bf-4b83-84ba-cb3426f2e069" xlink:to="loc_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock_8debe9dc-27fd-45b9-bdd3-b4c692dc94ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock_bbdaf1f6-c951-4a06-be97-2d950e70fd94" xlink:href="sny-20221231.xsd#sny_DisclosureOfPrincipalMarketedProductsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_e28a1d3f-d3bf-4b83-84ba-cb3426f2e069" xlink:to="loc_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock_bbdaf1f6-c951-4a06-be97-2d950e70fd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock_976f2608-1769-447a-bcc0-57f835c95826" xlink:href="sny-20221231.xsd#sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_e28a1d3f-d3bf-4b83-84ba-cb3426f2e069" xlink:to="loc_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock_976f2608-1769-447a-bcc0-57f835c95826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentTables" xlink:type="simple" xlink:href="sny-20221231.xsd#ImpairmentofintangibleassetsandpropertyplantandequipmentTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentOfAssetsAbstract_f1874666-1a69-4b02-a750-72b5a4232fea" xlink:href="sny-20221231.xsd#sny_ImpairmentOfAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock_afcb0ed6-f1c2-499f-82ca-93778d34551a" xlink:href="sny-20221231.xsd#sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ImpairmentOfAssetsAbstract_f1874666-1a69-4b02-a750-72b5a4232fea" xlink:to="loc_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock_afcb0ed6-f1c2-499f-82ca-93778d34551a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock_15402fcd-d5a9-4cfb-abc3-6ad3a340c83c" xlink:href="sny-20221231.xsd#sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ImpairmentOfAssetsAbstract_f1874666-1a69-4b02-a750-72b5a4232fea" xlink:to="loc_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock_15402fcd-d5a9-4cfb-abc3-6ad3a340c83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodTables" xlink:type="simple" xlink:href="sny-20221231.xsd#InvestmentsaccountedforusingtheequitymethodTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_e80c0d4d-6735-42fc-9401-ce07c1b83185" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock_66de94e5-e651-45c9-be29-df0d65b11336" xlink:href="sny-20221231.xsd#sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_e80c0d4d-6735-42fc-9401-ce07c1b83185" xlink:to="loc_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock_66de94e5-e651-45c9-be29-df0d65b11336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock_303547b4-a23c-4baa-bf6e-71a7587d1487" xlink:href="sny-20221231.xsd#sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_e80c0d4d-6735-42fc-9401-ce07c1b83185" xlink:to="loc_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock_303547b4-a23c-4baa-bf6e-71a7587d1487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_49c765d1-a612-41c1-b008-b2fcacad1e44" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_e80c0d4d-6735-42fc-9401-ce07c1b83185" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_49c765d1-a612-41c1-b008-b2fcacad1e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OthernoncurrentassetsTables" xlink:type="simple" xlink:href="sny-20221231.xsd#OthernoncurrentassetsTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OthernoncurrentassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_2d10ca53-643c-4a13-9285-28c8a219f56b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock_4311e23b-2fff-40e3-b29b-711a7c7907f5" xlink:href="sny-20221231.xsd#sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_2d10ca53-643c-4a13-9285-28c8a219f56b" xlink:to="loc_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock_4311e23b-2fff-40e3-b29b-711a7c7907f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeTables" xlink:type="simple" xlink:href="sny-20221231.xsd#AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cc795736-908e-4680-bc19-dbdfa0691c53" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock_754f0f80-a21d-47e1-91d3-046234cf2786" xlink:href="sny-20221231.xsd#sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cc795736-908e-4680-bc19-dbdfa0691c53" xlink:to="loc_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock_754f0f80-a21d-47e1-91d3-046234cf2786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InventoriesTables" xlink:type="simple" xlink:href="sny-20221231.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_fe1e2e42-3987-49c9-a01d-71b756d54b61" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock_c3b12680-404f-49fb-9725-f3df27253277" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_fe1e2e42-3987-49c9-a01d-71b756d54b61" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock_c3b12680-404f-49fb-9725-f3df27253277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/AccountsreceivableTables" xlink:type="simple" xlink:href="sny-20221231.xsd#AccountsreceivableTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/AccountsreceivableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_640a4813-269e-417c-9c34-d175223254c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock_db742133-63bb-4187-82be-fe389aa7dd32" xlink:href="sny-20221231.xsd#sny_DisclosureOfCurrentTradeReceivablesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_640a4813-269e-417c-9c34-d175223254c3" xlink:to="loc_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock_db742133-63bb-4187-82be-fe389aa7dd32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock_069be8af-936e-4797-a4c2-e1d86a692873" xlink:href="sny-20221231.xsd#sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_640a4813-269e-417c-9c34-d175223254c3" xlink:to="loc_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock_069be8af-936e-4797-a4c2-e1d86a692873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OthercurrentassetsTables" xlink:type="simple" xlink:href="sny-20221231.xsd#OthercurrentassetsTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OthercurrentassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_3f2848eb-a555-4ed2-9888-5cb96ef833f9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock_f7263122-8943-4d4e-986b-259ae8ff5f71" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_3f2848eb-a555-4ed2-9888-5cb96ef833f9" xlink:to="loc_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock_f7263122-8943-4d4e-986b-259ae8ff5f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueTables" xlink:type="simple" xlink:href="sny-20221231.xsd#FinancialassetsandliabilitiesmeasuredatfairvalueTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueMeasurementAbstract_101fd5a4-2d2b-4b17-a92c-666394e3d233" xlink:href="sny-20221231.xsd#sny_FairValueMeasurementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock_9059c60a-fc4f-4639-ba80-622dcd41c425" xlink:href="sny-20221231.xsd#sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FairValueMeasurementAbstract_101fd5a4-2d2b-4b17-a92c-666394e3d233" xlink:to="loc_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock_9059c60a-fc4f-4639-ba80-622dcd41c425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/CashandcashequivalentsTables" xlink:type="simple" xlink:href="sny-20221231.xsd#CashandcashequivalentsTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/CashandcashequivalentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_86f09969-c07a-43c3-a4b7-55c9533d401a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock_cd2d9ec9-8cc7-4fdb-9996-2a6ee6440a21" xlink:href="sny-20221231.xsd#sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_86f09969-c07a-43c3-a4b7-55c9533d401a" xlink:to="loc_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock_cd2d9ec9-8cc7-4fdb-9996-2a6ee6440a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/NetdeferredtaxpositionTables" xlink:type="simple" xlink:href="sny-20221231.xsd#NetdeferredtaxpositionTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/NetdeferredtaxpositionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxesAbstract_d2845fcd-afac-4414-b905-09415242e622" xlink:href="sny-20221231.xsd#sny_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_216c4bc6-bc3d-4237-b9f7-25bff48f48db" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_d2845fcd-afac-4414-b905-09415242e622" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_216c4bc6-bc3d-4237-b9f7-25bff48f48db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock_122b3d7d-3937-42d5-b6d7-dfbdf846a748" xlink:href="sny-20221231.xsd#sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_d2845fcd-afac-4414-b905-09415242e622" xlink:to="loc_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock_122b3d7d-3937-42d5-b6d7-dfbdf846a748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequityTables" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequityTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_169c5c0d-bfef-4147-a29f-cb3aa50ea327" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_169c5c0d-bfef-4147-a29f-cb3aa50ea327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock_efb3462a-c21e-48b9-b2f6-e7ce5f50af54" xlink:href="sny-20221231.xsd#sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock_efb3462a-c21e-48b9-b2f6-e7ce5f50af54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_f89e23c6-f6e7-40dd-858c-fbb1d190cfeb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_f89e23c6-f6e7-40dd-858c-fbb1d190cfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock_e15f29a9-2a6c-4470-8c51-2630f4597900" xlink:href="sny-20221231.xsd#sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock_e15f29a9-2a6c-4470-8c51-2630f4597900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock_368d2919-8fd5-441d-94c8-e3c1954812db" xlink:href="sny-20221231.xsd#sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock_368d2919-8fd5-441d-94c8-e3c1954812db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements_efa35b2d-8da5-480b-974d-fddf3732379b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements_efa35b2d-8da5-480b-974d-fddf3732379b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock_1f281b17-bfd4-4a1a-aa49-907957c08630" xlink:href="sny-20221231.xsd#sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock_1f281b17-bfd4-4a1a-aa49-907957c08630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock_229adf6b-b947-4d2b-88af-608ded2e453f" xlink:href="sny-20221231.xsd#sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock_229adf6b-b947-4d2b-88af-608ded2e453f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock_fc5b01b8-9189-4cea-81cb-a3c623ce8733" xlink:href="sny-20221231.xsd#sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock_fc5b01b8-9189-4cea-81cb-a3c623ce8733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock_4d42bdfa-6787-4dcd-af3f-bdeee2853842" xlink:href="sny-20221231.xsd#sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock_4d42bdfa-6787-4dcd-af3f-bdeee2853842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock_9192851c-e8ac-4a57-96bc-d49d986e8d2f" xlink:href="sny-20221231.xsd#sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock_9192851c-e8ac-4a57-96bc-d49d986e8d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock_5a9b0bae-1e14-4824-be14-66ed6b07b374" xlink:href="sny-20221231.xsd#sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock_5a9b0bae-1e14-4824-be14-66ed6b07b374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock_50bdfaea-6575-4970-9e73-e9153696ab27" xlink:href="sny-20221231.xsd#sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5615108a-914f-47aa-b1ee-5b44d8388b2f" xlink:to="loc_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock_50bdfaea-6575-4970-9e73-e9153696ab27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfChangesInFinancialPositionTableTextBlock_55b443ba-5630-4179-8878-57c4454056ed" xlink:href="sny-20221231.xsd#sny_DisclosureOfChangesInFinancialPositionTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfChangesInFinancialPositionTableTextBlock_55b443ba-5630-4179-8878-57c4454056ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock_6f74b042-9e0d-49fd-ba4f-5e4641629d15" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock_6f74b042-9e0d-49fd-ba4f-5e4641629d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_b310505d-96f9-4259-88d3-2551657a6256" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_b310505d-96f9-4259-88d3-2551657a6256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock_0fdec620-2527-4a39-9faa-367d96b558eb" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock_0fdec620-2527-4a39-9faa-367d96b558eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock_e1e8a158-4e02-46aa-b35d-db33aab6d990" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock_e1e8a158-4e02-46aa-b35d-db33aab6d990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock_50802148-2130-40b1-a14f-79bed7cf401c" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock_50802148-2130-40b1-a14f-79bed7cf401c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock_4c3456b0-a5cd-4716-92a6-84023c0a300c" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock_4c3456b0-a5cd-4716-92a6-84023c0a300c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock_3da696fc-76cf-4c39-998d-d2aeebfd9f47" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock_3da696fc-76cf-4c39-998d-d2aeebfd9f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock_09d50eb6-7b87-4792-85a6-135c35096b24" xlink:href="sny-20221231.xsd#sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock_09d50eb6-7b87-4792-85a6-135c35096b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock_e8a70ef8-b5a3-4703-bdf1-ba45ba8c1379" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock_e8a70ef8-b5a3-4703-bdf1-ba45ba8c1379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock_6447768f-e095-4f28-8bc9-2569c64df647" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock_6447768f-e095-4f28-8bc9-2569c64df647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock_b7c78b29-f81f-46f0-bd4b-1ccf1db8c54e" xlink:href="sny-20221231.xsd#sny_DisclosureOfMarketValueOfNetDebtTableTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock_b7c78b29-f81f-46f0-bd4b-1ccf1db8c54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock_db50e39c-8476-4300-ad37-f12685ba6637" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock_db50e39c-8476-4300-ad37-f12685ba6637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock_d6b0dc39-f291-4f67-8446-d27452fa770a" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_668a513e-8f03-4001-bd54-96c5e0cdb640" xlink:to="loc_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock_d6b0dc39-f291-4f67-8446-d27452fa770a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsTables" xlink:type="simple" xlink:href="sny-20221231.xsd#LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_f5bb61b2-a85a-46e4-b636-2a483d2e32b3" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock_1bafa556-05ff-42e2-86e7-d2d6212c2b9e" xlink:href="sny-20221231.xsd#sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_f5bb61b2-a85a-46e4-b636-2a483d2e32b3" xlink:to="loc_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock_1bafa556-05ff-42e2-86e7-d2d6212c2b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock_ec55acc2-909a-4b0b-b90e-c19d150f357d" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_f5bb61b2-a85a-46e4-b636-2a483d2e32b3" xlink:to="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock_ec55acc2-909a-4b0b-b90e-c19d150f357d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock_9b0c9dc2-5640-4071-a1de-78f42ddf4d77" xlink:href="sny-20221231.xsd#sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock_9b0c9dc2-5640-4071-a1de-78f42ddf4d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNoncurrentProvisionsTableTextBlock_63507f8a-01d6-4605-bd6d-c79ad3756578" xlink:href="sny-20221231.xsd#sny_DisclosureOfNoncurrentProvisionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfNoncurrentProvisionsTableTextBlock_63507f8a-01d6-4605-bd6d-c79ad3756578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfActuarialAssumptionsTableTextBlock_ce25b491-7f38-4ce4-bad6-487ee5d2b208" xlink:href="sny-20221231.xsd#sny_DisclosureOfActuarialAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfActuarialAssumptionsTableTextBlock_ce25b491-7f38-4ce4-bad6-487ee5d2b208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock_afdb1bbd-a326-4ea1-bab2-4ec962662ba1" xlink:href="sny-20221231.xsd#sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock_afdb1bbd-a326-4ea1-bab2-4ec962662ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_e4b1843b-245b-410d-8c1a-32b6376a412f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_e4b1843b-245b-410d-8c1a-32b6376a412f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock_d5a5e63d-1270-4c8b-84c7-90a5a2092075" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock_d5a5e63d-1270-4c8b-84c7-90a5a2092075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock_7a2f12fb-0ba0-499f-8e69-d61781743128" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock_7a2f12fb-0ba0-499f-8e69-d61781743128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_2941e876-343a-4b8a-95f3-963de3a224a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_2941e876-343a-4b8a-95f3-963de3a224a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock_526a8537-bb74-431d-897c-897013c406bd" xlink:href="sny-20221231.xsd#sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock_526a8537-bb74-431d-897c-897013c406bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock_9f2d49de-e324-45bd-88a4-fde461282845" xlink:href="sny-20221231.xsd#sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock_9f2d49de-e324-45bd-88a4-fde461282845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock_85ab61a8-5d36-43f4-b7d4-07fd06f7df8e" xlink:href="sny-20221231.xsd#sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock_85ab61a8-5d36-43f4-b7d4-07fd06f7df8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock_61d9b914-5b0b-49ae-bc6a-371de9606d03" xlink:href="sny-20221231.xsd#sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock_61d9b914-5b0b-49ae-bc6a-371de9606d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock_6484ad9b-2184-4a37-9840-2a2137c4d26b" xlink:href="sny-20221231.xsd#sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock_6484ad9b-2184-4a37-9840-2a2137c4d26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock_30733a14-866c-449c-95c5-8d7e542fc2a0" xlink:href="sny-20221231.xsd#sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock_30733a14-866c-449c-95c5-8d7e542fc2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock_61839a07-0c11-4136-9018-d4df578905f3" xlink:href="sny-20221231.xsd#sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock_61839a07-0c11-4136-9018-d4df578905f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock_4c7061ea-2368-4904-ba69-e847b47e74e1" xlink:href="sny-20221231.xsd#sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock_4c7061ea-2368-4904-ba69-e847b47e74e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringProvisionsTableTextBlock_d20c9fed-95af-434b-9d3f-4d1dea621f18" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringProvisionsTableTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfRestructuringProvisionsTableTextBlock_d20c9fed-95af-434b-9d3f-4d1dea621f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock_0e7b0c60-a1ec-4044-ad48-c695782e5650" xlink:href="sny-20221231.xsd#sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock_0e7b0c60-a1ec-4044-ad48-c695782e5650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock_4cf0da97-495e-4752-b14d-4ffe21275f19" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherLongTermProvisionsTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock_4cf0da97-495e-4752-b14d-4ffe21275f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock_ae2a41af-41ce-4688-9746-9f1fefc6b5fb" xlink:href="sny-20221231.xsd#sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_cca7813b-f608-4690-a346-5284f56015d0" xlink:to="loc_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock_ae2a41af-41ce-4688-9746-9f1fefc6b5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksTables" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_e3aeb5e0-1cde-4e2a-8c9d-4d4bd02140d7" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock_0cd2fc87-b508-4ed6-83c9-cef40315cc5b" xlink:href="sny-20221231.xsd#sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e3aeb5e0-1cde-4e2a-8c9d-4d4bd02140d7" xlink:to="loc_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock_0cd2fc87-b508-4ed6-83c9-cef40315cc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock_c0bd6354-c5bd-447c-8047-98f267aab9d6" xlink:href="sny-20221231.xsd#sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e3aeb5e0-1cde-4e2a-8c9d-4d4bd02140d7" xlink:to="loc_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock_c0bd6354-c5bd-447c-8047-98f267aab9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock_fcfdb547-e90a-44d7-aaa6-152c8336d978" xlink:href="sny-20221231.xsd#sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e3aeb5e0-1cde-4e2a-8c9d-4d4bd02140d7" xlink:to="loc_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock_fcfdb547-e90a-44d7-aaa6-152c8336d978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock_d1a22303-ea40-4df6-88ea-eb4d75bbb531" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e3aeb5e0-1cde-4e2a-8c9d-4d4bd02140d7" xlink:to="loc_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock_d1a22303-ea40-4df6-88ea-eb4d75bbb531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock_74fc0667-11be-41f3-82c7-b9a3f7e05f9e" xlink:href="sny-20221231.xsd#sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e3aeb5e0-1cde-4e2a-8c9d-4d4bd02140d7" xlink:to="loc_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock_74fc0667-11be-41f3-82c7-b9a3f7e05f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsTables" xlink:type="simple" xlink:href="sny-20221231.xsd#OffbalancesheetcommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OffbalancesheetcommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_aa6ff17a-0c37-45bb-825b-d3b82fdc2543" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock_e9077d33-1fe7-4593-abcc-33f3960879db" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_aa6ff17a-0c37-45bb-825b-d3b82fdc2543" xlink:to="loc_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock_e9077d33-1fe7-4593-abcc-33f3960879db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock_d5414695-9652-46fc-9ba8-dd437f2e5f75" xlink:href="sny-20221231.xsd#sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_aa6ff17a-0c37-45bb-825b-d3b82fdc2543" xlink:to="loc_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock_d5414695-9652-46fc-9ba8-dd437f2e5f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock_8d74e02a-0094-4de4-bfd5-20d4be1a5b06" xlink:href="sny-20221231.xsd#sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_aa6ff17a-0c37-45bb-825b-d3b82fdc2543" xlink:to="loc_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock_8d74e02a-0094-4de4-bfd5-20d4be1a5b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsTables" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsfordiscountsrebatesandsalesreturnsTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_58fffdeb-def8-489c-a58a-e0caf356e2ba" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock_c9caa395-18db-447b-942c-3d46c2055ed2" xlink:href="sny-20221231.xsd#sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_58fffdeb-def8-489c-a58a-e0caf356e2ba" xlink:to="loc_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock_c9caa395-18db-447b-942c-3d46c2055ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PersonnelcostsTables" xlink:type="simple" xlink:href="sny-20221231.xsd#PersonnelcostsTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PersonnelcostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeeBenefitsAbstract_3e57800b-a6bb-457e-86c6-4dd5e3a9a4b2" xlink:href="sny-20221231.xsd#sny_EmployeeBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock_9af4b215-5df2-4509-a824-9f1041cf1f56" xlink:href="sny-20221231.xsd#sny_DisclosureOfPersonnelCostsDetailsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_EmployeeBenefitsAbstract_3e57800b-a6bb-457e-86c6-4dd5e3a9a4b2" xlink:to="loc_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock_9af4b215-5df2-4509-a824-9f1041cf1f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OtheroperatingexpensesTables" xlink:type="simple" xlink:href="sny-20221231.xsd#OtheroperatingexpensesTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OtheroperatingexpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_8911a348-1669-4115-b299-bef9c35f5bc8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherOperatingExpensesTableTextBlock_18d04425-480d-49cd-ade0-731a9252ecf9" xlink:href="sny-20221231.xsd#sny_OtherOperatingExpensesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_8911a348-1669-4115-b299-bef9c35f5bc8" xlink:to="loc_sny_OtherOperatingExpensesTableTextBlock_18d04425-480d-49cd-ade0-731a9252ecf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/RestructuringcostsandsimilaritemsTables" xlink:type="simple" xlink:href="sny-20221231.xsd#RestructuringcostsandsimilaritemsTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/RestructuringcostsandsimilaritemsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_e3dc191e-bec8-4283-8869-d8f88bcab8c1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock_a014503d-b160-40d5-a817-ed0cd1dac714" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringCostsDetailsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_e3dc191e-bec8-4283-8869-d8f88bcab8c1" xlink:to="loc_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock_a014503d-b160-40d5-a817-ed0cd1dac714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/FinancialexpensesandincomeTables" xlink:type="simple" xlink:href="sny-20221231.xsd#FinancialexpensesandincomeTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/FinancialexpensesandincomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_1c5bc60c-512d-4235-bb26-4b9eda48ec9f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock_d7cfda7f-71ac-483b-99c0-483c66851167" xlink:href="sny-20221231.xsd#sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_1c5bc60c-512d-4235-bb26-4b9eda48ec9f" xlink:to="loc_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock_d7cfda7f-71ac-483b-99c0-483c66851167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/IncometaxexpenseTables" xlink:type="simple" xlink:href="sny-20221231.xsd#IncometaxexpenseTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/IncometaxexpenseTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxesAbstract_d02e5221-6752-4d5e-a6c3-43d5e4aa1942" xlink:href="sny-20221231.xsd#sny_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock_389a6ad3-fb7e-4925-99ae-492b5e0effee" xlink:href="sny-20221231.xsd#sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_d02e5221-6752-4d5e-a6c3-43d5e4aa1942" xlink:to="loc_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock_389a6ad3-fb7e-4925-99ae-492b5e0effee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock_adc1c6c4-81d9-449c-80b1-fec2665c9cfc" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_d02e5221-6752-4d5e-a6c3-43d5e4aa1942" xlink:to="loc_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock_adc1c6c4-81d9-449c-80b1-fec2665c9cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsTables" xlink:type="simple" xlink:href="sny-20221231.xsd#NetincomeattributabletononcontrollinginterestsTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_102b7b92-0cff-4afa-b4b3-52c92519bec9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock_fda71844-43bb-4ce5-859d-d27da0b0681b" xlink:href="sny-20221231.xsd#sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_102b7b92-0cff-4afa-b4b3-52c92519bec9" xlink:to="loc_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock_fda71844-43bb-4ce5-859d-d27da0b0681b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/RelatedpartytransactionsTables" xlink:type="simple" xlink:href="sny-20221231.xsd#RelatedpartytransactionsTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/RelatedpartytransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_RelatedPartyAbstract_e92a3069-2ce0-4a61-a2d9-0fc78794c698" xlink:href="sny-20221231.xsd#sny_RelatedPartyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock_a0e1d151-687a-4ca9-8c63-513d434c6fbc" xlink:href="sny-20221231.xsd#sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_e92a3069-2ce0-4a61-a2d9-0fc78794c698" xlink:to="loc_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock_a0e1d151-687a-4ca9-8c63-513d434c6fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_d020c0b4-e1e1-4494-b88c-4ab651b99df6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_e92a3069-2ce0-4a61-a2d9-0fc78794c698" xlink:to="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_d020c0b4-e1e1-4494-b88c-4ab651b99df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationTables" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SegmentinformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OperatingSegmentsAbstract_4dd344c2-e4d9-48ee-a6f7-c6d0f8f91103" xlink:href="sny-20221231.xsd#sny_OperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock_a8b2b6db-0837-4951-8833-e1c4758b2f5d" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_4dd344c2-e4d9-48ee-a6f7-c6d0f8f91103" xlink:to="loc_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock_a8b2b6db-0837-4951-8833-e1c4758b2f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_ba8fa318-ac76-4cf8-94ee-71e606d29bce" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_4dd344c2-e4d9-48ee-a6f7-c6d0f8f91103" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_ba8fa318-ac76-4cf8-94ee-71e606d29bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock_3edc3b3b-e9ac-452b-b9b6-7cb513d76c82" xlink:href="sny-20221231.xsd#sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_4dd344c2-e4d9-48ee-a6f7-c6d0f8f91103" xlink:to="loc_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock_3edc3b3b-e9ac-452b-b9b6-7cb513d76c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock_dbc32112-7b9e-46f8-bbc1-81252d58568e" xlink:href="sny-20221231.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_4dd344c2-e4d9-48ee-a6f7-c6d0f8f91103" xlink:to="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock_dbc32112-7b9e-46f8-bbc1-81252d58568e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_b0186489-cb8d-44bc-b5dc-a5e0becea94b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_4dd344c2-e4d9-48ee-a6f7-c6d0f8f91103" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_b0186489-cb8d-44bc-b5dc-a5e0becea94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesTables" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalaccountantsfeesandservicesTables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_1f0656f6-cae6-4dc4-8bfe-1a8edbe3211c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsRemunerationTableTextBlock_0a822309-220f-4471-8213-4011d47767fd" xlink:href="sny-20221231.xsd#sny_AuditorsRemunerationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_1f0656f6-cae6-4dc4-8bfe-1a8edbe3211c" xlink:to="loc_sny_AuditorsRemunerationTableTextBlock_0a822309-220f-4471-8213-4011d47767fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022Tables" xlink:type="simple" xlink:href="sny-20221231.xsd#Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022Tables"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022Tables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_a5e2fbb5-0677-4a09-9610-bafd72ab86ad" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_92604792-40af-4eea-9ff3-ba765a82f08f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_a5e2fbb5-0677-4a09-9610-bafd72ab86ad" xlink:to="loc_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_92604792-40af-4eea-9ff3-ba765a82f08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock_1be0458c-a583-4d79-8247-27f269c74976" xlink:href="sny-20221231.xsd#sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_a5e2fbb5-0677-4a09-9610-bafd72ab86ad" xlink:to="loc_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock_1be0458c-a583-4d79-8247-27f269c74976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#BasisofpreparationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_69f4e165-37ce-40bd-bd0d-c395579f5659" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_0bf1d7ca-0263-4824-91ba-ba28bc493301" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_69f4e165-37ce-40bd-bd0d-c395579f5659" xlink:to="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_0bf1d7ca-0263-4824-91ba-ba28bc493301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_4e55ad2e-a92c-4b4f-8a2d-afed5a3b15bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_0bf1d7ca-0263-4824-91ba-ba28bc493301" xlink:to="loc_ifrs-full_GeographicalAreasAxis_4e55ad2e-a92c-4b4f-8a2d-afed5a3b15bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_98fca8e9-2e8d-4e27-95cf-88e76d1cc4f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_4e55ad2e-a92c-4b4f-8a2d-afed5a3b15bd" xlink:to="loc_ifrs-full_GeographicalAreasMember_98fca8e9-2e8d-4e27-95cf-88e76d1cc4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AR_460b5820-abab-4cfb-88b3-9ce133ab2dab" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_98fca8e9-2e8d-4e27-95cf-88e76d1cc4f0" xlink:to="loc_country_AR_460b5820-abab-4cfb-88b3-9ce133ab2dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TR_21f3d38a-aef5-4ac1-a246-dc30badf1026" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_TR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_98fca8e9-2e8d-4e27-95cf-88e76d1cc4f0" xlink:to="loc_country_TR_21f3d38a-aef5-4ac1-a246-dc30badf1026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_RU_9cead612-02be-4dd3-be62-9069ab5d3e6d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_RU"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_98fca8e9-2e8d-4e27-95cf-88e76d1cc4f0" xlink:to="loc_country_RU_9cead612-02be-4dd3-be62-9069ab5d3e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementAxis_89da3dc9-2b83-4b11-bc61-03da3b0e4770" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_0bf1d7ca-0263-4824-91ba-ba28bc493301" xlink:to="loc_sny_TypesOfAgreementAxis_89da3dc9-2b83-4b11-bc61-03da3b0e4770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_d41dc86e-dcec-4b68-be18-3e115b770e21" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementAxis_89da3dc9-2b83-4b11-bc61-03da3b0e4770" xlink:to="loc_sny_TypesOfAgreementDomain_d41dc86e-dcec-4b68-be18-3e115b770e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementWithGSKMember_948da269-6a3b-4f45-be9b-ffbe12c50b05" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementWithGSKMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementDomain_d41dc86e-dcec-4b68-be18-3e115b770e21" xlink:to="loc_sny_CollaborationAgreementWithGSKMember_948da269-6a3b-4f45-be9b-ffbe12c50b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_71af67cc-b458-41be-8caf-2b25488a7293" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_0bf1d7ca-0263-4824-91ba-ba28bc493301" xlink:to="loc_ifrs-full_CounterpartiesAxis_71af67cc-b458-41be-8caf-2b25488a7293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_985b2cf0-7cf3-4a3c-a946-b2560a90b219" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_71af67cc-b458-41be-8caf-2b25488a7293" xlink:to="loc_ifrs-full_CounterpartiesMember_985b2cf0-7cf3-4a3c-a946-b2560a90b219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_USGovernmentMember_ca4906dc-bd39-4c67-a8f0-6a420e9feb84" xlink:href="sny-20221231.xsd#sny_USGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_985b2cf0-7cf3-4a3c-a946-b2560a90b219" xlink:to="loc_sny_USGovernmentMember_ca4906dc-bd39-4c67-a8f0-6a420e9feb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_0bf1d7ca-0263-4824-91ba-ba28bc493301" xlink:to="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears_4ca535d8-8125-4c94-ad85-8a6b60fe48d3" xlink:href="sny-20221231.xsd#sny_CumulativeConsumerPriceInflationOverTheLastThreeYears"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears_4ca535d8-8125-4c94-ad85-8a6b60fe48d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfVaccineDosesToBeSupplied_93c6f2e0-1741-4be3-802d-ca66c8bdee92" xlink:href="sny-20221231.xsd#sny_NumberOfVaccineDosesToBeSupplied"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_sny_NumberOfVaccineDosesToBeSupplied_93c6f2e0-1741-4be3-802d-ca66c8bdee92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses_6f6b9aef-e8eb-4e69-ae98-4745cc92df04" xlink:href="sny-20221231.xsd#sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses_6f6b9aef-e8eb-4e69-ae98-4745cc92df04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilities_9a6d76a3-5ba7-404b-aff7-0d437865f75f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_ifrs-full_CurrentContractLiabilities_9a6d76a3-5ba7-404b-aff7-0d437865f75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_8709754e-8405-4919-adf8-5468960dfed0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_ifrs-full_ContractLiabilities_8709754e-8405-4919-adf8-5468960dfed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_0afc2f90-3d3b-4cb7-a622-b046f886dd7b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_0afc2f90-3d3b-4cb7-a622-b046f886dd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue_3642928e-8144-4346-a0af-f803b6b7f662" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_33c8e3c7-4f70-479f-8cbb-15d5b06f8222" xlink:to="loc_ifrs-full_PercentageOfEntitysRevenue_3642928e-8144-4346-a0af-f803b6b7f662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_58ef706f-81bf-4a2c-8cf7-3d98f4afe864" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_7a387e0b-490c-4c11-b689-c6d4d48aa826" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_58ef706f-81bf-4a2c-8cf7-3d98f4afe864" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_7a387e0b-490c-4c11-b689-c6d4d48aa826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_e4712b66-3b9a-451a-880d-18934d60b562" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_7a387e0b-490c-4c11-b689-c6d4d48aa826" xlink:to="loc_ifrs-full_RangeAxis_e4712b66-3b9a-451a-880d-18934d60b562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_82cfc647-97ae-4356-a833-e6f7fe59529d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_e4712b66-3b9a-451a-880d-18934d60b562" xlink:to="loc_ifrs-full_RangesMember_82cfc647-97ae-4356-a833-e6f7fe59529d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_02b2f145-dd56-4e39-9f7b-1f8ff1037c48" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_82cfc647-97ae-4356-a833-e6f7fe59529d" xlink:to="loc_ifrs-full_BottomOfRangeMember_02b2f145-dd56-4e39-9f7b-1f8ff1037c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_ce1e5cc9-e7cf-4d5e-9b3e-699732306ca1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_82cfc647-97ae-4356-a833-e6f7fe59529d" xlink:to="loc_ifrs-full_TopOfRangeMember_ce1e5cc9-e7cf-4d5e-9b3e-699732306ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_3e39e2f7-f0f9-435f-b061-919337de735a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_7a387e0b-490c-4c11-b689-c6d4d48aa826" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_3e39e2f7-f0f9-435f-b061-919337de735a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7823a9b9-c59d-449a-bc72-8464099e72fa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_3e39e2f7-f0f9-435f-b061-919337de735a" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7823a9b9-c59d-449a-bc72-8464099e72fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_4ba55cec-5a70-4428-8ac2-9ccf118b57db" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7823a9b9-c59d-449a-bc72-8464099e72fa" xlink:to="loc_ifrs-full_ComputerSoftwareMember_4ba55cec-5a70-4428-8ac2-9ccf118b57db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_64106510-5424-43f9-b483-68d27809e41a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_7a387e0b-490c-4c11-b689-c6d4d48aa826" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_64106510-5424-43f9-b483-68d27809e41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_b12c6692-e97d-4719-8ef9-0fb478bb49e0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_64106510-5424-43f9-b483-68d27809e41a" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_b12c6692-e97d-4719-8ef9-0fb478bb49e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_8d6524eb-3370-48b7-98b6-35b389dff2d0" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_eee04038-24ab-460b-b974-10c4d9bc50fc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_8d6524eb-3370-48b7-98b6-35b389dff2d0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_eee04038-24ab-460b-b974-10c4d9bc50fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_ba7974c6-996f-4117-b7c7-7e32f7ad6b4b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_eee04038-24ab-460b-b974-10c4d9bc50fc" xlink:to="loc_ifrs-full_RangeAxis_ba7974c6-996f-4117-b7c7-7e32f7ad6b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_d3082cd9-9485-4630-8410-bb9bc5fc0291" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_ba7974c6-996f-4117-b7c7-7e32f7ad6b4b" xlink:to="loc_ifrs-full_RangesMember_d3082cd9-9485-4630-8410-bb9bc5fc0291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_3a1b31d0-d1e5-4922-9afc-cab68dab4bea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_d3082cd9-9485-4630-8410-bb9bc5fc0291" xlink:to="loc_ifrs-full_BottomOfRangeMember_3a1b31d0-d1e5-4922-9afc-cab68dab4bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_e0a1b46f-6437-4a05-8c8c-71f752fe8045" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_d3082cd9-9485-4630-8410-bb9bc5fc0291" xlink:to="loc_ifrs-full_TopOfRangeMember_e0a1b46f-6437-4a05-8c8c-71f752fe8045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ec738a51-39c5-440c-a659-6aea1a5d838f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_eee04038-24ab-460b-b974-10c4d9bc50fc" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ec738a51-39c5-440c-a659-6aea1a5d838f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ec738a51-39c5-440c-a659-6aea1a5d838f" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BuildingsMember_731c2ca2-fdaf-42d8-8aba-95f219bdf149" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:to="loc_ifrs-full_BuildingsMember_731c2ca2-fdaf-42d8-8aba-95f219bdf149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_0e57ddf3-b471-4791-ac25-d9a7f7de7c42" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_0e57ddf3-b471-4791-ac25-d9a7f7de7c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MachineryAndEquipmentMember_7cd69791-be35-4a99-95d2-64b50594e730" xlink:href="sny-20221231.xsd#sny_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:to="loc_sny_MachineryAndEquipmentMember_7cd69791-be35-4a99-95d2-64b50594e730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_80059548-c836-4031-a1ef-5171d88156fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_300d5d53-debe-4cfc-b10c-c3881752cf27" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_80059548-c836-4031-a1ef-5171d88156fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_d44eeb1e-5db3-49f1-92b0-438b77b8942e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_eee04038-24ab-460b-b974-10c4d9bc50fc" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_d44eeb1e-5db3-49f1-92b0-438b77b8942e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_f6de8784-ac6b-4586-a826-c152b1c2c3dc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_d44eeb1e-5db3-49f1-92b0-438b77b8942e" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_f6de8784-ac6b-4586-a826-c152b1c2c3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTreasurySharesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesTreasurySharesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTreasurySharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_daee1e1a-737c-491a-bbe4-099819b8fa2d" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainLossOnPurchaseOfTreasuryShares_9d891869-802d-449f-a808-c0d672530d3a" xlink:href="sny-20221231.xsd#sny_GainLossOnPurchaseOfTreasuryShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_daee1e1a-737c-491a-bbe4-099819b8fa2d" xlink:to="loc_sny_GainLossOnPurchaseOfTreasuryShares_9d891869-802d-449f-a808-c0d672530d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainLossOnSaleOfTreasuryShares_2165f39a-050e-4d2e-875a-5e01e9e1c1c8" xlink:href="sny-20221231.xsd#sny_GainLossOnSaleOfTreasuryShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_daee1e1a-737c-491a-bbe4-099819b8fa2d" xlink:to="loc_sny_GainLossOnSaleOfTreasuryShares_2165f39a-050e-4d2e-875a-5e01e9e1c1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainLossOnImpairmentOfTreasuryShares_6d2591c5-0741-41f4-9072-ae4d610c4110" xlink:href="sny-20221231.xsd#sny_GainLossOnImpairmentOfTreasuryShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_daee1e1a-737c-491a-bbe4-099819b8fa2d" xlink:to="loc_sny_GainLossOnImpairmentOfTreasuryShares_6d2591c5-0741-41f4-9072-ae4d610c4110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainLossOnCancellationOfTreasuryShares_7443b77b-c5e6-49b5-a3fa-3931ad967388" xlink:href="sny-20221231.xsd#sny_GainLossOnCancellationOfTreasuryShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_daee1e1a-737c-491a-bbe4-099819b8fa2d" xlink:to="loc_sny_GainLossOnCancellationOfTreasuryShares_7443b77b-c5e6-49b5-a3fa-3931ad967388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesProvisionforRisksDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesProvisionforRisksDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesProvisionforRisksDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_a1976763-24fe-4119-a01e-1c0ddf1aadbb" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsRecordedForFutureOperatingLosses_15fe4a7e-39a6-4183-a219-22117b291b00" xlink:href="sny-20221231.xsd#sny_ProvisionsRecordedForFutureOperatingLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_a1976763-24fe-4119-a01e-1c0ddf1aadbb" xlink:to="loc_sny_ProvisionsRecordedForFutureOperatingLosses_15fe4a7e-39a6-4183-a219-22117b291b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_a3edc981-4ce1-4914-80bb-617a382b83e8" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_b4591fd7-3e94-420e-9594-80503018793a" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_a3edc981-4ce1-4914-80bb-617a382b83e8" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_b4591fd7-3e94-420e-9594-80503018793a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_12001036-2fcb-4717-bc93-ca4b39d32dfb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_b4591fd7-3e94-420e-9594-80503018793a" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_12001036-2fcb-4717-bc93-ca4b39d32dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_576aa834-6ffe-4bf9-a87d-05cc56705f90" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_12001036-2fcb-4717-bc93-ca4b39d32dfb" xlink:to="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_576aa834-6ffe-4bf9-a87d-05cc56705f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_54996e6f-9306-48ed-86a8-cc8d0eca4fac" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EliminationOfIntersegmentAmountsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_576aa834-6ffe-4bf9-a87d-05cc56705f90" xlink:to="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_54996e6f-9306-48ed-86a8-cc8d0eca4fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_03130206-55d5-46aa-a2ec-e70caf095633" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_b4591fd7-3e94-420e-9594-80503018793a" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_03130206-55d5-46aa-a2ec-e70caf095633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_86657648-89e2-496a-b6d5-e2e214f7e938" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_03130206-55d5-46aa-a2ec-e70caf095633" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_86657648-89e2-496a-b6d5-e2e214f7e938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember_6981c1a7-9928-4913-93a8-d7cd4a40e234" xlink:href="sny-20221231.xsd#sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_86657648-89e2-496a-b6d5-e2e214f7e938" xlink:to="loc_sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember_6981c1a7-9928-4913-93a8-d7cd4a40e234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems_db3c571b-77e2-4a37-bd09-10d9e125699c" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable_b4591fd7-3e94-420e-9594-80503018793a" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems_db3c571b-77e2-4a37-bd09-10d9e125699c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_6d36db59-d8a0-4375-a6d2-1aaa99a6db4a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems_db3c571b-77e2-4a37-bd09-10d9e125699c" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_6d36db59-d8a0-4375-a6d2-1aaa99a6db4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_fae58dd5-80ed-4185-b954-731c8f792d71" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable_383b282f-de64-4b43-bd72-42e1399663c6" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_fae58dd5-80ed-4185-b954-731c8f792d71" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable_383b282f-de64-4b43-bd72-42e1399663c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7027486d-680c-46bf-b0e8-6a5042a0f315" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable_383b282f-de64-4b43-bd72-42e1399663c6" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7027486d-680c-46bf-b0e8-6a5042a0f315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_915a2775-33a3-4a5e-8c50-8967f900c025" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_7027486d-680c-46bf-b0e8-6a5042a0f315" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_915a2775-33a3-4a5e-8c50-8967f900c025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionPlansMember_e63f31e6-5785-4441-a857-75510c7b2a61" xlink:href="sny-20221231.xsd#sny_StockOptionPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_915a2775-33a3-4a5e-8c50-8967f900c025" xlink:to="loc_sny_StockOptionPlansMember_e63f31e6-5785-4441-a857-75510c7b2a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlansMember_25f5c100-3a4c-4baa-a233-976b686adb6c" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_915a2775-33a3-4a5e-8c50-8967f900c025" xlink:to="loc_sny_RestrictedSharePlansMember_25f5c100-3a4c-4baa-a233-976b686adb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems_33de09ba-3d7b-492d-b5b8-27c84d70c525" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable_383b282f-de64-4b43-bd72-42e1399663c6" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems_33de09ba-3d7b-492d-b5b8-27c84d70c525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OptionVestingPeriod_18c57019-996f-48ee-b95c-7c39e3eeaf79" xlink:href="sny-20221231.xsd#sny_OptionVestingPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems_33de09ba-3d7b-492d-b5b8-27c84d70c525" xlink:to="loc_sny_OptionVestingPeriod_18c57019-996f-48ee-b95c-7c39e3eeaf79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_6e6f3c03-35b6-496e-a278-de65c13e91e4" xlink:href="sny-20221231.xsd#sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems_33de09ba-3d7b-492d-b5b8-27c84d70c525" xlink:to="loc_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_6e6f3c03-35b6-496e-a278-de65c13e91e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SummaryofsignificantaccountingpoliciesSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_6cabe930-1128-4708-b9e9-97d92cc88021" xlink:href="sny-20221231.xsd#sny_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOperatingSegments_06e0abb9-95ec-4e1a-b58f-37e7506e93b4" xlink:href="sny-20221231.xsd#sny_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract_6cabe930-1128-4708-b9e9-97d92cc88021" xlink:to="loc_sny_NumberOfOperatingSegments_06e0abb9-95ec-4e1a-b58f-37e7506e93b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_RelatedPartyAbstract_96d3d90e-5aa9-495e-95c9-e3808d2db5dc" xlink:href="sny-20221231.xsd#sny_RelatedPartyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_96d3d90e-5aa9-495e-95c9-e3808d2db5dc" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_eb78ad14-fc90-44c9-84b8-73fe5b15ca9d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_ifrs-full_CounterpartiesAxis_eb78ad14-fc90-44c9-84b8-73fe5b15ca9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_a7af9141-d16c-42df-9952-5c3070cf1449" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_eb78ad14-fc90-44c9-84b8-73fe5b15ca9d" xlink:to="loc_ifrs-full_CounterpartiesMember_a7af9141-d16c-42df-9952-5c3070cf1449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_44be4d81-5445-4283-90de-0def18bb7a73" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_a7af9141-d16c-42df-9952-5c3070cf1449" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_44be4d81-5445-4283-90de-0def18bb7a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_3758e43c-e3f7-46ed-84d1-77190f382022" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_sny_PrincipalAlliancesAxis_3758e43c-e3f7-46ed-84d1-77190f382022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_b288af3e-1adf-4ba2-8e80-f6d1d52d3cd8" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesAxis_3758e43c-e3f7-46ed-84d1-77190f382022" xlink:to="loc_sny_PrincipalAlliancesDomain_b288af3e-1adf-4ba2-8e80-f6d1d52d3cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember_ccf8a6df-7523-4174-b4d5-1fd1fb3f86bf" xlink:href="sny-20221231.xsd#sny_AntibodiesCollaborationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesDomain_b288af3e-1adf-4ba2-8e80-f6d1d52d3cd8" xlink:to="loc_sny_AntibodiesCollaborationAgreementMember_ccf8a6df-7523-4174-b4d5-1fd1fb3f86bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImmunoOncologyCollaborationAgreementMember_3b16aee8-ecd3-4fdd-b3aa-6309ff273537" xlink:href="sny-20221231.xsd#sny_ImmunoOncologyCollaborationAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesDomain_b288af3e-1adf-4ba2-8e80-f6d1d52d3cd8" xlink:to="loc_sny_ImmunoOncologyCollaborationAgreementMember_3b16aee8-ecd3-4fdd-b3aa-6309ff273537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesMember_360b7fb8-e59f-4e62-9201-75e9068b013e" xlink:href="sny-20221231.xsd#sny_AntibodiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesDomain_b288af3e-1adf-4ba2-8e80-f6d1d52d3cd8" xlink:to="loc_sny_AntibodiesMember_360b7fb8-e59f-4e62-9201-75e9068b013e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1eced509-0124-489a-87b8-5c6c4d99edcb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1eced509-0124-489a-87b8-5c6c4d99edcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_3f2ec264-4a06-427b-9954-e60d6a161dcf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1eced509-0124-489a-87b8-5c6c4d99edcb" xlink:to="loc_ifrs-full_GeographicalAreasMember_3f2ec264-4a06-427b-9954-e60d6a161dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eca94dbb-a3ba-420c-941e-b1971a904230" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_3f2ec264-4a06-427b-9954-e60d6a161dcf" xlink:to="loc_country_US_eca94dbb-a3ba-420c-941e-b1971a904230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OutsideUnitedStatesMember_5929d648-7f9d-4b0e-8f78-9224590fcf98" xlink:href="sny-20221231.xsd#sny_OutsideUnitedStatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_3f2ec264-4a06-427b-9954-e60d6a161dcf" xlink:to="loc_sny_OutsideUnitedStatesMember_5929d648-7f9d-4b0e-8f78-9224590fcf98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_8e89d77f-8276-49fe-b05b-2ae0ae6d1b2e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_ifrs-full_RangeAxis_8e89d77f-8276-49fe-b05b-2ae0ae6d1b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_f1162a31-a104-442b-99d9-d220c0166739" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_8e89d77f-8276-49fe-b05b-2ae0ae6d1b2e" xlink:to="loc_ifrs-full_RangesMember_f1162a31-a104-442b-99d9-d220c0166739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_f3054c53-4eef-4cd8-b719-01fcf8675ba9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_f1162a31-a104-442b-99d9-d220c0166739" xlink:to="loc_ifrs-full_BottomOfRangeMember_f3054c53-4eef-4cd8-b719-01fcf8675ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_c9442100-0e75-47ad-9c20-ce0bafdab0ad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_f1162a31-a104-442b-99d9-d220c0166739" xlink:to="loc_ifrs-full_TopOfRangeMember_c9442100-0e75-47ad-9c20-ce0bafdab0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementAxis_878a246a-60ed-403d-8fb0-ff754da7626a" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_sny_TypesOfAgreementAxis_878a246a-60ed-403d-8fb0-ff754da7626a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementAxis_878a246a-60ed-403d-8fb0-ff754da7626a" xlink:to="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesOfAntibodiesFirstAchievementMember_eba3b9b0-b625-48f9-a65b-049e081bc926" xlink:href="sny-20221231.xsd#sny_SalesOfAntibodiesFirstAchievementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:to="loc_sny_SalesOfAntibodiesFirstAchievementMember_eba3b9b0-b625-48f9-a65b-049e081bc926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesOfAntibodiesSecondAchievementMember_efcab50e-d355-490c-9f6c-6a563801295d" xlink:href="sny-20221231.xsd#sny_SalesOfAntibodiesSecondAchievementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:to="loc_sny_SalesOfAntibodiesSecondAchievementMember_efcab50e-d355-490c-9f6c-6a563801295d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PriorAgreementMember_58293ae7-5367-46e4-b830-3fe5bfc97174" xlink:href="sny-20221231.xsd#sny_PriorAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:to="loc_sny_PriorAgreementMember_58293ae7-5367-46e4-b830-3fe5bfc97174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NewAgreementMember_50297cd1-9b95-4ccb-8fc0-a9a512669d02" xlink:href="sny-20221231.xsd#sny_NewAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:to="loc_sny_NewAgreementMember_50297cd1-9b95-4ccb-8fc0-a9a512669d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesOfAntibodiesThirdAchievementMember_f4119c12-2fc1-410b-b807-a802aabff235" xlink:href="sny-20221231.xsd#sny_SalesOfAntibodiesThirdAchievementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementDomain_bd4db293-9158-49ff-a6c6-7ed48c5f3213" xlink:to="loc_sny_SalesOfAntibodiesThirdAchievementMember_f4119c12-2fc1-410b-b807-a802aabff235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a6e9eba4-4268-4ea9-9067-dc3291b7cbc5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_srt_ProductOrServiceAxis_a6e9eba4-4268-4ea9-9067-dc3291b7cbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_65411acf-8093-4c13-aa83-f7c1ce0fc7db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a6e9eba4-4268-4ea9-9067-dc3291b7cbc5" xlink:to="loc_srt_ProductsAndServicesDomain_65411acf-8093-4c13-aa83-f7c1ce0fc7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesAllianceMember_d408631f-1b5c-4ffc-a6b0-d961a68bca17" xlink:href="sny-20221231.xsd#sny_AntibodiesAllianceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_65411acf-8093-4c13-aa83-f7c1ce0fc7db" xlink:to="loc_sny_AntibodiesAllianceMember_d408631f-1b5c-4ffc-a6b0-d961a68bca17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesMember_7bb7807f-5a2e-45fc-b2e8-309ab870acc9" xlink:href="sny-20221231.xsd#sny_AntibodiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_65411acf-8093-4c13-aa83-f7c1ce0fc7db" xlink:to="loc_sny_AntibodiesMember_7bb7807f-5a2e-45fc-b2e8-309ab870acc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_76fa4235-5325-4fee-8964-121daf0e1b42" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_76fa4235-5325-4fee-8964-121daf0e1b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsMember_ebe9ca96-f05f-4cd2-949f-5a6433ad2a6d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_76fa4235-5325-4fee-8964-121daf0e1b42" xlink:to="loc_ifrs-full_NonadjustingEventsMember_ebe9ca96-f05f-4cd2-949f-5a6433ad2a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MajorCollaborationAgreementMember_4b1b6c07-0503-49b6-9450-b441b9da5e79" xlink:href="sny-20221231.xsd#sny_MajorCollaborationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_ebe9ca96-f05f-4cd2-949f-5a6433ad2a6d" xlink:to="loc_sny_MajorCollaborationAgreementMember_4b1b6c07-0503-49b6-9450-b441b9da5e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_696cff9b-c82f-452a-b10d-f1b4bd27d1fb" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfAgreementsSigned_2bc85993-86db-4868-9274-603977cbda83" xlink:href="sny-20221231.xsd#sny_NumberOfAgreementsSigned"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_NumberOfAgreementsSigned_2bc85993-86db-4868-9274-603977cbda83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFunded_a47d9109-c244-4378-acdb-6c524c3f3941" xlink:href="sny-20221231.xsd#sny_PercentageOfSecondPartOfDevelopmentCostsFunded"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFunded_a47d9109-c244-4378-acdb-6c524c3f3941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty_88793e7e-293c-491d-bde6-29a6b43081d2" xlink:href="sny-20221231.xsd#sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty_88793e7e-293c-491d-bde6-29a6b43081d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_f24f2400-7fc3-446f-9203-3d29ebda6e93" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitShareOnCounterpartiesProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_f24f2400-7fc3-446f-9203-3d29ebda6e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_50ea40d1-fd13-4912-a940-7a2bbc8d39ef" xlink:href="sny-20221231.xsd#sny_PercentageOfCumulativeDevelopmentCostsReimbursed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_50ea40d1-fd13-4912-a940-7a2bbc8d39ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared_4d26751a-6ac0-4ab9-9085-4050963b6ca8" xlink:href="sny-20221231.xsd#sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared_4d26751a-6ac0-4ab9-9085-4050963b6ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations_885ce88a-b2c1-46d7-962f-ec7bb1c80a48" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations_885ce88a-b2c1-46d7-962f-ec7bb1c80a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitsArisingFromCommercialOperations_bd9c71f4-3c66-4477-903f-c49c0db5ecb5" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitsArisingFromCommercialOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfProfitsArisingFromCommercialOperations_bd9c71f4-3c66-4477-903f-c49c0db5ecb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfLossesArisingFromCommercialOperations_57b16a2e-1b27-4938-8df3-978054f1ac4c" xlink:href="sny-20221231.xsd#sny_PercentageOfLossesArisingFromCommercialOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PercentageOfLossesArisingFromCommercialOperations_57b16a2e-1b27-4938-8df3-978054f1ac4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPayments_96a9ada7-5eb4-4bc4-9fd5-e2714beec4b2" xlink:href="sny-20221231.xsd#sny_NumberOfPayments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_NumberOfPayments_96a9ada7-5eb4-4bc4-9fd5-e2714beec4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentRelatedToAttainmentOfGoal_bea2bfd6-ef6f-4d21-a2ce-3afba21efbcd" xlink:href="sny-20221231.xsd#sny_PaymentRelatedToAttainmentOfGoal"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_PaymentRelatedToAttainmentOfGoal_bea2bfd6-ef6f-4d21-a2ce-3afba21efbcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_cec277fe-bfda-4dfb-a384-3fc486004184" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_cec277fe-bfda-4dfb-a384-3fc486004184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltyExpensePercentage_7ba9c988-da44-4dd4-b0ca-87852ea63411" xlink:href="sny-20221231.xsd#sny_RoyaltyExpensePercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_b2675874-120d-4130-836d-16e5c27c2d1b" xlink:to="loc_sny_RoyaltyExpensePercentage_7ba9c988-da44-4dd4-b0ca-87852ea63411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_RelatedPartyAbstract_d3bbf601-2c28-4cc3-90ab-bcddb27e0d55" xlink:href="sny-20221231.xsd#sny_RelatedPartyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_d3bbf601-2c28-4cc3-90ab-bcddb27e0d55" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_677d8945-3c1a-41d9-a52d-3a5d83e07075" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_ifrs-full_CounterpartiesAxis_677d8945-3c1a-41d9-a52d-3a5d83e07075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_0d05d440-e7eb-4174-b22b-dc1cfa3ced92" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_677d8945-3c1a-41d9-a52d-3a5d83e07075" xlink:to="loc_ifrs-full_CounterpartiesMember_0d05d440-e7eb-4174-b22b-dc1cfa3ced92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_92bc7ecb-bfe7-4177-8a38-304495480f2b" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_0d05d440-e7eb-4174-b22b-dc1cfa3ced92" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_92bc7ecb-bfe7-4177-8a38-304495480f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_fcefdce6-e6a1-40bc-9a93-e6ffb90202f2" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_sny_PrincipalAlliancesAxis_fcefdce6-e6a1-40bc-9a93-e6ffb90202f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_0beba9e0-081b-4475-9afd-1e3f8c974cdf" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesAxis_fcefdce6-e6a1-40bc-9a93-e6ffb90202f2" xlink:to="loc_sny_PrincipalAlliancesDomain_0beba9e0-081b-4475-9afd-1e3f8c974cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImmunoOncologyCollaborationAgreementMember_f34d578e-eae0-40d8-9d73-026f9a3d5b60" xlink:href="sny-20221231.xsd#sny_ImmunoOncologyCollaborationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesDomain_0beba9e0-081b-4475-9afd-1e3f8c974cdf" xlink:to="loc_sny_ImmunoOncologyCollaborationAgreementMember_f34d578e-eae0-40d8-9d73-026f9a3d5b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementAxis_f46bffc4-882d-4abd-b784-4321973dbdc0" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_sny_TypesOfAgreementAxis_f46bffc4-882d-4abd-b784-4321973dbdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_dd842930-319b-454d-9911-1eeb72740edf" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementAxis_f46bffc4-882d-4abd-b784-4321973dbdc0" xlink:to="loc_sny_TypesOfAgreementDomain_dd842930-319b-454d-9911-1eeb72740edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DevelopmentOfCemiplimabREGN2810Member_02e0786f-7b7b-4687-90f1-b476a807d7c1" xlink:href="sny-20221231.xsd#sny_DevelopmentOfCemiplimabREGN2810Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementDomain_dd842930-319b-454d-9911-1eeb72740edf" xlink:to="loc_sny_DevelopmentOfCemiplimabREGN2810Member_02e0786f-7b7b-4687-90f1-b476a807d7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MilestoneTypesAxis_fb1abca5-50ac-400c-aecc-d631399294d6" xlink:href="sny-20221231.xsd#sny_MilestoneTypesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_sny_MilestoneTypesAxis_fb1abca5-50ac-400c-aecc-d631399294d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MilestoneTypesDomain_aea610b2-d306-41b7-8f0c-5e536bf0eb6b" xlink:href="sny-20221231.xsd#sny_MilestoneTypesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_MilestoneTypesAxis_fb1abca5-50ac-400c-aecc-d631399294d6" xlink:to="loc_sny_MilestoneTypesDomain_aea610b2-d306-41b7-8f0c-5e536bf0eb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_USFDAApprovalMember_dd61f7a0-4fcb-4db2-b22a-00252a6e658e" xlink:href="sny-20221231.xsd#sny_USFDAApprovalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_MilestoneTypesDomain_aea610b2-d306-41b7-8f0c-5e536bf0eb6b" xlink:to="loc_sny_USFDAApprovalMember_dd61f7a0-4fcb-4db2-b22a-00252a6e658e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ecb431b5-921d-4801-96a1-1e9054621a0c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ecb431b5-921d-4801-96a1-1e9054621a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsMember_e5a52ff3-9fed-4907-b9cf-9e39d4262026" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ecb431b5-921d-4801-96a1-1e9054621a0c" xlink:to="loc_ifrs-full_NonadjustingEventsMember_e5a52ff3-9fed-4907-b9cf-9e39d4262026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MajorCollaborationAgreementMember_a1a33b6d-0952-42f7-880b-c3158cfae782" xlink:href="sny-20221231.xsd#sny_MajorCollaborationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_e5a52ff3-9fed-4907-b9cf-9e39d4262026" xlink:to="loc_sny_MajorCollaborationAgreementMember_a1a33b6d-0952-42f7-880b-c3158cfae782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ce9b0a64-4343-4dca-b17d-82479ed12db3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ce9b0a64-4343-4dca-b17d-82479ed12db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_9fe48bc6-bbb0-4e7c-9e21-175babd060ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ce9b0a64-4343-4dca-b17d-82479ed12db3" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_9fe48bc6-bbb0-4e7c-9e21-175babd060ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_5e800797-7cbf-4907-8a0c-80a181f80c12" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_9fe48bc6-bbb0-4e7c-9e21-175babd060ef" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_5e800797-7cbf-4907-8a0c-80a181f80c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:href="sny-20221231.xsd#sny_DisclosureOfPrincipalAlliancesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_6f1430af-0d25-411e-9cba-87a75475f982" xlink:to="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfAgreementsSigned_6c8c9c8b-c736-4023-9565-fd789c5dc58d" xlink:href="sny-20221231.xsd#sny_NumberOfAgreementsSigned"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_NumberOfAgreementsSigned_6c8c9c8b-c736-4023-9565-fd789c5dc58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PriorDevelopmentBudget_afd34683-c14b-483f-8297-fcfa17fdafa9" xlink:href="sny-20221231.xsd#sny_PriorDevelopmentBudget"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_PriorDevelopmentBudget_afd34683-c14b-483f-8297-fcfa17fdafa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1_e5bcd005-9105-409c-98ce-57721ee581fa" xlink:href="sny-20221231.xsd#sny_ContractualAgreementForAntiProgrammedCellDeathProtein1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1_e5bcd005-9105-409c-98ce-57721ee581fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany_d556cf85-6fe3-4f82-852b-668d5721ae6b" xlink:href="sny-20221231.xsd#sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany_d556cf85-6fe3-4f82-852b-668d5721ae6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment_88a6ee9e-9fd2-4100-9958-bab57f781104" xlink:href="sny-20221231.xsd#sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment_88a6ee9e-9fd2-4100-9958-bab57f781104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment_22f253a5-cedb-4b8e-b2bc-dd5144491f2c" xlink:href="sny-20221231.xsd#sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment_22f253a5-cedb-4b8e-b2bc-dd5144491f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_54064b10-3000-43d5-8058-acf73fd220d1" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitShareOnCounterpartiesProfit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_54064b10-3000-43d5-8058-acf73fd220d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_2f4a79c6-7b3a-4e77-9f51-9db4595da515" xlink:href="sny-20221231.xsd#sny_PercentageOfCumulativeDevelopmentCostsReimbursed"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_2f4a79c6-7b3a-4e77-9f51-9db4595da515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements_4fc9c4da-e6a4-4026-be1f-0e8d87be7bb9" xlink:href="sny-20221231.xsd#sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements_4fc9c4da-e6a4-4026-be1f-0e8d87be7bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements_6585d029-e6df-42fb-ab1a-fa2baeee85cc" xlink:href="sny-20221231.xsd#sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements_6585d029-e6df-42fb-ab1a-fa2baeee85cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltyIncomePercentage_9d86720f-7070-4e5c-a72c-c58d7d8ce8a9" xlink:href="sny-20221231.xsd#sny_RoyaltyIncomePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_RoyaltyIncomePercentage_9d86720f-7070-4e5c-a72c-c58d7d8ce8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_4f3ab12c-78eb-4a0a-86a0-2333440ef835" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_4f3ab12c-78eb-4a0a-86a0-2333440ef835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProceedsFromCollaborationAgreements_cbf061e2-0404-4f6e-97ae-b55aefb2c435" xlink:href="sny-20221231.xsd#sny_ProceedsFromCollaborationAgreements"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_sny_ProceedsFromCollaborationAgreements_cbf061e2-0404-4f6e-97ae-b55aefb2c435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_e1ae25d9-35c5-4562-811b-55dd44e097c7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_e5364dd5-6d31-42dc-84b8-018615beecd0" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_e1ae25d9-35c5-4562-811b-55dd44e097c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_RelatedPartyAbstract_3938089f-9237-4b5d-9687-d3f786845a07" xlink:href="sny-20221231.xsd#sny_RelatedPartyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_3938089f-9237-4b5d-9687-d3f786845a07" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_53116828-9dff-4b78-b9e8-db0d1938d4d9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:to="loc_ifrs-full_CounterpartiesAxis_53116828-9dff-4b78-b9e8-db0d1938d4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_112b7958-829f-4816-93d8-0bcd8e4c70d2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_53116828-9dff-4b78-b9e8-db0d1938d4d9" xlink:to="loc_ifrs-full_CounterpartiesMember_112b7958-829f-4816-93d8-0bcd8e4c70d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_4493e050-ca54-4759-8452-a2b04fe0737c" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_112b7958-829f-4816-93d8-0bcd8e4c70d2" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_4493e050-ca54-4759-8452-a2b04fe0737c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_d4fcff7f-88c5-4b94-8c69-134bcf515e3a" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:to="loc_sny_PrincipalAlliancesAxis_d4fcff7f-88c5-4b94-8c69-134bcf515e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_6e333bff-e60b-423c-968b-faf31d72a89c" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesAxis_d4fcff7f-88c5-4b94-8c69-134bcf515e3a" xlink:to="loc_sny_PrincipalAlliancesDomain_6e333bff-e60b-423c-968b-faf31d72a89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TwoThousandFourteenAmendedInvestmentAgreementMember_4dd5cc64-bb19-4468-b3e7-da9b33ab0ecf" xlink:href="sny-20221231.xsd#sny_TwoThousandFourteenAmendedInvestmentAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesDomain_6e333bff-e60b-423c-968b-faf31d72a89c" xlink:to="loc_sny_TwoThousandFourteenAmendedInvestmentAgreementMember_4dd5cc64-bb19-4468-b3e7-da9b33ab0ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockAxis_2c8e4321-3d85-496a-80d0-b499d989b20f" xlink:href="sny-20221231.xsd#sny_SaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:to="loc_sny_SaleOfStockAxis_2c8e4321-3d85-496a-80d0-b499d989b20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockDomain_12e24449-d9df-4b79-aaf5-2a1e51a5f569" xlink:href="sny-20221231.xsd#sny_SaleOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_SaleOfStockAxis_2c8e4321-3d85-496a-80d0-b499d989b20f" xlink:to="loc_sny_SaleOfStockDomain_12e24449-d9df-4b79-aaf5-2a1e51a5f569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PublicOfferingMember_405acf95-b024-42e3-ab8c-e7c4e014b138" xlink:href="sny-20221231.xsd#sny_PublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_SaleOfStockDomain_12e24449-d9df-4b79-aaf5-2a1e51a5f569" xlink:to="loc_sny_PublicOfferingMember_405acf95-b024-42e3-ab8c-e7c4e014b138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_00eb16c8-02d7-454d-944f-31287bea58a0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_00eb16c8-02d7-454d-944f-31287bea58a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_db60da77-8f4f-4294-af04-044f42d64568" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_00eb16c8-02d7-454d-944f-31287bea58a0" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_db60da77-8f4f-4294-af04-044f42d64568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_b70f8c33-a9ab-4718-9abe-c970abcd8216" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_db60da77-8f4f-4294-af04-044f42d64568" xlink:to="loc_sny_RegeneronMember_b70f8c33-a9ab-4718-9abe-c970abcd8216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_8caf460e-e14d-4107-af71-db9cd5d6a6e4" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_345a5e6f-1b20-4c7a-9b0b-5432acefa30b" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_8caf460e-e14d-4107-af71-db9cd5d6a6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumOwnershipPercentageAllowedToAcquire_5f1b5d47-678b-4837-be68-2b612b29d002" xlink:href="sny-20221231.xsd#sny_MaximumOwnershipPercentageAllowedToAcquire"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_8caf460e-e14d-4107-af71-db9cd5d6a6e4" xlink:to="loc_sny_MaximumOwnershipPercentageAllowedToAcquire_5f1b5d47-678b-4837-be68-2b612b29d002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_c2aebb55-a35f-4f13-8556-410b64dfc4e0" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems_8caf460e-e14d-4107-af71-db9cd5d6a6e4" xlink:to="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_c2aebb55-a35f-4f13-8556-410b64dfc4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_RelatedPartyAbstract_2a334772-3a8e-47f3-a43e-7a8b256a6031" xlink:href="sny-20221231.xsd#sny_RelatedPartyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_2a334772-3a8e-47f3-a43e-7a8b256a6031" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_ee8d3fd4-aee4-4fbf-9ec9-cb843a95edd1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:to="loc_ifrs-full_CounterpartiesAxis_ee8d3fd4-aee4-4fbf-9ec9-cb843a95edd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_33287893-e31d-4dba-ae31-7980b2906294" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_ee8d3fd4-aee4-4fbf-9ec9-cb843a95edd1" xlink:to="loc_ifrs-full_CounterpartiesMember_33287893-e31d-4dba-ae31-7980b2906294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BristolMyersSquibbMember_27756cf2-6659-4c4b-acf2-4972815ecf6e" xlink:href="sny-20221231.xsd#sny_BristolMyersSquibbMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_33287893-e31d-4dba-ae31-7980b2906294" xlink:to="loc_sny_BristolMyersSquibbMember_27756cf2-6659-4c4b-acf2-4972815ecf6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_941bf14e-0c74-4e89-a74c-8a667aecb884" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_33287893-e31d-4dba-ae31-7980b2906294" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_941bf14e-0c74-4e89-a74c-8a667aecb884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_18dbd8cf-ab53-41dd-9cf9-777124bcefaf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_18dbd8cf-ab53-41dd-9cf9-777124bcefaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_669b8f86-a9c9-4f6c-821c-d99567c7e081" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_18dbd8cf-ab53-41dd-9cf9-777124bcefaf" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_669b8f86-a9c9-4f6c-821c-d99567c7e081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember_249b572f-04c2-4d9b-8994-38dad2155ae8" xlink:href="sny-20221231.xsd#sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_669b8f86-a9c9-4f6c-821c-d99567c7e081" xlink:to="loc_sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember_249b572f-04c2-4d9b-8994-38dad2155ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementAxis_aeb5ead3-c9b1-42ee-a48b-3e35fe64fb06" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:to="loc_sny_TypesOfAgreementAxis_aeb5ead3-c9b1-42ee-a48b-3e35fe64fb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_28920645-7684-4600-9564-0c05fe8e815b" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementAxis_aeb5ead3-c9b1-42ee-a48b-3e35fe64fb06" xlink:to="loc_sny_TypesOfAgreementDomain_28920645-7684-4600-9564-0c05fe8e815b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NewAgreementMember_ff709602-2c6a-47ff-9c54-74b066858918" xlink:href="sny-20221231.xsd#sny_NewAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementDomain_28920645-7684-4600-9564-0c05fe8e815b" xlink:to="loc_sny_NewAgreementMember_ff709602-2c6a-47ff-9c54-74b066858918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PriorAgreementMember_58e21c71-530a-4194-a692-11fe70dd509a" xlink:href="sny-20221231.xsd#sny_PriorAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementDomain_28920645-7684-4600-9564-0c05fe8e815b" xlink:to="loc_sny_PriorAgreementMember_58e21c71-530a-4194-a692-11fe70dd509a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_d2ab0358-48e4-4cd5-97ec-146e46a0c9c2" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:to="loc_sny_PrincipalAlliancesAxis_d2ab0358-48e4-4cd5-97ec-146e46a0c9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_6313d7f3-cd3e-4723-83bb-34a267466823" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesAxis_d2ab0358-48e4-4cd5-97ec-146e46a0c9c2" xlink:to="loc_sny_PrincipalAlliancesDomain_6313d7f3-cd3e-4723-83bb-34a267466823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember_b6cd0faf-0b92-488c-9e83-fc40b6d0405e" xlink:href="sny-20221231.xsd#sny_AntibodiesCollaborationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesDomain_6313d7f3-cd3e-4723-83bb-34a267466823" xlink:to="loc_sny_AntibodiesCollaborationAgreementMember_b6cd0faf-0b92-488c-9e83-fc40b6d0405e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:href="sny-20221231.xsd#sny_DisclosureOfPrincipalAlliancesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_3a005ba0-a164-497a-85d8-2b8d9302753f" xlink:to="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfProductsJointlyDeveloped_7008b85e-cb14-46af-969b-02c9ed68d923" xlink:href="sny-20221231.xsd#sny_NumberOfProductsJointlyDeveloped"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:to="loc_sny_NumberOfProductsJointlyDeveloped_7008b85e-cb14-46af-969b-02c9ed68d923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltiesPaymentsMadeBySanofi_98f56b2f-1c09-4ef5-abe2-b5e4494f5c0d" xlink:href="sny-20221231.xsd#sny_RoyaltiesPaymentsMadeBySanofi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:to="loc_sny_RoyaltiesPaymentsMadeBySanofi_98f56b2f-1c09-4ef5-abe2-b5e4494f5c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_2c8e70a4-cd07-49b0-90b1-831dee8114d6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_2c8e70a4-cd07-49b0-90b1-831dee8114d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_0cfca452-db10-4cfc-b035-c272df7eb1a5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfPrincipalAlliancesLineItems_dfea0326-ef2b-46ab-a832-077ff750b9dc" xlink:to="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_0cfca452-db10-4cfc-b035-c272df7eb1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_66e3a0ec-fb48-494a-a859-5b9fb8b51bef" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_66e3a0ec-fb48-494a-a859-5b9fb8b51bef" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_49ab173d-14ae-4836-aa77-585f29065129" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_49ab173d-14ae-4836-aa77-585f29065129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_b8473af6-e22c-4091-8593-e18763411e87" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_49ab173d-14ae-4836-aa77-585f29065129" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_b8473af6-e22c-4091-8593-e18763411e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixPharmaceuticalsIncMember_acbe6ad4-2292-4269-8335-826fc8e3817f" xlink:href="sny-20221231.xsd#sny_AmunixPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_b8473af6-e22c-4091-8593-e18763411e87" xlink:to="loc_sny_AmunixPharmaceuticalsIncMember_acbe6ad4-2292-4269-8335-826fc8e3817f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_30b2537f-c773-4f8c-a573-00b10b7b9ed5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_30b2537f-c773-4f8c-a573-00b10b7b9ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_84ed9c86-4205-4d76-aa64-1b5f90e3501f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_30b2537f-c773-4f8c-a573-00b10b7b9ed5" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_84ed9c86-4205-4d76-aa64-1b5f90e3501f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_a0e66c7a-6a00-4a3a-bc94-ad1f9e262a2b" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_84ed9c86-4205-4d76-aa64-1b5f90e3501f" xlink:to="loc_sny_EuroapiMember_a0e66c7a-6a00-4a3a-bc94-ad1f9e262a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_28ff25d6-bafd-43cb-8755-64e098611cad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_CounterpartiesAxis_28ff25d6-bafd-43cb-8755-64e098611cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_fdec2bc4-8b12-4fbd-92f7-8779a41ee840" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_28ff25d6-bafd-43cb-8755-64e098611cad" xlink:to="loc_ifrs-full_CounterpartiesMember_fdec2bc4-8b12-4fbd-92f7-8779a41ee840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EPICBPIFranceMember_1141a219-6acf-4b5e-a255-96141c872db1" xlink:href="sny-20221231.xsd#sny_EPICBPIFranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_fdec2bc4-8b12-4fbd-92f7-8779a41ee840" xlink:to="loc_sny_EPICBPIFranceMember_1141a219-6acf-4b5e-a255-96141c872db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_9d52ea92-c56c-4cdf-a185-b57a411bb495" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_9d52ea92-c56c-4cdf-a185-b57a411bb495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_4eef640b-ed90-4c5a-9a8f-26163c18fc18" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_9d52ea92-c56c-4cdf-a185-b57a411bb495" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_4eef640b-ed90-4c5a-9a8f-26163c18fc18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_9a9c9ee2-5b8e-40cd-a5dd-96bd7e5106c4" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_4eef640b-ed90-4c5a-9a8f-26163c18fc18" xlink:to="loc_sny_EuroapiMember_9a9c9ee2-5b8e-40cd-a5dd-96bd7e5106c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_9d610565-94d0-46b1-ad32-d848a92d2542" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_9d610565-94d0-46b1-ad32-d848a92d2542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_f32e2937-77be-4ef8-906b-b7713bbe9387" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_9d610565-94d0-46b1-ad32-d848a92d2542" xlink:to="loc_ifrs-full_EquityMember_f32e2937-77be-4ef8-906b-b7713bbe9387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_cfc02497-6fbe-4def-a686-c6be9ce65fae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_f32e2937-77be-4ef8-906b-b7713bbe9387" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_cfc02497-6fbe-4def-a686-c6be9ce65fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_08380f56-f904-429b-910e-b84f06e2cfa9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_08380f56-f904-429b-910e-b84f06e2cfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_7afc9ae0-a76d-491a-9980-e1a4de113035" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_08380f56-f904-429b-910e-b84f06e2cfa9" xlink:to="loc_ifrs-full_OtherProvisionsMember_7afc9ae0-a76d-491a-9980-e1a4de113035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember_876cb4a3-486f-437d-9a71-2796853de830" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_7afc9ae0-a76d-491a-9980-e1a4de113035" xlink:to="loc_ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember_876cb4a3-486f-437d-9a71-2796853de830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegulatoryComplianceCostsMember_ca43d428-c840-4103-bb97-813979a9985e" xlink:href="sny-20221231.xsd#sny_RegulatoryComplianceCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_7afc9ae0-a76d-491a-9980-e1a4de113035" xlink:to="loc_sny_RegulatoryComplianceCostsMember_ca43d428-c840-4103-bb97-813979a9985e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementAxis_8deb3085-cfd5-4e7b-8eaa-e1d8afd56bb7" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_sny_TypesOfAgreementAxis_8deb3085-cfd5-4e7b-8eaa-e1d8afd56bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TypesOfAgreementDomain_ad89b03f-eb1e-494c-94e5-16a96c5a0e08" xlink:href="sny-20221231.xsd#sny_TypesOfAgreementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementAxis_8deb3085-cfd5-4e7b-8eaa-e1d8afd56bb7" xlink:to="loc_sny_TypesOfAgreementDomain_ad89b03f-eb1e-494c-94e5-16a96c5a0e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ManufactureAndSupplyCollaborationAgreementMember_bf5e5cbb-dcf3-40fd-a96e-752977faf98e" xlink:href="sny-20221231.xsd#sny_ManufactureAndSupplyCollaborationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementDomain_ad89b03f-eb1e-494c-94e5-16a96c5a0e08" xlink:to="loc_sny_ManufactureAndSupplyCollaborationAgreementMember_bf5e5cbb-dcf3-40fd-a96e-752977faf98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2d270d1e-9922-48cc-8811-66e84a3e53bd" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashTransferred_fbb1d75a-bd2a-4145-b68c-6303ba3e0eed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_CashTransferred_fbb1d75a-bd2a-4145-b68c-6303ba3e0eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations_9b498a20-341d-4ca9-9280-103533513883" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations_9b498a20-341d-4ca9-9280-103533513883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_9caf768d-3ac1-41dd-8cfa-10c2d03d009c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_9caf768d-3ac1-41dd-8cfa-10c2d03d009c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_5ac39ce2-6f6d-4ec9-92d0-e824a525e4c5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_5ac39ce2-6f6d-4ec9-92d0-e824a525e4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossOfAcquiree_a75fe09b-d74a-4e8a-b8d9-0c61f95cc0da" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossOfAcquiree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_ProfitLossOfAcquiree_a75fe09b-d74a-4e8a-b8d9-0c61f95cc0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_80006592-75e8-4612-ab5a-c0df4a72e9c7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_80006592-75e8-4612-ab5a-c0df4a72e9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital_471421c9-0b80-4b69-b9b9-545ac6cf353d" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital_471421c9-0b80-4b69-b9b9-545ac6cf353d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfVotingEquityInterestsDivested_ed08d4af-db0b-4eb8-a322-a9f3c7ac5e27" xlink:href="sny-20221231.xsd#sny_PercentageOfVotingEquityInterestsDivested"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_PercentageOfVotingEquityInterestsDivested_ed08d4af-db0b-4eb8-a322-a9f3c7ac5e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsiderationTransferredMaximumAmount_2f29562c-02a2-4d28-b2ff-7648ed56cc8d" xlink:href="sny-20221231.xsd#sny_ConsiderationTransferredMaximumAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_ConsiderationTransferredMaximumAmount_2f29562c-02a2-4d28-b2ff-7648ed56cc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsiderationTransferredValuationPeriod_58c46c8c-ac69-4b2b-890f-89fff4e57661" xlink:href="sny-20221231.xsd#sny_ConsiderationTransferredValuationPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_ConsiderationTransferredValuationPeriod_58c46c8c-ac69-4b2b-890f-89fff4e57661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_ad1dbd12-8884-4600-9c5c-1f1ffb66450f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_ad1dbd12-8884-4600-9c5c-1f1ffb66450f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod_227c9850-1b9d-4266-81a1-59a8552fb947" xlink:href="sny-20221231.xsd#sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod_227c9850-1b9d-4266-81a1-59a8552fb947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital_e0f788c0-8d27-43a3-a68e-1885d87aa510" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendPercentageOfShareCapital"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital_e0f788c0-8d27-43a3-a68e-1885d87aa510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares_d618151b-d4c3-4379-8b16-9812476d06fd" xlink:href="sny-20221231.xsd#sny_SpecialDistributionSharesReceivedPerConversionOfParentShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares_d618151b-d4c3-4379-8b16-9812476d06fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SpecialDistributionNumberOfSharesConverted_1072b1c0-822b-4cd2-95e7-7caa3e681140" xlink:href="sny-20221231.xsd#sny_SpecialDistributionNumberOfSharesConverted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_SpecialDistributionNumberOfSharesConverted_1072b1c0-822b-4cd2-95e7-7caa3e681140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SpecialDistributionPercentageOfShareCapitalDistributed_d16126c7-e9c6-41f8-aaca-930e1e4652d4" xlink:href="sny-20221231.xsd#sny_SpecialDistributionPercentageOfShareCapitalDistributed"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_SpecialDistributionPercentageOfShareCapitalDistributed_d16126c7-e9c6-41f8-aaca-930e1e4652d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_b9213092-0d2c-4500-9352-1184924f15a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_b9213092-0d2c-4500-9352-1184924f15a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets_ff585952-fc4c-47b9-8d64-b185dd14d817" xlink:href="sny-20221231.xsd#sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets_ff585952-fc4c-47b9-8d64-b185dd14d817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill_7b189a0c-d129-4078-a4cf-93b63e9b8561" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill_7b189a0c-d129-4078-a4cf-93b63e9b8561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_0bd0eb4b-d9da-46c9-b67e-825b2e3e7249" xlink:href="sny-20221231.xsd#sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent_0bd0eb4b-d9da-46c9-b67e-825b2e3e7249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_1ff9712b-4d07-4e2e-ae4b-ed22a8a7d1fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_1ff9712b-4d07-4e2e-ae4b-ed22a8a7d1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_6e704405-20d8-479a-8356-3dc0a75237a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_6e704405-20d8-479a-8356-3dc0a75237a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_86d61ae5-628e-48eb-bf09-734558386611" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeLoss"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_NetForeignExchangeLoss_86d61ae5-628e-48eb-bf09-734558386611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisions_a85c50a1-bf37-48e8-aff2-fb1b7b875c7e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisions"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_OtherProvisions_a85c50a1-bf37-48e8-aff2-fb1b7b875c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGainsLossesAndLitigation_69ea2296-f8df-4485-b238-420640eb4896" xlink:href="sny-20221231.xsd#sny_OtherGainsLossesAndLitigation"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_OtherGainsLossesAndLitigation_69ea2296-f8df-4485-b238-420640eb4896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_3960793b-c45b-411f-95b5-b8d25976cdaa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_3960793b-c45b-411f-95b5-b8d25976cdaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_10d24523-5669-41b9-9f0a-3c445257bfe9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_10d24523-5669-41b9-9f0a-3c445257bfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementPeriodAfterLossOfControl_3e7eeb0f-dd3f-4426-8e10-291fe4ab0458" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementPeriodAfterLossOfControl"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_CollaborationAgreementPeriodAfterLossOfControl_3e7eeb0f-dd3f-4426-8e10-291fe4ab0458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementAnnualNetSalesTarget_f71a6f99-29ba-4857-a60e-1c41b2f12f7f" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementAnnualNetSalesTarget"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_CollaborationAgreementAnnualNetSalesTarget_f71a6f99-29ba-4857-a60e-1c41b2f12f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CollaborationAgreementCommitmentAmount_24beb297-72f3-4879-9a65-e0c78dc59420" xlink:href="sny-20221231.xsd#sny_CollaborationAgreementCommitmentAmount"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5e2116fc-cc3d-4930-ad9f-4dfbbd0b2103" xlink:to="loc_sny_CollaborationAgreementCommitmentAmount_24beb297-72f3-4879-9a65-e0c78dc59420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_f355dcfd-5d8b-42fe-b523-b5d689bdb7d6" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_8b890cfd-75d9-42b2-9cee-f552916c4a49" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_f355dcfd-5d8b-42fe-b523-b5d689bdb7d6" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_8b890cfd-75d9-42b2-9cee-f552916c4a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_12022ea0-5a2d-47ba-ae92-6b214aaa867f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_8b890cfd-75d9-42b2-9cee-f552916c4a49" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_12022ea0-5a2d-47ba-ae92-6b214aaa867f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5abfbb29-f76d-4463-84da-bd83bfcbb7a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_12022ea0-5a2d-47ba-ae92-6b214aaa867f" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5abfbb29-f76d-4463-84da-bd83bfcbb7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixPharmaceuticalsIncMember_0de220ba-d26f-4dda-af2c-12e88c53a617" xlink:href="sny-20221231.xsd#sny_AmunixPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5abfbb29-f76d-4463-84da-bd83bfcbb7a8" xlink:to="loc_sny_AmunixPharmaceuticalsIncMember_0de220ba-d26f-4dda-af2c-12e88c53a617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_8b890cfd-75d9-42b2-9cee-f552916c4a49" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_5dab3bf5-86c5-49c5-84c5-eb8fb82d0576" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_5dab3bf5-86c5-49c5-84c5-eb8fb82d0576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate_fbf1a1da-fc59-4f32-8540-37e18d931da9" xlink:href="sny-20221231.xsd#sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate_fbf1a1da-fc59-4f32-8540-37e18d931da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_7b957c27-ab7b-4cc4-a46b-2dee45227a1d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_7b957c27-ab7b-4cc4-a46b-2dee45227a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_258a0a8e-30bb-4098-bdfc-204ed803b5f6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_258a0a8e-30bb-4098-bdfc-204ed803b5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_3f23ec9c-3b05-44cd-8f43-eb23cd8f9041" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_3f23ec9c-3b05-44cd-8f43-eb23cd8f9041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_4b151c50-d6e2-485d-a19b-bd8eca8a27d5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_4b151c50-d6e2-485d-a19b-bd8eca8a27d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_93c6cdf6-edb1-4b1f-a88b-ab999e2a7440" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_5c118196-2c1e-4fdd-aa40-66d4999961bf" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_93c6cdf6-edb1-4b1f-a88b-ab999e2a7440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_58be55fb-d3db-4c8b-8dea-774572b06ddb" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_58be55fb-d3db-4c8b-8dea-774572b06ddb" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_04d5059b-21c1-49eb-b5a3-4229801656e9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_04d5059b-21c1-49eb-b5a3-4229801656e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_04d5059b-21c1-49eb-b5a3-4229801656e9" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KymabMember_df9ad208-4dc2-40d3-974c-5b6c2f1df1f0" xlink:href="sny-20221231.xsd#sny_KymabMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_KymabMember_df9ad208-4dc2-40d3-974c-5b6c2f1df1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KiadisMember_f5f39089-d645-4502-b566-fd26b1e9b469" xlink:href="sny-20221231.xsd#sny_KiadisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_KiadisMember_f5f39089-d645-4502-b566-fd26b1e9b469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TidalTherapeuticsMember_bea47390-155e-4a8e-8de3-2105607826fd" xlink:href="sny-20221231.xsd#sny_TidalTherapeuticsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_TidalTherapeuticsMember_bea47390-155e-4a8e-8de3-2105607826fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_844a185f-76f9-4cdc-8363-0d0a47ef7f9e" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_TranslateBioMember_844a185f-76f9-4cdc-8363-0d0a47ef7f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KadmonMember_521db566-4cae-4024-90bb-eada9e0991f9" xlink:href="sny-20221231.xsd#sny_KadmonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_KadmonMember_521db566-4cae-4024-90bb-eada9e0991f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OrigimmBiotechnologyGmbHMember_e098338c-efd2-4b3e-8ff7-c083b8931263" xlink:href="sny-20221231.xsd#sny_OrigimmBiotechnologyGmbHMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_OrigimmBiotechnologyGmbHMember_e098338c-efd2-4b3e-8ff7-c083b8931263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipiaBiopharmaIncMember_0eb2c624-c188-4b7a-b408-7273ae515970" xlink:href="sny-20221231.xsd#sny_PrincipiaBiopharmaIncMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_PrincipiaBiopharmaIncMember_0eb2c624-c188-4b7a-b408-7273ae515970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxMember_1f98da54-2747-4102-a6f0-6c92cf66f233" xlink:href="sny-20221231.xsd#sny_SynthorxMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34f6fc46-af37-4b9d-84cd-53318dd8e54b" xlink:to="loc_sny_SynthorxMember_1f98da54-2747-4102-a6f0-6c92cf66f233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_35a96c41-ede7-44f1-98ff-cb60a7f0e49c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_35a96c41-ede7-44f1-98ff-cb60a7f0e49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_af60fd2e-bbc5-4c17-950e-c468901858d3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_35a96c41-ede7-44f1-98ff-cb60a7f0e49c" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_af60fd2e-bbc5-4c17-950e-c468901858d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_be6c1c33-fcca-4992-9b95-02ced07dd33b" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_af60fd2e-bbc5-4c17-950e-c468901858d3" xlink:to="loc_sny_RegeneronMember_be6c1c33-fcca-4992-9b95-02ced07dd33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockAxis_69fad9bf-8a5a-4d0b-8b0f-2b68d7b99b8d" xlink:href="sny-20221231.xsd#sny_SaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_sny_SaleOfStockAxis_69fad9bf-8a5a-4d0b-8b0f-2b68d7b99b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockDomain_0dd8b27e-b38f-4a26-b32e-9f63506ae6a9" xlink:href="sny-20221231.xsd#sny_SaleOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_SaleOfStockAxis_69fad9bf-8a5a-4d0b-8b0f-2b68d7b99b8d" xlink:to="loc_sny_SaleOfStockDomain_0dd8b27e-b38f-4a26-b32e-9f63506ae6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PublicOfferingMember_c36f28fd-aa9d-4299-85b3-3078f543047b" xlink:href="sny-20221231.xsd#sny_PublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_SaleOfStockDomain_0dd8b27e-b38f-4a26-b32e-9f63506ae6a9" xlink:to="loc_sny_PublicOfferingMember_c36f28fd-aa9d-4299-85b3-3078f543047b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RepurchaseFromTheCounterpartMember_a0c72dca-4c8d-4f3a-9873-fda909c1deec" xlink:href="sny-20221231.xsd#sny_RepurchaseFromTheCounterpartMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_SaleOfStockDomain_0dd8b27e-b38f-4a26-b32e-9f63506ae6a9" xlink:to="loc_sny_RepurchaseFromTheCounterpartMember_a0c72dca-4c8d-4f3a-9873-fda909c1deec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fc458865-ac59-4553-aa85-255d7e41b8b4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_dei_LegalEntityAxis_fc458865-ac59-4553-aa85-255d7e41b8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a232b2f8-5ccf-4873-9abc-8e193a3b5a8e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_fc458865-ac59-4553-aa85-255d7e41b8b4" xlink:to="loc_dei_EntityDomain_a232b2f8-5ccf-4873-9abc-8e193a3b5a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSAMember_43504b8d-6d09-43d9-9d1c-1b8f5bfbfd6f" xlink:href="sny-20221231.xsd#sny_SanofiSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a232b2f8-5ccf-4873-9abc-8e193a3b5a8e" xlink:to="loc_sny_SanofiSAMember_43504b8d-6d09-43d9-9d1c-1b8f5bfbfd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_edab48e8-8e6c-49e6-a69d-fcae2670e94f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_ifrs-full_CounterpartiesAxis_edab48e8-8e6c-49e6-a69d-fcae2670e94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_77d97b6e-99ca-4a2c-905e-7ac92aacd815" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_edab48e8-8e6c-49e6-a69d-fcae2670e94f" xlink:to="loc_ifrs-full_CounterpartiesMember_77d97b6e-99ca-4a2c-905e-7ac92aacd815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_f230af35-3eee-4bef-8e77-f4eae844951b" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_77d97b6e-99ca-4a2c-905e-7ac92aacd815" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_f230af35-3eee-4bef-8e77-f4eae844951b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_5c3fe232-0f6b-4604-ba4e-db31fb767bd9" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_sny_PrincipalAlliancesAxis_5c3fe232-0f6b-4604-ba4e-db31fb767bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_24184b52-8c73-4a8f-9eed-738d1021815e" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesAxis_5c3fe232-0f6b-4604-ba4e-db31fb767bd9" xlink:to="loc_sny_PrincipalAlliancesDomain_24184b52-8c73-4a8f-9eed-738d1021815e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TwoThousandEighteenLetterAgreementMember_bdf4537d-39d7-4f75-82ae-b4e1c03270b3" xlink:href="sny-20221231.xsd#sny_TwoThousandEighteenLetterAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesDomain_24184b52-8c73-4a8f-9eed-738d1021815e" xlink:to="loc_sny_TwoThousandEighteenLetterAgreementMember_bdf4537d-39d7-4f75-82ae-b4e1c03270b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_429cf89b-2ec4-4911-8568-c607f98156ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_429cf89b-2ec4-4911-8568-c607f98156ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_5bb1b1f6-379b-43fa-87a9-8711fd80b78a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_429cf89b-2ec4-4911-8568-c607f98156ab" xlink:to="loc_ifrs-full_EquityMember_5bb1b1f6-379b-43fa-87a9-8711fd80b78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_805491cf-845a-4c9e-90d7-977d5cea82d8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_5bb1b1f6-379b-43fa-87a9-8711fd80b78a" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_805491cf-845a-4c9e-90d7-977d5cea82d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_0377d39b-c293-4fde-951b-84e62a3eb96d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_0377d39b-c293-4fde-951b-84e62a3eb96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_a238c655-676d-4216-a911-78b16c6b9268" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_0377d39b-c293-4fde-951b-84e62a3eb96d" xlink:to="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_a238c655-676d-4216-a911-78b16c6b9268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_6fddb4db-eeba-4118-a09c-97dfc339fc9a" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_a238c655-676d-4216-a911-78b16c6b9268" xlink:to="loc_sny_TranslateBioMember_6fddb4db-eeba-4118-a09c-97dfc339fc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_b8658102-d863-46e8-a849-2e8f56152e0a" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashTransferred_d32ee78b-06a8-480e-a4e1-5ded780ea1bf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_CashTransferred_d32ee78b-06a8-480e-a4e1-5ded780ea1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements_b77b78af-8446-4b0d-ab70-cc81e711243c" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements_b77b78af-8446-4b0d-ab70-cc81e711243c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_8dfae46c-be05-4401-a70d-ddcf8a775301" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_8dfae46c-be05-4401-a70d-ddcf8a775301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_46a4b781-7734-4291-9cf4-2e68790165d9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_46a4b781-7734-4291-9cf4-2e68790165d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering_05fea828-6f68-4788-811d-9b2bab13da69" xlink:href="sny-20221231.xsd#sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering_05fea828-6f68-4788-811d-9b2bab13da69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationPurchasePricePerShare_1bbf420e-b8bc-495b-96fa-4c210e0953ce" xlink:href="sny-20221231.xsd#sny_BusinessCombinationPurchasePricePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_BusinessCombinationPurchasePricePerShare_1bbf420e-b8bc-495b-96fa-4c210e0953ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering_879bda90-4951-4e79-b32c-9de540b7d98e" xlink:href="sny-20221231.xsd#sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering_879bda90-4951-4e79-b32c-9de540b7d98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_56cd78ad-5d78-40df-8b2c-06ba5e32b53a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_56cd78ad-5d78-40df-8b2c-06ba5e32b53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired_0835c2c0-f660-4d4a-bc14-3064bded58d6" xlink:href="sny-20221231.xsd#sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired_0835c2c0-f660-4d4a-bc14-3064bded58d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_c61eaac9-604a-4aa9-959f-64a8df9e4fb6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_c61eaac9-604a-4aa9-959f-64a8df9e4fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage_4869b5e7-e175-4b3e-b104-0b4a8d0a0efb" xlink:href="sny-20221231.xsd#sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage_4869b5e7-e175-4b3e-b104-0b4a8d0a0efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis_2bb597b6-9170-490e-8f77-1a306031765c" xlink:href="sny-20221231.xsd#sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis_2bb597b6-9170-490e-8f77-1a306031765c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinancialAssetsNumberOfShares_987f1ba5-4a39-458b-8654-e0549db702a1" xlink:href="sny-20221231.xsd#sny_NonCurrentFinancialAssetsNumberOfShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_NonCurrentFinancialAssetsNumberOfShares_987f1ba5-4a39-458b-8654-e0549db702a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_65f9401f-54fe-461a-aace-e4c49a5c79c8" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_65f9401f-54fe-461a-aace-e4c49a5c79c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockPricePerShare_625ed69f-09ac-428a-9c30-9d9245d2b19a" xlink:href="sny-20221231.xsd#sny_SaleOfStockPricePerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_SaleOfStockPricePerShare_625ed69f-09ac-428a-9c30-9d9245d2b19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts_d29305fb-29e9-4a9c-b989-4290f1eb8556" xlink:href="sny-20221231.xsd#sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts_d29305fb-29e9-4a9c-b989-4290f1eb8556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction_30ddc650-31d5-47a9-8bfc-840a5719a9b0" xlink:href="sny-20221231.xsd#sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction_30ddc650-31d5-47a9-8bfc-840a5719a9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts_4f28bfaf-99cb-4986-a402-f8cecbe916ee" xlink:href="sny-20221231.xsd#sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts_4f28bfaf-99cb-4986-a402-f8cecbe916ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement_eaba18dc-c6d4-446b-a8e2-174f0ce5fcd4" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement_eaba18dc-c6d4-446b-a8e2-174f0ce5fcd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_68875964-692c-41c3-b3a6-c8a6cd735078" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_68875964-692c-41c3-b3a6-c8a6cd735078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnDisposalsOfInvestments_836c2686-0532-4bda-8275-56881fdd5412" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestments"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_GainsOnDisposalsOfInvestments_836c2686-0532-4bda-8275-56881fdd5412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockTransactionCosts_37010fb6-64bd-420b-905a-c7c09731e0c0" xlink:href="sny-20221231.xsd#sny_SaleOfStockTransactionCosts"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_SaleOfStockTransactionCosts_37010fb6-64bd-420b-905a-c7c09731e0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax_54c3e0fd-3a57-4589-8146-e0c31ad45bea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax_54c3e0fd-3a57-4589-8146-e0c31ad45bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockMarketPricePerShare_2f4558e8-62b8-4181-97c4-cd9980ebfcda" xlink:href="sny-20221231.xsd#sny_StockMarketPricePerShare"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_StockMarketPricePerShare_2f4558e8-62b8-4181-97c4-cd9980ebfcda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_11243142-9a76-4b90-8ddb-2d8dda705325" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_11243142-9a76-4b90-8ddb-2d8dda705325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxExpenseOnDisposalOfInvestment_b3979d12-5732-431e-bb9d-dc45440309e0" xlink:href="sny-20221231.xsd#sny_TaxExpenseOnDisposalOfInvestment"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_sny_TaxExpenseOnDisposalOfInvestment_b3979d12-5732-431e-bb9d-dc45440309e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_d2fb730a-0f0f-4b01-8ebe-3c730fb4ee3b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_d2fb730a-0f0f-4b01-8ebe-3c730fb4ee3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsOnDisposalsOfNoncurrentAssets_d2fa10df-7fcb-46d5-8bb3-fb1c2a25ef21" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsOnDisposalsOfNoncurrentAssets"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_GainsOnDisposalsOfNoncurrentAssets_d2fa10df-7fcb-46d5-8bb3-fb1c2a25ef21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_60e309c3-44b7-4bc6-a434-eca601f80e57" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_efcbeaa5-fb88-46ce-9580-53134ef64f61" xlink:to="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_60e309c3-44b7-4bc6-a434-eca601f80e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_8b7524fe-869b-418e-8baf-f09909ad609e" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_9f6d8513-d20d-4590-90a7-848354007b59" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_8b7524fe-869b-418e-8baf-f09909ad609e" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_9f6d8513-d20d-4590-90a7-848354007b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_621ce884-5e2b-4a38-b0b8-427ab95aced2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_9f6d8513-d20d-4590-90a7-848354007b59" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_621ce884-5e2b-4a38-b0b8-427ab95aced2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_edc5bf57-adae-4a33-9729-9c1fae50daff" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_621ce884-5e2b-4a38-b0b8-427ab95aced2" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_edc5bf57-adae-4a33-9729-9c1fae50daff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_8da01a63-74b6-484c-a23e-1d2da2f32e7f" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_edc5bf57-adae-4a33-9729-9c1fae50daff" xlink:to="loc_sny_TranslateBioMember_8da01a63-74b6-484c-a23e-1d2da2f32e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipiaBiopharmaIncMember_88e63ce9-bb3e-481e-b40c-439b2683e239" xlink:href="sny-20221231.xsd#sny_PrincipiaBiopharmaIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_edc5bf57-adae-4a33-9729-9c1fae50daff" xlink:to="loc_sny_PrincipiaBiopharmaIncMember_88e63ce9-bb3e-481e-b40c-439b2683e239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxMember_e3293511-b5b8-424f-9dd4-7eae322eb27d" xlink:href="sny-20221231.xsd#sny_SynthorxMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_edc5bf57-adae-4a33-9729-9c1fae50daff" xlink:to="loc_sny_SynthorxMember_e3293511-b5b8-424f-9dd4-7eae322eb27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_9f6d8513-d20d-4590-90a7-848354007b59" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2858abb0-1590-4f94-a2cc-bd15a8da6c71" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2858abb0-1590-4f94-a2cc-bd15a8da6c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_97b75965-51c3-4433-80f0-08ca15239ad9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_97b75965-51c3-4433-80f0-08ca15239ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate_19f1cf94-5630-4515-84a4-13191f079a91" xlink:href="sny-20221231.xsd#sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate_19f1cf94-5630-4515-84a4-13191f079a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_98c7e6cd-11df-4fec-b921-3d7325cffa13" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_98c7e6cd-11df-4fec-b921-3d7325cffa13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_3c78b0fc-5b0b-4f06-b10c-7cd0b5fd1874" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_3c78b0fc-5b0b-4f06-b10c-7cd0b5fd1874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_06997f5d-6f4f-493f-bfc7-d6d7645c304d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_06997f5d-6f4f-493f-bfc7-d6d7645c304d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_154e44d3-62e7-4aea-bad1-2d26d5b58c2b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_154e44d3-62e7-4aea-bad1-2d26d5b58c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PurchasePrice_ba14cc6d-5500-486a-b955-ebc2a5a92792" xlink:href="sny-20221231.xsd#sny_PurchasePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_18901939-243e-4d10-90a1-2fc565a2ec1b" xlink:to="loc_sny_PurchasePrice_ba14cc6d-5500-486a-b955-ebc2a5a92792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_ae36cbc3-4a99-446f-8db9-ca6d3d4521ba" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_3101ad9a-9598-4095-9bef-ea42ada346aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_ae36cbc3-4a99-446f-8db9-ca6d3d4521ba" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_3101ad9a-9598-4095-9bef-ea42ada346aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a692625-c1fd-4955-8656-588adf1e40da" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_3101ad9a-9598-4095-9bef-ea42ada346aa" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a692625-c1fd-4955-8656-588adf1e40da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a692625-c1fd-4955-8656-588adf1e40da" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LandMember_9b3456dc-9681-4906-93e8-35728ace85c0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:to="loc_ifrs-full_LandMember_9b3456dc-9681-4906-93e8-35728ace85c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BuildingsMember_4ce2b078-53de-4bbc-97ea-4bf82574a9a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:to="loc_ifrs-full_BuildingsMember_4ce2b078-53de-4bbc-97ea-4bf82574a9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MachineryAndEquipmentMember_fc81e777-024d-44b7-ada4-e8e8b625a0ec" xlink:href="sny-20221231.xsd#sny_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:to="loc_sny_MachineryAndEquipmentMember_fc81e777-024d-44b7-ada4-e8e8b625a0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_ed81a8a6-2384-4926-94a7-427f1fc42520" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_ed81a8a6-2384-4926-94a7-427f1fc42520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PropertyPlantAndEquipmentInProcessMember_c965fb96-3dda-4531-9451-c02de33af0b6" xlink:href="sny-20221231.xsd#sny_PropertyPlantAndEquipmentInProcessMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_45049f16-688c-4d6e-91a3-2f7492637c3d" xlink:to="loc_sny_PropertyPlantAndEquipmentInProcessMember_c965fb96-3dda-4531-9451-c02de33af0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7c2a2f65-1a66-4105-b28f-bce6a75e41ad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_3101ad9a-9598-4095-9bef-ea42ada346aa" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7c2a2f65-1a66-4105-b28f-bce6a75e41ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_d6a005d0-1e6e-4084-b4c8-edacc4230111" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7c2a2f65-1a66-4105-b28f-bce6a75e41ad" xlink:to="loc_ifrs-full_CarryingAmountMember_d6a005d0-1e6e-4084-b4c8-edacc4230111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_de004744-e237-43fb-a159-c9859e5c5811" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_d6a005d0-1e6e-4084-b4c8-edacc4230111" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_de004744-e237-43fb-a159-c9859e5c5811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_5d078352-7d88-45f7-a80a-82f97dfe543a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_d6a005d0-1e6e-4084-b4c8-edacc4230111" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_5d078352-7d88-45f7-a80a-82f97dfe543a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_3101ad9a-9598-4095-9bef-ea42ada346aa" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_d752ffe2-b4e3-4e5a-a33b-c1cbaf783af5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_d752ffe2-b4e3-4e5a-a33b-c1cbaf783af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment_43be3b09-aa77-4840-922c-03c259323257" xlink:href="sny-20221231.xsd#sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment_43be3b09-aa77-4840-922c-03c259323257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_cd3c9cd4-aaeb-4cf7-85e0-d99021371994" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_cd3c9cd4-aaeb-4cf7-85e0-d99021371994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_606b7fdf-c3c1-4283-84d0-9394b988f2a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_606b7fdf-c3c1-4283-84d0-9394b988f2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_7da14198-8cfd-41de-adb0-a962730f2bcf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_7da14198-8cfd-41de-adb0-a962730f2bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_f3664fcf-cfca-4f0b-bf86-37f7cdf9fc37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_f3664fcf-cfca-4f0b-bf86-37f7cdf9fc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationExpense_c5b50625-fe6d-4b7d-8a8a-a4bbbdf5cf8c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_DepreciationExpense_c5b50625-fe6d-4b7d-8a8a-a4bbbdf5cf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_11691149-fcc9-44da-bf51-0c8afacb1746" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_11691149-fcc9-44da-bf51-0c8afacb1746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_7d450e50-6179-444b-9b21-ce6e5540dd6c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_a642c484-37df-48e0-bca0-e9bd04e087d5" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_7d450e50-6179-444b-9b21-ce6e5540dd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_2f0d1278-cbc9-477b-88df-bc8b2b221007" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_08f22b6b-a134-4418-8ac7-3ba782f6654a" xlink:href="sny-20221231.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_2f0d1278-cbc9-477b-88df-bc8b2b221007" xlink:to="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_08f22b6b-a134-4418-8ac7-3ba782f6654a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_b5381d1d-c126-4101-aea0-d61164d98dff" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_08f22b6b-a134-4418-8ac7-3ba782f6654a" xlink:to="loc_ifrs-full_SegmentsAxis_b5381d1d-c126-4101-aea0-d61164d98dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_e7f71c65-3ba4-4a90-8372-068edcfdb52a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_b5381d1d-c126-4101-aea0-d61164d98dff" xlink:to="loc_ifrs-full_SegmentsMember_e7f71c65-3ba4-4a90-8372-068edcfdb52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsMember_0ecf3293-1cb7-4759-a530-65027a0ea4e4" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_e7f71c65-3ba4-4a90-8372-068edcfdb52a" xlink:to="loc_sny_PharmaceuticalsMember_0ecf3293-1cb7-4759-a530-65027a0ea4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesMember_16568a31-cd4c-4c4d-ad0c-f78ac6fedd5b" xlink:href="sny-20221231.xsd#sny_VaccinesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_e7f71c65-3ba4-4a90-8372-068edcfdb52a" xlink:to="loc_sny_VaccinesMember_16568a31-cd4c-4c4d-ad0c-f78ac6fedd5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareMember_f6fcb371-592f-4940-b6f4-144c8b338e2b" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_e7f71c65-3ba4-4a90-8372-068edcfdb52a" xlink:to="loc_sny_ConsumerHealthcareMember_f6fcb371-592f-4940-b6f4-144c8b338e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5f3038f5-2010-48d7-8226-3688cd626768" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_08f22b6b-a134-4418-8ac7-3ba782f6654a" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5f3038f5-2010-48d7-8226-3688cd626768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1f6fb5ad-2806-4a05-8395-e62880e52bb5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5f3038f5-2010-48d7-8226-3688cd626768" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1f6fb5ad-2806-4a05-8395-e62880e52bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IndustrialFacilitiesMember_ddb10ed8-a8c3-49cf-bef1-4d3de17297af" xlink:href="sny-20221231.xsd#sny_IndustrialFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1f6fb5ad-2806-4a05-8395-e62880e52bb5" xlink:to="loc_sny_IndustrialFacilitiesMember_ddb10ed8-a8c3-49cf-bef1-4d3de17297af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ResearchSitesMember_03a5ed0b-87cc-4ca5-8615-588c0e43fb79" xlink:href="sny-20221231.xsd#sny_ResearchSitesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1f6fb5ad-2806-4a05-8395-e62880e52bb5" xlink:to="loc_sny_ResearchSitesMember_03a5ed0b-87cc-4ca5-8615-588c0e43fb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherMember_22e15ab1-5e35-4c7c-95f3-10db058ba896" xlink:href="sny-20221231.xsd#sny_OtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1f6fb5ad-2806-4a05-8395-e62880e52bb5" xlink:to="loc_sny_OtherMember_22e15ab1-5e35-4c7c-95f3-10db058ba896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems_59c0145c-5b83-4d6c-b7db-f87a1d08a155" xlink:href="sny-20221231.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable_08f22b6b-a134-4418-8ac7-3ba782f6654a" xlink:to="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems_59c0145c-5b83-4d6c-b7db-f87a1d08a155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_b6a916be-1650-4b4b-8cf7-5a4e31cedff6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems_59c0145c-5b83-4d6c-b7db-f87a1d08a155" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_b6a916be-1650-4b4b-8cf7-5a4e31cedff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestCostsCapitalised_6e9f4c2f-9e60-44f6-8e14-0dfeb1fc68ec" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestCostsCapitalised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems_59c0145c-5b83-4d6c-b7db-f87a1d08a155" xlink:to="loc_ifrs-full_InterestCostsCapitalised_6e9f4c2f-9e60-44f6-8e14-0dfeb1fc68ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofOffBalanceSheetCommitmentsRelatingtoPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PropertyplantandequipmentSummaryofOffBalanceSheetCommitmentsRelatingtoPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofOffBalanceSheetCommitmentsRelatingtoPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_f310b014-b8b5-4ae8-938a-fcf474c58b4a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FirmOrdersOfPropertyPlantAndEquipment_49e3c7f8-1f56-4931-967a-9b701095720d" xlink:href="sny-20221231.xsd#sny_FirmOrdersOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_f310b014-b8b5-4ae8-938a-fcf474c58b4a" xlink:to="loc_sny_FirmOrdersOfPropertyPlantAndEquipment_49e3c7f8-1f56-4931-967a-9b701095720d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity_1e745c58-ecf0-4daf-9b06-d764b6bb0b2e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_f310b014-b8b5-4ae8-938a-fcf474c58b4a" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity_1e745c58-ecf0-4daf-9b06-d764b6bb0b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofImpairmentLossesRecognisedinPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PropertyplantandequipmentSummaryofImpairmentLossesRecognisedinPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofImpairmentLossesRecognisedinPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_88a8b76c-c0e3-44b7-8c7a-2a5ab4a0ae35" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_8eb67bb3-872e-46e6-9950-019a72a7ebbb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_88a8b76c-c0e3-44b7-8c7a-2a5ab4a0ae35" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_8eb67bb3-872e-46e6-9950-019a72a7ebbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_2aecc491-00e5-4833-9ba6-8badff6c77c8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c801071b-a1e5-4ec1-b41f-fa74291dcfd1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_2aecc491-00e5-4833-9ba6-8badff6c77c8" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c801071b-a1e5-4ec1-b41f-fa74291dcfd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1329a160-2a55-4b87-8303-614f40949558" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c801071b-a1e5-4ec1-b41f-fa74291dcfd1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1329a160-2a55-4b87-8303-614f40949558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_e832122c-1da4-4c82-a672-76b225202ac1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1329a160-2a55-4b87-8303-614f40949558" xlink:to="loc_ifrs-full_CarryingAmountMember_e832122c-1da4-4c82-a672-76b225202ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_386e3695-8cd0-4c65-b87c-92d8435a3ac6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_e832122c-1da4-4c82-a672-76b225202ac1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_386e3695-8cd0-4c65-b87c-92d8435a3ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_65dc3c4c-861e-432b-9b93-a57e170f89ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_e832122c-1da4-4c82-a672-76b225202ac1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_65dc3c4c-861e-432b-9b93-a57e170f89ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_702211c3-86de-4b70-acce-a1d6ca2de9b0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c801071b-a1e5-4ec1-b41f-fa74291dcfd1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_702211c3-86de-4b70-acce-a1d6ca2de9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_5691266f-b653-442c-b11a-48453257b001" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_702211c3-86de-4b70-acce-a1d6ca2de9b0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_5691266f-b653-442c-b11a-48453257b001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CambridgeMassachusettsMember_ff178682-5b98-4e76-82df-783b30e83ef4" xlink:href="sny-20221231.xsd#sny_CambridgeMassachusettsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5691266f-b653-442c-b11a-48453257b001" xlink:to="loc_sny_CambridgeMassachusettsMember_ff178682-5b98-4e76-82df-783b30e83ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OfficeSpaceCambridgeMassachusettsMember_f2f2fcaa-e83f-4e96-986a-c2b50ddd91cf" xlink:href="sny-20221231.xsd#sny_OfficeSpaceCambridgeMassachusettsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5691266f-b653-442c-b11a-48453257b001" xlink:to="loc_sny_OfficeSpaceCambridgeMassachusettsMember_f2f2fcaa-e83f-4e96-986a-c2b50ddd91cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LaboratoryFacilitiesCambridgeMassachusettsMember_6de8eb9c-66d1-4707-8687-a48116383820" xlink:href="sny-20221231.xsd#sny_LaboratoryFacilitiesCambridgeMassachusettsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5691266f-b653-442c-b11a-48453257b001" xlink:to="loc_sny_LaboratoryFacilitiesCambridgeMassachusettsMember_6de8eb9c-66d1-4707-8687-a48116383820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_c801071b-a1e5-4ec1-b41f-fa74291dcfd1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_11c8ce9e-c6a3-4352-b5f4-aa1dc19cd684" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_ifrs-full_RightofuseAssets_11c8ce9e-c6a3-4352-b5f4-aa1dc19cd684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets_1414a4c6-b867-4272-9dcf-df2f486fa532" xlink:href="sny-20221231.xsd#sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets_1414a4c6-b867-4272-9dcf-df2f486fa532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets_ffa1a0ae-cf90-43a3-8a0b-57bde582814a" xlink:href="sny-20221231.xsd#sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets_ffa1a0ae-cf90-43a3-8a0b-57bde582814a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets_c42be7cf-aa09-4951-9a41-64214b38755c" xlink:href="sny-20221231.xsd#sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets_c42be7cf-aa09-4951-9a41-64214b38755c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets_1f1563d9-4a4b-46aa-af45-de3c79db30d3" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets_1f1563d9-4a4b-46aa-af45-de3c79db30d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets_8f6b33de-13fb-490a-b7dd-1eb365b443f9" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets_8f6b33de-13fb-490a-b7dd-1eb365b443f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_be14eaa5-80cf-4819-9809-604731ea705e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_be14eaa5-80cf-4819-9809-604731ea705e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_fecb8e11-92a5-4b00-8285-c0889484d7a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_ifrs-full_RightofuseAssets_fecb8e11-92a5-4b00-8285-c0889484d7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfLeaseAgreementsSigned_d043ccd8-0fee-494d-8782-7a0dde505f62" xlink:href="sny-20221231.xsd#sny_NumberOfLeaseAgreementsSigned"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_NumberOfLeaseAgreementsSigned_d043ccd8-0fee-494d-8782-7a0dde505f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InitialLeaseTerm_736e2d44-bd95-44be-981c-1eadf2338001" xlink:href="sny-20221231.xsd#sny_InitialLeaseTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_sny_InitialLeaseTerm_736e2d44-bd95-44be-981c-1eadf2338001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_40678219-1dcc-425c-bb88-6db358a86179" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_ifrs-full_RightofuseAssets_40678219-1dcc-425c-bb88-6db358a86179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_40405424-0e59-4c51-a633-1237448cd3f2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_b2fecffa-b40d-4168-a44d-4616d2cab077" xlink:to="loc_ifrs-full_LeaseLiabilities_40405424-0e59-4c51-a633-1237448cd3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PropertyplantandequipmentAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_088bf48c-3e43-43d4-ab73-584d2ad49a86" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6eaa5794-ccac-42d3-8abc-6f1fccf88475" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_088bf48c-3e43-43d4-ab73-584d2ad49a86" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6eaa5794-ccac-42d3-8abc-6f1fccf88475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_6168eb57-6da3-47e2-ae55-0adb76f9bf05" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6eaa5794-ccac-42d3-8abc-6f1fccf88475" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_6168eb57-6da3-47e2-ae55-0adb76f9bf05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_d99beb7f-5cb0-4a1f-92b1-7ab57429b427" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_6168eb57-6da3-47e2-ae55-0adb76f9bf05" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_d99beb7f-5cb0-4a1f-92b1-7ab57429b427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LandAndBuildingsMember_c70d18de-4dcc-41b8-ba2f-84f6c8aed39f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandAndBuildingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_d99beb7f-5cb0-4a1f-92b1-7ab57429b427" xlink:to="loc_ifrs-full_LandAndBuildingsMember_c70d18de-4dcc-41b8-ba2f-84f6c8aed39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_VehiclesMember_466d2cce-b6a5-45e7-b152-b015a8da0a8e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_VehiclesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_d99beb7f-5cb0-4a1f-92b1-7ab57429b427" xlink:to="loc_ifrs-full_VehiclesMember_466d2cce-b6a5-45e7-b152-b015a8da0a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_60e7bf26-8dfd-4c7d-9746-95379fc078c7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_6eaa5794-ccac-42d3-8abc-6f1fccf88475" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_60e7bf26-8dfd-4c7d-9746-95379fc078c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LeasedAssetsPercentage_f47a8675-760c-47b9-b08d-3100c365184a" xlink:href="sny-20221231.xsd#sny_LeasedAssetsPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_60e7bf26-8dfd-4c7d-9746-95379fc078c7" xlink:to="loc_sny_LeasedAssetsPercentage_f47a8675-760c-47b9-b08d-3100c365184a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_dc68d49c-3412-4500-bf6d-56441ca67855" xlink:href="sny-20221231.xsd#sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_60e7bf26-8dfd-4c7d-9746-95379fc078c7" xlink:to="loc_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed_dc68d49c-3412-4500-bf6d-56441ca67855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashOutflowForLeases_e8a371f9-161f-42d7-8bf6-f10712182b6f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashOutflowForLeases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_60e7bf26-8dfd-4c7d-9746-95379fc078c7" xlink:to="loc_ifrs-full_CashOutflowForLeases_e8a371f9-161f-42d7-8bf6-f10712182b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_1ae5ceea-b58f-406f-a4ff-90b53d1f77e2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_3f906aee-2773-4617-a06d-094ea41f1cfc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_1ae5ceea-b58f-406f-a4ff-90b53d1f77e2" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_3f906aee-2773-4617-a06d-094ea41f1cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_76e4c1af-dcc8-4c13-8f41-339595b38076" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_3f906aee-2773-4617-a06d-094ea41f1cfc" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_76e4c1af-dcc8-4c13-8f41-339595b38076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_94eb2b6f-c995-4a01-97d7-5c1df6532034" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_76e4c1af-dcc8-4c13-8f41-339595b38076" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_94eb2b6f-c995-4a01-97d7-5c1df6532034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillMember_213ecafb-6fdc-4b4b-accf-faf4b4ed91ac" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_94eb2b6f-c995-4a01-97d7-5c1df6532034" xlink:to="loc_ifrs-full_GoodwillMember_213ecafb-6fdc-4b4b-accf-faf4b4ed91ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_3f906aee-2773-4617-a06d-094ea41f1cfc" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_4650436f-6488-423c-bbf2-07b8fd54117c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_4650436f-6488-423c-bbf2-07b8fd54117c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_72afe4f4-17eb-4e06-b86f-400cdc8e19b6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_72afe4f4-17eb-4e06-b86f-400cdc8e19b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill_e2a3e6f4-ec82-4658-81ec-8d28817932c5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill_e2a3e6f4-ec82-4658-81ec-8d28817932c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_594bad91-6783-4bee-b88f-e73e8b567322" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_594bad91-6783-4bee-b88f-e73e8b567322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_c0608e71-a9d7-4a49-89f2-e4ae9ffd109f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_df2bd961-e5f1-4724-aa72-788690743190" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_c0608e71-a9d7-4a49-89f2-e4ae9ffd109f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#GoodwillandotherintangibleassetsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_3a71b82e-9bff-4440-918a-c7535053194b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_f0c6f4bd-c542-43e8-9a3e-de09bc0b51c4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_3a71b82e-9bff-4440-918a-c7535053194b" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_f0c6f4bd-c542-43e8-9a3e-de09bc0b51c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_14c21834-b3f5-415b-b229-6b789a3d6a68" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_f0c6f4bd-c542-43e8-9a3e-de09bc0b51c4" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_14c21834-b3f5-415b-b229-6b789a3d6a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_14c21834-b3f5-415b-b229-6b789a3d6a68" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixMember_46211f36-9242-41fe-aa42-42827f4c8329" xlink:href="sny-20221231.xsd#sny_AmunixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:to="loc_sny_AmunixMember_46211f36-9242-41fe-aa42-42827f4c8329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_d733f45b-3d6b-4e38-945a-e77355731019" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:to="loc_sny_TranslateBioMember_d733f45b-3d6b-4e38-945a-e77355731019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipiaBiopharmaIncMember_ed6a6c48-4303-46b6-bebe-7a31f317d0bb" xlink:href="sny-20221231.xsd#sny_PrincipiaBiopharmaIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:to="loc_sny_PrincipiaBiopharmaIncMember_ed6a6c48-4303-46b6-bebe-7a31f317d0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxMember_9db956a0-d16e-4a8d-8975-fdc6e15efd51" xlink:href="sny-20221231.xsd#sny_SynthorxMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_f88a7e39-6df2-49e1-b31b-921f395cd2c7" xlink:to="loc_sny_SynthorxMember_9db956a0-d16e-4a8d-8975-fdc6e15efd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_77854710-e0f7-43b2-93d1-a88db8b69de4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_f0c6f4bd-c542-43e8-9a3e-de09bc0b51c4" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_77854710-e0f7-43b2-93d1-a88db8b69de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_77854710-e0f7-43b2-93d1-a88db8b69de4" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketedProductsMember_feb910f4-6eee-4929-9e5f-056e971f628f" xlink:href="sny-20221231.xsd#sny_MarketedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:to="loc_sny_MarketedProductsMember_feb910f4-6eee-4929-9e5f-056e971f628f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TechnologicalPlatformsMember_c0094b8f-09bf-4e30-92e9-f3ae41d2120c" xlink:href="sny-20221231.xsd#sny_TechnologicalPlatformsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:to="loc_sny_TechnologicalPlatformsMember_c0094b8f-09bf-4e30-92e9-f3ae41d2120c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherIntangibleAssetsExcludingSoftwareMember_a0337369-47f1-4972-8d52-c84fec6caf1f" xlink:href="sny-20221231.xsd#sny_OtherIntangibleAssetsExcludingSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:to="loc_sny_OtherIntangibleAssetsExcludingSoftwareMember_a0337369-47f1-4972-8d52-c84fec6caf1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EnjaymoMember_f81dfa55-cae6-4b46-aae0-7ae6eaeaa422" xlink:href="sny-20221231.xsd#sny_EnjaymoMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_ecf0c6b9-147c-4359-8371-0b0672b13ccd" xlink:to="loc_sny_EnjaymoMember_f81dfa55-cae6-4b46-aae0-7ae6eaeaa422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_314aadbe-db35-45ad-9d81-eaba069143e6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_f0c6f4bd-c542-43e8-9a3e-de09bc0b51c4" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_314aadbe-db35-45ad-9d81-eaba069143e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_c8273d2c-3877-4a86-b48f-177b6c169de4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_314aadbe-db35-45ad-9d81-eaba069143e6" xlink:to="loc_ifrs-full_CarryingAmountMember_c8273d2c-3877-4a86-b48f-177b6c169de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_2ca6ece2-be31-4244-8474-8f8faffd30c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_c8273d2c-3877-4a86-b48f-177b6c169de4" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_2ca6ece2-be31-4244-8474-8f8faffd30c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_be86c6c2-054f-44d1-892d-09ff0c0f88bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_c8273d2c-3877-4a86-b48f-177b6c169de4" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_be86c6c2-054f-44d1-892d-09ff0c0f88bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_f0c6f4bd-c542-43e8-9a3e-de09bc0b51c4" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_02b6765e-deaf-41ea-8f7e-fb87c0512cf9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_02b6765e-deaf-41ea-8f7e-fb87c0512cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_6816a137-5712-4469-a59e-6a6a6e48d1c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:to="loc_ifrs-full_Goodwill_6816a137-5712-4469-a59e-6a6a6e48d1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_0d0e8bed-940c-4541-9499-b330eb735724" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_0d0e8bed-940c-4541-9499-b330eb735724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1869be25-75e8-4f9d-8a4c-0337fc5008d7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1869be25-75e8-4f9d-8a4c-0337fc5008d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_efc4fee4-b55b-4221-9399-e26433934edf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_f5ff018c-1c7d-48f0-9148-50deea2fb5e3" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_efc4fee4-b55b-4221-9399-e26433934edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_304156e3-cc62-4c57-9286-02c047a6f708" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e6b477ff-38db-46ba-8db9-b0a4f306671e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_304156e3-cc62-4c57-9286-02c047a6f708" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e6b477ff-38db-46ba-8db9-b0a4f306671e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_280b5903-e565-4f1b-8f60-17e721f76427" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e6b477ff-38db-46ba-8db9-b0a4f306671e" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_280b5903-e565-4f1b-8f60-17e721f76427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_280b5903-e565-4f1b-8f60-17e721f76427" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AcquiredRDMember_be8a7479-30a3-4d3b-8f8a-fc6d76e5ad07" xlink:href="sny-20221231.xsd#sny_AcquiredRDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:to="loc_sny_AcquiredRDMember_be8a7479-30a3-4d3b-8f8a-fc6d76e5ad07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketedProductsTrademarksAndOtherRightsMember_5c68a305-3301-4ea5-bbc7-43b8cf9ff2e8" xlink:href="sny-20221231.xsd#sny_MarketedProductsTrademarksAndOtherRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:to="loc_sny_MarketedProductsTrademarksAndOtherRightsMember_5c68a305-3301-4ea5-bbc7-43b8cf9ff2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_bc95217d-771c-4340-8fd6-8b7cc7a6bddd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:to="loc_ifrs-full_ComputerSoftwareMember_bc95217d-771c-4340-8fd6-8b7cc7a6bddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IOLicenseAndCollaborationAgreementMember_0bb5d409-e708-41c4-a0fe-abc8e4c3aab5" xlink:href="sny-20221231.xsd#sny_IOLicenseAndCollaborationAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_d4777583-9d24-4348-bb6d-e1833b6e7928" xlink:to="loc_sny_IOLicenseAndCollaborationAgreementMember_0bb5d409-e708-41c4-a0fe-abc8e4c3aab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8567c6ed-8897-4b9c-a42f-c368bf61caad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e6b477ff-38db-46ba-8db9-b0a4f306671e" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8567c6ed-8897-4b9c-a42f-c368bf61caad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_332439a5-db78-4927-a641-5cb07ddda8c9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8567c6ed-8897-4b9c-a42f-c368bf61caad" xlink:to="loc_ifrs-full_CarryingAmountMember_332439a5-db78-4927-a641-5cb07ddda8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_559495e8-0a73-4f14-b84a-9254c6f2451a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_332439a5-db78-4927-a641-5cb07ddda8c9" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_559495e8-0a73-4f14-b84a-9254c6f2451a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_86b4f806-e8e1-409c-8727-d3cf8aa188b2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_332439a5-db78-4927-a641-5cb07ddda8c9" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_86b4f806-e8e1-409c-8727-d3cf8aa188b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_e6b477ff-38db-46ba-8db9-b0a4f306671e" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssets_85149216-cec5-475d-9105-c9f0b1277072" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_OtherIntangibleAssets_85149216-cec5-475d-9105-c9f0b1277072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets_60d3f2ff-a981-4a0e-9094-ced1ed22a178" xlink:href="sny-20221231.xsd#sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets_60d3f2ff-a981-4a0e-9094-ced1ed22a178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_8bd0d742-6067-485a-a17f-eb8f9fde9c36" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_8bd0d742-6067-485a-a17f-eb8f9fde9c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_87698b4e-00df-46cb-8915-1734d5dedfc5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_87698b4e-00df-46cb-8915-1734d5dedfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_75ba157e-2bea-4710-af39-610d7d3974f9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_75ba157e-2bea-4710-af39-610d7d3974f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_bc296425-71ab-4d63-9350-a238ea3fd0ac" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_bc296425-71ab-4d63-9350-a238ea3fd0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_cf145461-b0b5-47cd-97ee-4b8c08d4bb94" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_cf145461-b0b5-47cd-97ee-4b8c08d4bb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_d4b2f426-8b7d-4c18-be8d-e75525d6d07c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_d4b2f426-8b7d-4c18-be8d-e75525d6d07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssets_7229a300-7970-4a70-b6e9-e574f36106cc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_63056214-3810-4da1-8c8e-af8de7cfd67e" xlink:to="loc_ifrs-full_OtherIntangibleAssets_7229a300-7970-4a70-b6e9-e574f36106cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_b0544cfb-b102-4d0a-8293-2326e24cf648" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_3164cc73-5c96-423d-bb79-376367ad7917" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_b0544cfb-b102-4d0a-8293-2326e24cf648" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_3164cc73-5c96-423d-bb79-376367ad7917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_196b5db6-17cb-4c77-a334-43ab5a81564e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_3164cc73-5c96-423d-bb79-376367ad7917" xlink:to="loc_ifrs-full_RangeAxis_196b5db6-17cb-4c77-a334-43ab5a81564e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_4a15fc0c-50f8-4925-bc3e-e5beea8ab7f5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_196b5db6-17cb-4c77-a334-43ab5a81564e" xlink:to="loc_ifrs-full_RangesMember_4a15fc0c-50f8-4925-bc3e-e5beea8ab7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_c14f8f6e-58a3-4fe0-ae78-1c1f2b791626" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_4a15fc0c-50f8-4925-bc3e-e5beea8ab7f5" xlink:to="loc_ifrs-full_BottomOfRangeMember_c14f8f6e-58a3-4fe0-ae78-1c1f2b791626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_879f643a-57a7-44d0-bed9-293dbe32c154" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_4a15fc0c-50f8-4925-bc3e-e5beea8ab7f5" xlink:to="loc_ifrs-full_TopOfRangeMember_879f643a-57a7-44d0-bed9-293dbe32c154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_507a1bc9-6eb5-43b9-b03e-a79296eb4912" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_3164cc73-5c96-423d-bb79-376367ad7917" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_507a1bc9-6eb5-43b9-b03e-a79296eb4912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_e12a7c82-e413-455a-83ae-b135cdaddfed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_507a1bc9-6eb5-43b9-b03e-a79296eb4912" xlink:to="loc_ifrs-full_CarryingAmountMember_e12a7c82-e413-455a-83ae-b135cdaddfed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_336a09be-3e7d-45b3-9e5e-b802799024d2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_e12a7c82-e413-455a-83ae-b135cdaddfed" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_336a09be-3e7d-45b3-9e5e-b802799024d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_f5a3180e-eeb9-4a90-9487-2e88ead8e14b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_e12a7c82-e413-455a-83ae-b135cdaddfed" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_f5a3180e-eeb9-4a90-9487-2e88ead8e14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_2b7dcd92-7b10-4804-8e50-5d90bdf1a54d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_3164cc73-5c96-423d-bb79-376367ad7917" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_2b7dcd92-7b10-4804-8e50-5d90bdf1a54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_fbc39b2d-1ce8-426b-a395-fc0bc9030eba" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_2b7dcd92-7b10-4804-8e50-5d90bdf1a54d" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_fbc39b2d-1ce8-426b-a395-fc0bc9030eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketedProductsMember_35744456-d51a-48ef-8e55-029c87518597" xlink:href="sny-20221231.xsd#sny_MarketedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_fbc39b2d-1ce8-426b-a395-fc0bc9030eba" xlink:to="loc_sny_MarketedProductsMember_35744456-d51a-48ef-8e55-029c87518597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_fbc39b2d-1ce8-426b-a395-fc0bc9030eba" xlink:to="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsGenzymeMember_4696f510-c905-41fc-8a18-dc6784c589ae" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsGenzymeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsGenzymeMember_4696f510-c905-41fc-8a18-dc6784c589ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember_1d03151a-e7f7-493a-a1a5-8ec3e3c7e0de" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember_1d03151a-e7f7-493a-a1a5-8ec3e3c7e0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsAventisMember_7025e3f8-3926-41d2-ad52-d116a13e3ed2" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsAventisMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsAventisMember_7025e3f8-3926-41d2-ad52-d116a13e3ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsChattemMember_9e100618-b4e7-41b8-8613-5bb9fabc684f" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsChattemMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsChattemMember_9e100618-b4e7-41b8-8613-5bb9fabc684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsProteinSciencesMember_54533fe6-4f2b-42f3-b6b2-239facae81fe" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsProteinSciencesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsProteinSciencesMember_54533fe6-4f2b-42f3-b6b2-239facae81fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsAblynxMember_e9e70596-20c6-40b2-9b25-44a2225a7bb5" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsAblynxMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsAblynxMember_e9e70596-20c6-40b2-9b25-44a2225a7bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsBioverativMember_04c59ff1-f1f8-4102-ac97-9f61f2177212" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsBioverativMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsBioverativMember_04c59ff1-f1f8-4102-ac97-9f61f2177212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalMarketedProductsKadmonMember_1dc4f3b0-f057-4e25-8f1f-062793f4030f" xlink:href="sny-20221231.xsd#sny_PrincipalMarketedProductsKadmonMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalMarketedProductsMember_d973de08-0107-4f7d-aee7-7ab8d77be03c" xlink:to="loc_sny_PrincipalMarketedProductsKadmonMember_1dc4f3b0-f057-4e25-8f1f-062793f4030f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_3164cc73-5c96-423d-bb79-376367ad7917" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConcentrationRiskThresholdPercentage_b2063620-adb6-475d-b979-def2afb7bb66" xlink:href="sny-20221231.xsd#sny_ConcentrationRiskThresholdPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:to="loc_sny_ConcentrationRiskThresholdPercentage_b2063620-adb6-475d-b979-def2afb7bb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_a9041406-81c0-4eae-8c1f-0f3b30f11c45" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_a9041406-81c0-4eae-8c1f-0f3b30f11c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_ef1718da-bb6a-48c6-9b21-aecd85d3baf6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_ef1718da-bb6a-48c6-9b21-aecd85d3baf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_a6d09f69-6d42-417d-a871-2aae7dda742d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_c0601472-da71-419d-9ba2-155385a1dd88" xlink:to="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_a6d09f69-6d42-417d-a871-2aae7dda742d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_b81c514e-f0f3-43fd-bc37-ce0c363754bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_13c4d8e1-73e8-47d1-acd4-56e9bb4d73bc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_b81c514e-f0f3-43fd-bc37-ce0c363754bd" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_13c4d8e1-73e8-47d1-acd4-56e9bb4d73bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseCategoriesAxis_0934f9be-a9e7-45d3-8626-7fd6647cf75b" xlink:href="sny-20221231.xsd#sny_ExpenseCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_13c4d8e1-73e8-47d1-acd4-56e9bb4d73bc" xlink:to="loc_sny_ExpenseCategoriesAxis_0934f9be-a9e7-45d3-8626-7fd6647cf75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseCategoriesDomain_c528413b-907d-440b-8cca-15958c45464f" xlink:href="sny-20221231.xsd#sny_ExpenseCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ExpenseCategoriesAxis_0934f9be-a9e7-45d3-8626-7fd6647cf75b" xlink:to="loc_sny_ExpenseCategoriesDomain_c528413b-907d-440b-8cca-15958c45464f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember_ea2e26ee-ce44-497c-88bf-11e85e48c1e7" xlink:href="sny-20221231.xsd#sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ExpenseCategoriesDomain_c528413b-907d-440b-8cca-15958c45464f" xlink:to="loc_sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember_ea2e26ee-ce44-497c-88bf-11e85e48c1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_13c4d8e1-73e8-47d1-acd4-56e9bb4d73bc" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_273fa078-6a45-492c-b41f-51a11691701e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:to="loc_ifrs-full_CostOfSales_273fa078-6a45-492c-b41f-51a11691701e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_d37728a7-ffd1-48b3-83ce-1d1d98d8ec50" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_d37728a7-ffd1-48b3-83ce-1d1d98d8ec50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_f9f55f32-7e57-4f0d-938a-a9a02b984ec3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_f9f55f32-7e57-4f0d-938a-a9a02b984ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_2f8a4e39-f193-4aa9-a61e-a10673029086" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_2f8a4e39-f193-4aa9-a61e-a10673029086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_be9795f1-60c5-4b8c-9567-492c9a579922" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_05a45d3c-f62c-4012-a62d-f84ea1e02129" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_be9795f1-60c5-4b8c-9567-492c9a579922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentOfAssetsAbstract_d0b980b5-93b7-47f2-a4ef-11c2a88682da" xlink:href="sny-20221231.xsd#sny_ImpairmentOfAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_95a0415a-2f18-40a1-b774-c6265fc8be2c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ImpairmentOfAssetsAbstract_d0b980b5-93b7-47f2-a4ef-11c2a88682da" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_95a0415a-2f18-40a1-b774-c6265fc8be2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_fc1f3a9b-74c3-4067-8b7f-16ee283e9b25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_95a0415a-2f18-40a1-b774-c6265fc8be2c" xlink:to="loc_ifrs-full_SegmentsAxis_fc1f3a9b-74c3-4067-8b7f-16ee283e9b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_c9b0449b-d2d5-44e8-8bd0-64c9d5adc7b0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_fc1f3a9b-74c3-4067-8b7f-16ee283e9b25" xlink:to="loc_ifrs-full_SegmentsMember_c9b0449b-d2d5-44e8-8bd0-64c9d5adc7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsMember_dce041d8-d4d4-47e7-9f43-4a1a63a19a70" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_c9b0449b-d2d5-44e8-8bd0-64c9d5adc7b0" xlink:to="loc_sny_PharmaceuticalsMember_dce041d8-d4d4-47e7-9f43-4a1a63a19a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareMember_0fd63aa5-7176-4a4e-bd92-e3c3dd2669c1" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_c9b0449b-d2d5-44e8-8bd0-64c9d5adc7b0" xlink:to="loc_sny_ConsumerHealthcareMember_0fd63aa5-7176-4a4e-bd92-e3c3dd2669c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesMember_7d241b4e-9997-4115-bd2c-2846b9779cb7" xlink:href="sny-20221231.xsd#sny_VaccinesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_c9b0449b-d2d5-44e8-8bd0-64c9d5adc7b0" xlink:to="loc_sny_VaccinesMember_7d241b4e-9997-4115-bd2c-2846b9779cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_2b61e3a5-b885-4f18-a436-33bc5c59da33" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_95a0415a-2f18-40a1-b774-c6265fc8be2c" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_2b61e3a5-b885-4f18-a436-33bc5c59da33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_5a0775a0-ce83-451f-8ba2-9e605bcccff8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_2b61e3a5-b885-4f18-a436-33bc5c59da33" xlink:to="loc_ifrs-full_Goodwill_5a0775a0-ce83-451f-8ba2-9e605bcccff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentOfAssetsAbstract_772bc6ed-67b6-4b13-9f8d-8da2cd14e2b8" xlink:href="sny-20221231.xsd#sny_ImpairmentOfAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ImpairmentOfAssetsAbstract_772bc6ed-67b6-4b13-9f8d-8da2cd14e2b8" xlink:to="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_43f781d0-e46d-468c-ae64-108cf70f704d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:to="loc_ifrs-full_SegmentsAxis_43f781d0-e46d-468c-ae64-108cf70f704d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_af0bc29b-3dbe-4308-971b-162df4bfdf2e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_43f781d0-e46d-468c-ae64-108cf70f704d" xlink:to="loc_ifrs-full_SegmentsMember_af0bc29b-3dbe-4308-971b-162df4bfdf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsSegmentMember_a74299a3-67ef-4984-8ece-a67776665cdd" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_af0bc29b-3dbe-4308-971b-162df4bfdf2e" xlink:to="loc_sny_PharmaceuticalsSegmentMember_a74299a3-67ef-4984-8ece-a67776665cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareMember_f27f90a6-49b4-4ce5-a1f8-698905e93058" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_af0bc29b-3dbe-4308-971b-162df4bfdf2e" xlink:to="loc_sny_ConsumerHealthcareMember_f27f90a6-49b4-4ce5-a1f8-698905e93058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesMember_bbd4f876-bd17-4828-b13a-782dec164fcb" xlink:href="sny-20221231.xsd#sny_VaccinesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_af0bc29b-3dbe-4308-971b-162df4bfdf2e" xlink:to="loc_sny_VaccinesMember_bbd4f876-bd17-4828-b13a-782dec164fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_280aaa46-fa8e-4d86-8906-d84bc95c93c9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_280aaa46-fa8e-4d86-8906-d84bc95c93c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForCashgeneratingUnitsMember_bb3fa78f-35a9-4253-b041-2d7266610300" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForCashgeneratingUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis_280aaa46-fa8e-4d86-8906-d84bc95c93c9" xlink:to="loc_ifrs-full_EntitysTotalForCashgeneratingUnitsMember_bb3fa78f-35a9-4253-b041-2d7266610300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember_6985ff1c-1266-4430-b10b-0a2bae9d59de" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForCashgeneratingUnitsMember_bb3fa78f-35a9-4253-b041-2d7266610300" xlink:to="loc_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember_6985ff1c-1266-4430-b10b-0a2bae9d59de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_1f36add1-1638-4c3e-9624-d3d87b7b5175" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_1f36add1-1638-4c3e-9624-d3d87b7b5175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_86b17e80-80ad-4876-a333-b48a2c22da37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1f36add1-1638-4c3e-9624-d3d87b7b5175" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_86b17e80-80ad-4876-a333-b48a2c22da37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashGeneratingUnitsMember_19323049-bf49-4321-9301-4e9c7dc54a78" xlink:href="sny-20221231.xsd#sny_CashGeneratingUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_86b17e80-80ad-4876-a333-b48a2c22da37" xlink:to="loc_sny_CashGeneratingUnitsMember_19323049-bf49-4321-9301-4e9c7dc54a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_2cf196ee-16b4-4df6-bdfa-bc3e24cbaf5a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_2cf196ee-16b4-4df6-bdfa-bc3e24cbaf5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_72dcb089-5fca-4c11-92c7-aa9642447ef8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_2cf196ee-16b4-4df6-bdfa-bc3e24cbaf5a" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_72dcb089-5fca-4c11-92c7-aa9642447ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillMember_d22e9175-d9dc-4ce1-ba3c-4f7f0c196508" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_72dcb089-5fca-4c11-92c7-aa9642447ef8" xlink:to="loc_ifrs-full_GoodwillMember_d22e9175-d9dc-4ce1-ba3c-4f7f0c196508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_a8e221b0-8765-40b0-8213-c424d033223a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_72dcb089-5fca-4c11-92c7-aa9642447ef8" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_a8e221b0-8765-40b0-8213-c424d033223a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_b6a0ff65-ad02-4c28-b97f-cb42ebb47596" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:to="loc_ifrs-full_RangeAxis_b6a0ff65-ad02-4c28-b97f-cb42ebb47596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_91a7c177-eae9-471a-b92b-3a670dc9a31c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_b6a0ff65-ad02-4c28-b97f-cb42ebb47596" xlink:to="loc_ifrs-full_RangesMember_91a7c177-eae9-471a-b92b-3a670dc9a31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_b7f89a72-43f4-43f8-92a8-ef434d21c8f9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_91a7c177-eae9-471a-b92b-3a670dc9a31c" xlink:to="loc_ifrs-full_BottomOfRangeMember_b7f89a72-43f4-43f8-92a8-ef434d21c8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_be6da27f-0a6c-4bce-8260-c37f9578888e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_91a7c177-eae9-471a-b92b-3a670dc9a31c" xlink:to="loc_ifrs-full_TopOfRangeMember_be6da27f-0a6c-4bce-8260-c37f9578888e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_8a0f4c07-f5dc-4f1c-84a2-2c612c421c13" xlink:to="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentTestingPercentage_2b2b6569-06b7-4b8c-96ea-2f97c043f963" xlink:href="sny-20221231.xsd#sny_ImpairmentTestingPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_ImpairmentTestingPercentage_2b2b6569-06b7-4b8c-96ea-2f97c043f963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UniformImpairmentTestingPercentage_ef33cbc5-219f-435a-89c5-b6c65454d223" xlink:href="sny-20221231.xsd#sny_UniformImpairmentTestingPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_UniformImpairmentTestingPercentage_ef33cbc5-219f-435a-89c5-b6c65454d223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOperatingSegments_337fa719-2406-4dae-b2ed-106e95e1d2b2" xlink:href="sny-20221231.xsd#sny_NumberOfOperatingSegments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_NumberOfOperatingSegments_337fa719-2406-4dae-b2ed-106e95e1d2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PretaxDiscountRateAppliedForGoodwill_a104cd94-7eda-4a2f-b6a6-ee28cff3c83f" xlink:href="sny-20221231.xsd#sny_PretaxDiscountRateAppliedForGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_PretaxDiscountRateAppliedForGoodwill_a104cd94-7eda-4a2f-b6a6-ee28cff3c83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UniformPreTaxDiscountRates_1b8f00ab-c975-4576-8322-41285bd51448" xlink:href="sny-20221231.xsd#sny_UniformPreTaxDiscountRates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_UniformPreTaxDiscountRates_1b8f00ab-c975-4576-8322-41285bd51448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_eae84fe7-8e67-44f0-b963-bec774ddb03d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_eae84fe7-8e67-44f0-b963-bec774ddb03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss_6b5e4561-b57f-42d3-8fa2-4a180dd9c9ee" xlink:href="sny-20221231.xsd#sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss_6b5e4561-b57f-42d3-8fa2-4a180dd9c9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss_a89ba49e-e555-4314-aa5b-228f6979bc7a" xlink:href="sny-20221231.xsd#sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss_a89ba49e-e555-4314-aa5b-228f6979bc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss_6bb50840-ca3c-43ae-be6d-c5c1ae3211b0" xlink:href="sny-20221231.xsd#sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss_6bb50840-ca3c-43ae-be6d-c5c1ae3211b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_5fbc427b-3030-4830-a137-7de21618a9c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_5fbc427b-3030-4830-a137-7de21618a9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AfterTaxDiscountRates_d02a47ea-ee73-450d-8ef7-0da529483602" xlink:href="sny-20221231.xsd#sny_AfterTaxDiscountRates"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_9c8d9caa-8661-4a28-8ee7-5420f8360154" xlink:to="loc_sny_AfterTaxDiscountRates_d02a47ea-ee73-450d-8ef7-0da529483602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentOfAssetsAbstract_52bea0a5-f829-4ae5-bcfb-e02176d35bbd" xlink:href="sny-20221231.xsd#sny_ImpairmentOfAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ImpairmentOfAssetsAbstract_52bea0a5-f829-4ae5-bcfb-e02176d35bbd" xlink:to="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_5df393d6-4ebd-412d-bb03-ac6ede0cd00a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:to="loc_ifrs-full_SegmentsAxis_5df393d6-4ebd-412d-bb03-ac6ede0cd00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_60294081-0f5a-435d-86ff-cf2e64b082f3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_5df393d6-4ebd-412d-bb03-ac6ede0cd00a" xlink:to="loc_ifrs-full_SegmentsMember_60294081-0f5a-435d-86ff-cf2e64b082f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsSegmentMember_07fa49d8-6861-4fef-924c-833753554ee8" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_60294081-0f5a-435d-86ff-cf2e64b082f3" xlink:to="loc_sny_PharmaceuticalsSegmentMember_07fa49d8-6861-4fef-924c-833753554ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareSegmentMember_b209816f-9fa2-444f-88c0-93898badedbf" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_60294081-0f5a-435d-86ff-cf2e64b082f3" xlink:to="loc_sny_ConsumerHealthcareSegmentMember_b209816f-9fa2-444f-88c0-93898badedbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesSegmentMember_0be59ed2-09bc-4824-b9ce-f83c36e037ae" xlink:href="sny-20221231.xsd#sny_VaccinesSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_60294081-0f5a-435d-86ff-cf2e64b082f3" xlink:to="loc_sny_VaccinesSegmentMember_0be59ed2-09bc-4824-b9ce-f83c36e037ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7dd7f48e-ee39-4edc-a5f2-edbb26a08189" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7dd7f48e-ee39-4edc-a5f2-edbb26a08189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1f137596-3525-4439-a41f-3934ffaffb7a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7dd7f48e-ee39-4edc-a5f2-edbb26a08189" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1f137596-3525-4439-a41f-3934ffaffb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_cec584f0-f957-4bb7-9b9b-47afc9133da4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1f137596-3525-4439-a41f-3934ffaffb7a" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_cec584f0-f957-4bb7-9b9b-47afc9133da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_3b0d4518-14f0-4116-8d96-93d10aaa32aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_3b0d4518-14f0-4116-8d96-93d10aaa32aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesMember_4996dd7f-ea66-4083-a855-37fdaeb018ea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_3b0d4518-14f0-4116-8d96-93d10aaa32aa" xlink:to="loc_ifrs-full_ProductsAndServicesMember_4996dd7f-ea66-4083-a855-37fdaeb018ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketedProductsMember_2a18117f-1b4a-4735-a715-69b51ade006f" xlink:href="sny-20221231.xsd#sny_MarketedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_4996dd7f-ea66-4083-a855-37fdaeb018ea" xlink:to="loc_sny_MarketedProductsMember_2a18117f-1b4a-4735-a715-69b51ade006f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ResearchAndDevelopmentMember_ce7152f1-5c3f-41a6-9760-cf901029e992" xlink:href="sny-20221231.xsd#sny_ResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_4996dd7f-ea66-4083-a855-37fdaeb018ea" xlink:to="loc_sny_ResearchAndDevelopmentMember_ce7152f1-5c3f-41a6-9760-cf901029e992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SAR444245Member_efa4cf4e-af2b-4c0f-bb0a-666e758740b3" xlink:href="sny-20221231.xsd#sny_SAR444245Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_4996dd7f-ea66-4083-a855-37fdaeb018ea" xlink:to="loc_sny_SAR444245Member_efa4cf4e-af2b-4c0f-bb0a-666e758740b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_da985085-5dce-42f2-aeac-11eae6f8da93" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:to="loc_srt_ProductOrServiceAxis_da985085-5dce-42f2-aeac-11eae6f8da93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_418911d8-09f2-4823-afdc-cc32c4ab4b2a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_da985085-5dce-42f2-aeac-11eae6f8da93" xlink:to="loc_srt_ProductsAndServicesDomain_418911d8-09f2-4823-afdc-cc32c4ab4b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EloctateMember_e67d7b88-4e44-469e-ad75-2b752a87a002" xlink:href="sny-20221231.xsd#sny_EloctateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_418911d8-09f2-4823-afdc-cc32c4ab4b2a" xlink:to="loc_sny_EloctateMember_e67d7b88-4e44-469e-ad75-2b752a87a002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_98112ea5-8d42-40a0-af21-3762448817d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_98112ea5-8d42-40a0-af21-3762448817d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_7767641a-9b97-4cfc-bf8a-433d87f4d6e8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_98112ea5-8d42-40a0-af21-3762448817d0" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_7767641a-9b97-4cfc-bf8a-433d87f4d6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_132b22f0-90f3-482b-b549-9ed7c7c02774" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_7767641a-9b97-4cfc-bf8a-433d87f4d6e8" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_132b22f0-90f3-482b-b549-9ed7c7c02774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_a591b402-ee0d-46a8-951a-82511c340d56" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable_365242c8-f360-4818-bb9a-7e0073c407fe" xlink:to="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_a591b402-ee0d-46a8-951a-82511c340d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill_28a5fd48-8608-4969-bd84-8c7184fb5196" xlink:href="sny-20221231.xsd#sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_a591b402-ee0d-46a8-951a-82511c340d56" xlink:to="loc_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill_28a5fd48-8608-4969-bd84-8c7184fb5196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_39d523d9-dac8-48ac-931b-9a9e7cf4c947" xlink:href="sny-20221231.xsd#sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_a591b402-ee0d-46a8-951a-82511c340d56" xlink:to="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_39d523d9-dac8-48ac-931b-9a9e7cf4c947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_4b0870e5-676e-4c33-9572-5dd665616e9e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems_a591b402-ee0d-46a8-951a-82511c340d56" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_4b0870e5-676e-4c33-9572-5dd665616e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_80452a3d-5b56-4aa4-92ec-a5953620361d" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_a18c734c-c41e-4a40-af67-1374938a939f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_80452a3d-5b56-4aa4-92ec-a5953620361d" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_a18c734c-c41e-4a40-af67-1374938a939f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_53055414-0174-4290-b448-4130722101a4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_a18c734c-c41e-4a40-af67-1374938a939f" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_53055414-0174-4290-b448-4130722101a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_fceedead-5f87-4fd4-a458-96df59dc24aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_53055414-0174-4290-b448-4130722101a4" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_fceedead-5f87-4fd4-a458-96df59dc24aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_792e7280-1ae3-4c4a-bbe1-f44af21fcea2" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_fceedead-5f87-4fd4-a458-96df59dc24aa" xlink:to="loc_sny_EuroapiMember_792e7280-1ae3-4c4a-bbe1-f44af21fcea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MCMVaccineBVMember_52985c99-3c37-467c-aa0c-272c9561695a" xlink:href="sny-20221231.xsd#sny_MCMVaccineBVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_fceedead-5f87-4fd4-a458-96df59dc24aa" xlink:to="loc_sny_MCMVaccineBVMember_52985c99-3c37-467c-aa0c-272c9561695a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_4ea1550e-f3d5-4d3e-ab7f-754f1b5aea7b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_a18c734c-c41e-4a40-af67-1374938a939f" xlink:to="loc_ifrs-full_JointVenturesAxis_4ea1550e-f3d5-4d3e-ab7f-754f1b5aea7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_d9406c73-55c5-4e66-8d58-cc3e0112a9e4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_JointVenturesAxis_4ea1550e-f3d5-4d3e-ab7f-754f1b5aea7b" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_d9406c73-55c5-4e66-8d58-cc3e0112a9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InfraservGmbhAndCoHochstKGMember_e10eeae3-bfb9-492e-8bdd-c1819c6243a7" xlink:href="sny-20221231.xsd#sny_InfraservGmbhAndCoHochstKGMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_d9406c73-55c5-4e66-8d58-cc3e0112a9e4" xlink:to="loc_sny_InfraservGmbhAndCoHochstKGMember_e10eeae3-bfb9-492e-8bdd-c1819c6243a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSPVaccineCompanyMember_6d21d936-05de-44c7-973c-2301c2b6d509" xlink:href="sny-20221231.xsd#sny_MSPVaccineCompanyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_d9406c73-55c5-4e66-8d58-cc3e0112a9e4" xlink:to="loc_sny_MSPVaccineCompanyMember_6d21d936-05de-44c7-973c-2301c2b6d509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_80ec66ec-f6cb-45d1-8ecd-34982cd8d5e2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_d9406c73-55c5-4e66-8d58-cc3e0112a9e4" xlink:to="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_80ec66ec-f6cb-45d1-8ecd-34982cd8d5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_79e49347-e9d5-41ef-8f94-a5a744cf7b07" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_a18c734c-c41e-4a40-af67-1374938a939f" xlink:to="loc_dei_LegalEntityAxis_79e49347-e9d5-41ef-8f94-a5a744cf7b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4173cd3e-bf26-4d4e-815c-5c1556609579" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_79e49347-e9d5-41ef-8f94-a5a744cf7b07" xlink:to="loc_dei_EntityDomain_4173cd3e-bf26-4d4e-815c-5c1556609579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSPVaccineCompanyMember_32fbb505-f47c-4d71-870d-39955576671e" xlink:href="sny-20221231.xsd#sny_MSPVaccineCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4173cd3e-bf26-4d4e-815c-5c1556609579" xlink:to="loc_sny_MSPVaccineCompanyMember_32fbb505-f47c-4d71-870d-39955576671e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_a18c734c-c41e-4a40-af67-1374938a939f" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_2329ed6f-6bad-4f09-80ea-c632431da9db" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_2329ed6f-6bad-4f09-80ea-c632431da9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture_c10493c2-ba82-496d-9d1a-b96475c779d7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture_c10493c2-ba82-496d-9d1a-b96475c779d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInJointVentures_3cc028a5-9855-41cd-908f-3495c42598d4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInJointVentures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:to="loc_ifrs-full_InvestmentsInJointVentures_3cc028a5-9855-41cd-908f-3495c42598d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_81b61e73-b055-48b1-afd2-13c715756815" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_026d8ef1-16b9-4507-9467-3a454b31c2d3" xlink:to="loc_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_81b61e73-b055-48b1-afd2-13c715756815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_710e5944-2a02-474d-97d8-5a34f4c3fa7a" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_e61119c3-3332-4653-a71a-94e48102fc1f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_710e5944-2a02-474d-97d8-5a34f4c3fa7a" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_e61119c3-3332-4653-a71a-94e48102fc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ddd9f0-d2e7-43fd-b2e3-a2136b2c3a21" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_e61119c3-3332-4653-a71a-94e48102fc1f" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ddd9f0-d2e7-43fd-b2e3-a2136b2c3a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_a32abb41-fc8b-40ef-9291-36e579a797e3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ddd9f0-d2e7-43fd-b2e3-a2136b2c3a21" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_a32abb41-fc8b-40ef-9291-36e579a797e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssociatesMember_8ec9fb3a-5ae6-4953-a1bc-bbe286594d20" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_a32abb41-fc8b-40ef-9291-36e579a797e3" xlink:to="loc_ifrs-full_AssociatesMember_8ec9fb3a-5ae6-4953-a1bc-bbe286594d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_89ed00ea-067b-4b68-a4f1-bf57512839ba" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_a32abb41-fc8b-40ef-9291-36e579a797e3" xlink:to="loc_sny_RegeneronMember_89ed00ea-067b-4b68-a4f1-bf57512839ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_01d2b4c5-3554-4ae9-a293-e3b923abe7e2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_e61119c3-3332-4653-a71a-94e48102fc1f" xlink:to="loc_ifrs-full_JointVenturesAxis_01d2b4c5-3554-4ae9-a293-e3b923abe7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_45bde043-2f3b-4bd2-803f-54c3c9c12f9b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_JointVenturesAxis_01d2b4c5-3554-4ae9-a293-e3b923abe7e2" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_45bde043-2f3b-4bd2-803f-54c3c9c12f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesMember_6691c8f6-4a2a-4368-aed9-f0a0e0abf72c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_45bde043-2f3b-4bd2-803f-54c3c9c12f9b" xlink:to="loc_ifrs-full_JointVenturesMember_6691c8f6-4a2a-4368-aed9-f0a0e0abf72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_e61119c3-3332-4653-a71a-94e48102fc1f" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_5e1b334e-160e-4a90-ad90-d222a5164acb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:to="loc_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_5e1b334e-160e-4a90-ad90-d222a5164acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax_1d27a963-916c-429c-a183-806cccd806d7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:to="loc_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax_1d27a963-916c-429c-a183-806cccd806d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures_6dbb0384-e091-4fbe-abb1-f893ea544cbd" xlink:href="sny-20221231.xsd#sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:to="loc_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures_6dbb0384-e091-4fbe-abb1-f893ea544cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_d72a7229-7568-43e3-98c8-131198324814" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_ed6eb3e1-37c6-4cf9-b47d-2be38aa5f051" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_d72a7229-7568-43e3-98c8-131198324814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_7eafeede-7fc5-46f4-9f82-a03ea870ecbb" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_84ba22ea-faaf-49b5-b284-f0fa07b2e65c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_7eafeede-7fc5-46f4-9f82-a03ea870ecbb" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_84ba22ea-faaf-49b5-b284-f0fa07b2e65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7bfe54cd-4287-4476-bd5b-2f69ec256acd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_84ba22ea-faaf-49b5-b284-f0fa07b2e65c" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7bfe54cd-4287-4476-bd5b-2f69ec256acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_a7e065cd-87c7-4619-a59b-137d35337861" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7bfe54cd-4287-4476-bd5b-2f69ec256acd" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_a7e065cd-87c7-4619-a59b-137d35337861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AssociatesAndJointVenturesMember_4db28631-672a-48f8-9d00-f3dd4ae664f2" xlink:href="sny-20221231.xsd#sny_AssociatesAndJointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_a7e065cd-87c7-4619-a59b-137d35337861" xlink:to="loc_sny_AssociatesAndJointVenturesMember_4db28631-672a-48f8-9d00-f3dd4ae664f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_84ba22ea-faaf-49b5-b284-f0fa07b2e65c" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_970673bb-59d6-4b05-949a-64fc967867a9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_970673bb-59d6-4b05-949a-64fc967867a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions_a1cb8eb0-fb93-4f57-a8be-71c3d568718d" xlink:href="sny-20221231.xsd#sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:to="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions_a1cb8eb0-fb93-4f57-a8be-71c3d568718d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_d4c9eec9-6f29-4b07-96ef-e6f049d23781" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:to="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_d4c9eec9-6f29-4b07-96ef-e6f049d23781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions_cdb754af-90d4-4c79-9ea2-3b9de85c1e4f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchasesOfGoodsRelatedPartyTransactions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:to="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions_cdb754af-90d4-4c79-9ea2-3b9de85c1e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_f2f241e5-d77d-4ad5-8b48-9e53e9950472" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5db4547b-46c5-4488-85da-a414d49a83cc" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_f2f241e5-d77d-4ad5-8b48-9e53e9950472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_0dfbc20f-84f5-49c1-be0e-76a9bab8cb5d" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_297df12c-a1c6-4fd4-9246-ea64bca0d60a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_0dfbc20f-84f5-49c1-be0e-76a9bab8cb5d" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_297df12c-a1c6-4fd4-9246-ea64bca0d60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_e02618b4-7119-4f90-9d82-68b616920193" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_297df12c-a1c6-4fd4-9246-ea64bca0d60a" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_e02618b4-7119-4f90-9d82-68b616920193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_e1ea62b2-07be-4edd-9ed0-b574f9eba10a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_e02618b4-7119-4f90-9d82-68b616920193" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_e1ea62b2-07be-4edd-9ed0-b574f9eba10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AssociatesAndJointVenturesMember_70a43fc3-032a-44cc-ab73-45cbc80bbfe2" xlink:href="sny-20221231.xsd#sny_AssociatesAndJointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_e1ea62b2-07be-4edd-9ed0-b574f9eba10a" xlink:to="loc_sny_AssociatesAndJointVenturesMember_70a43fc3-032a-44cc-ab73-45cbc80bbfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_17e22aca-f857-45f9-9276-c52ef5c9f4c4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_297df12c-a1c6-4fd4-9246-ea64bca0d60a" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_17e22aca-f857-45f9-9276-c52ef5c9f4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_efe3ee94-18b9-49eb-ad7f-cbdeb9e237e5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_17e22aca-f857-45f9-9276-c52ef5c9f4c4" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_efe3ee94-18b9-49eb-ad7f-cbdeb9e237e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_4c9c6973-3376-409e-9970-3af2932859c1" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_efe3ee94-18b9-49eb-ad7f-cbdeb9e237e5" xlink:to="loc_sny_RegeneronMember_4c9c6973-3376-409e-9970-3af2932859c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_a5e11ac4-e708-4df5-83eb-7e14328454de" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_297df12c-a1c6-4fd4-9246-ea64bca0d60a" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_a5e11ac4-e708-4df5-83eb-7e14328454de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsMadeToJointVenturesAndAssociates_25701ed3-9f82-41d5-81a5-f402b4c510d7" xlink:href="sny-20221231.xsd#sny_CommitmentsMadeToJointVenturesAndAssociates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_a5e11ac4-e708-4df5-83eb-7e14328454de" xlink:to="loc_sny_CommitmentsMadeToJointVenturesAndAssociates_25701ed3-9f82-41d5-81a5-f402b4c510d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ea301ba5-c922-4837-99e1-41b31a8302e2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_fb795fba-134f-4d63-aec6-fba3202cfa68" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherNoncurrentAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ea301ba5-c922-4837-99e1-41b31a8302e2" xlink:to="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_fb795fba-134f-4d63-aec6-fba3202cfa68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_aada3497-a9db-4154-9270-1265e3e4d8c5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_fb795fba-134f-4d63-aec6-fba3202cfa68" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_aada3497-a9db-4154-9270-1265e3e4d8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_e9e42c60-e4d5-471b-8fdd-e6d60f73202c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_aada3497-a9db-4154-9270-1265e3e4d8c5" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_e9e42c60-e4d5-471b-8fdd-e6d60f73202c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradingEquitySecuritiesMember_0587fdf5-2f60-4e5b-b1b1-9ef140f30e8c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradingEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e9e42c60-e4d5-471b-8fdd-e6d60f73202c" xlink:to="loc_ifrs-full_TradingEquitySecuritiesMember_0587fdf5-2f60-4e5b-b1b1-9ef140f30e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DebtSecuritiesMember_d04ee1c1-82b8-43f5-9fb1-433a272b7111" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e9e42c60-e4d5-471b-8fdd-e6d60f73202c" xlink:to="loc_ifrs-full_DebtSecuritiesMember_d04ee1c1-82b8-43f5-9fb1-433a272b7111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_3efb3eb5-a10e-473c-935a-91c829cf3710" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_fb795fba-134f-4d63-aec6-fba3202cfa68" xlink:to="loc_ifrs-full_CounterpartiesAxis_3efb3eb5-a10e-473c-935a-91c829cf3710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_e04a1fdb-0b1c-4dc9-be6e-88d5b59268b2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_3efb3eb5-a10e-473c-935a-91c829cf3710" xlink:to="loc_ifrs-full_CounterpartiesMember_e04a1fdb-0b1c-4dc9-be6e-88d5b59268b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExscientiaMember_d11cfcc7-b03d-43ba-aeaf-52e33d91bb6e" xlink:href="sny-20221231.xsd#sny_ExscientiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_e04a1fdb-0b1c-4dc9-be6e-88d5b59268b2" xlink:to="loc_sny_ExscientiaMember_d11cfcc7-b03d-43ba-aeaf-52e33d91bb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IGMBiosciencesIncMember_419d6551-16d7-4063-af20-1d72f1ee62b8" xlink:href="sny-20221231.xsd#sny_IGMBiosciencesIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_e04a1fdb-0b1c-4dc9-be6e-88d5b59268b2" xlink:to="loc_sny_IGMBiosciencesIncMember_419d6551-16d7-4063-af20-1d72f1ee62b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherNonCurrentAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_fb795fba-134f-4d63-aec6-fba3202cfa68" xlink:to="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_8eb22d92-4044-4d57-8bf7-b203d3d73f91" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_8eb22d92-4044-4d57-8bf7-b203d3d73f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_34e6d336-b3fd-4c22-9607-f5a82953fb21" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_34e6d336-b3fd-4c22-9607-f5a82953fb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PreFundedPensionObligations_0c7fc9c4-36d0-4c77-8f4e-a49ad65e9ea2" xlink:href="sny-20221231.xsd#sny_PreFundedPensionObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_sny_PreFundedPensionObligations_0c7fc9c4-36d0-4c77-8f4e-a49ad65e9ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LongTermPrepaidExpenses_b76b2124-3aac-4973-b5a0-4f9c3ff8bcf0" xlink:href="sny-20221231.xsd#sny_LongTermPrepaidExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_sny_LongTermPrepaidExpenses_b76b2124-3aac-4973-b5a0-4f9c3ff8bcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLoansAndReceivables_11c35af1-ca64-47f4-8012-82af05cdb7a4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLoansAndReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_NoncurrentLoansAndReceivables_11c35af1-ca64-47f4-8012-82af05cdb7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_18af2510-651f-4766-95a5-fbb9ca863a94" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_18af2510-651f-4766-95a5-fbb9ca863a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_305faf82-584f-47a2-8f85-7f44aa42887b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_305faf82-584f-47a2-8f85-7f44aa42887b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UpfrontPayments_eb5577bd-2131-48b1-8508-de36466a65c6" xlink:href="sny-20221231.xsd#sny_UpfrontPayments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_sny_UpfrontPayments_eb5577bd-2131-48b1-8508-de36466a65c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_e919ead8-b828-4ab1-9e17-3504b0b20097" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinanceLeaseReceivables"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_e919ead8-b828-4ab1-9e17-3504b0b20097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinanceLeaseReceivablesGross_feb566d9-3f4d-48ec-9bcf-9432fc55a255" xlink:href="sny-20221231.xsd#sny_NonCurrentFinanceLeaseReceivablesGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_0de8742c-ea06-443f-9bb1-0ce4e21a91e4" xlink:to="loc_sny_NonCurrentFinanceLeaseReceivablesGross_feb566d9-3f4d-48ec-9bcf-9432fc55a255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OthernoncurrentassetsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d3cb4925-e117-4ec7-8b0a-07742759a960" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherNoncurrentAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d3cb4925-e117-4ec7-8b0a-07742759a960" xlink:to="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_4764099f-5d4a-4831-8c44-69f96e8aec7a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_4764099f-5d4a-4831-8c44-69f96e8aec7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_4764099f-5d4a-4831-8c44-69f96e8aec7a" xlink:to="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_a0b4de84-5c8f-454c-85e7-4963f805de84" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:to="loc_sny_TranslateBioMember_a0b4de84-5c8f-454c-85e7-4963f805de84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_c6724348-8790-4f27-b6f8-2475bff28fda" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:to="loc_sny_RegeneronMember_c6724348-8790-4f27-b6f8-2475bff28fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InnoventBiologicsMember_8b43e218-349e-47dc-900e-57bcb74603a3" xlink:href="sny-20221231.xsd#sny_InnoventBiologicsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:to="loc_sny_InnoventBiologicsMember_8b43e218-349e-47dc-900e-57bcb74603a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssociatesMember_70c3b67e-0ade-4f2c-9556-6ece3e368df6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssociatesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember_9dae979b-6366-40b5-a66e-2441e85df663" xlink:to="loc_ifrs-full_AssociatesMember_70c3b67e-0ade-4f2c-9556-6ece3e368df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_9650ca02-9f3e-4f33-ade4-d755adb1d306" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_9650ca02-9f3e-4f33-ade4-d755adb1d306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_87bafe4a-470d-4959-baea-f9e7e1bfb01c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_9650ca02-9f3e-4f33-ade4-d755adb1d306" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_87bafe4a-470d-4959-baea-f9e7e1bfb01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_ceb7f705-f525-443a-8104-bbdd3fed56f6" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_87bafe4a-470d-4959-baea-f9e7e1bfb01c" xlink:to="loc_sny_TranslateBioMember_ceb7f705-f525-443a-8104-bbdd3fed56f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_f7e7c6a2-c9cb-46e3-ae9c-48d202eb6b90" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_MeasurementAxis_f7e7c6a2-c9cb-46e3-ae9c-48d202eb6b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_bca1901a-81e0-4b3d-9e94-a75cf46c8c40" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_f7e7c6a2-c9cb-46e3-ae9c-48d202eb6b90" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_bca1901a-81e0-4b3d-9e94-a75cf46c8c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember_4df90258-cff7-4c2f-85bc-b31b12673887" xlink:href="sny-20221231.xsd#sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_bca1901a-81e0-4b3d-9e94-a75cf46c8c40" xlink:to="loc_sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember_4df90258-cff7-4c2f-85bc-b31b12673887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_09bb5290-7a7f-4d37-b42f-03da35fbfa96" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_09bb5290-7a7f-4d37-b42f-03da35fbfa96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_09bb5290-7a7f-4d37-b42f-03da35fbfa96" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradingEquitySecuritiesMember_ac18c564-bcda-4404-88b8-d8badc69454b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradingEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_ifrs-full_TradingEquitySecuritiesMember_ac18c564-bcda-4404-88b8-d8badc69454b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnquotedEquityInvestmentsMember_40bd1f93-9712-4f72-a219-8a615773ac53" xlink:href="sny-20221231.xsd#sny_UnquotedEquityInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_UnquotedEquityInvestmentsMember_40bd1f93-9712-4f72-a219-8a615773ac53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentsMember_ee499cd8-a7ff-457a-9db8-621b8452f270" xlink:href="sny-20221231.xsd#sny_DebtInstrumentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_DebtInstrumentsMember_ee499cd8-a7ff-457a-9db8-621b8452f270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedDebtInstrumentsMember_2d9cbb92-17e2-4227-a1ba-66385ee37cfa" xlink:href="sny-20221231.xsd#sny_QuotedDebtInstrumentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_QuotedDebtInstrumentsMember_2d9cbb92-17e2-4227-a1ba-66385ee37cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedEquitySecuritiesMember_8d57b9a9-2bdb-4bc8-88d8-270b7a07d584" xlink:href="sny-20221231.xsd#sny_QuotedEquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_QuotedEquitySecuritiesMember_8d57b9a9-2bdb-4bc8-88d8-270b7a07d584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SPMSDContingentConsiderationAssetMember_29b06553-71b7-41b6-94a3-b6eaadaa5d6a" xlink:href="sny-20221231.xsd#sny_SPMSDContingentConsiderationAssetMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_SPMSDContingentConsiderationAssetMember_29b06553-71b7-41b6-94a3-b6eaadaa5d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentAssetMember_eadeedbf-7b3b-4cab-a1ca-0ad609f684ec" xlink:href="sny-20221231.xsd#sny_NonCurrentAssetMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_NonCurrentAssetMember_eadeedbf-7b3b-4cab-a1ca-0ad609f684ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnquotedDebtSecuritiesMember_1c8ba04a-49bb-4676-a2ed-83d6055fa7e7" xlink:href="sny-20221231.xsd#sny_UnquotedDebtSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_3febdd76-20b3-49f5-95e9-84aa6676945d" xlink:to="loc_sny_UnquotedDebtSecuritiesMember_1c8ba04a-49bb-4676-a2ed-83d6055fa7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e1297835-45c2-4f3b-965a-41e1062269dc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e1297835-45c2-4f3b-965a-41e1062269dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_b0c48d81-d1c3-40e1-a36d-73e7a67bd93c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_e1297835-45c2-4f3b-965a-41e1062269dc" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_b0c48d81-d1c3-40e1-a36d-73e7a67bd93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedEuroDenominatedSeniorBondsMember_f29e4800-8508-4fe7-ba6f-149194020fb1" xlink:href="sny-20221231.xsd#sny_QuotedEuroDenominatedSeniorBondsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_b0c48d81-d1c3-40e1-a36d-73e7a67bd93c" xlink:to="loc_sny_QuotedEuroDenominatedSeniorBondsMember_f29e4800-8508-4fe7-ba6f-149194020fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SeniorBondMember_c8f593e6-dfb6-4fef-baee-abeb251df48e" xlink:href="sny-20221231.xsd#sny_SeniorBondMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_b0c48d81-d1c3-40e1-a36d-73e7a67bd93c" xlink:to="loc_sny_SeniorBondMember_c8f593e6-dfb6-4fef-baee-abeb251df48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember_018e6782-cc78-4e59-89ea-5ec40726842f" xlink:href="sny-20221231.xsd#sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_b0c48d81-d1c3-40e1-a36d-73e7a67bd93c" xlink:to="loc_sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember_018e6782-cc78-4e59-89ea-5ec40726842f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_fab303b6-d972-4b0e-8810-39c4bc07b11f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_fab303b6-d972-4b0e-8810-39c4bc07b11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_d0dea960-fae7-4f31-9d55-00eac327854b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_fab303b6-d972-4b0e-8810-39c4bc07b11f" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_d0dea960-fae7-4f31-9d55-00eac327854b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_bc19ac43-6a75-4609-b987-538681607915" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_d0dea960-fae7-4f31-9d55-00eac327854b" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_bc19ac43-6a75-4609-b987-538681607915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis_60ffb441-b6d6-45a3-ae06-fe3bada27515" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis_60ffb441-b6d6-45a3-ae06-fe3bada27515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember_50e18a80-e3ee-42a8-a50d-52f739ab4ad8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis_60ffb441-b6d6-45a3-ae06-fe3bada27515" xlink:to="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember_50e18a80-e3ee-42a8-a50d-52f739ab4ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfSPMSDContingentConsiderationMember_e066e06e-403e-4645-9cdd-50e5096322d5" xlink:href="sny-20221231.xsd#sny_FairValueOfSPMSDContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember_50e18a80-e3ee-42a8-a50d-52f739ab4ad8" xlink:to="loc_sny_FairValueOfSPMSDContingentConsiderationMember_e066e06e-403e-4645-9cdd-50e5096322d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalGroupNameAxis_6e844b95-d7ee-4f63-b07a-5875229e9c29" xlink:href="sny-20221231.xsd#sny_DisposalGroupNameAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_sny_DisposalGroupNameAxis_6e844b95-d7ee-4f63-b07a-5875229e9c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalGroupNameDomain_ea40158b-f963-4536-9e65-b8df79f6be16" xlink:href="sny-20221231.xsd#sny_DisposalGroupNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisposalGroupNameAxis_6e844b95-d7ee-4f63-b07a-5875229e9c29" xlink:to="loc_sny_DisposalGroupNameDomain_ea40158b-f963-4536-9e65-b8df79f6be16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OnduoMember_29e3a38f-6ae3-40da-abb1-994d426fa794" xlink:href="sny-20221231.xsd#sny_OnduoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisposalGroupNameDomain_ea40158b-f963-4536-9e65-b8df79f6be16" xlink:to="loc_sny_OnduoMember_29e3a38f-6ae3-40da-abb1-994d426fa794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherNonCurrentAssetsLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNoncurrentAssetsTable_3f04acf0-8be1-4641-ad5f-36c3d876d533" xlink:to="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_dbf97c8b-47db-43de-96bf-5b109eeda73a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_dbf97c8b-47db-43de-96bf-5b109eeda73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_e15b1ca8-8a56-4a68-a887-a606319d7e81" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_e15b1ca8-8a56-4a68-a887-a606319d7e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount_085d7e41-b126-4f49-a95d-a20852e93b2a" xlink:href="sny-20221231.xsd#sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount_085d7e41-b126-4f49-a95d-a20852e93b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage_57b2810e-bf15-4119-b6a8-31d9c8cdc77c" xlink:href="sny-20221231.xsd#sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage_57b2810e-bf15-4119-b6a8-31d9c8cdc77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_f2e2ac66-ce2d-4418-b6b8-f4d16ceedf0e" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_f2e2ac66-ce2d-4418-b6b8-f4d16ceedf0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinancialAssetsNumberOfShares_5dde6370-95f9-4930-996e-4aace06e0cac" xlink:href="sny-20221231.xsd#sny_NonCurrentFinancialAssetsNumberOfShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_NonCurrentFinancialAssetsNumberOfShares_5dde6370-95f9-4930-996e-4aace06e0cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_0c83a5b1-770e-44aa-8e71-b38fcbd5c439" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_0c83a5b1-770e-44aa-8e71-b38fcbd5c439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount_345ccef1-8f9f-426c-89ef-d01d132bb3b1" xlink:href="sny-20221231.xsd#sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount_345ccef1-8f9f-426c-89ef-d01d132bb3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome_82bc0874-1113-44bf-9a7d-d6e7a9f55733" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome_82bc0874-1113-44bf-9a7d-d6e7a9f55733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_5aa69dda-0e8b-4077-ba44-887dce8d9c81" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_5aa69dda-0e8b-4077-ba44-887dce8d9c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HeldtomaturityInvestments_e4e29293-1132-4612-8227-f47e8f553917" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HeldtomaturityInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_HeldtomaturityInvestments_e4e29293-1132-4612-8227-f47e8f553917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeBeforeTax_dce395b0-ada9-4ba9-bed9-b57efb17f02e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeBeforeTax_dce395b0-ada9-4ba9-bed9-b57efb17f02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity_c25bad3f-0383-47db-8a7e-2cc06b3d7c73" xlink:href="sny-20221231.xsd#sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity_c25bad3f-0383-47db-8a7e-2cc06b3d7c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseInContingentConsideration_e065198b-d352-42d3-a259-cb7acf1bb29a" xlink:href="sny-20221231.xsd#sny_IncreaseInContingentConsideration"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_IncreaseInContingentConsideration_e065198b-d352-42d3-a259-cb7acf1bb29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfTheContingentConsideration_7d9e5288-2739-45d2-8c5d-6deefa75a56e" xlink:href="sny-20221231.xsd#sny_FairValueOfTheContingentConsideration"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_FairValueOfTheContingentConsideration_7d9e5288-2739-45d2-8c5d-6deefa75a56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInvestments_e807b42e-c3a5-470d-b376-f6f876ea8415" xlink:href="sny-20221231.xsd#sny_FinancialInvestments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_FinancialInvestments_e807b42e-c3a5-470d-b376-f6f876ea8415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_a170a844-97cb-4e64-b116-3fa442af815e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_FinancialAssets_a170a844-97cb-4e64-b116-3fa442af815e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_699fd325-1785-48f1-8aa2-f6d9272de008" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_699fd325-1785-48f1-8aa2-f6d9272de008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisposalGroupGainOnDisposal_53276f56-c9d6-494c-b6fc-4e8ae3c22bd1" xlink:href="sny-20221231.xsd#sny_DisposalGroupGainOnDisposal"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_6c44ccaa-6bc7-4fc5-adc1-ac209e629bd9" xlink:to="loc_sny_DisposalGroupGainOnDisposal_53276f56-c9d6-494c-b6fc-4e8ae3c22bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeSummaryofAssetsHeldforSaleorExchangeandLiabilitiesRelatedtoAssetsHeldforSaleorExchangeDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeSummaryofAssetsHeldforSaleorExchangeandLiabilitiesRelatedtoAssetsHeldforSaleorExchangeDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeSummaryofAssetsHeldforSaleorExchangeandLiabilitiesRelatedtoAssetsHeldforSaleorExchangeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_4ec7b47b-cd56-4013-9594-f0255bb00394" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_929ad248-b270-4da3-9740-62ab15e2d1a3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_4ec7b47b-cd56-4013-9594-f0255bb00394" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_929ad248-b270-4da3-9740-62ab15e2d1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_55953699-2825-4dde-ad21-086783ce14de" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_4ec7b47b-cd56-4013-9594-f0255bb00394" xlink:to="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_55953699-2825-4dde-ad21-086783ce14de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InventoriesScheduleofInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_28eb1e23-d544-4a17-b24c-b9c6659daa5e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInventoriesTable_8855169a-2c2a-49de-86ed-e176f468f16b" xlink:href="sny-20221231.xsd#sny_DisclosureOfInventoriesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_28eb1e23-d544-4a17-b24c-b9c6659daa5e" xlink:to="loc_sny_DisclosureOfInventoriesTable_8855169a-2c2a-49de-86ed-e176f468f16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_fc47f4bd-7ca4-4681-852b-c6af34d8618c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInventoriesTable_8855169a-2c2a-49de-86ed-e176f468f16b" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_fc47f4bd-7ca4-4681-852b-c6af34d8618c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_c8942f00-0117-4b2c-9207-0e4bf6cdc9ed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_fc47f4bd-7ca4-4681-852b-c6af34d8618c" xlink:to="loc_ifrs-full_CarryingAmountMember_c8942f00-0117-4b2c-9207-0e4bf6cdc9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_88856198-1d2e-4eaa-9c45-12bf409d60ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_c8942f00-0117-4b2c-9207-0e4bf6cdc9ed" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_88856198-1d2e-4eaa-9c45-12bf409d60ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WriteDownMember_d2754e44-e211-48d3-bce9-667b0b9d6fed" xlink:href="sny-20221231.xsd#sny_WriteDownMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_c8942f00-0117-4b2c-9207-0e4bf6cdc9ed" xlink:to="loc_sny_WriteDownMember_d2754e44-e211-48d3-bce9-667b0b9d6fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:href="sny-20221231.xsd#sny_DisclosureOfInventoriesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInventoriesTable_8855169a-2c2a-49de-86ed-e176f468f16b" xlink:to="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RawMaterials_f1440e43-7a33-4e95-9574-47ec073225f6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:to="loc_ifrs-full_RawMaterials_f1440e43-7a33-4e95-9574-47ec073225f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WorkInProgress_5624e384-e65e-4d96-bd60-ac80c75b1d53" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WorkInProgress"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:to="loc_ifrs-full_WorkInProgress_5624e384-e65e-4d96-bd60-ac80c75b1d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinishedGoods_c2d35c30-f5a4-40ab-82c3-c4dea9944f51" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:to="loc_ifrs-full_FinishedGoods_c2d35c30-f5a4-40ab-82c3-c4dea9944f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_731363b8-4976-4e81-a03c-eaf77616ad7d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInventoriesLineItems_7222fde1-6b70-457b-81ef-49de95a251f0" xlink:to="loc_ifrs-full_Inventories_731363b8-4976-4e81-a03c-eaf77616ad7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/InventoriesAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#InventoriesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/InventoriesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_6a188bb2-6f0a-44e8-8267-bf23a7c4513e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InventoriesPledgedAsSecurityForLiabilities_6824910a-89a2-4a89-a2e4-8335cd7d2618" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoriesPledgedAsSecurityForLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_6a188bb2-6f0a-44e8-8267-bf23a7c4513e" xlink:to="loc_ifrs-full_InventoriesPledgedAsSecurityForLiabilities_6824910a-89a2-4a89-a2e4-8335cd7d2618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#AccountsreceivableSummaryofAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_4fd30bd3-0f3c-4ccf-95c7-e22ba6b5b2cf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAccountsReceivableTable_84d40e94-8fc0-4626-b4da-af6e333bf293" xlink:href="sny-20221231.xsd#sny_DisclosureOfAccountsReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_4fd30bd3-0f3c-4ccf-95c7-e22ba6b5b2cf" xlink:to="loc_sny_DisclosureOfAccountsReceivableTable_84d40e94-8fc0-4626-b4da-af6e333bf293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_39c31169-f499-429a-8eed-afb6d3b6c79d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAccountsReceivableTable_84d40e94-8fc0-4626-b4da-af6e333bf293" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_39c31169-f499-429a-8eed-afb6d3b6c79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_604a3b51-0688-4f0f-9887-f8a625f29387" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_39c31169-f499-429a-8eed-afb6d3b6c79d" xlink:to="loc_ifrs-full_CarryingAmountMember_604a3b51-0688-4f0f-9887-f8a625f29387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_833250da-231b-4ef9-8f2d-521056b65293" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_604a3b51-0688-4f0f-9887-f8a625f29387" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_833250da-231b-4ef9-8f2d-521056b65293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllowanceForCreditLossesMember_f0d35f3f-dbe8-42af-9d6a-2e376c2c08a7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllowanceForCreditLossesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_604a3b51-0688-4f0f-9887-f8a625f29387" xlink:to="loc_ifrs-full_AllowanceForCreditLossesMember_f0d35f3f-dbe8-42af-9d6a-2e376c2c08a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAccountsReceivableLineItems_6b98e41d-629c-4ae8-baa7-bc25c942d18d" xlink:href="sny-20221231.xsd#sny_DisclosureOfAccountsReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAccountsReceivableTable_84d40e94-8fc0-4626-b4da-af6e333bf293" xlink:to="loc_sny_DisclosureOfAccountsReceivableLineItems_6b98e41d-629c-4ae8-baa7-bc25c942d18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTradeReceivables_2d5c6da2-c0f1-40d9-9db4-e5ad7432ba43" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAccountsReceivableLineItems_6b98e41d-629c-4ae8-baa7-bc25c942d18d" xlink:to="loc_ifrs-full_CurrentTradeReceivables_2d5c6da2-c0f1-40d9-9db4-e5ad7432ba43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/AccountsreceivableAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#AccountsreceivableAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/AccountsreceivableAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_fa454ba2-011f-415a-ab1c-915f88b040de" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_601d5c0e-7880-4caa-8c39-7c56fd55618c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_fa454ba2-011f-415a-ab1c-915f88b040de" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_601d5c0e-7880-4caa-8c39-7c56fd55618c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OverdueReceivablesGrossValue_b5902757-1d82-4dc7-880a-0c6e01c4b5ba" xlink:href="sny-20221231.xsd#sny_OverdueReceivablesGrossValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_fa454ba2-011f-415a-ab1c-915f88b040de" xlink:to="loc_sny_OverdueReceivablesGrossValue_b5902757-1d82-4dc7-880a-0c6e01c4b5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerecognizedReceivables_09897ebe-83b2-4ff8-b0ec-66bb3a04bbd5" xlink:href="sny-20221231.xsd#sny_DerecognizedReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_fa454ba2-011f-415a-ab1c-915f88b040de" xlink:to="loc_sny_DerecognizedReceivables_09897ebe-83b2-4ff8-b0ec-66bb3a04bbd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_18c1e095-8e2d-4dd4-98af-eb1b2ba2f7ee" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_aa1a9373-b620-4b5a-9c84-2b1a27f9989a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_18c1e095-8e2d-4dd4-98af-eb1b2ba2f7ee" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_aa1a9373-b620-4b5a-9c84-2b1a27f9989a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_94d1f8ce-0186-4a63-a497-364a52cbea62" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_aa1a9373-b620-4b5a-9c84-2b1a27f9989a" xlink:to="loc_ifrs-full_MaturityAxis_94d1f8ce-0186-4a63-a497-364a52cbea62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_94d1f8ce-0186-4a63-a497-364a52cbea62" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneMonthMember_1b9e9c57-a7cd-478c-8b65-3e4851972da6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneMonthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:to="loc_ifrs-full_NotLaterThanOneMonthMember_1b9e9c57-a7cd-478c-8b65-3e4851972da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_39ff0485-83d7-4328-b15e-17437b1cc536" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:to="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_39ff0485-83d7-4328-b15e-17437b1cc536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_af94bc80-2076-486a-9da2-001764093e90" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:to="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_af94bc80-2076-486a-9da2-001764093e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_a2966216-12a4-4f71-8a91-ab0162b16b7a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:to="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_a2966216-12a4-4f71-8a91-ab0162b16b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearMember_32bdc2fb-86d7-452f-9bc7-865ea5c50acb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_a6808007-42eb-4666-904f-236d3e35a260" xlink:to="loc_ifrs-full_LaterThanOneYearMember_32bdc2fb-86d7-452f-9bc7-865ea5c50acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_369d2d3a-3164-49de-94c8-63ac81ab11d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_aa1a9373-b620-4b5a-9c84-2b1a27f9989a" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_369d2d3a-3164-49de-94c8-63ac81ab11d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OverdueReceivablesGrossValue_8af8f64f-d020-4712-95c1-84fb2234ca41" xlink:href="sny-20221231.xsd#sny_OverdueReceivablesGrossValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_369d2d3a-3164-49de-94c8-63ac81ab11d0" xlink:to="loc_sny_OverdueReceivablesGrossValue_8af8f64f-d020-4712-95c1-84fb2234ca41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OthercurrentassetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OthercurrentassetsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OthercurrentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7a14f5b3-5554-485e-9584-a819a72f8e80" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax_cc492dcd-ad9c-4df6-ae1f-f17e8a9c2a4d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7a14f5b3-5554-485e-9584-a819a72f8e80" xlink:to="loc_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax_cc492dcd-ad9c-4df6-ae1f-f17e8a9c2a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_2abc3bcc-5e88-4609-893d-5a5cf717c93e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7a14f5b3-5554-485e-9584-a819a72f8e80" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_2abc3bcc-5e88-4609-893d-5a5cf717c93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentReceivables_c7d95f82-b2e7-4b31-b19e-2893d84f4a7a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7a14f5b3-5554-485e-9584-a819a72f8e80" xlink:to="loc_ifrs-full_OtherCurrentReceivables_c7d95f82-b2e7-4b31-b19e-2893d84f4a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateDerivativesMeasuredAtFairValue_1bdf410e-e37c-480e-877a-834fb98a0115" xlink:href="sny-20221231.xsd#sny_InterestRateDerivativesMeasuredAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7a14f5b3-5554-485e-9584-a819a72f8e80" xlink:to="loc_sny_InterestRateDerivativesMeasuredAtFairValue_1bdf410e-e37c-480e-877a-834fb98a0115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesMeasuredAtFairValue_d5c715e2-235a-4d23-8357-ea6a0015d852" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesMeasuredAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7a14f5b3-5554-485e-9584-a819a72f8e80" xlink:to="loc_sny_CurrencyDerivativesMeasuredAtFairValue_d5c715e2-235a-4d23-8357-ea6a0015d852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets_2544fff5-7af6-462e-b959-ec6eb218d664" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7a14f5b3-5554-485e-9584-a819a72f8e80" xlink:to="loc_ifrs-full_OtherCurrentFinancialAssets_2544fff5-7af6-462e-b959-ec6eb218d664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentAssets_8659f150-e27e-4d68-a569-b63ee5346fcf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7a14f5b3-5554-485e-9584-a819a72f8e80" xlink:to="loc_ifrs-full_OtherCurrentAssets_8659f150-e27e-4d68-a569-b63ee5346fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueMeasurementAbstract_dc7327ec-847d-49e5-bb0c-c9463dcac698" xlink:href="sny-20221231.xsd#sny_FairValueMeasurementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_485264d8-682a-4872-a863-15f4d1dc6e8e" xlink:href="sny-20221231.xsd#sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FairValueMeasurementAbstract_dc7327ec-847d-49e5-bb0c-c9463dcac698" xlink:to="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_485264d8-682a-4872-a863-15f4d1dc6e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_55e06c5c-da61-4cd4-b606-230d59e2206c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_485264d8-682a-4872-a863-15f4d1dc6e8e" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_55e06c5c-da61-4cd4-b606-230d59e2206c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_ff5f8307-a334-400f-8f24-f0f6014cb9bb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_55e06c5c-da61-4cd4-b606-230d59e2206c" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_ff5f8307-a334-400f-8f24-f0f6014cb9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_b6be3135-ce5a-4b0d-b410-ca29a263651d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_ff5f8307-a334-400f-8f24-f0f6014cb9bb" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_b6be3135-ce5a-4b0d-b410-ca29a263651d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_6fcce768-5d0a-4c1e-b3d2-de308497a0f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_ff5f8307-a334-400f-8f24-f0f6014cb9bb" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_6fcce768-5d0a-4c1e-b3d2-de308497a0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_7dbc3a82-6f57-4abc-8a72-7d1ba1b16b47" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_ff5f8307-a334-400f-8f24-f0f6014cb9bb" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_7dbc3a82-6f57-4abc-8a72-7d1ba1b16b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_7efde3df-d2f7-43c1-a0aa-0068416a72b5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_485264d8-682a-4872-a863-15f4d1dc6e8e" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_7efde3df-d2f7-43c1-a0aa-0068416a72b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_7efde3df-d2f7-43c1-a0aa-0068416a72b5" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedEquityInvestmentsMember_71863415-bc69-424d-a11d-ee3d0b158906" xlink:href="sny-20221231.xsd#sny_QuotedEquityInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_QuotedEquityInvestmentsMember_71863415-bc69-424d-a11d-ee3d0b158906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnquotedEquityInvestmentsMember_430a4fad-db37-4ce8-9683-32593489d058" xlink:href="sny-20221231.xsd#sny_UnquotedEquityInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_UnquotedEquityInvestmentsMember_430a4fad-db37-4ce8-9683-32593489d058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QuotedDebtSecuritiesMember_f2e696f4-a0c1-4908-833b-e29128b0f5f9" xlink:href="sny-20221231.xsd#sny_QuotedDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_QuotedDebtSecuritiesMember_f2e696f4-a0c1-4908-833b-e29128b0f5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnquotedDebtSecuritiesMember_2e2b1ae3-8ab2-4bc1-a45c-c18acd5601fa" xlink:href="sny-20221231.xsd#sny_UnquotedDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_UnquotedDebtSecuritiesMember_2e2b1ae3-8ab2-4bc1-a45c-c18acd5601fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationRelatingToDivestmentsMember_60868a05-5feb-4def-a2fb-11d20f9a830c" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationRelatingToDivestmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_ContingentConsiderationRelatingToDivestmentsMember_60868a05-5feb-4def-a2fb-11d20f9a830c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember_f5e9b4a7-e2c0-4144-a7bc-c983785f353a" xlink:href="sny-20221231.xsd#sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember_f5e9b4a7-e2c0-4144-a7bc-c983785f353a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentDerivativesMember_4fa43b37-fbda-435f-b3d6-fdbe4f7c5851" xlink:href="sny-20221231.xsd#sny_NonCurrentDerivativesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_NonCurrentDerivativesMember_4fa43b37-fbda-435f-b3d6-fdbe4f7c5851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentDerivativesMember_9a5f8590-ca1b-439f-b65b-b10b58090930" xlink:href="sny-20221231.xsd#sny_CurrentDerivativesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_CurrentDerivativesMember_9a5f8590-ca1b-439f-b65b-b10b58090930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MutualFundInvestmentsMember_631b1477-b456-4f49-9f27-ebf87d675e62" xlink:href="sny-20221231.xsd#sny_MutualFundInvestmentsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_e015ffea-9860-474d-acf6-885c4c857370" xlink:to="loc_sny_MutualFundInvestmentsMember_631b1477-b456-4f49-9f27-ebf87d675e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_72b3d47a-cd84-498f-a5c5-cd7e517eccf2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_485264d8-682a-4872-a863-15f4d1dc6e8e" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_72b3d47a-cd84-498f-a5c5-cd7e517eccf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_72b3d47a-cd84-498f-a5c5-cd7e517eccf2" xlink:to="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember_ce493eed-3a7c-4f1c-9cc1-b067369b92d1" xlink:href="sny-20221231.xsd#sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember_ce493eed-3a7c-4f1c-9cc1-b067369b92d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_355be190-6ce9-40e2-8b74-b68c04c25987" xlink:href="sny-20221231.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_355be190-6ce9-40e2-8b74-b68c04c25987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationTranslateBioMember_19ce7295-0c05-4a61-b702-1dab5ccb8e9c" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationTranslateBioMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_ContingentConsiderationTranslateBioMember_19ce7295-0c05-4a61-b702-1dab5ccb8e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember_dda7637c-bf92-4a8d-9108-47cd08cf8be2" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember_dda7637c-bf92-4a8d-9108-47cd08cf8be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember_0509f4f6-27d1-47ca-aad6-8fa6a585b229" xlink:href="sny-20221231.xsd#sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember_0509f4f6-27d1-47ca-aad6-8fa6a585b229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentDerivativesMember_73fbed56-3bbf-488e-ae75-8081e47c5d31" xlink:href="sny-20221231.xsd#sny_NonCurrentDerivativesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_NonCurrentDerivativesMember_73fbed56-3bbf-488e-ae75-8081e47c5d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentDerivativesMember_34cf0087-ba1b-4cbf-8760-8692e9953d01" xlink:href="sny-20221231.xsd#sny_CurrentDerivativesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesMember_4530b711-a9c0-4168-bf74-ba7a4cc7f370" xlink:to="loc_sny_CurrentDerivativesMember_34cf0087-ba1b-4cbf-8760-8692e9953d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInformationOnIncomeStatementLineItems_6d6ddab8-060d-43da-92c4-1af288b0d4e3" xlink:href="sny-20221231.xsd#sny_DisclosureOfInformationOnIncomeStatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_485264d8-682a-4872-a863-15f4d1dc6e8e" xlink:to="loc_sny_DisclosureOfInformationOnIncomeStatementLineItems_6d6ddab8-060d-43da-92c4-1af288b0d4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_1bb35890-a182-4ce8-8337-60ecb187218f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInformationOnIncomeStatementLineItems_6d6ddab8-060d-43da-92c4-1af288b0d4e3" xlink:to="loc_ifrs-full_FinancialAssets_1bb35890-a182-4ce8-8337-60ecb187218f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_57a0b665-3b74-468e-9854-9371bc0f4a39" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInformationOnIncomeStatementLineItems_6d6ddab8-060d-43da-92c4-1af288b0d4e3" xlink:to="loc_ifrs-full_FinancialLiabilities_57a0b665-3b74-468e-9854-9371bc0f4a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/CashandcashequivalentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#CashandcashequivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/CashandcashequivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ba274f64-b534-4060-8494-2c2c123a4ff7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash_5f69c73c-d66e-474e-a239-e77c0482a28b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Cash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ba274f64-b534-4060-8494-2c2c123a4ff7" xlink:to="loc_ifrs-full_Cash_5f69c73c-d66e-474e-a239-e77c0482a28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents_17a8f644-a9a4-4f76-b519-070104e522af" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ba274f64-b534-4060-8494-2c2c123a4ff7" xlink:to="loc_ifrs-full_CashEquivalents_17a8f644-a9a4-4f76-b519-070104e522af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_a4df1717-44e6-421f-b4d6-9d22c78900cc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ba274f64-b534-4060-8494-2c2c123a4ff7" xlink:to="loc_ifrs-full_CashAndCashEquivalents_a4df1717-44e6-421f-b4d6-9d22c78900cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashEquivalentsMoneyMarketMutualFunds_322a327e-1983-46e5-a5e7-088bc53282a3" xlink:href="sny-20221231.xsd#sny_CashEquivalentsMoneyMarketMutualFunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ba274f64-b534-4060-8494-2c2c123a4ff7" xlink:to="loc_sny_CashEquivalentsMoneyMarketMutualFunds_322a327e-1983-46e5-a5e7-088bc53282a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_73c1d49e-ed13-4ff4-b153-53d972eb7f86" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ba274f64-b534-4060-8494-2c2c123a4ff7" xlink:to="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_73c1d49e-ed13-4ff4-b153-53d972eb7f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashEquivalentsCommercialPaper_e61fcda3-b7e3-4a1d-939b-d1c351dc4d4d" xlink:href="sny-20221231.xsd#sny_CashEquivalentsCommercialPaper"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ba274f64-b534-4060-8494-2c2c123a4ff7" xlink:to="loc_sny_CashEquivalentsCommercialPaper_e61fcda3-b7e3-4a1d-939b-d1c351dc4d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies_64874527-0615-48fa-abb4-94b5b9af0766" xlink:href="sny-20221231.xsd#sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ba274f64-b534-4060-8494-2c2c123a4ff7" xlink:to="loc_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies_64874527-0615-48fa-abb4-94b5b9af0766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxesAbstract_382f7ac0-1650-49c4-aa87-15454bde288b" xlink:href="sny-20221231.xsd#sny_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1772c355-e836-4978-9976-94adf0d2468a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_382f7ac0-1650-49c4-aa87-15454bde288b" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1772c355-e836-4978-9976-94adf0d2468a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_eae1dcae-7ab9-4a5a-a269-d0ba22cb5e7e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1772c355-e836-4978-9976-94adf0d2468a" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_eae1dcae-7ab9-4a5a-a269-d0ba22cb5e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_eae1dcae-7ab9-4a5a-a269-d0ba22cb5e7e" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember_78ed4079-919d-478d-8199-f39fb79aa422" xlink:href="sny-20221231.xsd#sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember_78ed4079-919d-478d-8199-f39fb79aa422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember_f4b6b1da-e9fc-47ce-93e7-32cb29edb567" xlink:href="sny-20221231.xsd#sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember_f4b6b1da-e9fc-47ce-93e7-32cb29edb567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember_4079e7f9-0883-4b0b-82ca-629d2e234663" xlink:href="sny-20221231.xsd#sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember_4079e7f9-0883-4b0b-82ca-629d2e234663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember_d961151a-da34-4db7-a82e-306c10278887" xlink:href="sny-20221231.xsd#sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember_d961151a-da34-4db7-a82e-306c10278887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember_d644e2fd-2dba-4871-b5b5-72b4ec46b0f7" xlink:href="sny-20221231.xsd#sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember_d644e2fd-2dba-4871-b5b5-72b4ec46b0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_89e6c545-9ed9-4411-a7ec-ab8f6534e665" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_89e6c545-9ed9-4411-a7ec-ab8f6534e665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionsAndShareBasedPaymentsMember_fd10f3c5-638f-4ff9-975b-9d0f99dc80b5" xlink:href="sny-20221231.xsd#sny_StockOptionsAndShareBasedPaymentsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_StockOptionsAndShareBasedPaymentsMember_fd10f3c5-638f-4ff9-975b-9d0f99dc80b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember_e3aeab71-5397-4864-8aaa-4cd5c8b8ff70" xlink:href="sny-20221231.xsd#sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember_e3aeab71-5397-4864-8aaa-4cd5c8b8ff70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_f1d8b6f3-0847-4248-a944-9de8c1722803" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_ifrs-full_OtherTemporaryDifferencesMember_f1d8b6f3-0847-4248-a944-9de8c1722803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DeferredTaxRelatingToRestructuringProvisionsMember_e72848d3-b512-4167-8d08-009288912906" xlink:href="sny-20221231.xsd#sny_DeferredTaxRelatingToRestructuringProvisionsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5c92c0f9-dc3b-41bb-a6a4-11efdc1313ca" xlink:to="loc_sny_DeferredTaxRelatingToRestructuringProvisionsMember_e72848d3-b512-4167-8d08-009288912906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d57c58ef-74e8-46cd-b21c-912516e7a7e1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1772c355-e836-4978-9976-94adf0d2468a" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d57c58ef-74e8-46cd-b21c-912516e7a7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_d57c58ef-74e8-46cd-b21c-912516e7a7e1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativMember_bb86e530-d045-4c64-b28b-0f49ccf3e644" xlink:href="sny-20221231.xsd#sny_BioverativMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_BioverativMember_bb86e530-d045-4c64-b28b-0f49ccf3e644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipiaBiopharmaIncMember_4bf1134c-0117-4681-8d7d-e77ff69400af" xlink:href="sny-20221231.xsd#sny_PrincipiaBiopharmaIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_PrincipiaBiopharmaIncMember_4bf1134c-0117-4681-8d7d-e77ff69400af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxMember_8c0231d5-665b-4bb8-b241-31c693be8dfb" xlink:href="sny-20221231.xsd#sny_SynthorxMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_SynthorxMember_8c0231d5-665b-4bb8-b241-31c693be8dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeMember_fcc06918-2c2e-4c90-bfd3-5d567a1e7b5b" xlink:href="sny-20221231.xsd#sny_GenzymeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_GenzymeMember_fcc06918-2c2e-4c90-bfd3-5d567a1e7b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AblynxMember_6b15a9c9-b9b2-4070-82f0-548792ee85d2" xlink:href="sny-20221231.xsd#sny_AblynxMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_AblynxMember_6b15a9c9-b9b2-4070-82f0-548792ee85d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixMember_9e1482de-67a5-4cb2-9e2d-2efe1c4e7165" xlink:href="sny-20221231.xsd#sny_AmunixMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_850d9bb7-2eb8-4a91-89d2-5b7d673149b8" xlink:to="loc_sny_AmunixMember_9e1482de-67a5-4cb2-9e2d-2efe1c4e7165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1772c355-e836-4978-9976-94adf0d2468a" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_c6f414b3-735a-43fb-b91c-362251a53cfc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_c6f414b3-735a-43fb-b91c-362251a53cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_9eb0e111-75ce-4df3-be88-574daccd762f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_9eb0e111-75ce-4df3-be88-574daccd762f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture_4889935c-4e43-4504-9707-7772d28e8229" xlink:href="sny-20221231.xsd#sny_ReservesLikelyToBeDistributedInTheForeseeableFuture"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:to="loc_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture_4889935c-4e43-4504-9707-7772d28e8229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_779f39b3-e1fa-4ce5-bc49-cb24496cfc62" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_a9bc84d7-9a97-46d7-b130-b118849e5a5b" xlink:to="loc_ifrs-full_DeferredTaxAssets_779f39b3-e1fa-4ce5-bc49-cb24496cfc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/NetdeferredtaxpositionAdditionalinformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#NetdeferredtaxpositionAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/NetdeferredtaxpositionAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxesAbstract_6f418d02-a96d-48d9-8af0-d34c106493b1" xlink:href="sny-20221231.xsd#sny_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures_1094d1c8-03a6-4b22-8767-50c328d61678" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_6f418d02-a96d-48d9-8af0-d34c106493b1" xlink:to="loc_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures_1094d1c8-03a6-4b22-8767-50c328d61678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards_f25ea4f8-54b1-462d-af9e-8b8e102bf0db" xlink:href="sny-20221231.xsd#sny_TotalDeferredTaxAssetsForTaxLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_6f418d02-a96d-48d9-8af0-d34c106493b1" xlink:to="loc_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards_f25ea4f8-54b1-462d-af9e-8b8e102bf0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_9ad3ad39-ca9c-421a-8109-1293b503509d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_6f418d02-a96d-48d9-8af0-d34c106493b1" xlink:to="loc_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_9ad3ad39-ca9c-421a-8109-1293b503509d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised_b9fc0939-c6b7-4bb1-a3b9-14097f00fdbb" xlink:href="sny-20221231.xsd#sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_6f418d02-a96d-48d9-8af0-d34c106493b1" xlink:to="loc_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised_b9fc0939-c6b7-4bb1-a3b9-14097f00fdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable_18b414b0-cf2a-4408-8d32-2d4315f67ac1" xlink:href="sny-20221231.xsd#sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_6f418d02-a96d-48d9-8af0-d34c106493b1" xlink:to="loc_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable_18b414b0-cf2a-4408-8d32-2d4315f67ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxesAbstract_ff7f7723-0cd7-4e37-b408-1655e300645b" xlink:href="sny-20221231.xsd#sny_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable_59918120-0d8a-44e1-8068-e79f637d2e1d" xlink:href="sny-20221231.xsd#sny_DisclosureOfTaxLossesAvailableForCarryforwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_ff7f7723-0cd7-4e37-b408-1655e300645b" xlink:to="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable_59918120-0d8a-44e1-8068-e79f637d2e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_449006c5-1526-463c-90f3-6fd8a25f3cd7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable_59918120-0d8a-44e1-8068-e79f637d2e1d" xlink:to="loc_ifrs-full_MaturityAxis_449006c5-1526-463c-90f3-6fd8a25f3cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_449006c5-1526-463c-90f3-6fd8a25f3cd7" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_86c1ca5c-09d6-4e40-82c7-dc8ef6683371" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_86c1ca5c-09d6-4e40-82c7-dc8ef6683371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_8228e935-6778-4804-a57d-694cbc43cfae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_8228e935-6778-4804-a57d-694cbc43cfae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_e25236fa-da58-499c-83f7-66c82bba78db" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_e25236fa-da58-499c-83f7-66c82bba78db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_cb8c5e73-c261-494e-ae2f-bfcda31e2a5d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_cb8c5e73-c261-494e-ae2f-bfcda31e2a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_05a3a598-e901-42d8-a91c-2dcd5fc0305a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_05a3a598-e901-42d8-a91c-2dcd5fc0305a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_4ad0b658-7db6-4861-9589-49c41904b525" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_433b81be-67fa-4dca-8386-8e5b39b51bda" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_4ad0b658-7db6-4861-9589-49c41904b525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems_84b01f14-25b2-43d4-b71b-ed92e63e416d" xlink:href="sny-20221231.xsd#sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardTable_59918120-0d8a-44e1-8068-e79f637d2e1d" xlink:to="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems_84b01f14-25b2-43d4-b71b-ed92e63e416d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxLossesCarryforwards_5ba4b9ea-e446-4e4c-a51b-4e23d949b3f3" xlink:href="sny-20221231.xsd#sny_TaxLossesCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems_84b01f14-25b2-43d4-b71b-ed92e63e416d" xlink:to="loc_sny_TaxLossesCarryforwards_5ba4b9ea-e446-4e4c-a51b-4e23d949b3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxLossCarryforwardsOnAssetDisposals_247c10ea-8267-4ebb-a965-66db7fd5c449" xlink:href="sny-20221231.xsd#sny_TaxLossCarryforwardsOnAssetDisposals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems_84b01f14-25b2-43d4-b71b-ed92e63e416d" xlink:to="loc_sny_TaxLossCarryforwardsOnAssetDisposals_247c10ea-8267-4ebb-a965-66db7fd5c449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_1fdcf0d8-5a07-4f91-be95-20a8ff8c5070" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a7f265fe-f821-43cc-8959-01842b19ab28" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_1fdcf0d8-5a07-4f91-be95-20a8ff8c5070" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a7f265fe-f821-43cc-8959-01842b19ab28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_9ebd2949-1895-4446-99b1-2ddbdf3e35cb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a7f265fe-f821-43cc-8959-01842b19ab28" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_9ebd2949-1895-4446-99b1-2ddbdf3e35cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_444e4d58-27c2-4d79-a04a-04291ee5e9ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_9ebd2949-1895-4446-99b1-2ddbdf3e35cb" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_444e4d58-27c2-4d79-a04a-04291ee5e9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanMember_581a7ca1-d061-4c44-9aec-ded1aec47956" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_444e4d58-27c2-4d79-a04a-04291ee5e9ab" xlink:to="loc_sny_StockSubscriptionOptionPlanMember_581a7ca1-d061-4c44-9aec-ded1aec47956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateAxis_fa37317d-f725-461f-8fe9-b060b74225a0" xlink:href="sny-20221231.xsd#sny_AwardsDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a7f265fe-f821-43cc-8959-01842b19ab28" xlink:to="loc_sny_AwardsDateAxis_fa37317d-f725-461f-8fe9-b060b74225a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateDomain_36745988-5835-4de3-9f03-7ef17e9a342a" xlink:href="sny-20221231.xsd#sny_AwardsDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AwardsDateAxis_fa37317d-f725-461f-8fe9-b060b74225a0" xlink:to="loc_sny_AwardsDateDomain_36745988-5835-4de3-9f03-7ef17e9a342a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April302021Member_5a369c6f-56f8-46e6-9ff8-fa38626af516" xlink:href="sny-20221231.xsd#sny_April302021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AwardsDateDomain_36745988-5835-4de3-9f03-7ef17e9a342a" xlink:to="loc_sny_April302021Member_5a369c6f-56f8-46e6-9ff8-fa38626af516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April282020Member_f2a1c486-c6da-4bd3-9b98-83ac129e82e2" xlink:href="sny-20221231.xsd#sny_April282020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AwardsDateDomain_36745988-5835-4de3-9f03-7ef17e9a342a" xlink:to="loc_sny_April282020Member_f2a1c486-c6da-4bd3-9b98-83ac129e82e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_May32022Member_c41830e0-1d04-404f-abbb-b45629efe64f" xlink:href="sny-20221231.xsd#sny_May32022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AwardsDateDomain_36745988-5835-4de3-9f03-7ef17e9a342a" xlink:to="loc_sny_May32022Member_c41830e0-1d04-404f-abbb-b45629efe64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a7f265fe-f821-43cc-8959-01842b19ab28" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_f4fb0e87-0af7-48d2-be46-2d12ef8ecd40" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_ifrs-full_IssuedCapital_f4fb0e87-0af7-48d2-be46-2d12ef8ecd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_8626d802-0088-4b1f-b1ab-24c02859b7e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_ifrs-full_NumberOfSharesIssued_8626d802-0088-4b1f-b1ab-24c02859b7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_de23cc21-4085-4c87-a715-5ee216b67909" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_ifrs-full_ParValuePerShare_de23cc21-4085-4c87-a715-5ee216b67909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PeriodOfShareRepurchaseProgram_ebcc114c-9f35-45a4-8e5e-dd3eb0b614c7" xlink:href="sny-20221231.xsd#sny_PeriodOfShareRepurchaseProgram"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_sny_PeriodOfShareRepurchaseProgram_ebcc114c-9f35-45a4-8e5e-dd3eb0b614c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax_f7f55d6b-747c-479b-94ce-2b6824322593" xlink:href="sny-20221231.xsd#sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax_f7f55d6b-747c-479b-94ce-2b6824322593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions_43722fec-93ca-4445-813d-984766a6a9f1" xlink:href="sny-20221231.xsd#sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions_43722fec-93ca-4445-813d-984766a6a9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSharesIssuedByExerciceOfEachOption_6f7b4e76-ea4e-4d82-a7a7-d753962a5c7c" xlink:href="sny-20221231.xsd#sny_NumberOfSharesIssuedByExerciceOfEachOption"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_sny_NumberOfSharesIssuedByExerciceOfEachOption_6f7b4e76-ea4e-4d82-a7a7-d753962a5c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionsWithNoDilutiveEffect_1bbe9185-5bf7-4d8d-aad0-2b4a3d96edd9" xlink:href="sny-20221231.xsd#sny_StockOptionsWithNoDilutiveEffect"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4f00b9bf-410b-467e-b8db-20f8392756df" xlink:to="loc_sny_StockOptionsWithNoDilutiveEffect_1bbe9185-5bf7-4d8d-aad0-2b4a3d96edd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofTreasurySharesHeldDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofTreasurySharesHeldDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofTreasurySharesHeldDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_dfc916b5-563b-4006-812d-e841021d38db" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSharesHeld_8899c2f3-3f83-4dbe-99d8-d65a9ea05266" xlink:href="sny-20221231.xsd#sny_NumberOfSharesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_dfc916b5-563b-4006-812d-e841021d38db" xlink:to="loc_sny_NumberOfSharesHeld_8899c2f3-3f83-4dbe-99d8-d65a9ea05266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfShareCapitalForThePeriod_9ccb1f15-517e-4cf8-9aa7-63f009a78fdc" xlink:href="sny-20221231.xsd#sny_PercentageOfShareCapitalForThePeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_dfc916b5-563b-4006-812d-e841021d38db" xlink:to="loc_sny_PercentageOfShareCapitalForThePeriod_9ccb1f15-517e-4cf8-9aa7-63f009a78fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5f1f3aed-636c-44da-871d-b672f234c579" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a72d450b-c2b0-48a4-afbc-762aa55848aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5f1f3aed-636c-44da-871d-b672f234c579" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a72d450b-c2b0-48a4-afbc-762aa55848aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_c1077fe9-38ac-48cd-9b16-7b11d01c6a17" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a72d450b-c2b0-48a4-afbc-762aa55848aa" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_c1077fe9-38ac-48cd-9b16-7b11d01c6a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_c925e72d-79f9-41a8-9963-921bde4a04ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_c1077fe9-38ac-48cd-9b16-7b11d01c6a17" xlink:to="loc_ifrs-full_EquityMember_c925e72d-79f9-41a8-9963-921bde4a04ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_4f984b5e-801b-4808-a79a-3fdddd83e017" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_c925e72d-79f9-41a8-9963-921bde4a04ef" xlink:to="loc_ifrs-full_IssuedCapitalMember_4f984b5e-801b-4808-a79a-3fdddd83e017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e7b8fc33-ad73-46f6-a0db-ee70227dec24" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a72d450b-c2b0-48a4-afbc-762aa55848aa" xlink:to="loc_dei_LegalEntityAxis_e7b8fc33-ad73-46f6-a0db-ee70227dec24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_84079e9f-17e4-4fc1-bc8e-c2b8056c9751" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e7b8fc33-ad73-46f6-a0db-ee70227dec24" xlink:to="loc_dei_EntityDomain_84079e9f-17e4-4fc1-bc8e-c2b8056c9751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiMember_27a2cebc-999d-4efd-b616-8ba4ee9a3c14" xlink:href="sny-20221231.xsd#sny_SanofiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_84079e9f-17e4-4fc1-bc8e-c2b8056c9751" xlink:to="loc_sny_SanofiMember_27a2cebc-999d-4efd-b616-8ba4ee9a3c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_a72d450b-c2b0-48a4-afbc-762aa55848aa" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_8e401a9c-0da4-4611-a8b3-ff234ae73a99" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_ifrs-full_NumberOfSharesIssued_8e401a9c-0da4-4611-a8b3-ff234ae73a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions_b3ccd8c7-bb8a-4c2e-93c2-be252ed48e29" xlink:href="sny-20221231.xsd#sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions_b3ccd8c7-bb8a-4c2e-93c2-be252ed48e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease_e729d8a5-b45b-485a-9beb-fbaabd811150" xlink:href="sny-20221231.xsd#sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease_e729d8a5-b45b-485a-9beb-fbaabd811150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees_4a5991d5-9ecf-477a-b286-afd812fc2151" xlink:href="sny-20221231.xsd#sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees_4a5991d5-9ecf-477a-b286-afd812fc2151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReductionOfSharesByCancellationOfTreasuryShares_ba19300b-d25c-4616-8852-db827ec5ce53" xlink:href="sny-20221231.xsd#sny_ReductionOfSharesByCancellationOfTreasuryShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_sny_ReductionOfSharesByCancellationOfTreasuryShares_ba19300b-d25c-4616-8852-db827ec5ce53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_f30ba522-6263-4a0c-a4c8-24c23e687510" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_af0a60d7-a8c9-499b-b5e5-8b0c2bb8f934" xlink:to="loc_ifrs-full_NumberOfSharesIssued_f30ba522-6263-4a0c-a4c8-24c23e687510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_46d6b16c-4b20-4d4c-b1b9-bd48fa588ab8" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_d3d78da8-3797-40d8-9e7e-0c4d1eef76e8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_46d6b16c-4b20-4d4c-b1b9-bd48fa588ab8" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_d3d78da8-3797-40d8-9e7e-0c4d1eef76e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10a05814-d65e-4c08-8a1f-d412d7f42e7d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_d3d78da8-3797-40d8-9e7e-0c4d1eef76e8" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10a05814-d65e-4c08-8a1f-d412d7f42e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_4ee194ce-3e91-4f2e-bf74-3e7835b77add" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_10a05814-d65e-4c08-8a1f-d412d7f42e7d" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_4ee194ce-3e91-4f2e-bf74-3e7835b77add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2022Member_2d20852a-93a1-4b3d-8090-1289a294c144" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_4ee194ce-3e91-4f2e-bf74-3e7835b77add" xlink:to="loc_sny_RestrictedSharePlan2022Member_2d20852a-93a1-4b3d-8090-1289a294c144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2021Member_6cbdc46f-51af-4193-ad59-1a7f583b2559" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_4ee194ce-3e91-4f2e-bf74-3e7835b77add" xlink:to="loc_sny_RestrictedSharePlan2021Member_6cbdc46f-51af-4193-ad59-1a7f583b2559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2020Member_81471a52-c533-4238-bd53-372d1b5ecb5d" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_4ee194ce-3e91-4f2e-bf74-3e7835b77add" xlink:to="loc_sny_RestrictedSharePlan2020Member_81471a52-c533-4238-bd53-372d1b5ecb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_bfe74056-0682-4140-aaf1-76f4fa173a08" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_d3d78da8-3797-40d8-9e7e-0c4d1eef76e8" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_bfe74056-0682-4140-aaf1-76f4fa173a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_bcf192bf-15a9-4321-b39f-12779e8e07b0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_bfe74056-0682-4140-aaf1-76f4fa173a08" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_bcf192bf-15a9-4321-b39f-12779e8e07b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceSharePlanOneMember_69dee6ac-7f21-4c43-9d5f-f0be83df9bcd" xlink:href="sny-20221231.xsd#sny_PerformanceSharePlanOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_bcf192bf-15a9-4321-b39f-12779e8e07b0" xlink:to="loc_sny_PerformanceSharePlanOneMember_69dee6ac-7f21-4c43-9d5f-f0be83df9bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceSharePlanTwoMember_788c9156-a469-4fd1-ba16-e6bf14a70a4c" xlink:href="sny-20221231.xsd#sny_PerformanceSharePlanTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_bcf192bf-15a9-4321-b39f-12779e8e07b0" xlink:to="loc_sny_PerformanceSharePlanTwoMember_788c9156-a469-4fd1-ba16-e6bf14a70a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketConditionAxis_3e5e0be9-4f70-441a-b7bc-2dac80a4baec" xlink:href="sny-20221231.xsd#sny_MarketConditionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_d3d78da8-3797-40d8-9e7e-0c4d1eef76e8" xlink:to="loc_sny_MarketConditionAxis_3e5e0be9-4f70-441a-b7bc-2dac80a4baec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MarketConditionDomain_6feaf742-59b8-4c03-9005-061dc97b264a" xlink:href="sny-20221231.xsd#sny_MarketConditionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_MarketConditionAxis_3e5e0be9-4f70-441a-b7bc-2dac80a4baec" xlink:to="loc_sny_MarketConditionDomain_6feaf742-59b8-4c03-9005-061dc97b264a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WithoutMarketConditionMember_bed064e4-2516-4ed0-aa35-689a819ed634" xlink:href="sny-20221231.xsd#sny_WithoutMarketConditionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_MarketConditionDomain_6feaf742-59b8-4c03-9005-061dc97b264a" xlink:to="loc_sny_WithoutMarketConditionMember_bed064e4-2516-4ed0-aa35-689a819ed634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WithMarketConditionMember_6b946014-e0fc-401f-bd62-aabc6d7acbc0" xlink:href="sny-20221231.xsd#sny_WithMarketConditionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_MarketConditionDomain_6feaf742-59b8-4c03-9005-061dc97b264a" xlink:to="loc_sny_WithMarketConditionMember_6b946014-e0fc-401f-bd62-aabc6d7acbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_d3d78da8-3797-40d8-9e7e-0c4d1eef76e8" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfYearsServicePeriod_736fdb6d-d9dd-42e0-bfa6-dfdf0e82d82e" xlink:href="sny-20221231.xsd#sny_NumberOfYearsServicePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_sny_NumberOfYearsServicePeriod_736fdb6d-d9dd-42e0-bfa6-dfdf0e82d82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_7f33c2ac-50fc-4a64-8af1-8895db4f008f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_7f33c2ac-50fc-4a64-8af1-8895db4f008f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod_e975edd8-6a37-4ba9-b8a4-8a98372c8eba" xlink:href="sny-20221231.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod_e975edd8-6a37-4ba9-b8a4-8a98372c8eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares_78df4063-01cc-492f-963d-8a5fea28e6d6" xlink:href="sny-20221231.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares_78df4063-01cc-492f-963d-8a5fea28e6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer_f3b68879-20e4-4425-bb4f-c80e7fa139d8" xlink:href="sny-20221231.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer_f3b68879-20e4-4425-bb4f-c80e7fa139d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfPlanAtDateOfGrant_57d5d337-bc7b-4349-b566-b854a05e237f" xlink:href="sny-20221231.xsd#sny_FairValueOfPlanAtDateOfGrant"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0303a2d9-5cd5-4589-b07e-0a60174a1061" xlink:to="loc_sny_FairValueOfPlanAtDateOfGrant_57d5d337-bc7b-4349-b566-b854a05e237f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_0aa47ba2-814e-44c8-a1b5-07779a1d3631" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_dfb25342-4533-4aa8-b1d7-fe5b88a6f58e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_0aa47ba2-814e-44c8-a1b5-07779a1d3631" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_dfb25342-4533-4aa8-b1d7-fe5b88a6f58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_b54628ce-c696-4d54-9bfb-5850cfc9c999" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_dfb25342-4533-4aa8-b1d7-fe5b88a6f58e" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_b54628ce-c696-4d54-9bfb-5850cfc9c999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_9a924803-8c29-4e48-95bc-34363ce8280a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_b54628ce-c696-4d54-9bfb-5850cfc9c999" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_9a924803-8c29-4e48-95bc-34363ce8280a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:href="sny-20221231.xsd#sny_RestrictedSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_9a924803-8c29-4e48-95bc-34363ce8280a" xlink:to="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2022Member_28433b93-c225-4340-8a5d-426c53641b8b" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:to="loc_sny_RestrictedSharePlan2022Member_28433b93-c225-4340-8a5d-426c53641b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2021Member_72820a94-5b76-4e2f-a2e5-a2a92298755d" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:to="loc_sny_RestrictedSharePlan2021Member_72820a94-5b76-4e2f-a2e5-a2a92298755d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2020Member_cdf997f6-1786-479b-9778-3d3ae8173d56" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:to="loc_sny_RestrictedSharePlan2020Member_cdf997f6-1786-479b-9778-3d3ae8173d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2019Member_0701312d-ce53-45c9-9c8a-842e23257d82" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2019Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:to="loc_sny_RestrictedSharePlan2019Member_0701312d-ce53-45c9-9c8a-842e23257d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestrictedSharePlan2018Member_f8d534da-7e7b-4782-9a2a-929d20534574" xlink:href="sny-20221231.xsd#sny_RestrictedSharePlan2018Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RestrictedSharesMember_edca071c-6c6f-4db5-bcc7-3448a95ca941" xlink:to="loc_sny_RestrictedSharePlan2018Member_f8d534da-7e7b-4782-9a2a-929d20534574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_03207b63-c597-43a1-b668-7d9d0f5f0a0b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_dfb25342-4533-4aa8-b1d7-fe5b88a6f58e" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_03207b63-c597-43a1-b668-7d9d0f5f0a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_83d92b81-5abe-433e-aca1-82b3436d81c9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_03207b63-c597-43a1-b668-7d9d0f5f0a0b" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_83d92b81-5abe-433e-aca1-82b3436d81c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfRestrictedSharesNotYetFullyVested_f2de938f-ed24-4ba2-b337-5411caf0a263" xlink:href="sny-20221231.xsd#sny_NumberOfRestrictedSharesNotYetFullyVested"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_03207b63-c597-43a1-b668-7d9d0f5f0a0b" xlink:to="loc_sny_NumberOfRestrictedSharesNotYetFullyVested_f2de938f-ed24-4ba2-b337-5411caf0a263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_2ac10d54-2c4b-4af7-9586-2b7bc8a7e6f0" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_4322f5f3-20ad-4b8e-8b7c-013d6db2cc93" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_2ac10d54-2c4b-4af7-9586-2b7bc8a7e6f0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_4322f5f3-20ad-4b8e-8b7c-013d6db2cc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e1cbf43d-2d07-4444-9017-60cbc07d9c26" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_4322f5f3-20ad-4b8e-8b7c-013d6db2cc93" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e1cbf43d-2d07-4444-9017-60cbc07d9c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_07fcbee7-aac6-40c1-8aad-73834a94a987" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e1cbf43d-2d07-4444-9017-60cbc07d9c26" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_07fcbee7-aac6-40c1-8aad-73834a94a987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeesShareOwnershipPlanMember_c4b5232b-06f7-4a11-b8ad-a9a164be3bda" xlink:href="sny-20221231.xsd#sny_EmployeesShareOwnershipPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_07fcbee7-aac6-40c1-8aad-73834a94a987" xlink:to="loc_sny_EmployeesShareOwnershipPlanMember_c4b5232b-06f7-4a11-b8ad-a9a164be3bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_4322f5f3-20ad-4b8e-8b7c-013d6db2cc93" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SubscriptionPricePerShare_591eca63-6f24-4033-a589-03851be0a76b" xlink:href="sny-20221231.xsd#sny_SubscriptionPricePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:to="loc_sny_SubscriptionPricePerShare_591eca63-6f24-4033-a589-03851be0a76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareSubscribed_ee9b0082-3127-4192-9eb9-c91a8eb226f3" xlink:href="sny-20221231.xsd#sny_NumberOfShareSubscribed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:to="loc_sny_NumberOfShareSubscribed_ee9b0082-3127-4192-9eb9-c91a8eb226f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution_8a644914-1035-4047-b99e-85656d5359a7" xlink:href="sny-20221231.xsd#sny_IssuanceOfFurtherSharesAsAnEmployersContribution"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:to="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution_8a644914-1035-4047-b99e-85656d5359a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAverageOfQuotedMarketPricesOfShares_7c4dab6e-6f21-4784-8a13-d500c50c762e" xlink:href="sny-20221231.xsd#sny_PercentageOfAverageOfQuotedMarketPricesOfShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:to="loc_sny_PercentageOfAverageOfQuotedMarketPricesOfShares_7c4dab6e-6f21-4784-8a13-d500c50c762e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfTradingDaysPrecedingPlanApproval_341a39ab-342b-4a57-8d21-e943d3e4eb2b" xlink:href="sny-20221231.xsd#sny_NumberOfTradingDaysPrecedingPlanApproval"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0002e5e8-2a89-4780-8756-1ea5c4a216d8" xlink:to="loc_sny_NumberOfTradingDaysPrecedingPlanApproval_341a39ab-342b-4a57-8d21-e943d3e4eb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5050dcac-d3e3-450d-935a-f5b55e2348f0" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_83d4dee3-17eb-4053-8ca2-563eeb308c1a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_5050dcac-d3e3-450d-935a-f5b55e2348f0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_83d4dee3-17eb-4053-8ca2-563eeb308c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_688ce994-39b9-4f6f-8880-c343d27a5373" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_83d4dee3-17eb-4053-8ca2-563eeb308c1a" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_688ce994-39b9-4f6f-8880-c343d27a5373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_3feb63a5-9d77-4c5b-9b2f-5d963c83a820" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_688ce994-39b9-4f6f-8880-c343d27a5373" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_3feb63a5-9d77-4c5b-9b2f-5d963c83a820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeesShareOwnershipPlanMember_898b4b04-c9b4-4e00-8e10-47bc87bca80c" xlink:href="sny-20221231.xsd#sny_EmployeesShareOwnershipPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_3feb63a5-9d77-4c5b-9b2f-5d963c83a820" xlink:to="loc_sny_EmployeesShareOwnershipPlanMember_898b4b04-c9b4-4e00-8e10-47bc87bca80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_2df6b06d-05fa-4b3f-b77a-2aa2fb867135" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_83d4dee3-17eb-4053-8ca2-563eeb308c1a" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_2df6b06d-05fa-4b3f-b77a-2aa2fb867135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_8f34549e-b8b2-485e-bcf4-86d7a00ef243" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_2df6b06d-05fa-4b3f-b77a-2aa2fb867135" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_8f34549e-b8b2-485e-bcf4-86d7a00ef243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution_3ea861a5-c93f-4183-90cf-a251f4c8d32f" xlink:href="sny-20221231.xsd#sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_2df6b06d-05fa-4b3f-b77a-2aa2fb867135" xlink:to="loc_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution_3ea861a5-c93f-4183-90cf-a251f4c8d32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_3d8c4bb8-df51-4377-a23f-d59e4e1f666f" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_98f34f3e-0384-4b8c-8994-592054657f1b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_3d8c4bb8-df51-4377-a23f-d59e4e1f666f" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_98f34f3e-0384-4b8c-8994-592054657f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateAxis_5492748f-2af8-4852-99dc-c15d331447ad" xlink:href="sny-20221231.xsd#sny_AwardsDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_98f34f3e-0384-4b8c-8994-592054657f1b" xlink:to="loc_sny_AwardsDateAxis_5492748f-2af8-4852-99dc-c15d331447ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:href="sny-20221231.xsd#sny_AwardsDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AwardsDateAxis_5492748f-2af8-4852-99dc-c15d331447ad" xlink:to="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2022ProgramMember_448702f4-d7d9-42f7-879e-2fc1ac80b288" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2022ProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:to="loc_sny_ShareRepurchase2022ProgramMember_448702f4-d7d9-42f7-879e-2fc1ac80b288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2021ProgramMember_edf1831c-ef1b-4a5e-a726-537da3b51019" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2021ProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:to="loc_sny_ShareRepurchase2021ProgramMember_edf1831c-ef1b-4a5e-a726-537da3b51019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2020ProgramMember_872be1d4-b03a-4df8-bc0f-7cfbed9ac715" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2020ProgramMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:to="loc_sny_ShareRepurchase2020ProgramMember_872be1d4-b03a-4df8-bc0f-7cfbed9ac715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareRepurchase2019ProgramMember_602cfcfd-12ef-4e20-bbb2-b7a7372630f1" xlink:href="sny-20221231.xsd#sny_ShareRepurchase2019ProgramMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AwardsDateDomain_b7f0d01f-2494-4ec9-8dc8-af467d19283e" xlink:to="loc_sny_ShareRepurchase2019ProgramMember_602cfcfd-12ef-4e20-bbb2-b7a7372630f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_1e83483f-1c79-4e48-8b70-884d8abad596" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_98f34f3e-0384-4b8c-8994-592054657f1b" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_1e83483f-1c79-4e48-8b70-884d8abad596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSharesRepurchased_33bf6034-8097-4042-b0b8-8da18d514a77" xlink:href="sny-20221231.xsd#sny_NumberOfSharesRepurchased"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_1e83483f-1c79-4e48-8b70-884d8abad596" xlink:to="loc_sny_NumberOfSharesRepurchased_33bf6034-8097-4042-b0b8-8da18d514a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmountOfSharesRepurchased_705d5130-9eed-4c04-ac14-373f05e00fd9" xlink:href="sny-20221231.xsd#sny_AmountOfSharesRepurchased"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_1e83483f-1c79-4e48-8b70-884d8abad596" xlink:to="loc_sny_AmountOfSharesRepurchased_705d5130-9eed-4c04-ac14-373f05e00fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_569d0d1e-2a66-476a-866a-eafa4c9e64c9" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_2d7ef388-30a3-4901-9e59-054ff17e3189" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_569d0d1e-2a66-476a-866a-eafa4c9e64c9" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_2d7ef388-30a3-4901-9e59-054ff17e3189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_dc40bb54-e618-4b72-967f-4f6d08b16a0d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_2d7ef388-30a3-4901-9e59-054ff17e3189" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_dc40bb54-e618-4b72-967f-4f6d08b16a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_d5d4d67d-28ed-49ba-9e14-5567628c28ae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_dc40bb54-e618-4b72-967f-4f6d08b16a0d" xlink:to="loc_ifrs-full_EquityMember_d5d4d67d-28ed-49ba-9e14-5567628c28ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_55bc52bb-f621-408a-9915-e5f9792737ce" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_d5d4d67d-28ed-49ba-9e14-5567628c28ae" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_55bc52bb-f621-408a-9915-e5f9792737ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_c830c2f1-3a36-4caa-9d6a-7558dcfa42a7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_2d7ef388-30a3-4901-9e59-054ff17e3189" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_c830c2f1-3a36-4caa-9d6a-7558dcfa42a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_7feb68fe-47a5-4d20-afbe-e55cefa431fc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_c830c2f1-3a36-4caa-9d6a-7558dcfa42a7" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParent_7feb68fe-47a5-4d20-afbe-e55cefa431fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncontrollingInterests_90d7656f-87dd-448a-a66f-9b50e75d8fd5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_c830c2f1-3a36-4caa-9d6a-7558dcfa42a7" xlink:to="loc_ifrs-full_NoncontrollingInterests_90d7656f-87dd-448a-a66f-9b50e75d8fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_5823d76f-26a4-4373-af39-90297175c766" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_c830c2f1-3a36-4caa-9d6a-7558dcfa42a7" xlink:to="loc_ifrs-full_Equity_5823d76f-26a4-4373-af39-90297175c766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_e114bbbb-a12d-4813-b9bb-c26e80c6bc0a" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_e114bbbb-a12d-4813-b9bb-c26e80c6bc0a" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_6037959a-472f-4037-b961-c38221db2607" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_6037959a-472f-4037-b961-c38221db2607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_9596e7c7-9906-4a44-ad72-50eb4250aedc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_6037959a-472f-4037-b961-c38221db2607" xlink:to="loc_ifrs-full_EquityMember_9596e7c7-9906-4a44-ad72-50eb4250aedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_53583496-0f1e-4147-bff5-95220c4bbd13" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_9596e7c7-9906-4a44-ad72-50eb4250aedc" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_53583496-0f1e-4147-bff5-95220c4bbd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassifiedItemsAxis_f5ca92fc-c84f-44f9-abcf-6f0915cfc8c1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReclassifiedItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:to="loc_ifrs-full_ReclassifiedItemsAxis_f5ca92fc-c84f-44f9-abcf-6f0915cfc8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReclassifiedItemsMember_ebdc80d3-edd4-43b8-8e3e-8258d99de1ed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReclassifiedItemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReclassifiedItemsAxis_f5ca92fc-c84f-44f9-abcf-6f0915cfc8c1" xlink:to="loc_ifrs-full_ReclassifiedItemsMember_ebdc80d3-edd4-43b8-8e3e-8258d99de1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember_8d83e07a-26ce-4b83-9acd-d9a7be312630" xlink:href="sny-20221231.xsd#sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReclassifiedItemsMember_ebdc80d3-edd4-43b8-8e3e-8258d99de1ed" xlink:to="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember_8d83e07a-26ce-4b83-9acd-d9a7be312630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_4f5d9661-1faf-465d-9cb5-b54b6ce65166" xlink:href="sny-20221231.xsd#sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReclassifiedItemsMember_ebdc80d3-edd4-43b8-8e3e-8258d99de1ed" xlink:to="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_4f5d9661-1faf-465d-9cb5-b54b6ce65166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_dc432d53-1bb4-42f4-b746-b37f93175db7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_dc432d53-1bb4-42f4-b746-b37f93175db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_dc432d53-1bb4-42f4-b746-b37f93175db7" xlink:to="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInstrumentsIncludedInFinancialAssetMember_edb7ea59-f02f-4aeb-b019-610adc44da99" xlink:href="sny-20221231.xsd#sny_EquityInstrumentsIncludedInFinancialAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:to="loc_sny_EquityInstrumentsIncludedInFinancialAssetMember_edb7ea59-f02f-4aeb-b019-610adc44da99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentsMember_4fb14a8c-6381-4060-91d1-b47e9bb68481" xlink:href="sny-20221231.xsd#sny_DebtInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:to="loc_sny_DebtInstrumentsMember_4fb14a8c-6381-4060-91d1-b47e9bb68481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember_cfca1d7a-4bae-4835-b884-09a72990f8e9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:to="loc_ifrs-full_EquityInvestmentsMember_cfca1d7a-4bae-4835-b884-09a72990f8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashFlowAndFairValueHedgeMember_becae682-1c03-4b2d-aeea-41b445e75bb6" xlink:href="sny-20221231.xsd#sny_CashFlowAndFairValueHedgeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:to="loc_sny_CashFlowAndFairValueHedgeMember_becae682-1c03-4b2d-aeea-41b445e75bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForeignCurrencyTranslationMember_066a45ee-8cf9-456c-8156-566739c6ace2" xlink:href="sny-20221231.xsd#sny_ForeignCurrencyTranslationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_f049e5dc-2ded-483d-aae6-bcf400e2b55a" xlink:to="loc_sny_ForeignCurrencyTranslationMember_066a45ee-8cf9-456c-8156-566739c6ace2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_eb4a845a-41c8-410d-85d3-161760e3da93" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_eb4a845a-41c8-410d-85d3-161760e3da93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_26b339c3-abef-408e-993f-2a4ffcf211a2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_eb4a845a-41c8-410d-85d3-161760e3da93" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_26b339c3-abef-408e-993f-2a4ffcf211a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_8662807b-a151-4cb9-9d00-d72ce8bb31dd" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_26b339c3-abef-408e-993f-2a4ffcf211a2" xlink:to="loc_sny_RegeneronMember_8662807b-a151-4cb9-9d00-d72ce8bb31dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_9b3d34df-c2e7-46d6-86ea-004081a083b1" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_26b339c3-abef-408e-993f-2a4ffcf211a2" xlink:to="loc_sny_EuroapiMember_9b3d34df-c2e7-46d6-86ea-004081a083b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_b84c4db0-7cbe-4db1-92e5-d96bfad20fb3" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_52cde75a-1613-4d6f-a7a8-02aee02f33f3" xlink:href="sny-20221231.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_52cde75a-1613-4d6f-a7a8-02aee02f33f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_0421ce94-31b4-408b-941d-feb8b8cc5ccb" xlink:href="sny-20221231.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_0421ce94-31b4-408b-941d-feb8b8cc5ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_791690d9-1724-4ef5-81b5-c70bd4c35bf6" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_791690d9-1724-4ef5-81b5-c70bd4c35bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_1d18ebab-661f-45f1-8ff9-7fb30a57d12f" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_1d18ebab-661f-45f1-8ff9-7fb30a57d12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_7cea3df2-6cbc-4937-ad37-da008911624d" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_7cea3df2-6cbc-4937-ad37-da008911624d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_37e21a4d-e31a-445a-adbb-cc825a63cfba" xlink:href="sny-20221231.xsd#sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_37e21a4d-e31a-445a-adbb-cc825a63cfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_7e8e7989-7976-4033-9a51-4b7507f8d887" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_7e8e7989-7976-4033-9a51-4b7507f8d887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_14152da6-766d-4a9d-b2ba-a5a5d213bcdc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_14152da6-766d-4a9d-b2ba-a5a5d213bcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_caa34f04-a354-4e76-bdc8-7ba18543a8f5" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_caa34f04-a354-4e76-bdc8-7ba18543a8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures_842ce631-0722-426b-9787-e56ae2c58af4" xlink:href="sny-20221231.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures_842ce631-0722-426b-9787-e56ae2c58af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_3499e97c-525b-4cd0-bd11-f10dfa71e637" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_3499e97c-525b-4cd0-bd11-f10dfa71e637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_c11271dd-0e67-4bff-85ea-5495382095b7" xlink:href="sny-20221231.xsd#sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_c11271dd-0e67-4bff-85ea-5495382095b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_4cb1cd1d-5193-4c2c-9929-94b54343b485" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_4cb1cd1d-5193-4c2c-9929-94b54343b485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_ab8eed26-5503-4888-9d7e-cca35eef8842" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_ab8eed26-5503-4888-9d7e-cca35eef8842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_2bd18a85-e8bf-440b-9952-ed86b318f401" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_2bd18a85-e8bf-440b-9952-ed86b318f401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_69a6882e-8ef8-4160-a0b8-a1cac647ca85" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_69a6882e-8ef8-4160-a0b8-a1cac647ca85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInCurrencyTranslationOnTaxEffects_df82d2da-cfff-4628-8d93-ee943e13eeae" xlink:href="sny-20221231.xsd#sny_ChangeInCurrencyTranslationOnTaxEffects"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_sny_ChangeInCurrencyTranslationOnTaxEffects_df82d2da-cfff-4628-8d93-ee943e13eeae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_325fa8fc-05e7-4043-a4d3-d3d79f812940" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_ee3d544d-95c1-4170-bdaf-26cf9e392f71" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_325fa8fc-05e7-4043-a4d3-d3d79f812940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_3b9b4cce-9d94-4392-9252-7a70114d5c8b" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable_858ed988-dd49-4e37-adc5-5984bb5dce1b" xlink:href="sny-20221231.xsd#sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_3b9b4cce-9d94-4392-9252-7a70114d5c8b" xlink:to="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable_858ed988-dd49-4e37-adc5-5984bb5dce1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_6c86b30d-6f36-48ee-8a20-7c643095d234" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable_858ed988-dd49-4e37-adc5-5984bb5dce1b" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_6c86b30d-6f36-48ee-8a20-7c643095d234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_37f3c47a-bb36-44d5-8cf4-ffe6601a5e59" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_6c86b30d-6f36-48ee-8a20-7c643095d234" xlink:to="loc_ifrs-full_EquityMember_37f3c47a-bb36-44d5-8cf4-ffe6601a5e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_37f3c47a-bb36-44d5-8cf4-ffe6601a5e59" xlink:to="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanThreeMember_3f854cc7-934c-422d-a35b-609a24eebcc3" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanThreeMember_3f854cc7-934c-422d-a35b-609a24eebcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanFourMember_fa9e4565-3193-4be7-9fe3-bbb8e0ab827b" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanFourMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanFourMember_fa9e4565-3193-4be7-9fe3-bbb8e0ab827b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanFiveMember_ee557194-8fc5-4dcd-b084-19b4abae842f" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanFiveMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanFiveMember_ee557194-8fc5-4dcd-b084-19b4abae842f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanSixMember_30e4c7d9-69fd-4ebf-adbc-748b59091cf9" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanSixMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanSixMember_30e4c7d9-69fd-4ebf-adbc-748b59091cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanSevenMember_cdb59547-0078-4692-add6-b040cc9b8e56" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanSevenMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanSevenMember_cdb59547-0078-4692-add6-b040cc9b8e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanEightMember_4d4779aa-e121-4432-9fa9-99d684631870" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanEightMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanEightMember_4d4779aa-e121-4432-9fa9-99d684631870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanNineMember_520b225f-6a13-45a2-951b-85bd1f998553" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanNineMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanNineMember_520b225f-6a13-45a2-951b-85bd1f998553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockSubscriptionOptionPlanTenMember_b04fb556-c4fa-4482-8894-5d5018e33f42" xlink:href="sny-20221231.xsd#sny_StockSubscriptionOptionPlanTenMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_StockSubscriptionOptionPlanMember_43b525e5-5971-47ac-a681-de1957a819c5" xlink:to="loc_sny_StockSubscriptionOptionPlanTenMember_b04fb556-c4fa-4482-8894-5d5018e33f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_48415428-a80e-4fd3-8d93-ab77d770f531" xlink:href="sny-20221231.xsd#sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable_858ed988-dd49-4e37-adc5-5984bb5dce1b" xlink:to="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_48415428-a80e-4fd3-8d93-ab77d770f531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_8da8956d-1be5-46a9-a368-7de70fade463" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_48415428-a80e-4fd3-8d93-ab77d770f531" xlink:to="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_8da8956d-1be5-46a9-a368-7de70fade463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockBasedCompensationStockOptionsExercisedPricePerShare_601222ec-6487-4dc1-ac42-ee95fb4e4a8f" xlink:href="sny-20221231.xsd#sny_StockBasedCompensationStockOptionsExercisedPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_48415428-a80e-4fd3-8d93-ab77d770f531" xlink:to="loc_sny_StockBasedCompensationStockOptionsExercisedPricePerShare_601222ec-6487-4dc1-ac42-ee95fb4e4a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_b28cb736-93b6-4bfb-8b8f-7856b48bb46c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems_48415428-a80e-4fd3-8d93-ab77d770f531" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_b28cb736-93b6-4bfb-8b8f-7856b48bb46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_07acb301-44c0-470c-839c-cc7341c7d806" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e19b9579-192d-4b02-b425-d71a0191ffa6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_07acb301-44c0-470c-839c-cc7341c7d806" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e19b9579-192d-4b02-b425-d71a0191ffa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1bf85f61-1cb7-40de-bc05-6e4610a6d7ae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e19b9579-192d-4b02-b425-d71a0191ffa6" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1bf85f61-1cb7-40de-bc05-6e4610a6d7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_02732a86-a9a8-4fd3-aa70-071e60792f4d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1bf85f61-1cb7-40de-bc05-6e4610a6d7ae" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_02732a86-a9a8-4fd3-aa70-071e60792f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalStockOptionPlansMember_60efadd5-f2d4-47c2-911f-db31c991939c" xlink:href="sny-20221231.xsd#sny_TotalStockOptionPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_02732a86-a9a8-4fd3-aa70-071e60792f4d" xlink:to="loc_sny_TotalStockOptionPlansMember_60efadd5-f2d4-47c2-911f-db31c991939c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_e19b9579-192d-4b02-b425-d71a0191ffa6" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement_02c29060-92a4-491b-bd37-fa885335f14f" xlink:href="sny-20221231.xsd#sny_NumberOfShareOutstandingInShareBasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement_02c29060-92a4-491b-bd37-fa885335f14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_8185683d-e610-4a77-a67f-defa239ee314" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_8185683d-e610-4a77-a67f-defa239ee314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3ae8da84-7090-4669-83ad-e83309fdb0dd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3ae8da84-7090-4669-83ad-e83309fdb0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_41a81439-3388-498d-8cc4-ad8682aed85d" xlink:href="sny-20221231.xsd#sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement_41a81439-3388-498d-8cc4-ad8682aed85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_3ae4d27c-478f-4379-843e-fd6b6d77b28f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_3ae4d27c-478f-4379-843e-fd6b6d77b28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement_1e264f1a-7739-4a8e-ba95-1339a71aa205" xlink:href="sny-20221231.xsd#sny_NumberOfShareOutstandingInShareBasedPaymentArrangement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement_1e264f1a-7739-4a8e-ba95-1339a71aa205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_946b691b-021f-431a-ab1b-bab6fd1d678a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_946b691b-021f-431a-ab1b-bab6fd1d678a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_66efbd9c-9ff9-4b97-9dac-d0183ec913b6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_66efbd9c-9ff9-4b97-9dac-d0183ec913b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_4af49ead-c5d1-4b42-9c34-2eb68fd67b8c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_4af49ead-c5d1-4b42-9c34-2eb68fd67b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_0cf4384b-cfb9-4b1f-96da-6d30f6a7a751" xlink:href="sny-20221231.xsd#sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement_0cf4384b-cfb9-4b1f-96da-6d30f6a7a751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_79da223e-43ae-48a5-a8f4-da4cb7bee5f9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_79da223e-43ae-48a5-a8f4-da4cb7bee5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_4f4a441d-5d8c-4c32-b012-e716a821c503" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_4f4a441d-5d8c-4c32-b012-e716a821c503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement_9d16e91b-8847-43ad-9ce0-749b6ed17221" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement_9d16e91b-8847-43ad-9ce0-749b6ed17221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement_f537c5cc-23e7-41a7-90db-7134a8901013" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement_f537c5cc-23e7-41a7-90db-7134a8901013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement_9d202201-f5c0-4010-9a37-747e6088ef30" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement_9d202201-f5c0-4010-9a37-747e6088ef30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement_01025d0a-9141-422a-8baa-6d25455a2088" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement_01025d0a-9141-422a-8baa-6d25455a2088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement_e4f1ac99-44d7-4cb3-9ed7-68d6962b507e" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement_e4f1ac99-44d7-4cb3-9ed7-68d6962b507e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement_7874a0aa-7a55-4142-ac68-eb06855c87aa" xlink:href="sny-20221231.xsd#sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_68baf18e-fb94-41da-9b21-a98c473a353f" xlink:to="loc_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement_7874a0aa-7a55-4142-ac68-eb06855c87aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_7021ba04-8973-4261-9d55-f436b7ee943d" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_98018f9b-67ad-42dd-ac61-b2d48ae455c8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_7021ba04-8973-4261-9d55-f436b7ee943d" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_98018f9b-67ad-42dd-ac61-b2d48ae455c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_cdf3ab44-6e83-41d8-b0d7-a6fb7e7f5eed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_98018f9b-67ad-42dd-ac61-b2d48ae455c8" xlink:to="loc_ifrs-full_RangeAxis_cdf3ab44-6e83-41d8-b0d7-a6fb7e7f5eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_5f674af3-75c2-467c-adec-15a9b432922a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_cdf3ab44-6e83-41d8-b0d7-a6fb7e7f5eed" xlink:to="loc_ifrs-full_RangesMember_5f674af3-75c2-467c-adec-15a9b432922a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_ecf65a7c-969e-4906-934f-0e1aed953bb7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_5f674af3-75c2-467c-adec-15a9b432922a" xlink:to="loc_ifrs-full_BottomOfRangeMember_ecf65a7c-969e-4906-934f-0e1aed953bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_6503a684-f3d4-4b84-b6e7-4fe2c7aee7d5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_5f674af3-75c2-467c-adec-15a9b432922a" xlink:to="loc_ifrs-full_TopOfRangeMember_6503a684-f3d4-4b84-b6e7-4fe2c7aee7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_047f4c44-c826-499e-9542-98802b02328f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_98018f9b-67ad-42dd-ac61-b2d48ae455c8" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_047f4c44-c826-499e-9542-98802b02328f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_8fb716a6-a073-4828-8ecb-3831b735002c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_047f4c44-c826-499e-9542-98802b02328f" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_8fb716a6-a073-4828-8ecb-3831b735002c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExercisePriceRangeTwoMember_bcd8219f-e403-489e-a6bf-85ed2689a63d" xlink:href="sny-20221231.xsd#sny_ExercisePriceRangeTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_8fb716a6-a073-4828-8ecb-3831b735002c" xlink:to="loc_sny_ExercisePriceRangeTwoMember_bcd8219f-e403-489e-a6bf-85ed2689a63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExercisePriceRangeThreeMember_5a784a24-875a-41c3-bdf9-54e8491003dd" xlink:href="sny-20221231.xsd#sny_ExercisePriceRangeThreeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_8fb716a6-a073-4828-8ecb-3831b735002c" xlink:to="loc_sny_ExercisePriceRangeThreeMember_5a784a24-875a-41c3-bdf9-54e8491003dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExercisePriceRangeFourMember_137adffb-fb89-4fbf-ace3-f880a3736661" xlink:href="sny-20221231.xsd#sny_ExercisePriceRangeFourMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_8fb716a6-a073-4828-8ecb-3831b735002c" xlink:to="loc_sny_ExercisePriceRangeFourMember_137adffb-fb89-4fbf-ace3-f880a3736661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_0e6ea46e-562b-4c3f-b8c1-ab3343b7e53b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_98018f9b-67ad-42dd-ac61-b2d48ae455c8" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_0e6ea46e-562b-4c3f-b8c1-ab3343b7e53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_c76b5367-9ac5-44db-bff6-2c18c5d9db41" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_0e6ea46e-562b-4c3f-b8c1-ab3343b7e53b" xlink:to="loc_ifrs-full_EquityMember_c76b5367-9ac5-44db-bff6-2c18c5d9db41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_StockOptionPlanMember_6bbe0b87-c049-4feb-b50e-3e376dc1f5f7" xlink:href="sny-20221231.xsd#sny_StockOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_c76b5367-9ac5-44db-bff6-2c18c5d9db41" xlink:to="loc_sny_StockOptionPlanMember_6bbe0b87-c049-4feb-b50e-3e376dc1f5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_98018f9b-67ad-42dd-ac61-b2d48ae455c8" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_e6f88a65-dd3e-4fc7-93a4-8b692e5bdd4f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_e6f88a65-dd3e-4fc7-93a4-8b692e5bdd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_a44a4160-0eb5-4bcb-a7ba-4218cb2fa010" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_a44a4160-0eb5-4bcb-a7ba-4218cb2fa010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_7f72d6cc-44a3-4246-89ac-9aa1941a2f65" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_7f72d6cc-44a3-4246-89ac-9aa1941a2f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1ce83d24-9495-4d23-b020-211ac4b97620" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1ce83d24-9495-4d23-b020-211ac4b97620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_c23f11ee-9865-48fd-9735-30ddb1306dce" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_c23f11ee-9865-48fd-9735-30ddb1306dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1ca19719-cee9-4373-94bd-2c31ee5acee6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_82197b74-9d0e-43f0-a09c-a1ed40effcf4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1ca19719-cee9-4373-94bd-2c31ee5acee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_94ae0179-a867-4b88-9fcf-3e8b559cfec9" xlink:href="sny-20221231.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares_b832ca7e-bd0e-4ec5-90a5-464618b89c26" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_94ae0179-a867-4b88-9fcf-3e8b559cfec9" xlink:to="loc_ifrs-full_WeightedAverageShares_b832ca7e-bd0e-4ec5-90a5-464618b89c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_0c418821-02df-45fc-a18c-b35c5452c071" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_94ae0179-a867-4b88-9fcf-3e8b559cfec9" xlink:to="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_0c418821-02df-45fc-a18c-b35c5452c071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares_dd1e5eda-6707-4cf3-90c6-1addca349595" xlink:href="sny-20221231.xsd#sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_94ae0179-a867-4b88-9fcf-3e8b559cfec9" xlink:to="loc_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares_dd1e5eda-6707-4cf3-90c6-1addca349595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_e933f041-cdd1-48ef-958e-05fff9d348f4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_94ae0179-a867-4b88-9fcf-3e8b559cfec9" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_e933f041-cdd1-48ef-958e-05fff9d348f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_e8e1b774-6a13-461f-a1dc-cb77b225cd50" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_8f957be9-e0ed-4520-8119-3ec1c273e241" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e8e1b774-6a13-461f-a1dc-cb77b225cd50" xlink:to="loc_ifrs-full_LongtermBorrowings_8f957be9-e0ed-4520-8119-3ec1c273e241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_61f65915-4627-46ba-9a96-40a80ed4e564" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e8e1b774-6a13-461f-a1dc-cb77b225cd50" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_61f65915-4627-46ba-9a96-40a80ed4e564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_deb0ce72-2a4a-41e5-af9e-73823a1a3d9e" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e8e1b774-6a13-461f-a1dc-cb77b225cd50" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_deb0ce72-2a4a-41e5-af9e-73823a1a3d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_47da18d8-45f3-44da-af0b-d958862519f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e8e1b774-6a13-461f-a1dc-cb77b225cd50" xlink:to="loc_ifrs-full_Borrowings_47da18d8-45f3-44da-af0b-d958862519f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_3619e8c5-9b17-4518-854a-e1d5b42d9298" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e8e1b774-6a13-461f-a1dc-cb77b225cd50" xlink:to="loc_ifrs-full_CashAndCashEquivalents_3619e8c5-9b17-4518-854a-e1d5b42d9298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_ce89b7ee-fdfc-4c41-90c6-378c6d223cbd" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e8e1b774-6a13-461f-a1dc-cb77b225cd50" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_ce89b7ee-fdfc-4c41-90c6-378c6d223cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_231574d5-988e-4c5e-8c70-2004c9bcbb3b" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e8e1b774-6a13-461f-a1dc-cb77b225cd50" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_231574d5-988e-4c5e-8c70-2004c9bcbb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_d9c1f75f-e185-40a4-a0c0-cab624244a51" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e8e1b774-6a13-461f-a1dc-cb77b225cd50" xlink:to="loc_ifrs-full_LeaseLiabilities_d9c1f75f-e185-40a4-a0c0-cab624244a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_a1d10e1c-1ac9-470a-ac79-396bb40a5916" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_145ee0db-0d9b-4690-8e43-0dbf4c80c3a6" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_a1d10e1c-1ac9-470a-ac79-396bb40a5916" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_145ee0db-0d9b-4690-8e43-0dbf4c80c3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_e969be33-3db3-40e1-9852-bf55cace9e9c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_145ee0db-0d9b-4690-8e43-0dbf4c80c3a6" xlink:to="loc_ifrs-full_MeasurementAxis_e969be33-3db3-40e1-9852-bf55cace9e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_5fce37fd-6f71-4377-a31c-dddbbbae67df" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_e969be33-3db3-40e1-9852-bf55cace9e9c" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_5fce37fd-6f71-4377-a31c-dddbbbae67df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmortizedCostMember_220a0e9a-2023-4969-b614-b29ae86ef229" xlink:href="sny-20221231.xsd#sny_AmortizedCostMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_5fce37fd-6f71-4377-a31c-dddbbbae67df" xlink:to="loc_sny_AmortizedCostMember_220a0e9a-2023-4969-b614-b29ae86ef229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember_d3b9b5f8-bebe-440d-b20e-7d024f6db910" xlink:href="sny-20221231.xsd#sny_AdjustmentToDebtMeasuredAtFairValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_5fce37fd-6f71-4377-a31c-dddbbbae67df" xlink:to="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember_d3b9b5f8-bebe-440d-b20e-7d024f6db910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionMember_f046edad-4206-40f9-ac6f-d60cc70bf296" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_5fce37fd-6f71-4377-a31c-dddbbbae67df" xlink:to="loc_sny_ValueOnRedemptionMember_f046edad-4206-40f9-ac6f-d60cc70bf296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_145ee0db-0d9b-4690-8e43-0dbf4c80c3a6" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_98def5f9-408c-46fc-a9ab-c06dfa5998bb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_ifrs-full_LongtermBorrowings_98def5f9-408c-46fc-a9ab-c06dfa5998bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_20b14524-38fb-47c1-9fac-1343f1324cf2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_20b14524-38fb-47c1-9fac-1343f1324cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_3552cfbd-4b9c-4fdc-a6f2-62e510b5a054" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_3552cfbd-4b9c-4fdc-a6f2-62e510b5a054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_e47eab92-43be-4e42-9edf-d41e180fde6f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_ifrs-full_Borrowings_e47eab92-43be-4e42-9edf-d41e180fde6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_8dae2a54-c6d3-45da-8da2-e1b9ee3805bb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_ifrs-full_CashAndCashEquivalents_8dae2a54-c6d3-45da-8da2-e1b9ee3805bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_b88ae286-8e89-47df-90a7-546d4c4f18a4" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_b88ae286-8e89-47df-90a7-546d4c4f18a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_7d502c9a-f68d-4d69-9dd4-87a0399195aa" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_3e2c70e1-e776-4510-8819-f7fd5da2f720" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_7d502c9a-f68d-4d69-9dd4-87a0399195aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_9080f226-1338-4c87-9d71-b5d3a032fecd" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtTable_523361a1-73b7-4dc9-a86d-2e6af64a6652" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_9080f226-1338-4c87-9d71-b5d3a032fecd" xlink:to="loc_sny_DisclosureOfDebtTable_523361a1-73b7-4dc9-a86d-2e6af64a6652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_ed9b2625-d2c6-4a87-8fc6-a4940544ad30" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtTable_523361a1-73b7-4dc9-a86d-2e6af64a6652" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_ed9b2625-d2c6-4a87-8fc6-a4940544ad30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_693efef5-dd8d-4d63-9f89-581f6745aa20" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_ed9b2625-d2c6-4a87-8fc6-a4940544ad30" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_693efef5-dd8d-4d63-9f89-581f6745aa20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowingsMember_a72baf27-023b-4147-9c64-4623d197ad15" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_693efef5-dd8d-4d63-9f89-581f6745aa20" xlink:to="loc_ifrs-full_LongtermBorrowingsMember_a72baf27-023b-4147-9c64-4623d197ad15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember_028dc3b1-9eb9-40ff-a8f0-fad593fbd02c" xlink:href="sny-20221231.xsd#sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_693efef5-dd8d-4d63-9f89-581f6745aa20" xlink:to="loc_sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember_028dc3b1-9eb9-40ff-a8f0-fad593fbd02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember_44a8036d-9f14-4863-85e0-5435deb7fdb1" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_693efef5-dd8d-4d63-9f89-581f6745aa20" xlink:to="loc_sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember_44a8036d-9f14-4863-85e0-5435deb7fdb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtTable_523361a1-73b7-4dc9-a86d-2e6af64a6652" xlink:to="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_10e146ca-7763-4efa-984c-11f15f397f70" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_ifrs-full_Borrowings_10e146ca-7763-4efa-984c-11f15f397f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_c3c7acc1-6ab6-48a9-b9a1-d46cda68e0a0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_c3c7acc1-6ab6-48a9-b9a1-d46cda68e0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_53684b61-24e1-4e4a-a0d0-fe5e5dc90518" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_53684b61-24e1-4e4a-a0d0-fe5e5dc90518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_dce67046-f4f9-4b3a-81e8-e1bfdf243c1e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_dce67046-f4f9-4b3a-81e8-e1bfdf243c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForeignCurrencyTranslationDifferences_43e3cb8c-f42a-422f-be2c-3bf01d0c7f2f" xlink:href="sny-20221231.xsd#sny_ForeignCurrencyTranslationDifferences"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_sny_ForeignCurrencyTranslationDifferences_43e3cb8c-f42a-422f-be2c-3bf01d0c7f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReclassificationFromNonCurrentToCurrent_e1e0f648-444c-473a-9c70-7e8c894ea0f4" xlink:href="sny-20221231.xsd#sny_ReclassificationFromNonCurrentToCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_sny_ReclassificationFromNonCurrentToCurrent_e1e0f648-444c-473a-9c70-7e8c894ea0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsForNoncashItems_3a2ec0d4-63b1-4436-a6ca-c7011a722174" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsForNoncashItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_ifrs-full_OtherAdjustmentsForNoncashItems_3a2ec0d4-63b1-4436-a6ca-c7011a722174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_a8a7a227-2ffa-4784-a7be-f1746380a770" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtLineItems_a16c2938-e5b7-4bac-ba8b-edf93db0055d" xlink:to="loc_ifrs-full_Borrowings_a8a7a227-2ffa-4784-a7be-f1746380a770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_a7c90c95-4330-4c68-a83e-3d97dc92f71d" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_03a92eef-6fdc-47e9-9c48-c4fca0905efc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_a7c90c95-4330-4c68-a83e-3d97dc92f71d" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_03a92eef-6fdc-47e9-9c48-c4fca0905efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_4e402e00-9662-4a00-83d8-3eb9f5be8531" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_03a92eef-6fdc-47e9-9c48-c4fca0905efc" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_4e402e00-9662-4a00-83d8-3eb9f5be8531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_4e402e00-9662-4a00-83d8-3eb9f5be8531" xlink:to="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSustainabilityLinkedCreditFacilitiesMember_8afe27d0-c18d-468f-8510-30792b7fc21f" xlink:href="sny-20221231.xsd#sny_SanofiSustainabilityLinkedCreditFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_SanofiSustainabilityLinkedCreditFacilitiesMember_8afe27d0-c18d-468f-8510-30792b7fc21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ParticipatingSharesMember_af65659b-baf0-4f6d-89ab-555ca3c78b6a" xlink:href="sny-20221231.xsd#sny_ParticipatingSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_ParticipatingSharesMember_af65659b-baf0-4f6d-89ab-555ca3c78b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SyndicatedCreditFacilityOneMember_38fc3e41-e13b-4aac-94ec-4bb77f9a90ad" xlink:href="sny-20221231.xsd#sny_SyndicatedCreditFacilityOneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_SyndicatedCreditFacilityOneMember_38fc3e41-e13b-4aac-94ec-4bb77f9a90ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SyndicatedCreditFacilityTwoMember_413eba50-8163-43d7-b753-d3a3769343b5" xlink:href="sny-20221231.xsd#sny_SyndicatedCreditFacilityTwoMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_SyndicatedCreditFacilityTwoMember_413eba50-8163-43d7-b753-d3a3769343b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommercialPaperProgramInFranceMember_569202b4-c111-4c03-ba7e-09b025669662" xlink:href="sny-20221231.xsd#sny_CommercialPaperProgramInFranceMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_CommercialPaperProgramInFranceMember_569202b4-c111-4c03-ba7e-09b025669662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommercialPaperProgramInUSAMember_48216f94-baf7-4fe3-adf6-e4c7ce541118" xlink:href="sny-20221231.xsd#sny_CommercialPaperProgramInUSAMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_CommercialPaperProgramInUSAMember_48216f94-baf7-4fe3-adf6-e4c7ce541118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember_3fcfaecb-ee21-4750-9df5-8e457531b42c" xlink:href="sny-20221231.xsd#sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember_3fcfaecb-ee21-4750-9df5-8e457531b42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member_d7ceb784-e2ce-4e47-840e-9ad5cc510460" xlink:href="sny-20221231.xsd#sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member_d7ceb784-e2ce-4e47-840e-9ad5cc510460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember_7ae9b35f-d7ba-4c25-84db-fa5cc4c6bdf0" xlink:href="sny-20221231.xsd#sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember_7ae9b35f-d7ba-4c25-84db-fa5cc4c6bdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember_91c0b413-18a4-489e-b7a6-5de36693f0f5" xlink:href="sny-20221231.xsd#sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember_91c0b413-18a4-489e-b7a6-5de36693f0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OneBillionBondsMaturingJanuary2022Member_c62697ee-0fe3-4525-b005-0833532ff942" xlink:href="sny-20221231.xsd#sny_OneBillionBondsMaturingJanuary2022Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_OneBillionBondsMaturingJanuary2022Member_c62697ee-0fe3-4525-b005-0833532ff942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member_1861ad3a-3a05-4797-90fb-0f0709e5201d" xlink:href="sny-20221231.xsd#sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member_1861ad3a-3a05-4797-90fb-0f0709e5201d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EightHundredFiftyMillionBondsMaturingJune2022Member_6d7731c8-79da-441f-9532-bf669e7aba5d" xlink:href="sny-20221231.xsd#sny_EightHundredFiftyMillionBondsMaturingJune2022Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_11287e17-5982-4cfa-8e2e-5aacee91dc18" xlink:to="loc_sny_EightHundredFiftyMillionBondsMaturingJune2022Member_6d7731c8-79da-441f-9532-bf669e7aba5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentAxis_8e33b36a-cae7-4175-bba3-74de96156b11" xlink:href="sny-20221231.xsd#sny_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_03a92eef-6fdc-47e9-9c48-c4fca0905efc" xlink:to="loc_sny_DebtInstrumentAxis_8e33b36a-cae7-4175-bba3-74de96156b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentDomain_f2f8fd64-4c7c-4eda-9189-f79a1342b0dc" xlink:href="sny-20221231.xsd#sny_DebtInstrumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DebtInstrumentAxis_8e33b36a-cae7-4175-bba3-74de96156b11" xlink:to="loc_sny_DebtInstrumentDomain_f2f8fd64-4c7c-4eda-9189-f79a1342b0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiEuroMediumTermNotesMember_29012419-20c7-42ee-90b7-12b2a9999a8c" xlink:href="sny-20221231.xsd#sny_SanofiEuroMediumTermNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DebtInstrumentDomain_f2f8fd64-4c7c-4eda-9189-f79a1342b0dc" xlink:to="loc_sny_SanofiEuroMediumTermNotesMember_29012419-20c7-42ee-90b7-12b2a9999a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_ca92ccf9-5610-4895-b849-d48d2d1beca1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_03a92eef-6fdc-47e9-9c48-c4fca0905efc" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_ca92ccf9-5610-4895-b849-d48d2d1beca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_8067ac79-39f0-4a1e-bba0-2793013b7707" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_ca92ccf9-5610-4895-b849-d48d2d1beca1" xlink:to="loc_ifrs-full_InterestRateTypesMember_8067ac79-39f0-4a1e-bba0-2793013b7707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember_8bfb44b0-3653-4a6c-97a9-28c63947ce60" xlink:href="sny-20221231.xsd#sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_8067ac79-39f0-4a1e-bba0-2793013b7707" xlink:to="loc_sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember_8bfb44b0-3653-4a6c-97a9-28c63947ce60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember_864d2fdf-5c94-49bd-8b86-bc193c498b9c" xlink:href="sny-20221231.xsd#sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_8067ac79-39f0-4a1e-bba0-2793013b7707" xlink:to="loc_sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember_864d2fdf-5c94-49bd-8b86-bc193c498b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_03a92eef-6fdc-47e9-9c48-c4fca0905efc" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_e80781b9-2658-4042-8d89-f8b2cf7ca684" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_ifrs-full_NotionalAmount_e80781b9-2658-4042-8d89-f8b2cf7ca684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfTranches_c038017a-638b-4b8b-a983-d13368f63e6a" xlink:href="sny-20221231.xsd#sny_NumberOfTranches"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_NumberOfTranches_c038017a-638b-4b8b-a983-d13368f63e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_1655129f-41cc-4c9e-ad72-ec8a4035f6f7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_ifrs-full_BorrowingsInterestRate_1655129f-41cc-4c9e-ad72-ec8a4035f6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceObjectiveMinimumNumberOfPatients_0ba5f28c-1eb9-45f1-a30a-89ecb4269dd5" xlink:href="sny-20221231.xsd#sny_PerformanceObjectiveMinimumNumberOfPatients"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_PerformanceObjectiveMinimumNumberOfPatients_0ba5f28c-1eb9-45f1-a30a-89ecb4269dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PerformanceObjectiveNumberOfCountries_1ffbb835-837e-44c7-b1a0-4eb72b7457b3" xlink:href="sny-20221231.xsd#sny_PerformanceObjectiveNumberOfCountries"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_PerformanceObjectiveNumberOfCountries_1ffbb835-837e-44c7-b1a0-4eb72b7457b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfBondIssuesRedeemed_dda38bb8-9df7-4b1d-b6dc-437ce83a865f" xlink:href="sny-20221231.xsd#sny_NumberOfBondIssuesRedeemed"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_NumberOfBondIssuesRedeemed_dda38bb8-9df7-4b1d-b6dc-437ce83a865f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCreditFacilities_32422c27-9ef4-425f-b1f2-530aeb9f348b" xlink:href="sny-20221231.xsd#sny_NumberOfCreditFacilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_NumberOfCreditFacilities_32422c27-9ef4-425f-b1f2-530aeb9f348b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfSustainableDevelopmentPerformanceIndicators_12dde9ef-27bb-4c2d-a2ce-e1b23b188413" xlink:href="sny-20221231.xsd#sny_NumberOfSustainableDevelopmentPerformanceIndicators"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_NumberOfSustainableDevelopmentPerformanceIndicators_12dde9ef-27bb-4c2d-a2ce-e1b23b188413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ParticipatingSharesNumberOutstanding_e207b12c-70c0-4723-8a39-ce45ee4c24fa" xlink:href="sny-20221231.xsd#sny_ParticipatingSharesNumberOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_ParticipatingSharesNumberOutstanding_e207b12c-70c0-4723-8a39-ce45ee4c24fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ParticipatingSharesCarryingAmount_94d39f2e-09af-411b-8656-d9af6d2feb1e" xlink:href="sny-20221231.xsd#sny_ParticipatingSharesCarryingAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_ParticipatingSharesCarryingAmount_94d39f2e-09af-411b-8656-d9af6d2feb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommercialPapersIssued_11ed0b35-5667-4e83-b804-7a6d2c61ae9c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CommercialPapersIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_ifrs-full_CommercialPapersIssued_11ed0b35-5667-4e83-b804-7a6d2c61ae9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BorrowingAverageDrawdown_009b4867-a3e3-43b0-a9e7-53957e48a1b9" xlink:href="sny-20221231.xsd#sny_BorrowingAverageDrawdown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_BorrowingAverageDrawdown_009b4867-a3e3-43b0-a9e7-53957e48a1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BorrowingMaximumDrawdown_779cdf10-abe3-4ddb-9169-974c070b3719" xlink:href="sny-20221231.xsd#sny_BorrowingMaximumDrawdown"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_BorrowingMaximumDrawdown_779cdf10-abe3-4ddb-9169-974c070b3719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BorrowingDrawdown_fe264031-869f-40d0-a96b-cf19fda7dd25" xlink:href="sny-20221231.xsd#sny_BorrowingDrawdown"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_BorrowingDrawdown_fe264031-869f-40d0-a96b-cf19fda7dd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCurrenciesDebtIsIssuedIn_83aa54a7-b5f7-4326-a221-7c5b5381c8fe" xlink:href="sny-20221231.xsd#sny_NumberOfCurrenciesDebtIsIssuedIn"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_NumberOfCurrenciesDebtIsIssuedIn_83aa54a7-b5f7-4326-a221-7c5b5381c8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashAndCashEquivalentsInvestedRate_ffaa34d4-5220-4129-8754-6a0f9f09f7ed" xlink:href="sny-20221231.xsd#sny_CashAndCashEquivalentsInvestedRate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_58f450df-baa0-4e44-8c39-547bb04bcac8" xlink:to="loc_sny_CashAndCashEquivalentsInvestedRate_ffaa34d4-5220-4129-8754-6a0f9f09f7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_e947fefa-19cb-4881-bf43-973017f8d612" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_e947fefa-19cb-4881-bf43-973017f8d612" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_f6f5570b-31cb-462e-9366-cbf62787ef25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:to="loc_ifrs-full_MeasurementAxis_f6f5570b-31cb-462e-9366-cbf62787ef25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_1a63ab4f-884e-4961-abd5-e3d7a4bf0e4e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_f6f5570b-31cb-462e-9366-cbf62787ef25" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_1a63ab4f-884e-4961-abd5-e3d7a4bf0e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionMember_42be2544-55ad-4dce-8fc2-54acab03a3c8" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_1a63ab4f-884e-4961-abd5-e3d7a4bf0e4e" xlink:to="loc_sny_ValueOnRedemptionMember_42be2544-55ad-4dce-8fc2-54acab03a3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_460f5507-6196-4781-a2cb-2b14e9760578" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_460f5507-6196-4781-a2cb-2b14e9760578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesMember_77e5251f-0d5a-47e4-96ca-8636adaa0ae8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_460f5507-6196-4781-a2cb-2b14e9760578" xlink:to="loc_ifrs-full_LiabilitiesMember_77e5251f-0d5a-47e4-96ca-8636adaa0ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NoncurrentLiabilitiesMember_0fa28fee-272c-46fa-aa65-f284079ee641" xlink:href="sny-20221231.xsd#sny_NoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesMember_77e5251f-0d5a-47e4-96ca-8636adaa0ae8" xlink:to="loc_sny_NoncurrentLiabilitiesMember_0fa28fee-272c-46fa-aa65-f284079ee641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentLiabilitiesMember_1a93d5a5-5702-445c-9bf4-b05a9f0ff74f" xlink:href="sny-20221231.xsd#sny_CurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesMember_77e5251f-0d5a-47e4-96ca-8636adaa0ae8" xlink:to="loc_sny_CurrentLiabilitiesMember_1a93d5a5-5702-445c-9bf4-b05a9f0ff74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_b122112f-e05d-45ac-aa9f-4c12bb020760" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_b122112f-e05d-45ac-aa9f-4c12bb020760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_b1800911-857c-4c09-90ed-ca5778e7e7c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_b122112f-e05d-45ac-aa9f-4c12bb020760" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_b1800911-857c-4c09-90ed-ca5778e7e7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentAssetsMember_30d07ead-3591-4795-96f8-44e612d80b6d" xlink:href="sny-20221231.xsd#sny_NonCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_b1800911-857c-4c09-90ed-ca5778e7e7c3" xlink:to="loc_sny_NonCurrentAssetsMember_30d07ead-3591-4795-96f8-44e612d80b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentAssetsMember_063f1779-1c91-4027-8e54-16fff8ec5a76" xlink:href="sny-20221231.xsd#sny_CurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_b1800911-857c-4c09-90ed-ca5778e7e7c3" xlink:to="loc_sny_CurrentAssetsMember_063f1779-1c91-4027-8e54-16fff8ec5a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_723ff351-b5d6-4c4a-ad6b-ea1cd2008439" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:to="loc_ifrs-full_MaturityAxis_723ff351-b5d6-4c4a-ad6b-ea1cd2008439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_723ff351-b5d6-4c4a-ad6b-ea1cd2008439" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_09f36489-fa85-4338-b718-0e74ffcc1d0b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_09f36489-fa85-4338-b718-0e74ffcc1d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_18ccaf61-59da-4cae-b56a-5c328019de60" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_18ccaf61-59da-4cae-b56a-5c328019de60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_9d1ff411-2368-467d-9399-a492311bb8dd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_9d1ff411-2368-467d-9399-a492311bb8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_ddc67d2f-8db4-4e10-abd7-f6409fbba89e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_ddc67d2f-8db4-4e10-abd7-f6409fbba89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_dd2f51ec-8981-4cae-ae63-ab0827dec5b3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_dd2f51ec-8981-4cae-ae63-ab0827dec5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_db97d7cf-d331-469b-aace-bda94df21735" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_f9f92acf-e04f-4907-ba6d-d080edc9fef0" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_db97d7cf-d331-469b-aace-bda94df21735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:href="sny-20221231.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_0df6d3ff-1378-42c2-869a-374ca76a10fb" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BondsIssued_9eb9a5cc-5014-4305-a478-6a7b5f413bf9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BondsIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_ifrs-full_BondsIssued_9eb9a5cc-5014-4305-a478-6a7b5f413bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherBankBorrowings_1589061d-f32e-487e-b15b-a89317c72935" xlink:href="sny-20221231.xsd#sny_OtherBankBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_sny_OtherBankBorrowings_1589061d-f32e-487e-b15b-a89317c72935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinanceLeaseLiabilities_f04a3190-ed17-4ca4-95c5-71ea8111cf1a" xlink:href="sny-20221231.xsd#sny_FinanceLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_sny_FinanceLeaseLiabilities_f04a3190-ed17-4ca4-95c5-71ea8111cf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherBorrowings_824e4eb7-6c16-44fc-9677-ba5a964766b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_ifrs-full_OtherBorrowings_824e4eb7-6c16-44fc-9677-ba5a964766b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_e0585f6c-04db-4dc9-a51b-e8ede3242d6f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_e0585f6c-04db-4dc9-a51b-e8ede3242d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_e6dd93bc-fc74-42e1-b7e6-a75cec85cf83" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_e6dd93bc-fc74-42e1-b7e6-a75cec85cf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_0b0769f4-be14-4453-9e78-e4a1cf36187d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_ifrs-full_Borrowings_0b0769f4-be14-4453-9e78-e4a1cf36187d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_cbdae267-7664-4008-89c1-1b02680c7255" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_ifrs-full_CashAndCashEquivalents_cbdae267-7664-4008-89c1-1b02680c7255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_cd78d58d-2f4c-42cf-ac5e-378181650ba4" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_cd78d58d-2f4c-42cf-ac5e-378181650ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_1ec0c6c0-4105-4674-aa05-041ba7a1901d" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_43d5e9b4-bc76-4646-bd9b-7ae0a4181a0d" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_1ec0c6c0-4105-4674-aa05-041ba7a1901d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_75b1e85c-600a-4407-8976-69bb6998231b" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_738e9b0f-3e82-4a3e-9284-fcf2abf1115d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_75b1e85c-600a-4407-8976-69bb6998231b" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_738e9b0f-3e82-4a3e-9284-fcf2abf1115d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentAxis_ef476e48-7ac1-4d31-9bf8-c5595d6f9ece" xlink:href="sny-20221231.xsd#sny_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_738e9b0f-3e82-4a3e-9284-fcf2abf1115d" xlink:to="loc_sny_DebtInstrumentAxis_ef476e48-7ac1-4d31-9bf8-c5595d6f9ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtInstrumentDomain_1b6ad518-c9b9-49dc-bda0-591bbcca0ebe" xlink:href="sny-20221231.xsd#sny_DebtInstrumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DebtInstrumentAxis_ef476e48-7ac1-4d31-9bf8-c5595d6f9ece" xlink:to="loc_sny_DebtInstrumentDomain_1b6ad518-c9b9-49dc-bda0-591bbcca0ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiEuroMediumTermNotesMember_6b78c36c-07f8-4ff1-9dfc-cbad88a83989" xlink:href="sny-20221231.xsd#sny_SanofiEuroMediumTermNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DebtInstrumentDomain_1b6ad518-c9b9-49dc-bda0-591bbcca0ebe" xlink:to="loc_sny_SanofiEuroMediumTermNotesMember_6b78c36c-07f8-4ff1-9dfc-cbad88a83989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShelfRegistrationStatementProgramMember_49804bd8-c712-45e2-b291-76256b71533c" xlink:href="sny-20221231.xsd#sny_ShelfRegistrationStatementProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DebtInstrumentDomain_1b6ad518-c9b9-49dc-bda0-591bbcca0ebe" xlink:to="loc_sny_ShelfRegistrationStatementProgramMember_49804bd8-c712-45e2-b291-76256b71533c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_ebf6b629-5f51-426b-a73f-a6ea4a543c93" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_738e9b0f-3e82-4a3e-9284-fcf2abf1115d" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_ebf6b629-5f51-426b-a73f-a6ea4a543c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_ebf6b629-5f51-426b-a73f-a6ea4a543c93" xlink:to="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_November2013EMTNISINFR0011625433Member_b2a541f6-f1bc-4b1d-ab4d-9ad0d696fe56" xlink:href="sny-20221231.xsd#sny_November2013EMTNISINFR0011625433Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_November2013EMTNISINFR0011625433Member_b2a541f6-f1bc-4b1d-ab4d-9ad0d696fe56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2022EMTNISINFR0014009KS6Member_2a31197f-e460-4adc-952f-baea22e7d8aa" xlink:href="sny-20221231.xsd#sny_April2022EMTNISINFR0014009KS6Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_April2022EMTNISINFR0014009KS6Member_2a31197f-e460-4adc-952f-baea22e7d8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_September2014EMTNISINFR0012146801Member_22bb3c50-6314-4ade-aa3a-f051e949ffb6" xlink:href="sny-20221231.xsd#sny_September2014EMTNISINFR0012146801Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_September2014EMTNISINFR0012146801Member_22bb3c50-6314-4ade-aa3a-f051e949ffb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2022EMTNISINFR0014009KQ0Member_2f6d363f-7c2c-49e3-9844-fc550ea3bde9" xlink:href="sny-20221231.xsd#sny_April2022EMTNISINFR0014009KQ0Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_April2022EMTNISINFR0014009KQ0Member_2f6d363f-7c2c-49e3-9844-fc550ea3bde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_September2015EMTNISINFR0012969038Member_2cbc6057-6368-4516-bbc1-88be2e15030b" xlink:href="sny-20221231.xsd#sny_September2015EMTNISINFR0012969038Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_September2015EMTNISINFR0012969038Member_2cbc6057-6368-4516-bbc1-88be2e15030b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2016EMTNISINFR0013143997Member_98816913-3364-4d0c-b6eb-10a528a1c803" xlink:href="sny-20221231.xsd#sny_April2016EMTNISINFR0013143997Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_April2016EMTNISINFR0013143997Member_98816913-3364-4d0c-b6eb-10a528a1c803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_April2016EMTNISINFR0013144003Member_94304fa1-f39f-4e91-a64d-9cd6c0641a8d" xlink:href="sny-20221231.xsd#sny_April2016EMTNISINFR0013144003Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_April2016EMTNISINFR0013144003Member_94304fa1-f39f-4e91-a64d-9cd6c0641a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_September2016EMTNISINFR0013201639Member_713887a6-4634-4b89-bf3e-058d558c50d5" xlink:href="sny-20221231.xsd#sny_September2016EMTNISINFR0013201639Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_September2016EMTNISINFR0013201639Member_713887a6-4634-4b89-bf3e-058d558c50d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2020EMTNISINFR0013505104Member_7a8b1979-31be-4655-99e9-4f05d4fd3b37" xlink:href="sny-20221231.xsd#sny_March2020EMTNISINFR0013505104Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2020EMTNISINFR0013505104Member_7a8b1979-31be-4655-99e9-4f05d4fd3b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2020EMTNISINFR0013505112Member_b63d3fef-f8fe-44f7-9730-02c70daab5e4" xlink:href="sny-20221231.xsd#sny_March2020EMTNISINFR0013505112Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2020EMTNISINFR0013505112Member_b63d3fef-f8fe-44f7-9730-02c70daab5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324332Member_3d4d3b32-50c7-4dc5-a935-27450d7749ff" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324332Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2018EMTNISINFR0013324332Member_3d4d3b32-50c7-4dc5-a935-27450d7749ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324340Member_01da1648-419e-4c66-8119-fb5dbfe231f9" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324340Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2018EMTNISINFR0013324340Member_01da1648-419e-4c66-8119-fb5dbfe231f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324357Member_8b4c8c4c-9e4e-4348-8ee8-d46fc72abadf" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324357Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2018EMTNISINFR0013324357Member_8b4c8c4c-9e4e-4348-8ee8-d46fc72abadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2018EMTNISINFR0013324373Member_9db2f599-ce53-4293-b66d-f08550aab9f5" xlink:href="sny-20221231.xsd#sny_March2018EMTNISINFR0013324373Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2018EMTNISINFR0013324373Member_9db2f599-ce53-4293-b66d-f08550aab9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2019EMTNISINFR0013409844Member_798d5a68-97af-4cf3-951d-645abe13f6b3" xlink:href="sny-20221231.xsd#sny_March2019EMTNISINFR0013409844Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2019EMTNISINFR0013409844Member_798d5a68-97af-4cf3-951d-645abe13f6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_March2019EMTNISINFR0013409851Member_03116176-daaa-44b5-8a1e-570c21e89b17" xlink:href="sny-20221231.xsd#sny_March2019EMTNISINFR0013409851Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_March2019EMTNISINFR0013409851Member_03116176-daaa-44b5-8a1e-570c21e89b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_June2018SNFISINUS801060AC87Member_1f389434-d581-40e3-bd05-e86cc61a2bf6" xlink:href="sny-20221231.xsd#sny_June2018SNFISINUS801060AC87Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_June2018SNFISINUS801060AC87Member_1f389434-d581-40e3-bd05-e86cc61a2bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_June2018SNFISINUS801060AD60Member_ce5f37f7-6174-4d66-a0c2-e6aaabd0d5f1" xlink:href="sny-20221231.xsd#sny_June2018SNFISINUS801060AD60Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_3905b5eb-cd86-48bb-868b-652493a8d036" xlink:to="loc_sny_June2018SNFISINUS801060AD60Member_ce5f37f7-6174-4d66-a0c2-e6aaabd0d5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_e6bd5e96-c332-40ac-990e-9a41659c471b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_738e9b0f-3e82-4a3e-9284-fcf2abf1115d" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_e6bd5e96-c332-40ac-990e-9a41659c471b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_9c40f334-d41e-41ca-b973-2b32e24e7343" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_e6bd5e96-c332-40ac-990e-9a41659c471b" xlink:to="loc_ifrs-full_BorrowingsInterestRate_9c40f334-d41e-41ca-b973-2b32e24e7343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_038a07c8-7c25-4e3d-b1d6-b36695a6b9c1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_e6bd5e96-c332-40ac-990e-9a41659c471b" xlink:to="loc_ifrs-full_NotionalAmount_038a07c8-7c25-4e3d-b1d6-b36695a6b9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_881ffd89-9203-4936-932f-9cb7888cfb4b" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_19f9e936-f992-474a-b12c-ba180699180a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_881ffd89-9203-4936-932f-9cb7888cfb4b" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_19f9e936-f992-474a-b12c-ba180699180a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_a8f54ec1-dacd-428f-ab1a-12892c128e71" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_19f9e936-f992-474a-b12c-ba180699180a" xlink:to="loc_ifrs-full_MeasurementAxis_a8f54ec1-dacd-428f-ab1a-12892c128e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_bfa62e43-fab1-41d7-9cb3-1fe787f5893f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_a8f54ec1-dacd-428f-ab1a-12892c128e71" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_bfa62e43-fab1-41d7-9cb3-1fe787f5893f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionMember_57ac0724-3da0-4e29-b331-f3c49d0b3949" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_bfa62e43-fab1-41d7-9cb3-1fe787f5893f" xlink:to="loc_sny_ValueOnRedemptionMember_57ac0724-3da0-4e29-b331-f3c49d0b3949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_9fda3b56-e309-40d7-b68e-e05cdb7710c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_19f9e936-f992-474a-b12c-ba180699180a" xlink:to="loc_ifrs-full_MaturityAxis_9fda3b56-e309-40d7-b68e-e05cdb7710c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_9fda3b56-e309-40d7-b68e-e05cdb7710c3" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_e008a2ba-e8e3-48da-9bac-3a8366107738" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_e008a2ba-e8e3-48da-9bac-3a8366107738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_ce2d0a40-d1a8-420d-b499-d0039807f98e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_ce2d0a40-d1a8-420d-b499-d0039807f98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_9653c021-8439-41d9-b7a3-1a6139239521" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_9653c021-8439-41d9-b7a3-1a6139239521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2cbeb7db-222b-46f8-8509-63cf71263533" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2cbeb7db-222b-46f8-8509-63cf71263533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_0073606b-f971-4bb0-9d3d-be006e2cf9e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_0073606b-f971-4bb0-9d3d-be006e2cf9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_4ed7ecc5-7aa3-4787-9820-980aaa69ac5d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_bee8b617-8832-4caa-b83e-711a7173c5ee" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_4ed7ecc5-7aa3-4787-9820-980aaa69ac5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_19f9e936-f992-474a-b12c-ba180699180a" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BondsIssued_a4ef6597-3c7e-40c0-bb38-c2e843d95d1a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BondsIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_BondsIssued_a4ef6597-3c7e-40c0-bb38-c2e843d95d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherBankBorrowings_248e6ba3-fc5b-44c6-ba6f-d0661281c936" xlink:href="sny-20221231.xsd#sny_OtherBankBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_sny_OtherBankBorrowings_248e6ba3-fc5b-44c6-ba6f-d0661281c936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherBorrowings_76e3ac77-698e-41cd-bbb2-58a85c0ba77b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_OtherBorrowings_76e3ac77-698e-41cd-bbb2-58a85c0ba77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_f7c93f26-88cb-44ae-92d1-55553b1d162e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_f7c93f26-88cb-44ae-92d1-55553b1d162e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_99bdb71d-c849-4885-8175-8f95d45ebdd4" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_99bdb71d-c849-4885-8175-8f95d45ebdd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_b59e7c0b-95c4-4ce9-9680-4ec2ad296145" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_Borrowings_b59e7c0b-95c4-4ce9-9680-4ec2ad296145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_8b9b85d5-ceb4-44a6-85be-eb041380f16e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_CashAndCashEquivalents_8b9b85d5-ceb4-44a6-85be-eb041380f16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_ced43268-da3d-4aef-825e-9bed0e1db46d" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_ced43268-da3d-4aef-825e-9bed0e1db46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_41e613e6-0f09-40eb-a84b-5149cea69ae6" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_41e613e6-0f09-40eb-a84b-5149cea69ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_227d670a-ae0f-43fd-9332-7a3dd98ac72a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_63727031-fd1a-4a4b-a59c-6d70618c8a15" xlink:to="loc_ifrs-full_LeaseLiabilities_227d670a-ae0f-43fd-9332-7a3dd98ac72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_43cf4613-1674-4f47-a504-5d7ec4579769" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_43cf4613-1674-4f47-a504-5d7ec4579769" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_9c9b3bf1-0f2b-4d7c-9e00-b51f5116de0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:to="loc_srt_CurrencyAxis_9c9b3bf1-0f2b-4d7c-9e00-b51f5116de0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_418bf5e1-31a9-4af0-8316-0862a1df7ca8" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_9c9b3bf1-0f2b-4d7c-9e00-b51f5116de0c" xlink:to="loc_currency_AllCurrenciesDomain_418bf5e1-31a9-4af0-8316-0862a1df7ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_7e837ed4-759e-4507-ab23-e1afbb9241fe" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_418bf5e1-31a9-4af0-8316-0862a1df7ca8" xlink:to="loc_currency_EUR_7e837ed4-759e-4507-ab23-e1afbb9241fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_7a5ffa53-a226-465a-9203-fd0649fe9cca" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_418bf5e1-31a9-4af0-8316-0862a1df7ca8" xlink:to="loc_currency_USD_7a5ffa53-a226-465a-9203-fd0649fe9cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_830aba18-0596-40df-b146-9c258ec9e696" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_SGD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_418bf5e1-31a9-4af0-8316-0862a1df7ca8" xlink:to="loc_currency_SGD_830aba18-0596-40df-b146-9c258ec9e696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_16cd602b-72e1-4cb6-a9b0-4b5f7dcd1f6e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:to="loc_ifrs-full_MaturityAxis_16cd602b-72e1-4cb6-a9b0-4b5f7dcd1f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_16cd602b-72e1-4cb6-a9b0-4b5f7dcd1f6e" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_cf4645e0-24f1-49d8-80e1-bafebffab3f8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_cf4645e0-24f1-49d8-80e1-bafebffab3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_7cbded75-a183-4dac-b0f9-643c6585a028" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_7cbded75-a183-4dac-b0f9-643c6585a028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_c96bd4bf-15fd-46bf-a77c-aa9395e8e824" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_c96bd4bf-15fd-46bf-a77c-aa9395e8e824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_52974857-f203-43f5-8be8-da244589640a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_52974857-f203-43f5-8be8-da244589640a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_f75c7be2-d083-476f-9b78-522c08cd88b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_f75c7be2-d083-476f-9b78-522c08cd88b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_aaee8a44-d586-4421-99ff-8932ed4adb8b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_69b698c6-3def-498d-a801-a7a09719497c" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_aaee8a44-d586-4421-99ff-8932ed4adb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_a104ec1f-50ba-4319-ba34-890c03600c09" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:to="loc_ifrs-full_MeasurementAxis_a104ec1f-50ba-4319-ba34-890c03600c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_455ccb86-1072-4b08-b1a6-60495555fd37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_a104ec1f-50ba-4319-ba34-890c03600c09" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_455ccb86-1072-4b08-b1a6-60495555fd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember_c4998f6d-8157-483d-b886-f161fbeb345f" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_455ccb86-1072-4b08-b1a6-60495555fd37" xlink:to="loc_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember_c4998f6d-8157-483d-b886-f161fbeb345f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_065bc906-03c7-4c7b-abd0-3c94d51d7bc0" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionAfterDerivativeInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_455ccb86-1072-4b08-b1a6-60495555fd37" xlink:to="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_065bc906-03c7-4c7b-abd0-3c94d51d7bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_dcf5f86f-982a-4576-9240-787b96b7fd24" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_dcf5f86f-982a-4576-9240-787b96b7fd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_73a2ffbc-07f5-43b6-ac4e-ee2879056e64" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_dcf5f86f-982a-4576-9240-787b96b7fd24" xlink:to="loc_ifrs-full_InterestRateTypesMember_73a2ffbc-07f5-43b6-ac4e-ee2879056e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixedInterestRateMember_96cf155b-0dd2-48da-8425-c56ca46d7eed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixedInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_73a2ffbc-07f5-43b6-ac4e-ee2879056e64" xlink:to="loc_ifrs-full_FixedInterestRateMember_96cf155b-0dd2-48da-8425-c56ca46d7eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FloatingInterestRateMember_59349e8f-02fc-4e86-b691-f07c81dd511e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FloatingInterestRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_73a2ffbc-07f5-43b6-ac4e-ee2879056e64" xlink:to="loc_ifrs-full_FloatingInterestRateMember_59349e8f-02fc-4e86-b691-f07c81dd511e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_7ac0a1f7-642a-445d-821e-acbae88f58f7" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseOfBorrowings_735fca47-4d84-4392-9ead-4392a84e5807" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseOfBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:to="loc_sny_IncreaseDecreaseOfBorrowings_735fca47-4d84-4392-9ead-4392a84e5807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtPercent_ef0b910c-c41c-497b-b888-257cd4a4d1d4" xlink:href="sny-20221231.xsd#sny_DebtPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:to="loc_sny_DebtPercent_ef0b910c-c41c-497b-b888-257cd4a4d1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_172eee10-ddef-403f-b3d5-c012965d2534" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:to="loc_ifrs-full_CashAndCashEquivalents_172eee10-ddef-403f-b3d5-c012965d2534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_38d23dd4-4b6a-49fd-b4f7-ba509040f69f" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_1ad6490e-0490-4f01-9284-c5457b94c66d" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_38d23dd4-4b6a-49fd-b4f7-ba509040f69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_75d0cc23-6605-4845-b2bf-414ea803ecc8" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_855166e9-7e27-410b-8027-ba6b60f2c6a6" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_75d0cc23-6605-4845-b2bf-414ea803ecc8" xlink:to="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_855166e9-7e27-410b-8027-ba6b60f2c6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_ffa451ab-3497-4e3e-8450-e13609af35a2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_855166e9-7e27-410b-8027-ba6b60f2c6a6" xlink:to="loc_ifrs-full_MeasurementAxis_ffa451ab-3497-4e3e-8450-e13609af35a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_35b44708-34ff-4e03-b85d-80a5513504e5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_ffa451ab-3497-4e3e-8450-e13609af35a2" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_35b44708-34ff-4e03-b85d-80a5513504e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_3726c3c1-3f5d-4fb0-8978-36b5a8beb92a" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionAfterDerivativeInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_35b44708-34ff-4e03-b85d-80a5513504e5" xlink:to="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_3726c3c1-3f5d-4fb0-8978-36b5a8beb92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_e4b47385-3751-47eb-9103-d09a5b175f75" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_855166e9-7e27-410b-8027-ba6b60f2c6a6" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_e4b47385-3751-47eb-9103-d09a5b175f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_c3dce2f7-a6de-4374-84bf-e9afe7564d53" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_e4b47385-3751-47eb-9103-d09a5b175f75" xlink:to="loc_ifrs-full_InterestRateTypesMember_c3dce2f7-a6de-4374-84bf-e9afe7564d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixedInterestRateMember_ef42266c-faff-4339-acc5-b0a28b752e68" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixedInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_c3dce2f7-a6de-4374-84bf-e9afe7564d53" xlink:to="loc_ifrs-full_FixedInterestRateMember_ef42266c-faff-4339-acc5-b0a28b752e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FloatingInterestRateMember_dd15c2d9-c73a-49bf-bec0-b9de72b5dd81" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FloatingInterestRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_c3dce2f7-a6de-4374-84bf-e9afe7564d53" xlink:to="loc_ifrs-full_FloatingInterestRateMember_dd15c2d9-c73a-49bf-bec0-b9de72b5dd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_855166e9-7e27-410b-8027-ba6b60f2c6a6" xlink:to="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_42208ff2-cf99-4e4d-b30a-0b10b876e43e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:to="loc_ifrs-full_Borrowings_42208ff2-cf99-4e4d-b30a-0b10b876e43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_212cc86a-3060-44d4-8f32-d761e7bcaa58" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:to="loc_ifrs-full_CashAndCashEquivalents_212cc86a-3060-44d4-8f32-d761e7bcaa58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_e682d15a-99ed-4209-acec-88f62861f27c" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_e682d15a-99ed-4209-acec-88f62861f27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtPercent_5c1f1f7f-e9b2-424e-bce8-a00de1e51d6a" xlink:href="sny-20221231.xsd#sny_DebtPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_309eb625-9bd6-43f3-be1a-50c1dbfa5835" xlink:to="loc_sny_DebtPercent_5c1f1f7f-e9b2-424e-bce8-a00de1e51d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_3b745d86-5507-4d4d-ba18-fb68c3d887b0" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_381de7ba-c2da-4e48-8c5d-e649e43d7156" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_3b745d86-5507-4d4d-ba18-fb68c3d887b0" xlink:to="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_381de7ba-c2da-4e48-8c5d-e649e43d7156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_fcf71530-8fce-4ac2-8842-58ce17773538" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_381de7ba-c2da-4e48-8c5d-e649e43d7156" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_fcf71530-8fce-4ac2-8842-58ce17773538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_fcf71530-8fce-4ac2-8842-58ce17773538" xlink:to="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlusHundredBasisPointsMember_f2b88aac-e9b7-482b-b534-64b9a835cc91" xlink:href="sny-20221231.xsd#sny_PlusHundredBasisPointsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:to="loc_sny_PlusHundredBasisPointsMember_f2b88aac-e9b7-482b-b534-64b9a835cc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlusTwentyFiveBasisPointsMember_d45dc6b9-8865-4c5b-b8d8-15913e4464ac" xlink:href="sny-20221231.xsd#sny_PlusTwentyFiveBasisPointsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:to="loc_sny_PlusTwentyFiveBasisPointsMember_d45dc6b9-8865-4c5b-b8d8-15913e4464ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinusTwentyFiveBasisPointsMember_ddd610a1-08b7-4863-ae4e-a040f9de8f12" xlink:href="sny-20221231.xsd#sny_MinusTwentyFiveBasisPointsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:to="loc_sny_MinusTwentyFiveBasisPointsMember_ddd610a1-08b7-4863-ae4e-a040f9de8f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinusHundredBasisPointsMember_34b21580-4dac-49d3-9ca9-8887e91fbb3e" xlink:href="sny-20221231.xsd#sny_MinusHundredBasisPointsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_9d9cf5c9-b74d-45ad-bbd1-1867e92896f5" xlink:to="loc_sny_MinusHundredBasisPointsMember_34b21580-4dac-49d3-9ca9-8887e91fbb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_a99c964b-5973-4b18-9f09-3dbf590a5b66" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_381de7ba-c2da-4e48-8c5d-e649e43d7156" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_a99c964b-5973-4b18-9f09-3dbf590a5b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameMember_9d28d7f4-b2d6-4f7f-8bc5-1a03c809f494" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_a99c964b-5973-4b18-9f09-3dbf590a5b66" xlink:to="loc_ifrs-full_BorrowingsByNameMember_9d28d7f4-b2d6-4f7f-8bc5-1a03c809f494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember_1d317498-5cf9-4e74-9f2a-e48418438580" xlink:href="sny-20221231.xsd#sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_9d28d7f4-b2d6-4f7f-8bc5-1a03c809f494" xlink:to="loc_sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember_1d317498-5cf9-4e74-9f2a-e48418438580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_8323db79-80be-4cb5-8ddc-4f904f98606a" xlink:href="sny-20221231.xsd#sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable_381de7ba-c2da-4e48-8c5d-e649e43d7156" xlink:to="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_8323db79-80be-4cb5-8ddc-4f904f98606a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpactOfChangeInInterestRateOnPreTaxIncome_ce6d8c24-4f83-4016-92f5-fc9956dfc757" xlink:href="sny-20221231.xsd#sny_ImpactOfChangeInInterestRateOnPreTaxIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_8323db79-80be-4cb5-8ddc-4f904f98606a" xlink:to="loc_sny_ImpactOfChangeInInterestRateOnPreTaxIncome_ce6d8c24-4f83-4016-92f5-fc9956dfc757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpactOfPreTaxIncomeRecognisedInEquity_bb71d718-32db-40c9-a1ac-222c6d3a0be9" xlink:href="sny-20221231.xsd#sny_ImpactOfPreTaxIncomeRecognisedInEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems_8323db79-80be-4cb5-8ddc-4f904f98606a" xlink:to="loc_sny_ImpactOfPreTaxIncomeRecognisedInEquity_bb71d718-32db-40c9-a1ac-222c6d3a0be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_354988ca-6028-4681-9491-8891943cbcea" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByCurrencyTable_ba3db0a5-e2bf-46d1-96ca-57a6654aee1f" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByCurrencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_354988ca-6028-4681-9491-8891943cbcea" xlink:to="loc_sny_DisclosureOfDebtByCurrencyTable_ba3db0a5-e2bf-46d1-96ca-57a6654aee1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_5f15d74f-7325-4c16-85e0-58eb39f73146" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtByCurrencyTable_ba3db0a5-e2bf-46d1-96ca-57a6654aee1f" xlink:to="loc_srt_CurrencyAxis_5f15d74f-7325-4c16-85e0-58eb39f73146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_5f15d74f-7325-4c16-85e0-58eb39f73146" xlink:to="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_da464f02-91e3-48f6-8dc4-3d5e00834341" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_currency_EUR_da464f02-91e3-48f6-8dc4-3d5e00834341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_61513dcf-6b88-4eee-8e1f-1d6970136ccd" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_currency_USD_61513dcf-6b88-4eee-8e1f-1d6970136ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_dd6db9fc-4331-4cd2-8e08-4c97e91d34df" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_SGD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_currency_SGD_dd6db9fc-4331-4cd2-8e08-4c97e91d34df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_7e489dcd-2930-4016-a6b7-1411fbad7f12" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_GBP"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_currency_GBP_7e489dcd-2930-4016-a6b7-1411fbad7f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_b6c66559-95a3-4108-ba2e-0de94f35eda0" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MXN"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_currency_MXN_b6c66559-95a3-4108-ba2e-0de94f35eda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCurrenciesMember_e4858b09-bc8a-4ef5-9686-8a26a4951e98" xlink:href="sny-20221231.xsd#sny_OtherCurrenciesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_83b66754-cd66-4970-b54c-5e5a4c6ceeb1" xlink:to="loc_sny_OtherCurrenciesMember_e4858b09-bc8a-4ef5-9686-8a26a4951e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_3168af2d-f4e5-4294-a994-28a905f3c191" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtByCurrencyTable_ba3db0a5-e2bf-46d1-96ca-57a6654aee1f" xlink:to="loc_ifrs-full_MeasurementAxis_3168af2d-f4e5-4294-a994-28a905f3c191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_d6b49151-696c-4604-b3ed-0c53f3fe9cdd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_3168af2d-f4e5-4294-a994-28a905f3c191" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_d6b49151-696c-4604-b3ed-0c53f3fe9cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember_eddc013a-41fb-41b8-b4a9-aae4708bc474" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_d6b49151-696c-4604-b3ed-0c53f3fe9cdd" xlink:to="loc_sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember_eddc013a-41fb-41b8-b4a9-aae4708bc474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_36e55a21-78c0-47b8-b4eb-e8155fdcab46" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionAfterDerivativeInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_d6b49151-696c-4604-b3ed-0c53f3fe9cdd" xlink:to="loc_sny_ValueOnRedemptionAfterDerivativeInstrumentsMember_36e55a21-78c0-47b8-b4eb-e8155fdcab46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDebtByCurrencyLineItems_bc3c5f9a-6018-45d4-bcdc-b5298eed0a96" xlink:href="sny-20221231.xsd#sny_DisclosureOfDebtByCurrencyLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtByCurrencyTable_ba3db0a5-e2bf-46d1-96ca-57a6654aee1f" xlink:to="loc_sny_DisclosureOfDebtByCurrencyLineItems_bc3c5f9a-6018-45d4-bcdc-b5298eed0a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_cd9557dc-bf6a-4abf-a998-991f3673104e" xlink:href="sny-20221231.xsd#sny_DebtNetOfCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDebtByCurrencyLineItems_bc3c5f9a-6018-45d4-bcdc-b5298eed0a96" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_cd9557dc-bf6a-4abf-a998-991f3673104e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_d48673e8-4c61-4ed6-942f-0d57798b9c46" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_88d8832a-865f-4ca0-8e39-ccb2ecf85970" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_d48673e8-4c61-4ed6-942f-0d57798b9c46" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_88d8832a-865f-4ca0-8e39-ccb2ecf85970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_37705566-5c2d-4768-abb9-2e6d422ac749" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_88d8832a-865f-4ca0-8e39-ccb2ecf85970" xlink:to="loc_ifrs-full_MeasurementAxis_37705566-5c2d-4768-abb9-2e6d422ac749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_9d2d9dff-aa04-407c-930e-0e82be891d65" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_37705566-5c2d-4768-abb9-2e6d422ac749" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_9d2d9dff-aa04-407c-930e-0e82be891d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtMarketValueMember_23b2b7ca-66a1-4abb-8c02-deef1c146148" xlink:href="sny-20221231.xsd#sny_AtMarketValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_9d2d9dff-aa04-407c-930e-0e82be891d65" xlink:to="loc_sny_AtMarketValueMember_23b2b7ca-66a1-4abb-8c02-deef1c146148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOnRedemptionMember_9a14713e-c6f5-487f-b0c9-de613cb5cd45" xlink:href="sny-20221231.xsd#sny_ValueOnRedemptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_9d2d9dff-aa04-407c-930e-0e82be891d65" xlink:to="loc_sny_ValueOnRedemptionMember_9a14713e-c6f5-487f-b0c9-de613cb5cd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6d47861a-3d40-4b70-a673-f1728c940302" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_88d8832a-865f-4ca0-8e39-ccb2ecf85970" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6d47861a-3d40-4b70-a673-f1728c940302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_71e7c4cf-71fb-47a2-8d33-c341b4875924" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6d47861a-3d40-4b70-a673-f1728c940302" xlink:to="loc_ifrs-full_Borrowings_71e7c4cf-71fb-47a2-8d33-c341b4875924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RedemptionOfDebtInstrumentIssued_f04866f8-159c-4e8b-9a93-ea26bf6d96c6" xlink:href="sny-20221231.xsd#sny_RedemptionOfDebtInstrumentIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_6d47861a-3d40-4b70-a673-f1728c940302" xlink:to="loc_sny_RedemptionOfDebtInstrumentIssued_f04866f8-159c-4e8b-9a93-ea26bf6d96c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_db6a3884-75c5-4309-b82f-42338330d3a3" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_ff2b6e91-fadd-4984-8c81-116222fe1e6e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_db6a3884-75c5-4309-b82f-42338330d3a3" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_ff2b6e91-fadd-4984-8c81-116222fe1e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_26842d30-a783-41c3-b7a0-c9eb88107f53" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_ff2b6e91-fadd-4984-8c81-116222fe1e6e" xlink:to="loc_ifrs-full_MaturityAxis_26842d30-a783-41c3-b7a0-c9eb88107f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_26842d30-a783-41c3-b7a0-c9eb88107f53" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_8e70c2d1-c1a8-4447-8702-5248a3d0b5f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_8e70c2d1-c1a8-4447-8702-5248a3d0b5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1455f704-d3f3-4393-b24f-4a5c31ae06dc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1455f704-d3f3-4393-b24f-4a5c31ae06dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_641b614b-7153-4802-b4ad-65f871e7ee83" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_641b614b-7153-4802-b4ad-65f871e7ee83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_272d359a-df8d-401c-aace-bfbc1ba8c9b2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_272d359a-df8d-401c-aace-bfbc1ba8c9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_d5e810ea-78fe-4514-b427-be0f898453bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_d5e810ea-78fe-4514-b427-be0f898453bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_badc3661-b07b-4686-967c-e63b46198365" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_67a45637-4101-4010-8fe9-74eeef2186c6" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_badc3661-b07b-4686-967c-e63b46198365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable_ff2b6e91-fadd-4984-8c81-116222fe1e6e" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_5f0a5dac-3bb7-48a8-8c61-88889be35c11" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:to="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_5f0a5dac-3bb7-48a8-8c61-88889be35c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalUndiscountedCashFlow_aef1a273-1572-4db6-b738-06f8f94fef71" xlink:href="sny-20221231.xsd#sny_PrincipalUndiscountedCashFlow"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:to="loc_sny_PrincipalUndiscountedCashFlow_aef1a273-1572-4db6-b738-06f8f94fef71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestUndiscountedCashFlow_625eb835-7f81-4da6-abb8-d9aba672571d" xlink:href="sny-20221231.xsd#sny_InterestUndiscountedCashFlow"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:to="loc_sny_InterestUndiscountedCashFlow_625eb835-7f81-4da6-abb8-d9aba672571d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_5969b5da-92d8-4521-8958-9e990cf8c8d4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows_5969b5da-92d8-4521-8958-9e990cf8c8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalUndiscountedCashFlow_8f5aef91-e09e-4c41-b65b-44a5ace0fc35" xlink:href="sny-20221231.xsd#sny_TotalUndiscountedCashFlow"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems_5fba1e89-d2ac-4ee3-8619-83ddaa1e5af2" xlink:to="loc_sny_TotalUndiscountedCashFlow_8f5aef91-e09e-4c41-b65b-44a5ace0fc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_3c56c700-9662-4f3a-87f8-ed2792aff27d" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_ca256244-22a1-4441-a5d1-ab2e9d123745" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_3c56c700-9662-4f3a-87f8-ed2792aff27d" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_ca256244-22a1-4441-a5d1-ab2e9d123745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_3bdb1dc3-21a1-4c23-8350-f42d3d6633fc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_ca256244-22a1-4441-a5d1-ab2e9d123745" xlink:to="loc_ifrs-full_MaturityAxis_3bdb1dc3-21a1-4c23-8350-f42d3d6633fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_3bdb1dc3-21a1-4c23-8350-f42d3d6633fc" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_79fe36ab-1848-4919-8dd3-bb14095f2a2f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_79fe36ab-1848-4919-8dd3-bb14095f2a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_865be04f-8d4f-4911-a665-1b221f75efe4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_865be04f-8d4f-4911-a665-1b221f75efe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_bdc97227-a3bd-4287-9c93-feb2199461e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_bdc97227-a3bd-4287-9c93-feb2199461e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_e16eddbd-4259-418f-bf7f-a498c593e3ec" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_6c76f179-c91a-4551-ab60-1c59b206050e" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_e16eddbd-4259-418f-bf7f-a498c593e3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a54f843-3c38-4bb8-822b-45d4e7c0e8fc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_ca256244-22a1-4441-a5d1-ab2e9d123745" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a54f843-3c38-4bb8-822b-45d4e7c0e8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_4488ca4d-43d3-44dd-a1d3-18e8aad45e7d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7a54f843-3c38-4bb8-822b-45d4e7c0e8fc" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_4488ca4d-43d3-44dd-a1d3-18e8aad45e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CambridgeMassachusettsMember_1372645f-7d2c-40bd-9bd0-7e9c5d2828c3" xlink:href="sny-20221231.xsd#sny_CambridgeMassachusettsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4488ca4d-43d3-44dd-a1d3-18e8aad45e7d" xlink:to="loc_sny_CambridgeMassachusettsMember_1372645f-7d2c-40bd-9bd0-7e9c5d2828c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_568696fd-7b8a-47b9-87f8-875f55df111c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_ca256244-22a1-4441-a5d1-ab2e9d123745" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_568696fd-7b8a-47b9-87f8-875f55df111c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_4aaa6237-05a5-445e-8284-4bf6269dc826" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_568696fd-7b8a-47b9-87f8-875f55df111c" xlink:to="loc_ifrs-full_LeaseLiabilities_4aaa6237-05a5-445e-8284-4bf6269dc826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LeaseLiabilitiesEffectOfDiscounting_457d0873-4d90-4c99-98e0-f7c958571638" xlink:href="sny-20221231.xsd#sny_LeaseLiabilitiesEffectOfDiscounting"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_568696fd-7b8a-47b9-87f8-875f55df111c" xlink:to="loc_sny_LeaseLiabilitiesEffectOfDiscounting_457d0873-4d90-4c99-98e0-f7c958571638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InitialLeaseTerm_b37bcc19-bfe1-498a-a124-0ea707df107b" xlink:href="sny-20221231.xsd#sny_InitialLeaseTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_568696fd-7b8a-47b9-87f8-875f55df111c" xlink:to="loc_sny_InitialLeaseTerm_b37bcc19-bfe1-498a-a124-0ea707df107b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_ccef517f-6d0f-46ea-bcc6-a7a0f73033f6" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_021cf22e-2886-4c0f-b079-3846981ca9a3" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_ccef517f-6d0f-46ea-bcc6-a7a0f73033f6" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_021cf22e-2886-4c0f-b079-3846981ca9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_513251e6-dcbb-4114-8125-ed55b79ca777" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_021cf22e-2886-4c0f-b079-3846981ca9a3" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_513251e6-dcbb-4114-8125-ed55b79ca777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_513251e6-dcbb-4114-8125-ed55b79ca777" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember_5d69ee84-1a72-4a84-af5d-3218becc58e4" xlink:href="sny-20221231.xsd#sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember_5d69ee84-1a72-4a84-af5d-3218becc58e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_0c9e1347-4cfc-4fcd-8aa8-1675db434c55" xlink:href="sny-20221231.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_0c9e1347-4cfc-4fcd-8aa8-1675db434c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember_6600217e-6c3e-4644-9784-947a2945c4c5" xlink:href="sny-20221231.xsd#sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember_6600217e-6c3e-4644-9784-947a2945c4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixMember_49bcd906-fb4e-498d-8f2b-6865cdbfeffe" xlink:href="sny-20221231.xsd#sny_AmunixMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_AmunixMember_49bcd906-fb4e-498d-8f2b-6865cdbfeffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherLiabilitiesMember_76f6f684-87ac-4fa5-ba94-a2c5d8082647" xlink:href="sny-20221231.xsd#sny_OtherLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_OtherLiabilitiesMember_76f6f684-87ac-4fa5-ba94-a2c5d8082647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioMember_21809d8e-190d-4a87-bd26-e1dc85c9111b" xlink:href="sny-20221231.xsd#sny_TranslateBioMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_067a1d11-7295-45d9-a30c-5a003773d535" xlink:to="loc_sny_TranslateBioMember_21809d8e-190d-4a87-bd26-e1dc85c9111b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_021cf22e-2886-4c0f-b079-3846981ca9a3" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_0d522727-57a4-456e-b1d9-6b5210faf26c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_0d522727-57a4-456e-b1d9-6b5210faf26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_ed600871-135e-4ca5-83f5-c0d2f4a650b1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_ed600871-135e-4ca5-83f5-c0d2f4a650b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_a2c28092-7f74-4acf-a7a9-5867fe54041d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_a2c28092-7f74-4acf-a7a9-5867fe54041d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherMovements_ea03d99d-979e-4138-8a67-e2fc8bac9b79" xlink:href="sny-20221231.xsd#sny_OtherMovements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_sny_OtherMovements_ea03d99d-979e-4138-8a67-e2fc8bac9b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests_a7973f18-6743-4f43-bead-f2a77efe0236" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests_a7973f18-6743-4f43-bead-f2a77efe0236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_63e30d73-ad2d-487c-baa2-487dde49930a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_63e30d73-ad2d-487c-baa2-487dde49930a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_ea17197f-7534-429c-94e8-4ad094a76038" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_ea17197f-7534-429c-94e8-4ad094a76038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_fd220062-b9fe-4e7f-831c-c3c9ce235f67" xlink:href="sny-20221231.xsd#sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_fd220062-b9fe-4e7f-831c-c3c9ce235f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_8c296b99-8dd4-4676-a7a4-47eb14887777" xlink:href="sny-20221231.xsd#sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_8c296b99-8dd4-4676-a7a4-47eb14887777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationLiabilities_b7e2920b-42fb-4d00-b8b6-6967d4771228" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_a99bda37-1de8-44c3-83f0-d10d96572712" xlink:to="loc_sny_ContingentConsiderationLiabilities_b7e2920b-42fb-4d00-b8b6-6967d4771228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_de8e9446-b48f-4367-9995-6e8e576594ac" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_c87ffdff-7c71-422f-b85c-21caa5498e7a" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_de8e9446-b48f-4367-9995-6e8e576594ac" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_c87ffdff-7c71-422f-b85c-21caa5498e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_2e9c7509-ab7e-42aa-b0b4-519bcfa305c3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_c87ffdff-7c71-422f-b85c-21caa5498e7a" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_2e9c7509-ab7e-42aa-b0b4-519bcfa305c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_2e9c7509-ab7e-42aa-b0b4-519bcfa305c3" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BayerScheringPharmaAGMember_8daa98e4-3970-4f61-b159-eb4652b24ab5" xlink:href="sny-20221231.xsd#sny_BayerScheringPharmaAGMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:to="loc_sny_BayerScheringPharmaAGMember_8daa98e4-3970-4f61-b159-eb4652b24ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_a2de50b4-6247-4545-b5d5-94de3c8bba61" xlink:href="sny-20221231.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:to="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_a2de50b4-6247-4545-b5d5-94de3c8bba61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShireHumanGeneticTherapiesIncMember_2aab0fc3-c183-4dab-96a0-474cd6282070" xlink:href="sny-20221231.xsd#sny_ShireHumanGeneticTherapiesIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:to="loc_sny_ShireHumanGeneticTherapiesIncMember_2aab0fc3-c183-4dab-96a0-474cd6282070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixMember_d31f63c6-cfcd-4598-a26b-e731cd3a4952" xlink:href="sny-20221231.xsd#sny_AmunixMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_e8005387-0928-47b1-967f-f8ddf03c54b6" xlink:to="loc_sny_AmunixMember_d31f63c6-cfcd-4598-a26b-e731cd3a4952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_f806c207-4e0d-43aa-8653-31875f16bc1c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_c87ffdff-7c71-422f-b85c-21caa5498e7a" xlink:to="loc_ifrs-full_RangeAxis_f806c207-4e0d-43aa-8653-31875f16bc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_45efd171-2de9-45d9-ba57-d88ab22380d8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_f806c207-4e0d-43aa-8653-31875f16bc1c" xlink:to="loc_ifrs-full_RangesMember_45efd171-2de9-45d9-ba57-d88ab22380d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_7696c410-9e0c-4aaf-8e01-eb855f3bd3b4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_45efd171-2de9-45d9-ba57-d88ab22380d8" xlink:to="loc_ifrs-full_TopOfRangeMember_7696c410-9e0c-4aaf-8e01-eb855f3bd3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:href="sny-20221231.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_c87ffdff-7c71-422f-b85c-21caa5498e7a" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PotentialPaymentsRelatedToPercentageOfSales_ba5dc26f-a102-462b-953b-73130884e19d" xlink:href="sny-20221231.xsd#sny_PotentialPaymentsRelatedToPercentageOfSales"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_PotentialPaymentsRelatedToPercentageOfSales_ba5dc26f-a102-462b-953b-73130884e19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentToSaleOfBusinessPeriod_ed32b768-88af-4f58-a46c-1a56d42ab8b6" xlink:href="sny-20221231.xsd#sny_PaymentToSaleOfBusinessPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_PaymentToSaleOfBusinessPeriod_ed32b768-88af-4f58-a46c-1a56d42ab8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MilestonePaymentTerm_88c59af0-c669-41a9-b410-9114d1cf8e11" xlink:href="sny-20221231.xsd#sny_MilestonePaymentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_MilestonePaymentTerm_88c59af0-c669-41a9-b410-9114d1cf8e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FairValueOfContingentConsiderationPayable_8e08f16a-224f-4eda-a3d1-2ca3220b9cfa" xlink:href="sny-20221231.xsd#sny_FairValueOfContingentConsiderationPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_FairValueOfContingentConsiderationPayable_8e08f16a-224f-4eda-a3d1-2ca3220b9cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageIncreaseInFairValueLiabilities_920b0971-33c7-446e-9b07-dbc9046583cb" xlink:href="sny-20221231.xsd#sny_PercentageIncreaseInFairValueLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_PercentageIncreaseInFairValueLiabilities_920b0971-33c7-446e-9b07-dbc9046583cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_e7f9645d-993e-4aab-983b-3073aecb52e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_e7f9645d-993e-4aab-983b-3073aecb52e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations_6a12eb48-a48b-4757-a5c8-febddc388fce" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_928c217a-1634-4181-bd20-5287048dc5e4" xlink:to="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations_6a12eb48-a48b-4757-a5c8-febddc388fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessCombinationsAbstract_b5708b1f-e982-4d31-b23c-6fffb36c5a60" xlink:href="sny-20221231.xsd#sny_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_6a14bcc7-4c2d-4b83-ba93-26cff4a07e20" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_BusinessCombinationsAbstract_b5708b1f-e982-4d31-b23c-6fffb36c5a60" xlink:to="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_6a14bcc7-4c2d-4b83-ba93-26cff4a07e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_58a8e5a1-4ee1-4a6a-ab7c-b7ba79adb7d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_6a14bcc7-4c2d-4b83-ba93-26cff4a07e20" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_58a8e5a1-4ee1-4a6a-ab7c-b7ba79adb7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34441daf-7642-4745-8dea-c90e8284af25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_58a8e5a1-4ee1-4a6a-ab7c-b7ba79adb7d0" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34441daf-7642-4745-8dea-c90e8284af25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BayerScheringPharmaAGMember_26dc30bf-e517-45b3-8604-3d19bd8c5f41" xlink:href="sny-20221231.xsd#sny_BayerScheringPharmaAGMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34441daf-7642-4745-8dea-c90e8284af25" xlink:to="loc_sny_BayerScheringPharmaAGMember_26dc30bf-e517-45b3-8604-3d19bd8c5f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_2f11518c-3810-4c87-ad20-8e6c2eedfe55" xlink:href="sny-20221231.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_34441daf-7642-4745-8dea-c90e8284af25" xlink:to="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_2f11518c-3810-4c87-ad20-8e6c2eedfe55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_25791e79-5772-44b8-a43f-aa41a267425e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_6a14bcc7-4c2d-4b83-ba93-26cff4a07e20" xlink:to="loc_ifrs-full_MaturityAxis_25791e79-5772-44b8-a43f-aa41a267425e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_25791e79-5772-44b8-a43f-aa41a267425e" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_da99bb81-0c37-46c5-aada-4572d2014ac5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_da99bb81-0c37-46c5-aada-4572d2014ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_0a25ca48-527d-42b0-a38a-189cc94efbd0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_0a25ca48-527d-42b0-a38a-189cc94efbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_d217434b-1bff-43bc-87f3-db0796ca27ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_d217434b-1bff-43bc-87f3-db0796ca27ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_883eaec1-08ba-4a40-9f84-5ce98a407418" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_105bc87f-726c-4ad6-a0db-1133b29f09cc" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_883eaec1-08ba-4a40-9f84-5ce98a407418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_f4e74538-e9fc-4902-9eea-9bf9f9a2c270" xlink:href="sny-20221231.xsd#sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable_6a14bcc7-4c2d-4b83-ba93-26cff4a07e20" xlink:to="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_f4e74538-e9fc-4902-9eea-9bf9f9a2c270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations_f676b2b4-ed47-47b1-b35a-db196378331c" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_f4e74538-e9fc-4902-9eea-9bf9f9a2c270" xlink:to="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations_f676b2b4-ed47-47b1-b35a-db196378331c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer_275f5a28-5f3c-47d4-a313-7f5af6286a1b" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_f4e74538-e9fc-4902-9eea-9bf9f9a2c270" xlink:to="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer_275f5a28-5f3c-47d4-a313-7f5af6286a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD_b5dd8061-0d68-4358-a65f-18c355aeea08" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems_f4e74538-e9fc-4902-9eea-9bf9f9a2c270" xlink:to="loc_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD_b5dd8061-0d68-4358-a65f-18c355aeea08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8224d818-1ef3-4ba0-a8d8-79a7754f249d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions_599ca18d-62ff-48d5-808b-92f240359f96" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8224d818-1ef3-4ba0-a8d8-79a7754f249d" xlink:to="loc_ifrs-full_NoncurrentProvisions_599ca18d-62ff-48d5-808b-92f240359f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_e7f2aa41-e273-4796-a51e-accc7c5593c8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8224d818-1ef3-4ba0-a8d8-79a7754f249d" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_e7f2aa41-e273-4796-a51e-accc7c5593c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_e54defe0-6f0d-4f2c-b6d4-b0c9cf17bdf0" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8224d818-1ef3-4ba0-a8d8-79a7754f249d" xlink:to="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_e54defe0-6f0d-4f2c-b6d4-b0c9cf17bdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_ccaf2a6c-1b38-43f4-919c-2934a7c21234" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8224d818-1ef3-4ba0-a8d8-79a7754f249d" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_ccaf2a6c-1b38-43f4-919c-2934a7c21234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ee57244f-fde1-4074-bc0b-6658eceab606" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNoncurrentProvisionsTable_ab28e98e-5713-41d0-b65b-6399de3797c8" xlink:href="sny-20221231.xsd#sny_DisclosureOfNoncurrentProvisionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_ee57244f-fde1-4074-bc0b-6658eceab606" xlink:to="loc_sny_DisclosureOfNoncurrentProvisionsTable_ab28e98e-5713-41d0-b65b-6399de3797c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_a9017c23-469d-4333-a1ef-d72fe94cf48c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNoncurrentProvisionsTable_ab28e98e-5713-41d0-b65b-6399de3797c8" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_a9017c23-469d-4333-a1ef-d72fe94cf48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_a9017c23-469d-4333-a1ef-d72fe94cf48c" xlink:to="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember_b5e8b796-16d9-4307-a91d-47603a8ff631" xlink:href="sny-20221231.xsd#sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:to="loc_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember_b5e8b796-16d9-4307-a91d-47603a8ff631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForOtherLongTermBenefitsMember_b11173ca-67a7-49f2-99f7-5b00f3ae862d" xlink:href="sny-20221231.xsd#sny_ProvisionsForOtherLongTermBenefitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:to="loc_sny_ProvisionsForOtherLongTermBenefitsMember_b11173ca-67a7-49f2-99f7-5b00f3ae862d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentRestructuringProvisionMember_c8a98b68-4a9d-4c45-aed3-4bcac522a3e6" xlink:href="sny-20221231.xsd#sny_NonCurrentRestructuringProvisionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:to="loc_sny_NonCurrentRestructuringProvisionMember_c8a98b68-4a9d-4c45-aed3-4bcac522a3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherProvisionsMember_71b4c84e-6934-4221-81dc-77377e7f6539" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherProvisionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_576a93bd-c995-4790-8c64-1a1ee4ff3828" xlink:to="loc_ifrs-full_MiscellaneousOtherProvisionsMember_71b4c84e-6934-4221-81dc-77377e7f6539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNoncurrentProvisionsLineItems_4a943fc6-49e0-48e4-bbb8-c2d7e1943a32" xlink:href="sny-20221231.xsd#sny_DisclosureOfNoncurrentProvisionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNoncurrentProvisionsTable_ab28e98e-5713-41d0-b65b-6399de3797c8" xlink:to="loc_sny_DisclosureOfNoncurrentProvisionsLineItems_4a943fc6-49e0-48e4-bbb8-c2d7e1943a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNoncurrentProvisionsLineItems_4a943fc6-49e0-48e4-bbb8-c2d7e1943a32" xlink:to="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions_2881bfa9-d05a-46a0-ba7a-8f2cd6f61a51" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_ifrs-full_NoncurrentProvisions_2881bfa9-d05a-46a0-ba7a-8f2cd6f61a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions_59b9bb0f-73f3-4a8f-af24-793fc618423e" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions_59b9bb0f-73f3-4a8f-af24-793fc618423e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInOtherProvisions_602bb728-081e-45e9-bb27-bee5eb9e9731" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInOtherProvisions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_ifrs-full_ChangesInOtherProvisions_602bb728-081e-45e9-bb27-bee5eb9e9731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions_b74daed3-051e-409a-a89c-af732560820c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProvisionUsedOtherProvisions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_ifrs-full_ProvisionUsedOtherProvisions_b74daed3-051e-409a-a89c-af732560820c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions_d4d2d33d-d7d2-4e55-a5b7-58e8d2acff54" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions_d4d2d33d-d7d2-4e55-a5b7-58e8d2acff54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_3872c99e-797c-4210-a733-3f16b5cbabe5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_3872c99e-797c-4210-a733-3f16b5cbabe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount_0027d0a4-3b07-4ba0-8311-07651ce54a2e" xlink:href="sny-20221231.xsd#sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount_0027d0a4-3b07-4ba0-8311-07651ce54a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_51be5018-91df-4f7f-877a-4360abe025a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_51be5018-91df-4f7f-877a-4360abe025a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans_218943ec-90d6-45a3-a53c-c7e92d13b661" xlink:href="sny-20221231.xsd#sny_ActuarialGainsAndLossesOnDefinedBenefitPlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans_218943ec-90d6-45a3-a53c-c7e92d13b661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions_751d192a-8237-4888-9f98-9213857cd3cb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_f37ee1a2-3c43-4ae2-97d2-bf635fb7f8f7" xlink:to="loc_ifrs-full_NoncurrentProvisions_751d192a-8237-4888-9f98-9213857cd3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_c37ca455-43ba-439d-add3-0064ff5b6ede" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:href="sny-20221231.xsd#sny_ProvisionsAndOtherNonCurrentLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_c37ca455-43ba-439d-add3-0064ff5b6ede" xlink:to="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_d17becb2-7606-4507-9397-d4c3ddbfc7d3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_d17becb2-7606-4507-9397-d4c3ddbfc7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_d17becb2-7606-4507-9397-d4c3ddbfc7d3" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LumpSumRetirementBenefitPlansMember_240d9eee-0066-413b-bee1-4c9117588346" xlink:href="sny-20221231.xsd#sny_LumpSumRetirementBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_sny_LumpSumRetirementBenefitPlansMember_240d9eee-0066-413b-bee1-4c9117588346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefinedBenefitPensionPlansMember_bc216d86-b2db-468c-b87d-31d4fc260c16" xlink:href="sny-20221231.xsd#sny_DefinedBenefitPensionPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_sny_DefinedBenefitPensionPlansMember_bc216d86-b2db-468c-b87d-31d4fc260c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TopUpDefinedBenefitPensionPlanMember_6b3e1ec2-0e48-490d-868a-f2ba9153d0c6" xlink:href="sny-20221231.xsd#sny_TopUpDefinedBenefitPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_sny_TopUpDefinedBenefitPensionPlanMember_6b3e1ec2-0e48-490d-868a-f2ba9153d0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiaventisPlusPensionPlanMember_7b24ab30-dbed-4418-b324-00ecc7a5fab4" xlink:href="sny-20221231.xsd#sny_SanofiaventisPlusPensionPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_sny_SanofiaventisPlusPensionPlanMember_7b24ab30-dbed-4418-b324-00ecc7a5fab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MultiemployerDefinedBenefitPlansMember_f55bd040-c433-46b5-a184-ee82f3c29822" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MultiemployerDefinedBenefitPlansMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_ifrs-full_MultiemployerDefinedBenefitPlansMember_f55bd040-c433-46b5-a184-ee82f3c29822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HealthcareCoverAndLifeInsuranceMember_1e2a1ecc-3f61-49db-9b65-6cc9e02bf502" xlink:href="sny-20221231.xsd#sny_HealthcareCoverAndLifeInsuranceMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_835687e2-8b4b-4c83-b847-6cb65c992064" xlink:to="loc_sny_HealthcareCoverAndLifeInsuranceMember_1e2a1ecc-3f61-49db-9b65-6cc9e02bf502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_6c9ccf3f-ec35-4087-9431-5c9e6d506820" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_GeographicalAreasAxis_6c9ccf3f-ec35-4087-9431-5c9e6d506820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_6c9ccf3f-ec35-4087-9431-5c9e6d506820" xlink:to="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_f496f051-d89b-478d-a782-cf30f66f688d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:to="loc_country_FR_f496f051-d89b-478d-a782-cf30f66f688d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_9d3dcb35-210e-41d4-af9f-81d8b61e4f6b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:to="loc_country_DE_9d3dcb35-210e-41d4-af9f-81d8b61e4f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5f8d8c9f-5169-447b-8ef5-3c5d0a2fb2ab" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:to="loc_country_US_5f8d8c9f-5169-447b-8ef5-3c5d0a2fb2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_0503b6fa-ef98-4969-bf55-9b04ed11f431" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_f15de550-8d94-489b-985d-ee8c25dd0ac2" xlink:to="loc_country_GB_0503b6fa-ef98-4969-bf55-9b04ed11f431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_9ebd668e-5a6a-445c-9a23-fe70ca4b32ea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_RangeAxis_9ebd668e-5a6a-445c-9a23-fe70ca4b32ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_06030ae4-ffa4-4ab2-a7f1-3014d63bad17" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_9ebd668e-5a6a-445c-9a23-fe70ca4b32ea" xlink:to="loc_ifrs-full_RangesMember_06030ae4-ffa4-4ab2-a7f1-3014d63bad17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_e8c4bbbd-9484-402e-9ded-2639532269ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_06030ae4-ffa4-4ab2-a7f1-3014d63bad17" xlink:to="loc_ifrs-full_BottomOfRangeMember_e8c4bbbd-9484-402e-9ded-2639532269ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_d185d0e0-59e7-4cee-bf6e-5a1137497bff" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_06030ae4-ffa4-4ab2-a7f1-3014d63bad17" xlink:to="loc_ifrs-full_TopOfRangeMember_d185d0e0-59e7-4cee-bf6e-5a1137497bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_4eda634a-e418-4da9-882d-2cc295a72ea3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_4eda634a-e418-4da9-882d-2cc295a72ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_4eda634a-e418-4da9-882d-2cc295a72ea3" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_QualifiedDefinedBenefitPensionPlansMember_7a03853f-0bb7-402a-ab80-5a6a92a0b717" xlink:href="sny-20221231.xsd#sny_QualifiedDefinedBenefitPensionPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:to="loc_sny_QualifiedDefinedBenefitPensionPlansMember_7a03853f-0bb7-402a-ab80-5a6a92a0b717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonQualifiedDefinedBenefitPensionPlansMember_67dd4171-79b5-44fd-b0ae-af772d3d8a63" xlink:href="sny-20221231.xsd#sny_NonQualifiedDefinedBenefitPensionPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:to="loc_sny_NonQualifiedDefinedBenefitPensionPlansMember_67dd4171-79b5-44fd-b0ae-af772d3d8a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsMember_a05b3516-f34e-4939-873e-96600675be01" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:to="loc_ifrs-full_PlanAssetsMember_a05b3516-f34e-4939-873e-96600675be01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UncertaintiesOverIncomeTaxTreatmentsMember_db95bb40-62bd-4906-bffe-e792cd0a447a" xlink:href="sny-20221231.xsd#sny_UncertaintiesOverIncomeTaxTreatmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_296b2748-a27d-4ee8-ad44-d7c117ffb736" xlink:to="loc_sny_UncertaintiesOverIncomeTaxTreatmentsMember_db95bb40-62bd-4906-bffe-e792cd0a447a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_5f1d022f-bcbc-4777-ab52-1e823bc61411" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_5f1d022f-bcbc-4777-ab52-1e823bc61411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_1d799e11-7b00-4eab-88c9-9a96e1791537" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_5f1d022f-bcbc-4777-ab52-1e823bc61411" xlink:to="loc_ifrs-full_OtherProvisionsMember_1d799e11-7b00-4eab-88c9-9a96e1791537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NewBusinessModelRolloutInVariousGeographiesMember_69dacef5-9afb-4ad3-825f-b312ae4b10f6" xlink:href="sny-20221231.xsd#sny_NewBusinessModelRolloutInVariousGeographiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_1d799e11-7b00-4eab-88c9-9a96e1791537" xlink:to="loc_sny_NewBusinessModelRolloutInVariousGeographiesMember_69dacef5-9afb-4ad3-825f-b312ae4b10f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherEnvironmentRelatedProvisionMember_843d9ced-b83c-4299-95c5-8508838277bc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherEnvironmentRelatedProvisionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_1d799e11-7b00-4eab-88c9-9a96e1791537" xlink:to="loc_ifrs-full_OtherEnvironmentRelatedProvisionMember_843d9ced-b83c-4299-95c5-8508838277bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_a21c5666-4f4d-4adb-8903-28bdd83ca722" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_a21c5666-4f4d-4adb-8903-28bdd83ca722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_9e333b61-1517-4e45-a2ef-a92848ce037e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_a21c5666-4f4d-4adb-8903-28bdd83ca722" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_9e333b61-1517-4e45-a2ef-a92848ce037e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EvotecMember_08f727a9-7d64-4d2d-a4de-2224a20997ed" xlink:href="sny-20221231.xsd#sny_EvotecMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_9e333b61-1517-4e45-a2ef-a92848ce037e" xlink:to="loc_sny_EvotecMember_08f727a9-7d64-4d2d-a4de-2224a20997ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_f2b1c005-66f6-40a6-b967-da1009c43ee2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_MaturityAxis_f2b1c005-66f6-40a6-b967-da1009c43ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_fe814282-8ea7-4c65-a464-70cb5cd55d2d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_f2b1c005-66f6-40a6-b967-da1009c43ee2" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_fe814282-8ea7-4c65-a464-70cb5cd55d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearMember_c1454241-e51d-41f9-b859-e0388c50c39f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_fe814282-8ea7-4c65-a464-70cb5cd55d2d" xlink:to="loc_ifrs-full_LaterThanOneYearMember_c1454241-e51d-41f9-b859-e0388c50c39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_b33bbddd-5d17-43e9-887b-56c31b8235c7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_b33bbddd-5d17-43e9-887b-56c31b8235c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_27235a40-04cb-45a7-914f-13428ffe939a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_b33bbddd-5d17-43e9-887b-56c31b8235c7" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_27235a40-04cb-45a7-914f-13428ffe939a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_USLegalRestructuringMember_8e3df5f2-e342-41d9-8624-bfcaeea48ff6" xlink:href="sny-20221231.xsd#sny_USLegalRestructuringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_27235a40-04cb-45a7-914f-13428ffe939a" xlink:to="loc_sny_USLegalRestructuringMember_8e3df5f2-e342-41d9-8624-bfcaeea48ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:href="sny-20221231.xsd#sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_2c67b05e-fb7b-4e9e-8fcc-a579cbc3863c" xlink:to="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCountriesIncludedInPensionPlans_ea0f1517-6047-4b26-abe8-3066feec7ce7" xlink:href="sny-20221231.xsd#sny_NumberOfCountriesIncludedInPensionPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_NumberOfCountriesIncludedInPensionPlans_ea0f1517-6047-4b26-abe8-3066feec7ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionObligationPercentageToDefinedBenefitLiability_8142a284-5bcf-4f0c-b9f0-834a8f652c44" xlink:href="sny-20221231.xsd#sny_PensionObligationPercentageToDefinedBenefitLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_PensionObligationPercentageToDefinedBenefitLiability_8142a284-5bcf-4f0c-b9f0-834a8f652c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionObligationPercentageToPlanAssets_3748aa06-5d53-4cc0-afbd-f6ead9011e50" xlink:href="sny-20221231.xsd#sny_PensionObligationPercentageToPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_PensionObligationPercentageToPlanAssets_3748aa06-5d53-4cc0-afbd-f6ead9011e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling_eab7b5f5-4da3-4ac9-bc75-3a2bfb52288c" xlink:href="sny-20221231.xsd#sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling_eab7b5f5-4da3-4ac9-bc75-3a2bfb52288c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_74f6f5f4-261a-467f-9dcc-1cfdcdba126b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_74f6f5f4-261a-467f-9dcc-1cfdcdba126b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfDefinedBenefitPlans_a6fc5ab3-ab1b-4394-bb4c-9e93b6175c09" xlink:href="sny-20221231.xsd#sny_NumberOfDefinedBenefitPlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_NumberOfDefinedBenefitPlans_a6fc5ab3-ab1b-4394-bb4c-9e93b6175c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_5cf9bea2-ca2f-42dc-adc1-a9fc911b2d20" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_5cf9bea2-ca2f-42dc-adc1-a9fc911b2d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefinedBenefitPlansVestingRightsPercentage_cf103393-7981-4131-9a6a-9195ec4e14ba" xlink:href="sny-20221231.xsd#sny_DefinedBenefitPlansVestingRightsPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_DefinedBenefitPlansVestingRightsPercentage_cf103393-7981-4131-9a6a-9195ec4e14ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RetirementAge_8fb5d91a-9413-4b44-b2b7-930561b542d5" xlink:href="sny-20221231.xsd#sny_RetirementAge"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_RetirementAge_8fb5d91a-9413-4b44-b2b7-930561b542d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NotionalRetirementAge_3c43a8d2-578b-4076-84d9-8c3e946b8f49" xlink:href="sny-20221231.xsd#sny_NotionalRetirementAge"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_NotionalRetirementAge_3c43a8d2-578b-4076-84d9-8c3e946b8f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans_42f39342-8d75-44ca-850b-d248404ed0d5" xlink:href="sny-20221231.xsd#sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans_42f39342-8d75-44ca-850b-d248404ed0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod_2025cb63-69a6-4575-a1ea-46697d86fced" xlink:href="sny-20221231.xsd#sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod_2025cb63-69a6-4575-a1ea-46697d86fced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths_32ef2021-c649-4ded-ab88-c1be70b26b76" xlink:href="sny-20221231.xsd#sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths_32ef2021-c649-4ded-ab88-c1be70b26b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive_0c485deb-43b8-43be-97ed-a07c751e2d3d" xlink:href="sny-20221231.xsd#sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive_0c485deb-43b8-43be-97ed-a07c751e2d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_2da36488-5106-434b-a32b-0bf072ec6e2f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_2da36488-5106-434b-a32b-0bf072ec6e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod_cca9773f-7789-4010-928b-ade9d93a6470" xlink:href="sny-20221231.xsd#sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod_cca9773f-7789-4010-928b-ade9d93a6470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LiabilityRecognizedRepresentingEstimatedCost_106ebe33-59e6-450e-bb6a-6c2bc652c8ee" xlink:href="sny-20221231.xsd#sny_LiabilityRecognizedRepresentingEstimatedCost"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_LiabilityRecognizedRepresentingEstimatedCost_106ebe33-59e6-450e-bb6a-6c2bc652c8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_d0197d44-e0fe-42f9-b2ac-e6a63c7721b5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_d0197d44-e0fe-42f9-b2ac-e6a63c7721b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised_7710e668-abda-40d1-8d8a-3057a9558142" xlink:href="sny-20221231.xsd#sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised_7710e668-abda-40d1-8d8a-3057a9558142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CapitalLossesCarryBackPeriod_5d3c0781-e71b-4381-b9a2-5936fe652ae7" xlink:href="sny-20221231.xsd#sny_CapitalLossesCarryBackPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_CapitalLossesCarryBackPeriod_5d3c0781-e71b-4381-b9a2-5936fe652ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CapitalLossesUsedAgainstCapitalGainsPercentage_900c6636-a359-4bf8-bd1d-dca8833a4feb" xlink:href="sny-20221231.xsd#sny_CapitalLossesUsedAgainstCapitalGainsPercentage"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_2d2b3bfa-1baf-4772-ba11-f9370ca8bec5" xlink:to="loc_sny_CapitalLossesUsedAgainstCapitalGainsPercentage_900c6636-a359-4bf8-bd1d-dca8833a4feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_5c71b1da-3b1d-45fe-a869-634cb731bbf6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_00efd1b5-a6b1-483e-897a-cdf55df32c7c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_5c71b1da-3b1d-45fe-a869-634cb731bbf6" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_00efd1b5-a6b1-483e-897a-cdf55df32c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_a6fc76c3-815a-4279-bdeb-b0e4c2bd2d67" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_00efd1b5-a6b1-483e-897a-cdf55df32c7c" xlink:to="loc_ifrs-full_GeographicalAreasAxis_a6fc76c3-815a-4279-bdeb-b0e4c2bd2d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_a6fc76c3-815a-4279-bdeb-b0e4c2bd2d67" xlink:to="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_9c034e78-572d-42d0-9af2-c8d5a3192744" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:to="loc_country_FR_9c034e78-572d-42d0-9af2-c8d5a3192744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_087cd224-1867-4ffe-b123-cd2a52799f2a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:to="loc_country_DE_087cd224-1867-4ffe-b123-cd2a52799f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_370b2968-6cec-45bc-9239-40af8c0d081a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:to="loc_country_US_370b2968-6cec-45bc-9239-40af8c0d081a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_37fc1b8a-fcbf-4ba9-abf1-f18c44664712" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_1972023b-1019-494e-95a1-28b29d23fff3" xlink:to="loc_country_GB_37fc1b8a-fcbf-4ba9-abf1-f18c44664712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_1d307ac0-86a4-44b0-886c-1b28fca2eb25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_00efd1b5-a6b1-483e-897a-cdf55df32c7c" xlink:to="loc_ifrs-full_RangeAxis_1d307ac0-86a4-44b0-886c-1b28fca2eb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_1d307ac0-86a4-44b0-886c-1b28fca2eb25" xlink:to="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_e18e6cfc-c52a-4d39-b1de-9c64cf1f7c57" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_ifrs-full_BottomOfRangeMember_e18e6cfc-c52a-4d39-b1de-9c64cf1f7c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_641f554d-817c-4065-81a3-82eef638796d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_ifrs-full_TopOfRangeMember_641f554d-817c-4065-81a3-82eef638796d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinimumPlan1Member_7aced359-e6e0-4884-9cd5-61d3479c943e" xlink:href="sny-20221231.xsd#sny_MinimumPlan1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_sny_MinimumPlan1Member_7aced359-e6e0-4884-9cd5-61d3479c943e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumPlan1Member_36e303fa-2c6e-49a1-9934-a369608dcf39" xlink:href="sny-20221231.xsd#sny_MaximumPlan1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_sny_MaximumPlan1Member_36e303fa-2c6e-49a1-9934-a369608dcf39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MinimumPlan2Member_df4e527e-c8b9-44a2-9ddc-140d2d177518" xlink:href="sny-20221231.xsd#sny_MinimumPlan2Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_sny_MinimumPlan2Member_df4e527e-c8b9-44a2-9ddc-140d2d177518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumPlan2Member_585ee70e-8775-4e27-8e7d-a211ce944399" xlink:href="sny-20221231.xsd#sny_MaximumPlan2Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_b8aa1dd0-f9f6-4b7f-9207-b0e068837fca" xlink:to="loc_sny_MaximumPlan2Member_585ee70e-8775-4e27-8e7d-a211ce944399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_00efd1b5-a6b1-483e-897a-cdf55df32c7c" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_9aaa1b3a-5007-4d7a-acf5-deb22c60f402" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_9aaa1b3a-5007-4d7a-acf5-deb22c60f402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_f9fb74a5-f903-4b13-b50e-ab1214e6cbf6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_f9fb74a5-f903-4b13-b50e-ab1214e6cbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_18a0c3fd-f3e5-4d83-bac3-d89938c6a42d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_18a0c3fd-f3e5-4d83-bac3-d89938c6a42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates_98990ea6-c15b-422c-8e43-59391b7796f2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates_98990ea6-c15b-422c-8e43-59391b7796f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange_3598600e-f810-44e4-a0be-cce9d0e3e6b2" xlink:href="sny-20221231.xsd#sny_ActuarialAssumptionOfRetirementAgeBottomOfRange"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange_3598600e-f810-44e4-a0be-cce9d0e3e6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialAssumptionOfRetirementAgeTopOfRange_8ece1789-578b-4796-9491-fd34435c4856" xlink:href="sny-20221231.xsd#sny_ActuarialAssumptionOfRetirementAgeTopOfRange"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_sny_ActuarialAssumptionOfRetirementAgeTopOfRange_8ece1789-578b-4796-9491-fd34435c4856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_90324afa-db7b-4ded-8c2b-23e3e15cd368" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_bbff259a-81a8-483e-861c-6559937f9e4f" xlink:to="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_90324afa-db7b-4ded-8c2b-23e3e15cd368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7b8f40e3-3e82-475e-8e9d-0737311d8f16" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_cfb86bb2-1e79-498c-b950-42f27c08cd84" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7b8f40e3-3e82-475e-8e9d-0737311d8f16" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_cfb86bb2-1e79-498c-b950-42f27c08cd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_fc9c7526-4ff1-433f-8714-954022b9ca6c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_cfb86bb2-1e79-498c-b950-42f27c08cd84" xlink:to="loc_ifrs-full_GeographicalAreasAxis_fc9c7526-4ff1-433f-8714-954022b9ca6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_fc9c7526-4ff1-433f-8714-954022b9ca6c" xlink:to="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_081f3381-1b0f-4558-81fe-4f29b03d593c" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:to="loc_country_FR_081f3381-1b0f-4558-81fe-4f29b03d593c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_8becaea5-91bc-436b-ba58-c79e6b2c99fa" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:to="loc_country_DE_8becaea5-91bc-436b-ba58-c79e6b2c99fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_52ff9997-b61e-4c2a-9d94-cd7652879da4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:to="loc_country_US_52ff9997-b61e-4c2a-9d94-cd7652879da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_73ea2580-b091-48b8-8b93-eca809e8ad05" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_8dac1bc3-67cc-43b5-aaeb-43028cc21005" xlink:to="loc_country_GB_73ea2580-b091-48b8-8b93-eca809e8ad05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_74ce87d4-9854-4644-98c3-3b0a3ab03727" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_cfb86bb2-1e79-498c-b950-42f27c08cd84" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_74ce87d4-9854-4644-98c3-3b0a3ab03727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_4f0ee3a3-e1a2-47a0-a1a2-c58ce233faf8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_74ce87d4-9854-4644-98c3-3b0a3ab03727" xlink:to="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_4f0ee3a3-e1a2-47a0-a1a2-c58ce233faf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_dec674b0-b5ca-4353-af4e-7c743ca2b370" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_5ed73301-f66c-4bf3-a8cb-06dc63c01593" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_dec674b0-b5ca-4353-af4e-7c743ca2b370" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_5ed73301-f66c-4bf3-a8cb-06dc63c01593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_cb271761-07a2-4131-aedf-c2a26088fbea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_5ed73301-f66c-4bf3-a8cb-06dc63c01593" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_cb271761-07a2-4131-aedf-c2a26088fbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_cb271761-07a2-4131-aedf-c2a26088fbea" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_fff9e774-0bf0-41b8-8b89-b54c80c8c205" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:to="loc_country_FR_fff9e774-0bf0-41b8-8b89-b54c80c8c205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_b574c252-77e2-4dac-8259-bc7c3fe864cc" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:to="loc_country_DE_b574c252-77e2-4dac-8259-bc7c3fe864cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d2658667-8620-43fd-b7dc-d59e07187908" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:to="loc_country_US_d2658667-8620-43fd-b7dc-d59e07187908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_fd9bb928-0728-4475-9067-84444fc119d4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_887012f6-343d-4d71-ba99-9b4225911810" xlink:to="loc_country_GB_fd9bb928-0728-4475-9067-84444fc119d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis_357e1f2c-33b6-4c92-b501-627763ba2b6d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_5ed73301-f66c-4bf3-a8cb-06dc63c01593" xlink:to="loc_ifrs-full_ActuarialAssumptionsAxis_357e1f2c-33b6-4c92-b501-627763ba2b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_357e1f2c-33b6-4c92-b501-627763ba2b6d" xlink:to="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_52486c28-d847-489e-9037-01edbedebd5f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_52486c28-d847-489e-9037-01edbedebd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_a88e1bfb-5be7-4b16-80fd-3a6f0b6c98ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_a88e1bfb-5be7-4b16-80fd-3a6f0b6c98ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_808854b4-9949-4e8b-8a0a-69cecb858cd6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_808854b4-9949-4e8b-8a0a-69cecb858cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember_cbc26c96-8364-4bcf-acc2-f11c04c1539d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:to="loc_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember_cbc26c96-8364-4bcf-acc2-f11c04c1539d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActuarialAssumptionOfMortalityTableMember_e7b3bd4c-4fe0-4352-97ec-e322c20e466d" xlink:href="sny-20221231.xsd#sny_ActuarialAssumptionOfMortalityTableMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsMember_a8648e9b-2aff-4fad-bda5-bf287edfea57" xlink:to="loc_sny_ActuarialAssumptionOfMortalityTableMember_e7b3bd4c-4fe0-4352-97ec-e322c20e466d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_5ed73301-f66c-4bf3-a8cb-06dc63c01593" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_1ced9c31-758c-40cf-baf7-c36a849e3672" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_1ced9c31-758c-40cf-baf7-c36a849e3672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_b0afcfe9-615a-4065-b1bd-6da0b3a526d4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_b0afcfe9-615a-4065-b1bd-6da0b3a526d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_35d7bc7b-e8f5-4c90-9cb2-9d10dee059f7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_35d7bc7b-e8f5-4c90-9cb2-9d10dee059f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PossibleIncreaseInMortalityTableInYears_c0915316-ff26-4f4d-9e5f-f29c34286558" xlink:href="sny-20221231.xsd#sny_PossibleIncreaseInMortalityTableInYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_ce6ea3ca-9075-41ad-b78b-05aa50de653f" xlink:to="loc_sny_PossibleIncreaseInMortalityTableInYears_c0915316-ff26-4f4d-9e5f-f29c34286558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_448ce63d-a821-4a63-95c3-4c3270552fbc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_448ce63d-a821-4a63-95c3-4c3270552fbc" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_ea93c465-0322-4348-b5d3-d8aba829a26a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_ea93c465-0322-4348-b5d3-d8aba829a26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_32db38cb-3ed3-4d15-b986-5591bdc27262" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_ea93c465-0322-4348-b5d3-d8aba829a26a" xlink:to="loc_ifrs-full_OtherProvisionsMember_32db38cb-3ed3-4d15-b986-5591bdc27262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember_fcbdb788-ecb2-4fcc-bb3c-074169646b98" xlink:href="sny-20221231.xsd#sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_32db38cb-3ed3-4d15-b986-5591bdc27262" xlink:to="loc_sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember_fcbdb788-ecb2-4fcc-bb3c-074169646b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_86610256-167c-4fbc-84d0-8629131dfe5c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_86610256-167c-4fbc-84d0-8629131dfe5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_36028c8e-c379-4908-807e-9f44641a44c1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_86610256-167c-4fbc-84d0-8629131dfe5c" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_36028c8e-c379-4908-807e-9f44641a44c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_c2b7b27b-1d39-48af-8722-af8556937d37" xlink:href="sny-20221231.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_36028c8e-c379-4908-807e-9f44641a44c1" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_c2b7b27b-1d39-48af-8722-af8556937d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_c1cc2119-f9ab-46d5-8934-f003676f097a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_c1cc2119-f9ab-46d5-8934-f003676f097a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_45bd11fe-db64-4400-bdb0-bf2768c803ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_c1cc2119-f9ab-46d5-8934-f003676f097a" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_45bd11fe-db64-4400-bdb0-bf2768c803ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_3d6069a6-5870-4c3f-be0b-723c41e3037c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_45bd11fe-db64-4400-bdb0-bf2768c803ef" xlink:to="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_3d6069a6-5870-4c3f-be0b-723c41e3037c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsMember_23e49292-432d-42ae-9826-3440603fbe18" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_45bd11fe-db64-4400-bdb0-bf2768c803ef" xlink:to="loc_ifrs-full_PlanAssetsMember_23e49292-432d-42ae-9826-3440603fbe18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfAssetCeilingMember_276b49d5-2356-4c3c-a726-d94717fdc95f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfAssetCeilingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_45bd11fe-db64-4400-bdb0-bf2768c803ef" xlink:to="loc_ifrs-full_EffectOfAssetCeilingMember_276b49d5-2356-4c3c-a726-d94717fdc95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_e5f471ca-90c4-4e4f-8312-b6d0b43bd0db" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:to="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_e5f471ca-90c4-4e4f-8312-b6d0b43bd0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_c1a000a9-dcf2-403a-9172-bd43ee6411e1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_e5f471ca-90c4-4e4f-8312-b6d0b43bd0db" xlink:to="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_c1a000a9-dcf2-403a-9172-bd43ee6411e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember_cd166355-7667-427a-95b5-87fe07e46a8f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_c1a000a9-dcf2-403a-9172-bd43ee6411e1" xlink:to="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember_cd166355-7667-427a-95b5-87fe07e46a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_de2b184e-8fc9-4eac-8728-4cfbd1a54625" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_de2b184e-8fc9-4eac-8728-4cfbd1a54625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_4c8fcda1-bad2-4182-87db-cee7837b5344" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_de2b184e-8fc9-4eac-8728-4cfbd1a54625" xlink:to="loc_ifrs-full_GeographicalAreasMember_4c8fcda1-bad2-4182-87db-cee7837b5344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_ecaf12be-7027-485d-b83e-1b0bc33e113a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_4c8fcda1-bad2-4182-87db-cee7837b5344" xlink:to="loc_country_GB_ecaf12be-7027-485d-b83e-1b0bc33e113a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_6d42a799-977f-439a-9e2d-190b0bf31bf1" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_0c4e2d91-9b00-4c33-a1b1-d8cf50906266" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_0c4e2d91-9b00-4c33-a1b1-d8cf50906266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_6b8d5880-618f-40b2-a8ee-6ec0c9d0e22a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_6b8d5880-618f-40b2-a8ee-6ec0c9d0e22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_e8c8c007-9a0b-4f28-bed0-fc991319472b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_e8c8c007-9a0b-4f28-bed0-fc991319472b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_55015121-69e6-4e68-80dc-40f8fd7fd656" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_55015121-69e6-4e68-80dc-40f8fd7fd656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_6db6c496-8e37-4977-bbcb-96832de6574c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_6db6c496-8e37-4977-bbcb-96832de6574c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_2a9388bd-6588-47b1-9da8-d4ab74c687fe" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_2a9388bd-6588-47b1-9da8-d4ab74c687fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan_44f25bde-88c2-46b5-9173-f4872f6ba010" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan_44f25bde-88c2-46b5-9173-f4872f6ba010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset_65240598-b557-46cf-bb48-22cfaa562f82" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset_65240598-b557-46cf-bb48-22cfaa562f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BenefitsPaidOrPayable_80fbb06a-819d-4213-a0f0-582e792cfc7f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BenefitsPaidOrPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_BenefitsPaidOrPayable_80fbb06a-819d-4213-a0f0-582e792cfc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset_53d58f13-c70a-4d83-bd61-f2087da92a1e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset_53d58f13-c70a-4d83-bd61-f2087da92a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_bdf2cb1f-91be-41fe-9d7d-bebbe269163e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_bdf2cb1f-91be-41fe-9d7d-bebbe269163e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_4bd8f19d-c963-428f-bd20-3777315dad81" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_4bd8f19d-c963-428f-bd20-3777315dad81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod_2fbc9046-17b4-4997-a16c-a3a43982ea3b" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod_2fbc9046-17b4-4997-a16c-a3a43982ea3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_47d39579-b256-4149-a17c-21268cd9d51c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_47d39579-b256-4149-a17c-21268cd9d51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_c96e88f4-f9ad-4b0b-a000-905372721d47" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_c96e88f4-f9ad-4b0b-a000-905372721d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_b705c691-9f84-4348-a994-4397f35cbfdb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_b705c691-9f84-4348-a994-4397f35cbfdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_c781939e-ce01-4623-8fa4-3e4fa5a7fa01" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_c781939e-ce01-4623-8fa4-3e4fa5a7fa01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PreFundedPensionObligations_3c7b72e8-9cb4-48b0-bbc1-28c44cce41d7" xlink:href="sny-20221231.xsd#sny_PreFundedPensionObligations"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_PreFundedPensionObligations_3c7b72e8-9cb4-48b0-bbc1-28c44cce41d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions_d597f63c-98b4-475a-b3f6-af9964c91e6d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_NoncurrentProvisions_d597f63c-98b4-475a-b3f6-af9964c91e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_1262a557-72cf-4ca6-8baf-0719731d4794" xlink:href="sny-20221231.xsd#sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_1262a557-72cf-4ca6-8baf-0719731d4794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_40191547-fd24-44f3-b631-faaa790903c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_40191547-fd24-44f3-b631-faaa790903c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_071f7d7c-3264-4b6c-ba88-94d3fffb592a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_071f7d7c-3264-4b6c-ba88-94d3fffb592a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeeBenefitsExpenseGain_79c0da97-9889-4ec6-8337-1e258e14f0c7" xlink:href="sny-20221231.xsd#sny_EmployeeBenefitsExpenseGain"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_c297001c-0c72-4949-b313-7178e57ca3e0" xlink:to="loc_sny_EmployeeBenefitsExpenseGain_79c0da97-9889-4ec6-8337-1e258e14f0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_1fed6757-8858-4992-93f2-95ab59169341" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_01a08aa3-0271-4ac3-9223-e63f808d970c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_1fed6757-8858-4992-93f2-95ab59169341" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_01a08aa3-0271-4ac3-9223-e63f808d970c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_3cbe9058-f3ae-4fc6-9fc9-9e5aae5da216" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_01a08aa3-0271-4ac3-9223-e63f808d970c" xlink:to="loc_ifrs-full_GeographicalAreasAxis_3cbe9058-f3ae-4fc6-9fc9-9e5aae5da216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_3cbe9058-f3ae-4fc6-9fc9-9e5aae5da216" xlink:to="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_00a7371a-a7cf-4e80-b7db-c9541e15118e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:to="loc_country_FR_00a7371a-a7cf-4e80-b7db-c9541e15118e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_994035c8-c511-42e9-a749-b65defae4236" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:to="loc_country_DE_994035c8-c511-42e9-a749-b65defae4236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_231cff0e-7fe7-4d3c-b00a-070d2f29beda" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:to="loc_country_US_231cff0e-7fe7-4d3c-b00a-070d2f29beda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_254e0dd0-9417-4f58-b138-2ba74eb7b5da" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:to="loc_country_GB_254e0dd0-9417-4f58-b138-2ba74eb7b5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_0941630f-881c-4954-b7f0-20b8a2205413" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_43df2d9e-5f1c-43cf-aad1-d801cdde9e1d" xlink:to="loc_sny_OtherCountriesMember_0941630f-881c-4954-b7f0-20b8a2205413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_6ec01ed6-3e5d-48d1-9293-bc231bd4070b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_01a08aa3-0271-4ac3-9223-e63f808d970c" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_6ec01ed6-3e5d-48d1-9293-bc231bd4070b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_7693b71f-d019-4302-9902-f0de685c59d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_6ec01ed6-3e5d-48d1-9293-bc231bd4070b" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_7693b71f-d019-4302-9902-f0de685c59d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_be7a4f11-5fcc-4e9a-8261-11c7acc6fbf3" xlink:href="sny-20221231.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_7693b71f-d019-4302-9902-f0de685c59d0" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_be7a4f11-5fcc-4e9a-8261-11c7acc6fbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_01a08aa3-0271-4ac3-9223-e63f808d970c" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_d265d183-ff0a-431a-84d6-ec588b3e22a6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_d265d183-ff0a-431a-84d6-ec588b3e22a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_a2e98ba2-4f42-4a54-bf7e-7a48f408e5e5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_a2e98ba2-4f42-4a54-bf7e-7a48f408e5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlanAssetsEffectOfAssetCeiling_5abb4943-a531-424f-8b10-dc2b5509197a" xlink:href="sny-20221231.xsd#sny_PlanAssetsEffectOfAssetCeiling"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:to="loc_sny_PlanAssetsEffectOfAssetCeiling_5abb4943-a531-424f-8b10-dc2b5509197a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_7c052601-98a1-4c7e-9576-8ffd85aa9f48" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_ccf507d1-9759-44ef-a36b-b46b5eed77d0" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_7c052601-98a1-4c7e-9576-8ffd85aa9f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_a95a8fb4-b34d-4b04-9f09-165f76085fd0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_6a5435ed-d88a-427d-ab17-323368f7e800" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_a95a8fb4-b34d-4b04-9f09-165f76085fd0" xlink:to="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_6a5435ed-d88a-427d-ab17-323368f7e800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_e2e43bca-2fab-4ac0-b455-bf9f06c1ccf0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_6a5435ed-d88a-427d-ab17-323368f7e800" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_e2e43bca-2fab-4ac0-b455-bf9f06c1ccf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_e2e43bca-2fab-4ac0-b455-bf9f06c1ccf0" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CashAndCashEquivalentsMember_849a4d9e-8cd7-4177-88b0-60ec08ebc070" xlink:href="sny-20221231.xsd#sny_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_CashAndCashEquivalentsMember_849a4d9e-8cd7-4177-88b0-60ec08ebc070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInstrumentsMember_17d6a1c8-964e-4458-8866-a2752d69a235" xlink:href="sny-20221231.xsd#sny_EquityInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_EquityInstrumentsMember_17d6a1c8-964e-4458-8866-a2752d69a235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BondsAndSimilarInstrumentsMember_ceb72cdd-5c8d-442d-a010-daffd5736f0b" xlink:href="sny-20221231.xsd#sny_BondsAndSimilarInstrumentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_BondsAndSimilarInstrumentsMember_ceb72cdd-5c8d-442d-a010-daffd5736f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RealEstateMember_2746e415-9e2a-4408-a132-30c237b63838" xlink:href="sny-20221231.xsd#sny_RealEstateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_RealEstateMember_2746e415-9e2a-4408-a132-30c237b63838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativesMember_a3de2377-5be5-411e-bdae-cacb01dbd0cd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_ifrs-full_DerivativesMember_a3de2377-5be5-411e-bdae-cacb01dbd0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommoditiesMember_6da30f9d-a6a2-45ed-bb73-aca7f574631f" xlink:href="sny-20221231.xsd#sny_CommoditiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_CommoditiesMember_6da30f9d-a6a2-45ed-bb73-aca7f574631f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAssetsMember_13e27b80-cbec-4431-94cf-d0222a829ed6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAssetsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_ifrs-full_OtherAssetsMember_13e27b80-cbec-4431-94cf-d0222a829ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HedgeFundsMember_3c5f9f3b-9c59-4d46-8b8d-a23769602fd8" xlink:href="sny-20221231.xsd#sny_HedgeFundsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_HedgeFundsMember_3c5f9f3b-9c59-4d46-8b8d-a23769602fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InsurancePoliciesMember_58572f42-5bbd-4a68-a4d2-2ade8d23a3ff" xlink:href="sny-20221231.xsd#sny_InsurancePoliciesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_598f03a0-cf48-467f-8524-85d264619c14" xlink:to="loc_sny_InsurancePoliciesMember_58572f42-5bbd-4a68-a4d2-2ade8d23a3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_bce7093d-5095-46fd-b38b-ea42a832eb25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_6a5435ed-d88a-427d-ab17-323368f7e800" xlink:to="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_bce7093d-5095-46fd-b38b-ea42a832eb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket_bd70f479-4745-4a92-b8a7-d929424ed501" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_bce7093d-5095-46fd-b38b-ea42a832eb25" xlink:to="loc_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket_bd70f479-4745-4a92-b8a7-d929424ed501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities_b7c6af37-7389-4561-ba56-2f4189a1d288" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_bce7093d-5095-46fd-b38b-ea42a832eb25" xlink:to="loc_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities_b7c6af37-7389-4561-ba56-2f4189a1d288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageContributedToFairValueOfPlanAssets_08d8f6b8-350c-4e0e-86e8-22a24d1781aa" xlink:href="sny-20221231.xsd#sny_PercentageContributedToFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_bce7093d-5095-46fd-b38b-ea42a832eb25" xlink:to="loc_sny_PercentageContributedToFairValueOfPlanAssets_08d8f6b8-350c-4e0e-86e8-22a24d1781aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_dce4ab9b-58ed-481a-b7f4-bf410d0fa2c4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_69f172ee-717e-48b7-bdd4-5fff2e8ec205" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_dce4ab9b-58ed-481a-b7f4-bf410d0fa2c4" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_69f172ee-717e-48b7-bdd4-5fff2e8ec205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_4e193c2f-bb0c-4b51-8fe2-772bf52c31b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_69f172ee-717e-48b7-bdd4-5fff2e8ec205" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_4e193c2f-bb0c-4b51-8fe2-772bf52c31b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_85f51fdf-15c5-493d-815a-b691f42be464" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_4e193c2f-bb0c-4b51-8fe2-772bf52c31b8" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_85f51fdf-15c5-493d-815a-b691f42be464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_9ff4697e-41cb-4a22-8bc3-f4b0531532c1" xlink:href="sny-20221231.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_85f51fdf-15c5-493d-815a-b691f42be464" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_9ff4697e-41cb-4a22-8bc3-f4b0531532c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_d0ecbe3c-60e5-4a8d-9bba-e1c565a4878c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_69f172ee-717e-48b7-bdd4-5fff2e8ec205" xlink:to="loc_ifrs-full_GeographicalAreasAxis_d0ecbe3c-60e5-4a8d-9bba-e1c565a4878c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_d0ecbe3c-60e5-4a8d-9bba-e1c565a4878c" xlink:to="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_d801568f-a84c-4b66-b888-9ef67257e405" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:to="loc_country_FR_d801568f-a84c-4b66-b888-9ef67257e405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_d33103d8-e489-41a4-a2c8-577d8c248f49" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:to="loc_country_DE_d33103d8-e489-41a4-a2c8-577d8c248f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_30e1ca4d-806f-4e0e-bd09-a4dfe965ec34" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:to="loc_country_US_30e1ca4d-806f-4e0e-bd09-a4dfe965ec34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_7eecb800-56d5-458c-b3be-e830e1d4c8a1" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:to="loc_country_GB_7eecb800-56d5-458c-b3be-e830e1d4c8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_3d2dffeb-3c29-4dfc-81a7-2866e36194e6" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_aa561b8f-3a33-43c2-aaeb-4e54ec09d468" xlink:to="loc_sny_OtherCountriesMember_3d2dffeb-3c29-4dfc-81a7-2866e36194e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_69f172ee-717e-48b7-bdd4-5fff2e8ec205" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_de810da9-e77b-4051-838c-1e74a21350f0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_de810da9-e77b-4051-838c-1e74a21350f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement_4741fe7c-cbfd-4e7a-a287-2bdb789acdc5" xlink:href="sny-20221231.xsd#sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement_4741fe7c-cbfd-4e7a-a287-2bdb789acdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset_921e69a1-ac4e-495c-a436-fb74d36d0365" xlink:href="sny-20221231.xsd#sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset_921e69a1-ac4e-495c-a436-fb74d36d0365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_8334f96a-3b35-4e11-be93-98e1d17e772b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_8334f96a-3b35-4e11-be93-98e1d17e772b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_79106108-026f-4561-962c-237b9cb3f9eb" xlink:href="sny-20221231.xsd#sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_79106108-026f-4561-962c-237b9cb3f9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_153b8c0a-ecc5-45b8-9129-aad104c292e9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_153b8c0a-ecc5-45b8-9129-aad104c292e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset_1ddf6181-d98f-4ff9-a1b4-4e550a720bed" xlink:href="sny-20221231.xsd#sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_013cc761-85eb-4c74-b9a8-8c679a0599ef" xlink:to="loc_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset_1ddf6181-d98f-4ff9-a1b4-4e550a720bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_382b7bea-8b74-48db-890e-6342b4474e6e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_eafde9b0-27d5-4309-be48-039677bcc194" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_382b7bea-8b74-48db-890e-6342b4474e6e" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_eafde9b0-27d5-4309-be48-039677bcc194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_176b9a72-0fb3-4d4c-af9c-67929de61989" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_eafde9b0-27d5-4309-be48-039677bcc194" xlink:to="loc_ifrs-full_GeographicalAreasAxis_176b9a72-0fb3-4d4c-af9c-67929de61989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_176b9a72-0fb3-4d4c-af9c-67929de61989" xlink:to="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_f4f27a46-2b49-4c5e-8db2-0dc9343490e7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:to="loc_country_FR_f4f27a46-2b49-4c5e-8db2-0dc9343490e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_5975236f-5bd8-4f8f-a516-077b6c33cd09" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:to="loc_country_DE_5975236f-5bd8-4f8f-a516-077b6c33cd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_65ac12c4-52dd-43a2-81e7-05be8ebcc07a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:to="loc_country_US_65ac12c4-52dd-43a2-81e7-05be8ebcc07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_5b2ec49f-c073-43fb-b240-36d046f4e3bb" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_868c25c7-2bc3-4b94-9bcc-45fd84880ac5" xlink:to="loc_country_GB_5b2ec49f-c073-43fb-b240-36d046f4e3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_eafde9b0-27d5-4309-be48-039677bcc194" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_16cc47dd-48c6-437c-a706-269561cde616" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_16cc47dd-48c6-437c-a706-269561cde616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments_09a13f10-092d-4f4c-a39c-608de1d44a8e" xlink:href="sny-20221231.xsd#sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:to="loc_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments_09a13f10-092d-4f4c-a39c-608de1d44a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_66416f0a-d609-4c2d-b744-20e6e5398d51" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_66416f0a-d609-4c2d-b744-20e6e5398d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_75b9d660-0e7a-41b5-8155-f9fa70fa252b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_8eaa9b29-65ca-4ae6-a32c-4ac584eb87ee" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_75b9d660-0e7a-41b5-8155-f9fa70fa252b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNetPretaxActuarialLossDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNetPretaxActuarialLossDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNetPretaxActuarialLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8f6efee2-f51b-43a5-8d0b-cadc599e86ce" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity_5998cc11-9a4d-412f-a6bf-19db14c76ae3" xlink:href="sny-20221231.xsd#sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8f6efee2-f51b-43a5-8d0b-cadc599e86ce" xlink:to="loc_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity_5998cc11-9a4d-412f-a6bf-19db14c76ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_2f2e95d1-e4b0-4984-a5b5-bd21faf76c6a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_e258db30-785c-4661-b541-51d8433c3c76" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_2f2e95d1-e4b0-4984-a5b5-bd21faf76c6a" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_e258db30-785c-4661-b541-51d8433c3c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_37ca10af-0e0a-41ea-b4a9-31d880343b1e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_e258db30-785c-4661-b541-51d8433c3c76" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_37ca10af-0e0a-41ea-b4a9-31d880343b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_82f2bb17-b0d2-4169-a8c9-ce8d271da2d1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_37ca10af-0e0a-41ea-b4a9-31d880343b1e" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_82f2bb17-b0d2-4169-a8c9-ce8d271da2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_a7c01065-73b8-453d-80e5-e3b2ce1d7a43" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_82f2bb17-b0d2-4169-a8c9-ce8d271da2d1" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_a7c01065-73b8-453d-80e5-e3b2ce1d7a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_74da1634-98ad-45a0-8e6b-92be973b2c54" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember_82f2bb17-b0d2-4169-a8c9-ce8d271da2d1" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_74da1634-98ad-45a0-8e6b-92be973b2c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_fecb05b2-0491-4661-ab5e-63a25745347b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_e258db30-785c-4661-b541-51d8433c3c76" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_fecb05b2-0491-4661-ab5e-63a25745347b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_1d06b4bb-8503-4f78-bad5-9ce38a6e9602" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_fecb05b2-0491-4661-ab5e-63a25745347b" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_1d06b4bb-8503-4f78-bad5-9ce38a6e9602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_3da4a288-9b81-4e21-a4eb-7f1d72fc8750" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetMember_1d06b4bb-8503-4f78-bad5-9ce38a6e9602" xlink:to="loc_ifrs-full_PresentValueOfDefinedBenefitObligationMember_3da4a288-9b81-4e21-a4eb-7f1d72fc8750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_8cdc95dd-125b-49b3-a3ac-e749649e786d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_e258db30-785c-4661-b541-51d8433c3c76" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_8cdc95dd-125b-49b3-a3ac-e749649e786d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_f6721200-ac81-4d4b-bda1-ef53724e795a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_8cdc95dd-125b-49b3-a3ac-e749649e786d" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_f6721200-ac81-4d4b-bda1-ef53724e795a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_26fa8fb9-94f2-48d6-a297-5b548db5b6de" xlink:href="sny-20221231.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_f6721200-ac81-4d4b-bda1-ef53724e795a" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_26fa8fb9-94f2-48d6-a297-5b548db5b6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_fd66c71d-c20a-44e7-859b-b417d65d526a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_e258db30-785c-4661-b541-51d8433c3c76" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_fd66c71d-c20a-44e7-859b-b417d65d526a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_2890f3b8-2c86-43a1-b475-b82631043311" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_fd66c71d-c20a-44e7-859b-b417d65d526a" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_2890f3b8-2c86-43a1-b475-b82631043311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_06b5aa88-cd46-448b-8619-37e6c4db6322" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_edbdea08-0f34-41cf-80a3-b76bbda65f03" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_06b5aa88-cd46-448b-8619-37e6c4db6322" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_edbdea08-0f34-41cf-80a3-b76bbda65f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_4fb79044-2c45-467a-a07a-fec9fd98a02b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_edbdea08-0f34-41cf-80a3-b76bbda65f03" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_4fb79044-2c45-467a-a07a-fec9fd98a02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansMember_ca0e7567-8f20-476e-bf0e-c474ddb33d1a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_4fb79044-2c45-467a-a07a-fec9fd98a02b" xlink:to="loc_ifrs-full_DefinedBenefitPlansMember_ca0e7567-8f20-476e-bf0e-c474ddb33d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_5c3d29c3-e6c8-43e9-b242-7b9c825b7d5e" xlink:href="sny-20221231.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansMember_ca0e7567-8f20-476e-bf0e-c474ddb33d1a" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_5c3d29c3-e6c8-43e9-b242-7b9c825b7d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_edbdea08-0f34-41cf-80a3-b76bbda65f03" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_32f4d0d3-d1bd-4f47-80fd-7b6c6d1f21c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_ifrs-full_CostOfSales_32f4d0d3-d1bd-4f47-80fd-7b6c6d1f21c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_eb210d37-4835-4ceb-a8ac-ba4261bcc0ec" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_eb210d37-4835-4ceb-a8ac-ba4261bcc0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_7c5f1df9-e46d-4cf9-9131-1327864eb91f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_7c5f1df9-e46d-4cf9-9131-1327864eb91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_3d3a5e66-dc06-49bc-9314-550c9df7c294" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_3d3a5e66-dc06-49bc-9314-550c9df7c294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RestructuringCostsReversedAndSimilarItems_157e5f63-3054-4a46-a57d-92287d5a0578" xlink:href="sny-20221231.xsd#sny_RestructuringCostsReversedAndSimilarItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_sny_RestructuringCostsReversedAndSimilarItems_157e5f63-3054-4a46-a57d-92287d5a0578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_e53e73cb-3f77-4c8d-abde-d9f14adcdaa7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_ifrs-full_FinanceCosts_e53e73cb-3f77-4c8d-abde-d9f14adcdaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_83174792-ccc2-4aa4-b0af-77f2d89326bb" xlink:href="sny-20221231.xsd#sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_607b82e7-bc42-4cd0-bf02-3e2ff544d246" xlink:to="loc_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss_83174792-ccc2-4aa4-b0af-77f2d89326bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_eff90cf0-8636-469d-b5b4-f875882e598b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_7c949e9f-2176-4ed4-b996-cbc28099caf2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_eff90cf0-8636-469d-b5b4-f875882e598b" xlink:to="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_7c949e9f-2176-4ed4-b996-cbc28099caf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_1ac98a73-af1d-4c79-96bd-f2f3ee764ea8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_7c949e9f-2176-4ed4-b996-cbc28099caf2" xlink:to="loc_ifrs-full_MaturityAxis_1ac98a73-af1d-4c79-96bd-f2f3ee764ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_4784ddd4-c04c-40df-93ec-2ad54058e2a0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1ac98a73-af1d-4c79-96bd-f2f3ee764ea8" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_4784ddd4-c04c-40df-93ec-2ad54058e2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1246bb44-7a56-4413-a597-f169cca083c1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_4784ddd4-c04c-40df-93ec-2ad54058e2a0" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1246bb44-7a56-4413-a597-f169cca083c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_7601698f-e492-4c61-b84e-5f7c30dcf1af" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_7c949e9f-2176-4ed4-b996-cbc28099caf2" xlink:to="loc_ifrs-full_GeographicalAreasAxis_7601698f-e492-4c61-b84e-5f7c30dcf1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_7601698f-e492-4c61-b84e-5f7c30dcf1af" xlink:to="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_506ff827-4a4d-4ed8-824e-7811aa4d19a2" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:to="loc_country_FR_506ff827-4a4d-4ed8-824e-7811aa4d19a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_08ccb6e7-49c9-42a7-9306-f8682ecc06bc" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:to="loc_country_DE_08ccb6e7-49c9-42a7-9306-f8682ecc06bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_067cf2c1-32eb-4955-9fce-5c76bf5ebb8e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:to="loc_country_US_067cf2c1-32eb-4955-9fce-5c76bf5ebb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_0d4aa447-e969-4876-b7b2-774b90ae361a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:to="loc_country_GB_0d4aa447-e969-4876-b7b2-774b90ae361a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_a6911e70-0d4e-492b-b108-7842e094938e" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_2bcfba7e-31dc-414c-ab7d-50d8f7f9e32c" xlink:to="loc_sny_OtherCountriesMember_a6911e70-0d4e-492b-b108-7842e094938e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_7bdd0735-c227-4a8e-a304-b52e63282979" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsTable_7c949e9f-2176-4ed4-b996-cbc28099caf2" xlink:to="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_7bdd0735-c227-4a8e-a304-b52e63282979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_2bc515cb-f14d-4df5-8f14-f7e61d14acc7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems_7bdd0735-c227-4a8e-a304-b52e63282979" xlink:to="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_2bc515cb-f14d-4df5-8f14-f7e61d14acc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_454f4493-6005-4a0d-8c7a-bf91c7104a68" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7745c565-804e-4663-87f3-eccadb74d371" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_454f4493-6005-4a0d-8c7a-bf91c7104a68" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7745c565-804e-4663-87f3-eccadb74d371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_066d93dc-0187-4640-97dc-0fa34878e2fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7745c565-804e-4663-87f3-eccadb74d371" xlink:to="loc_ifrs-full_GeographicalAreasAxis_066d93dc-0187-4640-97dc-0fa34878e2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_066d93dc-0187-4640-97dc-0fa34878e2fb" xlink:to="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_d3f5273e-a33d-4a7f-97fe-41b2e8773bd3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:to="loc_country_FR_d3f5273e-a33d-4a7f-97fe-41b2e8773bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_852c7c9e-e826-4582-aedc-5c26d61f8a05" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:to="loc_country_DE_852c7c9e-e826-4582-aedc-5c26d61f8a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3503a368-92d1-41a3-8d83-a1c7de7e0500" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:to="loc_country_US_3503a368-92d1-41a3-8d83-a1c7de7e0500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_7ce51c67-4423-4b68-bdf9-e6e1611940e4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:to="loc_country_GB_7ce51c67-4423-4b68-bdf9-e6e1611940e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_7e29d10e-2ef6-43fc-a0a5-083df9ea8269" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_52d44592-4756-47d0-9960-76f93b5e67ee" xlink:to="loc_sny_OtherCountriesMember_7e29d10e-2ef6-43fc-a0a5-083df9ea8269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_d5964443-fc38-4da9-8dad-f2f3a18d2546" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7745c565-804e-4663-87f3-eccadb74d371" xlink:to="loc_ifrs-full_MaturityAxis_d5964443-fc38-4da9-8dad-f2f3a18d2546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_d5964443-fc38-4da9-8dad-f2f3a18d2546" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_9e9d39da-5639-4297-b664-3f4d8e9eea68" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_9e9d39da-5639-4297-b664-3f4d8e9eea68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0b35cdc4-229b-438e-9883-c3a54a8f6e82" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0b35cdc4-229b-438e-9883-c3a54a8f6e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_bf64394c-6dff-41df-abd8-2fde8f321211" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_bf64394c-6dff-41df-abd8-2fde8f321211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_a7d93fa0-7616-4508-afa0-199b2da6ae46" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_a7d93fa0-7616-4508-afa0-199b2da6ae46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_bfff070f-e96b-4766-b965-625302edd2a9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_bfff070f-e96b-4766-b965-625302edd2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember_95db2740-1cf0-4c8e-9d0f-0951949621f0" xlink:href="sny-20221231.xsd#sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_0d987c39-e2fe-48c3-bf67-741926dfbf09" xlink:to="loc_sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember_95db2740-1cf0-4c8e-9d0f-0951949621f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_682ed4d7-d95e-4f02-819c-176662f8b338" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7745c565-804e-4663-87f3-eccadb74d371" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_682ed4d7-d95e-4f02-819c-176662f8b338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans_cfa2c89f-f16f-4fc9-8911-c26d043bbbb1" xlink:href="sny-20221231.xsd#sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_682ed4d7-d95e-4f02-819c-176662f8b338" xlink:to="loc_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans_cfa2c89f-f16f-4fc9-8911-c26d043bbbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_fc1a1924-3b8b-465b-beb0-eb927b9c3271" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_e851d647-dc38-418e-8bb9-89d92af1c9c2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_fc1a1924-3b8b-465b-beb0-eb927b9c3271" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_e851d647-dc38-418e-8bb9-89d92af1c9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_7a46211b-fd3d-4f33-be9e-b26f83ac121c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_e851d647-dc38-418e-8bb9-89d92af1c9c2" xlink:to="loc_ifrs-full_MaturityAxis_7a46211b-fd3d-4f33-be9e-b26f83ac121c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_7a46211b-fd3d-4f33-be9e-b26f83ac121c" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_060142cf-8692-4441-a44b-bcbb57c85d14" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_060142cf-8692-4441-a44b-bcbb57c85d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_35c5b656-f29d-453e-af38-54803995116b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_35c5b656-f29d-453e-af38-54803995116b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_96908cb4-8e76-4529-92ce-353163d15f71" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_96908cb4-8e76-4529-92ce-353163d15f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_5fdeb9ec-b274-4843-986d-ffb5fbdd18a2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_d56a1734-f6aa-48ba-ae3a-4af069a53246" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_5fdeb9ec-b274-4843-986d-ffb5fbdd18a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_e53fea17-3135-4849-88b3-0c471f7165f9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_e851d647-dc38-418e-8bb9-89d92af1c9c2" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_e53fea17-3135-4849-88b3-0c471f7165f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans_8d3b620e-a662-4796-87b3-9d605b1833ac" xlink:href="sny-20221231.xsd#sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_e53fea17-3135-4849-88b3-0c471f7165f9" xlink:to="loc_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans_8d3b620e-a662-4796-87b3-9d605b1833ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_21e74f3c-5c3a-484b-ab5c-d70227ad6d78" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringProvisionsTable_5461ce1c-399d-4df1-bc2f-605382e68e33" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringProvisionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_21e74f3c-5c3a-484b-ab5c-d70227ad6d78" xlink:to="loc_sny_DisclosureOfRestructuringProvisionsTable_5461ce1c-399d-4df1-bc2f-605382e68e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_5e1b76f7-a4ef-4303-9891-fafa9124bc81" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsTable_5461ce1c-399d-4df1-bc2f-605382e68e33" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_5e1b76f7-a4ef-4303-9891-fafa9124bc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_92a9c261-bb73-4d66-9eb8-22c3dfe8bdbf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_5e1b76f7-a4ef-4303-9891-fafa9124bc81" xlink:to="loc_ifrs-full_OtherProvisionsMember_92a9c261-bb73-4d66-9eb8-22c3dfe8bdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestructuringProvisionMember_b61caf38-9eeb-4cca-ab03-5e7f8316149f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RestructuringProvisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_92a9c261-bb73-4d66-9eb8-22c3dfe8bdbf" xlink:to="loc_ifrs-full_RestructuringProvisionMember_b61caf38-9eeb-4cca-ab03-5e7f8316149f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:href="sny-20221231.xsd#sny_DisclosureOfRestructuringProvisionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsTable_5461ce1c-399d-4df1-bc2f-605382e68e33" xlink:to="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_431a71ef-ead8-411a-9006-3d55ad70ce8c" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_431a71ef-ead8-411a-9006-3d55ad70ce8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestructuringProvisionAbstract_c9ee52bb-1fd9-400a-ab05-1732e999ac96" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RestructuringProvisionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_ifrs-full_RestructuringProvisionAbstract_c9ee52bb-1fd9-400a-ab05-1732e999ac96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermRestructuringProvision_d8d4e35a-eb48-490f-b667-5154f3703dc1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermRestructuringProvision"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RestructuringProvisionAbstract_c9ee52bb-1fd9-400a-ab05-1732e999ac96" xlink:to="loc_ifrs-full_LongtermRestructuringProvision_d8d4e35a-eb48-490f-b667-5154f3703dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermRestructuringProvision_d27823e8-378a-424a-b942-4c24952956e2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermRestructuringProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RestructuringProvisionAbstract_c9ee52bb-1fd9-400a-ab05-1732e999ac96" xlink:to="loc_ifrs-full_ShorttermRestructuringProvision_d27823e8-378a-424a-b942-4c24952956e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod_39eca69d-bcba-4e3b-a2ea-2df5b48c79e1" xlink:href="sny-20221231.xsd#sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod_39eca69d-bcba-4e3b-a2ea-2df5b48c79e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions_0b1b1ee7-e6d1-4957-92bd-74d106b5c227" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProvisionUsedOtherProvisions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_ifrs-full_ProvisionUsedOtherProvisions_0b1b1ee7-e6d1-4957-92bd-74d106b5c227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_776b7b60-544f-41c7-9ed6-1eaf2042053f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_776b7b60-544f-41c7-9ed6-1eaf2042053f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UnwindingOfDiscount_62dc3867-2599-405c-a450-b6c7d90a0fe2" xlink:href="sny-20221231.xsd#sny_UnwindingOfDiscount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_sny_UnwindingOfDiscount_62dc3867-2599-405c-a450-b6c7d90a0fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_fe507da7-1bb1-4344-910b-46c182965c41" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_fe507da7-1bb1-4344-910b-46c182965c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_a93f0ef6-10cc-4286-b842-7e2a931f3c70" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfRestructuringProvisionsLineItems_8722fd8a-dfa3-471d-b2bd-bd413e23c974" xlink:to="loc_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities_a93f0ef6-10cc-4286-b842-7e2a931f3c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_3f1bd0ac-c7a5-41d8-8832-337aed88cecf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_5bcc23c0-76a5-441e-90e8-faf14ff0e356" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_3f1bd0ac-c7a5-41d8-8832-337aed88cecf" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_5bcc23c0-76a5-441e-90e8-faf14ff0e356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_19dd80b6-aa95-4ae7-a9cb-a35170cfe23c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_5bcc23c0-76a5-441e-90e8-faf14ff0e356" xlink:to="loc_ifrs-full_GeographicalAreasAxis_19dd80b6-aa95-4ae7-a9cb-a35170cfe23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_cf9f51ac-0ffb-4062-b205-be3b3efc2d16" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_19dd80b6-aa95-4ae7-a9cb-a35170cfe23c" xlink:to="loc_ifrs-full_GeographicalAreasMember_cf9f51ac-0ffb-4062-b205-be3b3efc2d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_1c248eff-fd38-443f-a0a0-279422acd13a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_cf9f51ac-0ffb-4062-b205-be3b3efc2d16" xlink:to="loc_country_FR_1c248eff-fd38-443f-a0a0-279422acd13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_84ca4617-6493-4ae0-a841-dd19ee1de08d" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_cf9f51ac-0ffb-4062-b205-be3b3efc2d16" xlink:to="loc_sny_OtherCountriesMember_84ca4617-6493-4ae0-a841-dd19ee1de08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_ad2b4845-b134-412f-ba6b-a2ee2dbfd6e1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_5bcc23c0-76a5-441e-90e8-faf14ff0e356" xlink:to="loc_ifrs-full_MaturityAxis_ad2b4845-b134-412f-ba6b-a2ee2dbfd6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_ad2b4845-b134-412f-ba6b-a2ee2dbfd6e1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_86838806-c9f5-4b7d-b39e-7bb4f485fea6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_86838806-c9f5-4b7d-b39e-7bb4f485fea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_1623644a-2413-4192-85c7-9ba51effa75f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_1623644a-2413-4192-85c7-9ba51effa75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_3b307f28-f7cd-488a-9f0e-164da652ac87" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_3b307f28-f7cd-488a-9f0e-164da652ac87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_d212e820-9404-43d2-b43d-cd7dd9fd6144" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_5fdf05bf-7035-4b20-a6d9-fedc4366c5f5" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_d212e820-9404-43d2-b43d-cd7dd9fd6144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_02571359-3b1d-4aba-8d2a-4d98c110a812" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_5bcc23c0-76a5-441e-90e8-faf14ff0e356" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_02571359-3b1d-4aba-8d2a-4d98c110a812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_6a2bacdd-3385-46ec-b2e2-50068dce2079" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_02571359-3b1d-4aba-8d2a-4d98c110a812" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_6a2bacdd-3385-46ec-b2e2-50068dce2079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_924d6a35-be46-4ecd-8c68-8745b332a4c9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsAbstract_cae124de-487e-4d42-a944-e5a3fa4751ed" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherProvisionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_924d6a35-be46-4ecd-8c68-8745b332a4c9" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsAbstract_cae124de-487e-4d42-a944-e5a3fa4751ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionForEnvironmentRisks_df6d1b4e-8eaf-4a62-bc9d-33d913c46d08" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionForEnvironmentRisks"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsAbstract_cae124de-487e-4d42-a944-e5a3fa4751ed" xlink:to="loc_sny_NonCurrentProvisionForEnvironmentRisks_df6d1b4e-8eaf-4a62-bc9d-33d913c46d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_6ba23e38-389d-4251-a068-a4d94021ab97" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsAbstract_cae124de-487e-4d42-a944-e5a3fa4751ed" xlink:to="loc_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_6ba23e38-389d-4251-a068-a4d94021ab97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherLongtermProvisions_553dacd4-034b-4fd6-af5e-717053517a7c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherLongtermProvisions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsAbstract_cae124de-487e-4d42-a944-e5a3fa4751ed" xlink:to="loc_ifrs-full_OtherLongtermProvisions_553dacd4-034b-4fd6-af5e-717053517a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_dd1a376a-d8ae-4cc8-bfe6-202904b0d199" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:to="loc_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_dd1a376a-d8ae-4cc8-bfe6-202904b0d199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_8854a174-5b5a-4082-980f-7cc8b4b37ea1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_8854a174-5b5a-4082-980f-7cc8b4b37ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermRestructuringProvision_f3ca5a9c-e4cb-46e7-b547-61e458c0129d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermRestructuringProvision"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:to="loc_ifrs-full_ShorttermRestructuringProvision_f3ca5a9c-e4cb-46e7-b547-61e458c0129d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentInterestRateDerivativesPayable_5911303a-60bc-4aae-9620-05500e6fd3b7" xlink:href="sny-20221231.xsd#sny_CurrentInterestRateDerivativesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:to="loc_sny_CurrentInterestRateDerivativesPayable_5911303a-60bc-4aae-9620-05500e6fd3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentCurrencyDerivativesPayable_99dc665b-565c-4700-ada8-e90eff0d9eb2" xlink:href="sny-20221231.xsd#sny_CurrentCurrencyDerivativesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:to="loc_sny_CurrentCurrencyDerivativesPayable_99dc665b-565c-4700-ada8-e90eff0d9eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentEquityDerivativesPayable_bd4de6f5-e650-45d7-b816-382a76fb2477" xlink:href="sny-20221231.xsd#sny_CurrentEquityDerivativesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:to="loc_sny_CurrentEquityDerivativesPayable_bd4de6f5-e650-45d7-b816-382a76fb2477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmountsPayableForAcquisitionOfNonCurrentAssets_616ebcc6-e954-4a1d-a500-b356fc321ed6" xlink:href="sny-20221231.xsd#sny_AmountsPayableForAcquisitionOfNonCurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:to="loc_sny_AmountsPayableForAcquisitionOfNonCurrentAssets_616ebcc6-e954-4a1d-a500-b356fc321ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilities_7df64fee-1fed-4be5-8354-2f1b1aa340b4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentContractLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:to="loc_ifrs-full_CurrentContractLiabilities_7df64fee-1fed-4be5-8354-2f1b1aa340b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentLiabilities_036e4481-31dd-4640-9b5e-338237f6e7a1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:to="loc_ifrs-full_OtherCurrentLiabilities_036e4481-31dd-4640-9b5e-338237f6e7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_1c765b24-d153-4ef4-9548-54d5e6008fee" xlink:href="sny-20221231.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:to="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_1c765b24-d153-4ef4-9548-54d5e6008fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_a1be62e5-e51b-4cfc-9e9b-561e94fbfe7b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_b2cce1e5-c5c1-4a38-9efd-cfdc23e7a00c" xlink:to="loc_ifrs-full_ContractLiabilities_a1be62e5-e51b-4cfc-9e9b-561e94fbfe7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_2e518a65-1896-47d9-97c6-6124b5e58172" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_3577d988-4506-44e1-b53d-e5bd0b3cae34" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCreditRiskExposureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_2e518a65-1896-47d9-97c6-6124b5e58172" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_3577d988-4506-44e1-b53d-e5bd0b3cae34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_04998d15-4e49-479f-9088-b53d129f784b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_3577d988-4506-44e1-b53d-e5bd0b3cae34" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_04998d15-4e49-479f-9088-b53d129f784b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_04998d15-4e49-479f-9088-b53d129f784b" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesMember_24276e95-4ea6-4332-be63-804f5a048fd4" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:to="loc_sny_CurrencyDerivativesMember_24276e95-4ea6-4332-be63-804f5a048fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesOperatingMember_2d222ff4-0573-40aa-8c42-446c035cc9fc" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesOperatingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:to="loc_sny_CurrencyDerivativesOperatingMember_2d222ff4-0573-40aa-8c42-446c035cc9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyDerivativesFinancialMember_35ab92ee-3f3b-421a-bdc0-91cfbc262fbf" xlink:href="sny-20221231.xsd#sny_CurrencyDerivativesFinancialMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:to="loc_sny_CurrencyDerivativesFinancialMember_35ab92ee-3f3b-421a-bdc0-91cfbc262fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateDerivativesMember_0fe749f9-13b1-4e9c-845e-47d7863d9688" xlink:href="sny-20221231.xsd#sny_InterestRateDerivativesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:to="loc_sny_InterestRateDerivativesMember_0fe749f9-13b1-4e9c-845e-47d7863d9688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityDerivativesMember_1b063748-44e1-4675-8fee-5f221345a18f" xlink:href="sny-20221231.xsd#sny_EquityDerivativesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_9637cca0-a755-4d0f-8287-efd9437c63a9" xlink:to="loc_sny_EquityDerivativesMember_1b063748-44e1-4675-8fee-5f221345a18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_3577d988-4506-44e1-b53d-e5bd0b3cae34" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_7cca82be-b976-48de-95fe-12c6d9f1f797" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_7cca82be-b976-48de-95fe-12c6d9f1f797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialAssets_085f20bc-77f2-4170-a7ae-5ea4b43515ac" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDerivativeFinancialAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialAssets_085f20bc-77f2-4170-a7ae-5ea4b43515ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_369edde5-6c78-4a77-887e-a7833cefc6ae" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_369edde5-6c78-4a77-887e-a7833cefc6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_a4716640-9cb1-45de-9db5-fa495e48bd72" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_a4716640-9cb1-45de-9db5-fa495e48bd72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_a26a2e79-b3f4-4061-b4c0-c9f0421e8f70" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_a26a2e79-b3f4-4061-b4c0-c9f0421e8f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_5f6836f9-54f6-4c6d-827c-cf5d441cac6b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_5f6836f9-54f6-4c6d-827c-cf5d441cac6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_146f2aa7-594c-423e-a7b6-68e4fc38baf7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_09708a9f-97ba-405e-b801-4bc928e4bff5" xlink:to="loc_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_146f2aa7-594c-423e-a7b6-68e4fc38baf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_a5ade4a0-837d-4eef-9c44-434ef4eb7cc0" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_0a8eb863-6bb6-4b1f-81b9-7c52c4078836" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_a5ade4a0-837d-4eef-9c44-434ef4eb7cc0" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_0a8eb863-6bb6-4b1f-81b9-7c52c4078836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_fad87a0f-47d9-46c4-b147-0656595e9627" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_0a8eb863-6bb6-4b1f-81b9-7c52c4078836" xlink:to="loc_ifrs-full_MeasurementAxis_fad87a0f-47d9-46c4-b147-0656595e9627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_9ff9b38e-274d-435d-8df1-d52a7256f149" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_fad87a0f-47d9-46c4-b147-0656595e9627" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_9ff9b38e-274d-435d-8df1-d52a7256f149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtNotionalAmountMember_bc69ae38-909b-4ccb-b42f-81accf736c2a" xlink:href="sny-20221231.xsd#sny_AtNotionalAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_9ff9b38e-274d-435d-8df1-d52a7256f149" xlink:to="loc_sny_AtNotionalAmountMember_bc69ae38-909b-4ccb-b42f-81accf736c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AtFairValueMember_26e431f4-0288-4423-8594-1a5705b45089" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AtFairValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_9ff9b38e-274d-435d-8df1-d52a7256f149" xlink:to="loc_ifrs-full_AtFairValueMember_26e431f4-0288-4423-8594-1a5705b45089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfHedgeRecognizedInEquityMember_4c4a659c-ad0b-42fe-8f5e-0e2fb41465ba" xlink:href="sny-20221231.xsd#sny_ValueOfHedgeRecognizedInEquityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_9ff9b38e-274d-435d-8df1-d52a7256f149" xlink:to="loc_sny_ValueOfHedgeRecognizedInEquityMember_4c4a659c-ad0b-42fe-8f5e-0e2fb41465ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_5c75b8ae-5779-405c-9c03-7e5fe329526b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_0a8eb863-6bb6-4b1f-81b9-7c52c4078836" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_5c75b8ae-5779-405c-9c03-7e5fe329526b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesMember_970a7859-27e4-4746-9654-390cab03dc6c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_5c75b8ae-5779-405c-9c03-7e5fe329526b" xlink:to="loc_ifrs-full_TypesOfHedgesMember_970a7859-27e4-4746-9654-390cab03dc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowHedgesMember_4059c3ed-86b2-4d7e-b571-df431d1da052" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesMember_970a7859-27e4-4746-9654-390cab03dc6c" xlink:to="loc_ifrs-full_CashFlowHedgesMember_4059c3ed-86b2-4d7e-b571-df431d1da052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NotEligibleForHedgeAccountingMember_df90d907-01eb-4b5c-99b0-6b4d68fce51c" xlink:href="sny-20221231.xsd#sny_NotEligibleForHedgeAccountingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesMember_970a7859-27e4-4746-9654-390cab03dc6c" xlink:to="loc_sny_NotEligibleForHedgeAccountingMember_df90d907-01eb-4b5c-99b0-6b4d68fce51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_fcc739ef-38a8-46bc-a54b-0ab23f9d0223" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_0a8eb863-6bb6-4b1f-81b9-7c52c4078836" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_fcc739ef-38a8-46bc-a54b-0ab23f9d0223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_40c22908-f10f-4079-bd8e-5df99408c291" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_fcc739ef-38a8-46bc-a54b-0ab23f9d0223" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_40c22908-f10f-4079-bd8e-5df99408c291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_40c22908-f10f-4079-bd8e-5df99408c291" xlink:to="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInUSDollarMember_ec01ecbd-0474-4efc-a2be-447cfbe7f776" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInUSDollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInUSDollarMember_ec01ecbd-0474-4efc-a2be-447cfbe7f776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember_eeb15a7d-5e3d-4923-8274-3e9b168f235f" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInChineseYuanRenminbiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember_eeb15a7d-5e3d-4923-8274-3e9b168f235f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInJapaneseYenMember_5f791a42-ca6b-4d3a-9d1d-8c204ab8d53b" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInJapaneseYenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInJapaneseYenMember_5f791a42-ca6b-4d3a-9d1d-8c204ab8d53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInSingaporeDollarMember_3c9d39ec-fae8-4216-9e35-a80e29d11bb4" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInSingaporeDollarMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInSingaporeDollarMember_3c9d39ec-fae8-4216-9e35-a80e29d11bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInKoreanWonMember_21019995-4acd-44cc-8753-e53f22248802" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInKoreanWonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInKoreanWonMember_21019995-4acd-44cc-8753-e53f22248802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInTaiwanDollarMember_35e6a433-2a1e-4aa4-bbda-656e6c0dbfeb" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInTaiwanDollarMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInTaiwanDollarMember_35e6a433-2a1e-4aa4-bbda-656e6c0dbfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInMexicanPesoMember_8ce79c85-cb93-4f59-a5a9-a0ea2454df71" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInMexicanPesoMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_49a0a027-843e-467e-8179-a77be7230d88" xlink:to="loc_sny_ForwardCurrencySalesInMexicanPesoMember_8ce79c85-cb93-4f59-a5a9-a0ea2454df71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_40c22908-f10f-4079-bd8e-5df99408c291" xlink:to="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInUSDollarMember_0911f82b-32e6-4431-90b9-0c1a4ac13c59" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInUSDollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInUSDollarMember_0911f82b-32e6-4431-90b9-0c1a4ac13c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInSingaporeDollarMember_bb1dbd07-ca9b-4f8a-82f2-62f84d8fc55d" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInSingaporeDollarMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInSingaporeDollarMember_bb1dbd07-ca9b-4f8a-82f2-62f84d8fc55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember_f5767738-30a1-4db1-abe0-7af2ef7a53e9" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember_f5767738-30a1-4db1-abe0-7af2ef7a53e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInKoreanWonMember_5520cc28-47c9-4004-b292-66d3a7de5292" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInKoreanWonMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInKoreanWonMember_5520cc28-47c9-4004-b292-66d3a7de5292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInHungarianForintMember_89922387-ac90-431e-850c-4e2c6ca479da" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInHungarianForintMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInHungarianForintMember_89922387-ac90-431e-850c-4e2c6ca479da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInTaiwanDollarMember_a3df6d83-5c4d-4827-81f0-4385e2cb5d69" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInTaiwanDollarMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInTaiwanDollarMember_a3df6d83-5c4d-4827-81f0-4385e2cb5d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInRussianRoubleMember_b5dde2cc-6344-4d6f-9ac6-8e797c0bba1d" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInRussianRoubleMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInRussianRoubleMember_b5dde2cc-6344-4d6f-9ac6-8e797c0bba1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInJapaneseYenMember_9bcd1ab7-214e-4c09-b938-3bc769556c57" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInJapaneseYenMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_4deec75c-40cb-4fdb-88f5-923b5c1bf8d9" xlink:to="loc_sny_ForwardCurrencyPurchasedInJapaneseYenMember_9bcd1ab7-214e-4c09-b938-3bc769556c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_8d51c95c-3ce4-4fe8-ad90-c2be40dda3e9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_0a8eb863-6bb6-4b1f-81b9-7c52c4078836" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_8d51c95c-3ce4-4fe8-ad90-c2be40dda3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialInstruments_8a47a39f-a173-4e80-a1a2-909146195b73" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialInstruments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_8d51c95c-3ce4-4fe8-ad90-c2be40dda3e9" xlink:to="loc_sny_DerivativeFinancialInstruments_8a47a39f-a173-4e80-a1a2-909146195b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_373bf1ba-61b1-4393-960f-9245609f3fef" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_12304a20-9f7b-4dfa-a010-f654ba095d2c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_373bf1ba-61b1-4393-960f-9245609f3fef" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_12304a20-9f7b-4dfa-a010-f654ba095d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_6c69e95e-e215-4564-8a2e-a6423ad85596" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_12304a20-9f7b-4dfa-a010-f654ba095d2c" xlink:to="loc_ifrs-full_MeasurementAxis_6c69e95e-e215-4564-8a2e-a6423ad85596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_86b703e9-c2c3-45e2-b524-e51c88153530" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_6c69e95e-e215-4564-8a2e-a6423ad85596" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_86b703e9-c2c3-45e2-b524-e51c88153530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtNotionalAmountMember_439f180c-96fd-450f-a11e-ac0776efd1a6" xlink:href="sny-20221231.xsd#sny_AtNotionalAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_86b703e9-c2c3-45e2-b524-e51c88153530" xlink:to="loc_sny_AtNotionalAmountMember_439f180c-96fd-450f-a11e-ac0776efd1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AtFairValueMember_af1fe89e-97c1-4792-b664-4030b3315ea3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AtFairValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_86b703e9-c2c3-45e2-b524-e51c88153530" xlink:to="loc_ifrs-full_AtFairValueMember_af1fe89e-97c1-4792-b664-4030b3315ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_f7624de4-5d5c-4155-bc53-f10b7e516b1c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_12304a20-9f7b-4dfa-a010-f654ba095d2c" xlink:to="loc_ifrs-full_MaturityAxis_f7624de4-5d5c-4155-bc53-f10b7e516b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_d701f750-6307-4bfd-842f-e162dd87ba23" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_f7624de4-5d5c-4155-bc53-f10b7e516b1c" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_d701f750-6307-4bfd-842f-e162dd87ba23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_fa423711-d1f4-468c-88e2-7d0b19f84904" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_d701f750-6307-4bfd-842f-e162dd87ba23" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_fa423711-d1f4-468c-88e2-7d0b19f84904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_d27e369e-faa3-42c8-8c59-a7b6e3bad358" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_12304a20-9f7b-4dfa-a010-f654ba095d2c" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_d27e369e-faa3-42c8-8c59-a7b6e3bad358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_0a8e7b19-a2bd-47ef-9b05-7945bbd885f3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_d27e369e-faa3-42c8-8c59-a7b6e3bad358" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_0a8e7b19-a2bd-47ef-9b05-7945bbd885f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesMember_473dcc83-bcaf-4437-8cdd-7c72b24ab8bc" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_0a8e7b19-a2bd-47ef-9b05-7945bbd885f3" xlink:to="loc_sny_ForwardCurrencySalesMember_473dcc83-bcaf-4437-8cdd-7c72b24ab8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInUSDollarMember_5b2547e4-995a-4b9a-884a-15b3f53dabbb" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInUSDollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_473dcc83-bcaf-4437-8cdd-7c72b24ab8bc" xlink:to="loc_sny_ForwardCurrencySalesInUSDollarMember_5b2547e4-995a-4b9a-884a-15b3f53dabbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInPoundSterlingMember_51f37ff4-c24d-4ff7-9dc4-3e831dd0eb39" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInPoundSterlingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_473dcc83-bcaf-4437-8cdd-7c72b24ab8bc" xlink:to="loc_sny_ForwardCurrencySalesInPoundSterlingMember_51f37ff4-c24d-4ff7-9dc4-3e831dd0eb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencySalesInChineseYuanMember_4a2617c4-0503-4f5f-b166-b5c974289858" xlink:href="sny-20221231.xsd#sny_ForwardCurrencySalesInChineseYuanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_473dcc83-bcaf-4437-8cdd-7c72b24ab8bc" xlink:to="loc_sny_ForwardCurrencySalesInChineseYuanMember_4a2617c4-0503-4f5f-b166-b5c974289858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasesMember_e99d79f0-77ca-4731-ac32-89516cf22dc5" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_0a8e7b19-a2bd-47ef-9b05-7945bbd885f3" xlink:to="loc_sny_ForwardCurrencyPurchasesMember_e99d79f0-77ca-4731-ac32-89516cf22dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInUSDollarMember_fdcd44bc-e5fc-464c-9599-01d1821b1c48" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInUSDollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_e99d79f0-77ca-4731-ac32-89516cf22dc5" xlink:to="loc_sny_ForwardCurrencyPurchasedInUSDollarMember_fdcd44bc-e5fc-464c-9599-01d1821b1c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInSingaporeDollarMember_1733976c-6455-4aa6-b1a7-131d5bc98db0" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInSingaporeDollarMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_e99d79f0-77ca-4731-ac32-89516cf22dc5" xlink:to="loc_sny_ForwardCurrencyPurchasedInSingaporeDollarMember_1733976c-6455-4aa6-b1a7-131d5bc98db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ForwardCurrencyPurchasedInJapaneseYenMember_bef64f34-f49c-4d4e-95c8-b6cb1177c457" xlink:href="sny-20221231.xsd#sny_ForwardCurrencyPurchasedInJapaneseYenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_e99d79f0-77ca-4731-ac32-89516cf22dc5" xlink:to="loc_sny_ForwardCurrencyPurchasedInJapaneseYenMember_bef64f34-f49c-4d4e-95c8-b6cb1177c457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencySwapsInUSDToEURMember_bee969d7-b3d4-4a2a-af3a-fe5bf79992cd" xlink:href="sny-20221231.xsd#sny_CurrencySwapsInUSDToEURMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_0a8e7b19-a2bd-47ef-9b05-7945bbd885f3" xlink:to="loc_sny_CurrencySwapsInUSDToEURMember_bee969d7-b3d4-4a2a-af3a-fe5bf79992cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_12304a20-9f7b-4dfa-a010-f654ba095d2c" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure_101e9d74-777e-473a-a8d4-fdb7c646f0c6" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialInstrumentsToManageFinancialExposure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:to="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure_101e9d74-777e-473a-a8d4-fdb7c646f0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_785eea4e-b9cd-4ac1-98d7-7f66f52561e4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:to="loc_ifrs-full_NotionalAmount_785eea4e-b9cd-4ac1-98d7-7f66f52561e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_abf2a05f-22bc-4db8-a1f3-26356d7787cc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_abf2a05f-22bc-4db8-a1f3-26356d7787cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_5e497381-04c5-43a8-9c1d-5efe8aa7555f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_8b873580-752e-47ed-bc54-1d0799d6c178" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_5e497381-04c5-43a8-9c1d-5efe8aa7555f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_6ce023cd-2cfd-469d-bd0b-f89073d501be" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_6ce023cd-2cfd-469d-bd0b-f89073d501be" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_b8deaf1e-df93-4dc6-b6ac-d2ef82b4f7d8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_b8deaf1e-df93-4dc6-b6ac-d2ef82b4f7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgingInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_b8deaf1e-df93-4dc6-b6ac-d2ef82b4f7d8" xlink:to="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member_c63940e3-81bd-4810-992c-b4c0409eb40c" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member_c63940e3-81bd-4810-992c-b4c0409eb40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member_38cf341f-0753-4f68-9efc-bf81c814a429" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member_38cf341f-0753-4f68-9efc-bf81c814a429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member_010b6087-7db0-4bd3-b60f-765a979aab1f" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedEsterReceive069Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive069Member_010b6087-7db0-4bd3-b60f-765a979aab1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member_cb880321-7fc0-4d6a-8e05-3790308d6ddd" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member_cb880321-7fc0-4d6a-8e05-3790308d6ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember_ff084853-a483-4d3d-a8bf-bfa837d2cdb5" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember_ff084853-a483-4d3d-a8bf-bfa837d2cdb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member_40ff82cd-1461-4f1f-9865-1fedf6957599" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member_40ff82cd-1461-4f1f-9865-1fedf6957599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember_e77fc5c2-c4d7-4161-85fa-59064ac81368" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsMember_5bfe0aaf-165a-4381-8135-fee940c4e973" xlink:to="loc_sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember_e77fc5c2-c4d7-4161-85fa-59064ac81368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_079d4621-0bfb-4387-8caf-8d49858ac41f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:to="loc_ifrs-full_MeasurementAxis_079d4621-0bfb-4387-8caf-8d49858ac41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_911d2ef6-4ed9-4ffc-aa77-ccd142b2d7ab" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_079d4621-0bfb-4387-8caf-8d49858ac41f" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_911d2ef6-4ed9-4ffc-aa77-ccd142b2d7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtNotionalAmountMember_bba95202-009a-4f15-9a71-3d76c0d9c030" xlink:href="sny-20221231.xsd#sny_AtNotionalAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_911d2ef6-4ed9-4ffc-aa77-ccd142b2d7ab" xlink:to="loc_sny_AtNotionalAmountMember_bba95202-009a-4f15-9a71-3d76c0d9c030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AtFairValueMember_4880679f-2524-4b33-938c-e1e180df93ee" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AtFairValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_911d2ef6-4ed9-4ffc-aa77-ccd142b2d7ab" xlink:to="loc_ifrs-full_AtFairValueMember_4880679f-2524-4b33-938c-e1e180df93ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ValueOfHedgeRecognizedInEquityMember_f7a4feef-d971-4f4b-9b57-0f951713c4f2" xlink:href="sny-20221231.xsd#sny_ValueOfHedgeRecognizedInEquityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_911d2ef6-4ed9-4ffc-aa77-ccd142b2d7ab" xlink:to="loc_sny_ValueOfHedgeRecognizedInEquityMember_f7a4feef-d971-4f4b-9b57-0f951713c4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_21afab94-b0ec-4752-b729-00cea1538db7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:to="loc_ifrs-full_MaturityAxis_21afab94-b0ec-4752-b729-00cea1538db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_21afab94-b0ec-4752-b729-00cea1538db7" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_53a79416-a1cd-4c72-9db7-bb485c76797d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_53a79416-a1cd-4c72-9db7-bb485c76797d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_cf359405-35bf-4e1f-9831-2aa83433dbe3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_cf359405-35bf-4e1f-9831-2aa83433dbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_c1f57616-78d1-4342-b060-ed2c461553ea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_c1f57616-78d1-4342-b060-ed2c461553ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_95a1fcfc-2078-4731-9a2f-00bef215cc18" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_95a1fcfc-2078-4731-9a2f-00bef215cc18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_d0f03dd2-e49d-469c-b3f7-09d61b925516" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_d0f03dd2-e49d-469c-b3f7-09d61b925516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_afbe8161-c7ce-4ba0-8823-9f1f00379459" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_b582cbac-b644-4560-be04-5193833db78f" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_afbe8161-c7ce-4ba0-8823-9f1f00379459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_38acb254-5d28-48b3-afda-1926d8c9c5b0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_38acb254-5d28-48b3-afda-1926d8c9c5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfHedgesMember_8e9ed0b1-4f22-4f32-b91d-c066fc507984" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_38acb254-5d28-48b3-afda-1926d8c9c5b0" xlink:to="loc_ifrs-full_TypesOfHedgesMember_8e9ed0b1-4f22-4f32-b91d-c066fc507984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FairValueHedgesMember_513914ea-8368-42f4-9910-a1a211566bfd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FairValueHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesMember_8e9ed0b1-4f22-4f32-b91d-c066fc507984" xlink:to="loc_ifrs-full_FairValueHedgesMember_513914ea-8368-42f4-9910-a1a211566bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowHedgesMember_3ef3e82a-3aad-4d6f-b88e-36881d57aad9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesMember_8e9ed0b1-4f22-4f32-b91d-c066fc507984" xlink:to="loc_ifrs-full_CashFlowHedgesMember_3ef3e82a-3aad-4d6f-b88e-36881d57aad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7bbdd7f4-c92c-411f-9866-b75595ec6402" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_681cff87-dcf3-4af6-889d-4d9e5a667c17" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7bbdd7f4-c92c-411f-9866-b75595ec6402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateSwapsInterestRate_4d057e1d-c6fd-484b-a134-a2a9b4868d40" xlink:href="sny-20221231.xsd#sny_InterestRateSwapsInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7bbdd7f4-c92c-411f-9866-b75595ec6402" xlink:to="loc_sny_InterestRateSwapsInterestRate_4d057e1d-c6fd-484b-a134-a2a9b4868d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents_39232b17-868e-44d3-aa43-56f8374b1319" xlink:href="sny-20221231.xsd#sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7bbdd7f4-c92c-411f-9866-b75595ec6402" xlink:to="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents_39232b17-868e-44d3-aa43-56f8374b1319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialInstruments_ec2e8110-9a9b-4789-9db9-e5bb1ba5d952" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialInstruments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7bbdd7f4-c92c-411f-9866-b75595ec6402" xlink:to="loc_sny_DerivativeFinancialInstruments_ec2e8110-9a9b-4789-9db9-e5bb1ba5d952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_8bf1ae40-d6aa-4a16-9a11-4f4d8cb3321e" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_f889a7a6-4b01-4210-a9c5-04e75634f175" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_8bf1ae40-d6aa-4a16-9a11-4f4d8cb3321e" xlink:to="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_f889a7a6-4b01-4210-a9c5-04e75634f175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_3a9374ef-0bc2-44aa-8ab6-62962a4d223a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_f889a7a6-4b01-4210-a9c5-04e75634f175" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_3a9374ef-0bc2-44aa-8ab6-62962a4d223a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_36f11143-a539-4582-93fd-1fd496e27cb1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_3a9374ef-0bc2-44aa-8ab6-62962a4d223a" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_36f11143-a539-4582-93fd-1fd496e27cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialAssetsMember_4d44213f-4379-4cab-acac-ad801f23e2bf" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_36f11143-a539-4582-93fd-1fd496e27cb1" xlink:to="loc_sny_DerivativeFinancialAssetsMember_4d44213f-4379-4cab-acac-ad801f23e2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialLiabilitiesMember_4c1523d5-7252-4538-916d-9327e1a09eef" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_36f11143-a539-4582-93fd-1fd496e27cb1" xlink:to="loc_sny_DerivativeFinancialLiabilitiesMember_4c1523d5-7252-4538-916d-9327e1a09eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeInstrumentAxis_13edef7b-d6e1-427b-a180-8cf72c8c624a" xlink:href="sny-20221231.xsd#sny_DerivativeInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_f889a7a6-4b01-4210-a9c5-04e75634f175" xlink:to="loc_sny_DerivativeInstrumentAxis_13edef7b-d6e1-427b-a180-8cf72c8c624a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeInstrumentDomain_cb3c3a47-2021-4d87-bf47-869a65120e5f" xlink:href="sny-20221231.xsd#sny_DerivativeInstrumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DerivativeInstrumentAxis_13edef7b-d6e1-427b-a180-8cf72c8c624a" xlink:to="loc_sny_DerivativeInstrumentDomain_cb3c3a47-2021-4d87-bf47-869a65120e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember_184a2dea-8b52-468e-bf9e-c96769b7e625" xlink:href="sny-20221231.xsd#sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DerivativeInstrumentDomain_cb3c3a47-2021-4d87-bf47-869a65120e5f" xlink:to="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember_184a2dea-8b52-468e-bf9e-c96769b7e625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable_f889a7a6-4b01-4210-a9c5-04e75634f175" xlink:to="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset_71690203-1b9e-4c2b-8fa3-c7c4d741f45f" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset_71690203-1b9e-4c2b-8fa3-c7c4d741f45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32_7b6ebc1e-a019-45b5-af43-63f873915eb2" xlink:href="sny-20221231.xsd#sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32_7b6ebc1e-a019-45b5-af43-63f873915eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetAmountsAsReportedInTheBalanceSheet_125c0471-c4c0-4a1e-9a15-515b2bcd514d" xlink:href="sny-20221231.xsd#sny_NetAmountsAsReportedInTheBalanceSheet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_NetAmountsAsReportedInTheBalanceSheet_125c0471-c4c0-4a1e-9a15-515b2bcd514d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral_7ea3c723-bc39-4705-aa96-938658f3bfea" xlink:href="sny-20221231.xsd#sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral_7ea3c723-bc39-4705-aa96-938658f3bfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments_e2e12af5-a184-4522-b9f1-0b17ff639f0b" xlink:href="sny-20221231.xsd#sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments_e2e12af5-a184-4522-b9f1-0b17ff639f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetExposure_3c429fb3-6957-45ee-a05e-2a50c1a65e88" xlink:href="sny-20221231.xsd#sny_NetExposure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems_a7b6505b-1451-42ca-9d12-e23fe9ea475d" xlink:to="loc_sny_NetExposure_3c429fb3-6957-45ee-a05e-2a50c1a65e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_99c2c61b-22bf-4ba2-9c76-2eb1e22949db" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable_123cb28c-5743-4073-b0bf-5b57501d16a4" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_99c2c61b-22bf-4ba2-9c76-2eb1e22949db" xlink:to="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable_123cb28c-5743-4073-b0bf-5b57501d16a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_748037bc-4882-4071-898c-01381476f5b4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable_123cb28c-5743-4073-b0bf-5b57501d16a4" xlink:to="loc_ifrs-full_JointVenturesAxis_748037bc-4882-4071-898c-01381476f5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_b28b364d-0f44-4671-a114-d71c4b09cb8b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_JointVenturesAxis_748037bc-4882-4071-898c-01381476f5b4" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_b28b364d-0f44-4671-a114-d71c4b09cb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesMember_ab79c307-0a19-4a61-a14e-469fb48e2fe5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_b28b364d-0f44-4671-a114-d71c4b09cb8b" xlink:to="loc_ifrs-full_JointVenturesMember_ab79c307-0a19-4a61-a14e-469fb48e2fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6b9acf1c-8900-41aa-ac98-4d355d5da44a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable_123cb28c-5743-4073-b0bf-5b57501d16a4" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6b9acf1c-8900-41aa-ac98-4d355d5da44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_ba3ed54f-e5eb-42a1-9b1d-a6ee45887ba9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6b9acf1c-8900-41aa-ac98-4d355d5da44a" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_ba3ed54f-e5eb-42a1-9b1d-a6ee45887ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SuppliersMember_720fd6aa-13d5-4e65-ad67-5db630e41f12" xlink:href="sny-20221231.xsd#sny_SuppliersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_ba3ed54f-e5eb-42a1-9b1d-a6ee45887ba9" xlink:to="loc_sny_SuppliersMember_720fd6aa-13d5-4e65-ad67-5db630e41f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_a3abce63-07cd-4746-a76e-003a89078073" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable_123cb28c-5743-4073-b0bf-5b57501d16a4" xlink:to="loc_ifrs-full_MaturityAxis_a3abce63-07cd-4746-a76e-003a89078073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_a3abce63-07cd-4746-a76e-003a89078073" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_17ae33c0-585e-4617-8d99-b9e1ec9e8c3b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_17ae33c0-585e-4617-8d99-b9e1ec9e8c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_57af3b38-17e8-4d32-947d-f8a33869ec5e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_57af3b38-17e8-4d32-947d-f8a33869ec5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_dd5439cd-8299-47f0-98a6-e4a4e31ac1a3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_dd5439cd-8299-47f0-98a6-e4a4e31ac1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_9114b505-ed92-46a4-a8ed-4c190f131a99" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_2e2dbc0b-55f5-4a01-87b2-c2059aed06e4" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_9114b505-ed92-46a4-a8ed-4c190f131a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:href="sny-20221231.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsTable_123cb28c-5743-4073-b0bf-5b57501d16a4" xlink:to="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet_5f308b48-8219-46ff-ba04-54b6777a66d1" xlink:href="sny-20221231.xsd#sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet_5f308b48-8219-46ff-ba04-54b6777a66d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IrrevocablePurchaseCommitmentsGiven_8636201e-dc59-4bd6-b7e4-22e3b895836e" xlink:href="sny-20221231.xsd#sny_IrrevocablePurchaseCommitmentsGiven"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_IrrevocablePurchaseCommitmentsGiven_8636201e-dc59-4bd6-b7e4-22e3b895836e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IrrevocablePurchaseCommitmentsReceived_e67fd0d0-281b-4418-9d1d-0c5a5da14172" xlink:href="sny-20221231.xsd#sny_IrrevocablePurchaseCommitmentsReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_IrrevocablePurchaseCommitmentsReceived_e67fd0d0-281b-4418-9d1d-0c5a5da14172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments_21ce3cc0-0aa2-4a96-b70e-e0d0504493ea" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments_21ce3cc0-0aa2-4a96-b70e-e0d0504493ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress_426b4793-34cb-4057-bf4c-e23259fc7f0a" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress_426b4793-34cb-4057-bf4c-e23259fc7f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TotalOffBalanceSheetCommitments_115d0579-3391-4c9a-bb7a-5bc4a09fba4d" xlink:href="sny-20221231.xsd#sny_TotalOffBalanceSheetCommitments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems_3d837ee6-5e64-4568-8bbf-88faca0a7945" xlink:to="loc_sny_TotalOffBalanceSheetCommitments_115d0579-3391-4c9a-bb7a-5bc4a09fba4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OffbalancesheetcommitmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_10cd0ecd-2225-4afb-80a3-89d80a187124" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:href="sny-20221231.xsd#sny_ProvisionsAndOtherNonCurrentLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_10cd0ecd-2225-4afb-80a3-89d80a187124" xlink:to="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_5ab9ecee-0ca3-412b-9450-fb62b9065af2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_ifrs-full_CounterpartiesAxis_5ab9ecee-0ca3-412b-9450-fb62b9065af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_5ab9ecee-0ca3-412b-9450-fb62b9065af2" xlink:to="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DiceMoleculesMember_993d624c-8acb-46b0-87af-a52ee0855604" xlink:href="sny-20221231.xsd#sny_DiceMoleculesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_DiceMoleculesMember_993d624c-8acb-46b0-87af-a52ee0855604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LonzaMember_366bff7f-6f55-4608-ac14-3576ee8c2582" xlink:href="sny-20221231.xsd#sny_LonzaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_LonzaMember_366bff7f-6f55-4608-ac14-3576ee8c2582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ABLBioMember_60d18873-6b55-4e32-8a51-63d62e1597be" xlink:href="sny-20221231.xsd#sny_ABLBioMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_ABLBioMember_60d18873-6b55-4e32-8a51-63d62e1597be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AdageneIncMember_93a8f845-8b62-4ffd-97eb-f1fe5021ee15" xlink:href="sny-20221231.xsd#sny_AdageneIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_AdageneIncMember_93a8f845-8b62-4ffd-97eb-f1fe5021ee15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BlackstoneLifeSciencesMember_13b1b5eb-9264-4f0d-85e8-271aaca19a1a" xlink:href="sny-20221231.xsd#sny_BlackstoneLifeSciencesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_BlackstoneLifeSciencesMember_13b1b5eb-9264-4f0d-85e8-271aaca19a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IGMBiosciencesIncMember_4f25c3dd-c3e5-4b24-bf41-4d760e5de2c5" xlink:href="sny-20221231.xsd#sny_IGMBiosciencesIncMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_IGMBiosciencesIncMember_4f25c3dd-c3e5-4b24-bf41-4d760e5de2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SkyhawkTherapeuticsIncMember_0957c298-6c1b-435d-85df-076f627ab953" xlink:href="sny-20221231.xsd#sny_SkyhawkTherapeuticsIncMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_SkyhawkTherapeuticsIncMember_0957c298-6c1b-435d-85df-076f627ab953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InnoventBiologicsMember_6f9d4390-f88a-480e-8dde-13315648567f" xlink:href="sny-20221231.xsd#sny_InnoventBiologicsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_InnoventBiologicsMember_6f9d4390-f88a-480e-8dde-13315648567f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MiReculeMember_7a45c75f-4719-434a-8e30-a03db6763fd8" xlink:href="sny-20221231.xsd#sny_MiReculeMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_MiReculeMember_7a45c75f-4719-434a-8e30-a03db6763fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InnatePharmaSAMember_8497212d-deda-4cd4-abda-4d3bfc69bc46" xlink:href="sny-20221231.xsd#sny_InnatePharmaSAMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_InnatePharmaSAMember_8497212d-deda-4cd4-abda-4d3bfc69bc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExscientiaMember_1fcfb780-dd15-4681-9b3d-343456e3c0ad" xlink:href="sny-20221231.xsd#sny_ExscientiaMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_ExscientiaMember_1fcfb780-dd15-4681-9b3d-343456e3c0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AtomwiseMember_bdafb5e3-8654-4d67-99b6-add398918589" xlink:href="sny-20221231.xsd#sny_AtomwiseMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_AtomwiseMember_bdafb5e3-8654-4d67-99b6-add398918589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ScribeTherapeuticsMember_07f8186b-074f-4d6b-8e22-3e6929af17df" xlink:href="sny-20221231.xsd#sny_ScribeTherapeuticsMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_ScribeTherapeuticsMember_07f8186b-074f-4d6b-8e22-3e6929af17df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InsilicoMedicineMember_1b1df0a7-3b60-4d4f-957b-9b68fa1c2f1b" xlink:href="sny-20221231.xsd#sny_InsilicoMedicineMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_InsilicoMedicineMember_1b1df0a7-3b60-4d4f-957b-9b68fa1c2f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_69b8b577-4f52-4c0d-beb8-b4598796bc3c" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_357ca877-929c-48d5-9924-7463768a3cf1" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_69b8b577-4f52-4c0d-beb8-b4598796bc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesAxis_2c9578db-0301-49b4-bc83-c81c362f047c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_ifrs-full_JointVenturesAxis_2c9578db-0301-49b4-bc83-c81c362f047c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointVenturesMember_de496ed9-00f4-4a74-83f1-96b7a6429f37" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_JointVenturesAxis_2c9578db-0301-49b4-bc83-c81c362f047c" xlink:to="loc_ifrs-full_EntitysTotalForJointVenturesMember_de496ed9-00f4-4a74-83f1-96b7a6429f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointVenturesMember_528dccad-853c-45a3-9d0e-827102bf0a90" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointVenturesMember_de496ed9-00f4-4a74-83f1-96b7a6429f37" xlink:to="loc_ifrs-full_JointVenturesMember_528dccad-853c-45a3-9d0e-827102bf0a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_974b01c3-2546-4c7e-8192-7eb3c135f226" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_974b01c3-2546-4c7e-8192-7eb3c135f226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_bd96e910-c750-4ac4-ac37-f8856cf44cb1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_974b01c3-2546-4c7e-8192-7eb3c135f226" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_bd96e910-c750-4ac4-ac37-f8856cf44cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_WorldHealthOrganizationMember_a4e56706-e490-42e6-aa4e-d45699889de3" xlink:href="sny-20221231.xsd#sny_WorldHealthOrganizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_bd96e910-c750-4ac4-ac37-f8856cf44cb1" xlink:to="loc_sny_WorldHealthOrganizationMember_a4e56706-e490-42e6-aa4e-d45699889de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_9edda23f-07bb-4005-ba39-7de3ed676642" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_ifrs-full_RangeAxis_9edda23f-07bb-4005-ba39-7de3ed676642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_ec725424-1c2d-4e87-becb-2b76e773b57a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_9edda23f-07bb-4005-ba39-7de3ed676642" xlink:to="loc_ifrs-full_RangesMember_ec725424-1c2d-4e87-becb-2b76e773b57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_55a67060-2351-4d0d-8fa3-a2033e2b71c1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_ec725424-1c2d-4e87-becb-2b76e773b57a" xlink:to="loc_srt_MaximumMember_55a67060-2351-4d0d-8fa3-a2033e2b71c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_cffa954e-6585-4b26-bcb9-b7cbaa3806fa" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_sny_PrincipalAlliancesAxis_cffa954e-6585-4b26-bcb9-b7cbaa3806fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_3cefd8af-77e0-4eb7-9a1c-a279d52ec91e" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesAxis_cffa954e-6585-4b26-bcb9-b7cbaa3806fa" xlink:to="loc_sny_PrincipalAlliancesDomain_3cefd8af-77e0-4eb7-9a1c-a279d52ec91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember_f05f6e27-3a4e-4d3e-bdd0-3e886625fec2" xlink:href="sny-20221231.xsd#sny_AntibodiesCollaborationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesDomain_3cefd8af-77e0-4eb7-9a1c-a279d52ec91e" xlink:to="loc_sny_AntibodiesCollaborationAgreementMember_f05f6e27-3a4e-4d3e-bdd0-3e886625fec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_7d4fba40-913f-4baa-bc80-518bde10e1e3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_7d4fba40-913f-4baa-bc80-518bde10e1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_73e76d54-f861-4d35-b997-ae58aa948538" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_7d4fba40-913f-4baa-bc80-518bde10e1e3" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_73e76d54-f861-4d35-b997-ae58aa948538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AblynxMember_32eef557-359b-4ae6-bb3f-88c248487a36" xlink:href="sny-20221231.xsd#sny_AblynxMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_73e76d54-f861-4d35-b997-ae58aa948538" xlink:to="loc_sny_AblynxMember_32eef557-359b-4ae6-bb3f-88c248487a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KymabMember_3d63e8c4-7478-4ade-a5c6-4c41994d65f6" xlink:href="sny-20221231.xsd#sny_KymabMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_73e76d54-f861-4d35-b997-ae58aa948538" xlink:to="loc_sny_KymabMember_3d63e8c4-7478-4ade-a5c6-4c41994d65f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:href="sny-20221231.xsd#sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesTable_9f8b3542-97d4-4db0-a9d2-7863d0ee7f35" xlink:to="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase_69d10515-3720-4fd7-9d51-5f1ceea41ffe" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase_69d10515-3720-4fd7-9d51-5f1ceea41ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets_7354967b-22ae-45ab-845e-bc8c0b1c4494" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets_7354967b-22ae-45ab-845e-bc8c0b1c4494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements_d7db0be1-3b35-4d0b-a2fb-d806951bc5e3" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements_d7db0be1-3b35-4d0b-a2fb-d806951bc5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts_e915f83f-1f51-40e7-815f-d374b13a1153" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts_e915f83f-1f51-40e7-815f-d374b13a1153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement_e7dbb6d6-7be0-41ee-b29e-ab1d20057cca" xlink:href="sny-20221231.xsd#sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement_e7dbb6d6-7be0-41ee-b29e-ab1d20057cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UpfrontPayments_9bbc86c0-f0aa-42e6-933a-b234cb772fc3" xlink:href="sny-20221231.xsd#sny_UpfrontPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_UpfrontPayments_9bbc86c0-f0aa-42e6-933a-b234cb772fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements_69bebc17-cb0d-4587-abe7-51e30229bc53" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements_69bebc17-cb0d-4587-abe7-51e30229bc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement_dc0037d2-0e44-4761-94a0-a1f5802dccac" xlink:href="sny-20221231.xsd#sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement_dc0037d2-0e44-4761-94a0-a1f5802dccac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOncologyTargetsUnderCollaborationAgreement_84a8b39c-b51b-483e-9d40-1e8e2d45548b" xlink:href="sny-20221231.xsd#sny_NumberOfOncologyTargetsUnderCollaborationAgreement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_NumberOfOncologyTargetsUnderCollaborationAgreement_84a8b39c-b51b-483e-9d40-1e8e2d45548b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement_8e38bbf2-7659-456c-bd44-80161314ba9c" xlink:href="sny-20221231.xsd#sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement_8e38bbf2-7659-456c-bd44-80161314ba9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingentConsiderationCollaborationAgreements_2cd87fbb-44f3-43e8-b1b7-b86188da0433" xlink:href="sny-20221231.xsd#sny_ContingentConsiderationCollaborationAgreements"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_ContingentConsiderationCollaborationAgreements_2cd87fbb-44f3-43e8-b1b7-b86188da0433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfTargetsThatEncompassAllDiseasesAreas_006d74c0-0c4f-4773-a843-3db74024ae0a" xlink:href="sny-20221231.xsd#sny_NumberOfTargetsThatEncompassAllDiseasesAreas"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_NumberOfTargetsThatEncompassAllDiseasesAreas_006d74c0-0c4f-4773-a843-3db74024ae0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsReceivedForDevelopmentCosts_f6ac19e2-880e-4c02-8f93-a9a6d7eb2a1e" xlink:href="sny-20221231.xsd#sny_CommitmentsReceivedForDevelopmentCosts"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CommitmentsReceivedForDevelopmentCosts_f6ac19e2-880e-4c02-8f93-a9a6d7eb2a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CumulativeDevelopmentCostsIncurred_4d3ef61f-04a8-426e-81ec-eb2df7f5562f" xlink:href="sny-20221231.xsd#sny_CumulativeDevelopmentCostsIncurred"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_CumulativeDevelopmentCostsIncurred_4d3ef61f-04a8-426e-81ec-eb2df7f5562f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentsInJointVentures_172b059b-ae0d-46d1-bbfa-7d509922b4f8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInJointVentures"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_ifrs-full_InvestmentsInJointVentures_172b059b-ae0d-46d1-bbfa-7d509922b4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany_a4feeedd-803a-4040-af8e-92757b143212" xlink:href="sny-20221231.xsd#sny_PercentageOfFutureDevelopmentExpenseFundedByCompany"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany_a4feeedd-803a-4040-af8e-92757b143212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty_45556e30-b8e2-4116-874b-79de95525c3b" xlink:href="sny-20221231.xsd#sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty_45556e30-b8e2-4116-874b-79de95525c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmountsPayablePartnersInCollaborationAgreements_0a519e19-77b5-4d03-b8fb-db46633aa49c" xlink:href="sny-20221231.xsd#sny_AmountsPayablePartnersInCollaborationAgreements"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_AmountsPayablePartnersInCollaborationAgreements_0a519e19-77b5-4d03-b8fb-db46633aa49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod_d7d1c9f9-0708-4169-b1b2-54e70a269e43" xlink:href="sny-20221231.xsd#sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod_d7d1c9f9-0708-4169-b1b2-54e70a269e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TransferPercentageOfPandemicVaccines_03398a62-8b43-4ae6-951a-39578413c453" xlink:href="sny-20221231.xsd#sny_TransferPercentageOfPandemicVaccines"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_TransferPercentageOfPandemicVaccines_03398a62-8b43-4ae6-951a-39578413c453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReservePercentageOfPandemicVaccines_ea83181b-c8c6-464e-bb08-8816e5ef4f4a" xlink:href="sny-20221231.xsd#sny_ReservePercentageOfPandemicVaccines"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_ReservePercentageOfPandemicVaccines_ea83181b-c8c6-464e-bb08-8816e5ef4f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_beb894a9-a77f-4d3e-95a3-b89c84c43e5e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UndrawnBorrowingFacilities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_beb894a9-a77f-4d3e-95a3-b89c84c43e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments_0fb8a20e-3bdb-4180-9b68-e4b2251dfd0a" xlink:href="sny-20221231.xsd#sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments_0fb8a20e-3bdb-4180-9b68-e4b2251dfd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_88a5181b-7f75-49eb-9bc8-929fc2b9ab5a" xlink:href="sny-20221231.xsd#sny_PercentageOfProfitShareOnCounterpartiesProfit"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_PercentageOfProfitShareOnCounterpartiesProfit_88a5181b-7f75-49eb-9bc8-929fc2b9ab5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_a030bace-452e-41c8-868e-a77686a307bb" xlink:href="sny-20221231.xsd#sny_PercentageOfCumulativeDevelopmentCostsReimbursed"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems_4eba092e-044e-463e-adf7-052bc597f279" xlink:to="loc_sny_PercentageOfCumulativeDevelopmentCostsReimbursed_a030bace-452e-41c8-868e-a77686a307bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_0cb3f8cf-35bb-4813-80e3-0c4eb8216102" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLineOfCreditFacilityTable_94de03d2-d06e-4563-8f74-791cbe7b6741" xlink:href="sny-20221231.xsd#sny_DisclosureOfLineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_0cb3f8cf-35bb-4813-80e3-0c4eb8216102" xlink:to="loc_sny_DisclosureOfLineOfCreditFacilityTable_94de03d2-d06e-4563-8f74-791cbe7b6741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_bd70c8c7-551f-4bb8-9f60-aa12f3dd65aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLineOfCreditFacilityTable_94de03d2-d06e-4563-8f74-791cbe7b6741" xlink:to="loc_ifrs-full_MaturityAxis_bd70c8c7-551f-4bb8-9f60-aa12f3dd65aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_bd70c8c7-551f-4bb8-9f60-aa12f3dd65aa" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_6a2057b5-5ea7-49dd-9d1d-ada1b21f520c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_6a2057b5-5ea7-49dd-9d1d-ada1b21f520c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_91fab54b-3db5-4819-9438-95f1413eefe4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_91fab54b-3db5-4819-9438-95f1413eefe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_39cd34e6-5196-49f3-94b7-8612a1784e55" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_39cd34e6-5196-49f3-94b7-8612a1784e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_1510dc47-e8ca-472c-83a4-48d753b7cdf2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_3b89d539-5585-4ad6-940f-14673e474f25" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_1510dc47-e8ca-472c-83a4-48d753b7cdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLineOfCreditFacilityLineItems_bf90b150-5a2b-4b9a-921c-f08eb79ab2d7" xlink:href="sny-20221231.xsd#sny_DisclosureOfLineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLineOfCreditFacilityTable_94de03d2-d06e-4563-8f74-791cbe7b6741" xlink:to="loc_sny_DisclosureOfLineOfCreditFacilityLineItems_bf90b150-5a2b-4b9a-921c-f08eb79ab2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_9c2030b6-fc19-4b9b-8338-8603cf503adf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UndrawnBorrowingFacilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLineOfCreditFacilityLineItems_bf90b150-5a2b-4b9a-921c-f08eb79ab2d7" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_9c2030b6-fc19-4b9b-8338-8603cf503adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_4477ca53-87db-4a39-8631-562f63a8a714" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfGuaranteesTable_7ef3e51e-99de-4419-813f-650a65577afb" xlink:href="sny-20221231.xsd#sny_DisclosureOfGuaranteesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_4477ca53-87db-4a39-8631-562f63a8a714" xlink:to="loc_sny_DisclosureOfGuaranteesTable_7ef3e51e-99de-4419-813f-650a65577afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_95165234-c805-4be2-ad8e-916863eef5a7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfGuaranteesTable_7ef3e51e-99de-4419-813f-650a65577afb" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_95165234-c805-4be2-ad8e-916863eef5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_b0a1cd10-84fa-4c77-aaca-e77f044a5515" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_95165234-c805-4be2-ad8e-916863eef5a7" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_b0a1cd10-84fa-4c77-aaca-e77f044a5515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GuaranteesReceivedMember_d2b45c7b-5e5d-47db-bd05-bb1c6e778016" xlink:href="sny-20221231.xsd#sny_GuaranteesReceivedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_b0a1cd10-84fa-4c77-aaca-e77f044a5515" xlink:to="loc_sny_GuaranteesReceivedMember_d2b45c7b-5e5d-47db-bd05-bb1c6e778016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GuaranteesGivenMember_804315f4-ebbc-44c9-8ab4-c2f48e758830" xlink:href="sny-20221231.xsd#sny_GuaranteesGivenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_GuaranteesReceivedMember_d2b45c7b-5e5d-47db-bd05-bb1c6e778016" xlink:to="loc_sny_GuaranteesGivenMember_804315f4-ebbc-44c9-8ab4-c2f48e758830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember_b877a0ec-4ca1-4b2d-9e65-c8b2da4f8878" xlink:href="sny-20221231.xsd#sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_GuaranteesReceivedMember_d2b45c7b-5e5d-47db-bd05-bb1c6e778016" xlink:to="loc_sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember_b877a0ec-4ca1-4b2d-9e65-c8b2da4f8878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGuaranteesGivenMember_1c2df828-8878-4edb-89cf-60e69ff76e0d" xlink:href="sny-20221231.xsd#sny_OtherGuaranteesGivenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_GuaranteesReceivedMember_d2b45c7b-5e5d-47db-bd05-bb1c6e778016" xlink:to="loc_sny_OtherGuaranteesGivenMember_1c2df828-8878-4edb-89cf-60e69ff76e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfGuaranteesLineItems_aea4c83c-7aeb-494a-9e85-b164c8a6f613" xlink:href="sny-20221231.xsd#sny_DisclosureOfGuaranteesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfGuaranteesTable_7ef3e51e-99de-4419-813f-650a65577afb" xlink:to="loc_sny_DisclosureOfGuaranteesLineItems_aea4c83c-7aeb-494a-9e85-b164c8a6f613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_d3ace4fb-b399-405e-8aca-64c2a442c535" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfGuaranteesLineItems_aea4c83c-7aeb-494a-9e85-b164c8a6f613" xlink:to="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_d3ace4fb-b399-405e-8aca-64c2a442c535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/LegalandarbitralproceedingsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#LegalandarbitralproceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/LegalandarbitralproceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_202cae89-ce06-4aab-ac68-1bf283c79384" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:href="sny-20221231.xsd#sny_DisclosureOfLegalAndArbitralProceedingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_202cae89-ce06-4aab-ac68-1bf283c79384" xlink:to="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LegalAndArbitralProceedingsAxis_51003b17-4000-4e52-b26f-8537f544e8fe" xlink:href="sny-20221231.xsd#sny_LegalAndArbitralProceedingsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_sny_LegalAndArbitralProceedingsAxis_51003b17-4000-4e52-b26f-8537f544e8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:href="sny-20221231.xsd#sny_LegalAndArbitralProceedingsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsAxis_51003b17-4000-4e52-b26f-8537f544e8fe" xlink:to="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurHepatitisBVaccineMember_dc10e5e1-24c9-4e5e-800d-2283b5d6a455" xlink:href="sny-20221231.xsd#sny_SanofiPasteurHepatitisBVaccineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_SanofiPasteurHepatitisBVaccineMember_dc10e5e1-24c9-4e5e-800d-2283b5d6a455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxotereProductLitigationInTheUSMember_272ffc96-9b3d-4bf6-a2c7-9b86cb861875" xlink:href="sny-20221231.xsd#sny_TaxotereProductLitigationInTheUSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_TaxotereProductLitigationInTheUSMember_272ffc96-9b3d-4bf6-a2c7-9b86cb861875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember_717671dc-0b9c-4527-8fc6-4852b54b8a11" xlink:href="sny-20221231.xsd#sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember_717671dc-0b9c-4527-8fc6-4852b54b8a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ZantacLitigationInTheUSMDLCourtMember_8e06fa49-1a4a-445d-bd42-9714b10f250d" xlink:href="sny-20221231.xsd#sny_ZantacLitigationInTheUSMDLCourtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_ZantacLitigationInTheUSMDLCourtMember_8e06fa49-1a4a-445d-bd42-9714b10f250d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ZantacLitigationInTheUSMember_c766e55d-22e2-4ddc-a127-dcb3fad2c695" xlink:href="sny-20221231.xsd#sny_ZantacLitigationInTheUSMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_ZantacLitigationInTheUSMember_c766e55d-22e2-4ddc-a127-dcb3fad2c695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ZantacLitigationInCanadaMember_057b45ff-01d1-4ff7-bd26-a9e53311eeee" xlink:href="sny-20221231.xsd#sny_ZantacLitigationInCanadaMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_ZantacLitigationInCanadaMember_057b45ff-01d1-4ff7-bd26-a9e53311eeee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInFranceMember_8f3d9afb-896d-4a9b-83cb-2d65e083b314" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInFranceMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInFranceMember_8f3d9afb-896d-4a9b-83cb-2d65e083b314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInSwitzerlandMember_6aed192c-4daf-47c0-a14c-8c7d81acd79c" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInSwitzerlandMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInSwitzerlandMember_6aed192c-4daf-47c0-a14c-8c7d81acd79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInSpainMember_450bb731-40a1-4ebd-bd8a-c105beaeeecb" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInSpainMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInSpainMember_450bb731-40a1-4ebd-bd8a-c105beaeeecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInBelgiumMember_7bac548b-7adf-4be8-8f6b-62b556465a96" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInBelgiumMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInBelgiumMember_7bac548b-7adf-4be8-8f6b-62b556465a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInGermanyMember_7c2e9d14-9475-4ca4-a853-4a8fdfbaf3bb" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInGermanyMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInGermanyMember_7c2e9d14-9475-4ca4-a853-4a8fdfbaf3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DengvaxiaProductLitigationInThePhilippinesMember_2c4b371c-9c53-4e1d-b87d-23b777e1e849" xlink:href="sny-20221231.xsd#sny_DengvaxiaProductLitigationInThePhilippinesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DengvaxiaProductLitigationInThePhilippinesMember_2c4b371c-9c53-4e1d-b87d-23b777e1e849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RamiprilCanadaPatentLitigationMember_963638c3-5b57-4c6b-80fc-0f319a714e4d" xlink:href="sny-20221231.xsd#sny_RamiprilCanadaPatentLitigationMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_RamiprilCanadaPatentLitigationMember_963638c3-5b57-4c6b-80fc-0f319a714e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember_cb802529-9187-45b8-91cd-ca657cfa38ad" xlink:href="sny-20221231.xsd#sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember_cb802529-9187-45b8-91cd-ca657cfa38ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember_76102651-50f0-46a9-add4-066fe96ddfe9" xlink:href="sny-20221231.xsd#sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember_76102651-50f0-46a9-add4-066fe96ddfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_JevtanaRelatedPatentLitigationInTheUSMember_360f44c6-eafa-48e3-9cbb-f6e2203d5de8" xlink:href="sny-20221231.xsd#sny_JevtanaRelatedPatentLitigationInTheUSMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_JevtanaRelatedPatentLitigationInTheUSMember_360f44c6-eafa-48e3-9cbb-f6e2203d5de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixLitigationCommonwealthInAustraliaMember_62b081e1-6abf-4b35-afe4-778101940bf8" xlink:href="sny-20221231.xsd#sny_PlavixLitigationCommonwealthInAustraliaMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_PlavixLitigationCommonwealthInAustraliaMember_62b081e1-6abf-4b35-afe4-778101940bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember_b744fc48-1b7d-43df-95f0-aa806a8fd918" xlink:href="sny-20221231.xsd#sny_PlavixAttorneyGeneralActionInHawaiiMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember_b744fc48-1b7d-43df-95f0-aa806a8fd918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixRelatedLitigationInFranceMember_dfb77e51-be7b-46a8-92a4-730b3f627ac7" xlink:href="sny-20221231.xsd#sny_PlavixRelatedLitigationInFranceMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_PlavixRelatedLitigationInFranceMember_dfb77e51-be7b-46a8-92a4-730b3f627ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_A340BDrugPricingProgramInTheUnitedStatesMember_e5934454-12c1-48a9-885d-83f0e120802f" xlink:href="sny-20221231.xsd#sny_A340BDrugPricingProgramInTheUnitedStatesMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_A340BDrugPricingProgramInTheUnitedStatesMember_e5934454-12c1-48a9-885d-83f0e120802f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisCropScienceRetainedLiabilitiesMember_82ff9f58-b6ca-4cfd-a0df-5d22182d51b0" xlink:href="sny-20221231.xsd#sny_AventisCropScienceRetainedLiabilitiesMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_AventisCropScienceRetainedLiabilitiesMember_82ff9f58-b6ca-4cfd-a0df-5d22182d51b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InfraservHoechstRetainedLiabilitiesMember_665cf263-2047-4c1b-be4c-a97a8ecc2a49" xlink:href="sny-20221231.xsd#sny_InfraservHoechstRetainedLiabilitiesMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_InfraservHoechstRetainedLiabilitiesMember_665cf263-2047-4c1b-be4c-a97a8ecc2a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInIrelandMember_4f5a3de4-240d-4d66-ac16-d16e172a167e" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInIrelandMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInIrelandMember_4f5a3de4-240d-4d66-ac16-d16e172a167e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInGreatBritainMember_7103e6a8-fdf9-4ef5-b809-8793d7ccb9cd" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInGreatBritainMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInGreatBritainMember_7103e6a8-fdf9-4ef5-b809-8793d7ccb9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DepakineProductLitigationInNorthernIrelandMember_c72396e6-24b1-464e-b175-d2262fa250eb" xlink:href="sny-20221231.xsd#sny_DepakineProductLitigationInNorthernIrelandMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_92a1a895-f85e-4a2f-a158-2bb02ef899ef" xlink:to="loc_sny_DepakineProductLitigationInNorthernIrelandMember_c72396e6-24b1-464e-b175-d2262fa250eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefendantAxis_2562e67c-75a2-4833-a4e0-d26d99d0054b" xlink:href="sny-20221231.xsd#sny_DefendantAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_sny_DefendantAxis_2562e67c-75a2-4833-a4e0-d26d99d0054b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DefendantsMember_3e076f0c-1a99-4b6d-9442-dc91f2898672" xlink:href="sny-20221231.xsd#sny_DefendantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DefendantAxis_2562e67c-75a2-4833-a4e0-d26d99d0054b" xlink:to="loc_sny_DefendantsMember_3e076f0c-1a99-4b6d-9442-dc91f2898672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActionForWhichWeAreDefendantMember_7935e105-6f0f-4ab4-b226-d4936cc77b44" xlink:href="sny-20221231.xsd#sny_ActionForWhichWeAreDefendantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DefendantsMember_3e076f0c-1a99-4b6d-9442-dc91f2898672" xlink:to="loc_sny_ActionForWhichWeAreDefendantMember_7935e105-6f0f-4ab4-b226-d4936cc77b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ActionForWhichWeArePlaintiffMember_488de598-4015-44aa-a4c6-56608097d5d4" xlink:href="sny-20221231.xsd#sny_ActionForWhichWeArePlaintiffMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DefendantsMember_3e076f0c-1a99-4b6d-9442-dc91f2898672" xlink:to="loc_sny_ActionForWhichWeArePlaintiffMember_488de598-4015-44aa-a4c6-56608097d5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_1664b533-d7d8-4544-adbd-5a2fe22a873d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_CounterpartiesAxis_1664b533-d7d8-4544-adbd-5a2fe22a873d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_f4b084a7-ab9c-4f58-988c-284f64504c5b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_1664b533-d7d8-4544-adbd-5a2fe22a873d" xlink:to="loc_ifrs-full_CounterpartiesMember_f4b084a7-ab9c-4f58-988c-284f64504c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlaintiffMember_3bede628-6c64-4b9c-be70-15bc2bb8e4ec" xlink:href="sny-20221231.xsd#sny_PlaintiffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_f4b084a7-ab9c-4f58-988c-284f64504c5b" xlink:to="loc_sny_PlaintiffMember_3bede628-6c64-4b9c-be70-15bc2bb8e4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CaissePrimaireDassuranceMaladieMember_6247d856-d441-4e85-b4bf-3e5cb37c161a" xlink:href="sny-20221231.xsd#sny_CaissePrimaireDassuranceMaladieMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_f4b084a7-ab9c-4f58-988c-284f64504c5b" xlink:to="loc_sny_CaissePrimaireDassuranceMaladieMember_6247d856-d441-4e85-b4bf-3e5cb37c161a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_a548777c-9b7a-473c-87a4-b4857b569216" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_a548777c-9b7a-473c-87a4-b4857b569216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_741da41d-a782-471b-8ee0-f8eec22edbba" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_a548777c-9b7a-473c-87a4-b4857b569216" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_741da41d-a782-471b-8ee0-f8eec22edbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ContingenciesArisingFromCertainBusinessDivestituresMember_b0402e4b-8ca4-4977-a6b8-517bd0c1e50d" xlink:href="sny-20221231.xsd#sny_ContingenciesArisingFromCertainBusinessDivestituresMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_741da41d-a782-471b-8ee0-f8eec22edbba" xlink:to="loc_sny_ContingenciesArisingFromCertainBusinessDivestituresMember_b0402e4b-8ca4-4977-a6b8-517bd0c1e50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_7dbe57db-607f-4d2b-9cb1-84c5856711bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_7dbe57db-607f-4d2b-9cb1-84c5856711bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_4dd9cf28-2f3b-4ba0-bfcb-dd9ef0bcfed9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_7dbe57db-607f-4d2b-9cb1-84c5856711bd" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_4dd9cf28-2f3b-4ba0-bfcb-dd9ef0bcfed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProductLiabilitiesMember_6a19fd30-2ed5-454d-9c20-6d6c7f20bff5" xlink:href="sny-20221231.xsd#sny_ProductLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_4dd9cf28-2f3b-4ba0-bfcb-dd9ef0bcfed9" xlink:to="loc_sny_ProductLiabilitiesMember_6a19fd30-2ed5-454d-9c20-6d6c7f20bff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_d90be8eb-b470-4125-a6b1-3ff0e2fe52b6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_d90be8eb-b470-4125-a6b1-3ff0e2fe52b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_398d3921-d6f2-409c-b9da-1a7bd7c393f1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_d90be8eb-b470-4125-a6b1-3ff0e2fe52b6" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_398d3921-d6f2-409c-b9da-1a7bd7c393f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PatentsMember_eee025d5-fb40-43ad-a0a0-c86652134a5c" xlink:href="sny-20221231.xsd#sny_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_398d3921-d6f2-409c-b9da-1a7bd7c393f1" xlink:to="loc_sny_PatentsMember_eee025d5-fb40-43ad-a0a0-c86652134a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_d2a0f56f-a864-4cf5-b8ba-58eb87957c03" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_RangeAxis_d2a0f56f-a864-4cf5-b8ba-58eb87957c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangesMember_d89281ea-d773-4ddd-b2c1-9ff195a06203" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_d2a0f56f-a864-4cf5-b8ba-58eb87957c03" xlink:to="loc_ifrs-full_RangesMember_d89281ea-d773-4ddd-b2c1-9ff195a06203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f56dd3ee-8bac-4870-a001-6fda8c7153d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_d89281ea-d773-4ddd-b2c1-9ff195a06203" xlink:to="loc_srt_MinimumMember_f56dd3ee-8bac-4870-a001-6fda8c7153d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cf73d06a-af2c-4346-98ea-5658c81fad2c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_d89281ea-d773-4ddd-b2c1-9ff195a06203" xlink:to="loc_srt_MaximumMember_cf73d06a-af2c-4346-98ea-5658c81fad2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8700662a-0c5a-408c-be83-b548d3e366fc" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8700662a-0c5a-408c-be83-b548d3e366fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsMember_c4a9f69a-b01f-44c8-b8b8-72c8bd99f6f4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8700662a-0c5a-408c-be83-b548d3e366fc" xlink:to="loc_ifrs-full_NonadjustingEventsMember_c4a9f69a-b01f-44c8-b8b8-72c8bd99f6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommencementOfMajorLitigationMember_ce60da9d-ac94-4ae8-8b49-77cd2575fbfa" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CommencementOfMajorLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_c4a9f69a-b01f-44c8-b8b8-72c8bd99f6f4" xlink:to="loc_ifrs-full_CommencementOfMajorLitigationMember_ce60da9d-ac94-4ae8-8b49-77cd2575fbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:href="sny-20221231.xsd#sny_DisclosureOfLegalAndArbitralProceedingsLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_f21e4fc4-5f8a-4305-9db8-f70bf54a64d7" xlink:to="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_d2c37c0e-dbbe-43a6-9bbd-7b43d77234ad" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther_d2c37c0e-dbbe-43a6-9bbd-7b43d77234ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentProvisionForEnvironmentRisks_cd2a6221-34ac-4393-a03b-6baba2cbe7d6" xlink:href="sny-20221231.xsd#sny_NonCurrentProvisionForEnvironmentRisks"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NonCurrentProvisionForEnvironmentRisks_cd2a6221-34ac-4393-a03b-6baba2cbe7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCivilIndividualActions_9af8d3af-f6ab-417e-b9e5-8bb986392ece" xlink:href="sny-20221231.xsd#sny_NumberOfCivilIndividualActions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCivilIndividualActions_9af8d3af-f6ab-417e-b9e5-8bb986392ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOngoingLawsuits_a7729917-9dd0-49b4-a998-ff692fdbe185" xlink:href="sny-20221231.xsd#sny_NumberOfOngoingLawsuits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfOngoingLawsuits_a7729917-9dd0-49b4-a998-ff692fdbe185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPlaintiffs_2d0800e3-62ae-455c-87cb-907779453f1d" xlink:href="sny-20221231.xsd#sny_NumberOfPlaintiffs"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPlaintiffs_2d0800e3-62ae-455c-87cb-907779453f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfLossConsortiumPlaintiffs_7298eba4-a1e6-463a-bea2-18746b45702c" xlink:href="sny-20221231.xsd#sny_NumberOfLossConsortiumPlaintiffs"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfLossConsortiumPlaintiffs_7298eba4-a1e6-463a-bea2-18746b45702c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfBellweatherTrialsHeld_11541a68-9c14-44fb-8d48-85ab04a82d50" xlink:href="sny-20221231.xsd#sny_NumberOfBellweatherTrialsHeld"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfBellweatherTrialsHeld_11541a68-9c14-44fb-8d48-85ab04a82d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation_0ca05042-9f7f-4fcf-b50e-df83134003bf" xlink:href="sny-20221231.xsd#sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation_0ca05042-9f7f-4fcf-b50e-df83134003bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCasesDismissed_98f73319-5383-4b48-9201-bce100a1fef1" xlink:href="sny-20221231.xsd#sny_NumberOfCasesDismissed"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCasesDismissed_98f73319-5383-4b48-9201-bce100a1fef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCancersAssociatedWithDismissedCases_bf3e4fc8-d577-4749-951d-cb9f83af3041" xlink:href="sny-20221231.xsd#sny_NumberOfCancersAssociatedWithDismissedCases"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCancersAssociatedWithDismissedCases_bf3e4fc8-d577-4749-951d-cb9f83af3041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfComplaintsFiled_af53ad8f-ccfa-4b80-a742-ee428dfb7046" xlink:href="sny-20221231.xsd#sny_NumberOfComplaintsFiled"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfComplaintsFiled_af53ad8f-ccfa-4b80-a742-ee428dfb7046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfClassActionLawsuits_d4fe835c-2066-4205-953b-cb7211ae82bf" xlink:href="sny-20221231.xsd#sny_NumberOfClassActionLawsuits"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfClassActionLawsuits_d4fe835c-2066-4205-953b-cb7211ae82bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPeopleExposed_61e75d3f-ae5a-467f-b674-6ee754cdda45" xlink:href="sny-20221231.xsd#sny_NumberOfPeopleExposed"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPeopleExposed_61e75d3f-ae5a-467f-b674-6ee754cdda45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfLawsuitsRuledOnMerit_38b74521-9da3-4d1a-ab87-ec12206b9e5d" xlink:href="sny-20221231.xsd#sny_NumberOfLawsuitsRuledOnMerit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfLawsuitsRuledOnMerit_38b74521-9da3-4d1a-ab87-ec12206b9e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfFirstInstanceRulings_03c97bab-617c-4152-a473-b111f58b4873" xlink:href="sny-20221231.xsd#sny_NumberOfFirstInstanceRulings"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfFirstInstanceRulings_03c97bab-617c-4152-a473-b111f58b4873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LitigationAmountPayable_a7eb19ca-cc31-4f8a-94b7-90686d853068" xlink:href="sny-20221231.xsd#sny_LitigationAmountPayable"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_LitigationAmountPayable_a7eb19ca-cc31-4f8a-94b7-90686d853068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfFamiliesWhoFiledACivilClaim_e414047e-6e29-4096-a1ac-a13efb3259c8" xlink:href="sny-20221231.xsd#sny_NumberOfFamiliesWhoFiledACivilClaim"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfFamiliesWhoFiledACivilClaim_e414047e-6e29-4096-a1ac-a13efb3259c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCounterExpertiseExperts_af015254-b20b-4dc6-9d19-5033d45b7c44" xlink:href="sny-20221231.xsd#sny_NumberOfCounterExpertiseExperts"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCounterExpertiseExperts_af015254-b20b-4dc6-9d19-5033d45b7c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfMedicalAssessments_dc1ef185-fd86-4526-9c4f-ef643f2aaeec" xlink:href="sny-20221231.xsd#sny_NumberOfMedicalAssessments"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfMedicalAssessments_dc1ef185-fd86-4526-9c4f-ef643f2aaeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification_d8483ef7-5b3f-425a-8b80-27b9bfa01d78" xlink:href="sny-20221231.xsd#sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification_d8483ef7-5b3f-425a-8b80-27b9bfa01d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfAdministrativeProceedings_61c0ff0b-4b4d-4b6c-be0e-6611d584b36b" xlink:href="sny-20221231.xsd#sny_NumberOfAdministrativeProceedings"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfAdministrativeProceedings_61c0ff0b-4b4d-4b6c-be0e-6611d584b36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOngoingTrials_d047861c-d668-4f66-9824-27c6b1fcf949" xlink:href="sny-20221231.xsd#sny_NumberOfOngoingTrials"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfOngoingTrials_d047861c-d668-4f66-9824-27c6b1fcf949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPreActionProtocolCases_4e598166-f0e8-475c-b113-e5becd31c4c9" xlink:href="sny-20221231.xsd#sny_NumberOfPreActionProtocolCases"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPreActionProtocolCases_4e598166-f0e8-475c-b113-e5becd31c4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCases_a2dca97a-b415-42b3-b96a-e8269f2fc009" xlink:href="sny-20221231.xsd#sny_NumberOfCases"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCases_a2dca97a-b415-42b3-b96a-e8269f2fc009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfCivilClaimsOnGoing_f34f104d-a70b-42e2-8012-350c9c1e1769" xlink:href="sny-20221231.xsd#sny_NumberOfCivilClaimsOnGoing"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfCivilClaimsOnGoing_f34f104d-a70b-42e2-8012-350c9c1e1769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug_dbd8a103-8f49-494b-8ad0-9a7aaf9df3c3" xlink:href="sny-20221231.xsd#sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug_dbd8a103-8f49-494b-8ad0-9a7aaf9df3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AnticipatedDurationOfAppealsProcess_ad7b40d8-20fe-4550-8594-15670f57408c" xlink:href="sny-20221231.xsd#sny_AnticipatedDurationOfAppealsProcess"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_AnticipatedDurationOfAppealsProcess_ad7b40d8-20fe-4550-8594-15670f57408c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPatentActionsInitiallyFiled_254e0333-61bb-49f6-83d2-9e104bfb7a4a" xlink:href="sny-20221231.xsd#sny_NumberOfPatentActionsInitiallyFiled"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPatentActionsInitiallyFiled_254e0333-61bb-49f6-83d2-9e104bfb7a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPatentsAllegedlyInfringed_6221ab95-f476-42b6-a4db-008b02719edc" xlink:href="sny-20221231.xsd#sny_NumberOfPatentsAllegedlyInfringed"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPatentsAllegedlyInfringed_6221ab95-f476-42b6-a4db-008b02719edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfClaimsInvalid_caedd130-358e-4840-af61-cc4f528b6432" xlink:href="sny-20221231.xsd#sny_NumberOfClaimsInvalid"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfClaimsInvalid_caedd130-358e-4840-af61-cc4f528b6432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfPatentsCoveringProduct_2d14b9da-4438-43c4-83d2-602f8392b3ec" xlink:href="sny-20221231.xsd#sny_NumberOfPatentsCoveringProduct"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfPatentsCoveringProduct_2d14b9da-4438-43c4-83d2-602f8392b3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfDecisionsIssuedByTheDistrictCourt_53aee082-8409-4eeb-9de6-c21600387287" xlink:href="sny-20221231.xsd#sny_NumberOfDecisionsIssuedByTheDistrictCourt"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfDecisionsIssuedByTheDistrictCourt_53aee082-8409-4eeb-9de6-c21600387287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LengthOfTrial_bebe4e04-0651-4f03-a5be-8ea9da7c2a9a" xlink:href="sny-20221231.xsd#sny_LengthOfTrial"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_LengthOfTrial_bebe4e04-0651-4f03-a5be-8ea9da7c2a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing_bc6f35ed-e53f-451f-b5e6-02687020035c" xlink:href="sny-20221231.xsd#sny_NumberOfDaysAfterCompletionOfPostTrailBriefing"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing_bc6f35ed-e53f-451f-b5e6-02687020035c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo_106c9599-02d7-40e6-9a6a-dc334191f282" xlink:href="sny-20221231.xsd#sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo_106c9599-02d7-40e6-9a6a-dc334191f282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs_8b27fa42-cdf6-41c8-8fdc-685aef0a8c98" xlink:href="sny-20221231.xsd#sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs_8b27fa42-cdf6-41c8-8fdc-685aef0a8c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded_578f6760-bb01-40c8-935c-a11c31826c6c" xlink:href="sny-20221231.xsd#sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded_578f6760-bb01-40c8-935c-a11c31826c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GlobalPenaltyFeeIncurredByDefendants_6d3a634f-f5a1-47d3-ab6e-ff05746202e6" xlink:href="sny-20221231.xsd#sny_GlobalPenaltyFeeIncurredByDefendants"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_GlobalPenaltyFeeIncurredByDefendants_6d3a634f-f5a1-47d3-ab6e-ff05746202e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PenaltyFeeIncurred_1400b8fb-84d6-44db-86c9-455687380a5c" xlink:href="sny-20221231.xsd#sny_PenaltyFeeIncurred"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_PenaltyFeeIncurred_1400b8fb-84d6-44db-86c9-455687380a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PaymentOfDamagesClaimedByCounterparty_526bdb67-5e8f-4a43-9394-a8df24f9cc46" xlink:href="sny-20221231.xsd#sny_PaymentOfDamagesClaimedByCounterparty"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_PaymentOfDamagesClaimedByCounterparty_526bdb67-5e8f-4a43-9394-a8df24f9cc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOtherManufacturersInvolvedInProceedings_b81f6b6a-e7ca-4027-9ab7-e7a245297fcd" xlink:href="sny-20221231.xsd#sny_NumberOfOtherManufacturersInvolvedInProceedings"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_NumberOfOtherManufacturersInvolvedInProceedings_b81f6b6a-e7ca-4027-9ab7-e7a245297fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EquityInvestmentSoldPercentage_06712db6-ced0-4df7-a118-f00834028ded" xlink:href="sny-20221231.xsd#sny_EquityInvestmentSoldPercentage"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_EquityInvestmentSoldPercentage_06712db6-ced0-4df7-a118-f00834028ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking_59961510-92b9-4f80-a339-cf0e19fce866" xlink:href="sny-20221231.xsd#sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking_59961510-92b9-4f80-a339-cf0e19fce866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense_6d6d9172-18a9-418a-b3c3-7e15db042f50" xlink:href="sny-20221231.xsd#sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_0f959917-7a4e-4182-95d3-7617bbcab0cd" xlink:to="loc_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense_6d6d9172-18a9-418a-b3c3-7e15db042f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_da173b4f-7945-47c0-b8f5-b9e2cccb03d8" xlink:href="sny-20221231.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable_f5fe7644-077b-4d6b-9dd0-35426069072b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherProvisionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_da173b4f-7945-47c0-b8f5-b9e2cccb03d8" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsTable_f5fe7644-077b-4d6b-9dd0-35426069072b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_87a2d511-989f-483c-98ba-5a433a8f2d33" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_f5fe7644-077b-4d6b-9dd0-35426069072b" xlink:to="loc_srt_CounterpartyNameAxis_87a2d511-989f-483c-98ba-5a433a8f2d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_35dceae1-6f84-4e3a-92f4-e73b3b9ba41b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_87a2d511-989f-483c-98ba-5a433a8f2d33" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_35dceae1-6f84-4e3a-92f4-e73b3b9ba41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MedicaidMember_53dd8f9c-fb93-45c7-91fb-839b2b456132" xlink:href="sny-20221231.xsd#sny_MedicaidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_35dceae1-6f84-4e3a-92f4-e73b3b9ba41b" xlink:to="loc_sny_MedicaidMember_53dd8f9c-fb93-45c7-91fb-839b2b456132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MedicareMember_c52ac651-c36a-4782-bb4a-217bf2adb7bf" xlink:href="sny-20221231.xsd#sny_MedicareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_35dceae1-6f84-4e3a-92f4-e73b3b9ba41b" xlink:to="loc_sny_MedicareMember_c52ac651-c36a-4782-bb4a-217bf2adb7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_f5fd86e2-3390-433c-b6d3-43ee4ccbe17c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_f5fe7644-077b-4d6b-9dd0-35426069072b" xlink:to="loc_ifrs-full_GeographicalAreasAxis_f5fd86e2-3390-433c-b6d3-43ee4ccbe17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_7b216010-5879-42ae-8cce-5c10a18fed26" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_f5fd86e2-3390-433c-b6d3-43ee4ccbe17c" xlink:to="loc_ifrs-full_GeographicalAreasMember_7b216010-5879-42ae-8cce-5c10a18fed26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_99d983ab-91e8-46d6-adfc-f161e8408603" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_7b216010-5879-42ae-8cce-5c10a18fed26" xlink:to="loc_country_US_99d983ab-91e8-46d6-adfc-f161e8408603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_de9f01ef-ed15-46d1-af05-3e067556e170" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_f5fe7644-077b-4d6b-9dd0-35426069072b" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_de9f01ef-ed15-46d1-af05-3e067556e170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_de9f01ef-ed15-46d1-af05-3e067556e170" xlink:to="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GovernmentAndStateProgramsMember_5029481f-b11d-4df5-9f7b-e39b4e1d5fe3" xlink:href="sny-20221231.xsd#sny_GovernmentAndStateProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_GovernmentAndStateProgramsMember_5029481f-b11d-4df5-9f7b-e39b4e1d5fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ManagedCareAndGPOProgramsMember_ecdfc119-82b7-41e2-bab0-eff245885d96" xlink:href="sny-20221231.xsd#sny_ManagedCareAndGPOProgramsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_ManagedCareAndGPOProgramsMember_ecdfc119-82b7-41e2-bab0-eff245885d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChargebackIncentivesMember_b8fab536-4589-422b-bf81-0227ee4e2c23" xlink:href="sny-20221231.xsd#sny_ChargebackIncentivesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_ChargebackIncentivesMember_b8fab536-4589-422b-bf81-0227ee4e2c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RebatesAndDiscountsMember_96b82661-4d0f-4ae3-b5ef-687471a4bebf" xlink:href="sny-20221231.xsd#sny_RebatesAndDiscountsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_RebatesAndDiscountsMember_96b82661-4d0f-4ae3-b5ef-687471a4bebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SalesReturnMember_51c7327c-63d0-4d91-93ac-e5984e1957e9" xlink:href="sny-20221231.xsd#sny_SalesReturnMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_SalesReturnMember_51c7327c-63d0-4d91-93ac-e5984e1957e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherDeductionsMember_5110138b-567c-4b84-877e-674282e58bd5" xlink:href="sny-20221231.xsd#sny_OtherDeductionsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_OtherDeductionsMember_5110138b-567c-4b84-877e-674282e58bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ManagedCareMember_dd0cc5b1-ecc5-4a2a-b7fe-5562a8e0a8bf" xlink:href="sny-20221231.xsd#sny_ManagedCareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherProvisionsMember_629636b4-f810-482a-9a25-9009e41e4c9f" xlink:to="loc_sny_ManagedCareMember_dd0cc5b1-ecc5-4a2a-b7fe-5562a8e0a8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_f5fe7644-077b-4d6b-9dd0-35426069072b" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForDiscountsRebatesAndSalesReturns_4c6ef939-c4a2-4710-8669-86461ce6aae3" xlink:href="sny-20221231.xsd#sny_ProvisionsForDiscountsRebatesAndSalesReturns"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_ProvisionsForDiscountsRebatesAndSalesReturns_4c6ef939-c4a2-4710-8669-86461ce6aae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns_28869307-174f-4a90-87e9-bf42cb7a2142" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns_28869307-174f-4a90-87e9-bf42cb7a2142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales_07a0fe49-a624-4ba4-a473-2444523c59c9" xlink:href="sny-20221231.xsd#sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales_07a0fe49-a624-4ba4-a473-2444523c59c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales_e5702b06-4a7e-4f12-b9fa-958482a6acf6" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales_e5702b06-4a7e-4f12-b9fa-958482a6acf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns_bb1c9d39-0af4-4e08-b2d9-cf4263955219" xlink:href="sny-20221231.xsd#sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns_bb1c9d39-0af4-4e08-b2d9-cf4263955219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns_e3fe7baa-d999-4649-8a43-ec09dd0b9d6e" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns_e3fe7baa-d999-4649-8a43-ec09dd0b9d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ProvisionsForDiscountsRebatesAndSalesReturns_db5e5c7d-ef8c-4158-884f-ea8afc8b61ee" xlink:href="sny-20221231.xsd#sny_ProvisionsForDiscountsRebatesAndSalesReturns"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_5bed7436-21d9-416d-a761-1bc327bc1654" xlink:to="loc_sny_ProvisionsForDiscountsRebatesAndSalesReturns_db5e5c7d-ef8c-4158-884f-ea8afc8b61ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PersonnelcostsSummaryofPersonalCostsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeeBenefitsAbstract_2983e7e3-1d29-4d14-9580-920204370895" xlink:href="sny-20221231.xsd#sny_EmployeeBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WagesAndSalaries_0a1b4400-a0ae-4255-b4d2-707d9223cf53" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WagesAndSalaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_EmployeeBenefitsAbstract_2983e7e3-1d29-4d14-9580-920204370895" xlink:to="loc_ifrs-full_WagesAndSalaries_0a1b4400-a0ae-4255-b4d2-707d9223cf53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SocialSecurityContributions_09e1b845-1698-4226-b45a-f5660fe29efd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SocialSecurityContributions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_EmployeeBenefitsAbstract_2983e7e3-1d29-4d14-9580-920204370895" xlink:to="loc_ifrs-full_SocialSecurityContributions_09e1b845-1698-4226-b45a-f5660fe29efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_8b5e0324-2936-492e-b09a-de86addcf2a7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_EmployeeBenefitsAbstract_2983e7e3-1d29-4d14-9580-920204370895" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_8b5e0324-2936-492e-b09a-de86addcf2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_fd372324-06da-4400-813f-8a500bf1aa48" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_EmployeeBenefitsAbstract_2983e7e3-1d29-4d14-9580-920204370895" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_fd372324-06da-4400-813f-8a500bf1aa48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherEmployeeExpense_800bd4d5-74f2-4efb-b247-5aa8d4884e93" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherEmployeeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_EmployeeBenefitsAbstract_2983e7e3-1d29-4d14-9580-920204370895" xlink:to="loc_ifrs-full_OtherEmployeeExpense_800bd4d5-74f2-4efb-b247-5aa8d4884e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_3cf18343-9f18-4eba-b5a4-903dc5925f06" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_EmployeeBenefitsAbstract_2983e7e3-1d29-4d14-9580-920204370895" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_3cf18343-9f18-4eba-b5a4-903dc5925f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PersonnelcostsAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PersonnelcostsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PersonnelcostsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_EmployeeBenefitsAbstract_72213e97-d4ff-4ef9-b821-a0c02579b29e" xlink:href="sny-20221231.xsd#sny_EmployeeBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfEmployees_1e350b12-cb02-41ca-873d-84f48ae6c641" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_EmployeeBenefitsAbstract_72213e97-d4ff-4ef9-b821-a0c02579b29e" xlink:to="loc_ifrs-full_NumberOfEmployees_1e350b12-cb02-41ca-873d-84f48ae6c641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OtheroperatingincomeDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OtheroperatingincomeDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OtheroperatingincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_4b2ae192-3ab2-42f4-a063-33fea298a9bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeTable_858f8c2a-cf62-4e5c-a335-0b2505abf526" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_4b2ae192-3ab2-42f4-a063-33fea298a9bd" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeTable_858f8c2a-cf62-4e5c-a335-0b2505abf526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_547e71f5-8f23-46b9-b62e-b549892f2ec1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeTable_858f8c2a-cf62-4e5c-a335-0b2505abf526" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_547e71f5-8f23-46b9-b62e-b549892f2ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_c7ec2641-c88f-41d0-aa40-78a45eaca6ad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_547e71f5-8f23-46b9-b62e-b549892f2ec1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_c7ec2641-c88f-41d0-aa40-78a45eaca6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember_77b0be16-1544-4928-82e8-7a3f9c4d7a16" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_c7ec2641-c88f-41d0-aa40-78a45eaca6ad" xlink:to="loc_ifrs-full_OtherRelatedPartiesMember_77b0be16-1544-4928-82e8-7a3f9c4d7a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DaiichiSankyoMember_afccb819-4d5f-4f82-a14c-83738bc65d19" xlink:href="sny-20221231.xsd#sny_DaiichiSankyoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_c7ec2641-c88f-41d0-aa40-78a45eaca6ad" xlink:to="loc_sny_DaiichiSankyoMember_afccb819-4d5f-4f82-a14c-83738bc65d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ecfda4-e49f-4892-929e-356a1c5e6382" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeTable_858f8c2a-cf62-4e5c-a335-0b2505abf526" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ecfda4-e49f-4892-929e-356a1c5e6382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_fc2bab2d-d2b4-4b29-a1ed-484abb7baa35" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_85ecfda4-e49f-4892-929e-356a1c5e6382" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_fc2bab2d-d2b4-4b29-a1ed-484abb7baa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_3fed98b2-b7ea-4af5-a003-28f454117525" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_fc2bab2d-d2b4-4b29-a1ed-484abb7baa35" xlink:to="loc_sny_RegeneronMember_3fed98b2-b7ea-4af5-a003-28f454117525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationAxis_321eaf1a-1530-48d3-b83e-71d4eff52c6f" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeTable_858f8c2a-cf62-4e5c-a335-0b2505abf526" xlink:to="loc_sny_IncomeStatementLocationAxis_321eaf1a-1530-48d3-b83e-71d4eff52c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationDomain_ccad6032-35c6-421f-bbc0-4f7d9331c62e" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeStatementLocationAxis_321eaf1a-1530-48d3-b83e-71d4eff52c6f" xlink:to="loc_sny_IncomeStatementLocationDomain_ccad6032-35c6-421f-bbc0-4f7d9331c62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherOperatingIncomeExpenseMember_febc2f86-cb3c-4ede-aede-c0edb4a1b1d2" xlink:href="sny-20221231.xsd#sny_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeStatementLocationDomain_ccad6032-35c6-421f-bbc0-4f7d9331c62e" xlink:to="loc_sny_OtherOperatingIncomeExpenseMember_febc2f86-cb3c-4ede-aede-c0edb4a1b1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeLineItems_4deb78cf-2d69-42e5-a7db-0c9527aa70b5" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeTable_858f8c2a-cf62-4e5c-a335-0b2505abf526" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeLineItems_4deb78cf-2d69-42e5-a7db-0c9527aa70b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_6b02f596-e652-47aa-a211-6bd19461a6e6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeLineItems_4deb78cf-2d69-42e5-a7db-0c9527aa70b5" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_6b02f596-e652-47aa-a211-6bd19461a6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainsOnDivestmentOfProducts_e0889453-92cc-4431-9e56-4c2077678cc6" xlink:href="sny-20221231.xsd#sny_GainsOnDivestmentOfProducts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeLineItems_4deb78cf-2d69-42e5-a7db-0c9527aa70b5" xlink:to="loc_sny_GainsOnDivestmentOfProducts_e0889453-92cc-4431-9e56-4c2077678cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OtheroperatingexpensesAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OtheroperatingexpensesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OtheroperatingexpensesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_0086dbcf-f270-4da6-b674-e1f9b66cc63f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_a88c10db-af8d-4255-af0b-526ff7a3356c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_0086dbcf-f270-4da6-b674-e1f9b66cc63f" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_a88c10db-af8d-4255-af0b-526ff7a3356c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OtheroperatingexpensesOtherIncomeandExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_9028058f-4072-4527-bb0e-ea92ba897d7a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_9028058f-4072-4527-bb0e-ea92ba897d7a" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c977f893-141c-4b88-afc8-0adc12e5676e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:to="loc_srt_CounterpartyNameAxis_c977f893-141c-4b88-afc8-0adc12e5676e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46ba4884-cd27-4a2b-b058-1f9bb41f33cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_c977f893-141c-4b88-afc8-0adc12e5676e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46ba4884-cd27-4a2b-b058-1f9bb41f33cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesAllianceMember_5934143c-603b-4a2c-9310-116555454de0" xlink:href="sny-20221231.xsd#sny_AntibodiesAllianceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46ba4884-cd27-4a2b-b058-1f9bb41f33cc" xlink:to="loc_sny_AntibodiesAllianceMember_5934143c-603b-4a2c-9310-116555454de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImmunooncologyAllianceMember_db8ffafe-33c6-4fb9-a59b-3636a42de9f3" xlink:href="sny-20221231.xsd#sny_ImmunooncologyAllianceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46ba4884-cd27-4a2b-b058-1f9bb41f33cc" xlink:to="loc_sny_ImmunooncologyAllianceMember_db8ffafe-33c6-4fb9-a59b-3636a42de9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OthersCounterpartyMember_571e65d6-6c72-460b-82f4-f6c4581770a2" xlink:href="sny-20221231.xsd#sny_OthersCounterpartyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46ba4884-cd27-4a2b-b058-1f9bb41f33cc" xlink:to="loc_sny_OthersCounterpartyMember_571e65d6-6c72-460b-82f4-f6c4581770a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationAxis_4d96396e-d6ea-4a80-b6d0-40a78215f183" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:to="loc_sny_IncomeStatementLocationAxis_4d96396e-d6ea-4a80-b6d0-40a78215f183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:href="sny-20221231.xsd#sny_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeStatementLocationAxis_4d96396e-d6ea-4a80-b6d0-40a78215f183" xlink:to="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember_3f9a682d-b198-437d-b070-b6158eba654b" xlink:href="sny-20221231.xsd#sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:to="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember_3f9a682d-b198-437d-b070-b6158eba654b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember_ce7e4688-d3af-419d-ab59-9aaffba5d45b" xlink:href="sny-20221231.xsd#sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:to="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember_ce7e4688-d3af-419d-ab59-9aaffba5d45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommercializationRelatedExpensesMember_4dd94c8f-e294-4014-b6b8-aa18de0627de" xlink:href="sny-20221231.xsd#sny_CommercializationRelatedExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:to="loc_sny_CommercializationRelatedExpensesMember_4dd94c8f-e294-4014-b6b8-aa18de0627de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherOperatingIncomeExpenseMember_d9dd36ae-0b1f-4f63-9c70-35b9794c8a24" xlink:href="sny-20221231.xsd#sny_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeStatementLocationDomain_4bc88161-8ece-4aed-a846-55501c92291f" xlink:to="loc_sny_OtherOperatingIncomeExpenseMember_d9dd36ae-0b1f-4f63-9c70-35b9794c8a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_c71e4077-e257-4a78-9dc1-45d2dc51bdf0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_c71e4077-e257-4a78-9dc1-45d2dc51bdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_16d95220-6072-495d-ab78-c7e0e083308b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_c71e4077-e257-4a78-9dc1-45d2dc51bdf0" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_16d95220-6072-495d-ab78-c7e0e083308b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_f8a90eb8-8af6-495d-b6be-f4b0410462ee" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_16d95220-6072-495d-ab78-c7e0e083308b" xlink:to="loc_sny_RegeneronMember_f8a90eb8-8af6-495d-b6be-f4b0410462ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_4ece2edc-0b00-4163-b92f-61f5833341c7" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:to="loc_sny_PrincipalAlliancesAxis_4ece2edc-0b00-4163-b92f-61f5833341c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_fada925f-8d19-4ce7-8251-b0d0e6d839a0" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesAxis_4ece2edc-0b00-4163-b92f-61f5833341c7" xlink:to="loc_sny_PrincipalAlliancesDomain_fada925f-8d19-4ce7-8251-b0d0e6d839a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember_bcafc5b3-0e60-4b53-bbf5-0c88dfe96d5e" xlink:href="sny-20221231.xsd#sny_AntibodiesCollaborationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesDomain_fada925f-8d19-4ce7-8251-b0d0e6d839a0" xlink:to="loc_sny_AntibodiesCollaborationAgreementMember_bcafc5b3-0e60-4b53-bbf5-0c88dfe96d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_ff92457b-918c-4448-a269-ce188c253399" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:to="loc_ifrs-full_CounterpartiesAxis_ff92457b-918c-4448-a269-ce188c253399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_e20d22aa-1ccb-4491-b4fd-5949077d3b52" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_ff92457b-918c-4448-a269-ce188c253399" xlink:to="loc_ifrs-full_CounterpartiesMember_e20d22aa-1ccb-4491-b4fd-5949077d3b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_2b982a49-f862-4365-8d39-da245b6f43f5" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_e20d22aa-1ccb-4491-b4fd-5949077d3b52" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_2b982a49-f862-4365-8d39-da245b6f43f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:href="sny-20221231.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_91e05f02-aea4-4713-80fc-51067dd4f9f9" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_ce550650-0516-473e-8db0-5d22d0f3ca3f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_ce550650-0516-473e-8db0-5d22d0f3ca3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_7679f4ad-c81e-47d5-b102-1886a04874bd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MiscellaneousOtherOperatingIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_7679f4ad-c81e-47d5-b102-1886a04874bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_39e7d641-e52c-47e7-9cae-45bc9a562608" xlink:href="sny-20221231.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:to="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_39e7d641-e52c-47e7-9cae-45bc9a562608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_98dc7371-1e5f-4d3e-910b-44bfff7eff2b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_98dc7371-1e5f-4d3e-910b-44bfff7eff2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CommitmentsReceivedForDevelopmentCosts_d9f812ec-0556-406c-84cf-7b6345bf28c7" xlink:href="sny-20221231.xsd#sny_CommitmentsReceivedForDevelopmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_9b6a7bff-b17a-44b4-8885-a687e0cdd41a" xlink:to="loc_sny_CommitmentsReceivedForDevelopmentCosts_d9f812ec-0556-406c-84cf-7b6345bf28c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_ec828d51-f203-44a0-b742-781dae6ca558" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_caae5273-41b1-4420-93f4-7c8f4eb5c159" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_ec828d51-f203-44a0-b742-781dae6ca558" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_caae5273-41b1-4420-93f4-7c8f4eb5c159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories_442bdad0-b0c9-46ef-939c-5575baa32419" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_ec828d51-f203-44a0-b742-781dae6ca558" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories_442bdad0-b0c9-46ef-939c-5575baa32419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts_50bf475e-38dc-4759-bdca-ba8facb3a263" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_ec828d51-f203-44a0-b742-781dae6ca558" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts_50bf475e-38dc-4759-bdca-ba8facb3a263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts_4597d20d-772a-47b0-8d3a-28a714c0a6c8" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_ec828d51-f203-44a0-b742-781dae6ca558" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts_4597d20d-772a-47b0-8d3a-28a714c0a6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherRestructuringCosts_4960a17a-6254-4bd2-b3b3-6546ad2c5879" xlink:href="sny-20221231.xsd#sny_OtherRestructuringCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_ec828d51-f203-44a0-b742-781dae6ca558" xlink:to="loc_sny_OtherRestructuringCosts_4960a17a-6254-4bd2-b3b3-6546ad2c5879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_79718cb7-21d7-4a65-bca7-366aea14f601" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseOfRestructuringActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_ec828d51-f203-44a0-b742-781dae6ca558" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_79718cb7-21d7-4a65-bca7-366aea14f601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/RestructuringcostsandsimilaritemsAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#RestructuringcostsandsimilaritemsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/RestructuringcostsandsimilaritemsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_3d3da557-e892-448f-8fb4-7efe38192851" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_517e53f1-7577-47ae-aa96-4901fba6ddee" xlink:href="sny-20221231.xsd#sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_3d3da557-e892-448f-8fb4-7efe38192851" xlink:to="loc_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_517e53f1-7577-47ae-aa96-4901fba6ddee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_efbc298a-f70c-417f-9d0f-35f849003641" xlink:href="sny-20221231.xsd#sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_3d3da557-e892-448f-8fb4-7efe38192851" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_efbc298a-f70c-417f-9d0f-35f849003641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/OthergainsandlossesandlitigationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#OthergainsandlossesandlitigationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/OthergainsandlossesandlitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_d0ecfd13-2350-42a8-bb43-ddbd047d2cb9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGainsLossesAndLitigation_a93c7488-e4ba-405e-9df7-3b516dfcc05c" xlink:href="sny-20221231.xsd#sny_OtherGainsLossesAndLitigation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_d0ecfd13-2350-42a8-bb43-ddbd047d2cb9" xlink:to="loc_sny_OtherGainsLossesAndLitigation_a93c7488-e4ba-405e-9df7-3b516dfcc05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/FinancialexpensesandincomeDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#FinancialexpensesandincomeDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/FinancialexpensesandincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_9bbcb3a9-585b-44d4-a53e-76fa088dacdf" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_ccaba45a-a28b-45ac-8f91-61bf35a5824e" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_9bbcb3a9-585b-44d4-a53e-76fa088dacdf" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_ccaba45a-a28b-45ac-8f91-61bf35a5824e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsAxis_cf77badd-bc1f-48ea-aca2-bfe04bb2b321" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgedItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_ccaba45a-a28b-45ac-8f91-61bf35a5824e" xlink:to="loc_ifrs-full_HedgedItemsAxis_cf77badd-bc1f-48ea-aca2-bfe04bb2b321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_HedgedItemsMember_47013754-345c-462a-9f19-a7929f622635" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_HedgedItemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgedItemsAxis_cf77badd-bc1f-48ea-aca2-bfe04bb2b321" xlink:to="loc_ifrs-full_HedgedItemsMember_47013754-345c-462a-9f19-a7929f622635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesMember_755ad189-e865-4095-8add-96234be684b7" xlink:href="sny-20221231.xsd#sny_InterestRateAndCurrencyDerivativesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgedItemsMember_47013754-345c-462a-9f19-a7929f622635" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesMember_755ad189-e865-4095-8add-96234be684b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:href="sny-20221231.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_ccaba45a-a28b-45ac-8f91-61bf35a5824e" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_222a3643-0be8-4b3d-b4db-20a091e420b4" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_222a3643-0be8-4b3d-b4db-20a091e420b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestIncome_59202a47-8969-4995-9d69-247cf3628fd6" xlink:href="sny-20221231.xsd#sny_InterestIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_InterestIncome_59202a47-8969-4995-9d69-247cf3628fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CostOfDebtNet_2dacb047-9532-4868-8c15-9ff5c3d4e119" xlink:href="sny-20221231.xsd#sny_CostOfDebtNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_CostOfDebtNet_2dacb047-9532-4868-8c15-9ff5c3d4e119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonOperatingForeignExchangeGainsLosses_28fb8158-897a-4a52-be68-e62d502f70e4" xlink:href="sny-20221231.xsd#sny_NonOperatingForeignExchangeGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_NonOperatingForeignExchangeGainsLosses_28fb8158-897a-4a52-be68-e62d502f70e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_dfa6b1b9-0b23-4d04-a3d1-d637f6b0ce57" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_dfa6b1b9-0b23-4d04-a3d1-d637f6b0ce57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NetInterestCostRelatedToEmployeeBenefits_79c95d46-4089-4600-8373-b1399e928768" xlink:href="sny-20221231.xsd#sny_NetInterestCostRelatedToEmployeeBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_NetInterestCostRelatedToEmployeeBenefits_79c95d46-4089-4600-8373-b1399e928768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets_64c1ade2-b942-43b0-bbf1-ecea64db4e60" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets_64c1ade2-b942-43b0-bbf1-ecea64db4e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_c46e6a9d-fa09-4212-a94f-4f4904800948" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_c46e6a9d-fa09-4212-a94f-4f4904800948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherFinanceIncomeCost_7e89d265-f610-45c9-b3e2-bfaa1328bfe0" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_OtherFinanceIncomeCost_7e89d265-f610-45c9-b3e2-bfaa1328bfe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_a89d585a-285e-46ec-b91b-d4b1e95c290e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_FinanceIncomeCost_a89d585a-285e-46ec-b91b-d4b1e95c290e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_b2384a74-0c51-46cf-b9fc-1bdaab9d80a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_FinanceCosts_b2384a74-0c51-46cf-b9fc-1bdaab9d80a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_8bf10358-1e23-4a06-be47-882d6664ece5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_ifrs-full_FinanceIncome_8bf10358-1e23-4a06-be47-882d6664ece5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainOnDerivativesUsedToManageDebt_38162398-e707-4639-a438-60aa7668187c" xlink:href="sny-20221231.xsd#sny_GainOnDerivativesUsedToManageDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_GainOnDerivativesUsedToManageDebt_38162398-e707-4639-a438-60aa7668187c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents_c30d981a-242d-4e0d-b041-022b50e20614" xlink:href="sny-20221231.xsd#sny_GainOnDerivativesUsedToManageCashAndCashEquivalents"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_799a412f-9a26-4af7-bf9a-ffc629b7c9d1" xlink:to="loc_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents_c30d981a-242d-4e0d-b041-022b50e20614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/FinancialexpensesandincomeDetails_1" xlink:type="simple" xlink:href="sny-20221231.xsd#FinancialexpensesandincomeDetails_1"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/FinancialexpensesandincomeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxesAbstract_32f0dd83-d253-4816-a9ea-6f7bee7c61e8" xlink:href="sny-20221231.xsd#sny_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_785f3168-775e-4ca0-8a5f-6f04d00d66d6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_32f0dd83-d253-4816-a9ea-6f7bee7c61e8" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_785f3168-775e-4ca0-8a5f-6f04d00d66d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_e8ed1bbf-b3eb-4967-ad04-55966c3213f5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_32f0dd83-d253-4816-a9ea-6f7bee7c61e8" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_e8ed1bbf-b3eb-4967-ad04-55966c3213f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_23804b5f-a4a6-42ef-b38e-a4546dc90103" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_32f0dd83-d253-4816-a9ea-6f7bee7c61e8" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_23804b5f-a4a6-42ef-b38e-a4546dc90103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_dbe4ddf8-ef4c-4a83-8a65-aa3dff4a0091" xlink:href="sny-20221231.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_32f0dd83-d253-4816-a9ea-6f7bee7c61e8" xlink:to="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_dbe4ddf8-ef4c-4a83-8a65-aa3dff4a0091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeTaxesAbstract_d20526c1-9d85-4dc0-a005-28b2457f5184" xlink:href="sny-20221231.xsd#sny_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ApplicableTaxRate_8df1e534-cca7-48c9-ab9c-7aa4987505ea" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_d20526c1-9d85-4dc0-a005-28b2457f5184" xlink:to="loc_ifrs-full_ApplicableTaxRate_8df1e534-cca7-48c9-ab9c-7aa4987505ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_3a453a8d-1c66-4a3c-9855-53e0c62fe40f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_d20526c1-9d85-4dc0-a005-28b2457f5184" xlink:to="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_3a453a8d-1c66-4a3c-9855-53e0c62fe40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes_d08d6d4b-4757-46e2-a699-eedb93144ef4" xlink:href="sny-20221231.xsd#sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_d20526c1-9d85-4dc0-a005-28b2457f5184" xlink:to="loc_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes_d08d6d4b-4757-46e2-a699-eedb93144ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations_34bbe70b-e65f-4af7-a949-43e4f2805d97" xlink:href="sny-20221231.xsd#sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_d20526c1-9d85-4dc0-a005-28b2457f5184" xlink:to="loc_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations_34bbe70b-e65f-4af7-a949-43e4f2805d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_9ef82112-f9bd-4caf-99ab-b9e21d0f5ea5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_d20526c1-9d85-4dc0-a005-28b2457f5184" xlink:to="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_9ef82112-f9bd-4caf-99ab-b9e21d0f5ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate_9e9765bf-6f9e-40ab-9583-25c00a4af173" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AverageEffectiveTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_IncomeTaxesAbstract_d20526c1-9d85-4dc0-a005-28b2457f5184" xlink:to="loc_ifrs-full_AverageEffectiveTaxRate_9e9765bf-6f9e-40ab-9583-25c00a4af173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_0becc23a-e612-4aa7-81b3-79b10e1a8c7f" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_ced6d247-b3e4-4bfb-9055-08cf78dee931" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_0becc23a-e612-4aa7-81b3-79b10e1a8c7f" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_ced6d247-b3e4-4bfb-9055-08cf78dee931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4fc4e1c7-e16f-4f4b-a92c-f08e923cf7ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_ced6d247-b3e4-4bfb-9055-08cf78dee931" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4fc4e1c7-e16f-4f4b-a92c-f08e923cf7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_8cea4651-5a8f-4237-b257-822241ccc9b2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_4fc4e1c7-e16f-4f4b-a92c-f08e923cf7ef" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_8cea4651-5a8f-4237-b257-822241ccc9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_b8af2c92-433e-470e-91c1-8f7d53d9978a" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_8cea4651-5a8f-4237-b257-822241ccc9b2" xlink:to="loc_sny_RegeneronMember_b8af2c92-433e-470e-91c1-8f7d53d9978a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_a93e507e-351a-402e-b36a-66f37674d7e9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_ced6d247-b3e4-4bfb-9055-08cf78dee931" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_a93e507e-351a-402e-b36a-66f37674d7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_e6778ac1-a19d-466e-a21c-70d84b3ffbf8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_a93e507e-351a-402e-b36a-66f37674d7e9" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_e6778ac1-a19d-466e-a21c-70d84b3ffbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#NetincomeattributabletononcontrollinginterestsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_3a56ab53-3791-4921-93a6-ba35cfc0ec3d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable_90b961f2-4d67-4883-9647-3ced1e2a83a8" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_3a56ab53-3791-4921-93a6-ba35cfc0ec3d" xlink:to="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable_90b961f2-4d67-4883-9647-3ced1e2a83a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_3922ae9f-35b4-462c-90d1-29f23aed5b70" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable_90b961f2-4d67-4883-9647-3ced1e2a83a8" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_3922ae9f-35b4-462c-90d1-29f23aed5b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_25faedca-caad-4c8c-a290-59c8a61a68df" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_3922ae9f-35b4-462c-90d1-29f23aed5b70" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_25faedca-caad-4c8c-a290-59c8a61a68df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_1130b1b2-8d0e-4a78-879a-99822fc3585b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_25faedca-caad-4c8c-a290-59c8a61a68df" xlink:to="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_1130b1b2-8d0e-4a78-879a-99822fc3585b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems_914e4ae2-d06f-4603-a360-03c4a77309e9" xlink:href="sny-20221231.xsd#sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable_90b961f2-4d67-4883-9647-3ced1e2a83a8" xlink:to="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems_914e4ae2-d06f-4603-a360-03c4a77309e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_8fc85175-6e8d-49ba-86ec-7c902f5493a3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems_914e4ae2-d06f-4603-a360-03c4a77309e9" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_8fc85175-6e8d-49ba-86ec-7c902f5493a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/RelatedpartytransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#RelatedpartytransactionsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/RelatedpartytransactionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_RelatedPartyAbstract_7f901182-460c-49f5-a7ac-c3e64843147c" xlink:href="sny-20221231.xsd#sny_RelatedPartyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfExecutiveCommitteeMembers_af298f57-bd9d-43fb-8c23-d76b63a06895" xlink:href="sny-20221231.xsd#sny_NumberOfExecutiveCommitteeMembers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_7f901182-460c-49f5-a7ac-c3e64843147c" xlink:to="loc_sny_NumberOfExecutiveCommitteeMembers_af298f57-bd9d-43fb-8c23-d76b63a06895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_RelatedPartyAbstract_2d3e4700-fe69-4e34-bd2f-d110e8a9d8e1" xlink:href="sny-20221231.xsd#sny_RelatedPartyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_c55f471d-8b4e-450f-816c-8fe6c0b0cf65" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_2d3e4700-fe69-4e34-bd2f-d110e8a9d8e1" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_c55f471d-8b4e-450f-816c-8fe6c0b0cf65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_f6397955-c255-47fc-bdea-b1df4c6decc2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_c55f471d-8b4e-450f-816c-8fe6c0b0cf65" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_f6397955-c255-47fc-bdea-b1df4c6decc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_d5172248-af06-4689-8377-cee3ca8a5d9f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_c55f471d-8b4e-450f-816c-8fe6c0b0cf65" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_d5172248-af06-4689-8377-cee3ca8a5d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2b0b9300-74be-42d3-ab7d-9349190f5811" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_c55f471d-8b4e-450f-816c-8fe6c0b0cf65" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2b0b9300-74be-42d3-ab7d-9349190f5811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_3eccb16a-3573-4a68-9bdc-beb3890a5b88" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_c55f471d-8b4e-450f-816c-8fe6c0b0cf65" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_3eccb16a-3573-4a68-9bdc-beb3890a5b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/RelatedpartytransactionsSummaryofaggregateamountsPayabletoKeyManagementPersonnelDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#RelatedpartytransactionsSummaryofaggregateamountsPayabletoKeyManagementPersonnelDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/RelatedpartytransactionsSummaryofaggregateamountsPayabletoKeyManagementPersonnelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_RelatedPartyAbstract_c535a56a-4712-4183-abb4-8cd7107f8d07" xlink:href="sny-20221231.xsd#sny_RelatedPartyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee_eaad885e-4480-46c4-9cff-4da2b68254f1" xlink:href="sny-20221231.xsd#sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_c535a56a-4712-4183-abb4-8cd7107f8d07" xlink:to="loc_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee_eaad885e-4480-46c4-9cff-4da2b68254f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits_503c3cf8-5902-4622-8e39-b20d312203b9" xlink:href="sny-20221231.xsd#sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RelatedPartyAbstract_c535a56a-4712-4183-abb4-8cd7107f8d07" xlink:to="loc_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits_503c3cf8-5902-4622-8e39-b20d312203b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#DisclosuresaboutmajorcustomersandcreditriskDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_FinancialInstrumentsAbstract_305ad15d-3ace-44f1-a552-63ce5103fac0" xlink:href="sny-20221231.xsd#sny_FinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_1c2e3298-0e61-4653-8031-48d86bbf8f26" xlink:href="sny-20221231.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_305ad15d-3ace-44f1-a552-63ce5103fac0" xlink:to="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_1c2e3298-0e61-4653-8031-48d86bbf8f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersAxis_27a9ac4b-039d-4582-84e3-2f0007a29671" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_1c2e3298-0e61-4653-8031-48d86bbf8f26" xlink:to="loc_ifrs-full_MajorCustomersAxis_27a9ac4b-039d-4582-84e3-2f0007a29671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersAxis_27a9ac4b-039d-4582-84e3-2f0007a29671" xlink:to="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LargestCustomersMember_90667d62-3ff1-4edf-a601-7d8908e56717" xlink:href="sny-20221231.xsd#sny_LargestCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:to="loc_sny_LargestCustomersMember_90667d62-3ff1-4edf-a601-7d8908e56717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CustomerOneMember_2a180ebd-08c8-4b3c-b776-0531d4a7112a" xlink:href="sny-20221231.xsd#sny_CustomerOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:to="loc_sny_CustomerOneMember_2a180ebd-08c8-4b3c-b776-0531d4a7112a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CustomerTwoMember_fdad0101-a76e-4975-9deb-18bcdf02a594" xlink:href="sny-20221231.xsd#sny_CustomerTwoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:to="loc_sny_CustomerTwoMember_fdad0101-a76e-4975-9deb-18bcdf02a594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CustomerThreeMember_c73d07fc-2f7f-4637-b52b-6094c88f8980" xlink:href="sny-20221231.xsd#sny_CustomerThreeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersMember_547302e9-2c12-4f87-89c7-ed2cfc539a20" xlink:to="loc_sny_CustomerThreeMember_c73d07fc-2f7f-4637-b52b-6094c88f8980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_9d60e78f-a578-484f-9a9a-a0bc9540ee33" xlink:href="sny-20221231.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_1c2e3298-0e61-4653-8031-48d86bbf8f26" xlink:to="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_9d60e78f-a578-484f-9a9a-a0bc9540ee33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue_0a59145c-ec2f-4080-82eb-c5fceac4ca16" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_9d60e78f-a578-484f-9a9a-a0bc9540ee33" xlink:to="loc_ifrs-full_PercentageOfEntitysRevenue_0a59145c-ec2f-4080-82eb-c5fceac4ca16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OperatingSegmentsAbstract_5f935e6b-93b4-437f-9fce-ef5ab2f0cc71" xlink:href="sny-20221231.xsd#sny_OperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_c0cc4e96-d367-4d0b-991b-0f70a00234b2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_5f935e6b-93b4-437f-9fce-ef5ab2f0cc71" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_c0cc4e96-d367-4d0b-991b-0f70a00234b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ed0b1b10-cc93-48a7-b97e-b85e089c963d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_c0cc4e96-d367-4d0b-991b-0f70a00234b2" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ed0b1b10-cc93-48a7-b97e-b85e089c963d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_55ceda31-b655-4714-afb6-5bb32840ab85" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_ed0b1b10-cc93-48a7-b97e-b85e089c963d" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_55ceda31-b655-4714-afb6-5bb32840ab85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_ecd47ada-b064-4886-9232-9d6fb900dcd3" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_55ceda31-b655-4714-afb6-5bb32840ab85" xlink:to="loc_sny_RegeneronMember_ecd47ada-b064-4886-9232-9d6fb900dcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_9f2cf379-ce25-4437-a3d1-fabf6879252f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_c0cc4e96-d367-4d0b-991b-0f70a00234b2" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_9f2cf379-ce25-4437-a3d1-fabf6879252f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NumberOfOperatingSegments_39d07bd6-12c6-45df-aea7-0d489f3a5e79" xlink:href="sny-20221231.xsd#sny_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_9f2cf379-ce25-4437-a3d1-fabf6879252f" xlink:to="loc_sny_NumberOfOperatingSegments_39d07bd6-12c6-45df-aea7-0d489f3a5e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinancialAssetsNumberOfShares_d848f644-697e-431f-984c-1cdf2523461f" xlink:href="sny-20221231.xsd#sny_NonCurrentFinancialAssetsNumberOfShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_9f2cf379-ce25-4437-a3d1-fabf6879252f" xlink:to="loc_sny_NonCurrentFinancialAssetsNumberOfShares_d848f644-697e-431f-984c-1cdf2523461f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OperatingSegmentsAbstract_02726311-76ef-4f65-bea7-ada7050308f0" xlink:href="sny-20221231.xsd#sny_OperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4c39923e-692a-43b4-87a1-45fb9bd7cdc5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_02726311-76ef-4f65-bea7-ada7050308f0" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4c39923e-692a-43b4-87a1-45fb9bd7cdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_191ca006-58c9-460f-b843-6b62747495ff" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4c39923e-692a-43b4-87a1-45fb9bd7cdc5" xlink:to="loc_ifrs-full_GeographicalAreasAxis_191ca006-58c9-460f-b843-6b62747495ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_22a4b58c-8703-4ff4-8be9-15cf5e4378f8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_191ca006-58c9-460f-b843-6b62747495ff" xlink:to="loc_ifrs-full_GeographicalAreasMember_22a4b58c-8703-4ff4-8be9-15cf5e4378f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0cf4e5fd-18fc-429d-8cf6-27f0c5a719c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_22a4b58c-8703-4ff4-8be9-15cf5e4378f8" xlink:to="loc_srt_EuropeMember_0cf4e5fd-18fc-429d-8cf6-27f0c5a719c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_740d550b-9842-4cb7-8cf8-7f613dd9c680" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_22a4b58c-8703-4ff4-8be9-15cf5e4378f8" xlink:to="loc_country_US_740d550b-9842-4cb7-8cf8-7f613dd9c680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesInSegmentResultsMember_7a9be312-ebd4-4d05-acdb-9854d5351a63" xlink:href="sny-20221231.xsd#sny_OtherCountriesInSegmentResultsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_22a4b58c-8703-4ff4-8be9-15cf5e4378f8" xlink:to="loc_sny_OtherCountriesInSegmentResultsMember_7a9be312-ebd4-4d05-acdb-9854d5351a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_79833c56-fc62-4ac7-a41c-e1b3c4a4a61c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4c39923e-692a-43b4-87a1-45fb9bd7cdc5" xlink:to="loc_ifrs-full_SegmentsAxis_79833c56-fc62-4ac7-a41c-e1b3c4a4a61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_028cdc09-fea2-4fda-8835-2cee69c4e0ef" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_79833c56-fc62-4ac7-a41c-e1b3c4a4a61c" xlink:to="loc_ifrs-full_SegmentsMember_028cdc09-fea2-4fda-8835-2cee69c4e0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsSegmentMember_1569f7a9-cd25-4ede-ad01-2b72f8908935" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_028cdc09-fea2-4fda-8835-2cee69c4e0ef" xlink:to="loc_sny_PharmaceuticalsSegmentMember_1569f7a9-cd25-4ede-ad01-2b72f8908935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesSegmentMember_1e8c0fcb-a145-4069-9482-b7370658d5a7" xlink:href="sny-20221231.xsd#sny_VaccinesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_028cdc09-fea2-4fda-8835-2cee69c4e0ef" xlink:to="loc_sny_VaccinesSegmentMember_1e8c0fcb-a145-4069-9482-b7370658d5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareSegmentMember_62246092-9f73-4921-80e9-7a498ae2495a" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_028cdc09-fea2-4fda-8835-2cee69c4e0ef" xlink:to="loc_sny_ConsumerHealthcareSegmentMember_62246092-9f73-4921-80e9-7a498ae2495a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_754ce55c-ea91-4ecc-9d58-3254ba1cd2c1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4c39923e-692a-43b4-87a1-45fb9bd7cdc5" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_754ce55c-ea91-4ecc-9d58-3254ba1cd2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_754ce55c-ea91-4ecc-9d58-3254ba1cd2c1" xlink:to="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DupixentMember_8ba397b9-56e6-4ef9-bd56-dc6499bc1270" xlink:href="sny-20221231.xsd#sny_DupixentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_DupixentMember_8ba397b9-56e6-4ef9-bd56-dc6499bc1270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NeurologyImmunologyMember_07a4e42f-3063-4ed2-94b7-2e0f8a5f4056" xlink:href="sny-20221231.xsd#sny_NeurologyImmunologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_NeurologyImmunologyMember_07a4e42f-3063-4ed2-94b7-2e0f8a5f4056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AubagioMember_d290b8d8-702c-4efe-a01e-9851be973d65" xlink:href="sny-20221231.xsd#sny_AubagioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_NeurologyImmunologyMember_07a4e42f-3063-4ed2-94b7-2e0f8a5f4056" xlink:to="loc_sny_AubagioMember_d290b8d8-702c-4efe-a01e-9851be973d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RareDiseasesMember_3b973703-184a-4cfa-abd9-0056720bbbba" xlink:href="sny-20221231.xsd#sny_RareDiseasesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_RareDiseasesMember_3b973703-184a-4cfa-abd9-0056720bbbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CerezymeMember_c6ebddc9-7405-400e-b4e7-a642b7423ca9" xlink:href="sny-20221231.xsd#sny_CerezymeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RareDiseasesMember_3b973703-184a-4cfa-abd9-0056720bbbba" xlink:to="loc_sny_CerezymeMember_c6ebddc9-7405-400e-b4e7-a642b7423ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_FabrazymeMember_d7d9a2ba-24c6-4aca-8f14-53f08b970bb2" xlink:href="sny-20221231.xsd#sny_FabrazymeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RareDiseasesMember_3b973703-184a-4cfa-abd9-0056720bbbba" xlink:to="loc_sny_FabrazymeMember_d7d9a2ba-24c6-4aca-8f14-53f08b970bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MyozymeOrLumizymeMember_0780dec4-f7ff-403c-9228-acdc42abc4a6" xlink:href="sny-20221231.xsd#sny_MyozymeOrLumizymeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RareDiseasesMember_3b973703-184a-4cfa-abd9-0056720bbbba" xlink:to="loc_sny_MyozymeOrLumizymeMember_0780dec4-f7ff-403c-9228-acdc42abc4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OncologyMember_549508ce-6c69-4891-858c-5a25c6468385" xlink:href="sny-20221231.xsd#sny_OncologyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_OncologyMember_549508ce-6c69-4891-858c-5a25c6468385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_JevtanaMember_2555da3d-21a8-43bf-89c5-01560bcabecc" xlink:href="sny-20221231.xsd#sny_JevtanaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OncologyMember_549508ce-6c69-4891-858c-5a25c6468385" xlink:to="loc_sny_JevtanaMember_2555da3d-21a8-43bf-89c5-01560bcabecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RareBloodDisordersMember_4f3cbfe7-29ec-493b-918e-89e33b116176" xlink:href="sny-20221231.xsd#sny_RareBloodDisordersMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_RareBloodDisordersMember_4f3cbfe7-29ec-493b-918e-89e33b116176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AlprolixMember_b7bf77db-45cf-4ade-90b0-e48c7a0d56f6" xlink:href="sny-20221231.xsd#sny_AlprolixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RareBloodDisordersMember_4f3cbfe7-29ec-493b-918e-89e33b116176" xlink:to="loc_sny_AlprolixMember_b7bf77db-45cf-4ade-90b0-e48c7a0d56f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EloctateMember_7ca03afb-e9f1-4940-9c27-3fed693ac855" xlink:href="sny-20221231.xsd#sny_EloctateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_RareBloodDisordersMember_4f3cbfe7-29ec-493b-918e-89e33b116176" xlink:to="loc_sny_EloctateMember_7ca03afb-e9f1-4940-9c27-3fed693ac855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CoreAssetsMember_719e6bb2-df06-496b-b0c7-18914489d274" xlink:href="sny-20221231.xsd#sny_CoreAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_CoreAssetsMember_719e6bb2-df06-496b-b0c7-18914489d274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LovenoxMember_605cc56f-4664-4ae7-a15f-998a421df653" xlink:href="sny-20221231.xsd#sny_LovenoxMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CoreAssetsMember_719e6bb2-df06-496b-b0c7-18914489d274" xlink:to="loc_sny_LovenoxMember_605cc56f-4664-4ae7-a15f-998a421df653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ToujeoMember_d30ec3de-396b-4672-80dc-e3e765da1a7e" xlink:href="sny-20221231.xsd#sny_ToujeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CoreAssetsMember_719e6bb2-df06-496b-b0c7-18914489d274" xlink:to="loc_sny_ToujeoMember_d30ec3de-396b-4672-80dc-e3e765da1a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PlavixMember_da74bb54-865c-4783-ad5d-de1163ce2ad6" xlink:href="sny-20221231.xsd#sny_PlavixMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_CoreAssetsMember_719e6bb2-df06-496b-b0c7-18914489d274" xlink:to="loc_sny_PlavixMember_da74bb54-865c-4783-ad5d-de1163ce2ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCoreAssetsMember_76c79eaa-baff-4178-aa0a-f56c3b4f1e1c" xlink:href="sny-20221231.xsd#sny_NonCoreAssetsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_NonCoreAssetsMember_76c79eaa-baff-4178-aa0a-f56c3b4f1e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_LantusMember_4d735199-c5ce-43ac-8940-6ec999a7ae24" xlink:href="sny-20221231.xsd#sny_LantusMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_NonCoreAssetsMember_76c79eaa-baff-4178-aa0a-f56c3b4f1e1c" xlink:to="loc_sny_LantusMember_4d735199-c5ce-43ac-8940-6ec999a7ae24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherNonCoreAssetsMember_05cd0a14-4ecc-4541-8347-6821881746bf" xlink:href="sny-20221231.xsd#sny_OtherNonCoreAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_NonCoreAssetsMember_76c79eaa-baff-4178-aa0a-f56c3b4f1e1c" xlink:to="loc_sny_OtherNonCoreAssetsMember_05cd0a14-4ecc-4541-8347-6821881746bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IndustrialSalesMember_d255898f-080c-4e18-aff1-f132964b46f4" xlink:href="sny-20221231.xsd#sny_IndustrialSalesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_IndustrialSalesMember_d255898f-080c-4e18-aff1-f132964b46f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PolioPertussisHibVaccinesMember_ca1f2629-5da8-479d-bb7c-794682749627" xlink:href="sny-20221231.xsd#sny_PolioPertussisHibVaccinesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_PolioPertussisHibVaccinesMember_ca1f2629-5da8-479d-bb7c-794682749627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InfluenzaVaccinesMember_79e1c5d6-082d-41cc-905f-feaafeb90588" xlink:href="sny-20221231.xsd#sny_InfluenzaVaccinesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_InfluenzaVaccinesMember_79e1c5d6-082d-41cc-905f-feaafeb90588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AllergyMember_e3191faf-c79f-4e73-9bb1-4388d97d106c" xlink:href="sny-20221231.xsd#sny_AllergyMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_AllergyMember_e3191faf-c79f-4e73-9bb1-4388d97d106c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PainCareMember_33378a77-1f3c-4329-ac45-4a745b5add1b" xlink:href="sny-20221231.xsd#sny_PainCareMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_PainCareMember_33378a77-1f3c-4329-ac45-4a745b5add1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DigestiveWellnessMember_13794e6a-b7af-48ce-828e-87ce959734a3" xlink:href="sny-20221231.xsd#sny_DigestiveWellnessMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_8db89b6a-f5fe-4229-a719-2f14f49516ee" xlink:to="loc_sny_DigestiveWellnessMember_13794e6a-b7af-48ce-828e-87ce959734a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_d8c4ac2e-da6c-43af-8859-3807bef76ae9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4c39923e-692a-43b4-87a1-45fb9bd7cdc5" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_d8c4ac2e-da6c-43af-8859-3807bef76ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_035f9297-ebab-4881-b67c-7552e41ede18" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_d8c4ac2e-da6c-43af-8859-3807bef76ae9" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_035f9297-ebab-4881-b67c-7552e41ede18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationScheduleofSegmentResultsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OperatingSegmentsAbstract_e357c75c-9061-42b5-a323-07f65de3fb8b" xlink:href="sny-20221231.xsd#sny_OperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_7bee15cb-2de1-4cb4-9e38-924d9191a3a7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_e357c75c-9061-42b5-a323-07f65de3fb8b" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_7bee15cb-2de1-4cb4-9e38-924d9191a3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_4b5dbbb3-b69e-46b2-9ad4-4d2768d5dda7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_7bee15cb-2de1-4cb4-9e38-924d9191a3a7" xlink:to="loc_ifrs-full_SegmentsAxis_4b5dbbb3-b69e-46b2-9ad4-4d2768d5dda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_4b5dbbb3-b69e-46b2-9ad4-4d2768d5dda7" xlink:to="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsSegmentMember_d18d4be7-945d-44d7-b813-7b9e1d583345" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:to="loc_sny_PharmaceuticalsSegmentMember_d18d4be7-945d-44d7-b813-7b9e1d583345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesSegmentMember_df4747c1-0b3c-48ca-ac7c-f290289649b2" xlink:href="sny-20221231.xsd#sny_VaccinesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:to="loc_sny_VaccinesSegmentMember_df4747c1-0b3c-48ca-ac7c-f290289649b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareSegmentMember_7d3d3e89-bf2e-4ef1-85e2-07943650f63f" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:to="loc_sny_ConsumerHealthcareSegmentMember_7d3d3e89-bf2e-4ef1-85e2-07943650f63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AllOtherSegmentsMember_1e0a1eff-80ba-4b14-884d-37aafc448065" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllOtherSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:to="loc_ifrs-full_AllOtherSegmentsMember_1e0a1eff-80ba-4b14-884d-37aafc448065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReportableSegmentsMember_e4144221-0e4c-40ad-9821-1b12a0724c15" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReportableSegmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_732135f2-3844-407e-851d-dea795fb2549" xlink:to="loc_ifrs-full_ReportableSegmentsMember_e4144221-0e4c-40ad-9821-1b12a0724c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_7bee15cb-2de1-4cb4-9e38-924d9191a3a7" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_4868bf64-8815-45f8-9e74-59f9ab284bb9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_4868bf64-8815-45f8-9e74-59f9ab284bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherRevenue_e8e3d10d-63b5-4cf1-8968-a618b4e5a200" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_OtherRevenue_e8e3d10d-63b5-4cf1-8968-a618b4e5a200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_8207a10e-2694-4efe-94f0-3b6baad309a6" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_CostOfSales_8207a10e-2694-4efe-94f0-3b6baad309a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_7ff15747-00da-491c-8eaf-8517dfc238b8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_7ff15747-00da-491c-8eaf-8517dfc238b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_6addbd0c-3ba5-4611-a18a-378838830801" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_6addbd0c-3ba5-4611-a18a-378838830801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_7c641c1d-9dd7-4b0d-b9c3-caf9204249ab" xlink:href="sny-20221231.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_7c641c1d-9dd7-4b0d-b9c3-caf9204249ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_d783f267-3a68-4ef9-bbb0-62bef90564ce" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_d783f267-3a68-4ef9-bbb0-62bef90564ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_44114a32-7143-4d3d-8e16-806ef7599d56" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_44114a32-7143-4d3d-8e16-806ef7599d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessOperatingIncome_9ff9aad4-a53e-4f87-8e57-91340f52f715" xlink:href="sny-20221231.xsd#sny_BusinessOperatingIncome"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_01dc1e83-9be6-4942-8c03-481add6b4d51" xlink:to="loc_sny_BusinessOperatingIncome_9ff9aad4-a53e-4f87-8e57-91340f52f715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OperatingSegmentsAbstract_5c9cb537-d72c-406e-8fdb-2e460922c4f7" xlink:href="sny-20221231.xsd#sny_OperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_5c9cb537-d72c-406e-8fdb-2e460922c4f7" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_0fc54895-ccbf-4558-805c-218cc7feca59" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_0fc54895-ccbf-4558-805c-218cc7feca59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_4bcfcd26-18ca-4343-8b71-d3ef2e3b12b9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_0fc54895-ccbf-4558-805c-218cc7feca59" xlink:to="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_4bcfcd26-18ca-4343-8b71-d3ef2e3b12b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingSegmentsMember_8d8505c9-1506-44c5-9de9-514538c95fa7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_4bcfcd26-18ca-4343-8b71-d3ef2e3b12b9" xlink:to="loc_ifrs-full_OperatingSegmentsMember_8d8505c9-1506-44c5-9de9-514538c95fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember_db1dd850-b8a3-4bd3-bb32-6e19a4f55ad9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_4bcfcd26-18ca-4343-8b71-d3ef2e3b12b9" xlink:to="loc_ifrs-full_MaterialReconcilingItemsMember_db1dd850-b8a3-4bd3-bb32-6e19a4f55ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_b6793ce8-6e83-4da8-aff9-3b82ea49dd3e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_b6793ce8-6e83-4da8-aff9-3b82ea49dd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_dbefeee4-43d2-44c0-bce0-9d430aaddff3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_b6793ce8-6e83-4da8-aff9-3b82ea49dd3e" xlink:to="loc_ifrs-full_EntitysTotalForAssociatesMember_dbefeee4-43d2-44c0-bce0-9d430aaddff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronMember_ec6fe16a-e6d7-4cd7-8a07-27374c1f7ef1" xlink:href="sny-20221231.xsd#sny_RegeneronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_dbefeee4-43d2-44c0-bce0-9d430aaddff3" xlink:to="loc_sny_RegeneronMember_ec6fe16a-e6d7-4cd7-8a07-27374c1f7ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockAxis_96a4bd43-67f7-4df0-bfa4-95a47367eaba" xlink:href="sny-20221231.xsd#sny_SaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_sny_SaleOfStockAxis_96a4bd43-67f7-4df0-bfa4-95a47367eaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockDomain_fd185597-a634-480a-a65a-53dba3117056" xlink:href="sny-20221231.xsd#sny_SaleOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_SaleOfStockAxis_96a4bd43-67f7-4df0-bfa4-95a47367eaba" xlink:to="loc_sny_SaleOfStockDomain_fd185597-a634-480a-a65a-53dba3117056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PublicOfferingMember_c8b70a90-8c53-4728-ab2e-ddff298dde20" xlink:href="sny-20221231.xsd#sny_PublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_SaleOfStockDomain_fd185597-a634-480a-a65a-53dba3117056" xlink:to="loc_sny_PublicOfferingMember_c8b70a90-8c53-4728-ab2e-ddff298dde20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RepurchaseFromTheCounterpartMember_8d0b7064-273f-4c56-99fa-af3c064db765" xlink:href="sny-20221231.xsd#sny_RepurchaseFromTheCounterpartMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_SaleOfStockDomain_fd185597-a634-480a-a65a-53dba3117056" xlink:to="loc_sny_RepurchaseFromTheCounterpartMember_8d0b7064-273f-4c56-99fa-af3c064db765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_ce72a5d4-3453-48e9-b31d-2516e0d2f3d1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_ifrs-full_CounterpartiesAxis_ce72a5d4-3453-48e9-b31d-2516e0d2f3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesMember_43fdb6de-eb1f-43da-bc0e-d99402b4c7fe" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_ce72a5d4-3453-48e9-b31d-2516e0d2f3d1" xlink:to="loc_ifrs-full_CounterpartiesMember_43fdb6de-eb1f-43da-bc0e-d99402b4c7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegeneronPharmaceuticalsIncMember_d619d39d-a3b8-47f9-ab5e-4a3a4cea06f4" xlink:href="sny-20221231.xsd#sny_RegeneronPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_43fdb6de-eb1f-43da-bc0e-d99402b4c7fe" xlink:to="loc_sny_RegeneronPharmaceuticalsIncMember_d619d39d-a3b8-47f9-ab5e-4a3a4cea06f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesAxis_d94432c2-3327-45bf-9e69-813467bb182f" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_sny_PrincipalAlliancesAxis_d94432c2-3327-45bf-9e69-813467bb182f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipalAlliancesDomain_2d97f25d-d6af-4596-b100-e3277713b544" xlink:href="sny-20221231.xsd#sny_PrincipalAlliancesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesAxis_d94432c2-3327-45bf-9e69-813467bb182f" xlink:to="loc_sny_PrincipalAlliancesDomain_2d97f25d-d6af-4596-b100-e3277713b544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImmunoOncologyCollaborationAgreementMember_6613b46d-f688-4ccb-8747-8ab6deb8a86d" xlink:href="sny-20221231.xsd#sny_ImmunoOncologyCollaborationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesDomain_2d97f25d-d6af-4596-b100-e3277713b544" xlink:to="loc_sny_ImmunoOncologyCollaborationAgreementMember_6613b46d-f688-4ccb-8747-8ab6deb8a86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_28169b7e-71af-42f7-9543-b0acb39a4c1f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_srt_ProductOrServiceAxis_28169b7e-71af-42f7-9543-b0acb39a4c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c06dfcbb-b784-4fbd-9a99-cc89abc5713e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_28169b7e-71af-42f7-9543-b0acb39a4c1f" xlink:to="loc_srt_ProductsAndServicesDomain_c06dfcbb-b784-4fbd-9a99-cc89abc5713e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EloctateMember_11cd4bc7-fb82-4be4-8dac-c30c151298d2" xlink:href="sny-20221231.xsd#sny_EloctateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c06dfcbb-b784-4fbd-9a99-cc89abc5713e" xlink:to="loc_sny_EloctateMember_11cd4bc7-fb82-4be4-8dac-c30c151298d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_9019047e-c8b1-46de-9ab6-6fa7cda813d2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_9019047e-c8b1-46de-9ab6-6fa7cda813d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_8a1d8cef-9b60-430c-923d-5133c2263346" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_9019047e-c8b1-46de-9ab6-6fa7cda813d2" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_8a1d8cef-9b60-430c-923d-5133c2263346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_8792be6b-0517-4a93-a1cc-ba03c089fa0d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_8a1d8cef-9b60-430c-923d-5133c2263346" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_8792be6b-0517-4a93-a1cc-ba03c089fa0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_8e27ce10-5aff-4cd5-b814-38c01256d3a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_8e27ce10-5aff-4cd5-b814-38c01256d3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesMember_c86a4fc0-7bfc-4d11-aa49-0d9c185a3e3e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_8e27ce10-5aff-4cd5-b814-38c01256d3a8" xlink:to="loc_ifrs-full_ProductsAndServicesMember_c86a4fc0-7bfc-4d11-aa49-0d9c185a3e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SAR444245Member_a111332a-2c4e-48b3-b40e-489c19ab26d4" xlink:href="sny-20221231.xsd#sny_SAR444245Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesMember_c86a4fc0-7bfc-4d11-aa49-0d9c185a3e3e" xlink:to="loc_sny_SAR444245Member_a111332a-2c4e-48b3-b40e-489c19ab26d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_cc888f8e-a503-49ca-8d21-94599301617c" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BusinessOperatingIncome_fc9dbd12-d48d-47a4-a589-3254a6fcb92b" xlink:href="sny-20221231.xsd#sny_BusinessOperatingIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_BusinessOperatingIncome_fc9dbd12-d48d-47a4-a589-3254a6fcb92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_638b0924-b2aa-4f26-95b4-53a219f76d35" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_638b0924-b2aa-4f26-95b4-53a219f76d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_bf6af6d8-528f-449b-afa0-6b9f478d2b1b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_bf6af6d8-528f-449b-afa0-6b9f478d2b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_a3f5a938-2d95-492b-8293-b8eb3b872d91" xlink:href="sny-20221231.xsd#sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_a3f5a938-2d95-492b-8293-b8eb3b872d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_0fb71128-d0df-4fef-a16d-b16327752fb3" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_0fb71128-d0df-4fef-a16d-b16327752fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_cef3de49-c676-4925-8c15-b767a18e419c" xlink:href="sny-20221231.xsd#sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_cef3de49-c676-4925-8c15-b767a18e419c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_11be1547-5549-4080-aa14-d1df2a6a1aff" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseOfRestructuringActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_11be1547-5549-4080-aa14-d1df2a6a1aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherGainsLossesAndLitigation_87eac66f-53cf-4c15-8dde-f85e276bb66e" xlink:href="sny-20221231.xsd#sny_OtherGainsLossesAndLitigation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_OtherGainsLossesAndLitigation_87eac66f-53cf-4c15-8dde-f85e276bb66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GainOnRegeneronInvestmentSold_f032fd13-358e-46a9-8ed8-9c30bde82a61" xlink:href="sny-20221231.xsd#sny_GainOnRegeneronInvestmentSold"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_GainOnRegeneronInvestmentSold_f032fd13-358e-46a9-8ed8-9c30bde82a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeResultingFromOutLicensing_ab483696-a92d-4360-8b20-4e503bd84f2e" xlink:href="sny-20221231.xsd#sny_IncomeResultingFromOutLicensing"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_IncomeResultingFromOutLicensing_ab483696-a92d-4360-8b20-4e503bd84f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_2bb2a1ed-b980-4787-bf5c-d22c8443319f" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_2bb2a1ed-b980-4787-bf5c-d22c8443319f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_b8c189d2-b43c-449d-a7ab-cc3dfde367ad" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_FinanceCosts_b8c189d2-b43c-449d-a7ab-cc3dfde367ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_a0710ebe-8594-44d5-b989-6cceb485a1df" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_ifrs-full_FinanceIncome_a0710ebe-8594-44d5-b989-6cceb485a1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_70ede18b-38ed-4a71-8726-e32e89a29c5d" xlink:href="sny-20221231.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_70ede18b-38ed-4a71-8726-e32e89a29c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_NonCurrentFinancialAssetsNumberOfShares_c005dc46-ce25-44ee-9151-c22e8aa11727" xlink:href="sny-20221231.xsd#sny_NonCurrentFinancialAssetsNumberOfShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_NonCurrentFinancialAssetsNumberOfShares_c005dc46-ce25-44ee-9151-c22e8aa11727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_65ad5155-5bc3-4bbb-8058-91fc3effda5b" xlink:href="sny-20221231.xsd#sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_65ad5155-5bc3-4bbb-8058-91fc3effda5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill_c5c138a3-8918-45d5-b4f1-950bc7e01ab7" xlink:href="sny-20221231.xsd#sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill_c5c138a3-8918-45d5-b4f1-950bc7e01ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_82aa8876-d336-4393-9145-e97a29edaf5c" xlink:href="sny-20221231.xsd#sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal_82aa8876-d336-4393-9145-e97a29edaf5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction_0b968495-b561-436c-8e51-15635de60790" xlink:href="sny-20221231.xsd#sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction_0b968495-b561-436c-8e51-15635de60790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements_4e261df2-4c99-4976-b11e-9a6e8d78e819" xlink:href="sny-20221231.xsd#sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements_4e261df2-4c99-4976-b11e-9a6e8d78e819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements_314ec6f8-e687-4fb3-b1b4-062d48233e06" xlink:href="sny-20221231.xsd#sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_686c68ed-80a5-47c0-8500-e966e721153e" xlink:to="loc_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements_314ec6f8-e687-4fb3-b1b4-062d48233e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OperatingSegmentsAbstract_6b718cff-c088-4f03-80c7-eb3aa2e9f2e8" xlink:href="sny-20221231.xsd#sny_OperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_8a33c67b-555b-47e8-9422-6696120df3ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_6b718cff-c088-4f03-80c7-eb3aa2e9f2e8" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_8a33c67b-555b-47e8-9422-6696120df3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_ab6bc01a-fac3-491d-8dfe-9f861b0add1c" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_8a33c67b-555b-47e8-9422-6696120df3ca" xlink:to="loc_ifrs-full_SegmentsAxis_ab6bc01a-fac3-491d-8dfe-9f861b0add1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_ab6bc01a-fac3-491d-8dfe-9f861b0add1c" xlink:to="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PharmaceuticalsMember_119e5ee7-da94-4270-9183-ba23737e8c5a" xlink:href="sny-20221231.xsd#sny_PharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:to="loc_sny_PharmaceuticalsMember_119e5ee7-da94-4270-9183-ba23737e8c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaccinesMember_e9a79cd2-671b-44b4-8563-1fa4234a360a" xlink:href="sny-20221231.xsd#sny_VaccinesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:to="loc_sny_VaccinesMember_e9a79cd2-671b-44b4-8563-1fa4234a360a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ConsumerHealthcareSegmentMember_a26770c0-2d0f-4347-87af-de3463227897" xlink:href="sny-20221231.xsd#sny_ConsumerHealthcareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:to="loc_sny_ConsumerHealthcareSegmentMember_a26770c0-2d0f-4347-87af-de3463227897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReportableSegmentsMember_3e6c893a-b158-4a57-b8a5-ab0aa0f322c8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReportableSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_1294a84d-c800-465b-806e-408dbbe96a92" xlink:to="loc_ifrs-full_ReportableSegmentsMember_3e6c893a-b158-4a57-b8a5-ab0aa0f322c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_f74ebfd5-d88c-4e6c-90c2-6fa88cc13402" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_8a33c67b-555b-47e8-9422-6696120df3ca" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_f74ebfd5-d88c-4e6c-90c2-6fa88cc13402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InvestmentsInAssociatesAndJointVentures_6b747124-6117-44fd-9618-85ddf14f4573" xlink:href="sny-20221231.xsd#sny_InvestmentsInAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_f74ebfd5-d88c-4e6c-90c2-6fa88cc13402" xlink:to="loc_sny_InvestmentsInAssociatesAndJointVentures_6b747124-6117-44fd-9618-85ddf14f4573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_8ef3c053-aecf-4af5-8644-d2d2bb8d74fb" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_f74ebfd5-d88c-4e6c-90c2-6fa88cc13402" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_8ef3c053-aecf-4af5-8644-d2d2bb8d74fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_ca6b7c78-f7aa-4934-a3e3-5e75a0ba131a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_f74ebfd5-d88c-4e6c-90c2-6fa88cc13402" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_ca6b7c78-f7aa-4934-a3e3-5e75a0ba131a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_OperatingSegmentsAbstract_eacd1e76-32bf-4551-918f-848cfc180d92" xlink:href="sny-20221231.xsd#sny_OperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4e25e519-23ad-45ca-b5ff-58a5dc1fecbd" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OperatingSegmentsAbstract_eacd1e76-32bf-4551-918f-848cfc180d92" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4e25e519-23ad-45ca-b5ff-58a5dc1fecbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_06841405-0816-4cca-bfa6-09485f598f12" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4e25e519-23ad-45ca-b5ff-58a5dc1fecbd" xlink:to="loc_ifrs-full_GeographicalAreasAxis_06841405-0816-4cca-bfa6-09485f598f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_046524f3-204b-45c3-ab0b-753888a9b4a9" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_06841405-0816-4cca-bfa6-09485f598f12" xlink:to="loc_ifrs-full_GeographicalAreasMember_046524f3-204b-45c3-ab0b-753888a9b4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ReportableGeographicalZonesMember_ebc15e08-9f65-4126-8178-822f30caa15b" xlink:href="sny-20221231.xsd#sny_ReportableGeographicalZonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_046524f3-204b-45c3-ab0b-753888a9b4a9" xlink:to="loc_sny_ReportableGeographicalZonesMember_ebc15e08-9f65-4126-8178-822f30caa15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_661d6e3a-c3b9-4959-b6cc-323210fda877" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ReportableGeographicalZonesMember_ebc15e08-9f65-4126-8178-822f30caa15b" xlink:to="loc_srt_EuropeMember_661d6e3a-c3b9-4959-b6cc-323210fda877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_53eae7b3-caaa-485b-a225-af85129bb79b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EuropeMember_661d6e3a-c3b9-4959-b6cc-323210fda877" xlink:to="loc_country_FR_53eae7b3-caaa-485b-a225-af85129bb79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_1a30d78c-94e9-4c0f-921d-f78c34b325e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ReportableGeographicalZonesMember_ebc15e08-9f65-4126-8178-822f30caa15b" xlink:to="loc_srt_NorthAmericaMember_1a30d78c-94e9-4c0f-921d-f78c34b325e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_42f579d1-1980-4da1-9c43-fe26a8caee92" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NorthAmericaMember_1a30d78c-94e9-4c0f-921d-f78c34b325e8" xlink:to="loc_country_US_42f579d1-1980-4da1-9c43-fe26a8caee92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_04eda3a3-89ca-47ba-9347-3a6e3efb55c9" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ReportableGeographicalZonesMember_ebc15e08-9f65-4126-8178-822f30caa15b" xlink:to="loc_sny_OtherCountriesMember_04eda3a3-89ca-47ba-9347-3a6e3efb55c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_4e25e519-23ad-45ca-b5ff-58a5dc1fecbd" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_265ffd22-ab5d-4af3-95e9-daa05440ee9e" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_265ffd22-ab5d-4af3-95e9-daa05440ee9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_7a29f80e-ec3b-4e72-a648-1a6b6918d9a2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_7a29f80e-ec3b-4e72-a648-1a6b6918d9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Goodwill_08398261-4b03-48e5-a03b-009df6af2c61" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:to="loc_ifrs-full_Goodwill_08398261-4b03-48e5-a03b-009df6af2c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_38e39a14-ad4c-4a7c-bfa7-46adaec4e871" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_05d0a97c-ab5d-4729-b7a6-1d13b9c2da42" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_38e39a14-ad4c-4a7c-bfa7-46adaec4e871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#PrincipalaccountantsfeesandservicesDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f6aa9438-50b2-4230-902e-c38e269df7b7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAuditFeesAndOtherServicesTable_29915be1-319e-4ee6-9d44-01176a42f16d" xlink:href="sny-20221231.xsd#sny_DisclosureOfAuditFeesAndOtherServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f6aa9438-50b2-4230-902e-c38e269df7b7" xlink:to="loc_sny_DisclosureOfAuditFeesAndOtherServicesTable_29915be1-319e-4ee6-9d44-01176a42f16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsNameAxis_3c9997dc-0e0f-4cb9-8141-add4c2f04c26" xlink:href="sny-20221231.xsd#sny_AuditorsNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesTable_29915be1-319e-4ee6-9d44-01176a42f16d" xlink:to="loc_sny_AuditorsNameAxis_3c9997dc-0e0f-4cb9-8141-add4c2f04c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsNameMember_cc0bcd6a-b9ca-4edf-b7db-7b2511462d11" xlink:href="sny-20221231.xsd#sny_AuditorsNameMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AuditorsNameAxis_3c9997dc-0e0f-4cb9-8141-add4c2f04c26" xlink:to="loc_sny_AuditorsNameMember_cc0bcd6a-b9ca-4edf-b7db-7b2511462d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ErnstAndYoungMember_4102a071-7d1a-418d-b878-6b424c3b6a30" xlink:href="sny-20221231.xsd#sny_ErnstAndYoungMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AuditorsNameMember_cc0bcd6a-b9ca-4edf-b7db-7b2511462d11" xlink:to="loc_sny_ErnstAndYoungMember_4102a071-7d1a-418d-b878-6b424c3b6a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PricewaterhousecoopersMember_9d5d7a72-6954-4a57-8255-7ac28e9347f1" xlink:href="sny-20221231.xsd#sny_PricewaterhousecoopersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AuditorsNameMember_cc0bcd6a-b9ca-4edf-b7db-7b2511462d11" xlink:to="loc_sny_PricewaterhousecoopersMember_9d5d7a72-6954-4a57-8255-7ac28e9347f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:href="sny-20221231.xsd#sny_DisclosureOfAuditFeesAndOtherServicesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesTable_29915be1-319e-4ee6-9d44-01176a42f16d" xlink:to="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForAuditServices_5b0941b7-0d63-4f05-9add-94a5e2e5a903" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForAuditServices"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_ifrs-full_AuditorsRemunerationForAuditServices_5b0941b7-0d63-4f05-9add-94a5e2e5a903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ServicesOtherThanStatutoryAudit_7c21f8ef-d21d-480c-923d-8512112ac40f" xlink:href="sny-20221231.xsd#sny_ServicesOtherThanStatutoryAudit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_ServicesOtherThanStatutoryAudit_7c21f8ef-d21d-480c-923d-8512112ac40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditorsRemunerationForAuditRelatedServices_8e89689c-245f-49a4-a543-ed8bed5becfc" xlink:href="sny-20221231.xsd#sny_AuditorsRemunerationForAuditRelatedServices"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_AuditorsRemunerationForAuditRelatedServices_8e89689c-245f-49a4-a543-ed8bed5becfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForTaxServices_cd1d95a6-6f99-4f4b-a8db-b6b43f6218a7" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForTaxServices"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_ifrs-full_AuditorsRemunerationForTaxServices_cd1d95a6-6f99-4f4b-a8db-b6b43f6218a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices_e80f1a8e-f59f-4c31-9af7-78e9672d33f1" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemunerationForOtherServices"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_ifrs-full_AuditorsRemunerationForOtherServices_e80f1a8e-f59f-4c31-9af7-78e9672d33f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemuneration_92e92f22-6c4f-4542-a79f-c2c4a585f572" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AuditorsRemuneration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_ifrs-full_AuditorsRemuneration_92e92f22-6c4f-4542-a79f-c2c4a585f572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorRemunerationForStatutoryAudit_ba37d97a-2ada-45bc-b71d-7a40e36da423" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorRemunerationForStatutoryAudit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_PercentageOfAuditorRemunerationForStatutoryAudit_ba37d97a-2ada-45bc-b71d-7a40e36da423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements_d357fa2a-0a27-436b-8b9a-960debcf1130" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements_d357fa2a-0a27-436b-8b9a-960debcf1130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PercentageOfAuditorsRemuneration_0e6610f4-e355-47d8-9c7d-d9a5447893bf" xlink:href="sny-20221231.xsd#sny_PercentageOfAuditorsRemuneration"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_PercentageOfAuditorsRemuneration_0e6610f4-e355-47d8-9c7d-d9a5447893bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries_e71b872e-c268-4008-bdd6-005b71ad1ee4" xlink:href="sny-20221231.xsd#sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries_e71b872e-c268-4008-bdd6-005b71ad1ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries_d6ce96d5-c1bc-489c-871c-d72eadbbd1c0" xlink:href="sny-20221231.xsd#sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAuditFeesAndOtherServicesLineItems_1303aff5-c30f-4122-bdba-a68a7410ef2d" xlink:to="loc_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries_d6ce96d5-c1bc-489c-871c-d72eadbbd1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_98e004c4-9e28-4325-acc1-9817b454861d" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_cfbe9ce3-903e-4d07-8e8e-38e303ba9010" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_98e004c4-9e28-4325-acc1-9817b454861d" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_cfbe9ce3-903e-4d07-8e8e-38e303ba9010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_4daa189f-8ed7-47d3-8c9d-eda653a06b0b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_cfbe9ce3-903e-4d07-8e8e-38e303ba9010" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_4daa189f-8ed7-47d3-8c9d-eda653a06b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_4daa189f-8ed7-47d3-8c9d-eda653a06b0b" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_HoechstGmbHMember_756578a8-923a-41e0-bc67-0fbeb1423606" xlink:href="sny-20221231.xsd#sny_HoechstGmbHMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_HoechstGmbHMember_756578a8-923a-41e0-bc67-0fbeb1423606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeutschlandGmbHMember_6b290362-89cb-40bc-86cb-a5abe0a03d9b" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeutschlandGmbHMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDeutschlandGmbHMember_6b290362-89cb-40bc-86cb-a5abe0a03d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_A.NattermannCie.GmbHMember_7dd89f66-9c1c-4767-9290-530e09971cce" xlink:href="sny-20221231.xsd#sny_A.NattermannCie.GmbHMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_A.NattermannCie.GmbHMember_7dd89f66-9c1c-4767-9290-530e09971cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisGmbHMember_a92bb7e7-ab69-4bd6-8da9-bce613e208d3" xlink:href="sny-20221231.xsd#sny_SanofiAventisGmbHMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisGmbHMember_a92bb7e7-ab69-4bd6-8da9-bce613e208d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBelgiumMember_2a82c84a-26db-4292-a29c-4aa49fc02bb1" xlink:href="sny-20221231.xsd#sny_SanofiBelgiumMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiBelgiumMember_2a82c84a-26db-4292-a29c-4aa49fc02bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AblynxMember_b33ea5a7-8a09-4b07-8ee4-549d5f794228" xlink:href="sny-20221231.xsd#sny_AblynxMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AblynxMember_b33ea5a7-8a09-4b07-8ee4-549d5f794228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeFlandersBVBAMember_99bf8456-bd64-4b05-8900-62bd7df87a54" xlink:href="sny-20221231.xsd#sny_GenzymeFlandersBVBAMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeFlandersBVBAMember_99bf8456-bd64-4b05-8900-62bd7df87a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiASMember_ab0430cc-d1fe-4220-becc-a9c0fc6378dd" xlink:href="sny-20221231.xsd#sny_SanofiASMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiASMember_ab0430cc-d1fe-4220-becc-a9c0fc6378dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSAMember_2e0644f6-89fb-489a-baff-c13458d23eb0" xlink:href="sny-20221231.xsd#sny_SanofiAventisSAMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisSAMember_2e0644f6-89fb-489a-baff-c13458d23eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareSpainSLMember_7e9c2433-479a-42d5-90eb-b0b899721f95" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareSpainSLMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareSpainSLMember_7e9c2433-479a-42d5-90eb-b0b899721f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiOyMember_2e1dd3cc-1187-4fdc-b55f-3862ffe9f681" xlink:href="sny-20221231.xsd#sny_SanofiOyMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiOyMember_2e1dd3cc-1187-4fdc-b55f-3862ffe9f681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiMember_7ec92afd-e72c-4599-b862-a294e7347375" xlink:href="sny-20221231.xsd#sny_SanofiMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiMember_7ec92afd-e72c-4599-b862-a294e7347375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisFranceMember_18e09193-3b7a-4542-b9ba-6fd37c6d93fb" xlink:href="sny-20221231.xsd#sny_SanofiAventisFranceMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisFranceMember_18e09193-3b7a-4542-b9ba-6fd37c6d93fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiWinthropIndustriesMember_e1fd6b5a-8f37-4ac6-969c-c94bb77d5b0e" xlink:href="sny-20221231.xsd#sny_SanofiWinthropIndustriesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiWinthropIndustriesMember_e1fd6b5a-8f37-4ac6-969c-c94bb77d5b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisRechercheEtDeveloppementMember_4982d52d-3afd-4f3b-8cfa-45c3c6fbf4ce" xlink:href="sny-20221231.xsd#sny_SanofiAventisRechercheEtDeveloppementMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisRechercheEtDeveloppementMember_4982d52d-3afd-4f3b-8cfa-45c3c6fbf4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisGroupeMember_33dbfd43-3cc8-4d4f-bdff-a71fc9564582" xlink:href="sny-20221231.xsd#sny_SanofiAventisGroupeMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisGroupeMember_33dbfd43-3cc8-4d4f-bdff-a71fc9564582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiChimieMember_ec1c3bbf-d11f-41cf-bb5e-9e8b3c15db8b" xlink:href="sny-20221231.xsd#sny_SanofiChimieMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiChimieMember_ec1c3bbf-d11f-41cf-bb5e-9e8b3c15db8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisParticipationsSASMember_007d7273-e919-420b-ab3d-79f7e708a6d1" xlink:href="sny-20221231.xsd#sny_SanofiAventisParticipationsSASMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisParticipationsSASMember_007d7273-e919-420b-ab3d-79f7e708a6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurFranceSAMember_8a1e8180-60d2-45b5-aa87-91fe3286fea9" xlink:href="sny-20221231.xsd#sny_SanofiPasteurFranceSAMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurFranceSAMember_8a1e8180-60d2-45b5-aa87-91fe3286fea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaSAFranceMember_5a5c047a-9c99-468d-9ba5-e60623daf1d8" xlink:href="sny-20221231.xsd#sny_AventisPharmaSAFranceMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisPharmaSAFranceMember_5a5c047a-9c99-468d-9ba5-e60623daf1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBiotechnologyMember_8b6335b6-34a8-4ce3-8a09-73c5c0049323" xlink:href="sny-20221231.xsd#sny_SanofiBiotechnologyMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiBiotechnologyMember_8b6335b6-34a8-4ce3-8a09-73c5c0049323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiMatureIPMember_8030a443-c513-4ab7-bdd7-a3d33d52f121" xlink:href="sny-20221231.xsd#sny_SanofiMatureIPMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiMatureIPMember_8030a443-c513-4ab7-bdd7-a3d33d52f121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurNVLMember_a491c3ba-0508-4b2d-ba11-7debe9658685" xlink:href="sny-20221231.xsd#sny_SanofiPasteurNVLMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurNVLMember_a491c3ba-0508-4b2d-ba11-7debe9658685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurEuropeMember_0c1cb5ad-3da0-42d5-a0b5-b6ae78a595be" xlink:href="sny-20221231.xsd#sny_SanofiPasteurEuropeMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurEuropeMember_0c1cb5ad-3da0-42d5-a0b5-b6ae78a595be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SECIPESASMember_634a85d9-7ed2-4525-9e6d-56083d750958" xlink:href="sny-20221231.xsd#sny_SECIPESASMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SECIPESASMember_634a85d9-7ed2-4525-9e6d-56083d750958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurMerieuxSASMember_05d1aa14-9d87-4568-8f86-fdd77e72d162" xlink:href="sny-20221231.xsd#sny_SanofiPasteurMerieuxSASMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurMerieuxSASMember_05d1aa14-9d87-4568-8f86-fdd77e72d162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_Sanofi2015DSASMember_565547cb-3347-43fb-b9d1-04da266e7286" xlink:href="sny-20221231.xsd#sny_Sanofi2015DSASMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_Sanofi2015DSASMember_565547cb-3347-43fb-b9d1-04da266e7286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareInternationalSASMember_e89a3a40-b5ff-428f-9e01-fb07f59c55e3" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareInternationalSASMember"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareInternationalSASMember_e89a3a40-b5ff-428f-9e01-fb07f59c55e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareFranceSASMember_afdcd88c-509c-499b-88ce-4990e3465a64" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareFranceSASMember"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareFranceSASMember_afdcd88c-509c-499b-88ce-4990e3465a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareGroupSASMember_a5080135-5f28-4669-983f-b157e72b6b4e" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareGroupSASMember"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareGroupSASMember_a5080135-5f28-4669-983f-b157e72b6b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiaventisAEBEMember_41e17606-e488-41e2-bc9b-081e3ecfa2bc" xlink:href="sny-20221231.xsd#sny_SanofiaventisAEBEMember"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiaventisAEBEMember_41e17606-e488-41e2-bc9b-081e3ecfa2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPrivateCoLtdMember_ba630ae1-77fd-48d6-96bd-e2644c136ec5" xlink:href="sny-20221231.xsd#sny_SanofiAventisPrivateCoLtdMember"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisPrivateCoLtdMember_ba630ae1-77fd-48d6-96bd-e2644c136ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChinoinPrivateCoLtdMember_8423125d-3c16-4d07-9d5d-49b66f356f5b" xlink:href="sny-20221231.xsd#sny_ChinoinPrivateCoLtdMember"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_ChinoinPrivateCoLtdMember_8423125d-3c16-4d07-9d5d-49b66f356f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareHungaryCommercialKFTMember_4fe67075-0939-4896-962c-f276b03dbdac" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareHungaryCommercialKFTMember"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareHungaryCommercialKFTMember_4fe67075-0939-4896-962c-f276b03dbdac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_CarraigInsuranceDACMember_783f93eb-f8fc-44b9-becc-c79854e9e187" xlink:href="sny-20221231.xsd#sny_CarraigInsuranceDACMember"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_CarraigInsuranceDACMember_783f93eb-f8fc-44b9-becc-c79854e9e187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeIrelandLimitedMember_311cf65b-6dc7-4772-8b68-bd1b2ea245e8" xlink:href="sny-20221231.xsd#sny_GenzymeIrelandLimitedMember"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeIrelandLimitedMember_311cf65b-6dc7-4772-8b68-bd1b2ea245e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisHoldingsIrelandLtdMember_ca8b550a-5345-44df-86ae-f2b579f3b671" xlink:href="sny-20221231.xsd#sny_SanofiAventisHoldingsIrelandLtdMember"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisHoldingsIrelandLtdMember_ca8b550a-5345-44df-86ae-f2b579f3b671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSRLMember_b9bcdf6b-a0a2-415a-8c1f-0b37c5915650" xlink:href="sny-20221231.xsd#sny_SanofiSRLMember"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiSRLMember_b9bcdf6b-a0a2-415a-8c1f-0b37c5915650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareItalySRLMember_82f7ed04-5f48-4ee6-a812-fee17e9dcdb0" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareItalySRLMember"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareItalySRLMember_82f7ed04-5f48-4ee6-a812-fee17e9dcdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeGlobalSarlMember_b4ee6b3e-8a3b-48af-bc86-26e6ac732e67" xlink:href="sny-20221231.xsd#sny_GenzymeGlobalSarlMember"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeGlobalSarlMember_b4ee6b3e-8a3b-48af-bc86-26e6ac732e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeLuxembourgSarlMember_10c7a780-3d30-43d0-a545-d933aa49deb2" xlink:href="sny-20221231.xsd#sny_GenzymeLuxembourgSarlMember"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeLuxembourgSarlMember_10c7a780-3d30-43d0-a545-d933aa49deb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisNorgeASMember_4f7d27cd-360b-47b5-b021-2c4f6b05dce2" xlink:href="sny-20221231.xsd#sny_SanofiAventisNorgeASMember"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisNorgeASMember_4f7d27cd-360b-47b5-b021-2c4f6b05dce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeEuropeBVMember_5ee2feba-16a3-4df9-93d5-35f916e351e2" xlink:href="sny-20221231.xsd#sny_GenzymeEuropeBVMember"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeEuropeBVMember_5ee2feba-16a3-4df9-93d5-35f916e351e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiForeignParticipationsB.V.Member_51a08a4c-b0b4-4ff0-919f-dcc95b78395d" xlink:href="sny-20221231.xsd#sny_SanofiForeignParticipationsB.V.Member"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiForeignParticipationsB.V.Member_51a08a4c-b0b4-4ff0-919f-dcc95b78395d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiaventisSpZooMember_b6c9cb76-984e-43d7-9123-a981386923b9" xlink:href="sny-20221231.xsd#sny_SanofiaventisSpZooMember"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiaventisSpZooMember_b6c9cb76-984e-43d7-9123-a981386923b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcarePolandSpZOOMember_314414f3-eca6-4504-95ab-8ca78b698ae9" xlink:href="sny-20221231.xsd#sny_OpellaHealthcarePolandSpZOOMember"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcarePolandSpZOOMember_314414f3-eca6-4504-95ab-8ca78b698ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurSpZooMember_112d58d1-1990-438d-b5c7-cfff2b14e207" xlink:href="sny-20221231.xsd#sny_SanofiPasteurSpZooMember"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurSpZooMember_112d58d1-1990-438d-b5c7-cfff2b14e207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiProdutosFarmaceuticosLdaMember_6a487e32-cbcd-45d3-a4c0-1ef5a6996c04" xlink:href="sny-20221231.xsd#sny_SanofiProdutosFarmaceuticosLdaMember"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiProdutosFarmaceuticosLdaMember_6a487e32-cbcd-45d3-a4c0-1ef5a6996c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSROMember_7a281c6f-920b-4aa7-85fa-08cc98cc3539" xlink:href="sny-20221231.xsd#sny_SanofiAventisSROMember"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisSROMember_7a281c6f-920b-4aa7-85fa-08cc98cc3539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareCzechSroMember_34e2f53e-7143-45bc-b094-1934a4dfb5d6" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareCzechSroMember"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareCzechSroMember_34e2f53e-7143-45bc-b094-1934a4dfb5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisRomaniaSRLMember_c93c9d1f-040d-4e9c-bce9-c5afcbaa743d" xlink:href="sny-20221231.xsd#sny_SanofiAventisRomaniaSRLMember"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisRomaniaSRLMember_c93c9d1f-040d-4e9c-bce9-c5afcbaa743d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareRomaniaSRLMember_8e43e5c3-3496-4216-a292-0debefdcbfa4" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareRomaniaSRLMember"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareRomaniaSRLMember_8e43e5c3-3496-4216-a292-0debefdcbfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisUkHoldingsLimitedMember_a22a739a-0af9-4c68-a9df-134ac8192f1d" xlink:href="sny-20221231.xsd#sny_SanofiAventisUkHoldingsLimitedMember"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisUkHoldingsLimitedMember_a22a739a-0af9-4c68-a9df-134ac8192f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaLimitedMember_9a48789b-1a02-45cf-a614-377e0c145501" xlink:href="sny-20221231.xsd#sny_AventisPharmaLimitedMember"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisPharmaLimitedMember_9a48789b-1a02-45cf-a614-377e0c145501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSynthelaboUKLtdMember_2b8613bd-29be-4785-b02a-cfd7f37b01e2" xlink:href="sny-20221231.xsd#sny_SanofiSynthelaboUKLtdMember"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiSynthelaboUKLtdMember_2b8613bd-29be-4785-b02a-cfd7f37b01e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaHoldingsLtdMember_00667c0e-c34b-469e-aa3a-6e47d4e0d497" xlink:href="sny-20221231.xsd#sny_AventisPharmaHoldingsLtdMember"/>
    <link:presentationArc order="56" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisPharmaHoldingsLtdMember_00667c0e-c34b-469e-aa3a-6e47d4e0d497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareUKLimitedMember_6c0db3b9-36a4-4f2a-ba62-3236afee72d0" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareUKLimitedMember"/>
    <link:presentationArc order="57" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareUKLimitedMember_6c0db3b9-36a4-4f2a-ba62-3236afee72d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AOSanofiRussiaMember_6da3f780-1900-4388-8335-344f4f5fcba8" xlink:href="sny-20221231.xsd#sny_AOSanofiRussiaMember"/>
    <link:presentationArc order="58" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AOSanofiRussiaMember_6da3f780-1900-4388-8335-344f4f5fcba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareLLCMember_e890bd08-46ba-460f-b95f-9c556f0e5bd8" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareLLCMember"/>
    <link:presentationArc order="59" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareLLCMember_e890bd08-46ba-460f-b95f-9c556f0e5bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiABMember_78776015-e939-4064-ac5e-5412ec0f3934" xlink:href="sny-20221231.xsd#sny_SanofiABMember"/>
    <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiABMember_78776015-e939-4064-ac5e-5412ec0f3934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSuisseSAMember_f2e76baa-4f77-46d1-a7a9-6c748205297e" xlink:href="sny-20221231.xsd#sny_SanofiAventisSuisseSAMember"/>
    <link:presentationArc order="61" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisSuisseSAMember_f2e76baa-4f77-46d1-a7a9-6c748205297e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember_bc634e88-b897-454e-8f56-87d0e08f88a7" xlink:href="sny-20221231.xsd#sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember"/>
    <link:presentationArc order="62" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember_bc634e88-b897-454e-8f56-87d0e08f88a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiIlacSanayiVeTicaretASMember_8d0d12d1-358f-40ae-9bb7-171c6b7addab" xlink:href="sny-20221231.xsd#sny_SanofiIlacSanayiVeTicaretASMember"/>
    <link:presentationArc order="63" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiIlacSanayiVeTicaretASMember_8d0d12d1-358f-40ae-9bb7-171c6b7addab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurAsiTicaretASMember_aae1a87e-6d20-48b4-9446-393c5758e431" xlink:href="sny-20221231.xsd#sny_SanofiPasteurAsiTicaretASMember"/>
    <link:presentationArc order="64" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurAsiTicaretASMember_aae1a87e-6d20-48b4-9446-393c5758e431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiSaglikUrunleriLimitedSirketiMember_2bd9c2e5-05e7-4832-9ca4-7659d71678dd" xlink:href="sny-20221231.xsd#sny_SanofiSaglikUrunleriLimitedSirketiMember"/>
    <link:presentationArc order="65" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiSaglikUrunleriLimitedSirketiMember_2bd9c2e5-05e7-4832-9ca4-7659d71678dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeTherapeuticProductsLimitedPartnershipMember_309abc42-8c12-4585-872d-cef2ede46a61" xlink:href="sny-20221231.xsd#sny_GenzymeTherapeuticProductsLimitedPartnershipMember"/>
    <link:presentationArc order="66" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeTherapeuticProductsLimitedPartnershipMember_309abc42-8c12-4585-872d-cef2ede46a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisIncMember_09abb589-e685-4323-8ec6-0aa2b5ceff59" xlink:href="sny-20221231.xsd#sny_AventisIncMember"/>
    <link:presentationArc order="67" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisIncMember_09abb589-e685-4323-8ec6-0aa2b5ceff59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiUSServicesIncMember_15c9a928-1d30-4686-9e15-b609e91d7c0e" xlink:href="sny-20221231.xsd#sny_SanofiUSServicesIncMember"/>
    <link:presentationArc order="68" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiUSServicesIncMember_15c9a928-1d30-4686-9e15-b609e91d7c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisUSLLCMember_8a10017a-eeca-4d85-bdf6-4728fe37376a" xlink:href="sny-20221231.xsd#sny_SanofiAventisUSLLCMember"/>
    <link:presentationArc order="69" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisUSLLCMember_8a10017a-eeca-4d85-bdf6-4728fe37376a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ChattemIncMember_3db4944a-984f-4e8a-8c58-1517e82702ce" xlink:href="sny-20221231.xsd#sny_ChattemIncMember"/>
    <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_ChattemIncMember_3db4944a-984f-4e8a-8c58-1517e82702ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisubLLCMember_765cb8e4-15ce-4d9d-bb92-4e4679512906" xlink:href="sny-20221231.xsd#sny_AventisubLLCMember"/>
    <link:presentationArc order="71" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisubLLCMember_765cb8e4-15ce-4d9d-bb92-4e4679512906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeCorporationMember_e2f4a17d-2363-49db-9950-0c3850527492" xlink:href="sny-20221231.xsd#sny_GenzymeCorporationMember"/>
    <link:presentationArc order="72" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeCorporationMember_e2f4a17d-2363-49db-9950-0c3850527492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurIncMember_fe9e45fb-cdf1-4405-9f7d-7d92e654773e" xlink:href="sny-20221231.xsd#sny_SanofiPasteurIncMember"/>
    <link:presentationArc order="73" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurIncMember_fe9e45fb-cdf1-4405-9f7d-7d92e654773e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_VaxServeIncMember_df892708-a4a1-4981-9033-c75f786c606e" xlink:href="sny-20221231.xsd#sny_VaxServeIncMember"/>
    <link:presentationArc order="74" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_VaxServeIncMember_df892708-a4a1-4981-9033-c75f786c606e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativIncMember_eb263cf9-e683-46f0-b81d-fc34a4610abb" xlink:href="sny-20221231.xsd#sny_BioverativIncMember"/>
    <link:presentationArc order="75" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_BioverativIncMember_eb263cf9-e683-46f0-b81d-fc34a4610abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativUSLLCMember_7d8c71d4-20c7-4f8a-a203-bd56523c8abc" xlink:href="sny-20221231.xsd#sny_BioverativUSLLCMember"/>
    <link:presentationArc order="76" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_BioverativUSLLCMember_7d8c71d4-20c7-4f8a-a203-bd56523c8abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_BioverativTherapeuticsIncMember_4d00c465-1672-4f21-b612-5950eefb1b15" xlink:href="sny-20221231.xsd#sny_BioverativTherapeuticsIncMember"/>
    <link:presentationArc order="77" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_BioverativTherapeuticsIncMember_4d00c465-1672-4f21-b612-5950eefb1b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_PrincipiaBiopharmaIncMember_b594e842-5d7c-4a97-8529-49a51d6425c1" xlink:href="sny-20221231.xsd#sny_PrincipiaBiopharmaIncMember"/>
    <link:presentationArc order="78" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_PrincipiaBiopharmaIncMember_b594e842-5d7c-4a97-8529-49a51d6425c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiResearchInvestLLCMember_d760d09a-ab01-4639-9b1d-62bca4c18f5b" xlink:href="sny-20221231.xsd#sny_SanofiResearchInvestLLCMember"/>
    <link:presentationArc order="79" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiResearchInvestLLCMember_d760d09a-ab01-4639-9b1d-62bca4c18f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBioverativHoldingsLLCMember_750222e5-a301-4c60-90f6-213be79d5a06" xlink:href="sny-20221231.xsd#sny_SanofiBioverativHoldingsLLCMember"/>
    <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiBioverativHoldingsLLCMember_750222e5-a301-4c60-90f6-213be79d5a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_RPRUSLtdMember_a71122b6-2f60-4a7a-a91e-a103afad80e9" xlink:href="sny-20221231.xsd#sny_RPRUSLtdMember"/>
    <link:presentationArc order="81" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_RPRUSLtdMember_a71122b6-2f60-4a7a-a91e-a103afad80e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KadmonHoldingsIncMember_506efdfe-b401-41d7-ba81-5c08bf7298fa" xlink:href="sny-20221231.xsd#sny_KadmonHoldingsIncMember"/>
    <link:presentationArc order="82" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_KadmonHoldingsIncMember_506efdfe-b401-41d7-ba81-5c08bf7298fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_KadmonCorporationLLCMember_07842b14-c479-4789-b441-82ad4c50e90b" xlink:href="sny-20221231.xsd#sny_KadmonCorporationLLCMember"/>
    <link:presentationArc order="83" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_KadmonCorporationLLCMember_07842b14-c479-4789-b441-82ad4c50e90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AmunixMember_74313dad-13ba-4408-a4bc-db1f80173e1a" xlink:href="sny-20221231.xsd#sny_AmunixMember"/>
    <link:presentationArc order="84" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AmunixMember_74313dad-13ba-4408-a4bc-db1f80173e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SynthorxIncMember_fa7b1975-78fe-46ab-b566-cb4ae7ec3ec1" xlink:href="sny-20221231.xsd#sny_SynthorxIncMember"/>
    <link:presentationArc order="85" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SynthorxIncMember_fa7b1975-78fe-46ab-b566-cb4ae7ec3ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_TranslateBioIncMember_a03e6a4e-4653-48a3-97cd-2dbc9ae1d835" xlink:href="sny-20221231.xsd#sny_TranslateBioIncMember"/>
    <link:presentationArc order="86" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_TranslateBioIncMember_a03e6a4e-4653-48a3-97cd-2dbc9ae1d835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSouthAfricaPtyLtdMember_1b2797ff-8c9a-462e-a480-1e2827460600" xlink:href="sny-20221231.xsd#sny_SanofiAventisSouthAfricaPtyLtdMember"/>
    <link:presentationArc order="87" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisSouthAfricaPtyLtdMember_1b2797ff-8c9a-462e-a480-1e2827460600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisAlgerieMember_d7efa076-dd45-420d-bd3f-f6ee65f5bc73" xlink:href="sny-20221231.xsd#sny_SanofiAventisAlgerieMember"/>
    <link:presentationArc order="88" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisAlgerieMember_d7efa076-dd45-420d-bd3f-f6ee65f5bc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiArabiaTradingCompanyLimitedMember_59e9e202-e7dc-45a0-8036-eed210047f7e" xlink:href="sny-20221231.xsd#sny_SanofiArabiaTradingCompanyLimitedMember"/>
    <link:presentationArc order="89" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiArabiaTradingCompanyLimitedMember_59e9e202-e7dc-45a0-8036-eed210047f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisArgentinaSAMember_b9c7325f-0836-4cd5-a625-e5d8baf213b3" xlink:href="sny-20221231.xsd#sny_SanofiAventisArgentinaSAMember"/>
    <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisArgentinaSAMember_b9c7325f-0836-4cd5-a625-e5d8baf213b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenzymeDeArgentinaSAMember_b0d54d3d-7fc8-42d6-ac9e-ed3a7da9c0ab" xlink:href="sny-20221231.xsd#sny_GenzymeDeArgentinaSAMember"/>
    <link:presentationArc order="91" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenzymeDeArgentinaSAMember_b0d54d3d-7fc8-42d6-ac9e-ed3a7da9c0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareArgentinaSAUMember_d55dc291-a8a7-4d4d-b87c-05a557935338" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareArgentinaSAUMember"/>
    <link:presentationArc order="92" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareArgentinaSAUMember_d55dc291-a8a7-4d4d-b87c-05a557935338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisHealthcarePtyLtdMember_5e468c3f-4ac1-4e89-ba62-c5d195020093" xlink:href="sny-20221231.xsd#sny_SanofiAventisHealthcarePtyLtdMember"/>
    <link:presentationArc order="93" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisHealthcarePtyLtdMember_5e468c3f-4ac1-4e89-ba62-c5d195020093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisAustraliaPtyLtdMember_18868cd2-5ba2-47a8-98e9-6b61a784d34f" xlink:href="sny-20221231.xsd#sny_SanofiAventisAustraliaPtyLtdMember"/>
    <link:presentationArc order="94" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisAustraliaPtyLtdMember_18868cd2-5ba2-47a8-98e9-6b61a784d34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiMedleyFarmaceuticaLtdaMember_11d40435-ba3c-4406-97af-8c63c07b9235" xlink:href="sny-20221231.xsd#sny_SanofiMedleyFarmaceuticaLtdaMember"/>
    <link:presentationArc order="95" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiMedleyFarmaceuticaLtdaMember_11d40435-ba3c-4406-97af-8c63c07b9235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisCanadaIncMember_1d0e37a9-4e7b-4038-9729-1611f3054258" xlink:href="sny-20221231.xsd#sny_SanofiAventisCanadaIncMember"/>
    <link:presentationArc order="96" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisCanadaIncMember_1d0e37a9-4e7b-4038-9729-1611f3054258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurLimitedMember_af0ec8ea-5995-410d-8767-1ae52b430d87" xlink:href="sny-20221231.xsd#sny_SanofiPasteurLimitedMember"/>
    <link:presentationArc order="97" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurLimitedMember_af0ec8ea-5995-410d-8767-1ae52b430d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MerieuxCanadaHoldingsULCCanadaMember_700a1596-6fa3-4f32-a924-3872b0de9776" xlink:href="sny-20221231.xsd#sny_MerieuxCanadaHoldingsULCCanadaMember"/>
    <link:presentationArc order="98" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_MerieuxCanadaHoldingsULCCanadaMember_700a1596-6fa3-4f32-a924-3872b0de9776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeChileSAMember_b832075e-a823-4dd0-84cf-78ee3cf41287" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeChileSAMember"/>
    <link:presentationArc order="99" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDeChileSAMember_b832075e-a823-4dd0-84cf-78ee3cf41287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiHangzhouPharmaceuticalsCoLtdMember_a0c7f739-1064-4fd7-a117-fb650a33af8c" xlink:href="sny-20221231.xsd#sny_SanofiHangzhouPharmaceuticalsCoLtdMember"/>
    <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiHangzhouPharmaceuticalsCoLtdMember_a0c7f739-1064-4fd7-a117-fb650a33af8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiChinaInvestmentCoLtdMember_23101bdf-273f-40ad-8bc3-ba5b69a6f896" xlink:href="sny-20221231.xsd#sny_SanofiChinaInvestmentCoLtdMember"/>
    <link:presentationArc order="101" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiChinaInvestmentCoLtdMember_23101bdf-273f-40ad-8bc3-ba5b69a6f896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiBeijingPharmaceuticalsCoLtdMember_ccf0367b-ab75-44fc-a946-069f63e1fbc6" xlink:href="sny-20221231.xsd#sny_SanofiBeijingPharmaceuticalsCoLtdMember"/>
    <link:presentationArc order="102" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiBeijingPharmaceuticalsCoLtdMember_ccf0367b-ab75-44fc-a946-069f63e1fbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurBiologiesCo.LtdMember_e6648846-bb19-4858-9d07-cbb9cdd4b29e" xlink:href="sny-20221231.xsd#sny_SanofiPasteurBiologiesCo.LtdMember"/>
    <link:presentationArc order="103" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurBiologiesCo.LtdMember_e6648846-bb19-4858-9d07-cbb9cdd4b29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember_8f278e84-61ef-4880-a9e3-916606f4afd2" xlink:href="sny-20221231.xsd#sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember"/>
    <link:presentationArc order="104" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember_8f278e84-61ef-4880-a9e3-916606f4afd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ShanghaiRonghengPharmaceuticalCoLtdMember_2b0b378f-82f3-4f3e-be5a-76434a12ef0c" xlink:href="sny-20221231.xsd#sny_ShanghaiRonghengPharmaceuticalCoLtdMember"/>
    <link:presentationArc order="105" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_ShanghaiRonghengPharmaceuticalCoLtdMember_2b0b378f-82f3-4f3e-be5a-76434a12ef0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GenfarSAMember_373ad26f-d6cc-4c8f-8a52-f2fdbfc0ef70" xlink:href="sny-20221231.xsd#sny_GenfarSAMember"/>
    <link:presentationArc order="106" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_GenfarSAMember_373ad26f-d6cc-4c8f-8a52-f2fdbfc0ef70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeColombiaSAMember_1e806a9f-bf30-475b-acd2-04d97959d5a8" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeColombiaSAMember"/>
    <link:presentationArc order="107" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDeColombiaSAMember_1e806a9f-bf30-475b-acd2-04d97959d5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisKoreaCoLtdMember_c0374002-93d6-4785-9a47-392793b121d7" xlink:href="sny-20221231.xsd#sny_SanofiAventisKoreaCoLtdMember"/>
    <link:presentationArc order="108" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisKoreaCoLtdMember_c0374002-93d6-4785-9a47-392793b121d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurLtdMember_ca5d90ea-06ec-454d-8927-44c76d9ac2e3" xlink:href="sny-20221231.xsd#sny_SanofiPasteurLtdMember"/>
    <link:presentationArc order="109" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurLtdMember_ca5d90ea-06ec-454d-8927-44c76d9ac2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareKoreaIncMember_f66f54f6-0dc9-42ed-b523-9abb92bdf413" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareKoreaIncMember"/>
    <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareKoreaIncMember_f66f54f6-0dc9-42ed-b523-9abb92bdf413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisGulfFZEMember_78d3da20-3170-41bb-a5bc-7448edb8c5ad" xlink:href="sny-20221231.xsd#sny_SanofiAventisGulfFZEMember"/>
    <link:presentationArc order="111" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisGulfFZEMember_78d3da20-3170-41bb-a5bc-7448edb8c5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiEgyptSAEMember_f5a77756-e14e-46df-90ea-f07db7b6e5e2" xlink:href="sny-20221231.xsd#sny_SanofiEgyptSAEMember"/>
    <link:presentationArc order="112" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiEgyptSAEMember_f5a77756-e14e-46df-90ea-f07db7b6e5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcareEgyptLLCMember_e529be3a-f4ff-4865-98ab-da7c7b54b535" xlink:href="sny-20221231.xsd#sny_OpellaHealthcareEgyptLLCMember"/>
    <link:presentationArc order="113" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcareEgyptLLCMember_e529be3a-f4ff-4865-98ab-da7c7b54b535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiHongKongLimitedMember_29368bc6-a18b-4ef5-9376-b18f27b54b8c" xlink:href="sny-20221231.xsd#sny_SanofiHongKongLimitedMember"/>
    <link:presentationArc order="114" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiHongKongLimitedMember_29368bc6-a18b-4ef5-9376-b18f27b54b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiIndiaLimitedMember_57f48911-3b1a-4892-9316-5ab5d5edb2a2" xlink:href="sny-20221231.xsd#sny_SanofiIndiaLimitedMember"/>
    <link:presentationArc order="115" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiIndiaLimitedMember_57f48911-3b1a-4892-9316-5ab5d5edb2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiHealthcareIndiaPrivateLimitedMember_deda407f-0028-4ebd-ac4a-6ffeee56df23" xlink:href="sny-20221231.xsd#sny_SanofiHealthcareIndiaPrivateLimitedMember"/>
    <link:presentationArc order="116" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiHealthcareIndiaPrivateLimitedMember_deda407f-0028-4ebd-ac4a-6ffeee56df23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisIsraelLtdMember_24da811d-7fd4-4d11-97ce-a9b9c1835c4b" xlink:href="sny-20221231.xsd#sny_SanofiAventisIsraelLtdMember"/>
    <link:presentationArc order="117" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisIsraelLtdMember_24da811d-7fd4-4d11-97ce-a9b9c1835c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiKKMember_fee8c90e-a44e-4042-a97c-5645c6379945" xlink:href="sny-20221231.xsd#sny_SanofiKKMember"/>
    <link:presentationArc order="118" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiKKMember_fee8c90e-a44e-4042-a97c-5645c6379945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SspCoLtdMember_0eb5a64f-e5ae-4831-b483-3735a83d6efb" xlink:href="sny-20221231.xsd#sny_SspCoLtdMember"/>
    <link:presentationArc order="119" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SspCoLtdMember_0eb5a64f-e5ae-4831-b483-3735a83d6efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisMalaysiaSDNBHDMember_13bba46d-7f22-46b3-874f-4d2ab238c523" xlink:href="sny-20221231.xsd#sny_SanofiAventisMalaysiaSDNBHDMember"/>
    <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisMalaysiaSDNBHDMember_13bba46d-7f22-46b3-874f-4d2ab238c523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisMarocMember_b7b442d1-dfa5-47e1-b1c0-caac4f4b4c2f" xlink:href="sny-20221231.xsd#sny_SanofiAventisMarocMember"/>
    <link:presentationArc order="121" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisMarocMember_b7b442d1-dfa5-47e1-b1c0-caac4f4b4c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeMexicoSADeCVMember_ffd07e85-303c-4353-b9c1-12d71256438b" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeMexicoSADeCVMember"/>
    <link:presentationArc order="122" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDeMexicoSADeCVMember_ffd07e85-303c-4353-b9c1-12d71256438b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiPasteurS.A.deC.V.Member_1b012a36-b9e9-4d9e-bd16-05fe1244855f" xlink:href="sny-20221231.xsd#sny_SanofiPasteurS.A.deC.V.Member"/>
    <link:presentationArc order="123" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiPasteurS.A.deC.V.Member_1b012a36-b9e9-4d9e-bd16-05fe1244855f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AztecaVacunasSADeCVMember_e25b92bb-8f40-409c-8056-62d27ecf41fa" xlink:href="sny-20221231.xsd#sny_AztecaVacunasSADeCVMember"/>
    <link:presentationArc order="124" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AztecaVacunasSADeCVMember_e25b92bb-8f40-409c-8056-62d27ecf41fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPakistanLtdMember_e6b96d7c-2988-4095-9d41-e26939cb6d14" xlink:href="sny-20221231.xsd#sny_SanofiAventisPakistanLtdMember"/>
    <link:presentationArc order="125" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisPakistanLtdMember_e6b96d7c-2988-4095-9d41-e26939cb6d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDePanamaSAMember_4a9b9771-8858-473c-b533-022abe840340" xlink:href="sny-20221231.xsd#sny_SanofiAventisDePanamaSAMember"/>
    <link:presentationArc order="126" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDePanamaSAMember_4a9b9771-8858-473c-b533-022abe840340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDelPeruSAMember_bef72d1f-554a-4a50-a09a-f1568edb6f19" xlink:href="sny-20221231.xsd#sny_SanofiAventisDelPeruSAMember"/>
    <link:presentationArc order="127" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDelPeruSAMember_bef72d1f-554a-4a50-a09a-f1568edb6f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPuertoRicoIncMember_03b035ab-a705-42ca-8465-505729e98c3e" xlink:href="sny-20221231.xsd#sny_SanofiAventisPuertoRicoIncMember"/>
    <link:presentationArc order="128" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisPuertoRicoIncMember_03b035ab-a705-42ca-8465-505729e98c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisPhilippinesIncMember_cbe4ac4e-1d16-4230-9815-960135f88b97" xlink:href="sny-20221231.xsd#sny_SanofiAventisPhilippinesIncMember"/>
    <link:presentationArc order="129" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisPhilippinesIncMember_cbe4ac4e-1d16-4230-9815-960135f88b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OpellaHealthcarePhilippinesIncMember_749506c3-2b0a-4e00-9ef7-8992e68ea76d" xlink:href="sny-20221231.xsd#sny_OpellaHealthcarePhilippinesIncMember"/>
    <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_OpellaHealthcarePhilippinesIncMember_749506c3-2b0a-4e00-9ef7-8992e68ea76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisSingaporePteLtdMember_827588ad-765b-429c-95fe-36cdfab3554e" xlink:href="sny-20221231.xsd#sny_SanofiAventisSingaporePteLtdMember"/>
    <link:presentationArc order="131" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisSingaporePteLtdMember_827588ad-765b-429c-95fe-36cdfab3554e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_AventisPharmaManufacturingPTELTDMember_cd89368b-004e-4a02-85f9-ecfbf35e6558" xlink:href="sny-20221231.xsd#sny_AventisPharmaManufacturingPTELTDMember"/>
    <link:presentationArc order="132" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_AventisPharmaManufacturingPTELTDMember_cd89368b-004e-4a02-85f9-ecfbf35e6558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiManufacturingPteLtdMember_07b6460e-6b03-4129-a62f-16b60ecbeccf" xlink:href="sny-20221231.xsd#sny_SanofiManufacturingPteLtdMember"/>
    <link:presentationArc order="133" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiManufacturingPteLtdMember_07b6460e-6b03-4129-a62f-16b60ecbeccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiTaiwanCoLtdMember_b51d492f-0be6-4e40-8c35-f6967c436b42" xlink:href="sny-20221231.xsd#sny_SanofiTaiwanCoLtdMember"/>
    <link:presentationArc order="134" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiTaiwanCoLtdMember_b51d492f-0be6-4e40-8c35-f6967c436b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisThailandLtdMember_8cde104f-20a8-446e-a115-c6210f7c539b" xlink:href="sny-20221231.xsd#sny_SanofiAventisThailandLtdMember"/>
    <link:presentationArc order="135" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisThailandLtdMember_8cde104f-20a8-446e-a115-c6210f7c539b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisDeVenezuelaSAMember_55b4cc2d-b442-43f4-8227-7a6cfee1fea8" xlink:href="sny-20221231.xsd#sny_SanofiAventisDeVenezuelaSAMember"/>
    <link:presentationArc order="136" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisDeVenezuelaSAMember_55b4cc2d-b442-43f4-8227-7a6cfee1fea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiAventisVietnamCompanyLimitedMember_db501cad-04b3-4a2e-8138-1ef39fe8b70c" xlink:href="sny-20221231.xsd#sny_SanofiAventisVietnamCompanyLimitedMember"/>
    <link:presentationArc order="137" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiAventisVietnamCompanyLimitedMember_db501cad-04b3-4a2e-8138-1ef39fe8b70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_SanofiVietnamShareholdingCompanyLimitedMember_12846ee8-65cc-4654-8ab2-d18b461a914b" xlink:href="sny-20221231.xsd#sny_SanofiVietnamShareholdingCompanyLimitedMember"/>
    <link:presentationArc order="138" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_4d9727a4-f921-4e70-9f23-169444283194" xlink:to="loc_sny_SanofiVietnamShareholdingCompanyLimitedMember_12846ee8-65cc-4654-8ab2-d18b461a914b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_5f107b3b-92dd-4372-b607-9f7ff51243a5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_cfbe9ce3-903e-4d07-8e8e-38e303ba9010" xlink:to="loc_ifrs-full_GeographicalAreasAxis_5f107b3b-92dd-4372-b607-9f7ff51243a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasMember_b9983984-5cbb-4541-ac61-eb4175170033" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5f107b3b-92dd-4372-b607-9f7ff51243a5" xlink:to="loc_ifrs-full_GeographicalAreasMember_b9983984-5cbb-4541-ac61-eb4175170033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_068fa7a9-9117-4dea-9c05-7f1e12106f30" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_b9983984-5cbb-4541-ac61-eb4175170033" xlink:to="loc_srt_EuropeMember_068fa7a9-9117-4dea-9c05-7f1e12106f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_95534b92-03f7-47c7-922b-9e920d851e49" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_b9983984-5cbb-4541-ac61-eb4175170033" xlink:to="loc_country_US_95534b92-03f7-47c7-922b-9e920d851e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_OtherCountriesMember_45d5b684-1abf-4e7f-a207-eecd14a88095" xlink:href="sny-20221231.xsd#sny_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_b9983984-5cbb-4541-ac61-eb4175170033" xlink:to="loc_sny_OtherCountriesMember_45d5b684-1abf-4e7f-a207-eecd14a88095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_8784ff25-1e36-4459-9a03-331ff606998a" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_cfbe9ce3-903e-4d07-8e8e-38e303ba9010" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_8784ff25-1e36-4459-9a03-331ff606998a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_5ab0dec5-7dcf-4657-9ade-989d4d5f9fc5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_8784ff25-1e36-4459-9a03-331ff606998a" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_5ab0dec5-7dcf-4657-9ade-989d4d5f9fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails" xlink:type="simple" xlink:href="sny-20221231.xsd#Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_38cea3b3-67f0-4706-9926-fd0bebdaeb1c" xlink:href="sny-20221231.xsd#sny_InterestsInOtherEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfJointOperationsTable_480fb899-68d5-4423-8b5d-953b63cfb46b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfJointOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_38cea3b3-67f0-4706-9926-fd0bebdaeb1c" xlink:to="loc_ifrs-full_DisclosureOfJointOperationsTable_480fb899-68d5-4423-8b5d-953b63cfb46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_JointOperationsAxis_4c49037f-29d9-4ead-87dd-87e136fef148" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_JointOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfJointOperationsTable_480fb899-68d5-4423-8b5d-953b63cfb46b" xlink:to="loc_ifrs-full_JointOperationsAxis_4c49037f-29d9-4ead-87dd-87e136fef148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForJointOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_JointOperationsAxis_4c49037f-29d9-4ead-87dd-87e136fef148" xlink:to="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_GlaxoSmithKlineConsumerHealthcareLPMember_db08df4f-aab3-4954-a3d2-36a339d225e0" xlink:href="sny-20221231.xsd#sny_GlaxoSmithKlineConsumerHealthcareLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_GlaxoSmithKlineConsumerHealthcareLPMember_db08df4f-aab3-4954-a3d2-36a339d225e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_InfraservGmbhAndCoHochstKGMember_6fe8543b-118a-4d8e-b68a-88f970f325f5" xlink:href="sny-20221231.xsd#sny_InfraservGmbhAndCoHochstKGMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_InfraservGmbhAndCoHochstKGMember_6fe8543b-118a-4d8e-b68a-88f970f325f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MapharMember_3f4d3f58-5a31-42c2-a423-15f795e678a0" xlink:href="sny-20221231.xsd#sny_MapharMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_MapharMember_3f4d3f58-5a31-42c2-a423-15f795e678a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MCMVaccineBVMember_fcd2a2dd-7fdc-4c1f-ba4d-fae32c5d09e8" xlink:href="sny-20221231.xsd#sny_MCMVaccineBVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_MCMVaccineBVMember_fcd2a2dd-7fdc-4c1f-ba4d-fae32c5d09e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_MSPVaccineCompanyMember_84ca335e-058a-4762-aa80-db5736a6e060" xlink:href="sny-20221231.xsd#sny_MSPVaccineCompanyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_MSPVaccineCompanyMember_84ca335e-058a-4762-aa80-db5736a6e060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EuroapiMember_afe833ff-bd2f-4de9-a2e7-5e4fe680cd09" xlink:href="sny-20221231.xsd#sny_EuroapiMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForJointOperationsMember_59a23b2f-c710-4d9f-ad41-c6943fee910b" xlink:to="loc_sny_EuroapiMember_afe833ff-bd2f-4de9-a2e7-5e4fe680cd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfJointOperationsLineItems_b4ed2d5b-b8d8-4d31-a4c8-bc2646b8d0be" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfJointOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfJointOperationsTable_480fb899-68d5-4423-8b5d-953b63cfb46b" xlink:to="loc_ifrs-full_DisclosureOfJointOperationsLineItems_b4ed2d5b-b8d8-4d31-a4c8-bc2646b8d0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInJointOperation_7c1ecbcf-5051-4716-9628-61afdc7c55d5" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInJointOperation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfJointOperationsLineItems_b4ed2d5b-b8d8-4d31-a4c8-bc2646b8d0be" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInJointOperation_7c1ecbcf-5051-4716-9628-61afdc7c55d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sanofi.com/role/EventssubsequenttoDecember312022Details" xlink:type="simple" xlink:href="sny-20221231.xsd#EventssubsequenttoDecember312022Details"/>
  <link:presentationLink xlink:role="http://www.sanofi.com/role/EventssubsequenttoDecember312022Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_4a0ce7b6-2d4f-43e3-ac56-cc12b12170f8" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_6db6d7a0-fda3-41dd-8b4c-99bfd29283f2" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_4a0ce7b6-2d4f-43e3-ac56-cc12b12170f8" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_6db6d7a0-fda3-41dd-8b4c-99bfd29283f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c78948fe-c549-42eb-91c7-05d56ca73e3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_6db6d7a0-fda3-41dd-8b4c-99bfd29283f2" xlink:to="loc_srt_ProductOrServiceAxis_c78948fe-c549-42eb-91c7-05d56ca73e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_14f4060e-76ce-4a71-b2c7-8430c2eaf6b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c78948fe-c549-42eb-91c7-05d56ca73e3a" xlink:to="loc_srt_ProductsAndServicesDomain_14f4060e-76ce-4a71-b2c7-8430c2eaf6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_EloctateMember_7101d852-e0ce-498c-808f-2cde27f3f986" xlink:href="sny-20221231.xsd#sny_EloctateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_14f4060e-76ce-4a71-b2c7-8430c2eaf6b8" xlink:to="loc_sny_EloctateMember_7101d852-e0ce-498c-808f-2cde27f3f986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_136fe0a7-02ed-4af1-a1d0-3ad2e8b82a84" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_6db6d7a0-fda3-41dd-8b4c-99bfd29283f2" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_136fe0a7-02ed-4af1-a1d0-3ad2e8b82a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_36abf569-e901-44bf-8a5c-e5c25a4ab588" xlink:href="sny-20221231.xsd#sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_136fe0a7-02ed-4af1-a1d0-3ad2e8b82a84" xlink:to="loc_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount_36abf569-e901-44bf-8a5c-e5c25a4ab588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e8d2bfa9-4cb5-4f8a-83c7-51494cdf8d7d" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_136fe0a7-02ed-4af1-a1d0-3ad2e8b82a84" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e8d2bfa9-4cb5-4f8a-83c7-51494cdf8d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>sny-20221231_g1.jpg
<TEXT>
begin 644 sny-20221231_g1.jpg
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M_]H # ,!  (1 Q$   &_P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                \L<Q/%'Y8/TCV9U ]6         ?
M4_7WF_=U?A^O[_5\_P =%XN;]7S_ "
M
M
M       !\)$0@60P(J$=3G@   .@DD"61-XL2)$@    'QD*+5.5\7*QQ>GY
M7\CT_8'V/GSOD/'3>JD%8?3*YZGG\@
M
M
M    !"<J"*NCCH       !\I=^:.    #PO7[TC:I>HL6"6    ]MR^%SV84
MF8U9A0
M
M                                      !_A604+$)           ;=
MB0P  !YCW]<_.QZ'Q*5[P    /M?GY=]E5$FE5X0
M
M
M            1?,T97^           #:&2Y   *;--NE?%RL8     'I_#RT
M:8GFOO\ CYP
M
M                                         !2X9R#SH
M/U3>2?O   YEW=6;O;],^M^OH      LSHM7MGSJH
M
M
M           #ZIFL*8             2]-GX  !6S>+-47H]Q       Z;P<
MNDW#\R
M
M                                    ^L9>BI$             N -/
M@  !29J=Y@Q;)X       :6,,S#H7'S@
M
M
M#.84;              TB%W   !0%L.A1BGI4       :#\:SJ1<+&@
M
M
M                       51F6 _P              !L))Y@  &??8]$C;
M.28       O\Q[/)/0,6
M
M                                                ..F*LYR
M        #YS> >U   *'=<O\1[',       #1/BV;]SB>
M
M
M              9>"HH              DJ;9P   5$:/<:W+Q9@      /N
M_G\Z=\&RW];S_
M
M                                         $2C%^?
M  6SFI4   $/K+,T3:U?@      )6UZ(OMR'/P
M
M
M     !ET*C@        #^SK9U4^X?C'*#F1_(!]\UY$^P   ?6^_<YNV:3R"
M2[0     !>#E-$FS5H,
M
M                                              #EYAM/Q0
M ?9+1BW0GN="  /*$;R-QS0G&2T    !$FQ2]$.N7_X?OT     2SKL/?)D5
M _L
M
M                               I5,UH       ))&IXF8
M "O.YV.GG2[G]?[]    $@(>.OIR'/\ V/-X@
M
M
M    #(F5W@      $BC8N=;            !%^>E:AM(N,?IF1   _0_'YL/
MI=;M>SRI?N^7F
M
M                                         /-F$0_"      !\AL6)
MQ              _DCC-R<2;'+\3E>[QW3[_ &?GSH/%S2,A(V:%7A/>\G.
M
M
M                            ("F/T       LM-9X
M
M
M                                 *.#.4       :HRUD
M
M
M                                      &8PIV       -TAU@
M
M
M                                           &0$@"      #JANH
M
M
M                                                ,21'       $
MO39^                                        ?R<B.#''#G!Y ^B#
MYSTQ[<Z4=<.X'10
M
M                8/CP@      )U&Q(
M          YZ5]D"2%9$P\,      >_)*$JB7Q-(F8>C
M      !^41&(=D6B.QQ0Y<>)/P#ZA^R?K'J#W9T@ZN=G.]$B23!)0_5
M                 !^01P(UD>CA1Q8Y(<W/!GD3\<_%/E/VCT9[,Z2=;.Y$
MB23Y+T[8                         ?7(I$,")Y'(X<<N/&'GCY#]\]F=
M0.TDB"4A,(F"?L@               '\& P^$      $_P U^@
M                          \852E3Y $_.          !^R39+$BRDF6?
M(                   <%*O2M@@<>7         /UR4Q,PFX3O)2G]@
M             _"(;$(R&!$(C(?F          ';">Q8T67'4@
M           >-*Q"L,KS.<        ](3L+*"T@[X              #SY@C
M       /?DP       #]HL#+T3[X   !%(HB.''\@    ]"69ETQ_8
M       !Q,HR*<CQ(             !W0M2+;R8X                /RBJ
MXIG(#'Q             '6RPLLA+)#J(             !]0A05SE?A" \^
M             ?H%C!<J6:'VP                  "(I2*51GDP
M   ?*3Y+GBTX_2             //F",                T5EZ(   /,&(
M<Y$      #327)@            'E"A<HZ/-@                F&72EMQ
MZ8              _'*:RB$X:                ?<)X%J1:@=>
M   /-%<!5X5K',P                 23+^"VL^8                 B0
M9ZRM _D             [X7SEQ)^@            >?,$8
M !8\:W@   09,=(      !:@:K             0*,OI'H
M    '4R[LNV/<             K3,WY&\                  'WRQ$N)+2
MC[(        (5%(A6,>,                    )NFF\E@
M  #PYGG*7SZ8              !*@TH%@@           //F",
M      G^:_0   0 ,@0      !9\:O@           ?X46&>0^D
M           =(+YB[,_;          !STS7E2H                    !.
M@UE'2@       4F&;X^N                     #]\T?%SX
M   (%&7(X*                #^RYHT;'J0          >?,$8
M      !/\U^@   @ 9 @      "SXU?           'PF:TI;
M           )2FNX[2         "&IE.(_                      %J9J
MI       (EF,,^F                       7?FC<^8            '^%
M'1G8/H                  $KC5X22          //F",
M  G^:_0   0 ,@0      !9\:O@          ?X9IREP
M       MY-08        !5Z9;#S                       /LFY\ZH
M   #."4@@                       %UYI,/\ 0           ?5,VI2N
M                  #I!K&)W          \^8(P               "?YK]
M   !  R!       %GQJ^          !189U@                       2
M[-H(        *AC,4?1                       !KT+"       9 B
M                       -'9>"           ? 9@BH<
M      'IS6$6)@        'GS!&                3_-?H   ( &0(
M   L^-7P         !!,Q_'T                        65FM$
M JG,LI]4                        U>EGX      ,8I#T
M            'ZAL5)I@          S:E)H                     /5FN
MLG,        #SY@C                )_FOT   $ #($       6?&KX
M      'X1BW(T                        &G\M]       !!(R&GX0
M                     -7I9^      #&$1
M  )<FS4^\         "DHS<                       Z>;)21
M!Y\P1@               $_S7Z   " !D"       +/C5\         "BLSK
M@                       '<3;F?L       '&S&,<@
M          -7I9^      #&$1                          !IP+C
M     "#ICY/RP                      "8!L;/0@       \^8(P
M          "?YK]   !  R!       %GQJ^         /+&'PY>
M               :.2\,       ^,R/E<X                         -
M7I9^      #&$1                          !(TVRGV@       #R!BZ
M([@                       %WIH_       !Y\P1@               %
MBQKF   !  R!       %GQJ^         *:S,N
M  =*-P9Z\       IN,R@                         !J]+/P      8P
MB(                          !K;+(0       #.*4>@
M           ^P;#"=       !Y\P1@               &A8OF   !  R!
M     %GQJ^         ,>9 \         ]037)5G=CH)^X?E'B3DIP,C 1:/
MQP        7^&@        YN8ECF@          !U$[D>W/E/R#PQR<Y8?&
M         #5Z6?@      QA$0           >W.M'OCT9]T'C3CAQD^,
M      %N!J,       !%8Q>GYP          .B'?CW)_)X<X><N
M  )@FS(^R      #SY@C       /?DP       #](L#+V3[X   ( &0(
M   L^-7P        .5&&$^L        3Y+ORR4_?    !^&0R*_"MP@V?6
M    /6&X(Z<       9TRB\         'LBTXLT)WG60  #RQ%\AF0.*\#C
M        -7I9^      #&$1         .Z%A)-HE^2A.B@   \&0=*Q"IH\"
M         =(-U1]H       RAE7X        !_18"6S%BAW\  ')B"!6.59'
MD          :A"W@      'GS!&       3_ #7Z            " !D"
M    +/C5\        "JTRJ@       ]&:8BW8_T       '&RJHI_(>
M%WQH^       .3F(,\N        #V1>P7;GNP      ? 5QF;LC4       #
M5Z6?@      QA$0       #VQIO+43Y@      #PY1*45'Y0        -GA,
M       $0C&(?&        ">AHX)H      YZ4>%%YY@        $DS:Z?<
M     //F",       G^:_0            0 ,@0      !9\:O@        9
MWBB0       _HU=%H          !"@I$*J3\L   _5-N1W4       S^% P
M       )YFI [R        #CIB?/"@      &KTL_      !C"(@       &
ME0NH         (*&3LYD        ::2Y,      &7PJ&        /M&A4O6/
MG       (WF5XAH        #5N6B@     'GS!&       3_ #7Z
M    " !D"       +/C5\        #)^5A@      %EAK0           !P0
MHK*<#\$  N'-.H      !^>8=SC8       !;6:>S]8         &4TJU
M    -7I9^      #&$1        -KQ)X         $*#'T>?       !> :/
M      #G!AI/P        ?<-1Y;"        #RYE,*W@       "Q(UU
M  'GS!&       3_ #7Z            " !D"       +/C5\        #&@
M0R       --Y<:            #A)0$5!'TP3--<9TP       K6,E@
M  !9H:NC[P         !F!*@0      #5Z6?@      QA$0       #;X2
M         *'C/(       "SXU?      %+QFD        -'Q=\         #
MS9D#(1@       ^<W!'<P     >?,$8      !/\U^@            @ 9 @
M      "SXU?         Q'$=       #6B65@             CX0<.FEA)^
M@       #+^5!@       D ;0#W@          ,P)4"       :O2S\
M &,(B        ;?"0          !YLP^'*@      "<!L<      ,A17P
M    "S,UD'^@         '!S%N>#       !H[+P0     >?,$8      !/\
MU^@            @ 9 @      "SXU?         Q!'        #2N72@
M                   'US"Z<M       !K4+*           #,"5 @
M &KTL_      !C"(@       &WPD           #-J4F@      $IS:J
M #P9A2/S       #]XVPG?0          "DDS<@       L&->P     //F"
M,       G^:_0            0 ,@0      !9\:O@        8B2/(
M !-TV-GR                       AR8R0       3Z-@0           ,
MP)4"       :O2S\      &,(B        ;?"0           *O#*,
M 2 -O@     *R#)T       "Z<TJ@           _(,1YPH       _<-WAZ
M0     \^8(P      "?YK]            !  R!       %GQJ^        !
MC"(@        T'%]P                      *2C-P       #5X6@
M        S E0(      !J]+/P      8PB(       !M\)            C(
M8G@      #OYM]     !G7**P      #_3:P2C            *'S/&
M  #8"3[     //F",       G^:_0            0 ,@0      !9\:O@
M      9,"M(        NU-$AZ,                     &7HJ(       .
MDFYX_5           !F!*@0      #5Z6?@      QA$0       #;X2
M       !S4PF@      '?S;Z     #(.5]@      $QS9J            #A
M1A[/X       -&!>8     >?,$8      !/\U^@            @ 9 @
M  "SXU?         SEE&X        )"F@,MB/T@                    8
MR2'(      !;.:E0           #,"5 @      &KTL_      !C"(@
M  &WPD           #GYA#       ._FWT     &%,Y>       7WF@T
M         Q@$0@      "WHU!     'GS!&       3_ #7Z
M" !D"       +/C5\        "J,RO@         [<7%EN))(
M        &#4\:       :7"Z             S E0(      !J]+/P
M8PB(       !M\)            Y^80P      #OYM]     .=&$@
M&M\L=             ,VA2<       3D-C     !Y\P1@      $_P U^@
M          @ 9 @      "SXU?         Y688SZ8         !_1,@M#+-
M27!_0                !S4PF@       V/$W@           #,"5 @
M  &KTL_      !C"(@       &WPD           #GYA#       ._FWT
M  A\8Q        ;G#L             !3H9C@      #M)N3     //F",
M     G^:_0            0 ,@0      !9\:O@        #(N5U@
M    '<RR(LC+"SW(               (LF*D       &[ Z8
M9@2H$       U>EGX      ,81$        V^$@           <_,(8
M !W\V^@    %;QDD       /9&\H             $!C'X       ??-\Y\P
M    //F",       G^:_0            0 ,@0      !9\:O@        "L
M RA              _4)UEE)9:2G              ((F/$       _>-[P
M           ,P)4"       :O2S\      &,(B        ;?"0
M .?F$,       [^;?0    "I<RU@      $F3;&             "-AB6
M    !N^/?     \^8(P      "?YK]            !  R!       %GQJ^
M        /A,:)#<               D@6AEIY-<_L            KF,C@
M    !UHW1             S E0(      !J]+/P      8PB(       !M\)
M            Y^80P      #OYM]     *:C,P       36-DP
M   .7F%,       &Y$[6    #SY@C       )_FOT            $ #($
M     6?&KX         $(3':?3                )$%MQ;^2'
M  *X#)$       =_-OH            ,P)4"       :O2S\      &,(B
M      ;?"0           .?F$,       [^;?0    "F S1       $_#8
M            #GYA#       !M\)      \^8(P      "?YK]
M  !  R!       %GQJ^          *"3/R                 ?.6+EW!9$
M?(         "N R1       '=S<*            #,"5 @      &KTL_
M   !C"(@       &WPD           #GYA#       ._FWT     I@,T0
M   !/(V%              Y^80P       ;?"0     //F",       G^:_0
M            0 ,@0      !9\:O@         #X3+J5)@
M   $MR_@M)/D        !789%@      #IQNN            !F!*@0
M #5Z6?@      QA$0       #;X2           !S\PA@      '?S;Z
M 4Z&8X       F2;,P             <?,,8       -SQUX    'GS!&
M    3_-?H            ( &0(       L^-7P          /H&88J+
M             !-LTCDV@       ""YCK       /N&^8^T            9
M@2H$       U>EGX      ,81$        V^$@           <_,(8
M!W\V^@    %59E7       .^&X              $4S%>       #>B>K
M !Y\P1@      $_S7Z            " !D"       +/C5\           ?P
M4.&?8^D                  ?9+M#0V>D       (M&*@       &XD[F
M          9@2H$       U>EGX      ,81$        V^$@
M<_,(8      !W\V^@    %?1D(       /UC>R?=             *X3)"
M     >B-[0    !Y\P1@      $_S7Z            " !D"       +/C5\
M            08,Q)&                   $LC5J25      !S(PH
M   UTEB8           !F!*@0      #5Z6?@      QA$0       #;X2
M         !S\PA@      '?S;Z     1A,4(       -LQ)8
M I#,WX      !(HVY     'GS!&       3_ #7Z            " !D"
M    +/C5\            #\0I&*&SG8                 !T8UB$\@
M #^#!8>9       -#!?(            9@2H$       U>EGX      ,81$
M       V^$@           <_,(8      !W\V^@    'G#!:?        :ER
MV4             R[E18      !8<:[@    #SY@C       )_FOT
M     $ #($       6?&KX             '/RE4I-./@
M  ]::U"?8     !BN(J       %B1KJ            ,P)4"       :O2S\
M      &,(B        ;?"0           .?F$,       [^;?0     8B2/(
M      !<F::0            ?R8>CA0      !=8:4     #SY@C       )
M_FOT            $ #($       6?&KX              'XQ5F4XE?I\
M               /=&Q$EB     #*B58@      'ZQN=.D@           S
ME0(      !J]+/P      8PB(       !M\)            Y^80P      #
MOYM]     !E$*O@      #L!N//N@           $.#&4       #3.7*@
M  'GS!&       3_ #7Z            " !D"       +/C5\
M     <)*I2JPA2?P               "21LW/9@    %")GQ       !H]+O
MP           9@2H$       U>EGX      ,81$        V^$@
M  <_,(8      !W\V^@     H?,\8       -999B            9NRD<
M     &T,ER     >?,$8      !/\U^@            @ 9 @      "SXU?
M                  X:5C%9I7\?@@              N>-+P    !729&0
M      =X-M1^T           9@2H$       U>EGX      ,81$        V
M^$@           <_,(8      !W\V^@     @T8Z        3V-@P
M    .;F( \4       =&-UA]H     \^8(P      "?YK]            !
M R!       %GQJ^                   /(E>)6D5K'%0            #[
M!LM)C@    \:82C\H       &APO@           ,P)4"       :O2S\
M   &,(B        ;?"0           .?F$,       [^;?0     ?GF%<YV
M      #5Z6?@          &<LHW       !:L:I@     >?,$8      !/\
M-?H            ( &0(       L^-7P                    /C(:%815
MF1;            +,C64     9 " 0       /0FR(ER          #,"5 @
M      &KTL_      !C"(@       &WPD           #GYA#       ._FW
MT      RZ%1P       .TFT$ZD          0E,=I^>       #4B6U@
M \^8(P      "?YK]            !  R!       %GQJ^
M        !$PJ/*ASCP          /F-L9),    %'AG&        ) FQ([2
M         9@2H$       U>EGX      ,81$        V^$@           <
M_,(8      !W\V^@     %;!DJ        )\FM\](         <>,;QP4
M    'J3<^>T     !Y\P1@      $_S7Z            " !D"       +/C
M5\                       #\LJT**R&P         !?H:"     <0,/A]
M4        DD:V22(         ,AA7L       :O2S\      &,(B
M;?"0           .?F$,       [^;?0     #Z)A_.(@       %AIJU/=
M       '%3(N15        +>34&      >?,$8      !/\ -?H
M   ( &0(       L^-7P          !Y?W]>2R79YKW]?W?'SZ?P<GN^3P
M        'QE6IG0.          $N#:(     9)BMP        'OS2*6[']
M      %>)D:/K       &KTL_      !C"(@       &WPD           #G
MYA#       ._FWT      %"QGL        !)8U"DX0      "O@RY'%P
M    ;)B:P     !Y\P1@      $_S7Z            " !D"       +/C5\
M         #Z'[_5?MQL-?=RL4?IF1^-] '5H_CG#5(*R.CUGH''S@
M  >2,W13J        #^S=2=0    !6N9*P         3=+Y2RP^\     #X2
M'!3N4VGY0       -7I9^      #&$1        -OA(           '/S"&
M      =_-OH      .<F( \0        #YRU\O3)A@    $4RA,J?/C
M   !8$:^@      >?,$8      !/\U^@            @ 9 @      "SXU?
M         '*I#KHUUB^<$EY    #T7CY7(9E2YT5.!          %$YG</\
M        #7 6.     ^,Q@$1@         #K9903O)6';SW!\Y^(>*.4$?R+
M9#4@L<Q         -7I9^      #&$1        -OA(           '/S"&
M      =_-OH      !0 4!          $K2R0FR29.OGJS\LYL1N(2E:9"@_
MD         _TV"$]P      >?,$8      !/\U^@            @ 9 @
M   "SXU?         \+U^^>_9=%Y?W]8    'R/EU&6TB=U2@          !
MGF*'        #1\7?     %99DW                          !J]+/P
M     8PB(       !M\)            Y^80P      #OYM]       /(F)X
MXD                         6@&KP       \^8(P      "?YK]
M       !  R!       %GQJ^        !2+JEY@_:YX     #]_Q\]&.*9KT
MKAY@         /HF-8AT       "\HT9     '^&1<KL
M          -7I9^      #&$1        -OA(           '/S"&
M=_-OH       *MC*8                        #UIM0._@      'GS!&
M       3_-?H            ( &0(       L^-7P       !QR3[<Y>V:3_
M  ^@     "R:CUBW3.*>          *SC)H       "X$T]@     C>8O#RP
M                         -7I9^      #&$1        -OA(
M   '/S"&       =_-OH       !EK*EP                       #2F7
M4@       \^8(P      "?YK]            !  R!       %GQJ^
M  *Q+Y::H-#MP      '2>'ETHX=F0          ^F88CE@      !:\:G@
M    "F0S/                          U>EGX      ,81$        V^
M$@           <_,(8      !W\V^@       'AC&F1H
M       +035P?V       #SY@C       )_FOT            $ #($
M  6?&KX        H\U:]PHM,X       -+.&9AT'CYP         !E *P@
M    "UXU/      '^&7DJ*                         -7I9^      #&
M$1        -OA(           '/S"&       =_-OH        (N&.<Y\
M                   2J-C)[D        \^8(P      "?YK]
M  !  R!       %GQJ^        ,^VQZ)&Z<DP      !H3QK.9#PL<
M     ,Y)1R       7 &GP      'X1D=(!
MUKEDH      ,81$        V^$@           <_,(8      !W\V^@
M   $##(Z>8                     .W&Q$[Z        #SY@C       )_
MFOT            $ #($       6?&KX        ST[-HT>YF1       &@G
M',[DC!Q@          S]%!       !>,:-@      #Q!D@(,@
M            &VXD<      #&$1        -OA(           '/S"&
M  =_-OH         *]3)X>0                    .UFO@DR         >
M?,$8      !/\U^@            @ 9 @      "SXU?        %#&NW^)E
MBF       !HWQ/->QQG$          ,Z)1B       :,R\D       'D3*H5
MN                       $T396       8PB(       !M\)
M   Y^80P      #OYM]          (6&34Y                    2A-;1
M($         'GS!&       3_-?H            ( &0(       L^-7P
M    !43H]QK;O%F       _8\_QIUP;+/N_GX          ,LY4V       :
MR2S,        ^B9Y"C ^,                     '1S7\2W       ,81$
M        V^$@           <_,(8      !W\V^@          X>97""P
M              !9@:C#H          !Y\P1@      $_P U^@
M  @ 9 @      "SXU?        $1[',4.ZY?P      )D5F%O2R:A
M    8I"+P      !N0.V         %;IF4.(                    'Z1:
MD:'#O@       ,81$        V^$@           <_,(8      !W\V^@
M       'YQ0P4)GXX               !Z8T,%W)\H          //F",
M    G^:_0            0 ,@0      !9\:O@       #X?OW.OM6D<3E.X
M      7Q9'0)<5R'          '$##H?R      "4)M;          /$E!92
M6?@@                 $DBX(N#.R@        QA$0       #;X2
M     !S\PA@      '?S;Z            1<,XI7                68&D
M D8           #SY@C       )_FOT            $ #($       6?&KX
M        $7YZ5H/U_0/J_K]     ";E5@KOLJHH          %4AE>
M - Q?L           <&**2GT\H               #O!:66M$W3^@
M  9"BO@      ']FZPZ:          #\@P8GY       )=&T(
M  @ 4)E>!_(            +!"_LGZ            #Z1@M/P@      67&L
MX            $03&"       6[&H8         @I;9ZF'3[O^=^_P!    "
M4L!$WK9+0OW_ !\P          (>F,\^J      21-EA[\            YZ
M5)E21",^(            ](3C+$2R,E^?T           5:&58^N      6T
MFI,           &;DI)      /Z--I<:              10*;RJ Y"
M     ="+5BYXF,              9Q"CX      ^Z:Q2RH            'Q
M&04@$      ?NFO8G2         #@,Q(5':-<(J6&7   ]+X>5E]%J]G-#JW
MW?S\            A,0>/B     .P%EA[,              XH5PE?Q!XCF?
M$       #TY)XEH3()L$R3]H             $0R!)](     D.66GVP
M       ?&5Q$8S^0    ?9)N$V@               ?5(-E<1 ,AH>5
M /NDLB?A9$6"G[0              !_!7*1?/Y    !]\G^2Q
M  !^&5@'&P    #]<L3)*@          '')/MB78I?B,KW^1Z?7YOCHW%S2,
MA(R7E;A_W_'S                                     \61>(ZG#SE)
MST\L?1!]L] >L/?G2SL!VX[\=K/F
M                             /I$;B,)P,XV<X/)'T0>E/=G7#NY)@E4
M>I
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                            /__:  @! 0 !!0+_ ):\8>$I=P0Z+9A.
M9GR: /;_ ._,WS_WYF^8'S: 10,ZC8C. CTC,Y3-GPA[!"X1@2O_ *4@:9,*
M]1 BH4<"'6>3W)DQXK%,_;1I3B@W:287AWN:YH^IML*\QS4Q5ZL.*P"U6JLE
MJ4;#O.2\(]T'' \3NZB%'U2#LMRN[H=UUMEJL?1*D%Q\]B\.JC# >8Y?]<67
M+@R$SJ+TCJF=B@N:XH.RD_!^3A<["-8@N++=%7&-5.X2W6E\C9??COU[V8.
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MR3MMNON+F^7IO3"Q+PY[?_ GDX*9!W0G!Z(6A5RM*VU_U"A1(X3KLU&5K4/
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MUY[7'UX)UY>@+:9-LX9/RZVZRZ6TY5]21R)!Y7&#M>@A8L2/%RQ4D%8>T!L
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ML_+8[W!/K6BD&Q,Z'+<S.ZO:<?4/IN,_O<D=I^K)96?BT=I^TX>T@.HQD(X
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M]7.]9K:/HJ/J'W))/@M[E$H8I69C24Q2*E"*Y/2HD,'&AGR;',UJ\D-'QO\
M!10_WYLFU-6V7/BNH?3<9_>Y([3]62RL_%H[3]IR&T31?W])^)$)&9J4Y;%
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M.B]^60,6E//$M30E0S*1G][DCM/U9+*S\6CM/VG)OHR)8[A&<DQFGC7PMOD
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M;MIZ&G*V\;;H5\)Q/BOOMEQY-G8^BJ&NTU&7$0L+)?/5MRK@ZVV0L5<953E
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M;>PN#4]A#)K'$H\@%5N3&/[YA\"'PX8_R,9>E_9PY%MM0#GCSM0KDDU%,YQ
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MXDD*H@JM?1L,FG.J&6H#>3AWV]D[-HW4SJ8=)7Y%5'5%\" _)S)]U-OJ/?\
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MTJ1,E/+F=DRGG)#[I=]QYTC<-??7=QEUDZ972@\23!DO1) ?T7HYMN#_ #[
M :L>O(H88Q=3,-7/68<F>>^@W'\TE,=FVM::+(?%ZVPTQ,S_ -)0J+0AX?\
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MV[:8FW"_WD6N0WZN$J?WO:\4YA78[/4=S97<\\?G-E+>EN"*_DVNM(A89'F
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MVG,*<$YMW!QLR;<;(3 P)1,#%<PF!#@HD*IP79F/Y[_::J:RIYLU/UEE@T.
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M@%QEYDQ<:=;-,P.-N J@8&*XHJ<%W,X=K/.TOT#,.G:;JY5@&9,06>XIA%K
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MJ798(H/S2$D)J+CCATW,!RHY,NKN?)L[6P>*1,G2W%=?><+OJO 0 400$<!
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M<RE=T>-M5HV..+SYQQ[5 9X<LEIGNEM[1I[6,6@$Z:CSAP.XFL(MA) E3#-
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MJJJX(B<555Y$1.=5V:U)?11+7%]%$W^M%%+3]<]@XU4L8IB$MP<"EE\?Y-.
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M:,7&G 51-MP"0@,"3B)"28IMI;5:*"NV]3'<G(WAD;M&,8ELR.'(+-E'=%/
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M+<'HD1$QZ+G9X*2'%Y5 ^K7G3NUE]'S/S=S<-#?:;U/U!O>N?LSZX:?W"%]
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M'_DI771%_P"ALW'U95-R6^0K*I^1D"GQG8+I=0\O] VOZ*[=LH;.//;'+UH
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M+>Q(41^?+4<>)88 &*HTVB"G)N=E]'S/S=S<-#?:;U/U!O>N?LSZX:?W"%]
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M0 !3*( (X((BB<$W>R^CYGYNYN&AOM-ZGZ@WO7/V9]<-/[A"^@+WR#>Y&TZ
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M+SG/8+ D\UU1JVZHN@O1>>ZMK!<P]9R;=BTM5 U(=;$)]S*R2+JSRX+\\G9
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ML,$19#C2+&GD(I@BR&GE%."8;$L76>IF6?@MR(U7)=3^D\VQ$$O^@FWUXO\
M]'5WX6WUXO\ ]'5WX6WUXO\ ]'5WX6WUXO\ ]'5WX6WUXO\ ]'5WX6WUXO\
M]'5WX6WUXO\ ]'5WX6WUXO\ ]'5WX6WUXO\ ]'5WX6WUXO\ ]'5WX6WUXO\
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M'MT*O&D8(.(F6%ULNI9* O5ER+T5WU'%G* 7*N4+,ZBQ2*:+E'*%F?\ !?\
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M3'<Y<\FV" "1<)U*N'%>.$.CYFE:<X7AM ',AJ;EF@>1U[@BP@@TX-$EPJ(
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M6,K21&K2=,>W([Y"-^:%:74R."3R0S^M-DE %T%C]I.B:N0<.1ISX;_?,RH
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M3#+)ER6 >#A-]%X$FD.&',F@&S(=L*+^_5N]K:MP\N""[5^L@_+HRCKA4/\
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M[IX>GY,,N+[OD->1J81@B2[=(XIAPS CV1G:\H5[$:MZR[0;AP(.H,,A/R?
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MC.;G9#Q)DPR^,OI8A02AA7,= ^1HEOMV82D,X)F(P*:7!&8. -81Z)V 3K%
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MU-=RX ;'S&D2]TX-:@2SU%B0&I! !,?"9"9NSXAI+]]K<(>J 06VJU=UQS>
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M"N-("I,*!50XY3M@U_48V?GT"ZQ8F"2LHF5?R%QI]\*-_P"#Q[[-+( W"MJ
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MH_UKT?L/[TGR7P:<YONS^]8.#T,_FZK-ZF?^<M__V@ , P$  A$#$0  $
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M         )))          +#2
M
M
M   !!!    ()(     .5$E+R
M
M
M)              "DDDDD(
M
M                                                        (
M        (   -TDDDDDB
M
M                                                    !
M     !    4DDDDDE(
M
M                                                 !
M       LDDDDDDD
M
M                                              !
M    *DDDDDDDL
M
M                                           !             !
M  DDDDDDDDN
M
M                                                       (   .
MDDDDDDDD@
M
M                                     !                   DDD
MDDDDDF
M
M                                  !                   $DDDDD
MDDE
M
M                                (              (   !DDDDDDDE
M8
M
M                                            !    (DDDDDDDN
M
M
M                          !          (!(      !JDDDDDDEP
M
M
M                       !         )(  !)(    !TDDDDDD>
M
M
M                     (       !             @DDDDD6
M
M
M                          !(            !LDDDMT
M
M
M                                      !,SHU@
M
M
M
M
M
M                  !
M
M
M        (       (
M
M
M             (
M
M
M   (                                                (!)))!(
M
M
M!                                              ) (       (
M                       ( ) )(! )                        (((!
M) )(! (                         !( ) ) )
M                                           !
M                  (           !)                    (
M    ))                      !)         !
M   (             )      (              !!              !)
M              !              !)(
M    (                    (            (
M              !       (                                (
M           )                  (           !)
M  )                  )              )
M                   !             !                   ((
M        (                   !          (
M (                (               !
M                 (                                 !
M    !                      (                               (
M               (                 (
M              !                                   )
M !                      !
M           !                   )
M            (                                   (         (
M                      !
M                             (
M         !                                             (
M                                                     (
M     !
M       (                                            (
M
M
M    !          !                        !
M                                                           !
M                       )
M  (                                  !        )
M                                              !
M                                                           !
M          (                        (
M                                            (         (
M                   (                                     (
M       (                        (       !
M                                                   (
M                                                      !
M                !) )                  (           ( !(
M                        !  !           !        (
M( !                           !                     (
M !         !               (                  )(    )(
M                   )((    !(         (                  !(
M!)          !                                    !         (
M        (        (              (          (       !
M                (       !                            (
M          (                                    (
M     (          !    !                 !         )
M             (         !        !       (                 (
M                                            !
M              !   !        (        (          (
M          !                          (        !
M                                          (                !
M             ) !(                           !
M        (                  !      !        !
M   !                                   !         (
M           !(        !        (           (
M     !           (                                  )
M                                     (        !       !
M                   (                   !
M   (          !       !               (           (
M                                  !         (
M                                     (
M!                   (     !                     (
M                                (
M             !                    !                       (
M         !       !              !
M                             !
M           (       (            (                      !
M               (                           (
M                           (                  )
M                !            !                       (
M            !      (                             (
M                        !         (         !!
M      (       (            (                      !
M          (     (
M                      (        !           !!
M   (                    !                       (
M       !     !        (             (       (
M                   !                      !)
M!        (            (                      !
M     (
M                 (                         (
M                   !                       (
M  !     !       !              (
M              !                          (
M   !             (                      !
M(     (                     !        (
M            (                           ((
M (            !                       (                  !
M   !                              !
M         !                                                !
M            (                      !                   (
M (                              (
M       (          !                                     (
M         !                       (                  !     !
M                     (       !
M    !           !
M       (                      !                   (     (
M    (             !
M  (                                        (       !
M    !                       (                  !
M                                                           !
M             (                  !(      !
M  (                      !                   (     (       !
M             !       !                                   (
M           !                  !                            !
M                       (                  !              (
M           (                                          !
M         ((                         (                    (
M                    !                   (     !       !
M        !       !                                   (
M        (                  (     !        (           !
M                  (                  !      (       (
M     !        (                                  !
M      !                 !                           (
M               !                   (
M   (                                           (
M     !(               !              (           !
M             (                  !
M!       !                                   !
M     !(             !                          (
M          !                   (              !
M      (                                   (
M     (            (              (          !
M        (                  !      !        )
M   !                                   !
M    (           (             !(          (
M     !                   (                         !(
M                                     (
M  (                (        !(
M   (                  !       (                 !(        (
M                                  !           !A-0
M!(         (               (
M!                   (                (        (
M                                (         !+2DE30          (
M                                                          (
M                 !       !         !      )
M                             !          @DDDDJP          (
M                       !)! !!                          !
M               (                  (!(!
M                           (         :DDDDDB@
M    (                                                (
M            !        (                         (
M                        !         .DDDDDDE0
M                                                  !
M          (       !                         !
M                      (        !4DDDDDDJ                   (
M     !                                          (
M       !        !                        !
M                   !         DDDDDDDEP          !       !
M   !                                         !
M     (        !                       !
M                 (        ,DDDDDDDEP          (       (
M !                                         (
M  !         )                      !
M              !         DDDDDDDDJ                  !
M                                        !
M(                               !(
M            (        $DDDDDDDE
M                      !               (                  !
M                             !(
M         !        !4DDDDDDD@
M                                   !                   (
M      !                   !(
M       (        $DDDDDDD@P          (
M                !                (                  !
M    (
M    !        !$DDDDDDE           !       !          (
M             !(               !                   (
M
M  (         $DDDDDDD          !       !
M         !!                 (                  !
M!                !                                         !
M         -TDDDDDF           (                   (
M     !                   !                   (
M                                                         (
M       "DDDDDK           !       )             (
M               (      !                   !              !)
M          )
M     "\DDEFP            ))))))(              !)(         (
M             !)))))(             !)))))(
M      (                 ))))))(              )))))))
M    /K 8                                      (!))(!((
M                                                        (())
M(!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M?#RK1E$($+MF1B3H?L1";0 7A%+[H2C:HE$ *Z7?]92^T  =8-)C<P&D:,B
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MH32U:Y$DS(FG( !P@LE%TWNS!MERA4.81L%4.I8'(\"JBN(G7"10(VQD!M%
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MG\$K=BPM "!M(>(&CNQO)0!YJ:89R+WY2Y.9CM$8)&QI4[!Y"&3FP0? L*\
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M 70>" ]:0VFM;$<.*<3,TL*<)X@N &@@YGR1-A$D7PV*2RUM&#X *D83+ 0
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M5A%K'=';MCX%(DJ ONA*-HB041IW(:X62^EAD$H"EK@5!F5]:(!. 'NCQVL
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MJP!04-U&[P>AVI<T<A2.WH51 C1H!R@4A>+)?="4;5$H@!77/15:E791Q!<
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M,LHRG1.>./4L [")2#48='9FY 5.#> )2I"X$EV*()!\Q\A6,9L1XYPA0 $
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MPBR( <#8V[49FLQ@W5_N )__ #_! "0/&Q#"=WO#8J2@?B"DLM;P![$,#0,
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GZ:EZNHY4=4#'MOYQHYEO1_ /W:,?DI]TOD#3M7YI7YY>FW_.6__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>sny-20221231_g10.jpg
<TEXT>
begin 644 sny-20221231_g10.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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MS;5?SLOWY)HVBPVXZ"6\=I33QX)Z8!_V1SG.I>?_ #GJ@99]=N((V_8M:6X
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MXK_LB,Y'K/YP:M<\XM%LH]-BZ"::DTWS ("#Y$-G+M3UC5M9D]35-1N+X@U
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MOR>$@E$4.TC;$A=]L4B9Y6-S^^BX;E#12P! /^UER&66$36T OA4J?3D)!W
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M?P<_[+QSU%FS9LV;-FS9LV;-FS9LV; =_?VFF6D]]?3K;VMNO)W;\ !U)/0
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MO*,5;CO2NW7P\,$W4<$@0B%;F5 6/-"% %"#R'3IF%[#Z0,@:(. Y4;\03Q
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MDJ_"K$U44^R1U %.QWPYMUCMK8J:@JH4@ R%.M>5._\ 7%XBT97A&6M^"E:
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M7J>XP(\XK++-$Z,:54?%\/T5VS>L)4$B2E P- 5:NY'52,%)=(6"\Q\7L:5
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MT<?1N,\[>;(7@OKJU^LFX1&#*7^(<>(" FO50*5[]>^0A&/J*._\?;)AI[[
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M6URR6Z?7()/4D=@#;EIVD9T^%2L7Q!:_!LS;QG7O,&J^5M.O5A\P75A80O\
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MD44W&U(S5=J==L :SY2\O^;337?*-G<SR\4EDG0-)R;>JL>)1:=@:YU?\O\
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MY'M?2MH=J$TSZBZ7J3:C^1,MXKGU(_*=Y;\PU3SM;:6 FOC6+ /YSW%8]'M
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MC9R*XVH"_P#;D7_(;R['H?DZ3S%<Q\'2 NFW4OV_')W:J3&TC_;D)9OFV_\
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MS*Y07#.PX!=Z'D U".O;KG';W49!];:1NH*@@@$$ "OTXK:O+(BU(;C& 0*
MJQ ('S[Y)M.@F:XB@(0RJYD+@? 338#??.FZ7&]H&EE97C=J<0:[UWY9T[2;
MHWD,2(3#.U8U!-!4=3[X<74*VZJZL&*]6/CWPJEO+9HQ&Q7DM6%>JUVVV\<+
MY [HD@;X 0@8=*'H1D:NE=1.JKS8"L8%!04[>PQ!5;GZ+)S?ARYCL-J'B3OU
M.V&-M \,N]0W(E.-/A4BE:'?B>M#XY*X88H4DDA^!2:U%=D(5@3XT8?YTP9#
M))'-*H13#+$#*C;!I6_:'LW1O>A[X+MF9884D4O 0Z GKPY<D5AU#*00?GFG
MDY0JL<G%B \?<D G;Z"#@$./561A4<@Y7QIU]\\%^;=*^K_G)YKLH#_H8O4D
MMT'1%G57*CW!)ST]J<D.@^5F9V"#2=,GOWIL05C(0GZ<^=.E^8&8"5G+/,S2
M-ON2YY']>2*V\PCD4,@ \*]L,OTE'<$ L",,K<Q%>@WQHBCY,]!3&-Q[ =,3
M% WSQC7'!BI[86ZA=\86J:;9Q3S3J7$2_%TSSEYCU3B[[[9S.74^3,:CJ<+G
MON<@4'KAR'_=*#]&.BJ-QG0O*D'*9"16I&>\ORPLO2M8/A'09ZL\MV_-E:E:
M;9Z8_+Z+CI7GM?'RU>C[TR6_FS_QVU_Y@X_^)/GCS\P8B]K/\C^K/DY^>5IQ
MU&<TVY9S?R8>$B;=\]B>1I5,2#8[#/7/DN7E'#OV&=XTYAPC/3)C;L"M"<78
M5H1VP3$/AV[8L[+Z3"F1.ZD4,X[UPFN9 8V PFMI?WI'@<-E8>K\\/K)Z9=[
M)\)W[9SS6'W:N<YU !BQZY&)A0G%(.U,-A-Z: ]R,YYKFE_I:T:WCD,$]G<N
M1(.HY&O\<ZMY7]31] TY;BX$]X@ 8MMS)Z?AD>U._P#0U:]+(%-W%P<^S KM
M7.?ZD5ED6U213?02<I14;U ^('ML-\#'TI0HMY0UM>/ZX:M1ZQ4<'IV#'8')
M_H\OJ6H>9 7CG]$*2"5:,TJ?&E3O[Y/5GBBMXX;B2,1K$%:11R #,&,A8>]
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MCL*D 9-[:_FF>)N8/(\#7J0-Z?/?;)SI=UP0*2-OA0CX:L1M4_+)/#26GJ(
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MJZV3_O(WW'#:V\J:V94'U5A3V.=G\D^6]:ANXC]684/AGN3R7;W\4$"RQTH
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M','$#H/;.P^1H"ECYT7]E_+UX/\ A1DI_,M.>O(/^72/_B3YQR_L!*&%*UR
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M/M"K5)( ()!VR9Z9<&YMO35^<%!S6K<E>@()*_%QKL>E,E5O'<$<9WD]*O
M'D* 5Y,M*"H.Q'7.3^;XFO\ S5Y3TT1_Z-)>M>S[;&*S'*-#RKR!<KT\,DU\
MT8=+JY!Y ,08U]1F2M M6!X]13;VSDWFSS?IND26,$CM#%J5VMJ?K,E&3D0[
M%2"!3X*9RS7/SHT.RO)['2YH]6EMG,C"V*31PL!]EVJ I/AA?!^;OF2[D2:S
MO8]+LH27E4(9D#LH4H7I7=:_",FDWFK6S:I-<^9[NQEN&##E;NJE!5V6-!ON
M"#[BO3!=IYOMY[R:ZB\R7*QQ6O$!)(P'2@^-27J0&[')/::Y=QLNH'7KF?TT
M15+R*R TK4IR6E3[T\,DE[YXO+Z-!+J$T'U6)V>-%$3*U*4"N1]H-UZ88:9Y
MBC_=6L_F">*:\ACE@+$\O3F)"QU!(Y,ZT]LF>D:K;W-T]G;ZZUO/ LZ<XJ!"
M\<G(J&*R+S5=GW'RR9P>;M3L(^5W,FIVJ"JR1A3++&H'Q*%/%AN*]#[8_P S
M^:=&E\K7E\NH02J_I,J.PHSF2,K'0$$M7HO7M@+1-96XM$2*5YYHU"2!7!D(
MY$DJ 6&P.X .V<R_-_0*#3?-^EP++-HLZ_6 PX\[::B2)44Z?"P':F^*>6([
MX)&H!CBD917U*.Q=MG<$@;#;8U.=[T>&WMPOH6H24U#KR=5J:$U5@0#O4 '?
MP(R7R/')]792?3XLK,#44%/A^6_3M\L1>@'-V3T5/(DGHH7E3PI09YGU[S3^
MD]7O;N.0FW:0I#_QC4T'W]<+!K+?S8HNLO\ S]<676&[MBRZPW\V++J[']K;
M'?IAA^UE'67\3C?TRP_:(S?IINS$Y7Z:8'[1.-.MMON<:=;?NQ.-.MO7<G$F
MUR0=R<0?79?$TP))K\OB<!2>8)_$X E\QS^)PME\RW&]"<+)O,]R*_:IA/<>
M:[L5^T,[5^17F&YO++\[&>M;7\N]8G7YH@SVG^9G_'>3_F$C_P")/G&=1J%:
MASGFIM*"V]*81K++XX*CED)^U@E9)-M\65W\>F*AG\<>&?QQ2K^..!;8\JYJ
MO_-F)?Q.-^/Q.42_B<:>7B<:>>WQ'&?'XY7Q>.4>9K\1QOQ?S9J/_,<L!O$X
MZC^.. ;Q.^07\RY&B\FZF=SRXK0;]2,\_P <<4VDW,,3QF2[@YH#0#U$ '(.
M?LT HP^1[9%;6[597CGD-G(R"(<H^!D('Q+QH?B% 1V-* C.BZ-J"SVL;33@
M1*5D9!7X'-?LT((%3]._>F3^QG2YM(GL9BX*D"(K5-B0R/4$@U]]L/=(OKJ.
MZ>RCB5_00,@J5)# ;5! Z5H"U 1\\Z;ILC3[P\1&5$R^FW+DIZ@ T!/L/8Y#
M=;L^7FG2-1H MO#<1J[#D.<W ** TI\)K@77=1-EI[W$Z4BMD9BPD^'B:_LM
M3;;M\L\-Z=Y"U/\ YR&\T:UYE\TM<Z9^7.@3M::'I57B34)H:B2[N0*<E5B!
M&M:=2<,-2_(E?+C07?EJPALIP9/4M;9?39V% K0FK*6-=^0^+N<*E\O.X>V6
M\N-+O6 *02VPXN"*<E+-12O&NWO3)9I7DSS[<74,=O\ F'#<QVZB&*"\T^.6
M,)"33B2\3U !)HU:=Z8=S?E7YHFNVFU36-*EMV1V$EE9M"7=E!"%YICWZ!3\
MLGWE_P AW&GB&QGUU;IWCCDX2I(OV:. >#$<3VW[4P_OO(\=S#/'=W>E.ENH
M>***!HV0$JS!7>5R0Q/0; Y*;'\O7*(EG>QVA,Z7RRJH;TI0O!0%9FXG?ML2
M!MAQI_Y*:L8+BXD_,KS):M/)SFCBEM1$P)X$A# RJPJ*E0,Z)%Y$M['3"FJ:
MW<W=R0?])E1.?)1Q'(*H!I\L\=?F/^0]W9WESYK\N:KKUM=:8+C4$TR.]E>"
M:XX$@O$S,@9GJPXTIT&3;\G_ ,S(_,^C0WEU:R:8[P^@W,_';R#X)(Z*O'DI
MW\"?;/4BK;:KH<^FM(DD<]HZL2G%) !Q+-&3R%=Z]J[UR#^5HO2B,;QL9K3C
M$%D)4!T^$IOTW ()'7YYVC2':*8U]6171TE0A0%X\3N5-12NV]*$=*9()Y6Z
M&,L6HPX_:'0_$.AR)^?-5BTGRQJ!B<FZU*,6-LZ]>4P/-J]@J!CMGF00TV H
M!V&*+#[8LL/<#;%UB'SP0L72HZ8L(O''&.F-,7>F,,?7&^GF]/VKE&.GTXTQ
MXPQ^VV)E/; [1T!P(\7? ,D?TC"^6/VVPKFC\=\*YHNHI3"2YCJ#X=\[Y_SC
M]9,=#_/R[WI#^7NIP'IUEBD8?\FL]S_F<M-<MS_/8QG_ )*2C.,Z@-F]\Y_J
M:[MD>XT/]<$QK^&#$7;Z<75=JCH,4"XJ%Z8H$[X\)TVQWIY?IY7IXTQ]LKT\
M:8\:4]ML9Z=?GE%*?3F]/-Z=,WICPRQ'^./$?AN<AGYAV9NO)^KJHY/%&)57
MQX;G]6>2=.)M;B">>(SZ=?HS\J@>DXJI/Q$ U!^_!>I:5-?B6>$@/8\U:5MS
M<1KT>,UV.P##?I@CRGJT3SO;SVYB+\EDC95)?X2I9!Q-":]/$;9U WDL21QP
MR%8G9IHHPY4M(34AFIW6IWZ'KAZ-8_1UA)J1E:?T45V,9YK&!Q/ F,$FM?'?
M<9-_+^IK<10W$)$*+&'D'"@2AW])*451RR5:A;QWD;2.BI0 J_$45P>7Q#J-
MQMG'_.#:AJVGO9BQ$-U?NT,,7(RD._PM(5K\*)4FOW"N'FGZ38^5]#TVQM0/
MJUJBVR@#>4HQ0L$'2H!K\]\0OHB+;ZNW%%DC%$IR=592/M$&C$&O?(Q=Z7HT
MMI<Q7\8NH+8@.Q4%E!XA2K4.X&QI@JV\I:*@DBMKN:)9)./IW'%DXMQ-:"I
MK7XAOA[%Y;NO3E6TO;6]CC/"2.9CQ+@=*J5Z4JII49=KY=U. Q2I;I'(ZO1D
MEYHRBNP!%%-#MOCQY-\R2<)G$<SN*H%DY7"1L#R5V(IW-& KDO\ +>AZS:16
MX-L \7'DKD$-5N7&2J5=3M7.P:?H5[659K^-!<T_N@0:']@BM#M\L-K?RW%!
M+RF87<1C^$."Q5U( X!JT!7K\L":C8VDD/U=X0EO4+2E!P8$4;K4'I[9YJU/
MR):>4O,>HW>B&*33;LRW3VTD01E>JO)M7B57K4]!7M3.D:'J'J0HS*:E#%2F
MR\Q154K6HZBO[2GVR4P:4D;7;I"(B8J2D+S7D*#D#UK3QVR66T3HT+<BX #%
MD&XKQH01^RPZCIM@R@;TU-66*H*\NWO4D[9QG\RM1^N:O!I<3EH=)C!<'IZ\
MH!('^JM!].<\$./$77;%1"<66+IBZQ$=L6$-,OTNM<8T=-Z8PH.F-X97IXTI
MC/3KE&/WZXDT>V(/'O@1X^N I8^W3"Z6.F%DJ>.V%DT?4=/'"2YBV/TYZC_Y
MQ\TXI^5?_.16IL/AF\N2VJ?..QU%W'7_ (L7/87YJ0<9M)NA_NR.6(G_ %"K
M#_B9SA-^-FR!ZD-VVZX0!=^F"8UW'SP8J4Q95Z=L65/;%@@KBH3^S% F/]/+
MX> RN&-*8TIC?3QI2F-X97#KVKE%/;-PIEB,>&6(_P ,L+O3 ]_9I>V5W:2
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M:E-Q]^&L>M2"X-N/4B%F%19":1NS"II4%>B[U[Y+X-1O)%Y>H[<4H&*4JS=
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MBUH2J\GIRHU:$T.36'A)';2LM!QHW$D4XT^(T"T/TX+)5HVJ%$2DJS$ U)V
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MK*"RC(%*B"-4Y'W-*GWPXS9B 0014'/$GG+23H>OZIIE*1V\Q,7O$]'C-?\
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MQHO0=<.Q04Q-Y!3$T-3\L^'7_/U;3ULOS<_)_6U'%M3\M7]H[>/U>[C==_\
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MQZL01V#<0*9T+3[I9(U@E/%Q6A)Z^V"Y[5)%((K3".9&BJM-AA%J6DVVJ@_
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M6VE1<H[&.DU].H_NH%(Y;].3'9?<^ .>][.TMK"UMK&SA6WM+2-888D%%1$
M"J/D!@C-FS9LV;-FS9L\.?\ .=/_ #BM;_\ .2'Y9/>>7K6-/S4\C137?EV;
M9#?1D!I],E<D#C-Q!C+'X) -U5GK^72Y@NK"ZN=/O[::RO+.9X+BWG1HY898
MV*NDB. RLK @@BH/7 !:K&E2 :;X]Z\A5=JD8S[ZY0!V\:D8UE(X@GY8X U&
M^P)Q[+\)-*T/XGMB86M16M<8R_"*#H,#V,8EOF=A\%JA))Z<SLN2J.O!02&
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M &02-Z=SC&W!'<?B<8!Z9)<U!(%!XY; @5[#J!^L8ZA8*KKOV^?AB\;&A4J
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M_. WY;_EE]1\P_F 8?S)\ZP<9%6YC_W#V<@((]"U<?O64]'EJ.A6-#GO@
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M9!&YJ/ZX%8;#X"%Z]3N?HS+]L [KL 3L2!\N^&$+ENC<:_9-.WB/?#ZVD#J
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A>WAAOFS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-G__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>sny-20221231_g11.jpg
<TEXT>
begin 644 sny-20221231_g11.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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M< EV6JCDW$FH! <=@=L,]3N[A-1\NV.H7*V_EKS)! !=0']V)MO2>>1#1^0
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M2,JLM31_B !Z#()<?\YH^7;Q[K3K?RMK*&+@ETUQ+;):QAE#49H>7(!17BK
M 4W)PGB_YR-\O:YZES;>7&TR&%W>WO+6::+TV:L9]6WBM92P*BKL4;YJ,ZBW
MGK0-9TZPM;O\RM'2#4[=D1)FMG@,'$K+%*TLT9H202' ((XCQ/@B_LIM#\PZ
MF-"UFPU)Y;E9>=NEPMO(R-56GB662U=6#&-B:= 1_-G/OS \YZMYBU0S^;/K
M&K:C9<K86UQJC!(D+5X0GU9 !0  J#4;-MG']0FL=3:ZE;09K6]EYLMU;7KS
M@%MB'5H@E#Q['Z,)M-@NHO3.D12W%Q"1,T$K*&95W"MQI4=UJH]O##_4;^&"
MPN)[:SGN/*-]-SEBD*B:PNN8);X117Y"C@  GC( *G!26[M-!=QR"YTO4RMD
MDQ%5#7!"K4UV:%E6O?BP(KG6O(GDG5-#/F#7UM4F?RTTJLLT?.*C=!Q-:H#0
M@U'5L.=9N=*\C+!J6NO!/K=]9/JA$*JC6\,DC1A0 2 TA I0[)7Y9S"'SCJV
MO:T4O8IKV[NVCE72[9A'#8IMP278!IN(#,6^",=34YVC1]*UVXAC>XN-/T^&
M D*L\H-LA-:(TTQ(>7I\"(3WZ9TK]!:M/ C7FG6$*S14C>2.4FA%>#3SW432
M*QK7X% [$X9:'YB\Q>3=2@O]#\P_HV\L6(C"S*'7ELWIK'<S?": %&!J!\7(
M9[\_*W_G(2Q\W6]OIGF2S-GKW#^^LHI);:4(-YBJIR0[?$H!I\L]'6EW:7D*
MWEM=PW4,@%)(G#( =P-CMUZ'?!893MR'WX^FW3-^L9OHZY=/OS4.W?-0=,HC
M>F45Z95/;?+H/'*(IC2*Y7'Z<:4\<4ADEMI8I[>5X9X7#QR1L5=&7<$,*$$9
MZ3\@_F;'K'HZ/K\B0:H:+#<FBQW![*W0*_X'V.V=CS9LV;-FS9LV;-FS9LV;
M-FS86:OJ]AH=A/J6I3B"V@'S9F/1$'=CV&>3_-_G#4?-MX))_P#1]/@8_5K5
M3LH/[3>+D=3]V0_AU[[Y@.FV73,13METKVRPM!4[US &@!%1VS<=_&F.I7H*
MY1&:@]Z90IX=\W7MTQI6O:H\,!7$TD(9@"0JE@*"K4[5Y _AG@3_ )R?_/76
MM'O;G\N-$BLI+P0+=7UD;X1W"1JP-/21X'9SR! ,@)H0H)SYC^8Y_--]RNK)
MSJ*7#M/<1A+H)!<22NSB:,U9"684+G;;'1Z1KMT5.HZ;)HUM$0)85D:661E%
M/4X1EUY.0:<F%!V.*:MK.A^7K(6_K17,DR@HDLZNQ+MR?F%))H1N OMG.KGS
MOJMR@3Z\;,+NHA@5(R*FG($J:BO5:>XPB?S0T\%Y;7>HRD-^^MY$8(J7$0V6
MJL  Z@@C_5/;-IVM3+>06\7F>+3Y6XCG/<2H@#4-2_Q+3V.=DT#6-2C27]/6
M,>N:9)%)&^IZ7Z$]Q;56G-XC'Z<@'4TH?<Y*CH7E*1;>YGL=%U_3M6F,$6I?
M%9W E(!]$SQ&$K/0U5)4%:?#RW&%?GO\I-#AM'U[2-7O=->S6.>Z@BMA=2:?
M&Z\XA>0_6(Y@CAMYE+H&H":-4<K\OZ9Z5[Z?URT\QZ/J=;6>XMN9]:OV)##(
MJR1S(QHQ([TW!-9)I7EFZT74Q#9Q)=V+/++%;N%D66*W<R26YK]B6$;H]21\
M5112,]$Z3K$<'EC3KYC+<6NJ7,%O?F16'%H2RLDG4+(8X2C#I4"G49XW_.3S
M+)KGYC:M%!'Z:"6RBC2*E2(K=3P'+8,7E8&@I7#;R7K5GY:L[VZBM@-6NX9+
MRZDCE E0L&,-L)F+MR(^*1]N -!^\<4ZUH7YC:C)Z6H)>KI4*A+9]2(6V1#^
MU!:<R3%$M!LG$L=W<YWW1X;6^TQM6U&*Z<)&/WUZQ@]4RJ62B-24\@":FG+M
M7KA?=^5SJEG;7MG8:3I^B2-P@NKF::!KJ:,5,=G6UN)9#RV+1@BO?(I/96V@
M)'<3>:/+>ER%@?0N[B>Q:":,@H@>2P!+#NWJBI-=CL.[_EW_ ,Y57WD^.,>;
M[6^U'0X']']-V-Y:7$J1FI'&XA><.J]DN -MJ5SZ'_EQ^;?E3\Q+*.31M8AO
MW/%0U%A<N1R$4T%3Z4M-P 2C?LMMQ'6 *BJ[>WZP?#'T!W[9=#X4!RZ=Z917
MOXYJ#IFH.OAE$5Z;5RJ=/ YJ>^8J?;-Q'?*H16F53&\<;0CIMG?OR]_,KEZ.
MA^9;@\R0EK?2'8UV$<S>/@WW^.=YS9LV;-FS9LV;-FS9LV;-@+4=1L]*LY]0
MU"=;:TMEY.[?@ .I).P ZYY+\X^;[WS;?B5P;?3K8D6MM7[(/5G\6--_#H,B
M'2E<U/'+]J9J=LW$DY=,OCCJ =JY=*D 9?&G3KC2*=J9N.-X_++H,:12@4$G
M/$'_ #DY_P Y-C\K+67RWY,DM[[SA=*C7-U*/633K>0\?6"BB.X(/%02$)!H
M:9\5]5AOO-6O2&WN;[S%YEU[4#-%?$+-/<2N3Q]:YE8\0H6I)/V17X5J<Z7H
M_P"F_+6E7>H>:_,+:A%<72+:74#LSW,D(X"*V:41\HHZM22G!F(H&IG,=>\V
MZ[J,\EB9[/RII3ER8WGBCG9345>.O(L:[EEK2M!G.IXK[U!!:7>FWLBDJDUI
M(9&:IW-6XNW7N*#PRT\K:S-#>7FH-;6]C8FES=.)9VCXT^$QPB1UK78N%7MR
M&$EC#'/<B*Q<&1&HINH!Z35JIY <Z<E)V(^1KCI-#N&$$EM:L?4HKP,>9#-4
MCB!4E6H>)'@1U&&NGR:]H")J>BW4]F;1?5)B8DHQ/5@/V2-@?H/AG2--_-OU
M3?R:EI4;QW]NMMJM@HY6UU%T/.)B/A)-00>4;?$N]".Z>2/,GEWS;J$'EUM7
MD6"Z4R>6M;BF]+7--F8<4@F9Z),K!3')&U4<\:CXJCFUWY?U3\LOS(M[C4;2
M*VCCN[>VUF*V7C9WMA>DBVU6U!^S%(14@?W;@H:=,] ^8/+VK>6O-T,ELS'1
M/--V-8TR[B _<:S;1JLH('V5N(JK38%@M:[U7U'2KV\TK5?T8\BZ5YKLUOI=
M,C!26-5;T/4C$E#ZUI<QA9*[^E)&WVEW^<^NW-[/K&I37AK?13E9B 5HZ 1M
ML:D4*XCIMT]M<>JJ+( CAHW^S+S0J4:FYY5Z#?\ 7GIK\J?+#>8;R&^U*Y5;
M;36A275%"W#VS?"T>GZ+;N##]9:HK.RL(NJU:G+VC,2J2Z+I(LM/;2^%M<7=
MV7GL]->X/'T9&;G-<3LQ)F>I>9^*5X T(O-VKZCIVGO?Z+J_Z/TV.(0R^9M4
MI-J6H16W!62T4K-'#;Q%U5C&IY.RQQ\C^\SSQYGM(X'TJ\O[+5?,FOZQ&;M+
MC5]OJ8FD*Q-) I+UH?[FI--R_+X,YH?+7FG2[B5KOS5HND:Y;@\[*U::XDM^
M1#+ZL]G8W2 L"**6.W7J1G0?)OYI_F7Y$O7UG4+)?-=O:!+>\U/2!Z&H10H:
MA)T$$$CQGB#^^B8&FS@[Y]FOR#_YR%T#\T=/L=.O=2MEU^Y@,UC*"8X]3AC'
MQ^F'8E9XP/WD98F@Y+MGIQ:&I&XK^.*98Z>%,U:@;9@#X;9@/QRB/$=,U,;3
M\<NGTYN/3&\<KB?GFI0GVRJ#?&\:?+.]?EM^87]SY=UZX\([&ZD/T"*1C_PI
M/R\,[SFS9LV;-FS9LV;-FS9L3EEB@BDGFD6*&%2[NQHJJHJ23X 9Y6\^^=)?
M-%]]7M7:/1;-R($W'JL-C*X_XB.P]ZYSVG48^G09@.P&:F8#VQP&6>ORRZ=\
MNE/GE#IMN3CQ2OCC:5.^65J*91%!3$R14J%+'N.@'S.>4_\ G(;_ )R!TS\K
M[&?R_H0CUKSM<_N_J<*EHK9Y$!1+N8&B'BX<I]LCP!Y9\A?,3ZS>2SWGFF\&
MJ:E?2O>7JI661FE;D?4E5N!!%#X+TJ.F:WM_*/D^TGU)K1$^NP$21-027435
MX6TLJLP$+N*.J,'D'4JE<X'Y]\^7WF/5;BY76H8W=N'UXJ8Y#&HHD-M!"K?5
MX5^RHV) !Z;9S:'39IIN,.HV$KR5;U'D(#,>QD8"A)/[1&'EOI6O6TCQSZ2U
MW]65IIK.9/C: ;M)#+Q*LH KR%:#?<9Z'\J:3%=Z?#YC\LZ[)<0V*);7$DD:
M)Y@\OI+45N4/[NXLV.Q24&-U-$:-]CRO\R=!'E'59KNUTR/0M9F%O<7%K9,T
MFF2P2^H#=Z<Q!#V=P>-8W^*)P8_EV?\ *+R7Y3\]:7#;1K':W\]OJ5W822/S
M=?J:V\D\-PQ4TC7ZPI%!R)#%3RH1R231ET+S@?+E[<-IZ:@QAMK^[WCLKR1%
M9$N6W$EM,DB$O0<HW5_M*1D2U;RM>I:2ZA!8'3M:\N7*Z9J>F$5E61!.2Y7?
MD*1<6/0[4K7(WI]Q=Z,VB^8K7C&C7LJ1(HKPFMO2<@@U&XF7;PSZ0:D;#\R_
MRU\N^<%LX9M1\J1W/-RP'K:5.H.HVA+=?3<R.E?V@.F^=$U&YTZXT#R9I.K<
MWO[-X1-\)# 1VACE8T%:LC!AXD^PR!^<[^#1DOKIX1'%Y8U6RUQD^(J^B^8[
M:/2M399!R)].ZBMYCO\ #6F],\@_GCY+CT/S1:Z]#Z,UGYYT>YN?AH E]:*/
M6HL9-*E58=C7PSAWE[3GO8]3F=S%!;P)$TE 54SR*M6V_E5C0=:4Z9ZR_+:\
M^J-I26,BQR+<):Z!;JX6.-SQ66]D:FW ,S\NH)Y \N/#J?E7S3IFO^;+E$9I
M_)GDZPNKV;UA]7%S%&QBN;N=P#Q>YE86\5?LH9./V:&67VIQ>;M3U#SMYJ1[
M+R)Y0>"ST2.V2-'N[B&1X"T*BHK]85X+4 4#^I<$EH4SE_YP7U[IEA;V.@6#
M(MV[VH,$4K//<1)']:D@D!5Y(H7DC@4TY.P*J>"9P_4/*/YA21W-Y=_7EM+6
MW1J0Z )"2SJH00S%6([U .PWIA=I]]YUTIS<P6 O?1:-W1=/N=)O JGB%4+'
M%!( 205/.H)'0FG;_P H_P T8] \UQ/J!?0;"^NQ/=%4^K0BYK5;RU%04D0@
M%X5HK+4J!1D/W*_*WSF?-NADW1C.IV#B*9H6#Q3JZK)%-$R[%9$8.O\ D.NV
M=/H-L=2FW?'4 %<PIOM\LL=QURMMNYKE<?NQU/NRJ#&TW^>:FW3IC>.52F,H
M3FI_9E4IT^>>C/RU\^'4TCT#69JZC$M+6X<[W"C]AB?VU'0_M#WZ]DS9LV;-
MFS9LV;-FS9L\]_F?YT-Y-)Y;TR;_ $2W>E](IVED4_W8/\JGKXGY9Q@"@[9N
M/4XZFVWW9BN7Q/\ 3'A12O?ME!>NV^7^OIC^))%1FX[>-,KC[9=!OV!RJ B@
M[YJ4Z_+&4-:@@GWSD?YR_F79_E7Y!UOS->SP63PIZ%K,[\@DLH8>IZ=*L4H2
M$K\347H33\^FL?G1YFU2[U'5],@07>K3RB&>=6FNW$LM6>WBX?:8D\W'Q5_:
M[88^7_*WF759QYA\V:G<W=Y<W'K:7HRA> E%?])NHC2&.-%!I4UK\1Z8"U_1
M-0\XEY8[J"'0HW^/5&/JW-X/LNUJLC1I';*58+(W'GU'(9S+S%Y'U'1]-CNM
M)\N-<:<%-=8M6_2"3-'7FW-"4 %=RJ4'0G(1Y>O+=KZ."^E:)K@A(KB,HGIR
MG9"3QH![_>*=/2OEWS5IFGR+IVH0QPZK;% T3NL=C(:TCFB=RPA,E"C_ +/*
MG(?M9$O-MPWY>>:]!\^?EOJ#16$R--':3\VBC99 MU9NC 43D>,D+FJD^'!R
MIYVOX_-GER*PL+2.'3K8C5K"WFDYS:?;W<AB>2.0DMZ,4J-;W"DT4)%)0;Y&
M/RA\W7_D[5].N;=1+:VVJ7+WL+,RBXA^I2KZ;$=B5K3NW'PSHNH^:]/O=$T9
M1;V\]TR2:5<>HH9?JEO>17]E(>>_P0QB(C<?!3?NI?:V=*N]0E4)<?7+?4-.
MNIEJK2K;W7H6;22 $U%NR@@;Y ?/WDI-"O;#2[3U);:>\NK^-POPA7$2,M5!
M')6AH!3O[C.Y?EIJ<D?D1-&F$JMK=[KJ'C7X8/J=^*$T( ,K@ ?TR3W6HW]D
M;R_N;]Y+K1-/\NM>-4M)ZKV0M[A:=2YFBY&M=CD]==,\P^4]&O$@:/4=1M=1
M\J7UI*I8,KVD4X5W!9:>I"]*;U7;PSBOG#33J/Y26]@)KEYO+&L3PV4,R@E1
M)"L$SGX5^)B_0=E'P\@<X1#Y>ATO0H8)O4-E+=2WUXR$$.L ]**(ML&4'G7:
MA)H-J9*]#.K6T%[JCQ,FJ:DCQPQ+13;V=%7@K,PX-*SD$D[#FW09)/+=BFJW
MFG>28+EH_+"1QZCYQU:-VB2YAM$^ *Q(X6\!DXPU%2W.7J?AGH\RVOGSSYH]
MRS?X=\D>24.J06)!DCC^J0Q6MFLD7)06A0*D2@U9N5=VD.2;3A+^:/F#3=7U
M6XNO+>C:1#))#IEFWJR/:P<S:?7)0R L\H8M3[;?$S+G;?*N@Z7H_E6.?RM*
M-+T:PFDMK[5YV7E-.J<W]6=_37F&*L1RKL:E*#(I+Y?DU]+RNJ>8M>B#N[4O
M5%H4'VR L<2#A4T/J ;_ +6<9U#\N/+_ -<NIA^8<&BO.Q%G%'=6.H7%F\:!
M.+NM^G*NY6H/8#?/5O\ SBQ^8M_Y/UORUH>KZW:7^F2S-IMT[EX2UK=3O'&X
M]6*-/4BD99$CC>0A7E44 4+]8U!5VB<\G0E?$U7QIBP7;IE\>F;B/H)S!<LK
M3;* /T9=#3,13I^.-I]-,:1W';*/RQOAFV^_*(]OGE$> Z8^.26&2.>&1H9H
MF#HZ$JRL#4$$="*9ZI\@^<D\SZ>8+IE76;%1]878>JO03*!V/0CL?F,G^;-F
MS9LV;-FS9LV<W_,7S=_A_3_T?8RA=7U%"$(.\,1V:3YG<+[[]L\P;UJ=R3U.
M6!4987I3;*(^X8[CT(S"O?;%*;T[Y0!ZY9%*5R\NE:^V9O?* ]\;X=\QZBNV
M(R,.BCD[=!ON3L!0;DGL!GQ8_P"<Y/SSD\W>=G_++RU<+J>F^2)2-0,)K9I?
M\:2-<,HH?2Y%%1379B2,\F:/'Y>\OPV]UILM[K^KW,L<::E!$\#33O7C%:1$
MD4.ZJ?"M/YAU>:QO$M(['4D@M[*:&>75;X.&MXH;.%#>1JJ$%UB,JP+4<6DY
M,00,':'HNBMIB^8==1;*RU)#%INGW#M%:K91_:NIV"E@H-2QIN=J-N&\A_FA
MY\TGS%JL*^6K8V<&DL4CO8U,9G*DA7@!8O#& /A7DQ/5CVSGLL4NJ6DVJR\%
MDMI$BO74'DWK<C'.Z@=R"&8=32N[5,L&E>8X;F*;4[>0QZI"K-'(O*21'5:N
MH ^&H4$5W[\<[-Y<L+TZ6/+^JQ_7=,O 38:E$@]6J@JL<X%>3*% 5F'V!P/)
M0%!;:_EOYHL9!'9K]6N(1<OIUR@8Q-%<<1-&%(( /$AE[<F5A0[R#2?R8U 6
MY@2T+"\07$5!0T<(#\==PO,TI4BF^='T_P#)"\>".&6#_0K1C<3W%/M.BJZ<
M-R1'6HIL3W]CF'\K[DQSS?5S*]U*)H[=PX)56=E;:I!9V+$#LHP3K/E66-C'
M;VK:OK=J%59)08HK>-E$<[FM?BD,=%IT[;BN#/)/D:_MM)TQI$,MY$EPZ6P4
MJLLEW)Q9:*7(XIS)+'=F&]#7.G7?Y77,L;V(M5DU&_O8+B^N Q4JJ/)*R*-@
M**2JTVJ:D_#G1/*?Y:0Z=Y9L=,F#10Q77USG5:QCAZ#2,K AB%FE;D=Z@ 5Y
M9!=;\@726%K9:'8+;2S75Q>_5 @GDMH9":*@# ,[*H%6-%%23X\MO?R7%M/!
M8QP)>7H$(D6-CZ$4="$A#TJ0 :L=N1/PJ1AF/RCN+B::QTZ!%LG7T[J]OF$,
M'I(T9:6XDKRXEEJ%45(%*&IXE6M_EW>:;IMQH6ERJF@7=SZNJ7#QFVO=4$0_
M=PM""U(ZK\$8+-Q8LP5F/'DFL:#>:99);-<)I6E6;?I#4K^X!(N9V!;TXA&O
M-C$DII'&!1F8>+ #9:_;6%F\BZ+<S6K!YK/3KAA'/>?"$B>2&!O@B55"Q([$
M4)('(EF)]0UCS+^8NIPC7_,UL]_I,,=E;V!]>32-/*EI&1EM8S%56)/$MQ3[
M4IH""0:QYX>U];R]I&IR:XVFN$U3S'<(;B%90>"P:1;HHAMX1N&F(]28U-4%
M%PR2^U#4K**<^7-*U@1)R<>G-H^JR@D5DM;UD$$AVK17;;]@X'B'F#1+UX8=
M;N8+*Z4->Z-KMR(]2@0@,983&6CEVW!4=J,@^UGVJ_YQK_/6;S;Y5L(/,%Y)
MJ$5A.NBOJL[,9;74(U ^IWQ(/)6"UBN0=Q19!T8^S033=2I\#_9F(IUR]NE*
MY=!US4S "N4=LHY1]M\Q!.U*97$-WZ97$5/CC2HZ^&-IVIE?=MFIT\,,=(U6
M\T/4;;4[&3T[BV:M#]EEZ,K#N"-CGK_0=;L_,.EVVJ61_=S"CH35HY!]I&]Q
M^(WPXS9LV;-FS9LV;"S6=6M=#TR[U2\:D-JA;CW=NBHONQVSR!J^J7>MZC=Z
MG?-RN+IZD#HJ]%1?8"@&%U#]^8+^&6H[5K3?;'<:U.6!3>F;C4[X^G3+ %#M
ME!030G+X@9?'I2N,XGQKFIUWZ9J D5RF"J"3T&>'O^<J/SYUCRM%J/Y=?EIJ
ML6F><52$>:/,@594\K6.H(X@MX*T4ZE=(C-$M>2(I?;X3GRAC\K>5[&*.ZO[
MPQ:8B-)QU"8F=JU>26:C"(ON2Q)+$@U(P+:WEO'J3WMK9_5EL=-DU*WMDI%-
M%IK*/3CC0'DMUJ#LBLY/-8#Q4#FU.JC0VN_,5IY0OY/0CB2(>8+I&#0HMCQF
MFMUC!%!)*'E:M*<HP<\Q?G!^94FO>MY>L]0N4TFWG:*Z2,\DFD@/&-$^R%@C
M%0HW8D$MG(M&T&+5OKL-I;7$LT42S1O*AX<%90Y(C:O1J_1G?/)'Y7:E>7%@
MTVGPLT< @DDA]16E"MRB9RS* 5H*[?L@]<]2^6OR?B^K3K=(]T+IVE)564/,
M3\3LU:L2223O7QSN.B?E!%%P]"V6".:(+*8VX*\@VJ58=0/'KTKOD[7\K4/#
MT3Z!=OBEB'[LE1054_"3VK3]0R4Z9^6ZP1K MHJ7$#%X&CCHJO4&M.@# T(W
MPTF_+V PRB5!"W$ATW*BI+5VH3]HG?;'MY(AM[2,O&(.,1^,)Q<%P "!M0C;
M[LYA<^0&MY(_J.G%P0#&H8&0L6HJ,[\5 J:LQ!)[ YV3RE^5]O80(TD/K3(P
M]>948%Y14OZ88 \0#2NU2:CMG1;+\O\ 3],>:2:Q2:_OV_>-PJ[@+0*M:\=A
M3>@ P;<>3"\/H".V1Z5E#1^LI<CHJ';B@;8FN_0;9'KCR#8" V01K"T4J)C!
M/PEG(I\,C*?4>O5ARH* 8!A_+S2X$,6G::I"EB'=*LG+M0*P'7>@Y']HGIC)
M?(-Y=-()H$>W;X>#VZD<1N2%=V/RH!3KD?U#\K-,O2?]&>[NU C,K_$X4,#Z
M0!V*MQ%1\0'A7.4^;_R)T&]AN]0ETZ:6_MHI)%DNG/&0E6#((44 +\5!Q"@=
M\\)Z]^7NMO\ F-8&YO&$"L8;.RA!M[7ZYZ4GU<D!0Y*S!./(,]14=LX!*MGI
MCW!O-:T6TU&-%Y:9<7[Q6ML\8 'JPVL<TDI'%6]/G4L.4E6%,FOY7ZKY7TZ\
MA^O^:WUI?6$\6E:3IDL:7,Q)Y+'Q@20  ;NR]-UJV>L[;SUY>MK?ZM!Y)U+7
MK2".0&"^AFNV-LRAGD>WN868#XMW$:A1OTSFFL_F3^2NNW3>4[[RK=>7C'*?
MJ<EG7TW%>/!+6831.JLNPX1R#]EDVSI/Y+ZOH_Y>^<]*N(]7NM=_*/\ ,74$
M\O:T.2NNG7\AC2"[+H[M'&CJJ$R[TW61^'P_73R-JMY?6.L:3JB&+6O)NK3Z
M'?*XXM)Z*I);7(4@'C-;RHZ[>/ADSIOME_PRP._3-3QS '[\NG:F^-*_AE\=
MLS=-LH@TKE$8TCQZY5-ZXT@?V8TT &,XUZ#VSH'Y?^:6\M:IZ5U(3I.HE8YQ
M7:-J_#*/E6A]OD,]3@@@$&H.X(R\V;-FS9LV;-GF_P#,[S,=5U1=(M9*Z?I3
MGF0=I+CHQ_V->(^G.7]<OB<NGCVS$''4--^^/IMTRJ9?$;'WQP'7WS=O?*'6
ME<U -LHC*[4RJ5WZ 9S#\VO/=[Y#\JBZT&R35/./F"_M]!\LV,AI'-JMY4H\
MIH:0V\://,U#1$IU89\C?S633]-O;+RI+K(U&\LK^?6=7NF)EN]4\P:E19]1
MO'X<S-)R58H@/@01Q1J/C8^7=1FT2[UEH=2DEN/+GEQI+O575ZQW*67IL]M'
M154JIHA^SZDK!*TY$2GR==#5_-&KZY?645Q$RKK>JRO1XT =98XN:UVAAB)9
M@=V;!?YD^9KWRYY5F(2\N/,_YEW<UY>^BOIO;:5*S)!%+)0LK7"J'Y #X.-/
M'.)6WD\^8_,"VNE:7IME9100"Z5X'?A.D4:W $D[U8-)4@\B=^F>J/)'Y8II
M[Q3*]EIZ'XO05 \;JB\2#P^$!Q4$5&]*[YZ.\O>4=-MHVBL(F,$D18\UKP!(
M"K3E7?OG<-&T:&VA7UV#.NR\D"J3L2JTKO3]7CODS@LK4W"3S,[ @T]0FB*0
M ?AZ=.NV3JSTU6@"*>0:C,VQ7CTZGQPZ%L(XY&)Y5V)WY4&Y(H1BZ:?!,B,Q
M+$$;[;D;BNW0=,6DTJ.9095#[4=:@U J#3PP39>6;8RB>141%91$NY^SL#2N
MYW_CG1K338+:*'ER 2@(9MR"2:UVIOV^_!(M8_3G0*K T'+C\5/;Q^>7)!;J
MJB2-07%!3J01W(Z86R:/9NW,QA:4IQ  &VP[;>W?&2:3:!0/0+5!^,%N9]Z@
MD]?'"R;R[!*.;1O,66HYR, Q4U%>! :GN,;]1@5'YVS1R+15W8@%37MT%-Z=
ML(+C3P_JRV\<,D\?2CL7'B/BJ.@W'3Y4SSY^:_Y=1ZUIUQ?QV227EF/4$L1^
MJ74:(:\K>2,@.R#XDJ"*C/EA^>?Y/:_I5WJ'G/2[19M&UQ3+?W,(CMX(+MG9
M9IG1H&*"9VY49C1F933BM?.VCV,[S3VVIZ[<6-H5"RSI*\HH!_=F(K1@*BI
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M=0?<<W$>%*98&:@VVRZ#-0XZE,L+VS4S4[]*95*=Z^^-IOE$^&V(R,521F(
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M+$<C4J3Q.W^WCY2S*%4@*M0 IVK[[#"US)5>8J!O4"I5]CM7:E,<K/6A6J@
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M1^77Y?6<ELUK)_AO39Y[9G]0Q2W$"2.>=!R8LQ+GN3RZYT_;ICJ&@[Y@.^.
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M:13VUF\4E&F_=VUN9!R(D8>I,Q'V$7B:,#DM\\Z4;^XNHKN_^I^5K*-)KYH
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MBAFC:(QP\:I.P6C(5'-UX]7!SSUYSLKKR:ZZ);+;:)J^F^DT\]N7CE?FH4K
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M<HH4AV$7"K*HY(.6W&M/;G_.$?E2SU;\^M 6]1]3T>SL+W61;3(2&) *1LA
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M5'A7/'_F/_G%GS;I9GOO)'GBSU^QO+2</;:CRMEFBOHQZZ13*9(V5Q0J6X]
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MIGEGS*]NT\,=W!:7UI>1R!>+VUUZ)62A-"O(%=Z@-OGDCS=^1GD"W@U:>_\
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MYC_,;S,NAZ?+=0W.O:@UO;6L:GD#=2E0$4+L:5V[9U<Z'JVAV*C6=&O-(:,
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MEY%"P^KW:#I1[6X64>%&';/H5Y@\EVEY]<NV@:3ZPK,]!5TD_P"*^I%2.F<
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M"NP!Y ;&O;[]H1KK&1@TJI)!>Q2%X9D1D*2,8SZB@L&Y4H0?A[&K5KP?5_\
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M6-#0@@TV-#C_ #3:)+;"(U-NG%I56G+@31CU%!UJ#M]YSGL-JUKSD>/@K=7
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MN/#3@]Y;I(P Z L14CV-1GF;S]90:9YWUBVM[:*SLR\$T$$"B*-(WAB("1H
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M)YMP>(],\@!4;A4R:>4//7GK4-9U32M1\PQZ)96E!I\FHV"QM<<F8BK.B\D
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M4\>V5\NA/3!NGQEYY *"EM<MO_DP2$_JQNH1E+^^CX\?3N)%IX4<BF!*=\<
M?IRZ4^>5]/SR^O7OF_CMFW_AF%>NV53K_#-3VRP-SX9?^8RO>N6?QS;CZ,V8
M#+IF[?TS'I3QRP >ORKETWP#JFEVVM:9?Z1>?[RZG;O;2-W4.*!Q[J:$?+/G
M[KUK<Z3=W5A> I>64TMM.S[\9(F*;CCT9MQ6@SF6JUF]4QKS:WX,3P%5H*L
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MOAFZ5[97MWS'PROEL,VY&Y]ZYJ5[_+-4YO?QS?/IFWS"E,NE=\:0.O7?*/\
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M[$\?$[_?B@M+&1VB]-))%^+<]AOXU&^P&%UW/(T;20K1+?@0M1U.WS&1[4Y
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M2I^[(Y>^> _Y]_FY^5]_(%NM+M])\S:+7[4MA?6D,5[&/'TKF/G\I/;)?6A
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M%MXXY"&"L2!)7[?(]@*^&Y%,DFD2WUW)2,1HB!0IWHU #45->E/G^&='TVR
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M)1!9HJ*KA"U !RHH([T)(\,<UF U&A^L-&!P%-JC^913< >&2*'A"D/.$&E
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M&UO*#&54,R(G%!7[)CBJ:MUV/;/*WYD>9I(A+!&\<4KTI+&!ZBBIXUV*\J=
M-ZTIA%_SCCY3;S;^;L&L7*-/9>1+9M79IOC<WTY,-B&-2">1:3O]C/J1IVGF
M_P!?M;.,!S:36\1'7XXU4N3\N)&>MM(LUL[6.("AC6AVI4DU)^_/&/\ SGYI
M[:C_ ,XX^?RB"1]-GTB_6O;T;M%8@CN!(<^!L$L8,;/3@85Y%D/V2!L"W]/#
MWP,]NEQ'*D#M'Z1H.@+'K6K&M178CMUPA9*$K<1%58<65NAKN10GL<2K)%)\
M/).!%/4/0*#N:\B*5Q3XWG"HM%(J C,*?.M*[^V!CS<^IQ9Y>U0"G'?:E<7$
MQ$8#D 1NJCX5^$=5+-0&OZ_HP=;3D^FI*!HV)0L%XU(Z5/7K0#IAM#+)Z@!9
MV6E%(^$D;A@*5K0>_P L,6*%"W2-&* >(KU%2*U\:;G%FA,D2$+R"_"".Y Z
M^)WZ4RF1O6$LC"M "&%02-F6N]*5[8C+SDI'*I<+4!A\2N36IY';:E/B_7B1
MC=VY%*[4)!9:KU'*M *C8X=>7O.?FKR'J4>J^2_,6I>6+QR \VFRM TAH#Q>
M+>-P/!U89Z_\A?\ .=OG/3O0M/S \L6?G*SKP^O:?QTS4=C2K*OJ6SG:IJB?
M//:/D+_G)7\G/S":"TT_S5'Y>UJXH%TKS#QT^9G/[,4KN;>3IMQDJ?#.\LC)
MQY A7 9&[,IZ%3T(/B,;T[],OV&8G;?,#]P\,Q('T9AX#K@NPM)=0O+:RA'[
MVYD6-=NG([D^PZG/3EK;Q6EM;VL(XPVT:Q(/\E  /U8OFS9LV?F(_P"?DGY&
MQ_E#_P Y"ZIYGT^V,7E+\W5E\QV-%_=I?LZC5+8$4W$Q$M   LJBNQSYUM21
MU (YR;D259:K^O8[;]<'+&H3:@;D P#'K0 GIX[=<$/$$221SZ4C,*+6JBE"
M: _+Q]L9< #U2Z<2'Y'E5OA[K]%3OUPLD4L**0:="2*T-01R_7B36[@?"RL%
M4.*#JVQ;;N0:;@XH()&)^$DA0QH.Z[=^OT8,&GS*'&Q 8 *A4@-2M >1H#3!
M$5L5IP 91159RO$M6NQ(Z=ABI@*CA4'C(7)C&P:E-MR._A@<0MZ3'C6:0GBP
MKTCJ 36A(/3_ &L*[BK LH:-FH*_$3R'V=S^S3:F0O4;O4=)NWOH1#-'*#&>
M2<C&#]I2#TKXX=Z=YAM]1D05XN(0#!(H-&4&I0[\J^'7#(RHZM,RM3[()J.*
M[A?AIX_?@)AR-:\R %9:GKX4IA?/(JD!5)<[D"E:>].@\< F+TV9R2S[A_G6
MOC388&D4JQV(YDF@ Z"FY)Q>$*00W[U?GQI[^V.EC%"&XDD4HG0_(GWSU7_S
MA3YE_P /?G3!82R^G;:]8/ 0QZO&PH#]#G/O'IUS3AO4%?HR;V,M0=]LD5O+
MN#7KDKT4R7-Y;P15+%@!]/4X5>9=>74]9X6LIDT_2U^KV]2>+.I/JR ?Y3?@
M!@@:GJ*PBXL=5N[9!M(B3,.+?*OW9']=TKRYYSMGL?.OE^U\PPLI"WJHMOJ=
MN2*<X+Q%#5'6C\E/0C/)?YC_ )/ZSY >'5--N3YE\F:K*8]/U)8N,D4O7ZI>
MQK7TY@._V''Q)3=1R^TF@DC<3JT35XU.W$CI4&G0UR1:)>@L?2=F"<B"93R)
M&Q4J578UV^+.A00WLZK):- D)*AFE:K'[JDBGODWLK))$:&\NF>(,K%&D*PI
M4#C4U=F44Z>W;#B.ZAM.,19&6GV& ))K\/ DL!MT9M\+=0U(E3) HDA5:&1&
MX,M/$D4+;;_?G'O-&NFU@E6( 'CS;U"4!!)JSR"M!WIM7J<\E>8-1N;V66>6
MY]-)*E#'MR)!!6*M %/7E]&^>\O^<5?)'^$_RYE\T:G%Z5_YLNCJTG($.8 O
MIV*M45^Q5Z?Y>>YO)OER#2K?3;]YE74Z27]]/,W&.VA*DLS$[#KU)[$YSN\_
M.[49_P R=,?3;PP>33.FEB.4'C.LK@?6WK0ABY 7P3M4Y+?^<F-'/F+\COS7
MLD4EYO+%S<1BNX:'C,-_;CGYJ+(^M;*W$\XU4_%N0"HVW_RAUITP=#<%99%J
M:M]AF%!R6@H:CH*D@;8VXA9G##>5>*D$$$H/&@Z?%3ID;G]1G#\%)@857YGK
M6M:^_?'*9"K<0"RFH56/$#8U:O6F+B%9#QY>GQ:BENC4_: Z'MMX8R6#DJ,\
M#E5 !:I!!))!%:#?M[X&MX[B#:XBD0./4$KT;D&:@-0:#;#"WNI5:%AQDGJ0
MIH"% V%.GCXX903_  IP9"[,">)^(TVXL#7<D==_;#J$IO)RX^HW5:$U4@>(
M(IX#VQ<AV3C!(0:#[-=J ,5*G92?88Q%;C*DA#A14C[!%/B%0=NN^W7,"SO(
M_P#NK8-Q6O%J;\@"._:N!YEDJJL"9A42!^1H5J: &F^QW. E#(T4IAX%I:/M
M16IM44XU [[;^./=?5"PO&LD:<J&F]%[A2-]^WOG5/(WYU_F;^7TBQ^4/.>I
M:?91L'.EW+_6].(5@"/J<XD0*?\ )XD9[1\@_P#.=-I,\-C^:'E V3$A6UGR
MVWJ0[ \GDL9WY#<?[KD/^KGMWRAYU\I^?M&3S!Y,U^T\Q:2S!'EMF/."3_?=
MQ"X62)QX.H]JC),#7;OE^.^;8@?QRZ=LZ9^7&DF6ZN=7E6L=J/1@)_WXP^(C
MY*:?3G8LV;-FS9XF_P"<^_R&;\]?^<??,%OI%C];\Z>0R?,F@B-:SRFV0_6[
M2,]29K?D%7O(L?@,_*S:QD%V6,N\;DUH344H#0_?_7#N& -&W!HT!(!)!XU)
MH-J4/T#?+DB978+&P8*=JC[J$"A%:8%>V1NH4@M4[L*!:T.W4'^S 30+5F(Y
MJ&++44(+<C\7RQC6O,D/R8@BB@;\QUKW KWQ6"U8K4HR!?B8MV+'<^![5^G#
M'T'+.K45F8;J:<@#6@%#X'KV&## 'Y(A6B)50[+^[)[+L!L14[[8UH0"B\62
M60"H+&G1>(%1O4CK3OA=,J;_  @@\B16C<B/$C>@KMA7.G[MV<AS4J*D$$[
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M:@XA1LW,"H%0#7WPS$:L(3(H#P ET0L'8G8==JFO;MBRP,U$*@*QY%F &W$
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M2QHLK[A011E5@"I'7OL/8XZ2$"$1*5%6^P-WJ!6I9NE*G;IA6J+N_P )4/4
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MZ>&12_TUE8N%WQ>PN6!17^VFPKW'AAU-;K*O.,?:%?D>M,+UJCT-5->N=/\
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M%9&D].HXAY*^G'M7D:_9#4_2KH>B:3Y:T;2O+V@V$6EZ)HEI#8V-G .,4%O
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M69Z?/Z<_23_SB3_SCM8?\XX_E/I/EB9HK[SIJL<5[YGU%*,);PI06\34!,,
M/!/$\GH"Y&>H<V;-FS9LV;-FS9L^0G_/PC_G$YKL:C^?_P"7NGUGB3U?.>F6
MX"ET1335(@%.Z[>N!U%).TA/QU%JDD7K?7(Y6H6KS5>,8H#R'$CMUROJSL%E
MCIP(9B RFHI0?#N*K45RX5_?<BG)S1G;@$'*@)/PL=NWTX*:U9FE<HL2A"Z!
M6((K5BI_ TIO3+-LT,8X3?NU (,BE$5J_:!) WV^[WPMF+,LA=#&>)+,RT!2
MIIL!6M*@>)P.[-3X5!AI20EB14D@%MR:"I!H.^$=[:I)$Z&1) 4^-BHV&S4)
M K1:^.>>K:.33-6U?3A)Z$T<ZSQ*5JK1,W[SC7H0M#WK2E,['8.;B&)+=*B.
M/ERH32H/*FP&PZ5PXC7U1P<H)/A8E_BZ'BM*5IV_##:.W8J3+&W)7*?8KT'(
M"A IN?#[SEFT]28,6# *%"(CAJ5%06KMTZC DD0MX?41/3>&D;"2H<KOQXTJ
M*[]:_+"^[,CR D+(O'C*9J \J$4!% H VZG?.<:O92)(S2RK\19JU(-:;;=2
M#['(Y'&8^)Y^G(IW4 \C4\5*TKL? C.B: XI 2X1C\,;&M$/0J10&M=Z=L[E
MY(U.3RYYH\I^9U5XYO+^LV.I<F'$,L-PK2T-*[J6'7/MY^2NBQQ>?/--^+<C
M1;*3])M)U1I2@J!V^(@'.NB>634)Y9#REGD:5J]26))_7G2M+A6:-&%/B'7)
M)'94# [AJ$8C/IHD7IU'AD.U70N:L>/N,YQ=V4UA<*]*"OW_ #R4:%<+('C8
M_%;-0@]XVW4_1TP[\P>6_KUE]=M%K(@J0.^1SRAJ"VMW+87:>I:W"M#-&W1D
M<%64_,$C//GG?1CY<UW4M#EDD>*V<O$PHOJVS_'%)VK5"*FO4'.4W\\MW-::
M?ICR7$UY*EO!$FYEEE/&)%J?VF8;#/HK^4?Y2VWE/1=/BO8P]Q9J99305>[E
MH9I6IU8G8?RJ .N=Y2(*O$"@%*#$Y8]@:?/ L4 Y TZX9_5U*<2!WKG%_P R
M/*2ZK:\HHOB%>W?/'FM:9=:3/)#,A62,L\9[$J:C\1G'_P#GY!$-3_+;\D/-
M*N&MXM0U:T)KT-[9072'8&NT!SY-Z=*KQQ+(KD$?$ :/4FNV_CVVR96R55)!
M54]-60AB P4@4;F?'?Z:=L?)$T@$E:QJICY$G]BE P^$#8]/UX0W2(0J1DTH
M.;*&V5ARXDGK4]\#<50*'2JJH*$ D@5-=M^G3MO[XK' KM*'CK'(BJ\8( ?D
M=B-C4CD>M:90,4;7-6:0R$"!V' J 02'H0*D"@WZ[G;;!LB,&D<,TI],R+2G
M(#8?$14]6P3J5)M/ME9?5F+JJS#B*A>5$DI1OVNW?"2:*7C5DKX$D;4V))6G
M'>F(.CJQK10FZL&'*J@=2.X^\XY X(Y'ER%-B%4  +7OUZ5.+1RB"H>.2I_F
M'$*L9(92#M48=PRC[;/^Y;X0C%0K;5+$KR'C6O?K[#85:9HO5"BK;JIJ53KQ
M!H".QZ_1@:XAC#AC'ZRQ(3W8\A4@G8;#]7SI@7]VK49:Q\*"GPF/<<B: C;!
M+>LBNJ1D<44%WXE6W)^([;'K_#%Q+-'%R-76-XY2?AY<O BIV([$?=GV9_YP
M0_YQFF\KZ;!^<_GVQ_YV#6X.?EFPN4'.QLYA4WCJ:TEF!^#^6,UZO\/TRS9L
MV;-FS9LV;-FS8R2..:.2*6-98I5*.C@,K*PH00=B",^!W_.;?_.(MQ^3FM7?
MYE^0;)I/RKUN=I;BTB0,NA7DK;P.%7:VD)I >BG]VV_ O\]H8P;::5(THPH(
MP"A(8@]B.O?O^&.'/A\(J!RX!F8-38_ I%12O?M@Y&7F@D<\SQ("@,#(%W8[
M$DU.P]\S15/%5#%21\ (8 'H   ?>H[X374;EN=O(S/".0+J-A4?#44KOL,*
M7E>.LAMN:!3L2""&[T(VWW!'RP)+/*Y*5X(R1QLK,6=@I)7DM: _"!MMWZYQ
M7SM%^C?-.EZDB)(FH5MIQ*GP,K_ 0:GL&R:>6W::46'-K?\ 1Y:!XY?ADY1D
MJ0 P.^P._P \F%JC&22&:-4YLI-*EC0]3R-*U\<.8%;A&P=8Z(QY;N*JQ4@C
M:@)IWVQ=(:QH47U2%9(T?=:N/M"A!->Q'M] 9@TT#A@SJ2:@L%XL-J;$5:NW
MAA5+!Q56))9B"H05'P$&H)!J:>V]1D!UFV'JR*C^EZE*"H*DT/$#J:>/RR$.
MJ"9UA 9ZM]L4--J@GJ"-^W7)GH%R]0[%CUXQ-\2 D@=*$'J!G:=+0SV[1S#F
MTJ^D3)R))<$,/AVI\6U.IZY^@3_G'54O?R(\GZZ2'O?,NG07%[( ?B:!3;A:
MD#HT)KAY<2B&\#U_:SK?EQEF@6@^R:@?/.AI 1&&"D_#6GRQ\4<<@ Z[]#C)
M]*296'#MD!UWROZL3TC_  SF,,$^E:@2ZD'CQ8=F .=?\KWMNY6TF^*"X'[L
MGW_9^C(AYY\JOHFI1:K9I2UN&J2!L&_MSC/YY:<MQY=T?SE']K3..G7QZCT9
M27MW-.ZR<EK_ )0R=?D+^2Z:(MIYR\R6E?,U\AFL+65132[>85Y<:4%Q(#N?
MV%-!\5<]CK$D, B0<504H,I5_7B,P%">F(P@;'WIAAXC EQ:QW*,KJ&!\<Y%
MYY_+&Q\P6$XBI;W:AFBDIT:GWTSY)_\ .=_F:ZO?)7Y;_EX=(U&TU+RM<3WF
MJ/<6S+9CZO8RVRM#<5"ORKR''MUH<^8^BW'-8@12BJV]3TV!:A!H:'MX9/H5
M'&)^9X$*!4!B">K* %'X?3AK)-&J@M&49 2'#55>%:UK0D'Y;84WL@D _>?'
M+0R*4*GD2 "2.M*5'RPC(*E@#1FH"Y8 $@5'4D\O#?YXZ)><L<?'TBQ4%6#%
M:D@ BM/#!5RAYL6=9F55Y/2M6WK38"@\.OZ\71"+C@W/F4#<00!SKN-QTJ=N
M^#+U!);6\4<@-P9">/$"J*I->52:K38$TWPG, ])2C'DM&XR"JE202K?$?B]
ML0X,%J94C-4<*8RQ!ZFI"CH:# Q6C)&68%'"^P;:A(.Q-?HZ8HA _?1QNWQ
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MIE;TAQD(V\&;E6O0 'YX<V[&4@Q1JB*R!@M?5[_""1NI!KN*>^^.]*,++'%
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M^77&JR"DVT3A 2J@;;58<2?M;[8(A2-.;\#Z#ED?TU;<JQ*M4#?I3:H^_#5
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M._7$S5!OUKUP%.2:_/$H/M'\,,E^ROAF'6O@3B%S]@]-\\*_\Y76GJ^7(9J
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M+O/^D^IIS3A8TN8G,M%8\@HJ*D4ZD ;Y+/*E]%)?:;J*2"W@\P6,"E'E'][
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M6IH?CDY5-1X=0,-+%V]0%TDD92L@:M5XD<:':@\?'\<D,4:R^H(":R(./(D
MEC2JFE.W4TIT&(WP215C5WJHX-Q)/0;#EL2H Z??A!=1*H66/BK<35E'+XJ_
MLC8KL/E\L0D0NTDK,JHZU95.W,TZBO7OC4"E E3#QH2CBI+=":[&E:^.+B-A
M"TH@) :A ))H!2E QH>NYZ8>R"MDICG=2&+(826]0BAXTKR%*5ZC%1"99(1\
M85R7 J5Y$@FNX:M?#Y[],9<PK*G)%IZ;<V2@7CT8U/<> I7$)$65B9XF?C\-
M$VXKQW+T-*[5))PIDBA02*%,;. .0#\0.0V*FN]/HZ=\+6,? JB!FDV154EB
MS-0BO$UZ]O:N?4C_ )Q+_P"<#-5\T?H[\POSRL)M)\L<Q<:;Y6F0V][J( '&
M6_ /.&$]HQ1WZMQ6G/[065E9Z;9VNG:=:0V&GV,206UM;1K%##%&H5(XXT 5
M54   "@&"LV;-FS9LV;-FS9LV;-FS9LV;-FS9X\_YR5_YPX\@?G_ &MQK5J1
MY-_,F..EOKUHG[NZ*BBQ:A I42K382"DB=B5' _ C\W_ ,G/S+_(GS-)Y7_,
M30VTB2X)^H7]OZDNGZA"&'JR6UQLL@-=PU'4$54';.)RW0GHGKF)(T>BN-BK
M$E3LAZJ:BI'7 <EWZ*\I>*!'7DC)6-/4) H1Q)J0*9']0@_25L%FBH&C)<1B
MJDGX2*=0IVW]_#(QY*>[@T_7]"EM/K,GE:Z6^MP:"189B4D5 2">M2-SOL,[
M5I5VTUO;R>L9YI66-D 1!Q458+0; 5WJ/IR0Q"$1<8EHM3R(4 '<DFC5WZ4-
M*>&#H6)45HE=U7N&J5X_'T&_@,2E(<T8D&0\":\W!45%:U%*4'RPGN660F6Y
MKR<4:@YL444W%"._C3QSG^I0)R90QEYIZ?+9PI78,30 5WH!3Y9!I7:"3BLA
MF1E+!2: 5%!2@!)KUKX9)- D$<D:^IZ\C\82(P 6+ ]#MOW!SO.BS1RRJ K-
M!=#TI10490IZ@D =Z?//T+_E!Y@?SQ^07Y7>8+C>]E\NV]E>4-1]8T[E8R_>
MUO7(O/$+;5P*\#R[[#/3_D2Z,FG6ZEJTVV/AG19 &7(9JD?"0G??"V"4I)2M
M1@N27B!)RJ!U]AG.O,LS&MO&?BGDX*!W+T _7G?+*%;:TMK9/LV\21#_ &"A
M?X8)S9C@:8_"PPG<U4GKC;4T.W6N'*GX,PZXA= <3[_CGEK_ )R%M1<>2M80
M"K>C(1_P)[Y^=3\T$2U_,C699 5:=(I :;\7AC(H=Z?$3C;%@Z([2RQ.Y*J1
M1&^'J=O$4_S.2^"59ED4J?1F^ #B"$!%*M6I)- *8C<^O'&1)%5.%5##DZ?"
M!L*57880S"):E(CQ*EZ@@\3S(()%:4IN#X],+VB1&]5:-2@=:G8$[MT!/3^.
M.B,<2TY4!2JOQXT0J0: [[DCK@HE *+&EN7 4JS!=U J!UIN*GQ^70ZMI)#9
M7$0C#NIC!Y$*"C-V;?<<0:"GABX$OJ'DCL[;!'VJP8TZ*PZD$]-_OQ@$H8M]
M;0>FP+?"58\NO(\>U:'V^66()'9F"K*T9]/U .!HP%#1O8"GAAWY1\B^;?S"
M\Q6WE7R=H5YYC\PZB]$LK?<+Q^U(S'[$:DU+L0J[U(&?:/\ YQD_YP7\I?E(
MUGYS_,)+7SA^8H*SPQ_%+INER"E#"LBKZLPI_>,H"G["@CD??^;-FS9LV;-F
MS9LV;-FS9LV;-FS9LV;-D/\ /?Y?^3/S-\MWWE'SYY=L_,WE[4!^]M+Q.7%Q
M]F6)P0\<BUJKHP93N",^)'_.2O\ S[9\X^29-2\X_D;+<^>O*ZQM-<:#/^\U
MRU50:+;A0JW:J.E*2]!PD-6SY7W]IJ%I)<VES;SVE]:2^E<VTZ/'+&PJKH\<
M@J"&4UV\>F)PM \Y26X$S3A$HZ.!]GNI.QIO] R#ZQ&GE[SCHFNS MIUZRV-
M\R*:LDPZDU&X/ZLZMHTJVUW+I\9D)=I6@:15:40&K14*T (7P'CXY,;0+5>:
M*LZ(V\AJ7 8@+RV'T=/PP9&JL@%:*1MU8$&FQY KWK4#[\2NHRZ*TTB1A@JM
MS)'$ '[)ZD BE:5_#"RY8^G*O+X113(S%5Y$5 (J =Z$9!-02&<R,6JLA*AD
M^(GBW*C %MP-J#PR"WX$K"(,5X,2"%JJIW- 3^T*X.T4NDB.CF([JRD\JA37
M8GK\/^>^=OT"62X$84O'&CQLJU!WJ.!79A05ITH,^X7_ #@CY@76OR5\R>6?
M6]:7R?YBF:,%BQ^K:I"EPG7HOJ))3.N^9+80WI:AJIJ#\CG8/R\O*VZ+6A4B
MH]CG;5(*CWR-ZU!LQZ>&0V-BDH6NQ-,-7H8 I[C(&L?UWS+HEJ1R O$+ ^$9
M#?PST  !TR\V8],!2L*/M7"@D'DM,JU-#AROV?G3+'RQ&Y X'Y9YU_.B 3^5
MM40[UB>ORXTS\YWYW0K!^8D#(K1&2RMR7Y5#,J< 54+M14 ^8WVPGTQZ/$ [
M\T/-">H<]*\:AA4>&2D$>C(5:LCU9P!1B$[J%V^DC&RN$I,2S%&^%@A#<&J*
MA22">6_C^.%$P>7A$L9AD)IR5:FH4*3N12E.I)PHDX22,LP0E04+J*,Y [E:
M4J>_;+A='4!HB0IHS &N^WVP/'Y_1BT"\E6D98AE5B:\0&._0=23OL?OR2A%
M%C<HTJ0!6YHA2G*O$MR'VC11L0>HP,:HRE[KTO2JJLD;&K,3R+M04-3U(_M$
M+=3QD'U/7,K",<0:+O\ :_9K4=?GGL/\B?\ G#O\SOSO-EK6I1'R'Y <5.KW
ML),UW&Q-3IULQ!D)'^['XIX%R..?:;\I/R4_+W\D_+ZZ!Y$T5;/U0IOM1G(E
MO[Z11_>7,Y +=Z* $7]E1G5\V;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9Y;
M_/W_ )Q!_)O_ )R$@DO/,VC'0O.2H%@\SZ-QM[\<:<5N1Q,=PGP@4E4D#[#(
M=\^)OYX_\X*_G5^2$E[JEOI0\^>1H#)*->T-)9&BMP:_Z?:4::$@;EASB'^_
M*[#POYLT*+6]!OX3&TLZQEH.$E>)%.)"DM0 @"FYP#Y5U=]4TG0]<FA*3PJN
MCW4T<?-?6BJ*S,O'B[K2A)IX5IG6(/3,9BY50HM6F(+#P%!M_JD8;#UE1&2(
MB)6X<%HH"@5&WQ&G<4Q4PAEJ&J5"LN_4@5)%03M2O3"FY5@%(0.S(!R93NH.
M_$ FAV/0;=ZY"M2@+Q,B\(_23U$#[HQJ>H4"OM4^&0/41]7)4R'F0"RH?WB+
ML/M5H017;8?A5.Q81NS!0DT+EE8]@I'3L*4'3IG8M E,L?I+$"LI)@6AXE>M
M#U-:D_3GU1_Y]V^:!:^>_.7E":6L?F?RX;JWVHIN-)N5+#CV/IW+_0,^A'G*
MRI(7'?;;\!AGY N*$QUX\=M^OCGHNU?G"C>(&!-5A]2!CUIG-KCDLPI4T/7#
MB/\ >6S?S 9#O+X,GG>R0C^Z:9ONCSO&;-E'H<+&:K.*_P"8PL<@%@0=ZY=M
M4.W@#6N'*GX .M,4'OWP-<BBG;.%?FG'ZGEW4EI6L;5S\ZO_ #D%";7SSH\J
MJW.:T]&FXY<9YTI3I04WKD+TPE_JPH9'  JK4DW(Y=Z@==_#)1$RM;,KH&BF
M2BL*E"M05HVQ#4'A[XI-]CBUQQ9XB\C/4AF.Z<&%/YO[<(Z3+)(@=8W5^+,0
M./V3R,E:C?PPNDY'F@ (D55J? ;#J*;DYCR( D1D+$\2J  FI!%-A4<=P<5/
M)VF5H&28L5J3N!0,U.O<^(^>&TTB+II0PFX=N)5V1O4B8L#V[$K^SG3?RC_(
MW\S/SJU(:?Y!\JRZE"DJI<:G)^YTNT4%:FXNG"J"%8G@ TC#[*DC/L9^1/\
MS@9^6WY:/:>8_/D5M^8/G2,K*$FBIH]G**$&"V<5E92-GEJ.XC0Y[Q    %
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MX!W\?M[;YR+3(@PCX5!:I(^T>*H"?YCO2E!DVMV<I(A*SR2J0'8U<E@>*@J
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MK"('*!R9#R"[4*"J@FIH33>@P$EM+=W,<5G$]U/,ZI#!$7>60OT^"/D6)-0
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)FS9LV;-FS__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>sny-20221231_g12.jpg
<TEXT>
begin 644 sny-20221231_g12.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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MS9LV;-FS9LV;-FSEWYG>=/\ #>F_H[3Y>.M:FA"%3\4$)J&E]B=POOOVSR<
M223N>IQX&6%%/UXSC^.8+4^&*!?HQ11V\<$*O3%^.W?-2GSQI'RQA'],3*^'
M3PQ(BE<0<;$=L#N._P". Y!UI@"3OW[FN<\\_P!Y!IGEO5M4FN?JK6%N[H]2
M5!I0%E&YSXUZQ)=7/UN69EF349VN))I=I0I8FKQ^_;D=L"Z1)::G?&[OX_T9
MY8TJ B& +^^OYZ46I&_$TJQZ ;9["_)O1+N[F&MZG ;>)F].PMVW8)MQX\MT
M2G;J<]B6=@EO'&03)(BD,RBG-B?LCVKAW=R7"+% TG ,RI(:5()WI4]<00,\
MTO+B8%(92*EGX#<T/B>@PMGMS,R,&Z<B !N*=2?$_+$H;:0.LAD(BH6D9.O#
MP!-<0NEE-Q;VG]X8Y3*K(A(*$?"2#6AIVQ*\/K'ZO!P5&CJKNI^R*U8DGKX8
M1%:E#) ZF&I#&J@D; U]\=(IYRRLC?O%J8D 8+6GV:UPE:%I><7J(5ZAC^R*
M_9/W8&DC6XC>%64SQ_:;J.(\#XY'[Q)C^\+1%8*(G+LC;&AZUKB[12);I'*E
M"Q((!W#4VZX67T\D48,JDA!QDY#J.Q^0PI:*-"KQL)(R2?43[+$[4&)26D]R
M/4,J1A-BW78=1@&XL@4HLA56((X&G(GJ3UKA=-)=HJQ+(''+X9*BH'<$&N^+
M7$D?I(D;F:X Z ?$"WVNG;!,#RW"HG,+"H*L "#_ +$X:0UD256A ]/X02=T
MIT+&M3[Y/K"[CEDLXK>%V4\20K;,5H*DCKOO\LDPU1$L_B]/T978),X#+ZM"
MK,!U!IMTPW\MW+P/<^DE;:*+CN>;$[$U7;MXX?\ YJ?EU9_FA^2'F?RS^CUN
M-9T:!M7L7(Y\B]!QY]B*=/?/AYH27FFW^IZ)=Q3P7]A<":U7C\)]+X98SW#
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MB$DXGD&-"0OVJ827T:L)+:%JP,?@>N_'N-J"N$5[)";06].+6U70U))^[J<
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MKRC>RTCN*W6G\CTD _?1+\P.0'LWCGJS-FS9LV;.>_F7YB/E_P MSK!)PO\
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MXX8S56"]7=NE/\P.^=#LH9%1[0MRBBJ05'&E"*;^'CA_]6Y1L&G+2-5&C%0
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MV^C"B6.2H51^[*CE4;U(WW[8*N&0PLK0*:P#TS6C?YC"4VJ*/WH!$H0(3T
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M\*WD887 \"58\#^&='5;/S5IB+<FUU/2]1CWC=4N$-!\2L"2O+?Z,\U^<O\
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M@("!2GV>^<6_YQ6_YQXU[S#YG/YU?FQ$UYK]U+]8TNVNP6"$_P"[F4UH%!^
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MO36M+FU/HLM!W 2OTXE#8""4 2/:."2@<40UZ"JTR;:3<0$A-6M(I'! 61Z
M$>ST'W-G2M/L[,<'TZ7ZO4?O(IQZJ';L":_<<-I?+%G.T;"Q2X2,,ZR6[#D7
M() X, >II\L/=&L-&E:VC;0);.]2=%872?N)$Z<&/4 GN#GM+RK>3)Y6U&\O
M$%CI4=B;;3M,'+ZM!+*IC>1'G *J$)-%K7Z<\K>:O-_E+69X/)-OH\;:%H]U
MIUI8W\,*RM)!:OS:9Y>JR.U0U3]GX<\2_G5Y*UW\\O\ G)7RC^1WD(1WUUIT
M7U:6YL8VEM[*&X875Y<.HZ+;0TY GK1<^WWY.?DWY0_(CR5_A+R3H$.B:8+-
M89=0EB1-6U&X45N+N]F-9&9SNH!XJ-E&V?-?\X_S#O-=\[:YI-A*\-E#,8G8
M'=@AI3.76TBQE4/2N>E/RYG2'0-?G+5$5DXK\P<\\>0]%N?,WG%;6",S&>\*
M@#?[3]<]!_\ .2&JI#>:!Y0MZ+#H-HB.HZ<P/#/*,QZX";Y[Y2$]NF"(R/#;
MKAE!7OWP_M1TIDEL>H.3C3^HSH>D#XEIG4])&ZT]LZEHPW3.JZ5T3)E WPC+
ME;X<CE^X"MWPV_+Z\HOGZSK3UO+EW-3Q](%:_P#)7(OYRD]7S;YD;XMM2N4^
M(U/P2,OW;;9'Q7%!V[XH-_NQXV(VZ8X?ACL</E\L8QQ/OX8X=L>#VQ=?P&"8
M\5%/GCO;-\SME?JQI%>V-88DWA3VP%<01SH8Y5Y+V]OEG/-<TCS-&K_HJY%P
MI^RKN58?3G-)/R\\Y>89@FNZF-,TWE61(Y"\KCN!V&=(M]!T?RYID6F:39Q6
MELA!/%0'D?N[FFY/B<2)83,&4'C0IX4KOCY_2X3RBB_80$_M5.PQ6-7LK=I8
MV,B,K (@W,CF@;Z,D$!%C9^HK@ES\7*I))/VF_F(K3%WFXJ7:U"K.XY T8DK
MM4U!WIAGSB6(\A&LW%HXD*"G\I  J1V'7Q.!FMK8PQ6KA&>.'UW9Z<"U:L.
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MYOUKS+I6C0K'<0H)&+*KR54A3V--JDG.5:_KT>MB?TW4,"SOP4 .S@*@  %
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MG""&%._WY(;<4X[=0#DCLNH\<FNG=5['QSI6D#[/OG4M''V<ZOHP^SG3=-%
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M*NP9JI52#X@]L(6O);6X,]G=\/1(/U><D,&-"4Y4'T9.[?5(-7L1ZAX7,/\
M>1U_:I[877FE7,MA>21H6XI7DN_'O3/)GG779M/NKVT#JD\GPKWKQ'3 _P"3
MNGB^\VK<O(8WMXWN6?CR(:E0>)V._3/3OF[1;>\6"[O*M#'$S22R./4"U)*U
M[U[CYY\W/^<A/,>E^9M:T3R[I'"2W\M^M)<21_$JS3T"Q[?RJNX[9Q6P@:V'
M#8L>I'3VIDZTR65JEE"NO9N_N,GEA.AB5F^)E!J*4H:=!7);97<1VDD*J 2.
M]304_'.M^5KRWN;81,J6UU'^[!ZB5'Y$^KXTZ#/1GEO2Y)+6UUO3[J"9+NW-
MM<6O+@S,B*&CD#4 :B C?OAYYNU59_(.M1. UW%9S(Q(IR8 <"Q.X90_!A2A
MH,%_ES8O>6D%TP=HDB@C])S\)]%0-QV :IR/?G<\VKZ:OE>UEI+?MZLRQU ,
M:B@%,\K>3?(ETOF"WTRX40V\<G.21^@C'6F=(_-+1K_SO:6N@>7H>>DZ$0&"
M;\B.YIA]Y2\NV7Y3^2;[S)?QJNJSQ&.U0CX@2*5_'/)&NZG<:K?76H73EY[I
MR[$^YR%7K4KD;G;<TPK<_3B)WZ8M&.^]/;!L?$@"A-.^&]KUWW44P\@ H*=Z
M;9([,;J<FNF[LF=.T==EIG5-'&Z5]LZMHPV3.D6'V5^6'!-!A->M2N0/59*!
M\Y?+/_N:LQ7?D_\ Q!\Z^I/?%1CZ[XX'WQ]<<#TWQ]<O>A]\08XVN^8'% Q[
MX(0],%K4;8\>^.S5S'MC:]Z[G&,WWXDQH*UQ!B*GO@9SU Z4P')L#[;_ '9R
M.X:1]3ON+%1,&Z>/;!&ENX7TIRTB*&#%-CL/X')K856-:HI$H6IK7E0=< 7_
M .\<6R 33$$)4_"">E?'J3D/T^20^9=0N+E'6*6U,$3=60+(BH/8"N2?1H8+
M;4+R$<C*Y!J?L;DG8TW/P[G!VKR*OPD"X#CU#5>*'V^+?:F<CU?6].M)7$SK
M$IIS''CQ4"@"[;;FF$VGSP:G>37#TDM@1"DI 6DJD,&CH-]N^=6M[55/HF1#
M&P]5>((55)V4M_,/;KBTDTD4T<A5HV)"KQ($DC*M6X;TV4]#A8LPB0),:2%G
M=2_[(K04%>N_3 US?17$G">.D4"<G9=P6Z?$Q&P&^1U=4?0Y1J#7@>(L08TZ
M/$3V%:U'7.BQZ].NEW7H7=;:\B]2&1>C [@'/(GG6W:\U%Y=VD#\P/I-3G;_
M /G'^PT]?TG->$2M$A7@:!QR%=CUWSAG_.2OYRW-]>S_ )<^5+TV-M9<QK-Y
M:M\9D'2S@<;BFW,CY9XDM[>2WDC4PL3(Q8DG]H[[G?MXY)(881Q=6#!AL3T!
MWV-,,[,>E1 .0<UW[>U?#)39/]78R5+(WVC]I![>(.'NFWT,S!Y95B*LU01T
M5=@/F?#.H^4F%R.44BQNK5CZD,1VI7[-*U'8YZ"TS6+F+00EVR\I9HOC0;L(
MY @9AX@/0'N.N2?S,3=:1>)Z2K/JK0Q%DJK/)<21(&IO4LH%<] ^5].M]"\M
MQ)(X7TH@TDG56XJ.1KMT .>$M6_,U]=_,#6[^"7C9PW+6]J#T]-#Q_AD_P!3
MF6]TEKVQ(2[0"KIX'MMG6OR0T9+"RU?5M=8"S2!G=I.E:5ZG/,?YP^?Y/-FK
MS6MD?2T>Q9HX8U/PM0TK3//=V?M;Y&+P[G?([,>N%STJ?\ZXG\^_WXO'\1%!
MN=C@^-35?#MAQ;*2>N_^>^'D Z=SWR16:UXCM7ODUTU/B7;?;.GZ0M GT9U3
M1UW3Z,ZQHZ;)G0[(4489-L#A!?-L<Y]J\GPN<Y<@]?S!:1E^-$N9:TK_ '5O
M*]/IXYW&1?2FECZ^D[+]Q(]LP-??'@GWKBBG'5^7CC@>V.KTRR=C3IB)(Z=L
M;6F;F!F$H&+QR TVPP1U/7\,745Z=\5]$]2U#E&)QW&)$,.U,94_3B;>';$B
MWWX@[=QUP,Q'AVP#.](Y#X*3^&<:EN"M_$\;$+*SJ6[5KTP=H\H:<QN&=HRQ
MZ[_&"*9,+&8P#@#Z@ !6O4%OO\,$W$<<JB2$ 3,CG<] =N1:GW#(=IZB/S']
M6D)>6.V1P0?[QI9P3OMO\( R;16ZQW;K)1F=S)MMP*UH-O<DY _.VL0:8ZW$
M[\F7D Q_WXN^W;MX4SQ=^8WGR_:2>>UA>25R0 ".W8C<9 OR_P#SE\[_ *3G
MM&\D+J5C$P$C1WZPNJ@T)5# X?\ X(9[U\HZ[:>8='2[TV[%S Y"2Q2OZ<L!
M/5)$H2&!P\EBO);R"&&5%6&KM(]2$W%8U7?[0[YKZQ9HKJA65Y%;]X%XE>(^
M$!?B#;[=CD9N5N+8);*XD<JDLK< *)04!(ZYR7S3KS#U"81:GB J%J5!JI-0
MO>G3 7DC\QIM.TJ7RU?61NK:*1Y+6X5]X@^YB(XFJ[[&NW2F%OF'4XFE>8J?
M5-:KL2/#N*9&[O\ ,JX\GZ-?:%Y=G^L>8];@=I;Q&'#3@1L!2O.2A\0!GG;]
M&O/&96GXWLBO-7[3T6O(GD3R)-2=\=!ILAB5GI*Q'$%1]HT^UUZC _U2:"2-
M2Q1V!5HZU!7J2?ZX;):2N.*T:8K2AZ"F]*[8C!K8L+E;6Z0JSF@#J.+FG8[Y
MT72#87K(RTCE)4+(G6,]0[+0A@,ZCIVFW.B:YH.G,\4]GYCE$\-TH*",@ D$
M'E\+UJ#7VR9_XBMM0\SV?E"WG$2O<RP3S(:HAC(>1@0":<EX?0<]*>7]+&LV
MVGEB?W][;W"<Z-QCC/$4(K_)7?)_^;VNQ>4OR[N9(7K+=1FTB'V3RE''EWZ#
M/E_%HNJ6E\9;-/KL4KEN:FA!8U-0?GGH_P E>I;::!KEW%963_:YD,Q'A08-
M\Z?FT]UHS^5O+ENUEIOV9KCE\4P&W3B*??GG*\:@-?O[Y%[IMS[Y&+MJEN^$
M$N 6IOWQE"3W]L$1]ATIOAC"M?EWPYME%-@3AS -AWR262_9'7)QI:59>XSJ
M&DI]C:N^=5T5!5=]MLZOI*4"9/K044?=@N1J+[9&[Y]G[9SK6I*(YSF&G^K/
MYIMXX>)<6FHR'FQ4<([&Y=^BMOQ4T'<]QUST'JZ>AJ^J0\>!ANYTXCMQD84P
M(#UQ0&F/!Z#IC@<>#CJ]<S-M[C$"WM3$7>FWA@9YOHQ,SBO7%DN0*;X/BN 3
MAG%<@4%<'1R@]\%*0U?;-Q5MJ=1@5XJ>]<#.II@1JBNV(-U^6!G(I[X773@0
MS'_(;]6<CU&T$FFM<=#&YD4#8[5Q31C&9 X)#F('KUK3IDIMUY*S$T]'D /$
MU-!7!<[O-&7Y%'C%"JG<BG2OM7"'3XH;36["[)]1[NXX%?!4C/ 'V%,E0D_>
M3RKR2K-R-.7) !Q!!WV]LY!^8H%[QCC <!**TA/#M\5!_*#].>>KWR!;7YD1
M)YJ.:5*\6Y.=JL*[$=.^3?\ *;\L],T>_OTGLR5,I^-SS=N52/BH=ML[/JOY
M?0M<3:GHHDT[4$C'*2!>.RCHZC9AX5SGVL:]YN\O6SSV]E)K*Q4,ABXB0<>X
M#$84:-^>.B:G?6^F7MQ%9ZJQ53:7@-M*'4\AQ#_"=_Y3DTU3S-IH5#,1&S[E
MW:H.Q%2?EG)?-=I!KC&YM+E0I0HZI^W]_P J5R*:99C3HY6N9E=G97$5*"/C
MU(/L,+?,4 GE:DD<KW!)<IM0-N-O$#(4N@1VZ7Q8K*MQ0QLQ"\68@<:=R>^.
MF\MN(K6YMT2-!-R*KO0+0-0#>F]-\!7D26@FXPM"BRM'%&U!7U=Y/"NWWTID
M9U"[M@98T55D,9+!MCZE?;MW.):7+# P=I6N&1A7B=VKT K6@SHUGY7T;S99
MK9W2E9KHM")%(!611R6A'8>.1&TTC4O*NO7'ES5IC)/:.CV]P"!ZMO,"49@.
MXH0<[S=ZL/+OEUO,EVJ7$VEV::;8(P!,US<_&'-"1R4 5/AA)^4ED9;S4]4N
M/WTT]NQ#=2&G-.0/;<DY]!_)=C);-IMOS*106D$S!:,2P9PR[=*G.6_\Y5>8
MUEOO+OEB)J?58OK<Z#L6V4&GMGE*!G6A4E3[8.:61UHTC,.M"< 3FGRID?O&
MIR]\B]T>IR-73;GM7"2;<_+ +=Z9E!--^G3!,:'8[88P ';I0[;8<VZT'O7K
MX##JW7I4>&2:Q7=:]LG.E+\2TZYT[21NGOOG5M%7[/T9U72ALM,FUNU$7Y8Z
M5Z*<C-_)LU,YOKLU$?()Y/07?G=@RLR0:'YAG;C^SZ>BZ@RD^W(#/1WF^+T/
M-GF6( !4U.ZI2NRF5B.O@#A K?/% : =L4&/#=,?7KUKEU/RKE,?A'CXX'9N
MOC@*5P.]< O*0#O7 +7%#6N9;FI#>'3?#&*ZH10U)&&D,_+ON<.()JA:FHIA
MM$Y._ABX?ME,P9>F^ Y*=Q@*3 ,AI_' KM]%<*[]RMM.?!#^K(+% EW:21E:
M]?A/OD"AO'LKBYTX#_2;5B8R_=":T%/#.CV4TC+;\*"3TUD<GH>?88>301"W
M*L2\A95(&Q!/@3[827]NT>M:/=%A&+>^1)(@ #\:,*'Z!].2(MRCDGY$KZGP
MJ!14&X!\?'..^;K6.>\2 3GZL[ LL>S%N6R[DEO';I@@:>8XU5(U8N42)7W,
M8&[,5H-Z=*],F=O#';HQBD94HKEM@6.W$T.U!3;.@B[4*LR!J%!4-4)[D_/"
M#7/+.G:PPE@'U6Z*L]"OP2,!7IL-\Y=KOY2^7]3DMYM8T2(R)0N\T:L&)WV(
M&Q^6<[\U^4TM(WL=*N62SM$J$=3)[A0Y->V><=<C\\6$CFRL8;ABW6&4Q'BW
M0 -7IXYRV^U_SPDTGUZSU!0M5=4*NGL05.^_7"<^:]1BD=I7U,/TH\#CXJ4H
M:#8# $OYGQ:=*D4]XS2<BS<K::1BQVZA-CDHM?S/E@L6O6AFET^!&+"*"2I#
M$$_"5J3MD$U_\];S5PT&@^4[DA6_WJOOW* ^/'=LY/!KWG:_ULKJ=R$@EE%8
M;9.(/+P=B2=O'/47EHVOU6%Q%)"ZJ%D28=:]",ZM^7ED;OS#9AF=(F<^G2@
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MF"!0-Z;/&_WYZ)_/:R]?RK8WJBK6&H)R]DE1U/\ PP7/)X;MWQ53]PQ0-3%
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MIC)\#MG$K-E$;QUW(J2?',@F56DB(YJ34^.(^K+<L9)%8.PIQ'9A@,5!,-T
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MEIHPC_O% #1]E%>OADDAU".:99%G _=@N0/4H14_"I[U.#KS4$%F;I 9I(E
M6 T$CN2.C'H!6M2<B5[<6UN]T;F\9'N)FB=Y  Q4*.!C ]]ER+:S]4B:W=&#
MR6ML(@]!2,@_M#^;?<[[YQ+S!>W$5U$EK=!GC_>RDE2SEJEQ3M\-/ED#M52Z
MOVN5'&2.X!/JD\G4;@+\NF2&:*^U'3+C4OMF"Y:W,9 JB[!I$]CMUR,WM^\:
MQ1/S^L+)Q-"*<3MR)W^(]1DA\L26TUE<O+<$2NW&V>A(ADD>AD5#L7(^'?:I
MSHVGVC6\$^DV8BL[Z[C@6G&M+AG6**,UV+2!C6NU*D],[9Y:TNREB:6!%N8]
M*N)M%C25V$3VTU0[)44KR/PD=:8'\R6%I._HVLOH36LD,:?#5E:)2%62O7X3
MOGG;SK+=:>LA:.WBG]8O9B(*Z%N(5RS"H &]1\LY996)6.4W-LO.YN#2<-5
MVS%BI -.)^_)CIFGK(KW-95B,T8"NM4)/0@_/.K75SHWDCR^^K:RZP1P4DAM
MU(+RR$46., ]23\1\,\I>:?.>K>>-:DU;4W])!\%K:H?W=O$.BK_ !/?$K,?
M9'?IDGM!TWR1V_04ZC#!" *^V)SM130X073]:Y&;I^N^^1ZZ?KWPAF-2?#MA
M?)W.)>/CXXJGAT.#X=J>/RPTAI4 =>GT8<P=J;4VP]M12E,EFG#==J;YT+2M
MN/OG2-(ZJ:;9U'2>BCY9.K5J*#X#!;/\-*Y'=0EV;?.<ZQ/]LUKL<+_RBT0^
M9_SG\A::4]6*VU1-1F!%5X:>K79Y5VH3"!]-,^O^;/#WYN:7^B?/>L!5XPZE
MPOH_?UE_>'_D8K9S<-6G?OB@;QQP;;;Z<4Y=.V.!Z>V(,W7]>,J>O3'@$^^*
MT"BKL%'OA-J'F?0=)4O=W\8X]@17.8>8/^<@O)>@(P:\BY@'=W _#/.7FW_G
M,_3H!)!I(>X<=/27X?O.><_,O_.5GG?4^8L8_01CUD?D1] H,XSK7YI^<]>5
MA=>8)XP^Y2(\.O7IOD.]:XNY2T]S)=2'<F1BQ/CU."%D,@],1DF/J?#%K:V<
M.:-Q63$=1LI%D0$5 (-<,+:86\#&2(2&E-^WOGI?_G"[1;;7OSRL+KTJR:?9
MR2&O0%V51GZ)+.(0^DO0* ,=YATV/5](O+*0<A+&R_>,^:?F#39M)UW4='N
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M*[8HK??BJGL/EBJ@[]\28*H)D<(!UKMD:U;S=Y?T:-GNKY.2]@0>F<,\W_\
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M('%YKU"VFDA@EAO@%]/TG 65"@_;4TJ*]*85-YOM+JZ]2^G2W=%;C!*K)(E
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M:O**\AV]L99(TT84&I3ODDAM7:-0$J4WPX@M6^KN[QU8FE1AA;*T:5=B&4;
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MN.)7(YK0#J?'PP#J]LJHCQQGD-JCOB=I+;K;$.A9^E#VQQ1" 5%*[8LL')*
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MX%>2NT",DC*6 I0D;9$KNP22.82%O4^T":G?W.<5UQO2NF0&E#^.!K%&EF0
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MP*RQKZGGS2[5-W110:Q$BCJM*7('44E[2,?B+)Z)(C0\7"D%J[$#OC!+01Q
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M='C]?4;^&T116LC@?A7(]YI_YR%\L^7[:0Z5:76NSKT%O&2E1_E=,\C^:/\
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M-#22OY5>6KOEHVGW*T'F#4;=Z'DI'Q6D#K^\/21QZ>X$@'Z0@ H"J  !0 =
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MLV;-A%YG\L>7_.?E_5O*OFK2+;7?+NNVSVE_87:<XIHGZ@CJ"#0@@@J0"""
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M4B5Z/W\,]?>4)*QE#W&1CSY8K*9&*UVWSAV@73Z;KC6Q;BI:J_?GIK3KPR6
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MOZ>L%W-("JJMXBTV  EZ#C(:MGR[U:QU#3BB7Z?H]XY6AG@="KQRQ'BRW$#
M,C C>HP#>P+%QO)D4DL.+Q,6@8$=CU4X*CO_ %(=H_7F?[ F-&''_?<HR06\
MMY>(D/H,TTT?IPU;TITIX'8/\L"/#Z=Y S*L:P#A)-$E7Y+U$T!_6,(I[U.4
MDJQI&C3<A7XK=JGN.J9SGS?%Z3\HU,2\ZD \UW_WVX_4<[/_ ,XWWM-5U.#C
M5BJD'H>OAGU$_+2\]&YC4FA-!3/9OE67E/$0>H!R4^95/ >-,XWY@M_7L+@
M5(KMG(?+EZ^FZUQ)**ST/WYZ(2X%S:<@:D ';?/-_P#SD7^8EQY4\FCRKI=Q
MZ6I>;"4G*GXEM5^UO[Y\[IKAI[%H %]&"J(0*D]S4CKOC;3SQYRL-/M-/M-?
MN+>RTN.2&SB'$K"DA)<+R4]22<\^:[5KN220\I'=F9CU8DUJ<Z1Y)\XMY?\
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M95) V1DZY\./S]_YP-_//\D([[4!8?\ *Q/($:NS:YY<@D9X8UZ/?V'QR0T
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M)KO\NV))'179MT792-R<1B4@,ZD%#N0>N^#H+LHJQI%Q0;DCW\,'B.U=XI8
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MJ?[N2W5Z^X(SZ9>29S>:DBC<+3;/1\W[JQ/;BI_5GSJ_-^\$WFFYWZ/_ !R
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M7!5G^6W_ #@A8HHAU'R Z1MR'UCS6MP*^_K:I)4>QVPK;0O^?;6F7\CW\_Y
M2ZD*^I^E]1\NW<OQ?S"\N)3\J].V=_\ )?\ T+;RC_Y5Y_RK3G4^G_AW]#UK
H\%>/U3O]G\/;.X9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>sny-20221231_g13.jpg
<TEXT>
begin 644 sny-20221231_g13.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
M!2$2,4%1!A-A(G&!%#*1H0<5L4(CP5+1X3,68O D<H+Q)4,T4Y*BLF-SPC5$
M)Y.CLS875&1TP]+B"":#"0H8&82414:DM%;352@:\N/SQ-3D]&5UA96EM<75
MY?5F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]SA(6&AXB)BHN,C8Z/@I.4E9:7F)
MF:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H " $!   _ /OYFS9LV;-FS9LV;-FS
M9LV;-FS9LV;-FPFUGS'Y>\N0?6O,.O:=H-M0MZNHW4-JE!U/*5T&V<1\P?\
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MV"6"-+:20 Q2&>YG/3DP^!8: 4"@FNVWML,*;F_DO+TW49XAZK A)<Q1*?@
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M;-FS9LV;-FS9LV$'F?S/H7DW0M1\R^9=1BTK1M*B,MQ<2G8#HJJHJ69B0%4
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MW$MW>2?69Y&+R2S@N.1[E#]H^ .WT8\W$M^1ZLKQ6J,%;E5ZD#8&@JSD= *
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MU._I@CX5/0,6SS,%]NN7Q ZC'!3X5VRROTY73;+%6Z8H/P]\VU:??XXTC<G
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M['#9- ]:XBCTZ>.^YPK-6,@U#,P 4=?LKOM4=Q@J+2B?K,:Q>M,%941P*L[
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M.X0%. 4A%#KQ(45K6E OAUR-WGY36;P7#V\_U8R#CQ*D*O 5W6N[=@>WVER
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M>/B1OA5(M*[;]?[< OW-:;;?/ +@%F!Z'P_# <J!J4.%EQ#U%-N_OD=O[;D
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M$,3\QX8HRAUC<#[5 3[KN/PSH/DJ$K<K<!><TC".!.IJ=RWT9]8/R TQ]*M
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M]1F-1\QOD:\P^6;3S1_AF"\0R+H7FC1O,$2%>0=]-NED9&'@T;.I^>=]L_\
MG,;RAY5U\:5YE\O:TT4-PL-_J5JB3" ,.0?T PD8"N_$$^QSU9J=K^7/YO\
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MEK%WQWW^JPO'7I3;ZSD-_.FY-]^;GYD3.6)7S)J, Y=:07#PCIVHFV<R*B@
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M</*_!6TO54!ZU9]/N54?26I@FE*4Z'Z<<%VQO'?PQP7PZ^V8@4VQJC>I&V*
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M;F"WNKL#]U&\%O&CHO9F+D[#Z<][?\XN?E+:>4-$;5Y;8K?WS<89R*GTZ<9
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M<;'Q/7$YX2ZL%I[>]#OO7-!:P2)/;7,*SVLZ%)HG4,DJ$$%)%(8,I#4H01G
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MF9A_I#))L0'J:#L1A]H?DJWT]*K8@3'?U&!Y"FU*UIDJ_0#%$9HJ!>U-CM0
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MS9K$<,4R!P 8Z CP&]/I(%<\C^;=:]>>8>H"%)"@&GA3&^4]%]&NKWB_Z3<
M_5T(^PC=7->[=O;YY-R"?8>WME>_4C+%.GCB++O4=\8%KN!C2*>PQR\37M[9
MF7:@Q,]#0 5QHH3FH ?EF)Z=P?QQ,@8T]*YNPQM:_0,8^Q\/#*J1[97OE&AW
M.8#P'W^V4W3I]&(?/>N7M\L^N?\ SAQY4_P_^3]OJ\L7"[\WZA<:B211O0C(
MMH5/M^Y9A_K9ZNS9Q[\^_*9\X_E1YMTV*(RWUE:_I.S"[MZUD?6XJ-]W163_
M &6?' CZ1E 4RZXVA/OET]L:12F4*BH\,L;_ $X[CWICMJ?+*ICNU0:5QM:#
M-6G;'J?';+-,Q(&]-\W?]676N^^5T_V\=4_2<KIAOH.B7_F/5['1-+B$M]J$
MHC0,:*HZL[FAHJC<G/2&M_E!I7D9/+C-)/JVH:I,RM>L>$"2Q(9&1(E&U0#3
MD2: YT2SLN-C$P6A% 01X"G3Z,-M(*B>2,I\18-4^)_M&3N.#U(P: $@_3MV
M/TX3:GIBW$!#K4\>!(%#[5&<9U[RI63U;=2LR[JR?:4CN.^%NGZW-ITWU35Z
MH@V6Z ^$D=/4&U/G]^="L[T*P:H*G<,"#53N"-]\EMK>(W&@W&RD=^G]<-[>
MX# ?%53L>^W]F&:3HP!5]J[@#P'TX=V]RH4!@?BV6F#8Y^-*$G?O]H']6"A=
MD#GRI0=_Q&8Z@#^TO$ &FV]*['"^XN^2]*5J2>E-^O7WR.3W+U*JU*=2-B *
M]<C5[>$MQ)W!Z=*4[Y"]1U2*'F&E %>OR]LXSYI\RQ0D\)>85=U'8KO0;^V>
M:?.7G0<9@DO)_LION,Y=Y=T>76;@ZG?K73XI/A!Z3N#T'^2._CT\<ZD$.YIO
MX8X;4QI^_P">,]AURZCN<3]MAX9B,9T)--O 91(/7MC3^OIB6P(IMOMF:H^>
M-)_VCFH0*XVGON<HTH<8-JY9&^^45^7AC"*;UKE#]>6/HQC#KB9\*?1@W3=,
MNM6U&PTJQC]>^U.YBM+:,;%IIG6.-?I9AGWT\K:!:^5?+6@>6K$ 6F@:?;:?
M$0*<EMXECY'W/&I/<X?9LH@,"K ,K"A!W!!SXH?FGY1;R)^8'FKRL5*V^G7K
MFTK7>TG FMS\_2D6OO7(!M3Z<;7?PIEU'A_#'T'6N)-\\H>!QX .X[XZE-LH
MG-4'?IECY=LKQR^/T4S#KEL:TS4.V^QRP*DC+[['*IM6E*=,JO2FYZ9MZ[_A
MGKK_ )QZ\F&WM9O-]Y%_I&I5MM/!&ZP*?WLF_P#.RT'L/?/6NH>6K/S!I$FE
MZBG.%RDL3H/WL,J;QRQDUHRD[>U0=B<YS=Z!=:#+'9Z@ RS56&X44BFH.W6C
M4W*GZ*C?"18&M[@/3=7WH.H;I7)WI3K*J(0 #U'?;#6\TY>'J**-7L?P.0R]
MTT-S/$ 5 -?#Q&<ZU_R[%<))6$4>NX['Q!SF9?5?+4I6 ?6+)>MK(:+7_(-"
M5/X>V3'1O-VGZBP2&1HKM?[RTE^&5?&@Z,/<')_9:HK&H->U?#YX?PW8/V6H
M%(!\:=Z88+?+P"D;G<&NWOBHU):<0XJHZ'N:;>&5^F2"PY4X $ C8CZ>N)MJ
MX-2LB@D"H)I4]:86W6OI&I4L!0</A/4U&^16Z\S1@&CU!%#OUIOD$U?S9$@+
MM(%4'B?BI\A[_1G%O-OYBVUH[KZP:HH2I ()ZTWSS;YC\^SWTTO"7C$00*$B
M@/?>O7(AI.DWOF:]6XN><6E1G]Y+T+\?V$]_$]LZU%#%!%'# BQ0Q*$C1!15
M4= ,>3UH.N^(%Z'V_CFY@C8XPO7?KE'H2=J]L:'J?"GAF)!^@XF6[_=C:_?E
MUZXPGQRMOEF &WMFKB;-4G&CPWJ3CA0[_1E=#7&$G?OB9Z?3C*TZC_,XIT%<
MH@^&53QSTU_SB7Y,'FO\X-*OIXN>G^3X)-:FY=/5CI':BOB)9%<?ZIS[ YLV
M;/GY_P YI^2O2NO+'G^TB^"Z4Z+J##_?B<YK5COU*^H"?\D9X/KV.X&8>/CC
MP1]V],=SZ[9NHQGX8_:E,HGVS5RZ^&;:OAF'C3'CW'T8TU.U=\H>_P!...WS
M]\L5(S [> .-8['QQHKMMDJ\G>6KGS=YCTW0;8F/ZV_.:4=8K=*-+)\PO3W(
MSZ7>7-(MK""UM;6$0VMC"EO;QC]B- %7I[9U&QA 4&@)P;=:;::E:R65[;K<
MVLX =&VW[,I&X8=B-QG(->\I76AN9Z->:6SJJ7!^V@)V2<#H>P;H?8[8W3(4
M4E3LR;U\1DB7BX^)*D#B?;V.$VH61<%XQ4UZ=_;(K>V*LI+C@"?O]J'.>Z_H
MZ/$65 QKT(^[.*:QH0+/)$#S0U!W#*>Q!V.%MOYGU[1Y!%<?[D+8?"&+<9D]
M^71A\_OR8:7^9EAR6*:[,<A.R3DHU>OPL=B/IR8P^>K1@&,Y4%2*L:J#_$8A
M)YZM5YQ_7(N;*:4(%:5WZ[C;"_\ QS K^G)<HW &AY "O4$BM>F)R^?].B0N
M9E9R:4^R.1W&YI3Z<AFI?F/8(Q)G7B!5OB(\0P7IX9 -3_- N"MH#P)*J>HV
MV]^M>N<LUOSI>W9=GN%@J3]IPM*YST176MRS>C.)^%/5/.M*UI4U/AAC9^3;
M)'66]<W!4U](;)])ZGY9,55(E5$58XXQQ55%  .@ &6QK_08PG8[[X@1O4CH
M,:WZO\QC0Q!Z#;IEDUW!WKC1X$',?88D:&OXXPFGO_'+KUQI]L;7>OCEDFE/
MUXVIRO?IE[5^>56AQA>AZBN-)KC:U[XSPQX--ABE!3YXF33/JS_SAAY(/E_\
MM[SS9=1<+[SO>&6,D4/U*R+PPBE>\AE;W!&>PLV;-G._S8\E)^8/Y?>9O*_!
M6O+VT:2P9MN-Y 1+;GEV!= "?Y2<^*4L4D,KPS(T<L3,CHPHRLIH00=P01B7
MZ\V]/GCA3OEU]LK??]68'Z<?UW\,P&/&73?I[XZGM2G;*Z'IE$]AOC<LTH-L
MU=J';-M2O;-M3QR@=]]AGM7\@O(ZZ5HS^9+V"FHZ\@,/-:/%: @JOMS(Y'VX
MYZLTV)05^$U)[Y-+4 A:"M.F',25[8+,$<J/%+$LL,RE'1QR5E.Q5@=B#G+M
M:\KOHA-S9AI--K\!)Y-!7_=;D]5K]EC\CXDOBHZ ]_'O\L>=V7;?O7W&WX86
M7=FDJNWV9&':GW^&0/4[(@247IM7L3\LYMJVCQRAZJ4=13D10BGC[9S'4-!4
MN21L0 >(K05/:N<^U+05D,BR#DI)IQH:#OMVSGFI:=J-I4V4\J4&W&1EH:]"
M!D$OM6\RVA:EZ[E*T+HK&GN>.12\\Y^9U8\+Y%VZF)3MX9'+OSUYM/+E?!NH
MHL2"E1X%??(]-YQ\P2#B]_*1T/$@=>NX'7"TZMJUS)\=_<.:[#U& )/L#AK!
M'ZOI\VY4ZD[GWJ3G8?)UG]6T@S, K7LS2 >")\"_J)R5TWQK5/ME4]M\IA[#
M&<2>U"<1*T[T(S!0.HQU%'SQ,]/X91&Q/Z\2/CU[Y0WQVP'38XP[@8T Y3=]
MLKL<QV[4VQA-=OUXWKF(Z^)ROGOFH.NV,KUS?ACN0 WZ8>>5/+E_YR\SZ#Y6
MTL%K_7KZ&RB/$L$]5@#(P!^RBU9O  Y]Z=!T6P\N:)I'E_2X_1T[1+."QMD.
MY$5NBQI4]S1=SAMFS9LV?)W_ )RD\@?X+_,N[U2TA]/1O.8?5;<@ *MR6 NX
M^W21N?3HX&>:R?#OMEU WS?CETVS4Z=LU!\]\NOT8\4^66.^6"13P/OF!_AE
M%@:_AE'<=<;W(K[9JUS5QW:M,W4'VSKWY1?EY/YTUQ;NZCKH.DNDERQ_W;("
M&2W'^L!5O!?F,^A>GV*VT2PH@"J*  ;4'8=J>&2NRBXTK[&G7;)/:BJ@$4.'
M,*DTPR1.GCBQC1T:.1 Z.I5E85!!Z@@]1G*O,&A'19A=VJEM-E8 @U/HL=@I
M/\I[$_(]JDA0!J@D\MP/;&SCX&1JJ&'W ^%3D5O(0:@)R6F_N0<B>H6,<]0R
M[L*[UV]L@NH:2 S%$YU[[5KT^1R(76B)(.1CHR[J2-B/'?(#J>@Q$5HF_5:=
M?D>O3.7:QY:#EQZ54+4HG?[\Y)KWEBK-&B,@&X)'@?'QSGU_H+(S!N) I[U/
MCTR-RZ#1R2M2@J0-A].4FF* RL016@'^?7#*.%43X14*-B?8'.VV,0M[*RMU
M'$10QK0^-!7\<&@9C05\,82*BF,->H!-,H$]^^4W7;MB1!W V^>8G;PQE"?I
M/?+(Z8B^U<94 ^W7'5V.^-'WX\ =Z@XFQQ/\=\LG?YXSWRAOMXY>_;OE'&FH
MQA[5.4#XXTU[Y[M_YPA_+HZEY@UO\RK^#E9^7D;3-+9ALU[<(#.ZFO6.!@O_
M #T]L^FF;-FS9LX'_P Y'_ET?S"_+?45LK?UM?\ +?+5--"@EW,2GUX5IU]2
M.M!W8+GR#W[]<<"#EC\<NO8Y?R.;]68#QRSMU'W9J[$=_#*KN.OCFJ=O#IE5
MIV/WY5>XW!S'P.6OWTRSU^7ZLNN2;RCY5U+S?KEGHNG(0]R>4LQ XP0J0))F
MK2H6O3QVSZ8^3?*FD^6-'M-*TRU2WM[=0:*H#2/0!I'/=FI5B<G,-N*@D?"H
M_P _'#B*(*!MOXX=VJT4;4.'UNFU:5P>HH,=B,\,<\3Q31K-%("KHX#*P/8@
MU!SD^NZ:VCWE$!_1]XW^CN:D1N>L+'M7JI[].HWCLTI44XD+TJ=_HPIEX,2
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M<XGE=/IQ)C4[#;QRN.Q)I0XP^^].V4*;';*-?V>_X9EK2OCE_3L<82?'$R?
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M!E,???$R 3OC"H]CC:>V6"1T."(K@J:/N#W_ *X/!#+4&H.!IE)!\!B$;$$
MUP0#6H.5XY1 QA%!_#(SKFE6NKV-W8WL"W5K>1O#-%(*K)&XXE3]&>$/,>D:
MAY!\PRZ!?R/)8S S:5=N*&:W%!P)'5XR0&\=F[Y'[B5)0WHN02:LQ%!3V[9R
M;S;<"."4R@1>H"JT'M4&N^<(NM6-O,4YE?4^&F['8>V%%[<---QY\R1N&ZC;
MK[9&I[=N9X @\S4C>GS."8+4QCU64"C#;OU!)SY9^7?,;C5KR<N5,UY/(P)W
M!>5F_CGU$_YQQ\Q1:BEO")%^(!9!7MGLO6_+L]M$-2M86E@8<IT45/?XUZU(
M'VA].1)[?FH*?$&W##H:CM@.6T!%&7P_MPN>R85JNV GTN-ZDH WB-O\^F W
MT.0EO3?IV/4?(X7S:3>PU(B,E*U"]1]'?Z,*3^KME"O096W2G3*]\VQVI0XV
ME3TZYBM>V7Q\>N7T&4=]^YQA^_-3;+KX]<3/4Y1\*9],/^<2OR)?R_9P?F?Y
MMLN&M:G#70[29?BM;64;W+*>DDJGX?!#XMM[HS9LV;-FS9LV;-FS8UT21&CD
M4.C@JRL*@@[$$'/EW_SDA^0TOD#49O-_E:T9_)6JS5EAC4G]&7$A_NS0;0L3
M^[/8_ ?V>7E&G7+'XX\>/2AQX H-NV/X]/?'4VQ_'KXY)?*/E36O.FOZ?Y;\
MOVWUG4]2>B\MHHHUH9)IF%>,:#=C] W(SZR_EUY"TC\O/*]CY9T@%T@_?7EV
MR\);R[<#U9Y*>- %7]E0%[9T%0-J;#%@>^8OV'7*![\2<OD/]]M]W],:3&>_
M$^^V45VJIKB+=]J'&\B.NXI7%89S"VQY1D[C#4,LJAE-01@=XZ;C;?&JU.O7
M'D]#ECKE$;8@\=:^.<<_-;R#:>=-"EL9F^K74;>M9W:J&>VN "%=?8@T8=U)
MSY]:A+K?ERZO=%URT:#4]-?T)HC4 $BJN@_:1UW5NX-<YWYEN%FC:1OCD*\B
MF] /$YPO5)/]*^!5"L=R=R"/"O;'-'56;TO4++\-10CW/T9=K9>MQ,A(X#C0
M8:W>C/#923N!01NX Z#X3U]\^&-K<2VLJSQGX@23[BN>R?R!_,UM#U>QN!.8
MXRZQS+7>E16N??S\N9]/\W>6+&>"19TGMU*$$;@CI7.>>;O)\_ER\FDBC9K%
MV+LJKLE>K@>'B.W7(@;4,!2E#TITH<3:Q!V*]]OHQ$Z?4UIML<>EC0@TIWVP
M4NGJZ@,O*@V]OEA9?^3[6_!9U:"7?]_&/B'^LO1A^.<VUKR_J.AR*MU'R@D/
M[NXCWC?P%>Q]CA&5QO&AV[[9@*],OC\Z?PQP7O3IE$$;T_SZ8SY]LH@GW&,H
M>M.^5['&]??*IO\ 3GLC_G%W\@&\\ZC!Y^\W6=/)NE35L;64;:G=1-W!&\,;
M#XNS-\.X#Y]3@   !0#H,V;-FS9LV;-FS9LV;-@'4M-T_6-/O-*U6SBU#3M0
MB:"XMYU#QR1N*,K*<^4GY\?D3J/Y6:O)JFE1R7OD?5)C]3N=V:T=JD6MP=]Q
M^PQ^T/\ *KGGDKT^_,/NQ9<L>'X8H/G\L'6%A>:E>VFG:=:RW^H7\J6]M;0*
M7EEED-%1%'4D_P!NV?4?\E/RCL_RQT BZ6*Z\VZPB/K%XGQ*M#R2T@8C^[CK
MN?VVJQVX@=R4 >U.F*@TZ"F:I/8G-1O#+^+*Y2#<9?K.-F4,,H^FVZ?NV[TQ
M-N71OB]\1>HWZC\<3!%*C?!$-P8FJK57N,-T9)DY)@"92C<EZ=\N.4-3?;I@
MD'?KC^V:@I@&Z@62-E(!Y BGSSS#^=_Y5?XLTI;[1X%_Q=I,1-B%V-];J2S6
M;;[OU,1/1OAZ,<^=&K*]S;S+Z+MZ0,9C>J/ X)#(ZD5# BA![_+.*7$8%TQ>
MK!253D0>)]\.;:&L8(8%1T'[1)V\,DFE:8T]$,(W(V I7?QR5^:-(DAT*Z2-
M>#FU<@'XFY\&XD_2<^ ]WHDD*J"A5U4!A0CXN^V;2;F]T2]2[MJ_"1ZD?0,!
M_'PS[6_\X)_GM;7+V_E75+NMO=D+;NY'[N78<&KN!4_0<^NVL^6;/S'I@KQ$
MRJ?2F'4$=]NQ[YY;U[R==:3=SB*W*JC5F@ /P'NR?Y)\,C@M :BF_?YXHNGH
M?V*U[#%!IX!KZ>^"([$;46F"DLF'5#0>&.FT>*Y@D@EACG@F'%XI%JK?TSCW
MFK\N+FQADU'0TDN[1*M-:$$S0CQ7NRC[\Y.06&4%[?JQQ%*UZ''#:E.M<:QV
MQ$[4[^V;M7;Y9O#[L2IUQO&E,])?\X]_D#J/YL:RFK:S#-9^0=+EI>W()C>\
MD7?ZK;M2M>G-A]D=^1&?7;3]/LM*L;33--M(K'3["%+>VMX%"1Q11@*J(HV
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M63RD+>4DPD ;D@=>QQ5M'AB4Q>F!QW'A0]\\G?G1H3/;W(:( ,"*4\1G;_\
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M:*\M+R,Q3PR"JNAV-?\ /Y9XE_,'\O;[R)?N45[SR_?,5M+JF\;$?W,I'[8
MV/[0]ZYSE;56Y"G(GO2N_8' WZ-5F!9*JQ(6IKOVKA)J6C"2.5'0-&]"*;D$
M#/EO_P YC^1381:1K\%N?]'O9+2=@*42Y7G&3_LXJ?3D'_YP>_YR(G_YQ_\
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MA_\ .6GYER137?DBV_+C19S0WWG"[6S;B=S_ *#"+F\! I]J%03M7K3]&O\
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J1]5^IUWIZ7I^U:<<,LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9L__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>sny-20221231_g14.jpg
<TEXT>
begin 644 sny-20221231_g14.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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M<':2)E8=/'/2'D[_ )S-_P"<DO)0CCL_S-O]<M$I6W\P)%JH8#H#-=))./\
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M/TX_4XVN9+J">LK7+Q2ZBT7VI9_M16@ _9049OH&)>;+^3R]I;65E&)?,&N
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M%PK3N6F%" $HH1#MM4;GO\AGI6W$@C--F8DT]AO_  Q'5)RRSSH0?2B(!/\
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M8*!6@J<\>^=/SRT_6=(N+W0M>M= T6=!=:5KCA9&E:-O@N)S)58K5J$?%\;
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MIB9&)&F)'IB1IO7$6Q,^^&.@ZU=^7==T7S!8_P"]VA7]MJ%N:T_>VLJ2IO\
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MDE@" O)F)JS4SBTWY(?5[I[RSNY](OG4NMQ83-%*\I?=D=00*@$5(]CA??\
MY-?FU=3_ *5AU?3#=7BQVAGUN.2YN8[.($Q@R+P,DB\S\0"GZ,'Z7_SCGYLF
MFAFUW\PYKB2W^-8PKEE.U%8<@ >N_CVSL6F?E;IFC/'(][=W:.IEFN;^9IG8
MK0KZ:?945J-AOG2AY?L;F!(KBH'PU>@5OB!VV'?;)':6^G+I9$$"V9A(5$CH
M"0/A)^GPR1V+PPV3VU/WC[FFVPZ'MM\L0C9DN-B:H1QI0_KI@B^NN()#G8;C
M8[_AD%CF7U)7H:$_"IV^_ %W:J&GN"@ED*5-.A^0/2G;(G=Z7%?O)(0>;*"4
MD!K2H8"J]1MMCX[*QCLS!<QCT>(BI<1\U4$<058 \:4&1"\_)?\ +F_N4>_T
MT/&4+B.$\8.0  :3B0S4(Y"AJ2>N1>]_(3\O8+>:WCM6$'I",?6I97<3$5,O
M+FI)\*].F!=._*?R]IS*FG:1!86HB FDC7@+AB:C]V-@U*\B.HIG0FT VZ1S
M6*R2)% L92%N##B*&AH01X@C*A@M%ME:9+D31GD!(=Z^"]!B2RM()"QW*-\)
M-:;=#3VSQ?\ F6EE::MJ U%/5T:<AU?HT4C&AX,*4WP%Y>MTNA;1PR"X0#C'
M*7"R #=0ZD _1OG0;72KA@X^K(I)ZJ03]W?%=2LY?JHMS&"C BO[73/.OF&W
M>QG>V=B5-67?[()^U[4R%7>H7=A.MMR$]O*:LLHY!J_RG^W$[B[GLIHGMG$,
M=P.2,*E&\5=22#X>.5=1VUY&)DA,%TM?6A3>M/VHZ]1[=?GD)U"Q](F6%1+"
M^X9=BM>S#">E,:1C#B1Q(^(QN8D^'TY64?\ ,XQCU[8B>F)$XF3B+=_PQ%A^
M&)$>^)MMGZ'_ "CYID\S_P#/O6[UV*X8W%M^3FMZ>9ED)?UM(TN\L&;F-^7.
MU))ZU]\\L?\ /U'S"7U#\G/*L<E!;V^L:M<)79O6:T@@8BG;T90-^^?) 8H#
M^&* X\$8_P"67XY=,56NV/\ ]K'XH,>/GUQU/?'@;C%5&^_08;:1;->ZG9VZ
M$#U) 23L%4;DGV&>C_RZTV'4=<M$X\SJ<Q$,73]U "58^ Z9]&=/TST=.2JD
M*MO0"G;B*4^[.17=D'UV0N&]&%$Y4WZ 5'S)S@?G_19M5\ZW4\I3TA''%$&^
M*M*GC3#6/RPJP&XN)8+9E.TCM6@50H(4[[#M3!_DWR[9W>M6^H6Z->6,$B()
MIDX>M5OLH#3X:]3X Y[%\MS>J]S-"!Z(+JH78<8R5%/NKDG>0ET5%HH&U.['
M<G#JP]= D:W/&A^$<0=_#PPT:RNKF?E<W#,G,\33?Y*HK7[L*)]']22=1.W#
M8NS@LJ<V ^*E22?Y1OCUL7LVD+37=U;NG$QI9D!FK6O!"K4^D8YKG42DL=KY
M<N0C@G]_)'$DA:G8R<OG7; L6B^:9I%=WM=,MF7XHU99Y"VV]550./3KOAS%
MY?CB:.62:6ZN(Z'U)!7<FFP)*@?(5P8]ERY,@)=*@*S%?CWHVU0=C7M@ZUTP
MOZ?UAPO1R6-*#J0*^^*WIX2&.-@44_"*&J'PW\?#"EY*R@IX[U%0?Z8ZZE7T
M2Q5^)^&IITR)\_3E=4:I!%:FO\,-8HO5B;F S4V3K7^/WX!?2N#.U)&%3\2]
M*[=B?$8,72Q,J@2<793\2L!N3N#L13YUPMNO+NHVC$Z=';F9VV65W7X>YXT9
M/N &%DOEY7$BR_6;20@"0,#+ [ FI5J, #X5Z]L1?2+R-(UN+B.:&O",%0 >
MO<$'I@F"(VZ-")2EP4!=#4U%#OOLP]QOXC">["L.<BJ$8]1N*C;Z,B4\9BDE
MB&ROR.PH>G?/._F'R[:ZY9:E#=Q^I'*\AA:@8KXK0['Y9YZ@LM?L;^UM]/TP
MW5B)3&5]2C1,IZ@J2:'MOG?=#MYWEI.)(34*O,D]>N^'UY:SV:,"#+&C=3O6
MOCMG&?S!T!;F*6]LDK6,\P/M"F]#GG0R&='MKD$/"YX$]@.V*/QD672[@ "=
M0\#']F0#L?\ *'XX#F$C::S.[+/;E>+]"0.F_B,+9)C<QV\H)BN8E9&/0, =
M@V$5TJAR>'&OAV/A@!J=CMC#7$CB1_7C>N:ON=\K?IC"?IQ(D_[>)GQQK8BV
M)'?&,?IQ!CB)S[/?\XM>8)=8_P"?>GY[:9+.LG^%=(\\Z=#&!1HXIM':^ .Y
MK5[QR#0>';/.G_/R_6_TE_SD)IFF(_P>7?*.GVK(.@EFN+VZ8_,K.GW#/GKT
MQ0'?%0<>/#OC@<4!QPZ=*URQXX\';YXK7\<<*_=BH V[X\=.N.7%U\"<.-.Y
MV[/=J 64%$!Z%CMO\L]E_P#./>@O>Z[HMS*.4L<,CH6ZD=#] H,^DUUI:QZ7
M$L:<>$#<B.O0"AS@VH6!75I!"E1(K_.M0"<\\^=E>SUB[:$M Z2\GE&Q %-Z
MT.W;";1_,-U<?5(I+2.[G6XE69KB'C0 U5N2MQI3N<[?Y:ADUV]FEC5%L=&5
M?0])>/K2'9Y2.RC[*_?G<O+=O]5B,9'VU.Q&P7L!A_)&5>-:$5-3A_8"-"K&
MK<:=#1 >G;>ORWP^A^-F10S$?#QY$%N6X!H:_) ?<G!CS6T?$!5,MN:JHWCB
M;I6@XI44Z#[\ S3I*"TZM*Y:OK,@9M]N*FH"CPH,'Q7$<*#TX0LA7B&-)>5!
MO]I=L5CN2RJ%)84')B3V[[4Q4JTYH*N:_98#B2:CZ#[#!");6YC,[<E8%NOQ
M%O#KMBTDX-JK,4;U*J :5V/44_'(]/(0P!DJ2*R<NOMOXX6+1IE*MQ3E5B*B
M@[8(U1>5L/0 YT'("O;>M<AW-6(H/C%5:NW\,,K>21#$%WV'Q=_"HR0Q2Q %
M6"^D$1@6'1FK4'MN5_'%9H'"\K.58B6#;#9U[_>-L>=250(;R#U(C4#>K&N]
M*D=!C#=QORC4RQPM0<1(013KQ)VV^61^[D@256B^!U;;G5P&W'%U)Z?1A++P
MOC0+0H_(PJ:%&&_*$]_]7"S4U7TV8_"[@-R ^"4#O3L?'(?.0/7F8%?2A<DG
MJ.(-1G/-(TZ-[,B1?4@NJDU^T#ON,\P^9X[O2_.\EC>3"UC%PIM'C/'U0QV2
M56V)\&!SO.FV;I?6D?I<89X%=6WJ''B">^3.;299DG#1@$(&'@<Y!KNGH)+N
MS"%9WC)"'8-7N/U9Y+\S:6+6"ZNDVE63CTW%#WR(:A++-'SH!)$JLA'MO@N_
MVTZR5JA[N,NU?<5R,2MZ<8'7XZ_1@=F2XC:(_;-2A\".Q^CIA0PH2#VQ,_3C
M&[XDV,^>;IVI3&U&)L0<3/MC?U8TX@YZG]??$OF<3;\,1;$&/T9].?\ G"[7
M6G_YQ?\ ^<UO+3/1=-\GW^IQH3U-[HNK0R$#EV^IK7;N-SVX)_SG1J_Z9_YR
MF_-*57#0V$VFZ?$ 0>/U73;..05 '^[ QWZ=.V>2Q]^*K^.*?QR\<,4'<8J,
M<,44=<4'RQP'OB@.. QXQ90-LD^GV<TD,"*?3#S!:^)[@9]._P#G&3RN6$&H
MM!_=6ZP1.W@&H2/F:Y[EO;,-9RQJM."A/'>N^<-U/2"-?B 6D:1MU\.0KGE;
M\W%>QO+BYL_@F9:^HR@A0A8$T/4YYATOS]YCO=3MK&QU!+&TN@WK3K G.L?+
MU'?:E0 *>&>]_P#G&*;3O-6C^:;R(R7)L9UM TQJ\G%:L[-T)J>VW89Z O+%
M;2>(!#P(V/A7L< W)KQKLR=-Z5P79W=91!"P$T(Z#[**?VCV)/:OZL.(KDVR
M\82 [CB'<[_']JGN>[>&'=M9F1%#J7'0FE!7K2G7\,&O:K"$"R1LJL%/J#[Z
M<:_%7!D$,)YL:-T7H0M*]:]S7VQ*>,1,JQN#&VQ5!L:#L33QP%/=I;@+&:]?
MIKXD[_3A2+])Y&D=F(YLM*D@U%*$]#2F+QW,\T:HY$GIJ*,HXCVZ4!P#(9#0
MM\=222!O3\/#"]VD5FE64I&JAC38J2=Z>'3*N]0<V[L5WH:@'?Z*4KD>B:0R
ML684<?23U^_?#2(L%+G8;$4[?YTP5-?BC).Q12J\2A%.NQ.V_P!&#++4B.,*
M$,=]J$<5WI^ &'D:I-'V8#H>N_SP(UB9"">*%258\J4\.O?;"SZC,XE$D2^J
MCG[)ZK78^U>^1VYA,+%D'V"21WI7M\N^%MQ*D@55!Y#XJ]5#= WT]\(8;#](
MW%W92$K'+'(&/@*'IG,/+*WUUJMQHT$+O%92LK2,IH0#G'_SHM89O/5GI,,*
MEX($D,I )$@^("OT9V#3[:2?3]&NV4K/%&O)J['8#\<Z_;Z8E[91SQH _IUV
M]CN,X[Y]T)+6ZMM050%3=J[?#6M,\H_F7806&KQ1A4ET[6?B4TW#-N14?0<X
M7J5J;;5#;O&55J(BCH??$]>:,0V1)XF+D@'6@WR)78'HP+R%0"<+(WXR"I^
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M@0K=*#L?; LVJ2_'4T8[D@_C0;9$-5U69@Y>0"( D#Q/RZ9PO5-!N/-VHBW
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MMB+8D3X"N(-TW\,1)PTT.OUV8_\ :OU'_J#N, +BRGPZ8H#X;XX$X\'>F/\
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M?XP=E\1COLT'ADC@MFGGTZRB?B;CB\G;[1H/PKGM/\B((I;'S1=H>%O!$D4
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M;$FST=_SC-IOU_6_S>NJ5_0WY.^?;SK2G+1;BUZ=_P#>GID@_P"<WM+;1_\
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MG5UIRM(VIX'^S#*/\S9":3Z<1L*\37^F&D7YC:2X'JQ2Q'IN/]O#RU\V:)>
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M'\-_L[';Z<<L83G4BO+IX4P#=;4 .YWP7Y:G"W=Y 3LU' ^BF3%F]^F>W/\
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M'%9?B%.]</XW#(%!H"*G%@71.%1P<U/O3&&I% -R>V/C)X\"M3XY@" 1T./
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M0RLRZ!: W]XJ\3>ZC.?4O+HUWH\K-Q!)XIQ3HHSL.;-FS9LV;-GPM_Y^-?\
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M%)8B1)&11D/N#E@AB144(^G \B@U-:^'MB2[K4;$'OW^6+*.0VV)&^.XL3Q
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M[O\ +0R6<C?6KRZ@YJAW])&+$ =]C6GMGR4\Q7QU"\N1$Y,=K%&B$'J */\
M/<X'MP$B1:4*@5Q[*0 >I.!V;XOB)Z;4QZK3<[5Z=]\4]9+9&FDV0=^Y/8#)
M#H]BZTU.[4_6)5JBD5]-.P^9P??MZL1(?:I.^<+\\T:]L87W4PL?O;IGI_\
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MM>#HU>O7;^&=5TPO15=257<?JR2Q(C1ER:&I IL!7K7QQ<PAU<-MR%/AIO\
M3B\2K&H1E+BE:#^/TX ^JI#=S2I&")2-Z4H>_7!DP#-R"\0._51M3? T:NLO
M O\ "=R*[8N_Q,4!ZC8]MO; ZQD,04#@CMMN=LY1Y[18]0M. H'C-?&M<C-@
MU"034UKXX?*:@DUK\LO<UJU6IWQP*TI2G@:XL!LM10G?YG/:7_.(O_.('FK_
M )R1\QQ:GJ<5UY>_*C1I@-7USAQ:[9#5K'3BZE7E/[;[K$#R:K%$?])'E#RA
MY:\@^6=%\G>3](M]!\M>7[9;6PL;84CBC!).Y)+,S$LS,2S,2S$L2<DF;-FS
M9LV;-FS9LV;-FS9LV%.O:#HOFC1M3\N^8M+MM;T+6;=[2^L+R-98+B&04=)$
M8$$$9^?[_G+_ /YP%US\H=0O//\ ^5\-QKWY33RF:\MOBEO?+_)F8K+U:2U4
M4"S&I7I)_.W@>^N&?4YK*/\ NK%!;1@="P4 L?OPT_2<2>4]3:<L8I-2AMF9
M/MQT!*LOR(STY^7]T^OQ>7[XRK->Z);D+*#N4G5HF.^]*E21VKGL7\I=':/S
MK<WTR,SZ1;2$D_9Y.VU,ZAY\O5N=6\OS./4-O-)''QZ*S)\7TYXZ_P"<E];>
M[\AF*"^'UB&Z"+&I^($ %?ENISYM"*.ZL7UJ-0BW1$$T0Z+<$@F@\&%3\ZYA
MR4 E>VV4S<@">@P(22S$':O?!T2UX@G;KRQ]G$-6OHW!'U"U;X!_.X_:^5<F
M9:3B%4T4;-X$867C%HG4;J@W.<0\Z?\ '4LP.GU>IK[MGU#_ .?=,$.M?DI_
MSG'Y5*>I-?\ D)YHX^I);3M4C%!_K*N>>?*D\OG;_G"#7-.,(N+O\FO.5CJT
M4M?CBLM2!@E '\O^D[_+/+A#OVIQW^G,2R\7&W':G3[\OD>3 DG;VRBJD$_L
MJ>O\<Q*J_6M0,;*A##DY^(;4Z5]\T+4;TRIW!()]LW$5 W:1P:GPS,&"*IK2
MN*A8R" "-MCF:XD:%+0D\$)*KTI7KB2(0:5H%&WSQS@K4"K"0?37,J-&BDQE
M2Q(%>FW7?"J\KS0J:L3M3/H)^2<;>5O^<!_^<OO-3'TYOS!U[0?)D$PV/I6Z
M1S3JI\.-X]<^:5Z07MTVKQ'(>%!BL"*5-1LW?)IY*<?6]0B!^U;@CMNK?VYU
M?37(*DL!Q&X[TZY( _)0X9EH0I!&VYZX/$BA3(5+\" .A[==LMYC)]CJK4/;
M?N33'1EI 0[\N9#&O8'KC@OPNK?#&G:M>7RP.ZH5HI/+E\1ZFGAC_44Q JH:
M2E0>YIMC8!(2\CH0"H/<&OOG)_/_ /QTK(&@ A)_$[9$K(DL13IWZ9)8C\/C
MF)--QL3CD%*UWIO\O;/H%_SA[_SA)YC_ .<@K^W\Y><XKORO^4-E*0UVH]*[
MUF1.L&G\T(],':28@@;JG)^7#]$GECRQY?\ )GE_2/*OE72;;0O+NA6R6EA8
M6B<(H8DZ #<DDU)))+$DDDDG#W-FS9LV;-FS9LV;-FS9LV;-FQKHDB/'(@DC
MD!5E85# [$$'J#GR%_YRM_Y]Z6\CZ_\ F?\ D#IE-0E22ZU#R3$ L<LAJSRZ
M5N I[_5SL?\ =1'PQGXZ6]I.NEWWES5M/ET[5);JXADCG1HIHKB -5)(W (9
M7V((J.F=?_(^X:#6M"L5NB\DJ%&C((/%F *D;^)SZD_E[';V-EKFNL2&OY3%
MQ]H:@TKXD4R#:_KD]QJ?EB$,8[B_OKN58CUX@K&=O #OGB'\X6N#?^;@\U+>
MV\Q65O&93\*0Q1<&/WL:YXLN=6MK"+S!H@_=C3[ZJR']J1)2M0/"A.,MM72<
M)SX[[<@<'-(#N&KRS#<@#?YXR437$RV$%:D5F8?LH>U?')?:K%:0)#&H"Q@"
MO88(-P9&X;@D'?QQ"Z;]P]&W&U>E<XCYS9&U>T!%&] #;YG/J-_SZ8F74/S$
M_/3R6[?\I;^7Q6-2?M-'<-"1]USGG+_G$BT;5[;\_?RAO9FC?S1Y%OUAB KS
MO]+#\:+X\T&>7XY7%LC2*.3*&;V)&X^C%5'J, U>E:'*DC3DQ!V&P\<KT^0(
M.PZBG?*(I6OPT%,57E_OM5'?EUK[8D7)%&JE"?B'AE<N)3CO7IERDL(30K0_
M><44(:#C\0/CES*A <'BW*E/';QQC;4 '0>.65*\:L :U_LS.6<)S) 4DJ.H
M%<*;L?O8Z-N#OX9ZW\S_ )F^6=+_ .<#_('Y2Z1J\5QYM\R_F7JGF37K.(?O
M+>VA66"V,A\''"F>&+D^M>UK0)3I@TD  +MMODE\J.!J7 'B&@<&G4]#G7-/
M/P'8['B 1L!AU'*Q/$?9J237I7#"-EVK1 IJ5&X^_'I,%^%>/$$D=R03WS22
M\C5!Q*"A[5^1RA<1?&.1)/3>M/EBX96C=@>9.^QI4C\<1#\9%DX<HQ2IJ1TZ
M_1@V%31U)K&6^$?KSC?G\@ZM :@J(-O85.V1C3ZLU?$BAR2QT"^_C3+X,S45
MB6K0 #K7IGUM_P"<//\ GW9J/FQM*_,O\_=-GTCRN"MQI?E&8-#>:B!0I+J
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M= "@*H  % !T R\V;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;/(7YT_\
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M(_*[_G!;\_/S)-O=W7EP?E[Y?G*N;_S/6VF*]^%DH:Y)(Z<D13_-GTJ_*?\
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M^>_*AE'F7R7KOEY8S5_TEIMU:!=@=S-$E-CD08'BP.RMVKB;"@4 GC04VQ1
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;9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>sny-20221231_g15.jpg
<TEXT>
begin 644 sny-20221231_g15.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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M:6Z<2D#90-N7A2HJ/<Y"->UO3]-7U+_47DN_5$4D-FQ2-(_AYB:12H'6@Y,
M.O&E3D'N=6EU8236EM&MM&Y6-_4,5K&U0%*VZ2+/<L2#]EHU[BO7'I#:>I'<
MG76T5+I&]8VX^HQ^H.+*YG0.I;DPJA+5Z$D_"9>MUJ.FH%&H2:@8J<XV>)HS
MRWC_ 'Q1E*$="># T#!@&H91:]8I.YNY/0NYI$C$LOI1,LB. 8WHP"]ZAOA(
MW!.36WD1Z&)E:-E+#@05V-*J02*&OWC!70^%,V]2.O?IXYJD'IMEBI]SCX;B
M>"0/#*]O*O1D8J?H((R367G/S)94":F\Z#]F<"6OTN"WXY+;'\T+E:+J.F)*
M.[V[%#\^+\OUC)II_GORY?\ %3=FQD;]FZ7A_P ."R?CDLBFBGC66"5)HFW5
MT8,I^1%1BF;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV1
MC5O.&@:/R2XO5GN%V]"WI))7P-#1?I(SFNJ?F?J,_*/2;2.Q3M))^]D^8!'$
M?2#D OM5U+4WYZA?371!J!(Y*K\EZ#Z!@#I7?&.K&C*0KCI7<;]C[9HW!J""
MK+]I3O3Z>X/8YB57<FA;[_H'?*YR'H@0>+[?<!_9C69%KSN#\EVVKV J?QP/
M/=1PJ[*CDHI8L[%: ?M&IK3Z!B(G4E?2?ZRSD %OWH-:FH*KX#MD9U;58@T5
ME:Q_HZ2$37=U<$((C%%'([(&DX!R[4)!*D@=\BWEQ42))+6&,3ZI$DM[]>D=
M;VXN9*F25D/'^\ZKR #4*JG; D'F6U\N:P;">X5]%U&1C#*I)BAD7TP(D=&=
M0J_9H2*52G$\ADSO]?2^BMH(XF%(N3+-Q0>KZ3&KD$J&4?$%)\'I3CD#\U^8
M[Z%!:?I"4:A#%,(+>$*TL[1 I\"$ %F )!:E*<FX**F!W?Z%@,%Q#!^E;R%I
M5,J%I(48QO)<%'8%B5)X/<2<>3?!& HXX.UKSG9^4+))-:LM-BUI+0"WL)F/
MJ1HX*J#;P1B0.]1]MP%!JX Z\DNOSNUV%[YHQ;KIMT%ADC4/QX@!2L4;-"&%
M*%MN.U1L>.&/D+S<FM7MW86<!N+B\'JO;W]].(RL );UHDA=0-P00./4;UKG
M5],U&'4+@VWU4:M'IU(/1L&YJ*U(^$5E"4 4T9]U/V1MAWI.LV6B2/J-@CBR
M^MF%C<?!#&O$*8:PJVQ>O$\:@TKMG5--\WZ'J$<3#4;>S=UJ8KF:-6K0$[<J
M@#Q-,E$,\$_/T)XYBGVA&ZOQKXT)IBU-]\OZ,:QZD[D;X[-UK7-UP7:7][I\
MGJV-W+:R=S$Y2OL:$5R<Z9^9&LVO%+^*+4HQW(]*6G^LHI]ZYT/3//?E_4>*
M/<'3YVVX7-%%?9P2OWD9,5974.C!E85!!J"#W!R\V;-FS9LV;-FS9LV;-FS9
MLV;-FS9LV;-FS9LV;-FS9LIF55+,0JJ*DG8 #N<@.M_F)HNF%X;(G5;I:BD1
M B4^\F]?]B#G)M8\YZ]K)=9;OZK:-_NBVJB4_P HUY'Z3D6[UZ>&;PKVR^OT
MY?T=/IS$[=: >-*# +W$4YXPRCDFXD0<MN]*5%#[]>V6MS!'432+ X^URY*"
M!WY,!48!.J27 )TFR^LQU"K=3,8X'8U_NJ!GDZ=0 O\ E8[_ $N) ][<.DK5
M9_JR< Q\  [R%16@I^O"/4+Z#U8X?JNH."2YFB$LE&4!E0HS!B& /;;YTR%Z
MSYL\LZ>7MAK5]IMS;Q,P62%+OB2#NRF"2E/ \#N,\Z^9/SGBEM3HUCJVFMIF
MHLL5[]<F2UG> 4"1M;N[5Y[L>(I4GE\-%PFE\ZIJ:/IMC8I%##+&UYJ=S)'=
M/0H"_&:*-)I(Y*"H)"I_E'<'3R03>6%_W,,Z12CT)1"D#QRR']X)J*LBCC(5
M'(LBD? PI3)9H7F__1+>PU!"-*@@DN2X0@S,RL3;,_PJI@*!PS&AW^+B ,C=
MYYKGN]7:TO+!C=^;%CLK=A*.<=J6 DMTHK-&TC(>;#?B>.^1N[\UW%O)<6.A
MS1P7$+QRW^I3N$ALV$G-8(DKP6DOQ!0';H*M3CA5:V%FMT\DD3ZC/J(=O6NV
M+/)R)*N4:IDD+ ^FK CD5)6OPXR[U&+ZJ8HX-+MH[<1Q*]SQ9W=9&D5GNE 8
MK0M14<!0.I[<Z\Q7AT/S/I.LZ?YJM9;BP$49&CQ2%#$R\)']22D3\E?<\?BZ
MC??.BO\ FA<%;>:.Z-U#;VZ0R0SSQLS1J[\1S9P2H)-!VKUKU.+7S[J336WI
MJEE9R0@0.]U];V I&D<TDD3( ?%Q3VZ9USR;YFTO5IUL==GBTS59XD>'Z[;H
M;>ZXJJ-Z;)(L32=?M?$:5#_LYV1[&#3Z3RM#,MN OUD1K')%05)]1 13:O$E
M#X$Y*=+U*>2UBN!&UW;L:!XB"W'8<NM&4GOU]_$\74+8T5Y1"Y-%$@9.1'9>
M0%3[8)Y2L"P01K38MN2/&@V_'''U0>H(^7]N* UVZ$=>X]B,Q.^VXI7YY?T9
M7X'QR_#OAOI>OZMH[ V%])"E:F(GE&?&J-4?3G3M'_,NVEXQ:U:FU?IZ\ +1
M_-D-6'T5SI-G>VFH0K<65S'=0M^W&P85\#3H?;!6;-FS9LV;-FS9LV;-FS9L
MV;-FS9LV;-FS9LV;-FR$>8//FCZ+ZD$+?I*_7;TH2."'_BQ]P/D*G.*ZWYLU
MG7687ER8[;JMM#5(AX5%26/N:Y'1T/\ #+V'4;Y8WI[]<NM*GQS?0?\ ;Q%I
M_B*1T=J^.P(Z].OT?A@)SZTGH\3,8_[RM&H=_AX \1[U-<J2\%O%+5Q^X3FR
M(0>" =6;X57IW;(A=WT]V6?4)A;VT0+K"&<  TX-)(:@?ZO>N^W0+-J=WRJ8
M:W?$CG:3CTU%*@$S$(6(W*J&/@",C^K^<+318VN-3U"RTZ!QR2X<R2RR _S1
MR_5Y%&_9*> Z9Y3_ ##_ #VN=74Z-Y/OOJ$,="U]!+% 9V!XREI'8.%*D@4)
MY?ZI%>-7EQI-Q8.][)?:UJ5\QE:;US-;F4DL4%LL:1GBAVYE@3T VR,:EIME
M'/:O;:6DNGM(%:!1$CE$#"M16I8UJI.Y/3N366+1;F>-_P!):SH5X4:X6:\G
M9[=&/-W6)X(Q1J4!JJCN""*88Z1YKU'3YUBOZ6MQIUO)%#<JR?""  ?@9E=9
M%#%@00PY49>@FL7GPQ6\=A)ZTR23(\<7"LU8D1 50R,I20+&6K0$A?<L)N7U
M35)S>75S)=W%P1'!#;N'DE4$U03<>*(&Y<FW6O7D:( PUUX(5TU7M[V^E96M
M[&T0O9V<E&'JC?\ >RA33DW+<[<J5 6_GO;BS6D:SW$3<G8\G/P JP:6C)&%
M'9=Z=%&V0RXN9)(9WCO([G5:JA6QFDBM[<K0@@)"68@T(!"C;(Q?WPFBN5N3
M9VO"4LTOH7$DQ%/3IZLBNNS FNQ)[4PITV[T_3YP]YZ3Q2,SVX+-OR!J6C+!
M0-SQ %*UP\,FA7;_ +B_NM)D1V$<5S(S@2J11F)1UX<:[<5^_+37M:\N*\*W
MC7164M#+ILQ16<+\+R12EK>4T.Q*!O?.]^1O^<E/,%I);1ZBL>L:3'2.18F6
MUU"V"J.;^C=?NID&]5J6'95&>NM"_,72=6TFVUOR\YU"WN'$4UI$R[RD EHP
MW[R*05_>1N*,/B5FXUSJVG7,.HV\-XCQ7!F0?&A/'D  556%8W7HRL 3WVPQ
M40%7"TBE39A$]!OT/&M-_E@E6EW5)%F8;\7^!Z>/?&B?C*%DB>$FN]"R&O@R
MU[CO3!*NK?9<-MV/3[L>=AUIF'7PKE&IZ=,QVKMOWRZ[?/!ECJ-_IDWUC3[J
M2UE'5D- ?9@=B/8C.J:'^92.4@UV 1D[?68 2OS>/<CYC[LZC;75M>0I<6DZ
M7,$FZO&P93](Q?-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV%.KZYINAVQN=
M1N1"IKP0;R2$=D7J?U>.<+\Q^?\ 5-9,EM9,VF:>:C@A_>R#_+<= 1V'XY 0
M?^&[^V.!V&.!![;G+!^?SR_IZXTERQ5:"GVBWX4 P.6DE<(LG%"#5N)^(=.O
M+I_GTP,]RD8]+D($8\5D'[9%*A:5/P@C8#?M@07+3$V=C">,9(E:M A[AFZ5
M\17Y[](GJ&J+</<""59-/TL<I92H^KO.?L**]>/4?"2S4-=A7BWG;\W?+?DQ
M9DNM0:[OT#%AM+/]8=J,QABVB0?L\B'VW49P75OS8_,/SC:7<GEB&^TC2+)?
MK$UX1Z2N@'(\9I9$;<T)%":GQSB.IS:C?7L$FM:Q.9Y2',LTKR12&A!XR_&>
M6^WPTJ?M$[9')-7\JV:N]_>227)!2<M&AD4H3MZJR*^QV-17;"Z/7?**WK75
MC>2W%NQY2"TBJP6/E(:A@33]W6M*Y)+?7-26%[[2[K]+VD8!5)&HXCD%.+HR
MT4C8%6--Z]:83:CYQG:XE?3[N71=71C*;6X1C)"Z,W*((:\P2M5(XF@'PGKD
M7O\ S>UK<60O1;R:AJ=NTEV(/AMZ3!%4<#0(S1E6W&U3TPWT/S0EJ)YY)E]2
M=C#%P)+/R!8H$J*Q]2VX'N!R.2.7\Q);:U>VLO7$=T5$]QZHHZBI]./B0SAD
M6@I]H5X#C3"5/-]_+.MHUS%H-HR)'6:,/.X_9:."/[+4-!R)(&Y45R=3^;O+
M5M;M!?SZI=/;0DK'/-#8(P%1M"B32]NFW:N [7SQIZVJQV7DR\G5HSQN7LY)
MEW%>/.6[@C-1W"_?D.UKSFUP]$\H7TGHE@S4MW8 U)90DKL!L.M<BCZS=WT@
M#>5[IT50Z2!8A/1MQ4QM&S#>M*_AEVT%O<BW<7$FGR-T:]!50WV23*0RD5Z5
M^6/DL]4T].4-Q%)9.0PBCF0HU6XDB*?DAWVV9?EWP4+XQK*;UK>\6-P6;DL?
M$'N02>._0[?,'?)WY6\R:OY=NWN])O[VPM98T6>[L96=HV-.(NTE1D=*TIMM
M_-O4^[/RM_.>V\RQ6.D:S?P6][-&%&I4H9I(ZCB_(%8R2*AB">NU :>HK+46
M5J<VN8(T%7%"X H6+<=F%"&!7P/7).PCF0%N+H:,K#:G?D#V^_$;9G<RESR(
MH$)V+1G<,?GO@ED1B.2!CXD5/WY00"@!84[5J/QKC@2-B-^WOCLKJ-LW7-VR
MJX:Z5K6I:--ZVG7+1$_;3K&].S*=CG9O+WG[3M5X6VH<=-OVV'(_N9#_ )+'
MH?8_><G^;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FSG'FK\P;/2/5LM+X7VI+4
M,U:PPGOR(^TP\!]/AG"+[4+W4[I[R_N&NKB7J[GIX #H!X "F P37898J.HV
MQX ^G+IURQ7Z,8P6G,LR!14T8@ ?+"J>5928X_4"K]J3FRUK^R"*?3O]&^ Y
M'?TY'_3EO;6\56DHL<I# ;+R+"@'AWZ9S[4/.&E64D,NJZS:V40DEC%U Y:>
M5.#>IZ2AVD4%FXU5=Z?"0H)//_,GYQ>5K>RD6XOXX/+UDE(](T^5HIKN@!+W
MDXHJ)4T]-')9OM,Q/ ^/?.'Y[^;?,37-GH]Q-H4"U>TM+!@ BA*O&DC+SC)7
M8."7:E"W0#A7Z:U%I4O!HL%&)8->-*8G)%>;1H#ZC4.W,T^C#NYUNZUE;9=1
MU2[O'A546.$VL86AH@1'N@H:@VY$,/#!OZ$TB9KNV%MJ,K6_!F]5$N&#/4NI
M"&1EI3<*=Z-OD=U*72D=;.XN[::]C8".6>!P[H@IZ3J))"6H* T^S\)J>)"V
M@Z3HFJ2ZC-8Z@PO;>.0M9"=GXAB4#+Q;]X@_F(^S]HY'O,-W?^5GC>*2,Q3%
MDMYR$,$NZJ/4=3)4U(-'5&["N</G_,E-3O9KMH"7@G-M8.[O*DW)ZIZ35;@T
M:!GH"%KVK]I'3=6N=4N[V0JUS>:HS73(K^I,D0+<$8@B->0WD=FI2FP-232W
MUW2-/A>)[Z>[U"2/U)X;41R2D&G[L%ZHJ"G1>7(@%B:?"//YBV]CZ]O;VL*)
M#&?3I.;BXD+T8_6;@\RS4.Z*OML!@(?F3K\8*Z5I*VJE2HE:VALT?]LEC(C2
M-M_,_7H!TP/)YO\ .+3L\GF0Z&[_ !M%;L(2>0-*\*$^%2WRQ%-1U"[!EO=<
M36_3^*1;F>S+!B>('*59'%1X'I7&W#+* (]!-E*22+JQE_2""G6MK(0Z#WC)
M_P!1L*(M;O;261%U2]M)(V(0QVR1"AY"A^KR6[#K2A4-OTP\M==GN)3##KMY
M+& O*/UIB\3"M*J9XFJ-]@!]&2RQUKS#'&\FGZS=R6X8QE5DDG6M:'U8;@@C
MEU^WOXUPSL_-SS PZC80&YC^&.>+A!)S X\GCE Y"G7TY ?=LEECJ:2/SMW7
MTUXO(D:/$T.]=TX@C[76A![MAKHOFBYT._:2UB?2YY&Y-(O":WD"E6#%&V3P
M&_$]!6N>[?RV_/?2T;2C-.+1K0BSO+2XYLK0BH$B2@D!HR[*0]":C<[9[*T7
M7M*U1#]3O(9M,+?"4D5DY/5E7F"11@/L]>0.V^2B-F:1GXD!UV+;;5VV._OC
MI.2J65V+= *BA8F@VI[XL2-^GM3,>H\/',?'O7+KV(]LKP[]LWT=<;TICCWS
M;9.?+?GJ_P!&,=K>EK_3AMQ8_O(A_P 5L>H'\I^BF=PTW5+'5[9;NPN%GB;8
MTV93_*R]0<,,V;-FS9LV;-FS9LV;-FS9LV;-FS8E--%;Q23SR+##"I=W<@*J
MC<DDYPOS=^8<U^9=.T)VM[$$K)<CX9)O$+W53]Y]NF<L!I4^&6HW^>6!]'3'
M=JCZ>^V7W\-\<*;XUW5 6=@B@;D]L W-[Z<#3AA!$%)$DH%2>Q"FFU3N6R*3
MWHXW3TFGB0C_ $FY)",K*/L1CTP17D:F@]\Y%YR\WZ#IT4T>IRQ6]K9H&=#*
M(IYMZ_OHX^'!#4'C6I[G/*'G;\[_ %3-;>6[GZLWU1U]?TD5W'A;CTR8UH "
M*U.Y)WSR[JOFN.ZN#/JFJ7%T9=Y):E1TJ5 <T)H3N1]&%#>8-(E%O]5DFEMK
M202@R3\F1SQY.45/AH%&WMOM@J^FM9KB.XLY;ZWGNX1/'&T:2VTM6K(!(QY@
M*5;H&[;9?UUS2ZO9+6WM V[^@D<G\HD;TB:[5H>-#V.22Z\WZ4472X;GE/Q%
MQ(\+*XC(0DDH3(105)H=J[5!SFWFC6Q=K))=:I'?"\6HCEG!M[@+Q6J+-%&8
MI"10T)4]**=SSQ?/5Q9RK/9W;:)K]K?V_P"\X!N3J[*A<M'T8-P;D&5CQY#>
MH6?\RKB];4;#6]-1--E>YB$TJD-Z9^".VF+<_C4E624?%P/%V;B./%H;2XU#
M5'LM(D=;2.1C)7CQXQ*5I,5^$M4U##8D[;FF3*622W06FG0-'$["6::4")9I
MJ$5*O\1" 404^@;X#BT>>Z7T9;EHR[?&D(G>5RYH59DM7%33?8^&U,E-EY0A
M1[6Y: B*>18[47L<D<*H*UJ.,9 Y@FI"@]^N32#3;B*06=EJ_DZU#QF5I%?U
M'=U+ *2B,P8UZ?$/$C;#&QLKF)T_25Y;:A+''ZGJZ;:W,3< >C-*!&=S2HJ.
MF#1=: )#!=)/R<,1;7MO;6\AY+1")6I\-3XCZ,=ITFANB"71M4TOZJ0HG56U
M.(AOA#"*!>8%>FS#Q[8,_1>IZG)72]1T;SQ;6W(26L;^C>0K'Q! C<K)'L1U
M0"N ;SR;8:\YC^KIIVJ*3Z5CJ%;9V'_%-R!PD \"2>AID&N;K5O*TD>G:II:
M6'%Z^J(VE>(QC?U%D+O2AKSB>A^CCDHTZ71=;CCBU-E:&5J07#%I(G^$J2ER
M*RH0".SD> Q:\\L7^AK]8T/4)-0L7HPMKR3A."WV0DBJ8)=NX*FNS#I49I_F
M87(;3M2@GM;Z"19'0.8+J,[?$Q*BI((W/4;-3KG2+#5%BE2"-7$KDBVNX:4D
M#;CUU4<@2 15:,*?[L6M?<?Y)>=-)\VP_H_S.&A\R6BK;_6D;T[D!"K0W,4J
MA26JJED<L#\OL^T]%U:7A';ZC+6[+^DW)@:\3P$BFM>)/B=J[Y)A\9#G9%W7
MW/C\O#[_  Q:@^DG-4#VI]V,YI0D,"*^-?U9:NC$T8&A[$8ZA'S^>:@R_E44
MROD,Q]QE'Q[UPRTO5[_1KD75A.89!3DO5'7NKKW&=[\M>;K'S!&(C2UU)!\=
MNQ^U3JT9[CVZC\<EN;-FS9LV;-FS9LV;-FS9LV;-FP'?W]GIEK->WTZV]M *
ML['\ .Y/8#/.GFSSE>>8Y##'SM-)C:J0 [O3]J6AH3X#H/QR%"E!X#PQWZ_U
MY?T=\P'O3+\*;'+'CX91>C<$ +@5->@![G"R]N[:SA^MW;<D#*L2TY-)(Q 4
M*@ZDL0 /I/B()KNJ)#$UYJCQ3W$<T?IVW-/1M2""#([_  LX&^P-#NH.S'SE
M^9?GF=KB6VNM9*Q749#6T)DB!C#? TTYY. 34@J.9IT'3/%OFSSC ]+N1T6&
M,LT<2'DO%=HV9FJS,U*T)\#04"G@.N>;Y[R<H]S<%9B[+%9\@%[T=V7D^Y\*
M5&V1PWMZG^DM-';QRHO+](EHT+ ].;QH*^&^"?4OH@MV=$TV>+U!6XA?T)02
MPW5X6CC;;_:R4'6_+%YH<\-I<7=K!87:\D<>L+>6Z5@W()'#*@YQ"AX$&N^Y
MK@>>[NHM/N)YXXO,NFPTB&H6_+DN]#&X)K3O1PK?ZV0O5=:@TF:&QNREUI]_
M$9K<#X?39@XC,;L20=J'??<5.<;U_6)@ ;:\BD2:+U7C9&0<'8\]HU8%13<4
M_KD>3S$/JZR6,]Q/JZ,JQLZDQ$$%0".LD@!(%0 =NNR@WTYFU(MI_-Q'"R2#
M@YXP3(#4%P34+4J#O\)(-32DP%+:$Z=:61TJV;TRRNWHM*4/7A&3*1W J*4\
M<%PQ0I&RPR6K3[%G$9'([T"\U)-/\KZ<DNE65[-%Q1)+D14'"*Z2)6'<E8HA
M5A3?OD@AT_58PC'2[5!(_+U&EGCD85858\5!'05PZ&AWQGCC,,OJ2(%4I>Q2
M&CDA6 F2/\:;8-M-)\P6;U@%P#&6C8O:(K[5J!+ Y#*:'HV_7)5IUYID#F#6
M(KFSDD%86GY( 2..QECXT!Z;_P"R&3FY\NV-] \B65CJ G5#RE@C4NRJ")DF
M *!@P(++0TZU.0?4_*-F+A1JVG7$.J024]&25[:22(DD&WN93.'+=1QG4FNR
MT-,;I]M?65X=-LM:=FF+-!I/FI3;M,0A"+;W48EBY[T5C0']J)J\LZ+8C3=5
MNAY?U32KK3-;MZUT_48T:X"@@,UE(@9+A!PV]*0LH_W6N^1?S!^6.KZ?"VK:
M*LD+"W,LL;>A+:7*1!J)(%0K)Q IR4%EJ>0ZL"GROJNGZA=G3EEN?*>N!C#-
MI]ZG*U>6FRQ.I- U>C5Y B@IBWF#RQ9E([B72+NUU.T?E+<0?Z5#QJ02\/'U
M$ !K^[8@4IQW)$+G%YI<T$J6[QV+N(8YD;U(91U/!Y ?3<TKZ;G_ %A^UG7O
M(?F1X[A)EO(F7BRS"0$ @-18Y58%Q1Q3DO(HU#4_M?1W\H_S$@\Y6<FA:KZT
MU[!P$B.0;Q9$=5,H*U#%006X_:W8<A49Z>TF\:ZL;9WD6:0Q@F6/[$P!X^JF
MYV:E?;# N>7!1R<=:]%!Z5^?AEA!L9#ZC#^;^ Z#'UVZ?+&FC4J.A^D?+,#Q
M(4FM?LGQ]C[X[KN.A%,U1]_^>V84[Y7@.IR_"NV5CXI)()$EAD:*6,AD=#1E
M8=""-\[;Y2\\QZCZ>FZNZQ7YHL4YHJ3> /0!OP.=*S9LV;-FS9LV;-FS9LV;
M-FS87ZIJEEH]E-?W\PAMX1\V9CT51W)[#/-?F?S3>^9KH/,/1L82?J]NO1:]
MV\6([_=D9/X9MOOQV_4?+*![4VR_>F;?Y;XUGX1LU*GLOB3L!@>XE2VB^,EF
ME-2J_;D)H"!4]^G@!UR"O(VIZG<:M?S*=,TN)1911-Q3FRN99 Y(!4(0"YHH
MWZG8<=\U^8V$5A]7CC>]O(Y[B)$0M!90T+>NJ<06D",#5J!2PV#'/ /YA^<=
M*N)-36)WN2\#-+<--5)>-6XE_P!A2*#:GP@A?M#/'WF3SI=:U<1QQ3 PP+Z<
M7&((D<:B@XJ!L -A7\<BEY<748A<W$C QAN):A)8EJDDBFQV WQ]KYAU0F6Q
M6_\ JXV*Q7$A<MR^R#&"Q'7]HC:N*VNLZ@LAGEMM-LI)$*L+>5+*20+]KF#^
MZ;Y$'YY+H(KAQ>W4VGFR:XL3/'=O$ZQ-)#(A*DK78A6Z5&_3(;?:MK7E>Y34
M+=)XK:X# &!B;=HP02JR\F5J;5!Z]#A1K6MZ=KFF1?4WELYDDEFM[4T:,NWI
M^LL!()*$@%T8544([YQ^]FNHV4/,EH;<_NXY).3QD$[*!R--^AP79V]&BU&
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MV-:6\SG>91^RQ_F ^_Y]>G9LV;-FS9LV;-FS9LV<*_,?S=]:ED\OZ?+_ *+
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MZ?$3T&$UOY>U>^)DL_+EU:Q%>37S1M9QNH!-1),ZJ 3O0=<,;3R]:V;!7UF
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MEVBLQ2-45$0N>7II!'Z8+$CJ7;KX;8FOG[RIY>*V<$,\]Q"6*A(@TI<4Y/&
MJ(*5/Q-7VPKN//47F"0\[&ZU"I(1+JXF!"C>E0I4[#L=NPQ,6GDR\$RZIY52
M%9F Y_79GF5@*J"AC5B#VP$WD[0WBIINESJA%2C-<PG?[/)IN:4^5,$PZ#]3
MEC=1/I$84?\ 'S$ [4IN&J2#[4&*PZ%I<\I9-6BBO.8XJ'6O*O7DA"UIX@?/
M)EI]C:W/IV+ZM:O=D<DMYHN$XD!8DJ'*AB1O53X5KAY!HMCIKR&ZMKK47ACK
M(&(MZ!]BXY<G/P[^_3M0I0V'Z062:S]/30.58XH^8EYFE0-@-A4U"?ZR]Y/H
MVNZMY>N7M;ZRFU&RTW@L\$E&:-6!H562,-Z;=BK*1_E9VC2M7T/S':VZP:E=
M_60RM;V+N6FAY$<WLYF(E %:!27K^R <.KV*SO;DQ7P:]E<\8[R- +LE&*\)
M.;)R<=XWZ@U0UVP+:^K"#/87$7FC3)>=O-9Q.?4B5BP;ZN\I&X&YM9J$]BVV
M<_U+08.)N[-?J]K$5^JNG)?B;:BGA5&4@J490:\M^Q(=!UZSTF[-E,S6TUD2
MD,L0J 2S!J0T*LCAB&CVKU0T^ ];DBM[J"TO&BD'UGB\4UN%>1E(/)4=B4=N
M*AU4FK+7[+JXPH47UG]<-G<VMQ! _K-:_P!V6A('[R%6K2(G<C?@3T7< HU2
MZEN9KF\M*VZW 1+RPF<2+*".+2-PJ6H=^0W[2%MGR+R65E/;2!+Z6325'HS@
M(&O-/>I]-Q$W!Y;8K4AA]GZ"<A6NZ8\<=MIFO0QW-E<!OJ%];5>*> '^^MV%
M2#7[2=0>PKRR(0VVI^6YTDAD2723*7MKN  QI( 6X34^(%XP2I.QI\-#MGL_
M\F?S'TZVDF_3<4EWH&O216VL1,W/ZM.QI',M.J35)K^S(*]&SVI8?6M"N=/@
MM]1-S97EK"T&H6S!FFLR&2-YHP0LB $AE8 C8J13BO5],O)J I=?5_J9_=R%
M>7IL*BJM53Z3K12"/A;J*5 Z78WK7409E2:8 55?@#=]E-:?(G!JW,7V'!AD
MH2(Y!Q) Z\=R&^@G%%JJ*.I4 '%*U[UVR_\ ,97?KF\.^77H.GMFKM[9?XY7
MX"F:N^Y(IUP=IFHW6DWT%_9R<9H&KOT8=U;V.>E]'U:UUK3X-0M#\$HHR'[2
M./M(WN,-,V;-FS9LV;-FPMU?5+;1M.NM2NVI%;(6XUH7;HJ#W)VSREJNIW6L
M7]SJ-X_.:Y;D0.BJ-E5?8 4&%XH2#X9=-MMO?W^_+IWS4[5R_#ICATK[9N5
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M>S,O_&K9?*4T'HA34?M@CK\OX8!E:5I XF].!%*N8ANU2-D8UWKW ^6?-?\
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MGNHQBQ+7-C.4CN4=Y4H7:%TKR60"G-"-U<?$!L<!Z3*3+'+!*#)*:26A/)9
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M6A[$].^037?)&GZM$5EB#.@^'DQ!!Z$D]#UW.>8/S!_*&"[BG/HJ JFHVK0
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M2V9BNHWGL;J9!=QD?%"3O51[CPZCI_+CK9W\J7_IPRR7'EN9P[ 4D-J9""K
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M*47+,+Q8SQ4). 2R@; /\+#^5B/YMH]<0QPZA#)&A>>WN0)T2BEPS+*DQ7H
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MH/**"[J:M]8MVWW)6(2BN5--)+;32*:NU\0#2E?LT(^=,ZAY5T\0W$3EP/5
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M. VZURP #OX'+'MMF/3?L<U.Y/SR]NAI_;EUW\<WA3IURR"1L>-.^-;D $Y
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M9C\LNG:FQ\,JM=^OMX9NGSS4K['P]LWM^O-\^I_5GH:TNC<_EZ\X;=='GCY
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M=[=LFGVL!97>XYSU/\LDA(9?]4(* _C7(%KLKRM:V*J6!FY<5H"[U:I-:D
MT. M?NN%J84F",T9@A/4I&KE 0%_F8EOHPFTN#TF^N3QF\M[.D,4!^'UG_D.
MU>(V/3;>G7#B\O)FD^KKPE$E1=RKL4F-.47$'X2U14U\:'J,ZKY6@C:+ZM_=
M-);E^1 V-17E2AZ$4\,ZK:0F-YZQ[1<>84T'PFE >G[/7.D^4896O+9:<D5E
M9EJ!WV^'J*=ZYZ/L957_ $6$\6C=?5[CIW)/>HPS;S)HEISCN+V*%HV(XEJT
M8'O0'Z:TP[MO-6A?5WFGU&V4B@XEP6(%.RG<^PKDCTS7-&O$BD6^AYNU%3D%
M:@\!6HV/>F2F-[<(&69Y(B#TH6!&Y4C>AQ\-PWI3+$!0?%RKR-#O0_$H^>&-
MM>2E%4$,]*?$"M#X5-=Z],-8;^0% 7,9J0Z^_?KVPPCFA$1!+,KU*LE":TH
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M^8CIME5Z =\U2:YCMTS5ZU.;Z>OAF'3QSI_DR:OECSI;$[1V<DH'^O#*#_Q
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MBO?/4?EC1=)TR Q:5910V_#K$B* @(+ &@)Z4W/?)ZT:<69ZUF 55(XE!O\
M9%/I/7 M[IUG>0+'..89M@P/(CJ0#3IVR"Z_Y56:UE>S=4FX%%5ZK&I:O(@)
M0TJ=_NSAFI>2&M9YI[NY=9[9'E212(UC10WPQ(@HAI6IW-.A[X0^8_+$/FKR
MU+I]Y;1\%C)4<>)X,  Q!!^(UK3W\<^=^L:!>^2-0N](OH&GL3<R42A!:)P"
M6CJ*<MJKXFH[X!>!5,#)+];M+IV,$ZTIP;XSU(H14BAZ5[C"HVDTTEK=02I%
M>6/-%DF#%98J@^C,1O\ $&(%?D?$R31M4CN$C6^B6TC@F-G+'(.3P+.J)Z<L
M1/[V(TJIW(H? 9M)N[*&[/"6.:"0^E$4N5DBI)Q"%!(/47?HI_ID\T^YAO[.
MUCM;J-[S3)1%'ZX$4QAD,G[M92U' 8, .ZM3KUZ)<^4M$\R:8EM:D?6S!-&8
M>0#B3X02@HQJ13K7;.1?E[H,V@^8=<T2*X:9].N:B-UX31AVY\67X@05)!XD
M]NF?57_G&ZRF702E3(UU?M&)&!XB*%/48$;DDM"0:$4I3O7/9<=B46"9F:6Y
MM"6 I0&HJPIO7KMX'#0,"JL#R5@"".X.^.]Z5^>40?#+[5ROQ(..)J=ONRCU
MRB>W?*IWICCX>&5TZ[^V;Y]>GRRMAN-\NH^7RR<>3I2MKYOMZ[RZ+<24_P!1
M2/\ C?(5YMD];S-KS$GX;^=/^ <K_#(\.M".N7O2E>F72I[&M,P.YKT&:M:X
M[>OO3+&WTY?RV/3*W^_,"I .^Q)!_#&\>3BI)VZ'W/A]&<<\]VT6I^5O-R<"
MQF@ENXO54\0Y7>I\!P1=O'/B+YY*VCZ[$%"SQ>GR %*<RPW%>K/O\A[YR>VC
M+17='5?07UF,@V)8,"* =:$?.N$]E:/>Z5>RJK*TDI#2AA5HF*TCI7ER+; #
MO^ >1)HKI[F1(XS$G$JM 56'JA*T]J_USEFH3->7-Q<S2%9)GH"?V%W);Z*T
M&-]4-?10JPC2)XW/@$BC/]:9ZR\BSROIEF2"5EB!H %&U-@2:5W_ !R=22I
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M?WCR3+Q,?B5DY+7PZ?1GBG\T//%[YUU-=%T6X];2(6$LDIW,CBM.<G@!OQZ
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MX&1/OTZ8[Z>O?+%?"AZ9?;YYOD,<#04'3+K7,-S3]>61UVRZ; =:Y9Z;[YF
M8%36C[?(' T(G]&,,T9JBU:AJ?$]0,\5?\YE>4)=5\I>7O.%M:AKCRU<S/--
M3DZPS&(K4 4(_=T%>E<\&_D[;WD7GBU%E;1,UKJ4DJPR@-"\,L3'T60DU4B0
M@U^>#OSP\FN+FXU&,316VI%UXSA3);W$7V87"K4,J<2*DUZ\FZYXAF5K"[9)
M@T;<BI%!0,.CC<;#$=9L&GU&"Z:2WBC94DYS2A"P '0&K$=J@&N"OJ$5K>V=
MFA,]P[1BYF3D%Y J[1I6A8BH4D@ ;U!VSV1Y8T^=FLI[0,TT(5P%8 &BE2IK
M7KTWSM-O<6EZ\+W(;3]2MP%#2+1N/\I!-&6O@?D<7U&&"2UDCDB@FA;XBADH
MG(#X7CD JI^[//GF/RJNI23(DQ+$L4"OZKAB"*J03Q^9I3/.=_Y9@T"_2,VK
MRP'DMRX%'%23R3?<@]B,]C?E!^8EOH6GV6F7C-J>EVL03UX&K,G#XE:6*M:@
M=<+/S/L5E\R0^??(>I17U]%$8[RQC)22XADZ\%?BW-:FE>H.<NU;6/+.L6\D
MB>77;5C<!J26<DDZN":G=6\-_P"W.GZ;Y2O?-T'ENSUJV&B^1C*EU=*%XWLH
M6C&-(**55NA8T Z5-,]\6WYSPZ5I$5GY1\OQ2V5G$EK&LKAQ'Z0("HB\>H'B
M<\Q?F7?>;?S:OK>SOO)T,)MW8HJ45IZD, 8W)(.U: [CI@[\F_(7G#R?KYO$
MMC;>7=6=B;16#1,ZGAZ\*BM*D4)!WIG7_P W]#L)-$BOYMK^67C'7<O4 U]Q
M0[YYPT1#:75JM-_6"@=&&_3P[]:9[R\C(8[*W<[AT&]*;_CG8[>4F!N1!H-A
MUKA1JR"5'9Q\(K3?;;H<@G!!ZH@*MMXG]7;Z,-_+QT^%Y4O8@6<$(=P!OU^B
MM,Y=^:&G1:M=016,/ V162.=%5P'4U# %6%=O#/(VLZ7+]=*7%U/Z,51Z;*J
MEV4@T"KPH 3MO]&3_2O-\FFQ65E;7L\4H5G;@Y"*!NI:I-&KVP1K=[/^86@7
M,7F#3DUJQ,3\UNT);U%;]W$&^%@2H+!QMM0'./>7ORF_+RWF6?5;;5KG2M1*
M6C6@U2\BAM);H^FES,881(4MZ\BH:C@D;D$"<VNF:]Y;C?R[Y(\OVEEHHGD3
MT;=Y+(%5=>4C2/SJI4FG-RVP&YVR-^8_RS\T:R+=M9D@B@EGYV\,!;F$E "L
MTC*KM]D$ @4)K2F=(_*3\E8+75A=:A L[0R^JD;J.("@'9N_PJ/ISV3;Z!I!
M!B>U"GAQ96!4_.HW.*VF@6VF2H;>62&-WY"GQ*#X'_;R3I];C4*/2HI%#1A4
M?23B<KS?%6-%Y;M0]02*=:9"]8D<O7T" M:TH1O_ +6<\UOE-92 J9/71@%;
M8#\#6E<\L^8/)TUW?73+ZB^@4D#P@%HH7)"L0RLM(V;COMQIVR0^4/*^M)J$
M<%U/!8Q'C#%>Q0+)'(H'Q".7XTA84[+6G0]QZ&TWR[:V>K:;9+<O-#.899N8
MB]:0PDR*SC?BO+=5.]!\7CG==$\O11R7&M3PB>]U%TB21R"ZVX<%8Z]JL.;
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MJ5,MNM0-A501T_KA,=(6)UF]+@:_%W(W(!PR32;=FCE].G)12@V#"M:@&H!
M^_%I_+.C7(*R6,09A0E!Z9 H.NX_CA>/(.DEAZ/,-6B^I1@!X @AC]^"H?*Y
MM24HI1*D_&P4GP%2WXX-ALIHZ,J>DGV51WJI([\:4^[!%Q:JP/JP1A5V8JM2
M-@:A@=C@:>QO+<LUM<.6XGFC-R7CWH>M,'+%;7$41GK!=JH7FE0#44^>.=+B
M)>$Y]1 *!QU \>F I4*Q$@^JJ]:TK3_,Y"-8(DCD4?"RG>OZSG)]64U6"HY5
M&S"H-.H^C$[_ $Z=[&&6 >E<S5W<;AST)%-QQ_##SR/I]WHUPES>RK=*9%C8
M*.8%*4IL:BASI&C0BYO[^[N1RGO#P@5MPJN2M=]@=J[9TU]*A@:SB12)[RZC
M$\Q<M(T:5;<^Y %.E,E#^HJ\N8<*0=Q0T!'<;?ABL.RJI%&5%-/H'A\L6]Z_
M1C!]MQTKQ(^[^S'G^W-MVW[9JTV[_KR_"@RC6E*U]\KY=LU#XYOQR^HK3J<;
M[Y9/X97SWK^.8BOO[5P;IZEYW4=?JMTV_@L$I(^X9%-40Q:KJ</'B8[J9.((
MVXNPIM\L"5\>E1CPU#C@?$_?BG;PX],P-*XZM#OCMB1X98\:G?+[_10_/+&:
MHWVZ5_S_  S*?A4^%/QS;;\B./2AZ80W=O%>PRVDL)N%<.3&XHLD;U# DC;?
MN!MMGAW\R_RVO?+FKKJ=BHTZ".?ZQI>LR!N5G-0+]1NG4']VP!XN1\2GN5SF
MGYN7]S^8?Y>7>C^8X&L_/'Y=R1W024J9)K2X7BYJBD-\-&5N7!PM4WY*OSHM
MHIK"]UFVBYHL#1S$@4%*\6/>M:Y#[^Z*7UMP'I0>K&:*0"$7@J"OL0>^>X?*
M;"9K.XF)=&16""HZ4))^[/0=MS].(R*(^0!6$GC0#N? #.A:+;27,0+ -T-&
MV5!O389*C;Q6RHMH%>Z8;D^YZ[;8)-K=L\0NKIICQ- E478[CX=_QR21:?$D
M"RM:1.P'4U)-?OPZBTQ"PX6\**PZJO7WZX;0Z1R#?#VW 4 ?=AC#IHXJHC^U
M4TZ?TPS33TAC9R.,L5?X;' 5R/1B' 4EI6M:[GK3(3JI+HX!Y2$]1U!/6N^<
M3\T2FWAG6,_O"I*GH144H#G'M+7T;V)B!S]:IWIUZ?CGK'R;J$;Q148$,%*U
M[_QZYVFQC$P#(M0=CX5-=J4PMU?D1Q";&H'<[]>^11-YA[]:'\#[;9(HE^$5
M'$^!I0X.A,L,@E2JN=R0:#?M](R4R<+B.-U("L7YH*@@$U[^!&*Q26_I()-B
M?BVZ;[CQQ1A$X!V:,=>A%>^^QQD4W#X:U5*<6-#0?.N/9A.>;DJJ&M3WIT+4
MQ*5A(ZA$*1BO^L0._M@>Z$@C5')4,VX6A-*],!/ZRLSJ!$0/'8K_ +6+&XA>
M%!<0#[)XLO4'Y8BDSIR'(2(>H-.0!I3 5VZB-GC'$BI(V/3(!JTR\9&[D4((
MW^[.97W[R\BBWY,0*=:EV  V\03DSM;*76)((T7A':\58CH64U[UVVIDKO=(
M;3(H[E/A$D85EZ-4[("*^!--OU8=>6;:.YU6T,3^HB1B9^/0<15:_2<Z@P#-
M!(^])XZ=Z$DC^(_'#"0TBD_FIL??%10D#K5?]K]>.KU'>GWY@/B!KU4T^@C^
MN.Z"OW97T[YM]J9>_P".5T.PIFJ-R!E;;4S4_P ^V;K2NV5]Y\<VWAE^WA^.
M5XX<:(GJ7EP*55+"_8D>UI.1^.1CS5'Z/F;S#$!0+J5R13L#(Q'X'"(':O3V
MQZT(]]\?[G'#MM3OCNX\#TQP^ZF.&X! ICM^O0]3F_CC@/HR^U#C$J0H!WI2
MGACJ $L:=]SUQ!D8QJZ?%*E& _FVW4GWPFU?2-/U_3;BQU"UCO;6\0!XY5J&
MHU0"#T*D?PSRKYT_+47]B^B:GHR^8["V$L&AZE"1#JMG7XOJDDIX^HJL-E8_
M$ 10G/E'YST*[\N>9GLM2A:V]=7LKE6!4K(IK&S CH2O7WSDFL:).9)(X%+,
MJBK]1\+ TV]SGKO\LKD2Z/H]S.5+Q1$-4$_$"%Z#W'ZL])Z)/&X,T_$0QGHQ
M Z&GAT^6=0TN<M"$D MX#N% H[ FNXR4+.BP(D0"-Z@)4;LWA4TR3K!-<6JI
M&R"4/R!;]D'\<DFG6<TB+ZA6@H&-/BKU(([9(H+582"/[OP/[->M,-HC2,B-
M1Q%?BK78_1FMEI(7KN-BQ^C;!<L1,?Q; _$=NOMVR-Z@QJ8U --R>PR#ZI5%
M9D;XF&^W\/GG&?,<:26TS<B3Q)]QWZ&FVV<=MT>2[Y44AF"T_'\,]&^42P6V
MXFK)3X0=^M:$YZ%T>X7T:-3D.@_RCX[^^(:H!(]2*.WVO!2/#(E.CPR +MTJ
M2>IK_G3#NWG# #8OT/S\-O?#BU8.5B8_ U14^'??Q&'_ *:1( )B#,C\>Y.Y
MIT'<5[[8&>TE2@9PP[BAJ>((-.@[#%H_4XL3134$*5 -.E:[]1BZ*&4&0E"0
M" 10^'V14U^C!2(TA 4? .@7>GSZ;X:I: [D$A?M+T4D;[_+$9;9'8S$"B;*
MI]^_3;":8Q%@&45(K6F%\TBGB*;+6A^_\< &7D*J?#?H=O'[\)[VY,:EN?04
MH3XYSS4[RK2-RHI-.E=\A3R.^I60KQ=IE;J.16(%C4'MOG7/+$0AL&N)I@/3
MEJ :4YL.1^(4Z9(-0>2;3;2VF?\ TB>5G:IW"*O-:=>BTR4^2[&.UL/KA3][
M-^[ZU/&/90#\\F)4K:@?:95#=>I# G]6#".9*"E M?F6V&/0\EC8]U'XC'[&
ME=J>'RRFW9*^!_AE]:[_ $YMLWA7?OFZT\#FK4>.4??-7N17*V&;J:#Y?AF'
MW?AFK2@&54T/CF!V%-QVR2^68_4GU=_]\Z/?O]\++_QMD?\ S%A^K^=-<0BG
M*6.3KU]2)'_XVR& T^''AAVZG'ACV-=NOTX\$;=J'' U/A^O'"O0GZ,<"-O'
M' U'^?;VQPVR]MAURZ^.^4@HM/GM].9QR5EIN13[]L<.H^C88&D4Q.T@J4?^
M]7W_ )Q_'[\C.H6=O/(\4T?.*]F5B#_,NST/CGSC_P"<P_RLDLIM-\WQ,]W;
M:A*;*\E8#U!*M6A>0@ $E%(Y4ZKXYX:T;2IF?4+6<%A;1!T)K\2LW?Y'.G_E
MQ2TTV>*0\/JE[(#RJ1N%(._;KT^C/1OEZ^9N D X4_=!B*+W#$'N?PSK&F7
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MITBU.BDJER !'*:#;U!L2>X]\\3>7C);WLXD5HWN%96 '>+<4/O3.JZ/=\2
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MJ>YM'709X91NU@8B/VB\JJ"-MJT'^>^3O2E$.FZ<E/B$4:"IKNJA3OMW&'
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M2H4]JD=?<@8J&^=,L"JLM#O7[CA0G*;ZWONY52PV-"  /^!W^G"O48$]8V[
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MI82 :(Y(8J>VQ.WL<@FG7<ME+%=QC]W+LP!Z,/M#KX=,])>4O-<4L<"O+L0
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M?FFY5'8/+;46WB+@%5=E8&A -.1\:81WGEJT@"-)J^IR*2K%>:[EA4  H:5
MR5>5ORVU+7YR]C83O'%\,MU<EGXT-:5?8';L,]9^1?RTTG0K<2-;J]S(H+3$
M5<U%:;YT>[\OVFJ6C07$(D %48#=:4IO[8G8:))I/%5N'=AU67=2#W!4?UR6
MV1)8,RFH['H*]?HP\DN%:G44/C^K"J[N>"F@Z=/?QWPNDCY+"-RTI!*]>OM\
ML#ZK/^\[@1J6V[4&<LU/4HH4N9KB4+!:H\[L3T2-2['J3T!.?(_\F_SOUKRU
M_P Y'1_F$)BUOK^MW/Z7C=W4-I]]-QE+*6"GTHN+J'- RY]ZO*R-%J.K75O(
M'L[AD, "LI>TB9@"%:I!C:1Z @U3I[2?5-+DX)?:?;I%>6$<BJA?X"B-R6A4
M$LO%B.)Z=BI R!F";0+^VGLZVEK<7+3-;D$I:75:NBT^U#)Q-3X>! &=BTJ9
M/2C:!3'&9:JO7:0GDO(5!HW3[O##BQ;TY[NUXT4/ZT?@5D^(T_V1.&!.5RKW
M[91(Z=?[#FZ]@,JI/T=#FW\/ZY5=Q4=/'-\SU.74]*'WZY76N:N_3?-\]MLH
M^/CE?Y[9J_/>N3O\O-,_2/F2WE<<H=-4W3^'):"/Z>3 _1GI#-FS9YP_/30R
MDVD^8X5HLH-C<L/YE!>(GYCD/H&>?A7J"*_CBJL/YC7[NF**:CKUQ8;D^V/I
M0UZX[;Y5]\>#7OM[98-#]!Q936G^=<44CL:X\'^F*#<T_P Q_G7'@;=.I[_[
M>.J-RQH .O;$5%%:0BC_ +(\ "=OZXZ38[ L2M!OL2QQ*!! AAW(&X/<D_:^
M\[X*50Z$=B2*CMO@*XMA/#+$PI4AU;P)-=OQSSW^;WD?_%>AZA;)&JZE;KZM
MJP KZJ TK7LW3_:SP)IZ\WFL+@'ER*R*=BI0TK3QJ*9)M*:YLKDJ#Q=6V_E8
M>/7._>4?..\<,KE)E'$JU0<] V=^MY:5!^$J*]#[#.>^9(PAE8'<DUV^7OOW
MSDMXT:2E68;@CXMZ?(5R%:C:*+AFC%$:A(I6G@1MOD7O=%L+^)K34+".]M)
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MV%#AY' C*338$T IL*],$HXB1> %3V^1Z=<3FG1FIWJ?U=,5MW6OP$"AIX4
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M,+I))28'C[$#;?";4+/T>A^/<@';D!]V$WJ@?Y(- /U]-Z8-L6#S'I0DA@?
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M6OTC)!%;JH/)1&14=14]&XBHZ5KCPQ0HO$E:;;4)'7KOL<MJ7%6C+,:$(5)
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MC#L:LRT[;?1GUB_YQ$_YS:3RS-IOY3_FQ=\_*$OH0^7O,UPY9]-:6)%%E=D
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MMTKW\<0FHJL1^WL?;M7"F!/2EU!:$E)ED ]G4&OW@XM<017D#QNBS13H496
M961Q1E(.Q!%00<^)K_F)Y4_Y6;^8?EWRU,+>T\N^8+ZULH X;G;VT[1*\)K4
MJ.)! Z#Q&=RTWS)!=Q1F&XCD204H&V^6_OD7\QSF*[BNXVZ&C$T^8_72N"=/
MU$-('_F&U3WV[T[4SH>G:B(E =JAJBOO4C#U/2NU)^TS5->O0=3UV->N#(+(
M1T3CR[';>F2&TT^!(B60CE\.WO[[X?V459!P2L<8HW'J!\@/;)!;6ZNQJ(Y:
MUI516NQWK\O'#];56C*_5T9U^)5H!0#J*\NQW&#%19(B@],25(7@"S"IKQW(
MKOVQCPRK1I82*D@, %V';9>OMBQA8+5%.U"12FQ/>IKMEQV,CBC($%*FIJ >
MOC@@0$HQIZ;-]LC]GE[&OA@*XI3E* W#<"O1>NYZY&;VX1CR!(0D$&O6HZFF
M%AF,D@!:H7H1]^&,9JH1*<WV^0IUQ"_N+>RB*+5I7W9NK,?"F<LU?4[K4KV'
M3;1>=S<-2*(_9KW=R*_ H&_ZLDTD^E^4M$GDN[N*WM+"&2:\O)V$:U1><LSE
MJ4  []!MGQ=_YR-_.^7\VO,S6NC2RIY+T>9S9"0%#=R_9:Y=*_""/L [@==S
MGG+^4,-C^/Z\&1!Y!;P,_&)W85J2H4D<J@> &*-))+=,U/VJ1<B M6<D D[4
MJ>N';1R#2IT*LPNC BA:$J45PXJK$;T ^_/N!_S[\_YR-U+\R?)%W^4GG766
MO_/?D&$3Z9<7<@-S>^7HA'&B5VJ]JP$9)J?39?Y3GT#NKB"2VM#]8*VO,R22
M0FG..)6=ASZ_=7#/0+,VEI')+$$FO/5N9%I3B97]3C3M0/3#ZI/:ARQ\LKL-
MNN,(ZY?2OL,U?IS$#I7[\;\^^:H\3E?1T\,=7;PS?3[Y0_IG4?RPT'Z[J4FL
MW"?Z-IFT-1LT[CK_ +%37YD9W_-FS9LV;-D'_,'RHGFWRY<V4: ZC:_Z19,?
M]^H#\!/@XJOW'MGAYE>-WC=6CDC)1U8492*@@@^!Q0'IW)'7%0?'%%.PQ53M
M4#[\4!IL=L4!_''K0"OACQX=S\L>IW!ZGKMUQ8';Q_KBB^&^_A^-<=L=Z;C;
M'UVZ5./Y=3TQVQ4@[@[8W=!L*CP[_0<NH<$=_ C<'WPJFK;WJ7,3$17$8AD0
MCX0P)9&ZBG4C,QEA8>E'SCD;=-B%8FG0\=B>HS\FGFB^O])\_P#F:]L[A[._
MM->U!DEB-&C<74E2"2?UYZC_ "S_ #<?7X!'>R?5=9M1QD5#2.9?YU!(I4]1
M7^F=Z3S$U_ D5TZDD50C<^X.PVPWTN^+;BM4W!&YXYTS2KU9;=?]^A:$,:UZ
MFH_#)%I6I^G(RL>+KM0G]>V^=&L+M+@(!05H5[4/@3DEMUXD@=!N1\]S7^&&
MD+)R)ZL5)WKR%=O'KTR3Z7%(]&DI2OPTWJ=AOW[TK_#)&.+$*X4AEX.FX(*D
MD&NW?O7OBH=;=)$B@Y#?8L!O3H*]/H&#8G,HH8Q#Z1!<.#O3X0 I/7'31QHP
M**65Q\(<;D [U]@ <4:0JAX*I#;<BM3U/[))VH#3 $LB()8V8\5(# U-6WVW
MZG;(SJERH!C^R10T\:]!^&12\NU5N-00#W(WPL,WIH"7^.OPC]7AA@-1CLXF
MEGDI*10]Z#PSEVO>:[FXN_JFFQFYO+MA%#$FYJW\U,E&C:5;^5;"6_U*Y235
M9TYW=PS#@@%28D;H%7N?'/E9_P Y0?\ .24WYB7ESY(\G7K)Y+M):7UW&2GZ
M5FC/V0:#]PI%1_,=^@&>,.0!5B*U%34=O[<Q;L1Q#?3U\,%Q-Z<1:IJJT'MR
M/;[SB18L#O1!0GH>WXG#6&_D3@O[N-5(('!70TI0.I4D]\G7D?\ ,O7_ ,M_
M./E[SMY2>/2-:\N7D>H0&UDD]*9@.,B312"0,LBEE9>E"?GGZ4_R3_,7R=^<
MWE/3O.OEVXAN8+L-))I[S^M/8R,0YAN8@YXLI(I4;['?KG=ZU<'V8D]]\=F!
MVH-J#,<HGP'M[9NYWZ>&5N/??\,L5^53C37Z/;*Z;4^[-7-OOF)-!44^6+VE
MM<7MU!:6R&2YNI%CC4=V8@#/6>@Z1#H6E6FF0_%Z"?O'_GD;=V^D]/;#?-FS
M9LV;-FSRM^<_DTZ9J*^9K"'_ $#57XW:J-HKFGVC3M(!7_6KXC.'JV_A7:N+
M;#W\,4!'WXH*5 Q8&@Z5IMCQ4#\/#%5;I7J>F/!I6F_AWWQX)V/2GOX8]2?I
M.W7'@[CL:4W[XJ-R=]JXKVS"A'3;+! %#U\<>"*U.]3C>(._V6'0CJ/\_# T
ML8<M#*%*RJ!TV[U&^!0S*1#<H6B *B0"K 4W#$;]._W^.?E8_/K18_+WYU?F
MSHT1+1:?YNUB.(GJ4^MRLA^RO9O#Y9S72=3GTJ]CNH'*E=F [@]<]/>4?/\
MZ_U:&67DS#B.1H 1X^U-ZYZ"T3S G&,JX//<[DGP^GIG6]*U.WDDA9'^V1R'
M?;;?QZX=WL_H3)<1L:&A8;[&NWZ\G_ES6MHT=@2U*&M01_F<ZQ;7"S1(%;DQ
MH>(W.PIAG"R*U6-:D&E=S3YX>Z=J2QS(#O'45 '84Z_1WR67%Q#&8I(6HDQI
M\1.W+L0?EO@T3F7XPH4BAXA:?#V(ZU!K]WT8;1S4BJ542 _" =BIJ:<OUX'E
MGC5%Y#DJ@EAT\.IP'/?QLM4(]1^@Z;'KOMOA+=W+;?& ?&M/G3IWR%7MQS-3
M,78'QWJ>_P!%,BMY<J&JS!Z#JW8D;=_;"2YUZ"&)II9.(C^PI_:]S_#.=ZKY
MKO=1F:QT]6E9_AXJ3RXC:I/[(SI'E70;;RW9OJ^IL)=7N(ZUIM"C#9$!)HQ[
MY\Z?^<I/^<E7UYM0_+CR/J#'2D=H-;U&!J"<J.+6EN:[QCH[?M?9'PUKX&["
MM-A3M2F8$+\ZG,3R(H*TH-AU\*X)5^"\&-5:C%1U%!MV]SE;.:5H@V/R^[^&
M6YV4 D@;U[?>?XY?)BT:( 6E847:A)Z&I(SK'Y:?F]Y[_*;7K?7O(?F&ZTB\
MBI"Z1GG!=(36DT#51AR<TJ.^Q&?9+_G'_P#Y^#^3/-,<?E_\X)H?*&NU6.VU
MOXFTR\J-Q*U"8&!VWJIZ\@,^D]M<0W=O;W=I-%=VEU&LL,\+B2.5& *NCJ2"
M"#U!Q<]?GF/Z\KVVIF VVS _KS'_ &_\ZY1'^8RM]]MLLBOT95-\K[ML[5^5
MWEHJ'\QW<="P:*R#>'1Y!_Q$?3G:,V;-FS9LV;-A=J^E6>MZ;>:5J$0EM+V,
MQN.XKT9:UH5-"#XYX6\S>7KWRMK-YHU\.3P&L<H%%FB:OIR+UZC[C4=L) 0=
M^E?#'J12A/?%D*FG3% >AWWQ4-6FWO[TQ2H 'XX\'<>!_P Z8X,.XQXV%>W?
M'AAT/ABBMT'W''\O#I3%010$FM.V;\1UQ]>W7I[XZHK4=1OE4!\"#XXA,I&X
M <#J#M6G3>A^_/S!_P#.75C-8?\ .1GYJ)/?VVI2W6K?6VN;0 1L9XHW84J?
MB4U#?Y0.>:L/]$U26QNH6#40.I84KT/;/4/EG72Z1'U R.*A@=UZ="/NSMND
M:[-;F%G<%&(%:5KVWV.==6[.HP(2U4EIL:5! ZXMHNJ2V-T(I2 JU KT##:H
MJ:G.YZ#JZ/#&Q<KR! [[@&M#D[BG^M1QECZ1/PACW8; $=L5M)O09XI6#&(_
M:;H:_3WKAQ#?P2 ,LHY4H.3=Z';K[8;)JC+%$)&)$;? FU*^/CAY'JOJ1*L2
MGFJ\2_M0_3OEB]5E 9 ":"B[5V.W;L,!W%U$I_E[@$@4-=P<BNJ:P'8_$K+&
M#XCD3M[^&0'5-92)))3+Z; ]CTIN-OEG*=4\]V\+']\#7["G[3KT'T#QR.VO
MZ6\VSL5+6UI&WQS-U.Q/P#Q^>V=C\N:!IFE5N946.UAJ_.0@>I(G[3-MLOW5
MSP'_ ,Y-_P#.3QU>6]\A?EMJ9&E4:#5M9@)7UR?A>WMGV/"@H[C[71=MSX"7
M<>"CZ:?KS !B!6BU';?[ML:3W&U!_M8X-7B M&4;^]=]\>3R))ZG<^'X9?*O
M$\0 NW0"N]=R.OTXXLQ;[1K0>(/L:9GE2) 'C#.XI4'BRK[[$5(]MA@N*0%1
MZ:^GZ@Z\N34I3K\(_#!MI>M;NT8*M&2M8R=B5V4[]Q7/5OY$?\Y7_F?^1EXD
M?EZ_75_*I=/K?E[4W:6Q**U:0-5GMR>1WCV/=:Y]R?R(_P"<H/RQ_/K3K=?+
MNJKIOFU83)?>7;XA+R K0.T?[,L=3LRGI]H*=L]&5Z;YMC]/8Y=?N[D9CN-Q
MOF)[YJ[4IE?1UZY1/<8PGK[;Y(_*WE^?S)JT%D@9+=?WMS*/V(@=_I/09ZKM
MX(;6"&VMXUA@MT6.-%V"JHH /HQ;-FS9LV;-FS9LYK^9?D>/S=I)GLXU77M-
M4O:OL#*O5H&/@?V:]#[$YXS99(W>*2-HY(V*,C AE*[$$'H0=L=44 KL,5Y#
M:OCUQRM4DD[]<65A\ABBFOO3%23W-.V.J?I/\,<.W:M,<"?F1CP:=-@/IQ17
MZ;]L4#$$8\-3;I7'#>M-P#E\A\COL<Y5^9OYV_EQ^45I)>^>_-%IHT8B9Q 7
M5[F0@$A(X%)<EJ&FU/EGQC_YR6_YSS\Q_FM;:IY.\@Z:GEOR#=H]M<7%]%'+
MJ%_$Q'4,'6%33HOQ>XSYUW$IF56(^S5?QK_'"\Y8-"#X9TORAK_U>5()" *B
MFW4C/4FCSB[L8F4U#4!\=O\ :R1V.L7&GR*-BRCN!3B>VWC7)_8:[#>((RU)
M16H;;L!78#.EZ)YDM[?BC2JX 4LIH#2@W!%.V=6L==MKVV$;/5EH5 &XK6G?
M?;)-%J=M0 RCF#0D]B?'IXX^"_A DB$R,H) X]0>_(&O?#NVU>W2$QS3AHR/
M@?:A]MM]\,$UF!5' A@AK4D#<=.XRVUJ)ZR&0&( D';J:'(WJ&OQ<7/JC?<=
M/A%>YI3MG-M:\XV5H&:6XC-"22/U#[LXIY@\WWNMS""PA_<(W($K4EB*5W'2
MF*^5O)=W?7D=S=*U7H0HVJ*[[@;> VST#!;VMC;-:"3TH;="TTCG9$45+,3L
M*]O85SYU_P#.2_\ SD;%YN%W^7ODJ6WG\KP,([_4E7F+QD*D1V[,#^[4J*OU
M8]/AW;Q0222P-2-J]N^8&GQ@[KN-NM,H$** []!C>0'OUQ506 ^FO],LDD'N
M!O3I3OCZD@'H!3<[=OZ9D<@@J3O\O?I_;@9SR(7W(4>%:8*A CH6W12>NQZ;
M8K*3S9J ACO3_;P7%,#&@J 8^Q-*@^Y%,.++4I+&YAN[16CDBX2U;B:,IK7<
M']6?9/\ YQ/_ .<[[#6(K'R#^<-_::1>1QHFGZW(L=K;2)&JHD,@0!48!=W:
M@/MTSZGZ7JNG:WI]IJ^D7L.I:9J$8DMKJW8/%*AZ,CJ2"-NV#QO3P&^6#MUI
MFJ!6FXS5->G3K\\U2!L*T.-+5![5_CBD,,UU-';P1M+/,RHD:BK,S&@ SU'Y
M0\LP^6=+2 A7O[BDEW*.[]D!_E6M!])[Y*\V;-FS9LV;-FS9L\Z_G!^7_,3>
M;]'@JZ?%J<"#<@?\?"@=Q^W_ ,%XYYQ4]&!KWQZM78&F*K[]32F**=Q4T/;W
MQ8&M!X;[[8\-XBE/''UJ=L>#T!/3'<O:N/%213%-O?YXY6Z5Z#;YTRS*B(SR
M.$C058L:  5)J3GE/\R?^<T_R)_+6.]AN?,Q\PZW:/Z8TO25]>8R"FS-LB;&
MM2<^:_YI_P#/QW\UO-(OM/\ (EG9^0M*D++'<HOUC4?3(H.+N2B-WJ!MGSW\
MQ^9M;\SZC<:MYAU:ZUC4;IF>:ZO)FFFD9C4EG<D_1D6EF,A]LT9JKH>^_P!V
M)'J<K%X)FAD5U-"IJ,]0_EKKWUZP]&1OC7X3WWIU_#.J*#(RT +"M/?;8]/#
M$TN)X9O61RL@)'PFFQK7)#8>8KN)T#LM(U(KQJ2*[UK\\E]AYW$? J22E #7
MBU-_LT/@!DJM/S+CBJ9I9&1Z!MJ_$*4(;;Q\,7N?S%BE8!2JM6J@D!J^]*@X
M7_\ *R+L _O.:$UXFM#\_HZ4PSC_ #.=:$M+*Q''@["@%.FV5/\ F?>3KQ@2
MFU-SR^[[L#+K6OZT.(ED12!4*:4'7V&&4'E"\OFC:X#N -J]Z[FI)Z9/=!\E
M6B .\*D*:?$!3_:R37]_IOE^UGGGNHK.&WB:62>8B-(HT +N[&@"@ DU[9\U
M_P ^O^<C[[SL+GR?Y*NY[#R<K%+V[!,<VK.#0D@4*P?RJ=V'VO#/)8!&U/H%
M?GFV%=^G4G*)7K0CI3QQ/H"2?';PQP7O[]_'%EXT8<6#>Q'XBF.4F-AQ Y&A
M%:$@CP/;_/Z4V[ 5/>ON<M:4K0>%2/U@8B2I:E*^'M@JG)2#OV]_;'*Q-"5Y
M%"00U"*TI7%4:C;=.A/2HWW[CIBAJ#0DU!VWP7;3M&R#FHKN.5?G2IVWIGKK
M\A?^<L?S0_(]X[/0=1_2OE*2=&O-#OU,ML0NSBV9B3"QY?L['J0<^X_Y&_\
M.2OY;?GSIBR>6-1%AYB@C+7N@WC(M["5IR*IR/J(*[,M1GH+E7?K[Y=:T\!F
MJ:5&5R.W?&GKOXYWC\M_*!LHT\P:E%2[G3_0XV&\<;#^\(\6'3P'SSKF;-FS
M9LV;-FS9LV;*9592K ,K"A!W!!['/(_YH_ET_ENY?6=(A+:!>2'G&HVM)'_9
M-!LA)^$]OL^%>0U_M_MQX)((Z]3MBH._T5Q0-L-\4#=*8H"32IQ]>@QP.U:]
M/HKCU8&H![T/B3D3\S^??)WDF![OS9YCL- MHP"TE[.D0WZ;$@[TSP3^:_\
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MV?/[_G,/_GWO^5'_ #E/9WGF2S2+\O\ \X8H:6OFBRA!COBBT2#5K=2HF38
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+-FS9LV;-FS9L_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>sny-20221231_g16.jpg
<TEXT>
begin 644 sny-20221231_g16.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
M!2$2,4%1!A-A(G&!%#*1H0<5L4(CP5+1X3,68O D<H+Q)4,T4Y*BLF-SPC5$
M)Y.CLS875&1TP]+B"":#"0H8&82414:DM%;352@:\N/SQ-3D]&5UA96EM<75
MY?5F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]SA(6&AXB)BHN,C8Z/@I.4E9:7F)
MF:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H " $!   _ /OYFS9LV;-FS9LV;-FS
M9LV;-FS9LV;-FPEUKS)Y=\MP?6O,6OZ;H-M0MZNHW4-JE!U/*9T&V</\P?\
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ML56GL1N/G@=K<-$@Y!I(>5(V%0!X@G^N!H;='-P))VBXT*\@0-Z;==\CEUI
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MAW\/?.?:Q: ,R-&#&[5H10;>*T]NV0W2[VZTK7TA]-Y;&.0S+Z:?9)V:M0&
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M(;W3K&Y0.X:%#\0+$ U&VQKXY%;_ $^ /P$Y83 !A0U&XITPJN=(92T5TX)
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M/'IA[;1(D@$O[R-*,0VQ92-MP0,F5E;0#A<7$"T( W^$<!T.VW3KDQMK!96
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M@+*GJKZP)^#ER5E.VU.N-^LA0T2D%:\00"U-M@=J_?@&T2Y5YG=E%:#B]>(
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MN8GM'T^Z2XA9+<::I$MF:"8K4D!E._ZJYR[SEY+\D7?FN_D\NI*^DHX)?TS
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M;0$H5:0JI(Y"A.VV%WF99T8Q1![:VD)$=N& XQ?LJ2.M.V0VRL_JFMZ*S$L
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M'3)7H6FW#AS-\"CNNYKAEK.BRB,NJ^HP^)7IQ)]CG%M;A>*5F<A'J#2E-QU
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M\L:6^1IC.53TI[Y8VVZ=\NHZ=,PQXQU?HRQOVQW?+Z_V9?AMF\<O^&V>N_\
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M4G92#3KQ';PPWMH4B]2B%%*@4K6K#<<=B#0CZ, W0E9XKA$<>DR+(J <F1V
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MAJM*U'4;?KR/A41'5'+_ %A^4;]21NP-!6G3QR7V NYK=(S(GK\B8F8[@D;
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M=<_6;81L 2C\9'8O7DFZ@;'(;JG.[DU=;)X[J_UNX:>.RAD@N63TJ2,':7@
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MD$I]&X4TVXO]EOIQ*1/@C/$O.(U'QGT)P2=^+CX6^G$>:,\88UF!<_%^YN*
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MA8T6M6=F"KU)&?8+\@?^<-O+/Y=7%CYT_,(P^<OS BXS6Z2?O-/TN0#[4$;
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MT B^0_O 2>QVQDC-;CU75K>"0M(\EL3=6I-"!S1BY7[Z]=C@*=1(5B'"*/\
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M1$SW&ODQQRJ/B+161Y72M2E*HJG^89]!/RS_ .<&?RD\E"&[\UB?\Q]5C;U
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M&Y'0;81IJ&HV9L]72SN]8ET]9H7MIH[E)(A<_$CJSQ.SJ0A%0-CUI7$/+5[
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(S9LV;-FS_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>sny-20221231_g17.jpg
<TEXT>
begin 644 sny-20221231_g17.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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M5%+V\ =$((H40/(#LRKUSX_?G)_SDW^;GYW3S1>:?,#Z?Y;9^47E[2B]MIJ
M&J^I'R9IF'7E*S$?LT&V>?J'IFI]^9:G^S,?OS 8H -CE'+ R^IRZ>&V9CQ4
ML>@ZXX ;8T,09 5)*'H!O0[],51[>=?2CEC2[0U_>,%612>G)J ,.U3O\\+K
MR_MM.E*7[M:)RIRD6@6OB?XXVYU2SM#$99HS'.G.*19$*2BM*QORH>H_5UP1
M+>V,1MC)=Q1)>+RA>5A$K]C1G(!H00? C'F:VX1.EW!,LI( BE1V!'^2"2?;
M*ED6-)'D/!8164BI,:]#R\/IP!<ZYHMNRK'JEO+(:5A+@,/DVRG[\N+6M,G5
MB+Z .A(*,ZJU1VH3@RWNH[CBT'[V-@?B!'4;TI7[L7+U"LHY UKX[=J>..#!
M@&7=3T(QK'*J<L$C*K].43TH,H5IOETQI!RJ5^G&XXC;]6-(_#&#)EY'_,/S
MQ^6NLQ^8/(GF>_\ +&K)Q#2V4G%9E4U$<\3<HY4KOQ=67VSZA_DI_P _'[*Z
M:UT+\\=%73I*",>9M%B=X2=ARN[$<W7;<M$6WZ1*,^GGESS-Y=\X:/9^8/*N
MMV7F'1+]>5O>Z?,D\+TV(#H2*@[$'<'8T.'F;-FS9LV;-FS9LV;-FS9LV;-F
MS9LV;-FS9LYC^:7YP_E]^3>@G7_/NOQ:7#)R%I9I^]O;V114QVUNIY.=Q4[*
MM1R91OGQD_/S_G.'\Q_S8:]T#RC)-^7OD2;E$;:SEIJ-[&:C_2[I.)564[Q1
MT7<JS2#?/$(&-.YV[=LL#;,-SCMA3&D^U,P../3*H>N/ITVS $F@&*-$P4L'
MB)H2!Z@'3OO3*O#"MVT=L)5@95*+<H%D(*CD:J>!%2:$'IBL5G(%B<Q-;QW+
MK%"T]8N<C;A*DA02.A.Q\<#6UJ+Z_:.*_FM[.8KQN_2=HN=>'&01EBIJ/'%;
MBQ\JV-S+-J5S9:I,Y*T>^FMB* <@/50)L>E0/GMB-O=Z;9))/%'J=QIDA81V
MUSZ-U;RQEJ<5:B1Q@] 0:UZX8P>8M$0"QGM=&TJ&5>9,3VT%RK <2/4?@Y;A
MUXD!P #7"C4?-7ENVL1I]I<>7K_A65HM1LH6]4&AJQ,LB@4._%@W@/"%6]Q;
M:Y<-IFF6>CZ?/%(LD#0W,2B0J.3^F#<.R**4 YFO\N(2Z=K,%]/!JVHV5F3'
MZC)!=2Q+$01LX2,U2AW^*G?(SJUAK[)-]033;F2,EB/JJFX!:IXTXS<TH!W^
MG(A8:1KEQ<3MJ-E:O'>,J1WL,WU189R.4/QE0(B:4_>H%/1F78X<Z7?ZAHL6
MI2OK,ME?6\JQ(74-&9%J&2Y@ZA6%*2+45Z'?)9I?YBPZE!>S/;A+S2UB-Q!
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MCM]&K<#+&4$)Y I0[]=NF$4RGUO3 #1N&-7'RVJ??K7"N>$! 0M>'Q$@?$5
MKWZC? %W$8DD9(E9=U(0D%D:E"*;[5R)ZM+_ *+/$)4>0+RW8%@ *?$*USRO
M^:DK/86MVB^DZRA9710Y 'P\N)V)WZ;?//%/G6Y@#M<>JD44K%)2$HG%OA H
M3\)%00?'B:9S%([7U5M+UX+B"]NY$2"5N"R+Q4%1(:\0P<E3N/D?B$?M+"'R
M9YSE:ZD T37X4O+.9?C42/2DS<&I7;C*M>[ ]<D%UIYM->EFBBKHFHN+NVCC
M)=8YG4JP#]-N5*CP\<G4$?$5-:J!1ZUY+V!^6+UQA.V4"!WIE&F57J<;3VRJ
M?3BJBHS4S#;KF-,K\,;4Y9)QM<=0D8RAK3+ )S[<_P#. O\ SD$OGGR?_P J
MF\TZ@'\W>2+=?T3)._[R_P!'79$%3\3VNR'_ (KX=:,<^B6;-FS9LV;-GF'_
M )RS_.Q?R5_*G4;[3;H0^<O-//2?+Z@_''-(O[Z[ H=H(SR!(IS* _:S\\\A
M=W:21R[N2S,QJQ)-223UQ@%,PV^8QU"=_OQM/PS?JRQEE3L30]\:1RK^O&<!
M49?&F8K0YMP/GCJFE=_HW.$7F)I7TO4"9_J]O#:NU$-'D:JD1 @BE=R37MG!
MM"%K-:W4SN"-0DX=>3M%'RGG$9Z?%0)]!WST]^2VB0OJ-UK+1)%J.HLL7 #F
ML*NW-@33<F@Z>'4],]W>6[18;:0N!\554KU 7;PZU/Z\FUJ.++)"&)4=1^R*
M]_G7.@: SF0SD4'$T%-S2@4]>FV=%TWDX?X:LNQ<'<*:DT^D4P]A>/U%B(+
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ME],NN_7'"G3,=\U/HS5Z#'#*)QO3KB@(/SRZT%.V-J.YRB?#KG0_RE_,"_\
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MB/?:7YU\RS)&[7.K6FFQ2S**,+:W:>8*3T/.Y%<]B:C:06S+:MQ6&4\(TI\
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M1?ZTKG+?S+MHYUNI[R8I9W\,>CQA11$^L55S)\/V69AO38T.>5/R_P!*N?\
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M**'D68?O-A(P!')MUK78TSY)?F/<GS#^?=]87#&6"7S6T;AR&I:VDO(J0?\
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M]::<L2.3. >.XV V';)[IFAW+*AND=;&",\YW"JBJ-U+U!533>A.V<\\Z_\
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M'JLQ0&O'U+N9J5VK2N0H8_85RUH>N;:OCE$[>^4&IMVRSOC>F:I^9QIV]CE
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M"@.$+'U [T]/BH/I"O)JUI3/DYYCN=>\@:PVM:%K-M8W(JR0N6:4Q@<PDH'
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M;/4)?20((Y'4>J* T^&NU33C3Z"'5G>?4>,"E9H)HHRY7A7ENZ@-N H;:O7
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M9Z>\@006H D8<BP1I&!W"TKMGL'RM_SC]Y-:#3'6Q9Y*AI9I+F1G9?AXL6#
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MNC\0S;'FI:E"QF%W:6MQ<:F-3M;8VWEG5KE;E(HA [K(DB3^F#0QDM(U/3-
MZ[D 4SDWE2REUG7KC1M>NKC6;76DU?ZKJ=JW.2>W-O<F2WO$D)XIZ0^%EZR4
M4USQQYC@O(K_ $"&Q=I[/5KZQU*T+2EHT6\]2WNF"[J6]2UE;FB_N@I)6@.1
M'4//-O/J-Y=6U_'J.A:+=JBMSXQ30"WD:*/DRD/(]71*[)O79!2%><=3,&I6
M5C&(EDTNY%O!%"0T+66ZQQ<U+HT;QL6?DQ^+D30X57/UG6I-$N8["Y>\L]1N
M%E,)YD_7F]6 LJ\B>-64=Z5H=\]#^6+:2VMUTJ3T_JEG66XCMD^KVT4R4B4O
M%R/*0E2S<Q6O@,[9Y/L/1\K:AJ\D8]36KABA8BOU>$>G'0]^A.>5_P#G);\O
MWN?+EEYRLH/].T ^A>4'Q/:2G8G_ %&/W'.):4C6WE'3$D45EMQ(>0!W>I6G
M?H<6\AZR-/U"72[APEM?-RCY'9)>V_\ E=,[/6FW3'AL>#]./!I7OB@;Z3B@
M-<5'SZ8J!TQ5=CBRBN/ITQ5>@Q9>XIB@_''#\!CZCMEBIR_\]\L9C7YY]X_(
M7EW_  Q_S[[U&P,?![W\JO,>KMM0M^E;&_OU)KN?AN!3V]L[%_SE?Y:/FO\
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M0Q_HV)KZ.*1O@>#[3! ?VDY5X].);KQPW]"]O/J5O>'ZX($D+1PTD+L?1$2
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MQZMBRG\<4!Q9&Q='Z8N'Z;XJK>.*AP*CQQXDH*=\<'RP=\64CQZX\?V8ZN*
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M<A\)N(2L-DH/\PN)DD'LAS]!.;-FSY)?\_*/RT]&^\D?FS8P4COD;RWJSJ*
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M(9;MZ(B@FK;5"CWV[]Y=U#3+J]O;S1[%I-)TZ*TMFNF+0PW)M7$D*Q6[B2<
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M(+_#O0@T-/HZ8"-4DB/J&(HW+DH^) :4-=M]LZ'H'G>2$BSUDM-"M!'=J/B
M.P]0=Q[YU"&:.>-)H9%EBD%5=#52/8X(#=/PQ8/3%A)MF5M]]AB]?NSZF?\
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MSG/YD:\+2QBT;3^4=YK#E)&'PLMNOVR!_E':O? /E:W-E:1M XMP$V8@G?Q
M^C;*UG6X;52DD;S2\J*(W],'WH5;YX7V=V]QP,EDB)M\-6)XGN6J/U8;K:LZ
M!XIR'85$<M.1'?B_3J-J@=,OZGS!B=F8R4#CC\8-.@K3;;<XD+$H@'+C0B@8
M;H>@K\ZX%&GL_P"['/KN6IMU!'T]\!S:6)!^[6HEJ$5B.JUY DT^C".?3I81
M5%--^-=M_#YX/TOS!?Z%*/2!>!J>I&?L'\13;O09UO1]?L=8C5H&]*>GQ0.1
MR'R\1A^'VQZO]^+*V&NDZ=J&MZIIVBZ3:27^JZO=0V5E;0BLD]Q<.L<4:#N6
M9@!\\_45^1'Y667Y,?E3Y/\ R]M?3DNM'LP^IW$0H+G49SZMW-6@)!D8A:[A
M H[9U[-FS9LV;/SY?\YF_DK_ ,J?_-Z_FTJV,/D_SUZFM:/Q6D<+N_\ IEFM
M*#]U(U5 Z1N@SR3[XVO^UE8W&GKMA;J6JV6EP-/>2B-1T'<GV&<6\P^>;_4/
M4BLW-C9[BH^VP^><AN;J:>9RKLQ<[LQJ3CH[(D R$GQKUP<ELH6G4=/?%!;F
M@K4;[#KF6 ?M"@RF1:<1O4]*?KQBPK6K4]LOTF->(V'8=<$Q0J 00??;^.#!
M$JBJGD?VO;VQ$EJ\*5[CV&-8#@16B]-NI_LPB=>(E0#=6^UVH<+)*'B":LE?
MEA?(OM0#K\\D^CQ?Z.25 /6N>LO^<7K/ZQYH\QFFPLK=2=@:F8G^&?0']%@"
M@ 5'-.; ;'K^O.%_FOY&DU.#],Z7"9+_ $X%N##>90*NC ?S ;>^<,'EVWO[
M'ZW;*L[/']AV;B?%>)) IT[4R+S^3;"85>WFL;@&I9"2 W0-OT]\)C9W$,W"
MVMY;J:*E)XW5-@2&/IUY#I0[8.2WTJ9EAO>=N\C#U8U4!JUV8BM"?N&=/TJ;
M2UAG N+: LK1NI<>JX*TK6NU1TIAG#^C#!%:O"LL?$#D8ZBO@JD5^G!KBQMH
MTMH+?FC'E*J1]2I!45&VYH/HRHHJH)[R18(1]F(;"IV^&M2?;.B>4OR^N-7I
M<WL1TS1RP98%HMS<\NA;C]A3_P %X4ZYZ7\OZ%96$,$<%NEK;VZ!%@B'%0!X
M4SH4<:@^EQ/P@&H\"*@#QP2L895XI1NH)W[[[XJ8XXF/*@:E6&] W@/OSQ+_
M ,Y5?G ^B64WY9Z!<4U?5K<'6;H$@VEC(/AME(_W9,/M&OPIMU;/GN*"AI2-
M8S3B* 4IV[8H%D^,,RE#4U<4KX4'7Z<%Q(ZO& H?G0[&M#3:H-17!<)6,4(*
ML06XDAAMMRV\2>F#83 OIM0EZFHIU/Q=?$8*B6(K&&3D58C?8UVVZC!4$A:6
M,JO E %5%).]:=:[[XH&9W4,K2,5)J5/T $]&VP03]7C$LC4"@$N:*!T!-33
MQWSS9<WDOF/S3?ZDW)H%E]"VWI2&,D*:$]^I^>3^8QV%HP62BIL.3@#IN=M]
M]\AT,4NIW9NI8P(E^% QV7?8[=1DUM+!4C#NBE%V 8'H1]HC?KVPX$ 4('50
MA^U3>NW0@^)ZXXHS[,P)C' 2 UXG<D;4J-Z?JP--<P)/2=660[G:I8#^4]*$
M^!P-/?P( 8H:,Q!H"37MQ(\=ML*9]3;XE1 &4_80UVVZ]^_7"2:YN)268N5J
M2 M#MOX],+VC,C.IY*K'X2QVJ*T#=!_# @EDM)5EMW>)T(82*:$MVWIVKX9T
M31?/ZDQVNN)P)V6ZC&PI_OQ?XC.EP313Q)-#(LL4@JKJ:J1['! <Y]+_ /GV
MU^2H\Y?F+J?YM:U:B30?RW ATP2"JS:U=(>+ &H/U>$ESX.\;#IGW5S9LV;-
MFS9YQ_YRD_).#\\?RHU?R_:PH?-FBUU7R[,2%(OH5;]P6)'PSH3&:F@)5C]D
M9^<VXAGM9YK6ZA>VNK:1HIH95*21R(2K(RL 0010@],0)^G-RZ8TT\,*=6U.
MWTFRFO;A@!&#Q7^8]AGG36-8O=<O&NKN4JA/[J,?909&-0G+,(5/38D9K>S5
M4J5'(^.&'H^*E13\<4-O5:_9'AWS" J=C4+V[Y3H2IVK7I7MB8AH*E?B/?&B
M*K4-0HZ8LB!5J %(!^9P0B%5Y;5.X&/$:C>I44)V_7@*1T"?;"TV^G AD)B9
M@I*_+K]&%UU&H1B5Y,XK["GMA+(!T!^SW';"Z3=B*D]/HR>V,3+:Q@**E=SX
M[>&>SO\ G$:Q^L:UYPN34!([.,T^;FOXY]"7TWUX8SS(1#1Z?9J.IPKU+2Q/
M:&-/A1A\( H21^T3XGPSRWYO\KOY9U$ZK;0.='U&3E<(BAO0G:H,G$?LM^U3
MH=\*H[*&\'&-&)9>7(-L =@:G<?+ TOEDP-),3Z,;$,]%4,#2C$DGH=JXV\\
MOQB ,G *#4D*B<O]8Y%);*.VN5D^IP3%:E8W!96V-.91@:5[5PUL4N(45EMA
M/,ZU4J**O;H.NVPVR5:;:S7\RVMG9_6M1G(Y!O[NW4]6D-*#KTZYV3ROY(L+
M&<75R/K]_0+ZTR[1^T:FH7]>=FTO2XV4.I/$]32E![UR5V, 4.#" -@H[;G;
M#/A1RM!&K,/H(VVPP2-3&96!!7;8[  C>F<C_.G\RK7\L/)U[KX$=WJ]R?J>
MAVLG26]<$J67ND:@N_L*=\^.FIW5Y?7]_K>H7DVHW>JS276HSR/66665N33'
MKW.X';V&.2* ,U*-'1-B6'4]-]NP[X*6.!BR<Z!JA>)[@>&U/#!$<25B4 NV
MP) W79C_ #>&#!&"9-EY!: !B 0*;T)/SZXM"C5'P4 7?;8D ]P:X*A+.*\Q
ML_,T!&[-T%/"F^#H2RRN01\)1F;KQ/\ DGL=L55"X0U_>!3LFU22-ZD>YKVR
M*^>M3DTWRUJ$J59KF(VL).QYR_#3MT!)^C.3^5;1((?4(Y'B *5Y5[$"F_3#
M"]>36+R*T0\;>W)+N-@[?RCY9)K'3(XD%>+(:!U&W<TJU/;#I HH>+,$/(D'
M8D?"">(-1B;[48OS6NY;9C\R!M6I^6$E[J4,0D8,$DW5$J2  >M01L,CMUKE
MS+6+T_5AKR974-N?LLP(H.O;$HH[F05>)3ZP)+<G&V_7XJ?+!2Z>5"F"Y*\=
MN+@<2:@U!"G\1@62UD5B'B9)"*49MF\"I'8UZUP.\8=F,S^FK+52NY# 4J5
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M8)5QS9F )%**:]:]R,8:U95 (Y4J_2O4]-J^!KB3K)(72.0KS4@ ;DUH2:U
M[=<XKY]DDN_,UKI\;"26PLTY[5XF5B33IX;8MIUC]7@'"-7DVJ6W-3\J=?QP
MZ8JB?$*2_:?;J#X'I6NV%US?%OA1'+?9$8/6A'VAUW\1@..R>0F252]&/$%J
MJ#W&^U0.^&T5@D2!45>9;BR[FM!T[4/A@CT5% B ,=@   HZJ/A-2:]<<5%>
M"QNP8?S"@-?BKT[#*%JK%456"QG8$<E)I0  _+;?&.E24 8F0_$S?M'IM7Y[
M^.!7A:-(XXT)D6H9&(;Y_+??,L$AJ6'[UJ*HI7B34]*>!Q.ZL+>[#?6)@TS
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M!4DFE32GW^V37TB%"QJP"4HG'<G>@\,WI>H_(@AGW2M %!Z4I[C!MM8UX\G
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MZ@K706T( G,9-I<1/0(PHO.04K2NW7?H?'/,'FFR\R'7)H/,DSW4Z,1%*IK
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M"IZ;.!0@?RUZ[_J.2?RAYGU[\MO-&D>=_*TB_I/1R>5O(2(;ZW.T]I/0_9D
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M_$UO*6O74^,DS.:^P\,ZM^=/DRW\^>3=#_.#RU&L\T\7#5XX5%/7"AY&%/\
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M=4%5C0@_ -NF]1^&V3K3]-AMXXD$'[QE -3N?:@Z9(HX8D1$;D"YK)6A!(W
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MN*\?K<ZFK#WC1N_[1R6!&2.,-3@%9B/AK0 *!L#M3&MR]-"5Y$J#1*@UK4;
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M^\E_F?Y:OO*'GWRY9^9_+VHK26TO$Y!6 (62)Q1XY%K\+H0R]B,^('_.2O\
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M"B4 @L?G4UZ@]M\$1R>GQ H)%W4B@J.A8[>/>F(35!9Y%*R,01R%/'[6_?\
M5@"01#AP/J32#D7.X4BG0;;>-,$H'C"QQ_&SU7XCTZ@FH\*?1DNT?R/YNUNW
M>X\L^3M>\SQ%/W2:3I]U?2,RAC15@B<DD@T K7.G^0_^<*_^<I?-/JZM_P J
M2\P66IZM\7'5DBT?ZO" #' !J,UKQXAJM7JU<]1^5_\ GV)_SD%K;PR^8M2\
MK>3[8&DJ75]+=W(';TX[.VFC-*]Y17/2GE/_ )]1>5H0LGGS\V]5U8R4]6#0
M=/@T\*-JJLUR]\#TZ^DH_P G/5GDK_G S_G%_P E-#.GY=IYHOX:?Z3YBNI]
M0#TI]NU9UM3T_P!\_AGJK0_+OE_RQ8IIGEK0M.\O:;']FTTRUBM(%[;1PHBC
M[L.<V;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9L
MV;-FS9LV;.2></\ E1%9?\??X"K7]Y_B#]%]>9^U]:_RZ_3[YYTUK2O^?<&J
M/)'JLO\ SC[%.3-'(8KSRU9R\W-)*M!-$W.O>M0?#(?+^5G_ #[*O0S+J?Y2
M(C*$/U/SC;VZ=Z4$&K( =^O7([>?D'_S[%N8S%'YI\@6#APSR0?F(Y<]?A;U
M=;E'4^%<*Y_^<<O^?:,L;QC\Q?)]O(2?WJ?F# 75]JGX]1=2?F#A:G_.,?\
MS[?#$Q_G#Y=Y5[>?M-.__21UP?9?\XV?\^W+5Y&E_-#ROJ!84I<>?[0!>M2!
M#>Q;GWKAK:?\X_?\^S[:<22^<O(]]\'PQS_F%04VH08]7C;\:8?V?Y1?\^R=
M.^KB/5ORLD]%R\7UOSNEU4UJ:_6-9DY#V-1DYTS0O^?=>DJHM)_R*E5.5/KF
MHZ#>_:ZU^M7$U?IZ9Z \H?\ 0O\ RC_P%_RKWG4\/T!^BJU^"M/JO?[/X9V+
=-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>sny-20221231_g18.jpg
<TEXT>
begin 644 sny-20221231_g18.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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M^9>JPER25LQ!:'=N6WU:**GM3Y9$;G\W_P U]0<M>_F7YIN1S+4?6+PHI/\
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M?^%/''%_B*,*L#6A.V]0.@]L=RY5KL>)ZT!Z]Z935^$_%0@G?;[_  Z90)/
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M-92)(K/^R90/4=SN:DR+MVZU+H-/TB*8+/YBN)Y0ADB;U%B,\1%0W(2R*_\
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MS9LV;-FS9LA_GOSWY8_+;RQJ/F[S=J*Z=H^FIN?M2S2M7A! E07D<BBJ/F:
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M].G' WY@?E]I_FN72_,^@W*Z/^8NEEKC0O,.F*L+WM5]3T7"543%5J8Z^G,
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M;Q4H% )/0GIMX^V(%>@IQZTVW.,)(-=P=Q4^/A4[XBVS?,[&FWW;8FU6JK*
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M%/GE[&@^T*'KMM]'SQ:PNKW3KNTO].NIK*]L9DGM;BW=HY898V#H\;+\08$
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MY8-Q]&J[[BF^PR-ZYY OC<JZVE+F"YE3D5 CW',QFI4TY, NVQ(4[,,YE?\
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M8SQ8T'$<> 5?;VZ9W;1_+,2$GTP_&C.9F!J:T!*C?M0#;.I:3HO%BS*68+Q
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MNG:UHMPWUFVN JO1';D'!;>A'?W!!]O# WF&6RUB#]&ZD[6DK+(B7(('I&0
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M !04V[5IC222 H :E"3[?3WRPM2W$\*[J/[/#?'\J#8U'6H]O??&#X2#TH?
M^V]#MF(%%/7<[U^[L>^8.>M?#H:TIV-3MC&^)0Q JHHO?O\ /&L-E)/(C?XJ
M[&OC]&!GY,>FXZGJ=\K<4&X--@W?K3K0C&<^5*=Z = :4QI;XMP!U._<;"A)
M[?1GTZ_Y]]_FH7/F7\I=4N2*\M=T-)&J1N([V!/^$D"C_+:G7/I[FS9LV<G_
M #P_,)/RO_*WS?YP$BI?V5FT&FAOVK^Z(AMMNX61PS?Y(.?GM=YIYY);B1IY
MIW:21W8L[.Q+,S$DUKWJ<:%Y&M*@B@!':FWAX??CBA  ;X*BA/7H:>^V5Q
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M'IM[XF58"A%012IZ@]A3>FV('K\+=QM\CU!J/QRPU5((I3IUIT[[^],]H?\
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MZ#MB(% "W8$\>NPWWVZ8\JQ!VH*5J-ST&VQS<=S0&HW(-=@1M\LNA-5Z%O8
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MV/;!"@@D%?BIMX=]]_<]L?0"E%! .XK3]>)&E#4U(KMX_(X@W5=]CW[;^/\
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MM7I@=JT%7/Q#H>O^=<:14@\BHK7MU]Z>^:M%>C\23L1L=S^JO;$Y 2QJ?VJ
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M4BF?;;RUYB?7_P#G"FYUA)V,T'Y8:M9&97J_JZ;I]U9LW,;\N5N2>]<\Z_\
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MKFXN1&EC(EP\TLNXB'P4"4I12W0$#?8>$*T2R1IQK5WI3:5]3#317<LG-@"
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MZZN8F+4!N=.N(KU"U:4Y*&3.1)<P7,_F729P)UDNHQ$@/IK#>VW&6("O+X6
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ML%IKNF_68-0AFB&H@3.QNHCT:C'X64G;C3[Q@\"W,CN%,(8GA3XUI4#H344
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M-??\,M22!U84KX=:=OEF+$*O(?[9\<&HANHT:WB9[F)5$L:#[8799%7;Y/\
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M_;%$81<)&Y_NB'K$WIR;;GBXH5-.ASL'E[S+/IOYD^7KJYTI4/F*VCATS4U
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MB)(FC#"@!)H6)5J?(')+HWUM)IDN11HF556I*A* \NI[G^RF=4TPB5#M5QN
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MWKC@*4Z%?"G0>/X8[D =GJ&/0]_8TQFYJ205V^5?\^V(\BQ6H)Z=!W))/;%
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MQ0#J"0#0_+&4(%=@=R 1W%!X8C6E>@V\?"M"OW8\$T#=Z;U-.G3P&V),QKQ
M KVZ?12E<Q9:-Q IM6O8]MQX8QW)'(;$4 _K45\,8PJRL!56Z^/3]7\,I5!J
M2">NQ.Z[FE-L:0PHVRL:GEL013M0910#B#]H<232E:UH:;;9:1$DL?V=@%[
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M^L[?1CMR!\55I](%.NW3?.[_ )!:>+K5?S-N:5.F?EAYRNNM*%M*FM_I_O\
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M@JP)(^FNV4"./4?#M2@/S[9=68<2:A>H'3H/<_3F<CIONI^'>E17[\=S.U
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MD1UX\:]%H21RJ=@!7I^%*X8P2R&)' 1R%"GCTVV%-R3[82ZEJ$D()))(4R$
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MK"K=02.]/HRD;B%*_%UI0;]Z[>_SQZLPXTV5B10[4^G>N+%S4;MR %*[#?\
M7EF6NP8%B=Q_G\L:7J>!&[?%0['MOMX8LG([G<!=B:4/3;?Y8T&BBFW('8 ^
M!J!MMF5BI+=/BK4[;=L=R2K #8#?W/C]V+G:I K38T]O"N.C)H!0A5/V1[#V
MIXYZ1_YQW\GZWKWY@>6]:LM.^M:3Y7U>SU&\E8\5:2T<7$%O'W>1YDC^ =JG
MMB?_ #DAJ]]??G%YU;4IUGN4NH(4 D]1DAM;2W@C5M@58^D69>H9C7?."DL!
M4&JUV4_%WVK@FWD:":WN4YJ;*=)>2&C  T/$G:M.F>EK.=;LZ=>1,I%U!RX\
MBRHT?$[LQ!/$'<G<T/CAO;6XC*ERQ0D(%8!0>3&C':AW)VIW.]=L4M5>&69+
MAU B+#P^$EB=O$U_LSI.E6WUF"!&575$H'![DU /CN3_ )TPT&BQ31O#,O-;
MCD]'04#*:UH/&F0C5O(UG>QO+?0F4+3BD@-$4 FM#L0Q/?I2O7/$_P"?'_.*
M>E>9K>XUOR_#%9:B(B6*CBE0*B,TZ]>N>(?RP_+GSGH/FZU\K:?>WN@:^MS(
M+F**1D614C>1G,=>#@JE1L<^H'Y1_P#./GGCS+)HTOFB_3ZEJ5M+=/<VE$E1
M@08HV4\B25)J:=L[;JO_ #B_K=CYITFSM=2>XT'4.*NU!ZD9I6I<#=2H)KMX
M8E^:O_./NM^1;.RUSRY>RW-I*8X[F*0MR0L0 5<EA[4('SP':_E!^;<-G;RN
MT5U"J!A'ZOI2#O2ACI7Z<A%\/-]MK$.B1Z+<#5)F,,2,H8EE7DWQT(% :_(X
M;ZAY'_-FTM'O[G38K>&TC+%%8S2"@->5%XUIMUR :7/^8^LZ==SV/ERY%O97
M#PW,O%?B< U%"1T\,@L'F_6]9:_LX(9W;3I#%=A$*^FRDCBX,9%/A/?(!K_F
MO3;.&>[U76K?3;6V(69[B=$ <UVH3L2>P%?;//>L_P#.17EBRN6M?+EK?^:K
MQ6X 0H;> L"* RR"I^A",[/^6VJ?F/\ F!-%+J&D+Y=L)@CP%I'N&;B14LSJ
MB=A^SM[Y[X\L>6I;"TCDN+ZXN[Y2T:O(0S?O  1Q"4VV'3]62N/R['*JRRV_
MIQ\F*1F@-&.Y-.M: U)K3"37&BM8IJ,:/\+"F[<C^SM_K=3V\<X;=2?Z3<RA
M@WIL OPE=JT  ('2O+Z<@][(TG-#PH6(!&_(E2>!Z @D':GAD$\Q3Q3SS6 B
M :V,<+;%N:K$K'XR2"0S4I3IUKA99ZQYDT:W.GZ1YAU#3]/ HMO#-^[4=?@#
M\N [?!3.C?D]I:^;?,M]Y$U:XEG?SMI]]'ILLLA=TUVUAEO-/:LA:OJF"2!Q
MW$@\!G++Z P2R*V_Q5%34D&M#7P[[85FH#5KN17CX^.8*S4Y&A/VJ]>PZ^.*
M* 5!V(!-:?03^O%"K$$CH *G:H/CN*XD*DDR5XD4['ITQ3B3\)%* BBC;>G6
MAIVIB7("@KN2:4[=,3Y=-Q3M[ #[L3$J@<0M:C>G;VW^6;DP*U%*=2/ZY50>
M]=MB??QY8\2<5%:]*#W->X/S^_& B@9AN2#7?MU\<IB""0 ? GH>Q(P,S%B:
M4//<>WS]\8O-G8J"&:@!\?"H&*_'O\-!W^9J/\]\>#R'4D*:]-M^F+!OA '?
M?XO&M#U[[X.L+:YU2^L=-LU,UY>SQ6T$:[EY)&"(.A[L,_2Y_A+3_P#!'^!.
M1_1?Z#_0/*F_U?ZM]5K2O\O:N'NI:?;:MIVH:5>IZEGJ=M+:3J/VHID*.._4
M,<_-!K^DW'EW7M:T"]8_7]"U"YTZ<#8^K;2M"_<]&0[83*7J:&E  :"E!2IZ
M>.*<:GK56)IW([@?=C-^BM]JNQZ"M=MZX[G0<2QVZ=J]-^E<R[L*?$]* CO\
MR?IQ6@&_V0#4@4.Y^_'[TKR-.PVW]]O;&'C0FM*[=!6HI\O]K+K0$\N@W VK
M0=-\P-*<30#>IW%3T'2HQ?E7BI/$'85KU[^%.GCBE1WJ%)([==O$8ZFPJ2VQ
MK38"@Z'[L>2S*WQ ]3L-_'ICEXD */AKO\NF_3'JH3H:]MQUV_53,(Z D;$$
MG;;YCMURS10-Z=2!MT\2.V*QGB3ML"*[C<]Z[9]"/^<6;AD\B^8;'1[VRC\V
M:K>W@TY=0E%N(REG"JLLG&0E>35=U4&.BFOCXW\_:#YC\OZU;1>8T<3ZE!+<
M^K(6YR2BXFCNRU16JS1NM!4 !=\A0<BAWXK0;TH?NP5;RISX'?D"K4V%#W_S
M\,[?Y-O]0N=.2TND+6^F*L$%P S1ED)=(#3HW%R:@]%^6=7TU5FDW+2-,QJY
M"DAJ$BM=_:GA7#2:S,3I/Q*Q*4]2HW"K5'8FGL/I&=#T2R%S;0_5_A<I0UV'
MQ<AN/D/QR=V=I'+2,NRAJH"/M+2M-MMZ&N-U+38 JGTPC@F)P%H2C#8]=Z=_
MGG-=4TJ,+)!(GJ0-4.E:CAX5\0!M\LY?JGY=Z/?:S9>8K2R@C\U:9&1;W?IJ
M!-;/NT;%020W$5[@@]MLZ%Y/_,RV\DOY=M?-$0T:6*[.GS"1@R5DD,:,K+4%
M3537L.O0YZ-\P?F+9:9JWE2U58Y1>7;>LS'>"W4-5P!XNP&_OWR4^=-;T2]T
MS1]-O+F(QZWJ=M'&K,/B6*19W*[[T$8!/N/'.@6MO9362E^!^$=LY+/Y5T[_
M !X-4,:%ULC$J  _$7^V?<+5<FVIZ=9+I\IXJ?@(I04Z4R$Z9I^B:7Y:"6\,
M,,<JF1RH /):KQ[]*4^C.$^7-!\B+IGF&]T@6D[^8=4N[F[FC9'K+ZA5HMNG
M%EZ>.?&/\U=&N_S+U[S+8^6XX[?1KC7KFY-R "KQQ3.%"$4!.P/7)-^5?_./
MNF6,\&H:A8BX2)JIZE?B>G5OI%1XY]$O)7E&#2;"WED@,,E%6(<>*JU.I %
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M.Q[['Y5 I@A"$H!45%*CKTW[_P"=,^C/_/N3RB=2\_\ GKSO-'SM_+.CPZ;
MQZ"YU*7ES7W6*S=3[-[C/L'FSYB?\_%_)9DMOR\_,"".@CDN?+U]+O4\P;NS
M7Z.%P?ISY;5/6FW3>IZ#IE!/?DOC\_ G,%/PU&_;M3%2O"O?\!0?V5WQFX!'
M&C$?:[U[#K4XKQ9?LBM*GXJ5)\!]^)<*#MS_ &33N?;IF5*L!X>'4]17% -N
M@!7J1W_U<LGI5JTJ>2]?<_CC=FH>NPV&PZT)-?ECTW(50% (-!VV[UI7'E1\
M050RKM6E?BJ?XYJT/)=N0H3M0 @_Y[Y8<[*I )-!2FWMWQ930MQ-*C84^CKE
MJZG<,*,NW7V&U<4YLHK6AK]_TD9?JGB.1#;@4I2N_B,4BN DU"!*&)4CI4&H
M84WZUH1G</S0N[CSUI&@?FA!--?2S65IH/F,2LT@M-6L(A#'("2W!+R"-90-
MAZHE(W)SAO(=0=CMOMMCZUVZDDUW\30'OX8-@,$K"">3TXF8%F[ #<@@@@@]
M\[_^7>M6EY8H]K/'+#I4WZ/?TF94B!7U8DJQ9OB7?KX4%*9Z0L+@S05)J2O%
M@M * %2*#PJ*;8ZVD^K7B/\ #50J.2: Q@;'D3M4;]\Z[8?O(*M5_JZ*Y J-
MNX'>FYIA\R17%I)&U0 @6H-2 :%6V[<AD*>M75B&8U&]:G8TI4; XO"D5Q&\
M$Z"164JP91O38@#I4'[\@OF3RD.#RVRLR$$HJU5HR*@E3UR#6U[KVES!BK7T
M*J0_J$&JCI4<2:9TS2/.\[Q!;FV>,!A]C]ZJ_0[J^P'C\LEA\W0B%UXN!)R0
MMS8@<.X#A?\ B1Q:XUR!EC(N5C+! 581L  M2!2;N/GD$UOSA9V[7#QW"3%*
M*&DD"JM:U AC#5W[L3]&<<U+S%?78?TH6YEF#3-2,-R .W-F8C[AD N8+_4I
MY"U9T2H98OC!:A^VQH.N^V3'3-'X(';B64*%I5%7D:\0#09U'3XDL((HD3E)
MN[D #B>((%#W[4'\<7OYHXD2.6BHJJI*DAMZLYKMT H/&IZ9S_5M::TCO)9.
M".B%Y"/C537C0CEN*U Z=#UR'6SO:V3WMTS"\U$^H$<5>,$_".O7B!7M6OOB
M+JR6TTSBLEPK,]*&H._?L!M\JY$S;BYN&E9A%:K1W;H *,:$'I4FOSR#ZO:2
M7OF+RWJ-M),^D^9] EG@CD  CO--U&[L+N-?E]75J=N0SHGEG0OK5MKVCN@9
M7<NH85%+J,,*@]@X.<\\Y^1;C2(=.UJTA+:1JR*T;=?0FXGG [?-3P/<;=1O
M%O*6BV&L^:]&TS53Z=K=,Z!W=5B$W&L/K%MN/.A-*D] ,]S><_.?DN7\IM3\
MEZ,(+;1O+]BVE3-&'E6(I.KV4:<C*:BYM:>IN6](IS'$U^>LI)+,2#(.HK2@
MJ=O# O()R1P14^Q)/ZJUQ,FGQ$'X>HKN33V&)LS4W4=J]NV)/U-:&BCVK^O&
M%&)8UW!]]Z4ZG[L0<-4N"-]O'<^^,YT.X'\I K]'AX8BV[.3]GIW IXU]\8Q
M '(-\2U!&]-_O!Q)AOOLRCM7PKOE !0II7B"/D.FU/EF5BU!L@(K7P^G;$F#
M?$. 8-T--S]Y'?,J&OQ=* BE:5/6OCBP% ]*!J[4WIVKUQD@(WIN?A6HWZ?,
M9B:4/VJ *">@IM09EX_#L O2E:=*GW['/N;_ ,X%^2O\+_D5;:W/#Z=[YYU2
M[U4EA1Q;0D6<"'8?#_H[.O\ KY[5S9P#_G*'R,?S _(WSYH\$!GU+3K(ZSIX
M3=_K&G'ZQQ0 &K.B.@'^5GY^N6_3EQWK2@\*8HE?H'6M1TZ5.*"@/V=SN ?;
MK6FW?-U!(!';<4VVIMB:N 10[DDCL2:CMU[Y88 <1L#N3\_\^^4X!)_:WH*]
M.GR]\1+4&_C]D=._N,N,@_#2I&] *AJ5W !&*FG2M=^I'A6M-QE#DX-!\2BO
M'H3XT!Q50 -MJ=J&F^_6N8L:UV%/L]BV_CM]&.-26/$T78;[5[^^U,P5:A@!
M3N0-O"G?,I:AKU%2%!JVU=J[XN#T() V(/6GRVQ0$$A 2O'XA45^D>.)-L:4
MH"=B.G;+!Y<0#4$_3L.N^3;R?YPO?*=W>K]5CU+0]8@^IZOI%R2+>^M">1C<
MJ>2,I >.1?BC<!E[@F.K>5=$U-!J/D'7%O(+@_O-"U1XK75;4G?BI<I#=#P>
M,JQ[QKD"NK'6+):W&DW4+KM1X9$%>A^)P /G7#OR9Y \T?F)K,.CV4?U:T*M
M+.5/(101T,LDC 450*5H._$;D9]!;O\ *K0/(7Y<:=Y/\OVJVL>G0W.L7,X6
ML]S?%/4EN)"2S,[,W$ D\5"J-E&1'R]?GTVA>0$\:,3N*T7B:^]![8=7%Q\6
MV[&J=OAV#&@Y;"M<ZCY4U..6VCEJK2)57=7K12!0=Z@<LGUHQ">CQ//@2I[,
M#6J_>/U>.1S4;<V\S2#D>;LC CX:C<4/@0U?Z8513!)J%JL.)4,0!MLN_3J,
M$+-S% Q'7:2C*21N 2/; %SIFGWW]];1B2AW"BOAO2@(W\<)HO*BI,6MY?A6
MJE220>IW\<'MH%[( ALXC2OQ\MJ;[ $#K@2;2;R!/]YT)8<0P<TH3X=.^1N?
MRV)#6>)T4$,'5J!>)[4!V]_?""3RWIZ'D#]8Y<Z\CSXU!K7C3H/'$+;3;:SC
MD&QY_8% JD;5V6NWM7%((JR <2AKZDDJ@U6@!XCQZ=/;)#9Q NBJO!G[=> Z
M@J06WZ;D^&(ZX$@AGF]'F8XP5&P&WP[D &II3QKTSAFLTE^J6TI5FO[@WMRX
M<BHA("(M5'(5 IOM\^6!;RX:_N! &X*O'J*5H * D^^WSIXY=Q*TG&-#4OQ5
M$!!*T)&XZ]J?1G.//VOII(TW1;5.4EU=Q1WKJWQ#U*@ [$T# DT[TQNEO=KK
M.B>5[MPD&C7%WKFELW62VU8VMOJ< J?]US6Z34\';._^7M/-KKQ0#X;RQZ]?
MBMI.W3]F7)[;^7;76?)OF+R_?6@NX();N(H>M%?ZQ'0BA! (H1N-CGD_S9Y(
MMO(?FC0Y/,8N;WR=<WEGJ'KV\8EGO=,BFADN8(T)4-<^G5"G<LK#8T"/YQZ;
M::#YUO?+EE;+ /+-I8:-,*!>=S;0)+>$\2P'^F7%QL#MTWSCK$D$A:5)(!45
MK6GB=L#N" :"A9@%\*]\2(/(BI84:M!U'WXUME8>)-.WR[5[>&)L-Z[$CN>Q
M'\,3<L14,PKN#6E>5-FJ=L0):H.S5/8[#+8T/3F 6!^(56@K@1Q058T(VK]-
M*TV-!B?%A2A-.M!U*D=]J[4QI[FC#E0?=[[97$C]OE7?IN?\Z5S)'4#8M]JJ
MT--QVQ[Q*.1,8 H-V.VW8[Y:H!OQ+4\>WCU^68TW^$G?<"H)^C;KC2%)(0-0
M>!\>G8'&,N_(+0CJ37IW^ZN#=%TJ^U[5--T73(?6U'5KNWL;6)33U)IY%CC4
M?-F S]-GDSRS9>2_*/ECRCIP L?+.EVFF0D"G);6%(N9\2W&I/<FN27-E,JL
MI5@&5A0@[@@]01GYS?SI\AO^6/YI>=_)7#T[72-2<V!;>MC< 3V9J1U]&1.7
MO49R\5-30D,1] K3J0/#%T8@J:5'@30?.E>_L<TH5B=MJD4Z]-O XCQY$$"O
M'I[$>&:K57BU*5-?F?UY:MO4?$]-B:[]1TZ993Q 4 ]CTZ"@^FN- .XW"G:G
M?%B@!( ()I4;5-/Z4S*N]6-68[D?.AWKMCCR('[5 :5'W#IB=.M""!0TH#_G
MOBBJJU)'*FP/7Y'Z*Y?!&Z 'CL":=/P[8X(0>) +]P.A(VV\*X)5%'1BU2>G
M?V)[X\("./>O*O7Z ,P4'@5Z[ ;[<@=AVH<>(1\->AH#05\>E*YN%!T'2HJ-
MNE0?PWQ0(Q55XUI\._0]M]N^'>A^7[K6[^PTW3K)KN]O)D@MX8AN\CGBJJ/$
MG^N?43\MORPLOR^T.T\O1B.YUW4Q'>:]>)N%CB/*.UC-*\.6P_F/)CU%)-K_
M /I)U*8T*M)'8(1V"'G,U?G4?1GG+7=+-O=/>V:?!$0TJIL% 8@-X4)#"E.U
M<*$N_44QRG<4H>GQ=:[U!W/ZZ9+?)^KO'++$TU =PI(^+>H)-?$G.S6FH((F
MDC;^Z"DBG$56C CVZ#)!>1Q7ELLJ'D'3<4% =CO7P.0MXG4NK!JARG(&C@TZ
M#H#6M?H]M\BF/E0FI(J#0<J=#2H%=L'Q,%16XU )I2C$?ZP/]<&+(H^(J0 .
M+,*UX_(5_IBSSQ $&G@6 Y+MO4A:_B,([F[=2  !RV%/AJN]=SW\-AA%=UE
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M&0G[AGBK\F$]'4[>;[(60 $^]0<]\Z1=MZ:HS,:4XBE!3W ]SD@4LEV'Y%Y
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MG.M?\XK>0I//_P"<^E7MS!STGR;"=9G'51,I].T7?J3(>7^QS[+V%MQUN^D
M^"WLH(5/NQYFN"[0&2[U.?\ 9C:.$4_XJ4LQ^]\H*8_+K5%'DMB:=/CE:I_%
ML,-2B_T2"V'5IK>&GMR6OX+@B])EN]/A4 AIFF8'^6)2?UG*<,VK6JUJ+:WD
ME([UD(0?A@CDKZHH&_U6U/('QE:@_!<$1.LFIS?M?5X$CJ/%SR(^[-(W.36I
M8S1VBAM$(.X9P1M7PYURY[?TSI<2BB)*H ]E  P7J**;2)6'^[XMO>IPROE
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MO)GD[UXUXK^ QD!9KNTB XB\FGO)0>ZK6.+O[5PYO8_W^G4_W\?U#-JB@00
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M_J06JQH?]+NWH#UI))N3\E'ZL8T<:O!;J:06:<S7QH0M?N)PJNP[VLA4\7N
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MEZ/H6HV.I>>="A%F]GKLN@ZW;H$6%IC&'BN8415 #@$'WW'<GA\NG">.="E
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,FS9LV;-FS9LV;/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>sny-20221231_g19.jpg
<TEXT>
begin 644 sny-20221231_g19.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
M!2$2,4%1!A-A(G&!%#*1H0<5L4(CP5+1X3,68O D<H+Q)4,T4Y*BLF-SPC5$
M)Y.CLS875&1TP]+B"":#"0H8&82414:DM%;352@:\N/SQ-3D]&5UA96EM<75
MY?5F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]SA(6&AXB)BHN,C8Z/@I.4E9:7F)
MF:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H " $!   _ /OYFS9LV;-FS9LV;-FS
M9LV;-FS9LV;-FPFUGS'Y>\N0?6?,.O:=H5M0MZNHW45JE!U/*5T&V<2\P?\
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MU)X:4'412VTU:G_+&=9T+_G._P#*74>*:OHOF'09"?B=K>"Y@44Z\HI_4/\
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MC ;U'B,#UH0*=34TQ_JFM%^$$[GVQ[EG H/;$Y#$D<CSN0L*&1UI]E1U9F)
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MY@].TU9CHFLL0"LP/IR'L0YZ5]\['R5N/IDR!A7D!4'8=QMEJ9.U2!]V8EV
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MXA$TH%?;(E-<1W=8K5HKE#7DL2.X%#TV-![UP NEWTM4]".R+[4BC5G/A^[
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M#Z+ILFB6TX\J65RO&[F=EN-7OD5>\$1<QHP.RDJM.ISE]_J=M(Z?5+]HK62
M-&MP3(%8;!GX_:VZ;T'[/C@?3KRPL2FHPWJZE>1$HMW=QE$22NWU6(@EOGQ
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MK%MF7D'DE9?V1_PI.&]_/,?TC=:A/>6UQ>RM!&A(:]F*@;QJ6?TD);8L>9[
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M5P]M;1F+4BX@ @D'E6G@#BZV#E"2M .XZ5Z@TQ6W)BE]%Z^G+NA(I1^X^G#
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M6VY57<]<X;J!>^UX+<'A!!6ZFVV/+I3J3\- ,[C^7VJ_OHDH3%<2@>EVXJ:
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M6B_EGY[;RCJ/EF&STJWU/S);K>VGF0-)ZFH3O';/ZENRE/W.PJK'HP"^C_\
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MJGVA4T([#PQ8T-#T./ !WY 4Z_+/J'_S[,\YBV\T_F1Y FEHFLZ9:Z[:(QH
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MS/:A'4A20[ 5^?4TSQ'^66F-HOYO6>D<W$=IJ$Z*U./*);GU" 3X*V>_]?\
M*T")I6I&,4CU &)2M> -.7+PV8 #/-7YC>F?.VOLL*Q1M,!PIT &PR$EN*D
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MZ!9S\9%0?&RU7CW49O,OF^'RIHIN^'UJ^N95MK"V'VY)G/4[[*HW8^ SP?\
MG=^;.H:5;OY8\O7@USS_ *[<A)!:W$D%Y;,1_>L8ROPK6@4_"!GE3SUY*\U>
M3KE8K^6>V\U:Q:1:C=:S<R275W)ZM>,<+R$^FBG8D?$>YPXA\Z?E&WF_RM?W
MWY:>;-:MH?+4NF>:X[OS.T-SK&O.L?H:G;7$,+?5X(2K@0@+R#+4? >7N/\
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MOQ3_ "FV[]<2)H.0-/\ )S5VZT)!V&)U+'B3M\L53EU8$=M\%HU!0$T(WQZ
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MI]L4J37?(MJ<8-2B>G(!4%AW]CD9L;IY+B0;J3\)\/\ ,X90ZO?Z1<^K$Y:
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MGJ;S1]4A<CXNWU1:[>&Y[<8_YS/U0ZM_SDK^9,L9#K8RV%C&-B!]7T^TC<5
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M.15GL8;E6NKC4$<(\4D(E=BW(&M1[G.4>4O*EOK/F277;JT%O)>3K<2QK0I
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M^E3L*U W/7%3Z@V6AH-ZY7 @<F((RN-#RI0D]\?LQ .QKWQ;@5JM:UZ4QP!
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M3R8]O84ZUS,0H(I]'OB5.X'7;%%([@8B0*CL">GOBG&E0PW/3$R.M0?<XWB
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MIB1&Q;IXUP,XK4TH!]PQG '9=JCZ,2?DH%/L':H\<HT4BOPKXCK7YX@H*FM
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M:@UI[90V)'?I3++\:#N<E?D?RAJ?G[SAY8\F:,A.I^9M1M]/A/$N(_6<*TK
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MUQL<;QO-'O\ :Y*>W%NPWWW&"DC9Z  M4GL<%"W9=FHAZT) KF/H"G[T-X!
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M4IXTZT\<PZ;C:N/H>M=]L:VWSSF7YIZ*FL>3M7C](R/:JEVBJ-^4+!]OH&<
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M2<1,A8$\.A[]SE>)I4]\^KW_ #[V_(=X!=_GGYELRK3+-IWE2*5:$*:QWE^
M1WWAC->GJ[;J<^JN;-FS9LV;-FQ&X@CNH);>8<HY5*G^HSCNK:?):W$]E,HH
MOV2*_$IZ,/#"58G4,64\DH&!.U.Q P?&2*5H*]>F#D2M/ =,5(%0"34]^V45
M'2OTY7'>IZ=JY5"*KN13 DJ@\@>P[]<#!?';?% -@3] IBJ@BE!\(QK&O0=_
M\^N4O4'I3% *$D#?K4XL/?<=C7%UZ'OBBJ"/GBP4;5&/H,Q44WV\,1X#J<I
M.Q->V/* #L:X5:E9K=6UQ;,/@N(GC/R<$?QSP'HHUC3;W4;&.-6^IW,L4RU+
M&B2$;5W[>.=#MO,EK#&XO(KF,$4(:)BIIUX\:[^&1^3SQH=I=2VC3QWFD7;
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MY^./[BHS4[CIX5S-X]:#&4%?"OAE@4V)'3;$94J#0#YYY"U;1_J_GWS)!'$
M/K0F!Z I,H;;Z3@ZYT]70U3?>M10@CIM_'(?J&@032AEC F/2H_#IBNBS/I"
MW-K,)&TZY8&\M"2(W!(JP"[C[(K3PR;17AMKCZA)Q,2*EQ;2FA$L,FZ.K#J"
M/I\1D@M)HG8*$X\S\ :M-^]<5F522-UJ1L/[<(I9/0>M:_%4D=,#W1#QEXSM
M_G7!>GT=>E:"E#T-<D$$(1%8[C]6*W2J8J]#3K7"ZVC4$D#[7M4X%U52+>0
M<O"@Z^V>>O/6G1W6FWD3HS;JW%?M$D[@>^%FE1LFFVA7TVA8O&?6X \6*CB
M_1O"@KX9.S'-&T<BR\?AV %.@VH#7+=U+#U)-FV)(_9 [C'&)742AR H^'V'
MCG+OS U"]TBTM?-&CL1K7E2\AU>U(JN]JW)XSX!TY+].>Z;#6=*\]^3_ "_Y
MNT.<7&D:]8PWMK(M"#%.@< D=2*D'W&0=V*^K ]"$)%.AKXXHB%D1Z[C[0K7
M[L.[!E>A6M%V(/WU'ODCM@0I&W&G7QPJU:*C)*!0J01XCWPPL7#(K#)# ?A
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MK4CKXX/T\A)2M2#3>OO3);;LKT(-2!U[>^;48?4@--^(^G;I@32GYQE:5,9
M/C].22+X3ML#V'MADM&6BBF%EU #RH*UR(7,1A?P)\=@<*KV16AC)JG%P:D?
MPR+^9]&2[MO4#E'4<D8 C@P[[;YXA_YR/_+QM7T1/S+TFTXZKH96R\QH@_OH
M1\,-U3Q7H3X?+/$+2;BO1MZ9]B/^<%_^<9F\K6-M^<_GG3O3\Q:Q;U\MV-PO
MQV5G,N]XZD;2S*:)_+&:]7HOTJS9LV;-FS9LV;-FS9B*['<'.?Z]I7U*5+V$
M'ZHS<9 .D8;;[J],(>!5B!V./XD[G?\ AFIM7QRPO[5,OB"*[FO7PP)*E=MQ
M3H<"]]ZT)I_F<57?MM2FW3&M2H%:$>&4!4D?30?CFXFH(-1X^.7W\?GVRQU(
M^G%5[U.PZ$X*BK3IMBP^GVKE^';Z<<*;=01OET';IC16E!F!QS"M3G$OS.5K
M/6/+E^AX^HLT!H-SNK"N!E:.Z2-S0EE/(T[]*8!EAH=E-">(+'?\,!-9Q$M(
MP.^PIT^1^6$M]IX8%4!(7<5->OO@+AZD;NT)-_:*/K(0<I;J%?\ CX-%'Q1@
MT8;_  T.*VMS;W;SM&X/U=N#!E.S #:M!78]1A?>W7[WTU/7K7N?IPQLXU$*
M%B*4[^)P<@*/]F@--QTPXMI*\0QH/;;; ^HSJB\>BTHON?[,#618[MT^?7#J
M.(2*RJI(._\ 7WR ^:[ Q0,5A$ZR5!C8T!'N"1\\Y?SN(KOZLQ1"TB%"  71
M:D4!!.QITIAW#>)Q-(^'('EM3<&F5*[.(D)"M0E2=R?#;!J1.Z>I)\7PU8_Y
M^.1ZUTB+S7^8OY;>5V E@NM?M[VY1EV%OIP:[>H]S&,]@>>-:71/.ODR^E=8
MX-<N9=)N&8T%9@'A)_V:T^G OGO2?6MGN8$_>Q@R#;;;?.=Z5<B6..16IR &
MVXJ,.DD*S<OM=QWK7ITR46;$**F@<?$H'7VPR=1)"1OTV_ID>LW-OJ#Q-L'Z
M ;9,43D 3^&&$ -#78C+GCV-1OD8U*UK7X:D TSG6J3F%.&_/U5I4^],.+R+
MG9E1O\'3N*]3OG-+;3;.ZU2\T2^A$VFZ_;2V-Q&PJC"12-P=N^<4_P"<;_\
MG"JZO/S,UOS'^85F9/('DG5'CTBVF IK<T;!XBR[U@B!'/L[CAN X'U^
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MC?(1Y?TU-!_2GEM2?JUE.TUHI[6]Q\:CZ'##.3><K0V&MI=BBK<U0TVW7??
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M825 (WZ[=\Z+Y;T'5M?E5=.LVE16'J2'X(D-/VF.WT=? 9Z \O>0[#2ECGU
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MR4_F!'\,18;5R)ZPA2\C<@\94Z^XR1:'=.%B"D@J?M#K]/CG1K:<RQJ3\1H
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@?ABF;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>sny-20221231_g2.jpg
<TEXT>
begin 644 sny-20221231_g2.jpg
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M_\0!!  !  (# 0$! 0            D*!P@+!@4#! $!  (" P$! 0
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M$0,1 #\ O\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MLLX-S2^/-736MHFMHUC6-8G28UB8F/R3J^PX;Y
M
M
M
M
M
M
M
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M1$1&D1$>D1$1Z1$1Z1$>Q_&^S]
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M-E:*[S%EQ6M&L1>MJS,?;'5$:O5.J<8
M
M
M
M
M
M
M
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M=8]=6#F<.Y
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M2+3,1&LRQ+?\!SO%Q,\GLMWMHK$3/S<.3'I$SI$SUUC369B(U]L^QF9AKJ0
M
M
M
M
M
M
M
M              'XW%Q;V=O/=W<\-K:VL,MQ<W-Q+1!;V]O!15+-//-+53'#
M##'3S5555SQ333QSSSS]'[QX\F;)7%BK-LMIB*UB)F9F9TB(B/69F?2(CUF7
M]K6U[16L3-IG2(CVS/V0U$['^07P;ZD]V/L+RW\>]?OH?M.9<)_*MI^6V:F*
M^]7VMS^ZV$RN2V.JSEXIYY]_BUYAIX_;S5QPVWVY]/\ YP[MTMV_VEW!N,%N
MK3)]QW%,.M?SH^?DI3#U1_2]?5/NAE/']C=Y<II.QXO?Y*3K\7R<E:>GMCKM
M6*:_DUU1^]E?D/\ QC:%1<\8#LOL+MVZM8;FJNRZUZHVV"N2ZMKCV/L+:^[+
MMNN,-<S3\<<R134755G7'Q]?>^O/''._^V_P]?J:YZU?O_&\?Q&*TQ\6\WV"
M8BLQKU379SO,E8CV36:1DB?3H]NF<\?X(\B[Z8^?M\&UK,QZY<U/9,:ZS&*<
MMHT]DQIU:^YHKV/^5%TCBYY:>HO$SM3>+;B\M*()>Q^P=2ZLGDQ]>/JDO[F6
MWUG$]Q1PWEME?I##!Q+)1/;\\S5315\>QSO/MS\+3O;=4B>[N[.*V.3HM,QL
M]IGWT1>+Z5K$YLG'S-9I\5K:1-;_  12\?I&:<?]-?,9(C]U.4VV&VD_L6*^
M;UU](UO;!Z37UF=(TGTTF/B:!=A?E ^9V>M*K+KSIKQ[Z]]^SDAGRF2QN];Q
MF[:[JEIJBO<1)<[C@<%;>W%QS3S'=XZ_IJYY^O[/V<-^=O\ X8GAK89?G=P\
MSW!R'3>)BE+[;;8YKIZUR1&WRY9UGUUQY<4Q[/5F^Q^G+M+!;KW^[W^?2?2(
MG'CK,?9;3':T_JUM5I#V%\[GRC=A5WL5?DI-I>)NYK*>/#=>]>=9ZM1CZ[.W
MBAYILMA@U&XW;B&\FCJFFCERDL=<DE7'%/$7%$=&[>WOH5^E_M^M+1VW&]W=
M(M$Y-WN][GF\6F9^+%.XC;:UB8K6:X*S$1$ZS;JM.8[#PMXWV$1,<?&;+$3'
M5ERYKZZS[Z]<8_3V1,4B=(^W69T5WSS'\N.TOI3V1Y0^0F]PT?JG$%IMG<G8
M>=Q]G%FO:XRUM88[([#<6./L\A3;QTRP01QPUT1T4\T^FBGCC>? ^'?$O:_K
MVYVQV_L;ST:VP<?M,5[3CU^7-[TQ1:]J:S-;6F;1,S.NLS,YILNT^U^-_P#N
M?QNPPSZ:S3!BK,]/YLS,5B9F-9TF9F?69][6]L=WX
M                                                         #,W
M7OD;Y"]1T64?5'?'<W6,>-AO;?'1]>]H;OI=&/M\E<2W>1@LJ=;SF-IM8;^Z
MGKEFIC]-,LE=557'////+#>X?'/CWNVU[=U\%PW)VRS6;SN]EMMS-YI$5I-O
MG8K]4UK$5K,ZS6(B(TB'4[_@."Y29GD]EM-S-IB9^;AQY-9B-(F>NLZZ1$1&
MOLCV-V-$^9_Y/^NK>BVU_P O^PLA''C;+%4U;WA]"[1N.;6PHHC@EKN^S=1V
MZZER5=-''O7E5?-Y<U?7F66OGGGGG2O._1G],7<62<O(=H<?CM.2U_[UR;K9
M1U6G68BNRW&WK%(U^''$?+I'I2M8B&'[WQ)XYW]NK/Q6"L]4V_1VR88UG\F&
M](T^ROYL>Z(;R:)^3-\@6LW%%.V:GXZ]CX^3)65Q>\9K0]JP&8CQD5='%]C<
M-D-1W["8RQFO(.*O1<7=AD.89>>*O171QS'5H_G?PT? ')8YGB=WW%QVXC':
M*_+W6#+CF\Q\-\E,^UR7M%9TUICRXNJNL=59GJC#=[]/'8VXK_>N7?[?)TS$
M=.2EJZ^Z;1?%:9T^RMJZQ[XGU;O]<?E4?]ZM>W?#K_\ &ZYL]UQV[_\ 0\V%
MM%J6S:1_^_B:?G-?_<YIA_Y&DNX_PL?;E[1[P_I8C%O-A_\ 96G/AW/_ -C7
M[M^K?WL.Y#Z:?;;B^6^SX<N#_AGKID_X(^7_ $6]777Y+OQ[;;;PT[E@^_NJ
MLA3#A^+[C8] PFQ8?[V^HDXRG&)R&B;ALV3OL;@YXOX<USC[">XBDHJBM^:^
M9(X]&=Q?AK?4%Q.29X?/P'*[>9R=/R=UDPY.FLQT?,INMOAI6^6)]*TRY:UM
M%HMDB.FUL,W_ -/7?6UM/W2^QW./6VG1EM6VD>SJC)CI$3;[(M:(F)UMII,[
MX=>_,'\9G9U=E'K?F-U+C:LA->P0<]A7.>ZCHCKL+>6YGJO9>U\)I<6,ADCA
MYXADN>8H[F3FF.&JNNJFGG1/</T@_4MVS6]N2[.Y;)&.*S/W2N+?S,6F*QTQ
ML<FYF\Q,_%%.J:1K:\5K$S&%;_Q5Y#XZ)G<<3NK=,1,_*BN?VSI&GR;9-?RQ
M&LQ'K.D1+>O0^U.L.U,?SENL.Q]#['Q=-GB\C5DM#V_7MOQ]./S<,MSA;[F\
MU[(Y&WXL\O;V\DEK+ZO1<44551\U<<<\M&<]VMW/VMN/NG<_';_CMUUWIT;K
M;Y=O?KQS$9*].6E)ZL<S$7KIK29B+1$RPO>\;R/&W^5R.WS[?+K,:9*6I.M?
M2T:6B)UK,Q$Q[O>]XZ%P@
M
M
M
M
M
M
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MTI$>GY&-V1N>
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M_!?=5KY.=[0[=S;G)-9OEC8;?'GM-(BM=<^+'3-,16(KIUZ=,1$QI$0Q;?\
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MGV3TWBMM)]TZ:2PO<;;<[3)\G=8[XLNFO3>LUG2?9.DQ$OO. ^
M
M
M
M
M
M
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M
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MP4Y;J&7&SQVEQ?5P7N9[ Q^"U.O_ !%MSQ3+;Y&>WKFJHAIDJFKICYC1W?\
M1G]2O9EKSO>U=_O=M733)Q_R]_%XFT5UKCVM\N?VSZUOBK>*Q-YK%(FT:[Y7
MQ)Y#XB9^=QF?-CC]=@Z<^OK$>E<4VO[9]DUB=-9TTC5(WIV]Z1V)A^-AZ_W+
M5=YP%4W%MQG-.V'$;-A^;CFUM;[B#C)X6\O;+F;FRO89O3Z_5[4U%?T]-=//
M,=>8X+F^WMY^Y_/[/=;'?Z:_*W&+)AR:=5JZ]&2M;:=5;5UTTZJVCVQ+ =WL
MMYL,OR-]BRX<^FO3DK:EM-9C72T1/MB8_5B8]SU3JG&
M
M
M
M
M
M
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MCQUK2E8^RM:Q%:Q^2(B&=XL.+!CC#@K6F*L:16L1$1'V1$>D/FN2^@
M
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MBCUC6/5NRTJP\
M
M
M
M
M
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M>'X_:8,D>R]<=9R?T<EHG)/]&S5=M)DH
M
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M>8YTOCR5M2]9^RU;1%JS^28B6OLN'+@R3ASUM3+6=)K:)B8G[)B?6'TG&?,
M
M
M
M
M
M
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MR6B<D_T;-5VTF2@
M
M                      ,M=4]^=X]%9/G,]*]P]G=39.N:F>>[ZZWK9M.K
MNZZ>*:.:;^G 9*PCR$,D='%$D<],D<D?\"NGFGGGAB?=7878_?6V^Y]Z</QG
M+;:*Z17=[;#N(K']3\VEII,3ZQ-9B8GUB8GU=9R?"<-S6/Y7+[3;;K'IIIEQ
MTR:?J=43I^28TF)]8]4MW2/Y#?R2=2?9VFT;SH??&$M?1#3C^W=#QU60IM./
MIQ)11L_7T^A;'=WG/'-55%Q?W-_537SQZN*Z..(T2^]OP]OIP[MZ\W%['?\
M [V^L]>PW5^CJ]T_)W<;K#6OLB:8J8HF/9-;3U-7<QX(\?\ *:WVV'/LLT^_
M!DG37_B9?F4B/R5BOY-)]4P/2/Y3'4V5^SL/(GQCWS29OX$-UL?46U8/L''S
M2U_3CF]KUG;(^OK_ !-G'55_#CHR&2FXHIYJI]RKGB-$+O;\+GNS:]>?QYW-
ML-[3UFN'?X,NTO$?TOSL$[NN2T^Z9Q8:ZSI/3'Q-5<Q]-O*8M;\#R.#-'NIG
MI;%/ZG73YL6G\LUI'VZ>U,ET-\O7QT^1%%A!I?E!U[K>?R$U%G%J7;%[+U'L
M563EN,;:P8BR@[!BP&.S^2O+C+046\>+N;[BYKYDIAYKJ@GXCAUWW](WU$>/
M+9+\UVQR&YV&..J<^QK&_P /1$7M.2T[2<M\5*QCM-YS4Q=$=,WBL7I-M3\W
MXL[]X&;6WG&Y\F"L:]>&/GTTTF9M,XNJ:Q$5G6;Q73TUTUKK(WCLCC\OC['+
M8F^L\IBLI9VV1QF3QUS!>X_(X^]@HN;.^L;RVKEMKNSN[:6F2*6.JJB2BKBJ
MGGGCGCE'3<;?<;3<7VF[I?%NL5[4O2]9K>EZS,6K:LQ$UM68F+5F(F)B8F-6
M Y,=\5[8LM9KEK,Q,3&DQ,>DQ,3ZQ,3Z3$^Q_8^+\
M
M
M
M
M
M
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MI$1$>D1$>D1'I$,^K6M*Q6L1%8C2(CV1'V0_%^W]
M
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M<YV=W3VW-OW;V&YV^.LZ3>:3.+773TRUZL5O7V=-YUUC3VPVH:L8T
M
M
M
M
M
M
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ML=:3;2(C6TUB)M.D1K:TS,Z>LRPRS)VP
M
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MEK.DUM$Q,3]DQ/K#Z3C/F
M
M
M
M
M
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M=?\ BTQUK6/9'LCW-K[7:;7988V^RQ8\.WCV5I6*5C]2M8B(_P"!YMV+D
M
M
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M;EI:EOU8BT1K'K$Q,>DQ,3'I+)#''7@
M
M
M
M
M
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M)$1#:F+#BP8XPX*UIBK&D5K$1$1]D1'I#YKDOH
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M^C&.:Q/ZLZR]7_5Z> G]!WP__P!VCI?_ $*=5_.#\]_Z<=W_ /7/(_Y2XO\
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M_P#*0_U@]_?OYS'[<W/]T/W=YS_#-W_9LG_C'^SST#_J-Z>_]&>E_P#RD/\
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M3$QFR1,3'K$Q,6UB8GUB8]C%G]7IX"?T'?#_ /W:.E_]"F4_S@_/?^G'=_\
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M;&V_[SL_YR?!_O9N_P"R8V'_ .Z]^??^M[P__P _^Z/^']E_^\\\"?O1W?\
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M66M9TF:6K:(G[)Z9G1Y9VCD@
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MKT?W!]/?=_&1;+PN7!R."(]D3\G+/KZ_!DF:>SU],TS/K$1KIK.KT_WWTEY
MZYQMO1_;/7O;&O<0V,USDM!VW";/1C.<E%+-:6N;@Q5Y<W6!R5=,$E-5I>QP
M744D4E%<=-<==-,&>[^P^]>P.1_<GO?B>0XGD-;1%-U@R89OT3$6MCF]8KEI
MZQ,7QS:EHM6U;36T3.F.5X3F.#W'W7F=KGVN?6=(RTM373VS6;1$6CUCXJS,
M3$Q,3I,,M,3=6
M
M
M
M
M
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MH^RN,3LU_'=>KBB^R/9><N<SO%CF+2.2JB.;!W6#AXX]-7,/,M%,O%A_C'Z
MOI^\>].[YC99NY>:K>MHR<E:+X:S7];39XHQ[:V.TQ$S7<TW-O;'7T3-6^NW
M/!W8O!:9=WAOR&[B8GJW$Q:D:>Z,58KCFL^^,D9)]VNDZ(8=GVK9]VSV2VK<
M]CSVW;/F9J;C+['L^8R&?SV5N*(8[>B?)9C*W%WD+Z:BWAHHXJEDJJXHHXI^
MOTXXX3,XSB^,X388^+X;;8-IQF&-,>'#CIBQ4B9F9BF.D5I6-9F=*Q$:S,^V
M6V]MMMML\%=MM,=,6VI&E:4K%:UCVZ16L1$>OKZ0^"YS[
M                               /:ZKUIV-O5O=7>DZ!NVXVMA-1;WUS
MJNJYW8;>SN)*/=C@NIL187<=O-)'_"IIKYXJYI_;QQ]'2\KW+VYP62F+F^0V
M6SRY(F:USY\6*;1$Z3-8R6K,Q$^DS'IJX>YY'C]E:*[S/AQ6M&L1>]:S,?;'
M5,:MN]4^+SY%=S^__2/"KR0L_P!-^U^X_>OJK:M#]S[S[GV?L/WYL-=_5?1]
MK5[OVOO>Q]:/<]'N1^K4?*_4_P#3OPWR_OG>G;E_F=6GR-]@W6G3IKU_=K9N
MC\Z.GKZ>KUZ=>FVF+[KR/V%M.GYO+\?/5KIT9J9/9I[?ES?I]OIKIKZZ:Z3I
MMIIOX_'RD[7ZZ\ET5K>AV_V=O>6MSN7<'57^6_<?3GBUHLM3VS:LI97D,=7%
M4E%Y;VWH_P";SSZ^.:>-3\S]?_TN\5I7;<[N=_DZYK:-OQ^^^'3]=-L^#!2U
M9GTB<=[Z^WV>K%]WYR\;[;TQ[W)GMK,3&/!F]-/?K>E*S'V369_X&UVE_B^>
M;>7KQT^[]R>-.F8^\QL=W=P8S/\ 9&W;'B;Z:WCEIQ5YC:.M\%@)YK:6NJ*X
MEMLM/#371SS%5-1SQ5SJGFOQ//"FTKDIPG#=R[W<4R36LWQ;/;X<E8F8^96_
MWS+EB)C2U:WP5M,3I>*3K#&-Y]1O9^*+5V>TY'-DBVD3-<5*6C7\Z)^;:WK[
M8B:1/VZ2VCT_\5#(208:ZW[S8L[2YXO*:]AP.G]#3Y&"O'Q9"OBNVPVVYKMG
M%R1WE[BJ*>>)Y\+51:W$G/'LW%$?',FL.7_%1V];YL7 ]E7OCZ-,67<<I%)Z
MYI^=DP8]A>)K6^OPUW,3>D:]>.;:5QS=?4O2)O78\/,UT^&U]SIZZ>VU*X)]
M(M[HR>L1[:S/ILYJ?XMWB'9_?_OSY">2&Q>Y]K^E_NG-UCIGV?H^Y^]^_P#U
MC0M]_4ON/5#[7M_:>SZ*_5[OKI]O67*_BA^7<WR_W#[?[<V^G5U_/C>[CJ]G
M3T?+W6UZ-/BZM>OJUC3IZ9ZL<W7U(]TWZ?N6QX_'[=>OYV37V::=.3'IIZZZ
M]6OI[-/7:+6/QU?C&P%_C;O*]?\ 9V[6]C#7%=8O9^WMMM+#,UU6<MKQ<9*3
M3)M1R<4T<\G%SQQ9W-K'[U%/'-/,7JBJU?R?XB'U-;_!DP[7D.,V62\ZUOAV
M&"UL<=46TI&XC<4F)B.C])2\],S,3UZ6C'-SYZ\BYZ6IBS[;#:T^DTP4F:^N
MND?,ZX_)\46G3WZ^K8K5_A8^+S4,?-C<3X@Z'=V\]Y)?5R;1L/8N\9"F:6&W
MMZJ(<MNFYY_*6]GQ';4\TV\<U-O17S7731Q7)755KOE/K/\ J>Y?<1N=WW?O
MZ9*TBL1@Q;3;4TB9G6<>VV^*DVUM.MYK-YC2)M,5K$=!N?+OD?=7C)EY7/%H
MC3X*XL<>^?S<>.M9GU]LQK[(UTB&R^L>!WA!I=]C<KJ7AWXNZ[F<1#5!C<YB
M>@^K++/6E$EG)CIZH\Y#JM.6YFNK&>2*:2J;F2:B2OBNJKU5?76W)^=O-W-8
M,FTY;O#NC<;/-.M\63E-];%:8M%XUQ3G^7I6T1:L172LQ'3$:0Q[<]Z]X[RE
ML6ZY;DLF*\ZS6VYS36?76/AZ^GTG28C32-(T]C835=$TC1;>[M-(TW5=-M;^
M:BXOK;5=>Q&O6]Y<1T>U'/=PXBSLX[B:./\ @TU5\<U<4_LXY^C7W*\[S?.Y
M*9>;WFZWF7'$Q6V?+DRS6)G68K.2UIB)GUF(]-71;G>[S>VBV\RY<MJQI$WM
M:TQ'V1U3.CU3JG&
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M+ST^GQ?#,^GK'K[/6/M8^9 YP
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MQ,Z4Y+B>4X?<3M.6V^?;;J/UN6EJ6_5B+1&L>L3$QZ3$Q,>DLD,<=>
M
M
M
M
M
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MZ16/U9TB-9GUF;3K,S,S,S,RQBR9V(
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MA&OG1
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M/M-*Q[K>LV]]*LMVGU(]LW_\^V&_Q^D?L<XLGK[X^*^+T^R??]D-(=Z_'_\
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MU9FMH_+$S#)\6;%GQQFP6K?%:-8M68F)C[8F/27S7)?0
M                          ![;K_LOL?J;8X-PZK[ W;K3;;:&NWMMIZ_
MVK.Z;L=O;R2P3R009O7+_&Y.*&N>VCKYIIEXIYKCIYYX^M/'TZ7G^VNW.[..
MMP_=/'[+DN)M.LX-U@Q;C#,Q$Q$SCS5O29B+3&LUUTF8]\N)ON/X_D]O.TY+
M!AW&UF=9IEI7)29]FO3>)CV3/N]Z=3QD_(]\Y>EJ,?@^XK+2?)W4K::UXN)-
MSM:]-[)XL8;B62>TQV_:G;TXSF:Z@GYHYN<K@\Q-3S'%5QS]*9*98,^3/PYO
M!_>=LF^[/OO>V.6M%M(V]OO&SZIB(BU]KGGKTK,:]&#<[>LZVC3UK-=+]Q>
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M;UG28G2T1.DQ/LEJ#<[;<[//;;;O'?%N:3I:EZS6U9]NDUM$3'IZ^L/O. ^
M
M
M
M
M
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MKS3K^=KEOK>.KWUK,5]T5B(B(TM;G9<
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MZ=/1A._[H[EY37]TN0WN>)B8F,F?)>-+>VNEK3$5GWUB-/=HV$:^=$
M
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M?M;KR[_9WR[&DZ?.P?I<<Q_33TQUTKKZ:Y:4]=(T]8UDM1K:]
M
M
M
M
M
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M3'MZ1I6M8BM:Q'LB*QI$1^2(?'<M]0
M     &T74WA'Y@]Z\6,_47C'WEON,R,,5Q:[%@^M-LDU'FWN<97F+.>?<;C&
M6^JV<.1QM'N6M4UY'3=>NBF+FNJ2BFK6'=GFSQ!V+.2G=W<W![#<XYF+8<N\
MP1GUB\8[1&WB\Y[32\Z7BN.9II,WZ8K:8QSE.\.U.%ZHY7D=E@R5G2:VS4Z]
M8GIF(QQ,WG2?2=*SIZZZ:2DRZK_'2^2_L6..?9--ZKZ4AF]VJ&OM3M+$W,E<
M--I:75O/)9]3V?:=_:?>57-4-,4\45Q%-#)Q-'%3Z*JXT=T_B(_35V[::<;O
M.5YJ\::_<=EDK&O5:LQ%M];95MTZ1:;5M:EJVKT6M/5$:[Y/SUX\V$Z;?+N=
MY,?\SAM'OF)]<TX8G3376)F)B8TF?723GJO\5JPCDCO.[O+R\NH?\;1+KW5?
M6$-A)QZ;NTJAN8]RV[9\E3S[MA3/15!S@>/;FKCKXFKIHJCDC-W3^*9N+5G#
MV3VC2E_28R[[>S:/S;:UG;X,-/9;IF+?>O6L6KT1-HM77?)?4K>8Z.'XJ(G^
MFS9M?=/I\NE(]^GK\SUC6-(UUB2#JO\ '2^-#KJ6.?9--[4[KFA]VJ&KM3M+
M*VT5$]5W:75O/)9]3V75EC=_9T6U4-,4\4MO+#-)Q-'+5Z*J(X]T_B(_4KW%
M6:<;O.*X6DZ:_<=ECM.G3:LQ%M];>VKU:Q:;5M6];5KT6K'5$Z_Y/SUY#W\:
M;?+MMG$_\SAK/NF)]<TYIC7776)B8F(TF/762;K#P2\+>E^;.;J_Q5Z!T_)V
M$,UO;[%CNJM-EV[FWGR=&8K@NMQOL3=[5?0T9*&*2.F>\DIB]B*FCBFF*.FB
M-_<_G3S/WG%Z=S]U<_O-MDF)G#??;B,&L4G'K7;UR5P5GHFT3-<<3;JO-M9O
M:9U]R/>G=W+ZQR7)[[+CM.LUG-DZ-8CIUC'%HI'IK$Z5C76=?;.NU[5+&0
M
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M,Z1Z2V!Q?=?;/-Z1Q/(;/<7G3X:9:3?UUTB:=77$SI.D3$3.DM;VQW?@
M                                 )&O%7Y8?/#P\M\3@NJ>],]E>O</
M##9VG5/9=-/8G7=KC+>BXXM\3@\3L-<^3TG&QSW',W,>OWF)YDDXX]?-5/-5
M-4=?*GTI>"?,&3+ONZN#P8NX,TS:V^V?]Z;NUYF-<F7)BTIN;S$=.N[QY](G
MX8B=)C >Y?&/97==K9N3V5*[Z\ZSFP_HLLS.FMK6KI&2?337+6^D>S3T66?%
M'\G3HK=:,;KWEWU9GNE<_)-Q;W?8775&0[!ZWDHDN(*:<E?ZW3%5V%K<,$$]
M?N6]K%L4E7%OZZ:^:I>(8ZV/*OX9??/"VR<AXCY3!S6PB-:[3=S3:;R)B)^"
MN;7[IFF9B-+WMM(CKZ9KI2;VCWW-].O-;.;9^UMS3>8--8Q9=,67V3Z1?]BO
M[/2;3BCUTF/36;%/2?D5T/Y(:Y<[9T+V]U[VY@+":WMLK>Z'M.)V&O!WEU%5
M/;8_8K&QN9,AKN2GMZ.9*+:^BMYZH_X7%'I_:KO[U\=]]^..1KQ/?G$<AQ&_
MR1-J5W6#)BC+6LZ3?#:T13-2)])OBM>L3Z:ZM"\QP/-=O[B-KS>US[7/:)FL
M9*6KU1'I,UF8TM$3Z:UF8U]-69F&NI
M
M
M
M
M
M   83[T\D>A/&75:=U[_ .W-#ZEUR;[RG'7>Z;#8XJ[SUSC[?B[N\=JV&KDJ
MS>V9B&VY]S[+&V]W=U4_MXCY9KV-XX[\\F<K^XO8/$;_ );D:]/77;XK7KBK
M>>FM\^2(^7@QS;T^9FO3'K[;.XX;M_F^XMS]SX/:Y]UN(TUC'6;16)G2)O;\
MVE=?3JO-:_E5K/+;\GW0-:N+S6?"_IR;LF]CAXXI[4[H_5-7TN.]XKADXXP_
M7&%N;/<]EQLMM)515->Y36YX;BCGCBWFC],E5DGB;\,;G^2QTY/S-S$<;AF?
M_,>.Z,VYFNDQ^DWF2MMOAO$Q$Q7'AWE;5F-<E+:UB0?:_P!.>^W%8W'=V[C;
MTU_8=OI?)I_59;1..DZ^ZM,L3'ZZ)]%8CRB^0;S"\Q\A?S=^]Y;AM> O+SF[
M@Z^Q]W3K'6>,IHFM9K*WL="UVC&ZY)^G<V,'M7%S!<7M=<7$LL\D]5<M5FWB
M_P"G[Q!X=V^.G8/![/:[^E.F=W>OSMY?TM%IMNLTWS1U]5NJE+4QQ%IK2E:1
M6L2*[;[%[4[3I6.#V>+%GB-)RS'7FGVZS.2VM_76=8B8KZZ1$1I$:9MR,M
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MO+<AO-QBM[:7RWG'[(CTQZ]$:Q'KI6-9]9UF9;.-9,=
M
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M,'N'\?\ ^3;J>6]EQG3^M]R82Q]'NY_I[L+6LS%-[MW;V</V6L[;<Z5V!?\
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M1I$ZQ69F-)F(G7V3,1/JP^R]VH
M#V&B=A[_ -6[-8;KUEO.X=<[EBO<_2]MT39LUJ&S8WWJ/;F^PSVOWN/RMG[M
M'/IJ]N6GU<?LY=1SO;W =T<9DX7N;8[/D>'RZ=>#=8<>XPWT]8ZL66MZ6TGV
M:UG1Q=[L-CR6WML^1PXMQM+>VF2E;TG]6MHF)_HPG^\4?R3/,7IVO&X#R(U[
M5?*'2;6'BUDR5_3:];]L6T45O!:6',.Y:WB;G6,Q#941U2S\9+ W.1R$G/\
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M;;7)7_PJZ1DIIK&LVI%?Z6UM)E+&BBUB
M
M
M
M
M
M T"\N_DZ\+?"6TKA[L[BP]6ZU?7BSZHT3V]W[0NZJ9>8^:KK5L//5^Z]GS[4
MOHN\W/B[*:N"2*.:N:GVN=^>(_IE\S^:\L7[*X?-'"_KM]NM=MLJ^FOPY\D?
MIK>M=<>VKFR5BU;6I%)ZF<=K>.N[N\+:\/M+_<_?FR?H\,?J7M'QS[/AQQ>T
M:Q,Q$>JK)YA_DO>1?:%%UJOB-H^-\<=8YFFCKW_9/T;L7MC+VM%Q7[$EC99/
M%2Z#H\-]8U^BYM^+/.7D4O'$EMD8>>/VVC^'_P -7QWVQ:G*^6]]D[CY/2)C
M:X?F;38X[:>L6M2\;K<S6T:TO\S;8YC6N3;7A)+M3Z>N XV8W/=.:W(;G3]B
MIU8L-9T]=9BWS<FD^R>K'68]+8Y5T>R.TNRNXMKOMY[8W[<.R=RR7JXO=GWC
M8LKL^;FBJN+B[XMOU#,75W<Q6<5Q=RUQP454PQ\R5>BGCCE8GVWVOVWV?Q5.
M#[4V&SXWA\?YN';8:8<<3I%=>C'6L3:8K6)M,3:=(UF6^^/XWC^)VU=EQF#%
MM]I7V4QUK2OLB-=*Q$:Z1&L^V=/5X-WKF@
M     ,V=/>-GD)Y!Y"G&=&](]J=M7/WE-C<2=?Z)LFT6&-F]_&6\M>:RV)QU
MSB\%9V<F:M.;FXO)H+>UHN8ZYJZ**^*N<*[P\D>/O'^WG<]\<WQ7$X^CJB-U
MNL."]XTO,1CQY+Q?+:T8\G13'6U[S2T4K:8F'4<KW!P7!4^9S.\VVUKIK'S<
ME*3/MGX:VF+6F>FVD5B9G28B)F$NG1OXZ7R,]L?IU]O&N];^/V"N_M+N2X[1
MWJSR6?YQ-Q^D35S6>K]:V^]7D.8YL\C-5'8967$RTS64L-S5:U<Q<R1([X_$
M2^G7M3YF#@]QR7<&^IU5B-EM;4Q?,CYD:6S[R=K6<?52L3EP5SUFN2E\498B
MT5U;S/GOL'C.JFSR;C?9HUC3#CF*]4=7MOEG''3K$:VI%XTM$UBWKI+?TQ^+
M+T]B*[*^\@/*'L+>ZN8;.XO-?ZIT[ =:V=O>_;PUWF-YV+:+WLJ]S&-HO>*Z
M.+BBQQ<\T'TYXH@KY_@Q+[R_%'[PW=;X.P.V./V$:VBN7?;C+O+3768K?Y."
MNSKCOTZ3T3ES5K;TZLE?;J[E_J2Y7+$TX/C<&#UF(MFR6RS,:^D]-(Q16=/=
MU7B)]]H2W=/_  P?&ATO%9587Q5T/=<E:^NJ?+=P59;MZ7)3R6EQ8USWN&[
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MG69TB(B/R1H^PX;Y
M
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M>-Y/:7M,:]-KQBOI]OR\O1?T]_P^GO:0MVLQ
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M"8^X
M
M
M
M
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M/)DOEO;+EM-LMIF9F9UF9GUF9F?69F?69GVO['Q?@
M
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M]E;V^3>?SM=,>:,=YTBLS.E?2-)GTF)G0]O9F@
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MP&H6*@
M
M
M
M
M                        /X\CD<?B,??9;+7UGB\5B[.YR.3R>1N8++'X
M['V4%=S>7U]>7-<5M:6=I;1522RR54T1T4\U5<\<<<\OMM]ON-WN*;3:4OEW
M66]:4I2LVO>]IB*UK6(F;6M,Q%:Q$S,S$1&K]X\=\MZXL59MEM,1$1&LS,^D
M1$1ZS,SZ1$>U !YI_D3^('CI<9#3NA+6;RS[(LYJK6YN=+SD6 Z<P\M%?MS<
MW':<N-S4>US41R430<:]897'75/%4=>0MI./HGWX8_#Q\O>1,>/F._;1VGVY
M>.J(W&*<O(9(F-8TV,7QS@B9B:V^]Y<&:DZ6C;Y:RWAVCX&[JY^M=WS<QQ?'
MS&L1DKU9[?J8=:]'V3\VU+QZ3&.T*G7F/\N/F]YJW&:Q78/:V2T?J_+PW-A)
MTQU1=9+2NN[G$7%=-=6,V:UM,A+F=]AKYBHJKXSEYD(N)*?5%'%Q]*>+7/#O
MTE>$O"V/#NNW^*Q[[N?#,6CD=]6FYW<9(C\_#:U(Q[68UF(^[8\5M)TM:\^L
MR<[3\7=G=H5IEV.VKFY*DQ/WC-$9,L6CWTF8Z<?_ .#K6=/;,HS4EFPP
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M7%8>UL["#ZTQT\?P(^/V<<?_ '$4>6YGE^>WMN2YS=;G>\C?\[+GRWS9+?\
M&ODM:T^V?;/O:QW6[W6]S3N-[ER9MQ/MM>TWM/ZMK3,S_P +TCK7'
M
M
M:Q][>%WB=Y-Q2\=\^/?5?9=_+ZOIL6>U/&T;C;^NTL["O['=\=%8[?CO<LL;
M;15>Q?1^J.VAIY^O$4?IV;V+YG\K^,[1_$3N#E>-P1_R6+/?[O.EK6CJVUYM
MM[Z6O>T=6.=)O>?UUM<BX7N[N?MV8_<3?;G;TC];6\_+GUF?7'.M)]9F?6L^
MLS]LH9N^_P 9WPB[#BNKSI'<.U/'?-R?=?9V5MEOY5=%MO=M+FFV][ [O=4[
MI=?:Y"J"3GZ;-%[D%$D7/TKDHGAF1V'^)7YL[>M7#WML^*[AV4=/5:<?W'=3
MI:O5IEVU?N]>JG5'_F=M+36WYM9I?;7"?4-WCL)BG,8MMO\ #Z:S-?DY)]8U
M^+''RXUC6/V*=)TGV1,3#-WU^,[YN]>2W5YTCN'5?D1A(_NOL[.VR_\ )5O5
MS[5W=4VOOX'=[FK2[7[K'TP2<_39I?;N*Y(N?K1'1/-,GL/\2OPGW#6N'O;9
M\KV]O9Z>JTX_OVUC6M>K3+MJ_>+=-^J/_,ZZUBMOSK32FVN$^H;L[?Q%.8Q;
MG89O369K\[''I&OQ8X^9.DZQ^Q1K&D^V9B(6^]O#WRE\8[N6V[\Z![4ZMMZ+
MRJP@SVT:?E[?3LI=QQV<LL6 WBWM[G3MC]GC(0TR56%]<TQR2<45<\5_6E,_
ML7R_XN\F8HR=A<_Q7*9)IUSBP;C'.XI69M$3EVTS&XPZ]%IB,N*DS$3:-8]6
MW>%[K[;[BK%N$WVVW-M-9K3)6<D1Z_G8YF,E/9.G56-8C7V-;VQG?@
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MGCH_Y?;]62D?\>.F,F/3TB9O2*3,Z5M9*BBTUJ
M
M
M
M
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MNNOIBKTXJ^OLZ:1II&GLAM0U8QH
M
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MDC6F3':MZ6C[:VK,UM'Y8F8;,Q9L6?'&;!:M\5HUBU9B8F/MB8])?-<E]
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M,3[8G[)?L_#^
M
M
M
M
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MY;<9]SNI_79;VO;]2)M,Z1Z1$1'I$1$1Z0R0QQUX
M
M
M#"?=7C;X_P#D=A(]>[XZ:ZW[:Q=O^VPCWK4<-L%WB)/3-1]S@LI>VDF5P-YQ
M1<RT\3V4T$W%,M?'%7TKJXYS7LOR1W_XYWL\AV)S/)<3NK?G3M<^3%7)'IZ9
M:5M%,M=8K/3DK:NM8G36(T[CB.X.<X#-\_A=WN-KDGV_+O:L6_):(GIM'I'I
M:)CTC[$)'D+^-5X-=HUYC+],;#V=XW[#>PR<XW'8++T=C=;6%]7;\4_=W.J;
MQ7-N%U#S>4\356]ML]C#3Q77'%Q%1[?$4U_'WXDOG#M>N':=Y[?C.X^/I,==
M\N/[IO+5B?S:Y]M$;>L]/PQ>^RRVG2+6FUNKJW!P7U!]Y<;%,7+X]MR&")]9
MM7Y668U]D7Q_!'IZ:SAM/LF=9UU@D\A_QOO/CJ*+)YGJJ7K?R1UFS^\N+:#1
MM@JU+L']-L;2VN)KK(Z7OD>%Q=5Y/77-3;V6(S6:NI_8^E-'NR1Q53J\>_B-
M^!>[;8MGW5')=M\E?IB9W.+Y^TZ[6F(K3<;6<E^F(BLWR9]OMZ5ZO6>FMK1N
MG@?/_9'*37#R<;CC]Q.D3.2O7BUF9C2,F/JMI'IK:^/'$:^W2)E"?VOT9W3T
M1FX=;[LZE[(ZDSMS]SS98OL?2MBTR[R,5G5#3<W.+CV#'6'ZI9Q_<Q<^_;^[
M#S3+15Q5S373SS-3M3OGLOOO93R/97+<;RVQKT]5]GN<.XK2;:Z1><5[=%IT
MM\-]+:UM$QK$Z;?XSF>(YK#.XX?=;?=88TUG%DIDB-?9$],SI/I/I.D^D_8Q
M6REV0                           "0CQ!^4?S6\)<AC(^GNX,QD]"Q_M
MQ2]-=D3W^\]1W=E1/)<R65IJU_D(;C3_ +JXD]4UUKMWALA-Q3Q17<<Q_6GF
M/OE[Z7O"WFO;Y;=X</AQ<]DUF.1V<5VV_K:8B(M;/2DQN.F(TK3=X]QBKK,Q
MCBWJP7NKQOVAWA2T\KM*5WMO^7Q:8\\3[-9O$:9-(]D9:Y*Q[8KKZK<?A9^1
M9XB]_P!OC]5\BX)O%7LZJ&F.2]V.\FV'IS8+J.CZ5R8G?[2QM[K59KBF&2>N
MWS]E96=K351!'D;V;GCU5*^9_P .[RWV#DR<IX[M'=7;.NL5PUC%R&*LS[,F
MUM::YXC6*Q?:Y,F2\Q:]MMAI'I%WN[P+W3P=K;G@)CD^.U]E(Z<]8_JL4S,7
MT](UQVM:?6TXZ0G_ -?V' ;9A,7LNJYS#[-KF;LX<CA=@U_)V69PF7Q]Q3Z[
M>^Q>5QT]S87]G/3^VB6*2NBKC_!SR@)R''[_ (G>Y>-Y7!FVW(X+S3)BRTMC
MR8[Q[:WI>(M2T>^MHB8]\-'9\&?:YK;?<TOCW%)TM6T36U9CVQ-9TF)_),/L
M.&^0
M
M
M
M
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MZO.MKY+6O>9]NLVM,S/K]LO5.J<8
M
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M1W!P?/X?G\+N]ONL<>WY=ZVFOY+1$]59]8]+1$^L?:PFS5VX
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MR
M
M
M
M
M   ?C<7%O9V\]W=SPVMK:PRW%S<W$M$%O;V\%%4LT\\TM5,<,,,=/-5557/%
M--/'////T?O'CR9LE<6*LVRVF(K6(F9F9G2(B(]9F9](B/69?VM;7M%:Q,VF
M=(B/;,_9" #SK_(5\4_&*[SG7O0]K_M2=O8WUV5Q/JN8@QO3&LY+F+CU49CL
MF*'(_O9>6'OQR\VFOVM]:RU42VL^1L;FBKBB??@S\/GRIY-Q8.X.^[_Q7[1R
M:6B,^.;\CFIK[<>SF:?(K;2:]>[OBO6)KEIM\^.T3.\>R_!7<W<5:;[FI_<W
MBK>L====Q>/ZG%Z=$3I,=66:S'I:,=ZS&M.;S*^1CRQ\[-FN<QWKV1>2:MQ>
M47F#ZDU"3):]U)JM<=%-,/.&T^O)Y#[R\B^G/TO\G<9')\\5<TU7/-/TIXN%
M\.?3MXH\%\979]B\;2.4Z.G+O]Q%,N_SZ^WYFXZ*=-9_YK#3%A]-8QQ.LS*[
MM/L'MCLO;QBX7;Q]YTTMGOI;/?\ XU](TC^II%:?U+1MO!F0
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MW(<AR>XG=\EGS;C=3&DWRWMDO,>W3JO,S[9GW^][9TCA@
M
M
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M=)B?R3#[#AOD
M
M
M
M
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MS'4EKV9XO[5[*I&38X?G\I[]QFBMLFOOBGI%<=?LBD=6GI:UO:C'29;$
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M/PTB(C6=(9R8.Z8
M
M                                                     !Y7=-%T
MCLG7,CI_8FFZKONI9>&2WRVK;IKV(VG7,I;RQ202P9'"9RSOL9>PR035T54R
M154\T5<\<\?3GEVO"\[S?;?(X^8[=WFZV'+89B<>?;9<F#-28F)B:9,5JWK,
M3$3$Q:)UB)]SD[/>[SC]Q7=[#+EP;JDZUOCM:EXGVZQ:LQ,>OV2A.\H/QYO
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M$^V)^R7[/P_@
M
M
M
M
M      #0+S7^3#Q(\#,)/5W9V-9S]B7&'DRVL=+ZAQ3L7:&S45TS\8^O]"M*
M^8=5P^4FM9:(,KFYL;C):X):(YY)J/:YWYX5^FKRUYWWM8[*XZ]>WJYHQYN1
MW'Z'98?9U_I;>N?)2+5FV#;5S9JQ:MK4K2>IG':'CSNCO7-$</MYC81?ION+
M_#AI[-?BG\^T:QK3'%[QK$S$1.JF%YX_/1Y>>7GW^E]:Y&\\8>EI_O+:;5.M
M]AO:=\VVQN/1%Q'O/9UM!BLU/9UVO$D<F.Q,>*QUQ#<R17D=[Q3'71<OX)^@
M_P 1^(_E\SW+CIW/WI7IF,^\Q5^ZX+1ZZ[;93-\<6ZM)C-GG/EI:E;8;89FT
M3+;LKPIVMVMT[OD*QR/+QI/7EK'RZ3'_ #>&>JNNNDQ>_7:)B)I-/6)@W3@;
MD                        9LZ+\;N^_)K:ZM*Z ZCWSMK8X?LZ\C::7KU
M]E;3 VU_<?:6F2VG,T1TX74\/-=<>W][DKBTM*:OV<R<,*[Y\C]A^,^*_=KO
M[E]AQ/'6ZNBVXRUI;+:D=5J8,<S\S/DBOK\O#2^33V5=1S/<'"=N[;[YSFZP
M;7;SKI.2T5FTQ&LQ2OYU[:>O32+6_(L:^)GXP_<6W_H6T>8O;>'Z@P4_VE[D
MNK>JZK#>.S*K:OWJ+S"Y7=[FF7KG4,Q#53171<V$>WVE='/TYXXJYY]-=7EC
M\3;L_B/G\7X>XG-R^^KU5IO=]U;;9]7ITY*;:--WN,<^L33+.PR1/K[/;H+N
M?ZB^)VO7MNU-K?=9HUB,V;7'AU]UJXX_2WK^2TX++*7BC\5O@UX;T8V_ZDZ1
MP.0WG&S<7=':O8O%&_=D<WU%Q!<0WUAGLY#):ZM-;U6D/$=&$M<9#3S%Z_1[
MM<DE=;?E7ZIO.'F*V3;]V\WGQ\'DCIG8[3^]=GTZ3$UMBQ3%L\3U6UG<WS6G
M7IZNF*UK'SN;R5WEW9-J<IO+UV5HT^3B_18M-)C2:U];ZZSK\R;SZZ:Z1$1(
M>CTP0
M
M                                                 !B7N#H3I+R!
MUSG4N\.INO>V->XAOH;;&[]J6$V>C&<Y***&[NL)/E;.YNL#DJZ8(ZJ;NRD@
MNHI(HZZ)*:XZ*J<L[0[\[U[ Y']UNR.6Y#B>0UK,WVN?)AF_1,S6N2*6BN6G
MK,33)%J6BUJVK-;3$]IQ7-\QP>X^]<-NL^USZQK.*]J:Z>R+168BT>L_#:)B
M8F8F-)E7T\H/QD_%SL/[C->+_8^X>.N;IL[OVM1V#[_MOKJ\NX_5-CH8IM@S
M=IV!@?N)*N8+FZDR^7IHB]N2.TYKCDIN+ ?&/XF'E#M[IV7D[CMGW%LIO77/
MBZ-ANZUGTO,QBQVVN72/BI2,&"9MU5MEBMJSCWGVY]1'<FPTP]Q[?%O\.L?'
M73!EB/?^;6<5M/;$12GKK$VTF.FN)Y4?"G\@GBM<7]_D^FLEW#H=G#D+WCL3
MHF+(=BX>+'8VN2NZO,WKUA80[SK$-K8<47,TU_BX;*B*JKFFXD]F?V[&/%GU
MI?3_ .4\>/!MN9Q\/SMYI7[IR<TVF2;WB.FN/+:T[;--K:TK7%GMDFT1KCKU
MTZM^]M>7NQNY:UICW==IO9F(^5N=,5M9]D5M,_+OK/I$5O-M?;6-8UB=2N;.
M                         23>%GRP^9_@S<8_%=7]D3;5U?:S4U7/3'9?
MWFV==UV_-?KFBP=K+>6V9TF:7GGFKF3"WEC3))SQ5-1-QQZ>8W^9_I2\-><<
M>3==S\;&U[GM'P\CL^G!N]=/2<MHK./<Q'LTW&/+,1Z4FD^K7_=WC'M+O*ML
MO([>,7)3'IN,.E,NO]5.DUR?J9*VTCV3"Y7X)_.QX<>8?[M:-M^<_P!G;OC,
M?I^,_<#LJ\MK74MGV*[]J#[+KKLKZQ:_F?O;^>*WLK'*?H^9O;F7B&VL[CZ>
MY53AYT^A?S%X?^\\YQ&#^,78F'KO]ZV=9MGPX:ZSU;O9^N7'TTBU\F3!]XV^
M.E>O)FQZ],1,[T\+]V=J?,WFUI]_X6FL_-Q1,WI2/77+B_.KI$3-K4Z\=8C6
MUZ^Q-BA6U
M
M
M
M
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MA(C!@P;7#7;[:E,>WI&E:UB*UK$>R(K&D1'Y(A\=RWU
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MN2W%MYR.;+N-W;VWR7M>\_JVM,S/]&7L'3N(
M
M
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M=*]7OQS/I&EXC69TK-O:DG1N:^
M
M
M
M
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MC2)MI$)7<)P'#=M[&O&\'M\>VV=?UM==9G[;6F9O>W]5>UK?E839J[<
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MB-_='DWO+NZ;8^3W=J;&TS^@P_HL41,:368B>K)'M_9;Y)]9]4C:.C 0
M
M
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MNN/)&M;>GMB)ZJ^RT5M$Q&T35[&P
M
M
M
M
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M3[9BD1$SZZ:LY,'=,
M
M
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M^I/LGW/;.D<,
M
M
M
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MRY,V[R3K:][3>]I^VUK3-IG\LS+TCK7'
M
M
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MZL=9^=2/_*8HUF8K[[XYM'3$WM&.-8B>%!-I4
M
M
M
M
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M9GUF6G;6M>TVM,S:9UF9]LS]LOV?A_
M
M
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M/;6&Z33#$0
M
M
M
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MZMM\W[EQ-O3Y."9KU1]F3)^??\L:UI/])"8%$)JH
M
M
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M;%:(FMHF)B8F-8F)CTF)CUB8])AN:MJWK%JS$UF-8F/9,?;#\7[?T
M            ![#0.P=ZZJW' ]A=9[ALF@[UJUYS?Z[MVHYF_P !L.&NZX)K
M267'Y7&3V]Y;_<6=S)!+337Z9H):XZ^*J*ZJ>>HY_M_@NZN'S]O=R[/;;_@]
MU3HS;?<8ZY<62NL6B+TO$UG2T1:LS&M;5K:LQ:(F.+OMCLN3VE]AR.+'GV62
M-+TO6+5M&NOK6=8G28B8^R8B8]86Z?CO_))Q^1_1>K/D%L_T[(U^U88_R1TS
M7H*<3=S\_<R?<=J:%KEM!^B^OTT14Y#7+&6WYEKHXDQUO#3+=4U(_4+^'!N-
MO\[NGZ?[_,V\:VOP^XRS\RL>D:;'=9K3\S3UM\K=Y:WZ8GIW&2\TQ3%OOSZ?
MKX^ODNQIZL?MG:9+?%'L],.2\SU>^>G+:)TUTR6G2JV+I^Y:AV%K.&W70=JU
MO>--V.SIR.O;;I^<Q>RZSG<?777'1?8;/86ZO<5E+.N2.JGB6"6NCGFGGCZ_
M7CE5'R_#<OV_R>;A>>VNYV/,;>_1EP;C%?#FQ7CUZ<F+)6MZ6TF)Z;5B?7V(
MQ[K:;K8[B^SWV+)AW>.=+4O6:7K/V6K:(M$_DF(>D=:XX
M
M
M
M
M               #\;BXM[.WGN[N>&UM;6&6XN;FXEH@M[>W@HJEFGGFEJIC
MAAACIYJJJJYXIIIXYYYY^C]X\>3-DKBQ5FV6TQ%:Q$S,S,Z1$1'K,S/I$1ZS
M+^UK:]HK6)FTSI$1[9G[(5@ODE_(HZVZBHV#I_P8KP/</9O$.0Q65[TNZ:<I
MU!HU]Q<56-4NC045\1]M9ZVCCFF@O*:Z=8BKJM9J)<Q#5<6E%G/TW_AX=R=W
M6V_=_G&,_#]LZTO3C*_!R&YKIU:;F9]=ABM,UK;',3O;1\VDUV=XQY9D9X_\
M"\ARDTY7O/KVG':Q:NVCTSY(TU_2?\Q6?2)K^S3\43&*>FTTU.Y^\.V_(CL'
M,]J=W=@;)V7V!GO:IR.R[/?<W=WS;6W%5-ICK&"BF&QQ&'L**^:;>RM(H+2W
MIYYIBCHX_8N.[,[([2\>=OX>UNR>/VW&\!@UZ,.&O37JG\Z]IG6V3);VWR9+
M6R7GUM:92SXCAN+X'8TXWA\&/;[&GLI2-(UGVS,^VUI]]K3-I]\RQ6REV0
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M]_RQK6D_TD)@40FJ@
M
M
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MFXR60R[Y\4]R]CVG<YJQNN%ZIBNXQ1.D1[OFT]9Q3,?;-J:^D9+2EC11:Q
M
M
M
M
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MX8FEX^\2<#V12N]S17>=PZ>N>U?3'K$1-<-9UBGOCYG[),3,:Q6>A#:F*VP
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MZMM\W[EQ-O3Y."9KU1]F3)^??\L:UI/])"8%$)JH
M
M
M
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M8XZ\
M
M
M
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MTTOFTB?6/;&.*1IZ3U0G;06:7
M
M
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MD:]/N^.-:3[YK,]*:5#!J(
M
M
M
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MOD
M
M
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M3C.6PY-OO\4Z6I>-)C[)CW368]:VB9K:)BU9F)B62&..O
M
M
M
M
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M:/!=G<='&\%AC'CG\^\Z3DR3&NELE](FTQK.D>RL3I6(CT:KMI,E
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M<[V_MODM-K:>Z(F9]*Q^MK&E:QZ1$0R0QQUX
M
M
M
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MO<'8N>V?)6=SP,S\&YI'PQK.D5RUC6<5]9B(U^"TSI2UIZHK*ZBHUD
M
M
M
M
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MWKG=Q?)2)UIBB9KAQ^FGP8]>F)T])M.M[?KK2W :A8J
M
M
M
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MX,^US6V^YI?'N*3I:MHFMJS'MB:SI,3^28?8<-\@
M
M
M
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M8N*-W.FZ[AM72^>T>E-8TFN&OZRNGI-IUO?6=;168I6(5+IM,
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M]#-J0
M
M
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MX.RM_.RYK#-<5IGY>6OKBRQ$^VE_9KII,TMI>L3'56-8UW,:;8D
M
M
M
M
M   AX^3WYA>D/CVP=YI6(YQO:WDWE<;57K_4]A?_ %LM.XR&*FN\+M?:][9U
M\28/ \R5VTL>,HDBR^4@FHJ@XAMZZKR*8'TR?2!WM]06^IS6[^9Q7C/%DTR[
MZ]/BW'1>*Y,&QK:-,N72+UG-,6P8+5F+S?)$8;[6\<^*N8[ZS1O,O5MNW:V^
M+-,>N32VEJ88G\ZWMB;Z32DQ/5K:.B:"GE-Y9][>9?:N4[@[^W:\V[9[O[FT
MPUA3Z[36=*UZ7(WF2M-1TK!^[+#@];QDU])Q%%ZI)Y>>>9;B6>>N26N^WQ;X
MG[%\-]JXNT.P=E3:<932V2_YV;<Y8I6EMQN<ND3ES7BL=5M(K7\W'2E(K2)N
M]M=L<+VEQE>*X/#&+;QI-I]M\EM(B;Y+?KKSI&L^D1[*Q%8B(UO;&=^
M            ]MUWUKV%VYMV)T'JW2-J[#W;.S>QB-5TS!9+8\]D*^.>/75;
MXS%6UU=50P4\^J63FGB.*CCFJNJFGCGETO</<G;_ &EQ.7GNZ-[M>.X7!&N3
M/N,M,.*D>[6]YK76?9$:ZVGTB)GT</?\AL.+VMM]R6;%@V=(UM?):*5C]6;3
M$?J1[9]RW3\>WXV.,Q%>#[1^0+*0YN_IALLG8>.6B[!S^C65U+;R52X_M;?,
M+5Q)FIK"2:GUV&MWD=G]S!QSSD[RVJK@DJ1^H+\2+<[NN?M?P#BG!@F;4MR^
MYQ?I+5B8TOL=KD],<6B)TR[S'.3HM,?=L.2*WK%SOKZ@LF6+\;V-6:4UF)W6
M2OQ3&OMPX[?FZ_TV6LVTG]CI;28M?Z?INH=>ZSAM*T'5=;T?3=<LZ<=KVI:?
M@\7K6LX+'T5UR46.&P.%M;+%8NSHDDJJXB@BHHXYJYY^GUYY53<OS/+]P<GF
MYKGMUN=]S&XOUY<^XRWS9LMY].K)ER6M>]M(B.JUIGT]J,FZW>ZWVXOO-]ER
M9MWDG6U[VF][3]MK6F;3/Y9F7I'6N.
M
M
M
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MTKZ1$S>M8CJFP6K^:,
M
M
M
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MO,>VTMTFF&(@
M
M
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ML=\8?_9.;HW]8UMM\FE<U8C368KK/72-8CKI-JQK$6TF=$>Z03.@
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M8@[[8[WC-W?8<CBR8-[CG2]+UFMJSIKZUG28UB8F/MB8F/27L'3N(
M
M
M
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M-[0BG+\Y\O=]R>V/3JPX-)UB<46K$SD](F<LQ$Q[,<5^*UX!T^&[P
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M_@
M
M
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M:ZSBRU]?6EM(]?3UI;2]??&DQ,[F--L2
M
M
M
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M'2/2M?U(UGVVF9]6R#7#'P
M
M
M
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M$1DK$5M/MK29B)G#0B:<
M
M
M
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M3,3,8J3[.FDS>8CXLG3:V.+':N=H$
M
M
M
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MA_
M
M
M
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M8I2/AQXZSIK&.GLKKI&L^MK:1U6F8AM<U2QD
M
M
M
M                                  !K?Y0>)'C]YC]=7'6'D+UUA][U
M_C[N?"7UQ1S9[-IV6N[6JTYS^F[):^WE->S$='-/UKAK]J?BCB.>.6+U1\['
M\8^6O('AWN*O<_C[D<VPY#X8R5CXL.XQUMU?*W&&VM,N.9]UHZJZS;':E]+1
MD';G='.=I[^.1X+<7PY_2+1'K3)6)UZ<E)]+5_5C6/;68GU4;?DB^"7R!\,O
MUSL_IO\ 6/('QSL_;N9\]B\;Q+V9H-M+[G,O&^:EB8:_OL/8>G^'F\;15:<4
M?XRZ@L>/IQS>!]./UT^/_,GR.V.\?D]O^1;ZQ&*]]-GNIC33[KGR3\.2WNVV
M:8R:_#BOGG68F3X_\T<'W;T<=RW1L>?GTBLS^ARS_P"3O;V6G_F[SU>ZLW0/
MIV-T@                )VOBD^:_L_P6O,1TYW'5GNUO$^6:6*TUNWJLKC<
MNG[K(7WW=]G.O+R^X@DR>!GDEEDN]=NKJ*SJFKYN+.2TGJNN+V"WU5_17VQY
MRPYN\.SOD<5Y6B(FV:>J-OR%:5Z:XMW6NL4RQ$1&/=TI;)TQ\O-7+2,4X=+^
M3/$''=YTORW$]&V[GB/6\ZQCSQ$:17+$>RT>D5RQ$VT^&\6B*]%]KIWN?JOR
M"Z[U[MGI?><#V+UWM,,\V#VG7;FJXL;KFTN9;.^M9HIHX+W'9+'7L%<-S:7,
M4-S;3451RQT5\<\<4-]X=F=T^/\ N'<=J=Y['/QW<6UF(RX,U=+5ZHBU;1,3
M-;TO68M2]+6I>LQ:MIB8E";EN(Y+@M_DXSE\-]OO\4QU4O&DQK&L3[XF)B=8
MM$S$QZQ,PR<QEUP
M
M
M
M          #\;BXM[.WGN[N>&UM;6&6XN;FXEH@M[>W@HJEFGGFEJICAAACI
MYJJJJYXIIIXYYYY^C]X\>3-DKBQ5FV6TQ%:Q$S,S,Z1$1'K,S/I$1ZS+^UK:
M]HK6)FTSI$1[9G[(4VOET^?6XVBC8/&OP,VR:RUJ:'-:YVAY$XNFNWR><YYN
M+G%7>O=,9'BOU8_ RVL==4FS1<<75YQ-1SC*[>..F\NKB_I(^@G'Q=MOY(\[
M[2M^2B<>;9<3?2:8O2,E<O(TT^/+%IB(V5O@Q],QN8R6M.'%+'Q;X1KMIQ]P
M=ZXHG<1-;X=K/K%?2+1;<1[[:^S#/I72?F1:9Z*U*%LJ4
M #TFG:=M?86UZ[HVC:[F-MW+;<Q8:_K&L:_87&4S>=S>4N([3'XO%X^TCEN+
MN\N[B6FBBBBGGGGGEUW,<QQ7;_%;CG.<W&':</M,-LN;-EM%,>+'2)M>][VF
M(K6L1,S,RX^[W>VV&VR;W>Y*8MIBI-KWM,16M8C69F9](B(7'_C+_'7US3.-
M:[P\]Z,;N6U50V>8P'C78U17VEZ]S=XRJ2FCN#+\T54[?GK&ZO./5AL=S1B+
M:XL_\==Y2&>J"&G;ZE_Q#^1YF=SV1X&G)L^+BUL>7F+:UW.7IOI_[/Q__B^*
MU:^FXRZY[UR?!BVMZ1DO%#R)YYW&[^9PW9/5AVVLUMNY],EM)_Y"OZRLQ'[)
M;XYBWI7',=4VL\=CL?B,?8XG$V-GB\5B[.VQV,QF.MH++'X['V4%%M9V-C9V
MU$5M:6=I;14QQ11TTT1T4\4T\<<<<<*K-QN-QN]Q?=[N]\NZRWM>][VFU[WM
M,S:UK3,S:UIF9M:9F9F9F9U1GR9+Y;VRY;3;+:9F9F=9F9]9F9GUF9GUF9]K
M^Q\7X
M
M
M
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MZ=5+:1[/3JK,1:NL:Q$369W&:>8F
M
M
M
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M&EKP
M
M
M
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MYS^N?M[)DF,6>/;'IK%,L1Z5OIK$3^;DZ9M73UK66E$YK
M
M
M
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M?+YK[C?Y9CJO>=9G2-(CW1$1$:16(B(CTB(ADYC+K@
M
M
M
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M+5M$Q,3$I7;3=[;?[;'O=EDIEVF6D6I>LQ-;5F-8F)CTF)AYMV+D
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MOZ^NOLF^*-?2\1-J5B?FSI'S+6*5>#0H
M
M
M
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M%3VQ/K-[UGUZ(F:S9K5GH[@
M
M
M
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MD_+UUKCBWJJ+18
M
M
M
M  :3^>/GCTI\?W2E_P!M=M7_ .H9C(?>8OK/K/%WEO!MG9VV06]$M&&PU$M$
M_P"GX?'^_%+ELM+%7;8RVKIYYIEN);6UN-U>"?!/>OG[O7'VGVGC^7L\?3?>
M;R]9G!LL$SI\S)IIUY+Z6K@P5M%\UXF(FF.F7+CR_LKLKF.^>8KQ?%UZ<5=)
MS9IB>C#37\ZWVVGUBE(G6\_96+6KSH?.#SM[[\_>W.>UN\,S9T1XNSKQ&C=?
MZW3?66A]>8*3F&NYL-8Q5]?9&XXO,O<043Y&_N)I[R^FIHXKDX@@MH(/1+X1
M\%=A^ ^TOXJ]D8;S;+?YFYW6;IMNMWEC6*WS7K6D=..)FN'%2M<>*LS,5Z[Y
M+WGMV=V7PG8_%_N9PU)UM/5DRWTG)EM[IO:(B-*Q.E:Q$5K&ND:S:9TS;D9:
M               W \+?!OR!\\NU8^KNA]6_4?T[],OM[W?+2TX[2>M]<R.1
MHQ_[P;5EY/\ \+);8^TIN,ID*;>;[6WF]F7FC4/F?SAV!X([5GNCOO=?+^9U
MUVNVQQU[G>9J4F_RL&./_!B^6\TP8IO3YN2G77JQ7N[O+@^RN,GDN:R]/5K&
M/'7UR9;Q&O32O_!$VMI2NL=5HUC7H$_'-\6'CS\>.DVU6J8JSWKO7-8>WL^P
M>]=@QEK5LV3EECBER>!TR.3B>O1=#DOZ.*J<=:R<S7?$4%5_/=RP0UQT!_45
M]4GD+ZA>:M'*Y;['L7#FFVTXS%>WR:1$S%,NXF-/O.ZBLZ3EO'3CZKQ@IAK>
M];0<[^\E<[WWO)^\VG#PM+S.+;5F>B/LMD]GS,FGZZ8TKK,4K6)F)DY1F:Z
M
M
M
M
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MZ2^DXSY@
M
M
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ME>)X+#&+;1.MIF>J^2^D1-\EI];6G3\E:QI6E:UB*QK2V2R$
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M_<O)7Y;FL]\^^O[Y]E8]=*TK'I2D:SI6L1$:S.FLS+-C"G3@
M
M
M
M
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M[[9<GM*;_CLN//LLD:TO2T6K:-=/2T:Q.DQ,3]DQ,3ZP\>[=R@
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MG"
M
M
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M-K6F=9M:9UF9F9UF9]9GUE])QGS
M
M
M
M                                             1C?(S\6'CS\AVDW
M-6UXJST7O7"X>XL^ON]=?QEK3LV,EBCEEQF!W../B"O>M#COZ^:JL==2<36G
M$L]5A/:2SS5R29^G7ZI/(7T]<U6.*RWWW8N;-%MWQF6]ODWB9B+Y=O,Z_=MU
M-8TC+2.G)TTC/3-6E*UV+V#Y*YWL3>1]VM.;A;WB<NVM,]$_;;'[?EY-/UT1
MI;2(O6T1$1S]O-+P;\@? WM63J[OC5OT[]1_4[[1-WQ,M.1TGLC7,=D:\?\
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MMCW6K/LM2WMK:LS6T>L2S Q!U0
M
M
M
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MZZTPS[J>E[Q^R:1:<<6+U=K0@
M
M
M
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M#.+<1K-9]M,E=9B+X[?KJ3I.D^DQ[+1%HF(V0:X8^
M
M
M
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MFUIF9F4]>&X;C>W^-Q<1Q&*N'88:Z5K'_=M:?;:UI];6G6;3,S,ZL2LL=H
M            V$\8O%ONOR_[<UOI?HK3[S:=MV&\ABN;RJBXM]9U+$\\U57V
MT[KGJ+>XM]>UO%6\=<DLTG%4LO-/$-O'/<R0P2:^\F^4.RO$/:6Y[S[ZWE-K
MQ.WI,UKK$YL^3];@VV*9B<N:\S$5K&D5UZ\EJ8ZWO7HNXNY.'[5XO)R_-98Q
M;7''I'I-[V]U,==8FU[3Z1$>D>VTUK$S'0;^,+XG>E?CNT:SS/VN-W_R9V7
MTV'9?<DT=W71#%=20WMWI/7-C?\ --.N:38W45%-<],,.1S4D5,][SQ13:V=
MGY^_J;^J[O3ZAN<OL^K)L/&FVS]6SX^)K$S-8FM=SO+5_9MS:LS,5FUL.VBT
MX\,3,Y<V:#'D;R=R_?F\G#K;!V[COKBP>GN](R99C\_),>[6:8XGIIZS:]Y8
MT46L0
M
M
M
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M&LZUM$6B8;4-6,:
M
M
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MQCQU],>*LSKTTKK/M].JTS-K:1K,Q%8C<9IYB8
M
M
M
M
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MLN3VE-_QV7'GV62-:7I:+5M&NGI:-8G28F)^R8F)]8>/=NY0
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M8[&YBW%\I7JQ6UG#FB)Z,U-?SJ_9:/2+TF=:3]M9K:V[#2K$
M
M
M
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M77TAF9AKJ0
M
M
M
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M*VLX<T1/1FIK^=7[+1Z1>DSK2?MK-;6W8:58@
M
M
M
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MG#<-QO;_ !N+B.(Q5P[##72M8_[MK3[;6M/K:TZS:9F9G5B5ECM
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M]O\ )?-O,MIM>]YFUK3/OF9]9>J=4XP
M
M
M
M
M#3_S2\&_'[SRZJDZN[XU;]1_3OU.^T3=\3+5CMVZWV/(XZO'_O!JN7C_ /P4
MESC[NFXQ>0JMX?NK>;V8N:-O>&/.'?\ X([JCNCL3=?+^9T5W6VR1U[;>8:7
MB_RL^.?_  HIEI-,^*+W^5DIUVZLJ[1[RYSLKDXY+A<O3U:1DQV]<>6D3KTW
MK_PQ%JZ7KK/3:-9UYW/R!_'-WW\=O:%OH_;%M9[%IFS_ 'U[UCVWK-O?<:=O
MN)LYJ>)8:?O(J9L!N&(AFA_5<-/5)+9R2TUQ2W5I);W<_H9\ ?45V']0_;%N
M;[4M?;\SM>FN]V&::_>-KDM'I/PSIEV^28M\C<5B(R168O3%EKDPTGCV-W]P
MG?G&SO.,F<>[QZ1FP7F/F8[3^I^=CMZ]&2-(M$:3%;1:E= V_&;@
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MU[*YCL;F+<7RE>K%;6<.:(GHS4U_.K]EH](O29UI/VUFMK;L-*L0
M
M
M
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MZS/K+Z3C/F
M
M
M
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M]&:FOYU?LM'I%Z3.M)^VLUM;=AI5B
M
M
M                                                          #3
M_P Y/-+JKP-\?MI[X[1D_4?T[VL3I&B6.3QV.V/LC=LC5[>(U77_ -0K_P#H
MKO(7,<5Q5C\7;W%U[,WL\15[>\'^&.ZO._?^U[$[7CY?S-<FYW5J7OAV>VIZ
MY,^7HC]2F*DVI&7/?'BZZ=?57*NS>T>3[UYS%PO&QT]7Q9,DQ,TQ8X_.O;3_
M .QK$S'5>:UUC76.;+YB^8O=?G%W7G^[N[L_^H9C(>K'ZSK./JN(=3Z^U.&X
MFFQ>G:=BYIIOT_#X_P!ZJJNNJJNYO;FN2YN9);B622KTA^'O#W97A#LK!V3V
M3@^7L\?QYLU])S[O/,1%]QN+Q$=>2^D1$1$4QTBN/'6F.E:Q8'VIVIP_9O#T
MX?AZ=.*OK>\Z=>6^GKDR3[[3_P %8TK6(K$0U7;29*              MZ_#
MC\$.0YR&E^6/G#J]G1BZ+/&[7U/XZ9VUGDR$^0DGEN,5M'=F'OK2*WM+.TMX
MH+RRUNJJ>NXKGH_5:8.()<?<5&?6']=>W^[[WQ1X0W5YW4WO@WW+XK1%(I$1
M%\'&Y*VF;6M,VQY-Y'3%(K/W6;S>FXQQ9\L>::=&;MCL[)/S-9IFW59](CV6
MIM[1.LS,ZUME]--)^5KK&2MPU3^BF
M
M
M
M
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MZOV6CTB])G6D_;6:VMNPTJQ
M
M
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M/FQ[)QX9B=?E3[+9/2<D?#7]'K;):S56(S@
M
M
M
M
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M)VP]K]VWBO(S$4P[FT^F:?97'EUCTRS[*Y-=,L^EM,FDY*K"TU)4
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M@#W7VIS'9O,7X?F*=.6OK2\:]&6FOIDQS[ZS_P -9UK:(M$PVH:L8T
M
M
M
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M(<^7O+UN=MD[7[7R3'"Q,US9JSZ[B??2D_\ ,?;/_*__ &O]DL[JR4=
M
M
M
M
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MB+1:L9^8"Z,
M
M
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M$_%DKIU=-9M2;*:MM'P
M
M
M
M
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M&VEJS_W+5GV6K:/6MHUBT3$Q.C+3$W5@
M
M
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MLF,,3&M*3ZVG2]XUZ:TL1J\FAP
M
M
M
M
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M>EHF+5M$Z3$Q/K$Q+TCK7'
M
M
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M9E5I(\
M
M
M
M                                                    *[GS._#%
MA_,/#YGR1\;L-C<%Y3X+&^_LFMP?:XO#]_8?%VM,<./R$TE4%ECNSL=904Q8
MS)RU417\5%%C?5\1\6MU96&_1I]9>\\0;S#XX\CYLF?Q;GR:8<T]5\G%9+VU
MF](C6U]E>TS;-AK$VQ6F<^")M.7%FWQXD\MY>U,M.W^X+VOVU>VE+SK-MM:9
M]L>V9PS,ZWI'K6=;TC7JK>AEF<-F-<S&5U[8<5DL%G\%DK[#9S!YFQNL7F,-
MF,7=2V.3Q65QE]%!>X[)8Z]@KAG@FHHEAEHJHKIXJXYX7N[/>;/D=GBY#C\N
M//L,^.N3%EQVK?'DQWK%J7I>LS6]+UF+5M69K:LQ,3,2FMBRXMQBKGP6K?!>
ML6K:LQ-;5F-8M68UB8F)UB8])CUA\UR7T             6!/A.^7F7PCVNO
MH'O_ "V8RGBSOV8MI<9EJY;O)R]!;7>W%SS?;-B,9'1/<7&A[+<7E,F?Q]OQ
M5)!-'QD+./F?F\@R$ OK5^D:OFSBH[^[ Q8<7E'889B^.(K2.4P5B.G#DO.D
M1NL,5F-KEOI%JS.WS6BGR;[?1WE_Q9'>&V_=S@ZTKW)@I.M?2/O-(B-*6GV1
MDI$:8[3Z3$_+O/3T6I?XM[BWO+>"[M)X;JUNH8KBVN;>6B>WN+>>BF6&>":*
MJJ.:&:.KBJFJGGFFJGGCGCGZ*#,F/)AR6Q9:S7+69BU9B8F)B=)B8GUB8GTF
M)]8E!^U;4M-;1,6B=)B?;$_9+]GX?P
M
M
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M^R6=U9*.@
M
M
M
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M)C)=54N(A@
M
M
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MFLK'/9W>D^[%[N-[*[$L:_;FCW"2&3B3$8:;CC](IJXN;NG[_F*''TT?6_\
M6?M^XL6]\*^)MQ3)P%NK#RG(4F+5W.DZ7V>TMZQ.WB8TS[BO[/,3BQ3\CJON
M(D^9/+N/?US=G]KWBVQG6FYSQZQD^W%BG^D]U\D?G_FUGHUF]L55&C&
M
M
M
M
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MEWM,1-:Q'R[3Z1T3\%HE6 C@
M
M
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M5UQ^MIMT7&5/2*(
M
M
M
M
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M&1-NV]UDMT:1,_(O/K\FT^L=.DS\FTSU6K6:VUM2;6G)0?:;
M
M
M
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M:7GE'*&8
M
M
M
M
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M1$UM$Q,3$QK$Q,>DQ,>L3'I,)G5M6]8M68FLQK$Q[)C[8?B_;^@
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MB=A[_L+G)V.;JOQ>:;6VV6=/TE(TUB=/2,F/JBN2-(]9BT1%;U2-HZ,!
M
M
M
M        48OGN^6*+R)VO)>&OCOM7WG0FB9B'^5O<]?R5I=X#NW>,3<8K*8[
M#8NYMH.9;W0^M<[95<T34W'-IF,U']S1')!8X^[FO&^@SZ4;>/.*Q>8_(>UZ
M._-]AG[AM\M+5R\;MLD7I?)>LSI7=;S%:-:S3YFWV\_*M:M\^XQ4F9X2\8SP
M.VKW;SV+3F\U/T&.T3%MOCM%JS:8F?3)EK/LTZJ8YZ9F+7O6*S2RU(8
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M,R@[ERY=QEMGSVM?/>TVM:TS-K6F=9M:9UF9F9UF9]9GUE])QGS
M
M
M
M
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M$:Q,>R=:SI:LQ&PC7SH@
M
M
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MB(B(>\=$X0
M
M
M
M
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M)]8F)>D=:XX
M
M
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MF<\,$=*
M
M
M
M
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MN;'6/V2/6-<F.(]?2;7II$>M*Q:\,I$0Y
M
M
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MCW3>8TG)?36]OLK%:UWD:/8:
M
M
M
M
M                        ^;F<-A]CP^5U[8<5C<[@,[C;[#9S!YFQM<IA
M\SA\I:RV.3Q65QE]%/99'&Y&RGKAG@FHKBFBKJHKIYIYYX<G9[S><=O,7(<?
MER8-_@R5R8LN.UJ9,>2EHM2]+UF+4O2T1:MJS%JVB)B8F'TQ9<NWRUSX+6IG
MI:+5M69BU;1.L6K,:3$Q,:Q,>L3ZPY]_S1?$GG_!SL'(=X=/XC]0\2^Q=DYB
MPT-AS>W-WTKLV5XEN8M V'F^N[^^N=;O:H9:L)E:Y*N*J>/LKGT7%$$E[?\
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M^+V[MW7PE(C@]Q?]+2L1$8,MI].FL::8LD^R(B8I?6NL1:D+*:MM'P
M
M
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MVF!1":J
M
M
M
M
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MOQIY$V/?O#Q:9C'SNWI6-QB]GQ::?-Q_;CO,3,1K,TGX+:_#:\5Z4K90
M       #V'7V_P"X]5;UI_9G7N>O-6WK0=DPVW:CL5AQ!7=X;8<!?P9/%9"*
M*[AN;.X^WO+>BJJ*>.6":GZT245T554\]1W!P'#]U<%O.VNX<%-UP>_VV3;[
MC#?7IR8LM9I>DS68M&M9F(M6:VK.EJVBT1,<7?;':<GLLO';^D9-EGQVI>DZ
MZ6K:-+1Z:3&L3[8F)CVQ,2Z3/Q8?(SI/R'>/.*VNJYP^%[UT6SQFO]Z]?6=Q
M'%+C-FIM>(X]SP.,EEKOX]#WJN"2ZQU57,O%I-Q/853SRVE<TGF\^J3Z=>:^
MGKR%EXJ*YLW8N^O?+QF[M$S%\/5K.WRWB(K.ZVVL4RQ'3\RO1GBE*YJTK7YY
M*[!WG8G.VVVE[\+FF;;;+,>VFO[':?9\S'K$6]G5'3>(B+1$2<HS-=
M
M
M                                                          *N
MWY!WRD?R.:AD_!CHG8O8[;[ P]MSWSLV*NO\JZ\ZSV'&?=6^@VTEO73)9;AV
M3B[V&:ZJKJXKL]<E_9'55D[>>VL__#]^E[^./+XO./?6WZNTN/S3^Y>&]?AW
M>\Q7Z9W4Q/I;;[.];5I$1IDW=?SHC;9,>21_@OQO^ZVZKWGS6/7B\%Y^[4M'
MIES5G2<LZ^W'BF)B/Z;+'M_1VK:D,NT3#             7G?@?^)"#QZU3$
M^8?D;JUG-WKO6'M+WJ/3-@PV0@S'1VIY&WO*+K,92RRW%O38]D;I8W<?%=/-
MKQ<X7&T^Q3/Q+>WL$5'/UV?5I?R#RN7P_P".MU>.QMCFM7?[C%DI./D\])K-
M<=+8]>K9[:U9TGKZ-QFGKFDUPX;VAIYJ\HVYW<V[4X#),<+AO,9\E;1-=Q>)
MC2L3777%CF)]^F2_KII2EILRJTD>
M
M
M
M
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M.D:TO&EJSI&L3&L1.L,V,*=.
M
M
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MD.P
M
M
M
M
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MYGC>X.-Q<OQ&6N;89JZUM'_=K:/;6U9]+5G2:S$Q,:L2LL=H
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M^L3$^DQ/K$H)VK:EIK:)BT3I,3[8G[)?L_#^
M
M
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MF;6M:9]LVF9F9]\R^\X#X
M
M
M
M
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MF
M
M
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M$STXZ1^;CI$S.E*^Z-?69FTZVF9G9!KACX
M
M
M
M
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M:S6WIU:1**C UP
M
M
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M5VU)C2=)TBV6_OZ\DUB=)_,KTTCUBUK2NHJ-9
M
M
M
M
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M/O948LZP
M
M
M   !AGR$[]ZR\8.G-][T[?ST.OZ'U[@;S-Y2;F:QHR.5N(8ZN,9K6N6V0O,?
M;Y7:MFR',=CC+/WHZKJ]GCCXJI]7JXS+Q]V%W-Y.[QV'8W:&"=QSO(9ZXZ1I
M;HI$S\>;-:E;S3!AIKDS9.F8ICK:VDZ:.VX+A.1[CY;!PO%4G)O<]XK'MTK'
MOO>8B9K2D:VO;2>FL3+F"^9?ECV3YL>1/87D-V=<S1Y3<,ES#KFL\7]5_BM
MT;&U26^IZ'@:_MK"#]-U[&<\4R346UO5D+Z2XOIZ.;FZGKJ].7AOQ1VWX5\>
M<?X][9K$[79X]<V;IZ;[K<WTG/NLOQ6GKRW]8K-[QBQ1CP4GY6*D18SVEVQQ
M_9_ X.!XZ(^7BK\=]-+9<D^M\EO6?6T^R-9Z:Q6D3TUK$:NMGLC
M   76_Q]OBKHZUUS">=WD!K,T/9&V8VZD\?=/S=M<6T^CZ;E8I\?<=DY?$9+
M&6UQ;[5N6/YKXPM=$M<,6 N_N./5)>T?;4L_B ?5/;N3D<_@KL#<Q/;FTR5C
ME=QCM$QN=Q28O&SQY*7F)P;>^GWB)K%K;K'\OTKAM\R(7G/R7/(;B_9?!Y(G
MC\5H^]7K,3&3)728Q5M$S$TQS^R>D3.2O3[*3U6IU62-0
M
M
M
M
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M%,:1^OQ:VM33VUF]9UGHZ;ZBAY"@
M
M
M                       !0?\ G^^26ORA[OJ\8.I]@FFZ&Z"SUY:[#>8S
M(6]QA>SNW[+WL?E<]')9U5QWV!T>.6?%XWGFNJB2XJO+FGU1RP54WS_0+]-]
M?&'9,>3NZ]O6._.?P5MBK>DQDV6PMI>F*8MI-<NYF*YLWI$Q2,..=+5R1,VO
M!_C^.W.'_C'R>.(YO?4B:Q,3%L."?6*^OLMD]+W]/2.BOMBRNZL,;X
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M6F9F9F9UF9F?69F?69GUF4&;6M>TVM,S:9UF9]LS]LOV?A_
M
M
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M%EQ6M&L1>MJS,?;'5$:O5.J<8
M
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M>WTID^*^.(B*U^+'$1%:ZV$5?;18
M
M
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MURU^O?9[ZS]E8]E:5C6=*4C2M8UG2(C69G66;&%.G
M
M
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M>.)^SYN.;8_=.GQ>L1,Q[&XS3S$P
M
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M]-*Y<<^M,E?6?2T>V-9Z;1:DSU5M$;1-7L;
M
M
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M[>J9EI1.:P
M
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MD^Y[9TCA@
M
M                                    *<WY#OQ;_I=WF/D$Z%UWZV&4
MO+./R<T_"6OIIQ^0FBHL;'NVPQ\%/$--GDIHH;39O9XXK^]EARE<<G,^4NH[
MA?P]?JA^]8L/T_\ ?FX_3XJ6GAMQDM^?2)FUN-O>?7JI$VR;+J]/EUOM:VKT
M;7%:5W@CR1\RM.QN;R?'6)^Z9+3[8]L[>9GWQZVPZ_K8G'$QTXZS466W)2
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M3$Q.DQ,3ZQ,3Z3$^L2@;:MJ6FMHF+1.DQ/MB?LE^S\/X
M
M
M                                   HG_D/_(Q;^07;]AX@=2[##?\
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MG6(G=WK,^GK$UP1,3_X66-)C2:4UU^96+@ZH)%0
M
M
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MZ7K-;UM'I-;5M$368]\3$3#[S@/@
M
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MNK"R^K51Z
M
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M7V'#?(
M
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M:^LX;SK'I:9I,SI3)>8G25%%IK4
M
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MJ9BX
M
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MG6;7GUUM,^O3$1&\C1[#0
M
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M%FU;4M-;1,6B=)B?;$_9+]GX?P
M
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MCCWY(BOI%[2Z*3SP(&
M
M
M      *?WY(_R*?_ %,^/[J3/_\ R(W7R2S&(O/_ *.]TGIZXEMKW_XCL&:M
MY;?_ .1%,<W_ -.P+>OPX?IW_9?/W=NW_P"<VW#X\E?_  =SR$1-?^-M-M>M
MO\+FU/V&Z5/T_P#87YW?/*4_IL>TK:/Z&3/&L?JXL<Q/_.ZQ^9*G\MY2I
M         7>?QV_C3AZHZZM/.ON+ ^GL_M?#UQ]#8G(09"WNM(ZCRUK)#<;O
M7!<5V]O5F.V;>?BNRK]B7B'7*()H+BJG*W$,5)?XAOU)W[K[BOX,[/SZ]L<5
MFB>4R4FDUW._QVB8VT3$3/R]A,:9(ZJ]6[F]+XXG:X[VAYYX\A3R>_GLOB;_
M /L[:W_OFT3$QDSUGTQZQK/3@F/B]8UR]46K^BK,VB58".
M
M
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MI,3$S%HF+5F8F)>\=$X0
M
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M8U5U-!@
M
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M-IG69GVS/VR_9^'\
M
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M.WW$;[+QG)XKX=_AO-;TM&DUF/\ N3$QI,3$S%HF+5F8F)>\=$X0
M
M
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MPSPP1TH
M
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M_4UFUYB(BV2U[1$=6D;C-/,3
M
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M7SYIC2V3)II_X..OLQTUF*Q,S.MK7M;0-OQFX
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MQWQ;O%>:WI:)BU;1.DQ,3ZQ,2](ZUQP
M
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MV&=;QZQ'1.7VST0OA*)T+
M
M
M     $%7SR?(/+X<^+U75G7.P_IO?WDC9YW4-:FQ\UW%F=)ZXHM.+#L#L&UO
M;"2&;!YBB')PXS"W',L-QQ?7<EW:<UU8Z;VYS?0C]/U?,/D^.Z>XMO\ -[![
M;OBW&:+Q6<>YWG5U;7:6K:)C+CUI;-N:=-J?*QUQ9=(W%.K<_A3L6.Z^X_W2
MW^/JX/CYK>^NG3DRZZXL4Q/YU?2;Y(TF.FL5MI\R->>D]!J=8
M"[#^.?\ &[_)OI7'GCV[@_;WKLG#W6+Z QEW)ZI-<ZSR<=5MF=\FL^8^/M\Q
MOWHYM["OGGUQX2FJ2GZT9#Z4TK?B)_4=_&/FO]1/:.?7@^-S5ORMZQZ9MY2=
M<>UBVOKCVOYV6/9.YF*S\6W]8@^>_('[H;S^)7%W_O+;WB=S,?K\T>M<>OOK
MC]MOMR:1[<:U"JU1K
M
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MOXJ\<X>Q>'^;O(K;N+<UB<UOAGY<>V,-+1^MKZ=<Q,Q>\=6LUBFD/*7[:P
M                               "RQ\#/RRS^..WX;PY\@MG]OQ[WO,2
MP=6;1F[W'VF,Z3WS/Y2XO[RSR&3R-Q9QXSK?>,I?RRW?-4E<.-S$G%U31''=
MW\W%;'UW?2A3R-Q&;S#X_P!MKY!V.&)WV#'6]K\EM<5(K6U*4BTWWFVI6M::
M1%LVWB<4VM;%@HCWYK\85Y_:W[LX/'_[=PTUS4K$S.XQUB(B8B(G7+CK$17T
MUO2.G69K2%ZI1FAB
M
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MG64P*(350
M
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MIFUK3,S,S*OC+ER[C+;/GM:^>]IM:UIF;6M,ZS:TSK,S,SK,SZS/K+Z3C/F
M
M
M                      IM?D3?)W%G\ADOC]Z.V3W<1A;RRG\G-BQ,EI<6
M64S=G/C\W@NH;._XAEJ_\F;ZW@O<_5:RT\TY"F+'2U4R6V0M^;B_P\?IDML-
MOC\_]\;;3=YJ6CA<.2+1:F.T7QY=_:NL?LU9MCVL7K.N*;;BL37)M\B6/@;Q
MU.#'7OGF<>F6\3&TK;6)K6=:VSS']7$S7'K'YNN2/2U+*D2VA*$
M                          !?3^ 7Y-[SRJZKO?%SNO8ILEW_ -(8&VO-
M7V#+3WUYE>U>H+6JSQ<66R>7O[Z_GRN[:-D[F*SRDDO,%=W8W=C/1Q<34Y"6
M.A[Z^?IFP^+.Z:>4.R]O&/L'F\]JY\6.*UIL=_;JO..F.M:Q3;;FD6R88KU1
MCRX\^.9QTG;UM"CS?X[IVUR4=R<1CBO![R\Q>M8B*X<\ZSTQ6(B*X\D1-J1&
MO3:MZSTQT1-B]7:T(
M
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M$Q,>Z8?><!\
M
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M&T_1[>EI_-Q5GTM,>R+Y)^.\1KI,Q7JM%8E(JCNP(
M
M
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MFLZTF>JLMG&LF.@
M
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M2(VV:8Q[J(B(Z<GLQY?3V_,CX+SI&EZUF9F<GI:_53(R
M
M
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M961<-Q&QX'B\'#\;3HV.WQQ2D>V=(]LS/OM:=;6GWVF9][%;*79
M  +7/XW?QW_OGN-_Y\]JX7UZOU_>9+5O'C'7T7KML[OE<%[B=S[$JAYN:*9+
M/1;&>K&XWW8+B&7*WD]Q'5#<XJ*JJJG\1WZA?W&X?'X%[6S:<IR%*9^6O6=)
MQ;6)KDV^TUTG2VYM$9LW3:MJX,>/':+XMU>(C-]0'?GW3:5[(XR_]\YXB^ZF
M/;7'K%L>+V>W),==])B8I6M9UKEF%TE3$B,
M
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MUUY?CJ6M,1_RFW];9*^S6;4G])3UTT^9&DS:-+^2@]"$
M
M
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M8R4GUIDK$Z^EZZ3IK.DZUF=8ELLUJQX
M
M
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M)O>T^^9]T1[(K$:16L:16L16L1$1#)#''7@
M
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MB7''<CL>7V.+D^,RTS;#-2+4O6=8M$_]V)B=8F)B)K,36T1,3#P;O7-
M     ?M;W%Q9W$%W:3S6MU:S17%M<V\M<%Q;W$%=,L,\$T55,D,T,E/%5-5/
M/%5-7''/'/U?C)CQYL=L66L6Q6B8M68B8F)C28F)])B8])B?28?RU:WK-;1$
MUF-)B?9,?9+IK?$]YIV_G-X8=;]H97(0W7:&JP_R:=SVU-5'%Q1V)J=G9Q76
M<EAH^G$4.[8:YL\U'Q3QQ''5?5PT\\\PU?3S0?5;X8R>#O,O)=L;7'->V-U/
MWSCK>NGW3/:TUQ1/OG;9(R;>=?68Q1>?2\*[_)W:-NS>[=QQV*LQQN6?G;>?
M=\J\SI7_ /!VBV.??/3$^]),C<U\
M
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MA4
M
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MMBO['3V^R]HG2^D3_H"-'@
M
M                                            /QN+BWL[>>[NYX;6
MUM89;BYN;B6B"WM[>"BJ6:>>:6JF.&&&.GFJJJKGBFFGCGGGGZ/WCQY,V2N+
M%6;9;3$5K$3,S,SI$1$>LS,^D1'K,O[6MKVBM8F;3.D1'MF?LAS!?D_\P\GY
MP^9_;/<_W4TFC6.2JZ\Z=Q\DW$L6*ZGTJ\OK+6*X>*:YJ;>;:;J>[V"\AIEF
MBBR.8N*8JZHN*'IQ^F+P_MO"/AKB>S.B(YR^/[WR%XC2;[[<UK;-KZ1K&"L8
M]KCM-:S;#M\<VK%ILL9\<]J8^SNTMKQ&D??;5^;GG^FS9(B;_J]$17%6=(F:
M8ZZQKJC];_9P          D.^.3XY.X_D4[CBT;1HIM8ZTUB:PONWNWKZPDN
M<#H>!N9*^8[2TCYKMX\[NV=CMY:,5BJ):*YZZ*YIJX;2&XN(H]?47]1?9WT[
M]G3SG.3&Z[EW46KL-A6T5R[K+6/6UI]9Q;;%,UG/GFLQ6)BE(OEOCQVP3O[O
M[B>PN)G>;R8R<CDB8P8(G2V2T>^?;TXZZQUWT]/2(B;36L]$#PV\*>A/!CJ/
M%=3=&:E9XN.BSQ_[Y;Q>VEC)OG9N=LN+NOG8][V"WMH+C+WG%QD;GFUM_P"#
M9XV&?F"SB@@XXCX\]7F/S3WYYQ[MR]V=\;N^6TWO]WVU;6C:[+%;I_0[7%-I
MC'72E.N_KDS6K&3->]];((=V=W\WWGREN4YG+-IUGY>.)GY>&LZ?!CK,S%8T
MB-9_.O,=5YF?5MHU,Q<             !&S\C?QC="_(GUW+C]VL(=3[HUK
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MVN@@H!0:
M
M                                 05?.U\=/^V;XW?RJ=9:S9WWD9X^
M6>2S^N2VU/V^9WGK.F*6_P!TZYYDBXX_5KR#V>,KA(9N)*XKZ&>WM?:YR5QS
M).;Z%OJ)_P!37D?^*W<VYO3QUW!>F+-$^N/;;S6*;;=Z3^QUG7Y&YM72+8K4
MR9>J-MCZ=S^%^_?XI=P?N9R.2:\!OIBM]?6N/-[,>7^IC]9DF--:S6UM?EUT
MYZ3T&IU@          /VM[BXL[B"[M)YK6ZM9HKBVN;>6N"XM[B"NF6&>":*
MJF2&:&2GBJFJGGBJFKCCGCGZOQDQX\V.V++6+8K1,6K,1,3$QI,3$^DQ,>DQ
M/I,/Y:M;UFMHB:S&DQ/LF/LETM_B+\\<?YZ^(>I[KFK^S_EIZW^VZW[QPU%Y
M!+?<[9B+*+],WGBTXHM[J+#]E86F/)12>Q3;1Y'[^QADFYL)).?-=]6_@G<>
M!_+F[X798[_Q+Y+JWG&9.F8K\C):>O;=7K6<FSR:X;1U3><7R,]ZTC/6JO7R
MEV5?LGNG+L\-9_<C<:Y=O;3TZ+3ZX]?6.K%;6DQKK->B\Q'7$)148&N
M
M
M                                '/C_ " O..X\G_+_ "736G9Z:[Z:
M\8YK_1,?;6=Y75B-A[4IFYC[)VJJ&.O[>YFQ>0BIP-M)SQ7Q3%C998:N*;JO
MU>@3Z _!^/QCXAQ]Y<Q@BG>/<T5W5[6K'S,6QTUV>#68UB+TF=U>/36V:M;Q
MKBKI.?P=V;7MSM6O+;ND1RW(Q&29F/BKA_Y*GVQK'Z28^V\1/K6$#*=[=8
M        "9+X2_C_ +CS>\M,+E]UUV')^/?1,V-W_MJO+V-=W@-JOH+KU:7U
M9)'7;7%CD)MQRT',]]:S^B&3!6%_Q55Q)5!'+#KZUO/V/PEXGS;3A=Q.+R#S
ML7VNP^7:*Y<%9K_?&^B8F+4C;XYZ<5ZZVC=9<$Q'3%[4U/Y@[XKV=VQ?%L\D
MUYW>Q.+!TSI:D3'Z3-[8F/EUG2LQZQDM3TTB9CHX/.B@*
M
M
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M7,ZZVQ6^+%:9TC69QS773TZM8B9T;:-3,7
M
M                                                           <
M^/YZ_CPH\0/)3^6;K+5X</X]>1N2RN=P=GA;2XHP>@=GQ40Y#>-(YCBAYQ^
MQN;N+NO,8*SIJB@^UDN[6SAIM\9531Z!/H.^H6WE[QM_$WN;=3F\@]N8Z8LM
MLEH^;NME.M-MN=9GKRWQQ6-ON<DQ:W7&++FO.3<Q,SG\)]^3W5V]^Y/(Y)OS
MO'UK6TVF.K+A]F/)]MIK$=&2WK/5%;7F;9/6!E.]NL          !+1\-'GC
M_L*^8&N9C:[_ .VZ3[D_2NK>X_N;S[7&X#$Y3,VWZ!V5=>JB2C_\W.4FJNKB
MKTU2\XF>^CBX]R6E$[ZR/!/^O/Q#N=GQ6/J[UX;KWO'Z5ZKY<E,=OF[.OLG^
M^Z1%*1K%?GUP6M\-9:P\M=E?QS[5R8MM77F-IU9L&D:S:T5GJQ1_]MCTCW=<
M4F?2'24M[BWO+>"[M)X;JUNH8KBVN;>6B>WN+>>BF6&>":*JJ.:&:.KBJFJG
MGFFJGGCGCGZ/.!DQY,.2V++6:Y:S,6K,3$Q,3I,3$^L3$^DQ/K$J_;5M2TUM
M$Q:)TF)]L3]DOV?A_
M
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MCN?-RWK784_1[>L^DUPUF>F9C6=+WUF]])G2UNF)F(A(0CZP4
M
M
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MM[Y6\V'=&&OP9:3M\LQ&D=5-<F*9GWVM6<D>OKTXXC68CX;:*IU&
M
M
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MT1:)A8YQO([/EMAAY/C[QDV6?'6]+1[ZVC6/U)CV3'MB8F)]8>#=ZYH
M     #H$_CZ^>/\ M1^*?\A.\7_N=P^*]G@-.EFNKSWKO;^H[R"YMNN=ECXF
MHAFDO->AQDV!R%$?W'$5-C97,TO$F0ICHH$_$ \$_P"J_P J?QZX3'IVAW3?
M+N(BM=*[??UF)W>&=-8BN6;UW6*9Z.J<F;'2G3MYM,'/.?97\6^YOW:V==.*
MY*;9/2/2F>)B<M/3W6UC)7737JO6(TQZS/R@.T@
M
M
M              YOOS;>;?\ MF^:VW?NOE_U'ISHO[[J3JW[:?W<;E?TB_K_
M 'WW>U]%54$W[W[3%)]O<4?]_P 39V'U_;2]&WT4>%/]37A;:?NIA^7WCSO3
MO][K&EZ?,K'W;;6]\?=\$QU4G\W/DSZ>U/[P_P!G_P 4NT,7WFO3RV]TSYM?
M;7JC]'CG_B4TUCW7M?[4/Z7K:@          "T'^-SX#6_:W;6>\V^R,3#>:
M/T9DIM7ZAQF2QU%S9YWN.]QL,]_MG'-US);20]8Z]DJ*[7CF"JJG,Y.UNX)H
M9\;]*ZQ/Q'O/63M7M/!X4[<RS3G.<QQGW]Z7F+8N/K>8K@^'2T3O<M)B_P 4
M1.WPY<5Z7IN=8CE]0'>]N,XNG9_'VF-YO:]>>8G2:X(G2*>GK^FM'KZ_L=+5
MF)C)Z7?U(Z'0
M
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MQ.+@N$VG"X=)Q[7;8\6ND1U32L5FTZ1$:VF)M:=(UF9GWL,LR=L
MNP_C=_'Q::'UQ?\ G?V=K]G-NW:5GDM9Z%CR,,DE_J/7%KD+W$[9N$%G=1T4
M8W,=@97'<VMI<TT?<<8*VJJAE^URLU$E*WXCOU Y>>[CQ^"NV=Q>.$XN],W*
M328BN?>6I7)@V\VK.M\>TI?KR4F>C[U>(O3YNUI-8@_4!WU;>\A7LKCLDQL]
MM,7W.GLOEF(M3'K'MKBK.MH]GS)]8ZL43%J%5JC6
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M-='3$>:A7F
M
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MN<FSW=+8]UBO:EZ6C2U;UF:VK:)]DUF)B8]TP^\X#X
M
M
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MD>OKJS\P%T8
M
M                                  "*[YJ^Z?Y#_C0\G\O;3^C,;_I]
MMTMAK?V_5]]_*_EK+1ME@]Z3%9:UMOMM%RV6NO5+3#Z_M_;BGAN)(9.)2_1;
MV7_'?ZE>V-GDKKL^/WD\CDG7\W[ACMN<,Z1?':W5N<>"FE9MIU]5Z7QUO6=E
M>(>(_=GR'QN*T?HL&6=Q:?L^16<E/UU9G7)6D>FOMUFLUB8<TYZ3EA
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MUK;UBNL6K$6B>F-8F)B(B6;&%.G
M
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MM3O'95B-CO)K3-$?K<]:SI;[(C+2L?\ ATM:9UO"T&K#1R
M
M
M                   <TWYBO-O_ &X?-;?=OUK+_J73G6'KZDZ6^VG]S&Y'
M4M7O[S]5W>U]OFB"Y_E#VFXO,I;W%44=S^DRV-M-]>;6GZ>D[Z/?"?\ J1\+
M;#B.2P_+[QY/3?\ (ZQI>F?/6O1MK:^L?=,$8\%Z1::?/KGR4T^;*PCQ1V?_
M !.[0P;7<4Z>6W/Z?<:QZQ>\1TXY]\?*I%:3&LQUQ>T?G(KTI6R@
M  %SW\:GP(_=?4]F\\^R,)9R9G?+/(:#X^Q7]K[E[A-3LLE>6'8N]V\=U!71
M:7FU93'QXC'W4%45S'C[/(T<U56^1^G--'XDWGG]U.6VW@CMS/>-EL+TW7*S
M6VE<F>U*VVFUF:SK:N"EYW&6EHFDY<FWG2,FWUB)/U"=[?>=UC[*X^\_)P3&
M7<Z3Z6O,1.+'.D^L4B9O:)UB;6QS^=C6Q54:,8
M
M
M  "JE^4_VI'C.D?%;I&B3US;KVIN?:ES%1%:2?;Q]8:E#J-E)<S<W=-]:?>5
M=O7'$%-,%<-Q[$W-4E%4%--=J'X6W:UMSWMW5WM:-*;+BMOL8F9M&L[W/.>T
M5CIZ;=/W"G5,VBU.JFE9B\S62_TV<9.3F.3YB?9AVV/#'M]?G7ZYT]-)T^1&
MOKK&L>DZ^E*I=&EV         NG_ (P7BE7K'6'<?F+L>-ABR?9V2_D@ZTNI
M>+>N\XT;4;VVRV]9*WKIMZYH,;L6[16=GS1S/357/KU55<7%/$,E=+_XG/E6
MO)]S\/X>X[),[;C,?[H;RL:Q7[SN*VQ[6D^NDWP[:<F37IF(KNXB+ZS>M8B_
M49W-&YY':=J;>TSCVU?GY8]=/F7B:XXGU]9KCZK>SV98TGVQ%K-58C.
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M^M\5IG72=9GTTT3>H2M.@
M
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M
M
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MFY+?6F^\SY;9+VGWVO,VF?\ AGTCW1Z/;.D<,
M
M                            !_'D<CC\1C[[+9:^L\7BL79W.1R>3R-S
M!98_'8^R@KN;R^OKRYKBMK2SM+:*J2662JFB.BGFJKGCCCGE]MOM]QN]Q3:;
M2E\NZRWK2E*5FU[WM,16M:Q$S:UIF(K6(F9F8B(U?O'COEO7%BK-LMIB(B(U
MF9GTB(B/69F?2(CVM".V?E6^.GI+F^BWWR^Z9YO<7-+:Y+$Z/L,O;&>QUY;Y
M.C#W6/OM?ZIL]US=IDK._K],]M);TSPT45R5T4QQUUT[Y[3^E?ZB.]8QVX'M
M#F?DY8BU,FYQ1L<5ZS2<E;UR[ZVVQVI:OK6\7FMIFM:S-K5B<VXOQIW[S'3.
MRXK=]%HUBV2OR:S$QU1,6S3CK,3'LF)TGTB)UF(1I]G_ )-7@;J'-Y9]>:3W
M]VYD(X89;"_QVHZWINHW5?.3KM;FWNLIM^VV.UV4T>.AYNH^:<%/')[D4554
M==4OL23[8_#0\[\O%,W<.]X#B=O,S%JWW&;<9ZQT1:)K3;X+8+1-YZ)UW59C
M2]HBT13KV%QWT[]Z[K2^_P VQVN/7UB;WR7CTUB8BE)I/K\,_I(F-)G28TUT
M4WG\JS8)_N+;K3PPP^,]G,2_:9G>>Z[W.?J& C^[C@^XUK =;Z]^D9BZ^L$M
M?IRU]!;^F2+CWO53-3O/@_PK]A3IR=R]YYLNN&.K'MN-KBZ,L],SIFR[S+\S
M'7XJQK@Q6OK6_P &DTG,]E]-."-+<AR][:T]:X]O%=+>FNE[9;=58]8_,K,^
MD^GL:B[I^3AY^;#1D;35M"\:= M9LE)<8N^QFC;UG=CL,93<25VV-O+W9NS,
MGKV1F^VJICGN*<3;\RUT\UQT0<<^GC;G"_AF^ ^/MCR\IO\ N7?Y8QQ%ZWW.
MUQ8;7TCJO6N'9TRTCJUFM)SWZ8G2UKZ:SE.S^G;LC!-;;G/R.>T5TF)R8ZTF
M=/68BF&+1Z^R.N=/9,S[6 =K_(2^4G8OL/TCNO3]#^S^Z^X_=3IGJJ\_5?N/
MMO9^_P#WYU7<_;^Q]BKVOM?MOK[U?N>Y](_1GW%?A]?2[QWS/OG"[S?]?3I\
M_D=]7HTUUZ/NV?;Z]6L=77U_FQT]/Q=7>;7P5XWV_5\W9Y<^NFG7N,T=.FOL
M^7?'[??KK[(TT]=?'_U]ORQ_TK?_ %%^-G_N==O_ ##?I1_T5_[3YC_.#E_Z
MD_&/[V?](W?]W/Z^WY8_Z5O_ *B_&S_W.G\PWZ4?]%?^T^8_S@?ZD_&/[V?]
M(W?]W>DU?\@GY4,!D)KS+=]ZWO%O+9R6U&)VCI7INTQ]O-7-;RTY&&32]'U#
M*57D4<-4=-,ES7;\T35\U155\45T==RGX?\ ]+7(;>,.TX'<[')%XM.3!R/(
M6O,1$QT3&YW.XITS,Q,S%(OK6-+1'5%N/N?!GC7/2*8MCDPVB=>JFXSS,^WT
M_29+UT]_I$3Z1ZZ:Q.<M5_)C^1+7K>[AR^N>-.]27$U$L-WM76NXV=Q844T>
MBJWM*=([.TVUKADJ_A5<SQ32>K_!5QQ^Q@_*_AI_3QR&2E]IN>Y=C6L3$UP;
MS;VBTZ^VWWG9;BVL>R.FU8T]L3/JZ;<_3SV'GM$XLG(X8B/93+CF)_+/S,.2
M?^"8C\C<#2_RJMWM;BXI[$\-=5SEK--84VDVE]R9?5;C&V]-<_&4EN+;.:!N
M,>:FDCKBYMXZ9<?315'5Q777Q)Q5%J#FOPL.$RXZSV]WENL&6L6ZHW/'X\\7
MG2.B(MBW6WG'$3KU3-<LS$Q,1'3,6Q3=_33L[5C[ARV6EHB=?F8*WB9]--)K
MEQ]/OUG2WMC2(T]=]^J_R:_!3<)([+LG1.^.H+RKW:Y,E>ZQKV[ZI'%Q=VEO
M!1QD-3V6?::[RN"XKGKH_1.(J(X*^.):Y.8Z*]#=T_AG^<^'K.?MO?<#R^'T
MB*5S9=MGF>FTS/1GPQ@BL3$5B?O/5,VB9I%8M:N$\E]._>FTCKX_/LMU3[(O
M;'?V3,^EZ133TT_9-=9CTB-9B43I;Y/_ (_/(+V8NK_++I_(9&Z]S[/7]LV"
MOK#;+[V?U6JX^PT_M&UTW:;_ .V@PMQ/+[-G7[5M31/7](98JZXP=Z?3'Y_\
M?]5NZ.T^8Q[>NG5EP8HWN"NO1IU[C96W&"O5.2E:]62.J\S2-;TO6NN.7\<]
M\\%K/)<7NZXX]MJ5^=2/S=-<F&<E(UFT1&MO6=8CUB8C?%HEA0
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MZ>#[_P!KCM;3:[Z+;:_L]9R:3C]ND:_.KCCTGJTF8C69Z9YRST5)\
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MJXYR4UB=/S\?73U]WQ?%'K&L>K=EI5AX
M
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MGY66*X=SI'LO6-,.6W_&K'RIM.E8FF*OYUUM=4TB^
M
M
M            YIOS%>;?^W#YK;[M^M9?]2Z<ZP]?4G2WVT_N8W(ZEJ]_>?JN
M[VOM\T07/\H>TW%YE+>XJBCN?TF6QMIOKS:T_3TG?1[X3_U(^%MAQ')8?E]X
M\GIO^1UC2],^>M>C;6U]8^Z8(QX+TBTT^?7/DII\V5A'BCL_^)W:&#:[BG3R
MVY_3[C6/6+WB.G'/OCY5(K28UF.N+VC\Y%>E*V4           O@_CA^$G\B
M'C/F?*C=<1]MV-Y,>Q^Z7W<'HO<'TI@;N7]!]GW*>);?]_L[1+E9/3SS'<X^
M#&2<?MX43_B,^:_X[^2L/BWA<W5V[VUK\_IGX<G)9:Q\W73TG[KBZ<$>^F6V
MYK[T+//W>'[L=PT[:V=M=AQVO7I[+;BT?%^K\NNE(^RTY(605<C0
M
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M?5M_B> X3@L7R>%VFVVN.8C7Y6.M)MI$1K::Q$VG2(UM:9F=/69899D[8
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MP
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MEF!B#J@
M
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M7+:;9;3,S,SK,S/K,S,^LS,^LS/M?V/B_
M
M                    #YN8S.'U[&7N:S^5QN#PV.AYN,AELQ?6N,QEA;T\
M\4U3WM_>RP6MK#Q55QQS57733]>?\+D[/9[SD-S39;#%DS[S).E,>.MKWM/V
M5K6)M:?R1$R^F+#ESY(PX*VOEM.D5K$S,S]D1'K*#;RW_(1\%O'.C*8'K#+Y
M+RH[$M8;R.SQ?4]Y8P=;19.UN.8([?.]NY"FXPWZ;><1UU1W> LMDXYXXIYY
MC]%=-:<'B7\/OSGY%MBW_<^''VMV[::S:^^K:=Y-+1K,XMA33)UUUB)Q[K)L
M_?'5K68;D[7\%]Y\_-<_(TKQNPF8UG-$_-TF-=:X(TMK'OKEMB]_KK&BM-Y6
M_D%>>OD37DL+UYLF-\8-!O(>;6'#=05W,>\R6]=O<132Y+M;)<<[/#DJJ[JK
MFB?"T8*F.F.+TQ^[15+)9/XJ_#^\#^/*X][W#MLG<_/TGJG)R'3.VB8F)B*;
M&GZ&::5C6NYG<S,S?6W3,4K(7MGP9V3P,5S;_';D=]$Z]6?3Y>NL>S#'P:>G
MLR?,UUGUTF(B$_9]JV?=L]DMJW/8\]MVSYF:FXR^Q[/F,AG\]E;BB&.WHGR6
M8RMQ=Y"^FHMX:*.*I9*JN**.*?K]...$U>,XOC.$V&/B^&VV#:<9AC3'APXZ
M8L5(F9F8ICI%:5C69G2L1&LS/MEM_;;;;;/!7;;3'3%MJ1I6E*Q6M8]ND5K$
M1'KZ^D/@N<^P                "0[Q"^4[S:\)[C#V73_;^2R?7N*FKJKZ
M<[&IGW;JN]M9:XYKBPAP-[=P9/5H;B>&BNN; 7V(O.>>*N.)N*9)::X]^7?I
M;\*>:L>;/W?Q&/%W!EC_ .Z&STVV^K:(F(M.6M9IGF(F8BNZQ;C'[)Z-:UFN
M"=U>->S^\*WORNUK7?6C]GQ:8\T3[IZHB8OI]F6MZ_D](TMQ^$GY$OB1Y$_I
M&F>0T7^RGVE=>Q:??[7E:<KTIGKVKTQ>]8=E?;6/[F>_[<EQ+'L=KC\?91\T
M14Y.[EY^O-2GFS\/+RUX\^=S/CV?XU=KTUMTX*=')8J^W2^SZK?>--8I6=G?
M+ER3K>=MAK[(N=X>!NZ.!Z]WP,_NGQL:SI2O3N*Q^7%K/S/=$3BFUK3K/RZ0
ML"X[(X_+X^QRV)OK/*8K*6=MD<9D\=<P7N/R./O8*+FSOK&\MJY;:[L[NVEI
MDBECJJHDHJXJIYYXYXY0!W&WW&TW%]INZ7Q;K%>U+TO6:WI>LS%JVK,1-;5F
M)BU9B)B8F)C5H[)COBO;%EK-<M9F)B8TF)CTF)B?6)B?28GV/['Q?@
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MNL?9/3:U=8]=)F/9,M*>?JUGQ[>9B)F-WAF/R3K:-8_H3,?J3+H.//V@P
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M5GI25[:[+[8[2V\8."VF+#?3XLDQU9;_ /&RVUO/O^'6*5UGIK6)T:BMMLI
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MGXYC29E[1%:L
M
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M "<+@*H5%8
M
M                                      !S??FV\V_]LWS6V[]U\O\
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MI/Z.)^RDS'I:4\Z"#2@
M
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M\6+-TZ3EGX\MOMZLEM;>L^LUB8K[HK$1$1IRW"RL
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MY9RYZ3NN%F9Z=SCK/3$:^D9:^LX;::3I:9I.NE,EYBVDJZ*[6@
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MDF'V'#?(
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MVRVI;[)TGTM']3:-+5GWUF)9@8@ZH
M
M                                                       !%%\S
M?F9:>&?@SV7F\3DOM>U>X;.]Z5ZC@MKJ6VR5IL.Z8F_M\]N5K+:2TWME^X&H
M47V2M[KBBJ"G+1V%O+S3]U1SS*OZ-?#>7S)YQXW9;O'U=K</>O([^9K%J6Q;
M?)2<6WM%HZ;?>MQ.+#:FL6G!.?)77Y4MF^)>TK=V]Y[?#EKKQFTF-QGF8UB:
MX[1-<<Z^D_-OTTF/;T3>T?FRYK3TD+!0          $DWQ/>%EQYS>9_6_5^
M5Q\UUU?JLW\I?<]S337Q;T==ZG>6<MU@Y9J/IS%-NV9N;/"Q\T\\21TWU<U/
M'/$-7TC?]5OF?'X.\-<EW/M<D5[GW4?<^.KZ:_>\];17+$>^-MCC)N)U])G%
M%)];PU_Y.[NKV;VEN.1Q6B.2RQ\G;Q[_ )MXG2W_ .#K%LD^Z>F(][IK6]O;
MV=O!:6D$-K:VL,5O;6UO%1!;V]O!13%#!!#%33'###'3Q3333QQ333QQQQQ]
M'F?R9,F;);+EM-LMIF;6F9F9F9UF9F?69F?69GUF5=UK6O:;6F9M,ZS,^V9^
MV7[/P_@
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MFMHF+1.DQ/MB?LE^S\/X
M
M      I8?DL>"%QJ&_ZUYWZ#BX:=5[(FP?7'=5M915\S8[L2PQ=Y'I^Z7,,,
M-5$>-VC6,+3C+J>KFB.*_P ?;<5<U37]/UN@_#9\ZX^7X#<^"N>RS^ZO&QEW
MG'6M,:7VEKUG<;:)F=9O@S9)S4K&LVQ9<FD13!*77T]]ZUW6QR=E;ZT_>=O%
MLNWF??BF8^9CC\M+VZXCVS6UO=15,6II,           +@/XRGFW_P#/!\$M
MYR__ ,D^V^B_O)__ (E_*=I%C[E7_P 1SUI;Q\?_ "5FJ5#?B8>%/_N?YTX/
M#_2;#D^F/U?N6YMI_P"%M<EY_P#V6D(K?41V?^P=Z;.OV8-SI_\ J<D_]W':
M9_\ )PN JA45@
M
M                                       '/+_(!\Q[?R@\WLEU_J6:
MFR75_B_C;_JC!1Q7-$^'ONQ*\GS=]M[-CJ*:?K'-<9FSL\'+7Q77'/%KD,M'
M[*_KSZ$/H#\.Y/&'A+'W!RV&,?<_<^2N^RS,3&2NTBG3L,-_MB,=LFYK&D36
MV[O6WK'I.WP=VG;MSLZN^W5(KR7)6C-;TTM&+33!2?U*S;)'OB<LQ/L08IQM
MR@          .A#^/YX2?[+WAQ9=M[?B/LNV_*/])[#RWW4'MY#"=9P6T_\
M);KE7KIXDB^\Q>0GSDU/\&OUY>F*3CU6]/T\_'U^^;/]9_F*_:7$9NOM/M?Y
MFTQ],ZTR;R9C[[F]/2>F]*[:L^L:8)O6=,DH+^<>\/XQ]V3Q>UOKQ?&]6*ND
M^ELTS'SK_P!"8C''_$UC\Y/"@FTJ
M
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MMXCYN>T1\S),1&OK^LQZQK7'$Z5]LS:VMIT#;\9N
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MH[(M.XW-(W/#:^FXQ1,UCV^F2OYV*?RVUI.L16]IUB)5T5VM
M
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M';TF(F:6F.J-?UMM.JL^^LQ,>DLJ,6=8
M
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MR6RY;3;+:9FUIF9F9F=9F9GUF9GUF9]9E7=:UKVFUIF;3.LS/MF?ME^S\/X
M
M                                         T_\P?.[QC\%M)M=S\A^
MQ;/7)LQ]U1J.CXF+]=[%WFXLX_7<Q:KJ%I)3?W5G:U51QW.1N.;;%64L\-%S
M=0U31<5[>\0>"O)OG+FK<-X]XZ^YIAZ9W&YR3\K:;:+3\,Y]Q:.FMK>LTQ4Z
M\^2M;SCQ7BE^G*NU>R^XN\]Y.TX';SDBFG7DM\.+'$^SKO/I$SZS%8UO:(F:
MUG2=*//R&_.?Y0^:OZGU[H-U>>/'C_7>7]'[FZ5F;N'=M[QLGKMK3CL[=[2N
MVO+ZSJLZZ^:\-CN+/$UU3\\75%_7#;SQW=_3W]#GC#PO\KN#GZT[A[_BE9^\
M;G'6=MM;QZV^Y;:W56MNK33<9OF9XBL3BG!%\E+3'[$\,]N=H=.^WT1O^<TC
M])DK'R\<^V?DXYUB)U]F2_5?T^&:1-HF$--IN$
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ME:9*6K$#>Z^U.8[-YB_#\Q3IRU]:7C7HRTU],F.??6?^&LZUM$6B8;4-6,:
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M,?T6<F#NF
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M>FRI^CS:8-SI'Z^L?H<D^_XJ1..TSI$?+Q1[;+:*IU&
M
M
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M$VE0
M                                            'XW%Q;V=O/=W<\-K
M:VL,MQ<W-Q+1!;V]O!15+-//-+53'###'3S5555SQ333QSSSS]'[QX\F;)7%
MBK-LMIB*UB)F9F9TB(B/69F?2(CUF7]K6U[16L3-IG2(CVS/V0J[?)1^11HW
M4EQG.GO!2O5>W-^BANL;FN^+ZF3-]5ZA>\UY''7,6A645=K:]E9['U11W5KE
M.)I]8^M455/&4BJEAIL_^F[\/#G.[<>#O#SG&ZXG@)FM\?%UTQ[[<5TI>L[J
MT]5MGBOK-+X>FN]]+1/W6T5O,C_'W@7><I6G*]Z?-VNQF8FNVCX<UX])CYD^
MLXJSZQ--(S>W]CG25-3MON#M#OGL'8NU>Y-[V3L?L/:[SF]SNU;3DILCDKJK
MCCT6UG;^OGBWQF'QEOQ3;V5A:QPV5A:QT06\44,=$=-QW:7:';'8?;^W[5[.
MV.VX[M[:4Z<6#!2*4K[YM.GK?)>=;9,MYMDRWFV3)>U[6M,L^+XKC>$V./C.
M)PX]OL,4:5I2-(C[9GWS:9];6F9M:9FUIF9F6-V1N>
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M./U;7M/YU[V].J]M/6?U*UB*Q6L8!9\[L
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MX6YCM*+<GPLWWW :S,S$:YL,:^GS:UC2U8C3]+2(C77KICC3JGS0*:1
M
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MU5G28]+1I,>DPK7Y#8;KB]_FXW?5FF\P9;8[UGW6I,UF/^&/2??'J]LZ1PP
M
M
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ML_#^
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MTF;13W_'ZY)B;1U16>E#FF$VN
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M<A;C.=V]]ONXC6-?6MZ_TU+QK6]?=U5F8B8FLZ6B8C/S 71@
M
M                             *?WY-?A)_\ .^\[=&Q'_P C.I.]/LX/
M_BO\F.[WWMT__%L#=W$G/_R*AI6]?AG^:_\ [H>"^<S?T^_XSJG]3[[MJZ_^
M#NL=(_\ VJ\I4_3OWA^S]E[RWVY]MK_^NQQ_W,E8C_RDJ?RWE*D
M !>+_&D\T[?LSH3;O#';<A#^^WC]-?;IUO')513=9OIS<]@EN\U;QT<>Y<7<
MV@=B9N2FXGEJIIIL]@QUO%3Z;>KGBD+\2CPQD[:[]VGF7B<<_N+W!%=OO)C7
MIQ\AM\45QS/LBL;K:8XFE:Q,SDVFYR7G7)"''U"]HVX[F\7=NUK/W/?1&/+]
ME<^.NE9^R/FXJQI$?KL62TS\4+.ZLE'0
M
M                                                      !4$_*
M\N*.+?ICPIU?*0U25S0]Z]L16-Y<?<04149G6>M-;R=-MS3:\PW54^5RL]E/
M57)Q5#C;GVZ..8)*[=_PQ?$MIR<SYIY3%,5B)XS8S:L:3,SCS;S-37XM:Z8,
M%<E8B-+;G%U3/76LJ/IR[7GJW?=^YK.FGW;#K$:?K;YKQKZ^GP4BT>GKDKK/
MQ1%/A;XE4           OO\ XX_AQ;]&>(N1\C-HPLUKV5Y0Y*'+X^?(6U$5
MUB^F]6FO+'1;.QHDJFGMX=JR=QD,U+-1S#3D+.YQWKCYXM8I*J&?Q%_,63OC
MRWC\=<7FB_;?:^.<=XI,S6_(9XK;<VMII$S@I&+;5K/5.+)3<:6CYMZQ"7S[
MW9;F>Z:\!MKQ/'\;7IF(GTG/?2<DS]O1$5QQ'KTVC)I/Q3$6(U>30X
M
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M+8,,Q$UQ^L=5;WUZLL>GKT4FNN.9M "GVW@
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MLM9KEK,Q,3&DQ,>DQ,3ZQ,3Z3$^Q_8^+\
M
M             ,/^0'2.D^2/2G9W1'8MI]YIO:6GY?4LQZ*(Y+FP_4+?G]/S
MF.]WCF./,:]E8X+^RDY_[U=VT=?_ '++^P.]N:\<=Z\9WUV[?HYCB]YCSX_6
M8BW1/QXKZ>LX\M)MBR1^NQWM'O=KP?,;SM_F-MS6PG3=[;+6]?LG2?6L_P!3
M:-:VCWUF8<KWR Z1W;QN[K[.Z([%M/L]RZMW#+ZEF/11)';7_P"GW'/Z?G,=
M[O'$DF'V'%207]E)S_WVTN8Z_P#NGJ5[ [VX7R/V5QG?7;M^OA^4V>//C]8F
M:]<?'BOIZ1DQ7BV+)'ZW)2T>Y91P?,;/N#A]MS6PG7:;G%6]?MC6/6L_U59U
MK:/=:)AA]E[M0         &[WQT>6V8\)O+_ *@[XM+R:'6,7GH=:[0L(^+J
M2+,]5[3+#B]UM)K6SAN+B\FQV/KXR5G'3')SQD;"WKXIJYHXXYTE]1/B;9^:
M_$/+]B9:1;D\N"<VRM/3$X]]@B;[:T6M,16+WCY.29F/T.7)&L1.K#N_>U\7
M>':NZX6T1.YM3KPSZ?#FIZXYUG2(UGX+3K'PVM&OJZC&.R./R^/L<MB;ZSRF
M*REG;9'&9/'7,%[C\CC[V"BYL[ZQO+:N6VN[.[MI:9(I8ZJJ)**N*J>>>.>.
M7E_W&WW&TW%]INZ7Q;K%>U+TO6:WI>LS%JVK,1-;5F)BU9B)B8F)C57#DQWQ
M7MBRUFN6LS$Q,:3$QZ3$Q/K$Q/I,3[']CXOP
M
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M^XR7FUK3ZS:UIUM,S]LS,S+[#AOD
M
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M*VG6F&B7O:?8W;?96U^[\'@BN6U8B^6_Q9LFGOO?2/?Z]-8K2)]E8:6MSLN
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MXQ1,T]W[)7UMBGU_7_#,ZQ2]M)TE+1=:V
M
M             4\OR=?#.TLY^KO.73\=[<V5O,?TKW+19VLM?W%W'C\GE.M-
MROJK>*JF+TV&-O,+=W4]5-/\#%P4\^KFGCFX#\,KS)ES4Y3P?S&36F*E^1X[
MJM'I6;TIO-O76?7XKX]SCI6)GUW62?2)F)6?3KW;:\;GLW=V]*Q.XP:S[(UB
M,N.-?RS7)6(_\I94*6YI3           .@K^/)Y??[17A%9]/;%D[S(]C>)]
MYCNM\G+?2>]/=]9YOG,7_3UW1)3''%#9XC!8J[UVW@X^M=%OKU%=7//,G'//
MG^_$)\0_ZN_-E^\..Q4Q]N]UTOO*16-(KO,?RZ<A68UF9MDRWQ[N]O9-]W:(
MTZ=$&?._:O[@]XSRNWK%=AR<3EC3W9J],9X_5M:U<LS]N68]R>U UI,
M
M
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MT3ZPM'JO4;P
M                                               &C?F5\C'B=X)Z
MS<YCO7L>SCVGFSHO,'U'I\F-V'MS:J)*Z:(><-I]>3Q_V=G+]>>>+_)W&.QG
M'-/--5SQ5]*>=X>'/IV\K^=.3KL^Q>-O/%]?3EW^XB^+88-/;\S<=%^JT?\
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MM<OGX7EJ=&^P7TG[+1[:WK.D:TO&EJSI&L3&L1.L,V,*=.
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M%C7:_;FP[3X/;\%QT?H,--)M,1%LEY];Y+:?KK3K/Y(TK'I$-;VQG?@
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M--<QWKW;S]K6Y?D=WFI?76GS)KC^+6)B,5.G'$3$Z3$5B-/3V>C;1J9BX
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M(UIDQVK>EH^VMJS-;1^6)F&U,6;%GQQFP6K?%:-8M68F)C[8F/27S7)?0
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MT(
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MU:P\O=J?QK[+W&+;TZ^4VOZ?!I[9M3\^D>^>O%-XBOLF_1,_FPZ33S>J_
M
M
M                  '--^97R\_VQ//'MC:L+>?<];=77DG2G5W,-]]_8WVL
M]?Y'(V63VFQFBN);*6SW?;Y\CEK6N*B+G].NK:.3BJ2.JNKTG?1QXC_U/^">
M)XO>TZ>Y.4I');W6O3:N;=4I:F"T3$6BVVV\8<%XM-OTM,MJS%;1$6$>)NUO
MXJ=E;7;9HTY#<Q]XS>FDQ?+$3%)]-=<=.BDZZ_%%ICTG1%>E*V4
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MW5:9F8B/=6/96OLK6(B/2&2&..O
M
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MV)([7:;78[>FSV.+'AVF.-*TI6*4K'V5K6(K$?DB(>;=BY
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MZS]EJVB+1/Y)B'I'6N.
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M4_BCWEN=C@IT<9FGYV#3\V,>29GIK^3'?JQQ'MB*QK,ZZS)RC,UT
M
M
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MSK$:3CI,:ZSI<Q4W(E@
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M..X';8]OM_?TQK:\_P!-DO.M[V]?2;3.D>D:5B(C7ML%WH
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M\UW5R5N4YS/?-NK>D:_FTK[J8Z?FTI'V5CUG6TZVF9G81KYT0
M  #S>X:;J'86LYG2M^U76]XTW8[.K';#J6X8/%[+K.=Q]==$E=CF<#FK6]Q6
M4LZY(Z:N8IXJZ.>:>.?I]>.'9<1S/+]O\GAYK@=UN=CS&WOUXL^WRWPYL5X]
M.K'EQVK>EM)F.JMHGU]KD;7=[K8[BF\V.7)AW>.=:WI::7K/VUM68M$_EB85
MXO-O\</QG[O_ %?=?%?,_P"S/V-<^_=_NE[%WGNE,Y>U^J3V?T'W:\[H/W$O
M/%/N8J6?'VT?'TCQG/*PGPI^(SY*[(^3POE+#_&7MVNE?GZUQ<ECK[-?FZ?*
MW6D>[/6N6\_G;F&]^S_/W</#].S[EI^Z.PCTZ]8KN*Q_QOS<FGV7B+3[\BH5
MY@^ /E/X+;-:X#R&ZUO->Q>8O+JSU3?\+<1[#UUN5=I1[LG&O;58\?;_ 'GV
M_P#C>;"\HL\G%%SQ5+;4<+=/$'GWQ;YRXRV_\>\E3<;K#2ML^UR1.+=[?J](
M^;@MZ].OP_-QSDPVMZ5R6E*;M3OCMKO/;SGX+<1DRTB)OBM'3EQZ_P!-2?73
M7TZJ]5)GTBTM,VY&6@                -V/#?Y"_*SP2V:G-= =DWF,UR[
MS$&9VCJS9*9]@ZJW:>.BU@N/WCU&2ZMJ8;R_L+**UDR6-GQV8HMZ*:(;R+TT
M\\:5\Q?3YXK\Z<9.R[_XVF7D:89QX-]ATQ;[;1/5,?)W$5MK6MK6O&'-7+MY
MO,S?#;6=<0[L[$[9[TV_R><V\6W$4FM,U-*YL<>LQT7TGTB9F8I>+8]?6:2N
MD^ OSZ>*?EK^[N@=P7%GXR]ZY+_(.,)N6:@JZMVO*4>YQ#3IW9=['C;&QO,O
M3'3S#B\U'87/W4U-E:39&7T2RTQ>>_H*\J>)OO'/]H5OW-V-B^+YFWQS]]P4
MG37[QLZS>UJX]9ZLVVG+3HK.;+3;UUK2(W>_A'N;M?YF^XJ)Y'A:^O5CK/SJ
M1_Y3%&LS%???'-HZ8F]HQQK$3PH)M*@
M
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M4
M
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MJ&K&-
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M>?3W:16M8B*TI6*TQTK7'CK6E:UB"'(\CON7WV7D^3RWS;_->;7O:=9M,_\
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M8IUTB.OTBV.VLQ72\1$V]*6O&DS):C6UZ
M
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MDKKI/HK3[GX+<=L]P;O@=UK\W;9[4B9C3JI[<=]/LR8YK>/R6AL(U\Z(
M
M
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MW9+3'K5?^4$H/
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MVGT;S?5CD.:K,6C+EK\%)C33Y>+6U8F)C6+WZKQ,:UFOL0AIM-P@
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MB*UB(B(B(B-$@L>.F*E<6*L5Q5B(B(C2(B/2(B(](B(](B/8_C?9^@
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M:UUG357-SO-\CW'RV?FN5O.3>Y[S:?;I6/=2D3,S6E(TK2NL]-8B&9F&NI
M                  :Z^2_B;X]>8.A<];^1/66!['UJ&:>\Q%>0XN;'/:QD
MYX/MZ\MJFS8JXL<_KF2JB^E-<EI<1<344\42\21_6CG8GC7ROY!\0<]_&3QY
MR>?CN2M$5R='3;%FI$ZQCSX;Q;%FIKZQ&2ENF?BI-;>KONWNY^=[5WW[H<#N
M+[?<3$1;32:WB)UZ;TM$UO'Y+1.GMC2?52=^1;\?OOKQ6M\UVCXW7>>\CNCK
M2;*9"^Q=OBHJNX^NL#;42WD<^SX3$1166\8VQLJ.:;C*X:VMZ_515++CK2'C
MU<74_3O]?O8?E/)A[7\CTP=N=[WBE*WF\_N?N\MIBLQAR9)FVVO:TZTP;B]X
MTF*UW.6_HE_V%YRX3N6U.-[@BG'\S,1$3-OT&6T^FE+6]<<S/LIDF?LC):5>
ME8,WJ                 _LQV1R&(R%CEL3?7F+RF+O+;(XW)8ZYFLLACLA
M9347-G?6-Y;5Q7%I>6EQ%3)%+'537'73Q53SQSQQR^.XV^WW>WOM-W2F7:Y:
M6I>EZQ:EZ6B8M6U9B8M6T3,6K,3$Q,Q,:/SDQTRTMBRUBV*T3$Q,:Q,3Z3$Q
M/I,3'I,3[5B[P,_(L\B>@*-<Z[\JL=DO);JFRFM[*;=I\C5SW]K^*KN/K<75
M.R9F]IQG9TUE!775';YN6UOKFOBFBO+1T<<>FNWSO^'=X\[^MN>X?%>3'VUW
M5>)M&VBG_LK+?3TK\G'7KV46F(B;;:M\5(UFNTM;VZ$[U\"\#SDY-_VU:O'\
MG,3/RXC^]K6T](Z*QKAU]\XXFL>V,4RN0>*?FMXS^:NDU;SXZ=H8?>+.S]J+
M8=?DBN\'NVHWM<<55=EM&GYJ"RSN,]$LG,<=U[,F/NZJ*JK6XGCX]?-._E3P
MMY*\+<U^X?D3B\VQS7UG%EB:Y=MGKK/Q8-QCFV*_I&LTZHRXXF(RX\=OA1/[
MF[0[A[0WGW+G]M?#>?S;>EL=X^VF2NM9^V8UBU?UU:SZ-J&K&-
M
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M>LSI&G32/6;1I;C5*(N
M
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M/W?#'LC3',_,M^7KR]<Q;2)FG1$_FPEO1+:N
M
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M%BQ;?%7!@K6F"E8K6M8B*UK$:16L1I$1$1I$1Z1'I#YKDOH
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M_J<<XXC2-(]NLV/2WY0OBKMOLVG>717<'361G]S_ "W4\AKO<&IVGM?JLO\
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M48N8X/F.W]Y.PYK;9=MNX_6WK,:Q]M9]EJ_9:LS6?=+,#$'5
M
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M'Q?@
M
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M]66?6/2DZ:SI$].YYDU=(
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M)^1/XT<1';_*Y->>V6.(BUIUMGPQZ5O[/6^/X:9)F9M;X<DS,VMI7O6!MZ
M                                  +??XZGQD5R5VOR!=X:[-#3!->8
M[QDUG+P6_-%Y1S;W./V+N.]QMU8S24PT22\V&M2^]%)[D5[>^SS1SC;FNHG\
M1#ZF:UK;P!V1N(M-HK?F<V.9UK.L7Q<?6];1&ND?-WE>FT:6PX>OJ^\XXBQY
MZ\B1$3V-PV2)UB)W=ZS/IZQ-<$3$_P#A98TF-)I377YE8N#J@D5    &D_R
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MT3$Q,3&L3$QZ3$QZQ,>DPWY6U;UBU9B:S&L3'LF/MA^+]OZ
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MVFZV.XOL]]BR8=WCG2U+UFEZS]EJVB+1/Y)B'I'6N.
M
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M]L1.2@^TV
M
M                        CV^4WRF_V/?!?O?M_&Y3],WB;6_W!ZOJAN?M
MLE7V+V!+QK6 OL353>6$U=YJT-[<9ROB*7B6BUQ<TE'%55'%/,@OI;\6_P"M
M_P Y<%VAN<7S>$C<_>M[K&M/NFUCYV6N3X;1%<\UIMHZJ],WSTK,Q$ZQG7C;
MMK^-?>>RXK)7JV<9/FYO36/E8OCM%O2?2^D8_6--;Q$Z:ZN8,].*Q@
M    !>%_&0\4(M"\=^RO+?8;+Z;'WWLDNC:%-/;VE?VG5_661O+#,9'&7U'/
M-Y#^]G9%5_:WUO)]*/\ R:M)*?\ G<J1?Q,O*UN>\A\;XEX^_P#[.X';1N=U
M$3:.K>[VE;8Z7K/PS\C9_*OBO'K_ 'YEK/LA#GZB>YYWO/;?M?!/][[''\S)
MZSZYLT1-8F/9\&+IFLQ_SMH6?58R.8
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MUI@Q_#AI_P"#K,WM[^O)-K>LQ$Q72L;^-!L'
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M+$]COMIR>RQ<CL+QDV6?'6]+QKI:MHUK/KI,:Q/LF(F/9,1+Q[MW*
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MS?)WF^[SWFT_96/96E?LK2NE:Q]D?:SDP=TP
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M-V;Y%[8[XP_^R<W1OZQK;;Y-*YJQ&FLQ76>ND:Q'72;5C6(MI,Z(]T@F=
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M,:M"9,=\5[8LM9KEK,Q,3&DQ,>DQ,3ZQ,3Z3$^Q_8^+\
M
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MUT]OR_S<\3[NF*?I;>_]%Z3[8GH7//D@H
M
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M%:',\KN><Y;<\QO)UW6YSWR6]9F(F]IGIC7];77IK'NK$1'I#*C%G6
M
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M&UG:\!M:8>J(Z[^MLN33^GR6UM;UF9BNO169GIK6)T:HMJLF
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MG;W<'%]T<1BYKA\GS-EFCTU]+5M'I:EZ_K;UGTF/6/?$S68F<#L[=T
M                          WJ^/;P-[4^0/O[!]2:):9+%:=CYK+*]N=G
M1XRF_P -UEI<DTE$F4O.+B[Q]K?9[+56\EOB<;Q/3<7USQ55QQQ;P7,T.C/J
M"\[]K> .P<_=O.WQY>8R1;'L-E-^G)O=S$1I2NE;VKBQZQ?/FZ9KBII$ZY+X
MJ7PSOKO7C>QN#ORF]FMMW:)K@PZZ6S9/LC2)F*UUB;WTTK']5:L3TIO&WQTZ
MK\3^E=%Z#Z8PDV#T#0<;+98R.]NZLCF,I?7UW<9/.;%G\E71%SD,]L.9O)[R
MZDIHBAXEEYH@BA@HBAH\V_DCR)W3Y6[TWW?O>6>,_/[_ "1:\UKT8Z5K6*8L
M.*GKT8L6.M<=(F;6Z:ZWM>\VO:OGN#GN2[GY?-S?+WB^^SVUG2-*Q$1$5K6/
M=6M8BM8]9TC69FTS,YR8.Z8   !2J_(;^4"7L#:\EX&]%;3]=%T7,4\>1FPX
M.\NX>=G[!PEQ<QT]2\WMED*;/(:WI-YZ9<U;2Q2>K8+>.&KVZ\=)Q)='^'M]
M,5> XK'YW[YVO_MW?8?_ &1BRUK/R=IDB)^_]-J=5,VYKK7;7K:--I>UXZJ[
MBLUEYX)\<QL=M7O7FL7]^YJ?WK6T1\&*T1^GTF-8ODCTQS$Q^BF9]8R1I526
MH)+           .A#\$OQN_[&7C]_+)V?@_L_(SR!P^-RF>M[F3W;G0>LY*H
MLMJ6ATQ<QT_8YB_]<>2S='U]?%W5!:R?ML>.>?/Q]=/U'?ZY/('\3NV,_7XZ
M[?S7IBF(TC=;R-<>?=:Z_%CKZX=M/L^7%\M?3/,1!?S1Y _C;SG[D\=?7@-C
M>8K,>S+F_-OD_+6/6F/^IUM'YZ>%!-I4
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MB6E;5M2TUM$Q:)TF)]L3]DOV?A_
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M:UF=-;8YTMBO.GI$WQVK:8CV:Z-G&LF.@
M
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M(7@
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M;WM-I]NL1'NK6-?AI6(K6/2L1'HR<QEUP
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M8/6]?369FDY*5CUM>/8FQ0K:@
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M^L6OBG[)UK&2)]FD4K[=9TMKJFD7P
M
M                                         $)WS^>2G^S_ /';V'K>
M)R7V6Y>1.8Q/1N"HM\E]ID*=?S]%UFNR+K[*+_*[_#W6A8*^Q%U].8X**\Q#
MQ+5SQ)3#--3Z!O&W\?\ ZA^/Y+=X^OA^W<.3D\NM.JGS<4UQ[.O5/PUR5W67
M%N*>VTQM[S6(Z9O3;_@_M[]W._,&XRUUVFPI;<6UC6.JNE<4:^R+1EM6]?;,
M]$Z1Z:QSKGH?3S           =+'X8?%W_93^/?I35<G8?8[OV99W'>?8W'/
M'HDKV;LNWL+W$VMS#Q=7<<-YK_7]CA,5/Z:^.*YL?5)Z:.:^:*?-C]9?E#_6
MK]0/-<KMLG7PG&7CC-I[X^3LYM7):)Z:S-<NZMN<]=8]*Y8KK:(B9KW\M]R?
MQF[ZWFYQVZMGMYC;XO\ B8IF+3'I'I;+.2\?9%M/735*BBTUJ
M
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M1"[N[\[E[UW/SN;SS.WBVM,--:X<<Z::UIK/KI,QU7FU])F.K3T;O-),.
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M>E,=:UCTA73S/+[[GN4S\QR5^O?;C)-[S[(UGV1$>ZM8TK6/=6(CW,J,6=8
M                                 BN\]OB"\2//6TR6Q;5K7\F7>4MG
M';XOO+K^WIL]AYKAEYFCCW/7:;BUUSL&SDY^D==>0B_4XX*>([:]MJ?K]92^
M!OJ[\M>!\N/CN*W/[I]CQ>9OQFZGJQ>L:3.WS:6S;2T>V(Q6^3-OBRX,DME=
MD^5.Z.R;5P;;)]XX:)UG;Y9UK_\ @[:3?%/O^&>B9];4LI)>>/Q%^7G@5D+_
M #6ZZG_*1TM]Y>48;O+K>VO<OJ?%C%-1]IQO.,]JK-]:YB6UN(?<BR<?Z=)<
MU20V-_?\0R2<77^"?JW\1^>-OCV7"[O]S>].BOS.,WEJX\_5,?%]VOK\O>8X
MM%M+89^;%(K?/@P3>M4P>RO*7:W>U*X=GE^[\OI'5M\LQ6^OO^7/YN6NL3I-
M)ZHC2;TIK$(NTGVQP                  $J'A)\Q7FMX/?I&M:AOO\I_3F
M-]BV_D6[;KO]HU+'8V/Z1_:Z1E?O+?:>O/MH*Y:K>WQ=Y%B?N9/>N;&ZYX]/
M,6O-GT>^%O-WSN2Y?8?N9WCDUG]T=A%<&>]Y]>K<TZ9P;O6>F+WSX[9^B.C'
MGQ:ZM:]X>*.T.\>O<;K!]VY:VL_>,&E+S/VY*Z33+K.FLWK-](TK>JX#X2?/
M%X4^7/Z1J>WY[_9E[CR'L6W[B=MYBPAU+,Y*;Z<?:Z1VS[6,U;.>Y/+%;V]O
ME(\#EKZYK]%M8R\<>KFH7S9]"?FGQ)\[E>(P?QF[.QZS]ZV&.TY\=(_7;G8:
MWSXM(BU[WP3NL&.D=63/371%;O#PKW?VMU[K:T_='B:ZS\S!6>NL?;DP>MZ^
MFLS-)R4K'K:\>Q-BA6U
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MPM(B=U?%U8M8UTRXYB^/3WQU6KT3,>O3:?28UB>H\\OBM\
M
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M!GF(5R
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M*?M+QWVGV72)X;;1.^TTG/DTOGM[I^.8B*1,>VN*M*3[9KKZM V_&;@
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M(7?/F7N;N_JV6TF=APD_\ECM\=X]?V7+$5M:)B?6E>G'/ZZMIB)38H5M0
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MR3C[ \H<#WWMXPXIC;\[6NN3;VGU]/;;%;2(R4^W3XZ_KZUB:S:*E*ALL
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M_D[YY_3:S,<#M)M3!7^FUGX\UORY-(Z8]E:5K&D6F\VE[1%:L
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M69FDY*5CUM>/8FQ0K:@
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ML@
M
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M.MHB)'U'=QVS<ALNUL,S\K#3[QDCW3>_53'$^OMI2+S[/9DC2?686OU4R,@
M
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MUPQ:,>VB??\ .O.:L^EMO[V^>T? /<?,UKN^XKQQVRF-8I,1?/;]6FL5Q_\
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MSK:UIFUK3/MF;3K,S^69?8<-\@
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MQ:MJS$UF/=,3$PJ.?)%^.#_]7.X/CVJ__EWV9\8]GS?_ ,4COKCJ'>-@O/\
MXE-S@\]=?_C-=MDO_I3&+:_IQ_$:_8.T/J"_+7'S.''^I-8W^VQ5_P"-7[SM
M:?\ -QDVW[+N4HO'_G[\SBN^OU*[NE?^",^.L?JQ\S'']+%L?YV14BV_3=OZ
M]V;,Z5OVJ[)H^XZY>58[8=2V_!Y/6MFP60HHHDKL<S@<U:V65Q=Y11)35S%/
M%17QQ5QS]/V\+:.(YGB.X.,P\UP.ZVV^X?<4Z\6?;Y:9L.6D^G5CRX[6I>NL
M3'56TQZ>U*':[O:[[;TWFQRX\VTR1K6]+1>EH^VMJS-9C\L3+S;L7(
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M])B?6):>M6U+36T3%HG28GVQ/V2_9^'\
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MUUO,*/$-0
M
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M)O>>R1:/O.>UJQ:=9KC_ #<=)G^HQQ6OIZ>GIZ-EFM6/
M
M /$]B=E=>]1ZCEM^[2W?5>O-)P4/OY?:MSSN-US X^CGCGT4W&3RMS:VM,T]
M7'IBCXJYDEKYXIHIJJYXX=WV]VWW!W;RV+@>U]ENN1YK/.F/!M\5\V6\^_2E
M(M;2/;,Z:5CUF8CU<S8<?O\ E-U78\;ARY]Y>=*TQUF]I_4BL3/ZL^R/>KB>
M;?Y*G0_57ZOI/AMJ7^T)O5O[]I_*5MD.8UCI3#7M'UH]ZPL/_%>]=D?:W4-<
M4L<'&"Q\T==$]KD[FCGZ<V,>$_PVN^^ZOD\WYCW?\7^#MI;[G@G'FY+)6?=>
MWQ[;9]59B:S;[UEK,33+ML=O6-^]G_3YS7)]&\[LR_<=E.D_*ITWW%H_+/KC
MQ:QZQ,_,M$ZUMCK*IUY5_(+Y?>:>0IG\ANZ=DV_!6MY+>8C0L=38ZKUUA*^9
MI);7FQTG6;7%X*YO+"*3V8K^\BNLG5%3QQ+<R5?6KFUSQ7]/_B+POM^CQ[PN
MVVF^M2*Y-U?JS[O)Z1%NK<YK7RQ6TQU6Q8[4PQ:9Z<=8TB).=L]C=J]HTTX+
M9X\6:8TMDG6^6WVZY+S-HB?;-:S6FOLK#3-N1EH                  #TF
MH:;M_86S8;2M!U79-XW'8[RG':]J6H8/)[+LV=R%=%<E%CAL#A;6]RN4O*Z(
MZJN(H(JZ^>*>>?I^SEUW+\SQ';_&9N:Y[=;;8\/MZ=>7/N,M,.'%2/3JR9<E
MJTI768CJM:(]?:X^ZW>UV.WOO-]EQX=ICC6U[VBE*Q]MK6F*Q'Y9F%H_P0_&
MGW_;[C%[]YW[+-UOJM4,5[;=*]<9S%W_ &)D9N*X9H;;=-PCL\UK&KXV2BGF
MF>UQE60OY8Z^:>+FPFI]7%7OG7\2;@.(QY>!\%;:.2Y76:VY'>8KUVE(TF)G
M;;>;8\V>\3ZUOFC%BK,1/R\])T1O[U^H38[6MMCV5CC<;G72=QEK,8H_+CQZ
MUO>?LF_36)_6WA;OZ1\?^E/&[2;3KKHCK'3^K=-L_17^CZEB+?'_ ']S''Q%
M^HYS(?23*[#F)(^/I)>W\]S=R_\ =R5*CN]N_P#O7R/S5^XN^N3WG*<Q?7])
MGR3?IB9UZ,5/2F+'$^S'BK3'7W5A%KF.<YCN#>3O^:W.7<[N?UU[3.D?96/9
M6OV5K$5CW0S Q!U0                                        #"?D
M7X]]7^5'3&]]#]QX+]>T'L##UXO)Q0UPP93%7<<E%UB-CUZ^FM[JC&[)KF5@
MAO;"XYBDIBN8:>:Z)(_5'5FOCOR#W1XM[RV'??9V?Y'/<?FB])G6:7K,=.3#
MEK$UF^'-2;8\M-8FU+3I:MM+1W' <[R7;7+X.:XF_1OL%]8^RT>RU+1K&M+Q
MK6T:QK$SI,3I+F+^:_B%V3X.>1.\>/79O,-_D-;FAR6L[596]5KBM[T;+532
MZQN6+MZY[JJTARUK%53<6W,LU5C?0SVM4E=<-57/II\+>7>V_.'CS8^0>V>K
M'M]S$TS8+3U7VNYQZ1FV]YTKU3CM,36_36,N*V/+%:Q>(BQ3M#NGC^\N!P\[
MQVM<>2-+TF=;8\E?S\<SI&O3/LG2.JLUMI$3HU1;59,          _:WN+BS
MN(+NTGFM;JUFBN+:YMY:X+BWN(*Z989X)HJJ9(9H9*>*J:J>>*J:N..>.?J_
M&3'CS8[8LM8MBM$Q:LQ$Q,3&DQ,3Z3$QZ3$^DP_EJUO6:VB)K,:3$^R8^R70
M;^$OY6HO.CK.?ISNG-V=/E9U7AZ+K,W'V=IB8.VM%MY8,?:[]B[:WN.8:MDQ
MLTL,&PV\,%M!3<7$-S;QTQ7%<-MY^_K6^E6W@WN6O>'9>"_^JOE<TUQQU6R3
ML-U,3>VUO:8U^3>(M;:6M:]II6^/):;XXOE@QY@\9SV9R,<MQ%)_BSN;Z5C6
M;?(R3ZSBF9C\R?6<4S,SI$UM.M8FT\*";2H     #0_S7^-[Q3\]-4GQ/=O7
MUG'NMM9R0:KW#J=$&![0U*XXMY[>TJM=BMX>?W@P]M]Q55^DY>._Q5=?/$GV
M_$U$4L>]O"OU'>5/ _*UW?97(7GA;7B<_'YYG+LL\:Q-NK#,_HLEM(CY^WG%
MGB/A^9-)M2V:]H>0.YNR=S&7A\\_<YGX\%_BPWC76=:S^;:=/SZ36_NZM)F)
MI=^=_P "7EQXB6^4WKK:VF\G.FK2:6238.N-=RM78FLXZBB:XKO=TZTM/U?(
M6^-LK>&JJ?(XRXR5E!'1S+<\VM//''%S7@KZ\O$GES)BX+N2T=L]Y7B(C%O,
MU/NF:^L1T[;>6^72;VF8BN+-3#DM,Q3%&6?5+CLKS9VMW3:NRY"8X[EIC\W+
M>ORKS[-,>:>F)F9]E;Q2TSZ5ZI08IQMR@                  /L:_KV?VS
M-XO6M5P>8V;8\W>0X["Z_K^,O<SF\OD+BKT6]CB\5CH+F_O[R>K]E$44===7
M/^#CEQ.0Y#8<3LLO)<KGP[;CL%)ODRY;UQX\=(]MKWO,5I6/?:TQ$>^7RSY\
M&UPVW&YO3'MZ1K:UIBM:Q'MF;3I$1^696.O!#\<3R [LN,7O/F%E,EXW]7RP
MQ7L>CXO]+R7>>S125P^FUKLKN/):]UC#);25U\W&4BR&1AEBXADQ/'$G,T5<
MWG7\1CL#LK'EX/Q!BQ]Q]SQ,UG<WZZ<9AF(GXNJLTR[V8M$1T8+8L-JS-Z[N
M9KT6T#WKY^X/AZVV?:E:\AR43I\R>J-O3\NL:6S>OII2:UF)UC+Z:3<:\7O$
M#QV\-M!HZ[\>.L\#H6)GAQO&PY>V@INMNW:^Q4$T%KF-WVJYXKS.RY*/FZGJ
MCYGEYAM?N)*+>.&*KV^*>O)_E[R'YCYZ>X?(7)Y]_NZS?Y6.T].#;5O,3;'M
ML%=,>&D]-8GICJOTUG):]HZD4>X^ZN>[LWWW_GMQ?/EB9Z:S.E,<6G6:XZ1\
M-(](UTC6=(FTS/JV6:U8\      J:?/W\M5&I8S/^"OC1N,->UYB&?%^2'8&
MK9>XHNM1QG/-45YTQB[^RAHCXSV<CJXIV*2"ZYYLK/UXR6CF:XNX[:U_Z!OI
M-GEMS@\Y^2MG:.*PVB_#[7/CCIW%_;7D;UM,S\K%/KM(M3])DTW-)Z,>*V23
MO@_Q?.ZR4[S[AQ3]VI.NTQ7K&EY]VXF)_6U_Y*)CXK:9(G2M9M3(7*):@
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MG<[C>;G)O-W>V3=9;VO>]IUM:]IFUK6F?;-IF9F??,OO. ^
M                            #5?RL\*?&?S5TFG1O(OJ_#[Q9V?NRZ]L
M$<MW@]VU&]KCEIHO=7W#"SV6=QGHEDXDDM?>DQ]W5133=6\\?'HYVGXK\T^2
MO"W-?NYX[Y3-L<U](RXIBN7;9ZZQ\.?;Y(MBOZ1I%^F,N.)F<63';XF2]L]W
M]P]H;S[[P&YOAO/YU?2V.\?9?';6L_9$Z1:OZVU9]5-/SO\ QUO)3QZM\IO_
M (NWN2\H^L;::6>?5,7B*+7O/6<?Z)I**Z]1L:I+7LB&"JBB'FO \?JDTLO%
M5.*HAIDECN.\%?B(>-O(.3%P'D^F/M?N:T1$9[Y.KC,U]8C_ ,XMI;9S/K;3
M=?H:UK,3NIO-:VEEV5YZ[>YVU=CW)%>-Y&8]+S;7;WG_ (\^N+[?TGP1$?LL
MSI$UW<CCLAB,A?8G+6-YB\IB[RYQV2QN1MIK+(8[(64U=M>6-]9W-$5Q:7EI
M<151RQ24TUQUT\TU<<<\<\+#-ON-ON]O3=[2],NURTK>EZ6BU+TM$36U;1,Q
M:MHF)K:)F)B8F)T;YQY*9:5RXK1;%:(F)B=8F)]8F)CTF)CUB8]K^-]GZ
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M]L66LURUF8F)C28F/28F)]8F)])B?8_L?%^
M                                                      %2[\HC
MQ=_6-.Z&\PL!8>J^T^\NNC.Q[JCCURRZSGI[_;.M[JOFJZHXMK/!;'^N6]?H
MADYEFS<7JJHXCXXKMB_#!\H?<^8Y[Q!O\FF#>4KR>SK[(C-BBN#>5CX9UMEP
M_=K1K:.FNVOI$]4Z2?\ IP[D^5N][VIGM\&6(W&*/ZNL13+'L]9M3Y<^V-(Q
MS[=?2F<N12S          9F\=>Z]C\;^^.H>^M3MH;_/]1]A:MOEEBKJ>6UL
MLY1KV6MKZ^U[(7,%-=Q!C=BQ\<MC<UQ\>Y3!<5\T_2KZ<L-\B=E<=Y'[$Y?L
M/EK3CV'+\?GVMKUB+6Q3EQS6N:D3Z3?#>:Y:1/I-J1KZ.IY[A]OW!PNZX3=3
M-<&ZP7QS:(UFO568BT1/I,UG2T:^FL1JZN6B[IKG9.D:;V)I^1AR^I;[JNO;
MIJV6MY(I;?*:YM.(L\YA,C!+!)-!)#>XR^BDIJHKJHYIJXYXYYX_:\J?.\+R
M/;?-[SMWF,<X>6V&ZR[;/CF)B:9L&2V+)28F(F)K>MHF)B)UCUB%9F]V>XX_
M>9=ANZS3=8,ML=ZS[8O2TUM$Z^OI,3#U3JG&
M
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M#W&##:(W>_M&VKZQKT7B9S3I[XG%6U)GTTF]?772)Z+#SNH%
M
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M*DS-,58Z<6/7^EI'IKIZ=5NJ\QZ3:6YC3;$@
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MB]XL;SL/.65W[L<^>R<<%U:Z[:21UP\WD4EY<<506G%K>SI^BOZ5,WG+N?\
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M.[N1[UY[+S6_F8K:>G%CUGIQ8H_-I6)F=/Z:\Q^=>;6TC72-QFGF)@
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M1ZQ,QZM!;_C]_P 7NK;'DL.7!O*3I:F2LTM'ZL6B)_4GV3[GMG2.&
M
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MM$9)]WZ72/9I$\*";2H
M
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ML]*1BK,1[+1:)G6-(L4J\&A0
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M.M<?_P"$G6;99](_/F:Q.LTI3682?HQM<@
M                    *D7Y"OQ719S'Y_Y NA,'[>:Q%G:5>2^DXFVM(;;*
M82QANJ..\;.FN[AFXS&*AHM;+/V]O%+Q=6G$61YHBKM\A/<VT?A\_5-;8[C;
M^ ._<^NRS7M^XVYR3:9IDM-9_<VVE9CY=YZ\FUO>U>C)U;?6U<FWIBE#X*\E
M3AO3L;F[_H;S/W3):9UBTZ?WO/I^;;UMCF9C2VN/68MCBM-I<6EB
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M4M6*]>Z^U.8[-YB_#\Q3IRU]:7C7HRTU],F.??6?^&LZUM$6B8;4-6,:
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M_:W>V*/W*SQ3D-/BV^6:US1I&LS%=9ZZQ[[4FT1^NTGT1XI",[
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M)'Y:6M'Y6PC7SH@
M                              '.M^??Q=_V=?D([ VK#V'VFD>2-G#W
MG@.:./K''LVPW$UEVA:R3574\DUY==@6-[E:_K1#Q'#EHHZ:>>*>*ZO0_P#0
M1Y0_UB?3]Q_%;S)U\WVW>>,R_;.'%$6V5HCIB(K7:VQX(];:VP7M,Q,Z1//P
MAW)^[W8N#;9;:[SCY^[V_P")6-<,^R/2,4UI[]9I,^_2(3TU&WP
M%@K\<+R;HZ6\Y;WIW.9":VU+R=TFZTR.WYNKB&QX[)TVNXVS0<C=P1Q3P74W
M.,ISF*MN*^(^:9LQQS3+3QZHY:__ ,1GQG;O/P?3O#8XXMRW;&]KN)GIB;?<
M]QI@W5*S,Q-8Z_NV>^FNM=O.M9]+5T9Y^[=GE^S8Y;#6)W7'9HR:Z1K\K)I3
M+$3[8]?EWGV^E/9[XO\ "@Q"
M
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MV_XU[3:8CV>D:Z1$1$1'I$1#)#''7@
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MY3-$5O.L>DTIT4F/2T6]J<-")IP
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MF8F)5_<SPW)=O\EEXCE\5L._PVTM6?\ N6K/LM6T>M;1K%HF)B=&6F)NK
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M%:(]?F?#=A4K(@@
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MML^1PXMQM+>VF2E;TG]6MHF)_HPL+>(_Y*7E7U#1B]8\F=1P/DSI]I#9X_\
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MZ=5IB(MCC[)RUI[8]_HDG1N:^
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M]\5O^-2TUF8]OI.FL3$S$QZQ,PR0QQUX
M
M                                       #GW_D8>2-?<_GW>]68N^F
MGU+QHTG"=>6]OQ3;_8R[SLD,.[[YEK22BJNZKFXIS&-P]SQ)Z*:9L)SZ(_IS
MS++?]^'9XXKV9X$IW3NJ17ENY=[DW<SZ]4;;#,[;:X[1Z5T_1YMQ3369KN8Z
MK>RM)R^!.WXXCLB.2R5B-UR.:V69]=?ET_1XZS[OUM[QIKZ9/6?=$!J>K=H
M        "PA^-WXU_P L'G1?]S9C&_=ZGXR:'DMLHGN,;^H8WGL7?(KW2M&L
M+JN7Z6EG>1XBXSN6LI:O7+'=8:BN*CBNGWH:_/Q'?)/\4/!N/LW9Y.CE>YM_
M3!,1?HO]TVLUW.YM73XK5G)&VP9*QI6:;B8O.D]%]%_4!W#^Y79E>)Q6TW7(
MYXII$Z3\K'IDR3'OF.J,=+1[)C),3.DZ3?R4'H0@
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MOR]_VE_F1_/#DOXJQ+TS?2+_ +-79W\#T_MF18GXK_D\XG_%(_KK(WTC6?@
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MWM:UK3ZS:9F4 MSN=QO-SDWF[O;)NLM[7O>TZVM>TS:UK3/MFTS,S/OF7WG
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MW5)TM3)6U+Q/LTFMHB8]?MAZIU3C
M                                       /!]I=;ZKW'UKOW4^\V/ZC
MIW9.G[%H^SV?%-M5+-A-GQ5UA\AS;<W=O=VT5Y%;W=5<$E<4G$<U--?IY^CO
MNU^Y.5[/[DV'=?!W^7S'&[S#N<-O72,F&]<E->F:S-9FL1:(M&M9F-?5S>-Y
M#<\3R&#D]E;IW>WRUR4GU_.I:+1KI,3IK'K&L:QZ.4#W'U=LW2';79G3FYP?
M;;9U9OFV=?[#'QQ1[566U'.7N#O9[:N*6>&:SNIK+F6"2.22*6&NFNBNJBKB
MKGU9=G=T<9WMVGQG>/#6ZN*Y388-WBGW_+SXJY:Q.L1,6K%NFT3$6K:)BT1,
M3$6:\3R6WYCB]ORVTG7:[G!3+7_BWK%HB?9ZQKI,3$3$^DQ$L;LC=@
M    OX_C=^2G\L'@O?\ 3.8R7W>U^,F^9+5*(+C)?J&2YZZWR6]W71K^ZIE^
MEW9V<>7GSN)LHJO7%':X:BB*OBFGV8:$/Q'?&W\4/.6/O+9X^CBNYMA3/,Q3
MHI][VL5VVYK73X;6G'&VSY+1I:;[B9O&L]=X0_4!V]^Y7>=>6Q5TVO(X(OK$
M:1\W'ICR1'NF>F,=[3[9G),S&LZS815]M%@
M
M                                         /$]E]@:YU-UQV!VIN$\
MUMJ76FD[7V!M-S;T127%OKFFX*_V/-SP1SSVT%<T6,QLM5/%<D='-7'''-5/
M'[>.[[:X#D>[.X^/[6X>L6Y;DM[@VN")UB)S;C+7#CB9B+3$3>]8G2)G3V1/
ML<SC]CN.3Y#!QNTB)W6XS4Q4B?9-\EHI7736?;,>Z7)U[<[)SW<O:W9W;^U>
MS^\_:O86Z=D[']O'##;_ *]O.R9+9\Q[$5O!;6\4/ZAE)/33'''133].*::>
M/IQQZN.TNV]AV;VKQG:'%Z_N9Q7'[;9X=9F9^5ML-,./69F9F>BD:S,S,S[9
MF?59QQ?'X.)XS;<5MM?NVVP8\5-?;TXZ12NNNL^R(]LRQZR!S@         '
M0/\ QS_&ZCICP$LNT\I8PP;;Y+[MF^PY[CFJX^^BT;6YIM(T3$W<==-%K1#S
M5A\EF+?F/UU50YOCUR?7CB*&@'\1/R/;O/SW?M;:WFW$]M;+'M(CTZ9W.:(W
M.ZR5GUMK^DP[>^ND1;;3TU]MKP;\]]P3R_>\\;CM,[7CL-<41Z:?,O\ I,EH
M]_ZZE)UT]<?I'OF?- II$
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M;[+DS;O).MKWM-[VG[;6M,VF?RS,O2.M<<
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M_1M:;7M,VM:9V6:U8\
M            QOVQT[U5WMI.3ZX[FZ\T_L_1<OZ:[[5]VP&.V'$U7,<<L=MD
MK:WR,$WZ?F,?[]55K>V_,5W:2\^Y#)'7QQ5QD?:G>'=78O-8NX^S>1WG&<YA
M_-S[;+?%DZ9F)M2TTF.O'?2(OCOU8\E?AO6U9F'8<9RO)\+O*\AQ.?+MM[3V
M7QVFMM/?$S$^M9_75G6MH])B856/._\ &?L;VXRG8/@'M<.&IJAEN[CQ^[0S
MUY=6/%Q37-7]KUUV;D>;O(6\,EO[4<-CLE=S5[W$DLF7IHJHACM.\%?B5Y\&
M/%V_Y[VDYIUBL<KLL5:VTTCXMWLJ=-)F)UFV79Q2.GIK7:3:)O:2O97U#7I6
MNQ[WQ3?UTC<X:Q$Z?;EPQI$^NLS;%IZ:1&+6)F:IG=WC_P!U^-V[7?77>_6.
MX=6[E9^NO]'VW$7&/^_MHY.8OU'!Y#Z28K8</))Q]([VPGN;27_N)*EJ?9/?
M_97D?A:=Q=B\GL^4X>^GZ3!DB_3,QKT9:>E\62(]N/+6F2OOK"3'#\YP_<&S
MC?\ "[G%N=I/ZZEHG2?LM'MK;[:VB+1[X8?9>[4                    !
MGCH;R@\AO%_9J=N\?^XM\ZIS=7KXO.=4SMU:XG,12444U6VQ:Y/S<:YLUG]8
M8Z^(,A:7,/$L4<G%/%<=%5."=^>,/'OD_C/W([_X?8<KLO3I^?BK;)CF-?7#
MFC3-AMZS'5BR4MTVM77IM:)Z7F^W.![CV_W7G-I@W.'W==8FU?RUOZ7I/M]:
MVB=)F/9,K%/B9^3QW%J'Z%J_F+U)A^W\%!]I99+M+JNFPT?LRFVH]ZN\S65T
MBYJBZYV_,3554446UA)J%I11Q]>>>:N.?57AY8_#)[/Y?Y_*>'N6S<1OK=5J
M;+?=6YV?5Z=..FYC7=[?''K,WRQO\DSZ>SV:%[G^G3B=UU[GM3=7VN:=9C#F
MUR8=?=6N2/TM*_EM&>RR9XK?*WX)>8/Z+B^JN]=;Q6_9V\YQECU/V5-#U[V9
M<Y;_ )\>*P^OYZXBMMOO)K?GB6C]"N<I'S1ZN/7Q)%-1'6]Y3^E7SIX@^=NN
MZN"W.7@<%.NV^V<3N]G&/WWR9<43.WK$_#/WJF"==)TZ;4FT?NY?&?>G:O7D
MY/99+;&D:SFQ?I<,5_IK6K&M(U]/TD4G\FDQ,R*H[L"
M                                                     4*_R6/&
MZCJKS5U3O;$6,-KKWDSU[;9'(RQU7%/,_9/5<>+TW:^:;>JGFS@AJT^ZUB:J
MJ&JGF6ZGGKDCXKJYEFOA_#9\CV[J\+;KL7=WF_(=L\A-*1.GIL]]-]Q@]?SI
MG[Q7>UTM$]-*TK6TUCII-CZ>^X)Y/M#+PN6TSGX[/,1[/3%FUR4]?;^?&:/7
MV1$1$Z>D5T5B3?0         "?+\<_R1KZ8\^[+JS*7TT&I>2^DYOKRXM^:;
M?[&+>=;AFW?0\M=R5U475$W-.'R6'MN(_735-F^/7']..)8H%?B)^.*]Y^!+
M]T[6D6Y;MK>X]W$^O5.VS3&VW6.L>M=/TF'<7UTF*[:>FWMK?27GOM^.7[(G
MDL=8G=<=FKEB?77Y=_T>2L>[]=2\ZZ>F/TGW3T$% *#0
M
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M?DMW,3NMQFOEO,>R;Y+3>VFNL^V9]\O;.D<,
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M9_4CV1[GMG2.&
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M6BV*T1-;1,3$Q,:Q,3'I,3'K$QZ3";5;5O6+5F)K,:Q,>R8^V'XOV_H
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MO32-9BUK2KHKM:
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M:LSHSG>T>YNV;]'.['<;:-9B+6KKCF8])Z<M=<=O=^;:?;'VPV<:R8Z
M
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M8F:R.6XW<</RFXXG=QINMMGOBM_QJ6FLS'M])TUB8F8F/6)F&2&..O
M
M
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M+^H#N']RNS*\3BMINN1SQ32)TGY6/3)DF/?,=48Z6CV3&28F=)TF_DH/0A
M
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MW_%78G;D5OL]ABR[J(_9<_Z:^NOMCKUI2?=KCI3T_5G6,U)9L,
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MEFRY]Y>=;7R6F]I_5FTS/ZD>R/<]LZ1PP
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M:JZF@P
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MB82/XSE>,YK9UY#B<^+<[*_LOCM%JZ^^)F)]+1^NK.EJSZ3$2QNR-SP
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M;>MN:X_<X<-?;DZ>O%[_ $^=CZL6OI,Z=>NGK[&X#4+%0
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MLZ3,>LV:=O\ +X>?X/:<U@],>ZV],FG]+-JQ,UGV^M;:UGUGUCVRPFS5VX
M       #H$_CD>14';_@#:=49#(?<[7XU;YL>AW$%Q-D+K)2Z3MU]==@:1E+
MJYO)[F'FSHFSN3PUE##5'3;VN#HC]JBFFBN2@3\1;QW?M#S[?NK;X^GBNY=A
MAW43$4K2-S@K7:;FE8K$3U3&+#N,EK1,WON9MUS,VBL'//O SQ7?$\GCKIM>
M0P4R1II$?,I$8LD1$:>OPTR6F==9R3.LSK$3\H#M(
M
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MF28TCTGIMCI:-9TG'/LG6%@5 %HT
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MZ([[_D-_RFZMON2S9<^\O.MKY+3>T_JS:9G]2/9'N>V=(X8
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M_P#:8:O_ #/]L_Q38H)_B+_[-6Z_AC8?VRS2WGW^3S)_C>#^NET(GGX06
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M_DF-Q,:;K-2T?#$^W;UFLZ]4^S-/ITQKCTF;7Z;E:G%$T
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M&N&/@
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M*&$)0
M
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M(K&Y;DMQS'*;CEMW.NZW.>^6W_&O:;3$>STC72(B(B(](B(9(8XZ\
M                                             !&-Y+?,/\>WBOD,
MSK>_]^X?9M^POW$5SUWU3C<GV5LU.0M)[.&[P]]?:Y;SZ;K.8MN+SBNJWS.5
MQM?/$<E-/JDHYH29\:_1_P#4%Y3V^'DN X#-MN!S:3&[WUZ;/#T6BTUR5KFF
M-QFQSTZ1?;X,T>M9G2MHEL7M[Q3WUW+2FXV.QOCV5]-,N:8Q4TG72T1>8R7K
M.GMQTO[8]TZHE]^_*?Z"QWZM_)?XK=P;A[/V/Z'^_P!N>E];_J/N?9_J?ZM^
M[T/:OZ-]IZ[CV/9^_P#N/:C]?L>[5[,L>!_"V[^W'ROXT=U</L]>KYOW7;[G
M>=&G5T?+^;.Q^9U:4ZNKY71U6TZ^F.O9^Q^FSG,G3^Z7)[3%KKU?*QY,NGMT
MZ>KY/5KZ:Z].FLZ:Z>N =D_*QV>ZQE<6H>$6!P>9YFAJHO\ 9/(#(;5C*;>G
MGGWXJ\3C.GM-NJYI*?IQ1)Q>TTT<_MYHK_P,^X[\*WC,6YB_+][9\^STG6N'
MBJ8+Z^Z?F7Y#<5TCWQ\N9G[8=YM_IHVU<FNZYB]\6GLIMHI.ON^*<^2/Z'3_
M $8:Z;S^4)YIYC[BWT+I;QOTBSNL/-9?=9?#]B[IG[#+3?=T?K6+OOY0-;P5
M'VL4L-4%M=XN\BXGBJJEYFCK]FG8G!_AA^&-GTY.>YKN/>YJYHMTX\FTV^*V
M..F?EWK]US9?BF+1:^//CMTVB*]%J]<]]LOIQ[1Q:6WV\Y#->+ZZ5MBQUFOI
M\,Q\J]O7UUFMZSI/II,:SI/V/\\/RA]C>[;_ .T9^XF*E^TJ_2NN.O>NM7]N
M>T]7/OQ;!^[%]N5'W/-7UFB_4_MZ_IQQ[?''[&ZNW/H3^F'MW3)_%W[_ +J.
MKX]YN]WFUBWNG%\ZNW^'];;Y/7']-JS#C_"OCC8:6^X?/R>OQ9<N6_M_J>N,
M?I[IZ-?RH]^T?*7R8[OAGM.Y/(3NSM.QN/KQ)C.P.T=VV[$TQ?J$65HMH,3G
M,W?8VULX<E!'/'!%%1#%+'15133S33])!=K^+O&G9-ZY>SNWN$XO/7V7VFRV
MV#)KT336<F+'6]K329K-IM-K5F8F9UG7.N-[;[=X>8MQ.PV>VO'OQ8<=+>SI
MUFU:Q,SIK$S,ZS$SK[6!V=NZ                          ;C>+'@#Y=>
M9V3AM?'OI3:MPPGZE1C,EOMY##KG6V"FXXKENN<MO6?EQ^O436%M'5+):P33
MW]?''%$4$LM<<=>GO*7GWQ)X:VULOD'FMKL][\OKIM:S.;>98]E?E[7%%\NE
MIF*Q>U:XH]9ODK2MK5Q3N7OCM;M+'-N=WF+%FZ=8Q1\>6WV=..NMO6?2+3$5
M]\VB(F8ME^$GXU?0_57Z1NWF3MO^T)O5O[%W_)KJ<V8UCI3#7M'TK]F_O_\
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MM:9F?Z,O8.G<0
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M&T1:)AM<U2QD   !S'?E[_M+_,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_%?\
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M]9E"&UK7M-K3,VF=9F?;,_;+]GX?P
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M28E)3@NX^#[FV?W_ ('=8MSMO36:3\59GV1>DZ7QVT]>F]:VT]=-&!V=NZ
M                        ;1=3>;GF#T5Q8P=1>3G>6A8S'0Q6]KKN#[+V
MR/4>+>VQE>'LX)].N,G<:K>0X[&U^W:TS6<E-KZ**HN**HZ*J=8=V>$_$'?4
MY+]W=L\'O]SDF9MFR[/!.?6;QDM,;B*1GK-[QK>:Y(F^LQ?JBUHG'.4[/[4Y
MKJGE>.V6?):=9M;#3KUF>J9C)$1>-9]9TM&OKKKK+?S1?R /E&TNWCL[WO;
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M<QL<U-K69_2TB,F+2)])G)CFU:ZZ^D7FMI^S6)B-ZFC&%@
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M:S3<XKVI>L^VMJS-;1.GIZ3$QZ/O. ^
M
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MEIT].N/6)F'1 >>E!
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MXJ38[$\0]M]F5IO,M8WO/UG7Y^2/2D_9AQZS%-/Z:9MDF=9ZHB8K6&U,5M@
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MKVGWVM,S/OEHS/GS[K-;<;F]\FXO.MK6F;6M,^V9M.LS/Y9E]APWR
M
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M?D'Q?SG8>XG-DB=SP-IB*;FM=(UG]9EK$VG'?7TC6>F_MI:9ZJUE=14:R
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M:9F9I<;QG'\/LL?&\7AI@V.*L5K2D:1$1&GZLS/OM,S:T^MIF9U8]9 YP
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M(B$"=[O-UR.[R;_?9+9=YFO-[WM.LVM:=9F?U9>J=4XP
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M?%CF>G+3_C8K:7CW_%I-+:3TVM$:M16VV4@
M   /VM[BXL[B"[M)YK6ZM9HKBVN;>6N"XM[B"NF6&>":*JF2&:&2GBJFJGGB
MJFKCCGCGZOQDQX\V.V++6+8K1,6K,1,3$QI,3$^DQ,>DQ/I,/Y:M;UFMHB:S
M&DQ/LF/LE8B^.+\@;O;QJN\-UEY57.R>0_2$EY:6M&U9+(UY3N;KK&\1?;U2
M8C-Y2XH_?[#V_P!*:^<?EKCBZIIX^EO>QT4\055Y_49] /8ODG%F[F\65VW;
MW>\4M;Y%*13CMW?773)CI']ZY)]8^;@IT3/KDPVF9O&A^_\ P;PO<-;\CVU&
M/8<QI,]$1I@RS[?BK$?HK3_34C3^FI,^J\EU)W!U?WSU]KO:O3>]ZWV/UYM=
MGQ>X+:M6R4.1QMU3QSZ+FSN/1SQ<8S,8RXXJM[VPNHX;VPNHZX+B**:.N.FC
M[NWM#N?L/N#<=J]X['<\=W#M+].7!GI-+U]\6C7TOCO&EL>6DVQY:37)CO:E
MJVF&W*<5R7";[)QG+8<FWW^*=+4O&DQ]DQ[IK,>M;1,UM$Q:LS$Q+)#''7@
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MY!W5J1$8-[6NZK[/^4UKDF=-/;FIDGUC68TF=9GJF9-#EJ8
M
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M?-I\6;)IZVGWQ2)UC'372E?MM-K6T;;P9D
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MG69F9]9F9]9F?69:AM:U[3:TS-IG69GVS/VR_9^'\
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M=6
M             ^/L&O8#;,)E-:VK!X?9M<S=G-CLUK^P8RRS.$R^/N*?1<6.
M4Q61@N;"_LYZ?V5Q2QUT5<?X>.7,X_D-_P 3O<7)<5GS;;D<%XOCRXKVQY,=
MX]EJ7I,6I:/=:LQ,>Z7UP9\^US5W&VO?'N*3K6U9FMJS'LF+1I,3^6)5^O,S
M\<SQ"[WM,ELWCA<7GBOV9)]U=T6>#CO=KZ?S][-++=50Y71,IDZ;_4_>KXHM
MX)-?OK''V$/-5?Z9=5\<4I_>&_Q%/+O8N7'QGD:M.Z>VHZ:]66:X.0Q5B(KK
M3=4ITY]/6]HW6+)ERVTK]YQ1K+>7:7GSNKA;5V_/Q')<=Z1K;2F>L>SX<D1I
M?[9C+6UK3Z?,K"J9YC_$=YO>%5QFLKV#U3DMXZOQ$-S?R=S]46N2W7KNVQ%O
M7315D]FNK3'Q9G0H:.9:*:^<Y9X^+F2KTQ22\?2KFU/P[]6OA+S3CP[7M_E<
M>Q[GS3%8X[?6IMMW.28_,PUM><>ZF=)F/NV3+;2-;5I/I$F.T_*/9W=]:8MC
MN:X>2O,1]WS3&/+-I]U(F>G)_P#@[6G3VQ",U)9L,
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M,(#Y<67;Y;8,];4STM-;5M$Q:MHG2:VB=)B8F-)B?6)])?2<9\P
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MQ[;/;#>?ZC+'569C3V5OCTB=8TG)[)UUK=B4K(@@
M
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M\..M:QK$>D>R/9&T35[&P
M           %-/\ )P\T[C*[3UMX+Z9D)H\5JT.-[C[ID@JKBHO]ERMI>6G6
M>GS5\>Q+7#@<!<W69O(:O>M+F3*8V3CFF>RJXIN._#-\,8]KQ?)><N9QQ.ZW
M4WX_CHG29IAI:MMYN(]L:Y<L4V^.T=.2D8-S6=:9HUEE].W:-<6VW'>>[K'S
M<LS@V^ONI68G-D]_YUHKCK/I:(IDC\VZI2ME2@
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MDQ'Q7B/=\V^28]TI%4=V!
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MJ[._@>G]LR+$_%?\GG$_XI']=9&^D:S\       !/!^./_:8:O\ S/\ ;/\
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M^O32NOI'ZMK3-IM:<_,!=&
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M:->&[CIW%M*Q&RY&)F\1^MSTB.N?_P )6:W_ "VZY6.U<[0(
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M X*.Y.S>0XB*3?/?;6MCB-=9RX_TF*(T]?6]:QZ>V)F-)B9B>I(\O*MX
M
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M>[#Y'?8IB-S?#\FGV]6:8Q:Q^6E;6O'_ !?9/LGIN/,XKM
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M:4I'K/PTK6/6?3UEGY@+HP
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M8=6S:GLV)KDKL<QA<I@\/<6ES'1/'!=6LW%-7HFMYXXKFVFIKBFCHEHKHIL
M^FCMSG.T/!';/;'<NVR;/G]AQ_R<^')$=6/)3+DBU9TF:VCWUO6;4O68O2UJ
MS$SO/QWQ^\XKLKCN-Y'';%OL&#HO2WMK:+6B8^R?R3$S$QI,3,3$M%6\V9@
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M=\CN/S%FIW!W%T5M&QK$TXW!>=)F+^L9=]:LQI$Y/D[>8M:M]MDTI>,)[)\
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MYB_5EMZ4I&O1BIKZ8\<>ZL?\-IUM:9M,RVH:L8T
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M$[AX/N3:_?>"W6'=;>)TF:6UFL^Z+U]+4F?;$7B)F/731@UG#N0
M               $SWP#=RW'47R9=.X_F6:+#=RX'>>FM@]CBNNNNWS^"DV?
M78JHJ./\9#7OFG8CW.>>>*8X_5)^WT?3F&GU\=FX^[OIIYC<1%9WG#9]MR.+
M72(B<66,.:=?=/W7<;C3WS.E?UVK4GF_B:\KX\W>3T^;M+X\]=?MK;HM_P#J
M\E]/MGT][HR/.N@0
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MK%;O?_!QVYWGR/#TK%,.+<VG'6--(Q9-,N*/3T],=ZQIZ:>S2/8W8:58>
M
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M;7ON<E?36.F)Q89^W2>K/'NB>GWZ>EQE3TBB
M                           \3V7M5QHO7'8&[VEI#?W6FZ3M>U6UC<5U
MQV][<:]@K_+PVD\D7UDCAN)+/BBJJG^%Q3SSSQ^UW?;7%8^=[CX_A,MYQXMY
MO<&"UHB)FL9<M<<VB)])F(MK$3Z:N9QVVKO>0P;.TS6N7-2DS'MB+6BNL?J:
MN1F];"T8                      !]+#X;+[#D[/"X#%9+.9G(S<6^/Q.'
ML;K)Y._N.>.:N(+.PLHI[JZFYIIYYXIHHJJ^G'^!QMYO-GQ^VOO=_EQX-GCC
M6^3):M*5C[;6M,5K'Y9F(?/+FQ8,<YL]JTQ5C6;6F(B(^V9GTA-YXI?CZ^>O
MD37C<UV'K>-\8-!O(>+J;,]OT7,>\R6]=O;RPQ8WJG&\\[/#DJJ[JGBN#-5X
M*F.F.7U2>[13%)"7RK^(#X'\>5R;+M[<Y.Y^?I/3&/C^F=M$Q,Q,WWU_T,TT
MK.EMM&YF9FFE>F9O73W<WG/LG@8MAV&2W([Z)TZ<&GR]=9]N:?@T]/;C^9KK
M'II,S%F7Q1_'T\"_':C&YKL/6\EY/[]9S<74N9[?HMI-&CN*+B"6&+&]4XWG
MC6)\;31:T\5P9JO.U2522^JOVJZ8HZTO*OX@/GCR';)LNWMSC[8X"\=,8^/Z
MHW,Q,3$S??7_ $T7UM.EMM&VB(BFE>J)O:/'<WG/O;GIMAV&2O';&8TZ<&OS
M--)]N:?CU]?;C^7II'IK$S,WN'PV'U[&66%P&*QN#PV.AXM\?B</8VN,QEA;
MT\\U4P65A9106MK#Q55SSQ31133]>?\  A+O-YO.0W-][O\ +DS[S).M\F2U
MKWM/VVM:9M:?RS,RT[ES9<^2<V>UKY;3K-K3,S,_;,SZR^DXSY@
M
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MK+;TI2->C%37TQXX]U8_X;3K:TS:9EM0U8QH
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MUMV/S,6B)C]R]U/K]L8,DQ/]"?6/RNIX\MJM@
M                              !SK?R ?'S^0OY'NQL]8Q^C7/(#6]:[
MSPU%%O[<5KD,[Q?:MNEK)<TUUQ75Y<;QJ&0R%?'ICKCAR$5-5//\&63T/_0'
MY _CS].?';#/.O(]O[G-QF3UUFU,73GV]HKIK6L;;<8L4>LQ-L5YB8]:UGGX
M.YW]V>P-O@O_ .<;')?;V]?;%=+XYT]T1CO6OOUFL^ONB$]-1M\
M!=M_%T[[BV7H#R"\<<C=?7*]5]D8?LO7X[JZM*99]5[3PU6(O[#$V?W/WL]G
MKVRZ!-<W<GL<1PS9V'CF2KF6FBBE'\4#L.W&]_\ ;_D;;T_O7E>-R;/+-:VT
MC/L<GS*VR6Z>F+9<.ZK3''5K:NVO,5B*3,P^^H_A)V_.;'G\<?H]SM[8K:1/
MY^&W5$VG336U,L16-=9C'/IZ:S:55=(W
M
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M;>GIZZQKKK,M*)S6
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MVM77V6F/5:-LMWBW^SQ;[!K\C-BKDKKIKTWK%HUTF8]D^Z9C[)EY9VCD@
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M>FD:Z1JVB:O8V
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MZ;X[Z1,TR5GUK:-?RUM&EJ6M68M.M+9+(0
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MSC63'0
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M\?\ +[B^FEMEDQ>OVYX^3']'7)&GY='3Z>8Y7.
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M-4DEMK>.:NF:YVC2+6QCGXH^D%-]7S75'!S-7Q"+\07L:W>/TX[[DL%:VWW
M[W;<A3UB)Z*S;;9XB9F(TC#N;Y9KK\4XHBL6O%(G3GG7A9Y;Q_FW%(B<VRS8
M\\>R)TB9QW]9^RF2;3'OZ8TB9TAT0'GI00
M
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M:TZS.D:1&LS[(B(^Q]APWR
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M7??<L6Q;K>VP;.TS^BV\?)II,ZZ3:L_,M'I&D7R6_P"[.LI:+K6P
M                                                           #
MQ^\]AZ!UA@+C;.R]YT_KS5K3W?N]EWG9L+J6 M?M[*[R4_W&9S][C\=#[..Q
M\]Q7ZI./3!!)7S]*:*N>.XX/M[G^Y]_7BNVMCO.0Y2^G3AVV')GRVUM6D:8\
M5;WG6]ZTC2/6UJU]LQ$\O9;#?<CGC:\?ARY]S/LICI:]IUF(C2M8F?;,1[/;
M,1[91:=T_.M\9G2UQ<XV3R A[3SUI--%)A^EM:SO8-O)1!7E;>NYMMRM+2RZ
MWNX:[S%>U1Q%FJY)*;B">FGFUDXGXE%V7]#/U+]Z8Z[FO 3Q>PO$3&3D<V+:
M3$S%)TMM[6MO*STWZIZMM$1-+TF8RU^6V1Q'ACR'R]8R1L9VV"8_.W%ZXI]>
MF=)QS,Y8]+:^N/2-+5UZHZ49O8_Y472.+GEIZB\3.U-XMN+RTH@E['[!U+JR
M>3'UX^J2_N9;?6<3W%'#>6V5^D,,'$LE$]OSS-5-%7Q[',ENW/PM.]MU2)[N
M[LXK8Y.BTS&SVF??1%XOI6L3FR<?,UFGQ6MI$UO\$4O'Z1L3C_IKYC)$?NIR
MFVPVTG]BQ7S>NOI&M[8/2:^LSI&D^FDQ\32#:ORD_+6[M[6G2?'?QUUZZHFK
MJOIMJY[+W&WN+?FCZ1Q6MMB-UT62SFID_;5)7+/353^SBCCG^$W;Q7X7GB;#
MDO/-]P]Q;C%,1TQ@^Y[>8G7UFULFVW46C3V1%:S$^NL^QF.V^F[M>EI^^;_?
MY*Z>G1\K',3^6;8\FOZFD?JL#[)^2A\C^<R=5_C*>@=-M:H88N,+K?5V1NL9
M17'QSQ7<4R[?N6U9GF:XYY^M?%5WS'QSQ_!IIX_8SSCOPW/IRV.VC!N?W?WF
M769^9FWM*WF)]VFWV^#'I'NTQZ_;,NZV_P!/O8&''T9/OV6VOYU\T1/ZGP8Z
M5]/^+K]LO[-5_)9^1G7KB[FR^-\==ZCN(:(H;3:NL=AL[>PKHK]=5Q:5:1V!
MIMU7-)3_  :N)Y9H_3_@IXY_:^/*_AL?3KR&.E-IE[BV-JS,S;!O<5IM&GLM
M]YVFXKI'MCIK6=?;,QZ/QN?I[[!SUB,5M_AF)]M,U9F?R3\S%DC_ ((B?RI
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M#,QUX;Z?FV^VL^LTO$:7C[+1:M=)VZF7@
M        )8OC"^)WNKY$=YL\S]KDM \9M:SU-AV7W)-':45S2VL<-[=Z3US8
MW_-56Q[M?6LM%-<],,V.PL<M,][SS75:V=Y%'ZF_JN[+^GG@[[/JQ[_R7N<'
M5L^/B;3$1:9K7<[RU?V';5M$S%9M7-N9K./#$1&7-AUCY&\G<1V'LYPZUS]Q
M9*:XL'K[_2,F68_,QQ/NUB^28Z:>D6O3H:>/?CITQXK]7X+ISH?1,/U_H.!]
M<T6,Q=$DEWE<I/#;PWVP['E[JN?*['LF2HM8N+B_O9IKF6F.BCFKVXXZ:?/?
MY!\B=Y>4NZ,_>/?>_P W(<]G])O>8BM*1,S7%AQUTIAPTFT]&+'6M*S-ITZK
M6F8)\[S_ "_<O)7Y;FL]\^^O[Y]E8]=*TK'I2D:SI6L1$:S.FLS+-C"G3@
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M66:P&5QN<PV1AXN,?EL/?6N3QE_;U<\TTSV5_92SVMU#S53SQQ51753]>/\
M"C-O-GO./W-]EO\ %DP;S'.E\>2MJ7K/V6K:(M6?R3$2UUEPY<&2<.>MJ9:S
MI-;1,3$_9,3ZP^DXSY@
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MO]ZX;=8-U@TC6<5ZWTU]D6BLS-9])^&T1,3$Q,:Q+$K+'9@
M   +.WXPOCG<;IY,]O\ DKE+2;] Z1Z]BTO7)Y;*NFWN-][6N)H:[BQR4E7$
M,LV"TG7,E#=P1TUUT4YBWKKJCIJHIFK*_$W\BX^&\:<1XVVMZ_?^;Y"=QFB+
M1K&UV,1,1:D>L1EW.;#:EIF(F=ODBL6F)FD=?J+Y^NT[=VO;V.8^?O,_S+QK
MZQCPQ[)C^JR7I-9GT_1VB(GUTO&*04-P
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MW$:;C#DM2T?9:DS6T?T)B7I'6N.
M
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M=8F+S&GKZ=!9Y_D&0
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MM-LMIF9F9UF9GUF9F?69F?69GVO['Q?@
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M\CFMIM]UCCV?,I6TU_+69CJK/K/K68GUG[4\WC=^35Y===UV.*\C.O>O?(O
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M5K8^B/=>?:EO1+:N
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MUJKR\J=U4[N[TW7([:W5QV+3!@GVQ./%K\43_2Y,DWR5U]8K>(GUA)RC,UT
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MT<-^XWD/>]%>G!NNC<4]--?FU_23^;6)US5R^L:_U5IMU)@40FJ@
M
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M+>W]DSVTF)C2(G2F*DQ,3,?',>DQ*SZK&1S
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MYMOW?VUM>?V^D6S8_P!)6/UF6OPY*>OKI%XGIF?6U)K;V6AJ6VPR<
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M1TQIU1/KK/MF9G?%HEA0
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M/PTR^E,.>?2*QZS\&:W])Z4O;]CTFU<45OUC;?X
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MV2_9^'\
M               ?C<6]O>6\]I=P0W5K=0RV]S;7$5$]O<6\]%44T$\,M-4<
MT,T=7--5-7'--5///'/'T?O'DR8<E<N*TURUF)K:)F)B8G6)B8]8F)]8F/6)
M?VMK4M%JS,6B=8F/;$_;"-COOX?OCF\BI;K(;KXP:'K>QW7W4M>U]317G4.;
MDR%[=W5]=YC)1]>7.OX39<Q=75[+5+<9>SR%<G-7'K]7HH],D>P_J]^HKQW6
MFWX7N??[GCJ],?(W\UW^.*5K6M<=)W=<N3#CK6M8K3!DQ1&GIIK;78/">5>_
MN!B*;/D<^3;QI\&?3/72(B(K'S8M:E8B(TBEJZ>[VSK6(^5+X4/$WP,Z<O\
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MGR8-?:U7Y@[P_BEVAE^[6Z>6WNN##I[:]4?I,D?\2FND^Z]J?:Z03SDH @
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M?^-'S,4?T.G+_P /Y%QE3TBB
M
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M69G69WK:,86
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M>NVO,_*S5U^7EB-)F:S/LM&L=5)TFL_;72T[R-'L-
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M/29A6KN=MGV>YR;3<UFFYQ7M2]9]M;5F:VB=/3TF)CT?><!\
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M:X]]L,E,VSRUBU+TF+5M$^^)CTEY5VCD@
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MO6;\7QL7VG;.O['Z?,S:3K$YK1KI'IK&*MII$^MIR3%;1.2@^TT
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M7]?\,SK%+VTG24M%UK8
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MS[JR9=M;7A]IU8<&DZQ:L6GJRQ_]MGUCW]$4B?6$M*)S6
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MQ?,C^CJZ33S>J_
M
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M)GT8UWES'[@=J\AS$3IDP;3):D_^4FLUQQ_1R36'5:>5Y6D
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MN1H
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M=A>$^ [5^7R/,Q3?\]2>J+6C]#BGW?+QS^=:OMC)>)F+:6I6DQ"!-/)NP
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MWV.L3DP7TC)3V:SI[+TUG3KKK&ND3TS.B/UO]G
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MC[)CW368]:VB9K:)BU9F)B62&..O
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M/OUR>N.D>GI-[:Q-(BU_A08A
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MN;:[C)BM[/SL=YI/LFT>VONF8^R9]K)#''7@
M
M                                 *RGY0?<5>J>)O1_2UG<0V][V_W-
M<[+D*:I+>JXO=6ZGUJXDR%C%:3X^XKXAYV?><+<27,-Q;RPU6]$7TECN).*;
M,/PP^SZ\KY7YSO/-6;8>(X:,-/2=*Y]]FB*6FT7B-?D[;<TBEJ7K:+S?6ML=
M=9$?3EQ,;GN?><O>)FFTVD4CVZ1?->-)UB8_68\D1$Q,3K,^DUA1H7AIE
M       +%'XT'27\H'G;LW;M]:>YB^@>G]ERV/O?;]?VN[=C30:#A[?Z\\<4
MQ?>:=D-BY]?'/J_Q/IXXYXJJYIKP_$J[V_<#P7MNT<%]-US_ #&''>NNG5MM
MI$[K)/Y>G<4VGI[/BUUUB(G0WU"\Q]Q[+Q\72?TF^W=*S'VX\6N6T_T,D8O^
M%?:4-H3
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M6H
M   ""3Y./G)Z1\)*-BZGZ>XP/>7D_:PSV=>NV]]]]UMUAEJ;B^L)J.T\S@\C
M;WLV>Q%[9<\SZU93V^2YX^E-S<8_B2*2J=/TS?0]WMYLMM^Z^\/G\'XQO,6C
M-->G>;W'I6T?<<>6DUC%DK;X=YDK;#[\>/<=-JQNCQUX:YCO"<?)\KU[/MR9
MUZIC3+FKI$_H:VB8Z;1/IEM$T_I:WTF(HH>1GDUWEY9=F9;MSO[L',=@;KEO
M;BIN;_[>RQ.%Q\$44%MA]9UW&PV>"UK#V\4%/TM[*WAHDE]4TGKFDDDKO/\
M'7C/L?Q1VUB[2[!X_#Q_"XM9Z:ZVR9+S,S.3-FO-LN;),S/QY+VF(TI7II6M
M8FAP';O#=L<=7B^#P4P;.ONC6;6GVS:]IUM>TZ^VTSI'I&D1$1@=G;N@
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MTS,VM,S,S,S,ZHY9,E\M[9<MIMEM,S,S.LS,^LS,SZS,SZS,^U_8^+\
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M=-,D?\GDTC6:^M9_6VMI.DHJ,#7
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M4QUF=/2E=(UTC6=;3&LRV6:U8\
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M6[ICSUU^RU>BW_ZS'?3[(]/<F?0S:D
M
M                            4,?R:.Y8MY\YM(ZGQV2^YQO1O2>NV67Q
MWNVDGZ9O78>6RNYY?GTVM]=20?>Z/-K5?HN(K:X_@^OT50U0R5WO?AH]G6X/
MP=ONZ]QCZ=SSG-Y;8[Z6CKVNTQTV^/\ .K6)Z=S&\C6EKU]=-8O%ZUFM]._$
MSL^S,W)Y*Z9-YO+36?7UQXJUQU]L1KID^;[)F/=KK$Q%<M8JWX
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MQX[?"C-W-VAW#VAO/N7/[:^&\_FV]+8[Q]M,E=:S]LQK%J_KJUGT;4-6,:
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M8JQ7%6(BM8B(B(B-(B(CTB(CTB(](A)6M:TK%:Q$5B-(B/9$?9#\7[?T
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M=<8]GO+QQ_-WF(^5EG]'>TSI$8LWI6VOI$5OT7FT]-:WTZIA)37;@
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M7NWN'N[>3O>>W-\U]?AK^;CQQ[-,>.-*U]/;,1U6]MIM:9F=HFKV-@
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M]8GXKQ,Q>O38%0!:-
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MN,J>D40
M
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M%Y&Y?]W>^>4Y*)UQVW=J5G[:8=,..=.FLQK3'6=)C6/9,S.LSOBT2PH
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M>YYKNNY+5F+9M)BN.+1&M,-9F=(CV3DF(R7B9UZ:V^7$-J8K;
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MS$Q,3"&F[VFYV&YR;+>X[XMWBO-;TM$Q:MHG28F)]8F)>D=:XX
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M,<QI\5XM2[FI-0]
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M1#SC(
M
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M&FKHNY^5C@^W-]S$STVVVTRY*SZ?G5I,TB-8F-9MI$:Q,:SZ^CJ_/*:K*
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M#_?]E^CWV+IKGPS.ML5YB=/7TZL=])G'?2-8B8F(M6U8CW2"9T
M                            S!T)WQVAXS=MZ3W=TWL]YJ?8&A9B#+8?
M(VTDW%M=Q4\^C(8+-VD4L-&7UO/V-4EID+*7GV;NTFKBKX^E3$._>Q.U_)?:
M6][)[QVU-WP&_P ,X\E+1'56?;3+CM,3\O-BMIDQ9(^+'DK6T>L.JYOA>-[B
MXO-P_+8XR['/2:VB?;'V6K/ZV]9TM6T>M;1$PZ4WQS?('U?\B70EMVQH]O\
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MN[Q7YV>W[)EM'OGUGII&L]..OPUCUGJM-KVT/;V9H
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M]V9HS<_N\NXBLS-:3.F.DSKZTQUTI6=)TUBO5,:1,SI#:AJQC0
M           "BW^0M\:^8Z4[CS7FSU3@YKGIKN[/1WO:]EC+6ZN*>N>X\O)5
MQE\_D>+;'<6^.U7M+(547M-U<7,M7.R75W#5S%3<6,55Y/X?/U([/O7L[#X4
M[JSQ7O'A,$UV-KVK'WOC\<?H\5-;ZWS[*FN.:4I$?<Z8;QU3CSWB9O@GR#BY
MCB:=G\G>(Y;9TTPS,Q'S<%?S:QK.LWPQ\/3$1^BBD^LUO*M"LJ2%
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MUK:804YKA.4[=Y+)Q/,8;X-]BG2:VCVQ[K5GV6I;VUM69K:/6)9@8@ZH
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M16L>Z(B$\,&##M<%-MMZQ3;XZ16M8](K6L:5B(^R(B(A\=RWU
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M^?/FW6>^YW%ION,EYM:T^LVM:=;3,_;,S,R^PX;Y
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M=EN(TW&'):EH^RU)FMH_H3$O2.M<<
M
M                        !!5^1/W++U=\;>W:I8Y+]/RG>G9'7G5</V\M
MW%DI<7;Y&Y[)V".UDLKZTK@L[S%]?UV5[5+1/;2VMY7;21_6XHJIG-^'AV=7
MNCZC]IRN?'\S:\%QN[WTZQ6:1>:1L\4VBU;1-JWW<9,<5FMZWQQDK;3',3N?
MP-Q,<EY Q;F]>K%LMOES>NFFLQ&*NNL3ZQ;+U5TTF)K%HGX9<])Z#4ZP
M     $]GXXW34O97R,X?>I\;]UB.A^J^P>Q)KVYBN^<?;YO.V=KUA@[7B6.Q
MNK"3,34[Y=7=K!<26_/-%A-<15<R6W%%4#?Q&.\:]M_3KFX+'DZ=WSW*[3:1
M6)KUSCQ6MO<MM)M6T8X^ZTI>U8OZY:8[1%<NL:3\^\M'']@WV5;:9=[N<6+2
M--9K69S6GVQ/3^CBMIB)_.BLQI;5T%GG^09
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M,7X?F*=.6OK2\:]&6FOIDQS[ZS_PUG6MHBT3#:AJQC0
M          "/'Y&_D;Z<^.OIR7>=YEAV?LO9X;^QZAZAL;^.VSV^9ZVCHXDN
M[N3BBXDP6DX*2XBKRN5KBKH@HKHAAHFNYK>WED+].GTZ=X_41WC'!\'$[7MK
M:S6V_P!_:LVQ;7%:?2M8](R[G+$6C!@BT3:8F]YIBIDR5SSL'L'EN_>6C9[.
M)Q\=CF)SYYC6N.L^Z/9U9+:3T4U]?69F*Q:T<Z'RM\NN^O-3MC)=R>06Z3;9
MM%S#SC<+C[:VBQ6K:7K45S/<X_4M,U^U_P EPV!QU5Q5]/KS+=W<M5=Q>3W-
MW+-/)Z)?%7B3L/POVIC[.\?[*-IQ=9Z\EYF;Y]SFF(B^?<9;?%DRWTC^EQTK
M$8\-,>*M,=9Z]L]K<)VAQE>)X+#&+;1.MIF>J^2^D1-\EI];6G3\E:QI6E:U
MB*QK2V2R$                 !^UO;W%Y<06EI!-=75U-%;VUM;Q5SW%Q<3
MUTQ0P00Q4U233325<4TTT\<U55<\<<<?5^,F3'AQVRY;17%6)FUIF(B(B-9F
M9GTB(CUF9](A_+6K2LVM,16(UF9]D1]LK4_Q%_ CM6\YO4_);SGU+]WNLK+[
M;/Z#X\[##<P;7OU]'5%<XW,]L82>WC_=[0X_KQ)'A)Z^,CEY*>:;Z&WL>/:R
M-67U;_7EQ7![+=^-?!V[^\=S7ZL6ZY;%,3@VM9UB^/8Y(F?F[J?9.YK'RMO$
MZX+Y,\]6WC5Y2\V[;98<O;W9F7YG(SK7)NJZ33%'LFN&T3\63W3DCX:1^9-K
M^N.Z?;V]O9V\%I:00VMK:PQ6]M;6\5$%O;V\%%,4,$$,5-,<,,,=/%---/'%
M--/'''''T4OY,F3-DMERVFV6TS-K3,S,S,ZS,S/K,S/K,SZS*(EK6O:;6F9M
M,ZS,^V9^V7[/P_@                        #F(_+9CL?BODD\PK#%V-G
MC;&W[ARWL65A;0V=I#[N/QDTOM6UO1'#'[DTE5=7TIX^M57///[>>7IL^DS<
M;C=?3AV?N-U>^3/;AZ:VO:;6G2]XC69F9G2(B(]?9&BQ;Q?DOE\?\5?):;7G
M:5UF9UGVS[Y1UI#L\        3J?CIX['Y#Y,--^_L;.^^QZK[3R-E]Y;0W/
MV>0ML39_;7UK[U%?V]Y;^OGT2T?2NCZ\_3GCZH,_B([C<;?Z:MY]WO>G7RNR
MI;IM->JELEM:VTF-:SIZUGTGWPTQYZR7Q^/,O1::]6YPQ.DZ:Q-IUB?MB??#
MH7//D@H                         \?V#H&G=JZ+N'6?86!L]IT7?M;S.
MH[=KM_S/1:9G7L_83XS*X^66TFMKRW^XL[BNFF6"2*>&KZ5QUT5TTU<=QV_S
M_,=J\[L^Y>WL]]KSFPW./<;?-33JQY<5HO2\1:)K.EHB9K:+5M&M;5FLS$\O
M8[[=\9O<7(["\X][@R5O2\::UM6=:SZZQ.DQ[)B8GV3$PH)_*;\'_;_A3D\U
MVUT3C]J[G\6.8;S+7^=AM(,GO/3<,'%U=W%CV-CL511<9'5;/'V]4M&SVUI%
M814T51W]%G)]O7>7V?2W];G:'FG;8>T^^LFUX;REK7'7%-IIMN0F>FL6VE[^
ME,]KS%9V5\ELMIF+8)S5^9&&;GC;S%Q7=^.G%\U;%M.Y=8K%=9C'G]D1.*;>
MD7F9T^3-IM/MI-XZHI RG>W6                   D.^.3Y&^X_CK[CBWG
M1I9MGZTV>:PL>WNH;Z_DML#OF!MI*^([NTDYHN(\%NV"CN):\5E:(JZX*ZZX
M9J)K2:XMY8]?47].G9WU$=G3P?.1&U[EVL6ML-_6L6R[7+:/6MH])R[;+,5C
M/@FT1:(B])IEICR5P3O[L'B>_>)G9[R(Q\CCB9P9XC6V.T^Z?9U8[:1UTU]?
M28F+16T=%+Q"\Q.C/.#IS$=V=#;'-EM=OIJ\;G=?S,5IC]TT/9;>..6^U+>,
M%:7V2CP^>LXYJ)./;GN+2ZMY([BUGGMI8YJ_/#Y=\/\ ?/A'O'-V5WYMHQ<C
M2.O%EQS:^VW6&9F*Y]MEM6DY,5IB8]:TR4M%L>6F/)6U(@9W5VIS/9W+7X?F
M\<5SQ&M;5UG'DI/LOCM,1U5GV>L1:)B:VK6T3$;1-7L;
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MF93\X;AN-[?XW%Q'$8JX=AAKI6L?]VUI]MK6GUM:=9M,S,SJQ*RQV@
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MQ$5K$1$0]XZ)P@
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M\N\3'$>0^2PUB?E9LT9XGU]?GUC+>8UF?9DM>OMTUB=(B-(B4M%UK8
M
M                                                 !3:_*B[@BNM
MO\3.@;*]],V#UOL'N#9L?Z+2OWXMIRF)TO1KWW*K?F_MOM*].V*CZ42TPS^]
M]:Z*JHJ.:;B_PM.T+8N([L[^STUIGW.TX_#?XHTG!3)N=S737IGJ^\;2?6LV
MKT^DQ%[1,L?IKXJ:[7E.<O'I?)BP4GU].B+9,D>W2=?F8I]FL:>D^LJD2VA*
M$         !=#_%BZ:M[#JGRD\A+B*&:ZVKL+5.FL/-5S1S<8^WT#6Z-WV2*
M*FGGB2B',2=E8KF3FKZTU56-'I^G--?UIE_%([RR9^ZNU_'V.9C%M>/S\CDC
MUTO.ZS?=L,S[M<<;//IIZQ&6=?;")'U)\M:_)\;P59F*XL%\]OLF<M_ET_\
ML?E7T_XTZ^Y:_53(R
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MPW,XIQ[S'/ZM;UG\V]+>G52VGI/ZM;1%HM6,_,!=&
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MB.VN-IQ/"X*8-C3W1[;3Z:VO:?6]YTC6UIF9TB-=(B&$V:NW
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M2MH]=(RVFTWR>GMK,QCF8BWRXF(TEC11:Q
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MK1;%:(FMHF)B8F-8F)CTF)CUB8])AEE;5O6+5F)K,:Q,>R8^V'XOV_H
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MIDI:L0![K[4YCLWF+\/S%.G+7UI>->C+37TR8Y]]9_X:SK6T1:)AM0U8QH
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MEY?E\MLV_P UM;6G_N5K'LK6L>E:QI%8B(B-&6F)NK
M                                             4S?RGNEOL]_\5O(
MFSA]S]XM/W+I;8[CW/1]G^YF:BWG2X?:ERM7W'ZE^_N?J]4%C1[/VGTGGK]V
MWCCN1_"V[T^=P'=7CS-;3[OO-OR.&-/SOO&.=MN9UBGIT?==K&ELD]77^CI7
MIR6M+3Z;.7Z]CR? WG]CRX]Q2/M^97Y>3];Z:?+Q>VWKU?#6-+3-2];$D\
M        NP_BS]P_K70WDYT-<5?X[KOM35>T,=5-5_C9<?VOJTFM7EG9<UY.
M6JNSQ=]U+Q-)''9P4039'UU2S57'IAI6_%&[/^Y=]]L]]XX^#D>*S[*^GLB^
MQSQFK:VE(TM>N_Z8F<EIM7#I%*1CUO$'ZDN*^3S?'<W7V;C;7PS^KAOUQ,^G
MMF,^D3-IUBFFD=.LVH56J-8
M
M                  #G-_/WVSSVE\G/=-A;W\V0PW4N!Z\ZFPDDLN3YHM^,
M)J6/V39;"VM,G1%^GPV.^;9EXN:+>GBUGDIJN:.:_?YDK]%'T#=IQVO],O"Y
M\F.,>\Y;/N]_DB(IK/S,]\.&TVI,]<VVN#!;6\]=8F,=HKT16)[^#^+_ '-\
M=;2]JQ7+NKY<]O9Z]5YI29F/;KCI2?7UB-*SITZ1#"F6VV          Z3_P
M?]3<]1?&-XRV%U83669WO [%VSF))XLG;5Y#CLG;<WLFL7]-IDZ^?8AJT.ZQ
M,4==O3':W4<5-S'Q5[W,E?FZ^MSNR.[OJ:[FSXLD7V>QSX=ACB)I:*?<\&/#
MFKU4CUG[U7/:8O,WI-IQVF.B*UK[\Q\I^ZGD7D;UM$XL-ZX*Z:3I\JE:7C6/
M_*1>9UUF)GIGV:1+&BBUB
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M-9UO3TM,U];XXCXM8TM:']+UM0
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M$#>Z^U.8[-YB_#\Q3IRU]:7C7HRTU],F.??6?^&LZUM$6B8;4-6,:
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MS,S*>O#<-QO;_&XN(XC%7#L,-=*UC_NVM/MM:T^MK3K-IF9F=6)66.T
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M:6Y7G>:YS-.?F-WN-SEF9G7)DM?37^EB9F*Q[HBL1$1Z1$0S Q!U0
M                       #F._+W_:7^9'\\.2_BK$O3-](O^S5V=_ ]/[9
MD6)^*_Y/.)_Q2/ZZR-](UGX       ">#\<?^TPU?^9_MG^*;%!/\1?_ &:M
MU_#&P_MEFEO/O\GF3_&\']=+H1//P@L
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M\3VMQ.+AN&Q1CV>./U;7M/YU[V].J]M/6?U*UB*Q6L8!9\[L
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M,H6[O=[G?[G)O=[DOEW>6\VO>TS-K6F=9F9GUF9EZ1UKC@
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MQ(Y"D1U[+=X\DSZ:]&37#,>V/;?)CF=(M/PQZ::S%_A08A
M
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M95?\CO<O)<AGY'/K.?<9KY+:S,SU7M-IUF?6?6?;/K/ME[9TCA@
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MI,),UM6]8M68FLQK$Q[)C[8?B_;^@
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MLKDYXWFL73U:SCR5]<>6D3IU4M_P3-;:7KK'56-8UW :A8J
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M &F&K_S/]L_Q38H)_B+_ .S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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MNFXQ3Z6B)Z<E)_-R4F8C6EO=.GI,36=+1,1L@UPQ\
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M>7;O;O$]K<3BX;AL48]GCC]6U[3^=>]O3JO;3UG]2M8BL5K& 6?.[
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M;5<(V
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MQBO?/%?NWV?R7%Q^R9=GDZ?^/6LWQZ^EITZZUUTB9T_-]=)=4)Y:E:X
M
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MYY7Y2G$^/>4SVF(MEVTX*QZ:S.>8PS$1,QKI6]K3IK,5B;1$Z:.F@\T2O
M
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MV^]=K]XX//%LM:Q-\5_AS8]?=>FL^_TZJS:DS[+2TM;G9<
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M)Y3E>2YO?9.3Y;-DW&_RSK:]YUF?LB/=%8CTK6(BM8B*UB(B(9(8XZ\
M                             !S'?E[_ +2_S(_GAR7\58EZ9OI%_P!F
MKL[^!Z?VS(L3\5_R><3_ (I']=9&^D:S\       !/!^./\ VF&K_P S_;/\
M4V*"?XB_^S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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MSSKI,SQ[YFX3O"V/B^3BNR[AM.D4F?T66?=\J\^RT^[';XM?2LW02ITMT
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M)5_<SPW)=O\ )9>(Y?%;#O\ #;2U9_[EJS[+5M'K6T:Q:)B8G1EIB;JP
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M7@QZQBIZ^DS&OQW_ *N^L_9TQZ)"4?6"@
M                                        .7#\F'3TO0_GYY:]9\V7
MZ=88WNS<=CUVP]=W+]GIW8=[QV+I%M[]_<7=[=>SJ&UV-/O2RUR3?3UU<\\U
M/4']-7=]>^_ ?:7<O7\S/DX3;X<MOACJW&TK]TW,Z5BM:Z[C!DGIK$17\V(]
M%D'CSE8YKL?B^1UZKVV>.EI]/7)BCY62=(B(CXZ6](C2/8T;;P9D
M  ZPGBEVSQWQXQ^/G=%5_#D;KM'IGK;>,K<0RXR7FC/;%J.)R.PV-U^C418N
MWR6,SD]Q;7<$-$=%O=0R1>BCFCFCCRE>5>TY[$\F=P=F1CG'BXOF=YMJ1,7C
M7%AW&2F*U?F3-YI?%%+X[6F9O2U;=5M=9K)[FXO]Q>XM]Q'3-:[;=Y<=8]?S
M:WM%9CJ]9B:Q$UF==8F)UG75GY@+HP
M
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MC28CTG7TO)*/D-@
M                     'B>Q.M>O>W-1RV@]I:1JO8>DYV'V,OJNYX+&['@
M<A1QQSZ*KC&96VNK6J:"KGU12<4\215\<5454U<<<N[[>[D[@[2Y;%SW:^]W
M7'<U@G7'GV^6^'+2??I>DUMI/LF-=+1Z3$QZ.9L.0W_%[JN^XW-EP;RDZUOC
MM-+1^I-9B?U8]D^]52\^?QI\9F+C+=D> VRPX*]N9LCD\ET%V3G.?T'FN6OB
M:#']7;S-9UW6'AHIXYHBL-@EN8^:ZO5SDX(Z:8N+4/ OXDVYV>/%VYYZVTY\
M-8I2G*[/%^ETB-)OO=M%NG),^V<NTK2=(T^[7M,VF2_9'U"9,5:\?WOCF](B
M(C<XJ_%^6<V/72WY;8HB?_)S/JJ==V=#]Q^.&^Y#J_O3KC:NK]\QL,=W-KVV
M8R2PN+G'33W-M;9G$77',F/SV!O;BRFHM[^QFN+*XJBK]N6KTU?2USLKOOL[
MR-P./N?L;D=KRG!9)FL9<%XM%;Q$6MCR5]+XLM8M6;8LE:9*1:.JL:PDYP_-
M<3S^QKR7"[C%N=E:=.JDZQ$^DS6T>VMHB8UK:(M&L:Q#$K+'9@
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MRVCUBDU_Y&)FOK/7.2>GIGA03:5
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MK,3$Q,(&;O:;G8;G)LM[COBW>*\UO2T3%JVB=)B8GUB8EZ1UKC@
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MF%MMMMMGMZ;39XZ8MKCK%:4I6*TK6/2*UK6(BL1[HB(B'P7.?8
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M,S,S,ZH]Y,E\M[9<MIMEM,S,S.LS,^LS,SZS,SZS,^U_8^+\
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MAYWXO]SO(>?/6L5Q[S!ASQ$:1'YORK3I'VWQ6F==)FTS/LF)F<-")IP
M
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M5;3./:[+JF/72+YKVFT:3Z>M*8YF8]NL1,_#I%E]6JCR
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M,3$S$QH_.3'3+2V++6+8K1,3$QK$Q/I,3$^DQ,>DQ/M7 ?BI_(2M)HM>\?\
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M]<]WQR/WWELFFVI,_*PUU^7BB=(F*Q/MM.D=5YUFT_972L;R-'L-
M                              <QWY>_[2_S(_GAR7\58EZ9OI%_V:NS
MOX'I_;,BQ/Q7_)YQ/^*1_761OI&L_        3P?CC_VF&K_ ,S_ &S_ !38
MH)_B+_[-6Z_AC8?VRS2WGW^3S)_C>#^NET(GGX06
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M"?*YSNZM,_,1I:FW]+8L$^OY\Q-JYLD>DQI\%+1\/7,5O%8Y9FD2
M                            W,\7?CY\PO,?(6$/071NX;7@+R\XM)^P
M<A:4ZQUGC*:)KJ&]N+[?=BKQNN2?IW-C/[MO;3W%[77%S%%!)/51%5IORA]0
M/B#P[M\E^_N<V>UW]*=4;2EOG;R_I6:Q7:X8OFCKZJ]-[UICB+1:]ZTBUHQ+
MN3OKM3M.EIYS>8L6>(UC%$]>:?9I$8ZZW]=8TF8BOKK,Q&LQ:G\./QE^FNO;
MC"[CYC]D3=X[#!#;75SU5U_1EM0ZKL<G175S-:9+;)9[+?-\QM/IHJCKC@UG
MCGGFJB:"6C]E567F+\2[O+N''FX?P[QL<'Q]IFM=]NIQ[C?6I,>EJ8(BVUVM
M_;$Q-MYIZ33)6?9&KNSZA^6W];[3M/;QL\$S,1FR]-\TQ]L4TG'CG[=9S?;%
MHE99Z[ZUZ]ZCU'$Z#U;I&J]>:3@H?8Q&JZ9@L;KF!Q]'/''KJM\9BK:UM:9I
MZN/5+)S3S)+7SS57555SSRK8[A[D[@[MY;+SW=&]W7(\UGG7)GW&6^;+>?=K
M>\VMI'LB-=*QZ1$1Z(][_D-_RFZMON2S9<^\O.MKY+3>T_JS:9G]2/9'N>V=
M(X8
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MK69M-HJ?4KQL1?BN8I[9C-AM[/=T7QZ>FOOR:^ND>FD1K.MO546BP
M
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M'RNXGV8]S.&/;&GW>L8?9,S[\<S/NF9F8B-=$EJ-;7H
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M^3V\;OC<^'<;69TB^*]<E)GVZ=5)F/9,>_WO$NZ<L
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M+QC3AMG3N[GL43S&>D3@I:/7;XYU^.=9TC)EK,3'IU8Z>FL6O>L5CEF:1(
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M5_YG^V?XIL4$_P 1?_9JW7\,;#^V6:6\^_R>9/\ &\']=+H1//P@L
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MWK$7M]M:1K/RL<SZ]%9F9TCKM>:Q,1FI+-A@
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MU_8^+\
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M;S[Q_P!\\>9-QI_YIN\&7VZ::VG!_1_9M-/Z/N=")Y^$%@
M
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MTCW0J\W.XR;O<Y-UFT^;EO:]M/2-;3,SI'ZLOO. ^
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M[G<[G>9[;G=Y+Y=S>=;7O:;6M/LUFUIF9]/3UE]YP'P
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M>*3:DS,1,Z1:(UTB?37T=4AY9U:P
M
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M,XKM
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M$1$1$)Q;3:;;8;;'LMECIBVF*D5I2L1%:UB-(B(CTB(AYMV+D
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M9FUK3.LS,SZS,R](ZUQP
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MWN[W,6B(GYN;)DUB)UB)Z[3KI,1,:^R?8S,PUU(
M
M#F(_+9U7'TU\DGF%I<$?LV]WW!ENP[6#B6TEBMK3N/'8SMZTM;;BQM+*WM[.
MUMMYICA@XH]5O%33%75)715)5Z;/I,[IMWC].'9_-7G7)3AZ;2TZ6B;6X^]]
MA:T]5K3-K3MIFUM=+VF;1%8F*Q8MXOY.>6\?\5N[>MHVE<4SZ^LX)G!,SK,S
M,S./69U]9]8B(G1'6D.SP         !UG/''LRONGQYZ'[CEHFBD[9Z9ZO[,
MDCN+:WLKB.O?-(P>TUT3V=I<WEK:34597Z51132QQU?6FFNKCCBKGR?>1NVJ
M]E^0N>[.K,37B>9WNSB8M-HF-KN<N#6+6BMK1\'I:U:S,>LQ$^BL/G^.CB.=
MWO$QIIM=WFP^DS,?H\EJ>DS$3/YOMF(F?LAF9AKJ0
M
M                                $/'SS=F5];?%_P"0=%K1-5D^PINO
M^L\=)3;6]U:P4;-ONOSYZN_XGN8*X(9=2Q>1BAEBIFDHO)(>?1Z?571,#Z$.
MVJ]R?4[V_.68^[<?&ZWEXZIK:9P[7+&**Z1.LQGOBM:MIK$XXOZZZ5G:WA3C
MHY#R-L9MI\O!&7-/K,3/1CMTZ>DZ_'-9F)TCIB?77TGG"/1FGX
ML@?C%=<?O-YR=E]A747KL>LO'O9/LY:+OV98MFW/<-,PF.]RUXIYYO+.37(,
MQQ7^WCB.;VN?\/T5R?B:]Q_N9X/XSM_%.F?D^X,/5$UUB<.WV^XR7TM^MM&:
M=OI]M>N/M: ^HKD/N_9NWV-9^/<[^FOI^LQX\EI]?=/7./\ 5C5?"43H6
M
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M6L1$1$0E3BQ8MOBK@P5K3!2L5K6L1%:UB-(K6(TB(B(TB(](CTA\UR7T
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M>6\VO>TS-K6F=9F9GUF9EZ1UKC@
M        .8[\O?\ :7^9'\\.2_BK$O3-](O^S5V=_ ]/[9D6)^*_Y/.)_P 4
MC^NLC?2-9^        G@_''_ +3#5_YG^V?XIL4$_P 1?_9JW7\,;#^V6:6\
M^_R>9/\ &\']=+H1//P@L
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MXWOSAJ[O;VK3E<5:QN,/LG'?3UM6)F9G%>8F<=M9]/AM/76T1'*D4SX
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MY/D\M\V_S7FU[VG6;3/_ '(B(TB(B(BL1%:Q$1$/>.B<(
M
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MW4Z?<@%YJX_[AY'W_3'Z//\ *RU]=?S\5.K]3])%](^S1,"B$U4
M
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MVZZ3_P";^D:1,>NLSK&EJ=5DC4
M
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M?^1^&[^V,WVFN'EL-8^=@M,=5=8C6])_7XNJ>F+:1,3I%ZUFU=8S4EFPP
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MYM>]IUFTS_W(B(TB(B(BL1%:Q$1$/>.B<(
M                !S'?E[_M+_,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_%?\
MGG$_XI']=9&^D:S\       !/!^./_:8:O\ S/\ ;/\ %-B@G^(O_LU;K^&-
MA_;+-+>??Y/,G^-X/ZZ70B>?A!8
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MV#]E=Z\/WSP]>4XNW3EKI&;#,QUX;Z?FV^VL^LTO$:7C[+1:M=)VZF7@
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M_@^ P_(X7:;?:XY]ORZ5K-ORVF(ZK3Z1ZVF9](^QA-FKMP
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M9.1Y++?/OLMNJ][S,VM/Y9G[(TB(]D1$1$1$1#VSI'#
M
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M8LM*JND;@
M
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M4P'\W<E'(^1MY6DZX]M3%AB?7];CK:\:3[-,E[QZ>DZ:QKKJF90V:E
M
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MGVWPS/M]/BMCF>NGKIU5K-T*J:+;H
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MF;F.6R3EWV>\VM,^R/LK6/UM*QI6M8]*UB(AF!B#J@
M                         ',=^7O^TO\ ,C^>')?Q5B7IF^D7_9J[._@>
MG]LR+$_%?\GG$_XI']=9&^D:S\       !/!^./_ &F&K_S/]L_Q38H)_B+_
M .S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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M:9UFUIG69F9G69GUF?67TG&?,
M
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MLQ'GZCN-C<=J[/E*UUR;;>]$SI'I3-CMU3K[8B;X\<:1Z3,QK[(7GE'*&8
M
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M(_NOW/R/)Q/53/O<UZ_%UQTVR6FD1;]=6M=(K,:1TQ&D1&D-D&N&/@
M
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MBQQ^;BQ1,]-(]9]?7JO/ZZ\S/I&D1N8TVQ(
M                   !S'?E[_M+_,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_
M%?\ )YQ/^*1_761OI&L_        3P?CC_VF&K_S/]L_Q38H)_B+_P"S5NOX
M8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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MNRR4R[3+2+4O68FMJS&L3$QZ3$P\V[%R
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M9MU'MO[IKMYB?2GMB<OI:W_)]-8B][:*IU&
M
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MNE?8
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M(B9_1X[7](M\,SZ>D3Z3[_1UEGE!5B
M
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M;O;;_;8][LLE,NTRTBU+UF)K:LQK$Q,>DQ,/-NQ<@
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M9;"TQVWM+S&*--/FWC6ML\^_XH],<3^;3UF*VM>$U:%K4(
M                               #F._+W_:7^9'\\.2_BK$O3-](O^S5
MV=_ ]/[9D6)^*_Y/.)_Q2/ZZR-](UGX       ">#\<?^TPU?^9_MG^*;%!/
M\1?_ &:MU_#&P_MEFEO/O\GF3_&\']=+H1//P@L
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M=Z1-<<?#6?SIO,1,3DH/M-
M
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MO37[SM,V+373]DQVI[?=[?;[G6B>3M6$
M
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M=?9/24><!7Z
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M][=O]Z["-[PN:+9:Q'S,5O3+BF8]EZ>W376(O76EIB>FTZ3IIFW(RT
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M_P!IAJ_\S_;/\4V*"?XB_P#LU;K^&-A_;+-+>??Y/,G^-X/ZZ70B>?A!8
M                                           !15^=CXB[OQSV_.>7
MOCAJ=Y/X_;UF+S+=K:IA+:*6RZ1WC.Y3F63(X_'6<456)ZKVR^ON.+2BBBJT
MPF0YYL^*H+:?'6]-YGT,?5OA\B\1@\1>1MW2O?\ L<-<>QSY+3%N2VV*FD4O
M>TS\S?8*U^.9F,FYQ:9M+Y,>XR3,[POY2IS^UIVKS^6(YS#2*X;VGUW&.L>R
M9G\[-2(^+UZLE?C];5R6FM.LG2$                            2??'7
M\4?D=\B6Q\W>F00]<=)8;)58_<>]-KQE[>:Y8W5K+C*LEK^GXBVEL[C>=VM\
M?DZ;FFPCN+*SHHIXXNKZT]R+F2,?U#_57XY^GCCOD\S:>1[VS8^O;\9@O6N:
MU;1?HR[C),6C;;:;TFDY9IDR3,ZXL&7IOTZY[]\F\!V'M^G=S.XYB]=<>VI,
M1>8G72U[3K&/',QIU3%K?TM+:3I?X\*/ [QY\"NK[?K;HW5_:O+SV[K=.Q,_
MQ:Y#L'L#,<0P129#9,Y';6_HLZ/MZ?ML;:46^-L_X7,4%,DDTDE!GFKSMY"\
M\=T6[D[XW6N&FM=MM,753:;7'K,Q3#BF9UM.L]>;)-\V3TB]YK6E:P@[O[UY
MWO;DIY#F<FM(],>*NL8L5?7TI76?7U];VUO;WSI$1&YC3;$@
M
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M/D[[/2/AZ=:QDMTVBONBU=+5]9C28TF8]6RS6K'@
M
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MN7+BR1I[)Q>OM1[^HW?6P=I;384UCY^_B9GW37'CR3TS^K:U;1_Q5ZI1FAB
M
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M]=BK;_G;>R\UF)Q1Z1/S)GHNVJ4$/@
M                 ',=^7O^TO\ ,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_%
M?\GG$_XI']=9&^D:S\       !/!^./_ &F&K_S/]L_Q38H)_B+_ .S5NOX8
MV']LLTMY]_D\R?XW@_KI=")Y^$%@
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M!\
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MC%ECUF?SL-.N9U]FN2+SI[(C332-(3#H?M4@
M
M                         *Y7Y-W8\&K^"&@:##+9U97M#R$U.VDM+FTR
M$LW[LZAJ>Z;)ELCCKRWJBQ]I>6FP1X:"JFXJKYEM[N7VXJN::I8;%?PS>W+\
MIYVW_/7B_P!UXOM_/:+5M2(^=N,^VPXZ7K.M[5MBG<6B:1'3?'7JM$3%;[\^
MG;CYW/>N??3$_*VVPO.L3'Y][XZ5B8GUF)K\R?3V36-9]TT,E[R:P
M  "Z?^*WU_7C>F?+?M3F#)4Q;EV=UOU_1<RUV_.(EKZTU7/[')!8QTP4W5.2
MMZ>V::KOFN2N.J*6WXHIHYXDYKI?_%,Y^NY[R[2[6ZL?5L^,WFZTC7YD1O,^
M+#$VG7IZ)^X3%-(B8M7)U3,36*Q%^I7?1DY;B^-UKKAVV7+IZ]7Z:]:>ONTG
MY/P^FNL6UU]-+6:JQ&<
M
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M.LS/MF?ME^S\/X
M  YCOR]_VE_F1_/#DOXJQ+TS?2+_ +-79W\#T_MF18GXK_D\XG_%(_KK(WTC
M6?@       )X/QQ_[3#5_P"9_MG^*;%!/\1?_9JW7\,;#^V6:6\^_P GF3_&
M\']=+H1//P@L
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MY<:>RUY])R7_ "V](G\VM4G*,S70
M
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M/68M$5AM]2&R^5W1L>0CV9MAT:::>N++>9GJ]\S&6(TT](B/6=8TLXJS$=@
M
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MZJ#+3
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MD.)SXMSLK^R^.T6KK[XF8GTM'ZZLZ6K/I,1+&[(W/
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M?</7PG:EK[?@YB:WR^M<N>)C2U=/;CQ3K,3'Y]XB.J:Q,T64U;:/@
M                                          #F._+W_:7^9'\\.2_B
MK$O3-](O^S5V=_ ]/[9D6)^*_P"3SB?\4C^NLC?2-9^        G@_''_M,-
M7_F?[9_BFQ03_$7_ -FK=?PQL/[99I;S[_)YD_QO!_72Z$3S\(+
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M^>]IM:UIF;6M,ZS:TSK,S,SK,SZS/K+Z3C/F
M
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M1I,3[8UNN*640@
M
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MKB\C[W]T._.6W/N^_P"6D>O5K&*TXHF)^R8I$Q'NB=(F=-6^+1+"@
M
M                                           &M_DSXB^.7F'I,>@^
M1?5>M]DX2R^^DP-YDH9K+9M3N\C';QWM_I^V8N:RV/6+RZXLX??JL[F*FYXA
MHIFIDHIXI;'\:>6_(OA_FIY[QWRNYXW>WZ8RUI,6PYZTF9K3<8+Q;#FK7JMT
MQDI::=5II-;3JR#MWNGG^U-Y]^X#<Y-OFG3JB/6EXC72,E)UI>(UG3JB=-9T
MTE5 \Q_QC^S]9N,UMWA-V3C>RM>CAN;ZVZB[7R5EJ_8D=?%=/LX;6=YCL[/0
M]FFE]SGFBK+\ZW'#'1]*YYJ_VU6L^'?Q,NV.2QX>(\U\;DXWD)F*VW^QI;-M
M)C3UR9MM-K;K#$:>L8/ODVF?2E*^D2:[3^HGCMQ6FU[PV]MOGUB)SX8F^+_C
M7QZSDI_X'S9F?96(5E.V.GNU>B=VR?7'<W7FX=8;UA_37?:ONV R.O9:FVDD
MECMLC;6^1@@_4,/D/9JKM;VWYEM+N+CB2&2NCGBKFS#M3O#M7OKA<7<?9O([
M/D^#S?FY]MEIEQ]41$VI::3/1DIK$7QWZ<F.WPWK6T3"1/&<KQG-;.O(<3GQ
M;G97]E\=HM77WQ,Q/I:/UU9TM6?28B6-V1N>                EB\ /AS\
MM//6]PVSXC7YNG^@;R;BN^[W[!Q-U%A<C80WU-G>_P FNKUW&-S/9V2CYCN>
M(Z[2NVPM-S:2V]UD[2;T4U11\^_6%XG\#X<W&;O<5YCOZD:5XO:9*SDI::]5
M?OF?2^/94G6FL9(ON9IDKDQ;;+368UCWQY7[7[)I?;Y;QN^<B/3;8K1U1.FL
M?-OI-<,>S7JUR:6BU<=HUE>D\#_C<\:?CYTF3!=.ZU^J[WFK..#>>X]KML?>
M]B[?57'C:KO'<Y:*UCKP&GU7^+BN(,)9\T644M/$M?$UQZ[BNC;SM]1_DGZ@
M.:C?=X;GY7!8+S.VX_!-Z[3;^M^F_P N;3\W<=-[4MN<FN2U9FM>C'ICB&?>
MOD#N'OK>?.Y;)T[*DZX\%)F,5/;I/3K\6329B<EOBF/2-*Z5C?QH-@X
M                                             #F._+W_ &E_F1_/
M#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO^3SB?\ %(_KK(WTC6?@       )X/QQ
M_P"TPU?^9_MG^*;%!/\ $7_V:MU_#&P_MEFEO/O\GF3_ !O!_72Z$3S\(+
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MO;^V^2TVMI[HB9GTK'ZVL:5K'I$1#)#''7@
M
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MWZ1/0T>>]!(
M
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M-ITUF9TUGTUF?U7I'6N.
M
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M1^FOU:YU;[^0Q=Y[4G'\&;.3Y>OUT\214V]7\'BI3S9]?OF+R?\ .XCM*_\
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MY@?[R_='^FI_-\\"?Z#]H?\ 4W'?Y,?Q$[(_>;BOVIM_[F?UA?GW_3B\P/\
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M?/ G^@_:'_4W'?Y,?Q$[(_>;BOVIM_[F?UA?GW_3B\P/]Y?NC_34_F^>!/\
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MIZ1U9<MKWMI'LUM.C1>]W^^Y+<6WG(YLNXW=O;?)>U[S^K:TS,_T9>P=.X@
M
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MC^CK3X9]UM)]SJ /,6KE
M
M          <H'RWW+^4;RL\F^PO;LXOW[\A.Z-R]K'7'W>/C_>CL?9,W[=C=
M?6K[FSH^^^D4GUY]='''/_*]67B7AOXN^*NV>W];S]Q[?X[;ZWCIO/R=GAQZ
MVK^MM\/Q1[IUA9KVOM/N';/';'UGY.PV^/UC2?@Q4KZQ[I]/6&O;8+O0
M    &W7@%U[7VMYP^(^@?939"RV+R*ZABSMM;WMOC[C]UK'><+E=NN(+NYEA
MHBFLM8L;N:GBGGF6NJ/BF*FN3FBBK4GGSN&O:OA'NWG^N,>;;]N[^<4S6;Q\
M^VVR4P1-8B9F+9K8ZSK\,1.MIK6)F,6[XW\<9V=RF^UBM\>PS],S$S'7..U:
M1,1]MYK'V>OK,1K+JD/+.K6
M
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M=TY8
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MOMQN8UF8K:VF.)GUGIQ5TQU]WYM8]D?9#9QK)CH
M
M                                     #F+_+KU[7UC\EGF3K<EE-CZ
MLEW-FNPN()[VWOZY*.W++&]KQ7M,]M+-''#DXMTXN8X>>>)+:.6F&2FFNBJG
MCTT_21W#7N;Z;.SN2K>,D8^&Q[36*S6(G86OL9KI:(F9I.VZ)M[+S6;UF:VB
M9L4\6[^.1\>\3N(F+=.TKBUB)C]@F<.FD_9\O29]DS&L:Q.J.5(IGP
M  #U.B[5<:+N^G;M:6D-_=:=M6O;5;6-Q77';WEQKV7L\O#:3R1_62.&XDM.
M**JJ?X7%////'[75\[Q6/G>$WG"9;SCQ;S:Y<%K1$3-8RX[8YM$3Z3,1;6(G
MTU<;>[:N]V>79VF:URXK4F8]L1:LUUC]35UT[>XM[RW@N[2>&ZM;J&*XMKFW
MEHGM[BWGHIEAG@FBJJCFAFCJXJIJIYYIJIYXYXY^CR1Y,>3#DMBRUFN6LS%J
MS$Q,3$Z3$Q/K$Q/I,3ZQ*K>U;4M-;1,6B=)B?;$_9+]GX?P
M
M                                  !X/M3<OY.>L.Q^PO;LY?W$T/;]
MR]K(W'VF/D_=?7LCF_;OKKZT_;6=?V/TED^O'HHYYY_Y'?=K<-_&+N?CNW];
MQ]^W^WV^M(ZKQ\[+3'K6OZZWQ?#'OG2'-XW:??\ D=OL?6/G9Z8_2-9^.T5]
M(]\^OI#D<O6JM%          3#? OU[1V!\HWCK5=V4-_B=%A[*["RD4M[<6
M5<->O=9[9#K=[;\VLL,UU-8[MD<7-S#ZO;DCHJXDIKB]=%40/KP[AMP'TO\
M<48;SCW>^G9[2DQ6+1,9=[@G-6>J)BL6VU,U>K36)F.F8MI:-4^:]_.Q\;[^
M*S-<N:<6*/2)_.S4ZXG7V:XXO&OMB=--)TET?'G+0#
M
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MJD-Q/"<1P.U^Y<-ML.VVNNO3CK%8F?MMIZVG\MIF?RL2LL=F
M
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M^YO?)FMIK:TS:TZ1I&LSK,Z1$1'Y(T?8<-\@
M
M                                      '/O_)&Z_HTWY)K_8Z8,;%5
MVST;U7V!))8UW%5U<UXVK9.J^)\S3-!%''DJ8^M*8Z>(JI8_LXX.>:N*^:Z*
M+_OPX>?MS/TWX^.FV28XGG-]M8BVG36+_)WVF/29F::[R9GJBL_,F\:=,5F9
MR_3_ +Z=WX^KMYFT_==[FQ>NFD:]&;X?R?IM?72>J;>[29@-3U;M
M  =5_P (-ZM^SO#3Q1[ MY,;55MGCKTUF;V'$WM&0L<?F+KKW7^<YAH[FBNO
MGF;!YFF>SFHKYXEBF@KCDXIKIJIX\KGFW@LG;/F3NO@,D9--IW%R..LY*S2U
M\==WE^5DFLZ>F7'TY*S'PVK:+5F:S$JT>\=E;CN[>3V-NK]%O\]8ZHTF:QEM
MTVT_JJZ6CW3$Q,>C:-J]C8
M
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M (=L<Q^I^1>V46H7
M
M                        /!]F=H]==,Z3G>Q^UMUUOK[1=:LY;[-[1M>5
MM<1B;&"*.N3BCFXNI*/N+RX]'-,%O%Q)<7$O/$<5%==5-//?=M=K]Q=Y<U@[
M<[5V6YY#G-S>*X\&"ELF2TS.FNE8G2L:ZVO;2E(UM:T5B9<WCN-W_+;RG'\9
MAR9][DG2M*5FUI_H1[(CWS.D1'K,Q"HYY\_DL9/,6^6ZW\!M:FP5E<PY'&9+
MOWLG!\?KW-$M'$4&0ZNT::\KM</-15QS7'?[!#<R<T5>GG&024TR\6U>!?PV
M=ML\F+N/SUN8SYJS2].*V>7]%K$ZS3>[F*]62)]DXMI:D:QK]YO69K,H^R/I
M[QXK5Y#O?)%[Q,3&VQ6^'\L9LFFMORUQ3$?^4F/152[$[*["[<V[+;]VEN^U
M=A[MG9O?R^U;GG<EL>>R%?'//HIN,GE;FZNJH8*>?3%'Q5Q'%1QQ31333QQP
MM1[>[;[?[2XG%P/:^RVO'<+@C3'@V^*F'%2/?I2D5KK/MF=-;3ZS,SZI+;#C
M]AQ>UKL>-PXL&SI&E:8ZQ2L?J16(C]6?;/O>)=TY@
M
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MT_2X]9MC^V9B;XXB8_2:ZQ$PZ'[5(
M
M                                       "EW^5/HEOC^U_#[LVFC&\
M76W=>]K:)-)%9449>NWZZV34-@MJ+[(<4<276-CD[1EYM(>:N:8):KBKCCCF
M;GGFYK\++G<FX[5[O[9F<GRMIR&QW41-IG'KN\.XQ6FM/96\QLJ]=M-;5C'$
MZ]$:2X^FK>VR<9RO'?%TXL^')[?AURTO6=(]T_H8ZI]\=/V*H*UE)H
M   !TF?@SWG]_/BV\6;V:XP\F1UW#[_HV2M,/-Z_TW]S.U-XP.%M\I!5=WD]
MGF+S5K.PO9Z).:/<^[IFCCHAECIX\WOUQ<'^X/U1=TX:5S1M]QFVNYI;)'Y_
MWC8[;+DFD]-8MCKGMEQUF-=.B:6M:];2K\\R[+[EY(Y*D1?Y>2^+)$V]_P S
M#CM:8G2(FL7FU8T]G3I,S,2EI1.:P
M
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M^56D_JQIDC\FOY5O546BP
M
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M:^^8I6*XZS,S6E=9UTY;A96
M
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MRRHQ9U@
M
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M7J_3\=BM.OLZJY,V/2OI[JTK,QZSK.OLF(BQ&KR:'
M
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MVS$>[2>I9!5R-
M
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M<58B(B(TB(CTB(B/2(B/2(CV/XWV?H
M
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M$_+OZ:],^WHR1ZZTM.OI,UFU?B2*H[L"
M
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MWG$;S6>K)BW%-/=$8[8;1/\ 1^9.OZD+:ZII%\
M
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MYXX\Y_UY\[^[?U1=PTQY*9-KL:;+:TFL::?+V.WOEK:??:FXR9JS/Y-/9&J
MGFW>_?/)&_BMHMBPQAQUT_J<..;1/VS&2UX_H:>Y,:AXU0
M
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M4V\6B/AI[IR1&L6R_EFM/AUM> U/5NT
M
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M?#:9]*9=/28GV4R1$1:?AM%;=/7.&A$TX
M
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M&P
M                                                 "BK^4/MEWD/
M-?I+3.+FSFQ>L>,>"S<<$/$55W9YO;.T.S[?*17LM%=5=/NXO6,;)'%7Q3S1
M35Z^/KQ)QRO,_#!XG%M_"O-\STWKNMUW-EQS,Z]-L>#9;*:36/9Z7S9HFT:Z
MS'3[:IG?3CM:X^T-YN])C)DY&U=?=-:8<,QI_P"%>\3/]#W*TZR=(0
M   !U(_C2TZWT3X^/"[7K?C)45<^-/3^P7T.7XHIOK7,;EI6(W#.64D=%K9\
MP0V.9ST\,,=='NQ0T44255U\55U>7GZE.8R<[]0/>?(9/ES'\9>0Q5G'KTVQ
M[?<Y-OBM$S:VLVQXJVM,3TS:9FL5K,5BM[R%N[;WOKE\]NG_ .Z.>L=/LFN/
M);'6?;/MK6)F?9,ZS&D>C=]I)AP
M
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M?6*1/YUO2<DQK.E8K6L.:8;:X
M
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MK.E+SKTVO8C5Y-#@
M
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M>-I;<>.=SFCITP9\&2=?;I.2N+X?2?77)'V?#U>ONGH@//2@@
M
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MS7O$3[8BUIMI/ZFKVSI'#
M
M                       ?!VK:-<T?6-CW7<,WC=:U+3\#F-HVG8\S=Q6&
M'P&N:_C[C+9O-Y6^GJH@L\;BL9:2SSRU\\41Q1U5<\_3AS^+XOD><Y/;<+P^
M#)N>6WF?'@P8<=9MDRYLMXQX\=*QZVO>]JUK6/6;3$0^^VVVXWFYQ[/:4MDW
M66]:4I6-;6O:8K6M8CVS:9B(CWS+GE_,?\KN;^0#M"+1.K,ELF!\4>M[RJC4
M->O:JL;5V9M5K-?07';&S8?BWMKRW^XL[CBVPN/OJYI,=94U3<T6UU>W<%'H
M0^COZ5-EX![8GG>Z<>VW'E7DJ?WQEK\?W/!:*S&QPY-9K.EHZ]QEQQ6,V28I
M$Y,6'%>T[/$_C+#V/QOWWDJX[]S;B/CM'K\FDZ:8:6UF)TF-<EJZ1:WIK:M*
MS,)Z:C;X
M
M                    #[VJ[1L>C[/KFZZ?F\EK6VZ?GL/M&K;'AKN6PS&
MV/7\A;Y;"9O%7T%5$]GDL5D[2*>"6CGBN.6.FKCGZ\.#RG%\=SG&;GA>8P8]
MSQ.\P9,&?#DK%L>7#EI./)CO6?2U+TM:MJSZ369B7QW.VV^\VV39[NE<FURT
MM2]+1K6U+1-;5M$^V+1,Q,>^)="'X;_ENP_R Z-<]7=K?INN>576N!MK[9[6
MSHM;#"]L:Q!)#CY.QM5QT7-%.-R5M=2PQYW&1T<6]K<W,4]K]+:X^VL_/O\
M6)])F\\ \Y7NCM7YFY\6<EGFN&UNJV38YIB;QM,]YUZZ36+3M<TSUWI2V/+K
MDQ_,S06\L>+\O8V\CDN,ZLG;6XO,4F=9MAO/K\J\^^)C6<=Y];1$UM\5>J\X
M:$33@
M
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M\J[.-]X\Y;#-)OT[6<FD:Q^PVKEZO28_-Z.J?=,1I,3'HZ;CS.*[0
M
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MU'<.ZC8\!OM]:\XZX=GFO-HUUKT8[6ZHZ?BUC36-/7T]/5UEWE!5B
M
M                                                        *-'S
MS_+57W_MV4\.?&[<9I.B-'R55MV[N^L9>WEPG=^X6O./N8=?QMY90^_?]>]?
MY."6/FNFXJLLWEJ>9Z8Y;>SL+J>\/Z$/I-KV#Q&+S#Y'V<1WUOL>NPVV;',9
M.-V]NNLY;UM.E=WNJ36=)I&3;8)C'-JY,V?%297A3Q?'![6O=G<&*/W:S5UP
M8[UGJV])UCJF)]F7+&D^SJQT^'6+7O6M919@D0
M
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MV76^WRSI\>/7V6T]F2FL5O&D>NEHCIM5(JCNP(
M
M                                          !R_P#Y6-/M]&^1_P T
M,+;<9*F.][^WS<*N,KQ1Q=?<=AY+G?[OF+V[6TI_3:KK9J^;/^!S5S9\Q?6N
M3GZR5^G3Z5N8R<Y].79F]R_+ZJ<!M=O\&O3IM*?=:ZZVM\?3ACYGKI\SJTK6
M/ABQKQGN[;WL#B,UNG6-CCQ_#[-,4?*CWSZZ4^+^JU](]D1^M_LX
M ;%>(&U7&B^6GB[N]I:0W]UIOD5TGM5M8W%=<=O>W&O=EZSEX;2>2+ZR1PW$
MEGQ1553_  N*>>>>/VM=^7N*Q\[XF[HX3+><>+>=N\E@M:(B9K&79YL<VB)]
M)F(MK$3Z:NA[JVU=[VOR6SM,UKEV&XI,Q[8BV*]=8_4U=7AY4%98
M
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M(FLX1Y*W-]KV#R^7'$3:=AEIZ_9DK\NWLF/6*VF8_+IK$QZ.H,\Q"N0
M
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M2?W7OS[_ -;WA_\ Y_\ ='_#^?[SSP)^]'=_[5X[_.I_..[(_P %Y7^Q;?\
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M_G_W1_P_G^\\\"?O1W?^U>._SJ?SCNR/\%Y7^Q;?_*3^Z]^??^M[P_\ \_\
MNC_A_/\ >>>!/WH[O_:O'?YU/YQW9'^"\K_8MO\ Y2?W7OS[_P!;WA__ )_]
MT?\ #^?[SSP)^]'=_P"U>._SJ?SCNR/\%Y7^Q;?_ "D_NO?GW_K>\/\ _/\
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MQCN_NSCNR^&MSG*4SY-I7)6FF**VOK>=(]+WI73[?B_H2F,_NO?GW_K>\/\
M_/\ [H_X?T//]YYX$_>CN_\ :O'?YU:G_G'=D?X+RO\ 8MO_ )2?W7OS[_UO
M>'_^?_='_#^?[SSP)^]'=_[5X[_.I_..[(_P7E?[%M_\I/[KWY]_ZWO#_P#S
M_P"Z/^'\_P!YYX$_>CN_]J\=_G4_G'=D?X+RO]BV_P#E)_=>_/O_ %O>'_\
MG_W1_P /Y_O// G[T=W_ +5X[_.I_..[(_P7E?[%M_\ *3^Z]^??^M[P_P#\
M_P#NC_A_/]YYX$_>CN_]J\=_G4_G'=D?X+RO]BV_^4G]U[\^_P#6]X?_ .?_
M '1_P_G^\\\"?O1W?^U>._SJ?SCNR/\ !>5_L6W_ ,I/[KWY]_ZWO#__ #_[
MH_X?S_>>>!/WH[O_ &KQW^=3^<=V1_@O*_V+;_Y2?W7OS[_UO>'_ /G_ -T?
M\/Y_O// G[T=W_M7CO\ .I_..[(_P7E?[%M_\I/[KWY]_P"M[P__ ,_^Z/\
MA_/]YYX$_>CN_P#:O'?YU/YQW9'^"\K_ &+;_P"4G]U[\^_];WA__G_W1_P_
MG^\\\"?O1W?^U>._SJ?SCNR/\%Y7^Q;?_*3^Z]^??^M[P_\ \_\ NC_A_/\
M>>>!/WH[O_:O'?YU/YQW9'^"\K_8MO\ Y2?W7OS[_P!;WA__ )_]T?\ #^?[
MSSP)^]'=_P"U>._SJ?SCNR/\%Y7^Q;?_ "D_NO?GW_K>\/\ _/\ [H_X?S_>
M>>!/WH[O_:O'?YU/YQW9'^"\K_8MO_E)_=>_/O\ UO>'_P#G_P!T?\/Y_O//
M G[T=W_M7CO\ZG\X[LC_  7E?[%M_P#*3^Z]^??^M[P__P _^Z/^'\_WGG@3
M]Z.[_P!J\=_G4_G'=D?X+RO]BV_^4G]U[\^_];WA_P#Y_P#='_#^?[SSP)^]
M'=_[5X[_ #J?SCNR/\%Y7^Q;?_*3^Z]^??\ K>\/_P#/_NC_ (?S_>>>!/WH
M[O\ VKQW^=3^<=V1_@O*_P!BV_\ E)_=>_/O_6]X?_Y_]T?\/Y_O// G[T=W
M_M7CO\ZG\X[LC_!>5_L6W_RD_NO?GW_K>\/_ //_ +H_X?S_ 'GG@3]Z.[_V
MKQW^=3^<=V1_@O*_V+;_ .4G]U[\^_\ 6]X?_P"?_='_  _G^\\\"?O1W?\
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MX+RO]BV_^4G]U[\^_P#6]X?_ .?_ '1_P_G^\\\"?O1W?^U>._SJ?SCNR/\
M!>5_L6W_ ,I/[KWY]_ZWO#__ #_[H_X?S_>>>!/WH[O_ &KQW^=3^<=V1_@O
M*_V+;_Y2?W7OS[_UO>'_ /G_ -T?\/Y_O// G[T=W_M7CO\ .I_..[(_P7E?
M[%M_\I/[KWY]_P"M[P__ ,_^Z/\ A_/]YYX$_>CN_P#:O'?YU/YQW9'^"\K_
M &+;_P"4G]U[\^_];WA__G_W1_P_G^\\\"?O1W?^U>._SJ?SCNR/\%Y7^Q;?
M_*3^Z]^??^M[P_\ \_\ NC_A_/\ >>>!/WH[O_:O'?YU/YQW9'^"\K_8MO\
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M>\/_ //_ +H_X?S_ 'GG@3]Z.[_VKQW^=3^<=V1_@O*_V+;_ .4G]U[\^_\
M6]X?_P"?_='_  _G^\\\"?O1W?\ M7CO\ZG\X[LC_!>5_L6W_P I>)VK\:;Y
M&=>N+2'$9+QUWJ.XAKEFN]5[.V&SM["NBOT4V]W3N_7^FW5<TE/\*GF"*:/T
M_P"&KCG]CN^*_$G^G7D,=[[O%W%L;5F(BN?98K3:-/;7[MN]Q72/9/5:LZ^R
M)CU<S;?4)V#GK,Y:[_#,3[+X:S,_ECY>7)'_  S$_D:N[S\&?RDZ%]Q->^+.
M8V+'1YB7#VF1T;?NJ]T_4O1]W7!E+?"X#>+S:;/#WD%GS)1/>V%I[?KCCFIB
MFKICYV?P?UQ?2[SW33#W3AV^XG#&2U-SM=]M^C\W6DY,NVK@MDK-M)KCRWUT
MM:DVI6;,DV7F7QOO=(IR5,>3HZIC)BS8]/9K$VMCBDVB9TTK:VOK,:Q&J/'L
MSH+O;I:NB+N/I7MKJ:26:VMXX^S.N-QT.N2XO;>YN[."BC:<-BJJYKNULYI8
MJ>/X4D<5=5/'/%-7/$A>VN_>Q>]*S;L[FN)Y:L1:9G9[S;[J(BLQ6TS\C)?T
MK:U:VGV1-HB?689YQW-\+R\:\3O-KNHTF?T.7'D](F(F?@M;V3,1/V3,?:Q*
MRQV8              #=+P&\V>R? CR.U#O30:YLEB8)H<%V=HM5W7:8_L;K
M:_O;678]7N9?I)':9+V[>FZQ=[5'+Q892W@GJCFBID@ETQYZ\*=M^>?'.\[&
MYZ*X]W:LY=ENNGJOM-Y6MHPYZQZ3:FLS3/CB:_-PVR4BU+36]<1[W[/X_O;@
M,O#;[2N68ZL.336<66(GHO'VQZZ7KK'52;1K$S%HZ;G1_<_7WD1U'U_W=U7F
M/U[K_LO6['9]:R-<7-M<_:7?%5$]ADK3FJNJPS&(OX9;2]MZN>:K>[@DBJY^
MM'+S.=[]F=P>/.[>0[)[IP_(Y_C=S;#FIKK7JKZQ:EOUV/)6:Y,=X]+X[5M'
MI*N[F>(WW \IGX?DJ=&^V^2:7CVQK'LF)]];1I:L^^LQ/O948LZP
M
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MOA5KN=ODVFYR;7-I\W%>U+:>L:UF8G2?U8?><!\
M
M                         'S<SF,9KV'RN?S5[#CL-@\;?9C+9"XYYIM[
M#&8RUEO;^]GJIXJJXAM;6"NNKGCCGGTT\N3L]GN>0WF+8;*DY-YGR5QXZ1[;
M7O:*UK'Y;6F(C\LOIAQ9,^6N##$VRWM%:Q'MF9G2(C]67(;R.1R&7R%]ELM?
M7F4RF4O+G(Y+)9&YFO<AD<A>S5W-Y?7UY<URW%W>7=Q+5)++)557)75S55SS
MSSSR]<FWV^WVFWIM-I2F+:XJ5I2E*Q6E*5B(K6M8B(K6L1$5K$1$1$1$:+3,
M>.F*E<6*L5Q5B(B(C2(B/2(B(](B(](B/8_C?9^@        $SWX_>N9/.?*
MGX]Y.PIAJM=.P/=>QYKF6;B.NC&772>_ZC%5;T<\<\W$W.9VJTIYHX^G/$?-
M57^"GE#3Z_N1VVQ^EGN#;9YGYN\S\;AQZ1K$WKR6UW$Z_9'R\&2=?MTCWM2>
M<MQCP^--]COKU9;[>E?U8W&*_K]GPTM_1TAT9'G70(
M
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MK>;G=6UB8^9DM:(TUTZ:S/3736=(K$1&L_;+.3!W3
M                           .8[\O?]I?YD?SPY+^*L2],WTB_P"S5V=_
M ]/[9D6)^*_Y/.)_Q2/ZZR-](UGX       ">#\<?^TPU?\ F?[9_BFQ03_$
M7_V:MU_#&P_MEFEO/O\ )YD_QO!_72Z$3S\(+
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MP
M
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MS[9BN:]8UTB(UTCUTB/U&SC63'0
M
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M"_ H80E
M
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MUL7([B<7&S/IM\.M,6G]5&LVR?JY+6TGV1"29&YKX
M                             !S'?E[_ +2_S(_GAR7\58EZ9OI%_P!F
MKL[^!Z?VS(L3\5_R><3_ (I']=9&^D:S\       !/!^./\ VF&K_P S_;/\
M4V*"?XB_^S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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M#\N]C?Q*[GM]TKIPF]ZLN#[*>OZ3#[(_8IM'3[?T=\>MIMU)@40FJ@
M
M                                                        %-3\
MJW5;>SW?PKW>F[FKNMAU7O+59K&JBCBWM[?3<OU?E[:[BDX_QE4UY)O4M$E/
M/\&FF"CGC]O-2X[\*[E<F;A.].$FD1BV^ZXS/%M9UF=QCWN.U9CV:5C:UF)]
MLS:=?9"67TT;FU]GR^STCIQY=O?7WS.2N:LQ_0^7&GZLJE"V5*
M!TP_A?V/&;5\7_B!D\37-7:VO7N8UR7F>'F"OC)Z=ONW:CFJ*:*N>>:H:,S@
MYZ8Z_P#!)'Q35Q^SEYJ/K,X[<\7]3O=^VW<1&6W(8\T:3K'1N-KM]QC_ *,X
M\M9F/=.L>Y7GY;V^3;>1N5QY=.J<];^GV9,=+U__ $;1K]D^B3]&-KD
M
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MTQ&;ZE<^*O%<5MIG]-?<9K1&D^M:4I%IU]GI-Z^DSK.OIKI.ETI3$B,
M
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M9C]BQVU_,C6\Z1-KQ%IQQ8[5SM @
M                  .8[\O?]I?YD?SPY+^*L2],WTB_[-79W\#T_MF18GXK
M_D\XG_%(_KK(WTC6?@       )X/QQ_[3#5_YG^V?XIL4$_Q%_\ 9JW7\,;#
M^V6:6\^_R>9/\;P?UTNA$\_""P
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MWQ7MBRUFN6LS$Q,:3$QZ3$Q/K$Q/I,3[']CXOP
M
M                                        JR?E.ZO7=^/7BUNO&$AG
MBU_N;;-7KV.JUMZ[C%5[AI%66CPD5]53S=6\.?IT>J>N*CGB.:K&T55\<\Q1
M_2TC\+?E*XO(7='"_/FMMQPV#/\ )ZITO&WW/RYR37\V9Q?>8K%I]:QFF*^E
MK))_39N8KSO);/KF)OM*7Z-9TMT9.GJT]D]/S-(GVQUSI[94F%U:7X
M   #HE_CS[5<;#\7/3N(FM(;>/1=V[EU6TFBKKKKO[>\[,V+=ZKNXIK_ (,<
MU%UN4L'%-/\ !]N&GG_#SR\\?X@_%8^/^J#F-W2\VMOMEQ^>T3$:5FNRP[;I
MC[8Z=O6VL^NMICV1"!WG;;5P>2-WEB9F<V'!>?R3&&F/2/Z&.)_5F4VZ%#3P
M
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M32O3K:)GU+;KKWW$;+I_8\6XOKK[?F6Q5TTT]-/EZZZ^O5[(T];:*IU&
M
M                                                        !S3?
MF*\V_P#;A\UM]V_6LO\ J73G6'KZDZ6^VG]S&Y'4M7O[S]5W>U]OFB"Y_E#V
MFXO,I;W%44=S^DRV-M-]>;6GZ>D[Z/?"?^I'PML.(Y+#\OO'D]-_R.L:7IGS
MUKT;:VOK'W3!&/!>D6FGSZY\E-/FRL(\4=G_ ,3NT,&UW%.GEMS^GW&L>L7O
M$=..??'RJ16DQK,=<7M'YR*]*5LH         !G[QD\9.X_+WN/5NC.C-6FV
M?=]GFYDKKDYDML#J^!MI(:<ON&X9>F&>/!:K@HYZ:KFYJIKKJKKC@@CFNIH(
M)<!\F>3.SO$79VZ[X[XW4;7A-K&D1&ELN;+:)^7M]OCUB<N?+,3%*1,1$1:]
M[4Q4O>O2=Q=Q<3VMQ.7F>9RQCV>./U;7M/YM*5].J]M/2/U;6F*Q:T=%[XY/
MC&Z%^.SKN+'Z380[9W1LN!L,=VOW9E;>6G/;=<0W->1GQ.!LI[F[M]-TFVR$
ME/L8ZSYIJN*+:WDOI;NYAIGX\[?U%_4UWY]0_<,[CFLD[3LS;9[7V/&TF/E;
M>)CHC)EM$5G<;F:1/5FR:Q2;Y*X*X<5YH@3W]Y%YOOW?SDWEIQ<1CO,X=O6?
MAI&FG5:8B)R9)CVWM[-;12*UF823(W-?
M                        .8[\O?\ :7^9'\\.2_BK$O3-](O^S5V=_ ]/
M[9D6)^*_Y/.)_P 4C^NLC?2-9^        G@_''_ +3#5_YG^V?XIL4$_P 1
M?_9JW7\,;#^V6:6\^_R>9/\ &\']=+H1//P@L
M                            _&XM[>\MY[2[@ANK6ZAEM[FVN(J)[>XM
MYZ*HIH)X9::HYH9HZN::J:N.::J>>>.>/H_>/)DPY*Y<5IKEK,36T3,3$Q.L
M3$QZQ,3ZQ,>L2_M;6I:+5F8M$ZQ,>V)^V%+;YDO@IM^J,9M?ECX4Z]DKOK^W
MFR>R]P=#XZ*B\KZZL:^:KR_W+JFRM+6.ZEZ]Q]/%<F1PW/,\V$C]5Q:U<XRF
MN#&W._1U]<^3NO<[3Q1YIW&.G/VBF'C^4O,UC=V_-KM]]:UIK&[OZ1AW'PUW
M,Z8\L1N9B^YESXG\SVY/)B[8[OR5C?3$4P;F?3YL^R,>:9G3YL^RN3TC)/PV
M_2:6R53%J:3           "_[^.UYF7?D3X<2]&[ED?O>P_%*\Q6B6D]Q=13
M7N7Z?R]M<W'5]U)%5+3-1^ZT./O==HHHAXABQ^)LN>9*YI9.*:"OQ#?#>+QY
MYBCOCA\?1V]W52^ZM$5F*X^0QS6-[6)TTGY\WQ[N9FW5;+GSQ%:TI76#_GGM
M*O ]V1S.TKIL.3BV28B/2N>LQ&:/_#UKE]NLVO?TB(A8%0!:-
M
M                                                   5Z/R8]5N-
MA^.W6\O#=PV\>B^2W6NU7<,M%===_;WFG=GZ33:6]5'\&.:BZW&*?FJK^#[<
M-7'^'GA8/^&GRN/C_J'W.TO2;6WW;6\P5F)C2LUW&RW/5/VQT[>U=(]=;1/L
MB6]OIYW-<'?F3%,3,YN.RTC\DQDPY-9_H8YC]684%%]B;@         "^/\
MC#;17E_ KL[7+K-PWUUJ/E%NL%CAN;NWKO<'KF:ZUZERUE5S945?<VV-RFPR
MY:2&22GT33T7'%%7/,=7%-$GXF_%UVGGCC.1Q8)IBW?:^VFV3IF*Y<V/>;_'
M;XOS9O3%&"+1$ZUK..9B.J)F%?U%[:,7>VVW%:36N7C<<S;2=+7KESUGU]DS
M%>B)B/9'3K[86.U<[0(
M
M    " #\E#8\9@_C@IQE_7-3=;CW_P!7:YA>(H>9**\G:XW<]NEHN*^.>.+>
M'C#:K=U<5\_7CF3BFG_#5PGW^&YQVYWWU&_><$1\K9\!O<V36=)BEK[?;QI]
ML_,SXXT^S6?<WA]/NWR9N_\ YE-.G%L<U[?J3..GI]OQ7K_0UES_ !?PG$
M        O4_BZ8#$VWA'WCM$-IZ,[F/*C8L!DK[W[FK[G$ZWU)U#D<+:?;5S
M56</V5YM=_7[D<=,LGW'TDJJIHCXHHS_ !/]_N\GFS@^+O?78X>UL.6E=*^F
M3-O]_3);JTZIZJX,4:3,UCIUK$3:TS#'ZC\^6W>&SVTS^AIQE+1&D>EKY\\6
MG7V^L4KZ3.D:>FFLZV65;"/8
M
M                      "(3YO_ "XH\3_ ;LZK#92&Q[([TAGZ*Z^BCO+B
MURT%>[XK(0[ILF-YL>>+^UFUC1H;^6"]IJBCM<E+9\<R<221422Z^B3Q+;RM
MYZXR-YBF_;G!S')[N9K%L<QMKTG;X;]7PVC-N9Q5MCF+3?#&;2LUK>U=I^'>
MUY[G[WVT9JS;C]E,;G+Z1-9^7:/ETG7TGKR=,37UFU(OZ:1,QS>'HY3_
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M!W]W]RW?O+3O-Y,X^.QS,8,$3K7'6??/LZLEM(Z[Z>OI$1%8K6)#D>F!@
M                                                 .8[\O?]I?YD
M?SPY+^*L2],WTB_[-79W\#T_MF18GXK_ )/.)_Q2/ZZR-](UGX       ">#
M\<?^TPU?^9_MG^*;%!/\1?\ V:MU_#&P_MEFEO/O\GF3_&\']=+H1//P@L
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M\U:O0
M
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M]NM+TFWI^IDKI_1^Q:_53(R
M
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M%9C77IF:S;IF/=Z6BVGIZ6B?>G;06:7
M
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MF,-?9\RVD1;->-9UFVDQCU_,QS[(M>^LS*&S4H
M                               #F._+W_:7^9'\\.2_BK$O3-](O^S5
MV=_ ]/[9D6)^*_Y/.)_Q2/ZZR-](UGX       ">#\<?^TPU?^9_MG^*;%!/
M\1?_ &:MU_#&P_MEFEO/O\GF3_&\']=+H1//P@L
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M]]YL,5)IL<M_GX=?9./+K;2OOZ:7Z\4:^OP3K,^V9+4:VO0
M
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M&'ZEMKU['B-[U?L>7<4TT]OS*XK:ZZ^FGR]--/7J]L:>MS)3<B6
M
M                                     J1?E7[1D+34/";2XX;.K%Y_
M9.^=HO+BN.;G(19#4,9U-B<;#;2TW%-O19SV^\7=4]-<5==5<</-%='%-?$E
MM'X5W%[?+R_>O-6F_P!ZV^VXO!6(F.B:;B^_R7FT::S:)VV.*S%HB(F^L6F8
MFLH?IHVU+;KF-Y,S\VF/;4B/=I><]IU]-=8G'73U]\ZQ/II3:7%I8@
M   .DS\%V RVM_%3XEX[-6GV5Y<8?M+/PP^_;7'KQ.U]Z=G[1@+OW+2:>*G[
M_!9BVG]OFKB6+W/1)31)3513YO?KDW^TY+ZJ.[-QLK]>&N;98IG2T?I,'&;+
M!EKI:(GX<N.]==.FVG569K,3-?GF;/BW'DOE,F&=:1?#7V3'Q4V^&EH]=/9:
MLQK[)TUC6-)2THG-8
M
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M.*U^*N6T1=)4Q(C
M          .8[\O?]I?YD?SPY+^*L2],WTB_[-79W\#T_MF18GXK_D\XG_%(
M_KK(WTC6?@       )X/QQ_[3#5_YG^V?XIL4$_Q%_\ 9JW7\,;#^V6:6\^_
MR>9/\;P?UTNA$\_""P
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M8:Q\S!EG!DGUUFF2.O',^[2EZVCW3KECVQ[+J"E]$4
M
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M^L6F8FL>?J0VU+=I;+>3,_-IR,4B/=I?#FM.OIKK$XZZ>OOG6)]-+SRCE#,
M
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MU^W';Y=O9,^DVK,Q^336(GT;^M!L'
M
M                           0)?D:=]R]2?'CE.O,9=>QG?(GLC3>M/\
M)[J[M,E;:I@[B;LG:K^UDM+JU]5G<_N;9XB]CD]V.:US%<54?--?-5$\OPZN
MPZ]V_4+B[AW5.K8]N\;N-YZUK:DY\L1L\%;1:MOBK]XR;C',=,UOMXM%HFL1
M.[/ ?"1RG?==_DC7#L-ODR^L1,3>T?*I$ZQ/K'S+7K,:3$TB=?3UY]3T IS
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MO.:Y//RW(6Z][N<MLEY]W5:9F8B/=6/96OLK6(B/2&2&..O
M                                          <QWY>_[2_S(_GAR7\5
M8EZ9OI%_V:NSOX'I_;,BQ/Q7_)YQ/^*1_761OI&L_        3P?CC_VF&K_
M ,S_ &S_ !38H)_B+_[-6Z_AC8?VRS2WGW^3S)_C>#^NET(GGX06
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M.K-EVUII&DSKDIIDQ>D1,_LE*^R)G[(F?1U-GEP5M
M
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MX_G)DC6^+>X;5]9]+3%Z:^GM^&]HTG6/77VQ$QT"E B#@
M
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M([F\1/MB+9KVTG]35LLUJQX
M
M                    !1M_*%[I_>WRJZ*Z-M)_?QW373]_M=[_ (OVOL]M
M[@V+_P :6'^-Q5M/<>G5NO,%<>[1=W5MS]S[=%$,T=Q[EX'X879?[D^+.=[X
MS5Z=QS/,4P5]=>K!Q^'X+^EYB/T^[W-.F<=+_!U3-Z6Q],R?IQXC[KVUO>9M
M&F3=[N*1^6F"OI/YTQ'QY<D:=,3Z:S,Q-=*QZS-(D        !<]_&'\0?T#
M0^V_-7;<99\Y'?KRKI_J"6:/UY"RU/6KRG(=E9^"3B26"FSV?::;#&Q?LCN8
MJ\!=<<\<PW%'-5-'XFWE[[_SO$^%^)RW^[["G[H;^(GX+9\U>C9XIC2)ZL.#
MYN:WMI:-UBT^/',1$GZB^ZOG[W:]H;6T_+P1\_/]DWO&F*L_EI3JO/MB?FU]
M]96Q54:,8
M    #F._+W_:7^9'\\.2_BK$O3-](O\ LU=G?P/3^V9%B?BO^3SB?\4C^NLC
M?2-9^        G@_''_M,-7_ )G^V?XIL4$_Q%_]FK=?PQL/[99I;S[_ ">9
M/\;P?UTNA$\_""P
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M+,QI,[C-/,3
M
M            <C+LO5;?1>QM_P!)M+J:_M=.W;:M5MKZXHHCN+RWU[.W^(AN
MIXXO\7'-<1VG%=5-/\'BKGGCC]CUL]M<KDYWMSC^;RTC'EWFRP9[5B9F*SEQ
M5R36)GUF(FVD3/KHM&X[<VWO'X-Y:(K;+AI>8CV1-JQ;2/U-7BG=.8
M   F2^ 3,9/&?*UXUV5A>36MKL.-[OP^:@BYXXHR.,@Z#[-S\5G<<<\<\\PT
M9G!VEQQQQ].?<@I_Y/KQS#KZ^=GMMS]*O<F;/2+9=ODXW)CF?;2\\ILL4VC\
MLX\N2GZEI:G\X8L>3QGR%[Q$VQVV]J_DG[SAKK'_ (-K1^I,NC@\Z* H
M
M                                         "@#^2IM&0V#Y'+7$WD-
MG%;:/X]]8:OB:[:.>B>XQ]WF=YW62;(U2W$T<MY3E=PN8Z:HJ8:.+>B*GFCF
MNFNNN_;\-KB]OQ_TZ7W>&;SDWW<&]SY(M,3$7KCVVVB*:1$Q7HV])F)FT]<V
MG728K6</T^;:F#L&<M)F;9M_FO;7W3%<>/T]/9TTB?77UF?732(K]I^MX@
M       .N-U7J^0T?K#KC2LM-9W&5T_0]0U?)W&.DGEQ\^0U_7L=B;R:QEN;
M>TN9;.6YM*JHJI(HJZJ.>.:J*>?KQQY*NZ>4V_-]S\CS6TB]=KO-_N,](O$1
M>*9<M\E8M$3:(M$6B+1%K1$ZZ3,>JKKDMS3><CN-YBB8Q9<][Q$^V(M:;1KI
M,QKI/KI,_JO>.A<(
M
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M;W'S>X[CY[=\YNOV;<Y[7T_I:S/P5C\E*16L>LSI'K,SZL\,$=*
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M4-Q?W/O?'R%*Q&/>;+':9](UOCFV.8G3UG2E<?K;W3%8G2ND6(U>;0X
M
M                                                       #E,^;
M&KX_1_,SRXTK$S7EQBM/\G.^]7QEQD9()<A/C]?[4VO$V<U]+;6]I;2WDMM:
M4U2U1Q1455\\\TT4\?3CCU3^%>4W'-^&^TN:W<4KNMYVSQ>>\4B8I%\NQP9+
M16)FTQ6)M,5B;6F(TUF9]5F'9^YOO.TN+WF6(C+EX[;7F(]D3;#2TZ:S,Z:S
MZ:S/ZK6-LQD0        "3+X;LQD\'\G/AY>XF]FL+J?L^?#RSP<\<5UXS8=
M2V3 9JRJYJXJX]G(X;)SV\G'^'F.6KZ?3G]J-/UB[/;;[Z9>\,.[I&3%7C(R
M1$^R+XL^'+CM^K3)2MX_+6&O/+&+'F\=<K3+$6K&VBWK]M;TM6?Z%HB8_+#I
MH/-$KP
M                                                    <ZW\A+:_
MWB^4GNO$?8?9_N'I_3.J?<?=?<?JOWG56J[S]_[/VT'V/M_OG]K[7JF^OVWN
M>OCW/;H]#_X?7%?N=]+O"[SYG7]_WG(Y].G3HZ=]GVW1KK/5K]WZ^K2OY_3I
M\/5:>?@K:_=_&^SR]6OS\NXOIIITZ9KX]/;Z_L>NOI[=-/3683TU&WP
M   'W=5US)[CL^N:CA:8:\SM6>P^N8FBXFXM[>O)YS(6^,L*9YZN.:8(:KJZ
MHXJKYXYXII^O/_(X/*<CMN'XS<\OO9F-GM<&3-DF(UGHQ4F]M(]\]-9TCWR^
M.YW&/:;;)NLVORL5+7MIZSI6)F=(_4AUY7D:59@
M
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MU_Y36V2)T]UL-,M?72/73UUTGHU/.H@.
M                             YCOR]_VE_F1_/#DOXJQ+TS?2+_LU=G?
MP/3^V9%B?BO^3SB?\4C^NLC?2-9^        G@_''_M,-7_F?[9_BFQ03_$7
M_P!FK=?PQL/[99I;S[_)YD_QO!_72Z$3S\(+
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MZ>GZ2M+Q$V^W]%;ICW_%,>R5SY30B2
M
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MMQV+S&/-&M(XS<V]LQ\5,5[UGTT]EJQ.GLG32=8UAU*GEV5N
M
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MR(C%:9F?U(=9%Y1%8P
M
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M6F7/:-8U^*:X\?I[8CX<GK[+>[\V5NE4BBV
M                                YCOR]_VE_F1_/#DOXJQ+TS?2+_LU
M=G?P/3^V9%B?BO\ D\XG_%(_KK(WTC6?@       )X/QQ_[3#5_YG^V?XIL4
M$_Q%_P#9JW7\,;#^V6:6\^_R>9/\;P?UTNA$\_""P
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MU36)TE]0&TC<^/K9IK:?N^]PY-8UTKKUXM;?D_2=/KZ=4U]^CH(* 4&@
M
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MV(MBO6=-8F-=)]-8G]1U?WE-5E
M
M            .8[\O?\ :7^9'\\.2_BK$O3-](O^S5V=_ ]/[9D6)^*_Y/.)
M_P 4C^NLC?2-9^         W ^/3_P"#[\'?_AP/&C_VT:4U#]0?\@G?'_WH
M<S_\.W+%>^__ *$<S_!6[_\ 1\CJA/+4K7
M
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MOGS?SN_(>7;S,S]UVN#%II$::UG-I$^_]FUUG6=9F/9$0G;06:7
M                                                <QWY>_[2_P R
M/YX<E_%6)>F;Z1?]FKL[^!Z?VS(L3\5_R><3_BD?UUD;Z1K/P       $\'X
MX_\ :8:O_,_VS_%-B@G^(O\ [-6Z_AC8?VRS2WGW^3S)_C>#^NET(GGX06
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M28_HQ72/RRZ5CS:*^
M
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M%Z1,^R)M6:QKI$SIK/KI$_J.N.\E*KH
M
M                !RO?D+_^#[\XO_AP/)?_ -M&ZO4K]/G\@G8__P!Z'#?_
M  [;+*.Q/_H1PW\%;3_T?&T_;>94         D:^(NWM[KY+/#:.Y@AN(Z>Y
M\)<4QSQ42T4W%I99*[M)Z:)*:J>)K6ZAHECJ_P"=1)135QSQSQQRCK]6^3)B
M^FSO&V*TUM/#9(UB9B=+6I6T>GNM69K,>R8F8GTE@/E*UJ^/>6FLS$_=+1Z?
M9,Q$Q_1CTG\CIT/,LKK
M
M                 08?D5YC)XSXQNP+*PO9K6UV'L_J'#YJ"+GCBC(XR#;8
M<_%97''/'//,-&9P=I<<<<?3GW(*?^3Z\<SC_#OV>VW/U-<?FSTBV7;\9O\
M)CF?;2\X)Q3:/RSCRY*?J6EN;P+BQY/(N"]XB;8]MGM7\D]'3K'_ (-K1^I,
MN>8]""=@        #IA_"_KF,U7XO_$#&8FB:BUNNO<QL<O$\W,]?.3W'?=N
MV[-5TUU<<<TPUYG.3U1T?X(X^::>/V</-1]9G([GE/J=[OW.[F)RUY#'AC2-
M(Z-OM=OM\?\ 1C'BK$S[YUGWJ\_+>XR;GR-RN3+IU1GK3T^S'CI2O_Z-8U^V
M?5)^C&UR
M     YCOR]_VE_F1_/#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO^3SB?\4C^NLC?
M2-9^        G@_''_M,-7_F?[9_BFQ03_$7_P!FK=?PQL/[99I;S[_)YD_Q
MO!_72Z$3S\(+
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M0
M
M '/=_(X_M,-H_F?ZF_BF^>@?\.C_ &:MK_#&_P#[95.GP%_)YC_QO/\ UT('
MT[&Z0         '7\M[BWO+>"[M)X;JUNH8KBVN;>6B>WN+>>BF6&>":*JJ.
M:&:.KBJFJGGFFJGGCGCGZ/(?DQY,.2V++6:Y:S,6K,3$Q,3I,3$^L3$^DQ/K
M$JKK5M2TUM$Q:)TF)]L3]DOV?A_
M
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M^FFL:ZQTLGFQ5[@
M
M            ('OR.?[-#9_YX>IOXUOT[/PZ/]I7:_P/O_[75NKP%_*'C_Q3
M/_6PY[ST#IT         .G#\0?\ 9G^''\S^._C;+O,U]77^TKWC_#%_[7C5
MV>5/Y0^6_P ;G^MJDA1Q8
M                   YCOR]_P!I?YD?SPY+^*L2],WTB_[-79W\#T_MF18G
MXK_D\XG_ !2/ZZR-](UGX       ">#\<?\ M,-7_F?[9_BFQ03_ !%_]FK=
M?PQL/[99I;S[_)YD_P ;P?UTNA$\_""P
M                            "A[^4)_\'WU#_P#"?Z!_[:/(!>Q^&'_(
M)R__ -]^Z_\ AW%)I_3C_P#0C=?PKE_]'VRM^L;;_        ;@?'I_\'WX.
M_P#PX'C1_P"VC2FH?J#_ )!.^/\ [T.9_P#AVY8KWW_]".9_@K=_^CY'5">6
MI6N
M
M    H>_E"?\ P??4/_PG^@?^VCR 7L?AA_R"<O\ _??NO_AW%)I_3C_]"-U_
M"N7_ -'VRM^L;;_          =:'QY_^<#T;_,]UG_\ ,7A'D[\@_P#T^YS^
M&-Y_Z3D5A<[_ /=S>?XWF_MEF86(.J
M
M               <ESR%_P#G^]X?SP=E_P#S:9IZQ/'W_P! >#_@?9_^C8UG
MO!?_ '#V?^*8?[75B!E[M0        $P'P)?VL?BE_\ 9T_^UL[B1"^O+_91
M[J__ #9_\8X]JOS9_)CR?_Y/_P"EX'2"><E $
M
M                                  !!)^1I;W$_QF[?+#!--'9]M]27
M%W)%%7)1:V]6=N+2F>XKHIYI@AJNKJ*+BJKZ4\R24T_7ZU<<<SI_#JR8Z?4M
MLZWM$6OQ._BL3,1-I^5%M(^V>FMK:1ZZ1,^R);H\!VK'D/%$S$3.USQ'Y9Z8
MG2/Z$3/ZD2Y[#T%)U         .F?\-V8QF<^,;P\O<3>0W]K!UC<8>6>#GG
MFBC)Z]MVRX#-6=7-7%//O8[,XR>WDX_P<215<<?7C]KS1?6+L]SL?J:[PP[N
MDX\MN3C)$3[9IEP8<N.WZE\=ZWC\EH5X>6,63#Y%Y6F6)K:=S%O7[+4I:L_T
M:S$Q^24F:-+7@
M         #F._+W_ &E_F1_/#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO^3SB?\
M%(_KK(WTC6?@       )X/QQ_P"TPU?^9_MG^*;%!/\ $7_V:MU_#&P_MEFE
MO/O\GF3_ !O!_72Z$3S\(+
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M&NKI0/-TK[
M
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M99K5CP
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MRUH\>98B9B)W6")_+'5,Z3_1B)_5B'0H>?5!4
M
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M0\\;*VU\C;G//5IN<&#)&L:1I&.,/P_;&N*?7^FZH]R<-")IP
M                                             !S'?E[_ +2_S(_G
MAR7\58EZ9OI%_P!FKL[^!Z?VS(L3\5_R><3_ (I']=9&^D:S\       !/!^
M./\ VF&K_P S_;/\4V*"?XB_^S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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MHBI]1W<\6ML^T=O/YO\ ?.;28]L]6/%6??$Q'S+36=/2:6TGTF+>JHM%@
M
M                                                         !2=
M_*>_^?\ >*W\SVY?_-I$NI_"V_\ H#W5_#&W_P#1I2^^FS_[A\G_ (WC_M:J
M^M*24          =4+X]/_@!/!W_ .$_\:/_ &+Z4\M7U!_R]]\?_??S/_Q'
M<JU^^_\ Z;\S_"N[_P#2,C<!J%BH
M
M            #C^O7FM2          3S?CA6]Q/\EFORPP331V?3/;%Q=R11
M5R46MO58XJTIGN*Z*>:8(:KJZBBXJJ^E/,DE-/U^M7'',$/Q&<F.GTV;BM[1
M%K\SL8K$S$3:>K);2/MGIK:VD>ND3/LB6E//UJQX]O$S$3.[PQ'Y9UM.D?T(
MF?U(ET''G[08
M
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MOHY/C.:K6?TN#)@M/KI'RKQDI$S^;&OSKS7V3.EM=8B-+7ZJ9&0
M                                               !S'?E[_M+_,C^
M>')?Q5B7IF^D7_9J[._@>G]LR+$_%?\ )YQ/^*1_761OI&L_        3P?C
MC_VF&K_S/]L_Q38H)_B+_P"S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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MW,S,-=2
M
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MX8TI.]R6]LS\5YZ[3ZZ^VUIG3V1KI&D:0D)1]8*
M
M                       Q)W]<7%GT3W7=VD\UK=6O4G8]Q;7-O+7!<6]Q
M!IV9EAG@FBJIDAFADIXJIJIYXJIJXXYXY^K+.PL>/-WUPN++6+8K<MLXM68B
M8F)W&.)B8GTF)CTF)])AVG!UK;FMG6T1-9W6*)B?9,?,KZ2Y+#UCK/@
M    %D#\7O\ ^#[[>_\ A/\ ?_\ VT>/ZN3\3S^03B/_ +[]K_\ #N5: ^H[
M_P"A&U_A7%_Z/N5\)1.A8
M
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M>.$CE>P<N\I&NXV&?'GC2(UFLS\J\:Z:]/3DZ[1$QK\N)]=-'0N>?)!0
M                                                    !S'?E[_M
M+_,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_%?\GG$_XI']=9&^D:S\       !
M/!^./_:8:O\ S/\ ;/\ %-B@G^(O_LU;K^&-A_;+-+>??Y/,G^-X/ZZ70B>?
MA!8
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M+=^\M.\WDSCX[',Q@P1.M<=9]\^SJR6TCKOIZ^D1$5BM8D.1Z8&
M
M                                                     I_?E<__
M *!7_P"M)_\ LZ+>OPJ?_P"O/_S)_P#S=*GZ9O\ ^-__ )'_ /O2G\MY2I
M        =.'X@_[,_P ./YG\=_&V7>9KZNO]I7O'^&+_ -KQJ[/*G\H?+?XW
M/];5)"CBP
M                                                     !A[R&_^
M<#WE_,]V9_\ ,7FV7^/O_I]P?\,;/_TG&[7@O_NYL_\ &\/]LJY+SUB+/0
M       %D#\7O_X/OM[_ .$_W_\ ]M'C^KD_$\_D$XC_ .^_:_\ P[E6@/J.
M_P#H1M?X5Q?^C[E?"43H6
M
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MF8G5DYC+K@
M     ',=^7O^TO\ ,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_%?\GG$_XI']=9
M&^D:S\       !/!^./_ &F&K_S/]L_Q38H)_B+_ .S5NOX8V']LLTMY]_D\
MR?XW@_KI=")Y^$%@
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M>Z(948LZP
M
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M9B<N._K]N3!BR3']";:1^2$JZ*[6@
M
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M-Y^W6F*\5]?U,EM?Z'V+P"D=#H
M
M                        !1#_ "<.EKC2?-/K;N6UMIJ,'WATSC;>XO)8
M:Z:+C=^K\O>:]GH+:XCQ5I9RPVNGY;6ZN::KJ[NZ)):N9.(H*K6GF]7\,WO3
M'S7A?DNSLMHG?<)S-YBL3&L;;>XZY<4S$WM:)MN,>\]8ICQS%8Z>N\99B:7T
M[<O7>=H[CB;3'SMGNYF(^S'FK%JS,=4SZWKE]U:Z1&FLQ96Y6/)
M +R/XSGEY_*5X[]@>).T7GJVGQ[S%.V:)5<WWN3Y7JKL/(WUU>6%G9SW$]U5
M^X^]477W,M/$=O1;YVPBHHXJHKJKH_\ Q+/$?\6O(?'^6>,IIQ?<&'Y&ZTKI
M%-]M*5K6]K1$5_OG;33HK.MYOM<]YG2:Q$-OJ&[6_<_GL'=&VC^]M]3HR:1^
M;FQ1$1,SI$?I,>FD>LZX[S,Z3$19Q5F([
M                             .8[\O?]I?YD?SPY+^*L2],WTB_[-79W
M\#T_MF18GXK_ )/.)_Q2/ZZR-](UGX       ">#\<?^TPU?^9_MG^*;%!/\
M1?\ V:MU_#&P_MEFEO/O\GF3_&\']=+H1//P@L
M
M
M                                                JN_E/_\ S@O%
M7^>#<_\ YBX5I7X6W_T^[J_@?;_^DRDI]-G_ -W.3_Q3'_;%)]=2E\
M    Z0/P)?V3GBE_]G3_ .V3[B><GZ\O]J[NK_\ -G_P?CT O-G\IW)__D__
M *)@3 HA-5
M                                                      -/_D+_
M /@!/.+_ .$_\E__ &+[JV]]/G\O?8__ -]_#?\ Q';,J[$_^F_#?PKM/_2,
M;E>O4JLH          6H/Q8?_G_>5/\ ,]IO_P VDJK7\4G_ .@/:O\ #&X_
M]&A&OZD__N'QG^-Y/[6NQ*5D00
M
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MCJI>MJVTF?6)5R;O:[C8[K+L=Y2<>[PY+4O6?;6])FMJS^6+1,3^H](ZUQP
M                                                     ',=^7O^
MTO\ ,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_%?\GG$_XI']=9&^D:S\
M !/!^./_ &F&K_S/]L_Q38H)_B+_ .S5NOX8V']LLTMY]_D\R?XW@_KI=")Y
M^$%@
M
M
M             %5W\I__ .<%XJ_SP;G_ /,7"M*_"V_^GW=7\#[?_P!)E)3Z
M;/\ [N<G_BF/^V*3ZZE+X         !T@?@2_LG/%+_[.G_VR?<3SD_7E_M7
M=U?_ )L_^#\>@%YL_E.Y/_\ )_\ T3 F!1":J
M
M                     :?_ "%__ "><7_PG_DO_P"Q?=6WOI\_E[['_P#O
MOX;_ .([9E78G_TWX;^%=I_Z1C<KUZE5E          "U!^+#_\ /^\J?YGM
M-_\ FTE5:_BD_P#T![5_AC<?^C0C7]2?_P!P^,_QO)_:UV)2LB"
M
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M6I:+1K$3I/K$2LTVVYP;S;8]WMK1?;9:5O2T>RU;1%JS&OKZQ,3ZO@N<^P
M      "YO^-[\BMOLNN77Q_]KYJ;G:M9AS.V^.N7RV3HFYSVHPQ2Y7<.JK:B
M\EHNOU+3J8Y\UBX8>;CW<17?T\TVT.,BXFIK_$<^G?)QO(T\^]J8(_<K<SCP
M<OCQTT^5GF8IM]]::QT]&XUKM\]K='3GC!.N2^YMT1*\_P#85MON([XXRD?=
MLDUINJUC\V_YN/-.GIID],=YG32_1^=.2=+9:J!&(
M                                   !S'?E[_M+_,C^>')?Q5B7IF^D
M7_9J[._@>G]LR+$_%?\ )YQ/^*1_761OI&L_        3P?CC_VF&K_S/]L_
MQ38H)_B+_P"S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
M
M
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MW]#24SZ&;4@
M                                                      #3_P"0
MO_X 3SB_^$_\E_\ V+[JV]]/G\O?8_\ ]]_#?_$=LRKL3_Z;\-_"NT_](QN5
MZ]2JR@         !:@_%A_\ G_>5/\SVF_\ S:2JM?Q2?_H#VK_#&X_]&A&O
MZD__ +A\9_C>3^UKL2E9$$
M
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M9EUOM\DZ?'C]-:SZSI?',]%M=)GTOI$6A) CBP
M                                !S'?E[_M+_,C^>')?Q5B7IF^D7_9
MJ[._@>G]LR+$_%?\GG$_XI']=9&^D:S\       !/!^./_:8:O\ S/\ ;/\
M%-B@G^(O_LU;K^&-A_;+-+>??Y/,G^-X/ZZ70B>?A!8
M
M
M                                                    !6^_*$_^
M $ZA_P#AP- _]B_D L;_  P_Y>^7_P#O0W7_ ,1XIO\ ^G'_ .F^Z_@K+_Z1
MME#Y>PFF          Z$/XXW]FAK'\\/;/\ &M@\_'XB_P#M*[K^!]A_:[(+
M^??Y0\G^*8/ZV4\*";2H
M
M   #3_Y"_P#X 3SB_P#A/_)?_P!B^ZMO?3Y_+WV/_P#??PW_ ,1VS*NQ/_IO
MPW\*[3_TC&Y7KU*K*          %KC\5K 9:Y[?\O-HAM/7@L/UOUC@,E?>_
M;4_;9;9-GV;(X6T^VKFIO)OO;/5+^OW(XZHH_M_I)5357'Q753^*9O\ :8^T
M>T>+O?3?9N2WN6E=+>N/#APTR6ZM.F.FV?%&DS%IZM:Q,5M,1F^I7/BKQ7%;
M:9_37W&:T1I/K6E*1:=?9Z3>OI,ZSKZ:Z3I=*4Q(C
M
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MQ7YW7VIS'9O,7X?F*=.6OK2\:]&6FOIDQS[ZS_PUG6MHBT3#:AJQC0
M                                              #F._+W_:7^9'\\
M.2_BK$O3-](O^S5V=_ ]/[9D6)^*_P"3SB?\4C^NLC?2-9^        G@_''
M_M,-7_F?[9_BFQ03_$7_ -FK=?PQL/[99I;S[_)YD_QO!_72Z$3S\(+
M
M
M
M     *WWY0G_ , )U#_\.!H'_L7\@%C?X8?\O?+_ /WH;K_XCQ3?_P!./_TW
MW7\%9?\ TC;*'R]A-,         !T(?QQO[-#6/YX>V?XUL'GX_$7_VE=U_
M^P_M=D%_/O\ *'D_Q3!_6RGA03:5
M
M            :?\ R%__   GG%_\)_Y+_P#L7W5M[Z?/Y>^Q_P#[[^&_^([9
ME78G_P!-^&_A7:?^D8W*]>I590          N _BC?\ Z>O_ .JW_P#M%JAO
MQ5O_ .@__P ]_P#\H16^IG_^"?\ Y9_^ZK@*H5%8
M
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MB5C'CONVG>G:>VYF9C[]$?+SQ'ZW/2(B_I'I$7B:Y:Q[J7K$^NK0-OQFX
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ME_F1_/#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO^3SB?\4C^NLC?2-9^
MG@_''_M,-7_F?[9_BFQ03_$7_P!FK=?PQL/[99I;S[_)YD_QO!_72Z$3S\(+
M
M
M
M          *WWY0G_P  )U#_ /#@:!_[%_(!8W^&'_+WR_\ ]Z&Z_P#B/%-_
M_3C_ /3?=?P5E_\ 2-LH?+V$TP         '0A_'&_LT-8_GA[9_C6P>?C\1
M?_:5W7\#[#^UV07\^_RAY/\ %,'];*>%!-I4
M
M                   !I_\ (7_\ )YQ?_"?^2__ +%]U;>^GS^7OL?_ .^_
MAO\ XCMF5=B?_3?AOX5VG_I&-RO7J564          +@/XHW_P"GK_\ JM__
M +1:H;\5;_\ H/\ _/?_ /*$5OJ9_P#X)_\ EG_[JN JA45@
M
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MI^?&N.WI\46MT1,.A^U2
M           YCOR]_P!I?YD?SPY+^*L2],WTB_[-79W\#T_MF18GXK_D\XG_
M !2/ZZR-](UGX       ">#\<?\ M,-7_F?[9_BFQ03_ !%_]FK=?PQL/[99
MI;S[_)YD_P ;P?UTNA$\_""P
M
M
M                                 "M]^4)_\ )U#_\ #@:!_P"Q?R 6
M-_AA_P O?+__ 'H;K_XCQ3?_ -./_P!-]U_!67_TC;*'R]A-,         !T
M(?QQO[-#6/YX>V?XUL'GX_$7_P!I7=?P/L/[79!?S[_*'D_Q3!_6RGA03:5
M
M                                           :?_(7_P# "><7_P )
M_P"2_P#[%]U;>^GS^7OL?_[[^&_^([9E78G_ --^&_A7:?\ I&-RO7J564
M        +@/XHW_Z>O\ ^JW_ /M%JAOQ5O\ ^@__ ,]__P H16^IG_\ @G_Y
M9_\ NJX"J%16
M
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MTZJ7K,UO'Y:S.GLG2?1L4UVZ$
M             !S'?E[_ +2_S(_GAR7\58EZ9OI%_P!FKL[^!Z?VS(L3\5_R
M><3_ (I']=9&^D:S\       !/!^./\ VF&K_P S_;/\4V*"?XB_^S5NOX8V
M']LLTMY]_D\R?XW@_KI=")Y^$%@
M
M
M                                    %;[\H3_X 3J'_P"' T#_ -B_
MD L;_##_ )>^7_\ O0W7_P 1XIO_ .G'_P"F^Z_@K+_Z1ME#Y>PFF
M   Z$/XXW]FAK'\\/;/\:V#S\?B+_P"TKNOX'V']KL@OY]_E#R?XI@_K93PH
M)M*@
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MG=$\
M
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M:S,3$QI,3'I,3$^L3$^DQ/L?V/B_
M              #F._+W_:7^9'\\.2_BK$O3-](O^S5V=_ ]/[9D6)^*_P"3
MSB?\4C^NLC?2-9^        G@_''_M,-7_F?[9_BFQ03_$7_ -FK=?PQL/[9
M9I;S[_)YD_QO!_72Z$3S\(+
M
M
M                                 *WWY0G_ , )U#_\.!H'_L7\@%C?
MX8?\O?+_ /WH;K_XCQ3?_P!./_TWW7\%9?\ TC;*'R]A-,         !T(?Q
MQO[-#6/YX>V?XUL'GX_$7_VE=U_ ^P_M=D%_/O\ *'D_Q3!_6RGA03:5
M
M                                        :?\ R%__   GG%_\)_Y+
M_P#L7W5M[Z?/Y>^Q_P#[[^&_^([9E78G_P!-^&_A7:?^D8W*]>I590
M    M0?BP_\ S_O*G^9[3?\ YM)56OXI/_T![5_AC<?^C0C7]2?_ -P^,_QO
M)_:UV)2LB"
M
M             J:?D1?&%7MN'R'G[T?@(>=AUC&VMMY)ZSBK2WAES>K8VUDM
M[#N/BNN_AJN,EJUK;VV.RT,-O-+-CN8;NKFBBRN:Y+7_ ,//ZG*\3O,?@/O?
M<6_<_=9+3P^:]IF,>>]HFW'_ )LZ4SVF^7!:UZUKFZ\4=4Y\<5D[X'\C1M<M
M>Q^9O/R,EIG:7M,_#>9UG![/2+S,VI,S$1?6OK-ZQ%,A<HEJ
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M]B?_ #<_FS?^^_\ H?\ ZT?WKG_H%?\ 6D_[.A_NJ?\ Z^?]B?\ S<_FS?\
MOO\ Z'_ZT?WKG_H%?]:3_LZ'^ZI_^OG_ &)_\W/YLW_OO_H?_K1_>N?^@5_U
MI/\ LZ'^ZI_^OG_8G_S<_FS?^^_^A_\ K1_>N?\ H%?]:3_LZ'^ZI_\ KY_V
M)_\ -S^;-_[[_P"A_P#K1_>N?^@5_P!:3_LZ'^ZI_P#KY_V)_P#-S^;-_P"^
M_P#H?_K1_>N?^@5_UI/^SH?[JG_Z^?\ 8G_S<_FS?^^_^A_^M']ZY_Z!7_6D
M_P"SH?[JG_Z^?]B?_-S^;-_[[_Z'_P"M']ZY_P"@5_UI/^SH?[JG_P"OG_8G
M_P W/YLW_OO_ *'_ .M']ZY_Z!7_ %I/^SH?[JG_ .OG_8G_ ,W/YLW_ +[_
M .A_^M']ZY_Z!7_6D_[.A_NJ?_KY_P!B?_-S^;-_[[_Z'_ZT?WKG_H%?]:3_
M +.A_NJ?_KY_V)_\W/YLW_OO_H?_ *T?WKG_ *!7_6D_[.A_NJ?_ *^?]B?_
M #<_FS?^^_\ H?\ ZT?WKG_H%?\ 6D_[.A_NJ?\ Z^?]B?\ S<_FS?\ OO\
MZ'_ZT?WKG_H%?]:3_LZ'^ZI_^OG_ &)_\W/YLW_OO_H?_K1_>N?^@5_UI/\
MLZ'^ZI_^OG_8G_S<_FS?^^_^A_\ K1_>N?\ H%?]:3_LZ'^ZI_\ KY_V)_\
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MN?S9O_??_0__ %H_O7/_ $"O^M)_V=#_ '5/_P!?/^Q/_FY_-F_]]_\ 0_\
MUH_O7/\ T"O^M)_V=#_=4_\ U\_[$_\ FY_-F_\ ??\ T/\ ]:/[US_T"O\
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MH_O7/_0*_P"M)_V=#_=4_P#U\_[$_P#FY_-F_P#??_0__6C^]<_] K_K2?\
M9T/]U3_]?/\ L3_YN?S9O_??_0__ %H_O7/_ $"O^M)_V=#_ '5/_P!?/^Q/
M_FY_-F_]]_\ 0_\ UH_O7/\ T"O^M)_V=#_=4_\ U\_[$_\ FY_-F_\ ??\
MT/\ ]:/[US_T"O\ K2?]G0_W5/\ ]?/^Q/\ YN?S9O\ WW_T/_UH_O7/_0*_
MZTG_ &=#_=4__7S_ +$_^;G\V;_WW_T/_P!:/[US_P! K_K2?]G0_P!U3_\
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M^2[;[BX>)MRVPWFVI'ORX<E*^WIUBUJQ$QKI$3$Z3,QI[6>&".E
M
M
M                          5OORA/_@!.H?\ X<#0/_8OY +&_P ,/^7O
ME_\ [T-U_P#$>*;_ /IQ_P#IONOX*R_^D;90^7L)I@         .A#^.-_9H
M:Q_/#VS_ !K8//Q^(O\ [2NZ_@?8?VNR"_GW^4/)_BF#^ME/"@FTJ
M
M                                     T_^0O\ ^ $\XO\ X3_R7_\
M8ONK;WT^?R]]C_\ WW\-_P#$=LRKL3_Z;\-_"NT_](QN5Z]2JR@
M!:@_%A_^?]Y4_P SVF__ #:2JM?Q2?\ Z ]J_P ,;C_T:$:_J3_^X?&?XWD_
MM:[$I61!
M
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M@\EU[TXS]R^6O$=S;6D=<STQ\^FLQ&6M8_75](S1$:1:8M&D7Z:P5IS-S@
M
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MQ.TY;;Y]MNH_6Y:6I;]6(M$:QZQ,3'I,3$QZ2R0QQUX
M
M
M             "M]^4)_\ )U#_\ #@:!_P"Q?R 6-_AA_P O?+__ 'H;K_XC
MQ3?_ -./_P!-]U_!67_TC;*'R]A-,         !T1?QX]7R&O_%YU-EKR:SE
MMMXWSN/:,31;23USV^/M.Q,WI4D.1IEMX8XKRK*Z?<R4TQ534<V]<57-?%=5
M=%'GF_$)Y3;\A]3W+;3#%XR;'8<?@R3:(B)O;:8MS$TTF9FO1N*1,S%9ZXM&
MFD1:T#_.^YIG\C[K%2)BV'!@I;7WS.*N3T]?9TWB/73UB?3329F]0E:=
M
M                                        :?\ R%__   GG%_\)_Y+
M_P#L7W5M[Z?/Y>^Q_P#[[^&_^([9E78G_P!-^&_A7:?^D8W*]>I590
M    M0?BP_\ S_O*G^9[3?\ YM)56OXI/_T![5_AC<?^C0C7]2?_ -P^,_QO
M)_:UV)2LB"
M
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M;"
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MF^PB?V?#,Y,7MTUF8B+4U]WS*TF?LU]$C:.C 0
M
M
M      %7S\I;9,G:^+?C;J$54/&&SG?V0V2_HJAXJN*LGJO7>R8S$U13_7U1
MPT6NY7O$E'''TKJJHYY_YG"SS\+KCMME\H]R<O>)^^8. KAK.OIT9]WAODUC
MWSU;?'I/NB)^U(WZ;=OCMW)R&ZG7YM-C%(^S2^6DV]/U<==/Z/VJ0"[=,4
M       !T@?@2_LG/%+_ .SI_P#;)]Q/.3]>7^U=W5_^;/\ X/QZ 7FS^4[D
M_P#\G_\ 1,"8%$)JH
M
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MQ,^R)F*VF(]LQ6=/9*-OU)UM^X7&VTGIC=WC7W:SC](_HZ3I^I*[0I30_
M
M
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M]^\3&\V<QCY''$1GP3.ML=I]\>SJQVTGHOIZ^L3$6BU8CQ2%9V
M
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MB:6GU^#)%;3I,UBU8ZID": 8,
M
M                                                    JN_E/_\
MS@O%7^>#<_\ YBX5I7X6W_T^[J_@?;_^DRDI]-G_ -W.3_Q3'_;%)]=2E\
M        Z0/P)?V3GBE_]G3_ .V3[B><GZ\O]J[NK_\ -G_P?CT O-G\IW)_
M_D__ *)@3 HA-5
M                                                          ,/
M>0W_ ,X'O+^9[LS_ .8O-LO\??\ T^X/^&-G_P"DXW:\%_\ =S9_XWA_ME7)
M>>L19Z          L@?B]_\ P??;W_PG^_\ _MH\?U<GXGG\@G$?_??M?_AW
M*M ?4=_]"-K_  KB_P#1]ROA*)T+
M
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MS,?;:DSTVU]+6BC2K;,
M
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M<<Z6I>LUM']"?;$^Z8UB8]8F8>\="X0
M
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MB=?6NUP5M'I[XM$Q,>Z8F)]82ZHD-6@
M
M              ,/>0W_ ,X'O+^9[LS_ .8O-LO\??\ T^X/^&-G_P"DXW:\
M%_\ =S9_XWA_ME7)>>L19Z          L@?B]_\ P??;W_PG^_\ _MH\?U<G
MXGG\@G$?_??M?_AW*M ?4=_]"-K_  KB_P#1]ROA*)T+
M
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MY[TK3).E<6XG2(]LZ1CRVG7X/2MIF(QSK,4BN6L5;\
M
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M8MQ2)^7D]\1.OK3)I'KCMZ^DS6;UCJF0Y'I@@
M
M
M"H5^5MD<A%C_  4Q,=]>1XN]O/)7(WF-HN9J,?=Y#%P]"VV-OKFSIKXMY[S'
M6^7NXX):Z>:X:+J:FCGCB2OBJW3\*K;[>VX[ZW=J4G=4IP]*WFL==:7GE)O6
MMM-8K><>.;5B=+32DS$S6-)3_3-CI-^:RS6/FQ&TB)T]8B?O,S$3[8B9K69C
MWZ1K[(4\EOZ58         #IP_$'_9G^''\S^._C;+O,U]77^TKWC_#%_P"U
MXU=GE3^4/EO\;G^MJDA1Q8
M
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MD:WQ;W#:OK/I:8O37T]OPWM&DZQZZ^V(F.@4H$0<
M
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MR7V[A[L[$Y';<GP&?TKEPVF>FW36TX\M+17)AS5K:LWPYJ8\N/JB+TK,I?\
M"\YQ'<6PIRG";C'N=C?V6I/LG2)Z;5G2U+Q$QK2\5M76-8AA]E[M0
M
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MW9/32<<SZ4R1[YBMXB>FUY\T"FD0
M
M                                                  %/[\KG_P#0
M*_\ UI/_ -G1;U^%3_\ UY_^9/\ ^;I4_3-__&__ ,C_ /WI3^6\I4@
M    .G#\0?\ 9G^''\S^._C;+O,U]77^TKWC_#%_[7C5V>5/Y0^6_P ;G^MJ
MDA1Q8
M                                                   X_KUYK4@
M        $\'XX_\ :8:O_,_VS_%-B@G^(O\ [-6Z_AC8?VRS2WGW^3S)_C>#
M^NET(GGX06
M
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M6U;UBU9B:S&L3'LF/MA^+]OZ
M
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M':^.9X69FV;#6/7;S[[TC_F/MC_DO_M?['9W5DHZ
M
M
M  *5_P"5'F,G/W/XD8"6]FKPV,ZP['S%ACZN>/M[7)YS:L#99:]BX^GJXFO[
M77K*B3GGGGCFFVH^GT_;];H/PL]GMJ=F]V[^E(C>9>3V>.U_?:F+!EMCK/Y*
MVRY)C\MY2Z^FK%CCB>4SQ$?-MN<59GWS%:6FL?T)M;3]654U:FDP
M  ZGGQVV]O:^ '@_%;00V\=7B+XX7%4<$5$-%5Q>=/Z?=W<]5$=--/,UU=3U
MRR5?\ZN2NJJKGGGGGEY;?J&R9,OGWO>V6TVM'=W+QK,S,Z5Y#<5K'K[JUB*Q
M'LB(B(](5L]^6M;OCF9M,S/[J;J/7[(SY(B/Z$>D?D;C-/,3
M
M                                 <E;ORWM[3O7NFTM((;6UM>VNQK>
MVMK>*B&WM[>'<<S'#!!#'33'%#%'3Q3333QQ333QQQQQ]'K'["R9,W8O"Y<M
MIMEMQ.SFUIF9F9G;XYF9F?69F?69GUF5G_!VM;A=G:TS-IVN*9F?;,_+KZRQ
M,RQV8        "8SX"<CD++Y7?&*VL[Z\M+?+V?>&.RUO;7,T$.3Q\7CWVIE
MH['(Q15T1WMG'E,9;7-,4G%5'%Q;Q2<<>N.CGB'OU[[?;YOI4[FR9J4ODPWX
MV^.;5B9I>>6V..;4F8UK::7O2;1I/1>U==+3$ZH\W8Z7\9<C:]8FU)V\UF8U
MTG[UAKK'V3TS,:Q[IF/9,NCL\YR @
M
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ML6?'&;!:M\5HUBU9B8F/MB8])?-<E]
M
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MF/Q-7MV;]T]MTTX.]_TV&(_\WM:?2U/_ "-IG33_ ).TQ$:TF(I9E5I(\
M
M
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M,1/HK2[SSXMSWARVYP3U8<G)[JU9TF-:VSWF)TG28UB?9,1/VMJ&K&-
M
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MF*_K]F/<8KV__1K.GVSZ.E \W2OL
M
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ML4R16;3'KKT=4>DS$S'JC];_ &<
M
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M7\O>-,G9?)?NIQE9GMK=7GHTBT_(O[?E7F=?2?6<5IG6T1:LQK36TYZ#C3(
M
M
M                  "A[^4)_P#!]]0__"?Z!_[:/(!>Q^&'_()R_P#]]^Z_
M^'<4FG]./_T(W7\*Y?\ T?;*WZQMO\         !UH?'G_YP/1O\SW6?_P Q
M>$>3OR#_ /3[G/X8WG_I.16%SO\ ]W-Y_C>;^V69A8@ZH
M
M                             !RO?D+_ /@^_.+_ .' \E__ &T;J]2O
MT^?R"=C_ /WH<-_\.VRRCL3_ .A'#?P5M/\ T?&T_;>94         D@^(3^
MTO\ #?\ GAQO\599'+ZNO]FKO'^![_VS&P#RI_)YRW^*3_75=.)YF5=@
M
M
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M[3'DIEI7+BM%L5HB8F)UB8GUB8F/28F/6)CVOXWV?H
M
M                        !D[ICN+L3Q][4T;NCJ;89M6[$ZZSUML6K9R&
M"VN^+6^MZ9(98;JQO(I[+(XW(V4\MM=VTU%<-S;32124\T5\\<XSWGV?V]Y
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M69UBT3[8F)G=YI)AP
M
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M;)>;6G2(UM:=9G2-(C69]D1$?8^PX;Y
M
M                .8C\MN.Q^+^2GS+ML;8V>.MY>[=CR,EO8VT-I#)D,O%9
M9;+7U<5O1''7>9/*7LUS<2\\>N>XFKDKYJKJJYY]-GTE[C<;KZ;>S<FYO?)D
MCA,-(FUIM,4QS;'CK$S,STTI6M*5]E:5K6(B(B%BWB_)?)X^XFV2TVM&SI&L
MSKZ5UK6/7W16(B(]T1$1Z0CK2'9X         W ^/3_X/OP=_P#AP/&C_P!M
M&E-0_4'_ ""=\?\ WH<S_P##MRQ7OO\ ^A',_P %;O\ ]'R.J$\M2M<
M
M
M
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M5M$^R:S$Q,>Z8?><!\
M
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M)G368CU<?=[FFSVN7>98F<6+':\Q'MF*Q-ITUF(UTCTUF/U77?>1U5J
M
M                                         YK/SA:OC]/^5#RWQ.,F
MO)[:[V3K[:)*[Z2"6>G(;QTWUSNN6AHJM[>VCXL[?*[!-';T\T\UT6]-%-=<
ME?%5=7I(^B+E-QR_TM=I;O<Q2N2FVW>"(K$Q'1MN0W>VQS.LVGJFF*LWG72;
MS:8BL3%8L&\.;F^Z\:\7ER1$6C'EIZ?9CSY<=?;,^LUK$S^772(CT11I5MF
M        ,[^+.?RVJ>3OCEM& N_L,[K??'4.?PM][%M=?99;#]@Z]D<;=_;7
ML-S9W/VUY;45^W+')%7]/I5353SSQS@GE+8;3E?&7<?%[^GS-CN>!W^+)76U
M>K'DVF6EZ]59BT:UF8UK,6CVQ,3ZNE[EP8MSVYR&VSQU8<FRSUM&LQK6V*T3
M&L:3&L3[8F)^QUBWE'5C@
M
M
M                            .8[\O?\ :7^9'\\.2_BK$O3-](O^S5V=
M_ ]/[9D6)^*_Y/.)_P 4C^NLC?2-9^        G@_''_ +3#5_YG^V?XIL4$
M_P 1?_9JW7\,;#^V6:6\^_R>9/\ &\']=+H1//P@L
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MNL>R8UUK/I,1/HDAL.0V'*;6N^XW-BS[.\:UOCM%ZS^I-9F/U8]L>]XEW3F
M           +C_XV/R$UY?&93X_>T<Y#5?X2'8-Z\<K_ "=[;Q75[AOK5FM\
MZIQ\54<,E_-A9.;S9+"CU3W/V<F3XYYIMK."B.G?\2+Z?:[3<XO/W:^"8P9Y
MQ;;EZTK,UKD_8]KOKSK,5C)'R]GEG2M/F1MM(G)FO:T4/J"[%C%DKWSQM)Z+
MS7'NHB)TBWYN/-/V=7PXK>R.J,?ZZ\S-N-4HBX
M
M                                                        YK_S
MD[)C-J^5/RUR>)KFKM;7/=:ZW+S/#S!7QD]-Z3ZUU#-44T5<\\U0QYG!STQU
M_P""2/BFKC]G+TB_0]QVYXKZ6>TMMNXB,ML&\S1I.L=&XY+>;C'_ $9QY:S,
M>Z=8]RP3PUM\FV\:<7CRZ=4TRW]/LR;C+>O_ .C:-?LGT1.I7-G
M,X^,.'R>P^2OCS@,+939',YSO+J;#XG'V_''-Q?Y/)[]@+*PLH.*N::>9KJZ
MGHHIXYYXX]57#!_)V\VW'^-NX=_O;QCV>#@]_DR7GV5I3:Y;6M/Y*UB9G\D.
MF[CRX\';V_SYIBN*FRSVM,^R(C%:9F?U(=9%Y1%8P
M
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MQBRX[4F8]L1:)K.FL3&ND^FL3^HZ[[R.JM0
M
M
M                                          ',=^7O^TO\R/YX<E_%
M6)>F;Z1?]FKL[^!Z?VS(L3\5_P GG$_XI']=9&^D:S\       !/!^./_:8:
MO_,_VS_%-B@G^(O_ +-6Z_AC8?VRS2WGW^3S)_C>#^NET(GGX06
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MLK?[O[9WG:'<.YX#>^M\-_AM[KX[1U8[Q^K68UB/S;1:OMK+:AJQC0
M
M
M          #F"_*_G\3LGR1>9V1PMW][9V_?.Z8":;V+FW]&6U2ZHU?/VGMW
M<,$M7V&=P]S![G%/,4OM^N.JN.JFNKTX_2EL-WQOTX=F;?>TZ,UN!V^6(UK/
MZ//6<^*VM9F/BQ9*6TUZJZ]-HBT3$6,>,L&7;^/^(QYHTO.RQV]L3\-XZZSZ
M:^VMHG3VQKI.DZPCW2"9T         W&^.VWN+KS_P#!^*V@FN)*?+KQPN*H
MX(JYJZ;>S[@T^[NYZJ(Z:JN(;6U@KEDJ_P";1'1555SQQQSRT]]0V3'B\!=[
MVRVBM9[1Y>-9F(C6W'[BM8]??:TQ6(]LS,1'K+%._+5KV/S,VF(C]R]U'K]L
MX,D1']&?2/RNIX\MJM@
M
M    !S^_R4-;R>#^1^G)W],--KN70/5VR87F*;B2NO&6N1W+4):KBCCCCFWF
MXS.JW=/%'/UYYCXIJ_P5<+^?PW.1VV^^G+[M@F?F[/G][AR:QI$7M3;[B-/M
MCY>?'.OVZQ[DXOI]W&/-V!\NFO5BWV:EOU9C'?T^WX;U_HZP@!3Z;P
M    =<SK3:KC>NN.O]WN[2&PNMRTG5-JN;&WKKDM[*XV'!6&7FM())?I))#;
MR7G-%-57\+FGCCGG]KR3]R\5CX+N/D.$Q7G)BV>]SX*VF(B;1BRVQQ:8CTB9
MBNLQ'IJJYY';5V7(9]G69M7%FO2)GVS%;376?U='MG2.&
M
M
M                                                    YCOR]_VE
M_F1_/#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO\ D\XG_%(_KK(WTC6?@
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M^V?E9)UB(](KDR6M.E5Y)1^AL
M
M                                          Y4OG3G\3M?FYYC;1@+
MO[_!;)Y4>0F?PM][%S:_>XG,=M[=D<;=_;7L-M>6WW-G<T5^W+''+1]?I533
M5QSQQZH?!FPW?%>$^SN+W]/E[[;=K<3BR5UK;IR8]AMZ7KU5F:SI:)C6LS6?
M;$S'JLM[,P9=MV?Q.VSQTYL?&;6MHUB=+5P4B8UC6)TF/;$S'V-5VTF2@
M     )(/B$_M+_#?^>'&_P 599'+ZNO]FKO'^![_ -LQL \J?R><M_BD_P!=
M5TXGF95V
M                                                      *+?Y1F
MN9.U\U.BMNEIAXPV<\7<)KEA73-Q5<59/5>V.ULGEJ98/IZHX:+7<;+F.OGG
MZ5U55\<?\SE>3^%_R.VR^%^=XBDS]\P=T9,UHT].C/L=C3'I/OGJV^36/=$1
M]J9OTX;C';M#>[6-?FTY*UY^S2^'#%?7]7';7^A]JM"LJ2%          =6S
MPNVJXWKPZ\3MVN[2&PNMQ\:>B=JN;&WKKDM[.XV'J[5LO-:022?222&WDN^:
M*:JOX7-/''//[7E6\S<5CX+S!W7PF*\Y,6S[EY/!6TQ$3:,6]SXXM,1Z1,Q7
M68CTU5G=W;:NR[KY/9UF;5Q<CN:1,^V8KFO76?U=&RS6K'@
M
M
M                                                     ',=^7O^
MTO\ ,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_%?\GG$_XI']=9&^D:S\
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MC8
M
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MZ:VMI'KI$S[(EJGS;:L>,N2B9B)F=O$?EG[U@G2/Z$3/ZD2Z/CSEH!@
M
M                                        *8/Y5&KY"T[/\.MUDFLZ
ML5L&A]NZO9V]$D_.0BR&G[#I&6R<US%5;TVU%G/;;Q:4P542UUU5QS<5T4<4
MT<R7+_A8\IM\O;'>'"UB_P!ZV^_V&>TS$=$TW&+<XZ16==9M$[;)-HFL1$33
M2;3,Q66WTT[FEN.Y;9Q$_-IGP7F?=I>N2L:>NNL3CMKZ>^-)GUTJ=K7$G
M       '4%^*W:,AN'QQ^%V6R<-G!<VGCWUYJ\=%C'/%!5C]'PT.E8F:NFXN
M+F3F\N,5K\,EQ5Q5Q17<55U441T<TT4^8CZIN+V_$?47WGM-M-[8[]P;O/,V
MF)GKW.2=SDB-(K'3%\MHI&FL4BL3-IB;37+Y*VU-KW]R^+',S6=_EOZ_;DM\
MRWLB/2+6F(_)IK,SZM_6@V#@
M
M
M                              .8[\O?]I?YD?SPY+^*L2],WTB_[-79
MW\#T_MF18GXK_D\XG_%(_KK(WTC6?@       )X/QQ_[3#5_YG^V?XIL4$_Q
M%_\ 9JW7\,;#^V6:6\^_R>9/\;P?UTNA$\_""P
M                 "EM^0+\4-MUWD-D\]O'W">QI6QYBSN/(?0L388FPQ>D
MY_+SV.(MNT,!;6=5E+)A]RSMS%3F[>F">:#,755_5)5#=3<6ESOT _59E[BV
M^V\#>0,_5S6VPVCB=UDODM?<XL<6R3LLLVZHC)M\46G;7FU:VV](P16+XJ?-
MESX-\FVW],?9/.WUWF.DQM<EIM,Y*UUM.&TSK\6.L3\N=8B:1T::UCJJC+5D
MF0         %N_\ %Y\KJ[?)]Z>%^R9*&FUR,-'??5=O<<V\-?ZG:\8C3^T\
M/#=3S\7%[->X_C 7]G8PT<\0QV62N>>/I5)5Q4=^)[XJKDVW!^9N-QS\W',\
M7OIC68Z+?,W&QR36(TK%;_>L63+:?BG)ML?NK$Q:^H[MF+8]EW=MZSU5G[MF
MF-?9/5?#;2(TC2?FUM:?;-L=?L7$U/J*0
M
M                                               #S>Y;1C]'U#:]
MURT-Y<8K3];SFT9.WQT<$N0GQ^OXNZRUY#8Q7-Q:6TMY+;6E5,5,DL5%5?/'
M%5=/'UYX[+AN+W'-\OM>%VDTKNMYN<6"DWF8I%\MZXZS:8BTQ6)M$VF*VF(U
MTB9]'(VFVOO-UBV>*8C+ER5I$S[(FTQ6-=(F=-9]=(G]1R(7KA6E
M  )[/QO<=D+WY*</<V=C>7=MB.D^ULCEKBVMIYX,7CY8<'B8[[(RQ45QV5G)
ME<I;6U,LO--'-Q<11\<^N2CCF!OXCFXV^'Z;<V/->E,F;F]C3'%K1$WO$Y<D
MUI$SK:T4I>\UC6>BEK::5F8TGY_R4IX^O6]HBU]YABL3.FL_%;2/MGIB9TCW
M1,^R)=!9Y_D&0
M                                                          %2
MC\JW5;B\TCPKW:F[AHM=>VKO+59K&JBOFXN+C<<1U=E[:[BDX_Q=$-G'HLM%
M=//\*JJ>CGC]G'*V7\*[E<>'F^].$FDSEW&UXS/%M8TB-ODWN.U9CVZVG=5F
M)]D16=?;"4'TT;FM-YR^STGJR8MO?7W1&.V:LQ_1^9&GZDJ:BXY+(
M  !TF?@NS^6V3XJ?$O(YJ[^]O+?#]I8"&;V+:W]&)U3O3L_5\!:>W:0P15?8
M8+#VT'N<T\RR^WZY*JY*JJZO-[]<FPVG&_51W9M]E3HPVS;++,:VG])GXS99
M\MM;3,_%ER7MIKTUUZ:Q%8B(K\\S8,6W\E\ICPQI2;X;>V9^*^WPWM/KK[;6
MF=/9&ND:1I"6E$YK
M
M
M                       !S'?E[_M+_,C^>')?Q5B7IF^D7_9J[._@>G]L
MR+$_%?\ )YQ/^*1_761OI&L_        3P?CC_VF&K_S/]L_Q38H)_B+_P"S
M5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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M/X
M
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M]@HP0P
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MUK,>Y/.@@TH
M
M
M                  YCOR]_VE_F1_/#DOXJQ+TS?2+_ +-79W\#T_MF18GX
MK_D\XG_%(_KK(WTC6?@       )X/QQ_[3#5_P"9_MG^*;%!/\1?_9JW7\,;
M#^V6:6\^_P GF3_&\']=+H1//P@L
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M85Z>6N!CM_O[?[7%7IVN;)&?'Z1$=.:.NT5B)G2M<DWI$>GYGI$1HE%1@:X
M
M
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MJ6W-*\=Q.SF)^;?/GO$^[2E<=9U]==9G)73T]TZS'IK<^4T(D@
M
M                                   (!OR3,!B<Q\;LV1R-I]Q>:IWS
MU;G\!-[]S#]AEKBUVS5YKOVX)HHKKUX+9+V#VYJ9(N/>]?%/$E$==,^/PW]_
MN]G]1]=OMK].'=<#O<66-*SU8XM@SQ768F:_I<..VM9BWP].O3-HG=_T_9\N
M+R!&/'.E,NRS5MZ1ZUB:7T]?9\5*SK&D^FGLF8GG[+^TXP         %Z/\
M%SV3&77A7WKJ$5<W.9P?E%F]DOZ*H>:;>G&;5U/U3C,37%/]?3)-7=:;>\24
M<<?6BFFCGG_G\*-OQ0..W.+S1P7+WB/N>?M?'AK.OKUX-]OKY-8]T=.XQZ3[
MYF?L0S^H_;Y*]W[+=3I\J_&UI'VZTS9IMZ?J9*Z?T?L67U:J/(
M
M
M                                                        #F._
M+W_:7^9'\\.2_BK$O3-](O\ LU=G?P/3^V9%B?BO^3SB?\4C^NLC?2-9^
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M+[;)/KIZ?I<,>S3WYYG6VL^G3'I:5OM40BN
M
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MF)]LS:=?9")7U+;FU^0XG9Z1TX\.>^OOF<EL59C^A\N-/U96RU4",0
M
M                                       "(3YY,-<9KXI?*B.SQ4V6
MO<?#T]F8([:QKO[JQM\5WYU;=YC*Q4112RVT.-P%%W+<S\>FF&SXEJKJXCXK
MY2Z^A+>8]E]57:ULV6,6')/(8YFUHK6TWXO>UQTG68BTWRSCK2OK-LG1%8FV
MC:?A7-7#Y,XV;VBM+3GKZSI$S;;9HK7\NMNF(CWVTT]='-X>CE/\
M !<K_%2VJXO-(\U-)JM(:+77MJZ-VJ&^IKKYN+BXW'$=HXBYM)8^?\71#9QZ
M+%715Q_"JJGKXY_9QPIQ_%1XK'AYOLOFXO,Y=QM>3P372-(C;Y-EDK:)]NMI
MW5HF/9$5C3VRB;]2^VK3><1O-9ZLF+<4T]T1CMAM$_T?F3K^I"VNJ:1?
M
M
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MFMHF)B?LF)]8?2<9\P
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M?-W%1R?CO>7B(G+M;X\]=8C];>*VTF?9/R[W]8]9_-]DRZ-3SJ(#@
M
M
M      *^GY+6U6^O?'/C,1-:S7$F]>1766JVDT5=%-%A<6FN]@[M5=7%-?\
M"DAKM=.E@XII_A>Y-3S_ (..5@/X;'%9.0^HK+NZ7BM=CV[O<]HF)UM%LNTV
MW3'V3U;BMM9]-*S'MF&\_I[VUL_?ULL3$1AV&:\_EB;8L>D?T<D3^I$J!"_)
M-\         !>O\ Q=L/C(/!ONS/Q64-&9R?E=M.'O\ (4\<_<76,P?4/3%[
MB;*6KZ^GF&PNMAO:X^....>*KFOZ_7Z\?2C#\3_>;F_G#A=A>\SL\7:F#)6G
MNK?+O^1KDM'Y;5Q8XG\E(0P^H_+DGO+9X)F?E5XREHCW1-L^XBT_T8K77]2%
ME-6VCX
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MQZ]/5[NKHUTU^+HU]>GTNQ*5D00
M
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MK$1>D>LS>E8Z8UFU*UB;+"*OMHL
M            !S'?E[_M+_,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_%?\GG$_
MXI']=9&^D:S\       !/!^./_:8:O\ S/\ ;/\ %-B@G^(O_LU;K^&-A_;+
M-+>??Y/,G^-X/ZZ70B>?A!8
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M,3'HZGG^.GE^"WO$QKKNMIFP^DQ$_I,=J>DS$Q'YWMF)B/LEUG'D^5A@
M
M
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M->K%@P4M^K..+^GV_#>O]'6$X:$33@
M
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M^OLTT]=8OY*#T(0
M
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M<5=(KBM:8BN3'7_F[VG2](_8[:36.BTQCM-JMT;
M                        ',=^7O\ M+_,C^>')?Q5B7IF^D7_ &:NSOX'
MI_;,BQ/Q7_)YQ/\ BD?UUD;Z1K/P       $\'XX_P#:8:O_ #/]L_Q38H)_
MB+_[-6Z_AC8?VRS2WGW^3S)_C>#^NET(GGX06
M                    4D?RDNFHM?\ (3QP[WL<;]O#V9U7L/7F9O;6*TCM
MKS-]5[)1F+6ZR/%O8Q7-68N,)V5#;TSW-Q+S/:8^***FBFUK]5U_X7G>-N0\
M?=Q]BY\G5?C.5Q;O'6TVFU<>^P_+M6FMIK\N,FSM>:TI7IR9;6M-IRQI,'Z;
MN6G/P7(<+>VL[?<URUB==8KFITS$:SITQ;%,Z1$:6M,S,]4*M:T1)$
M  !UA/%#>KCM'Q:\:NS+N3)2W78O0/3F]7,N9O:\CF)+C;NN]<V":3*Y"6N2
M2_R5<F0YYGFJJJJEEYJJYYYYY^KRE>5N"Q]K^4>Y.V<48XQ<=S_(;6L8ZQ3'
M$;?=YL412D:16FE/AK$1%:Z1[E9/<VRKQO<G(<=7IBNWWV?''3&E=*9;U^&/
M='IZ1[H9^8"Z,
M
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MB/1**C UP
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MO+C^3DK_ %/3GQ=5OZ&.;Z_DU=()YR4 0
M
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M16M8B(K6(B(B(B(T6)8\=,5*XL58KBK$1$1&D1$>D1$1Z1$1Z1$>Q_&^S]
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M_P!I?YD?SPY+^*L2],WTB_[-79W\#T_MF18GXK_D\XG_ !2/ZZR-](UGX
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M3)$_JS%XF?RS*3E&9KH
M
M                               !1)_*!V^;+><?3^G0YFSOL7J'C'K-
M]+B;:K'RSX/9MI[+[1ERU&1DMZ.;^WO,CKV(PTU-O<5_2BWYBECHIXGJKDO2
M_#$XBFT\(<QS%\-Z;K>=S9JQDMUQ&7#@V>RC'-(GX)K3+DW%9O2/6_52UIFD
M16:/TY;6,79N[W<TFN7+R-XZIU^*E,.'ITU])B+6R1K'OUB9^'2*V:R%($
M       !U5/ [6+[2_"#P[U+*XV'$9G7?%WH/$YS&P56<E%IGK+JS58<Y'5/
MCI)[&ZFYRU,U4DT4DE$TG-5?%=7J]7/EB\[<G@YKS=WARVTR3FV>X[HY3)BO
M/5$VQ6WV><4Z7B+5CY?3$5M$36-*Z1IHK3[UW--YWCRVZQ6F^+)R6YM69U]:
MSFOT^D^L?#II$Q&D>FD-KFJ6,@
M
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MTS$1QV>_I]N/'.2(_HS72?R2ZC#R_JX
M
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M3'S<4:_DTS3$?EG33UUN)J?44@
M         ',=^7O^TO\ ,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_%?\GG$_XI
M']=9&^D:S\       !/!^./_ &F&K_S/]L_Q38H)_B+_ .S5NOX8V']LLTMY
M]_D\R?XW@_KI=")Y^$%@
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M><]M?!Y*WV6\Q-<V/;WKI[HC!CQ^OI[>JDSZ:^DQZZZQ$TJ&#40
M
M
M   #G6_D);7^\7RD]UXC[#[/]P]/Z9U3[C[K[C]5^\ZJU7>?O_9^V@^Q]O\
M?/[7VO5-]?MO<]?'N>W1Z'_P^N*_<[Z7>%WGS.O[_O.1SZ=.G1T[[/MNC76>
MK7[OU]6E?S^G3X>JT\_!6U^[^-]GEZM?GY=Q?333ITS7QZ>WU_8]=?3VZ:>F
MLPGIJ-O@         .N]INKX_1]0U32L3->7&*T_6\'J^,N,C)!+D)\?K^+M
M<39S7TMM;VEM+>2VUI35+5'%%157SSS313Q]../(]S/*;CF^7W7-;N*5W6\W
M.7/>*1,4B^6]LEHK$S:8K$VF*Q-K3$::S,^JK7=[F^\W67>98B,N7):\Q'LB
M;3-ITUF9TUGTUF?U7I'6N.
M
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MODI$3[)F])K$3^2=?5UNWDO5>
M
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MI:6DOJ Q8\GCZU[Q$VQ[W#:OY)^.NL?^#:T?J3+H(* 4&@
M                             ',=^7O^TO\ ,C^>')?Q5B7IF^D7_9J[
M._@>G]LR+$_%?\GG$_XI']=9&^D:S\       !/!^./_ &F&K_S/]L_Q38H)
M_B+_ .S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
M                      $;WR^?V9_F/_,_D?XVQ"1WTB_[2O9W\,4_M>1G
M_BO^4/B?\;C^MLYCSTRK$P        '0A_'&_LT-8_GA[9_C6P>?C\1?_:5W
M7\#[#^UV07\^_P H>3_%,'];*>%!-I4
M
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MK^\IJLH
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M./BDXXP;K+CZ9UF:]&2U>F9F9F=--/69G\K+3$W5@
M
M                                                  .;[\]O]K'Y
M6_\ V"__ +6SIUZ-OH-_V4>U?_SG_P#&.03^\)_R8\9_^4?^EYT/Z7K:@
M    ";#\>W:_W=^4GI3$?8?>?OYI_<VJ?<?=?;_I7V?56U;S]_[/VT_WWN?N
M9]K[7JA^GW/N>OGV_;KA7^(+Q7[H_2[S6\^9T?<-YQV?3IUZ^K?8-MT:ZQTZ
M?>.OJTM^9TZ?%U5U!YUVOWCQOO,O5I\C+M[Z::]6N:F/3V^G[)KKZ^S33UUC
MHI// @8                                            YCOR]_P!I
M?YD?SPY+^*L2],WTB_[-79W\#T_MF18GXK_D\XG_ !2/ZZR-](UGX
M">#\<?\ M,-7_F?[9_BFQ03_ !%_]FK=?PQL/[99I;S[_)YD_P ;P?UTNA$\
M_""P                                          "-[Y?/[,_S'_F?
MR/\ &V(2.^D7_:5[._ABG]KR,_\ %?\ *'Q/^-Q_6V<QYZ95B8        #H
M0_CC?V:&L?SP]L_QK8//Q^(O_M*[K^!]A_:[(+^??Y0\G^*8/ZV4\*";2H
M
M
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M/E+>3L?'O+9HO%.K:6QZSI/[-,8NGUB?SNOICWQ,ZQ,3ZNG0\RRNL
M
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M].MK3\4US>3-I79=_P#+X:]6D[[)D^+VZY9^;/NCTUO\/]3IZS[9D#: 8,
M
M
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MWOCGE<-NK2,%<GP^W7%DIECW3Z:T^+^IU]8]L=,1YJ%>8
M                            #F._+W_:7^9'\\.2_BK$O3-](O\ LU=G
M?P/3^V9%B?BO^3SB?\4C^NLC?2-9^        G@_''_M,-7_ )G^V?XIL4$_
MQ%_]FK=?PQL/[99I;S[_ ">9/\;P?UTNA$\_""P
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M;2@-YPRY,GDSD*7F9KCKMZU_)'W;#;2/_"M:?U9E,FARU,
M
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M)CSQH&@
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MK/KK:8]D0@=YVVU<'DC=Y8F9G-AP7G\DQAICTC^ACB?U9E-NA0T\
M
M
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MW_:7^9'\\.2_BK$O3-](O^S5V=_ ]/[9D6)^*_Y/.)_Q2/ZZR-](UGX
M  ">#\<?^TPU?^9_MG^*;%!/\1?_ &:MU_#&P_MEFEO/O\GF3_&\']=+H1//
MP@L                                           K-?E"]I1:YX@](
M=36^0^TRO9_?$>QW%I1?6D<F4U7K/3-@XRUM)CI*OO;NS@V7=L)/7-%3[=O+
M%%3)SQS+'Q59;^&%VO;D?+O-]V9,?7M>,X*<,6Z;3%,^\W&+Y<Q>/AK:<.VW
M-8K;UM6UYK&E+3$A_IQXV=QW5O.4M77'MMET1.D^E\V2O3.OLB9ICR1I/K,3
M.GLE1B7C)E@        .G/\ $5J]>G_&GX;8F3"0X"J[Z9PNT<6,%K;V=$]&
M\7V2W6+-U0VU-,=<VRQ;!QD9)>>/<GDNJI9.>:ZZN7F7^K?E*\O]2?>.[KGG
M<13F<F#JFTVF)VU:;:<>MO73#.+Y,5]E8I%:_#$*Z_*6YC=>0N6RQ>;Z;NU-
M9F9T^7$8^GU_I.GHB/9$5TCTA(VCHP$
M
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M[6V.RZ?V3D.O77V?+PY*Z::>NOS-==?3I]DZ^EY)1^AL
M
M                                KH?DX:77L'@'H.TVN.QLUUH/DMHV
M3OLI<1V].3L-<SNB]F:U>V>-N:XZKGV<CL.2Q-5Q;T54T2\6]$E?'/,%'TL2
M_#-YJO'^?-_Q>7)DC%O^VMS2M(F>BV;%NMGFK:]=>G6F*F>*6F)FO7:L:=<Z
M[[^G;>1@[WS[:UK17/QV2(B-=)O7)AO$S'L]*Q?2?=K,1[94+%\*:X
M   "\C^+=MGWGB'Y":-]A[?[N^2$VV?JGW7K^\_?/K'0L/\ 8?9?;4_;_IO[
MA>Y[OO5^]]WZ?11[7JDH_P#Q0^*^3Y=[?YSYFOWCMR,'1T_F_=][NLG7U:^O
M7]ZTZ>F.GHUUMU:5AM]2.UZ.Z=CO>K]DX_HTT]GR\V2VNNOKK\S333TZ?;.O
MI9Q5F([
M
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M0>)MP?>W)\;.L5IN[VKK[>C+/S<>OV_!>OK[_:W?:28<
M                           YCOR]_P!I?YD?SPY+^*L2],WTB_[-79W\
M#T_MF18GXK_D\XG_ !2/ZZR-](UGX       ">#\<?\ M,-7_F?[9_BFQ03_
M !%_]FK=?PQL/[99I;S[_)YD_P ;P?UTNA$\_""P
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M]_'*<[O>3B8M&YW>;+K$3$3\S):^L1.DQKKKI,:Q[&9F&NI
M
M                                                           0
MA?D.;E^Z_P 7G;.$]NSK_E&WSIS3?5<W'LS1?8]B83L+W,=']>/N[SG]Q/35
M'^WZ6]4M?_<?5-K\/;AOW3^I[B=[K>/W.V'(;CX8UB>K:9=II>?UM?[ZUB?Z
M>*U][<7@C:?>?(^US>O][X,^3TC[<5L7K]D?I/;]ND>]SNGH93P
M 7'_ ,5+3[BVUCS4W^;C&R6N9SW1NGXVJGBNK+VMQK6/[1S6<XEYKM:8X,;?
MQ[9C_1[<U54LMM7[E%/$<=5=._XJ/,8\G)]E\!3YD9<.#D]Q?V?+M&:^RQXM
M/BUF]9P9==:Q%:WCIM/5:(BA]2^[K;<\1L8ZNJE-QDG^EF+SAK7W^LQT6UUC
MTB8TF=9TMQJE$7
M
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M33V_,KBMKKKZ:?+TTT]>KVQIZW,E-R)8
M
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MNL$X;^L^F3#.L3.OI'52\1$1Z?HYF8B?6;2JKI&X
M                      !S'?E[_M+_ #(_GAR7\58EZ9OI%_V:NSOX'I_;
M,BQ/Q7_)YQ/^*1_761OI&L_        3P?CC_P!IAJ_\S_;/\4V*"?XB_P#L
MU;K^&-A_;+-+>??Y/,G^-X/ZZ70B>?A!8
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M2(F(])F)=6QY559P
M
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MA0
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M??X<D^FNL37+BTF=?A]<D3KZ^L1&GKK%_A08A
M
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M.[V&*L6WV*OS\/LU^9BB9TC6/2;TF^./9^?ZS$:RZ:#S1*\
M                              ',=^7O^TO\R/YX<E_%6)>F;Z1?]FKL
M[^!Z?VS(L3\5_P GG$_XI']=9&^D:S\       !/!^./_:8:O_,_VS_%-B@G
M^(O_ +-6Z_AC8?VRS2WGW^3S)_C>#^NET(GGX06
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M#:LQ/I,3,3[70Z>>Q!$
M
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M-XM:-/;U:S$3,I:43FL
M
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M8G2T1:/9,1/HM(P9\6YP4W.">K#DI%JSI,:UM&L3I.DQK$^R8B?M?(<M]0
M      $GWPP;W;]=?)_X@;!<UXV./(=A9C1*:LK>T6%KS<=HZ%MW65I1%/)7
M137DI;K;J*;.'Z^JYO.8HN..>:^..8Q_69P63N+Z8N[^/Q1DFV/C\>Z^"LVM
MILMUM][:9B-=*17;S.2WLICZKSI%=6N?+>RMO_'/*X*]6M<%<GPQK.F')3-/
M]#2GQ3[JZS[G3$>:A7F
M
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ME_%6)>F;Z1?]FKL[^!Z?VS(L3\5_R><3_BD?UUD;Z1K/P       $\'XX_\
M:8:O_,_VS_%-B@G^(O\ [-6Z_AC8?VRS2WGW^3S)_C>#^NET(GGX06
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MM^DQTXL-\]X]/;DMT4UGVQI&.\Z>GI>)F)^'2U^JF1D
M
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M]$WFF7D-Q:O5^=%9RVZ(GUG3IKI6(B9B(C2/2(;4M6,:
M
M                                 <LGY%=$_DT\]/,738["SQ=AC?)#
MM^\P>-L)/=M+'6<]N^8V'5K6+G]O-'L:YE;6FJCGGGF.KCFCGGGFGZO4?]._
M._QE\#]G\S;)?+GR=N<?7+>\:6MFQ;;'BSVG]7-CO,3[XTGWK)>PM[^Z'9/$
M[N;3:]N/P1:9]LWKCK6\_P#V=9_5]K3-N1EH        #-GC3O?\EOD;T!V;
M]_9XK^3GNSJK>_U/(Q^]C\=^Z&]8'8/O[Z']ONV=G^G^Y+3_ -U13SPPKR5P
M7\:/'7/]L_+OE_='A-]M>BDZ7O\ >-KEQ=-9]UK=>E9]TS#J.X=E^Z7 ;[CN
MF;?>-GFQZ1[9Z\=JZ1^6==(=99Y058@
M
M                                         "AO^3)X^W'77FKI7>]I
M;0T8#R-ZQQ]5U=4\5T7%QOO44>-TS88I>/:]F2&WTF[U?FB3B3F3FJ2NFJBF
MFBBJ2]O\-/R!C[B\+;WL7-:9W_;G)WZ:^FD;7?S?<8ICUUB9W-=[K&FFD1,3
M,S:*S5^GCG*[_M#-PMIGY_'[F=(]T8\^N2O_  Y(S:QIIZ1.LZSI7%6,-^@
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MTO\ ,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_%?\GG$_XI']=9&^D:S\
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MV.X^]^1Y+'>;[;Y\X\<^NGR\6F.DUB?9%HKUZ:1ZVF9C692!M ,&
M
M
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MSK,S[9G[9?L_#^
M
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M58?/[".+YW>\9$16-MN\V+2)F8CY>2U-(F=9G33369UGVLS,-=2
M
M
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M3\<SK^FG69UR1$6FU6Z-@
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M=/71U!GF(5R
M
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MZ?%L,N/UG3]EK\K_ (?C](]\Z0Z@SS$*Y
M
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MKK1,SI,S"4M%UK8
M
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MR=XYWG8?+S\F+Y.W<]OT&6?7W:SBR3'I&2GKI[(R4CKKI/76DL:*+6(
M                                  #F._+W_:7^9'\\.2_BK$O3-](O
M^S5V=_ ]/[9D6)^*_P"3SB?\4C^NLC?2-9^        G@_''_M,-7_F?[9_B
MFQ03_$7_ -FK=?PQL/[99I;S[_)YD_QO!_72Z$3S\(+
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M;>TSCVU?GY8]=/F7B:XXGU]9KCZK>SV98TGVQ%K-58C.
M
M                                                         U0\
M[NP*.J_"GRS[!YGQL%UJWCKW%D,/QF*+B3&76QU:%G;;6,;>1VD]M<RPY;8;
MBUM?1'+%75S-].*Z.>?5QM;P5P%NZ?-/:?;_ $Y+8MUW%Q],GR](O7#]ZQ6S
M7K-HM6)QXHO?6:VB.G6:S[)R;LO8SR7=_%['2TUR;_!%NG36*?,K-YC76/AK
M$SZQ/L]DN58]3JRP         !.=^.KU_7N7R<]?;'1!DI:>INL>WNP)9+&N
MWIM;:C):E/U7Q/F:9H)9),;5+V73'3Q%5%)]Y)!SS5S1Q717!S\1#GZ\-],O
M(<=-L<3RW)[#:Q%M>JTTSQOM,>DQ$7TV<S/5%H^7%XTZIK,::\];Z-IXZS[>
M9K'WK<X,7KKK.E_G?#^7]#KZZQTQ;WZ3'0T>>]!(
M
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MB(CUB(K\N?7VS:=)]T6-5=308
M
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MT5I<]S&Z[@YG<\WO9F=SN<UKSZZZ1,_#6)TCTI72M?2/2(]&9F&NI
M
M
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MT:?J4Y"<?#\7Q>L].;<Y<OLC3]#2M(UG\Z)_3SI$>DZSKZQ5=64N(A@
M
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MOL].B^D>V>J?L7'U.Z)X
M
M                              ##_D!TCI/DCTIV=T1V+:?>:;VEI^7U
M+,>BB.2YL/U"WY_3\YCO=XYCCS&O96."_LI.?^]7=M'7_P!RR_L#O;FO''>O
M&=]=NWZ.8XO>8\^/UF(MT3\>*^GK./+2;8LD?KL=[1[W:\'S&\[?YC;<UL)T
MW>VRUO7[)TGUK/\ 4VC6MH]]9F'*]\@.D=V\;NZ^SNB.Q;3[/<NK=PR^I9CT
M421VU_\ I]QS^GYS'>[QQ))A]AQ4D%_92<_]]M+F.O\ [IZE>P.]N%\C]E<9
MWUV[?KX?E-GCSX_6)FO7'QXKZ>D9,5XMBR1^MR4M'N64<'S&S[@X?;<UL)UV
MFYQ5O7[8UCUK/]56=:VCW6B88?9>[4         !EKHSO/M3QM[4U#NCI?;\
MEI'8FD9*G)8/.8VJFKBKBJFJ&^Q>4L9J9++,X',V4E=M?6-S1);7EM)7%+15
M15SPQ/OGL;M;R1VMO.S.\]GCWW;N^Q]&7%?_ (:WI:-+8\N.T1?%EI,7QWB+
M5F)B)=7S/#<;W!QN7B.7Q5S;#-72U9_[EJS[:VK/K6T:368B8G5?E^++YING
M/.K#ZWU1V;<8WJKRP@QL%KD-1NJX[+4>ULC:6N2N,AF>I;R>\N;B6;]/Q?-[
M>86[]N]LO>YHMZ[Z"&2YIH5^J/Z,.\?!F\W/=?;-<G*^*;9)M3<5UMGV-+6I
M%,>_K%8B(Z[_ "\>YQZX\G3$Y(P7O7',)/)/B+ENS,N3D^.BVY[8FTS%X];X
M8F8B*YXTB/;/37)76MM-;129BJ<-")IP
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M5XG):)TF/EXI]EES)3<B6
M
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MBU?2(B)FS6K/1W
M
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M&0
M
M             %4S\E+P&N-YTO5_.WK;$S7.R=:8VRZ_[SQF,QU<\N3Z[FO[
MB?4.P)N;3FGFF;2,SD9L?D9I(II)L=D+6JJ2&WQGTKM3_#;\]8^#YK=>"^Y,
ML5XWDLEMUQE[WB(INXK$;C:QU>[<XZ5RX:Q:L5S8LL16^3<ZQ)CZ?.]Z[+=Y
M.R^0M$;?<6G+MYF=-,ND1?%Z_P#.5B+4B)B(O6VD3;)Z4L%T"70
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MWF,&3;[ZGMI>-)TGV3$^RU9]UJS-9]TRRHQ9U@
M             #F._+W_ &E_F1_/#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO^3S
MB?\ %(_KK(WTC6?@       )X/QQ_P"TPU?^9_MG^*;%!/\ $7_V:MU_#&P_
MMEFEO/O\GF3_ !O!_72Z$3S\(+
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MK'I$*W.>YK?=Q<QN.;Y&TVWFYRS>WKKI'LK2-?UM*Q%*Q[JUB/<S,PUU(
M
M
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M^FGYF*G5^K^DF^D_9HF!1":J
M
M              ?!VK6\9N6L;'J&:HFDPVU8',:WEJ+>;FWN*\9G,?<8R_H@
MGIXYJ@FJM;JOBFOCCGFFKZ<_\CG\7R.YX?D]MR^RF(WFUSX\V.9C6.O%>+UU
MCWQU5C6/?#[[;<9-IN<>ZPZ?-Q7K>NOK&M9B8UC]6'(XVK7,GIVS['J.:IAH
MS.JY[,:YEJ+>;BXMZ,G@\A<8R_I@GIXXIGAINK6OBFOCCCBJGZ<_\KUK<7R.
MVYCC-MR^RF9V>ZP8\V.9C2>C+2+UUCW3TVC6/=*T7;;C'N]MCW6'7Y66E;UU
M])TM$3&L?J2^$YS[         -\/B_[-_DA^0SP\W:N]_3+.COC1-4R^2KSO
M[MVV.U_L;)T==;%?Y++\TU10X>RP6UW$M[%+S1!=6E,D$M=$<E5=.B?J=[9_
MC=]/?>'"5I\S-/ [K/CI\KYUKY=G3[WAI3'[9R6RX*5QVKK:F2:WK%K5B)PO
MR/QW[J]B<KLXCJO]RR7K'3US-L4?-I$5_IIM2(K,>L6TM$3,1#J)/,$KA
M
M
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MW;FX^Z\YM,^VS>[KK,5M^6M_6EX]OK6TQK$Q[8EGA@CI0
M                  ',=^7O^TO\R/YX<E_%6)>F;Z1?]FKL[^!Z?VS(L3\5
M_P GG$_XI']=9&^D:S\       !/!^./_:8:O_,_VS_%-B@G^(O_ +-6Z_AC
M8?VRS2WGW^3S)_C>#^NET(GGX06
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M,>SV88ZJQI.DWM?77IK,64U;:/@
M
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M:1TQ&D1&D-D&N&/@
M
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MVOL]UEV>68G+BR6I,Q[)FLS6=-8B=-8]-8C]1Z1UKC@
M
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M_>;E?VIN/[F?UA?@)_3B\/\ _>7Z7_TU/YOGGO\ T'[O_P"IN1_R8_B)WO\
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M_P!-3^;YY[_T'[O_ .IN1_R8_B)WO^\W*_M3<?W,_K"_ 3^G%X?_ .\OTO\
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M %-R/^3'\1.]_P!YN5_:FX_N9_6%^ G].+P__P!Y?I?_ $U/YOGGO_0?N_\
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M:Q[/368UGTCUF(8&VOYM?BVTS[#]7\NM/O/U+[K[?]U-.[5WSV_L_MO>^_\
MW&T+8OTKU_=4^U]U[/O_ $K]OU^W)Z<[XKZ*?JBYGYGW/M'>4^7TZ_/W&QVN
MO5KIT?>=UAZ_S9ZNCJZ?3JTZJZ]UM?#_ )(W?5\KB\L=.FO7DPX_;K[/F9*=
M7L]=-=/3736-=&^Q_P F[P0U>"6'0= \A.T,K59VES:26VIZGJ&L^]+D*K>\
MQV1RVR;I'L%I>6F/BJN*:H,-=V\O-<4?NT\U2U0[P[<_#-\[<I>+\]O^W^+V
MO7:MHMGS[C-I%-:WICP[:<5JVO,4F+;C'>NEK=,Q%8OF7'_3MWKN9B=]GV&V
MQ:S$ZWO>_LUB8K3'TS$SZ>N2LQZSI[-8NN[ORB_(_9OO+'H+Q]ZKZHL)O7##
MF-^S&P=L;-#%Q]>([VQXL*>N]<L;R3GCBKF.XLLE#'QSS1_C.>.)$H.R?PO_
M !SQG1G[][@Y7E<\:3./:X\6QPS/OK;K^]YK5CV:TR8;3Z3\/K5LCA_IPX#;
MZ7YO?;G=7C];BK7#3]2=?FWF/RQ:DS[?3V(0_(GY#?-CRNBGLN^_)#LC=\%<
M^QS<Z=;9&TTWKZXEMK3[&&YFZZT.QUC19;RFUJKIYGJQW,U7NR<\U<U2R<U3
M:\>?3WX5\4VKF[#[<XW8[ZNNFXFEMQNXB;=4Q&[W5LVYBO5I/3&7ICIK$1I6
ML1N'@>Q.S^V9B_"<?M\.:/9DF)R98UG73YN2;Y--?=U:>D?9&FF;<C+0
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MF9G69F9]9F9]9F?690-M:U[3:TS-IG69GVS/VR_9^'\
M
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MRQI$3/Z/':_I%OAF?3TB?2??Z.LL\H*L0
M
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M(VCHP$
M
M                  !52_(+^*F7LK"9?SP\?=>]S?M1P]%7D3I.&QUW=W^^
M:KC*<?88[LW!V6,M)ZZMDT?%454YWW/\7=8*WHNO7#)CY>+VU#\/[ZJ*]M[W
M#X)\@;C3@=WF_P#9.YR7K6NUSWZ[7V66U[1'R=S>8G:Z>M-S><6EZ[BLX9+^
M#/)<<?FKV5SN3^\<M_[UR6F(C'>=9G#:9G\S)/['IZQDF:Z3&2.BE4NC2[
M
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M;2OZS'2/=2E=*Q[Y]MIFTS,["-?.B
M
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M?XXY"=8^;FC'BK$Q,Z]>6D6]GLF,?7:)F=-8CV^R>D<\X:O\
M
M                                       !3Q_*HZXFHR'AUV[:Q7DM
MO<6?;O7&>FKN\?QC[*:SGTC9M2BMK#FF/*5WF4HOLUS/-QS-;TT6<-//$-=7
M'OW ?A8]QTG;]X=HY9I&2M]AO,416_7:+1N<.>;6]:=-)KMNFOPWF<EYCKB)
MZ)6?33R$33EN+M,1:)P9:^DZSK\RE]9_-TC3'I'I/Q3[8]E0M;FE,
M   OL_C-=HP;AX$[=UW-/_XUZA[XV_&1V?UR$GMZSN6#UG<<3?>[<1<8^+[S
M8<AF8OM[>2KFC[7W9*:>9J:JZ&_Q+>U[\/YYVG<-*_WKR_ [>\V^"-<VWRYM
MODKI$]<].*FWMU7B->OIK,Q28K"?ZA^-G:=[8M_$?HMULJ3KZ?GX[7QVCT]?
M2L8YUF/?I$SIZ6*5>#0H
M
M                                 "A[\X'P]Y#Q<VO-^5'C3IWJ\8=I
MO(;K>-0UZ&>:GHC;,E<<0S548VFF2JQZKV2_EHJL)HZN;;$7LU5A53;P58^F
M6]CZ(_J^V_E#BL'BWR5O/_\ 9VUI-=MN,LQ'[IX*1K&M_3JWV&L3&6LQUY\=
M8SQ.3)&XFLT_#GE6G<FVIVUW#E__ +CQQICO;_\ &:1'V^_-2/SHGUO6.OXK
M?,TK?K&V_P
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M?GVB<?#X)M7;XM9]*S/KDO\ ;DR:1,^FE8BM(UTFUI/T8VN0
M
M
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M+R2C]#8
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MIQL7X[B^8K7UQY\N&UM(]?F5K>L3/M]/E7FL>SUM/O7/E-")(
M
M
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MUR8X]GK>D=&L4@K3F;G
M
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M[^SYMZ^R(B-8Q5F.JL3:;:6O-:S>H2M.@
M
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M-(G-DM6?3VQ.F&LSK[NE:#5AHY
M
M                  -"/E(ZKH[F^/#S"T7[2;(77/1NY;GA\=:XJXS5YD=B
MZOM*>S]9QV/QMK/!<W&2O]AT^UAMN8^:ZXYZZ*^(YN:?:KWS]+W=-NS?J%[/
MYWKC'B_=S;[?)>UXQUIAWMON6:][VB:Q2N+<7M?72)K$UFU->J,V\;\E/$]^
M<5O=8K7[[CQVF;16(IFGY-YF9UB(BN29G7VQK&L>V.7H]/2QP         !-
M)^/[VE+UK\GG3&,DR'Z;B.V-;[,ZMS<M5]=VD%S%D=*RNVZ]CYX;:KB+)?J&
M\:;BH8H)^*H>+BN.7Z<21454PQ^OSM>O<GTR<SN:X_F;OB=SL][CCIK:8FFY
MI@RWB;>M.C;;C/:UJZ6Z(M7\VUHG4?G'C8Y#QSN\D5ZLNUR8<U?2)TTR12TQ
MK[-,>2\S,>NFL>R9=%YYVD"0
M
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ML
M                                            >\ZOZO[![I[!U/JK
MJK4\QO/8>\YBWP.JZK@;?BXR66R5QQ77Z:?77%;VEG:6\4EQ=75Q)%:V=K%)
M//)'#'))3T7<_<_;_9?;^[[J[JW>'8]O;'#.7/GRSI3'2/3W:S:UIF*TI6+7
MR7M7'CK:]JUGA<CR.QXC8Y>3Y/+3#L,-)M>]ITBL1_W9F9TB(B)FTS%:Q,S$
M.@3\3/PV]??'YB^.U>Q[[#]G^4VQX>&UO-J@Q_/&M]38W(XV&C.:AUO]Y7+<
MW=Y=W,LUO?[#)':W5_9\4P0V]G!7<QW5 ?U8?6+W!Y_W7\5>W*9N,\7;;--J
MX)O^FW]Z7F<6XWG3I%:UB*VQ;2)O3%DUR7R9LE<5L4'/)_EC?=\Y?W,X^+[;
MMO'?6*:_'GF)^&^73TB(C2:XHF8K;XIM>T5FLWJ$K3H
M
M
M"@S^2]VE%NOR Z]H%ED/>L^F^A]'US)8VB^M+J*PVK;,QL_8&0N9+>WJJGQM
MYD-6V3"<5PS^F2J*"*7CCVY**JKZOPU>U[<+X!W'/YL?3FYGG=SFI>:VK-L&
M#'AVM(B9]+UIGP[G2U?2+6O29ZJVB)M_3UQL[/L?)OKUTON][DO$Z3&M*5IB
MB-9])B+TR>L>FLS'MB5>-82WN          Z2?P8=8<]7?%_XT6UU9PVN9WC
M&[GV?F)8)LG+1?\ &][[LN7UB\JCR=$/VLW&AU8F&2BWCHM:I(:I(^9?7S/+
MYP/KC[GCNCZG>Y<N*\VV>QR;?98XF*1-/NNUPX\U=:3/5'WKY]HF\S>(M%;1
M72*5K^\S<C^Z7D;D;5F9Q8;8\-==/3Y>.E;QZ>W])US&LZZ3I.FG3$MZ);5P
M
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MK:/6/25H/';W%R7'X.1P:3@W&&F2NDQ,=-ZQ:-)CTGTGVQZ3[8>)=TY@
M    #/WBGVSST/Y-^/G='-]-CK7J[N;K;>,K<0RY.'B3 Z[MV)R6PV-U^C42
MY2?&Y/!P7%M=P0T25W%M-)%Z*^*^:.<!\J]IQWWXS[@[,C'&3+RG#;S;4B8I
M.F7-M\E,5J_,F*1>F6:7QVM,12]:VZJZ:QTG<W%_NUV[ON(Z8M;<[3+CK'I^
M=:EHK,=7I$Q:8FLSII,1.L::NL(\I2L@
M
M                                               !\W,X;#['A\KK
MVPXK&YW 9W&WV&SF#S-C:Y3#YG#Y2UEL<GBLKC+Z*>RR.-R-E/7#/!-17%-%
M75173S3SSPY.SWF\X[>8N0X_+DP;_!DKDQ9<=K4R8\E+1:EZ7K,6I>EHBU;5
MF+5M$3$Q,/IBRY=OEKGP6M3/2T6K:LS%JVB=8M68TF)B8UB8]8GUA2V^6+X
MLYUE7L?D-X(ZUDMEZTBA@O\ </'?&UY78=RTGB*WNJLML/74E_<W^9V_5>>8
M(I)<3S)<Y>SFFKJM^+BT_P 79W._2C]?6Q[FKMO'OG7<X]MW+,S3;\M>*8MO
MN=9K\O%NXI6N/;Y_6T5SZ4P9*UK&3Y>7XLTN?&/G##R,8^![TR5Q\C,S%-U/
M37'D]8Z:Y=(BM+^LQ%](I:(CJZ;>MZK"TU)4
M
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MI%=;3:45&!K@
M
M                              !R[?D_[;_EP^0?R[[$CNOOK"Y[LVW5
M,'?\7GW\5_K/6EQ'UIJU_;7'VECS39WVN:C:RP1<Q\\P0UTQ<UR<T>Y7Z??I
MB[2_B1]/W:/;UJ]&>O"8,^6O3TS3-O(G>9ZS'5;XJYMQ>MK:_%:)MI77IBQ[
MQSQ?[C=B\5L)CIO&SI>T:::7RQ\V\3&L^L7O,3.OK/KI&ND:'M[,T
M  ?M;V]Q>7$%I:0375U=316]M;6\5<]Q<7$]=,4,$$,5-4DTTTE7%---/'-5
M57/''''U?C)DQX<=LN6T5Q5B9M:9B(B(C69F9](B(]9F?2(?RUJTK-K3$5B-
M9F?9$?;+K1=!=9T=+=$]*].1UPRQ]3=2]<=9QR6US<7MO)1H>G8;5J:X+R[M
MK.ZNX:Z<5]:9988I)*?I5513SSS3QY.^_>Y;=Z=]<UWC:)BW+<MO-Y,36*S$
M[K<9,^DUK-JUGX_6M;6B)](F8]587-\C/+\UO.6G77=;K+F]8B)_29+7]8B9
MB/SO9$S$?;++3$W5@
M
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MF+@
M
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M+Q6U=8UB&'V7NU
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M.W*\YFG+N)UBL>RF.NLS%,=?UM(UG2/69]MIFTS,[(-<,?
M
M
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M1%:UB(BM8B(B(B(C19_CQTQ4KBQ5BN*L1$1$:1$1Z1$1'I$1'I$1['\;[/T
M        W,^.WJN3NKSK\3.MN(_=L\[WQUU>YV/B6[@EKU36-AL]LW#BVGLK
M2]G@O/W6P=Y[-?-'$=$OIYDKCCXJDITW]0_=->R_!G=G<DSIFP<#NZXITK,?
M/S8K8-OK%K5B:_/RX^J-=9KK%8M;2LXEWYR4<1V7RG(?KZ;++%?9/QWK-*:Q
M,QZ==JZ^_3V1,Z1/4V>7!6T
M
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MI$]J!K28
M
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MHLEIC2;>V,=]+1,]-;9-.J8'T[&Z0
M
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M,S:TS,S,S.LS,SZS,SZS,^LRCO:UKVFUIF;3.LS/MF?ME^S\/X
M
M
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M?4!R4[+L"=I6?7>;S#BF/3\VO5GU]?72+8J^L:3K,1,Z3,3T"E B#@
M
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M@O/KI\45R8XU_-C3HRS'LFVL^V*^ER!3NB>
M
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MVY:VD?=\^E+S/V8[:S3+K.ND4M-](UM2J*]*5LH
M
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MDP=TP
M
M                          "J!^5!VSQ8=4^*/15O?PR5;9V%O7;.8QD4
MN,DN+3CKW6['3];O[Z"JBO,VD.0Y[.RL=I735':W%5K<<5<25PT<Q6L_A:]I
MSN.ZNZ^^<F.8C:<?MMACO,7B+?>\UMQFK6=?EVFGW+!-XF)O2+X])K6\]4F_
MIKXOKY/D^:M6?T6#'@K/KI/S;SDO$3^;.GR:3;VS&M=-(F=:7BYI+<
M   !<?\ Q7.IN;?6/+?O6]L)JJ<MGNM^IM;R=463AMX>=?Q^>W#=K"*?UT8;
M(37'&S:_))1Z9+JSIBHY^L=%S])*=_Q3.[(R<GVEV-AR1KBP;S?YJ:TF9^;?
M%M]M:8T^92(^3NHB=8IDFT^EK8OABA]2O*=6YXOA:6CX:9<]X]-?BFN/'.GY
MT:=&6(]D6UGVS7TMQJE$7
M
M               $8'S-]3<=Q_&9Y98&*PAO,AJG7L?;.-GJBQE=UB^>G\[B
M.R<Q?V$^4KBHLYJ]7UJ_MIJX:^+J2SN)H8N*ZY>(ZY.?1MW9/9_U+=I[^V2:
M;?=\A.PO&M^F_P"Z&+)L\=;12)FT1FS8KUBT=$9*4O>:Q7JC8WB7E/W)\A\7
MGFTQCRY_D3'KI/SZVQ5B8CV_'>LQKZ1:(F=(C6.9X]*ZPP         !,]\
MG;//5OR<]+6%Q?S8_#=M8'L/J;-R12Y/BBXXS>I9#9-:L+FTQE$OZA#?;YJ>
M(BXHN*>;6"2JFYKYH]CB2B&GU\]IQW1],O-9\>.,F\XG/M-_CB8IK'R\],.:
MT6O,=$UVN?/;6D]=HB<=8MUS6=2><.+_ '2\=;N]:Q;+M;XL]?9Z=-XI>8F?
M9ICO>?3UF-:QKU:3T9'G70(
M
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MVZ=5)F/9,>_WO$NZ<L
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M\^_\]NLNYW/KI-Y^&L3[8I2-*8ZZ^O32M:Z^NFK/#!'2@
M
M
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MK:)0*\X\K/)^1-WCB>K#M,>+!7V_K:1>\>L1[,N3)'V3[8F8E-*A@U$
M
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M:3$QZ3$Q/K$Q/I,3[']CXOP
M
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MZ6K,6K.DZ3I,:Q.DQ,3^6-'R'+?4
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MF+VM&OLTB(B)+4;&O0
M
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M??'I>]K1$1,S,1$3$1$S.D>FK-C"G3@
M
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M1&DSZ17)&GOT]NDZPW]:#8.
M
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MGR:Q/I\O2;L*E9$$
M
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M*UF=/2^2/EXY^+TGX[UTB=>J?ATF9T=21Y>5;P
M
M                                 "CS^47T_%K'D_X^]V6EE]K;=M=/
MYC3K^>BNT]K);%U'LU-Q>7DD5-Q7D*;R/7NR<5;UUR11P50P1<155UTS<4W=
M_A?]WVY/QCW!V5EOU9.)YC'N*QI;6F+?X=*UB=.CIG+L\]XB+3:+6O-HB)IK
M,;Z<.5G<]N;[A[3K;:[NN2(]?2N>FD1[--.K%>?29G69UTB8UK!K.$C
M     %Z/\8+N6WV[Q"[CZ6GDAJS/37<WZ]%'%Q117%J/:^OVUWA>+BBGCUR3
M5[/IN>YXEJY_A1^FCCCCV_KS1M^)SV;DXCR[P_>F.+1L^9X;Y4S.LQ.?8Y9K
MDT]T1\G<;7X8]DZV_7>D,OJ,XFVU[JVG+UU^5N]IT_\ AX;3%M/_  ,F/T^W
M6?>LOJU4>@
M
M
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MS,=/K,SCM29M-NK28%$)JH
M
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MU[S>4K/K,1T8XMDG73V_'&/2)]/?[:POM*&T)@
M
M                                 %<K\FCIJ7>?!G1^V,=C?N<ET=W9
MKU[ELC[5W)^F:+V'B<KIN7X]5K8W44'WV\3:U1Z[B6V@_@^CUU35PQUV*_AH
M]XUX/SCONU-QDZ=MSG"9:XZ:UCKW6TR4W&/\ZU9GIVT;R=*5O;UUTBD7M7?G
MT[\M&S[SS<9DMICWFSM%8]/7)BM7)7VS&NF/YOLB9]^FD3,4,E[R:P
M   "R-^,?W3<:3YI]D]-75S-1@^\.F<E<6]G%-731<;OU?E[/8<#/<V\F5M+
M.6&UT_+;)3Q53:W=W1)+3Q'S%!5=5<UP_B9=EX^:\+\;WCBK$[[A.9I$VF(U
MC;;W';%EB)BEK1-MQCV?I-\>.8K/5UWC%$1_^HGB*[SM';\M6(^=L]W$3/V8
M\U9K:(GIF?6]<7OK72)UUF*KWBBI"T
M
M
M                               !S'?E[_M+_,C^>')?Q5B7IF^D7_9J
M[._@>G]LR+$_%?\ )YQ/^*1_761OI&L_        3P?CC_VF&K_S/]L_Q38H
M)_B+_P"S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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MB:VCW3$PKHSX,VUSWVVXK--QCO-;5GTFMJSI:)C[8F)B7V'#?(
M
M
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MAK;2?=:)CVK1*L!'
M
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M/C9TFU]I>U=?9UXH^;CU^SXZ5]?=[74D>7E6\
M
M
M                                       YCOR]_P!I?YD?SPY+^*L2
M],WTB_[-79W\#T_MF18GXK_D\XG_ !2/ZZR-](UGX       ">#\<?\ M,-7
M_F?[9_BFQ03_ !%_]FK=?PQL/[99I;S[_)YD_P ;P?UTNA$\_""P
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M]G_N9S6+NS9TTV6^^#+I'I7<4KZ3]D?-QQK$1ZS;'DM:=;+.*LQ'8
M
M
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M69])M2;3IZ3-IM$1JDM1K:]
M
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MR[_AHC3'MMWDI7\M(M/RY_.M/K3IG2;3,:Z3.NK9!KACX
M
M
M                                             #F._+W_ &E_F1_/
M#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO^3SB?\ %(_KK(WTC6?@       )X/QQ
M_P"TPU?^9_MG^*;%!/\ $7_V:MU_#&P_MEFEO/O\GF3_ !O!_72Z$3S\(+
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M'=9=CO*3CW>'):EZS[:WI,UM6?RQ:)B?U'I'6N.
M
M
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MY@
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MF+3-A%7VT6
M
M
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MW[PE=YCFF/E\417<88F=:6]8BU=?6<>2(ZJ3ZZ>M)M-JS*-E)!L
M !?E_'&\O_Y=?#W*^/VS9.\O.P/%?,66OVM5])[U5]U'N=64R77DMM<UQPUR
M?N]?XS*X?FWI]WBRLK&QYYDXXN(XZ*%OQ%_$/\1O+^+O_C,5*<!W3AMEMTQI
MT[_;]%-W%HUG3YM;X-QUST_,R9,^E=<=K6A)Y][5_<7NNO.;>L1L>2I-IT]V
M?'I&76/ZJ)IDU].JUK^GPS,V'5>K1
M
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MOI]D^ON=&1YUT"
M
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MULN9K&N3:;N:3^2F>OK/YT1/QXL<:=,SZZQ,1%M;R2C]#8
M
M
M                                              !S'?E[_M+_ #(_
MGAR7\58EZ9OI%_V:NSOX'I_;,BQ/Q7_)YQ/^*1_761OI&L_        3P?CC
M_P!IAJ_\S_;/\4V*"?XB_P#LU;K^&-A_;+-+>??Y/,G^-X/ZZ70B>?A!8
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MOG']OZ*+?,CVQKKBF^D>NMHKI$S$.D$\Y* (
M
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M8\<Z>V/S<L1,QI.LZ>R5N]4<BT
M
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M.L>M?;>E8]9T]?6)C6)ZC#R_JX
M
M
M                           ',=^7O^TO\R/YX<E_%6)>F;Z1?]FKL[^!
MZ?VS(L3\5_R><3_BD?UUD;Z1K/P       $\'XX_]IAJ_P#,_P!L_P 4V*"?
MXB_^S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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MN[@K]L]S;[@KZZ;;<6K69C29QS\6*VD_TV.:V]L^WVS[6SC63'0
M
M
M             ',=^73O+_:#^1GRIWBVR/ZC@L-V1>=7ZO+;W?W>)_=_J&SL
M^M;>\P%<>7S5G^CY^\UB?*T26\U$%U+?R7/$4-4]45'IF^DCL?\ U?\ TZ]K
M<'EQ_+WV;C:[W/$UZ<GS=_:V\FN77'CM\S%7-7!,7K-J5Q5Q3>\4BTV)^+>&
M_<+L'C-G:O3FOMXS7UC2W5GF<LQ;X:SU5B\4TF-:Q6*ZSIK,;Z1K/P
M   '2!^"7HW^0_XT.B/O,=^G[%V_^\G>6Q_Y)]I]]^_^6D_<O(_XW$8F^N?N
M>K<3@/\ '3_<^OT_XBXDM.+;Z><GZZ>^/X[_ %*\[\G)\SCN(^3QF'XNKI^Z
MXX^\T],F2M>G>Y-U\->C37])CKF^9K +S1S/[L^0][T6ZL&UZ-O3UUT^57])
M'YUHC3-;+Z1I_55BW4F!1":J
M
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MP\1ICP;O)6D?^3FTVQS_ $<<UEM0U8QH
M
M
M                               !S'?E[_M+_,C^>')?Q5B7IF^D7_9J
M[._@>G]LR+$_%?\ )YQ/^*1_761OI&L_        3P?CC_VF&K_S/]L_Q38H
M)_B+_P"S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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M6(Q[[:Z6G3\[)@GIM,S[_P!';#7[=(CW::64U;:/@
M
M
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M+SZSK:]IM:=9F9]LS[9F?MF9>P=.X@
M
M                            #G9_D%]&W'3WR3]E[%!8S6FN][:KI'<.
M YJ]<MO7<7N&HTO;N(KR7)Y*:::XW;3,A>212<6M5O3>41QV]-MQ;R2^AS\/
M[OC'WA]-W&\=>\7Y'@MUN>/R^R)TKD^\[?6L4I$1&VW&+'$QUQ><<VMDG)\R
MM9Y>#.9KROC[;[>9B=QLLN3!;[=(M\RGII'LQY*UB8ZM>F9FW5U1$)*:[<
M        "^#^,GWE^_GA3V#TMD,C]SF.@^X,G^F6'W?O?IN@=IV$6UX/_)9\
MO>75G]YO5GM%?^+M;.RD^GUC]VX^[KXHG_$P['_<'S3Q_>FWQ].SY[AZ==^G
M3KW6QM.#+\48ZUMT[:VRCUODR1[+=&/Y4(6?41PWW+N_!R^.NF+?;2-9T]N7
M#/1;UZ8B=,<X?;:UH]^E>F%D%7(T
M
M
M                             YCOR]_VE_F1_/#DOXJQ+TS?2+_LU=G?
MP/3^V9%B?BO^3SB?\4C^NLC?2-9^        G@_''_M,-7_F?[9_BFQ03_$7
M_P!FK=?PQL/[99I;S[_)YD_QO!_72Z$3S\(+
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MUT1]0O%3O>QZ<C2/CV6\QWF?7TQY(MBF--=/6]\7K,3,::1IK*_,H50D
M
M
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M7+]L3.D3$UF71\><M ,
M
M                  !5&_*8Z1_5>IO&/R)L+/\ QVD[YM746QW4-'KEFQ_8
M.#CVS6:[WGCBJJ.SQ-_U]D*(Z_X-'$V2]-7/-4D?"U;\+GO;[KW9W-X\SW^#
M>[#!O\-9GTB^TRS@S=/VVR5W>*9CUGIPZQZ5LDS]-O,?*Y3D>!O/IFP4STC\
MN*W1?3\MHRUF?R4U]TJ6RYU+D         !8B_&E[UHZZ\\,]T]D+J:C&>0_
M4NS8+%6445Q71<;SUO3_ "CXBYN*XHY(88;32<-LE/%4OHIYDGIIXK]7/%$E
M>?XE'8UNXO!.#N_;UB=SV]RV'+>TS$3&VWG]YY*Q$S$S-MSDV<Z5UG2LS,:1
M-JZ'^H3A9W_95.5QQ'S-ANJ6M/IZ8\OZ*T1^KDMB]FOI$^GOB_ H80E
M
M
M                :T^4/E_X[>&V@U]B>0_9F!T+$SPY+G7L1<STW6W;M?8J
M"&>ZP^D:K;<UYG9<E'S=04R<01<PVOW$==Q)#%5[G&RO&'B'R'YCYZ.WO'O&
M9]_NZS3YN2L=.#;5O,Q7)N<]M,>&D]-ICJGJOTVC'6]HZ60]N=J\]W9OON'
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M38H)_B+_ .S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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M,:NI(\O*MX
M
M                               !1)_)O[[BW_S'ZUZ*QUU[^-\?.JXK
MG+0?=6DOV6]=NW-GL^7A^VM;FXEM/=T?#ZU+]+BF">OU^KV_9]F66]+\,WL.
MW >'>2[YW%>G<]P<K,8YZ;1U;781;#CG6U8BVFYR;ROP3:L::=77UTI-'Z=N
M$G8]I[CFLD:9-]N=*SI/KCP1-*^LQ&OZ2V6/36(T]NNL16S60I @
M +C/XL/2/LX#RI\C[^S]7ZCF--Z1U6_]'T]G]&LI=[W^S]SGCGW/N?U[6J_3
MQZ?1[7UY]7JI]-/7XI/>W7O^U?'."^GR\.XY+/77V_,M&UVMM/=I\K>1KZZ]
M7III.L4?J3YC7/QG 4G\VF3<7C_C3\O%/]#IR_\ #^1;I5(HM@
M
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M,3ZQ,3Z3$^Q_8^+\
M
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M_,C^>')?Q5B7IF^D7_9J[._@>G]LR+$_%?\ )YQ/^*1_761OI&L_
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M'\AGV%IF;8,U\<S,=,S-+3768UG3V>S6=/9J]LZ1PP
M
M
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MQY?YFW->0N1R1,SAV^6-O2/Z6,$=%XCTK/KEC);W^MIB)F-)2KHKM:
M
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M]L^V;->V^7KS_ ;+FJ:1]ZVV/),1[*VM6)M7W_FVUK[9]GME@=G;N@
M   '3)^'/OV3R*^.;QJV_(Y&\R>SZEI]74>W7&1^[DR$F;ZIO)]+MKN^O[NG
MGG+7F9US%V&0ENJ9)N9*[OGW:_?XEII\TOUA=A5\=_45W+Q&VQTQ<9N]Y]_V
M\4Z8I&/?5C<36M:_L=<>:^7%6DQ72,<=,?+FDS7EY7X2.![^Y#:XZQ7;Y<OS
MZ1&FG3FB,DQ$1^;%;S:L1I&G3Z1TZ2DY1F:Z
M
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MYN0V&ZXO?YN-WU9IO,&6V.]9]UJ3-9C_ (8])]\>KVSI'#
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MT]L_F]>FOOTUTC72-\6B6%
M
M                                          (Y/EJ\@K?QK^/3R;WZ
MFXFM\_G.O<CU;IGVM5%-]3MW;/IT#%Y"Q]V6&/WM;BSTV6K^O//TAQ]?/%$E
M7'$=<B_I-\?Y/)/U!]L\!-8ML,'(4WNXZM>GY&P_OJ]+:1,Z9IQ5P1Z?G9:Z
MS6-;1GWB_@K=P]]\=L9B)P4SQFR:^SHP_I9B?^/TQ3]6T>L>V.8P]-"Q0
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M_+:TS,_EE6-FRY,^6V?-,VRWM-K3/MF9G69G]67TG&?,
M
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M)]^OKEQ1_;OU/3376=+?:HA%<
M
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MMOW%MZ:8=_BFN32/3YV'2.J9]D3?':D1&D:_+M/KZZ695:2/
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MY.N.L5K,X)TB-/6VUP6M/I[YM,S,^^9F9]92ZHD-6@
M
M
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M+//\@R
M
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M](F='2^>:M7H
M
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M_P!L_P 4V*"?XB_^S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
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M6(B"GGO'2GD3-:E8BU]M@FTQ&FL]'3K/VSTQ$:S[HB/9$)U4&6F
M
M
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M8CUUFRRK81[
M
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M=[DWW"6B>G;;G)2LS[9QQ:9QV]L_GXYK;369C7U]6R#7#'P
M
M
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M^*L2],WTB_[-79W\#T_MF18GXK_D\XG_ !2/ZZR-](UGX       ">#\<?\
MM,-7_F?[9_BFQ03_ !%_]FK=?PQL/[99I;S[_)YD_P ;P?UTNA$\_""P
M                       "/;Y8,!EMD^-WS.QV%M/O;RVZ'W//S0^_;6WH
MQ.J6T>T9^[]R[F@BJ^PP6'N9_;XJYEE]OT1TUR54T52"^E+?[3C?J/[,W&]O
MT8;<]M\43I:?TF>TX,5=*Q,_%ER4KKITUUZK3%8F8SKQEGQ;?R!Q&3-.E)WN
M.OLF?BO/16/37VVM$:^R-=9TC67,&>G%8P         Z&?XZF'R>,^,;K^]O
M[*:UM=A[/[>S&%GEXXXHR.,@VV; 2WMOSQSSSS#1F<'=V_///TY]R"K_ )/I
MSSY[_P 1#>;;<_4UR&'!>+9=OQFPQY(CVTO.",L5G\LX\N._ZEH03\]9<>3R
M+GI28FV/;8*V_)/1U:3_ .#:L_J3"<]!QID
M
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M---(]C:AJQC0
M
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M>8]=9VF79TI-H^*,5HK,Q28I#/ZBN"G9=S[;GL5(C!OMMTVF-/7+@GIF9_\
MP5L41K[8K.DSII%E]6JCR
M
M                                      YQ/S[8[(67RN^3MS>6-Y:6
M^7L^C\CB;BYMIH(<GCXO'OJO$R7V.EEHHCO;./*8RYMJI8^:J.+BWECYY]<=
M?''HQ^@C<;?-]*G;./#>E\F&_)4R16T3-+SRV^R16\1.M;32]+Q6=)Z+UMII
M:)F??A')2_C+CJTM$VI.XBT1.ND_>LUM)^R>F8G2?=,3[)A#FF$VN
M EB^#;9,9JORI^)63RU<U%K=9[LK6XN8(>9Z^<GN72?96H86BJBGGCFF&3,Y
MR"F2O_!''S55S^SA%'ZX>.W/*_2SW;MMI$3EK@V>:=9TCHV_);/<9/Z,8\5I
MB/?.D>]K'S+M\FY\:<ICQ:=44Q7]?LQ[C%>W_P"C6=/MGT=*!YNE?8
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M8G2T1:/9,1/HL\P9\6YP4W.">K#DI%JSI,:UM&L3I.DQK$^R8B?M?(<M]0
M     '4%^+'I^7HGX\?$CKFYLOT[(V_3^#W'-8_FN[KEL-A[2N+WM+8[.YYO
M;BZEIO+7.[G<43T45^Q1-353#31#Q113YB/JD[OKWU]0O=O<>*_S-O;F,NWQ
MWTK$6Q;**[+#:.F*QTVQ;>DUF8ZIK,3>9O-IFN7R3RL<UWWRG(5GJQSN[8ZS
MZ>M<,1AI,:1'I-<<:>_3VZSK+?UH-@X
M
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MB=,UMO.*GK$3UYYC%6:ZS&LTZYO,1K.E9G2='3N>9-72
M
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M5==SL,M-Q&FFO1&M,L:SZ],4O.2T1,:_+CVS$1/0Z>>Q!$
M
M
M  !S^_R4-;R>#^1^G)W],--KN70/5VR87F*;B2NO&6N1W+4):KBCCCCFWFXS
M.JW=/%'/UYYCXIJ_P5<+^?PW.1VV^^G+[M@F?F[/G][AR:QI$7M3;[B-/MCY
M>?'.OVZQ[DXOI]W&/-V!\NFO5BWV:EOU9C'?T^WX;U_HZP@!3Z;P
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MXX_]IAJ_\S_;/\4V*"?XB_\ LU;K^&-A_;+-+>??Y/,G^-X/ZZ70B>?A!8
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MF(GV_+]<MH_I:3'MF'3T>9!70
M
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M;X[WMN<D:Q[*Q./%K&FNEIMET]8C6GLM,1-;DJG1$X
M
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M6FLS'M])TUB8F8F/6)F&2&..O
M
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M^9_MG^*;%!/\1?\ V:MU_#&P_MEFEO/O\GF3_&\']=+H1//P@L
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MTQ,5M^96(K[>J9EI1.:P
M
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M3I$1K[(CV+-^/V.WXSC\'&[2)C:[?#3%2)]L4QUBE==-(]D1[H>)=TY8
M     #I2_"=X\1>.?QP] 8BZQGZ;M/:>'N>]MSJDM+2RN[W*=I<PYC79;^&U
MN;RKF\Q_7,6#Q]7,\GW/ILZ>)8[>KCFVA\V_UJ>0K>1?J,Y_=XLOS.+XO-'&
M;?2UK5K39:X\T4FT5^&^[G<Y8Z8Z-<DS6V2)^9>OKR_ST\_W_OLM;=6VVUXV
MV/UF8B,/PVTUB/2<OS+>D:?%Z3:/BF5U%1K(
M
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M3[9G),S&LZS815]M%@
M
M                                 *NWY2O6\N8\9_&SMB*QLY_W![LS
MFCW-YZ;NO*6%IV=I-YF.>8>(K>NSCP]U>=80474DLL=7%S]I1137ZZO39_\
MA=]R5V?DON3M2][U^_\ "8MS%?AZ+6V6YKC]=9BTY*UWMII%:S'1\V;3'3&L
MC_INY",7<7(<9-ICY^SKDB/329PY(K]NO5$9ITB(GTZIG33UI#+M$PP
M   '0)_'(\BH.W_ &TZHR&0^YVOQJWS8]#N(+B;(762ETG;KZZ[ TC*75S>3
MW,/-G1-G<GAK*&&J.FWM<'1'[5%--%<E GXBWCN_:'GV_=6WQ]/%=R[##NHF
M(I6D;G!6NTW-*Q6(GJF,6'<9+6B9O?<S;KF9M%8.>?>!GBN^)Y/'73:\A@ID
MC32(^92(Q9(B(T]?AIDM,ZZSDF=9G6(GY0':0
M     <QWY>_[2_S(_GAR7\58EZ9OI%_V:NSOX'I_;,BQ/Q7_ "><3_BD?UUD
M;Z1K/P       $\'XX_]IAJ_\S_;/\4V*"?XB_\ LU;K^&-A_;+-+>??Y/,G
M^-X/ZZ70B>?A!8                             !&E\C_P 8/1/R+]?1
MV.YP?N9W/J>'R-GU;W/A;6BO-Z[+<<R7=O@=FLN*HJ-OT.;*U>[-CIZZ)K?F
M2:2QGM)III))*?3E]3G?7T[=P3GX:WWSLW=YJ6WO'9+:8\T1I6<N&WK.WW44
M^&N6L36^E*YZ9:4I6NPNP/(W-=A;[KVD_.XC+>)S;>T_#?3TFU)_69-/2+1Z
M3I$7K:(B(H*>:?QS>5/@CMV0PO=?7F2KTSC)56.L]Q:Q:7^8ZKV^*OGU6<F-
MV>FUBCQ>2N8_V\XW(T6>1CYIY^L/-'IKJOL\,?45XL\Z\3CWO9?(8XYGY?5F
MX_-:N/?;>?UT7P]4S>D3_P MAG)AGT^/76L3=[1[^[:[TVM<W$9Z_>^G6^"\
MQ7-3[=::^L1_3TZJ3]NOHT5;S9F   V<\7_#CR1\Q]VM]&\>NK-DWN\XO+2V
MS>P6]G+9Z3I\-W)33QD=RW"ZHCP6O6<<7/,G%,TW%Q/31S3!%+)Z:.=9^3O,
M7CCP[PMN<\@\IMMCAZ+6QXIM%MSN)K'YFWV]=<N6TSZ:UKT5F8G):E=;1CO<
M?=G;_:>SG><[N<>&FDS6LSKDR:>['CCXK3[O2-(_73$>J^#\6?PU=1_'M:1]
ME[9DK/MKR@R^'GQ>4[ KM>*=5T*RO9;RF_PW4^,O;*#)8S]3QL\=KD,M=U5Y
M"^CCKHBILK:XGM*Z)OJC^L?NWZ@LL]M<5COQ/C'#FB]-KU?I]U:L5Z<F^O6T
MTOT7B;XL&.(Q8YF)M.;)CQY:PK\D^6>4[ZM^Y^UK.U[<I>)C%K\>28TTMFF)
MTG2=9K2OPUF8F>NU:VB:5#%J,
M
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MSK,S/K,S,^LS,^LS/M?V/B_
M
M                            "BK^3?XZSZ!Y;]:^1.,Q_M:]Y!=;Q8?-
M7U$./I][L7J2JSP&1YN9+*&"[Y][0<MKM$%5[[LLGVTU,4M44/$-O>9^&;Y$
MIS_B7DO'FYR:\AV_R4Y,=9F_IM-_U9:=,6F:^FZQ[N;1CZ:QUTFU(O?KR3.^
MG;GHWW:^XX');7/L=QU5CU_8L^MHTU]/V6N69Z=(C6-8UG6U:=9.D(
M    GR_'/\D:^F//NRZLRE]-!J7DOI.;Z\N+?FFW^QBWG6X9MWT/+7<E=5%U
M1-S3A\EA[;B/UTU39OCUQ_3CB6*!7XB?CBO>?@2_=.UI%N6[:WN/=Q/KU3ML
MTQMMUCK'K73])AW%]=)BNVGIM[:WTEY[[?CE^R)Y+'6)W7'9JY8GUU^7?]'D
MK'N_74O.NGIC])]T]!!0"@T
M
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M=WQN7YOLUM.&^E,L1]FGP9;3[.G%/OTTZ B@9!T
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M;VG]6;3,_J1[(]SVSI'#
M
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MCJM'K^Q8-+3KIZ?LML4QU:Q.DZ1K&M;U2C-#$
M
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MC3=;;/?%;_C4M-9F/;Z3IK$Q,Q,>L3,,D,<=>
M
M                                                    \?V'HV [
M/T#>>M-LM_N]6[#T_9M&V6T]JRN/NL!MN%O<!F;?V,E:9#'3>]CLA)3Z+B">
M"KZ_2N.NGGFGGN.WN<W_ &QS^Q[EXJW1RG'[S#N<-M;1TY<&2N7'.M+4O&EZ
M1.M+5M'ZVT3I,<O8;W/QV^P\AM9TW.#+3)2?6-+4M%JSK$Q/MB/9,3]DQ+DN
M]AZ-G^L-_P!XZUVRW^SVGKS<-FT;9;3V;VW^US^I9J]P&9M_8R5IC\C![&1Q
M\E/HN(()Z?I]*XZ*N.:>/6)V]SFP[GX#8]R\5;KXOD-GAW.&VM9ZL6?'7+CG
M6EKTG6EXG6EK5G];:8TF;/=AO<'(['#R&UG7;9\5,E)])UK>L6K.L3,>R8]D
MS'V3,/'NW<H       !Z33=OV;KW;]5W[2LS>:YN.C[)@]OU+8<=511D,%LV
MM9.US6!S-C7)1)11>8O*V44\7-5-7'%=''UXY_P.NYGB.,[@XC=<#S6&FXX?
M?;;+M\^*_K3+AS4MCRX[::3TWI:U;:3'I,N/N]KM]]M<NQWE(R;3-CM2]9]E
MJ7B:VK/Y)K,Q/ZKJA>&GDMK/E]XQ].>0^KS6?L]BZ?87^?QUEQ71%KV[6'KQ
M.\ZSS#+<W=Q#^[^V6-W:T<225U5PQT2<554UTU<^6KS)XUY/Q%Y-YCQ[RD7Z
M^.WEJXKV]N7;7_2;;-K$5B?FX+8[SI$1%IFND3$Q%:_=O;VX[5[BW? [F)UV
M^68K,_KL<_%CO[(CXJ36?2(]9F/31LXUDQT
M !S'?E[_ +2_S(_GAR7\58EZ9OI%_P!FKL[^!Z?VS(L3\5_R><3_ (I']=9&
M^D:S\       !/!^./\ VF&K_P S_;/\4V*"?XB_^S5NOX8V']LLTMY]_D\R
M?XW@_KI=")Y^$%@
M
M
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MZ_+CUF--)O4)6G0
M
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M3,QK.LV$5?;18
M
M                            #G-_/CX]5]#?)#VQEK##PXG4N^L;K_>N
ML_:QV]%O=WFUVTF)["NI:K7GV^,E?]H:]FKV>B2FB?TW<<E?%7$M$LGHH^@O
MR#7OOZ<>)VF?-.7EN!R9>,S=4SK6N"8R;2L=7KT5V67;XZS$S77':M9CIFM9
M[^$N=CF^P-KBO>;;K96MMKZZZQ%)ZL4>ONC#;'6-/3X9B/9,1#"F6VV
M    M!_C<^?-OU3VUGO"3LC+0V>C]YY*;:.H<GDLC1;6>"[CLL;#!?ZGQQ=<
M1VT</9VO8VBBUYYGIJJS.,M;2"&:?)?6BL3\1[P+D[J[3P>:^W,4WYS@\<8-
M_2E)FV7C[7F:Y_AUM,[++>9O\,Q&WS9<M[TIMM)CE]0'9%N3XNG>''UF=YLJ
M]&>(C6;8)G6+^GK^AM/KZ?L=[6F8C'ZW?U(Z'0
M    #F._+W_:7^9'\\.2_BK$O3-](O\ LU=G?P/3^V9%B?BO^3SB?\4C^NLC
M?2-9^        G@_''_M,-7_ )G^V?XIL4$_Q%_]FK=?PQL/[99I;S[_ ">9
M/\;P?UTNA$\_""P
M
M
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M3.OKZS,R]4ZIQ@
M
M                    % W\D3QK_D?\Z+#N;#XW[34_)O0\;ME<]OC?T_&\
M=BZ'%9:5O-A:UQ?6TO+R3$6^"RU[+3Z)9+K,UURT<UU>]-?A^'%Y)_C?X-R=
MF[S)U\KVSO[X(B;]=_NFZFVYVUK:_%6L9)W.#'6=:Q3;Q%)TCHI-[Z?^X?W5
M[,MQ.6VNZX[/--)G6?E9-<F.9]\1U3DI6/9$8XB)TC2*]ZP-O0         !
M.I^/1Y,R]$?('K/7V6ROV.C^2VMY7J;,07%5W5CZ=QAHJV?K3)<6UK7QQ7F)
MMCQ56#M99*)8XJ,]-ZN**:N98X,_B#^-*]]^ -SW!M,77S?;6YIO\<QT]?W>
M9^3O*:VC]CC#>-S>(FLVG:TTUF(I;3'G;MV.:[&R;[%77><?DKGK,::_+_,R
MQK/ZWHM\R8B8F?EQ[?9/0N>?)!0
M
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MXX_]IAJ_\S_;/\4V*"?XB_\ LU;K^&-A_;+-+>??Y/,G^-X/ZZ70B>?A!8
M
M
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M$\9VABX7%:8S\CGB)]GKBPZ9+^OM_/G#'I[8F8F=/2;ZBAY"<
M
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M3:[B^/7^FBMIB+1[/2U=+1Z1Z3[(9L84Z<
M
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M7GS?"\EV[RF;A^6QSBWV"\UM$^R?LM6?UU+1I:MH]+5F)AF!B#J@
M                ',=^7O\ M+_,C^>')?Q5B7IF^D7_ &:NSOX'I_;,BQ/Q
M7_)YQ/\ BD?UUD;Z1K/P       $\'XX_P#:8:O_ #/]L_Q38H)_B+_[-6Z_
MAC8?VRS2WGW^3S)_C>#^NET(GGX06
M
M
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M]D?HXT^V9ST'&F0
M
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M6*<<5CTU^7:8U]=+-:L]'<
M
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MD7_9J[._@>G]LR+$_%?\GG$_XI']=9&^D:S\       !/!^./_:8:O\ S/\
M;/\ %-B@G^(O_LU;K^&-A_;+-+>??Y/,G^-X/ZZ70B>?A!8
M
M
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M]WFXY#>9=_N[3?=9\MLE[3[9O>TVM,Z^OK,S+U3JG&
M
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M?[<MW)V'N\.&)MO-K$;G'$>NML,3-XB(B9F;8IR5K$>LVF/U)Z4#S=*^P
M
M
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M%@
M
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M2B="P
M
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M'C]=(B=*VBMIB-.NMH]VC=YI)AP
M
M                                          "@_P#D1^"%QX\^3_\
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MC_VF&K_S/]L_Q38H)_B+_P"S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
M
M
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MC_=_OO<8,4S]TV$?=JQKZ=5)F<LZ>R)^;-JZ^V:TKKI^;$TJ&#40
M
M
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MS;U]:S.VS3$>Z=;X;3I'LB8R5F9GVVI6-/?<94](H@
M
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M=(G%NL75AM,Q-9G'-ZYL?56,N.EIZ46NY>R^Y^TMQ.#G=IEPTU^')$=6*_\
MQ<M=:3[OAUB]=8ZJUF=&W34C%@                   ',=^7O^TO\ ,C^>
M')?Q5B7IF^D7_9J[._@>G]LR+$_%?\GG$_XI']=9&^D:S\       !/!^./_
M &F&K_S/]L_Q38H)_B+_ .S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
M
M
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M,
M
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M8LF#+;!FB:Y:6FMHGVQ,3I,3^I+Z3C/F
M
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MU;1/MB:SK$Q^283>>*WY"/GQX^?HN![&V/#^3W7^*L^<=SA^VXJJ-\IM./\
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M_#&P_MEFEO/O\GF3_&\']=+H1//P@L
M
M
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M+B(8
M
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MPYJS/LFWS(G).GNRUU]=4X:$33@
M
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MXMGBR9<L;G#,Q2LVF(ZIC72L3.FLQ&OY8=$9YYD#@
M
M
M                                   $#WY#'EG_ +/'@EE>K==SOZ7V
M-Y3YBOJO&6]I=_;Y:CK.RA@RW<.5ABJAEBN\/=X*6TUJ_HYYIKXBVBGFG]O'
M/-,[/P^/$_\ K"\Z8NZ.1P?-[=[6PQOKS:NN/[Y:9Q\?29UB:Y*Y8R;S%/K'
M5LIB?LG=7@GMC]WN]*\EN*=6PXVGSIF8UK\Z?AP5_):+=66OY<,ZN>\] Z=
M          #IP_$KXN_[(_@/T)UIDK#['=]@UNGM3LVF3CTW=.^=ETQ;+?XJ
M_IHNKJTYO-/Q%S8X&JNWJXAFIQ5,G'UJKJJJ\S7U9>4/];7GKGNY=MDZ^$V^
MY^X[+3\W[KL]<-+TUK6W3N,D9-UI>.JLYYKZ1$1%=GE#N3^-'>^^Y'';JV=,
MGR</V?+Q?!%H](G3):+9/7UCKT]VB2%'%@
M
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M].K?\;?YT3$:V^3/PYZ_DK%>G+;\F&-'0B>?A!8
M
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M^6V$Q7<1$5S8M?BQ9=(FU?=K6?;2^FEJ^Z+1:M=(6[68@
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M368UG2(O2)^W)2GMB/;,0DS1I:\
M
M
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MTGHT]^CIQ/,RKL
M
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M8[R[>R]J]S[S@LNO3@S3T3ZQU8K?%CMZ_;2:Z^LQ$ZQK.FK:YJEC(
M
M
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M>UA';O<7$]T\3BYGALL9-GDC]2U+1^=2]?7IO77UC]2U9FLUM. 6?.[
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MS,%9ZZQ]N3!ZWKZ:S,TG)2L>MKQ[$V*%;4
M
M
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MTG28S>OL]+3:KA&P
M
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M_P!1O:\=.T[OVU8UU^[9M(G7]=?#>=/3T^.DVGU]<==9^&(N#J@D50
M
M
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ML#N/L?=_(YC%KM+3ICSTUMAR>DSI%M(Z;^DZX[Q6_I,Q$UTM.^#1+"@
M
M
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MT_I8F?AI'K/I2NE*^LZ1$1JSDP=TP
M
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MCW>'):EZS[:WI,UM6?RQ:)B?U'I'6N.
M
M                                                 TG\\? [I3Y
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MXNN_XN\5W58CYV";1\S#;[+1[9I,Z]&2(Z;Q]EHM6NC;>#,@
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M*L1,S..TSU9:1II%)UR^S3YGK,6E572-P
M
M
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M8H20B
M
M                     0A?/[XH1>2'@'N>[X:R][L#QAO*^[]?FAM[3FYN
MM.Q5E+8=L86>]N>>);/#QZ1/+G9:8?K)/=Z_:Q_X.>4VOH%\K6\<>?-GPF\O
MT\!W/3]S<L3-M*[B]HML<D5CTMDG<Q7;5FWI7'NLMO;HW%X/[GGM_OC#L\LZ
M;'D8^[V]9TC):=<-HB/;;YD1CC7TBN6TN=T]#*>           "_+^.-Y?\
M\NOA[E?'[9LG>7G8'BOF++7[6J^D]ZJ^ZCW.K*9+KR6VN:XX:Y/W>O\ &97#
M\V]/N\65E8V//,G'%Q''10M^(OXA_B-Y?Q=_\9BI3@.Z<-LMNF-.G?[?HINX
MM&LZ?-K?!N.N>GYF3)GTKKCM:T)//O:O[B]UUYS;UB-CR5)M.GNSX](RZQ_5
M1-,FOIU6M?T^&9FPZKU:(
M
M                                        89[]\>^G/)_K+/=0=Z:%
M@>PM#V"&;B;%YNSCFN,5D:[&\Q]ML>M9/BGC(:SM6*M\A-]GD[&2"]M:I*N8
MY*?55]<R["\@]X^,>YL'=_8V_P _'\[MYC2^.TQ%Z=5;VPYJ?F9L%YI7YF')
M%L=XB.JLZ0[;A.=Y;MSD:<KPN>^#>XY]M9]+1K$S2\>R]+3$=5+1-;:>L*&/
MR@?"'W5X,7&;[6ZF_7N[/%B.:6XKW&FWM+C?>K+22OFJVLNUL/B;>SCN,;''
MSS1QLF.M(L5))1_E4.-DFMH)KWOIB^MKLOSCCP=J]V?(X7RE,1$;?6T;7?6B
M/6VQR9)M,7F?7[GER3GB)_17W-:9+TFOXY\Q<1WG6G&<IT;/N68T^7K,8LT^
M^<-K3.D_^2M:;_TLY(BTQ!BG&W*
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MDV6]QWQ;O%>:WI:)BU;1.DQ,3ZQ,2](ZUQP
M
M
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M9Z+3\R\>Z>K)-HZH]+4K3UF(B4PZ'[5(
M
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M"R;LKN/'W7VMLN>II\S/ACYD1&G3EIK3+$1]D9*VZ?MKI/LEJ*VVRD
M   !*A\-7EY_L=^>/4^U9J\^VZV[1O(^E.T>9K[["QL=9[ R..LL9M-]-+<1
M645GI&WP8[+75<M$O/Z=:W,<?%,DE-=,6OK'\1_ZX/!/+<7LJ=7<G%TGDMEI
M7JM;-M:7M?!6(B;3;<[><V"D5FOZ6^*UIFM9B=:^6>UOXU]E;K;88UY#;1]X
MP^FLS?%$S-(]-=<E.ND::?%-9GTC1TLGFQ5[@
M
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MOGMC3DN'SX]QL;^R])UC6/;$Q[:VCWUM$6CWQ#%;*79
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M[DQ,:3$Q,Q:)BU9F)B7O'1.$
M
M
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M/P_@
M
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MD?+R1>E8]O1%+3^<E717:T
M
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M,3'I,3'K$Q[7\;[/T
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MR;+>X[XMWBO-;TM$Q:MHG28F)]8F)>D=:XX
M
M
M              "(3YO_ "XH\3_ ;LZK#92&Q[([TAGZ*Z^BCO+BURT%>[XK
M(0[ILF-YL>>+^UFUC1H;^6"]IJBCM<E+9\<R<221422Z^B3Q+;RMYZXR-YBF
M_;G!S')[N9K%L<QMKTG;X;]7PVC-N9Q5MCF+3?#&;2LUK>U=I^'>UY[G[WVT
M9JS;C]E,;G+Z1-9^7:/ETG7TGKR=,37UFU(OZ:1,QS>'HY3_
M%UO\8CQ(KU'J7M;S+V?%S6V9[;R5SU-U?<7=G;T<R];:;DK2\W//8J^XXDN)
M<;LO8EG3C98_5'Q3=:M5S535_ JXI9_$V\M5Y?NSBO#?&98ML^)QQOM[%;3Z
M;S<4M7;XKU](B^':6G-6=)UIO8TF/BB8A?47W1&ZY3;=I;:T3BVM8S9HB9_9
M<D3&.MH]FM,4]<3Z^F;V^U:G59(U
M
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MQEIRSZ?%."8TS1'_ !=*Y9F?97';3UET!% R#H
M
M
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MJ[WC,^+<;2WLOCM6]?9$Z:UF8UTF-8]L:^KP;O7-
M                         61O@=^6*OQCW?$>(G?NQ0VWCIV/GJH.O-ER
M,%O1%U#V?M&7LXXZLMFY;JUIQ?6.WW5Q)^HR3TSP8K(UQ7O-5M:UY*;FN'Z[
M/I1KY-X3-Y<[!V\V\B<=@UW>&DSKO]E@QVF?EXXK;KWNWK$?)BLUMGPQ;#IE
MRUVU(C_YJ\8QW%L[]T\'CF>?V]-<M(F?T^&E9_-KI.N:D1'1$:3>NM/BM&.%
M[Q14A:
M
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MUW!S.YYO>S,[G<YK7GUUTB9^&L3I'I2NE:^D>D1Z,S,-=2
M
M
M     H2_DB^)7\BOF%@/(77,=]OH_E'K<V6R<M%Q[M-MVYH-.-PF[6_%K31S
MS86>6UR_P61BKDK^MU>W%_Z...(:OI?)^'%Y9_CIX@W'C[D<G5S?:^YC'2--
M.K8;KKR;:>K]?;'FKNL5HB/@QTP=4ZWA-GZ?^Z/W7[4OP6XMKO.-R=,>GMP9
M=;8YU]\UO&2L_P!+6*:^U776'M\@         /I8;,9/7LOBL_A;R;'9G!Y*
MQS&)R%OSQQ<6&3QEU%>V%Y!S5Q53Q-:W4%%=///'/'JIX<;>;/;<AL\NPWM(
MR;//CMCR4GV6I>LUM6?R6K,Q/Y)?/-BQY\5L&:(MBO6:VB?9,3&DQ/ZL.I)\
M?7E9C_-3Q!Z6\AH*;.USNW:W5CM]Q%G+!S1A.Q=5O;G6MVL>+6*226PL[G.X
MN6\L(IO3+5C+JVEYX],E///EY^H#Q7N/"_EWFO'M^NVQVFYZ]KDM$_I-IGK7
M-MK=4Q$6M&*]<>6U=:QFIDKKK68BM[OGMF_:/=6\X*=9PXLFN.T_KL5XB^.=
M??,5F*VF/3KK:/<W,:;8D
M
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MZPQ^NQ9*9*^V8]M)M'MK,?JQ,>Z6-V1N>
M                O4_ !\I'^T3U]8^&G>6Q?<=Z]3:W++UCL^9NOI?]L]6X
M7FB.G$W%U/5Q1DM\ZWL)8X9*:>>+O(X**B[JHFEL\G=<T9_7W]+W^KSN"_F3
ML?;]/8W+;F(WN''7X=AO<GK\R*Q^9M=Y:)M$S\&'=6MAB:5S;;%$,?.'C?\
M<'?6[MX;'IPNZR?IJ5CTP9K?KHB/9CRSK,?K:Y)FNL1?'5995L(]@
M
M
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MZ\L5TG7UK2]=)B9TO/*.4,P
M
M                                          $77S$>(/\ ME>"7;6E
M8/&6=]V?U[9T]P=2RSQ^JYYVS1(;B_R6 L).)(.*;S>--KR>%@]V2BVHN[^"
M:;GTP_7B3_T?^7O]3GG3B>:WV6].V.0O^Y^_B)^'Y&ZF*4RVC2?AVVX^3N;=
M,3><>*]*>M_78_BGNK^*?>FUWF:TQQV>?D9]/9T9-(BT_DQY.C).D:]-9B/6
M7-">E186           M!?C-^8]QU[WKO_AQMN:A@TGO'&W?8'6]M?7-=%%C
MW'I^/MH\UC<5#Q33;TS;YUW92274DM?-54FLV4,5/JEJ]58GXEOAW'W#V-L/
M,7$X9MS7!Y*[7>6K$3-N/W%[3CO>?;IM=W:(I%8TTWF:]YTK&D<OJ'[3KO\
MA<'=FUI,[S9VC%EF(]N"\STS;W_H\LQ$1'NS7F?9"\ I'0Z
M
M
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MG_P$_P!XO]-7^%<Q^T,G_C'^OWQY_P YN_[!;_OG]W'^3#_S7Z?_ /2SB?\
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MF\6KK.FK;IJ1BP
M
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MB0E'U@H
M
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MU4]N.^GV9,<UO'Y+0V$:^=$
M
M
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M/0B>?A!8
M
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M>*\GOYG!C]?BBMH_37CW_#CUK%HF.F]Z6B=8B)Z,CSKH$
M
M
M       ( /R(_#BX\B/##^6S3L+#?]D>*V2ONP+F2&VKERN0Z<R-GQ:=J8VV
MJCJCCIAP$=M8;)/)/S53#8X.[ICI]R;CCF??X>7F+'X\\R_Q*YC-./MSNK'7
M:Q$S$4IR%+=6QO.NLZY9MEV=8KI-LNYQ3:>FGIO#P/W97@>[?W'W=YKQ_)UC
M%'K\,9XG7#,_\;6V*(CVVR5U](<_Q?PG$           MH?C*>;?Z'MO8/@E
MO.7^F.W7]3[;Z+^\G^OL[;A\;%_*=I%C[G,T\GZYJV,ASUI;Q\16UM^C92:K
MU37?[:G?Q,/"?W[B>/\ .G!X?[XV71L.3Z8]N#)>?N6YMII$?*SWMM<EYZKW
M^\;6D:4Q>D8?J([/^=M<'>FRI^DPZ8-SI'ZRT_H<D^[X;S..TSK,_,Q1[*KF
M2FY$L
M
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M2(UF>B*6G\Y*BBTUJ
M
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M0/\ -O=MNY.\LFQPVUXSC=<&.(G6)R:Q\^_OC6;Q%/2=)KBI.D3,PF]0E:=
M
M
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M/"[^--WMLMJ6^R=)]+1_4VC2U9]]9B68&(.J
M
M
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M2
M
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MV7+:;9;3,VM,S,S,SK,S,^LS,^LS/K,JYK6M>TVM,S:9UF9]LS]LOV?A_
M
M
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M /4Y)_[N.TS_ .3A<!5"HK
M
M
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MN&_QXIUGVS\NU>KUG2VL3,S$MP&H6*@
M
M
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M
M
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M6-)64]N<[L^YN#VO/;#_ ,VW.*+Q&NLUM[+TF?9U8[Q:EM/3JK.GHP.SMW0
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M8&(.J
M
M                                                   <QWY>_P"T
MO\R/YX<E_%6)>F;Z1?\ 9J[._@>G]LR+$_%?\GG$_P"*1_761OI&L_
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M,S[[6K.2/7UZ<<1K,1\-M%4ZC
M
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M?U7I'6N.
M
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MS_Y.%P%4*BL
M
M                                                         YCO
MR]_VE_F1_/#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO^3SB?\4C^NLC?2-9^
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M(F-9MCC)2/;^=KI,Z.EP\URO4
M
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M41W;;<\E@[/VMO[WVT1FSZ3[<MZ_HZS'NZ,<]>D^WYD3[HE:M57HT
M
M
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M[;+-)G32+5]M+Q'MZ<E)K>NOKTVC7U9X8(Z4
M
M
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MWM2==-8]L>Z9C[&3F,NN
M
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M5K$1'I#)#''7@
M
M                                       *9OY-?A)^A[;U]YVZ-B/I
MCMU_3.I.]/LX/K[.VX?&R_R8[O?>WQ-/)^N:MC)L#=W$G,5M;?HV+AI]4UW^
MVY'\,_S9]^XGD/!?.9O[XV77O^,ZI]N#)>/ONVKKI$?*SWKNL=(ZKW^\;J\Z
M4Q>DM/IW[P^=M<_9>]O^DPZY]MK/ZRT_IL<>[X;S&2L1K,_,RS[*JEZV))X
M         !:S_&G\[[C4-_V7P0W[*0TZKV1-G.Q^E;F]EKYFQW8EAB[.3<-+
MMIIIJJ(\;M&L86K)VL%/%$<5_C[GFGBJ:_J^M5GXDW@K'R_ ;;SKP.*?W5XV
M,6SY&M8C2^TM>T;?<S$1K-\&;)&&]IUFV++CUF*8(1G^H3LJNZV./O78UG[S
MMXKBW$1[\4S/R\D_EI>W1,^V:VK[J+IZE]$4
M
M
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M/_:8:O\ S/\ ;/\ %-B@G^(O_LU;K^&-A_;+-+>??Y/,G^-X/ZZ70B>?A!8
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M\Y/UV=N?Q=^I[N+Y<:;7?_=-Y3XNJ9^=M,/S9G^E_OBN;IK[J=/N0"\U<?\
M</(^_P"F/T>?Y66OKK^?BIU?J?I(OI'V:)@40FJ@
M
M
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M9UUZL=M(FL3-N-4HBX
M
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MR
M
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MUKC]TPAQ]2&RKB[GV&_C6)S;'HGT])G'EO.NOOG3)$3]D159W5DHZ
M
M
M                      -.?/?S U'P8\6^S/(7:(H<ED->QOZ/U]J\M?%/
M[Y]FYZ.:STK6J_3<VL].-GR?'W.3EAJJGM<1:W=Q'1)7%Q'5N'P-XAY;SCY1
MXSQ]Q<SCV^XR?,W>>/\ \7V6*8MN<WLM'7%/@PUM$5OGOBQVM6+S:,L[)[5W
M7>?<FWX+;3-<>2W5EO\ \WAKZY+^R?6(]*1/I-YK69B)UCES[EM^S=A;?M6_
M;KF;S8]QWC9,YM^V[#D:J*\AG=FV7)W6:SV9OJXZ(Z*[S*96]EGEYIIIXYKK
MY^G''^!Z@>&XCC.W^(VO \+AIM^'V.VQ;?!BIZ4Q8<-*X\6.NNL]-*5K6NLS
MZ1"Q[:;7;[':XMCLZ1CVF''6E*Q[*TI$5K6/R16(B/U'FW8N0          S
M!X_]([MY(]U]8]$==6GWFY=I;AB-2P_KHDDMK#]0N./U#.9'VN.9(\/KV*CG
MO[V3C_O5I;25_P#<L0[_ .]N%\<=E<GWUW%?HX?B]GDSY/6(FW1'P8J:^DY,
MMYKBQQ^NR7K'O=5SG,;/M_A]SS6_G3:;;%:]OMG2/2L?U5ITK6/?:8AU0O'_
M *1TGQNZ4ZQZ(ZZM/L]-ZMT_$:EA_71''<W_ .GV_'ZAG,C[7'$<F8V'*R3W
M][)Q_P!]N[F2O_NGEJ[_ .]N:\C]Z\GWUW%?KYCE-YDSY/69BO7/P8J:^L8\
M5(KBQQ^MQTK'N5K\YS&\[@YC<\UOYUW>YRVO;[(UGTK']36-*UCW5B(9@8@Z
MH
M
M                             !3-_)K\)/T/;>OO.W1L1],=NOZ9U)WI
M]G!]?9VW#XV7^3'=[[V^)IY/US5L9-@;NXDYBMK;]&Q<-/JFN_VW(_AG^;/O
MW$\AX+YS-_?&RZ]_QG5/MP9+Q]]VU==(CY6>]=UCI'5>_P!XW5YTIB]):?3O
MWA\[:Y^R][?])AUS[;6?UEI_38X]WPWF,E8C69^9EGV55+UL23P
M "R!^.7YV?R$>1N2\4>P-E^PZJ\E+RV_<J+*9#V,/@.^[:&WL,!]G'<2TVEI
M>=H8BWHP<GHX]^_R5MB(./KZ:>%<GXBO@O\ CUXZQ^5> VWS.ZNVZ3]YFE-<
MF7BYF;Y>J8CJM799)G<QK\.+#?=W]-9EH#SYV7^[7 5[FV./JY/CXGYFD:VM
MMIUFVNGK,8;3.3[*TG+9?"43H6
M
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M &E_F1_/#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO^3SB?\ %(_KK(WTC6?@
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M9R5PVB?Z'RYU_5A<K4XHF@
M
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MNLE)_P#V6\(K?41WA^P=E[.WV9]SI_\ J<<_]W):)_\ )RN JA45@
M
M
M                      &!_)_Q\TGRL\?>V?'CL*/_ ,ENU=/R&MW%]1;1
MW=SK^6]461U?;L=;321P3YC3-IL;++65,G/M<W=E'Z^.:?KQSG?C'R!S7BOR
M!Q/D+MZ?_:G%;RF:*ZS6N7'ZTS[>]HB9C'N,%LF#),?%\O);32=)=UVYSN\[
M9YS:\]L/_.=MEB\1KI%J^R])GV].2DVI;3UZ;3IZN5[W#U/NW1/:O8?3/8^,
M_1]ZZPW#/Z3M%C15));4Y;7LC/CKBYQUS)%#^H8?(>QQ<65U13Q%=VDL<T?/
M-%=///J5[/[KX7OKM7CN\NW,OSN#Y/9XMS@MZ1;Y>6D7BMZQ,]&2FO1DI,]6
M/)6U+:6K,+*>*Y/9\UQF#EN/MU[+<XJY*3[^FT1,1,>ZT>RU?;6T3$^L,;LC
M<\         !_9CLCD,1D+'+8F^O,7E,7>6V1QN2QUS-99#'9"RFHN;.^L;R
MVKBN+2\M+B*F2*6.JFN.NGBJGGCGCCE\=QM]ON]O?:;NE,NURTM2]+UBU+TM
M$Q:MJS$Q:MHF8M68F)B9B8T?G)CIEI;%EK%L5HF)B8UB8GTF)B?28F/28GVN
MG#\6WG!C_/CQ#T3N"[YL[7LS!?7K[NK#6E4%,5EV9K5E8_JN7M+2&&WHL</N
MEC=6V:L[>FFJBTAO_M/<EKMZY*O,U]4/A'<>!?+F_P"T,/7;MK/_ 'WQV2VN
MMMGFM;HQVM,SU9-M:M]MDO,Q.2V+YO32,E:Q79Y([.OV1W3GXJNL\=?]+M[3
MKZX;S/369]=;8YB<=I_737JTB+1"15'=@0
M
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M^TO\R/YX<E_%6)>F;Z1?]FKL[^!Z?VS(L3\5_P GG$_XI']=9&^D:S\
M  !/!^./_:8:O_,_VS_%-B@G^(O_ +-6Z_AC8?VRS2WGW^3S)_C>#^NET(GG
MX06     <H?R_P!5N-%\M/*+2+N[AO[K3?(KNS5;F^MZ*X[>]N->[+V;$37<
M$<OUDCAN)+/FNFFK^%Q3SQQS^UZK_$/*X^=\3=K\WBI./%O.W>-SUK,Q,UC+
ML\.2*S,>DS$6TF8]-5FG:NYKO>U^-WE8FM<NPV]XB?;$6Q4MI/ZFK75L1WP
M      "S5^+?M5Q9^8O?^DTVD-=KL/C3>[5-?55U\7%O<:=VCUSB+:TBCX_Q
M=<-Y'O4M==7/\*FJ"CCC]G/*L_\ %"XK'F\/\!S<WF,NW[EK@BND:3&XV6[R
M6M,^W6L[6L1'LF+3K[(1W^I#;5OVIL=YK/5CY&*:>Z8R8<MIG^A\N-/U97F%
M'B&H
M
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M2L?U-8TK6/=6(AF!B#J@
M
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M[O[6ON-I6)YK8Q;+BF(UM>L5GYF'[?CB(M6/Z>E(]DRZ,CSKH$
M
M
M               ,/>0W_P X'O+^9[LS_P"8O-LO\??_ $^X/^&-G_Z3C=KP
M7_W<V?\ C>'^V5<EYZQ%GH        "^#^+W_P# "=O?_#@;_P#^Q?Q_43_B
M>?R]\1_]Z&U_^(\JA9]1W_TWVO\ !6+_ -(W*R"KD:      <QWY>_[2_P R
M/YX<E_%6)>F;Z1?]FKL[^!Z?VS(L3\5_R><3_BD?UUD;Z1K/P       $\'X
MX_\ :8:O_,_VS_%-B@G^(O\ [-6Z_AC8?VRS2WGW^3S)_C>#^NET(GGX06
M   <KWY"_P#X/OSB_P#AP/)?_P!M&ZO4K]/G\@G8_P#]Z'#?_#MLLH[$_P#H
M1PW\%;3_ -'QM/VWF5        +('XO?_P 'WV]_\)_O_P#[:/']7)^)Y_()
MQ'_WW[7_ .'<JT!]1W_T(VO\*XO_ $?<KX2B="P
M
M
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M4ZC
M
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M)K'S<4:>D1%IB](B(B*7BD1\$S,X:$33@
M
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MD,@
M
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M1S\KR-YR;[<9;9+V^VUIUG2/9$1[*UC2*Q$1$1$1#(3'W
M
M
M                   5-/R9/!RXV75M \Z>O<#-=972(;3JWO>/&6=<M<FE
MWEU<W?7F_9"BWCCBBAUK/WESAK^[EYEN)H\MC(_X,%GSS3:_^&EYPQ\;RF_\
M&]PYXKM=]-M[QDWM$1&YK6M=WM::S,S.;%6FXQ4KTUK.#<V];YHUD[]/'>5=
MON<_9F_O$8LTSFVVL_\ *1$1EQ1K_3UB,E:QI$33)/K:ZF0N42U
M  ;R?'/YE;-X)^6/6_>N'N;SG5H[R/4.V\'9T425[5U)L.2QE>X8;B&JGGW;
MRS_3[?)V''UIXXR>.MJJN?3Q5QSH_P"HGPYQGG3Q1R78N\K3]U)I.XV&6WI\
MC?XJ7^[Y-?=6W7?#E]OZ'+DB/68F,-[^[3V_>G;&XX7+$?>=.O!:?UF>L3T6
M_4G6:6_J+6=/K3=PUGL+4-5W[2LS9['IN\:W@]PU+8<=577C\[K.RXNUS6!S
M-C7)1')79Y3%7L4\7-5-//-%?'UXXY_8\QW,\1R?;_+[K@>:PWV_,;'<Y=OG
MQ7]+XLV&]L>7';36.JEZVK;29]8E7/N]KN-CNLNQWE)Q[O#DM2]9]M;TF:VK
M/Y8M$Q/ZCTCK7'
M
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M4T(D@
M
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MV.SFM\TQ^NSVK.E?LF,5+1_X=[5F-:0M!JPT<@
M
M
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M+5IZS.3TMBJHT8P
M
M                                      '*?\WM$N.L?,ORMZ_GHR5-
M.I>17<N%L9LM95V%]D,/:]A;!Q@\S);5T4<<0YS#<P7D-='',4L,]$D?-5%5
M///JD\)<[C[F\-]J<_CG'KN^W>.R6C':+UIDMM,7S<<6C7UQ9.K':)^*MJS6
MT1:)A9?V=O:\CVEQF^KT_I=A@M/3.L1:<5>JNO\ 4VUK/OB8F)]6KK9[(P
M     $KGPD=V6G1WR7^-.4RE?IPO8NR9#I/)<4VLMS/7=]MXF[T[4*(.88IY
M+;_\X&0Q',LOI]--OQ)Q7511S573%3ZU^RLO?'TU=R[7:QKO>.VU.2I\41$5
MV&2NXW&NLQ$_WK3<=-==9OTZ1:T16=9^8.'MS/CSD,>/]FV^.-Q'KIZ8+1DO
MK[-?T47TC[=--9]'2F>;=7R     YCOR]_VE_F1_/#DOXJQ+TS?2+_LU=G?P
M/3^V9%B?BO\ D\XG_%(_KK(WTC6?@       )X/QQ_[3#5_YG^V?XIL4$_Q%
M_P#9JW7\,;#^V6:6\^_R>9/\;P?UTNA$\_""P   ");YP^[OY#_C0\C+RUO/
MM<[V?A\3TC@8_7[?WW\I^6ML'MMGZ^.?5_\ .Y_6I?3QQ5Z_:]//TIYYJXEC
M]$79/\=_J5[=PY:=6QXS-DY++.FO3]RQSEP6_;?W:NOIIU:QK,1$[/\ #G#_
M +L^0]A2T:X=M>VXM^3Y-9M2?[+\N/Z.KFS/2$L#         79_Q8NO:,;X
M]>4O:_%E#')NG<VI]>U9&F]N)+BZHZQTBC9([*7'52\VMK#CZNW*I(YJ**9+
MBJYKIKJJXACXII4_%([AMN?(7:_:G7,UV7#9]WT=,1%9WNY^3-HOIU6F_P!P
MB)K,S%8I$UB)O;6('U)[^<G.\;QFLZ8=I?+II&D?.R=&NOMG7Y&DQKI&D3'M
MG6TVJW1L
M
M                                  5-/R4?/^C7-6P/@1UIF8:LWN4.
M-W?R&FM>;BFZPVK6EWC,SUSHO%Q'7Q;\S;5D+>K+9&+GZ2PV=E8\?PHKVOA:
M_P#AN> K<CRF?SSW+AF-ELYOMN)BVG3DSVK?'N]SI/KI@I,8,5OS;9,F?V6P
M1*3OT^=CSN-S?O;D*3\G#,X]KKII:\Q-<N33V_!$]%9]DVM?WTA3(7*):@
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MT_EFTS,_JO2.M<<
M
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M9TM68C:)J]C8
M
M                                  #G'_/CUASUK\H'?5S;V<-CANS,
M;UQV?A(HILG<5R\9[0L#B-EO+B3)T?LFO]\U[+S<46\DUK%')3'1S'Z>8(O1
M=]!?<\=R_3%P.+)>;[SC,F\V629BD1'RMUER8:Q%)]E=KEP5UO%;VF)M:+:Q
M>\^O"7(_NAXYV5;3,Y=O;+AM[(_-R6M2(T^S':D>L1,S$S.OYTPVIBML
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M#\<?^TPU?^9_MG^*;%!/\1?_ &:MU_#&P_MEFEO/O\GF3_&\']=+H1//P@L
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MK:@
M
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MZ=ZU[D[ECA=C:9XOC9M3\E\\SIEMZ>V*]-<==?9-;S$Z73_H"-'@
M
M
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MZVR5]FLVI/Z2GKII\R-)FT:7\E!Z$(
M
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M_:7^9'\\.2_BK$O3-](O^S5V=_ ]/[9D6)^*_P"3SB?\4C^NLC?2-9^
M   G@_''_M,-7_F?[9_BFQ03_$7_ -FK=?PQL/[99I;S[_)YD_QO!_72Z$3S
M\(+   /$]E=B:CU'U[N_:6_9:'!:3UYJN=W/:LO/].:,?@=<QMSE<G<4T?7B
MJ>:FUM:N(XJ?K7+)S313QS55QP[OMOM[EN[>X-EVOP.*<_-<CNL6WP8X]M\N
M:\4I&ONCJM&LSZ5C69](ES./V&ZY3?X>-V-9OO,^6N.E8]]KS%8C_AGUGW1Z
MN5[Y;^1&Q^67DIW+Y%;3%-:Y/M3=LCL%KC)[J6]KP6N0T08C3]9INII)*YH=
M7U+&V..CYXYXH]NVIXIIII^E/'J4\2^/..\4>-N&\=\7,6VW%;*F*UXK%8RY
MIUR;C-TQ$:3FSWR99]^MYUF9UF;*.U^!V_;';VTX';:3CVV&*S,1IU7_ #LE
M]/ZN\VM/Y9]?5KJV([X        !U?O$OI^+Q^\8/'[I.FR^PN>L.G^OM.RT
M'-=I)+7L6'UG'6^S7ES+C[B[Q\MYD=AXN;B>NWED@JFEJYCJYHYXY>4WRQW?
M;O\ \G=P=ZS?YF/D^8W>XQSI:(C%DS7G#6(O%;Q6F+HI6+5BT5K$6C7565W/
MRL\YW'ON8F>JNYW>7)6?7\VUYFD1K$3I%=(C6(G2/7U;"-?.B
M
M
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MS,^LRKYM:U[3:TS-IG69GVS/VR_9^'\
M
M
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M8B/9T3,37TB.BU8C6:VTF?0S:D
M
M                                                0>?D*]%U]Q_&
M]O6R6%K#<9SH7=M+[DL.*I;>VN*\9:7-WHVUQQ7-Q)#15#;:QN]U?20<U_6>
MJQHXHIDGXAHYF[^'UWS7L[ZCMCQN>UJ['GMEN>/OZ3,==HKN<$S$1,ZSFVU,
M46T^&,LS::TF\QN/P5S4<3Y P[>\S&'>X<F"?;,:S$9*>D?;?'%8GW=4ZS$:
MRYX#T+)W@        ,Y>-'D%OOBKWUU;Y"]97,,&Y]5[5:;'CK>[JGIQV:L>
M8I\=L6K9G[66"[JP.X:U?WF*OZ89(IJK*\EXCKHKYIKXP?R5X_X'RGV'RGC[
MN:LVX;E=K;#>:Z=>.VL7PY\?5$U^;M\U<>?%U1:L9,=9M6T:Q/3=P\%LNY>$
MW/!<C$SM-SBFDS&FM9]M+UUUCJI>*WKK$QU5C6)CT=23QP[]Z^\H^C>M._\
MJW(_J6C]G:W!GL577]>+G'W<5Q<XO8->R-/--'%&8U;8\?=XV]IX^M--W:2<
M4\\T\<<\^7GR-V%W!XO[XY+L'NC'\OF^,W,XK_9>LQ%\66GVX\^&^/-CGVSC
MR5F8B?16]S_";[MOF=QP?)5Z=YMLG3;[)C2)K:/ZF])K>O\ 4VAFQA3IP  '
M,=^7O^TO\R/YX<E_%6)>F;Z1?]FKL[^!Z?VS(L3\5_R><3_BD?UUD;Z1K/P
M      $\'XX_]IAJ_P#,_P!L_P 4V*"?XB_^S5NOX8V']LLTMY]_D\R?XW@_
MKI=")Y^$%@  %3K\E#Y +37-.PW@-UME?<V7<_T;>?("]L[B6.K!:=93VN8T
M+0).*(:J)KS;\I%1F+VGW8I+6RQ]I3S1+'D>?;M<_#<\ Y>1YC-YZ[DQ:<;L
MOF;;BJVB)^;N+1;'NMU&LZQ7;TF=OCGIF+Y,N:8FMMO'5)SZ?>Q[;C=W[WY"
MO][X>K'MHF/SLDQ-<F7\D4CX*^DZVM?UB<?K3"7+I;         )"/BJZ"D\
MD_D#\8>MIL=>9'7[?LC&;_N=-M]W##'IW6-$V_YV+(Y"RJBFQ5GF(=>IQU,]
M,L,GW%[%'%73-)%]8^_51W[7QOX [G[DIDICW]N-OM=OU=,S.XWLQM<4TI;6
M+VQSEG--9K:.C':UZS2MF"^2^;CM_L;D>0BT5SSMYQ8]=/V3-^BKI$_G37JZ
M]-)C2LS,:1+I]/,<KG
M
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M[\K][3WKW3DS[:VO#;77%M_;I:L3\67U]^6WQ1Z5F,<8ZVC6LS,KJ*C60
M
M
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MFN??;'=\9O<O';^DX][@R6I>DZ:UM6=+1Z:Q.DQ[8F8GVQ,P]@Z=Q
M
M
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M(E@
M
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MO;T=O["\UY?D:S69C37'M_9DM^2<G[%7T_-G):)K:E5^Q0DA$
M
M
M                             TG^0OPWUGSM\4^R>@,U3A[38\G9T[)U
M9M&9@KD@TGM77X+J34=C^X@M;V_L+.:JYGQN2DM8J[BO#Y&\AHIJ]WFGG=7T
M^>8N3\%^5.-[_P!E.:_'8K_)WV#'.D[G8Y9K&XPZ3:M;6CIKFPQ>T4C<8L-Y
MF.G6,P[$[LW'9?<VWYS#USMZST9J5GUR8;3'7329B)GTB](F=/F5I,^QR_\
M>='V[K/<MIZ]W[7\EJF[:5GLIK&U:WF(.;;)X3/86\EL,GC;V'ZU4\36MU!5
M3SS3S515QQZJ>>:>>.>?3KP?-\3W+PVU[AX'<8]WPN]P4S8,V.=:9,62L6I>
ML_9:LQ/KI,>R8B8F%C.RWFUY':8]_L<E<NSS4B]+UG6+5M&L3'ZL/*NT<D
M        !;7_ !O?D6M];R=U\?\ VOFIH\5LF2S.V^.N7RV4HIQ^(SUWQ)E=
MPZJM:+R6FFTAV:Z]_-8N&'FFBO*5W]/IJGO(N.:FOQ'/IWR<EMJ>?>U,,3NM
MMCQX.7QXZ3UY,5=*;??6FL?%.&O3M\]K:S&&,$ZQ3#;2+_G_ +"MN,<=\<92
M/FXZUINJUCUM6/AQYIT]O1&F.\S[*='ZVDKE:G%$T
M
M
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M4=V!
M
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MQXZ^E*5^S2/6VFD6O-KZ:VEM<U2QD
M
M
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MFS,>DY,4_!?V3/PWZ:UO6$D".+
M
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M]_VE_F1_/#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO\ D\XG_%(_KK(WTC6?@
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MN&\UY/=Q\C!I.EHM>)Z[Q[X^7CBUNK3\_HKK$VB72@>;I7V
M
M
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M6@
M
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MTO2T>ZU+1-;1[IB85ZY\&;:Y[[;<5FFXQWFMJSZ36U9TM$Q]L3$Q+[#AOD
M
M
M                   YK_S.^%>3\,?-[L?'XS#36?4'=&2RG<73N0@L.+3"
MQ87:LG/>[/HUAS:PTXZVFZXVNXN,='9TR5W,6'YQUS-Q1]Y']?2+]&GFC;>9
M?"7';C<YHOW=PV.G'\A2;=62<F"D5P[FW5/7:-Y@BF6<DQ%+;C[QCI,_)MI8
M)XD[OQ]V]G;?)DO$\KM*Q@SQKK;JI$13).OK/S:1%IMII-_F5C7HE$ZE<V<
M          G:^-7YTN^O">WUSJ7MF#)=[^-.)A_3L=K%W>Q4]B=<8ZFB**TA
MZ\V;(R>W<X'%QQ<4Q8'(5<V5$?'$=K-8T_7GF"WU)_0UV'YJR;GNSM.V/@O)
M66>N^:M9^Z;R^LS:=WAI&L9;S.MMUBCYDS\66F>=--+^0O#/"=X6R<IQDUV7
M<-IUF\1^BRS[_FTCV6GWY*_%KZVBZ\-XL>9WC7YGZ-#OOCOVC@=YL:(:*LYK
MW$E>)WG3[KF2N"2PW'2LG3;;#@)J;F.NB*:6#[.]II]VTFN(*XY:Z1?*7AKR
M3X9YRW ^0^+S['/,_HLNGS-MN*Z:Q;;[FG5BRQTS$VK6WS,<ST9:8\D6I$.>
MY>TNX>T=Y.RY[;7PWU^&WYV/)'MUQY(UK;T]L1/57V6BMHF(YW_R]_VE_F1_
M/#DOXJQ+T+?2+_LU=G?P/3^V9$[_ !7_ "><3_BD?UUD;Z1K/P       $\'
MXX_]IAJ_\S_;/\4V*"?XB_\ LU;K^&-A_;+-+>??Y/,G^-X/ZZ5A?Y%?G^\>
MO%6WS76_C?5@?(_O^WFR>)NJ[.\N9.G.M\G942V_,VX;-BYK:?=,E;9/FBGG
M#8*XIXKIBN*+G)8Z:B*B:OGZ=_H%\@^4\F#N3R/&?MSL"T4R5ZJUCD-Y2VDZ
M;?#>+1MZ6IK/WC=4G2;8[8MMN*3:::)["\'\[W+:G(=P=?'\',1:-8CY^6)]
M?T=)B8QQ,?\ *9(]]9KCR1,S%(#R,\FN\O++LS+=N=_=@YCL#=<M[<5-S?\
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M,<?\36/SD\*";2H
M
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MV1$0]@Z=Q
M
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M
M
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MVM:]IM:9FTSK,S[9G[9?L_#^
M
M                                               *H'Y&_P DM>EZ
MY_L =.;!-;[9N6-QN=\D<YA\A;Q3X'1LA%!E-9ZEKDM:I<A:9+?+>N'*9F/F
MJTJ_0.;2WJXNK3+W,<=K/X=/TWUYKD?]?O>.WBW$[/)?%P^+)29C+N:3-,V_
MTMI2U-K/5@V\Z9(^]?-R1\K+M,=K2;\!>/XW>X_CQRU(G:X;37:5M$Z6R1K%
M\_KZ3&.=:8Y^+])U6^&V*LS2\7-);@           .A_\%/Q[5^&'BW;]@]C
M8.&R\@O(:''[AN,=W96].6T;1O15+H?7/WG$DUQ3-3CY>,OE8_I;U1Y*_P";
M26BOFPBEJ\]/US_4%7S-Y1MV_P!NYYOX_P"WIOM]O-;3\O<[G73=;OITB-.N
M/D8)^*)PXHRUM7Y]J1!#S/WU'=O<D['87F>"V$SCQZ3/3DR?\IET]GM^"D^N
MM*]43'7,1.&A$TX
M
M
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M)GX;]-:WK"2!'%@
M
M                                    "A7^0;\<]QXX=]7'E;U=KTT/
M1WD-GKF^VN#'6M?.*Z\[JO8J[[/V$M?,]Q);8WLF2"YS=GZO3#'?57UO%3%#
M%;1KX?P_?J)Q^1NPZ^*NZ-Q$][]O8(K@F]HZ]WQU9BN*T>D1-]G$TVV336TX
MHP9+3:]LEDU_!??U>?X2.V>2R1/,["D129GXLNWCTK/LC6<7ICM[YKT6G69M
M*NBL2;[                                   ?8U[7\WMF?P>JZUB[S
M-['LV8QFOZ_A<=#5<9#+YO,WL&.Q6+L;>C^%/>7]_<QQ14<?MJKKXX_Y7$Y#
MD-EQ.PS\KR66F#CMMAOERY+SI3'CQUF][VGW5I6)M:?=$3+Y9\^':X+[G<6B
MFWQTFUK3Z16M8UM,S]D1$S+I;_%%X"8CX^_%; =>9"UQMQW+O4UOO?>FQV=5
MK>\WFZ7=A!;V^J8[,1V\5Q=ZKH>/HXLK&/UU6]5U7>7D=-%5]+QSYK?JK\][
MSZ@/*>X[AV]LE>SMC$[7C,-NJO3MJVF9SWQS,Q7/NK_I,DZ1:*1APVF8P4TK
MU\F][Y>^>Y;[_'-HXG#$X]O2=8TQQ.LWFNND7R3\5I]NG12=8I"3-&EKP
M
M
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MW?=>V.WIX387FO.<A2:QI[<>"?AR7U]TVC7'28]8F;6K,335T$% *#0
M
M
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M[:VB8]-8GVQ,Q,2KTWNSW7';O)L-]CMBWF&\TO2T:36U9TF)_4EZIU3C
M
M
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M_@\'.\9/Z#+&EJS/Q8\D>E\=_LM6?Z%JS6]=:VK,ZQMF,B
M                    6[_QS_C.KOKBR^0GN7$P\X^UFS>$\;-7R5M;W/-[
M>V]<N%V/N&ZAFCEIMH<;=476*P7'/-,_-U'=WG-%%$=A/-4=^(G]2U<&._T^
M]G99^\6C'DYC/2TQTUF(R8>/K,3&LWK-,^Z]M>B<.'JM-L]*1:\]^0XI6>Q>
M)M/S)BMMW>)F-(GXJ8(^W6-+Y/=I-*:S,WB+B:GU%(
M
M
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M=;6F9VH:L8T
M
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MFFLVI-;>D8[3:YZIH1)
M
M                                        1%?+]\9V ^0OH2J75K:S
MQ/DCU-9YC/=.;+Z+*"O9OK8W$]_U%L=[?7=A9Q:WNEY%#]O=SRT?H^3CBN::
M^+>J^@NI;_2)]2V_^GSOR*\I:^;QQRU\>+D,.MI^3\417?X:UK:TYMM6;=>.
MM9^\89OCF/F1@OBVEXK\AY^Q.;TW,S;M_=36N>GK/1ZQIGI$1,]>.-=:Q'QT
MF:Z=71:O.6W'3MKZ]VO8M&WG7<QJ6Y:EF+_7]GUC8+"XQ>;P6;Q=Q):9#%Y3
M'W<<5Q:7EI<1545T5T\<\<\/17P_,<5W!Q6WYS@]QAW?#[O#7+AS8K1?'EQW
MB+4O2]9F+5M$Q,3$I\;3=[;?[;'O=EDIEVF6D6I>LQ-;5F-8F)CTF)AYMV+D
M                                )AOAZ^,+.?(3W=QE]UL\EBO&3JG)
M8^_[8V"BC*X_G<;SCT7EEU1JF:M(8X^,]G(^8Z\G)%<PSXO$2\STUTW$MG3+
M$#ZO_J;V/T^]D_=.%OCR^3.5QWIL<4]%_N]?6MM]GQVF9^5BG6,,6I:N?/6*
M3$XZ9IIJGRKY&P]B\/\ *V<UMW%N:S&&OPS\N/9.:]9_6U]>B)B8O>.G2:Q?
M3HR:]K^$U/ 8/5=:Q=GA-<UG#XS7]?PN.AIM\?B,)AK*#'8K%V-O1_!@L["P
MMHXHJ./V4T4<<?\ (\Z_(<AO>6W^?E>2RWS\CN<U\N7)>=;Y,F2TWO>T^^U[
M3-K3[YF90(SY\VZSWW.XM-]QDO-K6GUFUK3K:9G[9F9F7V'#?(
M
M
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MVC\V<D^L=6.LQ:55=(W
M
M
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M>W<S;!;V]$_K\-ITC2:3ZT_IL<U];6B^DPZ'[5(
M
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M3$QK$Q,>DQ,>L3'I,)HUM6]8M68FLQK$Q[)C[8?B_;^@
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M9SDP=TP
M
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M^LF2^6]LN6TVRVF9F9G69F?69F9]9F9]9F?:_L?%^
M
M
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M6T:Z3$Q%=?<'!<AVUS&?A.3I--W@O-9^RT>VMZ_;6]=+5G[)^UG)@[I@
M
M
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M$Q,3$QK$Q,>DQ,>L3'I,)C5M6]8M68FLQK$Q[)C[8?B_;^@
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M
M
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MNPI^CP8]9^#%$SI,Q_3W_/O^6=/96$A*/K!0
M
M
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M$_9+]GX?P
M
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M]9FMH]WI/I,3$Z3$PFCL][M.1VN/?;#)3-L\M8M2])BU;1/OB8])>5=HY(
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M1^K:TS:;6G/S 71@
M
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MOD"<N3^(_$Y)^728MN[5F-+3[:8/3^E]+Y(_INFOZVT+<:I1%P
M
M
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MGPVH56J-8
M
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M]R3K>][3:UITT];3K,Z1$1'V1$1'I#V#IW$
M
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MT^^U[3-K3[YF95[9\^;=9[[G<6F^XR7FUK3ZS:UIUM,S]LS,S+[#AOD
M
M
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M7UQWMTQ'S,?ZZ(]M9K;TZM(E%1@:X
M
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M?U;'MV9F/EUG])EKII^GO'MB8UUQ5TIZZ7G+-:W3AH1-.
M
M
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M43.DS']/?\^_Y9T]E82$H^L%
M
M
M                   51OR,/C3FWW <^??3&!][;M+P]KB?)+"8Z#'Q29_0
M\+94VNN]L\\^NUO+W,:-9V\6*RO[+R:;"?924\6\&*FJEM6_#L^I.G [_P#U
M"=Y9^GB-[FMDX?)>;S&+=9+=6;8^RU:X]S:9SX/V.M=S\ZL_,R;JD4DSX$\A
M1LL_\2.7OIM<UYMM+3,_#DM.M\/OB*Y)F;T_-B,G7'Q6RQI2V7.I<@
M     -M/"3S%[0\%?(;3_(#JR;[F\PWN87<=2N+V:QP_8O7V4NK*;9=%SLT4
M5S[=GE/L()[>?F&?[')6MK>41UR6]%/.I_-GA[M?SGX]WG8'=,=.'-IDV^>*
MQ;)M-W2MHP[G%$S&MJ=5JWKU5^;AOEPS:*Y)EC'>':G&]Y\%EX/DHTI?XL=X
MC6V++$3T9*^SUC68F-8ZJ3:DS$6ETW/&WR+ZK\L.E=%[\Z8S<V<T#?L;+>XR
M2]M*L=F,7?6-W<8S.:[G\;77+SC\]KV9LY[.ZCIKEAYEBYK@EF@KBFK\SGDC
MQWW3XI[TWW87>6",'/[#)%;Q6W7CO6U8OBS8K^G7BRX[5R4F8K;IMI>M+Q:E
M:[>X.!Y+MCE\W"<O2*;[!;2=)UK,3$36U9]];5F+5GTG2=)B+1,1G)@[I@
M
M
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M8F)B8G1N?'DIEI7+BM%L5HB8F)UB8GUB8F/28F/6)CVOXWV?H
M    !L)X^>)_DCY6;-'J7CQTQOG:N4^\MK&^NM;PLO[LZ_/=T5UVU>W;KD:K
M'3M,LY^(^?3<9:_LK?GGZ<>OZ\\<<Z^\@>5O''BOC)Y;R%S.PXK:]$VK7-DC
MYV6*Z1:-OMJ=6XW%HU]:8,62_OZ=(ET7.]S]O]L[?[USV[P;;%I,Q%[?';3V
M]&.-<F2?R4K:?R+7/@I^,_J>J7>#[%\[-WL^P<G;^B_BZ$ZTO<E8Z1#/5%S5
M!;[[V)53B]CV;V.)^.9L?AX,5;Q7=OQ_XQO[2NN.2JGSG^)5RW*XL_;O@O97
MX_:VUK/*;RM+;F8U]9VNT^/#AUT^'+N+9[VQWG^]]OEB+5C-WI]0VZW-;[#L
MO#.#'/I]YS1$Y/RSCQ>M*>STMDF\S6?V.EHB8M']=]:]>]1ZCB=!ZMTC5>O-
M)P4/L8C5=,P6-US X^CGCCUU6^,Q5M:VM,T]7'JEDYIYDEKYYJKJJJYYY5?=
MP]R=P=V\MEY[NC>[KD>:SSKDS[C+?-EO/NUO>;6TCV1&NE8](B(]$;]_R&_Y
M3=6WW)9LN?>7G6U\EIO:?U9M,S^I'LCW/;.D<,
M
M
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MLZTP^Z)KCF(O?\Z)R=$?#;%.MKE52C,
M
M
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MU;1.DUM$Z3$Q,:3$^L3Z2^DXSY@
M
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M]5+<W?V,%M!V1J=QGM!N;R2ZYIHX@CR5<W^-CY]/TECYJL!\>>=?$'E:M?\
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MD<V7<;NWMODO:]Y_5M:9F?Z,O8.G<0
M
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MS:UIF9M:9F9F9F9U0#R9+Y;VRY;3;+:9F9F=9F9]9F9GUF9GUF9]K^Q\7X
M
M
M                                                       :K^:'
MB/UGYO>/.]>/O:$'M8W9K.J]UC9889;C):%OF/M;NG4][Q,$-]C:KN\UZ_N>
M:Z[6J>*&_M:YK2;GV9Y..=I^&?+7<OA+R%L?(';%M=SMK].;#,Q%-UM;VK\_
M:Y)FM^FN6L:1>*VMBO%,M(ZZ59+VCW1R/9W.X>=XV=<F.=+T]D9,<S'7CM.D
MZ1:(])TF:SI:/6(<Q'R+\>^T/%CN?>^A^X\%^@[]U_F),7DXH:II\7E;22BB
MZQ&QZ]?3V]K)DM;V/%SQ7MA<<Q1U2VTU/-=$=?JCI]-?COR#VOY2[-V'??9V
M?Y_ \AAB])G2+TM$].3#EK$VBF;#>+8\M-9BMZSI:U=+38MP'.\;W+Q&#FN)
MOU['/36/MK/LM2T:SI>DZUM&LZ3$Z3,:2PFS5VX           "V[^/Q\L4N
M#R&N^ WD=M7N83+WD.,\9-]V3)7<USB\W?3XS&XKH"YGE@FAYP^5FKDDUBN>
M:+FUN^:L5'5+1<8VWMJE_K_^E&N^V^X\]>.=KIO<-)OS.UPTK$7QUB][\K$1
M,3\RD:1O8K6W7CB-U:*VQ[G)EB]YR\8QFID[WX#%^FI&N[QTB-)K&LVW,1K^
M=7TC-$1.M?TLZ37):UR53HB<
M
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MMWN=UDB9T^;DM>*ZS,Z5BTS%8UF=*UB(C7TB&9F&NI
M
M
M           5IOGR^5B7QPTF_P##OQ_VB\QGD#V+A[2;LK<<%/=V64Z@ZXRT
M<-U%98C*P\146>^=A6'/,4,D-==QB\/7+<T^Q<W./N:+)_H+^E:OD;FL?F#O
M_:TR]@<=FM&SV^6*VIR&\QS-9MDI.O5M=I;XK1:(IGW$5QS\S'CW&.TA/"7C
M..?WE>Z^<QQ;@]O>?E8[:3&?+7TUM7WX\4^LQ/I>\17XJUO6:*R\Q,X
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M\[OO2<DZ4I[L>*NO12/U(]9G]=:;6][;1J9BX
M
M
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M=LL(/,GC*>TM_/.\-29[<W62=8B(B-ODM,S\O2/^3MZ_*G2(K^QS.L5FU@5
M%HT
M
M                             !S'?E[_ +2_S(_GAR7\58EZ9OI%_P!F
MKL[^!Z?VS(L3\5_R><3_ (I']=9&^D:S\       !/!^./\ VF&K_P S_;/\
M4V*"?XB_^S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$%@
M
M
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M6:8X]8GXKQ,Q>O38%0!:-
M
M
M                      4?_P A/XO[?I7<KOSBZ/PD-EU3V7GH+;N[5L?%
M1'!HW:F>O)^8=WQT,7%%,&J]D74G%-U'Z/I99_FJKW*J,C!!;7<?A]?4[D[T
MX:GA#O?/:_=7&X)MQN>\S,[G8XJQKMKS/MS[.L:TG7])M=(Z8MMKWRS%\%>1
MK<OM([-YF\SR>WI,[>\^W)AK$?HYG^GQ1^;/Z['[M<<S:KZL[2-
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M
M
M                          YCOR]_VE_F1_/#DOXJQ+TS?2+_ +-79W\#
MT_MF18GXK_D\XG_%(_KK(WTC6?@       )X/QQ_[3#5_P"9_MG^*;%!/\1?
M_9JW7\,;#^V6:6\^_P GF3_&\']=+H1//P@L
M
M
M    UI\NO*WJ?PKZ%W3R"[DR4UMJ^IPVUMC\+C>;:79=TVG*R_:Z_IFI8^YG
MMZ<CGLS=?7GZ>JF*TM(I[RXKBM+:>:/97B3Q5W7YH[\V7C_L['%N4W<S-\E]
M8P[;!2.K+N,]XB>C%CK^2;7R6IAQQ;+DQTMD/:W;/)]W\WAX+B:Q.YRS,S:=
M>C'2OK;)>8B=*UC^C:TUI6)M:L3S-?,?RV[4\V^_MS\@.V[R&K.;)-388' 6
M/%-.%T?2\=-<\ZUI."IIA@JKQN!M;FJGF>2G[B\N:Y;F?FJ>:2KGTM>'?$W:
MWA/L'9]@=I4M]QVT=67+;]DW.YO$?.W.7UGX\MHB>F)Z<=(IBI$4I6(L.[3[
M7XWL_@\/!\7$_)QQK:T_G9,DZ=>2WY;3'LCTK&E8](AJZV>R,
M!98^ 'XMO]HGL&Q\R^\M=^XZ*ZGV26+K'6,U:_Y!VSVEA>**Z<M<6L]'%63T
M/K>^ECFDJIXXM,CG8J+2JN:*SR=KS6Q]??U0_P"KSM^_AOL?<=/?/+;:)WN;
M';XMALLGI\N+1^9NMY6)K$3\>':VMFB*6S;;+$>_.'DC]P=C;M+ALFG-;K'^
MFO6?7!AM^MB8]F3+&L1^NKCF;:1-\=EZI1FAB
M
M
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M,1K2WNG3TF)K.EHF(V0:X8^
M
M                                                YCOR]_VE_F1_
M/#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO\ D\XG_%(_KK(WTC6?@       )X/Q
MQ_[3#5_YG^V?XIL4$_Q%_P#9JW7\,;#^V6:6\^_R>9/\;P?UTNA$\_""P
M
M
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MPN%^5?2_.;B*VW&2)F8UC7IQT](TQTUG2=-;3,VGTZ8K%>E*V4
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M3D^2WO,<AFY3DLELN^SWF][6F9F9G]7V1$:16/96L16-(B&0F/N
M
M
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M[_#>:WI:-)K,?]R8F-)B8F8M$Q:LS$Q+WCHG"
M
M
M <QWY>_[2_S(_GAR7\58EZ9OI%_V:NSOX'I_;,BQ/Q7_ "><3_BD?UUD;Z1K
M/P       $\'XX_]IAJ_\S_;/\4V*"?XB_\ LU;K^&-A_;+-+>??Y/,G^-X/
MZZ70B>?A!8
M
M                                   !^-Q<6]G;SW=W/#:VMK#+<7-S
M<2T06]O;P452S3SS2U4QPPPQT\U555<\4TT\<\\\_1^\>/)FR5Q8JS;+:8BM
M8B9F9F=(B(CUF9GTB(]9E_:UM>T5K$S:9TB(]LS]D*&/SH_+91Y<[=<^+?CW
MLL-WXQ]?9ZTOMGV["RW%$7=V_P"&^YHINHKVFN.G(]8ZG=3<\8R+BCFUR>1A
M_4_5/''C)(+WOH;^DRWB3B:^4?(.VFGDWD,%JX=ODB)GC=KDTGIFND]&]SUC
M]-;7KPX;?=M,=K;FMYK>&?%\]K;6.Y.=QS'<6>DQ2EM/[WQ6T]-/=FO'Y\^V
ME)^7\,SDB:Z*Q)OL           !D+J?JO?>\.R=+ZDZOUO);=OV_P">LM=U
MG 8JUGNKJ\OKRKGFN:6FWCEJML;C;6B2ZO+FOCB&SLX99Y:J8HZZN,?[K[IX
M'LCMO>]V]S[G'M. V&"V;-EO:*UK6ONC68UO>TQ3'2/BR9+5I2)M:(G@\GR6
MRX?C\W*<EDKBV."DWO:TQ$1$?J^V9G2*Q[;6F*QK,PZ7WQM> VA?'OXXZ_U1
M@*,;F>Q<Y#C]B[I["MK>"JZW3?9+*GB]AL\CSB\5DYM)UB>>>UP-M<QTR6]G
M55)73]S<7-<GFK^I#SUSWU!>1MQW7OYR8>W<$WP\=M)F>G;;6+?#-J==Z1N<
MT16^ZO29B^2(K6?EX\<5KT\@=[[WOKG[\GGZJ;"DS3;XIF=,>/7TUC68^9?T
MMDF)TFWI'PUK$2!- ,&
M
M
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MQ7MBRUFN6LS$Q,:3$QZ3$Q/K$Q/I,3[']CXOP
M
M
MYCOR]_VE_F1_/#DOXJQ+TS?2+_LU=G?P/3^V9%B?BO\ D\XG_%(_KK(WTC6?
M@       )X/QQ_[3#5_YG^V?XIL4$_Q%_P#9JW7\,;#^V6:6\^_R>9/\;P?U
MTNA$\_""P
M
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M-!@
M
M
M         *9'Y!?Q2UZIF-D\^O'S7)I=:V3)5Y3R7TS"V-O3%K>QY.ZXXG[G
ML88KFB>;&[7D[JCC8(XK>NNWR-=62EKJCNKNNVN4_#^^JJO*[/;>!/(&YK')
M;;'T<-N,EIUS8:5]..M,Q,1?!2L_=)M>(OAB-M6(MBQ5R2U\&>3(W6+'V1SN
M2(W&.NFTR6F?CI$>FWGTTUI$?HIF?6GZ.(UK6+5-%KZ3H            "U#
M\$_S%?R3Y#!^&GEEOOL]37_V>&Z$[)V>OU0=:9::?B"UZ[VW8[J\I^PZWO\
MUTQXFYN**XL'<<\022Q8VJCFPJU^NCZ/?XU[?/YD\4;#7NS'U9.4V>&/7>8X
MC6V[P8:U^+>5]9STK,6W-/TE:VW,6C/&OS1XH_=/'?NWMC!KRE=;;G%3_E:^
M_+2D1ZY8]MXCUR1\41.37KNPJ5D00
M
M                                                   ',=^7O^TO
M\R/YX<E_%6)>F;Z1?]FKL[^!Z?VS(L3\5_R><3_BD?UUD;Z1K/P       $\
M'XX_]IAJ_P#,_P!L_P 4V*"?XB_^S5NOX8V']LLTMY]_D\R?XW@_KI=")Y^$
M%@
M
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M'Z&P
M
M
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MP]\<-]VWEHKW'M*1&:OL^9768KFI&LZQ;2(R:?F9)]D5O36&=,AMH
M     !=5^"?YCLAVQ^A^%_EENEG-V+86=GB>A.U=GR4].6[+@A^EO:]9;;D;
MJ*JWO]\L+>BGC$Y"XN*+C.1<<6LG$N1IHDOZ7/KH^CS;]J?/\S>*-E>.W<E[
M9.4V.&D?+V<SZVWN"E9UKM;3K\_%6DTVUOTM>G;S:N"(GFCQ1CXSK[N[8PS&
MPM,VW.&D?#B]\YJ1'K&.9_/K$:8Y^*-,>L4M6JKT:
M
M
M   ',=^7O^TO\R/YX<E_%6)>F;Z1?]FKL[^!Z?VS(L3\5_R><3_BD?UUD;Z1
MK/P       $\'XX_]IAJ_P#,_P!L_P 4V*"?XB_^S5NOX8V']LLTMY]_D\R?
MXW@_KI=")Y^$%@
M
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MB%?V]WFZY'=Y-_OLELN\S7F][VG6;6M.LS/ZLO5.J<8
M
M
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M?=KWMI%=(TCY-K3%<<Q'P3,8[?K+7L4J[VA0
M
M                                                        ',=^
M7O\ M+_,C^>')?Q5B7IF^D7_ &:NSOX'I_;,BQ/Q7_)YQ/\ BD?UUD;Z1K/P
M       $\'XX_P#:8:O_ #/]L_Q38H)_B+_[-6Z_AC8?VRS2WGW^3S)_C>#^
MNET(GGX06
M
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M:XL43,TQ5](]*ZSK.D3:TVO/Q6EM<U2QD
M
M
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M1$UM\5>J\X:$33@
M
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MJU^'IMHOZA=U]W["IBZ=?G\AAIKKITZ4RY-?9Z_L>FGI[==?32;^2@]"$
M
M
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M,Z=4^L3FO&D?'>/9$Z_+K/3$ZS:;2WHEM7
M
M
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M)TZJS[9Q9/ZNL>L6B-+UC6-)BU:S HA-5
M
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MOCF<FXO77V1'Z/%,UU]==<T1,QZ:3$3ZV7#5/Z*8
M
M
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M]C<;V'PD<9LY^9N\DQ?/FF-+9,FFG_@XZ^S'368K$S,ZVM>UM V_&;@
M       +R_P,?$K1T!J.+\QO)'3H8^]]XQM-SU%I&SXBXBS?2&GW7&0MIM@R
M5G>S>Q8=A=@8R>*3BBJWIO<)B:N(*I(KB\O[6"CSZ[_JRMW]R^7P]XXWDSV+
ML<FF_P!SAR1./DMQ7HM&*EJQK;:;6\6C6+SCW.>)R16V/#@RWAKYK\H3SFZM
MVGV_EG]Q<-M,^2EHZ=Q>-)Z8F/;BQ3K'MZ<E_BTFM*6M9K5GH[@
M
M
M
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M#S6GY&?3V^_Y>33TKEK'ZD7B.NGZZM)2D76M@
M
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M/DB/17-Y"[IGO'NW=\W37[G:_1AB=?3#CCIIZ3^;-])R6K[KWM#?%HEA0
M
M
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M_CCQUQW8'%SCK,9N:SQ$Y\WVS'LQXXGUKCK,SI[+7GXK:?#6D7:3[8X
M       "T=\!WQ)T=SYS!^;ODAK4-UT_J^2EN.BM"R\5Q1QV+O.OY6VXC[#S
MMK713;WO7NHY"SGAM+2KFJG+Y>+FJ;CBSM*X<A5]]>GU9V[-V.?PEXXW,T[O
MW6.(Y/=8YC^]-MEI.NTQ6UUKN\]+5MDR1I.WP6B*?ILT7V\;_-OE">)PW[.[
M?R3'*Y*Z;G)73]%CM6?T59]L9;Q,3:WZRD^GQWB:7=%)J'H
M
M
M
M   "C#\['Q"?[.>P9SS&\;\!>3=&;QLEYD.VM#Q&-]=ETIMFP7O-S3GL+#81
M^C&]5[1E+JN*.#F..VP&0KCM8J^+6ZM+>VO&^ACZNO\ 6)L,'A[R/N*1WQL=
MM6FPW62^EN2P8JZ?*R3:=;[[!2L6FVLWW6*+9;1\W%FR99F>%_*?[OX*=I]P
M7B.9PXXC!DM/KN*5C3IMK[<U*QK,ZS.2L3:8ZJVM:LVLM2&
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MN;ML\D7R<1EF;;?-,1I>OI,UMIZ1DQS/3>/37TO%8K:(23(W-?
M
M
M        * /S??$UEO#CLK*>1'1FL7EWXI]E9B3(9&VQ=E;4VG1.^;!E;NN7
M2+FQQEO!#C.M\G-/%QKEYS'1#;52?I4W-,L5I-?W[?1)]5^T\P]MXO'G?.YI
M3RIQN&*4M>T]7)[7%CK$;FMKS,WWE(BWWS'K-KQ'WJFM;9J8)P^'?)V+NSCZ
M\#S.2([FV]-(F9G7<XZUC])$S/KECU^;776=/FQZ3:*5^T_6\0     %N_\
M'O\ BHO)LGK'R"=_8.&/&6<-Y<>-F@9_#WU%Y=9.;BBW@[QR-OD*+>R_3;.R
MDFIU?CF*ZXGGFXRT54%5KCYYJCOQ _JHPTVVZ^G_ +!SS.YO-8YC=8LE>FM(
M]9XVDTUMUVM%9WOQ4Z:U^Z7B\9=Q2D6O.GDND8\G8W!WGYDS$;O+6T:1'M^[
MQ,:SK,Z?.]8TB/E3U1;)$7$U/J*0
M
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MIM:UIF;6M,ZS:TSK,S,SK,SZS/K+Z3C/F
M
M
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M>DQ,UFMID.1Z8&
M
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M/P_@
M
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MWK==&;N3-3]+E]L4B?7Y6+7UBD3^=;TG),:SI6*UK#FF&VN
MD4^-+X\.S/D2[[L= UJ"\P_5.FWFOYKO?LB.2*VATG2<A?7%/%EB[BYL\A;7
M.^;;;8N\M\%9U034RW$,D\U/%G:W4L<>/J4^H7MKZ>>P[\_R5J9NZMY3+CXS
M9S$S.YW-*Q\5XBU)C:X)OCONLD6K-:6KCI,YLN*ML#\A=^<=V'PEM]N)B_)Y
MHM7;8O;\S)$1ZS$3$QCI,UG);6-(F*Q/7:L3TFND>E.L_'/JC2.DNG=7L]-Z
MVZ\P_&%UC7[*J66FWADNKG(Y"]O+NYKEN\EF,UE[VXOK^\GKKN+R]N99Y:JI
M)*JN?-YWMWIW+Y%[KWW>O>&ZOO.Y.0S?,S9;:1K,5BE*UK$16F/'CK3%BQUB
M*8\=*4I$5K$*_.8YCD>?Y/-S'+9)R\AGOU7M/O\ 2(B(B/2*UK$5K6/2M8BL
M1I#*C%G6
M
M
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M_/I,ZQ[:]5)BTR*H[L"
M
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M$SZZ5B(U]=&9F&NI
M
M                                    >;W'<=4Z]U38MYWG8L/J6FZE
MA[_8-GV?8+^WQ>$P6$Q=O)=Y#*93(7<D5O:6=I;Q55UUUU<<<<<.RX?A^5[@
MY7;\'P>WS;OF-WFKBPX<59ODRY+S%:4I2L3-K6F8B(B'(VFTW._W./9;+'?+
MN\MXK2E8F;6M,Z1$1'K,S+GZ_,+\PNU^>6UWG3G3EYF-2\2-2S%,EA824W&+
MS?=6;Q=QZK/=MVLZO:N+36[2XBXFP>#FXXY@YXIO;VG[WV8<??W]('T@<5X(
MXJG>'>%,.[\M;O#I:T:7Q\=CO'Q;;;6]8MFM$].YW-?SO7#AGY/7?<3C\4^*
M=MV5MHY;EHIE[HRT]9])KMZS'KCQS[)O,>F3)'M]:4GHUF\%:<S<X
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M
M
M
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M$:9<6&!7D?QQR78/)=-NK-P>:T_(SZ>WW_+R:>E<M8_4B\1UT_75I*4BZUL
M
M
M
M
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M'XI\4[;LK;1RW+13+W1EIZSZ37;UF/7'CGV3>8],F2/;ZTI/1K-X*TYFYP
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M'1@(
M
M
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M?!DB)FND]5*2WHEM7
M
M
M
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ML?#^Z?*?+S]S9(F)O&LTPUGTZ,4S$3-K1^?DTB9CX*Z5ZIO!NG W(
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M:U^=D_JYK,]-?9CK::QK:;VM,:AXU0
M
M
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M$_)=CYK<ELM=QVS?)I6_MOAUTZ:9HTB(UF>FN2/AM,1KT6M%9FQ0K:@
M
M
M
M
M                                 >#[0[0Z^Z6Z^VSM7M7;,/HW7FC8
M>XSVU;5GKCFWQN)QMOS11ZJO11+<7=Y=W$L=O:VMO'+=7EU+'!!')-)''5WO
M;';'<'>G<&T[5[5VF;?=P[[-&+!@Q1K?)>?7WZ16M8B;7O::TQTK;)DM6E;6
MCF\=QV^Y??8N,XS%?-O\UXK2E8UFTS_W(B(UF9F8BL1-K3$1,N>+\LWRS=@_
M(?V#SJFJ<YC1O%G1LQ-/U]U]/-Q;Y+;LE;\36L?9'9$=K-+;7>R7=M+7Q86'
M%<MKA+66J**J2>2ZNKGT)_2?])_;_P!/7;_[J\K\G?>4=]AB-WNXC6FWI.EI
MV>SFT1-<-9B/FY=*WW-ZQ>\5QUQ8L<[O&'C#8]B;'[UNNC-W)FI^ER^V*1/K
M\K%KZQ2)_.MZ3DF-9TK%:UAS3#;7             ?2PV&S&QYC%:]KV*R6=
MS^=R5CAL'@\-8W64S&9S&4NHK'&8K%8RQBGO<CDLC>ST0P00T5RS2UTT44\U
M<\<.-O-YL^.V>7D.0RX\&PP8[9,N7):M,>/'2LVO>][3%:4I6)M:UIBM:Q,S
M,1#YY<N+;XK9\]JTP4K-K6M,16M8C6;6F=(B(B-9F?2(]97\?A0^(JW\)--I
M[X[^P.!R/E5O>-I_3[2JBC)U]$ZCD[/FBZU#&9&FZN<9-NV;@EYXS>0M*./9
MCYJQUM-);?<S7E"'UJ?5OD\U\S_$3L'/GQ^+-CD^.VLTCD]Q2VM=Q>G3%XVV
M.8_O;%DGXITW&2E<GRZ880^7_*5N\-W^XO!WO7MK#;UGV?>;Q/I>8TB?EU_Y
M.MO;/Z2T1;IBD_Z C1X
M
M
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MOYHP
M
M
M
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MF(T_1Q^DLUJST=P
M
M
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MWN[:2N"2>UNH>:J?7#<022VUS#51+#)7%7175Z%NV^X^#[OX':=S]M;G'O.
MW^"F;!FQS/3DQWC6MHUB+5GW6I:*WI:)I>M;1,1/#C^0V?*[+%R7'9*Y=CGI
M%Z7K[+5F-8G[8_+$Q$Q.L3$3$P\2[IRP            ']F.R.0Q&0L<MB;Z
M\Q>4Q=Y;9'&Y+'7,UED,=D+*:BYL[ZQO+:N*XM+RTN(J9(I8ZJ:XZZ>*J>>.
M>..7QW&WV^[V]]INZ4R[7+2U+TO6+4O2T3%JVK,3%JVB9BU9B8F)F)C1^<F.
MF6EL66L6Q6B8F)C6)B?28F)])B8])B?:NM_#G\ZV'[9M]'\3_,W89L?W'+-:
M:MUAWIF);6/ ]G\<41VV%U;LC)SW44F+[.N9/3;662JCJMMAK]-%Q)%DZJ*L
ME2S]87T,;SM/)OO*WAK;QD[.B+9][QF.+3EV7K,Y,^SI%9B^RB-;Y,,3%]I&
MML=;[:)C;1"\K^&,O&6S=S]I8XMQ,1-\VVKKU8??:^*(CUPQ[;4UUQ>VL3CU
M^7:;5<(V
M
M
M
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M^)_X-U=T_J'LPX^F[ZU_K7_=?[WX<\.;O_V1\6'D^3PV_P#./;7)L]GDK/\
MYO[:[C<5G^^/7%BG[OUWW$3/,'F#[U\WM/M/+_>OK3<;BD_G^ZV+%:/UGNR9
M(_/]:UGHUF]M%4ZC
M
M
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M++6:Y:S,6K,3$Q,3I,3$^L3$^DQ/K$HEVK:EIK:)BT3I,3[8G[)?L_#^
M
M
M
M
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M_K/6E?CUFER53HB<
M
M
M                                                 @J^87X>M4\\
MM4O.X^G+/#ZEY;ZEAZ8["_DJM\7A.ZL)B[?TV>D[M>5>U;VFR6EO%Q#@\Y-S
MQQ!QQ397M7V7LS8^<WT@?5_RO@CE:=G]X7S;OQ+N\VMJQK?)QV2\_%N=M7UF
MV&TSU;G;5_.]<V&/G==-QN?Q3Y6W/96YCB>6F^7M?+?UCUFVWM,^N3''MFDS
MZY,<>WUO2.O6+\_;<=.VOKW:]BT;>==S&I;EJ68O]?V?6-@L+C%YO!9O%W$E
MID,7E,?=QQ7%I>6EQ%517173QSQSPO\ .'YCBNX.*V_.<'N,.[X?=X:Y<.;%
M:+X\N.\1:EZ7K,Q:MHF)B8E./:;O;;_;8][LLE,NTRTBU+UF)K:LQK$Q,>DQ
M,/-NQ<@             !80^)3YPMZ\-[O#=$^2-WLG9_C%?WF)Q>$S5SDK_
M #&X^/UI'%!C:+G5;:>'(7FQ=;V=G#%Q/KD=<55C''S<8SZ2<2V-_7Y]67T1
M<%YBQ9N^O'%-MQGDW'3)?)CBE<>WY6TS-^G/,32N'>6M-NG>3%HR3/R]S\,T
MSX-%^4/#FR[LK?FNWXQ[;N*L6FU8B*X]S/MTO/I%,LSKIEG7JF>G)Z:7I?(T
M?>=-[,U'7]^Z\VG [MI.UXV#,:WM6L92SS6!S>,N?K[5YC<G82SVMU#S53S3
MSS35SS373535]*J>>.*).;X/F>VN6W' ]P[7/LN:VF2<>;!FI;'EQWCVUO2T
M1:L^_P!8]8F)C6)B4*MYLMWQVZR;'?X[X=YBM-;TO$UM68]TQ/K#U3JG&
M
M
M
M
M                          1L_(W\G/0OQV==RY#=K^';.Z-EP-_D>J.D
M\5<2TY[;KB&YHQT&6SU[!;7=OINDVV0DJ]_(WG%-5Q1;7$=C%=W,-4'$D?IT
M^F7OSZA^X8V_"XYVG9FVSUION2O$?*V\3'7./%69K.XW,TB.G#CUBDWQVSVP
MXKQ=L'L'QUS??N_C'LZSBXC'>(S;BT?#2-->FL3,3DR3'LI7V:UF\UK,2YV?
ME-Y9][>9?:N4[@[^W:\V[9[O[FTPUA3Z[36=*UZ7(WF2M-1TK!^[+#@];QDU
M])Q%%ZI)Y>>>9;B6>>N26OT.>+?$_8OAOM7%VAV#LJ;3C*:6R7_.S;G+%*TM
MN-SETB<N:\5CJMI%:_FXZ4I%:1/+MKMCA>TN,KQ7!X8Q;>-)M/MODMI$3?);
M]=>=(UGTB/96(K$1&M[8SOP             %LOX0?A1M]\M]*\U/+[6(;K1
M;J'&[9T)TMG+:B>WWBWGHBR&"[1[#Q\]-4<VDS1U1W.$Q,M/-.:IYHN[JG].
M]F+(50?6W]:>3@LF]\+^(MS->=K-\'*<CBF8G;3$S3+LMI>/6-S$ZTW.>LZ[
M>=<.*?O'7?;QB\Q>7K;*V;M#M7),;V)FFYW%9]<<^RV'%/\ SGMC)>/V/UI7
M])K-+FZFM$H
M
M
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M6,_,!=&
M
M
M
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MOV?A_
M
M
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M1/R\D?9ZQ\&2(_.QS.L>V)M32\R!- ,&
M
M
M
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MLOV?A_
M
M
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MB'DNR\EN3XOKW7;4S,]>GQX-;:13+I[8]8BN6(B+3K%JTG3JG/0<:9
M
M
M
M
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M+:9FUIF9F9F=9F9GUF9GUF9]9E$*UK7M-K3,VF=9F?;,_;+]GX?P
M
M
M
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M^L3$^DQ/K$HMVK:EIK:)BT3I,3[8G[)?L_#^
M
M
M
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MD^4Z-UW+,1/7I\&#6NDTQ:^V?68MEF(FT:16M(UZH,4XVY0
M %M'X2?A)_?#]T?,GS)U'_R/_P AV3HWHW9+'_\ +#_F7>([*[*Q%W1_^1__
M #)\-AIZ/_''\&ZNZ?T_V8<A4[]:_P!:_P"Y'WOPYX<W?_M?XL/)\GAM_P";
M^VN39[/)6?\ SCVUW&XK/][^N+%/WCKOMXP^8/,'W7YO:?:>7^^O6FXW%)_,
M]UL6*T?K_=DR1^9ZUK/7K-+F*FY$L
M
M
M
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ML
M
M
M
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M6@
M
M
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M?/CSG^P]Y\KDZQDX^]IC%N*1/R\GOB)U]:9-(]<=O7TF:S>L=4R'(],$
M
M
M
M
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MK6(F[P7 <1VUQM.)X7!3!L:>Z/;:?36U[3ZWO.D:VM,S.D1KI$0PFS5VX
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M7D[9NV.TLD5XF8FF;<UUZLWNM3%,3Z89]EKZ:Y?968QZ_,M-JN$;
M
M
M
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M\/YV;!'MF:^_+CC[8B<E:Z=47B+9%EE6PCV
M
M
M
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M2-)BE;&JNIH,
M
M
M
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MC+ROQO?&WKQV]Z=OW/2FM\?LIEZ?;?#,^WT^*V.9ZZ>NG56LW0JIHMN@
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M)9(8XZ\
M
M
M
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MDUQ1,Q6WQ3:]HK-9O4)6G0
M
M
M
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MFP=P_+[>[HM3#S<4B*9YF*TW$QKZ6C2(QY=-/37IR3KT]-NFDUIEDZ0@
M           #=[P=^07R.\ .Q)-WZ.V6&O!YF:UYWSJ_9N+V_P"N^PK6SMKZ
MULJ-BQ%G>V%U#DL53D99+*_LY[>\MI.?IZZX*Y89=)>;_I_\<^?>WHX3OC;3
M&^PUM]UWN'IIN]I:TUM;Y.2U;5FE^BL9,62M\=X]>F+Q2]<.[R[&X#OC8?<^
M9QS\ZD3\O-32,N*9F)GIM,3&EM(BU;1-9CW1,1,7Z_CP^5CQN^0_68+;2K_^
M3_N_&X>3*;KT-L^2BNMFPL%G79V^1S&KYBBSQUGO>GPWE]'11D+:"WN*.*Z/
MN[2SKDICYH2^H7Z5O(_T]<G;)S6/]T.R,F:*;;E,-)KAR3;JFF/-CZKVVNXF
MM9F<5[7I.EOE9LT5FR$??GC/N#L3<3;>5^?P]KZ8]S2-*6UUF*WKK,X\FD3\
M,S,>WIM>(U2<HS-=
M
M
M
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MM@
M
M
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M,3$QI,3ZQ/I+Z3C/F
M
M
M
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M8K$>D0ECMMMMMGMZ;39XZ8MKCK%:4I6*TK6/2*UK6(BL1[HB(B'P7.?8
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MW>:28<
M
M
M
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M3X_F-ECY+B\U,^QRUBU;TG6)B8U_5B8]]9B+5GTM$3&C'K('.
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MM]]RYW!-*VF?EY:ZVPY8CWX[Z1K[IFEHKDK$Q-J5UC7<9IYB8
M
M
M
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M8YK+.;>Y/37V5K6/S:4K'I6E?=$>^9F=;3,SGA@CI0
M
M
M
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M,6K,3$Q,3I,3$^L3$^DQ/K$H\6K:EIK:)BT3I,3[8G[)?L_#^
M
M
M
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M6F=9F9GUF9EZ1UKC@
M
M
M
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M@\<^5>'[ZPQL\O3MNXJU^+#,^F32NMKX9G\ZOMF::S>D1/5K6.N8>4OVU@
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MQ,
M
M
M                                                        !BON
M?O#J/QWZ^S':G=W8&M]:=?X'VJ,CLNSWW%I:?<W/-7%IC;""BF:_R^8OZJ.:
M;>RM(I[NXJXYIBCKY_8RGLSLCNWR'W!A[6[)X_<\ES^?7HPX:]5NF/SKVF=*
MX\=?;?)DM7'2/6UHAV?$<-RG/;ZG&\/@R;C?7]E*1K.D>V9GV5K'OM:8K'OF
M%)WY+_R#.W/(:7-]0^'-YLG1O24OJQ^9[$CJYP_<_8L=O=WG$OV&7L;R6;K?
M3\E#Q;5TV]C5'FYZ8ZJ;B\CM[B>P74_35^']VEX]K@[N\PTVW.=ZQ\>/:3^D
MX[:3-:Z=>.U8C>;BD]<=>6)VU9F)QX;9,=,Z7WCSP9Q?!13E>ZXQ[WF(]:XO
MSL&+6(]M9C]+DCU];:XXUUK2;5K=6S60I @               /[,=CLAE\A
M8XG$V-YE,IE+RVQV-QN.MIKW(9'(7LU%M9V-C9VU$MQ=WEW<2TQQ11TU5R5U
M<4T\<\\\</CN-QM]IM[[O=WIBVN*EKWO>T5I2E8F;6M:9B*UK$3-K3,1$1,S
M.C\Y,E,5+9<MHKBK$S,S.D1$>LS,SZ1$1ZS,^Q<E^)#X!;34_P!UO);SQURS
MRFS\_HVS]:>.5_S+-C]7JI^E_9YCN_'W%I%#DMDIFXBDBUGBN6RLZ./3E/?G
MDEL+.G3ZM/KXR\M]Z\:^"=S?%QGZ3#O.7KI%\WZVV/C;Q:9IATZHMO-*Y,D^
MNUZ,=:Y\T3O*/F^VZ^9V]V5DFNW^*F;=1[;^Z:[>8GTI[8G+Z6M_R?36(O>V
M7;V]O9V\%I:00VMK:PQ6]M;6\5$%O;V\%%,4,$$,5-,<,,,=/%---/'%--/'
M''''T509,F3-DMERVFV6TS-K3,S,S,ZS,S/K,S/K,SZS*,-K6O:;6F9M,ZS,
M^V9^V7[/P_@
M
M
M
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M,:3$QZ3$Q/K$Q/I,3[']CXOP
M
M
M
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M\<>$>WX[?\?\?3;TMZYMQ?3)N]S;^FSYYB+7_J:1TXL?LQXZ1Z)G=K=G=O\
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M+Y+\O<EWIDMQG%]>U[:B9CHU^//I;6+Y=/9'I$UQ1,Q6=9M:\Z=,YZ#C3(
M
M
M
M
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MQ,)G\3R_&\[L,?)\1FIN-AEB>F])UB=)TF/=,3$QI-9B)B?28B6,63.Q
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MT5F4BJ.[ @
M
M
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MV[\YWOKDOOG*WZ=I2;?)P5_8\59]T>D=5YTCJR6^*T^D=-8K2N^#1+"@
M
M
M
M
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MNQO(? =^;/YO&6G'R%*Q.7;WF/F8_=,QIZ7QZSZ9*^GK$6BEIZ8CQ2$9V
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M;\;R^#+M]]2?6EZS6?;I$Q[K5G3X;UF:VCUK,QZLG,9=<
M
M
M
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M99UM>VGK[HB(B(K6L1Z5K6(K6-(K$0RHQ9U@
M
M
M
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MZS%:_P!\8_;^=CK&EZQ&GQX_7777'6(UFPBK[:+
M
M
M
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MRVF9M:9F9F9G69F9]9F9]9F?691CM:U[3:TS-IG69GVS/VR_9^'\
M
M
M
M
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M?=X^-^Z>R+]7*X.OCIG2NXQ:WPSZ^D6MI$X[3KZ5R16;>O3U1$RD51W8$
M
M
M
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M+SZVM,I6<1PW%\#L:<;P^#'M]C3V4I&D:S[9F?;:T^^UIFT^^98K92[(
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MHBM6
M
M
M
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M6MX_IL=XUI>OKZS69TGTG2T3$;"-?.B
M
M
M
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MMIF9V$:^=$
M
M
M
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MM-9CUB4I=MN=MO-O3=[/)3+M<E8M2]+1:EJSZQ:MJS,6B?=,3,2^"YS[
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M !>ZML>2PY<&\I.EJ9*S2T?JQ:(G]2?9/N>V=(X8
M
M
M
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M9F9F=9F9GUF9GUF9]9E&6UK7M-K3,VF=9F?;,_;+]GX?P
M
M
M
M
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M#/@S[7-;;[FE\>XI.EJVB:VK,>V)K.DQ/Y)A]APWR
M
M
M
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M)UIML<S\N)_IK^SYF3^JM'PZS%*UB9B9+4:VO0
M
M
M
M
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MKAZ>;P?WU6-*9L<]&:GZEM)BT1[JY*WI'MZ=?5<!\)/R)?$CR)_2-,\AHO\
M93[2NO8M/O\ :\K3E>E,]>U>F+WK#LK[:Q_<SW_;DN)8]CM<?C[*/FB*G)W<
MO/UYJ&\V?AY>6O'GSN9\>S_&KM>FMNG!3HY+%7VZ7V?5;[QIK%*SL[Y<N2=;
MSML-?9%7O#P-W1P/7N^!G]T^-C6=*5Z=Q6/RXM9^9[HB<4VM:=9^72%@NWN+
M>\MX+NTGANK6ZABN+:YMY:)[>XMYZ*989X)HJJHYH9HZN*J:J>>::J>>.>.?
MHK^R8\F');%EK-<M9F+5F)B8F)TF)B?6)B?28GUB6C+5M2TUM$Q:)TF)]L3]
MDOV?A_
M
M
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M2(CTB(A[QT+A
M
M
M
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M;1,6B=)B?;$_9+]GX?P
M
M
M                                      !^-Q<6]G;SW=W/#:VMK#+<
M7-S<2T06]O;P452S3SS2U4QPPPQT\U555<\4TT\<\\\_1^\>/)FR5Q8JS;+:
M8BM8B9F9F=(B(CUF9GTB(]9E_:UM>T5K$S:9TB(]LS]D(!O._P#(.\5_%VXR
MF@]%6T/E+VY;PRPR3:AL-A:=.:M?<5S6U<6P=B6G&5DV#)6,G%,W-AA+2[AF
MIIKAFO[&7Z<\3X\%?A^^4_*&/%SW?-I[6[2M,3$;C%:W(9ZZ1.N+:6Z(Q4M&
MM?F[G)CM69B],&>C=_97@ON7N2M=]S4SQO%S/Z^LSGO'M^'%/3TQ/LZLEJS'
MI,4O"G-YG_(_Y:>>.Q_JG?'8TU>J6DW$NO=2:7'=:OU/J_%,LL\56.U2B^O)
M,ODH9+BOBG)YFYRF7]KGB+F[YACCCHN%\,_3EXG\$\=]U[$XZ(Y6\:9=_N9K
MGWV;TB)Z\\UK&.DQ$:X=O3!@UUO\KKM:TRO[1[ [7[*V_P OA=O'WF8^+/DT
MOFO[O6^D=,>GYF.*4U]>G69F=%6\V9@                  -HO$[PT\B?-
MCLFVZQ\>>O<EN&4CFL.=FV.;BK&Z-H&*OZKGT9[?-LN(^<9KV-]BPN:X8ZN9
M+[(56]<%C;W5SS1!5K#ROYD\>>%>V[=S>0N0Q[/:S%ODX8^/<[J]>G]%M<$3
MUY;ZVI%IC3%BB\7SY,6+6\8YW/W;P/9_'SR//9ZXL>D]%/;DRVC3X<=(];3Z
MQK/I6NL3>U:ZVB]K\;7PG>.W@O9Z_P!B;I:XWNWR9@AQ^1N.QL]84SZYU[FO
ML::+ZRZEP5Y#13C8;:ZEDICS-Y%5F)Z..*Z>;.BNJVIHL^I#ZU/(?G+-N.WN
M&ODX3QI:;TC:8K:9MWCZM:VW^6LSUS-8B9V^.?N]9])^=-8R3"[R!Y?Y[O.]
M]AM)ML^W9F8C%6?CRUU])SVCVZQIKCK/1'LGKF.I-6A<U"
M
M
M
M
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M)])B?8_L?%^
M
M
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MC69Z:UC2M*1,SI2D5K76=(AF!B#J@
M
M
M
M
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M1-;5F/;$UG28G\DP^PX;Y
M
M
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MT58BFDZ7^9-:V3>H2M.@
M
M
M
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MNY-C7DN#W&/<[.WZZNNL3]EJS$7I;^IO6MOR,)LU=N
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M
M
M
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M-QM<'WGEJZ3]XSZ7O$_;CKI%,6DZZ32L7TG2U[(KTI6R@
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M&^O[;WG6=(]D1'LK6/=6L16/=$,J,6=8
M
M
M
M
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MMHF)K:)F)B8F)T2#QY*9:5RXK1;%:(F)B=8F)]8F)CTF)CUB8]K^-]GZ
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MJB-)F(UAM0U8QH
M
M
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M\5M*6WM?^7RZ9,\S[-8O,:8]8]L8JXZS[9KKZH]T@F=
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M]S][WG#N;_=N'CV;?%,Q2?RY;?G9;>S\[X(TUI2LS;65%%IK4
M
M
M
M
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ML0
M
M
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M;/9G;7:&W^[\!M<>&TQI;)^=EO[_ (\EM;S&OK%=8I6?S:UCT:EML,G
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M?:TS,^^4:\^?/NLUMQN;WR;B\ZVM:9M:TS[9FTZS,_EF7V'#?(
M
M
M
M
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MEI:EM)]DZ6B)TGW3[)]TRR$Q]P
M
M
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M^:^OPU_-QXX]FF/'&E:^GMF(ZK>VTVM,S.T35[&P
M
M
M
M
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MGKI&GK&LEJ-;7H
M
M
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MRY-*VR_EK,5QZZ3\O6(E+VB*U8
M
M
M
M
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MFWCTGXJ3,3I.DLY,'=,
M
M
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M[:[$[4[2I$<'L\6+/IZY;:WRSZ:3^DO-K1KZZUK-:>LZ5B/1I:W.RX
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MF9F=4?,F2^6]LN6TVRVF9F9G69F?69F9]9F9]9F?:_L?%^
M
M
M
M
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M]9B8F)B:Q.L3'N:=WFRWG'[BVTW^++@W5)TM3)6U+Q/LTFMHB8]?MAZIU3C
M
M
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MTVGVZQ$>ZM8U^&E8BM8]*Q$>C)S&77
M
M
M
M
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M;4O6?LM6T1:L_DF(EJK+ARX,DX<];4RUG2:VB8F)^R8GUA])QGS
M
M
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M=,SZMG&LF.@
M
M
M
M
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M)B8UB8F/28F/6)CTF&Z*VK>L6K,368UB8]DQ]L/Q?M_0
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MVIEK.DUM$Q,3]DQ/K#Z3C/F
M
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MCV3VO6MN/V.*^[K.OSLT1ERZ^S6+7B8IZ>GZ.M(TU]-9F9CE2*9\
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MN)R\WN;3MNK6N&FM,-/LBN/6==/9%KS>^GMM+=YI)AP
M
M
M
M
M                                                  "-GS3^)[PP
M\YK?(97M#K>'5>T+J&JFV[GZT^SU/L2BXXH]$,N<NHK.YPV[0Q<<<4\1YJSO
MJHX^.:8:X>>?5Q)'PQ]5OF7P=DQ[7MCDIW7;%9^+CMYU9]IIKZQBK-HR;:9]
MNNWR8HF?6\7CT;![1\G=V]FVKBX[<3EXV)]=OFUOBT_J8UBV/]7':NL^V)5+
M?-/\=GR_\=+?(;CT)<P^6?6]G#5=7-OI>#FP'<>'BHH]<W%QU7)DLU)M<-$D
ME$,'.O7^5R-U5Q5)7C[:/A;%X8_$.\0^1,F/A^_:SVGW'>>F)W&6,O'Y)F=(
MTWT4QQ@F8B;6^]XL&&D:5C<9;2D]VCYY[5Y^U=IS<3Q?(3.D3DMU8+?J9M*]
M'VS\VM*1Z1&2TH <CCLAB,A?8G+6-YB\IB[RYQV2QN1MIK+(8[(64U=M>6-]
M9W-$5Q:7EI<151RQ24TUQUT\TU<<<\<\)];?<;?=[>F[VEZ9=KEI6]+TM%J7
MI:(FMJVB9BU;1,36T3,3$Q,3HWCCR4RTKEQ6BV*T1,3$ZQ,3ZQ,3'I,3'K$Q
M[7\;[/T                           SETOY->0_CID^,MT3W9V=U/=53
M3SW,6C;GG<#C,C7=<6%-U3F,+97D>&S4-SQB[7W([N":.3FUAYJIYYBC].#]
MY^,_'OD7;?=.^N$XSEL6D1$[G;XLMZ17JZ?EY+5G)CFO7?2<=JS'7?2?BMKT
MW+]N\#S^/Y7-;/;;JND1'S,=;3&FNG3:8ZJZ:SI-9B8UG[93M>.WY-GF%US%
M!C/(+KGK?R2Q47OUR9BV]/3'8-S)7:>S!'-FM3PF:T&FS@NZ*9N:(]6CFK]4
ME'N\<51\PP6\A_AG^(.X[6W/C_D>2[;W4Z:8Y_\ :.TK$6UF8QY\F/==4UF:
MZSO9K&E9Z-8MUZ7Y[Z=^U-_,Y."W&XX_)/ZV?[XQ1Z_TM[5RZZ>GKFF/9.GM
MUG;\??R)/CN[CM[>TW_9]V\=-GEFIM><5VEJ60R6!NKCFB*3F7';GU_1MN'@
MQOTDJI]_+<8BKUQ5\<Q\<<QU206\@?AY?4-V=DMEX#:[+N+C(CJZ]EGI3+6-
M9C2^WW7R,DW](GIP?>(TF/BF>J*Z6YWP/WYQ-IML<>'?[:(UUPWB+1'Y<>7H
MM,_DIU^V/7VZ32]?]E]<=LZY!N'5?8&D]EZE<S5V]MM/7^UX+<M<N+B.*">2
M"#-ZY?Y+&2S407,=?--,O-7%$E///'TJX^L,>?[:[C[3Y&W#]T\?O>-Y:L:S
M@W6#+M\T1,S$3./-6EXB9K,:S736)CW2U'ON/Y#C-Q.TY+!FV^ZB-9IEI;'>
M(]FO3>(GVQ/N]SVSI'#
M
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M(B(C2(B(](B(](B/2(;)K6M*Q6L1%8C2(CV1'V0_%^W]
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M?)'=/>]^GE<_1QT3K7;XM:88]?2;5UF<EHT]+9)M-?7IZ8F82*H[L"
M
M
M
M
M
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MU5M,>GM;ZVN[VN^V]-YL<N/-M,D:UO2T7I:/MK:LS68_+$R\V[%R
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M&IF+@
M
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MUM)]D0DF1N:^
M
M
M
M
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M[J(UFF6EL=XCV:]-XB?;$^[W/;.D<,
M
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MY,D>O5Z9<LWR>DQ$Q'5I$Q&GLC32UN=EP
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M3,WF)]ELMKWCV1;3T;^M!L'
M
M
M
M
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M5M:98]-9_1WBMIT]=;5BU/2=+3'JTM;G9<
M     ]AHW8>_]89^WVSK7>-PZ\VFS]G[39=&V;-:EG[7[>]M,E!]OF<!>X_(
MP>QD<?!<4>F3CTSP1U\?2JBGGCJ.<[>X#N?86XKN78[/D.+OKU8=SAQY\5M:
MVI.N/+6])UI>U)UCUK:U?9,Q/%WNPV/(X)VO(8<6?;3[:9*5O6=8F)UK:)CV
M3,>SV3,>R4L71/SU?)9T=;XS%S]RXWNG7L5#;P6^#[VU:QW:XGHMZ*8O5D]X
MQTVM]H9::>.BGB22ZSLLE57'-?JXKJKJJBCWU]!WTV=[Y,NZQ\-DX7D,LS,Y
M>,SVVT1,SK\&VO&;98XB9G2*;6L1'IITQ$1K'FO"?CWF;6R5VEMGGM,ZVVUY
MQQ&OV8YZ\-=/=$8XCW>S1,/TC^4]@)OL[#R/\5LQCO3Z/O\ :ND=RLLS[WU^
MG$GV>@;W%@?MO;^GUI]>RR^OU?3GT^GU50_[V_"VW].O/XY[JPY-=>G!R6WM
MCT^SJW6UG+KK[]-G7337UUTC5/,?39GC6_ <G2WV4W&.:_\ #EQ]6O\ 8H_H
MIC.B?FU^-;OJ**+'^1^M]79NKT_<8#O:&;J26S]=I>7E/N[-M','7]S_ (NP
MEHY^VS,_IF]N.KZ5SV],L/.^OHI^I+L.TWW';FYY391[,O&3&_BWQ5KZ8<&N
MZCUO6?CV]=:]5HUK3)-=4<UX?\@\),SDX_)N</NMMOT^OK$?F4URQ[8]N./3
M6?96VDHN V+7]KQ-IG]7SF'V3!7_ +_V.:P&3LLQB;W[6YFLKG[3)8Z>YL[G
M[:\MI(I/17SZ)8ZJ>?I53SQQ&#?\?O\ BMW?8<I@S;;?8].K'EI;'DKU5BU>
MJEXBT:UF+1K'K68F/28:WSX,^VRS@W-+X\U=-:VB:VC6-8UB=)C6)B8_).K[
M#AOD
M
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MI[/@PTI7T]WIZ-K['C>.XO#]WXS;X-OM_P"EQ4KCK_\ 8TB(_P"X\&[US0
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MQ'IU3$WG]=:9]6X#4+%0
M
M
M
M
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M^D>F'TC6?72*S+1TU\]'QD]P18V"?O2\ZDS^2]KZ:WW+I>RZE+8^NTL;BO\
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M/MLNLQTY<=\<ZQIK&EXB?36-?LUC[60F/N
M
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M,^NFK.3!W3
M
M
M
M
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M;%EK-<M9F+5F)B8F)TF)B?6)B?28GUB6&6K:EIK:)BT3I,3[8G[)?L_#^
M
M                                        /FYC,X?7L9>YK/Y7&X/#
M8Z'FXR&6S%]:XS&6%O3SQ35/>W][+!:VL/%57''-5==-/UY_PN3L]GO.0W--
MEL,63/O,DZ4QXZVO>T_96M8FUI_)$3+Z8L.7/DC#@K:^6TZ16L3,S/V1$>LH
MZNZOE]^-[HBWNN=M\L.L=DR<$,W,6 ZFR%SW)E[B^BHRO-&'EIZPM=IQV%R4
MMQAY8:N,G<6,-M+)#]Q)#3/%57(CLOZ1/J.[[R5CB>U.3VVVM,:Y=_2./QQ6
M9IKDC[[;!?)2(R1:/DTRVO6+_+K>:7B,]XCQ7Y YJT?=>,W./',_G9XC!6(^
M'XOTTTFT:6B?@BTS$3TQ.DZ14]P?E%^,&L2WMITGX^]P=M7%KZ*(+_<<QK/4
M>O9&7[NWIEDL[RWI[)V".SIL*Y9**[C%0353QTQ<Q4T5\S4RH[0_"_\ )W)U
MIE[U[@X?B<=M=:[?'FW^6D=,Z1:L_<\4VZ^F)BF>U8K,VB\S'1.R^*^G#N/<
MQ%N8WVTVM9]L8ZWSVCTGVQ/RJZZZ1Z7F-)UUF8TF)#N+\E?Y -]KN+;K/%=,
M]$XSF&2*SN=:TJ7=]ICKGM\?37<7V5['R.RZU>36MW:SUVW$6%MHZ(KGFB:F
MXJHHEXEIV?\ AL^ N!K7)W-EYGG=SK$VC-N8VV"8B;Z16FSIAS5BU;5B_5N;
MS-J1:DXXM:L[1XGZ>^Q]E$6Y&V[WN37UB^3Y=/29](KBBEXUB8UUR3.L:Q-=
M9A$CW;YQ>8'D?]W#W=Y(]P=@XN^]S[C6,MNV9MM)X]WZ^[]OHN)N,?IUG[M/
M/TK]FQC]5/'''/UXIXXXEIV3X0\0^.>B_9/;?#\?NJ::9L>VQVW/I[-=UDB^
MXMI[NK+.DZS'K,MH</V;VKP&D\/Q^TP9(]EZXZSD_HY+1.2?Z-FJ[:3)0
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MD=:XX
M
M
M
M
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MIEK.DUM$Q,3]DQ/K#Z3C/F
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M$\5Q&+Y'%;;;[7#/ZW%CICK[9GV4BL>VTS^K,S[Y8W9&YX
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MQ6)U2HHM-:@
M
M
M
M
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M#O'MCNFDWX'>X-Q,>VL3-<D>_6<5XKDB/LF:Q$Z3]DZ:KMI,E
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M1U3@R329F-8B+Q6:3.FOI%ITTF)]8G3;5J9BX
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M,5S9W&2V';*L_P 9*UBAHEXICQ,MM)1-3QQ/Q7Q731(KMK\,WSEREIOW%R/
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M_)6GI2D>WTK6(UF9]LRSPP1TH
M
M
M
M
M
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MO+<7S&WC=\3N,&YVL_KL5ZWK^I,UF=)])B8GUB8F)]88W9&[
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M%9MKDP9:1TQ[;?%2/2/?/LAGY@+HP
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ME,>.M:4K'V5K6(K6/R1$0R_%AQ8,<8<%:TQ5C2*UB(B(^R(CTA\UR7T
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MZS,SZS,^LRU?:UKVFUIF;3.LS/MF?ME^S\/X
M
M
M
M
M
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MND3.GY)>\="X0
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M_*PX\?3KKKT]-8TUUG73VZSK[6(&7NU
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M:Q6L1&D.4Y?E.;W5M[R^XS;G=6GUMDO-I_4C69TB/2(K&D1$1$1$1#)S&77
M
M
M
M
M
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MW-GO=GR&WKN]AEQ9]K>-:WQVK>DQ[=8M69B?3[)>5=HY(
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M^93D-O72?='RXF/METVX^FC;6R:[7F+TQ:>R^VB\Z^_XHSXX_H=/]&6;,/\
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M=9_4CU9;_K"_ 3^G%X?_ .\OTO\ Z:L2_F^>>_\ 0?N__J;D?\F=7_$3O?\
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M;:3[ITTEUVXVVYVF3Y.ZQWQ9=->F]9K.D^R=)B)?><!\
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M6*MIUF*5K6)G[9Z8C5Y9VCD@
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MD
M
M
M
M
M
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M>F9T]8F-)TG6)CVQ+&+)G8@
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M7/%8C[(B(B/9$1#^S^OM^6/^E;_ZB_&S_P!SKX_S#?I1_P!%?^T^8_S@_/\
MJ3\8_O9_TC=_W<_K[?EC_I6_^HOQL_\ <Z?S#?I1_P!%?^T^8_S@?ZD_&/[V
M?](W?]W9.P_Y%7R<XS&6=A>]@]8[#=6L/$4^:S'4.HP9/(U\<\\\W%Y%@(,'
MAJ)JN.?ISQ;VD$?TX_93]?KSSC.\_#O^F7<[F^?#Q_)[?%:=8QX]_GFE(^RL
MY9RY)C_CY+3^5UV7P+XZR9)O3!N<=9G\VN>^D?DCJZK?\-IG\KZ7]XX^3#_S
MHZ?_ /1-B?\ PYQO]W1]-7^"\Q^W\G_BOG_J"\>?\WN_[/;_ +Q_>./DP_\
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MC_=T?35_@O,?M_)_XI_J"\>?\WN_[/;_ +Q_>./DP_\ .CI__P!$V)_\./\
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M:1$1'I$1'I$1Z1#M*UK2L5K$16(TB(]D1]D/Q?M_0
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ME8M)_6SCQ]-;Q$>D3?JG3769F9F=\6B6%
M
M
M
M
M
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MZNC+[O7Y.3IRZ>L1KT::^GM:?MO,J
M
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MM)<]Y"[S[EBU.7Y#<7V]]=<=9^7BF)B(TG'CBM+1I&GQ1/MF?;:TSO*T>PT
M
M
M
M
M
M
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MQ[)B?;[)B?9+Q[MW*
M
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M&E*^R/96/9'V0V6:U8\
M
M
M
M
M
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MVB9B8F)B=&P<>2F6E<N*T6Q6B)B8G6)B?6)B8])B8]8F/:_C?9^@
M
M
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M<8
M
M
M
M
M
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M%&?;7IDPVUTM68M6=)TG28UB=)B8G\L:/D.6^H
M
M                                      #:[HGP6\P_)BXQL?1OC?VU
MO^/RTUO!:;38ZCD<5H5-=W711;U7_8NPT8C0\3#)Z_5[EUD88^(Z:J^:N**:
MJN-5=]><O#_C3'EMWQW'Q.PW&*)FV"V>E]UI6-9Z=IBG)NLDQ[-*8;3K,1IK
M,1.,\UWGVIV[6T\SR&UP9*Q.M)O%LGI[=,5>K);]2M)G7T]LIDNC?QE/-??/
MT[(=T]@=/]!X>Y^T^_QGZG?]I[_C?>_2)[K_ ,1ZG%9Z+>?9VMY=1_P-HX]R
M]L_;X_R>6B[XASWQ^)AX6X'YFW[+X_F.>WE>KHOT5V.UOI\R*_I<\VW->JU:
M3Z[+TQY.J?TE)Q-3<S]1':&RZL?$8-WOLL:Z3I&'%/YVGQ7UR1K,5G]A]*VU
M_.B:IC>A/QG?"+KR*UO.[MP[4\B,W']K]Y97.6_DJT6Y]JTMJ;GV<#I%U5NE
MK]UD*9Y./KLTOMP5QQ<?6N.N>:'G?GXE?FSN&UL/9.SXKM[93U=-HQ_?MU&M
MK=.N7<U^[VZ:=,?^9UUM%K?FVBE-4<W]0W>._F:</BVVPP^NDQ7YV2/6=/BR
M1\N=(TC]BC6=9]DQ$3,]$^%WB=XR11<=#>/?5?6E_%Z?KL6!U/&U[C<>BTO+
M"C[[=\C%?;?D?;LLE<Q4^_?2>F.YFIX^G$LGJAOWUYG\K^3+3_'ON#E>2P3_
M ,EESW^[QK:MIZ=M2:[>FMJ4M/3CC6:4G];734O-=W=S]Q3/[M[[<[BD_K;7
MGY<>L3Z8XTI'K$3Z5CUB/LALXUDQT
M
M
M
M
M
M
M  !C?LKIOJ'N?$Q8#N'JKK?MC!0^OV<+V5HVL;UB8O<N;"]D]K';1B\K9Q^Y
M>8JUEJ^E''UEMHJN?X4='/&1]M=X]W=F;N=_V?RO)<5OK>W)L]SFVN2=*VK&
MM\%Z6G2M[U]OYM[1[+3KV''\MRO$9?G\5N=QM<T_KL62^.WLF/;2:S[+3'ZD
MS'OE%1W+\ WQF=NV\G./Z=SW369DAX@_>#IK>L[@+BBBBCBB*J/7=HDW'0Z)
MH_VU<R?I'N25<_XRJOZ<?25/9OU\?4MVCDB-QS&#F=G%M?E<CML66)F9]=<V
M&-ONM)^S[QI$?FQ7U;+XGS?Y#XJWZ3=TW>+77ISXZVC_ .RI\O)_0Z](]VB*
MGN7\5VPDER60\>_+.\M8?\;^D:CW+U]#?R\^J[OI(?U+L32,MC:>/:L*K:&K
MVM7Y]R:B6;CT4UTP1RH[._%+W%:X]OY![3I>_I\S/Q^[FD?FUB>C:;G'?VVZ
M[1U;WTK-:>LUF]MF<3]2EXBN/G>+B9_77P9=/='LQ9*S[]9]<WI&D>NDVF*+
MMO\ 'T^3;J[[J?$=4:?W)BK+[RJXRO4G9&M7_P#B+7[3VI[77]YFT/<LE^H<
MW57$,5KC)[CCV).9(X^/;YDE7VE^(#],_='3CWG*[SAMU?ITIO\ 9YJ^MNK6
M+9=M&ZV].CICJM?-6GQ5Z;6GJZ=F<7YS\=\EI7+NLNTRSII7/BO'MU])MC^9
MCC33UF;Q'K&DSZZ1:]L^.?D#T-<16W=W2';74<EQ-1!:5=D=>;9I=OD*Y:\E
M';U8R[V'$X^UR<-U5A[OV9+>N2.:FVEYHJJXHJYXE%VGY%[ [\QSE[)YOB>7
MK6)FWW/=X-Q-(B*3/77%DO:DU^9CZHO$36;UBT1-HUV3Q?/\'S=>KA]YM=U$
M1K/RLM,DQ[-=8K:9C3JKK$Z3&L:^UAEF3M@
M
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M'TT]_I'3I$>D:1Z-TVF&(@
M
M
M
M
M
M
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M^K6NQ^,^I+@<TZ<OQV[V^OOQ7IGB/6-->KY$Z::S.D3,:1$1.NL1F]L_!_\
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MZ3K29CUTG3[=)^QCUD#G
M
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M=[FMO;7)EO:OMB=(I,],1K$3I$1&L:^UL(U\Z(
M
M
M
M
M
M
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MKIZTFT7C6?9K6-?28UB8:KMI,E
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MDR7RWMERVFV6TS,S,ZS,SZS,S/K,S/K,S[7]CXOP
M
M
M
M
M
M
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M[:VK,UM'Y8F893BS8L^.,V"U;XK1K%JS$Q,?;$QZ2^:Y+Z
M
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M#31'1;U6_//,L4D_TFXCUW'^(E]3'-WF_&;[BN'K-ZVTV>PPWB(BG3-(^_\
MWZ>F\_I+3,S>+^E;5I\# ^0\]^1-Y,SM\VVVD:Q.F+!2=-(TT_3_ #ITF?BG
MUUU]DQ7T2*=<?'UX-]2>U)U[XD>/>OWT/W?$6;_DIT_+;-3%?>G[JV_>G-XK
M);'59R\4\<>QS=<PT\?LXIXX1W[C^H#SAW;K7N#NWN#<8+=.N/[]N*8=:_FS
M\C'>F'JC^FZ.J??+ N0[Y[RY36-]RF_R4G3X?G9*T]/9/16T4U_+IJW!:A8J
M
M
M
M
M
M
M
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M[*?OWU[MNH?IN0F^GLV-_P#O!B,?]G>2_7^#%)Z:ZO\ DX;;X+OGLGNCY?\
M%GF.*Y'YM)O3[KN\&XZZ1[;5^5DOU5CWVC6(^UE.RYKA^2Z?W.W>VW'5&L?+
MRTOK'VQTVG6/RPQ6REV0
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M?69F9]9F9]9F?:_L?%^
M
M
M
M
M
M
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MIB/2-=*S,Z:S$:_EAX1WKF@
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MC73VZ0V0:X8^
M
M
M
M
M
M
M                                                        \'M'
M5?6&\9"'+;KUQH>X96WLX\=;Y/:-0U[8,A!CXI[BYBL8;S+8Z[N8K.*YNY9*
M8J:N**:Y:ZN./K5SSSWW%]T]S\)MYVG"\CO]GM;7F\TP;C+BI-YB(FTUQWK$
MVF*UB;3&LQ6(UTB'-VW)<CLZ3BV>XSXL4SK,4O:L3/I&NE9B-=(B-?R0P;F/
M WP;V')WF:S_ (9>*.<S.1FYN,AELQX[=0Y/)W]QSQQ3S/>7][I\]U=3<TT\
M<<U5UU5?3C_"SC9^=_.''[:FRV'>7=>#9XXTICQ\MOZ4K'V5K7<16L?DB(AW
M.+O7O+!CC#@Y?DZ8JQI%:[K/$1'V1$9-(8 R/PZ_&3E,??8VY\.^JXK?(V=S
M8W$F._>;$9".&[AKMY:['+8G8++*8R\HCDYYBN+::&X@K^E<==-=/%7&?;?Z
MP?J8VNXIN<?>'*SDQWK:(O\ )R4F:S$Q%L>3%:EZZQ\5+UM2T:Q:LQ,P[S'Y
M7\B8[UR5Y;<S:LQ,:]%H]/7UK:LUF/MB8F)]DQ,,)Y_\?_XJ<QB;O&X[QSS&
MJ7ES['LY_ =V]Z7.6L/9N89Y/M(=H[&V3!5_=1150R>_93?2*2KFCT2<424Y
MKL/K[^JC9[NFYW'<6'=8:ZZXLO&\9&.VM9B.J<&TPY?AF8M'3DK\41U:UUK/
M<8/./DO%EC)DW],M(U^&VWV\5GTT]>C%2WI[8TM'K'KK&L3AG8_QK_C@SF,K
ML,95W_IUU5-#+QFM<[1QMUDZ*(^>>:[>B+;M,VK#<PW''/TKYJM.9.../X-5
M//[69<=^)']1NQW,9]S^X&\Q:3'R\VRO6DS/OUV^XP9-8]VF33[8EVVW^H+O
M_#DZ\GW'+73\V^&8C]7X,E+>G_&T^V&&=H_%Q\,[O'PQZ5WUY.:_E:;R.NXO
M-HRG5>X8^7'\07%,MM#C,3UCH]S!>5W-45=,]5W)131171S#5S7Q7'F7%_B@
M^9,6XFW-<#VSN-KT3$5P4WVWO%]8TM-\F]W,36(ZHFL8XF9F)ZXBLQ;M]M]2
M'=M;S.\V7'7Q:>D4C-2=?3UUMFR1,::^G3'NG7TTG$NQ_BL=4W6,KBU'S!["
MP>9YFAJHO]CZIUO:L93;T\\^_%7B<9N&G75<TE/TXHKXO:::.?V\T5_X&6<=
M^*;W5BW,7Y?M#C\^STG6N'?9L%]?=/S+[?<5TCWQ\N9G[8=IM_J5Y.N37=<5
M@OBT]E,UZ3K[OBFF2/Z'3_1ABO,?BEYB#&7LN \YL;D\S1#S5C[#,>.-U@\9
M=7'UX],5[EK+O+8;JPAYI^O/,E%E<U<<\?3T<_7Z\95L_P 539WW-*;_ +&R
M8MG,_';'R]<MZQ]M<=N,Q5M/Y)R4C\KLL7U,8IR1&?AK5Q:^LUW46F(_)6=O
M6)_4ZH_58P_NL/?W]*GI[_,W=/\ XZR;_>D]@_Z*\Q^V-M_WG8_SD^#_ 'LW
M?]DQL/\ ]U[\^_\ 6]X?_P"?_='_  _LO_WGG@3]Z.[_ -J\=_G5VO\ ..[(
M_P %Y7^Q;?\ REC?/_C:?)%A\M=XW'0=#[79VWL>SG\!VG<VV)O_ 'K:&>3[
M2':-4UO.T?:RRU0R>_90_66.KFCUQ\T259'L/Q(/IPWFTIN=Q;GMKFMKKBR[
M*LY*Z6F(ZIP9\V+XHB+1TY+?#,=6EM:QV&#Z@?'^7%&3).]Q7G7X;88FT>NG
MKT7O7U]L:6GTGUTG6(\3L?X[WR@8/&5W^,ZMZ]W&ZIFABXPNN=PZ%:Y.NB3G
MGBNXHEV[*ZKAN(;?CCZU\57?$G/'/\&FKG]CN^._$+^F+?;F,&YY3D-GBTF?
MF9N/W5J1,>[3;TSY-9]VF/3[9AS-OYX\<YLG1DW.?%73\Z^#),?J?!%[>O\
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M>T3BWN+#$1[*;?!,3^6?F8\D_P#!,1^1G+ ?#-\8>MXFTPN.\/NM[BSLO?\
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M3]L=4SH]LZ1PP
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
=                                   '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>sny-20221231_g20.jpg
<TEXT>
begin 644 sny-20221231_g20.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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MME'8_,_JRJ>^54U--@,QJ3TH/#OC>)/>GO\ PRB#0DG&9O$>.*JI \*_3E@
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MEC;+S96;,>F8"F8BH]\9E>/AAWH'F37O*VHQ:OY=U>YT?48MA-:R%"RU#<'
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M27]JU!-$?AN+:0]8IXCNC"GR/525(.2_-FS9LV;-FS9LV;-FS9LV;-FS9LV
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M0GB6X:[MMN,L=TI59P/AJZ,"?VZML.:6;R6US!/9W$AFAD!_T=FCFJK AXV
M!V(!'<'MMGU1_P"<:OSPE\[V6E:/YDN/K>L6[FT^OS%4>1HH:IZD8/PDKT:I
M!)/2A&>U,KK[C*IN!U]\U >G?&T VI[$Y5.M-@3C:$8W-[XT]/GE95-O&F8
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MD*MV+ 4ZY&]*\X>?O,OF2TT35OR^T'5XEBDE]?5-0#:F[M]E7-G"#'5:D_"
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M.#3X>/#8^YRK4:;;6]W8Q6C/ZI6:WG$##TV2H8%!RJKJ:;]" <C]WJ4D$8D
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M/'$(6:JLA-5J/]7":>WC7UH25X1HU6(KOUV&Q)(PK]/X)H5BY1VW4]#Q<U(
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M8!8+02Q,DI ^%EKM\.TCN-*CUZ+S+>V4@M?.-K:6R2RPS"2"XME9TM+J-&Y
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MH)J.C6,RLQ<1A) QJW-/A;\5.'_RROX96_SRC]V5FS97?*H*^)QV4?ORSE4
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MFE+B6[40R/&?BJZ U4D^)KXX)N-%2.V(AMUU.ZNVC7C /WHH*R*K<^A.W*H
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MN>[,L?PCB1N3^O([<J@XDT>XCAYAZBJHU14D^*G?(D7LN$LRRJ3)('X#XY5
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ME[>^6017TD+13I:6\0D9=R%9E*$,0NQJ3C[J^EO)I)9!?WD:NI>?4IRT)DJ
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M[:*RVNM6-O?PAOM".YC650?>C8:9L\0?\YA>9-_)_E"&8_[NUB[BIM_RSVK
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M2(+=IE$4:JW&0JW)B12I ;D>O6F^(_4K977U!);^BJLZ<ECV<L 2P(VK3M7
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M0M1^!R/WEFWU>7TV,\YN.$?'BB,&%2VP[=?]K(/J=MPAGEKZ8N>+,L:_%R4
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MAVUU?6S6]K,DU_;N46)J+56W5PX!H"IHU.^;7O+J3:?)96]O=V]W9DH\+O\
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M*QZEH4BI++#797M9&!]SN<X+YH\LZKYOU\VD7DG5-2T[4#Z>HZM>7,%N5M2
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M>9W;P\,]"_G9%>W%CY;T.22<IJ#F3T(3SCFMKL(TWH%:T ,:(*&E#D$_+?\
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MPVMV$4F")VJRJ&7<5(\#G;- U>R:+3M5@@^JR:E:Q27/**B+*&,<J@;F@=6
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M?/?D[7(I5L]'UM]3TUI%9$$-]M-&H;JH)+"A[G#>XC#P75GZAD2-I%68,-R
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MVW3-W_5E;?CE[=A2O8Y@*[9L8>N_7IFW.W88W+_CCT4R.L:(7=R%50*DD[
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M;>:6VFCK2DB20JU*[BJG8D9PW7M#U/RUK>K>7M9MC9ZMHEW-97<)WX30.4<
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M6&V/<]<W,>P]ZXQWI7<;=@<]2?\ .*GY?_XG\XS><-0M^>C>3N+0<UJLNHR
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MTU+ZWE#ZQ!Q6<R.%FAFKQ9%6E&%.A(WSKGEOS3=I]7(*\+F-Y4D6,1EH@X#
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M1&ZOH65_KS1ZQ"#S>.8.R-R'V P9>VY'C3!"W"I)#-!:K';VH+(L!#1LJ@*
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M-FS9LV&.D:1JFOZKIFA:'IUQJ^M:U=0V-A8VD;37%S<W#K'##%&@+,[NP55
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M0:A*8 2M"@WH-MCN:?3GR4_Y^%?G.OIZ9^2NC7,C2S&WUGS#(CC@(@"UE9L
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M>5='MD46*6K7U6$TX4%%"D]"]*'; QTF"RMY+J.[$A848<%D5G8[!$4 %J]
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MLV;-FS9LV;-FS83>8?+VB>:]$U+RYYCTV'5]$U>$P7=I.*I(AH1N""K*0"K
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M23_L8L1X<5 ;[06NWB$_YJERI K,0OQ -O3L"]/U1X532LL?ID;NE 1XE/\
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M)@BA :A"\".OQ<4CZ?.0XC*0\G)=E+5J=P 9"VWT1X4RS-%"!3F2G<]PG?\
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M\Y0PWNKZYHG^"OS*F3]SYR\OQI#>R2*G%/TA!017B;*#Z@]4*H5)8QGYTO\
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MW%U_1'H?F?0/-^A:7YI\I:[9^9?+6M0"ZL=4L7]2"=/C=J'J&1AQ=31E8%6
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M-U<?ES^?]K>W!E/U?3_,FAO:HL1#$>I?6=Y<DL#0;6P!W.U*'RAYS_Y]#?\
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+S9LV;-FS9LV?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>sny-20221231_g21.jpg
<TEXT>
begin 644 sny-20221231_g21.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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M/[R%JUKL 0X!!)PM2.],C1(TGJKTC/VC[!?'#;3-6:W=0\LJN#3E&U#X?$I
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M;:LLT@=@/ *-\C=M%+/>+%;VL,</(RN6D,LKLFREF9B-STVV^_!\X9;P*CM
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MJJ.)I55'*A-?A))&U=F_&3Z3:".XEMI^,SI^]B4[K<0"G+84/)>IIU%>X.=
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MKR^TL9%,\C^9_/GFC7]4:&ZG74-3F8QS6D;^O$CD[+*[!5'P_: 0;;=]RM-
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M<O/GF:34;X:-I%5"T@CB6GPJ-_B/8GJW]!A!%#9V%JMM;S>J7<>K(PXB:5J
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MXY)22)5NY4YL\=6H%0<20#N* [TH?>5H)KR>;2-2LU4/=25>,<5EYFBS1UH
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M^>50&=ZF5D45J0Q9%I_+\.&&L>6%UC08GNF%A;>99Y+FY$C<_2TZT_=M4BM
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MB3#[L1*XDRX'9<D?DSS9JGD;S3HGFO1Y&6]T6Z2<('9%F0&DD+E:'A(A*L/
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M#NI;'ZO>3!%O-0<>FC&J)S8@<5(!XHK4)_:8_1DMTV='344GG51"I#$KMR+
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M&7$2N)LN(%?;$67$2OMB)%.V(L,19?;$&&>[O^<,_P S/JU]J7Y8:K=4@O\
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M=SV;F"2?GRZ_TP[T#[-E>*PC@NX%=(^-/]*0JM :[;G8>YP7YI\OEYFE5?\
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M6-7.] 14_AG(K[RV5@U: $B"24P+W?@8U90/8<<YOY1\L3R>9GF9&'UB&S+
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MLI!Z?KP"9%U:*&.&/C!;\K*)WKR95E25I*'Q#E1\L]=^2O*$TWDZS9(BKW-
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MW4MOW8[*!])K]&?*?6X3K/FF&S8,\%QJ\MY=U'("%+AI&4@FAY%54 ^.2?\
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M_P"P9T+\BK:;5/S?\IK"I9H7221V%2B!5=BI[4,0W\"<^M7IJ*@"@KC''8#
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ML3U'(#DO$DTXDU^6>A+:TM[B($*AM[D<9:4()(H"0#]&"+3339.\K*6:,D3
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M%%.^+BN+*,$KBRCIWP2OSP4F"%Q=<$)@I,%H,%I@Q!WP8E,%IVP6F#$_#!:
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MI H"HHP/[7WGKDRMXH^"!( B$4Y "I'N0*=<%QQVJ1-_HZ2$GD6XC;QIA==
M2MR6)0@J2H&Y\.H&1J[16)8\:\BHVZU%2-A^K(G=6Z\_B0"O?8L>M!7>F&-G
M&9Y$%2$ Z#I3:M?E6OM3!VIM#:P5FWH/LD_%OT W/4CQSEFH:U'#=EVD^P14
MDU((6M .G4[9 -<\Q"&%9#&6'((%KR9F\=NWT_QSB^N^9FF=Y>0J*A0IJ&['
M<]E&>%/ST_,UK^6;RGI-V9Y[E_2OIXS]DU)= >FW?^S.%Z38QV,2%4(*@\32
MI%.]3W->N#7N5YI$*R#X99*]SU1?I.Y'@/?)1Y5T2Z\Q:TEI"ID2TC,DS=>3
MN0JKMU9V944>)S[=_E-Y!M?RT\@>7_*D$:I=VULD^I.-VEU"<>I<LQ[T8\1[
M#.@-U(Q$C;$'\<!R8#DP&X K@9QW&!7&!F[X&:F!G\,".*U]\"./QP*XZX$?
M\,"L*]\#./IVP.WWX'<4P]\JP-/JMS&A *Z/K,A+=*1Z9=N>@/9=LXMYTM38
M><O-MB8A#]2UJ_@,8((3T[B1>-02-J9'%Q1=]L74>.+J,6 Q5<67I^K%U[8)
M08(7PP2N++@E*8*3!D>"XQ@Q!TP8G]F"TP7'7O@V/!:8,C&#$PF\V>6K3S=Y
M;U?R_=H&CU*W>(5 -&(^$[^!H<^2OF;RW>:;/J&BZG#Z6LZ%*Z(QV+-%LH/B
M"NQ]J'MD<T/4X'N;74 I$:2AIH^Z./A9?IW!SLWF&WT^2UDA@=7T_6[1GM6&
MWI3Q#DH!/3<9Q3S#):ZWY-22=:76EL5:HJ1$3O\ #[5.$7Y-WM]Y;\R7"6DP
MBMIHR\T5:!TI3C7<$;\E/;/=?ECSM"8X)89O4M" M""&1Z4:-AV8$;>(SO6B
M>:DD6,K*2' (/+J1L14U%:?VY.;+S#;2A@91U!*>)6E"0=JCQ_ADMLM?C-Q
M6E-7/%B"./$FI4 ;'<]":YT?2M1'UB)F)*R(D;'J"!V->_A[?3AW=_'O&06%
M*=/BVV'8GZ,*XI/BX.>7$D[[[CYBN3+3'#LAHL9<!0J$_:/MV%.M.^3NUXR
M  "+C6FY/3<5(.Q/]F#)T)B9/ABXKR4\2P13V&_2G8Y&+ZZ4.VP3@@ '^2I
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M(_A1?LBHW!W/7W.";?S490RA^1)')&IL:; _V8I)KSM\*  N.(4;T)[5J/\
M/QQ6)IY@M9 C$U8L:F@'11WIA?J/F"&S%%?XP*)&-_BZ G. _F'^80A1K2UN
M1<W3@F1N55!%0:=J YYFO]1GOY79Y"W-RS,34LQ/6OSPJFD*J5K5AN=JC":)
M?5N:L:T;K\N^<1\\7B/YGGD::./ZJOHQACR)JHJ54=,[7^4/_.,7G/\ -866
MHZC#-Y3\EW7Q&_NA2\O8P=_0B.XC\#T/OGT3_+W_ )QQ_++\NPL^FZ.NI7L
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M35/RB=IXO)7G"PEL;_74B,FH(A=0\$2-6,1<%(<HS/N>-,\L_E7=^6]'\_\
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MSN:J*<MZ]QX[8-AMF/!R.3KO7]>*S6CD&D=!N26\<+!''$D@8<36F]-Z>/\
M#(OK$A9)8QLC#IUWKO\ 3D/)XV\HWYD-Q'A[YYK_ #:\JG7]%UB\C2D^DO:2
MHU*A6;FH^^E,X_Y:U)QI\N@7-G'<R7T:M:,S$M931L&=XR/$"A&%'FFP;3]=
MUJVN(#')<Q17-K)]EOWB+)4>(K7?.Z?E_>+J>@F>XY&XBME@DY5I4@U(/<GK
MB]W#';QM&2_^EB,B0="!V]\E>B^8O,'EZ\M]:\K:I+IMY;QA058A6X[@.O1A
MMWSW/^6/_.3VC:_%9:7YT"Z5JDT:A;Z/>VD?H>7=37/4\<L=Q$D\$B3P2J&2
M2,\E8'H01B3' [M[X&?O@1SXX$=ML#,0*X&<C 3GPP&QZ]\#L?HP-(V!6->^
M!7.!'; KM@1VKCK&PNM5U"QTNQC,U[J5S%:V\8V+2S.$1?I9@,^YOEG0K7RQ
MY=T+RY9 "UT*PM[&(C]I8(UCY'W/&I/CAYFRF564JP#*PH0=P0>QS\]_YQ^1
MW_+;\S_.?DTH5M=)U%S8UJ>5E< 3VI)/4^C(M?>N<W!Z8J#OBBFE,74_?@A3
MBZG!"G!"'!:'!2]O?!4>"D_5@R/Z37(QJ/GWRUI4UQ:"];4]2ME)>RT]#<2@
M^#,OP*?FV<DOOS*N-=ENK>Y9_+?U*53]6DN'C,@9"RK+QA)'8[$@]*;YRJ>[
MO;[6^27#6NH/((X$C"S2L/5"H_*6-."L6V8TH>XP9J'Z2:[M7\P&W-A:ZY#H
MNKKIBCA=BX0OZR.O)#+'7]Y2O2GSFFL>5?+FF^2O,DOE:S2/58-2?1[*_(]5
M;M92L?)>5>!X\B'6A#BN^0WS,KP>8O(_F*_DDN8-*C'E"^TU/B,&J14?TY"K
M?$&2570[\B"#BD\-Q--)#:/::Q>:<DC7"V%N+?48N#%&66U*#U0*@54$]_;!
MVBZ:+M4OH-&,D3H(9XH86D21B_%DD@1JQ/44.R>V'T/F:STO64AU*_NK6X+F
M&*354:6V7B?@_OGCD(%:$,2138TSL'ESZS<K<Z3<:8L<?J!YA;)+<6I05831
M6[RMZ88BA:-W0]#Q/5?5K?2"TSQ69B:V!YW2V.EK)$*JQK$;@.XZ44U;PS06
MLFMVT[I%8ZD\08?5E:6 ;FHEMV63UH6;8F,J16O$C.<:[I6EW<<MCJNB&T8.
M*NPC:2U:=@H=O@CFXFAHQJA.S,*Y%+?\M[.^U*_\GU&@Z]9!3&84=;+4(&'(
M7 @=V,;L >7$[&H4]L)OR9T#R7Y2_.O0[KSW;G3+'4H]2T#S!)>(1;Q66K:=
M=Z?]88<22E+D'D!T^_/8OG7\T?*^E^?/+?D#5_+Z>9?+&GV5@OE\F=I9=3\M
MQ"*?]!/*Q8FZM#R>PGY<N+F$U%#B7E;S'I?Y>>;/./E'S#=MYP_*O5;YM7T#
M6=/"R:KHEEJ!Y6=_ HX\T>,*US:-L?B*<77XNG3^C.U+;4+744AH8KNRDYV]
MPC;I)&U/LN*$5W'0[UPIG0&)U?X)5J?A!I]V^!DE'V6V+ <0V]:=:4ZX,@(<
M,K+\:TVK@]8D.Y^)QM[4]Z4WQS6D3 EP"E:$4W [X2ZAHT$G.5%/&E"%-"W]
MN$)TJ/;ERV)H*5W\*^.6=)A1JL=FWV\#BRV5K'R(HI4;^-,++Y$",%HWT=_#
MWR#WI,8=%^$-79>M?I^>1+494BC?DH8KVJ:#^N1BWC]4RF38OM0]AUVR(:Y/
M8Z=Y3_-D7-M]9FGT/3I[.,J36>UU).70BGP2?3GFS\L?*=]YO\_0->)]1B@A
MDN[QDC^"VM4%'/$=_C'TX$\UW6G^:-=\SQ6%JL[Z5?7*Z;.S$,((F,84CIQ*
M+4C)=^6T41:;0IN)@FC%Y:3H=B H (\0<E4^G<;>YA4LHB! #;LJL>5$K7O@
M.87$#2F%5]01"1Q)LJB,_'3YC'SV\D<UG-IPVGM1,BD44#J02?&N="\O>=_S
M#T+2;:;RSYMN[9(59D@D_?0\DW,95JT'R.=R\H?\Y=WT;V5E^8'EV.UY_NY;
MVR<D@CJYB(&WRSUIY:\]>5/.5JMWY<UJVU%& /!& D%?%3ODB=COVI@1VZX$
M<G<8%=S7VP,[5K@9L!OU.^!F/? CG [':N!)&P"[=^V!7.!7/X9Z*_YQ8\H?
MXI_-O2[V>+U+#RE#)K$U1MZL=([85\1+(KC_ %3GUGS9LV?,/_GX#^7_ *-[
MY/\ S.LX?W=XK:!J; 4'JQ\Y[-CON67U5)I^RHSYO@]-L47%@<67!*XNAZ8(
M7M[XNN^"D-,%(WT8+1N]: "I)V 'N<BNH^>M-M/7CLH)M2:%7Y7*+QLD9#1@
M\[,H-":46OMG&_-?G;5]2,+1ZP+6SC8)<VFG7-9)XF!)H8'8+2G0L#38Y"?J
MT.E31:OI0O(6T^.&9HT/I6\L=[M%.S2F0&M&^$QC>OQ'%M-T2=-4TQ[Z"6>S
MU64'5X;9HK>TD:[J($MYP>&XH:$)1EI3?)@UI'Y+?\W[:SG'U+RW8V%E;0Q+
M0@ZE(%-U< $<GBY'?IR QVNL3#HT"?5(+O4_J/F+RW?0R(MFVK0P*MY;W  "
M?OQ3[5*-[$X;>6/.FF3M]6U#1H(M*\P7KKZ,3!'TO6+(M+Z2?$.()/- U1MQ
M.QR)ZYH%[I_D[5=*O)S'YLL/,;^:XKV7]S'JJ1\R_HO2HDXN!Q%2I_9(WP9K
M9DU,)JTFF-#Y<OK:*\B-H)6N+:1U"RB.?CZB,:$GDW$G?OA+#8/674-##>?8
M87:6>ZTR^GLM96%59@;B$,QYJ!4N W0UPRM+YY"MWJL_KSSJ6ATKS7#]76YA
M"\E,-VR""0D?".2@ECUSK_E?6;+4[BVM_P N=3N8-&N83]8T>XBCN/1_=486
MSSL6B*G9T;DC4V/;)?%IEC)=RVCR:3JNHRRR&?36T^T661(T#2 L(U#A:J3P
MW /(5PGO-#T^R]/1;?2=7B2,CX+2XGN-/0S?%02R07#(7_9'+B#X897\+1W&
MFZ/-:W=QZ5K/^BM0U:%!<03O'01R/4EHY ?3<'L13P'/+ZVNK2UT^S\U>OIM
MUHL?#3-4:1HC:1^IRCMI;J"O!P:M%*PXNM*K52N%VKP+<V\S:_I/^(8I23!J
MMO=JDA=S^U- #&K,/M? @)W K3(9IS>4K+S!Y?\ \0MJ2^6I;F2UN;74X5GN
M+6RO(VMY;G3)X359[5G$\.P/-!XG/0?E/38(]6N]/?4K+68+B:;3K?6K#][9
M7C6CL9)K<_9,4A8R(#N%DX]5R4Z?:3_E_P"938,S_P"'M<?A K&J17#&H7VY
M]!_E4\<ZQ+$M%96Y!]U8UHPZCN,CMW"\;,#45;D/F-]O XI"S$JS59C3>A'L
M:TP^A<N 5(4'JPH:8+6K U.Z;$ ]?<XA<\@#Q4E@*;#8@>&1ZZ8*&H"K#J:U
M/3H,*&G"M\9(KT\:TKO@=IO4%2OJ*>O7J.V ;R3D *%:]:@$UH<B6I +)Q'W
M'IXY ]8;TW$1H'<U4#I0]":XE-9FUA28"KJ S4[UPIO_ -%Q?ES^;UW?(AU-
MM)TYM.J*MS74(VEX_P"Q&^<-\GZW_P JX\BVWF>PEM-3\U>=5,J13$3+%9V]
MYZ9BGCK_ +M9>5/ #.)^6>7_ "L?RSHMU$GI^9=173A$HXHD5^PB9R.[.\H
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M*&'!7 J2"%_V\(KJ.>A7[(K4@&O(@_/MD9NB8)6=R:MU]AVK[X">5GA')2$
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MK4SN[B;2-9L(/,,4$WZ?G@M]/\R6CF2YCCU!FMUO'F"TG5=XV.T@)02\QQ?
MOD.\OM&\P>:/+WF33Q=>7=6>Z+"&$.D>IVZD7T<2'M(5]8)UXN*>T<N[Z\U.
M/1-2TR.P@\^>0+.:VGM3REMM6TFXY GFY<R6DL>Z.23%0I)\/(KS[4-<U'3]
M)T'S%Y3@*7FERW%G;V:R<[W1UM 6N=,N48L9;-T=O2$@)0J5C+(:8G\5YY[_
M "SAM;E4T.X0BQ"(L55NG4W*"0<04)4!5Z*2>-%H,"Z1J45MH/YA^>YM&@M(
MQY@AL+G12TBP3VM^7CGTZ9:U/ 0E@Y^)6Q2ZTV]?7M'M='OH%MO+]W'Y;TC4
MKU"M[;MJ,"7FFPWW/TU*1/*Z1R@;^X & G\TW6A>8GU&ZTJ"31/.Q;2?-&ES
MQ<(4OXWI=J8TX\68KR%"*&I'CDHT>Q\P6_F72]&MKUCH^OZ5<Q:#JTL0N!<6
MR$3R65T2>*R*D0HYKR4<MV!&!+NTD@@,%Y8V$T'.0V<-TS<)F)42+87*% 'Y
M"I3D">O"N!K Z1YBMKK0]<B\PZ1;VK11%5GEOA92N28Y&@FBY!*_$"C!MM@1
MMBNOO?6TFM6LC:?YMN],:#].V<#,?K\<42BSUNU XMS9?W<QC!(H"V[-2,Z8
M8-0FM+VQ\S#1C/.I:VU+BUFI5J^G))\'$DF@/$D=<](Z-=^8;C3I[>]NM$U"
MZNBT*\]2>YNX(64+Z4<L<*2%>(!H&KW/?'"+S#/%<6-W+J-KHUE%%=1B25;Z
M.$PR4]=/K4*W"HK -RCG:F]0!2JE]:>8+N[*ZKY0T/66CD1(-5MK*&]DG67X
MUFB3U[61Z=U(8U[[X'O8_+@MYM/U72]+N(XW]4R6,5UHU];RJ&!2:W*O1Q04
MX.01U%<*-*M-'2X1=(UZ\T6_F12+;4)TU&TY..($KQT=DWI^]CK_ "N#DQLK
M._::YN+;T+VX=&LM8TVZX7$T,0)/%?[H7%JPJ8P6#+7X*;IB/FS30EK;6VFV
M]WHD%E:GTM4@]2,0NIH\%5,LZJ03Z9^+84*]\\\G2;""^.J^3M?B?6F8K=:3
MJ\,$L=YS0F4!S&(:4Z+*JFI^$USENNZNT/F&>^\O6UUY5U#4+"3T[>"Y9I8[
MJW/J,;)^$<B-5"46I93T;/0GY,?GGYDTSR]IMEK&BP0>49IPNF:O=I,BD3-3
MA/?,6599&J6$I(YDD,M=_>&ERVFMP27%LCP75OQ%S!.OISP$BHYI^T".A&Q&
MXP5+9^E]J,<2/#J/'[\(+F(HK$A#N:@#D0>U._3(Q>6R. J@!M^7+XB/<^_A
MA8--EE*HL8X\J*=P6\2<ENG:##Z3*>56/[(-3].'(\OVX3D84K^S45-/>O?(
MMKVB1QQ2$HJJ>@3J:X&T?R[]6A]9T^.0B3?L%Z#\<+?,EO<I97,\%JUPT1Y"
M./J>)!-!GG3SAYCEB@DNHN<;@$&/:A\ ZGMXUSD5U/J=]HGF348($MM5TG2;
M74;F(*71+6ZN_JX$JDT*L'W'OG./*A6T\UZ?#YOD%AY \[7HTY=9M5++HMRX
M,,=WP&Q6&0U=#]J/D,Z%Y[T[3XO+]OY8UZ>6'\]/)7FJ^TC4/2*RZ=<:-!9^
MK%=VUPOQ,6>,%34AT=#VSI6GPM/Y)\JRKZB23ADDA?[3+<P \Q7K0CK[YS[7
M(;6.Y*V0>ZG74);21T/)9"[*%*D=1L:G#6=KZW^K_H^,&TMKV2%XX?M3M;MR
M9N7AQ>A^6![B"WTJ_;3KB:*&&*PO"(7J6Y,2PZ'8]""<;>E7M]0N7@, M[&T
MN8:5&QX U Z4I@^.2":_-(HX8/+UH9'1SQ]6[N%)1B%[ ],7LM/%KY9M[O6(
MY?2TZ.X^LIRJ1(S U '<L]!B/F2:5(].TJ4Q)]<3U#&JARD?"JQU[$U%<BEY
M:WME/^C904UNVA+6R.O)+NT=36&7L>)Z'K@"V@M4C\B3:Q<K)IFK?6;*:=JJ
MT >JA"P[*<(I/*]WIEQ-$X$$UC=_5+AZ\XY;60_N+@>*G8&G3.F>1_S:\U>0
M5N+>[BEO=&TF<0WEA.2653^U Y\!N!W&>VO+?FK1_-^D6VMZ)=+<V=RH)%?B
MC8C=7'8C#=S6OWX$8X&=OHP,[5P*S?1EVEG=ZE>VFG6$#W5[?SQVUO#&*O)+
M*P1$4>+,0!GVL_*_R/;?EUY%\O\ E.#@\VGVX:]F0;37DOQW$E>I!=B%KT4
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MS2[K7?*=U?3*(Y;77K-I!(T\/V9+JUN/WL,Z\>BFA'6O>?>0-*TOR[^6]_\
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M)%?3[;4A:K&U/[X1*\I5@*-P5.+'QR+Z>DT,#R+)(?J=OZ0G7]VY@N+ADE4
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M0:5J36DLDW(T+JES,K "AX!\GVG:.\4?F/2+/TK^\E]::"$GBMRT4R:@UNA
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M2WCT M$.0-SI<D;48GH#]FO>F&>DWMG-YULK>ZE>"S\OZ(HA@ ^%+C@\TM0
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M1"EK=7<$$Y%HTS;>K&QME>C>I'4)A2VK:QI>N:_;M/J_E>]FN"]U=\GK:NS
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M?S1Y$BTF^^MB[@TZUUB"2XTK4KAT_1D=^W(3V=W5:>A<HOP,P!^*O8C/2GY
M?G!%JGU'\M_-L\VG^:=-C^J60U-CZQ*_W=HTS,WJ'TQ2&2M74<6^,5;UU!'.
M;2ZD"-'PD42*M &'\Q!^>^%KHD3A)7$Y#_9/P@@=:$5^6 ;E"(RJEE0550:,
M:'?/'?\ SE*!_A&T@C;A+)>K(IY<6?@I")UW+.X%,BWFX16/DM?+SPB::QT>
MQM8H!U6_NIUCBA"]V=;<D"O2NW?(Y^84D\&K):2W'UO7]3TU=)L7=4 LV$L*
M7%Q%# JK4*L@H:TV.YID)E?1+JYU&XN!)#H'Y=:%+I5E9S3$R7E^Y/*2,G@U
M'G?DWP]  <+--T>T*V<&KK'93R:Q;0F>I2&"-[59EB6'>@YLI)IN< VFL75E
M<:>KW*:=#Y*@O[PGU &GNIV"T3J2[,JJH7J*GI7#70+*Z_PIJT=XDECK&HWC
MI*9"0D,4,9N;KF P+$*!4#J:#OA=#?1:;Y.N([*VDM- U;5K<W6H77P2SPQ_
M''"(D!XJ2"_?PWKAAKTMQ/:V]@]S)!%K%Y%=72(>*K;7Q,L8G93_ #%*@^%,
M-/,< L/T-Y-Y*]IY6M-1NRZL%/%U=HY6"F@Y"/D -P",@&C>0_.7YG7WESR+
M^7^@7GFOS-K#FZ%O:Q?$KBC"21F*K%&!]N1R%4=3GWQ_YQG_ .<)/+'Y1W][
MY_\ /'U;S-^8GF".TEFM$4/I6ERQ)&S"W1@/5D]5>7J,-B!P4$<C[RS9LV;-
MFS9LV;-FS9LV;-FS9LV;-FS9LBWG/R5Y6_,+RYJGE+SEHMOKWE_6('M[JUG!
M%4D4H2CJ5=&HQHRD,.QSY3_G-_S@MYE\B*FM_D]+=^;_ "K#JT>J7>AS&,ZE
M96]M81V,4-L @^L1I'"-A^])X@ T+'Q3K6H7FF>=_-31QF&_>RBN$:56$EL?
MT46JU!R1XVMSL:T! WQ"Y\R)H\)T%X(!K/DS5X?,=K:K\2ZA$UV\]U;_ -Y0
M2TFE4L"5.Q&QID:2?4/)]EK\GEZZ74YORSOHKS3X)$9X-5\N7GQ20O&0100R
M@GX0R.G7XF&")[/2[M?/0TSC>:=)JJ^8S91\F9M%U2.:UO J-0<H?4E5U(JK
M1=.F1_4[K4+'0OR_\UVUVT>NZ;#%I]\ZG<W&C7[63RJ!0T]*^8,1_-L<&O/]
M<\Y:)HNH,;BPAUWS'H_"0JMQ;S""/ZG.'4 T>UG5P!12P+@U..M;]5\H6ZE_
M3;RQKVF:O#N6=K*:5GN;?D7*F2'ZK/\ "M.2QUH:[BY1!'YNU/1[E$?1?S!L
MYX+?T9 JWD;N]S:HC$D RV]W,BDT4/$M:!6.%4.F006\&E:T3JD_ERW-A),@
MD@EU3R](ZJ9Z!E=9[&X'(J:% 3Q9@J8<^6DN-(_,+5?)^IQ0SZ9YKC'Z1<QE
M899T#Q37<4?Q<4EB"2D [<V P#9:.;RWT_RIIVK1&_T$76L_E_J^X:>W.UQI
M-VRGX2PXJ6->+T<51V CGF6*VU1[?5;*&:7R]YU98[C2XY"+BUUBS4)-$2:D
MRS(@DB>G'UHAV+#)IIVJ_I"*6]E:W7SMY:M+96EMD$$'F70V"M#)*KDJDX#<
MHWX_!)R1JJQI$IK#1]:36M T"Z,^FPRP7FEW5'1[#Z_#<W,>GON )+:]MCQ4
MT*!^(%'.2.XU"[UGRSY0_,&],\MCK%FND^:I+>JUL+PBW=]B:-%(T3ESLKDL
M-V-">2+_  E/J<4OU&WT3SRWH7CR<A:VWF2W!#2/0@"VO/368$?"T;2+OQIG
M)[KRY?>29Q>?EZ\PT'4M36X&@7TC1OH^L1QN9[2&>.1'B=%D+6T\; 2QTV>A
M7.A>3?-'EW4I]5CU&RBTW5YHBVHVU_"JVMTI% =5M85CB:,$\OK=N *_$ZPO
M4M([G1(O+D%I:Z#YBF\N+<%9XM+UE1JVAS2N.7*SN1ZC1QN#5"4?X=F=22<+
MX[/1;FREUW41/Y"UW2IDT[S ^GH)5@FG*FTOOJCRE9H6<!;B.H'QH\>VYE.D
M:==WNJZQH\.BK_B'4;-+WS-Y>BG%O:ZY9H'E@UC1+E^+170H)48;<MB8VY+C
M_J.LVEW:WOFK1-:M[R)1^C/,@MG-TQC=6BYRZ>08G'5U;DH(^%>^$&E)JKI?
M7]GK2V^GZK=O#:S74<%WHLTDA+/%<#TD,1,BNP+1$4!)C0K5DH)[>S-Y8?X0
MEFMPG/7]"MF>\TVYL794&J:>T;NRTE7C)Z9^&HDBX&J@[&H6^EZ!#J%U+=^8
MO(5\671/,2W!%_HUV'^.SO;F,2NDRACP,@H^RN#0KDFTLB]LTT"UA34-.6"<
M&[TR\%I#?6T82O\ HKM*E-U4*(V2M2K#IA_H^LZ5)'8PW.MM)9Q:@L&E7MWQ
M6>PU&SC'&UEEY.CHZJ54UJ3R#* R#*\R^4M2EU03:1:M'K4%TM]/IT4HT^2X
MY;Q:CI<IY"&Y 7C,I!20#A*#L<B?PV\LMIYPT2YOEU2T^J?79(REQ,C&LB7E
MDDDMM<**FIC9FI\2QKU'+-;\JP+<6VA7.H36MEI\KKY>\Q6P>:1 6YB"YEB/
M.15-%#)5_P!M=PV?0#\C/SAA\WZ:/+FM77J^;M-013H\J2/=^@GQR<E"\VX+
MR+ #F#R !#JO=Q!;S274C6RM$PXQA:U4G^8]B",CUS"\3R;$*6'VN@4#J!_;
MGAG_ )R>U@Q>:O)-JD".ND0S:Y.DTA2"46[J4C8 AC7TS0"IK2F =%^HZ?'I
M?G?S/=OJFNW<[WME8!"S)=-(MNLZ!J@L6 BBKR*HH I\39&?-&H)IOFSSGK^
MH62KJ.A:796VG6@/J)%--Z8X3'B"S!I 6V^+[LY?J6BMI46O6FJW42ZH]E;7
MUR7 +V[7-W&KI-Q(XL%<L54&GV>HR76T(U&XTV_M(KE$\P>8.6FF\!0/9V%H
M8Y+HIQJ!4BI[;^&<Y@@TJ/0=.O9X'N=7O6NEXNY$+$LJVKU)!(!:I \/#);?
M6MQI#:''=3?6+W6K6YNKN%J,\5K>1/$KO39>: N.]*$XGKB7%Y8_EOY<98;>
MUI->-ZK@*!<7"QB9F![)">O3M@[5OT5>ZMK,-A?/]0\S7L5AIS$ >GIMC*KR
MW(4@,2WI<4&U2V>I?R(_YPS_ #!_/F\N_.%\9_(7Y?ZF\<4&IZA$QN+NQB C
M"V-NU&<%4%'8JF]0S<>)^UGY0_DA^7/Y(: F@^0M"CL6DBBCOM2GI+J%^8@0
MK7-QQ!:E20H 1:GBHSK>;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LX'^;7_
M #C?^6?YN&XU/5M)71O.#VLUM#YBTY5CO )8)(!ZXIPG55DV$@)'[++GRK_-
M?_G#'SY^76H:-=+I4OG3RQ;1S0W?F'3G=7CA@C]:U%Q;(&EB)EA D<EHN)X5
MWV\UZ1-J4TVNZ9#I45DUFIA=)RI*_HJZM[@;LP#+-;7:N  >3*RD -RPFOKN
MZTG4/+OGW2&%FFK74GZ9M)"KT:6>&PUI'<NNTLDJ2]AR3F"I=LK7?+[-<:_I
MAN)?J,%]<7!L%0#T].U2"'3[Z6-B 1Z4L4=R25)'B.N0R>74-4M?+>L-:QGS
M)J"16S,I#!_-&@L8$AY"@Y7]@9(T)8!I(U7J-^EWT]I?LWFK3K:,^4?,NG?6
M;R6VE2&8,\\LDTT71HKB"Y1I"JU(9BQ5U#80S:?HFG7VAZ?YR29_+TL27=M)
M:SCZJL32+&+FU]- \8$LD8DB)(A:3E'6&1E05YS\P3V-WY9N6:63S5I.MOI4
M>IO&HCU#3([.3U8[@*"M51X:C[,D;JR['BLB\Z>9-$TSS?H.O6-E<:;-Y1].
M&[F(C:/ZG/;0-P2(FHX(PD)8<MFW^(9&+S2]5T>SM=/M%(NO+]]=>:_*-PK-
MQO[0\OK^F\PY'(+(XJ3N.!!/($0>]U'6S8K%%Z%[8ZSKNEZI-+$Y+V]ZW*6"
MYA^*BFXAD*LM:B3U ?V<Z%YLATJRTKSEJNEQI%JGD#5+:TTR[MR8I2)&1KNU
M*$T:*07DE01L0O8&L:OC9:5YWUB*#4IM)L=3T/3]8N[^6LOU6[MQ6*Z=  LG
M&6"-G/<5Z5-#WR=:OY?M-;L-'LY]14RW.I:OY;F%8I;2<SPS/8%^*^I"2\+1
M/R21%!!#$5*K\V]QH5EY?N;V/4?)/FY..B2))(QLII&Y1VI9ZRFVD9#P+$M;
MRBF]!SC]S:W&OZ'JNAW$33>8/*T4-A#?0H%GN[65#<Z3.ZJ"?4@O(A&U:*OJ
M,J'C486^8])@\V^6?RG\XV%TWE[S1-K4MC#JMJY6<F:S,S1.3^RLBUH>H-!M
M48)T7SW#Y<9?)?F+2+&RU76@+C]$7M+32]66*:6%[W1[]?\ >"]%Q"ZNA"QN
MPIW-9C9^4+K5;2Z\PZ+/;ZA:>A*EQI.I0@BXBA+^K:WD=LT,T<JAC1@B%J5%
M=J$6G&5X=-L5T3_$FC6/J:E;>7-3N%BU:Q2XB!$^CZE%Z9G@<'8H0] 5>-C6
MISIFJ^9[*#6_JVN^;M!\NZ? IO[*[TR34)-.:5RT3D2F)W@!4AF&Z5KO1LC6
MI76H:;>6RW\EKHTOG"SBFM=0@Y'1-:M@?41W+,C&1&"T1V$T9%5F%0I&6TT]
MW=:3Y874+ORCYDL&^N60U%(KF"2ZXD.]K<+;QSF"=3O&&/$;\&-:G6DWFLGS
M)J5V)+;RMYZU"VKJ%A='GI^OQ?$&E)AK',IZI,"9$:HJ5)0)S)IFF6_UB?RE
M_@;4=1<0)JBQ/96I*2JPC%S;M%&$4[]R3L5;M(9X=>M;CZSJ]_"_UN(B;5VB
M2[M+B'X6CMM8MX@([RV7J)XU$T%34+0G)#8ZG<Z0\T&J>6M0.B6ZO/)9W+?I
M1;8OQ_?Z;J5'6:V=""JL5DC^SNO)<D#+8:WITLFAZF9&E,4OU>54Y2F(J4)M
M@6MY]P-E 8J?AD5Z8$U^WTR?0I8;?1XY+R"Y:._TZ(1SL_JTF>6-6#<MZ.K$
M5D4_SBJ^<KK3Y_+=YI'FCRQYK,MSILRW5LUM*8M6T^17JZP+<&DX4MO"S$E>
MM1\6?2/\F/SGT7\SM'OK>WN(3YFT(1_IJV1#$2L@ CO88G^(1N=F0_W;?"?V
M2>DWU9&,YY\#]IC\.XW-:^.?.[\[)+;5_P Y8+F]^'0_*%A9W%U0<A(6=IT@
M!;X><K (/#<Y+I;*UBUKR8LKI91:?8,]T6I6!&%[(KR/0=%JPZB@K7./66IK
MKL-CI-9KJ_\ .?F5=1U:ZDCJJ:;9S)*&!^(T^%:^P/93A7.+;6'18$GE'G37
M+J]NI/2 C@TG2W A$;-N26?FQ-*<1MO@KS!J][>:3>W.FQ>E)KUD;+0K>U8.
M^G>5K)W%W,SM]A[CA\;=7J>VV1;5W1GTPRK%;)ID4%E86T2U5HD+M)+N.1)<
MGDW<FG09(FNKCS'YIO\ 2["&0Z[KNH):7C+NEM8A8T6",4-/4=37^5%IG4_R
MH_(KS]^<?G3S=:^2O+,VHP:)+'I$%[(XCTJVD@=5GDGNF!0@<G/!27-*HK'/
MK!^0_P#S@'^7/Y:WNG>;OS#EC_,OSS8Q\+5;B.FC:<O4+;VK#]ZRU/[R:M?M
M"-#GOP    4 V ';+S9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9L\Y?FM
M_P XO_EC^:,-_<OIP\J^8[^2*:75M)1(GG>$IQ^LPBB2CBG$DT;CL&&?+/\
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M_P"< ?.?EQ;;5/RU\[)YYGTQ1I@MO,U+74[S09*!M/NKZ#C%<O"RJ\,Q6%P
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MI QY*RGU$VI)(!QR#W(T6[O;B+S 9=)U/S+Z^F:G%'&;BWN%D7G%- X Y,"
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MM(.B2HAH15UE5?V@Q"!3>".RNKO4K".WT;4[A[37[-$"O87\8"+>0U?EP4!
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5V;-FS9LV;-FS9LV;-FS9LV;-G__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>sny-20221231_g22.jpg
<TEXT>
begin 644 sny-20221231_g22.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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MLV;-FS9LV1#SCY[\L>0]-_27F74DLT>H@@7X[BX8?LQ1#=O<]!W(SP;^9/\
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M8HU;U&C)+N4%65#3H -RH^["!?,FD.&-Q821,F[O(L06-  >0,C+R-"-P3U
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M;4^T1U\<4BLWMPP8Q,SGDW 4%1T(!:N"%B0>IZD($G,<)  #7KRXT'Z\8UH
M$CX*D(-*K\(4^( )Q$6=N7:&9#+0?O*[D_3WPHGTRW@ 2(D(20H;=>.^W$]#
M3J,(;_18Y16%5<$_&BT*4/7DI!\,X_YC\D1:N:V=\=-FC:LEJX1X)#4BG%E8
MK3L!M7J,Y@8/,^FZP+)FO(T21D2.V+@,&%556"^F21M2AV[5R40I:V__ !T+
M:*S1PJ30W,;M*5%/B$AJ>O52B^S=LDUI9Z7&G+2E@,)^(JJE%)/<<7?[]\'\
M64DK$5![KT_'?,:D;C;IWVQO$*/GC"-SV&)G?YYB!0 XVAJ !TZY2J020:TR
MZC[)J"<JE=JXVA!!!W\<]H_DC^?OJ?5?)_GV]/JDK%IVL3'9J[+#=.>_\KG_
M &7B?9>;-FS9LV;-FS9LV;-FS9L)O,'F#1_*VCWVO:]?1Z=I>G1F2::0].P5
M0-V9CLJC<G89\J_S<_-K6/S5UU;J=6T_R_IS.FF:?4'TT:E992-C(]!7L.@\
M3R;8_(?KQP85X@],44;;D_/'J1L.M/#%Z4H">HQ2E*$8L* [?=BH(IMN3BJ4
MIX^V*@T'3%$)- <4%!N#R!QX.^YKB@C63X&0,IVXD5&!W6*#FJW#0A=B >0'
MS#<J?AG(_/OYJVOE$&U@TS]/:C*.,"%A!'R%-R3ZC4Y$ D)V^'Q'@WSOY^U[
M7=;GG!EU+7HI)>5P\S1V&FQ.&!2!$F!4C<@[LQZ\JYS]O+T7**Z\T:A<QSR#
MU/1N58,4)*CT[<EF??\ : W/7Q!=YECT^XFAOW(FM84]* W+ -.4._&(!UY"
MM*45 *"FV%EM(UPMI"AND2*5HFAYAE=)_38H %4&A!-.@KU.37RA^66O^:;R
MUM+V"YAT^68Q*C?$]34<8]@!TW';L*9[I_+7\I+#RK";/ZD)#/3U9R P/$$N
MK,1OMTWWW\,]:>7-*M4L?5@C*PMNW!>)D"[4^+CT \ ,Z+!9J(!SB93L$4"K
M<=O<CYY((8Y1)%"L2Q/("?4IL*;$[C;^.*/+#&A!_>#JI:JG;H=Z?C@)[MVC
M+47UY>('-N #$F@K7Z:#!@DEBE8T(MVC)+,5558;G8?%OB]8&CB97YJX#AB*
M"GB*@>.#K6&6K"1%B4*2M:"I&_+OM\L$"26@ E9T=P"I.^PWW KWZ5P52%AP
MH68BE*\0OZB,#26 >X6Y>1O:J_;7QH#M3$Y+6)PYC:8HY',@DT:GPT!!]L$R
M6=5/I@Q-Q[5)+'J?#Y8&>.0$M(4>@IS"D=.E1]V:2)):(2O[P$\&%14=P>WR
MPA>U8*%4K#**GA)4J4'R)^BM<C>HZ<LAJ5'*2H! X'IX =<Y_JFE6]]%):W*
MLZBJ?M131'>K*P/)3ON5/?MGF;SGJGF_\K+D7+:8?,?EB254BO*\7MV9C19X
MH2&8[;,=C[';%/*_YQ^1M=1)_JLVCW;\DD+.8H_4Y;JLC(G<]B0.C#.W:?>6
MUQ!'<12275HZ@^MP1V3_ %A&02/<#Z#@Y@G$%9/W9/PNC$J?I/3Z<K@PI\18
M=]M_G44S$#;O3*X=L3*;GYY6W0=LH#N1C2!WZY:^)K3^N9EW)QNQV[C/9GY"
M_G@O^B>1O.=]UXPZ/J,Y^A;:9R?D(V/^J3]G/9V;-FS9LV;-FS9LV;-FP/=W
M5M8VMQ>WDZ6MI:1/---*P5(XT!9F8G8  5.?+;\]OSFNOS-UHV&ES26_DS1Y
M6^I0;J;IP*&ZF6NY._ $?"I\2<X#S;IU!_CC@^P[>^*(U#4]ONQ<,":'H<5C
M'2N""0*GPZ9E:I]@>V+@ FO;L<60^.*;GZ/UXJ*&NWRQ1#XGWQ:@8T&V.I3;
MOX_VXUA6O)W:.E."[ _=0GY5ID \^^;HO*^G>H6*W4JM]7BBE1&+(#N013_6
M9B%0;DDT&>$//?GBUU8K%;21A[N1A-!Z;,)'W#//>$L6IS(J%"FOV0*#()-/
M:Z/I::O,+6-N3W,D:L9)F8T0/+*_%=V! 6.-0-P6)!&<WN==U#5[T7*6$@N=
M3F*22.XDGD<!>58^"JI() '[(&XPKB34-2OZLANDEV14)D$CDFD:FH#<1W&P
MSU'^57Y1W%]=Q7FI(W$*$$=P@;B_64'C7X5(H-NOW9[4\K^1+?31:NI6>^],
M0Q22BJHI/VSUZ#H*G.E-/9::+:R$GIB:011E@7+O7XG;[_E6F=9LK?C;+:M(
MTRQKN%&P8'< U&]>OMAW';R>D4@A"!?B:4L:';M08Y9+V&*1/7J[4"\0O+V/
M$BNP/A@N.RN9RDLS\00"034NRCX:D4J1@J/28KV16GK<>@YI5?@4FGQ;#]DC
MKAH%!$<  BW!]1S5R%.Y H?EOABJ*?A8CN68?$PKTJ#UZX*C6&-3".9<@L0Q
M^S6HJ!B-G% JR,DDDH?X'=B34#<TKT^[!7&W4<(E' [;U(IVIC;15N%;UI%:
M!#M(U*!NFU3TVP<UK'(BJ&*(Y'!D%1L?#?MF%M2)HVB9%8;!P.YIVZ84O!+S
M)X$QU^P_5#T)!!Z8R>*D:J695&]1X[_M;TPBI'%6%E,RNQ'Q NX:O*@J:[?/
M QMU >6JS?$10$E22.A!H1A'J5A;W  DC5> %" 30#IR<5)'SR ZIIL,]I/;
MWD$=]9W"^E,KJ'1T;:DB&M=M^]<^?_YN?E'YA_+V6X\V_E_+<7WE7E6_TV%Z
MS6C!B?4&WQ1 ;"H)2FY(H<AGD?\ -#S#:S->VTZV4I<^K9B152<#8E+9BE:$
M MZ3TW/P!L];>6/S+M-3M%EOX)-/9BJS,R&B,P!Y,*E>+5%"K$FM>(WSI]M<
M17,<4UK<130R"J\"0&'M48NW):!HZ$_RD'^AQO)2:$T;L""#^..(VKX]<2(&
MX\<O:@'7&4WJ=JY8 !&^^4237OC  *^_7&<2""/GMU&>[_\ G'_\Z#YAA@\D
M>:[NNNVJ<=-O9F^*]C6I]*0GK*@&Q_;'7X@2WJW-FS9LV;-FS9LV;-FSY[_\
MY/?G/^FKNY_+?RQ>_P"XK3I>.MW,3;7-S&:_5E(/V(V'Q>+BG[._C DTZDBF
M^4":;&OO[8LIV\:=1W[XLK-2G?ICZGQW.PKBZ,1TIBO5A4UQ9?N.+!J#%@?B
MKU_A@@'IM[8\]O#[L4 IW^9RZT)'^8R_4D4?%$[>\8YBORZ_AD<\S^:]-\JZ
M7<ZM?7*6L4:%5DE!))W("1&A)\!W]\\*_F)YLFU">YU#4IGGU.<(+:Q<K.L/
MJ,75YU#+ZMQQ *Q B.)15A^UG(I!:V$3:KJGJ:]KDJ^LNG0 N8V&T<<LB$$\
MW<;*!4]-JX7-92VMP(/,-^MYYBU5(V%K:#E!I4$2EU7U6)Y,Q3@*;#[2].0)
MX[&;6I?2L8_TE]>F^H6<\%?JYC05E@M:!3Z:_P"['H2W2I'7T#Y'\DQ6>II:
MQ6J37ZTJ1']N4,%=W/V5$9/PH* 4&U<]F>6]!M+=(;:"(JJK29Y6+,S=V)-2
M-^V=,+?4[=4AB61Y#P  WX]?@&^P\<,M&T6>?4K6[O+<)/-3T4?<0Q@EB54
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M?GV(SR?"0M 3T[XYG)KW]_EC0=A3<G:O\,%*XVWW&"D!%&)!VVQZNHD-1N?
M8ORY4H!6F/\ B'3]G;%D-.-1OL<%K1EJ.ORQP &Y/WX*5@.AIX^V+H:]ZXJ*
M \J[8I7:O0GOB,D_I!B]* 5#5H-NQ/;/!G_.5/Y@Z>MSIWE9]0NI1?6_/T4Y
M+%(TM/@D#@CTR8@25'(CX0VYSS3:7,EQ%/>LR-HN@6T+7$O%:2RE(I8XOL\&
M,C5<['X%X@$-0RR&6:PU&P$J-::E?-ZLZ.@2VTVU0AV]7ES+F/U.4AV9YV7]
MH(,[/IVEM^9?F6RBGNFT[RYI=K+<6\B*IATR"*@N=5U"6@264JYXE>=9&*JU
M,F&L:W8:]YEL?+_EJQELO*=C'QM!*SB:"R0L@NG?>LTS GFV[-ZLB[+'G0-
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M)Q)((K05IMMOA9<V9<AHWXR5K\:AM_GOVQ&&SNCZ\DI65&I0;BAIN:=-\ -
MJR&45A4&A!VJ#TWZ=<)-7MK?BU?LR$ E1526'VAOM3(_>6?"O-C(T8'-E/$@
M'8?"*?/(Y?VZ7L84QEY0* %BI(K0;=U[9#[RU]$,HG,<ELQ,3 4YH-BIK]V1
M/5(#.[R6@X-(?2GCV/Q;D,F_?M7/,'Y^?EM:>;M$&K+$9-5\O(SH\?4Q4K(I
M4D= *]1WSR5Y(LKW2]:L[[R[K#66LV\A4?61ZD%Y;<PLKK2H<$.1)'Q^)6((
MY*"?='D_S%::NQMTCBL-16V$DMJ :(UO(\$J5>I*J14;DA:$$K4"<$,"0P*L
MA*LIZ@]P:5S BE&KC-R1V\<2.QZ_=F'4^&.H:%C2@KE%5.X.^-[T[^V-*D;]
MNN-\&Z5S'?WSWY_SC;^9?^(]#;R9JUQSUKRY$/JCN?BGL 0JC?J8B0O^J5\#
MGI[-FS9LV;-FSA/_ #D+^:*_E?Y O+NRG]/S+KW+3]'4?:25E_>7 V/]TAY#
MMRXCOGQW]0O(SN2S.26)W))ZU^>*UW-#M3'<J#X3N>^6C[@4^GQP2-]EZ=_H
MQ4-2M":XNK@$$CE[XLI-0?VL%H2.HKBH8'YXNI(6E<6!J/EXX\-3Y>)P0I/0
M'8X(7?KOBNU*#H,(=<U.WTRQGDG;XG'%(^7$OL2WQ'8 *IJ>W?/C7^87FD>=
M?S/\SZ]KEX\T,TTL(M;:ID2UB7X(T=ZK'%\(2H^)JG85)"ND:MJFJS?7=+A@
MTO2])O;:6"RDD81-<",&!IHT"!F^#E4D;@*!0YTGRMY0U+S!>O>W%HUW%'=>
MI?'U!!;F=)2T=J9RS%H87<LY&QE+$\FC&>O)=%L_)WE^VT6.Z62[N+5-6\PS
MJ \-E;PU:"RGD5 'DXL2L5.,5:'DZKA;Y2TE[/R^VOWKM<ZYK]\LMLA7TC+-
M, @)1@28X%F"+7:IKW('5-#LD2WD8JQODDE=@RT\.)(J!3XO#?:N=)T!Y3-*
M)CSETZ @"NPED.]*4'3L/IR7(LA@,I:D:D*I&PV'4U/CTR1^4+0RZW:W) 06
MT+S<^_)QU(7?<'QSIMH92&,J^FTH9R'V/%2*)OVKAU:+<F%1&7E,G$-2@5?D
M=O$=,ENE?9*U#;L(^( -:CK3;;YY)?J%TG"8+RCD:DGQ;@_R@]P3U)_'#F*#
MDB11H4W!Y#:OB2=MOGAE:PV\2D3R($+44*>51]%/QP8%4DQQ1C8U!Y$GKT.V
M"XTE8AJA0O[*D _/J3WP5]7)+$BI;?W(&V)-'1G%5"THH'7L*;5\<J0A"B 2
M*&( 8(: T[M7;*], ^F2&<ML :ACUVJ:8H>24 4!"=PVP![UZ_?C@CD@-T!I
M4+7MU!([XM+" H!158@T %>F_?"V:#XBJD4>C4.PZ;C% H"*L2<> %""2"O0
MC"Z2,.&'"D8H-ATKUKWPEEA= ZT0Q<CQ!&]!U!IMVPIEM &)),984 H"C*=Q
M7J:BF1+4K']Y&ZG;CP5A\/VMP2:;BO8Y$KVUN(VFCD)YL*$5!V(ZBM=_I^60
MMX3%-/#&BH\Q!#$$$L*%>M:D$9#]8BI0\51I27"M7BOBM*?/Y9XM\V^5+#0O
M-6L1:A#<)I6K1K<VES'&H2WDE<%W/!5H8RM"0!78]?BSJVEIJMY/I6N0B2R\
MPE&M+RWB56BN7EA1H7YHH!),0^/92-F"GD#UJ"?U88IV%&9$1D%" *$ 5!(J
M#M^%<$HRD<NO]?#$V-&J!MF(!4G[OGE<1U[Y8KE$=:]L:>E1N>E.^,)/?*K4
M=/H\<:"?E7\<D7E3S)J'D_S%I?F/2VXWFF3B7C6BRITDB8C]ET)4_//K!Y=U
M[3_,^AZ7Y@TN3U+#5;=9XB:<EY?:1J$@,K JP[$'#G-FS9LV;-GQQ_YR-_,M
M_P ROS'U&>QN3-Y;\N%M,TD*WP.D3'UKA1T/JN"0:5*! >F<)4[5VQ5#OMOV
M^C+:A) V-:XH&X@TQP;B!1JL?PQ6-Z^]<74L3NW3?!BD$T\,&"0A0 *CQQT8
MW/45^[!: BA)J!].+"I(-*+XXLH!IX^.+H5K0C!"J3W-,OD:4KG-OS2>6+RC
MK$EKRDO/JLHC0%1P0J1-(.7<1\O<[ $9\8K/3;B2WDO)K0PS:M>"*.24..4D
MD@4JBA:T0 $G<5-/EUSRW)I]O-8:W+;R:H\5W=6NCPQNUO$]RD?ISW4C!I/W
M5K'Z:AV( (Y"K5!]5^3%TZ*VM=2UYDMM$LP+C3-.]$IZCVR+(KFT8AC&P 94
M)JP*AN')V:8_7EU#0VU&_D-U<>9M2AU8VP0\8[6WFF@L(" U9&EN&DN)GIPD
M=(P*1*N(^6+F[UGS%:37DZNMM9/>>L'+JDS2M#:VP.XHHEK6GVF9N@&=CTY9
M6]"63X)I"Y<'X5(95(JU:;=J_=D\TF)H;.W<1!I-1G9VE>J5"&BJO*A(V^7S
MR9*L4I^JPOS9%].< U^+[3$T[@5R9>6O4_24[P*@=K<,4W'M3Z!W]O?#ZWU
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M9RO7D!X':@%<&Q!> MS\"CX:+4 #P VWVQ5PS>BX1DCB))WI0FHKMU^G%(@
M'**Q8D"JJ&IX^^/F2-%8F-G-1RJ:UJ: #D33Y8A($B9VX@4IT7EN-J;?/PP7
M'* CA )67;CR*@D[]:KOX;8*<<XT!'-]B%W.X/<CO[XB\S)1@Q8G8[&AW^_
MJW$C.0PW4\@R\E!\.I._O3+41U!4?$I)8'<CQ&_X;XBP:5-Z-PZ<D4?TR/W\
M7I1<V%2E"37:G85K7(Y.*4:/>9AR6O?EUJ:T';"Z<I%"5!$=:4%.A&Y]]JX4
M2,\MPL4<89*"K;]?A/ZS@:]C=+9U9A(4/(2$4VZ$BE?NSFBA))=0>A>MQ&X
MWI\0[^PR/:Q+QM+J/C6E(PM-Z4ZD]=JYY<>YF_Y7 ='MARGE73V<@@R&(SJ3
M&E:;D<BK5!4D$=\GGYEV]R%L=8T]KBY-HEG<V\C3-&&D@=)'#*:A@Y=D*D5&
M^].D@T.<2V4%Q+;SQ1ZI%#=\9&HT<\D8+KQ,8I7N">ON</S%&RUCE5B!4H?A
M8>PKL?H.!*@-^O+VK3MUQG(5XG[\Q )X@XDZ@==L3&Q_CCMR#4;=LH].E/[<
M0;:E.F---O#WS;5V%<^CW_.-OFP^8?R]ATNXEYW_ )5F-BP)JQMV_>6['<[
M$H/]3/06;-E,P4%F(55%23L !W.?!G\X/.C?F#^9OG'S8LOJV>HZA(MD:_\
M'G !!;?(^E&I/O7.<5Y$;U!&/Y"A W\<?&U :;5[8TS5)-:$>_CEI( :GJ<<
MTON:C'1L!U J3X_C^."(Y"#N-A]^"_4V!'?^-1BZ@DBG0^^#HBQ'6OSP54@C
M>A.U<&1FBU.X\,6!(;FN_AXX,C?8>/;W\,,HV  Z_P"W@V$H'4R<BM=^/7Y
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M@_UL^B^;-G%?^<B/./\ @?\ )WSOK$4WHWUS8G3+(C[7UB_(MU9*[519"_\
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M$U/HWY!J-Z_';M^O)-:_\Y6>73:_5+SR7J<=#M+#<V\AXG>AY<.FU/;#=/\
MG*3\OKBS2VO=/URR"2!JF&"2@%>2J1<$]#W%.V273?\ G(W\KS;Z5)<76IPZ
M=<:D;"&0V#R".?TTE])B)&('%JCKT/AG0O\ H8#R%922?5UU#4A$S>F;6V2
M$TXU9Y7Y4H.@ ^_"C5?^<C8=49/T-Y2OY&@4H6,T9V:O51&U#\CM[X$_Y6YY
MIU&W-K)^5#ZGIJJ@BA<W<01T^RRR6EK".6Y[]\GGES\U?SF,<5MI?Y+&]6%
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MD49BD8D*\:T XKLO1>M.^>JH/R"_*AK1HY?*5BSF*G, J]0.S*PWV\,^>_\
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MNL1&VBE5!^[= 6 *C>A^W4G<BF=PT;3K(Q@.#;M#^[$C1<5<\10L*#>I&_\
M#)]#H[16OHV]C'=P2+P**@EC2E22ZN=ZD]*U^6 M1TB+T;>OE>UM9H.,*R+;
MJ>)5_A:-2Y"B@!(V[TH<ED882);W.FV=D/35N$,E10U%":$;T'4'?\ D.A(U
MQ#<Z9J$FF7<QX"XA=HG0D$5Y(0:;=<A,?Y;ZGHFK_7[/6G@7F5ECI&8G(Z\B
M%7E7<U[DU/7.+?G=8:%81?6EE6!I.*>A4$O),WPQQ &A)/;.+>4-!NM=\RV^
MA67IZIK#H+,PS%GM83<'BL;,#6B$%WI2O$"H[?:/\F_+&G^0/(GECR9I@:2S
M\O6$%HDC@ N47XB%H2 34C?.PB]0(_,@2 "E2#2GTY\^?^<U/(A\Q2^0_/UD
M%,F@RW6B:G$S,@DL-7]( GC_ "S1*HKM\=>V>?/*]UYKU7\L/)LNDSV=I/#;
M2:1J2SP,TTUUILK6DWQ U4LD8-6!ZCN<C5M^7FOVVM6WF'Z[';W7,3K$I,H7
MF.):LC.X->BB@[BF O,WY*?XKUNZUR;S-+IFN:A";>[E>.)H""GHMS5E7@67
M9FK2FY.<U3_G#2;3X-3OM/\ -FGW-WRAX/%;M'9@2,23*>;EB@H1Q%!U:F=;
M\A_EE=^0O+^L317%AJ6HW<ZVYN[='D,*Q!C\$;,M>1?E4#P\,\U>>/R"77_7
MU2-KK3]8EED:C!11D(>)QP4<6/4=\Z#_ ,X_^;/.,DVL?EWYRURYC\QZ/$+S
M39;T"<7=DQ*AN; -R0BA-2.Q%13.G>:;&XN4NK,+(=0F8\&D9BE(QQ9Z]/B!
MIUKG;?(Z:7Y9_(JV\QZX_P!2T_18+N[O9:5D$45Q*:*O<L_%5'<G/'OY\:1:
M^=+30?,]Q!<6>IZ+:036]I;4<R-?S1#ZNPH68[K3C2I]CGHO\G/RAN?^<<_+
M_FC\Q/S5\RVF@2ZG:+]8TDJ&_1_JM;EHC,I=IIV^KQJ8T6BMR52VYSN>F>8-
M&\TZ'::YHK.UAJ 5H)'7@TBL P/ T(Z]\6IXUQK$G8;97Q,/B&V-?;?K3MC
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M,9VHQ!H&%>Q!Q>PMRJ6[U$\EJ2"62OQ>] 1T[UPB\[0VY$#P4JYY;#X@S$
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M8FO4G8Y-?RTN3':Z(]Q;M%:_7Q-,YHRJ54K&=OG]Q\,].:XL,^E3M%OZJ5Y
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MK+49(A(4D<P$\Y5W*.P+54D=:?/PPJG\A:-=6D\<T*M L)5R5^*1&-3\(VH
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M954TW%0 :GW&26[(L;>8/\)>)FC  H!U%-O;(YIT;+I]_?T ]:XY**T^&!>
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M/O=4U*00V=C"\TC]31!6@'<GH!GSJ\^:I?\ F75K_6[R>FI:A&;F2UC^+ZI
MP$26WVNBIQ+ &M36G?/6G_.(GEU[7\D/..H-$AU+4-3OEEV)JJ<DXEU)Y=*=
M?ISB'DO41=QWSKZ9%A-,&60\09;:1BW3VVSMU@MM)K=LL2,=/U2W]7BQXQL5
M/(1J:@@DL?QSK.@J>1"3JDT=/50*51UJ2I7E2OV2/>A.#;^QCN4::WK'<Q2^
ML"E?B4K1@M2=S05PRLK]9K:V#T]>)J&JUIP!Z$_,4P#K$(N.$B0<U<$M7VV^
M>=%_)C6);'4;W1+BIBN2/1Y$U-*UIVZ?AA;^:?ERX\K>8W\XZ;(\MCJ02"ZC
MCJS(5:J..)V^(=??PR3^6?/%O-/;3I=B,W$2R,&HR*]%1R1TH0=OF<[_ !^8
M!:V 2-'>0H#53RHZT!%5%.U/I]LYOJ]T;N^29&^JW4 XR,S? :$%>150"*[_
M '=,Z3Y0U:247$UPO!0(_P!S%5G4'D*FHZ_#4J/GG3Q*(T4J")50"I[!MEZT
MZ^&!4BD:[K(GJ(5"AE^R &KW'?OMB<^B6DK,Q51\1H48CB%W4*0:"FWL<+)=
M+1KB7H'0\P_#D2>Q![;;BF.LH9)8X_2?C)4AE*K\?$;!@:TH??)"FG?6/524
MD"$AA0!J].M:]^NWXX#ET>*VD1[=A+=**R2/7@48TV56'2E14?/;"^[M9 \<
MULC.6C*\0M"*$L'V+5'CMA1)Z\<0]1C/((C%(=D"<J$+0$T/],BLD%O>L[AV
MA>.BNB <.-:J?B%:"@WI3YTR1:9#&T+*=U(1EH*CBP-#4GM3PPOO ?K9@DDY
M-"0[.#L4I7^.$RZB?K*PPU* ASZ9%*MVKL.N=$MO,$-O9(LCE5X\*I4GX0>X
MIL3T]^N0J.9]<U6.!(C'9[S7#5V6&.C<:FAY.P ^_P ,COY@:\'D2S$HD!K+
M(B]/A("** ?:8TSEB@A?B/)B2S'Q8FI/WY5:C?;&,-J_YFN)E*D5^[$W&Y\/
MUXUU&P&)[@4-=L:S$]MO#,&+ CL,HT;;Z<1:@J,JHI4['$R:^].N)'QS$[;?
MY^^4 ?F,SK1.NVWW8T;"AV/4XRE*U%2<=##<7MU;VENA>>ZE2&)1U+N0J@?,
MG/LM^@;7_#7^&.1^I?HS]%UIOZ7H^A6E?Y<&ZIIMKK&F:CI%\GJ66JVLUG<(
M/VHIT:-QN#U5CGY7?,6CW?EGS!KWEN_VO_+^HW.FW%!2DMK,T+[5/[2'"8/7
MIUW_ (XHIZ;[TKBP;N=SC^1I4'IB@;X03UQ=78]]O8TQ8,:COW&*H3\Z_P <
M$JQJ.U<%(U#3J#X8+1J4[$]=\'Q$M3M7#>'JM#O^.&<1W%?[<-(:?,X:0$?(
M_=AI%0].V&"+2FWW881$+[=!@[ER7L*;U/0#N2?#/'7YL_F7)YKN?T!Y>+S^
M7[26CR1T_P!/N(C4. 3_ ',9'PUV8[G;.5Q:);SP?5G N99 \AE+<5C>E3LQ
MZ\B&->HSZ'_\XF>6+B#\B]2M'42UO+QI)%:J!^95D#5/0C?<C/ ?E20Z1^;_
M .8ODV>-A%!KLTT<=0#Z4[U<*&IU]04ST=I$D:06-PDZ7"Z9=F!6C8%0B,/3
M)-30A7H?#.V6ES'+<&9@:R? ' !))W"GH!6GPCPPY*"(".5R'/Q(Q #,!XBM
M.GATP+>Q&V:.1%XQ.>6WPA33=:5!Z=/N[97KAV*>H#+P+*"?M"NY^=",!Z?=
MRZ9K5AJ5N>+P2 2QOL3Q(8&H\ #]^>O]3M]/\V>6B/3+43UE4<1RIN4*$D5H
M3USR[J7EU_+VL)8I0Z?J:?6[(R"@2XC8B6(C;V^@C/17DO6%U'3H(DE4SQ2<
M&*J9 W[ ) WZ=SV[Y!M9N9+'S,8U(2.\M)7EAXL"U""I((':FV3#R9KRR7>H
MVQE<7JD@"@H6'V7-:BE"2<] :;<"XA(JLLT77G4D,0*,!]'CAY' GJ#T6-5H
M)'+?M&O+YGVPP:R61@A8IS)!7;B? $ 4S)86TBI:[\D^)7H2&%/LU.WSW!P,
MWERW0*89 8F?U"H^%N>X^+P^_?!UO8O'&HH958U)>AH#MP9A7<>)'3KC+NV>
MAB9&8NS!8U#<FZ$G<TVV[9'KFUEY0<@R+&KQA@>I WI11X[X3/:)/'*L<;!C
MLQ<* E!NP!ZU%/'?"H:+%'-&5_<B4 LR#XV,9ZL?#>G3!E\6X0B,DSCX5 )^
MR>YV[X1ZDCVZR. LC.#SI0$,058$G;M7Y9Q.X\UB'4GM[.W?U;=-_A-:GXA\
M(W.Q^[!HU6Y>SCO+J=S:\0"5!C,C'944&GQ,3\(I\\FEIJ+:/H\MS=V[6DLM
M6=9*5954%56C'85XD]Z5[YR2>Z?4;V:\E4J2_*A-:$CX1] -?F<?4$?+;$SL
M/;WRB:4)ZY34(%.N(L3X[C$V8 BIZ#Z<19JUIC2:"N)\P>FWMEGH:?TQ(]0?
M'KC&8=M_?$ZTJ=SF!J:D]<HCP[8F&I_GX9BX&U<;4C<#;*+[9U+\E-%_Q!^:
M7DNR,?..WOUOY!2J\+(&Y^+M0F(#Z<^L>;/SO_\ .<'DS_!G_.1WG@0Q>C9>
M:_J_F.VVIR^O1CZP_P!-S'-GDT>/3^S%4J-^GOBP8]:T)Q0$FE1UV^>**YKX
M<L7#"@H>G6OCBT8WJ>VVV" 5IBR-N <%Q@=MQ@E&.W+>N&$<@J*?3XX;0OL3
MT\<-H'VW.YPRB;<=*?Y[X:Q$#>N&<#K4#;W^C#&,D$%3MTWP<K4&_0#?.'_F
M-YXFU*-O+?EZY*6TD@BU.]B)H54@O"&H!PH0'8'O0=\\]P6<S<+:.)'FD+<)
M5HH *L1Z: BGQ*%_7DITZP_1[7-Q]72-%"E:'=V8-1E3BS&J,1M0; 4SZ>_\
MX1VZ:CY(\Z:(M+A--U(2K(W+D1=1ABA5E!H"AH>_X#YK_P#.4WDR[_*7_G+/
M3-46'TM+\ZI:W$3.#P9PWHS ^X*JWTYU2""/Z[=:>IX+<*DTGI !2\8*AR!U
M) &PV)SM6A^G+9PAW/JQ1 R[55J[!B0!OX^%,.OJ\,R()E].> OPE'V"C"IW
MZBM.I[YBBW%M) $#%VXBAZ _9->@%>F126[%K(8I.2)]F&1J?M?"R&FP(K3\
M,$S1N8E8@S,NP-0*TW\?"N=[_+SS&RZ6T$SK+/$513T^#DPXDGN*=?HPRUZR
MAUJP*7#11O%<">U9J%TD4&B-TIRY"IKU IA'Y34:5=R'U0%E;U;61221ZHHX
M(K7?K3QK@GS=ZESK'E^Y:'BU7MI-^RBJG>O[2CKV.(:"MM9><Y;M.36EZJE5
M X.C4:A4;4HQZ#^&>EM)O$BN+.1I#)#*K J .*CC4D]A4#OD^2,,C72CE(5#
M*NQ:BTIW'W89Q72-$TL=)6C)!(/+8;GZ/?&BZH654$0IO0"I!';L*8*AG)=4
M63F%2I:E>2@;$D#<X*D7DC>H@ 84]_\ 9#;]6(LTBPH!('!85 -!44^D#;$'
ME1#(9VY1.*L#2FXI4;=?UY')75I8XX@T:A77U-E5RQ WH:B@'4X7^B([F.V/
MQ\D:0,:$']GXF\=N@P!?"3E (HA3XC0DJS#?IX5ID!\S:Y#;0/"6")OZS?LJ
M#2H\ *"E<XQ9V-H;C4M1EMXFG5U4M6JO&22@!!%>NWADJ\M:?];N&\P:G5[>
MS9HK!'VC0TXR3\=JG>BGYX2>;]<?4]2;3[(TBB-6K7]W0[!AML*5]]L*(U2-
M%0&H7N>I[DGW..7&LU-SB)<L<U>/7J>V)DDDGMB)H6IVQK&NPVQ \C\/AWQP
M4;>%<S$4XKVZX@U=QU&,V!%>M<S-TVS*@J#^.8LH_LQ(LI[=>V)D4(QE0=CX
M[#+84/S&>N/^<1-!%YYH\R>9'3E'HNGI9QEATFO9.7)?<);L#_K?+/?^;/DW
M_P _._(Q:V_+/\R[>$4ADNO+6H2^/J WEDOT<+C[\^1RL"*5Q2HKX?JQ53V-
M?IQ4-4;';%ATZ[XJ"![=L65QXTQ526Z[C_/QP6@IWKM@E&VX].VW?!"D CO3
MO@Z(BG4^!PV@8TH-_GAO"0 #UIO_ +6&D+ @4._AA@A)[_1AK$P-#2A&^&$<
MA*$#;C_#OG(?.WGYVCGTO0IF2#[%WJ,+ T&X:.W)V+'H6-5 KWSF\&D-&MQ+
MJ$+0VD2U".P*FC-$I(J%).QW([#?I@.ZMI(X(/J_-8Y!*_Q(\DCL#&YWXJ"$
M=^W<]-JDYT^UO)N#W=PEA:/9T1I2[2L\L:H#Z:*Y^&1.-:?"#TSZ)?\ . U]
M/;^</.WEZ:]FN(+[2K>\ACG7TRC0SRAU],D[4N!2GAO3 G_/SS\FVU?\M_+W
MYIZ58^IJ?Y9:W;W=U(@ 8:5=NL-P2?Y4?TWI['/%_ER^%[<Z%K+/PD+A'F>I
M'%@55@-Z$$T/XYZ-L(Q:!8S&7>29H[<5)#>L6ZD&M!W)^7?)!):"U#PMS%P2
M_P ;G8LV_(<J?#_DC8=,!F)OW%S'QBB+>E(KMO&4!'%@!T\.V1?5[""6:[MU
M9FYL)4!(8I+2A4$T"@CM]W09#_TU=:-+]5N0TU@ >+*"SQ ;C8_RUZ==LZ)Y
M<UN!)4N[.9+BSGHX9#4,XV- .^W3QSM]E?P:K;6QY$I*&=T.[(1PD1@O4BH\
M=LVF#T;R26=P\=S^_=5!XIR)6B@=B=ZC<5.%OF>XF"R1L!(8$5@:\GYA059:
M#8T^^E,(]%ODU*.YD+<[J-8KC:K!P*E^-:D;"N>D_+R7!M8W=EN)#&A5@."L
M50=JG<]/;IG3=&O888HEF2GJ+R/[05Q0!03N3OMAI:3!)9H'KN[1E:"G'H!U
M\/Q.7P994I\*Q#IM\0[$&M=L-;:Q6,+)%Q1FY,P HI-:FNPJWT]\-T53P63X
M%.ZUITZ[#?;OB5S$)(BR\O12K578?#3KXUK]^V1B^:8"595$D'IU()I(S5)(
M&X% !D>,MO%'QC?D9N-!0H30?:H>U!@HM)#"1-&'X]R*C?Q!KL0!OXX2:K?(
M*/&WV$H !L* L2<X[K5U%)#-SK':Q2<F(W#;@T(V]ZYSG2?K&I\+8MZ8GG8
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M5>W02YKZ5(Y[:1@651\2, ?L\@U3N*?*F=-TS6[0*\4#L\T[*I@=:T9 6HA
MW%#MX5/RPY.I,)X0)(PC*5]-B2I;8@$CITV&$U[YMM;*VF,DL<;0.P^/<@#<
M-UZ?=D#O_.ZT]18#*6),;$THK4(^(GI45KD>NO/4Z^FLET?W_)0J,/MN#3@1
MTV/; 4-ZUZZWDJ5AM%#!4!*HBU/*IH3_ )G(QYE\V6UFLSH.$,GQT8D%F&Z[
M5! H.IIG&=-UJXUG4V.FVTE\T3 %XE/!*,027!50"?'<#8#.IVL$X59+ID:8
M#9(Q2-/<&F[>)H/;!ZB@H<<:'IC-P>NV)N^Y[8DWQ5KMX8CVW[93,*  G$J-
M3V]\U1T.)]*C?*;K[9FKMW[G$R*[8W[(.YZ8T5K7Z,38U[[G$BW7:M?#&$GM
MB1&^V-/P]-_GC*5.]=\[_P#\XU>4O\2?FAIM[/%ZECY6B?59*]#+'2.W%?$2
MNK#_ %3GU!S9LV?(3_GYG^61M]0\B_F[86]([]&\LZNZB@$L8>YL7.^Y9/64
MFG1%'AGRE4;U.*U'2E*=!CRY!%.AVQ0$&N^XZXLM:;=^N+H-C4]>V*J-Z?=3
M!B T\<%1CX=P=L%(>E-S[;8,C--Z[^&&4)J &.#U8 $D_?TQ1KT1A/3M_KLD
MB%TB20"HW4<F%2H+;=,C.H7^KS6DL-]>2G2@\K1Q0'TU60T7U5X%B6391L2W
MT9&O+#F.RMCZ4GU>*.5'@6%N4;Q3!2)&8"K,JT-3W^63.!@TJ3QW$1C#;B2/
MC$X D)_:7B'5SWKUSH'ESR[/K#:GJ&@Z>VJ7FE0B]O+24K*PM;:6..5FC=OB
M6D@+4 "?$3TPWTFTTVWMKQKIWDAD:*X>*XXK*T<=P]L\254$'C&0U.S!?MTK
M,+:&R>.:2UABG>XAAX2HK>M''('!5(S(P7[(5F!8 LJD/2I=#<7Y6*:&(PQ
MFS$A8D>G,I*$J!0#U000&/44/Q<F+(S<WJW*>EZ8BY1V[QDQ*DK0-+&['U(E
M#A8&#OR0[O([QD?6+7ZD?\XI^:YM:\@2Z)<NAD\JW?U2%05!2SG1;BU1D6&W
MX%$DX\3&AXA247D"WI76-)L-=TJ_TC5+5+W3M3MY;2ZMY-TEAF0I)&?]96(S
MXR7OD*^_)_SKYA_+>]$DUEI<XN],N265;K2[AF:W8LW5@GP/3HZL,ZAI\!N(
M/76;G-#6+G0?$E.4<@Z_:85_S&";C3(V$3R(I^JAA&JF@ (/*I%*D=Z>V$MQ
MHSL)N58[25CRB_:<;T8'I0]_EMD6U2TM/JTD##ZQS6D8/7B2?A\.V<TU..[4
M0P-(:.P5N2A^<:@['<4Y ?@,A-Y%:R>M9S'>!N%&JI5B2> /0D4_'"J*Q,,4
M8E!*,>-=NH-.A[TID9UC1P4YQKZ=QS;BXW!+5J#O7QQGEKS/<6<<VG7D9,<B
M!%]8&BNAK0@=>FV3F9[?6@LL5TUG*HW9 I53NP+;G;D.U-Z^.$WZ3\[^46"6
MLK:CI*%B0.,BG>K#>A KU';\</;+\]-3TV*0VDDVG7:D\XWYF*1AL2U>_$4V
M^>=$T'\]O+OF)88=2NVTW787903(DD)!)IP<LI(W-%._4=,ZGI7YF0VYA@>0
MQQV\7JB11R9C4_8D8D;@U'4^^'.H?FA]8AEY7*>C.E$]9N,NX)+3&@]NE=^F
M06^UJ\U56CEF>*TNTD,PMY"Q XD H7-0U#U \>^(_ICR]I,$44DDETT'HG@)
M#(J\MF=V?F J^^(6GY@^5+!I7U'4U$Z2!HU+D#<@A10#>M1O6@IA!J'YJ7]^
MPT[R];3W+ZC.Z%HHR()BXX\47CR/$=ZT \<D&C^4I;F3](>:%CO+AOB2QJ7@
MC]Y=R';V^R-NO:?1Q)%&D,<:Q1)LL: *JCV44 ^C%0E"=^N-8$#EV.,)Z;T]
ML2):M/NRJ<J8QMNAZ8P@L!N<IA04K7N?'$R=J?B,;R'0CZ<2<T.V,(/?-7H.
M^-!Z]/;*(V\*=<2VIN<812FW48SCW\<3)&V->AZ;D[XP"M-JXFQWIGT>_P"<
M4_*)T3R'=>9+F/C>>;;HR1D]?JEH6BB'TN9#\B,]19LV;..?G_\ EE%^;WY0
M^=_(@C1]1U.P:;2F?8)J5J1/:'E^R#+&%8_REAWS\R$T$UM-+;7$30SV[M'+
M&X(9'0T96!W!!%#C:U_ABPK0'J._T8HM#04H?ZX(&P\>F**=Q3M_MG!*FOL!
MM@E&VW&^+<S4 'OTP4K; 4K@Z/[(-/HQ<3QQ4+. Q;B!WV%=AU/3L,O3]8M+
MGA)=:;=+8W ,2!EIZCD L'!*%:*0=C45&U>AT+*UM)KN.ZMFL[F)S;16]>$5
MNZ@*G.X)9SZ04T#5J1T&*3GZJUU>M E]'+:L(+>X,J</4_WGF$<)!]1.18>I
M1:5^$_:'/_+6FW]UYEU30[0>J==N/521N +":.3B\C$G_=J<Q6E33P.=HT_R
MS:#66L]0,=CZ-L8*)$LO-Y[8"2, *_Q*Z \JG8GMDU\OZ"EO+%;Q-RF8R6LR
MHP])Y9H1%<1QJ0IWN.#("O4UIQ'!CW4?*=K;Q274@]>2UO[Q6%4]$>I)$'KR
M4DLTB[D_9'8;",U.G:C"D,$47HVUJEQ;QSRM&RQ)/<?6%JIC'(+&&'"H/Q%B
M?BD,B6G:??)'JL1M'1KCT;OUT64M!QGD 8E^41(>X-&9 $Z J[5P99Z)?)]=
MM[-X89K@JX=Y>#HW%6A*JAF8$-%R%!R8*'E!5(P/2'_.*NJ7.D^?VL?K#IIO
MF+2. MY&8@2Q$31!>=&^%3)0D#E6H!!#'Z4QM4#O[YY._P"<K?RS;S/Y8LO/
M&DQ$^8/(GJ3.$7DTVFR4-R@&Q)C($B_)O'/*OEEA=06TL9#*D3(R)4I+%Q_9
M/B-FR>"T;TS"(?6,**K14W>,"BNNW45_S[E-Y8D1^C$](8CR1S2J$;D-L-B>
MHSGFKZ(FH-),L;HK\6"';B]2*!@>0W%?NR$7FG-Z7I-ZDC"H&U&4-N#6@KT'
M;MMG)]6TI+<L$!G9 9966M0Z;[&N]0=A_$870R&4?#O5C2F^X'0CYG"^ZCWE
M?D"Q'%U8[*&'PC.?:Q:I%-RH4>@HI/$UVY=O&F2;2K:>[ACGM)C;74!%!2JM
MMU(!&QZ'YX.M6N;5KVUOWFE6YE,J+.PY*6_WT:#X33>O3H>V%]Y90%6+IZL;
M-50J5XMXU&0^_P#+VCREGDBCXL.1!4$D;;#8@_KP%96UG8,&M[BYM2I(C$4C
MA1OM\->(K3#9]0?=9-4N_B_9J":FE#7L1B]O<RNP,6J7JI7XBMS(IH3WHPQ:
M6QMYHD]2>>2A^!5ED(KWJ.0Z^V273-'JEK]5L(JR.J0*4$DDCL2 ?G6GTG/4
M7E;RS;>7M/A1HHY-4EC_ -+N0H+%FW,:-39%Z #K2N2V,4RV ZDD4RAL*_=E
M,3T[>^)BA;WRGH!M@8DBI&V-J=J[DY52.FU,2)-!ME$@;>V)MXGMB3&IWVRJ
MDCK7&D=*D_1E @ GMXXPG;IUQO(5!WVQLC;[XF&-#B;TK^O&$@; URP2?B)J
M*;X<^6]"O/-'F#1_+VGK6]UF[BM(S0D+ZC ,[ =E%6/L*Y]C]'TJST+2=,T7
M3X_2L=)M8;.W4[D1PH$6I[FB[G#+-FS9L_/S_P YX?E&WY9_G;J&NZ?;^EY;
M_,Q9->L^( 1+TL!J$.U-Q,PDZ;+(H[9XM5CV[8N#3Y=\>K<S3<8(2HZ],$(=
M]_I]\7C)9UC4K5CU8@ ?,G%V#0L%GK'5/4)IT2A-3X  8/MM1\OP6THU*29I
M)422%;9XN3%ASCY\ZE$9 3503RIRXBE0(U?2$N%M/5O9KH1H[+"B\.5 6!JI
M95WZT^>QKC]/UJ&6XA:XMIXK&) ;HK2.8L48_ 62556M":CN-ZD##^PM[BYG
M AN;6)+5:NL=(YI_K2T59'9N8"KNXH%H 17#)F@T^ZLS)#=BYB8>A$>'K<45
M3$1(W'F7/Q= ..P'?%(%6&"-]1MUE]?G,"MP A!8\S"H4_O9">->)H!QJ*$B
M1P6ZWAE;4+:CPQ3"!%.[RUY2<.5'E,2&A+;;; #J \QZ?#8V^G:Y8P^G;?68
MK(R$%8Y'N& 2(%10\''-F(H$?;D-LZ3IUW()M(?3;18WA1/JZLXD/K2UMY+G
MD#10KKQ'0%Z*!T;#K2+<B:%_56&UD>)976/U622:,Q+Z+K1:L26(ZU!H>8],
M]$^N07$6M0?6#<HT0NDA#QF(Q3>BBS1$R*A>1T 2IX-\3\A+^Z(2#7H%O_1]
M:-I)#+;S).9;AW(G598PS>H6H0#TY/4N5=_]%!Y:7VG\-/NIH_5:2YEB$DPM
MW6,22.A+$/;KR! +'UD 3BT<D,?.12J*=IF]"::>:;U8%E:02EXE:^E@-NB-
M:2D'UVW7T7!.YAFN62U@7_+OS3J/E[S9Y6UV(S\K"[T\R_'S/U5VN+>99%C5
MQ(TIA^$+)*78L5-W('G@^Q^FW45Q$DD,@EA<!D=2&#(P!5@P)!J#U&#[JWBN
MX)8)HUEAE1D='%5=6!#*P[@@T.?-#S+Y)N?RO\[:GY<5G.BR.-1T1ZFILY7I
MZ9( '[MO@I_D@]\E%E>$6P])1*L:L?AVD7E2C"M/A!.X^G$;NVEF0%0GQ(U5
M5@5Y4-:&F]:';QR%:AI\EN6$:\XGC)212/3:M 6>NX-!3;PR(ZQIR%7)9H[L
M JX<D*0 #U!\3MG-]1TR))GDGC  YB +N>7&H#$#CX@;=-NV<[O["6.Z::*'
MX1+P(  !V^(*#7H3A-JEH]97%4Y;5 \-ZFM>N0/6$:0*K1@ @5#FM=]@>I_9
MI^.'ODMIXWD9DYD/LNWV32@)'XD9UC5?+=MKEJLO!58H.E25<'K5:5VZD9S2
MZTS4+!6MS*)2KE !NS#L30^'7WPGFT)E >0A97-1R'($T.P !Z4Z8'E\NS)&
MO <XV!'+8"@%3532GAMG.[O3KU[@Q5)XM0*M#TVIO3?PKD\T7RR8K<7=S&R@
MI7B:<MN@--NV^^3*ST-8V2>2$)R6J*REB%3N17KMM7.X^4= 1"FL7=L([@)Z
M=HCK1HTW!DIM0L/L]Z5\<Z(JA1OV_P ]L<1T/AE<@>H[XF2 3F)J#7;&$]_\
MSB3$$**TIC& KL:XD>OL,39MJ8SXCWIE&E1MOC2IX[UKC* [=QB=*;$_/&DG
MH>_;&$4WS$_#N.F)BE:[#*8BN_<8E0U(!Q(GM2E#E #L=L:"0?\ /;/8O_.)
MGD?Z_K>K^?+R&MMHB'3]/8C8W<ZUF=3XI$P'_/3VSWSFS9LV;/)7_.:/Y.2_
MF_\ DGK,6D62W?F[R8WZ>T84/J2>@I^MVZ%023+ 6XKT:14KXC\[18 @$@5Z
M =SX#&0W4$THBAD]8T8D)O\ 9Z_=CK:>]N[@VMGILTMP@Y2)4#A&*DL3]F@&
M_7^&2-]-N.*2AFCA,P0\(N;%>3+5><D*G[/0FOM3%GTI!/;5U(I97+J1)PCC
M<QGH0AGD()^=*T%<UIY?N-0@DN?4E5;>14DF2,*S,?A"1KR=:NS@!>/O3889
M)Y4I=230R7%^LBD26XX&/V9PA+5%4W!H3T-<5'DCT[F&X9I;:LI>0)!Q5Y&9
M0JT"!2X(H!3H=P,D*>2HK"*[>]UB,7C2I"MM)ZCE^0;UD67D0/2CXN30\B*"
MA%5#R6VDPV?UA8X(H+0B%))%9I%E9R8X9&C+$3R."W5MJ]A7 Z:?J7I#48'3
MT[D+RX\'2)I)"I1C\2&1P#L16NU2<LRFYTZ5!<^O=2RN&5&$CIQ)'*=S(O&,
M%0(S4 [T6HR6Z3I5;2]OED:[@BFMXVGA<)#%$.0CA@0(0J %0STY<FX@8VRC
M>))8G>2-[)H50Q0*D:(M9%CF *\4^,M(35MP"K X8:M8W6H:3J5C'>W47UZ$
M02S%48122."CH"$57_=HR_9X #:H+9,O*&M)YIL;;6F+0S&"6.^M8XT6EQ:7
M*Q7?%26!I(%<;4/)A3BP&="MX83)/8-Z?IB,Q<%$95)$:4-R%6_:JU"&JO$.
M':G$O2-)[VWGDADOK<6?U*Z$D/$+((I4210T;AARHH5@:T?FTGPD&NH6B7K7
M%RJO#%=3S>I!&>;,76!)A^]J640QT4D$U!#^HH!4[M)9K>7ZPLBH$O4D984F
M)1WO.<NXE+<3(L;*0>5:NQ:2LN,NY86N;\0PQ>G<7-S#+%=0H%!EO$8B001&
M-D9$^.-5HQI& ]M^Y8KM;(7,K)&ICAFE9JR<YYIH9KN5I7?U5D21R_'U.8,;
MOQ$BR1(L4?U-_)_S2NO^2_+5X7]6=;1;2Y;<5GM@(9*U9^I2M:FM:^P[?$W)
M1\LXY^<OY;#S[H,<E@5A\Q:&SW.G.0#ZM5_>6K$D467B-^S '/&6CWDX]6SN
M8GAN%<6XC<E'CD%>5=B3TXM7^&3JUADDMUE;BW!N()X[<!U)4[5I0U&%E[;H
M_K3M''6V:D\#BCPE]ZDCD#M2OMOD*U2Q(C'IJT=NJBC\:TH"=Q0D5&VQH>^0
M75;-Q%P41L&7]V8UK53R I0GMM7?.:ZI9+,>$0 9) R<3RW3H34^V%FHZ,)[
M8W2BKM&W!:_:!(H:]*CJ">V<FU?0KB-ZRR*2RF0)3XOAVX]Z[]!@[RY!Z32!
M"9"8^6X() WIN>]>G^8ZYY;GCEM9(6<479>>S'8;4Z]_]O"^?0X[S4)YE0#@
M:DL-^5*5IMN!TQ&?2X(T$;CDQ/<"@^BA_5@:YT81IRD<^@P/P!:#VHP8T]]L
MYS#Y2@NKL4N3;RI,>"O&Q3D/B!ZBOTD#YY/;RRAM7CA4QGBH9^ V)K0+L3L2
M-Q7Z<E7EORO)?/%JFHM2V63E' RU,RBH!))V2OM\7^KUZH%4;@=<4H._^UE<
M@O\ 3$G9:[&E<2.U#RJ,3,A:E#3*+4J#]&,.XH33?&C8D@YMB.F(EMZ 5/W;
MXGW^64:@@TJ>V8N HV!.!]^I[Y0V!)WQ.AITW.7Q8FK=!E $5WKVQAIUK7?$
MV(5O$^&57NN]<2W)((IX[Y0VY5Z]\6M;.XU&[M;"R@>XO+V9+>WA05:265@J
M(H\2QH,^O?Y;>3H?(?DK0/+*",W-C;*U[)'NLMW+\<[AB 2.9(6H^R ,G.;-
MFS9LV? ?_G+O_G'71?RP_-K4KV.RD3RCYX,^KZ.R-Z:0/,W^E60J2"L,C<@
MOP1LG7?/,[^6_+ER]K=Q2/$TJI'-,Q8,K>E1>'+X?AC(H.H8;[[ UL_)EOJU
M]Z%A>(@M$:827$TD<< !Y/Z@!^!BB@"HXU %2QV1G\O:@DZPV^I3O);<II/C
M*UC"U8JI+LB*%^(\FHN_VM\-!IKPL?KD2W4HNHF)EE5DD+LB11>F JJ7Y<0K
M"J*2=V8Y.=-\M>:[MH](3R\X])CR9G4>C# 69V<,.2(Z46(D?O&%!]K<^_Y5
MG=7-ZD[WL.FQI54F97];G&SP,JCB*!$^%7%3]IG^(<6%3>5-(T"SBMIKZ07'
M&5[B[*B-FC"QF&%1"X]&2'<UC*EP_P :_!R<UT[RSIT<EU=O;V<5[1/4A6VA
MX!U5X^1C5)(P'!K)_NMC\3@ISCE"6NB65NUC)%ITDK*L]C+(:H2LH:W)>)J1
MTXP,B@\F4))Q D%Q(P8^7K3ZO%QM$+Z:\$-M*TR^F8(E=;:*KN@/I[\0SK0M
MQ!4?OH(S=VYA GOM'EDM1*WJM#_H[L5EBNH7V$8D=7/J+2-:!J!8U*PH#N[2
MW?UDC/$K><_2B,R6CQ?&$!$?JL06ECVK5B$7X0]L&$6VG3W%Q<SM=&"]NDDN
M1$LEND'JQ,!!&3Q8-5@P=^1V9&J%Y9-QY>MUM1;0:E<ZGIUU,SVTLD,<C.)E
MCD!:>H5I0&_>,JGE&PV41S"*(Z1Y>NO*/YA7FC&2:ZL?,MF-7AA8IQ2>,K;W
M<Q+NK((IE24+S"KZGPLC -DZMYGM+> :A;OI3I;W!E2X41M')RCGD]7U4CZ%
MI W,+0TYB)R+AY^]O/I%A:\==M;IVB>5V61BT+132P2_6.2%A(L;1.P5&(Y<
MV5N1N4#ZG;S7VAOJ4"?N8C\,JF-KB1KFV22-O383MS,?*,&C?"?W/US;@$AG
M1T>V;B94NH5=X52CK,;<<8GA1_B<&J,"Y^%A$SR^I$HV[2[LKJ^F4QQ1K/'<
MNR1(5Y13FI9H)U%0L:E?WG&E6B=%6:\A#PQQ1/QN+>-WCGFH\TB<HY8YJNQ+
MR1A0G-7;9 P"RM]7AK>R^O/^<7==E.G:SH<B\(=--K=Q)7DT?UM6]5)"$C ;
M9&H4C-&Y!/29))/;]A<"1!O4$5&&;*&6GCGBS\\O)2^7_,4'FRT@8:/YEE]'
M4&C-/J]]Q^!QX"8*14?M#_*R#6-T(D,D5PZM 2US!*M.<98J" >O2OT') 8Y
MRI/IIS#5AG6J\U4[*:U.X--ZY'KG2Y)&5(IY@(6$\!#L1U >"7K3OQ/R\,Y_
MKEB\D:D#T(YW81;=V7=*@BGV=J^&<X;1DM=169%:2.:$\N-3Z+!@%E*T^(57
MB17:N&.N:+]7"+"B.8D^-!4*>?V:D#<$$_(YPKS-#+9SL]QPAYMP5F&X !#!
M?$ D#?&^5[-KB\F3TZ$@!.Y^R&ZGPZ5SM=K91VUM&+E%AEC4?%P*MTWH2-OO
MQEEIZR+++Q9O4D8CP '<DX'?38A*&](,:@+2@ZTZ==\#ZG82"T:'ZL"'4GC0
MAA7;J-^QPATZRBM!++)7E&E**#R;_)[;[87^7(+35M;N8+K@(K<&=+?D.4M&
MX\:$U*KU8#Z>N=?4*"-J?+I]&*; YMQOW QA(H=ML".:5[XTU(KC*'K3?VR@
M&!J?ORFW'6@&40>M1O\ ?C*'J.W;&[$=*93;#;I3&=<:>E3^.(-6E!OF4T%,
MHMQ7Y;8WER'OC>5.HQ!V()\,90,.5*'*#!>NYVKB9D)KQ%*XP-3KL?;/5W_.
M*WY?_IWS1<^=M0M^6E^5OW=GR'PR7\JFA'8^DA+'P9D.?1'-FS9LV;-G!O\
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M\[?1H2LINIQ)&B@QT^$%A1B.0K4 T&Q]L#ZG;J(HK9'#30DR&7B>)W!"<1N
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MD!B8S$Y=VE__ #C[=WEEYO\ S$\O77-5NX].UN$2 1L&*R6<H$2T15I;H:J
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MS@N=.NI)A'^D6E!@@)]1@$V/+<*E1L =\BLDA64K,QD<*W".'^Z++XL5KLH
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MUDG<G<[X89LV;-FS9LV;-FS9LV;-FS9LV-95=61U#HX(92*@@]01GC;\Z_\
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MI-UHGF'3HM3TV[6CQ25!4C=7C=2KHZD JZD,I *D$9\]?SB_YQ-U;17N-?\
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MC658P0RL 05/B#X$9PM-*?1)G%U&3#"=Y.)5B00%,S$;=:(.XRK35+RYU%P
M5MU)6W4?" @V%5&U54#?]9)R?::\ !>6Z1!)*R<7HE62GVCT%/$XCK[>E?6,
M26R_Z5^[65T4@L=^ .WTTP59NA_T<,9F%0QCJD;$_;'$"M<\^_\ .1/G/3_R
MT_+Z7SU<(BZKIY.DZ5*59W%_>LJ6R%UCF;BOQ2=#3CT8_"?D%Y\MXIT7S-5I
MX]1_TB9G8M()6XRDQD/(PJ9F!!+4!"\BRN1RBQGYWT:%2C7*'B2_&C)N X%
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MCOQ4YZ7    % ,V;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-GF_\T/\
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MX^7-4T"TA:6W?4G47'UI5-PP$%V8@LJ.SU+.06JSE0TD=O;Q&:>WTBT@M+"
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M#X'.$^9?^<:/R@\QRW5Y#Y8C\L:K=J5>^T/C:2;FNT?!X0:[U"5]\\V^=O\
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MY"TU)$D^N>8IDMGI]IE:V075T30T/*-0>E>N>_/*O_. /E"32K"V_-'S;?\
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/-FS9LV;-FS9LV;-FS__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>sny-20221231_g23.jpg
<TEXT>
begin 644 sny-20221231_g23.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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MYR!U1 !:Z7/8L"&+"^FE4_[!UW^_(_<_G)YRO1_HFLWT*N?CDE$0ZFI*MP)
M'3J=L(+O\RO.5X/277KZ[4@H.<TLK$D[FG.A/R7;L,"O8^<=3#7>K7=Q86DB
M5>YOY/1'!?\ ):C'Y4Q.$:=86P/Z5N-2ED)5%BMRR[GJ))'4+4]=M\EVG_F5
M^8EE"MMI&I2Z=90T*%DB"KP\&XFE>AH:'),GYQ?FG&X=/,EM<.G6WEBH2?\
M8C?VWR3Z=_SD;YKA)35-/TF[,3 2\6:-B"-^2D5'SSIVA?\ .1/EJX:--2A_
M1Z2+4-ZGK(I)I0,H+ #W&=?TKSEY>UA3=:;J=M>1,*R>A(LA44^T0I)!'?;)
M8") KHP9& (8;@@]P1CQRZ$&N.44V\<>!N-ZC+*_1CJT!IWQIH<0DH$)K]D@
M_B,4K\5-\L^W^UDJ\H^=_-OD+5$UOR=YAO/+VI)0-):2%5E534)-&>22+7]E
MU(]L^A?Y3_\ .=MK<-;:/^;VE+8N0$&OZ5&S1$["MS9CDR[;EHRV_2,#/H-H
M7F#0_-&EVNM^7-6M-;TB]7E#=V4JS1/38@,A(J#L1U!V.^&^;-FS9LV;-FS9
MLV;-FS9LV;-FS9LV;-FS9LY[^8OYI>2/RKT8ZUYTUJ/3HI.0M;5/WEW=NH^Q
M;P \F.XJ=E6OQ$#/E3^<W_.7GGS\RVN]%\L/-Y'\G2\HS!:R4O[N/<?Z3<I0
MJ&'6-*#>C%^N>1NAH<>!X;XJO3?&%-ZY6U<:?$97<8HH#=<NA VW(Q*E2:XX
M;>.7QK[8SB0?;ICQMU[Y3-Q'*M -R3G-/.WGVW\N0RPP".XU(K\$)^)8R?LF
M6AI4]>-?GGC+SYYU.K2N]W+^G+Y7;G=W!(AB<J"(K>)?AXKV-*,<X'+=.7<E
M%,7(;4HWWY2W!]0&.(-))M05))/2@H>N2K3_ "]=LL5YJ$,BQ&I2W6/DQ'45
M)%!]WOAI%H5]J,JR7]D8M*@=4989(X1R;MS=@7-.O$$>XSHNG^6FCMO4T>WN
M(H .'*&%$*@[U>=BTAH.M/QQ*Z\JZ>@=K_3YM=OE%6O[J65XMMRJ<VB I2@V
MWP-;Z28'$I73-+@!,J1\TDXT_:;C4DBFX'ADE&KZ?+')"\T.O/;IS8QVPB6O
M5:&0,IV->F!+5F:6*-+&7297V1G$9C#$ EN7).OM7#5(-8F1TN]+AN(F)19(
MA$79C]FC2$4^_P"6$&HZ-=%/4O\ 140PR*9$NK=XN2B@IZD:\1]YZY&)- B@
MGDO=/M!IUY&/[^PN9/3A)H>2RQ!EH!U/(9TSRE^9/GG1Y!%!KR:E!QH\.I@3
MPU4  >I$Q9?#D-Z[[YVO1/SNTZZF:RUK3&T74$%2\<QN+1Z="DH6O?HP&3.U
M_-#RQ,PCN;Y+<L 1(?L4[[BHV[T)SHD,\=Q##/#(DL,Z!T>-@RLI%:JPZCWQ
M8ML/#*#$[C?''[C@:6AI%U9B#[#?%*4J2<<#E$['P&5OQ5CMM4_3G0/R[_-3
MSU^5NK#5O)6O3Z6\A7ZS:G]Y9W2C]F>W>J-ML#3D/V2#GU-_)?\ YS%\D_F&
M;70O.?H>1O-TM(T,TE-,O'.P$$[G]VQ/1)#X!7<Y[(S9LV;-FS9LV;-FS9LV
M;-FS9LV;-FS9LV>+_P ^O^<O?+GY=F\\K^1/JWFKSK$6BGFY<].TYQL1*Z$>
MK*IV]-3137FP(XGY1>;/-_F7SSKMWYC\VZS<:YK%X?WD]PP-%_92-  J(.RJ
M H[#(_2G3<91%<H5V\!BC-0#VQ,DD;'8XX %2>ARJTZXFQH=L<#L3TQY.W7$
MZ_AC@U3\L45B32E,I^V9F55Y-10!5J[4SCGY@_F$FE>EI&F2K'=S@M+.XJ(H
MP#\5.U:;'/%_FOSE]=NY;6VDDDA6L?,$L\I/5N0[L3N?HZ9S6\O75F]5$9BC
M* >JUZ^.^_T801B1B2J<B!\1(%%^=>^2;0EU3ZRAMX!,S#9Q#S<)T/I FE3T
MZ9VNUM+R!.'F26"WLHW6<Q^MRE8$_"K-$RE0M!4<B3^&&EG.LTCR6M@\[R#]
MW,O]ZU1_OR0.Y!]A@V66.V,OZ5#53XFLXF+2!NJF0C8&AWJ/HR&ZAYI2.4Q0
M03/<3?"WUEVEJ":U5:@ >U!D5O=?\WNCA+@<$H1&8HW&VPXAE:GWX#3SAYK$
M:K=R07,:U2-VCC1A4BJJT7 CKT_#$;?SQJUC(G-8KH1L6$5TSL@/@"C1L!@]
M/S%H9)3I\NE3UY5L;B7TJCHV\C'KVJ?GAC9?F;?VQ4OJ5W<1\AR4NK\:BA-)
M%-=O>N2 ><-#U:&5Y-2CL=04\BMPY0RA1L\<C*%K7]EF!\,CC7MG+*;:ZM5G
MHU?552K@#8NA'&3:N_$-OB$NH:AI\Q9-4FN=+7X%=*7J1MU(/V)E! Z&AQ(>
M9=$6QEAFBEMKEV9EO;-G=:GP5VY#_AA[#)%Y8_,KS3Y*DBN-.U=-8T24\O3#
MLJ5_:7TZ$(W<T&>O/(?YKZ+YS@_=E[:]1>4L4AX@$_RM6F^=5@G4%HN7[?P@
M_:',%@#3;L:'!9D91L*LQHOSQA6@#]?3-:^)/VC]QQ84H1L<;T^77$Y-P%'[
M9I]'?,:L/#'( * [UQQW^C/7/Y&_\Y<><_RP:S\O^9_5\X^1H^,:P2O6^L8^
ME;6=_M(HZ1/\.U%*;Y]:/(GY@>4?S*T&#S)Y-UF'5]-F^&0(>,UO+2IAN(C1
MHW%>C#<;BH()F>;-FS9LV;-FS9LV;-FS9LV;-FS9L!:EJ6GZ/87FJZK>PZ=I
MNGPO/<W5PZQQ11(*L[NQ   '4Y\J/^<AO^<QM3\V27_DW\K+F?1O*]6@N];6
ML5YJ"BH98.C0PGQV=AUXBJGPBI-.N-->0]\5H: ]LU3\CX91:F*4J-\:5WRA
M4=\QWW[Y1%*URJ ],</#J/OS&F52E*98.V_7+4FNP "BI9ME [YP'\P_S7MK
M**[LM'E,ACY1)*JU]:<?L(#U [L=@/$YX_U'7[W4)+C])2SW<\LGJ31^IRYO
M2BJS_B:=MLA]^]PKK$X2.Y;I'&H!CKX "O3QW^6"M'\IOJ<H6><P*15G-#3<
M T6O3?J3D[6P\NZ+$J:9:)=I&"CWNH!)^;[%S A C7CTYD'Z,':>EE*[WEU-
M"WH\?2]0MZ!(J>*@!7(_FH*'M3) QNM3*S(&6W!XEDA%NCE%JW",_$0.H+5\
M=L&VMXMO#+;175\2JAV%HHN+B;U"5(YDQ0Q)T')AO[TR*SO9P.8F>YU"7ZS(
MHTG3;GZU*S;ED:<1>ER-*OPCV!KB>M:U96%L]GJ,J>67)7_0XV^LWJDK7]Z$
M:6AWWY%#_D9R:\OH[AW,279MVJL;A6C/MR9WE+"@_P!K"<H73BL+,5)-3O6O
M7EMCTMU0Q"94C5Z"O(U'8F@KL,?]5@$I,=V(&-!6I(WV^R1^&!IX9H90G*"Y
M&V_I\.0[=*'&<+>6O"X6VEK3T^+,GS#"I ^8S(9X6],R<X8]^+ \>O8'B1D[
MTGS+?K:/ NEFZM]U),@E<$@]/45W7I4;X/U#2GEM6OTM9);;TQ)++Q5^+'O(
M\'JLO2GQ)](R.-H,T:)?:85=IXP_H_;,BL-U],CXN-=^))'48KY?UR[TG4;>
M>*];3[F*1HY)(JE0C;5*L""M3O7<9ZK\C_G!=-<VFEZRBSQPN8UN5/VUY49%
M8?"0IHR$T(Z&N>H]/U"WU2);JWE#1**'L0W[6V& 8M'4T'-:T\ ?[#EHW)%(
MW-!CA0G?&=2Q[?9'\?QS5/0YJ4[[YM_IR]^^3G\OOS)\X_E=K\/F3R;J\FF7
MB42>(_%;7<0-3#<PUHZ'WW!W4AJ'/L9^0_\ SDGY1_.BR33W,?E[SU;1\KO1
MI9*B8**M/9.:>HE!4K]M/V@11V](YLV;-FS9LV;-FS9LV;-FS9LV;(YYL\V^
M7?(^@ZAYF\U:K!H^BZ:A>:XG:E3^RB+U=V.RJH)8[ 9\8?\ G(3_ )R2\P_G
M7J'Z-LTET/R%I\WJ66E\OWEPZ@ 7%X5)#/UXJ/A2M!4U8^9PHI[XHI IOUQ0
MT%#F#'M]&7VREZUKB_6N- WV/OE$T.:O7,6^GY8UB*=#7*!-/;-X_+' ^.-D
MDBA5Y)7"1H*L:[9YP_,SSW]=#Z9;%X](B<!Q$U)+J3H.G[ /3>A._3KYYU:V
MFD?T_2#74G!I;>-JH@7^[C>05K2NX ZX"7R]<1((QR^M7G(33%0-NZ1+L%7;
M=B?Z8M;Z"END=N+B.RC!5YIQ]I2>B;;DTWZ_(8KZR/.MI:0FTTFS;BTLQ43R
M, =UC5>P!))Z=^. [B.TFNU40-*L[@0H96>2;D>7Q2 %NIW$:A:=7;.FVVBQ
M:?'']>EE:XDM6D2QMYEM8XD1:M-<R#F88T7<5JW@!NV<YO\ S<^HW<-AI-K%
MJL7K"&WEC5D0R=62SB9A\(&QD;KU-<YIYL\UZA>3FSAO"8K<"*00D"$>F6 2
M )0>EOUZN?B;;B,(UU"ZD@2&1W>2<+))/)(S/P*B,1Q@_"@(6A('*@I4+MEP
MVTK%1& JK\0%!3MO[_3CG)A569F=F-&910#?H#7I[XC'/Z8<)5I1L&XCH>HK
M7&A0*RS1%SWZ@#V[DXO]76M.*Q@ MR+BFW84%3E3D$QI)-&8DV(1J$?3QP'(
MT9D"PJ4X_M\Z\CU!)_@!AM;QV\UN4)]0HQ9F,;KU['@H(J.F_O@E+2]D_>VM
MFQC11S,<FWMS0!=R.@.,2\N+-!%):>FC2*X25&1EWZHP;B/;;#Q]6N &Y@K;
M3I\#,%/J]5J"KD$BIVY$CPQ.34#K,!_2*_6[V%E2*^KQE"G8+)L68"O4\O?;
M 5M>I9_6+&ZBC9G/!)"2*+S%64BM=EZYUO\ +SS_ #Z%J1B34)9-/:>-?0?X
MG<<J*R<:BE-F'A]&>[K;5(;FW$P/[MXRX8&HH#0D;;BOTCPPRC>J"@(IMOWI
MWS.Q^P#\5>.V]._ZL51@W, ;)\-?<=1]&*"G??'; $G$S4],H TJ30C,-J]@
M<%65_=Z==VNH6%S+8WUC*D]M<P.T<L,T3!DD1U(*LI ((.QSZO\ _.-G_.6]
MGYX-CY&_,JYATWSBP$5AJS<8K75#T6.0?"L<YZ ?9<]*-13[MS9LV;-FS9LV
M;-FS9LV;-FS9$?/'GCRU^77EK4?-GFS4%T[2-.6I/62:0@\(84J"\CD451\S
M0 D?$W\]/SX\T_G=KJW.H Z7Y7TN1_T3HT3$QPJU0)IC6CS%=BU*#HH K7A:
M)C@N;B!U[91/;KF!\,?]H95#O3+4FN_;%MOIQJC<T[?KQK U)KMX92@#OUQQ
M /W8X* N^QQ.F.I7]6V<7_-?S[IWE*U-LL,5]K-T1':V@(+,S;&24=E%=J]<
M\G3:D66XU#5KGU+Z0^J52E 7)"A0104_8%/<#;!VA7,EW]9F$:H[=)P/@MHJ
M'DJ-6G)ANS&I[ ]<*]=\WZ?IKQZ?9?OB4/J4JVW[$3'J.5*L!N>GCA);>8)Y
MY:7<A>3FS!$!]0<^H_=BJ@T[?%T!8##GG>3(+>,+IJ79" QHLL[0BAH/V%"C
MLM0.YKDBTV*"T>ZM="-O'=(&-WK-PQ86\2_%*YDEJ2U!0#IUVH,Y7YL\T-JM
MQ^A--DEATMG,MW)*2LEP$W+W!!)*J%)"UI7<U.&ES<_X-\IW-VR >9O-J-8V
M*2*PET[3(CPN9*$#C),W[L$=%+]S4<=CA9R6.S,W7L:]=\/+>V:MJK"M4XGL
M $)ZGIW&#+B50[P11\.- [NW)W]J= /;&-:?%\2\6"U/3B /EE11\22M0 36
MNR_33$)1R(KR!]A^H8BZL3\1;GT6H)(^@8GP6@Y*22=R:G\!@D_NU%(J2 4!
MI0$]J# M9D4L9@&D-30@MX5RP[_9>X+1]*AN1 'L#BWUVZ5&].[F^K@\07EJ
MM1ONI)QD5_(C%2T4@-*_ 17_ %QP(;Z1AL9VN1SCL51Q16>#E\1?8&C$_P!N
M+37+7:B*\"M<J-BX,9/$<0:['EVZ[]ZG? ]M="*\1^*VTL;<E>4D4\"C*/IW
M'TY[H_+[SHE_8Z?<:A<!)X+B)&<4:.57/!W&_P )/VAR._W9W2%).3QU] $\
MZ;&0\JFG@ #X8-MI$A9)U 6>:-A;+[*U#<&O4 DA:]3\L>$" *.@^_Z<:[\%
M/&G(C8>_CBB*0BH3RX@5)\>^.&V^-:O4#+!&U>V4X I3+0D$&I!&_OGTR_YQ
MA_YRT$OU#\N_S8U0_6&9+?1O,5TVS\OA2VOI#T-:!)3UZ.:_$?I'FS9LV;-F
MS9LV;-FS9LV;(_YI\TZ#Y+T'4O,WF;4HM*T72HC+<7$IV Z*JJ*EG8D!5 )8
MD "N?$;\^?SUU_\ .WS(M[<H^F>5M):1-&TH$'T4>@::8C9IG"CD>BCX5[D\
M&*GH.F46(^>6#W\<NE=SC._3ICEIEDU\,P)&U*Y8K6IQX!&XZ8ZM!TRJ%AE4
M VQVVQRSOC"I&_?(-Y_\[6?DC0I;^3]_J,]8;&V7[4LQ'PCM^.>$KUM5UB>^
MUV^DCGOKB0AYV8TY,:-Z1W.Q- >^0V[G074=NEPTOI!GNIB1Q7E4,JUKT&Q;
M[L&SZS>2VOZ/TZ5XSP+2&,!5BB!!(WZ$D5).^0>WADFO8X8"9+EV"\S4@%CU
M)-.M<Z;8?5]!A:-4@O-0[J_QQ0U[R4 YOWXCI^.![?5KJ\NW:"6X?UZ&[GJ"
MS<9#14H0 .5  #2O4FE<DOFM[CRYH_H7+HMZD?.XACH(XW)'"W VJ$/$L:;M
M0?LYPFSFD66)HG8WDTBL)*_&C!P4 -#0EJ?=DAU._N-=U42WS"6%8([.)34
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MU^^N_P I/)U^?T)I4W#S%=PMM>741K]35@=XXF'Q^+BG1-_GZ: >&8$ ;G,
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M2+_*JW[%#\9>3,Y+L69B22>I)ZDX_8GKCAU]L=Q%30_1F8 4&6IQW #OFKE
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MRJ;[G&,*9+_(/GC7_P M_-FD><?+5T;;5-)F#A37TYHFVD@E (Y(Z[,/I%"
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M2A 8-4=^+=L,0*\G!V HNU:_1@9P.5&K0]1C& W;I48#D0JW7[\",M:TW/\
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MWNU6M26&U?#Y4Q.2\#*W$;*/QQL-Q4^[4V&_RK@WU44DFM1].->6H)Y;TKW
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M-?NRU)/WX)78#%5-1U[X[H.M<>-_;%A^O';9= :BNV-(X^^634;'*!RZ_?F
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M:*HX+QJH[9.].B'KP#95:<H?'X=ZT\!3#/S<\UO8M':L$9_A9QM0.:5._CG
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M#7K2E,\C?\Y1?\X%:MJ.L3^<_P FKB+U[HCZYH-]*5CJ  )+6X/+@ /V&%/
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M>:+YL\@V+:/Y<\Q75SI]SI1D:6&UO;=4DK;M(S-Z;H_V23Q8&AIG,/\ G'A
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M!B*8\-0C'AB,6C)/7;!B4Q88XG;VS5Q0=/?+!WJ-\5#;8\5WKE@#Y8VM33'
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MR1E9=UIL!WJ<DMKJ$C"J:M;D>HR*&MPW,@A025==R=MAB5[?N2W^D6#*IJ.
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ME1RRM$FW)DWKO3XN1W%?QR4I<VMD%93Z,*,6EJ*@D[L6H/M'?MN/EAC#<&Y
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MMQJ*=<K8=<NN,K7MFWI3N,V]=N^8M3KWQK,"*=1C&Z5!^[&%B/GWRN5:XDS
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MS-I,L%VRCU+B(*R%ZU)H&Y4KOD!\Q?\ .3/Y?7%A<-%K<5D64?NYQ22J?9
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MM2=Z#J?6*?< HP+?>2=/L_/FMZC-:@2ZGI409Z;\@)$K](%,XQ^7]HLFEQP
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M))]M\()/*ML5^M/ R0)0(91\;4[A3T!P-?F.T\F:P1&;=8;M!&ZDJ6Y\>0\
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M958%A6B("#]!/RQR,14T%8@/M;FIZCIVP8K*0-A\502U0!R/7O4?(8\#H Y
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MJC8[G8$8/=6K4@<7 %#].V,5"5'$@*HH3X$=\:D3R2%J&@(H*[DG#[3; R3
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M:@LY 84K0[ #I[8#N5-M?,:5M[SE)5@&I, /44*!T*T;KN0V*J.%#Z@8J=P
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M+!:\WI0 [ ]=L4AN#ZJJ:@D[?$"#MX&F'9@95(/Q @GXA7?VIL?;"Z]+U$$
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MTS7D_H1(ZLY)5A4"M3M2E3[>&V [2)I5]>5@!+7[1(5J[!MCO^&)ZO1;&_\
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M15>'D-N+CX=OPR.ZH_Z/B];<?5BK-_E*3N.W2N=>T%1<Z=;RI&71TK4FM%_
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MR-^5A>^7O,"VZ Q0:KSAFCWX2;$QL/\ *5NGM49U74?-T E:W@<O,U$4#IR
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M 7FP^VHK2G\WWY2)0@*H5&! VZ'K0]NF,>@%"6#5WKN:UIL!_7$FKR3@*DD
MD$'<;5I]V^+)'&07JPI]GQ'>A'TYW;_G'R-E_.#R!453Z\S@_P#/&44Z=,^N
M]^@:PA;^25#7Z<C.D%8[S48#7X9N5#X,*X8ZM8O,L7U6(2W&_$$T%/<Y$_\
M!U\S"XFNDA=#R+,"P#=N(KV]\&6_EIY"3-=M/(#4\J*/IR?:9HVGVB![>%1(
M0 [$?$3[_P ,-V4*#087RGXJ8LB_!OA;(*W:CL%ZXAJ;\8.(.[9SO\U/- \C
M?E/YPU^.86]X+!K*S<_\M5Z1!'](]0M]&?((GA&%8$1Q?"!L2*#O7?;$0>+(
M)&/%?B=CT&VP)\=_QS%0P#H0OJ-]D;[B@-/#YTRRZCBDA(!KR4= -Z5 K7?-
M')&(E5E],@E>-13<5!VIT/XY;+Z<?Q&G=F J"3O\5-NXPDM0MM++I@+2(%>2
MSJ/]U'[<(8]P3MOT]A@I0I*HU6<DUVZD#<;$=5-?GBS\1(*(:*56H.^PJ 34
MUV/7I\\B?G?SGY>\DZ/=:[K5ZEO:VJ$!*(9&-" B(WQ,Y.P';K04SQ7HUMK_
M .<WFE//WG"V:#0K%BNBZ7UBX*Q8,ZO6HVK4C<CP SV'H?E_T4CGN$HNRA&!
M(K^R*?=DQ,D<'*"-0S,@J  61N0ZH:'C\LPN K*>*%58U!Z<B!04(J#VH=C@
MU')/JGDZ$,!0_"U2?M@GMTP60L4*E: HO[!-5!I7C6M1A?<2D1\'*JJ+6G%3
M56Z#J*$Y ]2O&D58@ZJ 5&U/F=E]Z#\<.O+VF>E&+RX4QNQ) (Y;5^T>M-P=
MAD4_,WS;'IECZ,;M-(W$ ]"['[(5?#OO]U,YAY2TY[M%O;M%O0W*1B]":UW9
M@-R12@W[YWC1]/-P8[J2W$<"(!!'7A\(VY&O$@]JGMMDUA "E#12 -J#HQ^$
MKOW/ZL'6%A?:K>V>DZ=:R:EJ5]*EO;6\*5DEGF;BJJ#N=_XY]F/R)_**Q_*+
MR9%IA$<_F35BMYK=XN_.X*T$2-2OIQ T7Q/)MN6=KS9LV;-FS9LV;-FSY4?\
MYW?\XO&Y-[^>GD.QK/'23S?IL"5]1%%/TE&H[@;3@=J2=G)^6VGQD&(LHCXC
MIVK3?MOUR<:.WI55 >1[MO6M*G?%_,&E&_T_UX S75O605:@92#R4[[YPSRU
M(FG^>5DI2+4K?:OC&02"#WZC/3%K%\$;QGD7%3V6A(.XI3#$*@4QHS+2JHQV
MW(I3:NV-)XNIXT !V)ZT%,09@I^(!@* ;]"?&GM]^+%1"'9 4)V&]:U[TP!=
MRQ^BY<L6-*-0TV&P[]\B$A<.P6DG#<U^$T[DG?Q\,,;-E9E#$$ @=/V3U)KU
MR40LI*,&J$4GF/A^SL*GQWV.<R\T>6M0TCS%IOGCRU [W=S+'9:Y8QT87<+'
MB)Z"GQQUK7PZYTB&)Y4/UMAPV9$%14[$<V'6OAT^>&3.JHGPJ J@+0TZ=1M[
M>V)&1RA6/B"#0BE15O"O? TFX;D_)2WAO2O2FVP/?'Q@D%-C3?;WVWS.$" Q
M$MRJ22*'P/2M-Q@-^*\54AQ7[-*%1LU*"N+14YJH4\=SR^U6H[5&^=U_( B+
M\W/(;%6J-0= 2VU3#*!WIGU]N/BTQB16G$_<1D0#>CK-QV]5%/T],E=I,2'D
M J:\17V_V\TXDE:$,:QH>3FE*L:T&+SM L5RL;W$7&*+>%>0#,=R!0U:O6O;
M%[1F$TL2U*)6GR';!S-7;[\!/1I2!T!P2!0$=<*A\5VY'\H&%^IGE)&O@<\@
M_P#.8OFA+70O)GDN-F]2_GDUF[53MZ5N##!RIO\ WCL1\L^?]357B4!4 -2-
MV;_*-.YS&4D$,.:EC\1 !J145Z^^91&U'JIC[@-6E/'^&^4"):$ FAJ.FX.U
M*#N<"R<T/P$BE?V=UZ@4J:$U'TY2S,%8U(D901Q%%)-30^V^^!9$2YDCC>BW
M$)#*ZBH1A^T2.QJ5.U:$X*A>%DY/2*=%I<1@FD;C93TW!['O\\YU^9GYJ>7/
MRSTOZUJMP9KRX#+86%L5:XN)$6@XKN O+JQV%/'/$UC:>:OSK\T)YB\YN8]$
MM9%-KIJLWHQ1UH(T'<FGQ.=SV]O:7E3RW#:QV7HVZQ+&!&D/&@" 4 %2>PSH
MJ2>DHA2DC[!@BAV [AT-#L>X)PMD=V7M(:4$3;]6%?AE4&@IV.![N>&O%F=M
MBE#44% "F]-J=0<,[*:@(5PAIP!!^)E(.Q)KT]QOXX<R.R)&4*A!0\>BL:5^
MC?QPGU)S';L8BP+-1E)WV/1B :U!ZC(I96+7URADC0@?$4%*DFFW8]_89)]2
MNTTS3W)<!%(0AT.SUJ*-X]!WSQ_K^K2></.:Z99MZ]CIDG*5E! $K-4@M4D@
M**YZ%\J^7Q#;0Q!2(%8&.,+3D-MRI^$BO3?.KQ1I"D=%1 @#D4J*@&E>O2E>
MNV)GU5B(0H6!JM2.)X[U( -33L?$Y]-/^<3/R+?0;*V_,[S;9<-:U& _H*TF
M4<K6UE&]TR[TDE7[(K\*'Q;;W+FS9LV;-FS9LV;-FQDD<<L;Q2HLD4BE71@"
MK*10@@[$$9\8/^<LO^<7I/ROUF?SUY*T]I?RYUB8M+:P _[AKJ1A2%@!06[L
M?W1_9/[L_L%O'.G&CMR)!)H21T &]:=Z[9)K5@8J,0PX[<@=QU'3.#>9[--&
M\^Z(]NI]'4)N8+?94N#ZB@FNV]1G?K!OW$99&9./52*#VI\\'/ZB[-NJ_%MM
M2O7*:G/@*,O4=#NP^=/'$^-7+ GNV]*;;"GW8I)(0OQ@-T(#?R]/XG"6^N#Z
M0]156H(6E*D ;?37(S1^2NH";\-CR/$'EV^9&'EMS5P73X0*@U')O;KAO&YY
MHD<0<FA%">"UJ!SZ4.W3K@N. UHS%I'VYL?A4#L >G7';1.@XJV_%^Y ZKWW
MZXYQQWY>FO+X>@WVZ^&5SXR<0 Q93T--_>O3+Y\"6/%B25IU(I2E/GC"%Y\P
MVS+X$[5KOE@$*0JCFA)XFH(!^1'3 9C"I+O7CO2M>E10@$>."D5ED5#\,7IC
MXB!6NY/@3G:_R#!_Y6OY#*JS4OR6)^(?W,IVW/2G7/L&1RTQQ_Q7VR%ZA1+Z
M&8=UH3[;9+;.W'U2"1I"K,G.@_RM\'1^E(&C8_"Z\20=P1W^C"B4:Q#.L,=C
M!>\F(CF]8PU ZEUX-T'@<.X"]M%QFD1[A^HC%$7V%:D_,Y=2?GFA0EBS>-<&
M  @X4HM)YV/8T^["BY/J7BCK0Y\O/^<D_,Y\R?FWYD$$@DL_+D<.BPBE16U6
MLI'SE=_NS@8:,*>H4DD5W]]P.GOB@E#D!@.:UJ=P#\JD;8F$!*[&-""I))J:
M=.O85VIC>2(0"Q5P QWK[>XQCEN C^$AJ;[4)[&M2/X8&F/(#B=J!:'[(!)-
M?$?TS) J@@$*>18TW(/9J'Q ^CYX4>8AJ*Z9</HA@CUE(G>S%UR,+D_"4D""
MM#4$$#K3MU^?VA^3M<\W:M)YL\]7;W>I74IB].6M1P-!##'^RBDT[9ZK\I^7
MXK:&..%%B2&BT5 JJ0 -MNIZ^V=DM+9(0H39(T' &A!2G\H()5A7<=\1D9:.
M[,&.X*CTY: 5Z>IP?Z <TP,<$8D?A&OVB*T[;!7,B[_,>V$MY2-W*#8CBH*F
ME1VJQ[#QK[8964O-A6A$K(7-*J* &@7;[^HP^8M3G%)&H 8LR#F6(.P*^.V$
MMW%+<!P&+11[U!HQ/04ITZ^'M@JR@2T=@/A?B3'4A6:OO3J-C[^&<(_.SSR-
M%T?T;4^IJ-ZPMK15-7:1AQ!44%>]:"F ORE_+R33+&+4=7D+:C>MZTY8T>KA
M2U!N#N?NSTO:6WH!R%4,%W^'@(T.W[7PU.W3!.RAN2,&:BG>AKU_8J-_U9[&
M_P"<7?R /GG48//_ )NL67RCI,_*QMI00-4NXFW)!I6&-A\1.SL./0-GU,
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M7-2GEO+C]IC).[2.*FG=ML .S%&0$R*IWVH=NM.G<8RGPLZ5.P^)MQ7IMO\
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MA^$ANV&H9.:<0P(W''K45V-?88&XU)D'P$N!39B*^_A7!BJQHW)0RU8@CJ<
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M0Q/&98)>7!@22*C[#@=00-N_T]0<LRO,ZFC<?A0,.=-AL5DX$5/N<? X17<
MH"#1/WD0&YH?B+J.^5(]8%+"BR \>*J*_"-OA^%A^.1N21YGE+?$LG+K4T-:
M  ^-/OI@ZW,QC"^H5I\80#=CR/'<]#3?WP]A#<51E,?*/8;T4=216E:\?LX.
M+#G&H"^J.0VY,#45WKU _#.*_FGJ-Y+:P^7],E?],:S.MA;D%R?WHH[FJJ:*
M@9MZ],Z/Y4\NVWES1[#1K2W$5O8PI""6*5H .1'&A)-=^]3DI1A5']18HXV-
M>/)46@[ @AO;WST3^0?Y!ZY^<6J_7=06?3/(MA/2_P!1VK<LA%;>V('$N>C'
M<(/M5/%6^O\ H.@Z1Y8T?3] T&PBTS2-*A$%M;1#X405)W-222268DDDDDDG
M#?-FS9LV;-FS9LV;-FS9LV; &JZ5INN:=>Z1K%C#J6EZC"T%U:W""2*6-Q1E
M=34$'/C=_P Y7_\ .)VK_EQI'F+S?Y*B;6/(#K+<31(C-=:,AY,1+5G,D*]I
M>H&SC;DWDSRRYETG3958L)($;E\J5%/"OMD@G(</1A0%CQ/4[]C@:*AEHI(?
MC]U / 8(8L8T1]AUY$U._P## \X-Q(+>/9DH6%"14D4':II0T[8FEK;6CAWY
M2O*03R-2#THOP@ ?CBC<%>2@H33XF W)ZF@_$8(57V-.0KU/[-?QVS#TCR0T
MY&M0-^H \/IQ('E4<2:['YCH3UVV[^&8-(U*A55-P3U'<]-JUQ2+D"R-0T^+
M:A!/\>E:8YHWW"E3R)->E10FART9BK GF/A8!J4K6E?V2*C;]>6Q5RO(_LTJ
M.].Y%?HQJBL;JQXE:BM-^E>Y^C$BH/&G(KQH0.IVJ0/#8XO"%!J14FHH3R\:
M5]]L[[_SCBGJ?FYY6Y<@85O)#7OQMI.@/;^S/KE9&MNI.^U<CFB)Z^HW?+86
M]S.JG_5Z?\2R8>BJU"G?Q_ICEBIWKBP7<8NJTP//)V& Y3]A/'?*N3Q@1 /[
MU@/HP%</0!!GSQ_YS!\RM=^:/+WE"-QZ&A:<;Z4#K]:U E5)WI\,,0IM^UGC
MDO0?$_%:]1L=B* = <39E9/CXHDKM1J[ =:D;; 8U>554NBC8LI) K3Y&N/^
M,Q@\:!A3>@JM:&GCX;9F;XPG#EQWJI)ZC<!3U Q(4D5).9(W"C8U HI) I3N
M/U]\8RN#0."TIXQE@: &@+&G39AU[_+*'JNG)E-*JX1:T'VI5! ![\?\Z92A
M6 K5HRQJ5W+;D\C7<[M^([#=X:.2:4D<R2OPJ*<@I-.O0GI_G4/D"MSBD0&%
MCR* U%3]JH_CA+<0FSC20LTUG+LW-R1%N0 >2T(-1N2/XY9JJJJ[?S$+Z>Y/
M421<A7YFF,OIT$A"J&17YGD  :4%&"U4T\:G""1:(?L4E!%"?M4WK3<@_P"W
MAC;<6C_=R@&HY&A%6%0 ?A.WRKA];,'5%DWITK048"@X]*-OCKJ2.-)P8T8K
M'ZRDD+2E2=F9:$^W7.3>5K6/S#YHU;S-/,1%H;-8:<O9KB109Y*'D:A2%!!V
MJ<[+;A A42&26FP7[.YJ>A45K[9ZH_(+_G&_6/S4N(?,.N^IHOD6UGJ;E5XS
M7Y1A6.S)5?A%*-*:@'9>1!X_6;1M&TOR]I=CHFB6,6F:5IL0@MK:!>*1HO8=
MR2=R3N3N=\,\V;-FS9LV;-FS9LV;-FS9LV;&NB2(T<BAXW!5E85!!V((/;/G
M+^??_.&D %YYN_)JRCM&!,MYY6A 2,CJS:=2@7Q]$[?[[(V3/G+JD4]C-<V=
MQ%);7D+M')%,A26-D-&#1M0@@BA!Z8"AW+G<Q$_:!I0C?K6N"O539R>-&!)Z
M]^WX866A<)+#(X>6WFEXMOR;D_,, O39AMAA)\4E&;E6H6M!6N_0'W^G+D%9
M:R@#F5 &X*@CH#X?1MBI#(KC8$!C\6PW/?YYE5TE4F.L14;C>K#8CJ,>P(Y>
MFFS,6JQY4]NB[T_#&,J /\3?(;@5Z;;8UF5"BG?8I5NH->AH#W%/IRXV/(#B
M6(!%#0"@._\ ;X8XGDQ J QJ12M:]1\NQQ6558, 0P5>7$"C C8@[=ML8.KM
MQXE5#L>I!-0-CXUQ!(^)KS^%G(X=N)!-.W6F*(Z!R5)=MB !0BGS/05STA_S
MC2.?YK:%QI1-/U&0@'?:'CO7W;/K!I_^\HIU"X3>7T8W6M.HW6\E ^;<3DK"
M2';<'Q_LP2J'OBP&6YXC"VI9B<1^W/3PQM\0)K9/"IS1P":8U[L ,^./YU^9
M$\T?FIYWU=).=L=3DM[85H!!9@6Z#;L1%49RHR!@%62OJ-L:4I3<BF9U 'P
M\2E/BZK3ON: ?UQG%MF4A6DW<TK0=]NHW_AF#@EO4<GTB#4"J@D=.YR]N0XR
M<G8T'PU%#L17IV_#$I#0!S&:!2!L0:[@5-222??I[G&B8NO&,L&D^RA(:@8&
MF[$_[]%?EBB@HLLA59%!=UHU.56Y T%"..U*^%,HM7E7BRO1=A3B![_P\,H^
MFY"-&%4@!E/Q *HW->O[._\ G1B++P>4%F4/1>I^UWVQ2&0,H22DBE#L=N0-
M0=^_4[?YDF0I'=7ELC%FBD#(00&"$#B.49#[ ]P<!WAI&DI)D%0PH!T(JQ%
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M_C\L?ZS,#&Q52"&J-C3M4[_1OC^(^%S*68[5ILH4=:U]^F^V,JLOJ<5)( +
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,FS9LV;-FS9LV?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>sny-20221231_g24.jpg
<TEXT>
begin 644 sny-20221231_g24.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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M$EW?W4U]=3&LDT[M+(Y\69R2<25?'%0N73?%0,4"],> ,=C&&-I[UQX%.V.
M^C% ,651CN/MB;+B#"F)Y1S?1@_3=6U31;I+[1]2NM)O8_LW%E,\$J]]GC93
MV\<[SY6_YRO_ #]\I>FEK^85[K%LE*P:VD>I!@.QEN%>8?0XSTWY0_Y^)Z[
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MW3)5-M;2"HI>7@#(A!%"B!W!ZJO7/DS^;O\ SDE^:OYS3RQ^9]>:P\O,U8M
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ME(0,PH4:E>+=: COD9U* /)*0BAR SI0!@!T-=P=Q3;KG-]>T<1-+>VH!B0
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M(1<65:X6ZQ<?5[9(PP1[EP@)Y4 [D\=Z>.'GEN55Y,C,UTT?ILS/Q ?8 $D
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MI-.S%Z ,H+$%0*$^W7(ZPMGB2-U*<2KR!C3D*?VU&12[%LL+*.7I*S\#79*
M'?\ '(Y;_4UKQN.?%2"[ ;/O\)/0CWP@U.R=;7ZY%,]Q$@JKJ =B!X_.FW7.
M:37&H3RW>FZE:1F(#UK6XC !DB7<JXWHR]#3"JZG8F*^CF:XB15!#4(^([,1
M3J#D3U!F-Y,T2%I#(LDELO10:U*>]:U]L&V0.L:1=:,."O'+') [J"_J4(10
MP7E1BQ4[GMMD%="K,K*592596%""-B"/$8'9<#LF(,M,3(Z8@PQ!E]L#.,#.
MN!F&(,*_3B1&(L,3(QA&)D9ZQ_YQ*_/V7\F//:Z=KERW^ ?-\D5KJR,QX64U
M>,-^H[<*TD\4)ZE5S[NHZ2(LD;!T<!E934$'<$$8[-FS9LV;-FS9\2?^<[/S
MR'Y@^?8_R[\O7QE\I?E]-)'<M%(?1O-8(X3R$ T86XK$A(V;U*&C9X248,0?
M=@M5Q=1M3'A:8H!3%@.F*!?;% N+*,4 Q0"N**,$*.FV"4&"D%<%*OM@E$P0
MJ9S77;N2ZUX1H0UK9,MN5) !D'Q,:[^-/;)[IDZ3@0.%BD ^(C<%1UIN*&AI
M[_/K*5NB+>1 X!4\0I.].U1U ITJ/EX8(M9Q'&"JB60AI6I0T &Q)VWQ96:;
MTYV)2)%%1T)?W\<FME=0^E&"58BAHAH:4IN>^W?)(-1C@6*.WN$G>7903NE-
MJ@_+#6*\U-RJO$S*8@J$4 DKN>N'UC)?3 0.HM1.*\R26'8<A[$4.3#2K:\%
MX(7F0+%QE8B@+$#8C)8C+"\<_KL)!)\3#EMT )%/ ]LDMG=0\S(\I13L0P/2
MN]:]L$R7BP4]-E*-+S#.-@&ZT-"/QPVMGL)6E:.Y1C)]M@1\)-*; [=<$RNJ
MA8UD5R1\2[GF!U-=_HP)]=6KM' Q "_"X!-?]H8RYU*?T0D&GNYX["@KL.U>
M^1J_O=5=)"MF/C-06<&A8;E@!TID1N&U25G$$44A1"Q D/P?%V(7IM7;(_)9
M:L[W$[_5QNID#$L!79B.GVAA)/I[,70?Z*D,?#X-UWHP)J0>VV$MU!J]DLD3
M-!<1RT&S'<#8<2=MP* 5SG^JZC# ',RO'/Z0XHVWVF((7:OL0,CUY'6*.ZM7
M$0>GVZA0>@Z_1A3JD165)60PR"OP.?LE%KLU>E*C(AI=]+:73.I^)U*GDS4/
M*JJ>2]*;=/;#?7HHWF@U&!2L6HH'D#&I%RH'K5)"TJ2&I3OD<9<09<088BRX
MBP&!G&!F&!G'7QP,PQ C$B,28=<2*[XF1B9QC9]DO^<%/SS'G/RA)^5GF*^:
M7S1Y)AYZ;+/(SR7FD%J*H+$DFV+".G:,QTZ-GO[-FS9LV;-FSS'_ ,Y8_G6O
MY+?E7J%[IMT(?.7FCGI7E]0?CCF=?WUV!0[01GD*BG,HI^UGY]N3R.SR,7=R
M69F-2234DGN<708+C&#$'XXL%QX&* 8LJXL!CP,648H%KCP,44=,$*.F"T7V
MZX,1<%(AP8B8^1TMXI;A]D@1I&/L@)/ZLX1I@E>?Z[(X9KB>2X>K;$L2QJ.Q
MIG3+!I$ME:4+(IJ6]2E"3ML30U%1_GOAY$[<&CG/&(!04K4TWZ=2/'KAW9RN
M3Z=NS!2>$@I\/IL :_%0TV['#/4"UK$BBM7!XJX-*C[ )%>_?[\&>7[::[CF
M,TAC5@K-&#\5&)K3V.=)LH[0/9SP0")[:O&B?;KL0?F/U9*$O990SK $7F&$
M;?L$]0*=CUP^TXTD),I9SR8\C7B0/XX=Z?>*UP9I)$])Q^ZY'X@/>GRR96U[
M$RQQO-$LD="#R ;B138$T)VR56CHZ)/&ZR(YW:M*LQH:C?OXX.2*%WCD$0AD
MB!\0-Z[[920VTS.LUK&LC-\>P^*M.XI6N"!I\2,T<4DUO^\ ^!OA-:?#1JT\
M:8*CM+N%@&<.6:I#"@/6AV.!I9I4F'/B."DGXC5>Y()I[Y';J<&Y,4CL]:R
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M2D= U?&G08:QZYZIG^)R&!4 $BB@[$$]?NPDN]361W>)6EE3BICC0\>1Y'D
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M48(4?1@E!7!2#;!*+TVP4JXLJ8(1/;!$:;[#/,WYC>=4L?,5Y-)-2WTV9K5
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M<(/.9\V_D%H-G-)ZE[Y,O+K0)B3\7")EN+?;P$-RBC_5SUYFSX ?\YP><O\
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M1_GOG +GSU]6]1GF-2#R6O*OT9SW6/S<FCDX6UBUS(/YGX_?0'"ZU_."5?\
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MAU]-)J]/ &F0;5[?3],Y/>)J%I,0S"$K(4;?XC0L:$ = VWAG/\ 4]'U'S2
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MB] 2H4M0=:G(\VFVHX"7TW,9#"@%* @]QL-L9:>3;35&6Y@T] J2;EE!VJ
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M*RG:,2GX*@D \1X$@@[8*31FAA]:2XEDD:O)5'%5;H*4/\,T6EW21L+6X9Y
M.7( BBCJIH:]>V$=Y;ZC !+R%QS-2@!-*=#04^G"@RZDZ!([*3UI&!=4!^(&
MH I3<C#_ $?R3K%]+&VHR1P1$!C$.1/38$E1U'4=LZY::)!816MG"J H5537
M< ]>WMODEBAA]>-/BE?Q[L%WH>M!XX8RR6[.D*+QDC/(G;B8_!JU)(K0'%-8
MURSL+-VM_@E,(",A'(**[ ; @=\\K^9O,#7EXTE7!F9CP)HI(\17:N<7UBX<
MN6-2:F@!)VJ>@R+7\_[PPJ" HJU6/2A[_+/H!_SC+Y2?RY^7*^8;P?[DO/LZ
MZH1N#'91*8K--P/M#E(?]<;YWR23KA9,_;"R5NN^%<S]37"N5NN%<S]=\+)7
MZX D;PP"_7 S=\08^V!V; KM@9VP,Y.($XBQZXD37$V.V(,<08]<"N<#L>O?
M/7G_ #B?IOK:1_SD_JY6JZ?^3'F:U%:;-=1(X-.M:6QW&&?_ #\9T;]%_P#.
M1/U\+0>8_+&F:A7Q,;W-EXGM:#PSPBI^XXL,64XNIP2AP2AZ8*1MQ@R-O?!J
M$'YX*3!D9P?&W3?!B-@V-\&QMN-\&HWOTP9&XP;&^#4?!T3U( J3TIG+//\
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MG!%!=1*!Z;OS4$;CG1@5.WCN,A/F2T"Q&[56Y(P9N7;:C?AD2>(E :;@UKW
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M<#,_O@9WK7$&:OO@<MB1/W8DQ.),V(EL19L09JXB3WQ,G/K7_P XPZ%^C?\
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M64]Z\0Y(*1JQ^TYV510YPBYDDN+AYI6Y2S.78^+$U.=-\KP&6V"_MP,+J/\
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M4PJN41IC&RO&U45.)W))Y':@_7BLEQ)$W!UY[$,>G7Q[#[\%P2 CEZKQD+Q
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M6 ((.Q'B,:6Q,MC2W?&$Y7*N,)ZXVOOB9.?1O_GW5^2Q\W?F#?\ YL:U9\]
M_+T>CI?J+5)]9N$(#"M0?J\+%SX.\;#IGV]S9LV;-FS9Y-_YS/\ ^<=[7_G(
M_P#)+7/*]I;QMYV\O\M;\J3L0I&HVZ-_HS,2!PN(RT1J:!BKG[ S\I<EA-87
M-Q9WMI);7EK(\,\%PC(\4L9*NDB, 592""#T.#+:.I(I2O<?V5PXB60%?W9
M4TKP)'XX;1L03R4@4IT _"F6?4"[*7(W'M_#$5,Q%#&Y(/7;Z>V*%V *\"&
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M ]\*[R_+R-964G.XCKZDK?%#"#7B\@%221T4;GV&%T20VP:-"SRFK2N^YFD
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MQ'#](:<"6"U/VG@8[=?@&?6Z6)2H* 5.Q'T>.%DD(4[;U'S_  ]L)[F%6JQ
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MQAC/S'(C]KB1GSGUJR2:WNPBBACJ/#[((S@3*4FD4]58C!(!Q5!@Z+IUI@H
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M-CN?I/3KCR40_#^\J=J=*C<>_P!.+*2:@&O([#N*T[?1@A&< 1CX2U>2KU+
M;?YUP4GQ$!F*A":\3U/N1V]A@^-BIY,RB@!J=@ 1L0-_'MB;GFI' \"=^1K3
MN/EM_F,C<.I?H/7M'UN'XOT/?VUVQ.X(@D5V'T@$9]W8ORT\NW]G::A90 VV
MH6\5U"R]#%,@="*U_9;&'\L+.)JK'R%-]@.GC7!FGZ FDW4;11\4-!1?'IMW
MZ9TF32X;FV4.@;8>PW^@YSK5_*D0+.B<2IIMTVKD*GT0(ZGC38]>GWXU=%5N
M/J $$;T\#X?=@:Y_+ZTO0TD"B*5M^GPL1UJ.WSR(7ODFZLRRF$BG?Y?+(O=Z
M#*&*D4W!Z=\0\N^6)]1\S6%J\ ^JV];F78&O T05/^4?PSUWI.D);1(G#:FV
MWM_G_'!EYHOUI>)6NW;M_F/\Z9S?S-H-GY:G'F>__P!'3R[!+J7J!:,ZQ+3T
MJTZN6 WSYAZK9-<:C=7+Q\7NW:<KV!D9G(_X;/(OYA:>;#S5>)2@DHX^G([$
MGPY@F_M7%E%*=L$#M7OWQ2B[T.^*( 2 =EK@A1]G< ^%>V+KL.@/A[9G VV(
M)';I@20U@F3JU0??;".3O^R,24_3AO;-R _AAU"?A IUV)Q9E/$L*^YPHNUH
M.F%,2LUS"BBK,X 'B2<^X7_.&?\ S[)OO/4FA_FG_P Y&Z9<:/Y0B"7.E>2Y
MN<%[J@ #)+J-"LD%N>T6TC_M<$^W^@#3M.T_1]/LM)TFPM]+TO38([6SL[2)
M(+>W@B4)'%%%&%5$50 J@  ;#!F;-FS9LV;-FS9LV;-FS9LV;-FS9L\/_P#.
M4O\ S@U^6W_.14%]YDTT1^0OS8,-(?,EE$/3OC&M(XM4@7B)5Z 2"DJBE&91
MP/YT_P Y_P @/S5_(;S-+Y:_,[RX^E7)9VLM2AY3:;J,2FAEL[GBHD&X)! =
M:@.JG;.+Q*H/(GE\6[=OH&^.><<@SCD@Z*>I/L,+I)%2IKQ#G?NQK_# Q=Y5
M/$E*=CU.*+Z?$%^PI[@;T[^.73>K&E"*_L[#WQ4$N!L5X_9[5Z?=F"U4GG0L
M36OVJTWIUI@B-U5]@068'<G<UWKMO@[U0:>FI^):$]16E"=A[?VXO&L891/5
MW)H HW /48Z1GIQ^T*;* %IM^.W7(IJZ*0W(;LI!J.-*Y]]?^<4/,J^?_P#G
M'O\ +C5Y'$]]IM@=$O#W$^F.;;>OBBJ?ISO\FG(*T3;E3;P.12_TKBU57@RL
M:&F]"?[,'Z>A"*C]*4RKS3TD#$C9NE?;VR!ZKH=2U(P0:]!3".+3D5N+FA H
MI'L3MAM%9LC.%4MT96'>H^>#_P!'I<Q\)8P>(]^WO\LBFL^3;>ZBDEMTXRQ#
MEPILP'AA?^7GEB2-KR^N(OWES*50$=(D)"_>:G.X6^F*H"@CCMN=O\_;$M4L
MC96C79N(;:*W!=Y96"(J+NS,3L !USP;^:_YM7/YEW\NA:)(4\GZ=* L@%&U
M"2,_WK="(@=T7O\ :/;/.^L:3Z>HJO$T:)=_OSR-^>VD&R\PZ?=<*+=V]*TZ
ME3TSD<$8*UKVRN-&)\?#'*!VWQ>/B.J\@0?;?L??%@ :=.FU-L40"M1\'@.N
M^W?%%6A%>IZ$XLHV->FQ!&.< C8GIU. ^0,$Z'<T!W\/8X22]3B -#X8;6C
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M!?OIGWRB(930]>E=P:8A=)SC;:A W/\ GMD6I20UV'0ACU&#F)X@;@,I'?\
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MS9LV;-FS9LV;-FS9LV;-G._._P"47Y6?F5$T7Y@?EUY<\X\AQ$NKZ;;74R;
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>sny-20221231_g25.jpg
<TEXT>
begin 644 sny-20221231_g25.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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MC\DO+Q\Q?F%YABTF&4,+.R3][?7TBBICM;93R<[BIV5:CDRC?/B)_P Y"_\
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MSXH_\Y5_\Y[ZQYW?4O(/Y+7MSY?\F5>VOO,*<H+_ %5=U9;<[-! WCM(XZ\
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MS9LV;(IYV\\>5?RY\LZGYO\ .FM6^@^7](C,D]U<-2I_9CC7[3R.=D1068[
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MKS:+^[C?2/)FB/)'Y?T4$'T(WH&GN"-GGD"CD>BCX5VJ6\T\:8ZG7J=J9BM
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M]&"+2YG>.75))/K6I7+*(-FD7U.ADD!Y \2/A7N?BWI@4^7M0F$]WJ]PEO$
M999+MRLLU3QHD2DR%BQH.17QWP;#I5K%;70@TKZ]>1+&LTSJ;>*VYTX*4^-R
MP)H.3 ,>@WPVAL;%HIQJMPL484Q_5TE<-)*"  8DK0$CH:G^4=\4GEL]'D7E
MI1MR0K10RS,;J4 ?$7CCH!7L&+-3J!DSCO=2O;)8S8MIBL8O3.FQI"CS2(H^
M-BX8$BBJ79>F5'Y=\P20M#]8:/ZF[/PN?K4T\1)^*K*"J';]@D8%MO3@CF,]
MY>W@D?CZ,)BC D X@%IHY:[M6OIBN_3&:B\>D.9"9(FM8O3E:_M?31H!4!6$
M'((*5%&6IZ^^%Z</,<,UUIU[;)>QI1X+P_6+6>,F@BY45E--QSIX5K3(=J5M
MJ=GP6_M)]),B@6SVT2R1;$J0AH2*E#7?YY'ENH2WU*![MFF=96G>3T]QQX$,
MI/PKU![9/(K^_P!5EMGA)>X@?_2V+\@&&WK,K*.H!W ]LGZW26=G:17=M-+=
MQQ&3ZS=P>@BQ%CZ<:,2*D@[=MZ4PZTZ6/6;9[K3!)((6XS1D;(:E0>5>A((]
MCL<5D5HSZ<JF-R*@-U(\0>A^C,!5:KTRB,;3V.4?[<;QWS4_'*XCJ?HS<1M4
M5.44! H*91'3?&\>^-XTZ?+?-Q'6FYQI7IE<0">V;C7Z,3*?3E%3X4P187U]
MI5]9ZIIMY/IVHZ?-'<VMU;2-%-#-$P>.2.12&5E8 @@U!S]$/_.'/_.3]I_S
MD!Y,.E>8)XK?\T/*<"+K-N L8OH*A$U&!% '%B0LBJ*(_8*Z5]EYLV;-FS9L
MV;-FS9X:_P"<V_\ G)3_ )4UY,'D[RI?B+\R?.MLZVTD9_>:9IS$QRWNVX=B
M&2$_S<G_ &*'X%L2[%RQ9V))+;DD[DU.85Z =\U,?Q!RJ;_/+X_>/'*X^/7+
MH-\U*4_5F J.F72@!IURZ?><Q&QVRJ;9J=\U/EFH2/LU/AA5J6I1Z>SQFXA:
MX2*1Y(HRSNG$;<@  -_$Y"9K^*8>OZTRZBD4DZ$L! D"=YF%0*L:#[NN%-HD
MLYENK_4Y+=1P*QV]FKJ4)H%24<50^'+KV.&$E[-IJW<%MZDZ-O2."-9^/97%
M7*C?X^_AXY"Y[S5[R2.**V10SED(C:0@U-2.1))V^CPPJDAOSR66213)(2_%
M0KR/0KQ("U8G!<6BO'#:S:B\$ GG%O#$I+W$TSL$"_%4!JL!L.GOB]X^HSO'
M!$9+&U24QVT,;LA168"M11@2JGXB:[UQ]GI=SK6HK869BMXC6:=U<1!8TV!J
MY/R!W)P\YSAH].TRPN:6LI!(23A'R8;JSG[5=N;D.3WI09((--L+&55U::*Q
MN'<F*. -<2P@<@RLT-2&-=_C6OA@2\N])MK29+6W<2AGCD#*BIL027<-5*5W
MY/7MUZD]I=Z_+?M<Z% MU0EB70D58\24B785IL!O05(R1KI&KZG;JOF+S1!I
MEK!4+#&K3);BH%)EJQ)/4+U'X8"NK#RY# MK:M?:NTO06<<*"-%_W9/<R<8^
M3$_85^5*5P'::GK.G2FUTK])S% %C%W=%X!R4@QB,50GCTY4(Z8/:RO']/4?
MT?\ 5Y)5H9H4:V(*U/HOZ1^V3N'(9=NG7!%U?-/)!61H6FNXD7U%18:LR+*L
MABHJN0!(I!IOMTR+ZK]2N)[J&]TXZ9/&SEYXEXTHQ 9HZH&V&_1COO7;'64]
M[8^O,]TTL*6[+&PG'$24Y ! J/S\0XI2F^'VDZTLD=EJ$5JM_- [PF"Z;UXP
M8^O&+X:]Z!O"E<[+I>N0221QPV\ULE[%+!!%%#!]7$M5<3,0P(]1/V2"*5&Q
MP#9^AJ%_J&GI-Z,-C"7N'4D(2&>D*P.'8, *BG$^([8O-97%NDD=PPE9$22*
M95H'0]3T!W_AA:5VWK_3*(H3WRB/ORN.W3-2I[Y9 Z]AC:'?P]\JE:^V41]^
M,IOED8TKL*&GCF*CL.G?&!*TW[Y1%!MB?'KMC2.E?'&D4Z#)Y^6?YC^9_P I
MO.V@^?/*%Z;36=#G$BJ2?2N86VFMYU!'*.1*JP^D4(!S],_Y._FQY9_.K\O]
M#_,#RK*19ZHA2ZM'8--8WL8 GM)J4^)&/6GQ*5<?"PSI^;-FS9LV;-FS9 ?S
M/_,7R_\ E/Y$\Q^?O,LW#3/+]JTPB!I)<SM\,%M%L?CED*J.PK4[ G/S1?F5
M^8/F/\UO.^O^?/-5QZ^KZ_<&5D6OIV\2CC#;P@](XT 51X"IJ:G()QKE\>M?
M#-3IL<<.P(J,N@ZT^G*IM[9BN_MFI[YC7>F6![>V7CN-=STRJ8PAATJ0>_AE
MB@VZ9E/*O!6EX]D7D?D ,#:A?2VT,T%C/;V<S[">5E>=OAW5& 94(/85/B<Y
M3JCSQ6BPRW5'EDY)' PDED1@Q+-*5 J: ;[T_9& ["6MU:M;P+++=6@ 6=W"
MLP>JUX\>1'#:HZ]!DF=M:M)9Y-'TTV[\ _**) PZL9I"QX1L*[5/ZLBXDDNT
M8$W%\PD/J2O<""$.VQI-3DYV_9Z^.&*:=<3O&=1U33],M&-$^IQM=W(_RI96
M81@4V!=C\AA)?7EG!1=,Y)91K\<RR$RL":$$\4-2>BB@&!X+.8SQ:W?@6EK
MM8X6JS%*TBAB&YW/<;\M]SAU/ILEW(\H(CAN#' ]M(2#*[BGH!D##E\-7(Z
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M3K&2=RB9^B)'21$DC<21R ,K*:A@=P01U!QV;-FS9LV;-FSX8_\ .??Y]_\
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MTLGG*"9E*I-)(Q"&63D\AZ4;DQ+;+\(J&.[RWM]'6**^E@G;U%GCT[U1'I\
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M-N*0H^R%B2QY$!CT@]Q^86H&5=(TP/'=3*S\8HO7N&9J</24U5%H*!F'*E:
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M".;2K#U75;?3KM)+F1B2RI!S;@E-F<L%"USREI/D6XU74IY;Y6L8KF2ZN/\
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M8#=ZT SG/F4&U963][4@$1[CO7?MN.F%-A<+ZYAE7DH4U"[#8U%3XY*+'DI
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M8&%7YVV(T_\ .'\T[(!5BC\V:NT:J20(WO)G05.^RL <YAQV]AMC@M-O''4
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MXTKON!^K$RN]:;XTK7MB3+7I@=D/;$&4 ].G<X'=:5P,5IO3K]V(N@&>EO\
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MY5GLHS_QCT[4Y).__%B=L-_^?A&C>GK?Y:>8 M?KMCJ.GNPKM]5D@E0';O\
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MI)!J*]L+KI]2:>6SD'"1'7CQ/*-5 JH.]*T%.^<Z_-[3IKKRGHVI3*OJ1ZS
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M:-A(U:UXG=5J!W.U!UP?8PI?FDL#1VD4GJ?$2LK.:<5\:;;TVR7:85DOHHU
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M94^PH#= QY$@>]3QZ&F)D2LT_#DLLD@-"5#  _$R']8]\%21K<+RF3X)!P'
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MT,"RCESMRL95=S1EZ _KP.&>Y9_6++&4#($8GC$O=@-J-U.^^&"2F;D*HB*
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ML*UV]\.;40EN5O(P8+QXDEC78DTH"#@CD*!I*=SR+5Z5KUH!G@'\_P#\P/\
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MI*Y53Q67>A4TI6I%!_4X%ECX,JJ*\OV1NH+=0Q^C*2=@I?G^Z%5*T[L?V?;
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MUUAN)2_&0A11G._"BJ-H]NN<R\UZ*-/-M+ 7,=WR1S]E7(->1W( [#PR#QQ
MW;,[\GC!8.>5%+4KL2 30T&2RVD@^-0T@8H!68!> _9<BE2Q/OBUI/.K"X5S
MZD5"RJ@:J@DNI#<22P%.NV2R0QEE9>$EDPX@P CX9:$(0O4@-O3H>YP1HVHK
M?6<\!Y.=/62&BFC*L9._$'?8\-CL=ZY%K9IV(DE5DBE/,-(8ZAB:*325R:^
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MO,Q8,1%)SJ5"*U "QV)VWITZ8'E]8_4Q0_NC\1)HS4^T0OME>K'R5.<A$8-
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MKHH$T@=!(2^U7V8_/?IA9YG_ #(L/+$YTZ!!J%\BD2 'X(R=Z5 Z[[YRV_\
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MEN7HS,S+Q4,I(I4D&@!V!Q*"1B#ZPKS)WJ"M *CD/U[9*=/FD/VD64J RAF
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M\HT#2,Y%:[4^ #M385]\=J$CSK.8W402^G2+[- 0IZ%12@\<\U?\Y/:X=/\
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MFA^1I7)#Y=\N:SYBU&#1]"LI=4U.]JL-O;4*!5^T[MML#3DQ(4=3GO?\I_\
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M9[&>P7U(9],NY;%N,3)(C $(L415F05%=V->OCD4\[+YCUB"QAUW2+#S4FG
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MCX@67DQJ&"TK4C;P\,()Y#.:\&44!)=@I)KT4 #IAW;_  6JH3Z8->;D[%O
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MC)(>'$HP.^X7XB":;4^?A@D%09&<<5/5UW9J[ 4VH#BGIJEM*YD$?J+ZFQ!
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MR4BM:TZ5P'9D3F7C&$=8WK'O1FJH#/0'NW?V[X6:K+Z[Q1QO(0J*W&( U#L
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M9LV;-FPHU'0-#U??5-(L]0;L\\*.XVI56()!IX'.>ZI^2OD/4@OIV5QIC("
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MT-%O5H*UVZ8:VODK_G%6TE)AO/*;S*Y=O5U\3-R+;\O5OGJ.78[5R0V6G_\
M.-%F$%M)^7[\:\?5N=.G.]>\LCU[YT/0_P#E6W_3-?X:^U_TK/J?VMO]\]^F
>3C-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>sny-20221231_g26.jpg
<TEXT>
begin 644 sny-20221231_g26.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2       4  DE$_]L
M0P " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%!04%!04%!P@(" <%
M"0H*"@H)# P,# P,# P,# P,# P,_\  "P@"3P)/ 0$1 /_$ -(    ' 0$!
M 0$           0% P(& 0 '" D*"Q   @$# P($ @8' P0"!@)S 0(#$00
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MS9LV;-FS9LV;-FS9LV;-@+4=1L-'L+S5-5O8=.TW3XFGN;JX<1Q11(*L[NQ
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MZ3Q!2JUILXVR8364L%P?JT$=DZNKS#A]5MRQ+ 2(&DN82"?Y)-]Z#-=W'H+
MLVG7%G:7%P29+F-?JLQB !D1N5S$H.].+BA)W(Z:TU:339IX7CMY$C D?T0;
M>61&-08N+E&85!/$L=P=\D4>KZ9KMA+?VKR7%Y$>+I<?$QXU-'Y(CKMTW\,
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MRR5JM!BM/U8C(<+KB7@551N[4 ^G?.1_F5^97EK\OM%N-:U^_P#JL2K*T**
MTLGHJ2Q1"5KNP WZD#J0,^0?YN_GGYG_ #5U@M>S2Z7Y;@EY:?HT;-5@6#!I
MN)')VV)]_LFE,A.EI$W$7/&WA-4BMX 7FE/9$16 .YZ*/]8]LGJ3Q$!)+-4B
M<J!;^K& S@"@EHKM,P!%>*A%Z*?!74M2E2VEL=.$NH:DY#7T\Y1$B"BBJA4Q
MB15!XC<<>U17#ORMY1UC7YK.ZU4.L$(4*H9@A*5$85 $HJA017^&=_\ +OD3
M3M*%O!';I#!1?ACC4,PV/0 ;;>&=AT_3[:)10"&)2754%*5 6I'C7?)-:V/I
MRE545E)+%NX%.HZG#V#38RZ NY)8,0J['>N_L<.(-(5YO5*T=&JH:A;;P%/$
MXRYTR)Q\)6I 7[1H=^NU=L(KK1O2CXQR1#DVRD%OC[<013[\*3Y9CGC,5Y$L
MK<EJD:D*#&RM2@))8$5)/X=,7_P^@!A:.L1'%XPJT(-31ZL23\1PI?0SZALH
M_P#28&/-8BW&1@31HV9B16NX/?WH<3G\IF-6 @%L(U#^D$$H)93\0<E:^&R_
M@<CJ^4[28)<%7D$%>,L3M$Z[]0%HA/8;5QUOIB6Z0P1,]TU@Y:..Z+*R.P.R
M4"*K';93OX5WPP&F64BSNPC26:,B[Y*\D99Q2K _O(_"A#C_ "J9"-9\B1>K
M)/IEXT@2)60&LT0,E><1C,G/B2 R= IW!W.0][7S'8S11P6UO?6$KJ]P"4:X
MMHH^7,J5A3U5J25 %=^A)&'>A^=;*YN9;/4KJ*TGG=891.KF!W0$ R(_QQ.0
M.5:[;$U6ASHT6GPH/4N[)HK;D48QJ&2*3P#1_$*\@>K#V\#ZQTQK:=)8W^LV
M+482#9EWIQD7J*'O2A^>V=HT"@5"3X9U&R :,$;@C;!3K\).<T\SI^[D^1SQ
MI^9*?#<4]_XYYU"[T[5P=$O0YZB_)]/W<.W?^.>]?*"_N83[#.Q6Z_NUP6RU
M VP%(.N=@_+_ ,]T]+0=;G\([*YD/T")V_XB3\O#.VYLV;-FS9LV;-FS9LV;
M 6HZC8:1I]]JNJ7D6GZ9ID$EU=W4[A(H885+R2.QH JJ"23GYVO^<R/^<J=2
M_P"<@/-;:)Y>N)[+\JO+%RXTFU/.(ZC,HXG4+J,G<MOZ2D51#T#,^>,[-?WR
MYU;0A]BNU,ZKIR_"!3MAVB=,&*NW3',NW;"FY2M<(YUZCM7 ZK3I@V%!4?KP
MXMT/ADBT]*21[=QG9_+BT"9V725'%?EDI44 RS@*611RW&0'SEYPT7R;I6H^
M8=<N1%I^C64UW*0:D\!54&XW<BBUZG89\-/SE_.KS-^:/F$7^L3&#3;&L>GZ
M<IK'&@9F5F%!R8EB23G*-,,T\C2,9'E<,[4;XR@_RNH9\ZIY>T'4K^>AN&%S
M;P+*T-N:F&-R1&@;[-:&IWV7W8U[=H7Y?2VTMA*T,*K;6T3NI8.DR2D_8("]
M6:H(+<A^T*TR4:1^7P>:.]NP+"RB*LD4E.4NQ(+H#WW%#G7M*TN"UA5+-?04
MTJTHJ3M2H4;#;)_INEO$BNREN=0'<5;>G?)7:6D:R CDQ)J.W6M1]^2FSM**
M2H"UVH-SUZ5P]CB6"I?91T Z&O0?VX:K:121D,M25 HO+I3W'\<R0&,>C% \
MW8M]D;^)-/NIBL6G#X/4AY.WQ*XXCIV%6-,5@TJ"WCF#0AI'#5*[T%:\:[=,
M1NM,M_47A &D905(%>->AJ:85KY=3U#=+;(&/PL%.RNN^ZD4W!\.F*3:4]R(
MTGMU2-?M+R(#CM1A0T_UAE+Y>60![>T^KBI:I9G#5ZE:K&.W2N$FI^5%:0<;
M6.:-R09/BY@\:T(!H=AD/N_+<?[EX$N[2XC)<%)VB#'H0H9:4]JFO<'"B\LY
M)P\<T,T5]&>$%S !%20[AGHJK\)KR/;JJ]0>)>=1YAT42)<:I8W"7Z342]E,
MGJA*LA 8QDL"N])$/V34]1SJPU6WN^/UD2W5K9.CL)'5YC"1O'&?W4H*EZ"J
M,KJ:_$<Z]Y.\QRP,JP3E;<%8VD56GM9[61#P]2WIR0J 5;X:KX&F=TTRYM/@
MDMXA$RFH4!>"G8,I!K4$'<>&_3.H:-&K)%+&0(FV* DE#3<<B:D>![_/.G6(
M4Q#@5(  VZ?+;!SCX2<YKYG7]W+0=CGC;\R4^&8GW_CGG$*:GYX/B789ZC_)
MU*Q0[=37\<]Z^40/1A^6=AMU_=K@AAM@.5>N ''WC.^?EYYW.HI'H6KS5U")
M:6T[G>=1^PQ/[8'0]Q[]>M9LV;-FS9LV;-FS9LV?&K_G/W_G)B3S'<WOY)^1
M]0(\O:3.%\T7D#;7UY"P(LE9>L4+BLG\T@IT3XODS,NQVWKEV@I*,ZKH0V3Q
MSJ^G+\"]ML/8UZ8,5?\ :Q[)\.%-RG7"2X3>OO@95\<'0KTPZMT&U1DAL$_>
MQ_/.R^75V3M\\[%I0'%1DE'MC'8 '(MY@UF/1-+O]0>(RFSB>81[@-Q!-20"
M0/$TSY'_ )W?GMK?GZ&_\NW<-NNG6\Y>XMK-G4S3P.X2KD@UH*I[=AM7S/::
M&-7+W%O)'Z(B;TBR*)5E Y/&Y*#X@N]"-QOM0C)QI_DY-'MENYX5OOKCK6'B
MS.34A(0_5:MNQ/1%H-Y%.=UT*RL-/\N&S&EIJ5Y-)ZL]^1Q82LQ7]VIY4X@$
M<>BBG3)];,\5E;>K(P2!0D,<JBE34]%Z?:/0X9V F:>M!)(O1!\*+VX[_P!-
MLZ/I.GHL:2W);TU 8$C^\:M!3VR>VUN'C0L#'RIQ5 "0.VY[Y(K>U)X?#2E.
MH'3L*Y(+> IQ'$#E3I].V'-E:*Q<E37J:]2?GA]';TH -J#>M3].V"?05*U(
M4GH!OTWVQ6&$< ZT 'Q MTJ:#WQ"YM9#&)(U57.S%36@H>@/7Z<$1Z>D8<>F
M'YM4UW)-:5/;'2:?L03Q#;,5VY#P)/?WQK:?#P->;HNW%S2GTD;C[\&"T4KR
M0D"GC3IV'3"N6T=?C92C+4\@*[=#U'AA'>Z4+B 0AP\; <Z;5!-3N/AVKOL<
M))/+%G&G Q",H?@D44()W) IXYSWS9Y&L/,=E=V6JV'KQ\EF0JC,T4T5/3E3
MC1CQVK0[C/&OFOR[YB\C7P2XLGN].FE9!Z</*%HVJWJ0EFX*&2HX!EH>2BGP
MG 48DT>#2-8TJ3ZU9:F?5:!W*3P)"9(W%6')@Q;<$<UXU;D&YGTY^77F&UUV
MUGM[F0VUU#$K6=U)12_&H].<'^4C@3X%3USOWE:Z5P5X;J/3D4BIJ":C>O0@
M@;YUK3^/I_"P*[$?TPQ=?A/RSFWF9?W<GTYX[_,F/X)]A3?/-?&C';J<,(5W
M%,]2?D\G[F#V/;YY[S\HK2*+Y#.PVZ_NU."67 ,@Z[8!9<31Y(9(YH7:*6-@
MR.AXLK*:@@C<'/37D;S:GF2Q,-RRKJ]DH$ZB@]1>@E4>_<=C\QDZS9LV;-FS
M9LV;-FSQU_SE]^?K?E1Y0/E?RS>>EY^\VV[+;R1GX].L6)22[VW#M0I%_E5;
M]BA^"FNH7,CL2S,222:DD[[YSZZ38]!OB-J*3+OWSJV@@GAG6]-7X!MVZX>Q
MJ:"GW8,5=_>F*%?AZ5PGN5ZTPEG7KM@94'AUPQA2I%1AW F']DG[Q,Z_Y>6G
M#Z,Z_I?V5(]LD5=A@::546K&@SSM^=WY@Z7H?E#7M/Y![_4+>2T0^JB>DUPK
MH'^URVI0 =3X@-GQ(U#5DEU 2@?NWF$?K,6".P!4N*LU:@DD]L[+Y T^6[US
M2HYOWVF:@.<_J*T=!)"$E:M#6@+4\*^V=&T[GJ6N6HN()(_J!:=BHY*8D@4[
M@\MR4517:NV3CRW;<B)+J-(I[5!6M5W=2Q#J11@69MZ=>F2&.0ZC>1K&H$$)
M'$ 44=R2.G;)UIFG@-24!6??D/V1]W?.B:;$S)#%(W)46JLWA7Z=\G=K$ 4)
M%'/B.YJ/U8?VL$6XIN#3EXGMAU;PU&PJ57J>@KT[8=0Q.J_9"TW9AW_CADL-
M45E)4 BK!02:^%:C'+:*7$KEI 37B['CX5XB@[X84YJ(E#4/A\((KX]<>\+<
M%1/AJPZ=-B*CMV[X-1:4)C_>#J?;$F+;B-.;D_ZH!VZG?$OJKE0TKAB3R50E
M46@[=Z^]<2:!9$*M.U0:;/4=?#? PL%?FK,[\NA>O(<16F]33;;$Q&\2A6D+
M&2E.1-.M2>O; DZKZ@YQT/7D!2GOA#=:>LLC24YD"F^Q![&H/OG+?.OD^UU[
M39[2:%!(3ZD4P7C)'*M*,CBC*VU"00:9X^\QV\^AWUGI]Q;7-J7>-+J.4 VK
MR^E$J.O$#B:(14'8AOM,:--/+<,+FPU+1Y5Y>I)'Q ;A. 0I65 %*R J0:>!
M]B?2GDV_$LT%T7HLL;&=:@&-EI3D#78TV;OGHK3(HU1G1*/)0LQZDT'4>-,-
M6'PGY9SKS*E8Y/I&>/OS(3X)S['/-#+1B/\ *.#H1TJ-CGJ'\G_[N$4[_P <
M]Z^41^ZAVZ@9V&V7X%P2P%.F 95[TP ZX@PKVP;I>IWFBZA;:E8OZ<]LU?\
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M(YW'-FS9LV;/./\ SE#^93?EW^6&H16%QZ/F#S:6TC3RIH\:2*?K,Z]_@BJ
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M"M:].NVWCMAW9S)ZJ1*&19EYIL*U'7J:9-;7C&.6Q%!3<;D8;6RR.20 5?\
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M(SVYY32B1;;T&=BM!^Z7!;+M@"4=?#"]QO@=EQ!EQ!AB+#KXX@1G9_RHUO\
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MT311Z4"R+ZBQQ@,S( T=2S?#7E0FH^CMWSH?E[3U&FS7%&XQ2*HV  (ZT/\
MM9-+=WK9P.0Z%Z4 IR!^(UI7.G:2?35W'PL4 Z"H-3L!7Q.3*R9H(FEG:C&@
MV[ G;)1'JEO IDGF2&.,<FDJ H4>)Z#WWQ>#S+I:?O1<(Z,:-*35=Z4J=@!3
M)-9><-+)I'=6ICC_ +QFFC2N_@6!)\ !DTTC7]/O9*&XB91_E@U!WJ"-M_\
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M\2*AY0/A^'P VR-7EL9)HY(^*M2-64#XE' <OA'RP!?W,*,8H2S3R?&>9IQ
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M0 -C3OOUSSW8>5VA\U:Y=0R-"T]M++:A2"#=2%1(QJ2*,=J=JFE>5<FVC:-
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M;V?U=9IQ6-[G8 FNXVJ!MOERQRE22A6NQ;?<&FV_:HPLEM_[RJ-Z@^/IMQJ
M*^Q(R(ZQ>1?6&=$8Q.*  [5\:'[OHSBGGR?U;9;<\4$LA8U/;.16\2IJ0>/[
M/)14[U))KN<]4>1+@PVJJX,S GBQV)))/3.U,%:"%B%5F4T %/QPJ3X+D\J$
M$4('2HZ8?:?+$TX69?M_#4#KL=MZ8:3V,3AU:%)HEW4$5'3KM\\CTV@"5I9
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MB@'N0:YS[SGJNFQ6#TN$GN[N.L<9^%FH2.1^UMVSB%KY<AU%Y+F<$&2@7<[
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MQ&9;NWAKP9@H4TY;ML:#Z,[7^7FFUFN=1F4\H@((V8UW ',BH^C.N 81ZO\
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M5\<B9'Q'YY._*Y/).^>CO+?V8]^V=0MOLKVKAE&:"F*5IWPLNV-#D:N7W.^
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M8YX)_P"<U9+9M-\HVPC1KD7<\G*A+JB1'8'84):M.V?.]965A6M%04\?N^G
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M8#/7 \OV6R!:V/@?.(Z]]IO8[Y$6^UUR8^6R/57QKGHKRVWP1'.IVI'IKO\
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M3FJJUR2H05^><^_,Z]^I^2]:4&C:C%]0\*K<@H__  A.?%;S9I$NB:S?Z<[
M_4Y62)QN&C->!Z[_  G().G';J2.OV10=ZG"UBSL:'X1LU12G2F'VEWDMK(D
MD9XM4-Q;_)._+IGIKR7KZ/!;-(2LL3C@M3L16@ KW!H#GIO0=?AC>.W>)C5
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M)J0M\L\Z^>V_=3#V/\<\+>;FIJ[^))_7@.R(-,ZS^7QIK$0KOM^L9]$?(?\
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M:_CG1;%@4XB)N<80Q2HXK)V9CR(!J0*TIVV.3&WNGCCCE1^+=.#,@X,/AJ4
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M5N[C5I4^"U!AAK_OQQ\1'R4_CG7,V;-FS9Q/\_/(C>>?R^U!+. 3:WH-=2L
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MQ":(, "-_P"N 5'$TIN*U^_!,<8<[[[X9);5'3Z<773PVY7'?H97'V1OC?\
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M,-)+J7J!QCJ"!MU-!GAW\ROS\\W>>S+IVFE_+GEMV*_586_?RBH(]:4'>O\
M*-OGG I*5!D;<FH/4U_&N)+Q(!6,L:THH-3\\$QPN#SE98@5WY;N16M /H]L
M7$*(I8+S"D5,F^YK38;=.U3C9IIF%.; 4^RNRCON  ,2T&8%;RTJ?5M)RZ
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MY=0-VI0=0U*U[#>N^V8 L33<D4(H2#7Y8E(O6HH5/$ \JCVWQ%@*EN0K4[U
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MBCJH %P -Q27M(3\.DMX8R'*^LZDFK5"^WP^(IXXLS%J,Y^('J#L/E3^&,W
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M9R3Q(%0/UYW;\E/^<?OS9_/O54TG\N/*ESJEO#(L=[JT_P#H^EV0-*FXNW'
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M.PAOH);>04$J]=Q1E.Q%:;X;>5-:N+R-M!U29([RRW+R @SPE@%=36FW1O\
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M\N&(CF-3T^ZM0-P?B,T:'PZFGN,(8I&&ZD;FM 26V! H1OV_VQO@L.O((IX
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M\[?1H2LINIQ)&B@QT^$%A1B.0K4 T&Q]L#ZG;J(HK9'#30DR&7B>)W!"<1N
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MD!B8S$Y=VE__ #C[=WEEYO\ S$\O77-5NX].UN$2 1L&*R6<H$2T15I;H:J
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MS@N=.NI)A'^D6E!@@)]1@$V/+<*E1L =\BLDA64K,QD<*W".'^Z++XL5KLH
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MUDG<G<[X89LV;-FS9LV;-FS9LV;-FS9LV-95=61U#HX(92*@@]01GC;\Z_\
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MI-UHGF'3HM3TV[6CQ25!4C=7C=2KHZD JZD,I *D$9\]?SB_YQ-U;17N-?\
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MC658P0RL 05/B#X$9PM-*?1)G%U&3#"=Y.)5B00%,S$;=:(.XRK35+RYU%P
M5MU)6W4?" @V%5&U54#?]9)R?::\ !>6Z1!)*R<7HE62GVCT%/$XCK[>E?6,
M26R_Z5^[65T4@L=^ .WTTP59NA_T<,9F%0QCJD;$_;'$"M<\^_\ .1/G/3_R
MT_+Z7SU<(BZKIY.DZ5*59W%_>LJ6R%UCF;BOQ2=#3CT8_"?D%Y\MXIT7S-5I
MX]1_TB9G8M()6XRDQD/(PJ9F!!+4!"\BRN1RBQGYWT:%2C7*'B2_&C)N X%
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MCOQ4YZ7    % ,V;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-GF_\T/\
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MX^7-4T"TA:6W?4G47'UI5-PP$%V8@LJ.SU+.06JSE0TD=O;Q&:>WTBT@M+"
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M#X'.$^9?^<:/R@\QRW5Y#Y8C\L:K=J5>^T/C:2;FNT?!X0:[U"5]\\V^=O\
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MY"TU)$D^N>8IDMGI]IE:V075T30T/*-0>E>N>_/*O_. /E"32K"V_-'S;?\
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/-FS9LV;-FS9LV;-FS__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>sny-20221231_g27.jpg
<TEXT>
begin 644 sny-20221231_g27.jpg
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M  (1 0,1 ?_$ -L  0 " P # 0             ("08'"@,$!0(! 0
M               0  $# P,# P,$ P        8$!0<  P@! A@0%18@%S<P
M)3A0@!$4$R,D$0 !! $" P0$!PP&" <    # 0($!081$@ A$S$B% <003(5
M49(CTY75-B!A<4)20R0TE#46MF(S)75VUC!0@9%R<Z8(0,&")A<W.!(!
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MS7%.@!L(SHR,'B,:-% W^=OH      !Z) (CB>$        S0MK
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M=4P1,KZ7WY^&V<1EVL5)1O'(5UR]6+":2VEL1LC7EQ)CL]&P9J:VWR+LNO\
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M9WF-S<7EP(7UV0T8_:,.ND3_ "GUE0!226#W3\N#0'%>.DR6(,<;2H1R'FY
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M+ZE^]P,&(^1&0Q32BACQ++,Y3Z6M=).] A U)L6JC2'E,NU-)K5_\LUK,X!
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M!%"$UI44TO5VUL&Q?C%IC3;)\@D/W/7$K+,C=1N.EBN'4N9Y9'>-)6J/L\B
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M"QEQ(ZDBKD85+Y=ALTJ+>Z97;CJ^Z>T45=N'WQ#MOR1_UX&5B,@"D10Z#/\
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MV@ ( 0,# 3\A_OQ__]H # ,!  (1 Q$  !                      0
M       "   " "2         22    0 00   "0" "22 0  2 00  202  2
M20   0002  22"0 0"0" 0  20 0 " 200 20" 0 00    0"22 0 02 0 "
M0    """22 "22 0  22  " 0" "     0      0 0  0   0 0      "
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LL6+%BQ:LZ=BG%?3%%P_AO__:  @! @,!/Q#^_'__V@ ( 0,# 3\0_OQ__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>sny-20221231_g28.jpg
<TEXT>
begin 644 sny-20221231_g28.jpg
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MH;%0<,'1X4#Q_]H # ,!  (1 Q$   'OX
M                                "-X[:ZJ:S<UF-BJ26Y720
M                                 ,#T27Y]J)^G&F8<]GN^-_0'>OS+
MWG-UW5S,&0-?-@(S,(3.0&2:;>:^; 0V9 E0\2O1.!KQI1-9Y
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M!PJO%Y4?S$]4:YI\MQ[14=:?3NJ]^               \0>0
M            !K^1T8;OZ]YP,L
M                                  ?_V@ ( 0$  04"\\$9; "C?;L
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M-?7CTU_Q<4+3[MQ4G26,=K\@9%C**'3GZ$&Y'_[7T3?Y_HO^.3CQI_R!AO\
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M&H\AEQ&VD&OR$H(<1[G1^YU0LG>U'+KQYM'BEKD,6''C"<N%7\:R@V> SB"
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MD,<5>AAN(P:N5!J5R-T;HU/$%39&G,KWU/DP\V/!F'@K8! +#G^WRCQ7CD+
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M%<:,][P.V%<C5?\ ,UOF0-A<9!)IO(EU$!79/<UXH5O;1J^DK(DNYC5O9P
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MY-O.FJ<4A;?(VQ'R(4)IR1Q.6*TA':"8Q_)']3$HN*44Z\D0KJ;(EBA-8YP
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M@7'*)'H)Q/5:<M'=_P"X>,DJL78)!.O@.9WK5S$Q1/N&,HG6%C8MVCG9 KY
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M#! ^+$S[RN-TZ0YVD_4:<EN0"MP 1U3">F!(.4VUP#BI.E L5B [-%3H*_\
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MPD"Q?D>?1[;+N8N&^\_E9$E#&W> \/*"@+)Z4^!6Z@%]BU]L"#R'^T7VOP:
MZ$F?5X\G@.PV@39C44H?TA?D])<PEA\_X [O;[PR\%RY0#1L1Y<+AD?9R_+I
M\)FX>DTC[A!X@^V F/BOX/R@>^ P^R$3BG,3R]) R[<>^Q^2/CH$<Q4!"?@.
M ]XP40$W=UYM^,#$4NWN'A3L._P:05M;G-^-O_I])#70^U2?X/NZ<CM,J_'^
M[_SH6=P^!K^U]) C+$?U^'D=F&EAV./Y/TKCIG[ =OA4GY90#M'^??[]\10J
MS=LD;D/*^%X#L6\Z]*>PK0)^^?K2B:/[%__:  P# 0 "$0,1   0
M                                                    =X
M                                   $M   $@@ $@$$@
M   @   $@ $$$ $@  PV[$@D$@  $D$    @ $@$DD DD  D $D DD @$$ D
M &.O0D$  @@@  D@ $@@@  @$@ @@ @@$DDDD@$@@$@  !_Z$@  $@$  D@
M @@@ @$D@ DD                $8I0
M             #0
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BI$ *J\ &U?&+D*^Q ^R\A(6/2K_YE@H)GNZUC\D_V+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>sny-20221231_g3.jpg
<TEXT>
begin 644 sny-20221231_g3.jpg
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M_\0!!@ !  (# 0$! 0            D*!P@+!@4#! $!  (" P$! 0
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M  (1 Q$ /P"_P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M9VO^HGA'_@;BO^U-O_U,_P"<+\^_^7%Y@?\ QR_='_NZG_J^>A/_ #'\0_\
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MFW_ZF?\ .%^??_+B\P/_ (Y?NC_W=3_U?/0G_F/XA_\ <;CO_D8_U$\(_P#
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MTUT[HU^,.HW6PWVR[?UN'+A[M=.^EJ:Z::Z=T1KIK&NGPUA[!T[B
M
M
M
M
M
M
M
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M=.Q]JWZNRS'-O)3%?9&3!X'K:G)XVBZYHKJM(Z;26J.GFCBXIYJXDIV;PO\
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M;C]ECPUUTK7!BK6-9UG2(K$1K,S,_MG5@AG;N@
M                        &1\!W)V]JF)M,!J_:G9&MX*P]_X.%P&\;/A\
M39?*N9KVY^)CL=E+>SM_D7EQ)+)Z*./7+)55S^:JN>><<W_AWB/*[N^_Y3BN
M-W.^R:=V3+ML.3);MK%:]U[TFTZ5B*QK/2L1$=(AP,_$\5N<LY]SMMODS6TU
MM;'2UITC2-9F)F=(B(C]D:-D<!]D_P!A&MY:TS6.\W/*BXO++W_9AS_>W9.U
MXFOY%M-:2?+P&T;%F,%?^F*>KF/W[:3VI>*9*/3)1153KC?_ &W?;[R6TOLM
MQX3XM7#?36<7&;/!DZ6BT=N7!AQY:]8C7MO'=76MM:S,3C^?U]X+N,4X<G#\
M9%)T_=VV*ENDZ]+4I6T?#KI,:QTGI,PSQJ?W:?:3IGS_ -'\NMPO/U+XOR/Z
MLT[JO??;^'\GV?@?USH>Q?I7K^55[OQ?9]_\4>YZ_;C]."<K]E/VN\S]/]9X
MCLZ?3[M/H;C?;77NTU[_ --NL/?^[';W]W;U[=.ZVO2;KT_ZWW?;]7B\4=NN
MG9DS8_CI\?IY*=WPZ:ZZ==--9UV*U?\ <9_9GK]&$IRVX=2[Q5BIK26^DVCJ
M3 VE>RT6]Q3--;YOC2I]0C@AOXZ>8I><=3CY.(^>>8JHZ_Q7QKOE/Z=7VT\A
M;/.TV?+;&,L6BL8-_EM&&9C2)Q_J8W$S-9^:OUIRQK^]%J_*Z'<^@_7F>;SB
MQ;K#W1.G9GM/9K'QK]2+ZZ?&._NC7XQ,=&RVJ?ND?+VS^?\ USX^>-^Q>Y\7
M]+_I2'L[3/A^CY/S?G_J^_;Y^I?(]4/M>W\3V?17ZO=]=/MZUY7^EYZBS?3_
M )'Y!Y'M].[O^O.RW'=\.WL^GM=KV:?-W:]_=K&G;VSW8]NOMN\6OV_HM]R&
M/XZ]_P!')K\--.W'CTTZZZ]VO3X:==E])_=6V]5>(M.Q_"N:*/V9J<]L&D]Y
M47%?-Q3;W%=O+B-/SO5UM33#/=<11UQS9WFJ*.JN3BN3FGB*K6W-_P!*[)%<
MV;QSS2)MK'TL6YXR8C36-8R;C%O;=8KW3$UVVEIB*S%8F;1CV\^VBVE[\?R\
M3.ORUR;?3IK&O=DKFG\-9UC'UG2-(^+9;5_W1WAG=X^:3=>A?)S7\K3>246]
MGJ^+ZKW#'RX_B"WJBN9LGENSM'N8+RNYJEHJ@IM)**:***^)JN:^:(]:\I_2
M^]R8MQ%>%Y[QG<;7LB9MGOOMO>+ZSK6*8]EN8FL1VS%IR1,S,QV1%8FV/;G[
M;_+:WB-GO>.OBTZS><U)UZ]-*X<D3&FG7NC\8TZ:SM=JO[ACZN=AN+N'+]Q;
MMHL=O#1+#=[5TUV9>6]_777Z*K>TITC7=RNJ)HZ?YJN9XH8_3_HJYY_@U3RO
M]/C[H./QTOM.'V6^M:9B:X.0V59K&GQM^IS;>ND_".VUIU^,1'5C.Y]$^R,%
M8G%M,.:9GX4SX8F/VS]2^./]B9G]C9S2/MU^M/L"O$1X'S)Z9L*LW#-/9<[O
MFK[K.B&B"WN+FNG+R]CXW5(M?FJCMJN*([_FVDDDYHCHIJKKHIJUGS?VD?<G
MP%<UM]X=S.2,$Q%OTV.N\F9F8K'TXV=\\Y8UF-9Q=\1&MIF*UM,8YO/5OL+8
MQ><W$[NW9.D_3K&;XS$?+]*;]WQ^-=8B-9GI$MK]$\EO''M+X']LN_\ I/L;
M]5O),=B_Z$[5T3;_ -2R$/Y]ZQL/Z?SV0^9>1?C^:*/U5T_[/#5/.^M?8OB_
MU/\ 6;@.;X[Z5(O?]5L=UM^RD_"UOJXJ=M9_"TZ1/YL9WOCW/\;W?S'8[S;]
ML:S]3#DII'YSW5C2/VRS8PITX
M
M
M
M
M
M
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M-==*UB*UC6=9TB-(C69F9_;.KY#EOJ
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M&0F/N
M
M
M
M
M
M
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M?$N,KV;#C-ABZ:3,8,?=,?[:TUFUO^6F6J[:3)0
M
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M;:VO@R5I\O[TQ>:]LQ$1KW1,QIUUTZMEFM6/
M
M
M
M
M
M
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M*QI%HPX^_29[M)R36;SUTF-;3II&GPC35%M5DP
M
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M[#EPY)UZ9*6I/3I/2T1/2>DO8.G<0
M
M
M
M
M
M
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MTC5A-FKMP
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M8=Q'QK>LTM']M;1$Q_L/2.M<<
M
M
M
M
M
M
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MG<5Z\\'X6(_EW%[.MZ_"U\<9<D=)B=,F7OOUB9B?FZQ\6C;>#,@
M
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MO;TB->Z^*\4TB(F9B^G9.G=&NEITF=)TGHV6:U8\
M
M
M
M
M
M
M            TG[M^R#P2\=?EP]N^4_3^O92P]SYNL8G9X=YW:T]O\_GY&BZ
M#'M&XQ>JJGGBC\V/'KJIYXI_//'/'&ZO"?MR]Z>Q.R_B/BW,;C:Y-.W-DPSM
MMM;7\MUNIP[>?V_Q>D3$SI$PS#A_ /-.>TGB^-W>3';X7M3Z>.?[,F7LQ_\
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M&V&TVV2/[U,=8O/[WQR:=\]+6B-;3I$S$=.C6]L9WX
M
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MFK.9\%\P\>K.3E^.W6'#69B;]DWQQVZZ_P 2G=3X1,Q/=I-8FT:QU;CM/,3
M
M
M
M
M
M
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M-6-(R12+9=-(C3ZM^[)_=B9UOUGYIZS,SJ*VVRD
M
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M+9,=HI,Z1.E;Z=EM-8U[;3I,Z3I/1L4UVZ$
M
M
M
M
M
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M2^@
M
M                   #]K>XN+.X@N[2>:UNK6:*XMKFWEK@N+>X@KIEAG@F
MBJIDAFADIXJIJIYXJIJXXYXY_+\9,>/-CMBRUBV*T3%JS$3$Q,:3$Q/28F.D
MQ/28?RU:WK-;1$UF-)B?A,?E*0[H3[9?L.\<);6+KSRC[(R6"MOBP_TCV7?V
M_;>J?IMO=VMW)B;#$]DVVS_TW9W?Q?;DKQ%>/NJ8Y).(IHZI*JN8]^>?:A]O
M7L:M[>0^+\;CWUNZ?U&SK.PS]\UM6,ELFSG#]:U>[6(W$9:3,5[J6BL0P3F_
M6'@G/Q,[_C=O7-.OSXHG!?68F.Z;8IIWS&NL1>+1K$:Q.B:KHO\ =+=I8RNU
ML/)+QHTG<+7V98I]EZ;V/,Z-DXJXK>3FUN)-6W"3=\?E)KJXHHHGXCR6.CHX
MDJECI_%%-O5"WSG^EUXONJVW'K?R7>[/+W1,8>0PX]S28F8[HC/MXVUZ16)F
M:ZX<TSI%+3UG)&H>:^VWC<D3?Q_D<V*VO2F>E<D?'K'?3Z<QI'PUI>>D1,]>
MZ)M^A?OD^M;O:6UQ\O<]YTIG[OXOMX/OK7IM"BB^5=VMCQ\K<[.ZV'K.T^/<
M7D?N^YG*?1#ZYN?\"*:2.%'GGV)?<EX+6VXKPU.:V%.[7+Q>6-U,]M;6^7;V
MKBWEM8K/;IMIUMVT_?O2MM/<WZ5]@\+$Y(VD;S!&OS;:WU/A$STQS%<TZQ$Z
M:8_CI'QF(F6G4]RU#?<):[+HVU:WNFN7OY^'L&IYS%['A+O\4T5\_%RN'NKR
MPG_%,E//\DG/\.>/_FHG<MPW+\#O;<;SFUW.RY&G[V+/BOAR5_W5,E:VCX3\
M8_!K#=;3=;+-.WWN+)AW$?&MZS2T?VUM$3'^P](ZUQP
M
M
M
M
M
M                                                   'P=GVK6-)
MP.2VK<]CP.HZQAH:+C+['L^8Q^ P.*MY)HK>B?)9C*W%IC[&&NXFHCXJEDII
MYKKII_/YYXX<_C.+Y/F]_CXOAMMGW?)YITQX<..^7+>8B9F*8Z1:]ITB9TK$
MSI$S\(??;;;<[S/7;;3'?+N;SI6E*S:UI^.D5K$S/3KTA#]Y"_?C];W0U&8L
M,3VQDN^MMQ,TMK_3/16OW.U6=U<47'Q:9;7L++2:]U??XWB3U253V6:NZN8*
M.:XXY>:HJ9)>^OOL+^X[SNV'/N^)Q\#Q.6(M];D\L8+5C3NTMM,<9=[6^FD1
M7)M\<=TQ6UJZ6FNU."])>?\ -S2^7:UV6UM&O?N;128C37KBKW9HG\-+8Z]>
MDS'68@>\A?W0'D=N%&8PWC?TEU[TSC+B:2WQNV[O?7O:6\P6<5QQ5;Y*SL?C
MZSI.*R5[#'Q[MO=6&:@@IDKCIKDJXHGXG9Z^_IB^N>(MAWGL?F^0YG<UK$WP
M;:M=EMIM,=:6MKFW-Z5F?EO3+M[6F(M-:Q,XVZN"^W+@-K-,OD&\S[O)$:S3
M'$8<<SIUB9UODM$?A,6QS.D3,1&M4%?D%YS^7_E1S<Q=_>0_9W8V)NIJKF74
M\AL,V)T*FXYR<N7IGM^O-<HPVC6<T-_)Q5%5%CZ*HHXH8Z.:8H(:(YS>O_1O
MJ'U;%;> ^/<9QV[K&D9Z8HR;K3LC'I.[S?4W-HFL:6BV68M-KVMK:]YMN?@O
M#/%?&M)X/8;;;Y8C3OBO=DTT[=)RW[LD]/CK;K,S,];3,ZHMJLF
M
M
M                9.ZL[K[AZ.SU&T=,]I]A=5;#3-;SU9CKW<,_J%]/7:PW
MMM#3=SX*_L:KV&FUR=S#S'-ZXZH;F6.JGFB6NFK&?*?"O#_-]A/%^9<7Q_*\
M?,3'T]WM\6XK$6FLSVQEK;MGNI2VM=)BU*6B>ZM9CKN2X?BN9P?IN6VV#<X-
M)CMRXZWB-=)Z=T3IUB)UC2=8B?C$)GNA/W&GV'=216N,["RO6_D3@H/BV_\
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M6_6E^FO[MI^$_E+81KYT0
M
M
M
M
M
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MM;2L1KI$:;EXCQ_@^ P_0X7:;?:XY^/TZ5K-OVVF([K3TCK:9GI'Y,)LU=N
M
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MXV?_  8C_P!?+[4?_.K_ .]G,?\ SO/^.SUC_P"$_P#ZWW?_ % _YA+[8_\
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M_P"H'_,)?;'_ ,E+_P!_IXV?_!B/_7R^U'_SJ_\ O9S'_P [S_CL]8_^$_\
MZWW?_4#_ )A+[8_^2E_[_3QL_P#@Q'_KY?:C_P"=7_WLYC_YWG_'9ZQ_\)__
M %ON_P#J##__ #0GV7_\C?N'_P!K<5_V69A_ZW7VU?\ GCP__O\ )_U-VO\
MQJ>O/_"VT_V;?_"G_-"?9?\ \C?N'_VMQ7_98_\ 6Z^VK_SQX?\ ]_D_ZF?\
M:GKS_P +;3_9M_\ "OFYCZF?LEP>,O,M>^&7><]K80\SSQ8?5*]AR==''/%/
M--GA<!<9/,Y&;\U?PCMX)9.>/X\4_CCER=G]V'VW[[<TVF'S+@ZY<DZ1.3/]
M*D3_ +;)EBF.D?MO:L?M?3%[/]?9LD8J<MLHM:=/FOVQ_EM:(K']LS$,8_\
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MF=(FT8[6F(F>D3/35R=MR/'[VTUV>?#EM6-9BEZVF(_.>V9T>*=TY@
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M_P 7FT\UL,^+!6?\2(^IB^&L?Q<?=2-8ZZ3:)Z3K$3$Q&Z33#$0
M
M
M
M
M
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MGNW%NVVD_'3%6+98M$?W;UIK,Q&L==*]WE%^Y9\ONU?GX3QRU#3_ !EUF?\
M,,.:]-EVIV97!_JM,E?Z[M&#M=.QOR^(I?Y8,#5<6U$_ICN>9(J)^;!/5_\
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MVR36T?LF)AP,O,<MGQSAS[K<WQ6C2:VRWF)C\IB;:2R>QEUP
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MY;Z1\9[:7M;2/QG32&1[?E.,W>3Z.UW.#+ETU[:9*6G2/C.D3,L?,@<X
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MA'T8C6.MHB?EG^\:_LV\%_++]-LNF?(K0\AMF3_388.N]LO9>O\ L6O)9/\
MPZ,38:=NL.#R^QWEK=\>Q+7B:,A:^[S1Z)JZ)8:I(">R?MG]Y>I_J9_,O'=_
MCXK%WS.[P5C=;2*4Z_4MN-M.7'AK:OS5C/.*_;KK2)K>*Z/\A]=^9^,=U^6V
M&>NUKKKEI'U<6D?WIR8^ZM(F.L1?MG376(F)B-\6B6%
M
M
M
M
M
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MVC77YK];WZZ?O6GX1^4->VP7>@
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MS+HLN;+GR3FSVM?+:=9M:9F9G\YF>LOI.,^8
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MB8G3X3\6)66.S
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MC%@
M
M
M
M
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MY/XN6)CX36^3NFG]F/LC6-=->K0-OQFX
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MZW,VF)GZN7)DUF(TB9[[3KI$1$:_"/@RTQ-U8
M                                              #">]^-/CCVE\_^
MYO0'2?8WZK>1Y'*?UWU5HFW_ *ED(?Q[-]?_ -08'(?,O(OQ_++)ZJZ?]CEF
MO!>RO8OB_P!/_5GG^;X[Z5)I3]+OMUM^RD_&M?I9:=M9_&L:1/Y.XV7D//\
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M;3,1]+-CR:S$:S$=EIUTB)F=/A'Q899D[8
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M&EHZQUK,QU9@8@ZH
M
M
M
M
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MJ4Q[>D:5K6(K6L1\(BL:1$?LB'QW+?4
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M/69GK,L6M:U[3:TS-IG69GXS/YR_9^'\
M                                                       :Z]B>
M('B?V[<37O:?C+T#V)D)YLQ=5Y7=.G^O]DS%%[L-<<N<R%OE\MK]UD[3)9:>
M*B2>YBEHGDEHIKYKYKIIYXV)X[[>]K>(XXP^+>3<_P =MZQCKV;?D-UAQS7%
M$QBI./'EK2U,<3,5I:LUBLS6(TF8=]L/*O)^*K%.-Y'?;?'$5CMQY\M*Z5_=
MB:UM$3%?A$3&D1K&FC0CL?Z'OJ\[&]V?_+I_0F5E^)3^J]<=A=BZQ[<%IZO\
M"+ ?U/?:;1\GBK\32_IG-Q7^..?<XY_BWSXY]]GW/>.Z8_\ 6+]?M8[ODWFT
MVF;6;?C.7Z-=Q\O]VOUNR/\ -T9OQ_NKV/L-*_K_ *^/K\N7%BO\?]MV1DZ?
MA'?I^Q'[V5^UL\7\S1<U]2^1W>6@74T-SS#3O.*T;M#&6EY+<>Y;\Q6F&Q75
MV0DQMK;\\Q^S)>5SU\_BKFX_/'/'._\ QO\ JB>S]G:M?+/'.#Y#%68U_37W
M.RO:L1I.MLE][2+VGKW1CBL=8C'\-,XX_P"Y'R/%,1RG'[+/6)C_  [9,,S&
MG7K:V:-9GKK%=/\ :H_.TOVN/E)@(LA<]0>0O2?9<-G\Z:ULMQQFX]6YO*VU
MM:536D%G;6-CV/A(<QD+JGV:(KG(P6D?-5-5=U33ZO3O_P 7_J@^K]_;'B\N
M\>YOC;W[8M;;WV^]QTM-M+3:;6V>2<=*_--J8;9)TF*XIG37.>-^Y#QO/-:\
MKL-YMYG36<<X\U:S,]9F9G%;MB.NL5FT_"*H\>S_ *,?M ZNXO+JZ\9\EO&&
MM9H8(LQUAN>A;WS?URXR3)R56>L8?9:M\XAM?8DMZY)L3#'5<T<1T55^[!S+
M(3QC[X_MB\HFF+%Y+CV.\M$S./>[?=;7LB+Q2.[-DP_I=;:Q>(KGM,4F;6B.
MV\5SSCO<WKGDM*UY&N'+,:]N;'DQZ==.M[4^GUZ3I%YG3K.FEM(Z^S.@N]NE
MJZ(NX^E>VNII)9K:WCC[,ZXW'0ZY+B]M[F[LX**-IPV*JKFN[6SFEBIX_FDC
MBKJIXYXIJYXD1XUY[X+YI6;>'<UQ/+5B+3,[/>;?=1$5F*VF?H9+]*VM6MI^
M$3:(GK,,]X[F^%Y>->)WFUW4:3/\'+CR=(F(F?DM;X3,1/Y3,?FQ*RQV8
M                                   #U6E[UN_6^QX[<.N]QVK0MMQ$
MT=QB=ITO8<OJVQXNXBECGBGQV;P=Y8Y.RFBGAHKIJBEIJIKHXYXY_/'#J^:X
M+A/)..R</Y%L]KO^)S1,9,&YQ8\^&\3$Q,7QY:VI:)B9B8FLQI,Q^+C;S9;/
MD-O;:;_%BS[6\:6IDK6])CX:36T3$]/SA/!XL?N.O.#I&N'#]W6NJ^5.F4S4
M5<T;A';Z'V38VL5O7'188?L/4</5CYH9KBKW9ILU@\Y>5\\<4T31T?RH)^TO
MZ<_I'S:MMYX3;=>*\S,?_D\SNMG:TSKW9-IN,G?$Q'RUKMMSML<?&U+3U:5\
ME]!>'<Q$Y>'G+QF[T_WO7)BF=?C;%>VOPZ1&/)CK^<3*R/XN_?O]?'D5\##[
M5V!>>-V\7?XHYP'><-OK^LR2\?*JFKM>T+*:]Z_M;.&."CGUY:]Q,TG,U-,<
M557%?%-<'M#["/N!]=_4WG%<?3R3A*?[[QDSES1'RZ1;96BNZM:9F>F#'GK'
M;,VO$3&L?_)/2'G7 ]V7;8(Y#9Q_>V^MK_A\<,Z99GK_ '*WB-.LQTUFEQV1
MQ^7Q]CEL3?6>4Q64L[;(XS)XZY@O<?D<?>P47-G?6-Y;5RVUW9W=M+3)%+'5
M51)15Q53SSQSQRACN-ON-IN+[3=TOBW6*]J7I>LUO2]9F+5M68B:VK,3%JS$
M3$Q,3&K4>3'?%>V++6:Y:S,3$QI,3'28F)ZQ,3TF)^#^Q\7X
M
M
M
M
M
M                       :W^0WE_XQ^*&$_7O(CNW0^K;>NSKO[/&9[+?(
MVO,6E%-YSS+KVDX>+);ELGJJQ\U%--A87-5<D?-%/'-?\K8_KWU#[-]K;W]!
MZ\X3?\IDB\4M?%CTP8[3V],NYR33;X?WZS,Y<M(B)BTZ1U9!P/BOD7D^;Z'
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M\ER/)7^KR.XS[C+K,ZY+VO.MNMIUM,SK:8B9G\?Q>\="X0
M
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M(C)IWXK:_"(RTFV.9_VO=W1^,1+;IJ1BP
M
M
M
M
M
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M$=?@W;M=IM=CMZ;/8XL>':8XTK2E8I2L?E6M8BL1^R(AYMV+D
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M$-;<AS'+<M?ZG*[K<[G)KKKERWR3KIIKK>TS\(B/[(T9.8RZX
M
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M
M
M
M
M
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M]/TS:)J7-M5[?MV&?R5A<5[CO%G35!'+[&;R=_:47-'$T,,-7X_%IOJ'[/\
MT7Z<^EON%XFG(>3TI$3O^0TW6?NZZVQ4O'Z?;6ZS7NVV'%DFD]E[WCXR5\5]
M4^%^)]N;9[6,_(Q&GU\_\2^OYUB8^GCGXQKCI6VG29F$7:3[8X
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MS,RP3+FRY\DYL]K7RVG6;6F9F9_.9GK+Z3C/F
M
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M68O2LQ'731M3B?)O'N>K%N&WNUW,Z?#'DI:T?VTB>ZO]EHB6 6?.[
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M^UFQA3IP
M
M
M
M
M                            &-^V.XNJNB=)R?8_<W8>G]8:+B/31?;1
MNV?QVO8FFYDCEDML;;7&1GA_4,QD/8JIM;*WXEN[N7CVX8Y*^>*><C\4\/\
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M R9+Y;VRY;3;+:9F9F=9F9ZS,S/69F>LS/Q?V/B_
M
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MKDR['-,?C:W?^KPVM'QTICPUGI'R];-L\/\ <?S^WTIS>QVVZI'][%:V&_\
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MYVGU.&WFVW5=-9^EDI>8^$_-6LS:LQW5UBT1,:Q$Q$RPFS5VX
M                   #WG6_:7973NUV.\]3[]N'6VY8WT\66SZ/L65UC-PQ
M4W%O=\VWZAA[JTN9;.6XM(JY(*ZJH9.8Z?73SQPZ+R3Q?QOS#BK\'Y7L-GR7
M#Y/WL.YPTS8YG2:Z]F2MHBT1:T1:(BT:SI,.%R'&\?RVVMLN3P8MQM+?&F2M
M;U^$QKI:)C729TGXQKT6+O#S]R]Y%]7T6NJ^7.CXWR.UCB:&.C?];_1NNNV,
M1:UW%'OR7UEC,5%H.\0V-C1Z+:WYL\'>2R\\R7.1FYY_A79[@_IJ^N_)[7Y7
MU)OLGCG)Z3,[7-]3=[');3I%;7O.ZVTVM.M[_4W..(TKCVU(:$\K^WK@.2F=
MSXMFMQ^YT_PK]V7#:=.FDS;ZN/6?C/=DK$=*XX6F_$3[.O"WS:M*(>D^XL/3
MNM/XXO.J-[]O2.T+2JJ7B/BJUU;,3T_U19\>[%Z[O"3Y2RAKGCBDFHFJ]KBK
MCVY]LON?TIEF_FO#YIX7^[OMKKN=E;IK\V?''\&W2VF/<UPY+16UJTFD=R-O
ME/KKR[P^VO,;2_Z/\,V/^)AG^V]8^2?C\N2*6G29B)CJW]:#8.
M
M
M
M
M
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MC^SC8<+ML6VVD?W:5B-9_.T_&UOSM:9M/XRP^R]VH
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M/FO>W7\>O5JO?<ER/*9OU')[C/N-Q_G9;VR6_P#?7F9_Y+WCH7"
M
M
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MV];7F(CKKDQ1K>FD=9G2U(_STQJ'C5
M
M
M
M
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MKBQV^EBTF8GMFF/MK>(TC2;]T]-==9F9W]:#8.
M
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MK'5N'A?*_&_(JQ;A-]MMS;36:TR5G)$=?WL<S&2GPG3NK&L1K\&M[8SOP
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M8M68B8F)B8U:3R8[XKVQ9:S7+69B8F-)B8Z3$Q/6)B>DQ/P?V/B_
M
M
M
M
M
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M8^%:Q&E>=\N\F\FOW\[OMQN8UF8K:VF.)GK/;BKICK^'[M8^$?E#9QK)CH
M
M
M                    #^/(X['Y?'WV)RUC9Y3%92SN<=D\9D;:"]Q^1Q][
M!7;7EC?6=S1+;7=G=VTM4<L4E-5$E%7--7'/'//#[;?<;C:;BF[VE[XMUBO6
M]+TM-;TO68FMJVB8FMJS$36T3$Q,1,3J_>/)?%>N7%::Y:S$Q,3I,3'6)B8Z
MQ,3UB8^"+3R,^E7ZY?)*WNYLSX_8'JK9[B&]H@W3H3V.ILQ:7%_13Q/D:\#@
M;2KKW.9+B:BF:F;*X3(5<2\5<\_GB27B247KK[T?N+];Y*4V7D&?E>,K-9G;
M<IKO\=HK/2D9<MOU>*FDS6:X-SBCMTCXUI-=D<![>\^\?M$8=]?<[:)C^'N?
MXU9B/P[K3]6L?AI3)7I_9&D%?D9^ULW.QN+O*^)_D=@=AQ]<U[+;:5WWBKS7
M<Q96<==,EC;T=@Z'BLYC-AR4\%54=7,FOX:#B6.FKU<42\\0SF]=?U1.&SXZ
M;7VMXYGV^XB*Q.YXN]<V.UIC2TSM-U?'?%2)TF--WN+=LS&DS6._<_ ?<CM+
MUC%Y/Q]\>32-<FVM%JS/XS]+):LUB)Z],N2=)^&L=8&/)3ZRO.CQ,_4KWN;Q
MUWS':IC/U*:?L35+*+L#KJ/&XW_$JRU_N.E39S$:Y9W5IS[\4>6KQ]U[7%?K
MAHJBFICG?ZV^YCT;[8^G@\-\BV&3E<O9$;3/:=KNYO?I].NWW,8LF:U;?+:<
M$9:=VFEYBU)MNSQ[V)X9Y/VTXG?X+;JVFF*\_2RZS_=C'D[;7F)Z3-.Z-=-)
MF)B9T/;V9H                            WP\1/LM\S?"&6BRZ&[CS&/
MTBN\XO,AU3ML,&Z=7Y"N2[IO;[F'4\[Q<PZS>9>:GCB\O\')B\G<4<<4U7/I
MXXX:)]N?;7Z:]VUG-YWP^')S<4[:;[!,[?>TTKVUUSXM)S5QQ_AXMS&?#2>L
M8]6%^4^O?$O,8[^;VE+;S32,U-<>:.FD?/73OBO]VN2+TC\*K:/A)^X\\9^[
M_P!(TKRHPW^6?L:Y]BT_JWW[O/=*9R]K],?O?KWM5YW0?D2\\U>WE8I\?;1\
M?F3)\\JG?=?].;V5X1];FO5N;_67QVNMOH:5Q<ECK\=/I:_2W6D?C@M7+>?W
M=M",'F'H'R'A^[>>-7_F.PCKV:17<5C_ '/[N33\Z3%I_#&L4Z_L. VS"8O9
M=5SF'V;7,W9PY'"[!K^3LLSA,OC[BGUV]]B\KCI[FPO[.>G^-$L4E=%7'^CG
ME7AR''[_ (G>Y>-Y7!FVW(X+S3)BRTMCR8[Q\:WI>(M2T?C6T1,?C#0N?!GV
MN:VWW-+X]Q2=+5M$UM68^,36=)B?V3#[#AOD
M
M
M
M
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M(?(\OU><WFXW,ZZQ%[S-*SII\M.E*=-?W:Q\9_.6PC7SH@
M
M
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MJS'QB:SI,3^R8?8<-\@
M
M
M
M
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MS)GBN(XS@]E3C>(P8MOL:1TI2L5CX:3,_C:TZ?->TS:T];3,]6,63.Q
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MXQ37I'Y1IMHU.Q<
M
M                                                  !H=Y*?63X+
M^67ZE>]S>.NAY#;,G^I33]B:G92]?]BUY+)_XE>6O]QTJ;!Y?8[RUN^/?BHR
MU>0M?=YK]<-=$LU,F]O6WW,>\O4_T\'AOD6_Q\5B[(C:9[1NMI%*=/IUV^YC
M+CPUM7Y;3@C%?MTTO$UI-<U\>]B>9^,=M.)W^>NUKIIBO/U<6D?W8QY.ZM(F
M.DS3MG3328F(F*]_E%^UT_\ H_.^''?G_P V:WZZ\@8O_P!5JF@L>R]&P/\
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M]KFMM]S2^/<4G2U;1-;5F/C$UG28G]DP^PX;Y
M
M
M
M
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M$_&-4GZ,;7(
M
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MX/>;?<QIK,4O$WK&NGS4Z7IUT_>K'QC\X:]M@N]
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MK,3$Q,3I,3$]8F)Z3$]8EI"U;4M-;1,6B=)B?C$_E+]GX?P
M
M
M
M
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M.1S9=QN[?&^2]KWG^VUIF9_RR]@Z=Q
M
M
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MF"NYVF2F7;7C6MZ6BU;1\-8M69B>O3I+X+G/L
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M5)W_  T1K];#6=:Q_P ]Q?-;'^<S$WQQ$Q_$UUB)DT.6I@
M
M
M
M
M                                   &@?G!]EGBGX":SSD.ZMW^=O>0
MLZ[G4^G-*C@S_9FU5<5PTT248GBXM[#6</Z9N9.<CF;G'V5=$4E$$DUQZ+>O
M?GI'[;/:GOOD_P!/X7L?I\%COIGY#<S.+9X/CTG)I-LV3II]';TRY(FU;7K3
M'W9*YQX=Z]\F\WW'9Q&'MV59TOGR?+AI_P MI,WM^'9CBUNL3,176T4H_/\
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MZZ32FG?I^$Y)O:/\YOXT&P<
M
M
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M_#6VFN.TST[,D4M,Q/;%JZ6F0E'U@H
M
M
M
M
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M#!@VN&NWVU*8]O2-*UK$5K6(^$16-(B/V1#X[EOJ
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M0?)\KR?-;RW(<MGR[G>W^-\EIM;3\(B9GI6/[M8TK6.D1$,D,<=>
M
M
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M+1,1%+G_ !OG/&-]/'\[MLNWW$3.G='RWB)TFV._[N2O^VI,Q^'QZ,_,!=&
M
M
M
M
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M,4Q'=:(UODFL:1;)>?FO/6=-9TC68K$1T:TMDLA
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M<MIMEM,S:TS,S,S.LS,SUF9GK,SUF6H+6M>TVM,S:9UF9^,S^<OV?A_
M
M
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M-M_U7 [O!N<6D3,4M\]=?AWXYTR8Y_9>M9_8U[;!=Z
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M?&)K.DQ/[)A]APWR
M
M
M
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MYEK&]Y^LZ_7R1TI/Y8<>LQ33_.F;9)G6>Z(F*UAM3%;8
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M##$X\7QUTF(F;7T_#ZEKS'YZ]4C:.C 0
M
M
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M;'\:3^=H[L?6/GUUK$QJ'C5
M
M
M
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M:QBCY,5?R[<==*](Z1:8FWXS:9F9G<9IYB8
M
M
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M9V')VB/X>>8K6;?E3-_AVZZ16+32]M8BM)G6(AA3+;;
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MSQ/?SQW.[>^'/UFLSUIDK$Z=V.\=+5_LG6/A:(GHV0:X8^
M
M
M
M
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M=;Q-'POUQXSX/AUXO%W\E:D5ON,FELMOSBL_#'29ZS2FD3I7NFTUB4=:0[/
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MNXR1/RUF=*4U_"F.NE*?\K$3/XS,MEFM6/
M
M
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MQ/6)B>DQ/P?V/B_
M
M
M
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MDB?EK,Z4IK^%,==*4_Y6(F?QF9;+-:L>
M
M
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MS$372T[^-!L'
M
M
M
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M/5%;R;S/R7R_<?J.?W63-6)UKC_=Q4_#Y,==*1.G2;:3>T?O6M/5MHU,Q<
M
M
M
M                    !I/Y=_7CXD><&$KL._NI\/F=CBL^;/"]F:_Q3K/:
M&NT4T\\6_&+W/'14W]U9VM57KHL,A3?8RJO^-=M6W5ZC^X7VUZ1WL;CP'ELV
M'CIOW9-GE_C;+-^??M[SVUM;X3EQ?3S:=*Y(9AXMYWY1X=F[^#W5Z;>9UMAM
M\^&WYZXYZ1,_YU>V_P"5H5%?-O\ ;A^3'2'ZONOBOF?\S'7-M[]W_27L6F![
MKP=E1ZI/9_0?=HP6_?'BXXI]S%2P9"YDY_$>,XX6W>E/ZC/K7S?Z/"^TL/\
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ML]Q?:;S'?%NL=IK>EZS6];1TFMJVB)K,?C$Q$P^\X#X
M
M
M
M
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MVSV]-IL\=,6UQUBM*4K%:5K'2*UK6(BL1^$1$1#X+G/L
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MQ/+/-+S',[F8V.NL8,>M,%?QCY(F9O,3\+9;7O'PBVG1OZT&P<
M
M
M
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MCUG'>.FD6_''?28UI?XSKV6O6.Y(TCHP$
M
M
M
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M:<-:?\##,Q%H_++?][+^VLZ8YG2>R)B)2WHEM7
M
M
M
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MLUIV',WZ1BS3';:?RQYHB*6_*(O&.]I_=I/Q0MIG-N
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MFMHG28F)C28GK$])?2<9\P
M
M
M
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MLS/Q?V/B_
M
M
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M?.=G:NTR6M^EWN*+6V>[I7XVP9IK$=]8F)R8+Q7-B[JS?'%;TM:$_F'A'/\
MA/(?H>9Q3&*TS]/-76<66(_&E](ZQT[J3I>NL:UB)K,[I-,,1
M
M
M
M
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M'HW9<+V<QYA7'N>5CK7!TMAQ3UCY_C7-?28F.G92WP[YB+16.69I$@
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ME>7Y/G-[?DN7SY=QOKSUO>TVGXZQ$?A6L:_+2L16L=*Q$=&3F,NN
M
M
M
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M?\LV<;S@MSCS4TB;5B=,F/7\,F.?FK/X=8TG^[,QU:QMF,B
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MN%'\
M
M
M
M                !I#YQ?8+XX^ '7<>[]X[+-7G,S#=<Z'U?K/%E?\ 8G85
MU9W-C:WM&NXB\O;"UAQN*JR,4E[?WD]O9VT?/X]=<]<4,N[?2'V_^QO?OD,\
M)X/MHC8X;5_5;W-W4VFTK:+6K];)6MK3>_9:,>+'6^2\]>V*1>]<Q\-\&Y_S
MC?\ Z/AL<?1I,?4S7UC%BB8F8[K1$SK;28K6L3:9_"(B9CG]_8+]H7DC]ANX
M\7G8V7_HWJ?"WDEQHW1^JWLM.G:W[D%E!7?YB[]BSOMXV2>JQXEYO\EQ7\:2
M66FRBM()*H5_/V__ &P^N/M[X?Z/CN']9Y7FI$;GDL]8_49M)M,5QUUM7;88
M[NWZ6'3OBM9S7S7K%TXO!O7'C_@FT[-A7ZO)WC3)N+Q_$OUGI6-9C'2-=.VG
MQB([YM,:HWTC6?@                 )F/KO^DWRA\[/T7?\O#_ &)\=KWV
MKS^ZNYXF[GRVX8VKY-'YZKTSUV5SMGKN8::*K^ZN<=B:(JJZX[FXEB^+)#?[
MA?O5]8>B_K<!LY_GOL.FM?T.WR5C'M[]/^';CYHP=)F?I4IFSS:(K;'CI;ZM
M=2^>>W_'/"^_8XI_6\]'3Z..T17'/3_&R=8IT_NQ%KZZ1-:Q/=%WKPH^M[Q3
M\"]4@Q/277UG)NMS9QP;5W#ME$&>[0VVXYMX+>[JNMBN(>/Z?P]S\>FK])Q$
M=ABJ*^.9/C\S5RRR4E>ZON.]J>^.5MN_->0O'"UO,X./P3.+98(UF:]N&)_B
MY*ZS'U]Q.7/,?+]2*16E8>>7^P/)O-MS.7F,\_HXGY,%/EPTC76-*Q^]:-?W
M[S:_X=VD1$;X-$L*
M
M
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ME]COMER>TIO^.RX\^RR1K2]+1:MHUTZ6C6)TF)B?RF)B>L/'NW<H
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MPRTQ-U8
M
M
M
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M6B
M
M
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M#F[1$=F2T?2R6G2-,629B-;3/RTO%;3,]M>^>J#%.-N4
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M/O6?.^![F;[F/K\+>^F/<4B>V=9MVTR1_O>32-9KUK/]VUM)TE%1@:X
M
M
M
M
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MQ$1$1$:1$1'2(B.D1'2(2<K6M*Q6L1%8C2(CX1'Y0_%^W]
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M1%YKGN8\BWUN1YO<9=SO+3/S7GI&O72E8TK2OY5I%:Q^$0S,PUU(
M
M
M
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MCK&D=GS9(^.MXU[;3:K=&P
M
M
M
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M\\VGXXJQBVT5BD3AO>MLMX8^=^WO)/,[7V>*T[+@+1I]#'/6\?GFR:1-]?\
M-B*XXC2.V9B;6F30Y:F
M
M
M
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M[??XICNI>-)C6-8G\8F)B=8M$S$QUB9ADYC+K@
M
M
M
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M)R?+9LFXW^6=;7O.LS^41^$5B.E:Q$5K$16L1$1#)#''7@
M
M
M
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ME^CY6G=M+S;Z.>O^'EK'XQUGMO&L=V.WS5GK'=6:WMO@T2PH
M
M
M
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M?C. X['Q/#X:8./Q1I6E=>GXS,S,S:UIGK:UIFUIUFTS+%;*79
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MV?CVO3!6W7)I,S%LUHTF_P"$_3_PXF(G2;1WIDT.6I@
M
M
M
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MI%<L1%=?EO%9FO?.V@LTN
M
M
M
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MI2)F=*4BM:ZSI$,P,0=4
M
M
M
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M$_&)_*7[/P_@
M
M
M
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M%Y'Y?2+<Q6W=BV\S6U,6G[M\FFL7RZ]:1$]F/I,]V33Z=7!:"D@
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MR>M^(\<^KLN"F-+6UTSYXGXQ::S_  \<_"<=;3-XU[[36TXXL1J\FAP
M
M
M
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MF)B7O'1.$
M
M
M
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MN"G*\S7'N/*+=>[]ZFWB8F.W%K\;S$SWY-/]K32L3:\#Z=C=(
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M
M
M
M
M     (TOL(^K#QI^P[68JNP<5_0O<.%L^+/4.]=.QF/IW;&6D5=4L&!V6.7B
M"'>M/CFKKJHQU])Q5:52RU64]I)/-7))3[??ND]E?;UR<QX_E_7>(9K]VXXS
M<7O^FO:>DY<,QK.VW$Q$1.7%&F2*TC/3-6E*UV%X+[*\A\$W$_H;?6XJ\ZWV
MV29^G,_YU/C]/)_MJQ\VD1>MHB(BA!YU_7!Y,_7[O,FO]RZE-?Z%E,E59Z%W
M1K,%Q?\ 6V]121W=S:V]ME>*.:M>VKXMA/5<83)<6^1BX@DECHGL^8;N:^;T
M7]QOK3W_ ,''(>';N,?/8L?=NN.S3%=YM9B:Q:;4_P!]P=UJQ3<X>_#;NK2U
MJ9N_%2;7A?G_ ([YSL_K\3EBN]K77+M[Z1EQ_")F:_WJ:S&F2FM)UB)F+ZUC
M0EOEFP               "3CZX/M+[[^NO>I)]4F_K_I;9[S'<=A],;'D+[C
M"7MM!?QS7>?TBYHGYHTO?*;&N>&.]HBFM+CB7CB]M;KB*#V8S?<;]KG@?W$<
M%%.5C]!YIM:7_2<CAI7ZE;368KBW,:?Z1M>[MM..;5R4[9^CEQ3?)WZ[\_\
M6W">>[+MW,?0Y?'$_2W%(CNB=.E<D?[YCUTF:S,6C3Y+5UMKT-/%+RZZ%\U.
MI\;W)X^[I#MFKW,W&-S6/N;:7%;3I>RQ6T%SD-2W/7[K_6L-GL=3<4_G\<RV
MEW%51<6<]S:2PSR>>_VKZD\\]+^5Y/#O8&RG:<I6._'>)B^#<X9F8IGV^6OR
MY,5])_S<E+1./-3'EK?'6"7DWBW-^(<G;B>=PSBW,1K68GNIDIK,1?':.EJS
MI^RU9UK>M;1-8V6:U8\
M
M
M
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M2=WN]SO]SDWN]R7R[O+>;7O:9FUK3.LS,SUF9EZ1UKC@
M
M
M
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M6<W&7G^%N:UF,>3768B>LQ3)$1/=CFTS&DS6;4TM,BB.[ @
M
M
M
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MOQ^E@K;NMBV])FF/OM,S?):^2\]_"/ N#\$XZ=GQ=9ON\D5G-FM^_EM$:?\
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MZ9<\=8GZLUGICM$_X,3-9^-YM.D5GM0-:3
M
M
M
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MR])MBFTSICS1'6)B>D9-(I?6O6M[=D32H8-1
M
M
M
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M?I8:Z_3Q1.D3%8GXVG2.Z\ZS:?RKI6-Y&CV&@
M
M
M
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MXNNL7^:U(B?J3I'?:QJKJ:#
M
M
M
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M5GWX[X[Q/BW$XN&X;%&/9XX_MM>T_O7O;IW7MIUG^RM8BL5K& 6?.[
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M=>
M
M
M
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M#7NMGV]>OTXUF9R88_YG'][''^'$=U?DUBEKE52C,
M
M
M
M                       BU^T/[0^J_KEZKXN;GC&[OY!;OC;O^T?4?RZJ
M>;GFFJ6TYWG>>;26.]PW7N&O8ZJ:JJ:H[G+W,=5G9U4\TW5U9RB^V'[8?*?N
M+\I^GC^IL?7^QR5_7[_M_=^%OTVV[HFN3=Y*S$Q$Q-,%)C-FB=<6+-LGUQZX
MY+S[DNVO=AX/#:/KY]/A^/T\>O2V6T?VQ2)[[_W:WYT/>?>?:GDEVIM_='=&
MWY+=^Q-WR562SF<R55-/%/%--,-CB\78PTQV6&P.&LHZ+:QL;:B.VL[:.B**
MBFBGCAZ)?!O!O%O6_BVS\,\,V>/8^.[''V8L5/\ 9M>]IUMDRY+3-\N6\S?)
M>9M:9F9E/7AN&XWQ_C<7$<1BKAV&&NE:Q_R;6GXVM:>MK3K-IF9F=6)66.T
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M3;+:9FUIF9F9F=9F9GK,S/69GK,HNVM:]IM:9FTSK,S\9G\Y?L_#^
M
M
M
M
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MM;1,1-#C>3X_F-ECY+B\U,^QRUBU;TG6)B8U_MB8_&LQ%JSTM$3&C'K('.
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MRUFN6LS%JS$Q,3$Z3$Q/6)B>DQ/6)1(M6U+36T3%HG28GXQ/Y2_9^'\
M
M
M
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M*)FNOS7FTQ7LG;06:7
M
M
M
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MU;1,6K:)TFMHG28F)C28GK$])?2<9\P
M
M
M
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MOC_&XN(XC%7#L,-=*UC_ )-K3\;6M/6UIUFTS,S.K$K+':
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M))D;FO@
M
M
M
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M1:EH_&MHB8_&$*L^#/M<UMON:7Q[BDZ6K:)K:LQ\8FLZ3$_LF'V'#?(
M
M
M
M                             !%K]H?VA]5_7+U7Q<W/&-W?R"W?&W?]
MH^H_EU4\W/--4MISO.\\VDL=[ANO<->QU4U54U1W.7N8ZK.SJIYINKJSE%]L
M/VP^4_<7Y3]/']38^O\ 8Y*_K]_V_N_"WZ;;=T37)N\E9B8B8FF"DQFS1.N+
M%FV3ZX]<<EY]R7;7NP\'AM'U\^GP_'Z>/7I;+:/[8I$]]_[M;\Z'O/O/M3R2
M[4V_NCNC;\EN_8F[Y*K)9S.9*JFGBGBFFF&QQ>+L8:8[+#8'#64=%M8V-M1'
M;6=M'1%%1313QP]$O@W@WBWK?Q;9^&>&;/'L?'=CC[,6*G^S:][3K;)ER6F;
MY<MYF^2\S:TS,S*>O#<-QOC_ !N+B.(Q5P[##72M8_Y-K3\;6M/6UIUFTS,S
M.K$K+':              ))OKD^L;OK[$^Q(L?I-A-J?2^M9ZPQW:_=F5MXJ
ML#J-O-;5Y&?$X&RGN;2XW+=KG'QT^QCK/FJFWKN;>2^EM+::F?F-_P!Q?W->
M!_;QX].XYK)&[\SW."U]CQM)GZNXF)[(R9;1%HV^VB\SW9LFDWBF2N"N;+2:
M-?\ GWL7A/ MA.3>6C+R^2DSAV]9^:\ZZ=UIB)C'CB?C>WQTM%(M:)AT.O$+
MP[Z,\'^G,1TGT-KDV)UVQFKR6=V#,RVF0W3?-EN(XXK[;=XSMI8XV/,9Z\CA
MHCX]N"WM+6WCCM[6""VBCAH\]GMWW!YS[N\QS>:^>;F,O(WCLQ8L<6IMMKAB
M9FN#;8K6O./%69F>MKY+VFV3+?)DM:\P1\J\KYGS'EK\QS>2+9YC2M:ZQCQT
MCX4QUF9[:Q\>LS:9F;6M:TS,[1-7L;
M
M
M
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M8GK$Q+TCK7'
M
M
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M"(B(B*UK$=*UK$5K&D5B(948LZP
M
M
M
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M)B8F$'-WM-SL-SDV6]QWQ;O%>:WI:)BU;1.DQ,3UB8EZ1UKC@
M
M
M
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M._W.3>[W)?+N\MYM>]IF;6M,ZS,S/69F7I'6N.
M
M
M
M
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MM-SL-SDV6]QWQ;O%>:WI:)BU;1.DQ,3UB8EZ1UKC@
M
M
M
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M3%2E*V"^.^.\3XMQ.+AN&Q1CV>./[;7M/[U[VZ=U[:=9_LK6(K%:Q@%GSNP
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MN6TVRVF9M:9F9F9G69F9ZS,SUF9ZS*(EK6O:;6F9M,ZS,_&9_.7[/P_@
M
M
M
M
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M'
M
M
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MV
M
M
M
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M;1.DUM$Z3$Q,:3$]8GI+Z3C/F
M
M
M                                                  P;Y)>1?5?B
M?TKO7?G<^;FP>@:#C8KW)R65I5D<QE+Z^N[?&8/7<!C:*XN<AGMAS-Y!9VL=
M5<4/$LO%<\L,%$LU&<>M_7?E/M;S38^!>&X(S\_O\DUI%K=F.E:UF^7-EOU[
M,6+'6V2\Q%K=M=*5O>:TMW/C_ \EY/R^'A.(I%]]GMI&LZ5B(B9M:T_A6M8F
MUIZSI&D1-IB)YM?V,_8'VA]B7?=SVQO%O_3&F:[9W&L]2=8V5]->8G0M.YOI
M;STS2\TPPY?<,_-53/F<K[,4EY+'%%13':6MI;P>C_[=?0'C'V\>!U\4X2WZ
MKF=Q>,V_WMJQ7)NMQVQ7I'6<>WQ1K7;X.ZT8XF]YFV7+FR7L"\!\&XWP/A(X
MS9S]3=Y)B^?-,:6R9--/^5QU^&.FLQ6)F9UM:]K:!M^,W             ?M
M;V]Q>7$%I:0375U=316]M;6\5<]Q<7$]=,4,$$,5-4DTTTE7%---/'-557/'
M'''Y?C)DQX<=LN6T5Q5B9M:9B(B(C69F9Z1$1UF9Z1#^6M6E9M:8BL1K,S\(
MC\Y7;?IM^C+ ]0XS5/*?S1TV',]TS38S:>J>FL]3-5C.GN(>:;W%;3O>)XDH
MM<QV=75S1-;XV[HFMM=YXIDECJRO%/Z;2C]XOWQ;_P NW.[]6^F-Y.'PN(O@
MWW(XM._D-?ER8-KDT[L>RCK6^;'-;[OK6MHVLS^IA][8]RY^5R9?&O$<LTXB
M(FF;/7XY_P +4QV^-</X3>NDY>L1/TO\2T>J]1O
M
M
M
M
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MR6Q9:S7+69BU9B8F)B=)B8GK$Q/28GK$H4VK:EIK:)BT3I,3\8G\I?L_#^
M
M
M
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MO6YVV3Q?Q?),<+$S7-FK/7<3^-*3_P P_.?]]_\ B?\ B6=U9*.@
M
M
M
M
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MQ'U?\2[FI-0]
M
M
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MH4
M
M
M
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M@*H5%8
M
M
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M?Q_Q^]J>-4MI>\:Q;<VB?C/PF,,3&M*3UM.E[QKVUI8C5Y-#@
M
M
M
M
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MQV=U9*.@
M
M
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MO;UN=MD\7\7R3'"Q,US9JSUW$_C2D_\ ,/SG_??_ (G_ (EG=62CH
M
M
M
M
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M,=I[HK:\]J!K28
M
M
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MB'7N+VWDYC+F\2\:R37B*6FF?-6>N>8G2V.DQ_O$3TFT?XWX?PO\2T&K#1R
M
M
M
M
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M^WZ628B(C)6/V1%ZQW5^%HK*ZBHUD
M
M
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MM,=+X<<_&*1.M<E_[_6E?DUF]MU4NB\
M
M
M
M
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MMB0
M
M
M               #"?D7Y"=7^*_3&]]\=QYW]!T'K_#UY3)RPT0SY3*W<DE%
MKB-<UZQFN+6C);)L>5GALK"WYECIEN9J>*ZXX_5)3FOKOU]Y1[2\RV'@GAV#
MZ_/<AFBE(G6*4K$=V3-EM$6FF'#2+9,M])FM*SI6UM*SW' <%R7DO+X.%XFG
M?OL]](_*L?&U[3I.E*1K:TZ3I$3I$SI#F@^?WG!V9Y^^1>S]X=@<_I>'H]_6
M^K=&AKBDLNO.L[+*Y&^UW6.+F&&#]7S''ZC)<9/(UT4UWV0GEKHH@M^(+:#T
MJ>@O2/C7H/UWM?"/'_XN\G3-O=S.L6W>\M2E<V;MF9^GC^2*8<,3,8L5:Q,W
MR?4R7L+\'\.X[P?@<?#;'YLO2^;)^.7--8BU].O;7I$4K_=K$1,S;NM.D[=3
M+P            %KGZ+OIHQ/:=IJWFQY7:Y\_0([RC+=&=-;!BKF.TWF>REH
MEL>S=ZL<E;10Y+0Z9J>),+C^.);?-U4\7-QSS84QPW]5/WR?>1N_%LNZ]*^J
M=S]/GYI./D^0Q7K-MM%HTMLMK:EIFFZTZ;G+\M]M$_2QZ9YM?!&;W-[9R\;;
M+X?XSD[=]IV[C/6T:X]?CAQS$],GX9+=)Q_NU^?6:725,2(P
M
M
M
M
M                                       #YN9PV'V/#Y77MAQ6-SN
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MB)M2\:6I;2.ZLQ+,S#74@
M
M
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M7+:;9;3,VM,S,S,SK,S,]9F9ZS,]9E"VUK7M-K3,VF=9F?C,_G+]GX?P
M
M
M
M
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MXL*L=A^S]6MX)8;[B\Q55$$67MH??YR&'HKXHMYKR"R]$-_O"^UW9?<#X?\
MS7@*4Q^TN*PS^AR6O].FXQ]W?DV6>9B:]M_FMM[V[?I;B8FV2F')FUU+[7];
MX?.N*_4[&(KY+MJ3]&TV[8R5UUMAO,]-+=9I,Z=M]-;12U]>BEKVP83;,!@]
MJUK*6>;US9L/C-@U_-8Z:FXQ^7PF9LH,CBLI8W%'\L]G?V%S'+%7Q_"JBOCG
M_9>>#D./WO$[_/Q7)8KX.1VV:^++CO&E\>3'::7I:/PM2T36T?A,3"!F?!FV
MN>^VW%9IN,=YK:L])K:LZ6B8_.)B8E]APWR
M
M
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MVO:9M:?QF9E!+/GS;K/?<[BTWW&2\VM:>LVM:=;3,_G,S,R^PX;Y
M
M
M
M
M                                               /!]H=7]?=T]?;
M9U5VKJ>'WGKS></<8':M5SUOS<8W+8VXYHK]-7HKBN+2\M+B*.XM;JWDBNK.
MZBCG@DCFCCDI[WQCR?R#POR#:>5>*[O-L?(=CFC+@SXITOCO'3\=8M6T3-;T
MM%J9*6MCR5M2UJSS>.Y'?<1OL7)\9EOAW^&\6I>LZ368_P"1,3&L3$Q,6B9K
M:)B9ASO_ +:_JAWGZZNQ(-GUJ;);IXO=BYZ>PZSWZ[XCDRNMYF:VO<K3UAO]
M5O'#!%M5EC+&XFL;RBB.VS=C;23Q4QS0W=M;>A;[3?NLX/[B/'K<9R48]E[/
MX[!%MYM:ZQ3-CB:T_6[769F<%KVI7)CF9OMLMZX[3:E\.7+._P!7^S=GY[L)
MVVXBN'R3;TB<V./W;UUBOUL6O]R9F(M769QVF*S,Q-;6AY3 ;6
M   6@_H.^V?GI+8\'X2>0^Q0Q=.[IGI:.FM_V#*9.OCK'=,[+;0P=?WE4_S+
M&QZ]V_+5>Y:U\?$M\1E[F:6:JJ"\DDM:Q/OT^T^/-N.S^Z_7NWM/F&RP1_,=
MKBI2/UNVQ1,SNJZ=MK;O;X^EX_B6SX*4I2(R8:URQR]V^L/YQM[^8<#CF>6P
MT_CXJQ'\;'777+'PF<M*])_>F](B(CNI$6N_J1T.@
M
M
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MS>]K3,S,S_;\(B-(K'PK6(K&D1#(3'W
M
M
M
M
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M3%;TK%F56DCP
M
M
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MS6K'@
M
M
M
M
M   &NOE9XN]3^8W1F[]"=R8.'*ZOM^-N*,?E(X+:O/:1M,=I=0Z_ONGWES%-
M3C-JUBZN>9K:3TU134<R6UQ1-:3SP2[$]5^S_*_3WG.Q\]\.SSBY39Y([Z3,
M_2W.";5G+M=Q6)COP9JQVWC6+5GMR8[4RTQWKWWC/DG)^*<SAYOB;S7<XK1K
M&L]N2FL=V.\1\:7B-)CXQTM68M6LQS6?._P7[C\ .\\ITUVQ;PY*QN89<YUS
MV'B8)(M;[)TNN[FM;/8,71))/)C,E!)%S!DL9-)7<8Z[IYI]4T%=O<W'I(]%
M>\O#O?O@^+S+Q2TX\]9C%N]IDF)S;/<Q6+6Q7F(B+TF)[L.:L17+CG72F2,F
M+'8-X5YGQ/G'#5Y;C)FMXGMRXK3\^+)IK-9^&L3\:7B-+5_"+1:M=+6YV7
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M,Z1IW8[Z?W\<VB-=(B]>V\:3-JUE717:T
M
M
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M?3QZ].[29UR7TB<DZS&O2ORUK$2'(],#
M
M
M
M
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M-9TM$Q&R#7#'P
M
M
M                %&[]P3]HG]]=ZR'A-TAG?=Z>ZLV2>/N?8+"O_5^Q^TM=
MOXX:-7B^3C(+NG6^K\O8STU20W%=IE,K7S+Q35'96D\EX']/_P"V#_4;@L?N
MOS;!IY?RFVB>.Q7^.SV6:LS]>=+S7ZV]QVK,1:D7P8(BNL6S9:5F3Z-]<?R7
M95\PYBFG*[G'_ K/QQ8;1^_TF8[\U9CI,=U*=.DWM$5CEF:1(
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MM7QK:WF*1K,?7O$S'U[1TZ:=,5;=:UF;3I:]JQ.&A$TX
M
M
M
M
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M>EH_"U+1-;1^$Q,("9\&;:Y[[;<5FFXQWFMJSTFMJSI:)C\XF)B7V'#?(
M
M
M                                                          !
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M?\2=8F;Q..8[:V[K7ZJ9&0
M
M
M
M
M                          !7Z^[CZD;3S1T6Y\@>A=?P]AY3=>8>:?*6
M5K9RV]WWQIV'L.?8T^\FMI:;>3?,+;P>G!7DT,DEU3Q3C9Y:(.;:6SG]]D_W
M9Y?3/.U\ \\W&;)ZNY#-$4M:T37B]QDMUW%8F-8VN29UW6.MHBDZ[FE9O]6N
M;>7I[VA;Q'>QP?-Y+V\;SWZ3,ZQMLEIZY(UZ_3M,_P 2L3$1_B1$V[HO0(N+
M>XL[B>TNX)K6ZM9I;>YMKB*N"XM[B"NJ*:">&6FF2&:&2GFFJFKCBJFKCGCG
MC\K\L>3'FQURXK1;%:(FMHF)B8F-8F)CI,3'6)CI,)OUM6]8M68FLQK$Q\)C
M\X?B_;^@           +7_[>S[4*]*SF!\ ^_-AAITS9\E39>,FTY&JWMN-9
MW+.Y6^O;WJ3*WM5-'-[C=[S.3]S7ZY:_>MLO7584\S47UI'9U3?U!?M:KS6Q
MS^_/ MO,\SM<?=S."FL_6V^*E:UW]*_W;[7'33=16.V^"(SSV3@S6S1E]Z^M
M8WF&_F_"8Y_5XZZ[ND:SWXZUB(SQ'X3CK&F73I--+])I:;W0U,J(X
M
M
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MEO7I2-(FM9^I$Q,4[K\"AA"4
M
M
M
M
M                              !4B^_GZD)]DBV/SQ\:=6O+S8X/Q?\
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M;PSE_P":<928\:WEY^GI\,.68FUL,S^4Z6MB_P!I$UZSCFTSGH.-,@
M
M
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M>;WO;XVM,ZS/Y1^R(B(B-(B(B(A[9TCA@
M
M
M
M
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M^,:SVVBU=9F-6US5+&0
M
M
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M-;^9BMI[<6/6>W%BC]VE8F9T_P Z\Q^]>;6TC72-QFGF)@
M
M
M
M
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M+36U;1,6K:)TFMHG28F)C28GK$])?2<9\P
M
M
M                             $;/VE?8)JWUZ>,V>[#YDQN3[BW2'(ZG
MT-IF1HNYK?/[S7;P\2YW+0VD5556JZ':WM.3R--<MK3=TQQ6-%Q#/>0U\21^
MUWT!RGW!^R\'CVF3%X?LIIGY3<4FL3BVVLZ8L<VG_'W5JSAPS%;SCF;9[8[X
M\-ZSL'UMX-N?._(J;#YJ\3AF+[G)&FM<>O[M=?[^28[*=)[=9O-9K28<T':M
MHV/>-GV/==PS>2V7;=PSV8VC:=CS-W+?YC/['L&0N,MF\WE;Z>JN>\R65R=W
M+//+7SS7)+)55SS^>7I4XOB^.X/C-MPO#X,>VXG9X,>#!AQUBN/%AQ4C'CQT
MK'2M*4K6M:QTBL1$+"]MMMOL]MCV>TI7'M<5*TI2L:5K2L16M:Q'PBL1$1'X
M1#X+G/L           _:WM[B\N(+2T@FNKJZFBM[:VMXJY[BXN)ZZ8H8((8J
M:I)III*N*:::>.:JJN>.../R_&3)CPX[9<MHKBK$S:TS$1$1&LS,STB(CK,S
MTB'\M:M*S:TQ%8C69GX1'YRZ'_TJ?5WC_ [IC^Y/:."L^?*SN##QU;S>3403
MWW6>DW5>+R5AT]CKZTR>3QL_L9+&19#-75K[5-[D?:AJYFBQ]K+SYZ?O2^Y_
M<>]O,O\ 5OQ?/?\ XJ^'S3^FK&L5WFYK%Z6Y"];4I>-:7MBV]+ZSCQ=UX[+;
MC+6((>WO8^3S7E_Y?QMY_P!6=I?^''PC-DC6)SS$Q$_"9KCB=>VNL])R6A-Z
MA*TZ
M
M
M
M
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M;Z?ORN JA45@
M
M
M      'E=YWC4>L]-VGL/?M@QNJ:3I.!RFS[5LF8G^-C,)@<+9RW^3R5Y+^*
MJN(;6U@JJYXIXJKJYX]---57/''/:\'PG+>2\SM?'N!V^3=\UO<],.##CC6^
M3+DM%:4K'YVM,1UTB/C,Q$3+D[+9[KD=WCV&QQVR[S->*4I6-9M:TZ1$?VRY
ME_V9^=NU_8#Y0[5V[?\ S,7UYA/=T[IK3YKFXKAUSK[%WD_-C>7%K+7S##LF
MV3559+*5T4\?ZQ-Q!Q55#;P_CTN?;1Z+XKT#ZPVOB6W[,OD.?3<<AN(B(G-N
M[UCNK%HZSAP1_!P1,_N5F\Q%\E];#_7GA>V\&\<Q<732V_O_ !,^32/GRS$:
MQ$_YE/W*?LC7XVE'ND$SH           !;1_;Q?5W_4^4P_V =YX+U:Y@KR\
MI\:-8R%'\N8V;%Y*O'7_ '#<TVV3IKHL]6OL?=X_$6MY;5<7%[5)?T\4?%LY
M9JG?ZA7W/_RS:YO0/@^?_OCGI7^<YJ?[WAO2+TX^NM.ML];TR[B^.\=N.*X)
MU^KFK2,/O?V/^FQW\'X:_P#I%XC]7>/[M)C6,$:Q\;Q-;7FL]*Z4Z]UXBYBI
MN1+
M
M
M
M
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M;8K3.L]^*9TUF9FU.V\];36LKJ*C60
M
M
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M.MIF?SF9F9?8<-\@
M
M
M
M
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MLQ:LS$Q+)#''7@
M
M
M     (QOM>^P+"?7SXO9O>K"XL[GNG?_ )^E]$Z]=6M-_#=;C79TR7FTY6RJ
MKHHDUO1;&>F]NO7_ (<]Q5;6G/XYNJ>>),_:GZ WOW ^S\'![BMZ^%\?V;CD
M\M;=DUV\6TK@QVTG3-N;1].FG6M(R98_PIAL7UEX-F\Z\CILKQ,<1@TR;FT3
MIICUZ4K/^?DF.V/QB.ZW]US3MAV#-[9G\YM6RY2\S>Q[-F,GL&P9K(S57&0R
M^;S-[/D<KE+ZXK_FGO+^_N9)9:^?XU5U\\_[+TG\?Q^RXG88.*XW%3!QVVPT
MQ8L=(TICQXZQ2E*Q^%:5B*UC\(B(6$8,&':X*;;;UBFWQTBM:QTBM:QI6(C\
MHB(B'QW+?4          !FSQT\>^T/*?N?1.A^G,%^O;]V!F(\7C(IJIH,7B
MK2.BNZR^Q[#?06]U)C=;US%P2WM_<<12516T-7-%$E?ICJPKV)[!\7]6^&[_
M ,[\QS_0X'C\,WO,:3>]IGMQX<59FL7S9KS7'BIK$6O:-;5KK:.HY_G>-\:X
MC/S7+7[-C@IK/YVGX5I6-8UO>=*UC6-9F-9B-9=.[PO\1^L_"'QYT7Q]ZO@]
MW&ZS9TWNS[+-#+;Y+?=\R%K:4[9O>6@FOLE5:7FPW]MQ71:TSRPV%K1#:0\^
MS!'QQYE/<WMKR7W;["WWL#R>VFYW-^W#AB8FFUVM+6^AM<<Q6G=7%6=)O-:V
MRWF^6\=][*Z?+O*.1\QYW-SO)3IDR3I2GQC'CB9[,=9TC6*Q/6=(FTZVGK,M
MJ&K&-
M
M
M
M
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MTTS5K$:Y,$=9M^<VP]9_'7'W1_=K"](HV0R
M
M
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MCZ\\+VW@WCF+BZ:6W]_XF?)I'SY9B-8B?\RG[E/V1K\;2CW2"9T
M   Z#?T6_617X4=*S]U=NZ[-C?)SO3 V5.>QF5@M^,CU9UM5=QYC#=>QT26,
M.3Q.>S<\5KD-EMZY>>.+VUL[:N.F3'\UR>?O[Y?N9K[J\TKX7XCN(R>LN#SV
M^E>DSV;[>=LX\F[G2TTR8L<3?%L[Q7_#OFRQ::[B(K!CW-[%CR_EXXCB\D6\
M=V5Y[9KKIFRZ=MLOQTM6L:UQ3I^[-[1,Q?2)YT$&E
M
M
M
M
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M\'3I$1^]BC2/DF:1W3BO9.&A$TX
M
M
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M#I:N/YNG?2R\\HY0S
M
M
M
M
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M,6K:)B8F)6![3=[;?[;'O=EDIEVF6D6I>LQ-;5F-8F)CI,3#S;L7(
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MU0
M
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M/-Y[-7DM_D\E>S?BFGF:ZNIZJN>*>*:*>.?33QQ3QQQQZ:>#X3B?&N&VOCW
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MBM8BM8B(B&2&..O
M
M
M
M
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MK_\ G_$?ZT\737F-CCGZD1\<NWC6UNGXWPZS>O6)FDY(^:T8ZQ?"43H6
M
M
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MZS69F5=%=K0
M
M
M
M
M                               !^-Q;V]Y;SVEW!#=6MU#+;W-M<143
MV]Q;ST51303PRTU1S0S1U<TU4U<<TU4\\\<\?A^\>3)AR5RXK37+68FMHF8F
M)B=8F)CK$Q/6)CK$O[6UJ6BU9F+1.L3'QB?SASH?NA^LZ]\!^_I=HZ[Q.2E\
M9.YLEDLWUI?4VU]=6'7N<N)KF^RW3V3S$L=<?,V#CXKGPG-Q-7=7F%II]==Q
M<6EY,]$OV9?<MA]]> QQGD67''LSAL=,>\KW5K;=XHB*X^0ICB8G3+.E=SV5
MBF/<S.E<>/+AHGMZC]AT\VX.-MO[5CR+:5BN6-8B<M8TBN>*_P"V^&32.VN3
MX16MJ0AA3+;;            =%?Z1?L6M_.'QFLM-WW-37?D5T)C<+J79$F8
MRE%[FM^P-%OS::OVK35/+5D+^;-V]K\;,32>NNG,0R2UU<4W<''/G=^]G[=\
MGI'V7?F.!PQ3UWSV3)GV<8Z37'M<NO=GV/2.RL8YMW[>L:1^GM6M8F<5](%^
MX? K>'>13N]E2(X'?6M?%VQI7%;76^'\H[9G7'$?W)B(_=E-6A<U"
M
M
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MO8E=OMY\'X?)/ZG)$3N[5G]VG2:X-8ZZY.ELFDQI3MI/=&2\1<W4UHE
M
M
M
M
M
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M,V+^/\[Q_DO#X.;XR\7VF>D6C\ZS\+4M^5J6UK:/SC\F#6<.Y
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MYPW(Y^*Y&DX]]M\ML=Z_E:LZ3I/PF)^-;1K%HF)B9B8ED)C[@
M
M
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M1"NW>[S=<CN\F_WV2V7>9KS>][3K-K6G69G^V7JG5.,
M
M
M
M
M
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MTKET^,SBG2MYC7^',6G2N.9BZJI<1#
M
M
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M;:X]M7K^[K\V68G32^:8BT](F*1CI.LTUF5%%IK4
M
M
M
M
M
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MU\
M
M                                            CJ^TGS@Q_@/XA[WW
M!:<V=UV9G?QU]TKAKNJ"J*][,V6ROOTK+W=I-#<47V'TNQM;G-7EO5331=PV
M'Q/<BKN*)*9$?:]Z1W'OKVYL/$,W?7QK!_I?(Y*ZZUV>&U>_'6T3';DW-K4V
MV.\3,X[9?J]MXQVK.>^M_#K^;^4X.*MK''4_B[BT:],-)CNK$]-+9)F,=9_N
MS;NTF*S#F5;#L&;VS/YS:MEREYF]CV;,9/8-@S61FJN,AE\WF;V?(Y7*7UQ7
M_-/>7]_<R2RU\_QJKKYY_P!EZ8./X_9<3L,'%<;BI@X[;8:8L6.D:4QX\=8I
M2E8_"M*Q%:Q^$1$+$,&##M<%-MMZQ3;XZ16M8Z16M8TK$1^41$1#X[EOJ
M        M3_MR/KDK[ WG_/KVS@89M'ZXR62PG0.,R4=O<0;'V3;1SXW/;]+
MCKJWFCFQO7\=Q5#BY_X<TY_GFXAJHGQM/*K+^HM]Q=> X/\ XA_$\\UYSD<=
M,G*WI,Q.'9S,7Q;6+UF)B^ZF(MFK^.U_AWBU-S,(U>_?/HV.R_U)XN\QO-Q6
M+;F8UB:8ITFN+6)^.736\?\ ,_EG6,BZVI91"
M
M
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M)W?^Q7_X8_YWSZS_ /EC]/\ _MCEO^Q!_P"J+]RO_F=S'_O,?_5#_BK]A_\
M@G=_[%?_ (9[;5?L\^NW<K>[N<1YK>--G'9S4034[5VYIVBW%=<E'N4U6EIN
M^4UZZOX>*?\ ;20421TU?R\U<<_P=)ROVR?</P^2F+=^%>2WM>)F/H;#<;J-
M(G3YK;:F6M9_*+3$S'6(T<3<^N?/-I:*Y>'Y&9F-?DP9,D?Y9QQ:(_LG27J_
M^<+\!/\ EQ>'_P#\<OTO_P"[JZK_ -7SWW_YC^7_ /W&Y'_Y&<7_ %$\W_\
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M-8F)C]DZOL.&^0
M
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M[XKVQ9:S7+69B8F-)B8Z3$Q/6)B>DQ/P?V/B_
M
M
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M,MLE[?G:TZSI'PB(^%:QI%8B(B(B(AD)C[@
M
M
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MVZZZ=TZ?&7;[78;'9=WZ+#BP]VFO92M-=-=->V(UTUG37X:R\@[=R@
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M#DQ]NNFG=W5C376--?CK&GQ9@8@ZH
M
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M0
M
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M>Y_.H\M\DG8["\SP6PF<>/29[<F3_?,NGP^/R4GKK2O=$QWS$3AH1-.
M
M
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M5B8CZ6+'CTB9UF([*QIK,S,Z?&?BQ*RQV8
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MB->6V6[VL:1/\;#DQ])F8B?GK7XS$Q'YS$_DS,PUU(
M
M
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M-;1_M;TFMZ_[6T,V,*=.
M
M                                                          \W
MN6X:SU[J&U;]NN9L]<TW1];SFX;;L.1JKHQ^"UG6L7=9K/9F^KCHDDHL\7BK
M*6>7FFFKGBBCG\<<\_P=EPW$<GY!R^UX'A<-]QS&^W.+;X,5.M\N;->N/%CK
MKI'=>]JUKK,=9AR-IM=QOMUBV.SI.3=YLE:4K'QM>\Q6M8_;-IB(_M<O/[!O
M,#/><WE?VCY"92+)8[ 9_)1X3K?6\I7#S=ZGUEKO%=AI^#N(K6XN[*WR4EEQ
M5?9&F"62"K*WEU715537QSSZ>OM^]0[#T=ZIXOU]M9QY-_M\<Y-YFIKVY][F
M^;<98FT5M-(MICPS:L6C!CQ5M$3&BQSP7Q7!X9XSMN"QS6V>E>[+>/A?-;KD
MM&L1,QK\M=8B>RM8F.C2UN=EP          "?CZ"/KO_ ,V?DC'WWV3A?E]"
M>->8Q>P2V]Y%[F/WSN*VEM,MH^F2Q<W-O\G#X#\4YS+4\TW$$E%O:6-S!7!D
M:N:(#_?O]PO_ !3^N)\"\;S=GGGDF&^*)K.E]KQ]HMCW.XB=)[<F7KML$ZTM
M$WRY\=ZWV\1.D/=_GG^K'C_\DX^^G-\A2U=8^./!.M<F3X3I:W^'3X3&MKUF
M+8XUZ!2@1!P
M
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MQ>+\0\6X6(CBN/V>"T3$]U<5._6)F:S-YB;S-9F>V9M/;\(TAK(V8R(
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M_L/2.M<<
M
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M^%JSIK$Q,V.^/\[Q_DO#X.;XR\7VF>D6C\ZS\+4M^5J6UK:/SC\F#6<.Y
M        6??VX'V 6G4/:^<\*.S,K\71>],Q3L/4.2N[B7FWP/<\=K:8^[U7
MVN8:HH;/LS!6<=,,M4M%,>5QEO!1'77D*JXZQ_ZC7H'+Y=XI@]T^-8N[G>"P
M_2W]*Q&N7CIM:]<^NNLVV>6TS:L5F9P9LE[6K7;Q6T<_?_@]N5XRGE_'5UWN
MRIVYXB.MMOK,Q?\ ;.&TSK&G6E[3,Q%(B;PJD1#D
M
M
M                 !58_<I>>=&B]=ZOX-];['-;[EV;#9;UW?5B;BXBEQ/6
M%M<W$>JZ9?W=OZ8J9M\S]E7>75KQ)[]&.QD?$\?QLC%S):;_ $V_1%N<\AW7
MO#R/;1;AN,FVVXWZD1,9-[,1.?<5K/73:XK1CI?3MG-FMV6^IM[=LE?M\\*G
M>[_)YER&.)VFWF<>W[HCYLTQ'?DB)_YG6>VMM-.^\Z3W8YTI2+IDO0
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M>4;WS#R'<<]OIF+9;:4IK.F/'7I2E?RTCK;32+7FU]-;2VN:I8R
M
M
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M:S,S/[9U?(<M]0
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M1K68M&L=:S$QTF&ML^#/MLLX-S2^/-736MHFMHUC6-8G28UB8F/V3J^PX;Y
M
M
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M%;U5W>Q_#LOA/E.?BM)_E]YG+M[=9UPVM/;$S/QM32:6G\9KW?"82'H],#
M
M
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ML3]2\3$ZVG'II-)UMHJG48
M
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M8\?Q_&;>-IQN##M]K$ZQ3%2N.D3\->VD1'PB/P_!XEW3E@
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MQRVG.;'<[:LSI%KTGLF?RKDC6EOC'PM/QC\X;+-:L>
M
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M'G70(
M
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M;O=;C?;K+OMY><F[S9+7O:?C:]YFUK3^V;3,S_:](ZUQP
M
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MI?8\=@ON(_WS-$YKZSIUB<G=%9Z1IV173KIIW6UC?2-9^
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M=)IAB(
M
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M6[Z1$1$5O%(CY)F9R4'VFP
M
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M<_ZU^36X_8W[N#X^;8Z:6UKDR?#+EZ=)C6.RDQ,Q-*]]9^>83DH/M-@
M
M
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M[
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MM/3K\&RS6K'@
M
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MPWR
M
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MQ'-[[7%BC7YJ4F/XN;36)^2ORUG\,EZ3I,1,.B\\[2!(
M
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MB(B.D1$=(B/@_C?9^@
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MGOL63#N\<Z6I>LTO6?RM6T1:)_9,0](ZUQP
M
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MJ/(
M
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MK769Z1"R#:;7;[':XMCLZ1CVF''6E*Q\*TI$5K6/V16(B/['FW8N0
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MO7K&F&MI[9F)^%KZS>T?A-NWX1"0]'I@8
M
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M_>O;3IW7FUOVL)LU=N
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M&6([\,_#28R5UIUUC2)F+==)B)UB-S6FV)
M
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MCO6?PM29K,?[,=)_&.KVSI'#
M
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M=ICDN0KKDT_N;>+:3K^/\:T32--8FM<L3ITUO8*,$,
M
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M1$:1$1'2(B.D1'2(;>K6M*Q6L1%8C2(CX1'Y0_%^W]
M
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M'S6B/SOA_P 6ND1K:8B]*Q\;IF4-FI0
M
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M<Z1_?K'\')/X_-2)QVF=(CZ>*/C9;15.HP
M
M
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M*4K'X5I6(K6/PB(A8[@P8=K@IMMO6*;?'2*UK'2*UK&E8B/RB(B(?'<M]0
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M>.-.GRUB(F?[UM;3K:TS.T35[&P
M
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M->*^M_$/#Z5GBMI2V]K_ +_ETR9YGX:Q>8TQZQ\8Q5QUGXS77JCW2"9T
M
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MC\:VB)C\8:*SX,^US6V^YI?'N*3I:MHFMJS'QB:SI,3^R8?8<-\@
M
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M_75W\S3>TM/Q&VX?UUQR7-A^H6_'ZA@\C[7/,<>8U[*QSV%['Q_U*[MI*/\
M<O+;Y_X3S7KCS7D_!?(J=G,<7O,F#)TF(MV3\F6FO6<>6DURXY_O8[UG\5;'
M.</O/'^8W/"[^--WMLMJ6_*=)Z6C_:VC2U9_&LQ+,#$'5
M
M
M              *)_P"Y/\Q[CMGR;UOQ2U7-0W.@^.6-M\IMT&/N:YK7)=Q[
MEC(+Z^HOJZ*>+.YFTO3[FTLXN**I*K.\OLC!)S3+[D<=Y_\ 3=].X_$_6>Y]
MJ\KAFO/^1Y)IMYO$1:G'[>\UKV_WJQN-Q7)DMK$1DQX]O>L37MM::'V^^)UX
MOQW)Y-N:3&^Y"TQ29CK&#',Q&GXQ]2\6M/P[JUQS'329K6K)$@@
M %LK]LWX.6^S;3O_ )T=A8&&ZQ6D37?5O1$>3M*):)-UO+2VN^P]^Q]%Q1'+
M%-K. O+;#6%W'[MO-)ELG'_+/9\<TU0?U+?>&3C>+V'HWQ[/-=UOHKO>3FEI
MB8VU;6KM-K?29B8S9:WW&6ENVU8P;:W6F:=8Q?</YE;;[;!X9L+S&7-$9MSI
M/^]Q,QBQ3I_GVB<EJSI,13'/6MUSA36B4
M
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M=ON=MN\?UMKDIEQ:Z=U+1:-8^,:Q,P^$YS[
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M,3VVK$]?@C]NMINMCN+[/?8LF'=XYTM2]9I>L_E:MHBT3^R8AZ1UKC@
M
M                                                  *!O[A+P%_R
MS^3G'D9UWKOZ=TEY,7EUF[_BR_\ 8W5.\O\ 6KW?,#1#S+/-9V>Y0QT[%:>N
MJF.NZN\C!;QQV]G11Q?A_3[]]_\ &7ZR_P"+KR+<?4\U\:I7'7N_?S\9\M=K
MEF=(BUMO,SM+Z1,Q2FWR9+6R9K3,WO17F_\ K%X[_(-_D[N8XZ(K&OQOM^D8
M[:_C./\ PK?CVUQVM,VO,J]ZP-O0          !<!_;*>;?_ '0?!+><O_\
M5/MOHOYD_P#ZE_<[2+'W*O\ U'/6EO'Q_P#56:I4-_4P]*?_ "O]Z<'A_P S
M8<GVQ_;^BW-M/^6VN2\__P!+2$5ON(\/_P #S39U_+!N=/\ \3DG_DX[3/\
MSN%P%4*BL
M
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MTK6/PK$0S Q!U0
M
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MXIX]XKM?TG [7%M\<Q\UHC6]]/QODMK>_P#RTS$?A$0UI;)9"
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MQW%]GOL63#N\<Z6I>LTO6?RM6T1:)_9,0](ZUQP
M
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M/;>EJVKK$=)A8]M-UM]]M<6^V=XR;3-CK>EH^%J7B+5M'[)K,3']KS;L7(
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M,0=4
M
M                               I"_N9O,7^X7=O7?AUJ&?^3J?1]G'O
MW9UA9U?FTNNW-NQG,>N660K]Z2.>\TGK^_JKAYCHCYAJV.ZCDYKJIXIBNU_I
MI>GO]7_">1]P\OM^WE>;O.UV5[?O5V&"^N:U(TB8KN=U6(MK,]T;3%:L5B=;
MS$^WCQ3]!P^?RO=4TW6\GZ6&9^,8*3\\Q^49,L====?I5F-(^-7=9\D<
M       N,_MH/ [X.)V?S^W^P_%QFOZEZMZ$L;RS_P!IB;.Y@QW8G95C<U5U
MQU?.REM<:U:54<42Q?#RM%?'-$L?/-/7]2KWM]?=[;T%P&3^'A^CO>4M6W^^
M6K-]IL[5^/RTM3>9(G6MOJ;6:]:6A%'[A?->_+C\'V-OEIV9MS,3_>F)G%BF
M/V5F,MOPGNQS'6)6Z52*+8
M
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MC;<#MJ8KS6(ODGYLV3]M\D_-.L]>V-*5F9[*UCHU%;;92
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MQ6B)K:)B8F)C6)B8Z3$QUB8Z3#,JVK>L6K,368UB8^$Q^</Q?M_0
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M3&K0^3'?%>V++6:Y:S,3$QI,3'28F)ZQ,3TF)^#^Q\7X
M
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M16^XCP__  /--G7\L&YT_P#Q.2?^3CM,_P#.X7 50J*P
M
M
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M6L1$=(9(8XZ\
M
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MF3':MZ6C\ZVK,UM'[8F8;#Q9L6?'&;!:M\5HUBU9B8F/SB8Z2^:Y+Z
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MHF90V:E
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MW=?6/>_75W\/<NK=PQ&VX?UUR1VU_P#I]QQ^H8/(^USQ))A]AQ4D]A>Q\?\
M5;2YDH_W3$//_">%]C^%<GX+Y%3OX?E-GDP9.D3->^/DRTUZ1DQ7BN7'/]W)
M2L_@ZKG.'V?D'#[GA=_&NTW.*U+?G&L=+1_MJSI:L_A:(EU0O'_N[2?)'I3K
M'O?KJ[^9IO:6GXC;</ZZXY+FP_4+?C]0P>1]KGF./,:]E8Y["]CX_P"I7=M)
M1_N7EJ\_\)YKUQYKR?@OD5.SF.+WF3!DZ3$6[)^3+37K./+2:Y<<_P!['>L_
MBK7YSA]YX_S&YX7?QIN]MEM2WY3I/2T?[6T:6K/XUF)9@8@ZH
M
M
M             !3F_<\>8OSLMU)X1Z9G_P VV$]/<G=UC9U?[?+7EM5CNI]:
MOKF&:B2GX.*N<IE[NQEIKBE^9B[G^%<4?/%PO],GT]]#:<M[LYG!_$S?][^-
MM;_F=;=^^S5K,:?->N#!CRUF+5^GNL?PO:$KOMT\4[,6Z\PW=/FO_ V\S_FQ
M.N:\1^V8I2MHZQVY*_"95%EMR4@          "YC^V4\)/T/4^P?.W><1^,C
MNGZGU)T5\R#\^UJ>(R47]SMWL/<IE@D_7-IQL.!M+B/F*YMOT?*PU>J&[_C3
M=_4P]V?KN6X_T7P>;_1]EV;_ )/MGXY\E)_1;:VFDQ]+!>VZR4GNI?\ 4;6\
M:7Q=(F?<1YA];=8/"]E?^'ATS[G2?[]H_@XY_'Y:3.2T3K$_4Q3\:K:*IU&
M
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MWC/BG9ON0K'(<Y7MGOR5_AX[1U_A8IUC6)TF+W[KQ,1:G9UA!NG W(
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MQ8]Q2/R^G;Z>3^[UU^IB^-NG;\M9UM,4SER*68
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MK#P
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M)QVG\HQPM]JB$5P
M
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MVC;LE;0UQSSX?3-6L;W+7M,?/N\VEE)Z..:OQQS@GL[V!POJOU_RWL+R&?\
MO7Q6SOFFNL5MER=*8-O2TQ,1DW&>V/!CF?E^IDKKI&LNE\CYW9^,\'NN>W__
M  ;;8IO,:Z3:WPI2)^'=DO-:5UZ=UHUZ.J%T[U/I/1/577G3/7&,_2-%ZPT_
M :3J]C75')<TXG7L=!CK>YR5S'%!^H9C(>SS<7MU53Q+=W<LDTGYKDJYY\M7
MF'E?->=>5<CYEY'E^MSG)[S+N<]NL5^IEO-YK2LS/9CIKV8Z1/;CQUK2NE:Q
M"M?E>3WG-<GGY;D+=^]W.6V2\_AW6F9F(C\*Q\*U^%:Q$1TADACCKP
M
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MF-9C!BR4PXK5UK;)ES]8O@A)O[>O"J[K=9?-=_6?I;>TXMM$_"<DU_BY.O\
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MV".[3<X,^.=)TC2,<YOF_.-<4=/\[MG\'/ >A9.\
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M#DP;W'.EJ7K-;1_DGXQ/X3&L3'6)F'O'0N$
M
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M)CI+)#''7@
M
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M:S$QAI/X](FV2:STZX[:3.DQ;O5'(M
M
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M_37>*_\ VS_^8_(-J^D__2=QG_U1_P!R9W-^>C9/T
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MS6MH9^Q?3_,>%VMR''=^]\=TF9R17Y\/PZ9JQTTZ],E?EG2>Z*3I$SAH1-.
M
M                                                *CG[F#P0M[[
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MQVM9^ANHKAS_ +,M*Z8[3_N\=>W\HG''XV6IU62-0
M
M
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MUC2M8_"L1#,#$'5
M
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MUB(B(B$XL6+%M\5<&"M:8*5BM:UB(K6L1I%:Q&D1$1&D1'2(Z0^:Y+Z
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M$7UC>_V]<=;=><9-[_O6UV62VNFOS7M3'%==?EF8M>=>O2LQ^.J@TOI3;
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M,TO7_;4M:O[6;&%.G
M
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M6=)F-8Z3,*V]SML^SW.3:;FLTW.*]J7K/QK:LS6T3ITZ3$QT?><!\
M
M
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M]V2LY+1TF)QXY^%ES=36B4
M
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M%/\ I>1G_JO_ -(?$_\ 9<?_  -G,>>F58F
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M1/CGFOBWE>/OX'>X<^329G'KV9:Z?&9Q7BN2(_VW;VS^$S#45MME(
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M)=_(\3W[[@(ZS:(_C8H_YY2OQK'_ #2D=OXVBB>%!-I4
M
M                              !3^_<U^$G_ '/O.W1L1_\ 4SJ3O3X<
M'_JO]L=WOO;I_P#5L#=W$G/_ -2H:5O7],_W7_\ +#T7SF;_ #]_QG=/]GZW
M;5U_Y7=8Z1__ %5Y2I^W?S#_ !_"]Y;\\^VU_P#QV./^1DK$?\\E3^6\I4@
M         +[/[</S%_OEXD9GQTV[/_.[&\8,Q!B<):W=7XO;WI3::9;S1[B&
M>:;W<E_2^=M<KB)*(H_;Q^/AQE%?/',\?'-#?]1GT]_J/[:P^Q.(P=GCOD^&
M<F2U?W:\E@TKN8F(C2GU\5L&XB;3KERVW-HCY+(3^_O%/Y-Y13G]K3MV'(TF
MUICX1N*=,D?L[ZS2\:SK:TY)C]V5BE7@T*
M
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M<]N]8R;C+,UK\>RD?+CI'^XI$5_;,3/QELLUJQX
M
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MON6UADIHOB=G6F O?SQ'317\3T22P15US1Q.^]OU[M_87VX<_CM3NY#AL/\
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MUCI%8B(6#[;;;?9[;'L]I2N/:XJ5I2E8TK6E8BM:UB/A%8B(B/PB'P7.?8
M       !U(_K5ZUKZC\ ?#_1;BVFLLA8] ]<YO-V-Q;6]I<8_8]SP%KNNRX^
M>&U_PN9K#/[#<PU5_GFN6JCFNOGFNJKEY>?N2\DKY;[]\OYW':+[>_/[O'CM
M$S:+X=OEMML-XFW72V+%2T1\*Q/;'2(5O>PN0CE/..5WM9B<=M]EK68F9B:8
M[3CI,:_G6L3I^'PCHW?:28<^;F,-A]AQE[A<_BL;G,-D8>;?(8G,6-KD\9?V
M]7/%54%[87L4]K=0\U4\<\TUT54_GC_0Y.SWF\X_<TWNPRY,&\QSK3)CM:EZ
MS^=;5F+5G]L3$OIBS9<&2,V"UJ9:SK%JS,3$_G$QUA QYB_MX?"WR&_7]JZ4
MM[SQ8[,R?JNX:M!LX\CU'=9+_&YY^;U3<W%I8X&SN*:HX^(=>N\-:P<1\2<6
M]=?,G$L[_3W]0KW/Z]_3\5YK:GE/C6+Y9_56FF_K3I^[OHBULMHZSW;NFXO;
M6:SDK$5[=U^*>]_+N![-MS$QR7'5Z?Q9TSQ'[,T1,VF.LZY:Y)G73NB--*K'
MF/\ 2[YT^'-QFLSF>M9NX.J<7#<Y"CMOIJ*^VW V^)@KHYDN=IUVFT@W/3)K
M&VGBJNZ[VPXQM%?-?%O>W-$4DO%IOIW[S?1GN''AV>SY*.'\JRS%/T'(S7!E
MG),=(P9NZ=ON(M,6C'&/+]:8[9R8<5KUK,E?$_;GAGE=:8<6XC:<G:8CZ&?2
MEIM/X4OK./)K.O;VV[_AW4K,Q")U*YLX                    !9 ^MW]P
MEW/XY?H?4WEWQLGD#TE;^Y98W?/E49#O+KVWK]NNUH_5LM=6\/:&MVDU,E/Q
M,K<PY6WCN/S#D:[>UM\;77)]QW]/OPWV+]?RSU'^F\?\UMI:^U[9IQF[F-8M
M/T\=9G99K1I/?@I;!>::7V\9,N3<QH#V!Z*XCG^_E/%OI['F)ZSCTTV^6?Q^
M6L3]&\]/FI$TF8ZXXM:V2+MW3'>'4?D1U]A^U.D>P-;[+Z_SWNT8[9=8ON+N
MT^3;<T\7>-OX*Z8;_$9BPJKXIN+*[B@N[>KGBF6.CG^"E#S/PCRWUYY!F\6\
MVX_<\;S^#3OPYJ]MNV?W;UF-:Y,=OC3)CM;'>.M;3"'_ "_#<IP.^OQO,8,F
MWWU/C2\:3I/PF)^%JS^%JS-9_"9948LZP
M
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M\SBNT
M
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MK%<58B*UB(B(B(TB(B.D1$=(B.D0L8K6M*Q6L1%8C2(CX1'Y0_%^W]
M    66/VU?AU_=CR8VWRLW# ?-T7QTP\V)T:ZNZ?]2N^Z]RM/AVEQ%!-#-:Y
M/^C-%GR%S)1SZ9++(9#&75'/%=%'*MC^I+[A_P!5/6NT]5</G[.<\BS1DW-:
M_O5XW;V[K1,Q,6I^HW,8J1/6,F+%N<5HFMI1[^X/RO\ EGCV+QG:7TWN_OW9
M(CXQM\<ZS&OQCZF2*Q'X6K7)6>DRO5*,T,0
M
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MTB=$8O+?9_E_F%K8^0W,X>.G73!AUQXM)Z:6B)[LG3X_4M;]D1'1):C6UZ
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M/-HG>[:D;?-'XQ?%$5BT]9_?IV7U^&MITB--(BU2B;(
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M^/<1XOQ>/A^%Q1AV6/KI\;6M/[U[VGK:]OQF?PB(C2L1$8'9V[H
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MK1$UM$Q,3$QK$Q,=)B8ZQ,=)AN2MJWK%JS$UF-8F/A,?G#\7[?T
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M-%%K$
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MZL>;;CZ,:;#>Z[G'I&D1]2UOJ4C2-([,D6TK'[M)I^<)@40FJ@
M
M
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MB^2VDZ:) V@&#
M
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M,3'6)CI,)Y5M6]8M68FLQK$Q\)C\X?B_;^@
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MCKM\F*)GK>+QT;!\1]G>6^&VKBX[<3EXV)Z[?-K?%I_M8UBV/^W':NL_&)5
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M3TE])QGS
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MAK$16*Y)_#^'U_..A$\_""P
M
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M"LNVP3IR'(3^GII.DUI:)G-?XQ.D4^3I\+9*3.L:PZ*3SP(&
M
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M36T3$Q,3&L3$QTF)CK$QTF$M:VK>L6K,368UB8^$Q^</Q?M_0
M                                        %]_]MGXPW'3OA5L/>N>L
MIK/9_*+=JL]8T31UV\M/676LF7U+2.+FUN+2&YHFOMAN]BR$,ON5P7&.O[26
M+CCBKFJ2AC^I#[.Q^8>Z=OX-L+Q?C/%]E]*TQ,3'ZW>1CS[G2T6FNE<5=IBM
M72+4S8LM;:S$16$OW ^1UY;R_'PN"8G;<;A[9_'^-E[;Y-)B=.E8Q5F--8O6
MT3^46(U>;0X       "-GS3^I[PP\YK?(97M#K>'5>T+J&JFV[GZT^'J?8E%
MQQ1Z(9<Y=16=SAMVABXXXIXCS5G?51Q\<TPUP\\^KB2/IC[K?<OH[)CVOC')
M3NO&*S\W';SNS[337K&*LVC)MIGXZ[?)BB9ZWB\=&P?$?9WEOAMJXN.W$Y>-
MB>NWS:WQ:?[6-8MC_MQVKK/QB5-_SK^A[S'\1KO.;;UY@+SR8Z-LO7>0;QUI
MA[FXW?7\;3%Q++SOO5=O+D=CQOP>(YZYK_%<YC$PVD/%Q=7-I5)S;QW$>C/O
ML].^V\6#B?(=Q3QKSB^E9VV\R1&VRWUTC]+OIBF&_=K6*XL_Z?/;):<>+'FB
MOU+2P\+]U>)^4UIM=_>..YF>DX\UHC':?^=YITI.O32M^R\VGMK6VG=,(:;3
M<(                  "9+ZR_N4[Z\ LQC=%V&;)=O>,E[DHZLYU;E;R*3,
M:;'>W6,CR>Q=5YJ^_%QB,E:8^RKYHPLUQ1@[R623FNBWN)>;RB'7W+_9SX'[
M\V>3G./C'Q'LRF.?I;VE9C'N)K6\TP[['7IDI:]HUW%:3N<=8K$6R8Z_1MJ?
MV)ZFX3SC%;>X(KM?(HK\N:L?+DTB=*YJQTM$S/\ B1'U*Q$:3:L=DW[/&;RG
MZ)\O^K\5V[X_]@8?>M3R'HM\C#:340[#J6;XAHFN=7W;79:^,IJVR6<<E-=5
MK=1T<RP5QW$%4MM-#-)0E[+]6^=>H?)\OB/G_'YMCRV/K2;1,XL^/68KFVV:
M/DSX;3$Q%Z3/;:+8[Q3)2]*PB\B\:YKQ7DK<7SF"^'=5ZQK^[>OX7QW_ ';T
MG\ZSTG6LZ6B8C81KYT0
M
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MM^<>-9/$O*=YP5HM]'%EUQ3/][%?YL=M?A/RS$6F/[T6B=)B8C<9IYB8
M
M
M            "LU^YC\KY>M/&CK_ ,6M:O?8V/R&V2K/[ES#<7<<]MU?UQ=V
M.1YL:X[?B*+_ (3;Q<8[TU22U456^,N8^8:_<XDBLM_II^J:^2^RN0]H\E3N
MX[Q[;?2V^L5F)WN\K:G=K.L_P=M&;6(K$Q?-BM%X[9K>0_V\^,1R/D.?R3<5
MUV^PQ]N/I'7-EB8UZ_YF.+_"/C>LZQII-&)>,F6           Z*/T(^(?\
ME>\#M2VK8+/V>R?)6\A[KVKF>Q^+?8K6<KCK>RZQU:J:6WMKV>SLM0AHRW-$
MU''-OD<Y>1T<UQ\45U>>#[\O;G_&?[VW?%\??N\;\:I/&X-+=U;YJ7FV]SZ1
M-JQ:VXF<&M9^?%ML-IB+:Q$#/=OE/^LGFN7;8)UX_CX_3TTG6+7K,SFO\9C6
M;_)T^-<=)G2=838H5M0
M
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M*I::VYCBXM$Z3$[O!K$_E/\ $?M_S>GGW_R'?,#_ .-H[H_]TI^/_6#]"?\
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MUOIKKIKVS.FNDZ:_'27D';N4
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M<=]>D:SVW^-+3/=6LKJ*C60
M
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M?M:Q]3!/T,_YS2\ZXK3^RE^ZD_&9^K7\*RN>J:$20
M
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M
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M*S?X3/[FL7^$3,3VZ3$3,?"6M+9+(0
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MYO/&YVFUP1>F3)K.?6;16*SDU^>NG=,SDBV368^?MZ15E6CI)
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MK,X_QR8HB9F8GY\=8UF;QK:MG=62CH
M
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MU_'16CO]EN.-WV;CMY7MW>WRWQWC\KTM-;1_DF)A[!T[B
M
M
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M:;5<(V
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MX^'WV&^ZM$?PKS./+K,=8C'DBMK::=9I%JQ^>DQ,Z*MYLS
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M$5T[[?;OD][EY'?WG)O<^2U[WG36UK3K:>FD1K,_"(B(^$1$/8.G<0
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M[S@/@
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ME>/GL%8C9\EBUG33IFQ16F3I$=.ZDX[ZSUM><D_A*Q>KM:$
M
M
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M_-\MNN>Y?<\SO=/U6YS6R6T^$3:=>V/V5C2L?LB&6F)NK
M
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M'M;VMN?-=S/$\3-\7B^*_2.L6W%HGIDR1\8I$]<>.?ATO>._2*3JH,M,
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MS%JVB8FMHF8F)B8G1NW'DIEI7+BM%L5HB8F)UB8GK$Q,=)B8ZQ,?%_&^S]
M                        /L:]K^;VS/X/5=:Q=YF]CV;,8S7]?PN.AJN,
MAE\WF;V#'8K%V-O1_-/>7]_<QQ14<?QJKKXX_P!EQ.0Y#9<3L,_*\EEI@X[;
M8;Y<N2\Z4QX\=9O>]I_"M*Q-K3^$1,OEGSX=K@ON=Q:*;?'2;6M/2*UK&MIF
M?RB(F9=(?ZAOKBP_U[^.-IC=EM,;>^0G:D.)VGNO8K>*UEFQ=]Q9<2XKK#'9
M&TO\G:WN!Z^JO+B#Y%O+[.0OY;BZIXXCDBHC\XOW<_<9O/N"]C7W/&WR4]?<
M5.3!QV&9M$7KW:7WMZ6K2U<N[[:V[+U[L6*N/%.MJWM: 'M/S_+YUS\Y-O-H
MX+;3:FWI.O6-?FS3$Q$Q;+I$Z3&M:Q6OQB9F6-%%K$             !0-_<
MM[Y_5?V(XC6(^/:AZP\>^N=3EBHRGS8ILAF,]O&_SW\EC3%%1A[R:QW*U@KB
MYYDKEAM8IN:_3)11'?A_37X'^5?;SFY.W6_)^0;S/$]G;,4QXMMM8I%M9^I6
M+;>]HMTBMKWIIK6;6F]]O6R_3>!WW,]9W._RW^&G2M<>*(U_O1KCF=>FDS,:
M=)F:]ZP-O0                    !,9]7?W#=S_7IG[72]@CS';GB_EKR:
MK/=27&7H@R&FW&2O>+F_W#JK(Y"*XAPN8BFEFN+G$5U0XK,UR2<3<VUS)1D(
M(>_<_P#9_P"&_<'L+<UQ\X>)]G8J1]+?QCF:;B*5TKM]]2DQ.3',16E,\1;/
MMXBLTC+CK.WR:H]C^J>(\[P3N\'9M?(ZQ\N>*ZQDB(TBF:(T[J_"(OUOCTC3
MNK$TMT$.@O(3ISR?ZRP/;_1>^X'L+0]@AAYARF$O(YKC%9&NQL\A<ZYLN,YJ
MXR&L[5BK?(0_,QE]'!>VM4E/$D=/JI_- 'GOK[S'UCY-G\0\YV&?C^=V\SK3
M)68B].ZU*YL-_P!S-@O-+?3S8YMCO$3VVG24&N;X+EO'.1OQ7-8+X-[CGX6C
MI:-9B+TGX7I:8GMO69K;3I+,S#74@
M
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ML1'7NFL]=-)Z4#S=*^P
M
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MCK7ORSCTGX6K7)7\U[!1@A>
M
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M WS#PSG/">3_ );S..([HF<>2O7'EK$Z=U+:1\.G=68BU=8UB(FLSN,T\Q,
M
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MS^I]3#TG3Z.3YZ1&OQ[-9QS/XVI9OXT&P<
M
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MW>\PSW;'!/Z?#UB8G'BF8FT3'QKDR3DR5_'MO$3\$HJ,#7
M
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M_P"#V$<7PNSXR(BL;;:XL6D3,Q'T\=::1,ZS.FFFLSK/Q8E98[,
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MQ,:S2UHK;23)&EKP
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MI<1#
M
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MQ:O^VQU[\O7\,<NG$\S*NP
M
M   !!M]NOW'Z=X 82GJCJ6+6^Q/*[8K.TO8-:RM4^0U7JC7KVF.>#9NQ(,9?
M6%Y/F,Q9U?G$86BX@GECKXO;FJ.UXMX[Z<'VD?9WS'OW>_ZU>63N>.]5;>]J
MSFII3/OLM=8G#M)O6U8QX[?X^XFEJUF)P8XME^I;!N3U;ZGW?G&;^9\I]3!X
MSCF8F\:1?-:.G9BF8F(K6?W\FDQ$_)76W=-* 7:':'8/=/8.V=J]J[9F-Y[#
MWG,7&>VK:L]<<7&2RV2N.**/55Z*(K>TL[2WBCM[6UMXXK6SM8HX((XX8XXZ
M;]O&/&/'_"_']IXKXKM,.Q\>V.&,6#!BC2F.D=?QUFUK3,VO>TVODO:V3):U
M[6M,X>.X[8\1L<7&<9BIAV&&D5I2L:16(_Y,S,ZS,S,S:9FUIF9F7@W>N:
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MV3R#<8YKON0RSVS/Q^ACUK32/C'=?ZEIGIWU^G.DQ%9FN*L8;]
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M-<-?Y5N(KR&FMMODTIFKI\=*ZZ9*Q'7OQS>L1,=TUMK6(]T@F=
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M*\KY/QW&WB)Q[C?8,=M:]T=M\M:VF:_WHB)F9B>DQKK.CE#O5>LT
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M6BU:S)H<M3
M                                                *0O[F_Q+_H7O
MCK7R^UO'^G!=Z8>+0>QKJBX]?L]F=>8>SL];O;J"6BBJ+^I.N;6"V@XBJDH_
MX/3<R<1554<S7:_TS?;/\]\$Y+U%R637?<'FG=;2LQ\=GN\EK9JUF/C]'=VM
M>W=$3_I=(K-HBW9,3[=O*/UO"[CQ7<6_C;*_U<4:?[SEM,WB)_VF69F==/\
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MZR['>4G'N\.2U+UGXUO29K:L_MBT3$_V/2.M<<
M
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MY8C3_%RQ\D3UG]S%I:(Z=,LS.O32T>J]1O
M
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M8CI$)J;;;;;9[>FTV>.F+:XZQ6E*5BM*UCI%:UK$16(_"(B(A\%SGV
M         20?7U]7ODC]ANX\V?7.(_HWJ?"WD=OO/>&U64M.G:W[D%[/188>
MT]^SOMXV2>JQYBXL,;S7\:26*J]EM()*9D<ON ^Y[UQ]O?#_ %O(LWZSRO-2
M9VW&X+1^HS:36)MDMI:NVPQW=WU<VG?%;1AIFO6:, \Y]C^/^";3OW]OJ\G>
M-<>WI/\ $OUCK:=)C'2-=>Z_QB)[(M,:+]G@G]<'C-]?NC1:_P!-ZE#?[[E,
M;39[]W1LT%O?]D;U+)):7-U;W.5YHYIU[5?E6$%5O@\;Q;XZ+F".62B>\YFN
MYJ$O>GW&^R_?_.3R'F.[G'P.+)W;7CL,S79[6(BT5FM/]]S]MK1?<YN_-;NM
M2MJ8>S%2$7FGG_D7G.\^ORV6:[*MM<6WIK&+'\8B8K_>OI,ZY+ZWG68B8II6
M-]FAF$@              ,;]Q]HZSTAU+V9W)N<_QM4ZLT/;.P-ADXYK]VK$
MZC@[[.7L%M1'%/-->74-ES%!''')++-73111555Q3SD?AWB_)^;>6<9X=PU>
M[E>4W^#:8H_#ZF?+7%69UF(BM9MW6F9BM:Q,VF(B9CL.)XW<<QRFWXG:1KNM
MSGIBK_NKVBL3/PZ1KK,S,1$=9F(<H?MKL_;N[.TNQ>X=^O(;_=NT=VV??]JN
MK6'XMG)GMLS-YG,G3C[/UR4V.-ANKVJBVMZ:N:+>"FB.G^6GAZL/$_&.)\*\
M7X[P_@:3CX7B]EAVN"MI[K1BP8ZXJ=]M([KS6L3>\QK>TS:>LRLTXOCMKP_&
M[?BMC$UV>VPTQ4B>L]M*Q6-9_&=(ZS^,ZS^+'K('.          94Z/Z8[!\
MB.V^O^D>J\-^O=@=E[)8ZQK6.JEXMK;F[N^:JY[[(W=5-=%AA\18PRW=[<5<
M<TV]I!)+5Q^*.6+>;^9^/^O/$N0\V\IS?0X#C=M;-FOIK;MKTBM*_P![)DM-
M<>.D=;Y+5K'676\SR^QX'B\_,<E?LV.WQS>\_&=(^$1'XVM.E:Q^-IB/Q=/3
MP;\/.MO!?QQTCH'K>UAKIQ$/ZYO>S^S1'D-_[)RUE81;7NN6KXHHDDFR$EA%
M;VE%?JYL\7:6MI3SS1;T/,A[P]P>2>\O8V]\^\CO,3FGZ6UPZZTVNSQVM.#;
M8XUTB*1:U\DQI]3-DRY9CNR2KH\R\KY#S/G\W.<A,_-/;CI^&+%69[,=?[-9
MFW^=>UK?&TMNFI&+                                        /C[!
MKV VS"936MJP>'V;7,W9S8[-:_L&,LLSA,OC[BGT7%CE,5D8+FPO[.>G^%<4
ML==%7'^GCES./Y#?\3O<7)<5GS;;D<%XOCRXKVQY,=X^%J7I,6I:/PM68F/P
ME]<&?/M<U=QMKWQ[BDZUM69K:LQ\)BT:3$_MB5<3SO\ VXGC_P!V6^4WGP]R
MF-\<.T)9I;V31\I^JY+HS9I9*)O7:T65I'DMAZQFDN9**^+C%Q9#'0Q1<PQX
MGCF3B:*QCT5_48\_\*R8N#]OXLGD?C$1%8W-.RG)X8B8^;NM-,6]B*Q,=F>V
M+-:TQ>V[F*]EM_>%>_N<X>U=GY76W(<;$:?4CMC<4_;K.E<W3II>:VF9UG+T
MTFH)Y5^#/E/X5;-3KGD7U#LFCV]Y>2V>O;G'%'G.NMNKHHDGHXU??<+7>ZSE
M+RJRCXN)+#Y%&3LXJZ?E6T%?/-'%N_JOWCZM]T\9/(^N^7VV^R4I%LNWF9Q;
MO;ZZ1_'VN2*YJ5[I[(R]DX<EHGZ63)'5*CQGS/QKR_;_ *C@-UCS6B-;8_W<
MM/P^?';2\1KTBVDTM/[MK1U:EML,G               3&?7Q]*?E9YT2Z_O
M-[C/[(^.V1]F_E[=WBRGXN]HQ'%W';ST=7:=3S%E-OO)H^:ZX;R>JPP?-,4G
M^O52TT02P]^X'[TO5?HVNXX/!E_G?L/'K6-AMK1VX,G;,Q^MW'6FWK$Z1;'6
M,NYUM7^!%)G)75'G7M[QGPR,FRI;]9SU>GT,<QI2VFL?6R?"D?G6.[)UCY--
M;1>8\)OKV\9O C1J-5Z,TJ&+9<CC;2QW?M78:;?)]D[_ "VTG-Q[F?SU,$%-
MKC>+JKFN'&V,=KCH.>.*J8?<]4E5'?NO[@O9?OGG)Y3SC>S/&X\EK;;8XM:;
M/:Q,::8L6L]U^WI;-EF^:W6)OVZ5B&OF'G7D7FV]_4\SFF=O6TSCPUUC%BUZ
M?+77K.G2;VF;S^>G1N\TDPX                !$)][O85'7OU<^2E45[#:
M9;=8>O.O<+%/97%Y1D*]I[,U&'8+*GF&*2&SF_HFVRLT<TU4<=$D5/'%7,O,
M=%<NOL5\>MY!]T'C<6I-]ILIW>[R3%HK-(P;+<3BMUF)M'ZF<%9K6)F8M.L=
ML6M&T_2VPG?^R./B8F<6&<N6VDQ&G9AOVS^W^)-(F(UG2?RUF.;P]'*?X
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MQ:TZZ];6V\S,1V9)^,TUF(ID_P"5O\T1:\\Z"#2@
M
M                "/#[4O%&CS(\&N[NI+#&S9+><?@>>Q>JJ+3BXKON.R-!
MHFSF!L+&&W@NZKB;:;6.ZPE<?,,O-4.3K]'HE]N2B0OVL^U;>G?>'">6[C)&
M/@\F?])OIMIV_H]UIBRVM,S72,%IIN8GNC2V&O=K7NK;._6ODT^)^9;/E+VB
MNRM?Z6;733Z67Y;3.LQIV3IDUUCK2-=8UB>88]-RQ<          !T%?V[?E
M3_?SP2M.JL_FK._W[Q=V2OK6[L>./1EJ>L\Q#+G^J\OD(X_]6^'\?]3P5G71
MQ'77%KM7N4U5\533>?[^H;ZL_P!0O>E_*MAAOCX'RC;1O*V_WO\ 68YC%OL=
M)GKW:_1W62)UB)W<=LQ72E(,^^/&OY)YI/)X*378\EC^K$_W?K5^7-6/QUU[
M,EOCUR].G2)[4#6DP
M
M                           %7;]SYY,W>E>/W3?BWKV5O+._[PW"\WO?
M;>RKBXAO.ONK:K&7#X+-4UU^Y59YOL#,V.1MN(Z*OS<:YSS571Q3Q3+9_P#T
MQ_6F+FO/^9]H\ABI?!PFSKM=K-M=:[O>]T9,N/2-.['M<>7#?68^3=](MK,T
MD?\ ;GX[7><YN_),]8FFSQ1CQ3/X9<VO=:O[:XJVI.OX9?A/QBD,NT3#
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M9Z4KI2O6=(B(U9R8.Z8
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M9\C7PWC;Z[#:7BVXF/[^>-8C'\/W<-9Z]=)R6F)C7%65HE6 C@
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M7DT.
M                                         YJ?W1>+%'B?]@G<6L8J
M&&WTGM*:#O?KZ&&BXBXMM<[)R&6GRN,XAGKF]N' [YB\SCX/1+)17;6D=?\
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M[QUXS5T^/TYTIFCKTTBLQDG\?X<:3\8GH4//J@J
M
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M,UM&C_?GD=>'\+_E..8C=\EEC''Y_3QS7)EF.O\ N*3TF-,GX3,2Z B@9!T
M
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MM(B)A?;?Q$8. W_-WB8R;C=5Q1,Q/6F&G=K69^,3;-:)F/QII/6JKBM!20
M        ;[?6CX89/SQ\O^M.B/QDK71O>N-W[BSN+YXCNM>ZGU.:TGV>>WNJ
MH;FG'Y+8KJ[M,%CKFJ&>*WRN7M:Y8ZHJ:^&AON4]S;;T3ZAY+SK^';G-(VW'
MXK]:Y=]GBT88FNM>^F&M<FZS4BU9O@P9:UM%IJPGV'Y=C\*\5W'-?+.]TC'@
MK/PMFOKV1,=-8K$6R6C6)FE+1$Q.CIZ:]K^$U/ 8/5=:Q=GA-<UG#XS7]?PN
M.AIM\?B,)AK*#'8K%V-O1_+!9V%A;1Q14<?PIHHXX_V'F1Y#D-[RV_S\KR66
M^?D=SFOERY+SK?)DR6F][VG\;7M,VM/XS,RKHSY\VZSWW.XM-]QDO-K6GK-K
M6G6TS/YS,S,OL.&^0        # _D'Y/^/OBGI,G87D/VSI_56K?ZS18W&R9
M"K]6V"YM(XYKG':CJ^.BOMIW/,002<2566)LKV[XB_-?M^GCGGC._7_K'V![
M4YJ/'O7O$[SE>4Z=T8:?P\5;3,5ON,]YK@V^.9C2,F?)CQ]W3NUF(=UP7CG.
M>3;S]!P.UR[G<]-8I'RUB?A-[SI3'77IW7M6NO3755P\M_W0%QS7E=7\*>F(
M8XZ9KRQB[8[UAKFKFM^;?FVIR>M]9ZSF8:;6;BZJJGLI\KE9J>8Z(_DXWCFN
M2"BT+U+_ $Q<<5Q<I[IYF9M,5M.QXR8B(G77LS;S-CGNCMTKDK@P5G6;?2W.
MD5O:2'B_VY5TKN?+]W.ND3]';?GKKI?->O7ITM%*1UU[<G2+36L\C_-[RR\N
M<A#?^17>^^=EPVOJYLM?O[^VPFDXZ6N;BXEN<7H&K6F#T?&7DTM%'N36^/CE
MDIABIJJYIBCXILD]<^DO4_J3;VP>N^"V'&WM^]EK6<FYO$1I$7W6>V7<WK$:
MZ5OEFL3:TQ$3>TS(/@/#O&/%J33@=E@V\S\;1$VR3^&DY;S;),?E$VF(UG\Y
MUU7;29*      ]AHG8>_]6[-8;KUEO.X=<[EBO<_2]MT39LUJ&S8WWJ/;F^!
MGM?O<?E;/W:.?35[<M/JX_ARZCG?'N \HXS)PODVQV?(\/ET[\&ZPX]QAOIU
MCNQ9:WI;2?AK6='%WNPV/);>VSY'#BW&TM\:9*5O2?[:VB8G_+"PMX6?N0_)
MOIJXQ^J>5F%A\ENO>)J8Y-JM^,9JO<>"M:Z_YY(,G:6UMK&Z0VU'//--OD;>
MVO)JOQQ5D:*>..%?'N?^G'ZS\RQY.5]5YI\:\@TUC!/?GX_+;3X32UK9MO-O
MQOBO?'6/AMYGJT3Y=Z \=Y:MMUXS>>/WVG[DZWP6G]L3,WQZ_G69K'_,Y7 O
M$+SG\9O./1N=W\>NQL;LDEA#;R;5HV2KM\1V3HDMU)/#;P[EIDMS+D\3#=SV
MLM%M>4>]CK[F&3FUN)N**N>*A?;OHWV7Z/YS^2>P>.R;:N29C!N:1.39[J*Q
M$S.WW$5BF2:Q:LWQSVYL7=7ZN.DVB)BMY3X9Y%X;O/T?.[>V.+3/9DC6V+)I
MIK]/)II;36-:]+UUCNK&L-NFI&+                       (TO)GZAOK\
M\K)<KE^P?'_6]8WC+>J6?L?J;FOK'<:\A+=UW=SF,E5K'%KKFUYB[YFKCEN,
MYCLI77'5Q_NHXJHY)^M/NY]_^JZXMIX_S^YW7"8ND;/?Z;W;]D5BL8Z?6[LV
M#'72)BFVS88B8_*UXML+QWVGYSXS%<6QWV3)LZ_#%G_C8]--(K'?K>E8Z3$8
M[4Z_VSK /Y#_ +6K:[*7)Y;Q5\D\/G;/_7)L7I'>V#N<%E((J+NVYL[*7L71
M;+*X[+WDV.DFXYDYUS&0_)ACXY],<]==M/CU[_5$XK-7%M/:?C>;!F^6+[GC
M,L9:3,UGNM&TW-J7QUB\5Z?J\UNRUIZVQQ7+N_@?N1VUXKB\EX^]+]-<FVM%
MH^$ZS]+)-9K&NG3ZMYTF?C-8BT,W<'TP?9?TO+>U9OQ5WS=<;:^BJ#+=/U8K
MMZ+(PR7=O943V6&Z_P AG=KH_P >YXYYBN,=!<40TUS51\0T52<3)\0^\S[:
MO,ZTC9>5;#9;FVNN/D/J;":3%9MI;)NJ8L'PCI:F6U)M,4BTWF*SMKBO;?KS
MEXCZ/)X,.2?[N?NP:=)GK;+%:?"/C%IC72-=9T1O;1INWZ/D(<3NFJ[)J&4N
M+./(V^-VC!Y/ 9"?'RS7%M%?0V>6M;2XELY;BTECIEIIYHJKBKIXY_-//'$C
MN+YGB.;V\[OA=UMMYM:WFDWP9:9:1>(B9K-L=K1%HBU9FLSK$6B=-)AG^VW>
MUWE)R[/+CRXHG29I:+1$])TUK,QKI,3I^V'G'8N0   ]MHO6G8_:.8CU[K/0
M-V[%S\LUE;18/1=5SNW9B2XR5U18XZ"/&:_89"]KFO[V2F&&GBCFJ66KBBGC
MFKGCATO.^2^.>+[.>0\FY#9<=L(BTSEW6?%M\<12O=>9OEM2NE:Q-K3KI6L:
MSI#A[WD>/XW%]?D<^';X(B9[LEZTKI$:S.MIB.D=9_*.LI,NDOH]^R_O#XEU
M9^.>8ZPP5U[?N9[NW+8GK#X/N?CFCY>I9VY_N-_M?SS5[6%E]'I_%7XJYIXY
MC1YM][OVU>$=^+-Y%AY/?5UTQ<;CR;WNT_S<^*/TG]G=N:ZZZQK$3,:\YCW'
MZ\X;6M]_3<YH_N[>MLVO]EZQ]+_9R1^Q-CXZ_M:L):3X_+^5WDG>9BBCV:[_
M $3H;!TXJVDDXQ\,DD?'96]V5Y=SV?&7DDBJHIUFUFEM(>*Z9899_3;0K]B?
MU1-[EIDVGJKQNF&9UBNZY3+WVB.^8B?T>UM6L6^G$6B9WEZUR6FLTO6FN34'
M/?<CFM%L7C/'Q2?PR;FW=/Q_YECF(B>W2?\ &F(M.FDQ7YI__&3ZTO!_Q#KQ
M^2Z0\?-)PVX8Z&UHB[(V6WN-[[)XNH+>6"XO['=-QN,UF=>FRG,]==S#B:["
MSDYJXIXAICCBHH@)[,^Y3W=[<KDVWF_D&]S<1DFVNSPS&UV?;,Q,5MM]O&/'
MEBFD12V>,N2.LS>;6M:VC_(O87F/E,6Q\QOLU]K:9_A4F,>+29Z1./'%:VTT
MZ3>+6C\]9F9WJ:,86                     I(_NF^QY\IY'>+_454MYS;
M:/TGLG8\4%=ICZ,?'/VGO=WK-Q+;7\=7ZK<WDT?3L7$\,W'%O!1'#5#SS7+/
M^+K_ .EOXY3:^NO)_+HBGU-]S>'9S,6O-YC8[6N:(M6?DBL3R$]MJ_/:9O%^
ME,:8/VV<?&/@.2Y32.[-O*8OC.O\''%XUC]V(_CSI,=9UG7I%56M:(DB
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MYU[;7L1J\FAP
M                                               %:S]R]XHU]I>*
MNC^3NMXV&;9_&O:O@;=/'Q;PW5SU/V?>8K 7LTG-$%=]F)M<WZ#"5V\'K]NS
ML\AD;C^7CW.:K)/Z:OM6OB_M3?>LN2R37C/)-KW;>)UFL;[95OEK$=>W'&;:
MSN8O;37)DQ;;'UGMTD']O7DT<;Y-F\=W%IC;<ABUI\=(S88M:/QTKWXIR:S\
M;6KCK^2B@O/3/          ?>U79\]I.SZYN>JY*;#;/J.>P^SZYE[>F&NXQ
M6>P&0M\KA\E!1<1S6]<UCD+2.6GBNBNCFJGCU<<\?GAP>4XS8<WQFYX;E,<9
MN,W>#)AS8YUB+XLM)IDI,Q,3I:EIK.DQ.D])B7QW.VP;S;9-IN:Q?;9:6I>L
M_"U;1-;1.G7K$S'1U;/%[OG6?*#QYZ=\@=1Y].%[6T/!;7Q9\T5QRX?+75KQ
M!LFNW--=<O'S-9V.WN\?-S1)+%5+;5<QR24<TUU>57V?X'R?K#V%S'@'+_\
M#>*W^7!W:ZQDQUMKAS1TCY<V&<>6NL5MVWCNK6VM8K-\CX3<>.<]N^#W7^-M
ML]J:_P"=6)^2T?LO2:VCI$Z3UB)Z,\,$=*
M
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M+!>+;+CJ1@KI,Z?4_>S3_NHO/TK?#_"B/PUF<]!QID
M
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M1$1$1&D1$1TB(CI$1TB$QJUK2L5K$16(TB(^$1^4/Q?M_0
M$QGTI_7Q+YT>5F,O=YU_]1\=ND?A;QV[+?PW?&(VB[XGYIT[JZB>WCYCFO-O
MRD54]Y#77%3S@["^_P 2F6J"B6'OWI?<#7T;ZKRX.#W'T_8?-]VVV$5FOU,%
M=/\ 2-[I,ZQ7;TF*X[1%I_4Y<'RS2,DUU1[>\ZCPSQFU-ED[>>WFN/!IIW4C
M3^)FTG\*1TK/7^):G33NF.CA;V]O9V\%I:00VMK:PQ6]M;6\5$%O;V\%%,4,
M$$,5-,<,,,=/%---/'%--/'''''X>=')DR9LELN6TVRVF9M:9F9F9G69F9ZS
M,SUF9ZS* MK6O:;6F9M,ZS,_&9_.7[/P_@                 #FR_>3V%=
M]B?:'Y074U5Y18:GF-+Z]P]G>212_!M-+Z[U/#Y"FUYBIXXIL\EL<5]?T4\_
MFJGY?/'//Y>D+['O'\7CWVP^,8J=DY]WAW.[R6K$QW6W&[SY*=VO]ZF&<6*9
M^$_3Z+ _36QKL/7'&UC3ORTR9;3'XSDRWM&O[8IVU_Y5$NEBV>
MO:_MKO$#^TGBYM/E'M&,O+3=/)/,<V>KTWT?L56?4>AW]_C<3=6UM5)S<0_U
M9ME61NJJY:*.+FRMK&:+CF*JB22BW^I'[>_UM]H;7U?Q>6E^%\;P]V?MG7NW
M^ZI2^2LSII/T,'T::1,]F2^>EM+Q-:PO^X+RK^:>28_&]M:)VG'TUOIUUSY(
MB;1,_#Y*=M=(F=+3>)ZQ,19-5O(^@       /FYG,X?7,/E=AV'*XW!8#!8V
M^S.<SF9OK7%X?#8?%VLM]D\KE<G?2P66.QN.LH*YIYYJZ(H8J*JZZN*>.>7)
MV>SWG([S%Q_'XLF??Y\E<>+%CK:^3)DO:*TI2E8FU[WM,5K6L3:UIB(B9E],
M6++N,M<&"MKY[VBM:UB9M:TSI%:Q&LS,S.D1'69Z0JO?8Q^X]U'0[C8>H? N
MRQO86V6<USBLKY$[#:\7'7>$O+:N"*XXZTU>[M^).PYJ).9XZ<M>\VV&ID@I
MEM8<M:3T34VE?;M_3FY;GL>W\N]\7R<?Q-XK>G$XK:;O)68F8_69ZSIM(T[9
MG!C[]Q,6FN6^TRTFDR4\!] [K>UQ\KYM-L&UF(M7:UG3+:)UT^K>)_A?A/97
M7)I,Q:<5JS"H5W9WQW'Y'[[D.T.].Q]J[0WS)0QVDVP[9DY+^XML=#/<W-MA
ML1:\<1X_ X&RN+V:NWL+&&WLK>J6OVXJ?55^;=/"O!/#O7/ X_&/!N.VO%\%
MCF;1BP4BL6O,16V3);K?+EM%:Q;+DM?)>*QW6G2$I^'X7B> V->-X7;XMMLJ
MSKVTC2)GI$VM/QM:8B-;6F;3I&LRQ*RQV8         #)'4G<':'0W8.N]J]
M-[WLG7'8>J7G%[@MJU;)38[)6M7/'HN;.X]'/-OD\/D[?FJWO;"ZCFLK^UDK
M@N(I89*XZL<\M\0\8\\\?W'BOF.QVW(^/;NG;EP9Z1>EOQBT:]:9*3I;'EI-
M<F*\5R8[UO6MHX'*<5QO-[')QG+8<>XV&6-+4O&L3^4Q^,6B>M;1,6K,1:LQ
M,1*^#]2?W::3YP_I'0_><&'ZY\IK/#\UV$MM7'C])[M_3_ER7UWI-O/-)7AM
MPLL7!'<WV%KDK]^GWKFPYJ@CF@LZ)_NS^RGFO2/UO._!K9N1]77S:6B8F^YX
MWO[8K7<S$1&3;VO,TQ;F(CMGLQY]+VIDS0K]H>G]YX=W\UPTWW'C<WZZ]<FW
MUTTC),?O8YM,Q7)ITZ5O\TQ:T_* [2                         #X^?U
MW7]KQ-W@-HP>'V3!7_L?.PN?QEEF,3>_%N8;VV^7C<C!<V=S\:\MHY8_71SZ
M)8Z:N/Q53QSQS-AR&_XK=TW_ !>?-MM]CU[<F*]L>2O=6:V[;TF+1K69K.D]
M:S,3TF7UP9\^VRQGVU[X\U==+5F:VC6-)TF-)C6)F)_9.C5?;_KX\$=]_69-
ML\-_&/*WVP>KG+YO^Q_7%CLUW)7Z/5<_U3C==L]CM[SGB/CCWXKJB;\<?CU?
MAM+B/N!]Z\#]&O$^8^38L&W_ ,/%_,MY;#6/R^A?-;#->O[MJ37]C)=IYUYI
MLNR-KRW(UIC_ ':_J,LTC]G9-II,?LF-&'O^:#^L_P#Y''3_ /[79;_LNS#_
M -;K[E?_ #QYC_W^/_J;M?\ C4]A_P#A;=_[-?\ X4_YH/ZS_P#D<=/_ /M=
MEO\ LN?^MU]RO_GCS'_O\?\ U,_XU/8?_A;=_P"S7_X5GG4_!?PHT2[MLCIG
MB%XQZQE+.SYL(,QA.B.K\?F^+2J*B&6*7-6^KT92X^111Q[M4DU54O/\:^:N
M>>>6"<M[R]U<[BMM^9\N\FW6UO?OG'DY/>WQ]VNL3&.<\TC29^6(K$5^%8B'
M2[KS/R_>UG'N^5Y')CF=9K;<YIKK_N9OVQI^&D=/P;+8?#8?7L9987 8K&X/
M#8Z'BWQ^)P]C:XS&6%O3SS53!96%E%!:VL/%57//%-%%-/YY_P!#6N\WF\Y#
M<WWN_P N3/O,DZWR9+6O>T_G:UIFUI_;,S+'LN;+GR3FSVM?+:=9M:9F9G\Y
MF>LOI.,^8                       #G$_?;V/!V)]H?D%%8RV=QBNO[/K
M?KC'W-M:9"SFEGU_KK6KS8XLC3D*N.9[S';EE\E:4S0QQ6\MO;Q<Q\2<?XTO
MHQ^PWQR_CWVP^/WSQ>NZY"^\WEXM:EHB,N[S5PS3L^%;[?'AR36TVO%[VBW;
M/R5GWZ3X^=AZXV,WB8RYYRY9B9B?WLMXIII\(G'6EM)F9B9G73X1#FF$VN
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M^I,OBF6_D'C]+7\:O;6](UFVVM,_"?C,X9F=*7GK6=*7G7MM>Q&KR:'
M
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MQ,19CQ/);?F.+V_+;2==KN<%,M?]S>L6B)^'6-=)B8B8GI,1+&[(W8
M    +PO[8KR@_KKQS[7\5LY<7DF;Z(W"/>-,JNKOW;2OKKM6:]NK[#8BSJJD
MDM?Z<[ Q.2O;NKCT125;##Z*>:^)JN:1?ZFOK'^1^Q>*]I[&M(V7.[.=MN.V
MNEHW>QBM:Y,END6^MM<F''CCK:(VE]9[>R(AS]Q7CGZ+G]KY+AB/H[W%]/)I
M'7ZN'2(M:?Q[\5J5K^,?2G7II"SZK&1S
M
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M]I^-K6F;6F=.G69F>C[S@/@
M
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MWE.?E=9_E])G%MZ]8TPUM/;,Q/PM?6;VC\)MV_"(2'H],#
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MQF]X[Z_&=M:TZ169GK.*UIB*6GK69BE^LUM>PZKU:(
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M;7M_O:=G[OX_#\75<[R'\IX/><IKI^FVF;+KIK_AX[7^'X_#X?BZT3R=JP@
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MUN(\[P1M,_9M?(ZQ\V";:QDB(UF^&9T[J_&9IUOCTG7NK$7M#FF$VN
M        ^EALSF-<S&*V'7LKDL%G\%DK',X/.8:^NL7F,-F,7=17V,RN*R=C
M+!>X[)8Z]@HF@GAKHEAEHIKHJXJXXY<;>;/9\CL\O'\ABQY]AGQVQY<62M;X
M\F.]9K>EZ6B:WI>LS6U;1-;5F8F)B7SRXL6XQ6P9ZUO@O6:VK:(FMJS&DUM$
MZQ,3$Z3$])CI*^;],7W.X?S#P^&\;O)',XW!>4^"QOL:WLD_Q<7A^_L/B[6J
M2;(8^&.F"RQW9V.LH*I<GC(J:(K^*BN^L:.(^+JULJ(OO+^S3>>H-YF]C^N,
M.3/ZMSY-<V&.Z^3BLE[:12\SK:^RO:8KAS6F;8K3&#/,VG%ES0I]M^I,OBF6
M_D'C]+7\:O;6](UFVVM,_"?C,X9F=*7GK6=*7G7MM>Q&KR:'
M
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MC69MABTVB(^,S;%.2L1'7NM'Q_=GI3/-NKY
M
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MQDWN6<F33_F>&:S6)Z_WLDUM'28UQS\)B-;P"D=#H
M
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MK$5K6(B(B(36Q8L6WQ5P8*UI@I6*UK6(BM:Q&D5K$:1$1$:1$=(CI#YKDOH
M               LX?MP/ 7^[_<^<\SNRM=^3UMT1>4X3J3B^_EM]A[RGCM+
MV7.VT-,E7-W9]7ZY<<3<^]'1'SE<M8RV\E<EE<445F?U&O??^J'AN#TUXUN.
MWR3G:?4W_;\<7&1-JQBM.GRVWN:.WY9F?H8,],E8KGQS:.WO_P W_E7$4\2X
M_)IR&]CNSZ?&NWC6.V?RG->-.DZ]E+Q:(B]9F\DH_0V
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M6(FUP7 <1XUQM.)X7!3!L:?A'QM/36U[3UO>=(UM:9F=(C72(AA-FKMP
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M)'6V'NUF,>6.LQVZ:1DT[+1VZS%Y[8FQ0K:@
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MI4
M                                   !#Q]ZGB_<>3?UX=K<X'&0Y+>>
MBIK/O_4**YJ[>;FWT&TR-/8%M!)%S[EW-/U?E,U7;V?IEIO+^&VHXH]WVI(Y
M@?8U[/Q^L_N%XK]?EG'P?.Q;BMQTB8UW5J?I9F)Z5B-[3;Q?)K6<>*V2TSV]
MU;;6],>1U\=\\VWU[379;V)VU_QZY9CZ4S^6F:,>MNG;6;3KIK$\X1Z,T_
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M\9_A6TOBUUZZSBM29^/7\9^,[:-3L7
M
M                                     :E^=_D3%XG^'OD-Y!<3_'RO
M7?6^8N=2DY@M+F/GL'8*K?4^MX;F"_\ S:26=SOV>QL<_%=,O^#75^(Y>?Q'
M5MCT5Z\M[6]O^/>O^WNVO(\ECC/&MHG])BUS[R8FOS1:-KBS372:_-$?-6/F
MC*/"^!GR?RO8<%IKCS[BL7^,?PJZWRZ:==8Q5O,?#K^,?&.5B]3:RH
M    !TI?I4\7_P#*S]>?2V!R-O>6NX]MV=7?^^V]]:?I]S:9_L_&8>[P^+GQ
M]=/%W8WF T'&X7'W4=Q55/\ +M):JN(N.>((O-O]Z7L[_C2^X3FM_M[4MP_$
MW_E6UFMN^ML6RODKDO%X^6U<NZON,M)K$5^GDK$3;2;VKZ]O>1_ZR^=[S/CF
M)VFUG]-CF)UB:X9M%IB?A,6RSDM$QT[;1\?WIE=14:R
M
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M,LS6OQ[*1\N.D?[BD17]LQ,_&6RS6K'@                   '']>O-:D
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MM+O'9'$])T7,,-Q->0W$W\FV<\4PT50<R8JF:B2WR5-MWVK_ -/O+>VW\_\
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MTQS,_@DG1N:^
M   1%?>MV/!UQ]7GDK+Q+9TY7=K/1.N,);7UID+J&]GV_L75;/.1456%47%I
M>6FFQ9.[MYIY*+>FXMJ.*N).:J899;_8SXY?R/[GO&J:7_2[*^ZWF2:VI6:Q
MM]IGMBF>[7NK;<3AQWK6)O-+VF.V(F]=I>F./GD/8_'QI/TL,Y,MIB8C3LQ7
MFOQ^,3D[*S$1KI,_#XQS<GH\6           ++'[8'JZ#9O,KN+M*]@^1;]6
M]#WN,QG/XR$?P]F[#V_7K*SOO>MI8[*3\:SKV8M_CW/$G$GR?=HI]<'%=%;'
M]3GRB_&>G.'\7PV[<G*<]6]_W)[L.TV^6UJZ3$VC^-EV]^ZFFG9VVG2^DQ[^
MXSDIV_B>TXVDZ6W.]B9^'6F*EIF.O7]^U)UC33329TG2;U2C-#$    !4Z^W
MOZ$;3>/U_P E_!#4L/@]JMK/)9SL_P =<)#+88_=*H?<O)]BZ:Q5I;RV.-W"
MJFJKY&NQ_%LLE11Q58<1WW'Q<A:Y]HOWY9>$_3^M?>N[S9^*M>F+9<MDF+7V
M^NE8P\C>TQ:^W^'9NY[\F&9F-QW8/XNWDYZL]VVV?9X]YKEO?;3,5P[JW6<?
MX13/:9UG'^66=;4_OZT^;'3(N+>XL[B>TNX)K6ZM9I;>YMKB*N"XM[B"NJ*:
M">&6FF2&:&2GFFJFKCBJFKCGCGC\KE,>3'FQURXK1;%:(FMHF)B8F-8F)CI,
M3'6)CI,):UM6]8M68FLQK$Q\)C\X?B_;^@            /2:=N.U]>[7KN\
MZ-L68U+<M2S%AL&L;/K]_<8O-X+-XNXCN\?E,7D+22*XM+RTN(J:Z*Z*N.>.
M>'7<QP_%>0<5N.#YS;X=WP^[PVQ9L.6L7QY<=XFMZ7I:)BU;1,Q,3#C[O:;;
M?[;)LM[CIEVF6DUO2T1-;5F-)B8GI,3#HE_4A]L6A?81UM;Z=N%UC=1\JM P
M-K5V+I-4D%K:[Q8V=%O93]H=?0<<14W.!R5U71SD;".GF;!WDW$-?%5M):7-
MQYX_NT^U'GOM]\DMS'$5R;OU9O\ /;])N=)M;;6MK:-ENYZZ9:5B?HY9GMW.
M.LWKIDKEQXX'>T?6.]\%Y"=WM(ME\:SWGZ63K,XYG68PY?RM$?NVGIDK&L:6
MBU:S)H<M3
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M,4S/XVM6<D=>O;CB-9B/EMHJG48
M
M                                  %4S]T5Y(T8'J?H+Q4PU]#^I]A[
M5D>XMXMHJ;CB\M=6T:VGUS3;2XDJJIM*\;LNR[!?W'%--,DO$^ IYYJBI_'$
MUJ?],#UQ;?\ E?/^U-Y2?TW'[6G'[:9T[;9]S,9MQ:(_>[\.'%BIK,Q7MW4Q
M$6GK23'VX>/SGY/?>39JS]/!BC!CGII-\D]^28_'6E*UC\(TRS\9^%+!= ET
M          VT\$?':7RP\PO'KQ]Y@^1B^Q.R,/;;;'Q/=VTM/7VOTW&V=D3V
MT]C^+J.\MM!P.2D@YHJB_P :BG\R1<?F2G4_O7V'7U3Z@\A]@=W;NN.XW)."
M=*S'ZO+I@V<3%OEFL[K+ABVL6^69^6T_+.,>:<]'C'BF_P"=UTR8-O::?"?X
MMM*8M=>FDY;4B?CT_"?A/5(M[>WL[>"TM((;6UM88K>VMK>*B"WM[>"BF*&"
M"&*FF.&&&.GBFFFGCBFFGCCCCC\/+/DR9,V2V7+:;9;3,VM,S,S,SK,S,]9F
M9ZS,]9E6K:UKVFUIF;3.LS/QF?SE^S\/X
M
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MM:9[\=QVQXC8XN,XS%3#L,-(K2E8TBL1_P F9F=9F9F9M,S:TS,S+P;O7-
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MZ:Z6SY(C2NNFL8:?#'&L?O3W9.LQW]L]L1"I=-I@
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MYU;AL\YMWX;O.[)QV]M32,V./WL.6:QV1NMO,Q7+6NG?6:9ZTI3+6E8 ^QO
M-]X%S4[2_?EXC-K;;YIC3OK^-+3'3ZE/A:(TUCMO$1%HB)+4:VO0
M
M                        %,[]T=XU_I6[>//EKA,;Z+/;,/D^C>P+VUQO
MQ[:C8-;DOMQZ\NLCD(?S%?9C/X+)9RWI][BF>FTP45%-4D='%,%R/]+[V3^J
MX7R'U-O<FN;:9J<GM:VOK,XLT5V^[K2D]:X\66FVO/;K6<FYM,Q6UM;RT^V_
MR'ZNSW_B^:WSXKQN,43.L]M],>6(C\*UM&.>G3NR3.D3/S5+EL23P
M  "3+Z?O)&OQ?^POQXW:\OIK/4MQVJ/I[?J:*;?FWFU;M3T:I'=Y&J>JBN+&
MZSL]YC<U-5%5Q+Q3C/QQ3)QSS%)&G[O?7%?9_P!OGD/"8:1?EMGM9Y#:ZZZQ
MGV/\>:TTUB;YL-<VWK%H[=<W6:]+UUY[5\?CR/P3?[.E8G=8L7U\7QU[\/SZ
M1^V](OCC7I\_X?&.F@\T2O
M
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MG\-+WM:?QG7%'PCXW4%+Z(H
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MC_ \;XQQ&'A.(I--C@KI&LZVF9F9M:T_C:UIFUIZ1K.D1%8B(P:SAW(
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MY'SN\\FYS=<]O_\ A.YRS>8UUBM?A2D3\>W'2*TKKU[:QKU9X8(Z4
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MIEK.DUM$Q,3^4Q/6'TG&?,
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MOL<7)\9EIFV&:D6I>LZQ:)_Y,3$ZQ,3$368FMHB8F'@W>N:
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M^'\GX3SF3AN2TMI'=CR1$Q7+CG7MO77X?"8M76>VT3&LQ$6G<9IYB8
M
M                         "/#[6?&ZORJ\!/(WJS&V,U_MMKI,_8?7]O:
M56]%]<;SUE-%N^"Q-C)=TU6L<VT5863#U\R>BGV<A7_B1<_B6B0OVJ^QZ^K/
M??CGE.YO&/B;;V-INIMK-8VV]B=MER6BOS3&#ZD;B--9[L5?EM^[.>>L_((\
M:\WV')9+17:SFC%EF==(QYOX=K3IU^3NB_3\:QTGX3S#'IN6+
M.IA]=ODC1Y:^%7COWM/?0W^P[9U[C,=ODL--Q%Q3V3I\D^F]A\?'NZJ[RVAG
MW# WDT%,E4G-5K+'73)+173+7Y<_N']<6]3>Z?(?!:4G'Q^TY"]]K$Z3_H>X
MB-QM.M?EF8V^7'6TQ$:7K:LUK:)K%;?GGC\^+^7[_A8K-<&+/,X_A_A9/XF+
MK'2=*6K$Z:=8F-(F)B-TFF&(@
M
M                             ->_+'OG$^+_ (T]X>0.8YLZH>J>M]GV
MO&V=_1<R6F8V:UQ\L&GZ[+39UQ7'_";;+BRQ]//$D7'%5SQS5)'3QS73L'U1
MX'N_9_LGA/ -GW]_*\EAP7M2:Q;'AM>)W&:.Z)C^#@C)EGI;I3I6TZ5GO?&.
M$R^1^0[/@\6NNYW%*3,::UI,_/;KT^2D6M\)^'PGX.4;D<CD,OD+[+9:^O,I
ME,I>7.1R62R-S->Y#(Y"]FKN;R^OKRYKEN+N\N[B6J2662JJN2NKFJKGGGGG
MEZK-OM]OM-O3:;2E,6UQ4K2E*5BM*4K$16M:Q$16M8B(K6(B(B(B(T69X\=,
M5*XL58KBK$1$1&D1$=(B(CI$1'2(CX/XWV?H         !TL?I=\:_\ +%]=
MG0NMY'&_INX]EX>7O/?:9<;^E9"O/]I46V:P]KF+*O\ -U%F->T&/"XBXXN.
M?>XKQWXJIB_'$,?FQ^\WV3_QF_</SW);?)]3A^-S1QFUTO\ 4I]+93;'DMCM
M'RSCR[J=QN*=ORZ9=8FVLWM7O[<\A_UC\\WNXQV[MIM[_I\?7NCMPZUM-9^'
M;;+]2\:=/F^,_&9446FM0
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MQ\-QNMM)[LF28B+9<DZ=U[:?#X1%:ZSVUB(UF8FTZ<MPLK
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MQ$176L>LS2)
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M:S\=+1^%Z3,1-J7C2U+:1W5F)9F8:ZD
M
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M7%$=-(UM<JJ49@
M
M                  %;C]S5Y!7'7?AKU[T/B[F&'(>1G9T%6;AEYKYKN]"Z
M@XQFX9:*WCHEB_$T>^9#6).9*^)(Z8Z*J?1ZZZ*Z+'OZ:'K_ !^1>X^0\[W5
M9G;^.\9/TYC32NZY#OV^.9F8GI.UIO8TC29F8G72LUM(#[=^#KO_ "S/S62)
MG'L-M\O[,F?7'77_ .-QFC3I.OXZ1,31$7JII          -M/!'QVE\L/,+
MQZ\?>8/D8OL3LC#VVVQ\3W=M+3U]K]-QMG9$]M/8_BZCO+;0<#DI(.:*HO\
M&HI_,D7'YDIU/[U]AU]4^H/(?8'=V[KCN-R3@G2LQ^KRZ8-G$Q;Y9K.ZRX8M
MK%OEF?EM/RSC'FG/1XQXIO\ G==,F#;VFGPG^+;2F+77II.6U(GX]/PGX3U2
M+>WM[.W@M+2"&UM;6&*WMK:WBH@M[>W@HIBA@@ABIICAAACIXIIIIXXIIIXX
MXXX_#RSY,F3-DMERVFV6TS-K3,S,S,ZS,S/69F>LS/695JVM:]IM:9FTSK,S
M\9G\Y?L_#^
M                                            /']@[_IW56B[AV9V
M%GK/5M%T'6\SMVW;%?\ $]=IAM>P%A/D\KD)8K2&YO+CX]G;UU4Q01RSS5?B
MB.BNNJFGGN/'^ YCRKG=GXUX]@ONN<W^YQ[?;X::=V3+EM%*4B;3%8UM,1-K
M36M8UM:T5B9CE['8[OD][BX[84G)O<^2M*4C36UK3I6.ND1K,_&9B(^,S$.<
M3]L?V:;C]BG>4MWB)<QKGCCUU>7=CTIU]D*8+:]YBGM[6UR^_P"XQV<LT-UN
M&US6O,E$7,DL.(Q_,=G#577Q=75YZ,/M0^VCA_MX\'C#NXP[GV-R-*VY'=TU
MM76)M;'M=O-HB:[?!%M)MI%MQE[LUXBOTL6&??K'UWM/ N&BN6*9.?W$1.XR
MQK,?&9KBQZ_#'37372)O;6\Z1VUI%&E6V8                  ^]JNL9[=
MMGUS3-5QLV9V?;L]A]8US$6]4-%QE<]G\A;XK#XV"NXDAMZ)K[(7<<5/-==%
M'%57'JYXX_/+@\IR>PX3C-SS/*9(P\9M,&3-FR3K,4Q8J3?)>8B)G2M*S:=(
MF=(Z1,OCN=S@V>VR;O<VBFVQ4M>]I^%:UB;6F=.O2(F>CJ;>#OBY@?#'Q4Z9
M\<,%<PY*3KS5:(]HSL'O<P[)OV>O+K9=_P!AMOE447D>-RNX9>\DL89O5):6
M',%O^>>(N'EP]W^T-_[E]J<S[&WU9QUY'=3.#%.FN':XJUP[7%/;\LWQ[?'C
MC+:ND9,O?DTUO*MGS+R3/Y;Y-N_(,T36,^7Y*S_<Q5B*8JSITUK2M8M,=+6U
MM^+:YJEC(                     "##]PKXW5]Z_7IM6[8>QFO-M\<-JP?
M<..IM:K>BXN-6H][5.PK26JYI]'.-L-8V&O-3TT51RU58:/BBJKG_"EG'_3Y
M]CU\&^X/:\)O+Q3B?(]KEX^_=K,1GG3/M+1V]>^V;%&WK,Q-8C<6UB/WZ[F]
M%>01POG>+9Y;1&UY#%;!.NND7_?Q3T_&;U^G'QC^).OYQSS'H03L
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M
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M1IU^;\?A/2L>;17P
M
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MFA^
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M7[\\I_DOB4<)MYTWW)W[)TG2:X:3%LL_'7YI[,>DQI-;WZZQ&M_)0>A"
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M8]SABTQ$Z]M_W<E-?]I>+5G]L=>K75L1WP
M                            #^S'9'(8C(6.6Q-]>8O*8N\MLCC<ECKF
M:RR&.R%E-1<V=]8WEM7%<6EY:7$5,D4L=5-<==/%5//'/''+X[C;[?=[>^TW
M=*9=KEI:EZ7K%J7I:)BU;5F)BU;1,Q:LQ,3$S$QH_.3'3+2V++6+8K1,3$QK
M$Q/28F)Z3$QTF)^*9CQ0^^?S\\8XK+ 9S>[/R(Z_M/CQT:MW?1>[#F[&V@M.
M;/B+"]BVEU9[Q;_F*.'TQWUWDK2+F'\QP4\R3<R0W]K?8AZ#]F6OO]CL;^/<
M_?69S\;VXL=K3;NUR;2U;;:>LVUG%3#DMW?-DF*TBNI?)_2GA'D4VSX<,[#?
M3K\^WTK69F=?FQ3$XY_'K6M+3KUM.D:6C_#C]P%X0^4%QA=2[!R62\7^T,E#
M;128+M>_QM?7=]EYZZJ:L?K/;=IS9X:XACX]'%$N<L]<EGDK]$4-?/''YJ]]
MQ?8'[M]88\W+>/X\?D_C&.9F,NQK>-W7'$?OYMA;NR1,]=:[;)NZUB.ZUXCX
M1O\ +/1WF/CE;[K8UKR7&UF?FPQ/U8K'XWP3K:/[,=LL1'69A.3;W%O>6\%W
M:3PW5K=0Q7%M<V\M$]O<6\]%,L,\$T554<T,T=7%5-5//--5//'/'/X0?R8\
MF');%EK-<M9F+5F)B8F)TF)B>L3$])B>L2TU:MJ6FMHF+1.DQ/QB?RE^S\/X
M                               Y&79>U6^]=C;_ +M:6LUA:[CNVU;5
M;6-Q71)<6=OL.=O\O#:SR1?X<DUO'=\4554_R\U<<\\?P>MGQKBLG!>.<?PF
M6\9,NSV6#!:T1,1:<6*N.;1$]8B9KK$3UT6C<=MK;+C\&SM,6MBPTI,Q\)FM
M8KK']NCQ3NG,         29?3=U_1V7]G/AYKDD&-N*<;V=/V!Q'E:[BBUIK
MZFU+9>U(YXJK:"XDYR5M)IO$EEQS3Q'5>41<2544<U5TQI^\7G[>-?;+YAR-
M;9*SDXR-KK32;:;_ #X=C,3W3$=EHW&F3KK&.;36+6TB=>>V-]/'>NN5W$3:
M.[;1B^737^->F'\=.D_4TM^/;KIK/1TT'FB5X           (M?M#^KSJO[&
MNJ^+:YYQND>06D8V[_M'VY\2JKFVYJJEN^=&WGBTBDO<SU[F;V2JJJFFF2YQ
M%S)5>6=-7-5U:WDHOMA^Y[RG[=/*?J8_J;[U_OLE?U^P[OWOA7]3MNZ8KCW>
M.L1$3,Q3/2(PYIC3%EP[)]<>Q^2\!Y+NKW9N#S6CZ^#7X_A]3'KTKEK']D7B
M.R_]VU.=#WGT9VIXV]J;?TOW1J&2TCL32,E5C<Y@\E335Q5Q533-8Y3%WT-4
MEEF<#F;*2BYL;ZVKDMKRVDHEBKJHJXY>B7P;SGQ;V1XML_,_#-YCWWCN^Q]^
M++3_ &+4O6=+8\N.T33+BO$7QWB:VB)B83UX;F>-\@XW%R_$9:YMAFKK6T?\
MFMH^-;5GI:LZ368F)C5B5ECM             %G?Z%?MJHZ%V/'^&ODGN,-E
MT=MV2KYZ@WW:LO<48_J+<,C+SS7IU]=7,-Q;XWKW=,A-Q)'+)-;66%RE4DTG
MXAO+B:"LG[\?M-GSSCLGN/UOL[7\WVF/_3]K@QQ-]_MZ1_PBM8F)ON]O2-)K
M%;Y-QABM*ZWPXZ9(Z^[/5\\WM[>6>/XIGF<5?X^.E8USTC_?(B-)G+CCI,1$
MVR4TB.M*Q:\6I"0W
M                                               :'?9MXU_YLO!?
MR*Z9LL;^I[9D-#O=LZ[@AQOZGDJ^Q>OY8=UTZPQ-$?XN[6\V/+X.C$URP?F7
MXN0FH]$M%=4,F]OMG]D_\4_O+QWS+/D^EQ6/?UP;N9OV4C:;J)VVXMDU^6U<
M./+.>*V^7OQ4G6LQ%ZYKZ[\A_P!6/,]ARU[=NUKGBF6==(^EE_AY)M^$Q2MN
M^(GIK6)UB8B8Y=ST^K'0         ']F.R.0Q&0L<MB;Z\Q>4Q=Y;9'&Y+'7
M,UED,=D+*:BYL[ZQO+:N*XM+RTN(J9(I8ZJ:XZZ>*J>>.>..7QW&WV^[V]]I
MNZ4R[7+2U+TO6+4O2T3%JVK,3%JVB9BU9B8F)F)C1^<F.F6EL66L6Q6B8F)C
M6)B>DQ,3TF)CI,3\75@\-N^[?RA\5N@^_P"*B&&Z[1ZQU?8\]9V\E$MOC=NY
ML*+#=,3!+'%;T30XC;;*]M::^(XO53#QSS11SSZ>/*Y[C\#R>L/:?/\ @-YF
MV+B^3SX<5IB8F^#NFVVR3$S.DY,%L=YC6VDVT[K?&:T/+.$MXYY+ON#G6:[;
M<WI69^,TUUQVGX_O4FL_&?C\9^+99K5CP
M
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M5
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MS26X
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MQ?>[.)W_  E8UG+CKI>D:_[YBUFT:?&;T[J1'6TU^";="AIX
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MS[A-W;;> UPQ$S&XW^''/732(KERZS&GS=<<1ITZS$Z]-)O\*#$(
M    $6OVA_5YU7]C75?%M<\XW2/(+2,;=_VC[<^)55S;<U52W?.C;SQ:127N
M9Z]S-[)555333)<XBYDJO+.FKFJZM;R47VP_<]Y3]NGE/U,?U-]Z_P!]DK^O
MV'=^]\*_J=MW3%<>[QUB(B9F*9Z1&'-,:8LN'9/KCV/R7@/)=U>[-P>:T?7P
M:_'\/J8]>E<M8_LB\1V7_NVISH>\^C.U/&WM3;^E^Z-0R6D=B:1DJL;G,'DJ
M::N*N*J:9K'*8N^AJDLLS@<S9247-C?6U<EM>6TE$L5=5%7'+T2^#><^+>R/
M%MGYGX9O,>^\=WV/OQ9:?[%J7K.EL>7':)IEQ7B+X[Q-;1$Q,)Z\-S/&^0<;
MBY?B,M<VPS5UK:/^36T?&MJSTM6=)K,3$QJQ*RQV@            "\[]"/V
MQ2^1.J8WPU\B-J^9WWHF'F_M)N>P9*[N\_W;H^)M\KE,CALI<W,',5[OG6N"
MLJ>:YJKCF[S&%C^37')/8Y"[FHY^_/[4:^O.5R^X_7FU[/ ]]FC]?M\5*UQ<
M;N<DTI3)2L3K7:[S+:=*Q3Z>WW$_2K:M,^WQ4AI[M]8QP.YMY;P.+3A,U_X^
M.L1%=ODM-:Q:(B>F/+:?AIVTR3VQ,5O2L695:2/
M
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MKK.*V.(UB.E.DSI,5LRJTD>
M
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M?+;/FF;9;VFUIGXS,SK,S_;+Z3C/F
M
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M$)ZXL6+;XJX,%:TP4K%:UK$16M8C2*UB-(B(B-(B.D1TA\UR7T
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M_D+\5S."^WW^.?FI;3_)-9B9K:L_W;UF:VCK$S#+3$W5@
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MCZF.9TG3]ZLUOI$VFM9446FM0
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M/U&PS4SQ\-9KUQY(UG\.W)WS$3'=-*_&8B)Z&CSWH)
M
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MYW^7^'8^&I,?5Y#<UB8Z?X>&8RVF->O3)]'K$::3,3,:Q%KZBAY"@
M
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M;;GE=IXK@M/T-M3Z^6(^$Y<FL8XF-/CCQZVB8Z:9ICXQTM3JLD:@
M                 $<OV<_7KI?V)^.U_P!9Y"YQNM=J:G-<;-TGV)D8;^:W
MU';JJ;:F]Q^6AQTT=Q<ZKN6/M.,?D:?;N?CTU17L<$UQ:04<R+^V7[@^:^WC
MV'C\EV]<FY\6W<1AY+:4FL3N,'7MOCF\3$9]O>WU<,ZT[YBV&V2F/->6?>NO
M.]YX%SU>1QQ;)QN6(IN,4::WIUTFNO2+XYGNIUC7K2;16TRYJ?:'5_8/2W8.
MV=5=JZGF-&[#T;,7&!VK5<];\6^2Q.2M^**_35Z*Y;>[L[NWECN+6ZMY);6\
MM98YX))(9(Y*O27XQY/X_P":>/[3RKQ7=X=]X]OL,9<&?%.M,E)Z?CI-;5F)
MK>EHK?'>ML>2M;UM6+!^.Y'8\OL<7)\9EIFV&:D6I>LZQ:)_Y,3$ZQ,3$368
MFMHB8F'@W>N:                      R=T[TQVIY!=B:]U-TOHV>[%[$V
MF:>'!ZMKMM3<7UUQ:6TMY?74TLTD%ECL;CK*"N:YN[F6&VMH:*I)9**..>>,
M9\P\S\6]?^/;CROS/?8..\=VL1.7/FMI6O=,5K6(B)M>][3%:4I6U[VF*UK,
MS$.NY;E^-X+89.3Y?-3;[#%$=U[SI$:SI$?C,S,SI%8B9F>D1,KX_P!6?T==
M2>%=I@.X.]8-;[D\HZ/:R-GDI++C)]?=0W-,N-OK.'KVPR]KQ7?[AB;ZPYKX
MV::"WNX_7S'9Q6U/$DES1)]T?WO>6^Z,NX\0\&MN>&]7SK2U(MV;O?UTO6T[
MNV.WR;?)6VGZ.MKXYT[LU\L]M<<*O9/N3E/+[7XKA9R;3QOX3&NF7/'6)^K-
M9Z8[1/\ @Q,UGXWFTZ16>U UI,!7Z^WGZ3M4\W(LMW_T#7A]!\IL7AY:\MC)
M;:WLM4[]BQEI1'C,1LU]S<V=OK6^6]O!Q;X_/R4R0SQTQV>0XX@X@O,?/[[1
MOO5Y7TG;%X!Y]&;?^KLN:(QWB9MGXN;VUODPUTM.;:S,]^7:Q,6K,VS;>>^;
MX=QO+U9[?W/A\UX/G._/XW:_RSK,WVVL];4C29OCF>ML<:3$ZWQ_-W4O0RW_
M *^WKJK<<]U[V9I^R:#O6K7G%AL6H[=AK_ ;#AKNN"&[BBR&*R<%O>6_R+.Y
MCGBJJH],T$M$E'-5%=-7-[W >0<%Y5P^#R'QK>;;?\'NJ=^'<;?)7+BR5UFL
MS2])FLZ6B:VB)UK:MJVB+1,1-;8[[9<GM*;_ ([+CS[+)&M+TM%JVC73I:-8
MG28F)_*8F)ZP\>[=R@                             &^'@1]B'D#]>W
M:%.\=0YK]1TS/WF*H[3ZDS4M-6G=EX+'32<TVMYZ[:\FUW9+*&XE_3LU94TW
MEE)7S15Q<6DMS:7&B??/V]>O_N"\8GA/+L/T^9V]+_H=_CC_ $C9Y;Q'S5TF
ML9L-IBOUMMDF<>2(B8^GEKCS8\+\V\#X+SKC?T?*T[=W2+?1SU_Q,5I_&.L=
MU)TCNQV^6T=8[;16]>C5X=>8O2GG%TI@.[ND<_\ J&'R'IQ^S:SD*K>';.OM
MLAMX9LIIVXXN&:;]/S&/]ZFJBNFJNVO;:N.YMI);>6.2KSJ^X?3WFOI#S7/X
M3YM@^GO,?SX<U-9P;O!,S%-QM[S$=^.^DQ,3$7QWBV/)6F2EJQ ;ROQ3F/#>
M8OP_,4[<M>M+QKV9::],F.?QK/\ LUG6MHBT3#:AJQC0
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MM$Q&PC7SH@
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MX1?'::6TUTGXQ/X0]LZ1PP
M
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M?5O_ !,DQI'2>VV.EHUG2<<_"=86!4 6C0
M
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MOSNYBMMQ>/A$QKVXJ]9CMQZS'=&G?:9M/3MBL3J5S9P
M  #[&O:_F]LS^#U76L7>9O8]FS&,U_7\+CH:KC(9?-YF]@QV*Q=C;T?S3WE_
M?W,<45''\:JZ^./]EQ.0Y#9<3L,_*\EEI@X[;8;Y<N2\Z4QX\=9O>]I_"M*Q
M-K3^$1,OEGSX=K@ON=Q:*;?'2;6M/2*UK&MIF?RB(F9=6;Q.Z&Q/B_XT]'^/
MV'XLZH>J>M]8U3)7EA7<R6F8V:UQ\4^X;%%5>417'_";;+B]R%7',<7'%5SS
MQ3''3QQ13Y6/:_GF[]G^R>;\_P!YW]_*\EFSTK>*Q;'AM>8V^&>V9C^#@C'B
MCK;I3K:TZVFL_P GYO+Y'Y#O.<RZZ[G<7O$3IK6DS\E>G3Y*16OQGX?&?BV$
M:^=$                           @V^X_ZBL)Y_Z=%VUU159Z[Y7==ZW5
MBM:GO;NFRU[M?5<?/?9.#KO9IYY*;/#YB"\O[BO"Y?GT1Q3SU6U[SS:R1W%C
M.#[._NWWOH+F)\3\J[]QZJY'<]^:*U[LNQSWBM)W>&(CNR8YK6D;C!UFU:QD
MP1]6ML>?<GJ?VEF\'W?\KY/7)XSGR:WB(UMAO,1$Y::=;5F(CZE/C,1W4^:)
MK?GU;CIVU]>[7L6C;SKN8U+<M2S%_K^SZQL%A<8O-X+-XNXDM,AB\IC[N.*X
MM+RTN(JJ*Z*Z>.>.>'H"X?F.*\@XK;\YP>XP[OA]WAKEPYL5HOCRX[Q%J7I>
MLS%JVB8F)B4YMIN]MO\ ;8][LLE,NTRTBU+UF)K:LQK$Q,=)B8>;=BY
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M!WGCW7]?W==AVUU+?_J&'R'P\7V9UGE+RX@U/L[4X+BN6O#9FB*B?]/S&/\
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M*TFF[PV_R7K/6MZS\)K>.L?E\)TM$Q&?F NC
M 0_??;_Z)SRM_P#M%_\ X2?3J7OV&_\ TUWBO_VS_P#F/R#:OI/_ -)W&?\
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M])B?@_L?%^
M                                       '*Q\[O':7Q/\ ,+R%\?>(
M/CXOKOLC,6VI1\SW=S+5U]L%-OMG6\]S/??FZDO+G0<]C9)^:ZI?\:NK\22\
M?B2KU-^BO8=?:WJ#Q[V!W=VZY'C<<YYTK$?J\6N#>1$5^6*QNL6:*Z17Y8CY
M:S\L65^%\]'D_BFPYW77)GV]9O\ "/XM=:9=-.FD9:WB/AT_"/A&I;;#)P
M       '0_\ V^'D+7W?]=.D:IELQ#D]K\?-JV7IO)QR2V].3BURREM]IT"2
MXLXN(ZX\;:ZELL&*M)_;XHGXQ,E/-5<T4U3ST_U _7U?"/N(WW*[3#;%Q7D&
MUP\A28B>R<UHG!NHBTZZWMGPVSY*ZZU^O6=*TM2$$/>G!1P_GN;<XJ37;;[%
M3/'QT[YUIETG\YO2;VC7IWQTB)A.&A$TX
M
M                                  U+\\.^XO&'PX\CN]?E?#R6A=5[
M+<ZO/\JTL_\ AUG+;C6.OH?DWMS:11_*WC-X^+\455SU>OTPQS3<QQ5[9]$^
M!V]G>XO'/!NWOVV_Y7#&>.VUO]%QS];=SI6MIGMVV/+;K$5C36]J4BUZY1X5
MPD^1^6<?PNFN//N:1>-)G^'6>_+TB)^&.MI_+\YB-9CE8O4TLJ
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MB.D,P,0=4
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M]T4OJ#WAY#_(_ \^WQ6TW>_O7;UTG2>VVMLLZ?&:SBK:EOA$=\:SUTGHI//
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MNG7OFN32>[):+<:I1%P
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MAV
M
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M'">OM],3IGW<1MJ=8C7ZW2\=9UG^#&2=(B9Z?#368Z1SSAJ_P
M
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M:)ZX\=,5*XL58KBK$1$1&D1$=(B(CI$1'2(CX/XWV?H
M   !>O\ VROC=1UWXB]A>1N5L8:,_P"1?84^.P%[Q5<2UR=;=139/5\?QQQ/
M31#:33=A7VR4S4P<<\31VUOS))7513'#1A_4O]CV\A]M\?ZZVMYG8>.\?%\M
M>D1&\W\4S7^'6T1M*[.:S;]V;Y(K6(F;7AA]Q'D$[_RG!P&*T_0V&#6T=/\
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MN7QORZM-EOK5V'.S$1]/);Y,D]-9Q9)TK.LSTQVF,G^;%XB;(24UVX
M         &XWA_X$>4GG/MTNK^/76>2V''XV:B+:.P<Q[F!ZRTSBKFWY].R[
MK>0\XR#)5075,T6,MOE9>Z@IKDM[26B.3FG3WM[WSZN]'<3'*>P>3Q[?<9(U
MP;3'IEWNX^/^#MJSWS36LUMFOV8*6FM<F6DVK$XIY5YMXWX9M8W/.[BN/):/
MDQ5^;-D^/[F..LQTTF\Z4B=(M:)F-;N?UW_11XQ^%WZ+V+V519^1?D-9^U>0
M[IM.(^-H>BWW/R:N8NN^O[FZO[#YEM3/'1^L9:J^R/,UM3<6=.,XEDMU)OW"
M_?/[-]S_ %O'?&IOX[Z]OK6=M@R:[K=5Z==WNHK2W;.DS^GP1BQ=MYQYIW/;
M7(AYYY[H\B\N[]AQ^NPX*>GTZ6UR9(Z?XN6(B=)TG^'3MKI/;?ZFD63DH/M-
M@        ,;]L=.]5=[:3D^N.YNO-/[/T7+^FN^U?=L!CMAQ-5S''+';9*VM
M\C!-^GYC'^_55:WMOS%=VDO/N0R1U\<5<9'XIYAY5X+S6+R/PWD=YQG.8?W<
M^VRWQ9.V9B;4M-)COQWTB+X[]V/)7Y;UM69AV'&<KR?"[RO(<3GR[;>T^%\=
MIK;3\8F8GK6?[U9UK:.DQ,*Y7E_^V9Z"[%_4]K\0^Q,QT/M=S>27G]O=WDO=
MYZDN(I?;I_3\-D?QSV!I?IDKDFJFFN=AAYXXI@BM8*.?<IL6]0_U+?/?'?I<
M5[<X[#SO%5I%?U>VBNVW\3&OSY*?\%W'32L5K3:6^-[9;S\L[\\5^X?F]AV[
M;RG!3>[6(T^KCTQYX_;:/\+)^$:1&*?QFUIZ36F\J?J*\^/$/]:RO8W1V8VK
MK_#7G%OSVMU+)SV-H=S:5_R19FYJP\%.UZGAYKC_  :9=@Q6'J]ZJBCFCCF6
M+UV3^K/NW]"^W/H[7QWG,.UY_-37]#OX_2;J+?CCK]2?H9\D1\TUVN?<1VQ:
M==*W[9">->TO"/*>S%L-Y3%OKQK]'/\ PLD3_FQW3V7MIUTQ7OTUG7I.D::2
M;80                           #H0_M_/-O_ #0^'%EU)M^7^;VWXN?I
M/7F6^5/[F0S?6<]M/_:W8ZO75S)+\/%X^?!S5?S5^O$4RR<^JXI_/GX^_P!]
M)_\ %A[BOY;Q&'L\3\H^IN\?;&E,>\B8_6X>G2.Z]Z[FL=(TSS2L:8Y07]X^
M'_ZN>63RFUIIQ?)=V6ND=*YHF/K4_P LS&2/]WI'[J>%!-I4
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MU.V\];36LKJ*C60
M                                          "$[]P%X^?WT^N'L;/6
M,?KV/Q_V36N\\-11;>Y+=8_!<WVJ[I:R7-$E$MK9V^D;?D,C7_+)1)+CXJ:J
M>/Y98IJ?8'[ _P!1ON,X[89YTX[R#;9N,R==(K?+VY]O:*Z:6M.YV^+%'6)B
MN6\Q,]:VV_Z.YW^3>?[?!?\ X/OL=]O;K\)MI?'.GXS.2E:_AI%IZ_A/.N>A
M]/,         !NE]='>UOXT^<OB_W1D<G#AL!JG;6N66X9>XN*+6WQF@[E7-
MHW8%_//+5'#1#:Z3LM_75ZZJ*.::>>*JJ:>>:N-,?<3X+D]D^C_)_#-OBG-O
M]WQ.:VWQQ$VF^ZV^FYVE8B-9F;;G#BB-(F=9UB)GHQ'SWA;>0^&\EQ&.LWSY
M=K><=8C69R8_XF*(C]N2E?V_DZF#RYJVP
M
M                                 %!G]RKWM+V/YYXGIZUE_&(\=>J]
M7P%U:^J[J_&X]D6L'969OOQ<6=I;Q_*U3-Z_#Z8*KF/_ %;\U3>Y57!!?5_3
M:\%KXYZ(R^898_TOR+E<^6MOE_X/L[3L\=>EK3/;GQ[JVMHI/SZ13MB+WFW]
MOG"QQ_A5N5M'\7?[F]HGI_AXIG%6.DS/2]<L]=)Z_#32UJ\:PEO<
M !<E_:R=$Q6^H>4'DU?1>Y-F-DUOHG6)_3:<?$BUO&6G8&]1>NF\EOJ_U"K:
MM=Y_%=O!#3\7^22>JJNFWIT_JD>=6R<OXQZSP3I3#MLW)YH^;YIS7MM=M/[L
M5^3Z&[^%[6GOZUI$5G)$[[D^:FVZXWQVD]*8[[F_QZ]\SBQ_AIT[,OXS/7K%
M>G=;=5+HO
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M=<
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M7]GY-TFF&(@
M
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MIHDS1I:\
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MNK/<W.5X/U]O=)F,^\B-M3]LY=>^)_\ C-<OPUUGI\-9CI$/.,@
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MPUO2>L3,=.V9U?&[Z/OKE\;*[')X_I*'N/;;":J:'<?("^@[-O.>?CTP1?\
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MO:M7S7A)\<\LY#A=-,>#<WBD:3'\.T]^+I,1\<=JS^7Y3,:3.VC4S%P
M                  ')=\A>N/[.=^]X]1>U[']J^X.R^N/8^7\_V?Z'W3-:
MS[7S_31\WV_TO\>]^./<_'J_'\7K$]?>1_ZX> \'Y=KW?S3A]GO->WLU_4[;
M'FU[?[NO?^[^'P_!9[P7(?S;@]GRFNOZG:8<NNFG^)CK?X?A\?A^##[+W:@
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MQ<^5\537F-EC_BUC2/JX*ZS:?AUR8OWHZQKCB]8[K12J]LHM0N
M
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MM,M(B(B(^29ZS,K/JL9',
M
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MRWMERVFV6TS,S,ZS,SUF9F>LS,]9F?B_L?%^
M
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M>O36)K%,GX]8R1K'PE;+50(Q
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MTB(_>Q1I'R3-([IQ7LG#0B:<
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M.^Q5FV;8[G'EZ1K/9;7%?_)'?6]ORBFL](ET$% *#0
M
M                                        "KM^Z+[M_IGQP\?>@K&[
M]F^[7[4S&_9B*&O\RRZSU/K]./XLKV/CGGB.SOMC[$LKB/FKCCF2;&_R<\\1
MR<+/_P"E_P"$_P S]C>0>>YZ:X.*XK'M<<S'2,V^R]_=6?QM7#M,E)T^%<W6
M/FK*1_VX</\ J.?WW-WC6FUVU<5?]WFMKK'[8IBM$_E%^OQA2&7:)A@
M    + G[;GHF+M#[ ZNSLE%^<1X[]5[AO-I753:3PS[CMU%OUGK^.GMI;R&Y
MI_&%VS+Y"*XH@N(X+C&Q\5>W))#7Q +^H]YU;Q?T!'C&VG_2_(>5V^VM'S1,
M;?;Z[S+>+16:_P")@V^*U)M6;4S6F.ZM;PT=]P'-3QO@W\NQS_%W^YICGXQI
MCIKFM.NFG[U*5F-8F8O/QB)A?^4$H/
M
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MT3%IK-XG7KW:Z1KVQ).C<U\
M                                        ^/G]=U_:\3=X#:,'A]DP
M5_['SL+G\999C$WOQ;F&]MOEXW(P7-G<_&O+:.6/UT<^B6.FKC\54\<\<S8<
MAO\ BMW3?\7GS;;?8]>W)BO;'DKW5FMNV])BT:UF:SI/6LS$])E]<&?/MLL9
M]M>^/-772U9FMHUC2=)C28UB9B?V3HC [R^D_P"M/O:WOJ\GXT:KUIG+F'VK
M/9.C9[[J.XP]?-&,AKN+'6-1FL^N[N:NWQ5%'XO\+>1TU2S2TTTSS22U2<\'
M^]3[D_!<E(VWDNZY+8UG6V'DXKOXR1K>=+9MQ%MW6-;S/\+<XYF*TK,S2E:Q
ML;AO;_L+A;1&/D<NXPQ/6FXB,\6^/2;WURQUM_=R5GI$3.D1"%OR"_:RV_Q[
MG(^*WDW-Q=<3<TVFG^06"HJMY+>JB6JF6Y[(ZYQ=,D4T,E-%',=.J5TR4UU5
M^NCFCBB29_K_ /JCY/J5V_M/QF/I:?-N.*RSK$ZQTC9[N^DQ,:SK.^B8F(C2
MW=W5V[P?W)6[HQ^2\=';IUR;:W77]F++/_\ NZ?#2==8@8\F/J3\_O%#'WFQ
M=G^/VR9/2+'XO-SV!UK<6/9>IVD5U#17\G,3ZC/DLOJ]G!=U<VM<V7L["*JY
MXIIHJKXE@JEG?ZT^[/T%[6W%./\ &/(-MBYN_=IM=Y%MGGM-9^&.-Q%,>>TU
M^>*X,F6W9K-HB:7BNZ_'O:'@_DUXP<=OL==Y;73%EB<5YT_"O?$5O,Q\VE+6
MG3XZ:6TC?2-9^            MB?M5]R^#V?YB]>^W9\_P!4:'U%N7NUW'IR
M%']";#N^$]NVM?S_ (UG)_<;\SR?C_"KHAX__2?QJC_JG<-]?QCP_P @UO\
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M3^-;5UB)FEZS%Z3I'=6T3IU9@8@ZH
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MDQWQ7MBRUFN6LS$Q,:3$QTF)B>L3$])B?@_L?%^
M
M                                     % ']R7W!+V!]AW/7,-[[F.Z
M'Z?T#3I<?11=T16NP[A;W?:62O).;FWBBEO+_!;KBJ*Z[>N6#V;:*GFKB:F:
MBF_;^F_XA7@/MZ_UCO33<<[S&ZW$7F:ZVQ;>:[*E8[9F8K7+ML\Q%XK;NO>=
M)I-)F</V_<5&Q\$_F$Q_$WN[RY->G6N.8PQ'2?A%L=_CI.LS^&DJ_:?K>(
M       "\O\ M?\ HZXTSQ2[M[VR-E-97O>/;5CKF'DEXKYHRNE].X6XM,;E
M[>NG)W%MQ#_6>\[#9<T?$MKCB2QJJKKFCJ@XBH\_J=><8^9]J\)X+MKQ?#P?
M$VS9(C36FYY#)%KXY^2)U_3[;:9-?J7KIDB*UI:+]T-?N-YFN[\FV?"XYB:;
M/:S>W^UR9[1,UGI$_P"'CQ6_>F-+1I$3$ZV:U9Z.X
M
M          #GZ_?A]CMIY@>0-OT1U5F;/)>/WCCF,OC+/.8J[EN\?V7VO73S
MB]NW*WN:/;L+[6];HBKP^#EAIFBGHIO;^&YFMLC#3#?W]A?VYY?4/K^WG7E6
M&^/S_P CPX[VQ7K%;[/8_OX-O->MJYLVL;C<UM-;5F<."^*F3;WF\X_27@%O
M%>"GFN3I-><Y"E9FMHTG%A^-,<Q\8O?_ !,D3I,?)2:Q;',S .GPW>
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M;3;+:9F9F=9F9ZS,S/69F>LS/Q?V/B_
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M$Q,3HLGQY*9:5RXK1;%:(F)B=8F)ZQ,3'28F.L3'Q?QOL_0
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M::3V3DU[M*1%[91:A<
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M1V=(TV^3/]>G2(CMSQ&72L1$1%:6M:D1IT[=.OQF2U&MKT
M
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M'2O]C=AI5AX
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MM-IO=MQ^69_5;N]ZXXB)G_#QVR7M;_-I$1%9M/3OO2OQM#&[(W/
M 3M?MT^E;?M7[(=8VW(6L-SC.A.L>P>V:HKV&B:QGR]S;8_K# 1<T3XK(V\N
M2L,CV-QD[.GW;.6*;'?(CFYJM_:E@M_41\TR>*_;CN>)V]IKN>>Y/:;#6LS%
MHQQ-][EG6+TF*6IM/HY)TR5M7-].U-,G?72_OKE[<9Z_R;7',QDWVYQ8.GQ[
M8F<UO[T3I,8NRW2T3%^V8^;6.A0\^J"H
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MT_Y9F6L;9C(@        $\'[<?\ ])AJ_P#Q/]L_]:;%!/\ J+__ $M6Z_\
M'&P_Z99I;W[_ .CS)_V7@_\ @I=")Y^$%@                        %
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M+#/7OF^S\Z\?IR>+LIR%-*;C%$Z_3R?G$:S:,=])MCF?PUKK-JV1[I LZ
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M=)C@=Y-LF"8CI29GY\'PB/X<S\L=?X5J:S-N[28=#]JD
M
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M3CN>I'3-@O@O/[<5N^FO[;1EM$?LII^$+7*JE&8
M
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M>C&O,N8_D'BO(<Q$Z9,&TR6I/_/)K-<<?Y<DUAU6GE>5I
M
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M,Q./#DSVCKI/U+1CQS\-.GTLFFEIGYIUB.DS;+50(Q
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MF7<8X_\ >TRUK_ETUG\49O8>_;9VKO\ O/:&_9;]>WKLC<-FW[=,Y\'&XO\
M6=LW#-7NP['EOTS"V>.P^._4<QD9IO8M+>"VA]?HBCHHXIIXDOX]P/$^*\!L
M?%^!Q?0X/C=GAVNVQ=U[_3P;?'7%AQ]^2U\E^S'2M>[)>U[::VM:TS,[$V&Q
MVO&;'#QNQKV;+;XJ8L==9GMICK%:5UM,VG2L1&MIF9^,S,O'NW<H
M!/!^W'_])AJ__$_VS_UIL4$_ZB__ -+5NO\ QQL/^F6:6]^_^CS)_P!EX/\
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MM68GKI,?"8B8F%BNRWFUY':8]_L<E<NSS4B]+UG6+5M&L3']L/*NT<D
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M)5T[W9[KCMWDV&^QVQ;S#>:7I:-)K:LZ3$_V2]4ZIQ@
M
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M*1:9^72>A$\_""P
M
M           "N)^YJ[IN-%\(=#ZAQMS-!?=Z]S86WS,-,U<5O>:1UMC+W<,G
M!+';Y6SFN)H]VYUR6.F6VO+3BF.NJOB*>FUK6,?TT/"\?.^[=_Y=N:Q;!P7#
M9)QSI$S7<[R]=O28F:6B(G;?JZS-;X\FLQ$=V.<M6_OMWXBN]\QS\KDB)ILM
MI::_G&3+,8XGK6=/X?U8G2:VZQ$:U[H4.%[::@         "PM^VHZ=KWW[
M,KV9<V\/.,Z)Z9W79;:\ECMYZX]IW>7'=<8JQMZ*LA:W=K->:ULN:EYN:(+F
M*B.VJAKXHJN(J^*^?ZDWF%>!]!8O&<=I_4\[S.VPS6)F(G!MHOO+VF>RU;17
M-AVU>R;4M,WB]9M&.U9T5]PG+1LO!Z\=69^IO=WCI,=8^3'KEM,])B=+TQQI
MK$ZS$QKVS"_8H20B
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MK_\ &Z1W_C,?XDWTTTZ::Q%M4P*(350
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MK:R8\>\-\8\5Q?2X+9X<%M.M].[+;2-/FR6UO/X].[2)F=(C66J+:K)@
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M0_L..,WD>%\M?38[G)_HUITTIFM\<<S,Q\N6=.R(U_BSI$?Q)F*22ZY,$
M        !<?_ &V/V$UY?&93Z_>T<Y#5?X2'8-Z\<K_)WMO%=7N&_-6:WSJG
M'Q51PR7\V%DYO-DL*/5/<_#DR?'/--M9P41T[_U(OM]KM-SB]_>+X)C!GG%M
MN7K2LS6N3_#VN^O.LQ6,D?3V>6=*T^I&VTB<F:]K10^X+P6,62OG/&TGLO-<
M>ZB(G2+?NX\T_EW?+BM\([HQ_P!Z\S-N-4HBX
M
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MDQWQ7MBRUFN6LS$Q,:3$QTF)B>L3$])B?@_L?%^
M
M                                   %&']T%W#+M7EUTITS:WOR<1U#
MTGSL=U;^B[B_3MQ[6VC(2YFV]-Q;Q03^[J>D:_/[T%<L=7N^W5SQ)%733>-_
M3$\0KQ7J3FO,LM.W=\OS?T:S\L]^WV."D8YZ3,QIGW.ZKVVBLQV]T1-;1,S,
M^W+BHVWBV\Y:T:9=UO.R)Z=<>&D=L])U_?R98TG2>FOPF)5FUEJ0P
M  "\C^UZZ6_I+Q5[U[RNX?8R/<O<&/U.R_Q/=^7J?3^N_P"]=_\ X65N8+?U
M;3V'G+?VJ[2UN>/B^Y77-#);^W1__4]\T_FWM/@O!\-N[;\-P]\]NFG;GY#-
M\].M(F?X&TVU^Z,EZ?/VQ%+UR=T-ON.Y?]5Y+LN&K.N/:;2;S^R^>W6/W8F?
MDQ8YU[ICKI$1,6ULXJS$=@
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MDB=8KTB%8/-<A/+<QN^4M,S;<[G+EG6(B?XE[7ZQ7Y8GKUB.D?AT948LZP
M
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M)F*WBU-9FLMM&IF+@
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M'X=F:(S5B/V5B_;_ )-)ZQ*0E'U@H
M
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M0E'U@H
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MIL,T5F(B=+VI-*3I/28BUHF==>D3TGX3U-GEP5M
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M--+=VM8P_<MNNS8\1LNW_$R[B^NOP^G7%7333KK]3777IV_"=>ES)3<B6
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MU_A08A
M                                HV_NA>EOZ2\JNBN\K2#V,=W+T_?Z
MI>_XGN_,VWI_8O\ ?2__ ,7*W,]OZM6[#P5O[5%I:VW'QO<HKFFDN/;O _IA
M>:?S;U9SO@^:W=N.&YBF>O33MP<AA^2G2D1/\?:;F_=.2]_G[9BE*X^Z9/VX
M\O\ JO&M[PUIUR;3=Q>/V4SUZ1^[$3\^+).O=,]=)B(BNM8]9FD2
M  O+_M?.XJ]K\3>\.EKRXAN+WJ#N:VV7'TTR6]-Q9:MVQK5O)C[&6T@Q]O7S
M#QL^C9JXCN9KBXEFJN*XOQ%';Q\54>?U//#Z\5[7X/S/#6:X>7X:<-^DZ6S[
M'-,7M%IO,:_1W.VI-*TI6L4B^MK9+:0U^XWB8VWD^SY>D3%-WM)I/QTF^&\Z
MSK,S_<R8XF(B(C2)ZS:5FM6>CN
M
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M,S,ZS,SUF9F>LS,]9F?B_L?%^
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M
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M5L3\?X'C?&.(P\)Q%)IL<%=(UG6TS,S-K6G\;6M,VM/2-9TB(K$1&#6<.Y
M                         7?_ -K3IUQ9>+7DEV!5QC?B[-W]8:=#S%Q7
M^L<W&C==ZWFKGB^YYM:(^<;Q'V)#\3\325>[S<?FB/CTU24D?U1>8QY_:/C?
M 1]3ZNVX"VXG73Z>FYW>;'7M^;7OUVEN_P"6([?IZ6MUBL.ON2W=;^2<?L?F
M[L>QG)_M=,F6]8TZ_'^%/=TCIV]9_"T&K#1R
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MZVF(EC11:Q
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MUZ8\M;8[?")TUR?2^,Q'X:ZS$3?.40H4@
M
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MLUC2?CKI$]$QYXT#0
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MQ.P?56PCD?8?$[>8BW;NHRZ3,Q_@5MFUUC\OIZQ'PF8TG6)T<R1Z8EB(
M     "US^U:Z]M,EV]Y>=K5TV?SM+ZWZPZ]MJJXY><AQ:=F[/L^R7M-M-Q5[
M-%G5-U);^_35QS577Q#S3SQQ35^:J?ZIGD&7;>(^(^*QW_0WO);W=SI,=G=L
ML.'#7NCXS;3?W[9CI$=^OQA&;[E=];'Q7%<9&O9FW&;+/Y:X:4I&O[?X\Z?Y
M5TE3$B,
M             YY?WS>?-QY=>6F6ZJTG+32]&>,^2S77^M46F1KGQ.Y]B6=U
M59=B=@>Q#QQ8SPTY:UJP^*FHKN8Y<;C^+N&2FF_DBI]"'V(>A<?J3U/B\JYO
M%$><^2X\>ZS=U(C)M]I:O=M-KK/S1/T[1N,]9BDUS99PWK,[>MIG;Z4\(KXM
MXO7D]Y6(YGD:URWUCYL>*8UQ8M?C^[/U+QTF+V[)CY(E!BG&W*
M                  Z2?T9]1WG4'UC>-]IEK2:SS?8.-VGMS)42_.IHFL^Q
M=MS.<TZ[MX<A9V,T,-WU[7AY.?115!+)55+#)+%)1+7YP/OB\MP^7_<UY'FV
MEXOLN/R8-A28[=8MM,&/%N*S-+6B9KN_U$=9BU8B*WK2]9K%?WN7E*<K[%Y"
M^*8G#@M3!'P^.*E:Y(G29^&7OC\XC2)B)B8B6]$MJX
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MMHF+1.DQ/QB?RE^S\/X
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MLS$1\]*]9G2/BZCSR^*WP
M
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M[;3/?%8J_<KRD]W%\+29TTRY[QTT_NX\<_'7I_%UUC3K&DSUTM]JB$5P
M
M                      %:S]QWYWV_2?C_ (OP]T;*31=H>1^-_5-XDLI:
M(Y=9Z,QN5DM+VBZK]Z.YCF[.V'&RXNWXHHEBFQV/RT<W,?/,/$MDG].?T5D\
MU\_R^W^<Q1/C'CF3LVT6B9C-R=Z1:O;TFLQLL5ZY[ZS%JYLNTM2+1%^V0?H'
MPJW,<Y;RO>5B>-X^VF/7^_N)KK&GX?P:S%YUTF+6Q3&O72B@O/3/
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MF/\ =?V+,JM)'@
M                  !&!]P'F/<>%7@UVGV!K&:AP_;.\0P=4=.2<7-=OD;;
M=-UHFM+S9L37%3)71DM"U*+)9RUKKHJM^;W'P12_RR\<<R<^T/T[C]T^\.+\
M?Y/#.;Q/8S.^Y"-(FD[;;:6KAR:Z:TW6><.VO$3%OIY;WKUHV-ZK\3KY?YEM
MMCN:3?B\,_6S]-8G'CZQ2W[,M^S'/X]MK3'P<SQZ5UA@
M           #.7C-T;L?DQY!].=!:I1-^L]L=A:UIM-W#%+-QAL9E,C#1G]D
MNJ8+>[EHQNKX"BYR-W73%+S';6LE?HJ]/XYP?V7YQQWK7U_S'GO*S'Z/B>/S
M;CMF8CZEZ4GZ6&NLUCOSY>S#2)M&M[UC6-=73>1<SM_'N"W?-[G3Z6UP7R:?
MYTQ'RTCK'6]M*5ZQK,Q&KJY:KK&!TG6-<TS5<;#AM8U' X?6-<Q%O7-);XK
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M&DY:S^$=TV^I7\^ZT1&E)3YH%-(@
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MA[Q,3MMUEQQ\>L4O,5F)F(F8M6(FLS$=T3$_BSDP=TP
M
M                                    #G]_N2NV>=^^Q:;0H+Z:2RZ-
MZ9ZYT>?&\2Y/BSM,]M$63[6OK[BUO*(["G)9'";_ (R.:>T]=$L%K;T25\R0
MU41W\_TW_$XX'[=XYZ^.(S<YS.[W,7TIW6Q89IL:U[JS-NRF3:YIK7)I-;7R
M6K7MO%K3B^W[B_T/@4;VU8[][N\N2)Z:S6FF&(UCKI%L5YB+?"9M,1I.LP I
M]-X          .BC^WSZD_M=]9/5.8GMOAY3N3<.R.V\K;U6?Q9N/G;+-HV
MN9YN+RZXR'ZEIVA8VZBFXI@_%O/'%S'^8^9)//!_4!\M_P!:/N8Y79X[=^UX
M;9[/84GN[H^7#&YRUB.VO9V;C=9J6KK;YZVMW:6[:P,]Y\I_,O8FZQ5G7%M,
M6+!6==?A3ZEHCI&FF3)>)CKUB9UZZ1-BA6U
M
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M'\;+;)0W<-W%:36EWA.Q>T;2.N..VKL\I;7L^N8R;BNNJJFC+>N.FBJWEDJ
M_J1_<#7+;#Z"\6W&N./I[GF)I-9K-HM7)M-E:=9GNI-:[O-72(B9VFEIF,E:
MQ3^X+SJ+33P?C<FM8[<F[F---=8MBPS^.L3$9;Q_\2TG7NB+>JHM%D !6"_=
M*[1D+3Q3\<M*CALZL5L'D)<;1>7%<<_.0BR&G]<;9B<9#;2TW%-M19SVV\7=
M4]-<5==5<</-%='%-?$EG/\ 2[XO;Y?:OD?-6F_ZK;^/Q@K$3'9--QO,&2\V
MC36;1.VQQ68M$1$WUBTS$UD9]MVVI;R;?[R9GZM-A%(C\-+Y:6G7IKK$XZZ=
M?QG6)Z:4>EW28P         #HK_M\=5M]>^K/HW+PW<UQ)O6U=T;5=PRT44T
M6%Q9]N;CI%-I;U4?S20UVNFQ3\U5?S>Y-5Q_HXX>=[^H%RN3D/NCYS:7I%:[
M':\=@K,3.MHML-ON>Z?RGNW%JZ1TTK$_&90+]Z;FV?V3O<4Q$1AQ;>D?MB<&
M/)K/^7),?V1":M"UJ$
M                      !1M_<Z^2G]=>3G5'C-A<E[V$Z%T.3:]MM+7)>J
M.GL7MCX61AL,MBX?\/B\PG7^&Q%U:2SU<RTQ9R;B.B.B2JN>\'^F5ZV_D7K+
ME?9>]QZ;WGM_&#!:U.OZ38]U)MCO/7MR;K)GIDK6.V;;:G=-K5B*3)^W7Q[]
M%X[NO(LU=,V]S]E)F/\ >L.L:UM^5LMKUM$=-<<:S,QI6L>LR2)
M                   6Z?VS7@QD+C-[IY[[W9>SB,?9YSJ?HFSF]^F7(9:[
MJA@[+W[BGVX:.+/%6%'& L*Z9)XKB:[RM,D<<EI!774C_4M]X[?'LMEZ&X*_
M=N\E\6^Y.T::4QUUG9[7XS\V2VNZRQ,5M2N/:S6UJY;UB+?W#^9TKAP^$[*=
M<MIKFW,_E6/\+%_;:?XMND3$5Q:3,6M$7&5/2*(
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MB1?C/N'P;R:*XJ;J-GO[3I]+<Z8IUUB([;ZSBMW3/RUKD[Y_&D?!$BEHV@
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M)A71GP9MKGOMMQ6:;C'>:VK/2:VK.EHF/SB8F)?8<-\@
M
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M-BA6U
M
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MG_\ *MWER_C'2][6B(B9F8B(F(B)F=(Z:LV,*=.
M
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M]>_!3D+Y-8_".W<8])_&9G\DL/MHV^2NVYC=3I]*]]M2/SUI&>;=/[,E=/\
M+^2HXMK2B          =0OZM-5N--^N;PLQ%S=PWLEYXZ]9[53-!17'11;[U
MKUKN]I:54R?S<S6%KL-$$E7^UJDCJYI_ASP\POW1<KCYC[BO--WBI-*T\BWF
M#29B9UVN6VVM;I^%K8IM$?&(F(GJKC]D[FN[\^Y?+6)B(W^:G7\\=IQS/^6:
MZQ^R6^[0S"0
M               '*9\T>]I?)ORP\@^^>9?=L>R^U-LS^O<>J[K^/IU.2EQV
MDV/N7]GCKV3].U"QL8/5+;6TE7M_GF&+G_#I]4_ICP6OK/U1X_X)IIGXWBL&
M++^[&NX[(ON;:5M>L=^XMDMI6]XC7I>W[TV8>(\+'COC&QX332^WVU*V^'7)
MIKDGI,QUO-IZ3,=?C/Q:QMF,B                           ;[?7/X$]
MD_8/Y$Z]U'J4&2PVA8R:VSG<G9L5C7/BNNM&CJGDFGKGKCKM9=JV6JSDL<%8
MU>JJ[OJ_<KXIL[>\N(-#?<3[X\;^W[UYN/+>6MCS<]EBV+C]E-M+[O<SI$1$
M1,6C!A[HR[G)&D4Q1VUF<V3#CR83Y]YMQ_@O Y.4W4UOO;1-<&'72V7)TZ:?
M'LIK%LEO[M>D:WM2MNFAU=UGI/3/76E=4]<8*SUK1>OM;Q6J:OA+&*.*"QQ.
M(M8[6WXKYCHH^1>7'HYEN)ZN.9;BXDKEDYJKKJJY\T?E'DO->9>1;WRKR//?
M<\YR&YOGSY+3,S;)DM-ITUUTK&O;2L=*4BM:Q%8B%>')<CO.6W^;D^0O.3>Y
M\EKWM/XVM.L_V1'PB/A$1$1TA[QT+A
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MTF$A."\G\?\ )MO^JX'=X-SBTB9BEOGKK\._'.F3'/[+UK/[&O;8+O0
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M(:>2[.NFPY'7OT^%=Q6/F_L^I72\?G:,DK(*N1H
M
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MS%/C,9L-OA^'9?'ITU_')KUTCII$:SK;U5%HL
M
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MGEV5N
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M\#M-)Q[?%$6M\.^\_-DO/^[O,V_9$Q'PAK2V2R$          !T%?H"\!_\
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MQO(]S?>>0[_=Y+1?)EWN>\VC32TVRVM,QITZS.O3I^3.3!W3
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MQXX_"L?[-IUM:9M,RVH:L8T
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M[[;<5FFXQWFMJSTFMJSI:)C\XF)B7V'#?(
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M<1UG9[G#F_'\;3AGI$3KI&:9G72(B)G7II/0N>?)!0
M
M                                  !#E]]?:D75_P!8??<$<GMY?LV\
MT'JO"<U16DT%4NR;KALCL,<]%S=VTO'KTC!97B*J"F>:.X]NOV_;IKDCF']A
MWBUO)_N;X&]HUVG&4W6^R=;1.F';9*8IB:UF/^$Y<'=%IK6:=T=W=-:VVOZ3
MXV>2]C;&T_X6WC+FM\?[F.T5^$3_ +Y:FNND3&L:ZZ1/.*>C!/L
M!80_;5=2?UW]A&0[#NK;\V/1_2>^;9:7]=G\F*'9MNN,-UICK".XXO+?G'7E
M]KFW9B6B7V[CBJ&UEB]'',G$E%?G]27RW^1?;]C\>Q6_C\WS>UP6K%NV9P[>
M,F\O:8[9[ZUS;?;UFNM=+7I;6>V:VT7]P?*?HO!:["L_/O-YCI,:Z?)2+99G
M32=8B],<::QUM$Z]-)OY*#T(0
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M^?Z;G';;8_;E^IP1/U=YS^]S9-9UB;UIM]O&GY1]/!CC3\]9_%.+[?=OCP^
M?4IKW9=]FO;^V(QTZ?E\M*_Y=90 I]-X         /KZ]@,MM>?P>KX"T^?G
M=DS&,P&%L??MK7YN6S%[!CL=:?)O9K>SM_D7EQ11[DLD<5'Y_-55-/'//'$Y
M#?[3BMAGY3?W^GL=MAOER6TM;MQXZS>]NVL3:=*Q,Z5B;3\(B9Z/EGSXMM@O
MN<\]N''2;6G29TK6-9G2-9G2(^$1,_DZ];R+JL@
M                                           $+7[@7L/^A/J\[NQL
M-U>6.1[*V3JGKS'75CD?TZ;CY/8NO[9FK6OFB6*>]L\IJVHW]G<6T?//NV]Q
M7Q)3S#Q)PF?]@/CW\]^Y[A-S>E+[?C=MOMW>MJ=\?+M,N#':.DQ6U,^XQ9*7
MG]V]*]LQ?M;=]&[#];['V>28BV/;X\V68F-?ABM2L_E$UO>MHF?A,1IUT<Z)
MZ)$]0                        &3NINE>W>^-NL=#Z7ZUW;M'<,C-%#;X
M#1]<RFQ7U'$OKY^5?4XVVGCQF-@CBKDGN[FJ*VMX8ZY99*(Z*ZN,9\L\T\1\
M$XG)SOF?);+B^(QQ,SEW.:F&LZ:?+7OF)O>9F(K2D6O>TUK6LVM$3UW*<OQ?
M";6V]Y?<8=MM:QUMDO%8_LC68UF>D16-9F9B(B9F%H_P5_;.[-D+O!]A>>NX
M6>OXBCT7E?CWUIEZ,GL-[ZHJO38[[VCB[K]$P7QKJC\36FO<Y7Y4%?',>4M9
M..:57OO/^I7QFWQ9_'_0^SON-W.M?YMO,?9BKU_>VNRO7ZF76L_+DW?T.RT3
M%MKEK,2C?YI]PVWI6^Q\)Q3?+\/U6:NE8_;CPS'=;6/A;+V:3\<=H6Z>L^KN
MNNF=)P77'5.E:WU]HNM6<5CA-7U3%6N(Q-C!%'1'S7Q;VL='R+RX]'%4]Q+S
M)<7$O/,DM===557-27DOE'D7F7-9_(_*M[N>0YS<WFV3/GO;)DM,SKIK:9TK
M&NE:5TI2-*UK%8B$6^1Y+?\ +;R_(<GFR9][DG6U[VFUI_RS\(C\(C2(CI$1
M#WCH7"                                           >#[,ZNZZ[FT
MG.]<=K:5K?8.B[+9RV.;U?:\5:Y?$WT$L=<?%?-O=1U_'O+?U\U07$7,=Q;R
M\<215T5TTU<=]XUY1Y%X;S6#R/Q7>[GC^<VUXMCSX+VQY*S$ZZ:UF-:SII:E
MM:7C6MJS69AS>.Y+?\3O*<AQF;)@WN.=:WI::VC_ "Q\8G\8G6)CI,3"GQ]D
MO[<C8]+HV#N/P _4MRU.WAR&8SGC=G<E+D-YP,$5Q5=24=2[-E)Z[C?,;:8^
M6KB/#92;G/\ IM.*;>[R]W=1VT=OGVW_ -1;CN:MM_#O?OT]GRUIICQ<QBI%
M-MEF8[8_7X:1IM;VO$:[C!7]+KDUR8MIBQ6R6E7Z_P#?NWW<TXGSCMP[J9BM
M=W6-,=ITT_CTB-,<S/QR4CZ?S?-7%6LVFJEF<-F-<S&5U[8<5DL%G\%DK[#9
MS!YFQNL7F,-F,7=2V.3Q65QE]%!>X[)8Z]@KAG@FHHEAEHJHKIXJXYX6H;/>
M;/D=GBY#C\N//L,^.N3%EQVK?'DQWK%J7I>LS6]+UF+5M69K:LQ,3,2DMBRX
MMQBKGP6K?!>L6K:LQ-;5F-8M68UB8F)UB8Z3'6'S7)?0          !?'_;*
M]TW&]>$.^=0Y*YFGONBNYLU;X:&J:N6WL]([)QEEN&,@BCN,K>36\TF[<;'+
M)3%;6=IS3)151Q+/5=5J)/ZE_A>/@O=NP\NVU8K@YWAL<Y)TB)MN=G>VWO,S
M%*Q,1MOTE8FU\F36)B>W'&*J%?W$<179>8X.5QQ$4WNTK-OSG)BF<<STK&O\
M/Z41K-K=)B=*]L+':N=H$       !^-Q;V]Y;SVEW!#=6MU#+;W-M<143V]Q
M;ST51303PRTU1S0S1U<TU4U<<TU4\\\<\?A^\>3)AR5RXK37+68FMHF8F)B=
M8F)CK$Q/6)CK$O[6UJ6BU9F+1.L3'QB?SAS._ML\&,AX'>8&Y:!C;+V^I>P?
ME]G])7L/O2VT6AY_,9*'C4I[FN/BCC,:)E;2;'2Q<UUS56D=K=5\4TW<?Y]*
M_P!IGO';^]O4.SY_<WU\LX_MV7)5G2+3NL6.D_7B(G7Z>ZI:N:MM(K&2<N*-
M9Q66&^K_ #.GFOBN'?9)_P"^F#3#N(_'ZE:Q\\1_FY*S%XGX=W=6/W91CI,M
MB           +X/[</S;_O?XSYGQ7W7+_)[&\9_8_I+Y<_KO<YTIGKN7]!]G
MW*N9;C^@<[7+BI/3QQ';8^?&1\?QY43_ -1GTI_J1[*P^TN%P]OCODNOU^V/
MEQ\EBK'U==.D?JL7;GC\;Y:[FWX(6>_O#_Y/Y#3R79UTV'(Z]^GPKN*Q\W]G
MU*Z7C\[1DE9!5R-
M                                      /$]EZ)A^T>N.P.LMAHAEP'
M8ND[7HF<BN+*UR-O)A]NP5_K^3HGQ]]1)97\-=ED*^*H9J:HI:?S37QS3SSP
M[OQKG=YXOY'Q_DW'S,;_ ([>X-UBF+6I,9-OEKEI,7KI:L]U(TM68M6>L=8<
MSCM[EXWD,'(X-8S[?-3)729B>ZEHM&DQUCK'QCK'QAR2MAP&6U3/YS5\_:?
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M--)UT=6!Y6U:
M
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M
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M/;T9MJ8/6NQRTF9MFR;B]M?PF,^3'TZ?#MI$]=>LSUTTB(6TSFW
M&=_%G 9;:_)WQRU? 6GS\[LG?'4. PMC[]M:_-RV8[!U['8VT^3>S6UG;?)O
M+FBCW)9(XJ/S^:JJ:>.>>,$]I;_:<5ZR\CY3?W^GL=MP._RY+:6MVX\>TRWO
M;MK$VG2L3.E8FT_"(F>CI?)<^+;>.<AN<\]N''LL]K3I,Z5KBM,SI&LSI$?"
M(F?R=8MY1U8X
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M*U9TG2=)BTQ.DQ,3^V-'Q_\ +UW[_P!X_N#_ ,&FZ?\ 85S/^,'P'_PYP_\
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MIS&XG=\MN,^YW4_WLM[7M_9$VF=(Z1$1'2(B(CI#)#''7@
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M3$]8F)Z3$_!_8^+\
M                                      .8[]O'3W]COLD\N--BI]-C
MF.U+_M#%\QT_BTIQ_<^.QW;4=G8<TXS$P\6>'FW.NQXCCBJHMZK6J'B6?F/F
M:OTS?:-YA_KO]N'B7,VG^/AXJNROK^]W\=>^PFU_GR3W9(V\99F;1-XO%^RG
M=V5L3]6<K_.?7_%[N?WZ;:,-OSUV\S@UGK;K;Z<6UF>NNND:Z1&^D:S\
M     !U>/$+M2OO'Q3\;NX;B\AO<AV5T;U;N6;DARMOF^8-CSVE8:_V7'764
MM8+6*[R6)S\MS:W?/LPUTW4,E-<<=?%5%/E0]N^+5\(]J>2>'XZ33;\;SF^V
M^.)I./7#BW.2N&]:6FTUIDQ12^/YK1-+5F+6B8M-9?E7&QPWDW(<56)C'M][
MFQU^6:ZTKDM%)B)UTBU=)KUGI,:3,=6Q37;H0
M
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M
M                         K3?N5/,7^T_C/J7BEI^?^%O7D7F(<MO-K:5
M?Z[:=*:;=_,N[>:>*:*ZQG]9[U;X^VCKX]4=[C\=D[6OCFBNOA9/_3:]/?ZU
M^RMW[5YC!W\'X[AG'MK6_=MR6XKVUF(F)K?]/MIRWF.DX\N7;9:S%JPD)]OG
MBG\S\AR^3;NFNRV%.W',_"=QDC2)T^$_3QS:9_&MK8[1UB%%9>8F<
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M_N?(ZH3RU*UP
M                '.S_ '!'?]'=_P!D/8FOXV\AO=:Z U74ND<//:SW%5O/
MD\1;7.X;Q5+:SVEI\;)8O?-SR6)GYX]WB6G&1U4RU1^W31Z'/Z?_ (#;PG[<
M>.Y#<TFG)<_NL_)9(M$:Q3):-OMM+1:W=2^UV^'/7]WMG-:)K%NZ9GEZ,X.>
M']?[?/DB8W&^RWW%HF(UB+3%,?76=8G'CI>/AIWS&FNNL)*:[<
M#I&_13UQ!UQ]7GC5%S%9TY7=K/>^Q\W<V-WD+J&]GV_L7:KS!RUTW],7%I>6
MFFQ8RTN(8(Z+>FXMJ^:>9.:JII?.']\WD=_(_N>\EOK?]+LK[79XXM6E9K&W
MVF"N6([=>ZMMQ.;)2UIF\TO6)[8B*5K_ /<_(3R'L?D)UGZ6&<>*L3$1IV8J
M1;X?&)R=]HF9UTF/A\(EU1(:M
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M^*?R'RZ>8VU.WCN2B<O3X1GC2,T?LFTS7+.LSK.2VG2-(GY0':0
M
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M
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M7D6^Y?NFU=SN\N2L]?W;7M-8CNZQ$5F(K$Z:1$1I&FC/S 71@
M
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MOBF:VG97KT_*VE;1_EK,Q/[)=/1YD%=
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M:5K$1$1&D=(A9KLMGM^/V>+8;2L4VN#%7'2L?"*4K%:Q&G3I$1#RKM')
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M)F(_>^$3,1^<LM,3=6
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M_:_BD^6^&;G:8(B>1V\?7P_#K?'$S-(_^*4FU(ZQ'=-9F=(ETN'FN5Z@
M
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M.OU<G;72)^6T]>NELM5 C$
M
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MGA_%>1Y2MNW)@V6:]9UF/GC';LB)CK$S?MB)CK$RZLSRL*SP
M
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M3_T><M_V)/\ \%5TXGF95V
M                          *P7[F_ROBT+QWZU\2->O?QL??>R1;SOL,%
MQ:5_$ZOZRR-G?X?'9.QKXYO(?ZL[(JL+JQN(_P 4?\&KN.K_ &W"SG^F;ZIM
MSWL/DO;7(4_[W<#MIVVUF8M'=O=[2U<EZ6CY9^AL_JTRTGK_ *9BM'PE(S[=
MO&)WO/;CRC/'^C['']/'TGKFS1,6F)^'R8NZ+1/_ #6LJ/2[I,8
M!(1]4W2/^8/[#O%+KJ>S^=B(NU,3OVR6\E'JM)]9ZIM[OLW.6-_5SQZ(K/+V
M&IU657//-/-=5S311SQ)70C[]U7FW_%_]O7E?D5+]F[GBLFUPS$_-&;?3798
MK4_.V.V>,D?'2*3:8[8E@OLSF/Y%X)R>_K/;EG;6Q4G\>_-,8:S'[:S?N_R:
MSTB73Z>8Y7.
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M1%HA+&BBUB
M                               BB^[SJV7M?ZP_*/&66/\ G9?3M;UO
MM+%RTV-WD)\;%UKNNN[;LV0@ALJ:I8O3H^-RD,L]7',-M;S22R<\1T55<2K^
MR7RBOBGW-^+[G-D[-IO-SFV5X[JTB\[S;9L&&DS;I/\ I-\%JUCYKWK6M=;3
M$3LWT[R4<9[&XW)>W;BRY+X9ZQ&OU<=Z4CK_ ,\FDQ'QF8B(ZRYK3TD+!0
M       %AS]M#VE%I7V [#H%[D/9L^Y.A]XUS&XVN^M+6*_VK4\QK'8&/N8[
M>XJIGR5YC]6UO-\40P>J2F*>67GCVXZZJ:]OZE7B]N:] [?G\./NS<-SNVS7
MO%;6FN#/CS;6\3,=*5OGS;;6UNDVK2D3W6K$Z(^X7C9WG@^/?4KK?:;W'>9T
MF=*7K?%,:QTB)O?'UGIK$1\9A?F4*H2
M
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M)K&D]LS;7Y718>=U H
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M_P"CSEO^Q)_^"JZ<3S,J[
M                        '\>1R./Q&/OLMEKZSQ>*Q=G<Y')Y/(W,%EC\
M=C[*"NYO+Z^O+FN*VM+.TMHJI)99*J:(Z*>:JN>...>7VV^WW&[W%-IM*7R[
MK+>M*4I6;7O>TQ%:UK$3-K6F8BM8B9F9B(C5^\>.^6]<6*LVRVF(B(C69F>D
M1$1UF9GI$1\7+Y^RWR[E\WO,WN/OFRKO*-(R&8AU+JG'WG-W'7C^K]+@XP6I
MS<V-[55-B+S9H;:3.7]GQSS1;Y/*7--//-/XY>G?[:_4=?27IKA_!,T4GF\>
M&<^^O7MGOWNXGZN>.ZO3)7#,QML63XWPX,<SU6-^O?%H\.\2VG"7T_65IWYI
MC3KFR3W7ZQ^]%-8QUM^-*5EH>WLS0         !:@_:Z>/\ _47>'D%Y*Y2R
M]=AUCH>'ZOU:XFF],=6S=DY.K,YN\LK?BRDYEO,-KFF4V\DG-S#Q%#F/3Q%/
MS+Z[:K7^J!Y__+O"/'_6VUOIGY/?Y-[GB(Z_1V=/IXJVGNC2N3-N)O$=ENZV
MWU[Z=O;DC7]Q_.?I^&V/CV.?GW.>V:\?[3%';6)G7X6ODUB-)UG'\8TTM=B4
MK(@@
M      (>/M_^T76/KSZ<IP&J2PYOR;[<P.?M>HM>BYQ]U%I=O%'^FS=M;C:7
ML%_;T8'7\A=<?IMG<6]=.>R-O7;4<?'@OYK68'VA_:_R?W">8SO^5B<'K/B,
M^*V_RSWUG<3,]\;#;VK-9G+EI7^-DI>)VN&\9)GZF3!3+M;U7ZWW/G?+?7W,
M33QW:WK.>W6/J3\?H8YC2>ZT1\]HG^'28M/S6I%N=1N.X[7V%M>Q;SO.Q9C;
M=RVW,7^P;/L^P7]QE,WG<WE+B2[R&4RF0NY);B[O+NXEJKKKKJYYYYY>B+A^
M'XKQ_BMOP?![?#M.'VF&N+#AQ5BF/%CI$5I2E*Q$5K6(B(B(3TVFTVVPVV/9
M;+'3%M,5(K2E8B*UK$:1$1'2(B'FW8N0          MH?M6NLOF;_P"7G<MS
M9>W_ $[I_6'66&R,^"]?S/ZSS6S[5LMEC-FDJI^/^F_T%B:[ZPBXK][Y=I++
MS1[4/N5._P!4SR;Z/ >(^'8[Z_J-YO=[DI&7]W]/CPX,-KX8^/?^JSQBRVT[
M>S+2G=W7[8P_<KR/9L>*XFL_XF7-FM'=\/IUI2DS3\=?J7BMI^';:(UUG2YD
MIN1+           1L_;#X66_G-X8=D=7XK'PW7:&JP_W+Z8N:J:.+BCL34[.
M\EM<'%-7^.(H=VPUS>863FKGB..J^HFJXYYAI_$D?M2]SY/1WN7C?)]UDFOC
M&ZG]'R->NGZ3/:L6RS'XSMLD8]Q&G68Q32.EY;!]8^76\-\MV_(Y;3'&Y9^C
MN(_#Z5YC6W_QNT5R1^,]LQ^+F4W%O<6=Q/:7<$UK=6LTMO<VUQ%7!<6]Q!75
M%-!/#+33)#-#)3S3535QQ535QSQSQ^7I?QY,>;'7+BM%L5HB:VB8F)B8UB8F
M.DQ,=8F.DPL0K:MZQ:LQ-9C6)CX3'YP_%^W]          6!/VZOE_\ V!\T
MJNC]GR=Y!UWY3X>+2(;?B3\XW&]MX*2;+=;9FZB]N>;G]5AKR6 IIAIIYKNL
MS;235<0P<\TP"_J(>H?]?O3'^N_&8J6\A\6S3N9G3Y[[#+$8]YCK.L1_#GZ.
MZF;3.E-ODK2)ODB)T=[Z\5_GGB/\YVU8G?\ &W^IK^,X+?+EK'^Y^3+U_#':
M(ZV7_E!*#P
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M+$=>LX)C-&G;UF=<<=L?"9TB>DRZ>CS(*Z
M
M                         $#W[CGL?^A_K0VC6?=]O^\?<'4W7'H^)\GW
M_P!+RM_V[[7O>KCX'X_M7Z_>_CZO1[7X_P 3\\3L_IT>.?SO[E=KR>FO\GX?
M?[S][33OQUV&NG]__AVG;^&O=_=;J]!<?^L]AX]QI_P3:9\OQTTUK&#_ "_X
MVFG^7\'/>>@=.@         !:Y_:N]70Y+M[RS[JF@]-QIG6_7_5V.N:^,A3
M[L/9FSY;;,U!;<T2TXN?X]?4UA5/[E%=Q%[L/MU4422<254_U2_*+[;Q'Q/P
MNEOX>\Y+=[V]8[.D[/#CP8YMT[XUC?Y8KI,4MVW[HM-:]L9ON4Y*<?%<7Q$3
M\N;<9<TQT_WFE:5F?[T:_7MIITG2==9B-+I*F)$8
M
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MSB?^Q(_^"LC?2-9^         D@^H3_TE_AO_P <.-_ZU99'+[NO_I:O,?\
MQ/?_ *9C8![4_P#1YRW_ &)/_P %5TXGF95V
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MV^RBNUK\/]ZFTY/A^6:^6(UF9TT^'PB8U#QJ@
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MC;Y9BEIC2;XY^;'>>D1K:DUF=.D6UB)G35M0U8QH
M
M!RU?LBZN@Z9\]O+CKNR@^)BL1WQV%D\!9_C(<_!UG;<Y<[CK%C[N4EGR%W\+
M7L_;1?(EDDYN/1[O%57%?%7/J)^W'RB_F7H;Q+R'-;OW67@=I3+;Y/FS8,4;
M?-;2D12O=EQ7MVQ$=FO;I$QHLC]?\E/+>$\7O[SKEMLL46GIUO2L8[STTB-;
M5F=(B-/AIT:3MU,O         ?=U78\GIVSZYMV%JAHS.JY[#['B:[B'BXMZ
M,G@\A;Y.PJG@JYXIGAINK6CFJCGGCBJG\\?[+@\IQVVYCC-SQ&]B9V>ZP9,.
M2(G2>S+2:6TG\)[;3I/X2^.YV^/=[;)M<VOTLM+4MITG2T3$Z3_9+KCZKLF,
MW+6-<V_"US28;:L#A]DQ-=Q#S;W%>,SF/M\G85SP5<\U0356MU1S51SSSS35
M^>/]AY*>4X[<\/R>YXC>Q$;S:Y\F')$3K'?BO-+:3^,=U9TG\85=;G;Y-IN<
MFUS:?5Q7M2VG6-:S,3I/]L/O. ^
M
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M]1YEM]C6?DVVPIKT_OY,F2T]?QCLC'_9.JR"KD:
M
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M:FZ\#YC%DF8K''9[]/SQX[9*_&)Z3:L1/[-=)B>KJ//+XK?
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MV7+:;9;3,S,SK,S/69F9ZS,SUF9^+^Q\7X
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MZ_ILVD3K_>OAO.G3I\])M/7KCKK/RQ%P=4$BJ
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MWM\D1I$:1F_C5TB/PTR1V_LT2!M ,&
M
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M&-KD
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M:QK$:VM@O$1K.D1K,_&9B/S=5IY7E:0
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M:?AIVU^.O2Y*IT1.
M                  5ROW#WV#R^.?05IXJ=9;!^G=S^1N'KDVNZL)KN#,:;
MT3S>WN-S=_:W%O)#':WG9&5Q=Q@8>:_=IKQL>5_%,<U,$M-BO]/7[?J^Q?/;
M^U/)MO\ 4\-\<S1&"MHK./<<GVUOCI:)B9M79TO3=6B.W3-.UUFU)O2=^>B/
M!8Y_FY\FY''W<1L+_)$Z37)N=(FL3$_&,43&2?A\\XOC'=$T,E[R:P
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M2:VK.EHF/SB8F)?8<-\@
M                                       %/']U1UQ-1D/#KMVUBO);
M>XL^W>N,]-7=X_C'V4UG/I&S:E%;6'-,>4KO,I1?9KF>;CF:WIHLX:>>(:ZN
M/?N _I8^1TG;^8>(Y9I&2M]AO,416_?:+1N<.>;6ZT[:37;=M?EO,Y+S'?$3
MV2L^VGD(FG+<7:8BT3@RUZ3K.OU*7UG]W2-,>D=)^:?C'PJ%K<TI@
M  '0/_;<=@5[E];5CKE<^2EIZF[R[4Z_BCOJ+>FUMJ,E3K?:G,&&JAGEDDQM
M4O9=4E7,M,4GS))^.*>:.**ZZ ?ZCW 5X;[D,G(Q7'$\MP>QW4S77NM-/K;'
M7)K$1%]-G$1VS:/IQ2=>Z;1$&_N V,;3V#;<1%8_5;+#EZ:ZSIWX?F_;_!TZ
M:QVQ7\=8B?- II$
M
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MUBO2(5@<UR$\MS&[Y2TS-MSN<N6=8B)_B7M?K%?EB>O6(Z1^'1E1BSK
M
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M8C6?[9=<%Y+%78
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MF%;7F?D>;RSR?><]EZ5SY9[(_P W%2(IBK^'6,=:]TZ1K;6VD3+;1J9BX
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MWEZ%\J_D?EW\FW-IC8<E3Z>GX1GK\V*T_P"Z^?%T_')69Z54 E^J<
M    #H9_M]/*ZCR)\"];Z\S62FO-^\8,E1U!F8KKFXKN)-&CMN<EU3DHII9[
MJBK&P:QS7A8*.*HZHZL%73[5$7M52>>_^H#ZJMZ\]\;GR'98XIP'D^/^88YK
MI$1N9MV;ZDQ$5GOG-IN;3I,3&YK/?-N^*P3]Y^,SP/FV3?X:Q&QY&OUZZ::?
M4UTS1\(Z]_\ $GXZ_4CK,ZQ$YZ#C3(
M                                                 "O=^Y8ZR_K3
MZ\\7NUO9>N\Z>[XZ^VNYR4."_4KFUU_9,9M/75]83Y>BJB77,/D,[M^+EEEJ
MYJ@N+NUM8*J.9*X:X[!/Z;'DW\F^X3+PF2^F'F.!W>"M)R]E;9<-\&[K>,<Z
MQFR4Q;?/6M8TM3'?+>)[:WBV]/M[Y'])YW;9VGY-WLLM(CNTB;4FF6)BO]^T
M5I>(CXQ6UK:Z1,30.7WIO          +AG[5?L>"NP\QNHKJ6SBN8+SJ+L?
MP46F0YR%[!=P[QK.VRW-_P 528JBSQ<EEA>((>>(;BJN\FJXYFHIY]BH#^J=
MXY>-QX?Y=BB\X[4W^SRS-J=E9K.VS8(K7I?NO%MSW6^:D1CI$]DS'?%3[EN/
MF+\3RE8F:S&?%;K&D:?3O32/WM9UR:SUCY8^$_&WLJ+18
M
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M^IEFF.-/QLQKS+?5XSQ+D]_?3^%L,\Q$_";?3M%:_P#+6F*_Y75:>5Y6D
M
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MLZ:Z:Z:SI^;V#IW$
M               >)[)['T;J#0MN[0[,V;&Z=H.AX'(;-MFS9>N2BQQ&&Q<%
M5Q=7,E$$<]U=3<TT\40V\$<MS<S5410QR2UT45=WXWXYSGE_/;3QCQK;9-YS
M^_STPX,..([LF2\Z5K&LQ6L?C:]IK2E8F][5K$S',X_C]YRN]Q<;QV.V7?9[
MQ2E*_&UIG2(_*/VS,Q$1K,S$1,N9W]EGGUNWV%>2.>[8RW&8P/6N#^1K?3'7
M60OY)X-,TF&6CBF[NK&*\N\5;[AMM=O'>YJ:VJKIKN/;@IEDM[6WYI]*_P!M
MGH3A?M\]<8/%-I]'/Y)GTS<CNZ4B)W&YF)^6MIK6\[?!$SCVU;Q$Q3NR36N3
M+DUL,]>^$;/P7Q^G&8NR_(7TON,L1I]3)^43I%IQTUFN.)_#6VD6M9'ND"SH
M          !8<_;F>&EWWOY?7'D=LV.]SK/Q7LX\Y9UW=K%-99_N#:[+)XO1
M,5#3=1<4S?TG8TWVP23V]?,UAD+'&<5T\475/*O;^HI[DQ>"^HJ^N>,R:>2^
M4WG%;MM,6Q<?@M2^ZO/;/3Z]OI;6*WCMRXLFY[9UQ3#1'OSRVO"^*QP&WM_W
MQY*>V=)ZUP4F)R6Z?Y\]N*(GI:MLFG6J_,H50D
M                                        5%OW+_GC\'$ZQX Z!?\
MXN,U_37:7?=]9WG^TQ-G<SY'KOK6^MJ:*XZOG92VM]ENZ:^:)8OAXJNCGFB6
M3CFV[^FKZ)^ON]S[]Y_'_#P_6V7%UM7_ 'RU8IN]Y6WQ^6EK[/',:UM]3=1;
MK2LI2?;UX5WY<GG&^K\M._#MHF/[TQ$9<L3^RLSBK^$]V2)ZQ"G,N%2N
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M&Y/JQ/\ >^C;Y<U8_#33LR6^'3%TZ])Z"SS_ "#(
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MV^_QSK^/;>F2DUC^V9I:?]ROM*&T)@
M
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MCL\YR @
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MBQ5BN*L1%:Q$1$1$:1$1'2(B.D1'2(62UK6E8K6(BL1I$1\(C\H?B_;^@
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ML<CN)K6--(I;+:U-(CI$=DUTC\/A,1,:-S6FV)
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MFGEFYYF)G]#$_3P1/]W!29BG2>L3>9MEM'X7O:(Z:-_6@V#@
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M]K2L16NNLS$:VF;3,SGY@+HP               %1;]T%XE?.Q/2?FGK&/\
MS<X7\]%=L347'^WQ-Y<Y#9^K,O38<4444_!RESG;&]NN:JY9?F8^+\<41<?B
MV[^F)[9^AN^:]+\GD_AYO^^>QC3_ 'RM:8=]C[OC\U*[7)CII%:_3W%OC>4I
M/MR\H[,N\\0W-OEO_I.'I_>B(IFKK^V(QVK'PCMO/QE3F7"I7          /
M2:;M^S=>[?JN_:5F;S7-QT?9,'M^I;#CJJ*,A@MFUK)VN:P.9L:Y*)**+S%Y
M6RBGBYJIJXXKHX_/'/\ H==S/$<9Y!Q&ZX'FL--QP^^VV7;Y\5^M,N'-2V/+
MCMII/;>EK5MI,=)EQ]WM=OOMKEV.\I&3:9L=J7K/PM2\36U9_9-9F)_M=6SQ
MF[RUSR8\?.G._=5KA_1NV.O=9W*FTAEBFYPV3RF.AKS^MW54%Q=Q4Y+5\_1<
MXZ[HIEDXCN;62CU5>G\\^57V7X/R/K7V!S'@7*Q/ZSB>0S;?NF)CZE*7GZ6:
MNL5GLSXNS-29K&M+UG2-=%9WD7#;CQ[G=WPFYU^KM<]\>O\ G1$_+>.D=+UT
MO7I&L3$Z,Y,'=,
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M0UW[:V-N1]<\KMZ:ZUV\9>GY8,E,T_Y-,<Z_LU=,IYI5>(
M
M                                  "*[[LM\_MY]7GEIEZ./<N<UI^L
M:';6].4_2I[C^XO8NG:->\P3<13R7?PL5G[BZEM::?\ 6K>"2.JJBBJJ2F4O
MV5<#_K#]SWB>SGICP[S-NIGL[XC])M-QN:ZQK$5[KXJ4K>9^2]JVB+3$5G97
MI_9?K_8_%XI_=IEODF=.[3Z6+)DC7X::VK$1/X3,3UGI/-.>DY80
M  LX?M<=#_5?+CR [(DY]<.E^/?.J105XOY$5&0W_L/4<C!?QY:J7BC&WEO8
M:#=041<1U5W,-U+SQ713%73)6;_5!Y[]+ZEX#QRO2^]\@^O,Q?29IM=IGI-)
MQZ?/6;;JEIMK$4M2G29M$UCM]R&]^EXOL>/CXYM_WZZZ=,6*\3';^,3.6)UU
MZ3$=)UC2\DH^0V
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MV-KSW3&VO6O73I]>M[1_=B>N.)^$ST^,5Z4\EOZ58         #I&_1/O?\
M7GU;>,<T]_9WN4U2S[%T3*Q6<?L_IO\ 2O:FZV& L+J/_1\S^COTR>NKCGGW
M/>XKY_'-7/''G#^^C@OY#]T7DU,>.]-KN[[3=4FTZ]_U]CMKY;5G_-_4?6K$
M?AVZ?"-5?_NC9?HO9'(Q6LQBRSBR5U_'OPXYM,?L^IWQ'Y::)=42&K0
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M,M5\)1.A8
M           JO?N<O+S^C>HNL?#'6KST9ON&\M.U.RZ(;[VY(.NM,S4D.FXJ
M]L(;BF2>SVCL#&R7D=<U',5,VM_R^JO^,=I7],SU'_./+N3]R\E379</2VQV
M>M=8G=[C'$[B];S&D6P[6\8YBL]TUWG72O2TE/MU\6_5\KN?+=Q'\':1.'#T
M_P!]R5_B6B=.DTQ3%9TG73+UZ?&D\NI2^           >VZWZXWGM_?=1ZOZ
MTUK);COV^9['ZSJ>LXFB.N^S&:RD]-O:6T=<\D%K:P\55>N:XGDBMK:&FN6:
M2B*BNNGI?)/(^#\0X'=^3^2[G'L^ V&"^;/FR3/;CQTC6UITB;6G\*TK%KWM
M,4I6UIB)XG(<AL^*V67DN1R5Q;'!2;WO;X5K$:S/YS^R(B9F=(B)F8AT;_J<
M^LO3OKKZ-BM,O%A]C\C^Q;.TONZ^PL?5/<V7$L-Q<W6(T#3I+R*&:TT_5(;K
MB.N7B.*;+Y#B2\FIHHYM;6S\Z/W7_<OS'W#^<3FVDYMMZYXZ]J\=M+Z5MI,5
MKDW6XBLS%MQGFNL5UFNWQ=N&DS;ZN7- 7V=[$W?GO,S;%-\? ;>9C;XITB?A
M$6RY-/CDOIKIK,4KI2-9[K7E=14:R                 :W^7_CSA/*_P 8
M^[?'?/?#HM^TM#RV!QEY?T4UVF'VNW]K,:3L,O'-GD*J?Z;W+&V%_351#))1
M5;<54<>OBEL?U#["WOJGV;PGL/8=\Y.+W^/+>M)TMDP3KCW.*/FI_C;>^7%,
M3:(F+Z6G299!XKSV;QCR+9\]@U[MMGK:8CXVI/RY*_&/W\<VK\8CKUZ.57M6
ML9[2=GV/3-JQLV&V?4<]F-8V/$7%4-=QBL]@,A<8K,8V>NWDFMZYK'(6DD57
M-%=='-5//IYYX_'+U/<7R>PYOC-MS/%Y(S<9N\&/-AR1K$7Q9:1?'>(F(G2U
M+1:-8B=)ZQ$K+-MN<&\VV/=[:T7VV6E;TM'PM6T1:LQKUZQ,3U?!<Y]@
M     %X7]L5Y0?UUXY]K^*V<N+R3-]$;A'O&F575W[MI7UUVK->W5]AL19U5
M226O].=@8G)7MW5QZ(I*MAA]%/-?$U7-(O\ 4U]8_P C]B\5[3V-:1LN=V<[
M;<=M=+1N]C%:UR9+=(M];:Y,./''6T1M+ZSV]D1#G[BO'/T7/[7R7#$?1WN+
MZ>32.OU<.D1:T_CWXK4K7\8^E.O32%GU6,CF
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MO.,F(M&YVN7%I,S$3]3':FDS&DQKKIK$ZQ\76H>3A6
M
M                                KN?N9MZM]:^OW4M3IDQLF0['\BM#
MPU-E<7M$63HP^ U3?MMR&9QMCQ7Q/>0V.3PN/M+BOT\Q0\9"CU<\5UQ\56&?
MTT>"R<E[_P!WRTQDC;\=X[NLG=%9FDY,N?:X*8[V^%9M3)ER4C7NM]*VD3%;
M:;X^WC96W'G.7=?-]/;[#);6(Z=UKXJ169_#6+6M'XSVS^$2H0+YTV@
M    %T_]JWU_7C>F?+?M3F#)4Q;EV=UOU_1<RUV_.(EKZTU7/[')!8QTP4W5
M.2MZ>V::KOFN2N.J*6WXHIHYXDYKI?\ ZIG/UW/F7B7BW=C[MGQF\W6D:_4B
M-YGQ88FTZ]O9/Z"8II$3%JY.Z9B:Q6(OW*[Z,G+<7QNM=<.VRY=.O=_&O6G7
M\-)^C\O376+:Z]-+6:JQ&<
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MJ\;XOB\>PVB-UR&6)M$?&,.*8O,STZ=V3Z<1UCNB+Q&L1:%[Q14A:
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MIF%OW%[",'F.VWU(B*;C85UG69F;X\F2LSI/P^2<<1II$Z3TUUF;(ZN%'\
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MZ8\<:=/EK$1,_P!ZVMIUM:9G:)J]C8
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MS>4<G?Q[A\DQXWMKZ6TZ?J,M9G6\_GCI/3'7X3,?5G76D4L(J^VBP
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M
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M4^6L1$5KI'X*R?)ME7C?).0XZO;%=OOL^..V-*Z4RWK\L?A'3I'X0S\P%T8
M
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M--:SFTB?Q_QM=9UG69CX1$)VT%FEP
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M_O</DT^3><[J^*T6V&SG]-BTTTTQ3/?;6)F+=V6<EJV_&G9'X0EO1+:N
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M;]T8?N5X[OV/%<M6/\/+FPVGM^/U*TO2)O\ AI].\UK/Q[K3&FDZW,E-R)8
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MNNYST\(XV\3AQ6C)NK1.NM_CCQ:Q/]S7OR1,3\\TCI-+1-LM5 C$
M                                                      A^^\WR
MB_RQ_7GVQ^E7_P /=>]O1X_:=[?/^LT_W QF6_K6^B_%K=56WPNN<9E_;N?\
M'V+N2#T2QS50_F7OV.^K_P#C-^X3B?U6/OX7@M>5W&O[O^B7Q_IJS\U=>[=W
MP:T^;NQQDUI:D7TVKZ:\;_UB\[VOU:Z[/9?Z3D_+^%-?IQ\8UURS36.NM8MK
M$Q$N;\]&R?H          "P5^W[^O.W\J_(F[\A.S</#?='>-F2Q62@QV0MZ
M+FQWSN.6J+(ZEK4]I=6DUED,#JME'5F,K3S)Q5Q-^G05120WDO,=?_W^_<'D
M]5^O*>OO&<TT\W\DQWI-Z3,6VO'QK3/FBU;1:F7/:8V^"=-.W]3>+5OAI%M&
M>\O.[>,\#'!<=>:\SR%;1,Q.DX\'PO>)B=8M>?X=.GP^I;6)I&M_A08A
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M2QD
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M?")5T5VM
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MECLTK^5=(TCX1(2CZP4
M                                        !3L_=)^2-%SD_''Q(P]]
M#)3C(<KY ;]9<4W%=<5[>\970.L?Q-35390S0V5.T5S0U<23^W<V]?XBHJIY
MGN#_ *7?KBV/;>1^VMY28G+-.*VMND1-:]FZWO3]Z8FWZ**VC2NM,E?FM$]D
MK?MN\?FN/D/*,M9^::[;%/3X1VY<W[?C]'2>D:Q:.LQ\M1!;@E*
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MXZQK;Z,S$1\=(S3KW=(KK;XQ#H://>@D
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MUEO:][VG6UKVF;6M:9^,VF9F9_&9?><!\
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MG%DTU_Q,.G;:?]UCO%8T_#'.L1/6;1ZKU&\
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MQ;KYOI[C88[:S'3NK?+2:Q/XZ16MI_&.Z/PF%B-7FT.
M
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M[Y.LZS\]IMUG\9Z]9>\="X0
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MEXK.D?'332=='5@>5M6@
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MKQ6+7'ML<_W<<3^],1TC)EGY[_&8^6G=:M*RD@1Q8
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MFG[)Q:]\S_\ &;9?AII/7X:Q/2(><9
M                                                  !!Y^XAT2WV
M[ZP.T=@FHQM<G5W873V]VE5]9475U%<9#?<7UE57AIZZ*JL=DN;7L66FJ:GF
MFJJSJGB_/XEYXYF[_3TYW)Q'W.\7Q])R17E./Y#:V[;36LQ3:WWNF2/[].[:
M5F*SK$9(I?XUB8W'Z'WMMK[&VV".[3<X,^.=)TC2,<YOF_.-<4=/\[MG\'/
M>A9.\         !<9_:I[S[V \S^M;FXP\/Z;F.E-YPUI[WMY_(?K=EV1@-E
MN/8DN^?EX?#_ -/XFGUQ04_'GOOQ+)5[T---/7]5#@^S?^&>2XZYI^KAY+;9
M+::XJ?2ML\N&-8K\N3)]7/.EK3WUQ?)6.R\S%'[EMEIGXCD*Q>>ZFXQVG^['
M;.*U(UTZ6MW7^,]8KTCI*W2J11;
M
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MV&XR=)TGY,5[=)_">G275^>4U64
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MI'3_  XO/TYZ3,1K3MG3XQKI.DQHV<:R8Z
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M^C=KP\X^;\RK3/RD1K3;?+?#BF8^.3XURY(_"(F<=)UF/J3VVK5\6=I&@
M          +I_P"WB^KZOK_7++SU[WUN'^L-[P,7'C;K&:QEO)/JNC9F+W;O
MM^2.^@EN+3/;WCZXX,#+#[%4. EGN/5/'E8OCTO_ -0G[GJ^0<C?T/X+N;?R
MC8YY_G&;'>8C/N<<Z5V$368BV+:WUMNJV[HMNJX\>E+;6_U(B^]_8\;[<3X3
MPN2?TN&_^EWK,Z7R5^&#I.DUQSK.2)UUR16NE9QSW6LU5B,X
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M*\BXC)P'/;SA<NO=M=SDQZS.NL5M,5MKI&O=72T3I&L3\(^#.3!W3
M
M           - OM2TW^N_KC\T<)[EG'\'Q[[#W+U7UO\F'G^W.&F["]NB/\
M'/IO)?Z7]-O)_P#HKCFBO^'I_+?GVL\S_(ON+\,WNEY[_(-IM_EGMG_2\D;3
M69_S8^MK>/[U.ZOXLX]:[O\ 1>?<1FZ_-O\ %CZ3I_BV^E_L?/UC\8UAR^GI
MW6-          ++'[7O>?T?S3[IT*XN,/:V>[^-^8R]K\V;V<M?Y_2^Q>O\
MX.+POKNXHKKUX+9,I=W,%,,L_,5GQ+351'#-ZJV/ZGG!_K/3'"\]CKFMFV7D
M>/';MC7'7%N-INNZ^32LS7^+AP8Z6FU:]V3MF+6O32/?W';+ZOB.SWU8O-\/
M(5K.G[L5R8LNLVZ=/FI2L3K$:VTZS,:7JE&:&(
M
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MFZ_-@KCZ3I_BY<>+_8^?K'XQK#I?/-6KT
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M/()\:\(W_)8[37=3AG%BF--8R9OX=;1KT^3NF_7\*STGX3T]'F15T
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M]M,=YG_;X]<,QIW3/2E,<ZZ5B==(B9BTS815]M%@
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MKQ?P+Q7P_%%>%VM*[F(ZYK_/FMTTG7)/6-8F=:T[:]9TK#2%NUF(
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M6TS-K3,S,S,ZS,S/69F>LS/6905M:U[3:TS-IG69GXS/YR_9^'\
M                                                      4YOW3W
M=OO;!XK>.%A=^G].P^Y=V[58>Y^?>_6KV+1- N_:XYX]OXWZ#LM'JJXJ]?N_
MBGT^FKU7"_TMO">S8>5>QL]-?J9MOQN"VGP^G6=UNJZ_CK]79SITT[>NNL:2
MN^VSA],')\_>/WKX]O2?]S'U,L?Y>[%_L?M5%EMR4@         "9[Z&O%>W
M\FOL$T#)[!837>A^/F-NN]MFXKQ]%SCKW+ZMD,;8=?82ZNKJ.6P@FNMYRUE?
M>S71)+=66,NJ8Z:?Q5/##3[[O:>3UI]O^_VW'Y(ISOD&2O&8?GFMZX\]+VW>
M2M:S%IBNVQY,7=$Q6F3-BFTSK%+ZD]U^2V\=\&SX\%HC>[ZT;:G728K>)G+:
M(CK.F.MJZ](BUZS/X1/1D>== @                      !^-Q;V]Y;SVE
MW!#=6MU#+;W-M<143V]Q;ST51303PRTU1S0S1U<TU4U<<TU4\\\<\?A^\>3)
MAR5RXK37+68FMHF8F)B=8F)CK$Q/6)CK$O[6UJ6BU9F+1.L3'QB?SARM_.[Q
MVE\3_,+R%\?>(/CXOKOLC,6VI1\SW=S+5U]L%-OMG6\]S/??FZDO+G0<]C9)
M^:ZI?\:NK\22\?B2KU,>BO8=?:WJ#Q[V!W=VZY'C<<YYTK$?J\6N#>1$5^6*
MQNL6:*Z17Y8CY:S\L65>%\]'D_BFPYW77)GV]9O\(_BUUIETTZ:1EK>(^'3\
M(^$:EML,G          7T_VT7D%QV3X/[1T;?W,->9\;>SLQC\=:1<XRFN#0
MNU[C(]@8*XN(K>6G*<S76\3;/3Q+<P^BN.*FB&:3VY(K>A[^I3Z_GQOW=M?.
M,%9C9^2<9CO>T]^D[K8Q3:98B9CLTKMHV4]M+:Q-IF]*]U;9(4?<+P7\O\QQ
M\S2)^ER&VK,SU_Q,,1BM$:].F/Z/2)UUF9F(UB;6+U=K0@
M
M   #Q_8>I_U[H&\Z-\_]*_K/3]FU/]4^+\[]-_J+"WN'^?\ "^39_,^'\SW/
M:]Z+W/3Z?73^?5QW'CW*_P AY_8\Y]/ZOZ+>8<_9W=O?]')7)V=VENWN[=.[
MMMIKKI/P<O8;K]%OL.][>[Z.6E]-=->RT6TUTG373372=/R<BUZVUHX
M    "9CZ!-Y_HS[2>@+*:XP]GCM\P_;.C9&[S$WQ_;^9U7M^>PMOBYZ[NU@H
MS&5VG7;"R@HDXF]_Y-4,<?,TD=5,-_OYX/\ G/VN\_FI7-?<;#-L-S2N.-=>
MW?;?%DF\=MI^G3!FRY+3';V]D7M;LK:)U+[PV7ZOUOOKQ%YR8+X,D17K\,U*
MVF8TF>VM+VM.FFFFLSI$NC4\ZB X
M
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MX^GPG2+Y=+=8UK_"U_'YHK.GXQT"E B#@
M                                                      #G0_?Q
MW[=]W_9)VOA8<C\W5NB,/J_2>KQT>U1%;2X#'?U#N]%<<----5Y%V-L^7MZY
M:^9)JX;>*FJKBF.B./T2_81X%B\)^W#BM[?'V<ISN;/R6>>NLQEO]+;:3/\
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M[\9V?-8XF;[/=32W^UQYZQ$VGK$?XF/%7]V9UM&DQ$3K>84>(:@
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M>#<UWN'9[2F\I&E<E<..+Q$S$S$6BO=$3,1.D3\8AB!E[M0
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M9N8Y;).7?9[S:TS\(_*M8_NTK&E:UCI6L1$,P,0=4
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MC\$1:.O^-EB+W_9.F/Z4=/A/=$SKK$6-5=308
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MBA)"(
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M!UU_E^:T:1K,SCI.2(T_;-8C_+T=1YY?%;X
M
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M-Y%.%XSC^^8G+NLF3MZZ3]+'%>[733Y?K:1UUGNG2)TG2ZXI91"
M
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MC2(L[V&RP<=L</'[6--M@Q4QTCI&E:5BM8TB(CX1'PB(_*(AX]V[E
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MS9MM;Z<?\]I_$PZ])Z?5K372-=/AU=4)Y:E:X
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MDF2FM*3&L;:MH^$:_'-,3I>W]SK2G]ZUZZZP]OD
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MWJ:,86
M          ^;F<QC->P^5S^:O8<=AL'C;[,9;(7'/--O88S&6LM[?WL]5/%5
M7$-K:P5UU<\<<\^FGER=GL]SR&\Q;#94G)O,^2N/'2/C:][16M8_;:TQ$?ME
M],.+)GRUP88FV6]HK6(^,S,Z1$?VRY*/;G8>3[=[6[.[8S5$T>9[/["W3L/+
M1W%WQD+BC)[KLF2V2_HGOZ;6QIO9J;K)U\53<00\25?FKT4?GT\>LKQ+Q[;>
M(^*\9XILIB=GQG'[?:8YBO9$TVV&F&NE>ZW;';2-*]UM(Z=TZ:K0.+V&/B^,
MVW&8=/I;;!CQ5TC2-,=(I&D:SITCX:SI^<L>L@<X        !]?7L!EMKS^#
MU? 6GS\[LF8QF PMC[]M:_-RV8O8,=CK3Y-[-;V=O\B\N**/<EDCBH_/YJJI
MIXYYXXG(;_:<5L,_*;^_T]CML-\N2VEK=N/'6;WMVUB;3I6)G2L3:?A$3/1\
ML^?%ML%]SGGMPXZ3:TZ3.E:QK,Z1K,Z1'PB)G\G6+\?.H<)T!T5T_P!(Z[#9
MQ8CJGK?3M"MJ[&"FW@O9=9P-CB[W+5T\1Q5RWF:O[>6[N)I./>N+B>N63GF2
MNKGGRC>P/+M[Y]YSR_FW(VO.[Y7DMQNI[IUFL9LMKUQQUG2N.LUQTK'RUI6M
M:Z5B(5C\[RN;G.:W?,9YF<NYW&3).LZZ=]IF*_V5B8K$1TB(B(Z0S Q!U0
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M8M68B8F)B8U5DY,=\5[8LM9KEK,Q,3&DQ,=)B8GK$Q/28GX/['Q?@
M
M          !S0?NFTW^A/M#\OL)[EG)\[?-?W+U6-O\ &AX_N-UWIG87MUQ_
MCCU7D7]4>FXD_P#TMQQ77_'U?EZ5/LPYG^>_;#XAO=+QV;#+M_FGNG_1-WN-
MIK$_YL_1UI']VG;7\%A?J+=_K?7'%9NORX+8^LZ_X67)B_V/DZ1^$:0B[2?;
M'         >OZ]VO^@]^T?>?@?JO]&;AK.U_I?RO@_J7].YJRR_P/F_&O/A_
M,^'[?N^S+[?J]7HJ_'IYZCR'BOY]P&^X/ZGTOUNSS8._M[NSZV.V/O[=:]W;
MW:]O=77336/BXN_VOZW8YMEW=OUL5Z:Z:Z=]9KKIK&NFNNFL:_FZZ;R1JMP
M
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M?MZ:Q]2]:S:?[VEOI1$:]/DG3KW+5JJ]&@
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M%/.N<MXWXAR'-8YB,^';6^G,_",E],>+7X?[Y:O36)GX1,.IX\MJM@
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MOX&*>GX:3ER1'2<E^NGQC'2>RNL]]KRQHHM8@
M                                         -&OLR[,N^H?K^\OM[QT
MGL92RZ'W[!X>\XR$6,EQV;W;$2Z1A<K;7,UM=1UWF*RFQ0W,,'H_-U+%3#Q5
M1S)Q73O#[:?&L7EWO[Q#@MQ'=M;\]M<N2O9-XOCVV2-SDI-8FL]MZ8;4M;7Y
M*VF\Q,5TG,O7G'5Y7SCBMEDZXK;W%:T::ZUQV^I:LQK'2T5F)G\(G7KIHY<3
MU!K(          $M'T>])?WP^R_QSL[JT^5@NL,QEN[<])[?N?!_MAB;G.ZE
M=^CGCT_]T;]%B]7/-/H]WU<?FKCBGF)WWN^;?ZD?;5Y%FQ7[=]R>''QN*-=.
M[];DC%GK_P!J?J;:==>W2=(F9C6'N/F/Y-Z\W]ZSIFW-*[>O[?K6BMX_Z%]2
M?\FCI-/-ZK\                         ?-S.'QFPX?*X#-64.1PV<QM]
MA\MC[CCFJWO\9D[66RO[*>FGFFKF&ZM9ZZ*N..>.?35RY.SWFYX_>8M_LKSC
MWF#)7)CO'QK>EHM6T?MK:(F/VP^F'+DP9:Y\,S7+2T6K,?&)B=8F/[)<H'R:
MZ7R?CIY#]V=$Y;B:JZZG[.W/1HKF>?BZKR.,P.=O++"YBFZIL,7Q<PYK#1P7
M<<GQ;7F2.:FKF&+GGVZ?5EZS\SVWL7U[PGG6TT^ERW&;?<S$1VQ2^7%6V3'V
M]U^V<>2;8YCOOI-9COM^]-FOCO+X^?X'9\UBT[=UML>32(TTFU8FU=-9T[;:
MUF-9TF/C/Q8-9P[D         !TR?IO[N_OS];?BWM%S>?*S>I:'QU%L-,E?
MNW<&0ZAR-YU]85Y"3\U<RWF4US 6%_575557)3>4U5\^NJKCCS2_>)X3_J']
MQ_E'%XZ=FRW>_P#U^+2-*S3?TKN[=D?A6F;+EQ:1$1$XYBORQ"O+VQP_\D]@
M<EMJQIARY_KU_+3/$99T_9%[6K^SMTCHDY1F:Z
M                                                        <_7]
MR7HW])?9%/G_ (^'A_N?T/U9O/N8R+V[V[_3[K:^M/D;#7\2V^1F*?[>>U17
MZ[C\8^*VI]SCT^U'?W_3?YS^;?;A78=V:W\LY[>[;2\ZUKWUP;S3%\TZ8_\
M2^Z8TI_%MEGMG7NM./[?M[^J]?Q@UO/Z;>YL?7X1K%,NE>LZ5_BZ_A\TVG3\
M9@'3X;O          =83Q0W"W[#\6O&K?[3G)56N\] ].;A;59GFCG,56^S=
M=ZYFH><KS'=7L?.2YCO>/?\ 3--3[OJ_%=?'\W/E*]K</D\>]H^2<!E^G]78
M\_R&WM]/7Z>N'=YL<]FM:SV:U^76M9[=/ECX*R?)]I;8>2<AL;=O=AWV?'/;
M^[K3+>OR](Z=.G2.GX0S\P%T8
M
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MR(6"U?S1@
M                             "EM^Z8[M_5>VO&/QVL;O_!TG0]J[=V*
MVAK]<<V0["SD>IZU1>\<<U4QWF)L.OLA7'1_+7Q#DO55QS37'RN=_I<^$_I?
M$_)O8>>GS[W?X-AAM,=8IM,4Y\W;^=<EMWBB9ZQW8=(ZULES]MO#_2XOD>>O
M'7-GI@I/[,5>^^G[+3EK$_MII^$JHRU9)D         !:4_:Z="2[+Y >07D
M=D;7\XOJKK?#]::_)=6MW3'/M?:F9JRU]?XB\^+\*:\U_6= FMKN/W^)(8<Y
M#SS'5Q+3715W_5 \\KQO@'C_ *YV]_\ 2N5Y+)O,L5M76,&QQ_3K7)7N[HKE
MS;JM\<]NEK;:\1:)I,3&[[C^;C;\'L> QS_$W.XMEMI,?N8:]L1:-==+7RQ-
M9TTF<<]>FDW;E*"'P              #GE_N'>B;CJ+['-TW.VQDUGK7?^DZ
M5VKB)X[>NG&5Y>WQ=.A;A:V]UZ/:DR5>?TZO(W<7KJECYR<==7%,<T7Y]"']
M/7SK'Y=]N>RX;+EK?DN WNYV.2)F.^,<W_5;>TU^,4^EN(PX[:=L_1M6)FU+
MIV^B.:KRO@&':6M$[C8YLF&T:]>V9^ICF8_+MR=E9^$]DQ\8E!BG&W*
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M'6W6M9F9TM>U8FW0H:?
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M%>VLV?MZYR.0\,R</>T3FX_<VB*]-8Q9M<M9G\>N2<T1,_YND3TTBNNL/;Y
M         7,?VL/=/S-!\J?'6\G]O^G=PTWNG7+;V_7\S^L\++HVZ3^]%BJ?
MC_IO]!X"GTSWU?O?+_,$%'M7,DE-W]4GPOZ//^*^P\-=?U&SW''9IU_=_3Y(
MW.VC2;]>_P#5;J=:XX[>S^)>W=CK6)GW)\1V;[C.>I'^)BR;>\_E].WU,?\
M>ZZ_4R_"O3M^:TZUB+:*IU&
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MQ%8KK]I;.-C["Y;#%)IW;NV32=9_QHC+W=9G][O[H_"(G2(B.B1M'1@(
M
M                                         "GE^ZOW""3(>$^@VN9O
M.+FTL^^=PSVO459"+'UP9&?J;"ZEF;FCFBC%7MY')B\U!!SQ5)<6M%4WYXCH
MN..9+@/Z5W$7KM_->>RX:?3O?B]OBRSV3?6D;_)GQU_OUK,7VUK=(I>8IIW3
MCGME9]M&UF*<QOK4CMF=M2MNFO3Z]KUC^]$=<<S\(GI\9KTJ%+<TI@
M   '29^C'4[O3_JO\4K#(6UG;WV5P_9&V35V?,5?RK3;^Y.Q-CP=S=31T4\R
MWG.N9*SHK]7YJC]'$?Y_%'#S>_?'RV+F/NE\JS[>U[8,6;9X([M?EMM^/VF'
M+6L3\*_6IDF-.DZ]W]Y7Y[FW5=W[*Y.^.9FE;XJ=?PFF#%2T1^SOBW]OQ_%+
M2B<U@
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M<.;G;\YON R3_#W.WKEKK,_OX;=LQ6-=-;4RS-ITUF,<=>FDTDEUR8(
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MBVXM$],F2/C%(GKCQS\.E[QWZ12=5!EI@
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MC_<V^G?^]$=,>6\]>[732*]TQ,=%)YX$#
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M3_;,IMT*&G@
M                                                        %&?]
MTAM5Q>>8O0&DU6D-%KKWC39;5#?4UU\W%Q<;CVCV-B+FTECY_P .B&SCT6*N
MBKC^:JJ>OCG^''"\/^E[Q6/#Z?Y_FXO,Y=QY+;!-=(TB-OLMIDK:)^.MIW5H
MF/A$5C3XRF5]M^VK3Q3?;S6>[)R,TT_"(QX<5HG_ "_4G7^R%959@D0
M     ZE7ULZG::3]??A9@;.UO++_ /MCZ6S=]:7_ #+\NWS>UZ%@]JV&*6B:
MBB6#TYW-7/IBJXXYAI_%'^Y>7;[D.6R\U[_\TW^:U+__ -S<CCK:FG;./!NL
MN#%,3&L3_"QTUM'[TZV_%6[[!W5MYYSR^>TQ/_?'<5B8^$UIDM2O]ORUCK^/
MQ;L-*L/
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M'2/A6E*Q6M8_96L1$?LA9]AQ8\&*N##$5Q4K%:Q'PB(C2(C^R'S7)?0
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MFS8*Z;'?Q^HITB(BUIF,M>GY9(M:.D:5O6.NFLS2H8-1
M         (ZOM5\O_P#)+X1=N]PXC)V=AV-D[.UZWZ>BN9/1-=]F;S[]AC+O
M'1U1R175YI^"AR.Q50U^FB:WPTM'Y_//'',B/M7]0_\ '7[LXCP_=XKY/'<5
M[;SD)K'2NSVVE[UO.L36NXRSAVD6C6:WW%9_#5GOK3Q7_7#S':\5EK-MA69R
MY]/PPX^LQ/Y1>W9BU_"<D2YB3TUK%0
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MAO\ SW>1M]M%]OXWAMKCPS,=U[?#ZN;MF8F_Q[:Q,UQQ,Q69F;6M,.A^U2
M
M      J(?NM,QDX,1X,8"*\FHPV3R7D=F+_'T\\?'NLG@[7HVRQ-Y+Q^/5S-
M86NPWM%'/'/''%-S7^?S_#\6X_TJ]GMK[SSG?WI$[S%CXC'6_P"-:9;<G;)6
M/V6MBQS/[:0E+]L^+'.7F<\Q'U:UVM8G\8BT[B;1_EFM=?[(4[%P25H
M    #I;_ $HZK;Z=]7/B'B+:ZFO([O2=IVJJ:>BB.NBXWKLW>-VN[6FF/^7F
M&PNMAK@CJ_VU4<=/-7\>>7FN^]/E<G,?=!Y=N\M(I:F]P8-(F9C3:[+;;:MN
MOXVKBBTQ\(F9B.BO;V]N;;OV1RN6T1$QFI3I^6/#CQQ/^6*ZS^V4I:+K6P
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M-$URTM-;1/QB8G28G^R7TG&?,
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M935MH^
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M%K3:-=)F-=)ZZ3/]KWCH7"
M                                          0M?N .X(NI_K)[@QD5
M[\'-=R;)U[T_@)?1:2^[+F-EMMNV:R]F\M[F.3YW7^E9B'\T<4S0^OW8ZZ*X
MZ:N)G_8)XA;RO[F.'W-Z=^RX?;;OD,L?-&D8\,X,-M:S$QV[K<[>W76MM.VT
M36TPV[Z.XJ>3]B;3),=V':8\N>WQ_NTFE)Z3'PRY,<_E/PF)B7.B>B1/4
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M8L4]7\[7R'P3CM],S.>F",.37X]^'^%,S_N^V+_V6CI'PB.5(IGP
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M\92?X6VK:9QX]-8B9Z1%\DQ,]V2:Q,ZS%8K32L2*([L"
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MB,ORZQ'2+7FLZ=(FLUB9T26HUM>@
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M3@M&G3769R6UZ_A&D1UUMNJET7@
M
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MG2)TM6DS$Z3K$Z3'PF)C\W6[>2]5X
M                                                  J%?NHNY98[
M#Q,\>\?DO\&ZO.P>Y=NQ'NW=/XEL(<3I'7>2]F.^IL)?S3DMHB]4UM7-'^/Q
M#+137/3);I_2T\.K;<>6>P=QC^>E-IQ^#)I7X7G)N=W36:]T?N;*VE;Q6?[]
M;3%)K*?[:^)B;\ISN2O6(Q8*6Z?CW9,L?#7\,,])TG\8G2LQ3R6_I5@
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M\WFMFW=Y_LK2/PK2L=*5B/PCX_&=;3,SGY@+HP
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MBR8?.>8IEB:VGD]S;K^5LU[5G_+68F/V2W2:88B
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MMO(]CS%8TKNMI;',].ML%]9GXZZ]N6D=8B-(C368G2SZK&1S
M
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M:DVZ:Q-\4VB/S^:,<S.G3Y8U_!=T4FH>@
M
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MC)EU[9XW<4Z?GDQ6I7_\*T:_E'5U)'EY5O
M                                                       .=_\
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MTIKR7&=UYTCK;;VT^K'_ ,;TC+$S.E:UR:1K=?R4'H0@
M      /']A[9_06@;SO/P/U7^C-/V;;/TOY7P?U+^G<+>YCX'S?C7GP_F?#]
MOW?9E]OU>KT5?CT\]QX]Q7\^Y_8\']3Z7ZW>8<'?V]W9];)7'W]NM>[M[M>W
MNKKIIK'Q<O8;7];OL.R[NWZV6E-=-=.^T5UTUC737736-?S<CG(Y'(9?(7V6
MRU]>93*92\N<CDLED;F:]R&1R%[-7<WE]?7ES7+<7=Y=W$M4DLLE55<E=7-5
M7/////+UJ[?;[?:;>FTVE*8MKBI6E*4K%:4I6(BM:UB(BM:Q$16L1$1$1$1H
MM%QXZ8J5Q8JQ7%6(B(B-(B(Z1$1'2(B.D1'P?QOL_0
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MS,SK,S/69F9ZS,SUF9^+^Q\7X
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MYDK>D](B>O?./XZ1IKUUF(F^<HA0I
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MX7:_J/ J9>[3Z'(8;Z::]VM,N/3X]/\ $UUZ_#33KK%_)0>A"
M
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MOY9,^+',_P"2+:Q^V'2L>;17P
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M&7E^5W/*Y^F;=;C)EM\/WLEYO/PBL?&WX1$?E$?!DACCKP
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M%=OLKPZWA/E6;BL46_EMXC+M[3UF<5M=(F?QFEHM29^,]O=^*1M'1@(
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M=.[MTB-ZFC&%@
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M8B*]9F;8XB(_&=(F)C6'4 >8M7*
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M.NOQB)CHU/.H@.
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M,D7TZ_#YJ5G6-)Z:?"9B>AT\]B"(
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ME-UK$7MM;8:_'77/,88TTF)UCOUB?PT[IB8B8=.AYEE=8
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M0F!1":J
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M]SQF;7ZNVSY,5M8TG7'>:3K&LZ=8^&LZ?G+(3'W
M                                                         <IG
MS8U?'Z/YF>7&E8F:\N,5I_DYWWJ^,N,C)!+D)\?K_:FUXFSFOI;:WM+:6\EM
MK2FJ6J.**BJOGGFFBGC\<<>J?TKRFXYOTWXES6[BE=UO/&>+SWBD3%(OEV.#
M):*Q,VF*Q-IBL3:TQ&FLS/59AX?N;[SQ+B]YEB(RY>.VUYB/A$VPTM.FLS.F
ML]-9G^UK&V8R(        !(I]26P6FL_93X:9&]RGZ1#<]V:YK]%W[TL'NW>
MV17NJV&+]<7\U7ZW?9F.R]'/\LGR/15_+5RCQ]VG'Y>2^VWS+;X<7UKUX3-E
MFND3I7!-<][Z3_S.N.<FOQCLUCK$,#]H8+;CU]RV.E>^8V=[:?'I32\S_P K
M%9M^S35T[GF35T@
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M1,U_&87O%%2%H
M                                "#;]Q'VC#UY]9/86N53_ ![SN?LC
MJGJ[&R4\Y"F>J:VV7CM2_@@EL8JXH_E8+K"[BE^35';R6]<D?JYDKCCKG!_3
MR\7OY#]S''\C%>[#PW&[[>WCY--)P_H:S,6F)GMR[W'->R)O%XK;2*Q:T;D]
M#\;._P#8F#<::TVFWS9I^'XT^C$]?RMFK,::S$Z3\(F8YXST)IW
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MDNW\M\8VG.X)COS8HC)7_,RU^7+7_)>)[>D=U)K;2(M#45MME(
M"^;^WM^Q;_,=T3SXI]K[-9W7=OCYA[6STF6]J]G,;YT;8T6N/P5U7SSSQ#DL
MQUO-+'A[NN.FB2O&\XZ67B:XJNKBNB'^H)]NW_%SYU_QJ>*;:]?"O(,UK;F*
M]<>UY.W=?+6/QICWD1.XI$S,1F_44IV8XQ8XA3[U\"_D'-?ZS<9CF.'WUYG)
MI^[CW$ZS:/V5R]<E=>G?]2(TKVUBQJKJ:#                     8K[UT
M3^Z72/<?67P+/*_W&ZK["T3],R,GLX_(_P!7ZCE]?^!?3?P]JSO/U#VY:O\
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MNOTJ17%$Z_C%->D?E&FVC4[%P
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MYZ_S>%^07W.SQS_JYN[S?#:(^7':=9MMYG2-)IUG'$_O8NWK:U;Z3,H;-2@
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M'72]K5FT3I-HGX3TB4M%UK8
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MN:5UZ1K;#>(UG^V75@>5M6@
M
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MOPZ3>O29UG7IKI.ETI3$B,
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M6=:;;9S>>OPOFO.L::=)[,6.==9UB8Z1IULXJS$=@
M%63]S)X67&_]4Z!YK:=CYKK8>EX;3K3M6."FN6N;JO8L[<W>IYRJCCU>W#I^
M^9V>"3BGC\U1Y^J2OGBBWYYXM'_II>Y\? >5;_TMS&2*\?S,VWFQF=(B-]BQ
M5KGQ?MG<;7%6T:_"=K%8ZY$D_MX\NKL>3S^(;NT1@W<SFPZ_\VK6(O7_ ..8
MZQ,?MQ:1ULI,+K$OP          &<O&SR%[)\5>[NO.^NI\Q-A]SZ]SUOEK7
MBF6NBSS6,K_-MG=7S4=/'/%U@=GPTT]C>1<\?FJ">KFGFFOBFKC!_9'K[QOV
MGX3R'@?E>&N;AN0P3CMT^;'?XXL^.?[N7#DBN7';\+5C76)F)Z;R#@N/\EX?
M/PG)TB^TSTFL_G6?C6]?RM2VEJS^<?DZ=WAIY8];>;'CMU[Y#=8W,,>+W#&\
M0['K/-_3?Y70-YQM,=OMFAYZOXUA/^I:]D^>:8YJ[:WIR%C);WT%'-M=05U>
M93W)ZH\D]*^P^0]>^35F=UL\FN'-V]M-UMKZS@W6+YK1V9:=9K%[SBRQDP7G
MZN*\175Y;XQR'A_/9^!Y&)^IBM\E]-*Y<<]:9*]9Z6CXQK/;:+4F>ZMHC:)J
M]C8                    #E/\ FYU-QT5Y@^3G44%C#CL9H7>79>#UVUMX
ML9;6_&HQ[9D[C3IX+/#UUXW'0WFJW%G-3:Q^CXM,G$55$=5%5%/JD])^63YU
MZ@\9\NODG)N=_P 'L\N:TS>9^O."D;B)MDB+WFN>,E9O.O?,=\3:+1:;+_#^
M4_G7BG'<K-IMDS[+#:TSK,]_9$9(F;=9TO%HUGXZ:ZSKJU=;/9&
M  MH_4A]_-WJ?]+>-/GCL=YE-8Y_1M8ZT\C;_B*;(:O33Z;"SP_=^0N+N*;)
M:W3#3%'%LW%$M[9U\>K*>_!)+?V=3OW:?8/BY;]5[*]$[:F+D_XF;><176*9
MO[ULG&TBLQ3-KW3;9ZUQY(Z;7LR5K@S1A]H^D*[KZGD/A6.*[CYKYMK'PO\
MC-MO$1TO\9G%TK;_ 'OMM$4O<?PV9P^QX?%;#KV5QN=P&=QMCF<'G,-?6N4P
M^9P^4M8K[&97%9.QEGLLCC<C93T303PUUQ315TUT5<T\\<J=]YL]YQV\R\?R
M&+)@W^#);'EQ9*VIDQY*6FMZ7I:(M2]+1-;5M$6K:)B8B81/RXLNWRVP9ZVI
MGI::VK:)BU;1.DUM$Z3$Q,:3$]8GI+Z3C/F
M
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MQBL])ZWQ9+ZS,_"?EO2-(^$1&OQA9?5JH]
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M:V]X_/LZS%;9<-Z1,_")M6:ZS_9JZYKR3*N0
M
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ME]QCMN>'VL:_5I3<WG\M+S@BO7^W';7_ "?FMQJE$7
M
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MR$\=SV"V+)K/9?XX\M8T^;'>.EHZQK'2U=8B]:VUK&T35[&P
M
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M+[G@ZQ-LF*9URX*_&9CX3EQ5_.-<E*];Q>(MD64U;:/@
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MP=WDQ:Z_\VQ]_P /Q_P/C^&G[5V%2LB"
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MBTQ'2)F*ZS$=-57/([:NRY#/LZS-JXLUZ1,_&8K::ZS_ &Z/;.D<,
M
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M'[6-?JTV,WG\M+Y;Q7K_ &X[:_Y/S6@U8:.0
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ME/MY\P_1\EF\/WE]-ONM<N#6?AFK7YZ1_P#%,<=W]N/IULI/+J4O@
M    %K_Z ?MGXT7)ZUX&^1>Q3<Z=L.2DQ_CMV#G<IC+7'Z/F+OBZO*>J,]=W
M_P 2>K [1DZZJ<!-5<32VN4GCQU$?-O<0?$JF^_K[3YYW;;GWOZ[V]?YQM\<
M7Y;:8J7M?<XZ]M?UV*M.Z/JX*:3NJQ2M;X:VW$VC)CR?6C+[P]8?K<>3S7@,
M<?J\===UBK$S.2L:1]:L1K'=2/\ $C2(FD3DF>ZMNZZ&IE1'
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M8F)C28F.DQ,3UB8GI,3\']CXOP
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MV^3#EB(C7X9:TM/YQ%:7M:9CX1$Z]-71>>=I D
M                                                      !1;_=&
M:YD[7S4Z*VZ6F'C#9SQ=PFN6%=,W%5Q5D]5[8[6R>6IE@_'JCAHM=QLN8Z^>
M?Q7557QQ_M.5Y/\ 2_Y';9?2_.\129_68/*,F:T:=.S/L=C3'I/XSW;?)K'X
M1$?FF;]N&XQV\0WNUC7ZM.2M>?RTOAPQ7K_;CMK_ )/S5H5E20H
M#JV>%VU7&]>'7B=NUW:0V%UN/C3T3M5S8V]=<EO9W&P]7:MEYK2"23\220V\
MEWS1355_-S3QQSS_ !>5;W-Q6/@O<'E?"8KSDQ;/R7D\%;3$1-HQ;W/CBTQ'
M2)F*ZS$=-59WEVVKLO*^3V=9FU<7([FD3/QF*YKUUG^W1LLUJQX
M
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M7[B-QCS>=X<=->[%QN*EO[9RY[]/S^6]?\NL+$:O-H<
M
M  !R2N[.P*^V>YNW.U)9\E<R]E]G;[V!)<YFBWCR]Q7N6U978ZY\K':3W-K1
MDI:LEZI^(I)(^)>:N*:JN/QSSZS?"N KXGX;Q'BU:XZUXWC-KM8C'K..(V^#
M'ATI-HK::1V:5[HB>W36(GHM!X?8QQG$[7C8BL1M]MCQ:5U[8^G2M/EUTG3I
MTUB)T8R9,[$        !N!]??7']V_.3Q)Z]DB]ZPV#R$ZI_7(N+OX,M6LXK
M<<5F]I^-=>FKF*\XUS&W7,'XX_-4W%/''\>6H?N \C_U2]'^6^05GMS[?Q_?
M?3GM[H^M?;WQX-:_C7ZUZ=WY5UEBOG/(?ROPWE-]$Z7Q[#-V]-?GMCM6FL?E
MWS&O['5">6I6N                      \WN6GZSV%J&U:#NN&L]CTW>-;
MSFG[;KV1IKKQ^=UG9<7=87/8:^HCKCDKL\IBKV6"7BFJGGFBOG\<\<_Q=EPW
M+\GX_P OM>>X7-?;\QL=SBW&#+3I?%FPWKDQ9*ZZQW4O6MJZQ/6(<C:;K<;'
M=8M]L[SCW>')6]+1\:WI,6K:/VQ:(F/['+M\_O#[9O!;RG[*\><_=7F8Q>O7
MEOFM VN\M:+2O<NNMACYOM5V'F.+_5_F?']=G?\ $7YBBR=G<Q4\_BAZ??07
MM_C/>7JWC?86PK3#NMQ2<>ZP5MW?I]WBGMSXM9Z]NNF3%W?-;#DQVGK98[X/
MY7M_,_&MOSN"(IER1-<M(G7Z>6O2]?STU^:NO6:6K,_%IFW(RT
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M6;:X^L17):=8B6-%%K$
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M#%?.>/\ YIX;RFQB-;Y-AF[>NGSUQVM36?R[XC7]CJA/+4K7
M
M     4N_W4^MY.U[7\/MOEIAXPV<Z][5UNPKIFXJN*LGJNR:AD\M3+!^/5'#
M1:[E9<QU\\_BNJJOCC_:<KFOZ67([;+XKY?Q%)G]9@Y#8YK1IT[,^'<4QZ3^
M,]VWR:Q^$1'YI<?;5N,=N,Y7:QK]6F?#>?RTO2\5Z_VX[:_Y/S505K*30
M      #J(_5WMG]9_75X59CX'Z;\/QOZKU/X_P KYGN?T%JUAHWS_>^-:^C]
M5_IWY7M>GGV/>]OUR>CW*O,%]S_%?R;[B/--G]3ZG?Y'OL^O;VZ?JL]MSV::
MV_<^MV=VOS=O=I77MBN+V/M?TGGO+XN[NUY#-?733_$O.33XS^[WZ:_CIKI&
MND;XM$L*
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MG^R83GH.-,@
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MSYS7Q#R6-IOIF.%Y":X\DZ],=]?X67KTTK-IK?K&E+3;K-(K/.T>AQ/$
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M^6^&VMEY';SEXV)Z;C#K?%I_MITBV/\ LR5KK/PF4DR-S7P
M
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MWBW+9>&YG%./>8Y_MK>L_NWI;IW4MITG^VMHBT6K&?F NC
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MJ3,?"9K,UG36(G36.FL1_8](ZUQP
M                                           %1;]UE@,M<8#P=VB&
MT]>"P^8\A\!D;[W[:GX^6V2RZ5R.%M/C5S4WDWS;/5+^OW(XZHH_8_$E5-5<
M?%=MW]*S?[3'O_-^+O?3?9L/$Y:5TMUQX;<C3);NT[8[;9\4:3,6GNUK$Q6T
MQ*3[9\^*N?F=M,_QKTVMHC2>M:3N(M.OPZ3>O29UG7IKI.E.9<*E<
M   Z6_TH[5;[C]7/B'E[:UFLX[32=IU6J&>NB2NNXT7LW>-)N[JFJ/\ EXAO
M[K7JYXZ?]M3')3Q5_'CEYKOO3XK)P_W0>7;3+>+VOO<&?6(F(TW6RVVYK7K^
M-:Y8K,_"9B9CHKV]O;:VT]D<KBM,3,YJ7Z?EDPX\D1_DBVD_MA*6BZUL
M
M                                        JF?NI,QC(.F?$? 2WD-&
M9R?9W9&8L,?5SS\BZQF#U7 666O(J?QZ>8;"ZV&RHDYYYXYXJN:/Q^?SS^+4
M_P"EGL]S?S+RW?TI,[/%QFSQVO\ A6^7/EMCK/[;5Q9)C]E)28^VK%DGEN4S
MQ$_2KML59G\(FU[36/\ +%;:?V2I8+H$N@         '2!^A+_T3GBE_]O3_
M /"3[B><G[\O_IKO*O\ [6?_ #'X] +W9_Z3N3_^I_\ N3 F!1":J
M
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MS?#;#DK&2U=Q>LU?1_L2/(>,_P!6.6R1_.]G2/IS,SKFP1&D3K,SW9,7PO\
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M8F)ZQ,3TF)ZQ+4EJVI::VB8M$Z3$_&)_*7[/P_@
M
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MFO\ ;MOHW'A.;9VFOU-OO\D1$:Z]EZ8[Q-O[;3>(TTZ5^&O6:Z*Q)OL
M    !U'?K+W+^O?KU\,-BJCO*)J?&_J?7;N2_N/E7=WD-+U'&Z9D<E+<<\U5
M2_JE_@)+FGFKGFOTR\<5<\U?EY?/N7X;^0_<'YGQT32:?ZQ[[+6*1VUK3<9[
M[BE(C\.RN6*3ITUKTZ:*W_8FT_1>=\O@Z:?S#-:-(TB(R7G)$:?LBT1_DZ-Y
M6CV&@
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M*
M                                             I_?NN?_ (0K_P"*
MD_\ D=%O7]*G_P#CS_[2?_M=*G[9O_TW_P#4?_V4I_+>4J0         '3A^
MH/\ ]&?X<?\ $_CO^NV7>9K[NO\ Z97S'_QQ?_I>-79[4_\ 2'RW_9<__ U2
M0HXL
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MS:*P]^Y+?3D\AX[C=;:8=E;+IT[?XV6:=/QUGZ/S=--(KIKUTM'JO4;P
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MTF*6G37Y;]:7Z:_NVGX3^4MA&OG1
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M_/?^6?B^;+_X-W6'%V_]F8MSD[XK_P!BU[;7_;CK_B2E3]M.^_\ EOQM[?\
M6^6E=/\ XK7);73_ .)1I,_MK'[RG\MY2I          =%W]OQN7]5_5MT7C
M:X[SY.A;)W!IMS=7EQ\CYO\ [U3;-LLI+7GGFJ2&SLL5M=O9T1U<_P GQN>*
M?Q1Z>./.W]__  W\J^Z+G=S6:?3W^VX_<16L:=O^@X,%HM^$VM?!?),Q\>_K
MUU0*]Y;3]-[(WN2-.W/CP9(B(TT_@TI.O[9M2;3/[?S32H8-1
M
M     *WW[H3_ ,@3J'_SP- _\2_D L;_ *8?_I[Y?_Z$-U_\T>*;_P#MQ_\
M+?=?^*LO_=&V4/E[":8         #H0_MQO_ $:&L?\ '#VS_P!=;!Y^/ZB_
M_P!,KNO_ !/L/^EV07]^_P#I#R?]B8/_ (&4\*";2H
M
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MMJ5__!K&OYSU;O-),.
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M6>V=>ZT$??.]_5>QMQ@UO/Z;;X,?7X1KCC+I7K.E?XNOX?--IT_&9R4'VFP
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M@FQ0K:@
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M=*Z=(B-;+*MA'L
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M[C:UCSC;3$1$SQ>*9_;/U]S&L_Y(B/[(A8[5SM @
M
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M6CX3$3T5I>9Y\6Y\PY;<X)[L.3D]U:LZ3&M;9[S$Z3I,:Q/PF(G\VU#5C&@
M
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M-[[!Y;-%K6[=[?'K;77^%IBTZ_A7L[:_AVQ&G1(>CTP,
M         !0E^^KZM_\ *EVA+Y2=(Z[[/CKW1LE]+M.!PUK[>-Z:[2RLU60N
M<3'9PTTPXO0]ZFEGN<-3#Q\3'745QC^*+:'C&QSWR?8?]T/_ !J^,1ZN\VW'
M=[#X;;5C!ER6UOR.RI'97)-IZWW6UB*TW$V^?-2<>XURW_4VI-GTG[(_UFXV
M/&^8R:\]M,<=EK3USX:](MK^.3'TC)K\UXFN36T_4F*ZZP]OD
M  !M%XG>9?D3X3]DVW9WCSV%DM/RDDUAQLVN3<U9+1M_Q5A5<^C [YJ=Q)QC
M-AQOL7]S1#)5Q'?8^JXKGL;BUN>*)Z=8>U_3?KSW5XW;QGV%Q^/>;6(M]'-'
MR;G:WMV_Q=KGB._%?6M)M$:XLL4BF?'EQ:TG'/)_$N!\PX^>.Y[!7+CTGLO\
M,F*TZ?-CO'6L](UCK6VD1>MJZUF\C]<_WK>-?F?;Z]UQVK<8WQZ\D+N&VL:]
M1V'(5\==]@9:FB>F>ZZTW:]ICM;>:]J@HDIP>8DMLE')=4VUI+E?9ENN:/ON
M)^QCV3Z:R;CR/Q6N3R'UQ2;6_48J?Z7M<>L:5WFVKK:8KK,3N=O%\,Q2<N:N
MU[ZXD-O/O3'D/B5LF_XR+;_Q^)F>^L?Q<5>FD9<<=9TUT^ICB:3$3:\8M8JG
M/0<:9                 :K^8OAUTIYQ=*9_I'N[ ?J&'R'JR&L[-CZ;>';
M.OMLAMYH<7N.G92:&;]/S&/]ZJFNBJFNVO;:N2VN8Y;>62.K:?I[W#YKZ0\U
MP>;>$Y_I[S'\F;#?6<&[P3,3?;[BD3'?COI$Q,3%\=XKDQVIDI6T9+XIY7S'
MAO,4YCA[]N6O2])U[,M->N/)'XUG_9K.EJS%HB7-]\\? [NOZ_NZ[_J7MJP_
M4,/D/F93K/LS%V=Q!J?9VIP7%$5&9PU<M<_Z?F,?[\466Q,LM=SC+FNGCFJ6
MWEM;JX]&WHGWMX5[^\*Q^6>)Y/I[S'VTWFSO:)S[+/,:_3R::=^.^EK8,]:Q
M3-2)F(IDIEQ8Y_>%>:\/YSP]>4XNW;EKI&;#,QWX;Z?NV_.L]9I>(TO'Y6BU
M:Z3MU,O                     2T>!WW+^8'@K\#5,/L?]Y.D[;X=M_9SM
M+*YG*8G 8VU]=/Q>M<_\F;*=<_R25>FWM:9\3S+5S+)8RR?S(G>]OLW]0^\_
MJ<KO-M_)O-;=T_S#94QTR9;V_O;S%VQ3=]8C6]YKG[8[:YZUZ-8>:^I?%?,^
M[<Y<?Z3F)UGZ^&M8M:9_'+733+_;.E].D7B%Y'P2^S/Q>^P'5/G]1;5^B=B8
MNSMIMQZ:W&6TQG8.MSUV]$MU<6=CQ/5#MFMPS>JBC*8WF:W_ (4\3\6\U7L\
M4?\ O3[:/9_H'E?T_ENU^OX]EO,;?D-O%K[3-$3I6+6TUP9IC29P9NV_QFDY
M*1WS#;S3UYY'X-N>SE,7?L+3/T\^/6<5^O2)G3Y+_P"TOI/Y=T=4A*/K!0
M
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M_+\']3=^-_&>G=FP:1K,Y8K6(G'TF8RQ$1'PR17Y;7GY0':0
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MGNF-S2UNNG3Z%J5G^[$]<DQ\)GK\8KTMZJBT6
M                                                     $)W[A/4
M_P"HOJV[JS'S_A_T%N'3.V?'^+\C]5^9VIJVC? ][Y,'P?;_ *S^5[OIF_/Q
MO;]''N>Y1-3^GURO\N^Z+A=G]/O_ %^SY'!KW:=G;L<^Y[]-)[M?T_9VZU_?
M[M?E[;;?]%;K]/[(V>+MU^OBW%-==.W3#?)K\.O^'IIT^.NO32>=<]#Z>8
M       "\C^UNVSYGB'Y":-\#V_Z=\D)ML_5/E>OYG]9]8Z%A_@?"^-3\?\
M3?Z"]SW?>K][Y?I]%'M>J2C_ /JA\5]'V[X_SGU-?U'CD8.SM_=_3[W=9._N
MUZ]_ZK3M[8[>S76W=I6&WW([7L\IV.][O\3C^S33X?3S9+:ZZ]=?J:::=.WX
MSKTLXJS$=@
M                                                     %#W]T)_
MY??4/_F?Z!_XZ/(!>Q_3#_\ 0)R__P!%^Z_^9W%)I_;C_P"1&Z_\:Y?^Y]LK
M?K&V_P          !UH?'G_N ]&_\3W6?_N%X1Y._8/_ )?<Y_XXWG_=.16%
MSO\ \O-Y_P!EYO\ IEF86(.J
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M$:1&/YLL?A.37Y;4*K5&L
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MZ3-;UG\+5F8G\)3$P9\&ZPUW&VO3)M[QK6U9BU;1/PF+1K$Q^V)?'<M]0
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MCO'6MIA$KE^&Y3@=]?C>8P9-OOJ?&EXTG2?A,3\+5G\+5F:S^$RRHQ9U@
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MW^+;'>]W^'R'9II\?J8<EM==>FGT]--.O=\8TZWDE'Z&P
M
M"'[[[?\ T3GE;_\ :+__  D^G4O?L-_^FN\5_P#MG_\ ,?D&U?2?_I.XS_ZH
M_P"Y,[F_/1LGZ          NP?M8/^X%Y5?\<&F?^X7,I6_JD_\ E]XK_P")
M]Q_W3"(/W)__ "\XS_L3)_TQ:B5:HU@
M
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M4ZIQ@
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M1$UM68F)B80QW>TW.PW.39;W'?%N\5YK>EHF+5M$Z3$Q/6)B7I'6N.
M
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M[IQ;S#:)_P V9[J:_LZ7FO\ RVGXN@L\_P @R
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MS$1-IUBI]S..D7X7+%8^K,;N)G3K,1^FF(F?C,1-K3$?AK.GQE;U5%HL
M
M                                        .>[^XX_])AM'_$_U-_UI
MOGH'_IT?_2U;7_QQO_\ IE4Z?07_ */,?_9>?_X*$#Z=C=(         #L!/
M(8JM
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MQ,:3$Q,Q:)BU9F)B7O'1.$
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M9=QZTY3'AC6\4PV^,1\M-QAO:>NGPK69T^,Z:1K.D.DT\WJOP
M
M    !'5]MV.R&4^M;S+ML98WF1N8ND]BR,EO8VT]W/'C\1-99;+7U<5O1))1
M9XO%64US<2\\>B"WAKDKYIHIJYXD1]I>XV^U^Y+PW)N;TQXYYO#2)M:*Q-\D
M6QXZQ,S$=U[VK2E?C:]JUB)F8AGOJ_)3'[!XFV2T5K.\I&LSIUMK6L=?QFTQ
M$1^,S$1UES$GIK6*@         +@/[4;_P"'U_\ B6__ )(M4-_56_\ X#_^
MW?\ ^R$5ON9__0G_ -6?_8JX"J%16
M
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MO96;::Z3IKIIKI.GY.NF\D:K<
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M:-8M$Q,3HRTQ-U8
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M$*Y
M                   &G_V%_P#D"><7_F?^2_\ XE]U;>^WS_T]^#__ $7\
M-_\ -';,J\$_\M^&_P#&NT_[HQN5Z]2JR@         !:L_:NY'(1=W>66)C
MOKR/%7O577^1O,91<ST8^[R&+V[+6V,OKFSIKXMI[S'6V7NXX):Z>:X:+J:F
MCGCB2OBJJ_\ JE[?;V\)\3W=J4G=4Y7=TK>:QWUI?!CF]:VTUBMYQXYM6)TM
M-*3,3-8TC3]RF.D\/Q>6:Q]6-SEB)TZQ$TK,Q$_&(F:UF8_'2-?A"ZLI<1#
M
M                                           <WW[[?_2Q^5O_ -HO
M_P#!LZ=>C;[#?_I4?%?_ +9__-CD$_O2?_HQXS_ZH_[KSH?TO6U
M&7_'K_N^]'_\<'6G_N:85B'L'_R!YS_Q/O/^YLCJN=_^4>\_[$S?]+LZT;R=
MJP@
M                      '(:VK8\GN.S['MV:JAKS.U9[,;'EJ[>'BWMZ\G
MG,A<9._J@@IYYI@AJNKJOFFCCGGBFG\<?[#UR\7QVVX?C-MQ&RB8V>UP8\..
M)G6>S%2*5UG\9[:QK/XRM,VVWQ[3;8]KAU^EBI6E=>LZ5B(C6?[(?"<Y]@
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MB;JP
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MP
M                &G_V%_\ D"><7_F?^2__ (E]U;>^WS_T]^#_ /T7\-_\
MT=LRKP3_ ,M^&_\ &NT_[HQN5Z]2JR@         !:@_:P_]W[RI_P")[3?_
M '-)56O]4G_R!\5_\<;C_N:$:_N3_P#E'QG_ &7D_P"EKL2E9$$
M
M                                  !S??OM_P#2Q^5O_P!HO_\ !LZ=
M>C;[#?\ Z5'Q7_[9_P#S8Y!/[TG_ .C'C/\ ZH_[KSH?TO6U         &7_
M !Z_[OO1_P#QP=:?^YIA6(>P?_('G/\ Q/O/^YLCJN=_^4>\_P"Q,W_2[.M&
M\G:L(
M                       !XGLO:KC1>N.P-WM+2&_NM-TG:]JMK&XKKCM[
MVXU[!7^7AM)Y(OS)'#<26?%%55/\W%////'\7=^-<5CYWR/C^$RWG'BWF]P8
M+6B(F:QERUQS:(GI,Q%M8B>FKF<=MJ[WD,&SM,UKES4I,Q\8BUHKK']FKD9O
M6PM&          6"OVTVJW&P_8SDLO#=PV\>B^.O9VU7<,M%===_;WFP]?Z1
M3:6]5'\L<U%UN44_-57\OMPU<?Z>>%?_ /4GY7'Q_P!NN+:7I-K;[R+98*S$
MQI6:XMWN>Z?SCMV]JZ1UUM$_"):,^X3<UP> UQ3$S.;?X:1^R8KER:S_ ),<
MQ_;,+_"@Q"                                !%1]GOU5].?8CUM>3_
M  L#H'DAK6-J_MIW3#BHZ+R;FUIFEM-&[&N+"WJR>Q]>WT\M?%%-7O7.%GEJ
MNK*GGU75K>2H^V3[I_,?MY\DI3OS[_UQN<G^F<=-YFL=VD6W.SBT]F'=UB(U
MF.VFYK6,6:8TQ9<.R_7/LOEO ^0B-;Y_'\EOXNW[NG7XY,43.E,L?Y(R1';?
MX5M3GC>1?C;W5XG]J9OICOS1<EH._P"#AM+V3&7LMI?6.4P^1IKKQN?UW.8R
MXO,-L.!R'$5=,=U9SRQ<312P5\T3PS14>A/UW[(\+]K>+8/,O M]CW_ 9YM6
M+UBU;4R4_?Q9L5XKDQ9::Q,TR5K;MM6\:TO2UIW<#Y!Q'D_&TY?A,U<^QO,Q
MK&L3%H^-;5F(M6T?C6T1.DQ,:UF)G!K.'<@                  -D/'#R^
M\F/$79IMM\<>Y-PZMRMYZ?U2UPUS:9#6<[[='-$/]2:5L%IE]-V7XW'//M?/
ML+GV>?XT>GG^+7/L;U%ZU]M\97B?8O#[/E-K3]RV2+4S8M?C]'<XK8]QAU_O
M?2RT[OA.L.@Y_P 5\>\IV\;7G]IBW../A-HF+U_W&2LUR4U_'MM&OXK4/A)^
MYKU/.?I&C>=O7W]%Y'GV+/\ OKU)C,EE]3E_'IC^?N_6/NY+:<'[<$7,EQ=X
M&;,?)N9?3#BK2&G^%6GNS^F?RVQ^MSGHOD/UNWZV_EF_O3'GC\>W;;W2F#+K
M,Z4Q[JNW[*5UONLMYZQK\P^W?=8>_>^%Y_K8^L_IL\Q6_P#9CS=*6Z](KDC'
MI$=<MI6=^FN^>E_(?48]\Z-[0TGM34I)N;63-:3L%AG+>RO*>.>:\?E8K2:N
MZP^2HIX_-5M=1PSTT\\<\T<<<\<JR?,O _,_7O+3P7G'%[WBN6B.Z,>YQ7Q3
M:O\ GTFT=N2D_A>DVK,]-4=.6X3E^!W7Z+F=MFVVZTU[<E9K,Q^==>EH_;69
MC]K+3$W5@            /X\CCL?E\??8G+6-GE,5E+.YQV3QF1MH+W'Y''W
ML%=M>6-]9W-$MM=V=W;2U1RQ24U4245<TU<<\<\\/MM]QN-IN*;O:7OBW6*]
M;TO2TUO2]9B:VK:)B:VK,1-;1,3$Q$Q.K]X\E\5ZY<5IKEK,3$Q.DQ,=8F)C
MK$Q/6)CX*\7GC^W:\9_(;Y^\^+DN'\6NTI?F7=UK^)Q5W=]*;9>R^BJ"*XT^
MSN:?[;>CV^(Z)->AHQ\,?/-7.,FEYYK6$^B?ZAOLKU[]/@_:$9O*/%X[:URY
M+UKR6"L?&8W%J_Z9\=9C=VG+:=(C<TK':WOX5[Y\AX'MV7DD7Y+C8TB+6M$;
MBD?LR3'\7\],L]TS_OD1T4_O+OZ\?+?P?S==AW]U/F,-KDMYS9X7LS7^*MFZ
MOV*NJKGBWXQ>YXZ*JPM;RZII]=%AD*;')TT?QKMJ%O7J/[A?4ON[91N/ >6P
MYN1BG=DV>7^#O</Y]^WO/=:M?A.7%]3#KTKDE*GQ;SOQ?S'#W\'NJ7W$1K;#
M;Y,U?SUQSUF(_P ZO=3\K2TG;J9>                   E*^KS[0^U/KE[
M4YN;;C);OX^[ODK3^[G4?RZ:>+GBFF*TXWG1N;N6.RPW86&LHZ:::JJH[;+V
MT=-G>54\4VMU9Q=^Y[[8?%ON+\6^GD^GL?8&QQV_0;_M_=^-OTVY[8FV3:9+
M3,S$1-\%YG-AB=<N+-K?V/ZXXWS[C>VW;AYS#6?H9]/A^/T\FG6V*T_VS29[
MZ?WJWZ(WCIY)=*^6'5>$[GZ#WK&[]H&<FN[*/)V45W8WV+S&.JHHR6 V+!Y.
MWL\SKV>Q_,M%4EK>012\PRQ3T<5P30RU^>;V)ZW\T]4^4Y_#?/=CDV'/X(K:
M:6FMJWQW_<RX<M)MCRXKZ3$7QVM7NK:DZ7I>M8'<]X_R_C')7XCF\-L&^I$3
MI.DQ-9^%JVB9K:L_A:LS&L3$Z6B8C.3!W3
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MRS_G_ACO/[_2MOGTF]3I:XDX
M     R;TGF,9KW<W4F?S5Y#CL-@^SM"S&6R%QSS3;V&,QFU8J]O[R>JGBJKB
M&UM8:ZZN>..>?33RQGS79[GD/#>7V&RI.3>9^,W6/'2/C:]\&2M:Q^VUIB(_
M;+KN8Q9,_$[K!AB;9;[;+6L1\9F:6B(C^V76U>3)5\
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M4;_N2Q9)\>X[/$3]*N]M69_")MBF:Q_EBMM/[)7=%)J'H
M
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M#'/,=QDVGB'*[K#I]7%QNYO77K&M<-YC6/[8=6!Y6U:
M
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MA'S[C\N./#=G@F8^K;DZ6B/QF*X-Q%I_R3:NO]L+V"C!#
M                  !HWYX_7]T)]@/4=_UUVU@K/'[;C[.\KZS[>Q>*L9]\
MZQSL_%$E%UAK^7B"YR&MY"Y@BXRV%EGHL\G#13^>8KF*UNK?>'HGW]YYZ!\M
MQ^1>)Y[Y.)R7K^LV%\EHVN]Q1T[<E(UBF:D3;Z&YK6<F&TSIWX[Y<63,O"O.
M>;\&Y2N_XN\VVMICZV";3]/-7\K1\(O$:]F2([J3^=9M6W/1\]_KO\@?KV[0
MJT?M["_J.F9^\RM?5G;>%BIJT[LO!8Z:/BJZL_1<WDVN[)90W$7ZCA;VJF\L
MI*^*Z>;BTEMKNX]!OH;[A?7_ -P7C$<WXCF^GS.WI3]=L,D_Z1L\MXGY;:Q6
M,V&TQ;Z.YQQ./)$3$_3RUR8<<[/"?/."\ZXW]9Q5^W=TBOUL%O\ $Q6G\)Z1
MW4G2>W)7Y;1TGMM%J5T/;V9H                    RUTUWSW1X\;='O?1
MO:&[=5;;1#S:R9K2=@R&#N+VSJYYYKQ^4BM)J+7,8VNKG\U6UU'-!55QQSS1
M^>..6)^9>!^&>PN)G@O..+V7*\3,]T8]SBIEBMO\^DVCNQWC\+TFMHCIJZSE
MN$XCGMK^BYG;8=SM==>W)6+1$_G77K6?VUF)_:LR^''[G/?]9M\+IGFSU;#V
M591S6UI<]U=41XO5]TCL^**N)LALW6<D5GIFS9*6YDXJJEQ%UK<$-O1Z:+*:
M3GU55I>XOZ9? <EDS<SZ4Y2>-S3$VKQV^F^;;3;7I3#O(FVXPTB(TB,]-Y:U
MIUG-2O2(\>6?;KL=Q:^[\/W,[>^DS&WS:WQZ_E3-UR4C3\+QEF9^-XA:;\8_
M-OQ8\QL)/F?'/NC3^Q9L?9V]]G-8M+R3%;UK=M<TV_MW&QZ+FX<=MF'LZI[C
MB"FZEM.+26XIKCCEKJHJXXJX]F^E/:7I[>UV?L7A=YQU,EYKBS6K%]KFM776
M,.ZQS?!DMI'=-*Y/J5K,6M6L6C6-GD7A_DOB>:,//[3+MXM,Q6\QKCO,:]*9
M*ZTM.D:Z1;NB-)F(UAM0U8QH            !\?8->P&V83*:UM6#P^S:YF[
M.;'9K7]@QEEF<)E\?<4^BXL<IBLC!<V%_9ST_P *XI8ZZ*N/]/'+F<?R&_XG
M>XN2XK/FVW(X+Q?'EQ7MCR8[Q\+4O28M2T?A:LQ,?A+ZX,^?:YJ[C;7OCW%)
MUK:LS6U9CX3%HTF)_;$JZWFW^W#\9^[_ -7W7Q7S/^6?L:Y]^[_I+V+O/=*9
MR]K]4GL_H/NUYW0?D2\\4^YBI9\?;1\?B/&<\K#_ $I_49]E>$?1X7VEA_UE
M\=KI7Z^M<7)8Z_#7ZNGTMUI'X9ZURWG][<PWUX?[^\AX?MV?DM/YCL(Z=^L5
MW%8_W7[N33\KQ%I_'(J=>97UD^8_@KD+F3O'JV\ET*F\HL\9W+H==SM_4>7K
MFGXMK/CG:;:RMKC5[S)7'JIM;#/VF'R=QQ157';51\<5<VN>G/N9].^\]O6O
MA'*4CGNSNOQVZTV^_P >D=UOX$VM&>M(TF^7:Y-QAIK$6R1;HDYXE[$\3\TI
M$<-N8C?::S@R:4SU_&?DF9B\1'QMBM>D?";:]&@;?C-P
M $AWUR?8WW']=?<<6\Z-+-L_6FSS6%CV]U#?7\EM@=\P-M)7Q'=VDG-%Q'@M
MVP4=Q+7BLK1%77!777#-1-:37%O+'K[B_MT\.^XCPZ>#YR(VODNUBUMAOZUB
MV7:Y;1UK:.DY=MEF*QGP3:(M$1>DTRTQY*X)Y]X#Q/GO$SL]Y$8^1QQ,X,\1
MK;':?PGX=V.VD=]->O28F+16T=%+Q"\Q.C/.#IS$=V=#;'-EM=OIJ\;G=?S,
M5IC]TT/9;>..6^U+>,%:7V2CP^>LXYJ)./;GN+2ZMY([BUGGMI8YJ_/#[=]/
M^<^D?,<WA7GFVC%R-([\67'-K[;=89F8KGVV6U:3DQ6F)CK6F2EHMCRTQY*V
MI$#/*O%.9\.Y:_#\WCBN>(UK:NLX\E)^%\=IB.ZL_#K$6B8FMJUM$Q&T35[&
MP
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MQ6B)K:)B8F)C6)B8Z3$QUB8Z3"6%;5O6+5F)K,:Q,?"8_.'XOV_H
M                               #L!/(8JM
M                                                       8>\AO
M^X#WE_Q/=F?^X7FV7^OO_+[@_P#QQL_^Z<;M>"_^7FS_ .R\/_3*N2\]8BST
M         !9 _:]_^7WV]_YG^_\ _CH\?U<G]3S_ - G$?\ T7[7_P"9W*M
M?<=_Y$;7_P :XO\ N?<KX2B="P
M
M         !S'?M[_ /27^9'_ !PY+_K5B7IF^T7_ .EJ\._\3T_Z9D6)^J__
M $><3_V)'_P5D;Z1K/P        &X'UZ?^7WX._^>!XT?^.C2FH?N#_] GG'
M_P!"',__ #.W+%?._P#R(YG_ ,5;O_N?(ZH3RU*UP
M                                                           &
MG_V%_P#D"><7_F?^2_\ XE]U;>^WS_T]^#__ $7\-_\ -';,J\$_\M^&_P#&
MNT_[HQN5Z]2JR@         !:@_:P_\ =^\J?^)[3?\ W-)56O\ 5)_\@?%?
M_'&X_P"YH1K^Y/\ ^4?&?]EY/^EKL2E9$$
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MJY/C]/)I_=F=+:3-+6B)F).49FN@
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MVN'7Z6+/DI77K.E;S$:S_9#(3'W
M                                           8>\AO^X#WE_Q/=F?^
MX7FV7^OO_+[@_P#QQL_^Z<;M>"_^7FS_ .R\/_3*N2\]8BST         !9
M_:]_^7WV]_YG^_\ _CH\?U<G]3S_ - G$?\ T7[7_P"9W*M ?<=_Y$;7_P :
MXO\ N?<KX2B="P
M                                                         !S'
M?M[_ /27^9'_ !PY+_K5B7IF^T7_ .EJ\._\3T_Z9D6)^J__ $><3_V)'_P5
MD;Z1K/P        &X'UZ?^7WX._^>!XT?^.C2FH?N#_] GG'_P!"',__ #.W
M+%?._P#R(YG_ ,5;O_N?(ZH3RU*UP
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M&VW.TR?1W6.^++IKVWK-9TGX3I,1+[S@/@
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M?V6I/XUO6>M+1/X3\?C&M9B9P"SYW8
M       #K0^//_<!Z-_XGNL__<+PCR=^P?\ R^YS_P <;S_NG(K"YW_Y>;S_
M ++S?],LS"Q!U0
M                            ##WD-_W >\O^)[LS_P!PO-LO]??^7W!_
M^.-G_P!TXW:\%_\ +S9_]EX?^F5<EYZQ%GH         "R!^U[_\OOM[_P S
M_?\ _P ='C^KD_J>?^@3B/\ Z+]K_P#,[E6@/N._\B-K_P"-<7_<^Y7PE$Z%
M@
M                                            #F._;W_Z2_S(_P".
M')?]:L2],WVB_P#TM7AW_B>G_3,BQ/U7_P"CSB?^Q(_^"LC?2-9^
M W ^O3_R^_!W_P \#QH_\=&E-0_<'_Z!/./_ *$.9_\ F=N6*^=_^1',_P#B
MK=_]SY'5">6I6N
M                                 C>^WS_T9_F/_P 3^1_Z[8A([[1?
M_IE?#O\ QQ3_ *7D9_ZK_P#2'Q/_ &7'_P #9S'GIE6)@         +@/[4;
M_P"'U_\ B6__ )(M4-_56_\ X#_^W?\ ^R$5ON9__0G_ -6?_8JX"J%16
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M3!\1\TX'S7CHW_"Y8M:(CZF*W3+BMI$S6]?V:Z1>NM+=>VTZ3IIRW"RL
M                !]? ;#G]4RUIG]7SF8UO.V'O_!S6 R=[A\M9?*MIK*Y^
M)D<=/;WEO\BSN)(I/17QZXI*J>?S35SQSQ-_Q^PY7:7V'*8,.YV.33NQY:5R
M8[=MHM7NI>)K.EHBT:QTM$3'6(?+/@P;G%.#<TIDPVTUK:(M6=)UC6)UB=)B
M)C]L:MV>LOM ^PSJ'X5&D^8??%%GC/T*C&XC:][R?8VOXZVUOU<8C&V&N]BU
M[7@K+#PQ5<12V45O3:74%%$4\<D=%%-.E/)OMB^WOR[OMS?A_ SFR?5[\F#:
MTV>6]LW^)>^;:?0RVR3/S5R6O.2EIFU+5M:9G$.1]<>"<KK.\XK9=]N[6U,<
M8K3-_P!Z9OB[+3;\8M,]T3K-9B9F4BG5O[D[[$]'EQ\>\T=)]T6,7P8<G7N/
M7=>LYN^MH;NF6_GL[_K+-:3B,=F+VT]4-$M>.N;2'GTU_%KYXYXJCQY1_3=^
MWCG*Y+<'/-\+GGNFGZ?=QFQUF:Z5BU-[CW.2^.MM+36,U,ENL?5C6)C N2^W
MWP/>1:=E^LVEYUT^GE[ZQ.G2)C-7)::Q/73OBT_#NA(WU-^ZCUBXYL++O7Q(
MSV)IIFBIR>R=3=D8_8.9K>;)U^_+8:3N&!UGBWFQ^&KI]$<FP2TWEU'S^:[:
MB3CVXZ>6?TL^3QQDS>#>6X,LZ3V8=_L[XM)BD:1;<[?+FUB^3768VM9QTF.F
M6U?FP'E/MJW->Z_"\I2W3I3/BFO73IKDQVOKK;\8Q1VQ/PM,=9..G?W OUF=
MLUV]IE.V-JZ9RUU#'+!B^XNO\[AZ.:^;?(75U;W&R:?3N^E8^:QAL./5S<Y2
M&.>2XBCMZII:JJ*8R^8?8#]R_B=;9MKQ.UYG:4F8F_'[K%DG36E:S&'<?IMS
M>+3;IV8;36*7MDBE8B9UURWHWV'Q<3;'M<6[Q1/6<&6MOQB(F*7^GDG77\*3
M,1$S:(CK,HO4WD;X_=\V\MSTCWAU+VY';PUSW=/6_8>I[I<8^B*C&R7%.3M-
M>RV0NL9-:TYBT]Z.XHCDAJN8J:Z:>:Z>.8P>6>NO/_ \D8O-N$Y;B+6F(K^L
MVF?;Q>9F\1V6RXZ5O%OIY.V:3,6BEIK,Q6=-;\IP'.<);MYC9[K:S,Z1]7%?
M'$_'32;5B)U[;:3&L3I.GP9F8:ZD
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MVTUGNPVF*_5K$1W6B(BU/[T::6F)=+%L\
M         !U<O#?:_P"O/$+Q5WGX'Z5_6?C?T;M?Z7\KYWZ;_476.KY?X'S?
MC6?S/A_,]OW?9B]ST^KT4_GT\>5/W%Q7\A]N^5<']3ZOZ+R/D\'?V]O?]'>Y
M\??VZV[>[MU[>ZVFNFL_%6;Y9M?T7E/)[+N[OH\AN*:Z::]F:]==-9TUTUTU
MG3\VR#7#'P
M                        &'O(;_N ]Y?\3W9G_N%YME_K[_R^X/\ \<;/
M_NG&[7@O_EYL_P#LO#_TRKDO/6(L]          60/VO?_E]]O?^9_O_ /XZ
M/']7)_4\_P#0)Q'_ -%^U_\ F=RK0'W'?^1&U_\ &N+_ +GW*^$HG0L
M
M                                       <QW[>_P#TE_F1_P <.2_Z
MU8EZ9OM%_P#I:O#O_$]/^F9%B?JO_P!'G$_]B1_\%9&^D:S\        !N!]
M>G_E]^#O_G@>-'_CHTIJ'[@__0)YQ_\ 0AS/_P SMRQ7SO\ \B.9_P#%6[_[
MGR.J$\M2M<
M                            !&]]OG_HS_,?_B?R/_7;$)'?:+_],KX=
M_P".*?\ 2\C/_5?_ *0^)_[+C_X&SF//3*L3          7 ?VHW_P /K_\
M$M__ "1:H;^JM_\ P'_]N_\ ]D(K?<S_ /H3_P"K/_L5<!5"HK
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M1&L1COV9/PUUKEBE?QG2*Y+3,5GX6F*S,GTKY1^.'D=:27?0_>?5?;7Q[/\
M4+^PT7=]?S^;Q%I[L,/NYW7K*^DSN!_$MS%3S3>VT%7',M'YX_GI_,.?-/5_
ML;USEC#YWP?*\3W7[*VW6VRXL>2VDSIBRVK&++TBTZX[VCY9_*=-3<OXWS_
M6[.:V6YVNLZ1.3':M;3_ +6TQVV^$_NS/PG\F>&".E
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MWC6M\=HO6?[)K,Q_;'QC\7B7=.8
M  ZH7UZ?^0)X._\ F?\ C1_XE]*>6K[@_P#T]^<?_1?S/_S1W*M?SO\ \M^9
M_P#&N[_[HR-P&H6*@
M                               /C[%@,3M>OYS5\_:?/P6R8?)X#-6/
MOW-K\W$YBRGQV2M/DV4UM>6WR;.YKH]R*2.6C\_FFJFKCCGCF<?O]WQ6_P '
M*;"_T]]MLU,N.VE;=N3':+TMVVB:SI:(G2T36?A,3'1]<&?+ML]-S@GMS8[Q
M:LZ1.EJSK$Z3K$Z3'PF)C\W(5>N=::          L@?M>_\ R^^WO_,_W_\
M\='C^KD_J>?^@3B/_HOVO_S.Y5H#[CO_ "(VO_C7%_W/N5\)1.A8
M
M                                    YCOV]_\ I+_,C_CAR7_6K$O3
M-]HO_P!+5X=_XGI_TS(L3]5_^CSB?^Q(_P#@K(WTC6?@        -P/KT_\
M+[\'?_/ \:/_ !T:4U#]P?\ Z!/./_H0YG_YG;EBOG?_ )$<S_XJW?\ W/D=
M4)Y:E:X
M                         "-[[?/_ $9_F/\ \3^1_P"NV(2.^T7_ .F5
M\._\<4_Z7D9_ZK_](?$_]EQ_\#9S'GIE6)@         +@/[4;_X?7_XEO\
M^2+5#?U5O_X#_P#MW_\ LA%;[F?_ -"?_5G_ -BK@*H5%8
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MI'U<6D?WIR8^ZM(F.L1?MG376(F)B-\6B6%
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MB8ZQ,=)AO2MJWK%JS$UF-8F/A,?G#\7[?T
M      !U0OKT_P#($\'?_,_\:/\ Q+Z4\M7W!_\ I[\X_P#HOYG_ .:.Y5K^
M=_\ EOS/_C7=_P#=&1N U"Q4
M                                       !Q_7KS6I          +('
M[7O_ ,OOM[_S/]__ /'1X_JY/ZGG_H$XC_Z+]K_\SN5: ^X[_P B-K_XUQ?]
MS[E?"43H6
M                                                     .8[]O?_
M *2_S(_XX<E_UJQ+TS?:+_\ 2U>'?^)Z?],R+$_5?_H\XG_L2/\ X*R-](UG
MX        #<#Z]/_ "^_!W_SP/&C_P =&E-0_<'_ .@3SC_Z$.9_^9VY8KYW
M_P"1',_^*MW_ -SY'5">6I6N
M                                           C>^WS_P!&?YC_ /$_
MD?\ KMB$COM%_P#IE?#O_'%/^EY&?^J__2'Q/_9<?_ V<QYZ95B8
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MKL%;Y>.S3KI%LE([]QL[6UK7K&XP:Q;+?/@I,4K*;PO[@N'Y&M-CY?3]%O\
MX?6I$VV]Y_";5C7)BF>D?[Y3XVM>D=(K0[1JNSZ/L>;T_==<SVG[;K62N\-L
M>K;1A\AK^QX#,6$M4%]BLWA,M;VF3Q62LYZ.:)8)XHY8Z^.>*J>.5E7%\IQG
M.<=@YCA=S@WG$[G'7)ASX,E,N'+CM&M;X\F.;4O2T=:VK::S'6)2&VVYVV\V
M]-WL\E,NUR5BU+TM%J6K/6+5M69BT3^$Q,Q+X+G/L
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MHOE>$YC@]Q^EYG:Y]KGUG2,M+4UT^,UFT1%HZQ\U9F)B8F)TF&6F)NK
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M[+/MM9TBUHUQVG372F6LVQWF(ZS%;3I^+9QK)CH
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M-'_B7TIY:ON#_P#3WYQ_]%_,_P#S1W*M?SO_ ,M^9_\ &N[_ .Z,C<!J%BH
M
M             #Q_8>V?T%H&\[S\#]5_HS3]FVS]+^5\']2_IW"WN8^!\WXU
MY\/YGP_;]WV9?;]7J]%7X]//<>/<5_/N?V/!_4^E^MWF'!W]O=V?6R5Q]_;K
M7N[>[7M[JZZ::Q\7+V&U_6[[#LN[M^MEI37373OM%==-8UTUUTUC7\W(M>MM
M:.          L@?M>_\ R^^WO_,_W_\ \='C^KD_J>?^@3B/_HOVO_S.Y5H#
M[CO_ "(VO_C7%_W/N5\)1.A8
M
M        YCOV]_\ I+_,C_CAR7_6K$O3-]HO_P!+5X=_XGI_TS(L3]5_^CSB
M?^Q(_P#@K(WTC6?@        -P/KT_\ +[\'?_/ \:/_ !T:4U#]P?\ Z!/.
M/_H0YG_YG;EBOG?_ )$<S_XJW?\ W/D=4)Y:E:X
M                                                         "-[
M[?/_ $9_F/\ \3^1_P"NV(2.^T7_ .F5\._\<4_Z7D9_ZK_](?$_]EQ_\#9S
M'GIE6)@         +@/[4;_X?7_XEO\ ^2+5#?U5O_X#_P#MW_\ LA%;[F?_
M -"?_5G_ -BK@*H5%8
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MQ8^%YJU</E,5F/A%:;B*Q'S4_",DQK-L7[)M3Y=:T@-3U;M
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MKN.K&OU=O$WTB/CWX]/J5T^,S%;5B-9[M(G28U#QJ@
M                                            !AGNSQUZ'\D-<MM3
M[ZZAZ][<P%A-<7.*LM\U;$[#7@[RZBI@N<AKM]?6TF0UW)3V]'$==S8RV\]4
M?\O-?I_@S+PKV)YWZXY&W+>!\OR'$;_)$5O;:Y\F*,M:SK%,U:S%,U(GK%,M
M;UB>NFKMN'Y[FO']Q.ZX3=9]KGM$1:<=[5[HCK$6B)TM$3UTM$QKUT5]/)3]
ML5XQ[U^I9KQF[7WSH;-S?J5U::CMD?\ =CKJF6K_ !L5B+";(7N&[ PEG3)Z
MH);NZRV=FIBYHDXADKCKIGL!];?U-?9O!?3V7LOBMASVRCLK;/@G]#N]/A?)
M:*5R;7);32U<=,&VK-M:]]:VB:;S\>^XKR+9=N'R+:X-[AC2)O3^#E_VUITB
MV*T_C%:TQQKK&L1,=L#'?_T!?9#T?7>7F$ZQP/?6M6LT]-.>Z1V>VS]Y5;TV
M]I<V\M6E;'#JV^333_(DBYHM,;=TQSVTO'-?,=5O+/._P'[^OMQ\WK3#O>3S
M\#R5JQ_"Y+#.*NNMHF/U.&<^UB(TBVN3-CF:WK.G=&2N/=G!^\/7_,Q%,VYO
MLMQ,1\NXI-8UUF)_B4[\?32)UM>NL3'37NBL0N\]>;_UAG[C4^RM'W#KS:;/
MWOEZUO.LYK4L_:_'O;O&S_(PV?LL?D8/8R./GMZ_5'QZ9X)*.?Q515QQ+K@_
M(> \GV%>5\:WVSY#B[Z=N;;9L>?%;6M;QIDQ6O2=:7K>-)ZUM6WPF)G:>RW^
MQY'!&ZX_-BS[:?A?'>MZSK$3&EJS,?"8GX_"8GX2\>[=R@
M             '5"^O3_ ,@3P=_\S_QH_P#$OI3RU?<'_P"GOSC_ .B_F?\
MYH[E6OYW_P"6_,_^-=W_ -T9&X#4+%0
M                                             &'O(;_N ]Y?\3W9
MG_N%YME_K[_R^X/_ ,<;/_NG&[7@O_EYL_\ LO#_ -,JY+SUB+/0
M %D#]KW_ .7WV]_YG^__ /CH\?U<G]3S_P! G$?_ $7[7_YG<JT!]QW_ )$;
M7_QKB_[GW*^$HG0L
M
M<QW[>_\ TE_F1_QPY+_K5B7IF^T7_P"EJ\._\3T_Z9D6)^J__1YQ/_8D?_!6
M1OI&L_         ;@?7I_P"7WX._^>!XT?\ CHTIJ'[@_P#T"><?_0AS/_S.
MW+%?._\ R(YG_P 5;O\ [GR.J$\M2M<
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MY"3TT>G7.TO8Q^+L_=DY_EASD&(K]=7$<55Q5_-S4C[L^P+W%ZP^MR_B5/\
M6CQ.FMOJ;3',;S'2.O\ &V6M[VTCXVVUL\:1-KQCCHBWYAZ.\L\<[]UQ<?S+
MBXUGNQ5F,U8_V^'69G^W'-_SGM3MV]Q;WEO!=VD\-U:W4,5Q;7-O+1/;W%O/
M13+#/!-%55'-#-'5Q5353SS353SQSQS^$%LF/)AR6Q9:S7+69BU9B8F)B=)B
M8GK$Q/28GK$M+6K:EIK:)BT3I,3\8G\I?L_#^
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MF^2F7S3E\N*T6Q6Y3=3$Q.L3$Y\DQ,3'28F.L3'Q;:-3,7
M
M 8>\AO\ N ]Y?\3W9G_N%YME_K[_ ,ON#_\ '&S_ .Z<;M>"_P#EYL_^R\/_
M $RKDO/6(L]          60/VO?_ )??;W_F?[__ ..CQ_5R?U//_0)Q'_T7
M[7_YG<JT!]QW_D1M?_&N+_N?<KX2B="P
M
M               !S._N?UO)ZK]G_E_C,M3#1=7786'V2+B";B>CG&;EH>H[
M?A:JJZ>..*9J\-G(*I*/],<G-5//\>'I7^S/D=MRGVQ>(;G:3,XJ\?DPSK&D
M]^WW6XV^3_)&3%:(G\8TG\5AGJ3<8]SZYXK)BU[8P6IU_/'DO2W_ .%6=/SC
MJC!2<;&         ;@?7I_Y??@[_ .>!XT?^.C2FH?N#_P#0)YQ_]"',_P#S
M.W+%?.__ "(YG_Q5N_\ N?(ZH3RU*UP
M                                                 &G_ -A?_D">
M<7_F?^2__B7W5M[[?/\ T]^#_P#T7\-_\T=LRKP3_P M^&_\:[3_ +HQN5Z]
M2JR@         !:@_:P_]W[RI_XGM-_]S255K_5)_P#('Q7_ ,<;C_N:$:_N
M3_\ E'QG_9>3_I:[$I61!
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M^AXQY;?MY2?DQ;FT_+E^$4IEG\,L_"+STR3I%OXDZWJO+2DE
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MQ9\DHA^;>J_*/";6S[G'^HX:)TC<8HUK_P#'*ZS?%/X?-'9,]*WLE11::U
M
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MN=_^7F\_[+S?],LS"Q!U0
M                                   ##WD-_P!P'O+_ (GNS/\ W"\V
MR_U]_P"7W!_^.-G_ -TXW:\%_P#+S9_]EX?^F5<EYZQ%GH         "R!^U
M[_\ +[[>_P#,_P!__P#'1X_JY/ZGG_H$XC_Z+]K_ /,[E6@/N._\B-K_ .-<
M7_<^Y7PE$Z%@
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MI60
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M4F8F:QI'[[CL=)\+VF6:Q]6.4QQ$Z=8B<&XF8B?C$3-:S,?CI&OPA>V46H7
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MSXMQM+?"^.U;U^$3IK69C728UCXQKU>#=ZYH
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ME\-]OO\ %,=U+QI,:QK$_C$Q,3K%HF8F.L3,,G,9=<
M
MY[O[CC_TF&T?\3_4W_6F^>@?^G1_]+5M?_'&_P#^F53I]!?^CS'_ -EY_P#X
M*$#Z=C=(         #KC=5ZOD-'ZPZXTK+36=QE=/T/4-7R=QCI)Y<?/D-?U
M['8F\FL9;FWM+F6SEN;2JJ*J2**NJCGCFJBGG\\<>2KRGE-OS?D_(\UM(O7:
M[S?[C/2+Q$7BF7+?)6+1$VB+1%HBT1:T1.NDS'55UR6YIO.1W&\Q1,8LN>]X
MB?C$6M-HUTF8UTGKI,_VO>.A<(
M                                        !A[R&_[@/>7_ !/=F?\
MN%YME_K[_P ON#_\<;/_ +IQNUX+_P"7FS_[+P_],JY+SUB+/0         %
ME+]KMA\G/YR=V9^*SFKPV,\4=IP]_D*>./CVN3SG;W3%[B;.7G\^KB:_M=>O
M:Z....>.:;:O\_C^'YK;_J?[S;4]'\+L+WB-YE\KP9*T_&U,6PY&N2T?LK;+
MCB?VWA'S[C\N./#=G@F8^K;DZ6B/QF*X-Q%I_P DVKK_ &PO8*,$,
M
M                                     '-]^^W_ -+'Y6__ &B__P &
MSIUZ-OL-_P#I4?%?_MG_ /-CD$_O2?\ Z,>,_P#JC_NO.A_2];4
M9?\ 'K_N^]'_ /'!UI_[FF%8A[!_\@><_P#$^\_[FR.JYW_Y1[S_ +$S?]+L
MZT;R=JP@
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M;UT_&9KDQ]>GP[;S/33K$==-8F_\H)0>
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ME<V/K$:S76>ZG6-,E)M3K$3,6UK&A[>S-
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M0
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MBK$S:TS$1$1&LS,STB(CK,STB'\M:M*S:TQ%8C69GX1'YRZ_CR'JK@
M
M         &J_G5G\MJGA'YC;1@+OX&=UOQ7\A,_A;[V+:Z^%EL/U)MV1QUW\
M:]AN+.X^/>6]%?MRQR15_C\54U4\\\<[3]&;#:<K[L\.XO?T^IL=SY3Q.+)7
M6U>['DW^WI>O=68M&M9F-:S%H^,3$]62^&8,6Y\PXG;9X[L.3D]K6T:S&M;9
MZ1,:QI,:Q/QB8G\G*E>J!9:          M0?M8?^[]Y4_P#$]IO_ +FDJK7^
MJ3_Y ^*_^.-Q_P!S0C7]R?\ \H^,_P"R\G_2UV)2LB"
M
M                           YQ_W]X?)XS[6O)2]O[.:UM=AQO2&8PL\O
M''%&1QD'0?66 EO+?GCGGGF&C,X.[M^>>?QS[D%7^Q^.>?1=]@V\VVY^U7QO
M#@O%LNWR<ECR1'QI>>4WN6*S^V<>7'?^RT)]>C\N/)ZSX^E)B;8[;BMOV3^I
MS6TG_E;5G^R80VIBML         ,O^/7_=]Z/_XX.M/_ '-,*Q#V#_Y \Y_X
MGWG_ '-D=5SO_P H]Y_V)F_Z79UHWD[5A
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M9F8G#EV]X_;,Y\>/2?\ )DF?[8AT6'G=0*
M                            >;W#3=0["UG,Z5OVJZWO&F['9U8[8=2W
M#!XO9=9SN/KKHDKL<S@<U:WN*REG7)'35S%/%71SS3QS^/SQP[+B.9Y?Q_D\
M/-<#NMSL>8V]^_%GV^6^'-BO'3NQY<=JWI;29CNK:)Z_%R-KN]UL=Q3>;'+D
MP[O'.M;TM-+UG\ZVK,6B?VQ,*]'EQ^VS\2>X*,IL?C3L.>\8]VFAO+J# QU9
M'L#J?)966XYO>.+C 9_+_P!3ZS#=UU5P<<XW)\6-A%735#CZZ8N()+!O4O\
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M'6V3;]WPKDZ?-CUZ4R:S/PKDTMVVO/R@.T@
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M )1[S_L3-_TNSK1O)VK"
M                                    :?\ V%_^0)YQ?^9_Y+_^)?=6
MWOM\_P#3WX/_ /1?PW_S1VS*O!/_ "WX;_QKM/\ NC&Y7KU*K*
M%J#]K#_W?O*G_B>TW_W-)56O]4G_ ,@?%?\ QQN/^YH1K^Y/_P"4?&?]EY/^
MEKL2E9$$
M                                                   !SW?W''_I
M,-H_XG^IO^M-\] _].C_ .EJVO\ XXW_ /TRJ=/H+_T>8_\ LO/_ /!0@?3L
M;I         ?M;W%Q9W$%W:3S6MU:S17%M<V\M<%Q;W$%=,L,\$T55,D,T,E
M/%5-5//%5-7''/'/Y?C)CQYL=L66L6Q6B8M68B8F)C28F)Z3$QTF)Z3#^6K6
M]9K:(FLQI,3\)C\I=?QY#U5P
M                                           #E >6^KY#1_*SR;TK
M+36=QE=/\A.Z-7R=QCI)Y<?/D-?['V3$WDUC+<V]I<RV<MS:55152115U4<\
M<U44\_GCCU9>I>4V_-^JO&>:VD7KM=YX_P =GI%XB+Q3+L\.2L6B)M$6B+1%
MHBUHB==)F.JS7Q?<TWGC/';S%$QBR[#;WB)^,1;%2T:Z3,:Z3UTF?[6OC8+O
M0        $GWTP;)D]5^S_Q R>)JAHNKKL+,:W+S/#Q/1SC-RT/;M0S5--%7
M/'%,U>&SD],=?^F.3FFKC^/",?WF<=MN4^V+R_;;N)G%7C\>:-)TGOV^ZV^X
MQ_Y(R8JS,?C&L?BUS[;V^/<^N>5QY=>V,%;]/SQY*7K_ /A5C7\XZ.F(\U"O
M,                                                        !%%
MY?\ TO>!WF)^IYS8^L?[3=F9*\DR,_:O2->.TC9KZ^F]NJZDV+#58S)Z/M?Z
MC+!'S<SW^*FR/XXK]BZ@KDDKJE7ZA^\WWMZ?^ELN.Y/^;>-8Z12-CR7?N<-:
MQKVQAR=]-S@[(F>RN+/7%\._%DBM:QLWQ7VYYKXIVX=ON?U7'5C3Z.XUR4B/
MP[+:QDIIK.D5O%?AK6T1$*OGEM^V_P#,7I2XO,[X\Y? ^4VAQP\3TV^'CM=!
M[4Q_/%</$UO>:-G<S>X;+PP\7''$,V+S%W<W/$,E==G;?R45V>>IOZC?I[S7
M'38^PL.?Q;G9G37)-MUL;])TFNYQ8ZY,<SI\U<VWQTIW5B,V3YIB1OB_O_Q3
MF*QAYVE^-WNNFMM<N&?VQDK6+5^'6+XZQ&L1%[=9B ';]-V_KW9LSI6_:KLF
MC[CKEY5CMAU+;\'D]:V;!9"BBB2NQS.!S5K997%WE%$E-7,4\5%?'%7'/X_C
MPGWQ',\1Y!QF'FN!W6VWW#[BG?BS[?+3-ARTGIW8\N.UJ7KK$QW5M,=/BWAM
M=WM=]MZ;S8Y<>;:9(UK>EHO2T?G6U9FLQ^V)EYMV+D
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MUMC^,S-)F:695:2/
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M_G.#)$1_EGI'[74\>6U6P
M                                     T:^S7:,?I_UX>;&6R<-Y/;7
M?C'W+J\=%C'!+/3D-XT;,Z5B9JZ;BXMH^+.WRNP0R7%7%7-=%O37511)7Q31
M5O#[9^+W'+_<+X5M-M-*Y*>3<=GF;3,1V;;<X]SDB-(M/=-,5HI&FDWFL3-8
MF;1F7KO;7W7GG#XL<Q%HY'!?K^6/)7);X1/6:UF(_;IK,1U<N)Z@UD
M    "VA^U3U/YF_^9^\_/]O^G=/Z4U/]+^+Z_F?UGFNR,Q\_YOR:?C_IO]!>
MW[7LU^]\OU>NCVO3)4[_ %4.5^CP'AG!_3U_4;SDL_?W?N_I\>SQ]G;IU[_U
M6O=W1V]FFEN[6L8?N6W79L>(V7;_ (F7<7UU^'TZXJZ::==?J:ZZ].WX3KTN
M9*;D2P
M                                                 '/C_<>V]Q!]
MEFP2S030QWG3/4]Q:22Q5QT75O38Y6TJGMZZZ>*9X:;JUEBYJI_-/$D=5/Y_
M-//''H$_IS9,=_MLV]:6B;4YG?1:(F)FL]V.VD_E/;:MM)ZZ3$_"83G] VK/
MKVD1,3,;O-$_LG6LZ3_DF)_LF$#*=[=8         #L!/(8JM
M
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MI]2]N,W/;73NF;1AO--(ZZVBT1-=.O=$3'71U0GEJ5K@
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MF-9Q3/9FCXZQ..VE^FDZS$37IK$S&DSIFW(RT
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MK6=,=YFTTM>PBK[:+
M                               <D3N3/XG:^WNU-HP%W\_!;)V1O&?P
MM][%S:_-Q.8V?*9''7?QKV&WO+?Y%G<45^W+''+1^?Q5335QSQQZT/#MAN^*
M\1XKB]_3Z>^VW&[;%DKK6W;DQX:4O7NK,UG2T3&M9FL_&)F.JT/B<&7;<5MM
MMGCMS8]OCK:-8G2U:1$QK&L3I,?&)F/R8X9&YX        "3CZ9\!EMD^SSP
M^QV%M/FWEMV1?Y^:'W[:V]&)U32]IVC/W?N7<T$57P,%A[F?V^*N99?;]$=-
M<E5-%49OO(W^TXW[9/+]QO;]F&W&TQ1.EI_B9]S@P8JZ5B9^;+DI773MKKW6
MF*Q,QKOVUGQ;?USRN3-.E)V\5^$S\U\E*5CIK\;6B-?A&NLZ1K+IE/-*KQ
M
M              1O?;Y_Z,_S'_XG\C_UVQ"1WVB__3*^'?\ CBG_ $O(S_U7
M_P"D/B?^RX_^!LYCSTRK$P         %P']J-_\ #Z__ !+?_P D6J&_JK?_
M ,!__;O_ /9"*WW,_P#Z$_\ JS_[%7 50J*P
M
M                   "A[^Z$_\ +[ZA_P#,_P! _P#'1Y +V/Z8?_H$Y?\
M^B_=?_,[BDT_MQ_\B-U_XUR_]S[96_6-M_@         .M/T#<7%YT3TI=W<
M\UU=774G7%Q<W-Q+7/<7%Q/IV&EFGGFEJJDFFFDJYJJJJYYJJJYYYYY_+R<>
M>X\>'SKFL6*L5Q5Y;>16L1$1$1N,D1$1'2(B.D1'2(5@\Y6M>:WE:Q$5C=98
MB(^$1]2W2&6V)NK
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MQ<7?[7];L<VR[NWZV*]-=-=.^LUUTUC737736-?S==-Y(U6X
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M,X,MM-8_&V*\Q_?IK'72L7K\T1^]%98T46L0
M                                               'B>R]JN-%ZX[
MW>TM(;^ZTW2=KVJVL;BNN.WO;C7L%?Y>&TGDB_,D<-Q)9\4554_S<4\\\\?Q
M=WXUQ6/G?(^/X3+><>+>;W!@M:(B9K&7+7'-HB>DS$6UB)Z:N9QVVKO>0P;.
MTS6N7-2DS'QB+6BNL?V:N1F];"T8         !-A^WMU3^HOM)Z4R_S_ (?]
M!Z?W-M?Q_B_(_5?F=5;5HWP/>^3!\'V_ZS^5[OIF_/QO;]''N>Y1"O\ J"\K
M_+OM=YK9_3[_ -?O..P:]VG9V[[!N>_32>[7]/V=NM?W^[7Y>VVH/>NZ_3^M
M]YB[=?KY=O3773MTS4R:_#K_ (>FG3XZZ]-)Z*3SP(&
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M_ME;+50(Q
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M?QA63Y-M\FT\DY#:YM/JXM]GI;3K&M<MXG2?[89_8"Z,
M
M  !S^_W*&MY/!_8_3D[^F&FUW+H'J[9,+S%-Q)77C+7([EJ$M5Q1QQQS;S<9
MG5;NGBCG\\\Q\4U?Z*N%_/\ 3<Y';;[[<OTV"9^KL^?WN')K&D1>U-ON(T_.
M/IY\<Z_GK'X)Q?;[N,>;P#Z=->[%OLU+?VS&._3\_EO7_+K" %/IO
M   !UG/''=Z.S/'GH?L>/+S;!'V!TSU?N\>>N(;BWN,W1M>D8//4Y>>WN[>U
MNH)LE3?^]51+%')357SQ513SQSQQY/O8W"6\:]A<]XY;#&WMQ_,[W;3BB8F,
M<X-SEQ?3B:S:LQ3M[8FMIB8C6)F.JL/G]G/'<[O>/FD8YP;O-C[8TF*]F2U>
MV)B9B=--.DS'[69F&NI
M                      8'[Y\7O'GR@UGG4?('IW0^UL+3Z.;/C:\%:W66
MP\L====-SKNR0<6^QZS>?B62CF;'W=M+5%+)'S5S1)735G?@?L_V%ZPY/^;^
M <QO^*WO7N^AEM7'DB=.F;#.N'-7I$]N7'>O=6MM.ZM9CNN$\CY[QS<?JN#W
M>?;9OQ[+3%;?LM3K2\?#I:LQK$3\8A70\JOVP74&TV^6V+P^[CSW5FP\PS7%
MAUQVY[^Z]=W=YQ1;Q6N-L=UQ=M'OFG8W^2266XN[;:IZI*O31111^.*+$O5?
M]3GR_B\F+CO;_#X.4X_6(MO-AIMMW6NLS:]MM>T[7<7^%:TI?8UB(UFTVUF=
M]^-?<9RNVM7!Y5M*;G!KI.7!_#RQ'769QS/T\D_A$5G#&GQF9^-;+RM^JWSE
M\-Z\E?\ ;G2.>O\ 1L;#S=U]J]=<5[]UMS8TV]Q<37U_GL'#)=:M#;TVDW$E
M&;M<9-3Q'Z_1[5<4E=D7JK[IO1_N*N/;^)<W@Q\YDGMC8[O_ $7>=VL1%:XL
MLQ7/,]U=)VU\U9U[>[NBU:R"\9]E>&^616G%[RE=[:=/HY?X6776(TBMNE]=
M8T^G-XZZ:ZQ,1'BD(SL                      !8N^E'[C\]XH;/K'BWY
M$9R;,^,&W9ZVQ6I[1F,A#1<>/N>S^0ICYR=.0R5Q#;T=2WV0N^9LQ:22448J
MJJ3(VOXY^7;WE=OWI_9WL/:W&;GVAZ\P1A]G;3!-\^#'29CE<6*FO9V4B9_7
MUI7MV^2(F<\17;Y=?X63#H3V]ZGP>3;;)Y)P-(IY'BI-KTK'3=5K'PTB-?KQ
M$:4M$?/TQV_NVI?.M[BWO+>"[M)X;JUNH8KBVN;>6B>WN+>>BF6&>":*JJ.:
M&:.KBJFJGGFFJGGCGCG\*(<F/)AR6Q9:S7+69BU9B8F)B=)B8GK$Q/28GK$H
M4VK:EIK:)BT3I,3\8G\I?L_#^                /CY_7=?VO$W> VC!X?9
M,%?^Q\["Y_&668Q-[\6YAO;;Y>-R,%S9W/QKRVCEC]='/HECIJX_%5/'/',V
M'(;_ (K=TW_%Y\VVWV/7MR8KVQY*]U9K;MO28M&M9FLZ3UK,Q/29?7!GS[;+
M&?;7OCS5UTM69K:-8TG28TF-8F8G]DZ(KN_?H_\ K6[_ (LC<7?CUA^HMCO;
M/X=MM'05Y-U3+B/3:4VD=UCM,PE$G54EY'Q'1)Z[O7[KUS4\U5\5^N7URE\"
M^]S[DO ;8\>+R'-R_'4OW3@Y2L;Z,GS=TUON,DQOHK.LQI3=TTK.E=.VO;LK
M@_<?L'@YK6N_ONMO$ZS3<Q];NZZZ3DM_&T_#Y<L=.D::1I"3Y"_M:=CLZ,QF
M/%?R7QN<IXFEEPN@]ZZY+A+RBRIN/53;W79VC1Y.RR.2^%5S33S_ $OCX))Z
M./55#1)S5#-?U]_5%X[-;#L_:7C63!.D1DW7&9HR5[M/C79;F:6I3NZS_IN6
MT5F=(O:L1?</!?<EM[S3%Y+QUJ=/FR[:_=&NGQC#DTF(U_Y]:8C\)F.L%7DC
M]4WGWXJT7V2[3\<MVN=2L(:;NX[ Z\@A[-T:WL9+BJTCOLMG=(ES5.KPR75/
MM\49B/'S>JN/^3\2Q<USF]<?=5Z$]IVIMO%O(]E7ELD]L;7=S.RW,VB.Z:X\
M6YC']>8KUUV\Y:Z1;YOEMIN?Q_V9X1Y+-<?&[_#&ZM.D8LL_1R3.FNE:Y.WO
MZ=?DFT?'KTG2/%(5G8                 #9SP]\K^T/"GR!T3R$ZFO?1GM
M1O)+?,Z_=7$T6"WK3LG33;;-H^S0Q\5TW.'SMC_"FKFBN2RO([>]@]%U;024
M:S]O^J?&/=/K_?>OO+*:[#=TB<>6L1.7;;BG7#N<,SIIDQ6^,:Q&3'.3#DUQ
M9<E;8[Y7XQQOE_!Y^"Y./X&6-:VB/FQY(ZTR4_*U9_R6K-J6UK:T3TXO%CR9
MZO\ +_HGK_R ZBROZAJ>]8>&[FQUQ7#QF]2V&&BB+8M)VBVAKDCL]DU;*<26
MMU3157!+S13/;R36TL,TGF9]I>M/)_4/G7(> >78OI\ML<TUB\:_3SXIG7#N
M<-IB)MASTTO29B+5UFF2M,E+TK79Y+X[R7BO-9^#Y2O;NL-]-8_=O7^YDI/X
MTO72T?C'PM$6B8C81KYT0
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MD*)$*@
M                     $/WWV_^B<\K?_M%_P#X2?3J7OV&_P#TUWBO_P!L
M_P#YC\@VKZ3_ /2=QG_U1_W)G<WYZ-D_0         %V#]K!_P!P+RJ_XX-,
M_P#<+F4K?U2?_+[Q7_Q/N/\ NF$0?N3_ /EYQG_8F3_IBU$JU1K
M
M                                   4G?W3W_=^\5O^)[<O_<TB74_T
MMO\ R!\J_P#'&W_[FE+[[;/_ )1\G_V7C_Z6JOK2DE          '5"^O3_R
M!/!W_P S_P :/_$OI3RU?<'_ .GOSC_Z+^9_^:.Y5K^=_P#EOS/_ (UW?_=&
M1N U"Q4
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M-=)FNGV?M(V7L'EL,5M7NWM\FEM=?XNF77K^%N_NK^';,:=$AZ/3 P
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M'.<-SVW_ %?"[K!N=O\ C..\6TUUZ6B)UK/2>EHB>C#[+W:@
M        +F_[=W[/:]MP^/\  +O#/P\[#K&-NKGQLV;*W=O#+F]6QMK'<7_3
MG-%%A#5<9+5K6WN<CB9IKB:6;'<S6E/%%%E;424U_P!0S[8Z\3O,GOSPC;V_
ME^ZR5CF,-*S,8\][3%>0_>G2F>TTQ9ZUI6M<W9EGNG/DFL2O?'KF-KEMYQPU
M)^ADM$;NE8GY;S.D9_CTB\S%;Q$1$7TMUF]IBV6J@1B
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MT=6_/'/-?%O*\??P.]PY\FDS./7LRUT^,SBO%<D1_MNWMG\)F&HK;;*0
M           $\'T2_9%_DR\@?[-]GYSX?CGY YC&XO/3W,?NVV@]F2\0XG4M
M\XEYDI^!A[[UT8W-U_[3BTJ@NI/X6/'',$_OI^W'_CD]?_ZX^,8._P!B^/X;
MWQ1$Z3NMG&N3/M=-/FR5ZYMM'Q^I%\5>N>9C2WNCU_\ ZV\'_-N.IKS^QI,U
MB/CEP_O7Q_MM'6^/_;:UC]]T(GGX06
M                                         0_??)OW]!_5MY)?'RWZ
M5F-S_MGH.&_U'YWZE_47:FF?U+B?Y[.\M;/YFBV>6_QY?:]OT_X4E-QS#^9>
M_8EP/\^^Z+QOZF+ZNSV7ZS=9/F[>SZ.QW'T<G2U;6[=S;!\M>[77YZSC[VU?
M2NQ_6^R./[J]V+#];+;KIIV8<G9;XQ,Z9)ITC77\8[=7-^>C9/T
M!;0_:IZG\S?_ #/WGY_M_P!.Z?TIJ?Z7\7U_,_K/-=D9CY_S?DT_'_3?Z"]O
MVO9K][Y?J]='M>F2IW^JAROT> \,X/Z>OZC><EG[^[]W]/CV>/L[=.O?^JU[
MNZ.WLTTMW:UC#]RVZ[-CQ&R[?\3+N+ZZ_#Z=<5=--.NOU-==>G;\)UZ7,E-R
M)8
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MP
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MK3,S,RKJ]H8Z8_8/+5QUBM9WEYTB-.MM+6GI^,VF9F?QF9F>LI%4=V!
M
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M>/U.WP9.OPG3'&+6O2-:_P +3\?FBT:_A$Y*#[38
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M(BD:V"U?S1@
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M$5TA[]R6[B_D/';#NM,XME;)V]>V/J99KK'X:S]+2WXZ5KK^"T>J]1O
M
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M3_$TTZ_#77KI%A%7VT6
M
M   J4?NK=5N+S2/"O=J;N&BUU[:N\M5FL:J*^;BXN-QQ'5V7MKN*3C_#HALX
M]%EHKIY_FJJGHYX_AQRME_I7<KCP\WYIPDTF<NXVO&9XMK&D1M\F]QVK,?'6
MT[JLQ/PB*SK\82@^VC<UIO.7V>D]V3%M[Z_A$8[9JS'^7ZD:?V2IJ+CDL@
M       '2K^D/:KC<?JR\1LO<VD-G)9ZKO6JTPP5UR45V^B]N=@Z3:7=54G\
MW$U_:Z]1/)3_ +6F22KCC^''#S:?>UQ6/A_NC\MVF*\WK?=;;/K,1$Z[K8;3
M<VKT_"MLLUB?C,1$SU5\>X=M7:>R>4Q5F9B<N._7\\F#%DF/\DVTC]D)5T5V
MM
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M^Y+8SC\AX[DM+:9ME;%KT[?X.6;]/QUCZWS==-)KIIUUM'JO4;P
M
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M7C'E6+ZO!;S#GMIUIKVY:ZQK\V.VEX_'KVZ3,3I,Z2U1;59,
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M[9TCA@
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MYO(W/L/+AB\V_3[7!CTZ_+K6<O;'3K_B]W36-;3&NL3$3MH+-+@
M
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M8*V_9/9W:3_RMJS_ &3"<]!QID
M
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M&;%M[Q^R(P8\>D_Y<<S_ &3":M"UJ$
M                                                !%%]X&F_UQ]6
MWEAC:*[."XQ&MZ/N5M=7EO[_ +']#]JZ+ME[1:\\<<R07F1Q>(N+.B2GGCT_
M(YXJ_DYJXYE7]D?,_P D^Z+Q3<S%[8\VYW.WFM9TU_4['<X*S;\)K2^2F28G
MX]G3K$-F^G-W^C]D<9DG6:WR9,<Q$Z:_4PY*1K^<1:T6T_9^;FM/20L%
M      6FOVL785>-\AO*3JCB]FCBW3IG5.PJ\;396\EO=U]8[O1K<=[+D:HN
M;JUFQ]/;E4=$-%=,=Q3<UU5TU<PQ\TU<?U2/'J[GU[XOY7V1-MES.?:=_=,3
M6-[MOK36*:]MHO\ H(F;3$S6:1%9B+VUC;]R>PC)P7&\GI&N'=WQ:ZSK'UL?
M?II\)U^AK,Z:QI$1\9UNT*4T/P
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M:)B8F)C6)B8Z3$QUB8Z3#;U;5O6+5F)K,:Q,?"8_.'XOV_H
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M)7W#^&UV^YP>9["D1BS3&'<Z1_OD1,XLLZ?Y]8G':TZ1$TQQUM=;+50(Q
M
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M=?M+?SR/L+EMQ,S;MW=L6LQ$?X$1ATTC\OIZ1/QF(UG69U2-HZ,!
M
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M_)/2?VI>T16K
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M7\OFI;_)I*?] 1H\
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M+.L_YO='PET1GGF0.
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M_FFL1\(K>\WK7_E8M%?\C=EI5AX                         "'C[1?J
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M[9TCA@
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M;MF8[M=)F.JK[F-]/)\MNN2F;3.XW.3+K;3NGZE[7^;36->O729C5DYC+K@
M
M              %.S]UIF,9/F/!G 17L->9QF-\CLQ?X^GGGY%KC,Y==&V6)
MO9:?QZ>(;^ZUZ]HCYXYYYYJMJ_S^/QQ^;@_Z5>SW--GYSO[TF-GER<1CK?\
M"U\5>3MDK'[:URXYG]EX2M^V?%DC%S.>8GZ5K;6L3^$S6-Q-H_R1:NO]L*B"
MW!*4         !TX?J#_ /1G^''_ !/X[_KMEWF:^[K_ .F5\Q_\<7_Z7C5V
M>U/_ $A\M_V7/_P-4D*.+
M
M      $$G[C2WN)_K-V^6&"::.S[;ZDN+N2**N2BUMZL[<6E,]Q713S3!#5=
M7447%57XIYDDII_/YJXXYG3_ $ZLF.GW+;.M[1%K\3OXK$S$3:?I1;2/SGMK
M:VD==(F?A$MT>@[5CV'BB9B)G:YXC]L]L3I'^2)G^R)<]AZ"DZ@
M%Z/]KGLF,NO"OO74(JYN<S@_*+-[)?T50\TV].,VKJ?JG&8FN*?\^F2:NZTV
M]XDHXX_-%--'//\ M^%&W]4#CMSB]T<%R]XC]'G\7QX:SKU[\&^WU\FL?A';
MN,>D_C,S^2&?W'[?)7R_9;J=/I7XVM(_/6F;--NG]F2NG^7\EE]6JCR
M
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M&;MZZ?/7':U-9_+OB-?V.J$\M2M<
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MKVZS7%:8B+==)F8B(G2>L](EU<GE35F
M                                                *1?[IG,8R?R6
M\9,!%>0UYG&=&9W,7^/IYY^1:XS.;]E++$WDM/X]/$-_=:]>T1\\<\\\U6U?
MY_'XX_-V7]+C9[FGK;R;?WI,;/+SF+'6_P"%KXMK2V2L?MK7+CF?V7A,+[;<
M62/'N1SS$_2MO:UB?PF:XHFT?Y(M77^V%7%:"D@          ZGGUVV]O:^
M'@_%;00V\=7B+XX7%4<$5$-%5Q>=/Z?=W<]5$=--/,UU=3URR5?[:N2NJJKG
MGGGGEY;?N&R9,OOWS>V6TVM'EW+QK,S,Z5Y#<5K'7\*UB*Q'PB(B(Z0K9\\M
M:WG',S:9F?YINHZ_E&?)$1_DCI'[&XS3S$P
M
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MTMCM.O3328R5TZ_A.L1TUMBJHT8P
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MTZLD,<=>
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MO9G*7Q3%JQ;!7I^==MAK:/\ ):)B?VPEO1+:N
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ME<U?GPV_+3)'2)G_ #;=M_SK#=AI5AX
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M:Q^>D3TB'G&0
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M<[O;6F9M.[S3,S\9GZENLLSL-=2
M
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M>7<4T_&9R5PVB?\ )].=?[87*U.*)H
M                                                 "A+^YHZ]N]7
M\^].W;BF\EQ?9OCWI62CNIHXJ+2+-ZQL^ZZKE,195T5<R2_#Q6.QMU)S7QQS
MQ5?_ (X_/'''XOD_IH^08N3]";SA?DC=<9Y!N:36)GNG'FP[;/3):/A'=>^:
MD:?ABU^*;/V\;ZNY\(R[/I&7;[_)&GX]MZ8[Q:?[9F]8_P!RKKK#V^0
M    '2K^DKM2CMGZQO%K*27DUSD]-U7.=5Y:"YRMQF+K'5]9;;GM0PEG+=7,
M$%<$,NI8S'7-M:T\51V5G<0V]%55,7%7/FT^];Q:WB?W->4;6M(KMMYNL>^Q
MS6D8ZWC>X,6XR6BL3.LQGOFI>\Z3DR4ODF(FTPKX]P<9/%^Q>2QQ$1CRY:YJ
MS%8K$_6I6]ITB9_OS>)M\;6B;3$:I5T5VM
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ME=Y6:SCMO\T5FNNDTI>:4GKK\:UB9_;,Z1$=&Z;3#$0
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MXK>9..Y+%?!OL5NV]+Q,6K/[8G\XTF)^$Q,3$S$Q+VSI'#
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M,BTQEW&^[](MIW4Q8[Q:)K\;1%LN.?RB8KKU[5YA1XAJ
M
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MUF9F>D1$=9F>D0_EK5I6;6F(K$:S,_"(_.77\>0]5<
M
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M8GII>>4<H9@
M                              *EW[J7K+YF@^(?<EM9>W_3NX=G]99G
M(P8+U_,_K/"ZQM6M663V:.JGX_Z;_0>6DL;"7BOWOEW<L7-'M3>Y;%_2S\F^
MCS_EWAV2^OZC9[+>XZ3E_=_3Y,V#-:F&?CW_ *K!&7+73M[,5+]W=3MD_P#;
M5R/9ON5XFT_XF+#FK'=\/IVO2\Q3\=?J4BUH^';6)UUC2F<N12S
M 7D?VN_;?]2^*/?/35U<_)ONJ>[+7;+2BN\]R6PUGM;4K"''6$>/XLX^+6S_
M *CZ]S%S1+[\O,\US+3Z(^(N.9*/_P"I]XE_+?:W ^8XJ]N#E>$M@M/;I%LV
MQSVF]IOW3W6^CN]O2:]M>VM*3K;NF*PV^X_B_P!/Y-LN6K&E-SLYI/3XWPWG
M6==>L]F7'&FD:1$=9UZ6<59B.P
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MRVFV6TS,S,ZS,SUF9F>LS,]9F?B_L?%^
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M3RU_.LS'2T?"U)^:L_G6:VG=AI5AX
M              "HY^ZC[9YM]8\2.BK*_FJIRV>[([9V3&4RY.&WAYU_'X'3
M])OY8/11ALA-<<;-L$<=?JDNK.F*OC\1T7/YDMK_ *6?B<9.3\M\YS8XUQ8-
MGL,-]*3,_5OEW&YK$Z_4I$?1VLS&D4R3:.MK8OEE']M7%]VYY3FKUCY:8L%)
MZ:_--LF2-?WHT[,4S\(MK'QFO2G N(2O          7;?VLG7$.+\<O*#MVF
M*SXN-X[LUKKB6:B[R%>0DAZKT6TV:"*YL)*>,7;6<-?<<G,$T//-Q/77-3-Q
MQ1%!^:4?ZI'D=]U[%\8\1F;_ $]CPF;>1$UI%(G?;JV&9K:/GFTQQ\=U;?)6
M(I-.M\B'WW)\A.3G^-XO6>W#L[Y?A&G\;)-)TG]Z9_@1K$](TC3K-EI55TC<
M
M                 YH_W6[5<;E]HWEYE[FTALI+/=M7U6F&"NN2BNWT7K/2
M-(M+NJJ3^;B:_M=>HGDI_P!K3))5Q3_#CAZ4?LLXK'P_VO\ B.TQ7F];[+/G
MUF(B==UO=SN;5Z?A6V6:Q/QF(B9ZK"O4.VKM/6_%8JS,Q.&]^OYY,V3),?Y)
MMI'[(1:I1-D         ,X^,.'R>P^2OCS@,+939',YSO+J;#XG'V_''-Q?Y
M/)[]@+*PLH.*N::>9KJZGHHIXYYXX]57#!_9V\VW'^MO(=_O;QCV>#@]_DR7
MGX5I3:Y;6M/[*UB9G]D.F\CRX\'CV_SYIBN*FRSVM,_"(C%:9F?[(=9%Y1%8
MP
M                                             #P?:FKY#>.L.Q]*
MQ,UG;Y7<-#V_5\9<9&2>+'P9#8->R.)LYKZ6VM[NYBLXKF[IJEJCBEKIHXYY
MIHJY_''/?>+<IM^$\GX[FMW%[;79[_;Y[Q2(F\TQ9:9+16)FL3:8K,5B;5B9
MTUF(ZN;QNYIL^1V^\RQ,XL6>EYB/C,5M%ITUF(UTCIK,?VN1R]:JT4
M   !/Q^VTS^6P_V108[&W?QK/:^A^T\!GX?8MIOGXFVN=4VB&T]R>&66U]&=
MUNRG]R&J.7GV?1S5S'7)15 ?^I!L-IO/MPMN-S3NS;7GMEEQ3K:.W)-<^";:
M1,1;^%FR5TM$U^;NT[HK,:0^X'!BR^OYR9(UOBWN&U>L]+3%Z:]/C\M[1I.L
M==?C$3'0*4"(.
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MGKUO3'$Q'QUB9CY=8O2*-D,@
M                                         $47VZ?8W@/KX\;LGD\!
MD+.Z\B>T;/*ZQT3K5=-E=5V66XBA@R_9>:LKV"\MI-;Z]M[ZBZXBE@FBR.3J
MM+*JFF*>>>"5?VD?;IO_ +@?8^+;;_'>OKSB[TS<GF^:O=CUF<>SQVK-9C-N
MYK-.ZMJVPX8RYXF;XZ4R;-]6^ Y_.O(*X\]9C@=M,7W-^L:U^-<59C2>_+,:
M:Q,36G=>.M8K;FV9G,YC8\QE=AV'*Y+.Y_.Y*^S.<SF9OKK*9C,YC*74M]D\
MKE<G?2SWN1R61O9ZYIYYJZY9I:ZJZZN:N>>7H_V>SV?';/%Q_'XL>#88,=<>
M+%CK6F/'CI6*TI2E8BM*4K$5K6L16M8B(B(A8#BQ8MOBK@P5K3!2L5K6L1%:
MUB-(K6(TB(B(TB(Z1'2'S7)?0         !.I^W=Z$E[A^QG4]UO+7WM<\>=
M#W3MG)5W-K=UX^XS=S9Q=>:AC>+N&UEM8,Q%F]WXR]K%++#S+1AYJZ>:_:JH
MJ@S_ %#//*^'_;KN^%PWTY'R'?[?84TM6+QCK:=WN+]LVBTXYQ[;Z%[5K;MG
M<4B=.Z+1ICWQS<<5X#EV=)TW&_SX\$:3&L5B?JWG377M[<?9:8B=/J1'375T
M+GGR04                               42?W)7AG=]1>3V#\L-7QOHZ
M_P#)2SMK#:J[2UB@LL%W!IF%L<7?134VT4<$'];:I86N2CJJ_,UYD+;)S5\\
M\_GGF]+^F_[DQ>7>L<_JGD\FO/\ C=[7P=UIFV7C]QDM>LQK,S/Z;/:^&8CY
M<>*^VI$1'1-'[?O+:\IXY?QC<V_T[CYF::SK-L&2TS'QZ_P[S-)_"M9QQ"MF
MLA2!          ?>UK:MGTS*_KNG['GM4S?&-SN&XS.M9C(8+*\8?:,'D=8V
M7%?J&+N+6[_3=BUK,7>.OH/7[5W8W4T$M-<4M=%7!Y+B^,YG:_H>8VV#=[+Z
MF+)]/-CIEI]3#EIFPW[+Q:O?AS8\>7%;3NQY:4R4F+5K,?'<;;;;O%]'=XZ9
M</=6W;>L6KW4M%Z6TF)C6MZUM6?C6T1:-)B)?!<Y]@                 &
M?O&3R;[C\0NX]6[SZ,VF;6-WUB;F.NB3B2YP.T8&YDAJR^G[AB*9H(\[JN=C
M@IIN;:JJBNFNB.>"2&ZA@GBP'V9ZS\.]N^';KP?SC:QNN$W4:Q,:5RX<M8GZ
M>XV^329Q9\4S,TO$3$Q-J7K?%>]+=)Y%X[Q/E/$Y>&YG%&39Y(_LM2T?NWI;
MKVWKKTG^VMHFLVK/1V^N3[&^G/L4Z<BWG1I8=8[+UB&PL>WNH;Z_CN<]H>>N
M8Z^([NTDYHMY,[I.=DMY:\5E:(J*)Z**X9J(;N&XMXO.?]Q?VZ>8_;OYC/!\
MY$[KQK=3:VPW]:S7%NL59ZUM'6,6YQ1-8SX)M,UF8O2;XKX\EH">?> \MX%R
MT[/>1.3CLDS.#/$:5R5C\)^/;DKK'?37ITF)FLUM,AR/3 P
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MQIV_@@%[JY#]?['W_;/\/!]+%7II^YBIW?V_Q)OI/Y:)@40FJ@
M
M      '+5^R?/Y;9/L(\W,CFKOYMY;^5'>V AF]BVM_1B=4[)V+5\!:>W:0P
M15? P6'MH/<YIYEE]OUR55R555U>HG[;MAM.-^WWPG;[*G9AMXMQF68UM/\
M$S[/#GRVUM,S\V7)>VFO;77MK$5B(BR/U]@Q;?P7A\>&-*3QFVM\9GYKXJ7M
M/77XVM,Z?"-=(TC2&D[=3+P        &\GUE:OD-O^P_PGQ.-FLX+BT\G.FM
MHDKOI)HH:L?H^\X;=,M#15;V]S)S>7&+P$T=O3S3Q17<544UUQT<U5TZ/^YC
ME-OQ'V]>:[O<Q>V._C/(X(BL1,]^YVV3;8YG6:QVQ?+6;SKK%(M,1:8BLX;[
M$W--KX'S&7)$S6>.STZ?GDQVQU^,QTBUHF?V:Z1,]'4>>7Q6^
M
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MMXIAM\8CY:;C#>T]=/A6LSI\9TTC6=(=)IYO5?@
M                                                          #5
MSS<ZFY[U\/?)SJ*&PFR63WSHWLO":[:6T63N;CG;J]4R=SIT\%EAZZ,ED9K/
M:K>SFIM8_7\JJ/B*JB2FNJBK:'I/RR/!?;_C/EU\D8]ML.<V>7-:9I$?0C/2
M-Q$VR1-*1;!.2LWG3LB>^)K-8M&2>'\I_)?*^.Y6;17'@WN&UIG2([.^(R1,
MVZ1K2;1K/PUUUC35RH'JC67          )&OJ.[<KZ4^R'Q%V_F[FM+++]M8
MCK/*R4?'YM^<9W!;7G5=S7D:;N\L;6G&V=6WTW,TM=?/-M3#[]%$DD5%%4=?
MNU\2KYK]N/EW$=D7S8>)R;RD3KKW\?-=]$4[:VMWV_3S2M8CYYMV6FM;3,8#
M[1XN.8\ Y3:Z1-Z[6V:OQUUP3&:--(F=9[-(C\=>V9B)F73H>9976
M
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M_P +\1X[PK@<7"["(FU8[LN32.[+EG]Z]IB(U_S:1/[M(K76=-9TY;A96
M        O=_MH?%^XZL\1=X\C-AQD-KL/DONWIUJXYFKFNI.J^JYLKK.%EEM
MY.>/TJ;([Y>;'7S'313S=6<5G/57)15#Q'15_4J]GX_*?;>Q]=<?EF_'^-;+
M^-&D16-]OHIFR1$Q^_%-K7:1K,SV9+9J1%;1?NA;]POD=>2\IP\!@M,X..P_
M/'X?6S=M[=?[VF.,4:_A:;UTB==;(ZN%'\
M    !'5]J_B3:>9W@[W-U1;8;]7W["8>OL[J#F&*6;)6O:&AVE[D<);XF.&V
MO9*KS:\5-?:_7Q3#775:Y>:FCT2<TR42(^U?VSE]->[^&\KR9OH\#GS?HN0U
MF(I;9;JU:99R3-JQVX+QBW4:VB(OMZ3;6L36<]]:>46\2\RVG)VOV;&]_HY_
MRG#DF(M-NL=*6[<L=8ZTC76-8GF)/36L5
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MR?B7-9N#Y6NFXQ3TM$3VY*3^[DI,Q&M+?A.G28FLZ6B8C9!KACX
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MS,PUU(
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M3+6(F9Q8Z=?RR9\6.9_R1;6/VPZ5CS:*^
M
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M7UTU_P .DY-/C'[W9IK^&NNDZ:3U$GF"5P@
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M@\MQ^7B.5W/%9^N;:[C)BM\/WL=YI/PFT?&OX3,?E,_%DACCKP
M
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M,-OI/:4T'>_7T,-%Q%Q;:YV3D,M/E<9Q#/7-[<.!WS%YG'P>B62BNVM(Z_\
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M]ZS2FL3,=.^U=?QT^$3.D3U-GEP5M
M                                              /']A[9_06@;SO/
MP/U7^C-/V;;/TOY7P?U+^G<+>YCX'S?C7GP_F?#]OW?9E]OU>KT5?CT\]QX]
MQ7\^Y_8\']3Z7ZW>8<'?V]W9];)7'W]NM>[M[M>WNKKIIK'Q<O8;7];OL.R[
MNWZV6E-=-=.^T5UTUC737736-?S<BUZVUHX         "=3]NAK]IF?LVT;(
MW.+^?-J?5?;FP6%W[,LOZ)=W.L_TK7E/7'_+;^[8[--9>NO^7GY?H_VU5*#/
M]1+D,NS^V??;?'E^G3=\KL,5ZZQ'U*QF^O%-)^.EL-<FD=?X>OPB6F/?>>V+
MUWFQUMVQEW."LQ_G1%^_3]O6D6_Y77\'0N>?)!0
M
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ME9OCR[+/2:QKK:+8K5F(TZ]8G3IU_)UD7E$5C
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MXKV'N\G7Z6[ICSUU_*U>RW_XS'?3\HZ?@F?0S:D
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MWB='?<#RL;'P3^7Q/\3>[O%CTZ=:XYG-,]8^$6QT^&DZS'X:PO\ R@E!X
M
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M8
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MDMCFT1/6(F:ZQ$]=%6V]VUMEO,NSM,6MBRVI,Q\)FMIKK']NCU3JG&
M
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MU(GMB<FWO/X:SIDQ1KV_CIFUUM^$=M?WI7!U02*@
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M>MI5N>5^0[KRKR'=<]N]8R;C+,UK\>RD?+CI'^XI$5_;,3/QELLUJQX
M                           !KWY8]#8GR@\:>\/'[,<6=,/:W6^SZIC;
MR_KN8[3#[-=8^6?3]BEJLZ);C_@SMEO99"GCB.7CFJVXXJCDIYYHJV#ZH\\W
M?K#V3PGG^S[^_BN2PY[UI%9MDPUO$;C#'=,1_&P3DQ3UKTOTM6=+1WOC'-Y?
M'/(=GSF+77;;BEYB--;4B?GKUZ?/2;5^,?'XQ\7*3S.'R>O9?*X#-6<V.S.#
MR5]A\MC[CCCBXL,GC+J6RO[.?BGFJGB:UNH*Z*N..>>/53R]5.SWFVY#9XM_
MLKQDV>?'7)CO'PM2]8M6T?LM68F/V2LQPY<>?%7/AF+8KUBU9CX3$QK$Q_;#
MYKDOH                               D@^IWR\_R5^</4?:N5O/B=?[
M%>2=5]L\UWWZ?:4]=;[=V%EDLK?S5W%O;5V>H9JUQ^=YHGY]JJK%T_GT\^FN
MF.7W7>H_^.CTAR_BNUIW\_MZ1OMAI7OM^KVM;VI2D1$V[MQCMEVNM?FB,\_&
M-8G /9WBW^M_ANZXS%&N^QQ];#TUGZN.)F*QTF=;UFV/IU^?_(Z<3S,J[
M                                       %(7]T7W=_4WD?X^]!6-Y[
MUAU1U7F-^S$,-?XBAV;MC8*;#BQO8^.>.9+RQUSKNRN(^:N.>(X<E_)SQS))
MPNU_I?\ A/\ +/7/D'GN>FF?E>5Q[7',QUG#L<7?W5G\*VS;O)2=/C;#UCY:
MRF)]N'#_ *?@-]S=XTONMS7%7_<8:ZZQ^R;Y;1/YS3K\(5=UGR1P
M "Z3^UAZABQW4/E3WW/#9S3;AV1IO4.*N*X+2O(8Z+KC6)=SV"&VN>8^;^VL
M\U5VIC*IZ.*^(9Z["'GGCFJ'CGBF+^J3Y=;<>7>*^!X[7BFSXW<;^\1-HI>=
MYFC;XIM&O;:V/]#FBLZ=U8RWC6(OUB-]R?*SDY7C.$K,Q&+;Y,]HUG2?JW^G
M76/A,U^C?2?C'=/YK7*JE&8
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M&DQUUN2J=$3@
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ML?S!<[-SUIK46ST5QXNB*PM+RTV&*YAN+>.B/BVN(ZXN:*.:.:./++[ZXBG
M>[_,.'PX;[?:[?R;DZXL=N_6,/ZS-.&8F^M[5MBFEJ7F9[Z36_=:+:S6KYMM
M8V/F7*[2E)IBIR.XBM9UZ4^M?L^/68FNDQ,ZZQ,3K.NK;1J9BX
M
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M\)'-^OM]$1KGVD1N:=(G3Z/6\]8UC^#.2-8F)Z_'36)Z1SSAJ_P
M
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M&Y)TI-<F[F/A,]+8L,_GV],MX^$3]+2>ZMHK;I5(HM@
M                 .;7]X/C=1XV?8UW;C\98PV&I=QS6/D!IT,-5Q^.;+LV
M?(3[;^(9J?;M(8.T,7GX8(8:JX([:*/BCB/C_!C]'_V1>Q[>R/MTX3<;F\Y.
M6X>+<5N)G3][912,'6.MIG97VMK6M$6F]K3;N_?M8%Z<\@GR#P'9Y,EIMNMI
M$[;)\/CATBG]NN&<4S,]9F9UU^,Q(I:-H
M     .EO],WDW7Y3_7IT9MN5R$-_NW7N-NND^P?;N;>ZN(MCZR^/B<5<Y&J"
M*W]K);!H<V&R\T=<=%=-60_TR4^F63S7?>3ZSKZM^X/G.)VF.<?"\ADKR6TU
MK-8G#O=<EXIK,ZTQ;J-Q@K,3,3&+^[.M:U[>VO'8\:\[WNUQ5FNSSVC<8NDQ
M'9FUM:(UUZ5R?4I$Z_W?P^$2EHNM;
M          .8+]K/=W^8/[#O*WL6"\^=B(NU,MH.MW$=?JM)]9ZIM[3K+!WU
MA3QSZ(K/+V&ITWM/''%/-=5S577QQ)76]./VJ^$_\7_V]>*>.WIV;N>*Q[K-
M$Q\T9M]-M[EK?\[8[9YQS\=(I%8GMB%C'K/A_P"1>"<9L+1VY9VU<MX_'OS3
M.:T3^VLW[?\ )I'2(1[I!,Z          =*7Z1NGI>FOK)\8\9?67Q,WONMY
MKN',2^N[Y_4(NTMER^VZI>^S<W$\=M_[S^_P\/I@XBAD]GW?1ZY*ZJO-O][/
ME]?,ON8\FW."_?LMAN<?'XX^7Y)V.''@SUUK$3/^E4W%OFUM'=VZ]M:Q%?7N
M'E8Y;V)R.2DZX<&2N"OPZ?1I6EXZ1&O\6+SUUF-=-=(A*ZBHUD
M
M       @>_<<[?\ TU]:&SX7]9_2_P"X7<'4VH?!]7I_J/X65O\ ?OT;\>BK
MU^Q_0_ZA^/S3_P#0'Y_/\/QS.S^G1Q'\R^Y7:[WZ/U?Y?P^_W'=_S'NQUVOU
M/V:_J?I?C_B_Y8W5Z"VOZCV'CS=G=]#:9[Z_YFM8Q=W^7ZG;_P LY[ST#IT
M         +O_ .UIUO)VOBWY);?+3#QALYW]C];L*Z9N*KBK)ZKUWK>3RU,L
M'X]4<-%KN5ES'7SS^*ZJJ^./]IRI(_JB\CMLOM'QOB*3/ZS!P%LUHTZ=F?=Y
MJ8])_&>[;Y-8_"(C\T.ON2W&.WDG'[6-?JTV,WG\M+Y;Q7K_ &X[:_Y/S6@U
M8:.0
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MVE=>V*]_<&U_2>R.4Q=W=KEQWUTT_P 3#CR:?&?W>_37\=-=(UTB5%%IK4
M
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M=)B9B8^$S'56)RG'Y^)Y/<\5N=/U.VSY,5]/AW8[S2VFFL?&)^$RR$Q]P
M
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MXWR*D=:9+[:_PZ]\3EQ_CKT[,OX3'7K->G=<E4Z(G
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MN]W$Z[C-DM>T_G:\S:T_Y9F7I'6N.
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MDF?[)A/R@.T@
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M']D0GY0':0
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MZ-(B-(3AH1-.
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M/BKGPS%L5ZQ:LQ\)B8UB8_MA\UR7T
M2Q?1_P!L\=1?9SXR7]U?0V6&WO/;%U-F(YY<9;49#GLG4LWK6L6--WDZ.?8F
MJWRZQ,L=%O5'<W4D5-M'S5[W,=<4?O<\3GR[[9?)L&+'-]YL<&'?XYB+VFGZ
M//CS9K=M)ZQ^EKGK,WB:4BTY+1'9%JZQ]Q\7_-/77(TK69RX:5SUTUG3Z5ZW
MO.D?\[B\3KK$1/=/PUCI0/-TK[
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MT<S_ ";UYO>RW;GW79MZ==-?JV_B1^]69UPUR](U_P!M6:]SI!/.2@"
M
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MUUC]DI5T5VM
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M\;R'9,3EVE\?=UTGZ63N[=-=/E^MK/36>Z-9G2-+3:KA&P
M
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M3TZZQ=N4H(?
M                      *&_P"Y,\MZ^X/+;7O&K6\K-/I/C'@:8L]!:WEO
M-BLEVQV!CL3G]@N.>++FJB[FUG6/TO&_B>NN2PON,A#33%57/Q)>W_3>]2U\
M0]3;CV3R.**\UY-GUQ3:LQ>FQVM\F+%'S=:QFS?6S?+$1EQ?I[S-XBG;-7[?
MO%XXKQ?)Y#N*Q&\Y&_RZQ/=&'%-JUCK\.^_??ITM7Z<ZSI72N*L8;]
M      79_P!OQ]5=?5&N8KSF\@=9AI[(WC ^YT!J.9M;>XGT31LY%%77V3D+
M&_Q?R,3NVX8^GT8JN"X]5K@+N3F3\R7U4=O2I]__ -T]?*^1R^CO -S,^.;'
M/IRNXQVF(W6YQ3/^ATM6^F3;;>_7/%JZ7W6.L5^7!%LD0/>7LN.3W%O#.#R3
M_+\-_P#2;UF8C)DK_O43$Z6QXY_?UCKDK&G2FMK3:K=&P
M                      !ST?W!GB3=^.GG;G^SL/AO@];>4UG==KX"_MXH
MX\?SV##-;67;^&YYCMK7BK,4['=6^<NOQQ+^:-AAJJEJDJDIH]!O]/[VSB]B
M>B]OXSO,W?Y)XM>NQRUF9F_Z28FW'Y.MK?P_HUOMJ?N]=I>(K%8K-IU^C/**
M\_X73CLM]>0XV8PVB?C]+K."WQGY>R)QU^'^%,:1$1K!6G,W.
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ML[]L9/\ LZ.Z^+]F+)_C516^Y/F?_E9X]CM_S3<9*Z__ !K%.D6_^+1K-?\
M<V_?A<!5"HK
M                             *%?[G#=*-A\_-"U:TR.2FM= \:=&QE]
MB[B2XIQEAL>=WKLS9KV\QMM7)5;>]D=>R>)IN)XZ::Y>;>B.OGGB"G\7P_TS
M>%MQ_H/?\IEQXXR[_P EW-ZWB([[8<6UV>&M;VT[M*9:9YI69F*]]K1IWSK-
M?[=MG.#PC/N;5K%L_(Y)B8TUFE<>&D1,_'I:+Z1^&LS'QE716)-]@
M  .J=X#ZA-H/@YX>:=>8:SU_*8#QCZ+L<]B;&G'\06VS<=::U+L]=<F+KEL+
MN\N]AEN9KBXCKDXN;B2N7FNOFOFOGRR^^N7IS_N_S#F,.:^XVNX\FY.V+);O
MUG#^LS1AB(OI>M:XHI6E)B.RD5IVUBND5J^;;J-]YERN[I>;XK\CN)K:=>M/
MK7[/CUB(KI$1.FD1$:1IHVT:F8N
M
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M+:3.G[T_1^7K'2+=)TZ72E,2(P
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MD\0Y#A<<1.?-MK?3B?A.2FF3%K\?]\K7KI,Q\8B74\>6U6P
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M^.N+%76>L]M*5C7\=%FFPV6WXW8X>.V=>W:;?%3'2/RI2L5K'^2(B'CW;N4
M          L%?1G]4M?F1V3#Y$=YZY-7XP=4YZ/FQP^4L;>;&=W;_BJHKFG3
MJH+BYHDGTG79)(;C-RU6\UK?\_C&\>KF2[JMJ_\ [XONJKZ=\;GUYX-N:Q[.
MY7!/=DI:8OQNUOK'ZC6(TC<YHBU-M7OK?%UW,Z=N*,FC/<OLR/$^/G@>&R1_
MK'N:=;1,Z[?%;I]3I'3);K&.-8FO^)^%>Z_PH,0@
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M^"LGR?:6V'DG(;&W;W8=]GQSV_NZTRWK\O2.G3ITCI^$,_,!=&
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M6U=M2-=>V,,:7B/_ (].6=(_&9_'64MZ);5P
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M5MN=QDW>YR;K-I]7+>U[:=(UM,S.D?VR^\X#X
M
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M\?STC\5_Y02@\
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M6"@
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M-\EFY;D\DY=_N,DWO:?QF?PB/A%8C2*UC2*UB*UB(B(9(8XZ\
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MCQ?>\7:8FVVWO?'S1K%,V.ND=NFL1W8[S$S/S3-HC]V5959@D0
MZA?U:;5<;E]<WA9E[FTALI+/QUZSU6F&"NN2BNWT77K72+2[JJD_FXFO[77J
M)Y*?]K3))5Q3_#CAYA?NBXK'P_W%>:;3%>;UOY%O,^LQ$3KNLMMS:O3\*VRS
M6)^,Q$3/57'[)VU=IY]R^*LS,3O\U^OYY+3DF/\ )-M(_9#?=H9A(
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M\
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MI,XN/W%HB9TB9KBO,1K^V=(_R]'5F>5A6>
M
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M^$:RZ7SS5J]
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M+;O5'(M
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M^YUIM(^3!BUZ8L4?"/VWM^]DM^-IF(TK%:QOBT2PH
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M /"%?_%2?_(Z+>OZ5/\ _'G_ -I/_P!KI4_;-_\ IO\ ^H__ +*4_EO*5(
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M^"7V..=-QO\ /3#'Y]D3]3)/QC2-*129TM^_IIU[J]")Y^$%@
M
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MUC76.ED\V*O<
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M8]:U_O6^;Y8_&=(=%Y1M/U_C/(['K'UMAN,?2-9^?%>O2/QGKTAU?GE-5E
M
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MI\_;-.OX6GK'QCIZ/,BKH
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M9JQ.M<?[N*GX?)CKI2)TZ3;2;VC]ZUIZMM&IF+@       *?W[KG_P"$*_\
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M*\3@V.V[K1&G3+GGNF)_^-5Q3&OPBTZ1&NLV7U:J/(
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MR&&FNNG;I3+DU^'7_#TTZ?'77II-_)0>A"
M
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M396XWD]SQUNZ+;?/DQSW1I;6EYK\T?A/3K'X2R$Q]P
M
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M9CIK68TB8F(WQ:)84
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M;K/?<[BTWW&2\VM:>LVM:=;3,_G,S,R^PX;Y
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MOPBL_P LYNWD?DN^YR=8KN=S>]8GXQ373'6?A^[2*Q\(^'PCX-EFM6/
M
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M&R[?\3+N+ZZ_#Z=<5=--.NOU-==>G;\)UZ7,E-R)8
M
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M3:VLS71[/V,\=[!Y?;S%H[M[?+\VFO\ &TS?AITGZFM?Q[=-=9ZI#T>F"
M
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M\LPU_P#Z;+/_ +[)BF>O_P 5B9T_S8F?W87 50J*P
M                                                #F4_<3CLAB_L
MV\Q+;)V-YCKF7M6K(QV]];3VD\F/R^M:_EL3?417%$<E=GE,5>PW-O+QQZ)[
M>:B2CFJBJGGGTP?9]N-ONOMG\/R;:],F..*[)FMHM$7QYLN/)69B9CNI>MJ7
MK\:WK:LQ$Q,+$/5&2F3UWQ-L=HM6-MIK$Z]:WM6T=/QBT3$Q^$Q,3UA&FDFV
M$         RUT%VE<=&][=*]UVF/AR]UT]VUUQVE;8JXXKYM\G<=?;CAMLAQ
M\_$5Q:2<PWLF(XCJ],L57IJY_%=//\>,3\]\7Q^<>"\UX5ER3AQ<QQ.\V5LD
M::TC=[?)@F\:Q:-:QDUC6LQK'PGX.LYSC:\SPN\X>UIK7=[7+AFT?&(RX[4U
MCI/P[M?A/]CJY=:]B:CVYU[I':6@Y:'.Z3V'JN"W/5<O!^.*,A@=CQMME<9<
M54?GFJ":JUNJ>)(JOQ7%)Q515QQ53SP\J?DGCW+>)>0;WQ?GL4X.:X[=9=OG
MQS\:9<-YI>-?QCNK.DQTM&DQTF%9G(;#=<7O\W&[ZLTWF#+;'>L_A:DS68_V
M8Z3^,=7MG2.&
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MZKO>5W.]I,S3-N,EXF?C,7O-HF?VSKU9(8XZ\
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M4O&G7Y?C'QCI9/-BKW
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M?[K^Q9E5I(\
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M5;3#EUUF==(MAUF/P_P=-(TC2(GXS,IYT$&E
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MUFN6LS%JS$Q,3$Z3$Q/6)B>DQ/6)5NVK:EIK:)BT3I,3\8G\I?L_#^
M
M .=G^X7TNXU;[1NXLY-<331]D:3TUNEI'+85V=%I;V/66N==U6]O<5SRTY6&
MJZT*67F>FF*FF26J#T\\P\UU^AS^GQS./E/M?X?8TK%;<;O>0V]IBT6FTVWN
M;=ZS&D=D]NZK7MF;3,5B^NEXK$\O1.[KN?6^TPQ$1.WS9\<]==9G-?+K,:?+
MTR1&G7I$3KUTB$E-=N          !<9_;@_8[:7>)J^OSMK,V=I?8K];V;QP
MS&1NY:)\Q:7=S>9[<>K..9O5#5>8V:6YS.*I]7%4EO7>P_Z(+>CFGK^HU]N>
M7%N_^/\ \3PWO@R_3P\OCI6-,=JUKBV^^Z=>V\13;YYTTB\8;_W\DQ%'W]X!
M:N7_ %YXNDS2W;3=5B/W9B(KCS?V3TQW_*>R?QM*W2J11;
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MV7NTU[?IX[6[M-)UTTUTTG7X:2ZT;R=JP@
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MUO$S[D/(?J[S8>+X;?)BI.XRQ$ZQW7UQXHF/PM6L9)Z]>W)$Z1$_-;15.HP
M
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M-2@
M                                                  *\7[F73?ZC
M^O75]ACKLX9NO_)#KS899)K?W+NYQ^5U'L;39\;97%/'KM_=OMEM;F3CGGT5
MTVGXYXYJXH_%A7]-+F?Y=]P>ZXZT7M3D/'-WBB(G2L7QY]IN(O:/QTKAO2/Q
MB<GY:M[_ &\;O]/YWDP3K,9^/RU^/2)K?%DB9C\>E)B/]U_:H-+Z4VP
M    %T/]JQO5QD.J?,'K.J3)<VNH]A=4[U#%+>UUX>BX[%UO;]?N9+''\U\Q
MVN2DCZNBXNYN*>*IXJ+>GGGGB&GCBF7^J;P6/;^5>(>31&/ZN[X_?;69BL1D
MTVF;;Y:Q:_QM2)WMNRNNE;3DF-.^=8D?<KLJX^3XKD?E[LN#-C^'S:8KTM&L
M_C'\:>V/PGN_-:_53(R
M                                         (\/M9\;J_*KP$\C>K,;
M8S7^VVNDS]A]?V]I5;T7UQO/64T6[X+$V,EW35:QS;15A9,/7S)Z*?9R%?\
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M:\ZW>/%7MV.[G]3BZ:1IEF9O6.D1$5RQ>L1'PK%?[$M*)S6
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M\
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MWYYY!/E'E^_YJ+3;!ESS&/X?X6/^'BZ1TC6E:S.FO69G69F9G=)IAB(
M
M             #GW_N1NP*-R^R:_URF?&RU=3=&]5]?R1V-%Q3=6U>2JV3M3
MB#,U33RQR9*J/LNF2GF*F*/X<D''-/-?%===_P!_3AX"W#?;?CY&:Y(CEN<W
MVZB;:=MHI]'8ZX](B8IKLYB>Z;3]2+SKVS6(G+]O^QG:>OJ[B8M'ZK>YLO73
M2=.S#\O[/X.G76>Z+?AI$0&IZMV@         .IW]>77M?5?@GX@Z)<64V-R
M>%\=>I9<_83WMOD:[/:<SI>(SVV6]-Y:2SVD\,6RY2[XCYADDBXC]/%%55/'
M'//EM^X3R&OE7O3R_G<=XR;;-Y%OXQ7BLTBV#'N,F+!/;:(M$SAI37NB+:ZS
M,1.L*V?.]_')^:<KO:S%L=]_G[9B)C6E<EJTG2=)CY(KKK$3K\8;CM/,3
M
M                                             1@?<_HMQV+]7_E_
MK]M'DI),?U[A]ZJIQ5E7?W7%OU=ONH]F7<DL$=$E5&-BM=1KJO9OQZ;:SXEE
MJYXXHYYXDY]F?.X_'?N=\0Y#+..*Y.0R;7Y[16NN]VNXV58B9TUO-MQ$8Z_&
M^3MI&LVT;&]2;VNP]C<5GMVZ6SVQ_-.D:YL=\,?Y=;_+'XVTC\7,\>E=88
M        LO?M>=ZM\-YE]W=?W4F-MZ=X\=<CF<?-=WM%O?7>8TGL+1^(L-BK
M:2NCC(37&&V:_O):*.*I:(<?5)QQZ*9*N*U?ZGO!9-YZ;X3G\49+3L?(J8[Q
M6LS6N/<[3<ZY+VC]R(R8<6.LSI6;98KKW36)CU]QVRME\2V>^KW3]'?Q6=(U
MB*Y,63YK3^&EJ5K'X:VT^.B](HV0R
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M<
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M9ZQW5M'6F3',S%<E)_&MM)CKI,6BU;1%JS$;1-7L;
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MY%7QKP7?;N+17=Y\?Z?%K\9R9HFOR_[:F/OR1^'R3\?A/3*>:57B
M
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MMDR7GXVO>TVM:?VVM,S/[95<YLN3/EMGS3-LM[3:TS\9F9UF9_ME])QGS
M
M                                             89\CNO:^W/'GOCJ
MB*RFR<O9W3/:'7L>-M[VWQMQD*]TTC.:W1909&[E@M;":[JR7MTS2UT1Q55<
M555<<<<\LR]<^0U\2]A<%Y7:\8J\9S.RW<WFLWBD;;<XLW=-*Q-K17LUFM8F
M;1&D1,R[;@-_'%\[LN3F8K&VW>'+K,3,1]/)6^LQ&LSIIKI$:S\')C>L%9X
M         EZ^B/L*OKW[1O&NN6]FM,3NDW8?7N9C@LK>\KR%&T]9[=!KUE5S
M-%)-9P\[M;XN62:&J.2B.*KCFKF+F2BN(OWU>/5\@^U_R2*TB^[V4;3=XYFT
MUBDX-[MYRVZ3$6G]-.>L5M$Q,VC2.Z*VC5GNG81O_6_(1$1.7#&++769C3LS
M4[I_;_#F\1$ZQK/YZ3'2(><9
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M5N>#Y;<\/O(TW6VSWQVZ3$3-+3'=&O\ =MIW5G\:S$QTEE1BSK
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M=U+:=)_MK:(M%JQGY@+HP
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M8_"M*Q%:Q^$1$+*\&##M<%-MMZQ3;XZ16M8Z16M8TK$1^41$1#X[EOJ
M     NM_M?\ Q?N-4Z@[M\M-BQD,5[VQGK'JWKB\EFKYO*=+T*>>_P!UR%O#
M%S\:G&['N=];6G/,O-5QQ/KM7IHCCJXKGI9_J=>S\?*^7\)ZGX[+,X>)P6WN
M\K$1V_J=U$5VU)F>O?AV];Y/ETKV[N-9M:)C'$+[C?(Z[GE=GXQ@M/9M:3FR
MQ^'U,ND8XG\=:8XFW3IIECK,]*VIU62-0
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M$_G%KQVQ\;3I6)B9U=0QYA5<8
M
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M<1$=TZWQVK';'XVB9B:Q^>FCJ_/*:K*
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M)\7_ $7-;?RK;U_@[VGTLLZ_[]BK$4F8_P!OBB(C37_"G736-;1*L!'
M
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MZS^[>ENG=2VG2?[:VB+1:L9^8"Z,
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M(KI$5I>6<]D\G\DWO/9(M'ZG/:U8M.LUQ_NXZ3/^TQQ6O3ITZ=&RS6K'@
M
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M(="AY]4%0
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M'CXXGG]]Q=8B*[;>9L4:3,Q_#R6ITFWS3'3I,]9_'JS8PITX
M
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M6T3%HG28GXQ/Y2_9^'\
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M\6Y;+PW,XIQ[S'/]M;UG]V]+=.ZEM.D_VUM$6BU8S\P%T8
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M6B;99G\ZSCK..8_/)&NL:NB,\\R!P
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M<F;-EF.[IKCK2E=:_CK]6W;:?AI:(U[ITN;J:T2@
M
M                             %$_]T!U_1@?-;I[L&T@QMO:]@^.N&Q]
M]Q;UW'ZG>['I.^[S;7N2R4=<'%MQ#7KV<Q-K;UT2U5U<6E?%=%'%--4EY_\
M3%Y^V_\ 2W,>/Y;9+9>/\BR7KKIV5P[G:[:U:4G7NUC+BSWO$UB(^I68M.LQ
M6:'VY;Z<_B&[V-IM-L&_M,:Z:13)CQS$1^/[U;S.L?WHTF>NE:U9(D$
M     Z1OT4]CP=C_ %>>-4O,MG5E=)L][ZXS=M8VF0M8;*?4.Q=JL\'%75?U
M2\7=Y=Z;+C+NXF@DKMZKBYKXIXCYIJAB\X?WS>.7\<^Y[R6FE_TN]OM=YCFU
MJ6FT;C:8+99CMT[:UW$9L=*VB+Q2E9GNB8O:O_W/Q\\?['Y"-)^EFG'EK,S$
MZ]^*DV^'PB,G?6(F-=(CX_&9=42&K0
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M1@
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M_P -M+5G_D6K/PM6T=:VC6+1,3$Z,M,3=6
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MQCQ=)F)BE9^K>8TF.D_3K2T3K$Q>8TZ].@L\_P @R
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M8^3';I$ZXYB==(E/R@.T@
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M +)U605<C0
M
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MAM]Q_'?0\GV/)UC2FXV79/RZ1-L.2TS,V_O6[<M(F/C6L5ZZ3$19Q5F([
M
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M@]U^)?ZS>&9=UMX_[X\=W;BG^VI6O\:G^7''?$1&LWQUK'[TNBD\\"!@
M
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M%>6;'S7QW!SNRTK:\=N7'KK.+-6([\<_V:Q:DS$3;':EIB.[2-.6X65@
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MM6TP)Y'CM]Q&^R\9R>*^'?X;S6]+1I-9C_D3$QI,3$S%HF+5F8F)>\=$X0
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MG'L-M\W[,F?3);3_ .-QAG7I.OX:1$S9'5PH_@
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M(ZUQP
M                        %"7]S+VC-N'GMJ/7D,_^]?4/0^GXN2S_ #CY
M/1LVY9S9MQRU][MO%Q?Q?,U_(X:+V+B3GBCXONQTT\3555WR?TTO%Z</Z&W?
MD-Z_Z5R_/;B\6^>-<.WQ8=OCKI,]D]N6FXMW4B->_MM,S2(K-G[>.-C:>$Y=
M_,?Q=UO;SKU_<QUICK'7ITM&2=8C\=)F=.E==8>WR          Z8?TQ=:U]
M5_6-XC8">VFM[K/=>WW95Q7<VUO;75U1VSMNQ]EXVYE^/^>+B'G#;5;46TE?
M/,E5G1#ZOQSQ^./-1]Y?DE?*?N:\MW]+1;%@Y"NSCMF9K6=A@P[.\1K\)^I@
MO-XCI&2;Z?G->?MOD(Y+V+RF>)B:TSQBC29F(^C2F*8Z_#YJ3K'P[IE)^C&U
MR
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MWCO'\M$:WV^\MB_'I7-CFTS^6FN"L:S&NLQ$3&LZW>E)2'8
M
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M\9QS*15'=@0
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M%JVB=)K:)TF)B8TF)ZQ/27TG&?,
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MRZZ[G<7O$3IK6DS\E>G3Y*16OQGX?&?BV$:^=$
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MK1*
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MBK[EM];E.5W/)WU[]QN,F6=?CKDO-YU_;UZLD,<=>
M
M                               U*\]>N(.W/";RQZZEBLY;C9_'OMFV
MPU61N\A8X^UV:TTK,9/5,C?7.+IDO:+/%[-96ES+31'-Q)1%S37%+155'5MG
MT/Y'?Q+W7XIY%6;QCVOD&PMD[*TM>V&VYQTSTK%]*]U\-LE*S,UTFT3%JS$6
MC*/">0GB_,.,W\3,5Q[_  3;2(F9I.2L7B(GIK-)M$=8TUUB8GK'*R>II94
M         EN^C'L_CJ[[0/&>ZNKR:UPV\9+<^L,Q%!#C):[_ )WO0MEP^L6=
M4F3D@^+#QOE6)FDKMY*+FJ.&JB/B7U\P2Q+^^/QB?*/MB\EQ8J1;>;''M][C
MF9O$4_2[K#DS6TI$]T_I?KUB+Q-(FT6M-=(O75_N;COYEZYY&M8B<N&N/-77
M7I]/)2UYZ?'^'WQ&L::SK.FG='24><!7Z
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M\\2KS7BL<_MZ_P#?'C9[ITCK;!>8C)7I_F3VY8F>E:UR:=;+\RA5"0
M
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M7^)2(C^-2(_OTB)^I']^GS_OUGZET]2^B*
M                          YM?W<>5U?E9]@G;=]BLE#D.O>E)N.A.N:K
M7FWKM)L9U]D,C'MF8AN[*>>SS$.P=D9#,W=I?4<_F?%5V='YYIBHY>C_ .R?
MU57U5]O_ !.#=8YQ^0<U'\TW?=KW1?=TI.#'-;1%L<XMG3;TR8I_=SQFGI-I
M6!>GO&8\9\&VM,M9KO\ >1^IRZZZZY8CLKI,1->W%&.MJ_A?OG\91(I:-H
M        )DOH<\;J_(?[&NH\A?V,UUJ704-_Y ;--'5;Q<6]YHD]C!U[Z9;J
MFN.N;CM#,86;F&.FN>2V@GYHXHXHJFBAU]]OL>OKW[=.6V^"\5Y;GYIQ6&)U
MG6NZBT[OI72=/T6/<5[IF*Q>U(MKK%+:G]U>01P/@.ZQTM$;K?3&VI\>L9-9
MR_#_ )S7)&L](F8UUUB)Z.#SHH"@
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MV_./)<GEOE.\YVTV^CERZ8HG^[BI\N.NGPCY8B;1']Z;3.LS,SN,T\Q,
M
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M/;':M-8_+OF-?V.J$\M2M<
M
M             !R7?(7KC^SG?O>/47M>Q_:ON#LOKCV/E_/]G^A]TS6L^U\_
MTT?-]O\ 2_Q[WXX]S\>K\?Q>L3U]Y'_KAX#P?EVO=_-.'V>\U[>S7]3ML>;7
MM_NZ]_[OX?#\%GO!<A_-N#V?*:Z_J=IARZZ:?XF.M_A^'Q^'X,/LO=J
M    RUT%V97TMWMTKW'%1-+)U-VUUQV9'';VUO>W$E>A[CAMIHH@L[NYL[6[
MFKJQ7XIBEFBCDJ_%-5=/'/-7&)^>^-5\T\%YKPZTQ%>6XG>;.9FTUB(W6WR8
M-9M6+6K'S];5K:8CK$3/1UG-\='+\+O.)G33=;7+AZS,1_$QVIUF(F8_>^,1
M,Q^4NM0\G"L
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MW8:58>
M              I/?>Q].O\ :?(9SS+\3="]GJ:_^9F>^^MM8H]4'6F6FGYG
MNNQ-2URULZ?@=;W_ *ZI,M;6]=<6#N.>9XXHL;57Q874_8O]X7^M>WP>F_:^
M_P!?+,?;CXO>9IZ[S'$:5VF?-:WS;RO2,%[1%MS3^':UMS%9SR^]+^U_YGCI
MXEY/GUY2NE=MEO\ [[7\,5[S/7+'PI,]<D?+,SDT[ZKRTI)0
M !?9^B+[6(O+#KJ'Q?[YVBSX\DNJ\/;PZ?F,K/:6=[W;UQC;6;B.]M.*/9IR
M.^:%8V5,68CXIXN+W'^SD>/D5TY.2WH;^^K[5K>J/(K>SO!-K?\ XM^5S3.X
MQTBUJ\;O+VC6MOCV;7=6M-MO.O9CR]^WGZ=9VU<D)_=/K.?&-_/D?"8Y_P!7
M]S>?J5C68V^69^$_ECRS.M)^%;:X_ECZ<6L4J\&A0
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MNL:Z3VXHQ]LS$3$WO$=)ZV7U:J/(
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M7Z*D%OZ@GMJOKKT9F\8V&6*^1>4Y+;&E8M-;QLXKW[_+$1IW4^G./:Y(F?\
M\LKK%HUAI?WIY1' >&7X[!:(W_)6G#$:S$_2TUSVC3XQVS7%:/\ GL=)C5T*
M'GU05
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M/D@H
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MB/-.4X_^Y3>Y9K\9^2]IO369B.O9:NOX:_"9C29W-:;8D
M
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MV_%H#W]X?_./'J>2[.NN_P".U[]/C;;VGYO[?IVTO'Y5G)*^$HG0L
M
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MF;[:8[\.3_FF*TSVV_9:LQ-+Q^%ZSIK6:VG>IHQA8
M                             "DC^YR\MKO<^[>L?#G6\SZM6Z;P]IV;
MV1B[66.J*Y[0W?&5TZE;Y:.FYFJHO-3ZYO?DVG',<%?$.S3<U>[37%S1=?\
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MZ0K,YSE]QSW,[KFMW_PC<Y[Y)CXZ=TS,5CI'2L:5CI'2&8&(.J
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M3'2:UKI,QUF8U#QJ@
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M+?W*\E$8.*XBL_-:^;-:.O3MBE*3^4Z]V3]L:?A%NMQI3TBB
M
M                                        I"_NE>KI\)Y,^-G<=,'L
MV'8O2>;Z_P#<HXQ]$5UENI]VO<Y?SR40R_J5=Y3C>V["*N2>/B*J&.*B*NKF
M.6F.[7^EWY13>^M/)/#IMKGX[F\6[TGOUKCWVVKBK$:QV17OV&68BL]T6F\W
MB.ZLVF)]MW)1F\=Y#B9G6^WWE<OX]*YL<5B/RTUP6G2)UUF9F(UC6KNL^2.
M         =!7]N!VI'OWUMX72^9/Q<=']P=H=><P5Q6D,O%IG\C8]O6]U1Q!
M=SW%S9SW/9L\=$\]$%7,L$L5-/-$-,E?G^_J->+6X'[C\_-:?P^;X?9;O6)M
M,=V*EMA-9UK$5M$;*LS6LVCMM2TS$WFL09]_<9.Q]@7W?]W>;3#EUZ_&L3@F
M.L1$3$88G2)GI,3KK.D3VH&M)@
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MMF\C1[#0
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M3VWB\KQ4\?\ (+UIY+2NE+SI%=S6(^,?"(S1$:WI'2T:WI&G=6E=U88WP
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MEHF/SB8F)?8<-\@
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M^';GDL<S&^RQ]#!IK$_5R1;2T3'P[*Q?)_RFGXNFX\SBNT
M
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M:P<^X#DHWOG\[2L]-GL\.*8Z_O6[L^O7IK-<M>L:QI$1,ZQ,1/R@.T@
M
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M^6^7!>>NGS17)CC7]V-.S+,?";:S\8KTN0*=T3P
M
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ME<L:_NUKDB(UNO\ "@Q"
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MP'@GZ7<5\WXVL1M\LUQ[FL1IID^%,W3I,7CY+S.FEXI/S3DGMMBJHT8P
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M51P&WM_WNXV.V=)Z6SWB)R6Z?YD=N*(GK6U<FG2RPZKU:(
M
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M]ND1&BMWV!R4<MYMRF_I.N*V]RQ6>O6E+3CI/728UK6)TF(T^&G1NRTJP\
M
M                                                 !&-]RW5T_;G
MUD^76N6D'O7FO];P]HP24\8_B>U@Z=V7 ]J9:>"7(RPQ1?G!:A=1R^W5\B2W
MDDCBIKDKICJDS]G'E%/$ON8\1Y'+;3#N.2G93'SZ6GD,.78XXF*1,S_%W%)K
MK'9%XK:\UK$VC8OJ;DHXOV)Q>XM.E,FX^C/QZ_7I;#6.G^VO68UZ1,1,Z1&L
M<S9Z6EAH         ";#]OIVW_:[[-NJ,1/=?"Q7<FG]D=296XJO/BP?Z_K4
MV\Z_:SQ?$NN<A^I;EH>,M8H>*H/Q<3QR<R?B/F.2%?\ 4!\2_P!:/MGY7>8Z
M]^ZX;>;/?TCM[I^7-&VRVB>ZO9V;?=9KVMI;Y*VKVZV[JZ@]Y\7_ #+UWNLM
M8UR[3+BSUC37X7^G:8ZQIICR7F9Z](F-.NL=%)YX$#
M
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MJ\_:'AE_"O*LVQQQ_P!Z\^N;;S^'T[6GY)G_ #L=HFDQ\>WMM/[T).49FN@
M
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M\?\ (+UIY+2NE+SI%=S6(^,?"(S1$:WI'2T:WI&G=6E=U88WP
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MK;X=])^;'>/]W28M^R9F/C#99K5CP
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MXM-]QDO-K6GK-K6G6TS/YS,S,OL.&^0
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MF9UF9F>LS,]9F>LRK!M:U[3:TS-IG69GXS/YR_9^'\
M
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MB8F8F(F)F)B9B=)ZZ.LL\H*L0
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M^;V46RX-(F;6^'U<41'Q^I6L:1\9O6CH^/.6@&
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M=\MMO$]O:?H;2OULT1,:3ER5_AQ,?A./%,S'PZ9IZ?"5IM5PC8
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MSI$QUBV3)6T:U6<59B.P
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M&8_WNM]--9B=)TTUF.CL\YR @
M
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M?-K,3JW?:28<
M                                     \3V5UWJ/;G7N[]6[]B8<[I/
M8>JYW3-JQ$_XXHR&!V/&W.*R=O37^.:H)JK6ZJYCEI_%<4G%-=//%5/'+N_&
M_(>6\2\@V7E' Y9P<UQVZQ;C!DCXTRX;Q>DZ?C'=6-8GI:-8GI,N9Q^_W7%[
M_#R6QM--Y@RUR4M'X6I,6B?]F.L?C'1RR?,/QHV[P_\ )3MOQVW/B:;(=<;5
M=X_%9>6#F"C9]1OJ(\KINUV]'''HIAV/6+ZUN^:*>>?9DEJBJY]<=7''J/\
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MKI\*9M=<N/\ VL3,QDI'2NEIK2-,<Q$\*";2H
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M.YO$_)=WP&:9M&WRS%+3&DWQS\V.\](C6U)K,Z=(MK$3.FK:AJQC0
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ME*Q$5K6(B(B(3/VFTVVPVV/9;+'3%M,5(K2E8B*UK$:1$1'2(B'FW8N0
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M-Y.NZW.>^2W69B)O:9[8U_NUU[:Q^%8B(Z0RHQ9U@
M              "ME^XT\^/[$]!8WQ"Z]S=Y8]J^26'N;S>KC%W7Q;C6^A(;
MVXQ.8M;R6.>&[H_NQE[2XPU%%%$L%SBK++PS\T>J+B6R'^G5Z%_UZ\]R^W?(
M,%+^+>-YHKMHO7NC-RDUC)CM6)B:_P"@X[4W$S,UM3/DVEZ=VEYI(+T'X3_.
MN;MY5OJ1/&<?>(QQ,:Q?<Z1:LQ^'\&LQDGX3%[8IKKI.E$I>DF@
M  VT\&?%39O-7RGZA\=-<JO+.WWC9(I-SV&SBHKKU'KK!QUYK?=HXKGCDLJ;
MS%ZS97'P([CFB*\R==M:^KBN>CCG4_O'VIQGI;U;R_L3D8I?)L=M,;?%:=/U
M&[RS&/:X.DQ;MOFM3ZLTUMCPQDRZ:8Y8QYGY-M_$/&MUS^XTFV''_#K/]_+;
MY<=.G72;S'=,=:TBUOA674JTW3]9Z]U#5=!TK#6>N:;H^MX/3]2U['4UT8_!
M:SK6+M<+@<-8T25R246>+Q5E%!%Q555SQ11Q^>>>?XO+MS/+\GY!R^ZY[FLU
M]QS&^W.7<9\M^M\N;->V3+DMII'=>]K6MI$=9E6YN]UN-]NLN^WEYR;O-DM>
M]I^-KWF;6M/[9M,S/]KTCK7'
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MSC.%K:/XN?)GM'36/I4C'29C]Z-?K7BOPB=+:ZS$:71%,J(X
M
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MB,>\V6.TSTC6^.;8YB=.LZ4KCZV_"8K$Z5TBQ&KS:'
M
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MIW$
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MN,\UX/%S7&SV]WRY,<S$WQ9(_>I;3_WU9F([J36VD:Z1I^V\RH
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M[Z[+8_/ETGI;<7KTC\I^ECG2)CK%LF2MHUJLXJS$=@
M
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M(@_]P/*SOO._Y?$_P]EM,6/3KTMDB<TSUCXS7)3X:QI$?CK"P*@"T:
M
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MD3,S_P MAI7^VT?M7@%(Z'0
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M[B---=8KBS3^.LS,8KS_ /$M(U[IFWJJ+19
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MXUO2TUM6?VUM$Q/[85I9L63!EM@S1-<M+36T3\8F)TF)_LE])QGS
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MC2:XJSK&*FDS$Z?/:)TO:T=L5BC2K;,             94Z/Z8[!\B.V^O\
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M/6;3,RKCW.YW&\W.3>;N]LFZRWM>][3K:U[3-K6M,_&;3,S,_C,OO. ^
M
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M.DS'3I.C;IJ1BP
M
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MSS/J[P
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MZV*L]^*\QI]3#;7LO'X?A-;:=(O6T?@W2:88B
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M#Y]NLE*S&UWT1N:?#K.36,OP_P"?5R3I/6(F-==8F9DT.6I@
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MWG]'MKQ;<S&L1?-'[N+77K7%KK:)Z?4T_''$K3:KA&P
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MRSK,6C2Q&KS:'
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MB>^*3V1$Q%M-;]L:Z3$:ZSTB75L>556<
M
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M]$3K"SWA^0IRW$[7E<>GT]SML66--=-,E*WC372?A/XQ$_FQBR9V(
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M%;X?O8[S2?A-H^-?PF8_*9^+)#''7@
M                                                       /C[#K
M^$VS 9S5=EQ=GF]<V;#Y/7]@PN1AIN,?E\)F;*?'97%WUO7_ "SV=_87,D4M
M'/\ "JBOGC_9<SC^0WO$[_!RO&Y;X.1VV:F7%DI.E\>3':+TO6?PM2T1:L_A
M,1+ZX,^;:YZ;G;VFFXQWBU;1TFMJSK68G\XF(F',1^S#PHS?@9Y;]C])U6^8
MN.NYKS^K^E]GRT=5=>S=7[%57=X+UY#B"UARF8U6;F;"96>B*"B7)XV>2B*B
M&2+\^FO[:O=6R][^I>.\UBV&OD-:?I^1PXY_P=[A^7+\FMIICSQV[G!6;6FN
M'-2MK3>MEBWKSR_#YKXOM^8B:1OXCLW%*_W,U>ENFLZ5OTR4C6=*7B)F9B6@
M;?C-P          $U7TB_8K<>#WDS9:;ON:AM/'7OS)874NR9,QDZ[+"Z#GJ
MKCFTU?M6FN>6G'V$.$N+KXV8FD]%'.'FDEKJYJM8.*87?>S]N^/W=ZTOS' X
M9O[$X''DS[.,=(MDW6+3NS['I'?:<D5[]O6-9_45K6L1&6^NHO</@5?,?'9W
M>RI,\]L:VOB[8UMEKIK?#^<]T1KCB/[\1$?O2Z+#SNH%
M                                                       ,5]X=
M,=?>1'4?8'2/:F'_ %[K_LO6[[6-EQU$O-M<_$N^*:X+_&W?%-=5AF,1?PQ7
M=E<4\<U6]W!'+3Q^:.&4^$>9^0>O/+>/\V\6S?0Y_C=S7-AOIK7NKTFMZ_WL
M>2LVQY*3TOCM:L])=GPW+[[@>4P<QQM^S?;?)%Z3\8UCXQ,?C6T:UM'XUF8_
M%RR?)_Q\W;Q3\@>V?'CL*/\ X4]5;AD-;N+ZBVDM+;8,3Z8LCJ^W8VVFKDG@
MP^YZM?666LJ9.?=XM+V/U\<5?GCCU'^L?8'"^U/7_$^PO'I_[U\KLZ9HKK%K
M8LG6F?;WM$1$Y-OGKDP9)CY?J8[::QI*R7QSG=GY-P>UY[8?\&W.*+Q&NLUM
M\+TF?AW8[Q:EM.G=6=.C [.W=          +4W[6_OFO!=V^17C=DK^&+']B
M=>X7M?6K:[KMXN.=CZXS<6NYJQQ,DN2@EFR68P&]QW,MO':W-<EMAJI?<@HM
MZ^)ZLOZH7@E=]X5X[['VV.9W''<ADV.::ZS_  =YCG-CM>(I,13'EVLTK>;T
MB+[B*=N2<E9I&K[D.$C-P^P\@QUGZF#/;#>8U_<RU[ZS;I/2ML<Q$S:-)R::
M6FT:77%+*(0                                  ".KSM^T+Q3^O[">
MUVWM_P"O=I9/#W.5U+I/2ZH,OV#G8J::X["]RUM3)\/2=;R%Y3S''DLM7;0W
M'LS\6E-W+;RQ<2(]%_;#[4]_;WN\2V?T/%\6:*9^2W.N/:8I^-JX[:=VYS4K
MUG#@B]J=V/ZLXJY*WG/?"_7'DWG&;7B\79QM;Q6^XR:UQ5_.*S\<EXCK-*:S
M&M>Z:Q:)4;OL#^X/RL\^\AD==SN8_M+T+S>5RX;HO0\C/QB9X*)[JJTN.PMJ
M^-CLUV1F*;6:.B7Y%%KA^)8*9K7&6DM4E5=X'H#[0?5?H3;X^1V.'^;>>=FF
M3D]U2/J1,Q7NC:8.Z^/9X^Z)FO9-]QI::9=SEK%8B9/@WJKQGPC'7/AI^JYO
M3YMQDCYHGIK&*FLUQ5UUTTUR:3I;):--(HTJVS               $NGTZ_7
M)EO/[R1M.=IQ]Y#X[=/7F%V?NC-Q56T=&6]Z6ZNM9ZTLN)IX[B6\WJXQ$T=U
M+!17\+&0W$E55$M5M3+$C[P?N+VGH+UQ>.+R4GV'S%,F'CL<]T_3TBM<V\MI
M$Q%=M&2LTK:8^IFMCK$6I&2:ZM]K^?8O!_'Y_36B>>W<6IMZ]?E^$7RS^&F.
M+1,1/[UYK'6.[3H^8;#8?7,/BM>U[%8W!8#!8VQPV#P>&L;7%X?#8?%VL5CC
M,5BL98Q066.QN.LH*(8((:*(H8J*:**>*>..'G,WF\WG([S+R'(9<F??Y\EL
MF7+DM:^3)DO:;7O>]IFU[WM,VM:TS:UIF9F9E /+ER[C+;/GM:^>]IM:UIF;
M6M,ZS:TSK,S,SK,SUF>LOI.,^8                                #^
M/(Y''XC'WV6RU]9XO%8NSN<CD\GD;F"RQ^.Q]E!7<WE]?7ES7%;6EG:6T54D
MLLE5-$=%/-57/'''/+[;?;[C=[BFTVE+Y=UEO6E*4K-KWO:8BM:UB)FUK3,1
M6L1,S,Q$1J_>/'?+>N+%6;9;3$1$1K,S/2(B(ZS,STB(^+FI_;E]@EY]@OE3
MF-RU^2:VZ/ZSAO= Z,Q<M%];RWFK6]_5-E-^RMG?Q6D]KGNQ,G'Q>UQ56]O+
M9XZ.QLI:9);2N>7TE_:3Z P_;_ZLP\-R$1;S?DYKNN3O$UF*YYKI3:TM6;1;
M%M*3].+1>]<F:<^>DUIEBE+!_5W@U/!O&J;3/I/,[B8R[B>DZ7F.F*LQK$UQ
M1\NNLQ:_?>-(M$1%JE$V0           DR^ICP=R?G;YB:)U]D,5-==1Z+-;
M=E=Y9'FKB&SAT#7\C:?\&N;BNN+FO);[F9;?$0PP\U75,%Q<7=-',5I/71&G
M[L/=^V]%>G]]Y!M\L4\MWT3L^,I\;3NLM+?QM.NE-KCB^>UK:4FU,>*9[\U(
MMKSV?YEC\+\4S;ZEHCE,T3BV\?C]6T3\^GY8ZZWF9Z:Q6NNMJQ/3*M[>WL[>
M"TM((;6UM88K>VMK>*B"WM[>"BF*&""&*FF.&&&.GBFFFGCBFFGCCCCC\/-+
MDR9,V2V7+:;9;3,VM,S,S,SK,S,]9F9ZS,]9E7C:UKVFUIF;3.LS/QF?SE^S
M\/X
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M7>[G%BTC36:UF<UI^,3V_P .*VF(G]Z*S&EM706>?Y!D
M
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MG\(B9FL1I$:S5H7-0@
M                                            (//O@\!KCS'\2[K?
M] Q,V1[S\:H<YV!I>/QV.KOLMNNERVMO)V1U_:16W/-]<9*\Q.,BRF+AABNK
MBZR6+CLH8^*KZJ2B;OV*>^L?IWVQ3@.?RQC\&\EMBVNXO>\5Q[;<Q:8V>ZM-
MOEBE<EYP9K6M2M,.:V:]IC!%9W'Z5\WKXGY1&QWUHKPW(37%DF9TKCR:S]++
M.O2(BTS2\S,1%+S>9^2(GG@/0LG>            OF_M[?L6_P QW1//BGVO
MLUG==V^/F'M;/29;VKV<QOG1MC1:X_!75?///$.2S'6\TL>'NZXZ:)*\;SCI
M9>)KBJZN*Z(?Z@GV[?\ %SYU_P :GBFVO7PKR#-:VYBO7'M>3MW7RUC\:8]Y
M$3N*1,S$9OU%*=F.,6.(4^]? OY!S7^LW&8YCA]]>9R:?NX]Q.LVC]E<O7)7
M7IW_ %(C2O;6+&JNIH,
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MP3&6(K\MI[K12::1&MHM-=8UUCIQ/,RKL
M      8K[G[PZC\=^OLQVIW=V!K?6G7^!]JC([+L]]Q:6GR;GFKBTQMA!13-
M?Y?,7]5'--O96D4]W<5<<TQ1U\_P93X9X1Y;[#\@P^+>$\?N>2Y_/KV8<->Z
MW;'[U[3.E<>.OQODR6KCI'6UHAV?$<-RG/;ZG&\/@R;C?7^%*1K.D?&9GX5K
M'XVM,5C\9A3^^P?]R/OF\2[#U?X&8R\ZWTZOWL7==^;?B+.OL?.1Q7<D-W=]
M?:M?5Y+$:5A\K:1?BWOLE#<9OX]QQ)1!BKRBGF.WK[?OZ</ \)7;^3^]\M.2
MYB-+UXO;Y+1L\4S6)K7=YZ]F3<Y*6GY\6&U-MWU[9ONL-I[I4^"_;_LMG&/D
MO-;1N-W\8VU+3]*O3I&6\:6R6K/QK28QZQI-LM)ZU:M@V'/[9F\ILNU9S,;-
ML>;O)LCFM@V#)WN9S>7R%Q5Z[B^RF5R,]S?W]Y/5_&N662NNKG_3SRM%X_C]
MAQ.RQ<;Q6##MN.P4BF/%BI7'CQTCX5I2D16E8_"M8B(_"$D<&#!M<-=OMJ4Q
M[>D:5K6(K6L1\(BL:1$?LB'QW+?4              !L5XI^+O;'F-WGI'0G
M3>#FRNT;?DK>C(922"YKP.D:M'=VL.P;[N%Y;1358S5=8M;GB:YD]-4LU?,=
MM;T37<\$$NN_:GL_Q3T]X-OO/?,<\8N+V>.>RD3'U=SGFMIQ;7;UF8[\^:T=
MM(UBM8[LF2U,5,EZ]#Y-Y)QGBG#9N;Y:\5VV*LZ1K'=DOI/;CI$_&]YC2(^$
M=;6F*UM,=-#PO\1^L_"'QYT7Q]ZO@]W&ZS9TWNS[+-#+;Y+?=\R%K:4[9O>6
M@FOLE5:7FPW]MQ71:TSRPV%K1#:0\^S!'QQYH_<WMKR7W;["WWL#R>VFYW-^
MW#AB8FFUVM+6^AM<<Q6G=7%6=)O-:VRWF^6\=][*\/+O*.1\QYW-SO)3IDR3
MI2GQC'CB9[,=9TC6*Q/6=(FTZVGK,MJ&K&-
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MVJ0
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M(D?<GRUK\GQO!5F8KBP7SV_*9RW^G3_WOTKZ?[J=?P6OU4R,@
M
M                                            "GQ^Z@Z6MZ;CQ1\B
MK"VAINIX=ZZ6VN\JAHXN);>UKL=YZ^MHKB'%>Y)#;R7FS5R47-]S315+1S;0
M<<U7<G-OO]+7S3)./ROUWGM/TJSMN1P5UG2)M%MMN[3$WTB9BNSB)ICUF*S&
M2_3%5*O[:^7M->3X&\SVQ./<4C\-9UQY9T[OQTPZ:5_">ZW[L*@BW9*<
M     !;I_:P]V^SL'E3XX7]WZOU'#Z;W;JMA[GX]G]%O9=$W^[]KGGGW/D_K
MVM4>JGBGT>U^*O5ZJ?34C_5)\)[]AXK[&P4T^GFW'&Y[:?'ZE8W6UKK^&GTM
MY.G77NZ::3K%O[D^'UP<9S](_=ODV]Y_W4?4Q1_D[<O^S^Q<94](H@
M
M                     .=/]Y7@!7X5^6F2VW1\--:= ^1$V7[!ZYEBXM^;
M#5]IJNHYNQ^M:>(*+?FVAU[,Y"._QD?L41487*6EO1+<36MU73Z(OL>]^U]T
M>I\?$\YFK?S[QZ,>TW<3KW9\';,;/>===9RXZ3BS3W3:=SARY)KCIEQ5F>OI
MKSB/+_%Z[7>7B><V$5Q9?CK>FG\++UUU[JQ-;SKK]2EK3%8M6$*J:+;H
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MHB8KDI/6F2NO]VT:3^R=:SUB6R#7#'P
M                                        &KOFOXZXSRS\4.^?'C)4
MP^YV;U[E\7KUS<?GFWQF\XOF'8^N\Y/'Q<6GOPX#?,-C;VJ+F6.F6FWYHJJI
MXJYYXVAZ5]B;GU/[6X'V%MIGMXSD,=\L1\;[:^N'=XHG2VDY=KDS8XGMF:S;
M6(F8T9)XASV3QCR?9<]CUTV^>LVB/C..?DRUCI/[V.UZZZ3IKKHY5>1QV0Q&
M0OL3EK&\Q>4Q=Y<X[)8W(VTUED,=D+*:NVO+&^L[FB*XM+RTN(JHY8I*::XZ
MZ>::N..>.>'J=V^XV^[V]-WM+TR[7+2MZ7I:+4O2T1-;5M$S%JVB8FMHF8F)
MB8G199CR4RTKEQ6BV*T1,3$ZQ,3UB8F.DQ,=8F/B_C?9^@        'TL-F,
MGKV7Q6?PMY-CLS@\E8YC$Y"WYXXN+#)XRZBO;"\@YJXJIXFM;J"BNGGGCGCU
M4\.-O-GMN0V>78;VD9-GGQVQY*3\+4O6:VK/[+5F8G]DOGFQ8\^*V#-$6Q7K
M-;1/PF)C28G^V'6TZKWS']J=8=<=GXGBSIQ?8^AZAOF-IQV4AS>/IQ^WZ]CM
MAL^+'-6T5O;Y>SXM\C3[5U''11<4?B2FGCBKCAY,_*>!W'BWD_(^,;OO_5<=
MO]QM;]])QW[]OEOBMW8YF9QVUI/=29F:3K69F85?<ELK\;R.XX[+K]7;Y[XY
MUCMG6EIK.M9UFLZQUB9Z?![QT+A                              /QN
M+BWL[>>[NYX;6UM89;BYN;B6B"WM[>"BJ6:>>:6JF.&&&.GFJJJKGBFFGCGG
MGG\/WCQY,V2N+%6;9;3$5K$3,S,SI$1$=9F9Z1$=9E_:UM>T5K$S:9TB(^,S
M^4*Y7G_^XF\>O'ZC,]>^),>!\ENW((>8/ZTBN+JXZ!U7(<7%=%5%QL.)OL;D
M.SIH[>/B7BC7[FC%R434_C*\2T2P4V*^@OZ>/L'S^V'R#VS.?QKQ*TZ_IYBL
M<KGIIKTQ9*WILHF9[==U2<T36==K-+5O._?!_0W.\Y--_P"4=_'<7,_X>D1N
M;QI^%;1,8>O3^+'?&D_PM)B5,+R7\LO(7S W[GLGR)[-SW8^RPPSV>(HR'-M
M8X'6,9//S<5XC5-9Q5O8X#7,;5+^*JX[2WBYFKXXKEYDD_-?-R_K7U1Z^]0<
M#_JWZ\XS!QW&VF+9.SNMES7B-(R9\UYMES7TZ1.2]NV/EI%:]$MO'O&."\5V
M/\OX';TV^WF8FVFLVO,1IW7O:9M>?VVF=/A&D=&NK8CO@
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M'O//.8FU)M3@=O:8V^*8TG2>DY,D1,ZY+Z?GI2NE:_WIM*NBNUH
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M3C=!QY^T&
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MUUR1>9UUF)GMUF(A*NBNUH
M
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MVU*[BO[/HVBUY_Z%]2/\NKI-/-ZK\
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M)-HZ&CSWH)
M                     .:/]T71UOT)]D_DSKF+LH;+7=UVJQ[AUWBWXHBM
MY;?MC#6&ZY_B"SXR>4FL(;#=<IE;.F.OF"GFFVXDAMX+:N&.GTH_9EYQD\]^
MV[QKD=U>;\CLMK;C\VNLS$[');;8M;=E(M-MM3!DF8[IUOVWR7R5O:;"O4?,
MVYOU]QVXR3,[C#BG!;7XZX;3CKK.D:ZXXI;7K\=)M-HF46J439
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MQ6?OJCP'%X/X_'ZFL3SV[BM]Q;K\OQFF*/PTQQ:8F8_>O-IZQVZ1%I;MI
M        /8=?:!N/:N]:?UGU[@;S:=ZW[9,-J.HZ[8<P47>9V'/W\&,Q6/BE
MNYK:SM_D7EQ135+/)%!#3^:Y*Z**:JN.H\@Y_A_%>"WGDOD.>FUX/8;;)N-Q
MFOKVX\6*LWO>8K$VG2L3,5K%K6G2M:S:8B>+OM]M.,V67D=_>,>RP8[7O>==
M*UK&MIZ:S.D1\(B9GX1$RZ@W@#X?:SX+^+'6OCS@+JSR^5UZSN,UO^UV=K7:
MT;EV+L,G%]M6P\1R_P"L_#^3Z+.PXE_,L6,L[:*K^-#S#^_?;_)^\O:7)>PM
M_6^':[B\8]K@M;N_3[3%';@Q:QT[M-<F7M^6V;)DM'2RN3SCRO<>9^2[CG<\
M33%DF*XJ3.OT\5>E*_EKI\UM.DWM:8^+<QIMB0
M
M #$O?G:V,Z*Z.[A[JS/$->,ZFZQWKL6[@GJYIHO*-.UG)9^FPIXHJHDDFR$E
MA3!''1S[DDDE--'YJYXX99X%XKN?.O..'\+V?=&YY;D]MM*S'QK.XS4Q=WY1
M%(M-IF>D1$S/2)=IPG&9.:YG:<1BU^INMSCQ1I^'U+Q77_)KK,_"(C6>CDTY
MG,9/8<OE<_FKR;(YG.9*^S&6R%QSQS<7^3R=U+>W]Y/S3Q33S-=74]==7/''
M''JJY>K[9[/;<?L\6PV5(Q[/!CKCQTCX5I2L5K6/V5K$1'[(6=8<6/!BK@PQ
M%<5*Q6L1\(B(TB(_LA\UR7T         >\ZLZ]S?;?9W7'5.M4^O8^S=\U#K
MW7Z/;JF]6;W38,=K>*I]FBJBJ7U7^2CX]/'/'-7^C\NB\I\@V7B7C'(^5<ET
MX[C-AN-WEZZ?P]OBOFOU_#Y:3U_!PN2WV'B^.W')[C_@^WP7RV_W..LWM_R(
MEUHM-U/":%J&JZ-K5K\+7-+UO!ZGK]G^:>?B837,7:X?%6OYHHCIY]BPLXZ/
MX4\<?P_T</)WS/+;WGN7W7.<E;OY'>[G+GRV_P [)FO;)>WX_&UIGXRK"W>Z
MS;W=9=[N)UW&;):]I_.UYFUI_P LS+TCK7'
M
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M^"L+DMCFXOD=QQFX_P"$;?/?%;_=8[32W_)B7O'0N$
M
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MK,_LIFG6T:_NY.ZL:5M2L64U;:/@
M                                     "F1^Z@Z=HL>Q_%'R M+>:63
M:-)WGIW8+JF.XXM[*C0\[8[KI]O++7D)+6J;*5=C9RJBF.TBDXILZ^9)9>.8
MJ(;E/Z6OF%L_CGE?@&:T17:[W;<ABKK&MIW6*VVW$Q'9%M*?I-M$S-[1KDCM
MI2>Z;RU^VOEIOQ_)\'>8B,>;'GK'36?J5G'DGX:]/I8]=;3'S1I$=9FIHM?2
M=          7_?VU6Y?U/]<=WA/1>4?VZ\A.S]-]5S<>]!+\["Z-V#Z\='^>
M?B6?']=^FJ/^'YN*9:_]W^>:"OZDO#?RS[BZ;W6D_P Q\?V6X^6-)CMR;G::
M7G^];_1=8G_,FM?P0?\ N#VGZ;SZ,W3_ $C88<G2/RMDQ=?SG^'\?RTC\%@5
M %HT                          !KKY+^67CUX?:%SV1Y$]FX'KC6III[
M/$49#FYOL]L^3@@^17B=4UG%6]]G]CR5,7XJKCM+>7B&BKBN7F./\U\;$]:^
MJ/8/M_GO]6_7G&9^1Y*L1;)V=M<6&DSI&3/FO-<6&FO2)R7KW3\M(M;H[[Q[
MQCG?*M]_+^!V]]QN(B)MII%:1,Z=U[VF*TC]MIC7X1K/13-\_P#]Q9WUW]1F
M>N?$;'9[QKZIO(>;*?>Y<C%'W]LL7R*Y?E6^<P%[+C.JH98/;CYM\/<WV1CK
MCJKIRWHEY@CN1]!?T[O _ ;8?(O;>3!Y)Y52>Z-K%)GBL,Z:=LXLM8OOIB=9
M[]Q3%AF)BL[3NI]2TM/!_0O"<'--_P"4VIR')Q.L8]/]&IT^$UM&N;\9UO%:
M3K$?2UCNFN+D<CD,OD+[+9:^O,IE,I>7.1R62R-S->Y#(Y"]FKN;R^OKRYKE
MN+N\N[B6J2662JJN2NKFJKGGGGGE8QM]OM]IMZ;3:4IBVN*E:4I2L5I2E8B*
MUK6(B*UK$1%:Q$1$1$1&C?V/'3%2N+%6*XJQ$1$1I$1'2(B(Z1$1TB(^#^-]
MGZ                 >\ZOZO[![I[!U/JKJK4\QO/8>\YBWP.JZK@;?BXR6
M6R5QQ77Z:?77%;VEG:6\4EQ=75Q)%:V=K%)//)'#'))3T7D_D_C_ (7X_N_*
MO*MWAV/CVQPSESY\LZ4QTCI^&LVM:9BM*5BU\E[5QXZVO:M9X7(\CL>(V.7D
M^3RTP[##2;7O:=(K$?\ )F9G2(B(F;3,5K$S,0Z!_P!3OTW];_7[A[7M3L&Y
MQO9GE5L.!CL\MME-M3)K'5EKDK7GC-:KU?'<Q4W7,UU3/5:7^=FXCO,A;T<Q
MPQ6=M-<03T ?==]XGDGO[>6\6\?KDXSU9M\\VQX-=,V^M2W\//O9K/;I72+X
MMK77'BO/=>V;)3'>D&O9WMCD/.<L\;L8MM_&L=]:TU^?-,3\M\VG3I^]7'&M
M:SUF;VBMHFW0H:?                                   50/W%'V:<:
M9KE?@1T?LL-6U;EC:;[R4S^'O,9=\Z]I=]%7QB.GZZHZ;RZL<]M]-7&1S-/Y
ML[BVQ%%I#_CPY2>F&UG^GA]M$\SR,>^?-]M:.+V>3MX?%DK>OU=S6?XG(=>V
MML6W_P +;S_$K?/.6_R7VN.;R;]#>N_U>X_UVYG'/Z;#;3:5M$QW9(_>S_A$
MUI^[C_>B;]T])QUUI>+FDMP           %O7]M?]?$5W+F?/_M/7_>MX?UG
M1_&RVR4-I-:2W<-W=X3L7M&TCKCDN*;S%W%E/KF,FXKHIIJKRWKCJKIMY8ZC
M/ZD?W VQ5P^@O%MQIDGZ>YYB:3:+16:UR;396G6([;Q:N[S5TF9B-II:(G)6
MT6?N"\ZFL4\'XW)I:>W)NYC7732+8L,_AI,3&6\?_$M)T[HFX:I_13
M
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M-5^Z.9_DWKS>]ENW/NNS;TZZ:_5M_$C]ZLSKAKEZ1K_MJS7N=()YR4 0
M
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MP=SDI&F'>XZ;FL=/[^M+_"9^.7'>>L1/7X3&EIFE0P:B
M
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MEK6.>(^3;'R_Q_;\[L)CMRTTO6)ZX\L=,F.WXQ-;?#7]ZLUO&M;1,ZKMI,E
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MVTUV><>'[[PCR#+PN\UOACYL.332,N*?W;Q&LZ3\:VC6=+1,?#29W8:58>
M
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MSW>Z9>[;\)CF/I[:MYFNL?W\DZ5C)D^.DS72D3VTB-;6M*6BZUL
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M8B.NLS\9F9F96$;+9[7CMICV&QQUQ;/#2*4I6-(K6L:1$?V0\J[1R0
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MT_C:\S:9_P!F>D?A'1[9TCA@
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M9;XG_JN_=E8[YT^(_P#Z3D]FUO\ _P#*NK?_ .@Y%0W]4GSC_P E?6VVR?\
M7')[C'W?V;79W[8R?]G1W7Q?LQ9/\:J*WW)\S_\ *SQ[';_FFXR5U_\ C6*=
M(M_\6C6:_P"YM^_"X"J%16
M
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ME9C']R7"SDX_CO(<<?X66^"_QG6,E?J8Y^.D16<>2-=.LWB)GI$+GRFA$D
M
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MPW.39;W'?%N\5YK>EHF+5M$Z3$Q/6)B7I'6N.
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M?C,1-K3$?")M.GQE%7[F:UBW"VTCNF-W&OXZ1^ETC_)K.G]LK?:HA%<
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MIFU^$Q>:Q%)CIV5B?C:4TJ&#40
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M[L&U[-O3KKI]*O\ $C]ZT1IFMEZ1I_MJQ;N3 HA-5
M
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M \CLZ1KN,>#Z].DS/=@F,NE8B)F;7K6U(C3KW:=/C'36>9]7>
M
M                   Y]/WU?73_ )0O(V7N_K'6;/#^.OD1F+[+8:QPU/M8
MO0>TJX:LGNFDQV%/'$.&P^9FYER^&MXN*+2*VEN+.VCCAL.*./0#]A_W$_\
M&[ZZCPCR;<WS>P_'L-<>2V3K?=;*)[-ON9M\<F3'';M]Q>VM[7KCS9;6OGF4
MYO2?GO\ K5P$<-R.2;\]L*16TV^.7#\,>37^]:O2F29^:9BM[3,WU0)IY-V
M           +4/[?'[3?[8;-C/!7OW9_;ZYW;,7%?0.W[!DO3:Z+NV3H]Z?K
M6_R68S$5GC-/W.\@YJPT%O#ZH]CO*XOQ7QD/5!5K_4"^US_6?C,OO/P+:Z^1
M;+#'\UV^*GS;K;4Z1O*TQXYM?<;>LZ;BU[:3M,<6UC]/IDC7[T];?S';V\SX
M/'_I^&D?J:5CKDQQ\,L16NLY,<3_ !)F>N*L3T^G\UV%2LB"
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MYO=WR.ZR;[?Y+YMYEM-KWO,VM:9_&9GK+U3JG&
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M%MYZ6GX3I.7KCK^,5[[1I,5E?44/(4
M                                                        -8_-
M'O:+QD\3O(3OGF7VK_K3JO;,]KO'JM*/D;C7C9<=I%CZ[^SR5E'^H[??6,'J
MEMKF.GW/S5#+QQ[=6S?3'@MO9GM?Q_P337!R7*X,67]Z=-OWQ?<VTK:EI[-O
M7);2MZ3.G2]?WHR+Q'A9\B\GV/"::TW&YI6WQZ8]=<D])B>E(M/28GI\8^+E
M,O5,LP          >VZTZ_V/MGL?K_JO3X(;G;>R]VU7K_5K:XKECM[C8]RS
MMAKF$@GD@@N9Z(9<GDHJ:N:(Y*^*>>>>*:N?X<]+Y+S_ !WB?CG(>4\Q::\3
MQNRS[K/,:3,8=OBMFR3$3-8F8I2TQK,1K\9CXN)R&^V_&<?GY+=S,;7;X;Y;
MS'QBF.LWMIKI'PB?QAUG.O-&P'6&@:-UIJ=O\35NO-/UG1M:M/:LK?XN U+"
MV6 PUO[&-M,?CH?9QV/CI]%O!!!3^/Q1'13QQ3QY/O(><W_D_/[[R7E;=_*<
MAO,VYS6UM/=ESY+9<DZWM>\ZWO,ZWM:T_P!ZTSK,UA[_ 'N?D=]FY#=3KN<^
M6^2\]9UM>TVM.LS,_&9^,S/YS,O8.G<0
M
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MVYR4CKKK6+3V3K_MJ=L]>L:Z3I.L-A&OG1
M
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M-L<QTKUQS$=M9O/^@(T>
M                           C>^WS_P!&?YC_ /$_D?\ KMB$COM%_P#I
ME?#O_'%/^EY&?^J__2'Q/_9<?_ V<QYZ95B8         "X#^U&_^'U_^);_
M /DBU0W]5;_^ _\ [=__ +(16^YG_P#0G_U9_P#8JX"J%16
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MC]CW;+QW68^E6WSY:]-)SVCI/PUC'7Y*ZZ6G),19-NA0T^
M                       K0??U]J%'CYH66\,.BMAFMN]^S\##3VGM&*JN
M(;SJCK#.01S<XO'W_%-$$&[=D8R2J"BJ.J2?&X:2:XXX@N+G'W%%E7V#_:U;
MV#SV+W-YSMZV\%XS//Z'!?2:[[>XIF.^]?C.VV=XBTQ,17-N(IC^?'CW&.TA
MO2'K6>=WU?+N:QQ/"[:\_1I;33-FK^,Q_P SQ3UZZ1?)$5ZUK>LT7%Y*9@
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MS?)WF^[SWFT_E6/A6E?RK2NE:Q^4?FSDP=TP
M
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M=WQ[>O\ R]NZ\?Y<5,D?\ET:GG40'
M
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M>#0H
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MRVK,[^-!L'
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M,Q1^YC/BMGX;;1/\:E-U:8TGI6\[>*SK\.LTMTB=8TZZ:QK;I5(HM@
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MG>#>J_&O!\49<%(W7-3$=VYR5CNB=.L8J]8PUUUG2LS>==+Y+Q%=(J4J&RP
M                 '[6]O<7EQ!:6D$UU=74T5O;6UO%7/<7%Q/73%#!!#%3
M5)---)5Q3333QS555SQQQQ^7XR9,>'';+EM%<58F;6F8B(B(UF9F>D1$=9F>
MD0_EK5I6;6F(K$:S,_"(_.5D#ZY/V\W=7D+7@>U?+^K/= =*74,>4QFB04VD
M'=W8-G-;V\UC55CKV&]M>K<#<57%7,D^6MY<S7\:J*C&Q1W$.0CKD^XO^H1X
M7Z^KG\5]0Q@Y_P TK,TONI[IXW:6B9BWSUFMM[EC2-*X+5V\=\6G<VMCOM[:
M \^][<1P47XSQ7LWW,1.DY)U_3XIUG7K&DYK1ITBDQCZZSDF:S2;KG1?0'3'
MC-UUB.INANNM;ZQZ_P )^)+7 :Y:UT?+ON;6TLI\UGLK>2W>;VC9+ZUL(:;K
M*9*YN\C=^U3S--)SQQRI9\Y\^\R]E^19O+/.^1W/)\_GZ6RYK1/;7NM:,>*E
M8KCPX:VM::8<-,>+'W3%*5B40N:YSE_(M_?E.;W&3<[Z_P ;7GX1K,]M:QI6
ME(F9TI2*UKK.D0S Q!U0                                    ",#[
M5/L>TWZ[?'R]VF/G&[!WGV##E=:Z/T*>ZLZ^;C8_TZXJKWS9L7S>6V3FZ]TB
M>J&7(<V_'KN[F:VL:9(*KOY,$G/M8^W/F?N&]@4XNWU-OX-Q]J9N2W45M&F'
MOC_1<-^V:1N]S'=7%W],=*Y<\UR1B^G?8WK3P#=^><[&VGNQ\-@FM]QDTGI3
M6/X=)TF/JY(UBNO[L1:^ENWMGFV=@[_N/:N];AV9V%GKS:=ZW[9,SMVW;%?\
M047>9V'/W\^3RN0EBM(;:SM_D7EQ753%!'%!#3^*(Z***::>/2!X_P !P_BO
M!;/QKQ[!3:\'L-MCV^WPTU[<>+%6*4I$VF;3I6(B;6FUK3K:UIM,S-@6QV.T
MXS98N.V%(Q[+!CK2E(UTK6L:5CKK,Z1'QF9F?C,S+Q[MW*            ="
M'Z)?K=_R9>/W]Y.S\'\/R,\@</C<IGK>YD]VYT'K.2J++:EH=,7,=/P<Q?\
MKCR6;H_/KXNZH+63^-CQSSY^/OI^X[_CD]@?ZG>,9^_UUX_FO3%,1I&ZWD:X
M\^ZUU^;'7KAVT_#Z<7RUZ9YB(+^Z/8'^MO.?RGCKZ\!L;S%9CX9<W[M\G[:Q
MUIC_ -KK:/WT\*";2H
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M?\;P&.8UQ8LF>\?MR3%,>O3II&/)TBW6+1-JQI69MEJH$8@
M
M                                              %03]T[T-75;^+?
MD]C;"'VXIMKZ&W3)U46]-QS7<45]@]8V$5<6-XNIX::;7;I).)[RJ.*KFCV(
M:>9+BNJW?^EOYW6,GE'K'<Y)[IC!RFWIUTTB?TF]M,3?MB?FV$1VXXFT:_4O
M,5QUB5'VV<W'=R7CF2TZS%-SCCKIT_A9I^.GXX(C2NL]>Z>E84^%OB50
M     "Q1^VC[]EZW\Z-CZ4OLC>18+R.ZKS^*L<3#\NJTO>P>KHKCL/7\A>T0
MTR6M'Z7HMEM4<<DW%'IJN_31)Q57[<E>']2CP*OD?HW;>:X,=)WWCG*XKVR3
MV]U=IO9C:9:5UTM\^YML9F*ZZQCUFLQ7NKH;[A>#CD/#,?,4K$YN/W-9FW36
M,6;3%:(_'KDG#,Q'^;K,=-8OM*&T)@
M
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MTM6T=+5F)AF!B#J@
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M>/SS9-(F^O\ FQ%<<1I';,Q-K3)H<M3
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M#V%'CG$3XUQ=].<WN/YYB9B<."VL3:)CX7R:32O76([K=/EF;[2AM"8
M
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M.D6;^/\ $8> X/:<+@ZX]KMZ8]?\Z:UB)M/PZVMK:>D=9^$,)LU=N
M   Z:OT_="2^.OUS>,&E9"U^+L>R:'%VSM=$MK=V60CS?;UY<]AQXW,6E]:V
M5U:YC6L)L%GB+B*J*GF.O'^C\U^GUU>:#[O?/*^Q/N*\GYK;W[N.VV_G88-+
M5M2<>PK7:3?':MK5MCS9,63/2T6G6,NO37MBN_VKS<<]Y]R.\I.NWQY_H4ZQ
M,=N"(Q:UF)F)K>U;7B=>O=KT^$26HUM>@
M
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MT37+2TUM$_&)B=)B?[)?2<9\P
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MS3\:[O.L57T=%5W@<_:P\U4U452>Q<QS6TE7$\$M-/IL]1^TO&?<O@.P\_\
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MZ6FMJVB8M6T3I-;1.DQ,3&DQ/6)Z2^DXSY@
M                                      *K'[J#L*O&]$^*/5'%[-'%
MNG;6]=A5XVFRMY+>[KZQTZQUN.]ER-47-U:S8^GMRJ.B&BNF.XIN:ZJZ:N88
M^:;3?Z6OCU=SYUY7Y7V1-MEQ.VVG?W3$UC>[BV::Q37MM%_T$3-IB9K-(BLQ
M%[:R5^VO81DYKD^3TC7#M<>+76=8^MDF^FGPG7Z&LSIK&D1'QG6E(NF2]
M       = _\ ;<:71JWUM6.<IQV2LJNR.\NU-TDN;Z.XHM<O78TZWUWQD<-5
M-'1'+C8H]"IM*JHN:X^+RUGIYY]=-=-- /\ 4>YJW*?<ADV,Y,=XXW@]CMHB
MLQW8XM];=]F329F+S.ZG)$6TGZ=Z3IVS69@W]P&[G<^P;89M6?T^RPX](TUK
MKWY=+?M_B=W7KVS7\-$^:!32(               "/SSR^RKQF^O?4;?*=Q[
M'-EM_P!@QMW?:'T]J?Q\AONV\0\74-O?R6E<M%OK6JR9"UK@KRU_5%;>Y')1
M!Q<3Q\P<[_\ 1'VV^R_N!Y:VU\.VT8N V^2M=UR&?6FUP:]LS6+1$SFSQ2T6
MC!BBU])K:_TZ6[V<^%>O?(O.MU./B<<5V..T1DSWUC'3X:QK\;WTG7LKK.FD
MSVQ.JAQ]@7VO>4/V#9NXL-ZS?] =+6UY:W>O=$Z7?W=&G6D]A575997:+R2F
M"_WK9(ZJ_7\J]IIMX)/XVEM:\<\T\WM^@/M3]8?;]LJ[C@\'\P\TM2U<O)[B
ME9W%HOIW8\%8UKML,Z:=F/6]HZ9<F7I*:O@WK+QSP7#%]E3Z_+S$Q;<Y(CZD
MZ_&M(ZQCI^RO68_>M9&.DRV(                   ]YUGU=V+W-NV"ZXZI
MTK9.P=ZV6\BL<)J^J8JZS&6OII9*(^:^+>UCK^/9V_KXJGN)>:+>WBXYDEKH
MHIJJXZ+R7RCQWPWA<_D?E6]VW'\'MJ3;)GSWKCQUB(UTUM,:VG32M*ZWO.E:
MUFTQ#A<CR6PXG9WY#D\V/!LL<:VO>T5K'^6?C,_A$:S,](B96X_KV_;8XS$5
MX/M'[ LI#F[^F&RR=AXY:+L'/Z-974MO)5+C^UM\PM7$F:FL))J?78:W>1V?
MR8..><G>6U5<$E2GW!?U(MSNZY_%_0.*<&"9M2W+[G%_$M6)C2^QVN3ICBT1
M.F7>8YR=EIC]-AR16]8N^=?<%DRQ?C?!JS2FLQ.ZR5^:8U^.'';]W7_.RUFV
MD_X=+:3%KG1]&TWK/4=?T'KS5L#I.DZIC8,/K>JZQB[/"X'"8RV_/M6>-QEA
M%!:VL/%57-7/%-/'-5=5557YJJYYYJIYOG.9\EY;<<]Y#NL^]YK=Y)R9L^:]
MLF7)>?C:][3-K3^'6>D1$1I$1",N\WN[Y'=9-]O\E\V\RVFU[WF;6M,_C,SU
MEZIU3C                                      /-[CN.J=>ZIL6\[S
ML6'U+3=2P]_L&S[/L%_;XO"8+"8NWDN\AE,ID+N2*WM+.TMXJJZZZZN....'
M9</P_*^0<KM^#X/;YMWS&[S5Q8<.*LWR9<EYBM*4I6)FUK3,1$1#D;3:;G?[
MG'LMECOEW>6\5I2L3-K6F=(B(CK,S+G!_;1]FVT_8KW?1=8+]>UCQUZWFO<?
MT_H&5EM([J>N?T6^5[$VFWL8^(^=JVJ.WCYIMJYKJ/$V?%-M#)555<SW'HS^
MT[[9^+^W?PF<6^^ANO8G)16_(;JD6FL1'6FTP3:=?H8)F=;Q6DY\FN2]8B,=
M,<_/6'KO;>!</VY^S)SVXB)SY:ZZ1^-<5)G^Y36>NE9O;YIC]V*Q.I7-G
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M^^W.2;VGKI'X5K769F*4K$4I&L]M:Q&O1F!B#J@
M
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MM[9<MIMEM,S,S.LS,]9F9GK,S/69GXO['Q?@
M
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M
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M=S4FH>@
M          **O[G[M&#9O,KIWJVRG^1;]6]#V63R?'YR$?P]F[#V_8;V\L?9
MN8H[*3\:SKV'N/D6W,G$GR?:KJ]<'-%%YG],;Q>_&>G.8\HS5[<G*<]:E/W)
M[L.TV^*M;:Q,VC^-EW%.V^FG9W5C2^LS.^W/C9V_B>[Y*\:6W.]F(^'6F*E8
MB>G7]^UXTG3336(TG6:TZR=(0         !TS_INZ_KZT^L;P\UR2#)6]62Z
MQN.P.(\K7;UW55';.V[+VI%/%5;06\?&-N8MRXDL^.:>9*;.N+B2JNOBJNKS
M1?>+S]?)?N:\PY&ML=HQ\G&UUIK%==A@P[&8GNF9[ZSM],G72<D6FL5KI$5X
M>V-]'(^Q>5W$36>W<QB^773^#2F'\=>L?3TM^'=KII'1)FC2UX
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MCLN,VE-AQV+'@V6.-*4I6*UK&NO2L:1&LS,S^<S,SUEX]V[E
M       )_OKV^@'R4\JZ\'V-W_3DO&WH:]ALLG;39FSH_N_OF,OK>2ZM9--T
MR\AECUW&SQT4>K)9WXW/%%Q%+:V=_'S7[<!?N"^_KUMZKKG\=\!G'Y)YY2;4
MF,=O^]^UO68K:-QN*S$YKQ.NF':]_6MJY<V"W;W:/\Z]X>/>,Q?8<'V\AS<3
M,3VS_ QS$Z3]3)'[TQ_F8]?A,6O2=-;I7B%X,>,W@YHW.D>/77.-UN2_AMX]
MJWG)46^7[)WN6UDGFMYMRW.6VBR>6AM)[J6NVLZ/9QUCS-)Q:V\/%=7'-,/M
MWWE[+]X<Y_._8/(Y-S7',S@VU)G'L]K%HB)C;[>+33'-HK6+Y)[LV7MK]7)>
M:Q,1&\I\S\B\RWGZSG=Q;)%9GLQQK7%CUTU^GCUTKKI&MNM[:1W6G2&W34C%
M@                                      'XW%Q;V=O/=W<\-K:VL,M
MQ<W-Q+1!;V]O!15+-//-+53'###'3S5555SQ333QSSSS^'[QX\F;)7%BK-LM
MIB*UB)F9F9TB(B.LS,](B.LR_M:VO:*UB9M,Z1$?&9_*%#'[T?MLH\N=NN?%
MOQ[V6&[\8^OL]:7VS[=A9;BB+N[?\-\FBFZBO::XZ<CUCJ=U-SQC(N*.;7)Y
M&']3]4\<>,D@O>^QO[3+>I.)K[1]@[::>S>0P6KAV^2(F>-VN32>V:Z3V;W/
M6/XUM>_#AM^FTQVMN:WFMZ9]7SXMM8\DYW',>19Z3%*6T_T?%;3II^&:\?OS
M\:4GZ?RS.2)KHK$F^P           'TL-ALQL>8Q6O:]BLEG<_G<E8X;!X/#
M6-UE,QF<QE+J*QQF*Q6,L8I[W(Y+(WL]$,$$-%<LTM=-%%/-7/'#C;S>;/CM
MGEY#D,N/!L,&.V3+ER6K3'CQTK-KWO>TQ6E*5B;6M:8K6L3,S$0^>7+BV^*V
M?/:M,%*S:UK3$5K6(UFUIG2(B(C69GI$=9='OZ>?K8Q_UY^/,D6X0V=_Y%]O
M_I.R]SYFWN8;ZWP'PK:7^G.KL%=VDDEC/A])HO[FJYNH:I?U#*W=U+Q-):TV
M4<'G,^\#[D=Q]PGL*+\/-\?KOB/J8>.QS$UG+W6CZV]RUM$6C)N>VD4I:*_2
MP8\5)I7+.:UX!^UO8-_.^=UVDS7@-KW4V]9C2;:S\^:T3UBV32-(G3MI6L:1
M;OFTNJ)#5H
M                                     "F=^Z5\@_U#>O&SQ:QDGXAU
MC6\YWGM_HN?=BN,AME_>:/H]K);T1TT6EYA[#6,W-7ZJZZY(<I%SQ3'3QQ5+
M<C_2[]?_ *?@O)/:.YCY]UN<7&;?6-)BF"M=SN;1.OS5R6S;:L:1$1;#>-;3
MK%):?;=P7T]ER'DF3XY,E=O3I\(I$9,DZ_C%IOCC]DTGK/X5+EL23P
M   "QI^V=Z%E[#\W=P[NO+7W,)X[]5Y>YL[SXMW+\;>NU?DZ1@8/E4VM6/M?
ME:73LW/XDGHN)/:_$4<E'$]<-=7]2OSROCWI/9^$X;:;WR'E<<6KW5C7:['M
MW.6>WN[[=NX_1_"LUCN^:U;=D7T']PW-QL/#L7#TG^-O]S6)C6.N/#IDMTUU
MG3)]+X1I&O68G2)OG*(4*0
M
M                       % ?\ <D= 5]6>?<';./LYJ->\C^L=6W"6]X@M
M[:QIWG1X>.N-IP]I1'=RRS36^ U_!9*YFJB@IDFR_/XXKKIDKYOS_IP>?5\I
M]"6\3W%XGD/'.3S[>*ZS-OTVYG]9@R6F:Q$1.7+N<-*Q:TQ7!'[M9K6)O_;_
M ,Y')>$3Q>28^OQ^YOCTUF9^GD_BTM/3\;6R4B-9TBGX1I"OJL ;S
M   6U_VMGD9<6.Y^1WB?E;N:O'[#@<5WWI5M+>UQV=EF-=O,5H?8-%O8R4U0
M3Y+8<9G-?DYJCJCEX@PU7JIEHXXYAJ:_JB>NL>?AO'/:VUI$;C;Y[\7N9BL3
M:V/-6^ZVDS:.L4Q7Q[N-)B:]VXC2:S.EXO\ W(\!6^TX_P GQ1'U,=[;;).G
M6:VBV3%K/QB*S7+'76-<D?"?C<K4XHF@
M
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M'3'/S1$8]>RU"JU1K
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M+@ZH)%4
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M:UXO',3AV&VK2=)F?XF3^+?\(C]V<<3$:Z37K.NM:V%U?#1(
M
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MODOBM,7U>2_EN3<[6(K6UYW>S_TK!3'-IK%+9KXHP3?NC2F6\3K6;5G"/9'
MQY'X1R/&17NW'Z>V3%&D3/U<7\2D5UF-)O:O9,ZQTM.NL:Q/4&>8A7(
M
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M'[V>:X3'>WB^:>O][]/DM,_P[3\?IVZ?3O/XS].T]T5M>?E =I
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MXEQE>*X/#&+;QI-I^-\EM(B;Y+?WKSI&L](CX5B*Q$1K>V,[\
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M<7G6UK3-K6F?C,VG69G]LR^PX;Y
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MK7SWM-K6M,S:UIG6;6F=9F9F=9F>LSUE])QGS
M
M     :-?95Y#R^+/@OY*=T8_)_I&S8+K?*8#1;^.\N[*[M.P=\EM]%T>^L)+
M"VNKZN\Q6R[%;7E-,=-'\MO5S7-;Q\5W$6\/MM]>U]I>\O&_#-QB^MQN?DJ9
M=S2:UM6VTVL3N=S6\7FM>V^'#?'K,SUO$5IDM-<=LR]>\#'DOF?'\1>O?M[[
MB+9(TB8G%CUR9(G68C2U*S7KK\>D6G2L\N)Z@UD          #Z6&P^3V'+X
MK 86SFR.9SF2L</B<?;\<<W%_D\G=165A9P<5<TT\S75U/113QSSQQZJN'&W
MF\VW'[/+O][>,>SP8[9,EY^%:4K-K6G]E:Q,S^R'SS9<>#%;/FF*XJ5FUIGX
M1$1K,S_9#J_>,G2^,\<_'?I/HG$\0\VO4_6.F:-+<P3\W-&1R>!P=G9YO,57
M55ABN;J;-YFBXNY)/BVO$DD]57$,7'/HI\IOLSS/<^Q?87-^=;O7ZO+<GN-S
M$3';-*9<MK8\?;W7[8QXYKCB.^^D5B.^W[TUE>1<ODY_GMYS677NW6YR9-)C
M32+6F:UTUG3MKI6(UG2(^,_%G)@[I@
M
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M/AUBLZUC>5H]AH
M                                             #4OS;\.NK_.KQYW
M#Q_[3A^-9YGV\UIVW6]E#?9CKKL'%VU[#K6\X*&:6V]R\Q?SYX+F#B:#YV-N
MKJSKDHCN*ZN-L^D_</E'HSV%L_/_ !:>[-AUQ[C!-IKCW>TO:LYMMEF(G2M^
MVMJ6[;?2S4Q9HK-L<0RCP_RODO#.=Q<YQLZWI\N2DSI7+BF8[\=OCTG2)B=)
M[;Q6\1,UAS(_)+QT[4\3^ZMZZ#[GPD.#W_0<E%99..RNZ<CA\I8WUI;Y/![%
M@,E11%QD,#L.&O(+RUDJHBFXBEXHGBAGHEAH],7K?V)XM[6\+V/GOAN><_ ;
M_'-J3:O9DI:MIIEPY:=>S+BR5MCO$3:O=76EKTFM[6(^/\]QOD_$8>;XB\WV
M.>NL:QI:)B9BU;1^%JVB:VCK&L:Q,UF)G!K.'<@           /2:=N.U]>[
M7KN\Z-L68U+<M2S%AL&L;/K]_<8O-X+-XNXCN\?E,7D+22*XM+RTN(J:Z*Z*
MN.>.>'7<QP_%>0<5N.#YS;X=WP^[PVQ9L.6L7QY<=XFMZ7I:)BU;1,Q,3#C[
MO:;;?[;)LM[CIEVF6DUO2T1-;5F-)B8GI,3#HH_4S]LW7WV']?<:IM?.'T;R
MFT;#PS]@]?03<V^-V[&V_,-K)V1UO'=32W-WK=W<RT<7]AS7+=82ZEIBEJD@
MDM;JY\\'W8?:?Y!]O7D'\UXKZV^]7;[-,;3=S&M]O>=;1L]Y-8B*YJQ$_2RZ
M5IN:5F](KDKEQ8X&>S_6&^\$WWZK:]^;QO-?^%E^,TF>OTLNG2+Q'[MND9(C
M6-+1:M9C4/&J
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MB$J<6+%M\5<&"M:8*5BM:UB(K6L1I%:Q&D1$1&D1'2(Z0^:Y+Z
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M5_"->LS-IUM,S.R#7#'P
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M?Y%Z^WUJS$9]W6-K373K];6N2.O_ #F,DQI$S$QKTB)M'24><!7Z
M
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MTMYL/*,-?DRTG;Y9B-([J:Y,4S/XVM6<D=>O;CB-9B/EMHJG48
M
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M$Q,Q*>.++BW&*N?!:M\%ZQ:MJS$UM68UBU9C6)B8G6)CI,=8?-<E]
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M# CV/ZXY+P'DNVW=FX/-:?H9]/C^/T\FG2N6L?V1>([Z?WJTE*1=:V
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M^Y/E9OR/&<'6>F/!DSVCKU^I;Z=)GIIT^E>(TG7K.L=86Q54:,8
M#$O>?>?5?C;U7M_='=&WXW2.N](QM62SF<R5557-7-55,-CB\78PTR7N9SV9
MO9*+:QL;:B2YO+F2B**BJNKCAEG@W@WE/LCRG9^&>&;/)OO(M]D[,6*G^S:]
M[3I7'BQUB;Y<MYBF.D3:TQ$3+M.&X;DO(.2Q<1Q&*V;?YK:5K'_)M:?A6M8Z
MVM.D5B)F9T4)?M0^Z_M_SJO=AZ>ZKJR74_B?1DJHJ-6CY@BW+MN'&7U,V)SG
M9N4@XDDM,;[EO1=6^NV<WP()JJ:KN2_G@MIH+Y/M:^ROQ#T9AV_F'E/T^6]K
M3CU^O.L[?83>NF3%LJ3I%KZ3-+[O)7ZMJQ,8J[>E\E,DV?6OJ#BO#*8^5Y/M
MW7D_;^_U^G@UCYJX8GXSUTG+:.Z8_=BD6M%H,4XVY0                 $
MJW@)]/OEIY\W%KLFKX*'JOH_B:JC(=V]B6MU:8&]YBKM^);/1->CYBS^_P"2
MJBFKJIDM:(L1'7#7%<Y"WEYCHDBO[[^[WU/Z%QVXWE,\\KYOIK3C=I:MLM==
M=+;K+.N+:TUB(F+S;/,6BV/;Y*1:U=:>;^U?%_"*SM]S>=SS.G3;XIB;1\>N
M2W[N*/V6UO.L36EHUF+PO@C]5/B7X XRTR'5^I3;;VY7C;BPS_>6_?%RV_Y*
MB_YYKR-EA/8M[?#:3@9>.?9IM,7;P22VM$=-Y/>2TU3UTB^]?NH]L>_=S?;^
M4;N-IXE&2+8N,VO=CVM)I^Y;)K,Y-SEC]Z<F>]HK>;3AIAI,4K#GS3V7Y1YQ
MDG'R66,7%]T37;XM:XHT^$VZS;);\>Z\S$3K-*TC2L23HW-?
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MNG=WVM+JB0U:
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MG[D>>C+O^/\ &\-NF'';/DB)B8[LD]F*)C36+5K3).FO6N2)F/A,VQ54:,8
M
M
M  "I%^Z5\>(KW5?&SRJQ.,_US!9C.=$[QE(;2TKEGQ><M[S>NNHKV[XN8\C#
M9XC(XK8^(^.89K;WLG^.9()*J*+FVC^EW["MAY7R3U9N\O\ !SX<7)[:DVM$
M1?%-=MNYK72:3;)2^TU^:M^W#TKDK%IQ2A^V[GIIN>0\:RV^2]*[G'&L_&LQ
MCRZ1IIK:+8M>L3I3X6B)FM-I<6EB          D^^F[R%K\;OL6\<MKN\Q#A
M]4WC:O[-[S)>2V]MC)M<[3B_I:TDR]Y<<4T6&-PFVW6+RLD_N141<X_BJ2KV
M>)*:HQ_>+Z^K['^W?R/BL.&V;E=CM?YAMHK$S>,VQGZ]HQUC]^^3!7-@BNEI
MM]68K'?VS&N?;'!1Y!X%O]M6DWW.'%]?'IK,]^'YY[8CXS:D7I$:3KW=(UT=
M,1YJ%>8
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MCTP,
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M?!>"\;^CXJG=N[Q7ZV>W^)EM'XSUGMI&L]N.ORUCK/=:;7MH>WLS0
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M6.=)M,ZQ?)$:?+2+7M'JO4;P
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M
M
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M^/7\9^,[:-3L7
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MK'X3\>W)76.^FO3I,3-9K:9#D>F!@
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M[^W)<YN,FXW4_#NGY:1KKVXZ_NTI$S,Q6L1&LS.FLS+/#!'2@
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M@HP0P
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MQX^ND_4R_P .DQ^,]LV[YB.O;6>L1$S'4,>857&
M
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M^.?1WVR\JPQ/9FI.WR].D7IK?%.O^=>DWC2?PQ1I^*V*JC1C
M
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MM,AR/3 P
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M<!:-/H8YZWC\\V32)OK_ )L17'$:1VS,3:TR:'+4P
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MDWN]R7R[O+>;7O:9FUK3.LS,SUF9EZ1UKC@
M
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M[HG@
M
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MN;;UBT=NN;K->EZZ\]J^/QY'X)O]G2L3NL6+Z^+XZ]^'Y](_;>D7QQKT^?\
M#XQTT'FB5X
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M1>([Z?WJTE*1=:V
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M..N+%6*XJQ$5K$1$1$1I$1$=(B(Z1$=(A*RM:TK%:Q$5B-(B/A$?E#\7[?T
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ME^0Y/-DS[W).MKWM-K3_ )9^$1^$1I$1TB(A[QT+A
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M(B(BM:Q^%:UB*UCK.D:S,VF9G.3!W3
M
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M=(B(Z1$=(A9)6M:5BM8B*Q&D1'PB/RA^+]OZ          Z9_P!/OC=1XO\
MUZ>/&DWEC#9[;N.JQ]Q;]5'5<57$VT]J^C:X[3(TSTQT19+6M8O,;A9J8J>(
MN*L9^>*I.>>9I/-%]WOL>WL_[@_(>;PWF_$[/=3Q^UUTTC!L?X$VIIK,TS9J
MYMQ6;3W:9NL5Z4K7A[5\@GR/SO?[REIG:XLOT,7PT[,/R:Q^R]XODC7K\_X?
M"),T:6O
M
M             $9GW!>-U'E!]>GD/I-G8PWFVZ=JLG<6@U257%-Q#M/57KVN
M2TQU,%,E$N2V76+/)86&F6GF+FK)_GFJ/GCB:.2WVA>Q[>L/N#\>YO->:<3O
M-U''[K332<&^_@1:^NDQ3#FMAW%IK/=IAZ1;K2VP_57D$^.>=[#>7M,;7+E^
MAE^&G9F^36?V4O-,DZ=?D_'X3S,'I=6'@          .HQ]:7DW7Y>>#_CYW
M?DLA#D=PS.DV^M=D2T75O/=<]DZ)<7&G;I?7]O!%!SBYMAS.%KRT-M713S'9
MW\/-/,D=5$M?E_\ N4]9U]1^[O(/"-MCG'Q&'>SFV<=LQ7]'NHC<;>M9F9[X
MQ8\D8+7B>N3%>)BMHM6M</L+QV/%O,=]P^.LUVM,TWQ=)B/I9(C)CB)ZZ]M;
M129_&U9^$ZQ&]31C"P
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MK+;^'ETUG',S_A9IB-(M'PK;I7)'6-+1:M9DT.6I@
M                                %7S]S;Y;6^B>/_77A]KMY-QL_>N>
ML^P.P(XN*.;>UZKZZRL=WA,;?430\5<S;5V5;V=W:202<\Q4ZW<42T\<31<U
M6>?TSO4V3G?/^1]O\C2/Y9P6"VUVLSKK;?;NDUR7KI/PP;.<E+Q:/FG>8YI,
MS2VDC?MV\7MO><W'E6>(_3;*DXL7YSFRQI:8_P!QBFU;1,=?JUF/A*D NW3%
M          >JT72]C[(W?3NN]/QTV7VW?=JU[2]6Q-O'++<938]IR]G@\)CH
M(H(YIY9KW)WT45--%%==557''''//\'5\[S7'>-\)O/(N8R1AXG8;7+N<^29
MB(IAP8[9<EYF9B(BM*VF9F8C2.LPXV]WFWX_9Y=_N[13:X,5LE[3\(I2LVM,
MZ].D1,NK]T)T_KGC]TEU-T?J7$/.O=3]>ZEH.-N8;&+&\Y.C6,)9XJ?-W5I#
M+/31DL]=6TE[=U522R2W4\E=<DE=55=7E,\\\OY'S_S7EO-^6U_F'+<AGW5X
MFTW[)S9+7C'6TQ'R8JS&.D1%8K2M:UK6L1$5E<WRNXYSF-US.ZU^ONL]\LQK
MKIWVFT5B>G2L3%:](B(B(B(CHRTQ-U8    #\;BXM[.WGN[N>&UM;6&6XN;F
MXEH@M[>W@HJEFGGFEJICAAACIYJJJJYXIIIXYYYY_#]X\>3-DKBQ5FV6TQ%:
MQ$S,S,Z1$1'69F>D1'69?VM;7M%:Q,VF=(B/C,_E"DQ]QWWHYOMK(;IXJ^&.
MT_IO2_-GDM2[2[IPU=4>6[6EEGBARVO]=Y6*NB;%=;\0PRVESD8N>)MBBFEH
MBYHQO/%=_=9]GGV-[+Q/;[+VG[EVOU/,^^F?9<=DC7'L8B)G'EW=)Z9-YK,9
M*8;?+M+5K-XG<ZUP3 ]4>F</%X\/DOEN+NY?6+X=O;]W#_FVRU_O9?A:*3TQ
M3$3.N3I2K4M$21                ;=>'G@WY'><_9-IUOT#I$V7JIFA_J?
M>\YQ>XKK;0,?)51Q)EMUVN*POX\?#''7ZZ+2WBN\I><4\TVEK<5\>AJ3W![P
M]<^C?&[^1^?;V,,3$_1VN+MR;S=7C73'ML$VK-YF>DY+VQX<>L3ERXZ]6+>5
M^9<!X9Q\\ASF:*]/DQUTMERS_FXZ:QK_ +J9K2O]ZU8ZKX/UR_3#XS> MOBM
MYN[>'NWR/BAN>;GN7;\/;PV^JR7M%,$UEU1J,L^1LM'AHLJ>8:\C5-=YRXIG
MNJ.;R.SN/@Q43_<5]Y?LOWUDR\'BM/">N9F.WC]ODF9SQ6=8MOMQ$4MN9[OF
MC#%<>VI-<4_1MFQ_7M"SS[VWY%YO:VRK,[/@-8TP4M.M].NN:_2<G7KV:5QQ
MI6>R;U[YF'0_:I
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M;D^2M,8*S-<.*/W,6/7I$1^-ITB;W^-K?E6*UKN\TDPX
M
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M9UB(F8ZF#RYJVP
M
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MQI$3<'5!(J
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M7F<]]QO\D_->VG^2*Q$16M8_NTK$5K'2(B&6F)NK
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M@:X
M                                    <OG[0?*#_-]YT>0'<MA<6=QJ
M$VX3:1UQ)C;OYN-N.NNNHH]-U/,V=QZI*>?ZNL,/^M3TT5R14762EICJYCXH
M>G?[8?6/_%%Z-\?\.SUO7EXV<;G>1>O;>-WNYG<9\=HZ?X%LGZ:LS$6FF&LV
MB+:K&_7'CG^JOAFQXF\3&ZC%]3+K&DQER_Q+UF/]I-OIQ\)TI&O75H&WXS<
M        !;1_:X^-?ZKNWD-Y:YO&^NSU/#XSHWK^]NL;\BVKV#9)+'<>P[K'
M9";\16.8P&"QN#MZO9XJGJM,[+155''7S3/4[_5!]D_I>%\>]3;+)IFW>:_)
M[JM;Z3&+#%MOM*WI'6V/+EON;QW:5C)MJS$6M76D8?N0\A^EL]AXOAM\^6\[
MC+$3I/;37'BB8_&MK3DGKT[L<3I,Q\MS%3<B6
M
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M
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M>.MF\E\0QS?CM>[+M:Q,VQ:Z]U\41\<4=)G''7'K,UUQQI2U.JR1J
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M8S9X^:LQ_P [Q7K,?)IWS_>F(F:+(*N1H
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MUB=,=;:S6O72MKVB)L4*VH
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M[VCY'7RCS?>\AAM-ME2_T<7Y?3Q?)K'XZ7M%LD:]?GZQ'PB2=&YKX
M
M
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M8K_8EI1.:P
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MZ6FMJVB8M6T3I-;1.DQ,3&DQ/6)Z2^DXSY@
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MIBIY!Y!2M_);UUI2=)KMJS'PCXQ.:8G2]XZ5C6E)T[K7KNK#&^
M     &_G@+]<7D-]A78O.J]38;]%T3 7EA_<CN#8;2ZITG1<;<75I1<1<3T^
MS3L>X5V-S5/98.VEINKNFCFNNNWMZ9;F+0?OO[C/7OV^>._S7RS-];G=Q2_Z
M/C\5J_J=S>*VF)TZ_1V_=';DW-ZS2DSI$9,DUQVPCS?S_@?!-A^IY2_?O;Q/
MTL%9CZF28B=.G]S'K&ELDQI7X1%K:5GH"> WUM>./U[Z%1@.J-?ASG8N9QMO
M;=A=T[%C[*3?=TNJH,7SD;.&]XIGGUC29LGBH[FVP-K/59V\E--<E5Q<^NYD
MH']]?<A[&^X+GIW_ )7N)P>.X<DSM..PWM&UVU=;]EIKTC-N8I>:7W5ZQDO$
MS6L8\>F.L'?-_8'/^=;WZ_)WFFPI:9Q;>DS]/'&LZ3I_?R:3,3DM'=,=([:Z
M5B0)H!@P                                             #S>X[CJ
MG7NJ;%O.\[%A]2TW4L/?[!L^S[!?V^+PF"PF+MY+O(93*9"[DBM[2SM+>*JN
MNNNKCCCCAV7#\/ROD'*[?@^#V^;=\QN\U<6'#BK-\F7)>8K2E*5B9M:TS$1$
M0Y&TVFYW^YQ[+98[Y=WEO%:4K$S:UIG2(B(ZS,RHM_;C]Z.S^65OM'CEXL7.
M2TKQER$-ICMLW:XM,A@^Q.Y8J:)ZLMB9XI+F.35>L<A)-''5CN8:<CDX[?GF
M\ECMKF;'4WD_:5]C?&>J,FU]B^TJX][[,QS:^#;1:F7:<?.L?3R1,1,9][2(
MF8S=TX<,W_@UMDQTW$S-]7>F=MXQ;'S_ )+%<WD59F:8XF+8L'^;:.GSYHZS
MWZ]M)GY(FU8R*XJQAOT             !]+#8;,;'F,5KVO8K)9W/YW)6.&P
M>#PUC=93,9G,92ZBL<9BL5C+&*>]R.2R-[/1#!!#17+-+73113S5SQPXV\WF
MSX[9Y>0Y#+CP;#!CMDRY<EJTQX\=*S:][WM,5I2E8FUK6F*UK$S,Q$/GERXM
MOBMGSVK3!2LVM:TQ%:UB-9M:9TB(B(UF9Z1'65^7Z4/J!X\)-<I\A._K'&Y'
MRAWO TVN/UZJ#&9.SZ)UC)Q<U76!QF5ICN:INPLW:R\PYN_M)N+>&#FK'VU4
MD/R;B\H6^]3[O)]U\C_Q?> WR8_6&QS]U\NMZ6Y/-2?ERWIK&FTQVCNVV+)7
MOM;3<9(K?Z>/#"3V_P"U/]<-Q_(N#M:OCF&^LVUF)W-X^%IKT_A5GKCK:-9G
MY[:3VUI8+5_-&
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M\A_U8\,W_+4MV[JN":8IUTGZN7^'CFOXS-+6[YB.NE9G6(B9CJ)/,$KA
M
M
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MK%KS\9ZWJE&:&(
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M%J6^-;5F:VCK$LP,0=4
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MGJ3%XIBIY!Y!2M_);UUI2=)KMJS'PCXQ.:8G2]XZ5C6E)T[K7KNK#&^
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MHB^2DS_I-XTF>O3^#2W2L1K6\Q]29M'9VV.U<[0(
M
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MDV'BV"W2(G<Y8Z_CKCPQ/X=-,LS$ZSUK/3IK;U5%HL@
M
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M7'[GB>0S\9O:]N[V^6V.\=?WJ6FLZ:Q$Z:QTG2-8ZO>.A<(
M
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M;68G>Z3:\7UVOT^RF>\4?9_O&^;ZG >$99KBTFN7=UUBTS$Z:;:T3&D:1/\
M&^,ZZX^W2+S;=M[>WL[>"TM((;6UM88K>VMK>*B"WM[>"BF*&""&*FF.&&&.
MGBFFFGCBFFGCCCCC\*E\F3)FR6RY;3;+:9FUIF9F9F=9F9GK,S/69GK,HNVM
M:]IM:9FTSK,S\9G\Y?L_#^
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M,Q,YO$O#N#\+XR.,X7%%=8B<F2>N3+:(_>R6_'XSI6-*TUF*Q$2U%;;92
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M3'"Q,US9JSUW$_C2D_\ ,/SG_??_ (G_ (EG=62CH
M
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M?IUK,Q_G3.NLZS.YC3;$@
M
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M%=MR.+6VGP^MB[:WGX].ZDX[?".ZW=/6>Z5CM7.T"
M
M                    JU?<=]%V$[:Q^Z>57ACJWZ;W1S>9+;>TNEL-13'B
M>UHI8(ILML'7>*BHHAQ79'$T,MW<XZ+CB'8I9I:XN*,ESQ1?VB_9Y]\F]\3W
M&R]6>Y=U]3PSLI@V7(Y)UR;&8F8QXMW>>N39Z3&.F:WS;2M:Q>9VVML$D?5'
MN;-Q>3#XUY;E[N(TBF'<6_>P_P";7+;^]B^%8O/7%$1$ZX^M*3%Q;W%G<3VE
MW!-:W5K-+;W-M<15P7%O<05U1303PRTTR0S0R4\TU4U<<54U<<\<\?E=7CR8
M\V.N7%:+8K1$UM$Q,3$QK$Q,=)B8ZQ,=)A,"MJWK%JS$UF-8F/A,?G#\7[?T
M             !DCJ3N#M#H;L'7>U>F][V3KCL/5+SB]P6U:MDIL=DK6KGCT
M7-G<>CGFWR>'R=OS5;WMA=1S65_:R5P7$4L,E<=6.>6^(>,>>>/[CQ7S'8[;
MD?'MW3MRX,](O2WXQ:->M,E)TMCRTFN3%>*Y,=ZWK6T<#E.*XWF]CDXSEL./
M<;#+&EJ7C6)_*8_&+1/6MHF+5F(M68F(E>U^J[[T.L_,Z7!])>0E&M]/>3=Q
M\;'X.NWFEQG7'<F0N;N[AMK71Y,I>7TVO[AS#Q;QU86\NY*[^XE]6/DFYJJM
MK>BW[IOL;\E]-5S^;>OIW/,>LZZWRZQ%]YQ]*UK,VW,4K6,NWU[YC<X\<1BI
M73<5II&7)"[V5Z9Y'Q*+\QP7U-WX[&LVUZY<$1$:SDTB.['\9^I6L=L1_$B.
MEK6!4 6C0                                         $5WW%^;?\
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MDTF8BFNG;CB9CY8M:9G2*SSH(-*
M              *W'VJ??=H7C+1LW1'B)>X'L_R(MIKK![+OT]O!G.L.G[R&
MXRF+S=G3[=]#3N/9V"NK.GB.Q]N3#6,\E-5[)<UP38R2Q[[6/L-Y[V7;;>=>
MW*9^,]>6BN7#M8F<6]Y"LQ2^.W6L_I]EEK:=<NL;C)6)C#7'%Z;FL@/6GI+?
M>13CYKRF+[;@9B+4Q1/;FSQI$UGX?P\-HGK;6,EHC2D5B8R11Z['[(WWM_>=
ME[+[0V[/;YOVXY*O+;-MFS9"?*9K,7U<<<%$ES=W%557$-K:P1P6\-'IAMK:
M*.&*BB*BBBF[OQSQO@?$.#VWC7C&TP;#@-GCC'AP8:13'CKK,Z5K'XVM,VO:
M=;7O:U[S-K3,S'X_C]EQ6SQ\=QN*F#8XJ]M*4B(K6/V1'YSK,S\9F9F9F9F7
MB7=.6              _:WM[B\N(+2T@FNKJZFBM[:VMXJY[BXN)ZZ8H8((8
MJ:I)III*N*:::>.:JJN>.../R_&3)CPX[9<MHKBK$S:TS$1$1&LS,STB(CK,
MSTB'\M:M*S:TQ%8C69GX1'YRO"_2C]*-OX_6^L>6WEMK$-UWQ=0VV:ZGZGS5
MM1/;]*V\]%,UEMFV64U-4<W;4T=7%=K:U\<TZU3SQ55Q^J?CC'4B_>G]Z>3S
M_)N?4WJ;<S7P2LSCWV^QS,3R,Q.EL&"T=8V$3TO>.N\GI'^B_P#"(<^WO;UN
M=MD\7\7R3'"Q,US9JSUW$_C2D_\ ,/SG_??_ (G_ (EG=62CH
M
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MYB8F)B:XHR6K,=8M$?VQTH'FZ5]@
M
M                                       .;[]YGB[_ )8OL,[8_2[#
MX>E=[>CR!T[V^/\ 5J?[@Y/*_P!:V,7XNKJFV^#V-C,O[=M_@^Q:20>B*B&J
M'U>C;['?:'_&;]O?$_JLG?S7!:\5N-?WO]$IC_36GY:Z]VTO@UO\W=DC)K>U
MXOI/[TUY)_K%X)M?JVUWFR_T;)^?\**_3GX1KKBFFL]=;1;69F)0_I>MJ
M       );OI'\KJ_%/[!.I+[*Y*'']>]US<]"=C577-O1:0XSL'(8Z/4\Q-=
MWL\%GAX=?[(Q^&N[N^KY_,&*HO*/SQ3+7RB7]['JJOM7[?\ EL&UQSD\@X6/
MYIM.W7NF^TI><^.*UB;9)R[.^XICQ1^]GG#/6:PU?[A\9CR;P;=4Q5FV_P!G
M'ZG%IKKKBB>^ND1,V[L4Y*UK^-^R?PATE'G 5^@
M
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M_COAWF*TUO2\36U9C\)B>L/5.J<8
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M?U1_,\E/+?)\&O%UTMML5_\ ?;?AEO28ZXH^-(GIDGYIB<>G?2>74I?
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M(KTM>/W_ );?3BR"KD:
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MXYAF?H[#%W7Z])RYXK;X?CVXHI,3/7Y[1$1'6UF56DCP
M
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M7F.\XBD:;/ZGU,/2=/HY/GI$:_'LUG',_C:EF_C0;!P
M
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M (#P79?0XRD7W]ZQ&7<7B/J9)TC6-?[F/6(F,=9[8GK/=;6TQ^M_LX
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MS:/C7%TBU<<]9GYK]8K6E@M7\T8
M
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MU8
M
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M7K'7-/QF8TNW*4$/@
M                                                         $#W
MV\_33HOG%JF6[CZ-PNMZ)Y;X"SEO:;^WM[#!83O:TM+>BFC5^P+R.BWMZ-PH
MM[>B'#[!<\^J/BFBROI.;+V)L?.S[1OO'YWTARN+P_SC-N=_ZEW%XKVS-LN3
MC+6G_'VE9F9G;S,S;<;2G2=;9L%?K=]-QNKU9[9WOANYKQ/,WR9_%[SII,S:
MVVF9_?Q1UGLUG7)BCX];TCOUB]!3L?K??>H-YV7K3M#4<]H>_:=DJ\3LVI[-
MCY\7FL/?41QST1W-I<4TU<PW5K/'/;S4>J&YMI8YHJZXJZ*ZK[?'/).!\OX/
M;>2^,;O!O^ WF.,F'/AO%\>2NLQK6T?C6T36]9TM2];4O$6K,1-WC^0V7*[/
M'R/&Y:9]CEKW4O28FMH_9,?E.L3'QB8F)B)B8>)=TY8              #)'
M4G<':'0W8.N]J]-[WLG7'8>J7G%[@MJU;)38[)6M7/'HN;.X]'/-OD\/D[?F
MJWO;"ZCFLK^UDK@N(I89*XZL<\M\0\8\\\?W'BOF.QVW(^/;NG;EP9Z1>EOQ
MBT:]:9*3I;'EI-<F*\5R8[UO6MHX'*<5QO-[')QG+8<>XV&6-+4O&L3^4Q^,
M6B>M;1,6K,1:LQ,1*Z?]9?[A/K;O&WUKIGS7N\#U+W//-9X+"]MVT%.'ZE[%
MGJHJAMKG9ZI9ZK7K':KVJBCBXJDJIP%S<UU20UX^FN*RHI?^Y?\ I]>2>#Y-
MSYEZ5IGY;PRM;9<FPF?J;_:1KK:N'2.[>X*ZSV1$3NJ4B*WC<36V>8B>Q/17
M(<-;)RWB$7W7$1$VM@F>[/BC\8ITUS4C\-/XD1TF+S$WFS6K/1W
M                           ?QY'(X_$8^^RV6OK/%XK%V=SD<GD\C<P6
M6/QV/LH*[F\OKZ\N:XK:TL[2VBJDEEDJIHCHIYJJYXXXYY?;;[?<;O<4VFTI
M?+NLMZTI2E9M>][3$5K6L1,VM:9B*UB)F9F(B-7[QX[Y;UQ8JS;+:8B(B-9F
M9Z1$1'69F>D1'Q<R_P"UKSBO//+R_P!\[.Q&5R5SU!J\U>A]'8J\IOK2WM=
MP<U44>Q4XB^H@GQN2WS)\39>YHFACNHZ;F*VE_\ H:CBGTN_:KZ0P^B/4.P\
M9W>+'7R_=1^JY.]>VTVW66-9Q?4KK%Z;6G;MZ36TTF:6R5_Q+3-A_K/PVGA7
MBN#CLM:QRN2/J;BT:3,Y;?W>Z/C&.-*1I,Q.DVC]Z4;*2#8           "_
MC^W:\)/\NWB1+Y#;GB/B]I>5GZ5M=A\N#TWN!Z4Q5-S_ &UL(?=ID]C^L_G7
M6QR2V\G$=[C\AC*9:.);3C\4(?U#?=G_ !A^VH]>\-F[_%_%>_!;MGY<O)7[
M?UEYTTU_3]M-G%;QKCRXMS-)[<W6$/OGS#^?>41P.TOKQO&=U)TGI;<6T^K/
M_P ;TC%$3&M;5R:3I=815]M%@(NOM5^R72?KKZ$N,_1Q9[#WQV-9YS ]&:++
MS'-!-G[>Q],^];7;<7%O<?T'I5S>6\MY1%53/D+B6"RBKA]^NZMI/_:O]M_-
M?</YY786[]OX)QU\67D]U&L3&*;=-M@G28_5;F*WKCFT37%2M\UHOV5Q9-C^
MM/7^\\]YN,$ZX^%V\UMN,G^UF?\ #I.DQ]3)$3%=>E8B;S$]L5MS?NT.T.P>
MZ>P=L[5[5VS,;SV'O.8N,]M6U9ZXXN,EELE<<44>JKT416]I9VEO%';VMK;Q
MQ6MG:Q1P01QPQQQT^C?QCQCQ_P +\?VGBOBNTP['Q[8X8Q8,&*-*8Z1U_'6;
M6M,S:][3:^2]K9,EK7M:TS^X[CMCQ&QQ<9QF*F'88:16E*QI%8C_ ),S,ZS,
MS,S:9FUIF9F7@W>N:             D.^N3ZY.X_L4[CBT;1HIM8ZTUB:PON
MWNWKZPDN<#H>!N9*^8[2TCYKMX\[NV=CMY:,5BJ):*YZZ*YIJX;2&XN(H]?<
M7]Q?AWV[^'3SG.3&Z\EW46KL-A6T5R[K+6.MK3UG%ML4S6<^>:S%8F*4B^6^
M/';!//O/N)\"XF=YO)C)R.2)C!@B=+9+1^,_'MQUUCOOITZ1$3::UGHR>+/B
M9T3X:=58OI_H'2;/4=8M/C7>9OZO1=[-NNPQ8ZSQMWMVZYSVHILYLF3AL8^9
M9?3'!%QQQ%;Q0041Q4>=CVE[8\Z]R>59?+_/M[?=\G?6N.G[N';8IO:]=OML
M6LQBPTFT]M=9M;][)>]YM>8$>2^3\UY;R=N5YS-.7<3K%8^%,==9F*8Z_P!V
MD:SI'69^-IFTS,[(-<,?
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M+38['9<9M*;#CL6/!LL<:4I2L5K6-=>E8TB-9F9G\YF9GK+Q[MW*
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MFQ0K:@
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MX+*?$N Q>+>-;+@,4Q/Z;!%;3&NELDZVRWC7K$7R6M:(GX:Z-8VS&1
M    +%'[;7Q9_O!YFYSO_8,7\K3?&/3[G+8N:XMO?LKCM7?X+[5]1MY([FSF
MLI_TG6N<YDJ*^):+BTR%K931\?G^>BO#^I![2_U0]-8/ ./R]O,>3;RN.\1.
MEHV.UFN?/,3%HM'U,WZ;#,=LTR8KYZ6G\)T-]P/DO\J\2IP>"VF[Y'+%;:3I
M,8<4Q>\])U^:_P!.GPTM6;Q/Y3?:4-H3
M
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MVS7Q7B.L=U+36=)_&-8Z3^,:3^+(3'W
M
M             1(?:']2G3GV+:CQL5$\/6_DGJ&!N[#KOM6S@CIL<Q%'Q+<V
M&D]IVD-E<WN?TFJ]DKY@G@_&1PTTU<]MS+%5<V-Y+3[8?NR\Q^W;EOY=:L\E
MZWWF>MMWL;3/=CF=(ON=C:;5KBW/;$=U;?P=Q6L4RQ6T8L^':/KCVARW@6Z_
M3S$[CQ_+>)RX9GK7\)R89UB*Y-/C$_)DB(BVD]MZ<]+OWQ[[C\8.S<]U!WIH
M6>Z]WS7YIN)L7F[.2&WRN.HOKS'VVQZUD^*><?LVJY6XQ\WP\G8R3V5U3'5S
M')5Z:OQZ#? O8/AWL[QG!Y?X-O\ !R'!;B(TOCM$S2_;6]L.:G[^'/2+U^IA
MR17)29CNK&L)U\)SO$^1\=3E>%STS[+)'QK/6LZ1,TO'QI>L3'=2T1:NO6&&
M69.V                3A?6U]XWD3X/UZ_UCV17DN_/&:UFQ]A3H^=RE7.\
M]:X6"WIQ_P">I=LO^9:K;&XVUHAKCUS(\RX>NFUX@LZL57<3WG,(ON0^R#UY
M[NKN/)O'(Q\![+O%[?J<5/\ 1MYDF>__ $_!736][3:)W>'MW$3?OS1NHQX\
M+3GL#TWP/F,7Y'C^W8^13$S]2L?P\MM=?X](^,S.NN6NE^NMXRQ6M%Y[Q.\R
M_';S8ZVMNSO'GL+&[ABXX;#C9M<FYIQN\Z!E;^FY]&!WS4[B3G)Z]DO?L+FB
M&2KB2QR%-O7/8W%U;<T3U4<^U_3?L/TKY);QGV%Q^39[J9M]'-'S[;=4KV_Q
M=KGB.S+32U)M$:9<4WBF?'BRZTB&GD_B7/>'\A/'<]@MBR:SV7^./+6-/FQW
MCI:.L:QTM76(O6MM:QM$U>QL                                 !7$
M_<6^>=?0'CMCO%7KO8X;+M;R6QN1@W:&RN+>O*Z_T#S3>X;9*KJWY]<]E#V=
MDZ9<);R54<475C;9:.BKBN/\TV,?T[O1%?/O8>3VIY#MIOXKXUDI.VFT3V9>
M5^7)A[9Z1:=E3MW-HB=:9;[2TQVVZ[^]"^%1SG/6\EW^.9XSC[1./6)[;;GI
M:FD_C]&-,DQ^%IQ3/25#A>VFH           W\^LGPUR'G5YC]6]'26UY5H4
M5Y7OG<N3LZYX:\1U'J%S97.T\<7EMS\C&WFT7%S:8"PNJ::^+?)YBVDKIYCI
MJYXT']S/N/;^C/3O*>;UM3^?33]+QU+:3]3?[B+1@^6W2]<$5R;K+29COP[?
M)6)[IAA'L3RVGA?B>YYF)C]=,?3P1/\ >SWB8ITGI,4B+9;1^-*6B.NCI]8[
M'8_$8^QQ.)L;/%XK%V=MCL9C,=;066/QV/LH*+:SL;&SMJ(K:TL[2VBICBBC
MIIHCHIXIIXXXXXX>8[<;C<;O<7W>[O?+NLM[7O>]IM>][3,VM:TS,VM:9F;6
MF9F9F9F=5<^3)?+>V7+:;9;3,S,SK,S/69F9ZS,SUF9^+^Q\7X:N^8_EMU7X
M2= [GY =MWDU.#UN&FPP. L>*JLSO&Z9&&YYUK2<%33#/31DL]=6U5/,\E/Q
M[.VHEN9^:8(9*N-H>G?4WE/NSS[9^ >)4K^NW,]V7+;_  ]MMJ3'UMSEZQ\F
M*LQ/;$]V2\TQ4B;WK$Y)XGXOR7F'.8>#XN(^MDG6UI_=QXXT[\EOV5B?A'6T
MZ5CK,.9KY=>5O;'FIWUNGD%W)DH;G:-LFMK;'X7&\W,6M:7JV*B^+K^F:EC[
MF>XJQV!PUK^>?QZJI;N[EGO+BN6[N9YI/2UZD]5>*>E_ ]EZ_P##L<UXO:1,
MWR7TG-N<]Y[LNXSWB([\N2W[(K3'6F''%<6/'2MAOBWC/&>(<)AX+B:S&VQ1
M,S:=._)>W6V2\Q$:VM/^2M8K2L16M8C6ELED(            "4KZO/J\[4^
MQKM3FVMN<EI'C[I&2M/[N=N?$IJXMN*J8KOC1M&XNXI++,]A9FRDIJIIJIDM
ML1;24WEY35Q5:VMY%W[GON>\6^W3Q;ZF3Z>^]@;[';]!L.[][XU_4[GMF+8]
MICM$Q,Q,7SWB<.&8TRY<.M_8_L?C? >-[K=N;G,U9^A@U^/X?4R:=:XJS_9-
MYCLI_>M3H=>,GC)TYXA=.:MT9T9JT.L:1K$/,E=<G,=SGMHSUS'#3E]PW#+T
MPP29W:L[)!35<W-5-%%-%$<$$<-K#!!%Y[/9GLSS'V[YCNO./.-U.ZYO=3I$
M1K7%AQ5F?I[?;X]9C%@Q1,Q2D3,S,VO>U\M[WM!'R+R+EO*>6R\SS.6<F\R3
M_96E8_=I2O7MI77I']MK3-IM:<_,!=&
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M\=\(K7>VB-YS^DZY[UC2FO33#3K&/IT[];9)UM'?%+=D0\I?MK
M      ,_>,GC)W'Y>]QZMT9T9JTVS[OL\W,E=<G,EM@=7P-M)#3E]PW#+TPS
MQX+5<%'/35<W-5-==5=<<$$<UU-!!+@/LSV9X=ZB\.W7G'G&ZC:\)M8TB(TM
MES9;1/T]OM\>L3ESY9B8I2)B(B+7O:F*E[UZ3R+R+B?%N)R\SS.6,>SQQ_;:
M]I_=I2O3NO;3I']MK3%8M:.A_P#6)]774GUQ]9W%IC)K/?N^-ULX*>T^XKC&
M\6ES?PT2T74&E:;:SUW%SKVAXJYCHKYB]SY&4NX^+J[Y_DM;>S\]/W-?<_Y;
M]QGDM<NZB^P\$V5Y_0\?%^ZM9TFL[G<6B(C+NKQ,QW:=F#',XL4=<N3- _V+
M['Y3S_D8MDB<'"X9_@X(G6(_"<F2>D6R6C\=-*5GMK\;6O**C UP
M
M                              @ _<6>6UQX_P#A+!TSK5Y#;;SY79Z\
MZ_\ 55Q7Q=675>L06.:[2R5ASS#-:R37M5]A\#-'+QQS\//32QU4RQ45<3[_
M *=WJ;'Y_P"Z[>9<E2;<'XI@KNOP[;;[--L>RI;K%HBO;N-U6:_[YM:5M$UO
M,3O#T+XO7G/,)Y;<1,[+C*1E_9.:\S7#$_CTTODB8_O8XB>DRY_B_A.(
M      !T@?HY\3/\JO@'UG^NX+]'[*[S_/>'8'R[3X^9B_K"RM/Z'P>1]V:>
M[M?T30;7'^NQK]GX=]<7?J@BN))_5YR?O?\ ;'_&I[\Y/]#G^MXWP?\ WMVO
M;;7'/Z>UOU.6FD16WU-U;+IDCN^IBIBTO;'7'I +W)Y/_K+YON/HW[^/V7^C
MXM)UK_#F?J6CX1/=DFWS=>ZL5TF:Q5,"B$U4
M
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MY7JKL/(WUU>6%G9SW$]U5_0^]477R9:>([>BWSMA%11Q517571__ %+/4?\
MJU[#X_VSQE-.+\@P_0W6E=(IOMI2M:WM:(BO^D[::=E9UO-]KGO,Z36(AM]P
MWBW\OY[!Y1MH_P!&WU.S)I'[N;%$1$S.D1_$QZ:1UG7'>9G28B+.*LQ'8
M
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M)B=)B8GK$Q/28GK$M VK:EIK:)BT3I,3\8G\I?L_#^
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MK%D'B7C6S\1\>VW [*([,-/FM^.3);KDR3KU^:TS,1_=KI6-*UB(U=;/9&
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MF?..6MR7)VFN")TQ8:S/T\5/PB(Z:VG^_>8[K3^58K6N[S23#@
M
M                            '-W^[_RWK\L//GLZO#96:^ZWZ,FGZ*Z^
MCCO+>ZQ,]&D93(0[GLF,YL>>;"ZAV?>9K^:"]IJEDNL;'9\<R<QQQ41^CG[)
M/4M?5/H7C(WF**>1\Y$<GNYFLUR1.YI2=OAOW?-6<.VC%6V.8K%,TYM*Q:U[
M6G_Z=\7CQCPC;1FK%>0WL1N<O28M'U*Q].DZ]8[,?;$UZ16\WZ:S,S$*ETVF
M          W8^NKQ:E\R_,WHCH&YM+RXU39]P@R_94UG)=VE=GU?J$$VT[_S
MQE;2&;G#7F3US$SX^PN:^.*.,G>6U'YYJKIIYTK]Q'M&OIOTUSOGV.]*\KM=
MG./9Q:*V[M[N)C!M?DM,?4K3-DKERTCK]''DM\*S,8AY[Y)'B7B6]YRLQ&ZQ
MXIKBUTG7->>S%\L_O1%[1:T?YE;3\(EU)+>WM[.W@M+2"&UM;6&*WMK:WBH@
MM[>W@HIBA@@ABIICAAACIXIIIIXXIIIXXXXX_#R\Y,F3-DMERVFV6TS-K3,S
M,S,ZS,S/69F>LS/695NVM:]IM:9FTSK,S\9G\Y?L_#^
M
M                                                          .8
MC]J_B3=^&/G#W-U1;8;](T'-YBOLWI_F&*.'&W?5^^7=[D<';XFB*VLJ.+/5
M,I#?8"3BF&BBFZQ$U-'KHXIDK]-GVK^V<7N7TAPWE>3-];GL&']%R&LS-Z[W
M:UK3+.29M:>[/2<6ZC6TS--Q2;:6F:Q8MZT\HKY;X;M.3M?OWU*?1S_G&;'$
M1:;=9ZWKVY8ZSTO&NDZQ$=:0[/          $@7U>^6UQX6>;72W<UU>0VNC
M7&>BZ_[;IN>*^;7GJO>Y[;"[7DI>((9;J2;4:9(<];1Q<T<S7F*ABKJ]JN2F
MK0'W/>IL?NCTIS7AN*DVYRN"=UL.W3N_7;6)R8*1K,5B-QI;:WFVO;CSWM$=
MT5F,']C^+U\N\/WG$UB9WL4^K@T^/UL<3:D?E\_7',S\*WF8ZQ#I]6]Q;WEO
M!=VD\-U:W4,5Q;7-O+1/;W%O/13+#/!-%55'-#-'5Q5353SS353SQSQS^'F.
MR8\F');%EK-<M9F+5F)B8F)TF)B>L3$])B>L2KFM6U+36T3%HG28GXQ/Y2_9
M^'\
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MTPVG2F:FML.32-?DOI'7_:VBMX^,UT;L-*L/
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MO\UM;6G_ )%:Q\*UK'2M8TBL1$1&C+3$W5@
M                  - _.#[+/%/P$UGG(=U;O\ .WO(6==SJ?3FE1P9_LS:
MJN*X::)*,3Q<6]AK.'],W,G.1S-SC[*NB*2B"2:X]%O7OSTC]MGM3WWR?Z?P
MO8_3X+'?3/R&YF<6SP?'I.32;9LG33Z.WIER1-JVO6F/NR5SCP[U[Y-YON.S
MB,/;LJSI?/D^7#3_ );29O;\.S'%K=8F8BNMHHP_89]Q7E#Y_P!W=ZQD[O\
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MF=;3,SG)@[I@
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M=GXEMYUI@C]1FZQ,?4O$TQ5G\8M2G?:?PFN6OY+8JJ-&,
M
M
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M8*QTT0']S^*?ZL>:9LNWIV<7O_X^+3X1:W^-2/A$=N768K'2M+TA,RALU*
M
M                                         \3V/UMH7;^C;-UGVAJ.
M!WS0=QQM>(V;4]FQ\&4PV7L:Y(YZ([FUN*:J>)K6Z@CGMYJ.:9K:YBCFBKHE
MCHKI[OQSR3GO$.<VWDOC&[S[#G]GDC)ASX;S3)CMI,:UM'X6K,UO6=:WI:U+
MQ-;3$\SC^0WO%;S'R/&Y;X-]BMW4O29BU9_9,?G&L3'PF)F)B8F843_MB^B_
ML'Q"EVKO[QIM\QV9XO1?J6Q;)@_QQ=[QT'C?EP<<V69]Z_N,IO.AV4=US7#F
MX8JKK'VD,G&5HIHM^<E=WG_:C]\GC_MVNU\!]DVP\9[/GLPX<O[NVY2_;/S8
M]*Q3;;JTUTMMK6BF7):OZ6TSD_38IG^L?<VQ\JC%P?D,TV_D?2M+?#'N9TGK
M7I$8\DZ=<<SI:TQ]*=;?3K7C6$M[@                /8:!V#O756XX'L+
MK/<-DT'>M6O.;_7=NU',W^ V'#7=<$UI++C\KC)[>\M_D6=S)!+337Z9H):X
MZ^*J*ZJ>>HY_Q_@O*N'S^/>2[/;;_@]U3LS;?<8ZY<62NL6B+TO$UG2T1:LS
M&M;5K:LQ:(F.+OMCLN3VE]AR.+'GV62-+TO6+5M&NO6LZQ.DQ$Q^4Q$QUA;%
M^OC]RA+:1:_U9Y_X;WK>'V<;;>2>CX:[FNXK2&TCHCN^T>NL):7MQE+RJXCK
MYFR>N04554UQT?I-5=,MQ)5']P/]-RN6VX\I]!9M,DZWGA]SDK%9M-IUKLMW
MDM6*5TF.W#N[3$3%I_5Q$UQUC'YU]OL6G)R7@]]+3UG:9+1IKK\,.6TQ$1I\
M*99_.?JZ:5BVOUWV5U[VYJ.)W[JW=]5[#TG.P^_B-JTS.XW8\#D*.../73;Y
M/%7-U:U305<^F6/FKB2*OCFFNFFKCGA4UY#XWY!XERV7@?*-ENN.YK!.F3!N
M,5\.6D_AK2\5MI/QB=-+1UB9CJB_O^/W_%[JVQY+#EP;RDZ6IDK-+1_;%HB?
M[)^$_@]LZ1PP                           '/+_<5=DWV\_9SV#K%W[W
MQ^FNL>H>ML7[L=G11Q8Y34H>WY/CU6L,4\T/ZGVK<_FJYJDFXD]5/%7$5,5%
M'H0_IW^-X.#^V7C^3PZ?4YGD]_O+Z3:9[J9YX^->Z9B)[-C3I2(KII,QWS:9
MG;Z%X^FR]=8-S73NW>YSY9^/QB_T.NO[,,?#2--/QUF8,4XVY0
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M-KWM,S:UIG69F9ZS,R](ZUQP
M
M   %$G]RCY?_ -W/*/5O%W5\G9W>E^->'^9M%5C)[]-YVWOEAC\EE[6YN:8^
M()OZ3U2G'6O%$==?-M>W-]#+SQ+35''>E_3<]0_ZI>K]U[0Y3%>G->29NW!W
M1IV[#:WO3':(UUCZ^?ZU]9B._'3!>NM)BUIH_;[XK_*_&\GDFYK,;OD+Z4UZ
M:8,<S%9B/C\]^ZVLQ&M8I,=)B9K9K(4@0         'JM%TO8^R-WT[KO3\=
M-E]MWW:M>TO5L3;QRRW&4V/:<O9X/"8Z"*".:>6:]R=]%%331177555QQQQS
MS_!U?.\UQWC?";SR+F,D8>)V&UR[G/DF8B*8<&.V7)>9F8B(K2MIF9F(TCK,
M.-O=YM^/V>7?[NT4VN#%;)>T_"*4K-K3.O3I$3+JP>+W0VL^+_CST[X_:CQZ
ML+U3H>"U3B\YKKDES&6M;7B?9-BN:JZ(N/F;-L=Q=Y";BB.**F6YJXCCCHXI
MHI\K?L_SSD_9_L+F//\ E_\ AO*[_+G[=-(QX[6TPX8ZS\N'#&/%76;6[:1W
M6M;6TUH>1\WN/(^>W?.;K_&W.>U]/\VLS\E8_92D5K'69TCK,SU9X8(Z4
M
M
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M3K-L58CXRZ(#STH(
M
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MODGCEK;W@^[DN(UF?DK_ !\<?&(OCC7OTCIWXM==)M:F.-(3_H"-'@
M                    .9']P5Q<77V9>8TMS/-<24]MW5O3)/+7-73;V>"P
MEI:04UR555<0VMK!1%'3_M:(Z*::>.....'IC^T''CQ?;3X=7%6*UGB:SI$1
M$:VRY+6GI^-K3-IGXS,S,]96)>JJUKZ\XF*Q$1^EB>GYS:TS/^6>L_M1LI(-
M@          )5OIS\'+CSC\S]'UO8\#-D^DNJIK3M+N^YGLZYL+>:U@;R.7
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M,5->F/''X5C_ &;3K:TS:9EM0U8QH
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M5I$M_&O$O'O$=G&RX';4PTT^:W[V3)/QUR9)UM;K\(F>VOPK%:Q$1JZV>R,
M               !][5]5V?>-CPFGZ5KF>W#;=ER5IAM<U;5\/D-@V//YB_E
MI@L<5A,)B;>[R>5R5Y/7Q1%!!%)+)7SQQ33SRX/*<IQG!\=GYCFMS@V?$[;'
M;)FSY\E,6'%CK&MKY,F2:TI2L=;6M:*Q'69?'<[G;;/;WW>\R4Q;7'6;7O>T
M5I6L=9M:UIB*Q'XS,Q$+JOU1?0#K'3_& \@O.7"8'?.U.8;?)Z9T-<\8_9.N
M] CR&,AE^;V9:7N-FQ^Z=A8VXN*XH[**2?!XN2/F;BN_N*K>6QI<^ZO[^N3\
MOG<>O_1^?/L/%M9IN.4KWX=WNII>8[=G:MXOM]I>(BTY+17<YXF*3&#'&2F>
M(?LWWAN>5^IP7AM[X>,UF,FYC6F7+I/PPS$ZX\4Q&LVF(R7B=-*5[HO:/5>H
MW@
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M)UCNO].D1/2]9R1^$KYRB%"D
M
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M>&^6;KA:Z_HHM]3!,SKKAR=:1,_&9IUQVF=-;4F8C28;[M#,)
M
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M^O/O.>2\\YN>3WD?3VF.)I@PQ.M<>/77_ELEOCDOI$VF(B-*UI6N_C0;!P
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M,%;3\^DQ,7SSKIDOK$36-(I3IVQW=U[2ZHD-6@
M
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MF2_?>--/EFL3UC5*BBTUJ
M
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M+Q.O*>.X_)MM29WW'VB+S$=9P9)B)U_&?IWFMH^/;6V29Z:S%[!1@A>
M
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MGA=YGF=M,['72,^/6^"WX1\\1$TF9^%<M:7GXQ73JW]:#8.
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M;C8\MY;'IRVZI_!K:L:XL,_WXUZQ?-$ZZ])C'I']^T*S:RU(8
M!Z33M.VOL+:]=T;1M=S&V[EMN8L-?UC6-?L+C*9O.YO*7$=IC\7B\?:1RW%W
M>7=Q+311113SSSSRZ[F.8XKQ_BMQSG.;C#M.'VF&V7-FRVBF/%CI$VO>][3$
M5K6(F9F9<?=[O;;#;9-[O<E,6TQ4FU[VF(K6L1K,S,](B(=%?Z@/JZUCZ\^G
M*L_M<4.;\F^W,#@+KMW89>,?=1:7;Q1_J4/4NG7=E/?V]&!U_(77/ZE>6]Q7
M3GLC;T7-?/QX+"&U\[OW>?=!R?W">8QL.*F<'K/B,^6NPQ1WUG<3,]D[_<5M
M%9G+EI7^#CO2)VN&\XXCZF3/?+ OVI[(W/G?+?0VTS3QW:WM&"O6/J3\/KY(
MG2>ZT1\E9C^'29K'S6O-IAT/VJ0
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M=[R$1R/+1'[V6E?I4GXZX\,]T1,3\+7F]HGK7ME!BG&W*
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MDOD_->6\G;E><S3EW$ZQ6/A3'769BF.O]VD:SI'69^-IFTS,[(-<,?
M
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MWF&T1R.>/H8-?CWY-8FT?MQX^_)&L:=U8B>DNE\\U:O0
M
M
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MTB8F(K7\M\>W'BOD6[X'<Q.NWRS%9G^]CGYL=_A$?-2:STB.LS'31LXUDQT
M
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M
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MX#:W[MAQU)K:(^$[B_7)/[>RL4I&L:UM&2(_>E8I5X-"@
M
M
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M2IB1&
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MX/R_C8Y/@L\9<'2+5GIDQV_S,E)ZUM'^6MH^:EK5F+3K&V8R(
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M)8?;9P]8VW)>07B>ZUZ;>DZ=(BL?4R==>NO=BUC2--(ZSKTJ.+:TH@
M     %J']O[]4G]TL_@O.KR#UOW.M=0S%5WX^:AE./Q'O.[8"]JAK['S.-N;
M"2.ZT_3\I#53B>*9J*KO-VM4M=/Q[3BFZJU^_P ^ZK_5?89_1GK[<Z>2;O#V
M\KN*?';;;+76-GCO%HFNXW%)B<^M9C'MKQ6)^IEF<4:_>/LS^6X+^&<%D_[X
M9::;J\?[WCM'^%68GIDO'[_3Y<<Z1\UOENPJ5D00
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MQ8JQ7%6(BM8B(B(B-(B(CI$1'2(CI$-T5K6E8K6(BL1I$1\(C\H?B_;^@
M               -KO$+PH\B?./LGGK+QZT>;9,A80V][M6S9*:K$Z-HF*NJ
MIZ+?*;EL\L,MKB8;NJUEXMK>FF:^OJH9*;6":NBJGC57MWW3Z\]'^-_ZS>P=
M]&VV^2TUP8:1]3<[J]=-:;?#$Q;)->ZO?:9KBQ1:LY<E(M$SC/E/E_ ^&\?_
M #'G<T8\=IF*4CYLF2T::QCI\;::QK/2M=8[K1$POL_6_P#3AXX_7[C+?:Y*
M(>Z/(>\A_P!]^X]LPEE!1KW%7/'^]/5FLR5Y&/1\;1'3QQ-=\W%WE[V2J3F2
MZHMJXK."AO[C?O$]C>_]S;BJS/#>O:6_A\?@R6F<O_/-]FB*3N;Z_NX^RF#'
M$5[<4Y(MFR0F\_\ ;'/^<Y)VL:[3@8GY<%+3/=_MLU^GU)_*NE:5C32LVB;V
ME[1%:L
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MW67?;R\Y-WFR6O>T_&U[S-K6G]LVF9G^UZ1UKC@
M
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MTC]V+Z1DK7\*7K#0]O9F@         #)'3W;&[=$]J]>=S=<9/\ 1]ZZPW#
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MU[;1KU9X8(Z4
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M?(+:1$:S]#-.FL_3M:9FEIF)_AY)_&L4R9+3,1 .GPW>
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M;WO:?QM>TS:T_C,S*!&?/FW6>^YW%ION,EYM:T]9M:TZVF9_.9F9E]APWR
M                                  ?QY'(X_$8^^RV6OK/%XK%V=SD<
MGD\C<P66/QV/LH*[F\OKZ\N:XK:TL[2VBJDEEDJIHCHIYJJYXXXYY?;;[?<;
MO<4VFTI?+NLMZTI2E9M>][3$5K6L1,VM:9B*UB)F9F(B-7[QX[Y;UQ8JS;+:
M8B(B-9F9Z1$1'69F>D1'Q05>7G[A/P>\<?F8#JK)7GE9V!;_ #HN,;U7D[2S
MZZL[NT^1%#1E>V;VTO\ "W-G>W,/'%%Q@K7/4^U5[GX_'HXKG-ZC_I]^[_8W
M9O\ RK'3Q7@+=L]^^I:V[M6VDSV;"MJY*VK6>M-U?:SW1VZZZS7<_BWHKS+G
M],_)UCC-C.G7-$SEF)T_=PQ,6B8C\,EL?7I^>E4SS'^Z[SJ\Q;?-:ME^P(>G
MNJ<M-<QU]8]-4WVJ6-]B9:*;>/&;3M=5[=;GM<,UM1^;N">^CQMS-775Q9Q4
M>W%':GZ=^RST9Z>R8>4VG'SS'E6*(G];R/;GM7)$ZS?!@[:[?!,3/\.U<<YJ
M5BL3FM;NM:3'B?J#PSQ2U-SBP3N^3K$?QL^EYBWQUI32,=.O[LQ6;Q&D=\SK
M,Q(I:-H                     +$7UM?0#W?Y0UZ_VQY/TY[H+H::;'Y.S
MUZZL_A=O]G86XMZ;R.3 XK(0RQZ/@;Z.NCCC)92"JXDHJ]5M9RQU4STUY_<A
M]_7A/K"NX\4]8S@Y_P \BMZ6RUMW;#99(GMF,MZ3$[G+68G^#AM%(F-,F:MH
MG'.A_8'O#A_'(R<9XYV;[FXB8FT3K@PVB=/FF/\ $M'7Y*3I']Z\3\J\!T7T
M!TQXS==8CJ;H;KK6^L>O\)^)+7 :Y:UT?+ON;6TLI\UGLK>2W>;VC9+ZUL(:
M;K*9*YN\C=^U3S--)SQQRI'\Y\^\R]E^19O+/.^1W/)\_GZ6RYK1/;7NM:,>
M*E8KCPX:VM::8<-,>+'W3%*5B4.N:YSE_(M_?E.;W&3<[Z_QM>?A&LSVUK&E
M:4B9G2E(K6NLZ1#,#$'5
M
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MON-MX;M+?PJ1&XSZ3\;3K&+'.G6.VO=DM$])[\=OC5;=5+HO
M
M
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MQUUF-(BXFI]12
M
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M2\?3D^$STS[2\?&L]:S_ )MZS\U+1^-;1$_Y&#6<.Y
M   ;O>*?V->97A?<6T/0O=^U8+4H)KR>7K'/7/.V]5W,V1KXER%SQH.P<WN
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M>NM9GX3";_V][FN?P&V*(F)P[_-2?VS-<636/\F2(_MB5?58 WF
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M_*^9S<WRUYMN<MITC6>W'36>W'2)^%*1.D1\9ZVM,VM:9V*:[="
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MNL?4M69BE9B(_AXY_&T7R9*S$1/R@.T@
M
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MC16ESW,;KR#F=SS>]F9W.YS6O/772)GY:Q.D=*5TK7I'2(Z,S,-=2
M
M
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M_M;1I:L_C68EF!B#J@
M
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M<EL66LURUF8M68F)B8G28F)ZQ,3TF)ZQ+55JVI::VB8M$Z3$_&)_*7[/P_@
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M!2=8[Y_O9K1/7NO\*Q.G92*QI%IO-I>T16K
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M8_S:5CY:5C\*UB(_RLY,'=,
M
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MD]+HU_<1Y9^CXO!X?MI_C;O3-F_9AI?^'7_E\M)M^SZ7[5V%2LB"
M
M
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M..TS_P [A<!5"HK
M
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M'8_KN"SQDB/WZ3\N7'/Y7IKK'[)C6MO[MI:EML,G
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MDVNVW\U5I;]?]ASS=9;S<7U%O3=R6.)P6[Q86K:)H[6KW.:\/)D(?31)_/\
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M8-O,_&T1-LD_AI.6\VR3'Y1-IB-9_.==5VTF2@
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MU
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M7[K38UX!XCM_"O%]OPN/2=SI]3/;_/S7B.^>FG2ND8Z?CV4KKK.LSHJWFS,
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M[F*ORXZ=.FL4B.Z8Z6O-K?&TMM&IF+@
M
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M+1^"RC@^8V?D'#[;FMA.NTW.*MZ_G&L=:S_MJSK6T?A:)AA]E[M0
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MNN!W_P#PG;99I,Z:1:OQI>(^/;DI-;UUZ]MHUZL\,$=*
M
M                                    Q[VGU-UEWAHV<ZS[@T/5>R=!
MV.&B',ZGN6%LL[AKSF"2F>SNN+6^BEIMLEC;JBF>TNX>8[JSN8Z)H9(Y:*:^
M,@\6\L\F\(YS!Y+XAO\ =<;S^VF9QY]ODMBR5UC2U>ZLQW4O69KDQVUIDI,T
MO6U9F)Y_&\IR/#;RG(\5GR[??8Y^6^.TUM'YQK'QB8Z6K.L6B9B8F)F%1#[
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ML,%=U733+>/JY=8_O1DR=UJ3,]9BG;&NFD1$1$:'M[,T
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M]R6;+GWEYUM?):;VG^V;3,_V1\(_![9TCA@
M
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M\P_D_CU/&MG;3?\ (Z]^GQKMZS\W]GU+:4C\ZQDA?"43H6
M
M
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M3]R\SCM/6TQ?'\*TF8N?*:$20
M
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M\=B/Y)L=MM[Q_>K2/J3TF.N2=;STF8ZVGI,_G+6-LQD0
M         ">#P%^@ORL\M?Z=W_N""\\9>BLG_K_&;W+"SU]I;7BZ/<Y@JT[K
M2]DQM]8V>7JCIXAR>:DL+;XDU-[:0Y&+T12P3]]_?KZK]3?J. \0M3R;SG%\
MOT]ODC]%@O.FOZC>5B];6QZSW8=M&6_?6<.6^WMK:FEO-_=WC/B_U-CQ4QR/
M-5Z=N.T?1I/_ #S+&L3-?QICBT]T32TXYUF+J'AK]?GBWX(:C7K7C[U[#BLS
MDL;8X[;NRMBGCSW9N]_!XIKXGVC:*[>UIIAGNN.;CG'XZWQ^(AGJYJ@M(O\
M1Q2_[C]_^T?>O+1R7L#D)R[/'DM?;[/#$XMEM>[\,.#6W6*_+]7-?+GM6-+Y
MKHB>6><^2>:[K]1SF>;8JVF:8J?+AQZ_A2FL_AT[K3:\Q\;2W2:88B
M
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M%C?@GBV'P[Q?:\'32=Q2G=FM'][-?KDG7\8B?EK_ +2M8_!I.W4R\
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MM:W6?C.]31C"P
M
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M;G@MY$]^'),5M,:?4QSUQY(_9:ND]/A.M?C$MG&LF.@
M
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M7RFM]M;/&SXV\36<6WUIW5G\+Y)F<EM8^6T1:M+1K'9$3,)@40FJ@
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M-DTBV36)TFL13',:?P]=9F8U#QJ@
M
M                   !6"_<G>=5IUETEK_A1H6<]'87>7P-J[8IL:Y:;C7>
MF<%D^9\5A[FXHIAYM;SLC<L713QQ%+75SBL/?0747$-]#5)9S_3>]&9?)O-M
MQ[IY[!KX]P?=@V/=$:9N1RTTODK$Z]U=GM[S/S5B/K[C!?%:;X+Q61GV^^%V
MY'F+^7[ZG^@;+6F'7X7W%HTM:(_&,6.?QC]_)2U9UI.E'I=TF,
M L(?MVO"3_,3Y;R^0VYXCY75OBG^E;98?+@]5EGNZ\K5<_VTL(?<XC]_^C/@
MW6QR2V\E4EED,?C*9:.8KOC\U^?U#?=G_%YZECU[PV;L\H\J[\%NV?FQ<;3M
M_67G373]1W4V<5O&F3%EW,TGNP]-%^^?,/Y#XO' [2^G)<GW4G2>M=O73ZL_
M_'-8Q1$QI:MLFDZT7\E!Z$(
M
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M*MS'"X_*]C6)WW'UFN6/QOMYG77\=?HWF;1'2.R^6TS\L1-Z11LAD
M
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ML58KBK$16L1$1$1&D1$1TB(CI$1TB&8UK6E8K6(BL1I$1\(C\H?B_;^@
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M3,S:TS,S,S,SJT1DR7RWMERVFV6TS,S,ZS,SUF9F>LS,]9F?B_L?%^
M
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MW/,Q,_H8GZ>")_NX*3,4Z3UB;S-LMH_"][1'31OZT&P<
M
M
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MBN3V?-<9@Y;C[=^RW.*N2D_CVVB)B)C\+1\+5^-;1,3UAC=D;G@
M/L:]L&;U//X/:M:REYA-CUG,8S8-?S6.FJM\AB,WAKV#(XK*6-Q1_-!>6%_;
M1RQ5\?QIKHXY_P!AQ.0X_9<ML,_%<EBIGX[<X;XLN.\:TR8\E9I>EH_&MZS-
M;1^,3,/EGP8=U@OMMQ6+[?)2:VK/6+5M&EHF/RF)F)=//ZT?,_&>>/B!UIWO
M_O;:[S[-QH_<6"Q?',=IKW;&IPVD.S06]K5+<U8_&[%:W=IG<=;533R6^+R]
MM'+)5+37R\R'W*>F=SZ)]O<EX+_$MP>L;GC\M^MLNQSS:<,S;2O??#:N3:YK
MQ6L7SX,MJUBLU5T>P_$<GA7E6XX7YIV6L9,%I^-L-]>R9GIK-9BV.TZ1$WI:
M8B(T;[M#,)
M
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MU[?FIAQUMK3]V9O%>ZUJ_&+3,VUF9UUF9:WMC._
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M1'=:TST^*/VZW>ZWVXOO-]ER9MWDG6U[VF][3^=K6F;3/[9F7I'6N.
M
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MTY+D^ZDZ3UKMZZ?5G_XYK&*(F-+5MDTG6B_DH/0A
M
M
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MM3MCK9T-'GO02
M
M            >)[$ZUZ][<U'+:#VEI&J]AZ3G8?8R^J[G@L;L>!R%'''/HJN
M,9E;:ZM:IH*N?5%)Q3Q)%7QQ51535QQR[OQ[R3R#Q+EL7/>+[W=<=S6"=<>?
M;Y;X<M)_'2])K;2?A,:Z6CI,3'1S-AR&_P"+W5=]QN;+@WE)UK?'::6C^R:S
M$_VQ\)_%6@\S/VS/478-WD=Q\,NQ/[)9VZ^5<U=6]B29K:NKY[NN*6NWAPFT
M0<9/>M-LZ[KT\2\31;!3315S[,<=-%,=5E7IO^I;Y=X_BQ\/[EX[^=[&O;'Z
MW:1CP;V*ZQ$SDP3V;;<6[=>WMMM9F8^>UIF;1(7Q+[A^5V-:[3RW!^LPQI'U
ML7;3-$?CW4G3'DG3X:3B_;,ZZJHWE7X,^4_A5LU.N>1?4.R:/;WEY+9Z]N<<
M4><ZZVZNBB2>CC5]]PM=[K.4O*K*/BXDL/D49.SBKI^5;05\\T<6K>J_>/JW
MW3QD\CZ[Y?;;[)2D6R[>9G%N]OKI'\?:Y(KFI7NGLC+V3AR6B?I9,D=4FO&?
M,_&O+]O^HX#=8\UHC6V/]W+3\/GQVTO$:](MI-+3^[:T=6I;;#)P
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M#'&'!6M,58TBM8B(B/RB(Z0^:Y+Z
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M/3XH_;K=[K?;B^\WV7)FW>2=;7O:;WM/YVM:9M,_MF9>D=:XX
M
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MN>9B9_0Q/T\$3_=P4F8ITGK$WF;9;1^%[VB.FC?UH-@X
M
M
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M@)[@\)_U.\IM?:4BO";[NRX.V-*TZQ]3#$=(CZ=IB:Q'2,=\?776(F-0\:H
M
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M:O\ RDS,7TZ:VQ6R4B9B.[7HC];_ &<
M
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MMK6F;6M,_&9M.LS/[9E]APWR
M
M                     49_W'?G_7W'W5B_"[K?,S5]:]!9+]6[6FM>;?BS
MVSN^YM)((\5S-'7<2W&-ZMP%[7:<?BNW_.9R.0BGAKYLK29>'_3G]!5\/\+R
M^Y_(\-8\DY_']/8Q;7NP<;%HF;Z3I$7WN6L9/A?_ $?#M[4O7ZV6B97H'P>.
M)XBWEW(4C^8;ZO;AUUUIMXG][\-)S6CN_'^'3',3'?:%959@D0
M L@?MP_"3^]_DQF?*C=<1\GKGQG]C^DOEP>NRSG=>>M)?T'V?<IYBN/Z!P5<
MN5D]//$EMD)\9)Q_#E7)_49]U_ZD>M</JWA<W;Y%Y+K]?MGYL?&XK1]773K'
MZK+VX(_"^*NYK^#0'O[S#^3^/4\:V=M-_P CKWZ?&NWK/S?V?4MI2/SK&2%\
M)1.A8
M
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MF(F%=N7%EV^6V#/6U,]+36U;1,6K:)TFMHG28F)C28GK$])?2<9\P
M
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M1,3$Q,:Q,3'28F.L3'28;>K:MZQ:LQ-9C6)CX3'YP_%^W]
M
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M7?I]+!\MIC\KYO\ %MK$Z6B)I2T?&B9E#9J4
M
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MZ3>;6B(B=(W&:>8F
M
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MC<5_B39>E*[^SMN<%)7-=32W68ZWSN4XMJ/13%'^B7=E%''^;.>6NC_^HOZ
M_P!3_,,?NKQS'IX[SV:,>^I'PP\EVVM]6(BL17'O,5.^=9M/ZG'GM:W\:E8A
MO[]\&_E7+5\OX^NFPWM^W-$?W-QI,]WPZ5RUC7\9^I6\S/SUB+.*LQ'4
M
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M>0<)Y%MOUG![K!NMO&FLX[1::S,:Q%Z_O4MIU[;Q6W[&$V:NW
M
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MPQ$
M
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MK.O^TI-9C2Z[HI-0]
M
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M[6])K>O^UM#-C"G3@
M
M                     /'[WUYH':6LW^E=FZ-I_8VFY7V_U34M[UG"[?K.
M2]FOW(?GX'8++(8J\]JOCU4^Y%5Z>?X\.XX+R'G_ !?D\?->,[[><=S&+7LS
M[7-DV^:FO2>W+BM2]=8^.EHU<O9;_?<;N*[SCLV7;[NOPOCO:EX_LM68F/\
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MQ.C;&/)3+2N7%:+8K1$Q,3K$Q/6)B8Z3$QUB8^+^-]GZ
M
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MXM+;S>[SD-Q;=[_+ES[J\ZVODM:]YGXZS:TS,]?SEZIU3C
M
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M^6E(BL3\9TUG6TS,["-?.B
M
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MW:K&?7WEV'S7Q?!S==*[KKCS4C^YFIIW1^R+1-<E8_"EZZ]=6A[>S-
M     %G']N-]@?\ 9[N*_P#"CL?(^UUSWUF)\WU7D;BO\QZUW7186=MS@I*Y
MKJ&*UP_9&"Q?%M1Z:99/UNTLHHX^.+R>6BLS^HOZ _UP\/Q^ZO',>OD7 X8Q
M[ZD?'-QO=:WU8B*S-LFSRW[YUFL?ILF>UK?P:5F.WOWP;^:\37R_CZZ[_94[
M<T1_?V^LSW?#K;%:=?PCZ=KS,_)6)O(J/T-@
M
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MXJ[NW^]9I^EEUTUFL5OI%YB/C].;QTG2>DZ1UI#L\
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M_G=]N-S&LS%;6TQQ,]9[<5=,=?P_=K'PC\H;.-9,=
M
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MW#>:UO?%X1L;3\DUS;F8^&LQKAQ3^/2)^K:)C3KBF)F=8BW>J.1:
M
M
M                            08??;X(7'EUXC7/96BXN&[[E\8X=B['U
M^..*NK([-UW3BOE]F:794P0S7%[DI\?B+?)XZ"FFN2>]QO%M%QQ5=<\\SC^P
MWWKC]1^VZ^-\[EFGAODTX=GEF9CLP[OO[=GN;:S$5I%\E\.6TS$5QYIRWG3%
M#<WI/S6OBWE,<?O;3'$\C-,5ORIE[M,.2=>D1$VFEI^$5OW3TJYYCT()V
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M^]CF9F9FV*T]DS,ZVKVWG3OTB45&!K@
M
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MX;?'32/J=M;S/QB*6M.GQTF)B(TTDVP@
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M#SSR_P HFT<UO\^7!:?\.)^GB^&D?PL?;2=(Z:S69ZSK,S,S.Z33#$0
M
M
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MCH7"
M
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M-M<]]MN*S3<8[S6U9Z36U9TM$Q^<3$Q+[#AOD
M
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M\MV7\R\5Y'8<GQTZ?Q=IN,6XQ]?A\^&]Z]?PZ]6U]CR7'<IA_4<9N,&XV_\
MG8KUR5_]]29C_DO!N]<T
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MQ5[<=>L1.E:Q'2/RC3:)J]C8
M
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M2M:UUF>D0L4VFUV^QVN+8[.D8]IAQUI2L?"M*1%:UC]D5B(C^QYMV+D
M      +YO[=?P(_R^^.5QY6]@X2S@[8\G,/87FG57%K^<QJG0GO0Y+6K6FYE
M@IKM/[H7]O#L$]%O))!<XV+#UU\\3Q5QQT0_U#_?7_&![%KZJ\?SWMXIXSFO
M7<:6_AY^4TFF:VD3\WZ*LVVM9O$6IFG>176EXM:%/OGS;^>\_'C.QO,\9QUY
MC)I/RWW/PO.GX_1B9Q1K$3%YRQ'28F;&JNIH,
M
M
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MHT
M
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M;S\+4M%ZS_9:LS$_[+S;L7(
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MW$_&U[3>T_VVM,S/^R](ZUQP
M
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M9M:9F9F9G69F9ZS,SUF9ZS*O6UK7M-K3,VF=9F?C,_G+]GX?P
M
M
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M%BH
M
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M+GW,_&^2]KVG69F=;6F9^,S/Q^,S/QE[!T[B
M
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MJ
M
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MP
M
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M^1^/<G,1QN_V6XF;=L?2SXLFMM->WY+3UTF)T^.DL&LX=R
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M6(TTB>L1#.3!W3
M
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M.WE.0I/U-/C7;3W5M_T:8G''YUC)\.B^$HG0L
M
M
M                   5H/W%_P!>U'=W2MKYF]:8.:?M/Q]P,]GV=9XJRN+J
M\W'I&B[YR%QE[N.*2NFB;J*ZN;O)US4Q4_C#7=_)<R51VEM3'95_3M^X*WA/
MFEO37DN>*^+>09XMLK9+16NWY+M[(QUF8CIOZQCPQ6;3_I&/;UQUBV;)-I"^
MA/.IX?EY\2Y&\1QN^O$X9M,1&/<::16/_B\16FFO^)6D5C6UM:+B\E,T
M       !?!_;V_9%_F-Z8Y\1.V<Y\CNWQ^UNU_H/)7L?HN.PNC<?7:XG$^NZ
MHDJAN]DZOFN+;%7?JCMY+C%38Z;CY5Q1DKBBB?\ J"?;C_Q=>9?\;GB>#M\*
M\@W-OU5*SK&TY.\6R9-*S&M<.]B+YZ:3>*9Z[BD_2QSML<PL]Z^O_P"0<O\
MZT\733A]]DGZD1\,6XG6UNGX4S:3>O68B\9(^6LXZS9!5R-
M
M
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MTFE]J4WU>(M:[B2:G#8[CL36]]CEQL4=?$5-5W3=7G,=''-4]5?JKJV_PO\
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M1#$=_P YS7*3,\GO-UN9M,3/U<N3)K,1I$SWVG72(B(U^$?!EIB;JP
M
M
M                  '/C^^/[&Z_,/R)GZ2ZUST-_P"._CMGLOA,+=8Z2WGQ
MW8'9]K5/A=OWZ'(6=Q<VN8P-E5')C<#/'77!)9<37<-7-%_SQQZ!/L2^W2OI
M_P!>5\V\DP3C]A^18,>3)6\3%]KLK:9-OM9I:(MCRVUC-NJS$6C)V8KQ$X.L
MY_2O@,>*<#',<A2:\]OZ5M:)UUQ89TM3%I,1-;3TODB>L6TK/6B!E.]NL
M       !EKH?I/??(_N/KCHOJ_'PY+?.T-JQFIZ]#=R3PXZVN+^3GFZR^9N;
M:VO;BRP.!Q\<U]?W%$,M5O96\LGHJ]/IYQ/SOS7@?7/AW(^<^3Y)Q\%Q>UOG
MRS6(F]HK'RX\=;36+9<MYKCQ5FU8ODO6NL:ZNLYKF-CP'$[CFN2M-=EML4WM
MI\9B/A6L3,1-K3I6L:QK:8C7JZCWB;XT:%X?>/767CMUOQ--K77&!XQ]>7O(
M((,GL^>OKFXRNS;7EJ+?_"IR6QY^^N+N2BGFJB'B7B*CGVXZ../+Y[7]E<][
M?]@\G[#\DTKR7(Y^_P"G69FF'%6L4PX,<SU[,.*M,<3/6W;-[?-:5;WD_D.^
M\JYW<<]R&D;C<7U[8F9BE8B*TI77\*5B*Q^>FL]9EL4UVZ$
M
M
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MH:L8T
M
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M /C:.E__ '2F0?\ K!^^_P#SX\O_ /NSR/\ \DN=_KWYO_X9Y7_MO<?]4/\
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M6
M
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MHY
M
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MZ3$Q/6)B>DQ/6)0*M6U+36T3%HG28GXQ/Y2_9^'\
M
M
M
M
M
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M:U\][3:UK3,VM:9UFUIG69F9G69GK,]9?2<9\P
M
M
M                      %,C]R%]=-QK6QVOV =482'C5=FFPVI>16(Q.,K
MAXP.W3RQXK3^U;FNSBKM?TW<:I(,+E)IN+?VLO185<57,V3EYAN4_IQ_<1CY
M+CK^@O*\\_S7;1DS\1DR7U^K@B)ON-C6+3W=^WTMN,%:]_=@G/&F.FVKWRU]
M >>UW&WGP?D[S^IQQ:^UM:?WJ?O9,,:]=<?7)2(UUIW_ +L8XUJ:+7TG0
M        %X7]N_\ 9;+W1U])X1]U[/\ +[7ZHP\V3Z4SV>RMW<97L+JBRYXY
MO=-JN<E7/\_9.J_<X^+%'/Q+/K5<=,-M3%A[NXKI%_J%_;77PSR"/=GA>U[/
M%.5S13DL6*E8IM-];]W<:4B.W#OM/GM->VN\BTWRS;>8L<0Y]\>O8XC??ZX<
M1CTXS=7TW%:Q$5Q9I^&32/A3-^,S&D9==;:Y:UBSZK&1S
M
M
M
M
M
M        <]?[TOLJM_-COJ#J;J78X<MXT]$9*]M-8R..]%6.['[$JBDQVS=A
MPW<4LL>4P-M'ZL?@9:>>8Z[+B:ZCY]-]SQQZ"OL:^VS)Z5\#MY9Y9MIQ>RN=
MQUMFI?7OV>TUB^':368B:99G3+NJSUC)V8K=<&LSJ],^O;>'\)/)\ICFOD.]
MK$WB?CBQ?&F+3\+3^]DCX]VE9_<02ITMT           /L:]K^;VS/X/5=:Q
M=YF]CV;,8S7]?PN.AJN,AE\WF;V#'8K%V-O1_-/>7]_<QQ14<?QJKKXX_P!E
MQ.0Y#9<3L,_*\EEI@X[;8;Y<N2\Z4QX\=9O>]I_"M*Q-K3^$1,OEGSX=K@ON
M=Q:*;?'2;6M/2*UK&MIF?RB(F9=+?ZHO 3$?7WXK8#KS(6N-N.Y=ZFM][[TV
M.SJM;WF\W2[L(+>WU3'9B.WBN+O5=#Q]'%E8Q^NJWJNJ[R\CIHJOI>.?-;]U
M?OO>?<![3W'D.WMDKX=L8G:\9AMW5[=M6TS.>^.9F*Y]U?\ B9)TBT4C#AM,
MQ@II7K[-\WR^<^2WW^.;1Q.&)Q[>DZQICB=9O-==(ODGYK3\=.RDZQ2$F:-+
M7@
M
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M[9K,[X-$L*
M
M
M
M
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M+9QX5Q>28WF>(MNIKT[<,]:XM?C$Y9TM>(T_AQ%9UKDF)NJJ7$0P
M
M
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M[3<[#<Y-EO<=\6[Q7FMZ6B8M6T3I,3$]8F)>D=:XX
M
M
M
M
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MPG&X>)XS'&+8;?'%*5C\(C\9GXS:9UFUIUFUIFUIF9F6-V1N>
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MS<GR%YR;W/DM>]I_&UIUG^R(^$1\(B(B.D/>.A<(
M
M
M                            !1;_ '#/UM4="]J4^9/4&OPV?4'=>>JM
M>S<'A<?<46>A]OWU,UY<YZ;B*FNULL#V=53)<\<_R419FBXHY_'RK:A>3_3W
M^Y"WGGBT^G/+]Q:_E_"X.[99<EX[MUL*Z5C%&NEK9=ETI^,VV\XYZ_2R63-]
M$^P)YOC?]4^5R3/*[.FN&UIC7)@CI%?SFV'I'XZX^V?[MI5H5E20H
M    "UG^WB^T*CK_ &.R\"N]]DF_H_>\]%SXV[/FLG<20:KO.9E]J[ZADKOI
MY;>UP.^9"N.; Q0^Q3#GY9[?TSR96+X]5G]0G[8;>0<=?WQX+MJ_S?8X)_G&
M''2(G/ML<:UW\16(FV7:TUKNK6[IMM:X\FM*[6_U(S^]_7$[[;SYMPN./U6&
MG^ETK$:WQU^&?I&LVQQK&29UUQQ6VM8QSW73U+Z(H
M
M
M
M
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MOQU^I,1V?#3'6GRUM-]9C4/&J
M
M
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M=U+3IK6>WK-+2FW0H:>
M
M
M
M
M                                    4U/W$GV>UY_,9?Z^^D,_#)KV
M$FQ=SY+;1B+NWNHLQL=K=6^:Q?3EO-\"NF&'5+JUL[_-RVEW575D>:<;-Q%7
M9WT$EQW]/+[8Z[#9X?N \WV\QR&>+QPV#)6:SCPVK.._(3'=&LYZVR8MM7)C
MB(PZ[FG=7-@O667H;US&#%7SGF*3]>\3&TI:)CMK,36<\]?[\3:N.+5_<_B1
MK%Z3%2A;*E             LO?MYOK:H[Z[4J\R>W]?AO.H.E,]3:]98/-8^
MXKL]\[?L:8;RVST/$M-%K>X'K&JJ.YYY_GHES-=O1Q^?BW-"M7^H1]R%O _%
MH].>(;BU/+^:P=V]RX[QW;786UK.*=-;5R[WK3\)KMXR3T^KCLCU[V]@3PG&
M_P"J?%9)CE=Y37-:LQKCP3TFOYQ;-UC\-,?=/]ZLKTBC9#(
M
M
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M9K.M9ZQ+:AJQC0
M
M
M
M
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M)-[S\(UGX1$?A6L:5K'X5B(_!E1BSK
M
M
M                       %(S]Q%]9U?5._9#SQZ>Q,,76O:>>M;?O;7K"V
MMX*-.[8S<\E$?8%O%:QPT\X'M"Z]/.1JKHJDBV2J2>2:3G*1QV]V7]//[EJ^
M5<#C]$^89;3Y+Q>"T\9EM,S^HV..(F=K,VF?XNRKK]&(F(MLXK2M*_I;6R3"
M]#^PXY/8U\*Y6TSR&VI,[:TS,_4PUC_"G7^]AC]W\)Q:1$1].9M5P6@I(
M         )8OJ-^RG/?7=W]S?[!SDLUX]]J38?!=U:I8TPRW5I;V4US#@^Q<
M%'79W5U+GM&IRMS+S9PUPTY2SEEMJ^>)/CS011^[;[;=A]PW@/T./^GA]@\5
M&3+QV>VL5M-HB<NTRSW5K&+<]E*_4M%IP9*TR1$U^I2^L?:/K[!YYP?9@[:<
M[MHM;;WGX3,Z=V*W6([<FD1W3KV6B+1T[HMT@M5VC7-XUC7-UT_-XW9=2W#
MX?:-6V/#7<5_A\_KFP8^WRV$S>*OH*JX+S&Y7&7<4\$M'/-$D4E-7'/XY><G
ME.+Y'@^3W/"\Q@R;;EMGGR8,^')6:Y,6;%><>3'>L]:WI>MJVK/6+1,2@%N=
MMN-GN<FSW=+8]UBO:EZ6C2U;UF:VK:)^$UF)B8_"8?><!\
M
M
M
M
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MWSK\^:=>O\28CLUTTQUIK6MYOK,.A^U2
M
M
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MM2RB$
M
M
M
M
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MGI^&1=;4LHA
M
M
M       (TOM/^O?6?L.\:<KU]3+9X7N'1?U/<>BMOO.:XK3&;M3C^8I-:ST\
M5-<T>G[U#!'8Y&NFB6JTJX@O:8IY+2B&22GVM_<%R?V]>RL7D$Q?-XAONS;\
MGMZ];7VW?K&;%$Z1.XVTS.7%$S6,D=^";TKFM>NPO6OG6X\$\AKOM)OQ6;3'
MN:1\9QZ_OU_YYCUFU?AW?-29B+3,<T[<=.VOKW:]BT;>==S&I;EJ68O]?V?6
M-@L+C%YO!9O%W$EID,7E,?=QQ7%I>6EQ%517173QSQSP])W#\QQ7D'%;?G.#
MW&'=\/N\-<N'-BM%\>7'>(M2]+UF8M6T3$Q,2L(VF[VV_P!MCWNRR4R[3+2+
M4O68FMJS&L3$QTF)AYMV+D            +^_P!&?VM4>9'6T/CMWGL<-?D_
MU5@8^+',96^N)LGW=H&*IBMJ=PJFN+:B.?=M=CDAM\W%5<375_Q^,EQZN)+N
MFVH-^^+[5;>G?))]A^#;:T>L>5SSW8Z5B*<;NKZS^GTB=8VV:8M?;6[*TQ==
MM.G;BG)"#W+ZSGQ/D)Y[AL<_ZN;F_6L1&FWRVZ_3Z3TQVZSCG2(K_A_A7NL%
MJ_FC
M
M
M
M
M               %+S]P3]K5GV#>9OP+\>MCAO=,P>2M:/(O><)?6-]C]JV/
M#WT&1M>IL1<PVT_/&-T_,V$%QFKFWN::YLI%\"JFBBUN:;BYK^G_ /:KF\?P
MX/>_L';33F<^.T\1MLE;5O@PY*S2V_R5F8^?<8[6KMZ7I,5PV^O$S.7%..7'
MHSUG?8TIYKSN.8W=ZS^EQVB8FE+1,3GM&L=;UF8QQ,=*3W]9M7MJ@+64F@
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M(BO+?;[=\GO<O([^\Y-[GR6O>\Z:VM:=;3TTB-9GX1$1'PB(A[!T[B
M
M
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M#)36*WC2.NEHCMM5(JCNP(
M
M
M
M
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M]M*Q$BJ.[ @
M
M
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M\W"<O2*;[!;2=)UK,3$36U9_&MJS%JSTG2=)B+1,1G)@[I@
M
M
M
M
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MXKB]CPG&X>)XS'&+8;?'%*5C\(C\9GXS:9UFUIUFUIFUIF9F6-V1N>
M      NV_MZ/J_EZEU6R\Z.]=6^+V?OF'NH.@=?S5G=V^5T#K[,V][B\MO=Y
MC<EC[:3';)V-BIJH\=-%57Z=:N>:J:^:<E)''2C_ %!ON=KY9RM_1O@VZ[_&
M-AFK/*Y<=JSCW6[QS6^/:UO2]HOAVEXB<U;1&N\I$377;5M:'WO;V-'*;F?#
M.%RZ\=@O'ZFU9B:Y<M9B:XXF)G6F*W6\3_OL::?PXF;2JKI&X
M
M
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MTCK7'
M
M
M
M
M          83\B_(3J_Q7Z8WOOCN/._H.@]?X>O*9.6&B&?*96[DDHM<1KFO
M6,UQ:T9+9-CRL\-E86_,L=,MS-3Q77''ZI*<U]=^OO*/:7F6P\$\.P?7Y[D,
MT4I$ZQ2E8CNR9LMHBTTPX:1;)EOI,UI6=*VMI6>XX#@N2\EY?!PO$T[]]GOI
M'Y5CXVO:=)TI2-;6G2=(B=(F=(<T'S^\X.S//WR+V?O#L#G]+P]'OZWU;HT-
M<4EEUYUG997(WVNZQQ<PPP?J^8X_49+C)Y&NBFN^R$\M=%$%OQ!;0>E3T%Z1
M\:]!^N]KX1X__%WDZ9M[N9UBV[WEJ4KFS=LS/T\?R13#AB9C%BK6)F^3ZF2]
MA?@_AW'>#\#CX;8_-EZ7S9/QRYIK$6OIU[:](BE?[M8B)F;=UITG;J9>
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M3,S,S,ZS,S/69F>LS/6903M:U[3:TS-IG69GXS/YR_9^'\
M
M
M                                               0V?<I]9>'\_>A
M9MAT7&XVR\F^H<;>97JW.51VME)N6'CE^=FNJ]BR<>,O<A=XW+V_-Q-A:.:X
MXK/.5T5\R16]Q><US&^SG[E]YZ#\\CC^<R9+^L^7R5IO<6MK1M\DQVX]]AI-
MZTK?'/97<3I-LFVBT16V3'A[=L^IO8F7P?FXP;VUI\=W5HKFKUGZ=OA7-6-8
MB)K.D9/C-L>L:3:M-.=%F<-F-<S&5U[8<5DL%G\%DK[#9S!YFQNL7F,-F,7=
M2V.3Q65QE]%!>X[)8Z]@KAG@FHHEAEHJHKIXJXYX>B39[S9\CL\7(<?EQY]A
MGQUR8LN.U;X\F.]8M2]+UF:WI>LQ:MJS-;5F)B9B4]<67%N,5<^"U;X+UBU;
M5F)K:LQK%JS&L3$Q.L3'28ZP^:Y+Z            +,OT/\ VWS^/6UXGP\\
MC=IO)NBMZS%I9=1[GL&9Q\&'Z.VS(W%Y7=8?*7N6YMZK'K?=+Z[CYKJYNN+;
M"Y*GWZ8.(KV]GBK2^^S[2Z>P>*R^X/76UI'G.QPVMO\ ;XL=YR<G@I%8KDI7
M'KW;S;5K.D=G?N,,]DWFV'#2T>?=7JZO.[:WE? 8XCFL-)G/CK69MN*1$:6B
M*ZZY<<1/X:Y*=-=:4K-YU1RAF
M
M
M
M
M                             ^/L.P834\!G-JV7*6>$US6</D]@V#-9
M&:FWQ^(PF&LI\CE<I?7%?\L%G86%M)++7S_"FBCGG_8<SC^/WO+;_!Q7&XKY
M^1W.:F+%CI&M\F3):*4I6/QM>TQ6L?C,Q#ZX,&;=9Z;;;UF^XR7BM:QUFUK3
MI6(C\YF8B'.M^XS[2<W]@_<7&JZ#>WF/\5^J<Q/_ &IPMUBJL/E-PS?-A3CL
MQV?M-O/+-?<WF5JKGBQ%M-['./P]='%=O#>3WOK]#_V>_:[LOM^\/_FO/TID
M]I<KAC]=DK?ZE-OC[N_'LL$Q$5[:?+;<7KW?5W$3-<E\./#I//U1ZWP^"\5^
MIWT1;R7<TCZUHMW1CKKK7#28Z:5Z3>8U[KZZ6FE::0SID-M            -
MM/"3PZ[0\ZO(;3_'_JR'XUYF?<S6X[;<64U]A^NNOL7=64.R[UG88I;;W+/%
M_/@@MX.9H/G9*ZM;.B2B2XHJXU/[L]P^+^C/7N\\_P#*9[L.'3'M\$6BN3=[
MN];3AVV*9B=+7[;6O;MM]+#3+FFLUQS#&/,/*^-\,X++SG)3K2GRXZ1.ELN6
M8GLQU^/6=)F9TGMI%KS$Q673B\=/'OJ_Q7Z8T3H?IS!?H.@]?X>C%XR*:N&?
M*96[DDKNLOL>PWT-O:T9+9-CRL\U[?W'$4=,MS-5S11''Z8Z?,S[$]@^4>TO
M,M_YWYCG^OSW(9IO>8UBE*Q';CPXJS-IIAPTBN/%369K2L:VM;6TUV<_SO)>
M2\OGYKEK]^^SWUG\JQ\*TK&LZ4I&E:QK.D1&LS.LLV,*=.
M
M
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M
M
M
M
M
M   %'K[Z?MOA[YS>5\+_ !MVFSO^DM5S%K-VYV1JV9R%=OVMMF(JGIYT;&7%
MIS:XW*=;ZKDN:9IYN.;RVS.5MX9H*Z;>TBEN[N_L/^TN_@FRQ>YO9&UOC\UW
M6&T;#9Y\=(G8X,FG^DWBW=>F\ST^6M?X=]O@O>F2)R9K5Q3&])^KIX7#7R[R
M#%->8RTGZ&*]8UPTMI_$F)UF,MXZ1'RSCI,Q:.Z\Q6L$LX2,
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MOCGITZ=V6T?Y^28UT_NT[:=9K-K2KHKM:
M
M
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M=?P_>SS7"8[V\7S3U_O?I\EIG^':?C].W3Z=Y_&?IVGNBMKS\H#M(
M
M
M
M
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M;1,Q-,<_XG2)G)7M^%)[K4ZK)&H
M
M
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MI/?6DL:*+6(
M
M
M
M
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MB(B(B$YL6+%M\5<&"M:8*5BM:UB(K6L1I%:Q&D1$1&D1'2(Z0^:Y+Z
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M6F9F9F9UF9F>LS,]9F>LR@]:UKVFUIF;3.LS/QF?SE^S\/X
M
M
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MIM,D3?!FB-*Y,>NG_*Y*_#)369K,Q,:UM2UM_&@V#@
M
M
M
M
M                                      (M/M-^S;K;ZZ>G.;V;V=J[
M\[#QN7LNF>MX9:..9;RWCIMI][VZ7F.:G&:3K%U<QU5\54^_E;GBFTM^../D
MW-I*+[7/MG\D^XCS'Z%-=KX%QV3';D=Y,?"LSW1M<$:QW[G-6LQ&D]N"FN7)
M.OT\>79/K;UWR'GO+=D:XN$P6K.?+^R>L8Z?GDO$3^RD?-;^[6W.$[0[0[![
MI[!VSM7M7;,QO/8>\YBXSVU;5GKCBXR66R5QQ11ZJO11%;VEG:6\4=O:VMO'
M%:V=K%'!!''#'''3Z-/&/&/'_"_']IXKXKM,.Q\>V.&,6#!BC2F.D=?QUFUK
M3,VO>TVODO:V3):U[6M,_..X[8\1L<7&<9BIAV&&D5I2L:16(_Y,S,ZS,S,S
M:9FUIF9F7@W>N:            W\^N+P%[%^PKR&PW4VJ\WF T3"_$V'N#LC
MX%U<8W1=)INO3/Q%<46ES8U[AL=,,MM@[*>JBF[NJ:ZZ^:;>WN98M!_<9[[\
M=^WSU[F\LY7LW'.YN[%Q^S[ZQ?<[GMZ:Q-HM^GPZUON<E=9I28B-<F3'6V$>
M?^;[#P3@;\IN=+[V^M<&+6(G)DTZ=-8GZ=.DY+1^[&D1\UJQ/2^Z?ZDZ^Z&Z
MOT3IOJK7;/5.O.N-;QNK:K@K+CGFFUQN.AXH^1>7-?YN,GF,G<<R75_>W%4E
MU?WLTMQ/7)-+)75YJ_+_ "WR#SSR??>8^5;B^[\AY'<WSY\MO[U[SKI6(Z4Q
MTC2F+'6(IBQUICQUK2M:Q7IRO*;[F^2S<MR>2<N_W&2;WM/XS/X1'PBL1I%:
MQI%:Q%:Q$1$,D,<=>
M
M
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M9*6K%>_E?BG,>&\Q?A^8IVY:]:7C7LRTUZ9,<_C6?]FLZUM$6B8;4-6,:
M
M
M
M
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M%8F(C6T_&]M-;3/^;%8C>1H]AH
M
M
M                                    "GE^X&^IN6VEVS[ O'C ^NSK
M_.8\G]&QOR[B[CN[B[M[;GNG7\=33<>NSK^1QQM$,'MTVM,?&5YCYCYR=Q%<
M!]@/W7UR5VGH#V%GTS1_#X7<W[8K-8K,_P NRWZ:6C3_ $*UM9O,SM>Z+1ML
M=I6>C?9T6C%X-SU_G_=V>2=(C2(F?T]IZ=>G\&9UUU^EKK].LU"EN:4P
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M6EZ5K]\B\=Y;Q;ELO#<SBG'O,<_VUO6?W;TMT[J6TZ3_ &UM$6BU8S\P%T8
M
M
M
M
M                                                   #6/R_\M>H
M_";HG;._NYLA>6^L:[[&/Q6&Q%OQ>;#N6V9.B?\ 0-.UNTKKBAES&:FMZ_Q7
M-)%;6T$<MQ<21P0R24[-]0^IO+?=?G6T\!\-QTMR>XUO?)DGMQ;?!33ZNXS6
MZS&/'$QTK%KWM-<>.MKWK6<B\5\7Y3S#FL7!\36)W&36;6M.E<=(T[LEY_S:
MZ_A$S,S%:Q-IB'-?\Z?-GMCSW[^V'O3M2N'&TSPQX+1-%QMW<W>O]<Z-833R
MXG5\/+<\1R7<WN7$EU?WM4<55_D+B:?VX:*HX(O2+Z-]*>*>AO =OX-XM$Y)
MK,Y=UNKUBN7=[FT1&3/DBNL5C2(IBQQ-HQ8JTIW7M%KVL%\,\/XSPG@\?#<;
MK;2>[)DF(BV7).G=>VGP^$16NL]M8B-9F)M.G+<+*P           'TL-ALQ
ML>8Q6O:]BLEG<_G<E8X;!X/#6-UE,QF<QE+J*QQF*Q6,L8I[W(Y+(WL]$,$$
M-%<LTM=-%%/-7/'#C;S>;/CMGEY#D,N/!L,&.V3+ER6K3'CQTK-KWO>TQ6E*
M5B;6M:8K6L3,S$0^>7+BV^*V?/:M,%*S:UK3$5K6(UFUIG2(B(C69GI$=9=#
M/Z8/JNPG@?T_:]E]IX/#Y'RN[6P]I?[?E*[:FYONI]5R=GCKVWZ=P]_S=WEG
MS>8^\BYFS][8\11WV1_%OQ)<VMC:3R>>_P"\S[IM[[V\OMXUXMGS8_57%9K5
MV](G2N^STM>L\ADKVUMVWK/;M<>3NG%BUR37%ESY<=8)^V_96;S7E9X[C;WK
MXSMKS%(UTC->)F)SVC2)TF.F.MM9K7YM*VO:L3>H2M.@
M
M
M                                                       /QN+>
MWO+>>TNX(;JUNH9;>YMKB*B>WN+>>BJ*:">&6FJ.:&:.KFFJFKCFFJGGGCGC
M\/WCR9,.2N7%::Y:S$UM$S$Q,3K$Q,=8F)ZQ,=8E_:VM2T6K,Q:)UB8^,3^<
M.?W]W?U-W?A1V++WUT;@;RX\4^S<QSZ[2#VIO[*=@YBZR-U)H=Q##3Q-3H>2
MABXDU^]KXY]G^?'7%7NPVT]_?Q]DWW7XO=/CL>!^<9Z5]J<9A_>G6/YCM,=:
M5C=1,]/U5)G3=XX_>Z;C'';?+3!.+T][.KY?L(X3F;Q'DVWI\9__ "C%6(CZ
MD?\ /(^&6OX],E>DVK2 =/AN\            !)9]8/V/]@_71WM!N=C'F-L
MZ8W/XN%[HZML\CQ;Q;'A**ZN++9L#;W<G&+AWS4))JY\=-+[?%Q#7/8R30PW
M<DL<;/N<^W+Q_P"XGP6W#9YP[3S+9]V3CM[:FLX<D_O8<LUCOG:[B(BN6M=>
MRT4SUI>^*M+:]]C> ;'SWA9VE^S%R^'6VWS3&O9;\:6F.OT[_"T1KI/;>(F:
MQ$]'SHSO/JOR2ZKU#NCI?;\;N_7>[XVG)8/.8VJJGFGFFJJ&^Q>4L9J8[W#9
M[#7L==M?6-S1'<V=S'7%+1373SP\Y?G/@WE/K?RG>>&>9[/)L?(MCD[,N*_^
MS6]+1K7)BR5F+XLM)FF2DQ:LS$Q* ?,\-R7C_)9>(Y?%;#O\-M+5G_D6K/PM
M6T=:VC6+1,3$Z,M,3=6
M
M
M
M
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M#X#X#Q/@7$QL]G$9.1R1$Y\\QI;):/PCX]N.NL]E->G69F;3:TQXI"L[
M         70_H"^ICG1<9K7GCY%Z[#SN.P8VO(>.W7V=Q>3MLAH^(N^;FSI[
M8SUI?_$@JSVT8RJJO 0U6\T5KBYX\C1)S<7$'Q*9?OZ^[".=W.Y]$>N]Q;^3
M[?)%.6W>*]+4W.2O;;]#BM3NGZ6"^D;JT7K:^:MMO-8QX\GUHD>\/9_ZW)D\
M*X#)/Z3';3=9:S$QDM&D_1K,:SVTG_$G6)F\3CF.VMNZU^JF1D
M
M
M
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MP=CY[PWUZQ&/F,$5KN,6L=+3'3)3\\>329CIK68M2==(M:,%)QL8
M    !*5]7GVA]J?7+VIS<VW&2W?Q]W?)6G]W.H_ETT\7/%-,5IQO.C<W<L=E
MANPL-91TTTU551VV7MHZ;.\JIXIM;JSB[]SWVP^+?<7XM]/)]/8^P-CCM^@W
M_;^[\;?IMSVQ-LFTR6F9F(B;X+S.;#$ZY<6;6_L?UQQOGW&]MNW#SF&L_0SZ
M?#\?IY-.ML5I_MFDSWT_O5OT:NF.XNN_(+JO1NZ.IMAAVGKOL7 VVQ:MG(8+
MFTYNK&XJDAEANK&\B@O<=DL=>P2VUW;34436US#)%)3Q71SQQYU/,_#_ "'U
M_P"4[[PSRO;SM?(N.SVPY\4S%NVT:3$UM69K>EZS6]+UF:WI:MJS,3$H#<OQ
M._X+DLW$<GCG%O\ ;WFEZZQ.DQ^4QK$Q,3$UF.DQ,3'263F,NN
M
M
M
M
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MLIK;Y;3CE?"43H6
M
M
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MY$Q,:3$Q,Q:)BU9F)B7O'1.$
M
M
M
M
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M=[G?[G)O=[DOEW>6\VO>TS-K6F=9F9GK,S+TCK7'
M
M
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MQ&^R\9R>*^'?X;S6]+1I-9C_ )$Q,:3$Q,Q:)BU9F)B7O'1.$
M
M
M
M
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MLLV,*=.
M
M
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MS^5JS$]=)CX3$3$PGOLMYM>1VF/?[')7+L\U(O2]9UBU;1K$Q_;#RKM')
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MO>.B<(
M
M
M
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MI$:5C<QIMB0
M
M
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MDQ:LS$Q*!/,\-R7C_)9>(Y?%;#O\-M+5G_D6K/PM6T=:VC6+1,3$Z,M,3=6
M
M
M
M
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MJ?5.V\*VT<MRT4R^49:=9Z37;UF.N/'/PF\QTR9(^/6E)[-9O!6G,W.
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M_<;YC3?YL<[+PGCIR4X[9SI-J4O->_/N+5UB^YSQ2DWB)G'AK6N+'W:7RY8
M^R/8>_\ /^6C/>LX>'P3:-OBZ:UBVFM[S'QR7TC72>VD1%:ZZ3:TGR,;7(
M
M
M
M                    "LU]X'TTW?DU%F_+SQ>POO=_X?#PU]G]88ZWBIJ[
MIPF#M.(;?/ZQ'%1377VIA<5!1!S:5<U<9VR@BBA]-]#''?66_9']X^+UG;!Z
MC]GYM/ <V:?T6]O,_P#>[)EMK.+-,](V.2\S;OC3]+DM:]]<%[6P2'].>V:^
M.S3Q;R2^G!WO_!S3/_![6GK6_P#SFTSKK_O=IF9UI,S2C1<6]Q9W$]I=P36M
MU:S2V]S;7$5<%Q;W$%=44T$\,M-,D,T,E/--5-7'%5-7'/'/'Y7AX\F/-CKE
MQ6BV*T1-;1,3$Q,:Q,3'28F.L3'283*K:MZQ:LQ-9C6)CX3'YP_%^W]
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M,
M
M
M
M                                       !X/M#M#K[I;K[;.U>U=LP
M^C=>:-A[C/;5M6>N.;?&XG&V_-%'JJ]%$MQ=WEW<2QV]K:V\<MU>74L<$$<D
MTD<=7>^,>,>0>:>0;3Q7Q7:9M]Y#OLT8L&#%&M\EYZ_CI%:UB)M>]IK3'2ML
MF2U:5M:.;QW';[E]]BXSC,5\V_S7BM*5C6;3/_(B(C69F9B*Q$VM,1$RY[OV
MM?<+VOY_;7F^N-&O,QUYXD8C,6<FL==>FUM,WO\ <8*XN),?NW9]Y:>[<7=Y
M=W$M-S;8.BXDQ6,YBMZO3<7L'S:_01]JOV@>*>@N*P>1\Y3#R/MK-AM&;=_-
M;'M8RQ$7VVRK;2*UK$32^YFD9\W=DC7'AO\ 0K.GUGZIXSP?;4Y#>Q3/Y1>D
M]^7K-<46B-<>&)Z1$1TG)I%[ZVZUI;LB%M,YMP            !Z33M.VOL+
M:]=T;1M=S&V[EMN8L-?UC6-?L+C*9O.YO*7$=IC\7B\?:1RW%W>7=Q+31111
M3SSSSRZ[F.8XKQ_BMQSG.;C#M.'VF&V7-FRVBF/%CI$VO>][3$5K6(F9F9<?
M=[O;;#;9-[O<E,6TQ4FU[VF(K6L1K,S,](B(="WZ</JBPGU_]7R[WVGC=;SW
ME=V19TU[?L-E33DJ>L]5NH;&>WZGUG,<W%S9W'Q[RWYN<UD+&B&/(WM5,/%=
MS:V5I/7Y\?O$^ZO>^_O)XX+Q;)N=OZJXV_\ H^*WR?K,]9M$[[-CTBT:UGLV
M^+)-IPXXF\QCRYLM*P4]L>S<WG')?HN-MDIXSMY^2L]/K7C77->ND3&L3ICK
M;6:UZZ5M>T1-BA6U
M
M
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M +-9UK:(M$PVH:L8T
M
M
M
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MV/ZK==F;R3-3^+E^,4B>OTL6O6*1/[UNDY)C6=*Q6M8<TPVUP
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M?2]XG2=S:L_&=/AAB8UI7^_TO?\ NUI8I5WM"@
M
M
M
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MI^CGK'\/-6-)UCX]MHB8[Z3.M9_SJZ6G>IHQA8
M
M
M
M
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ML6&>7KCUQQO@/&]M>W-SF:L?7SZ?'\?IX]>M<59_LF\QWW_NUI%JE$V0
M          NY_1E]-N,ZAP.F^:/E/JDTW=.9AISW375.TXSF'CI[&532<8G>
M]IQ5[3S57V=F+6BB[QMO-1QSKMM-'+)3QE:O3C:3OOB^\7<^7;_>>F/5N[B/
M"\,_2Y'?8+Z_S"^D?4VN#)7X;+';7'FO6?\ 2[UM6LSM8UW,/?<OMC)RN?+X
MCXUEB.(I/;GS4G_'G^]CI:/]YK/RWF/\68F(GZ7^):/5>HW@
M
M
M
M                *1GWF_3;D^H<]N7FCXL:I#-TMF9JL]W+U3JV,XAYZ>R=
M4,?&6WO5L594\TU]8YBZHKN\E;PT<<:[<S22QT\8JKTXV[+['?O%VWEVPV?I
MCVENYCS3#'TN.WV>^O\ ,*:S]/:Y\EOAO<==,>&]I_TNE:UM,[J-=S,+TU[8
MQ\K@Q>(^2Y9CEZ1VX,UY_P >/[N.]I_WZL?+29_Q8B(F?J_XE7!:"D@
M         S]XR>3?<?B%W'JW>?1FTS:QN^L3<QUT2<27.!VC W,D-67T_<,1
M3-!'G=5SL<%--S;5545TUT1SP20W4,$\6 ^S/6?AWMWP[=>#^<;6-UPFZC6)
MC2N7#EK$_3W&WR:3.+/BF9FEXB8F)M2];XKWI;I/(O'>)\IXG+PW,XHR;/)'
M]EJ6C]V]+=>V]=>D_P!M;1-9M6>AS]9/VF].?8MUM[UESC>O._-5ABA[(Z9O
M<O'<7D7/-$G,6W:)/<TVUUL^DY.F&JKFNF/FYQ4_YM[NG\<VUS=^>S[F/M<\
MQ^W?R3LS_4Y'P+=3,[/D:XYBL_#7!NHKW5P[FFL1I,]F>NF3%.OU,>*"/L3U
MMRW@7(:7[L_"99_A9XKI'^XR1&L4R1_;I>/FK_>K64M%UK8
M
M
M
M
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MO;C5*(N
M
M
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M;1$Q$WG;06:7
M
M
M
M                                           :-^>/V ]"?7]U'?\
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MM9[]9I<Q4W(E@
M
M
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M'=CU^G:/5>HW@
M
M
M
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MUQQ\L:9-9I=54N(A@
M
M
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M,:3$]8GI+Z3C/F
M
M
M
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MS/QF?SE^S\/X
M
M
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M^,?A:L_"U+?&MJS-;1UB68&(.J
M
M
M
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MF=9F?C,_G+]GX?P
M
M
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MT?*T[MI>;?1SU_P\M8_&.L]MXUCNQV^:L]8[JS6]M\&B6%
M
M
M
M
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M(/+:4S<S';?%@^--O/QBU])[<F6.FD=:8YC6O?;MM6L<LS2)
M   6Q?I:^CJT[%Q^O^6OFQIGR- R5G'E>FNAMDM98OZVM+R#UV/8G96-E]N:
M/3Y(9.)L-B).*:LO^:;NYXXL/9BR%4?WG_>_E\=W&X]3>E=[V\_CO-.0Y3#:
M)_36K/S;39WC6)W$3';N,\:Q@ZXL4_7[[;>,?MWW);89+^+^'YM-]6=,^YI/
M^',?'%BG_/\ PR7C]SK6OSZS2YO;V]O9V\%I:00VMK:PQ6]M;6\5$%O;V\%%
M,4,$$,5-,<,,,=/%---/'%--/'''''X4UY,F3-DMERVFV6TS-K3,S,S,ZS,S
M/69F>LS/691*M:U[3:TS-IG69GXS/YR_9^'\
M
M
M
M                5*/NN^D&WV2WV?R^\*]*AM=FM8;G.=T=":EC:(+?:+>"
MBJ?(=A]78+'Q4QP[5#'35+EL);1\4Y:GBJZM*/G^[#D+9?LL^]O)QN3:^HO=
M&]FW&VF,7'<IGO,SAF9TIM-[EO.LX)G2N#<WG7!.F+-/Z?LOMY0>H/<5MO;'
MXKY?FF=O,Q7;[F\]:3^&+-:?[GX4R3/R?NVGLTFE-1<<ED
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M
M
M
M
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MFERM3BB:
M
M
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MQ/6)Z2^DXSY@
M
M
M
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M3/<'N#]5]7Q/Q/+_ *+UIN-Q2?W_ ,+8L5H_N?ADR1^_UK6>S6;VT53J,
M
M
M
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MK6=+1,1L(U\Z(
M
M
M
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MO;ON">?[_&?%LDQPGPS9HUB=Q^=*?"8PQ_>GI.7X?X?^)9Q5F([
M
M
M
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ME9CMF>D5S4Z_3M,](G6U+:QI;NF:5EU1(:M
M
M
M
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M+ J +1H
M
M
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MY?PGF?%UY3ALL6C2/J8YF/J8;3K\F2L3,UG6)TG]V\1W4F8ZM2VV&3@
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MRVP9ZVIGI::VK:)BU;1.DUM$Z3$Q,:3$]8GI+Z3C/F
M
M
M
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MVVSV=LF#QG'.E,6NDY=)B8R9HB=+6F8B:TG6N/IIK;NO:9E#9J4
M
M
M
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MR[G<,X\EHF:7CYL>2L::SCO\+::QK'2U=8[JQ,PVN:I8R
M
M
M
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MD9S;RTXN)QWF<.WB?DI'PBUOAWY)C7NO,?C,5BM?E20HXL
M
M
M
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M*^/QDWO QK:T1&N;!6-/WZQ_B4CK,Y*5^6L3.2M8CNFPBK[:+
M
M
M
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M6=/DQUF9BL:1&L_O7F.Z\S/5MHU,Q<
M
M
M
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ML5O[N3%:U9^&L3$Q$.^=\?YCQKD+\9S>"^#=TGX6CI:/\ZEH^6]9_"U9F/\
M*SDP=TP
M
M
M
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MW5@
M
M
M
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M<CL>7V.+D^,RTS;#-2+4O6=8M$_\F)B=8F)B)K,36T1,3#P;O7-
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MP
M
M
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MV'$[.G'\9AQX-ECC2M*5BM8_R1\9G\9G69GK,S+P;O7-
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M>Y<N7<9;9\]K7SWM-K6M,S:UIG6;6F=9F9F=9F>LSUE])QGS
M
M
M
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MCDN%R]W;I&3';IDQ7F->V]?]F(M76EM)[;3I.FG[;S*@
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M7XSF\%\&[I/PM'2T?YU+1\MZS^%JS,?Y6<F#NF
M
M
M
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MBF(F)F?GR5G28I&M;6=U9*.@
M
M
M
M                          #!OD7XV]*^6'5>;Z8[\T7&[]H&<FM+V3&7
MLMW8WV+S&.JKKQN?UW.8RXL\SKV>Q_,M=,=U9SQ2\PRRP5\UP3315YQZ[]D>
M:>J?*<'F7@6^R;#G\$6K%ZQ6U;X[_OXLV*\6QY<5](F:9*VKW5K>-+TI:O<\
M#Y!R_C')4Y?A,UL&^I$QK&DQ-9^-;5F)K:L_C6T3&L1,:6B)B@S]G_TO=W^
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M/BK'76]:],D1'QOCB/SG'6%A=7PT2
M
M
M
M                     K??9%^X2Z8\<OUSJ;Q$XUOR![MM_;LLEOGRJ\AT
M;U[<5^Y7=4?JV)NK>;M#9+2&F.GXF*N8<5;R7'YFR-=Q:W&-KL;^W'^GWYE[
M%^AY9[<_4^/^%6UM3:]L4Y/=Q&D5GZ>2LQLL-IUGOSTMGO%-*;>,>7'N8W_Z
M_P#17+\_V<IY3]38\//6,>FFXRQ^'RVB?HTGK\UXF\Q'3'%;5R12>[T[_P"Y
M_)GL7+]L]\]B[)V=V!F_S'=9_8[JBOXECQ=7=[!A<#BK.*TPFKZW8W5_-5:X
MO&VUICK3W:N(88^.>>%U/@W@/AOK3QW#XGX)QVVXS@,'6N+#68[K=M:SDRWM
M-LF;-:M:Q?-FODRY.V)O>TPE]PO!\1X[L*<7PFWQ[;8T^%:1\9TB.ZUIUM>\
MQ$:WO-K6TC698?9>[4               !G[QJ\8.[_+GM3!=.]"Z-DMUW'-
MS<>]5#3\7 ZYC**9);S8-MV"XXIQFN8&Q@BKJKGN*Z>9:^*88:9;B2**O ?9
M/L[PGU)XMG\P\\WV/9</@KTU^;+FOTBN+!BCY\V6TS$16D3I&M[S7'6UZ])Y
M#Y'P_BW&WY7F\U<.TI']MKS^%:5CK>TS^$?#XSI6)F.@']8/U ]*?7IK<&V9
M:G#]K>2^;L[638^VLCA[>N+3:[C#U6&6U+J.F^M_GZ[K===[=Q7%_P#B#)YF
M&7_6O;AXAM(*!_N<^[OS7[@^2MQ.TG-Q7K7!>T8=A3),3N-,G=CS[_MGMS9H
M[<=J8OFP[>U?X7=>;YLD'?8WM3F/.]Q.UQ=^U\>I,]F"+3_$TMK6^?2=+WZ5
MF*]:8YCY=9UM:8%$)JH
M
M
M
M                       !\W,X;#['A\KKVPXK&YW 9W&WV&SF#S-C:Y3#
MYG#Y2UEL<GBLKC+Z*>RR.-R-E/7#/!-17%-%75173S3SSPY.SWF\X[>8N0X_
M+DP;_!DKDQ9<=K4R8\E+1:EZ7K,6I>EHBU;5F+5M$3$Q,/IBRY=OEKGP6M3/
M2T6K:LS%JVB=8M68TF)B8UB8ZQ/6%0K[5/V]E<-&S>07U_X&:ZJYFNLYN?B_
M:4V]-=-$]QE,EF\WTQ>75];Q^S9QR0\0ZA[7,G,=$E&+EKK^+C*K=/M8_J"U
MO;;>O_?V>*QI7%M^:MKIK$4ICQ\C6M9G6TQ;NW_=IK-9W5:U^KN8E/ZT]ZQ,
MX^"\XO$=(KCWDZ_E$5KN(B)^/77/KIKI.2(CNR*B&1QV0Q&0OL3EK&\Q>4Q=
MY<X[)8W(VTUED,=D+*:NVO+&^L[FB*XM+RTN(JHY8I*::XZZ>::N..>.>%N&
MWW&WW>WIN]I>F7:Y:5O2]+1:EZ6B)K:MHF8M6T3$UM$S$Q,3$Z)2X\E,M*Y<
M5HMBM$3$Q.L3$]8F)CI,3'6)CXOXWV?H                !-A]=?W@^3GA
M!^@=<[G=WG??CACOAXZ'KC:\E_PFT+$1?"M.?[7[G<PW.2Q5GCL;9TT6V#O*
M[C!T<4\TV\-G7+)<<PK^X?[(O67NW]1Y'PU*<#[&R=UYWF"G\'=9)[K?Z;MX
MF*7M>]IF^YQQ3<SK$Y+YJTKC:@\]].>.^8]_(;2(V//VUGZM(^3);K/\;'&D
M3,S/7)73)/\ >F\1%5X;PW\^_%[SMTFG;O'[L.SRV5L[."ZVSK/8*K3!]JZ%
M)-':\UP[9IG-[=W,5G%<W=-O1E+&6^PEU<421VM[/S'7Z:1/<7H3V?Z+YJ>(
M\_XZ^+:WO-<&\Q=V78[J(FW7!N.VL3:8KWSARUQ;FE)K;+AQQ:NL.?+/"/(_
M"]Y^EYS!-<4S,4S5UMAR?']S)I$:Z1KV6BN2L:3:E=8;F--L2
M
M
M
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M?P^$:VG6U](FTS,-NFI&+
M
M
M
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M8ZQ,3&L3$HR[S9;OCMUDV._QWP[S%::WI>)K:LQ^$Q/6'JG5.,
M
M
M
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M)UO>]IM:TZ:=;3K,Z1$1'Y1$1'2'L'3N(
M
M
M
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M^$K&LY<==+TC7_?,6LVC3XS>G=2(ZVFOP3;H4-/
M
M
M
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MMK/R_OWC3O[-;8UDU6\CZ
M
M
M
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ME*C!GP;K#7<;:],FWO&M;5F+5M$_"8M&L3'[8E\=RWU
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M+/ ?)_"]Q.+FMO/Z;72N>FML%_\ <WTC2?\ :WBM_P#:MY&CV&@
M
M
M
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MT\?X1,Z];Y-)ZY+=>LQ6*5GMB0Y'I@@
M
M
M
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M_KN&RQ.6L1]3#;2,N*9_"]-9Z3U[;QK2VDZ6F8M$:6MSLN
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M9\;WUN-YS;Y-MO*_W;::3'YUM$S2]?\ ;4M:O[6;&%.G
M
M
M
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MQP7BNQ_E_ [>FWV\S$VTUFUYB-.Z][3-KS^VTSI\(TCHUU;$=\
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ML1$1#)#''7@
M
M
M
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M7I>LUM6=->M9TF-8F)C\XF)CI+V#IW$
M
M
M
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M[PKU?XMX3BKDVF*-QRT1\VXRQ6V373K].--,5===(K\VG2U[SU1@I.-C
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M&A0
M
M
M
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M"Y\&?:YK;?<TOCW%)TM6T36U9CXQ-9TF)_9,/L.&^0
M
M
M
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ML5Q5B(K6(B(B(C2(B(Z1$1TB(Z1#>%:UI6*UB(K$:1$?"(_*'XOV_H
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MB.ZTZ1IN8TVQ(
M
M
M
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M@
M
M
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MS,HQ9<N7<9;9\]K7SWM-K6M,S:UIG6;6F=9F9F=9F>LSUE])QGS
M
M
M
M
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M#^
M
M
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M#<7P.QIQO#X,>WV-/A2D:1K/QF9^-K3^-K3-I_&98K92[(
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MHA1YQ[(\C\ZW$_S')]+BJWUQ[;',QCK^$3;\<N2(_OW^$S;LK2MIJD@1Q8
M
M
M
M
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M/P?V/B_
M
M
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MM/X=9Z1$1&D1$(M[S>[OD=UDWV_R7S;S+:;7O>9M:TS^,S/67JG5.,
M
M
M
M
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MTM/:F9X;[#\:\XV\WXC+-=[6/GP9-*Y:_M[=9B]?]M2;1^$Z3T1^M_LX
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MX-!;K:;K8[B^SWV+)AW>.=+4O6:7K/Y6K:(M$_LF(>D=:XX
M
M
M                                                         #&_
M;'<7571.DY/L?N;L/3^L-%Q'IHOMHW;/X[7L33<R1RR6V-MKC(SP_J&8R'L5
M4VME;\2W=W+Q[<,<E?/%/.1^*>'^5>=<UB\<\-X[><GSF;]W!ML5\N3MB8BU
M[12)[,=-8F^2_;CQU^:]JUB9=AQG%<GS6\KQ_$X,NYWM_A3'6;6T_&9B(Z5C
M^]:=*UCK,Q"KMYM_N:]3P?ZOHW@EU]_6F1X]^S_OKVWC,EB-3B_/JC^?I'6/
MNXW:<Y[D$O$EO=YZ;#_&N8O3-BKN&K^-G_I/^F?RV^^CSGO3D/T6WZ6_EFPO
M3)GG\>W<[W2^#%I,:7Q[6NX[Z6UINL5XZ2/\/^W?=9NS>^:9_HX^D_IL$Q:_
M]F3-UI7KTFN.,FL3TRUE52\BO*[R,\M-JMMT\C.WMP[6SN/_ %'C#?U#>PQ8
M37(LO<Q7>4MM5U7$V^.U;5+._G@BYE@QME:PU\0QT\T^F.CBFU#UWZI]=>I^
M*MPWKKB-GQ6QR=GU/I5F<F:<<36DY\^2;Y\]JQ-NVV;)>T=UIUUM:9DMP/C/
M >+[:=IP&UQ;;#;3N[8^:_;&D3>]IF]YB)G2;VF>L_G+7ML%WH
M         "3+P$^J+RI^P3,6N0Z\P$.B]-6^2JL]C[TWNWO[32[/BRNK>/,8
M[5;>WAJR&][5:V\M?MV-EQ1;4W%-,=Y>6--?$O$:???W5^K/M_V=MOY#N)WW
MF-L?=AXS:S6VYMW5F<=\\S/9M<%IB-<F36\UF;8<.>8[)UYYO[-\:\&Q3CW]
MYS<M-=:;?',3DG6)[9O,],=)GXVMUTZTI>8T7L/ +ZMO%[Z]M9B_MEKO]7=O
M9/#Q8W=>]]SM;2[WS8/<K^3D<=@>*:*[/0=/N+SFGTXK&>CWH;>V_4)\A<V]
M-US1A[\^Z'V?]P7)S_K-N/TGB.+--]MQFWM:NUQ:=*7R_P![=;B*_'/FU[;7
MR_I\>WQY)Q1"_P X]D>1^=;B?YCD^EQ5;ZX]MCF8QU_")M^.7)$?W[_"9MV5
MI6TU20(XL
M
M
M
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MBW&QR1\M\=HM6?SC6/A,3TM6=)K,3$Q$Q,,>L@<X
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M@>9\?W4[+F]MFVVYB9Z7K,1.FFLUM^[>.L?-69CK'5F9AKJ0
M
M
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M;Y
M
M
M
M                                         -4?+3PE\:_-O0I= \AN
MN,;MEO!#<_TWM=G77A=]T?(3P3119;4-NL/1D\;-;3R\356DO-QB[R2.BF\M
M;F+CF+G:WJ?W7[)])\]'/^O>2R;3)::_6P6_B;7<TB8F<>XV]M:7BT1VQDKV
MYL<3,X<N.^EHR;Q?S#R'P_>QON!W%L5IF.^D_-CR1K^[>D])U^'=&EZQ,]EJ
MSU4M?/\ _;Z>3/C#7F>P?';C)>3/2D$W,U%CK^-N)^[M2L:;>JXGEV;2,98?
M%V;&VE5/M\7^#KGFD_%4L]A9Q\?GFYWT%_4!]:>SJX?'_8?T_&?-+1I-LMXC
MC<]M=(C#N;V[L-[?'Z6YBM8Z5IGS6G1+GP?WGX[Y'%-CSW;QW+S'QM,?I[SK
MI'9DF=:3/Q[<FD1\(O>5?58 WF                      R1U/W#VKT3NV
M,['Z9[#W#K#>L/ZJ+':-)S^1U[+4VTDD4ESCKFXQT\'ZAA\A[--%U97'$MI=
MQ<<QS1UT<\T\XYY7X?XKYUPN7QSS+CMGR?!YOWL&YQ4RX^Z(F*WK%XGLR4UF
M:9*=N3';YJ6K:(EP.3XKC.:V=N/Y;!BW.RO\:9*Q:NOX3$3'2T?W;1I:L]8F
M)60/#K]S-W;U[^@:AYB]=V?>&IVWIL[_ +.T&/&:CVY:VG'L^C(7NN2<V'7^
M[7D$<=<?$-%6N53<R<227555%7$M<GN'^FEX3Y!^HY?T]R-^$Y6WS4V6ZF^?
M86MUUI7-'=NMM69F)[IC=Q72:UQ1%H[- >5_;QP^_P"_=>*9YV>ZGK&'+K?!
M,_E%^N7'$_'7^+III%=)Z6D/$G[)O#7S9M[.VZ)[EP.1W:?&\Y.[ZHVBKC4N
MU,;#%1-)?\5:=EZXKK-PXFF#GF[NL17D;"#BJBJJ?TR1\U5>^V?MO]Q^E<E\
MOG7#9\?"UR=E=]@_C[&\S,17_2,<37'.37^'3/&'+;2T1CUK:(C?Y1Z^\L\/
MM-N:VEZ[.+:1FI\^&?R_B5Z5[O[M;]MIZ_+TG3>IHQA8
M
M
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MY%YGO(W?/;B<D4U[,=?EQ8XGX]E(Z1,](FTZWM$1%K3I&FX#4+%0
M
M
M
M
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MLQ$Q,3$QJT_DQWQ7MBRUFN6LS$Q,:3$QTF)B>L3$])B?@_L?%^
M
M
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MPX:;\=PENFE+?QLD:_')EC2:Q:--<>.8C29K:V2O69[4#6DP
M
M
M
M
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MO/;3/MLNLQ$WK\EM/CV9(UQY(_;2UH_:V$:^=$
M
M
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M_%O3GA/C&F;]/^MW\:3]3<Q7)I,:3K3'VQCII/6L]LWK_GS\4/Z7K:@
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M6M8K$0B]R/);_EMY?D.3S9,^]R3K:][3:T_Y9^$1^$1I$1TB(A[QT+A
M
M
M
M
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M
M
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MWRV_W66\VR3'6=*]W;&L]L1$M2VV&3@                      )[/ CZ
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MG=Q;)CK/R8J_+AQ_']S''2)ZZ3>=;S&D6M,1&FXS3S$P
M
M
M
M
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MC6(F8K::WT^-8ZMWFDF'
M
M
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M2+9/VQ\M)GK].$O:(K5@
M
M
M
M
M                #2'S#^NSQ+\YM<NL3WSU?C;[9_TV;'8+M?5Z+77.V-3Y
MJBKCM;C";C#9W$EY#CI*_=BQ^4AR6(JDXXYEM)>/SQSNWT_]P_MCT=R--WX)
MRF2G&?4B^78Y^[-L<_76T9-O-HBLWCY;9<%L.>(_<S5GJS'Q3SWRCPS<1EX3
M<VC;=VML-];X;_G%L>L::_";4FE]/A:%.OS;_;M>6_CM^K[GX\R_YK.K;7W[
MOX&IXJK%=UX&RI_,GLW_ %I\F^_K/V/<CMXI-<NLAD+V2FN6K&6D7'XXN#])
M_P!0WU+[#^CPWL*/]5?*+Z5[L]^_C<MOAK3>=M?T^NDWM&\IBQ8XTI&YS6^,
MK?#_ 'SXOSW9M.>C^6<E.D:WMW;>T_LRZ1]/\9F,L5K6-(^I>5?O(X[(8C(7
MV)RUC>8O*8N\N<=DL;D;::RR&.R%E-7;7EC?6=S1%<6EY:7$54<L4E--<==/
M--7''/'/"?NWW&WW>WIN]I>F7:Y:5O2]+1:EZ6B)K:MHF8M6T3$UM$S$Q,3$
MZ-Y8\E,M*Y<5HMBM$3$Q.L3$]8F)CI,3'6)CXOXWV?H
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MW;3\)_*6PC7SH@
M
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M,S,]9F9ZS,_%_8^+\
M
M
M
M
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MT6Q6B)K:)B8F)C6)B8Z3$QUB8Z3#=%;5O6+5F)K,:Q,?"8_.'XOV_H
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M8^:LS$Q,3$Z3#+3$W5@
M
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MK6(B(B(C2(B(Z1$1TB(Z1#:-:UI6*UB(K$:1$?"(_*'XOV_H
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MB(TB(A'/>;W=\CNLF^W^2^;>9;3:][S-K6F?QF9ZR]4ZIQ@
M
M
M
M
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MK:)B:VB9B8F)B=&Y\>2F6E<N*T6Q6B)B8G6)B>L3$QTF)CK$Q\7\;[/T
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MP1TH
M
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MS\GRO)\UO+<ARV?+N=[?XWR6FUM/PB)F>E8_NUC2M8Z1$0R0QQUX
M
M
M
M
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M^O\ S+QN;SR_'[FF"D:SDK7ZF*(TUUG+C[J1TZ];1,==8B8F(W>:28<
M
M
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M_"L(U\QSG,>0;R=_S6YR[G=S_>O:9TC\JQ\*U_*M8BL?A#,#$'5
M
M
M
M
M
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M<AL.4VM=]QN;%GV=XUK?':+UG^R:S,?VQ\8_%XEW3F
M           -\/'S[.?//Q?]NVZ?\FNR,;@H_CTTZ?M>0M>R=)BAM_73S!8:
MEV+:;1@L)\F*3FB67'P6MQ73Q1_B<51Q<T:)]@?;+Z(]GZY/+_&>-R;Z=?\
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MXP
M
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M^:W.7<[N?[U[3.D?E6/A6OY5K$5C\(9@8@ZH
M
M
M
M
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MN8]9^=\%K;?\9N9Q5^-\58S4T_.;89O%8_W6GY3I/1(2CZP4
M
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MG4>K?T_J; U6]5$M'..R//7]I@<QLF-_,U57LY:\OZ>:^**N?SS''Z)O>O\
M[1OMY];9*[K@/&MEGY.L:?J-[W[_ "ZZQ\]/U5LN/#?I$=V#'BG36/A:VNY.
M"]6>!^/6C+L>.PWW,1^_FUS6U_./JS:M)_;2M?Q_.=8W[BXN+RXGN[N>:ZNK
MJ:6XN;FXEKGN+BXGKJEFGGFEJJDFFFDJYJJJJYYJJJYYYYY_*1N/'CPXZXL5
M8KBK$16L1$1$1&D1$1TB(CI$1TB&?UK6E8K6(BL1I$1\(C\H?B_;^@
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M]VL:5K'2(B&2&..O
M
M
M
M
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M^M2/W=-<F&<E(UFT1&MNLZQ'6)B-\6B6%
M
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M-Q;=[_+ES[J\ZVODM:]YGXZS:TS,]?SEZIU3C
M
M
M
M
M
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M=MN=MO,%=SM,E,NVO&M;TM%JVCX:Q:LS$]>G27P7.?8
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M$_&/P:^W6TW6RS3M][BR8=Q'QK>LTM']M;1$Q_L/2.M<<
M
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M,SUF9GK,SUF6G+6M>TVM,S:9UF9^,S^<OV?A_
M
M
M
M
M
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MWE>/OX'>X<^329G'KV9:Z?&9Q7BN2(_VW;VS^$S#45MME(
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M$]8EA]JVI::VB8M$Z3$_&)_*7[/P_@
M
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M?Y5[*\P\PM>G*[JU=C:?\#%KCPQ'X1VQ,S?3\\MKV_;TC20]'I@8
M
M
M
M
M
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MVN^V]-YL<N/-M,D:UO2T7I:/SK:LS68_;$R\V[%R
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M<.?37MR5M2VFLQKI:(GXQ,?VQ,?@]4ZIQ@
M
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M&#;8HP;:E,>&NNE:Q%:QK.LZ1&D1K,S,_MG5\ARWU
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M: Y?G.9Y[<?J^:W6?<[C\)R7FVFNG2L3.E8Z1TK$1T9@8@ZH
M
M
M
M
M
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MUZ6C2T1.M9F(F/P_%[QT+A
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M72M8BM8UG6=(C2(UF9F?VSJ^0Y;Z@
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MF>LS,]9F>LRU7:UKVFUIF;3.LS/QF?SE^S\/X
M
M
M
M
M
M                     C\\GOJV\%/+RXO<QW)T!JLVYWTTEW-V+I-5[U[O
ML]]-7=2R7V5V'3[C$R;/-7)?2UU49>C(0U25<5U4<UT454[_ /6/W0^]/4>.
MFS\.Y_=1PU(BL;3<]N[VL5B*Q%:8MQ&2,,1%:Q$[><5HB-(MI-HG.?'/9'FG
MBU8Q<3OLL;2(T^EDTRX].G2*Y(MV?"/W.V=.FNDRKE^3?[77><+1D,]XC]^X
MW=K6F:ZEL^N^Z\='K.QPV?%Q%\.VMNQ-7@N=>S^2JMI*^).9\+@X.*X>.>*O
MQ+Z8K%?6?]3_ (/>VQ[#VWP&399=*Q;=\;><V&;:3W3.TSS7+BIW1&G;N=S;
M2VDQ\NMM^>._<?L\TUP>4[&V&VD:Y=O/?373K,XKZ6K&OPTR9)Z_#IK->CR)
M\$?,+Q/EGY\@O'KLCKO%V_L<2;;<X>G8.OJI;F[^#!;0=D:G<9[0;F\DNN::
M.((\E7-_BQ\^G\2Q\U6#^O/>OJ#VM6O_ !?^0\;R.ZMKI@C)]+=Z17NF9V>>
M,6ZBL5UGNG#%?EMUUK;3>W ^:>*>3Q'\BW^WSY)_N1;MR](UU^E>*Y8C3\9I
MITG\ITU+;89.                                           _:WN+
MBSN(+NTGFM;JUFBN+:YMY:X+BWN(*Z989X)HJJ9(9H9*>*J:J>>*J:N..>.?
MR_&3'CS8[8LM8MBM$Q:LQ$Q,3&DQ,3TF)CI,3TF'\M6MZS6T1-9C28GX3'Y2
MVHZ_\[O-;JNN#^WOEGY%:M:PY*O,<X?'=Q;[SKEUDY+>"TEO<EK%SG9]>RTT
MMM;11U<W5K-Q51%1QS^>**?QJWG_ $5Z6\IK;_6#Q/QW=9;8_I_4OQ^U^M6D
M3-HK3-7%&7'$6M:8[+UTFUICXSKC6^\+\0Y*)_7<7L,EIKV]TX,??$:ZZ1>*
MQ:O69GI,?&?S;L=>_?1]HW7]%E:5>14.]8FPAO8HL7V%UKUGL-<U=[<2W7-Q
M>[)#J>.W:^FM9IJO9XFRE<<<?ICXI]JBBBG2OD/V'_:_S]KYH\=G8[O)-9F^
MTWF]Q1$5B*Z5PSGOMJQ:(CN[<,3,ZVU[IM,X?O\ TIZWWTS:-A.'+:8ZXLN:
MOPC32*=\XXU_'2FLSUUUF9;L:+^Z&\R\-;QVO8'2/CKO%-OC;*TAR&&QW86D
MYB[OK>BB.YRN9EYWC9L-<39#BCFNN*SL,?#1+5SS'331Z8^-*<[_ $PO3>\R
M3EX#F_(MC-LEK33)?:;G'6LSK6F./TV')$4^$6R9<MIK$=TS;6TXAO?MQ\2R
MV[MCO-_AUM,Z6G%DK$3\*U_ATM&GYVM:=/CUZMV=+_=5=<WUQ<4]B>&N[:M:
MTS6%-I-I?<F"WVXFMY*Y^,I+<6V<Z_ZWCM9K..F+F".F6:FYJKJXKK@XHXJK
MTKS/]+#R/!CK/CWF6RW668MW1N./R[6(F(CLB+8MUO)M%I[NZ9K6:1$3$7UF
M*X?N_MIY"E8_0<MAR6TG7ZF"V.->FFDURY==>NLZ1ITTBVO3<S1?W*'UP;=<
M1P[!3W]U='7DK*QJN]ZZNQN0MXK6ZKHHGS,E/6>Y=BW7.-QU-7-4U-,55Y53
M3S[4$O/XXYTWSO\ 3<^XWB,<WX_^0<I:,=K=NUWMZ3-JQTQQ^MV^TKWW^%9F
MT8XF?GO6-9C$M[]OOG^UKK@_0[F>V9TQYIB=8_N_QL>*-9_#KV_G:&XVC?<Q
M]8?8?Q_T#S!ZWQ_RLQ#@XOZYQ^Z]8>F]G^)Z)[C^Y6JZE\/#T_-H]>1E]&/C
M],GJFX]J7T:=YS[-_N;\>[OU_B')9.W#.6?TU]MO?ECNZ1^CSY^[)\LZ8JZY
M9UKI2>^NN*;WU+[&V&OU^*W%M*=W\.<>;IU^'TKWUMT_=CYIZ:1UC7<'1O*?
MQB[/^/\ VU\CNA^P_F9B'7K3^ANW^OMM^5G[CXGL8.W_ $#8<A[^8G_4(/1;
M4_F>KWX_Q3SZZ?SJ'G/5OLWQCN_UE\<Y[C^S#.6WZG8;O!VXH[M<L_5Q4TQQ
MV6UO/RQVVZ])TQ3>^->1\=K_ ##C][@TIW3]3!EII6-=;3W5CY>D]?ATG\F>
M&".E
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M;::Z=*Q,Z5CI'2L1'1F!B#J@
M
M
M
M
M
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M>3^/>1XOJ\'O-ON8TUF*7B;UC73YJ=+TZZ?O5CXQ^<->VP7>@
M                                    /=Z;VGV=UUZ_[?=C;YHGNWEO
MD9/Z-V_8-8]S(6GX^+?5_HF1L?7>6WIX]N7G^>C\?PYX=%S/BWC'D6G^L'';
M#?:4FD?J-OBS:4M^]6/J4M\MOQK\)_&'"W?&\=O_ /AVWP9M(F/XE*WZ3\8^
M:)Z3^,-M=4^T/[%=,^?^D>:ODA>?J7Q?D?U7VKM6^>W\/Y/L_ _KF_V+]*]?
MRJO=^+[/O_BCW/7[<?IU-ROVP?;OS/T_UGA?CE/I]VGT-C@VNO=IKW_IJX>_
M]V.WO[NWKVZ=UM<8W7KCP+=]OU>(X^.W73LPTQ_'3X_3BG=\.FNNG7336==K
MM/\ W 7VFZM<<5Y'OW [U91XWC'P8S<.GNH^;>&NBNUYBR7-_JVF:MG[O)1Q
M6]4?KN+R:.2F:NJ2BN3T5T:JYC[ _M<Y3'IM^ S['-.3OF^WY#?ZS&EM:=F?
M<9\5:3,Q.E,=9B:UBMHKK6<8W?H[UMN:Z8]C?#?NUF<>?/K^/32^2]8CKKTK
M$QI&DQ&L3M1I/[GSSFPE>(MMUZH\:=YQEE#-%E;F#6.Q-4VG-5\V]QQ;7%65
ML.R;[6L?-'=UQUR<183VY(J*J*:8ZJ_=IU9S?],?T=O:YLG"\KY+L=S>8FD3
MFVF?!CC6-8[+;.N:\376([MSK%IBTS:([9QK>?;GX9FB]MGNN1PY)GY8F^*]
M*]8UCMG%%YZ:Z:Y-8F==9B-&SNG?NK=GMK?B#L#PKP.9NI,EQ55D].[RR&LV
M]KAZJ+6CF+C!YKJ_;9+_ "4$E,TGN?J%M%+371'Z(^::I:]9<Q_2NXS)D[^
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M.6WV6=K,3'TL?\+%,3\8M3'VQ?\ MR=\Z3IKIT;^M!L'
M
M
M
M
M
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M:VB-U\%Y=XSY-3OX+?;?<SI$S6MM,D1/6.[%;3)7\?WJQ\)_*6L;9C(@
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M-:.G3I:M)K,?E,3,3\8F8?V?\X7X"?\ +B\/_P#XY?I?_P!W5\?_ %?/??\
MYC^7_P#W&Y'_ .1GX_U$\W_\#<K_ -J;C_J;U6J^:/AUO5Q=VFD^6/C3N-U8
M0T7%];:KWMU=L-Q9V\E?MQSW<.(VF[DMX9)./3357QQ3S5_#CG\NKY7TS[@X
M+'3+S?BGDNSQ9)F*VS\9O<46F(UF*SDP5B9B.LQ'71QMSXCY7LJQ;><9R.*M
MITB;[;-6)G\H[J1J]K_F&Z!_[^73W_A,TO\ [-ND_P"+[S[_ ,!\Q_VGN?\
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MF\:_O8XO7K&G6M^ZL_'IK$Z3UCK$2P/MGF1Y>;[\#^N?*GR0W/\ 2OE?I?\
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M1I$:S,S/[9U?(<M]0
M       &PG0WB=Y+>4&6XPWC_P!']D=K34WE=A>9'5-8R%UK.'NX[:B[JBV+
M<)XK?5-9_P "6/GBK(7MM3SS+'3QSS5)1Q5K[SSVOZV]8;3]9Y_S?&\53LB]
M:9\U*YLE9M-=<.WB9SYNL3TQ8[S\MI^%;3'1<WY/X]XYB^KSF\V^VC36(O>(
MO:-=/EIUO?KK^[6?A/Y2GR\9/VQGDKO%>/S?E%VEI/1> FAMKBYT_39*.T.R
M:*Y+>62YQN1N;*6PZ]PTUO-5%'Q<6F5S<=?/N?BCTTT52P+]F?U-/6W!UR;+
MU?Q>]YS?Q-HC<;B/T6SF(F(K>E;1;=Y(F.Z>S)@VTQ\OS:S:*Z2\B^XKQ[9Q
M;#XWMLV]SQ,Q&3)_!Q?'I,1.N6VO6=+4QS\.OQTL.^-WT??7+XV5V.3Q_24/
M<>VV$U4T.X^0%]!V;><\_'I@B_X)3X_%]7P36DGJFAGAP$5S'/7Q7Q)^8X?;
MKU]C_>[]Q?LBM]MN.;GA^)R1I.WXJL[*OQUG^/%[[V8M&E;5MNK4FL=LU^:_
M=HCR#W'Y]Y!%L>3>3M-K:/\ #VT?1CX_Y\3.:=?A,3EF)CIIUG66/'8['XC'
MV.)Q-C9XO%8NSML=C,9CK:"RQ^.Q]E!1;6=C8V=M1%;6EG:6T5,<44=--$=%
M/%-/'''''"*.XW&XW>XON]W>^7=9;VO>][3:][VF9M:UIF9M:TS,VM,S,S,S
M,ZM8Y,E\M[9<MIMEM,S,S.LS,]9F9GK,S/69GXO['Q?@
M
M
M
M
M
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M/X>2?I9-9_"*9.V;:3TF:=U==.LQ,3.A+?+-@
M
M
M    &Q717B-Y.^3.3M<7T+T1V=VA5=32P<Y76=4R<^K6-</$GN59K<KF&VU+
M 0TUQ<Q^Y?7MO'S+S3'Q5ZZJ:>==^<^V_67K3;6W7GG.\9Q<5B)[,V>D9[1.
MFGT]O6;9\L]==,6.\]NMM.V)F.AYKRGQSQW'.3F][MMMI'[M[QWS_N<<:WM^
M>E:S.G7X)YO&O]L5Y.;U^FYKR9[7T/H7"3?IMU=ZEJD?]V.Q:8ZO\;*8F_FQ
MU[ANO\)><1^F"*[M<OG(J9>:Y.89*(Z*9X(^R?ZFOK+@OJ;+UIQ6_P">WL=]
M:Y\\_H=IK\*9*Q>N3=9*ZZVMCO@VUIKI7OK:TS32GD/W%>.[+NP^.[7/O<T:
MQ%[_ ,'%_M;1K%LMH_&:VICG32-8F9[9_P#QN^ASZY?'BBQO\AU)-W[MMK#5
M'-LWD!?P;W97',MQ3=34_P!O8+'#]7\PT244T0\S86>YC@HXHYGKYKFJE@)[
M'^^W[B_85KX-ORT<!Q-IUC#Q5)VMHTCMC_2YMDWNNDS-NW<5I-I[HI&E(KH_
MR#W5Y]STVICW4;':S/[FVCZ<QTT_Q9FV;]LZ9(B9ZZ1I$1,#A\-A]>QEEA<!
MBL;@\-CH>+?'XG#V-KC,986]//-5,%E8644%K:P\55<\\4T44T_GG_0B%O-Y
MO.0W-][O\N3/O,DZWR9+6O>T_G:UIFUI_;,S+567-ESY)S9[6OEM.LVM,S,S
M^<S/67TG&?,
M
M
M
M
M
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MF8GI^4O*NT<D
M
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MERVFV6TS,S,ZS,SUF9F>LS,]9F?B_L?%^
M
M
M
M
M
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MWL3PCG[13B^3VM\UITK2]OI9+3UZ5QYHI>?W9GI6>FD_"8F=%6\V9@
M
M
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MG3%%*VT_";1:?CUZSKOBT2PH
M
M
M
M
M
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M&3_+CM,9(_RU:KMI,E
M
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M^LSW9<EKS&ND=.Z9TZ1$:1I&D1'PB&3F,NN
M
M
M
M
M
M
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MUCK.FL-%6\V9@
M
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M\*_#2/A$1&VC4S%P
M
M
M
M
M
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M#8_'\QQ/+4^IQ6ZVVYQZ:ZXLM,D::Z:ZTM,?&)C^V-&,63.Q
M
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M2&X+4+%0
M
M
M
M
M
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M
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M\DQ_9-[6948LZP
M
M
M
M
M
M
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M6VT;LN;!Y.XXBN/;MK.6'M'7.O<9;9*Z@YXD]/%Y);4<<<T\S_G\?F07C?\
M4A^W3FK5IR_\\X>TS$6G<[.,M(UC6;1.RS;N\TK/37Z<7GI/T]-=,ZX_[@O
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MXQK$S#X3G/L
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M1.D-D&N&/@
M
M
M
M
M
M
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M'<6FT5TQY\5Y[I^%?EO/6?PCXRP"SYW8
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MN,\S,]V2]KVUF=9G6TS/6>L_G/67MG2.&
M
M
M
M
M
M
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MC75L1WP
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MS.D1$1^R-'V'#?(
M
M
M
M
M
M
M                                            !YO:--U#>,?#B=UU
M36]PQ5O>1Y&WQFT8/%[!CX,A%!<6T5]#9Y:UN[:*\BMKN6.F6FGBNFB6NGCG
M\5<\<]EQ?,\OPFXG=\+NMSL]U:DTF^#+?%>:3,3-9MCM69K,UK,UF=)FL3IK
M$.1MMWNMG><NSRY,668TF:6FLS'2=-:S$Z:Q$Z?LAK'M_P!?'@COOZS)MGAO
MXQY6^V#U<Y?-_P!C^N+'9KN2OT>JY_JG&Z[9[';WG/$?''OQ75$WXX_'J_#9
MG$?<#[UX'Z->)\Q\FQ8-O_AXOYEO+8:Q^7T+YK89KU_=M2:_L9%M/.O--EV1
MM>6Y&M,?[M?U&6:1^SLFTTF/V3&C6C:OI#^K+<;BTN<OXC:K9R6<-<$-.J[U
MVYHMO71)7[E55W::3V#KUK?S<5?[62>B22FG^'%7''\&RN*^]K[H^'QWQ;3R
MW=7K>8F?K[;8;J=8C3Y;;G:9;5C\XK,1,]9C5D.V]P^R=I6:XN4RS$SK\^/!
MDG_).3%:8_LC2&L>S_MN/K:S]CDK3%6/>6DW%]-3+:Y36.U*;N^PU%-Y'=<V
M^-CW/6]NQDL-<%'-MSS>6]W)[-?//%7$OIEIV;QG]1[[D-AGQYMUDX/>XZ1I
M:F;8]M<D]LUUO.WS;>\3$SW_ ,.]([HB)CLUK.1[;[@/8."];Y;;+-6L=8OA
MTBW336?IWI/[?EFL:_AIT:Z[1^UJ\4[O(0R:5Y&^0FOXJFSCHN+/:+?KC<,A
M+D.)[BJ6YAR>)U/1[:"SKMJHJ*8*K22NFNBNOF:KBOBB/8G%_P!43VKBV\UY
MKQSQ_<;KOF8M@G>;>D4TC2LTR9]S,VB>Z9M&2(F)B.R)K,V[[;?<CY-6DQO-
MAL+Y=>DTG+2-.G32U\DS.NO7NC\(TZ:SK?L'[4W(1VF4GU7SBL[R_I]ZO"XK
M8/'B?&VDGYE_-O;938,=W3E9H?1#S^*YXL9)ZJN/SQ#3QS^.-C\?_53V]LN+
M'ROA%Z8.D9+XN6B]HZ=;4Q7XZD3U^%;9HTCXWG3KD&#[F*3:M=SPTQ3^]:NZ
MUG]LQ6=O7_8F\?VM>MK_ &MWE[9_ _H;R#\;]B]SY7ZI_5<W9VF?#]'QOA?
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MIKV7K?37737MF=-=)TU^.DO(.W<H
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MNM_OM[V_K<V7-VZZ=][7TUTUT[IG372-=/CI#V#IW$
M
M
M
M
M
M
M
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M\8^G,S^<.7M_N/\ +ZY-=ULN-OBT^%*YJ3K^'S3FR1_D[?\ +#'G_18.@O\
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MF=/[=)_L9:_Z+#W]_P JGI[_ +3=T_\ 76)_^U)\!_\ -7F/^V-M_P"XZO\
M]9/@_P#P9N_^B8S_ *+#W]_RJ>GO^TW=/_73_P!J3X#_ .:O,?\ ;&V_]P_]
M9/@__!F[_P"B8WO=7_:H;?=X^:3=?-C6]?RM-Y)1;V>K]#93<,?+C^(+>J*Y
MFR>6[9T>Y@O*[FJ6BJ"FTDHIHHHKXFJYKYHCZ'E/ZJ/$8MQ%>%\*W.XVO9$S
M;/RE-O>+ZSK6*8]AN8FL1VS%IR1,S,QV1%8FW"W/W+[6MXC9\/DOBTZS?<Q2
M=>O32N#)$QIIU[H_&-.FL^D_Z*-_]WK_ />M_P#XQ;KO_:K?_P A_P#W[_\
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M]]O>W];FRYNW73OO:^FNFNG=,Z:Z1KI\=(>P=.X@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
:                               #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>sny-20221231_g4.jpg
<TEXT>
begin 644 sny-20221231_g4.jpg
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M_\0! P !  (# 0$! 0            D*!P@+!@4#! $!  (" P$! 0
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M Q$ /P"_P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MKX__ (KG_P#$*_\ SI/_ -G1W'_E4_\ ^>?_ &$__J[E?U9O_P"-_P#U'_\
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MQYYM[N"3X\?\[X?'CGC;S[.'X;]SMKX,./G-OEM&D9,>^UO2?GK&7#EQS/\
MU\=H^X^>7X?_ $^R8YI2N]QVF/OJYNL?=CNI:O\ TUF/N,G?\4)Y]_Q0^'__
M ' [H_\ $ QG_P L/T$_._E_XUQW_P!"G6_U<?"/X5RO[KM_XL?\4)Y]_P 4
M/A__ -P.Z/\ Q '_ )8?H)^=_+_QKCO_ *%']7'PC^%<K^Z[?^+'_%">??\
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M]APWR
M
M
M
M
M
M
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MK$7V^6LS'SQW4C5L4UVZ$
M
M
M
M
M
M
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M0
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M8F/N3J^PX;Y
M
M
M
M
M
M
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MQ772)[8CV:SI\VLZ/%.Z<L
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MVB9PG?\ B7E/%VFO(\;OL.DVZWP9(K/;]]-;=O;:(Z?2K,QI,3KI,-EFM6/
M
M
M
M
M
M
M
M   -2NU//3PJZ2DDM>T_*CH?4,I%Z7->O7O9FJW>U\1RW=W84W/&I8O)7^S5
M6=%[8SPUS<6G,,<D-=-=5/-//'&V?%O0?UH\VK&7Q;Q;GMYM9U_"UV>>N#6*
MUMI[^]*X>[MM6T5[^Z8M$Q$Q,,HXWPGR_F([N-XS>Y<?]M&&\4]D3IWS$4UT
MF)T[M9B8T1L]F?<:>V;H=%%6K;AVUW357#;2U1]9]29W%5Q5SW%S#+;5\]QW
M'4T?,UE'!3++S355'S'-1Q'5)7Q)11)#QK[.KXE^=M,<IL^)X6(FT:[S?XKQ
M,1$3$Q^3XW\Z6F9K76(G6L]T5KVVML#CO0/U#WLZ;G%M=GUG]NSUM[(CK^ C
M/[==(^76)UB(TF8WNS/NIX.**+7ISP^FKEJAMI9,WV9VM1%1!<?47/%Y8T:M
MJVH3574/-K3#5%=\YB&KB2NNFJWYXHIJKD=XU]EEDFTY?,?+XBL3:(Q[/8S,
MS&D=MISY]Q';/=W1:GU>T:1$QDUF8KL#COAJMKW<MRL::S]'#A^32-)[[WZ=
M==:^[GII]+KI$=?9_P!R'[D.]57E&G9/IGI:":&&WLZ] ZPML[?6?$&3DO?K
M*I^V,IV19W62O+*JFSN*N;:FUYAI^>&W@FYYE2'\8^SB^''@HI/,8^9YJ\3,
MV^M;V<5;:TBO;IL:;.U:5MKDI'?-^Z=+Y+T^BSWCO0#T_P!EI.[KN]Y:)UGW
MN::Q.L:::8:XIB(GZ4===>DVF.B/'M+W,?<![FER'._^7W?%Y9Y;Z[C)8+7-
M^S&@ZI?19"[JO;BVN=/T";6-6ELZ9ZOA#!S9^C;Q\<1Q4T1TTT\2%\7^&GT!
M\-KCC@/$."IFQ=O9ES;7'NL]9I7MB8W&ZC-GBVGWUO>=UYUM>;6F99WQOIYX
M/Q,5^H\5LHO732U\5<MXTC2)B^7OOKI[9[M9GK.L]6EN8S.7V')WF:S^5R6<
MS.1FYN,AELQ?763R=_<<\<4\SWE_>RSW5U-S33QQS57755\./]K<^SV>SX_;
M4V6PQ8\&SQQI3'CK6E*Q\U:UB*UC[D1$,NQ8<6#'&'!6M,58TBM8B(B/FB(Z
M0^:Y+Z
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M?F9:8FZL
M
M
M
M
M
M
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MF8Z3:9F9UG69UE@%GSNP
M
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M3IP
M
M
M
M
M
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M+7GK$3UM/6(GVM16VV4@
M
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M/N3J^PX;Y
M
M
M
M
M
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MTB>O7K\O5LWCN%X?AZS3B=IMMK2?;&'%3'$_JQ2M6*V4NR
M
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M
M
M
M
M
M
M                           :'=]>YWX#^-?XI;=K^4?5=CL&&]6/(Z7J
M>=X[&WRRNX_PWT["_P!+Z^BV;8\3>77&6@JBIO+>WIJAJKF^;B&&:2/>W@?P
MR^O7J3[K+XIXORM]AFTFFYSXOJFUM6>_6]=SNYPX<E:^[M%O=WO,6B*:=]Z5
MMFO">G7F_D/;;C.-W,X+^S)>ONL<QUZQDR]E+1';.O;,]=(]LQ$PM]]_=%]
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M=<1M-MM<>FFF+'3'K^KVQ&OW9G69GK/5B5ECLP
M
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M3'MA[!T[B
M
M
M
M
M
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MTTB-/>W[LGZV)G6_6?I3UF9G45MME(
M
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M]C]ND3W8N[MBW33O[9UF(F(GHD)1]8*
M
M
M
M
M
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M(BL1I$1\C:^SV6SX_;UVFPQ8L&UI&E:8ZUI2(]FD5K$1'3YH>5=HY(
M
M
M                #;3H7SP\Q_&&6U_05Y'=J:#C;/Z7T-7MMEN<WHO^Y7=K
M>VWK]?;/QF]'NO3DM*:.?5Q]?S6]<D%7QAFECKU/YYZ$^COJ=6WZ<^.<5O\
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M[;Q$^V)^3Y'MG2.&
M
M
M
M
M
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M(B(Z1$1TB(Z1#8]:UI6*UB(K$:1$>R(^:'XOV_H
M
M
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M$
M
M
M
M
M
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M=8_77FV\/'_2KP3QR*WV>PQ9=U$?MN?\-?77VQWZTI/R:XZ4Z?JSK&:DLV&
M                                                    ]KJO6G8V
M]6]U=Z3H&[;C:V$U%O?7.JZKG=AM[.XDH]6."ZFQ%A=QV\TD?[*FFOGBKFG\
MO''P=+RODOCG!9*8N;Y#9;/+DB9K7/GQ8IM$3I,UC):LS$3TF8Z:N'N>1X_9
M6BN\SX<5K1K$7O6LS'SQW3&K/^O^ WG/M=IB\CK?AIY49K%9KT><7F;#Q^[6
MGPE[%/+Z,=S%FJ=4_"OH_G_YT_,W$-'''/-57'''//& \AZ]>AW%9<NWY'S+
MQ;#NL.O?CORNQC)68C68G'[_ +^[3V5[>Z>D1$S+I,_F_AFVM;'N.6XVF6GM
MK.YPQ:-/D[>_NU^YIJV$P'LS^YYLF6M,+CO#[LBVO+WU_1FS]_I>J8FCZ:VF
MNY/J\_M&TX?!6'S105<1^O<Q^K+S3'1\TE=%-6OM_P#&1\,G&[2^]W'E_&VP
MTTUC%3<Y\G6T5CMQ8,&3+;K,:]M)[:ZVMI6)F.BS^K7ISM\4YLG*[>:1I][&
M2]NLZ=*TI:T^WKI$Z1UGI$RSEJOV^/NF[#<7<.7Z,U718[>&B6&[VKNCJ.\M
M[^NNOY*K>TITG<=QNJ)HZ?V57,\4,?R_[*N>?R,'Y7[0+X7./QTOM.<W6^M:
M9B:X..W]9K&GMM]9V^WKI/LCMM:=?;$1U=-N?73TVP5B<6]RYIF?93;YXF/N
MS[S'CC_HF9^XS9JOVSGN);#;W<V7V/QIT62WFHBAM-J[*W&\N+^BJCYZKBTJ
MTCK'<K6B&.K]C5Q/+#)\W^RGGC\K"N5^TL^'CC\E*;3;>2[ZMHF9M@V>WK%9
MU]EOK.]V]M9]L=M;1I[9B>CI]S\0W@>"T1BQ\CFB8]M,6.(C[D^\S8Y_Z(F/
MNLS:O]K7Y6W>/FDW3R-\>L!E*;R2BWL]7M^R-OQ\N/XAMZHKF;)9;4M'N(+R
MNXJEHJ@IM)**:***^)JN:^:(\-Y3[43TJQ;B*\+XYY!N-KV1,VSSL]O>+ZSK
M6*8\^YB:Q';,6G)$S,S'9$5B;=1N?B1\9K>(V>PW]\6G6;SBI.O7II6^2)C3
M3KW1\L:=-9S/K?VIVSW6,HEV_P W<#@\SS--378:WX_Y#:L93;T\\>A+1ELG
MW#IMU7-)3\>:X^;*FFCG\G%=?^UAG(_:I<9BW,TXCPG/GV>D:6S<K3!?7Y8]
MW3C]Q72/DGWDS/S0ZG<?$OMJY--KP][XM/;?<Q2=?E^C&#)']GN_L0RUJ_VJ
MW6-ICYH]T\QM\S^4JO)*[>\U?J+7]0Q\6/YAMZ8K:;&Y;>-XN)[RBXIEKJGI
MNXZ*J*Z*.(:>:.:Y,3Y3[4[R?+N(MPOA^PV^U[(B:Y]_EW%YOK.MHOCVVVB*
MS';$5G',Q,3/?,6B*]7N?B6Y&UXG9\3@IBTZQ?/:\Z]>NM<>.(C33IVS\LZ]
M=(RIJ?VMWB'9_7_GSY">2&Q>I]+^%_FG-UCIGT?R?4_6_7_C&A;[^)?4?-#Z
M7I_2>C\E?S>K\]/IXMROVH?J[F]W^0_'_'-OIW=_OXWNX[O9V]GN]UM>S3Z7
M=KW]VL:=O;/=UFZ^)'RF_;]2V/'X_;KW^^R:^S33MR8]-.NNO=KT]FG7)VN?
M;)^WI@\G3?Y/=/*+<;6F&:+G"['V/U]:XRNN3CCBBXJEU'J+5<SQ-;\\?&CB
MF[XCYYY_94U<?D8QR/VF/Q![[;3@VVR\7V>76)]YAV>[M>(CY--QO\^/2?EU
MQZ_-,.NW'Q$>=YL?9CP\;BMK]]3%EF?U/IY[UZ_]77YI9"_X<;VT/^S'</\
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MHUBU9B8F/GB8Z2^:Y+Z
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MR?>VGVQ\\-G&LF.@
M
M
M
M
M
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M(BL1I$1[(CYH?B_;^@
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MWM76/DG36&.;CE.3W>/W.ZW.?+BUU[;Y+VC6/9.DS,,A,?<
M                                 !^-Q;V]Y;SVEW!#=6MU#+;W-M<1
M43V]Q;ST51303PRTU1S0S1U<TU4U<<TU4\\\<\?!^\>3)AR5RXK37+68FMHF
M8F)B=8F)CK$Q/6)CK$O[6UJ6BU9F+1.L3'MB?GA@;8_%#Q:W'&5X7;O&KH#:
ML-7-#<5XG8^G.N\YC*[BWYYJ@GKL,GKEU:U305<\\T5<T?-3SS^3GAG?'>JW
MJCP^YC>\1Y)S^UWD1,1DP\AN\5])]L=U,U;:3\L:Z2[O;^3>2;3)[[:\AOL6
M733NIGRUG2?;&L7B6 =H]JWVX]PR$.3RWA=X]VES!9QV-$>K]>8;1\?5!%/<
M7%-<V)TJ'7\5<7G,ES5Q5<20U7%='%%%5?-$=%-.?<7\4WQ%\1MYVVT\S\@O
MCM>;3.?=Y-S?68B-(R;F<MXKI6-*1:*1.LQ6)M:9[S;>I7GVUI./%R^_FLSK
M]/+;)/R1]]D[K1'3V1.GMG369:T[/[ WM6;%8Y*WL_'+):ED,C-1/3G=8[E[
MLHOL=7]9%=S4XW'9[L'/:Q!#<T450<QU8^2..&2KB*F.OBBNC97&?'Q\4W'9
M\>3-Y'CW>WQQI[K-Q_&S6\=LUCOOBVF+-,Q.EM8RQ,VB.^;1-HG(=MZW^I>W
MO6U^0KEQUC3MO@V^D]-.LUQ5O.GMU[HF9CKK&L3KKM'VR_MX9_(0WF)VSR<T
M>WBLX[:O$ZOV1HUWC[B:B:XEJR,TFZ=4[?E*;R6.:F.JF.YHM^*(:.:8J:^:
MZZ]B<7]I=\0O'[><.[VGC.^R3>;1DS[/<UO$3$1V1&VWVWIVQ,3,3-)OK:=;
M3';%>^VWQ#^>8*33+BX[-:9U[KXLD3'LZ?@\U*Z?+UB9ZSUTTB-5]H^U6ZQN
M\?#'I?F-OF RE-Y'7<7FT=1:_M^/EQ_$-Q3+;0XW$[QH]Q!>5W%45=,]5W)1
M31171S#5S7Q7'M+B_M3O)\6XFW->'[#<;7LF(K@W^7;WB^L:6F^3;;F)K$=T
M36,<3,S$]\168MDNV^);D:WF=YQ."^+3I%,]J3KTZZVQY(F-->G;'R3KTTG6
MC=_M7^]K"O+\=<>5W4NUQ0PPU8&O=]&W'K^O)7%5O;U7$67CP-[V93A(8KJJ
M6BB2&K(521T45\T4<U\QT;*X3[4KP7/7#^D?BG+;2UIGWOU;<[?=12-9TG'.
M6NS]Y,U[9F+1BB)F:Q,Q$6MD.S^)3A;Q3\H<9NL4S/TO=Y,>72-9T[>Z,/=T
MTZ3VZ3K&LZ:SK'M7VTWN,Z]<6D.(R7CKO4=Q#7+-=ZKV=L-G;V%=%?R4V]W3
MN_7^FW5<TE/[*GF"*:/Y?]M7'/Y&S>*^TG^'7D,=[[O%Y%L;5F(BN?98K3:-
M/;7ZMN]Q72/9/=:LZ^R)CJR+;?$)X#GK,Y:[_#,3[+X:S,_=CW>7)'_3,3]Q
MJ7M7LB>Z9IMO:7.7\1MJO([R:N"&G5=YZCWJXHKCH]2JJ[M-([!V&ZL(>:?^
M;)/1''55^QXJYY_(VQQ7QM?"YS&2^+:>6[6EJ1$S[_;;_:QI,Z?1MN=IBK:?
MGBLS,1UF-&4;;UA]-MW::XN4Q1,1K]/'GQQ_8G)BK$_J1K+4O<?!_P S^O;?
MF]WGQ)\EM2Q_XESAX\KL'1O9N+P]SD_DNI:+*RR]WK,6,OIIH+*:2/B&63B6
M*.JNCYJ..>6V>'];O1GR#)[G@_+?&MWN/=^\FF+D]E?)%-:QW6QUS3>L1-JQ
M/=6.VTQ6=)G1E&T\Q\1WUNS9<IQV7)V]W;7<89M$=.LUB^L>V(G6(TF=)ZM:
M<CCLAB,A?8G+6-YB\IB[RYQV2QN1MIK+(8[(64U=M>6-]9W-$5Q:7EI<151R
MQ24TUQUT\TU<<<\<\-D[?<;?=[>F[VEZ9=KEI6]+TM%J7I:(FMJVB9BU;1,3
M6T3,3$Q,3HR''DIEI7+BM%L5HB8F)UB8GK$Q,=)B8ZQ,>U_&^S]
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MT^R?FEL(U\Z(
M
M
M
M
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MK6L>W2*UB(CKUZ0^"YS[
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M,1,]9B.FK%-SO=YO;1;>9<N6U8TB;VM:8CYH[IG1ZIU3C
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M[H]UDIDUKKIW?0M/368C7V:RQDR9V(
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M;J/UN6EJ6_5B+1&L=8F)CI,3$QTEDACCKP
M
M
M
M
M
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M6>MIF>L]9>P=.X@
M                                  #5;L+P9\,>UK2JS[#\4_'O:O\
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MQ,5XG?[/<WGY,6;'>WL[M)K6TS$Z:S,3&L1$Z^Q@=G;N@
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M6FMHF+1.DQ/MB?FE^S\/X
M
M
M
M
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M=?>[G3+.NL3';32,5>V8^C:N/OCY;S[42*6C:
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MW-IF)URY;Y.L1VQ/T[3UBO2)^2.GL948LZP
M
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MN7%:+8K1$Q,3K$Q/6)B8Z3$QUB8]K^-]GZ
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MJQC0
M
M
M
M
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MI7Z=M/9WY)UR9)^[>UI^ZU[;!=Z
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M
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M>2V>;-;V4C+6,D]8C]JM,9/;,1UK[9B/:U+;89.
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MQ$UM68F+5F(F)B8F-6H,F.^*]L66LURUF8F)C28F.DQ,3UB8GI,3[']CXOP
M
M
M
M
M
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ME*1%:5CY*UB(CY(;LP8,&UPUV^VI3'MZ1I6M8BM:Q'LB*QI$1]R(?'<M]0
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M=>VMYQ4U^?W>+LIT^3Z/3Y&[[23#@
M
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MHFLZ3TM$Q/6);!P9\&YQ1GVUZ9,-M=+5F+5G2=)TF-8G28F)^[&CY#EOJ
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M'RS2W6MXCV3-)F(GIKJSDP=TP
M
M
M
M
M                                               #^/(Y''XC'WV6
MRU]9XO%8NSN<CD\GD;F"RQ^.Q]E!7<WE]?7ES7%;6EG:6T54DLLE5-$=%/-5
M7/'''/+[;?;[C=[BFTVE+Y=UEO6E*4K-KWO:8BM:UB)FUK3,16L1,S,Q$1J_
M>/'?+>N+%6;9;3$1$1K,S/2(B(ZS,STB(]J SS'^XC\,/'>XS6G=)_B7E3V1
M80W,,=SU_?6>.Z<Q^5BKICIMLEVI=\7,>?AJCDXGCGUNPSEC-335'5=PR?'C
MB>OH[]GEZR^H>/#S'FON_%?',DQ,QNJVOR%Z3&NM-C7MG%.L=LUWF7;9:S,6
MC%>OMW;XGZ#^6\]6F[YCMXSC[3'3+$SGFOSQAC3M^:8RVQVCV]LPJF>97O(^
M<WFG]3@]O[)_1;UA-\E/Z)>E.<MH^I7U$?R\?-M.2_%LCN.Z^O5%%+7;93)W
M.,CN8^)K:TMZEJ?HY\'7H=Z+]N^XCC?RIY/'_P!W\E[O<YZZ_P#<4]W3;[;3
M6U8O@PTS329IDS9(28\2])_#/$=,VUV_UGD8_P"WW';DO'_4CMC'CTZQ$TI%
MYB=+6LBO2E;*                               ;%=(^(OE%Y)5U?H'\
M?^VNU;**:JWN\YI^CY_*:MC;BFWOKFF#,;;194ZQAIKBC&STPTW=W#5/+'S%
M'Q5)SQ1SKOS;U<]+_3>O_P#??/\ $\5FF-:XMQN<5,]XUK&N/!W>^R1$WK-I
MICM%:SW6TKK+H>8\I\;\?C_YUOMKMKS&L5R9*Q>8UB-:TU[[::QKVUG2)UG2
M.J9[I+[:#SM[ ^DONW=FZ?Z!Q<GI_6X_+;+-V-NUK\_PYY^GP^@P9#3KSTJ>
M.>*_CL4/[+X<4_-QSS53#3S;[2KT+X#OP>([;F.?W4:]M\>&-IMK:?/DW4TW
M%=?D_P 4MTUUTG2)U)S'Q"^%['6G%X]WOLGR36GNL<_JVRS&2/W*4R?0WVR7
MACH-%A?]Y=C=M>0.<MYJ*KW'P7EGU)U[D;>.XQMSQ%5K^KR9;?+6:;Z2>"22
M/:OEYMKJKBBBB>..XXASYW]ICZR\_;)@\'X[B?']C:/HWFMM_NZ3,7C7WN>,
M>UM$=U;1$['7OI&LVI:V.=3<W\1/EN^FU.&V^UV.&8Z3,3GRQ.DQ]]?MQS[8
MF(G#[:]9F)FJ8;HWV_O"CQM_#I^EO&/I_3,QBOI/H-N_-"PV+?[?Z'\(KM?_
M )XFV4YW>I?2NL%:W/[/(U?->Q?4\_&XJKEJA_YQZ_>M/J1[RGFGDW,;W9Y>
M[OP?6+8=K/=[SN_Q3![K;1K7+>G3%&F.WNH_!Q%8U3S/G'E_D'='+\CN\V*V
MNM.^:8IU[M?P5.W'[+6C[W[V>W[W2&X+4+%0
M
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M$TU^;+6EON=8UD/1Z8&
M
M
M
M
M                                      \?O?8>@=6ZS?[KV;O.G]<Z
M;BO3_%-MWO9L+J&LXWUJ_3A^OSVP7N/Q5GZM?/RT^I+3\W/Y.'<<%X]S_E')
MX^%\9V.\Y'F,NO9@VN')N,U].L]N+%6][:1[=*SHY>RV&^Y+<5V?'8<NXW=O
M93'2U[S^I6L3,_V(5OO-O[E3H?JK\7TGPVU+]83>K?U[3])6V0YC6.E,->T?
M&CUK"P_ZKWKLCZ6ZAKBEC@XP6/FCKHGM<G<T<_#FQOT3^S:\[\J]SS?K'N_T
M?X.VEOJ>"<>;DLE9^2]OI[;9]U9B:S;ZUEK,33+ML=NL;^\/^'SFN3[-YY9E
M^H[*=)]U3MON+1]V>N/%K'6)GWEHG6ML=951O+OW#O+?S@S==_W]VQF,SKD5
MYS>87K/7^:M9ZOUVNFKGFWYQ>F8Z6FPNKRUIJ^2B_P A5?9.JC\E=S6M6](_
MAZ])?1'91M_ >)PX>1FG;DWF7\-O<WS]^XO'=6MO;.+%[O#KUKCA)KQ;P3Q?
MP[#V<'M:4W$QI;-;Z>:WSZY)ZQ$_VM>VGS5AI.W4R\
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MRY;3;+:9FUIF9F9F=9F9GK,S/69GK,L!M:U[3:TS-IG69GVS/SR_9^'\
M
M
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MFN6LS%JS$Q,3$Z3$Q/6)B>DQ/6):AM6U+36T3%HG28GVQ/S2_9^'\
M
M
M
M
M
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M:\>\4\>\5VOU3@=KBV^.8^E:(UO?3Y;Y+:WO_P"U,Q'R1$-:6R60@
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MF2U]-?[6)F8K'R1%8B(CI$1#,#$'5
M
M                                            -/\ R \ /"WRD^MG
M[V\:^J]ZS>1]'B\W+\W8]8[%FC@^MYBMOTEZ=)KW8$=G1)D9I/0IR5,/,M?J
M<T_/Q35QM[P#U]]9_2_LQ^"^2<KL=ECU[=O[Z<VTB9[=9^I[B,NUFVE*QW3A
MFW;';KVS,3E7!^<>7>-Z5X7D-SAPU]F/N[\7R=?<Y.[%KTB->S73I[$)'?\
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M_<F'V'#?(
M
M
M
M
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ML/B;+ZJYFO;GZ3&XZ"VL[;ZF\N9)9/DHX^>62JKGXU5<\\Q%W_(;_E=W??\
M*9\VYWV33NR9;VR9+=M8K7NO>9M.E8BL:STK$1'2(:KSY\^YRSGW-[Y,UM-;
M6F;6G2-(UF=9G2(B(^Y&C[#AOD
M
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MKKP>^VVYM$:S6EX[XCY[8YTO7V3[:Q[)^:6M+9+(0
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MUB9CJT%O^/W_ !>ZML>2PY<&\I.EJ9*S2T?JQ:(G]2?9/R/;.D<,
M
M
M
M
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M.UQ;;;=-8I'TK3'LF]YUODMIT[KVM;3IKHP.SMW0
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M,ZM8Y,E\M[9<MIMEM,S,S.LS,]9F9GK,S/69GVO['Q?@
M
M
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MW76MM-X\#YIXIY/$?D+?[?/DG]9%NW+TC77W5XKEB-/EFFG2?FG34MMADX
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MQ^_XO=6V/)8<N#>4G2U,E9I:/U8M$3^I/LGY'MG2.&
M
M
M
M
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M
M
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MTUFD3VY(CIUG%>*Y(CK[9I$:]-=8EJBVJR8
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M+1^K%HB?U)]D_(]LZ1PP
M
M
M
M
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M@
M
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M6I:/EK:(F/EA'O/@S[7-;;[FE\>XI.EJVB:VK,>V)K.DQ/W)A]APWR
M
M
M
M
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MM[M-(F9T;:-3,7
M
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MC6F3':MZ6CYZVK,UM'W8F8;=Q9L6?'&;!:M\5HUBU9B8F/GB8Z2^:Y+Z
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MQ9:S7+69BU9B8F)B=)B8GK$Q/28GK$M'6K:EIK:)BT3I,3[8GYI?L_#^
M
M
M
M
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M1$1TB(CI$1TB&]*UK2L5K$16(TB(]D1\T/Q?M_0
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MM?V/B_
M
M                                                        #6/R
M/\,/%CRZQ,.(\CNC=#[2^CLZL=C,[F<;)C]VP6/KN>+R:QUOL'7[C$;UK5G<
MW7'%<L5AD;:B:K_G\5-F^G/K+ZI>DF[MN_3GG-_Q???OOBQWB^VRWB.V+9MI
MEC)MLUHKTK;+AO-8]DPR+@/+?)?%LLY> WN?;:SK-:SKCM.FFM\5HMCO,1TB
M;5G3Y%;[RO\ M?=9R$5[LGAGW9>:]?<?434]8=W\5Y;"7'PM.*XH,+V-K>/H
MR^*^%W#S13%?8G(^IQ<?-5=1<0_"6QOTI^T[Y/;VIQOK)PM-Q@Z1]=XW\'DC
MZ76<FSS7]W?Z,ZS;%GQ:=FD8K=^M-_\ C'Q&[C'-=OY;LXR4Z?AMO]&T=?;;
M%>>VW3Y:WKII][.O2M-Y1>WSYA>'&0OX>_>C=PU3 6=YS:0=@X^TIV?K/)TU
MS6L-E<6.^Z[7DM<C_$>;Z#TK>YGM[VBN7B*6".>FN*FR?TO^('T@]8MOCOX#
MSFSW6_O3NG:7M[G>4Z6FT6VN:*9I[.VW=>E;XYBLVI>U)K:9">-^=>*>64K/
M![S%ESS&LXIGLS1[=8G';2_32=9B)KTUB9C29TS;D9:
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MU](O*O#8R;RU(WG"4F9]_BC[VNO2<N/6;8_NS]*D3T]Y*7M$5JP
M
M
M
M
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M74<SY!PGCNV^N<YNL&UV\ZZ3DM%9M,1K,4K]]>VG7MI%K?<66?$#[8??,_\
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M;MQUTKTCI%IB;?+-IF9F=QFGF)@
M
M
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M$_)+=&#/@W6&NXVUZ9-O>-:VK,6K:)]DQ:-8F/NQ+X[EOJ
M         G@\!??T\K/$K\W= [@GO/)KHK&?[AQA-RS4]':6J8NOU.(*=.[+
MO8\E?7UGB*I*>8<9FH[^V^DAILK2;'1?)+%!/U[^ KTK]6?K'/\ B%:>,^<Y
M?I>\V^./J6>\::_6-G6:5K;)I/=FVTXK]]IS9:;BVM;Z6\W]$?&?*/>;[BHC
MCN:MU[L=8]S>?_>8HTB)M\M\<UGNF;VC).L3<^\-?<8\3O.S6;;,=%=CV<FT
M\6==YG.H]PDQNO=N:K1'751-SF=/HR>0^LLXOAQSS?XRXR.,YYJXIIN>:OC3
MQ31ZQ_#MZK^A?)VV?G7&WCB^_MQ;_;Q?+L,^OL]WN.RG;:?^ZS4Q9NFLXXC2
M9B1Y9X#Y/X7N)Q<UMY^K:Z5STUM@O_U;Z1I/]S>*W_N6\C1[#0
M
M
M
M
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M.FMIF=-9G2/9&O1[QT+A
M
M
M                    -7?)?PL\6_,# \X+R)Z5TGL>2'&SXK$;1D,7'8[]
MK%E/-S=5PZIO^*YL=PUR&J\^$U<-I>1032<<>K1)Q\>.=H>FOK1ZH^D&_P#K
MWIYS6]XZMLD9,F"EYMM<UHCMB<^UOW;?-/;]&+9,=K5C[RU9ZLD\>\N\D\5S
M^^X'>9MO$VBUJ1.N*\QT^GBMK2_3IK:LS$>R85FO+?[7^XXKRNT>%/<\,D=4
MUY?1=3]ZS5PUPV_%OS<TXS6^S-9PTU-U-S=4U064&5Q4-/$=<?U.2YYHDGKL
MM])?M.L<UQ<7ZT\-,6B*UG?<9$3$SKIWYMGFR1VQVZ6R6P9[3K%O=;;2:TK(
M;Q?XC:Z5VWE^TG72(]]MOGUTUOAO;ITZVFEYZZ]N/K%8K'>1'B1Y*>)NQQ:M
MY%=-;MU7D[J:Z@QEUL&.HFUS.UV4LD-U5K.X8B?):EM$,-<?//,F.OKF/Y.:
M:N*OEJIYYLR]//5KTV]5^.GE/3OF=ERNVK%9O7%?3-BBT1-??;?)%,^&9U]F
M7'2==8TUB8B17 ^4>/>3[?ZSP.[P[G'$1,Q6?IUU]G?CMI>GZEJQ/R>UKJV(
M[X                     !Z34-RV_KW9L-NN@[5LFC[CKEY3D=>VW4,YD]
M:V;!9"BBN.B^PV>PMU997%WE%$E5/$L$M%?'%7/'Q_+RZ[E^&XCR#C,W"\]M
M=MON'W%.S+@W&*F;#EI/7MR8LE;4O76(GMM68Z>QQ]UM-KOMO?9[[%CS;3)&
MEJ7K%Z6CYK5M$UF/N3$K2OM_?<F[CIGX#UAYXZ_>=@:O1^%8BP[^TBP@HWS!
M6U'PLJ[[L?3J.8+'>K..FN.:XR&+JL\K%#;RU?1Y6YFIXIJZ]?OLWN'YGW_D
M_H3N*<?RD]^2_%;FTSM<LS]+MV>XG6VVM.DUIBSQDP6M:L>^VN*DZQN\Y^'W
M:;OOY'PK)&#<_2M.VR3/N[3[=,63K..?;$5OW4F9CZ>*L+>O3'>'4?D1U]A^
MU.D>P-;[+Z_SWJT8[9=8ON+NT^IMN:>+O&W\%=,-_B,Q855\4W%E=Q07=O5S
MQ3+'1S^147YGX1Y;Z>>09O%O-N/W/&\_@T[\.:O;;MG[V]9C6N3';VTR8[6Q
MWCK6TPBSR_#<IP.^OQO,8,FWWU/;2\:3I/LF)]EJS\EJS-9^29948LZP
M
M
M
M
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MIMEM,S,S.LS,]9F9GK,S/69GVO['Q?@
M
M
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M/6):$M6U+36T3%HG28GVQ/S2_9^'\
M
M
M
M
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MN)VG&3K$8-O-L=9B>FF2T3WY=8]L7M-->M:5]B5U%1K(
M
M
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MF)B8F-8F)CI,3'6)CI,-Q5M6]8M68FLQK$Q[)CYX?B_;^@
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M[L"
M
M
M
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M:VD^R(23(W-?
M
M
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MFMZS\EJS,3\DM[X,^#=8:[C;7IDV]XUK:LQ:MHGV3%HUB8^[$OCN6^H
M              #[&O[#G]3S>+V75<YF-9V/"7D.1PNP:_D[W#9O$9"WJ^>W
MOL7E<=/;7]A>05?EHEBDHKIY_P!G/#B<AQ^PY;99>-Y7!AW/'9Z33)BRTKDQ
MY*3[:WI>)K>L_+6T3$_+#Y9\&#=8;;?<TIDV]XTM6T1:MHGVQ-9UB8^Y,+4/
MMW_<B;CIGX+U5Y\V%YV!J]'I6..\A]6QL%&^8*VH^IXAI[$TS$V4%CO5G'37
M!%^)8VFSRL4-O5)<096YFJEIJT^(7[.+A^9]]Y3Z"Y*<?RDZVOQ.>\SM<LSI
MK]4W&2TVVUITM;W.:<F"UK17'DVN*D4F-?GGP_[3=]_)^$6C!N?;.UO,^[M/
M3]JR6F9QS[9[+]U)F=*VQ5B(7!^K.V>LN\-&P?9G3^^:KV3H.QPUS8;;--S5
MEG<-><P2507EKS=6,LM-MDL;=4507=I-Q'=6=S'7#-''+151Q4%Y3XGY-X1S
MF?QKR_8;KC>?VTQ&3!N,=L62NL:UMVVB.ZEZS%L>2NM,E)B]+6K,3,5>2XOD
M>&WE^.Y7!EV^^QS]*F2LUM'S3I/MB8ZUM&L6B8F)F)B60F/N
M
M
M
M
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MZ$3,WF)]ELMKWCV1;3HW]:#8.
M
M
M                                           U%\I_!#Q0\SM<FP'D
M+TUJNY7O$-<>)W>VM>=?[)UN7F*F.*;7]_P=5CL]E#%7#%779UW$N.N^8(Z;
MJWGCHXH;;]+?77U6]&N1KO\ T^YG=;/#KKDVTV][L\T:ZS&7:Y>[#:9B;1&2
M*5S8^ZTXLE+3W,I\:\T\G\2W$9^"W>7#37Z6.9[L5_\ K8K:TGY?I:1>NL]M
MJS.JI/YM_;5]\=4_B^[>&VV_K":+;^O=_HUVN;#ZQW7A;*/YJ_1L+_\ ZKT7
MLGZ6UAKDED@YP60FDKH@M,9<U\_'FV7T3^TE\$\J]SPGK'M/T?YRVE?KF",F
M;C<EI^6]?I[G9]UIB*Q;ZUBK$3?+N<=>D2@\/^(/A>3[-GY9B^H[V=(][3NO
MM[3]V.N3%K/2(GWE8C6ULE85L]OTW;^O=FS.E;]JNR:/N.N7E6.V'4MOP>3U
MK9L%D***)*[',X'-6MEE<7>4424U<Q3Q45\<5<<_#\O"R+B.9XCR#C,/-<#N
MMMON'W%._%GV^6F;#EI/3NQY<=K4O76)CNK:8Z>U(':[O:[[;TWFQRX\VTR1
MK6]+1>EH^>MJS-9C[L3+S;L7(                    ;=>(7G/Y,^#F\\[
MOX]=C9+6X[^:WDVK1LE)<9;K;>XK6.>&WAW+3);F+&9::T@NI:+:\I]'(V/$
MTG-K<0\UU<\ZD]7?0WTT]<.#_(GJ#QV/<VQQ,8-S2(Q[S:S:8F9V^XBLWQQ:
M:UF^.>[#E[:^]QWBL1&+>4^&>.^9;/ZGSNWKDFL3V9(TKEQZZ:^[R::UUTC6
MO6EM([JSI"\C[=/OC>,WG!<83K+=*X>@O(J]AQEG;:)MN4M_S1[#S5U7%92V
M_56XSU06^3R4^0ECXAP=_3:9B3ZBFFTHOZ8;B:.C[XB/@@]2_1''G\FX:)Y_
MT[I-[3NL%)]_M,==;1.^V\:S2D4B>[<XIR;>.V9RVP3?'2T-O/?1OR+PZM^1
MVFN^X&)F9R4B>_%6.NN;'UF(B-=<E>ZD:?2FFM8F;="AI\
M
M
M
M
M              !H3YV>X_XS>W[HTNP=R;;#?[[E,;5>:#TOK,]O?]D;U+))
M=VUK<6V*XKYIU[5?JK">FXSF2YM\=%S!)%'7/><PVDV^?0OX<O4OU_YR./\
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M:VD^R(23(W-?
M
M
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MWK/R6K,Q_99R8.Z8
M
M
M
M                                        !^-Q<6]G;SW=W/#:VMK#
M+<7-S<2T06]O;P452S3SS2U4QPPPQT\U555<\4TT\<\\\_!^\>/)FR5Q8JS;
M+:8BM8B9F9F=(B(CK,S/2(CK,O[6MKVBM8F;3.D1'MF?FA5>]RK[BO3>OK?8
M^G/ JZQN^[]S#^'W_D5=V=GE>N]2GEHEHNJNO,)E+:>U[ SUA5S3S%?WD-6
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M_3R?=CZ-)]O9"75$AJT
M
M
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M?AL4?^\I7VUC_O*1V_+:*)X4$VE0
M
M
M
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M$5W^;3>>0:?MUZQICF8ZQ@K.O9\L=\_A)B9C6M;35#.F0VT
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ML_#^
M
M
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M9B8F)B=&]L>2F6E<N*T6Q6B)B8G6)B>L3$QTF)CK$Q[7\;[/T
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MM$0]YW@.7\:Y*_$\U@O@WU/DGV6CKI:EHZ7I.DZ6K,Q.DQKK$PS8PITX
M
M
M
M
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MK3[-8B(B)H\%X_P_C7'TXSA,%,&TI'LK'6T_VU[3]*]I^6UIF?[#!K.'<@
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MO-]ER9MWDG6U[VF][3\]K6F;3/W9F7I'6N.
M
M
M
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ME]J[/+:=AS,Q^U9K1VVGYL6;I6_MB(K:,>2W7MQS$3*&%,MML
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M-6A<U"
M
M
M
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M%BK%<58B*UB(B(B(TB(B.D1$=(B.D0D;6M:5BM8B*Q&D1'LB/FA^+]OZ
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M)_D'DW.>4[Z>1Y[<Y-QN/D[ITK2/[7'2-*4KTZQ6(UGK.MIF9V$:^=$
M
M
M
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MQWO&;N^PY'%DP;W'.EZ7K-;5G37K6=)C6)B8^>)B8Z2]@Z=Q
M
M
M
M
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M)/T8VN0
M
M
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M]IC%N*1/N\D:SI&OZS)I$S..T]T1UCNKI:9 F@&#
M
M
M
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MUF9GK,S,]9F9ZS,^U_8^+\
M
M
M
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M1.++BW&*N?!:M\%ZQ:MJS$UM68UBU9C6)B8G6)CI,=8?-<E]
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M#@[7Y?Q"N7=\/KK;#]]GPQ_<Q'7-CCV1I$Y*QIW1>(MD67U:J/0
M
M
M
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MW(?>1^5<]Y9OOK_/;B^?+$SVUF=*8XM.LUQTCZ-(Z1KI&LZ1-IF>K99K5CP
M
M
M
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MY+A-]DXSEL.3;[_%.EJ7C28^:8^2:S'6MHF:VB8M69B8EDACCKP
M
M
M
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M^.XGOV/ 3TFL3^&RQ_[R]?96?^[I/;\EINGA03:5
M
M
M
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M,FD3-L<SK&DS6;TTO,A"/K!0
M
M
M
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MU_;:\^R-9GMK6-*TI$S.E*16M=9TB&8&(.J
M
M
M
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MQ]]UUR8^NOO*QK6(GWD1%?>6L+J^&B0
M
M
M
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M,L3&D^^O$]:SU_!5F*:3I?WDQ%HG)0?:;
M
M
M
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MM$Z3$Q,:3$]8GI+Z3C/F
M
M
M
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MG69F9SPP1TH
M
M
M
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MB:S[+5M$S6U9^2U9F-8F)TM$Q&<F#NF
M
M
M
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MGI.''/2=(TR3'2TUB;4FRRK81[
M
M
M
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M<SK'MB;4TO,@30#!@
M
M
M
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MI^6]IFTZSUBND1O(T>PT
M
M
M
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M(C2/EBN2/HVT^EV6M%9FW0H:>
M
M
M
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MXH?M N(\.^L>"^AV7#R'EM>ZF;E-*9=GM+>R8VL6[J;S<5G69O:MMICGM_\
M$S.3'CCCZD>NFUXGWG"^&6IGY2-:WW.D6PXI]FF*)UC+DCYYB<5>G[9]*M;J
M&CZ-IO6>HZ_H/7FK8'2=)U3&P8?6]5UC%V>%P.$QEM\?2L\;C+"*"UM8>*JN
M:N>*:>.:JZJJJOC55SSS2_S?.<SY+RVXY[R'=9][S6[R3DS9\U[9,N2\^VU[
MVF;6GY.L](B(C2(B$1-YO=WR.ZR;[?Y+YMYEM-KWO,VM:9^69GK+U3JG&
M
M
M
M
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M$2]XWD^/YC98^2XO-3/L<M8M6])UB8F-?U8F/EK,1:L]+1$QHQZR!S@
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MHIEX:,GD/B%+9.'K6;Y<&LVOATGK;'KK:^*(ZS$ZWQQ$S,VKKV6@U8:.0
M
M
M
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M"]^T\<G6)^3-GCV3[V8G2N.8_P"RK[=9[[7B8K6?E =I
M
M
M
M                                                       !H3YV
M>W!XS>X%HTNO]R:E#8;[B\;59Z#W1K,%O8=D:++')=W-K;VV5XHXIV'5?JK^
M>JXP>2XN,=+S/)+'1!><0W<.^?0OXC?4OT YR.0\.W<Y.!RY.[=<=FF;;/=1
M,5BTVI_V6?MK6*;G#V9J]M:6M?#WXKYMX7Y_Y%X-O/?\3EFVRM;7+M[ZSBR>
MR)F:_K;Z1&F2FEXTB)F::UF@;Y_>U_Y,^WIMW-IV?A(=LZKS.2O+71.[=.AN
M+K2]EMX>;:2"US4%?%>0T7:OI[V.F;&9+BFF2XHGXL;B_MX>;JJ_#T"^)WTT
M^(/B?>^,9YVGE.''6VZXW<3%=SAF=8FV.8^AN<&M9FN;#K,5FGO\>#)?W43>
M\']1O'?.]KW<=><7)4K$Y-ODTC)2>NLU^3)36)TO3V1IWUI:>U'*D4SX
M           !:Y]H+WZ,AU]^;/C'YR[5F-BT^^S%OB>O/(W9\M/D\MHD&0^H
MXBP';>6R,L^1S6GT9&J&.SS<LE=QAHI:J+NJO'QQR6-5/Q=_ ?M_(/K/J;Z'
M;7#M^8IAG)N^(PXXICW4TTUR[#'2(ICW$T[IR;:L13<6K$X8C<6M7/&;U4]%
M*;[WGD7AN*F/=Q2;9=K2NE<DQI]+!6-(K?36;8XC3),:TTO,Q>Z';W%O>6\%
MW:3PW5K=0Q7%M<V\M$]O<6\]%,L,\$T554<T,T=7%5-5//--5//'/'/P4RY,
M>3#DMBRUFN6LS%JS$Q,3$Z3$Q/6)B>DQ/6)1'M6U+36T3%HG28GVQ/S2_9^'
M\
M
M
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MA8
M
M
M
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MR;+>X[XMWBO-;TM$Q:MHG28F)ZQ,2](ZUQP
M
M
M
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MIE/3A>$XOQWC<?$\/AI@V.*-(K6/;/RVM/MM>WMM:TS:T]9EA]E[M0
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M,<=>
M
M
M
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MK6T:Q:)B8G1EIB;JP
M
M
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MF=G%\5QO";''QG$X<>WV&*-*TI&D1\\S\LVF>MK3,VM,S:TS,S+&[(W/
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MUF9GK,SUF47[6M>TVM,S:9UF9]LS\\OV?A_
M
M
M
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MX1Y_P/G>P^L\7?LWM(CWN"TQ[S',Q&O3]?CUG2N2(TM[)BMM:QH&WXS<
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M8C81KYT0
M
M
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M-CBXSC,5,.PPTBM*5C2*Q'_IF9G69F9F;3,VM,S,R\&[US0
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MKW)>:9+<9Q??M?&HF8[-?IY]+:Q?+I[(Z1-<43,5G6;6O.G;.>@XTR
M
M
M
M
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M6(M$3+;IJ1BP
M
M
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M(SN-]:</&4G\%MJVF<>/36(F>D1?),3/=DFL3.LQ6*TTK$BB.[ @
M
M
M
M
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MN8MQ?*5[L5M9PYHB>S-37[ZOS6CI%Z3.M)^>LUM;=AI5B
M
M
M
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M1$1"=6TVFVV&VQ[+98Z8MIBI%:4K$16M8C2(B(Z1$0\V[%R
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M^3\UY;R=N5YS-.7<3K%8]E,==9F*8Z_K:1K.D=9GVVF;3,SL@UPQ\
M
M
M
M
M                  !!)[K?LH=8>=-EE^X^FZ<#U3Y810Q2W>R7'%[;Z;W!
M:X^Q^DLL'V'9V/,\>,ST$<4<=IL5K:RWG$-'%O>1W<%-KS93I^%3XU/)_0W-
MA\/\Q]_ROI3,S%<,=L[CC[7MW6R[2UM)OBF9F<FTO>N/NGWF&V*\Y8S;H],_
M5_D?#+TXGEN_<^,3/2D:3DP3,ZS;%,^VL]9MBF8KK]*DUF;=]"#MOI_M#H;L
M'8NJNY-$V3KCL/5+SFRSNJ[3C9L=DK6KGCY[:\M_GXYM\GA\G;\TW%E?VLDU
ME?VLE$]O++#)1)5?/XEY?XQYYX_M_*O#M]MN1\>W=.[%GP7B]+?)-9TZTR4G
M6N3%>*Y,5XMCR4K>MJQ-OB^5XWF]CCY/B<V/<;#+&M;TG6)^>)^6+1/2U9B+
M5F)K:(F)AC=D;G@             -A/&+RD[K\0.W-;[HZ*W"\U;;=>O(9;F
MSJKN+C6=MQ/'-5-]JVZX&BXM[?8=;RMO)7'+#)S3+%S5Q-;R07,<,\>OO4WT
MO\*]7O$MSX9YULZ;KB=Q28K;2(S8,GZW/MLLQ,XLU)B)K:-8MIV9*WQVO2W1
M>1>-\/Y5Q>3B.:Q1EVN2.D](O2WR7QVTF:WK/6)CI/LM%JS,3T</;D]QOISW
M%.G(MYT:6'6.R]8AL+'M[J&^OX[G/:'GKF.OB.[M).:+>3.Z3G9+>6O%96B*
MBB>BBN&:B&[AN+>+SI?$7\.GF/P[^8SP?.1.Z\:W4VML-_6LUQ;K%6>M;1UC
M%N<436,^";3-9F+TF^*^/): WGW@/+>!<M.SWD3DX[),S@SQ&E<E8^2?;VY*
MZQWTUZ=)B9K-;3(<CTP,
M
M
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MCQ&QQ<9QF*F'88:16E*QI%8C_P!,S,ZS,S,S:9FUIF9F7@W>N:
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MK$'N1Y'?<OOLO)\GEOFW^:\VO>TZS:9_]$1$:1$1$16(BM8B(B'O'1.$
M
M
M
M
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MR5CY)]O;DKK'?37ITF)FLUM,AR/3 P
M
M
M
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MIFUK3,S,S*&N7+EW&6V?/:U\][3:UK3,VM:9UFUIG69F9G69GK,]9?2<9\P
M
M
M
M
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M)76.^FO3I,3-9K:9#D>F!@
M
M
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M$?M<S,]];B:GU%(
M
M
M
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M[/>1.3CLDS.#/$:5R5CY)]O;DKK'?37ITF)FLUM,AR/3 P
M
M
M
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M_6C)R?O_ !CQ*_;Q<_0R[FL_2R^V+TQ3\F*?9-XZY(UBOX.=;VH56J-8
M
M
M
M
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MG_LY*^S)369K,Q,:UM2UM_&@V#@
M
M
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MC6,FXTU[HCV=N"W3Z.D6O$?3F*VG&LCJX4?P
M
M
M
M
M             %/[WBO8=_\ F]\M?"+ ?_U[1V9XSZ]A_P#X9=;1N/3D-G+_
M .YW,VJ16W_VQ7C9/_>^,6]?![\=G_@/2;ULW'S8=GS.7)_U:X=OR$VC]6E=
M]:__ '<;FO[9N4J?2CUJ_:/%_,;_ -QAW=K?J13'GU_LQ&:9_M8R1]]D4_EO
M*5(             #:CPZ\Q>Z_!WNO =W=(Y_P##\QC_ )<?LVLY"JXFU/L'
M4YKB&;*:=N.+AFA_$,/D/1IJHKIJHN;*YHCN;:2*XBCDIU;ZP^CWA7K?X5G\
M)\VP>\V>3Z>'-32,^TSQ$Q3<;>\Q/9DIK,3$Q-,E)MCR5OCO:LXUY7XIP_F7
M#WX?F*=V*W6EXT[\5].F3'/R6C_HM&M;1-9F'2"\#O/'I3W >E+#MKJ6_P#P
M_,8_Z/%]F=9Y2\MY]LZQVR>WKEKPV9HBH@_$,/D/0EEQ.6BBHMLG;45<\4Q7
M$5U:V_G(]=O0GS7T!\UR>)^68_>;/)W7V>\I68P;W!$Z>\QZZ]F2FM:Y\%K3
M?#>8B9OCOBRY( ^:^%<QX-S%N+Y2O=BMK.'-$3V9J:_?5^:T=(O29UI/SUFM
MK;L-*L0
M
M
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MZVG2]XU[:TL1J\FAP
M
M
M
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M'28F.L3'283"K:MZQ:LQ-9C6)CV3'SP_%^W]             ;I>"'G1W'X
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MBG;EKUI>->S+37IDQS\M9_Z:SK6T1:)AM0U8QH
M
M
M
M!XGLGL?1NH-"V[M#LS9L;IV@Z'@<ALVV;-EZY*+'$8;%P57%U<R401SW5U-S
M33Q1#;P1RW-S-51%#')+7115W?C?CG.>7\]M/&/&MMDWG/[_ #TPX,..([LF
M2\Z5K&LQ6L?+:]IK2E8F][5K$S',X_C]YRN]Q<;QV.V7?9[Q2E*^VUIG2(^:
M/NS,Q$1K,S$1,N<W[LWN?;C[B?<_/& GV35O&KKZ\FM^I>M\G=0157MW11-9
M7G9>W6-A3Q;2;AL-M)5Q##)+=TX:RKYM;>6KF2[FN?1/\)_PQ\/\/'AO^/UV
MVZ]2>0I$[_>4K,]M=8M79X+6ZQM\4Q'=:*XYW&2/>Y*Q%<5,<]_3#TYVG@?$
M?AXQY/(<\:Y\L1/2/;&*DSU[*S[9B*^\M]*T=*Q6)=+%L\            !Z
M33M.VOL+:]=T;1M=S&V[EMN8L-?UC6-?L+C*9O.YO*7$=IC\7B\?:1RW%W>7
M=Q+311113SSSSRZ[F.8XKQ_BMQSG.;C#M.'VF&V7-FRVBF/%CI$VO>][3$5K
M6(F9F9<?=[O;;#;9-[O<E,6TQ4FU[VF(K6L1K,S,](B(= GV>O9ZU3P-U2S[
MC[CL\/MOEOMN'JCO[^.JWRF$Z5PF4M_EO-)TF\I]6WN]DN[>7F'.9R'GGB?C
MFJRLJOHO6FR% ?Q?_%_ROKORM_#_  ^^;:>DNTS:UK.M,G(Y*3]'<[FO2:X:
MS'=MMM;[WIFS1[[LIMX.>JWJMN?-=S/$\3-\7B^*_2.L6W%HGIDR1[8I$]<>
M.?9TO>._2*3JH,M,
M
M
M
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M(.!Y+QCE\W"<O2*;[!;2=)UK,3$36U9^6MJS%JSTG2=)B+1,1G)@[I@
M
M
M
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M2#TNIX?LHYKF\=+>49HZ?KOJ^.T1^#K/L]Y;K[R\?)/NZSVQ:UX!T^&[P
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MF3)'MBD3UQXY]G2]X[](I.J@RTP
M
M
M
M
M           @D]W[V<=-\Z-1ONWND\9@=)\LM4QL\EE=T46>%P/=F,MN)+GC
M4-XN>.(+6UVKBJJKC$9Z;GCFBNKBTOJ^;2J*>PG3\(?QA\SZ&\O3Q'S7+GWO
MI/N\D1:LS;)EXV\Z1]8VT=;6P>SZQM:^V(][@B,T7IGW1Z5^J^[\,W5>*YBU
M\WC&6T:QUM;;S/3OQQ[9I_;XX]OWU([M:WY_FXZ=M?7NU[%HV\Z[F-2W+4LQ
M?Z_L^L;!87&+S>"S>+N)+3(8O*8^[CBN+2\M+B*JBNBNGCGCGA?SP_,<5Y!Q
M6WYS@]QAW?#[O#7+AS8K1?'EQWB+4O2]9F+5M$Q,3$IQ;3=[;?[;'O=EDIEV
MF6D6I>LQ-;5F-8F)CI,3#S;L7(             2K>U7[GO9/MW=QV7KWF2V
M7QOW_/8J'NGK3YJKKB&SKDM["X[&T:TEFB@L>PM<QE/S4T<5Q09JVAILKJJG
MX6MU9Q7^*?X9/&_B&\.OV4Q[;U'V&"\\=O/O=;1$VC9[FT1,VVF:_29TM;;7
MM.;%$ZY<6;6GJ7Z<\?YYQ,Z17'Y!@I;ZOE]G7K,8LD_+BO/ZLXYGOKK]*M^C
MAU?VAU]W3U]J?:O56V8?>>O-YP]OGM5VK W'-QC<MC;CFNCYJ?GHBN+2\M+B
M*2WNK6XCBNK.ZBD@GCCFCDCI\Z/D_C'D'A?D&[\5\JVF;8^0['-.+/@RQI?'
M>.OR:Q:MHF+4O6;4R4M7)CM:EJVF O(\=ON(WV7C.3Q7P[_#>:WI:-)K,?\
MHF)C28F)F+1,6K,Q,2]XZ)P@
M
M
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MO96W[52?FC):.Z:UI/:@:TF
M
M
M
M
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MB8F-)B>L3TE])QGS
M
M
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M*3UM.E[QKVUI8C5Y-#@
M
M
M
M
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M:3.2L16)[JUK:\\HY0S
M
M
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M%:4I2L1%:UB(B(B$]=IM-ML-MCV6RQTQ;3%2*TI6(BM:Q&D1$1TB(AYMV+D
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MK%/([6\7\<O/Y#QW_"YJS,?6+5_6UTG2<%9ZZSK[RT5M&E:UF]E]6JCT
M
M
M
M
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M7Q_'$;>9UW6&E9^C,^W<5BL:=L^W-'3MG7)K,6OVVUU32+X
M
M
M
M #3_ ,Y/-+JKP-\?MI[X[1D_$?P[TL3I&B6.3QV.V/LC=LC5Z>(U77_Q"O\
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M]N'',3UQ_)DMUC)][7Z&LWM<JJ49@
M
M
M
M
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M],<Z=?=VF?P=IB(C]KF9MVS>P*@"T:
M
M
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M^M(_"=TX[FZFM$H
M
M
M
M
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M2FWBRXMQBKGP6K?!>L6K:LQ-;5F-8M68UB8F)UB8Z3'6'S7)?0
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M@C7)PNXFUMOD_N8G]KO.D1[S'$Q%M.EHF+Q$=TUK**C UP
M
M
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MU[3:TS-IG69GVS/SR_9^'\
M
M
M
M
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MI:LPVH:L8T
M
M
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M[O<E\N[RWFU[VF9M:TSK,S,]9F9>D=:XX
M
M
M
M
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M9TCA@
M
M
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MDG+R&>_=>T_+TB(B(CI%:UB*UK'2M8BL1I#*C%G6
M
M
M
M
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M%#R%
M
M
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M6.M;$_%/&.-\0X/!P7&1^ Q1K:TQ]+)DGK?)?Y[6G^Q6L5I72M:Q&L;9C(@
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M,@
M
M
M
M
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M*Q,QCR6_[6(B-*X\D_?ZSTR6C3I?2MIM5NC8
M
M
M                                         _CR.1Q^(Q]]ELM?6>+Q
M6+L[G(Y/)Y&Y@LL?CL?905W-Y?7UY<UQ6UI9VEM%5)++)531'13S55SQQQSR
M^VWV^XW>XIM-I2^7=9;UI2E*S:][VF(K6M8B9M:TS$5K$3,S,1$:OWCQWRWK
MBQ5FV6TQ$1$:S,STB(B.LS,](B/:YUOO1^YQD//GO;\SNN\I>0^+_2F8S.+Z
MQLZ.9[.#L//\U_AN9[?S%C7Q%--^-0V_,. BNZ.)L=AJ^:O2M;F_OXJO0_\
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M
M
M
M
M
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MOK,6CKW166-%%K$
M
M
M                  !4H^XD]SVC 8?+^WWTAGYH]AS<.+N?);:,1=W%K+A]
M<NK6WS6+Z<MYOH**IIMKM;JSO\W+:7=-%..XIQLW$M%Y?01VR_9Y?#';?[S#
M\0'F^WB>/P3>.&P9*Q:,F:MIQWY"8[ITC!:N3%MJY,<S.;7<T[;8<%[2@]!O
M3F<^6OG/,4CW%)F-I2T1/=:)FLYYZ_K)BU<<6K]_^$C2:4F::BXY+(
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MP'"99_1O;WTM-9^CN<E9^_Z1UQTG]KC6:VF/>?VG;815]M%@
M
M
M
M
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MV[K#?36/O;U_69*3\M+UTM'RQ[+1%HF(V$:^=$
M
M
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ME:5B*UCY(B(6!8,&':X*;;;UBFWQTBM:QTBM:QI6(CYHB(B'QW+?4
M    !;=^WX]IV7.9#7?/GR.U7T\)B+R')^,FA;)C;N&YRF;L9\9DL5W_ ',$
ML\,/&'Q4U$D>L43PR\W5WQ5E8Z8J+?&W%S4O\?\ \5U=CM]QZ"^G.ZUWN:DT
MYG=8;UF*8[1>E^*B8B9]Y>-)WLUM7LQS&UM-K9-SCQ1>]<O4Z,-,GA' 9?PU
MXTW>2DQI%9UBVVB=/OK=)S3$QI7\%.LVR5K<E4Z(G
M
M
M
M
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M5M$Q:MHG2:VB=)B8F-)B>L3TE])QGS
M
M
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MS,ZH(Y,E\M[9<MIMEM,S,S.LS,]9F9GK,S/69GVO['Q?@
M
M
M
M
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M2(C7_&Z5CY9F(KGB*U^6=8S3,^WMOI]_*WVJ(17
M
M
M                                       4,?N _<OB\G^VX?%'I_-_
M4=%=#;)?2;CE[&JTELNS.Y\?S>X>[O[/(VEY>T9#3] L)IK''54<6]-SD+J_
MGDIN(J,?+'>]\ 7PU6],?$I]5?+\';YSSVVK&WQV[HMLN.OVY*TM2U:]FXW5
MHKES:]\TQ4P4K..T[BMIK>AWIY/CG%SY-RM-.:WN./=UG77#@G2T1,3$:9,L
MZ6O[=*Q2([9F\37+6*M^            -TO ;PF[)\]_([4.B]!HFQN)GFAS
MO9V]56E=WC^N>MK"]M8MCVBYB^,<=WDO3N*;7%V54D7%_E+B""J2&*J2>+3'
MKUZU^-^@WISO/.>>FN3=UK.+9;7N[;[O>6K:<."L]9K36)OGR1%O=8:Y+Q6]
MHK2V(^;^8<?X3P&7F=]I;+$=N''KI.7+,3V4CYHZ:WMI/;2+3I,Q%9Z97CWT
M%UEXP=.:%T7U!@8=?T/KW V>$Q</$-C1D<K<0QT\Y/9=CN<?9X^WRNU;-D.9
M+[)WGHQU75[/))S33\WR\>:7U!\]\F]3O,=_YSY?GG<<[R&>V2\ZV[*1,_0P
MX:WM>:8,--,>''W3%,=:UUG357CSO-\CY'RV?FN5O.3>Y[S:?;I6/DI2)F9K
M2D:5I76>VL1#,S#74@
M
M
M
M
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MJB0U:
M
M
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M;XYT^ACZ:VGI&M\DQWVUUF.E-9BL)($<6
M
M
M
M
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M7C2U9TC6)C6(G6&;&%.G
M
M
M                :W^6_E!UUX<>/W8OD+V?<?'7]$P]=Q8X2"[M;3+;CLUY
MS]+K>FX#F[JXHDS&PY22B&CGY:^((O4GDX]**2KC8_I+Z8^1>L7J!QWI]XQ7
M_P"8;_-I;)-;6Q[?#7Z6;<9>WK&/%2)M/L[K=N.L]]ZQ.0>+^.;_ ,LYS;\%
MQT?A\U])M,3-<=(ZWR6T_6UC6?NSI6.LPY@ODUY&=F>67>78/?W;F6_%MU[
MS'U]S3%'%!C\+B;*WAQNNZSA[:"*"*WP^M8*SM[*WX^7U9*(?4FJDFKDDK].
M/IGZ=>->E'@_'^ ^)8O=<+Q^'MKK,S?)DM,WS9LDS,S.3-EM?)?KI$V[:16E
M:UBQCQW@..\8X;!P?%U[=G@II'SVM,ZVO:9UUM>TS:?DC72-(B(C [.W=
M         +U/L >UO^KMU]8^9?>6N_3]Z]LZW+%UCK&9M?C?]3=6YKFB2G+7
M%K/3S1C=\[(L(HYI*J>.;O'8*6BTJKAEO,G:\49_'W\4/\X?D%_1OP?<=W@W
M$[F)WN;';Z._WN/I[N+1]_M=G:9K$3]#-NJVS1%ZX=MEF&/KAZD?E[?6\2X;
M)KPNUR?AKUGIGS5_6Q,>W'BG6(_6VR1-M)BF.RRRK81[
M
M
M
M
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M2@1!P
M
M
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M[N9OM*&T)@
M
M
M
M
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MZY^GD\%RD^5\533A][D_"UC6?=9[:S:?9TQY?OHZSIDF]8[:S2JR:K>1]
M
M
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M%8C2*UC2*UB*UB(B(9(8XZ\
M
M
M
M
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ML3/;K.XS3S$P
M
M
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M:]
M
M
M
M
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MQ/28GV/['Q?@
M
M
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MN'I[:8_OLFNL3D[8Z3CGNM<JJ49@
M
M
M
M
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M%XC<Q'ZS-/2N33Y*Y/9;YLFD^W(M0JM4:P
M
M
M                       $&'OK>XQ;^&'C7<=5=<;##:>2'D+C<AKVHT6-
MS15ENO\ KOFNFRW;LNZ@I@GJLIKBUDDP^#JDKM9),E<RW=M5-^%747$X_@8^
M';)ZR^I-?*O(]O-_3CQ[)3+N.ZL^[W6[^^VVSK.L=T1:(W&YB(O$8:5PY8I]
M:Q6;F]&/ ;>6^0QR>_QS/C^PM%KZQ]'+E]N/%$ZQKI.F3)IK$4B*6B/>UESS
M'H03L            3&>S'[;N0\]_)&RRV]X.\K\9NF;S';/V_DJY)K&SV_(
M1RTW.M=0XV\AHJN9KS;[F'U,KS!5!7:8&&ZJIN;:[GL.98>_&5\1VW]!O3B^
MTX+/2/4OF:7P["FD6MMZ3&F;?WK,Z17;Q.F#NBT9-U;%$X\F*F?LU1ZM^H%/
M"?'YQ;*\?I%NXFF"/;-(]E\\Q[-*1TIKKW9)K]&U8OIT:L=CL?B,?8XG$V-G
MB\5B[.VQV,QF.MH++'X['V4%%M9V-C9VU$5M:6=I;14QQ11TTT1T4\4T\<<<
M<</.IN-QN-WN+[O=WOEW66]KWO>TVO>]IF;6M:9F;6M,S-K3,S,S,S.J ^3)
M?+>V7+:;9;3,S,SK,S/69F9ZS,SUF9]K^Q\7X
M
M
M
M
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MZ:QUK>(]EXGY-&[S23#@
M
M
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MC]2.LS^NM-K?*VT:F8N
M
M
M
M
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M_-+]GX?P
M
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M(F\Y)^E6,=HL@JY&@
M
M
M
M
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MQU0T]>/ )X?E)\OXVG_RS>Y/PT1$_@]Q.LS>?FKFZVU_[SN_MJPLRJTD>
M
M
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ML?)6E8BM8^2(B%B>#!AVN"FVV]8IM\=(K6L=(K6L:5B(^:(B(A\=RWU
M      3A>QS[;5?G!Y$T=D=G:_-=>,W0>2Q>=WBF_P ?;SX7LK>>*N+_ %/J
M7C\0IKM<EC;FJ+C([''1#=4T8>*FSGXMZ\K9S\0B^-_XD*^B/IY/CGC.XBGJ
M7S^.^+;=MYC)L]M][GW_ -#2U+QK[G:3-J3.XM.:GO(VN;&TYZR>H$>'<#^3
M^.O$>1;ZLUQZ3/=BQ^R^?IUB8^]Q3K'TYF\=T8KU=$!YZ4$
M
M
M
M
M
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M(>G_ )KL_.O'L?+8=*;VNE,^./UF6(CNTC69]W;[[',SK->D_2BT1H&WXS<
M         !F#H#O3L7QF[GZZ[YZFR_X)V!UCLEKL> NI.;KFQN_DHEL\K@<U
M!97=A=7VM[1A+NYQN4M:9HOJ\==S0\U<<2<\L0\^\&\=]2_#>1\$\LP^_P"
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M
M
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M8]LZ1W6FUYCNM:9VB:O8V
M
M
M
M
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M "@E!X
M
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MV
M
M
M
M
M                            I_?<?>V[_P WW">G\'_\A-8\G,-8R?\
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M.(]F.U:]9K,IJT+6H0
M
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MZS* 5K6O:;6F9M,ZS,^V9^>7[/P_@
M
M
M
M
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MZ:UM6=+1TUB=)CVQ,Q/MB9A[!T[B
M
M
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M8BT_?7TF=;VGKIHWD:/8:
M
M
M
M
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MW;BW45K[+>S'FM,?VVL8K3/36,4>VTK=*I%%L
M
M
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M>^#<7?\ M<F[M6?[./!.D_J9<D3'_=:3]_"X"J%16
M
M
M
M
M
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MK=<>2/D^E7I:(F8K>+4UF:RVT:F8N
M
M
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M^R(B(]D1$/8.G<0
M
M
M
M
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MXZLVGVZWV^DSDII'MFD_A*Z^R(O$=;K_  H,0@
M
M
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M?2FW0H:>
M
M
M
M
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M9,6VKIP^[[LV#2-(K6;3W8H_^%/2/E[)I,]92THG-8
M
M
M                   .<W[Y7G?;^:GF)DL/I&4FO>C_ !VAR_5_6M5,M%5A
ML6>XR,=79G8MG''-=1<0[9G\;!96<T<OR7>%PN/GYCBEDECX]%'P/>A63T7]
M'\>\YO%%/-_(IQ[W>=)[L6+LGZGM+3,5G7!BO;)DK,:X]SN-QCBUZ5K:9[^C
M7A5O$/%*Y=Y6(YG?S7-E^>M=/P.*?9]Y69M:)CZ.3)DKK,1$H84RVVP
M     $ZGL-^WQ%YC>4-/:?8VO_B707C;>8';]EAR$-I+AMU['KO.;_K_ *^N
MK&_CFASF'KFQDV3S5OQ%-;\V-I1:77%%.1A]2#/QW?$#;T>],)\6\=W'NO/O
M)*9=OAFDVC)MMGV]NZW=;5F)Q9-+UP[:_=6_O<ELN+6=O?MTQZU^=3XIXY^3
M=AD[><Y"+4IIKW8\6FF7+$Q][;K%,<ZQ/=:;5U]W.G0N>?)!0
M
M
M
M
M
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MF)B=)B8GK$Q/28GK$J\K5M2TUM$Q:)TF)]L3\TOV?A_
M
M
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MRFD3,1/6;WB)T]Y:\Q[6[#2K#P
M
M
M
M
M
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M1"Q2KP:%
M
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MZIH1)
M
M
M
M
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MQ,Q,2K@WNSW7';O)L-]CMBWF&\TO2T:36U9TF)_4EZIU3C
M
M
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M$S[*UB9F8K6-*UC6=*Q$:]&6F)NK
M
M
M
M
M
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MU(UGNO&MJU5>C0
M
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M/*T\.V-O\4V<QDSS$]+9[5^C3YM,5+=>OW][5F(G'UM$JP$<
M
M
M
M
M
M                           $)WOF>WY^NKXIWNYZ-COJ>^O'2SSV^=>0
MP4?"?;]9K@L[GL/KVKF*UNKJXO,OA<13>8F*BGXR9BQM[?YHHKJ:2F:GP.^O
M_P#,MZJ4X;G,G;X'Y%?%M=W,^S;YHFT;3=];5K%<>3).//:9Z;?+DR:6MBI6
M=O\ HUYS^B'DT;3>VTX3?S7'E^:E^L8LOMB(BMK=MY^3':UNLUB'.N>A]/,
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M%;?-</ON Y;<<+R58KO=MEFEM/9,Q[+5F8B9K:-+5G2-:S$Z=66F)NK
M
M
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M]I^6U[3-K3\LS,JX\^?-NL]]SN+3?<9+S:UIZS:UIUM,S\\S,S+[#AOD
M
M
M
M
M
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M^(CP_P#:/--G7YL&YT__ %.2?_3CM,_^[A<!5"HK
M
M
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M6\Q.ET_Z C1X
M
M
M
M
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M"MCR/@MYXSSFZX'?_P#B=MEFDSII%J^VEXCV]N2DUO77KVVC7JSPP1TH
M
M
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M*O&UK7M-K3,VF=9F?;,_/+]GX?P
M
M
M
M
M
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M]E5S)3<B6
M
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M^^UVM^[B>.[L&/2>EKZ_A\D?)]*\12)B=+4QTM'ME-BA6U
M
M
M
M
M
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MUA6MY'P6\\9YS=<#O_\ Q.VRS29TTBU?;2\1[>W)2:WKKU[;1KU9X8(Z4
M
M
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MO=4F;Q,]._LK/WSI3/-NKY
M
M
M
M
M
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MF2FY$L
M
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M>RW;/X3)'_7OKI/RTK3YDP*(350
M
M
M
M
M
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M+OXTW>VRVI;YITGI:/[FT:6K/RUF)9@8@ZH
M
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MTE'G 5^@
M
M
M
M
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M9[2L1,S&#<:?+.DSAR?]$3CM/S1CA;[5$(K@
M
M
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M'2T>V4V*%;4
M
M
M
M
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MKQ'6.ZEIK.D_+&L=)^6-)^5D)C[@
M
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MUK+=6.4T[3+NREM-1OJ>(N8.;/>]IN\?B+JFJ6"3C'7=S)%5S+%335&#XO\
MUDR^BGHAR7/<7D]WY7O]-AL)BT5M3<;BMHMN*]=>[:X*Y=Q28K:/>X\5;QVV
MF8UQZJ^6V\/\-W&^VUNWD\_X#!.NDQDR1.MX^77'2+7KTF.ZM8F-)F72^>:M
M7H
M
M
M
M
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MY7!Y;M*Z8=Y^"S:1TC-2NM+:^S7)CB8T_P#=3/765I55TC<
M
M
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M<^S683VH&M)@
M
M
M
M
M
M,;]Q=3Z3WMU5V'TSV/C/Q?1>S]/S^D[18T51QW-6)V''3XZXN<;<R13_ (?F
M,?ZW%Q975-/,MI=Q1S1_"N.GGC(_#_*^:\%\JX[S+QS+[GG.,WF+<X+=9K[S
M%>+Q6]8F._'?3LR4F>W)CM:EM:VF'8<5R>\X7D\'+<?;LWNVRUR4GY.ZLQ,1
M,?+6?9:OLM69B>DN5[Y/^/F[>*?D#VSX\=A1_P#I3U5N&0UNXOJ+:2TMM@Q/
MRQ9'5]NQMM-7)/!A]SU:^LLM94R<^KQ:7L?S\<5?'CCU*^F/J!POJIZ?\3ZA
M>/3_ /*^5V=,T5UBUL63K3/M[VB(B<FWSUR8,DQ]'WF.VFL:2LH\<YW9^3<'
MM>>V'_AMSBB\1KK-;>R])GV=V.\6I;3IW5G3HP.SMW0         #<#P(\I<
MWX9^6_2?D'B[N\AQ&G[A8VO8%A9QU7->>ZOV&K\"[%PG%CS-%!>WESJ=_<R6
M'J_-1;Y.*VN>*?4AHYXU#Z\^EVR]9/27F_3_ '5*3N]YL[6VM[3I[K>XOPNT
MR=VDS6M<]:1E[=)OAMDQS/;>S%?-O&\/EOB^\X+)$3ERXIG%,].W-7Z6*VOM
MB(O$1;3VTFU?9,NI5KVP83;,!@]JUK*6>;US9L/C-@U_-8Z:FXQ^7PF9LH,C
MBLI8W%'[&>SO["YCEBKX_)517QS_ ,KR[<AQ^]XG?Y^*Y+%?!R.VS7Q9<=XT
MOCR8[32]+1\EJ6B:VCY)B85N9\&;:Y[[;<5FFXQWFMJSTFMJSI:)CYXF)B7V
M'#?(
M
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M:TS,S,S,SJKDR9+Y;VRY;3;+:9F9F=9F9ZS,S/69F>LS/M?V/B_
M
M
M
M
M
M                                         "HM]SQX=?78GJ3S<TS
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M/)UG)/MTKFII&6-?[K6N3VZ]U[Q$16(6"U?S1@
M
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MOJU4>@
M
M
M
M
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M9N=I@B)Y';Q[_#[.M\<3,TC_ .)2;4CK$=TUF9TB72X>:Y7J
M
M
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M 'NXY+?9N1WEN[=[C+?)>?GO>TVM/]F9F7L'3N(
M
M
M
M
M
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MPUBO';K_ !C#I[(IDF>ZFG73LR1>L1K][%9TB+1"5U%1K(
M
M
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M9[+5BK\1OE$]VT\0VUITT^LYM)C3]=3#2=.O3Z=YK/3KCMI/T9BWVJ(17
M
M
M
M
M
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MR_?.D:S;#>8KECV:_1GLR:S.D5I?IK,:7\E!Z$(
M
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MZJT_)^=W'DWD&[Y[=:^]W.>UXB9U[:>S'37YL>.*TC[E8;"-?.B
M
M
M
M
M
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M;;;--8F?;:DQ%L=ITB/OL=JV]D>WV-EFM6/
M
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MUIZ>SOOV4Z]+5]Y&DZ6TOD*)$*@
M
M
M
M
M
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M7%:+8K1$UM$Q,3$QK$Q,=)B8ZQ,=)A8O6U;UBU9B:S&L3'LF/GA^+]OZ
M      N _:^^6?\ [:_"_:<[_P#N[PZDQ^0N_P#^7ZYV?@\/Z\/_ /*,E'8Q
MS_\ V_=40?\ ON54-]IWZ3__ %E]9N+P?_PW?WI7_KYMEER:3_E&&<DU_P"X
MQ6O^U416^(WQC_P?EVVI_P#L^>8C]6^&UM/_ &Z3:8_M*S/WL+@*H5%8
M
M
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M2_6(]D2<HS-=
M
M
M
M
M
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MEZ6CY+4M$UM'R3$PK5SX,VUSWVVXK--QCO-;5GI-;5G2T3'SQ,3$OL.&^0
M
M
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MOR=U(B?:Z7SS5J]
M
M
M
M
M
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M:)X4$VE0
M
M                      $9GN]>5M?A_P"!7='8>'R4.,W[<<;1U!U=-7S;
M\W%&\]BVU]C:,ECH;BXAHN,EJVL6^3S4-'RST_-C/FDBDBXKIYDM\(OI57U>
M]>.%\>WF.<O ;/)^4-[$:Z?5MI:MYI>8B9BF?-.';6G6LZ9M*WK::RV'Z6>,
MQY5YMM-AEK-MCBM[_-[=/=XIB=)TCI%[S3'/L^_Z3$Z2YF#TNK#P
M  %\'[:[Q,_1'XF[3Y)[-@OHMT\E=DY_-R[OK3T\E!U'H%S?X; _3>M-)<6-
MGLFV2Y6]J^6*WXO[6.QGY]:*FUDXHG^TC]6/TM]6-KZ;\9G[^%\:VWX:M;:T
MG?[J*9,O=I$1:V'!&#'UM?W5YSTCLO.6LPL^(+R?\J>3XO']O?7:<?C^G$3T
MG/EB+6U^29I3LK[9[9F\=)[H605<C0
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M?F][CFV/Y)T^EUB)F/8W&:>8F
M
M
M
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MCI^L5Z1K..L:9JS,^RONYG).G6;8JPZ(SSS('
M
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M;NW>XRVR7GK]]>TVG369G36>D:SI'1[QT+A
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MO]MCOI$6CY)^6L]+1$]&T35[&P
M
M
M
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MU[<&:>R>L=V*WTL=NOSTFNO68B=8UG35M<U2QD
M
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M:??[R_O<L1K^U8I^A$]8^_RZ6B.O7%,SITUNZ*34/0
M
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M2ENM<E)F(UK:/[-;1:EHBU;1&RS6K'@
M
M
M
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ME9F?HQ%O546BP
M
M                          @>^X=\HOT"> ^8ZTPE_P#3;QY/;)9]5V%,
M7/PN[70[#BC9>S<K1Q+:SVDUG=8BRML#<45543<4[!Q)%^6/FJB=GV>OI?\
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M+6L6K_<Y+=^7K\N24D*.+
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M_(,@
M
M
M
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MK,3$Q,3I,3$]8F)Z3$]8E6Y:MJ6FMHF+1.DQ/MB?FE^S\/X
M
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MU2\E_1;PC>;_ !7BF^RT]QAU]LY,NM=:_)W4IWY8UZ?0G6)]D]-9YGU=X
M
M                 "J]]T1Y%9#5NE.@?&/!Y#T/TM;AGNRMZAMIIX[F36>L
MK?'6&L8C(QTST03X?.[3M==]315')S]7K\57%4?R?"2TK[,'T[V_*>:\_P"I
MF^Q]WY)V>+9[6;1$Q&;>S>^;)2=-8R8L&",4S$Q^#W5HTMW:UDI\.' TW/,;
M[R+-77ZKBKBQZ^SOS3,WM'R]U:4[?;'T<LQUUZ4GEU*7P       #]K>XN+.
MX@N[2>:UNK6:*XMKFWEK@N+>X@KIEAG@FBJIDAFADIXJIJIYXJIJXXYXY^+\
M9,>/-CMBRUBV*T3%JS$3$Q,:3$Q/28F.DQ/28?RU:WK-;1$UF-)B?9,?-+JM
M>$O>M?DQXC>.G>]U=0WF9[)ZET[.[7-;Q6\%O3O,>*AQN^VT$-I'#;10V6YV
M%_#331''3Q3'Q\**/^;QY7_6OP:OIIZM^1>"XJS39\;RVXQ8(F9F?JTWF^UM
M,VF9F;;>V*TS,S.L^V?;-:7F'"QX[Y3O^%K$QBV^ZR5IKKK[ONUQS.O7KCFL
M^V?;[9]K:)J]C8
M
M
M
M                                        ");WM/%G]:?V]^X\;A\7
M^(]@=/6='>O7W$-M]3?29#KRWN[W;,18PPV=WD;R\V#KN?+VEK:V_-%=QD9+
M;CGFKBGY*I8_!3ZI?S6_$#P^YWF7W? <Q?\ )F[UGMK%-W-:X,EIFU:5KBW<
M;?)>]]8IBC+[)G6-G^C_ )+^C7G6TR9;=NQW<_5LO72-,LQ%+3UB(BN6*6F9
M]E8M^JYLSTA+ P          '2']C?R@M_)OV\.G^;[)S9#>>C(9>@-\IN8:
M(9H[CKZTL:=(N:)..*),E#?]7Y'!URWE5/S37_%U177)+%))5YQOC@],,GIG
M\0O,>XQ1CX/G)CE=KI,S$QN[6^LQ,=8I-=[3<Q7'$Z5Q>ZM$5K:M8@!ZR>.6
M\=\\W?96*[+>S]9QZ?-EF?>1]S3-&32OR5[9B(B8A+VB*U8
M
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M[3'[W+$?)FRQ]"MONUQ:6C3Y,W77II:55=(W
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MWM8V_J)FS12:SGVV"\S.OT]*>Z[HUZ:1&.*_1Z:UG]=JG509:8
M
M
M
M
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M,<QKTK%KS$QK,3>P48(8
M
M                               *Z'W+'DC7U5X5:IT3B+Z:UV'R9["M
ML=D8HZ;>GBXZVZKDQ>X[7Q3<55<WD$U6X76L0\TPTT\2VT\]$DG%%7,4UB7V
M;/IQ7RKUIW7G6[I%^/\ &>/F])G7IO-]%]O@Z?>S'U>N]MK:9[;UI:M9M'=3
M??P]^/QR?E^7FLM8G!QV"9CV],N;7'3I[/O(S3U]DQ$Q&O6*%B^%-<
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MUCK,Z1UF9ZL\,$=*
M                                     Y[OW''^IAM'\C_4W[DWST#_
M &='_+5M?Y8W_P#A*IT^@7]'F/\ RO/_ 'T('T[&Z0        %\'[7O^H)V
M]_? W_\ H7\?U$_VGG]/?$?\(;7_ %CRJ%GQ'?[;[7^2L7^<;E9!5R-
M
M
M
M
M                        *HWW07BS^</6?2GF#KV+];*==YCGIGL>[MK;
MY[GC2=LER&?T7)Y&>.SYYCP^O;E'?65/,MQ333=[%%31'SS)753:M]F)ZI?D
M_P EYKT@Y#+V[7D</Y1V=;3I'UG!%,6YI2)MUR9=O./)/;36<>TM-K1%:Q,F
M?AR\E]QR.\\5SVTQ9Z?6,43/3WE-*Y(B-?OK8^VW2/O<4ZSTA2V7.I<@
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M?V)B8>P=.X@
M
M                    #G6^_P">2GZP'N)]AZWB<E];IWCMA\3T9@J;?)?5
MX^K/X"NZS79%US91?[K89BUW[.WV(NN>.:YI*,/#Q+5QZ=,,/H?^ ;TV_0#X
M>./Y+=X^SF/(LV3D\NM.V_NLL5Q[.O=/TK8[;7%BW%/96)W%YK$]TWO//T/\
M>_(?@>#<9:Z;O?WMN+:QI/;;2N*-?;-9Q5K>OLB.^=(ZZS">FHV^
M  G:^WF\7[COGS[U[LK*XR&]T/QDP-]VEFI;J:N.WDW2^ANM<ZPQ\5-OS]3)
MDK?8;R3-P<<_);_+@I.):^?C3#-!;[0CU/Q^!^@FX\:VN6:<[Y-GKLL<5B)F
M-M6:YM[>=?HQ2<58VUO;;7<UFL1I-Z:7]=O(Z\)X1DX_%:8WO(WC#73V^[C2
M^:>O32:Q&.?E_"1I'MF.A0\^J"H
M                                                #GN_<<?ZF&T?
MR/\ 4W[DWST#_9T?\M6U_EC?_P"$JG3Z!?T>8_\ *\_]]"!].QND
M!?!^U[_J"=O?WP-__H7\?U$_VGG]/?$?\(;7_6/*H6?$=_MOM?Y*Q?YQN5D%
M7(T
M
M
M
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M(Z?]2\]9G7)\D3$)_P! 1H\
M
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M8B)3_H"-'@
M                               .>[]QQ_J8;1_(_P!3?N3?/0/]G1_R
MU;7^6-__ (2J=/H%_1YC_P KS_WT('T[&Z0        %\'[7O^H)V]_? W_^
MA?Q_43_:>?T]\1_PAM?]8\JA9\1W^V^U_DK%_G&Y605<C0
M
M
M
M
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M3'TGY)Z""@%!H
M
M                     !6L^YJ\D:.N_$7KWQRQ5]#1G_(OL*#(Y^RYIN):
MY.MNHIL9M&0YYY@JHAM)INPK[6ZH:I^>>)H[:XXCCKJHJDALD^S0].+>0^K?
M(>HNZI,[#QWCYIBMTB(WF_B^&GMZVB-I7>1:*_>S?'-K1$Q6\@_AW\?G?^4Y
M^?RUGW&PP:5GI^VY]:1^K^"C+KI[)FNLQKI-%!>>F>          RIT;U#M7
M?_<O5W2.CP^KM?:V^:OH6$KK@N+BVLKO9LO:XOG+9&FUCEFBP^%AN*KN]F^'
MRP6D$DM7/%-%7/&+><>7<5X#X=RGFW-SIQ7%;#/NLG6(FU<..U_=T[IB)R9)
MB,>.OMMDM6L:S,0ZWF>5VW!\3N>8WDZ;7;8+Y+=8B9BE9GMC7]=;3MK'RVF(
MCK+J\=:=?ZYU-UQU_P!5Z?!-;:EUII.J=?ZM;7%<4EQ;ZYIN"L-<PD$\D$%M
M!7-%C,;%35S1''1S5QSSQ33Q^3CRH>2\_P CY9Y'R'E/,6BW+<EO<^ZSS&L1
M.;<9;9LDQ$S:8B;WM,:S,Z>V9]JLOD-]N.3Y#/R6[F)W6XS7RWF/9-\EIO;3
M76?;,_++VSI'#
M                                   <]W[CC_4PVC^1_J;]R;YZ!_LZ
M/^6K:_RQO_\ "53I] OZ/,?^5Y_[Z$#Z=C=(        "^#]KW_4$[>_O@;_
M /T+^/ZB?[3S^GOB/^$-K_K'E4+/B._VWVO\E8O\XW*R"KD:
M
M
M
M
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MQ,3$S'5EIB;JP
M
M                    '/+^X5\D:.]?<+VK2</?0WFI>.&JX/IW&U6M-Q1;
MW&TQ^MM?85W+3<U?/SDK#9]AKPL]5%,<55.&CYHIJX_;I?0A]GSZ<6\&^'S:
M\WO*33EO(]UEY"_=I,Q@G3!M*QV].RV'%&XK$S-HG<6UF/O*SM]"O'YX7P3%
MO,M9C=<AEMGG736*?>8HZ?)-*^\CVS^$G7YH@Q3C;E          6+OMI_&Z
MCM7S5VOO;+V,-UKWC-U[<Y''2R57%7,'9/:D>4TW5.:K>FGBSGAIT^UV>:FJ
M:JKF*Z@@KCCYKIXEAKM^TF]1[>*^BVU\%VEYIR'DW(12\1IUV>QFFXS]?OHG
MZQ;95TK$=U+7K:T5GMOH7XA/()XSQ#%PN*TQGY'/$3[.N+#IDOU]OW\X8Z>V
M)F)G3I-]10\A.
M                                    Y[OW''^IAM'\C_4W[DWST#_9
MT?\ +5M?Y8W_ /A*IT^@7]'F/_*\_P#?0@?3L;I         7P?M>_Z@G;W]
M\#?_ .A?Q_43_:>?T]\1_P (;7_6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
M
M
M
M                       \?V'HFL]I:!O/66ZV'XKIO8VG[-HFVXOU*X?Q
M+6=OPM[K^>L/6C^%<7UF*R$L?S4_EI^;X\.X\>YWD_%^?V/DW"Y/=<QQV\P[
MK!?37LS;?)7+BMI/2>V]*SI\NCE[#>[CC=]AY'9V[=WM\M,E)^:]+1:L_P!B
M8B7*'[ZZ?V/Q^[L[8Z/VWB;G8>I^PMMT')7,UC+CN,G7K&;O,5!F[6TFDGJH
MQN>M;:.]M*J9)8Y;:>.NB22BJFNKU7^!^7\=Y_X5Q/F_$Z?D_EN/P;JD1:+]
MD9L=;SCM:(CZ>*TSCO$Q6:WK:MJUM$Q%FG"<KM^<X?:\SM=/<;K!3+$:ZZ=]
M8M-9GIUK,S6W2)B8F)B)Z,2LL=F          OI_;3^2-?:OA5M?1.7OIKK8
M?&;L*YQV.BDIMZN+?K;M23*;CJG%5Q35Q>3S4[A:[/#Q3-35Q%;0041R<T4\
M10T/?:3>G%?%?6G:^=;2D4X_R;CXO>8UZ[S8Q3;Y^GWL1]7MLK:UF.Z]KVM6
M+3W7A1\0GC\<9Y?BYK%6(P<C@B9]O7+ATQWZ>S[R<,]/;,S,QKUFQ>KM:$
M
M
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MM!/UU\@CFO.\NSQ6B=KQ^*N"--=)O]_EGK\L7M[N?9'X.-/GF<]!QID
M
M                 !SW?N./]3#:/Y'^IOW)OGH'^SH_Y:MK_+&__P )5.GT
M"_H\Q_Y7G_OH0/IV-T@        +X/VO?]03M[^^!O\ _0OX_J)_M//Z>^(_
MX0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
M
M
M
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M
M
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MZS,R]4ZIQ@
M                                '/=^XX_U,-H_D?ZF_<F^>@?[.C_E
MJVO\L;__  E4Z?0+^CS'_E>?^^A ^G8W2         O@_:]_U!.WO[X&_P#]
M"_C^HG^T\_I[XC_A#:_ZQY5"SXCO]M]K_)6+_.-RL@JY&@
M
M
M
M
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MF8TGI,QU9.8RZX
M
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MPQT]L3,3.G2;ZBAY"<
M                                         !SW?N./]3#:/Y'^IOW)
MOGH'^SH_Y:MK_+&__P )5.GT"_H\Q_Y7G_OH0/IV-T@        +X/VO?]03
MM[^^!O\ _0OX_J)_M//Z>^(_X0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
M
M
M
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ML5=-KR."+ZQ&D>]QZ8\D1\DSVQCO:?;,Y)F8UG6;"*OMHL
M
M                                                  !\W,YC&:]A
M\KG\U>PX[#8/&WV8RV0N.>:;>PQF,M9;V_O9ZJ>*JN(;6U@KKJYXXYY^6GER
M=GL]SR&\Q;#94G)O,^2N/'2/;:][16M8^[:TQ$?=E],.+)GRUP88FV6]HK6(
M]LS,Z1$?JRY/?DEW5F_([O\ [E[XV&/Z?*]M=D;=O4EAQ\WI8BTV#,W=]B\%
M;<5S7,G%G@<7)#90<52RU<0P4\55U\_&KGU:^F_A>R].? .&\$X^>[:\3QN#
M:Q;Y<EL6.M;Y9Z1'=EO%LEM*UCNM.D1'2+-_'^(P\!P>TX7!UQ[7;TQZ_P!M
M-:Q$VGV=;6UM/2.L^R&$V:NW          ="W[>+QVBZ4]O'5][OX/DVGR-W
M#9.V<I57/:7,MKKUO<4Z3I&-HELOFBILY<%K'XK1%77)/#-EY:).:*N.88O/
ME]H3ZAV\U^(7=<%@MKQ?CFSP["G2T1;+,?6=S>8MU[HRYO<3,1%;5P4FNL3W
MW@IZ[\]/,>=Y-E2?\6X_%3!'28UM,>\R3U^7NOV:](F*1,:QUF=5!EI@
M
M                   !SW?N./\ 4PVC^1_J;]R;YZ!_LZ/^6K:_RQO_ /"5
M3I] OZ/,?^5Y_P"^A ^G8W2         O@_:]_U!.WO[X&__ -"_C^HG^T\_
MI[XC_A#:_P"L>50L^([_ &WVO\E8O\XW*R"KD:
M
M
M
M
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M,TO,]8BM)UC3K%_A08A
M
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M-9F=/;,^U6/R&^W')\AGY+=S$[K<9KY;S'LF^2TWMIKK/MF?EE[9TCA@
M
M                   .>[]QQ_J8;1_(_P!3?N3?/0/]G1_RU;7^6-__ (2J
M=/H%_1YC_P KS_WT('T[&Z0        %\'[7O^H)V]_? W_^A?Q_43_:>?T]
M\1_PAM?]8\JA9\1W^V^U_DK%_G&Y605<C0
M
M
M
M
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MS6T?V)B7I'6N.
M
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MT''G[08
M                                <]W[CC_4PVC^1_J;]R;YZ!_LZ/\
MEJVO\L;_ /PE4Z?0+^CS'_E>?^^A ^G8W2         O@_:]_P!03M[^^!O_
M /0OX_J)_M//Z>^(_P"$-K_K'E4+/B._VWVO\E8O\XW*R"KD:
M
M
M
M
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M32H8-1
M
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MD%7(T
M                               Y[OW''^IAM'\C_4W[DWST#_9T?\M6
MU_EC?_X2J=/H%_1YC_RO/_?0@?3L;I         7P?M>_P"H)V]_? W_ /H7
M\?U$_P!IY_3WQ'_"&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
M
M
M
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ML]M\<16(GI[RTZ>V8NZ*34/0
M
M                          &J_G#W[%XN^(?D3WWQD;/%Y7KCJO:<IJ5S
M?_2<VDG8-_958+K?'RT7U,EI-^+[]E<;:4QUT2>I5-Q3Q')SSQ15M/T1\"MZ
MH>KGCO@7N[Y=KR/*X*9ZT[NZ-I2WO=Y>)KI:/=[6F;),Q,:177NK$:QDOAW!
MSY)Y3L.$[9MCW&YI%XC77W43W99Z=?HXJWMKTTTUUCVN5*]4"RT
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M7369F>LY^8"Z,
M                                     !SW?N./]3#:/Y'^IOW)OGH'
M^SH_Y:MK_+&__P )5.GT"_H\Q_Y7G_OH0/IV-T@        +X/VO?]03M[^^
M!O\ _0OX_J)_M//Z>^(_X0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
M
M
M
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M5]D3/S1,]'4V>7!6T
M
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MCI9/-BKW
M                                  <]W[CC_4PVC^1_J;]R;YZ!_LZ/
M^6K:_P L;_\ PE4Z?0+^CS'_ )7G_OH0/IV-T@        +X/VO?]03M[^^!
MO_\ 0OX_J)_M//Z>^(_X0VO^L>50L^([_;?:_P E8O\ .-RL@JY&@
M
M
M
M
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MYOR7&5KV8(W-KXX^2,>7\+CB.MM8K2\5UUUZ=8B=8C?%HEA0
M
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M-XUGY=<6*=-=.FF;K,3/7I,?2UMZJBT6
M                                                          '/
M=^XX_P!3#:/Y'^IOW)OGH'^SH_Y:MK_+&_\ \)5.GT"_H\Q_Y7G_ +Z$#Z=C
M=(        "^#]KW_4$[>_O@;_\ T+^/ZB?[3S^GOB/^$-K_ *QY5"SXCO\
M;?:_R5B_SC<K(*N1H
M
M
M
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M]7YG8^0XX^AN<%L-Y_N\4]U9F-/;:F32)UG6,?LC36UJ%5JC6
M
M                                                  _&XN+>SMY[
MN[GAM;6UAEN+FYN):(+>WMX**I9IYYI:J8X888Z>:JJJN>*::>.>>>?@_>/'
MDS9*XL59MEM,16L1,S,S.D1$1UF9GI$1UF7]K6U[16L3-IG2(CVS/S0Y0/E7
MW+<>0_DOWUWE/)-7'VKVUOF[8V.?BNFNRP.<V/(7>N8JFF7CB6B'#X"NVM8Z
M:_V=,<-/%7///QY>K+TK\-Q^GOIKP/@](B+<5Q.UVUYC32V7%AI7-?ITF<F7
MOO,QTF;3IT6;>,\37@?'MEPU8C7;;7'CG[MJTB+S_P"U;6T_=E@%GSNP
M     '3#]FKHJCH#VWO&/6Y[6:VSF[:31W)LO-Q+<57$N3[<N9=XL(Y[::2J
MC'S8O5\MC[&J".B+BBJTYYDI]>J6NKS4?&/YS;S[XCO)N2I:MMCLM[^3\.D1
MI%-A$;:TQ,1K>+YL>7+%IFVL7TK/9%(BO/U9YJ><]0.1W$3$X<.;W%----,$
M>[G2?EUO6UM9U^^Z3II$2?HQM<@
M                                                    .>[]QQ_J
M8;1_(_U-^Y-\] _V='_+5M?Y8W_^$JG3Z!?T>8_\KS_WT('T[&Z0
M%\'[7O\ J"=O?WP-_P#Z%_']1/\ :>?T]\1_PAM?]8\JA9\1W^V^U_DK%_G&
MY605<C0
M
M
M
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MT_W&>E>[<[+)3<5^?2L]F3KK&D1BO>TZ]VO;TKW:3'12>>! P
M
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M>V7+:;9;3,S,SK,S/69F9ZS,SUF9]K^Q\7X
M
M <]W[CC_ %,-H_D?ZF_<F^>@?[.C_EJVO\L;_P#PE4Z?0+^CS'_E>?\ OH0/
MIV-T@        +X/VO?]03M[^^!O_P#0OX_J)_M//Z>^(_X0VO\ K'E4+/B.
M_P!M]K_)6+_.-RL@JY&@
M
M
M
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M_/$2]@Z=Q
M
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MIUTG]=3'68UK,Q;VS6+1-_A08A
M                                                      Y[OW''
M^IAM'\C_ %-^Y-\] _V='_+5M?Y8W_\ A*IT^@7]'F/_ "O/_?0@?3L;I
M      7P?M>_Z@G;W]\#?_Z%_']1/]IY_3WQ'_"&U_UCRJ%GQ'?[;[7^2L7^
M<;E9!5R-
M
M
M
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M<XXTP;R*[FO2(_;-8R3TB(G7-7).NFOSS,ZS,QJ'C5
M
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M/:=TQ\V3/;NM'[G3%/\ 9^XLLJV$>P
M                                                        '/=^
MXX_U,-H_D?ZF_<F^>@?[.C_EJVO\L;__  E4Z?0+^CS'_E>?^^A ^G8W2
M      O@_:]_U!.WO[X&_P#]"_C^HG^T\_I[XC_A#:_ZQY5"SXCO]M]K_)6+
M_.-RL@JY&@
M
M
M
M                                            %*/[I#H:O!=V^.OD
MCC;"&+']B=>YKJC9;FTHMXN.=CZXS<NQ86^RT<6-@EFR68P&]R6T5Q)=7-<E
MMAJ8O3@HMZ.9[IOLO?.Z[[PKR+TXW.29W''<ACWV&+:S^!WF.,.2M)F\Q%,>
M7:Q>U(I2(ON)OW9)R6BDO?AOYN,W#[_Q_):?>8,]<U(G7[S+7LM%>L]*VQQ,
MQ%8TG)KK:;3I596FI*@         +<?VL7>M%OL_E)XSY"ZFKDR^!U3O74K*
MF*XYMX*-=R%&@=AW4LW$=5K1-=U;1K%$=-54<E5,%?-/$G%-7,=2GVI'@ULG
M&>+^I>WK$5PY\_&9[:QK,YJ?6MI6(U[M*^XWLS,1,1-HUFLS'=%WXD^%FVVX
MWR&D1I2]]M>>FL]T>]Q1\_3LS:^V.L>SY;CZG=$\
M
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M<>/\53@N"V?#8].W:[;'BUCY9I2*VMTBNLVM$VF>V-9F9F(F6$V:NW
M    =4'V_NC?U;?"CQCZ6GQWX5F-,Z?U#\[K#Z3Z'Z??]BL*=L[$_P!UKQ&"
MNHO5WK.Y&O\ WFUBO:OF^-S\UQS+75Y:O7[SC^<CUI\F\TID][L][S&X]Q?N
M[M=KAM[C:?2]YEK.FVQ8H^A>V.--,6F/MB*U_..9_2#R_D>7BW=BS;N_9.NN
MN*D]F+KW6C]KK7V6FO\ :_1TAN"U"Q4
M                                                         !SW
M?N./]3#:/Y'^IOW)OGH'^SH_Y:MK_+&__P )5.GT"_H\Q_Y7G_OH0/IV-T@
M       +X/VO?]03M[^^!O\ _0OX_J)_M//Z>^(_X0VO^L>50L^([_;?:_R5
MB_SC<K(*N1H
M
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MI,3[']CXOP
M
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MM*SK7U>XC\L^GG)8JQ^%P8HW%9^;W%HR7_75B=<=;QUU]NL5FT1#I9/-BKW
M
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MZ6D.J$\M2M<
M                                      !SW?N./]3#:/Y'^IOW)OGH
M'^SH_P"6K:_RQO\ _"53I] OZ/,?^5Y_[Z$#Z=C=(        "^#]KW_ %!.
MWO[X&_\ ]"_C^HG^T\_I[XC_ (0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
M
M                               !_'D<CC\1C[[+9:^L\7BL79W.1R>3
MR-S!98_'8^R@KN;R^OKRYKBMK2SM+:*J2662JFB.BGFJKGCCCGE]MOM]QN]Q
M3:;2E\NZRWK2E*5FU[WM,16M:Q$S:UIF(K6(F9F8B(U?O'COEO7%BK-LMIB(
MB(UF9GI$1$=9F9Z1$>U#]Y4^^K[?'C%^-8.S[1_3YV)B[/B2#2NB(K?=,?)?
M3_M=K:9#LFFXMNL[#T+CX\7\<65N\C841U_-9US>G#)+WTL^!GX@?4WW.^S<
M7^0?'LM])W/)S.VO%8ZVM39Z3O+ZQ^U3;!3%EF:Z9HIW7KM3QKT8\Z\C[,U]
MM]1V%I_;-SKCG2/;,8M)S3T^]F:5K;6-+Q&LQ7*\HON6?+[M7Z_">.6H:?XR
MZS/\88<U\MEVIV97!_NM,E?X[M&#M=.QOU?$4O[&# U7%M1/\L=SS)%1/S8K
MZ7_9L>D7BON][ZB[S>>3<E7K./Z6QV<3]+3\%@RVW%^W6O6VZBEYKK;%%;3C
M;\\;^'OQ7C.W-S^7+R.XC];UPX?E_6TM.2=.GMR:3IUKI,U0&]I]U]P]XYZO
M:.YNT^PNU=AJFN)Z<QV%N&?V^^@KNH;*VFIM)\[?WU5E#5:XRVAXCA^2.F&V
MBCIIXHBHIIGKXMX5X?X1L(XOPWB^/XKCXB(]WM-OBV]9BLVF.Z,5:]T]U[VU
MMK,VO>TSW6M,[NXWA^*X;!]6XG;8-M@TB.W%CK2)TUGKVQ&O69G6=9UF9]LR
MQBR9V(#83H;RQ\EO%_+<9GQ_[P[(ZIFJO*[^\QVJ;/D+76<Q=R6U%I5+L6GS
MRW&J;-^T11\<4Y"RN:>.8HZN..*HZ.:=?>>>E'IMZG[3ZGY_PG&\K3LBE;Y\
M-+9L=8M-M,.XB(SX>LSUQ9*3]*T>RUHGHN;\8\>\CQ>ZYS9[?<QII$WI$WK&
MNOT;]+TZZ_>VCVS\\K,O@Q]S+F[?(66B>>^EV>0Q$W[39][=3X.JTRV/EJGC
M^7G?NM()J[#*V?-$TE5=_@.;2:WB@CCIQ5W))7/16EZX_9I;+)M[\[Z#;V^/
M=UZVXS?9>['>-)_\+O)CNQVZ1$8MU&2M[6M:=UBK6M)CQYG\/&&U)WOA.::Y
M8]NVS6UK/_PLOMK/L^CE[HF9F?>UB(K-N/KCLG0NW]&UGLSJ_;L#OF@[CC:,
MOK.V:SD(,IALO8UR205R6UU;U54\36MU!)!<0U\4S6US%)#+11+'7134KY'X
MWSWB'.;GQKR?:9]AS^SR3CS8,U)IDQVTB=+5GY+5F+4M&M;TM6])FMHF8N\A
MQ^]XK>9..Y+%?!OL5NV]+Q,6K/W8GYXTF)]DQ,3$S$Q+VSI'#
M
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ML+EN/R\1RNYXK/US;7<9,5O9]]CO-)]DVCVU^29CYIGVLD,<=>
M
M                                                J[?=%]V_FSXX
M>/O05C=^C?=K]J9C?LQ%#7\99=9ZGU^G'\65['QSSQ'9WVQ]B65Q'S5QQS)-
MC?V'//$<G"S_ .R_\)_*?J-Y!Y[GIK@XKBL>UQS,=(S;[+W]U9^6U<.TR4G3
MV5S=8^E64C_APX?ZQS^^YN\:TVNVKBK_ -?-;76/NQ3%:)^:+]?;"D,NT3#
M         60/ME.C?S\\U^P.Z<ACOJ</T'T_D_PR_P#I/6_#=_[3OXM3P?\
MO4^(O+6S^LT6SVBC]KNK.]D^'PC]6W^KHXKD^TP\X_(/HMQ_A>WR=N\Y[F*=
M].[3OVNQK.?+]&,E;6[=S;93UIDQQ[;=F3W4M ?$1S/U+Q#!Q&.VF7?;N-8U
M]N+#'?;IW1,Z9)P^VMJQ\NENV5\)1.A8
M
MY[OW''^IAM'\C_4W[DWST#_9T?\ +5M?Y8W_ /A*IT^@7]'F/_*\_P#?0@?3
ML;I         7P?M>_Z@G;W]\#?_ .A?Q_43_:>?T]\1_P (;7_6/*H6?$=_
MMOM?Y*Q?YQN5D%7(T
M
M                                                   TL\H?</\
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M+XK8=_AMI:L_^BU9]EJVCK6T:Q:)B8G1EIB;JP
M
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M>W372*]L1,S8H5M0
M
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MY=:]LK(*N1H
M                                       !SW?N./\ 4PVC^1_J;]R;
MYZ!_LZ/^6K:_RQO_ /"53I] OZ/,?^5Y_P"^A ^G8W2         O@_:]_U!
M.WO[X&__ -"_C^HG^T\_I[XC_A#:_P"L>50L^([_ &WVO\E8O\XW*R"KD:
M
M
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M(UZ13WD1UF%\Y1"A2
M
M      I_?=/=&_U5O)7'8[_MET;N.6^D_P#<M^ZUQWUT&(_^ZR3T;J__ /[K
M6W_]^2+>OLMO./\ :KTVW.3^#\GM\?=^KM=Y?MG)_D,=U,7W,N3]IJE3\-G,
M_P#US\>R6_[O<8ZZ_P#VK+.DV_\ @QK%?^M;[R%/Y;RE2          MK?:O
M]Q5VN[^5WC_=W$,D>=U71>XM?M:I+>*XM*]4R]]I6X7$4-&/YNK^'(4[G@Z9
M*I+NF.TJM:.(XJN;F6NFIK[4KP^N7A/%//\ #68M@W6YX_+;29BT9\==SMXF
M>_MK-/J^YF(BDSDB\]UXC'6)B_\ $IQ,6V?&<Y6)UIER8+3UTGOK&3''MTC3
MW>332NMM9UGZ,0N6*<430
M
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M-8]E=*Z0W':>8F
M                                          Y[OW''^IAM'\C_ %-^
MY-\] _V='_+5M?Y8W_\ A*IT^@7]'F/_ "O/_?0@?3L;I         7P?M>_
MZ@G;W]\#?_Z%_']1/]IY_3WQ'_"&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
M
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M%\4ZZSK]"U8GK,ZQ,3UB8;C-/,3
M
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MT
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MOVS%/U/IS76?DCJZL#RMJT
M                                                   '/=^XX_U,
M-H_D?ZF_<F^>@?[.C_EJVO\ +&__ ,)5.GT"_H\Q_P"5Y_[Z$#Z=C=(
M   "^#]KW_4$[>_O@;__ $+^/ZB?[3S^GOB/^$-K_K'E4+/B._VWVO\ )6+_
M #C<K(*N1H
M
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M -FRS_\ 39,4SU_^+$SI_:Q,_>PN JA45@
M
M                     'C^P]&P'9^@;SUIMEO]7JW8>G[-HVRVGI65Q]5@
M-MPM[@,S;^ADK3(8Z;UL=D)*?DN()X*OC\*XZZ>>:>>X\>YS?^,<_L?)>*MV
M<IQ^\P[G#;6T=N7!DKEQSK2U+QI>D3K2U;1^MM$Z3'+V&]S\=OL/(;6=-S@R
MTR4GK&EJ6BU9UB8GVQ'LF)^:8ER7>P]&S_6&_P"\=:[9;_1[3UYN&S:-LMIZ
M-[;_ $N?U+-7N S-OZ&2M,?D8/0R./DI^2X@@GI^'PKCHJXYIX]8GCW.;#R?
M@-CY+Q5N_B^0V>'<X;:UGNQ9\=<N.=:6O2=:7B=:6M6?UMIC29L]V&]P<CL<
M/(;6==MGQ4R4GI.M;UBU9UB9CV3'LF8^:9AX]V[E         /8=>;SG^L-_
MT?LK4[CZ/:>O-PUG>=:N_6O;?Z7/ZEFK+/X:X]?&W>/R,'H9''QU?/;SP3T_
M#XT245<<5<=1Y#P>P\GX#?>-<K7OXOD-GFVV:NE9[L6?';%DC2];TG6EYC2]
M;5G]=68UB>+O]E@Y'8YN/W4:[;/BOCO'2=:WK-;1I,3'LF?;$Q\\3#K4:)N.
M'[$TC3>P->YFJP&\ZKKVXX/FYYM>;CG#[-B+/-8SF?FQNKVRYFYLKVCYO1FF
MB^;X_)773\*N?)QSO#[SQ[F]YP'(:?7]CNLNWRZ=VGO,.2V.^G=6MM.ZLZ=U
M:VT]M8GHK WNTR[#>9=CGT]_ARVQVTUT[J6FLZ:Q$^V/EB)^>(>J=4XP
M
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M=CX)''TF._>[O'CF.FO9CUS3/LGV7QXXG2:S]*.NFL3?X4&(0
M
M                  .>[]QQ_J8;1_(_U-^Y-\] _P!G1_RU;7^6-_\ X2J=
M/H%_1YC_ ,KS_P!]"!].QND        !?!^U[_J"=O?WP-__ *%_']1/]IY_
M3WQ'_"&U_P!8\JA9\1W^V^U_DK%_G&Y605<C0
M
M                                                           #
M$O<'??27C]KG.V]X=L]>]3Z]S#?36V2W[;<)K%&3YQL44UW:X2#*WEM=9[)4
M4SQTTVEE'/=2R2QT41U5R44U99XAX'YKY_R/Y)\(XGD.6Y#6L33:X,F::=\S
M%;9)I6:XJ=)F;Y)K2L5M:UHK69CM.*X3F.<W'U7AMKGW6?6-8Q4M?37V3::Q
M,5CI/TK3$1$3,SI$J^GE!]S9XN=>?487Q?ZXW#R*S=5G=^EMVP?7]2==6=W)
M\T..FBAV#"7?8&>^GDIYGN;63$8BFN+TXX[OBN22JWL!],?LS_5#R'MWOJ=R
M.S\=V47KK@Q=F_W=JQUO$SBR5VN+6/HTO&?/,6[K6Q36M8R;S\<^'?R3?Z9O
M(]QBV&'6/H5TSY9CY?O;1BKK[(F+WZZS-=(CNK?>4'O5^X9Y3?48[/=U7G4F
MFW5G=V-QH70-.3ZPU^[MLC\U&0M\IE[3+Y+?<_9WUIS3;R6N1S5W:>AQ533%
MQZL_,MC?IC\%OP]^EO;N-APM.6YBMZVC=<KV;W+6U.M)ICMCIM<5JVUM%\6W
MQY.Z8F;3VTBN_P#QSTA\$\:TR8-G&ZW<3$QDW.F:T3'LF*S6,59B>L37'6VO
MR]*Z14W%Q<7EQ/=W<\UU=74TMQ<W-Q+7/<7%Q/75+-//-+55)---)5S5555S
MS555SSSSS\4J,>/'AQUQ8JQ7%6(BM8B(B(B-(B(CI$1'2(CI$-EUK6E8K6(B
ML1I$1[(CYH?B_;^@                 -QO;^\FKCP^\Q>A?(+ZB:'":3NU
MM;[M1#17/S===[3:W6I;_!]+':7]=U-3J6;NY(*:89)*;F..N+BF6BBJG3WK
M]Z9X_5_T>Y[T_P"V+;W>[*9VTS,1V[O!:N?:SW3:G;'O\>.+3-HB:3:MM:3:
M)Q3SGQVOE7BF]X+2)S9L,SC^YEI,7Q3KK&GTZUB>L1I,Q/29AU-K>XM[RW@N
M[2>&ZM;J&*XMKFWEHGM[BWGHIEAG@FBJJCFAFCJXJIJIYYIJIYXYXY^#RX9,
M>3#DMBRUFN6LS%JS$Q,3$Z3$Q/6)B>DQ/6)5LVK:EIK:)BT3I,3[8GYI?L_#
M^
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MB(C%GRQGK,:1K[ZL7M.FLZ:9)O$ZZ3,QW:1$PE717:T
M
M                                       4P?NGNX);[L_Q6Z!MKWY(
M=8T/<NX,UCZ*+OCZJ7>MABTO6+VYDDM^+&3Z&CKO+T0<12U34?4S<RT4TU0\
MU7+_ &6WB%<'C'E7GV6FM]SO]OQ^.\S7Z,;;%.YS5K$3W1W?6]O-IM6*SV4[
M)F8O$2V^&SBHIQW)\Y:.N3/CP5GIT]W7WEXCKKU][29UC3I&D])5.UKB3@
M       "[/\ :V=+7&O=!^2G?M];30U=H=G:OUO@ZKN&N.J7$=3:]=YJ^R>*
MYFQ4'->-R69[1DM99H;RXBFN<55%5%#7;<U2TJ?:B>:8^0\]\;\"P6B8XOC,
M^\R]LQ.F3?Y:XZTR:7G2],>RB]:VQTM6F>+1:]<L12('Q(\O7/S?'\'28GZM
MMKY;:?VV>T5B+?2]L5PQ:(FL3$7UUF+=+3:K=&P
M
M       !SW?N./\ 4PVC^1_J;]R;YZ!_LZ/^6K:_RQO_ /"53I] OZ/,?^5Y
M_P"^A ^G8W2         O@_:]_U!.WO[X&__ -"_C^HG^T\_I[XC_A#:_P"L
M>50L^([_ &WVO\E8O\XW*R"KD:
M
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M9B(B8A+JB0U:
M
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M$;XD^*G'RO&<W6)F,NWR8+3I.D>ZO[RNL^R)M[Z^D>V>V?F6N55*,P
M
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M.?W%?;T]Q6,5HZQ$_?UM,_)K,Z3,:)148&N
M
M    '/=^XX_U,-H_D?ZF_<F^>@?[.C_EJVO\L;__  E4Z?0+^CS'_E>?^^A
M^G8W2         O@_:]_U!.WO[X&_P#]"_C^HG^T\_I[XC_A#:_ZQY5"SXCO
M]M]K_)6+_.-RL@JY&@
M
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MRS%9_P"MVY?=S$3][$WM$Q'=K>V46H7
M
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M@\
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MF=96?</Q].)XG:\5CT]WMMMBQ1IKIICI6D::ZS[(^69GYV,63.Q
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MQ.NXS9+7M/SVO,VM/]F9EZ1UKC@
M                                                       .>[]Q
MQ_J8;1_(_P!3?N3?/0/]G1_RU;7^6-__ (2J=/H%_1YC_P KS_WT('T[&Z0
M       %\'[7O^H)V]_? W_^A?Q_43_:>?T]\1_PAM?]8\JA9\1W^V^U_DK%
M_G&Y605<C0
M
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MB8W_ .-^DG@OC/;DVVSC<;RO_:[B8RW^7K%9B,59Z^VF.LS\NND(KTI6R@
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M5F\IQVZX?DMQQ6^B*[S;9KXKQ'6.ZEIK.D_+&L=)^6-)^5D)C[@
M
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M\4F::Z1,Z=\5UTB9F.FCJG/+(K4
M
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M\S'RQ$QK&NKI9/-BKW
M                                                <]W[CC_4PVC^
M1_J;]R;YZ!_LZ/\ EJVO\L;_ /PE4Z?0+^CS'_E>?^^A ^G8W2         O
M@_:]_P!03M[^^!O_ /0OX_J)_M//Z>^(_P"$-K_K'E4+/B._VWVO\E8O\XW*
MR"KD:
M
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MMAL>-V]=GQV'%M]I7V4QTK2D?J5K$1']B'CW;N4
M          OF_;7>5/Z7O#W:?'G8LU>9#=/&3<.;7$V]]Q\]5'4G8]5_GM.I
MMLA)\+C(?A.V6&P6=4//J<8^RCL8N*J8JX(HZ(?M(_2S]$?5_:^H7'8:8^%\
MFV?=DFO3_']GV8MQW4CI3WF"VTR=W3WN2<]IB;UO:T*?B"\:_)7E>/GL%(KL
M^1Q:VF/^_P 6E<FL>R.ZDXK:].ZTWG36+3-C574T&
M
M                             Y<_N;].T="^?_EIUE;6\UGC,;W-M.R:
M_93QW%%=CJW8LL/8^IV--=WD,I=WD-GK6V6D4=S-/5+=QT4S5\452<T4^H#X
M9O,+>>>@7B?DV2T7W.3AL&'+:)B8MGVD3L\]M*TI6LVS8+VFE:Q7',S2)F*Q
M:;'_ $[Y:>;\'XOD;3$Y+;2E+3&G6^+\%>>D1$:WI:9B(TK/2-=-6BK>;,P
M        '5R\.NV_T\^*'C?W+)=?5W_9'2?6NUYROF\_$98-FRFI8J7:;"YO
M_I,?Q>WF+V/ZJVGEX@AXDFBJJXHIXY^''E3]8/$OT#]5O(_#JU[,'&\WO,&.
M.WLB<-,]XP6BG=?MK?#V7K7NMI6T1K/M5F^5\7^1/)N0XF(TIM]YEI7II]"+
MV[)B-9TB::3$:SI$^UL@UPQ\
M
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M=FK.DQ.LUK,:=O6[HI-0]
M                                                   <]W[CC_4P
MVC^1_J;]R;YZ!_LZ/^6K:_RQO_\ "53I] OZ/,?^5Y_[Z$#Z=C=(
M"^#]KW_4$[>_O@;_ /T+^/ZB?[3S^GOB/^$-K_K'E4+/B._VWVO\E8O\XW*R
M"KD:
M
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M]>ZU:1IK$3'1V><Y 0
M
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M")IP
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MZ?>;794B?9]_DM>\]8F>G9./VZ3KKTTF)FQJKJ:#
M
M          <]W[CC_4PVC^1_J;]R;YZ!_LZ/^6K:_P L;_\ PE4Z?0+^CS'_
M )7G_OH0/IV-T@        +X/VO?]03M[^^!O_\ 0OX_J)_M//Z>^(_X0VO^
ML>50L^([_;?:_P E8O\ .-RL@JY&@
M
M                                       &NOEEY+Z%X?>/79OD3V1S
M--K77&!YR%&(LYX(,GL^>OKFWQ6LZIB:[C]JIR6QY^^M[2.NKBJB'B7F6OCT
MXZ^>-B>E'IKSWJ_Z@\9Z>>-Z5Y+D<_9[RT3-,.*M9OFSY(CKV8<5;Y)B.MNV
M*5^E:'?>,>/;[RKG=OP/'Z1N-Q?3NF)F*5B)M>]M/DI6)M/SZ:1UF'+S\B_(
M3M#RG[GWOOCN/._CV_=@9B3*9.6&F:#%XJTCHHM<1KFO6,]Q=28W6]<Q<$5E
M86_,LE45M#3Q77)7\TE7IZ]._3[Q?TM\-V'@GAV#W' \?ABE(G2;WM,]V3-E
MM$5B^;->;9,M](BU[3I6M=*Q8[P'!<;XUQ&#A>)IV;'!32/GM/MM>TZ1K>\Z
MVM.D:S,Z1$:0PFS5VX                                 #^S'9'(8C
M(6.6Q-]>8O*8N\MLCC<ECKF:RR&.R%E-1<V=]8WEM7%<6EY:7$5,D4L=5-<=
M=/%5//'/''+X[C;[?=[>^TW=*9=KEI:EZ7K%J7I:)BU;5F)BU;1,Q:LQ,3$S
M$QH_.3'3+2V++6+8K1,3$QK$Q/28F)Z3$QTF)]KJ>>!?DC9^6_B!T%W[%?0W
MV9WCKW"_GQZ--A%Q:=DX*+G7NQ;+Z;'5?36D,&YXJ]]"CBB'GFUJCKYBB^;Y
M*?+;Z[^G&;TE]7N?\"O2:;/8\AD^K:]T]VSRS[W:6[K];3.WOC[IUM].+1W6
MT[IK8\U\?OXOY5ON$FLUQ8<]O=^WKBM]+%.L]9UQS77V]=8UGVMNFI&+
M
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MG37Y<FO72.FD1K.MO546BP
M
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ML:3,S.LI V@&#
M                                           .>[]QQ_J8;1_(_P!3
M?N3?/0/]G1_RU;7^6-__ (2J=/H%_1YC_P KS_WT('T[&Z0        %\'[7
MO^H)V]_? W_^A?Q_43_:>?T]\1_PAM?]8\JA9\1W^V^U_DK%_G&Y605<C0
M
M
M        "GE]T7Y2W=60Z#\-,#=^G816<OD)V3'1'%5]5=W$^>T3J_'4WL4W
MK0?00VVR75Y9R4_++]3CY_\ ;'1SS<!]E_Z78HV_/>LF_IKGF\<3LYUGZ-8C
M%NM[?MF-)[YG9TQY(G6O9N*?KIA*SX</&Z]F^\MSQ].9^JXON1';DS3I\NNN
M*M;1[-+Q\LJA2W-*8                                   !<9^UW\I
MOJL)WSX<['E/C-B;RU[UZNMKFY]26K'Y*FPU/L_$6G%U>?/!9V%];8*^M[6U
MAYHYEOK^>3FFJKGFNGK[3[TM]UO>!]8>.Q?0RTMQF]M6-([Z=V?99+=M>MKU
MG<XKWO;7MQ;>E=8CZ,4?B/\ &NW-LO+-O7I:)VV:8CY8UOAM.D>V8G)69F?9
M6E8U^2W2J11;
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MKC)W_IYEW$=9V>YPYOE^6TX9Z1$ZZ1FF9UTB(B9UZ:3T+GGR04
M
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MK,^R(B/F?8<-\@
M                                           '/=^XX_U,-H_D?ZF_
M<F^>@?[.C_EJVO\ +&__ ,)5.GT"_H\Q_P"5Y_[Z$#Z=C=(        "^#]K
MW_4$[>_O@;__ $+^/ZB?[3S^GOB/^$-K_K'E4+/B._VWVO\ )6+_ #C<K(*N
M1H
M
M            !S6?>[[,N^T/<\\H[^:3_<=0V37.L\/:4Y"+)0V%IU[I6NZU
MD(X+B*VMN(?K]CLKZ^EM^::JK6XNY(>:Z^8_FY])'P2^-8O&/AD\7P4C\/O-
MMFWF2W9-)M;=[G-FI,Q,VU[<-L6.M^D7I2MXBO=I%@WH[QU>-].>-I'W^7'?
M-:=--9RY+WCIK/LI-:Q/RQ6)TC71%&E6V8
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M$Q.DQ,3UB8GI,3UB5;]JVI::VB8M$Z3$^V)^:7[/P_@
M
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MYF-)[,M(O76/DGMM&L?)*T/;;C'N]MCW6'7W66E;UUZ3I:(F-8_4E\)SGV
M       ;:>!G:D727FIXK]IW<GIXK3^^.L[W8:^(K267C5;O:L;B]MXMJ;^[
ML+*F\JUJ^N^(*YIX8XYN::ZJZ>*>>>-3^O'BUO-O1?RGQ;%&NZWG [RN+K:(
M]_7!>^#7MK:W;[ZM.Z*UM,UUB(F9T8QYMQL\QXAR?&U_;,NRS17V_?Q29IKI
M$SIWQ772)F8Z:.J<\LBM0
M
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M2^>:M7H
M                                      Y[OW''^IAM'\C_ %-^Y-\]
M _V='_+5M?Y8W_\ A*IT^@7]'F/_ "O/_?0@?3L;I         7P?M>_Z@G;
MW]\#?_Z%_']1/]IY_3WQ'_"&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
M
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M42THG-8
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M(G_[EW>7%\L]*7M6)B9B)F)B(F)F(UCKHS8PITX
M
M                              "%K[@+M*+K7VP^Y\9'D/P[+]L;)UGU
M;A):;ZTM)KB7([KB]NV''P0W-7$N2_$-(TW*PRP0<53<6]<DOPXCBKJIF?\
M 'XO;R3XF^&W-L?O-IQ.VWF]R1VVM$13;7P8KS->E.S<[C!:MK:5[XK7[ZU8
MG;OH=QL\AZC;3)->[%M<>;-;I,Z:8YI69T]FF3)28F>FND>V8<Z)Z)$]0
M      %E[[7_ *FYVCS"[G[=N[":ZQG4W1LV$L[NF+)TV^-V[LW:\-;8F>6]
MM:X\;ZT^JZEG88[6Z^?UJ9*Y8J.:K;FN.M7[3KRR.+](.&\1Q9(KN>6YR,MJ
MZTUO@V6#).2(K:)OI&?/M;3>FG;,12TZ9.VT>OB-Y3ZMXIM.*K:(R;K>]TQT
MUFF&EIM&D]>E[XYF8]FD1,_2TF](HV0R
M
M   <]W[CC_4PVC^1_J;]R;YZ!_LZ/^6K:_RQO_\ "53I] OZ/,?^5Y_[Z$#Z
M=C=(        "^#]KW_4$[>_O@;_ /T+^/ZB?[3S^GOB/^$-K_K'E4+/B._V
MWVO\E8O\XW*R"KD:
M
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M,D8]-9B*Q:\^V>MZI1FAB
M
M        HA_<[=9T:QYN]7]D6E</TO:/0."COH>;FXEO.-CT;;=KPU[<<V]=
MM1;6F-FUZ^Q-$/$<LE=<\-Q5731Q\O-=ZOV97DMN3]$^4\<RQ/O>+Y_+-9[8
MBON=S@P9*QKKW6O&6N>;:UB(K;'$3;KVS2^'3D9W/A^YX^VO=MM];3I&G9DI
M2T1KKK,]T7UZ1TFNDSUTK<K'D@          '1[]AGLROLGVO_'RBZHFIR?7
MLW8'6>1DJMK>UM9Z-9WW8)\#78<07,]<\,6I93'132RTPR5WD<W/R?+\M=?G
M,^._QJOC?Q.^03BF/JW(1M=Y2.Z;6B<VUQ1EBVL1I,YZ9;5K6;1&.:===:Q
M/UKXZ./]1M]-=/=YXQ9HZS,QWXZ]VO2-/IQ:8B-8[9CKKTB8=#]JD
M
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M3FR=OMCZ6LQAC6)Z1';,??2M'JO4;P
M
M'/=^XX_U,-H_D?ZF_<F^>@?[.C_EJVO\L;__  E4Z?0+^CS'_E>?^^A ^G8W
M2         O@_:]_U!.WO[X&_P#]"_C^HG^T\_I[XC_A#:_ZQY5"SXCO]M]K
M_)6+_.-RL@JY&@
M
M                        %4#[H/Q7N-BZ[Z/\P]<L(9;KKK)7/2_9LMOC
MZY<C7J.W7-QL'7F8O,A%'Q1:X'6-MAR=C53-55\U[LUOQ%Q3SS+S5:S]F'ZI
MX^.\AYST?Y'),8N1QQR.RB;Q%/?[>(Q;O'6DS]++FP3ARQ-8C3'L\G=,Z5TD
MW\.7DM<&_P!YXIN+3%=Q6-QAUGIWTB*Y:Q'RVO3LMT_6XK:_)I2\7-);@
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M$16M8B(K6(B(B(B(T6%X\=,5*XL58KBK$1$1&D1$=(B(CI$1'2(CV/XWV?H
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MW=Q$;K;YKXKQ'LB^.TTMIKI/MB?DA[9TCA@
M
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MP&3O]FFL?^(ZSK,3TTB-)UM-JN$;
M
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MV^6G;\B 7K5R'U_U'W_;/X/![K%7II]YBIW?J_A)OI/S:)@40FJ@
M
M                      '/=^XX_P!3#:/Y'^IOW)OGH'^SH_Y:MK_+&_\
M\)5.GT"_H\Q_Y7G_ +Z$#Z=C=(        "^#]KW_4$[>_O@;_\ T+^/ZB?[
M3S^GOB/^$-K_ *QY5"SXCO\ ;?:_R5B_SC<K(*N1H
M
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M7MK&O6UAU7JT0
M                                                           A
M^]^'KC](WM>>1?H1>KE=$_1[V/BOFN_I((_S8[%UC\?EG_8U<7/R:;?9/TH>
M?A\]QS'\.?CQPE[\"?D?Z._$]X[[R=-KO_K>SO\ 1[IGWVTS>ZB/[7_&*X>Z
MWR4[OD;5]%>0^H>H^P[I_!Y_>XK=-?O\5^W]3\)%-9^;5S?GHV3]
M  67OM?.RJ->\QNZNL;NYAMK7LCH&[S5C3+<W%%=_L?7V[ZO)98^WM*/C;7$
MW.O;3EKGFNO]G%':U<4<_"NKCFM7[3SQNW(>CW"^3XJS;+QO/UQVTB-*X=WM
ML\6O-OOHCWN#!32.EIO&OWL:1Z^(WCYS^)[/D:Q,VV^^BL](Z4RX[ZS,^V/I
M4I&D>V9C7V0O2*-D,@
M
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MC>1\C^6/(-]RNL6C<[O-EB8UB-+Y+6C2+?2B-)C2)ZQ&D3[&<F#NF
M
M                        <]W[CC_4PVC^1_J;]R;YZ!_LZ/\ EJVO\L;_
M /PE4Z?0+^CS'_E>?^^A ^G8W2         O@_:]_P!03M[^^!O_ /0OX_J)
M_M//Z>^(_P"$-K_K'E4+/B._VWVO\E8O\XW*R"KD:
M
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MM2NNGWT=%YYVD"0
M
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M(^G/)4B(G)BI3+6=)G3W62E[3&GSTB]=?9$3,RZ4#S=*^P
M
M                                     ')C\C>PJ.W/(7OCM>.]AR4?
M9W<W:'84>1M[*XQMOD*-TW?.;)3>P8Z[B@NK"&ZIR7J4PRT4214U<4U4\<\<
M\/6#Z<^/6\2]/>"\4M2<5N,X;9;2:3:+S2=MML6'MF]9FMIKV:3:LS%IC6)F
M)6><!L)XO@MEQDQ-9VVTPXM)F)F/=XZTTF8UB=---8G2?:PRS)VP
M#8KQ!ZZM^WO+#QEZLO(89L?V+W]U!I>5INL/1L-G1B-D[ U_$Y>XR&#EDA@R
MV-M,9=2RW,$E=$4D%%?%=5-'/-7&N_5[R+)XCZ4^3>4X9FNXX[@.0W%.W).*
MTY,.URY,<4RQ$SCO:]:UI:(FT6F)K$SI#H?*M_;BO&.1Y*DS&3;['/DKI;MG
MNIBM:L1;];,S$1$QUB=-(U=7AY4%98
M
M #GN_<<?ZF&T?R/]3?N3?/0/]G1_RU;7^6-__A*IT^@7]'F/_*\_]]"!].QN
MD        !?!^U[_ *@G;W]\#?\ ^A?Q_43_ &GG]/?$?\(;7_6/*H6?$=_M
MOM?Y*Q?YQN5D%7(T
M
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MCWB'C.S\0\>VW ;+K3#3Z5OEODM/=DO/ZMIG2)^]K%:^RL-5VTF2@
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MSCM69CKI,^V?;.U#5C&@
M
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M9CM3V_)[?;\CK1/)VK"
M
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M8J]-?O\ +3N_4_!Q?2?GT=()YR4 0
M
M'/=^XX_U,-H_D?ZF_<F^>@?[.C_EJVO\L;__  E4Z?0+^CS'_E>?^^A ^G8W
M2         O@_:]_U!.WO[X&_P#]"_C^HG^T\_I[XC_A#:_ZQY5"SXCO]M]K
M_)6+_.-RL@JY&@
M
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MQSW>XV/E>&(BF2/JV7II]*O=DQ3,_+,U]Y69G28BE8ZQ][;=5+HO
M
M                                      .<W[_O6M'7GN@=X7UK;0V>
M,[,P/6796.MH+:XMZ.*\GH6#UW/W-4D_QHNYLEMNKY&ZDEBYYC]2>JC\E5%7
M''HH^ 7R2WD/PQ<)@RVF^YXS/O=G>9F)G2FZR9L4:1][%,&?%2(MUTK$^R8E
M/?T/Y"=_Z<[.EIF<FWOFQ3,S$^S):]8^YI2]:Q$]=(U^5#"F6VV
M ZLWA3V'^EGP\\6>RZ[NSO+S=O'OI[8<O78Y'\6AM\_D-!P,NQ8VO(<RS2SW
MF)SO-Q:W'$M7KT7$-=$O'$E-7''E9]:?'OT3]8/*?&JTO3#LO(.0Q8^ZGNYG
M%3=98PWBFD1%<F+LO3MCMFEJS76LQ*L_R_8?DORODN/B)BF'?YZUUCMUK&6W
M;.GS6KI:-.DQ,3'31LXUDQT
M
M            !$A[Z/8%'7OM<^3US1/C:,GMF-T+K_$VN3HN)*,A7N/9NG8K
M-P6=%M/;U\Y*SU*O(WD'-5?IT26O%5=,E/',=<M/@;X"WD'Q0>,8[5R3MMID
MW6ZR6II$TC;[+<9,<VUB?H6SQAQVTC68OI$UF8M&T?1G8SO_ %(XZLQ;W>*V
M3+:8TZ>[PY+5UUUZ3?LK/RZ3TT]L<VQZ/U@(         "SM]K?UW<9?RP\A
M.TZH9I<?HG0,.EU5\X>NYLK;,=D]@:SEL?<<YSF3T,3DN<9UKD(H8/DYEO()
M;CFFJFB"2FNLK[4+R+'M/2GQ[Q:)B-QON?G<?MD1:<>SVN;'>/=::Y*=^\Q6
MM;7MQVKCB8F<E9K'7XD-_7%XQL.-UB,F??>\^^TF:XL5ZS';^NC7+69GV5F*
M]-;1I>,4@H;@
M                                           .>[]QQ_J8;1_(_P!3
M?N3?/0/]G1_RU;7^6-__ (2J=/H%_1YC_P KS_WT('T[&Z0        %\'[7
MO^H)V]_? W_^A?Q_43_:>?T]\1_PAM?]8\JA9\1W^V^U_DK%_G&Y605<C0
M
M
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MECNM7LF8Z]MIZ3&L3U'GE\5O@
M
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ML172L0#]:]A&Q]2-_-8BN+-&++'69^^PT[YG7V:Y(O.GLB---(TA,.A^U2
M
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MU:A5:HU@
M                                       .>[]QQ_J8;1_(_P!3?N3?
M/0/]G1_RU;7^6-__ (2J=/H%_1YC_P KS_WT('T[&Z0        %\'[7O^H)
MV]_? W_^A?Q_43_:>?T]\1_PAM?]8\JA9\1W^V^U_DK%_G&Y605<C0
M
M
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M([,TS-HB(]D5RQDI$?-6-(B.D2KHKM:
M
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MRUB8]M8BO72T:6=U9*.@
M
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M7C>VW7J-N<$]VFVP8,<:SK&DXXS?1^:-<L]/[;NGY4X:$33@
M
M                   #GN_<<?ZF&T?R/]3?N3?/0/\ 9T?\M6U_EC?_ .$J
MG3Z!?T>8_P#*\_\ ?0@?3L;I         7P?M>_Z@G;W]\#?_P"A?Q_43_:>
M?T]\1_PAM?\ 6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
M
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MR2C]#8
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M.ZR8M=8TCWV.+Z:>V=?<:Q.FD:3$^V-;KBEE$(
M
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M5M^?;Z.2\VY7>5FLX[;_ #16:ZZ32EYI2>NOMK6)G[LSI$1T;IM,,1
M
M                          <]W[CC_4PVC^1_J;]R;YZ!_LZ/^6K:_P L
M;_\ PE4Z?0+^CS'_ )7G_OH0/IV-T@        +X/VO?]03M[^^!O_\ 0OX_
MJ)_M//Z>^(_X0VO^L>50L^([_;?:_P E8O\ .-RL@JY&@
M
M
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ML6],_)?TJ\+V7)Y+S??5Q^ZS3/WTYL6E;6M\FMXTR=/DO'LG6(CK2'9X
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MD]MZ6C7Y=%9N_P!EN.-WV;CMY7MW>WRWQWCYKTM-;1_8F)A[!T[B
M
M                                    -7/-_1;?L[PT\KNO[B/&U5;9
MXZ]RX:RFRUE1D+''YBZZ]V#C!YF2VKHKYYFP>9I@O(:Z..)8IH*)(^::Z::N
M-H>B7.Y/&?63Q3G\<Y--IY%QV2T8[32U\==WB][CBT:=,N/NQVB?HVK::VB:
MS,,D\.WMN.\MXS?5[OP6_P %I[9TF:QEKW5U_NJZUGY)B9B>CE0/5&LN
M      3G?;J]@5Z;[G/7VN43Y**GMGK'M[K^6.QHMZK6YHQNI3]J<09FJ:>*
M2/&TR]:4R4\Q4RR?61P<<T\4<UUT0<^T0X"O,_#+R'(S7',\3R>PW43;7NK-
M\\;'7'I$Q-]-Y,3W36/=S>=>Z*Q.FO7K8QN_3K/N)BL_5=S@R]==8UO[GZ/W
M?PVG72.V;?+I$]#1Y[T$@
M
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M$:1WY;S>VD?)'=:=(^2%7.YW&3=[G)NLVGO<M[7MITC6TS,Z1^K+[S@/@
M
M                             Y[OW''^IAM'\C_4W[DWST#_ &='_+5M
M?Y8W_P#A*IT^@7]'F/\ RO/_ 'T('T[&Z0        %\'[7O^H)V]_? W_\
MH7\?U$_VGG]/?$?\(;7_ %CRJ%GQ'?[;[7^2L7^<;E9!5R-
M
M
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M#S\F4N-#W.ZYR>@W-[ZGPBFP^I[O3?6T=,=7$U-SL_Q^22/YZX+4/LQ?5/\
M)?E?->D/)9KQM.4PQO\ 94G[R-UMZ]FZK73K&3/MO=7F9CMFFRT[JVTB\E_A
MS\E^K<GN_%=Q>?=;FGO\-?DC)CC3+$?W5\?;,Z]-,/MB=(FE4NC2[
M   7\?MP/*+]-7A%DNE,W?\ U.X^+FX5ZI3#5SZDU?6>]_B&T=?7\\E-K;QT
M?)E;?/8N*+YIJZ+?$1U55_MG%%-"'VC7I?\ H7ZV8_-=EC[>'\HV?O\ 7V1]
M<VO9@W=8CNF9UI.USVMI6)OGM$1]&9F$/K]XW^2/,:\QAKIM.2Q=_P#]NQZ4
MRQ[9^2<=YGIUO,:=-9L(J^VBP
M
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MG+$::Q[9II$_K9ZZ3IHZACS"JXP
M
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M
M                                #GN_<<?ZF&T?R/\ 4W[DWST#_9T?
M\M6U_EC?_P"$JG3Z!?T>8_\ *\_]]"!].QND        !?!^U[_J"=O?WP-_
M_H7\?U$_VGG]/?$?\(;7_6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
M
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M3.L:@];_ !O\O>"Y]SBKKO./GZQ7_J5C3-'MCI&*;7^76:1'RZQT4GG@0,
M
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MRUF8M68F)B8G28F)ZQ,3TF)ZQ*K>U;4M-;1,6B=)B?;$_-+]GX?P
M
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MJ7UPWOU3TWWU(F\9,]\&.)KT]N:EK1,ZQ/;:E+5G377728TF71J>=1 <
M
M                            !SW?N./]3#:/Y'^IOW)OGH'^SH_Y:MK_
M "QO_P#"53I] OZ/,?\ E>?^^A ^G8W2         O@_:]_U!.WO[X&__P!"
M_C^HG^T\_I[XC_A#:_ZQY5"SXCO]M]K_ "5B_P XW*R"KD:
M
M
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MFWW!7UTVVXM6LS&DSCGZ6*VD_P!MCFMO;/M]L^ULXUDQT
M
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M1$3$ZQTF&U+5C&@
M
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M33'BRQ,3'RZSDB8_ZOZB\\HY0S
M                                                           <
M]W[CC_4PVC^1_J;]R;YZ!_LZ/^6K:_RQO_\ "53I] OZ/,?^5Y_[Z$#Z=C=(
M        "^#]KW_4$[>_O@;_ /T+^/ZB?[3S^GOB/^$-K_K'E4+/B._VWVO\
ME8O\XW*R"KD:
M
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M+IM?+=KR>.L1&ZV41;V_2OBO:LVF?9]Y;'72/9%8F?;ULIJVT?
M
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M6F)TB)K%YM6-/9VZ3,S$I:43FL
M
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M+=?[KI\JVZJ71>
M                                               <]W[CC_4PVC^1
M_J;]R;YZ!_LZ/^6K:_RQO_\ "53I] OZ/,?^5Y_[Z$#Z=C=(        "^#]
MKW_4$[>_O@;_ /T+^/ZB?[3S^GOB/^$-K_K'E4+/B._VWVO\E8O\XW*R"KD:
M
M
M                       <ZWWR_<#_ %U?*R]TS1LC]3T+XZ7F>T/KR:"O
MX0;?LU<]G;=A]A5<175U:W%GE\WB*;/$RT5?"3#6-O<?+%+=31T^A_X'?0#^
M9;TKIS/.8^WSSR*F+=;N)]NWPQ%IVFTZUK:+8\>2<F>LQTW&7)CUM7%2TSS]
M&O!OT0\9C=[VNG-[^*Y,OSTIUG%B]D3$UK;NO'R9+6KUBL2A/34;?
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M_P#!5P%4*BL
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MK.D>RM:3,:S,3;7V3$+%*O!H4
M
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MC>_6/.,.UK-^S;\?CK,3][W6R9;S-8UGVUM2)G2)F:Z>R(E8I5X-"@
M
M                          .>[]QQ_J8;1_(_U-^Y-\] _P!G1_RU;7^6
M-_\ X2J=/H%_1YC_ ,KS_P!]"!].QND        !?!^U[_J"=O?WP-__ *%_
M']1/]IY_3WQ'_"&U_P!8\JA9\1W^V^U_DK%_G&Y605<C0
M
M
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MKY+]<X3=>,9[?AMGD][BB9_[++,]T5C7V4RQ,VZ1&N6/;,RJ[K/DC@
M  %V'[6#KC\+Z"\J>W?2^'Y\=P:9UQZ_U?S^I^BO2YMF]+Z#Y>/IO1_3'\?6
M^//K_/\ +\./2_+2M]J3Y']:\^\5\1U_\#P^XWFG;II]>W,8=>[Y=?R?][^M
MTU_7H@_$GR'O.<XSB]?VG:9,NFG_ 'V3L]OR_M'L^33[JU"JU1K
M
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M\UGNR8MQ33Y(C';#:)_L^\G7]2%M=4TB^
M
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M .M&]^N^I'(S6TSBQ3BQUU^3LPXXM$?<]YWS'SZZI=42&K0
M
M                   '/=^XX_U,-H_D?ZF_<F^>@?[.C_EJVO\ +&__ ,)5
M.GT"_H\Q_P"5Y_[Z$#Z=C=(        "^#]KW_4$[>_O@;__ $+^/ZB?[3S^
MGOB/^$-K_K'E4+/B._VWVO\ )6+_ #C<K(*N1H
M
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M=^GLB(B15'=@0
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M-@
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M6-?;/MG6=9;C-/,3
M                                                 <]W[CC_ %,-
MH_D?ZF_<F^>@?[.C_EJVO\L;_P#PE4Z?0+^CS'_E>?\ OH0/IV-T@
M +X/VO?]03M[^^!O_P#0OX_J)_M//Z>^(_X0VO\ K'E4+/B._P!M]K_)6+_.
M-RL@JY&@
M
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MK=YQ'E'DGY)V-XMPW'6M2LQKIDS3I&6_S6BLU[*3UC2+6K,QD3SH(-*
M    .=/[X/M[Y/PK\J<QNVG8.:/Q[\@LEF-ZZ]R%C9<0X74-IOK^YO=RZIDY
MCDJIM)M?NIJ;W&T<T1128>]ACAYEDM+OTO1%\$?Q!;;UH]+,/"<QGB?4'Q_'
MCVV[I:VN3<8*UK7;[Z-8^E&6L3CS3K:T;C'>UXK7+B[IZ^CGG6/R_P :IL]W
M>/R[L:UQY8F?I7I$1&/-]WNCZ-_;,7K,SI%JZPJIHMN@      )PO8P]O"]\
MR_)_%=E]@ZQ-?^-_062@V?=KC(VE]%A=XWFUM_K-*ZWLKZF'FQR$T66DM,KF
M;7FJJG\'@Y@FXH^N@JJA%\<?Q"X?1OTQR^->/[J,?J/S^.<.VBEJSDVVVM/;
MN=Y:NO=2)QQ?!M[Z1/UBW?29]QDB-.>LWGE/$O'+<?L<D5\@WU9ICB)CNQXY
MG3)EF/;'T>ZF.?[>>Z->RSH@//2@@
M
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MSN<T=NF#/@R3K[=)R5Q?1Z3UUR1\WT>[K\D]$!YZ4$
M
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MUIMI'ZFKU3JG&
M                                              <]W[CC_4PVC^1_
MJ;]R;YZ!_LZ/^6K:_P L;_\ PE4Z?0+^CS'_ )7G_OH0/IV-T@        +X
M/VO?]03M[^^!O_\ 0OX_J)_M//Z>^(_X0VO^L>50L^([_;?:_P E8O\ .-RL
M@JY&@
M
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M65D7#<1L>!XO!P_&T[-CM\<4I'MG2/;,S\MK3K:T_+:9GY6*V4NR
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M\UR^2<FZRSTC];2D3/;CI'LK2L3I$1[9UM.MK3,["-?.B
M
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M;]NUG)I&L?M-JY>[I,?>]G=/R3$:3$QT=-QYG%=H
M
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MNB\HW--GXSR.\RQ,XL6PW%YB/;,5Q7M.FLQ&ND=-9C]5U?WE-5E
M
M                         .>[]QQ_J8;1_(_U-^Y-\] _V='_ "U;7^6-
M_P#X2J=/H%_1YC_RO/\ WT('T[&Z0        %\'[7O^H)V]_? W_P#H7\?U
M$_VGG]/?$?\ "&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
M
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M?EN7Y+G=_DY/E\U]QO\ +,=U[SK,Z1I$?)$1$1I%8B(B.D1$,G,9=<
M
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M:Q$]-70^5;:N]\7Y+9VF:UR[#<4F8]L1;%>NL?J:NKP\J"LL
M
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M;J=GZ?<MFK>*3.SO36=.OO=,4UZ]-;Q?MCY=9CM^EHZ=SS)JZ0
M
M                       '/=^XX_U,-H_D?ZF_<F^>@?[.C_EJVO\ +&__
M ,)5.GT"_H\Q_P"5Y_[Z$#Z=C=(        "^#]KW_4$[>_O@;__ $+^/ZB?
M[3S^GOB/^$-K_K'E4+/B._VWVO\ )6+_ #C<K(*N1H
M
M
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MS.K',F2^6]LN6TVRVF9F9G69F>LS,SUF9GK,S[7]CXOP
M
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M;3K&M9F)TG]6'WG ?
M
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MMJ#UUW7U?TWWF+MU]_EV]-==.W3-3)K[.O[7IIT]NNO32>BD\\"!@
M
M                          #GN_<<?ZF&T?R/]3?N3?/0/]G1_P M6U_E
MC?\ ^$JG3Z!?T>8_\KS_ -]"!].QND        !?!^U[_J"=O?WP-_\ Z%_'
M]1/]IY_3WQ'_  AM?]8\JA9\1W^V^U_DK%_G&Y605<C0
M
M
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MCQUB9F>JMSG^;WWDG,[CG.2MW;S<Y.ZWS1&D16L?W-*16E?[FL,V,*=.
M
M
M    H>_<]ZA^#>=W5FV6N&^BL=T\8]1^LR]%/PCS>S:[V/VEC<CZE7-?/-5Y
MC=<EP\5?Y*>.(>8O]O/Q7L?9C\O]<]"N4XG+F[\^R\FW';C^7'AS;/97II_<
MWS1N+1[?I=_W$T_ASW?OO"]SM;7UOAY&^E?[6E\6&8_L3?WD_JZJWZQMO\
M       !U9O";:,AO'AGXC[IEH;.WRFW^,?0FT9*WQT<T6/@R&?ZJU3+7D-C
M%<W%W<16<5Q=U4Q4R2RUTT<<<55U<_'GGRL^M7%[?A/63RWA=I-[;79^3<I@
MI-YB;S3%OL^.LVF(K$VF*Q-IBM8F==(B.BL_S#;4V?EO*;/%,SBQ<CN:1,^V
M8KFO6-=(B-=(ZZ1'ZC9QK)CH
M
M         #6GS1VJXT7PZ\L=VM+2&_NM.\:>]MJMK&XKKCM[RXU[J[:<O#:3
MR1_&2.&XDM.**JJ?V7%////'Y6RO1GBL?.^L'BG"9;SCQ;SR7C,%K1$3-8R[
MW!CFT1/29B+:Q$]-60^([:N]\KXS9VF:UR\CMJ3,>V(MFI76/U-7*3>JE9B
M         L=?;#:O1E_/7L[8[O"37UKJ/B[NL]CF>;2XKL\'L>:[*ZEQ-E3S
M>T4_36V2RFO2Y:.&.NKYYH*;CFBGGB.KFFN?[3?E+;3T'XSCL6>*9=WY1MHM
MC[HBV7#CV>_R6^C]]-*98P3:8C2MIQQ,QW1$Z"^(O<SB\)VVWK>*VR\ECB:Z
MQK:E<6>T]/;,1;LF9CV3VZ^V%\A1(A4
M
M     Y[OW''^IAM'\C_4W[DWST#_ &='_+5M?Y8W_P#A*IT^@7]'F/\ RO/_
M 'T('T[&Z0        %\'[7O^H)V]_? W_\ H7\?U$_VGG]/?$?\(;7_ %CR
MJ%GQ'?[;[7^2L7^<;E9!5R-
M
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M/7_SG\H\G7P[CKZ[+:3%MQ-;=+YYCICG3I,8:SUZS^$M:LQ%L:T2K 1P
M
M
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M?HWQTO6>FOMK:)T]L:Z3I.L).49FN@
M
M               $<GNZYFXP7MI^9-];96;#23],YK#57<%]7CJYK?8[[&Z]
M=XJJXCEAJDASMKE*[&2#X\TW4=Q5#535Q)S3S(OX2-GCWWQ)^'8,N*,U:\SC
MR=LUB\1.&M\M;Z3$Z3BM2,L6]M)I%XF)KK&?>EN*N;U"XFEJQ>(W=;:3&O6D
M3:+:?W,QW1/R3&O31S&'IH6*          +8GVJ^KY"[[/\ ,7=8YK.G%:_H
M?46KWEO7)/QD)<AN&P[OEL9-;14V]5M79P6VCW=,]5<M%=-<D/%%%?%5?,=4
M?VIW*;?%XQX?PMHO]:W&_P!_GK,1'9%-OBVV.\6G76+3.YQS6(K,3$7UFLQ$
M6C'\2VYI7CN)V<Q/O;Y\]XGY-*5QUG7KKK,Y*Z=/DG68Z:W/E-")(
M
M                          #GN_<<?ZF&T?R/]3?N3?/0/]G1_P M6U_E
MC?\ ^$JG3Z!?T>8_\KS_ -]"!].QND        !?!^U[_J"=O?WP-_\ Z%_'
M]1/]IY_3WQ'_  AM?]8\JA9\1W^V^U_DK%_G&Y605<C0
M
M
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M][3\MKVF;6GY9F95V9\^;=9[[G<6F^XR7FUK3UFUK3K:9GYYF9F7V'#?(
M
M
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M<F,-,>D?V,<3^K,IMT*&G@
M
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M53(R
M                                      .>[]QQ_J8;1_(_U-^Y-\]
M_P!G1_RU;7^6-_\ X2J=/H%_1YC_ ,KS_P!]"!].QND        !?!^U[_J"
M=O?WP-__ *%_']1/]IY_3WQ'_"&U_P!8\JA9\1W^V^U_DK%_G&Y605<C0
M
M
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MVS*9]#-J0
M
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M;CF9_MK1FSU_Z8K%8_4T6-5=308
M
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MX*W[J8^,QZUUUBMK9L\SK'ZVUJ]DS[)FO;/LT605<C0
M
M                 #GN_<<?ZF&T?R/]3?N3?/0/]G1_RU;7^6-__A*IT^@7
M]'F/_*\_]]"!].QND        !?!^U[_ *@G;W]\#?\ ^A?Q_43_ &GG]/?$
M?\(;7_6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
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MPQ>U]I5SR7O6FG50<R1U9>SL;[&R9K)P\4S6GTUA#:7M/I9&*B6"?QZ^O?\
M--Z5V\0X#<>Z\Y\FIDV^/MZWP;+2*[S<:Z3[NUJWC;8;:UOWY;Y<,]VWM--+
M>MWF_P"B_C,\5L<G;S7(Q;'73VTPZ:9<G]S,Q,8Z3TMK:;4G7',QT(GGX06
M
M
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MEK]5,C(
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MZ-Z_V=83AH1-.
M                                               .>[]QQ_J8;1_(
M_P!3?N3?/0/]G1_RU;7^6-__ (2J=/H%_1YC_P KS_WT('T[&Z0        %
M\'[7O^H)V]_? W_^A?Q_43_:>?T]\1_PAM?]8\JA9\1W^V^U_DK%_G&Y605<
MC0
M
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M6GY6Z33#$0
M
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MQ&\UCMQY=Q33Y9G)7#:)_L>[G7]6%RM3BB:
M
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M3RF6L3$1EQTZ_/CP8L<S_9FNL?<E*NBNUH
M
M        Y[OW''^IAM'\C_4W[DWST#_9T?\ +5M?Y8W_ /A*IT^@7]'F/_*\
M_P#?0@?3L;I         7P?M>_Z@G;W]\#?_ .A?Q_43_:>?T]\1_P (;7_6
M/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
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M'X@O.?<8*>#\?;\+EBN3=3'R4UBV+%[?;:8]Y>)B-*QCTUB\Z7,5-R)8
M
M
M       #5WSAUS)[CX5^7^HX6F&O,[5XN^0&N8FBXFXM[>O)YSJ?;<984SSU
M<<TP0U75U1Q57SQSQ33\>?\ D;0]$>1VW#^M'B'+[V9C9[7RCBLV28C6>S%O
ML%[:1\L]M9TCY99)X=N,>T\OXK=9M?=8N2VU[:=9TKFI,Z1^I#E/O5&LN
M       69/M<=HR%IYF=]:7'#9U8O/\ C'E-HO+BN.;G(19#4.U>L<3C8;:6
MFXIMZ+.>WWB[JGIKBKKJKCAYHKHXIKXDK2^U!XO;Y?1O@>:M-_K6W\FI@K$3
M'9--QL=[DO-HTUFT3ML<5F+1$1-]8M,Q-8\_$AMJ6\2V6\F9][3D8I$?)I?#
MFM.O376)QUTZ_+.L3TTO/*.4,P
M
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MNGR:Z:SIK.^+1+"@
M                                                 '/=^XX_U,-H
M_D?ZF_<F^>@?[.C_ ):MK_+&_P#\)5.GT"_H\Q_Y7G_OH0/IV-T@
M+X/VO?\ 4$[>_O@;_P#T+^/ZB?[3S^GOB/\ A#:_ZQY5"SXCO]M]K_)6+_.-
MRL@JY&@
M
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M?9$3KI6L:5I7V5K$5CI$,G,9=<
M
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MS&2G7Y_HWM_9TET!% R#H
M
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M?[B\Q'LB;9;VTC]35L4UVZ$
M                                                        !SW?
MN./]3#:/Y'^IOW)OGH'^SH_Y:MK_ "QO_P#"53I] OZ/,?\ E>?^^A ^G8W2
M         O@_:]_U!.WO[X&__P!"_C^HG^T\_I[XC_A#:_ZQY5"SXCO]M]K_
M "5B_P XW*R"KD:
M
M                             5E/N._/^CISI7%^%W6^9AI[*[]QOXMV
MM-:\W'-YJ?2-M=R018KF6.JWBM\EVEG[*NTX^%=Q\,-CLA%/#1Q>VDRS#[.?
MT"MYAYIE]9_(\-I\;X#)[O8Q;3MS\E-8F;Z3K,TV6*T9/93_ !C-M[4O;W.6
MB1'H#X//+<O;R[D*3^3]C;MPZZ:7W$Q]]\NL8:SW?)^$OCF)GLM"C0O#3*
M         7P?MU/ 7] 7C]>>6G8NN_0]M^2&'M?S'DN__?N!\?KFK%9S7_1H
MHEJCA_29E;.#-2?'CGF7'V^,J_85<24\T3_:(>O?Z>^H%/2?QW<=_B?CF:WU
MF*_>Y>5K[S%EUZ:S]3I:VVCYLM]S'6.V4+/7KS?\M\Y'C&PR=W%\?>?>:>RV
MYCNK;]QB9QQ\UIR>WHL@JY&@
M
M                                      '(L["U3\P]^WC1OK_Q7\S-
MPV;5/Q3Z7Z'\2_-W-7N(^O\ HOJ;SZ/ZSZ/U/2]:7T_F^7YZOA\W/K<\>Y7\
MO<!L><]W[KZ[L\.?L[N[L]]CKD[.[2O=V]VG=VUUTUTCV+2-ANOKNQP[WM[?
M?8J7TUUT[ZQ;372-=-=-=(U^9Y!V[E         )F/M_\_EL/[JWCGCL==_3
MV>UX?NW 9^'T+:;Z_$V_1?8VT0VGJ3PRRVOR9W6[*?U(:HY>?1^3FKF.N2BJ
M&_Q][#:;SX5_(MQN:=V;:YN-RXIUM';DGD]I@FVD3$6_!9LE=+1-?I=VG=%9
MC4OKC@Q9?33?Y,D:WQ7V]J]9Z6G<8J:]/;]&]HTG6.NOMB)CHU/.H@.
M
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MCV1-K3;2/U-7JG5.,
M                                                   Y[OW''^IA
MM'\C_4W[DWST#_9T?\M6U_EC?_X2J=/H%_1YC_RO/_?0@?3L;I         7
MP?M>_P"H)V]_? W_ /H7\?U$_P!IY_3WQ'_"&U_UCRJ%GQ'?[;[7^2L7^<;E
M9!5R-
M
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M,]9E7K:UKVFUIF;3.LS/MF?GE^S\/X
M
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M$Z[]6L&+<>G/*X\T:TC;Q;VS'TJ9*7K/33V6K$Z>R=-)UC6'3*>:57B
M
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M>WN]SBO?3737LK-M-=)TUTTUTG3YG73>2-5N
M
M           Y[OW''^IAM'\C_4W[DWST#_9T?\M6U_EC?_X2J=/H%_1YC_RO
M/_?0@?3L;I         7P?M>_P"H)V]_? W_ /H7\?U$_P!IY_3WQ'_"&U_U
MCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
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M\HR;G!:9X;;ZXMO$_P!K&G=D_5RWB;=>L4[*S]ZE11::U
M
M
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MCR\JW@
M                                                   '--][3;/S
MS]TGRZS'T'X;]'N&G:G]/]5]9ZGYA=5Z'HWU_K?36OR?BOYN_5>E\O/H>MZ?
MSR?)ZE7I.^"GBOR-\+OB.S]Y[SOV>XSZ]O;I]:WVZW/9IK;[SWW9W:_2[>[2
MNO;%A'H_M?JGIOQ>+N[M<62^NFG[9FR9-/;/WO?IK\NFND:Z1%>E*V4
M    V#\2-7R&\>5GC)I6)FL[?*[AY"=+ZOC+C(R3Q8^#(;!V/K>)LYKZ6VM[
MNYBLXKF[IJEJCBEKIHXYYIHJY^''.OO5KE-OPGI5Y-S6[B]MKL_'^1SWBD1-
MYIBV>;):*Q,UB;3%9BL3:L3.FLQ'5T7E&YIL_&>1WF6)G%BV&XO,1[9BN*]I
MTUF(UTCIK,?JNK^\IJLH
M                                                      !SW?N.
M/]3#:/Y'^IOW)OGH'^SH_P"6K:_RQO\ _"53I] OZ/,?^5Y_[Z$#Z=C=(
M     "^#]KW_ %!.WO[X&_\ ]"_C^HG^T\_I[XC_ (0VO^L>50L^([_;?:_R
M5B_SC<K(*N1H
M
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MK$1"QC;;;;[/;8]GM*5Q[7%2M*4K&E:TK$5K6L1[(K$1$1\D0^"YS[
M    +%WV\'M_V_D=Y"W_ )1=F:[-D>G?&W)6DFKP9&QHEU_<^\Y[:.^P&.EK
MNK:6#(0]:XRZBSUS##71+!D)L/5)\T$U<<M=OVA?K]D].?3['Z8>-;B,?F'D
MF.T9YI:8R[?C(M-<MX[9B:3O+UMM:6M$UMBKO(KIDI6U=">N_G%N X*OC?'9
M(KRW(5GOF)^ECV^NEIZ3T][,3CB9Z36,NGTHB8OJ*'D*
M
M
M'-']ZW5;C3?=&\O,1<W<-[)>;MJ^U4S045QT46^]=9Z1N]I:54R?LN9K"UV&
MB"2K_FU21U<T_DYX>E'X+.5Q\Q\+_B.[Q4FE:;+/@TF8F==KO=SMK6Z?):V*
M;1'MB)B)ZK"O2'<UW?IOQ66L3$1AO3K\^/-DQS/]F:ZQ]R46J439
M #8KQ VJXT7RT\7=WM+2&_NM-\BND]JMK&XKKCM[VXU[LO6<O#:3R1?&2.&X
MDL^**JJ?V7%////'Y6N_5[BL?.^DWE'"9;SCQ;SQWDL%K1$3-8R[/-CFT1/2
M9B+:Q$]-70^5;:N]\7Y+9VF:UR[#<4F8]L1;%>NL?J:NKP\J"LL
M
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MLE,?@W,VR6BM9XO=1K,Z=;8;UK'7Y9M,1$?+,Q$=9=39Y<%;0
M
M                       #GN_<<?ZF&T?R/]3?N3?/0/\ 9T?\M6U_EC?_
M .$JG3Z!?T>8_P#*\_\ ?0@?3L;I         7P?M>_Z@G;W]\#?_P"A?Q_4
M3_:>?T]\1_PAM?\ 6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
M                                                      YV?OI>
M?]'FAY7WFE:%F8<ET'XZS9;2.O+NQYN*+7;=INN,=1V/O4E,E=45Q#>9_&?A
MN-EC^,4N*QT-S1\O-U)P]#GP->@5O1GTIIS7/89Q>>^11CW.[K;3NP8*]_U/
M;1IUB:XK^^S5GZ5<^:^.VL8JRGEZ,>#SXCXS&\WM)KS>_BN3+$Z:TI&ONL?W
M-*SWWB>L7M-9^]A"2FNW           R1T]U/NW>W:O7G3/7&,_&-Z[/W# :
M3J]C75)';59;8<C!CK>YR-S'%-^'X?'^OS<7MU73S%:6D4DTG/%%%7/&.>8>
M5\+X+XKR/F7D>7W/!\9L\NYSVZ3;W>*DWFM*S,=^2^G9CI$]V3):M*ZVM$.!
MRO)[/A>,S\MR%NS9;;%;)>?E[:Q,S$1\MI]E:^VUIB(ZRZC'ACXL:-X8>-?5
MWCOH4,-=CHV!CXV'.4T2<76X;SEJZLGNNXW\D]<ES5-G]AN9Y88JZZJ;*S]&
MTB^2"WBCH\O_ *R^J7.>LWJ3RGJ'SUIC/OL\^ZQ=.W;[;']#;;>L1I73%BK6
MMK1$3DR=^6^N3)>TUP>6^2[SR[R'<\]O9GOS7^C7Y,>.O3'CC3I]&L1$S^NM
MK:=;6F9VB:O8V
M
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MDW?&;G:X=/>Y<&2E=>D:VI,1K/ZLNN"\EBKL
M
M                     !RO?<+_ *_?G%_? \E_Z:-U>I7X?/Z!/!_^$.&_
MU=MEE'@G^Q'#?R5M/\WQM/VWF5         )(/:$_P!2_P -_P"6'&_N5ED<
MOBZ_Y:O,?Y'O_A,; /53^CSEO\DG^^JZ<3S,J[
M
M             '/=^XX_U,-H_D?ZF_<F^>@?[.C_ ):MK_+&_P#\)5.GT"_H
M\Q_Y7G_OH0/IV-T@        +X/VO?\ 4$[>_O@;_P#T+^/ZB?[3S^GOB/\
MA#:_ZQY5"SXCO]M]K_)6+_.-RL@JY&@
M
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M^<4S9:>#\?;6N.:Y=U,3^NTUQX9^?MB8RV]L:SCC[ZMHBVZJ71>
M
M
M        <]W[CC_4PVC^1_J;]R;YZ!_LZ/\ EJVO\L;_ /PE4Z?0+^CS'_E>
M?^^A ^G8W2          [ 3R&*K0
M
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M;/EV_IIRF3#.EYIAK[(GZ-]QAI:.NOMK:8U]L:ZQI.DNDT\WJOP
M
M                         !SW?N./]3#:/Y'^IOW)OGH'^SH_Y:MK_+&_
M_P )5.GT"_H\Q_Y7G_OH0/IV-T@        +X/VO?]03M[^^!O\ _0OX_J)_
MM//Z>^(_X0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
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M.G<0
M
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M(W&2(B(CI$1'2(CI$*P><K6O-;RM8B*QNLL1$>R(]Y;I#+;$W5@
M
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MI_7#+CQ^F?(4O,1;);;UK]V?K.&VD?\ LUM/ZD2Z.#SHH"@
M
M                     .>[]QQ_J8;1_(_U-^Y-\] _V='_ "U;7^6-_P#X
M2J=/H%_1YC_RO/\ WT('T[&Z0        %\'[7O^H)V]_? W_P#H7\?U$_VG
MG]/?$?\ "&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
M                                                *IGW)GN 6^FZ
M-A/!#K+8IH]RWZ'$[MWO<X:^HX_!NN^)+J75^O<G-9W/,]KDMTR=K'D[VSEX
MCDXQ%M:\UTUVV2I^:U/[-[T!R<SSF?UU\FV\3PVPG)MN+KDK/X3=Z5C/NZ1:
M-+4VU+3AQY*ZQ[^^7MF,FVG23'P_>#VW>]OYKR..)VF";8]M%H^^R]._+&L=
M8QQ,TK:-8[YMII;'*E@N@2Z           =!7V O ?\ 51\6..ZM\PEYC>[_
M "<L\-L^9LLO:^AD-.ZSQLF1GZ]UB*VN(*+S%WF:L\G7F<G1SS17)7=6L$]'
MSV-'P\_WQ]>O/\ZOJE^A? YZ9/"/&;Y,..V.VM-QO+Q2-WFF8F:WKCM2-OAG
MK$13+>EM,\H,^N'FWZ3>2_DC97BW#\=-J5FLZQDS3I[V^L3I,5F/=T^;2TQ.
MEY3VH&M)@
M
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MTQ:V+?[BDS'LF:Y;UUC]71L4UVZ$
M
M            !Q_7KS6I          )X/MQ_]3#5_P"1_MG]R;%!/[1?_EJW
M7\L;#_"6:6]??Z/,G^5X/[Z70B>?A!8
M
M     !SW?N./]3#:/Y'^IOW)OGH'^SH_Y:MK_+&__P )5.GT"_H\Q_Y7G_OH
M0/IV-T@        +X/VO?]03M[^^!O\ _0OX_J)_M//Z>^(_X0VO^L>50L^(
M[_;?:_R5B_SC<K(*N1H
M
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M/6#S;]#O%K4VEYKS>^[L6#MG2U.D>\S1/28]W68BLQUC)?'TTUF.CL\YR @
M
M
M                 "D[]T]_[?O%;^1[<O\ UTB74_9;?[ ^5?RQM_\ -I2^
M^&S_ .L?)_Y7C_P:J^M*24          =4+V]/Z@G@[_ '/_ !H_H7TIY:OB
M#_I[\X_XOYG_ %CN5:_G?^V_,_RKN_\ .,C<!J%BH
M
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M#W-,'@,8KQ,VS;_#2NGR3%<F3KU]G;28Z:]9CIIK,7_E!*#P
M
M                      #GN_<<?ZF&T?R/]3?N3?/0/]G1_P M6U_EC?\
M^$JG3Z!?T>8_\KS_ -]"!].QND        !?!^U[_J"=O?WP-_\ Z%_']1/]
MIY_3WQ'_  AM?]8\JA9\1W^V^U_DK%_G&Y605<C0
M
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MMO6=>F&DSVVF.FELDS.2T?K9MVZS%8E(JCNP(
M
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M._RWZ_/DM[RWLB.D6M,1]S369GJW]:#8.
M
M                 P]Y#?\ L![R_D>[,_\ 4O-LO]/O]ON#_EC9_P"<XW:\
M%_\ 7S9_Y7A_PE7)>>L19Z          L@?:]_U^^WO[G^__ --'C^KD^T\_
MH$XC_B_:_P"KN5: ^([_ &(VO\JXO\WW*^$HG0L
M
M              <]W[CC_4PVC^1_J;]R;YZ!_LZ/^6K:_P L;_\ PE4Z?0+^
MCS'_ )7G_OH0/IV-T@        +X/VO?]03M[^^!O_\ 0OX_J)_M//Z>^(_X
M0VO^L>50L^([_;?:_P E8O\ .-RL@JY&@
M
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M,;_>U[LTQI]';]8[/GB<MH_^DK:)Z7A>,4A(;@
M
M                                                         *?W
MW7/_ . 5_P#E2?\ ZNBWK[*G_P#/S_\ (G_\W2I^&;_\=_\ WG_^%*?RWE*D
M         !TX?:#_ -,_PX_D?QW[K9=YFOBZ_P"97S'^6+_X/&KL]5/Z0^6_
MRN?[VJ2%'%@
M                                                       ##WD-
M_P"P'O+^1[LS_P!2\VR_T^_V^X/^6-G_ )SC=KP7_P!?-G_E>'_"5<EYZQ%G
MH         "R!]KW_7[[>_N?[_\ TT>/ZN3[3S^@3B/^+]K_ *NY5H#XCO\
M8C:_RKB_S?<KX2B="P
M                                                    !SW?N./]
M3#:/Y'^IOW)OGH'^SH_Y:MK_ "QO_P#"53I] OZ/,?\ E>?^^A ^G8W2
M     O@_:]_U!.WO[X&__P!"_C^HG^T\_I[XC_A#:_ZQY5"SXCO]M]K_ "5B
M_P XW*R"KD:
M
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M9B=WN<LWF(UTK'LI2NNL]M*16E=9F>VL:S,]6<F#NF
M
M
M  50/NI]<QEUU3X?;=+1-SF<'V%VMKEA73-S3;TXS:M;T_)Y:B6#X?+)-7=:
M=9<T5\\_&BFFOCC_ )_*UG[++D=SB\J\OXBDQ]3S\?L<UHTZ]^#-N*8])^2.
MW<9-8^69CYDF_AJW&2O)\KM8T]U?!AO/SZTO>*]?U,EM?['S*7BYI+<
M    !TO?98VC'[?[7GB#EL;#>06]IH>PZO)1?1PQ359#1^Q=STO+344V]Q<Q
M\V=QE,!-);U<U<5UV]5%5=$=?-5%/FK^,_B]QQ'Q/>7[3<S2V2^_Q9XFLS,=
MFYVFWW..)UBL]T4RUB\::1>+1$VB(M->GJ[MK[7U'Y7%DF)M.>M^GS9,6/)7
MVQ'6*VB)^[KI,QU2BHP-<
M
M     -8_-G:,AH_AGY<;IB8;.XRFH>,??>T8VWR,<TN/GR& ZJVO+6<-]%;7
M%I<2V<MQ:4TRTQRQ5U4<\\4UT\_#GC9OHKQ>WYOUD\2X7=S>NUWGDW%X+S28
MB\4R[[!CM-9F+1%HBTS69K:(G36)CHR+P_;4WGEO%[/+,QBR\CMJ3,>V(MFI
M6=-8F-=)Z:Q/ZCE,O5,LP          6H/M8?_;]Y4_R/:;_ .NDJK7[4G_8
M'Q7^6-Q_FT(U_$G_ /6/C/\ *\G^#78E*R((
M
M          #GN_<<?ZF&T?R/]3?N3?/0/]G1_P M6U_EC?\ ^$JG3Z!?T>8_
M\KS_ -]"!].QND        !?!^U[_J"=O?WP-_\ Z%_']1/]IY_3WQ'_  AM
M?]8\JA9\1W^V^U_DK%_G&Y605<C0
M
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MPWC[S]5VDQ?<:3TOFM6)I3I/6,59UG^[M,3'=1:55=(W
M
M
M     *KOW3__ + O%7^6#<__ %+A6E?9;?[?>5?R/M_\YE)3X;/_ *^<G_DF
M/_"*3ZZE+X         !T@?82_TG/%+_ ._I_P#I)]Q/.3\>7_-=Y5_^3/\
M4_'H!>MG])W)_P#WO_FF!,"B$U4
M
M           T_P#<+_J"><7]S_R7_H7W5M[X?/Z>_!_^+^&_UCMF5>"?[;\-
M_*NT_P XQN5Z]2JR@         !:@^UA_P#;]Y4_R/:;_P"NDJK7[4G_ &!\
M5_EC<?YM"-?Q)_\ UCXS_*\G^#78E*R((
M
M       #GN_<<?ZF&T?R/]3?N3?/0/\ 9T?\M6U_EC?_ .$JG3Z!?T>8_P#*
M\_\ ?0@?3L;I         7P?M>_Z@G;W]\#?_P"A?Q_43_:>?T]\1_PAM?\
M6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
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MON=Q:;[C)>;6M/6;6M.MIF?GF9F9?8<-\@
M
M                                                      %5W[I_
M_P!@7BK_ "P;G_ZEPK2OLMO]OO*OY'V_^<RDI\-G_P!?.3_R3'_A%)]=2E\
M         Z0/L)?Z3GBE_P#?T_\ TD^XGG)^/+_FN\J__)G^I^/0"];/Z3N3
M_P#O?_-,"8%$)JH
M                                                          !I
M_P"X7_4$\XO[G_DO_0ONK;WP^?T]^#_\7\-_K';,J\$_VWX;^5=I_G&-RO7J
M564          +4'VL/_ +?O*G^1[3?_ %TE5:_:D_[ ^*_RQN/\VA&OXD__
M *Q\9_E>3_!KL2E9$$
M                                                    !SW?N./]
M3#:/Y'^IOW)OGH'^SH_Y:MK_ "QO_P#"53I] OZ/,?\ E>?^^A ^G8W2
M     O@_:]_U!.WO[X&__P!"_C^HG^T\_I[XC_A#:_ZQY5"SXCO]M]K_ "5B
M_P XW*R"KD:
M
M                 4_ON6?/K_X@\ >M=B_^0N^>2<-G_P#\?:.J^O;Z2N+_
M -PV6[BIY_\ D57Q5_YRA;U]FQZ"?^(]??)-O_WFUX>;?_;,&^W=8B?^ML\=
MI_\ VJ-/O92I^'OPC[_SCD,?]MCVFO\ [5,V6/\ TXJS_P#$CYI4_EO*5(
M        #HN^QY[?]IX4^)V+VS;\5Z7?7D19X#L+LB>\MY8,EJNO2XWBXT/K
M#F*2:JF#\U[')3W=_P#M<<]66R5S%)5)%;6W$?G;^-WU^R^M/JOEXKB,NO@?
MCU\NTV<5F)IGRQ?3=;W6(Z^^M2N/%UFL8,..U8K;)E[H%>L?G%_+_)[;7:VU
MX383;%BB)UB]M=,F;[O?,16O68[*5F-)M;6:5#!J(
M
M
M  !6@^Z,UO&77A7T5M\M$W.9P?E%A-;L*Z9N:;>G&;5U/VMD\M1+!\/EDFKN
MM-LN8Z^>?C1337QQ_P _E95]E_R.YQ>M'.\128^IY_%\F:T:=>_!OMC3'I/R
M1V[C)K'RS,?,D-\.&XR5\OWNUC3W5^-M>?GUIFPQ7K^IDMK_ &/F47%Y*9@
M        #I ^PE_I.>*7_P!_3_\ 23[B><GX\O\ FN\J_P#R9_J?CT O6S^D
M[D__ +W_ ,TP)@40FJ@
M
M  &G_N%_U!/.+^Y_Y+_T+[JV]\/G]/?@_P#Q?PW^L=LRKP3_ &WX;^5=I_G&
M-RO7J564          +67VKF'R<_<_EOGXK*:O#8SK#KC#W^0IXX^GM<GG-J
MSU[B;*7GX_-Q-?VNO7M<?'''/'--M7\?A^3XU6?:F;S;4\-\2V%[Q&\R\GO,
ME:?+:F+!BKDM'W*VRXXG[MX1G^)7+CCB>+P3,>]MN<MHCY9BM*Q:?[$VKK^K
M"Z@I?1%
M                                          <]W[CC_4PVC^1_J;]R
M;YZ!_LZ/^6K:_P L;_\ PE4Z?0+^CS'_ )7G_OH0/IV-T@        +X/VO?
M]03M[^^!O_\ 0OX_J)_M//Z>^(_X0VO^L>50L^([_;?:_P E8O\ .-RL@JY&
M@
M
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M/=:;5U]W.G0H>?5!4
M
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MTU]LS,SDH/M-@
M                                                        -/\
MW"_Z@GG%_<_\E_Z%]U;>^'S^GOP?_B_AO]8[9E7@G^V_#?RKM/\ .,;E>O4J
MLH          7 ?M1O\ \/7_ /);_P#UBU0WVJW_ .8?_P"6_P#^4(K?$S_^
M)/\ [\__  5<!5"HK
M                                                    .>[]QQ_J
M8;1_(_U-^Y-\] _V='_+5M?Y8W_^$JG3Z!?T>8_\KS_WT('T[&Z0
M%\'[7O\ J"=O?WP-_P#Z%_']1/\ :>?T]\1_PAM?]8\JA9\1W^V^U_DK%_G&
MY605<C0
M
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MK-[Q$Z>\M>8]K=AI5AX
M
M                                         "M]]T)_4$ZA_O@:!_0O
MY +&_LP_Z>^7_P"$-U_K'BF__AQ_VWW7\E9?\XVRA\O833          ="'[
M<;_30UC^6'MG]U;!Y^/M%_\ F5W7\C[#_!V07]??Z0\G^28/[V4\*";2H
M
M                                        #3_W"_Z@GG%_<_\ )?\
MH7W5M[X?/Z>_!_\ B_AO]8[9E7@G^V_#?RKM/\XQN5Z]2JR@         !<!
M^U&__#U__);_ /UBU0WVJW_YA_\ Y;__ )0BM\3/_P")/_OS_P#!5P%4*BL
M
M                                  Y[OW''^IAM'\C_ %-^Y-\] _V=
M'_+5M?Y8W_\ A*IT^@7]'F/_ "O/_?0@?3L;I         7P?M>_Z@G;W]\#
M?_Z%_']1/]IY_3WQ'_"&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
M                                                    (D/>9\^;
M?P3\1L]>ZOEH;3O;NN'.=;=+6T&1HL\UAKZZQ7,6T=HV$/'$EQ)#UCC\E!<1
MR\45PTYB[QT4W["?\LM/@V]!<GKIZMX,/*8IOX+PLXMYR-II-L>2M;ZX-E:>
MD1.]O2U)C6+3M\>XO3Z6-M'TE\(MYIY32FYK,\+LYKEW$S&M;1%OH89^3\-,
M3$Q[>RN28ZU<W*XN+B\N)[N[GFNKJZFEN+FYN):Y[BXN)ZZI9IYYI:JI)III
M*N:JJJN>:JJN>>>>?B]'F/'CPXZXL58KBK$16L1$1$1&D1$1TB(CI$1TB%@%
M:UI6*UB(K$:1$>R(^:'XOV_H         "V7]M=X 5['M.>\]^R\--1A--FR
M6D>/,-UQ;U6N9VF[M<GANQMZ^GDIYN.(=5Q]Q3B<=+Q\8IKR]ON?V,ME1RJ@
M^TC]?:\=Q>#T&\:S1.]WD4W/+377NQX*VIDVFVUCIKGO$Y\M?OJX\>#VUSS"
M,7Q!^<1M]M3PGC[Q[[-$9-UIKK6D3%L6/7V?3F.^T>V*UI\EY7-U-:)0
M
M
M                   "M]]T)_4$ZA_O@:!_0OY +&_LP_Z>^7_X0W7^L>*;
M_P#AQ_VWW7\E9?\ .-LH?+V$TP         '0A^W&_TT-8_EA[9_=6P>?C[1
M?_F5W7\C[#_!V07]??Z0\G^28/[V4\*";2H
M
M                  "-[W?/],_S'_D?R/[K8A([X1?^97P[^6*?X/(S_P!*
M_P"D/B?\KC^]LYCSTRK$P         %P'[4;_P##U_\ R6__ -8M4-]JM_\
MF'_^6_\ ^4(K?$S_ /B3_P"_/_P5<!5"HK
M
M         .>[]QQ_J8;1_(_U-^Y-\] _V='_ "U;7^6-_P#X2J=/H%_1YC_R
MO/\ WT('T[&Z0        %\'[7O^H)V]_? W_P#H7\?U$_VGG]/?$?\ "&U_
MUCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
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M93PGQ;#Q^2L1RN;\+N9B==<MHCZ&L3,=N.L12.V>V9BUXZWF9C323;"
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M><Y//R_)7F^^W&6U[SU]MI]D1.NE:QI6E?96L16.D0R<QEUP
M
M
M           "M]]T)_4$ZA_O@:!_0OY +&_LP_Z>^7_X0W7^L>*;_P#AQ_VW
MW7\E9?\ .-LH?+V$TP         '0A^W&_TT-8_EA[9_=6P>?C[1?_F5W7\C
M[#_!V07]??Z0\G^28/[V4\*";2H
M
M          #2WW(,/C,Y[?7F[99:RAO[6#Q1[^S$4$_'/-%&3U[J_9\_A;VG
MBGFGGUL=F<9!<1\_[.)(J>>?CQ^1N?X<MYN=C\0'A.;:7G'EMY7Q6.9CVS3+
MO<.+)7]2^.]J3]RTLN\ RY,/G/#WQ3-;3R>VKT^:V:E;1_9K,Q/W)<L]ZC%D
M@         "X#]J-_P#AZ_\ Y+?_ .L6J&^U6_\ S#__ "W_ /RA%;XF?_Q)
M_P#?G_X*N JA45@
M                                                 '/=^XX_U,-H
M_D?ZF_<F^>@?[.C_ ):MK_+&_P#\)5.GT"_H\Q_Y7G_OH0/IV-T@
M+X/VO?\ 4$[>_O@;_P#T+^/ZB?[3S^GOB/\ A#:_ZQY5"SXCO]M]K_)6+_.-
MRL@JY&@
M
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M@JY&@
M
M                              %;[[H3^H)U#_? T#^A?R 6-_9A_P!/
M?+_\(;K_ %CQ3?\ \./^V^Z_DK+_ )QME#Y>PFF          Z$/VXW^FAK'
M\L/;/[JV#S\?:+_\RNZ_D?8?X.R"_K[_ $AY/\DP?WLIX4$VE0
M
M                                 &G_ +A?]03SB_N?^2_]"^ZMO?#Y
M_3WX/_Q?PW^L=LRKP3_;?AOY5VG^<8W*]>I590          N _:C?\ X>O_
M .2W_P#K%JAOM5O_ ,P__P M_P#\H16^)G_\2?\ WY_^"K@*H5%8
M
M                          !SW?N./]3#:/Y'^IOW)OGH'^SH_P"6K:_R
MQO\ _"53I] OZ/,?^5Y_[Z$#Z=C=(        "^#]KW_ %!.WO[X&_\ ]"_C
M^HG^T\_I[XC_ (0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
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M9F9F9F9U5[Y,E\M[9<MIMEM,S,S.LS,]9F9GK,S/69GVO['Q?@
M
M
M              !6^^Z$_J"=0_WP- _H7\@%C?V8?]/?+_\ "&Z_UCQ3?_PX
M_P"V^Z_DK+_G&V4/E[":8         #H0_;C?Z:&L?RP]L_NK8//Q]HO_P R
MNZ_D?8?X.R"_K[_2'D_R3!_>RGA03:5
M
M               :?^X7_4$\XO[G_DO_ $+[JV]\/G]/?@__ !?PW^L=LRKP
M3_;?AOY5VG^<8W*]>I590          MB?:K[1D+3L_S%TJ.&SJQ6P:'U%M%
MY<5QS\Y"+(:?L.[XG&0VTM-Q3;46<]MO%W5/37%7757'#S171Q37Q)5']J=Q
M>WR^,>'\U:;_ %K;[_?X*Q$QV33<8MMDO-HTUFT3ML<5F+1$1-]8M,Q-8Q_$
MMMJ6X[B=Y,S[VF?/2(^32]<=IUZ:ZQ..NG7Y9UB>FESY30B2
M
M                       Y[OW''^IAM'\C_4W[DWST#_9T?\M6U_EC?_X2
MJ=/H%_1YC_RO/_?0@?3L;I         7P?M>_P"H)V]_? W_ /H7\?U$_P!I
MY_3WQ'_"&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
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MWMYOY1?<[>9_(VVB<6WCYZQ/TLD]?;EM]*/9I2*5F-:S,RKHKM:
M
M
M                 *WWW0G]03J'^^!H']"_D L;^S#_ *>^7_X0W7^L>*;_
M /AQ_P!M]U_)67_.-LH?+V$TP         '0A^W&_P!-#6/Y8>V?W5L'GX^T
M7_YE=U_(^P_P=D%_7W^D/)_DF#^]E/"@FTJ
M
M                   T_P#<+_J"><7]S_R7_H7W5M[X?/Z>_!_^+^&_UCMF
M5>"?[;\-_*NT_P XQN5Z]2JR@         !:@^UA_P#;]Y4_R/:;_P"NDJK7
M[4G_ &!\5_EC<?YM"-?Q)_\ UCXS_*\G^#78E*R((
M
M               #GN_<<?ZF&T?R/]3?N3?/0/\ 9T?\M6U_EC?_ .$JG3Z!
M?T>8_P#*\_\ ?0@?3L;I         7P?M>_Z@G;W]\#?_P"A?Q_43_:>?T]\
M1_PAM?\ 6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
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MA::\IR-9BTQ.EL>")B+S_P#;>N*/[GWFG6(7X%#"$H
M
M
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M^JX)TC^S,S^K,IAT/VJ0
M
M   &G_N%_P!03SB_N?\ DO\ T+[JV]\/G]/?@_\ Q?PW^L=LRKP3_;?AOY5V
MG^<8W*]>I590          M0?:P_^W[RI_D>TW_UTE5:_:D_[ ^*_P L;C_-
MH1K^)/\ ^L?&?Y7D_P &NQ*5D00
M
M '/=^XX_U,-H_D?ZF_<F^>@?[.C_ ):MK_+&_P#\)5.GT"_H\Q_Y7G_OH0/I
MV-T@        +X/VO?\ 4$[>_O@;_P#T+^/ZB?[3S^GOB/\ A#:_ZQY5"SXC
MO]M]K_)6+_.-RL@JY&@
M
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MO]&OR8\=>F/'&G3Z-8B)G]=;6TZVM,SM$U>QL
M
M
M   !5=^Z?_\ 8%XJ_P L&Y_^I<*TK[+;_;[RK^1]O_G,I*?#9_\ 7SD_\DQ_
MX12?74I?          .D#["7^DYXI?\ W]/_ -)/N)YR?CR_YKO*O_R9_J?C
MT O6S^D[D_\ [W_S3 F!1":J
M
M        :K^=6 RVU^$?F-J^ M/K\[LGBOY"8#"V/KVUK];ELQU)MV.QUI]3
M>S6]G;_47EQ11ZDLD<5'Q^-55-/'//&T_0S?[3BO6SP[E-_?W>QVWE/$Y<EM
M+6[<>/?[>][=M8FTZ5B9TK$VGV1$ST9+X9GQ;;S#B=SGGMPX^3VMK3I,Z5KG
MI,SI&LSI$>R(F?F<J5ZH%EH         "U!]K#_[?O*G^1[3?_7255K]J3_L
M#XK_ "QN/\VA&OXD_P#ZQ\9_E>3_  :[$I61!
M
M            <]W[CC_4PVC^1_J;]R;YZ!_LZ/\ EJVO\L;_ /PE4Z?0+^CS
M'_E>?^^A ^G8W2         O@_:]_P!03M[^^!O_ /0OX_J)_M//Z>^(_P"$
M-K_K'E4+/B._VWVO\E8O\XW*R"KD:
M
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MRDUR;J8F=)M]]CPS\_;]'+;VQW3C_74F(MQJE$7
M
M
M       %5W[I_P#]@7BK_+!N?_J7"M*^RV_V^\J_D?;_ .<RDI\-G_U\Y/\
MR3'_ (12?74I?          .D#["7^DYXI?_ ']/_P!)/N)YR?CR_P":[RK_
M /)G^I^/0"];/Z3N3_\ O?\ S3 F!1":J
M
M                 8>\AO\ V ]Y?R/=F?\ J7FV7^GW^WW!_P L;/\ SG&[
M7@O_ *^;/_*\/^$JY+SUB+/0         %DS[7C(Y"+SL[GQ,=]>1XN]\2]Q
MR-YC:+F:C'W>0Q?<72%MC;ZYLZ:^+>>\QUOE[N."6NGFN&BZFIHYXXDKXJK>
M^T^V^WMZ%\-N[4I.ZIY9MZ5O-8[ZTOQ_)3>M;::Q6\X\<VK$Z6FE)F)FL:1^
M^(['2?"]IEFL>]CE,<1.G6(G!N)F(GVQ$S6LS'RZ1K[(7ME%J%P
M
M                         #GN_<<?ZF&T?R/]3?N3?/0/]G1_RU;7^6-_
M_A*IT^@7]'F/_*\_]]"!].QND        !?!^U[_ *@G;W]\#?\ ^A?Q_43_
M &GG]/?$?\(;7_6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
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M#IW$
M
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M;VZ9<=--=?VO#CQZ^R/ONS73Y-=-9TUF5%%IK4
M
M                     !A[R&_]@/>7\CW9G_J7FV7^GW^WW!_RQL_\YQNU
MX+_Z^;/_ "O#_A*N2\]8BST         !9 ^U[_K]]O?W/\ ?_Z:/']7)]IY
M_0)Q'_%^U_U=RK0'Q'?[$;7^5<7^;[E?"43H6
M
M            .>[]QQ_J8;1_(_U-^Y-\] _V='_+5M?Y8W_^$JG3Z!?T>8_\
MKS_WT('T[&Z0        %\'[7O\ J"=O?WP-_P#Z%_']1/\ :>?T]\1_PAM?
M]8\JA9\1W^V^U_DK%_G&Y605<C0
M
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MOG=O+O)+;'97F>"V%K8\>D],E_9DRS&LQ.MHFN.?^[B+=)O:$VZ%#3P
M
M
M                       "G]]US_\ @%?_ )4G_P"KHMZ^RI__ #\__(G_
M /-TJ?AF_P#QW_\ >?\ ^%*?RWE*D         !TX?:#_P!,_P ./Y'\=^ZV
M7>9KXNO^97S'^6+_ .#QJ[/53^D/EO\ *Y_O:I(4<6
M
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MF8G#O\-X^[,URX])_L9)G]6(7^%!B$
M
M     #GN_<<?ZF&T?R/]3?N3?/0/]G1_RU;7^6-__A*IT^@7]'F/_*\_]]"!
M].QND        !?!^U[_ *@G;W]\#?\ ^A?Q_43_ &GG]/?$?\(;7_6/*H6?
M$=_MOM?Y*Q?YQN5D%7(T
M
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M3$X\<Z:3$9)B8M2-;^2@]"$
M
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MV6CKI[+5F-?9.FL:QI*0E'U@H
M
M         #C^O7FM2          3P?;C_P"IAJ_\C_;/[DV*"?VB_P#RU;K^
M6-A_A+-+>OO]'F3_ "O!_?2Z$3S\(+
M
M     .>[]QQ_J8;1_(_U-^Y-\] _V='_ "U;7^6-_P#X2J=/H%_1YC_RO/\
MWT('T[&Z0        %\'[7O^H)V]_? W_P#H7\?U$_VGG]/?$?\ "&U_UCRJ
M%GQ'?[;[7^2L7^<;E9!5R-
M
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M-(W&XOKVQ,S%*Q$5I2NOR4K$5CY]-9ZS+8IKMT(
M
M
M        "D[]T]_[?O%;^1[<O_72)=3]EM_L#Y5_+&W_ ,VE+[X;/_K'R?\
ME>/_  :J^M*24          =4+V]/Z@G@[_<_P#&C^A?2GEJ^(/^GOSC_B_F
M?]8[E6OYW_MOS/\ *N[_ ,XR-P&H6*@
M
M               .25W9A\9KW<W;> PMG#CL-@^SM]P^)Q]OQS3;V&,QFU96
MRL+."FKFJKB&UM8:**>.>>>?EIX>LWPK>;GD/#>(W^]O.3>9^,VN3)>?;:]\
M&.UK3]VUIF9^[*T'A\N3/Q.USYIFV6^VQ6M,^V9FE9F9_5EC)DSL0
M $R7L"9C)XSW6O&NRL+R:UM=AQO=^'S4$7/'%&1QD'0?9N?BL[CCGCGGF&C,
MX.TN.../ASZD%/\ R?'CF'7Q\[/;;GX5?),V>D6R[?)QN3',^VEYY398IM'W
M9QY<E/U+2U/ZX8L>3TSY"]XB;8[;>U?N3]9PUUC_ -FUH_4F71P>=% 4
M
M                              !SW?N./]3#:/Y'^IOW)OGH'^SH_P"6
MK:_RQO\ _"53I] OZ/,?^5Y_[Z$#Z=C=(        "^#]KW_ %!.WO[X&_\
M]"_C^HG^T\_I[XC_ (0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
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M>30X
M
M                                  "CG]TGM5O=^6OCOI--K-1=:]XZ
M\[5-?55T<V]Q;[CV7NN(MK6*/C]LIFLY-%EKDJY_8U4ST<<?EXJ7>_9><5DP
M^DWD/-S>)Q;CR+W$5TG6)V^SVV2UIGV:6C=5B(]L36=?;"9'PW;:U/%]_O-8
M[<F_[-/EB<>+':9_L^\C3]258E9LD4          ZMGA=JMQHOAUXG:3=W<-
M_=:=XT]$ZK<WUO17';WEQKW5VK8B:[@CD^,D<-Q):<UTTU?LN*>>..?RO*MZ
MS<KCYWU@\KYO%2<>+>>2\GGK69B9K&7>Y\D5F8Z3,1;29CIJK.\NW-=[Y7R>
M\K$UKEY'<WB)]L1;->VD_J:MEFM6/
M
M              .3IY38#+:IY.^1NKY^T^@SNM]\=O8#-6/KVUU]%EL/V#L.
M.R5I]3937-G<_37EM71ZD4DD5?P^--55//'//JX]+=_M.5],O'.4V%_>;'<\
M#L,N.VEJ]V/)M,5Z6[;1%HUK,3I:(M'LF(GHLX\:SXMSXYQ^YP3W8<FRP6K.
MDQK6V*LQ.DZ3&L3[)B)^=@AG;N@        $M'L7Y_$ZW[JWB7D<U=_16=SF
M.TL!#-Z%S<_/EMKZ+[/U? 6GIVD,\M/U^=S%M!ZG-/$47J?/)51'3573$[XY
M-AN^2^%?RS;[*G?FKAV668UK'X/!R>RSY;:VF(^CBQWMIKW6T[:Q-IB)UAZS
M8,NX]-.4QX8UO%,-O;$?1IN,-[3UT]E:S.GMG32-9TATFGF]5^
M
M                         .>[]QQ_J8;1_(_U-^Y-\] _V='_ "U;7^6-
M_P#X2J=/H%_1YC_RO/\ WT('T[&Z0        %\'[7O^H)V]_? W_P#H7\?U
M$_VGG]/?$?\ "&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
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M^\ET''G[08
M
M                                          4/?NA/Z_?4/]S_ $#^
MFCR 7L?9A_T"<O\ \7[K_5W%)I_#C_L1NOY5R_YOME;]8VW^          ZT
M/CS_ .P'HW^1[K/_ -2\(\G?J#_M]SG\L;S_ #G(K"YW_P"OF\_RO-_A+,PL
M0=4
M                                                Y7ON%_U^_.+^
M^!Y+_P!-&ZO4K\/G] G@_P#PAPW^KMLLH\$_V(X;^2MI_F^-I^V\RH
M  !)![0G^I?X;_RPXW]RLLCE\77_ "U>8_R/?_"8V >JG]'G+?Y)/]]5TXGF
M95V
M                                      .>[]QQ_J8;1_(_U-^Y-\]
M_P!G1_RU;7^6-_\ X2J=/H%_1YC_ ,KS_P!]"!].QND        !?!^U[_J"
M=O?WP-__ *%_']1/]IY_3WQ'_"&U_P!8\JA9\1W^V^U_DK%_G&Y605<C0
M
M                                                  #6GRZ\K>I_
M"OH7=/(+N3)36VKZG#;6V/PN-YMI=EW3:<K+]+K^F:EC[F>WIR.>S-U\>?A\
MU,5I:13WEQ7%:6T\T>RO23TJ\K]://-EZ?\ AV.+<INYF;Y+ZQAVV"D=V7<9
M[Q$]F+'7[DVODM3#CBV7)CI;(?%O&>3\OYO#P7$UB=SEF9FTZ]F.E>MLEYB)
MTK6/[-K36E8FUJQ/-'\UO,GMSSG[[VWO/MG*WE<F4O+NRT?3?Q#F]P766AQW
MUS<:_HFN<46F.M^;/$6\_P#O%UQ;039*\JEO)^.9YY.>?2CZ+>CGB7H=X'M/
M!_$\5(KBI6VYW'9VY=[NIK6,NZS?2O/=DF/H4[[5PXXIAQSV4K"PKQ#Q/B_#
M.$Q<-Q=8TK$3DR::6S9-(BV2_69UM,=(UF*5TI7I$-2VV&3@          -E
MO$3Q7[-\SN_M"\?^JK":7.;ADH_QG/UX^^O\+HNHVTT'&Q;SL]5C'75:8' 6
MLW%555=4?KW,D-M'5S//%35K;U<]4O&?1KP'?^?^59(C8[/'/N\7?6N3=9[1
M/N=MA[I^EERVC2(B)[:1?+:.S':8Q[RGR7CO$N#S\YR=HC#BK]&NL1;)>?O<
M=-?;:T_JZ1$VGI673N\7/&[K;Q&Z%ZW\>^J+&:UT[KG Q8R*]O:J9<QLF9N9
M9,ALFWY^>.FB*;/;7G[JXO[KTJ([:*6?F*WBAMZ(HJ/,GZH>H_DGJWYYR7J#
MY7>+<QR.>;S6O3'AQQ$4P[?%$]8Q8,5:8J=TS>:U[LEKY+6O:NKR3R#D/*>;
MW'.\G:)W>XOKI'WM*QTI2O\ <TK$5KKK,Q&MIFTS,Y^8"Z,
M
M
M                  !SW?N./]3#:/Y'^IOW)OGH'^SH_P"6K:_RQO\ _"53
MI] OZ/,?^5Y_[Z$#Z=C=(         #K^6]O;V=O!:6D$-K:VL,5O;6UO%1!
M;V]O!13%#!!#%33'###'3Q3333QQ333QQQQQ\'D/R9,F;);+EM-LMIF;6F9F
M9F9UF9F>LS,]9F>LRJNM:U[3:TS-IG69GVS/SR_9^'\
M
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MJ>/+:K8
M                                          <]W[CC_4PVC^1_J;]R
M;YZ!_LZ/^6K:_P L;_\ PE4Z?0+^CS'_ )7G_OH0/IV-T@        +X/VO?
M]03M[^^!O_\ 0OX_J)_M//Z>^(_X0VO^L>50L^([_;?:_P E8O\ .-RL@JY&
M@
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MUB,MYZ6S6B8B>OWN.)CZ--9B(F]]9JT+6H0
M
M
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M,=8B9KI,QUT</D=S;9<?GWE8BUL6&]XB?9,UK-M)_5T=<UY)E7(
M
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M+L<]+:=)TMBO$Z3^I+K"O*4K(
M
M<]W[CC_4PVC^1_J;]R;YZ!_LZ/\ EJVO\L;_ /PE4Z?0+^CS'_E>?^^A ^G8
MW2         O@_:]_P!03M[^^!O_ /0OX_J)_M//Z>^(_P"$-K_K'E4+/B._
MVWVO\E8O\XW*R"KD:
M
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MG;32O7WENVZ&IE1'
M
M                                                  <TWWM-L_//
MW2?+K,?0?AOT>X:=J?T_U7UGJ?F%U7H>C?7^M]-:_)^*_F[]5Z7R\^AZWI_/
M)\GJ5>D[X*>*_(WPN^([/WGO._9[C/KV]NGUK?;K<]FFMOO/?=G=K]+M[M*Z
M]L6$>C^U^J>F_%XN[NUQ9+ZZ:?MF;)DT]L_>]^FORZ:Z1KI$5Z4K90
M  #8/Q(U?(;QY6>,FE8F:SM\KN'D)TOJ^,N,C)/%CX,AL'8^MXFSFOI;:WN[
MF*SBN;NFJ6J.*6NFCCGFFBKGX<<Z^]6N4V_">E7DW-;N+VVNS\?Y'/>*1$WF
MF+9YLEHK$S6)M,5F*Q-JQ,Z:S$=71>4;FFS\9Y'>98F<6+8;B\Q'MF*XKVG3
M68C72.FLQ^JZO[RFJR@
M
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MU-779>2!5L
M                                             Y[OW''^IAM'\C_4
MW[DWST#_ &='_+5M?Y8W_P#A*IT^@7]'F/\ RO/_ 'T('T[&Z0        %\
M'[7O^H)V]_? W_\ H7\?U$_VGG]/?$?\(;7_ %CRJ%GQ'?[;[7^2L7^<;E9!
M5R-
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MMDW66]KWO:=;6O:9M:UIGVS:9F9GY9E]YP'P
M
M
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MO2L=-?;:T1K[(UUG2-9=2IY=E;@
M
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MML<6F(Z1,Q768CIJJYY';5V7(9]G69M7%FO2)GVS%;376?U='MG2.&
M
M                            Y[OW''^IAM'\C_4W[DWST#_9T?\ +5M?
MY8W_ /A*IT^@7]'F/_*\_P#?0@?3L;I         7P?M>_Z@G;W]\#?_ .A?
MQ_43_:>?T]\1_P (;7_6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
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M]C8
M
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MOSVO2M8_LVF(C[LNF@\T2O
M
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MW-(F?;,5S7KK/ZNC99K5CP
M                                                       #GN_<
M<?ZF&T?R/]3?N3?/0/\ 9T?\M6U_EC?_ .$JG3Z!?T>8_P#*\_\ ?0@?3L;I
M         7P?M>_Z@G;W]\#?_P"A?Q_43_:>?T]\1_PAM?\ 6/*H6?$=_MOM
M?Y*Q?YQN5D%7(T
M
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M/?WB8B>^\?>Q,?@Z:5CZ4WFTO:(K5@
M
M
M     #D6=A;7^?F_;QO/T'X5^>>X;-M?X7]5]=^&_G%FKW+_ $'UOTUG]9]'
M]9Z?J^C%ZGR_-\E/Q^7CUN>/<5^0> V/!^\][]2V>'!W]O;W^YQUQ]_;K;M[
MNW7M[K::Z:S[5I&PVOU+8X=EW=WN<5*:Z::]E8KKIK.FNFNFLZ?.\@[=R@
M      $R7L"8?)Y/W6O&N]L+.:ZM=>QO=^8S4\7''-&.QD_0?9N BO+CGGGC
MGB&O,YRTM^.>/CSZD]/_ "?'GB'7Q\[S;;;X5?),.>\5R[C)QN/'$^V]XY39
M99K'W8QXLE_U*RU/ZX9<>/TSY"EYB+9+;>M?NS]9PVTC_P!FMI_4B71P>=%
M4
M                                              !2[^ZGUO)VO:_A
M]M\M,/&&SG7O:NMV%=,W%5Q5D]5V34,GEJ98/A\T<-%KN5ES'7SS\*ZJJ^./
M^9RN:^RRY';9?%?+^(I,_7,'(;'-:-.G9GP[BF/2?EGNV^36/DB(^=+CX:MQ
MCMQG*[6-?>TSX;S\VEZ7BO7]7';7^Q\ZJ"M92:          =07VK=HR&X>W
M'X79;)PV<%S:>/?7FKQT6,<\4%6/T?#0Z5B9JZ;BXN9.;RXQ6OPR7%7%7%%=
MQ57511'1S313YB/BFXO;\1\1?F>TVTWMCOY!N\\S:8F>_<Y)W.2(TBL=L7RV
MBD::Q2*Q,VF)M-<OJ5MJ;7S[E\6.9FL[_+?K\^2WO+>R(Z1:TQ'W--9F>K?U
MH-@X
M                                     #GN_<<?ZF&T?R/]3?N3?/0/
M]G1_RU;7^6-__A*IT^@7]'F/_*\_]]"!].QND        !?!^U[_ *@G;W]\
M#?\ ^A?Q_43_ &GG]/?$?\(;7_6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
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MLE'0
M
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M\DZ7R[W#6O2>MHB]].GL^C2TZSI'33VS$3T"E B#@
M
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MOZE\ICPQI2;X;>V9^E?;X;VGKK[;6F=/9&ND:1I"6E$YK
M
M                   !SW?N./\ 4PVC^1_J;]R;YZ!_LZ/^6K:_RQO_ /"5
M3I] OZ/,?^5Y_P"^A ^G8W2         O@_:]_U!.WO[X&__ -"_C^HG^T\_
MI[XC_A#:_P"L>50L^([_ &WVO\E8O\XW*R"KD:
M
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M[^I'0Z
M
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M
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M@LTN
M                                      Y[OW''^IAM'\C_ %-^Y-\]
M _V='_+5M?Y8W_\ A*IT^@7]'F/_ "O/_?0@?3L;I         7P?M>_Z@G;
MW]\#?_Z%_']1/]IY_3WQ'_"&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
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M,ZS:TSK,S,SK,SUF>LOI.,^8
M
M
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M*NFFG77WFNNO3M]DZ]+F2FY$L
M
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MR^K51Y
M                                        <]W[CC_4PVC^1_J;]R;Y
MZ!_LZ/\ EJVO\L;_ /PE4Z?0+^CS'_E>?^^A ^G8W2         O@_:]_P!0
M3M[^^!O_ /0OX_J)_M//Z>^(_P"$-K_K'E4+/B._VWVO\E8O\XW*R"KD:
M
M                                          89[]\A.G/&#K+/=O\
M>F^X'KW0]?AFYFRF;O(X;C*Y&BQO,A;:YK6,XJYR&S;5E;?'S?1XRQCGO;JJ
M.KB..KY:OAF7@7I]YCZG>38/$/!MAGY#G=Q,:4QUF8I3NK2V;-?[S#@I-Z^\
MS9)KCI$QW6C6';<)P7+>1\C3BN%P7S[W)/LK'2L:Q$WO/LI2LS'=>TQ6NO67
M/1]T/W:^X_<6V[C7:()NM_&S4,]=W_7?55G/)3?9B6/F6VL-V[3NX;VYLL_N
MU5E)7Q!!!\,=AH9JX+;B66JYOKST&_##\)OAWP[<3^4;6CDO4C>8*UW>^M$=
MN.)TF^VV-9K6V+;=T1W6M^&W%JQ?+-:QBP89V>G'I?Q/@6U^L3,;CR#+2(RY
MICI7Y9QX8TB:X]?;,_3R3$3;2.VE(D4M&T             $GWM<^V;V)[C_
M ''=X&ROYM,Z2Z[FPV0[H[)CIMI+[%X[*R7E6,U33[*YIDCR.[;3'B[FFVKD
MCKLL=#%)=7/%?RP6MW&/XH/B6\>^'+PZF_S8XWOFW(QDIQVSG6*WO2*]^?<6
MKI--M@F])O$3&3-:U<6/MUOEQ:Y]2/4/8> <3&>]8S<QGBT;?%UTM-=-;WF/
M9CIK&ND]UYF*UTUFU>D1U?U?U]TMU]J?5756IX?1NO-&P]O@=5U7 V_-OC<3
MC;?FNOY:?GKEN+N\N[B62XNKJXDENKRZEDGGDDFDDDJ\XOD_D_D'FGD&[\J\
MJW>;?>0[[-.7/GRSK?)>>GR:16M8B*TI6*TQTK7'CK6E:UB '(\CON7WV7D^
M3RWS;_->;7O:=9M,_P#HB(C2(B(B*Q$5K$1$0]XZ)P@
M
M
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MD6Z_J8ZZ?V?G6OU4R,@
M
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MD1CMAM$_V?>3K^I"VNJ:1?
M                                                        <]W[
MCC_4PVC^1_J;]R;YZ!_LZ/\ EJVO\L;_ /PE4Z?0+^CS'_E>?^^A ^G8W2
M       O@_:]_P!03M[^^!O_ /0OX_J)_M//Z>^(_P"$-K_K'E4+/B._VWVO
M\E8O\XW*R"KD:
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MX3Q'#[SF=Q2GU[?Y(_QC>9:1/TK:S:,.&LS;W.VQS&/'$S,^\RVR9LD\/"?
M^"\%XWZGQ5.[=WBOOL]OVS+:/EGK/;2-9[<=?HUCK/=:;7MH>WLS0
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M]J_/(O(N6\IY;+S/,Y9R;S)/ZE:5C[VE*]>VE=>D?JVM,VFUIS\P%T8
M
M
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M(O/7+YQM\5+:^[XW'$Q_:VG-GM_TS6:S^IHL:JZF@P
M
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M$
M                                  !SW?N./]3#:/Y'^IOW)OGH'^SH
M_P"6K:_RQO\ _"53I] OZ/,?^5Y_[Z$#Z=C=(        "^#]KW_ %!.WO[X
M&_\ ]"_C^HG^T\_I[XC_ (0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
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M:]F*FO3'CCY*Q_TVG6UIFTS+:AJQC0
M
M
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MAP4G[LSAIDUC^QDB/U8E-NA0T\
M
M            P!Y7ZYC-Q\6O)74<U1-7AMJZ [CUS+46\W-O<5XS.==['C+^
MB">GCFJ":JUNJ^*:^..>::OAS_R,^]*>1W/#^J/C?+[*8C>;7G^/S8YF-8[\
M6[PWKK'RQW5C6/EAWGC.XR;3R3C]UAT][BWV"]=>L:URTF-8_5AR?'JU6;
M        +"'VT.V?F[[BN;P_T'UGY^^-_9FI_4?5?3_A7T>T]<;S]?Z/TT_U
MWJ?F9]+Z7S0_#ZGU/GY]/TZZ_/M*N*_*/P[X-Y[SL^H>1[//IVZ]_=@WFV[-
M=8[=/K'?W:6^\[=/I=U=%_$+M?K'@5,O=I[CD,-]-->[6F7'I[>G[9KKU]FF
MG76+^2@]"$
M                                           !SW?N./\ 4PVC^1_J
M;]R;YZ!_LZ/^6K:_RQO_ /"53I] OZ/,?^5Y_P"^A ^G8W2         O@_:
M]_U!.WO[X&__ -"_C^HG^T\_I[XC_A#:_P"L>50L^([_ &WVO\E8O\XW*R"K
MD:
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M?O:_/:>DWO,:WGYJQ6M=V&E6(
M
M
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M:T;F*:QI[,=*8XCI_:Q6*S\NL=>NJ3-&EKP
M
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M (
M                                   #GN_<<?ZF&T?R/]3?N3?/0/\
M9T?\M6U_EC?_ .$JG3Z!?T>8_P#*\_\ ?0@?3L;I         7P?M>_Z@G;W
M]\#?_P"A?Q_43_:>?T]\1_PAM?\ 6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
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M&)GLPTU^]K\]IZ3>\QK>?FK%:UW8:58@
M
M
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M/ZK9QK)CH
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MV9KI/W)=1AY?U<
M                                                #GN_<<?ZF&T?
MR/\ 4W[DWST#_9T?\M6U_EC?_P"$JG3Z!?T>8_\ *\_]]"!].QND
M!?!^U[_J"=O?WP-__H7\?U$_VGG]/?$?\(;7_6/*H6?$=_MOM?Y*Q?YQN5D%
M7(T
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M8MRG*6[<5=8PX8F>S#37[VOSVGI-[S&MY^:L5K7=AI5B
M
M
M                           #G-_<!;A<;3[IO?N.KYQLEEHN!Z>T_&3X
M_FNNN:WXZCTS:;_C)2\W5Q%)DK3/[3>6]?ITPTQQPT1U4>I1777Z*/@#X?'Q
M?PN<!N(]Y&;?9^0W%XOII$_7]Q@IV1VQ,4MBP8[QK-IF;6M%NV:Q$]_0[:5V
MWIML<D=W?FOGR3$_/[_)2-.D=)K2L]==9F9UTF(B&%,MML        !_9CL=
MD,OD+'$XFQO,IE,I>6V.QN-QUM->Y#(Y"]FHMK.QL;.VHEN+N\N[B6F.**.F
MJN2NKBFGCGGGCA\=QN-OM-O?=[N],6UQ4M>][VBM*4K$S:UK3,16M8B9M:9B
M(B)F9T?G)DIBI;+EM%<58F9F9TB(CK,S,](B(ZS,^QUWM=P&)U37\'J^ M/H
M,%K>'QF PMCZ]S=?18G#V4&.QMI]3>S7-Y<_36=M11ZDLDDM?P^-5557////
MD>Y#?[OE=_GY3?W]YOMSFOER6TK7NR9+3>]NVL16-;3,Z5B*Q[(B(Z*M,^?+
MN<]]SGGNS9+S:TZ1&MK3K,Z1I$:S/LB(CYGV'#?(
M
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M5P.6VMM[Q6YV5(B;YMODI$3[)F])K$3]R=>KK=O)>J\
M
M                 <]W[CC_ %,-H_D?ZF_<F^>@?[.C_EJVO\L;_P#PE4Z?
M0+^CS'_E>?\ OH0/IV-T@        +X/VO?]03M[^^!O_P#0OX_J)_M//Z>^
M(_X0VO\ K'E4+/B._P!M]K_)6+_.-RL@JY&@
M
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M?=XJ?-6)]LSI$WO/TK3I[*Q6M=TFF&(@
M
M
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M::Z3IKIIKI.GS.KD\J2LP
M
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M,S/56#S>SCCN:WG'Q2<<8-UEQ]LZS->S):O;,S,S.FFG69G[K+3$W5@
M
M                           .>[]QQ_J8;1_(_P!3?N3?/0/]G1_RU;7^
M6-__ (2J=/H%_1YC_P KS_WT('T[&Z0        %\'[7O^H)V]_? W_^A?Q_
M43_:>?T]\1_PAM?]8\JA9\1W^V^U_DK%_G&Y605<C0
M
M                 #3GS*\\_&;P0T*C>?(/?(</=9.&^YTWKS 46^;[-["O
M,?!5-/9:=J7UEI)<0QR<QPS9&]FLL-93W$%%W>6_,T7S;A]'/0CU+]=N>G@_
M3_83FQ8IK]8W>77'LMI6\Z1;<9^VT1,QK:N''7)N,E:7G%AR=EM,L\3\*\B\
MUWWU+@L$WK68]YEMK7#BB?ER7TG3Y9BE8MDM$3-:6TG2B'[CWO+>2/N 7=YI
M47/Z&/'2"\@GQ?3VJY.6ZN]@DM(KF./*=G;C3;X^^W&\EJO)*J;".*SPEO31
M!SQ9RW4'-[+>K\.7P<>G'H#BIS5O_G/J):DQ?D,](K7%%IB9ILMOK>NWK';&
MN6;9-S>9R?AJXK^YI-+P#TF\?\'K&\G_ !OGYC2V>\:1773IAQZS&..D?2F;
M9)^E].*SV1#^EZVH               D4]N;VW.Z_<2[<MM1TFSO-6ZJUZ\M
MYNV.Y\AB[BXUG2<3\8I9<;CZJN;>WV'?,K;R<<8W$134RR\U>M/5!9QS7$<>
M/B*^(_PKX>?$K<MS=Z;KRK<4F-CQU+Q&;<Y.L1>_MG%M:3'X;<368C3LI%\U
MJ8[8%Y]Z@</X'Q<[K>3&7D\D3[G;Q,1?);YY]LUQUG[^\QI'LKW7F*ST4O$K
MQ Z)\)NH\?TST#J?YNZQ;WEQE\SE<A/1D]LW+8;SBBB[V3<<_P"A;S9K,2PQ
M1PT<_)'!;6T4=O;Q0P1QQT^>#U9]7O.O6ORW)YEY]N_K')VI&/'2D=F#;XJ_
M>X=OBUF,>.)F;3UFU[VMDR6O>UK3 SRCRKFO,.4MRW.9?>;B8BM:Q&E,=8]E
M,==9[:^V?EF9F;6F;3,MG&LF.@
M
M
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M.N5S3:U>[;1CUKKK^%O3%IT^2W?VV^3MF=>CIH/-$KP
M
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MKLO/^7PU[M)WV3)]+VZY9][/R1TUO]'^YTZS[9D#: 8,
M
M                 Y[OW''^IAM'\C_4W[DWST#_ &='_+5M?Y8W_P#A*IT^
M@7]'F/\ RO/_ 'T('T[&Z0        %\'[7O^H)V]_? W_\ H7\?U$_VGG]/
M?$?\(;7_ %CRJ%GQ'?[;[7^2L7^<;E9!5R-
M
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MN-X38X^,XG#CV^PQ1I6E(TB/GF?EFTSUM:9FUIF;6F9F98W9&YX
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M
M
M                                            !A_R&W[]%70/>/:'
MXM^ _HWZ?[,W[\<^A_%/P;\S]+S>P_BWX9]'D?Q'\._#O6]#Z>?UOD^3TZ_C
M\O.7^GW _I5Y]P?B_NO?_E+F-GM?==W9[SZQN<>+W??W4[._O[>[OKVZZ]U=
M-8[7@MC^4^<V?&]O?]8W>'%VZZ=WO,E:]NNL::ZZ:ZQI[=8<EUZQ%GH
M    "<[[=72Z-I]SGK[.58[)7M76_6/;VZ1W-C'<5VN(KOM2GZ[YR.9JACKC
MBQLL>^U6E-4O-$?-Y=04\<_/5135!S[1#FK<7\,O(;&,F.D<ER>PVTQ:8[LD
M5SQN^S'K,3-XG:QDF*ZS[NEYT[8M,::]>MW.V].L^&+5CZQN<&/2=-;:7][I
M7[OX/NZ=>V+?)JZ&CSWH)
M
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MK,IMT*&G@
M                                         '/=^XX_U,-H_D?ZF_<F
M^>@?[.C_ ):MK_+&_P#\)5.GT"_H\Q_Y7G_OH0/IV-T@        +X/VO?\
M4$[>_O@;_P#T+^/ZB?[3S^GOB/\ A#:_ZQY5"SXCO]M]K_)6+_.-RL@JY&@
M
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M:XX
M
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MN]WI:O6+1R^)+=VIXWQ^Q^CVY-].3^ZUQXKUC3K[/PL]W2>O;UCY;P"D=#H
M
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MN\V2VNNO77WFFFG3M]LZ]+.*LQ'8
M
M!SW?N./]3#:/Y'^IOW)OGH'^SH_Y:MK_ "QO_P#"53I] OZ/,?\ E>?^^A ^
MG8W2         O@_:]_U!.WO[X&__P!"_C^HG^T\_I[XC_A#:_ZQY5"SXCO]
MM]K_ "5B_P XW*R"KD:
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MF9ZS*+=K6O:;6F9M,ZS,^V9^>7[/P_@
M
M
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M5TTTZ:>[UUUZ]WLC3K;15.HP
M
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M[?>5Q6UUUZ:>[TTTZ]WMC3K<R4W(E@
M
M  .>[]QQ_J8;1_(_U-^Y-\] _P!G1_RU;7^6-_\ X2J=/H%_1YC_ ,KS_P!]
M"!].QND        !?!^U[_J"=O?WP-__ *%_']1/]IY_3WQ'_"&U_P!8\JA9
M\1W^V^U_DK%_G&Y605<C0
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M<N?376<LUF=,?7IBB9B=(M>9G2M9[4#6DP
M
M
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MRY-?9T_;--.OLUUZZ1815]M%@
M
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M+[_#DZ1\]<F+K\T?A/;\^D?*O_*"4'@
M
M   '/=^XX_U,-H_D?ZF_<F^>@?[.C_EJVO\ +&__ ,)5.GT"_H\Q_P"5Y_[Z
M$#Z=C=(        "^#]KW_4$[>_O@;__ $+^/ZB?[3S^GOB/^$-K_K'E4+/B
M._VWVO\ )6+_ #C<K(*N1H
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M*\<\.VGU7@MO3'>8TOEF(MFR==?IY-.Z8UZQ6-*5_6UAI^V\RH
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MQ($T P8
M
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M\>OLC[[LUT^3736=-9E11::U
M
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MO,
M                                  !SW?N./]3#:/Y'^IOW)OGH'^SH
M_P"6K:_RQO\ _"53I] OZ/,?^5Y_[Z$#Z=C=(        "^#]KW_ %!.WO[X
M&_\ ]"_C^HG^T\_I[XC_ (0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
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M?3SQ7PK'_P#)=O'UV:Z6SY)[\UH^6)OI$5B=(UKCK2DS$3-=8U:$M\LV
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M(9.8RZX
M
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M^WVZ1K[=&Q37;H0
M
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M8B9]YCM32)G2(UUTUF=(]KK./)\K#
M
M  <]W[CC_4PVC^1_J;]R;YZ!_LZ/^6K:_P L;_\ PE4Z?0+^CS'_ )7G_OH0
M/IV-T@        +X/VO?]03M[^^!O_\ 0OX_J)_M//Z>^(_X0VO^L>50L^([
M_;?:_P E8O\ .-RL@JY&@
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MK-G%68CL
M
M
M Y?_ +K&]7'8ON/^:&P7,F2DDQ_?V^:+35E;VN_NN+?J[)<]9VD<4\E<E5&-
MBM=1HILH?C\MM9\114\<<4<<<>G3X5N"Q^._#EX9Q^*,<5R<!M=U]"L5KKO:
M?7;3,1IK>;;B9R6]M\G=>=9MJL:],]E78> <1@KVZ6V./)]&-(US1[Z?[.M_
MI3\MM9^5'ZW^S@        !D'J31;CM'M;K'K.TCR4MUV+V%I>BVT6&LJ\CF
M)+C;MDQNOPQXK'Q4227^2KDR''$$---54LO--/''///P8_Y;SN/Q?Q7D_)LL
MXXQ<=Q^YW5IR6BF.(V^&^69O>=(K32GTK3,16NL_(X/*;VO&\9N>1MVQ7;X,
MF2>Z=*Z4I-OI3\D=.L_)#K@O)8J[
M
M                  <YO[@#1;?2_=&[VO;./&V]EOV!ZHWJ&RQEE18T6EQ>
M=9:QKV8DO*(J(XI\EE\_K=WD+B;CCYII+SFNOFJ3FNKGT4? )SN3FOA?X+!F
MG);-L,^^VLVO:;3:*[W-EQQ69UF*8\6;'BK7V5C'I72L1$3W]#M[;>>F^RI?
MNF^"^;'K,ZZQ&:]JZ?-%:WK6(^2*Z1TT0PIEMM@         .LAXP=@5]L^-
M7CSVI+/DKF7LOHWJ7L"2YS-%O'E[BO<M!U_8ZY\K':3W-K1DI:LE\T_$4DD?
M$O-7%-57'PYY\HGJ=P%?$_4GR'Q:M<=:\;SF_P!K$8]9QQ&WW67#I2;16TTC
MLTKW1$]NFL1/16-Y'L8XSR'?\;$5B-OO<^+2NO;'N\MJ?1UTG3ITUB)T9R8.
MZ8
M                                 !SW?N./]3#:/Y'^IOW)OGH'^SH_
MY:MK_+&__P )5.GT"_H\Q_Y7G_OH0/IV-T@        +X/VO?]03M[^^!O\
M_0OX_J)_M//Z>^(_X0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
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M)R6^E,=(TKI6-_&@V#@
M
M
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MS:+5UB<$]3]]''>GW+[B9K'=LKXOI:Z?AM,/R:=9]YI7Y.[376.CIZ/,@KH
M
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M[BQY)T]NNEK3$S\LQ,])Z1*BBTUJ
M
MY[OW''^IAM'\C_4W[DWST#_9T?\ +5M?Y8W_ /A*IT^@7]'F/_*\_P#?0@?3
ML;I         7P?M>_Z@G;W]\#?_ .A?Q_43_:>?T]\1_P (;7_6/*H6?$=_
MMOM?Y*Q?YQN5D%7(T
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M9FUK3.LS,SUF9EZ1UKC@
M
M
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M
M                                                  53/NI.OZ\E
MTSXD=J<09*J+3>SNR.OZ[F*NWXQ$5?9>JX#8XX+Z.J"JZJR5Q3U-55:<T241
MTQ17'%=-?/,?-%J?V6?/UVWF7EOBW=C[MYQFSW6DZ^\F-GGRX9FLZ]O9'U^(
MOK$S-K8^V8B+1:3'PU;Z,?+<IQNM=<VVQ9=.O=^!O:G3Y-(]]]+IKK-=-.NM
M+!= ET          OC_;&=A4;)X)]CZ'<WL,N3ZV\BMJCML?%97$-=GJVW:7
MHF=Q5Q<7E47%I>S7NR\9OCCBB2J6*.&GB2FFGF*JNB3[33QZW&^NG'<[CI,;
M;DO'<$S>;1,6S[?<;K%>(KKW5BN'ZM[8BMIM,UF9BT5A7\16PG;^:;?>UB8Q
M[C84UG6.MZ9,E;1$>V-*>[^329F=)GKI8[5SM @
M
M          .>[]QQ_J8;1_(_U-^Y-\] _P!G1_RU;7^6-_\ X2J=/H%_1YC_
M ,KS_P!]"!].QND        !?!^U[_J"=O?WP-__ *%_']1/]IY_3WQ'_"&U
M_P!8\JA9\1W^V^U_DK%_G&Y605<C0
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MTWM_<<1$Q-=MCF?=QI[+7GI.2_W;=(G[VM4G*,S70
M
M
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M8UZ?@ZTI$S7Y_P +;MGY/I1'ME<^4T(D@
M
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MY*IT1.
M                                      <]W[CC_4PVC^1_J;]R;YZ!
M_LZ/^6K:_P L;_\ PE4Z?0+^CS'_ )7G_OH0/IV-T@        +X/VO?]03M
M[^^!O_\ 0OX_J)_M//Z>^(_X0VO^L>50L^([_;?:_P E8O\ .-RL@JY&@
M
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MN=SN=YN+[O>9+Y=UDM-KWO:;7M:>LVM:TS-IGY9F9F7WG ?
M
M
M                                            !5>^Z?['_"^@O%;J
M+U?A^?'<&Y]C^A])\_J?HKTN'6?5^O\ FX^F]'],?P]'X<^O\_S?'CTORVE?
M9;>.?6O/O*O+M/\ P/#[?9Z]VFGU[<SFT[?EU_)_WWZW33]>DI\-G'^\YSD^
M4T_:=ICQ:Z_]]D[_ &?+^T>WY-/NJ3RZE+X         !>O^U_Z_KP/A3W#V
M%=09*WNNP?(K,XZQXN*[?\,O=<TG0M'MK+)8V*B#BYIFKV'.9:UN*I):J*N;
M2CBBBCFFJJ2C#[3KGZ[_ -:>'\?Q6QVQ<?X[CO;37OKFW.ZW-K4O.O;I&+%@
MO2(K$Q[RTS:=8BL,/B-WT9_+]IL:S6:X-A69TUUB^3)DF8GY/O:TF-(_73K,
M]-+*:MM'P
M                                                          !H
MI[G775QVI[>WF+IME#-=9"7H'L+8\58VN'KS]YD\OHF$GWO$8G'XN*2.>?)9
M?)ZW%;6U<?SRP3RT2T425T<1U;S^&7R+'XM\07A_,9IBNWCG]IAO:V2,5:8]
MUDC:Y,E[S$Q%,=,UKWB=*VK6:VM6)FT9IZ=;^O&^=<3N[S$8XWV*EIFW;$5R
M6C':TS\D5B\S.O28B8F8B=7+H>H!8\          GF^W"["HTOW+-?UNJ]AM
M:NW.F>U^O8X);*XNJ\E7C;'$]K\V5O/#%)'C9HX^L:KGF:7F..J.WJAXJ^>6
MBFJ"'VC/CUN:^&S<<E%)O'$<SL=W,Q:*Q2+VR;'NF)F)O$SO8IVUUF)O%].V
MMIC2GK]L)W?I[?<1$S]5W>'+KK$::S;#K,?+^W::1K.LQ/LB9=!QY^T&
M
M                            '/=^XX_U,-H_D?ZF_<F^>@?[.C_EJVO\
ML;__  E4Z?0+^CS'_E>?^^A ^G8W2         O@_:]_U!.WO[X&_P#]"_C^
MHG^T\_I[XC_A#:_ZQY5"SXCO]M]K_)6+_.-RL@JY&@
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MW\"X/C.)BT3%[[?;X\>7)%K=\QDS17WN6.Z(TC)>T5BM:QI6M8C</#>->/\
MCU)IPFSVVUUB8F<=*UM:)G72U].ZW73[Z9TTB(Z1&F 6?.[
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MI%K3$1IN,T\Q,
M
M
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M
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M+2+UUCY)[;1K'R2M%VVXQ[O;8]UAU]UEI6]=>DZ6B)C6/U)?"<Y]@
M &^'M?\ 9OZ(?<,\/-VKO?PRSH[XT35,ODJ\[^;=MCM?[&R='76Q7^2R_--4
M4.'LL%M=Q+>Q2\T075I3)!+71')573HGXG?&?TN^'OS#A*T]YFG@=UGQT]U[
MZU\NSI];PTIC]LY+9<%*X[5UM3)-;UBUJQ$X7ZC\=^5?!.5V<1W7^I9+UCM[
MYFV*/>TB*_VTVI$5F.L6TM$3,1#J)/,$KA
M
M      <]W[CC_4PVC^1_J;]R;YZ!_LZ/^6K:_P L;_\ PE4Z?0+^CS'_ )7G
M_OH0/IV-T@        +X/VO?]03M[^^!O_\ 0OX_J)_M//Z>^(_X0VO^L>50
ML^([_;?:_P E8O\ .-RL@JY&@
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MP_-8\^C)1Q51\O/"6GB'PU>@?@E:?HUXEPF//C^]RYMO7=[BNM9K.FYW?O\
M<1W5M-;:9/I1,Q;5M'BO3SP?A8C\G<7LZWK[+7QQER1TF)TR9>^_6)F)^EUC
MVM&V\&9                          -]O";VU_*_SUV.BRZ1T":/1K')6
MECMO;^VR\:_UMJ<4\O,<\DN7NN/JMFR5I33\:\;A8,CD:>*J:JX:(N>9*=#>
MM?Q(^E/H-QTY_-N0B><R8[6P;#!'O=YGF(UB(QU^CAI;Y,VYMAPSI,5O:VE9
MPGS#U!\9\)V_?S&>)WMJS-,%/I9;Z>SZ,=*1/]ODFM/DB9GHNJ^ 'L6>*'A?
M7AM]W6SA\BN_,9-Q?6G86[XKFUU;4KNNWICJCT7KBK(Y/ 6<UO+QZD62R7XC
ME(9>/4MIK7BKF-2YZ^_'+ZK>LU<W \+>?'? LL=MMIMLG=GSUUUUW.\[*9;1
M,=+8</N<%J_1R4RS$61$\X]9_)O+HOLMG,[#A+1I.+';6]XU_P"TRZ1:=?9-
M*=M)CI:+>U-NA0T\
M
M
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MB-(MUB58OD/(1RW/[[E*S$UW.\S98TB8C\)DM?I%OI1'7I$]8^7JS8PITX
M
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MGB'JG5.,
M                                       Y[OW''^IAM'\C_4W[DWST
M#_9T?\M6U_EC?_X2J=/H%_1YC_RO/_?0@?3L;I         7P?M>_P"H)V]_
M? W_ /H7\?U$_P!IY_3WQ'_"&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
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M^V9M.LS/W9E]APWR
M
M
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M8[6C29Z:S,1$?=T=81Y2E9
M
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MV[G+[=?V^M<__I]YKI\GL^1)"CBP
M                                                           !
MSW?N./\ 4PVC^1_J;]R;YZ!_LZ/^6K:_RQO_ /"53I] OZ/,?^5Y_P"^A ^G
M8W2         O@_:]_U!.WO[X&__ -"_C^HG^T\_I[XC_A#:_P"L>50L^([_
M &WVO\E8O\XW*R"KD:                8![Q\JO&SQIL8K_OSO+K'J>FZA
MM[C'V&Y[?A\3GLM;W5[5813X36I+FK8<Y#Q<T5\5U6=K/3%1%+77S31%)53G
MWA'I9ZD>I6>=OX%P?)\M-9F+WV^WR9,6.:U[YC)FBONL4]LQI&2]9M-JUC6U
MJQ/><-XUY!Y#>:<)L]SNM)F)G'2UJUF(UTM?3MKTT^^F-=8B.LQK%%V%]QI[
M9NET7M6M[AVUVY5:PV4L$?7O4F=QM>2KNKB*&>WLN>U[CK&..;&QR<RS<W-5
MO'5''5Q#5+7\M%4J_'OLZOB6YJU(Y+9\3Q$7FT3.[W^*\4BL3,3;ZC&]F8O,
M=M>R+S$S'?%:ZVC9FP] _4/=S$;C%M=KK,Z^]SUG32.DS[F,WM]D::SK/6(C
M66&?^*$\!/XH?,#_ +@=+_\ B 9E_P"6'Z]_G?Q#\:Y'_P"A3M_ZN/F_\*XK
M]UW'\6/^*$\!/XH?,#_N!TO_ .( _P#+#]>_SOXA^-<C_P#0H_JX^;_PKBOW
M7<?Q8_XH3P$_BA\P/^X'2_\ X@#_ ,L/U[_._B'XUR/_ -"C^KCYO_"N*_==
MQ_%C_BA/ 3^*'S _[@=+_P#B /\ RP_7O\[^(?C7(_\ T*/ZN/F_\*XK]UW'
M\6/^*$\!/XH?,#_N!TO_ .( _P#+#]>_SOXA^-<C_P#0H_JX^;_PKBOW7<?Q
M8_XH3P$_BA\P/^X'2_\ X@#_ ,L/U[_._B'XUR/_ -"C^KCYO_"N*_==Q_%C
M_BA/ 3^*'S _[@=+_P#B /\ RP_7O\[^(?C7(_\ T*/ZN/F_\*XK]UW'\6/^
M*$\!/XH?,#_N!TO_ .( _P#+#]>_SOXA^-<C_P#0H_JX^;_PKBOW7<?Q8_XH
M3P$_BA\P/^X'2_\ X@#_ ,L/U[_._B'XUR/_ -"C^KCYO_"N*_==Q_%C_BA/
M 3^*'S _[@=+_P#B /\ RP_7O\[^(?C7(_\ T*/ZN/F_\*XK]UW'\6/^*$\!
M/XH?,#_N!TO_ .( _P#+#]>_SOXA^-<C_P#0H_JX^;_PKBOW7<?Q8_XH3P$_
MBA\P/^X'2_\ X@#_ ,L/U[_._B'XUR/_ -"C^KCYO_"N*_==Q_%C_BA/ 3^*
M'S _[@=+_P#B /\ RP_7O\[^(?C7(_\ T*/ZN/F_\*XK]UW'\6/^*$\!/XH?
M,#_N!TO_ .( _P#+#]>_SOXA^-<C_P#0H_JX^;_PKBOW7<?Q8_XH3P$_BA\P
M/^X'2_\ X@#_ ,L/U[_._B'XUR/_ -"C^KCYO_"N*_==Q_%C_BA/ 3^*'S _
M[@=+_P#B /\ RP_7O\[^(?C7(_\ T*/ZN/F_\*XK]UW'\6/^*$\!/XH?,#_N
M!TO_ .( _P#+#]>_SOXA^-<C_P#0H_JX^;_PKBOW7<?Q8_XH3P$_BA\P/^X'
M2_\ X@#_ ,L/U[_._B'XUR/_ -"C^KCYO_"N*_==Q_%C_BA/ 3^*'S _[@=+
M_P#B /\ RP_7O\[^(?C7(_\ T*/ZN/F_\*XK]UW'\6/^*$\!/XH?,#_N!TO_
M .( _P#+#]>_SOXA^-<C_P#0H_JX^;_PKBOW7<?Q8_XH3P$_BA\P/^X'2_\
MX@#_ ,L/U[_._B'XUR/_ -"C^KCYO_"N*_==Q_%C_BA/ 3^*'S _[@=+_P#B
M /\ RP_7O\[^(?C7(_\ T*/ZN/F_\*XK]UW'\6/^*$\!/XH?,#_N!TO_ .(
M_P#+#]>_SOXA^-<C_P#0H_JX^;_PKBOW7<?Q8_XH3P$_BA\P/^X'2_\ X@#_
M ,L/U[_._B'XUR/_ -"C^KCYO_"N*_==Q_%C_BA/ 3^*'S _[@=+_P#B /\
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MK=NNNG=.GMEDNU\3\6V7=]2XSC\/=IKV;?#373737MI&NFLZ:^S66M[8SOP
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M>
M
M
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M?PF?W6*O37[_ "T[OU/P<7TGY]'2"><E $
M
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MJ[6A
M                                   '/=^XX_U,-H_D?ZF_<F^>@?[.
MC_EJVO\ +&__ ,)5.GT"_H\Q_P"5Y_[Z$#Z=C=(        "^#]KW_4$[>_O
M@;__ $+^/ZB?[3S^GOB/^$-K_K'E4+/B._VWVO\ )6+_ #C<K(*N1H
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M (,&#:X:[?;4ICV](TK6L16M8CV1%8TB(^Y$/CN6^H
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M\D,P,0=4
M
M
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MJ'H
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M &U*WK$_KIT]Q;33I&LZZ3,:W25,2(P
M
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MM9F-8Q4]E*]-=.^T=UI1LI(-@
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MO[;Y+3:VGR1$S/2L?K:QI6L=(B(9(8XZ\
M
M
M                                       !4<^ZC[9YM]8\2.BK*_FJ
MIRV>[([9V3&4RY.&WAYU_'X'3])OY8/DHPV0FN.-FV"..OYI+JSIBKX^$=%S
M\9+:_LL_$XR<GY;YSFQQKBP;/88;Z4F9][?+N-S6)U]Y2(]SM9F-(IDFT=;6
MQ?1E'\-7%]VYY3FKUCZ-,6"D]-?I3;)DC7[Z-.S%,^R+:Q[9KTIP+B$KP
M      %Y?[7GJNO7/$GO3MR[M(;:Z[0[RHUJQEYQ5O#>9#7>L=/Q%5E?<YJB
M>NYR.-IV'>,M;PVTD=%%G/;W%='-7-S5\M'GVGOE->1]6N#\2Q7FV+B^#G-:
M.^9K3-O=QD[J^[T[:7]UML%[7B9G)6^.LQ'NXUAK\1W)QN/*-EQ=9F:[;9=\
M_2G2+YLEM8[=-(GMQTF9B?I1-8G[V%FM6>CN
M
M                            T.]T'K+]+WMY^8>DT67XE>5]#[UMF(QM
M&"_.2YR.?ZXQE78VNV&.Q'%5,LV8O<[JEO%92Q<5S6MW5'/%17)'315O;X8O
M)OT1^(3P_F[7]WACGMK@R7][[FM,6\O]4S7OD]D8ZXL][9*VTK?'%J6FM;3,
M9KZ<<C^2O.^*WDSVT^NXZ6GN[(BN6?=7F;?VL5O,VB>DUUK,Q$S+EW/3ZL=
M         3,>P3VC!UG[GG1UK?3_ $N*[.P_8O5V0N/CD*OEGSNE9?,ZY!]/
MCXIN;G\0W+7,;;?MU/T\/K>O)51Q%\],-_CW\7OY+\,G.9<%>[=<9FVF]I'T
M/9BW./'FG6\QIV;?-FO]&>^W;V5B9MVSJ7UNXV>1].=Y:D:Y-M?%FB.GZW)6
MMYUGV:8[WGIUG32-=='1J>=1 <
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M8FJ8M328
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MRVM,S/RRTAGSY]UFMN-S>^3<7G6UK3-K6F?;,VG69G[LR^PX;Y
M
M
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ME717:T
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M=-Y'QWY8\?WW%:3:=SM,V*(C2)UOCM6-)M]&)UF-)GI$Z3/L=9!Y1%8P
M
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M:S,S,S/69F6-V1NP
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M;1$S;)'S1EM?V1\O5).C<U\
M
M
M                                   Y:ON1=HP=S>>WEQV)93_5XK+]
M\=A8S 7GQR''UVLZEG+G3M8OO2RD4&0M/K=>P%M+]/+''S;_ #^EQ33Q1Q3Q
MZB?AQ\7OX;Z#>)>/9J]FZQ<#M+Y:_0^CFSXHW&:NM)FENW+EO7NB9[].[69G
M59'Z?\;/$^$\7L+QIEKLL4VCITO>L9+QTUB=+6F-8F=?;KU:3MU,O
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M
M                                                     .:#[T/5
MLO4ON;>6&$XQ_P!%8[3OEGVEC)XK&[LK+*1=KZUA.P,ID+*NZIXXOOAL>P7M
MO=3Q<U0U9"WN*:>>.:.::?2I\&7E%?+/AG\4WOO._/M=A;97B;5M:D['-DVM
M*6[?O?P.+'>E;:6C%;',ZZQ,V%^D?)1RGIWQF;NUOBP3AGK$S'N;VQ1$Z>SZ
M%:S$3U[9K\Z+M)]L<         !U3? OM23NWPJ\5^T[J3U<IM_0_6=[L-?$
M5W%'SM=IJN-Q>V\6U-_=WU[79T[-87?$-<T\TDD/%-=5=7-7///EE]>/%J^$
M^M'E/BV*--KL^>WE<76LS[BV>]\&O;6M>[W-J=T5K6(MK$1$1HK5\VXV.'\O
MY/C:_M>+>YHK[/O)O,TUTB(U[)KKI$1$]-&VK4S%P
M
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M6M,5G8/I5LYWWJ'Q.&*1?MW49-)TC]IK;+W=9C[WL[H^69C2(F>CF2/3$L1
M
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M;G>6C2;Y;VO;2/9&MIF=(^2/9'R1#(3'W
M
M
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MC99*5GNBNE\L>ZI,3,3UBUXFL?KITK'6748>7]7
M
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MK$X)CK$1$Q&&)TB9Z3$ZZSI$]J!K28
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M3373]LPY,>OLG[WOUT^7336-=8YISTG+"
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MK:8XF>L]N*NF.OR?>UCV1\T-G&LF.@
M
M
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MPK/T]YO,=)C73Z%(MEF=-)UB+TQQIK'6T3KTTF_DH/0A
M
M                                      5CONB.I/SE\4>ANY;6V^IO
MNJ>[+K4[NNBS]26PUGM;4K^;(W\F0YO(^+6S_./KW#VU<7H2\SS7,57SQ\1<
M\269_9@^6_DWU6Y[P[+;MP<KPE<]8[M(MFV.>L4K%.V>ZWN=WN+Q;NKVUI>-
M+=T361/PX<I]7\FWO$VG2FYV<7CK[;X;QI&FG6>S+DG76-(B>DZ]*-R\!,D
M        !;1^U=[;^CW_ ,L^B+JY]3\XM/Z^[;P-G7>?)]'^9F:RVG;9<VV/
MXLZOJ/Q+\_<+1/-S<4>C])#3Q'7ZO-4=3OVI?B7ON \3\ZQ5T^K[S=[#+:*_
M??6,>/<8*VOW=.SZKN9K7MGN[[S-J]L1:,/Q*<7W['B^:K'[7ERX+3I[?>5K
MDI$SKTT]WDTC3KW3UC3K<Q4W(E@
M                                                        .>[]
MQQ_J8;1_(_U-^Y-\] _V='_+5M?Y8W_^$JG3Z!?T>8_\KS_WT('T[&Z0
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MQ6B)B8G6)B>L3$QTF)CK$Q[7\;[/T
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MQ[*UB-,\[Y=Y-Y-?OYW?;C<QK,Q6UM,<3/6>W%73'7Y/O:Q[(^:&SC63'0
M
M
M
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M^V8UMKI$QK:_53(R
M
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M/.H@.
M                                   Y[OW''^IAM'\C_4W[DWST#_9T
M?\M6U_EC?_X2J=/H%_1YC_RO/_?0@?3L;I         7P?M>_P"H)V]_? W_
M /H7\?U$_P!IY_3WQ'_"&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
M  .=_P"_?X5Y/Q<\VMI[)P&&FAZ>\FYKWM34LE;6'%OB<3O-[/\ _/1TFNX@
M@M[3\2L]EDYS,4=$=--&-S5K'\TDD4U;T+? 9ZT;;U0]%-KXWO\ -$^8>,Q7
M8YZ6OKDR;:L?XEN8B9FW9;#'U>TS,S.;;9;:5K:D)W^B7E^/R3P_'Q^>\3RO
M'1&&\3.MK8XC\#DTG6=)I^#F=?O\=IZ1,0@]3=;C
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MF?;,S[?;,S[9>P=.X@
M
M
M                                       #GN_<9]P_I+]R39=-@J^-
MAT/U7UKU?'S#5\;2YR&4QUWVUE+RCFC)W\,UY%-V938W$G$5G7358<0UQ<\P
M\32^@?[.OP_]&OAPVW,WC\/SW*[S>SK]]%*7KL*5GZ%9BLQLIRTCNR1,99O%
MX[^RLZ?0/BOR=Z?X]W;[_>[G+F^[$1,8*Q[(Z?@>Z(UM]]K$]=(@?3L;I
M       ='7V%.JXNK_;#Z$GDC]/+]FWF_=J9OBF6TF@JEV3=<SCM>D@KMK2V
MEX^?2,%BN9:9ZIYH[CU*/4].FB./SG_'CY3;R?XF^>I6==IQE-KL<?2T3IAV
MV.^6)BUIC_Q.7/VS6*UFG;/;W3:UH">MG)3R7J-OJQ^U;>,6&OM_68ZS;VS/
M_:6OIII$QI.FNLS,:AXU0
M
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M)B8Z3$Q/6)B>DQ/L?V/B_
M                                                  #GN_<<?ZF&
MT?R/]3?N3?/0/]G1_P M6U_EC?\ ^$JG3Z!?T>8_\KS_ -]"!].QND
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M.A<(
M
M
M                             !RD_,ON*OR!\LO([NGZB&YLNQ^YNPME
MP=5O);SV\.K76RY"/4K&"[ML?BJ+^'':Q#:6]-S5;Q2W-,7$LO'J5U\\^JKT
M;\/KZ?\ I1XYX9VS7-QW#;3#EUB8F<]<-)SVFLWO-)OFG)>:1>U:3;LK/;$+
M,?$N)C@_&./XC28OM]IBI;76)[XI'?,Q,VTUOW3IK,1KI'2(:TMDLA
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M',;OEKQI?=;G+FF/FG)>UYC_ /2948LZP
M
M                           !S._>:ZFYZ<]S+RRP,=C-:8_:^PH^V<;<
M519.BURG'<&"Q'9.8OK"?*5RUWD,>S[-?VTU<-?-M'>6\T,7%%$7$='I7^#;
MRR/,/AI\3W]LD7W&TX^=A>-:=U/R?ER;/'6T4B(K,X<.*]8M'?..]+WFTV[I
ML,])>4_*WIYQ>>;1.3%@]Q,=-8]Q:V*L3$>SZ%*S&O6:S$SK,ZS&"DXV,
M       Z?/M1=O2]Y>W-XA=@7,UY=7U/3^&T+*WV0GN[K(9/-]0WF0ZCSF6O
MKN^DEN[R\RV7T>:YEFKJJYEKEYK^//'/#S'?%7XC7P?XBO+N QUI3!^6,FZQ
MUI%:TICW]:;_ !8ZUK$5K7'CW-:5K$1VQ6(^17/ZF\5'#>?<KL:Q$4^MVR5B
M(B(BN>(SUK$1TB*UR1$1\FFB0E'U@H
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MY<>NNGO,>NM==)TMUI;2>VTZ2U%;;92
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M3:9CK,L#Y'G^=Y>-.6WN[W4:1'X;-DR=(F9B/IVM[)F9CYIF?G9F8:ZD
M
M
M
M                         !IQ[A/=-OX\^$'E)V])<PVE]JW3.YVVMS7$
MU%O;\[OM.-DT_08)Y*LKA)O1NMVS^/BJIM[F.[KIKYIMN*Y^8Z*MP_#[X7D]
M0O6WQ?Q&M9O@W7,[><T1$S/U;!>-QNIB.S)&M=MBRVB;4G'$QKDTQQ:T99X+
MQ%N=\QXWBHB9IEW>.;Z=9]W2?>99CZ-O9CK:>L36/;;2NLN6(]22R8
M   !OY[673\7>WN'>)'7-S9?B6.N.X,%N.:QW-=I1%?Z[U;;WO:6QV=SS>W%
MK%79W."TRXHGHIK]>N&JJF&FN;FBBK0?Q2>7V\%^'KRWR/%?W>XKP^7;X[Z6
MF:Y=[-=EAM';%I[JY=Q2:S,=L6B)O,4BTQA'J3RL\+X)RG(5GMR1M+8ZSUZ6
MS3&&DQI$]8MDC3Y-?;I&LNH,\Q"N0
M
M                        !1_^Z0ZFXU[R<\=>Z+>PAM+7M#IG-:/=W%O%
MC(>,IGNI=NER-[?7GTU?&4NLE'@^T<9;53W-'R<VMO;Q0UU<0UT1W<?9>^63
MR'IGY%X9DR3?+Q?,X]S6)F\]F+?[>*5K76.RM)R[+->*TG7OODM>L=]9M,7X
M;^4]_P".[_B+6F;;;=UR1$Z]*YZ:1$:](CNPWG2/EFTS'6)FKZL[2-
M    7E_M?.XJ]K\3>\.EKRXAN+WJ#N:VV7'TTR6]-Q9:MVQK5O)C[&6T@Q]O
M7S#QL^C9JXCN9KBXEFJN*XOA%';Q\54>?:>>'UXKU7X/S/#6:X>7X:<-^DZ6
MS['-,7M%IO,:^YW.VI-*TI6L4B^MK9+:0U^(WB8VWD^SY>D3%-WM)I/MTF^&
M\ZSK,S^LR8XF(B(C2)ZS:5FM6>CN
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M?W,/^R_3_P#.SB?^@G_F+_#5_"N8_$,G[(_G]]//^\W?[A;_ -9_PX_N8?\
M9?I_^=G$_P#03_S%_AJ_A7,?B&3]D?S^^GG_ 'F[_<+?^L_X<?W,/^R_3_\
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MI_\ G9Q/_03_ ,Q?X:OX5S'XAD_9'\_OIY_WF[_<+?\ K/\ AQ_<P_[+]/\
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M
M
M
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MLQ.FM[Q14A:
M
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MQ5:"^(CB+;WP[!RN.)F^RW=9M\T8\L3CF>E9T_">ZB-9K7K,3K;MA?(42(5
M
M                            .>[]QQ_J8;1_(_U-^Y-\] _V='_+5M?Y
M8W_^$JG3Z!?T>8_\KS_WT('T[&Z0        %\'[7O\ J"=O?WP-_P#Z%_']
M1/\ :>?T]\1_PAM?]8\JA9\1W^V^U_DK%_G&Y605<C0
M
M
M
M
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M.DUE9K5GH[@
M
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M/GW$3SOAG)\76(MER;2\TB8B=<E(]YC]NOZ^M=)]L3UCK$.I@\N:ML
M
M                      !SW?N./]3#:/Y'^IOW)OGH'^SH_P"6K:_RQO\
M_"53I] OZ/,?^5Y_[Z$#Z=C=(        "^#]KW_ %!.WO[X&_\ ]"_C^HG^
MT\_I[XC_ (0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
M
M
M
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MU@H
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M5<AP\1ICP;O)6D?^[FTVQS_9QS66U#5C&@
M
M '/=^XX_U,-H_D?ZF_<F^>@?[.C_ ):MK_+&_P#\)5.GT"_H\Q_Y7G_OH0/I
MV-T@        +X/VO?\ 4$[>_O@;_P#T+^/ZB?[3S^GOB/\ A#:_ZQY5"SXC
MO]M]K_)6+_.-RL@JY&@
M
M
M
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M;9;3,S,SK,S/69F9ZS,SUF9]K^Q\7X
M
M                           <^G[CGIJ7K7W&<QO4&-^EQ'?'5?7W8D-[
M;17?&/N,W@K.ZZPSEKS+)8VMA'F(:=#M;NZ@MY+CGBB_AN):N)+GFBGT _9S
M^8U\D^'7#P63)W;O@>5W>TFLS7OC'EM7>XK:1:UIQS]:O2EK13KBOCK$UQ:S
M.;T"Y:.0\!ILK6UR[+<Y<6DZ:Q6TQFK/MF>W\)-:S,1][-8C2NJ!-/)NP
M      !?K^VH[BHWWP RO65S<3<Y/HGN;=-;MK*62XGHBU;=XL=V/BKZWKYQ
M]K:6L-YLNR9N+FVHGN9:)+:J:OFBFXBHXH3^TF\/MP/K[B\FQUCZMSO#;;--
MHB(F<^VF^SO68[[6M-<.';6[YK2LQ>*5BTX[6F$?Q"<3.R\XKR-8CW>]VF.\
MSTCZ>/7%:)ZS,Z4ICG72(TF(C7MF5A=7PT2
M
M   Y[OW''^IAM'\C_4W[DWST#_9T?\M6U_EC?_X2J=/H%_1YC_RO/_?0@?3L
M;I         7P?M>_P"H)V]_? W_ /H7\?U$_P!IY_3WQ'_"&U_UCRJ%GQ'?
M[;[7^2L7^<;E9!5R-
M
M
M
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M9XST\W&&L]N3>9\6"/;\MIRVB-(TZTQ6B==(TF>NNCHC//,@<
M
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MX6-YXMM.:I$SEV6Z[9]ND8\]=+3\W[9CQ1&L?+.DQ[)O2*-D,@
M
M                 '/=^XX_U,-H_D?ZF_<F^>@?[.C_ ):MK_+&_P#\)5.G
MT"_H\Q_Y7G_OH0/IV-T@        +X/VO?\ 4$[>_O@;_P#T+^/ZB?[3S^GO
MB/\ A#:_ZQY5"SXCO]M]K_)6+_.-RL@JY&@
M
M
M
M
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M&<#2?VO%DW%X^?WEO=X_UO33W>7V6Z]WTJQI69MHJG48
M
M                                          $8WO(=(_IY]MORDU>V
ML_JLWJ6A\]NZ]5'1ZMW!D.H<C9]@W]&/C^%7,MYE-<P%_84T4TU5R4WE5-''
MSU4\\29^#OS;] _B/\7Y3)?LV6[W_P!0RZSI6:;^EMI7OGY*TS9<6769B(G'
M$V^C$MB^D_,?D3U XW<VG3#ES^XM\VF>)Q1K]R+VK;[G;K/1S-GI:6&@
M     -V/;@[N_5U\[?%CMV:\_#\5KO<&L8G9[[Y_3^DTG>)I-!WJX^/QXXJ]
M+3=GON?DYYIIK^'R\\T\<\\\:5^(WPG^<3T+\I\1I3WFZW'#YLF&NFO=N=M$
M;K:Q_9W&'%UZS'MB)F-&(>?\/^7O"^2XN([LF3:7M2/GR8_PN./W2E?U'4J>
M796X
M                                Y[OW''^IAM'\C_4W[DWST#_9T?\
M+5M?Y8W_ /A*IT^@7]'F/_*\_P#?0@?3L;I         7P?M>_Z@G;W]\#?_
M .A?Q_43_:>?T]\1_P (;7_6/*H6?$=_MOM?Y*Q?YQN5D%7(T
M
M
M
M
M                         Y?_ +J/>M'D;[@WE-V=9W4UWA*^SLCI&KS2
MQ7%M1+JW5UI9=;8"\M[*ZCAN+&'+8_5*+WF*2.*7U+FJJ6BF6JOAZ=/A:\&M
MZ=?#]XMXSFK6F]CC*;G/$3%IC/O;6WF6LVK,Q:<=\\X^Z)M72D169I%5C7IK
MPL\!X+QO'7B(S?5HR7]D_3S3.6T3,=)[9OVZQ,QI$:3IHC];_9P
M Z6/LJ=+?H/]M#Q@Q%S!\F8W_3[GNG,W'J?-]=^E_+7N\ZU/Z,>5RUK;?3:+
MEL3:_+%5#\_T_J2P0W$DT?'FQ^-+S3]-_B5\GWF.VNSX_>1QV.-/O?J&.NVS
M1K-,=K=VYQY[ZVBVG?VTO?'6EIKW]7N7_+/J'R66L_@L&6-O6/F]Q6,=_P!;
M69UR5O/77VZ1::Q$I446FM0
M
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M^SM2=8C2?;76-)G;IJ1BP
M                                               #GN_<<?ZF&T?R
M/]3?N3?/0/\ 9T?\M6U_EC?_ .$JG3Z!?T>8_P#*\_\ ?0@?3L;I
M 7P?M>_Z@G;W]\#?_P"A?Q_43_:>?T]\1_PAM?\ 6/*H6?$=_MOM?Y*Q?YQN
M5D%7(T
M
M
M
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M1&LS[(B(^9]APWR
M
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M&'Q%<+79>5[;F<=8C'OMKI:=/OLF">VTS/R_@[8:_/I$?)II935MH^
M
M                     .>[]QQ_J8;1_(_U-^Y-\] _V='_ "U;7^6-_P#X
M2J=/H%_1YC_RO/\ WT('T[&Z0        %\'[7O^H)V]_? W_P#H7\?U$_VG
MG]/?$?\ "&U_UCRJ%GQ'?[;[7^2L7^<;E9!5R-
M
M
M
M
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MT4GG@0,
M
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M8BTQV>R([IB_DH/0A
M                                            <]W[CC_4PVC^1_J;
M]R;YZ!_LZ/\ EJVO\L;_ /PE4Z?0+^CS'_E>?^^A ^G8W2         O@_:]
M_P!03M[^^!O_ /0OX_J)_M//Z>^(_P"$-K_K'E4+/B._VWVO\E8O\XW*R"KD
M:
M
M
M
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M/>.GMR6[*:S[8TC'>=.G2\3,3]'2U^JF1D
M
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M8\E)]M;TM-;5G[M;1,3]V%96;%DP9;8,T37+2TUM$^V)B=)B?U)?2<9\P
M
M                      '/=^XX_P!3#:/Y'^IOW)OGH'^SH_Y:MK_+&_\
M\)5.GT"_H\Q_Y7G_ +Z$#Z=C=(        "^#]KW_4$[>_O@;_\ T+^/ZB?[
M3S^GOB/^$-K_ *QY5"SXCO\ ;?:_R5B_SC<K(*N1H
M
M
M
M
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MFXY[S[D=Y2==OCS^XIUB8[<$1BUK,3,36]JVO$Z]>[7I[(DM1K:]
M
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M<<1&WW%XW%-(F(TS1WVTB9GV9.^O2=.G2*Q]&)5T5VM
M
M         '/=^XX_U,-H_D?ZF_<F^>@?[.C_ ):MK_+&_P#\)5.GT"_H\Q_Y
M7G_OH0/IV-T@        +X/VO?\ 4$[>_O@;_P#T+^/ZB?[3S^GOB/\ A#:_
MZQY5"SXCO]M]K_)6+_.-RL@JY&@
M
M
M
M
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MIMEM,S,S.LS,]9F9GK,S/69GVO['Q?@
M
M                               !0?\ N6NBJ.NO/# ]PX^UFHQGD/U+
MK.=RM[++<5T7&\];T_HXR]M;T2R20PPVFDX;6ZN:8ODIYDGJJYH^;GFN2^?[
M-?SFWD7H3G\0W%HG<^/<MFQ4K$1$QMMY_CF.TS$1,S;<Y-Y&MM9TK$1.D16L
MVOA[YJ=_X5?BLDQ[S8;J]:QTZ8\OX6LS^KDME]NO2(Z_)%=U88WP
M  MZ_:R=]2TY#R@\7\A=?-#/9ZWWUJ-E]5=_M4MK/:=>]B77T4EU)8\?447F
MKT>K##%-SZ7RS5RT\04PU&?:D>!UG;^,>I^WK].M\W%Y[=M>L6BV[VE>Z*Q;
MIV[V>VUK5ZZTK2>^;Q9^)/A(FG&^1XXZQ-]M>=(^77+BC737IIFZ3,QUZ1'T
MM;AJG]%,
M                                 !SW?N./]3#:/Y'^IOW)OGH'^SH_
MY:MK_+&__P )5.GT"_H\Q_Y7G_OH0/IV-T@        +X/VO?]03M[^^!O\
M_0OX_J)_M//Z>^(_X0VO^L>50L^([_;?:_R5B_SC<K(*N1H
M
M
M
M
M                    !3^^Z;\@/ZK_ (L8R]_[2>0&[8ZN'_X7UUU=>VT]
M%[_]V$<]$EM_]9YCD_\ .TK>OLM_ /\ :?U2W-/^YXK;7B?^KN][6T=O\GS6
M8O\ V_=7[V4J?ALX/_ZY>2Y(_M-MCG_HRYHF-/\ X$QI/SZQ[)4_EO*5(
M      "PY]M5T3+V/YYY;N&ZB^&(\=>J]HS]K=?+=U?#<>R+6?K7#6/QM[RT
MMX_JM4S>P3?-/3<Q_P"[?"F'U*J)X*]OM)?.J^.>A&+P_%/^-^1<K@Q6K]'_
M ,/L[1O,ENM;3/;GQ[6NE9I/T]9OVQ-+Z(^(/FHX_P *KQ59_"[_ '-*S'3]
MKQ3&6T]8F>EZXHZ:3U]NFM;7YE"J$@
M
M                               "N5]S%T)%V'X1:?W=9VOJ9OQW[4Q-
MS>WGTMI+]-HO:OTND9Z'ZFJVJR%K]5NE.L\_".>B"3TOA+')7Q!7#8K]FIYY
M;Q[ULWGA.:VFR\AXK)%:]UHUW6Q[MSBGM[NRW;M_KGMK-H[OHVK7OB^_/AYY
MN=AYCEX>\_@=_MK1$:SUR8=<E>FNDZ8_>^V-8UZ3$:Q-#)>\FL
MDR]GKR"X\;_<6\:-ROKB&VUK;=V@Z?V^2ZJQD%E#@>W(JM%CRF0R&4EMHL5C
M=:SV8L<M<W-$T5=$%A7QSS7'57%)&GXO_3^?4?X=_)>'P5FW);393R&WBO?-
MIR["?K,TI2D3-[YL6/+@I2:VB;98F.VT5O77GJMP7Z0>!<CM*1,[C%A]_337
M7NP?A-(B->Z;UK:D1I/6T>R=)CIH/-$KP
M                                                           <
M]W[CC_4PVC^1_J;]R;YZ!_LZ/^6K:_RQO_\ "53I] OZ/,?^5Y_[Z$#Z=C=(
M        "^#]KW_4$[>_O@;_ /T+^/ZB?[3S^GOB/^$-K_K'E4+/B._VWVO\
ME8O\XW*R"KD:
M
M
M
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MXWWF&'A\=IG%L-K6+1UZ9<T^\MIUF.N+W/72)UUUUB*Z6.U<[0(
M
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M^^FM+S#@[^-^4;[@[1,5V^YO6FL3&N.9[L5NLS/TL=JVC69Z3[9]L[1-7L;
M
M                        <]W[CC_4PVC^1_J;]R;YZ!_LZ/\ EJVO\L;_
M /PE4Z?0+^CS'_E>?^^A ^G8W2         O@_:]_P!03M[^^!O_ /0OX_J)
M_M//Z>^(_P"$-K_K'E4+/B._VWVO\E8O\XW*R"KD:
M
M
M
M
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M[S'%:ZZ1,Z=>K9!KACX
M
M                     #F7^\+X^\>-_N+>2^FV-O#;:UMN[3]P:A':TXR"
MRAP/;D5.]28O'X_%Q6T6*QNM9[,7V)MK:N&*NB"PHYXXKCJHED]+OP@>H$^H
M_P ._C7,9[3;DMILHX_<3;OFTY=A/U:+WO>9F]\V+'BSWO%K1-LLQ/;:+4K8
M?Z4\[^D'@7';N\S.XQ8?<7UUU[L'X/69G7NF]:UO,ZSUM/LG6(C-26;#
M      7B_MA?(RWW3QF[@\:LI=P_C_2/846Z:Y!+>T4W%QH7:MO-+);V.-DI
MXFEAP6[:YDIKN>.JN.BK,6]%=,=55%4U(7VF_IUDX;U+XCU)VM+?4.;X^=OF
MF*SI&ZV,Q$3:\=(G+MLV&M*S$3,;?)-9M$3%(<?$7P%MIY%M?(<<3[C>8/=W
MG3I&3#/MF?[K'>D5B>OX.TQ,]=+.ZLE'0
M                                                         !SW
M?N./]3#:/Y'^IOW)OGH'^SH_Y:MK_+&__P )5.GT"_H\Q_Y7G_OH0/IV-T@
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MM<<
M                            !6.^YU\E/S%\8^J/&;"Y+T<WWSODFV;=
M:6N2^66KKKJ?Z+(0V&7Q4/[959YOL#,XFZM)9ZN(JIL%-Q'1)7'57!9G]F5Z
M;?EWU-Y7U+WN/79<#L(P8+6IT^M[[NI-L=YZ=V/:X\],E:QW17<T[IK6T1>1
M/PZ^/?7?(MUY%FKKAV6#LI,Q_P!KFUC6MOGKBK>MHCKIDC68B=+4;EX"9(
M       "3CV<^@HO(KW&?&K4,CCK/)ZQJ>X5=M[=;Y'Z27'R83JFSGW2VL[Z
MPNZOAEK/,['B[#'RVM,<W$E%WSZM'H<2U4QF^,+SVWIW\.ODO+[;)?%R>[V?
MU#;S3NB\9-]:-O-JVK^UVQX;Y<M;S-=)QQVS[R:1.N_5?FYX'P'D-UCM-=QE
MQ>XI,:Z]V:8QS,3'WLUI-K1.L:=O2>[2'3*>:57B
M
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M:^V*QBM:]O;$]D:QTUCHI// @8
M                                                   Y[OW''^IA
MM'\C_4W[DWST#_9T?\M6U_EC?_X2J=/H%_1YC_RO/_?0@?3L;I
M
M
M
M     >DU/<MOT+-VNRZ-M6R:9L=E\?H\_J><R>NYNT^-5%?/TN5P]U9WUO\
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MQ,XYUF>V+Q/7'>8]M;=->E+WB-4F:-+7@
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M;2?;"X"J%16
M
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M7K,3$Q,3,=66F)NK
M                                        <]W[CC_4PVC^1_J;]R;Y
MZ!_LZ/\ EJVO\L;_ /PE4Z?0+^CS'_E>?^^A ^G8W2
M
M
M                                                           ]
M)IVX[7U[M>N[SHVQ9C4MRU+,6&P:QL^OW]QB\W@LWB[B.[Q^4Q>0M)(KBTO+
M2XBIKHKHJXYXYX==S'#\5Y!Q6XX/G-OAW?#[O#;%FPY:Q?'EQWB:WI>EHF+5
MM$S$Q,./N]IMM_MLFRWN.F7:9:36]+1$UM68TF)B>DQ,+X_LK>\9;^:>'L/&
M[R"NH<?Y3ZI@9[K$;)%:T6N'[SUC!6O$E_GH8;6*.RPW86&LH_5R]A13';WD
M5-5]94TQ\7-K942?&C\'F3T7WF3U']/Z3D]+=WGBN3#-IMDXS-EMI7%,VF;9
M-IDM/;@RS,WQVTP9IFWN\N:%?J]Z46\1RV\@X*)MXUEO$6IKK;;WM/2O7K;%
M:>E+=9K/T+]>VU["ZOAHD
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M\]Y'=TF)V^+-[BFFFG;@_!ZQ,:]T7M6UXG6>EH]D:1$F:-+7@
M
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MA/'XXSR_%S6*L1@Y'!$S[>N7#ICOT]GWDX9Z>V9F9C7K-B]7:T(
M
M               Y[OW''^IAM'\C_4W[DWST#_9T?\M6U_EC?_X2J=/H%_1Y
MC_RO/_?0@?3L;I
M
M
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MK&DSO4T8PL
M                              !70^Y8\D:^JO"K5.B<1?36NP^3/85M
MCLC%'3;T\7'6W5<F+W':^*;BJKF\@FJW"ZUB'FF&FGB6VGGHDDXHJYBFL2^S
M9].*^5>M.Z\ZW=(OQ_C/'S>DSKTWF^B^WP=/O9CZO7>VUM,]MZTM6LVCNIOO
MX>_'XY/R_+S66L3@X[!,Q[>F7-KCIT]GWD9IZ^R8B8C7K%"Q?"FN
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M69GK,JT[6M>TVM,S:9UF9]LS\\OV?A_
M
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M]=?=W_!Y*Q\GZZEYUTZ8^D_)/004 H-
M                                                       .>[]Q
MQ_J8;1_(_P!3?N3?/0/]G1_RU;7^6-__ (2J=/H%_1YC_P KS_WT('T[&Z0
M
M
M
M                 %EC[9?R9N^O?+/??&C+Y6\XU;R%T.^S.M8GYXIK2GM#
MJNVN]C@N(8KBNBJQ^NZYKSWU4EM\:[BJRM*9:*Z8HZX*V/M+_33%Y!Z3[#U*
MVF*GY4\>W]<>;)UBWU+?37#,3,1]+MW?U7LB_2D9,LTM6;VKDCW\1'CM=]XQ
M@\AQ5CZSL,\5O;Y?<YIBDQT]NF7W>D3[.ZVDQ,S%KU2C-#$
M
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MB=(M"\ I'0Z
M
M                 0G>_P">-?ZP'MV]A[)B<;];N7CMF,3WE@J[?&_5Y"K7
M\!1=87LBU^MB_P![L,/:Z%G;[+W7PXD@KKP\/,M/'$=,T,U/@&]2?T ^(?C^
M-W>3LX?R+#DXS+K?MI[W+-<FSMVS]&V2VZQ8MO3V6B-Q>*S/=-+[?]#_ "'\
MA^>8-OEMIM-_2VWMK.D=UM+8IT]DVG+6M*^R8[YTGKI/.N>A]/,
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M-?UMM.ZL_+68F.DLJ,6=8
M                                            Y[OW''^IAM'\C_4W
M[DWST#_9T?\ +5M?Y8W_ /A*IT^@7]'F/_*\_P#?0@?3L;I
M
M
M
M      ;@>WWV/^B3SD\2>PI)?1L-?\A.J?QR7BT^NEIUG*[CBL)M/TUK\U/,
MMYSKF2NN(/AS\:9N:>>/R\-0_$!XY^EOH?Y;X_6.[/N/']][N.[MCWU-O?)@
MUM\E??4IW?/76&*^<\?^5/#>4V,1K?)L,W;UT^G7':U-9^;OB-?N.J$\M2M<
M
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MTTB(F30Y:F
M
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M.1P1,^WKEPZ8[]/9]Y.&>GMF9F8UZS8O5VM"
M                                                           .
M>[]QQ_J8;1_(_P!3?N3?/0/]G1_RU;7^6-__ (2J=/H%_1YC_P KS_WT('T[
M&Z0
M
M
M                     &7_ !Z_]OO1_P#+!UI_ZZ85B'J#_L#SG\C[S_-L
MCJN=_P#K'O/\DS?X.SK1O)VK"
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M.D:1&LS[(B(^9]APWR
M
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M-6,=IR3/SXXUTC5T1GGF0.
M                                             4D?NF.KLMC?(WQI
M[JJ@O*L%N?2>6ZNBNOA;58^++=9[WG-LN(/C'+5>07EQ9]LQ5?MU%$4M$7[3
M575'/Q'=?]ESY1M-SZ=>2^%Q:GU[9\WCWLU^EWSCWFUQ8(GK';-8ML)CZ,S:
MLV^G%8MC[I@_#;R6+)P'(\1K'OL.\KFTZZ]N;'6D3\TQ$X)]G6->NFM=:M:T
M1)$
M
M
M                     !OM[6_5=?<WN'^'NB\6<.1M>>\M-W+,8ZZQ5OFK
M+(ZYU?=U=G[/CLAC;N>"VN,;?Z]I]U#<\R<UT1P5UU\QS<4^E7H;XH?*:^&_
M#UYASO?./+^0]QM\=ZWG':F;>U^I8;TO6)M%ZY=Q2U--)FT16+4U[HPGU(Y*
M.)\#Y7>ZS6WU+)CK,6FLQ?-'N:3$QK,3%LD3&GMG2-8]L=0QYA5<8
M
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MU]L1;2)TUB]@HP0P
M
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M]6?F NC
M                             0M>_/XH2^3?@'O6<U^R^K[ \=[RCN_5
MJ([>[GN;[":_97-IV-A8N+/FN7CU](O+J^CI]&;B6[QL$?/$?%7,T<S_ ($/
M5:OIGZ^;'8[^_9P'D-/R;GF9K%:Y,MJVVF2>[2.FYK3%,]U>W'FR6^E,12VW
M?13R>/'?-\.'/;38[^/J]^L1$6M,3BMU^;)%:SUC2M[3UTTGG1/1(GJ
M
M
M
M              ME_:_^*.3R6_=S^96Q8V:/7M8P,W276US<<<4V^1VG/SX;
M8]]RMG'5!ZM4VN8"QQ]E3-3+Q%53F9Z/EKKHYYBJ@^TZ]5=MMN!X;T<X[)$\
MANL\<EO(CVTP8HR8=K2TZZ:9LMLN2:S7NB=OCMK%;:6C%\1ODV/'L=IXG@M'
MO\E_K&6(]L4K%J8ZSU_7VFUM--?P=9UB)ZW-U-:)0
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MM2WMF>R-9Z:1-BA6U
M
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MK,]/UV.:UCK,Z8Y]D1&MH-6&CD
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MF-<M8Z5SQ&LS/=&GO)TB(RS/2*VIK#"F6VV
M
M
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M(K2E=?DI6(K'SZ:SUF6Q37;H0
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M[FTWW.6]KWM/MM:TS:TSITZS,ST?><!\
M
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M-QBZ1,]^'6UHC73K;'[RD3K^N^7V3TN'FN5Z@
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M'YYM8I@F-OS=*ZY-O:=;1$::WQST[\>LQ&ND6K/2U8Z3,6J439
M
M
M
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M?U'Y+S[DNZW=AX/#:?<8-?9\GO,FG2V6T?JQ2)[*?KK7E*1=:V
M
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MD3,:UO)*/D-@
M
M                     $*GOZ^,E?D1[>'8FPX;'PW>Y^.F2LN^L')Q:V_-
M[7KFK6E_CNS+/C(R2PS66-M^O<O?Y::*GU*+F?$6]/,?-?$<D<T?@)]3*^GG
MQ"\=Q^\R33AO(L=N+RQW3V^^SVK?9V[(B8M>=WCQ8*VG2:5W&28MI-JVV]Z(
M^11P/GFWP9K3&TW]9VUNLZ=]YB<,Z?+,Y:UI$]-(O;KIK$\ZAZ(D]
M    '41]LWRB_7"\(NA.Z[^_^OW*_P!/M=3[,FJY_;I.S-&_]%]SOYX^+6TH
MM_SARF-YRL45%-5$5O?1T\5U\<?/SY@OB6]+_P":#ULY[PK;X_=\/CWEL^SC
MY(V>Y_#[>L3W6F?=4O[BUIF)M?%:9BNND5Q>H?C?Z*>8[[AZ5[=I7+-\/_P<
MGT\<>V=>V)[)GY9K,Z1[&^+1+"@
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M=X/^&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/\
M9'ZO7?O\1_<'\VFZ?O*?S@^ _GSA_P <VW[X?EW@_P"&;3]VQ_LC]7KOW^(_
MN#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/]D?J]=^_P 1_<'\VFZ?O*?S
M@^ _GSA_QS;?OA^7>#_AFT_=L?[(_5Z[]_B/[@_FTW3]Y3^<'P'\^</^.;;]
M\/R[P?\ #-I^[8_V1^KUW[_$?W!_-ING[RG\X/@/Y\X?\<VW[X?EW@_X9M/W
M;'^R/U>N_?XC^X/YM-T_>4_G!\!_/G#_ (YMOWP_+O!_PS:?NV/]D?J]=^_Q
M']P?S:;I^\I_.#X#^?.'_'-M^^'Y=X/^&;3]VQ_LC]7KOW^(_N#^;3=/WE/Y
MP? ?SYP_XYMOWP_+O!_PS:?NV/\ 9'ZO7?O\1_<'\VFZ?O*?S@^ _GSA_P <
MVW[X?EW@_P"&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS
M:?NV/]D?J]=^_P 1_<'\VFZ?O*?S@^ _GSA_QS;?OA^7>#_AFT_=L?[(_5Z[
M]_B/[@_FTW3]Y3^<'P'\^</^.;;]\/R[P?\ #-I^[8_V1^KUW[_$?W!_-ING
M[RG\X/@/Y\X?\<VW[X?EW@_X9M/W;'^R/U>N_?XC^X/YM-T_>4_G!\!_/G#_
M (YMOWP_+O!_PS:?NV/]D?J]=^_Q']P?S:;I^\I_.#X#^?.'_'-M^^'Y=X/^
M&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/\ 9'ZO
M7?O\1_<'\VFZ?O*?S@^ _GSA_P <VW[X?EW@_P"&;3]VQ_LC]7KOW^(_N#^;
M3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/]D?J]=^_P 1_<'\VFZ?O*?S@^ _
MGSA_QS;?OA^7>#_AFT_=L?[(_5Z[]_B/[@_FTW3]Y3^<'P'\^</^.;;]\/R[
MP?\ #-I^[8_V1^KUW[_$?W!_-ING[RG\X/@/Y\X?\<VW[X?EW@_X9M/W;'^R
M/U>N_?XC^X/YM-T_>4_G!\!_/G#_ (YMOWP_+O!_PS:?NV/]D?J]=^_Q']P?
MS:;I^\I_.#X#^?.'_'-M^^'Y=X/^&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?
MSYP_XYMOWP_+O!_PS:?NV/\ 9'ZO7?O\1_<'\VFZ?O*?S@^ _GSA_P <VW[X
M?EW@_P"&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV
M/]D?J]=^_P 1_<'\VFZ?O*?S@^ _GSA_QS;?OA^7>#_AFT_=L?[(_5Z[]_B/
M[@_FTW3]Y3^<'P'\^</^.;;]\/R[P?\ #-I^[8_V1^KUW[_$?W!_-ING[RG\
MX/@/Y\X?\<VW[X?EW@_X9M/W;'^R/U>N_?XC^X/YM-T_>4_G!\!_/G#_ (YM
MOWP_+O!_PS:?NV/]D?J]=^_Q']P?S:;I^\I_.#X#^?.'_'-M^^'Y=X/^&;3]
MVQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/\ 9'ZO7?O\
M1_<'\VFZ?O*?S@^ _GSA_P <VW[X?EW@_P"&;3]VQ_LC]7KOW^(_N#^;3=/W
ME/YP? ?SYP_XYMOWP_+O!_PS:?NV/]D?J]=^_P 1_<'\VFZ?O*?S@^ _GSA_
MQS;?OA^7>#_AFT_=L?[(_5Z[]_B/[@_FTW3]Y3^<'P'\^</^.;;]\/R[P?\
M#-I^[8_V1^KUW[_$?W!_-ING[RG\X/@/Y\X?\<VW[X?EW@_X9M/W;'^R/U>N
M_?XC^X/YM-T_>4_G!\!_/G#_ (YMOWP_+O!_PS:?NV/]D?J]=^_Q']P?S:;I
M^\I_.#X#^?.'_'-M^^'Y=X/^&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_
MXYMOWP_+O!_PS:?NV/\ 9'ZO7?O\1_<'\VFZ?O*?S@^ _GSA_P <VW[X?EW@
M_P"&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/]D?
MJ]=^_P 1_<'\VFZ?O*?S@^ _GSA_QS;?OA^7>#_AFT_=L?[(_5Z[]_B/[@_F
MTW3]Y3^<'P'\^</^.;;]\/R[P?\ #-I^[8_V1^KUW[_$?W!_-ING[RG\X/@/
MY\X?\<VW[X?EW@_X9M/W;'^R/U>N_?XC^X/YM-T_>4_G!\!_/G#_ (YMOWP_
M+O!_PS:?NV/]D?J]=^_Q']P?S:;I^\I_.#X#^?.'_'-M^^'Y=X/^&;3]VQ_L
MC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/\ 9'ZO7?O\1_<'
M\VFZ?O*?S@^ _GSA_P <VW[X?EW@_P"&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP
M? ?SYP_XYMOWP_+O!_PS:?NV/]D?J]=^_P 1_<'\VFZ?O*?S@^ _GSA_QS;?
MOA^7>#_AFT_=L?[(_5Z[]_B/[@_FTW3]Y3^<'P'\^</^.;;]\/R[P?\ #-I^
M[8_V1^KUW[_$?W!_-ING[RG\X/@/Y\X?\<VW[X?EW@_X9M/W;'^R/U>N_?XC
M^X/YM-T_>4_G!\!_/G#_ (YMOWP_+O!_PS:?NV/]D?J]=^_Q']P?S:;I^\I_
M.#X#^?.'_'-M^^'Y=X/^&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMO
MWP_+O!_PS:?NV/\ 9'ZO7?O\1_<'\VFZ?O*?S@^ _GSA_P <VW[X?EW@_P"&
M;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/]D?J]=^
M_P 1_<'\VFZ?O*?S@^ _GSA_QS;?OA^7>#_AFT_=L?[(_5Z[]_B/[@_FTW3]
MY3^<'P'\^</^.;;]\/R[P?\ #-I^[8_V1^KUW[_$?W!_-ING[RG\X/@/Y\X?
M\<VW[X?EW@_X9M/W;'^R/U>N_?XC^X/YM-T_>4_G!\!_/G#_ (YMOWP_+O!_
MPS:?NV/]D?J]=^_Q']P?S:;I^\I_.#X#^?.'_'-M^^'Y=X/^&;3]VQ_LC]7K
MOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/\ 9'ZO7?O\1_<'\VFZ
M?O*?S@^ _GSA_P <VW[X?EW@_P"&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?S
MYP_XYMOWP_+O!_PS:?NV/]D?J]=^_P 1_<'\VFZ?O*?S@^ _GSA_QS;?OA^7
M>#_AFT_=L?[(_5Z[]_B/[@_FTW3]Y3^<'P'\^</^.;;]\/R[P?\ #-I^[8_V
M1^KUW[_$?W!_-ING[RG\X/@/Y\X?\<VW[X?EW@_X9M/W;'^R/U>N_?XC^X/Y
MM-T_>4_G!\!_/G#_ (YMOWP_+O!_PS:?NV/]D?J]=^_Q']P?S:;I^\I_.#X#
M^?.'_'-M^^'Y=X/^&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+
MO!_PS:?NV/\ 9'ZO7?O\1_<'\VFZ?O*?S@^ _GSA_P <VW[X?EW@_P"&;3]V
MQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/]D?J]=^_P 1
M_<'\VFZ?O*?S@^ _GSA_QS;?OA^7>#_AFT_=L?[(_5Z[]_B/[@_FTW3]Y3^<
M'P'\^</^.;;]\/R[P?\ #-I^[8_V1^KUW[_$?W!_-ING[RG\X/@/Y\X?\<VW
M[X?EW@_X9M/W;'^R/U>N_?XC^X/YM-T_>4_G!\!_/G#_ (YMOWP_+O!_PS:?
MNV/]D?J]=^_Q']P?S:;I^\I_.#X#^?.'_'-M^^'Y=X/^&;3]VQ_LC]7KOW^(
M_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/\ 9'ZO7?O\1_<'\VFZ?O*?
MS@^ _GSA_P <VW[X?EW@_P"&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_X
MYMOWP_+O!_PS:?NV/]D?J]=^_P 1_<'\VFZ?O*?S@^ _GSA_QS;?OA^7>#_A
MFT_=L?[(_5Z[]_B/[@_FTW3]Y3^<'P'\^</^.;;]\/R[P?\ #-I^[8_V1^KU
MW[_$?W!_-ING[RG\X/@/Y\X?\<VW[X?EW@_X9M/W;'^R/U>N_?XC^X/YM-T_
M>4_G!\!_/G#_ (YMOWP_+O!_PS:?NV/]D?J]=^_Q']P?S:;I^\I_.#X#^?.'
M_'-M^^'Y=X/^&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_P
MS:?NV/\ 9'ZO7?O\1_<'\VFZ?O*?S@^ _GSA_P <VW[X?EW@_P"&;3]VQ_LC
M]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/]D?J]=^_P 1_<'\
MVFZ?O*?S@^ _GSA_QS;?OA^7>#_AFT_=L?[(_5Z[]_B/[@_FTW3]Y3^<'P'\
M^</^.;;]\/R[P?\ #-I^[8_V1^KUW[_$?W!_-ING[RG\X/@/Y\X?\<VW[X?E
MW@_X9M/W;'^R/U>N_?XC^X/YM-T_>4_G!\!_/G#_ (YMOWP_+O!_PS:?NV/]
MD?J]=^_Q']P?S:;I^\I_.#X#^?.'_'-M^^'Y=X/^&;3]VQ_LC]7KOW^(_N#^
M;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/\ 9'ZO7?O\1_<'\VFZ?O*?S@^
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M=X/^&;3]VQ_LC]7KOW^(_N#^;3=/WE/YP? ?SYP_XYMOWP_+O!_PS:?NV/\
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MQS;?OA^7>#_AFT_=L?[(_5Z[]_B/[@_FTW3]Y3^<'P'\^</^.;;]\/R[P?\
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M,Z:S,L\,$=*
M                               CJ]UORI_4^\$N]>U<7FKS!;]E=;FZ
MUZGOL9Q_UM;=F=A0W&!U_,8J2OX6\-YJ%M+<YWYY>?DXCQ=?PIEDYHADD1\*
MOI9_._ZZ<%XKNL-,_ XMS&\WU;_M<[/:3&7+CO'MFNXF*;72O77/&LUKK>N>
M^F?C7Z5>:;+C,E(OL:Y/>YHG[V<.+2UJV^72\Z8^GRWCV1K,<Q)Z:UBH
M      #I&^QYXS1>-/MV=+Q9'%?AV\=U6<_?&[UR46G%S-+V'1!=Z3!+S;T?
M40?0=9VV%CDM[B2N:"[]?BKB*JKF&/SA_&[ZEV]2?B'YJVWR^\X3A;QQ>VB.
M[MB-I,UW,QK.D]^\G<3%Z1%;8_=Z3:(B]J__ %C\BGR'SS=SCMW;/9S]6Q^W
M3\%K&2>O3KFG),3$:37M]OMF75$AJT
M
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MQJ,VRV7EF"(]YAM]6R^W6:7[KXI^:(I?WD3\LSEK\TKFZFM$H
M
M
M
M
M
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MERVFV6TS,S,ZS,SUF9F>LS,]9F?:_L?%^
M
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M6=+1,?/$Q,2^PX;Y
M
M
M
M
M
M                /*[UNFN=;:1N78FX9&'$:EH6J[#NFTY:XDBBM\7KFK8B
M\SF;R,\L\D,$<-EC+&62JJNNFCBFGGGGGCC\KM>"X7D?).;V?CO#XYS<MO\
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M]N2J=$3@
M
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M[:;=N6WW<T:)X4$VE0
M
M
M
M
M
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MM\6B6%
M
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M3IUFV*L.B,\\R!P
M
M
M
M
M
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MS73IKJZ63S8J]P
M
M                           %5+[G_P 5OSHZHZ7\O];PMG7E^KLQ/U)V
M=E8>?DREQH>YW7.3T&YO?4^$4V'U/=Z;ZVCICJXFIN=G^/R21_/7!:A]F+ZI
M_DOROFO2'DLUXVG*88W^RI/WD;K;U[-U6NG6,F?;>ZO,S';--EIW5MI%Y+_#
MGY+]6Y/=^*[B\^ZW-/?X:_)&3'&F6(_NKX^V9UZ:8?;$Z1-*I=&EV
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M9I,1;3V7BU?;$MP&H6*@
M
M
M
M
M
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M[=.FLV:U9Z.X
M
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M-Z1TTZW*U.*)H
M
M
M
M
M
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MBL=9AP>4Y':\/QNXY7?3-=GML-\MYCK/;2LVG2/EG2.D?+.D?*ZMG1O4.J=
M=-=7=(Z/#Z6I]4Z'J^A82NJ"WM[F]M-9Q%KB^<MD:;6.*&7,9J:WKN[V;X?-
M<7<\DM?/-==7//E5\X\NY7S[S'E/-N;G7E>5W^?=9.LS%;9LEK^[IW3,QCQQ
M,8\=?97'6M8TB(A6=S/*[GG.6W/,;R==UN<]\ENLS$3>TSVQK^MKKVUCY*Q$
M1TAE1BSK
M
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MB8>J=4XP
M
M
M
M
M
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M#X@O)_R7XQB\?V]]-WR&3Z<1/6,&*8M;7Y8B]^ROMCNB+QUCNA?"43H6
M
M
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MT[+]>MK>\G6=+:6.U<[0(
M
M
M
M
M
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MUNO]ODF]HTB/HS6.NFLRNHJ-9
M
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M39%X+Y)3RSQ39\Y%HG/EQ1&6(^3-3Z.2)C2-/IQ,Q&D?1F)CI,3.F;<C+0
M       $F7M$^7MOX7>=/4W9>P9>'"=:[C--U#V_D+JBCFSLNN]\OL9'<YK(
M2U215VV-U#9\;B\W<R1_-)Q!C*^*:).>?3JC3\7'I%D]9_0SEO&N/PSG\DV<
M1O\ CZ5U[K;O:UO,8Z1I,3?<8;Y]M2)TCNS1,VKIW1KSU2\5MY=X9NN/P4F_
M(8H]_@B/;.7'$Z5CYYO2;XXB>FMXZQ[8Z:#S1*\
M
M
M
M
M
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MB\V6->G7BU?#_$=IP\_^,[/>9I^?-DTM>/U*=,=>D:UI$S&LRT#;\9N
M     D:]J'Q(K\T/.7IOJ?)8N;)=>X3)2]G]NU\6=O?6-MUMH-=OD\C99B"Y
MXKB_#=QS\F.USFKFB3BB;,Q\U4<T_'X1U^*SU:KZ,^A_,^5[;+&/R#/CC9;"
M.Z:VMO-UK2EL<UTGOV^*,V[TUC6NWM$3$Z,!]3?*(\1\-W?)X[17?7K[G!UF
M)G+EUB)K,?+CKWY?;'3'/5TZ'F65U@
M
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MBWFNXI@K,<=O/\8Q?-^$F?>4B?[C)%HB/;%9IK&DQ,RZHD-6@
M
M
M
M
M
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MY3^4.>P>+[:?\6V-._)I/WV;+$3$3&LQ^#QZ:3TG7)>)C2(F;.*LQ'8
M
M
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M=]QDVSQ[-9Q:?AZZ_)I6L9)^?W<1\SH4//J@J
M
M
M
M
M
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MY/><UR>?EN0MW[W<Y;9+S\G=:9F8B/DK'LK7V5K$1'2&2&..O
M
M
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MIHQA8
M
M
M
M
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M
M
M                   (V/=K\2*_,WP6[CZPPV+FR_8FKXWGMGJ*SL[.WOLG
M>=D]?6.1R&+P.)CN...(\ENV&N;_  $<E-<?-'&6YYYJ^3YJ:I(_";ZM5]&O
M7/A_)]YEC#X[NLGU'?VM::TKL]W:E+Y<DQ[:;;)&+=3$Q.ON(TC728V#Z7^4
M1XEYGM.1S6BFPR6]SGF9F(C%EF(FUM/DQVBN68Z_>>S71S)'IB6(@
M   ++WVU7F/;]3>2&X^*&Y9J:ST_R,QO&7T".ZN:*<58=R:78W%W39\4STT0
MV,V\:3%=V_,WJ\57-]B\?:4QR231\QUJ_:2^CN3ROTXV?JMPV&+\OX[D]WNI
MK$]]N/W%HKW=-9M&VW,X[]O;I3%FW&6;5K2W='KX@_$[<GX_B\FVE(G=;"W;
METCZ4X,DQ&OW?=Y.V=-.E;Y+:Q$3K>D4;(9
M
M
M
M
M
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M:T?VUI;O-),.
M
M                                 <W'WMO$#]47SQ['L\#C+RSZS[K^
M;N[KJ>2/YK&*#<<C?U;CKMG=4231?^C.\6]_%%;5\TW$&.ELZJZ/DEBDD]'G
MP4>KW\[?H3QV;?Y:7\EX7_Y;NXB?I3.WI7ZOFM68B?PVVG%:;QK2V6N:*SK2
MU:V >C_E7Z4^%;>^>T3R.S_Q?+\_X.(]W>8_N\<UF9]DVB^DZQ,1$6ENVD
M        ])INW[-U[M^J[]I69O-<W'1]DP>WZEL..JHHR&"V;6LG:YK YFQK
MDHDHHO,7E;**>+FJFKCBNCCX\<_['7<SQ'&>0<1NN!YK#3<</OMMEV^?%?K3
M+AS4MCRX[::3VWI:U;:3'29<?=[7;[[:Y=CO*1DVF;':EZS[+4O$UM6?N369
MB?U75(\//)?4?,#QKZD\B=,YAAQ_8^JVF0RN(BGXGKUC;K&N3%;EJEQ7SS\]
M4VN;/8W5IQ75QQZT<5,M/'R24\\^6?U@]->6](/4GEO3SF=;;CCMU:F/),:1
MFP6TOM\\1[-,V&U,FD?>S::3UK*M;ROQ[=>*^0[K@=WK.3;Y9BMO9WTGZ6.\
M?]>DQ;[DS,>V&RS6K'@
M
M
M
M
M
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MJ_1[PR_'8+1&_P"3F<$1\ON>W\/:(^6.V:XY^;WL3\CH7//D@H
M
M
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M=/4OHB@
M
M
M
M
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MY=8!^LGE<^4>:9ZX9B>/V,SM\6FDQ/9:?>7UCI/?D[NV8Z32*)AT/VJ0
M
M
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MEXCV]N2DUO77KVVC7JSPP1TH
M
M
M
M
M
M           #6GS#\E]1\/\ QK[;\B=SYAFQ_7&JW>0Q6(EGX@KV?;KZN/%:
M;JEO7QS\],VQ[/?6MIS73QSZ,<M4M7'R1U<\;*]'_37EO5_U)XGT\X;6NXY'
M=5IDR1&L8<%=;[C/,>S3#AK?)I/WTUBD=;0R'Q3Q[=>5>0[7@=IK&3<98BUO
M;V4CZ62\_P#4I$V^[,1'MERO=ZW38^R-WW'L3<,C-E]MWW:MAW3:<M<22RW&
M4V/:<O>9S-Y&>6>2:>6:]R=]++557777555SSSSSS^5ZE>"X7CO&^$V?CO#X
MXP\3L-KBVV#'$1$4PX,=<6.D1$1$16E:Q$1$1I'2(64;+9[?C]GBV&TK%-K@
MQ5QTK'LBE*Q6L1ITZ1$0\J[1R0         $F7M'>'%QYJ^;W5/7V5PL.7ZO
MT?)6O:_<\=_;5W&(N>N]*R6/N[K6<G315%S7#ON9EL\'S1373)Q%D)):?R15
M<\1I^+7UBQ^BWHEROD&US3A\GWV.VQXZ:S$9(W>YI>M<U/;I.UQQDW.LQ,=V
M*M9ZWC77GJCY97Q#P[<[[%>:<EFK.';Z3I:,N2)B+Q_\.O=D^;6L1\KIH/-$
MKP
M
M                          5CON7?#7])WCYIGF'JEM\VU^.]Y!J?845%
M?PJRW4>^9RRL,=?\1U5223WFD]@7]MZ44-%'^Y9N_N)Z^:+6/CBS/[-;UC_1
MGU WOI!RMO\ Y5Y#2<^TG_N]_M<5KWIKTB*[G:UOW6M,_A-M@QTC7+;61/P]
M>6_D[G<WBFYG_%=_$WQ?W.?'69F/N1DQ1.LS^NQTK$:VE1N7@)D@
M  +:'VRGFW^![;V#X);SE_ACMU_$^V^B_K)_CZ.VX?&Q?I.TBQ]3F:>3\<U;
M&0YZTMX^(K:V_!LI-5\TUW^6IW[3#T3^O<3Q_KIP>'_&-EV;#D^V/;@R7GZE
MN;::1'NL][;7)>>Z]_K&UI&E,72,/Q$>'^^VN#S394_"8=,&YTC]9:?P.2?D
M^C>9QVF=9GWF*/95<R4W(E@
M
M
M
M
M
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M1(
M
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MFDSII%J^VEXCV]N2DUO77KVVC7JSPP1TH
M
M
M
M
M
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M+,S*M_/GS;K/?<[BTWW&2\VM:>LVM:=;3,_/,S,R^PX;Y
M
M
M          *EWW-?A)^.:GU]YVZ-B/CD=+_#.I.]?HX/AZNIY?)2_HQW>_\
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MR4W(E@
M
M
M
M
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M0?F'Y3YK%XGL[Z[+8_3RZ3TMN+UZ1\T^ZQSI$QUBV3)6T:U6<59B.P
M
M
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M6:U8\
M
M
M
M
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M^>][3:T_V9F9>P=.X@
M
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M?F.QK$[G9UBF>(]ML-K1V6Z>WW5[3K_<7FTSI1=T4FH>@
M
M
M
M
M
M                            *)_W'?G?<=V>0&+\/=&RD,O5_C?DOQ3>
M)+*6N2+9N\\EBY+2]HNJO6DMI(>L=>R4N+M^**(I8<CD,M'-S)QQ#Q%>?]G/
MZ%8_"O ,OJ_SF*8\G\CQ]FVBT1$X>,I>+5[>D6B=[EI7/?69K;#BVEJ169OW
M3/\ 0'PJO#\';RO>5F.2Y"NF/7]9MXMK&GR_AK1%YUUB:UQ3&G76M:LD2#
M         78?MG_"3\QNK=W\V]XQ'I;-VY];UYU!]9!\)[#K/ 96G\[MCM?4
MI^-'YY;EC*;2BKX<5TV^$YJHYYCNN?C2M]I5ZV?ESRC9>BG"9M>-XCMW?(=L
M]+[S+3_%\-M/X/M[SDF/9-]SI,1;%TB#\0WF'USDL/A^SOKM]KIESZ3[<UJ_
M0I/_ ,/'/=^KDZ]:K4*K5&L
M
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MXIN/#/)=QP6>9OBQS%L5YC3WF*W6EOFUT^C;3I%ZVB/8W,:;8D
M
M
M
M
M
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M2(Z1"MKD-_NN4W^;DM]:;[S/EMDO:?EM>9M,_P#3/2/DCH]LZ1PP
M
M
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ME=(]ONYGWL3/LK7)$1,V7[%"2$0
M
M
M
M
M
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MU1K
M
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MWMM/WT).49FN@
M
M
M
M
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M?6F^\SY;9+VGY;7F;3/_ $STCY(Z/;.D<,
M
M
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M3$1K'2.><-7^
M
M
M
M
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MFU6Z-@
M
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MZ C1X
M
M
M
M
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MJW-WNMQOMUEWV\O.3=YLEKWM/MM>\S:UI^[-IF9_5>D=:XX
M
M
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M.W])Q[W!DM2])TUK:LZ6CIK$Z3'MB9B?;$S#V#IW$
M
M
M
M
M
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M?XOLO#_'MOP.QB)KBKK>^D:Y,ENM[V^?6>E==9K2*TUTK#5%M5DP
M  "^#]N'X2?H0\9\SY4;KB/INQO)CT/S2^K@^2]P?2F!NY?P'T?4IXEM_P _
ML[1+E9/EYYCN<?!C)./R\*)_M&?6O]-_4K#Z6\+F[O'?&M??]L_1R<EEK'O=
M=.D_5<7;@CY:9;;FORH6>OWF'Y8\AIXUL[:[#CM>_3V6W%H^E^K[NNE(^:TY
M(605<C0
M
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MXMU%8Z1/LQ9ITCIKTQ7F9TF?=1$:S,S;O5'(M
M
M
M
M
M
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M^U_8^+\
M
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MG9.(M[:+<]-FN)H+6>[AQ.3E^>SN:XH>;['36]UQ'1Q-Q3QYA/7+TBYST/\
M4OD?3[F]<E=MDF^VSS$5C=;/)-IV^XB(FT5G)2-,E(M;W6:N3%W6FDS-<?F?
MBV\\-\BW'!;S6T8[:X[Z:>\Q6F?=Y--9T[H^^C6>V\6KK.FK;IJ1BP
M
M
M
M
M
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MM?FOZ4^4VX_:6UXCCIMBII.L7R:Z9LGS:=U>RDQ,Q-:1>)^G,1.2@^TV
M
M
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M]*_'_P K<?3NYWCZ6M6(CZ67#]]DQ=(F;6C3OQ5Z_2[JUC7)+H1//P@L
M
M
M
M
M
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MQS._BV'#I[:QI^%R_P#VNMHB)C68R7Q]--9CHX/.B@*
M
M
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MII[,>6)URXON1UB](GIVVFM=?=VTG/0<:9
M
M
M
M
M
M      02>_'[A]'AYXS3]0];[1#CO(CR+QN6UG 48V[N(]AT3K">WGQF[]D0
MSX^:&ZU_)2TW'&*P-U5)!/5D)IKJSYDKQEQZ<Z?@2^'JWK!ZEU\N\DVLY/3S
MQW)CS99O6)Q;K>Q,7VVSF+Q-<M(T]_NJ1%JQBK3%FBL;G'W;H]%? Y\K\BCE
M>0QS;@=A:M[:Q';DS1.N/%I/2T=._)728[8BM](R5UY[#T%)U
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MK%9^]A)"CBP
M
M                                                  !0!^X&]O\
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MC2:VC6+5F+5F8F)9(8XZ\
M
M
M
M
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M].DS'KU]\WKQ/"U\3V-H_*&_KKETGKCP1,=)C_WTZUC^XKDB?;"](HV0R
M
M
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M\V]8KN8C69OBC2*Y=(CVXM=+S_W?TITC&NMJ640@
M
M
M
M
M
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MN+Z]L3,Q2L1%:4KK\E*Q%8^?36>LRV*:[="
M
M
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M%:9UF;8I^CKK,VIV7G2;3$2EHNM;
M
M
M
M
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M[1UCWDUB=+XNEJU5>C0
M
M
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MU3JG&
M
M
M
M
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M]SN+3?<9+S:UIZS:UIUM,S\\S,S+[#AOD
M
M
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MIDG^U[;?K;2N/J=T3P
M
M
M
M
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M/6(G6$O:(K5@
M
M                                                        #GW^
M_E[>-QXF^2EYWUUY@(;#H#R1SV3SV/BQ]5=5EI/;5U1)F-ZU"NVJYJIQF-SU
MU7-F<1%1\EM1!-<6EO''#8<4\7_? 5\0N/U7]-J>!^0[B<GGWC>"F*\WT[MS
ML*Z8]MN-?U]\58KM]Q:=;S:N/+DM:^>93E]$?.Z^3^/1PF_O-N<X^D5G7VY,
M$?1QWU^6:QICO,]9F*VM,S?5 :GJW:           ^QKVP9O4\_@]JUK*7F$
MV/6<QC-@U_-8Z:JWR&(S>&O8,CBLI8W%'[*"\L+^VCEBKX_+371QS_R.)R''
M[+EMAGXKDL5,_';G#?%EQWC6F3'DK-+TM'RUO69K:/EB9A\L^##NL%]MN*Q?
M;Y*36U9ZQ:MHTM$Q\TQ,Q+I2^TU[A^ ]PSQIL=LR$]G9=Y=9_@^G]\:S!'96
M5,>S7&/KFQ6\8;%VUY<S6NG]@0V5S-9<R40\1WMI?6E%-5-IZE?FV^*_X>M_
M\/GJ3?B=O6]_!^3]YN.+S3-K:X8O$7VV2\UK%MQM9M2N32;:X\F#+:8G-VQ7
MSZG>!Y_!/(;;6D3/#;CNR;:\ZS]")^ECM,Q&N3%K$6TUUK:EI^^TB45&!K@
M
M
M
M
M
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M9XS)$<QOJ3&33[['MYUBT_<MEZXZZ]>SWDQI;MM%\Y1"A2
M
M
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MF.DO>.A<(
M
M
M
M
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MAWIWX3M/!O'<?&XXK;D<D1?<9(B-;Y)CV:^V:8]9K2)^36W2;61XI",[
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M.T3N]Q?72/O:5CI2E?[FE8BM==9F(UM,VF9G/S 71@
M
M
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MV<^9\/2;<GMZ1&XI6)F<F&O2,D1&OT\7Z[IUQ:S,Q[N(M=Y4E(=@
M
M
M
M
M
M             *9'W%?N:7&R['=> /2&RP\ZKK,UG?>3&PX6\KFXSVW0RVV2
MP?3\=W!Q1:_ANG51Q7V>ICDN/5R]<%E)]--C+R&:Y3[._P"&C'QO'5]??-MM
M/Y4W,6KPV+)6(]U@F+4R\A-9^EW[C6V+:S,4[<$9,]?>4W.&]):^@OIW7;[>
M/..8QS]9R1,;2MH^]IUBV?2>NN3K7'K$:4[KQW1DI,5-%KZ3H
M"]K]O#[=/ZOW3%WY>=L:S>8_NGOG#T6>@6.8I]*XTGHVXDLLGC[J"P^%-=IF
M.T+^WAR,]<_J24XJUQ],7%OS+>4ST6_:%?$3^G_F5/2/Q3<TR>%\#FFVZMCZ
MQN>3B+4O6;?KL>RK-L-8KI$Y[[B;^\[,,TA?Z[^>_ESEX\6XS)%N(V5]<LU]
MF3<1K$Q,_+7#$S6--([YR:]VE)BR:K>1]
M
M
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M<S$?0GLUM..UIG#0B:<
M
M
M
M
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MGK,SUF4!K6M>TVM,S:9UF9]LS\\OV?A_
M
M
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M)K.EHF(V0:X8^
M
M
M
M
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M([M&YC3;$@
M
M
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M$]8F)Z3$^Q_8^+\
M
M
M
M
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M/U^:.M<>ORUQ^VWSY-(]N-:A5:HU@
M
M
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MZ^Z1O\A/7S-5>8V&6:[UCUN>:/HHIL71)'Q!B[62GK[0KX7OJN7-\0'@>W_
M9;UCF=OCK]Y>8BM>2I2.G;>8KCWO;U]Y:FZM6W?NLM8H^N_IO[NU_.>$Q_0M
M,?6\=8]D^R-Q$1\D]*YM/UTQDF)[LEHMTJD46P
M
M
M
M
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M,ZH 9,E\M[9<MIMEM,S,S.LS,]9F9GK,S/69GVO['Q?@
M
M
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M
M
M
M
M
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M(
M
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M*3][DI,Q&M+?).G28FLZ6B8C9!KACX
M
M
M
M
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MMDZZ:XZ2LXJS$=@
M
M
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MX/ZCR5XGR/91%<FL]<N/V4S1'RS/WF7372\1:>V,E*H0TVFX0
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MDV>[I;'NL5[4O2T:6K>LS6U;1/LFLQ,3'R3#[S@/@
M
M
M
M
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M>TVM,S:9UF9]LS\\OV?A_
M
M
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M
M
M
M
M
M         *IGW WNN\]=8?/^!?CWGYH=_P!DQL5MY&[OBKC)XZ\T76,K:XC,
M8WK/6\E936G%SGMWPUWSSGI.*J[>TPT_%E\)9[VXXL+4_@!^%2/(MYM_7CU!
MV\3P&VR3;B-M>*7KN<U+9,=]YFI:+:8MMDK_ (K&D7R;BOO]:4PX_?R8]#?3
M+Z_EIYKSN.)V..VNUQVB)C)>)M6<UXG72N.T?@X]MLD=_2M*]]+!= ET
M        V$\6/&;M#R_[VZ_\?^HL5^(;;O>8AM)<A<T3<834M>@KHEV+=MGN
M8:))+/6]6Q7$EU=544USR\4<06\<US+##)K[U2]2_&/2'P7D//\ R[+[OB=C
MAFT4C3WF?+,:8=MAK,Q%LV>^E*1,Q6NLWR6ICI>]>B\E\BXWQ7A<_.<I;MVN
M&FND??7M^LQTCY;WMI6/DCVVF*Q,QT]/%'QAZR\.NA=!\?>I;*:'5-&QM4,N
M5R$=CQGMKSU[+5=Y[;MFN<?:V5O>Y[/9"2J66NF.FB.CY(8Z:(8HZ*?,CZK>
MIWDWK#YYO_4#RR\3RN^R:Q2DV]U@Q5CMQ8,,7M::XL5(BM8F9F9[KVF;VM,U
MT>3>1\CY7S>?G>4F)W.:WWL:]M*QTK2D3,S%:QTCKUZS.LS,MBFNW0@
M
M
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MZ1IAO,QV1&L4MK3Z-9QPLCJX4?P
M
M
M
M
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M,16.Z-)O:$WJ$K3H
M
M
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MGLR4UTUTB+UTO&D]U:2NHJ-9
M
M
M
M
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MR3I=54N(A@
M
M
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MYWP,9<TUKSNWB*[C''3KU[<M8_M,D1KI^MOW4ZQ6+6BI2H;+
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M'Q+D_"^<R\+R<3/;.N/)$3%<N.?O<E?;[?9:-9[+1-9F9AMTU(Q8
M
M
M
M
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M ^"KQ^&8R<CETON,L:_3R:>RNOLQTUFM(TCIK:8[K61UI#L\
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MO+>;7O:9FUK3.LS,SUF9EZ1UKC@
M
M
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MBY#!?MO6?DZ1,3$QTFMJS%JVCI:LQ:)TEE1BSK
M
M
M
M
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MNM[:1W7FTZ1$Q6-TFF&(@
M
M
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MK:)F)B8F)T3QQY*9:5RXK1;%:(F)B=8F)ZQ,3'28F.L3'M?QOL_0
M   ";#V</==S?M_]H2Z)VGDMDSWBCV1>4T;?KUE55DJNL]JNIK&"W[8UG#\V
M]S>7'T]G;\VV:Q]C7#)D;*JF;BBYNK*T@KA7\8GPJ;+U^\8CG?%L>VV_JKQM
M/\7RV^A]<P5BTSL<V36*QK:>_;Y<D6C#DB:3./%FRWKJ#U8],L/G'&_7>-KC
MIY-MX^A:>GOJ1KKAO;6(C69UQVMK%;=-:UO:8Z'6O;!A-LP&#VK6LI9YO7-F
MP^,V#7\UCIJ;C'Y?"9FR@R.*REC<4?L9[._L+F.6*OC\E5%?'/\ RO/9R''[
MWB=_GXKDL5\'([;-?%EQWC2^/)CM-+TM'R6I:)K:/DF)A!'/@S;7/?;;BLTW
M&.\UM6>DUM6=+1,?/$Q,2^PX;Y
M
M
M
M
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M@SZR>H]O+^6_(_%9)_1S9WF(F)Z9\L=)RSI::VI&DQAG3[V;6_7Z1/.@@TH
M
M
M
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MZ:Y*_1U[JTK-ZE1FAB
M
M
M
M
M                  K*>^_[NE'CYKF;\-?'/8(9.\=VP,EMVSOV!S5Q!D.E
M-6R\5',.OX>ZP]S#<8_L[:L?)S)S75-'+AL7)1-Q'S->6TUO9A\"GPD6]0.1
MP>L?J+MYCPC99XG8;7+CB:<CGQS.N7)7)$Q?98+QII%9KN,T32;13#EIDD1Z
M+>EL\[N*>6<_CG\C8;ZX,=JQ,;B]?UUHM&DX:3T]DQDO$QKI2T6HT+PTR@
M          %L7[>WVKHMURFN^?W?6#]35M9S$MYXU:AD[:TGM]BVK Y*:SD[
M@R%'-W++!9Z5G<=-#@X9K>B27*P_B%%5%-I:U7%4?V@GQ36X7:[CT"\#SZ<I
MN<,5YC<4FT3AP9:1:./I/;$3;<XKUMN;5O,1@M]7M$SERQCC'ZZ>I4[/'D\'
MX2_^,Y*:;N\3.M:6C7W$=/;DK,3DF)TBD^[G6;6BMSU30B2
M
M
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M[_S'Q?!_;6W>&G_3[_'2(_5G-$3\V2*_MEEP%4*BL
M
M
M
M
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M.LS/69ZR^DXSY@
M
M
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M@
M
M
M
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MV7#\?AXOC<=<6QP4BE*UB(B(C]3VS,ZS:?;:TS:=9F6/60.<
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MO-]WFM_8I6.E:5CV16D=(^?VSK:9F<_,!=&
M
M
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MCO,Z8[3UB8]W>>[LM>P*@"T:
M
M
M
M
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MU&MKT
M
M
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M:EK3-NA0T^
M
M
M
M
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M]]+36?H[G)6?O^D=<=)_:XUFMICWG]IVV$5?;18
M
M
M                                                     "L1[\GM
M%U]^8'/>:7CAKTUQW=IV!L^.V.LM;PMO)>=Q:MB9O3JW'"08ZVCOLCV=J>)F
M_P!XBDYGES.&LHX+?X7=I;V][9M\"/Q;1X%O\'HQZC;B*^$[S/;ZCO<V28KQ
M^?)&OU?)-YFM-EGR1]"T=M=ON,EKY/P.7)DP2+]%?5*.$ST\1\@R1'#Y;S[G
M->TZ8+V_[.TS.D8;V]DQI&/):9M]&UK4HZ+O4QP            'O.K^T.P>
MENP=3[5ZJVS,:-V'HV8M\]JNU8&XXM\EB<E;\5T?-3\]$MO=V=W;RR6]U:W$
M<MK>6LLD$\<D,DD=71>3^,>/^:>/[OQ7RK:8=]X]OL,XL^#+&M,E)Z_)I-;5
MF(M2]9K?'>M<F.U;UK:.%R/';'E]CEXSD\5,VPS4FMZ6C6+1/_IB8G28F)B:
MS$6K,3$2Z'/M,^[-U][A_7W&J;7SA]&\IM&P\,_8/7T$W-OC=NQMOS#:R=D=
M;QW4TMS=ZW=W,M'%_8<URW6$NI:8I:I()+6ZN?/9\6'PG^0?#UY!^5>*]]OO
M2[?9IC:;N8UOM[SK:-GO)K$17-6(GW672M-S2LWI%<E<N+'!'U/],-]X)OOK
M6U[\WC>:_P""R^V:3/7W673I%XC[VW2,D1K&EHM6LQJ'C5
M
M
M
M
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M?$4@
M
M
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M=:V
M
M
M
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M9F>LS/690AM:U[3:TS-IG69GVS/SR_9^'\
M
M
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M6L?J1>([Z?KJTE*1=:V
M
M
M
M
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MELN^SWF][V]MK3.LS\T?<B(B(C2(B(B(>V=(X8
M
M
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MS6GW&?3V_+[O)ITKEK'ZD7B.^GZZM)2D76M@
M
M
M
M
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MF;3:TY^8"Z,
M
M
M                               !A/R+\>^K_*CIC>^A^X\%^/:#V!AZ
M\7DXH:X8,IBKN.2BZQ&QZ]?36]U1C=DUS*P0WMA<<Q24Q7,-/-=$D?S1U9KZ
M=^H/E'I;YEL/._#L_N.>X_-%Z3.LTO68[<F'+6)K-\.:DVQY::Q-J6G2U;:6
MCN. YWDO&N7P<UQ-^S?8+ZQ\UH]EJ6C6-:7C6MHUC6)G28G27-E]QGV_.T/;
MM[[N>I]XN/SGTS8K.XV;J3LZRL9K/$[[IW%]+9_--%S5-#B-PP$U-,&9Q7K2
MR6<LD4M%4EI=6EQ/Z0OAU]?_ !CXA_ Z^5\)7ZKS.WO&'?[*UHMDVNX[8MTG
MI.3;Y8UMM\_;6,D1>DQ7+BS8Z6!^ ^<\;YYPD<GLX]WN\<Q3/AF=;8\FFO\
M[6.WMQWTB+1$Q.EJWK70-OQFX            #)'4G<':'0W8.N]J]-[WLG7
M'8>J7G%[@MJU;)38[)6M7/'R7-G<?)SS;Y/#Y.WYJM[VPNHYK*_M9*X+B*6&
M2N.K'/+?$/&///']QXKYCL=MR/CV[IVY<&>D7I;Y8M&O6F2DZ6QY:37)BO%<
MF.];UK:.!RG%<;S>QR<9RV''N-AEC2U+QK$_-,?+%HGK6T3%JS$6K,3$2Z%O
MM,^[-U][A_7W&J;7SA]&\IM&P\,_8/7T$W-OC=NQMOS#:R=D=;QW4TMS=ZW=
MW,M'%_8<URW6$NI:8I:I()+6ZN?/E\6'PG^0?#UY!^5>*]]OO2[?9IC:;N8U
MOM[SK:-GO)K$17-6(GW672M-S2LWI%<E<N+'!/U/],-]X)OOK6U[\WC>:_X+
M+[9I,]?=9=.D7B/O;=(R1&L:6BU:S&H>-4
M
M
M
M
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MM;YJQ6M=WFDF'
M
M
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MRF:(]G7Z-<D1V7Z:]MK11-6A:U"
M
M
M
M
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M?$>![&N32F?R&]-,NXT^?29QXM>M<<3$?-:\QW6TZ5K%&E6V8
M  ]YU?U?V#W3V#J?5756IYC>>P]YS%O@=5U7 V_%QDLMDKCBNOY:?GKBM[2S
MM+>*2XNKJXDBM;.UBDGGDCACDDIZ+R?R?Q_POQ_=^5>5;O#L?'MCAG+GSY9T
MICI'3Y-9M:TS%:4K%KY+VKCQUM>U:SPN1Y'8\1L<O)\GEIAV&&DVO>TZ16(_
M],S,Z1$1$S:9BM8F9B'2!]KKVQ.L_;CZDFQEI<6>Z]\;]9XVX[B[3I@EHAO[
MFTXKGM=-TJ"ZHCN<5H>O7-Q)Z7-=$=WE+CXW=UQ1_N]K9^<CXG_B:\E^(SRV
M-UEK?9>";"]XX_8ZQK6MM(MN-S-9F+[K+$1W:3./!33%BF?PF7- 'U']1>1\
M_P"4C):)P\+@F8P8?FB?;DR3'2V2T1&OMK2/HUU^E:\HJ,#7
M
M
M
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MG6V3;]WLKDZ?2QZ]*9-9GV5R:6[;7GY0':0
M
M
M
M
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M3CC? >-[:]N;G,U8]_GT]OR^[QZ]:XJS^I-YCOO^MK2+5*)L@
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M:]=(F-8G3'6VLUKUTK:]HB;%"MJ
M
M
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M]>ZL^V^&/9,S]+'&DVFU>ZU;+*MA'L
M
M
M
M
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M\!XGP+B8V>SB,G(Y(B<^>8TMDM'R1[>W'76>RFO3K,S-IM:8\4A6=@
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M;Q_@IFOC6*\3:^FEMQ>L]+=>M<59ZTKTFT_3OU[:TL+J^&B0
M
M
M
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MQ%JS$3[XSDMES''X>4XW)7+L<](O2U9B8F)_4]DQ.L6CVUM$UG28ECUD#G
M           /VM[BXL[B"[M)YK6ZM9HKBVN;>6N"XM[B"NF6&>":*JF2&:&2
MGBJFJGGBJFKCCGCGXOQDQX\V.V++6+8K1,6K,1,3$QI,3$])B8Z3$])A_+5K
M>LUM$368TF)]DQ\TK@_LX^^]C^<?I?B=YP[1>492B\QNJ=3^1>=NH),?/CY(
M);?%:OW9F+Z[BN+2\M+B*"SLMDJIGHN*)Z/Q6J#F"7(7%0?QA_ IN/K&]]5_
M1#:TG:S2^??<1BK,7B\3$WS\;CK68M6T3;)DV<=LTFL_58O%Z;?'%7U8]%K]
M^;R?P[''N])OFVM8ZQ/MM?;UB-)B8UM;%TTTGW6NL8ZV]51:+
M
M
M
M
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M]8/5W\OSD\6\9O\ _)(G3-FC_P"Z)B?O*3\F&)CK;_M9CI^#_;+.*LQ'8
M
M
M
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MVB=)K:)TF)B8TF)ZQ/27TG&?,
M
M
M
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MCI6L3S\4\4X?PWAZ</P].W%7K>\Z=^6^G7)DGY;3_P!%8TK6(K$0U7;29*
M            ND^Q=[-&6ZLN]6\V/*[7/H-_DLZ,MT9TUL&*MI+O1H+V*B6Q
M[-WJQR5M+-C=\JAJXDPN/XXBN,)35Q<W'/%_5'#84Q?')\9&T\IQ;KT5]*=S
M[S@(O./D^0Q7M%=S-9TMLMK:EHB^UUZ;G+]*FYF/=8]<$6OGB-ZS>K.+DJY?
M#_&<G=L=>W<9ZVG3)I[<..8GKC^3);K&3[VOT-9O:Y54HS
M
M
M
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M28^:8^2:S'6MHF:VB8M69B8EDACCKP
M
M
M
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ML^3)DC[_ *UK/9K-[:*IU&
M
M
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ML3NX[D=CR^QQ<GQF6F;89J1:EZSK%HG_ -,3$ZQ,3$368FMHB8F'@W>N:
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MK6T3#:AJQC0
M
M
M
M                                     " #W=?>OTWPDM\]T#T/5C=[
M\JLC@:Z;O(?-9Y/4>B:\G1:U8[)[?:U\2P9O=IL9<UW>/PG/',</PAN<C3]-
M)#;7D^_A(^"OF?6O)@\^\[]YL?2S'GCMI]*FXY.*3;OIM[1I./;1>(QY=S[;
M?3Q[>?>5ODP[P]+?2#=^86ISG-=V'QJM^D=8ON=-=8I/ZW'K';;)[9ZUQ_2B
M;4H3;QO.Y=F;=L&_=A;3GMUW;:\E/F-DVK9\I>9K/9O)W//'K7N2R=_+/=74
MW--/%/'-57/%-%/%-/PIXXXXODX3@^&\:XG;\#X]M<&RX7:8XQX<&&E<>+'2
M/96E*Q%:Q\O2.LS,SK,S*;.SV6TX[:X]CL,=,.SQ5BM*4B*UK$?)$1TAY5VC
MD@             +=_L3>S9DY<GI_G)Y7:I#;8FVAM]B\>.HMFQG$MYD[R7B
M.XPW<FX8N^IYCLL;91\_4:U9S153W,]4>4Y]&*&RJNJCOCH^,;;5VV\]#_2G
M=S;=VF</+;_#?2M*QK&3C]O>O6U[3]'>9*VBM*Q;:_3M?/&*+7K1ZLXXQY?#
M?&<LSEF9KNL])Z1'LM@QS'MF?9EM$Z1&N/K,W[;B:GU%(
M
M
M
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M;&/)I&O;,S%HUFDVTM%9148&N
M
M
M
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MK6>_6:7,5-R)8
M
M
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M1K'2W69R8XUZ9(C6M8GWL:5]Y:PZKV:(
M
M
M
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M''TW?&O\:_Y7^M^CGHYN_P#Y1]+#R?)X;?\ B/;7)L]GDK/_ (?VUW&XK/\
MC'7%BGZOWWW$3/6#U@^M>]\3\3R_XKUIN-Q2?O\ Y+8L5H_6?)DR1]_UK6>S
M6;VT53J,
M
M
M                                                 "-GW&_;&Z%]
MQ/KN7'[M80ZGW1K6!O\ '=4=V8JWEJSVHW$US1D8,3GK*"YM+?<M)N<A'5Z^
M.O.:JK>BYN)+&6TN9JI^9(_#I\37GGP\>0QN.%R3N_#-SGK??<;>8]UN(B.R
M<F*TQ:=ON8I,=N;'I%YICKGKFQ4BC8/@/J+S?@6_C)L[3EXC)>)S;>T_1O&F
MG=69B9QY(CV7K[=*Q>+5B(<Z'R;\9.X_$+N/:>C.\]6FUC=]8FXDHKCYDN<#
MM&!N9)J<1N&GY>J&"/.ZKG8X*JK:YIIHKIKHD@GCANH9X(O1)Z9^IGAWJ[X=
MM?./!]U&ZX3=1I,3I7+ARUB/>;?<8]9G%GQ3,1>DS,3$UO2U\5Z7M/;QWR+B
M?*>)Q<SPV6,FSR1^I:EH^^I>O7MO77K'ZEJS-9K:< L^=V
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M(F$2<N++M\ML&>MJ9Z6FMJVB8M6T3I-;1.DQ,3&DQ/6)Z2^DXSY@
M
M
M
M
M          ,#^2?DOTQXD]1[%W;WON-GIFB:[Z-OS<245W>6SV;O>)?PK5]6
MPUOQ5?9_9,O7#7Z-K!3SS3%')/+5';PS31YWZ;^FOF7JSY;M_"O!-G?><[N-
M9TB8KCQ8ZZ=^;/DGZ.+#CUCNO:>LS6E8MDO2ENZ\?\>Y?RCE,?#\+BG-O<G7
M3V5K6/OKWM/2M*_+,_+,1&MIB)Y^ON?>[]W7[A>R3ZGB:LQU3XT82\NH]<ZE
MQV8N*)=RHM\Q3?XG;>W*K&X^@V+9**+*TEM[#XSXS#31?[KZDW,UW/?W\,?P
MB>%?#YQM>6W<8>5]2L]*SFW]\<3&WUQ]N3!L.Z.[#AGNR5OE^CFW%;?A>VD4
MPXYR>G/I7P_@FWC=9>S=>0WB._/-8_!ZUTM3!K&M*=;1-NE\D3]+2-*UA_2]
M;4               7,?9)]DG\S_ ,T?,GS)U'_TP_W'9.C>C=DL?_F/_P"9
M=XCLKLK$7='_ ,V'_,GPV&GH_P"I_P!C=7=/XAZ,./IN^-?XU_RO];]'/1S=
M_P#RCZ6'D^3PV_\ $>VN39[/)6?_  _MKN-Q6?\ &.N+%/U?OON(F>L'K!]:
M][XGXGE_Q7K3<;BD_?\ R6Q8K1^L^3)DC[_K6L]FLWMHJG48
M
M
M
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M<WAMAW=)_5K>/DM2T=+UF/ECV>R=+1,1GY@+HP
M
M
M
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M^$\9^3>&QS'=,3DR6ZY,MHC3NO;2/9U[:Q$5KK.D1,VF=.6X65@
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M9\5RS7AZSIFSTG2<\Q^LQS'6,,3[;1^V_)^#_;+/JL9',
M
M
M
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MUM,>XK'3K[*Y:ZS.._S:_0M^LM:8M%95T5VM
M
M
M
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MY)U]DUP_)%.DWB9G)&DQ2MC574T&
M
M
M
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MF)B8F)TF)B>L3$])B>L2C9:MJ6FMHF+1.DQ/MB?FE^S\/X
M
M
M
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M)'MBD3UQXY]G2]X[](I.J@RTP
M
M
M
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M2[U>V/F&+'PO-6KA\IBLQ[(K3<16(^E3Y(R3&LVQ?<FU/HZUI :GJW:
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MLUB8F(A;SOC_ #'C7(7XSF\%\&[I/LM'2T?VU+1]&]9^2U9F/[+.3!W3
M
M
M
M
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M$_4?U0Y;SW=?5XB=OX_BO,XL,3UM\D9,TZS%LFGLB/H8XF8KK/=>\MZ);5P
M
M
M
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MU/;28T^_C7';I]*+6[(F'0_:I
M
M
M
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M8<%9F:8XGVSUT[KVT^E>8UGI$1%8K6) F@&#
M
M
M
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M):LS$_)*8>#/@W6&NXVUZ9-O>-:VK,6K:)]DQ:-8F/NQ+X[EOJ
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MF)>D=:XX
M
M
M
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MC2M:ZQCQTCV4QUF9[:Q[>LS:9F;6M:TS,[1-7L;
M
M
M
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MY\>LXK]>D3.GT+_W%])^;NCJD)1]8*
M
M
M
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MW7O.LSI&D1\D1$1&D5B(B(Z1$0R<QEUP
M
M
M
M                             #1OSJ]OCQY]P'K.31NYM?\ I=GQ%G?4
M]==K8&&UBWSK?)7TME<SSX2]GCDAOL/D9L=#1D,9=4UVMY#Q^3TIZ8;B+>'H
M9\0/J%Z ^2QSGANX[N,S7K];V.6;3M=Y2L6B(R5B8FN2D7M.+-28OCM_;8YO
MCOF7AGG7/>#\C]=XG)KMKS'O<-M?=Y8C6(BT1[+1K/;>-)K/SUUK//1\]_;O
M\@?;V[0JT?M["_B.F9^\RM?5G;>%BIJT[LO!8Z:/BJZL_DN;R;7=DLH;B+\1
MPM[53>64E?%=/-Q:2VUW<>@WT&^(7T_^(+QB.;\1S>[YG;TI]>V&2?\ &-GE
MO$_1MK%8S8;3%O<[G'$X\D1,3[O+7)AQSL\)\\X+SKC?KG%7[=W2*^^P6_;,
M5I^2>D=U)TGMR5^C:.D]MHM2NA[>S-                'JM'WG<NL]NU_?
MNO=ISVE;MJF2@S&M[5K&4O,+GL)D[;GGT;W&Y.PE@NK6;BFKFGGFFKCBJBKF
MFKXT\\\<]7S?!\-Y+Q.XX'R':X-[PN[QSCS8,U*Y,62D^VMZ6B:VCY>L=)B)
MC28B7&WFRVG([7)L=_CIFV>6LUO2\1:MHGY)B>DKB?MI?<8:SM<6L=)^?7-G
MI^T?]58#7_)/%6M<6G;!)Q:464,G<.$MJ9*]-S%Y?04<S9W'T58222\YKNK7
M$VUM)<RT^?$I]G9R?%6W7FOH)W[SB_IY<O#WMKN,4=TVF./R3I]8QUK,]NUR
MS&YB,<5Q9=WER5Q5BEZA>@FXVTY.8\(UR[;K:VTM/X2O77\!:?VRL1[,=OPD
M172MLMK16+6>&S.'V/#XK8=>RN-SN SN-L<S@\YAKZURF'S.'REK%?8S*XK)
MV,L]ED<;D;*>B:">&NN*:*NFNBKFGGCE59O-GO..WF7C^0Q9,&_P9+8\N+)6
MU,F/)2TUO2]+1%J7I:)K:MHBU;1,3$3",^7%EV^6V#/6U,]+36U;1,6K:)TF
MMHG28F)C28GK$])?2<9\P
M
M
M
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MUF>LOI.,^8
M
M
M
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M:6_N;Q6?EC6.J0)H!@P
M
M
M
M             # /DCY1]"^(W6U]VOY"=D8'KG3K6:FRLI<G++<YG9,Q+35)
M!@-0UO'QW6?VO/3145R_2V%O/+%;1RW$O%%O#++1GWIQZ7^>>K?DE/%/3[C<
M_(\Q:.ZT4B(QX<<=)R[C->:XL&*)TKWY;UK-YKCKW9+TK;O/'_&^;\IY"O&<
M%M[[C=S&LZ=*TK_;7O.E:5^3NM,1,S%8UM,1-%OW(O?:\@?,W\<ZPZ;_ !CQ
M^\<[ST[:? XO)<1=F;];1>IQ+SOFVXF:CZ'#W_S?L\)C:Z;3FC]KNI[[CX<\
M7D_#C\"WI_Z-^X\G\Q]SY!ZBTUF,MZ:[/:S.FGU7!DCZ62OR;G-$Y-?I8J8)
MUB9F^G_HOP?B79R/+=F^Y^.L6F/P.*?_ '=+>VT?]Y>.[Y:Q1 ^G8W2
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MLON(]DUIK'=CQ3UUGI?)$Z6[*]U;6<59B.H
M
M
M
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M,Q,3$Q.B5&/)3+2N7%:+8K1$Q,3K$Q/6)B8Z3$QUB8]K^-]GZ
M     >JT?>=RZSV[7]^Z]VG/:5NVJ9*#,:WM6L92\PN>PF3MN>?1O<;D["6"
MZM9N*:N:>>::N.*J*N::OC3SSQSU?-\'PWDO$[C@?(=K@WO"[O'./-@S4KDQ
M9*3[:WI:)K:/EZQTF(F-)B)<;>;+:<CM<FQW^.F;9Y:S6]+Q%JVB?DF)Z2MQ
M^W3]R):3_FSU!Y_V'T5<=G3B['R:U;&RSPW-W#\/I)>U]$PUE5-:_50TU1R9
MC!12T_4>EZN-CBJGO(JE/B)^SBRT^L^7>@63OB;]]N&SWB)BL_?1L=UDMI;M
MG28V^YM6>SN[-S:T8\-XN^>_#_:/><KX/;6->Z=I>=-(^7W.2T]=/;%,DQTU
MTR3,5I-M'3]RU#L+6<-NN@[5K>\:;L=G3D=>VW3\YB]EUG.X^NNN.B^PV>PM
MU>XK*6=<D=5/$L$M='/-//'Q^/'*IWE^&Y?Q_D\W"\]M=SL>8V]^S+@W&*^'
M-BO'7MR8LE:WI;28GMM6)Z^Q&#=;3=;'<7V>^Q9,.[QSI:EZS2]9^:U;1%HG
M[DQ#TCK7'
M
M
M
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M6(F*_>8_96)MK>TO:(K5@
M
M
M
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M*6-%%K$
M
M
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MS,-NFI&+
M
M
M
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MNQV^]O29B8BU9F-8F-=8F&>&".E
M
M
M
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MQ$1$2[X+Q_A_&N/IQG"8*8-I2/96.MI_MKVGZ5[3\MK3,_V&#6<.Y
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MV#IW$
M
M
M
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MM%L5HB:VB8F)B8UB8F.DQ,=8F.DPDQ6U;UBU9B:S&L3'LF/GA^+]OZ
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M)B8F)C5'K)COBO;%EK-<M9F)B8TF)CI,3$]8F)Z3$^Q_8^+\
M
M
M
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MB/EQ8_DZ:9+Q'TIK6;4FR^K51Y
M
M
M
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MTC=<-$_M^*+36L:Q$>]KIKBUF8C6=:3,Q$7F>B6-%%K$
M
M
M
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MO[>ZXRDZX]O2?P=.D=;3I$Y+SIKW7]DS/9%8G1) CBP
M
M
M
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M/-J4X_=]NS\CTTG#,ZTRS$3,VPVGV](F9QV^G7K$3>([YA531;=
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M%0
M
M
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M[O\ )R?+YK[C?Y9CNO>=9G2-(CY(B(B-(K$1$1TB(ADYC+K@
M
M
M
M
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M:)B);['?;+D]I3?\=EQY]EDC6EZ6BU;1KITM&L3I,3$_-,3$]8>/=NY0
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MX[?):47N8X/F/']Y.PYK;9=MNX_6WK,:Q\]9]EJ_-:LS6?DEF!B#J@
M
M
M
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M)OM>&F9K?-[,V>NLQT^7%CM'72-,EHZ6FL3:DV4U;:/@
M
M
M
M
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M%TA-GP;U-\<\ZPQ397]QR\1,VVV28]Y&GMM2>D9*?=KUB/OJU1CI,MB
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M,
M
M
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M:?EO:9M.L]8KI$;R-'L-
M
M
M
M                                            ?'V#7L!MF$RFM;5@
M\/LVN9NSFQV:U_8,999G"9?'W%/R7%CE,5D8+FPO[.>G\E<4L==%7'^WCES.
M/Y#?\3O<7)<5GS;;D<%XOCRXKVQY,=X]EJ7I,6I:/DM68F/DE]<&?/M<U=QM
MKWQ[BDZUM69K:LQ[)BT:3$_=B533W)?MR,9E:-@[C\ /1P^3HAR&8SGC=G<E
MSQC,M=5W%5S)1U+LV4GICP<W,==7$>&RDWT?//'%-O=V]/$=MS:_\-_VBVYV
MMMOX=Z^ZYMM-J8\7,8J?3QUT[8^OX:1KEC6(UW&"OO/ER8LD]V2)/>G_ *^Y
M,4X^)\XUOCUBM=W6.M8TT_#TC[[[N2D=W]M6W6RH5O&C;EUGMVP:#V%JV>TK
M=M4R4^'V35=GQ=YA<]A,G;<\>M99+&7\4%U:S<4U<5<<54\<545<54_&GGCG
MFW3A.<X;R7B=OSWCVZP;WA=WCC)ASX;UR8LE)]EJ7K,UM'R=)Z3$Q.DQ,)3;
M/>[3D=KCWVPR4S;/+6+4O28M6T3\L3'27E7:.2                   VN\
M4O-[R?\ "C;I]N\<NU\]HM63FLY-GU:KZ?-Z%N<5EZE$,.VZ3F8KW7LO-#;7
M$T-O><P49&QHN)>;2XMZZ^:VJO57T2],?6KB:\1ZB\5@WT8HM&'/UQ[K;S;3
M6<&YQS7+CB;16UL?=.'+-*^^QY*QHQGR;P[QSR_:QM>?VM,W;$]E^M<N/7^T
MR5TM7K$3-=>RTQ'=6T1HMT^#GW)O17;]Q@>O_,75(?'G?LA-9XV/LW7*LAG.
MC,OD+FNB"B?+QW<M[N'5L-Q>7%$='UE6;Q=M%17<7N4M8N.>*:D?7#[-[SGQ
M#'GY_P!']W/D/ 8XM>=EF[,7)XZ1$SICFL5V^]F*Q,S[N-MFO::X\.URVGK%
MOS+X?>:XJM]]XIEG?[&L3/N;Z5W%8CY*Z:8\VD1K]'W=YG2M,5I64]?V' ;9
MA,7LNJYS#[-KF;LX<CA=@U_)V69PF7Q]Q3\]O?8O*XZ>YL+^SGI_+1+%)715
MQ_LYY5M\AQ^_XG>Y>-Y7!FVW(X+S3)BRTMCR8[Q[:WI>(M2T?+6T1,?+"/F?
M!GVN:VWW-+X]Q2=+5M$UM68]L36=)B?N3#[#AOD
M
M
M
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M;7M:>LVM:TS-IGY9F9F7WG ?
M
M
M
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MOCW%)TM6T36U9CVQ-9TF)^Y,/L.&^0
M
M
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MS;ZMPD3]';8YGM]NL3EMTG->-(ZVB*1,:TQTF9UE11::U
M
M
M
M
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M;3=;'<7V>^Q9,.[QSI:EZS2]9^:U;1%HG[DQ#TCK7'
M
M
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M,^]R3K:][3:T_P!F?9$?)$:1$=(B(>\="X0
M
M
M
M
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MU)]D_(]LZ1PP
M
M
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M._$_"Z1/#;:)WVFDY\FE\]ODGZ<Q$4B8]M<5:4GVS77JT#;\9N
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MK7'6==9745&L@
M
M
M
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MTS4T^E7[W)CGV:9,<Z6KU]DS';;VUFU9B9U=;/9&
M SQX^>3_ ) ^*>[1]A>/';.X=5;3_NU%]<:WD*?PG8+:TDKFML;MVKY&*^U;
M<\/!/)S)399:RO;3B7X5^G\W''/&">H'ICZ?^JG"SX]ZA<3L^5XOKVQFI^$Q
M6M$1:^WSTFN?;Y)B-)R8,F/)V].[29ATO.^.<'Y-L_J'/;7%N=MUTB\?2K,^
MV:7C2^.VG3NI:MM.FNBT?X>?<]42UVNJ^<'4L-K3Q##;P=M=&V-Q5177!;T1
M<3;7UMG\U<2>M>21\RW%YB<CQ'Q)7\L6-HH^'RU?>L'V9%J5OROHCRTVG69G
M8<G:-=)G73!O,6.(TK$]M<>?%KI&M]S:WMC?Y7\.DQ$[GP[=3/77W&XF/G_6
M9:UCV>R*WKKI[<DRM!^/GD_X^^5FDQ]A>/';.G]JZM_NU%]<:WD*OQ;7[F[C
MDFML=MVKY&*QVG3,Q/!'S)399:RLKOF+X5^G\O/'/-8?J!Z8^H'I7S4^/>H7
M$[SBN4Z]L9J?@\M:S$6OM\])M@W&.)G2<F#)DQ]W3NUB81QYWQSG/&=Y]0Y[
M:Y=MN>ND7CZ-HCVS2\:TR5UZ=U+6KKTUU9X8(Z4
M
M
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M?EF9ZR]4ZIQ@
M
M
M
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MWIN]GDIEVN2L6I>EHM2U9ZQ:MJS,6B?DF)F)?!<Y]@
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MI>NSUTC-33)AGKI'TZZ]DV_6UR12\_)5OBT2PH
M
M
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M+%=E6?H8,>M<5?N]NLS>W]U>;3\D:1T2!- ,&
M
M
M
M
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MQ/6)B>DQ/L?V/B_
M
M
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MB1?">/<'XWM?J7!;7#M=O,ZS%*Z3:?DF]NMKS'LB;S,Q'371@UG#N0
M              &>/'7QD[V\L.Q<?U9X_P#6NR=D;?>>C->0X6RKYQ.MXN6Z
M@LJMAW#8)_2PNHZW;W5S'')?Y">WMN)9*(^*N9*Z**L$]1/4SP7TH\=R>4^?
M\EMN-XBFL5G):/>9KQ6;>ZV^*-<F?--8F8Q8JWOI$VTBM;3'2\]Y%POC&PMR
M7.;C'M]K'L[I^E>=->W'7[Z]YB)F*UB9TB9TTB97/?;X^W7Z)Z'BU_LSR^N,
M/Y$=MP^CDJ.N:["B;HG4+B2TCIJQE_A<I#)<]KWEG<<R557&3BM<5)3731^&
M551<7$M-'Q _:'^=>=VW'C7I%7-X]XG.M/K<7F.3W$1:?ITR4F(V-;1I$4PS
M?/&DV^LQ%YQUB3YUZ\\US4Y..\5B^PXN>GO=?\9O&OMBT=,,3&G2DS>/;[SK
MVQ9'M[>WL[>"TM((;6UM88K>VMK>*B"WM[>"BF*&""&*FF.&&&.GBFFFGCBF
MFGCCCCCX*X<F3)FR6RY;3;+:9FUIF9F9F=9F9GK,S/69GK,H_6M:]IM:9FTS
MK,S[9GYY?L_#^
M
M
M
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M !?S7;^\X7<1]9B/I8,FE,U/EZTUGNCK]_CF]->G=K$Q&BK>;,P
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M9X8(Z4
M
M
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MU]C>^UVFUV.WIL]CBQX=ICC2M*5BE*Q\U:UB*Q'W(B'FW8N0
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MQ76911YOG^9\DWUN2YS<9-SO+?KK::1'S5K$12E?[FE:U^XS8PITX
M
M
M
M
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M,3TF)ZQ+5-JVI::VB8M$Z3$^V)^:7[/P_@
M
M
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MI&^+^D'A'B_;FQ;;ZWOZZ_A=SIDMU_M::1BKI\DQC[]/;:42Z6+9X
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MB>V(?^9^I7E'F]YQ\GF]WQ??K7;X_HXXT^][OER6C^VO,Z3UK%?8DA1Q8
M
M
M
M
M                                                   P_P!W>/\
MTIY(Z3=]==[]8Z?VEIMY\]?X/MN(M\A]!<R1\Q?B.#R'PCRNO9B./GX1WMA/
M;7<7_D24LO\ "?/_ #7TXYJGD7@O)[SB^8II^$P9)IW1$Z]F6G6F7',^W'EK
M?';Y:R[7A^<YCQ_>1O\ A=SEVV[C]=2TQK'S6CV6K\];1-9^6%4#SO\ MG\]
M8W&4[!\ ]KASF,YAEN[CQ^[0ST-CGH+CBN:OZ7KKLW)<P8;)PS\2Q1PV.R5X
M^JVHADDDR]S5)1#1:SZ%?:5[#/CQ>/\ KWM)P;G6*QRNRQ3;%,:1]+=[*FN2
MDQI:;9=G&6+S:M:[3'%9O:3?A7Q#8+UKL?-\4TR:Z1N<-=:Z?/EPQK:-.LS;
M%W:ZQ$8JZ3,U6.S.KNQ>F=VSO7':VE;)U]O6M7DMCF]7VO%76'RUC-%)7'Q7
MS;W4='U%G<?)S5!<1<UV]Q%SQ)%771535S:=XUY1X[YEPN#R/Q7>[;D.#W-(
MMCSX+UR8[1,:Z:UF=+1KI:EM+TG6MJQ:)A)7CN2V'+;.G(<9FQY]EDC6MZ6B
MU9_LQ[)CY8G28GI,1+P;O7-                        ;I>+_ +AWF5X=
M7&,BZ$[YW;5M5QN2FR?/6F2R'.T=5WTU[7S5EN+KKS8^,EK$$V9HJYIN+NUM
M[:_^/RR1SQS1Q24:8]3_ (>O1SUAQY;>><#LMURN3'%/KE*>XWU8K'X/MW>'
MLS3&.>M*7O?%[:VQVI:U;8CY'X'XGY76T\WLL.3<VKI[V([,T:?>Z9::7GM^
M2MIFOR368F8FR/XL_=$82Z_"]<\QNAKS$S<_36USVCT5=4Y+'U2R?1VO-WE^
ML-LO[:^L+."OUKJZN+'.WTO-'/$<%A553QQ77#ZI?9@[W%[WD?1[GJ9:=;5V
M7)U[+Z1W6[<>]P5FM[3]&E*9=MBKK]*^XB)^C'_R7X<,U>[<>)[V+1UF,.YC
M2?EG2N:D3$S[(B+8ZQ\MK]>EC7QI\Z_$CR]Q\-UX^=[:'OV5JL_KKO2XLK3A
M>Q<5;406TT\^6Z\S].,W&RL[;FZICJNJK+Z2J6FNBB6KFBKX5U>I7H9ZM>D6
MXG%Z@<%O]AM8OVUW,T]YM+SK,1&/=XN_;VM/;,Q2,GO(K,3-8B8UT'Y#X7Y1
MXK>:\[LL^#%KI&3M[L5IUG2*Y:ZXYF=-=.[NTTF8C5MHU,Q<
M
M
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MS3>G7D,]-?4R\6\4UM98^3F2FNFCUV^T ]5/5#WG">"]_BWB$]U9C;Y9MO\
M<5GIKFW<12<59B-8Q;6N.:]]Z9,VXKVS$2?-?7/R;R3NV?"Z\;Q4ZQ^#M,Y[
MQ[/IY8B.V/E[<<5TUF+7R1II/R@.T@
M
M
M
M
M                           UI\E_#SQK\P-1YTSR)ZDU7L?'PPSQ8C*Y
M"TKL=NUBN?CGFNXU3<L5)8[/KDU5?PJKXM+J*.;X<4RTR4?&GG97IKZP>I/I
M!RWY9]/.6W7';BTQ.3'2W=@S1'LC/M[Q;#FC3I'O*6FOMI-9ZLA\>\K\A\5W
M7UO@=UEV^29^E6)UI?3Y+X[:TO\ ^U$S'R3$JA/G']MAWKUA<9[??#+9(>^-
M!IFO,A'U5L=QC]:[CUS'_/)-18XG(W<]KI_94./LXJJJY:)<-E)JJJ(+?'7<
MO/-=5N?H?]I%X-Y/CP<#ZR[:>"Y^8K2=]AB^;C\U](CNR4K%MQLYO:8B*S7<
M8:QW7R;C%7I$I_#?B"X7D:TV7EN.=EOM(CWU(F^"\_/:(B;XM9^33)2.LVR5
MCHK6[?INW]>[-F=*W[5=DT?<=<O*L=L.I;?@\GK6S8+(44425V.9P.:M;+*X
MN\HHDIJYBGBHKXXJXY^'Y>%DO$<SQ'D'&8>:X'=;;?</N*=^+/M\M,V'+2>G
M=CRX[6I>NL3'=6TQT]J06UW>UWVWIO-CEQYMIDC6MZ6B]+1\];5F:S'W8F7F
MW8N0                        _LQV1R&(R%CEL3?7F+RF+O+;(XW)8ZYF
MLLACLA9347-G?6-Y;5Q7%I>6EQ%3)%+'537'73Q53SQSQQR^.XV^WW>WOM-W
M2F7:Y:6I>EZQ:EZ6B8M6U9B8M6T3,6K,3$Q,Q,:/SDQTRTMBRUBV*T3$Q,:Q
M,3TF)B>DQ,=)B?:EZ\7_ 'T_</\ &2WQF!Y[6A[UT;&S35TZAW_9W>_7'$-Q
M1S%)!;=@4Y'%]H00VD?R\V=O7FIK"SJBHXHMO2]2*2(WJ?\  U\/7J9DR[_\
ME3P7.9(C_&.*M7:QK$ZQ,[7LOLIFTZ^\O&WKER1:9MD[NVU=5^1^C'@?D5K9
M_JT[+>VC[_;3&*.GRSBTG#.OZZ?=Q:VLZVUTF+&OB_\ <O>(O:=QC->\C-'W
M;QHV&ZAFXN-EI];M3JN.ZAKYCMXI<UK.*L]\QTV5^-%4?%>N2V=KS573/>4T
M1\325T^I_P!FKZM^+8\O(>G6^V7DO'TF-,/38[Z:S&LS&/->VUO%.L3INZY+
MZ1-,,VMV5T'Y'\/7E/&UMGX#-AY'!$]*?M.;3Y?HWM..>WY=,L6GIVTUG2)[
M>G^^^DO('7.-MZ/[9Z][8U[B&QFN<EH.VX39Z,9SDHI9K2US<&*O+FZP.2KI
M@DIJM+V."ZBDBDHKCIKCKII@;Y?X'YKX!R/Y)\WXGD.)Y#6T13=8,F&;]DQ%
MK8YO6*Y:=8F+XYM2T6K:MIK:)G2?*\)S'![CZKS.US[7/K.D9:6IKI[9K-HB
M+1UCZ59F)B8F)TF&6F)NK
M
M
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M58B*UB(B(B(TB(B.D1$=(B.D0VM6M:5BM8B*Q&D1'LB/FA^+]OZ
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MUN]UOMQ?>;[+DS;O).MKWM-[VGY[6M,VF?NS,O2.M<<
M
M
M
M
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MS\EJS,3\DM]8,^#=8:[C;7IDV]XUK:LQ:MHGV3%HUB8^[$OCN6^H
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MB8^26G=]Q_(<9N)VG)8,VWW41K-,M+8[Q'LU[;Q$^V)^3Y'MG2.&
M
M
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MJUB*Q\D,P,0=4
M
M
M
M
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MO$>S7MO$3[8GY/D>V=(X8
M
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MQ_PKQ7Q>E8X38X,.6L?MG;W99Z:3KEMKDG6/D[M.LZ1UEJ*VVRD
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MJBQY#Y7Y#Y5NOK?/;K+N,D3]&LSI2FOR4QUTI3_V8B9^69ELLUJQX
M
M
M
M
M
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MUS6SW.UMK$1[S':L3KKIVVF.VVNDZ369B=)^:6<F#NF
M
M
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M]Z=^&>,=M^)V&"NZKIIEO'O<NL?KHR9.ZU)F>LQ3MC732(B(B-#V]F:
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M4^3Z&.NE(G3I-M)O:/OK6GJVT:F8N
M
M
M
M
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MUY#B<^+<[*_LOCM%JZ_+$S$]+1^NK.EJSTF(EC=D;G@
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M$9Z:1,QW3;%-^R)TUB+Q6=)C6(U2*H[L"
M
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M;NO\]I;L-*L/
M
M
M
M
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M-3<OX[SW 9/=<UL]SM;:Q$>\QVK$ZZZ=MICMMKI.DUF8G2?FEG)@[I@
M
M
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M[1]]:T]6VC4S%P
M
M
M
M
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M,N*^.==-=-+UB?9,3^I.K)S&77
M
M                          /CY_8M?U3$W>?VC.8?6\%8>A]=FL_D[+#X
MFR^JN8;*V^KR61GMK.V^IO+F.*/YZ^/GEDIIX^-57''/,V''[_E=W38<7@S;
MG?9->W'BI;)DMVUFUNVE(FTZ5B;3I'2L3,](E]<&#/N<L8-M2^3-;72M8FUI
MTC6=(C69TB)F?N1JBZ[V][7VUNA8I8LAY'ZWVCFZ?F^GP'1,,W;<MY\EI9WE
M7I;-J_,_7]M^UW\5''U.9@^:;U(Z?C7!<4Q2?\%^"GXDO/+1?;^.;GB]E/MR
M\G,;"*_2M7KASZ;J>M+3]#;VTKVVG2M\<VV1POH_Z@\W,3CX_)ML/RVW/X#3
MK,?>7TRS[)]F.>FD^RU=88>^?NG;>FN_QOC#XMS2Q^C75C-T[YVNBWKXN*K?
M)1417_6/7U=U35#!=<V<_,D>W<52QTS0?)'S51<4S,\$^RWR37'N?4[RB(MK
M]/;\7@F8TUI,S7>[OMZS7WE=)V&E9FF36T1;'.V^$^&RVE<GD?)1$Z]<>VIK
MTUCV9LNGR=T:3@Z3I;6>M4+7>OO=^Y9WQ1=6.0\C<]U=@+B:*>+!=%6-CU-7
M95Q7$=Q33:[CK,</954-545--4<V<FCKCXYHYIYIKDXKF=X-\$OPV>"6KGV_
MCF#E-_6)B<O)VMOXM$Q,?2V^:9V>O69B:[:LQ.DQ.M:Z;<X7T=]/>%F+TX^F
MYSQ'WVYF<^O33KCO^"_LQCB=>OR1I%?F,SE]AR=YFL_E<EG,SD9N;C(9;,7U
MUD\G?W'/'%/,]Y?WLL]U=3<TT\<<U5UU5?#C_:E+L]GL^/VU-EL,6/!L\<:4
MQXZUI2L?-6M8BM8^Y$1#96+#BP8XPX*UIBK&D5K$1$1\T1'2'S7)?0
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M5K77KIJSPP1TH
M
M
M
M
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M:Q:8UF(]LMBFNW0@
M
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M#AXEV9N4V._Y[>TTGOW^ZOV=WRS[G:1M<-J^V(IEIEB(]LVM'<VKP_H1Z?\
M%Z7W.'/O<T?+GR3IK_U,7NZ3'W+1;[NL]42/:W?G>/>N3XS/=7</9W;.3HFJ
MG@N^Q=ZV;<:[2NKBJCBFPIS^2OX\?#''7S1''!3''''^PHIXIXXX2T\5\"\'
M\%VWU/POA^,XG;372:[3;8=O%H_NO=4K-YF>LS:9F9ZS,SU;1XSA.&X7'[KB
M-IMMKCTTTQ8Z8]?U>V(U^[,ZS,]9ZL2LL=F
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MCRG)<QNIWW*[C-N=Y:-)OEO:]M(]D:VF9TCY(]D?)$,A,?<
M
M
M
M
M
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MQ[S+QCRK%[W@MYASVTZTU[<M=8U^ECMI>/EZ]NDS$Z3.DM46U63
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M;368UTM$3[8F/U8F/D>J=4XP
M
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MLN6TVRVF9F9G69F>LS,SUF9GK,S[7]CXOP
M
M
M
M
M
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M8GY);CP9\&ZPUW&VO3)M[QK6U9BU;1/LF+1K$Q]V)?'<M]0
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MU^;6/G9"8^X
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MK%AQ8,<8<%:TQ5C2*UB(B(^:(CI#YKDOH
M       S!TQX_=X>1.S?F=T7U1OG:VQT>CS=8[2-;R>=_#8KBBYK@N<S=V<%
M=CA+.6FSEYIGO)8(>?3J_9?DY8AYEZ@>$>G?&?ECSGE=AQ7'3KVWW.:F+OF.
MV)C'6TQ;):.ZNM<=;6ZQTZNJY?G.&X';_6^:W6#;;?Y)R7BNNFG2L3.MIZQT
MK$SU6.O$C[8SN7<Z\7LWF1VEC>FL!ZUG<7W6/6%>)WGLF]LI+?BN]QM[NU<M
MWU[IN2MYI.**;BUAVJ"OF.OCY/EYIKYKG]6OM-/#>&KEXWT=XO)S._TM%=[O
M8R;;9UM$Z5O7;:5W>XI,1K-+VV-HUCZ6L35H+RCXBN)VD6V_B>VMN\^DQ&;-
MW8\43KTF,?3+DB?FF<,]8Z^V%G?Q0]M#PM\,+2REZ2Z3UNVW*UL[>TN>T]O@
MCW/M#(50R\SR7'YW9N*>XP?UMQ\LD]OB(\=925Q1<^AQQ%%Q163ZK?$KZS^L
MV6]?->:W-N'M>;1L=O,[?94UC2(^KXYB,O;&L5OGG-DB+6^G].VL=/)O4/R[
MRVTQS&\R3M)F9C#2?=X8^33LKI%M(Z1-YO:-9Z]9UWQ:)84
M
M
M
M
M
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MO&+>8LF++,:Q%ZS69CK&NEHB=-8F-?N2](ZUQP
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MV6SV&+W&QQ8L.#77MQUK2NND1KI6(CV1$?J1$?(\L[1R0
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M)$,A,?<
M
M
M
M
M                                                   !%UY0>S;[
M>_E9]1D=PZ*P_7>Z2V=W:1]A='U6_5FS427GS55Y/(X[!V=6C[9F(9.::H[K
M.8?*34<1TQ\<^E\T=4G_ $Q^,7X@?2KMVW#\[FY'A8O6T[3DM=]ATK^LI?+;
MZS@QS&L33;;C#6=9MIWZ6C8_CGJQYUXSICVF]OGVD3$^ZW&N:G3Y(FT^\I7Y
MXQY*1.NOMZJZ'E%]L+WUIE&<V/Q0[?U7NG#6L,]]C>O.PXHNM^R9N/J):+?
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M3R?Q[R/%[W@]YM]S&FLQ2\3>L:Z?2ITO3KI]]6/;'SPU[;!=Z
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M%HC29K,:ZQ+%MSM-UL[QBWF+)BRS&L1>LUF8ZQKI:(G36)C7[DO2.M<<
M
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MZSUEG/'^,^.<3,3Q>PV6WM$Q.N/#CI.L1I$ZUK$S.GRS.OW6 6?.[
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M+\%BTTF-)K7K?76=?>3>>NFND1$2'H],$
M
M
M
M
M
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M1$Q,3$QK$L2LL=F
M ^EA\SE]>R=GFL!E<E@\SCIN+C'Y;#WUUC,G87'''-/$]G?V4L%U:S<4U<\<
M545TU?#G_:XV\V>SY#;7V6_Q8\^SR1I?'DK6]+1\UJVB:VC[DQ,/GEPXL^.<
M.>M;XK1I-;1$Q,?-,3TEM%HGGMYO=9?01Z)Y=>2&N6&-O);^UP=GW-V!+K/U
M<_Q]>6ZU:\S]SKE_Z_/Y:Z9[66FOGCCGGCGGCAK#G?0;T2\F]Y;G?$?'-SGR
M4BELEN.VD9NV/9%<]<49J:?)-;Q,?(QS>^$^'<CW3O>+X_)>T:3:<&+OT^Y>
M*Q>/[$PVTT;WS/=)T+Z>&R\ILQL6.CS$68N\=O.@]5[I^)?)])1/B[C-9_1[
MS:;/#WD%GQ'7!97]IZ?SR20U135U2<ZFYSX'?A=Y[NOF\6P[?<3AG'6^VW6^
MV_9]]I>,>+<UP6R5FVL6R8KZZ5K>+4K%6+[WT:]-][K-^-ICR=G;$X\N;'I[
M=)BM<D4FT3.NMJVUZ1.L1HVZT[[FGW!]=M^+78=/\:=_IKR7%W-D-@Z^W7%9
MBBQJHM8Y,592Z?V;K>&@AIX@KKCEFL+B:F6:KFNJ2CBB.G4G,?9H?#]R.3WO
M'[SR783&/MBF+=[:^/NUM,9+1N-EFR3/6(FM<M*S6L:16TVM.+;OX=_!<]N[
M!EY'!]'32N7':NO7Z4^\PWM/W8BT1I'32=9G:[4_NK-_L_K_ ,^?##3]B]3Z
M7\+_ #3[KS6F?1_)]3];]?\ C'6^^_B7U'S0^EZ?TGH_)7\WJ_/3Z>J>5^RO
MX#-[O\A^9[S;Z=W?[_C<>X[O9V]GN]YM>S3Z7=KW]VL:=O;/=C.Z^&G8W[?J
M7+Y<?MU[]O7)K[--.W+CTTZZZ]VO3V:==N]5^Z3\2[RXNZ=W\=_(K7K6B&BJ
MQFU7GK3<KBXN.:_A)%=VV7W718[*&B/\M,E$L]557Y.:../V34G*_9>>K.''
M2>$\A\=W&69GNC/]<V\1&G2:VQ[;=3:=?;$UK$1UUGV,6W/PW>44K'U/?[#)
M;7KW^]QQ$?<FN/)K^II'ZK9S2/N-/;-VNO$49[<.VNLZ<E#-+>R[OU)G;^C7
MZXK>XFHM\OQUQ<=@2S37$D-,-'-A3?1\22T<UU4T<5UT:RYO[.KXE^*KFG8[
M/B>3G',16-MO\59RQ,Q$SC^N1M8B(B9M/O9QSI6=(FW;6<<WGH'ZA[:+SAQ;
M7<=L]/=YZQW=8ZU][&+V>WZ7;.D3I$SI$[+:O[T_M>;?CYLEB?+[0[2W@O)+
M&N/:->[%T?(5310V]Q57#B=TTS 92XL^8[FGBFXCAJMZZ^*Z*:^:XZZ:=:\I
M\&'Q/<1N(VV[\0W]\EJ1:)P9=IN::3,QI.3;;C+2+:UG6DVB\1I,UB+5F<>W
M/I%ZC[6\8\O%9YM,:_0MBR1\L??8\EJQ/3V3.OLG328;4ZOYL^&>\9";$Z7Y
M<>,>WY2WLY,C<8W5^^^JL_D(,?%-;VTM]-9XG:[NXBLXKB[BCJEJIXHIKEHI
MYY^-7''.K>4]%?63A-O&[YKQ+R;9[6UXI%\_%[[%2;S$S%8MDP5B;3%;3%8G
M68K,Z:1+&MSX?Y;LZ1EWG%\CBQ3.D3?;9JQ,]9TUM2(UTB9T^Y+83 ;%K^UX
MFTS^KYS#[)@K_P!?Z'-8#)V68Q-[]+<S65S])DL=/<V=S]->6TD4GR5\_)+'
M53S\*J>>.-?;_C]_Q6[OL.4P9MMOL>G=CRTMCR5[JQ:O=2\1:-:S%HUCK68F
M.DPZ+/@S[;+.#<TOCS5TUK:)K:-8UC6)TF-8F)C[DZOL.&^0
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MMIFTZ1UM,S/6991@P8-MBC!MJ4QX:ZZ5K$5K&LZSI$:1&LS,S]V=7R'+?4
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MM>W7Z7;IOR3UZ\*X:+X>+G+R6]K$Z1BCMQ=VOLMFO'L^7NQTRQUC37KI8O\
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M9F>G3K+[S@/@
M
M
M
M
M
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MS\5S?#\YM_K7#;K!NL&D:SBO6^FOLBT5F9K/2?HVB)B8F)C6)8E98[,
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M/L?JW[5]7V>VP^ZT_P"[]WCKV>V?O=/:R':\%P>Q[/J.SVF'W?WO9AQT[?\
MJ]M8T_L:,0,O=J
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M-US>ZS[K/6)BLY+VMVQ/68K$SI6)GKI6(C7KHS,PUU(
M
M
M
M
M
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MWY%6+<)OMMN;::S6F2LY(CK]]CF8R4]DZ=U8UB-?8UO;&=^
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M /0+\;/_ *3I_4-^%'_=7_[)\Q_]$#^9/TQ_-G_U1N_W\_S[?=C_ +5O_P!
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ML]O@Q99C29I2M9F.DZ:UB)TUB)T^Y#PCO7-
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M,U5Q+IO7EC#UAHU5%5O3#QC<MEII]CW;.PQ3<US<7%E=8"3FKTZ>:/EHK]:
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M8]D?-#9QK)CH
M
M
M
M
M
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MR#2FQY'!3<3_ -GFF<-]8TZ1&3MBT]8T[)MKUTU[;:1OI&L_
M
M
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M/+81KYT0
M
M
M
M
M
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M5O-=8B=+169FLZ3&M;1$QKUB&&69.V
M
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MK/+;G/N<^LSW9<EKS&ND=.Z9TZ1$:1I&D1'LB&3F,NN
M
M
M
M
M
M
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MV3$^R7CW;N4
M
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M:]R9+Y;VRY;3;+:9F9F=9F9ZS,S/69F>LS/M?V/B_
M
M
M
M
M
M
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MMF/;2;1[:S'ZL3'R2QNR-SP
M
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M7F<_UGEMSGW.?69[LN2UYC72.G=,Z=(B-(TC2(CV1#)S&77
M
M
M
M
M
M
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M/VWF5
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M5B(C68B(B6;&%.G
M
M
M
M
M
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MI6T]LZ1TEL3B_*_&>;TCB>0V>XO.GT:9:3?KKI$T[N^)G2=(F(F=):WMCN_
M
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M]MEO;);_ .FO,S_Z7O'0N$
M
M
M
M
M
M
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MF'PG.?8
M                                      !MUUGX!^;G<5=?Z-_%#O[9
MK6*:YM9LQ%U=MN.URWO;.WMKNXQ]QL^8QF.UZWR5%M>0R<6U=U3/51+3S31S
MQ5PU)Y+Z^>B?A]8_2/RO@-MEF*VC'.]P7S36TS6+QAQWOEFDVK:.^*36)B8F
M8T8MR/F_A_%1_P#,.3V..TQ$]OOJ3>8F9B)BE9FTQK$QKIITGJD@ZS^W+]S/
M?*ZZ-IT_J7I:FB:YBIE[,[;P.5HEH@M[::*XHXZ<M^V9.(;V2>J*+BJFF3B2
M&OF2F.CF.NN./DOVBOPT<%6)XO><MS4S%9TV>PRTF)F9B8G\H3L(UK$1:VDS
M&EH[9M;NK7 .1]?/3S91KMLNZWG2/VG!:OMF>GX><'LTUGY-)C29G6(DLZS^
MU8@XHKNNX_,&:N6J&YBCPG6?5-$5$%Q]1;<V=]7M.T[?-5=0\VM,U,MIQAX:
MN)*Z*J;CGBBJFN-GDOVIN2;1B\.\0B*Q-9G)O-],S,:3W5C!@V\=L]W;-;_6
M+1I$Q./68FNO>1^)6VO;Q/%1IK'TLV;Y-)UCLI3IUTTM[R>FOT>NL23]5_;I
M>VAUU+'/LFF]J=US0^K5#5VIVEE;:*B>J[M+JWGDL^I[+JRQN_HZ+:J&F*>*
M6WEAFDXFCEJ^2JB-WE/VB/Q*^15FG&[SBN%I.FOU'98[3IVVK,1;?6WMJ]VL
M6FU;5O6U:]EJQW1.ON3]>O4/?QIM\NVV<3_W.&L_),3US3FF-===8F)B8C28
MZZR?].^&?B;X^T6_Z%O''IGKB]MIH[BG.ZWU[K5KM,UQ!<9"YM)[[;I,?-L^
M1FL*\K<4VU5Q=RU6T4O,47-$?PHXC'YAZR>J_J!:WZ9^1\SR.&T3'NLV[S6P
M1$Q2+17!%XPTB\4I-XICK%[5BU];=6N>6\M\GYR9_*_(;O<4F-.V^6\TTF(B
M8BFO9&O;&NE8UF-9UGJV6:U8\
M
M
M
M
M
M
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MGC=UMMQ$U[H]UDIDUKKIW?0M/368C7V:RQDR9V(
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MFOO<V3)[/9]_:?9\GS,P,0=4
M
M
M
M
M
M
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M-M=+5F+5G2=)TF-8G28F)^[&CY#EOJ
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M]U]]DOKV_K?F^31A?(<[SG+:_E3>;O<ZZ:^]S9,GL]GW]I]GR?,S Q!U0
M
M
M
M
M
M
M
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M-)AW6VW>UWE)R[/+CRXHG29I:+1$])TUK,QKI,3I]V'G'8N0
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M73OO:^FNFNG=,Z:Z1KI[=(>P=.X@
M
M
M
M
M
M
M
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M&+.L
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
8                            ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>sny-20221231_g5.jpg
<TEXT>
begin 644 sny-20221231_g5.jpg
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MA96E=J&"DF-S-,0E1<5&HH-$HV3D9>4F9D@G_]H # ,!  (1 Q$ /P"_P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                         #'NR=N=4:;DZL+M_9W7
MNJYFB&&XKQ.R;IK>#R=%O<<<U03U6&3R5K=4PST\<\T5<T?+5QQ^3GED''=I
M=U<QMHWO$<9R&ZV<S,1DP[;-EIK'ICJI2U=8]<:ZPY^WXOD]WC]]M=MGRXM=
M.JF.]HUCTQK$3##^Q^</A7IV3JPNW>7_ (NZKF:(8;BO$['Y =3X/)T6]QQS
M5!/589/;;6ZIAGIXYYHJYH^6KCC\G/+,..\D?.CF-M&]XCM#NC=;.9F(R8>*
MWV6FL>F.JF"U=8]<:ZP[7;]G=W[O'[[:\5R67%KIU4VV:T:QZ8UBDPP]LGNL
M^W!JN3JQ.3\T.@;JZHAAGYEUO>\=N6,YHGXYJHIIS6H<YS#5S4\<?JXZ9^9(
M^?R54\<LOX[X5OB-Y3;1N]MV9S]<4S,:9MK?;WUC_P!WN/=9(CY)FND^J9=K
MM_+/O_<X_>X^(WT5UT]O'..?_9OTV_NZ:3ZF*]J][SVLM.N+2VR_ESJMY)>0
MUSPU:KHO;F]6]%$=?IU4W=WI/7VPVMA-S5_V8YZXY*J?R\4\\?E93Q7P2_%'
MS&.^7:=I;JE:3$3[_<[#:SK,:^S7<[O%:T?+-8F(GPF=79;;R>\R=W6;8N+R
MQ$3I[>3!CG^Y&3+69_-C6&,=H^X)]J_7\?#>8GOO9-XN9;R.VKQ.K]*]R6F0
MMX*X+B6K(S2;KH^GXJJSBDAIBJICN:[CFN:CFF*JCBNNC)^+^C_^*7D-Q.'=
M\#MMCCBDVC)GY'C[4F8F(Z(C;;G<7ZIB9F)FD4TK.MHGIBW9;;R,\RL]YIEV
M./#6(UZK[C!,3Z/#['DO;7U^,1'A/CKI$XWR/W(7MK66/OKRVRW=N7N+2SN;
MFWQ..ZIEBR&3F@AKEBQUC)EL[C,7'>7LE'$<55S<V]OQ75QS)+'1\:^,CV_T
M<?Q)9MQ3#DP\)AQWO6LY+[Z)I2)F(F]HQXKWFM8\;12E[Z1/36TZ1//Q^0'F
M#>]:6ILZ5F8B;3F\(U]<]-9MI'IG2)GY(F?!BO\ K0G@)^]#Y@?Y =+_ /W0
M#*?[,/S[_"_:'W5R/_"G9_T<>]_VUQ7VW<?ZLQ[LGW2WBW:Y.J+4/&WO[.8;
MB&&JB_V3(==ZKDZKBKCGUXJL3C-DW*UHACJ^'%$G%[557Q^7FBC^PR'COHNO
M-'+MHOR_<G 8-YK.M<-=WGIIZI]Y?#M[:SZX]W$1\LN=M_AM[DMCUW7(;&F7
M7T4C+>-/5[4TQS_<Z?[LO-7'W4'15-O/5:>*/;4UU3#+5;0W&]:=:V\MQQ15
MS#%/<QV-W);PR2?#BJNF*6JBGGGGBBKGCX<]CC^BU[ZG)6,O=?$UQ:QU3&VW
M%IB-?&8K-JQ,Q'HB;5B9\-8]+D5^&OFNJ.KD]K%=?'3'DF=/J1K&OYFL?FL3
M?UKG_P#@*_\ YI/_ .G1EO\ 94__ .>?^"?_ -7=I_1F_P#YW_U/_P#BGXW'
MW6]Q5;STVG@?#!=50RTVTUQY.5W5O#<<T5<0RSVT7CY9R7$,<GPYJCIEBJKI
MXYXXKIYY^;C]X_HJL<9*SE[[FV+6.J(X6*S,:^,1:>5M$3,>B9K:(GQTGT/U
M7X9JQ:.KFIFNOCIM-)T^I/SJ=/S=)_,8D_K3W?W\E;I[_++=/[DRS^RV[!_E
M5S'W/MOSW9_T;.#_  GN_M>,_K3W?W\E;I[_ "RW3^Y']EMV#_*KF/N?;?GG
M]&S@_P )[O[7C>5VK[I/RUN[>UITGQW\==>NJ)JZKZ;:N>R]QM[BWYH^$<5K
M;8C==%DLYJ9/RU25RSTU4_DXHXY_5.TXKZ+SRFPY+SS?</<6XQ3$=,8/F>WF
M)U\9M;)MMU%HT]$16LQ/CK/H<K;?#=VO2T_/-_O\E=/#H]UCF)^K-L>37\S2
M/S7B?ZT)Y]_O0^'_ /D!W1_]T [O^S#\A/POW?\ =7'?\*<O^CCV1^VN5^V[
M?_5C^M">??[T/A__ ) =T?\ W0!_9A^0GX7[O^ZN._X4?T<>R/VUROVW;_ZL
M?UH3S[_>A\/_ /(#NC_[H _LP_(3\+]W_=7'?\*/Z./9'[:Y7[;M_P#5C^M"
M>??[T/A__D!W1_\ = ']F'Y"?A?N_P"ZN._X4?T<>R/VUROVW;_ZL?UH3S[_
M 'H?#_\ R [H_P#N@#^S#\A/POW?]U<=_P */Z./9'[:Y7[;M_\ 5C^M">??
M[T/A_P#Y =T?_= ']F'Y"?A?N_[JX[_A1_1Q[(_;7*_;=O\ ZL?UH3S[_>A\
M/_\ (#NC_P"Z /[,/R$_"_=_W5QW_"C^CCV1^VN5^V[?_5C^M">??[T/A_\
MY =T?_= ']F'Y"?A?N_[JX[_ (4?T<>R/VUROVW;_P"K']:$\^_WH?#_ /R
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M_P#J?_\ %']:Y_\ X"O_ .:3_P#IT/[*G_\ SS_P3_\ JY_1F_\ YW_U/_\
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M&ZK[Q<Y^T]W]IR?I686(.J
M
M
M
M
M
M
M
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MV6[P3CC6WO,.2G3$Q$Q-NJL::Q,3X^J89F8:ZD
M
M
M
M
M
M
M
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MY(
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M%EK-<M9F)B8TF)CPF)B?&)B?"8GT/['Q?@
M
M
M
M
M
M
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MQDR9V(
M                      #U.J[UN^BW%W=Z3N.U:==7\-%O?7.J[#E]>N+R
MWCK]2."[FQ%Y:27$,<G/S4TU\\T\5?EXX^+J^5X+A.=QTQ<WL]KO,6.9FM<^
M+'EBLS&DS6,E;1$S'A,QXZ.-N=EL][6*[S%BRUK.L1>M;1$_+'5$Z-V=%]UC
MW'^NKB.YU_S0[^R$D>2LLK33O6^9+M&WYNK"NB2"*2T[,YVZUEQM=4?'K655
M'-G<T_&F6*OCGGCG2G._"M\.7<6.<7(=F<!CK..U/]%VM-E/3:-)F+;+YO:+
MQK[.2)]Y2?&EJS$,0WOEGV!OZ].?B-C6.F:_8\<89TGZN'HG7Y+?71ZIANQU
M[]QI[F>EUV5>R;AU+VY3:37LL\7874F!QM&3HNK>6&"WO>>J+CK&6.'&R2<2
MP\VU5O)5)'3Q-5+1\U%6E>X?HZOAIYJMXXW9\MQ$WBL1.TW^6\TFLQ,S7Y]&
M]B9O$=-NN+Q$3/1%;:6C#]_Y!^7F[B8V^+=;76(T]UGM.FD^,Q[Z,WI]$ZZQ
MI/A$3I+=_KW[J7M[&VE-':WB'UONE]]''15<]>]G[/UE:<Y#B6KF:YILMDUC
MMN:FSKA^%-,'U'-=%7'-7,U7'/R\:2[@^BS[1W.77M7N[DME@ZYG3=[+#O;=
M&GA7JPYMA'5$^,VZ-)CPZ(]+#M]\-7%9+:\9RNXPTU]&7#3-.GR:TO@\?JZ?
MW&^'7OW0/ACGKNFR[$Z9\A.O?7O(X8,IC<;HN\82VM*HJJI;W+R6^X8#.VWI
MR\<4\1VF.OZJN.?C^3\O#1/<'T8GG+L,7ONWN9[?Y#II,S2]]SMLDVU\*XXG
M;Y<4ZQXZY,N*(]'BPK??#EW;@KU[#=[#/I'C$SDQVF?DKKCM6?S;6JWDZX]]
M;VO.QX(N(O)6STG*U6=W?7.$['T3L74)[*&UR%-A31+G+S59=-N[R[XECGAM
M[3)W-Q5;U\U<T4\QS4Q:/[C^!GXGNW+SU]M7WNUZZUC)L]UM-Q%IM3JUC%7/
M&XK6NDUM?)AI2+QI%IBU)MAO(>3'F/Q\SKQ\YL6L1%L63%?76-?K8O[R(CQB
M9M2(U]?C&L@?7_D_XU=LUP1=5^0W1O9<MSDJ\-;1]?\ ;6@[E7<9>.W@NY,5
M!1KFP9*J7)46MS'+S!3\9>(Y*:N:?A5QSSH#G_+'S)[3K:W=/;W.<;6N/WDS
MNMANMO$8YF:Q>??8J:4FU9KU3[.L3&NL2P;?=N=P\9$SR6PWNWB*]4^]P9<>
ME==.KVZQX:Q,:^C6&<F#NF
M
M
M
M
M
M
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M,&VQ1@VU*8\-==*UB*UC6=9TB-(C69F9^K.KY#EOJ
M
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M.G+COCG6--8TO$3X:QK\FL?*R$Q]P
M
M
M
M
M
M
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M;WC3VJ8J1?PUTF;]/7,QK.DS,S&LM;VQW?@
M
M               /[,=D<AB,A8Y;$WUYB\IB[RVR.-R6.N9K+(8[(64U%S9W
MUC>6U<5Q:7EI<14R12QU4UQUT\54\\<\<<OCN-OM]WM[[3=TIEVN6EJ7I>L6
MI>EHF+5M68F+5M$S%JS$Q,3,3&C\Y,=,M+8LM8MBM$Q,3&L3$^$Q,3X3$QX3
M$^EO)U)[G_N#]'_2Q]=^7?=EM86/T?%A@]KVVX[+UFPBL/J_I[:PU;LN/;M<
ML;.KF^DYE@BM:(9^>*.9::^8X_DT?W;\,7P_=[]5NX>T>$MGOU=67!@C9YKS
M;IUFV?9SM\UK>S'3:UYM7QZ9CJMKAO*>7/8O,ZSO^*V<WMKK:E(Q7G7369OB
MZ+S/A&DS.L>.FFLZR3=5_<M>X)I-=I!V!A^C>YL?3#BK>_GV71<AJ>Q7'&/M
MYXKR\L<EU[L&LX"QR6<EEIEN:I,3<VU%<?'%O!!1S53S&_NGZ-CX?^:K>_ 9
MN<X;<3-YI&'<TSX8ZYB:UM3=XLV6U,41-:1&>EYB9G)DR3$3&ON3^'OL;>1-
MMC?>[3)K:8BF2+TC68TB8RUO:8KZ(TO$^/M6M*2WJ;[J#JF_XL+?O7Q1["U.
MJ.&*+)YCJ;>M;["XN[B/&5U3WUAK>X6/6/./AN\S1331:296ZJM[63FKFXFK
MCXHEC7W9]%KW5MYR9.QNZ^/W<3,S3'O]MFVG3$WC2MLVWMO>N:X]9F\8*1>\
M1'NZ5MK77O*?#7R=.JW"\G@R^/A7/COBTC7PB;XYS:Z5_112-9C3IB)UB3+J
MOWZ_;#[0BCCG[[O.LLO)ZM7&$[4T'==;EI@AM+2YKGDV''8;.Z11\9;FJ"F+
MG*_42302?)'5'Z=<D:>Z?@.^)OMBTVIP-.3VD:?9-CNMMFC6;6K$1BODQ;GT
M1%IM[CHBMJZVBW56NN^2\D_,;C9UKL8W&+^^PY<=_7,?6S:N3U:Z]&D1,:SK
MK$2<]9=Z](]UVEQ?]-=Q]5]MV-I\WU=[UEV%J.^VEK\DOHU_47.JY?*PP_)-
MS\G/S5<?"K\G]E&7N;L;O;LK+7;]Y</RO$Y[_6UWNTS[6UM8UC2,^.DSX>/A
MZO%KOD>%YCA[13EMIN=K>?1&;%?',_F1>M65&+.L
M
M
M
M
M
M
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M^/K]KVI\9UGQ:3MU,O
M
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MG#GK:F6LZ36T3$Q/R3$^,/I.,^8
M
M
M
M
M
M
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M)7IX?9[7:Q,:3[K%3',^C76:UB9UZ:ZS.LSI&OH899D[8
M
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MM>0PY<&YCTTR4M2T:3,3K6T1/IB8]'IB8],/8.G<0
M
M
M
M
M
M
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MQ&ONL=:3;2(C6TUB)M.D1K:TS,Z>,RPRS)VP
M
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M=)B=+1$Z3$^B6M]SMMSL\]MMN\=\6YI.EJ7K-;5GTZ36T1,>'CXP^\X#X
M
M
M
M
M
M
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MD],1/UWIB)],0TS;D9:
M
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M[FF*/3>M8RXX\(GQR8IO2/"?7;TQ,>FMM-Y6CV&@
M
M
M
M
M
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MZ1$>J&VMCQ_'\9MXVG&X,.WVL3K%,5*XZ1/HUZ:1$>B(]7J>)=TY8
M
M
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M'Y8>J=4XP
M
M
M
M
M
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M&^S]
M
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MZM9F.FT>$^-9F/"?D9L84Z<
M
M
M
M
M
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M#\V=8S4EFPP
M   'H]7TW;]XR$V)TO5=DV_*6]G)D;C&ZO@\GG\A!CXIK>VEOIK/$VMW<16<
M5Q=Q1U2U4\44URT4\\_&KCCGKN4YGB.$V\;OFMUMMGM;7BD7SY:8J3>8F8K%
MLEJQ-IBMIBL3K,5F=-(EQ]SN]KLZ1EWF7'BQ3.D3>T5B9\9TUM,1KI$SI]26
M>=7\)_,S>,?-EM*\1_)S<,5;WDF.N,GJ_0G:FP8^#(106]S+8S7F)U2[MHKR
M*VNXI*HJJN*Z:):*N>/A5QSS@G*>=7DWPFXC:<UW;VSL]U:D7BF?E-CBO-)F
M8BT5R9ZS-9FMHBT1I,UF-=8ETNY[P[2V=XQ;SE..Q99C6(ON<-9F/&-=+7B=
M-8F-?J2SEA_:9]R7.8RSRUEX9=YP6M_#Q/!%F-4KU[)T4<\\T\4WF%S]QC,S
MCIOC3^6.X@BDXX_+S3\.>&#[SXL/AOV.YOM,W>7!VRXYTF<>?WM)G_!R8HOC
MO'U:6M'U739?,_R^PY)Q7Y;93:LZ>S?JC^Y:L36?S8F8;"8?V!/=:R>3L["]
M\:\;KUK=3<13YK,=W]!SXS'4<\<\\W%Y%@.S<YF:X>.>/ASQ;VD\GQY_[/P^
M//&OMY\?/PJ[;;7SX>Y,FXRUC6,>/C>4B]Y^2LY=EBQQ/^/DK'U719?/#RSQ
MXYO3D+9+1'UM=ON=9^I'5AK7_EM$?59LUO[:_P!Q_.9.FPR=70.FVM4,TO.:
MV3M'(W6,HKCXXYHMZHM0TW:LSS-<<\_"CFFTYCXYX_554\?E85R/TD?PY;';
M3GVWW_WF76(]WAV5*WF)]>NXW&#'I'KUR:_)$NGW'Q!=@8<?7C^?9;:_6TPQ
M$_F^WDI7P_QM?DAF;5_M<?,R[R$T>Z=]>,> Q=-G)7;WFKY3M7;\A+D.)K>F
M*VFQN6ZQT>W@LZ[>J6NJ>F[DKIKHHHXAJXKYKCPSE/I0?)O%MXMPO ]S;C==
M<1-<]-CMZ132=;1?'O=S,VB>F(K..(F)F>N)K$6ZG<_$AVE6D3L]ER-\NOC%
MXPTC3Q\=:YLDS.NGATQZYU\-)S!J_P!JOV?=Y":/=?,70]?Q5-G)7;WFK]1;
M#N&0ER'$]O3%;38S+;OH]M!9UVU4M=4]-W)737111Q#5Q7S7'B'*?2G=L8MO
M%N%[/W^XW77$37/O\6WI%-)UM%\>VW,S:)Z8BLXXB8F9ZXFL1;J=S\2W'5I$
M[/B<]\NOC%\]:1IX^.M<>29G73PZ8]<Z^&DY;US[4[6+7)TR[=YNY[.8;B&:
MFNPUSQ_Q^JY.JXJXX]"6G+9/N'<;6B&.KX\UQ\V555?'Y.*Z/[+$^1^E2Y/+
MMIIQ'9.#!O-8TMFY6^>FGKCW=./V]M9]4^\B(^276;CXE]S;'IM>'I3+KZ;[
MF;QIZ_9C!CG^[U?W)9:P'VL_C%;9:TFVCR7[XS&"H]?Z[&X#$=?:WEKGYK::
MBV^DS61PFUV=EZ-Y5'))\]A<>I%35'Q\E57$E&)[_P"E&\S<FTO3B^VN!P[Z
M=.F^7)N\V./:CJZL=,N"UM:ZQ&F6NEIBT]41-9ZO/\27<=L4QMN.V5,WAI-K
M9;UCQ\=:Q:DSX:Q'M1I/CXZ:3DC^J]^ G[[WF!_E_P!+_P#W/[&_[3SS[_!'
M:'W+R/\ Q5U_]([O?]J\5]JW'^LLP?U<;VT/\6.X?X6<K_@#$/[1?XE?VUP_
MW!C_ $SJOR^^8?\ G-I]HK^>]YJ_V^WM7Z_CYK/+=";)O%S+>27-&6VCNKN2
MTR%O!7!;Q4XZ&/2MXT_%56<4D-4M-4EM7<<US5\52U4<444=%RGT@'Q2\AN(
MS;3GMML<<4BLX\''<?:DS$S/7,[G;;B_5,3$3$7BFE8TK$]4VX6Y\\_,K/>+
MXM]CPUB-.FFWP3$^GQ^R8[VU]7A,1X1X:ZS/JK?V&?:?M;B"YB\4(:I+>:*>
M.FX[K\B[RWJKAKIDHIGM+OMV>UNH>:J?U4<M%<==/QIJIYXYYX=5D^.[XK<N
M.V*W=<Q6T3$Z<;Q%9TF-/"U=A%JS\DUF)B?&)B7%MYU^9MJS6>3G28T\-OM8
MG^Y,8-8_-CQ9:_F@_;/_ )''3_\ ^3LM^R[$_P"EU\2O\L>8_P#;Q_L;J_RJ
M>8?X6W?_ "U_2OL8#VG_ &W=;RUIFL=X8]#W-Y9>OZ,.?TRVVO$U_4VTUI)]
M7@-HDS&"O_EBGJYC]>VD]*7BF2CY9***J>'O_BM^(_DMI?9;CO/GJX;Z:SBW
M%L&3PM%HZ<N",>6OC$:]-XZJZUMK69B?EG\S?,#<8IPY.7WL4G3ZW)-+>$Z^
M%J=-H]'CI,:QX3X3,,D_S>G@)_(=\/\ _IHZ7_T*8W_2#\^_Y<=W_P#?/(_Z
MRZ_^'?>_X9Y7[KW'[(?S>G@)_(=\/_\ IHZ7_P!"C^D'Y]_RX[O_ .^>1_UD
M_AWWO^&>5^Z]Q^R,IX[QH\<<1C['$XGQ_P"DL7B\79VV.QN-QW56B66/QV/L
MH:+:SL;&SML#%;VEG:6\5,<44=--$=%/%-/'''''#%MQYE>8N[W%]WN^?YO+
MNLM[7O>^^W5KWO:9FUK6G+,VM:9F;6F9F9F9F=76Y.X>?RWMER[[>6RVF9F9
MS9)F9GQF9F;:S,SXS,^E_9_%YZ!_>-Z>_@STO]A'Q_*#W]^'.8^[-S^R/Q]_
M><_;F[^W9/TQ_%YZ!_>-Z>_@STO]A#\H/?WX<YC[LW/[(??WG/VYN_MV3],?
MQ>>@?WC>GOX,]+_80_*#W]^'.8^[-S^R'W]YS]N;O[=D_3/5ZKUIUQHMQ=W>
MD=?Z3IMU?PT6]]<ZKJF"UZXO;>.OU8X+N;$6%G)<0QR<_-337SS3Q5^7CCXN
MKY7N7N/G<=,7-\AO=YBQS,UKGSY<L5F8TF:QDM:(F8\)F/'1QMSR/(;VL5WF
M?-EK6=8B][6B)^6.J9T>V=(X8 #$EQT#T3>7$]W=]*=275U=32W%S<W'7&G3
MW%Q<3UU2S3SS2X:J2:::2KFJJJKGFJJKGGGGGXLLQ]^]]8<=<6+FN6KBK$16
ML;S<1$1$:1$1&32(B/"(CPB':5YSFJUBM=YNHK$:1$9<FD1\D>T_'^+ST#^\
M;T]_!GI?["/W^4'O[\.<Q]V;G]D?W[^\Y^W-W]NR?IC^+ST#^\;T]_!GI?["
M'Y0>_OPYS'W9N?V0^_O.?MS=_;LGZ8_B\] _O&]/?P9Z7^PA^4'O[\.<Q]V;
MG]D/O[SG[<W?V[)^F?!V/Q0\6MQQE>%V[QJZ VK#5S0W%>)V/ISKO.8RNXM^
M>:H)Z[#)ZY=6M4T%7//-%7-'S4\\_DYX<_CO-;S1X?<QO>([DY_:[R(F(R8>
M0W>*^D^F.JF:MM)]<:Z2^^W[F[DVF3WVUY#?8LNFG53/EK.D^F-8O$L??S>G
M@)_(=\/_ /IHZ7_T*9!_2#\^_P"7'=__ 'SR/^LN=_#OO?\ #/*_=>X_9#^;
MT\!/Y#OA_P#]-'2_^A1_2#\^_P"7'=__ 'SR/^LG\.^]_P ,\K]U[C]D8PS'
MM,>VSG,G>Y:]\,^C8+J_FYGGBP^JTZ]C**^>.*>:;+"X"YQF&QT/PI_)';P1
M1\<_E^7X\\LGV?Q8?$AL=M3:8>\N<MBQQI$Y,_O;S'^%DRQ?)>?JWM:?JNRQ
M>9_F#AQQBIRV]FM8T]J_5/\ =M:)M/YLS,OF_P T'[9_\CCI_P#_ "=EOV7<
MG^EU\2O\L>8_]O'^QOW^53S#_"V[_P"6OZ5B6X]AGVG[JXGN9?%"&F2XFEGD
MIM^Z_(NSMZ:YJZI*Z8+2T[=@M;6'BJK]3'%11'13\*::>....&68_CN^*W%C
MKBKW7,UK$1&O&\1:=(C3QM;83:T_+-IF9GQF9EVE?.OS-K6*QR<Z1&GCM]K,
M_P!V9P:S^;/B\WLGV_7M69S&5V&,\?,]IUU5-#+QFM;[K[LNLG'1'SSS7;T1
M;?O^U8;F&XXY^%?-5IS)QQQ^IJIY_*[+COC^^*;8[F,^Y[@P;S%I,>[S<;QM
M:3,^O7;[7!DUCU:9-/EB7(V_GEYEX<G7DWU,M=/K;[?;Q'YOL8J6\/\ &T^6
M&/?ZN-[:'^+'</\ "SE?\ 9!_:+_ !*_MKA_N#'^F<_\OOF'_G-I]HK^>Q7D
M?MA/;]O<A?7EMV;Y:8BWN[RYN;?$X[L+J>7'XR&>:N6+'6,F6Z-R>4DL[*.O
MB.*JYN;BXYHIXYDEDK^-?.4[?Z3CS_P[>F')QG:>;)2E:SDOM-]%[S$1$WM&
M/DZ4BUI\;12E*:S/36L:1'98_B,[YI2M+;?B[VB(B;3BS:SIZYZ=Q%=9],Z1
M$?)$1X,>[5]K9XEWEQ:5:1Y$>16O6M$-=-]#M7'6FY7%Q<<U_&.6TN<1I6BQ
MV4-$?Y*HZXIZJJOR\5\<?J60\5]*'YLX<=XYOM[MW<99F.F<'SS;Q$:>,6KD
MW.ZFTZ^B8M6(CPTGTN?MOB1[HI6?GFPV&2VOAT>]QQ$?5BV3)K^;K'YC&.T?
M:K=8W>/ACTOS&WS 92F\CKN+S:.HM?V_'RX_B&XIEMH<;B=XT>X@O*[BJ*NF
M>J[DHIHHKHYAJYKXKCR;B_I3NY\6XFW-=G[#<;7HF(K@W^7;WB^L:6F^3;;F
M)K$=436,<3,S$]<168MV.V^);D:WF=YQ."^+3PBF>U)U\/'6V/)$QIKX=,>J
M=?#2<2[)]J=L]KC*Y=0\W<#G,SQ-#318;)X_Y#5<95;U<\^O+7EL9W#N5U1-
M'3\.:(^+*JFOG\G-=']EEG'?2I<9EW,4Y?LG/@V>DZVP\K3/?7U1[N_'[>ND
M^N?>1,?)+M-O\2^VMDTW7#WIBT]--S%YU]7LS@QQ_=ZO[DL29_[6?R>M\3=S
M:OY+=#9C.T>A]#CL_B>P=;Q-Q\US#1<_5YK'8/:[RR]&SJDDC^2PG]26FF/G
MY*:N9*,MV'THWEEDW=*<IVUSV'8SKU7Q9-IFR1[,]/3COEP5MK;2)URUTK,V
MCJF(K/:8/B2[<MEB-SQV]IA\=9K;%>T>'AI6;4B?'2)]J-(\?'32<,[)]LG[
MAF#QE=_C-T\7=QNJ9H8N,+K?8_8-KDY*).>>*[BB7;^H]5PW$-OQQ\:^*KOB
M3GCG]335S^1F7'?28_#YOMS&#<[+NC9XM)GWF;9[2U(F/5IM]_GR:SZM,>GR
MS#MMO\1'8F;)T9,/)8JZ?77Q8IC\SV,][>/^+I\LL,[1]O'[H> Q\-YB>I=#
MWBXEO([:O$ZOW'UU:9"WAKAN):LC-)NF<U#%U6<4D-,=5,=S7<<US4<TQ54<
M5UT9EQ?TA/PP\AN)P[OEM_L<<4FT9,_'[NU)F)B.B(VV+<7ZIB9F)FD4TK.M
MHGIBW;[;SW\N,]YIEW6?#6(UZKX,LQ/H\/L=;VU]?C$1X3XZZ1.$]L]DOW2=
M,^@_&/$7<+S\2^J^G_-/<>J]]]/Z/Z;UOK_S&WS8OPKY_JJ?2^J]'U_A7Z?S
M^G)\N:\5\:WPN\S[SYGW=LZ>[Z=??[??;77JUTZ/G.UP]?UL]71U=/AU:=5=
M>WVOG!Y;[OJ]URF*.G37KQYL?IU]'O,=.KT>.FNGAKIK&N$]H]LKW#]0R$.-
MRWA/Y.7=Q/9QWU$FK]-;SO&/IAEFN+>FB;+:7AL_B[>\XDMJN:K>2:FXHHYH
MKJHXHDHJJS7B_B8^'KE]O.YVG>O;-,=;S68S\CMMM?6(B=8Q[G)BO-=+1I>*
MS29UB+3-;1'<;;S$[#W5)R8N8XZ*Q.GMY\>.?5/UN2U;3'CZ8C3TQKK$L&9C
MQA\E=>R=[A<_X\]Y8/,XZ;FWR&)S'4V_8S)V%QQQQ5S!>V%[@(+JUFXIJXYY
MIKHIJ^'/]AG&S\SO+;D-M3>[#N'@\^SR1K3)CW^UO2T?+6U<LUM'U8F8=SB[
MC[>SXXS8-_LKXK1K%JY\4Q,?+$Q;26#F<.Y
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M]F_C2_AK];:?1/R2V$:^=$
M
M
M
M
M
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M[[>9+W^NFV;):;:^G69M.NOU6;&%.G
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MU/M/R<TN_O?FKQ%I^=W7&QZSA)>?DXIH_#LEU;%L>2LZ>*>?U$N8XFYYJ_\
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ME[N8I.:^[V_5/C[S#,]/C/C;W5LOI]/L]4Z3&L1.L1JON/LP>Y_HUQS;9KQ
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M5VOO:S;9\EL,M:SI,TW&*T1/R3TWG1KJV([X
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MTW&UR3Z/>4M6+?5K,QTVCPGQK,QX3\C-C"G3@
M
M
M
M
M
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MSX_;UVFPQ8L&UI&E:8ZUI2(]&D5K$1'A\D/*NT<D
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MQD3\^Y388[UB)FOO\<WTF=(F*5M-Y_N5GPUGT1,MY-%^W_\ =&W2WCO+WHG
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M6[Y+D=__ //;C/FTF9^R7M?QGTS[4SXSZY>\="X0
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MP9MONHC6:9:6QWB/1KTWB)],3ZO4]LZ1PP
M
M
M
M
M
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M;S$3:9F&%;WDN1Y*_O>1W&?<9=9G7)>UYUMXVG6TS.MIB)F?7ZWO'0N$
M
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MF)],3\DOV?A_
M
M
M
M
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M(B/"(CPB&TZUK2L5K$16(TB(]$1\D/Q?M_0
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MZ:^]S9,GH]'U]I]'J^1F!B#J@
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M7C_[?RFRO?\ O9RUI?PB)F>B\UOIX^GITUUCTQ,1IFW(RT
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M_1/UMI\(U]#9!KACX
M
M
M
M
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MVKII,UKK>T>'UV2VN2_HCZZT^,:^EK>V,[\
M        !GCJ'Q;\E._Y8:.D>@^X.UH9;R"QKR.A==[7LV$LIKB[CL::\MGL
M7B[C"X6SBNI>*9KB[N(+>#CXU2UT4\<\\8)W=YH^6W8-;6[VY[A^*O%)MT;K
M=X,.2T16;:8\5[QDR6FL:UICI:]O16LS,0Z7E>Y.WN#B9YC?;3;3$3.F3+2E
MITC7V:S,6M.GHBL3,^J)2H=0_;O>Y?VC%#=;#H?6_1]A=6<%]9W?;W9F)IEG
M@N;2.[AHFPW6%KV=L>)O.>).(Z[>_LK6X@FXYHEHHYXY^$6N[OI"_AJ[8M;%
MQ^_Y+F\]+S6U=AL\FD3%IK,QDWMMEAR5\-8OBR7I:NDTM;6&M>5\^/+SC9FN
M#/N-Y>)F)C!AMX:3I]=FG#2T>N)K:8F/&)E*[T]]J[J%K+97W?WEGLF;AJ^?
M\1UCI[K[&:M+!\EW<4Q_1;UNF6W"FZ^IL>(JZOGUV'T)JJZ./5IIXKJBIW?]
M*7R^6M\'8/:>VP7CZS-R&[OGB=:QKU;;;8]OTZ6ZH\-W;JK$3[$S-8UEROQ*
M;JT33@^+QTGU7SY9OKX1Z<>.N/32=?1EG6-)\/0E$ZA]@OVR>IXH9+WI7,=M
MY>&S@L^<WV]O>R[#++\EI';75U-KV!N]6TBJ\R$M',\E?&*X]&:KGZ?B&/X4
M<1@[N^/7XF.Z[37#S6'B=I-YM[O8;7#BB-;3:M8RY:Y]STTB>F(]_P"U6(]Y
MUV]IKCE?.[S$Y.9BF\IM<4S,].#'2OKUB.JT7R:1Z(]OQCZ[6?%*+UET5TCT
MI:7%ATUTYU7U)8W?S?5V7677NHZ%:77SR^M7]1;:KB,5#-\\W'S\_-3S\:OR
M_P!E%_N;OGO;O7+7<=Y<QRO+9Z?6VWN[S[JU=(TC2<^2\QX>'AZO!KCD>:YC
MF+1?EMWN=U>/1.;+?),?F3>UF5&+.L
M
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MS$1-->N->F=-:QK$:QK'BUI;)9"
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MB6IK5M2TUM$Q:)TF)],3\DOV?A_
M
M
M
M
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MNVVF.F+;4C2M*5BM:QZ=(K6(B/'Q\(?!<Y]@
M       &U'27@[Y@>1_TDW2/C=W!V#B[[T_I]GQ.DYFVTGCU?AZ7U&]9:WQ^
MG6?JT\_&CUKZ/YJ>.>>/CQ3SSQJWO;SO\H?+GKIWMW)P_'[JFNN')N<=MSX>
MG3:XYON+:>OIQ3I.D3XS#&N8[R[5X#6.8Y#:8,D>FELE9R?W,=9G)/\ <JF
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MTS/RR_9^'\
M
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MVB8FMHF8F)B8G1GN/)3+2N7%:+8K1$Q,3K$Q/C$Q,>$Q,>,3'I?QOL_0
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MR4GU7I-JS/AJC]RW"<OP.Z^9<SMLVVW6FO3DK-9F/EKKX6CZM9F/JLM,3=6
M
M
M
M
M
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M?_>G/:QRG);O)CMZ:5O[O'/YN/%T8_\ \WP;L-*L/
M
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M6E<N*T6Q6B)B8G6)B?&)B8\)B8\8F/2_C?9^@
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MC"P
M
M
M
M
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MSZL<)-]K]@=I]H4K]Y=ICKNXB8G/>(OGG7PG[):.J(GUUITT_P %HVW@S(
M                          !]+#X;+[#D[/"X#%9+.9G(S<6^/Q.'L;K)
MY._N.>.:N(+.PLHI[JZFYIIYYXIHHJJ^'']AQMYO-GQ^VOO=_EQX-GCC6^3)
M:M*5CY;6M,5K'U9F(?/+FQ8,<YL]JTQ5C6;6F(B(^69GPA*MT%['_N4]_P N
M.N+3QZS'4>N7MY]'<[1W[>0]418CY;NJTDNLCIF;HD[4DLX_3KD^>TU^Z^>&
MGBJCBOYXN*XK]^_&Y\-O8-<F/+W#AY?D:4ZHP<76=].3V>J*TW&.8V,6G6(T
MONZ:6G2VG3;IUISGG'Y?<'%JVW]-UN(C6*;:/?=7AKI&2OV'7U>UECQ\)TTG
M2;'H+[63 0Q8[)>4?E!F,A-)9_\ K;3.@M;LL/%99"JTJ_\ L=V9V):9RK)V
M<-_73_Z74K2N6&/G_P!'5)_:H5]^_2D;^]LFV\K^V,..D7^Q[CE,ULDVIU?H
M]GM+8NBTU^3?Y(K:?T45]K4'.?$GGF;8^V^-I6-?9R;F\VUC7UX<4UTG3Y,]
MM)GUZ>,VW1/L[^W'X]7&,RFF>,6D['LN+FM[R#:NU:\IVQE^,G:5T2VN6M;?
M?;[.8#"Y*UECHDBDQUE9\0RT<24<4R?JD)^^OC ^(SS!QY=KS/<^]VW&Y:S6
M<&QBFQQ]%HTMCM.UKBRY*6B9BT9LF3JK,UM,U\&GN:\UN_\ G:VQ[OD<V/;V
MB8FF'3#72?369QQ6UHGT3%[6UCPGP\$D^.QV/Q&/L<3B;&SQ>*Q=G;8[&8S'
M6T%EC\=C[*"BVL[&QL[:B*VM+.TMHJ8XHHZ::(Z*>*:>.....$;]QN-QN]Q?
M=[N]\NZRWM>][VFU[WM,S:UK3,S:UIF9M:9F9F9F9U:_R9+Y;VRY;3;+:9F9
MF=9F9\9F9GQF9GQF9]+^Q\7X
M
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M.SNXIBG#\CMLN:VFE)MT9)UF(C[%DBF3TS$?6^F8CTS#3-N1EH
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MMJQ&L]6D3I,:AXU0
M
M
M
M
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MK'@DWV]VCVWVK@]SP.SP[>9K%;7B-<MXCQ]O+;6]_'QTM:8B?1$-76SV1@
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M<_S?.Y??<UN]SNLD3.GO<EKQ769G2L6F8K&LSI6L1$:^$0S,PUU(
M
M
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M3X3$^A_8^+\
M
M
M
M
M                     /$]B=E=>]1ZCEM^[2W?5>O-)P4/KY?:MSSN-US
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MW-YUM>]IM:T^C6;6F9GP\/&7WG ?
M
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M6T1:)^I,0](ZUQP
M
M
M
M
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M-.!VN+;XYCVK1&M[Z>N^2VM[_P#K3,1ZHB&M+9+(0
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M9F9F9F=6L,F2^6]LN6TVRVF9F9G69F?&9F9\9F9\9F?2_L?%^
M
M
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M=WCG2U+UFEZS\EJVB+1/U)B'I'6N.
M
M
M
M
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M1VSV=VYVAM9VO ;6F'JB.N_C;+DT_O\ );6UO&9F*Z]%9F>FM8G1JBVJR8
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MTS:T_5F9EJ3+FRY\DYL]K7RVG6;6F9F9^69GQE])QGS
M
M
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MQX'NKMWN?#[_ ('>8-S7368K;2]8\/KL=M,E/3'UU8\9T]+6]L9WX
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M6N.
M
M
M
M
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MCY?=K]E8>GA,'^E6C2^;)/7FO^;;2(K$^NN.M*3Z>G7Q:'M[,T
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M$1$1$:3Y+EN4YC<3N^6W&?<[J?T66]KV_,B;3.D>$1$1X1$1$>$,D,<=>
M
M
M                                    ^;F,-A]AQE[A<_BL;G,-D8>;
M?(8G,6-KD\9?V]7/%54%[87L4]K=0\U4\<\TUT54_'C^PY.SWF\X_<TWNPRY
M,&\QSK3)CM:EZS\M;5F+5GZL3$OIBS9<&2,V"UJ9:SK%JS,3$_+$QXPAR\GO
M86]O#R-M[V_P76,WCKNTL,G%IM'04]II^'IFHHNJ[*'(=:W-GDNMY<;1>7/%
M<_%CC<=?SQ4<14WD5--'-$P_+'X\/B%\NLE-OON3CN+A8F.K!RD6W&336O5-
M-Y%J;R+S6-*^\S9L5;3-YPVF;=6U^W/.SOS@+13-N8W^SB?&FYUO;U:Z98F,
MNND>'5>]8GQZ)\=:[GE%]M-Y?=5?7YOQRV_3_)K68/C-#A?FLNJ^S*(/[UJD
MH_ MHSEUIV2^DXEE_509ZFXN:(/FCMN)):(.+#/*_P"DG\HNZO=[+S%V>\[9
MY*WA.3VM]LYGVM/LN#%7<4ZM*^%MK-*3;2V6:UG(WQVW\0G:O)].'G\67CMQ
M/Z+QS8?7^BI6,D:^'IQZ1KXVTB;(#>V>E>W>A]NOM#[HZUW;J[<,=-+#<8#>
M-<RFNWU?$7R<_56-.2MH(\GC9XY:)(+NVJEMKB&2B6*2N.NBKF>O:?>G:/??
M$X^=[,Y+9<IQ&2(F,NVS4S5C77V;=$S-+Q,3%J7BMZ6BU;5BU9B-W<7R_%\W
MM:[WB-QAW.UM'A;'>+1^9.DSI,>,36=)B8F)B)B6,63.Q
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M-;5F/3$UG28GZDP^PX;Y
M
M
M
M
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M>U?!+SLKRE[5[,Z=SBQ_.^8C2??YJUFU9CUXJZ:8OS8UOIX3>81+I8MG@
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MF=9;C-/,3
M
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M3+2N7%:+8K1$Q,3K$Q/C$Q,>$Q,>,3'I?QOL_0
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MEK[OB:SR/$Q,S$XX^S5K_AXO3.D>F<?7'KF*QX)YT$&E
M
M
M
M
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M6M,VM/U9F9:;RYLN?).;/:U\MIUFUIF9F?EF9\9?2<9\P
M
M
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MZ^!WN'/DTF9QZ]&6NGIF<5XKDB/\+IZ9]4S#45MME(
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M(EC11:Q
M
M
M
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M+WWW7W;>9YS>9<N#7PQ5TIBCQUC['2*UG3PTM:+7\(UM,^+=)IAB(
M
M
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M5V3W)V9NHVW.[>V/':?8RU]K#D]/UF2/"9\-9I.EXC2;5B)C7<9IYB8
M
M
M
M
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MO)\UO+<ARV?+N=[?TWR6FUM/5$3,^%8_0UC2M8\(B(9(8XZ\
M
M
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M!;K#NMO$Z3-+:S6?5%Z^%J3/IB+Q$S'CIHP:SAW(
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MK,3,7>2XOD>&WE^.Y7!EV^^QS[5,E9K:/DG2?3$QXUM&L6B8F)F)B60F/N
M
M
M
M
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M;VRY;3;+:9F9F=9F9\9F9GQF9GQF9]+^Q\7X
M
M
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MK_I&/T_78ZQI>L1I[>/QUUUQUB-9L(J^VBP
M
M
M
M
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M[W9YO]Y]UUOMLN>-IQEIG[#@UI$U]&E[ZSDOX?71-HI,ZST1&D1+>B6U<
M
M
M
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M"9B)KI:=_&@V#@
M
M
M
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M:8M/\*-9MD_-R6MI/HB$DR-S7P
M
M
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M9/HGU/;.D<,
M
M
M
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MV''8L>#98XTI2E8K6L:Z^%8TB-9F9GY9F9GQEX]V[E
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MOAUIBT_PHUFV3\W):VD^B(23(W-?
M
M
M                                              -)_+OV\?$CS@PE
M=AW]U/A\SL<5GS9X7LS7^*=9[0UVBFGGBWXQ>YXZ*F_NK.UJJ^>BPR%-]C*J
M_P M=M6W5Y1_$+YM>2.]C<=@\MFP\=-^K)L\OV;99OEZ]O>>FMK>B<N+W>;3
MPKDAF':W??='9V;KX/=7IMYG6V&WMX;?+KCGPB9_OJ]-_DM"HWYI_;>>3?35
MQD-K\4\U#Y+=>\3521ZK<<XS5>X\%:UU_J(Y\9=W-MK&Z0VU'/'%5QCKBVO)
MJOCS3CJ*>.>5M?DQ](YY9]Y8\?%>:F&>VNX--)SQUY^/RVT],7K6V;;S;U4R
MTOCK'IW$SX)1=H^?_;O+5KM>YJ3Q^^T^OC6^"T_4F(F^/7Y+1-8_SDJ[NWZ;
MM_7NS9G2M^U79-'W'7+RK';#J6WX/)ZULV"R%%%$E=CF<#FK6RRN+O**)*:N
M8IXJ*^.*N.?A^7A8;Q',\1W!QF'FN!W6VWW#[BG7BS[?+3-ARTGPZL>7':U+
MUUB8ZJVF/#TM\;7=[7?;>F\V.7'FVF2-:WI:+TM'RUM69K,?5B9>;=BY
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M5(:]]^4/<G9EK[S%6=[P%8U]_CCQI'R9L>LS33^^B;8YC2>J)F:UF30Y:F
M
M
M
M
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M?9IP\7,^&WQ3-<6GJZ_'JR3ZYF\S&NO36L:5B3-&EKP
M
M
M
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MICP]*0.UW>UWVWIO-CEQYMIDC6MZ6B]+1\M;5F:S'U8F7FW8N0
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M.DRS Q!U0
M
M
M
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M>%H]BD^GW<)AT/VJ0
M
M
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M,Q/JEOK!GP;K#7<;:],FWO&M;5F+5M$^B8M&L3'U8E\=RWU
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M3:M$X:$33@
M
M
M
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M&9F?&9GQF6CK6M>TVM,S:9UF9],S\LOV?A_
M
M
M
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MQ6B)K:)B8F)C6)B8\)B8\8F/"8;NK:MZQ:LQ-9C6)CT3'RP_%^W]
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MMIA#_E^&Y3@=]?C>8P9-OOJ>FEXTG2?1,3Z+5GU6K,UGU3+*C%G6
M
M
M
M
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M8
M
M
M                                 !%UYS^T+X<>>/UNR[]J%YU]W')9
M_3V7=/6$UM@=LEKB]22VCVW%36UWJV]V?,_-%,M>1LZ\G3;4<PVM[:<5?-Q)
M_P COBY\XO(GHXW@-Y3D.SHOK;CM[$Y<$:Z1,X+Q-<^UMIK-8PY(PS>>O+@R
MZ:-C]F>:?=G96FWV.6,_$ZZSM\VMJ?5Z+:Q?'.GHZ+137QM2REYYY^RQY?\
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M,"B$U4
M
M
M
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M;Q1,[A[GYWNK???#GMQ?<;B(F*ZZ16D3.O32E8BM(^I6(U],ZSXMBFNW0@
M
M
M
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M(FMJS$Q,3"*.[VFYV&YR;+>X[XMWBO-;TM$Q:MHG28F)\8F)>D=:XX
M
M
M
M
M       #3/S7\\?'GP*ZON.R>\MH]*\O/4M=+Z[P'-KD.P>P,QQ#/+'C];P<
MES;_ "6='T]7U.2NZ[?&V?ZGB6>F22&.3<GDKY$^87GQW17MOL?:ZX::6W.[
MR]5-IM<>L1-\V6(G6TZQT8<<7S9/&:4FM;VKEO:'97.][<E''\-CUI'CDRVU
MC%BKX>-[:3X^/A2NM[>J-(F8Y_?N(^ZCY'>XCMU7.[9&;K[I3#Y*N^T?H35\
MU>W&HX:NCU([+,[9>^AC*NPMVM[62J/C*7EK#';^K-Q8VMC'/-%7?S\//PM>
M7/P\\3'WEQUY#O3-CBNYY3/CK&?)$Z3;'@KK?YIMIM$3[C'>TWTI.?+GMCI:
M)Q=A^6O =A[7_0ZQGYB]=,FYO6(O;Y:TC6?=8YGQZ*S,SI'7:\UB8C-26;#
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M.LI:+K6P
M
M
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MAR>&OLVF(TM'KI:(M&D^$UTF=Y&CV&@
M
M
M
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M]IM:UIF;6M,ZS:TSK,S,SK,SXS/C+Z3C/F
M
M
M
M                 U[\D_%3Q]\N^OKGK/R'ZPUOLC69/5EQDF5MJH-AU;(2
M\P<U9C2]KL*[78]0S%?%M11)<8^YMZYX.*H)O4@KDBKV#Y;^:GF!Y1]P5[E\
MO>3W/&\G&D7BEM<6>D:_8]Q@MU8=QC\9F*9:7BMM+TZ<E:VCO>W^YN<[6WT<
MCP.YR;?<>OIG6MX_O<E)UI>OCX1:)TGQC2T1,4W_ '"?MT.ZND:\YV7X976>
M\@NK((;W*WG6-Y!:5]WZ=9VMO'+):8BVQ_%M:]NPUU42U0T8RTM,SS\T=M'8
M7<E-5S)<1\/OTB79?>U<';7G+7!V_P!TVFN.N]K-OO;N+6F8BV2;ZVV$^-8M
M.;)DV_A;);<8:S&.LL.Q?/OB.8BG'=VQ38\E,Q6,T3/S?),SZ;3.LX/5KUVM
MC]-IO6/9BM;D<=D,1D+[$Y:QO,7E,7>7..R6-R-M-99#'9"RFKMKRQOK.YHB
MN+2\M+B*J.6*2FFN.NGFFKCCGCGA9)M]QM]WMZ;O:7IEVN6E;TO2T6I>EHB:
MVK:)F+5M$Q-;1,Q,3$Q.B0>/)3+2N7%:+8K1$Q,3K$Q/C$Q,>$Q,>,3'I?QO
ML_0                #)'4G<':'0W8.N]J]-[WLG7'8>J7G%[@MJU;)38[)
M6M7/'R7-G<?)SS;Y/#Y.WYJM[VPNHYK*_M9*X+B*6&2N.K'.[>T.V._.W]QV
MKWCL=MR/;V[ITY<&>D7I;UQ:-?&F2DZ6QY:37)BO%<F.];UK:.!RG%<;S>QR
M<9RV''N-AEC2U+QK$_),>N+1/C6T3%JS$6K,3$2N_P#M=>_IUMY17&O]'^5W
MX#T_W_?366&UC<;?Y,;U7VQD)Z\1B\;8037=[+/IW86=R=Y+\N.EIYQ=SS1Q
M]-<T32Q6/%(_Q/\ P%=R>5^/<=[^57O^8[!I%LF;;S[>^V-(C)>]YBM8C<;3
M%2L:YJ_9J:_9<=J5MGF'7F/Y(\AVW6_,]L]>[X.L3:^.?'-AB.J9F=(^R8JQ
M$>U'MQ^BK,1-UCM7.T"
M
M
M
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M^C'CB=/9QTC2M(\(UF(UM,1-YM;Q;.-9,=
M
M
M
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MB?5:)FMH\:S,3JR$Q]P
M
M
M
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M>L^%;1.DXZ3TS'A:;PGG00:4
M
M
M
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M2?"U8E*_B.9XOGMC3DN'SX]QL;^B])UC6/3$QZ:VCUUM$6CUQ#%;*79
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M'52VEJ^GQK-;6WJ:,86
M
M
M
M                       C]]P'W(?'SV[^MZ-M[5R,VR;[L$,\?7'36KWN
M._/G=[ZFF>B.]KANYZ:=<TFQNHOER.;N(ZX;6GXT017=Y5!9S;_\@?AQ\P/B
M%[DGB>U<==MP.WF)WG(9ZW^;;:OA,UB:Q]FW-JSKAVU)BUY]J]L6&+YJ9SV-
MY?\ .]^<A\UXRL8]ECF/>Y[Q/N\<?)X1[>28^MQQ.L^F9K36\<]?S@\_O(OS
M][,Y[ [PV?Y,/B_GAT;JW6Y\K9=9]>64D4,-SQK&NWV1R/PS&7]"BO(Y.XDG
MR%]73117+Q;P6T$'H*\D?(+R[\@^VOX/]D;77>9?'<[W-%+;S=VB9FOOLU:4
M^QX]9C#AI%<6*)F8K[R^3)>=79W8_ ]C\=\QX;']EM^J9KQ6<V6?5UVB(]FN
MOLTB(K7QF(ZIM:=)VZF7@                +'7MJ_;Z]O^3-OKG<GEA<9[
MHCHC)0_BN$TVWB@M>ZNRL?71%SC[J"PR5M=6O6NJY"J6J2F]R=O/E+J&#CT,
M?3;W=ODJ:Y_B2^D [0\M,FY[.\J*X.=[ZQST9-Q,S;CMG>)GKK-Z36V\STTB
M)QX;UPTM;[)N)R8LFVG07F%YY\5V[;)Q/;$4WO-5GIMDG6=OBGUQ,Q,3EO'H
MZ:3%(F?:R=5;8YNN=!>.'1OBYU]CNK>@.M-;ZQT?&_JZ,5@8+B6[R%SSS5S5
MD=AV#*7.0V/:<Q7Q7\*KW)7=W=U4\<4\R<T\<<<4L]^^8W?'FAW!D[H[^Y+<
M\GS>3]'EF(K2/[S%BI%,.#''JQX<>/'$ZS%=9E$+F^?YGN3?6Y+G-QDW.\M^
MBMII$?)6L1%*5_P:5K7ZC-C"G3@
M
M
M
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M[V*QI..(C]5C2(]%ZT]F;SYH%-(@
M
M
M
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MLL?^\O7T5G_-TGI]5INGA03:5
M
M
M
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MBU;1.DUM$Z3$Q,:3$^,3X2^DXSY@
M
M
M
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MI7U]-8B)F9M.MIF9S\P%T8
M
M
M
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MIG!EO>)K7:[F\VF;8L>#<;G+>:UF-Y?^=O"=U33C.=Z-AS]IBL:SI@S6F/\
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M$\QAO@WV*=)K:/3'JM6?1:EO36U9FMH\8EF!B#J@
M
M
M
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M/ETGTTF)UPXYT\/^<M6?:Z-;4695:2/
M
M
M
M                                  " #W)?81Z%\OJ]@[7\?J\#X\>1
M>0FR&7R<MICY8.H.T<Q=6]4E=>\ZWA[::?4\]D<G'1+/L&%MZY9:Y[JXOL?D
M[J:B6*??PW_'GWYY15V_:GF!&?N'R[QQ3'2+7B>0V6.LZ?Z-FR6B,^*E)FM=
MKN;Q6(KBQX-QML5)K;>'E_YV\WVK%.,YWKW_  %8BL:SKGPUB?\ F[VG2]8C
MPC%DG2-*UI?'6)B:-WD+XV=W>*O9.8ZG[ZZ\SW7NYX>:6GBURUO\^,S5G17Q
M3'FM7SMMS-AMGP-UQSQS%>6,\\%7/QIYJXKIJIXO \OO,CLGS3[;P]U]A\A@
MY#ALU8]K'/MX[>O'GQ3IDPY:_HL>6M;1Z=)B8F9D\%W!P_<O'TY/A,],^TO'
MIK/C6?[V]9]JEH]=;1$_W&#6<.Y                ;U>!ON$]_>WYVI:;W
MU)G)LAIV5R6,D[.ZCRM[-'I?9N&L*;NWXL\I'1'<58G/6-KD)^<;EK>/FYL;
MBKCFJF>WYFMIM&>>_P /O8/G_P!K7X+NW!&/F,6.\;+?XZQ.YV62W3/52=8]
MYBM:E??8+ST9:QI$TR13+3#.]>Q>#[YXV=ERE(KNZUGW.>L?9,-ITG6/1U5F
M8CKI,Z6C^]MI:.A=X&^X3T#[@?5=IO?4F<AQ^XXK&XR3L[J/*WL,FZ=99F_J
MN[?BSRD=$=O3EL#?76/GYQN6MX^+:^MZ>.:J8+CB:VA\^7GO\/O?WD!W3?@N
M[<$Y.'RY+QLM_CK,;;>XZ],]5)UGW>6M;U]]@O/7BM.D3?'-,MX*=Z]B\YV-
MR4[+E*3;:6M/N<]8^QYJQI.L>GIM$3'729UK/]]72T[U-&,+
M
M
M
M                                          8][4[8ZVZ/T+9.T.V]
MTP.@:#J.-NLKG]FV*]IL[&SM;6"2XJBAHXXKNLEDKFF+FBVL[6.:\O)N:8H(
MI):J:.<@[6[4[D[WY[;=L=I;+/O^?W>2M,6'#7JM:UIB-9]%:4C76^2\UQXZ
MZWO:M8F8Y_&\9R',;W'QO%X;Y]]EM%:TI&LS,SI^9$1Z[3,5K'C:8B-5 'W7
M_>:[)\^<Q7U?U=!GNI_%[7LE?56NL\96J+9^V[J&ZN[?';1V37C^((+7&\8R
MJBNUUR.2ZL[.XKKEGGO)J;:NVOV^%+X-NV_(79QW/W1;!RWF?N,=>K-T:X=A
M6:UF^#9]>LVOUZQ?>3%,F2D5ICQX:3DC+.#RR\I>/[(Q??+DIINNY,E8UOI[
M&"-(F:8M?3.OUV68BUHTBM:1U1:#U-UN,               !)![?7M>^2/N
M&[CS9]<XC\S>I\+>1V^\]X;592TZ=K?J07L]%AA[3U[.^WC9)ZK'F+BPQO-?
MTTDL55[+:024S(Y?$!\3WEQ\/?#^^[BS?/.Z\U)G;<;@M'SC-I-8FV2VEJ[;
M#'5U>]S:=<5M&&F:]9HP#OGS'[?[$VG7O[>]Y.\:X]O2?LE_&/&TZ3&.D:Z]
M5_3$3T1:8T7\?!+VZ?&[V^^OOS5Z8UGZW<\U9VT?8G;^R4Q7O8/8%[#S1)SQ
M?7_PYAP6MVTU%/TF&Q],&/M_DXEKHFNZY[J>@_ST^(GS'^(#N#[Z]Y;GHX;#
M>9VFPPZUVFUK/A[-?3ES3'ZIN,LVRWUZ8FF*N/%2$/>G?O<'?.^^<\ODTVE)
MGW6"GABQ1]2/T5Y_19+:VGT1,5BM8WQ:)84
M
M
M
M                                        UI\J/$3H'S.ZRO\ JKR
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M[3'3FT\<<SX=&:(\*SKX5OI%+ZQII:9I$R:'+4P
M
M
M
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MU#0.OM%ZJT[ ]>]9Z?K>@Z+JUGS8:[J.HX:PP&O8:TKGFNY8L?BL9!;V=O\
M47ES)/+531\TT\M<E?-5==57-+_/]P<[W5S&?N'N7>;G?\YNK]>;<;C);+ER
M6TBL3>]YFTZ5B*UB9TK6M:UB*Q$1$7?;[>\GN[[_ )'+DS[W).M[WM-K6G33
MQM.LSI$1$?)$1$>$/8.G<0
M
M
M
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M>J\665;"/8
M
M
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M[=E=E</V-P]>+XNO5EMI.;-,1UYKZ?76^2L>,4I$Z4CY;3:UM)VZF7@
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MM%@
M
M
M
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MDMBRUFN6LS%JS$Q,3$Z3$Q/C$Q/A,3XQ*)]JVI::VB8M$Z3$^F)^27[/P_@
M
M
M
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MF\]BY6"F.N>N>:2>\IUG58KJ/YK'!6$E%C:TT\5R?47E5Q>3T ^?'Q$^8?Q
M]R6Y;NW<3BX'#DM.RX_%;3;;2DZQ$1$17WV>:SIDW.6)RWF9K7W>&,>''!KO
M;O[GN^N0G=<IDFNRI:?<X*S]CQ5GT:>$==]/KLEHZK>B.FD5I7?9H9A(
M
M
M
M
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MEMYV[#N+W?"]SS3;<[.E:9/",.>?9K$?^[RWM,^QIT3^AF)F**WZQMO\
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M<[#<Y-EO<=\6[Q7FMZ6B8M6T3I,3$^,3$O2.M<<
M
M
M
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M8B(B/"(B&3F,NN
M
M
M
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MW^*=+4O&DQ\DQZIK,>-;1,UM$Q:LS$Q+)#''7@
M
M
M
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M6TVRVF9M:9F9F9G69F9\9F9\9F?&91<M:U[3:TS-IG69GTS/RR_9^'\
M
M
M
M
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M^;6T1:+5C/S 71@
M
M
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MX[8\1L<7&<9BIAV&&D5I2L:16(_],S,ZS,S,S:9FUIF9F7@W>N:
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MTN
M
M
M
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MUG6MHBT3#:AJQC0
M
M
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M\1L<7&<9BIAV&&D5I2L:16(_],S,ZS,S,S:9FUIF9F7@W>N:
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M4C:.C 0
M
M
M
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M5S'8W,6XOE*]6*VLX<T1/1FIK]=7Y+1X1>DSK2?EK-;6W8:58@
M
M
M
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MB(Z:8Z:S,4QUCPK6-?JVM.MKVM:9M.RS6K'@
M
M
M
M
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M/CN1V/+['%R?&9:9MAFI%J7K.L6B?_3$Q.L3$Q$UF)K:(F)AX-WKF@
M       -J/#KS%[K\'>Z\!W=TCG_ ,/S&/\ EQ^S:SD*KB;4^P=3FN(9LIIV
MXXN&:'\0P^0]&FJBNFJBYLKFB.YMI(KB*.2G5OG#Y/=E>=_96?LGO;![S9Y/
M;PYJ:1GVF>(F*;C;WF)Z,E-9B8F)IDI-L>2M\=[5G&NZ^U.'[RX>_#\Q3JQ6
M\:7C3KQ7T\,F.?5:/^2T:UM$UF8=(+P.\\>E/<!Z4L.VNI;_ /#\QC_H\7V9
MUGE+RWGVSK';)[>N6O#9FB*B#\0P^0]"67$Y:**BVR=M15SQ3%<175K;^<CS
MV\B>]?('O7)VGW9C]YL\G5?9[RE9C!O<$3I[S'KKT9*:UKGP6M-\-YB)F^.^
M++D@#WKV5S'8W,6XOE*]6*VLX<T1/1FIK]=7Y+1X1>DSK2?EK-;6W8:58@
M
M
M
M                                 AR]V;W9NOO;PZ^YU35.</O/E-O.
M'FGZ^Z^GFYN,;J.-N.9K6/LCLB.UFBN;36[2YBKXL+#BN*ZS=U%5%%5'!'=7
M5M,/X3_A/[@^(7N#[Z\K[[8^5VQS1&[W<1I?<7C2T[/9S:)BV:T3'O<NEJ;:
MEHO>+9+8L63:_EAY8;[OO??.MUUX>V\-_LN7T3>8\?=8M?";S'UUO&,<3K.M
MIK6W/&[0[0[![I[!VSM7M7;,QO/8>\YBXSVU;5GKCBXR66R5QQ11\U7R416]
MI9VEO%';VMK;QQ6MG:Q1P01QPQQQT^A/MCMCM_LOM_:=J]J[3#L>WMCAC%@P
M8HTICI'CZ]9M:TS-KWM-KY+VMDR6M>UK3.[CN.V/$;'%QG&8J8=AAI%:4K&D
M5B/_ $S,SK,S,S-IF;6F9F9>#=ZYH             ";SVF?9M[!]P/*<=J]
MCWV8ZP\6=<S$-K>;5!C^.=D[9R6.R4-&<U#K?ZRN*VM+.TMHIK>_V&2.ZM;"
M\YI@AM[R>BYCM82_%A\8O;_D!M?X*]N4P\GYH[G#-JX)O]AV%+TF<6XWG3K-
MK6F:VQ;2)I?+CUR7R8<=L5LNGO,_S8V/8V+[V<?%-SW)DIK%-?8P1,>S?+IX
MS,SI-<43$VK[4VI6:S;H"=5]3];='Z%K?5_4FEX'0-!U'&VN*P&LZ[94V=C9
MVMK!';TRS5\\UW62R5S3%Q7<WEU)->7DW-4L\LDM55?- W=/=?<G>_/;GN?N
MW>Y]_P _N\EKY<V:W5:UK3,Z1Z*TI&NE,=(KCQUTI2M:Q$1!WDN3Y#F-[DY+
ME,U\^^RVFUKWG69F9U_,B(]58B*UCPK$1&C(3'W
M
M
M
M
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MQ,UFMID.1Z8&
M
M
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ML^>UKY[VFUK6F9M:TSK-K3.LS,S.LS/C,^,OI.,^8
M
M
M
M
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M9K:9#D>F!@
M
M
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M9E%*UK7M-K3,VF=9F?3,_++]GX?P
M
M
M
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MR\V.-[XPUXW>Z;?N:F/6U/13-IKU7PSK,SI$=5L<^U6)G3KK6;1">FHV^
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M&P<
M
M
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MA73'K.2U.JR1J
M
M
M
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M6<.:(GHS4U^NK\EH\(O29UI/RUFMK;L-*L0
M
M
M
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MLS;%P75-<F;68ON8C]#$:1-,,SKK$^UDKIU=-9M2;*:MM'P
M
M
M
M
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M>6/E1YTUW$5[=[USQ&YUTP[J\Z1?6?U//;T1:/T.6=(M'A>8M$6O4H6RI0
M            -J/#KS%[K\'>Z\!W=TCG_P /S&/^7'[-K.0JN)M3[!U.:XAF
MRFG;CBX9H?Q##Y#T::J*Z:J+FRN:([FVDBN(HY*=6^</D]V5YW]E9^R>]L'O
M-GD]O#FII&?:9XB8IN-O>8GHR4UF)B8FF2DVQY*WQWM6<:[K[4X?O+A[\/S%
M.K%;QI>-.O%?3PR8Y]5H_P"2T:UM$UF8=*SPQ\Q^G/.3HS6>\>G,U#<V.2AA
ML-OU.XN8Z]DZXW2*TMY\UI.U6M-,4D&2QDD_',4_ITV^0M*XKJWYK@FCKY\V
MGG+Y.]X^1_?&Y[([QPS7/CF;;?/$3&'>;:;3&/<X+>,32\1[5=9MBR1;%DB,
ME+1%?'=O:?+=F\SDX;EJ3%ZSK2\1[&7'K,5R4GUQ/KC76MM:VTM$PVN:I8R
M
M
M
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MO&O36EB-7DT.
M
M
M
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MCG'NL4^$_H;TF9Z<E)]%J6B-8F/1.M9TM68C81KYT0
M
M
M
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MY<[3L/B/L\8\G<.>-<^6(GPCTQBI,^/16?3,17WEO:M'A6*Q+I8MG@
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M:SK%\GZ*M-?&F+P]5LD3;IK2>U UI,
M
M
M
M
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MLS6U9B8F8E,O%EQ;C%7/@M6^"]8M6U9B:VK,:Q:LQK$Q,3K$QX3'C#YKDOH
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M)NK
M
M
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MQBVXM$^&3)'IBD3XX\<^CPO>.O2*3JH,M,
M
M
M
M
M                  *[GO.^S%A_,/#YGR1\;L-C<%Y3X+&^OLFMP?2XO#]_
M8?%VM,<./R$TE4%ECNSL=904Q8S)RU417\5%%C?5\1\6MU96&_!I\9>\\H-Y
MA\N/,?-DS^5N?)IAS3U7R<5DO;6;TB-;7V5[3-LV&L3;%:9SX(FTY<6;?'E)
MYMY>U,M.W^X+VOVU>VE+SK-MM:9],>F9PS,ZWI'C6=;TC7JK>A]M&J[/H^QY
MO3]UUS/:?MNM9*[PVQZMM&'R&O['@,Q82U07V*S>$RUO:9/%9*SGHYHE@GBC
MECKXYXJIXY7L<7RG&<YQV#F.%W.#><3N<=<F'/@R4RX<N.T:UOCR8YM2]+1X
MUM6TUF/&)34VVYVV\V]-WL\E,NUR5BU+TM%J6K/C%JVK,Q:)]4Q,Q+X+G/L
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M.G<0
M
M
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MW_-.>\-S]X^#M>O;>"\ZV\8^<WB8TO:/3&.DQKCK/C,S[R\=716E@5 %HT
M
M
M
M
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M)B)A![+BR[?+;!GK:F>EIK:MHF+5M$Z36T3I,3$QI,3XQ/A+Z3C/F
M
M
M
M           K3>^Q[NEIXYZAG/$+QPVRSG\@=ZP]YB>U]LPES++>](Z1G<9S
M%7CL=D;.6*C$]J;987WQM*Z)*KS"8_GF[XI@N9\=<4V3_ Q\)&;S%Y?!YN^8
MVTO7L#8YJY-C@R5B*\EN<5]8O>EHGWFQP6K[<3$8]SETPZWQX]QCF0GDOY6W
MY_=4[JY_%,<'AO%L-+1X;C)6?3,3]=AI,>UX=.2WL>-:Y*S167F)G
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M^W^W[VIVU2VE[QK%MS:)],^B8PQ,:TI/C:=+WC7IK2Q&KR:'
M
M
M
M
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M7I>LS%JVB8F)B4X]IN]MO]MCWNRR4R[3+2+4O68FMJS&L3$QX3$P\V[%R
M          %H_P!B?WA;CIO,:OX6>4&VXVVZ3RDTN.Z8[.V:]KM.>J\]?W54
MUKH6Q92J&2WJZ]S^0N:N+*\O)(:,#=2?))+^'R4_05??'1\(&/O'9[KSH\L-
MIDMWKBB+\CLL-8M\^Q5KI;=8::Q/SO%2L>\QXXM.ZI'56GSBL^_C?YT>5->6
MQ9.[NW,5IYBL:[C#2-??5B/')6/3[VL1[5:Q/O(C6(ZXGKNYJ34/0
M
M
M
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M%JSX5I_[FLQKK_SEHB8TI$3>S*K21X
M
M
M
M
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M&*T^/OJ1Z?=VF9G)6/#'/M1]CF8QVK55Z-
M
M
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M8R?6U]C6;VN55*,P
M
M
M
M
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MKKVON<FE8UUG!DF)F<5M?&:3I:<=O'PCHM/56+7GA03:5
M
M
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MF)]W$QI.'',3.F28\,EO"<<>S7VYF:70U,J(X
M
M
M
M
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M>&OA>*Q6T0DF1N:^
M
M
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M+EM-LMIF;6F9F9F9UF9F?&9F?&9GQF4+;6M>TVM,S:9UF9],S\LOV?A_
M
M
M
M
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M$3TY*3];DI,Q&M+>J=/"8FLZ6B8C9!KACX
M
M
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M][3,VM:9F9F902W>[W._W.3>[W)?+N\MYM>]IF;6M,ZS,S/C,S+TCK7'
M
M
M
M
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MKC@
M
M
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M/-S'+9)R\AGOU7M/K\(B(B(\(K6L16M8\*UB*Q&D,J,6=8
M
M
M
M
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M36NLS6D+V"C!#
M
M
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MTS+:YJEC(
M
M
M
M
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M'"\WDI7NC#'A^A^<8ZQ'V2L>CWE?'WE(]4>\K'3-JT@'3X;O
M 7D?8#]U7]OG4,=X6>0&U_4]WZ#A^(^E]ESEY\^3[9Z\P.+O+J[U>22G'PQ7
M6X=98+%<2<R37,M]EL/\UQ537787EQ)1_P#'S\+'\ ^7R>='8&TZ>R-_FUY'
M#BKI38;O+>M:YXCKF:[?>Y;Z:5I7'@W&F.)B,^''6&_GAY:?>3=6[NX/%IP^
M>_\ I%*QX8,MIB(OZ?#'FM;32(BM+^SX1>E8LXJS$=0
M
M
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M5IX]/5,G",S70
M
M
M
M
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MUCTX[SI$>\IK&ND:6K-;1Z9B)2T76M@
M
M
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M7VT6
M
M
M
M
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M[8YG/P?*5Z=Y@OI/R6K,:UO68UUK>LQ:/7&NDZ3$Q&>&".E
M
M
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M<!E^S7C3=Y*3&D5G6+;:)T^NMX3FF)C2OV*=9MDK6Y*IT1.
M
M
M
M
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M$^,2@=:MJ6FMHF+1.DQ/IB?DE^S\/X
M
M
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MQF?&7TG&?,
M
M
M
M
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MF:UO%8\+:7\>J\Q;15.HP
M
M
M                     *&/W ?N7Q>3_;</BCT_F_J.BNAMDOI-QR]C5:2V
M79G<^/YO</=W]GD;2\O:,AI^@6$TUCCJJ.+>FYR%U?SR4W$5&/ECO>^ +X:K
M>6/:4^:O=^#I[YY[;5C;X[=46V7'7Z<E:6I:M>C<;JT5RYM>N:8J8*5G':=Q
M6TUO([R\GMSBY[FY6FG-;W''NZSKKAP3I:(F)B-,F6=+7].E8I$=,S>)KEK%
M6_            &Z7@-X3=D^>_D=J'1>@T38W$SS0YWL[>JK2N[Q_7/6UA>V
ML6Q[1<Q?&..[R7IW%-KB[*J2+B_REQ!!5)#%5)/%ICSZ\Z^V_(;RYWG?//37
M)NZUG%LMKU=-]WO+5M.'!6?&:TUB;Y\D1;W6&N2\5O:*TMB/>_>'']D\!EYG
M?:6RQ'3AQZZ3ERS$]%(^2/#6]M)Z:1:=)F(K/3*\>^@NLO&#IS0NB^H,##K^
MA]>X&SPF+AXAL:,CE;B&.GG)[+L=SC[/'V^5VK9LAS)?9.\]&.JZO9Y).::?
MF^7CS2^8/?O<WF=WCO\ OGN_/.XYWD,]LEYUMT4B9]C#AK>UYI@PTTQX<?5,
M4QUK76=-5>/.\WR/<?+9^:Y6\Y-[GO-I].E8]5*1,S-:4C2M*ZSTUB(9F8:Z
MD
M
M
M
M
M         !5V]_;VFIN[-?RGFUXY:S]3V]IN'CY[PT/"66/MI.Q]#P-ED+F7
ML7%PVUO#>9CLC4;..*"[@KJEFRV$AHI@YXN;"&WOK/\ X"?BOIV5O\7DIYB[
MGI[1WF:?O;NLMKS&SW66U(C:7F9FN/9[BTVM2T16N#<VM-]<>>^3!(_R1\SX
MX?/7L_G\FG%9;_Z/DM,S[K):8CW4ZSI7%>=9K/A%,DSK[-YM2D,NT3#
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MG37]%3IOX3::UE717:T
M
M
M                 0#>_-[EDWAQT;:]#]1Y[Z'R0[_P]W';9"PGQ]60ZPZC
MJN+C%;%N\EO/1=W%OF-MN;>XPF"K]&/CBNC(7D-Q'<8V..6?'P(?#93SB[XO
MWWW;@Z_+G@,U9M2T7Z-[O](OAVT3$UB<>")IN=U'5/A.WPWQVQ[FUJ;O\E/+
MV.[.9GFN4IU=O[&\:Q,3IFSZ1:N/6-(FM(F,F3QG_FZ36:Y)F.?LO[3C
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MN"V_OK3C,6M-OCG3V,?AK:?"-;Y)CKMKK,>%-9BL)($<6
M
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MCQUUC_G>_<O_ )9'</\ ^4L5^Q+9O]$7X:OY'</_ .QD_9&1?DK\O/P3M/\
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M@
M
M                HG^_5[47'C5N61\P>@\!#;= =C9ZBGLG4\3;XRQQ_3O8
MF<O.([67#8FP@LJ;/KW=KJ7^]:(HI(\9E/4MZJXX;FQAXO/^ [XJY\R>&Q^4
M'?NXM;O[CL'^AY\DWM?D-IBKK:,F2TVZMWMJQ[<VM$YL/3DB+7QY[S,_R3\S
M?X0[2O:G-WF><V]/L5[3,SGQ5CQZK3KKEQQZ9F8F]-+:3-;RK6K)$@P
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M;_*Y^&Y6DX]_M[]-Z_W(F+1/KK:LQ:EO1:LQ,>$LM,3=6
M
M
M                                         UO\M_*#KKPX\?NQ?(7L
M^X^.OZ)AZ[BQPD%W:VF6W'9KSGZ76]-P'-W5Q1)F-ARDE$-'/RU\01>I/)QZ
M44E7&Q_*7RQ[B\XO,#CO+[MBO_W#?YM+9)K:V/;X:^UFW&7I\8QXJ1-I]'5;
MIQUGKO6)R#M?MS?]V<YM^"XZ/L^:^DVF)FN.D>-\EM/T-8UGZLZ5CQF',%\F
MO(SLSRR[R[![^[<RWXMNO8&8^ON:8HXH,?A<396\.-UW6</;01016^'UK!6=
MO96_'R^K)1#ZDU4DU<DE?IQ\L_+KMKRH['X_L'M+%[KA>/P]-=9F;Y,EIF^;
M-DF9F9R9LMKY+^.D3;II%:5K6+&.W> X[MCAL'!\77IV>"FD?+:TSK:]IG76
MU[3-I]4:Z1I$1$8'9V[H           !>I]@#VM_XNW7UCYE]Y:[]/WKVSK<
ML76.L9FU^-_U-U;FN:)*<M<6L]/-&-WSLBPBCFDJIXYN\=@I:+2JN&6\R=KQ
M1G\??Q0_E#[@OY-]C[CJ[&XG<Q.]S8[>SO\ >X_#W<6CZ_:[.TS6(GV,VZK;
M-$7KAVV688^>'F1]_M];M+ALFO"[7)]FO6?#/FK^AB8]./%.L1^AMDB;:3%,
M=EEE6PCV
M
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M_:&.T[&)F^?;1X^ZCTSDPQ$:^ZCTVQ^,XX]JOV/6N.UFJL1G
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M+:>$_FUM$6BU8S\P%T8
M
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M:P+RS[^VW?G!1N;S2G-8-*;C'&D:6T\,E*]4S[O)^AF?1:+5\>G68NTGVQP
M          %ASV$O<[B\3>W*?&7N?9/H?'7O#9+:G!Y?)26D&)ZJ[=S/.-P]
MALN1R,L/$UAI^W0V=MC\K)+-398Z6B"_KY@ACO9:Z]OCR^&2WFOVE^4OLS;=
M?F'PFVGWN.D6G)OMACZ\EL-*1.EMQMYM?+@BM9R98G)@KUWMAK&B/.SRZGN?
MB_X1<1CZN>V>.>JL:]6;!76TTB/7DIK-J1$=5HZJ1K,TB+\RA5"0
M
M
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M
M
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M6U9B8M68B8F)B8U5_9,=\5[8LM9KEK,Q,3&DQ,>$Q,3XQ,3X3$^A_8^+\
M
M
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MKU4FU+5M-B7;O/\ '=S\-@YSB[=6SSTUCY:VB=+4M$Z:6I:)K/JG36-8F)G
M[.W=            +[_L%^YISY5=0?Q8>Y-EFR'D1TC@?6PF8S-YD\CFNU>I
M;">RL+38[_*W_$]-[M6G761M\=D?4GYN;NVJMKOX25\W=<=#/QZ_#1'E9W?^
M4WL[;1C\O.;SZ9,>.M*8]CO[1:UL-*5TZ<&XK2^;#I7HQWC)B]F(Q1:$OG=Y
M=_P:Y7^$?$XXKP.\O[5:Q$5PYYUF:16--*9(B;UTC2L]5?".F)L1J\FAP
M
M
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M$5B-(K6-(K6(K6(B(ADACCKP
M
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M,/A,S&;''5333Q]J8FDZ1,]-YTB?1/4,>857&
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M)Z_3,]41.2@^TV
M
M                             A:]Z/VQ\?Y]=$_GCUWB[.'R@Z4P^9RG
M65Y1Q#9S]B8#FCG)9GJ#+WU?,4,OXU-;\S8"6[JX@QV8KYI]6UMK^_EJF?\
M!C\3.X\A>^OO/W#EO/ECS6;'3>UG6T;3+KT8^0QU\9CW<3T[JN..K-MXB>G+
MDP;>L;=\H_,6_9'-?--_:9[<WEZQFCTQBMZ*YZQ_@ZZ9(KXVQ^JUJ4ASKLCC
MLAB,A?8G+6-YB\IB[RYQV2QN1MIK+(8[(64U=M>6-]9W-$5Q:7EI<151RQ24
MTUQUT\TU<<<\<\/0]M]QM]WMZ;O:7IEVN6E;TO2T6I>EHB:VK:)F+5M$Q-;1
M,Q,3$Q.B>>/)3+2N7%:+8K1$Q,3K$Q/C$Q,>$Q,>,3'I?QOL_0
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MO[6Y#LWGLW!<CI;)CG6EXC2N3';ZS)$:SIU1Z8UGIM%JZS,:MKFJ6,@
M
M
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M^X;;[2:<5AUQ[:D^F,>OU]O_ 'F32+6]/3[-(F8K$S):C6UZ
M
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M>.MW12:AZ
M
M                         I_?<,>UE_\ 97S\\?\ 6/\ _.3R;TW7\;_]
M(XM.Z<;B</A__I_&W74\_P#^ R%5/_V0G6]?1\?%'^I>0??^Z^2.&W&6_P";
MU<=?)DR?XOS"E:_YS;Q/_P OC2I\B?,GZWLCG,G[DR6G_EV\VM;\SW%8C^^I
M_>54_EO*5(           ":3V3?<=E\%/)&'5^PLS]-XX=YWF)UGLVJ_N[OC
M&Z'FZ):X-9[3MK>/U88OP6:XYM<M5Q1\9<3-77S\]=K;T\0Q^-7X<Z^>?EQ/
M*=OX>KS&X.F3-LNBM>O=8YC7-L9F=)GWD1UX(U]G/6M8TKER3.H_-_L".].W
MYW.QIKS^RBU\.D1KDKZ;X9G_  M-:>/A>(CPBUG18M[BWO+>"[M)X;JUNH8K
MBVN;>6B>WN+>>BF6&>":*JJ.:&:.KBJFJGGFFJGGCGCGX/.[DQY,.2V++6:Y
M:S,6K,3$Q,3I,3$^,3$^$Q/C$H%6K:EIK:)BT3I,3Z8GY)?L_#^
M
M
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M3CGJM<JJ49@
M
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MWV]_R?[_ /[:/']7)])Y_,)Q'_F_:_[NY5H#XCOXD;7\:XOWON5\)1.A8
M
M
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M6L1ICSS_ ,YX>BN?]%,QX9M9FVN6M8M!JPT<@
M
M
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M<<<<</.IN-QN-WN+[O=WOEW66]KWO>TVO>]IF;6M:9F;6M,S-K3,S,S,S.J
M^3)?+>V7+:;9;3,S,SK,S/C,S,^,S,^,S/I?V/B_
M
M                                                    "-[W?/Z,
M_P Q_P!#^1_7;$)'?"+_ %E>SOQQ3];R,_\ *O\ G#XG]UQ_DV<QYZ95B8
M      #IP^T'_1G^''Z'\=^NV7>9KXNOZRO>/XXO^MXU=GFI_.'RW[KG_)JD
MA1Q8                          YOOOV_TL?E;_W%_P#ALZ=>C;X#?ZJ/
M:O\ VG_OCD$_O)/^;'C/^D?OO.A_2];4        60/M>_\ C[[>_P"3_?\
M_;1X_JY/I//YA.(_\W[7_=W*M ?$=_$C:_C7%^]]ROA*)T+
M
M
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MSLWN+<<%O-;1CMKCOII[S%:9]WDTUG3JCZZ-9Z;Q:NLZ:MNFI&+
M
M
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MVR9)\;RKJ[Q[IWW>/<&?G=]X3DG2E/5CQ5UZ*1^9'C,_HK3:WK;:-3,7
M
M
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M
M
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M$Z3$Q/C$Q/A,3XQ*!5JVI::VB8M$Z3$^F)^27[/P_@
M
M
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M_+_P6XN^O#[')/O)CT9=Q&M;>/KIAUFE?"(F\Y)]JL8[19!5R-
M
M
M     (WO=\_HS_,?]#^1_7;$)'?"+_65[._'%/UO(S_RK_G#XG]UQ_DV<QYZ
M95B8        #IP^T'_1G^''Z'\=^NV7>9KXNOZRO>/XXO\ K>-79YJ?SA\M
M^ZY_R:I(4<6                          .;[[]O]+'Y6_P#<7_X;.G7H
MV^ W^JCVK_VG_OCD$_O)/^;'C/\ I'[[SH?TO6U        %D#[7O_C[[>_Y
M/]__ -M'C^KD^D\_F$XC_P W[7_=W*M ?$=_$C:_C7%^]]ROA*)T+
M
M
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M=;6\/53-I-Z^,Q%XR1[-9QUFR"KD:
M
M
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M<4ZQ[<S>.J,5ZNB \]*"
M
M                                   "-[W?/Z,_S'_0_D?UVQ"1WPB_
MUE>SOQQ3];R,_P#*O^</B?W7'^39S'GIE6)@        .G#[0?\ 1G^''Z'\
M=^NV7>9KXNOZRO>/XXO^MXU=GFI_.'RW[KG_ ":I(4<6
M          .;[[]O]+'Y6_\ <7_X;.G7HV^ W^JCVK_VG_OCD$_O)/\ FQXS
M_I'[[SH?TO6U        %D#[7O\ X^^WO^3_ '__ &T>/ZN3Z3S^83B/_-^U
M_P!W<JT!\1W\2-K^-<7[WW*^$HG0L
M
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MBT3$9^8"Z,
M
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M \-/$[K;PG\=NO?'GK&VADQ>GXWB;8]FYL*;#*[_ +SDJ8[C;-\SU'U-_/\
MB6PY/CFJ.&NYN*<?8QV]C!7Q;6L%%/F+\Y/-?N3SJ\P^0\PNYK3&ZWF33#AZ
MNJFUVU-8P;7%[-8Z,5/";12DY<LY,]X][EO,US=V]S\AWASV?GN1F?>9;>Q3
M76N+''A3'7PCPK'IG2.JTVO,=5K3.T35[&P
M
M                                                 $;WN^?T9_F/
M^A_(_KMB$COA%_K*]G?CBGZWD9_Y5_SA\3^ZX_R;.8\],JQ,        !TX?
M:#_HS_#C]#^._7;+O,U\77]97O'\<7_6\:NSS4_G#Y;]US_DU20HXL
M                    <WWW[?Z6/RM_[B__  V=.O1M\!O]5'M7_M/_ 'QR
M"?WDG_-CQG_2/WWG0_I>MJ        +('VO?_'WV]_R?[_\ [:/']7)])Y_,
M)Q'_ )OVO^[N5: ^([^)&U_&N+][[E?"43H6
M
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M6AO/7L/^$/"?PEX^FO,<?CGJB/3DV\3-K5]/IQ:VRU]<Q[R(B;36%]I0VA,
M
M
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M$,//?OZO.\K7M7B\D6XK97F<MJSK&3<>B8]'HPQU5C2=)O:^NO368LIJVT?
M
M
M               $;WN^?T9_F/\ H?R/Z[8A([X1?ZRO9WXXI^MY&?\ E7_.
M'Q/[KC_)LYCSTRK$P        '3A]H/^C/\ #C]#^._7;+O,U\77]97O'\<7
M_6\:NSS4_G#Y;]US_DU20HXL                          <WWW[?Z6/R
MM_[B_P#PV=.O1M\!O]5'M7_M/_?'()_>2?\ -CQG_2/WWG0_I>MJ
M+('VO?\ Q]]O?\G^_P#^VCQ_5R?2>?S"<1_YOVO^[N5: ^([^)&U_&N+][[E
M?"43H6
M
M                           *<'W&_MM5XK)_Q_\ IS7YJ\9F)L;@O)'!
MX?'V]%KB<GSQ!C-9[:KCM::).(<Y)5#B\S)S3SQQ>?27%7/-5Q<R<7$?1T_$
MA7=;;\@7>.XK&YPQ?+P^7)>>K)3QOFV&MM8UQ1U9]O&OZG[W''ACQUF6'D%Y
M@1EQ_P !^6R1[RD3;:6M,ZVCTWP>/][XWQQ_>]5?T-85'%M:40
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M@TUZ:3K]DPZSZZ3XUCQ^QVIXZ]41,:AXU0
M
M
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M3,VM,S,S,SK,S,^,S,^,S/C,H"6M:]IM:9FTSK,SZ9GY9?L_#^
M
M
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M
M
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MQ:)B?S'I'6N.
M
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M\C1[#0
M
M                      $;WN^?T9_F/^A_(_KMB$COA%_K*]G?CBGZWD9_
MY5_SA\3^ZX_R;.8\],JQ,        !TX?:#_ *,_PX_0_COUVR[S-?%U_65[
MQ_'%_P!;QJ[/-3^</EOW7/\ DU20HXL                          <WW
MW[?Z6/RM_P"XO_PV=.O1M\!O]5'M7_M/_?'()_>2?\V/&?\ 2/WWG0_I>MJ
M       +('VO?_'WV]_R?[__ +:/']7)])Y_,)Q'_F_:_P"[N5: ^([^)&U_
M&N+][[E?"43H6
M
M                                   (NO=N\ ,?[@/BGL&E8*SLZ.\N
MNOK-ZZ'S-S+!;4\[9;01?BNDWMW<WF/M+?#]CXBUYQLDMQ/1;6=[S:7TO%=-
MGZ=<G_A+\_=QY ^:FWYK?7O/8_(].UY3'6)M]@F9Z-S6L5O:<FSR6]]%:5F^
M3'[[!72<W5&Q_*_OB_8W<V/>9IG[S;C3'N:QX^Q/UN2(B)F;8K3UQ$1K:O52
M-.O6.:IF<-F-<S&5U[8<5DL%G\%DK[#9S!YFQNL7F,-F,7=2V.3Q65QE]%!>
MX[)8Z]@KAG@FHHEAEHJHKIXJXYX>DO9[S9\CL\7(<?EQY]AGQUR8LN.U;X\F
M.]8M2]+UF:WI>LQ:MJS-;5F)B9B5@^++BW&*N?!:M\%ZQ:MJS$UM68UBU9C6
M)B8G6)CPF/&'S7)?0          !<Q^VO]P/\X=>S/@%V5D?_6^HV>9WSQ[R
M-Q7\U62UF6^N\MV%U[+--=<5<WFOWU]^,XN***3F6RGR/%=44=E!3)3=])'Y
M ?>_D,/GYVWC_P!$W=\>UY:D?H,T5KCVF[B(K];EK7YOGM-HZ<E=OI%K9KS6
M)GQ!=C>XST[XX^OV++-<>ZB/5?2*XLOH]%HCW=YF8TM&/36;SI;15.HP
M
M
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MI:O[4BM_U:B*WQ =^_6]C<7?^]R;NU9_NX\$Z3^9ER1,?YK2?KX7 50J*P
M
M
M               "-[W?/Z,_S'_0_D?UVQ"1WPB_UE>SOQQ3];R,_P#*O^</
MB?W7'^39S'GIE6)@        .G#[0?\ 1G^''Z'\=^NV7>9KXNOZRO>/XXO^
MMXU=GFI_.'RW[KG_ ":I(4<6                          .;[[]O]+'Y
M6_\ <7_X;.G7HV^ W^JCVK_VG_OCD$_O)/\ FQXS_I'[[SH?TO6U
M%D#[7O\ X^^WO^3_ '__ &T>/ZN3Z3S^83B/_-^U_P!W<JT!\1W\2-K^-<7[
MWW*^$HG0L
M
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M;
M
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M:Q6(B*Z=]OMWR>]R\CO[SDWN?):][SIK:UIUM/AI$:S/HB(B/1$1#V#IW$
M
M
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M.A8
M
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M$WU%#R%
M
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M1%:UB(BM8B(B(B(C18=CQTQ4KBQ5BN*L1$1$:1$1X1$1'A$1'A$1Z'\;[/T
M          Z*/L9^WY_$J\4[+<]YQWTW?7D79X'?.PX9Z/C/J&LT07ESUYU[
M3S+:VMU;WF(PN7JO,M%73\8\Q?7%O\TL5K#)5YX/CB\__P M/FI?AN#R=78?
M;M\NUVDQZ-QFF:QN]WX6M6:Y,F.,>"T3X[?%CR:5MEO6(&><O?/\+^YIVFRM
MKPFPFV/%\E[^$9<OIF)BUJ]-)]>.M;>$VF$V*%;4
M
M                                                           "
M-[W?/Z,_S'_0_D?UVQ"1WPB_UE>SOQQ3];R,_P#*O^</B?W7'^39S'GIE6)@
M        .G#[0?\ 1G^''Z'\=^NV7>9KXNOZRO>/XXO^MXU=GFI_.'RW[KG_
M ":I(4<6                          .;[[]O]+'Y6_\ <7_X;.G7HV^
MW^JCVK_VG_OCD$_O)/\ FQXS_I'[[SH?TO6U        %D#[7O\ X^^WO^3_
M '__ &T>/ZN3Z3S^83B/_-^U_P!W<JT!\1W\2-K^-<7[WW*^$HG0L
M
M
M                 0A>^?[>7\=3Q>NM_P"O<99U^0'CQ9YC==-].P]3);WI
M,-I7=[OUCQ=VU%=Y5>7UG;<9'#4<T3TUY:SHM>.(:+^>XCFU\#GQ"?D7\SZ\
M!W!EO'8'<-\>VW&MM*;7<S;IVV]Z9]GIK:WN=Q.M9C!DG+,WG!3';<7DSWW_
M  0[CC8[ZT_>/?S7'D\?#'DUTQYM)\-(F>C)/A[%IMXS2*SSNGH93P
M     ?M;W%Q9W$%W:3S6MU:S17%M<V\M<%Q;W$%=,L,\$T55,D,T,E/%5-5/
M/%5-7''/'/Q?C)CQYL=L66L6Q6B8M68B8F)C28F)\)B8\)B?"8?RU:WK-;1$
MUF-)B?1,?)+I5^T%Y[6GGKXD:UM6Q9*SE[RZR^GZ_P"\L7;QRPU\[#9TW%.N
M[G''-S\9+/L'7+6+(5UQ\4P1Y/ZVVCX^6V^//FT^+OR&R^0_FUN>*X['>.Q^
M3UW7&7F8G[%;3WVWF8]%MIFM;%$3[4X?<9;>.17QYJ=DV[)[HR;;!68X;<:Y
M=O,_WLZ=6/\ -Q7F:^/C-.BT_7)446FM0
M
M
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M$Q];;QBF.=8GJM-JZ^[G3H7//D@H
M
M                                                C>]WS^C/\Q_T
M/Y']=L0D=\(O]97L[\<4_6\C/_*O^</B?W7'^39S'GIE6)@        .G#[0
M?]&?X<?H?QWZ[9=YFOBZ_K*]X_CB_P"MXU=GFI_.'RW[KG_)JDA1Q8
M                    YOOOV_TL?E;_ -Q?_ALZ=>C;X#?ZJ/:O_:?^^.03
M^\D_YL>,_P"D?OO.A_2];4        60/M>_^/OM[_D_W_\ VT>/ZN3Z3S^8
M3B/_ #?M?]W<JT!\1W\2-K^-<7[WW*^$HG0L
M
M
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M:EIK:)BT3I,3Z8GY)?L_#^
M
M                                                         (9O
M?#\\?XE'A_E,/J-_]/W9Y$_C_5O6?TUY])DM<Q->&Y_;![*M?A1\]?YFXO)V
MMK;U1U4RPY;,6,GPYCHD^$R?@B\B?RT^;V+><MCZNRNW?=;W>:UZJ9LD9/\
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MSW9NN]>Y,_.;CJKBM/1BI,Z^[PUUZ*1ZO7-K:>$WM:?6W2:88B
M
M
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M2B="P
M
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MYZ=E5[;[ECFMC68XODIM?ZE,\3KEKX>B+=5<E=?3-KQ$:43_ * C1X
M
M
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M[*PKRL[,_@5VGBV.XB/OMGGWVXF/[^T1TTU].F.D5IIZ.N+VCZY%VD^V.
M        ME_;7> %>Q[3GO/?LO#348339LEI'CS#=<6]5KF=IN[7)X;L;>OI
MY*>;CB'5<?<4XG'2\?&*:\O;[G]3+94<JH/I(_/VO'<7@\ANVLT3O=Y%-SRT
MUUZL>"MJ9-IMM8\-<]XG/EK]=7'CP>FN>81B^(/OB-OMJ=D\?>/?9HC)NM-=
M:TB8MBQZ^CVYCKM'IBM:>J\KFZFM$H
M
M                                                  !&][OG]&?Y
MC_H?R/Z[8A([X1?ZRO9WXXI^MY&?^5?\X?$_NN/\FSF//3*L3         =.
M'V@_Z,_PX_0_COUVR[S-?%U_65[Q_'%_UO&KL\U/YP^6_=<_Y-4D*.+
M                     '-]]^W^EC\K?^XO_P -G3KT;? ;_51[5_[3_P!\
M<@G]Y)_S8\9_TC]]YT/Z7K:@       "R!]KW_Q]]O?\G^__ .VCQ_5R?2>?
MS"<1_P";]K_N[E6@/B._B1M?QKB_>^Y7PE$Z%@
M
M
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MMM)GQB5<F[VNXV.ZR['>4G'N\.2U+UGTUO29K:L_5BT3$_F/2.M<<
M
M
M                         ! ]]P'YM_Q7O#B]ZDU#+_1=M^4?XMUYB?I9
M_3R&$ZS@MH/VTMCI^2KB2+ZS%Y"#!PU?J:_GR]4L?/S6]7PG9\ 7DG^4_P X
MJ=V\OAZ^T^U_=[O)U1K3)O)F?F6'Q\)Z;TMN;1XQI@BEHTR0W5Y'=G_PC[LC
ME-U37B^-Z<MM8\+9IF?<T_N3$Y)_Q-)^N<]YZ!TZ           &PGBIXV=@
M^7?D#UAX\]9VWJ;/V1LEMBI,G+%Q+C]6UZWIKO\ :]SS%/,UOS5A]0URUN<A
M<1T5^O/1;^C!37/)%'7K[S4\R.W_ "C\O^3\PNY;:<9QNVM>*1.E\^6?9P;?
M'X3]DW&:U,5)F.FLWZ[S7'6UHZ+N;N#8]K<'N>>Y&?\ 1]OCFVGKO:?"F.OI
M]J]YBL3Z(UUG2L3,=23H?I/0O'#ISKCHOJ_'S8W0^K]5QFIZ]#=R039&YM["
M/GFZR^9N;:VLK>]SV>R$DU]?W%$,5-Q>W$LGR4_-\O'EY[[[UY[S&[QY'OGN
M?)&3G>4W5\^6:Q,4K-I]G'CK:;37%BI%<>*LVM-,=*UUG356]S7,;[G^6W'-
M<E:+;W<Y9O;3T1,^BM8F9F*UC2M8UG2L1&O@RTQ-U8
M
M
M  "-[W?/Z,_S'_0_D?UVQ"1WPB_UE>SOQQ3];R,_\J_YP^)_=<?Y-G,>>F58
MF         Z</M!_T9_AQ^A_'?KMEWF:^+K^LKWC^.+_ *WC5V>:G\X?+?NN
M?\FJ2%'%@                         #F^^_;_2Q^5O\ W%_^&SIUZ-O@
M-_JH]J_]I_[XY!/[R3_FQXS_ *1^^\Z']+UM0       !9 ^U[_X^^WO^3_?
M_P#;1X_JY/I//YA.(_\ -^U_W=RK0'Q'?Q(VOXUQ?O?<KX2B="P
M
M
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MCWM*SK_ATFTSK=:/5>HW@
M
M                                                    /QN+BWL[
M>>[NYX;6UM89;BYN;B6B"WM[>"BJ6:>>:6JF.&&&.GFJJJKGBFFGCGGGGX/W
MCQY,V2N+%6;9;3$5K$3,S,SI$1$>,S,^$1'C,O[6MKVBM8F;3.D1'IF?DAS*
M?=A\T[CSF\S^R.T,5D)KKJ_59OVM.F+:JJOBWHZ[U.\O(K7.10U_#F*;=LS<
MWF:DXJXXDCIOJ(:N>>(:?AZ8/A2\F,?D=Y-<;VQNL<5[GW4?/.1MX:_.\]:S
M;%,^N-MCC'MXT\)G%-X\;RL1\L>T:]F]I;?CLM8CDLL>^W$^OWMXC6O_ .CK
M%<<>J>F9]:-E)!L           !=_P#ML_!"WZSZ:S?F[ON+FBW[N^'+:AU5
M;7L5%/.$Z<Q&6M8LCL$<,L4=Y:9+?]PPDOR\U<?+5B,;:3P5U17U?QI(^DA\
M]<G<O>6#R3X'+$\!PDX]QOK5F?LG(9,=IIBF8F:VIM=ODKKIXQGS9<=XBV"$
M.OB![UMR/+4[.V5HG8[.:WS3'Z+/:LZ5^28Q4M'_ *][5F-:0M!JPT<@
M
M
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M43H6
M
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MRO&;SA>3S\3R%>C>[;+;'>/5U5F8F8GUUGTUMZ+5F)CPEDACCKP
M
M
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M?7,S*N3/GS;K/?<[BTWW&2\VM:?&;6M.MIF?EF9F9?8<-\@
M
M
M        $;WN^?T9_F/^A_(_KMB$COA%_K*]G?CBGZWD9_Y5_P X?$_NN/\
M)LYCSTRK$P        '3A]H/^C/\./T/X[]=LN\S7Q=?UE>\?QQ?];QJ[/-3
M^</EOW7/^35)"CBP                         !S???M_I8_*W_N+_P##
M9TZ]&WP&_P!5'M7_ +3_ -\<@G]Y)_S8\9_TC]]YT/Z7K:@       "R!]KW
M_P ??;W_ "?[_P#[:/']7)])Y_,)Q'_F_:_[NY5H#XCOXD;7\:XOWON5\)1.
MA8
M
M                              YROOA^!W\2GS RF7U&P^GZ3\B?Q_M+
MK/Z:S^DQNN9:O,<_M@]:VOZOTZ_S-RN3M;JWICIIBAQ.8L(_CS)1)\/17\$7
MGM^6GRAQ;/ELG5WKV[[K9;S6W5?-CC'_ *)O+>N/G%*7I:9F;6S[?/;PK-4^
M/)SO7^%_:M<6ZMKS&PZ<.;6=9O7I^Q99_P#B1%HG7QF^.\^B80SID-M
M      +C_P!L_P"=]O?8':_ 3L'*3<9/!S9[M#Q^N+N6BJWFP-]-SD>S>NK7
MYYHN8)L9F9Z]DL88XIJ[FF_R\DLD=-M#173O])7Y%9,&_P!IY]]OXH^;9XQ;
M+E8K$ZQEK'1LMW;PG6+XXC9Y;3:L4G%M*UK:<EYK%#XANRK4SXN]]C6/=WBN
M'<Q'IZH\,.6?EUK'NK3,QITXHB)ZIF+<:I1%P
M
M
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M.F32)^4!VD
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MB8GQB8C.3!W3
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M_P &T:6K/KK,2S Q!U0
M
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M9F=9F9GQF9GQF9\9E7E:UKVFUIF;3.LS/IF?EE^S\/X
M
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M+(0
M
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M)+]GX?P
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M^(CL_P#4.]-G7Y,&YT__ &.2?_3CM,_^[A<!5"HK
M
M
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MG2U,=+1Z938H5M0
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MTP4K%:UK$16M8C2*UB-(B(B-(B/"(\(?-<E]
M
M
M         %K_ -@#W8\]K6W:CX%^16US9/2-HFM=;\:]OSDT-=WIVSS<UTXS
MJ/*YJ_R$$D^J[))339ZU#Z<]Q:966''1?&UN+>.SJF^/OX4=AR7$[OSX\N]I
M&+F]K%LW,;?%$].XPQIU[^F.M)B,^&-<F\MK6F3!6^XO]EQY+9HR^>'EC@W&
MUR][<#BBN\QQ-]W2OHR4]>>M8CZ^GUV6=8BU(G)/M5M-[H:F5$<
M
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M+CG]%CO6?6K7YSA]YV_S&YX7?QIN]MEM2WR3I/A:/\&T:6K/KK,2S Q!U0
M
M
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M[F<.#Y:S,>WEC_X5?&L^B,DTUB8F8=)1YP%?H
M
M        #Q_8>]ZSU;H&\]F[K?\ X5IO7.G[-O>VY3TZYOPW6=0PM[L&>O\
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M6ELED(
M
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MG_ WN_<<7BC389/LV#_X.2;:5_\ 4M%L?U>C7UI($<6
M
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M_8Y)_P#3CM,_^[A<!5"HK
M
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MBW3/V3)'^/?72?72M/D3 HA-5
M                                                         (-O
MN'^X\AU1[:VZX/%W/T=YWAV1U[TYS<TV\\T_&/O)LMV)F[:":*>**R_$L%US
M<VLLDM$U%5O/)%Q3Q))1+'.#Z/7L[;]U_$ELM]NJ]>'A.-W?(::Q$==8Q[3'
M,Q,3-NC+O*7K%9K,7K6TS-:VK;<GD1Q-.3\P<.;)&M-GM\N?37UQTXJS/AXZ
M6RQ,1&GC$3KI$Q//&>A-.X
M
M                                                         !:_
M^UB[EN+#M?RD\>[B2::UVKKW5.Y<1#5Q7S;X^XT#9*-(V.2*JGCB.B;,1]EX
MKB3BKGFJJFQH^7X<4U_&J;Z4CLW'G[5[7\P<<1&7:\AGX[)/AK>-UA^<X8GU
MZ8YV>?33PB<LZ^F$9?B3XFM^,XWG:Q$6Q9[X+?+,9:>\I_[/NKZ?XTZ^I=#4
MRHC@
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M6Q9(_0Y*6CU+(^#YC9]P</MN:V$Z[3<XJWK\L:QXUG_"K.M;1ZK1,,/LO=J
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M6?768EF!B#J@
M
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M2/\ $IKI/JO:GRND$\Y* (
M                                                      "K)]T[
M<7%/CUXM6E,\U-K/W-MEQ-;4RU\6\UQ:Z15%;3RP\5>G)-;QWDM,=7/'-5%,
MM?''/'%57QM(^BWQXY\PNZ,LUCWM>&P1%M(UB+;G6T1/IB)FM9F/1,UC7T0D
MG\-E:_?WDK:1U1M*1KZ])R>,?W=(U_,A2875I?@
M
M
M              )YOMPKBX@]RS7XH9YH8[SIGMBWNXXI:XZ+JWIL<5=TP7%%
M%7%,\--U:Q2\4U?&GB2.FKX?&GCGB"'TC./'?X;-Q:]8FU.9V,UF8B9K/5DK
MK'R3TVM76/'29CT3+2GG]6L^7MYF(F8W>&8^I.MHUC^Y,Q^9,N@X\_:#
M
M                              "G]]S7X2?N?>=NC8C_ .UG4G>GT<'_
M --_:QW>^].G_P"G8&[N).?_ +50TK>OHS_.O_:'D7SF;^_W_&=4_F?/=M77
M_P!7=8Z1_P#O5Y2I^'?O#]7[+WEOES[;7_\ ;8X_]&2L1_[R5/Y;RE2
M      N8_;*>;?XYJ?8/@EO.7^.1TO\ $^V^BOK)_AZNIY?)1?MG:18>I5%!
M'^![3DH<]:6\?$MS<_C&5FJ^6&T_)3=])AY)_,>6X_STX/#_ */O>C8<GTQZ
M,^.D_,MS;369][@I;:Y+STTI\WVM(UOE\8F?$1V?[G=8.]-E3['FTP;G2/T=
M8^PY)]?M4B<=IG2(]WBCTV6T53J,
M
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M:@
M                                   57?NG_P!P+Q5_3!N?^9<*TKZ+
M;^/W=7XGV_[YE)3X;/\ ;G)_N3'^N*3ZZE+X
M
M
M           !/!]N/_28:O\ H?[9_6FQ03^D7_JU;K\<;#]<LTMY^_S>9/W7
M@_RI=")Y^$%@
M                                             &'_ " Z1TGR1Z4[
M.Z([%M/K--[2T_+ZEF/DHCDN;#\0M^?P_.8[U>.8X\QKV5C@O[*3G_T5W;1U
M_P#FLO[ [VYKRX[UXSOKMV_1S'%[S'GQ^,Q%NB?;Q7T\9QY:3;%DC]%CO:/6
M[7@^8WG;_,;;FMA.F[VV6MZ_).D^-9_P;1K6T>NLS#E>^0'2.[>-W=?9W1'8
MMI]'N75NX9?4LQ\E$D=M?_A]QS^'YS'>KQQ))A]AQ4D%_92<_P#I;2YCK_\
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M>$^N/%[9TCA@
M
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MI%[UG28ZXI6?KG2X>:Y7J
M                                                       JN_=/
M_N!>*OZ8-S_S+A6E?1;?Q^[J_$^W_?,I*?#9_MSD_P!R8_UQ2?74I?
M
M
M                              )X/MQ_Z3#5_P!#_;/ZTV*"?TB_]6K=
M?CC8?KEFEO/W^;S)^Z\'^5+H1//P@L
M
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M,SXQ"SZK&1S
M
M                                  4PON>/+_\ ']\ZD\*M2R=YQCM!
MLZ>X.WXH9/DQ][MNRV=5AUM@)X^8XIZKS5]6JO\ )2_JI+:6C/VO/'/$UO7Q
M3<O]&3Y0_,."Y;SHY;%3YQO[_>_83,>W7!AMU[S+$ZS'3FS^ZPU]%ZSM<NOL
M9(F9;?#IVK[C9;KN_=5CWF>?<8/EBE)URVCZE[]-(]$Q[JWJM"ITM<2<
M       =!O[?3PLM_&GPPQ?<VR8^&CM#RMAPG9=[<U4T5W&,ZKXLYI>I\'%-
M3\W'HY'#9.;/2<T\\<\U9BB*3CGFWI^'G[^D!\Y\GF3YRY>S>-R3/;':LY-G
M6OCI??=41OLLQ\M,E*[6-?5MYM7PR2@QYY]W6[A[MMQ.WM/WMXR;88CU3FU^
MS6_N6B,<?XDS'UR>=!!I0
M                                                      !5=^Z?
M_<"\5?TP;G_F7"M*^BV_C]W5^)]O^^924^&S_;G)_N3'^N*3ZZE+X
M
M
M                            !/!]N/\ TF&K_H?[9_6FQ03^D7_JU;K\
M<;#]<LTMY^_S>9/W7@_RI=")Y^$%@
M
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M3X3$^A_8^+\
M
M                                /!]I=D:KTYUKOW;&\WWX=IW6VG[%
MO&SWG%5M3+#A-8Q5UF,AQ;<7=Q:6TMY+;VE5$$=<L?$DU5-'S<?%WW:_;?*]
MX=R;#M3@Z>\YCDMYAVV&OCI.3->N.FO3%IBL3:)M,5G2L3.G@YO&\?N>6Y#!
MQFRKU;O<9:XZ1X_77M%8UTB9TUGQG2=(\7*E\D>]-K\FN^^W._\ =:?1V/MK
M?-AW2[QU%Y<7]M@;3*WTE>&U;&W=W\+J;#ZGA:;?&V7J?JJ;2TCXY_L/5!Y<
M=C<5Y9]A\1V#POM<=Q.PQ;>M^F*6RVI6(R9[UK[,9,^3KS9-/#WE[2LN[?X;
M;=N\)M>#V?CM]K@KCB=(B;36/:O,1X=5[:WMI^BM+";-7;@         -]O;
M-\/;CSD\RNI.BKJF:/1ILE+NG;=_!/7:S675>F\PY3:[>VNH*Z;JTR6S4^CA
M+&>*F3FVO\G!-73Z4<G/&AOB6\W\?D?Y.<MWSBTGG*XXV^PK,1:+;[<:TP3:
MLQTVIA]K<Y:VF.O%AO2)ZK5B<)\P^ZZ]F]I[KFJZ?/8K[O!$QKKFR>%)F/1,
M4\<EHG36M)B)UF'4 QV.Q^(Q]CB<38V>+Q6+L[;'8S&8ZV@LL?CL?9046UG8
MV-G;416UI9VEM%3'%%'331'13Q33QQQQQP\Q>XW&XW>XON]W>^7=9;VO>][3
M:][VF9M:UIF9M:TS,VM,S,S,S,ZJYLF2^6]LN6TVRVF9F9G69F?&9F9\9F9\
M9F?2_L?%^
M                                           %5W[I_P#<"\5?TP;G
M_F7"M*^BV_C]W5^)]O\ OF4E/AL_VYR?[DQ_KBD^NI2^
M
M
M                    3P?;C_TF&K_H?[9_6FQ03^D7_JU;K\<;#]<LTMY^
M_P WF3]UX/\ *ET(GGX06
M                                                         4^/
MN</"RW@KZV\Z-,Q\,,EY-C>G.Z8X*:(Z[JXIM[R[ZSW":CCX53S4VMK=8:\F
MJ^-7$<>-CIX^%-7/%OOT9OG/DO7DO(WF<DS6D7Y#CIG68K&M:[S;Q\D=5J;C
M'6/#6=S:?&82J^';NZTQN.S-W:9B(G/M]?5&L1FQ_P#+,9*Q\LY)5!%NR5
M         #H*_;R>7W\8KPBL^GMBR=YD>QO$^\QW6^3EOI/6GN^L\WSF+_IZ
M[HDICCBAL\1@L5=Z[;P<?&NBWUZBNKGGF3CGGS_?2$^4/Y._.R_>''8J8^W>
MZZ7WE(K&D5WF/W=.0K,:S,VR9;X]W>WHF^[M$:=.B#/GOVK]X>\9Y7;UBNPY
M.)RQIZLU>F,\?FVM:N69^7+,>I/:@:TF
M
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ML(]@
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M;%!/Z1?^K5NOQQL/URS2WG[_ #>9/W7@_P J70B>?A!8
M
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MGP:>F;4^OI'KGKQ3>(KZ)OT3/UL.DT\WJOP
M
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M?&95J;W>;CD-YEW^[M-]UGRVR7M/IF][3:TSKX^,S,O5.J<8
M
M                      !5=^Z?_<"\5?TP;G_F7"M*^BV_C]W5^)]O^^92
M4^&S_;G)_N3'^N*3ZZE+X       !E_QZ_=]Z/\ TP=:?YZ85B'F#_$'G/Q/
MO/WMD=5SO^P]Y^Y,WZW9UHWD[5A
M
M                                           .>[]QQ_28;1^A_J;]
M:;YZ!_HZ/ZM6U_'&_P#URJ=/D%_-YC_=>?\ RH0/IV-T@       )X/MQ_Z3
M#5_T/]L_K38H)_2+_P!6K=?CC8?KEFEO/W^;S)^Z\'^5+H1//P@L
M
M                             I5?<U^&=WJW:77WFYJ>.^;7.T+/&=6]
MLRVUK%3]!V#JV*EIT?/9&>&*F2?\Z-'QO..IKEYJ]'\ BH^;^VQ4<71_1G^<
MF+E.U^0\D^6R:<CQ=[[W81:T^UM,]X^<XJ1,Z1[G<W]],5TZOG5K:>Q:9EY\
M._=M=SQN?L_=6_TC;3.;!K/IQ7M]DK$>KHR3UZ1Z?>3/JF55):@DL
M    Z9/M#^8O\=/P=ZKW_/9_\=[5T>SXZI[EFN*O_6EQOFF6EI;<;#E>.9I>
M9;S=]<GL,S+-1Q1#)<WTM-%$?R<QT>:7XN?)[\B_G?RO ;#;^X[5WU_GW'1'
MUD;7<6M/NJ>$:5VV:,NWK6=;13'2;3;JBUJ\O-/M3^"/>6YV."G1QF:??8-/
MK8QY)F>FOU,=^K'$>F(K&LSKK,G*,S70
M
M                                                  ")SWJ?+:W\
M1_ ;M7,8Z\FM^PNXX:NB>LZ+;BCF:'/;]B\K3G\W7)5#<_1PZUH>/RU[%-S%
M515?Q6L'-4=5Q1)3*[X+O*;)YM>?7%;/<4BW;_#S]\]YKKI.+:WI[K'$:UZI
MS;J^#':O5$QBMER:6C'-9V=Y1=KV[I[WVV+)$3L-I/SG-K_>XYCIKZM>O)-*
MS&OULVMX],PYL#TBK!           %PW[83Q ]"T[>\VMKQEG)7>^OTCU%)<
MQ^M=VT,$F-SO9FQVE%<E4-K]5-3C,7;W%-'%Q\L5_#Q73%))3+4!])QYO=>7
MB/)3BLMXBFG);^*SI69F+XMGAMX:VZ8]]FO29Z-;;>\Q-JUFD5/B,[JZK;7L
M_;6G2--QGT]$ZZUPTGY=/;O,:Z>-)TUB-+>JHM%@
M
M               !5=^Z?_<"\5?TP;G_ )EPK2OHMOX_=U?B?;_OF4E/AL_V
MYR?[DQ_KBD^NI2^        9?\>OW?>C_P!,'6G^>F%8AY@_Q!YS\3[S][9'
M5<[_ +#WG[DS?K=G6C>3M6$
M
M                                       Y[OW''])AM'Z'^IOUIOGH
M'^CH_JU;7\<;_P#7*IT^07\WF/\ =>?_ "H0/IV-T@       )X/MQ_Z3#5_
MT/\ ;/ZTV*"?TB_]6K=?CC8?KEFEO/W^;S)^Z\'^5+H1//P@L
M
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M^KTWZ+QK/LU]YI]=*^HH>0H
M
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M,=-?DQXXK2/J5AL(U\Z(
M                                                       !5=^Z
M?_<"\5?TP;G_ )EPK2OHMOX_=U?B?;_OF4E/AL_VYR?[DQ_KBD^NI2^
M   9?\>OW?>C_P!,'6G^>F%8AY@_Q!YS\3[S][9'5<[_ +#WG[DS?K=G6C>3
MM6$
M
M                   Y[OW''])AM'Z'^IOUIOGH'^CH_JU;7\<;_P#7*IT^
M07\WF/\ =>?_ "H0/IV-T@       )X/MQ_Z3#5_T/\ ;/ZTV*"?TB_]6K=?
MCC8?KEFEO/W^;S)^Z\'^5+H1//P@L
M
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M9*ZZ3X*T^Y^"W';/<&[X'=:^]VV>U(F8TZJ>G'?3Y,F.:WCZEH;"-?.B
M
M
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M=LXNW=M:8W7(W]O28UC#BFMK1/KCKO-*QZ(M6,E=9C6%[Q14A:
M
M                           JN_=/_N!>*OZ8-S_S+A6E?1;?Q^[J_$^W
M_?,I*?#9_MSD_P!R8_UQ2?74I?        ,O^/7[OO1_Z8.M/\],*Q#S!_B#
MSGXGWG[VR.JYW_8>\_<F;];LZT;R=JP@
M
M                                               '/=^XX_I,-H_0
M_P!3?K3?/0/]'1_5JVOXXW_ZY5.GR"_F\Q_NO/\ Y4('T[&Z0       $\'V
MX_\ 28:O^A_MG]:;%!/Z1?\ JU;K\<;#]<LTMY^_S>9/W7@_RI=")Y^$%@
M
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M\O5'5?%;ZNM8O69TC3II'C-HTMQJE$7
M
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M
M                                     JN_=/\ [@7BK^F#<_\ ,N%:
M5]%M_'[NK\3[?]\RDI\-G^W.3_<F/]<4GUU*7P       #+_ (]?N^]'_I@Z
MT_STPK$/,'^(/.?B?>?O;(ZKG?\ 8>\_<F;];LZT;R=JP@
M
M
M '/=^XX_I,-H_0_U-^M-\] _T=']6K:_CC?_ *Y5.GR"_F\Q_NO/_E0@?3L;
MI        3P?;C_TF&K_ *'^V?UIL4$_I%_ZM6Z_'&P_7+-+>?O\WF3]UX/\
MJ70B>?A!8
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MK,Q,3&DQ,>$Q,3XQ,3X3$^A_8^+\
M
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M:SU_D<=>XS5KZ&6WELI;/=]OGQV)NJ):XN?PZZN9(^:I(Z:*HM?&/YN?D?\
M(GEN4V5^GN3E*3QNRTMTVKFW5+UOGK,3%HMMMO&;/2:Q;[+3%6T16TS&M?-G
MNG^"G96ZW.&=.0W,?-\/CI,7RQ,3>/'77'3KO&FOM16)\)U=+)YL5>X
M
M                                "J[]T_\ N!>*OZ8-S_S+A6E?1;?Q
M^[J_$^W_ 'S*2GPV?[<Y/]R8_P!<4GUU*7P       #+_CU^[[T?^F#K3_/3
M"L0\P?X@\Y^)]Y^]LCJN=_V'O/W)F_6[.M&\G:L(
M
M                                                       !SW?N
M./Z3#:/T/]3?K3?/0/\ 1T?U:MK^.-_^N53I\@OYO,?[KS_Y4('T[&Z0
M   $\'VX_P#28:O^A_MG]:;%!/Z1?^K5NOQQL/URS2WG[_-YD_=>#_*ET(GG
MX06
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MY-]@KIL>2B=Q7Q_YR9TSQ\NO7]D]<:9(TGTQ$Y*#[38
M
M                                                         ",;
MW@_*;^*3X!]W[UC,I^%;UO.'JZ9ZRN(KGZ7(1[MV599#$_B>'EIO+*>G,:IJ
MT.4S=OS'S)517C/GYCKHIKI29^$'RM_*SY^<)P6YQ>]X/8YOOCO8F.JD[;9V
MIDZ,D=-H]WGSSAVU]=(F,W3%JVF);%\JNVOX4=[[/99*]6RPW^<9HTUCW>*8
MMI;PGV;WZ,<ZZ?7Z:Q,PYFSTM+#0          %\'[:[Q,_:C\3=I\D]FP7T
M6Z>2NR<_FY=WUIZ>2@ZCT"YO\-@?IO6FDN+&SV3;)<K>U?+%;\7]K'8S\^M%
M3:R<43_21^;'\+?-C:^6_&9^OA>VMM]FK6VM)W^ZBF3+U:1$6MAP1@Q^-K^Z
MO.>D=%YRUF%GQ!=S_?3N?%V_M[Z[3C\?MQ$^$Y\L1:VOJF:4Z*^F>F9O'A/5
M"R"KD:
M                                             57?NG_W O%7],&Y
M_P"9<*TKZ+;^/W=7XGV_[YE)3X;/]N<G^Y,?ZXI/KJ4O@       &7_'K]WW
MH_\ 3!UI_GIA6(>8/\0><_$^\_>V1U7._P"P]Y^Y,WZW9UHWD[5A
M
M
M        .>[]QQ_28;1^A_J;]:;YZ!_HZ/ZM6U_'&_\ URJ=/D%_-YC_ '7G
M_P J$#Z=C=(       ">#[<?^DPU?]#_ &S^M-B@G](O_5JW7XXV'ZY9I;S]
M_F\R?NO!_E2Z$3S\(+
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MRV]?V+PGTQ/0N>?)!0
M
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ME[3Z[7F;3/\ RSX1ZH\'MG2.&
M
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MK#<9IYB8
M
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M/+RE[:Y;M3L[%Q/-TKCW_OLEYK%JWTB\Q,1-JS-=8]$Z3,:^B9CQ14I4-E@
M      )X/MQ_Z3#5_P!#_;/ZTV*"?TB_]6K=?CC8?KEFEO/W^;S)^Z\'^5+H
M1//P@L
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M.=+8KSIX1-\=JVF(]&NC9QK)CH
M
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MC719AV[PVW[>X+:<)MM/=;7!3'K_ 'TQ'M7GPCQO;6]O"-9F9T8-9P[D
M     !:.^V,\4J]U[U[2\N]AQL,F Z5P,G777UW<<6]=<G9/8./EHV2_QM/-
MO/-!-K?7M4MK<2?/;\\Q[%131ZM/,W$=7WTFGFK7A>QN+\H^/R3&_P":SQN]
MW6-8B-GM+Q[FM_&(F,V[Z;TC2^D[2TVZ)Z)M&_XBNYHV?"[;M;!:??[R_O<L
M1K^I8I]B)\8^ORZ6B/'QQ3,Z>&MW12:AZ
M
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MGU3Z)]4RR$Q]P
M
M                     '\>1R./Q&/OLMEKZSQ>*Q=G<Y')Y/(W,%EC\=C[
M*"NYO+Z^O+FN*VM+.TMHJI)99*J:(Z*>:JN>...>7VV^WW&[W%-IM*7R[K+>
MM*4I6;7O>TQ%:UK$3-K6F8BM8B9F9B(C5^\>.^6]<6*LVRVF(B(C69F?"(B(
M\9F9\(B/2AF\H/?N]O/QQ^HQ.![&O/(W<J;.[FM\%T#%C-OU^*YH^:+'T93L
MB[R>,T*.SO;NFKB2K'7V4N[>"BJ6JVJ^:"F:9/EC\!GQ">8W3N]_QU.W>'ZZ
MQ.7E9OM\LU]-^C9UI?=3:M=-(RXL&.]IBL98TO--M=N>27??/Z9<^WC8;36-
M;;G6EM/7IBB)RZQ'HZJTK,^'5X6TK9>47W'_ )N]U_7X3I3&Z?XN:;<_&F&K
M4Z/SZ[,KAD^EJD@O^PMHQ]OBZ/DKMZO2EQ6!Q%Q11-735))S\G--D/E?]'+Y
M)]E^[WO>N3>=T<Q7T^__ -%V>L=6DUVF"\WG6)CJKGW6>DS6)BM?&)D#VWY
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MG2/[D3/YD2Z#CS]H,
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M^;9?3]?6+7Q3\DZUC)$^C2*5].LZ6UU32+X
M
M                                               "!C[B+R@N.AO
MO(=::]DX;+<_)O:K7JV.+B&N2^CZ[L+:38^R\A:5U\?11PW%E:6.$N?4^>3T
M<[SS%1Q73ZT,[_H\_+#'WYY\8^Y>0Q3?ANV=K;>S.L16=W:T8=G2WZ*9BULF
MYIII'5MHB\S$]%]U^0_;E>;[VKR&>LSM..Q3F^I[V9Z,43Z_"9MDC3PUQ^,Z
M>$\^1Z!$YP          '3M]J3Q6_B?>"717564PMY@M^RNMP]E=L6.3Y_\
M6UMV9V%#;Y[8,/E8Z/A;PWFH6TMM@ODBX^3B/%T?&J63FN:3S*?%5YI_E?\
M/3G>ZMKFIGX'%N9V>QM3]3G9[29Q8LE)],UW$Q?=:V\=<\Z16NE*UU>9G<O\
M*N]-[R>.\7V-<GNL,Q];.'%K6MJ^O2\ZY/'UWGT1I$2*H[L"
M
M                           5^ON5=#R&W^W':;#9\WG%MU9Y"=8;YEN+
M;%SW\'./R.%WGK"/C(W<4L<>$L_Q7L>VYINI>)**[CB*VXI^>XHJIG]]&USV
MWXCXB[\?FZ/><KV_O=KCZKQ2>NF3;;V>BLQ,Y+=&SOK2-)BG5DUTQS$[R^'S
M>TVO?TX+Z=6YV&;'76=/&+8\WA'Z*>G%/A&GAK;T5F% )?JG
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ME+2B<U@
M
M           TA\GO<>\*O#ZWO8^]._M)P&SVD,DE'7.!O)-U[-NI>*+KZ6'G
M0]2CS&PXN'(7-G);Q7F0AL\=3/QS3+<1\4U54[M\L?AS\Z?-_)2W8W ;W<<9
M>8B=WEK&VV58UKU3\ZSSCQ7FE;1>V/%;)FFOC7':9B)S'MSL#N_NJT3PNQS7
MVTS^JVCW>&/1K]DOTUG2)B9K6;7T]%9\%<3RF^Z(S=U^*:WX<]#6>)AJ^IMK
M7M'O2ZJR60JBD^LM>+O$=8:G?VUA87D%/HW5K<7V=OH>:^>8Y["JFGGBNQCR
MM^C!V6+W7(^<//7RW\+6V7&5Z*:QTVZ<F]SUFUZS[5+TQ;;%;3VJ;B)GV=^]
MM?#AAKT[CNS>S:?"9P[:-(]4Z6S7B9F/3$Q7'6?76_CX5OO(_P WO++RYR$-
M_P"17>^^=EPVOS<V6OW]_;832<=+7-Q<2W.+T#5K3!Z/C+R:6BCU)K?'QRR4
MPQ4U5<TQ1\4V.>7/DEY3^4FWM@\N^"V'&WM]=EK6<FYO$1I$7W6>V7<WK$:Z
M5OEFL3:TQ$3>TSO_ (#L[MCM:DTX'98-O,^FT1-LD^K2<MYMDF/DB;3$:S\L
MZZKMI,E            6B/M9^O;O)>3ODMVM13><V&E]#XGKVYKHCBYQ]-WV
M;V#@]CLJ;F7FKUJ+RJ'J2XY@IIXYIJHXFYJYXYII^-8/THW<&+;>67;7:L]'
MO][SV3=QK,]?3LMIEPVZ8]$UUW].J9\8GHT],HX_$EOJX^W..XR=.O-O;98^
M73#BM2=/J?9XU_N+O2DI#L
M
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M+XK?
M
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M&FOUFNDQ$NF4\TJO$
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MSVRS[>-=(M-=<<SX>%<M.K';TQKTWG36-6T35[&P
M
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MM8B(B(B-(B(CPB(CPB(\(AM&M:TK%:Q$5B-(B/1$?)#\7[?T
M !?!^V3Z-_,/PI[![IR&.^FS'?G<&3_#+_Z3T?Q+0.K+"+5,'_?4^(L[J\^C
MWJ\VBC^UW5Y91_'X1^E<?5T<T3_28=\??[SIX_LO;Y.K9\#P].NG5KT;K?6G
M/E]F,EJUZMM793XTQY)]-NO'[J4+/B(YGY[W?@XC';7%L=I&L:^C+FGKMX=4
MQ&N.,/IK6T^O6O3*R"KD:
M
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M+&2L1'ATUCT?6Q*ZBHUD
M
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M6L1$1$:1X1"S79;/;\?L\6PVE8IM<&*N.E8]$4I6*UB-/#PB(AY5VCD@
M     +O/VQ7BS^9'07:_ECL&+^3-=X;)'H.@7MU;?"6+KKK:]O8=@OL1<R6<
M4GT>S=@7$]K=\43315S:Y#Q\**XJ_FI+^DU\TOOWW[Q7E1Q^779<)MIW6ZK6
M?"=WO*UG%7)$6F.K#M8K?'K6MHKN[^-JVC2'GQ%=R_/.;VO;&"WV'9X_>Y8B
M?^=RQ'3%HU]-,41-?")TRSZ8F%HE6 C@
M
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M4TMO-EO./W%MIO\ %EP;JDZ6IDK:EXGT:36T1,>/RP]4ZIQ@
M
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M8"Z,
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M^(KMV-YV]MNY,-9G/LLWN\DQ$_J6;PB9GU=.6*5C6/3DGQ]4WC%(*&X
M
M
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MK.FJL[N+F=QW#SN[YO<Z^]W6>^33^]B9]FD>,^%*Z4KXSI$1&K.3!W3
M
M                                    *XGW&O@Y<=\^->(\H]!P,V1[
M*\98<A<;?'C;.NXR&:Z,R=?U>TSST6]%<\\/6^3CIS7S5?"*SQ<F5FJYXX^/
M*QCZ.KSPQ]B>9.;ROY[/&/MON::1MYO:(ICY.GLX(C7PB=Y29V^D>UDS1M:0
MW]Y!]Y5X3N&_;>^O%>/Y&8BFLZ17<1X4B-?\['V/Y;7C'"APO;34
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M,S70
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M]I]J5K/";+#CW-:Z>]F.O-.OUVN6^MXZO76LQ7U16(B(C2UN=EP
M         "R9]M[X29#N/R3RWEOMV(O..L_'#ZC':=>S031XW8^Z]@Q/,-K8
MVUSS33!>_F'JF5KR5Y%35ZEM=7V+KJX^27\M;WTCGG9M^SO+?%Y2\3FI_"7N
M/2^XK$Q-\/&XLFMK3'IK\ZSTC#CM,:7IBW41.M?"/WG_ -X4XGM^O:^UO'WQ
MY#2<D>NFWK;QF8],>\O7HK/HF*Y(],+VRBU"X
M
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M$Q$ZQXQ"LW>[/<<?O,NPW=9INL&6V.]9],7I::VB=?'PF)AZIU3C
M
M
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M''G[08
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M_8OXTOIZYI:8CT>EGY@+HP
M
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M6L$UUS'DMES-<L_,=4]Q]+#S';T2510Q_#S%^;WF?SWG'YA\GYA=PS-=WO\
M/-L>+KF]=M@K[.#;8[3%=:8<<176*UZ[=62:Q:]E<O=7<>^[LY[<<]O]8RY[
MS-:ZS:,=(\*8ZS.GA2ND:Z1K.MIC69;+-:L>
M
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MUR8[QZ+4O6+5M'U+5F)CZDK*L.7'GQ5SX9BV*]8M68]$Q,:Q,?FP^:Y+Z
M       .A#]O%Y1?M]^ ^'ZTS=_]3O'C#LEYU7?TR\_&[NM#O^*]EZRRM?$5
MK!:0V=KB+VYP-O1357-S3K_,DOY9.*J_/Q](5Y7_ , _/K-W+LL?3PG<^VKO
MJ:?6UW5=,.]IXVFTVMDK3=7G2*Z[J*T\*S$07\]^V_O)WO?D<-=-GR..,T?)
M&2/8S5],SK-HC)/J^RZ1Z-(GA03:5
M
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M+:/JSK3';T>.+T>N9^4!VD
M
M     &HOF[X9=3^=G0.U]%=JV4,%.2AKR6D;O!C;:_V#K7>;2&6G![EKWK26
M\GK6DDG,5Y;43V].1Q\L]I))31-S5QMOR3\Y>Z_(OO[:=]=JWFTXYZ-SMIO-
M<6\VUICWNWRZ1,:6B.K'>:VG#EK3+6LVI$3E/9W=O)]E\YBYKC)F>F=,F.9F
M*Y<<_78[>GT^FLZ3T6B+1$S#FO\ F+X==U^#O=>?Z1[NP'X?F,?\V0UG9L?3
M<3:GV#J<UQ-#B]QT[*30P_B&'R'HU4UT54T7-E<T26US'%<121T^D;R>\X>R
MO._LK!WMV3G]YL\GL9L-](S[3/$1-]ON*1,]&2FL3$Q,TR4FN3':^.];38)V
MIW7P_>7#TYCA[]6*WA>DZ=>*^GCCR1ZK1_R6C2U9FLQ+5=M)DH
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M;=X[XMS2=+4O6:VK/ITFMHB8\/'QA]YP'P
M
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M#X;@=O\ -.%VN#;;?UQCI%==-?&TQ&MI\9\;3,^+#[+W:@
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M'6?#WN2.J)SVKI$QK69KCK;6:TUG2MKWK$U:%S4(
M
M                        #G6^_OXN_P 77W".P-JP]A])I'DC9P]YX#FC
MCXQQ[-L-Q-9=H6LDU5U/)->778%C>Y6OXT0\1PY:*.FGGBGBNKT/_ 1YH?E$
M^'[C^*WF3KYOMN\\9E^6<.*(MLK1'3$16NUMCP1XVUM@O:9B9TB>?DAW)]_N
MQ<&VRVUWG'S\WM_B5C7#/HCPC%-:>O6:3/KTB$]-1M\         !80^V[\E
M/VG_ #HO^F<QDOI-3\F]#R6IT07&2_#\;QV+H<5[NNC7]U1+\;2\O),1;YW$
MV457R2R769HHBKYKJ]&:OSZ1WRV_A?Y&X^\MGCZ^5[9W],\S%.N_S3=37;;F
MM=/:K6,D[;/DM&M8IMYF\:1UTT7\0';WWU[,KRV*NNZX[/%]8C6?=9-,>2(]
M<1U3CO:?1$8YF8TC6+^2@]"$
M
M                                !6L^YJ\D:.N_$7KWQRQ5]#1G_(OL
M*#(Y^RYIN):Y.MNHIL9M&0YYY@JHAM)INPK[6ZH:I^>>)H[:XXCCKJHJDALD
M^C0\N+=P^;?(>8NZI,[#MWCYIBMX1$;S?Q?#3T^-HC:5WD6BOULWQS:T1,5O
M(/X=^WYW_=.?G\M9]QL,&E9\/U7/K2/S?L49==/1,UUF-=)HH+STSP
M   &6NA>G]C\@>[.I^C]2XFXV'MCL+4M!QMS#8RY'C&5[/F[/%3YNZM(9(*J
M\;@;6YDO;NJJ2*.*V@DKKDCHIJKIQ/OSN_CNP.RN6[WY;3[W\3Q^?=7B;13K
MC#CM>,=;3$^WEM$8Z1$6FU[5K6MK3$3UG-\KM^#X?=<SNM/<;7!?+,:Z:]%9
MM%8GQ\;3$5KX3,S,1$3/@ZO'7FB:SU;H&C=9:58?A6F]<Z?K.B:EB_4KF_#=
M9U#"V6OX&P]:3XUR_1XK'Q1_-5^6KY?CR\J'</.\GW1S^^[FYK)[WF.1WF;=
M9[Z:=>;<9+9<MM(\(ZKWM.GJU5E[_>[CDM]FY'>6ZMWN,M\EY^6][3:T_P!V
M9F7L'3N(
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M^X;)]EK^J8;S6,V*?5UUB9]FVGLWB9K;QB)ZHM6-)VZF7@
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MV2*3IXS$:PD)1]8*
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M_$['%&ZB8GWN3[+EB8]$UODZII^9CZ(UC737Q:!M^,W
M       9(ZDZ?[0[Y[!UWJKIO1-D['[#VN\XLL%JNK8V;(Y*ZJXX^>YO+CY.
M.+?&8?&6_%5Q>W]U)#96%K'7/<2Q0QUR4XYW;W?VQV'V_N.ZN\=]MN.[>VE.
MK+GSWBE*^J*QKXWR7G2N/%2+9,MYKCQTM>U:SP.4Y7C>$V.3D^6S8]OL,4:V
MO>=(CY(CUS:9\*UB)M:9BM8F9B%_'VBO9PT[P PE7:_;4NM]B>5VQ6=W93[+
MBJ9\AJO5&O7M,D$^L]=SY.QL+R?,9BSJ^&7S5=O!/+'7S96U,=KQ<27U!_Q;
M_&)S'G[O?X*]IQN>.\JMO>MHPWTIGWV6NDQFW<4M:L8\=OU#;Q>U:S$9\DVR
M^[K@A!YI>;&[[XS?>SB_>8.V<<Q,4G2+YK1X]>6(F8BM9^LQZS$3[=M;=,4G
M)0?:;
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M4W'$[N--UML]\5O\:EIK,QZ?"=-8F)F)CQB9ADACCKP
M
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M*0
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M+4R5FEH_-BT1/YD^B?4]LZ1PP
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MUM,X\-=8Q8M?#V:Z^,Z>$WM,WGY=/!N\TDPX
M
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MVGTS.29F-9UFPBK[:+
M
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M6I;TS/1&L^&D38H5M0
M
M      -8_(_PP\6/+K$PXCR.Z-T/M+Z.SJQV,SN9QLF/W;!8^NYXO)K'6^P=
M?N,1O6M6=S=<<5RQ6&1MJ)JO^WQ4V;Y<^<OFEY2;NV[\N><W_%]=^N^+'>+[
M;+>(Z8MFVF6,FVS6BOA6V7#>:QZ)AD7 =V]R]K99R\!O<^VUG6:UG7':=--;
MXK1;'>8CPB;5G3U*XGE/]KSJV7KFSWAOWI-J5U)-7SSUWWO1=YC7::*[>GY.
M<9V)J&(GV'&0P7,7/'HW6%RLDE$_Q^HHYA^6:QCRM^D]Y3:5KL/.+@XW>*(_
M^;XN:X\VNOZ/:;C)&*\S6?KJ;G!$373W<]>M-_=M?$=N<41@[LV49:Z?JNVT
MK?T^O%>T5G6/7&2D1I];.NL5N/*#VVO-CP\^HO>]>@]PP.J17EW:0]B:_'9[
MOUU<4VWS20W$NXZA<YG$83\2M*.9[>WR==C>UQ42?-!35#-3'8]Y8_$AY*^<
M'3@[%Y_9Y^5FE;3M,LVVV[C7PF(V^XC'DR=%O9O?#&7'%IKI>8O2;2 [<\P.
MS^Z]*<+OL5]U,1/NK:X\L:^KW=XK:VD^$S3JKKIXZ3$SHVW@S(
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M_@
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M/V+%,3IK6U:Z3DCPUTRVOI/HT\$C:.C 0
M
M                      %"7[E'QFM.H/-+5N\M>Q5GC-9\G-#XS63YM*)(
M*;GM#K>2PUC=KCZ2FCBRB^LUK(:Y=S215<5W-[=7$LU'J5U2S7R?1N>9>7N[
MR8W78_(9;Y>2[9W_ +NG5I/3LMY%\VVCJUZIZ<U-YCK%HTICICI2W3$4I-GX
M?>XK<KVCDX;/:;;CCL_3&OCIARZWQQKZ?"\9:Q$^BL5B)TC2*ZZP]OD
M    !/E]N?Y(U],>?=EU9E+Z:#4O)?2<WUY<6_--O]#%O.MPS;OH>6NY*ZJ+
MJB;FG#Y+#VW$?STU39OCYX_AQQ+% KZ1/RXKWGY"7[IVM(MRW;6]Q[N)\>J=
MMFF-MNL=8\:Z?9,.XOKI,5VT]-O36^DO/OM^.7[(GDL=8G=<=FKEB?'7W=_L
M>2L>K]%2\ZZ>&/PGU3T$% *#0
M
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M;6F=/#QF9GP?><!\
M
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M6CPO2=)TM69B=)C76)AFQA3IP
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MU9F7I'6N.
M
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MK'Y3C\_$\GN>*W.GSG;9\F*^GHZL=YI;336/3$^B99"8^X
M
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M+0'Q$<Y\P[1P<+CG3-O]S'5'RXL&F2WKCQC+.'U3&FOHG1?"43H6
M
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M%L5HB:VB8F)B8UB8F/"8F/&)CPF&U:VK>L6K,368UB8]$Q\L/Q?M_0
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M;1%HF&U#5C&@
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M+LW;5Y;F:8\_=%XUUF(M7;1,?68I\8Z])TR98]/C2D]&LW@?3L;I
M               ;[>+'MC><'F/1#D^D>AMJOM,FAHNN.R]PIM] ZVFM:KBN
MUKEP^W;=+B<?MDUO<4_+-;87\2O(>.>*JXJ:/U30WFE\37DCY.VMMN]N>VM.
M9B>GYGM]=UO(MIU:9-OMXR7P1,>-;[GW..WHK>9\&$]R^8O9W:<SCYC>XHW<
M3I[G'KERZZ:^U2G5--8]$Y.BL^B)U61_%_[7?K["?3YWR_[YS&]7W-G:5\]>
M]'VO.IZS9Y2GY:KZC(]@[789#8]IP]?%54<=%MA]>N:>:*9.9>>*N8::X?,[
MZ3[N#>]6Q\H>!P['!UV_TODK>_S6I^AFFTP6IAP9(\)F;[C=TG6:Q3PB\Q_[
MC^(_?9M</:NRIAIK/V7<3UWF/5IBI,4I;USK?+'JT]:QKX\^('C'XH83\!\=
M^DM#ZMMZ[.BPO,G@<3]1M>8M**;/CB+8=VS$N2W+9/FJQ\-=55_?W-5<D?%=
M7/-?ZI75YA>;WF;YK;WY_P"8?-[_ )3)%YO6F7)I@QVGJ\<6VQQ3;X?K[1$8
ML5(B)FL:1X-!\]W5W%W/F]_SV\S[FVNL1:VE*SX_6XZZ8Z>F?K:QX3IZ&R#7
M#'P
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MY'#7+$^&GO*?8\E8]?Z&EYUU\<GA/JB?- II$
M
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M,RLVX+BL/!\+M.'P1$8MMM\>.-(TUZ*Q$V_-M,3:9GQF9F9\98?9>[4
M    !T,_MZO&ZOHKV]-5W;,6,UGMOD?M6<[AR--U5;UW%OJU?HZIU[:156U/
MR<8V_P!8UZC-04UU22TU9F3BNJGG^U1>>_Z0;S'KWS\0>ZX39WB_$]N;7%Q]
M.G6(G/&N?=VGJ\>NN;+.WM,1%9C;UTB?K[03\]>X(YKOO+L\5HG:\?BK@C37
M2;_7Y9\?7%[>[GT1]CC3Y9G/0<:9
M
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MR6CTUO6=(UI>-+5G2-8F-8B=89L84Z<
M                                              !^-Q<6]G;SW=W/
M#:VMK#+<7-S<2T06]O;P452S3SS2U4QPPPQT\U555<\4TT\<\\\_!^\>/)FR
M5Q8JS;+:8BM8B9F9F=(B(CQF9GPB(\9E_:UM>T5K$S:9TB(],S\D.?W[UWNY
MY#S:WJ;HGH/8\QC_ !+T:\AXNI:(Y\5+WGNV*O[B3C<\O;U\0WW&AXJJB'\
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MNYNK'N=Y.WV=O^:V\3BIZO";1,Y;1X>B^2T1ZM-92HHM-:@
M
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M=CYC%77-Q^XBTSX>&+-ICO\ X7U_NIG2=-(F;1.D36^TH;0F
M
M                                                     0_>^QY
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M\EY\9UM>TVM.LS,^F9],S/RS,O8.G<0
M
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M_
M                %1S[B3W0+C!6^7]O?H_-S09/+8W%WGDUMN+EKMY;'$9*
MBWS.&Z9QU[1S1<<39S'U6V0V*N'GB*O'7%OCJI):;C)VL=M?T>7PQ8]]DP_$
M%WO@BVVQ9+UX;!>(F+9*:X\G(WK.L:8K]>+:1;VHS4R;F*UG'MLMI1^0WES7
M-:G?7,TB<=;6C:4GQUM&M;;B8]'LSK7%KX]<6R:1TX[33@7$)7@
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MA@
M
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M<!\
M
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MF.T3KK&28TF-9CH%* T'
M
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M+7UT_5*WFTZVKK9?5JH]
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MG_"Z>J?7,RVZ:D8L
M
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MZ'[5(
M
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MN=H$
M
M         !H=Y1>V;X1>87U]_P!U]":??[E?_&J;LS4[7\QNS))O[UXCGO\
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M:_71,1OS@>[.V^Y\<Y.!WN#<Z5BTUK;[)6)]$WQVTR4^3VJQX^'I:TMDLA
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MM$JVN5XS><+R>?B>0KT;W;9;8[QZNJLS$S$^NL^FMO1:LQ,>$LD,<=>
M
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M9;3,VM,S,S,SK,S,^,S,^,S/C,M5VM:]IM:9FTSK,SZ9GY9?L_#^
M
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MFL:OB0X*VXXC8=PXHC7;9K8;_+TYHBU)GZE;8YCT^G)'A/JNN*640@
M
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M%?3/IFLON3E[<_S^]YJ^L?.MSDR1$^FM;6F:U]?UM=*^F?1Z99X8(Z4
M
M
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MVM(C!O:^[RZ?Y['$=-IC_#QZ1X:^..TSI,QK:#5AHY
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M6GQMDO-I_,C69TB/"(K&D1$1$1$1#)S&77
M
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M97(\7$1.:VVM?'X3^J8OLN/328F-;4B-?DF=8M&M9ZC#R_JX
M
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M [ WV6MNG<[FD;;'XQ$S.;V;::Q/C&+WEO"-?9\)K/M1TIGFW5\@
M
M
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M;>$Z2![:\T>R>ZJUIQ^]IBWMH_4<^F++$^/LQ%IZ<DQ$:S[J^2(CUHV4D&P
M          $F7L_>2-?B_P"X7X\;M>7TUGJ6X[5'T]OU-%-OS;S:MVI\FJ1W
M>1JGJHKBQNL[/>8W-3515<2\4XSX<4R<<\Q21I^+WRXKYG_#YW#PF&D7Y;9[
M6>0VNNNL9]C]GFM--8F^;#7-MZQ:.G7-XS7PO77GFKV_'<?8F_V=*Q.ZQ8O?
MXO3KUX?;TCZMZ1?'&OA[?J],=-!YHE>
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MCPB;]5M-?'69F=Y6CV&@
M
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M8TGPF5G&RWFWY#9XM_M+1?:Y\5<E+1Z)I>L6K,:>'C$Q+RKM')
M=2KVX>_9?)[P7\8>Z[W(WF7SNT]5X7%;CELA]7S=Y3L'0Y;OKSL7(2UWU--U
M-];O6J9&2F2KFOU*:N*N))*>>)*O+M\1G85?+'SR[G[*PXZ8=CM>5R7V^.G3
MTTVFZBN[VE(Z?9CIVV?%$Q&FDQI-:S$UBMWO_@X[<[SY'AZ5BF'%N;3CK&FD
M8LFF7%'AX>&.]8T\-/1I'H;L-*L/
M
M                              4 ?N1N]HNT/<#IZQQLOQQ'COU7I^C7
M=%-5I/#/N.W47'9FP9&"YBLX;FGX87;,1CY;>N>XC@N,;)S3Z<DDU'%^WT</
M8MNU_(">Y]S'^E]P\KN-S6?:B8V^WTV>*DUFTU_5,&XRUO%:S:F:L3U5K24X
M?A_X6>-[&^^.2/LN_P!S?)'IC3'33#6--=/KJ7M$Z1,Q>/3$1*OVGZWB
M      N,_:R=!10X#R@\H\ECK.2;(9C6^@M,RW]Z59"RBP]E:=B=F8[_ +5=
M_#9Y.K.:E+_V8X9:[3^S)5'_ &JGKZ4COVU]_P!L>5^VR7BF/#FY3<8_:Z+3
MDM;:;._][-J>ZW\>NU8R?H8M[44?B3YR9S\;VWCM.E:7W.2OCI/5,XL,_)K'
M3GCUS'5ZM?&W2J11;
M
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M:JS^[N'KP'=&_P"&Q_J.WW>2E/'7['%IG'K,ZSKT37769G7UMG&LF.@
M
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MF9F?EF9\9?2<9\P
M
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ML^ZW.VG%:8CPZ\-M8UGU3:F2(CY8I.GHE:/5>HW@
M
M                                        /X\CD<?B,??9;+7UGB\5
MB[.YR.3R>1N8++'X['V4%=S>7U]>7-<5M:6=I;1522RR54T1T4\U5<\<<<\O
MMM]ON-WN*;3:4OEW66]:4I2LVO>]IB*UK6(F;6M,Q%:Q$S,S$1&K]X\=\MZX
ML59MEM,1$1&LS,^$1$1XS,SX1$>ER@?*/NJ[\CO(_O/OB[CO+?\ ;:[4W?>[
M&PO_ $OJ\1A-@V"^OM?P4OHS7,7'X#@I+>RIXIEEXXI@XX^>O_M<^K+RO[+Q
M>7/ESP?8F&:6^]/%;;:VM37IR9,6*M<N6-8B?LN6+Y)UK7QMZ(]$6:]M\17@
M. V7"TTGYKML>.9CT6M6L1:WJ^NMK;T1Z?1# [.W=          .F?[._1-Q
MX]>W'XQ:9E,9-B]EV/2:^U=J@O+>NTR?&7[8RE]OMO:Y:UEHCEM<EA<!G++'
M212442P\6?%$G'J4U/-%\8'?6/S!^(SN?F=KEKEXW;;V-C@FLQ:GN]C2NUFV
M.T:Q:F3+BR9HM$S6WO)M6>F85X>:W-5YWO\ Y'=X[1;;X\WN:3$ZQTX8C',U
MGUQ:U;7B8\)ZM8\-$F:-+7@
M
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M>.OU,,>C2--/7K,SYH%-(@
M                               ,#^4W:,_2'C-Y"]QVD_TU_P!6=)]H
M]@8R3CG'^KSEM1TG-YS$P6U&5BGQLUY=9*RBB@CGCDBEFKIHJHJXJ^7G._*[
MM>G>WF7V]V=EKU8.4YO9;2\>WI[O/N<>+),]$Q>*UI:TVFLQ:M8F8F--8[KM
MOC8YCN+8<3:-:;G>8<4^GZV^2M;3/3XZ1$S,S$Q,1XZPY.KU<+.
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M>7,Y.9Y:\S>TZ4I$^QBQZS-<=(]41ZYTUM;6UM;3,MKFJ6,@
M
M
M     *M7W1?0D6R] >/OD=CK7XY7JOLC,=:;!):VMI3+/JO:>&IR]A?Y:\^F
M^MGL]>V70(;:TC]?B.&;.S<\1U<RU5T6B_1?]^6XWO\ [@\N=Q?_ $7E>-Q[
MS%%K6TC/L<GN[5QUZNF+9<.ZM?)/3K:NVI$VB*1$R1^'#FYV_.;[@,D_8]SM
MZY:ZS/U^&W3,5C736U,LS:=-9C''CX:32277)@@         )SOMXN]KCJ+W
M'-+TRYR<UGK7?^D[KU5EX)+BNG&5Y>WQ=6^Z?=7%K\_I29*O/Z=1CK27Y*I8
M^<G)13S3'-+\8.?2%=BX^[OASWO,XL5;\EP&]VV^QS$1UQCF_P UW%8MZ8I[
MK<3FR5UZ9]S6TQ-J4::\]^%KRO8&;=UK$[C8YL>:LZ>/3,^[R1$_)TY.NT>B
M>B)],0Z&CSWH)
M
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MF9U5EY,E\M[9<MIMEM,S,S.LS,^,S,SXS,SXS,^E_8^+\
M
M
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MC>:SU9,6XIIZHC';#:)_N^\G7\R%M=4TB^
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M;395KERQ_?9LE=::Q_[O%:.F?"=<MXF-(B5H-6&CD
M
M
MTG]Q[H*7R>\%_)[I2RQUYE\[M/5>:RNG8G'_ %?-WE.P=#EM.P^NL?%18U4W
M4WUN]:ICHZHZ>*_4IJYIYCDIYYCJW5\.??M?+'SR[8[US9*8=CM>5QTW&2_3
MTTVFZBVTW=YZO9CIVV?+,3.FDQK%JS$6C,.P.<CMSO/CN8O:*8<6YK&2TZ:1
MBR:XLL^/AX8[VG7PT].L>ERU7J)61          ,D=-]E9;ICM[JKN' 1^MG
M>J.R-&[*PL/SVT?JY;1=GQ>T8V/U+VPRMG1\]YBZ./C+:W,7'Q^-44E/QHYQ
MSO'MK:=Y]H\KV?OYZ=CRO&[G9Y)]J=,>ZPWP7G2MJ6G2MY^MO2WR6K/C' Y;
MC\7+\5N>*S^&'=;?)BMZ?K<E)I/HFL^BWJF)^28]+K+:;MF$WW4-5WG6KKZW
M7-TUO![9K]Y\*>/J\)L>+M<QBKKX45R4\>O87D=?Y*N>/R_V>7E!YGB=[P/+
M[K@^2KT<CLMSEP9:_P![DPWMCO7U>BU9CT0K$W>US;+=9=EN(TW&'):EH^2U
M)FMH_N3$O2.M<<
M
M             !5&^Z8[N_"NIO&/QVL+S^W;MOFU=N[':PU_)+#C^OL''J>L
MT7O''--4EGEK_L'(5QT?JJ.9L;\U7'%4<?*U;Z+GLGYUW9W-YAYZ>QLMA@V&
M&TQX3?=Y9SYNGY+8Z[3%$SX3TYM(\+629^&WA_>\IR//7CPPX*8*3]7+;KOI
M]6L8JQ/U+Z>N5+9<ZER          L.?;5=$R]C^>>6[ANHOAB/'7JO:,_:W
M7RW=7PW'LBUGZUPUC\;>\M+>/ZK5,WL$WS3TW,?][?"F'U*J)X*]OI)>^J]N
M>1&+L_%/^E]Q<K@Q6K[/_P OL[1O,EO&MIGISX]K72LTGV]9OTQ-+Z(^(/FH
MX_LJO%5G[+O]S2LQX?J>*8RVGQB9\+UQ1X:3X^G36MK\RA5"0
M
M
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M9(U]>DXXUC^[I&OYD+KBEE$(
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M==-9F9\9VU:F8N
M
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M??>-Y\8TG[-&2-8F8\/3KK$2ZHD-6@
M
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M)G7T::3-DU6\CZ
M
M                                 YCON]_TE_F1^F')?K5B7IF^$7^K
M5V=^)Z?KF18GY5_S><3^Y(_RK(WTC6?@       +4'VL/[OWE3^A[3?\])56
MOTI/\0>U?QQN/WM"-?Q)_P"P^,_=>3];78E*R((
M                                                "![[CG^C0V?]
M,/4WZZWZ=GT=']97:_B??_K=6ZO(+^</'^Y,_P#DPY[ST#IT         .M#
MX\_N ]&_H>ZS_P R\(\G?F#_ !^YS\<;S]\Y%87._P"W-Y^Z\WZY9F%B#J@
M
M
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MZH)%4
M
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MD8L
M
M                      YCON]_TE_F1^F')?K5B7IF^$7^K5V=^)Z?KF18
MGY5_S><3^Y(_RK(WTC6?@       +4'VL/[OWE3^A[3?\])56OTI/\0>U?QQ
MN/WM"-?Q)_[#XS]UY/UM=B4K(@@
M                                    ('ON.?Z-#9_TP]3?KK?IV?1T
M?UE=K^)]_P#K=6ZO(+^</'^Y,_\ DPY[ST#IT         .M#X\_N ]&_H>Z
MS_S+PCR=^8/\?N<_'&\_?.16%SO^W-Y^Z\WZY9F%B#J@
M
M
M   $%7W$70D7</MS;7NUG:^ML?CSOFE]LXVNWM;2O(7&$NKR7KS;\;]7-;2W
M4&'BPN[\Y>ZBBEAXEKP\-57-?I4T53F^CS[\MV?\16TX7-?3CNX=AN-A?6UH
MI&2M8W>WOTQ:*SDG)MO<4M:MNF-Q>(TZIM&Y_(?FYXKO[%L[SIM]_@R8)UF=
M(M$>]I.FNG5U8^BLS$Z>\F/#75STGH-3K          2T>Q[W;^T?[E_CG>7
M5W]+@NS\QENDL]'ZGI_7?MGXFYP6I6GS\\_+^Z-^"R_+SQ5\_I?+Q\*N>*N(
MG?&[V3_#?X:NXL.*G5ON,PX^2Q3IKT_,LD9<]ON3YS77PTZM9UB)B=8><?#_
M 'Y\O-_2L:YMM2NXK]3W-HM>?M7O(_NZNDT\WJOP
M
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MV+'/VR]?S74J>796X
M
M                                     YCON]_TE_F1^F')?K5B7IF^
M$7^K5V=^)Z?KF18GY5_S><3^Y(_RK(WTC6?@       +4'VL/[OWE3^A[3?\
M])56OTI/\0>U?QQN/WM"-?Q)_P"P^,_=>3];78E*R((
M                                                    "![[CG^C
M0V?],/4WZZWZ=GT=']97:_B??_K=6ZO(+^</'^Y,_P#DPY[ST#IT
M .M#X\_N ]&_H>ZS_P R\(\G?F#_ !^YS\<;S]\Y%87._P"W-Y^Z\WZY9F%B
M#J@
M
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MD^'J5A<EL<W%\CN.,W'_ ,QM\]\5O\;'::6_],2]XZ%P@
M
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M[ZICY<>"O5:/ME\4_P!SZJ]4HS0Q
M
M                                                <QWW>_Z2_P R
M/TPY+]:L2],WPB_U:NSOQ/3]<R+$_*O^;SB?W)'^59&^D:S\       !:@^U
MA_=^\J?T/:;_ )Z2JM?I2?X@]J_CC<?O:$:_B3_V'QG[KR?K:[$I61!
M
M     0/?<<_T:&S_ *8>IOUUOT[/HZ/ZRNU_$^__ %NK=7D%_.'C_<F?_)AS
MWGH'3H         =:'QY_<!Z-_0]UG_F7A'D[\P?X_<Y^.-Y^^<BL+G?]N;S
M]UYOURS,+$'5
M
M                                 .:S[VG1,O0ON4^1^.BB^7"]H[)#
MWM@+CY;NCZR+MN'G:-FE^6\O+^3^]NP)\Q;?&B7T:O0^:.."CFFWB])'P4]]
M5[\^&WMS<7G7>\7MIXS+'L^S.PGW&&/9K2/':QM[^->J.K2UKVB<EK!O)_FH
MYOR^X_),_9MMC^;6CP\/<>Q3T1'IQ1CGT:^/C-I]J8HTJVS          '1I
M]@WNW]N?VT.F[.ZN_K<[TQF-QZ2STGJ?-Z7YJ9;C.ZE:?)SS55#]%USM>%B^
M7GGGX_)\W'PIJXIX\ZOQZ=D_P,^)7F,V*G1L>9P[?DL4:>GW^/W6>WU>K=X-
MS;7ZNDZS$S,!_.WA_O1YA[N]8TP[NF/<5_\ 7KTWG^[EIDG_ -"9E#9J4
M
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M5F/DR9=<MI_NXYQ?\BQ2KP:%
M
M                                            <QWW>_Z2_P R/TPY
M+]:L2],WPB_U:NSOQ/3]<R+$_*O^;SB?W)'^59&^D:S\       !:@^UA_=^
M\J?T/:;_ )Z2JM?I2?X@]J_CC<?O:$:_B3_V'QG[KR?K:[$I61!
M
M 0/?<<_T:&S_ *8>IOUUOT[/HZ/ZRNU_$^__ %NK=7D%_.'C_<F?_)ASWGH'
M3H         =:'QY_<!Z-_0]UG_F7A'D[\P?X_<Y^.-Y^^<BL+G?]N;S]UYO
MURS,+$'5
M
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M)RX+V\?7TY,4>C3U9I\9UGU1.EIBX:I_13
M
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M-P6H6*@
M
M                          .8[[O?])?YD?IAR7ZU8EZ9OA%_JU=G?B>G
MZYD6)^5?\WG$_N2/\JR-](UGX       "U!]K#^[]Y4_H>TW_/255K]*3_$'
MM7\<;C][0C7\2?\ L/C/W7D_6UV)2LB"
M                                          @>^XY_HT-G_3#U-^NM
M^G9]'1_65VOXGW_ZW5NKR"_G#Q_N3/\ Y,.>\] Z=         #K0^//[@/1
MOZ'NL_\ ,O"/)WY@_P ?N<_'&\_?.16%SO\ MS>?NO-^N69A8@ZH
M
M
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MG/M9IN*:^J<=HB\_6S,?8K9(C33QGQM%>IT?'G+0#
M
M                                      :E^>?<LOC[X7^4'<5GDOPC
M-Z1TGO\ >ZGD/5NX/0WK(8"[PF@\>OC[[&9"#U]TR=A'\]O<0ST?/\8ZZ:^*
M>6V?(CLZOF!YS=L=GYL?OMEO>;VM<]-*SKM:9:Y-UX7K>DZ;>F6=+TM6=-+1
M-=64=E<3'.]W<;Q-Z]6'-O,47CP\<<6BV7TQ,?J<6GQB8^6-'*Q>II94
M      VN\%>F:_(7S(\9^F^;*'(8_>>YM$L-CM;BSM\A;\Z;89RUS.\33X^[
MAGL[^&TT_&WTM4$U',,M-'-%?ZCGGEJKSS[RKY?>3O<O>,7MCW&QX;=6PVBT
MTGYQ;%;'MHB]9BU9MN+XZQ:L]59G6OC$,9[SY>."[3Y'EM9KDP[3)-)B9B?>
M36:X])C28UO-8UCQCTQXNJH\L*M,
M
M                                                !S'?=[_I+_,C
M],.2_6K$O3-\(O\ 5J[._$]/US(L3\J_YO.)_<D?Y5D;Z1K/P       %J#[
M6']W[RI_0]IO^>DJK7Z4G^(/:OXXW'[VA&OXD_\ 8?&?NO)^MKL2E9$$
M
M     ! ]]QS_ $:&S_IAZF_76_3L^CH_K*[7\3[_ /6ZMU>07\X>/]R9_P#)
MASWGH'3H         =:'QY_<!Z-_0]UG_F7A'D[\P?X_<Y^.-Y^^<BL+G?\
M;F\_=>;]<LS"Q!U0
M
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MSI,:QK$Z3'IB9CY'V'#?(
M
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MFL3K,3&O3,+]BA)"(
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MT/['Q?@
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M[^OI\??UC+:?&9GZ^UHGU:Q.D1&B45&!K@
M
M                             !2V^Z>[>ER/;WBMT)!->0PZ?UON7;V5
MMZ)[NC'Y&7LC9XM,P$US;<2<6%S>86GJO)4P2<T\S047\W''/%,O/'-SOT6W
M:-=OVCW5WYDK2;[SDMOL*3,5F](V>&=QEBLZ=5:Y/GV&;1KTVG%2=)FGA+GX
M;.*C'Q7)\W:(F<NXQX*SI&L>ZI[RVD^F(M[ZFL>B>F/D51EJR3(
M"[G]K?TS1K_CGY%=\W=E-!D.S>VL+UUC)KNSN(N;C7>J=7BS/-_BKB>*F*?&
MWV?[,N[:62WJJHKN<95')^K@XXII.^E"[RMR'F+V[V)AO%MOQG$Y-W>*VB=,
MV^S3CZ;Q$ZQ>N+9X[UBT1,4S1:OA>9F'OQ(<O.?G]APE)B<>WVMLLQ$QX7S7
MZ=+1'HF*X:S$3ZKZQX66CU7J-X
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M8B(B(EMV]VEV[VKMXVW [3%MXTTFT1KDMZ/K\EM;V\8B?&TQX>$1HUC;,9$
M
M
M
M    W>\2?<7\O_";,6=WT/V_GL7K$,W,E_U?LLTNT]5YF*2ZFO+J&[TK*35X
M_'37EQ<2527F-YL,CQS)5S1<4<U<\\Z2\V?AV\H?.O9WQ=]\1@R\G:-*[W#$
M8-]CF*Q6LUW-(B]XK$1$8\WO</A&N.8B&'=T=A=J]X8IKS6UI;<S'AFI[&:O
MAI&F2/&=(B-*WZJ^$:UE>%]L_P!Z3H'S\M[+KW9HL;T;Y*QPR4U]5YS8(;K#
M[]]+17)<9/J?8KVWQ=6Q356L?-U<822*G+V,5,O-%-Y:VTM]S2+\2OP8]_>0
M>2_<'&3DYSRVF8_T[%BFN3:]4Z13?8:S?W,=4]%=S%IP9;32)G#ER5P(<^8?
ME'SG9%IWVWZM[V]K^K5KI;%KZ(S4B9Z/'PC)$]%ITUZ+6BB9]#-J0
M
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ML-^J)G2->J:Y8C69G6M8B(CIE:55=(W
M
M                           .;7[YG;EEV_[G/DC>8F[AO,)U]DM6ZCQU
M<7T-5<-[UUJ6&P>XVEQ-C[R^AFFM.PJ,O'Q\]=,\4=-,4T<4L=<5'H_^!WM+
M-VA\,O;F'=TFF]Y#'GW]XGJTFN[SY,NWM$7K68BVT^;SX1-;3,VI:]+1:; O
M)KB[\5Y=<?3+$QFSUOGGT^C+>UL<QK$>G%T3\DSK,3,3$S$BEHV@
M  Z9/LU]0Q=+^VAXEZ]S#9TW^V];Q]O9.\M8+2*?(R]SY;)=GXN;(S6D='-Y
M>6&N;38V%-<O-4U%O9Q15<_"/CCCS2_&-W=;O/XE>[.0ZK^XVG)3L*5M-IBD
M<=CILKQ2+3/36V;!DRS%=*S?):\1[4S->7FSRL\OYA\IGUGHQ;CW$1,SX?-Z
MQAG37T1-Z6MI'AK:9]:3E&9KH
M                                                       !5J]^
MSW=,WT;%>>%GC!MGX7VMGL/)^WQV/@[FJ/,=9:]F;2VEQ6AZED;:7Y\;OFT8
MJZKN,A>T_)/AL;)!Q;5?67?K8^T7X#?A(V7?%J><_F=M/>]JX,T?>O9Y:ZX]
M[EQVM%]UGI:-+[7!>L4Q8YUKN,T9/>Q[G%T;B27DGY6X>9F.[NX\75QE+_Z-
MBM'LYK5F>K)>)]..DQI6OHR7BW5[%=+TDEUR8
M
M
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MQ3,Q]9/C.*9F9TB:VG6L3:>%!-I4
M
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M$:=4ROV*$D(@
M
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M3WN6]KVT\(UM,S.D?FR^\X#X
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M(K6L:1$?F0\J[1R0
M
M
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M=>
M                                   U[\M.GXO('Q@\@>DZK+Z^Y[/Z
M?[!T[$P<5VD<M&Q9C6<C;ZS>6TN0N+3'Q7F.V'FVN(*[B6."F:*GF2KBCCGE
ML'RG[OMV!YG=O]ZQ?W>/C.8VFXR3I:8G%CS4G-68I%KS6^+KI:*UFTUM,5C7
M1WO;'*SP?<>QYB)Z:[;=XLEI\?K:WB;Q.D3.DUUB=(F=)\/%R@7JR6:@
M     -TO;F[<O.B_.[Q.[-M;N:RM\+WEH6*S]Q;_ %W-QQINYYF#2-[A@CQU
MY87-Q-=:9L=_%3#S)S#-57Q1-1+%57%7ICXBNTL/?/D5W9VSEI%\F;@]U?%$
M].GSC;XYW.UF9O6T1%=QAQ6FVG56(ZJ6K>*VC$>_N+IS79?*<=:(FU]EDM6)
MTT]YCK.3'KK$Q&F2E9UTUCTQ,3I,=3!Y<U;8
M
M                              "/SW5NV>>DO;I\OM]BOIL7>\],[#H^
M)R5K+D[>\QV>[8EL^J=?OL?=8>BN_L\E:9O=;>2VGI^2B&>FBN2N..FNNG?_
M ,*_:<=Z_$1VAP-L<9</WYQ;G)2T4FM\6QBV^RUO7)/3:EL>VO%ZSK-JS-:U
MM:8K.<^6G%_?COWBME-8M3YW7):)TF)KAUS6B8MX3$UQS$QZXUB(F=(<P!Z=
M%C(         "5SV1NGXNY?<V\8L9?67U>%T+9,UW!EY?GM./H)>K-:R^W:I
M>^C=7$$ES_[P,?AX?A!Q)-'ZWJ_)\D==5,5/C9[OMV;\,_<VYP7Z-[O]MCX_
M''M>W&^S8\&>NM8F(_T6^XM[6E9Z>G7JM6)UGYP\K/$^7?(Y*3IFSXZX*^GQ
M]]>M+QX1.GV*;SXZ1.FFNLPZ4SS;J^0
M
M %2+[ION[(6&J^+7CMC+R\BL=CS&\=N[?:T5S0VES^;5OBM3T>B3BCGB&^^$
MVP9NNNBK_P!#5%%5\.>:^.:;:/HM^R=OGY7NGS#W-*3GVV';;#;VF(FU??3?
M/N=/77PQ;:(F/KHF\>KQE#\-G#TON>2Y[)$3?'3'@I/KCKFU\GYGUN./JZS\
MBFTN+2Q
M
M
M                  7Z_MKN]<GV;X%YCJ[.74US>^/G;6RZE@O4BXYXCT;<
MK:R[!PT55YQ'17<S0;/G<Y%Q175)5!;1P44U<1^G'10G])'V-MNV?/C#W1L:
MUKA[@XG#GRZ3Z=SM[6VF2>G72(G#BVUM8B(M>;S,=75:T(_B"X7'QW>U.2PQ
M$4WVUI>W_P 3',XK>'JUI7'/JUF9GTZS-A=7PT2
M
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M
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MXW=\L^GQC!3ITUUTTUSQ.DQ.LQ$Q,:3K=N4H(?
M
M         *"?W,>U6^P^XEKF(AM)K>31?&GK75;N:6NBJB_N+S<>SMWIN[>F
MC]5'#1:[E%!S35^J]2&KG^QSPOM^C3XK)Q_P\;G=WO%J[[N7>9ZQ$3K6*[?9
M;;IGY9ZMO:VL>&EHCTQ*;OP\[:V#L/)EF8F,W(Y;Q]2(QX<>D_W<<S^9,*]*
MP9O4
M
M
M              !;=^U0VC'VFW^;&E20WE65V#6^AMHL[BB.#G'Q8_3\IVSB
M<G#<RU7%-S1>3W.\6E4%-$5=%5$<W-=='--'$E2_TJ/%[C+Q'97-5FGS7;[G
ME,%HF9ZYON*;#)2:QII-8C;9(M,VB8F::1:)F:Q>^)?;7MM>'WD3'NJ9-S28
M]>MXP6C3PTTB,=M?'UQI$^.ER53HB<
M
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MZK0,\\^+^]OF)NLM8TQ;O%BSUC33TT]W:8\9UUR8[S,^'C,QIX:S-BA6U
M
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MSXQ,]>2;9)UT]'L3CTB?'U^BT+%*O!H4
M
M  !SW?N./Z3#:/T/]3?K3?/0/]'1_5JVOXXW_P"N53I\@OYO,?[KS_Y4('T[
M&Z0
M
M
M             %J#[6']W[RI_0]IO^>DJK7Z4G^(/:OXXW'[VA&OXD_]A\9^
MZ\GZVNQ*5D00
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M!>?#7V9KDQQK]=.O7EF/3%=)]$V\;<:I1%P
M
M                            !S@_?F[,H[)]T#R$IM:(:<9U]#U_UGCY
M:;:XM;J>O6="U^;/UW_$]S/1/-%MN3R,4,L5,,==G'#S\GS?-77Z-/@0[:MV
MW\,7;\Y9GYSR$[K>7CJBU8C-NLL8HKI$:1."F*UJVFTQDF_CII6)^>2G'3Q_
MESL9MK[S/.7-/C$Q'7DMTZ>$:>Q%9F)UGJF?'3PB'E+]M8         !T_\
MVJ>IN>DO;I\0="EL9L7>\],Z]O&6QMU%D[>\QV>[8EO.UM@L<A:YBNN_L\E:
M9O=;B.Y@J^2B&>FNB.B..FBBGS%_%1W9'>OQ$=W\]7)&7#]^<NVQWK-)K?%L
M8KL<5J6QQTVI;'MJ32T:S:LQ:UK6F;37-YE\I]^._>5WL6BU/G=L=9C28FN'
M3#68FOA,37'$Q/KC29F9UE(&T P8
M                                                          !S
MW?N./Z3#:/T/]3?K3?/0/]'1_5JVOXXW_P"N53I\@OYO,?[KS_Y4('T[&Z0
M
M
M
M         %J#[6']W[RI_0]IO^>DJK7Z4G^(/:OXXW'[VA&OXD_]A\9^Z\GZ
MVNQ*5D00
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M?#T6F<$QXQ,S$SFB=(F/&(G72-)Z"SS_ "#(
M
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MML^:9MEO:;6F?3,S.LS/YLOI.,^8
M                                                          #G
MN_<<?TF&T?H?ZF_6F^>@?Z.C^K5M?QQO_P!<JG3Y!?S>8_W7G_RH0/IV-T@
M
M
M
M         +4'VL/[OWE3^A[3?\])56OTI/\ $'M7\<;C][0C7\2?^P^,_=>3
M];78E*R((
M                                          #'O;G7F,[=ZH[.ZGS5
M<,>&[/Z]W3KS+27%ISD+>C&;KK>2UN_KGL*;JQJO8:;7)U\U0\3P\R4_&GYZ
M/C\W&0=I=P[GM'NKC.Z]E$SO.,Y#;[O'$6Z)F^VS4S5TMTVZ9ZJ1I;IMI/CT
MSIHY_%[_ "<7R>VY/#K[W;9\>6NDZ3KCO%XTG2=/&/3I.GR2Y*.9P^3U[+Y7
M 9JSFQV9P>2OL/EL?<<<<7%AD\9=2V5_9S\4\U4\36MU!715QQSSQ\U/+UE;
M/>;;D-GBW^RO&39Y\=<F.\>BU+UBU;1]2U9B8^I*S_#EQY\5<^&8MBO6+5F/
M1,3&L3'YL/FN2^@        #<SV[>U).E?.OQ,[)XD]*SP7?'75EG9.(KN>6
MC5-GV&SU/<.;:"RN[*>>\_-;.7GHT<U\QUR_+Q)1)'S5'5IOXA^UJ]Z>1G=G
M;<QKFS\#N[8HUK$>_P .*V?;ZS:MHBOO\6/JG36*ZS6:VTM&)=^<;'+]E\IQ
M_P"COLLLU]$>W2LWIK,Q/AUUKKZ]/1,3I,=39Y<%;0
M
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M3Z,=KS,>N(F-8UU=+)YL5>X
M                                                      #GN_<<
M?TF&T?H?ZF_6F^>@?Z.C^K5M?QQO_P!<JG3Y!?S>8_W7G_RH0/IV-T@
M
M
M
M     +4'VL/[OWE3^A[3?\])56OTI/\ $'M7\<;C][0C7\2?^P^,_=>3];78
ME*R((
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M[7=9</C,3/V/):GC,1$3];Z8B(GY(9:8FZL
M
M                          !"=]P=V;^UY[8?;N'AO?H,CVQN'5O66.N(
ML[^"WM7K;KC=YS5E90T4^OGOQ35M%O[6ZL(ZJ/4Q\UQ))S5#%)'7-3Z/WMG^
M$/Q-\1O+T]YM^)V>]WMXG%[ROAMK[;':T^C%T9]SBO3+,3IEKCK72]ZVC;_D
M7QWS_P QMKEF.K'M<6;-,=/5'ZG..LSZJZ7R5F+3Z+16(\9B8YUST/IY@
M      +-7VO/5=&Q^6_>G;=W9S75KU?T;1K=C+SBKB:RQVQ]F[AA^;*^YS5$
M]%MCLE5KVD9:WAMJXZZ[R"XN*Z.:>+:OYJS_ *3WNFW'>4O!]I8KQ7+RG.3F
MM'7$6OAV6WR=5?=Z=5Z>]W."]KQ,1CM3'68GWD:1W^([DYV_:^RXNLQ%MSO>
MN?:C6:8<=M8Z=-9CJR4F9B?9F*Q/UT+S"CQ#4
M
M        !SW?N./Z3#:/T/\ 4WZTWST#_1T?U:MK^.-_^N53I\@OYO,?[KS_
M .5"!].QND
M
M
M                    !:@^UA_=^\J?T/:;_GI*JU^E)_B#VK^.-Q^]H1K^
M)/\ V'QG[KR?K:[$I61!
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MO.;COO;YC<C6L3&+-;'FKKIX^\QTM>?#T?9.N(UC72-9UUZIEO1+:N
M
M                                              50/NH^RJ\?U3XD
M=/17,W,>V]A=D=E7]G%<V_T\=?7FMX#5\3<WUG^6Z]::GL^]IM)./A'\M%Q3
MS\>?A\MK/T6?;==QW5W;W?>L=6TX_9[.MIB=9C=YLN?)%;?6Z1\RQS>/3K..
M?"/3)OX:N/B_)\IRLQ&N+!BQ1.DZ_9;VO:(GT?\ ,UZH]/C52\7-);@
M    +POVN/5LN \7/(;M^YQ_T<W9?=F,TZRNIK&[MKG*X3JW3K&^MKR"[FII
MMLAAX<UV1D;:*N'YN([N"ZHJJ^:GY::1?I0>Z*[_ ,T.WNT<63KIQO"7W%JQ
M:LUIDWNXM6:S6/:IDG'L\-[1;37';%:(TG68<_$AR49^Y-AQ5;:QM]G.28UB
M8K;-DF)B8],6Z<59G7TUFLPL^JQD<P
M
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MN_>5/Z'M-_STE5:_2D_Q![5_'&X_>T(U_$G_ +#XS]UY/UM=B4K(@@
M
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MU=*T&K#1R
M
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MXJQ,1&G1BI%O1Z8G)UVB9G728]'HB75$AJT
M
M      !SW?N./Z3#:/T/]3?K3?/0/]'1_5JVOXXW_P"N53I\@OYO,?[KS_Y4
M('T[&Z0       $\'VX_])AJ_P"A_MG]:;%!/Z1?^K5NOQQL/URS2WG[_-YD
M_=>#_*ET(GGX06                         <KWW"_P#C[\XO^<#R7_VT
M;J]2OP^?S"=C_P#E#AO]W;991V)_$CAOQ5M/WOC:?MO,J        7 ?M1O_
M (]?_E;_ /HBU0WTJW_Y!_\ ;?\ ^*$5OB9__ G_ $S_ .E7 50J*P
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MON]_TE_F1^F')?K5B7IF^$7^K5V=^)Z?KF18GY5_S><3^Y(_RK(WTC6?@
M    +4'VL/[OWE3^A[3?\])56OTI/\0>U?QQN/WM"-?Q)_[#XS]UY/UM=B4K
M(@@
M                                     (9O?WZNF[,]L/O&[L8/JLIU
MCF.NNT<?;_#'T_-#@MUQ&%V.?ZC(2P\6WX?IVQY*Y_M-7U$WH^A'37S+\E4R
M?@([HIVU\3?!XL]NG:\GAW>RO/M^G+MLF3#&E(G7KW&'#3VHZ*]77:8BO5&V
MO)'DHX[S&V=;SICW-,N&9\?T6.UJ1I'IUR4I'CX1KK.FFKG+/14GP
M   L[?:Y=J5Z_P"5GD#T]/>0VN/[,Z-L]R@CN,K;VG&2V/JO=<388W'6>+F@
M]7+9+C =E9>ZIYBFIKM[6UN*N8Y*.:JX:ROI0.UJ\AY5]O\ >%*3?<<9SEMO
M,Q2;=&'?;;):][7B=,=/>[/!2>JLQ>]\<1:LQ%;QU^)#C8S]L['E:Q,Y-OO9
MQSI69TIFQVF9F?T,=6*D>,>,VKXQ/A-XQ2"AN
M
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M'V3):_A%O:B/'PB?&/7XLV,*=.
M                                                          Y[
MOW''])AM'Z'^IOUIOGH'^CH_JU;7\<;_ /7*IT^07\WF/]UY_P#*A ^G8W2
M       G@^W'_I,-7_0_VS^M-B@G](O_ %:MU^.-A^N6:6\_?YO,G[KP?Y4N
MA$\_""P                        #E>^X7_Q]^<7_ #@>2_\ MHW5ZE?A
M\_F$['_\H<-_N[;+*.Q/XD<-^*MI^]\;3]MYE0       "X#]J-_\>O_ ,K?
M_P!$6J&^E6__ "#_ .V__P 4(K?$S_\ @3_IG_TJX"J%16
M          4G?NGOW?O%;]#VY?YZ1+J?HMOX@]U?CC;_ +VE+[X;/]A\G^Z\
M?ZVJOK2DE        $D'M"?TE_AO^F'&_K5ED<OBZ_JU=X_B>_ZYC8!YJ?S>
M<M^Y)_RJNG$\S*NP                       !S???M_I8_*W_ +B__#9T
MZ]&WP&_U4>U?^T_]\<@G]Y)_S8\9_P!(_?>=#^EZVH        L@?:]_\??;
MW_)_O_\ MH\?U<GTGG\PG$?^;]K_ +NY5H#XCOXD;7\:XOWON5\)1.A8
M                     Y+GD+^[[WA^F#LO_/3-/6)Y??Q!X/\ $^S_ 'MC
M6>\%_L/9_N3#^MU8@9>[4       !=@^U@_<"\JOTP:9_F7,I6^E)_C]VK^)
M]Q^^81!^)/\ VYQG[DR?KBU$JU1K                         <QWW>_Z
M2_S(_3#DOUJQ+TS?"+_5J[._$]/US(L3\J_YO.)_<D?Y5D;Z1K/P       %
MJ#[6']W[RI_0]IO^>DJK7Z4G^(/:OXXW'[VA&OXD_P#8?&?NO)^MKL2E9$$
M
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MAC'EK,S,:=&6DV]'IF<?76(F--9CT>F.D<\X:O\
M
M                                <E?OWL*OMSO;NKM>6]FR<O9W;78_
M84F2N+*WQMQD*]TW',[)7>SXZTB@M;":[JR7J50Q441Q55<TTT\<<<</6/V%
MV]7M+L7A>U*TC%7C.)V>TBD6F\4C;;?'AZ8O:9M:*]&D6M,S:(UF9F5G_!["
M.+X79\9$16-MM<6+2)F8CW>.M-(F=9G33369UGTL2LL=F         V0\.NL
MOVY_+/QGZGKLOK[/L+OCJC4\O#7@OSFMHL!F-XPEIL5_D<!S5'%E</BL%)<7
M5[%+7'#S:0R<RUT1\55<:Y\X>YOX&>4_<O==;^[S<?P.^SXY][[FTY<>VR6P
MTIE\9IDOEBE,=JQ-O>6KTQ-M(GH.Z^1^]';'(\G$]-\&RS7K[71/57'::1%O
MT-K6TBLQK/5,:1,Z0ZN3RI*S
M                                                         '/=
M^XX_I,-H_0_U-^M-\] _T=']6K:_CC?_ *Y5.GR"_F\Q_NO/_E0@?3L;I
M     3P?;C_TF&K_ *'^V?UIL4$_I%_ZM6Z_'&P_7+-+>?O\WF3]UX/\J70B
M>?A!8                        !RO?<+_ ./OSB_YP/)?_;1NKU*_#Y_,
M)V/_ .4.&_W=MEE'8G\2.&_%6T_>^-I^V\RH       !<!^U&_\ CU_^5O\
M^B+5#?2K?_D'_P!M_P#XH16^)G_\"?\ 3/\ Z5<!5"HK
M        *3OW3W[OWBM^A[<O\](EU/T6W\0>ZOQQM_WM*7WPV?[#Y/\ =>/]
M;57UI22@       "2#VA/Z2_PW_3#C?UJRR.7Q=?U:N\?Q/?]<QL \U/YO.6
M_<D_Y573B>9E78                        YOOOV_TL?E;_W%_P#ALZ=>
MC;X#?ZJ/:O\ VG_OCD$_O)/^;'C/^D?OO.A_2];4        60/M>_\ C[[>
M_P"3_?\ _;1X_JY/I//YA.(_\W[7_=W*M ?$=_$C:_C7%^]]ROA*)T+
M                    ')<\A?W?>\/TP=E_YZ9IZQ/+[^(/!_B?9_O;&L]X
M+_8>S_<F'];JQ R]VH       "[!]K!^X%Y5?I@TS_,N92M]*3_'[M7\3[C]
M\PB#\2?^W.,_<F3]<6HE6J-8                        #F.^[W_27^9'
MZ8<E^M6)>F;X1?ZM79WXGI^N9%B?E7_-YQ/[DC_*LC?2-9^        M0?:P
M_N_>5/Z'M-_STE5:_2D_Q![5_'&X_>T(U_$G_L/C/W7D_6UV)2LB"
M
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MK+/*"K$
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M
M                                !SW?N./Z3#:/T/\ 4WZTWST#_1T?
MU:MK^.-_^N53I\@OYO,?[KS_ .5"!].QND       !/!]N/_ $F&K_H?[9_6
MFQ03^D7_ *M6Z_'&P_7+-+>?O\WF3]UX/\J70B>?A!8
M       !RO?<+_X^_.+_ )P/)?\ VT;J]2OP^?S"=C_^4.&_W=MEE'8G\2.&
M_%6T_>^-I^V\RH       !<!^U&_^/7_ .5O_P"B+5#?2K?_ )!_]M__ (H1
M6^)G_P# G_3/_I5P%4*BL                        I._=/?N_>*WZ'MR
M_P ](EU/T6W\0>ZOQQM_WM*7WPV?[#Y/]UX_UM5?6E)*        )(/:$_I+
M_#?],.-_6K+(Y?%U_5J[Q_$]_P!<QL \U/YO.6_<D_Y573B>9E78
M                YOOOV_TL?E;_ -Q?_ALZ=>C;X#?ZJ/:O_:?^^.03^\D_
MYL>,_P"D?OO.A_2];4        60/M>_^/OM[_D_W_\ VT>/ZN3Z3S^83B/_
M #?M?]W<JT!\1W\2-K^-<7[WW*^$HG0L                         <ES
MR%_=][P_3!V7_GIFGK$\OOX@\'^)]G^]L:SW@O\ 8>S_ ')A_6ZL0,O=J
M     NP?:P?N!>57Z8-,_P RYE*WTI/\?NU?Q/N/WS"(/Q)_[<XS]R9/UQ:B
M5:HU@                        .8[[O?])?YD?IAR7ZU8EZ9OA%_JU=G?
MB>GZYD6)^5?\WG$_N2/\JR-](UGX       "U!]K#^[]Y4_H>TW_ #TE5:_2
MD_Q![5_'&X_>T(U_$G_L/C/W7D_6UV)2LB"
M
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M<:1,1I3):L:1/CI,1$Q]31GY@+HP
M
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MHT],HX_$EOJX^W..XR=.O-O;98^73#BM2=/J?9XU_N+O2DI#L
M
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MRR.7Q=?U:N\?Q/?]<QL \U/YO.6_<D_Y573B>9E78
M     YOOOV_TL?E;_P!Q?_ALZ=>C;X#?ZJ/:O_:?^^.03^\D_P";'C/^D?OO
M.A_2];4        60/M>_P#C[[>_Y/\ ?_\ ;1X_JY/I//YA.(_\W[7_ '=R
MK0'Q'?Q(VOXUQ?O?<KX2B="P                        !R7/(7]WWO#]
M,'9?^>F:>L3R^_B#P?XGV?[VQK/>"_V'L_W)A_6ZL0,O=J        NP?:P?
MN!>57Z8-,_S+F4K?2D_Q^[5_$^X_?,(@_$G_ +<XS]R9/UQ:B5:HU@
M                  .8[[O?])?YD?IAR7ZU8EZ9OA%_JU=G?B>GZYD6)^5?
M\WG$_N2/\JR-](UGX       "U!]K#^[]Y4_H>TW_/255K]*3_$'M7\<;C][
M0C7\2?\ L/C/W7D_6UV)2LB"
M
MH_\ W2?6M>&\H/''MJBVFAM=_P"C<IHU4W%M;Q6=WD^L-YRN9NY>+B/X7%UD
MH\?VC9QS>IQ\*(*+?BGGGCX\<7<?1=]R5WGEAW'VG:T6R\?SE-SIK,VK3>[:
MF.L:3X5I-]EDFNGIM.29CUS,7X;N0C+VYR'%S,3;!O:Y/3.L1FQUK'AZ(C7#
M:8T]?4J^K.TC0         '2-]BGL>#L?VO/&J7F6SJRNDV>]]<9NVL;3(6L
M-E/J'8NU6>#BKJOZI>+N\N]-EQEW<3025V]5Q<U\4\1\TU0Q></XYNW+]N?$
M]W+32_S7>WVN\QS:U+3:-QM,%LLQTZ=-:[B,V.E;1%XI2LSU1,7M7_YS\?/'
M^8_(1I/NLTX\M9F8G7KQ4FWH]$1DZZQ$QKI$>GTS+JB0U:
M
M                                    K6?= =@5X'PIZ>Z]M9\E;W78
M/D5ALC?<V]%O^&7NN:3H6\7-[C<E+7/Q<TS5[#G,3=6],<55%7-I7S771S33
M3)9)]&+P%=_YT\QW!EKCMBX_MW)2NNO77-N=UMJUO2-.G2,6+/2\S:)CWE8B
MLZS-9!_#EL8S]W[O?6BLUP;"T1KKK%\F3'$3'J^MK>)UG]%&D3XZ44%YZ9X
M        "[;]K)UQ#B_'+R@[=IBL^+C>.[-:ZXEFHN\A7D)(>J]%M-F@BN;"
M2GC%VUG#7W')S!-#SS<3UUS4S<<410?&E'Z4CN.^Z\Q>V.T9F_N]CPF;>1$U
MI%(G?;JV&9K:/;FTQQ\=5;>Q6(I-/&^1#[XD^0G)S_&\7K/3AV=\OHC3[-DF
MDZ3]=,_8(UB?"-(T\9LM*JND;@
M                                                          '/
M=^XX_I,-H_0_U-^M-\] _P!'1_5JVOXXW_ZY5.GR"_F\Q_NO/_E0@?3L;I
M      3P?;C_ -)AJ_Z'^V?UIL4$_I%_ZM6Z_'&P_7+-+>?O\WF3]UX/\J70
MB>?A!8                        !RO?<+_P"/OSB_YP/)?_;1NKU*_#Y_
M,)V/_P"4.&_W=MEE'8G\2.&_%6T_>^-I^V\RH       !<!^U&_^/7_Y6_\
MZ(M4-]*M_P#D'_VW_P#BA%;XF?\ \"?],_\ I5P%4*BL
M        I._=/?N_>*WZ'MR_STB74_1;?Q![J_'&W_>TI??#9_L/D_W7C_6U
M5]:4DH        D@]H3^DO\ #?\ 3#C?UJRR.7Q=?U:N\?Q/?]<QL \U/YO.
M6_<D_P"55TXGF95V                        .;[[]O\ 2Q^5O_<7_P"&
MSIUZ-O@-_JH]J_\ :?\ OCD$_O)/^;'C/^D?OO.A_2];4        60/M>_^
M/OM[_D_W_P#VT>/ZN3Z3S^83B/\ S?M?]W<JT!\1W\2-K^-<7[WW*^$HG0L
M                        <ESR%_=][P_3!V7_ )Z9IZQ/+[^(/!_B?9_O
M;&L]X+_8>S_<F'];JQ R]VH       "[!]K!^X%Y5?I@TS_,N92M]*3_ !^[
M5_$^X_?,(@_$G_MSC/W)D_7%J)5JC6                         YCON]
M_P!)?YD?IAR7ZU8EZ9OA%_JU=G?B>GZYD6)^5?\ -YQ/[DC_ "K(WTC6?@
M     +4'VL/[OWE3^A[3?\])56OTI/\ $'M7\<;C][0C7\2?^P^,_=>3];78
ME*R((
M                                        "KA]TUU_1DO&KQD[4Y@Q
MM4FF]Y9[K^FYEKN.,Q%1V7H.3V.2"QCI@JM:L;<5=34U7?-<E$E,L5OQ137Q
MS)S1:%]%QS]MMYD]S=K=63IWG!XMUI&GNYG9[JF&)M.O5UQ\_F*:1,36V3JF
M)BL6DA\-N^G'W#R/&ZVTS;*N73PZ?L.6*>/KUCWWL^&FDVUT\-:1B[%,(
M      !>I^U^["N\]X8]S==WM5Y/^U[Y"9+)8N>:2*JTML)O&BZ?<1XBRBII
MXEC^FSN R-W)S5SSQ55?_D_L<\*,_I.^W\6P\Y>&[AP]%?OAV_2EXB)ZIR;;
M<[B)R6GT3KBRXL<:>B,7CZ4,?B-V-<'=NTW]-(]_L(B8]<VQY,D=4_FUM6L?
MXJRRK81[
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M_7>^8V[QTF)IM\6'%K%NJ)F,=;V_Q>FU[5FOCI:LS/C,Q$U:%S4(
M
M                        #GN_<<?TF&T?H?ZF_6F^>@?Z.C^K5M?QQO\
M]<JG3Y!?S>8_W7G_ ,J$#Z=C=(       ">#[<?^DPU?]#_;/ZTV*"?TB_\
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MM661R^+K^K5WC^)[_KF-@'FI_-YRW[DG_*JZ<3S,J[
M      '-]]^W^EC\K?\ N+_\-G3KT;? ;_51[5_[3_WQR"?WDG_-CQG_ $C]
M]YT/Z7K:@       "R!]KW_Q]]O?\G^__P"VCQ_5R?2>?S"<1_YOVO\ N[E6
M@/B._B1M?QKB_>^Y7PE$Z%@                        #DN>0O[OO>'Z8
M.R_\],T]8GE]_$'@_P 3[/\ >V-9[P7^P]G^Y,/ZW5B!E[M0       %V#[6
M#]P+RJ_3!IG^9<RE;Z4G^/W:OXGW'[YA$'XD_P#;G&?N3)^N+42K5&L
M                   !S'?=[_I+_,C],.2_6K$O3-\(O]6KL[\3T_7,BQ/R
MK_F\XG]R1_E61OI&L_        6H/M8?W?O*G]#VF_YZ2JM?I2?X@]J_CC<?
MO:$:_B3_ -A\9^Z\GZVNQ*5D00
M
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MKEI2T:SZI^PSTQZXZOD71%,J(X
M
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MB)UA6SWWOXY/O3E=[68MCOO\_3,1,:TKDM6DZ3I,>Q%==8B=?3#<=IYB8
M
M                             #GN_<<?TF&T?H?ZF_6F^>@?Z.C^K5M?
MQQO_ -<JG3Y!?S>8_P!UY_\ *A ^G8W2        G@^W'_I,-7_0_P!L_K38
MH)_2+_U:MU^.-A^N6:6\_?YO,G[KP?Y4NA$\_""P
M    #E>^X7_Q]^<7_.!Y+_[:-U>I7X?/YA.Q_P#RAPW^[MLLH[$_B1PWXJVG
M[WQM/VWF5        +@/VHW_ ,>O_P K?_T1:H;Z5;_\@_\ MO\ _%"*WQ,_
M_@3_ *9_]*N JA45@                       %)W[I[]W[Q6_0]N7^>D2
MZGZ+;^(/=7XXV_[VE+[X;/\ 8?)_NO'^MJKZTI)0       !)![0G])?X;_I
MAQOZU99'+XNOZM7>/XGO^N8V >:G\WG+?N2?\JKIQ/,RKL
M          <WWW[?Z6/RM_[B_P#PV=.O1M\!O]5'M7_M/_?'()_>2?\ -CQG
M_2/WWG0_I>MJ        +('VO?\ Q]]O?\G^_P#^VCQ_5R?2>?S"<1_YOVO^
M[N5: ^([^)&U_&N+][[E?"43H6                         .2YY"_N^]
MX?I@[+_STS3UB>7W\0>#_$^S_>V-9[P7^P]G^Y,/ZW5B!E[M0       %V#[
M6#]P+RJ_3!IG^9<RE;Z4G^/W:OXGW'[YA$'XD_\ ;G&?N3)^N+42K5&L
M                    !S'?=[_I+_,C],.2_6K$O3-\(O\ 5J[._$]/US(L
M3\J_YO.)_<D?Y5D;Z1K/P       %J#[6']W[RI_0]IO^>DJK7Z4G^(/:OXX
MW'[VA&OXD_\ 8?&?NO)^MKL2E9$$
M
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M^V$[OR]ON(B9^:[O#EUUB--9MAUF/7^K::1K.LQ/HB9=!QY^T&
M
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M5E5OFRY,^6V?-,VRWM-K3/IF9G69G\V7TG&?,
M
M         !SW?N./Z3#:/T/]3?K3?/0/]'1_5JVOXXW_ .N53I\@OYO,?[KS
M_P"5"!].QND       !/!]N/_28:O^A_MG]:;%!/Z1?^K5NOQQL/URS2WG[_
M #>9/W7@_P J70B>?A!8                        !RO?<+_X^_.+_G \
ME_\ ;1NKU*_#Y_,)V/\ ^4.&_P!W;991V)_$CAOQ5M/WOC:?MO,J
M7 ?M1O\ X]?_ )6__HBU0WTJW_Y!_P#;?_XH16^)G_\  G_3/_I5P%4*BL
M                      I._=/?N_>*WZ'MR_STB74_1;?Q![J_'&W_ 'M*
M7WPV?[#Y/]UX_P!;57UI22@       "2#VA/Z2_PW_3#C?UJRR.7Q=?U:N\?
MQ/?]<QL \U/YO.6_<D_Y573B>9E78                        YOOOV_T
ML?E;_P!Q?_ALZ=>C;X#?ZJ/:O_:?^^.03^\D_P";'C/^D?OO.A_2];4
M   60/M>_P#C[[>_Y/\ ?_\ ;1X_JY/I//YA.(_\W[7_ '=RK0'Q'?Q(VOXU
MQ?O?<KX2B="P                        !R7/(7]WWO#],'9?^>F:>L3R
M^_B#P?XGV?[VQK/>"_V'L_W)A_6ZL0,O=J        NP?:P?N!>57Z8-,_S+
MF4K?2D_Q^[5_$^X_?,(@_$G_ +<XS]R9/UQ:B5:HU@
M      .8[[O?])?YD?IAR7ZU8EZ9OA%_JU=G?B>GZYD6)^5?\WG$_N2/\JR-
M](UGX       "U!]K#^[]Y4_H>TW_/255K]*3_$'M7\<;C][0C7\2?\ L/C/
MW7D_6UV)2LB"
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MU:^,>[UKZNK372/%T]'F05T
M
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M=YA;VW']C<MNJ=49(V&:M9K.DQ:])I6T3ZNF;1;P\?#P\74D>7E6\
M
M                           Y[OW''])AM'Z'^IOUIOGH'^CH_JU;7\<;
M_P#7*IT^07\WF/\ =>?_ "H0/IV-T@       )X/MQ_Z3#5_T/\ ;/ZTV*"?
MTB_]6K=?CC8?KEFEO/W^;S)^Z\'^5+H1//P@L
M  Y7ON%_\??G%_S@>2_^VC=7J5^'S^83L?\ \H<-_N[;+*.Q/XD<-^*MI^]\
M;3]MYE0       "X#]J-_P#'K_\ *W_]$6J&^E6__(/_ +;_ /Q0BM\3/_X$
M_P"F?_2K@*H5%8                       !2=^Z>_=^\5OT/;E_GI$NI^
MBV_B#W5^.-O^]I2^^&S_ &'R?[KQ_K:J^M*24        20>T)_27^&_Z8<;
M^M661R^+K^K5WC^)[_KF-@'FI_-YRW[DG_*JZ<3S,J[
M       '-]]^W^EC\K?^XO\ \-G3KT;? ;_51[5_[3_WQR"?WDG_ #8\9_TC
M]]YT/Z7K:@       "R!]KW_ ,??;W_)_O\ _MH\?U<GTGG\PG$?^;]K_N[E
M6@/B._B1M?QKB_>^Y7PE$Z%@                        #DN>0O[OO>'Z
M8.R_\],T]8GE]_$'@_Q/L_WMC6>\%_L/9_N3#^MU8@9>[4       !=@^U@_
M<"\JOTP:9_F7,I6^E)_C]VK^)]Q^^81!^)/_ &YQG[DR?KBU$JU1K
M                  <QWW>_Z2_S(_3#DOUJQ+TS?"+_ %:NSOQ/3]<R+$_*
MO^;SB?W)'^59&^D:S\       !:@^UA_=^\J?T/:;_GI*JU^E)_B#VK^.-Q^
M]H1K^)/_ &'QG[KR?K:[$I61!
M
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M!DQSU1K72])K[4>N/'QCUPZX+R6*NP
M
M                  &'_(;?OVJN@>\>T/Q;\!_:WZ?[,W[\<^A_%/P;\S]+
MS>P_BWX9]'D?Q'\._#O6]#Z>?UOD^3TZ_C\O.7^7W _PJ[^X/M?W7O\ [Y<Q
ML]K[KJZ/>?.-SCQ>[Z^JG1U]?3U==>G77JKIK':\%L?OGSFSXWIZ_G&[PXNG
M73J]YDK7IUUC377376-/3K#DNO6(L]          35?;Z:7;[9[HW2>3N;B&
M./0=5[>W2FSGL*+ZC)W'[66RZC:6]-<D\5-A-8W6V47\<_R354R6=----/-?
M$D<+OI >:R<3\+_-[;%69MO]UL-MU1::S2/GN'<6GPB>N+5P3BFNM8F,DS,S
M$=-M1>>>[MM?+?>8ZQ.N?+@QZQ.FD>^I>9]'CK%.F8\/"VNOAI/18>=U H
M
M                               !SW?N./Z3#:/T/]3?K3?/0/\ 1T?U
M:MK^.-_^N53I\@OYO,?[KS_Y4('T[&Z0       $\'VX_P#28:O^A_MG]:;%
M!/Z1?^K5NOQQL/URS2WG[_-YD_=>#_*ET(GGX06
M    <KWW"_\ C[\XO^<#R7_VT;J]2OP^?S"=C_\ E#AO]W;991V)_$CAOQ5M
M/WOC:?MO,J        7 ?M1O_CU_^5O_ .B+5#?2K?\ Y!_]M_\ XH16^)G_
M / G_3/_ *5<!5"HK                        *3OW3W[OWBM^A[<O\](
MEU/T6W\0>ZOQQM_WM*7WPV?[#Y/]UX_UM5?6E)*        )(/:$_I+_  W_
M $PXW]:LLCE\77]6KO'\3W_7,; /-3^;SEOW)/\ E5=.)YF5=@
M             #F^^_;_ $L?E;_W%_\ ALZ=>C;X#?ZJ/:O_ &G_ +XY!/[R
M3_FQXS_I'[[SH?TO6U        %D#[7O_C[[>_Y/]_\ ]M'C^KD^D\_F$XC_
M ,W[7_=W*M ?$=_$C:_C7%^]]ROA*)T+                         ')<
M\A?W?>\/TP=E_P">F:>L3R^_B#P?XGV?[VQK/>"_V'L_W)A_6ZL0,O=J
M    NP?:P?N!>57Z8-,_S+F4K?2D_P ?NU?Q/N/WS"(/Q)_[<XS]R9/UQ:B5
M:HU@                        .8[[O?\ 27^9'Z8<E^M6)>F;X1?ZM79W
MXGI^N9%B?E7_ #><3^Y(_P JR-](UGX       "U!]K#^[]Y4_H>TW_/255K
M]*3_ !![5_'&X_>T(U_$G_L/C/W7D_6UV)2LB"
M
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M,NZ>3V75U>YY#<4UTTUZ,UZZZ:SIKIKIK.GRMD&N&/@
M
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MZ&P
M                                    #GN_<<?TF&T?H?ZF_6F^>@?Z
M.C^K5M?QQO\ ]<JG3Y!?S>8_W7G_ ,J$#Z=C=(       ">#[<?^DPU?]#_;
M/ZTV*"?TB_\ 5JW7XXV'ZY9I;S]_F\R?NO!_E2Z$3S\(+
M          .5[[A?_'WYQ?\ .!Y+_P"VC=7J5^'S^83L?_RAPW^[MLLH[$_B
M1PWXJVG[WQM/VWF5        +@/VHW_QZ_\ RM__ $1:H;Z5;_\ (/\ [;__
M !0BM\3/_P"!/^F?_2K@*H5%8                       !2=^Z>_=^\5O
MT/;E_GI$NI^BV_B#W5^.-O\ O:4OOAL_V'R?[KQ_K:J^M*24        20>T
M)_27^&_Z8<;^M661R^+K^K5WC^)[_KF-@'FI_-YRW[DG_*JZ<3S,J[
M                  '-]]^W^EC\K?\ N+_\-G3KT;? ;_51[5_[3_WQR"?W
MDG_-CQG_ $C]]YT/Z7K:@       "R!]KW_Q]]O?\G^__P"VCQ_5R?2>?S"<
M1_YOVO\ N[E6@/B._B1M?QKB_>^Y7PE$Z%@                        #
MDN>0O[OO>'Z8.R_\],T]8GE]_$'@_P 3[/\ >V-9[P7^P]G^Y,/ZW5B!E[M0
M       %V#[6#]P+RJ_3!IG^9<RE;Z4G^/W:OXGW'[YA$'XD_P#;G&?N3)^N
M+42K5&L                        !S'?=[_I+_,C],.2_6K$O3-\(O]6K
ML[\3T_7,BQ/RK_F\XG]R1_E61OI&L_        6H/M8?W?O*G]#VF_YZ2JM?
MI2?X@]J_CC<?O:$:_B3_ -A\9^Z\GZVNQ*5D00
M
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M];UZ:^O372-=(E11::U
M
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M>+<7UU]/O+8JZ::>&GN]==?'J]$:>-M%4ZC
M
M          Y[OW''])AM'Z'^IOUIOGH'^CH_JU;7\<;_ /7*IT^07\WF/]UY
M_P#*A ^G8W2        G@^W'_I,-7_0_VS^M-B@G](O_ %:MU^.-A^N6:6\_
M?YO,G[KP?Y4NA$\_""P                        #E>^X7_Q]^<7_ #@>
M2_\ MHW5ZE?A\_F$['_\H<-_N[;+*.Q/XD<-^*MI^]\;3]MYE0       "X#
M]J-_\>O_ ,K?_P!$6J&^E6__ "#_ .V__P 4(K?$S_\ @3_IG_TJX"J%16
M                      4G?NGOW?O%;]#VY?YZ1+J?HMOX@]U?CC;_ +VE
M+[X;/]A\G^Z\?ZVJOK2DE        $D'M"?TE_AO^F'&_K5ED<OBZ_JU=X_B
M>_ZYC8!YJ?S><M^Y)_RJNG$\S*NP                       !S???M_I8
M_*W_ +B__#9TZ]&WP&_U4>U?^T_]\<@G]Y)_S8\9_P!(_?>=#^EZVH
M  L@?:]_\??;W_)_O_\ MH\?U<GTGG\PG$?^;]K_ +NY5H#XCOXD;7\:XOWO
MN5\)1.A8                         Y+GD+^[[WA^F#LO_/3-/6)Y??Q!
MX/\ $^S_ 'MC6>\%_L/9_N3#^MU8@9>[4       !=@^U@_<"\JOTP:9_F7,
MI6^E)_C]VK^)]Q^^81!^)/\ VYQG[DR?KBU$JU1K
M     <QWW>_Z2_S(_3#DOUJQ+TS?"+_5J[._$]/US(L3\J_YO.)_<D?Y5D;Z
M1K/P       %J#[6']W[RI_0]IO^>DJK7Z4G^(/:OXXW'[VA&OXD_P#8?&?N
MO)^MKL2E9$$
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M"'XA=K\W[]IEZM??\?AOIIITZ7RX]/3X_J>NOAZ=-/#6;"*OMHL
M
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M;FN?OS'BB)B</'8J3]69R9LFL?W,D1^;$K"ZOAHD
M
M             !SW?N./Z3#:/T/]3?K3?/0/]'1_5JVOXXW_ .N53I\@OYO,
M?[KS_P"5"!].QND       !/!]N/_28:O^A_MG]:;%!/Z1?^K5NOQQL/URS2
MWG[_ #>9/W7@_P J70B>?A!8                        !RO?<+_X^_.+
M_G \E_\ ;1NKU*_#Y_,)V/\ ^4.&_P!W;991V)_$CAOQ5M/WOC:?MO,J
M    7 ?M1O\ X]?_ )6__HBU0WTJW_Y!_P#;?_XH16^)G_\  G_3/_I5P%4*
MBL                        I._=/?N_>*WZ'MR_STB74_1;?Q![J_'&W_
M 'M*7WPV?[#Y/]UX_P!;57UI22@       "2#VA/Z2_PW_3#C?UJRR.7Q=?U
M:N\?Q/?]<QL \U/YO.6_<D_Y573B>9E78                        YOO
MOV_TL?E;_P!Q?_ALZ=>C;X#?ZJ/:O_:?^^.03^\D_P";'C/^D?OO.A_2];4
M       60/M>_P#C[[>_Y/\ ?_\ ;1X_JY/I//YA.(_\W[7_ '=RK0'Q'?Q(
MVOXUQ?O?<KX2B="P                        !R7/(7]WWO#],'9?^>F:
M>L3R^_B#P?XGV?[VQK/>"_V'L_W)A_6ZL0,O=J        NP?:P?N!>57Z8-
M,_S+F4K?2D_Q^[5_$^X_?,(@_$G_ +<XS]R9/UQ:B5:HU@
M          .8[[O?])?YD?IAR7ZU8EZ9OA%_JU=G?B>GZYD6)^5?\WG$_N2/
M\JR-](UGX       "U!]K#^[]Y4_H>TW_/255K]*3_$'M7\<;C][0C7\2?\
ML/C/W7D_6UV)2LB"
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MFLZ^F$2OB6VUJ<AQ.\UCIR8<]-/7$X[8K3/]WWD:?F2MEJH$8@
M
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M1:Q
M                                     <]W[CC^DPVC]#_4WZTWST#_
M $=']6K:_CC?_KE4Z?(+^;S'^Z\_^5"!].QND       !/!]N/\ TF&K_H?[
M9_6FQ03^D7_JU;K\<;#]<LTMY^_S>9/W7@_RI=")Y^$%@
M         '*]]PO_ (^_.+_G \E_]M&ZO4K\/G\PG8__ )0X;_=VV64=B?Q(
MX;\5;3][XVG[;S*@       %P'[4;_X]?_E;_P#HBU0WTJW_ .0?_;?_ .*$
M5OB9_P#P)_TS_P"E7 50J*P                       "D[]T]^[]XK?H>
MW+_/2)=3]%M_$'NK\<;?][2E]\-G^P^3_=>/];57UI22@       "2#VA/Z2
M_P -_P!,.-_6K+(Y?%U_5J[Q_$]_US&P#S4_F\Y;]R3_ )573B>9E78
M                   YOOOV_P!+'Y6_]Q?_ (;.G7HV^ W^JCVK_P!I_P"^
M.03^\D_YL>,_Z1^^\Z']+UM0       !9 ^U[_X^^WO^3_?_ /;1X_JY/I//
MYA.(_P#-^U_W=RK0'Q'?Q(VOXUQ?O?<KX2B="P
M  !R7/(7]WWO#],'9?\ GIFGK$\OOX@\'^)]G^]L:SW@O]A[/]R8?UNK$#+W
M:@       +L'VL'[@7E5^F#3/\RYE*WTI/\ '[M7\3[C]\PB#\2?^W.,_<F3
M]<6HE6J-8                        #F.^[W_ $E_F1^F')?K5B7IF^$7
M^K5V=^)Z?KF18GY5_P WG$_N2/\ *LC?2-9^        M0?:P_N_>5/Z'M-_
MSTE5:_2D_P 0>U?QQN/WM"-?Q)_[#XS]UY/UM=B4K(@@
M
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M7V7%:VD3I];/N?:\8\8KX3IX7>E)2'8
M
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M8CT^+;IJ1BP
M                                            #GN_<<?TF&T?H?ZF
M_6F^>@?Z.C^K5M?QQO\ ]<JG3Y!?S>8_W7G_ ,J$#Z=C=(       ">#[<?^
MDPU?]#_;/ZTV*"?TB_\ 5JW7XXV'ZY9I;S]_F\R?NO!_E2Z$3S\(+
M                  .5[[A?_'WYQ?\ .!Y+_P"VC=7J5^'S^83L?_RAPW^[
MMLLH[$_B1PWXJVG[WQM/VWF5        +@/VHW_QZ_\ RM__ $1:H;Z5;_\
M(/\ [;__ !0BM\3/_P"!/^F?_2K@*H5%8                       !2=^
MZ>_=^\5OT/;E_GI$NI^BV_B#W5^.-O\ O:4OOAL_V'R?[KQ_K:J^M*24
M    20>T)_27^&_Z8<;^M661R^+K^K5WC^)[_KF-@'FI_-YRW[DG_*JZ<3S,
MJ[                        '-]]^W^EC\K?\ N+_\-G3KT;? ;_51[5_[
M3_WQR"?WDG_-CQG_ $C]]YT/Z7K:@       "R!]KW_Q]]O?\G^__P"VCQ_5
MR?2>?S"<1_YOVO\ N[E6@/B._B1M?QKB_>^Y7PE$Z%@
M       #DN>0O[OO>'Z8.R_\],T]8GE]_$'@_P 3[/\ >V-9[P7^P]G^Y,/Z
MW5B!E[M0       %V#[6#]P+RJ_3!IG^9<RE;Z4G^/W:OXGW'[YA$'XD_P#;
MG&?N3)^N+42K5&L                        !S'?=[_I+_,C],.2_6K$O
M3-\(O]6KL[\3T_7,BQ/RK_F\XG]R1_E61OI&L_        6H/M8?W?O*G]#V
MF_YZ2JM?I2?X@]J_CC<?O:$:_B3_ -A\9^Z\GZVNQ*5D00
M
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M+
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M>U[:>$:VF9G2/S9?><!\
M                                                      '/=^XX
M_I,-H_0_U-^M-\] _P!'1_5JVOXXW_ZY5.GR"_F\Q_NO/_E0@?3L;I
M  3P?;C_ -)AJ_Z'^V?UIL4$_I%_ZM6Z_'&P_7+-+>?O\WF3]UX/\J70B>?A
M!8                        !RO?<+_P"/OSB_YP/)?_;1NKU*_#Y_,)V/
M_P"4.&_W=MEE'8G\2.&_%6T_>^-I^V\RH       !<!^U&_^/7_Y6_\ Z(M4
M-]*M_P#D'_VW_P#BA%;XF?\ \"?],_\ I5P%4*BL
M    I._=/?N_>*WZ'MR_STB74_1;?Q![J_'&W_>TI??#9_L/D_W7C_6U5]:4
MDH        D@]H3^DO\ #?\ 3#C?UJRR.7Q=?U:N\?Q/?]<QL \U/YO.6_<D
M_P"55TXGF95V                        .;[[]O\ 2Q^5O_<7_P"&SIUZ
M-O@-_JH]J_\ :?\ OCD$_O)/^;'C/^D?OO.A_2];4        60/M>_^/OM[
M_D_W_P#VT>/ZN3Z3S^83B/\ S?M?]W<JT!\1W\2-K^-<7[WW*^$HG0L
M                    <ESR%_=][P_3!V7_ )Z9IZQ/+[^(/!_B?9_O;&L]
MX+_8>S_<F'];JQ R]VH       "[!]K!^X%Y5?I@TS_,N92M]*3_ !^[5_$^
MX_?,(@_$G_MSC/W)D_7%J)5JC6                         YCON]_P!)
M?YD?IAR7ZU8EZ9OA%_JU=G?B>GZYD6)^5?\ -YQ/[DC_ "K(WTC6?@
M +4'VL/[OWE3^A[3?\])56OTI/\ $'M7\<;C][0C7\2?^P^,_=>3];78E*R(
M(
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M7F
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M==)]#H.[-U\R[6Y/>]/5[GC]Q?3737HPWMIKI.FNFFNDZ?(ZN3RI*S
M
M                             '/=^XX_I,-H_0_U-^M-\] _T=']6K:_
MCC?_ *Y5.GR"_F\Q_NO/_E0@?3L;I        3P?;C_TF&K_ *'^V?UIL4$_
MI%_ZM6Z_'&P_7+-+>?O\WF3]UX/\J70B>?A!8
M !RO?<+_ ./OSB_YP/)?_;1NKU*_#Y_,)V/_ .4.&_W=MEE'8G\2.&_%6T_>
M^-I^V\RH       !<!^U&_\ CU_^5O\ ^B+5#?2K?_D'_P!M_P#XH16^)G_\
M"?\ 3/\ Z5<!5"HK                        *3OW3W[OWBM^A[<O\](E
MU/T6W\0>ZOQQM_WM*7WPV?[#Y/\ =>/];57UI22@       "2#VA/Z2_PW_3
M#C?UJRR.7Q=?U:N\?Q/?]<QL \U/YO.6_<D_Y573B>9E78
M          YOOOV_TL?E;_W%_P#ALZ=>C;X#?ZJ/:O\ VG_OCD$_O)/^;'C/
M^D?OO.A_2];4        60/M>_\ C[[>_P"3_?\ _;1X_JY/I//YA.(_\W[7
M_=W*M ?$=_$C:_C7%^]]ROA*)T+                         ')<\A?W?
M>\/TP=E_YZ9IZQ/+[^(/!_B?9_O;&L]X+_8>S_<F'];JQ R]VH       "[!
M]K!^X%Y5?I@TS_,N92M]*3_'[M7\3[C]\PB#\2?^W.,_<F3]<6HE6J-8
M                    #F.^[W_27^9'Z8<E^M6)>F;X1?ZM79WXGI^N9%B?
ME7_-YQ/[DC_*LC?2-9^        M0?:P_N_>5/Z'M-_STE5:_2D_Q![5_'&X
M_>T(U_$G_L/C/W7D_6UV)2LB"
M
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MMCRJJS@
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M^]O7%%?#QTO-^F?5I,]7LZNFL\SZN\
M
M    !SW?N./Z3#:/T/\ 4WZTWST#_1T?U:MK^.-_^N53I\@OYO,?[KS_ .5"
M!].QND       !/!]N/_ $F&K_H?[9_6FQ03^D7_ *M6Z_'&P_7+-+>?O\WF
M3]UX/\J70B>?A!8                        !RO?<+_X^_.+_ )P/)?\
MVT;J]2OP^?S"=C_^4.&_W=MEE'8G\2.&_%6T_>^-I^V\RH       !<!^U&_
M^/7_ .5O_P"B+5#?2K?_ )!_]M__ (H16^)G_P# G_3/_I5P%4*BL
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MTI/\?NU?Q/N/WS"(/Q)_[<XS]R9/UQ:B5:HU@
M .8[[O?])?YD?IAR7ZU8EZ9OA%_JU=G?B>GZYD6)^5?\WG$_N2/\JR-](UGX
M       "U!]K#^[]Y4_H>TW_ #TE5:_2D_Q![5_'&X_>T(U_$G_L/C/W7D_6
MUV)2LB"
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M,3]6%6N;%DP9;8,T37+2TUM$^F)B=)B?S)?2<9\P
M
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M71,>>- T
M                                          !SW?N./Z3#:/T/]3?K
M3?/0/]'1_5JVOXXW_P"N53I\@OYO,?[KS_Y4('T[&Z0       $\'VX_])AJ
M_P"A_MG]:;%!/Z1?^K5NOQQL/URS2WG[_-YD_=>#_*ET(GGX06
M               <KWW"_P#C[\XO^<#R7_VT;J]2OP^?S"=C_P#E#AO]W;99
M1V)_$CAOQ5M/WOC:?MO,J        7 ?M1O_ (]?_E;_ /HBU0WTJW_Y!_\
M;?\ ^*$5OB9__ G_ $S_ .E7 50J*P                       "D[]T]^
M[]XK?H>W+_/2)=3]%M_$'NK\<;?][2E]\-G^P^3_ '7C_6U5]:4DH
M D@]H3^DO\-_TPXW]:LLCE\77]6KO'\3W_7,; /-3^;SEOW)/^55TXGF95V
M                       .;[[]O]+'Y6_]Q?\ X;.G7HV^ W^JCVK_ -I_
M[XY!/[R3_FQXS_I'[[SH?TO6U        %D#[7O_ (^^WO\ D_W_ /VT>/ZN
M3Z3S^83B/_-^U_W=RK0'Q'?Q(VOXUQ?O?<KX2B="P
M     !R7/(7]WWO#],'9?^>F:>L3R^_B#P?XGV?[VQK/>"_V'L_W)A_6ZL0,
MO=J        NP?:P?N!>57Z8-,_S+F4K?2D_Q^[5_$^X_?,(@_$G_MSC/W)D
M_7%J)5JC6                         YCON]_TE_F1^F')?K5B7IF^$7^
MK5V=^)Z?KF18GY5_S><3^Y(_RK(WTC6?@       +4'VL/[OWE3^A[3?\])5
M6OTI/\0>U?QQN/WM"-?Q)_[#XS]UY/UM=B4K(@@
M
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M#<4UTTUZ,UZZZ:SIKIKIK.GRMD&N&/@
M
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M+:>/C6F'-U:SZ/"UJ>$SXSI,1X3I>P48(7@
M
M         .>[]QQ_28;1^A_J;]:;YZ!_HZ/ZM6U_'&__ %RJ=/D%_-YC_=>?
M_*A ^G8W2        G@^W'_I,-7_ $/]L_K38H)_2+_U:MU^.-A^N6:6\_?Y
MO,G[KP?Y4NA$\_""P                        #E>^X7_ ,??G%_S@>2_
M^VC=7J5^'S^83L?_ ,H<-_N[;+*.Q/XD<-^*MI^]\;3]MYE0       "X#]J
M-_\ 'K_\K?\ ]$6J&^E6_P#R#_[;_P#Q0BM\3/\ ^!/^F?\ TJX"J%16
M                    4G?NGOW?O%;]#VY?YZ1+J?HMOX@]U?CC;_O:4OOA
ML_V'R?[KQ_K:J^M*24        20>T)_27^&_P"F'&_K5ED<OBZ_JU=X_B>_
MZYC8!YJ?S><M^Y)_RJNG$\S*NP                       !S???M_I8_*
MW_N+_P##9TZ]&WP&_P!5'M7_ +3_ -\<@G]Y)_S8\9_TC]]YT/Z7K:@
M  "R!]KW_P ??;W_ "?[_P#[:/']7)])Y_,)Q'_F_:_[NY5H#XCOXD;7\:XO
MWON5\)1.A8                         Y+GD+^[[WA^F#LO\ STS3UB>7
MW\0>#_$^S_>V-9[P7^P]G^Y,/ZW5B!E[M0       %V#[6#]P+RJ_3!IG^9<
MRE;Z4G^/W:OXGW'[YA$'XD_]N<9^Y,GZXM1*M4:P
M    ',=]WO\ I+_,C],.2_6K$O3-\(O]6KL[\3T_7,BQ/RK_ )O.)_<D?Y5D
M;Z1K/P       %J#[6']W[RI_0]IO^>DJK7Z4G^(/:OXXW'[VA&OXD_]A\9^
MZ\GZVNQ*5D00
M                                                 %,'[JC5\A:=
MG^'6ZR36=6*V#0^W=7L[>B2?G(19#3]ATC+9.:YBJMZ;:BSGMMXM*8*J):ZZ
MJXYN*Z*.*:.9+E_HL>4V^7MCO#A:Q?YUM]_L,]IF(Z)IN,6YQTBLZZS:)VV2
M;1-8B(FFDVF9BLMOAIW-+<=RVSB)][3/@O,^K2]<E8T\==8G';7P]<:3/CI4
M[6N).          .G/[16T5[A[:?AMEI,W#GZK3IG"ZOQ?075O>404:/?9+2
MHL)5-;551T3:U%K_ !CI(N>?4@DM:HI..*Z*N'F7^+?BZ\1\2?>.TK@G;Q?F
M<F?IFLUF9W-:;F<FEO'3-.7WT6]%HO%J^S,*Z_-+;1M?,+EL44FFN[M?28F-
M?>1&3J\?[_JZXGT3%M8\)2-HZ,!
M
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M_JF7<7UU]'NZXJZ::>.OO-==?#I]$Z^%S)3<B6
M
M             Y[OW''])AM'Z'^IOUIOGH'^CH_JU;7\<;_]<JG3Y!?S>8_W
M7G_RH0/IV-T@       )X/MQ_P"DPU?]#_;/ZTV*"?TB_P#5JW7XXV'ZY9I;
MS]_F\R?NO!_E2Z$3S\(+                         .5[[A?_ !]^<7_.
M!Y+_ .VC=7J5^'S^83L?_P H<-_N[;+*.Q/XD<-^*MI^]\;3]MYE0
M"X#]J-_\>O\ \K?_ -$6J&^E6_\ R#_[;_\ Q0BM\3/_ .!/^F?_ $JX"J%1
M6                        4G?NGOW?O%;]#VY?YZ1+J?HMOX@]U?CC;_O
M:4OOAL_V'R?[KQ_K:J^M*24        20>T)_27^&_Z8<;^M661R^+K^K5WC
M^)[_ *YC8!YJ?S><M^Y)_P JKIQ/,RKL                        <WWW
M[?Z6/RM_[B__  V=.O1M\!O]5'M7_M/_ 'QR"?WDG_-CQG_2/WWG0_I>MJ
M      +('VO?_'WV]_R?[_\ [:/']7)])Y_,)Q'_ )OVO^[N5: ^([^)&U_&
MN+][[E?"43H6                         .2YY"_N^]X?I@[+_P ],T]8
MGE]_$'@_Q/L_WMC6>\%_L/9_N3#^MU8@9>[4       !=@^U@_<"\JOTP:9_
MF7,I6^E)_C]VK^)]Q^^81!^)/_;G&?N3)^N+42K5&L
M      !S'?=[_I+_ #(_3#DOUJQ+TS?"+_5J[._$]/US(L3\J_YO.)_<D?Y5
MD;Z1K/P       %J#[6']W[RI_0]IO\ GI*JU^E)_B#VK^.-Q^]H1K^)/_8?
M&?NO)^MKL2E9$$
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M1Z8E OSTVUL'F3O<LS$QFQ;>\?4B,&/'I/\ =QS/YDPFK0M:A
M
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M,S[JNVRVB/5$VO6+3_=BM=?S(6LU5B,X
M
M      #GN_<<?TF&T?H?ZF_6F^>@?Z.C^K5M?QQO_P!<JG3Y!?S>8_W7G_RH
M0/IV-T@       )X/MQ_Z3#5_P!#_;/ZTV*"?TB_]6K=?CC8?KEFEO/W^;S)
M^Z\'^5+H1//P@L                         Y7ON%_P#'WYQ?\X'DO_MH
MW5ZE?A\_F$['_P#*'#?[NVRRCL3^)'#?BK:?O?&T_;>94        N _:C?_
M !Z__*W_ /1%JAOI5O\ \@_^V_\ \4(K?$S_ /@3_IG_ -*N JA45@
M                 %)W[I[]W[Q6_0]N7^>D2ZGZ+;^(/=7XXV_[VE+[X;/]
MA\G^Z\?ZVJOK2DE        $D'M"?TE_AO\ IAQOZU99'+XNOZM7>/XGO^N8
MV >:G\WG+?N2?\JKIQ/,RKL                        <WWW[?Z6/RM_[
MB_\ PV=.O1M\!O\ 51[5_P"T_P#?'()_>2?\V/&?](_?>=#^EZVH
ML@?:]_\ 'WV]_P G^_\ ^VCQ_5R?2>?S"<1_YOVO^[N5: ^([^)&U_&N+][[
ME?"43H6                         .2YY"_N^]X?I@[+_ ,],T]8GE]_$
M'@_Q/L_WMC6>\%_L/9_N3#^MU8@9>[4       !=@^U@_<"\JOTP:9_F7,I6
M^E)_C]VK^)]Q^^81!^)/_;G&?N3)^N+42K5&L
M !S'?=[_ *2_S(_3#DOUJQ+TS?"+_5J[._$]/US(L3\J_P";SB?W)'^59&^D
M:S\       !:@^UA_=^\J?T/:;_GI*JU^E)_B#VK^.-Q^]H1K^)/_8?&?NO)
M^MKL2E9$$
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M5B-7FT.
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MWQ<9BK;PGPM.7/?3Q]/LWK.L:QXZ>F)B+%*O!H4
M
M             !SW?N./Z3#:/T/]3?K3?/0/]'1_5JVOXXW_ .N53I\@OYO,
M?[KS_P"5"!].QND       !/!]N/_28:O^A_MG]:;%!/Z1?^K5NOQQL/URS2
MWG[_ #>9/W7@_P J70B>?A!8                        !RO?<+_X^_.+
M_G \E_\ ;1NKU*_#Y_,)V/\ ^4.&_P!W;991V)_$CAOQ5M/WOC:?MO,J
M    7 ?M1O\ X]?_ )6__HBU0WTJW_Y!_P#;?_XH16^)G_\  G_3/_I5P%4*
MBL                        I._=/?N_>*WZ'MR_STB74_1;?Q![J_'&W_
M 'M*7WPV?[#Y/]UX_P!;57UI22@       "2#VA/Z2_PW_3#C?UJRR.7Q=?U
M:N\?Q/?]<QL \U/YO.6_<D_Y573B>9E78                        YOO
MOV_TL?E;_P!Q?_ALZ=>C;X#?ZJ/:O_:?^^.03^\D_P";'C/^D?OO.A_2];4
M       60/M>_P#C[[>_Y/\ ?_\ ;1X_JY/I//YA.(_\W[7_ '=RK0'Q'?Q(
MVOXUQ?O?<KX2B="P                        !R7/(7]WWO#],'9?^>F:
M>L3R^_B#P?XGV?[VQK/>"_V'L_W)A_6ZL0,O=J        NP?:P?N!>57Z8-
M,_S+F4K?2D_Q^[5_$^X_?,(@_$G_ +<XS]R9/UQ:B5:HU@
M          .8[[O?])?YD?IAR7ZU8EZ9OA%_JU=G?B>GZYD6)^5?\WG$_N2/
M\JR-](UGX       "U!]K#^[]Y4_H>TW_/255K]*3_$'M7\<;C][0C7\2?\
ML/C/W7D_6UV)2LB"
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M:A5:HU@
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M80.\]MS7/YD;O%$3$X<."D_5F<-,FL?W,D1^;$IMT*&G@
M
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M .)\/_Q _(GYG?@S_K&T_9S^?M]IS^5;_J+\D_\ <Z?T#?BN_DK_ .)\/_Q
M_(GYG?@S_K&T_9S^?M]IS^5;_J+\D_\ <Z?T#?BN_DK_ .)\/_Q _(GYG?@S
M_K&T_9S^?M]IS^5;_J+\D_\ <Z?T#?BN_DK_ .)\/_Q _(GYG?@S_K&T_9S^
M?M]IS^5;_J+\D_\ <Z?T#?BN_DK_ .)\/_Q _(GYG?@S_K&T_9S^?M]IS^5;
M_J+\D_\ <Z?T#?BN_DK_ .)\/_Q _(GYG?@S_K&T_9S^?M]IS^5;_J+\D_\
M<Z?T#?BN_DK_ .)\/_Q _(GYG?@S_K&T_9S^?M]IS^5;_J+\D_\ <Z?T#?BN
M_DK_ .)\/_Q _(GYG?@S_K&T_9S^?M]IS^5;_J+\D_\ <Z?T#?BN_DK_ .)\
M/_Q _(GYG?@S_K&T_9S^?M]IS^5;_J+\D_\ <Z?T#?BN_DK_ .)\/_Q _(GY
MG?@S_K&T_9S^?M]IS^5;_J+\D_\ <Z?T#?BN_DK_ .)\/_Q _(GYG?@S_K&T
M_9S^?M]IS^5;_J+\D_\ <Z?T#?BN_DK_ .)\/_Q _(GYG?@S_K&T_9S^?M]I
MS^5;_J+\D_\ <Z?T#?BN_DK_ .)\/_Q _(GYG?@S_K&T_9S^?M]IS^5;_J+\
MD_\ <Z?T#?BN_DK_ .)\/_Q _(GYG?@S_K&T_9S^?M]IS^5;_J+\D_\ <Z?T
M#?BN_DK_ .)\/_Q _(GYG?@S_K&T_9S^?M]IS^5;_J+\D_\ <Z?T#?BN_DK_
M .)\/_Q _(GYG?@S_K&T_9U7;W]_-?QD\U^W^@-H\9.S/VR\%I/6^RX#9[[\
MS.P--_#,MD-GCR-G:?3=@:IJEY>^M9T\U^I;QRQ4_P!BJKBK\BS[X"/)7S,\
MENT>?XOS,XS[V;[>\EARX:_.-IN.O'3#-+6ZMKGSUKI;PTO-;3Z8B8\4CO)#
MM#N+M#BM]MNXMO\ -\V;<4M2/>8LFM8II,ZXKWB/'U3,2@'3X;O        ;
ML>W'VYUYT-YQ^-/</;&P?FIUSU_V18Y_;MB_"<YG?PG$PX_(P27?X1K>-S&=
MO_EEGHX].UM9I>?C\>*?AQRTK\1G:7</?GD?W+V?VIM_G7<7(<;;%M\/O,6+
MWF2;TF*^\S7QXJ^$3XWO6OU6(=_\7O\ F^S>0XKC,?O=_GV\UI3JK7JMK$Z=
M5YK6/1Z9F(7J?Y^WVG/Y5O\ J+\D_P#<ZHS_ *!OQ7?R5_\ $^'_ .((8_D3
M\SOP9_UC:?LY_/V^TY_*M_U%^2?^YT_H&_%=_)7_ ,3X?_B!^1/S._!G_6-I
M^SG\_;[3G\JW_47Y)_[G3^@;\5W\E?\ Q/A_^('Y$_,[\&?]8VG[.?S]OM.?
MRK?]1?DG_N=/Z!OQ7?R5_P#$^'_X@?D3\SOP9_UC:?LY_/V^TY_*M_U%^2?^
MYT_H&_%=_)7_ ,3X?_B!^1/S._!G_6-I^SG\_;[3G\JW_47Y)_[G3^@;\5W\
ME?\ Q/A_^('Y$_,[\&?]8VG[.?S]OM.?RK?]1?DG_N=/Z!OQ7?R5_P#$^'_X
M@?D3\SOP9_UC:?LY_/V^TY_*M_U%^2?^YT_H&_%=_)7_ ,3X?_B!^1/S._!G
M_6-I^SG\_;[3G\JW_47Y)_[G3^@;\5W\E?\ Q/A_^('Y$_,[\&?]8VG[.?S]
MOM.?RK?]1?DG_N=/Z!OQ7?R5_P#$^'_X@?D3\SOP9_UC:?LY_/V^TY_*M_U%
M^2?^YT_H&_%=_)7_ ,3X?_B!^1/S._!G_6-I^SG\_;[3G\JW_47Y)_[G3^@;
M\5W\E?\ Q/A_^('Y$_,[\&?]8VG[.?S]OM.?RK?]1?DG_N=/Z!OQ7?R5_P#$
M^'_X@?D3\SOP9_UC:?LY_/V^TY_*M_U%^2?^YT_H&_%=_)7_ ,3X?_B!^1/S
M._!G_6-I^SG\_;[3G\JW_47Y)_[G3^@;\5W\E?\ Q/A_^('Y$_,[\&?]8VG[
M.?S]OM.?RK?]1?DG_N=/Z!OQ7?R5_P#$^'_X@?D3\SOP9_UC:?LY_/V^TY_*
MM_U%^2?^YT_H&_%=_)7_ ,3X?_B!^1/S._!G_6-I^SG\_;[3G\JW_47Y)_[G
M3^@;\5W\E?\ Q/A_^('Y$_,[\&?]8VG[.?S]OM.?RK?]1?DG_N=/Z!OQ7?R5
M_P#$^'_X@?D3\SOP9_UC:?LY_/V^TY_*M_U%^2?^YT_H&_%=_)7_ ,3X?_B!
M^1/S._!G_6-I^SG\_;[3G\JW_47Y)_[G3^@;\5W\E?\ Q/A_^('Y$_,[\&?]
M8VG[.?S]OM.?RK?]1?DG_N=/Z!OQ7?R5_P#$^'_X@?D3\SOP9_UC:?LY_/V^
MTY_*M_U%^2?^YT_H&_%=_)7_ ,3X?_B!^1/S._!G_6-I^SG\_;[3G\JW_47Y
M)_[G3^@;\5W\E?\ Q/A_^('Y$_,[\&?]8VG[.?S]OM.?RK?]1?DG_N=/Z!OQ
M7?R5_P#$^'_X@?D3\SOP9_UC:?LZD][N7??4WD][A7D%WET;M?Y[]6[O^U1^
M:^T?@6RZU^)_FUTCUKJ&;_\ 4FWX; ;%9?1;%@+NW_OBTA]3T?4C^:*JBNJZ
MGX2NP^[/+'X?.W^Q^^-I\Q[HV/S[W^#WN'-T>^Y+>;C']DV^3+AMU8<N._L9
M+:=73;2T6K$OO*[A.4[<[$V/#<SB]SR6'WW73JI?3KW&6]?:I:U9UK:L^%IT
MUTG28F$;Z1K/P       $V'L.>7/CUX8^7G8W:'DKV#^UOHN>\;]OT'$YS\U
M-WW#ZO;,IV=T_L-CB?PS0=:VG,0>OA]6OYO7DMZ+:GT/DJDXKKCIKA7\=OE)
MY@^<OE%QW:_EMQ_WRYS!W'M]UDQ>_P!MM^G!39<ABMDZ]UFP8YTR9\5>F+S>
M>K6*S6MIC4'G5VMSO=O:VWXWM[!\XWM.0IEM7KQX]*1ASUFVN6]*SI:]8TB=
M?'732)TMH_S]OM.?RK?]1?DG_N=5._T#?BN_DK_XGP__ !!&'\B?F=^#/^L;
M3]G/Y^WVG/Y5O^HOR3_W.G] WXKOY*_^)\/_ ,0/R)^9WX,_ZQM/V<_G[?:<
M_E6_ZB_)/_<Z?T#?BN_DK_XGP_\ Q _(GYG?@S_K&T_9S^?M]IS^5;_J+\D_
M]SI_0-^*[^2O_B?#_P#$#\B?F=^#/^L;3]G/Y^WVG/Y5O^HOR3_W.G] WXKO
MY*_^)\/_ ,0/R)^9WX,_ZQM/V<_G[?:<_E6_ZB_)/_<Z?T#?BN_DK_XGP_\
MQ _(GYG?@S_K&T_9S^?M]IS^5;_J+\D_]SI_0-^*[^2O_B?#_P#$#\B?F=^#
M/^L;3]G/Y^WVG/Y5O^HOR3_W.G] WXKOY*_^)\/_ ,0/R)^9WX,_ZQM/V<_G
M[?:<_E6_ZB_)/_<Z?T#?BN_DK_XGP_\ Q _(GYG?@S_K&T_9S^?M]IS^5;_J
M+\D_]SI_0-^*[^2O_B?#_P#$#\B?F=^#/^L;3]G/Y^WVG/Y5O^HOR3_W.G]
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M/_8?&?NO)^MKL2E9$$
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MA:\;>:QIZ?&*6\8C2-/'36-;C*GI%$
M
M               !4$^ZWN+BFW\#[2F>:FUGF\G+B:VIEKXMYKBUH\?(K:>6
M'BKTY)K>.\EICJYXYJHIEKXXYXXJJ^-N_P!%5CQSD[[RS6/>UCA8BVD:Q%IY
M6;1$^F(F:UF8]$S6-?1"5'PS5K-N:MI'5$;2-?7I/SK6/[ND:_F0I\+?$J@
M        '2W]E'5;?3O:Y\0\1;74UY'=Z3M.U533T41UT7&]=F[QNUW:TTQ_
MJ>8;"ZV&N".K_M51QT\U?EYY>:[XT^5R<Q\4'=V[RTBEJ;W!@TB9F--KLMMM
MJV\?7:N*+3'HB9F(\%>WF]N;;OS(Y7+:(B8S4IX?)CPX\<3_ '8KK/U92EHN
MM;
M                                     .>[]QQ_28;1^A_J;]:;YZ!_
MHZ/ZM6U_'&__ %RJ=/D%_-YC_=>?_*A ^G8W2
M
M
M                                                M0?:P_N_>5/Z
M'M-_STE5:_2D_P 0>U?QQN/WM"-?Q)_[#XS]UY/UM=B4K(@@
M
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M4=?B1VUK]K[#>:QTX]_T:>N9R8LEHG^Y[N=?S87C%(2&X
M
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M2O\ ^;6-?EGQ;O-),.
M                                                     <]W[CC^
MDPVC]#_4WZTWST#_ $=']6K:_CC?_KE4Z?(+^;S'^Z\_^5"!].QND
M
M
M
M   !:@^UA_=^\J?T/:;_ )Z2JM?I2?X@]J_CC<?O:$:_B3_V'QG[KR?K:[$I
M61!
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M/0A
M                                                 4/?NA/^/OJ'
M_D_T#_;1Y +V/HP_YA.7_P#-^Z_W=Q2:?PX_Q(W7XUR_O?;*WZQMO\
M   !UB?%C 8G5/&'QQU? 6GT&"UOH;J# 86Q]>YNOHL3A^OM>QV.M/J;V:XO
M+CZ>SMZ*/4EDDEK^'QJJJJYYYY\H_FEO]WROF;W'RF_O[S?;GGM_ER6TK7JR
M9-WEO>W36(K&MIF=*Q%8]$1$>"L?N7/EW/<?(;G//5FR;W/:TZ1&MK9;3,Z1
MI$:S/HB(CY&>6".E
M                                                   <]W[CC^DP
MVC]#_4WZTWST#_1T?U:MK^.-_P#KE4Z?(+^;S'^Z\_\ E0@?3L;I
M
M
M
M   6H/M8?W?O*G]#VF_YZ2JM?I2?X@]J_CC<?O:$:_B3_P!A\9^Z\GZVNQ*5
MD00
M                                         '(:VK7,GIVS['J.:IAH
MS.JY[,:YEJ+>;BXMZ,G@\A<8R_I@GIXXIGAINK6OBFOCCCBJGX<_^5ZY>+Y'
M;<QQFVY?93,[/=8,>;',QI/1EI%ZZQZIZ;1K'JE:9MMQCW>VQ[K#K[K+2MZZ
M^$Z6B)C6/S)?"<Y]@        $U7V^.U7&O>Z;T9B(;2&XCWK5>Z-5NYI:ZZ
M*["WL^H]QW:F[MZ:/U,DU=UIT4'--7ZGTYJN?[/'"%WT@7%8^0^%SG-W>\UM
ML=UQV>L1$:6FV_V^VZ9^2.G<6MK'CK6(]$RU%YZ;:N?RVWN69F)PY=O>/JS.
M?'CTG^YDF?S8AT6'G=0*
M
M      <]W[CC^DPVC]#_ %-^M-\] _T=']6K:_CC?_KE4Z?(+^;S'^Z\_P#E
M0@?3L;I          =>K7<!B=4U_!ZO@+3Z#!:WA\9@,+8^O<W7T6)P]E!CL
M;:?4WLUS>7/TUG;44>I+))+7\/C5555SSSSY&.0W^[Y7?Y^4W]_>;[<YKY<E
MM*UZLF2TWO;IK$5C6TS.E8BL>B(B/!5EGSY=SGON<\]6;)>;6G2(UM:=9G2-
M(C69]$1$?(^PX;Y
M                                                  .>[]QQ_28;
M1^A_J;]:;YZ!_HZ/ZM6U_'&__7*IT^07\WF/]UY_\J$#Z=C=(
M
M
M                                                           "
MU!]K#^[]Y4_H>TW_ #TE5:_2D_Q![5_'&X_>T(U_$G_L/C/W7D_6UV)2LB"
M
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MAI?P^7'FQY(C^[-=)^I+I</-<KU
M
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MXQK6DS&L?FPZX+R6*NP
M                                                      '/=^XX
M_I,-H_0_U-^M-\] _P!'1_5JVOXXW_ZY5.GR"_F\Q_NO/_E0@?3L;I
M
M
M
M     6H/M8?W?O*G]#VF_P">DJK7Z4G^(/:OXXW'[VA&OXD_]A\9^Z\GZVNQ
M*5D00
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M%^8^U^=]A<OBZNG3C\U]=-?U.DY-/3'UW1IKZM==)TTGJ)/,$KA
M
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MNDS'CHQ[N[<VV7:G)[RL1:V+CMS>(GT3-<-[:3^;HZMCRJJS@
M
M                        '/=^XX_I,-H_0_U-^M-\] _T=']6K:_CC?\
MZY5.GR"_F\Q_NO/_ )4('T[&Z0
M
M
M                                    %J#[6']W[RI_0]IO^>DJK7Z4
MG^(/:OXXW'[VA&OXD_\ 8?&?NO)^MKL2E9$$
M
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MCGI76?5'5:-9]4,<[QV^3=]H<KM<.GO<O&[FE=?"-;8;Q&L_FRZL#RMJT
M
M                                           '+S]TK:K?<?<8\T\O
M;6LUG':>179FJU0SUT25UW&B[%=Z3=W5-4?ZGB&_NM>KGCI_[5,<E/%7Y>.7
MIZ^%WBLG#_#KV7M,MXO:_;NSSZQ$Q&FZQ5W-:^/KK7+%9GT3,3,>"QSRVVUM
MIV#Q&*TQ,SL,-_#Y,E8R1']R+:3]6&A+?+-@        &\GME:OD-O\ </\
M"?$XV:S@N+3R<Z:VB2N^DFBAJQ^C[SAMTRT-%5O;W,G-Y<8O 31V]/-/%%=Q
M51377'1S573H_P")CE-OQ'P]=Z[O<Q>V._;/(X(BL1,]>YVV3;8YG6:QTQ?+
M6;SKK%(M,1:8BLX;YB;FFU[#YC+DB9K/'9Z>'RY,=L=?3,>$6M$S]372)GP=
M1YY?%;X
M                                          #GN_<<?TF&T?H?ZF_6
MF^>@?Z.C^K5M?QQO_P!<JG3Y!?S>8_W7G_RH0/IV-T@
M
M
M                                                     +4'VL/[
MOWE3^A[3?\])56OTI/\ $'M7\<;C][0C7\2?^P^,_=>3];78E*R((
M
M                               #F^^_;_2Q^5O_ '%_^&SIUZ-O@-_J
MH]J_]I_[XY!/[R3_ )L>,_Z1^^\Z']+UM0        !EGH.XM[3O7I:[NYX;
M6UM>VNN;BYN;B6B&WM[>'<<-)-//-)53'%#%'3S5555SQ333QSSSS\&)]^X\
MF;L7FL6*LVRVXG>16L1,S,SM\D1$1'C,S/A$1XS+K.<K:W"[RM8F;3M<L1$>
MF9]W;PAUJ7DX5@
M
M.5O[@5Q;WGGGYMW=I/#=6MUY=>25Q;7-O+1/;W%O/W+N<L,\$T554<T,T=7%
M5-5//--5//'/'/P>ICR QY,/D1V3BRUFN6O:/#Q:LQ,3$QQVWB8F)\8F)\)B
M?&)64]C5M3LKAZVB8M'%[2)B?3$^XQ^$M16VV4@        )(/:$_I+_  W_
M $PXW]:LLCE\77]6KO'\3W_7,; /-3^;SEOW)/\ E5=.)YF5=@
M
M                         #GN_<<?TF&T?H?ZF_6F^>@?Z.C^K5M?QQO_
M -<JG3Y!?S>8_P!UY_\ *A ^G8W2
M
M
M                                       M0?:P_N_>5/Z'M-_STE5:
M_2D_Q![5_'&X_>T(U_$G_L/C/W7D_6UV)2LB"
M
M                Y[OW''])AM'Z'^IOUIOGH'^CH_JU;7\<;_\ 7*IT^07\
MWF/]UY_\J$#Z=C=(         #L!/(8JM
M
M                   <ESR%_=][P_3!V7_GIFGK$\OOX@\'^)]G^]L:SW@O
M]A[/]R8?UNK$#+W:@        )@/82_I8_%+_OT_\-G<2(7QY?U4>ZO^S/\
M?''M5^=G\V/)_P#1_P!]X'2"><E $
M
M    !SW?N./Z3#:/T/\ 4WZTWST#_1T?U:MK^.-_^N53I\@OYO,?[KS_ .5"
M!].QND
M
M
M                !:@^UA_=^\J?T/:;_GI*JU^E)_B#VK^.-Q^]H1K^)/\
MV'QG[KR?K:[$I61!
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M.+%GO2)GTS%;36-=(B-=(\=(C\Q[QT+A
M
M                 .1EV7M5OO78V_[M:6LUA:[CNVU;5;6-Q71)<6=OL.=O
M\O#:SR1?VN2:WCN^**JJ?U/-7'//'Y'K9[:XK)P7;G'\)EO&3+L]E@P6M$3$
M6G%BKCFT1/C$3-=8B?'1:-QVVMLN/P;.TQ:V+#2DS'HF:UBNL?FZ/%.Z<P
M      !-A]O;JGYQ>Z3TIE_K_H_S#T_N;:_I_I?J/Q7ZSJK:M&^@];ZF#Z'T
M_P \_JO5^6;X_3>G\G'J>I1"OZ07E?O=\+O-;/W?7\_WG'8->K3HZ=]@W/7I
MI/5K\WZ.G6OU_5K[/3;4'GKNOF_EOO,73K[_ "[>FNNG3IFIDU]'C^IZ:>'I
MUU\-)Z*3SP(&
M                                                .>[]QQ_28;1^
MA_J;]:;YZ!_HZ/ZM6U_'&_\ URJ=/D%_-YC_ '7G_P J$#Z=C=(
M
M
M
M "U!]K#^[]Y4_H>TW_/255K]*3_$'M7\<;C][0C7\2?^P^,_=>3];78E*R((
M
M                                      "B3]T/CLA%YV=,9:2QO(\7
M>^)>G8ZSR5=M-1C[O(8ON+N^YR5C;7E5'%O/>8ZWR]I)/%15S7#1=0U5\<<2
M4<U7I?1@[C;V\B^9VE;TG=4[LW%[4BT==:7X_C8I:U==8K><>2*VF-+32\1,
MS6=)H_#CDI/9>[Q1:/>QRF29C7QB)P;>(F8],1,UM$3Z])T]$JV:R%($
M     !UF_'&XM[OQYZ&N[2>&ZM;KICJZXMKFWEHFM[BWFT?!R0SP31U51RPR
MQU<54U4\\TU4\\<\<_!Y/O,;'DP^87.XLM9KEKS.]BU9B8F)C<Y8F)B?&)B?
M"8GQB58?/UM7G=[6T3%HW>:)B?3$^\MX2S.PUU(
M
M                       #C^O7FM2          3P?;C_TF&K_ *'^V?UI
ML4$_I%_ZM6Z_'&P_7+-+>?O\WF3]UX/\J70B>?A!8
M
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M^Z[/XG=;J]\FYR<9M;7O:9M:UK8*3:UK3K-K6F9F9F9F9G6?%JNVDR4
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M /OGD?\ 63^'?>_X9Y7[KW'[(?S>G@)_(=\/_P#IHZ7_ -"C^D'Y]_RX[O\
M^^>1_P!9/X=][_AGE?NO<?LA_-Z> G\AWP__ .FCI?\ T*/Z0?GW_+CN_P#[
MYY'_ %D_AWWO^&>5^Z]Q^R'\WIX"?R'?#_\ Z:.E_P#0H_I!^??\N.[_ /OG
MD?\ 63^'?>_X9Y7[KW'[(?S>G@)_(=\/_P#IHZ7_ -"C^D'Y]_RX[O\ ^^>1
M_P!9/X=][_AGE?NO<?LA_-Z> G\AWP__ .FCI?\ T*/Z0?GW_+CN_P#[YY'_
M %D_AWWO^&>5^Z]Q^R'\WIX"?R'?#_\ Z:.E_P#0H_I!^??\N.[_ /OGD?\
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M_P"A1_2#\^_Y<=W_ /?/(_ZR?P[[W_#/*_=>X_9#^;T\!/Y#OA__ --'2_\
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M_D.^'_\ TT=+_P"A1_2#\^_Y<=W_ /?/(_ZR?P[[W_#/*_=>X_9% WWK^O-
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M_P#WSR/^LG\.^]_PSROW7N/V0_F]/ 3^0[X?_P#31TO_ *%'](/S[_EQW?\
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M_P"A1_2#\^_Y<=W_ /?/(_ZR?P[[W_#/*_=>X_9#^;T\!/Y#OA__ --'2_\
MH4?T@_/O^7'=_P#WSR/^LG\.^]_PSROW7N/V0_F]/ 3^0[X?_P#31TO_ *%'
M](/S[_EQW?\ ]\\C_K)_#OO?\,\K]U[C]D<Q#O3'8_$=V]Q8G$V-GB\7B^U.
MPL=C<;CK:&RQ^.Q]EMN7MK.QL;.VHBM[2SM+>*F.**.FFB.BGBFGCCCCCAZ;
M.QMQN-WV3P^[W=[Y=UEXK:7O>]IM>][8,<VM:TS,VM:9F;6F9F9F9F=5BW"Y
M+Y>'VF7+:;9;;;%,S,ZS,S2LS,S/C,S/C,SZ6+&4NR        6]/MM/&GQR
M[TZ2\E,MW=T!TGW'E,%VIJ6.P>2[4ZJT3L+(8;'W.I2W-Q8XJ\VW Y>XQUG<
M7''$E<4-5%%=?ZKGCGG\JHSZ2#S*\Q>QN]NV]IV3S_-\/M<_%9[Y:;'?;K:4
MR7C/$1:]<&7'%[1'A%K1,Q'A$Z(L_$#W#S_"\QQ^+A]]O-IBOMKS:,.;)BBT
MQ?2)M%+5B9B/#65D[^;T\!/Y#OA__P!-'2_^A2MW^D'Y]_RX[O\ ^^>1_P!9
M1]_AWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_A
MWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^
M&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^
MZ]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^
MR'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\W
MIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?
MR'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?R'?#
M_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z
M:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_
M]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_]"C^
MD'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]
M_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N
M.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^
M^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_
MUD_AWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_A
MWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^
M&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^
MZ]Q^R'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^
MR'\WIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\W
MIX"?R'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?
MR'?#_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?R'?#
M_P#Z:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z
M:.E_]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R'\WIX"?R'?#_P#Z:.E_
M]"C^D'Y]_P N.[_^^>1_UD_AWWO^&>5^Z]Q^R.=S[IFFZAU[[A/E?I6@ZKK>
MCZ=KG:N0QVO:EJ&#QFM:S@L?1C<9)18X; X6ULL5B[.BN2JKB*"*BCCFKGGX
M?EY>AGX7.9Y?N#X?>U.:Y[=;G?<QN.*I?+GW&6^;-EO-[QU9,N2UKWMI$1U6
MM,^'I3Q\MMWNM]V+QF\WV7)FW>3;1-KWM-[VG6?&UK3-IGZLS+0-OQFX
M   "U!]K#^[]Y4_H>TW_ #TE5:_2D_Q![5_'&X_>T(U_$G_L/C/W7D_6UV)2
MLB"
M                                          I._=/?N_>*WZ'MR_ST
MB74_1;?Q![J_'&W_ 'M*7WPV?[#Y/]UX_P!;57UI22@         #JA>WI_P
M">#O_)_XT?[%]*>6KX@_Y^^^/_-_,_[QW*M?OO\ COS/XUW?[XR-P&H6*@
M
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MRXNQ<&/'.E,O)XJV\(\:QBSWT\?1[5*SK&D^&GHF8F^TH;0F
M
M                        <]W[CC^DPVC]#_4WZTWST#_1T?U:MK^.-_\
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M+(Y?%U_5J[Q_$]_US&P#S4_F\Y;]R3_E5=.)YF5=@
M    #F^^_;_2Q^5O_<7_ .&SIUZ-O@-_JH]J_P#:?^^.03^\D_YL>,_Z1^^\
MZ']+UM0       !9 ^U[_P"/OM[_ )/]_P#]M'C^KD^D\_F$XC_S?M?]W<JT
M!\1W\2-K^-<7[WW*^$HG0L                         <ESR%_=][P_3!
MV7_GIFGK$\OOX@\'^)]G^]L:SW@O]A[/]R8?UNK$#+W:@       +L'VL'[@
M7E5^F#3/\RYE*WTI/\?NU?Q/N/WS"(/Q)_[<XS]R9/UQ:B5:HU@
M               .8[[O?])?YD?IAR7ZU8EZ9OA%_JU=G?B>GZYD6)^5?\WG
M$_N2/\JR-](UGX       "U!]K#^[]Y4_H>TW_/255K]*3_$'M7\<;C][0C7
M\2?^P^,_=>3];78E*R((
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M?[M9B8^I+=)IAB(
M                                                          ##
MWD-^X#WE^A[LS_,O-LO\OOX_<'^.-G^^<;M>"_VYL_W7A_7*N2\]8BST
M     !9 ^U[_ ./OM[_D_P!__P!M'C^KD^D\_F$XC_S?M?\ =W*M ?$=_$C:
M_C7%^]]ROA*)T+
M                                                  '/=^XX_I,-
MH_0_U-^M-\] _P!'1_5JVOXXW_ZY5.GR"_F\Q_NO/_E0@?3L;I        3P
M?;C_ -)AJ_Z'^V?UIL4$_I%_ZM6Z_'&P_7+-+>?O\WF3]UX/\J70B>?A!8
M                      !RO?<+_P"/OSB_YP/)?_;1NKU*_#Y_,)V/_P"4
M.&_W=MEE'8G\2.&_%6T_>^-I^V\RH       !<!^U&_^/7_Y6_\ Z(M4-]*M
M_P#D'_VW_P#BA%;XF?\ \"?],_\ I5P%4*BL
MI._=/?N_>*WZ'MR_STB74_1;?Q![J_'&W_>TI??#9_L/D_W7C_6U5]:4DH
M      D@]H3^DO\ #?\ 3#C?UJRR.7Q=?U:N\?Q/?]<QL \U/YO.6_<D_P"5
M5TXGF95V                        .;[[]O\ 2Q^5O_<7_P"&SIUZ-O@-
M_JH]J_\ :?\ OCD$_O)/^;'C/^D?OO.A_2];4        60/M>_^/OM[_D_W
M_P#VT>/ZN3Z3S^83B/\ S?M?]W<JT!\1W\2-K^-<7[WW*^$HG0L
M                <ESR%_=][P_3!V7_ )Z9IZQ/+[^(/!_B?9_O;&L]X+_8
M>S_<F'];JQ R]VH       "[!]K!^X%Y5?I@TS_,N92M]*3_ !^[5_$^X_?,
M(@_$G_MSC/W)D_7%J)5JC6                         YCON]_P!)?YD?
MIAR7ZU8EZ9OA%_JU=G?B>GZYD6)^5?\ -YQ/[DC_ "K(WTC6?@       +4'
MVL/[OWE3^A[3?\])56OTI/\ $'M7\<;C][0C7\2?^P^,_=>3];78E*R((
M
M                                   "G]]US_\  5_\TG_T.BWKZ*G_
M /+S_L3_ /&Z5/PS?_AO_H?_ -4I_+>4J0         '3A]H/^C/\./T/X[]
M=LN\S7Q=?UE>\?QQ?];QJ[/-3^</EOW7/^35)"CBP
M
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MZ_$CN;4[7V&STCIR;_KU]<3CQ9*Q']WWDZ_F0O&*0D-P
M
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M\77]6KO'\3W_ %S&P#S4_F\Y;]R3_E5=.)YF5=@
M  #F^^_;_2Q^5O\ W%_^&SIUZ-O@-_JH]J_]I_[XY!/[R3_FQXS_ *1^^\Z'
M]+UM0       !9 ^U[_X^^WO^3_?_P#;1X_JY/I//YA.(_\ -^U_W=RK0'Q'
M?Q(VOXUQ?O?<KX2B="P                        !R7/(7]WWO#],'9?^
M>F:>L3R^_B#P?XGV?[VQK/>"_P!A[/\ <F'];JQ R]VH       "[!]K!^X%
MY5?I@TS_ #+F4K?2D_Q^[5_$^X_?,(@_$G_MSC/W)D_7%J)5JC6
M                YCON]_TE_F1^F')?K5B7IF^$7^K5V=^)Z?KF18GY5_S>
M<3^Y(_RK(WTC6?@       +4'VL/[OWE3^A[3?\ /255K]*3_$'M7\<;C][0
MC7\2?^P^,_=>3];78E*R((
M
M"HA]UIA\G/B/!C/Q6<U>&QF2\CL/?Y"GCCZ>UR><M>C;W$V<O/Q^;B:_M=>O
M:Z....>.:;:OX_#\GQMQ^BKWFVIO.^=A>\1O,N/B,E:>NU,5N3KDM'U*VRXX
MGZMX2E^&?+CC+S."9CWMJ[6T1ZYBL[B+3_<FU=?S84[%P25H         #IP
M^T'_ $9_AQ^A_'?KMEWF:^+K^LKWC^.+_K>-79YJ?SA\M^ZY_P FJ2%'%@
M
M                                          #3_P!PO_@$\XO^3_R7
M_P!B^ZMO?#Y_/WV/_P";^&_WCMF5=B?QWX;\:[3]\8W*]>I590
MM0?:P_N_>5/Z'M-_STE5:_2D_P 0>U?QQN/WM"-?Q)_[#XS]UY/UM=B4K(@@
M
M                                   .>[]QQ_28;1^A_J;]:;YZ!_HZ
M/ZM6U_'&_P#URJ=/D%_-YC_=>?\ RH0/IV-T@       )X/MQ_Z3#5_T/]L_
MK38H)_2+_P!6K=?CC8?KEFEO/W^;S)^Z\'^5+H1//P@L
M         Y7ON%_\??G%_P X'DO_ +:-U>I7X?/YA.Q__*'#?[NVRRCL3^)'
M#?BK:?O?&T_;>94        N _:C?_'K_P#*W_\ 1%JAOI5O_P @_P#MO_\
M%"*WQ,__ ($_Z9_]*N JA45@                       %)W[I[]W[Q6_0
M]N7^>D2ZGZ+;^(/=7XXV_P"]I2^^&S_8?)_NO'^MJKZTI)0       !)![0G
M])?X;_IAQOZU99'+XNOZM7>/XGO^N8V >:G\WG+?N2?\JKIQ/,RKL
M                 <WWW[?Z6/RM_P"XO_PV=.O1M\!O]5'M7_M/_?'()_>2
M?\V/&?\ 2/WWG0_I>MJ        +('VO?_'WV]_R?[__ +:/']7)])Y_,)Q'
M_F_:_P"[N5: ^([^)&U_&N+][[E?"43H6                         .2
MYY"_N^]X?I@[+_STS3UB>7W\0>#_ !/L_P![8UGO!?[#V?[DP_K=6(&7NU
M      78/M8/W O*K],&F?YES*5OI2?X_=J_B?<?OF$0?B3_ -N<9^Y,GZXM
M1*M4:P                        ',=]WO^DO\R/TPY+]:L2],WPB_U:NS
MOQ/3]<R+$_*O^;SB?W)'^59&^D:S\       !:@^UA_=^\J?T/:;_GI*JU^E
M)_B#VK^.-Q^]H1K^)/\ V'QG[KR?K:[$I61!
M
M               57?NG_P!P+Q5_3!N?^9<*TKZ+;^/W=7XGV_[YE)3X;/\
M;G)_N3'^N*3ZZE+X         !TF?8NS^6V3VJ?$O(YJ[^MO+?#]I8"&;T+:
MW^3$ZIWIV?J^ M/3M(8(JOH,%A[:#U.:>99?3^>2JN2JJNKS>_')L-IQOQ4=
MV;?94Z,-LVRRS&MI^R9^,V6?+;6TS/M9<E[::]-=>FL16(B*_/.;!BV_F7RF
M/#&E)OAMZ9GVK[?#>T^.OIM:9T]$:Z1I&D):43FL
M
M                        &G_N%_\  )YQ?\G_ )+_ .Q?=6WOA\_G[['_
M /-_#?[QVS*NQ/X[\-^-=I^^,;E>O4JLH          6H/M8?W?O*G]#VF_Y
MZ2JM?I2?X@]J_CC<?O:$:_B3_P!A\9^Z\GZVNQ*5D00
M
M                  '/=^XX_I,-H_0_U-^M-\] _P!'1_5JVOXXW_ZY5.GR
M"_F\Q_NO/_E0@?3L;I        3P?;C_ -)AJ_Z'^V?UIL4$_I%_ZM6Z_'&P
M_7+-+>?O\WF3]UX/\J70B>?A!8                        !RO?<+_P"/
MOSB_YP/)?_;1NKU*_#Y_,)V/_P"4.&_W=MEE'8G\2.&_%6T_>^-I^V\RH
M    !<!^U&_^/7_Y6_\ Z(M4-]*M_P#D'_VW_P#BA%;XF?\ \"?],_\ I5P%
M4*BL                        I._=/?N_>*WZ'MR_STB74_1;?Q![J_'&
MW_>TI??#9_L/D_W7C_6U5]:4DH        D@]H3^DO\ #?\ 3#C?UJRR.7Q=
M?U:N\?Q/?]<QL \U/YO.6_<D_P"55TXGF95V
M.;[[]O\ 2Q^5O_<7_P"&SIUZ-O@-_JH]J_\ :?\ OCD$_O)/^;'C/^D?OO.A
M_2];4        60/M>_^/OM[_D_W_P#VT>/ZN3Z3S^83B/\ S?M?]W<JT!\1
MW\2-K^-<7[WW*^$HG0L                         <ESR%_=][P_3!V7_
M )Z9IZQ/+[^(/!_B?9_O;&L]X+_8>S_<F'];JQ R]VH       "[!]K!^X%Y
M5?I@TS_,N92M]*3_ !^[5_$^X_?,(@_$G_MSC/W)D_7%J)5JC6
M               YCON]_P!)?YD?IAR7ZU8EZ9OA%_JU=G?B>GZYD6)^5?\
M-YQ/[DC_ "K(WTC6?@       +4'VL/[OWE3^A[3?\])56OTI/\ $'M7\<;C
M][0C7\2?^P^,_=>3];78E*R((
M
M   "J[]T_P#N!>*OZ8-S_P RX5I7T6W\?NZOQ/M_WS*2GPV?[<Y/]R8_UQ2?
M74I?          .D#["7]$YXI?\ ?I_XD^XGG)^/+^M=W5_V9_N?CT O.S^<
M[D_^C_O3 F!1":J
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MGQK2E(M.OH\)O7PF=9U\-=)TNE*8D1@
M
M      '/=^XX_I,-H_0_U-^M-\] _P!'1_5JVOXXW_ZY5.GR"_F\Q_NO/_E0
M@?3L;I        3P?;C_ -)AJ_Z'^V?UIL4$_I%_ZM6Z_'&P_7+-+>?O\WF3
M]UX/\J70B>?A!8                        !RO?<+_P"/OSB_YP/)?_;1
MNKU*_#Y_,)V/_P"4.&_W=MEE'8G\2.&_%6T_>^-I^V\RH       !<!^U&_^
M/7_Y6_\ Z(M4-]*M_P#D'_VW_P#BA%;XF?\ \"?],_\ I5P%4*BL
M                I._=/?N_>*WZ'MR_STB74_1;?Q![J_'&W_>TI??#9_L/
MD_W7C_6U5]:4DH        DR]F[#Y/.>YSX>66)LIK^Z@[/GS$L$'''-=&,U
M[4MDS^:O:N*N:>/1QV&QD]Q)S_9XCBJ^'QY_(C3\8N\VVQ^&7O#-N[QCQ6XR
M,<3/HF^7/AQ8Z_FWR7K2/JVAKSS8RX\/EURM\LQ6L[:*^/RVO2M8_NVF(CZL
MNF@\T2O                        !SF_N!-<R>#]U/R$R=_3#3:[C@>E-
MCPO,4W$E=>,M>D] U&6JXHXXXYMYN,SJMW3Q1S\>>8^*:O[%7#T4? #R.VWW
MPL]O[;!,^]V>?DL.36-(B]N2W6XC3Y8]WGQSK\NL>I/?R-W&/-Y:;''37JQ7
MW%+?FSN,M_#Y?9O7^[K"&%,MML       !9 ^U[_ ./OM[_D_P!__P!M'C^K
MD^D\_F$XC_S?M?\ =W*M ?$=_$C:_C7%^]]ROA*)T+
M       ')<\A?W?>\/TP=E_YZ9IZQ/+[^(/!_B?9_O;&L]X+_8>S_<F'];JQ
M R]VH       "[!]K!^X%Y5?I@TS_,N92M]*3_'[M7\3[C]\PB#\2?\ MSC/
MW)D_7%J)5JC6                         YCON]_TE_F1^F')?K5B7IF^
M$7^K5V=^)Z?KF18GY5_S><3^Y(_RK(WTC6?@       +4'VL/[OWE3^A[3?\
M])56OTI/\0>U?QQN/WM"-?Q)_P"P^,_=>3];78E*R((
M
M                     "J[]T_^X%XJ_I@W/_,N%:5]%M_'[NK\3[?]\RDI
M\-G^W.3_ ')C_7%)]=2E\          Z0/L)?T3GBE_WZ?\ B3[B><GX\OZU
MW=7_ &9_N?CT O.S^<[D_P#H_P"],"8%$)JH
M
M                   !I#[EVR8S5?;S\VLGEJYJ+6Z\7>[=;BY@AYGKYR>Y
M=?9W4,+1513SQS3#)F<Y!3)7_8CCYJJY_)PW;\-?';GE?B#[*VVTB)RU[HXW
M-.LZ1T;?=XMQD_NQCQ6F(]<Z1ZV8^7NWR;GOOA\>+3JCDMO?Q^3'EK>W_P";
M6=/EGP<MMZAED(         "X#]J-_\ 'K_\K?\ ]$6J&^E6_P#R#_[;_P#Q
M0BM\3/\ ^!/^F?\ TJX"J%16
M
M<]W[CC^DPVC]#_4WZTWST#_1T?U:MK^.-_\ KE4Z?(+^;S'^Z\_^5"!].QND
M       !/!]N/_28:O\ H?[9_6FQ03^D7_JU;K\<;#]<LTMY^_S>9/W7@_RI
M=")Y^$%@                        '*]]PO\ X^_.+_G \E_]M&ZO4K\/
MG\PG8_\ Y0X;_=VV64=B?Q(X;\5;3][XVG[;S*@       %P'[4;_P"/7_Y6
M_P#Z(M4-]*M_^0?_ &W_ /BA%;XF?_P)_P!,_P#I5P%4*BL
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M:P?N!>57Z8-,_P RYE*WTI/\?NU?Q/N/WS"(/Q)_[<XS]R9/UQ:B5:HU@
M                     .8[[O?])?YD?IAR7ZU8EZ9OA%_JU=G?B>GZYD6)
M^5?\WG$_N2/\JR-](UGX       "U!]K#^[]Y4_H>TW_ #TE5:_2D_Q![5_'
M&X_>T(U_$G_L/C/W7D_6UV)2LB"
M
M      K3?=%X#$W/A'T=M$UI\^=P_E1KN QM]Z]S3]-B=DZD[>R.:M/IJ)J;
M.;ZV\U2PK]22.J6/Z?X1U4TUR<5V3_1@;_=X_.SG.+I?38YNULV6]=*^.3#O
M]A3';JTZHZ:Y\L:1,5GJUM$S6LQ(3X<,^6O>&\VT3]AOQE[3&D>-J9\$5G7T
M^$7MX1.DZ^.ND:45EYB9P         #I ^PE_1.>*7_?I_XD^XGG)^/+^M=W
M5_V9_N?CT O.S^<[D_\ H_[TP)@40FJ@
M
M               $;WN^?T9_F/\ H?R/Z[8A([X1?ZRO9WXXI^MY&?\ E7_.
M'Q/[KC_)LYCSTRK$P         %P'[4;_P"/7_Y6_P#Z(M4-]*M_^0?_ &W_
M /BA%;XF?_P)_P!,_P#I5P%4*BL
M
M   Y[OW''])AM'Z'^IOUIOGH'^CH_JU;7\<;_P#7*IT^07\WF/\ =>?_ "H0
M/IV-T@       )X/MQ_Z3#5_T/\ ;/ZTV*"?TB_]6K=?CC8?KEFEO/W^;S)^
MZ\'^5+H1//P@L                         Y7ON%_\??G%_S@>2_^VC=7
MJ5^'S^83L?\ \H<-_N[;+*.Q/XD<-^*MI^]\;3]MYE0       "X#]J-_P#'
MK_\ *W_]$6J&^E6__(/_ +;_ /Q0BM\3/_X$_P"F?_2K@*H5%8
M             !HU[D7BC_'2\,N[>A+"*SJW+.ZW^<'6<]]+]-;6_9FH3Q[%
MID4][S/;QX^SS.4L.,;=7-?-=%O:7LLG,<G%/R5;P^''S5_(QYR\)WYN)O\
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MSR%_=][P_3!V7_GIFGK$\OOX@\'^)]G^]L:SW@O]A[/]R8?UNK$#+W:@
M   +L'VL'[@7E5^F#3/\RYE*WTI/\?NU?Q/N/WS"(/Q)_P"W.,_<F3]<6HE6
MJ-8                        #F.^[W_27^9'Z8<E^M6)>F;X1?ZM79WXG
MI^N9%B?E7_-YQ/[DC_*LC?2-9^        M0?:P_N_>5/Z'M-_STE5:_2D_Q
M![5_'&X_>T(U_$G_ +#XS]UY/UM=B4K(@@
M
M            *WWW0G_ )U#_ ,X&@?[%_(!8W]&'_/WR_P#Y0W7^\>*;_P#A
MQ_CONOQ5E_?&V4/E[":8         #HN_;[;1C]@]J_H3$V<-Y%<Z/LG=6KY
M:NYC@H@N,A=]R;QNL<V.JBN)I);.G%;A;1U52TPU\7%$M/%'-%-%=?G;^D X
MO<<?\4O/;O--)Q[[;<=GQQ69F8I7C]MMIB^L1$6Z]O>8B)M'1-9UUF:U@5YY
M[:^#S*WV6\Q-<V/;WKIZHC!CQ^/AZ>JDSX:^$QXZZQ$TJ&#40
M
M                                "-[W?/Z,_P Q_P!#^1_7;$)'?"+_
M %E>SOQQ3];R,_\ *O\ G#XG]UQ_DV<QYZ95B8         "X#]J-_\ 'K_\
MK?\ ]$6J&^E6_P#R#_[;_P#Q0BM\3/\ ^!/^F?\ TJX"J%16
M
M                        <]W[CC^DPVC]#_4WZTWST#_1T?U:MK^.-_\
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MF9F9F9G5 +)DOEO;+EM-LMIF9F9UF9GQF9F?&9F?&9GTO['Q?@
M              !SQ?>O]KG-^#W==_VMU;K-Y)XI]NYB?(ZK?8S'U?@W4^XY
M*XOKN_ZCR4M%[?36MG##!S=X*XN*;>.ZL9*K6+U9;"XKY]"?P6?%!LO.[LK'
MVKW1N:1YJ<1ABF>M[_9-]MZ16M=_2.FL6M,S[O<TI-YIEB,MNFF?'6)W>4'F
M1A[QX>O&<EDC^$VUI$7B9]K-CB(B,\>$:S^AR1&LQ:.J=(O6$&Z<#<@
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MI2?X@]J_CC<?O:$:_B3_ -A\9^Z\GZVNQ*5D00
M
M                %;[[H3_@$ZA_YP- _P!B_D L;^C#_G[Y?_RANO\ >/%-
M_P#PX_QWW7XJR_OC;*'R]A-,         !T(?MQOZ-#6/TP]L_KK8//Q](O_
M %E=U^)]A^MV07\_?YP\G[DP?Y,IX4$VE0
M
M                 $;WN^?T9_F/^A_(_KMB$COA%_K*]G?CBGZWD9_Y5_SA
M\3^ZX_R;.8\],JQ,         !<!^U&_^/7_ .5O_P"B+5#?2K?_ )!_]M__
M (H16^)G_P# G_3/_I5P%4*BL
M
M Y[OW''])AM'Z'^IOUIOGH'^CH_JU;7\<;_]<JG3Y!?S>8_W7G_RH0/IV-T@
M       )X/MQ_P"DPU?]#_;/ZTV*"?TB_P#5JW7XXV'ZY9I;S]_F\R?NO!_E
M2Z$3S\(+                         .5[[A?_ !]^<7_.!Y+_ .VC=7J5
M^'S^83L?_P H<-_N[;+*.Q/XD<-^*MI^]\;3]MYE0       "X#]J-_\>O\
M\K?_ -$6J&^E6_\ R#_[;_\ Q0BM\3/_ .!/^F?_ $JX"J%16
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MY?+;-O\ -;6UI_\ 16L>BM:QX5K&D5B(B(T9:8FZL
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MW^YR;W>Y+Y=WEO-KWM,S:UIG69F9\9F9>D=:XX
M   #DN>0O[OO>'Z8.R_\],T]8GE]_$'@_P 3[/\ >V-9[P7^P]G^Y,/ZW5B!
ME[M0       %V#[6#]P+RJ_3!IG^9<RE;Z4G^/W:OXGW'[YA$'XD_P#;G&?N
M3)^N+42K5&L                        !S'?=[_I+_,C],.2_6K$O3-\(
MO]6KL[\3T_7,BQ/RK_F\XG]R1_E61OI&L_        6H/M8?W?O*G]#VF_YZ
M2JM?I2?X@]J_CC<?O:$:_B3_ -A\9^Z\GZVNQ*5D00
M
M                    %;[[H3_@$ZA_YP- _P!B_D L;^C#_G[Y?_RANO\
M>/%-_P#PX_QWW7XJR_OC;*'R]A-,         !T(?MQOZ-#6/TP]L_KK8//Q
M](O_ %E=U^)]A^MV07\_?YP\G[DP?Y,IX4$VE0
M
M                     $;WN^?T9_F/^A_(_KMB$COA%_K*]G?CBGZWD9_Y
M5_SA\3^ZX_R;.8\],JQ,         !<!^U&_^/7_ .5O_P"B+5#?2K?_ )!_
M]M__ (H16^)G_P# G_3/_I5P%4*BL
M
M     Y[OW''])AM'Z'^IOUIOGH'^CH_JU;7\<;_]<JG3Y!?S>8_W7G_RH0/I
MV-T@       )X/MQ_P"DPU?]#_;/ZTV*"?TB_P#5JW7XXV'ZY9I;S]_F\R?N
MO!_E2Z$3S\(+                         .5[[A?_ !]^<7_.!Y+_ .VC
M=7J5^'S^83L?_P H<-_N[;+*.Q/XD<-^*MI^]\;3]MYE0       "X#]J-_\
M>O\ \K?_ -$6J&^E6_\ R#_[;_\ Q0BM\3/_ .!/^F?_ $JX"J%16
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ME5^F#3/\RYE*WTI/\?NU?Q/N/WS"(/Q)_P"W.,_<F3]<6HE6J-8
M               #F.^[W_27^9'Z8<E^M6)>F;X1?ZM79WXGI^N9%B?E7_-Y
MQ/[DC_*LC?2-9^        M0?:P_N_>5/Z'M-_STE5:_2D_Q![5_'&X_>T(U
M_$G_ +#XS]UY/UM=B4K(@@
M
M*WWW0G_ )U#_ ,X&@?[%_(!8W]&'_/WR_P#Y0W7^\>*;_P#AQ_CONOQ5E_?&
MV4/E[":8         #H0_;C?T:&L?IA[9_76P>?CZ1?^LKNOQ/L/UNR"_G[_
M #AY/W)@_P F4\*";2H
M
M  "-[W?/Z,_S'_0_D?UVQ"1WPB_UE>SOQQ3];R,_\J_YP^)_=<?Y-G,>>F58
MF          N _:C?_'K_P#*W_\ 1%JAOI5O_P @_P#MO_\ %"*WQ,__ ($_
MZ9_]*N JA45@
M                                               '/=^XX_I,-H_0
M_P!3?K3?/0/]'1_5JVOXXW_ZY5.GR"_F\Q_NO/\ Y4('T[&Z0       $\'V
MX_\ 28:O^A_MG]:;%!/Z1?\ JU;K\<;#]<LTMY^_S>9/W7@_RI=")Y^$%@
M                      '*]]PO_C[\XO\ G \E_P#;1NKU*_#Y_,)V/_Y0
MX;_=VV64=B?Q(X;\5;3][XVG[;S*@       %P'[4;_X]?\ Y6__ *(M4-]*
MM_\ D'_VW_\ BA%;XF?_ ,"?],_^E7 50J*P
M
M            #DN>0O[OO>'Z8.R_\],T]8GE]_$'@_Q/L_WMC6>\%_L/9_N3
M#^MU8@9>[4       !=@^U@_<"\JOTP:9_F7,I6^E)_C]VK^)]Q^^81!^)/_
M &YQG[DR?KBU$JU1K                         <QWW>_Z2_S(_3#DOUJ
MQ+TS?"+_ %:NSOQ/3]<R+$_*O^;SB?W)'^59&^D:S\       !:@^UA_=^\J
M?T/:;_GI*JU^E)_B#VK^.-Q^]H1K^)/_ &'QG[KR?K:[$I61!
M
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M;
M                                             :*>YYJMON7MV^:V
M(N;N:SCL_&GMS:J9H**)*Z[C1=.RF[VEI53)^IXAO[K7J()*O^U3')5S3^7C
MAO/X9.5R</\ $/V5N\5(O:_<NPP:3,Q&FZW%-M:WAZZURS:(]$S$1/@S3RYW
M-MIWYP^6L1,SR."GC\F3)&.9_N1;6/JPY=#U +'@         %P'[4;_ ./7
M_P"5O_Z(M4-]*M_^0?\ VW_^*$5OB9__  )_TS_Z5<!5"HK
M
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MZ9_]*N JA45@
M                                                ')<\A?W?>\/T
MP=E_YZ9IZQ/+[^(/!_B?9_O;&L]X+_8>S_<F'];JQ R]VH       "[!]K!^
MX%Y5?I@TS_,N92M]*3_'[M7\3[C]\PB#\2?^W.,_<F3]<6HE6J-8
M                #F.^[W_27^9'Z8<E^M6)>F;X1?ZM79WXGI^N9%B?E7_-
MYQ/[DC_*LC?2-9^        M0?:P_N_>5/Z'M-_STE5:_2D_Q![5_'&X_>T(
MU_$G_L/C/W7D_6UV)2LB"
M
MK<?=#7%O3X&=.VE4\--U/Y=:1<0VU4M'%Q-;VO37?$5S/%#S5ZDD-O)>14R5
M<<<TT52T<<\\<U4_&Q[Z,+'DGSWYC+%9]U7M'<Q-M)TB;<CQ<UB9]$3,5M,1
MZ9BLZ>B4@/AQK:>]=W;2>F.+R1KZM9S[;2/[NDZ?F2HB+U4T@         '2
M!]A+^B<\4O\ OT_\2?<3SD_'E_6N[J_[,_W/QZ 7G9_.=R?_ $?]Z8$P*(35
M0
M                                            #3_W"_\ @$\XO^3_
M ,E_]B^ZMO?#Y_/WV/\ ^;^&_P!X[9E78G\=^&_&NT_?&-RO7J564
M   +97VJNU7%GV/YE:13:0UVNPZ3TWM4U]577Q<6]QIN=W_$6UI%'Q_:ZX;V
M/>I:Y*N?U5-4%'''Y.:E4'TI_%8\W;G9O-S>8R[?>\A@BND:3&XQ;7):TSZ=
M:SM:Q$>B8M.OHA&+XEMM6_'\3O-9ZL>;/33U3&2N*TS_ '/=QI^;*YPIK1*
M
M                                   <]W[CC^DPVC]#_4WZTWST#_1T
M?U:MK^.-_P#KE4Z?(+^;S'^Z\_\ E0@?3L;I        3P?;C_TF&K_H?[9_
M6FQ03^D7_JU;K\<;#]<LTMY^_P WF3]UX/\ *ET(GGX06
M          <KWW"_^/OSB_YP/)?_ &T;J]2OP^?S"=C_ /E#AO\ =VV64=B?
MQ(X;\5;3][XVG[;S*@       %P'[4;_ ./7_P"5O_Z(M4-]*M_^0?\ VW_^
M*$5OB9__  )_TS_Z5<!5"HK
M
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M7<]\8=KCO,QM^/QUM77PK>V3+DG2/1K-+8]9],Z1KZ(6*5>#0H
M              #F.^[W_27^9'Z8<E^M6)>F;X1?ZM79WXGI^N9%B?E7_-YQ
M/[DC_*LC?2-9^        M0?:P_N_>5/Z'M-_P ])56OTI/\0>U?QQN/WM"-
M?Q)_[#XS]UY/UM=B4K(@@
M                                                           *
MKOW3_P"X%XJ_I@W/_,N%:5]%M_'[NK\3[?\ ?,I*?#9_MSD_W)C_ %Q2?74I
M?          .D#["7]$YXI?]^G_B3[B><GX\OZUW=7_9G^Y^/0"\[/YSN3_Z
M/^],"8%$)JH
M                                                      !I_P"X
M7_P"><7_ "?^2_\ L7W5M[X?/Y^^Q_\ S?PW^\=LRKL3^._#?C7:?OC&Y7KU
M*K*          %J#[6']W[RI_0]IO^>DJK7Z4G^(/:OXXW'[VA&OXD_]A\9^
MZ\GZVNQ*5D00
M                                               '/=^XX_I,-H_0
M_P!3?K3?/0/]'1_5JVOXXW_ZY5.GR"_F\Q_NO/\ Y4('T[&Z0       $\'V
MX_\ 28:O^A_MG]:;%!/Z1?\ JU;K\<;#]<LTMY^_S>9/W7@_RI=")Y^$%@
M                      '*]]PO_C[\XO\ G \E_P#;1NKU*_#Y_,)V/_Y0
MX;_=VV64=B?Q(X;\5;3][XVG[;S*@       %P'[4;_X]?\ Y6__ *(M4-]*
MM_\ D'_VW_\ BA%;XF?_ ,"?],_^E7 50J*P
M
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MB#VK^.-Q^]H1K^)/_8?&?NO)^MKL2E9$$
M
M           !5=^Z?_<"\5?TP;G_ )EPK2OHMOX_=U?B?;_OF4E/AL_VYR?[
MDQ_KBD^NI2^          =('V$OZ)SQ2_P"_3_Q)]Q/.3\>7]:[NK_LS_<_'
MH!>=G\YW)_\ 1_WI@3 HA-5
M
M       -/_<+_P" 3SB_Y/\ R7_V+[JV]\/G\_?8_P#YOX;_ 'CMF5=B?QWX
M;\:[3]\8W*]>I590          M0?:P_N_>5/Z'M-_STE5:_2D_Q![5_'&X_
M>T(U_$G_ +#XS]UY/UM=B4K(@@
M
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M&R^K51Z
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M/OMOZ?9=-=<>VG6+>/HUS3$X])U^Q^\F8B9I*]XHJ0M
M         <QWW>_Z2_S(_3#DOUJQ+TS?"+_5J[._$]/US(L3\J_YO.)_<D?Y
M5D;Z1K/P       %J#[6']W[RI_0]IO^>DJK7Z4G^(/:OXXW'[VA&OXD_P#8
M?&?NO)^MKL2E9$$
M                                                     !5=^Z?_
M ' O%7],&Y_YEPK2OHMOX_=U?B?;_OF4E/AL_P!N<G^Y,?ZXI/KJ4O@
M    '2!]A+^B<\4O^_3_ ,2?<3SD_'E_6N[J_P"S/]S\>@%YV?SG<G_T?]Z8
M$P*(350
M                                                  #7KRXU?'[Q
MXI>3FEY::\M\7M_CUW1J^2N,=)#%D(,?G^M]EQ-Y-8RW-O=V\5Y%;W=5454D
M4M%-?''-5%7'QXYV#Y2\IN.$\U>V>:VD4MNMGW!QV>D7B9I-\6\PY*Q:(FLS
M69K$6B+5F8UTF)\7>]K[F^S[FX[>8HB<N+?[>\1/HF:Y:6C728G36/'28_-<
MH)ZLEFH         "T%]K3L>,M?*7R1U&6N;C,YSH"PV.PHIAYJMZL9JO8FM
M8S+5RS_'Y8YJ+K<;+BBCGCXUTU5\\?\ 8Y5B?2B\=N<OE=VWR](CYG@Y^V&T
MZ^/7GVF:^/2/7'3M\FL^J8CY4<OB2V^2W;?'[J-/=4WTTGY=;XKS7P_,QVU_
MN?*O *1T.@
M                                             '/=^XX_I,-H_0_U
M-^M-\] _T=']6K:_CC?_ *Y5.GR"_F\Q_NO/_E0@?3L;I        3P?;C_T
MF&K_ *'^V?UIL4$_I%_ZM6Z_'&P_7+-+>?O\WF3]UX/\J70B>?A!8
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MO6K:[T[AMW5W5ON?MX4W&>>B--)C%2(QXHF/[Z,5*1:?7;6?6VT:F8N
M
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M?);WF.0S<IR62V7?9[S>]K3,S,S^;Z(B-(K'HK6(K&D1#(3'W
M                <QWW>_Z2_P R/TPY+]:L2],WPB_U:NSOQ/3]<R+$_*O^
M;SB?W)'^59&^D:S\       !:@^UA_=^\J?T/:;_ )Z2JM?I2?X@]J_CC<?O
M:$:_B3_V'QG[KR?K:[$I61!
M
M  5(ONK]HR%IJ'A-I<<-G5B\_LG?.T7EQ7'-SD(LAJ&,ZFQ.-AMI:;BFWHLY
M[?>+NJ>FN*NNJN.'FBNCBFOB2VCZ*[B]OEY?O7FK3?YUM]MQ>"L1,=$TW%]_
MDO-HTUFT3ML<5F+1$1-]8M,Q-90_#1MJ6W7,;R9GWM,>VI$>K2\Y[3KX:ZQ.
M.NGCZYUB?#2FTN+2Q          =.'V@_P"C/\./T/X[]=LN\S7Q=?UE>\?Q
MQ?\ 6\:NSS4_G#Y;]US_ )-4D*.+
M
M             &'O(;]P'O+]#W9G^9>;9?Y??Q^X/\<;/]\XW:\%_MS9_NO#
M^N5<EYZQ%GH         "R!]KW_Q]]O?\G^__P"VCQ_5R?2>?S"<1_YOVO\
MN[E6@/B._B1M?QKB_>^Y7PE$Z%@
M
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M^RUM%VU2@A\
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M$Q,3$Z3$Q/C$Q/A,3XQ+!+5M2TUM$Q:)TF)],3\DOV?A_
M                             $>_G'[8WB=Y^X2BGN72?PCL3'V=%EKW
M=&B48W =H8>VMZ;GFRQ=UG9,=>P[/K=K->2UT8S*PWEI#7+)7!3#-7S*D%Y'
M_$UYK^0>]F>S=[[[M[)?JR\=NNO+LLDST]5ZXHO6<.:T5K$YL%L>2T5K7)-Z
M5BK.NS?,7N?L?-_]IS=>PM.MMODUMAM,Z:S%=8Z+SI$==)K:=(BVL1HJB^3'
MVT'F3UKD+R_\<-LT/R6U/^]?P_&SY'&]0]F<27$U%%W#>83=,SSU_59XV.7B
MKBZHV?B:ZHCKJXM(:N:(J[5O+3Z2KR=[EV]-OYC;3?\ ;7*^UUWBE]_L](CV
M9KDVV/YUU7F-.B=E-:3-8][>.J\29[>^(7M/D,<4[@Q9^/W7CK.DY\/AZ-+8
MZ^]UGY/<Z1K'M3&LQ$7O?MU>>G6GU\FY>'7DAC;#%V<=_DLY9]0;OGM9L;27
M^Q+=;3KV'RNN0?)SSQQ735=<51\\\<5\4\\\);\%\1'D/W+[NO#=X=N9,^6\
MTIBMR&VQ9K6CU5P9<F/-/U)BFD^J9;2V7?O9/(=,;3EN/M>TZ16<^.MYGZE+
M6K?_ -'CZF,-;\4/*3<LG3A=0\:^_MJS-<,UQ1B=;Z<[$SF3KM[?CBJ>>FPQ
MFN75U5#!3SQS75Q1\M/'/Y>>&3<CYK>5W#[:=[R_<G ;79Q,1.3-R&TQ4UGT
M1U7S5KK/JC7679;CN;MO:8_?;KD-CBQ:Z=5\^*L:SZ(UF\0WQZ)]CCW+.]KC
M&R0>/F2ZEUZ_FMXKC:>]LK8]96^'HN*Z*?J,EJ&2JNNT*H8(^:JY.+7 7,E-
M-'/'R_/S115HGOKXX/AL[%QY:Y.X,?+<ACB9C!QE+;V<DQ'HIN*=.RUF=(CK
MW5(F9UUZ8F8PKFO.3R]X6MHMOJ[K/6)TIMJSFFVGJB\:8?J1KEB/JZ:RL7^$
MGVV'073V0Q&^^76X?QC-TQMY!D;+KG"6U[K72F-N+6?B:VIST4\E.V=E>E/;
MQR^G=5XG%31UR6MYC;R+GYJJ[?.OZ2+OWO#;YN!\I-G_  <X;)2:6WF2U<W)
M7BT:3[J8CW&SUB9KK2,^>LQ7+AW.&_A&A.\/B"YSE:6V7:V+YAM+1I.6TQ?<
M3$^GI_08O"9C6.N\3$6IDI/HLFZ_KV U/"8O6M5P>'UG7,)9PX["Z_K^,LL-
MA,1C[>GY+>QQ>*QT%M86%G!3^2B**.BBGC^QQPK>Y#D-_P MO<O)<KGS;GD<
M]YODRY;VR9,EY]-KWO,VO:?7:TS,^N4?<^?/NLUMQN;WR;B\ZVM:9M:TSZ9F
MTZS,_5F7V'#?(                          !S'?=[_I+_,C],.2_6K$O
M3-\(O]6KL[\3T_7,BQ/RK_F\XG]R1_E61OI&L_        6H/M8?W?O*G]#V
MF_YZ2JM?I2?X@]J_CC<?O:$:_B3_ -A\9^Z\GZVNQ*5D00
M
M                        %/[[KG_X"O\ YI/_ *'1;U]%3_\ EY_V)_\
MC=*GX9O_ ,-_]#_^J4_EO*5(         #IP^T'_ $9_AQ^A_'?KMEWF:^+K
M^LKWC^.+_K>-79YJ?SA\M^ZY_P FJ2%'%@
M
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M>YW%=9^2.J8C6?7,1Z9A?.40H4@
M
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M/KMZ8F/36VF\K1[#0
M                                ',=]WO\ I+_,C],.2_6K$O3-\(O]
M6KL[\3T_7,BQ/RK_ )O.)_<D?Y5D;Z1K/P       %J#[6']W[RI_0]IO^>D
MJK7Z4G^(/:OXXW'[VA&OXD_]A\9^Z\GZVNQ*5D00
M
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MYC+DB(M'(YZ>'R8\EL=?3,^,UK$S]772(CP;RM'L-
M
M                          <?UZ\UJ0         ">#[<?^DPU?\ 0_VS
M^M-B@G](O_5JW7XXV'ZY9I;S]_F\R?NO!_E2Z$3S\(+
M
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M,36LTI:)TM24S*&S4H
M#5?N[SB\/_'#ZR'NWR2Z?Z^RMC\_U&L9;=L/<[M_:OCZOT^BXFXR&Y7GI<_#
MBOT;&OY:N>..?AS5QQSM/LGR0\WO,;HOV3VWS'(;6^FF;'MLE=MX^C7=9(IM
MZZ^KJRQK&LQX1+)>'[-[JY_2>'X_=Y\<^B]<=HQ_W<EHC'']VR'[N[[E_P $
MNO\ ZRQZBUCN#OW*Q_/]#D,3K4/7.DW7R?'CCZC,;]/C]RL_5YYXYH^&NR_J
M?CS5\O/'%-4O.R?HU?/3G^C/W=N>'X#:SIU4R9IW>YKK\F/:Q?;VT]?^EU\=
M--8UF-J\/\/7>F^TORF3:;''ZXM?WN2/S*XHG'/VV$,W>7W-?FOOGXCC^ENO
M^G^@\/<_5_09/\,O^T]_QOK?B\%K_P"O-LEL]%O/H[6\M9/U>K\>I>V?J<_W
MO+7:<3)['^C/\EN!]WN.].0YCGMY7IZZ===CM;Z>[FWV+!%MS7JM6\>&]\,>
M3IC[)2,K;/#?#OVALNG)R^?=[[+&FL:QAQ3];K[--<D:S%H_5O"MM/KHBR'_
M +R]P#S6\DOQ&#NGR<[@W/#Y7ZOZ_4?SOO\ 7= G^N_%Z+K_ -W>J58+18O5
MM<[=6WZC'4_+92_3<?"WIHBIE[V/Y ^2WEO[N_9?;/#[+>8NGHS_ #>N;=1T
M^[Z?]+S^]W,Z6Q4OXY9UR5][/V29M.U>&['[0[?Z9XCCMIARUTTOT1?+&G3I
M]EOU9/36L_7?71U?7:RT_;>94            VHZ2\XO,#QP^DAZ1\D>X.OL
M78^G]/K&)W;,W.D\^E\/2^HT7+7&0TZ\]*GCX4>M8R?+3SSQQ\.*N>.=6][>
M2'E#YC==^]NV^'Y#=7UUS9-MCKN?'TZ;K'%-Q77U].6-9TF?&(8US'9O:O/Z
MSS''[3/DGTWMCK&3^YDK$9(_N63#=$_<P><O7MQC;3NC5.I?(3 0S6]67NK[
M U]8;[D+>.NCZB*PV'1>(M)Q<US#\W'J5ZO=4T2<TU<4?+3517#_ +Z^C4\C
M^X,>7-V9N^6[?W\Q/NZUR_/=K29CPFV+<Z[F\1.GA&]I,QK$SK,6C5/-?#SV
M;OJVMQ&7=;#/,3TQ%O?8XGU:UR?9)T^3WU?#U^N)D^C?N;/"G?/P[']T]?=P
M=!YBY^D^OR?X98=IZ!C?6_"(+K_UYJDMGO5Y]'=7EU)^HU?CU+*S]3C^^):+
M3B'/?'T9_G3P/O-QV7R'#\]LZ]713KML=U?3WDU^Q9XMMJ]5:TCQWOADR=,_
M8Z3E:GYGX=^[]EU9.(S[3?8HUTC6<.6?KM/9OKCC6(K'ZMX6MI];$V3#]#>?
M'AAY.5V%IT;Y*]2[WG,G#1<66G0;59X+L*:WKM\;<<S\]<;1^";Y##%^+012
M528ZFF*YJJ@KYIGCDCIA_P!]^0OG+Y9UR9>^.VN6V&QQ3I;<3@MEVD3K>-/G
MF#WFUF9]W:T1&:9M2(R1K2U;3JGF^R.[>W8M;F>/W6##6=)R32;8M=9C3WM.
MK'^AF8TOXQ[4>$Q,[=-2,6
M                                  <QWW>_Z2_S(_3#DOUJQ+TS?"+_
M %:NSOQ/3]<R+$_*O^;SB?W)'^59&^D:S\       !:@^UA_=^\J?T/:;_GI
M*JU^E)_B#VK^.-Q^]H1K^)/_ &'QG[KR?K:[$I61!
M
M                    4G?NGOW?O%;]#VY?YZ1+J?HMOX@]U?CC;_O:4OOA
ML_V'R?[KQ_K:J^M*24          =4+V]/\ @$\'?^3_ ,:/]B^E/+5\0?\
M/WWQ_P";^9_WCN5:_??\=^9_&N[_ 'QD;@-0L5
M
M                       <BSL+5/S#W[>-&^O_ !7\S-PV;5/Q3Z7Z'\2_
M-W-7N(^O^B^IO/H_K/H_4]+UI?3^;Y?GJ^'S<^MSM[E?O]P&QYSW?NOGNSPY
M^CJZNCWV.N3HZM*]73U:=7377372/0M(V&Z^>['#O>GI]]BI?3773KK%M-=(
MUTUTUTC7Y'D';N4         FV^WHVJWU[W1NG<1-:S7$F]:3W+JMI-%7131
M87%IUEL>[575Q37^JDAKM=.E@XII_5>I-3S_ &..4*/I!^*R<A\+_,;NEXK7
M8[WC\]HF)UM%M[AVW3'R3U;BMM9\-*S'IF&G_/;;6S^6^[RQ,1&'-@O/U8G-
M3'I']W)$_F1+HF//&@:
M                                                       Y[OW'
M'])AM'Z'^IOUIOGH'^CH_JU;7\<;_P#7*IT^07\WF/\ =>?_ "H0/IV-T@
M     )X/MQ_Z3#5_T/\ ;/ZTV*"?TB_]6K=?CC8?KEFEO/W^;S)^Z\'^5+H1
M//P@L
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M8W!:3QO%[2N2/1:]??7CZ[73)FG)>-8M,3I;QC2)\(B(T/;V9H
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M*3];Z,FG1/C:L3I:=)F(GQ\&R#7#'P
M                                     ',=]WO^DO\ ,C],.2_6K$O3
M-\(O]6KL[\3T_7,BQ/RK_F\XG]R1_E61OI&L_        6H/M8?W?O*G]#VF
M_P">DJK7Z4G^(/:OXXW'[VA&OXD_]A\9^Z\GZVNQ*5D00
M
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MW.>>K-DWN>UITB-;6RVF9TC2(UF?1$1'R,\L$=*
M
M                        Y+GD+^[[WA^F#LO_ #TS3UB>7W\0>#_$^S_>
MV-9[P7^P]G^Y,/ZW5B!E[M0        $P'L)?TL?BE_WZ?\ AL[B1"^/+^JC
MW5_V9_OCCVJ_.S^;'D_^C_OO Z03SDH @
M
M        .>[]QQ_28;1^A_J;]:;YZ!_HZ/ZM6U_'&_\ URJ=/D%_-YC_ '7G
M_P J$#Z=C=(       ">#[<?^DPU?]#_ &S^M-B@G](O_5JW7XXV'ZY9I;S]
M_F\R?NO!_E2Z$3S\(+
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MBM8B(B(B-(B(CPB(CPB(\(AGM:UI6*UB(K$:1$>B(^2'XOV_H
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M(K:)Z;:369B=)F)F(9L84Z<
M                          !S'?=[_I+_ #(_3#DOUJQ+TS?"+_5J[._$
M]/US(L3\J_YO.)_<D?Y5D;Z1K/P       %J#[6']W[RI_0]IO\ GI*JU^E)
M_B#VK^.-Q^]H1K^)/_8?&?NO)^MKL2E9$$
M
M            !0E^YQS^)S'N$:'CL;=_4WFJ>*_76 S\/H7,/T&6N>R>X]HA
MM/4GABBNOGP6R64_J0U21<>M\G-7$E$E%-\GT9FPW>S^'W?[C<TZ<.Z[IW>7
M%.M9ZL<;/C\$VTB9FOV7#DKI:(M[/5ITS69FS\.V#+B[%SY,D:4R\GEM7QCQ
MK&+!37P]'M4M&DZ3X:^B8F:ZZP]OD         !UL^DL/D]>Z8ZCP&:LIL=F
M<'UAH.'RV/N...+BPR>,U7$V5_93\4\U4\36MU!715QQSSQ\U/+R9=Z[S;<A
MWER^_P!E>,FSS\GNLF.\>BU+Y\EJVCZEJS$Q]257W,9<>?EMUGPS%L5]SEM6
M8]$Q-[3$Q^;#)[&77
M
M  .5O[@5O;V?GGYMVEI!#:VMKY=>25O;6UO%1!;V]O!W+N<4,$$,5-,<,,,=
M/%---/'%--/'''''P>ICR R9,WD1V3ERVFV6W:/#S:TS,S,SQVWF9F9\9F9\
M9F?&964]C6M?LKA[6F9M/%[29F?3,^XQ^,M16VV4@        ))O9]N+BU]S
M+PYEMIYK>2KMNUMZI():X:ZK>\P6;M+N"JN.JFKF&ZM9ZXI*?^S7'7535QSQ
MSSPC?\7V/'E^&GO&N6L6K'$VG28B8UKEQVK/CZZVB+1/IB8B8\8:_P#-6M;>
M7G+1:(F/FLSX_+%JS$_W)\8^JZ;CS.*[0
M
M        '/=^XX_I,-H_0_U-^M-\] _T=']6K:_CC?\ ZY5.GR"_F\Q_NO/_
M )4('T[&Z0       $\'VX_])AJ_Z'^V?UIL4$_I%_ZM6Z_'&P_7+-+>?O\
M-YD_=>#_ "I=")Y^$%@
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M&E,>.M:4K'R5K6(K6/J1$0V'BPXL&.,."M:8JQI%:Q$1$?)$1X0^:Y+Z
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M1/YDQ/KADACCKP
M             ',=]WO^DO\ ,C],.2_6K$O3-\(O]6KL[\3T_7,BQ/RK_F\X
MG]R1_E61OI&L_        6H/M8?W?O*G]#VF_P">DJK7Z4G^(/:OXXW'[VA&
MOXD_]A\9^Z\GZVNQ*5D00
M                                                           '
M/=^XX_I,-H_0_P!3?K3?/0/]'1_5JVOXXW_ZY5.GR"_F\Q_NO/\ Y4('T[&Z
M0         '8">0Q5:
M
M    Y>?NE:K;Z=[C'FGB+:ZFO([OR*[,VJJ:>BB.NBXWK8KO=KNUIIC_ %/,
M-A=;#7!'5_VJHXZ>:OR\\O3U\+O*Y.8^'7LO=Y:12U.W=G@TB9F--KBKMJV\
M?7:N*+3'HB9F(\%CGEMN;;OL'B,MHB)C88:>'R8ZQCB?[L5UGZLM"6^6;
M      -Y/;*VC(:A[A_A/EL;#9SW%WY.=-:O)1?1S2PTX_>-YPVEY::BFWN+
M:3B\M\7GYI+>KFKFBBXIHJKHDHXJHJT?\3'%[?E_AZ[UVFYF]<=.V>1SQ-9B
M)Z]MMLFYQQ.L6CIF^*L7C36:3:(FLS%HPWS$VU-UV'S&+),Q6..SW\/EQX[9
M*^F)\)M6(GZFNDQ/BZCSR^*WP
M
M'/=^XX_I,-H_0_U-^M-\] _T=']6K:_CC?\ ZY5.GR"_F\Q_NO/_ )4('T[&
MZ0       $\'VX_])AJ_Z'^V?UIL4$_I%_ZM6Z_'&P_7+-+>?O\ -YD_=>#_
M "I=")Y^$%@
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MMA\C\WI_7[5TEN5[A?1^'PXE^DT#>XL]]3ZGQYJI^?98OD^7Y>?F^;YJ8?\
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M6F]V&^X[/.UY##EP;F/33)2U+1I,Q.M;1$^F)CT>F)CTP]@Z=Q
M                                              ',=]WO^DO\R/TP
MY+]:L2],WPB_U:NSOQ/3]<R+$_*O^;SB?W)'^59&^D:S\       !:@^UA_=
M^\J?T/:;_GI*JU^E)_B#VK^.-Q^]H1K^)/\ V'QG[KR?K:[$I61!
M
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MDJ^
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M[;6WO:G)[.LQ6V7CMS2)GT1-L-ZZS^9JZMCRJJS@
M
M               '/=^XX_I,-H_0_P!3?K3?/0/]'1_5JVOXXW_ZY5.GR"_F
M\Q_NO/\ Y4('T[&Z0       $\'VX_\ 28:O^A_MG]:;%!/Z1?\ JU;K\<;#
M]<LTMY^_S>9/W7@_RI=")Y^$%@
M                      'S<QF</KV,O<UG\KC<'AL=#S<9#+9B^M<9C+"W
MIYXIJGO;^]E@M;6'BJKCCFJNNFGX\_V7)V>SWG(;FFRV&+)GWF2=*8\=;7O:
M?DK6L3:T_4B)E],6'+GR1AP5M?+:=(K6)F9GY(B/&48W>7O1^VQT)<7V+V+R
M8U7=MBLIOI^==Z>L<SVQ<37$=>,XO(.<_I=AE-)L)K"'*<5RTWF5MJN:H+B&
M/BNY@DAIDSV/\&7Q(]^XZ;KCNVMULN.O&OON0MCV,1$Q?IGW6YM3<VBTTTB<
M>"\:6QWMTX[UO.Q>&\H_,'FZQDV_'9<.WF->K/-<,:>.D].28R3KIX=-)]-9
MG2LQ*'GNG[I[0;/U[/QU\5MPV+U/3^FV/NG<L+IGT?R?A4LWKZ7HT6^?B7U'
MS7T%/RY^T]'Y()^?5^>2VCF!V7]%MS^;IS>8?=6SV^FNN'CMODW'5]?$:;G<
MSM>C3[':==K?JUOC]GIKDMM;B/ALWU]+\]R>+'\M-OCMDU^N_P"<R>[TT]F?
MU*VOM5\-(M,-G>OO[>Y9W;7=6^/[;P/1V NX8HI==Z*U"QU:BBN.WC@JN+7;
MMFN-S[*LIIJJ:I*^(<Y''ZDG/PIXIICIHF-V-\!'PV=E5KDW'$Y^<W])F8S<
MGN+9YTF9G2V##&WV=HCPB.K;3.D1K,S-IMMCA?)#R]X>(M?:WWF>)^OW-YOZ
M]=)I2,>*?D\<<SI'I].L3O87:?9W;>;JV7M;L??.S=CK]3Y]@["V_8-TS=7K
M54US?-E=DR.2OZO5JHXYJ^,GZKGCCXI7=O\ :W;':6R^]O:O';#C..C3[%M-
MOBV^/P]'L8:4KX>KP\&SMCQO'<7A^;\9M\&WV_\ >XJ5QU_]FD1'_H>#=ZYH
M                                                 #V&C=A[_P!8
M9^WVSK7>-PZ\VFS]'Z39=&V;-:EG[7Z>]M,E!]/F<!>X_(P>AD<?!<4?+)Q\
ML\$=?'PJHIYXZCG.WN [GV%N*[EV.SY#B[Z]6'<X<>?%;6MJ3KCRUO2=:7M2
M=8\:VM7T3,3Q=[L-CR."=KR&'%GVT^FF2E;UG6)B=:VB8]$S'H]$S'HE*YT)
M[\?N4]$16N/E[GL^Z]?M/I?DP7?>OP[[++]+:6UCQ]5N=I=:_P!F7?KV]G'S
M+ZF<J^>;YYN?[=+-))%3OSX$OAM[ZM;<5X:_"[^_5KEXO+.UB.JUK>SM[5R[
M.NDVGITVT:5Z:?64I6NLN;\E?+[FIG)&TG9YYU]K;6]WZ9F?#',6PQI,SIIC
M]&D>B(B)C>D?NGL!-]'8>1_BMF,=\OR?7[5TCN5EF?6^/PXD^CT#>XL#]-Z?
MP^-/S[++\_S?#GY?E^:J'G>WT6V_IUY_+GNK#DUUZ<');>V/3Y.K=;6<NNOK
MTV==--?'72-4<Q\-F>-;\!R=+?)3<8YK_P N7'U:_:H_NIC.B?>U]M;OJ**+
M'^1^M]79NKY?J,!WM#-U)+9_/:7EY3ZNS;1S!U_<_P!KL):.?ILS/\LWIQU?
M"N>WIEAYWU\%/Q)=AVF^X[<W/*;*/1EXR8W\6]JM?##@UW4>-ZS[>WKK7JM&
MM:9)KJCFO)_S!X29G)Q^3<X?5;;?9]?&(^LIKECTQZ<<>&L^BMM)1<!L6O[7
MB;3/ZOG,/LF"O_7^AS6 R=EF,3>_2W,UE<_29+'3W-G<_37EM)%)\E?/R2QU
M4\_"JGGCB,&_X_?\5N[[#E,&;;;['IU8\M+8\E>JL6KU4O$6C6LQ:-8\:S$Q
MX3#6^?!GVV6<&YI?'FKIK6T36T:QK&L3I,:Q,3'U)U?8<-\@
M                                       ',=]WO^DO\R/TPY+]:L2]
M,WPB_P!6KL[\3T_7,BQ/RK_F\XG]R1_E61OI&L_        6H/M8?W?O*G]#
MVF_YZ2JM?I2?X@]J_CC<?O:$:_B3_P!A\9^Z\GZVNQ*5D00
M
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MMEVIR>\K$6MBX[<WB)]$S7#>VD_FZ.K8\JJLX
M
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M7#I[W+@R4KKX1K:DQ&L_FRZX+R6*NP
M
M     '/=^XX_I,-H_0_U-^M-\] _T=']6K:_CC?_ *Y5.GR"_F\Q_NO/_E0@
M?3L;I        3P?;C_TF&K_ *'^V?UIL4$_I%_ZM6Z_'&P_7+-+>?O\WF3]
MUX/\J70B>?A!8
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MMM<>FFF+'3'K^;TQ&OU9G69GQGQ8E98[,
M                              !DCK7N3M[IC+29_I[M7LCJC.S?)ZV:
MZUWG9]%RTOIVU_91^IDM7RF+O*_DL\K=1<?&OGX17,M/'ZF2OCG'.Y>SNT>\
M]I&P[PXKC>5V-?1CWFVP[K'&MJVG2F>EZQK:E+>CZZE9]-8TX'(<3Q7+XO<<
MKMMONL,?H<N.F2OIB?1>+1Z:Q/YL1/JA+IT3]P?[DG34L5MLO8>G]^Z]%\M$
M>%[FTG'7=W;127=Y=WLEMMNBR:-N5U>7'-[S3'7D;_(PV],,5$<5,5',=42.
M^OH_/AP[QK.3C>/WG <A/IR<=N;UK,Q6M:Q.#=1N=O6L=.LQAQ8K7FU[6O-Y
MBT:MYKR+\O\ EHFVWP9=CGG]%@R3$3X1$:TR>\QQ$:>/16LSK,S.LZIC>D?N
MF.ILK]'8>1/C'OFDS?J(;K8^HMJP?8./FEK^''-[7K.V1]?7^)LXZJOU<=&0
MR4W%%/-5/J5<\1H>=[?1<]V;7KS^7G<VPWM/&:X=_@R[2\1_>^^P3NZY+3ZI
MG%AKK.D],>TU/S'PV\IBUOP/(X,T>JF>EL4_F==/>Q:?JS6D?+IZ4PW1/O$>
MW'Y"W&,Q>F>3NDZYLN4FM[.#5>U:,IU/E^<G=UT16N)M;C?;'!X#-9*ZEDHC
MBCQU[><32U\1T<U2?J4/^^O@_P#B,\OL>7=<SVQO=SQN*LVG/L9IOL?16-;9
M+1M;9<N.E8B9M.;'CZ:Q-K1%?%JGFO*GO_@JVR;OCLV3;UB9F^'3-72/3:8Q
MS:U8CTS-ZUTCQGP\4D^.R./R^/L<MB;ZSRF*REG;9'&9/'7,%[C\CC[V"BYL
M[ZQO+:N6VN[.[MI:9(I8ZJJ)**N*J>>>.>.4;]QM]QM-Q?:;NE\6ZQ7M2]+U
MFMZ7K,Q:MJS$36U9B8M68B8F)B8U:_R8[XKVQ9:S7+69B8F-)B8\)B8GQB8G
MPF)]#^Q\7X                                                <Q
MWW>_Z2_S(_3#DOUJQ+TS?"+_ %:NSOQ/3]<R+$_*O^;SB?W)'^59&^D:S\
M     !:@^UA_=^\J?T/:;_GI*JU^E)_B#VK^.-Q^]H1K^)/_ &'QG[KR?K:[
M$I61!
M                                            <N'W-=HR&W^X?YL9
M;)0V<%Q:>3G<NKQT6,<T4-6/T?><SI>)FKIN+BYDYO+C%X"&2XJXJXHKN*JZ
MJ*(Z.::*?4'\,_%[?B/AZ[*VFVF]L=^V>.SS-IB9Z]SML>YR1&D5CIB^6T4C
M36*16)FTQ-IL@\N]M3:]A\/BQS,UGCL%_'Y<F.N2WHB/"+6F(^IIK,SXM&V\
M&9         -ZO;#U6XW'W$O"C$6UW#9R6?DMU%M54T]%<E%=OHNXXO=KNTI
MIC_5<37]KKU<$=7_ &:9)*>>?R<<M&?$WRN/A_AX[UW>6DWK?MK?X-(F(G7=
M;>^VK;Q]5;98M,>F8B8CQ89YC;FNT[#YC+:)F)X[/3P^7)CG'$_W)MK/U(=1
MAY?U<
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MBO:EM/&-:S,3I/YL/O. ^
M                                                        #GQ_
M<>V]Q![EFP2S030QWG3/4]Q:22Q5QT75O38Y6TJGMZZZ>*9X:;JUEBYJI^-/
M$D=5/Q^-//''H$^CFR8[_#9MZTM$VIS.^BT1,3-9ZL=M)^2>FU;:3XZ3$^B8
M3G\@;5GR]I$3$S&[S1/U)UK.D_W)B?S)A RG>W6        G@^W'_I,-7_0_
MVS^M-B@G](O_ %:MU^.-A^N6:6\_?YO,G[KP?Y4NA$\_""P
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M6 6?.[
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M6/\ &T^2=)\$A*/K!0
M  ',=]WO^DO\R/TPY+]:L2],WPB_U:NSOQ/3]<R+$_*O^;SB?W)'^59&^D:S
M\       !:R^U<P^3G[G\M\_%935X;&=8=<8>_R%/''T]KD\YM6>O<392\_'
MYN)K^UUZ]KCXXXYXYIMJ_C\/R?&JSZ4S>;:G9O:6PO>(WF7D]YDK3UVIBP8J
MY+1]2MLN.)^K>$9_B5RXXXGB\$S'O;;G+:(]<Q6E8M/]R;5U_-A=04OHB@
M
M                                    .4!Y;[1D-X\K/)O=<M#9V^5W
M#R$[HVC)V^.CGBQ\&0V#L?9,M>0V,5S<7=S%9Q7-W53%3)++731QQQ575S\>
M>?5EY2\7M^$\JNV>%VDWMM=GV_QV"DWF)O-,6SPXZS:8BL3:8K$VF*UB9UTB
M(\%FO:^VIL^V>.V>*9G%BV&WI$SZ9BN*E8UTB(UTCQTB/S&OC8+O0
M $HGLLZOD-P]T/Q!Q.,FLX+FTWS8-HDKOI)XH*L?H_7>Y[KEH:*K>WN9.;RX
MQ6OS1V]/-/%%=Q51377'1S573&#XS^4V_$?##W?N]S%[8[[#%@B*Q$SU[G=[
M?;8YG6:QTQ?+6;SKK%(M,1:8BLZX\W=S3:^7'*Y<D3-9P5IX?+DRX\=?3,>$
M6M$S]372)GP=+YYJU>@
M
M    "B']T-;W%/GGT[=U034VL_B+I%O#<U15\6\UQ:]R]\2W,$4W-/IR36\=
MY%5)3QSS513+1SSQQQ53\;U?HPLF.?(CF,46CWM>[MS,UUC6(MQW%Q69CTQ$
MS6T1/HF:SIZ)32^'&U9[*W==8ZHY3).GKTG!MM)_NZ3I^9*MRL>2
M   =7WQ'VC'[QXI>,>Z8F&\M\7M_CUTOM&-M\C'#%D(,?G^M]:RUG#?16UQ=
MV\5Y%;W=-,M,<LM%-?'/%-=7'PYY\IOFUQ>XX3S5[FX7=S2VZV?<'(X+S29F
MDWQ;S-CM-9F*S-9FLS69K69C36(GP5E=T;:^S[FY'9Y9B<N+?[BDS'HF:Y;U
MG36(G36/#6(_,;"M?.B
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MMNRL&QB8][N=_2-)B?K*4R7M,3'A$Q;W<>/IBTZ1ZXOG*(4*0
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M;3U=66=)UF/&9;4X?LWM7@-)X?C]I@R1Z+UQUG)_=R6B<D_W;-5VTF2@
M
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M[O'CKZ;UI[S''YN3%UX__P [Q;L-*L/
M            <VOWSNMK[K7W0/)B&X]:3'[MDM-[)P=Y/)9U5WECN6A:U?Y'
MY8;2:6NVAQNST9"QCIGICFKCM:9.:?DDHKJ]'_P.=R8.Y/AB[:OCTC<;+'N-
MGEK$6TK;;[K-6GC:(B9OAG%EF:S-8F\UUUK,18%Y,\A3D/+GCIKI[S#7)BM$
M:^$X\EXCT^G6G3:=-8UMIZ8F$2*6C:        "Z?]JYUM?8OIGRW[?D];\,
MWGL[K?K:TYJDL^;?Z[JK5<_L^1]**B:K(43?3]RVOJ52QT0U4_)Q%5753-Q1
M2_\ 2F=R8-UWEVEVA73YSL>,WF\MX6UZ=]GQ8::S,=$QKQU](K,VB=>J(B:3
M,1?B5Y"F3EN+XJ-/>8=MERSZ==,UZTCZGIP3II.OIUT\-;6:JQ&<
M
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MYVD"0
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M]6&];1C"P
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M.'VUHMM>-Q32?_C9)BV72==/9BN.D^&L6K:)U\-+"ZOAHD
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M
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M]Y7!,3LNN,6+328G'BCHK:)CT]<Q.3TSIU::Z1"0]'I@@
M
M                      #'O;FR9/3>J.SMOPM4-&9U7KW=-DQ-=Q#Q<6]&
M3P>MY+)V%4\%7/%,\--U:T<U4<\\<54_'C_RL@[2X[;<QW5QG$;V)G9[KD-M
MAR1$Z3T9<U*6TGU3TVG2?5+G\7M\>[Y/;;7-K[K+GQTMIX3I:\1.D_F2Y'[U
MIK0P         %@K[:;5;C8?<9R67ANX;>/1?'7L[:KN&6BNNN_M[S8>O](I
MM+>JC]3'-1=;E%/S55^I].&KC^SSPK_^DGY7'Q_PZXMI>DVMONXME@K,3&E9
MKBW>YZI^6.G;VKI'CK:)]$2T9\0FYK@[!KBF)F<V_P -(^I,5RY-9_N8YC\V
M87^%!B$
M                                                     "HA]UIA
M\G/B/!C/Q6<U>&QF2\CL/?Y"GCCZ>UR><M>C;W$V<O/Q^;B:_M=>O:Z....>
M.:;:OX_#\GQMQ^BKWFVIO.^=A>\1O,N/B,E:>NU,5N3KDM'U*VRXXGZMX2E^
M&?+CC+S."9CWMJ[6T1ZYBL[B+3_<FU=?S84[%P25H         #I5^R'M5QN
M/M9>(V7N;2&SDL]5WK5:88*ZY**[?1>W.P=)M+NJJ3]5Q-?VNO43R4_]FF22
MKCC\G'#S:?&UQ6/A_BC[MVF*\WK?=;;/K,1$Z[K8;3<VKX>JMLLUB?3,1$SX
MJ^/.';5VGF3RF*LS,3EQW\?ER8,628_N3;2/J0E717:T
M
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MO>]I]=KVF;6GUS,RKRSY\VZSWW.XM-]QDO-K6GQFUK3K:9GY9F9F7V'#?(
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M>Q> F+\=QNV]]$?7Y(G-?QC29BV6;S76-8GITC29C33P1^M_LX
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M7RW;/</ VFO,[+=;:-?3DQWK6?S+S'3;\VLS#/S 71@
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M"6[<XW)/W^WU-)FLZ3AP3K%KS,>,6R:3CI'AX3>^L36L6OV*$D(@
M
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MII;JUK';XD=UT=K;'9=/ZIR'7KKZ/=X<E=--/'7WFNNOAT^B=?"\DH_0V
M
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M(FG
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M?=4ZLGZ&8C2GC/LQXS$3,-T;]LIYK[Y^'9#NGL#I_H/#W/TGU^,_$[_M/?\
M&^M^$3W7_J/4XK/1;SZ.UO+J/]1M''J7MGZ?'][RT7?$/^^/I,/);@?>;?LO
MC^8Y[>5ZNB_178[6^GO(K]ESS;<UZK5I/CLO#'DZI^R4G$U3S/Q$=H;+JQ\1
M@W>^RQKI.D8<4_7:>U?7)&LQ6?U'PK;7ZZ)JF-Z$^V=\(NO(K6\[NW#M3R(S
M<?TOUEE<Y;]JK1;GTK2VIN?1P.D756Z6OU60IGDX^.S2^G!7'%Q\:XZYYH>=
M^?25^=G<-K8>R=GQ7;VRGJZ;1C^?;J-;6Z=<NYK\WMTTZ8_^3KK:+6^MM%*:
MHYOXAN\=_,TX?%MMAA\=)BOOLD>,Z>UDCW<Z1I'ZE&LZSZ)B(F-Z1\'?#_QP
M^CFZ2\;>G^OLK8_)]/L^)TG#W.[?VKX>E]1O66M\AN5YZ7/QYH]:^K^6KGGG
MCX<U<\\P][V\[_-[S&ZZ=[=R<QR&UOKKAR;G)7;>/ITVN.:;>NOKZ<4:QI$^
M$0U1S'>7=7/ZQS'(;O/CGTTMDM&/^YCK,8X_N5;4-6,: :?^X7_P"><7_)_Y
M+_[%]U;>^'S^?OL?_P W\-_O';,J[$_COPWXUVG[XQN5Z]2JR@        !T
M@?82_HG/%+_OT_\ $GW$\Y/QY?UKNZO^S/\ <_'H!>=G\YW)_P#1_P!Z8$P*
M(3536_NGP\\5?(OUY>\O'CI_L_(S^G_[0;7H6NW^VV_I?A5/]X;A]#'M.-]6
M#!VD$OT]Y%ZUM;T02?-#Q\C8_9?G!YI^7?37L?N'F.,V]=?L6#=9J8)UZ_K]
MOU3@OI.7):O7CMTWO-ZZ7GJ9!Q'=?<O :1PV_P!WML<?H:9+12?KO3CUZ)\;
M6F-:SI,S,>/BAL[U^VE\#^Q:[K(=/9[MKQXR=<,45EBL%LU79&C6]=%O'%7<
M7.(['_&-VNYIIH_5JXIV2&/BJ2OBFGBGY*8YB]C?24>>W;M:[?N_!Q/<.VB9
MFU\N'YGN9B9F8BN39^[VU8B)Z8UV=ITB)F9GJFVV.%^(3O781&/E:;7?X]?&
MUJ>ZR3X^B+8NG''R?J4SX1X^G6'CN[[8?S TKZR^Z2[;Z?[PQ5O\_P!/C\M5
MF.IMVO\ ^SS%]/A\M3L^FQ?-QQSQ7ZVQ1_+5SQQQ\W'QJIF!V3])MY0\UT8.
M]N)YC@]U;36^/W>_VU?EUR8_<[B?J=.TG6-==)TB=K</\1?:N\TIS&UW>SR3
MZ9KTY\<?FVKT9/\ DQ3_ '$.???MX^;OC'%=7G=WC-VIIV$L?JOK-LML#^=V
MBVWT5I<Y"Y];?M(GV32X_2Q]C/<<_&__ "P022<?&B.NJF8?8?Q"^2?F;:N'
MLGN;BMYO;]/3@G+\WW5NJU:5TVNYC#N)UO:M/U+ZZU:_76B)VOPG?G9W<4Q3
MA^1VV7-;32DVZ,DZS$1]BR13)Z9B/K?3,1Z9AIFW(RT
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MX3F>%R>ZY?:;G:Y-=-,N.^/7\SJB-?J3&L3'C'@RTQ-U8
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MX0
M                                        ",;WF<_B=;]L/S!R.:N_
MHK.XZWQ^ AF]"YN/GRVU[KJNKX"T].TAGEI^OSN8MH/4YIXBB]3YY*J(Z:JZ
M9,_!OL-WR7Q-]H;?94Z\U>2OEF-:Q]CP;;/GRVUM,1[.+'>VFO5;3IK$VF(G
M8OE+@R[CS&XK'AC6\;B;>F(]FF.][3XZ>BM9G3TSII&LZ0YFSTM+#0
M   %N/[4[6\9=;/YN[?+1-SF<'@?'_6["NF;FFWIQFU9#N')Y:B6#X?+)-7=
M:;9<QU\\_&BFFOCC_M\JE/I4N1W.+C.R>(I,?,\^?E<UHT\>O!3CZ8])]4=.
MXR:QZYF/D1=^)?<9*[;A]K&GNKWW-Y^76D8(KX_F9+:_W/D7'U.Z)X
M
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MTQZ-%D%7(T
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M-M2F/#772M8BM8UG6=(C2(UF9F?JSJ^0Y;Z@
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MQKT5R5]YIIKK..=,D>&OIK'HGY):NMGLC
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M9Z;9+:HY?X;-C?6_ \GEQ_)3<8ZY-?K?^<Q^[TT]J?U*VOLU\-)M,QO1/O\
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M/!J_?<;R/%YOF_)[?/M]Q_>Y:6QV_P#9O$3_ .A[QT+A
M           ,;]L=.]5=[:3D^N.YNO-/[/T7+_+7?:ONV QVPXFJYCCECMLE
M;6^1@F_#\QC_ %ZJK6]M^8KNTEY]2&2.OCBKC(^U.\.ZNQ>:Q=Q]F\CO.,YS
M#];GVV6^+)TS,3:EII,=>.^D1?'?JQY*^S>MJS,.PXSE>3X7>5Y#B<^7;;VG
MHOCM-;:>N)F)\:S^BK.M;1X3$PK3>5/VP?3NXY#-;1XC]R9CIRXNOA<V'5O9
M5G?]@:';W-4_R5X[$;O'?1[[KV'BM.>*Z*LA'LUWS-15Q5+\DM/H63^5GTG'
M>'#[?#Q?FUPV'F,=?9OO=G:NUW4QIX7R;::SM<N2;>$QBG98^F8F*ZUGKD)V
MU\1G+;2E-MW1M*;NL>$YL4QBR3'RVQZ>ZM;7^]G#73U:QXPP=A_;O>Z!I63H
ML-;ZMZ][=M:IKN+G-=>=PZ%C,9'1;<6O,-Q7%VQE>L,SS#D.;BOB'BFTJDIY
M@K]6F/CF/F29G;WTA?PQ<UMIS\ERG(<1EB*S[O=\?NKWF9ZM8UV--[CUII'5
MKDB)ZJ],V]KIVWL//CRYWF/KW&YS[6VD>SEP9)GQU\/L-<U?#3Q]K3QC29\=
M,5VGL3^ZU>WV5QT/B;DJ+C#36L%Y)=]M]"6%C-7>64-_#5BLI?\ :EMC,]#1
M!/33+)8S7$<$W%4,M5$M%=%.4Y?CH^%7#@Q;B_=F.<>:+36*[#E+VB*VFL^\
MI78S?%.L3-8RUI-JZ7K$TF+3V=O.CRSI2N2>4KTWB9C3!N9GPG3VHC#,U^I%
MHB9CQC6)B6U'3OVU'N ;[7;W/9F5Z9Z)QG,,<MY;;+NLN[[3'7/;Y"JBWL<5
MUQCMEUJ\FM;NU@HN>9<U;1T17/%<-5Q517%QJWO#Z2;R"X&ML?;.+F>=W.LQ
M6<.VC;8)B)IK-K[R^'-6+5M::=.VO,VI-;QCBU;3C7+?$)V/LHFO'5W>]R:^
M$TQ^[IX3'C-LLTO&L3.FF.9UC28KK$K!?AU]OAX4^,F6P&\=D49CR@[*P7RW
M-M?=F8^PL.L[/+?30P59+'=2V<N1Q=YZ5?$U=O#G+[.Q6]<M,E/'U$,,]%?W
MG#]('YT^9FTW'"=N3A[8[;S^S-=G>UMY;'U3/1??VBEZZQTQ>VVQ[6UXK-9^
MQWO2VC.Z_/3N_N+%?9\?T<;Q]_"8PS,YIKKZ)SSI:/5K..N.9TTGV9F)G;M[
M>WL[>"TM((;6UM88K>VMK>*B"WM[>"BF*&""&*FF.&&&.GBFFFGCBFFGCCCC
MCX(+9,F3-DMERVFV6TS-K3,S,S,ZS,S/C,S/C,SXS+2UK6O:;6F9M,ZS,^F9
M^67[/P_@
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MJR1J
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MC3\R5LM5 C$
M
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M3;+:9FUIF9F9F=9F9GQF9GQF9\9E@UK6O:;6F9M,ZS,^F9^67[/P_@
M #3_ -PO_@$\XO\ D_\ )?\ V+[JV]\/G\_?8_\ YOX;_>.V95V)_'?AOQKM
M/WQC<KUZE5E         #I ^PE_1.>*7_?I_XD^XGG)^/+^M=W5_V9_N?CT
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M:[+HVU;)IFQV7Q^CS^IYS)Z[F[3XU45\_2Y7#W5G?6_QKCIY_42<?EIXY_\
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M4R5K:/1/ICU-:;K:;K99IV^]Q9,.XCTUO6:6C\VMHB8_Y'I'6N.
M
M
M  KN?<V;'D\'[>FEXRPJAIM=Q\HNN-<S7$L/$E=>,M>ONW=NBIMZ^>>.;>;C
M,ZK:5<U\?'GF/BJG^Q5RL,^C.X[;;[X@][N<\3[W9]K[S-CTG2(O;=[#;SK\
ML>[SY(T^72?4WQ\.^WQYN^\V2^O5BXW+>OYLY<%/'Y?9O;^[I*A OG3:
M      7W_MD]<R>#]O3=,G?TPTVNX^478^QX7F*;B2NO&6O7W46HRU7%''''
M-O-QF=5NZ>*.?CSS'Q35_8JX4,?28\CMM]\0>RVV"9][L^U]GAR:QI$7MN]_
MN(T^6/=Y\<Z_+K'J0E^(C<8\W?>''37JQ<;BI;\V<N>_A\OLWK_=UA8C5YM#
M@
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MJ(X
M
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M'%CICKZ9GT4BL>FTS^;,SZY8W9&YX
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M9F9F=9F9\9F9GQF9GQF9]+^Q\7X            :?^X7_P  GG%_R?\ DO\
M[%]U;>^'S^?OL?\ \W\-_O';,J[$_COPWXUVG[XQN5Z]2JR@        !T@?
M82_HG/%+_OT_\2?<3SD_'E_6N[J_[,_W/QZ 7G9_.=R?_1_WI@3 HA-5
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MVI>L_):MHBU9^I,1+767#EP9)PYZVIEK.DUM$Q,3\DQ/C#Z3C/F
M
M                                                          J@
M?=3['C+7JGP^U&6N;C,YSL+M;8["BF'FJWJQFJZWI^,RU<L_Q^6.:BZW&RXH
MHYX^-=-5?/'_ &.5K/T67';G+W5W?R](CYG@X_8X;3KX]>?-N+X](]<=.WR:
MSZIB/E2;^&K;Y+<GRNZC3W5,&&D_+K>]YKX?F8[:_P!SY5+Q<TEN
M  Z*_P!OCJMOKWM9]&Y>&[FN)-ZVKNC:KN&6BBFBPN+/MS<=(IM+>JC]5)#7
M:Z;%/S55^J]2:KC^QQP\[WT@7*Y.0^*/G-I>D5KL=KQV"LQ,ZVBVPV^YZI^2
M>K<6KI'AI6)],R@7YZ;FV?S)WN*8B(PXMO2/JQ.#'DUG^[DF/S(A-6A:U"
M
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M:?)K/J:'^(C;Y,W8F')33IQ<EBO;\R<6>GA\OM7K_<UE?@4,(2@
M
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MYQQFXP;C;_WV*]<E?_:I,Q_Z7@W>N:
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MBT3I,3Z8GY)?L_#^
M
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M*U]F(5U^:6YC=>87+98O-]-W:FLS,Z>[B,?3X_WG3T1'HB*Z1X0D;1T8"
M
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MU;1,36T3,3$Q,3HM,QY*9:5RXK1;%:(F)B=8F)\8F)CPF)CQB8]+^-]GZ
M      3/?;]['D\'[J?CWC+"J&FUW' ]UZYFN)8>)*Z\9:])[_MT5-O7SSQS
M;S<9G5;2KFOCX\\Q\54_V*N4-/C^X[;;[X6>X-SGB?>[//QN;'I.D1>W);7;
MSK\L>[SY(T^72?4U)YY;?'F\M-]DOKU8K[>]?S9W&*GC\OLWM_=TET9'G70(
M
M
M  :3]V^Y!X)>.OU</;OE/T_KV4L/4^MUC$[/#O.[6GI_'X_4:+H,>T;C%\U5
M//%'QL>/GJIYXI^//'/'&ZNR?AR\]/,3HOVCVMS&XVN33IS9,,[;;6U^3=;J
M<.WGZOV7PB8F=(F&8</V!WISVD\7QN[R8[>B]J>[QS^9DR]&/_\ .\$/'>OW
M/7B/I-%U9=$=/]M=[9FWFBIBOL[+BNG=&O;>JXCHFEMLYDH=QW.B:.V^>2F.
M;6H::JN**?GI^:JJ.8'8WT9'FWS=JYN^N7XG@MG:)UKBB_(;FLZ3,1;%2=OM
M])G2)FN\M,1K.DZ1%MK<+\.G=.\F+\UN]KLL4QZ*]6?)$Z>NL>[Q^G2-8RSZ
MYT\(UAL[I^Y2]P/L/UK3J^SZ?Z QW'I_1WNIZ31O.V4__8J6X^ORG:-UMNK7
M?QGLKBB+T<':^G;7M=%?JS1Q7%$QNR_HV_(#M[IS=T7YCG]QX]5<^YG;8/T<
M1T4V5<&>OA:DVZMS?6^.)CII:^.=L<1\/G8VPTMR4[O?9/7%\GNZ?HM-(PQ2
M\>$QKKDG6:Q,:1,UF'GN[RZ\HO)*NG]OCR [:[5LHIJ;BTP>X;QG\IJV-N*;
M>QMJI\/J5=[3K&&FN*,;!5-5:6D-4\L?$LG-4G/-?,O^R?*/RO\ +>O_ /8G
M <3Q6:8TMEV^VQ4SWC6TZ9,_3[[)$3>T5B^2T5K/372ND-K</VMVWV_'_P!E
MV.UVUYC2;8\=8O,:S.EKZ==M-9TZK3I$Z1I'@UU;$=\
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MYXI?]^G_ (D^XGG)^/+^M=W5_P!F?[GX] +SL_G.Y/\ Z/\ O3 F!1":J
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MKCCTVI7WU(^MTUR89R4C6;1$:V\9UB/&)B-\6B6%
M
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M72-?D;(-<,?
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MQ@
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MVP9(TTO%(MD\(B(^RWZLD^CUV].L^F9F=2VV&3@
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M%8TU;R'+<KR^7W_*[G<;K-'Z++DODMZ(CTWFT^BL1^9$1ZH9(8XZ\
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M<5==;]$WQ1IU:_9:=6/T5M/UWUL=7UNDMP6H6*@
M
M                                  .<3[^.WS;9[J'D?;\9FSS.+U"S
MZCU#"U6-6/F@QD-ATWH62SF&KN;"CCF>\QVXY?)TW'$]<EQ;W'-<%7-/$5,=
M'HQ^ OB*<3\+7;F3W-\.ZWE]_N,G5UQ-YMR&ZIBR1%O16^WQX9ITQ%+4Z<D:
MS>;6GWY);6-KY:\?;HFF7+.>]M=?'7/DBMM)]$3CK3332)C2WKUF'-,)M<
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M,SXS,S/C,S/C,SZ7]CXOP
M
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MQVKT_P!W73^ZZT;R=JP@
M
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M;8X7R^[*[?B/O5QNUIDB?"]J^]R1XZ^&7+-\D?F=6GH^2&D+=K,0
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MDS$3X^#9!KACX
M
M    #ES^YYM5QN/N)>:^7N;2&SDL_);MW5:88*ZY**[?1=QRFDVEW55)^JXF
MO[77J)Y*?^S3))5QQ^3CAZ@/ADXK'P_P\=E;3%>;UOVUL,^LQ$3KNMO3<VKX
M>JMLLUB?3,1$SXK'_+G;5VG8?#XJS,Q/'8+^/RY,<9)C^Y-M(^I#15O-F8
M      #9;POU6WWKS$\3](N[N:PM=R\ENB=5N;ZWHHDN+.WV'M'5L1-=P1R_
MVN2:WCO.:Z::OU/-7'''/Y&MO.;E<G!>3_=?-XJ1DR[/MKD\]:S,Q%IQ;+/D
MBLS'C$3-=)F/'1CW=VYMLNU.3WE8BUL7';F\1/HF:X;VTG\W1U;'E55G
M
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MCQ\/'PCQ]4,A,?<
M
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MPB&=5K6E8K6(BL1I$1Z(CY(?B_;^@
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MQZ]$>-:S.E8UF(F?'Q;(-<,?                                :?\
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MG2M+V]UDM/CX5QYHI>?K9GPK/AI/HF)G15O-F8
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MI$^F/9M:(K:)Z;:369B=)F)F(9L84Z<
M
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M<>.OIF/"+6B9^IKI$SX.E\\U:O0
M
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MEYR:>F?K>O37UZ:Z1KI&^+1+"@
M
M          '@^PNT^L.I,)5LO:W8^A]9:Y1ZGS9_L+;]>TO"4^C337-\V5V3
M(XVQX]*BKCFK^V?J>.>.>7?=O]K=S]V[W[V]J\=O^3Y&=/L6TV^7<9/'T>QA
MI>WCZO#Q<W8\;R/*9OF_&;?/N-Q_>XJ6R6_]FD3/_H1%=T_<%>VAU!ZUMA^S
M]P[PS%MZ?U&&Z6T#+9;Y/6_"I(?1V7>9M T7(?-:Y.J6KZ7+3^E])/%)\EQQ
M'#)+;LOZ/_XE>[NG)O.+V?";.VNF3D=UCQZZ=<3KAVT;K<T]JD5CKP5ZO>4O
M7JQS:]=I<1Y&>8?*Z6R[;%L\4^BVXRUK_??H,?O<D>,:>-(UZJS&M=9B'[NG
M[I[?[SUK/QV\5M/UWT_3^GV/NG<LUN?UGS_A4LOK:7HT6A?AOT_RWT%/RY^[
M];YX)^?2^22WDE[V7]%MP&'IS>8?=6\W&NNN'CMOCV_3]?$:;G<SNNO7[':=
M=K3ITOC]KJKDKM7B/ALV--+\]R>7)\M-OCKCT^N_YS)[S77V9_4JZ>U7QUBT
M0S]V^\A[DG?/U=MM'E)OFIX6Z^>.G7^HN<=U#CX+27X^I85WW7ME@-CREG+Q
M5537Q?WUW5)15S155S1\*>)D]D_!W\.'8?1DXOM?8;O>TTGWN_Z]_>;1Z+].
M[MEPTM'A,>ZQ8XB8ZHB+>+;7#^4_E_PFEMMQN#+FC]%GUSSK\NF6;4B?\6M=
M/3'BC9S&9R^PY.\S6?RN2SF9R,W-QD,MF+ZZR>3O[CGCBGF>\O[V6>ZNIN::
M>..:JZZJOAQ_920V>SV?'[:FRV&+'@V>.-*8\=:TI6/DK6L16L?4B(AL#%AQ
M8,<8<%:TQ5C2*UB(B(^2(CPA\UR7T
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MV*G3C]%K1];];/3];I#<%J%BH
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MVFE.N*99UZ=/L5^G)Z;5CZWZZ>GZ[6&G[;S*@
M            ']F.R.0Q&0L<MB;Z\Q>4Q=Y;9'&Y+'7,UED,=D+*:BYL[ZQO
M+:N*XM+RTN(J9(I8ZJ:XZZ>*J>>.>..7QW&WV^[V]]INZ4R[7+2U+TO6+4O2
MT3%JVK,3%JVB9BU9B8F)F)C1^<F.F6EL66L6Q6B8F)C6)B?"8F)\)B8\)B?2
MD:Z&]WGW%O'>NP@TKRA["V/ 8^&BSAU+M>]C[<URC&16^-M;?$V,'8,6?R&
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M<T_H<N.^.WHB?1>*SZ+1/YDQ/KADACCKP
M
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M9TIY_;R-MY>WPS>:_.-WAQZ>/M:3;+TSX>'ZEU>.D:UB-=9B)Z#CS]H,
M
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MM2;3/U?E32H8-1
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M1OX>NV>O#V[?E>X-W&L1\UVTX</5']]EWL[>W3ZNO'BRQ/A-8FL]35?,>?\
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M+@W,>FF2EJ6C29B=:VB)],3'H],3'IA[!T[B
M
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M#T
M                                                 !6X^Y]TBC-^
M#74^ZVV(FO<GHWDMK$%SE8IKCBC"ZMM?7?9-CE:KBVXN*+22'(;+882+B2N.
MN6.3Y::*J*9)?FL>^C'YNVR\\>5X7)FBFVWW;6:8I,1KDSX-WL[4TG3JB:8;
M;FVD3%9C6;1,UKI(#X<]Y.'O/=;.UXC'FXZ\Q7P]J],N*:Z3IKX4G).FL1,:
MZZS$*(B]5-(         !>I^UZWG\8\+>ZM!N+C,7-YI'DAE\Q;?6R^MB;#
M;IUUU_\ 0XO"_/=RRVOR9W6LI=W,%,,4'$MYQ+357)+-\M&?TGG!_,_.?A>>
MQUPUP[WMS'CMTQIDMEV^[W75?)I6(M]BS8,=+3:UNG'TS%:TIK#'XCME[KN[
M9[ZL4BF;CZUG3ZZ;8\N76;>'C[-Z5B=9G2NGA$1K995L(]@
M
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MX-OM_P"]Q4KCK_[-(B/_ $/!N]<T
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MQF9\9E@5K6O:;6F9M,ZS,^F9^67[/P_@
M              #3_P!PO_@$\XO^3_R7_P!B^ZMO?#Y_/WV/_P";^&_WCMF5
M=B?QWX;\:[3]\8W*]>I590         Z0/L)?T3GBE_WZ?\ B3[B><GX\OZU
MW=7_ &9_N?CT O.S^<[D_P#H_P"],"8%$)JH
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M
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M5:_53(R
M                                                       (<O?O
MT3\^/:V\B)X+"\R.5T>\ZMWO%16<OR>A^$=J:=C\_?W4?//'$]GCM-R^3FKI
MYY_4_)Q7Q\>:>..9A_ 9SOWD^*+MZF3)3'M=]3>[6\VC77WFQW%\5:SZK7W&
M/#6)^KIZ)U;7\DM[\S\R-A%K17%FC-CMK_A8<DUB/DF<E:1_=T];G%/1@GV
M         MT?:I[SZ&P>9_6ES<9B;\3P_2F\X:T]7U,!C_P.][(P&RW'H27?
M'TN8R_YPXFGYXH*OJ(+'X2R4^C#354C]*AP?7L.S.Y<=<,>ZS<EMLEM-,M_>
MUV>7#&L5]K'C]UGG2UHZ+9?8K/7>8BW\2VRUP<1R%8I'3?<8[3^BGJC%:D:Z
M>-:]-_3/A-O"/&5QI3TBB
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M9QM>/X;%%;:1[S+,1.7+;UVO;TSK/C%8TI7T5K$-/VWF5
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M2UKWM/RVM:9M:?JS,RUYES9<^2<V>UKY;3K-K3,S,_+,SXR^DXSY@
M                                       -/_<+_P" 3SB_Y/\ R7_V
M+[JV]\/G\_?8_P#YOX;_ 'CMF5=B?QWX;\:[3]\8W*]>I590         Z0/
ML)?T3GBE_P!^G_B3[B><GX\OZUW=7_9G^Y^/0"\[/YSN3_Z/^],"8%$)JH
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M&;;9H]K%DC2-8\<>2(]WFQY<4VQVQWN?M3@^[^-GC.=P1EP>,UM'ADQV_O\
M'>/&MH_NUM'LWK:LS6>A1[9ONC=.>X_UW?WN!M(>N^[=,AID[)Z7R&9CRN1Q
M=C)<TVUEN&J9.JSQ<FTZ3D9)(XZ[FFVBFQU[7Q;74=/SVL]WY]/B6^%_O'X<
MNX<>'?WGD>R=[.FSY&F.:4O:(ZK;?/3JO&#<TB)F*3>U<V./>8K3TY:8H*^8
M?EORW8&_K3/,Y^'S3]BW$5Z8M.FLTO&L]&2/&=-9B]?:K,Z6BLGR,;7(
M
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M_$'N_G/?T8?#_1]AAQ^$_+;)E\?DG[)Z/DTGUK J +1H
M
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M$^K6;5M/JGICUQ"_ H80E
M                                                         8K[
MP[GZ^\=^H^P.[NU,Q^ ]?]::W?;/LN1HBYN;GZ2TXIH@L,;:<5457^8R]_-%
M:65O3SQ5<7<\<5//QKX93V1V9W!YA]V\?V3VMA]_S_);FN'#372O5;QFU[?H
M<>.L6R9+SX4QUM:?"'9\-Q&^Y[E,'#\;3KWVXR12D>B-9],S/JK6-;6GU5B9
M]3F"^;?F+VAYU>0VX>0':<WTUYF?3PNG:E;WLU]A^NNOL7=7LVM:+@II8K;U
M+/%_7SSW$_$,'UV2NKJ\KCHDN*Z>/3EY)^3W:_D9Y>[/L#M:.K#AUR;C/-8K
MDW>[O6L9MSEB)G2U^FM:5ZK>ZPTQ88M-<<2L8[/[4XWLS@L7!\;&M*>UDO,:
M6RY9B.O);T^,Z1$1K/32*TB9BL-2VV&3@
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M_1_WI@3 HA-5
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M;UGQI>O^#>LQ:NNDQ$Z6B+1,1GY@+HP
M
M    %)'[IO>_Q#R.\7^LOK[R3\T.D]DWO\+KC^&/L_VQM[N]?^OMIOA_;+S)
M?M6^G/3_ .91:P\_^<NO^BWX+YOY==S]S>[I'SOF\.UZXGV[?--K7+TVCU5I
M\]UK/KF]_D3!^&S9>[X#DN1Z8^R[RF/7US[K'%M)^I'OM8_QI5:UHB2(
M     #I>^RSIOYB>UYX@X3Y[R3Z[0]AW+YKZW^FGX_;%[%W/L'Y*(_A3\UG%
M^<_RV\G_ -]M^**_R_-\7FK^,_F?O[\3W=^]TI'1O\6W]F>J/]$VFWVFLS_?
M3[G6\?H;]5?4KT\W=W\]\Q^5S>'LYZX_"=?U+%CQ?\OL>,>J=82BHP-<
M
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MZ5CS:*^
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MV\U[V\?7X^+66^Y+D>4S?..3W&?<;C^^RWMDM_[5YF?_ $O>.A<(
M                                              !I_P"X7_P"><7_
M "?^2_\ L7W5M[X?/Y^^Q_\ S?PW^\=LRKL3^._#?C7:?OC&Y7KU*K*
M    '2!]A+^B<\4O^_3_ ,2?<3SD_'E_6N[J_P"S/]S\>@%YV?SG<G_T?]Z8
M$P*(350
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M6B:SI/A:)B?&);)P9\&YQ1GVUZ9,-M=+5F+5G2=)TF-8G28F)^K&CY#EOJ
M                           MQ_:\^5%Q:;'WIX;[#?P_A^8QM'>W6E%W
MD*X:XLQBY<1J78V$Q]K<R5P7LV5QEWB,A'#;^G+%'C;V:JF6BJJJ"I3Z3WRL
MQY>.X/SBX_'/SC#DGC-Y-:1,3CO&3/M,E[1&M8I>NXQ3:^M;3FPTB:3$1DB[
M\1W;5;;?9=V8*S[REOFV72/T,]5\5IF/&.F8O69G6)F](C2?"UQ]3NB>
M
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MS\P%T8
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MVXV.?''3&MM;XKU]F/7/CX1ZY=81Y2E9
M
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MX-7\GS?,\UD][R^[W.ZR:ZZY<E\FGYG5,Z?4B-(B/"/!EIB;JP
M                                                &G_N%_\  )YQ
M?\G_ )+_ .Q?=6WOA\_G[['_ /-_#?[QVS*NQ/X[\-^-=I^^,;E>O4JLH
M      =('V$OZ)SQ2_[]/_$GW$\Y/QY?UKNZO^S/]S\>@%YV?SG<G_T?]Z8$
MP*(350
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M)B=&P<>2F6E<N*T6Q6B)B8G6)B?&)B8\)B8\8F/2_C?9^@
M          $F7LX]GU=2^YEXA[%S>0VEOG^SJ.L+GBYAR=S:W=/<&"S/5MI9
MRVV*DCGKFER>W0<VU<GQMK>\IAGGXYBBK1I^,3MB.[/AI[NXZ*3?)M^,^>UZ
M9I6U?O?EQ[VUHF\3$1%-O;KB/;OCF]*3UVAKSS8X[[Z>7G*X-)FU-M[Z--(F
M/<6KFF=;?4I.NGC-=:U\9ATT'FB5X
M
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MQ&WVV3+K;7ICW=+7]K32=/#QTF)T=;5Y,E7P
M
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M9:8FZL
M                                        !S'?=[_I+_,C],.2_6K$
MO3-\(O\ 5J[._$]/US(L3\J_YO.)_<D?Y5D;Z1K/P
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M-6K.6[F[AYZTVYG>[K<QKZ,F2]JQ^929Z:_F5B(9^8"Z,
M                                               !I_[A?_ )YQ?\
MG_DO_L7W5M[X?/Y^^Q__ #?PW^\=LRKL3^._#?C7:?OC&Y7KU*K*
M '2!]A+^B<\4O^_3_P 2?<3SD_'E_6N[J_[,_P!S\>@%YV?SG<G_ -'_ 'I@
M3 HA-5
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MO*XM[7!;):/DQQ>)TF:S-?%M3A_,SL3G=*[#D]M&6WHIEM.&^OR17-%)M/\
MBZ_+&L>*/=()G0                     #<#V]/^/OP=_YP/&C_;1I34/Q
M!_S"=\?^4.9_W=N6*]]_Q(YG\5;O][Y'5">6I6N
M
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M53IZZX!YJ;[[W^7G+9^KHZMI.+737]6M7#TZ:3]=[SIU]6NNL::QTXGF95V
M
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M\KMXBL=6YC+[.NGV:E,WKT\9]YK;U=6NFL>*3-&EKP
M
M                !SL_N$.G:^J?<S[.S<5O#:8GN[2>N.XL+;01V\=%%%[@
MN>O=AN*N8<A>S239/=NNLK=R531VLGJ3U<<1<Q<1S2^ASZ/SO"O=7PT\9LK6
MF^[X3>[SC\EIF9G6N7YWBCQI6(BFVW>#'$5F\:5C6_5U4I/+R+Y:.3\O-MAF
M9G+L\V7!:9U]5O>UCT1Z,>6E8TFT:1Z==8B$E-=N                  !N
M!T;[?_FMY)?AT_2WC'W!N>'ROTGT&W?FA?Z[H$_UWX17:_\ O$VNG!:+%ZMK
MG;6Y_5Y&GY;*7ZGGX6]-<M.H>^//[R6\M_>4[T[FX?9;S%U=>#YQ7-NHZ?>=
M7^B8/>[F=+8KT\,4ZY*^ZC[),5G%>9[X[0[?ZHY?D=IARUUUIUQ?+&G5K]BI
MU9/36T?6_71T_7:0F&Z&^V2\S]^KL+_O+L7J7Q^P=Q#15>X^"\O.V^PL=<26
M^-N>(^=?U>3$Z'=0Q?5SP25Q[7\W%S:U<445P21S\P_[[^DQ\FN KDP=C\=R
MW<&^K/LWFM=AM+Q$WC7WN>,FZK,]-;1$['3HO&LUO6V.-4\W\1/:6QBU.&V^
MZWV:)\)F(P8IC68^NOU9(]$3$3A]%O&8F)JF3Z1^V@\$NO\ Z.^[=V?N#OW*
MQ_)]=C\MLL/7.DW7R?#GGZ?#Z#!C]RL_5YYYXK^.Q2_J?AQ3\O/'-54.>]OI
M*O/3G^O!VCMN'X#:SKTWQX9W>YKK\N3=3?;VT]7^B5\===8TB-3\Q\0O>F^U
MIQ>/:;''ZIK3WN2/S;99G'/VJ$P/2/@[X?\ CA]'-TEXV]/]?96Q^3Z?9\3I
M.'N=V_M7P]+ZC>LM;Y#<KSTN?CS1ZU]7\M7///'PYJYYYB'WMYW^;WF-UT[V
M[DYCD-K?77#DW.2NV\?3IM<<TV]=?7TXHUC2)\(AJKF.\NZN?UCF.0W>?'/I
MI;):,?\ <QUF,<?W*MJ&K&-
M                              -/_<+_ . 3SB_Y/_)?_8ONK;WP^?S]
M]C_^;^&_WCMF5=B?QWX;\:[3]\8W*]>I590         Z0/L)?T3GBE_WZ?^
M)/N)YR?CR_K7=U?]F?[GX] +SL_G.Y/_ */^],"8%$)JH
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MRU.)\O.0O-IC+N*5P4B)FLVG+:*VC6(G_F^NTQ.D6K6:S/BZ4#S=*^P
M
M                           &EGN.=@5]7^!'F'NMO/DK7(8[QU[7QV$O
M<31;UWV/V/9M0RFKZUDH^+J>"*F'&Y_,VT\U7QJKHACKJHHDKXICJW/\.G 5
M[G\^>S^%R5QWV^3N+8WR5R:Q6^'#N*9LU)Z8F=;XL=ZUCPB;3$3:L3-HR[L'
M8QR7>W%;.T5G';?X9M%M=)I2\7O'AKZ:UF(^K,:S$>+EH/48LD
M3Y?;<]?T;E[DUAL=4&-EJZFZ-[4[ CDOJ[BFZMJ\E5K?5?,^&IA@ECDR54?9
M=4=7$M44?T<D_/%7-?%%%<"OI'N?MPWPWY..BV2(Y;G-CM9BNG3:*>^WVF36
M8F*:[.)CIBT^\BD:=,VF-)?$!OIVGE];;Q-H^=;W#B\--)TZ\WM?4^PZ^&L]
M45]6LQT$% *#0
M
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MM#@
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MOOSO'N*)IS'([G+AMKK2+=&.=8F)^Q8XIC]$S'UOHF8]$RW-:;8D
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M]/\ Q)]Q/.3\>7]:[NK_ +,_W/QZ 7G9_.=R?_1_WI@3 HA-5
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MN<D?\N+#,3K_ /'B=8^32?3"X"J%16
M
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MQ7%Q,3:^7-EF.KQB*5I2NM?\+WENFTZ?6VB-=9TN6*<430
M
M                                   $#'W'O7M>Z>VGG]DHLIKNGJ/N
M;JCL*6>*]M[6C&49*]RW5'%[<032QR9*&27LZFVXABXDDIDN*9N:?DBKJIG?
M]'-W#7A?B3V_&S>*3R_#;[:1$UFTWFE<>^Z8F(F*3$;*;]5M(F*337JM6)W7
MY [^-IYA4V\S$?.MIFQ::3.ND5S:1/J_4==9TC2)CTS$.?(] B<X
M "WI]JOV/-1D/,7J*ZEO);>XL^HNQ\##1:8_C'V4UG/N^L[;+<W_ !5'E*[S
M*47V%X@AYXFMZ:+.:KCF&NKGUZC/I3NW*3M^S^[L44C)6^_V>69M?KM%HVV;
M!%:^-.FDUW/5;V;S.2D3UQ$=$6?B6X^)IQ/*5B(M$Y\5O&=9U]W>FD?6Z1ID
MUGPGVH],>BX<I_13
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M<X_3$Q$TPQ2MM)B-)M%IB8UUUUEOZT&P<
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MFT]J!K28                #3_W"_\ @$\XO^3_ ,E_]B^ZMO?#Y_/WV/\
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M9B=)C76)AFQA3IP
M    &C7>WMH^!GDI++=]P^+?5>?R]Q\WU6S8#$7776XWOSW=G?<_7;IUK?:C
MM=]\MQ8T_+ZUY7\L<DT?'PCN)Z9-X=B_$IY[^6U8Q=G]T<KM]I7ZW#ER5W>W
MK[-J^SM]Y7<8*^%IUZ<<:S%+3[6.DUS+A?,+O7MZ(KQ7);FF*/12UHRXX\)C
MPQY8O2/"?57TQ$^FM=(<^Z?M>O%7;?6N^C>]>X.FLC/Z?]Y;9C]=[@U.T]+\
M*B_O#%_^[S::?J(+:[KE^HSEU\;FZHKC].&'Z>28?9?TGOFGQ/3A[XX+A^9V
M]=?:P7S<?GMKUS[=_P#2\'A,XXKT;:GL4F+=5[^\KM?B/B.[EVNE>9V6TW>.
M/72;8+S]=Z9^RT\)FNFF./")B=9GJB&SO3[;[W!NL*[J\ZRAZQ\AL)%#%/#^
M9&XVFH[3Q13;QUWM-YKO97YJX_B:WN.).(H[+)W\EQ%31533Q+7S!1,;L;Z1
MOX?NYZUP]S3R?;V]FTQ/SG;VW&#76>GIS;/W]])C3JG)AQ12TS$S-*]<[9X7
MS_[%Y&(IR,[G89IG3[)CF]/3X:7Q=<^,::S:E8B=?5'5,/\ W+XJ>2_CQ<20
M=Y="]M=51T3<01Y+=M#V/!X&]KJKXBIJQ6QW>/HP&8AKEY^2F2UN9HZJ_C3Q
M5\>.>$O.S?-3RU\PL<7['Y[B>5M,:S3;;K#ERUC37V\-;^]QS$>,Q>E9B/'3
M1M7B>YNWN>K%N&WNUW,Z>C'DI:T?FTB>JOYEHB6 6?.[          =+WV9_
M'B7QL]N;QTU3*8S\,V_>=;N.YMWIEM+O'Y"7-]K7DNUXFVS&/O+FXDLLQKNC
MWF(P]Q'\(>?GQWQKBCDYKIX\U?QD>85?,CXBNXN5VN7WO$;'<QQVVTM6](Q[
M&L8,DX[UB(MCS;FNXW%)]KPS:1>U8K*O3S:YZ.X._M_NL5NK:X<D8,?C$QTX
M8Z+368B-:VR1>\3X_7^$S&B45&!K@
M
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MO?QG[QVVQI,33;["NL:3$Q?)DR6F-9]/L1CF--8C6?'76(LCJX4?P
M
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MZ>F\8]8T\8T?\07'SO.P?G41.NTWN'),Q$>$6Z\/C/JB9RU]'IF*N@(H&0=
M
M                                   <LGW#NA(O&/S=\F>D;.U^APFG
M=J9ZYU.S^EM++Z;1=N]#=]!A^FQ]M8X^+T]+V2PX^%O!!!S_ &8XXZ.::*?4
M?\/7?EO,WR3[9[VS6Z][O.*Q1GMU6MU;K;Z[;=3U7M:\Z[C#E^OM:W]]:UM9
MFR7L/FY[B[.X[F+SU9LNVK%YUF=<E-<>7QF9G]4I;TS,_+,SXM,VY&6@
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MUG6>K76=9U].LO2.M<<
M          !3"^X ]V7+;+LVT^!/CGL]YBM2U:\R.N^3>ZX6]MN*]US\=%I1
M==/87(X^XDN+/6]6N.+BUVFBJJ.:_P G37C9*([:TNJ<A<O\ ?PH;3C>,VOG
MSYB[:F7EMU2F;AMMDK/^C8IZNGD,E+Q$6S9XZ+[*8B:XL,QN:S;)EQ3MY;>1
MWECBV^WQ][<_CBVZRQ%]ICM$_8Z^.F>T3&DWO&DX?3%::9(F;6K-*G2UQ)P
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M7^$W;])C@LU],N.---ODM,=/3XZ^ZR3,Q6--,=HZ=>FU*Q9'5PH_@
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M7M+XANRK\)RU:;?NK:TO?CM]$?9-MFF/K+S$3-]KEF*QN,/CK$1>G3FICO7
MO,#L'B^_.'G9[J(Q\GBB9V^;3VL=YCT3Z[8[3$1>GKCVHTO6LQTH.F.XNN_(
M+JO1NZ.IMAAVGKOL7 VVQ:MG(8+FTYNK&XJDAEANK&\B@O<=DL=>P2VUW;34
M436US#)%)3Q71SQQYN>\^S^X?+_NG?=F=U[>=KW%QV>V'/BF8MTVC28FMJS-
M;TO6:WI>LS6]+5M69B8E7WR_$[_@N2S<1R>.<6_V]YI>NL3I,?),:Q,3$Q-9
MCPF)B8\)9.8RZX
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M6M,S-K3,S,S,S.JLW)DOEO;+EM-LMIF9F9UF9GQF9F?&9F?&9GTO['Q?@
M
M                             !1)^Y[['@V/S9ZGZZLI;.>WZU\>\)<Y
M.JBTR$&0M-FWC==RR=YCKFYN:J+*]LX]9QF'N8*K:/GBBNZFIKEKKXYCAO2^
MC'[<OQWDIRW<6:+UR<EW!DK36U)I;#MMMMZ5O6(]JMIS7W%+1>?&*4FM8B>J
M\T?ASX^=OV?NM_>)BVXW]HCQC2:8\>.(F(CQB>N<D3K/Z&)B(CQFMFLA2!
M        =*7V0>O/VM_:\\5<;-:6<&1V76]N[#R5U;8[\.GR?[8/8NW;9A;O
M(\UQ1SW]Y;:ME+"SIN9.:O4M[6+B.KT:8^./-O\ &WW#_"/XGNZMS2][;?;;
MG!M*5M?KBGS3:;?!DK3QF*UG/3+DFD::7O;JCKFROKSBW_WP\Q^3R1,SCQY*
M8HB9UT]UBI2T1ZHB;Q:VD>B9G7QU2NHJ-9
M
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M72)F-E?)$:3.LX?LU=(CUZXXZ?JZ.H \Q:N4
M
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M.>*7_?I_XD^XGG)^/+^M=W5_V9_N?CT O.S^<[D_^C_O3 F!1":J
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M/JB:7GHUGQM&2M9G2M8725,2(P
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M&M\A1(A4
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M3-KT_H=>OZWU>CU*PN=Y#[[<YO.4UU^<[O-EUTT_5,EK^CU>GT>IF!B#J@
M
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M:>,:UF8G2?S8?><!\
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M)B8G28F)\8F)\)B?&)5CVK:EIK:)BT3I,3Z8GY)?L_#^
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MEO:/#UUMCI,:SI-/5.L+!:OYHP
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M_>CMCD>3B>F^#99KU]KHGJKCM-(BWZ&UK:168UGJF-(F=(=7)Y4E9@
M
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M"4?6"@
M                                        /$]E]?ZYVSUQV!U7N$$U
MSJ79>D[7U_M-M;UQ1W%QKFY8*_US-P023P7,%$TN,R4M-/-<<E'%7/'/--7'
MY.>[[:Y_D>T^X^/[IX>T5Y;C=[@W6"9UF(S;?+7-CF8B:S,1>E9G28G3T3'I
M<SC]]N.,Y#!R6TF(W6WS4RTF?1%\=HO7732?3$>N')O[3Z]S?4G9W8_5.RT_
M)L?66^;?U[L%'IU0_+F]+V#(ZWE:?1KJKJB^6_QLG'R\\\\T_P!CXO5WVMW!
MLN[>V..[JXWQX[D]AM]WB\=?L>XQ4S4\?7[-X\?6LYXW?8>4X[;\GM__ )?<
M8*9:_P"+DK%Z_P#HF'@W>N:        D.]J+R"Y\9O<&\8^S+FYF@UZY["M>
MN]RIIYR<EK5J/:MI===9B]O[#$RT765AURG9:,O#;_)/\;S'PU\0RUT44<Q[
M^*OR_CS+^'[N;MK%6+<A7C[;O;_61;W^QM7=XZUMDB:TG-[F<%KZU^QY;UF]
M:VF8P3S-X+^$78O(\=6(G/&"<N/T:]>&8RUB)MX5Z^CHF?#V;3&L1,RZ>CS(
M*Z                                                   '.)]_;(
MY"]]UWR=MKR^O+NWQ%GT?CL3;W-S-/#C,?+X]]5Y:2QQT4M=<=E9R93)W-S5
M%'Q31S<7$LG/'SR5\\^C'X"-OM\/PJ=LY,-*4R9K\E?)-:Q$WO'+;['%KS$:
MVM%*4I%IUGHI6NNE8B)]^2..E/++CK4K$6O.XFTQ&FL_.LU=9^6>F(C6?5$1
MZ(A#FF$VN        LU?:W[5<6?F+W_I--I#7:[#XTWNU37U5=?%Q;W&G=H]
M<XBVM(H^/[77#>1[U+775S^JIJ@HXX_)SRK/^E"XK'F\G^ YN;S&7;]RUP17
M2-)C<;+=Y+6F?3K6=K6(CT3%IU]$([_$AMJW[4V.\UGJQ\C%-/5,9,.6TS_<
M]W&GYLKS"CQ#4              !I_[A?_ )YQ?\G_DO_L7W5M[X?/Y^^Q__
M #?PW^\=LRKL3^._#?C7:?OC&Y7KU*K*         '2!]A+^B<\4O^_3_P 2
M?<3SD_'E_6N[J_[,_P!S\>@%YV?SG<G_ -'_ 'I@3 HA-5             (
MBO??R.0Q?M1>6%SC;Z\QUQ+9].8Z2XL;F:TFDQ^7\A.IL3EK&N6WKCDKL\GB
M[V:VN(N>?DGMYJXZ^*J*JN.9;_ IM]ONOBK[4Q[FE,F.+\A>(M6+1%\?$[_)
MCM$3$QU4O6MZ6]-;UK:)B8B6TO);'3)YF\97)6+5B<\Z3&OC7:Y[5GQ]<6B)
MB?5,1,>,.;D]'BP         !U;/"[:KC>O#KQ.W:[M(;"ZW'QIZ)VJYL;>N
MN2WL[C8>KM6R\UI!))\))(;>2[YHIJJ_5<T\<<\_E>5;SFXK'P7G!W7PF*\Y
M,6S[EY/!6TQ$3:,6]SXXM,1X1,Q768CPU5G=W;:NR[KY/9UF;5Q<CN:1,^F8
MKFO76?S=&RS6K'@
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M_P MEYWF]WS6;6,FZW.3+IK,],7M-HK&LS.E8F*UC6=(B(]3,S#74@
M
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MKJCSLY"=AY<;Z*3,9<\XL43$1/UV6DWUU]$3CK>NL1,Q,QIIZ8Z.SSG("
M
M                                                 *<'W4_6M<&S
M^'W<-K;321Y7 ]K=:YN[IMK>FWLJ\!D-0VC5K:6\X^%U+-DZ=ES%5$=7QCCI
MM*ZJ?AS75\;B/HLNY*Y.,[O[0RVB+8L^QWF.NLZVC+3<8,\Q7ZV(I[G;Q,QX
MS.2(G6*QI+#X:N0BVVY7BK3&M;X<M8UG6>J+TO.GH\.BFL^F>J/D5'%M:40
M        "_7]M+VI1NWM]YGK^>\FKR'3/>6]:W!C[C*W&0YM]<VW'Z_V%C;Z
MSLYH(HL'C;[/[-EHZ;:*J2BNZMKBXYYXKGJIXH3^DG[6MPOQ 8>?I2(V_,\'
MMLTWBD4US8+Y=I>MK1,SEO7%AP3-[1$Q2^/'$3&.)F$?Q"<9.S[YIOJQ'N]W
MLL=YF*Q&MZ3;%,3.OM3%:4G6=/":U]%5A=7PT2
M
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M3_Q)]Q/.3\>7]:[NK_LS_<_'H!>=G\YW)_\ 1_WI@3 HA-5
M(?O?M_HG/*W_ +B__$GTZE[\!O\ 6N[5_P"T_P#<_(-J^2?\YW&?](_>F=S?
MGHV3]         =4+V]/^ 3P=_Y/_&C_ &+Z4\M7Q!_S]]\?^;^9_P!X[E6O
MWW_'?F?QKN_WQD;@-0L5
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MZ*TI6*UK'U*UB(CZD+-<.+'@Q5P88BN*E8K6(]$1$:1$?F0^:Y+Z
M)=/8SZ%E[Z]RGH2*>U^IP'3UYD^^MDD^EN[GZ.+K2&*\U&Z^-O:SV]M_[S+_
M  4?JW,EO#3ZGPIKJGYAAEB1\<7?E>P_AMYZU+=._P"8I3B\,=5:]4[R9KGK
MXVB9_P!#IN9Z:1:TZ>-8I%[UU;YR\W'">7V^F)TS[N(VU/&(U]]X7CQG6?L,
M9)TB)GP]&FLQTCGG#5_@
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M=A4K(@@
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MHP_$IQ?7L>+YJL?J>7+@M.GI]Y6N2D3.OAI[O)I&GCU3XQIXW,5-R)8
M
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M;P_YS!,1K,_X6.](B/\  GQGT19Q5F([
M                      .;[[]O]+'Y6_\ <7_X;.G7HV^ W^JCVK_VG_OC
MD$_O)/\ FQXS_I'[[SH?TO6U        %D#[7O\ X^^WO^3_ '__ &T>/ZN3
MZ3S^83B/_-^U_P!W<JT!\1W\2-K^-<7[WW*^$HG0L               :?\
MN%_\ GG%_P G_DO_ +%]U;>^'S^?OL?_ ,W\-_O';,J[$_COPWXUVG[XQN5Z
M]2JR@        !T@?82_HG/%+_OT_P#$GW$\Y/QY?UKNZO\ LS_<_'H!>=G\
MYW)_]'_>F!,"B$U4             A^]^W^B<\K?^XO_ ,2?3J7OP&_UKNU?
M^T_]S\@VKY)_SG<9_P!(_>F=S?GHV3]         =4+V]/\ @$\'?^3_ ,:/
M]B^E/+5\0?\ /WWQ_P";^9_WCN5:_??\=^9_&N[_ 'QD;@-0L5
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M_CZ9O,X\<:>J:Q3)/U8O'A'KMHJG48
M
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MIQM)UKMME$SZ?"^6]IF/'P^LK2=8UUUTF=8TBRRK81[
M
M                                   1[>Z]U=#W#[</F+ILT'U5=KTG
MLW8%E;<<9"J6XRW4/-KVWA8+:/&2Q7<]Y+E](@I@C^-44LW--$M%<7-=%4@O
MA3[HOV?\1G9_,TMT1;F\.TM;V-(Q[_JV&29F\36*QCW-IM/A:M=9K-;1%HSK
MRRY*>*[_ .)W<3I$[RF*9\/"N?7!:9U\(CIR3K/IB/&)B=)<P9Z<5C
M    ";#[?3MO]J[W-NJ,1/=?18KN33^R.I,K<57GTL']_P"M3;SK]K/%])=<
MY#\2W+0\9:Q0\50?"XGCDYD^$?,<D*_I >TOX4?#/RN\QUZ]UPV\V>_I'3U3
M[.:-MEM$]5>CHV^ZS7M;2WL5M7IUMU5U!YY\7]\O+O=9:QKEVF7%GK&FOHO[
MNTQXQIICR7F9\?")C3QUCHI// @8
M
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ML?E;_P!Q?_ALZ=>C;X#?ZJ/:O_:?^^.03^\D_P";'C/^D?OO.A_2];4
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M]_QWYG\:[O\ ?&1N U"Q4
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MC2-;3.D:I%4=V!
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MK6F+/&&/&9B/<TKBF(U]'MUM,Q'AU3;Y4HJ,#7
M
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MXO[]]L\AQ,1K?<;/+2OAK[<TMT3$:QK,7TF(UC68]+JY/*FK,
M
M                          <O_P!TWQZH\8?/OR7ZKQ^'FPNJT]A7V[Z'
M:<QW'%C'HW9$,&]:Y9X>ZN.:ZK_&X*US_.,XE]26JF:QDBDKYFCD^'IT^%OS
M!MYG>0G;7=.XS5S<I][Z[;=6UCJG<[.9VN:V2L?67RVQ>^Z=*Q-<M;5B*6JL
M:\MN=GN/LCCN2R7B^Y]Q&/)/AK[S%KCO-HCT3::]>FD>%HF(TF$?K?[.
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MB?3$^F(GY8B7L'3N(
M      YOOOV_TL?E;_W%_P#ALZ=>C;X#?ZJ/:O\ VG_OCD$_O)/^;'C/^D?O
MO.A_2];4        60/M>_\ C[[>_P"3_?\ _;1X_JY/I//YA.(_\W[7_=W*
MM ?$=_$C:_C7%^]]ROA*)T+               &G_N%_\ GG%_R?^2_^Q?=6
MWOA\_G[['_\ -_#?[QVS*NQ/X[\-^-=I^^,;E>O4JLH         =('V$OZ)
MSQ2_[]/_ !)]Q/.3\>7]:[NK_LS_ '/QZ 7G9_.=R?\ T?\ >F!,"B$U4
M          A^]^W^B<\K?^XO_P 2?3J7OP&_UKNU?^T_]S\@VKY)_P YW&?]
M(_>F=S?GHV3]         =4+V]/^ 3P=_P"3_P :/]B^E/+5\0?\_??'_F_F
M?]X[E6OWW_'?F?QKN_WQD;@-0L5
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MM7?\Y$Q&7;[:TTUTT]Y;V,43U>'CDM6-/&9]$1:=(GJJ/+"K3
M
M                        <LGW$NU).ZO.ORS[)YD]6SSO?'8ME@I.8KN"
M6O5-8V&\U/3^;F"]N[V>"\_-;!V?K4<5\1T2_-Q'1''Q3'3ZC_AX[6KV7Y&=
MI]MQ&F;!P.TMEC6LQ[_-BKGW&DUK6)K[_+DZ9TUFNDVFUM;39+V'QL<1V7Q?
M'_HZ;+%-O1/MWK%[Z3$1X==K:>O3TS,ZS.F;<C+0        'TL-A\GL.7Q6
M PMG-D<SG,E8X?$X^WXXYN+_ ">3NHK*PLX.*N::>9KJZGHHIXYYXX^:KAQM
MYO-MQ^SR[_>WC'L\&.V3)>?16E*S:UI^I6L3,_4A\\V7'@Q6SYIBN*E9M:9]
M$1$:S,_F0ZVG5>AX_JOK#KCK#$\V=6+ZXT/4-#QM6.Q<.$Q]6/U#7L=KUGS8
MX6VEN+?$6?-OCJ?2M8Y*Z+>CX1TU<\4\<O)GW3SVX[I[GY'N?=]?SKD=_N-U
M?KO.2_7N,M\MNK),1.2VMYZKS$3>=;3$3*K[DM[?DN1W'(Y=?>[C/?).L]4Z
MWM-IUM.DVG6?&9CQ]+WCH7"
M
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M1IHVC:O8V
M                                             I:_=)=!187M7QP\
MEL3CK.&'?-/V'J3<+NU^DMIY<WH>1HV75+S(P<51W.1O,EA-MOK:FZXHEYCM
M\5%#+713Q;4U7._1>=^VWO:O<?EKN\EYOL-YBW^WK;JF(Q[JGN<]:3XUI6F3
M!BO--:ZWSVO6)F<DQ+GX;N;G-QG(=O9;3,X,M<^.)UGV<D=%XB?1$1:E9T\-
M9O,Q$^U*J.M629         =%?V N_Z.\/;>ZQPEY>0W6R]"Y[9^D<[33/<5
MW%-E@;F#9-+JEM[FTM_IX8=#VK&VD?,4ES!)5:5\\2TR<2V\'G>^/KL&W9'Q
M'<GO<-+5XWGL&'DL7A&G5EB<.YTF+3K,[K!FR3U12T1DC6LUZ<F2!?GAP<\-
MY@;G-2)C;[VE-Q7PC36T=&3QB9U^R4O:=8B8ZH\--+6FK0M:A
M                                      <]'[B_KB?1_<VWG9I8KR./
MN+JOJ/L>VKN;O'W,,\&+UK]J*J7'0V=/%S86?%SU9)15#=_&XJN*)9>.?0DA
MXX]!OT=O<=.;^&?8\92:3;A^5W^SGIK>)B;YOG^EYMX7MIOHF+8_8BDUK/MU
MNG7Y"<A&\\N\.WB8UVFYSXITB8TUO[_QU\)G3-'C7PTTCZZ)05IS-S@
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M>*7_ 'Z?^)/N)YR?CR_K7=U?]F?[GX] +SL_G.Y/_H_[TP)@40FJ@
M     $:7O%=<3]I^V3YB:S;Q7DTF+ZKY['JHL;O'V4W$'3NRZ_V[<RUS9*FJ
MVKLX+;1ZZ[B&G^^+BWIKB@YXGKCY24^#[N.G:WQ,=G\GDFD5R\K\S]JM[1KR
M&'+L(B(IXQ:9W,12T^Q2\UMD]B+-A>5'(1QOF)Q.XM,1%MS[KQB9_5Z6P1Z/
M'69R>$^B)TFWLQ+F5/2^L0        ?V8['9#+Y"QQ.)L;S*93*7EMCL;C<=
M;37N0R.0O9J+:SL;&SMJ);B[O+NXEICBBCIJKDKJXIIXYYYXX?'<;C;[3;WW
M>[O3%M<5+7O>]HK2E*Q,VM:TS$5K6(F;6F8B(B9F='YR9*8J6RY;17%6)F9F
M=(B(\9F9GPB(CQF9]#K@=::K<:+UQU_I%W=PW]UINDZIJMS?6]%<=O>W&O8*
MPQ$UW!'+\9(X;B2SYKIIJ_5<4\\<<_E>2WN7E<?.]Q\AS>*DX\6\WN?/6LS$
MS6,N6V2*S,>$S$6TF8\-57?([FN]Y#/O*Q-:Y<U[Q$^F(M:;:3^9J]LZ1PP
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M^VMKP6.8]]O-SUVC6=?=X(UGPTT\<E\<Q,S'ULZ1/C-;S"CQ#4
M
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MLD3&GIG2-8],=0QYA5<8
M
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MJTM%8@IY]<9&P\P\NXCPC>;;#F]7JK.&?"(C36<,S.NLS,S.OCI$ZJ#+3
M
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M.2?"?5=H4IH?@
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MB><GX\OZUW=7_9G^Y^/0"\[/YSN3_P"C_O3 F!1":J             ?'V+
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M,;[>1.VQ:3I,6RUMU6UCQKT8HO:+1^BBL:Q-HF.DT\WJOP
M                                   !3R^Z;[ZEJR'B_P"+^/NOEA@L
M]D[ZVZR^JN_[;+=3W?7O7=U]%'=1V//T]%GM%'JS0RS<>K\L-<5/,],UP'T6
M_8=8V_<_F?N*^W:^'B\%NFOA%8KN]W7JFLV\>K93TUM6OAK>MYZ)I*SX;.$B
M*<EW'DCQF:;:DZ1ZM,N6-=-?'7#X1,1X>,3[.E0I;FE,         Z$_V[?C
M[;].>W=K&_W=O-%L_D7NVV]I97FZIHXN+7 XW(5]?Z9CHN8XH^/PV?#ZESEH
M/FJEK^;+R<\U\<<TQQ^?7Z0WS R=X_$-NN Q6B>,[=V6#94Z==+9;T^=;B\Z
MS/MQDS^XMI$1IMZ^&L3:T%?/CG;<MWYDV-9B=ML,-,,:>B;3'O<D_FQ:_1/H
M^LCP]<SMH+-+@
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MYO<=9CQC6F.+9)F=/"=+UQ^%O7,6B-:ZQ?@4,(2@
M
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MVBN3''HTC7IRZZS$SI&D3$3I<34^HI
M
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M-=)\(\8]$,5LI=D        W8]N'OV+QA\Z/&'NR]R-GB,%JW:F%Q>XY:_\
MI/I,9U]OD5WUYV+D):[ZFJUA^BT7:\C)3)5S1Z=5/%7$D=7'$E.E?B,["MYG
M>1O<_96''?-OMUQ62^WQTZNJ^[VLUW>TI'3[4]6YP8HF(UUB=)K:)FLXAW_P
M<]Q]F<CP]*S?-EVUIQUC76<N/3+BCP\?')2L:>.OHTGT.I4\NRMP
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MF9^67[/P_@              #3_W"_\ @$\XO^3_ ,E_]B^ZMO?#Y_/WV/\
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MGY;D]SRNYT^<[G/DRWT]'5DO-[:::1Z9GT1#(3'W
M
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MO$5B)\2?)SDYCC.'CT8=MDS3Z?'WU^B-?'2=/<3IX:QK/C.OA:M57HT
M
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M6L:Y=IEQ9ZQIKZ+^[M,>,::8\EYF?'PB8T\=8Z*3SP(&
M
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M(Q9-,F.(TF8TK2T5\-/1XQ6=:QO*T>PT
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M]^G_ (D^XGG)^/+^M=W5_P!F?[GX] +SL_G.Y/\ Z/\ O3 F!1":J
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MMQ_@5CPFN'Y==+9/1,12)B]F56DCP
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MB/&)Q4O6=9B/:\9F=*VZ+SSM($@
M
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M
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M:(M'HF(GP6@X,^+<X*;G!/5AR4BU9TF-:VC6)TG28UB?1,1/ROD.6^H
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M&)5B6K:EIK:)BT3I,3Z8GY)?L_#^
M
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MQUR=>+C]M$X-CBM&O3,88M:V:].JT4S;K)GSTBUJURQ6>E''N[S#[J[UR?\
MWK<3\RBVM<&..C#6?5,4UF;3&LZ6R6O>(F8BVDZ-]VAF$@
M                                    *V7W-_?4N@>''6O16.NO0R7D
M%VI%<Y>#ZJ[A^MT7J*VL]GR\'TUK=6\=WZ>\9C6I?A<4SV]'I_-Z?K>C+%9#
M]&;V'7G_ #BY+OG<5ZMMV_Q4QCGIK/3NM_-L..=;5F:Z[;'O*^Q-;3KIU='7
M2\@OAVX2-]W9N.:R1KCV.VTK.D>&3/,TKXS$Z?8ZY8\-)G7TZ:Q-$I>DF@
M       NP_:Z>/\ ^;O1_D%Y*Y2R^2^[-WS#]7:M<33?-+3K/6V,JS6<O+*W
MXLH^(;/,['N=-O))S<S<RS8?Y>(H.(OGN:5OI0.__OCWOV_Y;;6^N#C-ADWN
M>(CP]]O+^[Q5M/5.ML>';S>(Z*]-=QKUWZNG'$'XC^<^<<SL>WL<^QML%LUX
M_P /+/36)G7TUICUB-(TC)Z9UTK:A5:HU@
M
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M1DYC+K@
M
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MM*UQ^9'$SPG??*<?I$4C=WR5B--(IFTS4B-)GT4R5CTZ^'C$3K$;[M#,)
M
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MYIIKK$4GIRSX>J,-LEIU\/9B9]$3'1D>== @
M                                                  !I_P"X7_P"
M><7_ "?^2_\ L7W5M[X?/Y^^Q_\ S?PW^\=LRKL3^._#?C7:?OC&Y7KU*K*
M        '2!]A+^B<\4O^_3_ ,2?<3SD_'E_6N[J_P"S/]S\>@%YV?SG<G_T
M?]Z8$P*(350
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ML?V/%,:>'C2M9\/3,S.LS,S.[S23#@
M
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M8GU,%\S>5GANP>5WU9F+_-+8ZS$S$Q;/,8*VB8\8FMLD3$^K35T^GF.5S@
M
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M.[MMRU*Z8=YLXB9\?')AM-;>K3PQVQ1X3,_+$1,:V35;R/H
M
M                       #F4^\!T)%XZ^XSY/Z3C[7Z77-DWR7MG5*(K6T
MLL?'A.WK.V[#DQN'M+&VL[6UP^M9K8+S$6\5,5/$=&/^7XU_#YZO3!\(7?EO
M,3X=>V.:W%^KD=ML(V&?6UK7G)L+6VD7R6M:UK9,V/%CSWM-IUG+KX:],6(>
M57-SSW8/';R\Z[C'@]Q?QF9ZL$SBUM,S,S:]:UO,Z^/5KX>B(TTDVP@
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MLA,?<
M                   !I_[A?_ )YQ?\G_DO_L7W5M[X?/Y^^Q__ #?PW^\=
MLRKL3^._#?C7:?OC&Y7KU*K*         '2!]A+^B<\4O^_3_P 2?<3SD_'E
M_6N[J_[,_P!S\>@%YV?SG<G_ -'_ 'I@3 HA-5
M                                                   /@[5L^!TG
M6-CW/:LE#AM8U' YC9]CR]Q1-);XK X#'W&5S&2GHMXIKBN&QQ]I)+5Q'177
MS33S\M///PX<_B^,W_-\GMN&XO'.;D]WGQX<..-(F^7+>*8Z1,S$:VO:*QK,
M1K/C,0^^VVV?>;G'M-M6;[G+>M*5CTVM:8K6(U\/&9B/%R;^\^U\WWOW3VUW
M9LD/TV=[;[(W7L?*67%S5>18Z[W/8LCL$F+MKFJ&V]2SQ?U_T\'PBBIXABIX
MIHHIXXIX]7?8W:FR[$[+XGLKCIZMCQ/&[;9TMT],WKM\-,47F-9TM?IZ[>U:
M>J9F;3/C-G/#<9AX7B-KP^WG7#M=OCQ1.FFL8Z1768\?&=-9\9\9],L5LI=D
M        W8]N'H*+R>\Z/&'I.]QUGE\%M/:F%RFXXF_^D^DR?7VAQ7?8?8N/
MEHOJJ;6;ZW1=4R,=,=7%?J55<4\1R5<\1U:5^(SOVWECY&]S]ZX<E\.^VO%9
M*;?)3JZJ;O=37:;2\=/M1T[G/BF9C32(UFU8B;1B'?\ SD]N=F<CS%+33-BV
MUHQVC76,N33%BGP\?#)>LZ^&GIUCTNI4\NRMP
M
M           !70^YD[FHT7P6U#J:TO9H<MWIW-KEA>6,5Y<6M%[IO7=C?;KF
M9KF&"6BC(PV>VV^O_"":FN'B22F;\DL47*Q+Z-/LVW.^>>\[LRTK.TX/ALUJ
MVFL6FNXW=J[;'$3,>Q-L$[OVJS%M(FGC6]F^_AYXB=[WGEY2T1.+9;2\Q.D3
MIDRS&.NFOHUI.7QCQTB8]$RH6+X4UP         %EC[83J&3;/,7M[N"XAO*
M\7U!TG/B+>:&"[XM(=K[/V/&V&)XO;Z..JRI]76=8SG$=M+53)/5QZL?'/%O
M)\*V/I..[J\3Y/<1VACFD;KE^;C),3->J<&RPWMDZ:S/5X9LVVUO6)BL>S;2
M<E4>_B,Y6-KVIM>*K,>\W6\BT^,:]&&DS;2/3]??'K,>$>B?KH7JE&:&(
M
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MN(F=(UC'FK-9\?3'MUQ1,>B?"9\8A>P48(8
M
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M7\^>#^]/?=]]CC3;[_!3-'R=<1[O)'HC2=:1>8UM]?KKX]-9X4$VE0
M
M       &G_N%_P# )YQ?\G_DO_L7W5M[X?/Y^^Q__-_#?[QVS*NQ/X[\-^-=
MI^^,;E>O4JLH         =('V$OZ)SQ2_P"_3_Q)]Q/.3\>7]:[NK_LS_<_'
MH!>=G\YW)_\ 1_WI@3 HA-5
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M^36(TG6<?IC32UV)2LB"
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M=UW7M>*K,^[VNSBT^,Z=>:\S;2/1]93'K,>,^B?K8665;"/8
M
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M.)GF^Q^4XZL1.2VTO>L3IXWQ?9:1XS$1K>E8B9G2L^,ZZ:.HP\OZN
M
M                              !%1[UG0%?D+[;WD1A,?9S7FR];X&T[
MNU>FW@M[FXCO.J[GC8]@I@M[B[LO6FOM#CR]I3Q')S/\UQQS%%<2<4V\LJ/@
MM[^KY>_$=V]O=Q>M.-Y+/;C<^LS6)KOH]SBUF*VTBNZG;Y)UCITI[5L==<E=
ME^4/.1P7F!L,V28C;[B\[>^LS$:9HZ*ZS$3Z,G1;QC3P\9K'M1S5'I+6#@
M      +-7VPO?]>E>5/;_CWD;R:/#=X]8Q;/A;:J>WYMY-YZEOYKVU@BMI;2
MNYHFN],VC-2R20W$5/--C13+%-_:J[:L_P"DW[!KS7E9Q'F#MZ5G><'R<X<D
MZ3K&VW]8K:9M%M-*[C!MZQ%J6G7),UO3VJY([_$7P<;SMK:\[CB/?;/<]%IT
MG7W>>-)\==/#)3'$1,3]=.DQXQ:\PH\0U
M                                               >)[+TNW[(ZX[
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M8F
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M[)>]9UF9GICQTTK6:M"UJ$
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M\VF:Y?,GE8YKOOE.0K/5CG=VQUGP\:X8C#28TB/":XXT]>GIUG66_K0;!P
M
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MN7?\-$:8]MN\E*_5I%I]W/UUI\:=,Z3:9C729UU;(-<,?
M
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M\%_"7M7?\'$1.7<;:T4UTT]Y7V\4SU>'ADK6=?"8],36=)CJJ/+"K3
M
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M29U\(I/KTB>G0\RRNL
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M:TSKX^,S,O5.J<8
M                                                !@'RK[EM_'CQ
MH[Z[RGEACDZKZEWS=L;'/Q151>Y[!ZYD+O7,531+QS%7-F,_1;6L=-?PHJDF
MIXJYXXYYY9]Y5]FY/,+S*X'L>D3->5Y;:[:\QKK7%ES4KFOX>,1CQ==YF/&(
MK.GB[SMGB;<]W#LN&K$Z;G=8\<_4K:\1>?\ U:ZVGZD.4#<7%Q>7$]W=SS75
MU=32W%S<W$M<]Q<7$]=4LT\\TM54DTTTE7-5557/-557/////Q>K+'CQX<=<
M6*L5Q5B(K6(B(B(C2(B(\(B(\(B/"(6:UK6E8K6(BL1I$1Z(CY(?B_;^@
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MK,S,^,S,^,S/C,JQ;6M>TVM,S:9UF9],S\LOV?A_
M
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M7U=6./<S']RN.DS_ (T>O5/^@(T>
M
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MT2*H[L"
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M)YK^8-N^^>B=E-HX#:Q-,%9CIFTSIUYK1/CK>8B*Q.G3CK76M;S?67M$5JP
M
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MUU="YY\D%
M                                            $ WW('=W[67MXW77
M5E>>EE_(#M31]!KMXJ_3N^=9UFXN>S<]?45<<TU\6=%_IF.LKCBGGXUTY#BC
MGCF.NM/CZ.3LG^$WQ"T[BS4UVG;_ !6YW6LQK7WV:(V6*O\ C=.XRY*:^B<4
MVB8M%6[_ " X?[X]]QO[QKBV.VR9=?5UWB,-8_-TR6M'^+KZ8AS]E_:<8
M      "<C[>3I']MOW)-&VB[L_JL)T/H>^=NY"F:CXVE60IQT'7VL45R<\<<
M<7EIL>^VU_;T4U<5U56'-7PYHHDX0?\ I">]OX)?#AON+PWZ-[SV_P!KL*:3
M[71USN\VD?WML.UOBO,QI$98CPM:K3?GOS'WK\O\VVI.F;>Y\>"/ETU][?\
MN33'-9_QM/3,.AT\]B"(
M
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MJE> 4CH=
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M8_1DQVV]_#T329R8YU]<VB^2/J12/&?5;15.HP
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MX>+[;MF)C6)\,N>8\?LNEIB,<3XUQQKXQ%KS:>FM)[4#6DP
M
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MUFM6>CN
M                                          I"_=%]W?G-Y'^/O05C
M>>M8=4=5YC?LQ##7\(H=F[8V"FPXL;V/CGCF2\L=<Z[LKB/FKCGB.')?J.>.
M9).%VOT7_9/WL\N>X._<]-,_*\KCVN.9CQG#L<77U5GU5MFW>2DZ>FV'QCV:
MRF)\.'#_ #?@-]S=XTONMS7%7_$PUUUCZDWRVB?EFGCZ(5=UGR1P
M "Y[]K#T_%9=8^5/?US9?/-LV^:9T_A<C77:<_2Q:-K\VZ;/96T<=QS?Q_75
M=B8B2>J6*F&OZ>'B*NJJF;BFFCZ4GN^V?N?M7L'%?2FVV&XY#)2(M[4[G+&V
MPVM,QTST_--Q%8K:;1UWZXB)I,Q)^)/E9OR/&<'6?#'@R9[1X^/O+>[I,^&G
MA[J\1I.OC.L>,+8JJ-&,
M
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MTS$QK$]1)Y@E<(
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MVK?.7A(YOR^WT1&N?:1&YIX1.GN?&\^,:Q]AG)&L3$^/ITUB>D<\X:O\
M
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M8]?15HSF>X.;[BW/SSG-UGW6XC72<EIM%8F=9BE?K:5U\>FD5K]1FQA3IP
M
M            '/%^X6[]D[F]QG=M0LLC>76L>/VGZEU'B;>OZNWQ]&;ILZ]T
MW2[MK"YIAXIO.-CVR7'SW7$?'-U1C(?EKD@H@J>A/Z/GL*O9OPZ[+E\V.E.3
M[@WF??Y)CIF_N^KYOMJVM&OL^YP1EK37V)S7UBN2V2$[O(KA(XGL'#NKUB-Q
MOLM\]I\)GIU]WCB9CU=%(M$:^'7/A%IM"#=.!N0        !U3O _H2+QA\.
M/''HKZ7Z/):%U7K5MM$'TMI9_P#MUG+;G9^P9OIK*VM(H_JMXS>0E^-=-<]7
MS_--)--S)+7Y9?/;ORWF=YQ=Q]\]77MM_P KFG!/5:W^BXY]SM(UM:TST[;'
MBKX3%8TTI6E(K2M:O>O-SW'W9R'-:ZX\^YO-)UF?L=9Z,7C,SZ,=:Q\GR1$:
M1&VC4S%P
M                                          '+S]T/O*X\B?/_ ,JN
MS.;Z;(8J3MK8M+U2XE^>BB32NLY:.NM1N+>UEQF&EQ\.1P&KP77,$EO1<1R3
MU<3U2S^K-)Z>OA@['Q^7GD%VKVU%(Q[J.)P[G/$::QN=[$[O<1-HODB\TRY[
M4ZHO-9BL=$4ITTK8YY<<-7@>Q^,X[2*Y?FM<EX_]YF^RWB9UMKI:\UUB=)B(
MZ8BND1H2WRS8         !TL?94Z6_:/]M#Q@Q%S!\F8W_3[GNG,W'J?-]=^
MV_EKW>=:G]&/*Y:UMOIM%RV)M?EBJA^?Z?U)8(;B2:/CS8_&EWI_#?XE>Y]Y
MCMKL^/WD<=CC3ZWYACKMLT:S3':W5N<>>^MHMIU]-+WQUI::]_-[E_OSYA\E
MEK/V+!EC;UCY/<5C'?\ 0UF=<E;SXZ^G2+36(E*BBTUJ
M
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M;.-9,=
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M44M-8M&L1.EHB+5G2-8F)];,S#74@
M
M
M    /$]E]@:YU-UQV!VIN$\UMJ76FD[7V!M-S;T127%OKFFX*_V/-SP1SSVT
M%<T6,QLM5/%<D='-7'''-5/'Y>.[[:X#D>[.X^/[6X>L6Y;DM[@VN")UB)S;
MC+7#CB9B+3$3>]8G2)G3T1/H<SC]CN.3Y#!QNTB)W6XS4Q4B?1-\EHI7736?
M3,>J7)O[3["S?;?9W8_:VRU?/L?9N^;?V%L%?J53?-F]TV#([)E:O6KIHJE^
M:_R4G/S<\<<U?V?@]7?:W;^R[2[8X[M7C?#CN,V&WVF+PT^Q[?%3#3P]7LTC
MP]2SGC=CAXOCMOQFW_\ E]O@IBK_ (N.L4K_ .B(>#=ZYH       "13VFNA
M)?(_W#O%SKR6U^IP6-[(L.R]N]:UN[C&_FIU);W/9.6L,M):6MU])9[)^;%&
M(HDD]..JZR$,7,D=4E-7$>/BO[\KY<_#UW1W#6_3OLG&VV>WTM6+^_W\QL\=
ML<6M7JMA]].XF(UF*8KVZ;1688'YG\W' =B<EOXG3-;;SBIXQ$]>>8Q5FNLQ
MK-.N;S$:SI69TG1T[GF35T@
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M$:VM.LSI&D1K,^B(B/D?8<-\@
M
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MPB/#%[GPUF====(FNMCM7.T"
M
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M@YXWO>.4QQ/N.0VU,FND1'O,?V*]8\?56N.\SI&LW]<ZRL%J_FC
M
M
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M&2-9UB,<>[QZ^&DQ:;Y/7X3CC6/1*YNIK1*
M
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M)M$Q,3HZ(SSS('
M
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M/J:7U%#R%
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M5B??\?N8UGU1CSZ8[?\ +DC#I.NGA,:3K&E\A1(A4
M
M
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M2=(B(\?1KK,RZHD-6@
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MGO'U<MNBFOU:QBM,?4OKZX6N55*,P
M
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M(F)B8F-59N3'?%>V++6:Y:S,3$QI,3'A,3$^,3$^$Q/H?V/B_
M
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M6Q9=V?SE.Y.U]CSE9B;;C;4M?28G3)$=.6OA$1[.2MJSI$>,>B/1&KK9[(P
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M/['Q?@
M
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MS.D:1&LSZ(B(^1]APWR
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M1'HBS7MOB*\!P&RX6FD_-=MCQS,>BUJUB+6]7UUM;>B/3Z(8'9V[H
M  !TX?:*Z-_B^>W-XK:/<X[\.SN:ZWM.T=HCGM/I,M^/]O7EYV5<6>?HDQ&%
MO/QC 6>SP8JN.XAKFM8K".VYEFI@IEK\S7Q;]\?E ^(KNGG,63WFQP\E;98)
MBW5C]UL*UV<6Q:9,E?=Y;8;9XFEHK>V6V6*4F\UBNSS2YG[^]_<GO*VZL--Q
M.&FDZUZ<$1BB:^U:.FTTF^L3I:;3;2-=(DA1Q8
M
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M.:(R3$1'UL5O-JQ&D:=/A'3I*3E&9KH
M
M       !15^YUZ"BT+R\ZH[[QF.L[+%>075=>+S%S#])3=Y?L'IN]LL%FLA>
MT0U<7=7I:#L^K6D<DU'ZJFU^6B2KBCFB*\SZ,KOVW/>4?*]A;G)>^Z[?Y6+X
MZSU=./:<A6V7'2LS[/CNL.]R3%9\)OK-8FVMIG?#KSD[WM;=<)DM,Y-CN=:Q
MXZ5Q9XFU8CU?JM,UIB/EUF/'6:TZR=(0        !TO?9G\AY?)/VYO'3:\I
MD_Q/;]&UNXZ9W>J6[N\AD(LWU3>2ZIB;G,9"\MK>2]S&Q:/9XC,7$GQFY^?(
M_"N623BNKGS5_&1Y>U\M_B*[BXK:XO=<1OMS'([;2M:4G'OJQGR1CI69BN/#
MN;;C;TCV?##K%*UFL*]/-K@8[?[^W^UQ5Z=KFR1GQ^$1'3FCKM%8B9TK7)-Z
M1'A]9X1$:)148&N
M
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M%XYCW_(;FF/368GW>/[+>T>'JM7'28UC6+^N-87^%!B$
M
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MIG69GTS/RR_9^'\
M
M                4 ?N1NB8NK_<#I[.QL7PQ'D1U7I^\W==--I!#!N.HT7'
M6>P8Z"VBO)KFKXX74\1D);BN"WCGN,E)Q3ZDD<U?-^WT</?5NZ/(">V-S/\
MI?;W*[C;5CVIF=ON--YBO-IK%?U3/N,5:1:TUIAK,]-;4A.'X?\ FIY+L;[W
M9)^R[#<WQQZ9UQWTS5G733ZZ]ZQ&LS$4CT1,0K]I^MX@         +AOVLG?
M<55AY0>+^0NOEF@O-;[[U&R^JM/[;%=0VG7O8EU]%)<QW_/H56>KT>K##+#Q
MZGRS5Q5<P4S5 ?2D=AVC<=L>9^WK[%J9N+SVZ;>$UFV[VE>J*S7QZM[/3:U;
M>&M*WCKFD5/B3X28OQO<>./"8OMKSI/JURXHUTT\=<WA,Q/AX1/M:6]51:+
M
M                                    "!C[BWQ]N.X_;TRV_P"(MH9<
M_P".G86K=I<\\<5\WUSJ.2^KT#;L=9_"*2/T8(]MM<M<_/5%_:<1SSQ7S5QQ
M')._Z.[S Q]G?$'BX#=VF-AW%Q^?9>KIKGIT[K;WMXQ.LS@O@II$^UN(UC2>
MJNZ_(7G:\3WW78Y9F,&_P7P_4B\:9:3/YO1:D>GQOZ/7'/D>@1.<
M!<!^UD\@/^*#Q8R=[_BWY :3CJ(?_K3KKM&]N9Z[W_\ <^."B.V__#<R2?\
MHJ50WTI'8'\6/-+;4_SW%;F\S_C;O95K'3^,)M,W_O.FOUTHK?$GP?\ LWN7
M'']_MLD_\N7#$1I_\>9UGY-(],K@*H5%8
M
M
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MN1H
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M?:3/CI-]I0VA,
M
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MHGI9/-BKW
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MT=,1YJ%>8
M
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M,>/C.FLZSK+81KYT0
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MXAN;G?\ >.+AZ3]AV&VK$QK/ADS:9+>&ND:X_=>B-9T\9F-(BQJKJ:#
M
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M-MS>E?JTUUQV_P#6I-;1KXZ3X^+8IKMT(
M
M         #G'^_1X^\=!^Y+V_<65M#:Z]WKC<!Y!:]'%QC**Z^=[JR.+W2YN
M(L7%;QQS7?:&K9Z7CF:*BZDCKIDEJFKKYN)O1=\!_F!/?OPW\1CSVFW(<%DR
M\5EF>N8_T7HOMXB;S,S%=EGVM?9M-(F)K2*5B,=)]>2G._?OR^VM;S,Y]E:V
MUMZ?^;TMCB-=?1AOCCPG2)UB-(CIB&U,5M@       !_9CLCD,1D+'+8F^O,
M7E,7>6V1QN2QUS-99#'9"RFHN;.^L;RVKBN+2\M+B*F2*6.JFN.NGBJGGCGC
MCE\=QM]ON]O?:;NE,NURTM2]+UBU+TM$Q:MJS$Q:MHF8M68F)B9B8T?G)CIE
MI;%EK%L5HF)B8UB8GPF)B?"8F/"8GTNKEXF=V6GDAXR]#=[6E?S5]I=5Z7MV
M3B^EEL_H]BR6$M.=HQGH2Q0\<?A6QT75M\T?',$GI?/%57%5175Y4_-CLK+Y
M<^9G/=BY8\.+Y7<;>D]46ZL5,EO<WUB9^OP]%])]J.K2\1:)B*S.Y^'MV_W%
MO>%MZ-MN<E(\==:Q:>B=?\*G3/CXQKI.DZPV$:^=$
M
M
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M@Q5_O<>&E<=*^KT5K$>B%G.TVN'9;7%LMO&FWPXZTK'R5I$5K']R(AYMV+D
M       )/O9N\>J_)'W%O'+5+O#PYC5-'VK]N3>8[R*WN<9#KG5D7YTVD>7L
M[CFJB_QN;VVUQ>*D@].6B7G(<4R4^CS)53&/XQ?,&OEQ\._<?*X<UL/*[[:_
M>_;369B\YM]/N+3CM'UE\>"V;/%M:S7W4S6>OIB=<^;'.QV_V%O]S6\TW.;%
M[C'IK$]>;V)Z9CT36DWO$ZQIT^$ZZ.F(\U"O,
M
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M<_,6[@[BWO-6]&YW.2\>&FE9M/1&G^#3ICQ\9TUG6=9;"-?.B
M
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MB>!G8]T;?GL==,&^V_3:?#]5P:5G73Q_4K8HCJUF=)TG2-*V65;"/8
M
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M:8[>J/",4X?7,ZZ^B-%D%7(T
M
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M5^,(M$T_O.FWUT(K?$GSG^S>VL<_W^YR1_RXL,Q.O_QXG6/DTGTPN JA45@
M
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M_L'?[K%;IW6;'&#'XS$]6:>BTUF(G2U<<WO$^'UGA,3HZ7SS5J]
M
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MKV_/-=B9=YBK,[KC\M<\:::S3ZS+'CZHI;WD^B?L<:?)/0T>>]!(
M
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M5ZQX^NUL=YG2=(IZHUE?X4&(0
M
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M*C UP
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M]?'%BG]>_-\---)UM]JB$5P
M
M                          $47O8^/$7D9[</?^(M<9^);3U9A[;O;3*H
M[2TO;NRRG5O,V8V*6PANKFSJXO,AUS+G,?3S!)]3\MY5Q%'<5<\6TTJ_@K\P
MK>77Q&<!N\N7W?%\IFGC-QK:U:VIO=,>&+S6+>S3=QMLL]4=&N.)M;'$>\IL
MWR@YZ> [_P!CEM;IVVYO.VR>,Q$QF]FNND3X1E]W;QC3V?&:Q[4<UIZ2%@H
M        #V'7F\Y_K#?]'[*U.X^CVGKS<-9WG6KOUKVW^ES^I9JRS^&N/7QM
MWC\C!Z&1Q\=7SV\\$]/P^-$E%7'%7'4=P\'L.Y^ WW;7*UZ^+Y#9YMMFKI6>
MK%GQVQ9(TO6])UI>8TO6U9_15F-8GB[_ &6#D=CFX_=1KML^*^.\>$ZUO6:V
MC28F/1,^F)CY8F'6*Z<[1UGN_J7K/N33)_J=4[3T/4^P->DYYK]6G$[=@['.
M64%S1)%!-#>6L-[Q%/')''+%-15171353S3QY1N\>U^3[)[LY/L[F:]/*\7O
M\^TRQZO>8,ML5IC29B:VFO568F:VK,369B8F:Q^6XW<</RFXXG=QINMMGOBM
M_C4M-9F/3X3IK$Q,Q,>,3,,D,<=>
M
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M7;9[[;/'3FQWFMHUB=+5G28UC6)TF/3$S'R/L.&^0
M
M
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MS,S,S,ZJS<F2^6]LN6TVRVF9F9G69F?&9F9\9F9\9F?2_L?%^
M
M                       &$_)+NK">./C_ -R]\;#']1B^I>M]NWJ2PX^7
MU,O=Z_AKN]Q>"MOGFMJ.;S/96.&R@XJEBIYFGIXYKHX^-7&:^6_9>]\QN_\
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M\
M
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M;WWJ[SKRV*NFUY'!%]8C2/>X],>2(]4STQCO:?3,Y)F8UG6;"*OMHL
M
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M\;SXQI/V:,D:Q,QX>G76(EU1(:M
M
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M;C8=G8N'I/V;?[FL3&L>./#IDMX:ZSID]UZ(TC7QF)TB;YRB%"D
M
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MB?3X>J?1/5.>616H
M
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M/#'X3ZIZ""@%!H
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M8OB2X.,FPX[N/'$=6++?;Y)TG68R1[S'KXZ1%9ID]7C.2-9]$+FZFM$H
M
M
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M)C6=)IZIUA8+5_-&
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M>S[<PVF,F[S3ER::?J>'3IK/^-DO%HT]>.=9B/";NBDU#T
M
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MN--UML]\5O\ &I::S,>GPG36)B9B8\8F89(8XZ\
M
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MW&*F:GCZ_9O'CZUG/&[[#RG';?D]O_\ +[C!3+7_ !<E8O7_ -$P\&[US0
M     $BGM-=]R^.'N'>+G8<MU]-@LEV18=:;=ZUU=V^-_-3MNWN>MLM?Y:.T
MNK7ZNSUO\YZ,O1')ZD=-UCX9>8Y*HZ:>8\?%?V'7S&^'KNCMZM.K?8^-MO-O
MI6LW]_L)C>8ZXYM6W3;-[F=O,QI,TRWKU5BTRP/S/X2.?[$Y+81&N:NWG+3P
MB9Z\$QEK%=8G2;]$TF8TG2TQK&KIW/,FKI
M
M
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M.E8F*UC6=(B(]3,S#74@
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M?VZQTM,[78Q&VIZ/"<>LY?1_[ZV2-9\9B(UTTB(F30Y:F
M
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M:\C@B^L1I'O<>F/)$>J9Z8QWM/IF<DS,:SK-A%7VT6
M
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M3Y)F-)G;1J9BX
M
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M\OM],3IGW<1MJ>,1K[[PO'C.L_88R3I$3/AZ--9CI'/.&K_
M
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MS]659F;+DSY;9\TS;+>TVM,^F9F=9F?S9?2<9\P
M
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MRO-]D9.0Q5F=[QUXS5T]/NYTIFCQ\-(K,9)]?V.-)],3T*'GU05
M
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M.D:>\P3I/CKKXX[XXB)B/K9TF?&*V:U9Z.X
M
M
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MX
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M '^?6T>/ZE@TO/YGV6<6FOIB+:1.FL7L%&"&
M
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MM$:1;IM,1:(GQB+1I:-?'28U9F8:ZD
M
M     !I_Y_\ C_\ QI/"WR4Z)@LOQ'-[UU7L7YFV?,WH1S=BZQ''N/6GU,O%
MED9*+./L#7L;5/Z<-<O,--7$?PK^6KC;WD%W_P#DO\Y^V^^LE_=[+8\KA^<6
MTUF-IFF=OO-(ZJ1U3M<N:*ZVBO5,=6M=8G*NQ^<_@WW=Q_-6GIPX=S7WD_\
MNK_8\VGC'C[JU]-9TU]/@Y7KU*K*         $ZGV[O?<O3WN,ZGI5Y=>CKG
MD-H>Z=39*BYNKNC'V^;MK.+L/4,EQ:0W45K/F)<WI'&(M998IN8J,Q-13Q1Z
MM5=,&?I#.PZ]X?#KN^:PTUY'M[?[??TTK6;SCM:=IN*=4UFT8XQ[GW]ZUM7J
MG;TF=>F*SICSXX2.5[!R[RD:[C89\>>-(C6:S/NKQKIKT].3KM$3&ONXGQTT
M="YY\D%
M
M                                   %"O[F#O:X["\Y=4Z7M,E--@/'
MOJ7 V-UB*KBN2WQ^^]GU\;UL-_%;_/Z-M-E-)EU>B3X4\25TVM'-555/R4T7
MP_1J=BX^W_(_=]YYL41O^X.6RVKDTB)OM=E_HV*LSZ9BFYC>S'CI$WF(B)ZI
MF:_P\\+78]FY>7M6(S[_ '5IBVGC./#]CK&OKTR>^T]7M3]76NBL2;[
M    =.WVFNA(O'#V\?%SKV6U^FSN2ZWL.R]N]:UM+?)<[5VW<7/9.5L,M):6
MUK]9>:U^<T>(HDD]22FUQT,7,DE,=-7/F4^*_ORWF-\0O='<-;]6QQ\E;9[?
M2UII[C81&SQVQQ:UNFN;W,[B8C2)OEO;IK-IA75YG\W//]]\EOXG7#7<3BIX
MS,=&"(Q5FNLSI%^B;S$:1K:9TC5(JCNP(
M
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MZQU5UMEG3T1:,MK4MZ9GHC6?#2)L4*VH
M
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M$Q,19MQ/);?F.+V_+;2==KN<%,M?\6]8M$3Z/&-=)B8B8GPF(EC=D;L
M     %Y?[8_R;K[ \8.S_&+.Y"&3,^/F[4[+IMK+=6\5QSUMVU<93-3V-CC_
M $J+BZAP?8F.S%S=W/%<O%%6<MXJ^(_[5S+1Y])GY9UX#S.XSS-V..8V?<&R
M]SN+169CYYL(ICBUKZS%9R[2^WI2FE=8VV2T3;VNF&OQ$]NQL>X]MW'AK/NM
M]AZ,DZ3I[W!$5UF?1'5BG'%8\-?=VF-?'2S6K/1W
M
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M;28GU3$3'C#JJ/+"K3
M
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MGT.JT\KRM(
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M8X?$X^WXYIM[#&8RUBLK"R@IJYJJXAM;6"BBGCGGGGY:>'E6WF\W/(;S+O\
M>WG)O,^2V3)>?3:][3:UI^K:TS,_5E6=FRY,^6V?-,VRWM-K3/IF9G69G\V7
MTG&?,
M
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M-XB(B9F;8IR5K$>,VF/S)Z4#S=*^P
M
M     %+7[I+H*+"]J^.'DMB<=9PP[YI^P]2;A=VOTEM/+F]#R-&RZI>9&#BJ
M.YR-YDL)MM];4W7%$O,=OBHH9:Z*>+:FJYWZ+SOVV][5[C\M=WDO-]AO,6_V
M];=4Q&/=4]SGK2?&M*TR8,5YIK76^>UZQ,SDF)<_#=S<YN,Y#M[+:9G!EKGQ
MQ.L^SDCHO$3Z(B+4K.GAK-YF(GVI51UJR3(       #:+P?TZW["\S_$G1KW
MC)?A^V^2W1NOY63#\4?B=MA\IV;K-IE[VRKEM;V"&:QQDLLW$DD,D47$?SUT
M\T4\\-8>=W,9.W_)GNWG,/N_G&T[:Y/+2,FO1.2FRS6QUMI:LS%KQ6ND6BUM
M=*S$S#'.\=W;8]H\IO:=/O,7';BU>KT3:,-YK$^,>F=(TB8F==(\75@>5M6@
M
M
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M8F9CZV=(GQFMYA1XAJ
M                                                     YCONU>4
M7\;CSX[[[+QM_P#7:/@-DJZKZRJHY^:TJT/K3F36K#*V',EK:7?%GN&7MKW/
M<47%/,T-65JCY^'%%--/IF^$WRO_ "2^0O ]M;G'T<WN-M\^WNOUWSK>:9KT
MOI:U>K;XYQ[76D]-HP1;QF9F;$_*_MO^"_9&QX[)7IWE\?OLWR^\R^W-9\9C
M7'6:X_#PGHU]>J-](UGX         "SA]L5XU_GUY.=K^3.:QOK83H70X]4U
M*[NL;\T=/8O;'UN.FO\ $Y2;^U\7F$Z_PV7M;N*"GF6F+.0\R5QT24T3UF_2
M:^9/WB\LN*\M-EDTWO/;^<^>M;^/S38]-XKDI'CTY-UDP7QVM/3-MM?IBUJS
M-([?$5W#\R[=VO;N&VF;>Y^N\1/_ #6'2=+5^2V6U+5F?#7'.D3,:UO)*/D-
M@
M
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M$3I6T5M,1IUUM'JT;O-),.
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M3GGISE.([ S[2LQ&YWV6F"OC&NFOO,DZ3$ZQT4FDSX=,WK.L3IKT0'GI00
M
M
M                          4'_N5^@+WK;SKPO=EO9S<:]Y(=8Z]EJ\G5
M!?1V\^\]6V5AUUL>*BGN;NZLYYL;I]AK5Q)]/Q;4T4WU'%</S\\SW%\_T;/?
MV'N3R+S]E9+Q]\.W.3RXXIK69C;;VU]WAO,16MHB^XMO*QU]<S.*=+].F/'-
MKX>^<IR'9=^'M,>_X_<VKIK&ON\TSEI;PB)C6\Y8C77ZV=)T]FM=U88WP
M     Z&?V]7C=7T5[>FJ[MF+&:SVWR/VK.=PY&FZJMZ[BWU:OT=4Z]M(JK:G
MY.,;?ZQKU&:@IKJDEIJS,G%=5//]JB\]_P!(-YCU[Y^(/=<)L[Q?B>W-KBX^
MG3K$3GC7/N[3U>/77-EG;VF(BLQMZZ1/U]H)^>O<$<UWWEV>*T3M>/Q5P1IK
MI-_K\L^/KB]O=SZ(^QQI\LSGH.-,@
M
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MKZ^U?WG'W!'<'?V\R8[1;:[28VV/T^C#K%_S=<TY9B8\)B8TU],RWHEM7
M
M
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M']M=6'9=V;>OC69VV:8CU3K?#:=(]$3&2LS,^FU*QIZ[C*GI%$
M
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M<?%L-)B=:WR=7V7)729B:VFM:UM'A:M*VUTF$WJ$K3H
M
M
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M7I'6N.
M                                        I(_<\>5/YX]Y=2>(^MYJ
MSNL%TWK=/978UA9<?--;]F=@6]5&MXC-5R_&J.\U[KF.#(6U$/%%'-OLW-4E
M4M7R4P77_1D^5GWG['Y;S:Y+#>N^YC<_,]I>WHG9[6=<V3'$>FN7=S;%>;:S
MU[+2L5CJF\P?AT[:^:<-NNZ-Q28S;O)[K%,^O#BGV[5^I;+K6=?7A\-/'6K6
MM$21          ;@> OC/D/+_P PNA/'ZVL_K,1NV^8Z?>>>;J:PIM.L]8IE
MVKLJ\IOH*XI+>\BT?"WW%GQ3)%7/>U0PT5TR24<M0^??F7M_*'R@Y[O_ "WZ
M-WLMA>-M[,6ZMYFTP;.O3.L36=SDQ>\UBT5QQ>]JS6LPQ7O?N''VKVION<M.
MF7#@GW?AKKFO[&*-)],>\M7J\)TKK,Q,1+J>6]O;V=O!:6D$-K:VL,5O;6UO
M%1!;V]O!13%#!!#%33'###'3Q3333QQ333QQQQQ\'EMR9,F;);+EM-LMIF;6
MF9F9F9UF9F?&9F?&9GQF5;%K6O:;6F9M,ZS,^F9^67[/P_@
M
M                                                         "C_
M /<[^,-OHWD+U'Y3X&RABQ_>VJW>D[S);QT4U_G[U9;8FTQ.5R55%I#ZDV=T
M/*65G;U52SU\QX&NGGB.BF/BN[CZ,GS.R<YY?<OY6[^\SN."W5=SMHF9T^:[
MZV2V2E/:G2,6ZIDR7B*UC7=5F.J9MI,7X=.X[;W@MUVUGF9R;++&3'K_ )O-
M-IM$>/Z')%K3X1&N2/3,SI5]6=I&@         -J/"'R/R'B-Y9=$>15A#]5
M#UIOEA?[!9<5342Y'2<W;7>K;_B[:6WXKEAO,GH^<R%O#)\DU,<LE-544M/'
M,=6K?.WRYV_FWY3\[Y=Y[=-^2V%JXK>$Q3<XYKGVMYB?":TW.+%>T:UF:Q,1
M:DS%HQKO'@*=T]L;W@;SI.XP3%9^3)68OBF=?5&2M9F/#6(],>F.J1ALQC-A
MP^*S^%O8<CALYC;',8G(6_/-5O?XS)VL5[87L%57%-7,-U:ST5T\\\<<_+5P
M\L^\V>YX_>9=AO:3CWF#);'DI/IK>EIK:L_5K:)B?JPK6S8LF#+;!FB:Y:6F
MMHGTQ,3I,3^9+Z3C/F
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M3Z<=+5F/LT^BTQ/V*/#]4GV+O*DI#L
M
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MB=)TZLE]/T>2:Q.FLQ2O32-9BUK2KHKM:
M
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M=^)#N.V/!L>U,,S'O)G<Y?5K6O5CPQX3XQ-O>S,3&FM*3'C'A<?4[HG@
M
M
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MIZLM=?'5.&A$TX
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MF9F9G69F9\9F9\9F?&91XM:U[3:TS-IG69GTS/RR_9^'\
M
M
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M9ODF-=;VF9\9BL5K/3$A*/K!0
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MO*T>PT
M
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M3#&CH1//P@L
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M9\9F?2_L?%^
M
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MQ$1ZHAGA@CI0
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M1TIGFW5\@
M
M                      *FGW0WBQ1F=&Z+\R,###^)Z7DJ^B.Q..*+B2]N
M]6V.3+[?UWD^*_GXM+7&ZQLL.:M9OCQS+-/L%O\ #]3%5\+7_HPO-*VRYSG/
M)W?VGYMO<<<IM/1%:Y\,8]ONZ:?76OFPSMKU_0UKM,FOC:$G?AQ[EG#O=[VG
MGF?=YJ_.<7HTB].FF6/EF;T]W,>J(Q6^6%,A<HEJ          ^QKVP9O4\_
M@]JUK*7F$V/6<QC-@U_-8Z:JWR&(S>&O8,CBLI8W%'ZJ"\L+^VCEBKX_+371
MQS_Y'$Y#C]ERVPS\5R6*F?CMSAOBRX[QK3)CR5FEZ6CUUO69K:/7$S#Y9\&'
M=8+[;<5B^WR4FMJSXQ:MHTM$Q\DQ,Q+J>>#GDOB/,#Q0Z0\A<7S#'==@:3CY
M]KQT,]K/QA-^P_,F!WW"_-:<TT>CCMMQEY1!S5'!)):^E)5%%S7Z=/EM\[_+
M7>>4/FMS?E]NM9Q<?O;Q@O,6CWFUR:9=KD]KUWP7QS;2;1%^JL7MIU36QWEV
M]E[5[GWG!9=>G!FGHGQCJQ6]K';Q^6DUU\9B)UC6=-6US5+&0
M
M
M
M
M
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M0
M
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M;5C77YMFTB=?T5\-YT\/#VZ3:?'QQUUGV8BX.J"15
M
M
M
M
M
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M.<MN>8WDZ[K<Y[Y+>,S$3>TSTQK^AKKTUCU5B(CPAE1BSK
M
M
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MSXQ*M;=[7<;'=9=CO*3CW>'):EZSZ:WI,UM6?JQ:)B?S'I'6N.
M
M
M
M
M
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M<\AEUOZ-8PX9K:?7K7KRSCTGT6K7)7Y5[!1@A>
M
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M6M"3S][5^\O==><V]8C8\E2;3IZL^/2,NL?X433)KX=5K7\/9F9L.J]6B
M
M
M
M
M
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M-:@
M
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MVB:VC6-8UB=)C6)B8^I.K[#AOD
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M<[SC*8?'6:WSWM'AX:5G!2)\=(GVHTCQ\=-)QM_6G^@OY*O<'^6>E_W%D?\
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M'H9:8FZL
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M6FMHF+1.DQ/IB?DE^S\/X
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M[QO(\;?W7([?/M\NLQIDI:DZU\+1I:(G6LS$3'J];WCH7"
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MG]S_ ,$^R]YR6*_1O\E/<X)B=+>^RZUBU?\ "QUZ\OCZL<NG$\S*NP
M
M
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M-+5UTUSW9?=?;$S]_=AN,&./T<UZL7C.FGO:3;%,Z^J+Z^,?+&NVC4[%P
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M&VG72)O28I:=-?9OXTOX:_6VGT3\DMA&OG1
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MI'5;3366?;#B^,XO'[GC-M@VV+2(Z<6.F.-(UTC2D1'AK.GR:S\K'K('.
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MNB>0[@P=L[:TSM=C3KR1$QI.;)&L1,1_>8^G29G6)O>-(],V:U9Z.X
M
M
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M2VYY':^]XZOISX)][CB(],V\(R8Z^KJR4I69\(F92<HS-=
M                         /QN+BWL[>>[NYX;6UM89;BYN;B6B"WM[>"B
MJ6:>>:6JF.&&&.GFJJJKGBFFGCGGGGX/WCQY,V2N+%6;9;3$5K$3,S,SI$1$
M>,S,^$1'C,O[6MKVBM8F;3.D1'IF?DA"1Y?^_MX)>,/XGKFD[/>>379^/O),
M?+J?3\L,VI8NYA].J27/]K7\7YG?1_+ZD?PPE6>NX[FCB.:WBIYYDIFOY0_
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M9*S2T?FQ:(G\R?1/J>V=(X8
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M+RG\I-O;!Y=\%L.-O;Z[+6LY-S>(C2(ONL]LNYO6(UTK?+-8FUIB(F]IG?G
M=G=L=K4FG [+!MYGTVB)MDGU:3EO-LDQ\D3:8C6?EG75=M)DH
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MLT^O'".G='8'=G:%[??K:9*[2)B(STB;X)U\(^R5CIB9]5;]-_\ !;R-'L-
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MQ;-K\[S1,1.MZ6VDQU],5UI%[2-[9^'7A=G%<_=.YOO,^NLXL6N+%Z8\)O\
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ME.1W7,<EN.5WTQ;>;G-?+>8\(ZKVFTZ1ZHUGPCU1I'J9"8^X
M
M
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M+%>(OCG7US%9BMICPZZVCU-S&FV)
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M[4\N>TNSL<?>C:UMO=/'/ETR9K?^O,1%-?#6N*N.DS$3TZ^*/UO]G
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M6CQB9CQ1RW_'[_B]U;8\EARX-Y2=+4R5FEH_-BT1/YD^B?4]LZ1PP
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M+Z1-9G2=*Y*TO,1,Q72-6^[0S"0
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M<>&TQI;)]=EOZ_;R6UO,:^,5UBE9^MK6/!J6VPR<
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MS.+),:1_>Y+S,Z5A>&4B(<@
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MIC+NK1FS1$Q^I8YF,=;1Z=+Y8ZXGP\</I]*ZVI91"
M
M
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MKT6]./)$:>UCO&M;QXQK$3K69B+Q6W@V<:R8Z
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M*;#CL6/!LL<:4I2L5K6-=?"L:1&LS,S\LS,SXR\>[=R@
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MJ>FEXTG2?1,3Z+5GU6K,UGU3+*C%G6
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MO>V>R-OT<1AZM[:-+Y\GM9K_ /K:1%*^KHQQ6OA$S$VUM.@;?C-P
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M&DQ,>$Q,3XQ,3X3$^A_8^+\
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MWOON6_=O=>\YR9GW&7+TXH\?#%2(IC\)]&M:Q:T:1[=K3IK,MTFF&(@
M
M
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MGTS,SXK3<&#%ML%-M@CIPXZ16L:S.E:QI$:SK,Z1'IF9GY7R'+?4
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M;L_L7MWLG9?-N&PQ&XM6(R9K:3ERZ>/M6T\(U\8I6(I'R:^+2%NUF(
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M:1$1'A$1'A$1X1"0M:UI6*UB(K$:1$>B(^2'XOV_H
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M)/\ \KDGU8K:[:9\*SMZ^F-OF!Y";/D.OE.RNC;[WTSMIG3#?Y?=VG]3M/\
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M!]I["..X+;TPX/";3'C?):(TZLEY\;6_-G2/16(CP:WMC._
M      =6;PFVC(;QX9^(^Z9:&SM\IM_C'T)M&2M\='-%CX,AG^JM4RUY#8Q7
M-Q=W$5G%<7=5,5,DLM=-'''%5=7/QYY\K/G5Q>WX3SD[MX7:3>VUV?<W*8*3
M>8F\TQ;[/CK-IB*Q-IBL3:8K6)G72(CP5G]X;:FS[MY39XIF<6+D=S2)GTS%
M<UZQKI$1KI'CI$?F-G&LF.@
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M8+1&_P"2M.&(UF)]UIKGM&GICIFN*T?^]CPF-70H>?5!4
M
M
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M<7CVO1[5<5?1BQS.OA&M[1.E[VB*Q$5Z4K90
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M8Y]]>(]YFOI.7+,3,QU6B(C2NLQ6M8BL1ZIF9F=(6[68@
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M8'-;W[Y<QN^1ZIM\XW.7)K/IGKO:VL_5G7665&+.L
M                   4;?N5/-O]M;OC4O#;2<O]1HOCWZ.U]E?23^I99KNO
M9\/_ 'A83?)5-:W7[6VBY3B".6.NB2'(9W)VD]'%=MQ\+P/HVO)/^"O8F[\X
M^;P]/.=P:X-GU1I;'QN')[5X]%J_/-S3JFLQ,6Q;7;9:3TY)UF3\/G9_WLX7
M+W9O*:;W?>QBUCQKMZ6\9^6/>Y(UF)\)KCQVK.EE8]9FD2           Z0/
ML>>(?\4OP)ZZ_'+/Z?L;OKZ;OK??J;'Z3)8S\]<'B/S,U.Z^HMX,G;_FUI5I
M9?46<_\ ^*9:YO\ Y::>9*OCYR?C>\W/RL>?/(_,;]7;O Z\7M=+=5+_ #;+
MD^<9ZZ3-)]]N;9.G)7Z_!3!K,],:0"\X^Z?X3][;CW,Z[#9:[;'I.L3[NUO>
M7C2=)Z\DVTM'UU(I\D)@40FJ@
M
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MNQ^Y<?=O:VSYVLU]]EQ:98C]#EI[.2NGICVHF:Q/Z&:S&L3$SIRW"RL
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M.D^%H_P;1I:L^NLQ+,#$'5
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M.Q-WT;^OO>,O.F/<4C['?PCPM&LSCO&NG3?TS$]$VB-4D".+
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MY<6+<8K8,]:WP7K-;5M$36U9C2:VB=8F)B=)B?"8\)7#?:O^X6M\Y7KW0/N
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MR4\;SF+HO.LTR5UG%EK'Z+'?2-8\8UB8B]=8B]:S.C;1J9BX
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MLMIQVUQ['88Z8=GBK%:4I$5K6(]41'A#RKM')
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M,GR2W_;OO.:[8B^YX*-;7Q^,YL$>U:9_]YBI6(]O7KC]%$Q$W605<C0
M                   #2WS9\^?''P(ZVKW[O3;X8,MDH;NG1>L<#-97_9/8
MV0M:>/5MM7UR6ZMY/PVSDDCIO<I=56^+L.98Z9YZ99H(Y=S^2GD+YC>?/<D<
M#V-L[6VF.U?G6]RQ:NSVE+>BV?-%9CKM$3./!2+9LO3::8YK2]JY=V?V1S_>
MW(?,>&Q3.*LQ[S-;6,6*)]=[Z3XSX]-(UO;2=*S$6F.?W[B7ND>0WN)[M3=[
MQ=?F!T]@;RZET'HW6,K<W.LX&*>2+T\EL^3YML;-OVX<PV\=->2N[:&&'GY_
MHK6RCEDCJOY^'CX7O+WX>.%G#P=?G_=^>E8W7)YL=:YLLQ$ZTPTUO&UV^LS,
M8<=[6M[/OLN:U*VB<78?EOP78>SZ-G'O^5O$>]W%ZQ%[?4I&L^ZQ^,^Q69F?
M#KM>8B4::2;80                    "2#VE/&?(>57GYX^=?TV?U6K:ON
M%AVUV-)5=SV4%OH?6%Y:;1E+:>YLZZ,C%^<F1M;3#156W-,U%QDHZOGAIXJF
MCCE\67F7M_*SR#[@Y^;]/*;K9WV&TCIBTSNM[6V&EHBWL3[FELFXM%]:S3#:
M.F\S%+8!YH=PT[:['WV^UTW.3%.#%X:ZY,T32)TGP]B)MDG7PTI/A,Z1/3B>
M9E78                                      U=\T_)? ^'_BWW5Y$Y
MWG&S2=<:3E,AJ^(RL\T%EL^_7T?&*T#5)J[7GZRF'8]POK.TFKAXYDA@EKE^
M'PCYYXVAY+^6N_\ -_S1X7R\V/O*UY'>TIGR8XB;8=K6>O=9XBWLZX=O7)DK
M%O"UJUIZ;0R3M'M[/W5W)L^!P]41N,T1>U8UFF*/:RW\?#V*1:T:^$S$1ZW+
M#W+;]F["V_:M^W7,WFQ[CO&R9S;]MV'(U45Y#.[-LN3NLUGLS?5QT1T5WF4R
MM[+/+S333QS77S\../[#U)<-Q'&=O\1M>!X7#3;\/L=MBV^#%3PIBPX:5QXL
M===9Z:4K6M=9GPB%DVTVNWV.UQ;'9TC'M,..M*5CT5I2(K6L?4BL1$?F/-NQ
M<@         !)Q[0_AU_'3\X>J^O\]@?QWJK2+SCM;N6&XI_]5W&AZ;=VESQ
MKN4YYAEXEL]WV.>PPTL-'-$U=M?2U45Q^GS)1&;XN?.'\B_DARO/[#<>X[JW
MU/F/'3'U\;K<5M'O:>,:6VV&,NXK:=:Q?'2+1;JBMM=^:?=?\$>S=SOL%^CD
M\T>YP:?71DR1,=5?JXZ=62)]$36-8G72>F4\TJO$
M
M
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MHL#QY*9:5RXK1;%:(F)B=8F)\8F)CPF)CQB8]+^-]GZ
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MN!]YS/:5<FZX6-;7P_79L$>F9KZ\N./EB)R5KIU1>(MD665;"/8
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M$1X1$>$0DY6M:5BM8B*Q&D1'HB/DA^+]OZ
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MCLJUN1V,VW?;FOZK$>WB^MC3/6(B(UM.E;UUK.GM=$S%4VZ%#3P
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M3@N)[<XZG%<+@I@V6./16/&TZ1$WO/IO>T1'5>TS:VGC+#+,G;
M            +_OL!^W7D/$GQ^R7?7:^ O,/WWY$V>/NJL+F+.>PRW7?4=GS
M'>ZQJ=]C;^RM\CBMDV7(U5Y;+QUU_#B+C'6]<44]G-S)05\?/Q#[?S9\P,?8
M?:FXIF[#[=O>OO,=HMCW>_MK7-GK>MII?#AII@V\Q'UWSC)6UJ9J=,'_ #P[
M]IW1SM>$XR\7X383,=59B:Y<\^%[Q,3,6I2/8I/R^\M$S6\:6!4 6C0
M                                %)[[F#S;_/GM+2/"31\OZNL]1_1=
MA]O_ $<_Q@O^S,_BJOS1URZ].KX5_F;IN3JNZZ?CS15<9OBFOCB2UX^%U/T:
MODG]X^U][YU\WATY+E^K:<?U1XTV>*_^D9JZ_MC<4C'$^F*;;6)FN7QE]\//
M9_S/C<W>&\IIN-UKBP:QZ,-;>W>/_B9(Z?S,?AX657EI22@          "_O
M]NQX67'CIX@77?>XX^:S[(\LYL'NEM;75-=$N'Z<P$62BZLM^(9/4CHFVN/-
M7^P\SPU\4W6.RN/HDIXDMN5!OTAWG/C\Q/-ZO87#Y(OVYVG&7;S-=)C)R&6:
M3OIUC29C!./%M.FT:TS8-Q-9FN5"#SY[NKS_ '5'";2T3Q_%Q;',Q^BSVT]]
M/_J=-<6D^B],DQ.EE@M7\T8
M
M                                               Q[VWUAJ/=G5O8
MO3V_6<U_I/:.D[/H&U6MK-Q:WLF!VS#7F#R=6/O/3EJL<E#:WM5=M<4T\UV\
M]-$E/ZJGAD':?<_+=E=T<=WAP-XQ\UQ>]P[K!:T=58RX,E<M.NNL=5)M6(O2
M9TO69K/A,N?Q?([KA^2V_*[&8KO-MFIEI,^,=5+1:-8]<:QXQZXUCUN5OY/^
M/F[>*?D#VSX\=A1_^U/56X9#6[B^HMI+2VV#$_+%D=7V[&VTU<D\&'W/5KZR
MRUE3)SZO%I>Q_/QQ5\>./4QY8^8'"^:GE_Q/F%V]/_VOE=G3-%=8M;%D\:9]
MO>T1$3DV^>N3!DF/9]YCMIK&DK*>W.=V?<W![7GMA_\ +;G%%XC76:V]%Z3/
MHZL=XM2VGAU5G3P8'9V[H         !F#Q_[NW;QN[KZQ[WZZN_H]RZMW#$;
M;A_GKDCMK_\ #[CC\0P>1]+GB23#[#BI)["]CX_]+:7,E'_G,0[_ .R>%\Q^
MRN3[%[BIU\/RFSR8,GA$S7KCV,M-?",F*\5RXY_0Y*5GU.JYSA]GW!P^YX7?
MQKM-SBM2WRQK'A:/\*LZ6K/JM$2ZH7C_ -W:3Y(]*=8][]=7?UFF]I:?B-MP
M_P ]<<ES8?B%OQ^(8/(^ESS''F->RL<]A>Q\?^BN[:2C_P UY:N_^R>:\N.]
M>3[%[BIT<QQ>\R8,GA,1;HGV,M-?&<>6DURXY_18[UGUJU^<X?>=O\QN>%W\
M:;O;9;4M\DZ3X6C_  ;1I:L^NLQ+,#$'5
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MKGP6K?!>L6K:LQ-;5F-8M68UB8F)UB8\)CQA\UR7T
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M.L8J:3,3I[=HG2]K1TQ6*-*MLP
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M9GQM.LSXS*R7C]AM>+V&'C=C6*;/!BKCI6/56D16(_Y(\9]<^+Q+NG,
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M>][3Z[7M,VM/KF9E7#GSYMUGON=Q:;[C)>;6M/C-K6G6TS/RS,S,OL.&^0
M
M
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M<DVM/U(B9<[%S'$Y\D8<&ZVU\MITBM<M)F9^2(BVLL9,F=B
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MUK3*KB^*XWA-CCXSB<./;[#%&E:4C2(^69]<VF?&UIF;6F9M:9F9EC=D;G@
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M9G2(<=[^47='9GO-YT_/.#IX_.,<:=,?+EQZVMC^K.MJ1_?Z^"8%$)JH
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M8P8,&UPUV^VI3'MZ1I6M8BM:Q'HB*QI$1]2(?'<M]0
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M[QI?84F-CPE]8G#BF>J]9UC3-EG2V2-)F)K6,>.T:=6.9B)3,H;-2@
M                                *1?W)_G?;]F=K:WX1=?92:75>D,E
M;[?W%<VTM%6/S?:F7P4$FN:_%-!-)1=PZ!K&;F^IX^/'%.4R4T$E%,UC^2[+
MZ-WR*R=M=J[GSL[@Q1'*<WCG;\?6T3UX]CCRS&;+,3$36=UFQUZ/EPX:9*S-
M,Z87P^]E6X[C,G>.^K$;G>5FF")]-<-;3UV\?1[V]8T_P*1:)TNJXK04D
M        %Y'[:OPD_:JZ'VWS)W;$?3[UY">MJ?6OU<'R7N&Z4UC,?W_?P_/Q
M#=6O[9&]8OF>2*6BN.;'X+&74%?-%SS\:/\ Z27SL_A5WWM/)SA,W5P?;^F?
M>=,ZUR<EFQ^S2?36WS/;7Z8M$Q-<NZW.*\=6.-(;?$'WA]\^:Q=I[.^NRV/M
MY=)\+;B]?"/DGW6.=(F/&+9,E;1K59Q5F([
M
M
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MMOXR_B:[6K6FP[MY#/BK$5TWE<&_FU8G72;[S#GR:SZ)O%XR3'AU^C3*N/\
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MVUBE[:3+<W;WF/V7W1:N'B-_BMN[:?8K]6+)K.GLQ7)%9O,3,1KCZHF?1,M
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MQ8JQ7%6(BM8B(B(B-(B(CPB(CPB(\(ANRM:TK%:Q$5B-(B/1$?)#\7[?T
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M$Q,3%IC28GUMM[/>[/D-O7=[#+BS[6\:UOCM6])CTZQ:LS$^'R2\J[1R0
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M[S).E,>.MKWM/R5K6)M:?J1$R^F+#ESY(PX*VOEM.D5K$S,S\D1'C*%3RO\
M?]\ _&^*]PVD;G>>3W8$/U$,.O\ 2%=EE=.M;GBTXN;*?-=L7\L&D28>\EY]
M&J7!2[!=P2<?VRUXX_*FCY4_ +Y^>8]J;SF]G3MC@+:3.7DNJFXM'5I:,>QK
M$[F,E8]J*[FNUQVCZW+KX-O=L>1_?'<$QEWF&..V,Z>UN-:Y)C728KAC7)U1
MZ=,D8JS'HLJ=>;?O;>:WF;^+ZO\ G=^T7TYD?7MOVK>I+Z_Q'XKC9?FH^EW?
M=_GBVG;_ %H*ODN+?U+/$S_V?H*>5KGDI\%'DMY->YY3YI]_>\<>D_/=_6N3
MHO'Z+;;;2<&WTGQI;3)GKZ/?RDYV?Y/]H=I=.Y]U\]Y:OC[[/$6Z9^7'C^LI
M]2=+7C^_E#^EZVH                ]MU_UIV/VSL<&G]5]?[MV7MMS#7<6
MVK=?ZKG=RV.XMXY8())X,)KEADLG+#1/<QT<U4Q<T\5R4\<\_&KCX]+S_<O;
MG:?'6YCNGD-EQO$UG2<^ZSXMOAB9B9B)R9K4I$S%9G2;:Z1,^J7$WW(<?QFW
MG=\EGP[?:Q.DWRWKCI$^G3JO,1Z(GU^I-AX^_;I>X7W';V^7W[$]>^.F EFI
MY^':6T_B.W75CS1%S]7C]1T"TVV6";U).:/ILM=8B;^UU\\\<4\Q\R0J\P/I
M$?A\[.R6VG 9>0[BW\1_^I8.C!6VL^S?<;JV")C2(GKP4W%?&(UF>KIT_P [
MY]=B<3:<6QMGW^>(_P"9II2)^2;Y9IK^;2MX\8^KI,;TS]K?XYZ_197??/D5
MVUV;D()K.[FQG76%U?JG7;CF*XBGN,5?\YF+LS/WV-GBIJMY);:[QES715ZD
M=4%?PXIA[WE]*%YB\A:^'L3MWB>,V]HM6+[O)FWV:-8F(O7W<[/%6\3I:*WQ
MYJ1,=-HO&LSJCE_B0Y_/,TX38;7;XYB8B<MKYKQX:1:.GW-8F/3$36\>J>J$
MF76?LA^V'U?:1PV'BYK>WW__ *OJN\QV9LFZ]@W=_/C9;B6">3'[)L=[KEAZ
MW-S5Q<165C:6]U331Q-'7Q13\(T=R_&U\3?<^6;Y^Z-SL\'M]./9X=MM*UB\
M1$Q%\.&N:VG3[%LF6]Z3,S2U>J==><CYQ>8W)6UOR63%3QTKAICQ1&NFOC2D
M7GT>$VM:8\=)C66Z>J^'_B5HMO=6FD^+GCKIUK?S47%];:KTEUIKUO>7$='I
M1SW4.(UFTCN)HX_U--5?'-7%/Y..?@TQROF]YL\[DIEYONCN+>9<<3%;9^2W
MF6:Q,ZS%9R9K3$3/C,1X:L0W/=7=&]M%MYR6_P MJQI$WW&6TQ'R1U7G1G['
M8['XC'V.)Q-C9XO%8NSML=C,9CK:"RQ^.Q]E!1;6=C8V=M1%;6EG:6T5,<44
M=--$=%/%-/'''''# =QN-QN]Q?=[N]\NZRWM>][VFU[WM,S:UK3,S:UIF9M:
M9F9F9F9U=)DR7RWMERVFV6TS,S,ZS,SXS,S/C,S/C,SZ7]CXOP
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M-*5K6NLSX1"R+:;7;[':XMCLZ1CVF''6E*QZ*TI$5K6/J16(B/S'FW8N0
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M;WM-K3.OCXS,R]4ZIQ@
M
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MHY]TU.QN)./7HL]RU;&?B$-OS)Q;PWN)FYBHXGOYJI*K_I)_(S%S';FU\\N
MP?\ W?C>C:<ETQ/V39WO,;;/:(\.K;Y[^ZM?3KMCSTB]O=[>D5C3\0G9==WQ
M^+O/8T_TK;].+<:?HL4S]CO,>C7'>>F9],UO&L]-(TNJJ7$0P
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MNZNXNY\WO^>WF?<VUUB+6TI6?'ZW'73'3TS];6/"=/0V0:X8^
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MB9DWP'<G!]S[&.0X+<XMQMYB->F?:I,QK%<E/KL=O\&\1/K]'BP"SYW8
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MAZ;4B-?#UQKLO@/<G]O?9,3:9K'>;?BO;6=[Z_HPY_O;K;5,M1]-<S6DGU>
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M'WE^<YGGMQ\[YK=9]SN/5.2\VTUT\*Q,Z5CPCPK$1X,P,0=4
M                                   HD_<<^=5WW7Y$6'B'H^<]?JKQ
MSO(+_=8+2N*2RV#O:\QUY;Y&6:6GBKF7]KO7,Q5B(Z?C35!D+K)QU<<_J>>+
MTOHZ/(S%V7Y>9/-SF\'3W3W%2:;:;1,6Q<96]9I$1ZOG>;'&>9\>K%3;6C3Q
MUFCY!=EUXC@;=T[RFG)[^-,<SZ:[:)B8^VWKUS\M:XYA6S60I @
M +L/VS_A)^8W5N[^;>\8CTMF[<^MZ\Z@^L@^$]AUG@,K3^=VQVOJ4_&C\\MR
MQE-I15\.*Z;?"<U4<\QW7/QI6^DJ\[/OYW1LO)3A,VO&\1T[OD.F?"^\RT_T
M?#;3]K[>\Y)CT3?<Z3$6Q>$0?B&[P^><EA[/V=]=OM=,N?2?3FM7V*3_ /#Q
MSU?FY/'QJM0JM4:P
M
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MHCPK>+5]-9;:-3,7
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MHV.^V7)[2F_X[+CS[+)&M+TM%JVC73PM&L3I,3$_),3$^,/'NW<H
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M<?)5KK?;Y-*Y:QZ)M6(F8R4U_1TF=(FO7%+6BJ.5(IGP
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M?$<SRG [ZG)</GR;??4]%Z3I.D^F)CT6K/KK:)K/KB5/+W%/MQ-\ZZ_'^UO
MZYS':.D1?69?)=#;%D;.?LS6K6GZW(7D>@9VY_#K?L'#XZWHXBM,9<<_G'71
M3'%'7EKJ3FKFX#X>/I&>![B^;]J^>U</%\W/3CIRF&EHV>:WLTK.ZQ1USM,E
MY]K)FK_HD3-K6KM,5=(E7V%Y_;+?]'&=ZQ3;;R=*QN:Q/N;SX1'O:QK.*TSX
MVO'V+TS,8JPJX9G#9C7,QE=>V'%9+!9_!9*^PV<P>9L;K%YC#9C%W4MCD\5E
M<9?107N.R6.O8*X9X)J*)89:*J*Z>*N.>%H.SWFSY'9XN0X_+CS[#/CKDQ9<
M=JWQY,=ZQ:EZ7K,UO2]9BU;5F:VK,3$S$I(8LN+<8JY\%JWP7K%JVK,36U9C
M6+5F-8F)B=8F/"8\8?-<E]
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M[G[OO;:[6T[#A)UB,6*T]5XG_/9(TF^OC[-8I32=)K:8ZIFE0P:B
M        0>>X3[%/BWYGUYSL;KZWA\>?(*]AO;N3<=/Q]'YC;SEJK>/BS_;&
MT.*J+'U357$//J97$<6&2DJN*Y;OF_YHBBIF[\/OQS^:/DS7!V[W!:>X?+^D
MUK&WW%Y^<[;'K/5\TW4ZWTTGPP9_>X8BM:XHP=5[3N/L7SG[D[2BFPWTSO\
M@HF(]WDG[)CKKX^ZR>GT>BE^JD:1%>C69FD!Y@^"/DYX+;M:Z9Y#]=7FN0YC
MZJO4=XQ,OX[UUO-O9R?)<RZKM]I'3875Y:TU1R7..N.+;*V44\-=S:PTS1<U
MW<>4'GKY9>>7"VYGR]Y&FYOAZ8W&VR1[K=[:;1[,9]O:>JM;>,4RTZ\&2U;Q
MCRWFE^F8O:O>G;O>>SG=\#N(R333KQV]G+CF?1UTGQB)\8BT:TM,3%;3I.FG
M[;S*@                                         'V-?U[/[9F\7K6
MJX/,;-L>;O(<=A=?U_&7N9S>7R%Q5\EO8XO%8Z"YO[^\GJ_)1%%'775S_8XY
M<3D.0V'$[++R7*Y\.VX[!2;Y,N6]<>/'2/3:][S%:5CUVM,1'KE\L^?!M<-M
MQN;TQ[>D:VM:8K6L1Z9FTZ1$?5F5JWV\OMN-FVS\,[1\^\G>:;K,]G89'">/
M^E9>B/=LI7<_)<\\=G;=:T2V^H6<-O3Q'7BL55/DY:I^?4O<=);50SU7?$)]
M(]QG%>][7\A,5-YR5;VIDY7<X]=M3I]G_0MO;2=Q:9\8SYXKAK%8Z<.XKDB^
M.-'??Q ;?:]7&]D5C+N(F8MN<E?L<:>'V&D^-YF?&+WTI&GA3)%M:V]>I^G>
MJNB=)QG7'3/7FG]8:+B/FKL=7TG 8[7L33<R1Q1W.2N;?'00_B&8R'H4U75[
M<<RW=W+QZDTDE?/-7-1?=?>'=7?7-9>X^\N1WG)\YF^NS[G+?+DZ8F9K2LWF
M>C'368ICITX\=?9I6M8B$6>3Y7D^:WEN0Y;/EW.]OZ;Y+3:VGJB)F?"L?H:Q
MI6L>$1$,D,<=>
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MTWWF?+;)>T^NUYFTS_RSX1ZH\'MG2.&
M
M
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M@_/OLNW.=OU[CV-.KD>.BTWT]-MM/C?\WW4Q[R/DK.2?2OG*(4*0
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M>V_T"\8>6K77)MKS'O*QKIU5]$9*>CVZ:].M8O%+3$(V4D&P
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MZ;#Y_P 'FZM-(OCM'3EQSI$Z7IK/RZ=59M2TZ]-[:2T_;>94
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M7?GF=W#WWGFFZM\WX:)UIML=IFGA,S%LEO#WN2-=.J8K6--:TKXZRBHP-<
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M[.^NWVNF7/I/IS6K[%)_^'CGJ_-R>/C5:A5:HU@
M
M
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MBN3V?-<9@Y;C[=>RW.*N2D^OIM$3$3'JM'HM7TUM$Q/C#&[(W/
M?V8[(Y#$9"QRV)OKS%Y3%WEMD<;DL=<S660QV0LIJ+FSOK&\MJXKBTO+2XBI
MDBECJIKCKIXJIYXYXXY?'<;?;[O;WVF[I3+M<M+4O2]8M2]+1,6K:LQ,6K:)
MF+5F)B8F8F-'YR8Z9:6Q9:Q;%:)B8F-8F)\)B8GPF)CPF)]+IM^U?YO6_GMX
M@:+V_E9L;'VA@YKGK_N?$XV*BUM[#L378;:JZR5M8455<6>-V[#7EGE[>.GX
MQP4WM5O35SS!5\/,[\4ODED\AO-[?=H;6,D]L9XC=<=DO,VFVTS3/32UOT5\
M&2N3;WF?&TXXR3$1>%=OF5V=;LGNK-Q6*+?>V\1EV]I\9G%;72)GUS2T6I,^
MF>GJ]:1M'1@(
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M^$_JGHIBR>'IC3'>9TB*3I6:P2SA(P
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M+:9FUIF9F9F=9F9GQF9GQF9\9E&RUK7M-K3,VF=9F?3,_++]GX?P
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M:M[3:[>[CX?NGC:<KPF:N;:7C\RU)]=;UGQI:)]4^GTQK68F< L^=V
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MIK/N\^D1K;%,QI%IG7[#,S;3QI-XBW3!*G2W0
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MDW&^OZ;WG6=(]$1'HK6/56L16/5$,J,6=8
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M1PP
M
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M3[+B_P#TE:Q,1&DSDIC\=-8GHX/.B@*
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M/=][B<.69V_!5MKCV]9\/#T6RVTB<E_DU]BOZ"M9FTVE717:T
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MVI,^ZPUU]WBB=(F*Q/IM.D=5YUFT_)72L;R-'L-
M   1[^X![:OCI[AW7U6N]IX?\V>Q\+9^GU]W=JV.Q5/8.FS6_-_<66+N+RZM
MN:MFT.:_R,LE[@KF6BWG]6N2WDM+STKR&07D#\27F)\/?<'WQ[6S?.>W,U]=
MWQN>]_FFXB>F+7BM9^P[J*TK&/=4K-Z]-:Y*YL/5AOG78_F#SW8F^]_QM_><
M?>?LNWO-O=9-=(F8B)]C)I$17)$:QI$6B]-:3S]?.WVZ?)'V^^P?S4[GUGZW
M3<W>7-'7?;VMTRWW7W8%E#Q7)QQ8W_P];!;);0T<_5X;(4P9"W^7F6BB:TK@
MNI[^_(OXB?+CX@.W_OKV;N>CF<-(G=[#-I7=[6T^'M5]&7#,_J>XQ3;%?7IF
M:9:Y,5)R=E]^]O\ ?.Q^<\1DTW=(CWN"_AEQ3]6/T5)_0Y*ZUGT3,6BU8T/;
MV9H                                  ])IVG;7V%M>NZ-HVNYC;=RV
MW,6&OZQK&OV%QE,WG<WE+B.TQ^+Q>/M(Y;B[O+NXEIHHHHIYYYYY==S',<5V
M_P 5N.<YS<8=IP^TPVRYLV6T4QXL=(FU[WO:8BM:Q$S,S+C[O=[;8;;)O=[D
MIBVF*DVO>TQ%:UB-9F9GPB(A<]]K+[?'6>L/S8[]\ZL9A]V[&C_#=@U#H&BX
MKR>DZ+=4_@^8QM_V5/#Z%GN>X8R\BFMY\-3S>:Y'3\?5KR'-=/H4S_%'](%R
M?<_SKL+R,RYMEV[/7BW'*Z=&YW5?LF.]=G$ZVV^WO6:WKN)]WNYG3IC;Z3[R
M)/F3YZ;CD?><'V9:^'8>-;[G33)DCVJS&*/&<>.8TF,GLY9]48]/:M0JM4:P
M                                                  'XW%Q;V=O/
M=W<\-K:VL,MQ<W-Q+1!;V]O!15+-//-+53'###'3S5555SQ333QSSSS\'[QX
M\F;)7%BK-LMIB*UB)F9F9TB(B/&9F?"(CQF7]K6U[16L3-IG2(CTS/R0YION
M]^=]QYY^7^U;IKF4R4W276\//7'2&)NI:X[3\VL5-\V>W3BPHFYM*,EV'LO$
M]_S/S'1=\XOC'VD_-7T4?P])WPB^16/R'\H=KPW(XL<=[<E/SSDLE8B;>^O'
MV+;=4QU=&TP].+IUG'[_ .<9<<1[ZVMA/E9V57LGM7%M-Q6L<QN)][N+1Z>N
MWUN/7TZ8J:5TUZ>OWEJZ=<HM4HFR           %VW[:OP5N^M^K=M\VNP\'
M])M'=%G-I?3,5]1%];C^J,3E?FV3::(.>:I[+\_-LQ4<-OZM$<M>/Q%%Q%\U
MM?45UTH_22^>>+N/NC:>2G;V?KXOA;QN.1FLSTWWV2GV'!,^BWS7!>;7Z9FL
M9=Q;';3+@M%8??$'WI7D.2Q=G["^NVVD^\SZ>B<UJ^Q37T3[NEIF=-8ZKS6?
M:I,1:55=(W
M
M                                          ,/^0'2.D^2/2G9W1'8
MMI]9IO:6GY?4LQ\E$<ES8?B%OS^'YS'>KQS''F->RL<%_92<_P#HKNVCK_\
M-9?V!WMS7EQWKQG?7;M^CF.+WF//C\9B+=$^WBOIXSCRTFV+)'Z+'>T>MVO!
M\QO.W^8VW-;"=-WMLM;U^2=)\:S_ (-HUK:/769ARP_(?HG??&3N[LWH3L[&
M38O=NK]JO]:RT<MO/;0Y&WB].[PFQXRBYIHEFP.UX"ZM<ICIOA\MQ87D,M/Q
MIKXY>I+R][ZX'S,[)XSOSMG+&7A>4VM<V.8F)FDSK7)AOIX1EP9:WPYJ^FF7
M'>L^,2LGX'FMCW%P^WYOCK1;9[G%%Z^.ND^BU)T_14M$TM'JM68]3#+,G;
M         .A;["GGO_&X\3K'JK?,W9W/=_C39X30<S#-=?',[9UG9XVVL.O=
M[N([B>6\R%YQ9V=>*REUSS)7)?67%Q/537>T<<^?+X\?(;\DOFO?NG@<%Z]D
M=RWR;K',5^QX-Y:\WW>UB8B*TKU6C/@IX1&+)..D3&&=(*>=G9/\%NY[<GLJ
M3'#\A-LM?#V:9IF9RXXTC2(UGKI'JK;ICPI*=5!EI@
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M-(R4GQUFOJR4UB=+T]$:==:6GI1RI%,^
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M<YGOGWEO7.D5K'HBM*QI6E8T]%8C6?&=9F9G/#!'2@
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M1;%:(F)B=8F)\8F)CPF)CQB8]+^-]GZ
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M+YO<QWK:W';&+;3MS7]2B?;R_6SKGM$S$Z6C6M*Z5C7VNN8BR;="AIX
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M9;=5[WF9M:?JS/R1I$1Z(B(B(B(B'MG2.&
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MVZ;Y)_YS)I.DV\*Q^AK76=9148&N
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M/IM>\S:UI^K-IF9_->D=:XX
M
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MS,SXS,SXS,^,RCK:UKVFUIF;3.LS/IF?EE^S\/X
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MGU>U:9]S>?'V;S-)F/#)%K5QQ6_6-M_@
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M%\9%MEV]:-)I$_9<L>OWMX]%9]>.OLZ>%ING;06:7
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M=9G2-(CU1$1$:16(B(CPB(ADYC+K@
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ML?RUO.2%CM7.T"
M
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M''U^Q99KCW41ZKZ17%E]'HM$>[O,S&EHQZ:S>=+:*IU&
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M,0.Z.\.X>\-[.^Y[<6RVB9Z*1[./'&OUM*1X1IZ.J=;VB(Z[6GQ;7-4L9
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MF-)]YDCZV)_O,>GIF+7O&FD_Z C1X
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M=H]_]K]Z[?WG"[B/G,1[6#)I3-3U^--9ZH\?K\<WIKX=6L3$:*MYLS
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MCS>XR[G>6F?:O/A&OCI2L:5I7Y*TBM8]40S,PUU(
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M,Q:MHF)K:)F)B8F)T2!QY*9:5RXK1;%:(F)B=8F)\8F)CPF)CQB8]+^-]GZ
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M^$Y/"?&OLXO")Z.J.J9AT/VJ0
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MZ7]CXOP
M
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MG=X=.+BMU%=_:-?<98]WFCZD1/LWF/7[J^2(]<HZTAV>
M      )F/#KV*O.WRQ_ -FR^C?Q>^I,Q\MS^V%W)#-A<M=XW^TR?5:UUA\\6
M^YGZVTGIFL;BZM<;B;^+GYH[_P"7\J&_G#\<WD7Y4>_XS9[[^$/=F'P^:<?,
M9,=;^,=.;>^.UQ]-HFN6E+YL^*WA;!KX-2]U^<_9?;'7M\6;Y_RE/#W6#VJQ
M/R7S?J5=)C2T1-[UGTT7!_!#V;/#OP6M\7LF'U2'N+O"RFBO:N[>T,9CLIGL
M/?Q40\1U==:]53<8#KB&UEHEJAN;*B3-<T7$D4^1N(O3HHJ"\]?C&\X//+)E
MXW>;N>'[(O$U^]NRO>F+)69G7YWE\,N\FT:1:F28VVM*VQ[?'?JM:*O>OFSW
M7WG:VWRY9VG#3&GS?#,Q6T?^]MX6RZ^&L6TQ^$37'6=9F6-%%K$
M                          !IGY@^ /BQYT:S:X#R&ZUL]ARN(L[JSU3?
M\+<2:]V+IM%U7ZLG&O;58\?4_1_4_P!MYL+RB\QDLO'S2VU?+<GE!Y^^:7D;
MR=M_Y>\E?;[7->ML^UR1&7:;CI\(][@MX=6GL^]QSCS5KX5R5AEO:G?'<O9F
MXG/P6XG'BO,3?%:.K%DT_OJ3X:Z>'57IO$>$6A4)\V_MP_)CI#\7W7Q7S/\
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MWVWIO-CEQYMIDC6MZ6B]+1\M;5F:S'U8F7FW8N0
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M9<^\O.MKY+3>T_FS:9G\R/1'J>V=(X8
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M?3,VG69GZLR^PX;Y
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M(S9/DG6]>BDQX32D6CZZ4X:$33@
M
M
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M5='^>'8L=S=O??S84F>;X^LVTB)F<F#TY,>D>F:_JE/3Z+UB-;ZQT!% R#H
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MQW1YF]Y=W3;'R>[M38VF?L&'[%BB)C2:S$3U9(]/ZK?)/C/BD;1T8"
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M[O.0W%MWO\N7/NKSK:^2UKWF?3K-K3,SX_++U3JG&
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M,N&)UKCC2F*OR:8Z1%9F/1%K1:^GIM+<QIMB0
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M:TS,VM,S,S,S,ZM,9,E\M[9<MIMEM,S,S.LS,^,S,SXS,SXS,^E_8^+\
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MYT4!0
M
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M,=JU\9K,IJT+6H0
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MV>UKY;3K-K3,S,_+,SXR^DXSY@
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M-K3,S,S,ZS,S/C,S/C,SXS+7=K6O:;6F9M,ZS,^F9^67[/P_@
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MUB(U+RO-\QSFX^=<SNL^ZSZSI.6]KZ:^F*Q:9BL>$>S6(B(B(B-(AEIB;JP
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M1CF9BD*[?,KO&W>W=6;E<4V^]M(C%MZSX3&*NNDS'JF]IM>8],=73ZDC:.C
M0
M
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M,UF)5T<EQV\XG?YN,Y"DX][@R6I>L^JU9TG\V)],3Z)B8F/"7O'0N$
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MO,M[ZS\L]5IUGZLLJ,6=8
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M?SS^KC>VA_BQW#_"SE?\ /[1?XE?VUP_W!C_ $Q^7WS#_P YM/M%?SV3L/[
MGM2XS&65A>^->2V&ZM8>(I\UF.[^^X,GD:^.>>>;B]BP'9N#PU$U7'/PYXM[
M2"/X<?DI^/QYYQG>?'S\56YW-\^'N3'M\5IUC'CXWBYI2/DK.799<DQ_CY+3
M]5UV7SP\S,F2;TY"N.LS];7;[;2/J1U8;6_Y;3/U65-<]E_VO]5QE&)QGB!U
M[=6M$TT_$NQYC?=QR?-<_/%5=->:V[;LYF:X:>>/U$=4_,<?'Y*:>.&*\C\9
MGQ.\IN9W>Y[OY"N68B-,./:[>FD?^[V^WQ8XGY9BNL^N9=9N/-OS&W.3WN3E
M<\6TT]BN/''_ +-*5K_=TUGUMG=/\'_"_KZXXO-&\2?&G4LA^&\8>3*Z_P!&
M=98O+W.,^>UEKL[W+VFLQY.^AFGLH9).)I9.998Z:Z_FKXXY:SYCSN\YNX,?
MN><[M[EW>W]Y[R*9>3WM\<7TM'57';--*S$6M$=-8Z:S-8TB=&.[OO'N[?5Z
M-[RG(Y<?5U=-MQFFL3X^,5F^D>F8C2(TB=(\&RV.QV/Q&/L<3B;&SQ>*Q=G;
M8[&8S'6T%EC\=C[*"BVL[&QL[:B*VM+.TMHJ8XHHZ::(Z*>*:>.....&M=QN
M-QN]Q?=[N]\NZRWM>][VFU[WM,S:UK3,S:UIF9M:9F9F9F9U8]DR7RWMERVF
MV6TS,S,ZS,SXS,S/C,S/C,SZ7]CXOP
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M:F?&?7+WCH7"
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MS=.NG7N,U]-=-=.J\Z:Z1KIZ=(;(-<,?
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M]C:/OAOZZY=)\<>")CPF/_?3K6/\"N2)],+TBC9#(
M
M
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MX_#'>9UUIT?6QCG6YNIK1*
M
M
M
M
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MF=-9UM,S.PC7SH@
M
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M9-A2M_O1F^R;:\^/5CF?&LV]=\=O8M$^UITWF-+UF9+4:VO0
M
M
M
M
M
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M81BQ8MOBK@P5K3!2L5K6L1%:UB-(K6(TB(B(TB(\(CPA\UR7T
M76_ML_ "O0= S?G=V5AIK;;.T\;EM(Z.L;_BWJ_#>L(<I:T;/O5-E)1)<V&2
MW+8<'S96$M?$,_&(LY98_GM,G3572S])#Y^UY_G\'D5VWFBW$\5DQ[GDK4U]
MO>S2WN=MU1I6U-OBR^\RUCJK[_)6MNG+MIBL0OB![XC?;ZG9?'WB=KMK5R;B
M8U\<VD]&/7T3&.MNJT>,==HB=+8](M3JLD:@
M
M
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MS.Z=GWEV[M^=V>E9R5TR4UU]WEK$>\QZZ1KTS];.D=5)K;2-=&HK;;*0
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M;<;/<Y-GNZ6Q[K%>U+TM&EJWK,UM6T3Z)K,3$QZIA]YP'P
M
M
M
M
M
M            ?!VK:-<T?6-CW7<,WC=:U+3\#F-HVG8\S=Q6&'P&N:_C[C+9
MO-Y6^GJH@L\;BL9:2SSRU\\41Q1U5<\_#AS^+XOD><Y/;<+P^#)N>6WF?'@P
M8<=9MDRYLMXQX\=*QXVO>]JUK6/&;3$0^^VVVXWFYQ[/:4MDW66]:4I6-;6O
M:8K6M8CTS:9B(CUS+F4^YWYU['Y_^5.X]MRRY*QZQP4UUIG2.JWU4L'.!ZVQ
M5_<_A>1O\9]7>6MCM6WU5?B>6XBDDXHNI^+>F22&VAYX],'PR>1?'>07E9L^
MTZQCOW-GBNXY+/72?>[R]8ZZ5OTUM;!M_P!1P=41K2OO)K6^2\+$/+KLO;]C
M]M8N+B*VY&\1DW%X_19;1&L1.D3-*?64UB/".K2)M*/%(1G8          "0
MCVQO!S-^?GECI/35-5YC^N\1\F]]T;#9UU6]SA^K\!DL='G;7%WO-M>0VNR;
M/->PXK&5UQ2T0W=Y3/7'7##+PC[\37GALO(/RHWO>4Q3)W#F_P!%X[%;QC)O
M<M+SBM>O56;8<,5MGS1%JS;'CG'6U;WK+!?,7O+#V/VQFY;PMO[_ &/;UGQB
MV:T3TS,:QK2FDWOI,:UKTQ,3,.G%KVOX34\!@]5UK%V>$US6</C-?U_"XZ&F
MWQ^(PF&LH,=BL78V]'ZF"SL+"VCBBHX_)311QQ_Y'F:Y#D-[RV_S\KR66^?D
M=SFOERY+SK?)DR6F][VGUVO:9M:?7,S*NS/GS;K/?<[BTWW&2\VM:?&;6M.M
MIF?EF9F9?8<-\@
M
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M /\ RZXJG][3=UC^Y7'GB/\ DQY-)_S=HK^J67 50J*P
M
M
M
M
M
M         "G]]Q][D7_9]O;I_.?_ &DV?R<S-C'_ /6>P:/U#;WTDG_UKGLY
MS#%_]K;:BY_^R=HMZ^CE^''_ /V"[OP?YS#PV.T_XV+<[^:Q'^/M=MU6_;.2
M<?\ \ME2I\@?+_\ _+KE:?WU-I6?[M<F>8_Y<>/6?\Y::_J=E/Y;RE2
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MSFV+;^C2WC'O,L:?YVU8FL^GW=<>L1.L)>T16K
M
M
M                       '/%]]?V[_ .)=Y.5]E==X7Z/QY\C+S+[5I<-G
M%\;'1=\MOI;GL#KN7FFYGJMK/B_R%.6P_P \=M#SCKZJSMZ9><9<2/0G\#'Q
M"_EG\LH[:[BS=?F%V[3'@W,VGVMUM9ZHVN[CPC6W32<&XTF]O>XHS9)K\YQU
M3N\E^_/X7=N_>_?WUYW816F37TY,<ZQBR^B-9TCHR>,SU5Z[:>\K"#=.!N0
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M7N/)QVE[<5EUR;;)/Z+',_6S,>$Y,4^Q?T3/LWZ:UO6$D".+
M
M
M
M
M
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M$1"PW;;;;[/;8]GM*5Q[7%2M*4K&E:TK$5K6L1Z(K$1$1ZHA\%SGV
M    6.OMYO;PK\AN^JO*_M/5YKSI3Q^R5,NE0Y2TMZ\)OG=T<4,^&MZHKJ&6
MK(8WK6UNJ,S/S%S'\F6_#::JI(_J(:JY_I"/B%KY>]AQY4]K;J*=Z=P8]-S-
M+3&7:\;,S&2=:S'1?>6K.WKU:ZX/G,Q%;>[O&@O/;OR."X3^#'&Y(CF-]7[)
MI,]6/;_HI\/1.68]W&NOL>\\(GIE?(42(5
M
M
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MFLQ,UY;[8[OC-[EX[?TG'O<&2U+TG36MJSI:/#6)TF/3$S$^F)F'L'3N(
M
M
M
M
M
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MQX4I7_!I6(K7769B-;3-IF9S\P%T8
M
M
M               "JE]QW[=/Y^:3;>>74>LWE[NW7]GCM?\ (.PQ%/KR9?K.
MUC^CP'8TF-CXYN;B\T&XKCL\G-#3)73A)J+B;T[7&2RTVH?1S?$3]XN:MY$=
MV[FE.$Y"]\O%6R>$8]Y:>K+M(O/A%=U&N3#6TQ$[FML=.K+N:UF2_D#W[\RW
MD]E<IDB-GGF;;6;>'3FGQMBU]$1EC6U(G3[)$UC6V2(FE4NC2[
M  6K?MUO<OEZ_P!KL/ 3N+-_#1=ZS&3R'CQFKZJ[FYUCL'-W'.1S'6==Q->5
M6>/UO=KSZB^QL<<,?R[!<7%//,E>1I].J_Z1#X:J\_Q63S[[/P?_ 'W8X:4Y
M;'7ICWVTQQT8]YI%>J^;;5Z,6:9M.NTICF(K7;SU1I\^O+R-]MK=[\33_3<-
M(C=5C3V\58TKFTTUF^.-*WF9G[%%?1&/QNJJ7$0P
M
M
M
M
M
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M,3-(CP^R3DF>J(I,61U<*/X
M
M
M          #YN9PV'V/#Y77MAQ6-SN SN-OL-G,'F;&URF'S.'REK+8Y/%97
M&7T4]ED<;D;*>N&>":BN*:*NJBNGFGGGAR=GO-YQV\Q<AQ^7)@W^#)7)BRX[
M6IDQY*6BU+TO68M2]+1%JVK,6K:(F)B8?3%ER[?+7/@M:F>EHM6U9F+5M$ZQ
M:LQI,3$QK$QXQ/C#FI^[=X 9#V_O*S8-*P5G>5]&]B_6;UT/F;F6:YJ_-.YG
MB_%=)O;NYO,A=W&8ZXR]USC));B:NYO++BTOI>**KSTZ?27\)?G[M_/[RKV_
M-;Z]([XX[IVO*8ZQ%?L\1/1N:UBM*QCWF.OOHK2L4QY/?8*ZQAZIL'\K^^*=
M\]LX]YFF/OSM],>YK'A[<?6Y(B(B(KEK'7$1&E;=5(UZ-9B[2?;'
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MK:>W=W:;8ITF8Q6G6;8)M_@^G'K/5;'Z9M:MY3/H9M2
M
M
M
M
M
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MMERVFV6TS-K3,S,S,ZS,S/C,S/C,SXS* UK6O:;6F9M,ZS,^F9^67[/P_@
M
M
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MZ>XN Y'MCF<_!\I7IWF"^D_):LQK6]9C76MZS%H]<:Z3I,3$9X8(Z4
M
M
M
M
M
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M,V+=H=K<?V;P.'@N.UMCQQK>\QI;)DM]?DF-9TZI]$:STUBM=9B-6J+:K)@
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MSO3N//SFZUC%:>G#29_4\-9GW=/3,:Z3-KZ>%LEKVB(ZM&YC3;$@
M
M
M                                          %1S[C?VVJ,KC/X_P#T
MYK\-&3P\.-P7DC@\/C[BNZRV,XY@Q>L]M5QVU-<?,V#CIAQ>9DYIXYYL_I+B
MKGBFWN9.;:_HZ?B0MM=S^0+O'<6G;9IOEX?+DO'3COXWS;#6VDZ99ZL^WC7]
M4][CCQR8ZQ*/R"\P)Q9/X#\MDGW=YFVTM:8TK/IO@\?[[QOCC^^ZJ_HJPIP+
MB$KP           $X7LA^YG7X+]\_M;]IYV:V\7N[LE;V&\U2\6]=KUQO,D5
MO8:UVO1\]O5=<8VUIAHQV=CBFBIJQ4WUG-%Q-CK:"2$7QM?#17SR[#_A'VM@
MBWF?PF.;[;37JWFVB9MFV,Z3T]=M9S;:;5M,9Z^YB<=-QDR5TYYQ>7<=Y\)]
M\.-I$]Q[.LSC].N7'XS?#Z=-9^NQS,3[<=&M8R6M'0ZM[BWO+>"[M)X;JUNH
M8KBVN;>6B>WN+>>BF6&>":*JJ.:&:.KBJFJGGFFJGGCGCGX//9DQY,.2V++6
M:Y:S,6K,3$Q,3I,3$^,3$^$Q/C$H(VK:EIK:)BT3I,3Z8GY)?L_#^
M
M
M
M
M
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M0JM4:P
M
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M]N]^$Q_Z)EO_ *72L?69+3&F>(C]#DF=,OHTR3%O'WENFURJI1F
M
M
M
M
M
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M
M
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MSI&DVQ7]?7CFT1K/U]>F\>,VK65U%1K(
M
M
M
M
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M#CUUC%BB9Z*1\L^.M[:1U7FTZ1$Q6-TFF&(@
M
M
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MH@
M
M
M
M
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M\1DUXK:Y-<]JSX9<U?T'H\:89UUC6:VR>.FN.DK.*LQ'8
M
M
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MG28F)C28GQB?"7TG&?,
M
M
M
M
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M_9^'\
M
M
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ML===UCK$S.2D16L9J1&NEL=8^R1Z+8XZ_"U+==T]2^B*
M
M
M
M
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M<UOK8UZ:5CPK2D3,S%:QX1X^/C,ZS,RV*:[="
M
M
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M<6E8]WU6'5>S1
M
M
M
M
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M[SYK[W\??_\ MS9WF,>GHRY/&+9_1$Z3'LXXF9B*QU1I-[0F]0E:=
M
M
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MI.DUU\<=I]'O,?A%HB9UK-;^'5TQ)PC,UT
M
M
M
M
M                                        T_\ .3S2ZJ\#?'[:>^.T
M9/Q'\.]+$Z1HECD\=CMC[(W;(U>GB-5U_P#$*_\ ]:[R%S'%<58_%V]Q=>C-
MZ/$5>WO(_P F.ZO/?O\ VO8G:\>[]YKDW.ZM2]\.SVU/')GR]$?F4Q4FU(RY
M[X\773KZJY5V;VCR?>O.8N%XV.GJ]K)DF)FF+''UU[:?^S6)F.J\UKK&NL<R
M_P DO(OM3RP[JWKOSN?-PYS?]^R45[DY+*TIQV'Q=C8VEOC,'KN QM%<O&/P
M.O8:S@L[6.JN6;F*+BN>6:>N6:OTN^6_EWVMY4]E['L+LW!.#@-ACFM(M;KR
M7M:TWRYLM_#KRY<EK9+S$5KU6TI6E(K2MA_;_ \;VQQ&'A.(I--C@KI&LZVF
M9F9M:T^NUK3-K3X1K.D1%8B(P:SAW(           "U;]O)[7\O8&UXWSR[U
MU;XZ+HN8JY\<]>SEG=P\[/V#A+BVDJ[:XLKW'TV>0UO2;SYHL+<Q2R?-L%O)
M-3Z=>.CYDJO^D)^)VO <5D\B.QMU_P#?=]A_^[Y<5JS[G:9(F/F'56_53-N:
MZ6W-+5C3:7K2>JNXM%8T^>WF-&QVUNRN%R_Z;FI_I5JS'L8K1/V#6)UB^2/'
M)$Q'V*8CQC).EU52XB&
M
M
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MX"N\]FG,8(K3<XX_0WF)TO6/3&/+I-J:ZZ3%J:VFDS,9J2S88
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M_*=G\UEX/EJQ&XQZ36U9UKDI.O3DI/\ >VT]<1,3$UM$6B8;.-9,=
M
M
M
M
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M78?!5X_#,9.1RZ7W&6-?;R:>BNOHQTUFM(TCPUM,=5K(ZTAV>
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MEO-KWM,S:UIG69F9\9F9>D=:XX
M
M
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M6C6)AD)C[@
M
M
M
M
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M'KK&+%$ST4CY9\=;VTCJO-ITB)BL;I-,,1
M
M
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M)B8TF)\8GPE])QGS
M
M
M
M
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M,>W=_+?>?BLD_P '-G>8B8GPSY8\)RSI::VI&DQAG3ZV;6_1Z1/.@@TH
M
M
M
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MFM8GWE8\(ZX]N[RI*0[
M
M
M
M
M                   5E/??]W2CQ\US-^&OCGL$,G>.[8&2V[9W[ YJX@R'
M2FK9>*CF'7\/=8>YAN,?V=M6/DYDYKJFCEPV+DHFXCYFO+::WLP^!3X2+>8'
M(X/./S%V\QV1LL\3L-KEQQ-.1SXYG7+DKDB8OLL%XTTBLUW&:)I-HIARTR2(
M\EO*V>=W%.[.?QS]YL-]<&.U8F-Q>OZ*T6C2<-)\/1,9+Q,:Z4M%J-"\-,H
M           !;%^WM]JZ+=<IKOG]WU@_4U;6<Q+>>-6H9.VM)[?8MJP.2FLY
M.X,A1S=RRP6>E9W'30X.&:WHDERL/XA1513:6M5Q5']()\4UN%VNX\@NP\^G
M*;G#%>8W%)M$X<&6D6CCZ3TQ$VW.*];;FU;S$8+?-[1,Y<L8XQ^>GF5.SQY.
MQ^$O_I.2FF[O$SK6EHU]Q'AZ<E9B<DQ.D4GW<ZS:T5N>J:$20
M
M
M                                                        'S<S
MAL/L>'RNO;#BL;G<!G<;?8;.8/,V-KE,/F</E+66QR>*RN,OHI[+(XW(V4]<
M,\$U%<4T5=5%=/-///#D[/>;SCMYBY#C\N3!O\&2N3%EQVM3)CR4M%J7I>LQ
M:EZ6B+5M68M6T1,3$P^F++EV^6N?!:U,]+1:MJS,6K:)UBU9C28F)C6)CQB?
M&'/%]Z3VMLGX$=Q\]C=98K)7?BKW#GKV;1<CS'Q+:=8[ED9,QF+KI:_O>;R[
MOIX<;B;"2[P-U=TQS7V*CKBYKN;G'WEQ7Z$_@Q^*';>?/9W\'>YLN.GFGP^"
ML;FFNEM[MZ1CQUY&M>FM8F^2T4W5,<S7'GFMXKCQ[C#CB=WE'YD8^]N)^8<C
M:L=R[2D>\CUYL<=-8W$1I$1K:8KDK76*WF)TK6]*Q"2FNW
MN8^PW[PWYW1:#X$^2^5^&U6=G1K'CKVIDKSX1;-C\;:32XKJ3<[N\F^6#9+"
MQMOI=;O/FXHR<,<.-JIXOJ;7F_IN^.[X/_O1;?\ GSY:XO\ [5>_ON6V-*^.
M&][1%]_MZUCQPVM/7O,>FN&TWW,3."<L;>)GG5Y4_-9S][=O5_T:9Z]UAB/K
M)F?:SXXC]!,SKEK^@F9R?6=71;15.HP
M
M
M
M
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MF?&7TG&?,
M
M
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MJX4?P
M
M
M
M
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MWW>:W]RE8\*TK'HBM(\(^7TSK:9F<_,!=&
M
M
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MT^&.^GZ"9\,=_7X4M[73-YVT%FEP
M
M
M
M
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M,F:-+7@
M
M
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MWSK:]>;MO-?[%E],TF?'W673PB\1];;PC)$:QI:+5K,:AXU0
M
M
M
M
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MB?=1XQ:?LDZ^QT6%U?#1(
M
M
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M1UUT]JM)5T5VM
M
M
M
M
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MB:[S)73328\=O6?JQ.F;333]2F=?>5BXFI\12
M
M
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M/3Z_=Y-/"N6L?F1>(ZZ?HJTE*1=:V
M
M
M
M
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M);+EM-LMIF;6F9F9F9UF9F?&9F?&9GQF4'[6M>TVM,S:9UF9],S\LOV?A_
M
M
M
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M/E'YG8N]>/CBN3F*]R[7%'7Z-,](TK[ZL>JVNGO:Q&D6F+5]FW32#%.-N4
M          !EKHSO/M3QM[4U#NCI?;\EI'8FD9*G)8/.8VJFKBKBJFJ&^Q>4
ML9J9++,X',V4E=M?6-S1);7EM)7%+1515SPQ/OGL;M;S([6WG9G>>SQ[[MW?
M8^C+BO\ \M;TM&EL>7':(OBRTF+X[Q%JS$Q$NKYGAN-[@XW+Q'+XJYMAFKI:
ML_\ HM6?36U9\:VC2:S$3$ZNB][7GNA]5^XUU7S<VW&-TCR"TC&VG[;G4?U=
M57-MS55%:<;SHW-W+)>YGKW,WLE---554ESB+F2FSO*JN:K6ZO/.U\3WPP]T
M_#IW3[O)[S?>7^^R6^8;_I^N]-OFVYZ8BN/=XZQ,S$1%,](G-AB-,N+# KS'
M\N.2[!Y+IMU9N#S6GW&?3T^OW>33PKEK'YD7B.NGZ*M)2D76M@
M
M
M
M
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M(B(B-(B(B(A[9TCA@
M
M
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ML?F1>(ZZ?HJTE*1=:V
M
M
M
M
M  >#[0[0Z^Z6Z^VSM7M7;,/HW7FC8>XSVU;5GKCFWQN)QMOS11\U7R42W%W>
M7=Q+';VMK;QRW5Y=2QP01R321QU=[VQVQW!WIW!M.U>U=IFWW<.^S1BP8,4:
MWR7GQ]>D5K6(FU[VFM,=*VR9+5I6UHYO'<=ON7WV+C.,Q7S;_->*TI6-9M,_
M^B(B-9F9F(K$3:TQ$3+GB^[-[LW8/N']@\ZIJG.8T;Q9T;,33]?=?3S<6^2V
M[)6_$UK'V1V1':S2VUWLEW;2U\6%AQ7+:X2UEJBBJDGDNKJY]"?PG_"?V_\
M#UV_]]>5]SOO-'?88C=[N(UIMZ3I:=GLYM$37#68CWN72M]S>L7O%<=<6+'.
M[RP\L-CV)L?G6ZZ,W<F:GV7+Z8I$^/NL6OC%(GZZWA.28UG2L5K6'-,-M<
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M6][VKW[B[BY;NGELO,\SEG)O,D_F5I6/K:4KX]-*Z^$?FVM,VFUIS\P%T8
M
M
M
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M,"O,?RXY+L'DNFW5FX/-:?<9]/3Z_=Y-/"N6L?F1>(ZZ?HJTE*1=:V
M
M
M
M
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M6LVC!AU]G#CU\*QZIO,:3DOIK>WR5BM:[R-'L-
M
M
M
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MU:S&H>-4
M
M
M
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MA<$S&##\D3Z<F28\+9+1$:^FM(]FNOM6O**C UP
M
M
M
M    CQ]QOVY.G/<4Z<ET;>8H=8[+UB&_ONH>WK&PCN<]H>>N8Z.9+2[CXKMY
M,[I.=DMXJ,KBJY:*)Z**)H:X;N&WN(I"_#I\1?>/P[]XQSG!S.Z[:W4UKO\
M86M-<6ZQ5GPM6?&,6YQ1-IP9XK,UF9I>+XKY,=L\[![^Y;L+EHWFSF<G'9)B
M,^"9TKDK'KCT].2NL]%]/#QB8FLVK/-W\B_'OM#Q8[GWOH?N/!?@._=?YB3%
MY.*&J:?%Y6TDHHNL1L>O7T]O:R9+6]CQ<\5[87',4=4MM-3S71'7\T=/HY\N
M_,'M?S2[-V'??9V?W_ \AAB])G2+TM$].3#EK$VBF;#>+8\M-9BMZSI:U=+3
M/_@.=XWN7B,'-<3?KV.>FL?+6?1:EHUG2])UK:-9TF)TF8TEA-FKMP
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ME;F>6XF+Y>U\M_"?&;;>TSX8\D^F:3/ACR3Z?"EYZ])O.J@RTP
M
M
M
M
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M1L>-F^/MK;VGHK.L3FOZ/?7KZO#PQUMXUK,S.EKVK$VZ%#3X
M
M
M
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M)A/7AN9XWN#C<7+\1EKFV&:NM;1_Z:VCTUM6?"U9TFLQ,3&K$K+':
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M>/CX3/5?#XZQ:-9I6)C)X5Z[6.U<[0(
M
M
M
M
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M]@^7_#]A\7&UV<1EY/)$>^W$Q$7R6^2/3-<=9^LI$Z1Z;=5YFTQUI#L]
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M[=W9;=O\%,U[:Q7B;7TTMN+UGPMX^-<59\:5\)M/MW\>FM+"ZOAHD
M
M
M
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M/TU^QZUQVN55*,P
M
M
M
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MGUTI/^8^6?\ G?\ X?ZI9W5DHZ
M
M
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M[D=CR^QQ<GQF6F;89J1:EZSK%HG_ -,3$ZQ,3$368FMHB8F'@W>N:
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MM\ML&>MJ9Z6FMJVB8M6T3I-;1.DQ,3&DQ/C$^$OI.,^8
M
M
M
M
M              "/WW"O<;Z,]NOJNVWGLZ6;9]WV>::QZTZAP%_:6VW;Y?6U
M4/&0NZ)+BBXCP6JX*.XHKR&5GBKA@^>.&.B:ZF@MY=__  ^?#IWS\1'=-N#[
M9B-KPFUB+;S?Y:VM@VM;:]%9B-)RY\LQ,8L%;1:VEKVFF*F3)7.>Q.P>9[]Y
M*=GQT1CV>.-<V>T3-,<3Z(\-.J]M/9I$ZSXS,Q6+6CG3^8OF+W7YQ=UY_N[N
M[/\ XAF,A\V/UG6<?5<0ZGU]J<-Q--B].T[%S33?A^'Q_K555UU55W-[<UR7
M-S)+<2R25>B+R>\GNRO)#LK!V3V3@]WL\?MYLU])S[O/,1%]QN+Q$=>2^D1$
M1$4QTBN/'6F.E:Q/3M3M3A^S>'IP_#TZ<5?&]YTZ\M]/')DGUVG_ )*QI6L1
M6(AJNVDR4             !<]]CKV6LAUU=Z9YL>6NOWF-W^W^EV3H;IK*QS
MV=WI/JQ>KC>RNQ+&OTYH]PDADXDQ&&FXX_"*:N+F[I^OYBAQ]-'QO_&?M^XL
M6]\E?*;<4R<!;JP\IR%)BU=SI.E]GM+>,3MXF-,^XK^KS$XL4^XZK[B)/G)Y
MNX]_7-V?VO>+;&=:;G/'C&3Y<6*?[SU7R1]?];6>C6;VQ54:,8
M
M
M
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M,3$Q*<VTW>VW^VQ[W99*9=IEI%J7K,36U9C6)B8\)B8>;=BY
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M.WW$;[+QG)XKX=_AO-;TM&DUF/\ T3$QI,3$S%HF+5F8F)>\=$X0
M
M
M
M
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M/G7O>T^T\O\ HOC3<;BD_7^JV+%:/T'JR9(^O\:UGHUF]M%4ZC
M
M
M
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M9B+X[?HJ3I.D^$QZ+1%HF(V0:X8^
M
M
M
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MH_1^K)DCZSQK6>O6:7,5-R)8
M
M
M
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MK:L3NX[D=CR^QQ<GQF6F;89J1:EZSK%HG_TQ,3K$Q,1-9B:VB)B8>#=ZYH
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M.EII-JQ,I)D;FO@
M
M
M
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MK6M*Q6L1%8C2(CT1'R0_%^W]              6T?9)]DG\\/S1\R?,G4?\
MV/\ [QV3HWHW9+'_ //#_L7>([*[*Q%W1_\ F?\ ]B?#8:>C_P!<?J;J[I_#
M_1AR%3OQK_&O]Z/G?DYY.;O_ .[^UAY/D\-O_E_37)L]GDK/_P QZ:[C<5G_
M $?QQ8I^<==]O&'S@\X/FOO>T^T\O^E>--QN*3]9ZK8L5H_1^K)DCZSQK6>O
M6:7,5-R)8
M
M
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MM3,S.FMLNWC36?>Q$>.*-)TRQZ(\,D1.EKS_ * C1X
M
M
M
M
M   #S>X[CJG7NJ;%O.\[%A]2TW4L/?[!L^S[!?V^+PF"PF+MY+O(93*9"[DB
MM[2SM+>*JNNNNKCCCCAV7#\/RO<'*[?@^#V^;=\QN\U<6'#BK-\F7)>8K2E*
M5B9M:TS$1$0Y&TVFYW^YQ[+98[Y=WEO%:4K$S:UIG2(B(\9F94AO=O\ ?@VO
MR%GVGQR\/,MF-%Z*AO,SK^Y]N65W<8[;.\<//C^<3>XO#VM=G:7VE];WU5Q=
M<54<R59+-6W,%4_T47,]E+=I\)?P)\5Y?4VOF+YP8L.^[YFF/+M]A:L7P<9D
MB_O*WR6BUJ[G>5TII.D8=O?KBGOK13-68GE=Y*[;@JX^?[KK3-S4Q6V/!,1-
M-O:)ZHFTZS&3+&D>KHQSKIUSTWBLTLM2&               7#?9Q]B''\8_
M2_+'SAU>\KRE=YC=KZG\=,[:P1X^#'QP2W&*VCNS#WUI+<7=Y=W$L%Y9:W55
M!1;T04?BM,_,\N/MZ@/C#^.O<?.-[Y4>2&ZI&UBE\&^Y?%:9O-YF(O@XW)6T
M16M8BV/)O(ZIO-I^:S2*4W&2*GFQYTWZ\W;'9V2/=Z33-NJSXS/HM3;VB=(B
M(UK;+XZZS[K32,EK>JHM%@
M
M
M
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M'N#B.Y^-IR_"9JY]C>9C6-8F+1Z:VK,1:MH]=;1$Z3$QK68F<&LX=R
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MXLNWRVP9ZVIGI::VK:)BU;1.DUM$Z3$Q,:3$^,3X2^DXSY@
M
M
M
M
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MU[WM/M/+_HOC3<;BD_7^JV+%:/T'JR9(^O\ &M9Z-9O;15.HP
M
M
M
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M.7[:Y*_$\U@O@WU/5/HM'CI:EH\+TG2=+5F8G28UUB89L84Z<
M
M
M
M
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MB'OFSYR9N6RY.V^TLTTXBO57-GI.DY]8FMJ8Y]6'QF)M'CE]6F/Z^T2K 1P
M
M
M
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MYK.;A;WF,6YK$]$_)7)Z?=Y-/T,SI;29I:T1,Q)RC,UT
M
M
M
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M?%\5QO";''QG$X<>WV&*-*TI&D1\LSZYM,^-K3,VM,S:TS,S+&[(W/
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MNY,N7M_MK);%VW$33)>(TON?'Q\9CJIA\-(K&DWK,SD\+=%;':N=H$
M
M
M
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MQ\DS.6OA^J>U:MHE6 C@
M
M
M
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MZXL58KBK$16L1$1$1&D1$1X1$1X1$>$0DQ6M:5BM8B*Q&D1'HB/DA^+]OZ
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M%YI^;.][RW-N)X:^3!VO2=-(F:VW,Q/U^6/">C6-<>*?1X7O'7I%)X4$VE0
M
M
M
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M<'R_;N_OQ?-[?)MM]3TUO'IC68ZJVC6MZ3,3I>DVK;2=)EF!B#J@
M
M
M
M
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M'-[R\\JN#[%Q1NYTW7<-JZ7SVCPIK&DUPU_05T\)M.M[ZSK:*S%*Q"I=-I@
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M6EU1(:M
M
M
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MZX^8M:*8L^D5IFUCPKDTTK3+,^$3&E,DS$1%;:==7Q9VD:
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M_P#E9S_8N6=QDB=SP4VTIN*5G2/&(B,U?'W5IF8B-9FMI^MM,ZQ$L:*+6(
M
M
M
M
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M+:1UY)B)G2(B*UBM8D(1]8*
M
M
M
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MT36U9CTQ-9TF)^I,/L.&^0
M
M
M
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MV\*4C7HQ4U\,>./56/\ EM.MK3-IF6U#5C&@
M
M
M
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M&E413VUM)>Y# 1W=W#F=;DFOK?B+,8N:]QE5=Q1!7-'=TS6T5$/GA\.?F?Y
M\Q&P[WV?5PV6_3MN0V_5DV6YUBUHK3+-:SCS1%;]6WS5QYHBEKUI;%-,EH4]
MY=@=Q]C[OW',8M=I:=,>>FML.3PF=(MI'3?PG7'>*W\)F(FNEIWP:)84
M
M
M
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M%:UB*UC2*Q$,J,6=8
M
M
M
M               T)\_/;KZ!]PWK*'2NV\;-A]QUF'+7'6/:^ AAXV[0,SDK
M&NWYJHYKJAIV#5;NZH@ER&&N)*+:]^GCJIK@N(X;B+?/D'\1'?WP]]S6YKM+
M)&;A]S..-[L<LS[C=8Z6B?'T^ZSUKU5Q;BD3?'UVB8OCM?'?-NR._><[$Y&=
MYQ=HOM,DUC-AM]9EK$Z_^K>(UBN2(UKK/A-9FL\\OS@\ ?(OP"[,YZ_[PUCY
M\/E/GFT;M+6X,K>]9]AV4<4,USSK&Q7V.QWQS&(]>BC(XRXC@R%C75177%S;
MSVT\_H0\D?/WR[\_.VOX0=D;K3>8O#<[+--*[S:6F9BOOL-;W^QY-)G#FI-L
M66(F(M[RF3'2=O9W?' ]\<=\^X;)]EK^J8;S6,V*?5UUB9]FVGLWB9K;QB)Z
MHM6-)VZF7@               />=9]H]B],[M@NQ^J=UV3K[>M:O(K[";1JF
M5NL/EK&:*2B3FCBXM9*/J+.X^3BF>WEXKM[B+GF.6BNBJJGGHNY>U^W>\N%S
M]N=U;+;<AP>YI-<F#/2N3':)C372T3I:-=:WKI>DZ6K:+1$N%R/&[#EMG?C^
M3PX\^RR1I:EZQ:L_W)]$QZIC28GQB8E<E]MW[C#2NR/P/J+SQYP_6V]2>I:8
MSO\ Q=K'C.L]CDI]/BSAWS#6U-?Y@YBX^//%=_;\5822O]5)3CZ../FIS^([
MZ.SFNW/?]W>1/ON2X.-+7XJ]IOO,,>/5.UR3_P#-8X]6*VFYB/"L[BWHB=Y@
M>0F\X_KY3LKKW&R],[:9US4^7W=I_5*Q_>S]DCU3DE:5QV1Q^7Q]CEL3?6>4
MQ64L[;(XS)XZY@O<?D<?>P47-G?6-Y;5RVUW9W=M+3)%+'551)15Q53SSQSQ
MRJ[W&WW&TW%]INZ7Q;K%>U+TO6:WI>LS%JVK,1-;5F)BU9B)B8F)C5&[)COB
MO;%EK-<M9F)B8TF)CPF)B?&)B?"8GT/['Q?@
M
M
M
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MLVM,ZS,S,ZS,^,SXR^DXSY@
M
M
M
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MZ>,TM$7CY-/%N\TDPX
M
M
M
M            !@'R1\H^A?$;K:^[7\A.R,#USIUK-3964N3EEN<SLF8EIJD@
MP&H:WCX[K/[7GIHJ*Y?I;"WGEBMHY;B7BBWAEEHS[RX\K^_/-ON2G:GE]QN?
MD>8M'5:*1$8\../"<NXS7FN+!BB=*]>6]:S>:XZ]62]*V[SM_MOF^Z>0KQG!
M;>^XW<QK.GA6E?[Z]YTK2OJZK3$3,Q6-;3$31M]S'WW^[O,VC+=3]$VV>\?_
M !QDFN;>\M;?)_3]L=HV?U$E,%?8&=PE[)9:[@9[*B/FK7L5/-!ZM<U-Y?Y*
M+F"F"\#X:?@4[)\FK8NZ^^K8.?\ ,:*Q-;3378[*VD:_-<62L6S98MKIN\]:
MVTBDX<&VM%YR3)\O/);A^TIKR?-33?<_I$Q,QKAPSIX^ZK:-;6B=?LMXB=-.
MBF.=>J U/5NT               !][5]5V?>-CPFGZ5KF>W#;=ER5IAM<U;5
M\/D-@V//YB_EI@L<5A,)B;>[R>5R5Y/7Q1%!!%)+)7SQQ33SRX/*<IQG!\=G
MYCFMS@V?$[;';)FSY\E,6'%CK&MKY,F2:TI2L>-K6M%8CQF7QW.YVVSV]]WO
M,E,6UQUFU[WM%:5K'C-K6M,16(]<S,1"[G[2'L,ZST#^:WDAYF8;#[KWG#^#
M;+U[U+)+7D-3Z7R<7RW]KE]HJ@N/PK=NR,?)5'Q'%51/A\+<Q52P<WEU3;7=
MK2;\6GQW<GW]\Z\N/)O-FV78\^\P[O?Q'1GY&D^S;'@UCKVVSO&NMHFNXW%)
MBMXPXIR8<L/?-'SKW'.>\[?[2O?#PT]5,N?T7W$>B:TUCJQXI\=9\+Y(G2W1
M7JK:SBK,1U
M
M
M
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M8ZY<5HMBM$36T3$Q,3&L3$QX3$QXQ,>$PE#6U;UBU9B:S&L3'HF/EA^+]OZ
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MP9]KFMM]S2^/<4G2U;1-;5F/3$UG28GZDP^PX;Y
M
M
M
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M.N9AT/VJ0
M
M
M
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MOC;%:9F(B+^S:?"EKZ3I**C UP
M
M
M
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M?^2)M;6]M(ZK3I&FX#4+%0
M
M
M
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M^2U)M6?5,LS,-=2
M
M
M
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MO.![=X7MC85XW@]OCV^UCT],>U>=-.K);ZZ]YB(B;6F9TB(UTB(8'9V[H
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M1$0]LZ1PP
M
M
M
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MA>\[4P<I.E:;G2*X<L^C3+$:1BR3\L1&*WC^I^S6U7=9\D<
M     V*\:/++R%\/]^X[)\=NS<]UQLLT,%GEZ,?S;7V!V?&03\7%&(VO6<K;
MWV V/&TR_&JB.[MY>8:^>:XN8Y/A7QKOS*\J/+[S?X'^#?F'QF#D>-K,VQ]?
M57+AO,:3DP9J37+AOIX3..]>J/9O%J^#H>X>V."[JV/WOY[;TW&WB9FNNL6I
M,QIU4O68M2?JUF-?1.L>"YOX"_<5^/W?OYN]=>6EGA_&_MN^_O23>/JJK;Q^
MSU[_ &VNB;\X,YE;S*]9^M'3QQZ>:GN,?%SQ^JR?-5=,?%-?GW]'?Y@=A?..
MXO*>^;N/M.GM1MNGJY7%7P\/=8L=:;S2?7MJTRSZMMI$V1*[W\A><X3WF_[8
MF_(<77Q]WIKN:Q_BUK$9OS<<1:?\WX:K'=O<6]Y;P7=I/#=6MU#%<6US;RT3
MV]Q;ST4RPSP31551S0S1U<54U4\\TU4\\<\<_!7/DQY,.2V++6:Y:S,6K,3$
MQ,3I,3$^,3$^$Q/C$M VK:EIK:)BT3I,3Z8GY)?L_#^
M
M
M
M                         -)_-'W!_%[P*TZ/9^_MY^DS>3LYKS4NL-6B
ML\YVCO-$$]%M-SK.L39#&PTV<4U7--=_D+JPQD==/-%=S37S33SNKR9^'[S/
M\^.8GC.P=CU[+%>*Y][GFV+9;;6-8]]FBEYZICQC%BIES3'C7'-=9C,.T>Q>
MX^]MW\VX/#KAK.E\U]:X<>L:^W?2?'_!K%KSZ8KHHV^XA[V7E#YV?C6@8B;]
MHGQVO?5L_P!JK3,M=SY;<,;5]-7\.U-S^2RN=L^>YAJKIL+6VQV)HBJHHDMK
MB6+ZJ2\'X>O@J\L/(OW//[R/O[YATTM\^W&.L8]O?Q_^1V_M1@\)B/>WOFSS
M:)M7)CI;W59D=A^4';G9?1OLL?/>>CQ]]DK$5QSX_J./QBGA^BF;7UUF+5B>
MF(9TR&V@                'JM'T;<NS-NU_0>O=6SVZ[MM>2@P^MZKK&+O
M,UGLWD[GGGT;+&XRPBGNKJ;FFGFKGBFGGBFBGFJKX4\<\\=7S?.<-VUQ.XY[
MN'=8-EPNTQSDS9\UZX\6.D>FU[VF*UCU>,^,S$1K,Q#C;S>[3CMKDWV_R4P[
M/%6;7O>8K6L1ZYF?"%VWVL_M_P#3?'^XUOOGS.ML#V3W78S09C5NHHZ;/.=:
M=89""O)1PWFPW/,MYC.R]JC@EMKB'GF&/%XF\CYJA^MDH@NXZ4/BC^/OF>_\
M>Y[#\FK9^-[+R5G'GW\]6+>;VDQ29KBC2M]G@F8O2WM3FSXYB+^YK-\5H?>9
M/GCN^<KDX3M*;[?A[1-;Y_&N7-$Z>%8\)Q4],3XS>]9\>B)FLV:U9Z.X
M
M
M
M
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M\4M9#[O7RM[I[)O;-O,7SCB-9Z=QBB;4T]7O(^NQ6TF-8O'3,ZQ2]])E**C
MUP
M
M
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MN/;4M,TK\EKSI'O<D1X==HB(UGHK2+3$R9HTM>
M
M
M
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MQUV=YC:=PQ7VL%I\+Z::VPW]%XG7ZR=,E?'V9K7KF'E+]M8
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M&P
M
M
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M5[:?W(K$1%:UC]#2L16L>$1$,M,3=6
M
M
M
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MEUP
M
M
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MVVSZ[XJS$^-<V;WV>MO:QWQ1,U2]['\F.V>T9IO=Y$;_ )NLZQER5TI2=/\
MF\6LUC3TQ>_5>)\:S7T(24UVX                  &0NJ^I^R>\-]UOJ_J
M32\]O^_;=DK7%8#6==LJKR^O+JZGCMZ99J^>:+7&XVVJEXKN;RZDAL[.'BJ6
M>6.*FJOC'^Z>Z^V^R.!W/<_=N]P;#@-ICM?+FS6Z:UK6)G2/3:]YTTICI%LF
M2VE*5M:8B>#R7)\?P^RR<ERF:F#8XJS:U[SI$1$:_FS,^JL1-K3X5B9G1=;]
ML3[?/KKH6+6^ZO-.SUOMSNF+T\MANHZ:;78NHNN9+BTFHBM]E@OK.NP[+W"P
MIN>*I*ZZ.<)87M'/TO%[S%!?U4L_$W](#W%WY;<]E^2]]SQ/9<ZX\F_]K#O]
MW$6B9G#-;1;9[>VFD1$_.<N.?LLX.N^WB(7F+YY[_FYR<1VC.3:\1/LVS^-<
M^72?328G7#CG3P_YRU9]KHUM19E5I(\
M
M
M
M                                                     (ZO/WVQ
MO&GW"=)EQ?9V"_-/M#%V<M&C=WZ?8X^WWS6+NF/XVEGE9)H>(=TT^J:BGBYQ
M%_5\O,-4G-I-9755%W'(CR#^)KS*^'WFHW7;.?YWVQEO'SGC=Q:\[7-77VK4
MB)UV^XTUZ,^*->J*^^IGQ1.*V>]C^8O</8N\C)QU_>\=:?LFWR3,X[QZYK_F
M\GR7KZ].J+UUK-#+S]]K;RA]O;9I?VS==_.[J')YB7&Z5WOIEK=W>A[!ZE'U
M..QV>XJHKO-!W"XL^:OFQ63^3UIK>Y_#Y\A;6]5US>]Y!_%#Y8?$%QD?P9W'
MS3N[%AB^YXS<6K7=8M/"]\7Z'=;>+>C/AUZ:WQ?.,>WR9(Q1-;L?S([<[ZV\
M?>[)[KE:TUR;;),1DKZIFOJRXXG]'3T1->NM+6BJ-](UGX
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M?0CONMINMCN+[/?8LF'=XYTM2]9I>L_):MHBT3]28AZ1UKC@
M
M
M
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MCU5K$1'JA(S!@P;7#7;[:E,>WI&E:UB*UK$>B(K&D1'U(A\=RWU
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M
M
M
M
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M@
M
M
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M4H.'X/A^W]G&PX7;8MMM(_0TK$:S\MI]-K?+:TS:?7+#[+W:@
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M[G<[S<7W>\R7R[K):;7O>TVO:T^,VM:TS-IGUS,S,OO. ^
M
M
M
M
M             "-CSX]J[Q6]P+7+Z7L;5H=+[B@QLEKJO?6CV%A8;_B;B&*"
MG&6NSU>G':]B:K:U6E$7.,ROJ506LD]./N,?/-S<TR1\A?BE\T_(#D:5[<W4
M[WL^V2+9^+W-K6VN2)F>NV'QFVTSVZIGWV#2+7BD[C'N,=(Q3L'LGS*[E[&W
M$1Q^6<W$S;6^VR3,XK1XZS3UXKSKKUTTUF*]=<E8Z5$3S]]K;RA]O;9I?VS=
M=_.[J')YB7&Z5WOIEK=W>A[!ZE'U..QV>XJHKO-!W"XL^:OFQ63^3UIK>Y_#
MY\A;6]5US>KY!_%#Y8?$%QD?P9W'S3N[%AB^YXS<6K7=8M/"]\7Z'=;>+>C/
MAUZ:WQ?.,>WR9(Q1-+L?S([<[ZV\?>[)[KE:TUR;;),1DKZIFOJRXXG]'3T1
M->NM+6BJ-](UGX                   #?#PN]R;RW\#,W)=]#=B?+J&0O(
M;S8^I]VLZMJZOV:N&JNOGF\U^:YM+[ WEQ55QZM_@[S$Y.6BGB.JYYC^-'.B
M?.;X;_*7SWV48N^^.UY?'2:X=]MK>XWN'7^]RQ6U<M8_0XMSCSX:S,VC'U>+
M"^[O+[M?O7#T\W@_TJL:4S8YZ,U/S+:3%HCU5R5O2/3TZ^*X#X2?<2^)'D3^
M$:9Y#1?Q4^TKKT+3Z_:\K3E>E,]>U?+%ZUAV5]-8_F9Z_IR7$L>QVN/Q]E'S
M1%3D[N7GX\U#>=GT>7FUY>>^YGR]G^%7:]-;=."G1R6*OITOL^JWSC36*5G9
MWRY<DZWG;8:^B*O>'D-W1P/7N^!G[Y\;&LZ4KT[BL?5Q:S[SU1$XIM:TZS[N
MD+ N.R./R^/L<MB;ZSRF*REG;9'&9/'7,%[C\CC[V"BYL[ZQO+:N6VN[.[MI
M:9(I8ZJJ)**N*J>>>.>.4 =QM]QM-Q?:;NE\6ZQ7M2]+UFMZ7K,Q:MJS$36U
M9B8M68B8F)B8U:.R8[XKVQ9:S7+69B8F-)B8\)B8GQB8GPF)]#^Q\7X
M
M
M
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M=H;6=KP&UIAZHCKOXVRY-/[_ "6UM;QF9BNO169GIK6)T:HMJLF
M          ;O>$WM[>3/GOO-&J]&:5-+K6.R5I8[OVIL--QC.M] BN8^;CU,
M_GJ8)JKK)<VM/,D.-L8[K(S\<\54P^G\TE.DO.OX@O+3R&X.>4[XWL1R63':
MVVV.+2^\W4Q.FF+%K'33J\+9LLTPU\8F_5I6<.[P[Z[=[)V7SGF<T1N+5F<>
M&NDY<NGA[-=?"-?";VF*1\NO@OC^W)[1?C=[?& Q^?QF,L^T?(FZLZJ-E[VV
M?%1<9:RKNK*>RO<+UIB)YKZWZ]UN2VO)XI>;6NK)Y&*:JF]NYXJ8((*)/B+^
M+?S'^('?Y-AN<M^+\O*W^P\9AO/N[=-HM7)O,D16=WFB:UM7KB,.&U8G!BQW
MF]\D*^_O-+N#OK/;!DM.VX&)]C;4GV9TG6+9;1I.6^L1,:^Q68UI6L]4VE=1
M4:R
M
M
M
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MIK>EXBU+1ZZVB)CUPT1GP9]KFMM]S2^/<4G2U;1-;5F/3$UG28GZDP^PX;Y
M
M
M
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MP@
M
M
M
M                                  &C?FO[=WB]YZZ=/@.\=#LZ]OM,
M/)B=.[>UV"SQ?:&C4<3SWMK1A=DYMIJK[#P7US++5BK^B[QDE<TE7,'$E7J<
M;P\E?B&\S_(?F*[_ +(W]XXB^:,FXV&:;7V6Y\(K;WF'6.G)-:UK&?%-,T16
ML=?3'3.9=H=^=Q]D[N,_#9Y^:S?JR8+ZSAR>&D]5-?"TQ$1UUZ;QI'CIX*.?
MN'>REY2>"MQG]XQ%C-WIXY8Z&G(T=P:=BY(+[5;"NOB*2W[0TJFZO\GJ4UE/
M^2K(027V%DAKAKYNX9Y)+2"[[X>OC3\KO//'M^#W=XX/S%R3T?>_<7B:Y[Q&
ML3LMSTUIGBT>C%:,6YBT7B,-Z5KEO,CL3S>[;[SK39Y;1LN?M.GN,D^%Y^7#
MDTB+Z_WLQ7)$ZQTS$1:T-J8K;                     #=CQ$]P[RW\'\W
M1?\ 0/;&8PVN2WG%YFNL]@YJV;J_8JZJN.;CG*:9D9:K"UO+JFGY*[_'U6.3
MIH_)1<T-*^;GP]>4OG=LIV_?W$X<W(Q3IQ[S%]AWN'Y.C<4CJM6OIC%E]YAU
M\;8Y8AW3V)VOWCAZ.<VM+[B(TKFK[&:OR:9(\9B/[VW53Y:RM<^$GW*G0_:O
MX1I/F3J7\7O>KCT+3]LK4X<QL_2F9O:_A1ZU_8?^M-ZZW^JNIJ(HHY^,[CX8
MZ*Y[K)VU''PXJI\[/HVN^^U??<WY.;O^$'!UUM\SSSCP\ECK'JI;V-MO.FL3
M-IK\URVF8IBVV2WC,9>\/A\YKC.O>=IY?GVRC6?=7Z:;BL?4GPQY=(\9F/=V
MF=*UQVE9!T3L/0.TM9L-UZRWG3^QM-ROJ?A>VZ)LV%V_6<EZ-?IS?09[7[W(
M8J\]*OCY:O3EJ^7G\G*N3G>WN?[7Y/)PO<VQWG'<QBTZ\&ZPY-OFIKXQU8LM
M:7KK'HUK&K0.]V&^XW<6V?(X<NWW=?33)2U+Q^;6T1,?W8>P=.X@
M
M
M
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M"BWLX*3/C'JG-?PG)/KTF(I$^BNOC,MZ);5P
M
M
M
M
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M>U69CQCQ9F8:ZD
M
M
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M^T^RZ1/#;:)WVFDY\FE\]O5/MS$12)CTUQ5I2?3-=?%H&WXS<
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MGA6=?^9QWCVO\;)7I^2EO2MWZ!U]HO56G8'KWK/3];T'1=6L^;#7=1U'#6&
MU[#6E<\UW+%C\5C(+>SM_J+RYDGEJIH^::>6N2OFJNNJKFH_G^X.=[JYC/W#
MW+O-SO\ G-U?KS;C<9+9<N2VD5B;WO,VG2L16L3.E:UK6L16(B(M;[?;WD]W
M??\ (Y<F?>Y)UO>]IM:TZ:>-IUF=(B(CY(B(CPA[!T[B
M
M
M
M
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M^,:UB?!NDTPQ$
M
M
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M'7?6?&>GIB=$AZ/3 P
M
M
M
M
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M?5\SYR_A\WR3KU3\F+)I6N3ZD:5O/]YIXH?TO6U
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M^$Q/C$M2VK:EIK:)BT3I,3Z8GY)?L_#^
M
M
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M!VN+;;;PUBD>U:8]$WO.M\EM/#JO:UM/#71@=G;N@
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MOV?A_
M
M
M
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MU.RYO;9MMN8F?"]9B)TTUFMOK;QXQ[59F/&/%F9AKJ0
M
M
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MS/<F^MR7.;C)N=Y;]%;32(^2M8B*4K_@TK6OU&;&%.G
M
M
M
M
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M4G#\YP_<&SC?\+N<6YVD_HJ6B=)^2T>FMOEK:(M'KAA]E[M0
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M7
M
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M>Z>]KVQ\AF]SQ4S$QML6M<4::3'7XS;);6(MK>9B+>-*TC2(DM1K:]
M
M
M
M
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MYF/">G+77';U?6VGTQ\L-G&LF.@
M
M
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M8BTZSXI!<#VKV[VQA]QP.SP;:NFDS6NM[1X?79+:Y+^B/KK3XQKZ6M[8SOP
M                     &XWA_X$>4GG/MTNK^/76>2V''XV:B+:.P<QZF!Z
MRTSBKFWY^79=UO(><9!DJH+JF:+&6WU67NH*:Y+>TEHCDYIT]YO>?/E=Y'<3
M'*>8/)X]ON,D:X-ICTR[W<>G]1VU9ZYIK6:VS7Z,%+36N3+2;5B<4[J[V[;[
M,VL;GG=Q7'DM'L8J^UFR>GZS''C,>&DWG2D3I%K1,QK<Q\ /M]/&;QAHPW8/
MD3QC?)GNN"'B6NQV#&6\_2&I7U-Q1<02ZSI&3L/JMFR5I33Z?-_G*YX9/A3)
M#86<G'QYIN\_?I ?,OS.MF[?\O/>=L]EVG2+8KS')9ZZ:3&;<TMTX:6]/NMM
M%;1XUOGS5G1$OOCSS[B[CF^QX'JX[B)GTUF?G%XTTGKR1.E(GT]./28]$WO"
MP+;V]O9V\%I:00VMK:PQ6]M;6\5$%O;V\%%,4,$$,5-,<,,,=/%---/'%--/
M'''''P0!R9,F;);+EM-LMIF;6F9F9F9UF9F?&9F?&9GQF6C;6M>TVM,S:9UF
M9],S\LOV?A_
M
M
M
M
M       &I?E9X,^+'FKK-.N>1?4.M[Q<V=G+9Z]N<<4F#[%U&BNN6>CC5]]P
MM=ELN,LZ+V3BXDL/J),9=RT4_56T]''-'.V?*OSQ\TO);DYY'R[Y?<[''>\6
MR[>9C+M-QII'V?:Y(MAO;ICHC+T1FQUF?=9,<^+*.V>\^Y>T-Q\XX#=9,-9G
M6V/Z[%?U>WCMK29T\(MI%ZQ];:L^*H'YW_;B>0'2=QE-Y\/<IDO)#J^*&6]D
MT?*?A>-[SUF*.N;YK6BRM(\;KW9T,=M'17Q<8N+'Y&:67F&/$\\1\32V[>17
MTC'8'>N/%P?F_BQ]N=SS,5C<TZ[\9FF8CVNJTWR[*9M,QT9[9<-:Q%[;N)MT
M5E/V5Y_<'S%:[/NNM>/Y*9T]Y'5.WO\ 5UG6V'Q\-+S:L1&LY?'2*XNP:]G]
M3S>4UK:L'F-9V/"7DV.S6O[!C+W#9O$9"WJ^2XL<IBLC!;7]A>05?DKBECHK
MIY_L\<+&>/Y#8<MLL7)<5GP[GCL](OCRXKUR8\E)]%J7I,UO6?5:LS$^J6_L
M&?!NL-=QMKTR;>\:UM68M6T3Z)BT:Q,?5B7QW+?4
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MS8BT1K'C$Q,>$Q,3'A+)#''7@
M
M
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M;6GU>,^$1$1I$1"-^\WN[Y'=9-]O\E\V\RVFU[WF;6M,^N9GQEZIU3C
M
M
M
M
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MVB)CQ^6'JG5.,
M
M                                              _&XN+>SMY[N[GA
MM;6UAEN+FYN):(+>WMX**I9IYYI:J8X888Z>:JJJN>*::>.>>>?@_>/'DS9*
MXL59MEM,16L1,S,S.D1$1XS,SX1$>,R_M:VO:*UB9M,Z1$>F9^2$47D][V7M
MX>+=Q>X7.]T0]M[M832076B=!6MIV;E[6:WKNX+RVR&Q6V3QG6^'R6/O+7F"
M>QO<[;7\4M?'S0?+Q751*ORQ^"KXA?-''3>['A9XGA<D1-=UREK;+':)BLUF
MF&:7WF2EZVZJY<>VOBM6)TOK-8G9O;GE!WYW)6,V':3M=G:-8R;F9PUG728F
M*3$Y;1,3K%JXYK,>OT:URO)O[G#R@[ HR&"\8NL-)\?,-)-=16NY;)5!VUV3
M]/%<1?A]]8PYK%X[KO"375O17S<VESALW31S+Q1'<?VOF66Q7RS^C,\L> MC
MWWF;R>][@WD16;;?#KL-GK,3UUM..]]WEBLS'1>FXVTSTS-L?M=-=^=N_#MV
MYL9KF[CW.;?9=(UQTUP8M=/&)Z9G+;2?1:,F/736:^.D5]>Y_('O#R)V;\\>
M].U]\[6V.CUN+7([OLF3SOX;%<46U$]MAK2\GKL<)9RTV<7%4%G%!#SZ=/ZG
M\G"P'LWR_P"R/+OC/O/V-Q6PXKCITZJ;;#3%US'5,3DM6(MDM'5;2V2UK>,^
M/BWGQ'!\-P.W^:<+M<&VV_KC'2*ZZ:^-IB-;3XSXVF9\6'V7NU
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MF>Y-];DN<W&3<[RWZ*VFD1\E:Q$4I7_!I6M?J,V,*=.
M
M
M
M
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M?XLN#=4G2U,E;4O$^C2:VB)CQ^6'JG5.,
M
M
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MS=W]P]W[SY[S^YOFO'UM?"N.D?)3'72L?),Z3:WZ*UI\6U#5C&@
M
M
M
M
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MF-IN-MEB9C3)CM373^]F8B+1ZXFLS$QXQ,PS Q!U0
M
M
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MW?+7LKM>U<W%;#%\\I.L9<FN7+%O[ZM\G5T3_P##Z(]/AXSK'ND$SH
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MPTJP\
M
M
M
M
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MB8UUK/A,1/@D%L.0V'*;6N^XW-BS[.\:UOCM%ZS^9-9F/S8],>MXEW3F
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MK,3Z8TUK:(WK:,86
M
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M;KYS=7OMXG6N&OL8:_)ICCPF8_OK=5_EM+=AI5AX
M
M
M
M
M                                                       # _D'
MXP>/OE9I,G7OD/U-I_:NK?WS78V^R8^K\6U^YNXXX;G(ZCM&.EL=ITS,3P1\
M1U7N)O;*[YB^-'J?+SSQSG?E_P"9WF!Y5\U'</E[RV\XKE/#JG#?['EK69FM
M-Q@O%L&XQQ,ZQCSX\F/J\>G6(EW7!=Q\YVSO/G_ [K+MMSX:S2?9M$>B+TG6
MF2NOCTWK:NOCIJJ^>8?VPM$M=UM7@_VU#:T\0S7$_4O>5]<545UP6]<O,.J=
MDX#"W$GK7DD?$5O9Y;'<1\25_-+DJ*/C\MGGD_\ 2;VI6G%>=W$S:=8B-_QE
M8UTF=-<^SRY(C2L3U6R8,NND:4VUK>F1W:GQ%S$1MN\=K,^.GO\ ;Q'R_H\5
MK1Z/3-J6UT]&.95=O(+Q8\B?%7;KG1_(7I_=NJ\_!-S#;\['BJN<#FN*>9>/
MJM6V['5W^I;?C:JX)*:;O%7UY:U5Q24\2<U45\<6?>7_ )I>7GFGQ->;\ON8
MV7*;"T:S[F_V7'Z/9S[>\5S[>_C$]&?%CO$6K,UTM&LC^"[EX'N7:QO."W>'
M<X)CQZ+>U7ZEZ3I>D^,>S>M9\8\/&& 6?.[
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MI,:Q,>,>#+3$W5@
M
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MKV,==*1.GA-M)O:/KK6GQ;:-3,7
M
M
M
M
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M_,9=,>>)].D4F=,FD>F<5LE8]$VU\$>Z03.@
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M?_0]XZ%P@
M
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M.NE*?F5K$>KT-BFNW0@
M
M
M
M
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MWI:/EK:LS6T?5B9AN?%FQ9\<9L%JWQ6C6+5F)B8^6)CPE\UR7T
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MB)BTQ%;1,Q,1:)F+:>$RSDP=TP
M
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MK3/BVGQ/ <)P6+W/"[3;;7',1K[K'6DVTB(UM-8B;3I$:VM,S.GC,L,LR=L
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MX5C]#6-*UCPB(ADACCKP
M
M
M
M
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MM&L>-9B8\)A@6?!GVV6<&YI?'FKIK6T36T:QK&L3I,:Q,3'U)U?8<-\@
M
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M,1+9O%=O\%P5/=\-L]MM:Z:3[K'2DSZ(]JU8BUIGIKK-IF9TB9F9AA-FKMP
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MGQF9]+^Q\7X
M
M
M
M
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M)2U)\/"?"T1/A/A+V#IW$
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ML48-M2F/#772M8BM8UG6=(C2(UF9F?JSJ^0Y;Z@
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M(&T P8
M
M
M
M
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M,Q^I6GW>:/1K]COTVG29B)M6+4U]%I\&D+=K,0
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MQK$Z3&L3$Q]2=7V'#?(
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M6-(TAG>RX[C^-Q>XX[!AV^"(B.G'2M*Z1&D1I6(CPCPCY(\(>)=TY@
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M^9&LSI$>$16-(B(B(B(B&3F,NN
M
M
M
M
M
M         ?C<6]O>6\]I=P0W5K=0RV]S;7$5$]O<6\]%44T$\,M-4<T,T=7-
M-5-7'--5///'/'P?O'DR8<E<N*TURUF)K:)F)B8G6)B8\8F)\8F/&)?VMK4M
M%JS,6B=8F/3$_+"*+R>]DWV\/*2XO<UG>EX>I-VOYI)[K>^@KJTZRR]U-<5W
M<]Y<Y#7;;&9/K?,9+(7EUS//?7N"N;^66CCYI_EYKIKE7Y8_&K\0OE=CILMC
MS4\MPN.(BNUY2MM[CK$16*Q3--Z;S'2E:]-<6/<TQ5K,Z4UBLQLWMSS?[\[;
MK&'#NYW6SK&D8]S$YJQII$1%YF,M8B(TBM<D5B/5Z-*Y7DW]L?Y0=?T9#.^,
M79^D^0>&CFNI;73=DI@ZE[)^GEN(OP^QL9LUE,CUWFYK6WKKXN;NYS.$IKYB
MXKCM_P"V<Q16*^6?TF?ECS]L>Q\S>,WO;^\F*Q;<8==_L]8B>NUHQTIN\46F
M(Z*4V^YF.J8MD]GJMOSMWXB>W-]-</<>VS;'+I&N2FN?%KIXS/3$9:ZSZ*QC
MR::Z3;PUF 'NKQM[_P#''-QZ]WQTUV1U+E;C\MA'O6HYG7[3+Q?--1Q<X+*7
MUI'B\]9\R6TM/$]E-/#S5%73Q5\:*N.)]]E^9'8'F-LIY#L3F>-Y;:U^NG:Y
M\>6V.?#PRTK:;XK:36>G)6MM+1.FDQKO'B.X.#Y_#[_A=WM]UCCT^[O6TU^I
M:(GJK/C'A:(GQCY6$V:NW
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MSUM3+6=)K:)B8GY)B?&'TG&?,
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MWC$WO:8GQU9KQ_9W:?%1'WNXW8X;1$1U5PX^N=)UC6_3U3I/C$S,RU=;/9&
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M_8L/3/Z&T5GJR5]?V6^2?JI(4<6
M
M
M
M
M
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M3XQ,3X3$^,2Z*U;4M-;1,6B=)B?3$_)+]GX?P
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M^$:Z5B(UTB(U^I#SCL7(
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MV[W^7+GW5YUM?):U[S/IUFUIF9\?EEZIU3C
M
M
M
M
M
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M)FLSI/A,3$^,3$Q/C#&[(W8
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M(AWNV[7[9V=)Q;/CMABQ3.LQ3;XJQ,^$:Z5I$:Z1$:_4AKXV"[T
M                                       !_9CL=D,OD+'$XFQO,IE,
MI>6V.QN-QUM->Y#(Y"]FHMK.QL;.VHEN+N\N[B6F.**.FJN2NKBFGCGGGCA\
M=QN-OM-O?=[N],6UQ4M>][VBM*4K$S:UK3,16M8B9M:9B(B)F9T?G)DIBI;+
MEM%<58F9F9TB(CQF9F?"(B/&9GT)8O&[V/O<:\DZ+')X_I*;IS4K^&J:'<?(
M"^GZRLN./J*88>?S2GQ^4[0GANX_FFAGAP$MM)!1Q7Q)\)(?4BCYC_&[\.GE
MO:^VW'-QS'+8YTG;\56-[;T:S]GB]-E$UG2MJVW5;Q:>F:^S?IUCW!YQ]@]O
MS;'DWD;O=5G]3VT>^GT?W\3&&-/1,3EB8GPT\)TL1^-?VQ7C'HOX;FO)GM??
M.^<W#^&W5WJ.IQ_M3]=52T_V[*XB_FQ][F>P,W9U2?+!%=VN6P4U47%<G,,=
M<E%,%>?F3])KYF\[[S9>6G%;#@=E/76N?//S[=Z>BF2L7KCVN.VFMK8[X-S6
M+:5Z[5K,WT-W#\17<6]ZL/;NUP;+#.L1>_V;+_@VC6*XJSZYK:F2-=(UF(GJ
MG_Z-\9O'SQGURC5>@NG.O>I\-Z,4-W3INLX[%Y/,\PQ6\%-ULF?HAKS^T9*J
M*TBIKN\C<W5S)Q'3\\E7R\?" G?'F7Y@>97(SRO?O,<ARV\UF:_.,U[TQZS,
M].'%K[K!36UIBF&E*1K.E8UEH_F>XN=[AW'SGF]WGW677P]Y>9BOI\*5^MI'
MC/LTB(C6=(9R8.Z8
M
M
M
M
M
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M=R
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MJ
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M<;F-9F*VMICB9\9Z<5=,=?5];6/1'R0V<:R8Z
M
M
M
M
M
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M?C-P
M
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M.D3X:S/#X^>%_BGXJ8^.Q\>^A.M^L)J;.WL+C8,)@(+K=LI:6D-=O;Q9W?\
M,U9/>-A]..:3]5?9"XJYJEDJYYYJDKYJ@GY@><WFIYJ;B<_F#SW)<G3KF\8L
MF6:[:EK3$S.+:X^C;8M9B/#%BI&E:QZ*UB-*\[W=W-W-?KYW?;C<QK,Q6UM,
M<3/C/3BKICKZOK:QZ(^2&SC63'0
M
M
M
M
M
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M3IM;C.9XCFL,[CA]UM]UAC36<62F2(U]$3TS.D^$^$Z3X3\C%;*79
M
M
M         ,\=*^+GD?Y'7<EIT/T9VIVU]/>?07]]HFD;!L&$Q%WZ4,WI9W8+
M&QDP6!^$5S%5S5>W$%/'$M'QY_5T_'!.]/-#RY\N<49N^^<XKB>JG76NZW.+
M%DR5UF-<6*UHRY?&+1ICI:?9GY)TZ7E^Y. X"O7S6]VVUUC6(R9*UM:/\&LS
MU6]$_6Q/HGY$V'07VT?G1V1+CK[NO8^J_''!2WGHY:QRN?B[1[!LK2F[JAKO
M<?K_ %Y<7NBY3Y[6/F:..3:K2JKYXZ*ODJYD].%??OTE'D;VY7)@[*VW*]Q[
MZ*:X[4Q3LMI:W3KTWR[N*[FGM3TS,;')$:6F.J(KU:@YSXA>S./BU.'Q[GD,
MT1[,Q7W.*9T]$VRQ&2/'PF8PV]<QKX:SD^/GVVO@9U7Z>1[@O.R/)+.\?3U5
M0;7L-UH.DV\UM\]7$]AK775SAL[5Z\M?',L60S>1MZZ8Z*?3XI]7B6#_ )@?
M2/\ GOW3KM^T*<;VWL?'QP8J[K<S$Z>%LV[KDQ>$1[-L6VPWB9F>K7IZ=-<[
M\0/>O)_8^*C;\?A\?&E8RY)U^6^6+5\/5-<=9\9G7T:3;]/]"=)>/VN<:ET?
MU-U[U/KW,-C#<XW0=2PFL49/G&Q2PVEUFY\59VUUGLE13/)55=WLD]U+)+)7
M7)57)755"?N_OSO7O_D?OMWORW(<MR&MIB^ZSY,TTZYB;5QQ>TUQ4\(B*8XK
M2L5K6M8K6(C3_*\WS'.;CYUS.ZS[K/K.DY;VOIKZ8K%IF*QX1[-8B(B(B(TB
M&6F)NK
M
M
M
M
M
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MMY]%J6B]9_,M69B?^5YMV+D
M
M                               /I8?#9?8<G9X7 8K)9S,Y&;BWQ^)P
M]C=9/)W]QSQS5Q!9V%E%/=74W--///%-%%57PX_L.-O-YL^/VU][O\N/!L\<
M:WR9+5I2L?+:UIBM8^K,Q#YY<V+!CG-GM6F*L:S:TQ$1'RS,^$)2NB?9+]RG
MOJ6*7'>.&R=786KY?J,_WM-#U)%9_/=WEG3ZNL[1Q!V!<_VRPEKY^FP\_P L
M/IR5?"B>WJEB[WU\:WPV]AUFFX[CVW*;V/1BXR)W\V]FMO#-@UVL>%ZQ[>XK
MK;JK&MJ9(KK?FO.#R^X2)C)R&/<YO57;?9]?")^OIKBCTQZ<D>.L>FMM)I?'
M_P"UD_\ Q+)^4_E!_P#AJ,CI/C_K?_UE7!<V7:/8MI_]<QUP2:?_ /@Y.)O^
MU$ACW_\ 2D?7[;RM[8^2:;GE<W^-K6VRVEO\28M'(?WU>CT6:BYSXD_3C[:X
MW\S)N;_FZQ.'%/YDZQG^6-/1*:KH#V4_;>\>J[/(83QWP/9&RV<T%Q3M'=UW
M<]J7DEQ;6]W;V\].O['S)H=C-#];))Q5:8BWJ]?B*7GGF2WMZHH6]_?&E\1W
MF%6^WWO<.?C>-O68]QQM8V-8BTUF8][ATW5HGIB-,FXO'3U5^MR9(MJ'G/-[
MS YV)QYM_?;[>8F.C;Q&&-)F)F.JGV2?1$>U>?#6/1:VLHN'PV'U[&66%P&*
MQN#PV.AXM\?B</8VN,QEA;T\\U4P65A9106MK#Q55SSQ31133\>?[",&\WF\
MY#<WWN_RY,^\R3K?)DM:][3\MK6F;6GZLS,M<9<V7/DG-GM:^6TZS:TS,S/R
MS,^,OI.,^8
M
M
M
M
M
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M/HEX]V[E
M
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M8&(.J
M
M
M
M
M
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ML>,:Q,-8VS&1
M
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M/37\RL1#/S 71@
M
M
M
M
M
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M&T1#87'=Q]O\QI]ZM]M-S-ITB,6;'>=8CJF-*VF=8KXS&FL1XS$,&LX=R
M
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M[_E=SN-UFC]%ER7R6]$1Z;S:?16(_,B(]4,D,<=>
M
M
M
M
M
M
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M9AEV+-BSXXS8+5OBM&L6K,3$Q\L3'A+YKDOH
M
M        VHZN\&_,GNJ:"/JWQ<[XW.VN/A\,SB^K]OHUF#YL?+E(?KMKO<5:
MZUC?J[*+FN#ZB[B^HYJIHB^>NNBFK5O='GAY.=ETM;NCNC@=GDK_ ,W?>[><
MT^W%)Z<%;VS7Z;3I;HQVZ-)FVD5F8QKDN\NT^(B9Y+DMEAM'Z&<U.N?'3PI%
MIO.D^G2LZ>,SI$2D:ZF^WC]S/LWBPGSW7?7O2V/R,,5S!D.V>S<%1S':W&,K
MR4$M_A>MJ.R-HQ<U=?%%K7;7-A%>074G%,T,=%,E=$=.[/I"?AI[9G)CV'(\
MAS6XQS-9IL-EEG6T7BDQ7)O)V>&\1&MXO3+;':D3-+VF:UM@/*>>_EYQW57!
MGS[S)6=)C!AMZ8G2=+9?=4GY=8M-9B/"9G2)DFZN^U:V"6:"Z[J\O,/86\?P
M^IP/5W6%[EYKOU,?+QSZ&V;9L^$HQWT>4JHY_586Z^IMZ*N/[177QS1&[NCZ
M4S84I;%V7VCFR9)^MR[W>UQQ72\>G!@PY)OU4U]&YIT7F)]N(TMK[DOB5P1$
MUXCBKVMZK9LT5T\?72E+:ZQ_[R-)_OHCQDMZK^W ]MO08X^=TPO<'>%QSZM<
M_/8?:&1P%IS+-:6D'-%K;]0V/6-S!9VUQ!7/!1)//+Q5/53++-1Q'31&SNGZ
M1KXC^>M/WES\/PF/PB/FFRIEMI%K3K:=_;>Q-K1,5M,5K72L36E)FTSKWD_/
M[S WT_Z)?:;.OJ]UABT^F9\9SSFB9F)B)TB(\(TB)UUDXZK\"_"KI*2.ZZL\
M5^A]0RD7J\4;#9=9ZK=[7Q'+=VE_5;<[;E,;?[-59T7MC!-1#S=\PQR0T544
MT\T\<\1F[I\^/.CO:LXNZ>Z>>WFUG3[%;>9ZX-8K:NON*7KAZNFUJS;HZIBT
MQ,S$RUWR7>W=_,1T\ER>]RX_[V<UXIZ)C7HB8IKI,QKTZS$SJVU:F8N
M
M
M
M
M
M
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MD>^&_F;5CD<G.<3$Y.F9W6QZXK72)]Y/S'-O)Z)F9KI$3DUK.M(KI:<XV/Q
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M"T1.FNDLQVG(<?R%9ML,^'/6(B9G'>MXB+:Z3/3,^G2=/ETG1XIW3E@
M
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M<Q:-)C+FR7C2)ZHC2UIC2+>,1II$^,1#.3!W3
M
M
M
M
M
M
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M3'RP_%^W]
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M
M
M
M
M
M
M
M                           >;VC3=0WC'PXG==4UO<,5;WD>1M\9M&#Q
M>P8^#(107%M%?0V>6M;NVBO(K:[ECIEIIXKIHEKIXY^%7/'/9<7S/+\)N)W?
M"[K<[/=6I-)O@RWQ7FDS$S6;8[5F:S-:S-9G29K$Z:Q#D;;=[K9WG+L\N3%E
MF-)FEIK,QX3IK68G36(G3ZD-4-T]N'P#[!HR/&T^&?C3=766R4F8RF8QG3>B
MZWL>0R<UQ)=W-Y>;/K.%Q&PW$U[<S523\U77/%Q75SS)\W+:O"_$9Y^=OVQ_
M>OO+N6N+#CC'3'?D-UFPTI$16M:X<V3)BB*UB(KI3V8C2NC)MGW_ -[[&:_-
MN6Y&*UKTQ6<^2](C32(BE[6K&D>$>'AZM&KNW^Q+[5^XS9F^N/%RSU_*9BSJ
MMJ<AJ'9_<FLPXB?C'T8^VR.&US&]@QZ=:7EIQ%1-Q35C9+>:XXYDGBFYKD^?
M:'$?'3\4O#TPX,?=%]QM<-^KHW&RX_-.2.OKFF3-?:3N+5MK-=8S1>M/9QVI
M%:Z9)M?.CS*VD4I7DIOBI.NE\."_5XZS%KSB]Y,3Z/KXF(\*S&D::N[5]LY[
M=NPW%I-B-D\EM%CMX:XIK35>RM.O+>_KKK^>FXNZMVZPW&ZHFCI_4T\02PQ_
M+_9IYY_*VAQ7TEGQ#\?CO3=[;MK?6M,3%L^SW%9K&GHK\VWNWKI/IGJK:=?1
M,1X,DVWQ#=^8*S&7'QV:9GTWQ9(F/J1[O-CC_EB9^JU7W#[5CJF]M^:= \P>
MPM9NOQ+F6F;<.J=;WFWXP_R77'%CS;87<.O)*LEQ)7#S]7ZO$7-,=?'T_P 9
M*>8]I</]*;W5@R:\_P!H<?N<7N]--OOLVVGWFM?:ZLFWW<=&G5['3U:S6?>>
MS,6R7:?$KR=+?Z=Q6#)7I_YO-?'/5X>.MJ9?#T^SIKXQ[7AXZZ;9]JUV_9W=
MS1HWEYUOL=A19\5V=SMG6.SZ7=SY#TJ^>;:YLL/LV^PVEGQ-Q33Z]%Q/7S3S
MS5Z/QX^7G8G%?2F=HYL5;<YVCR6WSS?2T8-[AW%8IK]=6V3#M9M;36>F:5C7
MPZ_7'?;7XE>*O6)WO%;C'?7QBF:F2(CY8FU,>L_4TC\UJ[M7VSGN):];VDV(
MV/QIWJ2XFKBFM-5[*W&SN+"BFCYZ;B[JW?K'3;6N&2K]33Q!+-)\W]FGCC\K
M:'%?26?#QR&2]-WMNY=C6L1,6S[/;VBTZ^BOS;>[BVL>F>JM8T]$S/@R3;?$
M-V'GM,9<?(X8B/3?%CF)^I'N\V2?^6(CZK7O9_8&]U/7;[)6]GXXXW;<?CH:
M9Z<YK'<O2==CD:/HX[N:G&X[.]@X+9YYK:NNJ#F.K'QR231\\14R4<T5U[!X
MSX^/A9Y'!CR9NX\FTW&2=/=9N/Y*+4GJFL==\6TRX8B8TMK&68BLQUS68M$=
M[MO._P M-Q2MK\A;%DM.G3?!N-8\=/&:XK4C7TZ]4Q$3XZ3K$:W['[4_N/ZK
MC*\MD_"_O^ZM:)H8.8M<T/);CD^:Y^>::*J,+J/&<S-<-//'ZN2F#F./C\M5
M7'#8W'?%3\.7*;F-IMN\^ KEF)G7-NJ;>FD?^\W'NL<3\D3;6?5$L@V_F9V!
MN<GNL?+[&+::^WDC''_M7Z:_W-=9]3 &T>)'E9H^0AQ.Z^,GD)I^5N+./(V^
M,VCI?L?7\A/CY9[BVBOH;/+:W:7,MG+<VDL=,M-/-%5<5=/'/QIYXXS[B_-K
MRJYO;SN^%[F[?WFUK>:3?!R.SRTB\1$S6;8\UHBT1:LS69UB+1.FDP[O;=T=
ML[RDY=GR.PRXHG29IN,5HB?"=-:WF-=)B=/JPP=F,-E]>R=YA<_BLE@\SCIN
M;?(8G,6-UC,G87'''%7,%Y87L4%U:S<4U<<\TUT4U?#G^PSC9[S9\AMJ;W89
M<>?9Y(UIDQVK>EH^6MJS-;1]6)F'<XLV+/CC-@M6^*T:Q:LQ,3'RQ,>$OFN2
M^@                                            #Z^ U[/[7EK3 :
MO@\QLF=O_7^APN QE[F,M>_2VTU[<_28['07%Y<?3V=O)+)\E'/R11U5<_"F
MGGGCB;_D-AQ6TOO^4SX=ML<>G5DRWKCQUZK16O5>\Q6-;3%8UGQM,1'C,/EG
MSX-MBG/N;TQX:Z:VM,5K&LZ1K,Z1&LS$1]6=&?\ 5?"_S$WJWN[O2/$_R6W*
MUL)J+>^N=5Z)[1V&WL[B2CU8X+N;$:M>1V\TD?ZJFFOGBKFG\O''P8#ROG-Y
M/\%DIBYONOMK9Y<D3-:Y^3V6*;1$Z3-8R9ZS,1/A,QX:NCW/=W:FRM%=YR?'
M8K6C6(ON<-9F/ECJO&K9;3_9U]S;>)\-;X7P[[4LI,[9TWUE5N'&M=>P00UX
M^O)<49FYW[8-:MM<O.+:CFGFWR%=K<<7'P@YHXGYXCYUKR_Q@_#/PE,V3>]X
M<5>N"_3;YO[[=S,]?1KCC:XLTYJZSKUXHO2:?9.KHB;,>W7FOY=[.+VS<MMI
MBDZ3T=>77QT]F,5;S>-?776-/:UZ?%L5JOV]'NC;#;W4V7Z=TG19+>:B*&TV
MKN7K*[N+^BJCYZKBUJTG8]QM:(8ZOU-7$\L,GS?V*>>/RM=\K](/\+_'Y*4V
MG,;W?5M$S-L''[VL5G7T6^<X=O;6?3'36T:>F8GP=#N?/;RWP6B,6[S9HF/3
M3!FB(^I/O*8Y_P"2)CZK:+4_M>/-?(7=MSN?=OC'K&+FL^9IY,)G>T-LS=G=
MU145Q64N+N.L-8Q<ORUU<T2R1Y*JFCFGXT>IQSQRU?RWTGWDKM\5OO-PG<VZ
MW5;Z1&3%LL&.U=?&T7C>YKQX>-8G#$SK[73+&]U\1W:&.L_--GR.3)$^'57#
M2LQ\NL9KV_,B:?FZ-G=/^U0R$D&&NM^\V+.TN>+RFO8<#I_0T^1@KQ\60KXK
MML-MN:[9Q<D=Y>XJBGGB>?"U46MQ)SQZ-Q1'QS)K/E_I4=O6^;%P/95[X^C3
M%EW'*12>N:?79,&/87B:UOK[-=S$WI&O7CFVE<=W7Q+TB;UV/#S-=/9M?<Z>
M.GIM2N"?"+>J,GC$>FLSX;1:K]K?X=V=O=T[OW_Y+;#=5S456,VJWO5VFV]O
M;\4?"2*[MLOUUO4EY-5)^6F2B6"FFG\G-'//ZIJ_E?I0O.#-DI/"<!VUM\41
M/5&>N]W$S.OA-;8]WM8K&GIB:VF9\=8]#&]S\2'==[1\SV/'8ZZ>/7&;),S]
M2:Y<>GYFD_FMM-5^WG]KG7KB[FR_3N[;U'<0T10VFU=R]F6=O85T5_/5<6E6
MD;%IMU7-)3^IJXGEFC^7^Q3QS^5J;E?I!_B@Y#'2FTYC9;&U9F9M@X_96FT:
M>BWSG#N*Z1Z8Z:UG7TS,>#&-SY[>9&>L1BW>'#,3Z:8,,S/U)]Y3)'_)$3]5
MMIIWM3>W!HUQQ<X7POZ!O9.,;QBN*=QT3'=B6_TO%=K)ZO-IV!QLUK5DOFM*
M/[\YH^LYIYKI]7X22<5ZGYCXJ?B-YS'[K>]Y\_2OO.O_ $?=7VD]6EHTZMK[
MFW1[4_8]?=Z],].M:Z8ON_,SO_>UZ<W+[Z(ZNK['DG%.OCZ\71.GC];];Z/#
MPC3;O1NF^H.L/I_VM.JNM^O/I,/%KUI^8VC:QJ7TN M_I/0P=O\ @&+Q_HX>
M'\/@^2VI^$%/H1_"GCY*?AJ/G.\>[NY^K^$O*\ER'7FG+;YSN<V?JRSU:Y9]
M[>^N2>NVMY]J>JWCXSKBV]Y;E>1U^^&YW&?6_5/O,E[ZVG76T]4S[7C/CZ?&
M?E9(8XZ\
M
M
M
M
M
M
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MKK8+Z1]6>GJM_P E9GZC&/\ ,)>['_)2_P!>GC9_OB9-_3R^%'^57_AG,?\
M#W8_EL\L?PG_ -7W?[ \KM7LB>Z9IMO:7.7\1MJO([R:N"&G5=YZCWJXHKCH
M]2JJ[M-([!V&ZL(>:?\ LR3T1QU5?J>*N>?R.UXKXVOA<YC)?%M.[=K2U(B9
M]_MM_M8TF=/9MN=IBK:?EBLS,1XS&CD[;SA\MMW::XN4Q1,1K[>//CC^Y.3%
M6)_,C67B?YH3W+_Y&_</_P"3<5^RSN_Z77PU?RQX?_V\G[&YGY5/+S\+;3_E
MM^E?'S_M0>Y%K>)N\UD?#'OFXL[+T/6AP&EW6UY:OZBYAM(_I,!J]>8SM_\
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M1HSRP1TH
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
:                               #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>sny-20221231_g6.jpg
<TEXT>
begin 644 sny-20221231_g6.jpg
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M_\0!!@ !  ,! 0$! 0$           D*"P@'!@4#! $!  (# 0$! 0$
M      @)!@<*!00# @$0 0 !! (! 04!" T* @0!'0 # @0%!@$'" D1$A,4
M"A4A%I:W.%AX&B(CT]475X>7&+C8&3DQ)-255K8W=Z?703)",R6U)C;6)TB(
MF,A1<D-S-%0U=2A28E.#='9HJ$7H<41E$0$  @$# @,"! X+"PH" 14  0(#
M$00%$@8A!P@Q$T$B% E183(CDY2T%55UM38W&''10M+35-56=A<9@9%2,U,D
MA-2%%CAB<I)#LS1TI#6EH8)C);)S@T5$Q)7%)D:BY&7E9B?!HV3#_]H # ,!
M  (1 Q$ /P"_P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M#X?_ ( =T?V@#^S#\A/POW?]M<=_)1^KCV1_&N5^R[?_ %8_6A//O^*'P_\
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M-/BURY8M/CIX=>"E?#VSK:/"/#6=(GTC]8Y]-#_:?N'^:;*_Z>QS^SH]2O\
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M,Z:1+RMSQO([.D9=YM\^+%,Z1-Z6K$SXSIK:(C72)G3Z4OO'@OB
M
M
M
M
M
M
M
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MM=M@Q9=-.JF.E9TGVQK$1+SYD#[@
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MSII$L:W/&\CLZ1EWFWSXL4SI$WI:L3/C.FMHB-=(F=/I2^\>"^(
M
M
M
M
M
M
M
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M<?LK3;9X,.*UHTF:4K69CZ$],1J^*>T^P
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MC7SP@
M
M
M
M
M
M
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MO7L]IMM-=/=8<>/V^WZBL>WX?HO'V7O5
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M3+BOC\9CJB/CUCQFOC$?#'C['JC%GF
M
M
M
M
M
M
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M+Z
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M+>;#+[C?8LN'/IKTY*VI;368UTM$3[8F/V8F/@?5/*?,
M
M
M
M
M
M
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MRP9*SK%JX:=>L3U1,Y)B;SI/C&MIT\---(<NMGLC
M
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M'3DI:EM8G28TM$3X3X3]"?"7VSQ'Q@
M
M
M
M
M
M
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M$5B-(B/9$?0A_%_;_0
M
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M_0E_9_#_
M
M
M
M
M
M                                           !_CR.1Q^(Q]]ELM?6
M>+Q6+L[G(Y/)Y&Y@LL?CL?905W-Y?7UY<UQ6UI9VEM%5)++)531'13S55SQQ
MQSR_;;[?<;O<4VFTI?+NLMZTI2E9M>][3$5K6L1,VM:9B*UB)F9F(B-7]X\=
M\MZXL59MEM,1$1&LS,^$1$1XS,SX1$>U'5WEZNOIS>/GVC;;QY4];YK.X[YN
M"35^KKN\[>S_ -K6GVO'7@+RWZUL]GL\!F/G,+-;R496>PBM9JXN+F2"F:*J
MN1'8_I(]17F![O+P?:W)8=CDZ9C/O:UV&+W=O=S[VL[RV&V7'TY*WB<%<MKU
MB\XJWFEHC/.&\K>_N=Z;;/C-Q3#;2>O-$8*],]/QHG+-)M72T3'1%IM&O3$Z
M3I#_ -Y?5)=%X#[1QWCOXX=D=DWD?S=E:;%VCL.!ZOP'%S1]KP09JSQ& H[%
MSN;P_$L-C/';7-6%N[F&>6B3FSDBIYEEYV/\UYWSO_=[CS#[CXWC<,]-K8=E
MBR[W+T_6YG';)E^28L>32<E9O2-SCI:M+5]]6\].U>&]-W-9^G)SW(;?;T\)
MFF&MLUM/BS-9M;W5:V^JB9CWE8F(F.N)\(?N\OJ+?49[8^T;'1]BZW\?L%=_
M-VD=OU=HMGDL_P XFX^UX:(;S:.RKC>KR',<V>1AIDO\5%B9:9K**:VIM:N9
M>))>]C_-V^G7M3W>?G-OR7<&^ITVF=[NK4Q>\CW<ZUP;.-K6<?52TQBSVSUF
MN2],LY8BLUVKPWD)V#QG3?>8]QOLT:3KFR3%>J.GV4Q1CCIUB=*WF\:6F+3;
MPTB1[<\G/(SOV]N[[NSO7MKM62\F^-7;[WV!M&RXRWIIOKS)P6F.P^3R=QB<
M3C;&^R$\EM:6L$-M:\RU<0QT<<^Q+3M+RR\NNPL-,'97!<3Q5:1I$[7:X<-Y
M^+6DVODI2,F2]JTK%\E[6O?ICKM:6T.+[=X#A*13A]EM=M$1[<>*E)GPB)F;
M1$6M,Q$1-IF9MIXS+PUG#V0
M
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MZ4ZOV'QOR
M
M
M
M
M
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M3W?#;/;;6NFD^ZQTI,^R/C6K$6M,]-=9M,S.D3,S,/$V:O7
M
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MEZS]"U;1%JS]*8B6OLN'+@R3ASUM3+6=)K:)B8GZ$Q/C#])\S\P
M
M
M
M
M
M
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M,N6;Y(_8ZM/9]"'$+=K,0
M
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MFDVQ^$S$_7:=6.?9\%O9I/LF)GK1J9BX
M
M
M
M
M
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MD1'_ ,'P;W7V@
M
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M:VC6-8UB=)C6)B8^E.K]A\;\@
M
M
M
M
M
M                              ')?D3YW^'OB?%/QY!>0W6_7>5M_@<R
M:E<YBK8.P>8[FT^?@N8>M]3M\]OUS9R6G--?$\>-KA_;8^/>]LL?%6V/+SR*
M\W_-:U?ZO^WN2Y':VUTSQC]UM-8MTS$[S/.+:Q:+:QTSFBWQ;>&E;:91P/9?
M=?<\Q]XMAN,^.?W<5Z<7A.FGO;S7%$Z_!-]?"?H3I -Y$_5%]/Z])/B/%[Q]
MW#LFYI^!1]^7;.8L^O->CEHN_?NJ\;JV!IVO8,[9SX^CBB*NZNL+-'/)S55%
M71%Q3//CR\^:_P"[^0K7=^9_<&SXW'.O^;[#';=Y9CI^+%\^7W&+%:+^,Q2F
MYK-8TB\3?6F[^!].'*YXC+W'OL6WKX_6\%9RV]GAK>W16LZ^W2,D3$::Q,_%
M@8\D?7!]1KR3HOL9D.[9NG-2OX:89M.\?[&?K*RXX^8JFFX^^V#(93M">&[C
M]V&:";/RVTD%'-',?LDF^)._RX]$7IT\M[4W.WX2.8Y;'.L;CE;1O;>S2/K$
MTILHFLZVK:NUK>+3U1;XM.G=?;_DYV#V_-<F/9QN]U6?\9N9]]/L_P "8C#&
MGMB8Q1,3XZ^$:1.Y'(Y#+Y"^RV6OKS*93*7ESD<EDLC<S7N0R.0O9J[F\OKZ
M\N:Y;B[O+NXEJDEEDJJKDKJYJJYYYYYY2NV^WV^TV]-IM*4Q;7%2M*4I6*TI
M2L1%:UK$1%:UB(BM8B(B(B(C1L['CIBI7%BK%<58B(B(TB(CPB(B/"(B/"(C
MV/\ &_9_0
M
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MQ,Z=Y+B>4X?<3M.6V^?;;J/W.6EJ6_9B+1&L>,3$QX3$Q,>$O2&.//
M
M
M
M
M
M                                                      <K^1_F
M]XF>(V/AOO(KO?0^M)KKWN;+7[^_N<WNV1BH@XN)+G&:!JUIG=XR=G#%71\2
M>WQ\D,=4L5-57%4L?%6T_+GR2\V/-O<6P>7?!;_DJ5^JRUK&/;4F9TB+[K/;
M%MJ6F==*WRQ:8K:8B8I:8R7@.SNY^Z;S3@=EGW$1[;1$5QQ\&DY;S7'$_0B;
M1,Z3]"=*^GDC]45U/@:+[#>*G06U=AY/X-,5MO'<61MM&U:UO.+BJJ2XM--U
MR?8-EV7&UVE---/%Q?X"?B62KGFGW8N.)K /+CYL#NO?VIO/-3G]KQ^VUUG;
M<?2=SGM73PBVXS1BPX;]6LST8MU7IB(B=;3T;S[?].')YYKF[FWV+!CU\<>"
M)R7F-/9.2_32DZ_0KEC2/;K/A !Y*>M#ZB7D[]I8[9.^LQUKIN2^THJ]"Z-B
MKZMU^C'Y;]A>X>ZR^%N9-]V+#R6G'%O\OE\UD:.8/>IY]O,LW,D^_+;T9>GC
MRR]WN.-X'#R7,8^B?E7)S&]R]>/QKDKCR5C:XLD6^-U[?;XIZM)C3II%=X=O
M>4?8?;G3DV^RIN-W73ZYN/KUM:^RT5M'NJVU\=:8Z^.GT(TBUN+BXO+B>[NY
MYKJZNII;BYN;B6N>XN+B>NJ6:>>:6JJ2:::2KFJJJKGFJJKGGGGGVI18\>/#
MCKBQ5BN*L1%:Q$1$1$:1$1'A$1'A$1X1#9-:UI6*UB(K$:1$>R(^A#^+^W^@
M                                                   /TL/ALOL.
M3L\+@,5DLYF<C-Q;X_$X>QNLGD[^XYXYJX@L["RBGNKJ;FFGGGBFBBJKV<?Y
M'S;S>;/C]M?>[_+CP;/'&M\F2U:4K'T;6M,5K'TYF(?GES8L&.<V>U:8JQK-
MK3$1$?1F9\(>XZOXD>5F\9";$Z5XR>0FX96WLY,C<8S5^E^Q]@R$&/BGM[:6
M^FL\3K=W<Q6<5S=Q1U2U4\44URT4\\^VKCCG!^4\VO*KA-O&[YKN;M_9[6UX
MI%\_([/%2;S$S%8MDS5B;3%;3%8G68K,Z:1+QMSW1VSLZ1EWG([#%BF=(F^X
MQ5B9\9TUM>(UTB9T^E+WG5_2N]1S;\?-DL3X6^0MI;P7DEC7'M'7>:T?(531
M0V]Q57#B=TAP&4N+/F.YIXIN(X:K>NOBNBFOFN.NFG!.4]4WITXC<1MMWWGV
M_?):D6B<&[Q[FFDS,:3DVTY:1;6LZTFT7B-)FL1:LSXNY\RNP=K>,>7E]A-I
MC7XF6N2/ACZK'U5B?#V3.OLG328>Y8?T)_5:SF,LLM9>)N2@M;^'B>"+,=M]
M":]DZ*.>>:>*;W"Y_M3&9G'3>VG[L=Q!%)QQ]WFGV<\,'WGKH]*NQW-]IF[L
MQVRXYTF<>PY3+29_Y.3%L;X[Q].EK1]-XV7SH\L\.2<5^4K-JSI\7!N;1_<M
M7#-9_9B9A[ECOIQ_4OO?D?F=7Z?Q'S?RWS'VCVSB9?LOX_N?%^>^R;'*?$^2
M]_GXORWS'M]WGX?Q/N>W!]Q\XOZ:L/7[O=<QFZ.K3HV&2.O373I]Y:FG5^YZ
M^CVQU=/CIXV3S]\O*=73DW=M-=-,%O'3Z'5,>WX-=/IZ/9K?Z7GSSJN(*;ON
M+Q%@M:IHJ;F:WW?N6ZN(;?FNGB:6"VEZ'LX[B:./V\TQU2Q4UU<<<<UT\<^]
MQAN3YSWR(C':<7#]W6RZ3TQ.VXZL3.GA$VCE+3$3/MF*VF(\=)]CR+>H[LJ*
MST[3E)MIX:X\$1K].?E,Z?LZ3^P]@M_I7^]JKB"F[\KNI(+6J:*FYFM]&W&Z
MN(;?FNGB:6"VEO;..XFCC]O-,=4L5-=7'''-=/'/O<8AD^=*[%C':<7:G+6R
MZ3TQ.YV]8F=/")M%;3$3/MF*VF(\=)]CRK>I3A>F>GC-U-M/#7)CB-?ISI.G
M[.D_L/6_U4;_ /CU_P#Y6_\ ^XMB?]JM_P#R'_[W_P#PAY?ZS/\ ^Y/_ #G_
M .RO7_U6#H+\ZKN#\#-+_=F'_P!J3W]_-7A_MC<_M/*_63YS\&;3[)D>JX[Z
M7CP4BQ]C'ENY_+2]RL=G;49.\QVX=.XO'W>0H@HIO+FQQESTAE[G'6<]SQ57
M%!)=W5<-'/%%4TG/'-=6+;CYS[STMN+VVG#=ITVLWM-*WV_(7O6FL]-;7CDL
M<7M$:1:T8Z1:=9BE8G2/-R>H[O2;VG%M.+C%K.D3CSS,1\$3,;BL3,1[9BL:
M^W2/8]"U7Z:7TY]>M[J'+Y/R*WJ2XFHEAN]J[-UVTN+"BFCW*K>UITGK[3K6
MN&2K]E5S/%-)[W^2KCC[C'^5^<G]17(9*7VF+MW8UK$Q-<&RRVBTZ^VWRG=[
MBVL>R.FU8T]L3/B^#<^H3O[/:)Q5V&&(CV4PVF)^G/O,N2?[TQ'TGWF'^G4]
M,;&9.RO[WK_L_8;6UFXEGPN8[>VV#&9&CCCGCFWO9<!-@\S1#SSS[>>;>[@D
M]O'_ )O9[>.?!WGSB'J:W.VO@P\AQFWRVC2,F/88)O2?HUC+&7',_P#/QVCZ
M3XLOGUYBY,<TIGVV.TQ]57!36/IQU=5?[]9CZ3T[^X2])S\U+_KIY)_]XF,_
MKY>J[^=7_MG#_P GO._KL\SOPG_Y?:?P#[;5?11]+G3K>ZML1XAZ3=QWDU$\
MU6U;3V;O5Q17'1\.FFUN]VWC8;JPAYI_\T<%<<=57[+FGGG[KQ.5]:?J@YC)
M3+N^[M[2U(F(]Q@V6UC29U^-7;;;%6T_0FT3,1X1.CX]SYO>9&[M%LO*YHF(
MT^)3#CC^[&/'6)_9G67U7]T'Z9_YG'3_ /J[+?ON\O\ 6Z]2O\\>8_Z>/^#?
M+_6IYA_A;=_WZ_O7WFK^F5Z>&GX^;&8GPG\8[NVGO)+ZN3:.FM&WC(4SRP6]
MO51#EMUPVP96WL^([:GFFWCFIMZ*^:ZZ:.*Y*ZJO!Y3U,>H7E]Q&YW?>O<U,
ME:16(P<CN=M32)F=9Q[;)BI-M;3K>:S>8TB;3%:Q'Q;GS$[\W5XR9>8Y&+1&
MGQ,^3''PS]3CM6LSX^V8U]D:Z1#Z7^[T\!/S'?#_ /\ G:.E_P#XRGF_K!^?
M?\^.[_\ \<\C_K+Y_P#?OO?\,\K]M[C^$/[O3P$_,=\/_P#YVCI?_P",H_6#
M\^_Y\=W_ /XYY'_63_?OO?\ #/*_;>X_A'K-OXX^/-I;P6EIT-TQ:VMK#%;V
MUM;]7:/#;V]O#13'#!!#'@Z8XH8HZ>*:::>.*::>..../8Q/)YC>86;);+EY
MWF;9;3,VM.]W,S,S.LS,SEUF9GQF9\9EY=N?YVUIM;>[N;3.LS.;)K,_1GXS
M^W]'GH'^(WI[^;/2_P!Y'\?U@]_?ASF/MS<_PC_/O[SG\<W?V;)^^/Z//0/\
M1O3W\V>E_O(?U@]_?ASF/MS<_P (??WG/XYN_LV3]\?T>>@?XC>GOYL]+_>0
M_K![^_#G,?;FY_A#[^\Y_'-W]FR?OC^CST#_ !&]/?S9Z7^\A_6#W]^'.8^W
M-S_"'W]YS^.;O[-D_?']'GH'^(WI[^;/2_WD/ZP>_OPYS'VYN?X0^_O.?QS=
M_9LG[X_H\] _Q&]/?S9Z7^\A_6#W]^'.8^W-S_"'W]YS^.;O[-D_?']'GH'^
M(WI[^;/2_P!Y#^L'O[\.<Q]N;G^$/O[SG\<W?V;)^^/Z//0/\1O3W\V>E_O(
M?U@]_?ASF/MS<_PA]_><_CF[^S9/WQ_1YZ!_B-Z>_FSTO]Y#^L'O[\.<Q]N;
MG^$/O[SG\<W?V;)^^?-[1XC^*6\8^'$[IXQ^/6WXNWO(\C;XW:.E^M\_CX,A
M%#<6T5]#9Y;6KNWBO(K>[ECIEIIXKIHEKIXY]E7/'/I<7YM>:O";B=WPO<W<
M&SW5J32;X.1WF*\TF8F:S;'FK,UF:UF:S.DS6)TUB'T;;NCN;9WG+L^1W^++
M,:3--QEK,QX3IK6\3IK$3I]*'PG]WIX"?F.^'_\ \[1TO_\ &4]W]8/S[_GQ
MW?\ _CGD?]9?;_OWWO\ AGE?MO<?PA_=Z> GYCOA_P#_ #M'2_\ \91^L'Y]
M_P ^.[__ ,<\C_K)_OWWO^&>5^V]Q_"/B-J]+3TYMRN+2YR_A9XZV<EE#7!#
M3JO6>O:+;UT25_$JJN[32+77K6_FXJ_\LD]$DE-/['BKCC[CV^*]47J*X?'?
M%M.].XKUO,3/O]YEW4ZQ&GQ;;FV6U8^C%9B)GQF-7V;;S)[^VE9KBY??S$SK
M\?-;)/\ <G)-IC]B-(?*_P!T'Z9_YG'3_P#J[+?ON]7];KU*_P \>8_Z>/\
M@WT_UJ>8?X6W?]^O[U\?M?HE>EMN?R'VOXBZ?9_9OS7R_P!ZFX]JZ'\3YSY;
MXWS_ -XV^Z[]J^Y\K3\+YKXWP/;7\/W/B2>]Z_%>M;U1<-[SY'W=O+^\Z=??
M[?8[K3IUTZ/E.US='U4]71T]7AU:]-=/KVOG!YD;3J]URF6>K37KQX<GLU]G
MO,=^GV^.FFOAKKI&GQ_]PEZ3GYJ7_73R3_[Q/8_7R]5W\ZO_ &SA_P"3WU_U
MV>9WX3_\OM/X!YCF/IU/3&R>3O;^RZ_[/UZUNIN98,+A^WMMGQF.HYXXXXM[
M*7/S9S,UP\<\>WCFXNYY/;S_ .;V>SCC)MG\XAZFMMMJ8,W(<9N,M8TG)DV&
M"+WGZ-HQ1BQQ/_,QUCZ3T<7GUYBX\<4OGVV2T1]5;!36?IST]-?[U8CZ3X_8
M_IK_ $X,YC*[#&5=_P"G754T,O&:USM'&W63HHCYYYKMZ(MNTS:L-S#<<<^R
MOFJTYDXXX_8U4\_=>QQWSD?J-V.YC/N?O!O,6DQ[O-LKUI,S\.NWW&#)K'P:
M9-/HQ+ZMOZ@N_P##DZ\GR'+73ZF^&8C]GXF2EO#_ )VGT8>>_JO?@)_&]Y@?
MA_TO_9_9!_:>>??X([0^U>1_E5]_ZQW>_P#%>*^Q;C_67CWZK!T%^=5W!^!F
ME_NS+_[4GO[^:O#_ &QN?VGJ_K)\Y^#-I]DR/,LQ]*7B)\G>2X#SGR6,PU<W
M-6/L,QXXVN<R=K;^SCV17F6LN\M>M;^;BKV\\UT65M3SQS[/<^Y[><GV?SJF
M\IMJ4W_8V/+O(CX]L?+VQ4M/T:X[<9EM6/I3DO/TWHXO4QEC'$9^&K;+IXS7
M=36)GZ59V]IC]CJG]EY5LGTK':]KDZHM0\P>O<YAN(8:J+_9.JMDU7)U7%7'
M/QXJL3C-OW*UHACJ]G%$G%[557Q]WFBC_(RGCOG3>U<NVB_+]H<A@WFLZUP[
M[#GII\$^\OM]O;6?ACW<1'T9>GM_4KQEL>NZXK/3+K[*9J7C3X/C33'/]SI_
MNR\EVCZ7'S,M,A#'I??7C'G\759QUW%YM&4[5U#(19#F:XIEMH<;B>L=XMY[
M.BWIBKIGJNXZZJZZZ.8:>*.*Y,LXOYT'R;R[>;<UP/<VWW77,17!38[BDTTC
M2TWR;W;3%IGJB:QCF(B(GKF;3%?4VWJ0[2M29WFRY&F77PBD8;QIX>.MLV.8
MG77PZ9^"=?'2/']H^FK]1S7\A#9XFZ\>]XMI;..YKRVK]GYFTQ]O/7/<158Z
M:/==&T_*U7D4<-,M54=M7;\T34<4RU5\5T49AQ?SDOITY#;SFW=.X-CDB\UC
M'GV6.UYB(B>N)VVYW%.F9F8B)O%]:SK6(Z9MZNV]0?8.>DWRQO\ #:)TZ;X:
MS,^SQ^MY+UT^#QF)\)\--)GQG8_I^_53P>3JL,9X]X'<;6F&&7C-:YW7TG:X
MRNN3CGFNWIBV[?\ 5<SQ-;\\>ROFJTXCYYY_8U5<?=9EQWK^]+.^VT9]SW!G
MV>768]WFXWDK7B(^'7;[7/CTGX-,FOT8AZVW\\O+3-CZ\F^OBMK]3?;[B9_9
M^)BO7Q_YVOT8>)YCT;O4YP>3O<3>^'G9\]U83<P3RX>?4MAQE=?''%7-5EFL
M!LF3PV1A]E7W)+>>6/GG[GO>WCEFNS]8OIEWVVIN\/>'&5Q9(UB,D9\5XC_E
M8\N&F2D_2O6L_2>QB\V/+K-CC+3E=M%;1K\:+UG^[6U(M'[$Q$O!\SZ?WG?K
MUOE;W->%OE=CL?@X;ZZRV5N/'KMJG#V%EC*)9;_(3Y>G4JL9QC;6""N2JYXE
MY@^%3S7[_N?=9WL_/[R*Y#)BP[+O3M3)N,\UKCI'+;#WEK7F(K2,?O\ KZ[3
M,1%.GJZIZ=-?![6'OGLK/:M,/+\9;)>8BM8W6#JF9]D17KUUGV:::Z^&FKP;
M8^I.UM.QE>:V[K+L+5<-1-#;UY;8]+V3!XRBXN.>:8(*[_)XVUM:9IZN.>**
M>:_>JYX^YQRSOCN[>U>8W,;+B.3X_=;R8F8QX=SARWTCVSTTO:VD?#.FD/;V
M_*<9N\GN=KN<&7+IKTTR4M.D>V=(F9>?,@?<
M                               ^JTO>MWZWV/';AUWN.U:%MN(FCN,3
MM.E[#E]6V/%W$4L<\4^.S>#O+')V4T4\-%=-44M-5-=''/'/MXX>7S7!<)W)
MQV3A^XMGM=_Q.:)C)@W.+'GPWB8F)B^/+6U+1,3,3$UF-)F/A?-O-EL^0V]M
MIO\ %BS[6\:6IDK6])CV:36T3$^'T832>-WU"OJ%]%46.'W;:M5\C]2LX:K6
MG&]Q8/XFTV]O7<4W-4MIV%JDVO;/?Y+BOWJ*9\U7F::8I*J.(_93#\*&'F/\
MWSZ?.^;7WG";7==N<M>>KKX_+I@F8CITMM,\9<-:::3-=O&WF;1$]7C?JU'W
M!Y%=B<U-LNSQ9>/W4SKK@M\29TT\<5^JD1]+'[OQC77VZSV^/OU-7AKV)<6V
M+[XZ][.\<\A-#Q+-FZ8..W]"M*^*XJ)+>7+:?C,?ODDW/Q>:X^8]8KCJCCK]
MZJBOW**X&^8'S:'G'V[CMNNQ.0XSN+;Q.D8]?O?NK1I,Q,8]Q>^UB/#2==[$
MQ,QI%HZIKI+G/3OW9L*SDX7/MM_CB?J?\1DGZ?3DF<?[.N;768]L:S$[?2OD
MEX_^1V$DV'H?N7K?MK%V_P!R_DT7;L-L%WB)/=AK^6SN+LKN3*X&\XHN8JN8
M+V&";BF6CGFGV5T\\P6[T\M^_P#RYWL<?WWPW)<3NK?4QNL&3%7)'CXXKVK%
M,M=8M'5CM:NM9C76)TTOR_;_ #G 9O<<UM-QM<D^SWE+5BWTZS,=-H\)\:S,
M>$_0>V,*>.
M
M
M
M
M
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M%2N+%6*XJQ$1$1I$1'A$1$>$1$>$1'L?XW[/Z
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MS,S,S,SJ\3)DOEO;+EM-LMIF9F9UF9GQF9F?&9F?&9GVO]C\7\
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MO3TVG732==/9I.OL>0,O>J
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MC6TQ,2TORO#<MP>YG9\QML^VW4:_%R4M29B)TUKK$=5?H6KK6?;$S#U1BSS
M
M
M
M
M
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M?IR]48L\P
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M,.[QSI:EZS2]9^A:MHBT3]*8A](\U\X
M
M
M
M
M
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MZMK?Y?XMSC>R]CVK#<PW''/-<EM1;46=4G/O?!XYXX]F@.Y/67ZFNZ:VIO\
MNWD,&*T3739UP;":UF==(OL\.#)K'LB\WG)$>'7[=<&Y#S;\Q>2B8S\IGI68
MF-,44PZ1,Z^$XJ4MX?!.LVT^%W7UQT5TCTY#%;=1=.=5]5V\%G=XZ&#KCKW4
M='AAQ]_D*<M?V,46LXC%T1V=[E*.+F:+CCBB2XXXDJXYKX]K1G<??/>W>%YR
M=W<QRO*Y+7K>9WF[S[F9O2GNZVF<V2\S:M/B5M[8I\6)B/!AG(<US'+3-N4W
M>YW-IF)URY;Y/&(Z8GX]I\8KX1/P1X>QZHQ9Y@
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M>-+>-9UK,QI:(F8GX?@?"/=?:
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MY1F:Z
M
M
M
M
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MA$-KUK6E8K6(BL1I$1[(CZ$/XO[?Z
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MFR7K[>K2*VM,1&NDQ$1I$Q&GL>\,$>*
M
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M?>':G-=,<5R.RSY+3I%:YJ=>LSTQ$XYF+QK/A&M8U\--=8<NMGLC
M                              2*>*WJM>=OA]]BXOJKO79,KH."L^<9
M8]3]E33=A=9VV)_\\>*Q&O9^>:XU"SAN:>):/L*YQ<O%?O<>_P T2S421X\T
M_2KY%^;_ +[==U<%ML7/9[]=M]LXC:;R<GPWR9<41&XM,?%GY53/&FDZ=5:3
M7 ^Y?+/LONKKR<GLL==]>=9S8OK6:;?X5K5C2\Z>'UR+Q]+6(F++/BM]3QT;
MN/V+K?EQU)LG3F=NKSFRO^QNM:;CL#K.W@J_;:,UF-:DJC[&UZSBIYYBKML?
M!LUQS713)3S[LE5$%;'FG\V3WQP_ON2\I>6VW,;&M.JFTWFFUWDS[)QX\T:[
M3+:?JHOEMLJ:3-9\:Q:\>NY?3IS.TZ]QVONL>[PQ&L8LNF+-/_)K?_%6GX=;
M3ACX/@UFQ3T7Y(]">36JU;KT!VYH?;6N0_)TY&[TO8;'*W>!N<A;\W=ICMIP
MU$E.;U/,36W'Q/DLE;VEW33]WF/A7?WSY<=^>6?*_>7O[B-_Q/(VZNBNXQ6I
M7+6D]-KX,DQ[O/CBWA[S#>^/7V6:&YGM_F^W=S\CYS:Y]KN)UTC)6:Q:(G29
MI;ZF]=?#JI-J_3>V,*>.
M
M
M
M
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MX=M68TF:Q,WM'A.ELEIMDM[(^JM/LAS2V2R$
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M6F(TZK:1&D1K.GM>S,->2
M
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MQ,>S'EI>8\(F8FL3-JS$3$S68B:Z^,0\-9P]D
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MM9WFPK&OO=MKEC329GJII&6O3$?&M;'T1\%Y]J6]$MJX
M
M
M
M
M
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MI2NLS/36L1X^QN_:[3:[';TV>QQ8\.TQQI6E*Q2E8^A6M8BL1]*(A\V]%]
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MF9F9F9F=6$9,E\M[9<MIMEM,S,S.LS,^,S,SXS,SXS,^U_L?B_@
M
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MF/"8F/&)CPF&9UM6]8M68FLQK$Q[)CZ,/XO[?Z
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MGV3\$R]"8^^
M
M
M
M
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M3HW&+;_*N4IX^_S_ ![1/T:4\,5-)^IF*=<1X3>WM1+I8MG@
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M4GPCX:^V9GVVMKW*T>PT
M
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M,3'C$QX3#.:VK>L6K,368UB8]DQ]&'\7]O\ 0
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M=5B?!V U"Q4
M
M
M
M
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M>3)?+>V7+:;9;3,S,SK,S/C,S,^,S,^,S/M?['XOX
M
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M;N*8KPN_VNXRS&O17)7WFFFNLXYTR1X:^VL>R?H2Y=;/9&
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MO2*3,Z5M9*BBTUJ
M
M
M
M
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M>\UO-SNK:Q,>\R6M$::Z=-9GIKIK.D5B(C6?HR]R8.\8
M
M                                                          !'
M5WWZ37IX^1\5U+V%XN=;XW.W/S4WWW=:6%QU)M7&2N+2YM(\M?Y7K:YUG[Y;
MRS^:^)'1EX\C:U21Q\RPR4QTT\2([#]5_J%\N;4KV]W1R638UZ8^3[RT;_!T
M1:MIQUQ[R,WN:VZ=)G;SBO$3;IO6;3+/>$\S^^^ F(V');BV&-/B99C/32)B
M>F*Y8OT1.FDS2:SI,Z3&J$GO_P"EIZ]R5%YE/&#R7VK5+JB&>6UT[N[7,;N.
M,OKR:XM.8K>G?-*CU+(:[C;.W^8YXYKP69GEY^%155QSQ7+5-?L'YT7N#;6I
MM?,[MK:[O%,Q%MQQN:^WO6L1;6?DNYG/3->T]/LW6WK7XTQ$ZQ6-P<'ZDM_C
MF,?<?'8LM=8UR;>\XYB-)\?=Y.N+3,Z?]9CB/&=/9"$CR ]"?U*>@?G;W^ [
M^&K6;+X-/WS^/^:A['^;FE^=J^!9:+\OANVY_A0V7OUR_>[Q;T_%CH^)\6KW
M.)K]@>NCTV]_=&#[^?>7DKZ_6>5QSL^F(Z?&VYUR;"-9MI%?E?7\6T]/3'4W
M#P?G1Y?<YI3Y9\CW$_N-S7W6GL]N36V"/;[/>Z^$SII&J);/Z]G]4RUW@-HP
M>8UO.V'P/GL+G\9>X?+67S5M#>VWS>.R,%O>6_S%G<1RQ^_1Q[\4E-7'MIJX
MYYEEL.0V'*[2F_XO/AW.QR:].3%>N3';IM-;=-Z3-9TM$UG2?"T3$^,2V?@S
MX-SBC/MKTR8;:Z6K,6K.DZ3I,:Q.DQ,3].-'Y#ZWZ@
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MDMBRUFN6LS%JS$Q,3$Z3$Q/C$Q/A,3XQ+35JVI::VB8M$Z3$^V)^A+^S^'^
M
M
M
M
M
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M^8
M
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MP;K!I&LXKUOIK[(M%9F:SX3\6T1,3$Q,:Q+R5ECTP
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M@S[7-;;[FE\>XI.EJVB:VK,>V)K.DQ/TIA^P^-^0
M
M
M
M
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M;CX^WV_TXQQN;S&L3[JT>$B>S_3SR6\Z-YWAF^2[>=)]QBFMLT_2O?QQX_\
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M?,_,
M
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MMHFMJS'MB:SI,3]*8?L/C?D
M
M
M
M
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M=M=H;?Y/P&UQX;3&ELGU66_P_'R6UO,:^,5UBE9^IK6/!R6VPR<
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M/#QE^\^!^
M
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MF?\ .XMCWNND1->K<6I%HZII.MXMM7M_SJ[^X&:TR;J-]M8GZC<Q[R9\-/\
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M3&N[^([@X/G\/O\ A=WM]UCCV^[O6TU^E:(GJK/C'A:(GQCZ+Q-FKUP
M                    ';'B)ZAWEOX/YNB_Z![8S&&UR6\XO,UUGL'-6S=7
M[%755QS<<Y33,C+586MY=4T^Y7?X^JQR=-'W*+FAI7S<]/7E+YW;*=OW]Q.'
M-R,4Z<>\Q?6=[A^AT;BD=5JU]L8LOO,.OC;'+$.Z>Q.U^\</1SFUI?<1&E<U
M?B9J_0TR1XS$?X-NJGT:RMT^$GU'GC/W?]D:5Y48;^C/V-<_ M/OM^/=Y[I3
M.7M?NQ_&^WOA5YW0?F)>>:OAY6*?'VT?'MDR?/*I'SK^;F\RNR/?<UY6YO\
M>7MVNMO<:5Q<ECK[=/=:^ZW6D?#@M7+>?J=M"+?>'D#W#P_5O.VK_?'81X]&
MD5W%8_YOU.33Z-)BT_!C6*=?V' ;9A,7LNJYS#[-KF;LX<CA=@U_)V69PF7Q
M]Q3[]O?8O*XZ>YL+^SGI^[1+%)715Q_DYY5X<AQ^_P")WN7C>5P9MMR."\TR
M8LM+8\F.\>VMZ7B+4M'PUM$3'PPT+GP9]KFMM]S2^/<4G2U;1-;5F/;$UG28
MGZ4P_8?&_(
M
M
M
M
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M^[7[*P]/"8/\ZM&E\V2>O-?]FVD16)^&N.M*3[>G7Q<'M[,T
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MB(C2')<MRG,;B=WRVXS[G=3^ZRWM>W[$3:9TCPB(B/"(B(CPAZ0QQYX
M
M
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MFMHF+1.DQ/MB?H2_L_A_@
M
M
M
M
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M2>GX+6B;?#-IF9F>TVF&(@
M
M
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MCDPS,WK]&9I.2E8^JO'L32H8-1
M
M
M
M
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MGX;6F9GX9::SY\^ZS6W&YO?)N+SK:UIFUK3/MF;3K,S].9?L/C?D
M
M
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MD<$Y.*BVE=QC^-BF)G2O5\..9\(TO$:S.E9M[4DZ-S7P
M
M
M
M
M                               #Y7>-YTWK/4=@W[L/:<#I.DZIC9\Q
MLFU;/E+/"X'"8RV]GQ;S)9._E@M;6'BJKBGCFJKCFJNJFFGVU5<<<^KPG!\S
MW+RVWX'M[:Y][S6[R1CPX,-+9,N2\^RM*5B;6GX?"/"(F9TB)E].SV6[Y'=8
M]CL,=\V\RVBM*4B;6M,_!$1XRJF>H!]2GB<%=Y7K7P"P5GLUW;_,6&3\@NPL
M#<TZ]1/S%#S3<=8:+?RVE]F/EZI*J?M#/P6]O\>&KBC'75O5'<5VI^0/S;>[
MWV+%W+Y^9[[;%;2U.*VF6/>Z:SX;W<UBU<>ND3[K:VO?IM&NXQ9(MCB3'8_I
M\RYJ5Y#OB\XZSI,;7%:.K]C-DC6*Z_X.*9G2?')6VM8J.=I]L]F]X;SF^R^X
M-\VKLG?MCFHFS.V;EFK[.YJ\X@CI@L[7B[OII:K;&XVUHH@M+2'X=M9VT=$,
M,<<5%-'%M?:W:?;/9'!X.VNT-AM>-X#;1,8\&WQUQ8ZZSK:W36(ZKWM,VR9+
M:WR7F;WM:TS,RCXWB^.X;9TX[BL&+;['''Q:8ZQ6L?1G2/;,SXVM.LVF9F9F
M9F7GK('W                      /6NFNANZ/(?;H]$Z-ZOW;M7;:X>;J3
M"Z3K^0SEQ96=///%>0RDMI#7:X?&T5<>RJYNI(8*:N>..:_;SQPQ/O+OSLSR
M]XF>=[XY39<5Q,3TQDW.6F*+6_P*1:>K)>?@I2+6F/'1YG+<WQ' [7Y;S.YP
M[;:ZZ=62T5B9^A77QM/TJQ,_263?$CZ8CMK;J,7L_F7VMC>I,-<PV=W<=7]3
MW.-W+LF+BJXXXO\ %9W<[NUO.N]9R45O'5\.7&T[3;5<R4U<U?L:H^:WO-KY
MS;M/B+9>,\F^*R<MO*S:L;W?1?;[.?#XM\6WK:N[S4F9C6N:=E>-)C3QBT1]
M[H]1?%[6;;;M+;6W66)F(S9HG'B]GA:N.)C+>-?;%_<SX3^RM!^+7IT^&7AI
M%:7/0/1&GZQMEM9R6<O967@GV_M&\HN[2&TRO'._[3-EMCQEGFN(??N;#'S6
M>,YKYY]RVHHXIIXK#\T?41YR^<EKX^_N=WFZXJUXM&SQS&WV5>FTVI_FN",>
M&]L>NE,N6N3-I]5DM.LS'+N3OWNWNV9KSF]RY-K,Z^ZK,4PQI.M?K5.FDS7X
M+6BU_HVF?%VPTJP\
M
M
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M3$QK$Q,>$Q,>,3'A,-LUM6]8M68FLQK$Q[)CZ,/XO[?Z
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M-<>33X<>2/BVCX?"=8_=1$^#IQK)CH
M
M
M
M
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MF?"L?N:QI6L>$1$/2&.//
M
M
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MCM\:EJVB)?!R?%<9S6SMQ_+8,6YV5_;3)6+5U^"8B8\+1^YM&EJSXQ,2MK^
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MZS6U9TU\:SI,:Q,3'T8F)CPE]@\=\@
M
M
M
M
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MK6M,S-K6F9FUIF9F9F9G5I3)DOEO;+EM-LMIF9F9UF9GQF9F?&9F?&9GVO\
M8_%_
M
M
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MBKDQ1K]6DCVSW]VGW=6(X3>8K[J8F?<VGHS1I[9]U;2TQ'PVK%J_3<0MVLQ
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MC7XM?'7)2;5TCJM&/72)U4&6F
M
M
M
M
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MV3-&TXRVL3BV_52+1]#)>9F]_#PF.J*3[>B$NJ)#5H
M
M
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MXIF8IFKK;#D]OU&32(UTC7HM%<E8TFU*ZP[,:;8D
M
M
M
M
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M2/!%?N[S.[M[RM;%R.XG%QLSX;?#K3%I_P J-9MD_9R6MI/LB$DR-S7P
M
M
M
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M:M,SN2US/8^OGGCWZ;?)XJYM;JF&>GCW98^:N8Y:.>::Z:J>>>'B]P]M]O\
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M+5M6+1/A,(R[G;;G9[B^TWF.^+=8[36]+UFMZVCPFMJVB)K,?#$Q$P_>? _
M
M
M
M
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MCL=EQFTIL..Q8\&RQQI2E*Q6M8UU\*QI$:S,S/T9F9GQE\>]=]0
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MUL7([B<7&S/AM\.M,6G_ "HUFV3]G):VD^R(23(W-?
M
M
M
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M9Z=SCK/3$:^$9:^,X;::3I:9I.NE,EYBVDJZ*[6@
M
M
M
M
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M5QZ?!-_&;9+?1F\].OC6M?8DY1F:Z
M
M
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MB8EZ0QQYX
M
M
M
M                                 #^-Q<6]G;SW=W/#:VMK#+<7-S<2
MT06]O;P452S3SS2U4QPPPQT\U555<\4TT\<\\\^Q_>/'DS9*XL59MEM,16L1
M,S,S.D1$1XS,SX1$>,R_VM;7M%:Q,VF=(B/;,_0A5J]2KZBC3>K;C8^F?!.O
M ]E[]93?9N6\@;NFSSW5>O3QURQ7\?7EC37):]CY*"JCCB+*5U<X#CGV5P\9
M&*K[EHGIL^;PYGNC'MN\O/2,_&\!>.O'Q5>K%OLL3$36=W;PMLZ3^ZPQ'RK]
MS?Y-:/&27E[Y#;ODJX^6[TZ]OL9C6NVC6N:T?![V?;BCZ-/\9\$^[E3(W_L'
M>NU=QSW879FX;)OV];3><7^Q;=MV9O\ /[#F;NB"&TBER&5R<]Q>7'R]G;1P
M14U5^[#!%1'1Q31133Q<KP';_!=J\/@[>[:V>VV'![6G1AV^WQUQ8L==9M,4
MI2(K&MIFUIB-;6M:UIFTS,RUV.QV7&;2FPX[%CP;+'&E*4K%:UC77PK&D1K,
MS,_1F9F?&7Q[UWU                   )1/!CTA?,?SQ^2V70-0L^ONG)+
MSY>][I[/FN<!J4M$7PY+F/4L5#;7>T[W><P<UTQ5XZSDQE-S1Q#=7MIS5[W$
M8//'U<^3OD3U\;S^\OR'>,4UKQVRB,N>-=8B<]YFN#:UUTFT9LD9II/7BP9=
M-&N.\_-/M/LK7;[[+.?EM-8V^'2U_I==M8ICC7V]=HOIXUI9<W\'/1'\,/"^
MWP.S7>K0]]]VXR&SGN>V>TL59WMOC\U#115-?Z#U_++D=:T>&B[IYDM)*N<C
MF+6GGW.<C+[/;S37YX>MCSE\YLF?C,6ZG@>R<LVBNQV5[5F^.9\*[K=Q%,VY
MGI\+Q'N=O>?'Y/7V(E=Y></=O=UK[>N6=CP]IG3#AM,3-?H9<OA?)X>%H^)2
M?;[N$PZ'[5(
M
M
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M'X^'7K;'.M8ZXO;HB8=#]JD
M
M
M
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M%=WW%-8URVC6N*9CXT8*S'Q?ACWD_7+5UCXM;31#"F6VV
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MVFV6TS-K3,S,S,ZS,S/C,S/C,SXS+1MK6O:;6F9M,ZS,^V9^C+^S^'^
M
M
M
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M$QXQ,P^\>"^(
M
M
M
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M\S:UIGX9F?&7U3RGS
M
M
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M)Z?;X5R5UF<5YC3PF9I.NE+WF+:2EHNM;
M
M
M
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MG7II2L16D?2K$:^V=9\7137;P0
M
M
M
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M(^4?GMY8>=W#QRWE_P GAW&>M.K-M+S7'O=MX]/U_;3:<E*]7Q:Y8ZL.2?\
M%Y+Z):=K=Z]N=X[3Y5P6XIDO$:WQ3,5S8_'3X^/7JB-?"+1K2W[FTN/VWF5
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MFMHG28F)C28GQB?"7Z3YGY@
M
M
M
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M.+=9)VW#Z_%V^*9BGP?XRWA;+/A^[^+$ZS2E=9UE+1=:V
M
M
M
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MF(E#QO*<=S.SIR/%9\6XV.2/BWQVBU9^C&L>R8GPM6=)K,3$Q$Q,//60/N
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M&G52NL.P&H6*@
M
M
M
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MSK,SXS/C+])\S\P
M
M
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M*T6Q6B)K:)B8F)C6)B8\)B8\8F/"8;VK:MZQ:LQ-9C6)CV3'T8?Q?V_T
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MRPR\R/)GE.T?><OPO7N^W(UF?AS8(]L^]B(TMCB/^MK[-)ZZTB(M:?E =I
M
M
M
M
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MXL58KBK$16L1$1$1&D1$1X1$1X1$>$0D_6M:5BM8B*Q&D1'LB/H0_B_M_H
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M,1K:8B;S:WBZ<:R8Z
M
M
M
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M>]]OU\1FZ=[6-;X,GQ<U/_EUF+U^'KQS:OC$3,6UK' ;?C-P
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MW?';K)L=_COAWF*TUO2\36U9CX)B?&'U3RGS
M
M
M
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M&T:36MM,V6-)B?>WK/A6T3I..D],QX6F\)YT$&E
M
M
M
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M;^],UMI>NL=58UC7L!J%BH
M
M
M
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MXUY\(U\=*5C2M*_0K2*UCX(A[,PUY(
M
M
M
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ML3=,GL+S@[=[TFNQSZ;+G9G2,-[1,9)T_P"IOI$6_P"9,5O]"+1XH84RVVP
M               'MGCWY%]S^+':&"[CZ'WO,=?[]@?>ABR>+DHDM,KBYYK>
M>^U[8\1=43XO8];R4EK%S<6%[%-;2U1T5\T^_''53A7F#Y=]F^:7:^?L[OO8
M8>0X'/XS2\3%J7B)BN7#DKI?#FI%IZ,N.U;UB;1KTVM$^1SO <1W+QM^)YK!
M3/L;_!/MK/CI:EH\:7C6=+5F)C68UTF87Y?2^]:;I3SYM+'K3>Z,/TOY06UG
M[\_7]_E+>#5>R:XY;ZJ>ZZ=R>3R%>2S=Y:8VUHNKW"W-/&3M(ZY*X>;VVM[B
M[CH5]3OHP[U\A<M^Y>"G-S7EC:_ANJTF<^SUBNE>0I2D4QUM>TTQ[FD^YR3%
M8O[C)DQXK0C\QO*+F.R+3R&RZ]WVY,^&6(F;XO9X9XB-*Q,SI7)'Q+3I$]%K
M5K,V*%;4
M
M
M
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MN
M
M
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MQ:LQ,3$Q.DQ,3XQ,3X3$^,2BY:MJ6FMHF+1.DQ/MB?H2_L_A_@
M
M
M
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MSNXON-W,:1KX5I7_  :4C2M*_#TUB(F9FTZVF9GWY@+PP
M
M
M
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MVM3L.):K;&XVUHFHDV/'<2X>NFUYGO*<57<06?-XWIO];_EYYW5V_;/<<X^
M\R[Q2OR;+?\ S;>9)GH_S#/;36][368VF;IW$3?HPSNHQY,R9?E_YR<#WC%.
M.Y#IV/<4Q$>[M/UO+;73ZQ>?;,SIIBMI?QTI.6*VN@]3=;C
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M7R7&<AP^]R<;RF&^#?8K36U+QI,3$Z?L3$_!:)FMH\:S,3J]"8^^
M
M
M
M                                                !^;F<SA]<P^5
MV'8<KC<%@,%C;[,YS.9F^M<7A\-A\7:RWV3RN5R=]+!98[&XZR@KFGGFKHBA
MBHJKKJXIXYY?3L]GO.1WF+C^/Q9,^_SY*X\6+'6U\F3)>T5I2E*Q-KWO:8K6
MM8FUK3$1$S+],6++N,M<&"MKY[VBM:UB9M:TSI%:Q&LS,S.D1'C,^$*//JZ>
MN_L?D'7L/CEX:YK/:3T='-FL#OO;-M)+B=I[KQ\]O<8>ZP^OP\T1Y#5.L<A;
MS355\R<QY3,Q5Q\346</$UM<7=>DCT*<=Y?UV_F+YQX,&][WF,>7:["8C)@X
MZ\3&2N3+.LTS[VDQ6(TUP[>T6FDYKS3+CF-Y6^2VWX*,?/\ =E*9N9TK;'@G
MXU-O,3%HM;X+YHG3V:TQS$Z3>=+5K*K,$B                'H75?4_9/>
M&^ZWU?U)I>>W_?MNR5KBL!K.NV55Y?7EU=3QV],LU?/-%KC<;;52\5W-Y=20
MV=G#Q5+/+'%357QC_=/=?;?9' [GN?NW>X-AP&TQVOES9K=-:UK$SI'MM>\Z
M:4QTBV3);2E*VM,1/P\ER?'\/LLG)<IFI@V.*LVM>\Z1$1&O[,S/P5B)M:?"
ML3,Z+L_IC?3[=7] 18+N;S-Q^M]T=S56=CD\)U5=00YCJCJV_N;2*6>/-V<D
MD^*[0W#&22R0?%N:)<%:R^]);07,T=M?T4I^IKYP#N?O^V?LWR;R;GANS8O:
MF7?5F<>^WM:VF(G':(B^RV]XB+=-)KNKUTKDOCI;+@M#_P Q?/+DN<F_$]I6
MR;3B-9BV:/BYLT1/ATSX3AQSX3I&F28\+36)M2;+*MA'L
M
M
M
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M<UBFNLS./)'CCRUB?JL=OA]L:UG2U-8BT1,NNFI&+
M
M
M
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MW/,Y8C;4GZWAIK7%C_YM=9FUI^&]YM>?9K%8K6.ZFC&%@
M
M
M
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M<MHG<<!DOIBW$1'MF-?=Y:Q,]&2/'37XMXC6DZQ:M)745&L@
M
M
M
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M^;>9;3:][S-K6F?AF9\9?5/*?,
M
M
M
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MM-9CQB4K=MN=MO-O3=[/)3+M<E8M2]+1:EJSXQ:MJS,6B?@F)F)?@ON?L
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M2]["*OMHL
M
M
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M/3LKLKA^QN'KQ?%UZLMM)S9IB.O-?3ZJWT*QXQ2D3I2/HVFUK<3MU,O
M          >G=.],=J>078FO=3=+Z-GNQ>Q-IFGAP>K:[;4W%]=<6EM+>7UU
M-+-)!98[&XZR@KFN;NYEAMK:&BJ262BCCGGC&>\.\^UO+_M[<=U]Y[[!QW;N
MUB)RY\UM*UZIBM:Q$1-KWO:8K2E*VO>TQ6M9F8AYW+<OQO!;#)R?+YJ;?88H
MCJO>=(C6=(CX9F9F=(K$3,SX1$RO:^E?Z&'5?AC1KW=?D%3@>X/*6UFIR6)K
MAYJRG6'3UQ!<52XV;0[+)XO'76;W:&GBB6;/7T7%5I/311CH;;F*2[O*+?5+
MZX^Z?.6VX[+\OYS\1Y76CHR1/Q-[R$3&EXW5J7O7'MI\:UVN.VF2LS.YODBU
M<6&%WF5YS<EW;.3A^#Z]KVW,:6^#-GB8\?>3$S%<?P1CK/QHUG)-M8K2?] 1
MH\
M
M
M
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M15.HP
M
M
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MN#PQBV\:3:?;?);2(F^2W[J\Z1K/A$>RL16(B.;VQGO@              )
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ML
M
M
M
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MS/S
M
M
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M%BI_?M>]IUMDRY+3-\N6\S?)>9M:9F9E/7AN&XWM_C<7$<1BKAV&&NE:Q_\
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M=;7O.LS]"(^"*Q'A6L1%:Q$5K$1$0](8X\\
M
M
M
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MC&DQ/LF)B8F8F)?;/$?&
M
M
M
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MUF9F?&9F?&9GQF47[6M>TVM,S:9UF9]LS]&7]G\/\
M
M
M
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M=J=X<%WGQL<EP>7KI&D7QVTC+BM/[G)36=)\)TF)FEM)FEK1&KDMMADX
M          "7KTL/5O[4].7;KO7<GC\EVCXV;EDHKO=^JN<K39WVOY67F"VG
MW_K:[O8Y[+&;5!91<<75C)\&QSL,5$%Q);RT6U]:1%]4GI+[6]17$TY';9,?
M%^9&SQS7;;[W?57+2-9C:[RM9BU\$VGXF2.K+MK6M?'7)6V3!EU9YE>5W&]_
M;6-QCM7;=P8JZ8\W3K%J^,^ZRQ&DS29^IM&ML<S,UBT3:EM"[HSO/JOR2ZKU
M#NCI?;\;N_7>[XVG)8/.8VJJGFGFFJJ&^Q>4L9J8[W#9[#7L==M?6-S1'<V=
MS'7%+1373SPY\N^>QNZ?+?NG>=F=Y[/)L>XMCDZ,N*_]^MZ6C6N3%DK,7Q9:
M3-,E)BU9F)B4%.9X;DNW^2R\1R^*V'?X;:6K/_PM6?9:MH\:VC6+1,3$Z/6F
M)O+
M
M
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MEN,XOKVO;43,=&OQ\^EM8OET]D>$37%$S%9UFUKSITSGH.-,@
M
M
M
M
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MKCX#=]'%>9V/#-LNQM,]&XC'2LY<^RR6\+X]9M;Y/:T[G%2M[6C)CI.:9O\
MEUYK\-WUCKL<NFV[CK36V&9G3)TQ$VOAM/U5?;/1,^\K$3,Q:L=<PYIA-K@
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M:+5CWY@+PP
M
M
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MSU9)K$SK,5BM-*Q(HCNP(
M
M
M
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MQI>->C+37PR8Y^&L_P!^LZUM$6B8=4-6,:
M
M
M
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M8K'LICKK,Q3'7]S2-9TCQF?;:9M,S/2#7#'P
M
M
M
M
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M=.JEO[TS6VEZZQU5C6->P&H6*@
M
M
M
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M3Y/+?-O\UYM>]IUFTS_\(B(TB(B(BL1%:Q$1$/O'A/B
M
M
M
M
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MCO2]IT]O]P\1W1Q>/F.%RQFV63PU]EJVCZJEZSXUO7X8GX)B8UK,3/@[.WM
M             .J/#KS%[K\'>Z\!W=TCG_L_,8_W<?LVLY"JXFU/L'4YKB&;
M*:=N.+AFA^T,/D/@TU45TU47-E<T1W-M)%<11R4ZM\X?)[LKSO[*S]D][8/>
M;/)\?#FII&?:9XB8IN-O>8GHR4UF)B8FF2DVQY*WQWM6<:[K[4X?O+A[\/S%
M.K%;QI>-.O%?3PR8Y^"T?WK1K6T369AI!>!WGCTIZ@/2EAVUU+?_ &?F,?\
M)XOLSK/*7EO/MG6.V3V]<M>&S-$5$'VAA\A\"67$Y:**BVR=M15SQ3%<175K
M;\Y'GMY$]Z^0/>N3M/NS'[S9Y.J^SWE*S&#>X(G3WF/77HR4UK7/@M:;X;S$
M3-\=\67) 'O7LKF.QN8MQ?*5ZL5M9PYHB>C-37ZJOT+1X1>DSK2?HUFMK=L-
M*L0
M
M
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M:UIG6;6F=9F9F=9F?&9\9?I/F?F
M
M
M
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M$
M
M
M                                $6OJA^J'U7Z<O5?%S<\8W=_(+=\;
M=_P1]1_-U4\W/--4MISO.\\VDL=[ANO<->QU4U54U1W.7N8ZK.SJIYINKJSE
M%Z8?3#W3ZB^Z?=X_>;'R_P!CDK\OW_3]3[+?)MMU1-<F[R5F)B)B:8*3&;-$
MZXL6;9/EQY<<EW]R737JP\'AM'O\^GL^'W>/7PMEM'[,4B>N_P"YK?.A[S[S
M[4\DNU-O[H[HV_);OV)N^2JR6<SF2JIIXIXIIIAL<7B[&&F.RPV!PUE'1;6-
MC;41VUG;1T1144T4\<.B7L;L;M;RW[6V?9G9FSQ['MW8X^C%BI_?M>]IUMDR
MY+3-\N6\S?)>9M:9F9E/7AN&XWM_C<7$<1BKAV&&NE:Q_P#&UI]MK6GQM:=9
MM,S,SJ\E98]0             !;U]''T(<ASD-+\L?.'5[.C%T6>-VOJ?QTS
MMK/)D)\A)/+<8K:.[,/?6D5O:6=I;Q07EEK=54]=Q7/1]JTP<02X^XJ,]8?K
MKV_R?>^5'DANKSNIO?!ON7Q6B*12(B+X.-R5M,VM:9MCR;R.F*16?DLWF]-Q
MCBSYL>=-.C-VQV=DGWFLTS;JL^$1[+4V]HG69F=:VR^&FD^ZUUC)6X:I_13
M
M
M
M
M                                >)^0GCITQY4=7YWISOC1,/V!H.>]
MR:7&92B2.[Q64@AN(;'8=<R]K7!E=<V3&T74O%O?V4T-S%3)71Q5\.22FK-?
M+[S$[R\K>Z,'>/8F_P W'\]@\(O28FMZ3,3;%FQVUIFPWFL=>+)6U+3%9TZJ
MUF/8X+G^7[:Y*G+<+GO@WU/ACV6CPUK>L^%Z3I&M;1,3I$Z:Q$L]?U0_24[C
M].G;N-BHGF[(\;-OSUW8==]JV<$E5]AY9.9;FPTGM.TALK:RP&[4V4=?,$\'
MMQV9AAKGMN8I:;FQL^@KTP^K+L[U$\3][K5CC?,C9X*VW>QM,=.2(TB^YV-I
MM:V7;=4QU5M]>V]K13+%JSBSYIU>7'FAQ/?NU^3S$;?N#%2)RX9GPM\$Y,,Z
MS-L>OMB?CXYF(MK'3>\2*6C:              #JCPZ\Q>Z_!WNO =W=(Y_[
M/S&/]W'[-K.0JN)M3[!U.:XAFRFG;CBX9H?M##Y#X--5%=-5%S97-$=S;217
M$4<E.K?.'R>[*\[^RL_9/>V#WFSR?'PYJ:1GVF>(F*;C;WF)Z,E-9B8F)IDI
M-L>2M\=[5G&NZ^U.'[RX>_#\Q3JQ6\:7C3KQ7T\,F.?@M']ZT:UM$UF8:07@
M=YX]*>H#TI8=M=2W_P!GYC'_ ">+[,ZSREY;S[9UCMD]O7+7ALS1%1!]H8?(
M? EEQ.6BBHMLG;45<\4Q7$5U:V_.1Y[>1/>OD#WKD[3[LQ^\V>3JOL]Y2LQ@
MWN")T]YCUUZ,E-:USX+6F^&\Q$S?'?%ER0![U[*YCL;F+<7RE>K%;6<.:(GH
MS4U^JK]"T>$7I,ZTGZ-9K:W;#2K$
M
M
M                                                         $>_
MJ.>HEU'Z=/2G\(>]T_?+V#MWVMB.F^JK*ZXM,MV#LV,M[22]DFNOA3_8VGZU
M]IVLN9R=4=?%K%<111T375Q;6\T@O3GZ>.[?43WK_N]P4_)NW]I[O)R&^M7J
MQ[3#>;16(KK'O-QFZ+UV^&)CKFE[6M3%CRY*9UV!V'RG?O,?(-E];V.+IMGS
M3&M<5)F=/#PZLE])C'36-9B9F8K6UHS??)?R3[;\MNY]R[X[MV+[XM[W.\HE
MN.;:'FRPF!Q-G'Q;875M8Q7Q9J<3K> L*:8+6'WY):N..99Y)KB2::3HV\M?
M+?M+RF[-V?8G96W^3\%LZ3$:SU9,N2TZY,^:^D>\S9;:VO;2(CPK2M,=:4K/
M[M[M_B^U^(Q<+P^/W>RPQX:^-K6GQM>]OW5[3XS/A'P1$5B(CP=G;V@
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M=LW;':62*\3,33-N:Z]6;X+4Q3$^&&?9:^FN7V5F,>OO+3:KA&P
M
M
M
M
M                         !\KO&C:;V9J.P:#V'JV!W;2=KQL^'V35=GQ
M=GFL#F\9<^SXMGDL9?Q3VMU#S53Q5QQ53SS373353[*J>.>/5X3G.9[:Y;;\
M]V]NL^RYK:9(R8<^&]L>7'>/9:EZS%JS\'A/C$S$ZQ,P^G9[W=\=NL>^V&2^
M'>8K1:EZ3-;5F/AB8\84)?5U]%#<O"2XSW?W0].2WOQ5R.>KJN\?[MYD]NZ)
MHR==K3CL9M]U7S+/F])FR=S7:8_-\\\R0^R&VR-7S,D-S>7R>DCUJ<-YUX\'
M8/??N]CYIX\$=-_BTV_)S2+==]O6-(Q[F*1&3+MO9;X^3;Q[NM\>&;/E;YO[
M3O"M.#YKIP]RUIX3X13<Z:ZS2/W.32.JV/V3XVQ_%B:T@!3Z;P
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MWNOM3F.S>8OP_,4Z<M?&EXUZ,M-?#)CGX:S_ 'ZSK6T1:)AU0U8QH
M
M
M
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MOG'N>Y+Y>WNVKSC[<^IODC6+[GZ/TZ89]D5\+7CZOXMO=Q9!5R-
M
M
M
M
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MT\)B:SI:)B.D&N&/@
M
M
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M/Q[Q$]-:6'5>K1
M
M
M
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MD>W.6S\+RM)Q[W!>:S[=+1\%Z3,1-J7C2U+:1U5F)>S,->2
M
M
M
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MN+1/ADR1[8I$^./'/L\+WCKTBDZJ#+3
M
M
M
M
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M7%:+8K1$UM$Q,3$QK$Q,>$Q,>,3'A,)?5M6]8M68FLQK$Q[)CZ,/XO[?Z
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MV7C.3Q7P[_#>:WI:-)K,?_"8F-)B8F8M$Q:LS$Q+[QX3X@
M
M
M
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M>.?9X7O'7I%)U4&6F
M
M
M
M
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MS6]+1,6K:)TF)B?&)B7TCS7S@
M
M
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M/'/L\+WCKTBDZJ#+3
M
M
M
M
M   "NYZSOHQ8?S#P^9\D?&[#8W!>4^"QOQ]DUN#Y7%X?O[#XNUICAQ^0FDJ@
MLL=V=CK*"F+&9.6JB*_BHHL;ZOB/BUNK*PWT:>LO>>4&\P^7'F/FR9_*W/DT
MPYIZKY.*R7MK-Z1&MK[*]IFV;#6)MBM,Y\$3:<N+-OCRD\V\O:F6G;_<%[7[
M:O;2EYUFVVM,^V/;,X9F=;TCQK.MZ1KU5O0RS.&S&N9C*Z]L.*R6"S^"R5]A
MLY@\S8W6+S&&S&+NI;')XK*XR^B@O<=DL=>P5PSP3442PRT545T\5<<\+W=G
MO-GR.SQ<AQ^7'GV&?'7)BRX[5OCR8[UBU+TO69K>EZS%JVK,UM68F)F)36Q9
M<6XQ5SX+5O@O6+5M68FMJS&L6K,:Q,3$ZQ,>$QXP_-?2_0            !8
MZ]$/UA<QXM[=KGBMY(;;#+XN[7DKBSU'<=FO;KV] [+DN;BXMZHK[X-US'UC
MLN9KIBR%M-S%:8>YN><E3+;P\7]-Q7/ZVO2!L_-'B=SYI^7&TF/-#:8XMGV^
M&M?_ *JX::1.M=:Z[W#CB;8KUUR;BE/DTUR7G!./07G%Y4XNY-KD[E[?Q3'<
MF*L3?'2(_P YI&D3X>'UZE?&LQK:\1[N8M/1TWPK>XM[RW@N[2>&ZM;J&*XM
MKFWEHGM[BWGHIEAG@FBJJCFAFCJXJIJIYYIJIYXYXY]BB?)CR8<EL66LURUF
M8M68F)B8G28F)\8F)\)B?&)0KM6U+36T3%HG28GVQ/T)?V?P_P
M
M
M
M         5CO7F]6_P#@!UG,^&?C?M/P>\]UP\4?;786M9GX63Z7U/(5V\].
MKXBZL*JI,?V1NV*]^F63F2*YPN'GXGBIINKRTN;6S/T(^DO_ '^Y/#YR>8^U
MU['V6:9V&TS8]:<CGIK'O\E;>%]GMKZ36-)IN-Q6:6F<6'-CRR*\E/*[[^;B
MG=O<&/7AL-_K&*]?#<7C6.NT3[<6.WLC28R7CIGXM+5M1N7@)D
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MM^]J=M4MI>\:Q;<VB?;/LF,,3&M*3XVG2]XUZ:TL1J\FAP
M
M
M
M
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MT7O.WRL^41F[V[>I,[CZK=8:QKU1$:3GI$?NHTUS1$?&C7+X6B\VN2J=$3@
M
M
M
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M:UCPBL1$)Z[;;;?9[;'L]I2N/:XJ5I2E8TK6E8BM:UB/9%8B(B/@B'X+[G[
M           /[6]O<7EQ!:6D$UU=74T5O;6UO%7/<7%Q/73%#!!#%35)---)
M5Q3333QS555SQQQQ[7\9,F/#CMERVBN*L3-K3,1$1$:S,S/A$1'C,SX1#_+6
MK2LVM,16(UF9]D1]&5Z_T./1[_HNX"Q\J?)[3K/CR0VBSHGZUTS-P_-7O1>I
MY&RJHEO,C9S4_+8WM3:+:ZJHN^/=DN<+C_9:<5PW%QD(*:,/6_ZOOZS]_?RL
M\L=Y?^KC:WTWFXQSTUY//2VL5I:/&^QP36)IXQ3<9=<O3?'CV]YAAYR>:O\
MO)GMVUVYEG_=_'.F7)7PC<WB?9$^V<-)CXOLC);XVDUK2RR:K>1]
M
M
M
M
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MAR3,Z1ITXK?%UBMJ5BR^K51Y
M
M
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MGXL?6XF<EJ=5DC4
M
M
M
M
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MBV*T1-;1,3$Q,:Q,3'A,3'C$QX3":U;5O6+5F)K,:Q,>R8^C#^+^W^@
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M..\Q-IPWGVZQI:<<SKUXX^JFU;Z3/H9M2
M
M
M                                              /-^X.V^ONANK][
M[D[5V*SU3KSKC6\EM.U9V]YYYIM<;CH>:_E[.VH]MQD\QD[CF.UL+*WIDNK^
M]FBMX*))I8Z*LC[0[2[@[\[GV/9W:NWON^X>1W-,&#%7]U>\Z:VF?"F.D:WR
MY+3%,6.M\F2U:5M:/0XKB]]S?)8>)XS'.7?[C)%*5CX9GX9GV16(UFUITBM8
MFUIB(F6:;ZE7J =@^H=Y%YCM/8JKS"]<:S]HZMTCU])[+>'3>OJ<K<W5G<92
MRM[_ "-A-OFS4\Q7.=O8Y9?CW%$=O'7\G:6<4/2=Z;?('M_T]^7>'M;CNC-W
M'N>C/R6[CQG<;OHBMHI::TM&UP_&IM<<UKTTFV2U??9LUKV$>7W8^Q[$X&G&
MX-+\ADTON,OM]YEZ8B8B9B)]W3QC'68C2-;3'7>\S'ND$SH            !
M;C]"+T<+[*7W7_GCY0X.&'788;3;_'/J?,X^SO>=GYO;/F;7^XMQLLA;W,=K
M@;6.YHO]7MN*:;F[N:8,IS5%;16G%[4IZZO6)@VN#D/(GRPSS/(S-MOR^^QW
MM7W/3;3+Q^WM28FV6TQ.+>WUFE*3DVNELELON(N^=/FQ3'3/V5VY>9SS,TW6
M:LS'1I/QL&.8F-;3I-<T^RL=6/2;3;HN/J=T3P
M
M
M
M
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M'(]B<Y;B]Y,Y-I>.K#FBLQ7+3^[X1>OA&2L3/3.GC-9K,][-#,)
M
M
M
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M<O3_ /.3=XX\)UCW&&W3:,4Q.GUR9B)RS,>$Q&./J;6O .GPW>
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M,S.LS,SXS,SXS,^,RA?:UKVFUIF;3.LS/MF?HR_L_A_@
M
M
M
M
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M:Q$ZP]L84\<
M
M
M                    !4Z^H2]5&72L7L7@#T+G/A[3LV'BM/)7;\9<W<%Q
MKNJ9[&Q7D?3^/KXM(HI[S=<%D89LY-#<5QQ8J;[/KIKJN[JBWM<^;[]+->:W
M6W\_>_,&O%[;--N'V]XK,9L^*\UGD+QU3,5VV6EJ[:MJ1,YZ_**S$8L4Y).>
M1?EK&\R8^^.;I_FV.^NTI,1I:]9T]_/C[,=HF,<3&LWCWD:16LVIA+ETM@
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M?<9+S:UI\9M:TZVF9^C,S,R_8?&_(
M
M
M
M
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MSX,VUSWVVXK--QCO-;5GPFMJSI:)CZ,3$Q+]A\;\@
M
M
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MW)Y)R[_<9)O>T_#,_!$>R*Q&D5K&D5K$5K$1$0](8X\\
M
M
M
M
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M^-CC6/C5^-=A4K(@@
M
M
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M7'2/@K769\=9FTVM:9M:9GJ)J]C8
M
M
M
M
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M=CR4TQ]R[>L==8TB,U/9[ZE?@\?#)6OA6TQ,:5O6L0DIKMP
M+[/H1>JQ%Y8==0^+_?.T6?'DEU7A[>'3\QE9[2SO>[>N,;:S<1WMIQ1\&G([
MYH5C94Q9B/BGBXO<?\'(\?,5TY.2WH;]=7I6MY4=Q6\SNQ-K?^K?E<TSN,=(
MM:O&[R]HUK;V]&UW5K3;;SKT8\O7MY]W6=M7)"?SI\LY[8W\]Q\)CG_=_<WG
MWE8UF-OEF?9/T,>69UI/LK;7'\6/=Q:Q2KP:%
M
M
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MCP]Y?VVF-=(Z:1,Q6)F2U&MKT
M
M
M
M
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M4GXN2/#QTM$16]=9#D>F"
M
M
M                         *A7U$GJ@2V7S?@#T-M/NS7-G1<^3VTX&\NX
M)K6*Z^'+B.E+/*6.0@HD^<L>:KO:8.898:[>XM+#F7WN<E:TVZ?-Y>F*N?H\
M_>^]K\2MYCA<&6M9BTUUC)R-J6I.G3;3'LK=5;1>F7/%=/DV693^0WES%].^
M.;Q^$3ILZ6B/'3ZK<3$Q/LGXN&=8G6+7T_Q=IIY+?TJP           ']K>W
MN+RX@M+2":ZNKJ:*WMK:WBKGN+BXGKIBA@@ABIJDFFFDJXIIIIXYJJJYXXXX
M]K^,F3'AQVRY;17%6)FUIF(B(B-9F9GPB(CQF9\(A_EK5I6;6F(K$:S,^R(^
MC+0#]$3TF[3PHZZB[[[RP-G<>5G9N'X]RTG^+-_ IU]F+7'W4>AV\,U/$-&^
M9*:+F38+VCCGX/[#'6]7PH;J>_H'];/JOR^=/<4]A]CY[U\J^,S?51I'WQW>
M.UZSNIF/'Y+2)TVF.?JO'<9(ZKXJ8(.^</F=;N_?SPG#7F.V=O?VQ_\ ?&6L
MS'O)_P#HX]F*OP^.2WC-:TGY0':0
M
M
M
M
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M;UGX/")B8F/":VK,6K:/"U9BT3I+U1BSS
M
M
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M9R=C\#DCV37>9(B)]L1,8*6U_9]]I&L3ICUU]Y5<'5!(J
M
M
M
M
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MK,XM(\9R5GXV+VZ_&II,WK-= I0(@X
M
M
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M69GVS/T9?V?P_P
M
M
M
M
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MQ,3$Q.B=./)3+2N7%:+8K1$Q,3K$Q/C$Q,>$Q,>,3'M?XW[/Z
M 7>?I\?5(_ACU#&>#'>VQ?'[;Z_P]SST-LV5NO\ .NP^L]>QGS5QH-S)<5U2
M7NX=;8NRFFM:J*N:[S7(ONQTU8RXGN:2_G O2]_N=R^7SQ[%V_3VER&:/OIA
MI7XNTWF6_3&ZB(\*[?>7M6MXF-,>[M]5,;G'CQP\\]/+?[T[JW>?"X].+SWC
MY32L>&+-:=(RQI[,>69B)_P<L^WZY6M;1*L!'
M
M
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M:QX5K$1#V!B#R@
M
M
M
M
M                      %2CU_O25KVBWS?G=XS:=--LME#S=>277&IXBWY
MXSF,MZ,E?7_?&/LK::.ZESV/IXBAV6&V@FYO+;W<I73');Y*XNK9?0+ZLJ\7
MDP>17F7O(CC;VZ>'WF?)/UJ\S2M>+O:8FL8K_&ML[7M7W=]=K$VKDVV/%*#R
M/\T(VUJ=E]Q98C;S.FTRWM/Q9G2(VTS/ATSXSBF9CIG7'&L6QUK347')9
M         /L.OM_W'JK>M/[,Z]SUYJV]:#LF&V[4=BL.(*[O#;#@+^#)XK(1
M17<-S9W'R]Y;T5513QRP34^VB2BNBJJGGR.X. X?NK@MYVUW#@INN#W^VR;?
M<8;Z].3%EK-+TF:S%HUK,Q%JS6U9TM6T6B)CY=]L=IR>RR\=OZ1DV6?':EZ3
MKI:MHTM'AI,:Q/MB8F/;$Q+2R]+WU!=.]0WQNQ'8UGQ9X7MC3?DM5[PT:WDG
MD^]O<:8I_E,Q85SV5C3/K>\6-GSDK#F+B6.V]^6RJEDGM)JG-CZGO3_S'I[\
MQ\W;N;KS=J;SJS\;N9B(]]M]8ZL=HBUM,VVM;W.7JZ9OI3-%:TS4A7MYC]C;
MOL3N"VPOK?C,NM]ODG3X^/PUK/C.E\<ST6UTF?"^D1:$D".+
M
M
M                                               %>CU[_4TN/$OI
MRCQNZ8V6&Q\A>]<#D+?,Y3%WE<6>ZIZER$=UB\GL]G-;\?$Q.U;A)3/CL-<4
MUQW-G1'=7L-45Q!:R<V#^@STT8_-CO&?,?O+;6OY?<%GI..EZQ.+?;^DUO3#
M:)\,F#;QTY=Q28FF29Q8;Q;'DRU;V\DO+NO='+?[P<OCF>"V5XFL3'Q<V>-)
MBDZ_54Q^%LD>,6UK2=:VM"@HOL3<            >A=3]5[[WAV3I?4G5^MY
M+;M^W_/66NZS@,5:SW5U>7UY5SS7-+3;QRU6V-QMK1)=7ES7QQ#9V<,L\M5,
M4==7&/\ =?=/ ]D=M[WNWN?<X]IP&PP6S9LM[16M:U^"-9C6][3%,=(^-DR6
MK2D3:T1/P\GR6RX?C\W*<EDKBV."DWO:TQ$1$?L^V9G2*Q[;6F*QK,PTLO3.
M]/[1O3O\<<3U7AJ\;G^R]FFMMK[L[$M()/?W'>9+*.WYLL9<WD$&0CTG4K?W
MK/#6M=$--,?,UW7#'=WMWS7S8^I;S^YSU"^8V7NG>1DV_;6VK.#C=I:8TV^V
MBTSU7BLS2=SGG3)N+Q-IF>C%%[8L&&*U[>8??.\[\Y^W)Y>JG'XXFFWQ3/\
MB\>NNLQ&L>\O/QLD^/CI6)FM*Z2'(],$
M
M
M
M
M                                          ?QN+>WO+>>TNX(;JUN
MH9;>YMKB*B>WN+>>BJ*:">&6FJ.:&:.KFFJFKCFFJGGGCGCV/[QY,F')7+BM
M-<M9B:VB9B8F)UB8F/&)B?&)CQB7^UM:EHM69BT3K$Q[8GZ,*!OKF>E+7X;]
MDS>1'1FN34>,':V>DYOL/B[&WAQG2._Y6J6YJTZF"WN:Y(-)V*2.:XPDM-O#
M:V'/MQO/N\QVE5S?AZ'?557SB[;CR\[YW-9\SN*P1TY+VF;\EM::1\HUF-)W
M.&)K3<UZ[7R^&YC7JRQCF]Y->9D=V<?' \SDC_>/;4\+3,Z[C%7P]YXQXY*^
M$9(UF;?XSX;=-?58 WF            [P].GSM[!]/OR1UGN?5/G,WIM[[NM
M]O==T7/$-EV!U]?2\?/V/'$E=$-MLF"F]W(8:[]M/R^0@HHEYKM)KJ"?1/J)
M\B^W_4!Y<;GLWE>C#S-/KVPW<QK;:[NL?%MX>,X<L:XMQC\>O%:9KTY:8LE,
M+[][+V/?/;^3B-SI3=Q\?!ET\<66/9/TZ6^IR5^&LS,:6BMHTT.I^U-"[PZV
MTOMOJ_9,;MV@[_@;+8M9S^*NH+JUO+&\IYXKAEJMY):;;)8VZHDM;RVKYXFL
M[R&6"6FF6.NGCFB[K[6Y[LCN3>]I=S[;)M.?V&>V'-BO6:VK:OPQK$:TO68O
MCO'Q<F.U;TF:VB9KPY/C=[P_(9N+Y+';%OL%YI>MHF)B8_9]L3&DUGV6K,6C
M6)AZ$Q]\
M
M
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M2L6+\!P7&]M<1@X7B:=&QP4TCZ-I]MKVG2-;WG6UITC69G2(C2'B;-7K@
M        +X/H(>EE_1CZZM_++O;6/EO(3M3#\_>)KF>QOP\IT[UGE+6'X?Q\
M?EL/:976^R-SCDFYR7N2U5VV'K@M.?A22W\55$_KS]4?]9G<5O*CL7==7E_Q
M6;_.LV*^M.0WE+3KI?'DM3-L]O,5]SK6(ON(OF^-6N"\0L\[?,G_ 'BW\]L<
M+DUX+;7^N7K/AGS1/P36TUOBQ^'1X>-];>,125D%7(T
M
M
M
M
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M3Q=-.0QS%-QBB?\ %Y--=8B=9]W>/C8Y\?#6LS-J6TCQ2$9V
MLR?3Y^IW+T+V+9^%G=6R?"Z6[<V3BKJ/,Y:2[N(^N>W=BNK.Q@UJWEHAN:K#
M3^R[ZNBBN.KFBRL,W5Q=>R+B]R$]5:7S@/IDKWYV[?SH[+VVO>G$[;_/\>.*
MQ.[V&&MK3FF)F.K<;.L3,3&N3+MM<7Q_<;>D1Y\\_+J.;V$]W<1CUY?:X_K]
M:Z1[W!6)F;S[-<F&/A\;6Q_%\>BE5YY1RAF
M
M
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M[?,G_=W83VQPN33G=S3ZY>L^.##,?!-;1:F7)X='AX4UMX3-)7PE$Z%@
M
M
M
M
M
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M>EO&LK#N%YGC^X.*P<SQ5XR;#<4ZJ6_NS$UF/@M6T36]?;6T3$^,/)66/3
M          :%OH:>I?+YO=$S=4]K9OYSR5Z'P^*Q^T7EU5=R7W9/7T=%OB-=
M[,GO+Z\O;G*;)7<1\6FQ2<U?LLC7%=<\4<7U$='/EZX?357R2[ZCNKM7!T>6
MW.YKWP5KTQ79[N=<F;9Q6M:Q3#I/O-I&GABBV+69P3:T%/.7R\CL[FHY/C*:
M=O;V]II$::8LOC:V&(B(B*:?&Q1_@ZU\>B9F=5!EI@
M
M
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MB-(K'LK6(K&D1#T)C[X
M
M
M
M
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M]=+1\,>RT1:)B.A&OGA
M
M
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M 0
M
M
M
M
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M,UB/;EP_57Q_3M'C?'_RM:Q]6T(G/P@L
M
M
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MR.[MV5Q&2?D&WO\ YU:--,F6LQ,8M8F=:X;1\>)T^O1I,:XXF;3:K=&P
M
M
M
M
M
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MV[\X*-S>:4YK!I3<8XTC2VGADI7JF?=Y/W,S[+1:OCTZS%VD^V.
M   OO^@#ZDM'E!TC3XP=L;!#-WST%@;.UUV\R60N+C,]F]067P,?BL]))>55
MR7V>T>26#%Y+GBNJN2VJL[BKWI)9ZJ:&?7UZ;[>6'>T^9W:FWM'8?/Y[6RUI
M2(Q[+?VUO?%$5TBN+<Q%LV'PB(O&;'&E:XXF$OGAY?SVYS'^\?&8YCA-]>9M
M$1$5PYY\9KX>RN3QO3P\)ZZ^R*K$:O)H<
M
M
M                      ! EZ]7J+?T0O'.7H_K'9KS#^17D1A[[$X:^PU7
MPLIH/5M<U6,W3=8[^GGB;#9C,P\RXC#7$7-%U%<RW%Y;21S6%-7$\O0?Z=OZ
MW?,6.]^YMM3-Y>=O9JY,E<GC3=;V(Z]OMIK[,F/'/3N-Q2VM+4KCPY:VIGF&
M[/)/L+_>KGXYGD<<7X'87BUHM[,N;VX\>G[JM?"^2)^+,16EHF+Z,^IT IS
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MTS,S,S.LS,SXS,SXS,^,R@5:UKVFUIF;3.LS/MF?HR_L_A_@
M
M
M
M
M
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M7"\SQ_<'%8.9XJ\9-AN*=5+?W9B:S'P6K:)K>OMK:)B?&'DK+'I@
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M2+1$Q7)2?&F2NO[FT:3]*=:SXQ+I!KACX
M
M
M                    #ROO#N?K[QWZC[ [N[4S'V#U_P!::W?;/LN1HBYN
M;GY2TXIH@L,;:<5457^8R]_-%:65O3SQ5<7<\<5//MKX93V1V9W!YA]V\?V3
MVMA]_P _R6YKAPTUTKU6\9M>W[G'CK%LF2\^%,=;6GPAZ?#<1ON>Y3!P_&TZ
M]]N,D4I'LC6?;,S\%:QK:T_!6)GX&7GYE^6/9/FQY$]A>0W9US-'E-PR7,.N
M:SQ?U7^*T#1L;5);ZGH>!K^6L(/LW7L9SQ3)-1;6]60OI+B^GHYN;J>NKI[\
MF_*CMOR5\O./\O>V:Q.UV>/7-FZ>F^ZW-])S[K+\:T]>6_C%9O>,6*,>"D^Z
MQ4B+'.TNV./[/X'!P/'1'N\5?CWTTMER3XWR6\9\;3[(UGIK%:1/36L1RZV>
MR,          ![9XZ>/?:'E/W/HG0_3F"^WM^[ S$>+QD4U4T&+Q5I'17=9?
M8]AOH+>ZDQNMZYBX);V_N.(I*HK:&KFBB2OW8ZL*\Q/,'M?RM[-W_??>.?W'
M \?AF]YC2;WM,]./#BK,UB^;->:X\5-8BU[1K:M=;1Y'/\[QO;7$9^:Y:_1L
M<%-9^C:?96E8UC6]YTK6-8UF8UF(UEIZ>&GB=UMX3^.W7OCSUC;0R8O3\;Q-
ML>S<V%-AE=_WG)4QW&V;YGJ/F;^?[2V')\<U1PUW-Q3C[&.WL8*^+:U@HIYD
M?.3S7[D\ZO,/D/,+N:TQNMYDTPX>KJIM=M36,&UQ?%K'1BIX3:*4G+EG)GO'
MO<MYFNCNWN?D.\.>S\]R,S[S+;XE-=:XL<>%,=?"/"L>V=(ZK3:\QU6M,]1-
M7L;
M
M
M
M
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MKL&.Z^!GF./I-N>V%+6K$:ZY<,:VOBTB)FUH\;XXCQFVM8\;M!QS]H,
M
M
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ML1J\FAP
M
M
M
M
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MM8KCC6?- II$
M
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MU#0B<_""P
M
M
M
M
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ML>2/"\+%^SNZ=CWCV_@YW8^$9(TO3X<>6NG72?V)\8G]U6:V^%R6VPR<
M      !TMX@>4.^^&WD3UGY#]=US3Y;0L]!=9?7N,E/BK'=M1NJN+;:M(S%U
M##=<1XW9<-)+;\R507'RLW,=Q1'5+#'[-;>;WEAP/G'Y><GY>]PQ%=IO\$UQ
MY>B+VVV>OQL&YQUF:ZWPY(BVD6KUUZL<VBM[,>[J[<V/=G [C@=_I&+/28K;
M2+3CO'C3)6)T\:6TG36-8UK,Z3+4,Z [TZZ\F>F.NN^>ILO]M]?]G:W:['@+
MJ3FUXOK3WZY;/*X'-065W?VMCLFKYNTN<;E+6F:7Y3(VDT/-7/,?/+F$[^[&
M[B\M.\N1[$[LP^XY_C-S;#EK'5TVTB+4RXYM6MK8<V.U,V&\UK[S%DI>(B+*
MX^<X7?\ ;O+[CA.4IT;[;9)I:/'2?AK:NL1,TO68O2=(ZJVB=/%[ Q!Y0
M
M
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MYNZ.X]_W9SFXYWD9^OYKZQ6)F:XZ1X4QUU_<UC2/ISK:?&9=(-<,?
M
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M^ '=']H _LP_(3\+]W_;7'?R4?JX]D?QKE?LNW_U8_6A//O^*'P__ #NC^T
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MA_\ @!W1_: /[,/R$_"_=_VUQW\E'ZN/9'\:Y7[+M_\ 5C]:$\^_XH?#_P#
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M[?\ U8_6A//O^*'P_P#P [H_M ']F'Y"?A?N_P"VN._DH_5Q[(_C7*_9=O\
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MHC6:9:6QWB/9KTWB)]L3\'P/MGB/C
M
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MS,_$K"\DH_0V
M
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M^>O?T=P<Q';'&7F>(V%YC),:Z9=Q'A;X?&N'QI6=(UO.2?C5Z)6.U<[0(
M
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MOEM-LEXB?&(M:=/@<QMF,B
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M7B-8UZ9G36-=)=(-<,?
M
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M>?<S.7;V_P"1,_&Q^V?'%:>CZ,UZ+S$=6D2EHNM;
M
M
M                      /*^\.Y^OO'?J/L#N[M3,?8/7_6FMWVS[+D:(N;
MFY^4M.*:(+#&VG%5%5_F,O?S16EE;T\\57%W/'%3S[:^&4]D=F=P>8?=O']D
M]K8??\_R6YKAPTUTKU6\9M>W[G'CK%LF2\^%,=;6GPAZ?#<1ON>Y3!P_&TZ]
M]N,D4I'LC6?;,S\%:QK:T_!6)GX&7#Y=>3.[>8?D;VIY%[]'\EF^R=DFR5G@
M8[Z3(VFIZS90PXO4]/L+V2WL^;JSUC7+*VLZ9_@P\W-454U5%-<E7#J$\I/+
M3A?)_P NN*\N^!GKV7&[:*6RS6*6SYK3-\^XO6)MTVS9K7R37JMT1:*1::UA
M9!VMV[L^U. VW ;'QP[?'I-M-)O>?&^28UG2;WF;::SIKIKI#F]L9[X
M     "9[T2_3KH\[?)GC/;_C8;OQ[Z%FP6W=IVE]#<56N[Y.]N+NO4.LXZHJ
MHZ:H=BNL7-<9+GWN.*<5:31^VF2XAY0T]:WJ(MY%^6GR#@,DT\P>>C+M]C:L
MQU;:E8K\HWDZZ^.&MZTP^'CGR4MXUQWAJ3S@[]GLOMWW&QM,<[O8M3#,::XX
MB(Z\W_RQ,13_ )=HGV5EHR.== @
M
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M-EF(C6;W]NDS&L4KICK,STUC6=>+6YV7
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MOKI[W;Q&GU>FGO,?CK[RM8Z(U]Y6(KUVL(J^VBP
M
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MTF)B8TF)\8GPE^D^9^8
M
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M;L=8\6/W]]FYZ.WKVC:)^*Z>+J>&FFUM\=C^;CFJ>'$8^T@JY_:N/9S&^?\
MYQ\MYZ^:/(>8')1DQ[/+,8=GM[VZODNRQ3/N,,?N8GXU\V7ITK;/ES7CZM7/
MWSW9NN]>Y,_.;CJKBM/1BI,Z^[PUUZ*1\'PS:VGA-[6GX7:33#$0
M
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MXS%3#L,-(K2E8TBL1_\ &9F=9F9F9M,S:TS,S+X-[K[0
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MCZCQM6.C6*6T53J,
M
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MY_=BQQG)5[PXVD_(=Y;IW$1$Z4S_  9)GV1&:/;X1IDK,S,SDB(M!JPT<@
M
M
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M-U,3X6MI%L>&=/;%?#):)\.KW?PUE;=5+HO
M
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MB/V/;,SK-I]MK3-IUF9>>L@?<
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MNXM8=5[-$
M
M                             *,/U$/IQ2](]N2^:G5>&]WJKO79)^.U
M\;CK2[DCTON?*<W&1O\ 9;V7CXT,&'[3F^+=\R5<TTT9NFYIJYX^:MZ%XWS>
M?J,KWMVE'DOW3F__ #IX+;1\AO>U8G<\=32E<-8\)G)L8Z::1K,[:<<Q_BLE
MDS/(?O\ CF.+CM#DK_\ U3V6/ZS,S'US;QI$4CZ-L/A73_)]/^#:59M9:D,
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M=_VQS6XX/DJZ;K;Y)KKXZ7K^YR5UTF:7KI:LS$3I,:Q$ZP]X8(\4
M
M
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MNLN^WEYR;O-DM>]I]MKWF;6M/TYM,S/[+Z1YKYP
M
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MCM?#QEHK/)Y(]YN+1$>.6T>-=8UUKCCZW6?9,1-M(FTPCE2*9\
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M';QQY(T\/C5F)F/W-M:SI:LQ'435[&P
M
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MZ%K3/A2%XQ2$AN
M
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MK,:3:VLSZ&;4@
M
M           "N)]1]YIW'1WC!@O&+3<A-:;YY/37UOLUS:U5QRXGIS5[BRDV
M>#F:CV<Q3;MF;FTQG%/W:9L=3D**N./;3[;&/FY?)C'WQYG9_,WF<<7X+MB*
MSABVDQDY#/%HPSI\,;;'%\VOMKFG;VCX6_O('M&O,]QW[BW=8G9<=$32)_=9
M[Q/1/_VNL6O]*W1*APO;34
M                                6=OII/-.XZS[\V[PRVW(3<Z3Y!0W
MVZ=;QR55U6N$[CTS7Y;O-6\=''P[>TAW_KO"24W$\M5555YK^.MXJ?>GJYYK
M*^<H\F,?<O86T\Y>)QQ]^NWYKM]Y,:=63C]QEBN.9]LVG:[O)$TK6(B,>[W.
M2\Z8X1U]0O:->1X3%W;M:Q\LV,QCR_1M@R6TK/T9]UEM&D1^YRY+3/Q87C%(
M*&X
M
M                      "OU]0!Z>7]*SQRI\A>N<9>77>OC3A\GE*,9B[#
MYZ[["ZCFFIO]OU;F""CB^FS&IU4UYO$U452\>[1?VM,$DM]'+!/[T">H3^JO
MS%GR^[CRTIV-W+FI2;WMTUVF_B.G;Y]9^+&//X;;/$]/C.#+.2M<%JWWEY'=
M]_[L\_\ >+?VB.%Y"\1K,Z1BS^RE]9\.F_\ B[^S]Q;JB*3%J 2_5.
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MJNL\=?Z[M[3KXX;S/369\=;8YB<=I_=37JTB+1"15'=@0
M
M
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M8F_^+I[-=;VK.N.8:!2@1!P
M
M                      !F=^L7Y/7'E7Z@G>VWV][-=Z?UYGI^D>NZ:Y*Y
M+>/4>KLAD<++>8[BJZNJ(\;LNVUY7,P\4_"]M.2]ZJ.B2JNETK^CWRQQ^5?I
M_P""XC)2*<OR&".2W>D1$SGWM*9(K?XM=;X<$8-O;7J\<.D6M6(E89Y4=N5[
M9[&V6UM$1NL](W&7Z/7FB+:3X1XTIT8Y]OU'A,QHC!2<;&
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M8F8F/&)F'I#''G@
M
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MD\X^R*]W]K7W&TK$\UL8MEQ3$:VO6*S[S#]'X\1%JQ_ATI'LF6C(YUT"
M
M
M                                $(7KQ>=5IXC>'&>Z\U+.?)=X^3-G
MF.M-'@LZY:<EK^CW%M%;]J;[Q+'3'S8_9VN9'C$V$U$\-W#ELQ;75OQ)3:7'
M,<VO0GY&9?-OSBV_</+8.OL?MJ^/>;F;1'1EW,3,[':Z3KU=>:GO\M9K;';!
MM\F+)-9S8^K<7DKV7;NGNRF_W5->&XZ:YLDS[+9(G7#C^GK>.NT:36:4M6VG
M577.Z=#*>           #[;K7KO;NW.PM(ZMT'$S9W=NP]JP6F:KB(/;Q7D,
M]L>2ML5C+>JOV<TP0U75U3S)+5[*(H^*JZN>*:>>7B]R=P\3VEV_O>Z.>RQ@
MX7CMKEW&?)/LIBPTF]YT^&>FLZ1'C:=(CQF'Q\AO]KQ>PS<EOK139X,5LE[3
M\%:1-IG^]'A'PSX-0SP/\1-.\'O%[K+Q\U.BSN+_ %W#V^3["V.SXG]S=>T,
MQ:6DV];=QS=TTW=-GDLO%S'80R^VNTQD%M;>WGB'CES">>WFYS'G=YG\GY@<
MM-ZX-QFFFTPVT_S;98[6C;8/B_%ZJ8YURVKX9,ULF3PZU<?>O=.[[Q[CW'.[
MK6*9+S&*DZ?6\-9GW=/#PUBOC:8^JO-K?"[ :A8J
M
M                                       YO\P^Z?Z.GBKY#]Y13_ R
M/6'3^^[7K_[7\7YC;;#7;[[S[#]EBLY!%]I;3)9V_P 6>TN+:'XOQ)Z.8::V
MQ_)_LO\ K$\T^WNQ[5ZMOR?,;7!E\=-,%\U?E%_J\4ST8(R7Z:Y*7MT]-)B\
MU9!VIQ'W_P"Y=APTQKCW.[QTM]*DVCWD_55GPIU3I%HF=-(G71E&NJQ9D
M
M         T(?IT>\OX5_3FU[1[[(_-YWQ^[(WKJ^XBN[OYC+<Z_D[RW[*U>\
MFHFR^1O.</#9[U+BK"2J&R@IBQ-5M#%S3:\RR<_'SB78_P#NIZBMQSF#'T;'
MN#C=KO8FM=,?O:5G9YZQICI7WDVVM<^6(MDM-L\9;WB<L5K!?S[X;[V=_9-Y
M2NF'?;?'FC2-*]41.*\?4Q'5KCB]HUM.MXM,_&TB>%!-I4
M
M
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M==(C2(I:*Q]3*;U"5IT
M
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ML6/'V1Q]IB]XKEW,Q/[GQ]WAF/\ E3IEM'T(Q_!,KCZG=$\
M
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MS8_WQ_1Z[]_B/[@_FTW3]Y3^L'L'\.</]N;;^$/O[P?\<VGV;'^^/Z/7?O\
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M\?T>N_?XC^X/YM-T_>4_K![!_#G#_;FV_A#[^\'_ !S:?9L?[YY R]ZH
M    "WI]*OV/-1D/,7J*ZEO);>XL^HNQ\##1:8_C'V4UG/N^L[;+<W_%4>4K
MO,I1?87B"'GB:WIHLYJN.8:ZN?CU&?.G=N4G;]G]W8HI&2M]_L\LS:_7:+1M
MLV"*U\:=-)KN>JWQ;S.2D3UQ$=$6?4MQ\33B>4K$1:)SXK>,ZSK[N]-(^ITC
M3)K/A/QH]L>RX<I_13
M
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MJR8[XKVQ9:S7+69B8F-)B8\)B8GQB8GPF)]C_8_%_
M
M
M              "OI]0YYQW'C7XH6?0>@YZ;%]N>44V0UR:YQ=Y7;Y76>G,'
MS:2=B9:F:VDJDLYMNDO+37H*)J*:;NQO\G7#7Q+9\^RP'YO;R/Q^9/FM?OWG
ML$9>TNUXIFBMZQ-,W(9>J-ICTF-+1@BN3=VFLS./+BVT7K-,WCO/R([-KW#W
M-/-[ZD6XOC8B^DQK6^>VONJ^/MZ-+99T^IM7'$QI=0(7Y)O@          .E
MO#SQHV[S \E.I/';3.)H<AV/M5IC\KEXH.9Z-8U&QHDRNY;7<4<\>Y5#KFL6
M-U=\45<\?&DBIBIY]^2GCG6WG!YE<3Y0>6W+>8?,Z6V_';6U\>.9TG-GMI3;
MX(GVZYLUJ8]8^IBTWGPK+'NZ^X=KVKV]NN>W>DX]OBF:U]G7>?BXZ1_S[S%?
MI1,S[(:DG3O4^D]$]5=>=,]<8S[(T7K#3\!I.KV-=4<ES3B=>QT&.M[G)7,<
M4'VAF,A\'FXO;JJGB6[NY9)I/;7)5SSR\=X=U\UWUW5R/>7<>7WW.<GO,NYS
MV\8K[S+>;S6E9F>C'37HQTB>G'CK6E=*UB%;W*\GO.:Y//RW(6Z][N<MLEY^
M#JM,S,1'P5CV5K[*UB(CPAZ0QQYX
M
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M:(B_NZ1;HZ->F]HM:8M'1,6@U8:.0
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MVB8FMHF8F)B8G187CR4RTKEQ6BV*T1,3$ZQ,3XQ,3'A,3'C$Q[7^-^S^@
M   %E+Z7;,9.#SD[LP$5Y-1ALGXH[3F+_'T\\?+W63P?;W3%EB;R7CV>]S-8
M6NPWM%'/'/''%-S7[?;]SV5M_.?[/;7\C^%W]Z1.\Q=UX,=;_#6F78<C;)6/
MI6MBQS/TZ0CYZC\6.>S=GGF(][7DZ5B?AB+8-Q-H_NS6NO[$+V"C!#
M
M
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M&R[P[>V_/;&8BN6NEZ:QKCR5\+TM]#2?&NNDVI-;Z:6ARBVJR8
M!>[^G$\X[?NWQORGB9N^>AG[0\;H?F-,MKV\HYRNP]&92^CBQ4]K#+7\S>0]
M<[#??9%Q513\*SL;S$Q<\\<R<>VBKYQCR/R=E>8^+S8X3!->V.Y)TW%JUGHQ
M<G2LS>+3'A6=WBK\HI$SU9,N/=V]E90M\_NS;</W!7N?9TF.-Y"=,DQ'Q:[B
M(\8GX(][6.N/AM:N6?@61U<*/X
M
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M\<U3M396_P PX^\VRS$^%]Q-=--/_H:S-(^'JODB?9"RRK81[
M
M                                                  57?JG_ /@%
MXJ_\X-S_ -RX5I7S6WY_=U?B?;_=,I*>FS_USD__  F/_M%)]=2E\
M U//3MM[>U\ /!^*V@AMXZO$7QPN*HX(J(:*KB\Z?T^[NYZJ(Z::>9KJZGKE
MDJ_\U<E=557/////+EM]0V3)E\_>][9;3:T=W<O&LS,SI7D-Q6L>/P5K$5B/
M9$1$1X0K9[\M:W?',S:9F?OINH\?H1GR1$?W(\(^D[&:>8F
M                                        R7/(7_C[WA_S@[+_ -],
MTZQ/+[\P>#_$^S^YL:SW@O\ T/9_^$P_]G5Y R]ZH      "R!]+W^7WV]^A
M_O\ ^.CQ_5R?.>?H$XC^E^U_)W*M >H[\R-K^-<7W/N5\)1.A8
M
M
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M<&2U+TG36MJSI:/#6)TF/;$S$^V)F'V#QWR
M
M
M      *]WU$OFW_1V\2(O'G3,O\ *]I>5GVKJE_\I/[M[@>E,53;?PE7\WPJ
MI/@??G\]:ZY'%<1\1WN/R&3JBKXEM.?98)\WEY)_UA^;4^87,X>OM?M7HSUZ
MH^+EY*_5\CI&NFOR?IOO)M2=<>7%MHO'3F\=Z>0W9_W^[HGGMW37C>,Z;QK'
MA;<6U]U'_P!KTG+,Q.M;5QZQI=0.7WIO           ) O3'\+,QYV^7_6/3
M-6/R4G6]GDH]T[LSEC3=118+JO6I8[[8+>3)VO[9B<EN$E,6"QL_'%7,.1R<
M,O-/,<<G-.@/4SYS[/R+\H>3[RC)CCN.^.=OQN*W3,Y=]FB:XIBEO#)3;QU;
MK-7PZL.&]8F+6KK@_F+W=B[+[5W/+=5?OA-?=[>LZ?&S7\*SI/U48_')>/AI
M28UUF&G1KVOX34\!@]5UK%V>$US6</C-?U_"XZ&FWQ^(PF&LH,=BL78V]'[&
M"SL+"VCBBHX^Y311QQ_X.9?D.0WO+;_/RO)9;Y^1W.:^7+DO.M\F3):;WO:?
MAM>TS:T_#,S*NK/GS;K/?<[BTWW&2\VM:?&;6M.MIF?HS,S,OV'QOR
M
M                                                       57?JG
M_P#@%XJ_\X-S_P!RX5I7S6WY_=U?B?;_ '3*2GIL_P#7.3_\)C_[12?74I?
M       -4+T]/R!/!W]#_P :/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O
M[HR.P&H6*@
M  ,ESR%_X^]X?\X.R_\ ?3-.L3R^_,'@_P 3[/[FQK/>"_\ 0]G_ .$P_P#9
MU>0,O>J       L@?2]_E]]O?H?[_P#CH\?U<GSGGZ!.(_I?M?R=RK0'J._,
MC:_C7%]S[E?"43H6
M
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M6'O#9TTV^ZTQ9](]F:M?B7G_ .R8XZ?V<?CXV6H56J-8
M
M
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M\+)VT%FEP
M
M          %5WZI__@%XJ_\ .#<_]RX5I7S6WY_=U?B?;_=,I*>FS_USD_\
MPF/_ +12?74I?        -4+T]/R!/!W]#_QH_$OI3EJ]0?Z>^^/Z7\S^4=R
MK7[[_/?F?QKN_NC([ :A8J
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M'2,&YUG^YK&O[,+WBBI"T
M
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M'A+TACCSP
M
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MZV]^GEMS]8V^D^,7O$]62/ACW5(M>)TF.N*5GZII9.;%7N
M
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MCZC+K]'P^@MQJE$7
M
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M^$[2+#XE44$?V'M.2ASUI;Q\2W-S]L96:KW8;3[E-WSF'DG\AY;C_/3@\/\
MF^]Z-AR?3'LSXZ3\BW-M-9GWN"EMKDO/32GR?:TC6^7QB9ZB.S_<[K!WILJ?
M6\VF#<Z1^[K'UG)/P_&I$X[3.D1[O%'MLMHJG48
M
M
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M[$ O.#O#_>WN_+\FMU<3LM<&'3V6Z9^N9(_Y]]=)^&E:?03 HA-5
M
M                                                       *KOU3
M_P#P"\5?^<&Y_P"Y<*TKYK;\_NZOQ/M_NF4E/39_ZYR?_A,?_:*3ZZE+X
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M6GX79C3;$@
M
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M\_$\A7HWNVRVQWCX.JLS$S$_#6?;6WLM68F/"7I#''G@
M
M
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M^UJOS@[P_P!TNT,OR:W3RV]UP8=/;7JCZYDC_F4UTGX+VI]%I!.<E $
M
M                                                          !5
M=^J?_P" 7BK_ ,X-S_W+A6E?-;?G]W5^)]O]TRDIZ;/_ %SD_P#PF/\ [12?
M74I?        -4+T]/R!/!W]#_QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_ #WY
MG\:[O[HR.P&H6*@
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M>;F>U.VLT7XBLQ\HRTG6N:T3K&.EHG2V*LZ3:T1I>\1TS-*ZWM$JP$<
M
M
M                     %'GZDWP4N^LN[=?\U]"P?N=>=Y_(:KVQ58T14V^
MN]SX/&<P8K,7-O1S#Q:V?9.G8NBKCF**NFK*X>^GNI>)KZ&F2[OYM[SSQ=S=
MD[CR6Y[/KW#P?5GV/5,ZYN.RWUOCK,Z]5MGN+S'QK1/N-Q@IBK-,%YK,;T^]
MZ5Y'A[]H;Z_^?[+6^'7VWV]IUM6)^&<62?AGZC)2M8TI.E8-9PD8
M   N8_3*>;?VYJ?8/@EO.7]N1TO[3[;Z*^<G]GQ=3R^2B_A.TBP^)5%!']A[
M3DH<]:6\?$MS<_;&5FJ]V&T^Y3=\YAY)_(>6X_STX/#_ )OO>C8<GTQ[,^.D
M_(MS;369][@I;:Y+STTI\GVM(UOE\8F>HCL_W.ZP=Z;*GUO-I@W.D?NZQ]9R
M3\/QJ1..TSI$>[Q1[;+:*IU&
M
M                                                   !FU^M=YCV
M_F+YU=@9?5LU-ENJ>GH:>FNL:X[FB7$WUCJE]>U;7M.,CMZ:+::':]SNKZ>"
M[Y]^:YQL=GQ57[D44<?1_P"BSR=R>3WD9Q^TY3#&+NKF)^^.]UB8R5MGK7W&
M"\SK,3@V]<=;8_"M,TYIBO5:UK6!>4':=NU.S,&+<TBO)[N??YO#XT3>(Z*3
MKX_$QQ6)K[(O-](UF9F)%+1M           !I ^B3X2?T,O"G4?OHQ'V=W'W
MI\CVWVE\S!\+)8K[7L*/O(TBZ]^FF>'[T-6EC^8MZ_\ U&6O+_V?<J<Y/K7\
MZ_ZY?.G=_>O-[SL[@NK8;+2=:7]W:?E.YK\$_*,\3TWCZK!CP:^Q +S@[P_W
MM[OR_)K=7$[+7!AT]ENF?KF2/^??72?AI6GT$P*(350
M
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M'C_C<D17XMH]N.L17X+3>/%.>@XTR
M
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M-Y@RVQWK/P6I,UF/[\>$_#'B^V>(^,
M
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MOR:W3RV]UP8=/;7JCZYDC_F4UTGX+VI]%I!.<E $
M
M                                            !5=^J?\ ^ 7BK_S@
MW/\ W+A6E?-;?G]W5^)]O]TRDIZ;/_7.3_\ "8_^T4GUU*7P       #5"]/
M3\@3P=_0_P#&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH
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MYCEN0BT;_=;G/%[=5O>9;WUMKKU3U6G6=?'6?'5Z<QEYP
M
M
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MLUR8XF-/_HIGQUE:55=(W
M
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MAT]ENF?KF2/^??72?AI6GT$P*(350
M
M                                 "J[]4__ , O%7_G!N?^Y<*TKYK;
M\_NZOQ/M_NF4E/39_P"N<G_X3'_VBD^NI2^        :H7IZ?D">#OZ'_C1^
M)?2G+5Z@_P!/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M
M
M
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M6TM6864\5R>SYKC,'+<?;KV6YQ5R4GX>FT1,1,?!:/9:OMK:)B?&'F[(WW@
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MFYQ7M2]9]M;5F:VB=/#PF)CP?O/@?@
M
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MV]^CE-U]8P:>V+7^KO'PQT8HO,6]D7Z(GZJ&DTYO5?@
M
M                                                "J[]4_\ \ O%
M7_G!N?\ N7"M*^:V_/[NK\3[?[IE)3TV?^N<G_X3'_VBD^NI2^        :H
M7IZ?D">#OZ'_ (T?B7TIRU>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M
M
M
M                               4S?J:_"3[#VWK[SMT;$>S';K]F=2=
MZ?)P>WX.VX?&R_P8[O??#XFGD^W-6QDV!N[B3F*VMOL;%PT^]-=_=N1^;/\
M.SY=Q/(>1?.9O\XV77O^,ZI]N#)>/ENVKKI$>ZSWKNL=(ZKW^4;J\Z4Q>$M/
M3OWA[[:Y^R][?ZYAUS[;6?W%I^O8X^#XMYC)6(UF?>99]E52];$D\
M    OF_3?^9EWWGXL;%XU[EDOFMX\6[S%6&MSW=U%5>Y?I_<),K<:I%#%++\
MW=_>/E\;>XN2JBCF&TQ]>,BYYXJKIXYHA^<;\F\78WFEM_,CA\?1PG=%,E\T
M5K/3CY#;Q2,\S,1TU^4X[X\T1,]63+&YM$3$3I"GS_[2KPW<N/N#:5TV?)1:
M;Q$>%<^/IB_TH]Y6:WCX;6]Y/P+&JNIH,
M
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M
M
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M]-7\SN'_ .AD_A#^JOR\_!.T_O6_?'][WZE_YY'</^LL5^])^J+Z:OYG</\
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M2_<?E=WOVO6V;D-E>^RK/^-P_7<>GT9Z-;4C7PUR5IXZ1\,:R3HW-?
M
M
M      /!_)_Q\TGRL\?>V?'CL*/_ ."W:NGY#6[B^HMH[NYU_+>]%D=7V['6
MTTD<$^8TS:;&RRUE3)S\+F[LH_?XYI]O'.=^6/F!S7E7Y@<3YA=O3_\ 53BM
MY3-%=9K7+C\:9]O>T1,QCW&"V3!DF/C>[R6TTG27M=N<[O.V><VO/;#_ +SM
MLL7B-=(M7V7I,^WIR4FU+:>/3:=/%E>]P]3[MT3VKV'TSV/C/L?>NL-PS^D[
M18T5226U.6U[(SXZXN<=<R10_:&'R'P.+BRNJ*>(KNTECFCYYHKIYYZE>S^Z
M^%[Z[5X[O+MS+[[@^3V>+<X+>$6]WEI%XK>L3/1DIKT9*3/5CR5M2VEJS"RG
MBN3V?-<9@Y;C[=>RW.*N2D_#TVB)B)CX+1[+5]M;1,3XP\W9&^\
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MB?&)5TVK:EIK:)BT3I,3[8GZ$O[/X?X
M
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M<MIMEM,S:TS,S,S.LS,SXS,SXS,^,RKJM:U[3:TS-IG69GVS/T9?V?P_P
M
M
M  !5=^J?_P" 7BK_ ,X-S_W+A6E?-;?G]W5^)]O]TRDIZ;/_ %SD_P#PF/\
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M.4/Z7K:@
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M$S;2FXQQ,XYUF>F+Q/CCO,>VMO#7PI>\1JDS1I:\
M
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M]J1VUWIEW&WB8X_D8G<4]NE;VM/OJ:^SPR:WB(\*TR4K\":M"YJ$
M
M
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M6GCKTV]Y$::SK8O5VM"
M
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MSQTQ;7'6*TI2L5I6L>$5K6L1%8CX(B(B'X+[G[
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MM(GHM*JND;@
M
M                    '-/F'XT:CY@>-?;?CMN?$,./['U6[Q^*R\L'$]>L
M;=8UQY73=KMZ../?JFUS9[&UN^:*>>/C1Q515<^Y)5QSLKR?\RN6\H/,GB?,
M/AM;;CCMU6^3'$Z1FP6UIN,$S[-,V&U\>L_4S:+QXUAD/:G<.Z[5[AVO/;36
M<FWRQ-J^SKI/Q<E)_P"?29K]*9B?;#*]WK2]CZWW?<>N]PQTV(VW0MJV'2]I
MQ-Q'+%<8O8]6R]Y@\WCIXIXX9XIK+)V,L55-=%%=-5//'/''/W'4KP7-<=W)
MPFS[BX?)&;B=_M<6YP9(F)B^'/CKEQWB8F8F+4M68F)F-)\)E91LMYM^0V>+
M?[2T7VN?%7)2T>R:7K%JS&GAXQ,2^5>H^D         !-5Z#/F'1XJ^=VH:S
MLEU-'UKY+PV'1NU4_&N/E<5M.?S-E)U;M==I'7';2S8_<_AXN6XN*N(K'%9N
M^GY^[1QQS"[UW^3]O-/R*WG)\;2)[D[:FW)X/".J^#%CM&]P1:=9B+[?7/6E
M8ZLN?;8,?[IJ+SK[4GN7LO+N-O$3R''3.XI[-;4K6??4U]OCCUO$1XVOCI7X
M6BPYW4"@
M
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M$ZPL;\N^UZ]H=H;/AK1'RN*>\S3IIKFR?&O'P:]&L8ZS,1,TI76-7!+?+-@
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M?;R\Y-WFR6O>T^VU[S-K6GZ<VF9G]E](\U\X
M
M                                          "J[]4__P  O%7_ )P;
MG_N7"M*^:V_/[NK\3[?[IE)3TV?^N<G_ .$Q_P#:*3ZZE+X       !JA>GI
M^0)X._H?^-'XE]*<M7J#_3WWQ_2_F?RCN5:_??Y[\S^-=W]T9'8#4+%0
M       %5+UV/6.R'4_VYX7^)NZ6</8M_9WF)[[[5UC)3U9;K2";VV]UUEJ6
M1M8J;>PWR_MZZN,MD+>XKN,'%SS:Q\19&JN2PM0]"_H\V_=?N/.;S7V5Y[=Q
MWKDXO8YJ1[O>3'C7>YZ6G6VUK.GN,5J13<V^NVZMO%:YY+^2_E1CY/H[N[GP
MS.PK,6VV&\?%R_#&:\3XSCB?J*S&F2?C3KCTB]*I=&EV
M                                                   ND^A=ZR^6
M[3N]6\)_*[8_G]_CLZ,3T9W+L&5MH[O>8+**B*QZRWJ^R5S%-DM\IAIXCPN0
MXYEN,W33Q;7''-_3'-?TQ>N3T;[3M;%NO.KRIVWN^ F\Y.3X_%2TUVTVG6V]
MVM:5F*;77QW.+XM-M,^]QZ8)M3!$;SF\IL7&UR]X=LX^G8Z]6XP5K.F/7VYL
M<1'AC^')7PC']57XFL4M<JJ49@
M
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M1[PWG$UB(V4W][@T]GN<DS:D?1^)XXYF?;:DS'A,) V@&#
M
M
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MI,3686RU4",0
M
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M1$1$:1$>$1X0_-?2_0
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M>'>S:^'V_6YB8Z\,S\/1U1T3,S,TFNLS:+2F30Y:F
M
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MQ-;1,Q,3$Q.BQ['DIEI7+BM%L5HB8F)UB8GQB8F/"8F/&)CVO\;]G]
M    +.'TSGEY_!KY$=@>).SWGNZMY"8?C:]$JN;[W(<5VKUYCKZZO+"SLY[B
M"UI^_C1:[KYF6GB6XKN,%8144>[775169\Y9Y1_[R^7G'^;/&4UY3M_-[C=:
M5UF^QW=ZUK>UHB;?YMN8IT5G2D4W6>\SK%8F.WJ&[6^^' X.Z-M'^<[&_1DT
MCZK#EF(B9G29^MY--(\(TR7F9UB(F\DH_0V
M
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M;SPW&ZSVR3&LS%8M/Q:1,^/32NE*Z_N:P]L84\<
M
M                                              !5=^J?_P" 7BK_
M ,X-S_W+A6E?-;?G]W5^)]O]TRDIZ;/_ %SD_P#PF/\ [12?74I?
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MC9K^-HUCZJ,?ACI/PTI$Z:S*/UO]G
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M7/?;;BLTW&.\UM6?":VK.EHF/HQ,3$OV'QOR
M
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M;-;';3V3-9TZH^E:-+1]*8>M,3>6
M
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M]-*5K6NLSX1"RW:;7;[':XMCLZ1CVF''6E*Q[*TI$5K6/I16(B/V'S;T7T
M        +.'TSGB'_"5Y$=@>6VSV?O:MX]X?C5-$IN;'WX<KVKV'CKZUO+^S
MO)[>>UJ^\?1:+KYF*GF*XHN,[82T5^[173769\Y9YN?[M>7G'^4W&7TY3N#-
M[_=:6TFFQVEZVK2U8F+?YSN9IT6G6DTVN>DQK-9B.WJ&[I^]_ X.U]M/^<[Z
M_7DTGZG#BF)B)C6)^N9--)\8TQWB8UF)B\DH_0V
M
M                                                57?JG_\ @%XJ
M_P#.#<_]RX5I7S6WY_=U?B?;_=,I*>FS_P!<Y/\ \)C_ .T4GUU*7P
M #5"]/3\@3P=_0_\:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_P ]^9_&N[^Z,CL!
MJ%BH         ""3ZA;RJN/'OP+S77&MY:;&[YY09Z/J.RJLIJX+ZWZ[HMN<
MUVQ?<<\V\MM/C<GKT$.N7D-55$E4.Q^]'[?<JJHG3\WSY5X_,'SXP]Q\EBC)
MP7;&"=_;JB)K.[FWN]C7VQ:+TRS;=X[1$Q%MII;VQ$[H\B>VJ\[WM3D-Q6+;
M+C:>_G7V3EUZ<,>W6)BTSEK/LUQ>/M\<]AT%)U
M                                                 - GZ=7RON^_
MO!ZKJ+9KVSN=U\5]DBZXHXCN(Z\E=]7YZTFSW6.4REK1Q%\I\I\++8&V]V/B
MB6UP$=?-<DW,W/% GSB'E3B[!\[_ />WC*7KPO=.VG>>,3T5WN*T8M[2EIUZ
MNK7!NKZSK6^ZM6*UI%-8.>?7;%>#[R^^FWB8V?)8_>^SPC-6>G-$3\.OQ,D^
M/A.68TB-$_* [2
M
M                       ");UJ?#K^F)X)=D8C7,!]L]M]0?#[DZF^6I]F
M2GRVJ0S??;K5K\*&N[O_ +[="N,E:V]C351%<9;BPDK]M5O'[)8^B[SA_J?\
M].-WG(Y_<]I\OKQ^_P!?J(QYYCW&:VLQ6GN-U&&]LNDVI@]_6-(R6;/\H>Z_
M]U.]-OEW%^CB]U]8SZ^R*W^HO/P1T98I,V]L4ZXCZJ6;,Z0E@8
M"[#],/Y9_??T[VWX=;1G?CYWJ',5=J=6XV]N_?N:NL]XOZ;;=\5A;.B&FF'#
MZAV-+'?W-==?-==WM_'''MIX]E-*WSFWE/\ >CO#B?.'B\'3L>7P_(=[>M?B
M_+-M77;7R6U\<FXVD3BI$1I&/8>/C[8@^HOMCY+RVU[KVU-,.ZI[G-,1X>^Q
MQKCM:?\ "OBUK'_)P+4*K5&L
M
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M8UM[K!]",..9BND?!US-LL_\J\^SV1(>CTP,
M
M                                            !5=^J?\ ^ 7BK_S@
MW/\ W+A6E?-;?G]W5^)]O]TRDIZ;/_7.3_\ "8_^T4GUU*7P       #5"]/
M3\@3P=_0_P#&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH
M       "@_\ 4K]_WO9/G7A>D[>\FYU[QOZQU[$UXRJ>^DMX-Y[2LK#L78\K
M%!<VEK9P39+3[_6K>3Y?FYIKIL:.:YO?XY@M[Y_FV>P</;?D7G[UR4C[X=Q\
MGER1?2L3.VV5K[3#29BUK3%-Q7>6CKZ)B<LZ4Z=,F2;7I[X.G']EWYBT1[_D
M-S:VND:^[PS.*E?"9F=+QEF-=/JITC3XUJ[JPQO@
M                                                  !8$^F\[]N^
MKO/[CJ>ZR/P-9\C.M]JU":PE^'1:2[CH]C<=BZIDZYZJ>*X[RVQ>!S%A;T^_
MQ'+5E.:/=JDYB]V 7SCG86+NCR"_WKQ8^KDNW>2P;B+1KU1M]S:-IGII[)K-
M\NWRWG36L8(G6*Q?71WG_P )7DNQ_OG6NNXV&XI?7X?=Y)C%>-/H3-L=I^&.
MC7PC5?\ E!*#P
M
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MB5<5JVI::VB8M$Z3$^V)^A+^S^'^
M
M                                            ,N?U*O*>OS(\U>].
M\K2::34LKM4NL=;Q35V]7,/6VE1TZSI\_--K3Q!#-FL9CN,E/'37-Q'<WLE/
M$LO''$E74!Z;?*VOD[Y+<'V/EK$<MBVL9MY,:^.\W,^^W$?&\9C'>_N:S,5U
MICK/137IBQ_R][:CM/M#9<-:(^55Q=>7V_XW)\?)'CX_%F>B)\-8K'A'L<*M
MYLS          2]>B!XD5^6'GSUC1F<5-?=;]&30=Z]@R26=O=8F>C2,ICYM
M,UO)\7W'-A=0[/O,UA#/954RR76-CO.>(^8XY:XXB^MOS:KY4^0O)SL\L4[C
MYR)XS:1%IKDB=S2\;C-3I^-6<.VC+:N2)K%,TX=;1:U*VU9YQ=T1VQV1N9PV
MBO(;V)VV+QF+1[RL^\O&GC'1CZIBWA%;S3QUF(G2(<XR
M
M                                                       "J[]4
M_P#\ O%7_G!N?^Y<*TKYK;\_NZOQ/M_NF4E/39_ZYR?_ (3'_P!HI/KJ4O@
M      &J%Z>GY G@[^A_XT?B7TIRU>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1
MD=@-0L5          97OJ"=C_P +?G)Y;=A1R_&L-@\A.UOL.7FT^1EJUG%;
MCE<)JWS-K[U7,5YQKF-M>)_;S[:IN*N>?N\NI7T_]N?[I>1_:7;]HZ<^W[?V
M/O(ZNJ/?7V],F?2WPU]]>_3]"ND+*.QN/^]?9O%[&8TOCV&'J\=?CVQUM?2?
MH=<SI])Q^V\RH
M                       !U=X)]DWW4/FCXJ]D6'QJJM6[^ZJN[^WMX[.2
MXO\  W.Y8C';+BH/GX;BVAFR^O7EU:TR\T\5PU3<24545TTUTZJ\].V\'=WD
MQW5VYN---UP&^K29FT13+7;Y+X<D]$Q:8QY:TO-==+17IM$UF8G&>]./IRO:
M/)\??3ZYL<T1,ZZ1:,=II:=-)^+:(G3X=-)UCP:JCEA5I@
M
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M%$)JH
M
M                   !$MZVGE-_18]/?N/)8?*?9W8'<-G1T5U]S#<_+7T>
M0[#M[NRVS+V,T-Y:9&SO-?Z[@R]W:W5OQ77;Y&.VYYXIXJ]^F6/HI\K?ZTO4
M#P^VWF+WG </?[Y[O6.JLTVDUM@QVB:VI:N7=SM\=Z7TB^*<OMF-)V?Y/]M?
M[R]];3'EKU;':3\IR^&L:8IB:5GPF)BV6:5F)]M9M^PS9G2$L#
M 7Y?IP/%"+I;PRR7?N>LOA[OY0;)7GK22:WM*)K#J_29\CKVEV-$E',UWS]J
MY>O+92JJJ2.B6WO+7CX--47,DM"WSC7FM;O3SEQ]A;"^O"=L;;W5HB;:6WNY
MBF7<VTG2OQ,?N,$1$3,7QY9ZYBW36$GG]W//+]VUX3!;_,^-Q],^,^.;)I;)
M/T/BUZ*>R=)K;Q\=(L.J]6B
M
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M$:VF;3[9F9\5IN#!BVV"FVP1TX<=(K6-9G2M8TB-9UF=(CVS,S]%^0^M^H
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MS^NSRQ_"?_E]W_ ']PEZL?YJ7_73QL_[Q'Z^7I1_G5_[9S'\GG]=GEC^$_\
MR^[_ ( _N$O5C_-2_P"NGC9_WB/U\O2C_.K_ -LYC^3S^NSRQ_"?_E]W_ ']
MPEZL?YJ7_73QL_[Q'Z^7I1_G5_[9S'\GG]=GEC^$_P#R^[_@#^X2]6/\U+_K
MIXV?]XC]?+TH_P ZO_;.8_D\_KL\L?PG_P"7W?\  ']PEZL?YJ7_ %T\;/\
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M"?\ Y?=_P!_<)>K'^:E_UT\;/^\1^OEZ4?YU?^V<Q_)Y_79Y8_A/_P ON_X
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M*T3%JS$3$Q,:3$Q/A,3'A,3X3#_+5K>LUM$368TF)]DQ]"6OXY#U5P
M
M
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MNV(Y?M*O-X*_YYQN3JGPCQPY-*Y(^C\6W1?VSI%;>'CK%^90JA(
M
M
M      HJ_4Q^4W\)OE/U_P",VO93X^K>.FGU9;:;>VN?VF;M7LZ.QRU];WD5
MM>36MY][NBX_#4VU<T<=Q:7&0OXN..*:^>:[S/FT_*W_ '9\K>0\R^0Q=/*=
MQ;SW>"9CQC8[*;8ZS6;5BU??;F^XF\5F:7IBP6UF:Z5F=Z>>VOO=VUG[BSUT
MW._R]-)F/^IPZUB8UC6.O).3729BT5I/MCPK3K)TA          '0GB?X^;-
MY6>2/3'CQJ4=Y]J=J[YA=;NKZQMJ+N?7]9^+5D=UVZNVKKCXGL],TZQO\M<4
M^WV\V]E7[..>?9QSK[S6\P.,\J_+CF?,+EII\EXK89,U:VGIC+FTZ-MMXM$3
MI;<;BV+!2?\ #R5UTCQ>%W/SNW[9[?W?/;K3W6VP6O$3.G5?V8Z:_1R9)K2/
MIVAJM:;I^L]>ZAJN@Z5AK/7--T?6\'I^I:]CJ:Z,?@M9UK%VN%P.&L:)*Y)*
M+/%XJRB@BXJJJYXHHX]O///W7*_S/+\GW!R^ZY[FLU]QS&^W.7<9\M_&^7-F
MO;)ER6TTCJO>UK6TB/&95I;O=;C?;K+OMY><F[S9+7O:?;:]YFUK3].;3,S^
MR^D>:^<
M
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MV^I.UOO%QM=9Z9W=YT^#6,?A/]S6=/V97:%*:'X
M                               "D[]4]_Q^\5O^3VY?[Z1+J?FMOS![
MJ_'&W^YI2^]-G_H?)_\ B\?_ &:J^M*24        ; 3D,56@
M
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MSN[X3<Z^]VN>^/7_  HB?BWCPCPO72]?"-8F)T>Y,'>,
M
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M*
M
M            JN_5/_\  +Q5_P"<&Y_[EPK2OFMOS^[J_$^W^Z924]-G_KG)
M_P#A,?\ VBD^NI2^        :H7IZ?D">#OZ'_C1^)?2G+5Z@_T]]\?TOYG\
MH[E6OWW^>_,_C7=_=&1V U"Q4         !C^NO-:D        M0?2P_\?O*
MG_D]IO\ OI*JU^=)_,'M7\<;C[FA&OU)_P#H?&?^+R?]FNQ*5D00
M                                            %)WZI[_C]XK?\GMR
M_P!](EU/S6WY@]U?CC;_ '-*7WIL_P#0^3_\7C_[-5?6E)*        -@)R&
M*K0
M
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M+4O6+5M'TK5F)CZ4K*,.7'GQ5SX9BV*]8M68]DQ,:Q,?LP_-?2_0
M !=M^F'\J?OQZ-[;\1]DS5Y=9WIS9*NRNN;"]X]Z"WZS[ N*8]EP^%KB]M,5
MGKW8T<^0N:)>**^;C9N*HZI*??I@I1^<V\K/O/WQQ/FUQN&E=CS&V^1[N]?;
M.\VL:X<F2)]MLNTFN*DUUCHV6EHK/3-X?>HOMKY)S.U[HV](C#N\?NLLQ\.;
M%'Q+6^G;%I6-/@P^.GAK:55=(W
M
M                                       *]WU(GDI_ _X+V'3.'R7R
MFU^3>^8W5*X+?)?9^2XZZT.6RW7>;^UIB]MW>6<F7@P6)O8J?<BDM<S71+7S
M35\&:P3YN+RV_P![_/+)WEO,?7Q7;.POGB9IUT^5[J+;;;5MK\6MHQSN<^.T
MZVB^WB:1K'73>GI_[>^^O>=N6RUUVO'8)OK,:Q[W)KCQQ/P1/3.2]9]L3CB8
MC6-8H'+[TW@          &HCZ9OB[_0]\(NA.E+^P^0W*PT^UVSLR&KC]NC[
M,WG_ .%&YV$\G%U=T7'WO93)<XJ*6BJFB6WL8ZN**..?<XY@O4MYH?UO^=G/
M=Z[?)[SA\F\M@V<_!.SVWUC;VB.FLQ[VE/?VK,3-;Y;1,VTUFN+S#[D_WK[Q
MWW,4MU;2V6:8?_L./XF.?9&G5$=<Q\$VF-9]KO%HEA0
M
M                                                     "J[]4__
M , O%7_G!N?^Y<*TKYK;\_NZOQ/M_NF4E/39_P"N<G_X3'_VBD^NI2^
M   :H7IZ?D">#OZ'_C1^)?2G+5Z@_P!/??']+^9_*.Y5K]]_GOS/XUW?W1D=
M@-0L5          8_KKS6I        +4'TL/_'[RI_Y/:;_OI*JU^=)_,'M7
M\<;C[FA&OU)_^A\9_P"+R?\ 9KL2E9$$
M                        !2=^J>_X_>*W_)[<O]](EU/S6WY@]U?CC;_<
MTI?>FS_T/D__ !>/_LU5]:4DH        V G(8JM
M
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M]Z.R-]QV.O5O*8_?8?H^\Q?'BL>,1KDK%L?CX1UZ_!JTXG,RKL
M
M
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M8\>JL>SZJ-*9S;J^0
M
M                            %5WZI_\ X!>*O_.#<_\ <N%:5\UM^?W=
M7XGV_P!TRDIZ;/\ USD__"8_^T4GUU*7P       #5"]/3\@3P=_0_\ &C\2
M^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH         #']=>:U(
M       !:@^EA_X_>5/_ ">TW_?255K\Z3^8/:OXXW'W-"-?J3_]#XS_ ,7D
M_P"S78E*R((
M   "D[]4]_Q^\5O^3VY?[Z1+J?FMOS![J_'&W^YI2^]-G_H?)_\ B\?_ &:J
M^M*24        ; 3D,56@
M
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M=\GOL/T/=Y?CQ6/&9TQVFV/Q\9Z-?AU20HXL
M
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M9^3[##U7CZ.;/$6\8UTGIQ1CZ9F(F)O>(\)\;+ZM5'D
M
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M-D,SCNPMVS%I?7%%<=ME<-+QO&LX:WFQ_%?%=$5Y89"&N6GCF2FJCWH^=_\
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M/!W]#_QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_ #WYG\:[O[HR.P&H6*@
M    ,?UUYK4@       %J#Z6'_C]Y4_\GM-_WTE5:_.D_F#VK^.-Q]S0C7ZD
M_P#T/C/_ !>3_LUV)2LB"
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M.EJ9*VI>)]FDUM$3'C]&'U3RGS
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M5CV?&S?#KX73U+Z(H
M
M                           "L=]3KY*?>+XQ]4>,V%R7P<WWSODFV;=:
M6N2]V6KKKJ?Y+(0V&7Q4/[959YOL#,XFZM)9ZN(JIL%-Q'1)7'57!9G\V5Y;
M??WS-Y7S+WN/79<#L(P8+6IX?*]]U4FV.\^'5CVN//3)6L=45W-.J:UM$7D3
MZ=>WOEO<6Z[BS5UP[+!T4F8_ZW-K&M;?1KBK>MHCQTR1K,1.EJ-R\!,D
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M:ZZ==IM%8GP\*Q,5KX1$1$1$1'@]:8F\L
M
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M^,_\7D_[-=B4K(@@
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M%EK-<M9F)B8TF)CPF)B?&)B?"8GV/]C\7\
M
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MFMHGVQ,3I,3^Q+])\S\P
M
M                             &<?Z\?DC7Y#^HUVYC["^FNM2Z"AL/'_
M %F&2FWBXM[S1)[Z?L+WHK6JN.N;CM#,9J'B:2JN>2V@@XKYHXHIABZ+O0EY
M<5\O?3IQ.XSTBO+<_-^5S3&LZUW45C:>-M)T^18]O;IB(K%[7FNNLWM/KR5[
M?C@>P=KDO6(W6^F=S?V^,9-(Q>W_ .AKCG2/")F=-=9F8;4Q6V
M%@KZ<+QDH[I\Y;WN+.8^:YU+QBTFZW..XYM;B:QY[)W*NXU/0<==SQRP06LW
M&,JSF5MN:^9.:IL/QQ3%5Q[TD5?_ ,XSYF6[,\CZ=G[')%>6[GWM=O,=41;Y
M'M],^ZO6)B9M'7\FP7TTTKN)UM'A6VC//[N*>([-CB<-HC=<CFC'IK&ONL>E
M\LQ'MGQ]W2?9X7]OP3?X4&(0
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M:/1GV.VC-R=/'W^;3)DBW^%76.C'/T)QUK,1K&LZSK&.DRV(
M    DR\./5Q\WO"JXPN*Z^[6R6\=7XB&VL(^F.U[K);KUW;8BWKJKIQFLVMW
MD(LSH4-',M=5'&#O,?%S)5[TL<O'MIYC3YQ>DKR2\Z<>;==P<5CV/<^:9M/(
M[&M-MNYR3'U>:U:3CW4SI$3\IQY;:1I6U)\8UYW9Y7=G=WUOEWVVKAY*\S/R
MC#$8\LVGX;S$=.3_ .V5M.GLF%Q/P(]=OQ(\QOL31M_R=GXV]\96\M<39:#O
MV:IDU+;\E<_ @MJ-$[*FL,5K][>9+(7%%O:XK(_9V6N;F2F&U@N__6<T^>?/
MH6\VO)[W_.<!BOW)V)BI;);=;7'IGV](UF?E6SB]\M:TI$WOGP^^P4I$WRWQ
M?4HI=[>2_=':?7O-C6>0X6L3:<N*OQZ1&NOO,6MK1$1&LWIU4B(UM-?8F]0E
M:=                       57?JG_^ 7BK_P X-S_W+A6E?-;?G]W5^)]O
M]TRDIZ;/_7.3_P#"8_\ M%)]=2E\        U0O3T_($\'?T/_&C\2^E.6KU
M!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH         #']=>:U(
M !:@^EA_X_>5/_)[3?\ ?255K\Z3^8/:OXXW'W-"-?J3_P#0^,_\7D_[-=B4
MK(@@                                                    *3OU
M3W_'[Q6_Y/;E_OI$NI^:V_,'NK\<;?[FE+[TV?\ H?)_^+Q_]FJOK2DE
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MEIK:)BT3I,3[8GZ$O[/X?X
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MF:5#!J(
M
M               !SWY8]\XGQ?\ &GO#R!S'-G5#U3UOL^UXVSOZ+F2TS&S6
MN/E@T_79:;.N*X_^$VV7%ECZ>>)(N.*KGCFJ2.GCFNG8/E1V'N_,_P R>$[
MV?7U\KR6'!>U)K%L>&UXG<9HZHF/K.",F6?"WA3PK:=*S[O;'"9>X^X=GP>+
M77<[BE)F--:TF?CV\?#XE(M;V3[/9/L92>9S&3V'+Y7/YJ\FR.9SF2OLQELA
M<<\<W%_D\G=2WM_>3\T\4T\S75U/775SQQQQ[U7+JIV>SVW'[/%L-E2,>SP8
MZX\=(]E:4K%:UCZ5:Q$1]*%F.'%CP8JX,,17%2L5K$>R(B-(B/V(?FOI?H
M        T.?I\?&:[Z ]/C4]RV'%7F+W+R2V3*=U7\.1HBINX=.O[>TU[K*.
M#X5%/'.'S&G86'/6GO522<TYRJKFKCCGB*/GL^<"\R\7?WJ!W?#\?EIEX?MO
M;4XZLTUZ9W%9MEWLSK/^,Q[C);:Y-(B-=M$1$Z3:T$O/3N*O.=]9=I@M%MIQ
M^.-O&GL]Y$S;-K_RJY+3CM[(^M_W9G)0?::
M
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ML7R8[;[2FF_WT1O^=B(GWF2/K>.VGC[K'[/;[+WZKQI$UZ-9B8/4W6XP
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MZ3X(;=T]G=P=G;[Y#SN"<<S]1>/C8LD?1I?32?IQ.EJ_NJPZT:F8N
M              JN_5/_ / +Q5_YP;G_ +EPK2OFMOS^[J_$^W^Z924]-G_K
MG)_^$Q_]HI/KJ4O@       &J%Z>GY G@[^A_P"-'XE]*<M7J#_3WWQ_2_F?
MRCN5:_??Y[\S^-=W]T9'8#4+%0         &/ZZ\UJ0       "U!]+#_P ?
MO*G_ )/:;_OI*JU^=)_,'M7\<;C[FA&OU)_^A\9_XO)_V:[$I61!
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MSI%M(Z;^$ZX[Q6_A,Q$UTM/>#1+"@
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M0N
M
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MMKVFTZ1$:SX1$*R]SN<^\W.3=[FTWW.6]KWM/MM:TS:TSIX>,S,^#]Y\#\
M
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MN\WMU]UCQX?V/J_?^SX?;K])X]^M">??\4/A_P#@!W1_: 9?_9A^0GX7[O\
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M&W^YI2^]-G_H?)_^+Q_]FJOK2DE        &P$Y#%5H
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M                      ^PT#L'>NJMQP/876>X;)H.]:M><W^N[=J.9O\
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MN/VS.D=>.-)M%ZQ:];+ZM5'D
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M6T3$Q$ZQXQ"LG>[/<<?O,NPW=9INL&6V.]9]L7I::VB=?'PF)A]4\I\P
M
M
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MZ7F%'B&H
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M3\@3P=_0_P#&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH
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MB=)B?;$_0E_9_#_
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MGVQ]<C3Z$3GH.-,@
M
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MD4K ;SJ[@GGN_MUCI:9VNQB-M3V>$X]9R^S_ .FMDC6?&8B-=-(B)DT.6I@
M
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M0?Z>^^/Z7\S^4=RK7[[_ #WYG\:[O[HR.P&H6*@         ,?UUYK4@
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M%:UB(B(B$[,6+%M\5<&"M:8*5BM:UB(K6L1I%:Q&D1$1&D1'A$>$/S7TOT
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M3%HG28GVQ/T)?V?P_P
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M7-8JS.?CL\3/L\,6;3'?P]OU<89\/9$3,QIXQ?44/(3@
M
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M?F
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M^A_XT?B7TIRU>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M8_KKS6I        +4'TL/_'[RI_Y/:;_ +Z2JM?G2?S![5_'&X^YH1K]2?\
MZ'QG_B\G_9KL2E9$$    !22^IE\SLWN'=NE^$VJ9CX.B]0X?!]C]IV%K[T<
MN8[7W#&37NJXO+_$@]ZNSTWKG)VU]:?!EXBFFV.;X]%==M;U1W7_ #:7DULN
M'[)WOG7RN'JYWE\V79[&UO&,>QV]XKGOCTGZK<;NE\63JKU5KLZ=%HKER1:8
M/IX[2P[3A\W>&YIKO=U>V+#,_N<..=+S7Z>3+$UMK&L1BC28BUM:M2T1)$
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M%*Q6M:Q$5K6(TBM8C2(B(C2(CPB/"'YKZ7Z
M    +9?H%>KI7J%]J?@9Y*;#-/J^:R56+\=NT-CS5O'%IEY+9Q\8[IC8;O*W
M,%/WJY2ZM.8M9DIKKGL\C=4XSBBNTFLZ;"J#U[>DF.7P;OSW\M]O%>4PX^OE
MMEAQS,[BL6GKY'%6D3]?I6W5O8TBN3#2=S,URTS3GC%YW>5L;NF7O7M_'$;F
ME==UAI6?KD:^.XK%8GX\1.N:-(BU*SDUBT7Z[FZFM$H
M
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MY3Y@
M
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M$S&M;R2CY#8
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MK'P1$0GU@P8=K@IMMO6*;?'2*UK'A%:UC2L1'T(B(B'X[ZWZ@
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M)YJ^7F7L7G-=I%K=O;J9M@O.L]$_NL-IGQZJ>VLSKUTFLZS:+Q67M$5JP
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MQ^\5O^3VY?[Z1+J?FMOS![J_'&W^YI2^]-G_ *'R?_B\?_9JKZTI)0
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M9-+7I.D5KXX_"(KK815]M%@
M                                              /B>R^O]<[9ZX[
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MTW]*[BND:1U6UKEC7V3:<M;7M[)CKC6/'69L4*VH
M
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MVF9F9FSGB>-V_#\7M^)VD:;7;8*8J_\ -I6*Q,^WQG369F9F9\9F9>;LC>@
M         T5_0$\<[CH'TY>M\SF+2:TV?R#SV=[[R\%U95VMQ;X?:8,;@-!H
MBGFJYFN\;DNO=7QF5@J]V.+BK)R<QTU<<\S2\[OKY\Q<??WJ+Y+9;.\7XSM_
M!BXO'-;1:)R8)OEW4S$>%;TW>?-@M&LVTPUZIB8Z*P+\[^?KSG?VXPXIB=ML
M:5VU=)UB;4UME_8F,M[TGVS\2-?H1-6A<U"
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M<;C[FA&OU)_^A\9_XO)_V:[$I61!    <N^<.QY/3O"OR_V["U0T9G5?%WR
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MUDF/J8F?&<>*/B4]D3\:_36U[0C?2-9^
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M7HO'[,>$Q^YM%J_ ZT:F8N
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M
M
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M:=(B-9\(B%9.YW.?>;G)N]S:;[G+>U[VGVVM:9M:9T\/&9F?!^\^!^
M
M                "D+]2%Z@/\)_:^)\(.L<[\;0^F+RWV#NB_Q&5^+8;/VY
M=VO$F.TRZHLN:K2[L^K\1<<<W--4TG-.=O[BVF@AN,7355=K\W'Y _[L=J9?
M.WN;!T\]S-)Q<=3)32V'85MI?<5FWQJVWN2-*3%8UVN+'DI>^/=3$3$\@.QO
MO=QEN\>1IIO=W$UV\6KXTP1/CDC7QB<UH\/"/K=:VB9KD5=UGR1P
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M@3P=_0_\:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_P ]^9_&N[^Z,CL!J%BH
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M5^.-O]S2E]Z;/_0^3_\ %X_^S57UI22@       #8"<ABJT
M!4N^I0]0/[WM>PW@%UKD?_:^W6>&WSR$R-O7[M6-UF*^M,MU[U[%-#=<U<7F
MP7UC]LY2*6*/F*R@QW%%4L=[/3';%\VYY ??#D,WGYW)C_S3:7R;7B:3^[S3
M6V/=[N8FOU.*MOD^"T6GJR6W&L5MAI-I/^GWL;W^>_?'(5^M8IMCVL3\-])K
MER^SV5B?=TF)G6TY-=)I&M,Y<BEF            _M;V]Q>7$%I:0375U=31
M6]M;6\5<]Q<7$]=,4,$$,5-4DTTTE7%---/'-557/''''M?QDR8\..V7+:*X
MJQ,VM,Q$1$1K,S,^$1$>,S/A$/\ +6K2LVM,16(UF9]D1]&4J'0'HI^I#Y"T
M6>0PGCOGNN-:O(8+BG:.[KJVZJLH[>ZN+NWMYZ=?V3F+?+^&;Y*27BJTQ%Q3
M\#F*7GGB.XMZI8M=_>M+TX^7MK[?>]PX.2Y*EICW'&UG?6F:Q69CWN'7:UF.
MJ(TR;BD]757ZK'DBNM><\WO+_@IG'FW]-QN(F8Z-O$YIUB(F8ZJ?6X]L1\:\
M>.L>VMM)@>IOI7-WO+>QO>]?+?5=>NJ)HJLGK?4W6^7W&WN+?FBOX\5CNVX9
M[19+.:B3W?<KDU^>FJGV^VCCGV(A=V?.F<)AR9,/8W:6ZW&*8GHS;_>8]O,3
MK&DVVVWQ;F+1IKK$;JLQ.GC+57*>I79TM:G"\7ER5T\+Y\M<<Q/P:X\=<FO[
M$98_9=U:A],)X)8;[&NML[3\G-TO[+W:\O:??=UQKFLYN7CW^*J/L[&]6R['
MC;.KBKC]A%F.9N.:?_6^SGV-&<O\YQYZ[SWV+B>+[9V6"_\ B[?)]YFS8X^C
MUWWL8;V^G;;]/C]1\+#-WZC.],W77:[;CL-)^IGHRWO7^[.;HF?V<>GTGL'Z
MN-Z:'^S'</\ .SE?] 8A_:+^I7^-</\ :&/]\\K^OWS#_P IM/L%?VWQ.U?3
M.>G;L-Q:38C9/);18[>&N*:TU7LK3KRWOZZZ_?IN+NK=NL-QNJ)HZ?V-/$$L
M,?N_Y:>>?NO;XKYRSU#\?CO3=[;MK?6M,3%L^SW%9K&GLK\FWNWKI/MGJK:=
M?9,1X/LVWJ&[\P5F,N/CLTS/MOBR1,?2CW>;'']^)GZ;B?LGZ5C$5V'S'4'F
M#DK?)PPQT_8_9/5-K>V&1N*[R"F67[X]8V^PN,-#;X^J2JFC[*OZIIJ::>:X
MJ:N:Z-U=M_.F[RN?W?=_:&.VVF9^N;/?6K:D=,Z1[G-M[QDF;Z1,^_Q16LS.
MEIB(G+^/]2N6+]/*\56<<S]5BS3$Q&G^!>DQ;6=/'KKI'CI/LF*COWZ?+U'N
MDK3(YC7]#T_OW7L=^VRWO2>V<9?-\6DDM,<-=&D[;C].W+)WGMDIXEM\999&
MJ/GWJN.:HJ*I>)4=A?.!>G/O;+CV?(;_ 'G <AD\(KR6#W>/JB-9CY3@ON-O
M2OA/3?-DQ1/A&D7F*MF<)YZ=@<Q:N+/GR['/;X-Q3IKK_P#9*3DQQ'T)O:NO
MTIG1#;NFB[OUOL>1T_L33MJT+;<1-);Y;5MTU[+ZML>+N(I9()8,CA,Y9V.3
MLIHIX:Z*J98J:J:Z.>.>/;QRF-PO.\)W)QV/F.W=YM=_Q.:(G'GVV7'GPWB8
MB8FF3%:U+1,3$Q,6F-)B?A;8V>]V?(;>N[V&7%GVMXUK?':MZ3'MUBU9F)\/
MH2^5>H^D           !/!Z"GJ#W?B/Y0V/2^_;!>0= ^2N8PFH9:SN9HJL-
MIG:]]=VV'T+L'CF\DCAPEG=S77&)S=Q'7#%)8SP7-WS)3C+?X<$_7CZ?L7FU
MY87[SX';TMW]VUAR;C':L3[S<;&M9R;K:?%B9R6K%??[:DQ:T9:WQXNF=SDZ
MM+>=G8M>Z.W+<OL<<3SG'TM>LQ]5DPQ$VR8O#ZJ8TZ\<3K,6BU:Z>\MKH1.?
MA!8
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M^Q_L?B_@
M
M           !21^J+[[EV7R \??'''77MQ?576^8[+V".UNKNF.?:^U,S3B;
M&PR]G\U\E->:_K.@0W-I)\#B2&'.3<<25<2U4477_-?]AUXWL#N#S&W%/\ZY
M7DL>SQ3:M=8P;''[RUL=NGJBN7-NK4R1U:6MMJ3-8FD3,P?3APD;?@]]S^2/
MKFYW%<5=8CZC#7JF:SIKI:^68M&NDSCCP\-9JUK1$D0         %B+Z:OQZ
MH[1\Y=A[GR^'FO=>\;^L<OG<=DN8KBNQL.R.QJZ]'U2VO/=]VSYFNM/GV>YM
MJ9N:^:9K'B6.CWXN)(J\_G)?,&W:_D?M^S-IFBG(=Q\GCQ7IK$6ML]IIN<]J
M_NM*[B-E2\UTUKEFMIZ;=-M#^H/G9XWLW'Q&*\1GY#<UK,>&LXL7UR\Q\/A?
MW,3I\%M)G2=)OP*&$)0
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M_0_\:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_P ]^9_&N[^Z,CL!J%BH
M #']=>:U(       !:@^EA_X_>5/_)[3?]])56OSI/Y@]J_CC<?<T(U^I/\
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MG3G*;'NC=<'EF(KOMM%J^,>.3!-K16/#6?K=\MO"?96=8GVUHN+R4S0
M   &C'Z!?0%[T/Z;75=YE[.;'Y_O;/;+W_E;2>"^@KILMTIQ>"TF\I^=NYZ9
M8<QUKJ&$OHY((K6"J.YI]V.NKWKB?G8]>O?V'OOU(<KAVEXR;#@L&'BJ6B:S
M'5M^O+N:_%K&DX]YN-SCF+6O:)I.MJQICI CSNYRG->8.YIBF+8-E2FVK,3$
M^./6V2/"/W.6^2LQ,S.L>V/J:S/H9M2    *3OU3W_'[Q6_Y/;E_OI$NI^:V
M_,'NK\<;?[FE+[TV?^A\G_XO'_V:J^M*24        ; 3D,56@
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MR8/HH >;W9M>S^[<E=I2*</O(G-@B(TK6)GZYBC3PCW=_96/92U$O:(K5@
M
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MM-:@
M
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M+4G6=?"+!:OYHP
M                                   !1/\ J3_,>X[9\F];\4M5S4-S
MH/CEC;?*;=!C[FN:UR7<>Y8R"^OJ+ZNBGBSN9M+T^YM+.+BBJ2JSO+[(P2<T
MR_$CCO/^;=\G<?:?EGN?-7E<,UY_N/)--O-XB+4X_;WFM>G]U6-QN*Y,EM8B
M,F/'M[UB:]-K30]/O:=>+[=R=S;FDQON0M,4F8\8P8YF(T^&/>7BUI]G56N.
M8\-)FM:LD2"          =[> ?IU]_>H;V;-I74F-AP^G:S-B;CL[M?/PS<:
MCH&&R5]1;\55\T50U;!M5W:T3RX_#6\E%S>_+R555P6\<UQ%H;S\]1'8/I[[
M9KS7=N2<W,;F,D;+8XICW^ZR4K,^'M]U@K;IKEW%XFF/KK$1?):F.^$][]^\
M'V)QT;SE+3?=Y(M&'#7ZO+:(U_\ EI$Z1;),:5UCPFTQ6;_W@3Z9?C-Z?FFP
M8[JW6H=B[.R>-L;?>NZ]IL[>ZWG:;Z*SCAR%&,EDJNJ=+U6ZNN*Y(L/CY.(:
M:>:?F)+J:GF>J@KSX]2_F7Y_\S;<]T;F=OVSBR6G;<=@M-=M@K-IFDWB.GY3
MGK72+;C+'5,Z^[KBI/NX@]WMYB=Q=\[N<G)9)Q\=6TSCV])F,=(U\-?9[R\1
MX3>T:_X,5B>E(<CTP0         !'MYV^F9XO>H#JGR';NJ_8G8F+L[F'3NY
M=.BM,9V#K<]=O7%:V]Y?<P50[9K<,WNUUXO)<36_W*N8.;>:KXW$@O(OU+^9
M_D#RORCM+=>_[>RWB=QQ^XFU]IFB)UM-:ZZX,TQK$9\/3?V1>,E(Z)SKLOS#
M[C[&W/7Q>7KV%ICWF#)K.*_CXS$:_$O_ ,NFD_1ZH\&?YY^>G7W]Z>79L.E=
MMXV',:=LTV6N.L>U\!#-SJ._X;&WU=OS51S75-5K^U6EK7!+D,-<25W-E\Q'
M537/;R0W$M_'D'ZB.P?4)VS;FNTLDX>8VT8XWNQRS'O]KDO6)\?9[W!:W57%
MN*1%,G1:)BF2M\=)Q=D=^\'WWQT[SB[33=XXK&;#;ZO%:8U_^:DSK%<D1I;2
M?"+1-8X);Y9L          LF?3:^9EWU%Y/9SQ/VC)>YU_Y*6=S?ZK1=W44%
ME@NX-,PM]E+&6&JYEC@@^_;5+"ZQLE-/MFO,A;8R&CCGGV<<UO?.0>3>+N[R
MQP>:W&8]>?[;O6F?IK,VR\?N,E:6B=(F9^39[4S1,_%QXK[F\S$>*/WJ![2K
MRG;E.Y]M7_/N/F(OI&LVP9+1$^SQ^MWF+Q\%:SDF5[91:A<
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M9^IA*7T\=Y8\=LW96]M$6R6MFVVOPSTZYL?_ $:QDK'T(R?24[%P25H
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M)'I3L[HCL6T^<TWM+3\OJ68]RB.2YL/M"WY^S\YCOB\<QQYC7LK'!?V4G/\
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M=?*;#Z_BT]LUK_CJ1[9GJQ:S%8\;7I2&C4YU$!P
M
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MP<;W)CK&M;WVV2WAK/5$Y<,?1TCISS\,1U?!KXW&5/2*(
M
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M=<SNM??[K/?+,:ZZ==IM%8GP\*Q,5KX1$1$1$1'@]:8F\L
M
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M7K.D:Z*S^XN&W';W.[OA-SK[W:Y[X]?\*(GXMX\(\+UTO7PC6)B='N3!WC
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M1YH8^Z=Q_NWP&29X#!?7)DCPC<9:ZZ:3^ZPX_;7X+W^/I,5QV6.U<[00
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M=(KC\P^V_P#=3O'?</2O3M*Y9OA_^PY/CXX]LZ],3T3/PS69TCV.\6B6%
M
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M::UUZHTXG,RKL
M
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M(G2TQ:L36=4^=/.6X/R^WGNYB,^\FNVKK]#+K[R/[N&N33Z?C.L1I.CXYRT
MP
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MBY;NGELO,\SEG)O,D_L5I6/J:4KX]-*Z^$?LVM,VFUI]^8"\,
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MC>\^"Q<YQLZ4O\7)29UMBRQ$=>.WL\8UB8G2.JDUO$1%H<EML,G
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M^0)X._H?^-'XE]*<M7J#_3WWQ_2_F?RCN5:_??Y[\S^-=W]T9'8#4+%0
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M\P>ZOQQM_N:4OO39_P"A\G_XO'_V:J^M*24        ; 3D,56@
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M$WR6K76-=7D\[S?'=N<3GYKE;QCV6"DVGV:VGX*4B9B+7O.E:5UCJM,0TRO
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M1BK/Q9MMLL^'LGJRX?I^WWVL^,:S6/"9^-<34^(I
M
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MGQ]L^UTXUDQT
M
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M$S[8F*TM.GAK%XF8GXLK7*JE&8
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MWW;O/N2V+9WBW ;*9QX-/9>?#WF:?H]<Q$5^",=:Z1$S:;3)H<M3
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MEJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J          Q_77FM2
M     6H/I8?^/WE3_P GM-_WTE5:_.D_F#VK^.-Q]S0C7ZD__0^,_P#%Y/\
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MS?.3VMQ^2?O5L+Z9=/9DW,:Q;]F,.LXXUTTO[SPF.F5D%7(T
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M9J[:V6GAX]>'Z[7I^A-NCH^G%IB?"9:>CF05T
M
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M*0O]1/"1L>[-OS6.-,>^VVEITCQR8)BEO&(C7ZW;%'CK,:>W32(LFJWD?0
M
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M9GQF5G7"<9CX7AMIQ&+3W>UVV/%&GP^[I%=?[NFLS[9F=9\7DK+'I@
M   -//TH>B;?QV]/3Q:Z_P"<;#C,WD>L</V/M\?%O1#?5[=VI\3L+-0YB6FG
MB2[R6&DV.G&\UUU5^Y#91Q45?"CCXXYD?59WUD\P_4'W3S_O;9=ECY/)L]O.
MLS7W&QTVF.<<>RM,D89S:1$:VR6O:.NUE='F;S5N>[[Y+?=4VPUW-L5/'PZ,
M/UJO3]"+='7].;3,^,RD/1Z8(
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M^ZW:%]KM;]/+<CU8,>D^-::?7\D?#\6DQ2)B=:WR4M'LEHI.>! P
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M_CC<?<T(U^I/_P!#XS_Q>3_LUV)2LB"
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M$>*
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M.DS$4GV1,RO_ "@E!X
M
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M^R?8U8'*VK0
M                                 <!>J?VE+TWZ=GF!O-MD/LF^XZ3V
MK3L5DZ;Z[QMSC\WV=1!UE@[S'7]C51=VN8MLOM\-=E7153SQ=\1_LJ>/;SQO
MSTM]KU[Q]0_:'!Y,?O<'W[P;C)3IK>+X]E,[W+6];?%MCG'M[1DB8GZWU>$^
MQG'EKQL<MWYQ6RM7JI\LIDM&D3$UPZYK1,3X36:TGJ_Y.K+Z=.ZQH
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M_P X-S_W+A6E?-;?G]W5^)]O]TRDIZ;/_7.3_P#"8_\ M%)]=2E\
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M^A\9_P"+R?\ 9KL2E9$$
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M.\Q=UDK$UQ[K%BS1'3,1XTBEIB9GXVM\=IFT:1U3-=/BIJT+FH0
M
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MX
M
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M'M+;\-2TQFWVZB9CQTG%@CKM[)CV9+89B)BT>V?"8K*]XHJ0M
M
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M\5?^<&Y_[EPK2OFMOS^[J_$^W^Z924]-G_KG)_\ A,?_ &BD^NI2^
M =L>4OGCW7Y4=?>/'3FTW_WO].>,_3_6'5O7_7.&O+BO#766T#K_  FCY/LK
M9*JJ(/MG<-E^S):XJI*/A8FQG^4MN/;5=W%YI7RN\B>RO*SN#N'O#B\?RCO'
MN7F-[O=UN\E8]Y7'NMUDW--GA]ON]OAZZQ:(G7/EK[[)[,6/#B';?97#]M;[
M?\MMJ^\Y;D=WFS9<MHCJBN7+;)&*GMZ<=-8UT\;VCKM^YK3B=NIEX    #^U
MO<7%G<07=I/-:W5K-%<6US;RUP7%O<05TRPSP3154R0S0R4\54U4\\54U<<<
M\<^U_&3'CS8[8LM8MBM$Q:LQ$Q,3&DQ,3X3$QX3$^$P_RU:WK-;1$UF-)B?9
M,?0EH6^A5ZC>3\W/';(]==KYZ;,>1'CY#A,)N&8R4E/.1[#T;*4WMMIF_333
M7$EUE\]13B9;#/3^[55S>QPW4U7%>0HI<^7KF].FV\D_,/'W%VK@C#Y>=P3D
MR;?'2/B;3<TZ9W&UB(B*X\7URN7:U\(]W-\5(TV]I04\Y^P<?9W/5W_&4BG
M[Z;6QUCV8LD:3DQ>S2M?C1;''^#,UCPI*<]!QID !C^NO-:D        M0?2
MP_\ '[RI_P"3VF_[Z2JM?G2?S![5_'&X^YH1K]2?_H?&?^+R?]FNQ*5D00
M                                                  %)WZI[_C]X
MK?\ )[<O]](EU/S6WY@]U?CC;_<TI?>FS_T/D_\ Q>/_ +-5?6E)*
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MQ>GT$/O4GLO=\_QO(],_7=G?'K\$^ZR3;2/IQ[[6?^="TJJZ1N
M
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MH
M
M!G*^OEW=_#/ZE_<EG:WGSN"Z8P^G=(X&3W_>^%]ZF)YSFVV?N<<U4P_)=C;7
MFHO=XYY]ON>]S[*JN:>.BOT%]D_[F>FKA\V6G1ON9S;CDLL:>WW^3W6"WT^K
M:8-M;7Z>D:Q$3,^/)+A_O1Y>;2]HTS;N^3<6_P#GMTTG^[BICG_X(9TR&V@
M        %]_Z:7HJOKKP/SW<.0M8:,GY#]M;-G<5>Q2V]==QHW6]7\'&(MKB
MB*22:&:TW;#[)5Q3+\.KF.:FKBCW>::Y*&/G*.^:]Q>>V#M#;VF=MV]Q.'%>
MLQ,1&YWG^>9+1,Q$3%MMDV<:UUC6LQ,ZQ-:PE]0G-1O^]:<5CF?=[#:TK:/'
MPR9?KMIC]G';%[-?&)\?@BQ&KS:'
M                                                  5?/JEMDR=K
MXM^-NH150\8;.=_9#9+^BJ'BJXJR>J]=[)C,35%/[?>CAHM=RO>)*../9755
M1SS_ .3A9Y\UUQVVR^:/<G+WB?EF#@*X:SKX=&?=X;Y-8^&>K;X])^"(GZ*1
MOIMV^.W<G(;J=?>TV,4CZ&E\M)MX?LXZZ?W?HJ0"[=,4       !*5Z*G75O
MV=ZG_B5@[R&&2RP>[9[L6>6YP]&;M;:XZNT+;.Q,/-+;RR116<TF?UFTBMKS
MFKWK*\EBGHXKDHHHJB[ZTNXLG;/IB[LWV&9C-GV6+:1%<DX[6C>[K!M,D1,1
M,VB,6;):^/33)CK>EIBMIM&M_-[?VX[RYY3-29Z[X:XO"W3,QFR4Q6\?A^+>
MTS7]U6)B=(F9:7#FN5Z@                   ,U/UM^M+?JWU0/*O$6&-F
ML,5L^U:UV78358FC$VN4N.S="U7=]ER5A3###;9"'G<\WDH)KNCWZI[R";F6
MKF?XOLZ2_11W+D[H],7:N[W&2,FZVNUS;.\>\G):D;+=9]MAI;69FD_)\>&U
M<<Z17':D4B*="P?R?Y&W)>7/&9;VBV7'BOAGXW5-8PY+XZ1/PQ];K28K\%9C
M3XNB*E*ALL       !=_^EIV3)W7BWY):A+5#SAL'W]C]DL**8>*;BG)[5UW
MK>,RU4L_M]Z2&NUTVRXCHYX]E%5-?/'_ )^5)'SHO';;%YH]M\O2)^69^ MA
MM.OAT8-WFOCTCX)ZMQDUGX8F/H(=>I+;XZ]R<?NHU][?8S2?H:4RWFOA^SDM
MK_<^@M!JPT<@           %5WZI_P#X!>*O_.#<_P#<N%:5\UM^?W=7XGV_
MW3*2GIL_]<Y/_P )C_[12?74I?                )./1Y\F;OQ8]0?H#<I
MLK>8W3=\V2+I7LF&WKBHM+_3NTKBUUZ&3-?$KBYJP^K[C5B,]+[E7Q.*L115
M33)SQ\*N,WK \M,7FEZ?N?X>F*F3F-AMIY'9S.O53<;*+99C'I$_7,VW]_M:
MZQIIGF)FNO577?FMV[7N7L7?;2*Q;=X,?RC%K[8R88FWQ?\ E7Q]>./@^//L
M]L:93FE5X@ ,?UUYK4@       %J#Z6'_C]Y4_\ )[3?]])56OSI/Y@]J_CC
M<?<T(U^I/_T/C/\ Q>3_ +-=B4K(@@
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M]ZO\7EW%--/;[RN*VNNOAI[O333QZO;&GC<R4W(E@
M
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M$=&^XSGJ1_C,63;WGZ'N[>\Q_NO'7WF7V5\.GXUIUK$6T53J,
M
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M>WQ4PT\/@^+2/#X%GW&['#Q?';?C-O\ ]WV^"F*O_-QUBE?_ (1#X-[K[0
M       &KEX>=+?T=/%7QXZ-E@^!D>L.G]"U38/VSXOS&VV&NV/WX7_['*YR
M"+[2VF2\N/A07=Q;0_%^'!7S#30Y4_.#O3^L3S3[A[XK;JV_)\QNL^+PTTP7
MS6^3T^HQ3/1@C'3JMCI>W3U7B+S96;W7R_W_ .Y=_P S$ZX]SN\EZ_2I-I]W
M'U-9\*=,:S6)G368UU=(-<,?
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M)U^A'N\&2=?HZ1\+1_J"W&/#V![N^O5EWV&E?V8C)?Q^A\6EO[ND- 10,@Z
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M1%'U,8,5<_#;F(^O7INJS.L^-:3MYK&GL\)O;QB-9U\==(TMTJD46P
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MQ^\5O^3VY?[Z1+J?FMOS![J_'&W^YI2^]-G_ *'R?_B\?_9JKZTI)0
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MZDL&6W;G';F(^LTWMJS.L>%KXK36-/;XQ2WC$:1IXZ:QK=Z4E(=@
M
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M;$?%Q9,EIUZO"-(C728T6'.Z@4
M
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M,WZM)B8TB=8TU:@#F+5R@
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M+A6E?-;?G]W5^)]O]TRDIZ;/_7.3_P#"8_\ M%)]=2E\
M UK>BL=D,1TCTYB<M8WF+RN+ZJZ]QV3QF1MI[+(8[(66HXBVO+&^L[FB*YM+
MRTN8JHY8I*::XZZ>::N..>.>')KWSN-ON^]N8W>TO3+M<O*[N]+TM%J7I;/D
MFMJVB9BU;1,36T3,3$Q,3HK YK)3+S&[RXK1;%;<Y9B8G6)B;VF)B8\)B8\8
MF/:]58L\P!C^NO-:D        M0?2P_\?O*G_D]IO^^DJK7YTG\P>U?QQN/N
M:$:_4G_Z'QG_ (O)_P!FNQ*5D00
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MW-:=J;'9Z3U9.1B^OP1&/#EK,?W?>1I^Q*\PH\0U
M
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M$UM$S$Q,3$Z+-,>2F6E<N*T6Q6B)B8G6)B?&)B8\)B8\8F/:_P ;]G]
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MY,2^D>:^<
M
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M'R?@-CPE)TONMS;+;_F8:Z:3]*;Y:S'T9IX>R5WI24AV
M
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MC/\ Q>3_ +-=B4K(@@
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M3IG#/,7:6WW8G+[>LS%OD&:\:1K,SCI.3IB-8^JZ>GZ6NND^R=1AR_JX
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M\4VCWL[G+,1KXS$4K$S$>V8B;5B9^#6-?;"ZLI<1#
M
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M,Z:Z:3"5U%1K(
M
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MC2(^'6%@5 %HT
M                                   !7B^IHU?(9_T\-3RUG-9Q6^C^
M3G6^T9:BYDFHFN,?=Z-VMI<<..IBMYHY;RG*;?;254R50T<6]$M7%?-=-%%=
MA7S:/*;?C_4+N]IFB\Y-]VSO,&.:Q$Q%Z[G8[F9OK,3%>C;WB)B+3US6--)F
MU=[^GC<TP=^9<5XF;9N.RTKI\$QDPY/'Q]G328\-?&8\--9B@TOI3;
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M>*O_ #@W/_<N%:5\UM^?W=7XGV_W3*2GIL_]<Y/_ ,)C_P"T4GUU*7P
M          "Z3]-7X$9#1]3VWSK[+PGRN9[)P\V@]#661M9HKVPT./)?&WC>
M^+:\@]RC[\LIC+.QQ5U%S1-3C[*]YXJKM\A3[:8OG)?/G;\YRVT\C.VL_5LN
M-S1NN4M2T36^ZFFFVVNM9U_S>E\F7/2VM9RY,,3$9-O.D1O4'WM3>;K%V7QU
M]<.WO[W<S$^$Y-/K>/6)_P"KB;6O$^'5:GLM1:Y54HS  ,?UUYK4@
M%GSZ73<=5POD_P"06IYC8L/B]EW7I[#\:A@\A?V]IDMGEUS9N<IG;; VT\D<
MF5O,7BJ^;J:"'WYJ+6.2;W?AQ2545C_.@</RN]\L>W^6V>WS9>-V7,9/E&6E
M)M3#&;#T8IRVB)BE;WCHK:VE9O-::]5JQ,<_4?M-SF[<V.ZQ8[VV^'=VZ[1$
MS%.NFE9M,?4Q:?BQ,^&LQ'MF(F\,I$0Y
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MEL5=--/#3W>NNOCU>R-/&VBJ=1@
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MJ3XCHWW&<]2/\9BR;>\_0]W;WF/]UXZ^\R^ROAT_&M.M8BVBJ=1@
M
M                                                  9/?E7W+<>0
M_DOWUWE/)-7'VKVUOF[8V.?BNFNRP.<V/(7>N8JFF7CB6B'#X"NVM8Z:_P!G
M3'#3Q5SSS[>75KY5]FX_+WRUX'L>D1%N*XG:[:\QII;+BPTKFOX>$SDR]=YF
M/"9M.G@LW[9XFO ]O;+AJQ&NVVN/'/T[5I$7G_YK:VGZ<O 6?/;
M :N7AYTM_1T\5?'CHV6#X&1ZPZ?T+5-@_;/B_,;;8:[8_?A?_L<KG((OM+:9
M+RX^%!=W%M#\7X<%?,--#E3\X.]/ZQ/-/N'OBMNK;\GS&ZSXO#33!?-;Y/3Z
MC%,]&",=.JV.E[=/5>(O-E9O=?+_ '_[EW_,Q.N/<[O)>OTJ3:?=Q]36?"G3
M&LUB9TUF-=72#7#'P
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M^(TV]L\YL?C,_6\WURL:SXST=4TF9UG6L^,^V9%4=V!
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M_5]V#^ ^'^T]M_!GWBX/^)[3[#C_ 'I_2%[]_CP[@_G+W3]^C^K[L'\!\/\
M:>V_@S[Q<'_$]I]AQ_O3^D+W[_'AW!_.7NG[]']7W8/X#X?[3VW\&?>+@_XG
MM/L./]Z?TA>_?X\.X/YR]T_?H_J^[!_ ?#_:>V_@S[Q<'_$]I]AQ_O3^D+W[
M_'AW!_.7NG[]']7W8/X#X?[3VW\&?>+@_P")[3[#C_>G](7OW^/#N#^<O=/W
MZ/ZONP?P'P_VGMOX,^\7!_Q/:?8<?[T_I"]^_P >'<'\Y>Z?OT?U?=@_@/A_
MM/;?P9]XN#_B>T^PX_WI_2%[]_CP[@_G+W3]^C^K[L'\!\/]I[;^#/O%P?\
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MOI$NI^:V_,'NK\<;?[FE+[TV?^A\G_XO'_V:J^M*24        ; 3D,56@
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MA-NO-XQ\$S&6OL]L15/^@(T>
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M[?@M.*TQI.GA3+:9UUC2)\-=&B,YYD#@
M
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MUK^ZCP\-6'>8/+5X/LGD^2G2+4VEZUU]G7ECW6/7Z/Q[U\/A]C4D<O*MX
M
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M%XJ_\X-S_P!RX5I7S6WY_=U?B?;_ '3*2GIL_P#7.3_\)C_[12?74I?
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MK?\ )[<O]](EU/S6WY@]U?CC;_<TI?>FS_T/D_\ Q>/_ +-5?6E)*
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M54G23'IV[3MN.1W'>&ZI'N-O6<."9C_K;Q'O+U_YF.>CZ$QEM'MA2P70)=
M       -1?TR.G:^A?3_ /$OK.XMX;3)X[IG5]ES]G!';T466T]BQ3=C[78U
M5VF0REI>366R[;=127,,]45W)15-1Q13)Q13R_\ J9[PKWYY^]V=S8[3?;9.
M9SX<5IF9FV#:3&SP6TM2EJQ;#@I:*6K%L<3%)F9K-IKA\Q.6CF^^.4Y&LS..
MV[O2LSKXTQ?6J3XQ$QK2E9B)C6L>$ZZ:NZVC&%@
M
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MQ7MBRUFN6LS$Q,:3$QX3$Q/C$Q/A,3['^Q^+^
M
M                                 %=#ZF?MR\TGP1TSK+&7<T%QW7WE
MJ^*SMO3\]1;WVFZ+AL]N]]#+):7EM;5S1;GCM?ECANH[B&NFBNNFCB6*.6.Q
M+YM'M+#S?GKO.YMU2+8^%X//?%/Q=:[C<Y,6VK,1:LS$3M[[JLVI-+1,Q6;3
M2UJVWWZ>.+IO.],W(Y(B:[/97M6?#6,F2U<<>V)G_%SEB9B8GV1KI,Q-"Q?"
MFN          LC?3']+7&[>:?9/<MU;35X/H_IG)6]O>10UU46^[]H9>SU[
MP7-Q)BKNSBANM/Q.R5<4TW5I=UR14\Q\2P4W5/%</SF7>F/A?)?C>SL5HC?<
MWS-)FLS&L[;98[9<LQ$7K:9KN,FS\9IDQQ%IZNB\XIF/_J)Y>NS[1V_$UF/?
M;S=Q,Q]''AK-K3$=43X7MB^"U=)G729JO>**D+0
M
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M?KE,LSI[.J-8C6-:S:RU(8
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M)CH        "D[]4]_Q^\5O^3VY?[Z1+J?FMOS![J_'&W^YI2^]-G_H?)_\
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M96+3QF2?>;>TQ/CBM/A76==;8Y^MVGVS,1;2(M$)&T=& @
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M_@
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M9%<T1FK$?\VN2(_N>/BD#: 8,
M
M                     H__ %2';/&P^3GCKTO;W\-W:]7],YK>+NWMY<9-
MQB\]VUMTN.O;&\^6HYREKDI,'U=C+FJ"YK]SBUN+>6&BGB:NN2[CYKWM.>/\
ML^XN\\F.:9>4YG'MJS,7CKQ;#;Q>MJZST6I&7>YJ1:D:]=,E;VGHK%9B^F_B
M_<=N[_E[5F+;G=UQQ,Z^-<%-8F-?"8ZLUXUCX8M$SX1$5?5G:1H
M"\[]+[T_%JOB+W9W-=67RV7[>[LIURUN/?M)/M#3NJ=7Q\>&N?>M[B6X@^%M
M>[[!!\&>B*2GX7Q*>.8Y:*JJ.?G.^[[<KYM\+V;BOU;3B.$]]:/C1T;C?9[S
MDCQB(G7!MMK;JK-HGJZ9F+5F(AIZC>5G<]T[/B:SKBVNSZYCQ\,F:\]4>,:?
M48\4ZQK'CI[8F%F56DCP
M                                             IV?5)^-U%MD_''R
MWP]C#'3DX<KX_P"_7O%5Q17+>V7&5W_K'V0TTU64TTUE5M%$TU7,<_P[:WH]
MLM%-/$%P?S7?F/;)MNX_*7>7F9Q33E=K7PF(K;HVN]\?JHB+?(IK6-:ZWR6^
M+:9ZY6^F[N";8^0[7RVGXLUW.*/#V3TXLWT_;[G2/&-9M/A,_&J(+<$I0
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M]2//37#Q_;.*WA>;;G)'A[*ZX\7_ "M)F<WMB*S,1IU3'Q;C*GI%
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M\)K2;^.DS$YO#HY3_
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M7$D]AL&#M+FZLK>K:M,R$W-W9\U2Q_&AKN;7FNBFZJKIC3ZJ/3]L/4)Y:9>
MQ>[Q=X[&;;CC,]YFM:9](BV++:*VGW&XI'N\FE9Z;1CRZ3.*(G7GF7V+@[[[
M=ML:]->6PS-]O>9TB+Z:36TQ$ST9(^+;PG2>FVDS6(:5FG;CJG86J:[O.C;%
MA]MTW;</8;!K&SZ_?V^4PF=PF4MX[O'Y3%Y"TDEM[NSN[>6FNBNBKGCGCES:
M<QP_*]O\KN.#YS;YMIS&TS6Q9L.6LTR8LE)FMZ7I:(FMJS$Q,3"OC=[3<[#<
MY-EO<=\6[Q7FMZ6B8M6T3I,3$^,3$OI'FOG               4:/J#?4]H[
MZWVX\*ND\_-7U!U%M5S7W%G\7=W$-GV3VMK\]=A3JM<==A:3W6J]79.*YXY]
MD\]CD\S5Q<\1U?9UC<U7A_-^^F.W8? U\Z>]=O$=W\OM8CC\5ZQ-MGL<L1;W
M^O5:*Y][2:?N:Y<.WB<<VCY1GQQ,KR+\N9X38QW?S%(^^NZQ1[BMHC7%AMX]
M?MG2^:-/@BU,?Q=?KEZJRBS!(@        !8Z^F;\?;CL7S5W7O>[MH:\!XY
M=8Y"JUNJN*Z[BWWWMV/):9KT47'PO@QPW&DVFT<UR<R<2<51T4TT54UUU1US
M_.6>8&/MWR6V78N&TQO^X^3IU5\-)VNPFFXRS/CK,QN;;+2---)F9F)BL6T%
MZA^<KL.T,/"UF??\AN8UCX)QX-,EO[V2<.D::>,SK&D:WR%$B%0
M
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MAIZC>*G;=T[/EJQIBW6SZ)GQ\<F&\]4^,Z?49,4:1I'AK[9F5F56DCP
M
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MN5WU9B:?*[8ZS$Q,37!$8*VB8\)BU<<3$_#KJD)1]8*
M
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MMO)ORBR;"V'O#NBDUWT:7VV"?"<?T,N6/\/X:8Y^H^JM'7I%*G2UQ)P
M    !I_^EMXPW'B'X*= =-YBRFL=SAU6K=NQ8;N.N&^@WWL*]N-PV'%7T<MK
M8R43:Q)EJ,1137%3)3#CZ*:^:Z^*JZN8OU0^9V/S<\].?[QV=XOPT[KY-M)K
M,36=KM*QM\5ZS%K1,9HQSN)F+3$VRVF-(TK%<WF1W'7NGO3?<MBF)VDY?=XM
M/9[O%$8ZS'C/U?3U^W36TZ:1X) V@&#             *KOU3_\ P"\5?^<&
MY_[EPK2OFMOS^[J_$^W^Z924]-G_ *YR?_A,?_:*3ZZE+X          !.IZ
M/7H];7YY;79]Q]QV>8U+Q(U+,51W]_'5<8O-]U9O%W'NWFDZ3>4_"N+36[2X
MBYASF<AYXY@YXJLK*KYWXTV/@SZO_5_Q7D1Q5^S^S[X=WYM;O#K6LZ7Q\=CO
M'Q=SN:^,6S6B>K;;:WU7AFS1[GHIN-,>:WFMMNRMM/$\3-,O=&6GA'A-=O68
M\,F2/9-YCQQXY]OA>\=&D7T"M.T[5.O=4UW1M&UW#ZEINI8>PU_6-8U^PM\7
MA,%A,7;QVF/Q>+Q]I'%;VEG:6\5-%%%%/''''"@3F.8Y7N#E=QSG.;C-N^8W
M>:V7-FRVF^3+DO,VO>][3,VM:9F9F90<W>[W._W.3>[W)?+N\MYM>]IF;6M,
MZS,S/C,S+Z1YKYP      &;7ZS/@-<>"7EQGK+5\3-:=$]U39SLGI:Y@QU=I
MA<-8W65YDVCJZPFXYDMY)NL<ADH+>./BNN:G#W>.EF_9S_=Z/_1MY]8_/3RD
MP9N4RQ?OKA8Q;/D:S>+9,EJTTP;VT>$Q&]I2UYG2*SN,>XI3XN-8%Y2][U[T
M[6I?<VB>:V<5Q;B)G6UIBOQ,T_#]>B)F9]G77)$>%42*6C:
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M_-;?F#W5^.-O]S2E]Z;/_0^3_P#%X_\ LU5]:4DH        V G(8JM
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M9\?'R>O_ #ZSKFGV1XQEFU/AUBD3\.D38H5M0
M
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M,0
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M-LMIF9F9UF9GQF9F?&9F?&9GVO\ 8_%_
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MI>-+5M-9B4+^1XW?\3O+\?R>')@WN.=+4O6:VC^Y/MB?@F-8F/&)F'WCP7Q
M         /XW%Q;V=O/=W<\-K:VL,MQ<W-Q+1!;V]O!15+-//-+53'###'3S
M5555SQ333QSSSS[']X\>3-DKBQ5FV6TQ%:Q$S,S,Z1$1'C,S/A$1XS+_ &M;
M7M%:Q,VF=(B/;,_0A4N]6?Z@+&:_;[%XZ> >U8W/9R[ARF ["\EL1)S>X? 0
MR4?*38[HG+6=Y1:YC/5U<R4U[1Q3-86L7LKQ7-Q/)%?V=L7I/] >YY#)M_,3
MS[VN3!L:6IEVG#9(Z<F68GJB_)X[5ZL>+V3&RUKEO;PW7NZ5O@S2?\L/([)G
MMCY_O?%:F&)BV+:6\+6^'7<UF-:U]GUGPM,^&3IB)I>FU<7%Q>7$]W=SS75U
M=32W%S<W$M<]Q<7$]=4LT\\TM54DTTTE7-5557/-557/////M7%X\>/#CKBQ
M5BN*L1%:Q$1$1$:1$1'A$1'A$1X1"6-:UI6*UB(K$:1$>R(^A#^+^W^@
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M9F9GQF9GQF9]K_8_%_
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M_P DMDK$:S,VPZ9JQ$5\9F;8XB(^&=(F)C6&H YBU<H
M
M                                     "-+UB.U(^G_ $T/+[9*I/=F
MV#JN[ZKM8:8K2>:YD[GRV+ZGGC@M[R[LZ9/@6&Y33RU455306\4DU$<E4?%%
M4E/1_P!K6[O]2O:'&Q'Q-ORM=]:=;1$1QV.^^B9FM;::VV]:UB8BMKVK2UJQ
M;JC87E3QD\KYA\5MX]F/<QFGVQI\GK.;VQ$_#CB(^"9F(F8UU9E3I?6(
M      )C/05ZKD[0]3SH2>2/XF(ZRL]^[4S?%,MW#-1'K>E9G':])!);6ES%
M^PWC.XKF6F>J"&2W^)1\3XE5$<D/?7CW37MCTR<]2LZ;OD[[78X_"LQKFW..
M^6)BUHG_ +MBS],UBUHOTST],6M75'G9R4<;Y<[ZL?XW<3BPU]G[O)6;>V8_
MZNM]--9B=)TTUF-'9SG("
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ML8          !H0_3^>$G]%[PXLNV]OQ'R7;?E']D]AY;YJ#X>0PG6<%M/\
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M]G?79;'X^72?"VXO7PCZ$^ZQSI$QXQ;)DK:-:K.*LQ'8
M
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M^"9CZ#TYC+S@
M
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MIK1*
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M )7<]3MSOKC^0SVZ=I;+[K)/LB*9HG'U6UT^+2;5R3_S?A]DYCSIE6)@
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ML[?#&L6K/LFMZSI:EHT]EHC6/&-8F)GP=G;V@
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MJ_'&W^YI2^]-G_H?)_\ B\?_ &:J^M*24        ; 3D,56@
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M<
M                             !GQ_4<=1T=;^I#G-OM;2&WLN\NI>M^S
M/B6OS'-O7D\9;9+JO)T2TUV=M:V^2JJZXCN9XH:Y^*J;J.>2OB2>JBGH$^;H
M[MMW'Z<<'$9;S;-P?+;S9Z6TUZ+S3?4F-+6M-/\ /)I6UHKI-+4K'3CB9G/Y
M!<I/(=@4VMIF;[+=9</CIKI,QFCX9F8^NS$3.GLFL1I6)0,IWMU@
M -(WT+.U).U?3#\<)[V3XF7T"SW'JO*<4Q7=$,<>C;KGL=K,<$E[=WDMQ[-'
MDQ?,M5-5,/%QS)1''''33'3SA^N7M:O:OJ;[CIAC3:;^^WWU/&LS,[G;8KYI
MF*UK$?YS&?IB8FW1TS:UK3-IK_\ .?C8XSS&Y"M/\5GG'FCV?]9CK-_9$:?7
M.O3X=-)F9F=4NJ)#5H
M
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M6)G6-(G_ $!&CP
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MF9F90<W>[W._W.3>[W)?+N\MYM>]IF;6M,ZS,S/C,S+Z1YKYP
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M6?"8B?!O[8<AL.4VM=]QN;%GV=XUK?':+UG]B:S,?LQ[8^%\2]I]@
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M@]U?CC;_ '-*7WIL_P#0^3_\7C_[-5?6E)*        -@)R&*K0
M    '*/FUXEZ%YM^-?8_CSO\4,%OMF-HO-4V3Y:"?(:/ON%K^?U';\3++#+/
M;38W)T<17=,/,<EYB[BZLZJ^(KF7CG:WDIYL<]Y)^9/&^87 3-LFTR=.?#U3
M%-SM<GQ=QM\D1,1:+TGJQS;6,>:N+-$=>.LQDW9_=&][/[AV_/;&9FV*VEZ:
MSIDQV\+TM]'6/&NNL5O%;Z:UAE_]X=,=@^._;?8'2/:F&^P>P.M-DOM8V7'4
MR\7-MQ=VG--<%]CKNFFBB_P^7L9HKNRN*>.*;BTGCEIX]E?#IT[([S[?\P^T
MN/[V[6S>_P" Y+;5S8;Z:6Z;>$UO7]SDQVBV/)2?&F2MJSXPL:X;E]CSW%X.
M8XV_7L=QCB])]DZ3[8F/@M6=:VCX+1,? \K92](
M           !HH^A[Z=?]"#QCM-S[&P'V=Y']]V>-VOL:'(V?PLOH6L_MMSI
MG5_MN[*TR6.O,5C;FB\SEM733S1G+B6WJYEHL[>3GG@];OJ'_KM\S;\-VYN/
M>>7/ WO@V<TMKCW6;PC<;WXMK4O6]XG'MKQ,Z[:E,D12V;)5 SSC[]_WQ[BG
M:<??JX#8S-,6D_%R7]F3-X3,3$S'3CGX<<1;PF]H38H5M0
M
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MZ-
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M<E/+]Z<IR'[B^]RQ7VQ\2EII36)F?'HK77X-?9$1I$=FM-L2
M
M                 5'/J)/2_N,[;Y?U".C\)-/D\3C<79^36I8N*NXEOL1C
M:+?#8;N;'65'%=QS-@\?3;8_8J(>.8J,=;V^1JCBIM\G=26U_-Y>IW'L<F'T
M^][YXKMLN2]N&SWF(BN2^N3)QU[3I&F6_7EVDV^-.:^3;1:TY-MBK*/R&\QJ
MX;4[%YF\1CM:T[2\^&EIUM;;S/L^-.ML6OCUS;'K/5CK%.!<0E>
M                       N/_3M^E_<8*WQ'J$=X82:#)Y;&Y2S\9=2RD5=
MO+8XC)47&&S/<V1LJ^*+CB;.8^JYQ^NT3<<15XZXN,C3'+3<8RZCIW^<-]3N
M/?9,WI][(SQ;;8LE+<SGI,3%LE-,F/CJ6C6-,5^C+NYK\:,U,>VFU9Q[G%:*
M'GSYC5S6OV+PUXG'6U9W=X\=;1I:NWB?9\6=+9=/'KBN/6.G)6;<:I1%P
M             !S'Y?\ B5U'YL]$[9T#W-C[RXUC8O@9#%9G$7'%GL.F[9C*
M)_L#<=;NZZ)88LQA9KBOV431RVUS!)+;W$<D$TD=6S?*'S9[M\E.^MIW]V;D
MI7D]OK2^/)'5BW&"^GO=OFKX3./)$1XUFMZ6BN3':MZ5M&1=J]T<IV?S6+G.
M)M$;C'K%JVC6N2DZ=6.\?X-M/@F)B8BU9BT1+./\]O3G\B?3X[)GU+MS7ILG
MH69R5]%UEW)@[:J31NQ<5!7)7!7!-'/>5:UM45K1[U]@KZ2B^M*J>:X_F+.J
MWO)^BWR']1/EYZ@>VZ\MVEN(Q<]AQUG>\?EMIN=I>=(F)B8K[[!-ITQ[G%$X
MKQ,5M[O-&3#CGUV3W]P/?7'QNN+R17>TK'OL%I^N8K3[=?".NFOU.2L=-O9/
M3>+4KP2WRS8   !/QZ2OHG=B^9^;U7O+O[$YC0/$NUO*LA%1/7=83<>[OD*K
M.:##:?'53!?8S0\G7/51>;%'S3\2.*6WQ]7-QS7<V<"/5EZU>W?)G9;KL?L'
M+AY#S8M3HG3IR;?C>KJB<FXGQK?=4TUQ[2==)M7)N(C'$8LVD/-#S?V':.'+
MPW!VIG[HF-/@MCV^NNMLGP3DC]SBGV3,6R?%TK>_-IVG:IU[JFNZ-HVNX?4M
M-U+#V&OZQK&OV%OB\)@L)B[>.TQ^+Q>/M(XK>TL[2WBIHHHHIXXXXX4*\QS'
M*]P<KN.<YS<9MWS&[S6RYLV6TWR9<EYFU[WO:9FUK3,S,S*$F[W>YW^YR;W>
MY+Y=WEO-KWM,S:UIG69F9\9F9?2/-?.                 \E[@Z$Z2\@=<
MYU+O#J;KWMC7N(;Z&VQN_:EA-GHQG.2BBAN[K"3Y6SN;K Y*NF".JF[LI(+J
M*2*.NB2FN.BJG+.T._.]>P.1^^W9'+<AQ/(:UF;[7/DPS?HF9K7)%+17+3QF
M)IDBU+1:U;5FMIB?4XKF^8X/<?*N&W6?:Y]8UG%>U-=/9%HK,1:/&?BVB8F)
MF)C290G=Y?3:> '9MQ?97K.[[:\?<K<3?'M\?I>W1;;I4=<U>,XNJ;C =BV.
MS9^J'X5I<501VN:LHX+B\JYYIK@BAMJ)J]C_ #D'G[VSCIM>Y:<3W!M:QI-]
MS@G!N9B(OTZ9=I;#BUUM2+3?;Y)M7'$:UO:^2VW^&]0/?''5C%R,;7?8HC29
MR4Z,GPZ:6Q32OPQK-L=IF*Q[+3-IC3WOZ5CL>SN*ZNLO,'2=AM:X;V6.'>^J
M<[IUQ;W'%=?./L:[G7]OWJ.]AJC]WB:[XB@JIJ]O--OSQ[.$D^"^=-[<S8XC
MN;M#>[?+$UB9VN^Q;B)C3X]HKEV^VFLZZ]-.JT3'A.2/:V%LO4KQ]Z__ %1X
MK-CMK'^+S5R1,?#.EJ8]/I5UG_G.=/U7OS[_ (WO#_\ #_NC^S^V)_:>>0GX
M([O^U>._E5[WZQW9'\5Y7[%M_P#63]5[\^_XWO#_ /#_ +H_L_G]IYY"?@CN
M_P"U>._E4_6.[(_BO*_8MO\ ZR?JO?GW_&]X?_A_W1_9_/[3SR$_!'=_VKQW
M\JGZQW9'\5Y7[%M_]9/U7OS[_C>\/_P_[H_L_G]IYY"?@CN_[5X[^53]8[LC
M^*\K]BV_^LGZKWY]_P ;WA_^'_=']G\_M//(3\$=W_:O'?RJ?K'=D?Q7E?L6
MW_UD_5>_/O\ C>\/_P /^Z/[/Y_:>>0GX([O^U>._E4_6.[(_BO*_8MO_K)^
MJ]^??\;WA_\ A_W1_9_/[3SR$_!'=_VKQW\JGZQW9'\5Y7[%M_\ 63]5[\^_
MXWO#_P##_NC^S^?VGGD)^".[_M7COY5/UCNR/XKROV+;_P"LGZKWY]_QO>'_
M .'_ '1_9_/[3SR$_!'=_P!J\=_*I^L=V1_%>5^Q;?\ UD_5>_/O^-[P_P#P
M_P"Z/[/Y_:>>0GX([O\ M7COY5/UCNR/XKROV+;_ .LGZKWY]_QO>'_X?]T?
MV?S^T\\A/P1W?]J\=_*I^L=V1_%>5^Q;?_63]5[\^_XWO#_\/^Z/[/Y_:>>0
MGX([O^U>._E4_6.[(_BO*_8MO_K)^J]^??\ &]X?_A_W1_9_/[3SR$_!'=_V
MKQW\JGZQW9'\5Y7[%M_]9/U7OS[_ (WO#_\ #_NC^S^?VGGD)^".[_M7COY5
M/UCNR/XKROV+;_ZR?JO?GW_&]X?_ (?]T?V?S^T\\A/P1W?]J\=_*I^L=V1_
M%>5^Q;?_ %D_5>_/O^-[P_\ P_[H_L_G]IYY"?@CN_[5X[^53]8[LC^*\K]B
MV_\ K)^J]^??\;WA_P#A_P!T?V?S^T\\A/P1W?\ :O'?RJ?K'=D?Q7E?L6W_
M -9/U7OS[_C>\/\ \/\ NC^S^?VGGD)^".[_ +5X[^53]8[LC^*\K]BV_P#K
M)^J]^??\;WA_^'_=']G\_M//(3\$=W_:O'?RJ?K'=D?Q7E?L6W_UD_5>_/O^
M-[P__#_NC^S^?VGGD)^".[_M7COY5/UCNR/XKROV+;_ZR?JO?GW_ !O>'_X?
M]T?V?S^T\\A/P1W?]J\=_*I^L=V1_%>5^Q;?_63]5[\^_P"-[P__  _[H_L_
MG]IYY"?@CN_[5X[^53]8[LC^*\K]BV_^LGZKWY]_QO>'_P"'_=']G\_M//(3
M\$=W_:O'?RJ?K'=D?Q7E?L6W_P!9/U7OS[_C>\/_ ,/^Z/[/Y_:>>0GX([O^
MU>._E4_6.[(_BO*_8MO_ *R?JO?GW_&]X?\ X?\ =']G\_M//(3\$=W_ &KQ
MW\JGZQW9'\5Y7[%M_P#63]5[\^_XWO#_ /#_ +H_L_G]IYY"?@CN_P"U>._E
M4_6.[(_BO*_8MO\ ZR?JO?GW_&]X?_A_W1_9_/[3SR$_!'=_VKQW\JGZQW9'
M\5Y7[%M_]9/U7OS[_C>\/_P_[H_L_G]IYY"?@CN_[5X[^53]8[LC^*\K]BV_
M^LGZKWY]_P ;WA_^'_=']G\_M//(3\$=W_:O'?RJ?K'=D?Q7E?L6W_UD_5>_
M/O\ C>\/_P /^Z/[/Y_:>>0GX([O^U>._E4_6.[(_BO*_8MO_K)^J]^??\;W
MA_\ A_W1_9_/[3SR$_!'=_VKQW\JGZQW9'\5Y7[%M_\ 63]5[\^_XWO#_P##
M_NC^S^?VGGD)^".[_M7COY5/UCNR/XKROV+;_P"LGZKWY]_QO>'_ .'_ '1_
M9_/[3SR$_!'=_P!J\=_*I^L=V1_%>5^Q;?\ UD_5>_/O^-[P_P#P_P"Z/[/Y
M_:>>0GX([O\ M7COY5/UCNR/XKROV+;_ .LGZKWY]_QO>'_X?]T?V?S^T\\A
M/P1W?]J\=_*I^L=V1_%>5^Q;?_63]5[\^_XWO#_\/^Z/[/Y_:>>0GX([O^U>
M._E4_6.[(_BO*_8MO_K)^J]^??\ &]X?_A_W1_9_/[3SR$_!'=_VKQW\JGZQ
MW9'\5Y7[%M_]91[^<OI'>8O@%B<5MO;>NZWNO6V2]V&X[3Z>O=DVW0]=R4ES
M8V=OB=OOLSJFJY?4[R_N\C#%9UW]E!:W\U7,=M--)1713(+R.]6OD]Y^;O+Q
M/:6XW.R[DQ>,;'D*X<&ZS4B+6G)MZX\^?'GK2M+6R1BR6OBK$6R4I6:S.=]F
M^:/:G?&6VUXO)DP\A7V8<\4IDM&DS-J16]ZWB(B9M%;3-8\;1$3$HQTF6Q
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M6:)F)TG6N/76/CUF+QBD%#<
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MN^R<6_B/KNUWM)U\?J,E;X[1X>'C:<<ZS'P:1,:^-]I0VA,
M
M                                        _P >1R./Q&/OLMEKZSQ>
M*Q=G<Y')Y/(W,%EC\=C[*"NYO+Z^O+FN*VM+.TMHJI)99*J:(Z*>:JN>...>
M7[;?;[C=[BFTVE+Y=UEO6E*4K-KWO:8BM:UB)FUK3,16L1,S,Q$1J_O'COEO
M7%BK-LMIB(B(UF9GPB(B/&9F?"(CVLE'N3L*[[;[>[5[6R%5Y7?]F]D;SV%>
MUY&2*;(57>Z;/E-CN:KZ6&FF&6\JFR57,M5''%-5?MYXX]CK*[.[?Q=I=H\5
MVKM^B,'&<;MMI7HB8IT[?#3#'3$^,5TI\6)\8C35:!Q.QKQ?%;;C*:=&WV^/
M%&GLTQTBD:?2\/!YNR-]X        #UKH+K.ONGO;I7IR*N:*3MGMKKCK..2
MWN;>RN(Z]\W'#:M17!>7=M>6MI-15E?;3++#+''5[*JJ*N..:><3[][EKV7V
M+S7>-HB:\3Q.\WDQ-9M$QM=ODSZ36LUM:/B>-:VK,QX1,3XO,YOD8XCA=YRT
MZ:;7:Y<WC$S'UO':_C$3$S]3[(F)GZ,-:AR<*P
M
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M6/?T]GO:1&GC'A&6L1I69K:)TOI6#%.-N4
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MS+1UK6O:;6F9M,ZS,^V9^C+^S^'^
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MGJW%(UGIF9]N7%&D>WJR4^-I-J7M:LHLP2(
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M_?;[=\GO<O([^\Y-[GR6O>\Z:VM:=;3X:1&LS[(B(CV1$0^P>.^0
M
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M\,Z1,3&L-0!S%JY0
M
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M&_Z9^N9_=8J^&OU>6G5^Q];B^D_1T:03G)0!
M
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M\;W]QO57IP\YAK'O\&OL^#WF/7QMBM/[,TF>B_[FUXM4HFR
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M(@)R?);WF.0S<IR62V7?9[S>]K3,S,S^S[(B-(K'LK6(K&D1#T)C[X
M
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M>DVI/LUBT6K'"K>;,P                      &P$Y#%5H
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MNLL^$?N:4B9Z<=(]E:5B=(B/;.MIUM:9GH1KYX0
M
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MFL^$^,>,>R7V#QWR
M
M        ('OJ.>Q_O']-#:-9^+\/^&/N#J;KCW/E/F?C_9>5O^W?A?&][CY#
MV?P5^_\ &^[[WN?"]G[9[>)V?-T=N??OU*[7D]-?O/P^_P!Y]5IIUXZ[#73]
MW_W[3I^#7J_<MU>07'_+/,/'N-/^Z;3/E]NFFM8P?W?\=II_=^!GO.@=.@
M       !::^EBZSKROD-Y2=Q\5S<1Z'TSJG6=<=-S;T6]=?;.[T;3'7+9U6U
M5U/-'3TM5Q1+1-''#3573717S)'5'5Q\Z1W+7:^7O:_9VD=6_P"9S[S7IG73
M8;;W$Q%M>F(G[XQK6:S-IB)K-8K:+1M]2?(QBX+C>)\-<^[OF]DZ_6,?1[==
M(_[QXQI,SX:3&DZW:%*:'X
M                                                     #R7O/HS
MJOR2ZKV_I?NC4,;N_7>[XVK&YS!Y*FJGFGFFJF:QRF+OH:H[W#9[#7L=%S8W
MUM7'<V=S'1+%7373QRRSL;OGNGRW[IV?>?9F\R;'N+8Y.O%EI_>M2]9UKDQ9
M*S-,N*\33)29K:)B9AZG#<SR7;_)8N7XC+;#O\-M:VC_ .-;1[+5M'A:LZQ:
M)F)C1G<^I[Z3O=7IW;S>9GY7);_XS;+GJK#K3N2&.TKKAENHYKVTTGL:QL.:
M:M<W:QM8JZ:)ZH8<=FHXJI[+GBNFZL[/H9],GJN[+]0W!TV?5CV'F7ML'5O.
M/F;1$Q68K;<[.UO\=MK6F)FL6MFVTVC'FB8G%FS3P\N?,[B._-G&'6N#N+'3
M7+@\?@\)R8IGZO',_!K-\<STW\)K>\3J5S9P
M "6+TPO2=[J]1'>;/,_*Y+0/&;6L]38=E]R31VE%<TMK'#>W>D]<V-_S55L>
M[7UK+137/3#-CL+'+3/>\\UU6MG>11]3?JN[+]//!WV?5CW_ )E[G!U;/CXF
MTQ$6F:UW.\M7_$[:MHF8K-JYMS-9QX8B(RYL.L?,;S.XCL/9SAUKG[BR4UQ8
M/'X?",F68^HQQ/P:Q?),=-/"+7IHC=&=&=5^-O5>H=+]+ZAC=(Z[TC&TXW!X
M/&TU5<U<U5537V4RE]-5)>YG/9F]DKN;Z^N:Y+F\N9*Y9:ZJZN>7/-WSWSW3
MYD=T[SO/O/>9-]W%OLG7ERW_ +U:4K&E<>+'6(IBQ4B*8Z1%:Q$1$('\SS/)
M=P<EEY?E\MLV_P UM;6G_P"%:Q[*UK'A6L:16(B(C1ZTQ-Y8
M
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ME(UZ,5-?#'CCX*Q_?M.MK3-IF75#5C&@
M
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MO#S8X[[U^8?*X-(BM]S[Z--9B??UKFF=;?3O.NGA%M:U\(A)FC2UX
M
M                                             J(?53]G\Q8CP^Z7
MLKR&NF^R7:W9^R8^J')TW%OSBK74-4TF\BN/?CPTT-WQF-@HKH]V:ZBJ@HY]
ML-$GLGMQ^:R[8BV\[O[SS4F)ICV.RPWUII/7;<9]S68TG)$U]WM9B=:TM%IC
M2]J_6Y2^FKCM<O*\O>)^+7#AI/AI/5-[Y(T^J\.G%I[(G6?;,?%IV+@DK0
M       %Z_Z8+K#C6?"[M[M"[LYK;)]H]_93&V<]4V,EM\AJ/7NFZM8XFZBH
MM8ZLE;31[5L&=@DCNI?NTPT5Q144U\R3T8?.<]SSR7G/Q';&*\6VW%\!2]HT
MO$TS[O<9[9*SU3T6B<&+:VB:5]MIK:]IKTTAAZC.1^4=W;7C:S$X]ML8F8\=
M8OER7FT>/A/Q*XYB8CX9B9G32ME-6VCX
M
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MGYT<?W/3'PW<=J;7N&(BM;SX8MQ.D^,>$5Q9)T\<<STVF8]W/QO=UKNK#&^
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MD1'LB(B(B(B(?;/$?&
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MKXZ.4X+/7-MIG2WP6I;2)FEZSXUM$3'A/M]L3,3$N=6Q'O
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M]R3[;3X5C69BE(]E*5F9Z:5B*UU\(>S,->2
M
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M%\=&V[PVW(5TZ=SL:Z^,Z]>.]ZS.FFD1TS33QGQBVL1X:V1U<*/X
M
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M&*-)F8CW-*8ICQ]GQJ3K'LZIE)^C&UR
M
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M.9XOGMC3DN'SX]QL;^R])UC6/;$Q[:VCX:VB+1\,0\K92](
M      !ZITQT?VWY$=@X;JOI'K_9.R^P,]\6K':UK%CS=W?-M;<4U7>1OIZZ
MH;'$8>PHKXJN+V[E@M+>GGBJ62CC[K%N\^]^TO+SM_-W3WMR&VXW@,&G7FS6
MZ:]4_4TK$:VR9+>RF/'6V2\^%:S+S>7YGB^!V-^2YC/CV^QI[;WG2-9]D1'M
MM:?@K6)M/P1*ZWZ9WT^75?CS7B>X/,BWU7O/N*B&VOL!UK5;59;J#K:\FMXZ
MI),I8W]%-KV=M5E577'3)>P<X:TKYYD@MIYX[:^CI9]2WS@7=/F%7+VAY.VW
M7!]GS-JY=YK[O?[RL3.D4M6>K98+:1,QCM\HR1\6^2F.V3!:(7F'YZ<ESL6X
MKM.<NRXG68MEUZ<^6-?@F/'#2?;I6?>6]EK5K-J3935MH^
M
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MK?&_P9OI,Q!6G,W.                   V G(8JM
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MW1P?=FPCD>"W%,V#PBT1X7QVF->G)2?&MOV8TGVUF8\7-[8SWP
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M9M:9F9F9F9U1ER9+Y;VRY;3;+:9F9F=9F9\9F9GQF9GQF9]K_8_%_
M
M                             ""3ZC3K.C?/3-W#::JX:*NENVNI.S(Z
M9;FX@KEKRN=N.G.:+:*&VGCO9N(^V:JN8I:H8^(Z:I.*^:XZ(ZYT_-U=RVX+
MU+[/BXB9CFN)W^SG2L3$13%'(:S,S$UC781'56+3K,5TZ;6M7='D'R,[+S#Q
M;:-?\\VN?#[(GZFL9_'QC3_$>V-9UTC329F,]AT%)U          +5GTKO8\
M.+[N\LNHJI;/BXWCJOK_ +'BAKM,A7D)(>J]NRVLSRVU_'5QB[:SAK[CCXGA
MFXYN)ZZX:H>>*(I_;5?\Z7VY?==D]I]W1%_=['E=WLYF+4BD3OL&/-$6K/QY
MM,<?/3:OQ*Q%XOXWQHT^I3CYR</Q?*:3TX=SEQ>V-/KU*WC6/JIGZQ.DQX1I
M.OC-5U92XB&
M
M   S'?5\['_A4]2_S(V;XOQOLON#)=<>_P#*?)>S^!S%8GJ+X7P?>J]_X'WC
M^Y\;_P#V/=^+[./?]CIF](O;G^ZWIJ[.XS33WO#TWGU75_ZADR;_ %U^#7Y3
MKT_N->GX%B?E7Q_WM\O.)V^FG5M(R^W7_'VMG_\ C[S73X/9\"-](UGX
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M\\
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M1-IF?%TLUJQX
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M\3FQ[C898UK>DZQ/T8GX8M$^%JS$6K,36T1,3#S=D;[P
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MKZ3,=6G@[>:28<
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MC':8^&NE,EIFT>RL6B?"9F-%)SP(&
M
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MVK36/H=<QK])JA.6I6N
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M#7XF&OT-,<>$S'^%;JO]&TNV&E6'@
M
M         .(?-GT]O&;SWT:O5>\]*AEV7'8V[L=([5UZFWQG9.@2W,G%Q\3
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MO_@>ZNW>Y\/O^!WF#<UTUF*VTO6/#ZK';3)3VQ]56/&=/:YO;&>^
M    ](ZNZ<[:[OV:#3.G.L]\[3VRY]G,>O=?ZGG-NRU,7N2RUW,]E@[*]FM;
M.&&"222>7BB&**.NNNJFBFKGC'.Z.\>T^R>,MS/>/)[#B^*K[<N[SXL&/7PC
M2+9;5BUIF8B*UUM:TQ6(F9B)\_DN6XOA]O.[Y;<8-MM8_=9;UI7]B)M,:SXQ
M$1'C,S$1XRGX\3/IKO+/MS["V;R3VG6_&G2[WY2^N]<_S;?^W)\;)\:?Y;[
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M<>[V$_\ 48=<>'_YHZIM?_[9:^GP:)($<6
M
M               /XW%O;WEO/:7<$-U:W4,MO<VUQ%1/;W%O/15%-!/#+35'
M-#-'5S3535QS353SSQSQ[']X\F3#DKEQ6FN6LQ-;1,Q,3$ZQ,3'C$Q/C$QXQ
M+_:VM2T6K,Q:)UB8]L3]&&2CW9UM?=-=S=N=093XW&3ZJ[.WWK;(\7$EG-<?
M/:-M66UB[^/+CIKG'RS?,8NKWJH))(:JO;S1553[.>>LKLKN3!WEV;Q'=^UT
M^3<KQFUWE-(M$=.YP8\U=(O$7B-+QI%HBT1]5$3K"T#A^0IRW$[7E<>GN]SM
ML66--=-,E*WC372?9/PQ$_1>8LF>B         ZT\"NQYNH_-GQ.[%CEO([;
M6/(3J:ZS-..M,??9"ZUF[W7#XW:\=8VV4JCLJ[S*:U>W=M%57)#S17+Q51+%
M733)3J?SX[<IW;Y*=U]NVBDY-UV_OZX^NUZTKFKMLE\%[336W33-7'>T1%M8
MK,36T3-9QCO;CXY3L_D]A,1-LFPSQ769B(O&.TTF9CQTB\5F?"==-)B8\)U3
MG+(K4
M                                                        <?>H
M+V/_  2>#?EOV%'+\&^U_P >^UOL27FT^>BIV;+:?E<)JWS-K[U/$MG5L>2M
M>)_;S[*8>:N>?N<-O>G_ +<_WM\\.TNW[1U8-QW!L?>1U=,^YIN*9,^EO@M[
MFE^GZ-M(95V-Q_WT[RXO8S&M,F_P]7CI\2N2MKZ3]'HB=/ILKYU*K*
M    $X7T\/6M>^^ISUIG_EIKJUZBZ][7[*O:*;:WN;6*B?4KGK2QN;_X_MY@
MAMLSV/:UPR1\<R47E,/L]G'MYXA%\X5W)7@?3+R6PZHKEY?D-CLZ^,Q:9C/&
M\M%=/;-L>SO%HGPG'-]?H3ISSWY"-CY=;C!K$6W6?#BCQF)^KC+,1I[=:XIU
MB?#IU:(#GI00
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MW><AN+;O?Y<N?=7G6U\EK7O,^W6;6F9GQ^C+ZIY3Y@
M
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MDY+EN4YC<3N^6W&?<[J?W66]KV_8B;3.D>$1$1X1$1$>$/2&.//
M
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MZH]W>U/C::1KX>.D1&KTYC+S@
M
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M)UG7QBJZLI<1#
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MKK+UIB;RP
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M8_<[7<Y\6+77IIDO6-9]LZ1,0\!_N]/ 3\QWP_\ _G:.E_\ XRF??K!^??\
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M.\O;)N]_O<N2\:6F^?+:;1III,VM,SX>'C\'@]R8.\8
M
M                              !1#^IYZ]HUWSAZKW^SLH;:R['\===C
MR%S3>W$]QD=ITW>-ZQ60N);2>66BQAAUB]PL,?$/$<4E45=7N_$^)77>K\V1
MW#;D?)'E> S7FV;CNXLTTCIB(I@W&VVUZ1%HB)M,YJ[FT]6MHBT1KT],1-+T
MZ;^<_9VYV-YF;[??VTC2(B*9,>.T1K'M^/&29UUF-8\=-(BMRL>2
M   :9/HS]A7?9OIA^'VQWM5Y5-C>M\AU[1S?212S\6G4FZ[5U3CZ:*HJ::.+
M.BPTN/BWIY_946_%%-7/-7'/+FE]9';^+MGU-]W\=AZ(IDY*F[^+$Q'5O]M@
MWU]=?W75N)ZY]DWZICPF%>7FUL:\=YC<KMZ::6W$9?#Z.?'3-/\ =UR3K]/5
M)RC,UT
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ML]C7IGW.PBTZ3K,6R9<GQ;1\&E:5M'PZ6U]FBR^K51Y
M
M
M
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MPPWGVZ6GW=O96U;36DUK5DB00           #8"<ABJT
M
M
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M&.=?@ZJ7R4FL?L1%+3_SEBE7@T*
M
M                 I+_ %3O85>2\AO%OJCF]FDBTOIG:^PJ,;596\=O:5]G
M;O7K<E[%D:8N+JZFR%/4=,=<-==4=O3;4544T\S2<U76?-;]O5VWE[W1W7T1
M%M[S.#:=?5,S:-EMO?16::]-8I\OF8M$1-IO,6F8I728'ILV$8^"Y+D](US;
MNF+76=9]SCZ]-/9&GO\ 6)TUG68GV1I5E6CI)          -(?T(NO:.O?2Y
M\:Z9;*&TRVZP]A]A9J6"]N+RC(5[3V9MTVOWM7$TLD-G-]Y-MBH9(8:8XZ)(
MJN>:>9>9*Z^<;UU=PV[@]4'<DUO-]ILIVFTQQ-8K-(P;+;QEKX1$VCY3.>T6
MM,S,6C2>F*UB 'G3OYW_ )D<A,3,XL,XL5=8B-.C#3JCZ?UR;S$SK.D_0TB)
M>T16K
M
M
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M>TVV3=9M?=8J6O;3QG2L3,Z1^Q#7E<C2K,
M
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MQ6G6=?\ JKXXT]GA]<F9CQ\8B=?#2X.J"14
M
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M$1$1'@ZC:O8V
M
M
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M]*TX_?=.R[BTB/=6M\3+;QUG!:?&?9K..WQZZZ5G)$39"2FNW         F
M]"_QGR'DAZB_3%U79_&U#H*\_I#[G><W4UG59?P;WV/GT*FUJAKA^=O+GM6_
MP7%5K[_'Q+*FYDJIDCBDHJB%ZY/,O;^7'IVYG%6_3R_/T^].WKTQ;J^65O&Z
MZM=>FM=C7<Z7T\,DXZQ-;7K:-5^<W<./M_L+=UB=-UOH^2XXTUU][$^\U^A$
M88R>/P6Z8\)F):03G)0!
M
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MQV-BW7Q?>;??X[:S'CTVIEI-8GX-9M6T_!/3'PQ"_ H80E
M
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MO&;GD;=,5V^#)DGJG2NE*3;XT_!'AXS\$-<%R6*NP
M
M
M
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MS*&S4H
M
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M68G2T1:/9,1/@M&P9\6YP4W.">K#DI%JSI,:UM&L3I.DQK$^R8B?HOR'UOU
M        2?>C!O=OUUZG_B!L%S7C8X\AV%F-$IJRM[186O-QVCH6W=96E$4\
ME=%->2ENMNHILX?;[US><Q1<<<\U\<<QC]9G!9.XO3%W?Q^*,DVQ\?CW7Q*S
M:VFRW6WWMIF(UTI%=O,Y+>RF/JO.D5U:Y\V]E;?^7/*X*]6M<%<GQ8UG3#DI
MFG^YI3XT_!76?@:8CFH5Y@
M
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M8?@T\9]YI7X.K376/!IZ.9!70
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M\SN'_P"AD_A#^JOR\_!.T_O6_?'][WZE_P">1W#_ *RQ7[TGZHOIJ_F=P_\
MT,G\(?U5^7GX)VG]ZW[X_O>_4O\ SR.X?]98K]Z3]47TU?S.X?\ Z&3^$/ZJ
M_+S\$[3^];]\?WO?J7_GD=P_ZRQ7[TGZHOIJ_F=P_P#T,G\(?U5^7GX)VG]Z
MW[X_O>_4O_/([A_UEBOWI/U1?35_,[A_^AD_A#^JOR\_!.T_O6_?'][WZE_Y
MY'</^LL5^])^J+Z:OYG</_T,G\(?U5^7GX)VG]ZW[X_O>_4O_/([A_UEBOWI
M/U1?35_,[A_^AD_A#^JOR\_!.T_O6_?'][WZE_YY'</^LL5^])^J+Z:OYG</
M_P!#)_"']5?EY^"=I_>M^^/[WOU+_P \CN'_ %EBOWI/U1?35_,[A_\ H9/X
M0_JK\O/P3M/[UOWQ_>]^I?\ GD=P_P"LL5^])^J+Z:OYG</_ -#)_"']5?EY
M^"=I_>M^^/[WOU+_ ,\CN'_66*_>D_5%]-7\SN'_ .AD_A#^JOR\_!.T_O6_
M?'][WZE_YY'</^LL5^])^J+Z:OYG</\ ]#)_"']5?EY^"=I_>M^^/[WOU+_S
MR.X?]98K]Z3]47TU?S.X?_H9/X0_JK\O/P3M/[UOWQ_>]^I?^>1W#_K+%?O2
M?JB^FK^9W#_]#)_"']5?EY^"=I_>M^^?;:KZW?JF:;;W=MB/+G:KR.\FHGFJ
MVK1NH]ZN**XZ/ATTVEWN_7VPW5A#S3_YHX*XXZJOV7-///W7B<KZ)?2YS&2F
M7=]I;6EJ1,1[C<[_ &L:3.OQJ[;=XJVGZ$VB9B/")T?'N?)[RVW=HMEXO%$Q
M&GQ,F?'']V,>6L3^S.LI".FOJ??+W4;B*W[IZ<Z9[EPU$W,LDN!^^#JC;I:*
MZ^:J[?G-6ESN.L40QT>RF+GC _$I^[S75)[>/9'WO+YL;RBY?'.3LOF.9X;>
M372(R^ZWV")B/;[NT;?-K,^-O\ZTG]S%?AP7EO3GVKNJ]7$;O=[3+I^ZZ<U/
MV>F8QW_9^N:?0B%@OQ ]=CP.\K\AC-1OMUO/'[LS)_#AL].[NYQVMXG+WTDT
MD%-CKO8D%[<Z1?WD\GP:+>UN[O'Y&]EN*([>VEKXKXHK_P#-[T+^>WE3M\O+
MX-E3N#MK%K-MQQO7FR8ZQ$3U9MI-8W-*Q'5-[X\>7%CK2;9,M(FLSHSNKR7[
MU[8I;=4PQON.K[<FWUO:L>W6^+2,D1'CK:M;5K$3-K1&FLS*&S4H
M
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MM\$?'B(FDS/LKEK2\^V*Z>+OUH-@X
M
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M[CV,\GV]O^-B+3.XV6?%I73JGWF*U/BZZQKX^&L3&K60<HBL8
M
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M0Y]4%0
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MMAW^&VEJS_\ "U9]EJVCQK:-8M$Q,3H]:8F\L
M
M                    !^/L&O8#;,)E-:VK!X?9M<S=G-CLUK^P8RRS.$R^
M/N*?<N+'*8K(P7-A?V<]/W*XI8ZZ*N/\O'+[./Y#?\3O<7)<5GS;;D<%XOCR
MXKVQY,=X]EJ7I,6I:/@M68F/@E^N#/GVN:NXVU[X]Q2=:VK,UM68]DQ:-)B?
MIQ* #RN^G!\,.],GDMKZ3SVU>+&VY*;F:;':E86>Z=3\RR<3U7%S%USF;W$9
M/$S23UQ^Y#B\[CL=#%1511:<<U\5T3[\JOG&O.7L;;8^*[UP;7NGB<4:1?/:
MVVWVD::1.\QUR4R1$:ZVS;7-FM,Q,Y9TF)WCVSY_=V\+CKMN8IBY+:UCVWF<
M>;X-(][6+1;PU\;X[6F?&;>&DPP=E_3">;.MR92ZZU[8\>^S<1:?+_9MK>YO
M==#W'+_&NX[>7V8;(Z;F-3L?E+>3X]?Q=@^['1731[TGN423+[:^<X\E.2KB
MQ=R<3W!QF[OKUVKCVVZV^/2LS'URFXQY[=4QTQIM?;,3.E>J:[;X_P!1G9^X
MBM>0VN_V^6==9BN/)CKX:_51DK>=9\/#%[=-=(UF/*\!]-IZD68RUIC<C!T/
MJEG<_'^-G\_VG<W.)L/@VTT\?S<.KZILF=K^:EBIAC^!93>R62GFOW(^*Y*<
MIW_SD'IPV>TON=O;GMUFKIIBQ;*L9+:VB)Z9SY\.+XL3-IZLE?BQ/3K;2L^E
MG]0/E_BQ3DQSO<MXT^+7#$6GQT\.N]*^'MG6T>$>&LZ1/>_1/TL68DN,;D?)
MKRDQMI:QS6]68T_HG5+K(7%Y;^_15=Q8WLCL"C&1XZ;X=-5$<DNJ75/O5<5\
MT>RGW*]#=]?.D;.N/+M_+/M?)?+,3[O<<GGK2*SI\6;[/:]<WC729BN^I.D:
M1/CU1A/->I/%%;8^W>-M-M)Z<FYO$1$_!KBQ:Z_3B,T?0U\=8L=^(GIX^)'@
M_A*+#H'J?#X;8Y;/BSS79FP<4[-VAL5%5/'%QQE-SR,55_:V=U53[]=ACZ;'
M&4U_=HMJ%<_FYZA?-KSNWL[CO[ELV;CHOU8]GB^L[+#]#HV])Z;6K[(RY?>9
MM/"V26@NZ>^^Z.\<W7SFZO?;Q.M<-?B8:_0TQQX3,?X5NJ_T;2[8:58>
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MO;7#KUX,.NFG5$QIER1XZS.N*LS\2+36N2:TRR=(0
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M7+69BU9B8F)B=)B8GQB8GPF)\8E$^U;4M-;1,6B=)B?;$_0E_9_#_
M
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MME][>8W?'=,U^3[G+CTGVQT7M72?IQII+U1BSS
M
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M-NC6D:_4GOO=\'QG&]6GO=WDR].GM]UCZ>K73PZ??:::QKU:Z3IX78E*R((
M
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MSX36U9TM$Q]&)B8E^P^-^0
M
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MKGK$1I%Z1K.;V1:FN29BU;3>YZIH1)
M
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M?2F$BJ.[ @
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M3IUTC7QM0JM4:P
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MCV>_K69K;3X/>8ZSKI^ZQS:?C7F9M'JO4;P
M
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M6IKK.L5BTZ3;2),T:6O
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MIY][+Y+YB9L_3,?*=M@R:S^ZTI[G6/I?6M/V8E.J@RTP
M
M                                JF?52;I18],^(_7?.1R44FT]G=D;
MI3B8I+CC#WM&A:K@,')D;Z*F3BUKR6+J[(IBM*JZ*I*8KRXXHYIXJDXJM3^:
MSX6V?O+NWN'W>.:[7C-GMO>3$>\K.ZSY<L4K.G5T7^1S-XB8B;8\?5$S%=),
M>FK:3?EN4W_368Q;;%CZO#JCWE[6TCX=)]UK;X-:UU^!2P70)=
M-!OZ<+2*-4]-/ 9ZG$38VKLSN;M?=Y+V6:XEHV"NPO<3UQQE[>B:XFCMX88^
MOZ;#FB*F*/F2QJKYHYKJKKKY^_G&>;MROJ3W&QG-&2.,X;8[:*Q$1.*+5R;S
MW<S$1,S,[J<NMIM.F2(UZ8K6(,>?V\G<^85\,WBWR?:8<>GA\76+9>F?#Q_Q
MO5XZSI:(UTB(B>=!!I0
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MTZZQK$Z@#F+5R@
M
M                   ,[/Z@/R,N.]O46[!U:SNYI=2\>,#@>E<!#Q>URV<F
M7Q<<NR[[D>+#BFFVLLE]^>QW>-FKXYDEG@Q5OS77QQ31%%T.>@+RZQ]B^G?C
M^4S4K'+=PY\O(Y9Z8BT8[S&':TZ_;:GR?#CS5CPK6V?)TQXS>\\O([@*\+V%
M@W-XB-UO[VW%O#QZ9^)CC7VS'NZ5O'LB)O;2/&9F$E-=N
M                     !98^F0\BI] \M^RO';)Y#X6O>076\N8PMC7-CZ?
MC=B]257F?QW%M'>S07?/QM!RVQ5STV7Q99/EH:I8JHH>9K>MCYS+R[IS_E+Q
MOF'ML>O(=O\ )1CR6B+^&TW_ $XK]4UB:^&ZQ[2*SDZ:QUWBMXO?HR1[]1/
MQONU]OSV.NN?8[CIM/C_ (K/I6==/#_&UQ1'5I$:SI.LZ6O5*,T,0
M
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M.X>.W_3:)R[*V/J\>F?=Y9MI'P:Q[W6WPZ6KK\"T>J]1O
M
M                                 4H_JH-WKO\ O;Q1ZXYR\,T6J=2[
MSN]&!IAMZ;C&U]@;C98&3+RW%-O3=2PYNGK.F&.BN6N..K'U\T44<UR<UW3?
M-:\)7!V+W7W'[F:VW?+;;;>]UG2\;7;VRQCB->F)Q_+)M,Q6)F,L1:9B*Q67
MOIKV<4X7D^0Z)B<NZQX^KQTGW6.;=.FNGQ??:SX:SU1K,Z1I596FI*@
M    -,_T;M+HT+TQO#S!QX[)8NF^ZQN-TYMLK'<174M?9&V[+V))D8J;F.*3
MG&Y>3:>;NSJXXYCKLYXJH^:J.::N>:+UB\U;GO4UWAOK9,>6<?)QMM:3$UB-
MG@P[2*3TS,=>.,'N\D>V,E;1:(MK$5X>;&[G>^8O*YIM6W3N8QZUTT^M4IBT
M\/AKT=-OAZHG7Q29HTM>
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M:+1$]43K$2J^YC:1Q_+;K816U(P;G+CZ;:]4=%[5TMKXZQII.OCJ].8R\X
M
M
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M@KH
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MC%ZEMM6_'\3O-9ZL>;/33X)C)7%:9_N>[C3]F5SA36B4
M
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MI$SXZ*R^ZMS;>]T<EO+1%;9=_N+S$>R)MEO;2/V-7137;P0
M
M               &;[Z]O^+'Y6_R%_U;.G71MZ#?^%'M7_:?Y8Y!/[R3_1CQ
MG^D?=>=#^EZVH                                     U0O3T_($\'
M?T/_ !H_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J
M
M                                                         Q_7
M7FM2                                     =@>GI^7WX._I@>-'XZ-
M*:A]0?Z!.^/Z(<S^3MRQ7OO\R.9_%6[^Y\C5"<M2M<
M
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M7Q]FFGCK%_)0>A"
M
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MF<6+':\Q'MF*Q-ITUF(UTCPUF/V6N^Y'56H
M
M    #-]]>W_%C\K?Y"_ZMG3KHV]!O_"CVK_M/\L<@G]Y)_HQXS_2/NO.A_2]
M;4                                     :H7IZ?D">#OZ'_C1^)?2G
M+5Z@_P!/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M
M                                              8_KKS6I
M                              .P/3T_+[\'?TP/&C\=&E-0^H/] G?'
M]$.9_)VY8KWW^9',_BK=_<^1JA.6I6N
M
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M75_G/LYWGEMR5:UK;)CKBR1KIX=&?':TQ/P3T1:/#QF)F/9+24<X"OT
M
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M,1'TVJ$Y:E:X
M                                         #-]]>W_ !8_*W^0O^K9
MTZZ-O0;_ ,*/:O\ M/\ +'()_>2?Z,>,_P!(^Z\Z']+UM0
M                      !JA>GI^0)X._H?^-'XE]*<M7J#_3WWQ_2_F?RC
MN5:_??Y[\S^-=W]T9'8#4+%0
M
M                            &/ZZ\UJ0
M            #L#T]/R^_!W],#QH_'1I34/J#_0)WQ_1#F?R=N6*]]_F1S/X
MJW?W/D:H3EJ5K@
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MV?C5CP^'V-2IR[*W
M
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MB)\&M/.'<VVGEMRF6L1,SBQT\?H9,^+',_W(MK'TX:5CFT5\
M
M                  ,WWU[?\6/RM_D+_JV=.NC;T&_\*/:O^T_RQR"?WDG^
MC'C/](^Z\Z']+UM0                                    !JA>GI^0
M)X._H?\ C1^)?2G+5Z@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M
M                                                           !
MC^NO-:D                                     [ ]/3\OOP=_3 \:/
MQT:4U#Z@_P! G?']$.9_)VY8KWW^9',_BK=_<^1JA.6I6N
M
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MKD
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MQUY-)T^E2;>/AK6/AT:""@%!H
M                                                      !F^^O;
M_BQ^5O\ (7_5LZ==&WH-_P"%'M7_ &G^6.03^\D_T8\9_I'W7G0_I>MJ
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M&]-#_9CN'^=G*_Z ?VB_J5_C7#_:&/\ ?']?OF'_ )3:?8*_ML]YT#IT
M     -4+T]/R!/!W]#_QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC(
M[ :A8J
M
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M'</\[.5_T _M%_4K_&N'^T,?[X_K]\P_\IM/L%?VS]7&]-#_ &8[A_G9RO\
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ME]^#OZ8'C1^.C2FH?4'^@3OC^B',_D[<L5[[_,CF?Q5N_N?(U0G+4K7
M
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MFMYLXI..,6ZRTZ)B8FO3DM7IF)\8Z=--)\8T>M,3>6
M
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MV)K&GME'7U([FU.U]AL](Z<F_P"O7X8G'BR5B/[OO)U_8A>,4A(;@
M
M                      ,WWU[?\6/RM_D+_JV=.NC;T&_\*/:O^T_RQR"?
MWDG^C'C/](^Z\Z']+UM0       !?!^E[_($[>_3 W_\2_C^HG^<\_3WQ']$
M-K^4>50L]1WY[[7\58ONC<K(*N1H                 !C^NO-:D
M  U0O3T_($\'?T/_ !H_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([
M:A8J
M
M         Q_77FM2         :H7IZ?D">#OZ'_C1^)?2G+5Z@_T]]\?TOYG
M\H[E6OWW^>_,_C7=_=&1V U"Q4               !#]Z]O^$YY6_P A?]9/
MIU+WT&_\5W:O^T_R/R#:ODG^D[C/](^Y,[-^=&R?H       #L#T]/R^_!W]
M,#QH_'1I34/J#_0)WQ_1#F?R=N6*]]_F1S/XJW?W/D:H3EJ5K@
M
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MF2<D1_<BVD_3AW6T8PL
M
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M]G6\ZQ&YO:FLZ>/N*TM,>SX,D5GVQ\;Z,K?:HA%<
M
M         !F^^O;_ (L?E;_(7_5LZ==&WH-_X4>U?]I_ECD$_O)/]&/&?Z1]
MUYT/Z7K:@       "^#]+W^0)V]^F!O_ .)?Q_43_.>?I[XC^B&U_*/*H6>H
M[\]]K^*L7W1N5D%7(T                  Q_77FM2         :H7IZ?D"
M>#OZ'_C1^)?2G+5Z@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M
M                                                         !C^
MNO-:D         U0O3T_($\'?T/_ !H_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/
M?F?QKN_NC([ :A8J                A^]>W_"<\K?Y"_ZR?3J7OH-_XKNU
M?]I_D?D&U?)/])W&?Z1]R9V;\Z-D_0       '8'IZ?E]^#OZ8'C1^.C2FH?
M4'^@3OC^B',_D[<L5[[_ #(YG\5;O[GR-4)RU*UP
M
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MU]OAO:?'7VVM,Z>R-=(TC2$M*)S6
M
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MDK$?W/=SK^S"SNK)1T
M                                                9OOKV_XL?E;_
M "%_U;.G71MZ#?\ A1[5_P!I_ECD$_O)/]&/&?Z1]UYT/Z7K:@       "^#
M]+W^0)V]^F!O_P")?Q_43_.>?I[XC^B&U_*/*H6>H[\]]K^*L7W1N5D%7(T
M                 Q_77FM2         :H7IZ?D">#OZ'_C1^)?2G+5Z@_T
M]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M
M                                      !C^NO-:D         U0O3T
M_($\'?T/_&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\ /?F?QKN_NC([ :A8J
M             A^]>W_"<\K?Y"_ZR?3J7OH-_P"*[M7_ &G^1^0;5\D_TG<9
M_I'W)G9OSHV3]        =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3MRQ
M7OO\R.9_%6[^Y\C5"<M2M<
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MU?&/&L3>FOA[/C4M&DZ3X:^R8F9^4!VD
M
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M
M                              S??7M_Q8_*W^0O^K9TZZ-O0;_PH]J_
M[3_+'()_>2?Z,>,_TC[KSH?TO6U        %\'Z7O\@3M[],#?\ \2_C^HG^
M<\_3WQ']$-K^4>50L]1WY[[7\58ONC<K(*N1H                 !C^NO-
M:D         U0O3T_($\'?T/_&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\ /?F?
MQKN_NC([ :A8J
M
M                  Q_77FM2         :H7IZ?D">#OZ'_ (T?B7TIRU>H
M/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5                0_>O;_A.
M>5O\A?\ 63Z=2]]!O_%=VK_M/\C\@VKY)_I.XS_2/N3.S?G1LGZ        [
M ]/3\OOP=_3 \:/QT:4U#Z@_T"=\?T0YG\G;EBO??YD<S^*MW]SY&J$Y:E:X
M
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M-9U]L(:^I#;6IW7L=YK'3DXZ*:?#$X\V6TS_ '?>1I^Q*S6K/1W
M
M                                     5.OJJ=HQ]IUCX<Z7)#>593/
M[YV[M%G<41P\X^+'ZAK^CXG)0W,M5Q3<47D]QO%I5!31%7151'-S771S31Q)
M:Y\UCQ>XR]S]X<U6:?)=OL-A@M$S/7-]QEW.2DUC32:Q&VR1:9M$Q,TTBT3,
MUDYZ:=M>W(\MO(F/=4P8*3'PZWMDM&GAII$8[:^/PQI$^.E,)<NEL
M   T=?0)QV/LO2B\8[FSL;.TN<O>=X9'+7%M;003Y3(1>0?:F)COLC+%11)>
MWD>*Q=M;4RR\U5\6]O%'QS[D='''.?Z]]QN,WJK[FQYKWOCPTXVF.+6F8I2>
M)V.2:TB9TK6;WO>:QI'7>UM-;3,P$\[LE[^9O(UO:9K2-O%8F==(^2X;:1]"
M.J9G2/AF9]LRF-0\:H
M                                                9OOKV_XL?E;_
M "%_U;.G71MZ#?\ A1[5_P!I_ECD$_O)/]&/&?Z1]UYT/Z7K:@       "^#
M]+W^0)V]^F!O_P")?Q_43_.>?I[XC^B&U_*/*H6>H[\]]K^*L7W1N5D%7(T
M                 Q_77FM2         :H7IZ?D">#OZ'_C1^)?2G+5Z@_T
M]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M
M                                      !C^NO-:D         U0O3T
M_($\'?T/_&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\ /?F?QKN_NC([ :A8J
M             A^]>W_"<\K?Y"_ZR?3J7OH-_P"*[M7_ &G^1^0;5\D_TG<9
M_I'W)G9OSHV3]        =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3MRQ
M7OO\R.9_%6[^Y\C5"<M2M<
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M1I$>.MMU4NB\
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M'A\,6B8F/@F)B?&$BJ.[ @
M                                                   &;[Z]O^+'
MY6_R%_U;.G71MZ#?^%'M7_:?Y8Y!/[R3_1CQG^D?=>=#^EZVH        O@_
M2]_D"=O?I@;_ /B7\?U$_P YY^GOB/Z(;7\H\JA9ZCOSWVOXJQ?=&Y605<C0
M                 #']=>:U(        !JA>GI^0)X._H?^-'XE]*<M7J#_
M $]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M
M                                        !C^NO-:D         U0O
M3T_($\'?T/\ QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J
M               A^]>W_"<\K?Y"_P"LGTZE[Z#?^*[M7_:?Y'Y!M7R3_2=Q
MG^D?<F=F_.C9/T       !V!Z>GY??@[^F!XT?CHTIJ'U!_H$[X_HAS/Y.W+
M%>^_S(YG\5;O[GR-4)RU*UP
M                                                      '!WJB:
MG]^?IU>:N'^?^S?D_&_M3;/F/E?G/B?>%JU_O/R'P?F;7W/M7[W?E?B^]S\#
MXWQ/<D]SX=6]O3!ROWF]1'9>\]W[SK[CV.#3JZ=/E6>NVZ]=+?4>^Z^G3XW3
MTZUUZHS7RXW7R3OWB,O3U:\AAIIKI_C+QCU]D_4]>NGPZ::QKK&7<Z?5CH
M       "UE]*YF,G!W/Y;X"*]FHPV3ZPZXS%_CZ>>/E[K)X/:L]98F]EX]GO
M<S6%KL-[1'SQSQQQ3<U^WV_<]E5GSIFSVU^S>TM_>D3O,7)[S'6_PUIEP8K9
M*Q]*UL6.9^G2$9_4KBQSQ/%YYB/>UW.6L3\,1:E9M']V:UU_8A=04OHB@
M
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MR8B?HNJ&K&-
M                                         ,WWU[?\6/RM_D+_ *MG
M3KHV]!O_  H]J_[3_+'()_>2?Z,>,_TC[KSH?TO6U        %\'Z7O\@3M[
M],#?_P 2_C^HG^<\_3WQ']$-K^4>50L]1WY[[7\58ONC<K(*N1H
M        !C^NO-:D         U0O3T_($\'?T/\ QH_$OI3EJ]0?Z>^^/Z7\
MS^4=RK7[[_/?F?QKN_NC([ :A8J
M
M                                Q_77FM2         :H7IZ?D">#OZ
M'_C1^)?2G+5Z@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M    !#]Z]O\ A.>5O\A?]9/IU+WT&_\ %=VK_M/\C\@VKY)_I.XS_2/N3.S?
MG1LGZ        [ ]/3\OOP=_3 \:/QT:4U#Z@_T"=\?T0YG\G;EBO??YD<S^
M*MW]SY&J$Y:E:X
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M6@
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M
M                             ,WWU[?\6/RM_D+_ *MG3KHV]!O_  H]
MJ_[3_+'()_>2?Z,>,_TC[KSH?TO6U        %\'Z7O\@3M[],#?_P 2_C^H
MG^<\_3WQ']$-K^4>50L]1WY[[7\58ONC<K(*N1H                 !C^N
MO-:D         U0O3T_($\'?T/\ QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?
MF?QKN_NC([ :A8J
M
M                    Q_77FM2         :H7IZ?D">#OZ'_C1^)?2G+5Z
M@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4               !#]Z]O\
MA.>5O\A?]9/IU+WT&_\ %=VK_M/\C\@VKY)_I.XS_2/N3.S?G1LGZ
M [ ]/3\OOP=_3 \:/QT:4U#Z@_T"=\?T0YG\G;EBO??YD<S^*MW]SY&J$Y:E
M:X
M                                 #\?8L!B=KU_.:OG[3Y_!;)A\G@,
MU8_'N;7YW$YBRGQV2M/F;*:VO+;YFSN:Z/B121RT>WVTU4U<<<\?9Q^_W?%;
M_!RFPO[O?;;-3+CMI6W3DQVB]+=-HFLZ6B)TM$UGV3$QX/UP9\NVSTW.">G-
MCO%JSI$Z6K.L3I.L3I,>R8F/HLA5USK30         $\'TX_^)AJ_P#R?[9_
M]TV*"?SB_P#PU;K\<;#_ +2S2WG[^CS)_P"+P?\ UTM")S\(+
M
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M!^6?/BVV"^YSSTX<=)M:=)G2M8UF=(UF=(CV1$S]!KUN1=5D
M
M                   S??7M_P 6/RM_D+_JV=.NC;T&_P#"CVK_ +3_ "QR
M"?WDG^C'C/\ 2/NO.A_2];4        7P?I>_P @3M[],#?_ ,2_C^HG^<\_
M3WQ']$-K^4>50L]1WY[[7\58ONC<K(*N1H                 !C^NO-:D
M        U0O3T_($\'?T/_&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^
MZ,CL!J%BH
M
M             #']=>:U(        !JA>GI^0)X._H?^-'XE]*<M7J#_ $]]
M\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4               !#]Z]O^$YY6_R
M%_UD^G4O?0;_ ,5W:O\ M/\ (_(-J^2?Z3N,_P!(^Y,[-^=&R?H       #L
M#T]/R^_!W],#QH_'1I34/J#_ $"=\?T0YG\G;EBO??YD<S^*MW]SY&J$Y:E:
MX
M                                 #)$[DP&)U3M[M35\!:?(8+6^R-X
MP&%L?CW-U\EB</L^4QV.M/F;V:XO+CY>SMZ*/B2R22U^SVU555<\\\]:'9V_
MW?*]H\5RF_O[S?;GC=MER6TK7JR9,-+WMTUB*QK:9G2L16/9$1'@M#XG/EW/
M%;;<YYZLV3;X[6G2(UM:D3,Z1I$:S/LB(CZ#SAD;[P        $P'H)?XL?B
ME_+I_5L[B1"]>7_"CW5_LS\L<>U7YV?HQY/_ $?[KP-()SDH @
M
M                                   ,UGUPMHQ^X>JAY;Y;&0WD%M:;
M)U]J\E%]'!%/5D-'Z;ZYTK+344V]Q<Q\V=QE=?FDMZN:N*Z[>JBJNB.OFJBG
MI(]$7%[CB/2UVEM-S-+9+[;=YXFLS,=&YY#=[G'$ZQ6>J*9:Q>--(O%HB;1$
M6FP;R<VU]KY:\7BR3$VG'EOX?0R9\N2OMB/&*VB)^GKI,QXHHTJVS
M  'N/C#A\GL/DKX\X#"V4V1S.<[RZFP^)Q]OQQS<7^3R>_8"RL+*#BKFFGF:
MZNIZ**>.>>./>JX8/YG;S;<?Y;=P[_>WC'L\'![_ "9+S[*TIM<MK6GZ5:Q,
MS]*'C=QY<>#M[?Y\TQ7%399[6F?9$1BM,S/[$-9%RB*Q@
M
M               &;[Z]O^+'Y6_R%_U;.G71MZ#?^%'M7_:?Y8Y!/[R3_1CQ
MG^D?=>=#^EZVH        O@_2]_D"=O?I@;_ /B7\?U$_P YY^GOB/Z(;7\H
M\JA9ZCOSWVOXJQ?=&Y605<C0                 #']=>:U(        !JA
M>GI^0)X._H?^-'XE]*<M7J#_ $]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M
M
M    !C^NO-:D         U0O3T_($\'?T/\ QH_$OI3EJ]0?Z>^^/Z7\S^4=
MRK7[[_/?F?QKN_NC([ :A8J                A^]>W_"<\K?Y"_P"LGTZE
M[Z#?^*[M7_:?Y'Y!M7R3_2=QG^D?<F=F_.C9/T       !V!Z>GY??@[^F!X
MT?CHTIJ'U!_H$[X_HAS/Y.W+%>^_S(YG\5;O[GR-4)RU*UP
M
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M,?)9GQ^C%JS$_P!R?&/IM-QS.*[0
M
M             &8CZMN1Q^4]2GS+N<;?6>1MXN[=CQTEQ8W,-W#'D,1%98G+
M6-<MO7)'1>8S*64UM<1<\^_!<0UQU\4UTU<<=-GI+V^XVOIM[-Q[FE\>2>$P
MWB+5FLS3)-LF.T1,1/3>EJWI;V6I:MHF8F)6+>5^.^/R^XFN2LUM.SI.DQIX
M6UM6?'X)K,3$_#$Q,>$HZTAV>         .P/3T_+[\'?TP/&C\=&E-0^H/]
M G?']$.9_)VY8KWW^9',_BK=_<^1JA.6I6N
M
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MQ:L^R:S$QK$P[2:88B
M
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MT?CHTIJ'U!_H$[X_HAS/Y.W+%>^_S(YG\5;O[GR-4)RU*UP
M
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M,?3AJ8.7-6V
M                                                         RO?
M4+_+[\XOTP/)?\=&ZNI7T^?H$['_ *(<-^3MLLH[$_,CAOQ5M/N?&X_;>94
M        D@](3_$O\-_^<.-_]U99'+U=?\-7>/XGO_VF-@'FI^CSEO\ PD__
M %U6G$YF5=@
M                                         #-]]>W_ !8_*W^0O^K9
MTZZ-O0;_ ,*/:O\ M/\ +'()_>2?Z,>,_P!(^Z\Z']+UM0       !?!^E[_
M "!.WOTP-_\ Q+^/ZB?YSS]/?$?T0VOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@
M              &/ZZ\UJ0        "P)Z%_JHQ>&'9E?CWW;G/E_&3N'9(9
MZ,YD+FTML?TWV/DXK/%Q[Q=7,UIS-QI^P0V-I9YJF2XBM["B./(4^[Q#<TW$
M O7)Z6;><O;4>8/9.#J\S.'VTQ[JD6M?D-G2;7G;5B+:?*,4VR9-M,4M?+,V
MV\Z]>*<>CO.;RUGNWCOO[P]->XMICTZ8B9G/BC6?=Q&O^,KK:V/2)FVLX_AK
M-;_R@E!X
M
M           !2J^H+]5:+LK-Y?P/\?=A^)H.HYBBGR(W;#9&TNK#?-KQE5A?
M8[K+!WN,NYXZM;T?*4559WXG[9=9VWHM?<AHQ\O-[='\W]Z5[=M[+#Y[>8&W
MTY[=X?\ ZD[;)2U;;7!?KK?>Y:WK$^^W-)B-KIX4VUYRZWMN*QAEYY&>6D\?
MAKWKSN/_ #[+3_-<=HF)QTG6)S6B8^KR1_B]/",<S;69R1T54EJ"2P
M  #5"]/3\@3P=_0_\:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.P&
MH6*@               (?O7M_P )SRM_D+_K)].I>^@W_BN[5_VG^1^0;5\D
M_P!)W&?Z1]R9V;\Z-D_0       '8'IZ?E]^#OZ8'C1^.C2FH?4'^@3OC^B'
M,_D[<L5[[_,CF?Q5N_N?(U0G+4K7
M
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M%)F/;$6Q7K.FL3&ND^&L3^PU?W*:K*
M
M                9-WD]F,GL/DKY#9_-7LV1S.<[R[9S&6R%QSQS<7^3R>_
M9^]O[V?FGBFGF:ZNIZZZN>.../>JY=7?ECL]MQ_EMV]L-E2,>SP<'L,>.D>R
MM*;7%6M8^E6L1$?2A9SVYBQX.WMA@PQ%<5-E@K6(]D1&*L1$?L0\.9P]D
M     !+1Z%^ Q.R>JMXEX[-6GSMG;9CM+/PP_'N;;W,MJG1?9^T8"[^):302
MU?(9W#VT_P /FKF*7X?N24UQU5451.]<F_W?&^E?NS<;*_1FMAV6*9TK/UO/
MR>RP9:Z6B8^-BR7KKIU5UZJS%HB8UAYS9\NW\M.4R89TO-,-?9$_%ON,-+1X
MZ^VMIC7VQKK&DZ2TFG-ZK\
M                                                     9OOKV_X
ML?E;_(7_ %;.G71MZ#?^%'M7_:?Y8Y!/[R3_ $8\9_I'W7G0_I>MJ
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M !GC,QDMU>R\]-J=5DC4
M
M                      @ ]<_U4*/#'JNKQ]Z4V&:U\I>X,#Q-1EL;5<07
M'3W6&4JRF,O=\AR45/%,.[9NZQTMC@88JZ9[2KB;(UUQ<VUI'>3[]#GI:MYR
M]TQY@=Z;>+>5W$9])QWTF.0WM.B]=K-)]NVQUO7)NK6B:Y(Z-M$6C)EMAWAY
M,^6L]V\E]_.8QQ/;>UO]3.DQGS1I,8]/\G6)BV29\+>&.(GJM-* 5Q<7%Y<3
MW=W/-=75U-+<7-S<2USW%Q<3UU2S3SS2U5233325<U555<\U55<\\\\^U?KC
MQX\..N+%6*XJQ$5K$1$1$1I$1$>$1$>$1'A$)PUK6E8K6(BL1I$1[(CZ$/XO
M[?Z         U0O3T_($\'?T/_&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_
M&N[^Z,CL!J%BH               "'[U[?\ "<\K?Y"_ZR?3J7OH-_XKNU?]
MI_D?D&U?)/\ 2=QG^D?<F=F_.C9/T       !V!Z>GY??@[^F!XT?CHTIJ'U
M!_H$[X_HAS/Y.W+%>^_S(YG\5;O[GR-4)RU*UP
M
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M&MJ3$:S^S+7!<EBKL
M
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M2/A:D\\MQCP^6F^QWUZLM]O2O[,;C%?Q^A\6EO[ND-&1SKH$
M
M                   ,WWU[?\6/RM_D+_JV=.NC;T&_\*/:O^T_RQR"?WDG
M^C'C/](^Z\Z']+UM0       !?!^E[_($[>_3 W_ /$OX_J)_G//T]\1_1#:
M_E'E4+/4=^>^U_%6+[HW*R"KD:                  8_KKS6I
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M;^YM:VWO[>GX9PVF9F>K'$Q$3;QO72WMZHK+>B6U<
M
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MQ+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.P&H6*@
M(?O7M_PG/*W^0O\ K)].I>^@W_BN[5_VG^1^0;5\D_TG<9_I'W)G9OSHV3]
M       =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3MRQ7OO\R.9_%6[^Y\
MC5"<M2M<
M                                        !GN_4<?XF&T?\G^IO_=-
M\Z!_FZ/^&K:_CC?_ /:53I\@OT>8_P#Q>?\ ^NA ^G8W2          V G(8
MJM
M                                                8_KKS6I
M     )X/IQ_\3#5_^3_;/_NFQ03^<7_X:MU^.-A_VEFEO/W]'F3_ ,7@_P#K
MI:$3GX06
M                                       9OOKV_P"+'Y6_R%_U;.G7
M1MZ#?^%'M7_:?Y8Y!/[R3_1CQG^D?=>=#^EZVH        O@_2]_D"=O?I@;
M_P#B7\?U$_SGGZ>^(_HAM?RCRJ%GJ._/?:_BK%]T;E9!5R-
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MA,36=+1,1T@UPQ\
M
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M-'XZ-*:A]0?Z!.^/Z(<S^3MRQ7OO\R.9_%6[^Y\C5"<M2M<
M
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M,O.
M                                               ?!]J;1D-'ZP['
MW7$PV=QE=/T/;]HQEOD8YY<?/D-?U[(Y:SAOHK:XM+F6SEN;2FF6F.6*NJCG
MGBFNGGV<\>]VMQ>WYON?CN%W<WKM=YO]O@O-)B+Q3+EICM-9F+1%HBTS69K:
M(G36)CP?;QNVIO.1V^SRS,8LN>E)F/;$6M%9TUB8UTGPUB?V&1RZU5HH
M     "Q%],GK>,SGJ&;ID[^B:JZT[Q=['V3"\Q3<QT1Y.Z[!ZCU"6NXHXXYX
MN(><-M5W3Q1S[..).::O\M/"O/YS'D=SL?3YLMM@F/=;SNC9X<FL:S-*[3?[
MB-/H3[S!CG7Z&L?"T/ZB-QDP]B8<=-.G+R6*EOV(Q9[^'T/C4K_<UA?@4,(2
M@
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M<5FFXQWFMJSX36U9TM$Q]&)B8E^P^-^0
M
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MCHTIJ'U!_H$[X_HAS/Y.W+%>^_S(YG\5;O[GR-4)RU*UP
M
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M,T3$QI,3&2T3$Q/C$Q/A,3['MK"GC@
M
M             /'O(;_@#WE_R>[,_P!R\VR_R^_/[@_QQL_NG&]7@O\ US9_
M^+P_]I5DO.L19Z          L@?2]_E]]O?H?[_^.CQ_5R?.>?H$XC^E^U_)
MW*M >H[\R-K^-<7W/N5\)1.A8
M                                                        S??7
MM_Q8_*W^0O\ JV=.NC;T&_\ "CVK_M/\L<@G]Y)_HQXS_2/NO.A_2];4
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MA8XC3)$1I:FE_":6F]TE3$B,
M
M                    JR?4#^JI7U1KF5\&?'[9H:>R-XP/P^_]NPUU;W$^
MB:-G(I:*.ML??6&4^8Q.[;ACZ??RM$]O[UK@+N/B/VR7U,EO:1Z /2Q7NOD<
M7GCW_MIGMS8Y]>*V^2LQ&ZW.*8_SR];4TR;;;W\,$UMI?=8[3;XN":Y))^1O
MEI')[BO>?.8Y^]^&_P#FU+1,1DR5_P"MF)C2V/'/U&D^.2LZ^%-+4F%U:7X
M           #5"]/3\@3P=_0_P#&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9
M_&N[^Z,CL!J%BH               "'[U[?\)SRM_D+_ *R?3J7OH-_XKNU?
M]I_D?D&U?)/])W&?Z1]R9V;\Z-D_0       '8'IZ?E]^#OZ8'C1^.C2FH?4
M'^@3OC^B',_D[<L5[[_,CF?Q5N_N?(U0G+4K7
M
M          4G?JGO^/WBM_R>W+_?2)=3\UM^8/=7XXV_W-*7WIL_]#Y/_P 7
MC_[-5?6E)*          -4+T]/R!/!W]#_QH_$OI3EJ]0?Z>^^/Z7\S^4=RK
M7[[_ #WYG\:[O[HR.P&H6*@
M
M      .:?-':KC1?#KRQW:TM(;^ZT[QI[VVJVL;BNN.WO+C7NKMIR\-I/)'[
M9(X;B2TXHJJI_9<4\\\\?=;*\F>*Q\[YP=J<)EO./%O.Y>,P6M$1,UC+O<&.
M;1$^$S$6UB)\-60]H[:N][KXS9VF:UR\CMJ3,>V(MFI76/V-64FZJ5F(
M     "T1]+/@,3<>3WDMM$UI[^=P_0V)P&.OOCW-/R^)V3L'!Y'-6GRU$U-G
M-\[>:I85_$DCJEC^![(ZJ::Y.*ZP?G1M_N\?EEVUQ=+Z;'-SV3+>NE?')AVF
M6F.W5IU1TUSY8TB8K/5K:)FM9B./J2SY:]N<=MHGZS?>VM,:1XVIBM%9U]OA
M%[>$3I.OCKI&EWI24AV
M                                                  S??7M_Q8_*
MW^0O^K9TZZ-O0;_PH]J_[3_+'()_>2?Z,>,_TC[KSH?TO6U        %\'Z7
MO\@3M[],#?\ \2_C^HG^<\_3WQ']$-K^4>50L]1WY[[7\58ONC<K(*N1H
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M]"(M2?J(M>?- II$
M
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MMMM]GML>SVE*X]KBI6E*5C2M:5B*UK6(]D5B(B(^"(?@ON?L
M U0O3T_($\'?T/\ QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :
MA8J                A^]>W_"<\K?Y"_P"LGTZE[Z#?^*[M7_:?Y'Y!M7R3
M_2=QG^D?<F=F_.C9/T       !V!Z>GY??@[^F!XT?CHTIJ'U!_H$[X_HAS/
MY.W+%>^_S(YG\5;O[GR-4)RU*UP
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M'<JU^^_SWYG\:[O[HR.P&H6*@
M
M        ./\ U"_R!/.+]#_R7_$ONK;WI\_3WV/_ $OX;\H[9E78GY[\-^-=
MI]T8V5ZZE5E          "U!]+#_ ,?O*G_D]IO^^DJK7YTG\P>U?QQN/N:$
M:_4G_P"A\9_XO)_V:[$I61!
M                                                      9OOKV_
MXL?E;_(7_5LZ==&WH-_X4>U?]I_ECD$_O)/]&/&?Z1]UYT/Z7K:@       "
M^#]+W^0)V]^F!O\ ^)?Q_43_ #GGZ>^(_HAM?RCRJ%GJ._/?:_BK%]T;E9!5
MR-                  ,?UUYK4@             'IW3'<78GC[VIHW='4V
MPS:MV)UUGK;8M6SD,%M=\6M];TR0RPW5C>13V61QN1LIY;:[MIJ*X;FVFDBD
MIYHKYXYQGO/L_M[S [6WW9G=>WC==N\C@MASXIF:]59TF)K:LQ:EZ6BMZ7K,
M6I>M;5F)B)>=R_$[#G>-S<1R>.,NPW%)I>NLQK$_0F-)B8F(FLQXQ,1,>,-,
MKT\?._K;U!_'; =TZ5%#KVT6DU6N]J]:RY"B_P KUUO-G3SS<XR:X^#;59'
MYJU]R_Q%_P 1TTW=C/33)3%=Q75M!S2^H7R*[D]/WF'N.S.:FVXXN\>^V.\B
MG13=[:WLO$:ST9<=M<6?%K,TRUF:S?%?%DR5Y=]]E\AV+SU^(WDSDVTQUX<N
MFE<N.?9.GCI:L_%O77XMH\-:S6UNZFC&%@
M
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M[^F!XT?CHTIJ'U!_H$[X_HAS/Y.W+%>^_P R.9_%6[^Y\C5"<M2M<
M
M                         !3^^JY_^4*_^:D_^AT6]?-4_P#Z>?[$_P#R
MNE3Z9O\ [M_Z'_\ A2G\MY2I          :<_I%7%Q=>FGX;2W,\UQ)3TSAK
M>F2>6N:NFWL[[)6EI!37)555Q#:VL%$4=/\ Y:(Z*::>.....',OZM\>/%ZD
M^\:XJQ6L\SDG2(B(UM6EK3X?#:TS:9]LS,S/C*NOS2K6OF%RT5B(CY7:?#Z,
MQ$S/]V?&?II&T=& @
M
M./\ U"_R!/.+]#_R7_$ONK;WI\_3WV/_ $OX;\H[9E78GY[\-^-=I]T8V5ZZ
ME5E          "UQ]*U@,M<]O^7FT0VGOX+#];]8X#)7WQ[:GY;+;)L^S9'"
MVGRU<U-Y-\[9ZI?U_$CCJBC^7]DE5-5<?%=5/SIF_P!IC[1[1XN]]-]FY+>Y
M:5TMXX\.'#3);JTZ8Z;9\4:3,6GJUK$Q6TQ&;U*Y\5>*XK;3/UZ^XS6B-)\:
MTI2+3K[/";U\)G6=?#72=+I2F)$8
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M)9N)Y/'.+?[?)-+UGX)CX8GV368TFMHUBU9BU9F)B7I#''G@
M
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M.>5O\A?]9/IU+WT&_P#%=VK_ +3_ "/R#:ODG^D[C/\ 2/N3.S?G1LGZ
M    [ ]/3\OOP=_3 \:/QT:4U#Z@_P! G?']$.9_)VY8KWW^9',_BK=_<^1J
MA.6I6N
M                                       I_?5<_P#RA7_S4G_T.BWK
MYJG_ /3S_8G_ .5TJ?3-_P#=O_0__P *4_EO*5(         #3A](/\ PS_#
MC_D_CO\ WMEW,UZNO^)7O'\<7_[/&KL\U/TA\M_XN?\ ZVJ2%'%@
M
M                                    "/;U8,_EM;]-WS.R.%N_DKRY
MZ'W/ 33? MKGW\3M=M'J^?M/AW<,\5/S^"S%S!\3BGB6+XGOQU424TUTR"]*
M6PVG)>H_LS;[VG7AKSVWRQ&MH^N8+3GQ6UK,3\7+CI;37IMITVB:S,3G7EE@
MQ;CS XC'FC6D;W';VS'QJ3UUGPT]EJQ.GLG32=8UAF#.G%8P          N
M_2C?_+Z__,M__1%JAOG5O_T#_P!M_P#Y(16]3/\ ]Q/],_\ P5<!5"HK
M
M                           ,WWU[?\6/RM_D+_JV=.NC;T&_\*/:O^T_
MRQR"?WDG^C'C/](^Z\Z']+UM0       !?!^E[_($[>_3 W_ /$OX_J)_G//
MT]\1_1#:_E'E4+/4=^>^U_%6+[HW*R"KD:                  8_KKS6I
M               +"'H6>JK_ $/>S(_'3O?:_DO%[M3,226.<SEY\/$])]AW
MT7N0[1\;C'W=S;Z?MMQ;V]EEXZYH+''RUT9.JJ*B.]YGK\]<OI8_K?[:GS$[
M%VG7YG\5AB+8L==<G);2L^.#3KK$[C!$VR8)BMLF6(G;1%IMABFB_.?RT_WK
MX[[_ '"XM>X]M3QK6/C;C%'[CVQ$Y*1,VI.DVM&N.-9FG3?R4'H0@
M
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MPG/*W^0O^LGTZE[Z#?\ BN[5_P!I_D?D&U?)/])W&?Z1]R9V;\Z-D_0
M  '8'IZ?E]^#OZ8'C1^.C2FH?4'^@3OC^B',_D[<L5[[_,CF?Q5N_N?(U0G+
M4K7
M                                    5-/JJM5M[OKGPUW:JZFHNM>W
M;N358;&FBCFWN+?<<%U_E[FZEDY_;*9K.318J(Z>/V-5,]?//W>*5K_S6'*Y
M,/<?>7"12)Q;C9<?GFVLZQ.WR[K'6L1[-+1NK3,^V)K&GME)WTT[FU.0Y;9Z
M1TY,."^OPQ..V6L1_=]Y.O[$*9"Y1+4         !IP^D'_AG^''_)_'?^]L
MNYFO5U_Q*]X_CB__ &>-79YJ?I#Y;_Q<_P#UM4D*.+
M
M                           $;WJ^?X9_F/\ \G\C_P"]L0D=Z1?^)7L[
M\<4_[/(S_P J_P!(?$_^+C_ZVS,>=,JQ,         !<!^E&_P#E]?\ YEO_
M .B+5#?.K?\ Z!_[;_\ R0BMZF?_ +B?Z9_^"K@*H5%8
M
M              !F^^O;_BQ^5O\ (7_5LZ==&WH-_P"%'M7_ &G^6.03^\D_
MT8\9_I'W7G0_I>MJ        +X/TO?Y G;WZ8&__ (E_']1/\YY^GOB/Z(;7
M\H\JA9ZCOSWVOXJQ?=&Y605<C0                 #']=>:U(
M       !=G^GX]52OM?7,5X,^0.S0U=D:/@?A] ;=F;JWMY][T;!Q145];9"
M^O\ *?,9;=M/Q]7OXJB"W]ZZP%I)Q)[)+&J2XI4]?_I8KVIR.7SQ[ VTQVYO
ML^O*[?'69C:[G+,_YY2M::8]MN+^&>;6TINLE9K\7/%<<0//+RTCC-Q;O/@\
M<_>_-?\ SFE8F8QY+?\ 6Q$1I7'DGZO6?#):-/"^E;3:K=&P
M
M                                   ! EZXOJF6GA7U)/T5T_G_ '/*
M/N36[V/&WF.EEIN>H>OLGQ=8B_["FO+')6%]B=POZ^)X=9YHXK^'=V\MY)QQ
M3;1QW,\O1#Z7,OG1W;7OGN_;Z^5_#;FLWK>(Z=_NZ=.2NTBMJ6KDV]/BVWFN
MFN.],-?'+:V/=GDWY;6[OY2.:Y6G_P";>TR1K$^S/EC2T8M)B8MCCPG-]&LQ
M2/&TS7/PN+BXO+B>[NYYKJZNII;BYN;B6N>XN+B>NJ6:>>:6JJ2:::2KFJJJ
MKGFJJKGGGGGVK_L>/'AQUQ8JQ7%6(BM8B(B(B-(B(CPB(CPB(\(A.6M:TK%:
MQ$5B-(B/9$?0A_%_;_0               &J%Z>GY G@[^A_XT?B7TIRU>H/
M]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5                0_>O;_A.>
M5O\ (7_63Z=2]]!O_%=VK_M/\C\@VKY)_I.XS_2/N3.S?G1LGZ        [
M]/3\OOP=_3 \:/QT:4U#Z@_T"=\?T0YG\G;EBO??YD<S^*MW]SY&J$Y:E:X
M
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MH
M                                            "-[U?/\ #/\ ,?\
MY/Y'_P![8A([TB_\2O9WXXI_V>1G_E7^D/B?_%Q_];9F/.F58F
MN _2C?\ R^O_ ,RW_P#1%JAOG5O_ - _]M__ )(16]3/_P!Q/],__!5P%4*B
ML
M                                S??7M_Q8_*W^0O\ JV=.NC;T&_\
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MAB;<#N9M;;7F=9TC2;8K_#UXYM$:S]77IO'C-JUE=14:R
M
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M?W/D:H3EJ5K@
M                                            *KOU3_\ P"\5?^<&
MY_[EPK2OFMOS^[J_$^W^Z924]-G_ *YR?_A,?_:*3ZZE+X         !I ^@
ME_A.>*7\NG]9/N)SD^O+_BN[J_V9^1^/0"\[/TG<G_H_W)@3 HA-5
M
M                                     (WO5\_PS_,?_D_D?_>V(2.]
M(O\ Q*]G?CBG_9Y&?^5?Z0^)_P#%Q_\ 6V9CSIE6)@         +@/THW_R^
MO_S+?_T1:H;YU;_] _\ ;?\ ^2$5O4S_ /<3_3/_ ,%7 50J*P
M
M                    #-]]>W_%C\K?Y"_ZMG3KHV]!O_"CVK_M/\L<@G]Y
M)_HQXS_2/NO.A_2];4        7P?I>_R!.WOTP-_P#Q+^/ZB?YSS]/?$?T0
MVOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@                 &/ZZ\UJ0
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M(
M                                            #SWMCM30NC^MMT[;
M[0V3&ZCH.@8&]V+9L_E;J"UM;.QLZ>.*(8JKB2*FYR62NJX[6SMJ.>9KR\FB
M@BIJEDHIYR#M3M;GN]^Y-EVEVQMLF[Y_?YZX<.*E9M:UK?#.D3I2E8F^2\_%
MQXZVO>8K69C[^,XW>\QR&'B^-QVR[[/>*4K6)F9F?V/9$1K-I]E:Q-ITB)9H
M_J5>H!V#ZAWD7F.T]BJO,+UQK/VCJW2/7TGLMX=-Z^IRMS=6=QE+*WO\C83;
MYLU/,5SG;V.67X]Q1';QU_)VEG%#TH^FWR![?]/?EWA[6X[HS=Q[GHS\ENX\
M9W&[Z(K:*6FM+1M</QJ;7'-:]-)MDM7WV;-:]A/E]V/L>Q.!IQN#2_(9-+[C
M+[?>9>F(F(F8B?=T\8QUF(TC6TQUWO,Q[I!,Z                  :H7IZ
M?D">#OZ'_C1^)?2G+5Z@_P!/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M             0_>O;_A.>5O\A?]9/IU+WT&_P#%=VK_ +3_ "/R#:ODG^D[
MC/\ 2/N3.S?G1LGZ        [ ]/3\OOP=_3 \:/QT:4U#Z@_P! G?']$.9_
M)VY8KWW^9',_BK=_<^1JA.6I6N
M                                                           J
MN_5/_P# +Q5_YP;G_N7"M*^:V_/[NK\3[?[IE)3TV?\ KG)_^$Q_]HI/KJ4O
M@         &D#Z"7^$YXI?RZ?UD^XG.3Z\O^*[NK_9GY'X] +SL_2=R?^C_<
MF!,"B$U4
M                                                    C>]7S_#/
M\Q_^3^1_][8A([TB_P#$KV=^.*?]GD9_Y5_I#XG_ ,7'_P!;9F/.F58F
M      N _2C?_+Z__,M__1%JAOG5O_T#_P!M_P#Y(16]3/\ ]Q/],_\ P5<!
M5"HK
M                                   ,WWU[?\6/RM_D+_JV=.NC;T&_
M\*/:O^T_RQR"?WDG^C'C/](^Z\Z']+UM0       !?!^E[_($[>_3 W_ /$O
MX_J)_G//T]\1_1#:_E'E4+/4=^>^U_%6+[HW*R"KD:
M8_KKS6I                   )AO1Z]3W.>GMW=QB-UO,EE?&3M;)8^P[8U
M^BO*Y#G3KSGW+.R[7U3"VDTD?.>P<?$=&3CBMII\IB(N8*:*KB*SJBB!ZO\
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MA+])\S\P
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M?D">#OZ'_C1^)?2G+5Z@_P!/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M             0_>O;_A.>5O\A?]9/IU+WT&_P#%=VK_ +3_ "/R#:ODG^D[
MC/\ 2/N3.S?G1LGZ        [ ]/3\OOP=_3 \:/QT:4U#Z@_P! G?']$.9_
M)VY8KWW^9',_BK=_<^1JA.6I6N
M                                                           J
MN_5/_P# +Q5_YP;G_N7"M*^:V_/[NK\3[?[IE)3TV?\ KG)_^$Q_]HI/KJ4O
M@         &D#Z"7^$YXI?RZ?UD^XG.3Z\O^*[NK_9GY'X] +SL_2=R?^C_<
MF!,"B$U4
M                                                    C>]7S_#/
M\Q_^3^1_][8A([TB_P#$KV=^.*?]GD9_Y5_I#XG_ ,7'_P!;9F/.F58F
M      N _2C?_+Z__,M__1%JAOG5O_T#_P!M_P#Y(16]3/\ ]Q/],_\ P5<!
M5"HK
M                                   ,WWU[?\6/RM_D+_JV=.NC;T&_
M\*/:O^T_RQR"?WDG^C'C/](^Z\Z']+UM0       !?!^E[_($[>_3 W_ /$O
MX_J)_G//T]\1_1#:_E'E4+/4=^>^U_%6+[HW*R"KD:
M8_KKS6I                    +8OT]OJHQ:5E-=\ >^LY\/5MFS$MGXU;?
MD[FT@M]=VK/9*:\DZ?R%?-I%+/9[KG<C--@YIKBN2+*S?9]%-=-W:TV]4?S@
MGI9MS6UW'G[V'@UY3;88MS&WI%IG-@Q4BL<A2.J8BVVQ4K7<UK2(G!7Y1:8G
M%EG)&/ST\M9WF/)WQPE/\YQTUW=(B=;4K&GOX\?;CK$1DB(TFD>\G2:VFUSU
M30B2
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M[U[?\)SRM_D+_K)].I>^@W_BN[5_VG^1^0;5\D_TG<9_I'W)G9OSHV3]
M    =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3MRQ7OO\ ,CF?Q5N_N?(U
M0G+4K7
M                                       57?JG_P#@%XJ_\X-S_P!R
MX5I7S6WY_=U?B?;_ '3*2GIL_P#7.3_\)C_[12?74I?          -('T$O\
M)SQ2_ET_K)]Q.<GUY?\ %=W5_LS\C\>@%YV?I.Y/_1_N3 F!1":J
M
M                                    1O>KY_AG^8__ "?R/_O;$)'>
MD7_B5[._'%/^SR,_\J_TA\3_ .+C_P"MLS'G3*L3          7 ?I1O_E]?
M_F6__HBU0WSJW_Z!_P"V_P#\D(K>IG_[B?Z9_P#@JX"J%16
M
M                  9OOKV_XL?E;_(7_5LZ==&WH-_X4>U?]I_ECD$_O)/]
M&/&?Z1]UYT/Z7K:@       "^#]+W^0)V]^F!O\ ^)?Q_43_ #GGZ>^(_HAM
M?RCRJ%GJ._/?:_BK%]T;E9!5R-                  ,?UUYK4@
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M[0Y2>:XJG_YM[O).D1[,&6=;3BTB(BN.?&</T*Q-)\:Q-I[4#6DP
M
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M$16M8B(B(A8!M-IMMAML>RV6.F+:8J16E*Q$5K6(TB(B/"(B'S;T7T
M              -4+T]/R!/!W]#_ ,:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_S
MWYG\:[O[HR.P&H6*@               (?O7M_PG/*W^0O\ K)].I>^@W_BN
M[5_VG^1^0;5\D_TG<9_I'W)G9OSHV3]        =@>GI^7WX._I@>-'XZ-*:
MA]0?Z!.^/Z(<S^3MRQ7OO\R.9_%6[^Y\C5"<M2M<
M
M            !5=^J?\ ^ 7BK_S@W/\ W+A6E?-;?G]W5^)]O]TRDIZ;/_7.
M3_\ "8_^T4GUU*7P         #2!]!+_  G/%+^73^LGW$YR?7E_Q7=U?[,_
M(_'H!>=GZ3N3_P!'^Y,"8%$)JH
M
M         !&]ZOG^&?YC_P#)_(_^]L0D=Z1?^)7L[\<4_P"SR,_\J_TA\3_X
MN/\ ZVS,>=,JQ,         !<!^E&_\ E]?_ )EO_P"B+5#?.K?_ *!_[;__
M "0BMZF?_N)_IG_X*N JA45@
M                                                      &;[Z]O
M^+'Y6_R%_P!6SIUT;>@W_A1[5_VG^6.03^\D_P!&/&?Z1]UYT/Z7K:@
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M2(C+BF9BMM(F>F=8FMJS.L6B?;$Q,]O-),.
M
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MZ>GY G@[^A_XT?B7TIRU>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M              0_>O;_ (3GE;_(7_63Z=2]]!O_ !7=J_[3_(_(-J^2?Z3N
M,_TC[DSLWYT;)^@       .P/3T_+[\'?TP/&C\=&E-0^H/] G?']$.9_)VY
M8KWW^9',_BK=_<^1JA.6I6N
M                                                        JN_5
M/_\  +Q5_P"<&Y_[EPK2OFMOS^[J_$^W^Z924]-G_KG)_P#A,?\ VBD^NI2^
M          :0/H)?X3GBE_+I_63[B<Y/KR_XKNZO]F?D?CT O.S])W)_Z/\
M<F!,"B$U4
M                                                     C>]7S_#
M/\Q_^3^1_P#>V(2.](O_ !*]G?CBG_9Y&?\ E7^D/B?_ !<?_6V9CSIE6)@
M        +@/THW_R^O\ \RW_ /1%JAOG5O\ ] _]M_\ Y(16]3/_ -Q/],__
M  5<!5"HK
M                                        ,WWU[?\ %C\K?Y"_ZMG3
MKHV]!O\ PH]J_P"T_P L<@G]Y)_HQXS_ $C[KSH?TO6U        %\'Z7O\
M($[>_3 W_P#$OX_J)_G//T]\1_1#:_E'E4+/4=^>^U_%6+[HW*R"KD:
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MO-+UM$Q,3'[/MB8TFL^RU9BT:Q,/0F/O@
M
M         ?FYG,X?7,/E=AV'*XW!8#!8V^S.<SF9OK7%X?#8?%VLM]D\KE<G
M?2P66.QN.LH*YIYYJZ(H8J*JZZN*>.>7T[/9[SD=YBX_C\63/O\ /DKCQ8L=
M;7R9,E[16E*4K$VO>]IBM:UB;6M,1$3,OTQ8LNXRUP8*VOGO:*UK6)FUK3.D
M5K$:S,S,Z1$>,SX0SF_6,]3O*>H/WEQB-!R.8Q_B_P!4WD]CU3@;J+)8>3<,
MIS;TVN8[2VG!3W\T/.8RLU<\.(XFA@N<?A*Z(ZXH;F>]IKZ*/1[Z9-KZ?NQ_
ME?/X\.3S.Y6D6WV6LTR1MZ:]6/98,L5B?=TCIMN.FUJ9=S$VK>^/'AF)[^5'
MEUC[%X;WN^K2W<>YB)S6C2WNXUUKAI:(^IKX3?29BV368F:UII#FF$VN
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M[[TY#OKGK\OO(G'MHCHPXM=:XL<>R-?#6UI^->VGQK3X:5BM:Y<[J 6/
M     -4+T]/R!/!W]#_QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC(
M[ :A8J                A^]>W_  G/*W^0O^LGTZE[Z#?^*[M7_:?Y'Y!M
M7R3_ $G<9_I'W)G9OSHV3]        =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/
MZ(<S^3MRQ7OO\R.9_%6[^Y\C5"<M2M<
M
M   !5=^J?_X!>*O_ #@W/_<N%:5\UM^?W=7XGV_W3*2GIL_]<Y/_ ,)C_P"T
M4GUU*7P         #2!]!+_"<\4OY=/ZR?<3G)]>7_%=W5_LS\C\>@%YV?I.
MY/\ T?[DP)@40FJ@
M                                                           $
M;WJ^?X9_F/\ \G\C_P"]L0D=Z1?^)7L[\<4_[/(S_P J_P!(?$_^+C_ZVS,>
M=,JQ,         !<!^E&_P#E]?\ YEO_ .B+5#?.K?\ Z!_[;_\ R0BMZF?_
M +B?Z9_^"K@*H5%8
M                                              !F^^O;_BQ^5O\
M(7_5LZ==&WH-_P"%'M7_ &G^6.03^\D_T8\9_I'W7G0_I>MJ        +X/T
MO?Y G;WZ8&__ (E_']1/\YY^GOB/Z(;7\H\JA9ZCOSWVOXJQ?=&Y605<C0
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M]A/<?"8X_P!X-M2?>5C2)W&*(]D_1R8HC6D^VU=<?QI]W%;[2AM"8
M
M                            !3.^H/\ 55^^C*9SP(\>MK][7,%>2V'D
MWM^!O/V.8V;%Y*:*;I"&?G'TU46>K7^/BGS\MI=5<7%[5]F2^Y\K?0S7(_-^
M>EC[V;7!Y\^86T_^J.>D6X;;Y:_XO#>D3')3'7XVSUO-=K7)2.G'_G--?>X+
MTEIY%^6GR;'3O;G<7^<7C7:4M'U-)C_O'M]MXF8Q1:OA7ZY&O528J7+8DG@
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M3^\O$7G_ '<VEY\8F-,^6)FLY=8F8G'$>&+Z,3:\_5Q6D^:!32+']=>:U(
M      !JA>GI^0)X._H?^-'XE]*<M7J#_3WWQ_2_F?RCN5:_??Y[\S^-=W]T
M9'8#4+%0               $/WKV_P"$YY6_R%_UD^G4O?0;_P 5W:O^T_R/
MR#:ODG^D[C/](^Y,[-^=&R?H       #L#T]/R^_!W],#QH_'1I34/J#_0)W
MQ_1#F?R=N6*]]_F1S/XJW?W/D:H3EJ5K@
M
M     *KOU3__  "\5?\ G!N?^Y<*TKYK;\_NZOQ/M_NF4E/39_ZYR?\ X3'_
M -HI/KJ4O@         &D#Z"7^$YXI?RZ?UD^XG.3Z\O^*[NK_9GY'X] +SL
M_2=R?^C_ ')@3 HA-5
M
M  (Y/5UM[BZ]-/S)BMH)KB2GIG,W%4<$5<U=-O9WV-N[N>JB.FJKB&UM8*Y9
M*O\ RT1T555<\<<<\I%^DC)CQ>I/LZV6T5K/,XXUF8B-;5O6L>/PVM,5B/;,
MS$1XRS[RMM6OF%Q,VF(CY76/'Z,Q,1']V?"/ILQATT+%          %P'Z4;
M_P"7U_\ F6__ *(M4-\ZM_\ H'_MO_\ )"*WJ9_^XG^F?_@JX"J%16
M
M                         9OOKV_XL?E;_(7_ %;.G71MZ#?^%'M7_:?Y
M8Y!/[R3_ $8\9_I'W7G0_I>MJ        +X/TO?Y G;WZ8&__B7\?U$_SGGZ
M>^(_HAM?RCRJ%GJ._/?:_BK%]T;E9!5R-                  ,?UUYK4@
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M:5UGW66TS,Y8^ACR3/C'LID]DZ7K6MHE6 C@
M
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MIZ?D">#OZ'_C1^)?2G+5Z@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M             !#]Z]O^$YY6_P A?]9/IU+WT&_\5W:O^T_R/R#:ODG^D[C/
M](^Y,[-^=&R?H       #L#T]/R^_!W],#QH_'1I34/J#_0)WQ_1#F?R=N6*
M]]_F1S/XJW?W/D:H3EJ5K@
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M?9$?%ICI2L>&GLK6(U]LZ:SK.LI.49FN@
M
M                ''_J%_D"><7Z'_DO^)?=6WO3Y^GOL?\ I?PWY1VS*NQ/
MSWX;\:[3[HQLKUU*K*          %LKZ57:KBS['\RM(IM(:[78=)Z;VJ:^J
MKKXN+>XTW.[_ (BVM(H^/VNN&]CWJ6N2KG]E35!1QQ]SFI5!\Z?Q6/-VYV;S
M<WF,NWWO(8(KI&DQN,6UR6M,^W6L[6L1'LF+3K[(1B]2VVK?C^)WFL]6/-GI
MI\$QDKBM,_W/=QI^S*YPIK1*
M                                                       9OOKV
M_P"+'Y6_R%_U;.G71MZ#?^%'M7_:?Y8Y!/[R3_1CQG^D?=>=#^EZVH
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MDX,77DX/<:VV^2?;I&G5CO,1$>\QS.DZ?55FM](FTUK*BBTUJ
M
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M_H?^-'XE]*<M7J#_ $]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M       !#]Z]O^$YY6_R%_UD^G4O?0;_ ,5W:O\ M/\ (_(-J^2?Z3N,_P!(
M^Y,[-^=&R?H       #L#T]/R^_!W],#QH_'1I34/J#_ $"=\?T0YG\G;EBO
M??YD<S^*MW]SY&J$Y:E:X
M                                                     "G]]5S_
M /*%?_-2?_0Z+>OFJ?\ ]//]B?\ Y72I],W_ -V_]#__  I3^6\I4@
M   -.'T@_P##/\./^3^._P#>V7<S7JZ_XE>\?QQ?_L\:NSS4_2'RW_BY_P#K
M:I(4<6
M                                                   ./_4+_($\
MXOT/_)?\2^ZMO>GS]/?8_P#2_AORCMF5=B?GOPWXUVGW1C97KJ564
M   +4'TL/_'[RI_Y/:;_ +Z2JM?G2?S![5_'&X^YH1K]2?\ Z'QG_B\G_9KL
M2E9$$
M                                   !F^^O;_BQ^5O\A?\ 5LZ==&WH
M-_X4>U?]I_ECD$_O)/\ 1CQG^D?=>=#^EZVH        O@_2]_D"=O?I@;_^
M)?Q_43_.>?I[XC^B&U_*/*H6>H[\]]K^*L7W1N5D%7(T
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MBT3$="-?/"
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M?T/_ !H_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J
M        A^]>W_"<\K?Y"_ZR?3J7OH-_XKNU?]I_D?D&U?)/])W&?Z1]R9V;
M\Z-D_0       '8'IZ?E]^#OZ8'C1^.C2FH?4'^@3OC^B',_D[<L5[[_ #(Y
MG\5;O[GR-4)RU*UP
M                                                %/[ZKG_Y0K_Y
MJ3_Z'1;U\U3_ /IY_L3_ /*Z5/IF_P#NW_H?_P"%*?RWE*D         !IP^
MD'_AG^''_)_'?^]LNYFO5U_Q*]X_CB__ &>-79YJ?I#Y;_Q<_P#UM4D*.+
M
M                                           '+OG#KF3W'PK\O]1P
MM,->9VKQ=\@-<Q-%Q-Q;V]>3SG4^VXRPIGGJXYI@AJNKJCBJOGCGBFGV\_\
M@VAY(\CMN'\Z.T.7WLS&SVO='%9LDQ&L]&+?8+VTCX9Z:SI'PRR3L[<8]IW?
MQ6ZS:^ZQ<EMKVT\9TKFI,Z1^Q#*?=4:RX         !::^EBN+>GR&\I+2J>
M&FZFZ8U2XAMJI:.+B6WM=XHCN9XH>:OB20V\EW%375QQS315+1QSSQS5Q[:N
M/G2,>2?+WM?+%9]U7F<\3;2=(FVVUK$S[(F8K:8CVS%9T]DHV^I.MOO%QMM)
MZ8W=XU^#6<?A']W2=/V)7:%*:'X
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M)&78;BD7I;28UB?HQ.DQ,3$Q:)\8F)B?&'F+)GH@         )F/1I]3O-^
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MU;1,6K:)TFMHG28F)C28GQB?"7Z3YGY@
M
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M7TAO32UST]^@;2K9L=C<AY)]IXW$YGN?:8Z8KB;"5\P\7N/ZJPE[;Y+*8^O
MZ1<74D4]U9UTQYB_XKNJO;%3:QP<YWJY]2?(^H+OZ\<9DR8_+?B\F3'QV"=8
MC)&O3??9*S2EXR[F*Q:M,D3.WQ:8HTM.6UX">:?F%N.^N<GY/:U>W]M:U=O3
MV=7P3FM$Q$]62(B8BWC2NE?;U3:6]$MJX  !C^NO-:D         U0O3T_($
M\'?T/_&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH
M        "'[U[?\ "<\K?Y"_ZR?3J7OH-_XKNU?]I_D?D&U?)/\ 2=QG^D?<
MF=F_.C9/T       !V!Z>GY??@[^F!XT?CHTIJ'U!_H$[X_HAS/Y.W+%>^_S
M(YG\5;O[GR-4)RU*UP
M                                                  %,WZJS;/G-
M_P###1OD/A_>[I_=>V?:GS7O_.??GFNM\/\ (?)?+4_+_9OWA?$^+\:OXWS?
MN^Y1\+WI+D?FK^*]SP'>?.>\U^4;SC<'1T_4_)\>\R=?5KX]?RK3IZ8Z>C76
MW5I66GIIVO1L>7WO5_C,NWIII[/=URVUUU\=?>:::>'3[9U\*EZV))X
M    !J5>FQ@,3K?I[^$F.PMI\E9W/BOT3GYH?CW-S[^6VOK;7=HS]W\2[FGE
MI^?SN8N9_A\5<11?$]R.FB.FFBGEV]2._P!WR7J"[VW&]OUYJ]T\GBB=*Q];
MP;S-@Q5TK$1\7%CI773JMIU6F;3,S6[Y@Y\NX[ZYC)FG6\<GN:^R(^+3+>E8
M\-/96L1K[9TUG6=9=L-*L/
M
M      >/>0W_  ![R_Y/=F?[EYME_E]^?W!_CC9_=.-ZO!?^N;/_ ,7A_P"T
MJR7G6(L]          60/I>_R^^WOT/]_P#QT>/ZN3YSS] G$?TOVOY.Y5H#
MU'?F1M?QKB^Y]ROA*)T+
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M4Z(G
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M-'XZ-*:A]0?Z!.^/Z(<S^3MRQ7OO\R.9_%6[^Y\C5"<M2M<
M
M                   !2=^J>_X_>*W_ ">W+_?2)=3\UM^8/=7XXV_W-*7W
MIL_]#Y/_ ,7C_P"S57UI22@         #5"]/3\@3P=_0_\ &C\2^E.6KU!_
MI[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH
M
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M)FN/D\5K?2CW.XKK/_S6K'[,POJ*'D*
M
M  &;[Z]O^+'Y6_R%_P!6SIUT;>@W_A1[5_VG^6.03^\D_P!&/&?Z1]UYT/Z7
MK:@       "^#]+W^0)V]^F!O_XE_']1/\YY^GOB/Z(;7\H\JA9ZCOSWVOXJ
MQ?=&Y605<C0                 #']=>:U(        !JA>GI^0)X._H?\
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M5ITTBLSK.'QUZ8FDZS3JM.V@LTN
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M<WF5/:7'?>+A[Z=Q;O'KU1,Q.#%.L>\B=/\ &6TM7'I,372<GP5BU_Y02@\
M    Q_77FM2         :H7IZ?D">#OZ'_C1^)?2G+5Z@_T]]\?TOYG\H[E6
MOWW^>_,_C7=_=&1V U"Q4               !#]Z]O\ A.>5O\A?]9/IU+WT
M&_\ %=VK_M/\C\@VKY)_I.XS_2/N3.S?G1LGZ        [ ]/3\OOP=_3 \:
M/QT:4U#Z@_T"=\?T0YG\G;EBO??YD<S^*MW]SY&J$Y:E:X
M
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MR<ANLVGO<N^SWMIX1K;+>9TC]F7O[ 7A@
M
M                 ,?UUYK4@         $\'TX_^)AJ_P#R?[9_]TV*"?SB
M_P#PU;K\<;#_ +2S2WG[^CS)_P"+P?\ UTM")S\(+
M
M            ,WWU[?\ %C\K?Y"_ZMG3KHV]!O\ PH]J_P"T_P L<@G]Y)_H
MQXS_ $C[KSH?TO6U        %\'Z7O\ ($[>_3 W_P#$OX_J)_G//T]\1_1#
M:_E'E4+/4=^>^U_%6+[HW*R"KD:                  8_KKS6I
M -4+T]/R!/!W]#_QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A
M8J    _'V'7\)MF SFJ[+B[/-ZYLV'R>O[!A<C#3<8_+X3,V4^.RN+OK>O\
M8SV=_87,D4M'/W*J*^>/_%]G'\AO>)W^#E>-RWP<CMLU,N+)2=+X\F.T7I>L
M_!:EHBU9^"8B7ZX,^;:YZ;G;VFFXQWBU;1X36U9UK,3]&)B)AG$^K]Z9V?\
M3S[[JDU:WO,MXW=LWF8SW3FR^Y>ST:S[+ZXGO^HMCO;Z[O[R;9-*LY8?E[N>
M6O[8QDD5S37S<4WT%KT8>D3U+;#U!]AQ7E+4P^8_$TQXN0PZUCWWQ8BN_P -
M:UK6,.YM%NO'6L?)\T7QS'NYP7RS[\J_,/!WWPFFYF*]P;6*UST\(Z_"-,](
MB(CHR3KK6(^)>)KIT]%K1%I;MI          /8.A.^.T/&;MO2>[NF]GO-3[
M T+,09;#Y&VDFXMKN*GGW,A@LW:12PT9?6\_8U26F0LI>?@W=I-7%7Q[*F(=
M^]B=K^9?:6][)[QVU-WP&_PSCR4M$=59]M,N.TQ/N\V*VF3%DCXV/)6MH\8>
M5S?"\;W%Q>;A^6QQEV.>DUM$^V/H6K/[F]9TM6T>-;1$PTRO 'S@ZS\_?'36
M.\.O^?LO,4? UOM+1IJY9+WKSLRRQ6.OMBUCFYFA@^U\/Q]HQW&,R-%%-%]C
MYXJZZ(+CB>V@YI?/WR1[E\@_,3==D=P?7=G.N;9;F-(KN]G:]ZX<W3$S[O)\
M2:9L,S,XLM;1$WQ^[R7KR[X[.Y'L?GLG#;[XV+QOAR?!EPS:8K?3QZ;>$Q>O
M[FT3$3->FT]L-*L/
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M"(TB(B(B*Q'A$1$1X0].8R\X    !C^NO-:D         U0O3T_($\'?T/\
MQH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J
M   A^]>W_"<\K?Y"_P"LGTZE[Z#?^*[M7_:?Y'Y!M7R3_2=QG^D?<F=F_.C9
M/T       !V!Z>GY??@[^F!XT?CHTIJ'U!_H$[X_HAS/Y.W+%>^_S(YG\5;O
M[GR-4)RU*UP
M                                           %#WZH3\OOJ']#_0/Q
MT>0"]CYL/] G+_TOW7Y.XI-/TX_F1NOQKE^Y]LK?K&V_P         &M#X\_
M\ >C?^3W6?\ N7A')WY@_G]SGXXWGW3D5A<[_P"N;S_Q>;_M+/86(/*
M
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M#3QB/'36)T7G.T@2
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MHTFLQ_\ "8F-)B8F8M$Q:LS$Q+[QX3X@
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MN6*]]_F1S/XJW?W/D:H3EJ5K@
M                                                         ,]W
MZCC_ !,-H_Y/]3?^Z;YT#_-T?\-6U_'&_P#^TJG3Y!?H\Q_^+S__ %T('T[&
MZ0         &P$Y#%5H
M
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M6\4PV]L1\6FXPWM/CI[*UF=/;.FD:SI#2:<WJOP
M
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M1%\Y1"A2
M                              IS?4'^JQ+DKO.> GCQM%Y:6>+O)+/R
M?W/"3W=E+DKN**:#GHRPOJ>(?C8>'XW$^S50>]3<S4PXWF7B./)VTUPOS?GI
M6KML6#S[\PMK2^;+2+<+M\D5M%*S,3]\[U\=,DZ=.RBVDTK-]ST]5MMDI*_R
M+\LXQUIWOSV.)O:-=GCMI.D?QB8_PO@PZ^R-<FFLX[1466W)1@
M+_OH7^E=+X8]9U^0G=N#^7\F^X=;AMZ,'D+:[MLATWUQDY;/*1Z/=6TUWS#Q
MN&P36-I>9JJ2WBN+"N./'T^[S#<U7%!7KD]4U?.7N6/+[LG/U>6?#[F9][2:
MVIR&\I%J3N:S%=?D^*+9,>VB+VIEB;;B=>O%&.#_ )S>94=V\C]XN'OKV[M,
MFO5$Q,9\L:Q[R)T_Q==;5QZ3,6UG)\-8K8%0!:-       8_KKS6I
M  -4+T]/R!/!W]#_ ,:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.P
M&H6*@               (?O7M_PG/*W^0O\ K)].I>^@W_BN[5_VG^1^0;5\
MD_TG<9_I'W)G9OSHV3]        =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<
MS^3MRQ7OO\R.9_%6[^Y\C5"<M2M<
M
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MVFNDZ:Z::Z3I]!KIN2-5N
M
M       RO?4+_+[\XOTP/)?\=&ZNI7T^?H$['_HAPWY.VRRCL3\R.&_%6T^Y
M\;C]MYE0        "2#TA/\ $O\ #?\ YPXW_P!U99'+U=?\-7>/XGO_ -IC
M8!YJ?H\Y;_PD_P#UU6G$YF5=@
M                                                       #-]]>
MW_%C\K?Y"_ZMG3KHV]!O_"CVK_M/\L<@G]Y)_HQXS_2/NO.A_2];4
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M2(BM+_%\(O2L6<59B.H
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M  G/*W^0O^LGTZE[Z#?^*[M7_:?Y'Y!M7R3_ $G<9_I'W)G9OSHV3]
M  =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3MRQ7OO\R.9_%6[^Y\C5"<M
M2M<
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MM:9]D1&*TS,_L0UD7*(K&
M
M       9A?JS8?&8/U)?,VRQ-G#86L_>>UYB6"#CGBBO)[#7;Y_-7E7%7-7/
MQLCF<G/<2<_Y.9):N>/9Q]QTW^D_>;G?>F_LW-N[SDRUX/!CB9]L4Q:XL=?V
M*8Z5I'TJPL7\L,N3-Y?<3?+,VM&RI7Q^A76M8_N5B(CZ4(\4A&=@
M.P/3T_+[\'?TP/&C\=&E-0^H/] G?']$.9_)VY8KWW^9',_BK=_<^1JA.6I6
MN
M                                S??7M_Q8_*W^0O\ JV=.NC;T&_\
M"CVK_M/\L<@G]Y)_HQXS_2/NO.A_2];4        7P?I>_R!.WOTP-__ !+^
M/ZB?YSS]/?$?T0VOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@                 &
M/ZZ\UJ0        #5"]/3\@3P=_0_P#&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO
M\]^9_&N[^Z,CL!J%BH      #^-Q;V]Y;SVEW!#=6MU#+;W-M<143V]Q;ST5
M1303PRTU1S0S1U<TU4U<<TU4\\\<\>Q_>/)DPY*Y<5IKEK,36T3,3$Q.L3$Q
MXQ,3XQ,>,2_VMK4M%JS,6B=8F/;$_1A0!]<_TKZ_#'M2KR"Z4UZ&V\6NX,]Q
M#1B<=3;P6_3W9^5IRN3O=#AQL57%4.DYJUQ\M]@9HJ*8+2GB;'5T1<6UI)>7
M[>ASU2U\Y>UH\O\ O3<3;S1XC!K.2^LSR&RIT4KNIO/MW..UZX]U6TS;)/1N
M8FTY,M<,X?)GS*CNWC?O'S&29[DVM/JIUF<^&-(C)K_E*S,5R1/C;PR1,]5H
MI "GTW@          ^JT;>-NZSW+5NPM!V#):INVE9[%[/JNR8>?FVR>$SV%
MO(K_ !F2LIO953Q-:W4%-7'%7%5%7''NU<<T\\\<^7SG"<3W+PVZ[>Y[;X]W
MPN]P7PY\.2-:9,62LUO2T?0M69CPTF/;$Q,1+YM[L]KR.TR;#?8ZY=GFI-+T
MM&L6K:-)B?V8:2?I2>HYJGJ(>/-IM%[-A\)WQU_\GKG=VBV-=O9TVV;JM8Y+
M'=]:P]>5R>5CT/<8_?JLY)^>.8;VWN[3VR?+<2R<W_JJ].G*^GGS"OQF",V?
ML3D.K-QNYMK;7'U3%MMFR=%*3NMO.D9(K]5CMBS:5]YTUK]\S.P=SV'SL[:D
M7OPN?6^WR3K.M=?''>W3$>\Q_NHCVUFMO#JTB45&!K@
M
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M>V3=9;VO>]IUM:]IFUK6F?;-IF9F?AF7[SX'X        ,?UUYK4@
M &J%Z>GY G@[^A_XT?B7TIRU>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0
ML5                0_>O;_ (3GE;_(7_63Z=2]]!O_ !7=J_[3_(_(-J^2
M?Z3N,_TC[DSLWYT;)^@       .P/3T_+[\'?TP/&C\=&E-0^H/] G?']$.9
M_)VY8KWW^9',_BK=_<^1JA.6I6N
M
MS"_5FS&,SGJ2^9M[B;R&_M8.\]KP\L\'//-%&3UZNWP&:LZN:N*>?C8[,XR>
MWDX_R<215<<>WC[KIO\ 2?L]SL?3?V;AW=)QY;<'@R1$^V:9=<N.W[%\=ZWC
MZ5H6+^6&+)A\ON)IEB:VG94MX_0MK:L_W:S$Q]*4>*0C.P        '8'IZ?
ME]^#OZ8'C1^.C2FH?4'^@3OC^B',_D[<L5[[_,CF?Q5N_N?(U0G+4K7
M
M                                         9K/KA:OC]/]5#RWQ.,F
MO)[:[V3K[:)*[Z2"6>G(;QTWUSNN6AHJM[>VCXL[?*[!-';T\T\UT6]-%-=<
ME?%5=721Z(N4W'+^EKM+=[F*5R4VV[P1%8F(Z-MR&[VV.9UFT]4TQ5F\ZZ3>
M;3$5B8K%@WDYN;[KRUXO+DB(M&/+3P^ACSY<=?;,^,UK$S]/72(CP11I5MF
M        /<?&',9/7O)7QYS^%O9L=F<'WEU-F,3D+?GCBXL,GC-^P%[87L'-
M7%5/$UK=045T\\\<\>]3PP?S.V>VY#RV[AV&]I&39Y^#W^/)2?9:E]KEK:L_
M2M69B?I2\;N/%CS]O;_!FB+8K[+/6T3[)B<5HF)_9AK(N416,
M
M                    S??7M_Q8_*W^0O\ JV=.NC;T&_\ "CVK_M/\L<@G
M]Y)_HQXS_2/NO.A_2];4        7P?I>_R!.WOTP-__ !+^/ZB?YSS]/?$?
MT0VOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@                 &/ZZ\UJ0
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M  G/*W^0O^LGTZE[Z#?^*[M7_:?Y'Y!M7R3_ $G<9_I'W)G9OSHV3]
M  =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3MRQ7OO\R.9_%6[^Y\C5"<M
M2M<
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M:<3F95V
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M6CVQ,3XORSX,6YP7VV>.K#DI-;1K,:UM&DQK&DQK$^V)B?H->MR+JL@
M
M                         &;[Z]O^+'Y6_P A?]6SIUT;>@W_ (4>U?\
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M_P 1FF?<YZQ,1;X>B\>/1DB/'IUF+1XUF=+163E&9KH
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M@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4               !#]Z]O\
MA.>5O\A?]9/IU+WT&_\ %=VK_M/\C\@VKY)_I.XS_2/N3.S?G1LGZ
M [ ]/3\OOP=_3 \:/QT:4U#Z@_T"=\?T0YG\G;EBO??YD<S^*MW]SY&J$Y:E
M:X
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M:OEER<UF8G3;QX?0G=8(F/[L>$_2:1#G&0
M
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M;<KN=M@CIPX]QDK6-9G2M;S$1K.LSI$>V9F?HO2&.//
M
M             9OOKV_XL?E;_(7_ %;.G71MZ#?^%'M7_:?Y8Y!/[R3_ $8\
M9_I'W7G0_I>MJ        +X/TO?Y G;WZ8&__B7\?U$_SGGZ>^(_HAM?RCRJ
M%GJ._/?:_BK%]T;E9!5R-                  ,?UUYK4@        &J%Z>
MGY G@[^A_P"-'XE]*<M7J#_3WWQ_2_F?RCN5:_??Y[\S^-=W]T9'8#4+%0
M       %?3UU_2RN/,GK"/R&Z.UN;)>3G3^!ILY-?Q$%<^3[BZUL[V>^N=0M
MK>3)6MKSM6IU9*\R6)JBAFO,AQS+CJ:99)K/B&P'T,>J/'Y.=SSY>][[F,?E
MER^?JC+DF(IQ^\M6*QN)F*6M[C/T8\.>+6KCQ?%W$S6M,W7O/R7\R:]I\C]X
MN9R17MW=7UZK3I&#+,1$7F=)GHOI6E]9BM?#)K$1;6@0OR3?
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MK*N;N?M[?=J\[N.!Y#2=QM[Z=41,1>LQ%J7KK\%ZS%H^AKI/C$NBFNW@@
M                /@^T>S-)Z9ZZW7M;L?.V>M:+U]K>5VO:,W?2QQ06.)Q%
MK)=7'-'$E='S%Y<>YQ%;P4\\RW%Q)1%'Q57733S[W:_;7-=Y=Q;+M7MS!?<\
MYR&YI@P8ZQ,S;)DM%8UTUTK&O5>T^%*1:UIBL3+[>-X[><MO\/&<?2<F]SY*
MTI6/AM:=(_8B/;,^R(B9GPAF.^H;YP;YY^>2VV=W[9S>8S68OB:OU-I-S79U
MTZ%UGCLA?7>"P4DEC###>YBYFOYKW(W57,E<U[<R<4U\0401Q],OI[\D>!\@
M_+;:=D\3T9>3G3-O]S'5_G6\O2M<N6(M,S7'6*UQX:1I%<=*S,>\M>UK$^Q.
MSMEV1V]BX?:Z6W,_'SY(U^N9IB(M;Q]E8TBM(\-*Q'AU3,SPVW@S(
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M
M                                _-S.8QFO8?*Y_-7L..PV#QM]F,MD
M+CGFFWL,9C+66]O[V>JGBJKB&UM8*ZZN>..>?=IY?3L]GN>0WF+8;*DY-YGR
M5QXZ1[;7O:*UK'T[6F(CZ<OTPXLF?+7!AB;9;VBM8CVS,SI$1^S+(/==2TX
M        !.I].ACL?>^IMHUS>6-G=W&(ZK[=R.)N+FVAGFQF0EUG[)DOL=++
M17)97DF+R=S;52Q\TU\V]Q+'SS[DE?',&?G$MQN,/IGWV/#>],>;E=A3)%;3
M$7I&;WD5O$3I:L7I2\5G6.NE;::UB8TQY]Y+T\N\U:6F*WW."+1$Z:QU]6D_
M1CJB)TGX8B?;$-"YSY(*
M
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MFJ6,@
M                                  ,WWU[?\6/RM_D+_JV=.NC;T&_\
M*/:O^T_RQR"?WDG^C'C/](^Z\Z']+UM0       !?!^E[_($[>_3 W_\2_C^
MHG^<\_3WQ']$-K^4>50L]1WY[[7\58ONC<K(*N1H                 !C^
MNO-:D         U0O3T_($\'?T/_ !H_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/
M?F?QKN_NC([ :A8J           I,?4#^E71U/L>5\YO'[69J>M]XSWQ._\
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M_0_\:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_P ]^9_&N[^Z,CL!J%BH
M       "'[U[?\)SRM_D+_K)].I>^@W_ (KNU?\ :?Y'Y!M7R3_2=QG^D?<F
M=F_.C9/T       !V!Z>GY??@[^F!XT?CHTIJ'U!_H$[X_HAS/Y.W+%>^_S(
MYG\5;O[GR-4)RU*UP
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M'VT1,Q$\IBB?IQ[C<SI/]V(G]F(7R%$B%0
M
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M>G_.YG333ZJM;:_W===?AUU^%)"CBP
M                                              !SWY'^5OCOXBZ3
M#V%Y'=K:WU;JUY>58[%W&9XR.0RV=R$<?$TUCK>KZ_89?:=EO+:"KB26+'V5
MS7#%^SKXII^ZV#Y<^57F'YM\U;M[RYXK<\IRE*==XQ]%,>*DSI%LV?+;'@PU
MF?"MLN2D6GPB9GP>[P';//=T[R=AP&VR;G<Q&LQ72*UCZ-[VFM*1,^$3:T:S
MX0K<>1GU2&A8BXN\-XJ^.N>W.J*:]MZ-Z[JS4&HXBKFVKIBM;S':+J4N=S.6
MQN1Y]Z6BJZR^'N8HJ:.*[?BN2JF&Q[RZ^:]Y[=XZ;SS3[BP;.)K69VW'8YW&
M3QC6U;[K/&+'CO3PK,4P;BDVF>G)-:Q-Y <!Z;][EK&7N7?TPZQ$^[V]9O;Q
M]L3DOTUK,>SPI>)G72VD1,Q@9_ZDOU(LQEKO)8Z?H?5+.Y^!\' 8#JRYN<38
M?!MH8)/E)MHVO9,[7\U+%5-)\>]F]DLE7%'N1\41TR<V'S;_ *<-GM*;;<5Y
M[=9JZZY<N]K&2VMIF.J,&##B^+$Q6.G'7XL1U:VUM.QL'I^\O\6*,>2-[EO&
MOQK9HBT^.OCT4I7P]D:5CPCQUG69_CA_J1O4FQF3LK^]O^C=AM;6;B6?"YCJ
MNJ#&9&CCCGCFWO9<!LF#S-$////MYYM[N"3V\?\ F]GMXY_O>?-P^F_<[:^#
M#CYS;Y;1I&3'OM;TGZ-8RX<N.9_Y^.T?2?UE]/\ Y?9,<TI7>X[3'U5<WC'T
MXZJ6K_?K,?22'^.OU2LLV0Q^(\KO&RSM;"?X-%_O?0V<N_\ ,9*IH8I)..M=
M[O+R:XL^(9)):JZ=FYFC^'Q13%+S7[U$>_,3YKNM-ODW?E5W)>^>NLUVO*8J
M_&C29B/EFUK6(MK$5B)V?3.LVF].G2V!\]Z;HC';+VSR$S>/9CW-8\?_ +;C
MB-)]D?XG2===8T\;)OBGYS>+'FKK-6Q^.G;VM[Q<V=G%>;#IDDLF#[%U&BNN
M*"OG:-"S5%ELN,LZ+V3FWCO_ )>3&7<M%7RMS/1QQ7S6]YJ>1WFEY+<G''>8
MG$;G8X[WFN+<1$9=IN--9^L;K'-L-[=,=<XNN,V.LQ[W'CGP1^[F[,[E[0W'
MR?G]KDPUF=*Y/JL5_A^)DKK29T\9KK%ZQ]56L^#K1J9BX      #-]]>W_%C
M\K?Y"_ZMG3KHV]!O_"CVK_M/\L<@G]Y)_HQXS_2/NO.A_2];4        7P?
MI>_R!.WOTP-__$OX_J)_G//T]\1_1#:_E'E4+/4=^>^U_%6+[HW*R"KD:
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M-=IY<[?<5TUW6XSY9T^C&2</C]/3#']S1!NG W(
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M_+[\'?TP/&C\=&E-0^H/] G?']$.9_)VY8KWW^9',_BK=_<^1JA.6I6N
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M58K_  _$R5UI,Z>,UUB]8^JK6?!UHU,Q<
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MVPNK*7$0P
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MO:OC'C6-OBIKX>SXU+1I.D^&OLF)F9E#9J4
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M.NLS-K[>T^'QI]ML5I^IO/C69Z+^/3:]A=7PT2      S??7M_Q8_*W^0O\
MJV=.NC;T&_\ "CVK_M/\L<@G]Y)_HQXS_2/NO.A_2];4        7P?I>_R!
M.WOTP-__ !+^/ZB?YSS]/?$?T0VOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@
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M/JL=XB9TO7X8U\8F+1K68F>;VQGO@
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MOF!WOO>^N?OR>?JIL*3--OBF9TQX]?#6-9CWE_"V28G2;>$?%K6(D": 8,
M           Q_77FM2         :H7IZ?D">#OZ'_C1^)?2G+5Z@_P!/??']
M+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5                0_>O;_A.>5O\A?]
M9/IU+WT&_P#%=VK_ +3_ "/R#:ODG^D[C/\ 2/N3.S?G1LGZ        [ ]/
M3\OOP=_3 \:/QT:4U#Z@_P! G?']$.9_)VY8KWW^9',_BK=_<^1JA.6I6N
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MY,Y.V:9.X>V(OEX&)F<F'QM?;5\/C1:9FV3%$ZZVGX^.-.N;QU7BR:K>1^
M
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M:LS%'U,9\5L_#;:)^O4INK3&D^%;SMXK.OL\9I;PB=8T\=-8UMTJD46P
M
M                                         %;CZH/#6]WX(=09JG%0
MW.0PWE=IMO3EN+&B:]Q6'RW4O=%.0@XO^(JI['&Y/)V6/XFI]^F*:>&W][CF
MNB/V6/?-B;S)B\]>7V4Y9KM\W:FXGW?5,5ODQ[_CNB>G72UZ4MEZ9TFU:VR:
M:1-D@/3EFM7O7=8>J8QWXS)/3KX6M7/M])T^&8B;:?#$3;X)E1$7JII
M     +^/TT.U_?%Z=6;Q'R'R?WA^2'9FJ?,?-?,?:OSFJ];[S\_\'Y:#Y'X?
MWY_*_"]Z;V_+?$]_CXGPZ*$/G*N*^]WJ(P;SWG7\O[<V>?3ITZ.G/O-MT:ZS
MU:_)^OJTK]7TZ?%ZK0A]0NU^3]^TR]6OO^/PWTTTZ=+Y<>GM\?\ %ZZ^'MTT
M\-9L(J^VBP
M                       $?OJ8^<NN> 'BMM_=%[!#EMYRLU.C=0:Q))%3
MQGNR,[87\N(EO:).?>JP.N6MC/E,C[./;7;6G,-//$LT?MW_ .FGR/Y'S]\T
M]IV9@M.+@\4?*=_FB)^M;/%:L9(K,?\ 6YK6KAQ?0ODB\Q-:69SY>=F[COCN
M7%Q%)FNRK'O,]_\ !Q5F.K3_ )5YF*5^G;6?")9E_8._[CVKO6X=F=A9Z\VG
M>M^V3,[=MVQ7_$%%WF=AS]_/D\KD)8K2&VL[?YB\N*ZJ8H(XH(:?91'11133
M3QTN]O\  </VKP6S[:[>P4VO![#;8]OM\-->G'BQ5BE*1-IFTZ5B(FUIM:TZ
MVM:;3,S8?L=CM.,V6+CMA2,>RP8ZTI2-=*UK&E8\=9G2(]LS,S[9F9?'O7?4
M     _2PV9S&N9C%;#KV5R6"S^"R5CF<'G,-?76+S&&S&+NHK[&97%9.QE@O
M<=DL=>P4303PUT2PRT4UT5<5<<<OFWFSV?([/+Q_(8L>?89\=L>7%DK6^/)C
MO6:WI>EHFMZ7K,UM6T36U9F)B8E^>7%BW&*V#/6M\%ZS6U;1$UM68TFMHG6)
MB8G28GPF/"6CWZ-/J'_W@'B]Q?[G/9Q=^]+WF,T;N6RM8_@1YGYNTN)M)[)M
M+;F\OJX;/>\7C;BBX]^J'_VWC<CQ%#';<6_O<YGK']/7]0/F?\GX:MY["YJE
M]SQ]K3K./IM$;G9VGIK$VVM[TFFD6_S;-MIM>V6<FD _-GL/_<?N/HVD3/";
MN)R8)G]SI,>\Q3.D>..9C3V_6[X]9FW4EU1(:M     9OOKV_P"+'Y6_R%_U
M;.G71MZ#?^%'M7_:?Y8Y!/[R3_1CQG^D?=>=#^EZVH        O@_2]_D"=O
M?I@;_P#B7\?U$_SGGZ>^(_HAM?RCRJ%GJ._/?:_BK%]T;E9!5R-
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MF=8><G*QQ/EWR%HMTYMQ2N"D:S'5[V\5O76/_HO>3,3X3$3$^W2=)IS>J_
M                  %!/ZE?IVO0O4 Q79EM;P\8SO;IG2MEN;R*.W@KDVG2
M)<CUQE;&XHIR%U=W4UGK6M867BYK@MHJX[FF&CBNJWEKYOM^;9[PKSWD%E[9
MR6GY3P7,[G#%9F9B,&YBF\I:)Z*UK%LV;<UZ(M>T32;VFL9*UB;OI[Y:-[V/
M;CK3/O-EN\E(CQGXF33+68\(B-;WR1IK,ZQ,SIU1"O2L&;U
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M\)SRM_D+_K)].I>^@W_BN[5_VG^1^0;5\D_TG<9_I'W)G9OSHV3]
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M7L:S]X-YU9,$^V,<Z_'P:^V?=ZQ-9GVX[5UFUJWE,:AXU0
M
M  @J^HOV"[PWID[QCK;*?(0[;VIU'K^0M/C11?;=I;;+SM5&+]R3]E<?"O\
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M+.ZLE'0
M                                                    !!Y]1#K>
M3SGI@=HY.PIAJM=-["Z>V3-<RS<1UT8RZWS%ZA%5;T<\<\W$W.9VJTIYHX]G
M/$?-57^2GE-WYO3D=ML?4[Q>VSS/O=YQ_(8<>D:Q-Z[6^XG7Z$>[P9)U^CI'
MPMQ^0^XQX?,;;8[Z]67!GI7]F,<W\?H?%I;^[I#/ ="R=X         "[S]+
M/G\M<^,7DOJ\UW[^"P_?&(S^-L?@6U/RV6V3K["8[-7?S-$--Y-\[9ZI84?#
MDDJBC^7]L=--5<G-=)?SHVPVF/S-[:Y2E--]FX')BO;6WCCP[O+?'7IUZ8Z;
M9\LZQ$6GJTM,Q6L1#SU)8,5>X^.W,1]>OLK5F=9\:TRVFL:>SPF]O&(UG7QU
MTC2T2K 1P
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M)?Q_43_.>?I[XC^B&U_*/*H6>H[\]]K^*L7W1N5D%7(T
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MNY_([NVO;?=\<?NK=/'<E%<-IF=(KEB9G#:?@^JFV/6?9[R9]FK/2=!J=8
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MH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J
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M8^GDQ]>./@ZK1,^QI9.;%7N
M                                       K-?5';1C[3PSZ%TJ2&\JR
MNP>3F+VBSN*(X.<?%C]/ZK[.Q.3AN9:KBFYHO)[G>+2J"FB*NBJB.;FNNCFF
MCB2RWYK[B]QE\Y.>YJLT^2[?MF^"T3,]<WW&^V62DUC32:Q&VR1:9M$Q,TTB
MT3,UD/Z;]M>W=N]WD3'NJ<=-)CX=;YL-HT\--(C';7Q^&-(GQTHQ+QDRP
M      &@']-?KF,P?IP59.PHFINMQ[_[1V/-<RS<R45Y.UQNF:C%7;T<\<<6
M\/&&U6TIYHX]O',G%57^6KE0/\Y'R.YWWJ-^39YCW6SX#98<>D:3%+7W&XG7
MZ,^\SY)U^AI'P(.^H+<9,W?_ +N^G3BV.&E?V)G)?Q^C\:]O[FD)_P! 1H\
M
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M\EMMP^ZC3W5+[FD_1UO&":^'[&.VO]SZ*X^IW1/
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M.L*O.2VGR#D=QL?&?<Y[X_&-)^)::^,?!/AXP^\>"^(   !F^^O;_BQ^5O\
M(7_5LZ==&WH-_P"%'M7_ &G^6.03^\D_T8\9_I'W7G0_I>MJ        +X/T
MO?Y G;WZ8&__ (E_']1/\YY^GOB/Z(;7\H\JA9ZCOSWVOXJQ?=&Y605<C0
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MNYQUK'UR)F?'+'C[VNNLZ>]CPFT4K]I^MX@
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MSN-YN<F\W=[9-UEO:][VG6UKVF;6M:9]LVF9F9^&9?O/@?@
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M7R5XCN7:4B+]4QKGI'A&:L>&L_!EB-=+:6UTO$1!BG&W*
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MIT\5G';?'QQ/;NPXR*S7Y/L\./2=-=:8ZUGJTB(ZM8GJF(C6=9>#L[>T
M   _M;W%Q9W$%W:3S6MU:S17%M<V\M<%Q;W$%=,L,\$T55,D,T,E/%5-5//%
M5-7''/'/M?QDQX\V.V++6+8K1,6K,1,3$QI,3$^$Q,>$Q/A,/\M6MZS6T1-9
MC28GV3'T):SGCSV/_#'T#T=V[\7X_P#"IT_UGV/\?Y3Y#XWW\:7A-F^+\A[U
M?R7Q/M3V_!]O/P_;[OM^XY/O,'MS_<_O[G.T=.G[U\QO-GIU=>GR;<Y,.G5^
MZTZ/JOA]OPJP^=X_[T\YO.+TT^3;O-BTUU_Q>2U/;\/L]OPO8&(/*
M
M        5'/JL=CR=KK'A%J,54/&&SF>\@-COZ*H>*KBK)ZKC^GL9B:HI_;[
MT<-%KN-[Q)1QQ[*ZJJ.>?_)PMK^:MX[;9>3[VY>\3\LP8.*PUG7PZ,]^0ODU
MCX9ZMOCTGX(B?HI1^FC;X[;GF-U.OO:4VU(^AI><\V\/V<==/[OT5.!<0E>
M         TC?0CU^[UWTJ?%6WR&,^R[[)6?;.P3450Q137MIG^].S<I@\G/5
M']V?Y_7+FSKBKJYYJ^7YCI^YQ3QQQSA^NKD,7(^JCNK)M\OO<&.^PQ1XS,5M
MBXS94RTC7V=&:,D6B/#KZI^'6:__ #ISUW'F7R=L=NJE9P5_8FNWPQ:(^AI>
M+1/T]4NJ)#5H
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MI;+>3,^]IR,4B/@TOAS6G7PUUB<==/'X9UB?#2\\HY0S
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M%L5HB8F)UB8GQB8F/"8F/&)CVO\ &_9_0
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M>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3MRQ7OO\R.9_%6[^Y\C5"<M2M<
M   !C^NO-:D         U0O3T_($\'?T/_&C\2^E.6KU!_I[[X_I?S/Y1W*M
M?OO\]^9_&N[^Z,CL!J%BH
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MNOE??O+Y>GITY#-3377_ !=YQZ^R/JNC73X-=-9TUGO%HEA0
M
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MC!>=?@B<D8]8^GKDB/V)EH=.>Q!$
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M_P#&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH
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M:9U=W!Y@]Y=T5G%S._SY-K/MQUF,>*?I3CQQ2EM-/";1:8^CK,Z]R-'L-
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M@OSJNX/P,TO]V/[4GO[^:O#_ &QN?VC]9/G/P9M/LF0_58.@OSJNX/P,TO\
M=C^U)[^_FKP_VQN?VC]9/G/P9M/LF0_58.@OSJNX/P,TO]V/[4GO[^:O#_;&
MY_:/UD^<_!FT^R9#]5@Z"_.J[@_ S2_W8_M2>_OYJ\/]L;G]H_63YS\&;3[)
MD/U6#H+\ZKN#\#-+_=C^U)[^_FKP_P!L;G]H_63YS\&;3[)D>M]>_3#>#VNU
MV5YO_:GD5V/>VTU[5<X^+8M&TW5LC;SV\L%I%<8_%:+>[/#-8UR\3<20YJ*F
M26.GWJ/A^_'7B?</SF_G=R-;X> XKMWCL-HKI><.YW&>DQ,3:8O?<UPS%HCI
MTMMK3%9G2>K2T>7O_47WCGB:;';;#;TF(TGIR9+Q,3K.DVR13Q]FDXYTB9\=
M=)B6[QL].;PF\2);;(=$>/.AZILUM9Q65.]9.UO-S[!YBHNY[^7F/>-TO,_L
MMC\W>S_$EHMKF"&OX4%'N<1VUO1%$OS(]17G5YM5MM^^^X=_N^-M>;?)J6KM
M]IK-8I&NVV]<6&W36-*S>EK1U7MKU9,EKZO[@[^[P[HB:<UO\^7;S.ONXF,>
M+V:?XO'%:3I$:1K$SXS.NMK3/;+2K#P                 &/ZZ\UJ0
M    #5"]/3\@3P=_0_\ &C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,
MCL!J%BH               "'[U[?\)SRM_D+_K)].I>^@W_BN[5_VG^1^0;5
M\D_TG<9_I'W)G9OSHV3]        =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(
M<S^3MRQ7OO\ ,CF?Q5N_N?(U0G+4K7     8_KKS6I         -4+T]/R!/
M!W]#_P :/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.P&H6*@
M
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MH
M                                               !DH=Z:A#U[W=W
M'H-MAKS7+?1^U.PM0@U[(TY"C(8*'6MMR^%BPU]1EJY,I1>8NBRX@EXN:JKC
MBNCGXG/-?MY=978W+W[@[)X?GLF:FXR;[BMIN)RTZ)IEG-@QY)R5]WI3IO-N
MJO1$4TF.GPT6@<+NIWW#[3?6O&2V;;8KS:--+==*VZHZ?BZ3KK&GAX^'@\L9
M2](        !)QZ,^V7>E^IYX?9BRN;.TFO.R+_4ZY;[B+F&NTWW2MIT;(6U
M'Q:Z*?G+VPV.2&W]G/O<7$E'N\<U>SCF,WK(XK%S/ID[OV>:M[TIQM,\1777
MJVNYP;FEIT_<UMABU_@Z(MKI&LM=^;6UKN_+GE<5XF8C;Q?P^CCR4R1/[$32
M)GZ42TRG-*KQ
M                          8_KKS6I         -4+T]/R!/!W]#_ ,:/
MQ+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.P&H6*@   ,WWU[?\ %C\K
M?Y"_ZMG3KHV]!O\ PH]J_P"T_P L<@G]Y)_HQXS_ $C[KSH?TO6U
M%\'Z7O\ ($[>_3 W_P#$OX_J)_G//T]\1_1#:_E'E4+/4=^>^U_%6+[HW*R"
MKD:                  8_KKS6I         -4+T]/R!/!W]#_QH_$OI3EJ
M]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J
M
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M#OZ'_C1^)?2G+5Z@_P!/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M
M        9J?K=[5;[EZIGESE[:TFLX[/:M&U6J&>NB2NNXT7J/K[2+N[IJC_
M &/$-_=:]7/'3_YJ8Y*>*ON\<NDOT2\5DX?TN=I;3+>+VOM=SGUB)B--UO\
M=[FM?'X:URQ69]DS$S'@L'\GMM;:>6W%XK3$S.+)?P^ADSY<D1_<BVD_3A%2
ME0V6         ^OZ]U3[_-^T?1OG_LK[\]PUG5/M3Y7Y[[-^^+-66(^?^2^9
ML_G/D_G/B?"^-%\3W?=]^GV^]QY'</*_>'@-]SGN_>_(MGFS]'5T]?N<=LG1
MU:6Z>KITZNFVFNND^Q\N_P!U\BV.;>]/5[G%>^FNFO16;::Z3IKIIKI.GT&N
MFY(U6X
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M9P
M               #']=>:U(        !JA>GI^0)X._H?^-'XE]*<M7J#_3W
MWQ_2_F?RCN5:_??Y[\S^-=W]T9'8#4+%0   &;[Z]O\ BQ^5O\A?]6SIUT;>
M@W_A1[5_VG^6.03^\D_T8\9_I'W7G0_I>MJ        +X/TO?Y G;WZ8&_\
MXE_']1/\YY^GOB/Z(;7\H\JA9ZCOSWVOXJQ?=&Y605<C0
M  #']=>:U(        !JA>GI^0)X._H?^-'XE]*<M7J#_3WWQ_2_F?RCN5:_
M??Y[\S^-=W]T9'8#4+%0
M
M                        &/ZZ\UJ0        #5"]/3\@3P=_0_\ &C\2
M^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH               "'
M[U[?\)SRM_D+_K)].I>^@W_BN[5_VG^1^0;5\D_TG<9_I'W)G9OSHV3]
M    =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3MRQ7OO\ ,CF?Q5N_N?(U
M0G+4K7     8_KKS6I         -4+T]/R!/!W]#_P :/Q+Z4Y:O4'^GOOC^
ME_,_E'<JU^^_SWYG\:[O[HR.P&H6*@
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MNL7OCM2DQ,>,:6M'C'L]OP-3!RYJVP
M
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M,Q.D_LP_>? _
M                         !C^NO-:D         U0O3T_($\'?T/_ !H_
M$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J    S??7M_Q8_*W^
M0O\ JV=.NC;T&_\ "CVK_M/\L<@G]Y)_HQXS_2/NO.A_2];4        7P?I
M>_R!.WOTP-__ !+^/ZB?YSS]/?$?T0VOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@
M               &/ZZ\UJ0        #5"]/3\@3P=_0_P#&C\2^E.6KU!_I
M[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH
M
M                                      #']=>:U(        !JA>GI
M^0)X._H?^-'XE]*<M7J#_3WWQ_2_F?RCN5:_??Y[\S^-=W]T9'8#4+%0
M           $/WKV_P"$YY6_R%_UD^G4O?0;_P 5W:O^T_R/R#:ODG^D[C/]
M(^Y,[-^=&R?H       #L#T]/R^_!W],#QH_'1I34/J#_0)WQ_1#F?R=N6*]
M]_F1S/XJW?W/D:H3EJ5K@    ,?UUYK4@        &J%Z>GY G@[^A_XT?B7
MTIRU>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
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MX3TN=T9<63'3<[C'L]M2+S&MXS[_ &N/+2D3,=5_<3EO$5UFL5M?32DZ:O\
M.?>3L_+;DK5M6N3)7%CC73QZ\^.MHB/AGHFT^'C$1,^R&DHYP%?H
M
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MK.E)RVFGC,S,ZTFLQ,SK,>WQ==-2,6
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MT/\ QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J
M
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M
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MPTUUTZ=*9<FOL\?\7IIX>W77PTF_DH/0A
M
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M?(O,CDJ1%_=Y+XLD3;X?>8<=K3$Z1$UB\VK&GLZ=)F9B4M*)S6
M
M   #']=>:U(        !JA>GI^0)X._H?^-'XE]*<M7J#_3WWQ_2_F?RCN5:
M_??Y[\S^-=W]T9'8#4+%0   &;[Z]O\ BQ^5O\A?]6SIUT;>@W_A1[5_VG^6
M.03^\D_T8\9_I'W7G0_I>MJ        +X/TO?Y G;WZ8&_\ XE_']1/\YY^G
MOB/Z(;7\H\JA9ZCOSWVOXJQ?=&Y605<C0                 #']=>:U(
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MT/MKD?Y*/U<>]_XUQ7V7<?ZL?K0G@)_%#Y@?@!TO_: /[,/S[_"_:'VUR/\
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M?@!TO_: /[,/S[_"_:'VUR/\E'ZN/>_\:XK[+N/]6/UH3P$_BA\P/P Z7_M
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MP Z7_M ']F'Y]_A?M#[:Y'^2C]7'O?\ C7%?9=Q_JQ^M"> G\4/F!^ '2_\
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MI?\ M ']F'Y]_A?M#[:Y'^2C]7'O?^-<5]EW'^K'ZT)X"?Q0^8'X =+_ -H
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MCWO_ !KBOLNX_P!6/UH3P$_BA\P/P Z7_M ']F'Y]_A?M#[:Y'^2C]7'O?\
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M?Q0^8'X =+_V@#^S#\^_POVA]M<C_)1^KCWO_&N*^R[C_5C]:$\!/XH?,#\
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M!TO_ &@#^S#\^_POVA]M<C_)1^KCWO\ QKBOLNX_U8_6A/ 3^*'S _ #I?\
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MOZ'_ (T?B7TIRU>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M        0_>O;_A.>5O\A?\ 63Z=2]]!O_%=VK_M/\C\@VKY)_I.XS_2/N3.
MS?G1LGZ        [ ]/3\OOP=_3 \:/QT:4U#Z@_T"=\?T0YG\G;EBO??YD<
MS^*MW]SY&J$Y:E:X    #']=>:U(        !JA>GI^0)X._H?\ C1^)?2G+
M5Z@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M                                                    !%=ZVNU_
M>9Z6WEUE_D/M+YS3].U3Y?YKY/X?W^=JZ%HWS_QOEKKW_LK[XOFOA>[Q\?X/
MP_?C]_XE,I?13Q7WY]47:.S]Y[OHWFXSZ]/5K\EV.ZW/1IK7ZOW/1U:_%ZNK
M2VG3.RO)_:_*_,CB\75TZ9<E]=-?\7AR9-/;'U71IK\&NNDZ:3FG.DY80
M       MB?2KZ;\]V?YB]A?$L^/O7T/J+3?A5V_O9"O[^]AW?-_$MKKV?M-G
M'_!S[)X_;^VUUP\__6_N51_.G<S[CMCL_M_2_P#G6_W^XUB?B?YKBVV/2U?A
MM/ROXL_N8B\?ND8_4MN^CCN)V/C]<SY\GM\/K=<=?&/H_7?"?@\?HKGRFA$D
M
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M96M)F-9F)MK[)B%BE7@T*
M                                  Q_77FM2         :H7IZ?D">#
MOZ'_ (T?B7TIRU>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5    9OOK
MV_XL?E;_ "%_U;.G71MZ#?\ A1[5_P!I_ECD$_O)/]&/&?Z1]UYT/Z7K:@
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M*Q^Q%8B/V9]L_"^)>T^P
M
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M0^H/] G?']$.9_)VY8KWW^9',_BK=_<^1JA.6I6N     Q_77FM2
M :H7IZ?D">#OZ'_C1^)?2G+5Z@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"
MQ4
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M\=Q^M_K6RMDT_<_7<MJZQ&OU4^Y^-X1X17QG3PM$JP$<
M
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M$K=*I%%L
M                    !C^NO-:D         U0O3T_($\'?T/\ QH_$OI3E
MJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J    S??7M_P 6/RM_D+_J
MV=.NC;T&_P#"CVK_ +3_ "QR"?WDG^C'C/\ 2/NO.A_2];4        7P?I>
M_P @3M[],#?_ ,2_C^HG^<\_3WQ']$-K^4>50L]1WY[[7\58ONC<K(*N1H
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MKI-YUB:UGW>D3U]5==8>WR
M
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MIJ'U!_H$[X_HAS/Y.W+%>^_S(YG\5;O[GR-4)RU*UP    &/ZZ\UJ0
M  #5"]/3\@3P=_0_\:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.P&
MH6*@
M                 *EWU5FU_)Z#X8:-\A\3[XMP[KVO[4^:]SY/[S,+UMB/
MD/DOEJOF/M+[_/B?%^-1\'Y3W?<K^+[T=L7S5_%>^Y_O/G/>:?)]GQN#HZ?J
MOE&3>9.OJU\.CY+IT],]77KK7ITM)_TT[7KWW+[WJ_Q>+;TTT]OO+9;:ZZ^&
MGN]--/'J]L:>-,Y<BEF          T+?IT-$^]#TR='V#Y"SL_X4NU.W-[^8
MMI/?GROV?LO'67S^1I_^LWD?\'/RM-/_ (V]M%5_Z3GR^<2YW[[^IC?<?[R]
M_O7Q6PVNEHTBG7A^6]-/HUGY7US/^'>T? @IY][WY5YB9L'5,_)MM@QZ3^YU
MI[[2/I?7=?V9E.J@RTP
M
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M.V7O>T=GOJQ>;X>0K6=/J8KDQ9=9MX>'QJ4K$ZQ&MM/&9C2]4HS0Q
M
M      8_KKS6I         -4+T]/R!/!W]#_ ,:/Q+Z4Y:O4'^GOOC^E_,_E
M'<JU^^_SWYG\:[O[HR.P&H6*@   ,WWU[?\ %C\K?Y"_ZMG3KHV]!O\ PH]J
M_P"T_P L<@G]Y)_HQXS_ $C[KSH?TO6U        %\'Z7O\ ($[>_3 W_P#$
MOX_J)_G//T]\1_1#:_E'E4+/4=^>^U_%6+[HW*R"KD:
M 8_KKS6I         -4+T]/R!/!W]#_QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[
M_/?F?QKN_NC([ :A8J      A4]>#S3N/$CPAV/6]1R$UCVSY)S9'IS2KFUJ
MKCNL!K60QE<O:&X134_"K@FQFI3\XVTFAFCN[3*9FSNHN*J8)/=FCZ$_)C'Y
MM>=NVY+EL<7[3[;BG(;FMM)KES4OILMO,>.L7SQ[[)6U9QY,&WS8K:3DKKM[
MR5[1KW1WCCW&ZK%N,X^(SY(GV6O$_6<?T];_ ![1,36U,=ZS]5#.H=$2>@
M
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M'XE]*<M7J#_3WWQ_2_F?RCN5:_??Y[\S^-=W]T9'8#4+%0
M $/WKV_X3GE;_(7_ %D^G4O?0;_Q7=J_[3_(_(-J^2?Z3N,_TC[DSLWYT;)^
M@       .P/3T_+[\'?TP/&C\=&E-0^H/] G?']$.9_)VY8KWW^9',_BK=_<
M^1JA.6I6N     Q_77FM2         :H7IZ?D">#OZ'_ (T?B7TIRU>H/]/?
M?']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
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ME:S\*NKS0WOR_P P>6S]4VZ=Y?'K/_T.F'3]BO1I'THA(JCNP(
M
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M3-:8^EK[8T:H\[=E\L\M]_-:S;+AG#DKI_R<V.+3/T8C':\_W-?@:.SG.0$
M
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MQEWN[O,3I,:X\41CKIK[=+QE\8\-9F/;$JZ*Q)OL
M
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M5[[_ #(YG\5;O[GR-4)RU*UP    &/ZZ\UJ0        #5"]/3\@3P=_0_\
M&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH
M
M#./]?3L"C>_5&\@+:UGQMUC-!QO5W7^/NL=1<4URUXGK+5<KGX,E7//+1+DL
M9MN<R-G7S%1%'Q';T4^[S535)7T7>@K@+<%Z7^ R9:Y*[G?Y-[NKUOII$9-[
MGQXIII$:4O@Q8LD=4VG6]IUB)BM9]>2.QG9>6^QM:+1DSVS99B=/W6:]:Z:?
M!-*UMXZSK,_L1#:F*VP          UKNBM$_@MZ1Z<ZR^0L\5_!SU7U[HGV9
MCI/C8_'?>AJ.(U_Y"QF^[\6SL_L_X<57_I44\<N37OGG?]Z.]N8[F]Y?+]\>
M5W>ZZ[QI>_RC/DR]5H^"UNO6T?!,RK YK>_?+F-WR/5-OE&YRY-9]L]=[6UG
MZ<ZZR]48L\P
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M]:^WG"XK;K>"TN8IJ)9KW6+Z[AIYIXXEHJDXJBJHDXHKIU)Y^=O5[J\D>[>
MZ(R9MQV[OXQ1-II'OZ[;)?!,VB8F(KFKCM.OQ9B-+1:LS$XMWQL(Y/L[E-CI
M%KY-AGZ8F9B.N,=K4F9CZ%XK/T/#QB8UAJD.6=6L
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MZ?D">#OZ'_C1^)?2G+5Z@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M  !FC^M;M5QN7JC>7F7N;2&RDL]VU?5:88*ZY**[?1>L](TBTNZJI/V7$U_:
MZ]1/)3_Y:9)*N*?N<<.E'T6<5CX?TO\ :.TQ7F];[+/GUF(B==UO=SN;5\/@
MK;+-8GVS$1,^*PKRAVU=IY;\5BK,S$X;W\?HY,V3),?W)MI'TH1:I1-D
M
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M
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MT^-'MCQ>Y=[][NW.0Y#6\>XV6?)K7PM'1BM;6LZQ\;P\/&/'X8:Q3E'5C@
M
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M?'15QO=M;9;S+L[3%K8LMJ3,>R9K::ZQ^SH^J>4^8
M                                                    !C^NO-:D
M         U0O3T_($\'?T/\ QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QK
MN_NC([ :A8J    S??7M_P 6/RM_D+_JV=.NC;T&_P#"CVK_ +3_ "QR"?WD
MG^C'C/\ 2/NO.A_2];4        7P?I>_P @3M[],#?_ ,2_C^HG^<\_3WQ'
M]$-K^4>50L]1WY[[7\58ONC<K(*N1H                 !C^NO-:D
M    U0O3T_($\'?T/_&C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL
M!J%BH     #.S^H7T7,:CZHW<6P9..:BR[1TGIK>M>JELKJUHEP^/ZRUSK.:
M2VGN**8LE#QG^NKZGF:#FJ*F2FJ'GGXD4G''0Y\WQSNSY?TO\/Q^VF)S<7O>
M0VN72U;3&2^]S;V(F(\:3[K=XIZ;:6F)B_U-JS,\O(G>XMUY;[3!CTZ]MFSX
M[>,3\:<U\WC$>SXN6OA/CII/LF$)*:[<
M
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MIZ?D">#OZ'_C1^)?2G+5Z@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M
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MFQ5[@
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M_+X+=6MM]DR?&C2=,T^^C^YI?XL_#72?A2!M ,&
M                                                   8_KKS6I
M       -4+T]/R!/!W]#_P :/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O
M[HR.P&H6*@   ,WWU[?\6/RM_D+_ *MG3KHV]!O_  H]J_[3_+'()_>2?Z,>
M,_TC[KSH?TO6U        %\'Z7O\@3M[],#?_P 2_C^HG^<\_3WQ']$-K^4>
M50L]1WY[[7\58ONC<K(*N1H                 !C^NO-:D         U0O
M3T_($\'?T/\ QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J
M     J=?5"^+EWL.A]%>7NMXCX\W7MYD.G.S\A;6,4MS'JNT7GV[UQD,C?45
MT3VV'P6U\Y:SIXKIDCYN]@BXIYBJJYXFM<^;"\T,7'\[SOE%R6;IIR%*<ALJ
M6M,1.?!7W6\I2NDQ.3+@]QDG2:S[O:VUBT1'1)STX]R5P;W>]J[B^D9XC/AB
M9\.ND=.6(CV3:U.BWP3TXI]OP4PERZ6P
M
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M._H?^-'XE]*<M7J#_3WWQ_2_F?RCN5:_??Y[\S^-=W]T9'8#4+%0
M       $/WKV_P"$YY6_R%_UD^G4O?0;_P 5W:O^T_R/R#:ODG^D[C/](^Y,
M[-^=&R?H       #L#T]/R^_!W],#QH_'1I34/J#_0)WQ_1#F?R=N6*]]_F1
MS/XJW?W/D:H3EJ5K@    ,?UUYK4@        &J%Z>GY G@[^A_XT?B7TIRU
M>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M                                                   1[>K!V%:=
M9>F[YG;)>U6=,.2Z'W/KVCF^DEB@^;[;M8^J;"FBJ*FJKF\JOMTCXMZ>?V-=
MQS135SQ3SSRD%Z4NW\O<WJ/[,X[#US?'SVWW?Q8B9Z=A:=]?77]ST[>>N?;%
M.J8\8AG7EEL;<CY@<1MZ:ZUWN/+X?0P3[Z?[FF.=?I:LP9TXK&
M%B[Z9/K^O9O/?>=UG@R7&/ZT\==SR,%[:5V]%C3L>S[?H>KXW&Y7B:":66&]
MP%_EIXJ8N8J_C6=-7-?N4U1R5V_.8\_7C/(;8\+2V/Y1R7<6WI-;:]7N<.WW
M6:]Z:3$1-<M<%;3;JCIR3$5UF+5T)ZB=]&W[)P[.LU]YN-_CB8G77HI3)>9K
M^Q:*1.NOA;V:^,7U%#R%
M
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M*^XB(CY5M,.7769UTBV'68^#_$Z:1I&D1/MF93SH(-*
M                                                       ,?UUY
MK4@        &J%Z>GY G@[^A_P"-'XE]*<M7J#_3WWQ_2_F?RCN5:_??Y[\S
M^-=W]T9'8#4+%0   &;[Z]O^+'Y6_P A?]6SIUT;>@W_ (4>U?\ :?Y8Y!/[
MR3_1CQG^D?=>=#^EZVH        O@_2]_D"=O?I@;_\ B7\?U$_SGGZ>^(_H
MAM?RCRJ%GJ._/?:_BK%]T;E9!5R-                  ,?UUYK4@
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M,
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MT?B7TIRU>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M  0_>O;_ (3GE;_(7_63Z=2]]!O_ !7=J_[3_(_(-J^2?Z3N,_TC[DSLWYT;
M)^@       .P/3T_+[\'?TP/&C\=&E-0^H/] G?']$.9_)VY8KWW^9',_BK=
M_<^1JA.6I6N     Q_77FM2         :H7IZ?D">#OZ'_C1^)?2G+5Z@_T]
M]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
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M(F(\/&)G7PTM]JB$5P
M
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M-(O@
M               ,?UUYK4@        &J%Z>GY G@[^A_P"-'XE]*<M7J#_3
MWWQ_2_F?RCN5:_??Y[\S^-=W]T9'8#4+%0   &;[Z]O^+'Y6_P A?]6SIUT;
M>@W_ (4>U?\ :?Y8Y!/[R3_1CQG^D?=>=#^EZVH        O@_2]_D"=O?I@
M;_\ B7\?U$_SGGZ>^(_HAM?RCRJ%GJ._/?:_BK%]T;E9!5R-
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M69K,Z3I/LM$:UF8\7*[:3)0
M
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MO;6N;=TGPB/9--O:/;,^,6S1X1'^*F9F+UN&J@$4P       &/ZZ\UJ0
M    #5"]/3\@3P=_0_\ &C\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,
MCL!J%BH               "'[U[?\)SRM_D+_K)].I>^@W_BN[5_VG^1^0;5
M\D_TG<9_I'W)G9OSHV3]        =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(
M<S^3MRQ7OO\ ,CF?Q5N_N?(U0G+4K7     8_KKS6I         -4+T]/R!/
M!W]#_P :/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.P&H6*@
M
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MA=_;==]4VFL^[VVQQ4TZM8ZK6R9)MI^YF8O6)]LS%:SKII$6%U?#1(
M
M                                           ",SUD>OZ^R_3&\P]<
MC@R5Q5C>L;?L#F/%5V]%U31U-MNM=J2SRU7,%Q'SC;:+3>9+SCBGB2JSHEXC
MJHKYIKIDMZ.N?KVUZFNS^1M;'6,G)SM=;ZS77?X,VQB(Z9B>NT[C3'XZ1DFL
MVBU=8G8?E/OHX[S%XK<3-8ZMS.+XVNGUZE\/P:>,^\TK\'5IKK'@S,'2ZL/
M         6.OIC.PJ];\[.Q]$N;V:+&=E>.NUQ6UA%96\U%YM.H[IHF>Q5Q<
M7G,7-W90V6M<YOCCBB2F*62:GBNFJKB+FBN?YS3MZO)>1?'<[CI$[GC>XL$S
M>;3$UP;C;[K%>(KKTVFV;Y-[8FU8K,UF(FT6T%ZBMA&X[+V^]K$3DV^_IK.L
M^%+X\E;1$>R=;^[^#6(B=)CQUOD*)$*@
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M\@3P=_0_\:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.P&H6*@
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MIXV?]XC]?+TH_P ZO_;.8_D\_KL\L?PG_P"7W?\  ']PEZL?YJ7_ %T\;/\
MO$?KY>E'^=7_ +9S'\GG]=GEC^$__+[O^ /[A+U8_P U+_KIXV?]XC]?+TH_
MSJ_]LYC^3S^NSRQ_"?\ Y?=_P!_<)>K'^:E_UT\;/^\1^OEZ4?YU?^V<Q_)Y
M_79Y8_A/_P ON_X _N$O5C_-2_ZZ>-G_ 'B/U\O2C_.K_P!LYC^3S^NSRQ_"
M?_E]W_ ']PEZL?YJ7_73QL_[Q'Z^7I1_G5_[9S'\GG]=GEC^$_\ R^[_ ( _
MN$O5C_-2_P"NGC9_WB/U\O2C_.K_ -LYC^3S^NSRQ_"?_E]W_ ']PEZL?YJ7
M_73QL_[Q'Z^7I1_G5_[9S'\GG]=GEC^$_P#R^[_@#^X2]6/\U+_KIXV?]XC]
M?+TH_P ZO_;.8_D\_KL\L?PG_P"7W?\  ']PEZL?YJ7_ %T\;/\ O$?KY>E'
M^=7_ +9S'\GG]=GEC^$__+[O^ /[A+U8_P U+_KIXV?]XC]?+TH_SJ_]LYC^
M3S^NSRQ_"?\ Y?=_P!_<)>K'^:E_UT\;/^\1^OEZ4?YU?^V<Q_)Y_79Y8_A/
M_P ON_X _N$O5C_-2_ZZ>-G_ 'B/U\O2C_.K_P!LYC^3S^NSRQ_"?_E]W_ '
M]PEZL?YJ7_73QL_[Q'Z^7I1_G5_[9S'\GG]=GEC^$_\ R^[_ ( _N$O5C_-2
M_P"NGC9_WB/U\O2C_.K_ -LYC^3S^NSRQ_"?_E]W_ ']PEZL?YJ7_73QL_[Q
M'Z^7I1_G5_[9S'\GG]=GEC^$_P#R^[_@#^X2]6/\U+_KIXV?]XC]?+TH_P Z
MO_;.8_D\_KL\L?PG_P"7W?\  ']PEZL?YJ7_ %T\;/\ O$?KY>E'^=7_ +9S
M'\GG]=GEC^$__+[O^ /[A+U8_P U+_KIXV?]XC]?+TH_SJ_]LYC^3S^NSRQ_
M"?\ Y?=_P!_<)>K'^:E_UT\;/^\1^OEZ4?YU?^V<Q_)Y_79Y8_A/_P ON_X
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M_P#R^[_@#^X2]6/\U+_KIXV?]XC]?+TH_P ZO_;.8_D\_KL\L?PG_P"7W?\
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M'\)_^7W?\ ?W"7JQ_FI?]=/&S_O$?KY>E'^=7_MG,?R>?UV>6/X3_P#+[O\
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M #J_]LYC^3S^NSRQ_"?_ )?=_P  ?W"7JQ_FI?\ 73QL_P"\1^OEZ4?YU?\
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ME'^=7_MG,?R>?UV>6/X3_P#+[O\ @#^X2]6/\U+_ *Z>-G_>(_7R]*/\ZO\
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M>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3MRQ7OO\R.9_%6[^Y\C5"<M2M<
M   !C^NO-:D         U0O3T_($\'?T/_&C\2^E.6KU!_I[[X_I?S/Y1W*M
M?OO\]^9_&N[^Z,CL!J%BH
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MQ%:X=-)^A[O29]DS&L:Q.J2=&YKX
M
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M^/GDO+KE,$1,VI@C+&D1,Q[F],LSX^SXM)UGV],RTQ'-0KS
M                                                           8
M_KKS6I         -4+T]/R!/!W]#_P :/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_
MSWYG\:[O[HR.P&H6*@   ,WWU[?\6/RM_D+_ *MG3KHV]!O_  H]J_[3_+'(
M)_>2?Z,>,_TC[KSH?TO6U        %\'Z7O\@3M[],#?_P 2_C^HG^<\_3WQ
M']$-K^4>50L]1WY[[7\58ONC<K(*N1H                 !C^NO-:D
M     U0O3T_($\'?T/\ QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC
M([ :A8J
M   K??5"?D"=0_I@:!^)?R 6-_-A_I[Y?^B&Z_*/%-_^G'\]]U^*LOW1ME#Y
M>PFF        F ]!+_%C\4OY=/ZMG<2(7KR_X4>ZO]F?ECCVJ_.S]&/)_P"C
M_=>!I!.<E $
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M[O[HR.P&H6*@
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M&9CQ]K[QX+X@
M
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MJ]M6U+36T3%HG28GVQ/T)?V?P_P
M                                     !C^NO-:D         U0O3T_
M($\'?T/_ !H_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J
MS??7M_Q8_*W^0O\ JV=.NC;T&_\ "CVK_M/\L<@G]Y)_HQXS_2/NO.A_2];4
M        7P?I>_R!.WOTP-__ !+^/ZB?YSS]/?$?T0VOY1Y5"SU'?GOM?Q5B
M^Z-RL@JY&@                 &/ZZ\UJ0        #5"]/3\@3P=_0_P#&
MC\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH
M                                         "M]]4)^0)U#^F!H'XE_
M(!8W\V'^GOE_Z(;K\H\4W_Z<?SWW7XJR_=&V4/E[":8       "8#T$O\6/Q
M2_ET_JV=Q(A>O+_A1[J_V9^6./:K\[/T8\G_ */]UX&D$YR4 0
M                                              &/ZZ\UJ0
M  #5"]/3\@3P=_0_\:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.P&
MH6*@               (?O7M_P )SRM_D+_K)].I>^@W_BN[5_VG^1^0;5\D
M_P!)W&?Z1]R9V;\Z-D_0       '8'IZ?E]^#OZ8'C1^.C2FH?4'^@3OC^B'
M,_D[<L5[[_,CF?Q5N_N?(U0G+4K7     8_KKS6I         -4+T]/R!/!W
M]#_QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J
M
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M7,:_2:H3EJ5K@
M
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MUW[Q\<7WKRNQI$1BIO\ --8B9G2EKS>D:SXS,5M$3KKXQ/C/MGLUIMB0
M
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M7=_=&1V U"Q4
M       !6^^J$_($ZA_3 T#\2_D L;^;#_3WR_\ 1#=?E'BF_P#TX_GONOQ5
ME^Z-LH?+V$TP       $P'H)?XL?BE_+I_5L[B1"]>7_  H]U?[,_+''M5^=
MGZ,>3_T?[KP-()SDH @
M               ,?UUYK4@        &J%Z>GY G@[^A_P"-'XE]*<M7J#_3
MWWQ_2_F?RCN5:_??Y[\S^-=W]T9'8#4+%0               $/WKV_X3GE;
M_(7_ %D^G4O?0;_Q7=J_[3_(_(-J^2?Z3N,_TC[DSLWYT;)^@       .P/3
MT_+[\'?TP/&C\=&E-0^H/] G?']$.9_)VY8KWW^9',_BK=_<^1JA.6I6N
M  Q_77FM2         :H7IZ?D">#OZ'_ (T?B7TIRU>H/]/??']+^9_*.Y5K
M]]_GOS/XUW?W1D=@-0L5
M                                <*>ISVI7TOZ??EYV!;W<./R%IT;N
MNM82_FRMOAN;#8NP<?SU[K=]:WEU!<129*SS^TVTEI;>[[][<TQV]'--<M-7
M&\_3-VM7O/U =H\!DI.3;WYS;9LE(I.3JP[2_P KS5M6LQ,4MBP7B]]=,=)M
MDF)BLQ.:>77&1R_?/%;&T3;'.]QWM'3-M:8I][>)B)CPFM)BT_N8UM/A#+H=
M0"QX         !.%]/#UK7OOJ<]:9_Y::ZM>HNO>U^RKVBFVM[FUBHGU*YZT
ML;F_^/[>8(;;,]CVM<,D?',E%Y3#[/9Q[>>(1?.%=R5X'TR\EL.J*Y>7Y#8[
M.OC,6F8SQO+173VS;'L[Q:)\)QS?7Z$Z<\]^0C8^76XP:Q%MUGPXH\9B?JXR
MS$:>W6N*=8GPZ=6B YZ4$
M
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MTJ
M             Q_77FM2         :H7IZ?D">#OZ'_C1^)?2G+5Z@_T]]\?
MTOYG\H[E6OWW^>_,_C7=_=&1V U"Q4   !F^^O;_ (L?E;_(7_5LZ==&WH-_
MX4>U?]I_ECD$_O)/]&/&?Z1]UYT/Z7K:@       "^#]+W^0)V]^F!O_ .)?
MQ_43_.>?I[XC^B&U_*/*H6>H[\]]K^*L7W1N5D%7(T
MQ_77FM2         :H7IZ?D">#OZ'_C1^)?2G+5Z@_T]]\?TOYG\H[E6OWW^
M>_,_C7=_=&1V U"Q4
M            !6^^J$_($ZA_3 T#\2_D L;^;#_3WR_]$-U^4>*;_P#3C^>^
MZ_%67[HVRA\O833        3 >@E_BQ^*7\NG]6SN)$+UY?\*/=7^S/RQQ[5
M?G9^C'D_]'^Z\#2"<Y* (
M                 #']=>:U(        !JA>GI^0)X._H?^-'XE]*<M7J#_
M $]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4               !#]Z]O^$Y
MY6_R%_UD^G4O?0;_ ,5W:O\ M/\ (_(-J^2?Z3N,_P!(^Y,[-^=&R?H
M  #L#T]/R^_!W],#QH_'1I34/J#_ $"=\?T0YG\G;EBO??YD<S^*MW]SY&J$
MY:E:X    #']=>:U(        !JA>GI^0)X._H?^-'XE]*<M7J#_ $]]\?TO
MYG\H[E6OWW^>_,_C7=_=&1V U"Q4
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MC)FRYK1U1K'NZUI29K[?'WN3IMK$?%M'CXZ7-U-:)0
M
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M5.NGA7PCQUM^*B$5P
M                           &/ZZ\UJ0        #5"]/3\@3P=_0_P#&
MC\2^E.6KU!_I[[X_I?S/Y1W*M?OO\]^9_&N[^Z,CL!J%BH   #-]]>W_ !8_
M*W^0O^K9TZZ-O0;_ ,*/:O\ M/\ +'()_>2?Z,>,_P!(^Z\Z']+UM0
M !?!^E[_ "!.WOTP-_\ Q+^/ZB?YSS]/?$?T0VOY1Y5"SU'?GOM?Q5B^Z-RL
M@JY&@                 &/ZZ\UJ0        #5"]/3\@3P=_0_\:/Q+Z4Y
M:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.P&H6*@
M                                   *WWU0GY G4/Z8&@?B7\@%C?S8
M?Z>^7_HANORCQ3?_ *<?SWW7XJR_=&V4/E[":8       "8#T$O\6/Q2_ET_
MJV=Q(A>O+_A1[J_V9^6./:K\[/T8\G_H_P!UX&D$YR4 0
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M:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_P ]^9_&N[^Z,CL!J%BH
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ML:1,>'A?)>]YF)CQ\:3C\+::3$Z1I.LV+U=K0@
M
M                             "+KUHNK8NVO3)\L,+QC_GK_ %;0[/M+
M&3Q6-I>7N+EZIV7"=@93(65=W3SS8^W7-?OK>ZGBYIFIQ]Q<4T\\\5\TU2?]
M&7=%NT_4QVIO?>=&#=;^VRO$VM6MXWV')M:4MT_5?7LN.]*VUK.6N.9TTB8V
M/Y1\E/%^8G&9NK2F7/.&?&8B??4MBB)T]OQ[5F(GPZHK]!FA.E186
M   GL^G [4ET'U),)I?Q/;;=X=/]H=>505Q7<T7-W@,=9=O6]U'Q!=P6UM>0
M6_64\=$\]$]/$,\L5-/%<U,E$#?G&NUJ\]Z<,_-:?7.$YC9;O6)K$].6]MA-
M9UK,VK,[VLS6LUGJK2TS,4FLZ3\_N,C?>7]]W^ZV>[PY=?#V6F<$QXQ,S$SF
MB=(F/&(G72-)T%G/\@R
M                              Q_77FM2         :H7IZ?D">#OZ'_
M (T?B7TIRU>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5    9OOKV_XL
M?E;_ "%_U;.G71MZ#?\ A1[5_P!I_ECD$_O)/]&/&?Z1]UYT/Z7K:@
M "^#]+W^0)V]^F!O_P")?Q_43_.>?I[XC^B&U_*/*H6>H[\]]K^*L7W1N5D%
M7(T                  Q_77FM2         :H7IZ?D">#OZ'_C1^)?2G+5
MZ@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
M                                 !6^^J$_($ZA_3 T#\2_D L;^;#_
M $]\O_1#=?E'BF__ $X_GONOQ5E^Z-LH?+V$TP       $P'H)?XL?BE_+I_
M5L[B1"]>7_"CW5_LS\L<>U7YV?HQY/\ T?[KP-()SDH @
M                                         ,?UUYK4@        &J%
MZ>GY G@[^A_XT?B7TIRU>H/]/??']+^9_*.Y5K]]_GOS/XUW?W1D=@-0L5
M              0_>O;_ (3GE;_(7_63Z=2]]!O_ !7=J_[3_(_(-J^2?Z3N
M,_TC[DSLWYT;)^@       .P/3T_+[\'?TP/&C\=&E-0^H/] G?']$.9_)VY
M8KWW^9',_BK=_<^1JA.6I6N     Q_77FM2         :H7IZ?D">#OZ'_C1
M^)?2G+5Z@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4
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M7(SRGF%RVYG7XN[MA\8B/^[Q&#X)G_)^$^V8\9B)G2)&T=& @
M
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M385U]Y?8YNGQB/CUI-J1,S$^$VK$6^EKI,3XM3QRVJV
M                                                      &/ZZ\U
MJ0        #5"]/3\@3P=_0_\:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:
M[O[HR.P&H6*@   ,WWU[?\6/RM_D+_JV=.NC;T&_\*/:O^T_RQR"?WDG^C'C
M/](^Z\Z']+UM0       !?!^E[_($[>_3 W_ /$OX_J)_G//T]\1_1#:_E'E
M4+/4=^>^U_%6+[HW*R"KD:                  8_KKS6I         -4+T
M]/R!/!W]#_QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_ #WYG\:[O[HR.P&H6*@
M                                                      *WWU0G
MY G4/Z8&@?B7\@%C?S8?Z>^7_HANORCQ3?\ Z<?SWW7XJR_=&V4/E[":8
M    "8#T$O\ %C\4OY=/ZMG<2(7KR_X4>ZO]F?ECCVJ_.S]&/)_Z/]UX&D$Y
MR4 0
M&/ZZ\UJ0        #5"]/3\@3P=_0_\ &C\2^E.6KU!_I[[X_I?S/Y1W*M?O
MO\]^9_&N[^Z,CL!J%BH               "'[U[?\)SRM_D+_K)].I>^@W_B
MN[5_VG^1^0;5\D_TG<9_I'W)G9OSHV3]        =@>GI^7WX._I@>-'XZ-*
M:A]0?Z!.^/Z(<S^3MRQ7OO\ ,CF?Q5N_N?(U0G+4K7     8_KKS6I
M   -4+T]/R!/!W]#_P :/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.
MP&H6*@
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M6]KVT\(UM,S.D?LR_>? _
M
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MGC@
M            ,?UUYK4@        &J%Z>GY G@[^A_XT?B7TIRU>H/\ 3WWQ
M_2_F?RCN5:_??Y[\S^-=W]T9'8#4+%0   &;[Z]O^+'Y6_R%_P!6SIUT;>@W
M_A1[5_VG^6.03^\D_P!&/&?Z1]UYT/Z7K:@       "^#]+W^0)V]^F!O_XE
M_']1/\YY^GOB/Z(;7\H\JA9ZCOSWVOXJQ?=&Y605<C0
M#']=>:U(        !JA>GI^0)X._H?\ C1^)?2G+5Z@_T]]\?TOYG\H[E6OW
MW^>_,_C7=_=&1V U"Q4
M              !6^^J$_($ZA_3 T#\2_D L;^;#_3WR_P#1#=?E'BF__3C^
M>^Z_%67[HVRA\O833        3 >@E_BQ^*7\NG]6SN)$+UY?\*/=7^S/RQQ
M[5?G9^C'D_\ 1_NO T@G.2@"
M                     Q_77FM2         :H7IZ?D">#OZ'_C1^)?2G+5
MZ@_T]]\?TOYG\H[E6OWW^>_,_C7=_=&1V U"Q4               !#]Z]O^
M$YY6_P A?]9/IU+WT&_\5W:O^T_R/R#:ODG^D[C/](^Y,[-^=&R?H
M#L#T]/R^_!W],#QH_'1I34/J#_0)WQ_1#F?R=N6*]]_F1S/XJW?W/D:H3EJ5
MK@    ,?UUYK4@        &J%Z>GY G@[^A_XT?B7TIRU>H/]/??']+^9_*.
MY5K]]_GOS/XUW?W1D=@-0L5
M                                  <W^8O;?\ WBAY(=RQW7RE_UOTG
MV5M>#KXO/LZ6?9L7J65EU:PMK_Y3(<65YE-C^5MH)>8)N(YI::N:*N./9SL?
MR?[2_P!_/-;MSLZU>O!R7-[/!DCIZXC#?/2,]IIU4ZJTP]=[5ZJZUK,:Q[60
M=J<7]^^YN/XF8UIN-YBI;PU^)-Z]<S&L:Q%-9F-8UB/:RC758LR
M 23>CYUG1VSZF7ASJTE<,=.*[:M>S.*I[FXM*.:^EL%F^XXZ*9;:VNI*YI9-
M#XICBYIXCGDYICDKCHJJDIC?ZONY;=I^FCO'E*Q,SEXFVS\*Q:=.1RX^/F=+
M36-(C=:S;76L:VK%K1%9U_YJ\C/%^7G+;F-?C;6</A$3_P!XM7!\,Q_E/&?;
M$>,1,QI.FXYG%=H
M
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MM8TZ=(F?0S:D
M                      8_KKS6I         -4+T]/R!/!W]#_ ,:/Q+Z4
MY:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.P&H6*@   ,WWU[?\ %C\K?Y"_
MZMG3KHV]!O\ PH]J_P"T_P L<@G]Y)_HQXS_ $C[KSH?TO6U        %\'Z
M7O\ ($[>_3 W_P#$OX_J)_G//T]\1_1#:_E'E4+/4=^>^U_%6+[HW*R"KD:
M                 8_KKS6I         -4+T]/R!/!W]#_QH_$OI3EJ]0?Z
M>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :A8J
M                              K??5"?D"=0_I@:!^)?R 6-_-A_I[Y?
M^B&Z_*/%-_\ IQ_/?=?BK+]T;90^7L)I@       )@/02_Q8_%+^73^K9W$B
M%Z\O^%'NK_9GY8X]JOSL_1CR?^C_ '7@:03G)0!
M                                    8_KKS6I         -4+T]/R!
M/!W]#_QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_ #WYG\:[O[HR.P&H6*@
M          (?O7M_PG/*W^0O^LGTZE[Z#?\ BN[5_P!I_D?D&U?)/])W&?Z1
M]R9V;\Z-D_0       '8'IZ?E]^#OZ8'C1^.C2FH?4'^@3OC^B',_D[<L5[[
M_,CF?Q5N_N?(U0G+4K7     8_KKS6I         -4+T]/R!/!W]#_QH_$OI
M3EJ]0?Z>^^/Z7\S^4=RK7[[_ #WYG\:[O[HR.P&H6*@
M                                                     (,/J)NW
M+WK#TT]SU_'W<UC==W=G=:]1_,VWST=UQ957V1[-R]I%=6-Y:<6D.4P_6=Q:
M7/QJ9X+BSN)K>J/GF;BJB<?S>/:6'N?U)[+D-Q2+XN$XS>;_ *;=,UZNFFRQ
MVFMJVZIIDWE,E.GIM3)6F2+?$F)W-Y#<73D?,+#GO$6KL]MESZ3IIKI&&LZ3
M$Z]-LT6C328M$6U\-)SS'0@G8          LF?3#]5R;3YJ]J]IW$?O8OJ?H
M?+65O71+=QR1;7V'M6NXO$\R4QVE=E/9U:SALYQ71+/')\;F*N.B3BB3F.M[
MYS;NFO%^2_%=K8YTW7*\]CM.L5F)P;3!FODTUM%HM[[)MM)K68Z>N+369K%H
M_>HODHVW:&VXVO\ C-UO:S/L^HQ4O-OAUB>NV/V1,::Q,QK&M[91:A<
M
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M3B9KO.,YRL1I?%DP6GPUCHM&3''MUG7WF332NE=)UGXT0MKJFD7P
M
M &/ZZ\UJ0        #5"]/3\@3P=_0_\:/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^
M_P ]^9_&N[^Z,CL!J%BH   #-]]>W_%C\K?Y"_ZMG3KHV]!O_"CVK_M/\L<@
MG]Y)_HQXS_2/NO.A_2];4        7P?I>_R!.WOTP-__$OX_J)_G//T]\1_
M1#:_E'E4+/4=^>^U_%6+[HW*R"KD:                  8_KKS6I
M   -4+T]/R!/!W]#_P :/Q+Z4Y:O4'^GOOC^E_,_E'<JU^^_SWYG\:[O[HR.
MP&H6*@
M *WWU0GY G4/Z8&@?B7\@%C?S8?Z>^7_ *(;K\H\4W_Z<?SWW7XJR_=&V4/E
M[":8       "8#T$O\6/Q2_ET_JV=Q(A>O+_ (4>ZO\ 9GY8X]JOSL_1CR?^
MC_=>!I!.<E $
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M_&N[^Z,CL!J%BH
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MB>G#2=)^":S$>,S-H-6&CD
M
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M#
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MSGX3VGV/(?K3_07YJO<'X9Z7^XG]EMW]_.KA_M?<_MGZMG.?A/:?8\A^M/\
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M4/Z8&@?B7\@%C?S8?Z>^7_HANORCQ3?_ *<?SWW7XJR_=&V4/E[":8
M "8#T$O\6/Q2_ET_JV=Q(A>O+_A1[J_V9^6./:K\[/T8\G_H_P!UX&D$YR4
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MA]0?Z!.^/Z(<S^3MRQ7OO\R.9_%6[^Y\C5"<M2M<    !C^NO-:D
M U0O3T_($\'?T/\ QH_$OI3EJ]0?Z>^^/Z7\S^4=RK7[[_/?F?QKN_NC([ :
MA8J
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M!,S&LZ:I446FM0
M
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MG.UN0XFL=67<;/+2D>/^,FD^[GPF)G2_3.GLG32=8G1JS.5A6>
M
MQ_77FM2         :B/I=[9]^?IU>%68^0^S?D_&_JO4_E_FOG/B?>%JUAHW
MS_QOEK7W/M7[W?FOA>[S\#XWP_?D]SXE7,%ZG^*^\WJ([TV?O/>=?<>^SZ]/
M3I\JSVW/1IK;ZCWW1U:_&Z>K2NO3%<7F/M?DG?O+XNKJUY#-?733_&7G)I[9
M^IZ]-?ATUTC72.\6B6%    ,WWU[?\6/RM_D+_JV=.NC;T&_\*/:O^T_RQR"
M?WDG^C'C/](^Z\Z']+UM0
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M9R[G@XGX^.?C9L.OP_%B/>8HG]UIUTB8ZXM$6R+':N=H$
M                       !6^^J$_($ZA_3 T#\2_D L;^;#_3WR_\ 1#=?
ME'BF_P#TX_GONOQ5E^Z-LH?+V$TP       $P'H)?XL?BE_+I_5L[B1"]>7_
M  H]U?[,_+''M5^=GZ,>3_T?[KP-()SDH @
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M:LZ3&M;9[S$Z3I,:Q/LF(GZ+JAJQC0
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M/EODO/C.MKVFUIUF9GVS/MF9^C,R^P>.^0
M
M                            !EV^I_U)_ ?Z@_EWUW':_(V%MW9MNUX.
MPXL_D(K#6>R[B/LO5K"VM_F[[FJSL=<VZUB@EYDXYGAHIEYHCYK^'1T^^F+N
MW_??T_=H]PVMUY[<)@P9;=75-\VSB=GGM,]-?C6S;>]K5T^+:9KK;3JFQ[RY
MY3[\]B\5OYGJO.SI2TZZZWQ1[J\S.D>,WI,S&GA/AK.FL\'M[,T
M :IW@9W++Y!>%_B_W%>9+[7S>[])Z!>[9D/BW<_Q]ZQ^ M,)OW'Q\A?9/(3_
M  -TQE_'[]Q<33U^Y[9*ZJ^:N7++Y[]G5\O_ #F[G[/PX_<[+9<WNJX*:5C3
M:WRVR;7PI6E(UV]\4Z4I6L:Z5B*Z*U>]>)C@N[N2XFE>G#AWF6*1X>&.;3;%
M[(B/\7-9\(B/H1HZT:F8N
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MZ-O0;_PH]J_[3_+'()_>2?Z,>,_TC[KSH?TO6U
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M3J'],#0/Q+^0"QOYL/\ 3WR_]$-U^4>*;_\ 3C^>^Z_%67[HVRA\O833
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M1I$1X1'A#\U]+]
M        '8'IZ?E]^#OZ8'C1^.C2FH?4'^@3OC^B',_D[<L5[[_,CF?Q5N_N
M?(U0G+4K7    <->IIN7WA>GKYG[%3'>5S5>-_;&NVDEA<?*W=ID-TU'):9C
MLE%<<<TU1?9=_GX[FKFGGBOW8N>*>>*O8WAZ:.&^_P!Z@^S..F:13_>/8Y;1
M>.JMJ;?/3<7I,?#UUQ32-?#6WCX:LR\N]I\M[[XC!X:??##:=8UB8QWC),:?
M3BLQ_=\67$Z@UD         #7&ZKU?(:/UAUQI66FL[C*Z?H>H:OD[C'23RX
M^?(:_KV.Q-Y-8RW-O:7,MG+<VE5454D45=5'/'-5%//MXXY*NZ>4V_-]S\CS
M6TB]=KO-_N,](O$1>*9<M\E8M$3:(M$6B+1%K1$ZZ3,>*KKDMS3><CN-YBB8
MQ9<][Q$^V(M:;1KI,QKI/CI,_LOO'@OB
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M.O+M_<1$S'C\HM&&=-?;,4O:VD>.E9GX&F4YI5>(
M
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MVF.\S_R\>N&8TZIGPI3'.NE8G72(F8M,V$5?;18
M                                               #,%]5_1OX//4B
M\SL!\OF+7[0[XW/>?A9R'X%[5_"?=4=E?,04?*67O8>\^^WXN.K]RKXF/KAJ
M^)+[?BU]./I2YS_>'TX=F;_JPV]WP.WVVN*=:_YE6=GI/QK?7*^XZ<L:QIEB
M\=--.F+&/++>_+_+_B,^M)Z=ECQ_%]GUF/=:>V?C1T:6^A;6-(]D1[I!,Z
M      79_I:>W*,SX_>2_1L]W#7==?=M:YV986TOS'SM.,[2U./7+BBWDFO*
M[>7&VN0ZKYDYB@@CYMY[NJN6NOFXCXHI3^=%[2ML^_\ MKOC'28Q<AQ.;9VF
M-.GKV6><T3,16)B]J;[3JM:>NN.(K$>[M,Q ]27%SAYSCN9K$].?:WPS/AIK
MAOUQKX:ZS&;369G6*Q$1'3.MIM5PC8    S??7M_Q8_*W^0O^K9TZZ-O0;_P
MH]J_[3_+'()_>2?Z,>,_TC[KSH?TO6U
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M&M9B=/%6IR7'[GB>0S\9O:].[V^6V.\>/U5+36=-8B=-8\)TC6/%]X\%\0
M                                  "M]]4)^0)U#^F!H'XE_(!8W\V'
M^GOE_P"B&Z_*/%-_^G'\]]U^*LOW1ME#Y>PFF        F ]!+_%C\4OY=/Z
MMG<2(7KR_P"%'NK_ &9^6./:K\[/T8\G_H_W7@:03G)0!
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M=I[3A>F(W=<<7SS$ZZY[Q%LGC'MB+?$K/^!6KAMO!F0
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M.UNJ8F)B=--?&)CZ36I<G"L
M                                  !6@^I][EM]1\0NG.EH)(:<SW+W
M-]O2QR\45URZCU1K]S=YKBWHJX]^.:C9]RP//,M//[&/WJ.>.?B>WBRKYL;L
MW)R_F[S'>F2+3L^&X;W43&L1&??98KCU^"8]SM]U\6?;.EOW/C(7TY\3;==U
M;OE[:^ZVFTZ?_GS6B*Z__)CR>'T=)^!1<7DIF@         +/GTNG3\6S^3_
M )!=V7=E\U;=2]/X?3K">NNT^%C=B[<V:JXL[R.*JXHR%5Y)KW6V5MZ*XXI(
M*89Y>):J*ZH>*JQ_G0.[[<9Y8]O]E8K].3EN8R;BT:6UOBV&'2U9G3HZ8R[S
M!>8FT6FU:36)B+Z1S]1_*SMNW-CP]9TMNMW;),>/C7!328]FFG5EI/C,3K$:
M:Q$Z7AE(B'(
M
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M*34/0
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M>@W_ (4>U?\ :?Y8Y!/[R3_1CQG^D?=>=#^EZVH
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M=/ZMG<2(7KR_X4>ZO]F?ECCVJ_.S]&/)_P"C_=>!I!.<E $
M                       !$AZW?E%7XO>GIW#?X/.383L+N"&TZ/Z_FLI[
M>#(TWF^?&@W"^LY:Y:+RSFQ76]IF9H;JUHJGMKWBWYHJBJYIFCEIZ)O+"OF?
MZ@^'V^^P1G[?XBUN2W<6B9IT[72=O6T:=-HOO+;>MJ7F*WQ^\B8O$32VT?)[
MMN.X^^]I3-2+[':3.XRZQ,QIC\<<3\$]66<<36?":]6NOLG-L='ZP$
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MY">-\N^6W%9F)MMO=>$1/^/O7!/M\-)C)XS[8C6:_&B&FLYGU=X
M
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M_J&Y6-YWKBXZDQT;/9TK/C$SUY)MDG73V?$G'I$^/P^RT+%*O!H4
M
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MNP
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MTYFYP
M$VWH ^3=?C[ZA>@ZEE<A#9:3Y'XV_P"D]@^:N;>WMZ-CR_NY;K.YBIGBY^8R
M5YOF,L\1!'3)%7S3EY/=YKJ]D5<*/7UY9U\P/3YO^6VN.;\UVYDKR6+IK,S.
M''];WD3I/A2NUODSVF8M&N"NO3&MJZ?\\.W8YWL3/NL59G><?:-Q72)F>BOQ
M<T>'LB,<VO,Z3]1'L]L:)CGC0-
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M5EF\3$>'Q*S,S/A6LVLM2&
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ML^HQ4O-OAUB>NV/V1,::Q,QK&M[91:A<
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MR;N\4F9F=<=)]WC]NO[BM=(]D1X1X1#M-IAB(
M
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M+K[S:[G)BG7X?=WFNO\ =TUB?9,3K'@]:8F\L
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M:?#QUI2+IDO0
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MNC@L_;7<6\X+/%HMML]J1-O;:FNN._AI]7CFMX\(\+1X1['137;P0
M                            %;[ZH3\@3J'],#0/Q+^0"QOYL/\ 3WR_
M]$-U^4>*;_\ 3C^>^Z_%67[HVRA\O833        3 >@E_BQ^*7\NG]6SN)$
M+UY?\*/=7^S/RQQ[5?G9^C'D_P#1_NO T@G.2@"
M               ^5WK=-<ZVTC<NQ-PR,.(U+0M5V'=-IRUQ)%%;XO7-6Q%Y
MG,WD9Y9Y(8(X;+&6,LE55==-'%-/////''W7J\%PO(]R<WL^W>'QSFY;?[K%
MML&.(F9OFSY*XL=(B(F9FU[5B(B)G6?")?3LMGN.0WF+8;2LWW6?+7'2L>V;
MWM%:Q&GCXS,0RA_('N?9O(GO#M?O3<?V&Q]K;YLF[Y&UXFHN(L;]NY.>\M,-
M;3T6UG3+9X2QKBLX*N(H_;#!3^QX_P CJO\ +_LWC/+OLCBNQN'\>.XK88=M
M2VFDW]U2*VR3$VMI;):+9+1U3\:T^,K-.#XC;\#PVUX7:?\ =]M@ICB?9KTQ
M$3:?&?&TZVGQGQEX^R]ZH
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MAMZCN7^5=R[+AJSKCVFTF\_2OGMXQ]3$S\3%CG7JF/'2(B8MK9Q5F([
M
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MDO7Z=XK/NX^IM'C?IC6:S$:ZS&FK5R<J2LP
M
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M6)\*VJ@CY[\/]Z_,#-N:1IAWN#'GCZ&NGNK_ -V;XYM/_.U]DPG)0?:;
M
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MQEF3U@
M %V'Z8#RB^^OICNCQ)V"_P#?R_4VR0=J=?13<^V2;0]_KXQ^V8JRCAM:8H[/
M5MXQ]%[)7-+5-+-LWNT>V.+V1TK?.=>5_P!ZN\N%\V>/QZ;3EMM.QW<Q[(W6
MUCKP7M,VUFV?;7G'$5B*UKL]9TM;6T0?49VW\FY?:=T8*_6MUCG#E_\ LF+Q
MI:?'VWQSTQI&D1B\?&?&U"JU1K
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M6NOAI.?@O^3D
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M2LZ^.OMUGVNV&E6'@
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M//\ YC[W=B3L*3IEWVYQXM/AZ*3.:T_L:XZUG_G:>R9:!2@1!P
M
M                                               !3^^J>Z-_)6\E
M<=CO]LNC=QRWRG_V+?NM<=\]!B/_ -[)/@W5_P#_ )UK;_\ VY(MZ^:V[X_.
MKRVW.3^+\GM\?5^SM=Y?IG)_X&.JF+Z67)_B:I4^FSF?_4^WLEO\GN,==?\
M[5EG2;?_ &&-8K_SK?40I_+>4J0         %KGZ6?NW[*[:\G/':^N_VG=M
M#U7MW7;::OW(X<AU[G)-3V6BRXYYIIDO,M8=@X^N2C]E7S#C?>IXXIHDY54_
M.C=D_*NT^V?,/!3X^RW^?89K1'C--WBC/AZOH5QVVF6(GPCJS:3XVJC-ZDN'
M][Q?'<]2/'#GO@O/TLM>NFOTJSBM$?3OI\,+I*F)$8
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MJS$Q,Q*<&++BW&*N?!:M\%ZQ:MJS$UM68UBU9C6)B8G6)CPF/&'YKZ7Z
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M G4/Z8&@?B7\@%C?S8?Z>^7_ *(;K\H\4W_Z<?SWW7XJR_=&V4/E[":8
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M'*:Q&>,$X\?CI/O,OUNDQ\,],VZYB/'IK/C$1,QJ&.857&
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M?DVVOEMI_A9[16(M\;VQ7#%HB:Q,1?768MX6FU6Z-@
M
M                                       "'CUX>EK?N;TS.]I:+:&X
MSW4<VI]TZU)/#1+19W&F9VVM-IN>*N,5E+RWF_@WSN<CCKM_EJOB24TS3T6M
M5QQ5,#T)]Z9.S?4OP59M-=AR\9^.S1$S$VC<8IM@K]72LQ\LQ;:TQ?KC2)FE
M+98QZ;6\E>7MQ/F'LHF9C!NHOM[Z?#&2LS2/JHB?KM<<SKKX1X5FW2SA'1FG
MX          DR]'CO:W\>O4<\8MSRF2AQ>M;%NU?5>U3WEQ1:8RG#]L8N^T*
MWNLM=RU1Q6N-PN?SEED9)9*Z(H>;/BN3GB.FI&GU@=BY/,'TY]S\-M<5LO);
M;91OL$5B;7]YL;UW4UQUC6;7R8L63#%8B;6]Y-:QU3#7GFMPMN=[ Y':8ZS;
M<8\/OJ1$:SU89C),5CX9M6MJ1$>,]6D>.C30<T2O
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M1:(UCQC6LQ,\]M@O=
M            :@OI>^4']+[P7\?^Y;^XO+C;Y=/AT?L>O)7?SV2N.Q>NI:]-
MVS,WEQS5)7S]]U]A_MN"FNN26BUR45,E7,G%?+F(]3WEC_5%YY=P=G8*TKQ$
M;R=SLXI7II&TW<1N,&.L>'^(KD^36F(BLWPVFL1717+YC]N?[J]Y[[B:1$;6
M,OO,6D:1&++]<I6(_P"1%O=S[(UI.GAH[]:#8.
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ML/FWHOH
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M3$Q[+4M&GPVZ52*+8
M                           #+#]0?OFOR:\VO)ONVB_AR>)W'MK9H-1O
MH*[>2BXZ]U.>C2NMN:IK/)9>QGFHT'7,;3));W,UM))355#5\+FCCCJ2]/W8
ME?+/R4[9[*G'.+=[/B<,[BLZQ,;O/'RG>>%J8[1'RK-FF(O2MXC2+QU1*R?L
M7A([=[/X[AYK-<N+:TF\3KX9;Q[S+[8K,?7;WTB8B8CV^.KCEN%E8
M  #3A](KHW^CYZ<WBMH]SCOL[.YKK>T[1VB.>T^4RWV_V]>7G95Q9Y^B3$86
M\^V,!9[/!BJX[B&N:UBL([;F6:F"F6OF:]6_?']8'J*[IYS%D]YL</)6V6"8
MMU8_=;"M=G%L6F3)7W>6V&V>)I:*WMEMEBE)O-8KL\TN9^_O?W)[RMNK#3<3
MAII.M>G!$8HFOQK1TVFDWUB=+3:;:1KI$D*.+
M
M                                    'P?:?7N$[;ZP['ZIV6GW]<[-
MT/;^O<_3\.F;WL)NFO9'6\K3\&NJFB7VV.2D_8\\\<5?Y.>7O=K=P;WM+N?C
MNZN-\.1XS?[?=XO'3ZYM\M,U/'X/C4CQ^!]O&[[-Q?([?D]O_P!XV^>F6O\
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M8B(E[8PIXX
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M3^K9W$B%Z\O^%'NK_9GY8X]JOSL_1CR?^C_=>!I!.<E $
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M?']?OEY_E-W]@M^V?JX_J8?[+]/_ ,[.)_T$_M%_35_&N8^T,G[X_K]\O/\
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MCXN*GAX?$I%:SIX3,3/PNHFKV-@
M                                    .,O4/[ZE\8_"+R9[NL[KY'-Z
M=U7GK;4[SYJ[LOEMZV[Y?2-!G^:Q]U8Y"+X>Z;)8<^VWG@N.?\D<D=?--?&Y
M/3UV'7S-\[.V>R<U>O9;SE<4YZ]-;=6UV^NYW4=-ZVI.NWPY?JZVK_A5M76)
MRWL/A([B[QX[A[QU8<NYK-XTB=<=-<F7PF)C_%TM[8F/HQ,>#+*=1ZR4
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MF9GQF9F?&9F?&9GVO]C\7\
M
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MI
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MB8M6T3I-;1.DQ,3&DQ/C$^$OTGS/S
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M8[XKVQ9:S7+69B8F-)B8\)B8GQB8GPF)]C_8_%_
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MX%#"$H
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M4M.EHTO%9CXVL:$3GX06
M
M                    4_OJGNC?R5O)7'8[_;+HW<<M\I_]BW[K7'?/08C_
M />R3X-U?_\ YUK;_P#VY(MZ^:V[X_.KRVW.3^+\GM\?5^SM=Y?IG)_X&.JF
M+Z67)_B:I4^FSF?_ %/M[);_ ">XQUU_^U99TFW_ -AC6*_\ZWU$*?RWE*D
M        !9D^F$[VBTCRQ[DZ&OY?@V'>_5=GGL7S[UI_G6X].9*^R.,L?<DL
MZKWGWM0W//S^]%<QQT_+>R2&;FJ.2WK2^<X[%MS?E1PW?>".K/P7*VQ7^J^+
MM^0I6E[:Q;I_[QM]K72U)F>OXMZ:6KDCSZC.%G>=L;3FZ1K?9;F:S[?#'GB(
MF?;I]7CQ1XQ,^/A,>,6O/*.4,P
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MC&DQ/LF)B8F8F)?;/$?&
M        I@_5$>+_ -B=@]#^7^"M[SFPWK#W71_87-%I[N+L]FU/B_VKK_(R
M7U--7->8VG7,AF+:N*2JCBFVUV+F.FKGF;FFY?YL'S.^6]O\]Y0[ZU/?['-7
MDMI\;X]L.?IP;ND5^#'@S4V]XF(G6^[O%ICXD3+;TX=Q^^V.][5S3'7AO&XQ
M>/C-+Z4RQI_@TO%)UCX<LZ_ J=K7$G         &D#Z&7E%_2<]//J?[5O\
MYS=>B??\?MQ^)S_G-7\'^,Q/WE7TOMM;6JY^=ZYR>(^)<_MWQ[N.?WY9)J9O
M9SD^N+RO_JR]0G+?)<?1PO.Z<KM]/J?\[OD^4UCXUM.G=TSZ4^+TXYQZ4K2:
M:P"\Y>V_]W>^]U[JNFSWO^<X_H?79M[R/;.FF6+Z1X:5FND1$PF!1":J
M                              5OOJA/R!.H?TP- _$OY +&_FP_T]\O
M_1#=?E'BF_\ TX_GONOQ5E^Z-LH?+V$TP       $P'H)?XL?BE_+I_5L[B1
M"]>7_"CW5_LS\L<>U7YV?HQY/_1_NO T@G.2@"
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M-<F2=8_Y7NJ3'AK6\^V-8F_8H20B
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MQXZ3:9MDM&LQ%[VB)F-'>[0S"0
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MM_S\UM-)^G%,59CZ$7\/;*T2K 1P
M
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M]96DZQ&L>VNDZ3&J0Y9U:P
M                               "I%]2GZ?]WG<3@O/WK7%?,7>LV>!Z
M]\@L986\7$]>O57,MAHO9]Q5S-'5<?8]]=P8#(>[3-/\O<8ZOBFFWM;B2BVC
MYMOS^Q;'=Y_(/N7+TXMS?+N^*O:9T][I%MSLH\)T]Y6MMUBUFM>NFXC6<F7'
M690^GSOBF'+?L?D+:5R3;+M9F?W6FN3#'T.J(G+7V1K&2/JK5B:;2XM+$
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M)N]/+SN/L;<]'*8NO86F?=Y\>LXK^/A$SI\2_P#R+Z3]#JCQ2$H^L%
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M^V<'<>*(^4;#-TWGZ.'/,5\9TUGIRQCZ8F8B(O>8\9\;TBC9#(
M                       !6^^J$_($ZA_3 T#\2_D L;^;#_3WR_\ 1#=?
ME'BF_P#TX_GONOQ5E^Z-LH?+V$TP       $P'H)?XL?BE_+I_5L[B1"]>7_
M  H]U?[,_+''M5^=GZ,>3_T?[KP-()SDH @
M        *@GU1OE!;_+^/WAU@,G-S=<S7G?_ &78QPT4V\=O31EM'ZKMJ[^C
MBJ2::62K9KBYL^:J*8Z:+*>NBOFN"J.W?YK_ ,L,GO.X/.'?XH]UI7BMG:9G
M69UQ[G?3T^R(B/D=*9-)F9G-2)KTWBTJ/3?VY;JWW=>>L=.D;;#/PZ_%R9IT
M^PQ%OA^/6)C28FGPM\2J         :'_ -/QXPW'CWZ?>I;?G;*:UW#R3SUW
MW=D*;J.N.XM]1RV/Q^%ZVLXN)+6TKYQM[J6(BS,'//Q?>JS,E5,E4=5%-//3
MZ_\ S.Q^8/J W?$;&\6XCMO!7C:=,Q,3GQWODWEITM;X]<^2VWM]3I&WK$UB
MT6F8(>>7<=>=[YR[7#,3M>/I&WC3V3>LS;+/MGQB]IQS[/\ %QX:ZZSAH1-.
M                                               .2_+OS?\ &[P>
MZ^K["\@]_L]=AN/;%K>GXSB+,=@[K>^WFGBRU'4H9XK[)>[53[)KJ3F#'VGM
MXYN;B&GGCEMGRC\DO,?SN[@CM_R_X^^XO7QS;B^N/:;:O^%GSS$UI_R:1U9<
MGLQX[SX,H[6[.[@[QWWR'@L$Y)CZN\_%Q8X^C>^FD?2B-;6_<UE0Q]2[UC/(
M+U",ADM$AX_@G\9K3,6E]@.H,)/3+D-DDQ$TTV*V#M39:*:;G:,Q3<R\3QX^
M#Y?"6-<5O51;S7=O\_->]Z:_1[Y?^G[;X^=O_P#5;S+OAM7+O\D:4PQDB(OB
MV.'V8<>D=,Y;=>YR1;)$Y*8LGN*36\O?*C@^Q:5WL_YUW%-)BV>T>%.KZJN&
MGLI73PFTZY+:VUM%;=$0_I>-J           +.WTX/@!1V]V_F/-7LK#0W?7
M?1F2EU_J>SO>+BCC-=WU08S(<[-''[GRUYC>N=>O^:Z>*_\ ^KY"TFCJ]^RD
MI5D_.->?MNT>T,/DOVWFFG<7.8XR[ZU=/K?&ZWI[F9^JK?=Y:Z3I_P!1BRTM
M&F:LHZ^?W?$\5Q5.T./O,;_>UZLTQI\7;^,='T8G+:/^A6T3X7A>,4A(;@
M
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M[5Q^8_,VY[OCD^1UFV+Y5;'2?_H\/UJDQ&E=-:TBVDQK$S/5,VUF>]VAF$@
M
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MBFNOC-9UTGPCO=H9A(
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MSVUR[;<^.D7CXMHCVS2\:TR5U\.JEK5U\-=7O#!'B@
M                           ,Q?U8O%^X\2?/3OSK2VQD.+TS/[5=]I=8
M16DU<UCQUWV1<W.QX7'V-=QSS>\0ZK>W%UA*_C^V3F;&5\^_+1S1-)TT^E'S
M/Q^;/D/P'<N3+.7F=OM:[+>S:(BWRO9UC#DO;3XNN>L4W,=/ATYJQI2=:5L4
M\L>XZ]T=D['D+6FV[IBC#FU]OO<412TSIX?'B*Y/#PTO'A$ZQ$<J13/@
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M6/Q2_ET_JV=Q(A>O+_A1[J_V9^6./:K\[/T8\G_H_P!UX&D$YR4 0
M                          &6WZCWD]<>8/FKW]WK'>S7>L9_=KS ]<T2
M25\Q6O66E1Q:EH?,-K\W>6V/FRFO8>'(7D5O)5!5D;RXEIYJYDJJJZAO3GY8
MX_*#R6X#L:U(IR>WV5<N[F(C6V]W,SGW6MNFMKQ3+DMBQVO'5&''CK.D5B(L
MA[ [<KVKVAL>%F(C<TPQ;+]/-D^/D\=(F=+6FM9F->BM8^#1Q"W:S$
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MM:9T\/&9F?!^\^!^
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MK3,S)[BN(XS@]E3C>(P8MOL:1X4I6*Q[-)F?AM:=/C7M,VM/C:9GQ>8LF>B
M          Z0\2/%_L7S'\@>NO'KK"W]FP[WF*+>^S<]I=7>)T_6;.GFZV3<
ML_Q:4\R1X?7L5')-7Q[:.9Y>(X(^?BRQT\ZY\VO,[MWR=\O^1\P>Y[?_ %/V
M&'6N.+5KDW&:WQ<.WQ=7A.3+>8K'MZ:]62T=%+3'@=T=Q[#M/@]QSO(S]8PT
MUBL3$6R7GPICKK^ZM.D?2C6T^$2U!O'#H+K[Q<Z-ZTZ ZMQWV;H_6.MP8'%4
M5^WFYR%W+<7.4V#8<C5S57Q7F-IV/(7>2O:N/935=W<G-/'%//''',/YC=^]
MP>:'?')=_=T9/><WR>YG+?Z%*Q$4Q8J?0QX,-,>'''MC'CK$S,^*N3G^;WW<
MG,[CG.2MU;S<Y.JWT(C2(K6/^32D5I7_ )-8>V,*>.
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M5R8-K>:3KI]<M'3BC7_E9+4K'PZSX:RU5'+"K3
M
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M[BQ1'3GPVP7TTCXV*>NDS\,S:N2U=?'2,=8\/#6UFJL1G
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MN?>?O..6PQ/R7DL49/9I$9<>F/+6)^'PC'DGX=<D^R-%@5 %HT
M                      !6^^J$_($ZA_3 T#\2_D L;^;#_3WR_P#1#=?E
M'BF__3C^>^Z_%67[HVRA\O833        3 >@E_BQ^*7\NG]6SN)$+UY?\*/
M=7^S/RQQ[5?G9^C'D_\ 1_NO T@G.2@"
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M3
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M>S728O;*+4+@
M
M             %6KZHOH2+9>@/'WR.QUK[<KU7V1F.M-@DM;6TIEGU7M/#4Y
M>PO\M>?+?.SV>O;+H$-M:1_'XCAFSLW/$=7,M5=%HOS7_?EN-[_[@\N=Q?\
MS7E>-Q[S%%K6TC/L<GN[5QUZNF+9<.ZM?)/3K:NVI$VB*1$R1].'-SM^<WW
M9)^M[G;URUUF?J\-NF8K&NFMJ99FTZ:S&./'PTFDDNN3!          3#>A'
MY!6_0'J3=+<92YFMM>[MAS'C[G*H.:/?EN.QZK"K2+:J.66&.6&Y[0PF"HDX
MYJ]ZB/FJNBFNNFF.J('KJ\O\G?WIOYKY+6+<APDX^5Q:ZZ1&SZOE,ZQ$S$QL
MLFZF/#29TK,UK,VC5/G3P=N<\OMY[N(G/LYKN:Z_0Q:^\G^YAMDT^GX3I$ZQ
MH^.<M ,
M                 !52^H+]*F7LK"9?SP\?=>^)OVHX>BKR)TG#8Z[N[_?-
M5QE./L,=V;@[+&6D]=6R:/BJ*J<[\3]KNL%;T77OPR8^7B]M0^;^]5%>V][A
M\B?,#<:<#N\W_P!2=SDO6M=KGOUVOLLMKVB/<[F\Q.UT\:;F\XM+UW%9PR7\
MC/,N./S5[*YW)_F.6_\ FN2TQ$8[SK,X;3,_49)_Q>GC&29KI,9(Z*52Z-+L
M              !]MHO9?8_5V8CV'K/?]VZZS\4UE<Q9S1=JSNHYB.XQMU1?
M8Z>/)Z_?X^]HFL+V.F:&KBOBJ*6GBNGGBKCCEXO.]M=N=T;.>/[FX_9<CL)B
MT3BW6#%N,<Q>O3>)IEK>NEJS-;1II:LZ3K#X][QW'\EB]QR.##N,$Q,=.2E;
MUTF-)C2T3'C'A/T8\)2*=5^M1ZG/4=%I:X3ROW;:L9;S8JJYQ_:F+U+MFO)V
MN*N)Y^+"[SW86O[#MMO#D*+F2*ZFM,C;7D\?-/MFXJBAJCCOW3Z+_3+W;:^7
M>]J;+:[FT7Z;[&^?812UXB.JN+:9<6"9ITQ:E<F*^.LZ_$TM>+8'R7E%Y=<I
M,VS<9AQ9)BVDX;7PZ3:/;%<5JTG32)K%JS6)^#29U[2U?ZF?U#]?Q\UGEM4\
M8]XN9;R2YHRVT=;;S:9"W@K@MXJ<=#'I7:NGXJJSBDAJEIJDMJ[CFN:OBJ6J
MCBBBC3'*?-H^GKD-Q&;:;ON;8XXI%9QX-YMK4F8F9ZYG<['<7ZIB8B8B\4TK
M&E8GJFV(;GT\=AY[Q?%EY'#6(TZ:9<<Q/M\?KF&]M?@\)B/"/#769Z$_6GN_
MOS5NGOPRW3]R:^_LMNP?YU<Q]K[;]MX7ZMG!_A/=_8\9^M/=_?FK=/?AENG[
MD?V6W8/\ZN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z?N1_9;=@_P ZN8^U
M]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z?N1_9;=@_SJYC[7VW[9^K9P?X3W?V
M/&?K3W?WYJW3WX9;I^Y']EMV#_.KF/M?;?MGZMG!_A/=_8\9^M/=_?FK=/?A
MENG[D?V6W8/\ZN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z?N1_9;=@_P Z
MN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z?N1_9;=@_SJYC[7VW[9^K9P?X
M3W?V/&?K3W?WYJW3WX9;I^Y']EMV#_.KF/M?;?MGZMG!_A/=_8\9^M/=_?FK
M=/?AENG[D?V6W8/\ZN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z?N1_9;=@
M_P ZN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z?N1_9;=@_SJYC[7VW[9^K
M9P?X3W?V/&?K3W?WYJW3WX9;I^Y']EMV#_.KF/M?;?MGZMG!_A/=_8\9^M/=
M_?FK=/?AENG[D?V6W8/\ZN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z?N1_
M9;=@_P ZN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z?N1_9;=@_SJYC[7VW
M[9^K9P?X3W?V/&?K3W?WYJW3WX9;I^Y']EMV#_.KF/M?;?MGZMG!_A/=_8\9
M^M/=_?FK=/?AENG[D?V6W8/\ZN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z
M?N1_9;=@_P ZN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z?N1_9;=@_SJYC
M[7VW[9^K9P?X3W?V/&?K3W?WYJW3WX9;I^Y']EMV#_.KF/M?;?MGZMG!_A/=
M_8\9^M/=_?FK=/?AENG[D?V6W8/\ZN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]
M^&6Z?N1_9;=@_P ZN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z?N1_9;=@_
MSJYC[7VW[9^K9P?X3W?V/&?K3W?WYJW3WX9;I^Y']EMV#_.KF/M?;?MGZMG!
M_A/=_8\9^M/=_?FK=/?AENG[D?V6W8/\ZN8^U]M^V?JV<'^$]W]CQGZT]W]^
M:MT]^&6Z?N1_9;=@_P ZN8^U]M^V?JV<'^$]W]CQGZT]W]^:MT]^&6Z?N1_9
M;=@_SJYC[7VW[9^K9P?X3W?V/&^PU/ZJS?[/Y_[^?##3]B^)\K]E_>GW7FM,
M^3]SYGYWY_[8ZWWW[2^8]Z'X7P_E/@^Y7[WQ??I^'X_*_-7\!F]W]X^\]YM]
M.KK]_P ;CW'5[.GH]WO-KT:?&ZM>OJUC3IZ9ZOEW7IIV-^GY%R^7'[=>O;UR
M:^S33IRX]-/'77JU\/9IXR-]%?4H^!?9N3M<'VCA^VO'R]N9I8_MW;=:MMRT
M:/CGB3FSIES/7U[G=G@FN:Z*:*^9<'';0524U5S_  ^))*(Z]\_-N>?';.VM
MONU\W$]P8:UB?=8,UMON9]G5ICW=<6&8B-9CIW,WM$3$4ZNFML!YKT^][<=C
MG-QM]KOJ1'U-+SCR?3^+EBM)T^EDF9T\(UTB9U>L.V^K>[-1L]^Z>[%TGM'2
M;^::UM=JT#9\-MF!DO;7B/YS'U9/!WE[:PY*QJEIIN+:NJF>WKY]V2BFK[B#
M'<_:?='97+7X'O#CM[Q?-8XBUL&ZPY,&6*VUZ;]&6M;32VDS2\1-;QXUF8\6
MF.1XODN'W4['E=OFVV\K&LTRTM2VD^R=+1$Z3\$^R?@F7H3'WP
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M?8JZ[SC\E<]9C37W?U&6-9_<]%O>3$3$S[N/;[)T+G/D@H
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M,?:^V_;/U;.#_">[^QXS]:>[^_-6Z>_#+=/W(_LMNP?YU<Q]K[;]L_5LX/\
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MQ/%<1B]QQ6VV^UPS^YQ8Z8Z^V9]E(K'MM,_LS,_#+S=D;[P
M %J?Z?;TJZ^RMCPGG=W_ *S#-UOJ62NI/'W3\W:V]Q!O&Y8J6>PN.R<OB<EB
M[FWN-5TW(<5\86NB6B:7/VGS''NQV5'S-67S@'JGKVWQV?R*[ W,QW'N\=8Y
M7<8[3$[;;WB+QL\>2EXF,^XII\HB:S6NUR>[\;9K>[C5YY^9<<?M[]E\'DF.
M0RUCY5>LS$X\=M)C%6T3$Q?)'^,\)B,=NGVWGINMJ640@
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M?#:8Z;6O"#_J YJ.2[Y^]V.?K6PVU,<^R=<E]<UIUTU^IO2LQK,1-)]DS,+
MJ +1H
M
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M:NM9B59'.\5FX/FMWP^>)C+MMQDQSK&FO1:8BW[%HB+1,>$Q,3'A+V!B#R@
M
M         %$_US_2$N/&G9\KY:>->JY*Y\>MRR4]_P!IZMC>*\A%TGNF7R'M
MYR=M!Q[U[9]8[=>WG'%OS5\6WP^1YJM>9(;>XQ\%-Y_H<]76/S*XS%Y3^9&Z
MQU\P=GCBNQSWTI/);;'3ZBT_4VWN"M?CZ=-MQATRQ6^3'N+S,_R9\U*]P[:O
M:_<&6L<[BK$8;SX?*,=8]D_!.:D1X^R<E/C:3:MY5K5DB08
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MJ$_($ZA_3 T#\2_D L;^;#_3WR_]$-U^4>*;_P#3C^>^Z_%67[HVRA\O833
M       3 >@E_BQ^*7\NG]6SN)$+UY?\*/=7^S/RQQ[5?G9^C'D_]'^Z\#2"
M<Y* (                               #\':MGP.DZQL>Y[5DH<-K&HX
M',;/L>7N*)I+?%8' 8^XRN8R4]%O%-<5PV./M)):N(Z*Z^::>?=IYY]G#[^+
MXS?\WR>VX;B\<YN3W>?'APXXTB;Y<MXICI$S,1K:]HK&LQ&L^,Q#]]MML^\W
M./:;:LWW.6]:4K'MM:TQ6L1KX>,S$>+*3\H.^=F\H/(;N+R VZKW<WVMOF=V
MOFSXHHCBP^)NKKF#7-=MJ::YN?D]9URWM,?!S7)++S#;4\R225\U5U=5/EAV
M'QGEAY>\/V!Q'_<N*V&+!U:ZSDR5KKFS3X1\;-FG)EMI%:]5YZ:UKI6+,>W.
M$V_;G [3@]K_ (G;8*TU_P *T1\>T_3O>;6GPB-9\(B/!X.SM[0       #N
MKTTO&2CR\\X/'SI#)8^;(Z?F=VM]D['BIM;B>UJZVT2WN-RW2QO[B"6#C%P[
M#AL+)B8;FNNGB.\OX>*>))*J(J]&>I3S,MY1^2/<'>^VR1CY?#LIP[.>J(M\
MLW4QM]O:L3$]<XLF2,]J1'CCQ7F9K6+6KAGF%W%/:W9V^YC':*[JF&:8O&(G
MWN28QXYB/'7IM:+S'PUK/LC68U&'+^K@          1F^I)ZH?1GIR:%9W>X
M\3;SW+N6-R4_6/3F!N[2+,9?FV@NXK;9MNO)9?;J77L>9@IM)<AS%<7,\O,E
M%E;754%SQ#);TX>F'OCU%\]?#P^FQ[-V>2D;WD,M;3CQZS69P[>L1]?W<XYF
M]<6M:5KTSFRXHOCZ]A^7_EQS/?V^FFTTP\3AM'OL]HGIKK,:TI'[O+TSU176
M(B-)O:L6KK0!\RO4"\I/._;J-E\@NPILKAL;DK_(ZCUKKL$F!ZRT/B^YJHYM
M]7U>BXNJJIH;7GBWXR&1N,AEYH*>*9[N7_+S?MY.>0'E=Y%<3/&^7_'QBWF3
M'6FXWF:8R[W==/PYL^E?";?&]UAIBP5M.M,-$X>T^QNV^RMK\GX/!%<MJQ%\
MM_C9LFGPWOI'P^/36*TB?96'%K<[+@
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MGY@
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M+VFT5C69G2L3%:QK.D1$? ]F8:\D
M
M                              !EJ^H]T%%XP^='D]TG98ZSQ&"U;M3-
M933L38?*?*8SK[?(K3L/KK'Q46-55K#\EHNUXZ.J.GBCX=5/-/,<=7',=/43
MZ<^_;>9WD;VQWKFR7S;[=<5CIN,E^KJON]K-MIN[SU?&GJW.#+,3.NL3K%K1
M,6FR/L#G)[C[,X[F+VF^;+MJQDM.NLY<>N++/CX^.2EIU\=?;K/M<3MU,O
M        7Y?IK_(>+M/P7S/2^1R?S.R^-O9&9P,./EN[2YN[;K[L:6ZWK4;Z
MN.*VMKVWL[G9KC8K.WIN*KCV4X[GB.;X5--O;T+?.1^7MNUO/+#WGM\73QO<
MG&X\LWBMHK.[V<5VV>NLS-9M&&-IDO-(IXYHFU.J9R9(2>H+@9XWO.G+XZZ;
M?D-O6VNDQ$Y<6F.\>V8F8I&*TZ:?5>,:_&M8=5ZM$
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MV_O3WW';C.Z\O 9;1&TY'#.D3_EL,3>FD_!KCG+$QX=4]$:ZQ$30X7MIJ
M      +O_P!,1Y/7&\^/?;GBQGKV:7(=$[5:;MHT=Q)771]X7:=SEKO+XK&T
M5W4WPX<#OF+O;RXIIB@CXDSU%7',E=4G--)'SFWECCX/S!XCS2V%(C;\[M;;
M;<S$1K\JV-<=<=[_ !8UG+M;X\=)FUITVMHGIB*ZPZ]1?;E=ESNU[EP1$8][
MBG'DT_RF&*Q69\/W6.:UCQF=,<^R(C6T&K#1R
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M[CKDS['M3#,3[N)W.7X=+6ZL>&/"?"8K[V9B8UTO28\)\;<:I1%P
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MMWB\/#\3CC%L<%(K6(]L_1M:?W5[3K:UI\;6F9EX^R]ZH
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M(B*Q$5K$1$0^\>$^(
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M$SX>S368TCG.&K_
M
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M1]&-)FEYGQB*TG6-/&+_  H,0@
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MWFWY7>;^R[PICX3FIC#W16GM\*X]QT^VV/Q^+DT\;X](CVVQZUZJT@'3X;O
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M!+_%C\4OY=/ZMG<2(7KR_P"%'NK_ &9^6./:K\[/T8\G_H_W7@:03G)0!
M                             9_?U&?D]<=U^==?3>,O9IM,\7M5LM)M
M(>)*ZK&;?=SLL3N'8.5M(_FI8Z9J8YL5B+FKX4$G,V%YIYXKHICKYOY^;J\L
M<?9?D7'>.YI%>9[HW5MS:=(ZHVNWMDV^TI:>F)TUC/N*1U6CIW,3'3,VK$XO
M(/MRO#]E_?;)$1N^2RSDGZ/N\<VQXHGP_P"?>/&8TR?!,S" %/IO
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M.2R\OR^6V;?YK:VM/_PK6/96M8\*UC2*Q$1$:/6F)O+
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M[MS',].+%?<9(UC29R3[O'KX:Q-8ID^'QC)&L>R5LM5 C$
M
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MV>XX_>9=ANZS3=8,ML=ZS[8O2TUM$Z^/A,3#ZIY3Y@
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MW=ITKE^"*9IF-*Y-/9EF>F_[OIO\;)5&6K),@
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M7$\?BXCBMMQ6#QP[7;X\5?;]3CI%(]LVGV5^&9GZ,S[7F[(WW@
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M\I\P
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M'7'CI'LK2E8K6L?2K6(B/I0LQPXL>#%7!AB*XJ5BM8CV1$1I$1^Q#\U]+]
M        &H+Z7'CQ%XO^ _C-U5/C/LK9N.M\3O._6TUG:6N2B[![*IKWS;<=
MEIK.YO:,C>:WE-@JQ%%QS-)[]KCX::/<BIHCHYB/5!YA6\S_ #Z[E[JIE][Q
MOWRR;;:S%K6I.TV?^:X+XXM%9I7-3%&>:=,:7RWF=;3:TUR^9'/3W'WOR/)Q
M;JV_RBV/%.LS'NL7UNDUUB-(O6O7,:1XVG76=9GOUH-@X
M
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M8C:\ABKGC372+_498\?AF]?>3[8^N1I]")ST'&F0
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M,KA><XCN+84Y3A-QCW.QO[+4GV3I$]-JSI:EXB8UI>*VKK&L0\?9>]4
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M'D?W%/!=]X-KEM$;/D*SM[:S$1UV^-AGQ]LSDBM(C6/JY]OLG.T=#B>0
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MZ"7^+'XI?RZ?U;.XD0O7E_PH]U?[,_+''M5^=GZ,>3_T?[KP-()SDH @
M                          *T'U-7D];]>>*O7OC#A[V'G9?(C=H,]L]G
M3)1+7;]9=37F,V&OB[MXKJ.XLILQV)<X.NREECK@GCQE[13Q\2/WH[*OFT/+
M')W#YJ<AYF[RD_>WM[93BPVTF(G>[^M\4=,S68M&/:1N8R5K,6K.;!,_%MI:
M0WIW[<MO^YL_<>6)^3[##TTGZ.;/$U\)TTGIQ1DZHB8F)O29\)\:+B\E,P
M      !>=^F3\7_X//%SL?R@S5O9U9OR*W#[W]1E^4^)=V?774E_F]?FEAR,
MU-,EO]O=@7>7CNK:#CX5=.(M))))*^*8[>CGYS#S._WA\T..\L=E:\;+MW9^
M]SQU:5MN]_3'EB)I'A/NMK7!-+V^-$Y\M:UK69MDAIZB.X_E_<FW[<PS/N=A
MBZK^/A.7/%;>SX>G%%)B9\?CVB(B/&UF56DCP         \>\AO^ />7_)[L
MS_<O-LO\OOS^X/\ '&S^Z<;U>"_]<V?_ (O#_P!I5DO.L19Z
M                                 ^PT#K[>NU=QP/7O6>G[)OV];3><
MV&NZCJ.&O\_L.9NZ()KN6+'XK&07%Y<?+V=M)/+531[L,$5<E?--%%57'D<_
MW!P7:O#Y^X>Y=YMMAP>UIUYMQN,E<6+'76*Q-[WF*QK:8K6)G6UK5K6)M,1/
MR[[?;+C-I??\CEQX-ECC6][VBM:QKIXVG2(UF8B/HS,1'C*Z3Z6_T^.H=.?>
M[WMYSXS#]@=MP?*Y76>AN+G&;#UGUY=?L+B.YWZXM?G<7V3N%E)3313:PS2Z
MY9U\2<_^TZJH+BVIB]4/S@7+]X_*.Q?([+FX_M*W53-RFE\6\W=?9,;6+=-]
MGM[1K,WM6N[R1T_]VB,F/)$;S(\]-URWO.%[,M?!Q<ZUON=)KFRQ[-,43I.+
M'/T9B,MO#_%_&K:T2K 1P
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M,=73FQ[>U<<^,?7<GUO%ITZ6\+VK,Z3$Q$3.L::QJ5.796X
M
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M?4)V_/)]H8N:Q5F<_'9XF?9X8LVF._A[?JXPSX>R(F9C3QB^HH>0G
M
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M.0TV'.SX>[O;7'DGQ_Q668B-9TCZW?IMK/33WFDV0;IP-R
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M\4OY=/ZMG<2(7KR_X4>ZO]F?ECCVJ_.S]&/)_P"C_=>!I!.<E $
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M'Q:QX0K+YSE]QSW,[KFMW_WC<Y[Y)CVZ=4S,5CPCPK&E8\(\(>P,0>4
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M]Q]\;OW_ #&73:5G7'@IK7#C\)C6*ZSU7\9UR7FU_&8B8KI6.\&B6%
M
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M8ICB:8XGX)K>U[3IX_&Q1/AI&MTI3$B,
M
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M/WF78;NLTW6#+;'>L^V+TM-;1.OCX3$P^J>4^8
M                                                     !"1Y_\
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M'CM\VE,NO_)C6:Y/V<=K:1[8A&RD@V
M            EB]%SP\R?F!YW=6X^[M9OX->E,EC>\NT\A\'BNTKPNBYG'7N
MMZI7S-1Q;7$V\[GS88Z6WXDHN?LNN^N8?;S:U>R*/K.\X-MY0^17*;C%>/\
M>3FL=^,V--?C>\W6.]<V>-/&(VVW][EK?2:>_C!COI[V&L?-SNO'VKV7N<E9
MC[X;RL[?#'P]62LQ>_T8]WCZK1.FG7T5GZII0.;I7V           I/?4_\
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M[B1"]>7_  H]U?[,_+''M5^=GZ,>3_T?[KP-()SDH @
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M\N2T?+^-O-)CX9Q9)M?';V^.DS?'X1&D4C7VZS7U6 -Y@
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MP_P
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MUVUHVV/VZ1&&.F\1]*<WO;1IX3U:QKKK,L:*+6(
M
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MU9B8F8TGPF5G.RWFWY#9XM_M+1?:Y\5<E+1[)I>L6K,:>'C$Q+Y5ZCZ0
M     &AG]/5Y(U]Z^GIJNDYB^FO-M\<-JSG3V1JNJ;>BXN-6H^#M?7MW%3;5
M>YSC;#6-AHPL%5=,<M56&DYKIJY_;9>>_P"<&\N*]C>H/=<WLZ13B>X]KBY"
MG3K,1GG7!NZSU>/7;-BG<6B)FL1N*Z3'U%8)^>O;\<+WWEWF*L1M>0Q5SQIK
MI%_J,L>/PS>OO)]L?7(T^A$YZ#C3(
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MU;TM'T:VK,UM'TXF8;=Q9L6?'&;!:M\5HUBU9B8F/HQ,>$OS7TOT
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M[[[AG-M]8X3:]6/;UGX:S,=668F(F+9>FLS68UK6*UGQB9F5U%1K(
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M_JV=Q(A>O+_A1[J_V9^6./:K\[/T8\G_ */]UX&D$YR4 0
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M=;6M,VM:9]LS:=9F?IS+]A\;\@
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M7+:;9;3,S,SK,S/C,S,^,S,^,S/M?['XOX
M
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MJS.ZXW-%_")F?=99KCR1I'_*]U>9\=*TGV1K,7[%"2$0
M
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MB?!M'C.;X;FL?O>(W>VW6/377%DIDT_9Z9G3Z<3I,3X3XO)66/3
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MZ?U;.XD0O7E_PH]U?[,_+''M5^=GZ,>3_P!'^Z\#2"<Y* (
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M,.L>R?=4BN/6/@F:S;X==9F9[,:;8D
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M.UX/9]N8;3&3=YIRY--/\7ATZ:S_ ,[)>+1I\..=9B/";NBDU#T
M
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MS>6XW<</RFXXG=QINMMGOBM_SJ6FLS'M\)TUB8F8F/&)F'I#''G@
M
M             /\ 'D<=C\OC[[$Y:QL\IBLI9W..R>,R-M!>X_(X^]@KMKRQ
MOK.YHEMKNSN[:6J.6*2FJB2BKFFKCGCGGA^VWW&XVFXIN]I>^+=8KUO2]+36
M]+UF)K:MHF)K:LQ$UM$Q,3$3$ZO[QY+XKURXK37+68F)B=)B8\8F)CQB8GQB
M8]CB#M3TQO3[[HKN[CL#Q#Z-N\AD(<K#?YO6M*Q_7VQ7_.9MX+6\NK[9.O>-
M6S]YDHXK>GY:[DN:KFRK]M=O)%7555SNWM;U,^H#LRM,? =W<Y3;XYI-,>;<
MWW>&ONYFU:UP[OW^*M)F9ZZ12*9(TC)6T1$1F/&>8O?/$1%=CRN]C'6:Z5OD
MG+2.F9F(BF7KK$>/C6(TM[+1,. ^POIPO33W2N]KUO =S=1TW<UE+!%U[VO>
MY*C&46MO%#/;V7/:^)[.EDAR4D?,LW-S5<24R25<0U14>[13OSM[YQGU)\+6
MD<EN.&Y>:1:)G=[&M)O-IF8FWR')LHB:1/37HBD3$1UQ:VMIS?8>?WF%M(B-
MQ?:;K2)U][AB-=9\)GW-L/L]D::1I'C$SK+D7;_I8.@KW[9^\'RI[@UKX_O?
M>]]]^F:7O'V7[?<]S[9^Q9NO?MWW?95[?@?9WM]O'^3V<^W;?$?.D]_8?<_?
M[M7A]ST_XWY/N-SMNO\ ^Q^\C=^Z^#ZKWW]W7PRG:^I/G*='R[C-IDT^JZ,F
M3'K_ ,WJ][T_W>MX#LGTIVSVN,KEU#S=P.<S/$T--%ALGC_D-5QE5O5SS\>6
MO+8SN'<KJB:.GV<T1\655-?/W.:Z/\K/N.^=2XS+N8IR_9.?!L])UMAY6F>^
MOP1[N_'[>ND_#/O(F/H2]S;^I?;6R:;KA[TQ:>VFYB\Z_!\6<&./[O5_<E7*
M\W/%;,>$_DQV'XR[%M^-WK8>MH=.JS.R87%W6)PMY<;EH^M[]9Q8RWOKJXOI
M(;3$[3;1222TPU<W-$G%-'-%--==BWDGYI[/SJ\M..\S..V>38\?R4[CW>')
M>N3)6-ON<VUM-YK6*Q-LF"]HBLVCHFLS/5,UKOSL_N7%WAV]@[BP8K8<&XG)
MTTM,6M$8\E\4ZS$1'C:DS$1KX:>.NL1RBVJR8       !-5Z=7HM=C^HOT=L
M/=VB=W:3UYC]9[.SO5N3P.VZSG;^]DS&#UG3MKKR%C>8>[E@GQMQC-VM:./B
M40RTSQRT^YS1Q1)7"[U$>L_MST[=\;?LGG>$WO(;C<\9BWM,N#-BI6,>7-N,
M'1:N2L3%XOMKSX3:LUFLZZS-:ZB[]\W>/["YG'P^]V>;/DR;:N:+4O6(Z;7R
M4TF+1X3$XY]FL:3'CKK$=[?JL/?WYU/3WX&[I^ZM#?VI/8/\U>8^V-M^TPC]
M9/@_P9N_LF,_58>_OSJ>GOP-W3]U/[4GL'^:O,?;&V_:/UD^#_!F[^R8S]5A
M[^_.IZ>_ W=/W4_M2>P?YJ\Q]L;;]H_63X/\&;O[)C/U6'O[\ZGI[\#=T_=3
M^U)[!_FKS'VQMOVC]9/@_P &;O[)C/U6'O[\ZGI[\#=T_=3^U)[!_FKS'VQM
MOVC]9/@_P9N_LF,_58>_OSJ>GOP-W3]U/[4GL'^:O,?;&V_:/UD^#_!F[^R8
MS]5A[^_.IZ>_ W=/W4_M2>P?YJ\Q]L;;]H_63X/\&;O[)C/U6'O[\ZGI[\#=
MT_=3^U)[!_FKS'VQMOVC]9/@_P &;O[)C/U6'O[\ZGI[\#=T_=3^U)[!_FKS
M'VQMOVC]9/@_P9N_LF,_58>_OSJ>GOP-W3]U/[4GL'^:O,?;&V_:/UD^#_!F
M[^R8S]5A[^_.IZ>_ W=/W4_M2>P?YJ\Q]L;;]H_63X/\&;O[)C/U6'O[\ZGI
M[\#=T_=3^U)[!_FKS'VQMOVC]9/@_P &;O[)C/U6'O[\ZGI[\#=T_=3^U)[!
M_FKS'VQMOVC]9/@_P9N_LF,_58>_OSJ>GOP-W3]U/[4GL'^:O,?;&V_:/UD^
M#_!F[^R8S]5A[^_.IZ>_ W=/W4_M2>P?YJ\Q]L;;]H_63X/\&;O[)C/U6'O[
M\ZGI[\#=T_=3^U)[!_FKS'VQMOVC]9/@_P &;O[)C/U6'O[\ZGI[\#=T_=3^
MU)[!_FKS'VQMOVC]9/@_P9N_LF-_LQWTKO=TN0L8\MY9=566*DO+:C)WF.Z_
MV[*9"TQ]<]%-Y<V.,N<MB+;(WD%MS57%!)=VM$U?'%%4T?'/-=/X[CYTOLFN
MWO;:=I\K?=12TTK?=X*4M?2>FMKQCR32LSI%K1CO-8UF*6F-)_G)ZE.'BEIQ
M<7N9RZ3I$Y:1$S\$3,5M,1,^V8K.GMTGV._>B/IBO$30\A8Y;O3M?M3OV:S^
M0KEUZPCLNH=*RLL,\TF1CREEK][L&[\6=]%Q%''19[#9S04\2\_%DJDCYAT'
MWW\YKYN<[M[[3L;BN*X"E^K3+:;;_<TB8B*32V6N+;=59ZIF<FTR5M/3\2L5
MM%\'YKU%=T[VEL7"[7;;&)U^-.N?)7Z&DVBN/6/&9ZL5HGP\(TG6?_IKH;I?
MQXU&/0^C>K])ZKU*.;FZDPNDZ_88.WO;RKCGBO(966TAHNLQDJZ>?95<W4DT
M]5/'''-?/'''" G>7?G>?F%RT\[WQRF]Y7EICIC)N<M\LUK_ (%(M/3CI'P4
MI%:Q/CHT?RW-\OSVZ^6\SN<VYW6FG5DM-IB/H5U\*Q]*L1'TGK3$WE@
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MPG3PB>=!!I0                            !6^^J$_($ZA_3 T#\2_D
ML;^;#_3WR_\ 1#=?E'BF_P#TX_GONOQ5E^Z-LH?+V$TP       $P'H)?XL?
MBE_+I_5L[B1"]>7_  H]U?[,_+''M5^=GZ,>3_T?[KP-()SDH @
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MW<G<':7+8N>[7WNZX[FL$ZX\^WRWPY:3\.EZ36VD^R8UTM'A,3'@^S8<AO\
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MF,_58>_OSJ>GOP-W3]U/[4GL'^:O,?;&V_:/UD^#_!F[^R8S]5A[^_.IZ>_
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MK3I&D:S.LSI$1$?2C1^P^-^0
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M$1%:Q$1$1$1&BRC'CIBI7%BK%<58B(B(TB(CPB(B/"(B/"(CV/\ &_9_0
M      #23]#[QNK\;/3EZ2Q^3L9K#;>XX;[R W&&:JW]O-YV;!CY]2_:H*?B
M6DT'5^+P$,\,U5<\=S%)Q7Q'S^TQ\X'K=\QZ^9'J+YO<;:\9.)X>:\5MYC7Z
MG93>,_C/A:)WM]U:MJQ%9I:LUZOJ[5_><?<$=P=_;S)CM%MKM)C;8_;[,.L7
M_9US3EF)CPF)C37VS+>B6U<
M
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M3$S&D^$RLUV6\V_(;/%O]I:+[7/BKDI:/9-+UBU9C3P\8F)?*O4?2
M   OL_37>3-WV]X6[3T;L&5O,GLOC'OG.&QG%W7%/5;=7]D1W^SZ3;_-\U\W
MTOR>S8_9+2&.6GFBVLK6WBAK^'13%!0W\Y'Y:8NT?.?:]\<?BIBXWN;8>\OT
MZQU;W9S3#N9Z=.F.K#?9Y+36=;Y+Y+WKU3-[PG]07;M>*[NQ\S@K%=OR.#JG
M3PUS8M*9)T]GC2<5IF/;:;3,:SK-BE7@T*
M
M S??7M_Q8_*W^0O^K9TZZ-O0;_PH]J_[3_+'()_>2?Z,>,_TC[KSH?TO6U
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M,!Z"7^+'XI?RZ?U;.XD0O7E_PH]U?[,_+''M5^=GZ,>3_P!'^Z\#2"<Y* (
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M)L<Q.L37#-HM,3[)BV6<EHF/#IM'M^JF5U%1K(
M           !#]Z]O^$YY6_R%_UD^G4O?0;_ ,5W:O\ M/\ (_(-J^2?Z3N,
M_P!(^Y,[-^=&R?H       #L#T]/R^_!W],#QH_'1I34/J#_ $"=\?T0YG\G
M;EBO??YD<S^*MW]SY&J$Y:E:X
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MF9F9U5I9,E\M[9<MIMEM,S,S.LS,^,S,SXS,SXS,^U_L?B_@
M
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M.=I D
M                               !F^^O;_BQ^5O\A?\ 5LZ==&WH-_X4
M>U?]I_ECD$_O)/\ 1CQG^D?=>=#^EZVH        O@_2]_D"=O?I@;_^)?Q_
M43_.>?I[XC^B&U_*/*H6>H[\]]K^*L7W1N5D%7(T
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M^*LSGN'W';_-;KA-U,6S[7/?'-HC2+=-IB+1$^,1:-+1KXZ3&KV9AKR0
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M,VM,S,S,SK,S,^,S,^,S/C,JW;6M>TVM,S:9UF9]LS]&7]G\/\
M                        0_>O;_A.>5O\A?\ 63Z=2]]!O_%=VK_M/\C\
M@VKY)_I.XS_2/N3.S?G1LGZ        [ ]/3\OOP=_3 \:/QT:4U#Z@_T"=\
M?T0YG\G;EBO??YD<S^*MW]SY&J$Y:E:X
M
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M
M
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M]W\#D[8[GWO Y-=-OGM%9GVSCGX^*T^,_58[4MIK.FNFKJ)J]C8
M
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M^+'XI?RZ?U;.XD0O7E_PH]U?[,_+''M5^=GZ,>3_ -'^Z\#2"<Y* (
M                     "$+Z@/R@_H\^GQNVGXBXO(=T\E<Q9='X22PN_E9
M;#6<K;W.=[+R-[1Q5'+=X>^TC#76#FBHJ]O,N<AYKIKBXEIYFUZ O+'^L+U
M[+F-W6EN%[:PVY+)%J]46S4F,6SI7VQ7)7<Y*;FLS'U.VOI,7Z9;B\CNW/O[
MWUAW>6(G:<?2=Q;6-=;UF*XHCZ%HR6C)$_0QSII.C.Z=#*>         "X#]
M+IXN_P#'SS'SMA_^B\?NNKB;C_\  .\]EWT$-5U_^[]M%<_+_P#W5#'+_P#;
M$:H;YT#S0_\ 0?)W8Y/H\KNXC_[;MMG69Z?_ !=[4ZO\E>U/\79%;U']R?\
M<>T\-O\ _9RQ_P!+'BB?#_[+,QK_ (,S'U,K@*H5%8
M                !#]Z]O\ A.>5O\A?]9/IU+WT&_\ %=VK_M/\C\@VKY)_
MI.XS_2/N3.S?G1LGZ        [ ]/3\OOP=_3 \:/QT:4U#Z@_T"=\?T0YG\
MG;EBO??YD<S^*MW]SY&J$Y:E:X
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MN*.Y>^][NL5IML\%HV^+QF8Z,.M;3&NGA;)[R\1I^Z^'VS*6BZUL
M
M
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M8XG>H_MSW>XV/=>&(BF2/DV7PT^-7JR8IF?AF:^\K,SI,12L>,?4VW52Z+P
M
M                        #-]]>W_%C\K?Y"_ZMG3KHV]!O_"CVK_M/\L<
M@G]Y)_HQXS_2/NO.A_2];4        7P?I>_R!.WOTP-_P#Q+^/ZB?YSS]/?
M$?T0VOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@
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M/L3=TPTF^^VD1N,6D1,ZX_')$?#/5BG)$5CQFW3IK[)TE'. K]
M                  5OOJA/R!.H?TP- _$OY +&_FP_T]\O_1#=?E'BF_\
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M^.C2FH?4'^@3OC^B',_D[<L5[[_,CF?Q5N_N?(U0G+4K7
M
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MZ*VGX-6I(Y>5;P
M
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M^$Q/C$JW;5M2TUM$Q:)TF)]L3]"7]G\/\
M                                                          9O
MOKV_XL?E;_(7_5LZ==&WH-_X4>U?]I_ECD$_O)/]&/&?Z1]UYT/Z7K:@
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MKWO!:3&'#FF<?T\5XB^*==9U^):L3XS.L3$^,3#L9IYB8
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M.V^P][GI::[O<U^38M)F)Z\T3%IB8]DUQ1DO$_1K&DQ/C&E8YM%?
M                            "'[U[?\ "<\K?Y"_ZR?3J7OH-_XKNU?]
MI_D?D&U?)/\ 2=QG^D?<F=F_.C9/T       !V!Z>GY??@[^F!XT?CHTIJ'U
M!_H$[X_HAS/Y.W+%>^_S(YG\5;O[GR-4)RU*UP
M
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M32;15]2'<=NK8]J8+1TZ3N<T?#K\;'AC7[-,U^'XEIB-(F;?:HA%<
M
M
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MBLU3 HA-5
M                                  ,WWU[?\6/RM_D+_JV=.NC;T&_\
M*/:O^T_RQR"?WDG^C'C/](^Z\Z']+UM0       !?!^E[_($[>_3 W_\2_C^
MHG^<\_3WQ']$-K^4>50L]1WY[[7\58ONC<K(*N1H
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MZ?U;.XD0O7E_PH]U?[,_+''M5^=GZ,>3_P!'^Z\#2"<Y* (
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M@
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M.'-FF,?TL5(BF*--(T^)6LSX1.LS,^,S+L9IYB8
M
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MYQN3JGPCQPY-*Y(^C\6W1?VSI%;>'CK%^90JA(
M
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MI[.WW#XZQ;=7PS?%X1,^]QS&3'$3X:=5JQ29^"MI]L:Q.HPY?U<
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M>=W?-[G7WNZSWR:?X,3/Q:1XSX4KI2OC.D1$:O<F#O&
M                   0_>O;_A.>5O\ (7_63Z=2]]!O_%=VK_M/\C\@VKY)
M_I.XS_2/N3.S?G1LGZ        [ ]/3\OOP=_3 \:/QT:4U#Z@_T"=\?T0YG
M\G;EBO??YD<S^*MW]SY&J$Y:E:X
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MR?[N]B;KW5M-YO?\VQ_1^NQ;WD^R=-,47TGPTM-=)B9AI!.<E $
M
M
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MR\%NNVN>W?!;R)C/MLUJ:_X5?;2\>SPO2:WKX1X6CPCV/?F O#
M
M              9OOKV_XL?E;_(7_5LZ==&WH-_X4>U?]I_ECD$_O)/]&/&?
MZ1]UYT/Z7K:@       "^#]+W^0)V]^F!O\ ^)?Q_43_ #GGZ>^(_HAM?RCR
MJ%GJ._/?:_BK%]T;E9!5R-
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MB%Z\O^%'NK_9GY8X]JOSL_1CR?\ H_W7@:03G)0!
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M9./Q6F-[R-XPUT]ONXTOFGQ\-)K$8Y^'ZY&D>V8T*'/J@J
M                       A^]>W_"<\K?Y"_P"LGTZE[Z#?^*[M7_:?Y'Y!
MM7R3_2=QG^D?<F=F_.C9/T       !V!Z>GY??@[^F!XT?CHTIJ'U!_H$[X_
MHAS/Y.W+%>^_S(YG\5;O[GR-4)RU*UP
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MU0L=JYV@0
M
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MVRMEJH$8@
M                                &;[Z]O\ BQ^5O\A?]6SIUT;>@W_A
M1[5_VG^6.03^\D_T8\9_I'W7G0_I>MJ        +X/TO?Y G;WZ8&_\ XE_'
M]1/\YY^GOB/Z(;7\H\JA9ZCOSWVOXJQ?=&Y605<C0
M                  "+3UF?&2ORG]/3O/4L5CX;_=NO<;:]V=??$MK>ZN(M
MCZR^8RV5ML=3/+;_  LEL&AS9G$0R4245TU9#_))3[T4DHO1MYF5\K?4'P?+
M;O)./A>0R6XW=Z6FL3AWNF.DWTB=:8MU&WSVB8F)C%^YG2U=D^4O<4=M=][+
M=9;379Y[3M\OC,1T9M*UF=-?"N3W=YC3]S\'MC-(=**PD        !:.^F%\
MHJ-,[Z[?\4-CSD-KANZ=5B[#Z\QM]/<>R;LGK>*;[X<3@+>B7Y>G);'UW?7-
M_><U1\\R6VKQ^R2CX?N2U??.;^6%N9[#XCS6X[!-MYPNZG:;N]8CPV>\F/=9
M,LZ:]&'=UIBQZ3X7WMOBSU:UC?ZB^VYW?";3N;;TF<NSR^ZRS$1_BLOU-K3[
M=*98BM?'PG-/A.NL7=%)J'H                         "M]]4)^0)U#^
MF!H'XE_(!8W\V'^GOE_Z(;K\H\4W_P"G'\]]U^*LOW1ME#Y>PFF        F
M ]!+_%C\4OY=/ZMG<2(7KR_X4>ZO]F?ECCVJ_.S]&/)_Z/\ =>!I!.<E $
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M\)SRM_D+_K)].I>^@W_BN[5_VG^1^0;5\D_TG<9_I'W)G9OSHV3]
M=@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3MRQ7OO\ ,CF?Q5N_N?(U0G+4
MK7
M                            4;?J8_+S^$KR(Z_\2=8O/>U;Q[P_.U[W
M5;7WOPY7M7L/'6-U9V%Y9P7$]K5]X^BT6ORTM7$5Q1<9V_BKH]VBBJN\#YM/
MRC_W:\O.0\V>3IIRG<&;W&UUKI--CM+VK:];3$6_SG<S?KK&M)IM<%XG6;1$
MR?3SVM][^!S]T;F/\YWU^C'K'U.'%,Q,Q.D3]<R:ZQXQICI,3K,Q%8]9FD2
M         ]4Z-ZAVKO\ [EZNZ1T>'XNU]K;YJ^A82NN"XN+:RN]FR]KB^<MD
M:;6.6:+#X6&XJN[V;V>[!:022U<\4T5<\8MWQW=Q78/9W*=[<W.G%<5L,^ZR
M>,1-JX<=K^[IU3$3DR3$8\=?;;):M8UF8AYO,\KMN#XG<\QO)TVNVP7R6\8B
M9BE9GIC7]U;3IK'PVF(CQEJY=6];ZKTYUKH/4^C6/V=IW6VGZ[H^L6?--M3+
M#A-8Q5KA\?S<\VEO:6TMY+;VE-<\E$4?$DU55?N\>URI]T=R<KWAW)O^Z^<O
M[SF.2WF;<YK>.DY,U[9+Z=4VF*Q-IBL3:=*Q$:^"LSDN0W/+<AGY/>VZMWN,
MMLEY\?JKVFTZ:S,Z:SX1K.D>#[QX+X@
M
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MR8[XKVQ9:S7+69B8F-)B8\)B8GQB8GPF)]C_ &/Q?P
M
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M[G)M-S6:;G%>U+UGVUM69K:)T\/"8F/!^\^!^
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MR&\R[_=VF^ZSY;9+VGVS>]IM:9U\?&9F7U3RGS
M               (?O7M_P )SRM_D+_K)].I>^@W_BN[5_VG^1^0;5\D_P!)
MW&?Z1]R9V;\Z-D_0       '8'IZ?E]^#OZ8'C1^.C2FH?4'^@3OC^B',_D[
M<L5[[_,CF?Q5N_N?(U0G+4K7
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M_P XWV3WF3QCPPX9B:Q,>WX^7IFLQ_DK0O"J1$.0
M
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M3M>> [SOR."LQL.2K.:)TB(][KIGK&GMGJFN6T__ $L>,SJG;06:7
M
M                9OOKV_XL?E;_ "%_U;.G71MZ#?\ A1[5_P!I_ECD$_O)
M/]&/&?Z1]UYT/Z7K:@       "^#]+W^0)V]^F!O_P")?Q_43_.>?I[XC^B&
MU_*/*H6>H[\]]K^*L7W1N5D%7(T
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MY=N5X+OG+NL,1&UY"D;B-/9%[3-<L>R/&;UG)/M_QD>.NNDX:$33@
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MTP/&C\=&E-0^H/\ 0)WQ_1#F?R=N6*]]_F1S/XJW?W/D:H3EJ5K@
M
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M8M7_ ).2W7E\?AR2DA1Q8
M
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M8BRSM?GMOW/V]M.>VVD8]SABTQ$Z]-_J<E-?^1>+5GZ<>/BYU;$>\
M   F2]"SR]M_%'STT*SVC+PXCJ_OZ'GI/?+FZHHJM,=?;)<PR]<YZ::62"''
M0X[L*"PM[N\EKIAL\5>WDM?MXI^Y#KUR^463S5\A]_FXO#.;N?@)^^6UK77J
MO7#68W>*(B)F\WVDY;X\=8FV3/CPTKXRU/YS]JV[F[)SWVU)MR6QGY1CB/;,
M4CZ[7Z>N+JFM8C6UZTB/:T<'.B@*
M                                                   S??7M_P 6
M/RM_D+_JV=.NC;T&_P#"CVK_ +3_ "QR"?WDG^C'C/\ 2/NO.A_2];4
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M/[MV>7[-CEL-8G=<=FC)KI&ONLFE,L1/MCQ]W>?;X4]GPQ?X4&(0
M                 *WWU0GY G4/Z8&@?B7\@%C?S8?Z>^7_ *(;K\H\4W_Z
M<?SWW7XJR_=&V4/E[":8       "8#T$O\6/Q2_ET_JV=Q(A>O+_ (4>ZO\
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MB[\W?1:+;+93\FQZ?0Q3/O)^GKFG)I;X:],1,Q$2E[1%:L
M                        0_>O;_A.>5O\A?\ 63Z=2]]!O_%=VK_M/\C\
M@VKY)_I.XS_2/N3.S?G1LGZ        [ ]/3\OOP=_3 \:/QT:4U#Z@_T"=\
M?T0YG\G;EBO??YD<S^*MW]SY&J$Y:E:X
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M]YAGIWV>/D^'QF)C)EB8FT3'LMCQQDR5^#JI$3[6E\YJU>@
M
M
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MPZJZO,OM7_<_O'=<5BK-=A:8RX-?APY/&(CZ,4MUXM?AG',I%4=V!
M
M               ,WWU[?\6/RM_D+_JV=.NC;T&_\*/:O^T_RQR"?WDG^C'C
M/](^Z\Z']+UM0       !?!^E[_($[>_3 W_ /$OX_J)_G//T]\1_1#:_E'E
M4+/4=^>^U_%6+[HW*R"KD:
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MQ(A>O+_A1[J_V9^6./:K\[/T8\G_ */]UX&D$YR4 0
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MJV+6M>TVM,S:9UF9]LS]&7]G\/\
M      $/WKV_X3GE;_(7_63Z=2]]!O\ Q7=J_P"T_P C\@VKY)_I.XS_ $C[
MDSLWYT;)^@       .P/3T_+[\'?TP/&C\=&E-0^H/\ 0)WQ_1#F?R=N6*]]
M_F1S/XJW?W/D:H3EJ5K@
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MSXNW]O?7:<?C^/$3X3GRQ%K:_!,TIT5]L],S>/">J%D%7(T
M
M
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M:V]D:S[N_1:-?"M9R3X>*^$HG0L
M                                                 9OOKV_XL?E;
M_(7_ %;.G71MZ#?^%'M7_:?Y8Y!/[R3_ $8\9_I'W7G0_I>MJ        +X/
MTO?Y G;WZ8&__B7\?U$_SGGZ>^(_HAM?RCRJ%GJ._/?:_BK%]T;E9!5R-
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MP<CA^//P>^P]-+>'[G7'.*=/AM%[:S.NED=7"C^
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M4Y?'3XM>K'BB8^&)M[RTQ.D1-*SXS]3<E4Z(G
M                (?O7M_PG/*W^0O\ K)].I>^@W_BN[5_VG^1^0;5\D_TG
M<9_I'W)G9OSHV3]        =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3M
MRQ7OO\R.9_%6[^Y\C5"<M2M<
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MFY'>6ZMWN,M\EY^C>]IM:?[LS,OL'COD
M
M                                                   9\?U#7B11
MX[^<N1[8US%PX[KWRJQMUV?CJ+.SN+:QMNR<;788SMVRXGEXKBO,EE<_=VVQ
MWE5-?/-,VQ>SFBBGW/;T"?-[^;5O,/R/Q]J<CEG)W!VKDKLKS:T3:VSOU7V%
MM(\:TIBK?:8XF/&NTUUF>K2<_D3W1//=FUXS<6FV^XRT89UF)F<4ZS@G3X(K
M6)Q5\/9B]L^*!E.]NL         !])INW[-U[M^J[]I69O-<W'1]DP>WZEL.
M.JHHR&"V;6LG:YK YFQKDHDHHO,7E;**>+FJFKCBNCCV\<_Y'G<SQ'&=P<1N
MN!YK#3<</OMMEV^?%?QIEPYJ6QY<=M-)Z;TM:MM)CPF7S[O:[??;7+L=Y2,F
MTS8[4O6?9:EXFMJS]*:S,3^RU//"SR7P/F!XM]*^1."YQL,G8^DXO(;1B,5/
M-/9:QOUC'SBM_P!4AKNN?G*H=<W"QO+2&N;CB2:"*B7V>R3CGGEM\Z/+7?\
ME!YH\UY>;[WEJ\=O;TP9,D1%LVUM/7M<\Q7XNN;;VQY+17PK:UJ>VLJV>[NW
ML_:O<F\X'-U3&WS3%+6C2;XI^-BOX>'QZ36TZ>$3,Q\#J)J]C8
M
M          #-]]>W_%C\K?Y"_P"K9TZZ-O0;_P */:O^T_RQR"?WDG^C'C/]
M(^Z\Z']+UM0       !?!^E[_($[>_3 W_\ $OX_J)_G//T]\1_1#:_E'E4+
M/4=^>^U_%6+[HW*R"KD:
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M/N*Q;>[*8W-/@\,43[V(^CKAG)I7QZK16--=)C1\<Y: 8
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MWW+5M%MK.:<>*8F)CW6+XF.8F/#XT1U_#XVGQGVN]VAF$@
M                        (?O7M_PG/*W^0O\ K)].I>^@W_BN[5_VG^1^
M0;5\D_TG<9_I'W)G9OSHV3]        =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^
M/Z(<S^3MRQ7OO\R.9_%6[^Y\C5"<M2M<
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M]DKFZFM$H
M
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M.O;S[G<3$>/N[S]9O/P:4R3-)^&9RTCV0NAJ941P
M
M&;[Z]O\ BQ^5O\A?]6SIUT;>@W_A1[5_VG^6.03^\D_T8\9_I'W7G0_I>MJ
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M0)U#^F!H'XE_(!8W\V'^GOE_Z(;K\H\4W_Z<?SWW7XJR_=&V4/E[":8
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M[?\ "<\K?Y"_ZR?3J7OH-_XKNU?]I_D?D&U?)/\ 2=QG^D?<F=F_.C9/T
M    !V!Z>GY??@[^F!XT?CHTIJ'U!_H$[X_HAS/Y.W+%>^_S(YG\5;O[GR-4
M)RU*UP
M                            &?K]0]YB_P!(?S2N.E-5SWVGUGXL6=YH
M-,-I5[,;==MY&2WN>UK[V\3557%Y@;^TM=>FXDCCY@NL-<<1\<T5\R2W]_-Z
M^3W]7ODQ7O7E=O[KN7NF]=UK;ZNNPI$QL:^SPKEK:^[KI,]5-QCFTQ->FLX_
M(CM3[P]HQS&YIT\CR4QE\?;&"-8PQ]*+1-LL:3.L9*Z^,:1 .GPW>
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MK1J9BX
M
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M:L_#68E[ Q!Y0
M                                #-]]>W_%C\K?Y"_ZMG3KHV]!O_"C
MVK_M/\L<@G]Y)_HQXS_2/NO.A_2];4        7P?I>_R!.WOTP-_P#Q+^/Z
MB?YSS]/?$?T0VOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@
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M3''5&DZ3&7Q\8\+4*K5&L
M!#]Z]O\ A.>5O\A?]9/IU+WT&_\ %=VK_M/\C\@VKY)_I.XS_2/N3.S?G1LG
MZ        [ ]/3\OOP=_3 \:/QT:4U#Z@_T"=\?T0YG\G;EBO??YD<S^*MW]
MSY&J$Y:E:X
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M8_YVM<4Q/MKDMIXPT!% R#H
M
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MMN\=I2?CS&#<3$>&L1,X;S\/C$6QS:?#PQUUB=(FW>J.1:
M
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M+WW$XHF=W.+WF+3V^\Q3&2L1X3]7T]'LUTM.FD^+4 <Q:N4
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MAK]1CBM(\9\*QXS[7137;P0
M  $/WKV_X3GE;_(7_63Z=2]]!O\ Q7=J_P"T_P C\@VKY)_I.XS_ $C[DSLW
MYT;)^@       .P/3T_+[\'?TP/&C\=&E-0^H/\ 0)WQ_1#F?R=N6*]]_F1S
M/XJW?W/D:H3EJ5K@
M                                     *'OU'GFW_#?Y,8;Q7TK+_,]
M<^,_Q_OM^4G]^RSG=>>M(OM[XWPZN8KC[P<%7%BH_>XXDMLA/DX^?N<KV/FY
MO)3_ '(\M<WFES6'I[B[ET]QU1\;'QN*T^ZTU\8^59>K//P7Q5VUO@33\@>S
M_O/V]?N7>5TW_(Z=&OMKMZS\7]CWEM;S]&L8Y5OUC;?X          #2K]&7
MP\H\-O!'J_6<Q:S6_97;<,/>7:U-U#<6]UC]IW[#8>3%:I+:7=%-SCIM)TRP
MQF+N[?WJHN<K;7D\?LXN.>'-IZR?."WG'YZ\IR>SO%NV^)F>,V/3,36^#:Y,
MD7SQ:OA>-SN+9L^.^D6]Q?#CMK[N%?'FUW7/=G>FYW&*8GC]K/R?#II,33%:
MW5?6/"?>9)O>L^WHFE9^I2KHKM:
M
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MUM$JU^5XS><+R>?B>0KT;W;9;8[Q\'569B9B?AK/MK;V6K,3'A+TACCSP
M
M               &;[Z]O^+'Y6_R%_U;.G71MZ#?^%'M7_:?Y8Y!/[R3_1CQ
MG^D?=>=#^EZVH        O@_2]_D"=O?I@;_ /B7\?U$_P YY^GOB/Z(;7\H
M\JA9ZCOSWVOXJQ?=&Y605<C0
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M<2(7KR_X4>ZO]F?ECCVJ_.S]&/)_Z/\ =>!I!.<E $
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MM8B(^E"R[#BQX,5<&&(KBI6*UB/9$1&D1'[$/S7TOT        3>?3^^+_\
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M?W/D:H3EJ5K@
M                                .2_.;RLUGPJ\6.WO(O8Z;.\N='UN
M6/3->O):Z*-N[%SDE&%T+5^:()8[VNSR>RWMO\_);\5RVF,CN;KW>:(*^>-L
M^1WE7R?G3YI<1Y=\=-Z8]]N8G<9:QK\GVF*)R;K/XQ->JF&M_=1?2N3-./%K
MKDAE'9G;.X[O[EVO ;?6*YLGURT?N,5?C9+^/AK%(GIB?"UYK7VVAEJ[EM^S
M=A;?M6_;KF;S8]QWC9,YM^V[#D:J*\AG=FV7)W6:SV9OJXZ(Z*[S*96]EGEY
MIIIXYKKY]G''^1U$\-Q'&=O\1M>!X7#3;\/L=MBV^#%3PIBPX:5QXL===9Z:
M4K6M=9GPB%D6TVNWV.UQ;'9TC'M,..M*5CV5I2(K6L?2BL1$?L/FWHOH
M      2N>C)X:7?F7YS=:83*X[YKJOIZ\LNZNW)[FUBN<;=Z[I>6L+C!:;=1
M7<55E>_?_M]=CC+BUYKIGJQ,E]<1<5?*U\<14]97G)B\F_([DM[M,G3W3S%+
M<=L(BTUO7+N,=XR[BLUGJK\EV\9<U;Z36,\8,=M/>PUGYM=VU[2[,W&;%;3D
M]W$[?!$3I,6R5F+9(T\8]U3JO$^SKBE9^JAI3.;=7R
M
M
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MJ=1@
M                       9OOKV_P"+'Y6_R%_U;.G71MZ#?^%'M7_:?Y8Y
M!/[R3_1CQG^D?=>=#^EZVH        O@_2]_D"=O?I@;_P#B7\?U$_SGGZ>^
M(_HAM?RCRJ%GJ._/?:_BK%]T;E9!5R-
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ME_BQ^*7\NG]6SN)$+UY?\*/=7^S/RQQ[5?G9^C'D_P#1_NO T@G.2@"
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MC_D^ZI,>.EJ3[)UB+"ZOAHD
M   !#]Z]O^$YY6_R%_UD^G4O?0;_ ,5W:O\ M/\ (_(-J^2?Z3N,_P!(^Y,[
M-^=&R?H       #L#T]/R^_!W],#QH_'1I34/J#_ $"=\?T0YG\G;EBO??YD
M<S^*MW]SY&J$Y:E:X
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M'<9KBB(G6)S3I[ZWA\,3$8]/@]W/LUF$]J!K28
M
M
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M5F)CPEZ0QQYX
M                             #-]]>W_ !8_*W^0O^K9TZZ-O0;_ ,*/
M:O\ M/\ +'()_>2?Z,>,_P!(^Z\Z']+UM0       !?!^E[_ "!.WOTP-_\
MQ+^/ZB?YSS]/?$?T0VOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@
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M9-V-W%7NKM39<[K$YLV&(R?2RTF:98TTC3X];3'A$:3$QX3$N.6X65@
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M6?IUM$Q/TX5I9L63!EM@S1-<M+36T3[8F)TF)_8E^D^9^8
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M>VZMWN,MLEY\?JKVFTZ:S,Z:SX1K.D>#[QX+X@
M                  $/WKV_X3GE;_(7_63Z=2]]!O\ Q7=J_P"T_P C\@VK
MY)_I.XS_ $C[DSLWYT;)^@       .P/3T_+[\'?TP/&C\=&E-0^H/\ 0)WQ
M_1#F?R=N6*]]_F1S/XJW?W/D:H3EJ5K@
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M;3;+:9F9F=9F9\9F9GQF9GQF9]K_ &/Q?P
M
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M$=G^YW6#O394^MYM,&YTC]W6/K.2?A^-2)QVF=(CW>*/;9;15.HP
M
M          ,WWU[?\6/RM_D+_JV=.NC;T&_\*/:O^T_RQR"?WDG^C'C/](^Z
M\Z']+UM0       !?!^E[_($[>_3 W_\2_C^HG^<\_3WQ']$-K^4>50L]1WY
M[[7\58ONC<K(*N1H                                          !3
ML^J*\7:+;)]!>8&MX.&.G)PY'H_M3*6D%Q17+>V7$^T]67V0X@BJLIIIK*K/
MV<MW-S'/\.VLH.*I:*8Z8+@_FP/,^V3;<_Y0\EGF9Q6IR6QI:8F(K;3!OJTU
MGJB(M\ER12NM=;YLFE;3:;RM].'<DVQ[[M7<7GXLQN,,3,>R?B9HC7Q]ONK1
M6-8UF]O"9G6H@MP2E         :*_H%>3=?D1Z>'7>O9G(0W>Y^.F2O>A<Y'
MS=6_-[7KFK6EAD>L[SG'1Q0S66-M^O<O88F&6KXE%S/B+BKB3FOB2./G=]>W
MEG7R\]0O(\AL\<TX;N+'7E,4],]/OL]K4WE>N9F+7G=X\N>U8TFE=QCB:Z36
MUH%^=W;L<#WYN,^&LQM-_6-S7PG3KO,QFC7X9G+6UYCPTB]?#329FK0N:A
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MM7%P&&VFXY'+\;_[#AFM[?!X:Y)QQ[8UCJCQCJA?"43H6
M                           (?O7M_P )SRM_D+_K)].I>^@W_BN[5_VG
M^1^0;5\D_P!)W&?Z1]R9V;\Z-D_0       '8'IZ?E]^#OZ8'C1^.C2FH?4'
M^@3OC^B',_D[<L5[[_,CF?Q5N_N?(U0G+4K7
M                                                        4;?J
M5/-O^%;OC4O#;2<O\QHOCW\':^ROE)_B66:[KV?#_P"86$WN536MU_!MHN4X
M@CECKHDAR&=R=I/1Q7;<>R\#YMKR3_W5[$W?G'S>'IYSN#7!L^J-+8^-PY/C
M7CV6K\LW-.J:S$Q;%M=MEI/3DG69/I\[/^]G"Y>[-Y33>[[XF+6/&NWI;QGZ
M,>]R1K,3X37'CM6=+*QZS-(D          !>[^F\\++?IKQDS7E9M>/AX["\
MEIN;?59)*:*[K!=.:KD[FTQD$=?W:[6;=-GM;C(7%/'/NS6=KCJN>.*J.>%%
M7SCGG/D[R\S,/E7Q62?]W^VHUSQ&O3EY#/2MKS/^%&WPVIBI/MKDON(]DPA;
MY_\ =UN6[BIVSM;3\AX^-;_0MGO$3,_3]W28K'T+3D^BLCJX4?P
M
M
M                '-/F'XT:CY@>-?;?CMN?$,./['U6[Q^*R\L'$]>L;=8U
MQY73=KMZ../?JFUS9[&UN^:*>>/C1Q515<^Y)5QSLKR?\RN6\H/,GB?,/AM;
M;CCMU6^3'$Z1FP6UIN,$S[-,V&U\>L_4S:+QXUAD/:G<.Z[5[AVO/;36<FWR
MQ-J^SKI/Q<E)_P"?29K]*9B?;#+)[*Z[V[J/L+=^K=^Q,V"W;KS:L[IFU8B?
MV\UX_/:YDKG%9.WIK]G%,\--U:U<QRT^VB6/FFNGGFFKCEU']M]P\3W;V_LN
MZ.!RQGX7D=KBW&#)'LOBS4B])T^">FT:Q/C6=8GQB5DO'[_:\IL,/);&T7V>
M?%7)2T?#6\1:)_O3XQ\$^#XE[3[          'N7C1Y!;[XJ]]=6^0O65S#!
MN?5>U6FQXZWNZIZ<=FK'F*?';%JV9^5E@NZL#N&M7]YBK^F&2*:JRO)>(ZZ*
M^::^,'\RO+_@?-/L/E/+[N:LVX;E=K;#>:Z=>.VL7PY\?5$U][M\U<>?%U1:
ML9,=9M6T:Q/C=P\%LNY>$W/!<C$SM-SBFDS&FM9]M+UUUCJI>*WKK$QU5C6)
MCP:F'C_W=I/DCTIUCWOUU=_.:;VEI^(VW#^_7')<V'VA;\?:&#R/PN>8X\QK
MV5CGL+V/C_U5W;24?^BY<^_^R>:\N.]>3[%[BIT<QQ>\R8,GA,1;HGXF6FOC
M./+2:Y<<_NL=ZS\*MOG.'WG;_,;GA=_&F[VV6U+?0G2?"T?\FT:6K/PUF)>P
M,0>4
M                     S??7M_Q8_*W^0O^K9TZZ-O0;_PH]J_[3_+'()_>
M2?Z,>,_TC[KSH?TO6U        %\'Z7O\@3M[],#?_Q+^/ZB?YSS]/?$?T0V
MOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@
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M,5IG72*5M,_1B_ H80E                     5OOJA/R!.H?TP- _$OY
M+&_FP_T]\O\ T0W7Y1XIO_TX_GONOQ5E^Z-LH?+V$TP       $P'H)?XL?B
ME_+I_5L[B1"]>7_"CW5_LS\L<>U7YV?HQY/_ $?[KP-()SDH @
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MS>.KVS6M=?9$1,FARU,
M A^]>W_"<\K?Y"_ZR?3J7OH-_P"*[M7_ &G^1^0;5\D_TG<9_I'W)G9OSHV3
M]        =@>GI^7WX._I@>-'XZ-*:A]0?Z!.^/Z(<S^3MRQ7OO\R.9_%6[^
MY\C5"<M2M<
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M;:]YFUK3].;3,S^R^D>:^<
M
M                                                !28^ID\++?0.
MUM \UM.Q\-KKW=$UIUIVK'!31%1#VIKN"N;O4\Y51Q[OQ)MPT/!3P2<4\>RF
M3 525\\UW'//-UGS:7G/DY_M7?\ DMS&2;<APT6WFQF=9F=CERUKGQ?2C;[K
M+6T:^V-U%8\,:8'IX[NMON,S]H;NTSGVD3FPZ_Y&UHB]?_M>2T3'TLND>%56
M1:.DD           MZ_3.^=5I9S[AX%=A9SX<V5O,OV7X]T7E<M?Q[N/'W64
M[1T*QJ]E5$7LL,;SL-I#Q[M//N923GGWN:>.:C/G*_(S+FIL_/CM_!K3%3'L
M^6Z8CPK-ZTV6ZM]'XU_DF2WC/CM:Q&D3,19]0W9=KQB[VV-/"L5P[K3X(UB,
M.2?[L^ZM/_V.%PU3^BF
M                                    S??7M_Q8_*W^0O\ JV=.NC;T
M&_\ "CVK_M/\L<@G]Y)_HQXS_2/NO.A_2];4        7P?I>_R!.WOTP-__
M !+^/ZB?YSS]/?$?T0VOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@
M                             &:#ZR7B_P#T4O4'[UT_&V]Y#I?8>8X[
MPZ]DNK3Y.*K6>T[B\SN0QV,HIIXBFP^I[O3F,':RTU2<UQ8OCF2KXOQ*:>E3
MT=>9W]:OI^X+F-S:D\UQV'[V[N*VZI]]L8KBI>_PQDS[;Y/N;Q,1I;-/3'1T
MS-A?E/W'_O-V+LMWDF)W>"GR?+I.OQ\,16)G_E7Q^[R3'AI-_#PT1=I/MC@
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M=2TUF8]OA.FL3$S$QXQ,P](8X\\                   !6^^J$_($ZA_3
MT#\2_D L;^;#_3WR_P#1#=?E'BF__3C^>^Z_%67[HVRA\O833        3 >
M@E_BQ^*7\NG]6SN)$+UY?\*/=7^S/RQQ[5?G9^C'D_\ 1_NO T@G.2@"
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ME\M[9<MIMEM,S,S.LS,^,S,SXS,SXS,^U_L?B_@
M                    !#]Z]O\ A.>5O\A?]9/IU+WT&_\ %=VK_M/\C\@V
MKY)_I.XS_2/N3.S?G1LGZ        [ ]/3\OOP=_3 \:/QT:4U#Z@_T"=\?T
M0YG\G;EBO??YD<S^*MW]SY&J$Y:E:X
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M?/FL7:>SOKLMC\?+I/A;<7KX1]"?=8YTB8\8MDR5M&M5G%68CL
M
M
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M$7K,1:EZZ_!>LQ:/H:Z3XQ+HIKMX(
M                                            #-]]>W_%C\K?Y"_Z
MMG3KHV]!O_"CVK_M/\L<@G]Y)_HQXS_2/NO.A_2];4        7P?I>_R!.W
MOTP-_P#Q+^/ZB?YSS]/?$?T0VOY1Y5"SU'?GOM?Q5B^Z-RL@JY&@
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MTBNTY##$VF(G3WV+2M_I1K3W=O#QM:;3,:ZS-B]7:T(
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M(U0G+4K7
M                          1U>J3YP8_P'\0][[@M.;.Z[,SOLZ^Z5PUW
M5!5%>]F;+97WV5E[NTFAN*+[#Z78VMSFKRWJIIHNX;#Y3XD5=Q1)3(CTO>2.
MX\^O-S8=H9NNO;6#_.^1R5UUKL\-J]>.MHF.G)N;6IML=XF9QVR^]Z;QCM6<
M]\M^SK][]TX.*MK''4^N[BT:^&&DQU5B?#2V29C'6?W,VZM)BLPS'LCD<AE\
MA?9;+7UYE,IE+RYR.2R61N9KW(9'(7LU=S>7U]>7-<MQ=WEW<2U22RR555R5
MU<U5<\\\\\NF7;[?;[3;TVFTI3%M<5*TI2E8K2E*Q$5K6L1$5K6(B*UB(B(B
M(B-%B>/'3%2N+%6*XJQ$1$1I$1'A$1$>$1$>$1'L?XW[/Z          =+>'
MGC1MWF!Y*=2>.VF<30Y#L?:K3'Y7+Q0<ST:QJ-C1)E=RVNXHYX]RJ'7-8L;J
M[XHJYX^-)%3%3S[\E/'.MO.#S*XGR@\MN6\P^9TMM^.VMKX\<SI.;/;2FWP1
M/MUS9K4QZQ]3%IO/A66/=U]P[7M7M[=<]N])Q[?%,UK[.N\_%QTC_GWF*_2B
M9GV0U-NM>N]1ZCZ]TCJW0<3#@M)Z\U7!:9JN(@]G-&/P.N8VVQ6,MZJ_9Q5/
M-3:VM/,DM7MKEDYJKJYYJJYY<N'<G</+=V]P;WNCGLLY^:Y'=9=QGR3[;Y<U
MYO>=/@CJM.D1X5C2(\(A6UR&_P!URF_S<EOK3?>9\MLE[3\-KS-IG^_/A'P1
MX/MGB/C
M
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MLJS.^V<5IFB/W6"UITM]&9Q7M'_R7M:9TI"\ I'0Z
M                                                         9OO
MKV_XL?E;_(7_ %;.G71MZ#?^%'M7_:?Y8Y!/[R3_ $8\9_I'W7G0_I>MJ
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M5["?E-9T\>FD3&6-?;$>ZFUM/9-J5UT^JC1><[2!(
M"M]]4)^0)U#^F!H'XE_(!8W\V'^GOE_Z(;K\H\4W_P"G'\]]U^*LOW1ME#Y>
MPFF        F ]!+_%C\4OY=/ZMG<2(7KR_X4>ZO]F?ECCVJ_.S]&/)_Z/\
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MONL,Q,],XL7Q*VKK\%])R?LWF=(UT2'H],#
M                  0_>O;_ (3GE;_(7_63Z=2]]!O_ !7=J_[3_(_(-J^2
M?Z3N,_TC[DSLWYT;)^@       .P/3T_+[\'?TP/&C\=&E-0^H/] G?']$.9
M_)VY8KWW^9',_BK=_<^1JA.6I6N
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M?+.2P]G[.^NWVNF7/I/MS6K\2D__ &/'/5^SD\?&JU"JU1K
M
M
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M &CN.RNZ-QPN36=MK[S!;_#PWF>B?'3QKI.._P '72VFL:3/=31C"P
M
M        &;[Z]O\ BQ^5O\A?]6SIUT;>@W_A1[5_VG^6.03^\D_T8\9_I'W7
MG0_I>MJ        +X/TO?Y G;WZ8&_\ XE_']1/\YY^GOB/Z(;7\H\JA9ZCO
MSWVOXJQ?=&Y605<C0
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M_JV=Q(A>O+_A1[J_V9^6./:K\[/T8\G_ */]UX&D$YR4 0
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M<A6TUW=\4X<.GM][EB:5F-?#XD3;)X^&E)\)G2)TZ',LKK
M                              0_>O;_ (3GE;_(7_63Z=2]]!O_ !7=
MJ_[3_(_(-J^2?Z3N,_TC[DSLWYT;)^@       .P/3T_+[\'?TP/&C\=&E-0
M^H/] G?']$.9_)VY8KWW^9',_BK=_<^1JA.6I6N
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M:1'LB(B(A6[O=YNN1W>3?[[);+O,UYO>]IUFUK3K,S^S+ZIY3Y@
M
M
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M'O*U\9FU9K6-;^.A0Y]4%0
M                                    &;[Z]O\ BQ^5O\A?]6SIUT;>
M@W_A1[5_VG^6.03^\D_T8\9_I'W7G0_I>MJ        +X/TO?Y G;WZ8&_\
MXE_']1/\YY^GOB/Z(;7\H\JA9ZCOSWVOXJQ?=&Y605<C0
M                             "OI]1[XR5]T>#5CW%@\?#<[;XQ;M:[E
M)<<6UO-?<];;E1;ZGOV.M)Y)8)[6'C)U8/*W'-',G%4.'YXYCJY]VN*P'YN;
MS,KV9YX7[/WV2:\3W/LK;>(ZIBORS;ZY]K>T1$Q:>CY3@IKII;<1I:/&MMY^
M0/<4<1WE/$YK3&UY'#./36=/>X];XIF/9/A[RD>SQO[?@F@0OR3?
M 73_ *7SRBHV/JOO#Q$V+.0R9GK?/6W<76V)NY[B3(RZ-N55O@]]M,5%5+7;
M0X'5-SM<?=2TTT1U<7NT55>])\3GB*E_YSSRPMQW=/!^;G'8)C9\E@GC]YDK
M$12-SM]<NUM>=(F<N?;VRTK.LQ[O91&E>GXT1?4;VW.WY+9]TX*3[G<4G!EM
M$1I[S'K;'-OAZKXYM6/;\7#\&GC:S56(S@                  *WWU0GY
MG4/Z8&@?B7\@%C?S8?Z>^7_HANORCQ3?_IQ_/?=?BK+]T;90^7L)I@
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M[?\ "<\K?Y"_ZR?3J7OH-_XKNU?]I_D?D&U?)/\ 2=QG^D?<F=F_.C9/T
M    !V!Z>GY??@[^F!XT?CHTIJ'U!_H$[X_HAS/Y.W+%>^_S(YG\5;O[GR-4
M)RU*UP
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MPCZ$^ZQSI$QXQ;)DK:-:K.*LQ'8
M
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MW=IB:Q'A&.^/QUUB)C4/&J
M                                    &;[Z]O\ BQ^5O\A?]6SIUT;>
M@W_A1[5_VG^6.03^\D_T8\9_I'W7G0_I>MJ        +X/TO?Y G;WZ8&_\
MXE_']1/\YY^GOB/Z(;7\H\JA9ZCOSWVOXJQ?=&Y605<C0
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M8BS/A.5V_.</M>9VNGN-U@IEB-==.NL6FLSX>-9F:V\(F)B8F(GP>2LL>F
M      D@])7RB_HC^?'0G9>2O_D='S^R4]5]FU5\^[:4Z'V7S'K5_E;_ )CM
M;N[YL]/R]S99[FBWIXFFJQ5,?'MXKJIJCEZLO*_^MKR%Y[MK;8^OF]OMOEVR
MT^J^5;/7-2E-;5KU;C'&3:ZWGIK&>;>$Q$Q@'FAVW_O1V1ON.QUZMY3'[[#]
M'WF+X\5CQB-<E8MC\?".O7X-6G$YF5=@                  "M]]4)^0)U
M#^F!H'XE_(!8W\V'^GOE_P"B&Z_*/%-_^G'\]]U^*LOW1ME#Y>PFF
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M=-SN+6K$SK,8X^+BKK/^#CBM?9'L]D>QTXUDQT
M                     !#]Z]O^$YY6_P A?]9/IU+WT&_\5W:O^T_R/R#:
MODG^D[C/](^Y,[-^=&R?H       #L#T]/R^_!W],#QH_'1I34/J#_0)WQ_1
M#F?R=N6*]]_F1S/XJW?W/D:H3EJ5K@
M                                             *WWU%?GU_ %X_6?
MB7UUL7R/;?DAA[K[^([3_P"W<#X_7-65P>P?&KKBJCA_A,RMG/A8_9SSS+C[
M?)T_L*N(ZN;&_F[_ "$_W]\P+^;'<6WZ^T^W,U?DTV^IR\K7W>7%IXZS\CI:
MNYGZ&6^VGQCJAO\ \A>R/OWSD]S[_'U<7Q]X]WK[+;F.FU?L,3&2?H6G'[?%
M0^7L)I@          .V/3Q\1,WYP>6_4_0-A1>1:YF<QQL'9F:L^*J:]=ZOU
MFJ+([GE.+CCBJFUO+JPIIQ]A77^PJR=];4<_^=I7U"^;FR\D?*7EN_MQ-)Y'
M#A]UL\=O^NWN;6FWII^ZK6WUW+$>/N<>2T>QB'??=.'L[M?=<Y?2=Q2G3AK/
M[K-?PQQI\,1/QK?\BMI^!J&:KJ^N:/K&N:5I^$QNM:EI^!P^KZMKF&M(K##X
M#7-?Q]OB<)A,58P4T06>-Q6,M(H((J..*(XHZ:>./9PYA>4Y3D><Y/<\US&?
M)N>6WF?)GSYLEIMDRYLMYR9,E[3XVO>]K6M:?&;3,RKCW.YW&\W.3>;N]LFZ
MRWM>][3K:U[3-K6M,^V;3,S,_#,OWGP/P
M
M
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M!FVN>^VW%9IN,=YK:L^$UM6=+1,?1B8F)?L/C?D
M                                                    S??7M_Q8
M_*W^0O\ JV=.NC;T&_\ "CVK_M/\L<@G]Y)_HQXS_2/NO.A_2];4
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M[7M?O7?\5AK%-G[WWF*(^IC%ECWE*U^E3J]W^S2?&?;,A*/K!0
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MF9TCQF969;;;8-GML>TVU8IML5*TI6/96M8BM8C7Q\(B(\7X+[G[
M)I/01\7_ .D=ZAG7.>RMO>5:=XYV<O?^=N(;3W[:7/ZAD\7:=;XNO(2TUVEE
M>2;]E+'(4Q\TUSW%IB[FF+BGFFJ>&&/KS\SOZN?3WR.PVEJ??CN*\<5BB;?&
MC%N*7MO+]$?&M6-K3+BF=8K3)GQ3:9UBE]1^=O<?W@[$W&#%,?*]_/R:L:^/
M3>)G+.GMF/=1:NOLBUZZZ_4SHO.=I D
M               !#]Z]O^$YY6_R%_UD^G4O?0;_ ,5W:O\ M/\ (_(-J^2?
MZ3N,_P!(^Y,[-^=&R?H       #L#T]/R^_!W],#QH_'1I34/J#_ $"=\?T0
MYG\G;EBO??YD<S^*MW]SY&J$Y:E:X
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MLS7+"$GGQWI;G>Y9[=V=]>*XV>FT1[+;GQC+;_[7K[J(GZFU<DQX66'5>K1
M
M
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M]V+'&<E7O#C:3\AWENG<1$3I3/\ !DF?9$9H]OA&F2LS,S.2(BT&K#1R
M
M         9OOKV_XL?E;_(7_ %;.G71MZ#?^%'M7_:?Y8Y!/[R3_ $8\9_I'
MW7G0_I>MJ        +X/TO?Y G;WZ8&__B7\?U$_SGGZ>^(_HAM?RCRJ%GJ.
M_/?:_BK%]T;E9!5R-
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MCJX><XWE8B(G/M<F*9^C.&\6\8^E&:/'X8TC]RM-JN$;
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MICC%$1X],]<:ZS,18[5SM @
M       (?O7M_P )SRM_D+_K)].I>^@W_BN[5_VG^1^0;5\D_P!)W&?Z1]R9
MV;\Z-D_0       '8'IZ?E]^#OZ8'C1^.C2FH?4'^@3OC^B',_D[<L5[[_,C
MF?Q5N_N?(U0G+4K7
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MF9UF9GQF9F?&9F?&9GVO]C\7\
M
M
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MDK[?BWI,6B/;&NDZ6B8CH1KYX0
M                                     #.#]?*WN(/5@\I99H)H8[R'
MHVXM))8JXZ+JWI\=.I+2J>WKKIXIGAINK66+FJGVT\21U4^WVT\\<=&GH+R8
M[^E+M>M+1-J3R<6B)B9K/WWW]M)^A/3:MM)\=)B?9,)^>25JSY9<;$3$S$[B
M)^E/RK/.D_W)B?V)A#RE^VL        OC_3 6]Q!X =JRS030QWGEUV!<6DD
ML5<=%U;T]/\ 0UI5/;UUT\4SPTW5K+%S53[:>)(ZJ?;[:>>.*)/G.LF._G[Q
M5:6B;4[1VD6B)B9K/WPY2VD_0GIM6VD^.DQ/LF$*_4;:L]\;:(F)F.+Q1/TI
M]_N9TG^Y,3^Q,+':N=H$
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M2_ET_JV=Q(A>O+_A1[J_V9^6./:K\[/T8\G_ */]UX&D$YR4 0
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MMNYUW6YSWRV_YU[3:8CV>$:Z1$1$1'A$1#TACCSP
M                        $/WKV_X3GE;_ "%_UD^G4O?0;_Q7=J_[3_(_
M(-J^2?Z3N,_TC[DSLWYT;)^@       .TO3?P^3SGJ"^$5EB;.:_NH/*[H',
M2P0<<<UT8S7NT=8S^:O*N*N:>/@X[#8R>XDY_P O$<57L]O/W&F/4;O-ML?3
M_P![9MW>,>*W:G*XXF?9-\NRS8L=?V;Y+UI'T[0Q'O\ RX\/8W,7RS%:SQFY
MKX_1MAO6L?W;3$1].6I@Y<U;8
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MMM>'V'5APZ3K%[=7UW+'_P!DF*Q&GA-,=)]LRF90V:E
M
M
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MRBU"X
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M/>]YXN,Q:?YEM*5O]'WF69RS'MGP]W.*8\(G6;>V-%B]7:T(
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MKXVG%68TTFEK1/T)OP*&$)0
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M D
M               !G3^N'ZAEOYP^4DVK]=YB')^/?C[-F=+ZRR%A<436&[YZ
MZDL8]][)BEM;N\L;[&YW+8JBUPT\5?-$V%LK>YXIBDNIH^.B+T1>GS)Y(^5U
M>4[BPSB\P>X(Q[C>TM&EMMBK%IVNSF+5K:M\6.\WW%9C6NYR9,>MJXJ6F>OD
MYV);LWMN-SOZ37G=]%<F:)CQQUC7W>+QB)B:UGJR1/LR6M7QBL2A531;=
M        3>>A)X$?TQO+?&;_ +SA+/*]#^-MYA=^W^RRUK\SC=OVR2J_FZUT
M2NVG@N,?DK.]V'%?:.5M;BB2VN<3CI[66G_.X_;"7UT^?/\ 4]Y2Y> X//?%
MWWW)3)M=K;';2^WP1T1O-UK$Q>EJXK^YP7I,7IGS4RTGZU9I[SH[V_W3[7ML
M=G>:\UR$6Q8IK.DTIX>]R:ZQ,3%;=%)C28O:+1]3+1&<\R!P
M
M
M                         ""KUZ_ C^EQXG7W:NAX2SN>[_&FSS>_8::&
MU]N9VSK.SQMS?]A:);R6\$MYD+SBSLZ,KB[7CB2N2^LN;>"FFN]KYYG-Z#O/
MG^J7S7IVMSV>]>R.Y;X]KDB;?6\&\M>*;3=3$S%:5ZK3@SW\(C%DC)>9C#&F
MY_)/O;_=;N>O&;V\QP_(37%;Q^+3-,Q&+).LZ1&L]%Y^"MNJ?"D,])T&IU@
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M:FUK,<'NYMDV\_!6-8Z\/C,S/NIM$1,^,TM29F9F4MZ);5P
M                                                         "'+
MUQ_#'-^8O@]L\.@X?[:[;Z1S%OV]H.,AXJXOL]:8BTN;#>]7L:N)X^*KS*:=
M>W-U:P?#FJN\CC[:WIIIJEXDHF'Z(/.79>3WG?M;\]F]SVGS>&=ANKS]3BMD
MM%MKGMX3\6FXK2E[:UC'BRY<DS,5Z9VOY-]VX>U.\L<[Z_1Q>\I.#+/P5FTQ
M..\^'LC)$1:=8Z:VM:?9I.<4Z,$^P      '77@IXE[=YM^4G5/CSJT62@LM
MLST%YONR8ZVYGXT?K+"R1W^];?<2RPRV%M-C<)17%84W7,<%YE[BTL_?XDN8
M^.=2>>?FQQ/DGY7<KYA<I..V;:8)KM<-[:?*=[DB:[7;Q$3%IB^28MEFFML>
M"N;-ITX[3&+=Z=T;7L_MO<\]N9K-\5-,=)G_ !F:WACI'PSK;QMIK-:1:^FE
M9:FV&P^,U[#XK 86RAQV&P>-L</B<?;\<TV]AC,9:Q65A904U<U5<0VMK!11
M3QSSSS[M/#EPWF\W/(;S+O\ >WG)O,^2V3)>?;:][3:UI^G:TS,_3E6UFRY,
M^6V?-,VRWM-K3/MF9G69G]F7Z3YGY@
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MTS?)'P?'O-M)CVTBFOL2ZHD-6@
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M7-.XK/P(5^?W=U>9[CIV[M+1.RXZ)B\Q^ZSWB.N/_M=8K3Z5NN%CM7.T"
M
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MFM:Z2!- ,&
M
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MW>UW&QW678[RDX]WAR6I>L^VMZ3-;5GZ<6B8G]A](\U\X
M                                                       "ACZ[
MOI0Y#Q:[!S_ESTAA+/\ HV]J[A17M.JX"PG@IZ1[#V7B6YN;:NQAJGM;/K?<
MLU'/+BYX>+>QQ5[<TXCB&"CG&\75[WH5]5FW\T>W]OY2=[9[_P!9'%;.8P9\
MMXG[Y;3#I6MHM.EK;S;XYK7/6W7DSXZ3N^O):-S[J:WDMYFT[DV-.UN8O/\
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MS_C;ZZ6SVB/HQI7'$S,UIK,=,Y+U32H8M1@
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M\!LLO:W Y=>?STZ<MZS_ -WQVCQCJCV9KUGXL1\;'6>O6MO=S-[91:A<
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MF9F9UF9\9GQE^D^9^8
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M.][<9Q=.S^/M,;S>UZ\\Q.DUP1.D4\/'Z]:/'Q_Q=+5F)C)X7?U(Z'0
M
M
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MZ1,WM-O546BP
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M$>/M?/NMWM=CM[[S?9<>':8XUM>]HI2L?1M:TQ6(^G,PM9^FU].1L>6R>O\
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MG6;6F=9F9F=9F?&9\9?I/F?F
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MWV7D^3RWS;_->;7O:=9M,_\ PB(C2(B(B*Q$5K$1$0^\>$^(
M
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M4KKK/32D5I769GIK&LS/B]R8.\8
M
M
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M,SI$?'KI-,D:1\>LS$=,UF>\&B6%
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MK,S].9?L/C?D
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M6M,V?;[NE?\ +8:ZS'3I$3;%.*TZ?5:S/5-OJK6CP>#_ *KWX"?QO>8'X?\
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M:][:1[-;3HU;O=_ON2W%MYR.;+N-W;VWR7M>\_LVM,S/]V7V#QWR
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MLS,SXS,S[DP=XP
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M^W&XQZZ]$VTQQ.LSK&*O3CB?'PF*QI&D1X1$1U0U8QH
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M#1R
M
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M1.DQ,3&DQ/C$^$OTGS/S
M
M
M
M
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M6M,S,S,J[\N7+N,ML^>UKY[VFUK6F9M:TSK-K3.LS,S.LS/C,^,OTGS/S
M
M
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M6OU4R,@
M
M
M
M
M                                "G!]1OZDM>5R?] #IS8)J,9AYL;G
M?)'.8?(6]=KELGQQ!D]9ZEKDM:JY.8<')3#E,S'S5QQS>?*6]7'%5O<Q\W$?
M-T^F^NUVW]?O>.WK.YS1?%P^+)2>K'3QIFW^EM(URQU8-O.G^+][DCPR8[1+
M#R"\OXQ8_P#?CEL<>\O$UVE;1.M8]E\_C_A>-,<_X/5;]U651Q;6E$
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M;;1.+;Q]&L3\;)/C[<MOC1[-*12LQK69F5=%=K0
M
M
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M\&B6%
M
M
M
M
M                             (QO5>]0+">GSXO9O>K"XL[GNG?_ )_2
M^B=>NK6F_ANMQKLZ9+S:<K955T42:WHMC/3>W7O_ +7/<56UIS[.;JGGB3/I
M3\@-[Z@?,_!P>XK>O9?']&XY/+6W1-=O%M*X,=M)TS;FT>[IIXUI&3+'^*F&
MQ?++L;-WUW'397B8XC!IDW-HG33'KX4K/^'DF.F/AB.JW[EFG;#L&;VS/YS:
MMEREYF]CV;,9/8-@S61FJN,AE\WF;V?(Y7*7UQ7^RGO+^_N9)9:^?NU5U\\_
M^+I/X_C]EQ.PP<5QN*F#CMMAIBQ8Z1I3'CQUBE*5CX*TK$5K'P1$0L(P8,.U
MP4VVWK%-OCI%:UCPBM:QI6(CZ$1$1#\=];]0          %ECZ=?T[_X=NY[
MCS)[/POQ>JO'O9+"+K&TOHO\WW'O*SHAS-EEK;X=S3-\GU)#79Y*JJ2.F.7*
MWEC\*N3Y:[CHK8^</]0O^XO9M?)SMC-IW5W!MKSO;5GQV_&6F<=L=M8TZM_,
M9,.D3K7!CS]45]YBM,>_/GOS[R\1':?'7TY/?8Y]],>W'MY^+-9\/;G^-3PG
M6*5OK$=59F]4HS0Q
M
M
M  <*^HQX1ZCY]>+>]=&9OG&XK<>8:=GZBW6_B]O.D=FX6.27 9*6YHL<E=08
M',TU28K,\0P2SUXB^N/@T\7'$-=&\_3KYV<MY">:.Q[YV7O,O#Z^YW^VK/\
MWG99)B,M(B;4K.7'X9]OU6K6,^+'US..;UMFG8/>&Z[([DP\SAZK;37HSXX_
MZS#;ZJ--8B;5\+X]9B.NM=?BZQ.8CO.C[=UGN6T]>[]K^2U3=M*SV4UC:M;S
M$'-MD\)GL+>2V&3QM[#[:J>)K6Z@JIYYIYJHJXX]ZGGFGGCGGILX/F^)[EX;
M:]P\#N,>[X7>X*9L&;'.M,F+)6+4O6?H6K,3XZ3'LF(F)A8KLMYM>1VF/?['
M)7+L\U(O2]9UBU;1K$Q^S#Y5ZCZ0          $GWI/^H5L?I[^3.)V^]O\
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M6I:)K:/@F)A7QGP9MKGOMMQ6:;C'>:VK/A-;5G2T3'T8F)B7[#XWY
M
M
M
M
M
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MLS,S7#W!SO(=R\QGYOD[S?=Y[S:?H5CV5I7Z%:5TK6/H1]%[DP=XP
M
M
M                                       "H5]2)Z=/Q[2P\_\ J#6;
M..NR^S=6\FK'%T_!N[F&>6RPVB=KRVGLIANOE9JHL%F)(ZOF/=EQLOPJHH[R
M>*W3YN+U$]&7)Y!=W;F\Q?KS\-:_C6)B+9-UL8M[:]4=6YV\3'1K7<TZHM;#
MCO*?T_\ ?NEK=C\KDG2=;[2;>R--;9,.OP:^.2D3X>&2-8F:5FGDM_2K
M        6]?IS?4OBL?E_3X[GS?NPW-YE,SXS;%D*K2""UENOGLWMG4=_?SW
MEO5)\Y?\RY37J/@RS5W%Q?6E4WN\XZWIJ,^<4]-5L_5Z@>S<'QZTICYG#3JF
M;17IQX-_6L5G3IKI@W<]5:Q2F#+%-?E&28L^?GEY-]>^N(IXQ$5W=8U\=-*T
MSQ$1/LC2F7QB-(I;3_&6FX:I_13
M
M
M
M
M                                                 4JOJ*?4OE[
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MWDQ,UFLK%*O!H4
M
M
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MD
M
M
M
M
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MQ]^GG]]$TQ:3\;'3V9,WA,3$Q$]..?@R3%O&*6AHI.>! P
M
M
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M9NN^R,##G]<RL?%%$U-'QY[')8G)VU,DO./SVO9FSN,?D;2JKF2SO[6:"O\
M9QU.9GOKLCN3RW[OW_8_=VWG;=Q<;GG%FI/C&ND6IDI.D=>++CM3+AR1&F3%
M>EZ^%H5V<UPW(=O\KGX;E:3CW^WOTWK_ '(F+1/PUM68M2WLM68F/"7K3$WE
M@
M
M
M
M
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MNTNV./[/X'!P/'1'N\5?CWTTMER3XWR6\9\;3[(UGIK%:1/36L1RZV>R,
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MGYW?>$Y)TI3X,>*NO12/V(\9G]U:;6^%UHU,Q<
M
M
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MSJ\N9[JXK[_<32)Y_9TG6(B-<^&/&::ZQ\;'\:]/;,_&I$3-JZ7^%!B$
M
M
M
M
M
M              #/=]<OU//Z;O<\/3'4V9^8\9.BMDRM& OK&X]^Q[5[%MJ+
MG 97LJJ2RRM_B,MK>/M.;FTU:>FBF7[.O;JYYYXXO^88>@?T/>F3^I/LV>\^
M[,/3YF<[MJ>]K:/C;':3,9:;/2U*Y,>:]NC)O:S,U][CQ8XCZQUWG3Y->7/^
MYW$3R_*4T[BWN.O5$QXX<4Z6KB\:Q:MYG2V:/9U5K7]QK,#Z=C=(
M   "[_\ 3K^FU1U%UM1YS]P:_#QV;W#@:K3HO%97'W'%]HW4&4IHKGWF*F^I
MCCML]VU'Q159SPPU5Q:Q3%7#=50YB[MZ*2/G#_4A;N[N2?([M#<3_NSP^?JY
M.]+QT[GD*>$;:>G6;8MA.L9*VMI;>S:+XHOL\628=>?7F!/*<A_N9Q5Y^]VT
MOKN;5F-,F>/^K\/;7!^ZB9\<VL377%6TV@U8:.0
M
M
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M]Y=[;O#AZ:<5N<GU^L>S%FM/U?C,ST9K3/A$=-+^'A%ZQ%G%68CL
M
M
M
M
M
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MC,S/C,SXS* EK6O:;6F9M,ZS,^V9^C+^S^'^
M
M
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M
M
M
M
M
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M7HI&LS]&;6T\+7M>VD=6CL!J%BH
M
M
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MWV"\UM$^R?H6K/[JEHTM6T>%JS$P]@8@\H
M
M
M
M
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MR=5HUK6EILIJVT?
M
M
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M\K>_L'?7;]<F>T1SVVB*;FGA&MO97+6(TCHRQ&ND1$5OU4CPK%K11I5MF
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MF8M68F)B8G28F)\8F)\)B?&)03M6U+36T3%HG28GVQ/T)?V?P_P
M
M
M
M
M
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MK;+[=:VF8FF*?\*+6CQQRT(G/P@L
M
M
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M;=<!5"HK
M
M
M
M
M                  *EWU!_JJ_>QB\YX$>/.U^[L>=LY;#R;V_ WG[+#ZSE
M,;-%-TA#/SCZJ*[S:;'(139^6TNJ>;>RI^S)??\ FKZ&&V+YOSTL??/=8//G
MS"VG_P!3L%XMPVWRU_QF:EXF.2F.OPK@M2:[6N2D]63_ #FFGNL%[R?\B_+3
MY3DIWMSN+_-Z3KM*6CZJ\3_WCV^RDQ,8HM7QM]<C3II,TSER*68
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M<G<'(=T\WN.=Y.T3N]Q?72/J:5CPI2O_ ":5B*UUUF8C6TS:9F??F O#
M
M
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M?<7TB9Q6M/[FWC.&9G6:Q-9UFG5:=5!EI@
M
M
M
M
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M*A@U$
M
M
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MG;<9NM<FRR1-\&73PR8]9CQ^",E/",E?@G28^):DS($T P8
M
M
M
M
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M]>K)II-:16OC&2T5N>J:$20
M
M
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M[-;1%HM6/?F O#
M
M
M
M
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M\#\
M
M
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M>ZX[=Y-AOL=L6\PWFEZ6C2:VK.DQ/[$OJGE/F
M
M
M
M
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MHF>C'7V>$:S,SI'5>;7F(FTNM&IF+@
M
M
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MB?H2_L_A_@
M
M
M
M
M          "E)Z]_JXW'9><VGP9\;-HFBZVUO)7NN^1>YV%I7:S;SMV ROPK
MOK37LK7/\>K2=;R=CS1EIXX8OM6_AY@CDKQ\=?-]=-Z#/25C[:V.U\\?,C:Q
M/<FYQUR\1M[VBT;;!EIK7>9:::?*<U+:X*S:WN,5NNU:[BU8P2]\DO*ZO'8<
M?>7<&.)Y#)6+;7',Z^[I:OAEM73_ !EXGXD3,]%9UF(O,=%5A::DJ
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M%WG_ '9VE_K?MCWV332V:8G3PC6U<43XQ29M.DY+5B<E!]IH
M
M
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MU^JK$Y-8M6W7<Q4W(E@
M
M
M
M
M                  *P7KO^KW_ 1A-F\*?&W/WEKWAL^'LH>W.SL!DOE+CJ
M#6<O3!?<ZAK=Y:2<W,/9&V82JGBYN>/A\X7%7E-<%7-_<136%G/H4](O^_6]
MVWG3YD;>ENR-KFM.PV66G5'(9L>M?E&:MHZ9V>#)]13Q^4Y\<UR1[C':F>1G
MDMY6??K-C[O[@I$\-CO/N,-HUC/>NL==XGP]U2WLCQ]Y>NEOB5F+T>EW28P
M           "V[]/5Z5TN<R& ]0+OO!_#PF(O+NKQHTG+6UW#<Y3-V,]K'SW
MA>4T7<,/&'Q4U%U98"WN(I>;J[XER/%$5%OCY[FI?YP;U35V.WW'D!V%GUWN
M:E?OSN<<UF*8[1:?O;76LS[R\=&3=7I:O1CZ=OK:V3<4Q1>\]?,J,-+]C<)?
MZ]>(^5Y*S&D5G7_-X\/JK>%LDQ,:5TQZS-LD5N2J=$3@
M
M
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MI[BTZ1.2D1_U5K>-JQ_B[3,Q'NYTQVB58".
M
M
M
M
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M,OTGS/S
M
M
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M_0$:/
M
M
M
M
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ME8B(B*UK'P5K6(K6/&=(UF9M,S/N3!WC
M
M
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M9^N5C77JB]:S,H;-2@
M
M
M
M
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M&T=& @
M
M
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M1;%:(FMHF)B8F-8F)CPF)CQB8\)A.&MJWK%JS$UF-8F/9,?1A_%_;_0
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M+E)B8G+P6>\^XS1'A]'W63_!R5C^Y>L==?W5:2HHM-:@
M
M
M
M
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M2WC-:TGY0':0
M
M
M                           5%O7V](N[ST^S^>7C)J=Y?YJ3XN8\F.N=
M>MHI/FK2RQ\5$W=.M86UBCFYO((;/FK:H;?B6JX][[6JCXKIR=Q+;=Z"/5OA
MV%-KY$>9F[ICV4:8^&W>6TQTVM>=..S9+3,=,S;38VOTQ33Y)%IK.VQUE)Y(
M^:5,%<?97<66*X?J=IEM/LF9_P"[WM/P3K]9F=-/\5KI[NL4YEPJ5P
M      #UKHSO/M3QM[4U#NCI?;\EI'8FD9*G)8/.8VJFKBKBJFJ&^Q>4L9J9
M++,X',V4E=M?6-S1);7EM)7%+1515SPQ/OGL;M;S([6WG9G>>SQ[[MW?8^C+
MBO\ WZWI:-+8\N.T1?%EI,7QWB+5F)B)>7S/#<;W!QN7B.7Q5S;#-72U9_\
MA:L^VMJSXUM&DUF(F)U:/?I@^H_U]ZB_1,&YV,>'U/N?3/E<+W/U;9Y'FXEU
MW-UT5<66S8&WNY*LK-H>WT15SXZ:7XG-O-1/8R3336DDTG.9ZG/3EW!Z=N^K
M<-GG-N^S=YU9..WMJ:1FQQ]5ARS6.B-UMYF*Y:UTZZS3/6E*9:TK /S&[ WW
M87-3M+]>7B,VMMOFF-.NOPTM,>'O*>RT1IK'3>(B+1$26HUM>@
M
M
M
M
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M*X
M
M
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M37FE_O/MJ]M<]DF>X\-)FE[?_?&.L>V9_P K2/J]?&]8B^MK=>E<M8JWX
M          ]^\9/)ON/Q"[CU;O/HS:9M8W?6)N8ZZ).)+G [1@;F2&K+Z?N&
M(IF@CSNJYV."FFYMJJJ*Z:Z(YX)(;J&">+ ?,SRS[.\W>SMUV/WQM8W7";J-
M8F-*Y<.6L3[O<;?)I,XL^*9F:7B)B8FU+UOBO>EO$[B[=XGNGB<O#<SBC)L\
MD?L6I:/J;TMX]-ZZ^$_LUM$UFU9T=O3D]1OISU%.G(MYT:6'6.R]8AL+'M[J
M&^OX[G/:'GKF.OB.[M).:+>3.Z3G9+>6O%96B*BB>BBN&:B&[AN+>+G/]1?I
MT[Q]._>,\'SD3NNVMU-K;#?UK-<6ZQ5GQK:/&,6YQ1-8SX)M,UF8O2;XKX\E
MH"=_=@\MV%RT[/>1.3CLDS.#/$:5R5CX)]O3DKK'737P\)B9K-;3(<CTP,
M
M
M
M
M                                             !Y+WGWGU7XV]5[?
MW1W1M^-TCKO2,;5DLYG,E555S5S553#8XO%V,-,E[F<]F;V2BVL;&VHDN;RY
MDHBBHJKJXX99V-V-W3YD=T[/LSLS9Y-]W%OLG1BQ4_OVO>TZ5QXL=8F^7+>8
MICI$VM,1$R]3AN&Y+N#DL7$<1BMFW^:VE:Q_\;6GV5K6/&UITBL1,S.C-W]3
M+U&>S/41[VR.ZYJYS&O]-ZG>9#&=(]5W-Q%3::AK,E<<569R]I8RS6-WOFUT
M6L=SEKOXEQS15[EI#-5:6UOQQT=>FGTZ]M>GGL7'PNRKAW'>.[I2_);ZL3U;
MC-&L^[QVM$6KM<'5-,%-*:QU9;TC+ER3,_\ R\[!X[L/A:[/#%,G+98B=QFB
M/&]_\&LSXQCIK,4KI'PVF.JUD;Z1K/P            %AST./24E\P=VL?)G
MOG#>YXR=:[)1]C:KF<3=U0]\;CB)*J_L:'YN"/&WW6^MY**GC.3<53QWUQ'S
MB^(^>*KR2UKV];_JRKY0<+?RT[#S:^9G);;ZYGQY*Z\7M\D:>\GIF;UWF:DS
M\FKI6<5)C=3:-,-<NB/.3S0CM39SV[PE_P#\XMQC^->MH_S;';]UX3K&6\?X
MN/#IB?>:_41:_!;V]O9V\%I:00VMK:PQ6]M;6\5$%O;V\%%,4,$$,5-,<,,,
M=/%---/'%--/'''''L4,9,F3-DMERVFV6TS-K3,S,S,ZS,S/C,S/C,SXS*$M
MK6O:;6F9M,ZS,^V9^C+^S^'^
M
M
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MS6TR'(],#
M
M
M
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MO>\Z:VM:=;3X:1&LS[(B(CV1$0^P>.^0
M
M
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M.#/$:5R5CX)]O3DKK'737P\)B9K-;3(<CTP,
M
M
M
M
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MPP1XH
M
M
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MC7JI,_!,UFU?C)(4<6
M
M
M
M
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M:3N,TTW'<.6-,F;3PK77_%XHGQK3V3:9TM>?&=(BM:P_I>MJ
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MKWGRW?',VY;DYBM(CIQ8JS\3%CUUBL>S69]M[S&MK?!%8K6O:33#$0
M
M
M
M                '!_J(>!'5_J$^/V:ZAWBFSP&YX[XN:ZD[3HQ4.1SO6FX
MTU6U?SEK3S);S7NM[%#9TV6:QWQ:([VSJXJHYBN[>TN;?>WIZ\^>Y_3[Y@8>
M[N$F^XX;)ICW^QZYIBWFW\8Z;>$Q7-AFTY-MFZ9G'DC28MBR9L>3->P^]N2[
M%YVG*[/6^TM\7/AZM*Y<?CX3[=+UUZL=M-:V\)UK:];9M?DWXR=Q^(7<>T]&
M=YZM-K&[ZQ-Q)17'S)<X':,#<R34XC<-/R]4,$>=U7.QP556US3317371)!/
M'#=0SP1='_EGYF=G>;O9VU[X['W4;KA-U&DQ.E<N'+6(]YM]QCUF<6?%,Q%Z
M3,Q,36]+7Q7I>U@7;O<7$]T\3BYGALL9-GDC]BU+1]52]?'IO77QC]BU9FLU
MM/@+/GM@            /6NC.\^U/&WM34.Z.E]OR6D=B:1DJ<E@\YC:J:N*
MN*J:H;[%Y2QFIDLLS@<S925VU]8W-$EM>6TE<4M%5%7/#$^^>QNUO,CM;>=F
M=Y[/'ONW=]CZ,N*_]^MZ6C2V/+CM$7Q9:3%\=XBU9B8B7E\SPW&]P<;EXCE\
M5<VPS5TM6?\ X6K/MK:L^-;1I-9B)B=6B]Z7GJA]5^HUU7S<VW&-TCR"TC&V
MG\+G4?S=57-MS55%:<;SHW-W+)>YGKW,WLE---554ESB+F2FSO*JN:K6ZO.=
MKU/>F'NGTZ=T^[R>\WWE_OLEOD&_Z?JO;;Y-N>F(KCW>.L3,Q$13/2)S88C3
M+BPP*\Q_+CDNP>2Z;=6;@\UI]QGT]OP^[R:>%<M8_8B\1UT_=5I*4BZUL
M
M
M
M
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M^D=6GA6(BL:Z3:TG*,S70
M
M
M                                             "+KU1?3$ZS]1SJ2
M'&7=Q9Z5WQH-GDKCIWM.J"6N&PN;OBB>ZTW=8+6B2YRNA[#<V\?Q>:*)+O%W
M'LN[7BO_ #BUO)/^F#U-=R^G/NV=UBK?>]B;^](Y#8ZQK:M=8KN-M-IB*;K%
M$STZS&//37%EF/K>7#L?RX\Q>1[ Y2<E8G-PN>8C/A^C$>S)CF?"N2L3.GLK
M>/BVT^+:F<YWGT9VIXV]J;?TOW1J&2TCL32,E5C<Y@\E335Q5Q533-8Y3%WT
M-4EEF<#F;*2BYL;ZVKDMKRVDHEBKJHJXY=%'8W?/:WF1VML^\^S-YCWW;N^Q
M]>++3^]:EZSI;'EQVB:9<5XB^.\36T1,3">_#<SQO<'&XN7XC+7-L,U=:VC_
M .-;1[:VK/A:LZ368F)C5Y*RQZ@            #T+JOMCLGH_?=;[0ZDW3/
M:!OVHY*URN V;7;VJSOK.ZM9X[BF*:CGBNUR6-N:HN*+FSNHYK.\AYJBGBDB
MJJHYQ_NGM3MOO?@=SVQW;LL&_P" W>.U,N'-7JK:MHF-8]EJ7C76F2DUR8[:
M7I:MHB8^'DN,X_F-EDXWE,-,^QRUFMJ7C6)B8T_9B8^"T3%JSXUF)C5H6^D[
MZM_6WJ$:%:Z?N-Q@= \JM1QL=.[==4W5%G8[Q:VL'/,_8/5\%[<5W62P-S3%
M5)?X[BN:\P<W/-$W,EM5;7=QSY>J[TE]R>GWGK<OP]<^_P#*S=Y)^3;OIZK;
M:UI\-IO9K$5IEC6(Q9M*X]S7XU(KDC)BQP4\SO*[D.Q=[.[VD7S]M9;?6\NF
MLXYF?\5FF(TBT>RMO"N2/&-+1:M9DT.6I@
M
M
M
M
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M>GEQY<<;V#QO37IS<YFK'O\ /I[?A]WCU\:XJS^Q-YCKO^YK2+5*)L@
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M-9RVB-)S9(UUF9G7W<3IT4F/BUO:^LTJ&#40
M
M
M
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MJQ.[CN1V/+['%R?&9:9MAFI%J7K.L6B?_C$Q.L3$Q$UF)K:(F)A\&]U]H
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MQ;_#..)TBN7Z<5O\;2UY\T"FD0
M
M
M
M
M '/?D[Y2=*>('4>R=T=Z[A9ZMJ6O6<TMM9TUV]QLVVY;CBFFQU;2L#7<6]QL
M.R96XDHCBACYIBBXJYFN)(+:.:>/8/EEY7]Z^;W=NV[,[%V=]URVXO$6MI,8
M<&/]UGW.6(F,6&D1,VM.LVTZ,=;Y+4I;W>W>V^8[JY3'Q'"XIR[K)/C/C%*5
M^&^2VDQ6E8\9F?&?96+6F(G./]1OU&^X_44[CEWG>99M8ZTUB:_L>H>H;&_D
MN<#H>!N9*.)+N[DXHMX\[NV=CMXJ\KE:XJ*YZZ*(8:(;2&WMXNBWTZ>G3L[T
M[]G1P?!Q&Z[EW45MO]_:L5R[K+6/"M8\9Q;;%,VC!@BTQ6)F]YOEODR6GUV#
MV#Q/87$QL]G$9.1R1$Y\\QI;):/@CV]..NL]%-?#QF9FTVM,>*0K.P
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M\?!VO7MO!>=;>,?*;Q,:7M'MC'28UQUGQF9]Y>.KHK2P*@"T:
M
M
M
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M9RX(UO?!\,WI[;6PQ'U6NML6G5,S36:6<59B.P
M
M
M
M
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MD^>RNRN'[&X>O%\77JRVTG-FF(Z\U]/JK?0K'C%*1.E(^C:;6MQ.W4R\
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MV*=QVMVOVY>?O'CO]=S5F8^46K^YKI.DX*SXZSK[RT5M&E:UF]E]6JCT
M
M
M
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MQ*<>TW>VW^VQ[W99*9=IEI%J7K,36U9C6)B8\)B8?-O1?0
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M)B?&)B?"8GQB44K5M2TUM$Q:)TF)]L3]"7]G\/\
M
M
M
M
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MZ\G:_:7:^:9XZLS7<YJ3X9I\(]UCM'MQ1X^\M'AEGXL?6XF<EJ=5DC4
M
M
M
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M5YK>EHF+5M$Z3$Q/C$Q+Z1YKYP
M
M
M
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M^#)DCZOQK6>C6;VT53J,
M
M
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MMHF:VK/P6K,QK$Q.EHF(]R8.\8
M
M
M
M                                                    !7T]7+UN
M=-\+;?,=">/$F!['\H<CC;VSS&6IO;/)ZCT!7/15!;Y#:+2B"^M=C["IJ]ZN
MTUZ2J*.T]E%UDN?@_!LK^P'TD^B;F?.?)A[\\PHS\=Y88\E;8\?3:F?E8B=9
MI@MK6V':>R,F[B+3?QQ;;X_7FP;S\KO)[=]W6IS?/=>W[<K:)K728ON=/&8I
M.L33%_A98UFWC7'XZWI0RWC>=R[,V[8-^["VG/;KNVUY*?,;)M6SY2\S6>S>
M3N>>/C7N2R=_+/=74W--/%/'-57/%-%/%-/LIXXXXO>X3@^&[:XG;\#V]M<&
MRX7:8XQX<&&E<>+'2/96E*Q%:Q\/A'C,S,ZS,RFML]EM..VN/8[#'3#L\58K
M2E(BM:Q'P1$>$/E7J/I              7,?1)]$G[S_ +T?,GS)U'_X8?YC
MLG1O1NR6/_Q'_P#DN\1V5V5B+NC_ .+#_P D^&PT]'_L?]C=7=/VA\&''TW>
MM?UK_??Y7Y.>3F[_ /J1\;#R?)X;?]X]M<FSV>2L_P#=_;7<;BL_YQXXL4_)
M^N^XB9YP><'RKWO:?:>7_-?&FXW%)^K^"V+%:/W'P9,D?5^-:ST:S>VBJ=1@
M
M
M
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MLS%JVB8F)B4X]IN]MO\ ;8][LLE,NTRTBU+UF)K:LQK$Q,>$Q,/FWHOH
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MJSXQU5FM[=X-$L*
M
M
M
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M6M*Q6L1%8C2(CV1'T(?Q?V_T             !<Q]$GT2?O/^]'S)\R=1_\
MAA_F.R=&]&[)8_\ Q'_^2[Q'9796(NZ/_BP_\D^&PT]'_L?]C=7=/VA\&''T
MW>M?UK_??Y7Y.>3F[_\ J1\;#R?)X;?]X]M<FSV>2L_]W]M=QN*S_G'CBQ3\
MGZ[[B)GG!YP?*O>]I]IY?\U\:;C<4GZOX+8L5H_<?!DR1]7XUK/1K-[:*IU&
M
M
M
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M7'1?<]LVO.EXB9OAB=-*YXB-(C6>FN2/BVF(ZNBUJUF;U"5IT
M
M
M
M
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MQ\&3)'U?C6L]&LWMHJG48
M
M
M
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M#<SQO<'&XN7XC+7-L,U=:VC_ .-;1[:VK/A:LZ368F)C5Y*RQZ@
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MS,6K,3$Q,3I,3$^,3$^$Q/C$HOVK:EIK:)BT3I,3[8GZ$O[/X?X
M
M
M
M
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M$0_RUJTK-K3$5B-9F?9$?1E<K]$GT2?O/^]'S)\R=1_^&'^8[)T;T;LEC_\
M$?\ ^2[Q'9796(NZ/_BP_P#)/AL-/1_['_8W5W3]H?!AQ]./K7]:_P!]_E?D
MYY.;O_ZD?&P\GR>&W_>/;7)L]GDK/_=_;7<;BL_YQXXL4_)^N^XB;YP><'RK
MWO:?:>7_ #7QIN-Q2?J_@MBQ6C]Q\&3)'U?C6L]&LWMHJG48
M
M
M
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M,=5+QI,:QK$_#$Q,3K%HF8F/&)F'IS&7G
M
M
M
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M^]O#8YCJF)R9+>.3+:(TZKVTCV>/36(BM=9TB)FTSQRW"RL
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MJSX[B?AI2?\ (?1G_K?_ +'_ (RSNK)1T
M
M
M
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MW>2-9TC7]QDTB9G':>J(\8ZJZ6F0)H!@P
M
M
M
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M]H4
M
M
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M+[G@HUM?'XSFP1\:TS_])BI6(^/KUQ^ZB8B;K(*N1H
M
M
M
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M+Y[1[+Y8CV5B?''CU\/J[?&Z8I.>@XTR
M
M
M
M                     \E[SZ,ZK\DNJ]OZ7[HU#&[OUWN^-JQN<P>2IJIY
MIYIJIFL<IB[Z&J.]PV>PU['1<V-];5QW-G<QT2Q5TUT\<LL[&[Y[I\M^Z=GW
MGV9O,FQ[BV.3KQ9:?WK4O6=:Y,62LS3+BO$TR4F:VB8F8>IPW,\EV_R6+E^(
MRVP[_#;6MH_^-;1[+5M'A:LZQ:)F)C1GQ^J9Z0/;GIZ;5)MFKT[)VMXOYOX$
MF [:HP_-=WIM[<7%G8?>EVQ3B;?[-UW,5Y*]BBQ]_P \08_,TRT? ^'<\3VD
M'0+Z7/5WVEZ@^*CB>4G;<5YG8-8R[#WFE=Q6(M;W^Q]Y/7FQQ2MK9<7QLNWF
ML^\ZL<X\V2<_EMYJ<7WWMODNY]WM>XZ:]6#J\,D1$SUX>J=;UTB9M7QMCTGJ
MUKTVM#FF$VN                L@>EEZ]_8OC']['1/EE<9CM3Q[MOLW ZY
MO?LNLIV9T[BX_L?$X^#XGQI)-SZWUO%6DM?V;S#7F+:BKV6D\L<45A57)ZH_
M09V[YF?*N^O*BN'BO,"W7ES;7XM-GR%Y]YDO.FD1M]YFO:L>^ZHV]YCZ]2MK
M7SQH#S)\DMAW%[SFNV(IMN=G6U\?A&'//QK3/_T>6]ICX^O1/[J(F9NN]=2=
MP=7]\]?:[VKTWO>M]C]>;79\7N"VK5LE#D<;=4\<^Y<V=Q[G/%QC,QC+CBJW
MO;"ZCAO;"ZCK@N(HIHZXZ:2N[>T.Y^P^X-QVKWCL=SQW<.TOTY<&>DTO7X8M
M&OA?'>-+8\M)MCRTFN3'>U+5M,/.4XKDN$WV3C.6PY-OO\4Z6I>-)CZ$Q\$U
MF/&MHF:VB8M69B8EZ0QQYX
M
M
M
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M-(OEF/"U]-9B/J<?5-:Z^-K2THG-8
M
M
M
M                    /F]QT[5.PM4V+1MYUW#[;INVX>_U_9]8V"PM\IA,
M[A,I;R6F0Q>4Q]W'+;W=G=V\M5%=%=//'/'+TN'YCE>W^5V_.<'N,VTYC:9J
MY<.;%::9,62DQ:EZ7K,36U9B)B8E]&TW>YV&YQ[W99+XMWBO%J7K,Q:MHG6)
MB8\8F)46_5[]#?9_%*XVKR-\4L+DMK\78(><UM>DTWV0SVZ=%1>_[M_+++D9
MKS,[=UC9\U4R1Y.N:YR.+M^:^,C[\-O7D9;R?2+ZX.,\U<>U\NO-7-CVGFA:
M?=X-STTQ;;DYT^)$12*X\&]MXQ.&*TPYK:?)]+Y(V])F^5?G)MNYJXN [FO7
M%W),]-,FD5Q[GZ'LTK3-/LFFD4O.GN])M&.*XJQAOT               !W5
MX->HKY,^G[O,^T]&[7#-J^<FCJWKJ?;8KC+];[U%''Q%%-E</%<VEUBL]9TT
MT<VV6QL]GD8N*/@U2R6DD]M-HSSP]._EIY_\'7B^^-K->4P5GY+OL$QCWFUF
M9UF*9)K:M\5O'KP9JY,-M>N*5RUIDIAG>787;O?.SC;<SBF-S2/K>:FE<N/_
M )MM)BU9^&EXM2?;I%HK:+]?I[^J?XT^H=K,M/7V5^\7N'"V?-YM_16XY/'T
M[MC+2*NF*?/:U)%S!#O6GQS5T4UY&QCXJM*I8J;V"TDGAHDH3]07I;\RO3UR
M<3W!B^7=H9K].WY/;TO\FO:?&,6:)UG;;B8B9C%EG3)%;S@OFK2]JPB[Z\M>
MX>Q-Q'RZOON*O.E-SCB?=S/^#?V^[R?\FT_&TF:6M$3,26HUM>@
M
M
M
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M>VN%[5XVO%\'@IAVM?&=/JKV^&^2_P!5>\_1M/A&E8TK$1'/;8+W0
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M*UBM*]^-!L'
M
M
M
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MB:VB8F)B8UB8F/"8F/&)CPF$KJVK>L6K,368UB8]DQ]&'\7]O]
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M8F)\)B?8_P!C\7\
M
M
M
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M16M8C2F.L>RF.NL]-?;/PS,S-K3-IF73C63'0
M
M
M
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M^''?2-?@F:6BN2L3$VI76->QFGF)@
M
M
M
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MG69TC2(^"(B(C2*Q$1$>$1$/3F,O.
M
M
M
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MS>7X;B^>V-^-YC!CW&QO[:7C6-8]DQ/MK:/@M68M'P3"Z?Z;7U#/5??5>O\
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M6B=)B?;$_0E_9_#_
M
M
M
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MM:93!XCAN+X'8TXWA\&/;[&GLI2-(UGVS,^VUI^&UIFT_#,O*V4O2
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MS,S*(67+EW&6V?/:U\][3:UK3,VM:9UFUIG69F9G69GQF?&7Z3YGY@
M
M
M
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MN#L[??(>=P3CF?J+Q\;%DCZ-+Z:3].)TM7]U6'6C4S%P
M
M
M
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M/A?)$Z6Z*]5;6<59B.H
M
M
M
M                     #\':-5UC>-<S>G[KKF!W#4MEQMWAMCU;:,/C]@U
MS/X>_BJ@OL5F\)EK>[QF5QMY!7S1+!/%)%)1SSQ53SP^_B^4Y/@^1P<QPNYS
M[/EMMDKDPY\&2^+-BR5G6M\>3'-;TO6?&MJVBT3XQ+]]MN=SL]Q3=[/)?%NL
M=HM2]+36];1XQ:MJS$UF/@F)B84MO54^GXV/J>C9O('P9Q6>WCK>F:YS.W=
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M7\
M
M
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MZ\9P6WIM]I$ZSIXVO;_"O>=;7M\'5:9F(B*QI6(B/ 6?/;
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MIS/?6YMMJ3;;=NTM/1@K,Q-XB8F+Y])TO?6(F*_48_96)MK>TO:(K5@
M
M
M
M
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MI#T>F!@
M
M
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M.MKZ1-IF8==-2,6
M
M
M
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MD^V)CQK:-8M$Q,3,3$O0F/O@
M
M
M
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M$2]X+M_A^VN/IQG"8*8-I2/96/&T_P"%>T_&O:?AM:9G^X\-9P]D
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M\8
M
M
M
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M'P3PR2XG;]1O_?QF2AN8(N8:;N+BWREG1)559W5M+SQ+QJKS8\E/+;SLX&>
M\PN-Q[O'6+>YSU^M[K;7F)B,FWW%=+TFLSU3CMU8<DQ$9L62FM9QGNCL_M[O
M#93L>>V]<M8B>B\?%R8YT^JI>/&-/;TSK2TQ'76T>"Z?Z?\ ]0-XQ^3]IBM$
M\BKG#^,?=]?R]KS7L.1^#TQNEW/+-%1)JN\Y&XJ^]>\J^%35+C\_5:TT53QQ
MVM[?U_$^'2_Y_>@'S-\L<N7G?+NN;N;LB-;:8J:\CMZQ$3,9]M2/KU?&8KEV
MO7,Q6ULN'!'3U1%[X\C>XNW+6WO Q?D>'\9^+'^<8XC_  \<1\>/H6Q:^R9M
M2D::V!4 6C0
M
M
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M;</.L7S?4Y<\3$?%K&G5AQZZZZ3UWC36:5FU+695:2/
M
M
M
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M3$PF3Q/+\;SNPQ\GQ&:FXV&6)Z;TG6)TG28^"8F)C2:S$3$^$Q$O,63/1
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M
M
M
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MK;TM,TK].\Z1[W)X1\>T1$>/16D3,)+4:VO0
M
M
M
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M.W^^\$8<%OD_.5I$Y-O>?C>SXUL5O9EQQ.OC&EZQ&MZ5B:S,5Z4K90
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MZHUK>/\ "QWC6EZ^/C-9G2?"=+1,1T(U\\(
M
M
M
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MPB(AZTQ-Y8
M
M
M
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MR6'+@WE)TM3)6:6C]F+1$_L3[)^!]L\1\8
M
M
M
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MW8_DQVSVC--[O(C?\W6=8RY*Z4I.G_5XM9K&GMB]^J\3XUFOL0DIKMP
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M@
M
M
M
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M,>V)K.DQ/TIA^P^-^0
M
M
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MMMGMZ;39XZ8MKCK%:4I6*TK6/"*UK6(BL1\$1$1#\%]S]@
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MTA'WEW[W%WSO(W/,Y8C;4GZWAIK7%C_YM=9FUI^&]YM>?9K%8K6.ZFC&%@
M
M
M
M
M                     /C]_P"OM%[5T[/=>]F:?K>_:+M-GQ8;%J.W8:PS
M^O9FTHGANXHLABLG!<6=Q\O>6T<\555'O0SQ424<TUT4U<>QP'<'.]J\Q@[A
M[:WFYV'.;6_7AW&WR6Q9<=M)K,TO28M&M9FMHB=+5M:MHFLS$_7L=]O>,W=-
M_P =ER8-[CG6EZ6FMJSIIX6C28UB9B?HQ,Q/A*F=ZD7TY^[=;_;G;O@=QF.R
M=%C^'=Y+H#*74F3[,UN.KXG-Y-H>9N:J/O\ L/;^SCFBPN.:<W'1^QCJR%?/
M/--R/IQ^<3X7N/W':/GM[GC><G6M.5I6*;/-/ATQNL<?]UR3\.6NNVF?&T;>
MOMEGY?\ GWL^0Z.+[UZ-OO?9&YB-,-_H>\K'^+M/^%'UN?AC'"K5D<=D,1D+
M[$Y:QO,7E,7>7..R6-R-M-99#'9"RFKMKRQOK.YHBN+2\M+B*J.6*2FFN.NG
MFFKCCGCGA:)M]QM]WMZ;O:7IEVN6E;TO2T6I>EHB:VK:)F+5M$Q-;1,Q,3$Q
M.B26/)3+2N7%:+8K1$Q,3K$Q/C$Q,>$Q,>,3'M?XW[/Z
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M3$Q.DQ,3XQ,3X3$^,2T9:MJ6FMHF+1.DQ/MB?H2_L_A_@
M
M
M
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M:UIF;3/PS,S,OWGP/P
M
M
M
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MO^'RZ;NL:Y,%]*YL?C$:S76>JGC&F2DVIXQ$S%M:QP>WLS0
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M\8F)\)B?&):6M6U+36T3%HG28GVQ/T)?V?P_P
M
M
M                                                        !^/L
M&PX#4\)E-EVK.8?6=<PEG-D<UL&P9.RPV$Q&/MZ??N+[*97(SVUA86<%/W:Y
M99***>/\O/#[./X_?\MO<7&\5@S;GD<]XICQ8J6R9,EY]E:4I$VO:?@K6)F?
M@A^N#!GW6:NWVU+Y-Q>=*UK$VM:9]D16-9F?I1"N)YW_ %'?C_TG;Y31O#W%
MXWR/[0BFELI-XRGVKC>C-9ECHF]^ZHO;23&[#V=-'<QT4<6^+EQ^.FBEYFCR
MW/,?$,MC'D5\W/W_ -ZY,7.>;^7)VYVQ,1:-M3HOR>:)F/B]-HOBV4369GKS
MURYJVB*6VD1;KKO[LKR!YSF+5WG==K<?QLQK[N.F=Q?Z6DZUP^'CK>+6B8TG
M%XZQ3^\K?-[R?\U]N@V[R-[7SV]58R:\DUC5J?E\)H6F17OPZ)H=2TG#166O
M8B::VMX8;B\X@KR-]1;Q<W=Q<5T<5K>O*KR2\L?)7B;<1Y=<5@V,98K&;/XY
M-UN)KKI.?<Y)MER1%IM:N/JC#BF]O<X\=9T2I[9[.[<[0VL[7@-K3#U1'7?Q
MMER:?X>2VMK>,S,5UZ*S,]-:Q.CE%M5DP                  #M[PF]/;R
M9\]]YHU7HS2II=:QV2M+'=^U-AIN,9UOH$5S'S<?$S^>I@FJNLES:T\R0XVQ
MCNLC/QSQ53#\/WI*=)>=?J"\M/(;@YY3OC>Q')9,=K;;8XM+[S=3$Z:8L6L=
M-.KPMFRS3#7QB;]6E9P[O#OKMWLG9?*>9S1&XM69QX:Z3ERZ>'Q:Z^$:^$WM
M,4CZ.O@OC^G)Z1?C=Z?& Q^?QF,L^T?(FZLZJ-E[VV?%1<9:RKNK*>RO<+UI
MB)YKZWZ]UN2VO)XI>;6NK)Y&*:JF]NYXJ8((*)/47ZM_,?U [_)L-SEOQ?EY
M6_UGC,-Y]W;IM%JY-YDB*SN\T36MJ]<1APVK$X,6.\WODA7W]YI=P=]9[8,E
MIVW Q/Q-M2?BSI.L6RVC2<M]8B8U^)68UI6L]4VE=14:R
M
M
M
M
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M,2D]MMSMMYMZ;O9Y*9=KDK%J7I:+4M6?&+5M69BT3\$Q,Q+\%]S]@
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M6:Y:S,3$QI,3'A,3$^,3$^$Q/L?['XOX
M
M
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MN1Y+?\MO+\AR>;)GWN2=;7O:;6G^[/LB/@B-(B/"(B'WCP7Q
M
M
M
M
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M$_2F'[#XWY
M
M
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M\N^T^RZ1/#;:)WVFDY\FE\]O@GX\Q$4B8]M<5:4GVS77Q<!M^,W
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M5P
M
M
M
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MZ0QQYX
M
M
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M/LND3PVVB=]II.?)I?/;X)^/,1%(F/;7%6E)]LUU\7 ;?C-P
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M^_Y'+DS[W).M[WM-K6G33QM.LSI$1$?0B(B/"'V#QWR
M
M
M
M
M                      / ?)'Q<Z%\N>MK[JCR$ZWP/8VG74U-[919.*6V
MS.MYB*FJ.#/ZALF/DM<_JF>ABKKB^:L+B"66VDEMY>:[>:6*O/O+CS0[\\I.
MY*=U^7W)9^.YBL=-II,3CS8Y\9Q;C#>+8L^*9TMT9:6K%XKDKTY*4M7W.W^Y
M.;[6Y"O)\%N+[?=Q&DZ>-;U_P;TG6MZ_#TVB8B8BT:6B)BF;Z@'TZ'?72%QL
M79'A[=9+R&ZFMX;[,R==5P11]YZC9PUW,]6+QV)M..++MJ&VLHZ.89,71;9F
MZED^!'BI*J.)IKD?('YQ+L/O?'M^W/-^N/M[NRTUQQNXF9XS<6F(CKODM\;8
M3:TSU1GF^WI6.NVZK%NBDL^Q_/OA.8KCX_NN*[#E)F*^]U_S>\^'QIM/C@UG
MVQ?7'$>,Y8UTBMSD<=D,1D+[$Y:QO,7E,7>7..R6-R-M-99#'9"RFKMKRQOK
M.YHBN+2\M+B*J.6*2FFN.NGFFKCCGCGA8]M]QM]WMZ;O:7IEVN6E;TO2T6I>
MEHB:VK:)F+5M$Q-;1,Q,3$Q.B0./)3+2N7%:+8K1$Q,3K$Q/C$Q,>$Q,>,3'
MM?XW[/Z                     >S=(>1/>?C9MT&]=#=J[MU7L\4UK--?Z
MAG+O&V^4XLN9_EK78,3Q77AMEQL?%U+QS:9"WN;:JF6OBJ/GBKGCG#>]_+SL
M?S(XFW!]]\5LN5XR8M$5W&*MYIU:=5L63PR8;STU^/BO2\36)BT3$/)YC@>&
M[@VL[+F]MAW.VF)\+UB9C736:V^JI/A'QJS$^$>*S+X>?4[[I@:+74_-OJF'
M>K+B:&.+MSINVL-?VF"WKN*.)J]GZYR5U;:QGIJ*)ZZ^+G%WN%ICB@HC^2GD
MKJFXK2\X/FR>%W]K\KY*<K;8YNF9G8<A-LN"9B)T]SNZ5G-BC6(CHSX]Q,VM
M-O?4K6*(\=U^G39YIG==G[F<-]/\1GF;4F=/W&6(F]?9[+UR:S,SUUB(A:/\
M8_-OQ8\QL)/F?'/NC3^Q9L?9V]]G-8M+R3%;UK=M<TV_P[C8]%S<..VS#V=4
M]QQ!3=2VG%I+<4UQQRUU45<<5?>9ODIYI>3V]KL_,7A=YQU,EYKBS6K%]KFM
M776,.ZQS?!DMI'5-*Y/>5K,6M6L6C6-_<79_<O:>:,//[3+MXM,Q6\QKCO,:
M^%,E=:6G2-=(MU1&DS$:PZH:L8T
M
M
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M<S7%7VZ3,:_'O$3,==]9\9Z>F)T2'H],#
M
M
M
M
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M7_9/FIVOWM6N#;9/D_,S&L[?+.EO_M=M(IECX?BSUQ'C:E45Z4K90
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MSX9MOKDC2?\ "QZ>]IIX=4S3HB9TB]O:EO1+:N
M
M
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MS,S/C,S/C,SXS*/=K6O:;6F9M,ZS,^V9^C+^S^'^
M
M
M
M
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M.4X3=6V7+[?-MMU6?&N2DUG]F-8C6)\)BT:Q,3$Q,Q,/3F,O.
M
M
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MQKKTTI&E*5UF9Z:5K769G369>Y,'>,
M
M
M
M
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M2)^CDI3VQ'MF(29HTM>
M
M
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M^6\A32?>[C3)\:/AKCTC'729^+\6;5TB>J;1U(?TO6U
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M[I[VO;'R&;W/%3,3&VQ:UQ1II,=?C-LEM8BVMYF(MXTK2-(B2U&MKT
M
M
M
M
M                                              !S?Y,^(OCEYAZ3
M'H/D7U7K?9.$LOGI,#>9*&:RV;4[O(QV\=[?Z?MF+FLMCUB\NN+.'X]5G<Q4
MW/$-%,U,E%/%+8_EIYM^8OD_S4\]Y=\KN>-WM^F,M:3%L.>M)F:TW&"\6PYJ
MUZK=,9*6FG5::36TZL@[=[IY_M3>?+N W.3;YITZHCQI>(UTC)2=:7B-9TZH
MG36=-)5"?.OZ;+NWK*[SF^^%&P?PY]>4>_?4]3[5?XS!]SZ[;TQ<5W%MA\K/
MQB].[)L[7B&67CFFO#Y6JFN*U@L;Z;BJ:2W3R,^<A[)[FQ8.!\Z=O]X^X9TK
M\NP5OEX[-.ND6R4CKW&SM;6M?&-Q@UBV6^?!28I64W9?J"X?D:TV/=]/D6_]
MGOJ1-MO>?@FU8UR8IGPC_K*>VUKTCPBLWL&O9_4\WE-:VK!YC6=CPEY-CLUK
M^P8R]PV;Q&0MZO<N+'*8K(P6U_87D%7W*XI8Z*Z>?\O'"RWC^0V'+;+%R7%9
M\.YX[/2+X\N*]<F/)2?9:EZ3-;UGX+5F8GX)2'P9\&ZPUW&VO3)M[QK6U9BU
M;1/LF+1K$Q].)?COK?J                        D:\5?5A\\/#RWQ."Z
MI[TSV5Z]P\,-G:=4]ETT]B==VN,MZ+CBWQ.#Q.PUSY/2<;'/<<S<QZ_>8GF2
M3CCW^:J>:J:HZ^:GI2\B?.#)EWW=7!X,7<&:9M;?;/\ S3=VO,QKDRY,6E-S
M>8CIUW>//I$_%B)TF,![E\L>RNZ[6S<GLJ5WUYUG-A^M99F=-;6M72,D^&FN
M6M](]FG@LI^*WU/'1NX_8NM^7'4FR=.9VZO.;*_[&ZUIN.P.L[>"K]MHS68U
MJ2J/L;7K.*GGF*NVQ\&S7'-=%,E//NR5405M^:?S9/?'#^^Y+REY;;<QL:TZ
MJ;3>:;7>3/LG'CS1KM,MI^JB^6VRII,UGQK%KQ\[E].G,[3KW':^ZQ[O#$:Q
MBRZ8LT_\FM_\5:?AUM.&/@^#6;#O0WE#X\^4&L\;=X_=Q:'VMA:??XO.=4SM
MK=9;#RQUT456VQ:W/S;['K-Y[)8Z^(<A:6TM44L<G%/-$E%55>O?GEAYA>6'
M)_>CO_A]_P 5O?#I]_BM7'DB=?'#FC7#FKX3'5BR7KU5M77JK:(T1S?;G/=N
M;CY+SFTS[;-\'768K;Z=;^-+Q[?&MIC6)CVQ+WA@CQ0
M
M
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M>]'S9/Y5?-A;;'7'R7G-SDY,NNL['BXZ::1,36,F^W&/KM%HUKEQXMKCFO\
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M&VM:]IM:9FTSK,S[9GZ,O[/X?X
M
M
M
M
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M\>2F6E<N*T6Q6B)B8G6)B?&)B8\)B8\8F/:_QOV?T
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M><?N+;3?XLN#=4G2U,E;4O$^S2:VB)CQ^C#ZIY3Y@
M
M
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MJ5Q8JQ7%6(B(B-(B(\(B(CPB(CPB(]C_ !OV?T
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M9][DG6][VFUK3IIXVG69TB(B/H1$1'A#[!X[Y
M
M
M
M
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MXP_2?,_,
M
M                                         !%1Y-^M-Z>'BY1D+'8.
M\L;VIN>/FNK:OKWH6BT[0V+F\L+B*UR./O,SCLA9]>Z]DL?-+[LMMELYCY_?
MHDHIHJKCDIIE1Y9^C#U"^:%L>?C^#R<5PV2*VC=\I-MEAZ;1-J7KCO2V[RTO
M$:UO@VV6NDUF9B+5F=E]N^47?G<DUO@V5MMM+1$^]W.N&FDQK$Q68G+:)^":
M8[1[)UTF-:Z'E!]3KY&[U\Q@_%;JC3^A\))9W=K5N>[R0]J]BUW<GO4V>6PU
ME=66)Z_USY:.3]E:7N-V&F26BFOXW%'-4/-B?EC\V5Y=<'T[[S3Y7><[O8O6
MWR?;1.QVD5CZK'DM6V3=9NJ8\,F/-M)BLS'1U:7C??;GIUX#9:9NY=UEWN;6
M)]WC^LXM/AK:8FV6^O\ A5OBTCPTUTE7I[K\BN^/)#8[;;.^NWNPNW,_80SV
MN*O=\VG+;#1@[*ZEIGN<?KUC?7,F/UW&SW%'$E=M8Q6\%4G[+FCWN>>5@W97
MEWV)Y<<=;B>P^(X_B-ADF+7KM<&/%.6U8TB^:U8B^:\1X1?+:]HCPUT;VX?@
M>%[?V\[7A-K@VN"TQ-HQTK7JF/")M,1K:8CPUM,SIX:O&69/6
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M\_S/<F^MR7.;C)N=Y;]U;32(^A6L1%*5_P"32M:_2>V,*>.
M
M
M
M
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MVYV>>VVW>.^+<TG2U+UFMJS[=)K:(F/#Q\8?O/@?@
M
M
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M;W[?[#[0[7BL\+L,&+/6/\9,>\R^W6?KN3JO&L^.D6B/"-(B(B(XM;G9<
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MJEC(
M
M
M
M
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MBM%L5HB8F)UB8GQB8F/"8F/&)CVO\;]G]
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M3<KML^VW.FO1EQWQVT]NO3>(GV3$^SX7H3'WP
M
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M[?\ +/LCMJ:Y.-V&&=U6=8RY8]]DB=--:VR=71X>'Q(K'M\/&=8\4A6=@
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MO]&TNV&E6'@
M
M
M
M
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M
M
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MCWN36/AB^3JFNL^,Q3IKKIX1$1$<$M\LV
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M=/??='>.;KYS=7OMXG6N&OQ,-?H:8X\)F/\ "MU7^C:7;#2K#P
M
M
M
M
M
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MLXW_  NYQ;G:3^ZI:)TGZ%H]M;?1K:(M'PP\?9>]4
M          !WMT!ZH/GWXRT6=EU-Y0]G66O6$,%I9:7N&5A[-T:PL8KB[N:[
M'#Z?V/:[5@-=ANY;Z7F:O&P6<TE5?O>_[]%%5.AN_O3#Y">9=KYN[.U^,OR&
M29M;<;>D[+<VM,5K%LFXV=L&7--8K7IC-;)6(C3IZ9M$X3SGEQV1W%,WY3C=
MM.>TS,Y,=?<Y)G2(UM?%-+6TTC3KFT1[--)G6:KQ_P#JB^\-=^2Q?DKX^Z'V
M=84?&AN-IZOS&3ZVV:F.KY+FWO;S"9FG<]<S-Y%S'<\21V]6'AEXFBYI^%S!
M7\S"[O\ ^:_[(Y'KW7EMW!O^,SSI,8-[CIO,.OQM:URX_D^;'6=::3>-Q:O3
M?7JZZ^[U#SGIPX;<:Y.WM]GVU_@IFK&6GPZQ%J^[O6/9I,^\F-)]NL=,TO1/
MU"'IM]R116VR]A[AT%L$ONT1X7N72<C:6ES+1:7EW>R6VVZ))O.G6MG;\67-
M,=>1OL=-<53141Q52U\QTPP[Z^;\]1_9UIR<;Q^SY_CX]N3CMS2UHB;5K6)P
M;J-MN+6GJUF,.++6D5O:UXI$6G4?->1?F!Q,S;;X,6^P1^ZP9(F8\8B-:9/=
MY)F=?'HK:(TF9G2-4P/7O:?6';>$IV7JGL?0^S=<K^'[N?Z]V_7MTPE7QJ:J
MX?=RNMY')6//Q:*>>:?VS]EQQSSPB'W!VMW/VEO?O;W5QV_XSD8U^M;O;Y=O
MD\/;\3-2EO#X?#P:JWW&\CQ>;Y/R>WS[?<?X.6EL=O\ HWB)_P#@^\>"^(
M
M
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M1,1X=4Q-Y_=6F?%V U"Q4
M
M
M
M
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MS7S@
M
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MBN.FOP]-8U^%T@UPQ\
M
M
M
M
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M&7G
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M32?=8Z4F?9'QK5B+6F>FNLVF9G2)F9F'B;-7K@
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M<>>
M
M
M
M
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M</P]%HFU?I6IX7I/L\+5B=)B?9,/!V=O:
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MB?"8GV/]C\7\
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M,S,MG<5VWV]P<1'#[':;:8B(UQXJ4M.D:?&M$1:TZ>V;3,S\,R\'9V]H
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M&9GVO]C\7\
M
M
M
M
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M-736MHFMHUC6-8G28UB8F/I3J_8?&_(
M
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M+ZWA\/HUKXW\?'7)-Y^GI$1$A*/K!0
M
M
M
M
M
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M8F+5F(F)B8F-6,9,=\5[8LM9KEK,Q,3&DQ,>$Q,3XQ,3X3$^Q_L?B_@
M
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MC]SQFVP;;%I$=.+'3'&D:Z1I2(CPUG3Z&L_1>>L@?<
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M1$1$1$1#TYC+S@
M
M
M
M
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M7S>UKO>(W&'<[6T>%L=XM'[$Z3.DQXQ-9TF)B8F(F)>8LF>B
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M3'0
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MN]^Z>O%O]Y?%L;SK[G!]:QQ'^#/3/7>NOCIEO?QTG7PC22U&MKT
M
M
M
M
M
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M?':MZ3'MUBU9F)\/H2^5>H^D
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MQZ_EVSW>'W?U77AR4Z?^=U5C3^[H]@8@\H
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M]9KL,&'!68B)C'2M(F*ZZ1/3$>S6=/H:SH^*>T^L
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MF;3.LS/PM+;S>[SD-Q;=[_+ES[J\ZVODM:]YGVZS:TS,^/T9?5/*?,
M
M
M
M
M
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M/D-O7=[#+BS[6\:UOCM6])CVZQ:LS$^'T)?*O4?2
M                                ^OU3L+?M#^?^\;>-PTS[5^5^U/O4
MV;-:[]I?(_,_)?/_ &1>V?SGR?SDWPOB>]\/XM?N^SWJO;Y'*]O<!SWN_OYL
M=GO?==71[_#CS='5IU='O*VZ>KIKU:::],:^R'R[K8;'>]/RW#BS=.NG72M]
M-=-=.J)TUTC73VZ0Z7U?U#_/73*\)][GF?Y165KKL-I:X;#S]Z]E937+*RL;
M>FTLL?3K&6V2^UZ;&VEM13'';26M<%%%-/'%''%/'LUKRGIZ\A^9KG^^/9G:
M]\NXFULF2.,V=,UK6GJM?WV/#7+%[6UF;Q>+3,S,SXRQ[<]A]D[N+_*.(XV;
M9)F;6C;8HO,S.LSUUI%M9GQF8G7Z;H35?6M]4;3;B[N<1Y>;M>27L-$$U.U:
MOUGO5O11'7\2FJTM-WTC8;6PFYJ_\TD%$<E5/['FKGC[C7W*^BSTO\QCIBW?
M:.RI6DS,>XS[W:SK,:?&MMMSBM:/H1:9B)\8C5X6Y\H?+?=UBN7BL,1$Z_$O
MFQS_ '9QY*S/[$ZP]^P'U$OJ>8?$VF.R/976^UWEO\?XV?S_ $_I5OEK_P"-
M<S3Q_-PZO8ZW@J/E8I:88_@64/MBCIYK]^3FN2K =_\ -X^F3>;N^YV_&\EM
M<-M-,6+D-S..NE8B>F<]LV7XTQ-IZLEOC3/3I72L>'G\AO+G+EG)CV^XQ4G3
MXM<^2:QX:>'7-[>/MG6T^,^&D:1'16'^J)\Y(,G9RY_I/Q1R>&HFXJR%AA]6
M[>P>3NK?V<^V*SRU[W/L-K83<U>SGBNNRN:>../9[GW?;QKO>?-@>1]]M>FP
MYKNO%O)CXELF?89:5GZ-L=>.Q6M'THR4GZ;P,OIP[-G',8-YR=<NGA-KX+1$
M_3K&WK,_L=4?LO<M7^JH[/M,A-)NOAUH>P8JJSDHM[/5^W=AT_(19#F>WJBN
M9LGEM(WBVGLZ+:F6BJ"FTCKJKKHKXFIXHYHDP?E/FL>V,NWBO"]X;_;[KKB9
MMGV&+<4FFDZUBF/<[:8M,],Q:<DQ$1,=$S:)KXVY]-/'6I$;/EL],NOC-\%;
MQIX^&E<F.8G73QZI^&-/'6/<]5^JJZYN[>ZJW;PUW;7KJB:BFQAU7N3!;C;W
M%OS1[9);JYR_7^BR6<U,GW*8Z(IZ:J?N\U\<_L6#\K\UAW'AR4CA.\MEN,4Q
M/5.?C\NWF)U\(K7'NMU%HT]LS:LQ/AI/M>-N?33R%+1\CY;#DKIX]>"V.8GZ
M45RY-?V=8_8>S:O]4=X9W>/FDW7H7R<U_*TWDE%O9ZOB^J]PQ\N/X@MZHKF;
M)Y;L[1[F"\KN:I:*H*;22BFBBBOB:KFOFB/#>4^:^\Y,6XBO"\]VSN-KT1,V
MSWWVWO%]9UK%,>RW,36(Z9BTY(F9F8Z(BL3;R=SZ;^[:WB-GO>.OBT\9O.:D
MZ^/AI7#DB8TT\>J/AC3PUGVS ?4F>F[F,3:9'(S=\ZI>7'Q_C8#/]6VMQEK#
MX-S-!'\W-J^V;)@J_FHHJ9H_@7LWLBDIXK]R3BN.G"M_\V_ZC]GN[[;;UX'=
M8:Z:9<6]M&.VM8F>F,^##E^+,S6>K'7XT3TZUTM/CY_3]Y@8LLX\<;++2-/C
M5S3%9\-?#KI2WA[)UK'C'AK&DS[!@/J /2IS&)M,ED?(S,:I>7/Q_C8#/])=
MZ7.6L/@W,T$?S<VK]<[)@J_FHHJ9H_@7LWLBDIXK]R3BN.G$-_Z!/51L]W?;
M;?MW#NL-=-,N+DN,C';6L3/3&?=X<OQ9F:SU8Z_&B>G6NEI\K/Y'>9>++./'
ML*9:1I\:NXV\5GPU\.O+2WA[)UK'C'AK&DS[!@/69],/9,3:9K'>8/6]O9WO
MQ_@PY_'[KJF6H^7N9K23YO ;1JN'SMA[TL%7,?Q[:/XL7-,E'O1UT558?O\
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MB(B(B(T>[CQTQ4KBQ5BN*L1$1$:1$1X1$1'A$1'A$1['^-^S^@
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M?=9(G6(O:9K7X/B4\*4U^&*5B)]OM>_,!>&
M
M
M
M
M
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M(W#Q7-\/SFW^5<-NL&ZP:1K.*];Z:^R+169FL^$_%M$3$Q,3&L2\E98],
M
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M4Q,/ER]N=O9\<X<^PV5\5HTFML&*8F/H3$UTEZ?_ 'A?GW^?%Y@?_/+]T?\
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M4?YJ_P#N?,?R@?U)^6/X,_\ ,;O^'/[^WU8_SK?^A?C9_P!G3]0WTH_S5_\
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MA_M1T_\ S38G_3C^SH]-7\5YC[?R?O3^H+R\_P GN_L]OVC]8X]3#_:CI_\
MFFQ/^G']G1Z:OXKS'V_D_>G]07EY_D]W]GM^T\KR/K[>J[>Y"^O+;R=L\1;W
M=Y<W-OB<=T?X]RX_&0SS5RQ8ZQDRW5>3RDEG91U\1Q57-S<7'-%/',DLE?MK
MYRK;^@CTJ8=O3#D[9OFR4I6LY+\ERT7O,1$3>T8]]2D6M/C:*4I369Z:UC2(
M]+'Y(^65*5I;CIO:(B)M.XW6LZ?#/3FBNL^V=(B/H1$>#_'_ ']OJQ_G6_\
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M:-3L7
M
M
M
M
M
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M$[\[.[BF*</R.VRYK::4FW1DG68B/K62*9/;,1]3[9B/;,.,VY&6@
M
M
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M&@
M
M
M
M
M
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M>N2DS[=.JDS'LF/A^%\2]I]8
M
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M]F8:\D
M
M
M
M
M
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M,PV%BS8L^.,V"U;XK1K%JS$Q,?1B8\)?FOI?H
M
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MS]&9GQE^D^9^8
M
M
M
M
M
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MC$MBX,^#<XHS[:],F&VNEJS%JSI.DZ3&L3I,3$_3C1^0^M^H
M
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M.5[@YWG;^\YG>;G=6UUCWN2]XCVS\6MIFM8CJMI%8B(UF(B(E[8PIXX
M
M
M
M
M
M
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M)B8;*XKN3M[G(B>'WVTW,S$3ICRTO:-8U^-6)FU9T]L6B)CX8AX.SM[0
M
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M)::1]3[,>O1'C6LSI6-9B)GQ\72#7#'P
M
M
M
M
M
M
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MH\Q9,]$
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MRWR3'[$WM9ZHQ9Y@
M
M
M
M
M
M
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ML3$QX3$QXQ,>$PRFMJWK%JS$UF-8F/9,?1A_%_;_ $
M
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MM-?'V].NFD>R(B.S6FV)
M
M
M
M
M
M
M                      /*^Q^BND>XX9;;MWISJOM2WGL[3'30=C]>ZCO$
M,V/L,A5EK"QEBV;$92B2SLLI7S<PQ<\<T1W'/,E/'%?/M93VYWSWMV?>,G:/
M,<KQ62M[7B=GN\^VF+WI[NUHG#DI,6M3XEK>V:?%F9CP>GQ_-<QQ,Q;B]WN=
MM:)F=<66^/QF.F9^):/&:^$S\,>'L<!=F^B?Z8?:GSLV7\4M/U?(W7V[+;Y+
MK+.[KUA]F7N?]VN:]LL+HVRX/5I?LR>.F2PM;JPN<?9^[S'';\0UR1U[\[9]
M:GJ;[6Z*;/NK>;K;U]U$TWN+;;WKKB]E;9-SARYXZXF8RWIEIER:]5LDWBMH
MS?CO-_S&XW2,7)Y<F..G6,U<>;6*_!-LE+7\8\+3%HM;VS;6(F.">POIAO![
M8J[V\T#M3R*ZXO;F:RJML?+L6C;EJV.MX+>*"[BM\?E=%LMGFFOJXN9N9)LU
M+3'+)5[M'P_<CHWSV]\YOYW<=6F'G^*[=Y'#6+:WC#N=OGO,S,UF;TW-L,16
M)Z=*[:LS6(UGJUM.;;#U%]XX(BF^VVPW%(B=9Z<F.\S,ZQK-<DT\/9I&.-8B
M/'769X#[*^E<[7Q]%S+T]Y;]>[;)S#<RV=AV5UOLG7E$=Q\Q_F=C<Y;5\]VA
M5-#\KS[9;NFRCJ^)Q[*;?V<^VG?G;?SIG:NXM6G=_:7(;2NL1:VSWF'=S,:?
M&M&//BV6D]7LI.28T]N36/'../\ 4KQEYB.5XO/BC6-9Q9:9?#3QF*WKA^'V
M5ZI\/W3A3L?Z=#U-M'GEBUG1NJ^XHX[RTMJ+GKCMS6L7!/#<X^J\FR,5/;O\
M%ESQ9V%SQ\I-37'1<57'/',44D'MFXWGVY\XEZ9^;I%^3WW*\/::6MIO-AFO
M,3%^F*3\@^71U7CZY68F:13PM:M_B,SX_P ^_+O>1$[C-N=I.DSIEP7G32=-
M/K'OHUF/C1XZ:>V8MX.#^P_3-]07JWYNO<?#CR$AL\?9Y'(Y'+Z]UIL>\8#&
MX_$?%YR-]DMBT>SV/!8^SMHH:Y>99KBBBJ"GF6GGF/\ 9-[=O>I?T_\ ='17
MA^\>WYS9+TI3'EWF';9;WR:=%:8=S;#EO:9F*]-:3,6GIF(MX,UV'F'V+R6D
M;3EMA-[3$16V6F.TS;V1%<DTM,S[-(B?'P]KCC8]5V?3LG5A=NUS/:KF:(8;
MBO$['A\A@\G1;W''-4$]5AD[>UNJ89Z>.>:*N:/=JXX^YSRW%QW*<9S&VC>\
M1N<&ZV<S,1DPY*9::Q[8ZJ3:NL?#&NL,LV^YVV[Q^^VN2F7%KIU4M%HUCVQK
M$S#\)]S]@
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MI'5.LQ%)MTUB=(^+$1'A$::1#HIKMX(
M
M
M
M
M
M
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M6-;:S$::RRG:=Q]O<A%9V&_V6>+VZ:^[SXKZVUTZ8Z;3K.OAI'CJ\.9P]D
M
M   !Z_H/CUW[VK]D_P %_1W<'9'V]\]]A_>#UINFX?;/V7\Y]I_9/WO87(_:
M/V=]G7'Q_@^_\'X$GO\ L]RKV8ASWF#V#VK[W_>CG.'XWW'3[WY5O-MM_=]?
M3T>\][DIT=?73IZM.KJKIKU1KY6^YW@^,ZOOEO-IM^C3J][FQX^G733JZK1I
MKK&FOMUC3VNQ^O?1\]3+LZBRDUOPY[:QM.0AO9X..PK7!=1UQT6%Q+;3TWL?
M:^;TN3&S220\\PQW/$4ES'S3)#371535SI[N'U?>FGMFUZ\EWCQ.2<<UB?DE
MLN_B9M$6CIG8X]S%XB)^--.J*3K6\UM$Q&*;_P U?+SCIF-QRVUMTS$3[J;9
M_;&L:>YKDU^G,:Q$^$Z3$NS.O_IN?4FW*B"K8[#HWJ:J7&UWTD?8':E62KMK
MJFX@AIPT_/5>M]EQU9*2.6J7BJ.J2S^'%5QS/Q7S117IKG_G'O3?PUK1QV3G
M.6B,G3$[78]$6KI,^\CY=FV<]$3$5TF(R:VC2DUUM&);[U >7VTF8V]M[NM+
M:?6L.FL:?5?7KX?#X/'2VL_4Z:S';.E_2J]CWUO<5=B>96DZM=4PV%5I#I?3
M>=WVWGN)*)^<I%<7.<[ ZWDM8;.2F+B"NF*:JYIKJYKH@YHXXKTKS/SI_;F#
M)6.WNS=[NL4S;JG<<ABVLQ$3'1,5Q;7>1:;1U=43:L4F(B)OK,UP_=^I;CZ6
MCY!Q.;)76=?>9ZXYT\--(KBRZZ^.L:QIX:3;7P[>Z]^E^\,<#=TWO8G<WD)V
M%\"\CF@Q>-R6BZ/A+FTIBJIELLO';Z?G\[<_$EYXJXDM,C854\<>S[OW>6DN
MX/G._.7?XO<]O<-V_P ?U4F)O>FYW.2+:^%L<SN,6*-(\-,F++$^WP8=OO4;
MW;GKT;#:;#!K'C,QDR6B?HUUR5K'[%JV=O=>^A%Z7/7M%E+3XUP[KEK2&]@E
MS7878?9FTUY"B\N)9N*KW7YMNMM)^-9PR4PPR0XJ*2B..GGFKF7FN2O27</K
MJ]4'<%KUGN2=EM+S68Q[3:;+!%)K$1\7+&WG<Z6F)M:+9[1,S,:17IK&';_S
MI\R-_,Q/(3AQ3,3TXL6&FFD?!;HG)X^V8F\QK/T-(CNO0_#CQ'ZM]M76_B]X
M]Z)-7]E\SW>J=-]>8+(7<N%^+SB;F_R..UZWO\A>8^NXDJBGGDDFHKDKJXJ]
MZNKGG1G/><7FUW1X=Q]S]P;ZD=>E<_(;O+2L9-/>12E\LUI6^D1:M8BLQ$1I
MI$1&&;WNSNCDO_4.2W^:/'2+Y\MHCJ^JB(FTQ$3I&L1$1X1'P.D&N&/@
M
M
M
M
M
M
M
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M/=P<[P>ZZ/DN\VF3WFG1TYL=NKJ^IZ=+3U=6L:::ZZ^#R!E[U0
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MNFD::^S2-/8]@8@\H
M
M
M
M
M
M
M
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M)UODR6M>]I^C:UIFUI^G,S+Q<N;+GR3FSVM?+:=9M:9F9GZ,S/C+])\S\P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
2                    '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>sny-20221231_g7.gif
<TEXT>
begin 644 sny-20221231_g7.gif
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M\(L_^MUG^/C/C_[TJ[_YY;?W^M\/__C+O_CM%_?\[X____SK?_?U?_;^_P^
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M5+1A"R!%"4%7:;;\ 908))5K>Q\_Z4%O"[?OL9,FE+5UJQXZV4)>J[?E49.
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M=,7(C5P-CXQ7;"S)T$#)>V7)EZP,8$F*2/_)R<F@C(D%R*%,# ;*6*5LRKZ
MRI"ER*NL"\AX6:\,R[3 EI;HR;4L"[?\69FLRZP@EZ3ER[]L"L*X6KE,S*-@
MS*XURLD<"LLL6ZWLS)K@E[@ES=-,"=6\6]>,S8Z@S;_%R]WLS81I7.$LSHBP
MB\P5S.=L".3L7.O,SH#@SM$%S?',!_-<77AISWI0B]ZES_M,!_T<7M\,T&X@
MT.7%BP5MT+.X7@FMT&@ F>Z5S@]=!I99AOA,T5Q@T?>%T1EM!1NM7XKIT5@
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M=>@S=K9VFW6W][?2=B<X>;GY.7IZM/BXNOL[?'PB.WV]/8!\OO[_/C_U_3]
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MA__X)P#XF+K<_C"F0*N]..O-N_]@*(YD:9YHJJYLZ[YP+,]T;=]XWDI\[__
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M["5'>,4[WO3N#[[QC0Y^*=>K_-;$O<Q]K7\I"UV:"?B'^QUP9NT+Q_4J."4
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MZ":%^0,;_G.5KXOG)QQZRN%-4Z$_W>9'!VC)S_9RRZ*PZ="D>L*C'M.I?YV
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MQ1;;N-92VW9M2T1MZ0UK$2G)J#5JX;9BZ;87S39OYV]O,?)MW\9N[[9O_79
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MO^=K_RJC_VT^OYV"/Y'3/KI?OIZ;__E7/P5S?_?/?>@7/P'$Q]3E]H=13GK
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MIC_^!18__5'.HOOK_Y3SWS]^[>]_ 2B M]5_ \A>!6B ":B /06 "YAB#>B
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M[_)6V/(QWRLP3_-*J/(WG^\YK_.L.?,]3U,\#_0R*/1#O_ _;_026/1)'_$
MS_01N/1/O^TV+_7/B?15'[A1C_4*J/5;W_%=[_7^!_9A?S9U1/;6>?5GSQY8
MH_8!2/5M_^]I#_?%]_9S7_!C;_?,5_=Y?_1RS_>J9_9_/^Q[+_C(%_B%O_.$
MC_B[=_B+'_=^[_C_=M?XD7_W>$_YA#?YE]_WD*_Y4<?VG3_XB@_ZDI_YH]_T
M!F_ZGE_ZJ3_UJ\_Z7??YKY_XKB_[11?[M?_XG(_[]W;[NU_YEN_[#-?[P;_Y
MND_\T%9MQ]_NP*_\Y9;\S1_ZM _]Z/;\TS_[TF_]TU;]V9_[QL_](XK]WY_R
MVR_^R#_\Y7_Z#(_^*DK^ZU_\S._^>J8@\1_HHD__A#;_][_\]J__!! ?4Y?;
M'T8Y:;479[UY]Q\,Q9$L2P!-U95MW1>.Y9FN;=3,]9WO_1\8% Z)1>,1F50N
MF4WG$QJ53JE5ZQ6;-=ZX7>\7' 9HR67S&9U6K]EM]QL>E\_I=?L=G]?O__DB
M\1\P4-"EK]#P$#%1<9&QT?$1,E)RDM)D\!(SDZN2L]/S$S14=)2TU/04-55U
M%5'3]16657:6MM;V%C=7=Y>W%P06./C2E[C8^!@Y67F9N=GY&5I)>)JZ*_H:
M.UM[F[O;^QL<HGJ<7";\'#U=?9V]W?T=/OZIG+Y^3!X_7W^?O]__'Y<]@>0
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MNC^G(1311!5ETM \%WT4TDA#:W0B22V]%%,A**4FTTX]_?2M33\"E=12395
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M_O9&^Y9P[4]P 5>-_PXW10N7<:M <:-%BAYW2AN7<JU <D?%AB[7;"J7<Z]
M<V\EA#[773N7=/M/="LE@4[W5$N7=0=(=3E%?EX76UN7=BU7=L>A>VXW8VN7
M=]U/=P'E=WX797N7>+5 >)U$A(X7:8N7>9M+>:ND<9X7;)N7>M- >CUB;JX7
M;JN7>ZM+>UD"\KX7;[N7?!E%?.5#9LX7<LN7?4=2?8NBD=Z76-J7?N5 ?C?#
M8NY75>J7?^= ?P^#6OYW3?J7@/U7@%MC5@X8>0N8@>M @<$C4A[82!J8@O%
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>T9*VM*8]+6I3J]K5LK:UKGTM;&,KV]G2-HH%   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>sny-20221231_g8.gif
<TEXT>
begin 644 sny-20221231_g8.gif
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M^MF:AN"?:\F?BA.@8!@,!4J( THX"-J#[,"@!JJ@?/.@'1@1$_J#$6HW%EJ
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MZW(&QM(NG2 N\Y(O3V O^W*=OA(P!Q,&_I(P]9(N#U,Q20 O%Q,(#-,Q(S,
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MM= T=K;V-G>W]W>?M?@X>1/X.7JZ^CK[:3EY>[S\/'V]W/NXO?[_/G^__S]
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M^>GS%[WT.E"O/OSKH!]_T?/3?W]Y[#]A0OCX^[]@^?YW./L)L(#(T1\*^F?
M!3J#@ PLF0,?*,'8(#"![YL@!G$1P0Q*;(,<_.!F*FA!U8&PA,.@G FSYL$4
MLK P(ASA<%HHPUJL<(;R0J$-<XB;%\*P-SK\_Z$[< C$G-5PB$8\%OM:H, C
M,E$00FRBRHH(Q2DJA8<I6"(5LWB/)VI1;0'L(A@%8\4K7C",9DP#%\^H,"FJ
ML8V[2N(+L.C&.6(AC73<%QOOJ$>)C)%P9=PC(%EVGT NS(Z$/*1.^NA'$B*R
MD5,PI".WE<=(4C(>BEQD#"NI21M,<I.!ZJ0G0[F-2V+2AZ(\)0M B<HX07*5
MKLP.'%7RQU?2TE>#K*6U5(G+7=(PEK)D)"^#^:\O"E-7NBPF,DM!RE3.,IFX
M/*8SE=3*:%)S&LMD)C"K6<UI:G-2W.PF.(EQ36QF,IS;_*8YQX7.=#I1<>Q\
MF2\YV<QW:A*:](3>+?_OR1MSZ-,!XU3B//OIR'4*M$T$+:@:9H30?P(TFPAU
MI3T?JJ&(2M1]H! H0QM:SHK2\J <U9)'/UI'5N@SHQHUI4@A2LR4TBFD+)6"
M+]YITI/:YJ6KI*A- X33G+[K(N&<*4UKP]-3NG2H/"JJ465PFW-^;SH!36H8
MD0I5&$EUJBLP"#6!JHJG6C6+.^VJ>:H*UA,4Q)E:W:I#Q[I'L:J50VQMZ^T<
M@LRSHG6C< 7D6^_J/?CH528@$29=ZXK2ONKQJX0=U$H/JU21\#*P@JVI8@N;
MV,A2=;*4O2I/GAG/D:;ULEW,JV?79]G0DE4QKW1L'+E*6A8:=K7)&:UKI^?_
M$Y4VM0MRC*T-08O;H<%VMXMK"BI1"X/;^I:UO2TNA'1;7+F$4KC#52UR,:C<
MZ'+GN-1]&',WZ=SG=O:Z.IRN=Z$#WMC&1;N;M2UTP[O \:K7/]9M+Z?@4LGM
MQH"X\)W@>^_K'O:2%C&1I&]]TZM?__%WP*_-IX%_EI>!GO<+]DUP 0L,X==(
M^+*0022 %]O="7\POQRNKH<3?)E#9EC#=OUP"BN,XLZH.+*?"62)33S8%9NP
MQ33.C(T)"QJ\-AA2&[[Q T,,9/<B>,@*.(UD:^N&!QLY?3ENLF&>W%<DTS'&
M-& RE,4GY2R+4<@#%JH;K7QE 7/Y>5XN,P7/?%\P_ZM1S&/^,9KOM^4XVT7-
M\(7L&=W\YA/3.<)V[K-HYMS6&6M1SWLF-* %^.=$AW#1X47T% U]:#PSVL]%
MKO1O'/UH2GNUQV_ ,J:#)^A0BV748^5S$R5= U"3NG>:;G647TU=..?6TU<C
M,ZQ99^I<3T76LT;U$%4M3UKSVLR^+O9==@U68AM7R>' -;)A=^EHB^W8R&5V
MC6V]16Q3&WC6[G9;ONU;:!-8V]L&-KBKI^QT!T7<NR6WG,U];DBS6]W3KC=E
MUFU5>,=/V%!@-;XYY^Z F^C>6>:W^OS];X03_&_Z;OCN# YEAH]/X0OG-L3/
M)_&,=WGC1J9X]RQ^<71S7/]W R_Y4AX^59!G3^0CIS?*<Z?RF-O'XQ_'^'KE
MS0> =TE_/J?YSD\.]'8+G;PXM_3P)L%S8_B\Z5T;^I)M#G7P%-VU+'>>RV%Z
M]5<XO>M(F#K'^ IVUDA]R%L_7M:U?G2F>[WM#AN[(JH.]XB+/=%G][;._[#T
M7KJ][U^?N]GJ#OAPRWVU=S=YW@&Q=F'XO?'^&OP5"@_YDDB^OXN'7]JK</E;
M.+[SCY^\V@4/>K)4/K2'EUWF-4_R9WB^]7\??11*#WN*S'S?FZ]XXML)\P:Z
MOO<>FWW=U /\L<C>LZ=?7>J=NGMD^+[Y/AN^C,,#_:X4W\*WYU[RE<_IGCN_
M^WO_FWZ 10]^597]YJM7=.X)<?U4>+_]3Q\_.:4/?ZG4WO;G+[>S-[%\<;J_
M_^Z<?REI!P"2G_@!VO%U3O;9P?8U@_\U8.8,8 #N'01F1/59W_W13P(J()NQ
MG@-V(/%,(/^4'P@^A@B:W?HA3P9J8&MPGP=ZX B"3PF^X!L5H &>H*BEGR1L
M(.^U( _*H&P)GP\F4@P"V0%&3@IN@0XR'P\N81#&%0TV(0D^(9T58>,<(1)2
M&0<N(1-"(=]((1?.(!"2&A4:CA4&WHAEH19NX1?"TQ"N8414H/'9X.R4H1E>
M&!JF80^Z(0; H1Y>3!B&VA@Z' YBPHO=(1ZV8!\JF/PE_R)3M.&-!2+S#"(A
MGB$#'B(>,F)/_2$FUIP73J$<(I\D?D1B0(,E7N(F2@ ?GF(E=F*<0>+<T&&,
MC.(.EJ(6JF*KL*(M)D0J4I8KO@TL^EAY&2(MNF NBHXC%F,]["(O?B+H_"(:
M!>,L#J,:(N.1'",U6I(UTE@OEHTS/J-\":,T=N U'EDVCJ,Z**.+,:/E=&-"
MG04IAJ,IFB-SE*,\G@,Z*M8V@@T[AIU5L" \(F(]SJ,F!N0_W",^JJ,1AF(0
M784__J,X!J1!$N1"#B0@(F05*B0J,.0[.F0MUF-$2J0RT2.*Y6/5[..G&84T
M<&0:0J1(@B0VM.2'D634F.2M9?]62JKD-)KC1[HD)^SDE%FDX-!D'-AD0^*D
M [(D+O(D.OBD7LEDT@CEO,F5-1EE3EXC4RKE)5PE7#EE_6 DWTGE5%(E0'ID
M4F)E0\!D3 +EW4#E5Q#$*(GE6,JC5IIE(LSEH*GE*WHE, R$:< E,9)E6=*E
M'RXBKW&ESK"E'[P# /GE0\HE6@HFXP5F*^)EVB"FXEG#63)F8SHF14(F.-CE
M75Z@QN7?.<;4-VCF7W)F9WKF8JYF18JFM)&F_"S'9Z+F42*E:[+F8 I@M!EF
MS%CFGQQ%.MCF;>(F;^JF/4KF9,*FP.GE2S;(;!)G_TDD:")G6RHGFOEFR@"G
M)>@%-DK_I_M1YV-:)RQ4IUII)P0Y9W+^'CV YW2*9VZ2)S@RIR?2I^^HYXNX
M9WC")V'*9S:,9UK:YP#A9W[JI_>!I'GZ9]1A9W92IM1P)W88Z('R9W\JZ$;&
M)Z:A9\9 :(1*J/.Y)(!:Z"B$*(=IZ-80J(UXZ(<B*(.*Z"R0Z(29:,1P*(BI
M:.^!*(RZZ"2V:)G)Z!JAZ(W8J._Q9([J:'?R:(\Z:%?*YIH(Z8WB*(8:J2T4
MJ8@I:=#0Z)TX:>L1*95*:5TB*9?YJ,!@:99J:>=Q*9AZ*8%TZ9=9*1$!Z5&9
MZ9FB:86JJ0:EZ<&Y:<V0Z7?(Z9Q":9W:Z93BZ<3IZ6_":8_X_ZGC*66""JKV
M!6JQB:F]\&G^**K?826;.JK>9:I^2>H-(2J06.JE,BJA:NH^06JD&JK)4&I8
MB:K;86JIFFH.QJKY[1_=L&JKNJK7P2JMRNK1]"H1JFK(X&JNZJK3F26G^FI4
M2F"P"JC6$&NQ&NO/\2JJ*BLI)&NG"NN&@FJ22&O7(2NP6NME1FFK>:JX0.MY
M>.NQ4FNUBJO^8>N::6L'<:LTJ>NTLBNSNFO0D6NYRFLAT6N]VBO @B"\ZBLP
M'F>]F6NVH"M[""S#%F;!&JR#A6NSVJH^#FS .FSM"&;$2FP=(BR[*:RT/&S#
M:FS2T67'>JP6I*QZB>RRD&S)FNSI</\LQ:KL@K9KJCKKDI[LM,CLS*(LR]JL
MZO%KO^KLE6+LD_CLSP(MT0JM[N$LQ!KM82)MTBIMXD!FT#IM[-5LQ2Y@V,"L
MG%BMWF MUVHM&&2M=[ELL(!MV(HMUY!MV9HM>C6M&/IKO;!MV[IMSW@FVLKM
MJL7MBJEMKN!MWNIMQ_ MX/HM9T%MSEKLSFYLK!ANTR NW2KNLMIMRV)NNA#N
M?$CNWL)MY5KN289NAFINN7!NYWKNX5(NXXHNAB3N2)INN*!NZJINO[!FW[IN
M_.5KH4IM>C(IJMANP^ N[.IN#N3N=0ENJM#NS AON^@F\AIO:9%NZ?KNQC!O
M\SIOLT!O\4K_[]]2;Z4I+ZE@;_9J[ZIP+_AZ[\>*[UVQ[Z>0;_F:;Z*@;^NJ
MKS?6;]0Z[LK ;_S*[YD@9_3:;^K@;ZZY[Z7P;_^N8'3JKVJ"K  /9?<&* /_
M+L\6BP&/[@2/8P _, =L<'1=\*,@<'V \%_(+O!Y, >S(0$7L E;,-6V5 N?
MJM>":_JF<.@Y,,&1L*&(\'[H,#_.,+[ZL/2B\'+%L#&]<)T(\?T",:G6L V_
MG!*OG!'C"@^+EO6>T!2#'A$_,2I&<.Q><<!4L15G<#0F(>CR+A<_5A1#U1JS
M$A*;3A8')QB?XA:GL3]YL00SL<B(<7^T\<3.\2;6L1UCB1.';QP'_^\;]XD?
MQQT@8Z(@#W(U%C*C+?*\)+(B'[(A4'+CHC$D3^\*YZ\>;ROPOBPF_RH9ZR0>
M=[+72++=E;*G\/& :/(5-K(CI[(J[R$KMS(MGZXE?Y(K#X(LLW NW[(GXS#$
M!?.4P/*!(//BAG(3&S,Q/Y(ME^@O2XHR+W,U!P(S%^TG1[,:9[/5@?.A7#,V
M[_)7.C.=0K,W'^\PUZ YYU(O[[ X)^8\3]TC0_(T4_,[CVP\R_,^R\(V<S,G
MK_/DM'.?!720D'."(+1?_;,>WG,:0S1N,72<CO+LUO.^GG(##S1!X[)!UZ=&
M;VX_-PI%W[ 9$^]'=_0JJW/#E72*CC1)8__T=88T*G>S2L-@2B\G35^T1?.R
M0Y>G3$-=/M_T 4CT1 <UFRBTA+@T%"NP?QHU!T-U./_TX,)T""/UZU+U&DJU
M  ^U/N\T//>T2&LU^V$UT'GU3:,UA#$UBBBUA;"U(*%S$),U41-R3NNT7(]U
M!8^I64,P77,A5WMO8%O>7Y^*6U\(7 =?7J<S1]?U'=LTLB7VAAPV8O=U38*U
M!M^U8S\V2Q^S94L)95=V88?D:#>A6GOS8!,V9KNP6-_M9]_L8C.V9#_U:5=I
M:1^P5;_O:Y?P;?M@:HON;\=A;UMS;NOV</?D;I=<;=_R<AO8;"=7<1OW:@?#
M<X-T8V]V)'>V9Q__]SA'MW3']GP6HH@V-SZ3=[9R=Z&$]HA4=_0YM84&M]S"
MMP5.-ZVH]WHG]P^?M'7*M]::]WG3-ZS8]WVCMR@2.,%J-G87-8+CM7Y+DG>/
M+WZWHX%/H']S<87?68175FL;#'N''X C(W_;;(BGXX2[\89S>(8?;(,#\(5'
M=8MG;HD;U(,C<HS+\(JS.&0G^+/D>&^F>(H(^(_[^-D*>0XO^&:_.(Q_^'<O
M;101.2,K>3$BN?U*>=HZN5O-^*MT.'=!>2Z.N,%Z^4'6.)@ .3YQ^8M:.;Y1
MN?&J>?*B^5MC>8"[^<K*>;JQN>O:^0?3.72?^(F*^:SZ^?SAN>4*>A$#_WHR
MPWGDZGGD*3JU$7I\._J[,7HL(WJB&_HA:#F#8SJ@:C?':7IWD/E+6WHF2WJ/
M\[B.VS6G=SJICS'D'JVHFS)XTW"JGSIVF7JIF[DZ\?GUKKI)N[>.0KK3 OM1
MOWI"4SH5\_K6$COT@;FO,GN8X_HEZ_JP(GM38Z&4"KO'8KO1*3N4&'M5<[LV
M4[LPSSJM=[&MWWJLO[*W?SNT S6XG["1$[2V3W6[F_A>&XVG[ZZO_WJ\K_.\
M&YZX5ZJTKVK *_:-DZ>S.VK"'U:^$]F]/V7!#UN]J^*_6VO%JW:Z$_? ;V?$
M?^_$TW&_$_/%FU['6P>H=VO)_]+'!W+(,W?+-__HN[?UNK/VRD]DQL]US;O\
MN:/[P2\YYGQMRK>WM7OIR&OJPC-\T!_'R2])PT?@T%_[RP]RT0MWSA_ZQLM,
MTY-1S,/[SF/WU,_WS?ORU6-]TF]YV#_S=4?SUR_CUD_4S)-RVV?TV<MVW$OL
MVI-XU3/]V\-]WH]HV4]RU$=TX(?IW^?&TEM]WZ]IW8_>W1MIXS_[W-M[JU=F
MX0?5TT-]U]?UXR/]XB_TWO-SYV=UXC_TX-OPYNM8Y</&X8-4ZF-6Z$/>Z;]W
MZ>?IZ^O4YU=+UO=0S]-VYJ?U[/?NZ./(ZF])[A?S[LMG["/_[P-_Y%?RV#_N
M\=]D[0]>\B/\\C=9\7/_QO!S2?;C=/"[8?7O]_77:O/3SNUK2_=;U/>#?^]W
M=/AO9>L'VOFC?_QK_?IO]?BO>?YW;?030'Q,76Y_&.6DU5Z<]>;==R 41[(T
M3S155[9UTR^69[JV;SS7=[Z77V!0. 3XC,<<4;ED%I%/:%0ZI5:M5VQ6N^5V
M)TUP..@EE\UG=%J]9K?=;Z]8/D?![7=\7K_G]]MT0#&_0<)"KD#$1$%#QD;'
MQT-%22!(M\G+EDK-3<Y.ST]0/,Q1EU#34]14U5761])7E5;96=I:VU#8W)!;
MWEXH76!)WV'B8H_@5V,?9%)EYV?H:&E-9MWI:^QL[6WN@.K<[G#Q<7*][\OR
M_W39<_8E]7?XMW;%^(KYQ/I\_7U^T_O)?@$%#B0H\!_ @@D5+M1V$!!#B&L<
M3JP3T>)%"!3E1-2X".-'D"%%(NCX<.1)E"E5:BE)9^5+F#&WM&PBT^8/FA1O
M[BR7TQU$GTIX#B5:%%50,$:5+F7*$2F3IE&E*GTJ9*K4JO>N;K65E1)0KZ6X
MCB5;]E=8JV;5KF6K"FW:MG'EPGO+8F[,NM7N[C64-Q98OR?X#B;<-G"FPHD5
M+[YRV"YCR)%7.38A^2)E<)8UQ\$\PFGG79M%C_X(NC)IU*E5>S-=8O5KV!);
MQ^;7&A-MW$EF P:=V_?O:;9) "=>/*IPS\:5+Z=AF_^Y..3"GD_/N)NA<^K9
MM4.*'GK[=_ #NX<G#QY[>6?=\:'/?GZA>_;QY4>*/M_^?6CJ\>^/#9__.O4"
M^:\X_PHJ<$ $$P1A/ 4;=' 3_1Z4D+ #)^0D0 $M?*U"@ZS3\$,0&01Q1!+3
MB+!$%*?B,,5!,#2)1<U6[$=&&&LT3T0;<]11AQ-W]'$E&G_\P\4YA%PL2'V0
M-'))V'ID\DDH&\ Q2BH34K+*F8C<",NYKHS'2R[#',Q),<NTD4PSTR0'3#6?
MT'++-LMB4YTYX[03JRGOU--!-/?T4YDZ_[3A38\$/<Y#A0(U=-&7\F3TT?+Z
MA'12MQ"E=!E"D[K4*$7'Z73_4U 3K2]44IF3M%14&_DTU0<RU915F5;M1E98
M:UW345MSC7%477OE@]9>7:W)5Y6 ;<A28I/-YU1EFXT+5V>CY<PT:3$0%JIJ
M03(VFVVS];927K\5=RMFQS474VK/=>#:G]1]#UF"NG5W7D>@I??>8NW%=]]C
MX'677:'X%<_?#M,5^.#)PD5X88S*9?CA=0DV%V B(-Y'WN DMGCC%O7E^.-W
M' ;98HQ#I7B(D>G2N+:54W:9#9%?ECECY&9^N>1-3X;+YG!PSJ]EGH-FR6.A
MBQZ&:*/O]7E2G<=(>INETP/Z::J/B+EJK$^Y.NMOHV:TZ:^XEL9K8\@6^^P$
MD$9[_VWNU&8[6K/_!/N%MY^)^^BIZ];[ K?W]CN/K?_6]6X]YQ9+<%\([T5Q
MQ(,.O''(S^@[<E@9;]-PQ"CO*N\O.=>\\<<_%[TQA4<GUO(T,7_,=  -?M=U
MUED//7;:C9B\=J8]MU7U%7!G!?5:@/<=X=N'-[Z&V8_W4W@N>?]+>7]TIU-Z
MZ*LNOGKL,T@^^\NI1]5Y&+C_A/G6>Q-?\.W/5W^!]-=OWGM2P:_(?6K@]]1^
M^E-N/W_UK^?_?=C!37ZG^9\K\->S Q:09/Y3X/D8V, GD2^" W0-!%650&Y(
MT(*^>N &H==!#_I(@T:B8 5#2(@1@LM\)WP:"%E8N_V]L/]&*11A"9,CPS[0
M\"@8Q.&\7-C#T<40B"7288YL>,,A HZ'QPI@$O7W0R="#HI1U% 19WA$[U#1
M#E;$Q1*U6"TA?O%O4Q0CG[Q8."PZH8SR..,UN+C&.X41CF\CXQP']$8BIM&.
MEF@CS5:XQX?5$9!9$^0@[8/'$:51C89$ R([X4A&8JF0D2R:'"DY'TA:2)&7
M;&0?Q^9)3IJL=*&,G"5)&2E0BFF3IR1#)NO71%:.RY2QO-DH::G)5 +PB+?L
M@BLKX4M>7M&6P63;)(EIJEQ6:97'Q (P#0A+9CK+F-%<V#2I"1QGWE&/U[1"
M-B\(36YR<)CAI)HUR4D;;^YGF>?_C$(Z^Y),=I;)G/$\URSIB1MW'G*;]W03
M/,OF3WY2:9X!]98]";J:?,IGG0?M04([!DZ&@LJ@$2WH."FZ'8>B9Z$7U0U$
M9P10CM;0HB&%V$!)>B20[FBC)T5>2A/G4I;"R*0QK=5,:<J7C(9GI3>-04Y_
M!5.>DLBF08W?2(GJ&Y]B=)]'Q8E'6>94IG:O9E&MYE"I:I:DMF>I5UT05),$
M5*Z:<:IAW==$R?HLL.81BV?MEU>7E5:V_L>L<8645>F*)[?&<:MWM4!6E9A7
MOI+0KH%5TV )RRFX?FBGAZT.8%7F6,;JR+"1U:5?*=LYR)IIL9=E@&7OX%G.
M0F:RH872_VA)VZC$3FBSIR5):LO7&=8*U*BQ+>IL:7L7T/YFM;?-+1LS>]LJ
MVA:XE)KK<'?26WSNU;@'0.Z0?KM<L8X5NM\3[G2QZEH%[1:XS849=JV+5--^
M5ZC5%2]7N(M0Y5KWO&I8;WFO$E[W!E>Z\95+>TFCW>':5W+>I>^&R-O?U/T7
MP$O1[V;PFU_^JA"V U:K<!A<5P$_F"@%MLR!$?S<6V%8PAJ-\(9+"U\/?U7#
M0K+PA?\HJA&'^#O%5;%\Y]MB%248D^EU+X5;*6,8H[3#.5;ICGF<KQ1+EL8U
MQK'6BOQC"OD8R3)5\I)%8F/%E'BY4.[ED9V,VR9?>;POUO*$K?]\H[5ZF,KT
M.7&7]<EE,S,)Q&F&VI>5&F8QN]D38V;S=;)<9PFM&<]NE#-UI#Q=.@\MR'ON
MSYT)G2 6'WIZ@T;1GP'=YPM!6M%-2?2DP>Q@2\=*TLIQ]*,9S<0R9UH[>A8U
M.@U=:A&'6I)#9G"@L^!J5->#U+%&+YII79I-$Z?3ZLUUVSY]Z\C,&MCW/?6P
MTP'KZ\(YQ\CN9J^-C5I;/SNZS)9VEGZM6E9+F-I4V':U0=UM;^,ZVN&.E[--
MK6P>@[N=YB9W2(3=[B@7&][?QDR8=EU>=9_EVO.NK[SYC4U___N3^\YNMN-,
M\(&K6N"I>??"NQ1PATL-X=I$-Y+SW<__B4?<O!#7>*TQW?& 7+PH]XZOR*W&
M;I ;B.,I)_:X6=X3E+=\EV8VN>UB_O*/NASGTVGXSM^9\?N0G+XU1Y?"?1YO
MG1^=TRM7>BN(KNF*7_GI/)AZT\?7<ZL3F.E95W"]U6SP9=\<A6+G^K&W7O:]
M8!WMHB"[:,$>=J!+W.AK[W?2Z>Y?N]\=4&W7\<SQ7'4>\5WO]([[X->B=L-W
MM_#D$7JK!;\'P">^$(B7/) _7GD_+EBD?M]SY''@><S_-.^AEPSE27_CQ:_X
M[19_O#E:?_IBF![VXK[\[/^9^E&OGO6XQQOO;8_BVO_>P&<7_D/GGDC=[_[X
M3UU^\1$[>N=C_QGZT3>R[Y$9]<Z_GNW6IS[S0=]]"!$?_-MO/K:QGWWNW^+[
MX]_O]-F?[."_W^G:/WSRG;S^YM!?_CMT__XWWG__>Z;RF[82BC7\FX$##,!7
M$S\%1 G9:T"JTS^R:#P82\">DD (C#0 S$"MVT .] ,+##G[T[(0;*L!_$!M
M84 4M(@'7,%!P<#W&D$2A$'G.D$79$$5O,'7B3\=?"4;Y \*3#<:5+P?[$'@
M*T$C-(,63$(3U+P0D<$N0T(.D$(F_+P<K$(1]$ LK$$G=#$;>C8JU( PW$($
MO$(R3+4Q1+LTS##. [8U[*LA/,//,D,YQ"P>K,,<BL.1@\(T>T-[T/]#/.1"
M0 S$7Z)#0MP!/\P@/NS#06R_(CS$QTI$2(S .YS$.4P_U0A"J6M$)>1$2T2]
M2OS$DUA"49023X0)3=Q$3 R>4RQ%00M%5TQ!+8Q%TEG%T4A%57Q$L[-%6N0_
M6.Q%')Q%8)P"2<R\ FRW8HR 9!Q& R!%9@0%9QS&9;2;140_780Y7GS&.3-$
M;;R]7^Q&:[O&W#L_,&S%*LM&</3!:4S'+^!&=OQ#=&0,7*0Y<R2S+GQ';%Q'
M?&P5=]Q'9:Q'66Q#9 3(5[Q'?T0@83S(-OM&A90"?7PI<JRVAV0?@FS(EDI(
MBS3&>,Q(YJK(SQ!(>)M(!1#)6(Q&CH2\?CS_R;3Q2#N+2&\CR=;:2)7\*X:<
M282L29M$1)8\PF-T.)CL2)G,23@P2:'T+9PLRAOXR=^I1E%32M8(2J0D0J?$
M1Z+LQ:GTQ2_L.*>\RDE,R:@L1(S\2K[9R8%QR8&$RNH31[%,2[)<RS(\2K>\
M0+2L/[,\2[6$CK:,RX@)2[V</[CLRRG,RXMA2@,4S'6;2\"T1\-,3#CD2\8T
M1<2<0,(LS,B\NLI\S&9S3,R$1J_,2:Y\I,FDS+N\28/<3+_\2]-\K<64O\\,
MO[KDMZU<3<:LRM3DMLZTR=8$2Y $N=B\S-K4-]3\S:[S3:J433;,2I_KS=$4
MSK$+3N9D2^,<O]RL_Y?0=,/H++K2?,[H<4[MY$SN[,Z5)$ZJJ$[K%$]U]#KP
M3 7:3$]*G,YY<\_)(\_R7$Y%-$_V3,K;O,]S_,[[A$_C0\ZF4\[LU,_SM$\"
MM3G-%$[_S,/7U#@!1<\#W<8$C5":7-!PLU#7:U 'O<Z&XE"]7$\*?4O^9$\,
M)3\ S;H'I8P0E= 175$&;5'P+-$MDD]I2U''<%'0A%$<K5 /I3X9-<H3Y3H;
M/8P==<T?A<3\Q,T>E;L@%=(E[2CZ+%)'/%)"3-*9I%+VHM&7?%(K-% IM18K
M_5($Q=+Y'-#DTM"7&]+ $%,!)%,Y!%%:=-,RF$>[--.<BU(VW4\Y)4,X+?])
M+ET<+24W-?6+//TF'2U4$PG3D]Q3Q:2@RAO4O$#4GSM42>W$"?U-1BW(GDP\
M2*V+2HU/2OW4:0E5YLS49@K4D/S3%_124=U+4V7"/G7%5ZT".OVW3GV+5@7!
M2\W56IQ52_-5AT35]U35B\137B5&13W6K@)616-6C-M-P[M5M%#6#"55:K5-
M:U508DT8-$71;151.[W6*?U6MXQ56257Z'34V9/6L!#72\Q6=T4"<RU%9\7.
M33T]=O6*>!W*9-U7"IA74:S7]FS2T,O7K/!7(&55A&W&?LU(@0V\;E5#=/V
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M\07JJ'A&N1DGI+)8Z:J>EG(G1J^F*BN)K<YJJW.BWJKK5[&Z2,NN ; J[&T
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M.& -,?C"A)B0A^V X 3]-T(2 C&(1,3A$6FF0R0ND0XS9.(3#[%">O60BO=
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MG@ +^ 'YF8& Z_^CW_GX-Q[\!<^!#Y2@ 2OX" !:,(/6@)X&.W@4"F8.@M)
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MTG)_ZTC?.E>#T(UNGH*K@>%N#+&#I>WFCIM [>;-N]3=:V3'R\OIFO=,ULT
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M__._DXM#N4O#T=M!,#E#/"R,.S3$2T+$1%R_-U2Z/[0E+<S"0DR\-90O2=3
M0&3$Y_O"390^,?3$L,/$:!M%(BQ%%9C U3K%9BM"7J/$4"R+)H1%VI+%6=0[
M2-0^2PS -A0R3>2S5O2S50PY7;3%!ZK%8IPS4$3&>Q-&XP#&%7Q%58S&6W3$
M1QS$S</%91R/1=1&,SK&;ERI:3RD9KQ$<<RB9TPK<C0^8BRP/@3'G^O$=WRB
M;Y1'NO/%<#1'_PE41V?,1T'DQ:OZ1T)DQWHT(7HD2)OAQH/<J7MLL8%</(?,
MLGXL-X9LR&S\%W14R.R*QXR$*8/DR"JDR/FSR(4<26J\QO>3R&5*R=E;R8\D
M(F5T2=?QR)BDJ7V4,(S\-XCDL):LR&H4PI#D'9RD23>TR:&$FIDTR@,\R?;S
M21]LRI\LR=0J2O(12@J:RJ1D0Y[$RI!"RJTT0IT4OJK\/JU4/K!D/K.$LZ=L
M(;3T2FQ,Q;:$DX2$2V,"1F=;.+*L,J ,*+S$@;=4HJN<2X!DR\!4FJXDS)S4
MR]@#3%<<3&AL3*A42S2,2JGDR\/D/L.T3)7#S,R4QL>DN<4,R\KL2_^QM#G1
M?,'$%$73Y$R-!,'5#"&Y=,UVW,->1$V[FTQ]5,T"!,U@S$W=[,W8E,W;!$[5
M@<WA%$QW?$C/G,+:5$SEW#?G+$WHE,S(-$ZWV,SJY)7BQ$ZF#,BSE,Y*9,X6
M_$V0%,ZI*D]3&\_MY,[T5,].T<[V7*OPS,3S/#?V),7O[#SJ!$_ZO$O\A$^Z
MA,G_+,SK%%!!VTV_-()'0U X>L8%9=#=+-"OJ\$(]9[WI%"3[$Z>L<]AE,\M
M]$\,!4"BS%"4_- +]4,'-5$0L= 4]<<034[]C,0-944(34<9Y<<25<,.9=&+
M#- =];(>]=&OU%'R7$HXA-']+%(C'='U1$[_&N3/(%W+"872%"+0*74N""7-
MZ!S2:GO2H+31&^W2O<11*\5 *273UUG1,Q7/,66L+RW'+272)552%WW1)/T\
M.%53,373/ 6B*N53WF13"Z-1QSQ2))53""Q4$)U-/G2*/V4]/W74+4G32#5%
M-^TO/&7-1,U/.AU 3<U1.T740Z54M\O242TQ2,W3[K/4V\/42@U3/055:VQ2
M[(M54^6YC;15LYG47-4=&EW57FU5]@K6*WQ5>Q35._547KVV/576O=G59DW!
M0!748>6:8A7)6:553JU3;.W48X76KF/6;SV;3P,U<?5-:57)9"5);J5-=A5(
M;Y751LU#:C57[[3+_WI%+"#%5S,;5'K-RJ4H06N%U44]48(],'C=UV6]UX05
MF&=EV+%$UW35UFR-BH"MU5"M6&)%6/A1UX>]3'WUV%UQV)#]RU^]R8M%5H.M
MUHWE6):-3Y4]6)@E62,+UYGE)%0ETU;K6)K-6(MU5XI%"F:<6* -6IL%Q(4U
MVG09V:2=5I,]V9]U4H"-09=M6:@]SIC $JIE6@[$U:W5F*7UVK+T5U;M69@;
MVEW,B4>UVJM5";5=V["U3:2%6V@AU[EES+$%UK(U6[WU67G-VK?EP: (%L"U
M6ZYMS<*]69!%7"&I2L)UR[3]6+XE"L>U5\$=7)E=7/[#V<P=$+#E7%)K7/_,
M_0G175FIO5R_G5K4_5O3_5QT\-S6O:G7A=WI&M03LUR.DURAO5W<95W#A5S>
M[=W9C=RN%5ZEW=P@'3[5/=W?C5N3B,7@35WF!5[I+5X )=[JU4S%+5SO@UZW
M;0G7+=KGW=WA_5[QI5[LC=Z:1=]XD=WUI8/:?=_R-8OP3<VV+4BL'5B.N%_\
M==_T5=_^-=[CW=$)/-^Q*&!*<][]3>#\78BV.&  1MN(A>!3U=ZY347^56#]
MK<^1L$[Y9>!]^,"/F&#_1=$1/D0!9M&WM-\.%N%?Y. 0I@CTU& 6GF$3+MW#
MM6%YJ=L<YE>GG=$8-HP7=F$@/N$:[D^!".(6YN'_?\7;)?Z1]NU?!#5B&D9B
MRO0'<"/B(;[BPYAB)Q91'_;B'D%A$UW0!L;B*B9#>G ,,[9B-3[C+0[C=BWA
M.#;?Z_5B!X7C-W9CGHT&] -A/FX&8[P'.HY@"29D\]CA0X:!4CW!=AB-/1XG
M>'AD2%Y79?!"1U;D+S;D3!8/*%[?$I9DTL!D<+5D41[E2-X&\4ME3F9;@65E
M*TGD5Z9*^*7=4A;C0*Y:84A"7'Y)6U9E7Y9E)MWD8%Z.6";F7F#D2X6%1P'F
M*'V%V&AF4AX%9M;E8Z[<9+;FY?U?19YC9%[FV?"%QUT&:-8%$OT%V0CG;!;F
M)E9G"//DZNUFVS6'1CMG_W$N!,R;9GMV!WKFAG9>9U?V9UQYY^*-Y_A=A#R;
M9Z*M".48!H7^A^1HZ( N4[F5:"@9:.$MZ$9FB.@XZ-&5!LF[9Y_H:/#YZ(J>
MZ(PV:7T>YIS%YGQ[Z&W$!^\U@_.HAQZ*:42^Z92&3)36Z3FEY</DZ:<5"O<H
M X3K"'6)@CH^"1U+ZI[^YYUU:HN^:-@-ZG54"PIN!!BN"JS.Z@S>:JYFBJB^
MYI\6Z\F=ZL^MZK)6ZU TYK5VE+:6Y;1VZ[FN0[BF:[0Y:\Z5Z[OF:R3,Z[ZF
MMS'^S[T&[,)F0+LV[+C\:\0E[,1V[/!#[,>VO\7>WI:6[,L.0<K&;*:V8Q-N
M[/_-!NV_B^S0KI+1)N3/)NW4ECK35NWHTFRX1>W6ENV->^W9[F3!5L_8MNW=
M;C?6YFW,J>VMU>W?)FY;\^WB+I'C=N+A1N[F3K3@=FY\KF"29>[HMFXG4^[K
MWI#LSN'JUN[O#C'N!F\#$6_/MNSQ1F]-*^_T_H_UGF#O9N_X3B[WEF^BAFZ;
MA>_ZUF_0HN_]ING[GMG\]N\!MS, )W!4P6WC%/ #9_#42_ &;^-M[N[SAO *
M%S$#M_ BGFZ&7? ,]_#\P_ /9PMR+=?3IG 11_&XZN\4E^X-W]<.9_$8![P0
MEW&R6''LA?$:UW%%I/$=EVD<-G&R]O$AGZD;)_+5,'+_C#[Q(V?R;4KR)I_D
M!U_-'(?R*L<A$K=RG.YQ<Z7R+/?R"'KR+T=P%^?R)1?S,V^Y+4?S;J5H"S;S
M-8?S*<+R."_F,-?K-Z?S/+]R-==SGP9CN.SR/A=T)N3S0<]E"8?@0#?T1?<L
M*6?TDVYSKU7T1Z=T!2OT2C_:2!=N/,?T3C<>._?TU>UL@N;T4#=UX@3U4Y_7
M2[?525?U5_>85(=UD69U4W7U6<=UKG3T7/]434_:6^?U8 _@71?VB03R)0;V
M8E=VNJWU9:_?8^?A9'?V:9\Z8J=V"47T3R[U:^?V@YGS;J?B46]=:0?W<L=K
M:S?W-85V&R;W='=W!6SV=]=8_W&_<R&7]WNO)UG']Q@E\UQM]WT'>![1]X#G
MT7YO]6TG^(1_ZX%7^ C/=E*W]X:7^&I']XG/6WI?W'^W^(TG$(;G^ U>]_=&
M^(\G>2GY]I*/V8>?78U'^98GLWAW^9=5>:H>^9BW^>2&^9M_SI '8);7^9\G
MYYP'^DWU><$K^J%'^BBO^*2'6(RWVZ-G^JCG8H^7^DSE>6V/^*K7>BZA^JTO
M6*A7.[#W^K'7YJLG>X?W=0ZO^;-G>W3N^K;?5K&O.KF'^[I_5[.W>Y#'>XC_
M\[SW>RU?^K\7V[U7\JP7_,-GC9-'?+2G^Z!K_,6'?(6=^<BW^LEG[+6G_,S_
M<<O7_/]"7NGA?/S.%WWK-?C15W?"'W?,-_W5OWO.9_U6!NAZ#?W7I_VX5WW(
M)_$2Q_J^K_W>M_&W]WW<+/TSG?W@-_[E1/WCMWW#G\7B5_[G[_6TA_Z>='U)
MO_WIQ_[F=?Z)5WSWW?[L!__F'/[PW\GQG]+O)__TCU/TE_CN1U_V5__X?U.G
ME__'"WQYA/_ZU_^[I7\"B(^IR^T/HYRTVHNSWKS[#X;B2);FB:;JRK;N"ZO
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M,(IQC//Q8A"<:,8T5J&+:G0&&=\(QSC*42=MS D:ZXA'!MTQCW29HQ__",A
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MR[_9Y)[_N>!O__SK?Y;MW[_"^N]_ 2B PO9N _A_@F> ":B 7@2 "T@N#>B
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,)J$2+B$3=E<!   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>sny-20221231_g9.gif
<TEXT>
begin 644 sny-20221231_g9.gif
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M^MF:AN"?:\F?BA.@8!@,!4J( UHX")J#[<"@!JJ@?/.@'0@1$PJ$$6HW%EJ
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M-;,S]J[U-G>W]S=(-C8X>3FC^+BY^CI[N_O['[I\#7R]_3U^?NW_/#^,_C_
M@ (A]7LU\"!"$P5S)6SH\"'$B+86SI-H\2+&C!H14*RX\2/(D/ ZAA)I,B!)
M4"=7LFSI\N6%E-E@TJQI\R8EF>EP\NSIDY!.6#^'&@N:B"C2I$J7%C4:C"G4
MJ%*G8G#ZE"K6K%I'6-6S]:NEKGG DBUK]NP3L0;1LFWK]J!:5V_GTD4:]T[=
MO&GNFM'K]R]@LWQ5!BYL^'"LP9(0,VX\4/$8QY*#0'XV^3+FS TK3]+L^3/H
M+IP/A2YM^MCH):=7QTR=A#7LV+(GNL8[^S;NW!1JV];M^S=0WCJ RQ8^G#CR
MY,I;&8^\_#ETR<V=1Z]NW<KT8=<O9[^Q__T[^/ GNJL6;_Z\5/)*T+-O3T(]
M#?> X<^0;_\^>OK'\?/OKU%_#OX).&   "I"X%D&CH(@@PV:IJ -#DHX(3L0
MTD,AAMM9>$:&4VT(0(<ABIC7APN.>"**O)1H8HHMQE:BBT/!&".--=JU(H<V
MZKAC3CCR^"-F*P+YDI!#&GDD1CCFB"233:*A)(A.2CF7DE-F5*6566K9#I1;
M>ODE95B".69479()EYAGJKFF+V:R^2:<%J09)YU$NEGG.U!&B2>??6)RIY^!
MJ@FHH(5*I.>2AG*#Z)Z*.OHH'(1".JF1<U)Z:3Z,-HJI,IIR^BFH55@:*JDB
M2EHJJMUHFFBJ^_^LVBJLL;HPJJRUXG>JK;D2LRJKNIK"ZZ:^"CLL [02>VQU
MQB*[+"K ]LILC\Y".VVNN%)[;7'*8KMMM,!RZXBS_GP[+J;6DGLN=SZBN^XY
MX3[+;J3N!@LOO71J6R^^=9F;+[][R?MNOZ+].V_ !6>YK\$)9W6OP@WC,C#
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MROI[2JALRG&$I@: /<F@RJKL1Z_LR:[32GCP*)/Q2I'"2G\42Z(C2V$RL]Y
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M]U3X)P#XF+K<_C":0*N]..O-N_]@*(YD:9YHJJYLZ[YP+,]T;=]XKK]2[_]
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MHOU<-5S<U5W>ZZ3,T;?<^JQX9]W>IPS>[<%^XSW7].W-R5W2!8Z:6Q2A_&W
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M(WMA]8[WH*==\3WG>^(MB^;\@CU:C,E;X4E^>,%"OO$?9WSGU_/XOB/0ZZ!
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M1=%A[K942O%M0^'M_TJK=/C,E/^0PB_#4DF9STM'R:["E#YS%$@1CTK/M.M
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M*7H=3YISQ9FG972G^=.E+=&U>$JFG]FH=P=7<EH,;UI66=JITPNJ:Q"H&13
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M#.$=.QFX/HYR@Q\$/AL7Q;BGDVEJEZP;&D>GR50N,93'G-LIFQD[*N(CEIT
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MB2XII1129RLUIQ76YG92C61:8G8R9G1>9WB)IZH9T6O&Y7G^HG="8&FZI[;
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MJR7]\E><^>N/?YS /__AOS___Z\2_@> V22  VB '%& !WAY]*> #=@0">B
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MNANYZYM SNN^U'N^\<M \$N_VAN^]UL^]JN_X)N__=L]Z@O P"O  ^QF!6S
MQMNY">P^_,O YCN_#QP^SON\$IQ/%&S!\H/!&8R_$<S!)^3 '\R^QRO"@X;
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M?-(S'6<D;=/[_,@Y+70RS=/=[-,_72<N+=2:2=1%#2='C=0@'=)+76E![=1
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AG,W;W,W?',[C7,[GG,[KW,[O',_S7,_WG,_[/'T*   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456186768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover page<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Sanofi<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">I0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">,&#160;avenue de la Grande Arm&#233;e<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Paris<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">FR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelFaxNumber', window );">Contact Personnel Fax Number</a></td>
<td class="text">33 1 53 77 43 03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">1,260,835,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001121404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">,&#160;avenue de la Grande Arm&#233;e<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Paris<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">FR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Roy Papatheodorou<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">1 53 77 40 00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember', window );">American&#160;Depositary&#160;Shares,&#160;each&#160;representing one half of one ordinary share, par value &#8364;2&#160;per&#160;share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American&#160;Depositary&#160;Shares,&#160;each&#160;representing one half of one ordinary share, par value &#8364;2&#160;per&#160;share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SNY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=sny_OrdinarySharesNASDAQGlobalSelectMarketMember', window );">Ordinary shares, par value &#8364;2&#160;per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value &#8364;2&#160;per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelFaxNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fax Number of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelFaxNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=sny_OrdinarySharesNASDAQGlobalSelectMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=sny_OrdinarySharesNASDAQGlobalSelectMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456062960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLineItems', window );"><strong>Auditor [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers Audit<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Paris-La D&#233;fense<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_ErnstYoungEtAutresMember', window );">Ernst &amp; Young et Autres</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLineItems', window );"><strong>Auditor [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst&#160;& Young et Autres<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Neuilly-sur-Seine<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1704<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sny_ErnstYoungEtAutresMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sny_ErnstYoungEtAutresMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455574608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated balance sheets - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">&#8364; 9,869<span></span>
</td>
<td class="nump">&#8364; 10,028<span></span>
</td>
<td class="nump">&#8364; 9,365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">1,815<span></span>
</td>
<td class="nump">1,948<span></span>
</td>
<td class="nump">1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">49,892<span></span>
</td>
<td class="nump">48,056<span></span>
</td>
<td class="nump">44,364<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">21,640<span></span>
</td>
<td class="nump">21,407<span></span>
</td>
<td class="nump">18,341<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments accounted for using the equity method</a></td>
<td class="nump">677<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">3,095<span></span>
</td>
<td class="nump">3,127<span></span>
</td>
<td class="nump">2,734<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxAssetsNoncurrent', window );">Non-current income tax assets</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">5,381<span></span>
</td>
<td class="nump">4,598<span></span>
</td>
<td class="nump">4,176<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">92,611<span></span>
</td>
<td class="nump">89,589<span></span>
</td>
<td class="nump">80,627<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">8,960<span></span>
</td>
<td class="nump">8,715<span></span>
</td>
<td class="nump">8,352<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="nump">8,424<span></span>
</td>
<td class="nump">7,568<span></span>
</td>
<td class="nump">7,491<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">3,532<span></span>
</td>
<td class="nump">3,571<span></span>
</td>
<td class="nump">2,737<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxAssetsCurrent', window );">Current income tax assets</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="nump">1,208<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">12,736<span></span>
</td>
<td class="nump">10,098<span></span>
</td>
<td class="nump">13,915<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners', window );">Current assets</a></td>
<td class="nump">34,026<span></span>
</td>
<td class="nump">30,564<span></span>
</td>
<td class="nump">33,703<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale', window );">Assets held for sale or exchange</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">126,722<span></span>
</td>
<td class="nump">120,242<span></span>
</td>
<td class="nump">114,413<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilitiesAbstract', window );"><strong>Equity and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Equity attributable to equity holders of Sanofi</a></td>
<td class="nump">74,784<span></span>
</td>
<td class="nump">68,681<span></span>
</td>
<td class="nump">63,106<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Equity attributable to non-controlling interests</a></td>
<td class="nump">368<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">75,152<span></span>
</td>
<td class="nump">69,031<span></span>
</td>
<td class="nump">63,252<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="nump">14,857<span></span>
</td>
<td class="nump">17,123<span></span>
</td>
<td class="nump">19,745<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current lease liabilities</a></td>
<td class="nump">1,904<span></span>
</td>
<td class="nump">1,839<span></span>
</td>
<td class="nump">931<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests', window );">Non-current liabilities related to business combinations and to non-controlling interests</a></td>
<td class="nump">674<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities', window );">Non-current provisions and other non-current liabilities</a></td>
<td class="nump">6,341<span></span>
</td>
<td class="nump">6,721<span></span>
</td>
<td class="nump">7,315<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesNoncurrent', window );">Non-current income tax liabilities</a></td>
<td class="nump">1,979<span></span>
</td>
<td class="nump">2,039<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">1,841<span></span>
</td>
<td class="nump">1,617<span></span>
</td>
<td class="nump">1,770<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">27,596<span></span>
</td>
<td class="nump">29,916<span></span>
</td>
<td class="nump">31,881<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Accounts payable</a></td>
<td class="nump">6,813<span></span>
</td>
<td class="nump">6,180<span></span>
</td>
<td class="nump">5,295<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests', window );">Current liabilities related to business combinations and to non-controlling interests</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentProvisionsAndOtherCurrentLiabilities', window );">Current provisions and other current liabilities</a></td>
<td class="nump">12,021<span></span>
</td>
<td class="nump">11,217<span></span>
</td>
<td class="nump">10,132<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Current income tax liabilities</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current lease liabilities</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="nump">4,174<span></span>
</td>
<td class="nump">3,183<span></span>
</td>
<td class="nump">2,767<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale', window );">Current liabilities</a></td>
<td class="nump">23,964<span></span>
</td>
<td class="nump">21,295<span></span>
</td>
<td class="nump">19,248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale', window );">Liabilities related to assets held for sale or exchange</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total equity and liabilities</a></td>
<td class="nump">&#8364; 126,722<span></span>
</td>
<td class="nump">&#8364; 120,242<span></span>
</td>
<td class="nump">&#8364; 114,413<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Current assets; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale; Non-current assets or disposal groups classified as held for distribution to owners]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities other than liabilities included in disposal groups classified as held for sale. [Refer: Current liabilities; Disposal groups classified as held for sale [member]; Liabilities included in disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax assets. [Refer: Current tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current amount of current tax assets. [Refer: Current tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities included in disposal groups classified as held for sale. [Refer: Liabilities; Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 38<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_38&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph p<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_p&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Paragraph 22<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets or disposal groups classified as held for sale. [Refer: Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 38<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_38&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This account includes current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes current portion of liabilities related to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentProvisionsAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions and current other liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentProvisionsAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This account includes non-current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes non-current portion of liabilities related to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions and non-current other liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405438500368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated income statements - EUR (&#8364;)<br> &#8364; in Millions, shares in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAbstract', window );"><strong>Profit (loss) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">&#8364; 42,997<span></span>
</td>
<td class="nump">&#8364; 37,761<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 36,041<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">2,392<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,328<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(13,695)<span></span>
</td>
<td class="num">(12,255)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,159)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">31,694<span></span>
</td>
<td class="nump">26,920<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,210<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(6,706)<span></span>
</td>
<td class="num">(5,692)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,530)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="num">(10,492)<span></span>
</td>
<td class="num">(9,555)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,391)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="nump">1,969<span></span>
</td>
<td class="nump">859<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">697<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="num">(2,531)<span></span>
</td>
<td class="num">(1,805)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,415)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization of intangible assets</a></td>
<td class="num">(2,053)<span></span>
</td>
<td class="num">(1,580)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,681)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">454<span></span>
</td>
<td class="num">(192)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(330)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability', window );">Fair value remeasurement of contingent consideration</a></td>
<td class="nump">27<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">124<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Restructuring costs and similar items</a></td>
<td class="num">(1,336)<span></span>
</td>
<td class="num">(820)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,089)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherGainsLossesAndLitigation', window );">Other gains and losses, and litigation</a></td>
<td class="num">(370)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfInvestments', window );">Gain on Regeneron investment arising from transaction of&#160;May&#160;29, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,382<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="nump">10,656<span></span>
</td>
<td class="nump">8,126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expenses</a></td>
<td class="num">(440)<span></span>
</td>
<td class="num">(368)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(388)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments', window );">Income before tax and investments accounted for using the equity method</a></td>
<td class="nump">10,422<span></span>
</td>
<td class="nump">7,798<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,778<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="num">(2,006)<span></span>
</td>
<td class="num">(1,558)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,807)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">359<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">8,484<span></span>
</td>
<td class="nump">6,279<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">12,330<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Net income attributable to equity holders of Sanofi</a></td>
<td class="nump">&#8364; 8,371<span></span>
</td>
<td class="nump">&#8364; 6,223<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">&#8364; 12,294<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Average number of shares outstanding (in shares)</a></td>
<td class="nump">1,251.9<span></span>
</td>
<td class="nump">1,252.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,253.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Average number of shares after dilution (in shares)</a></td>
<td class="nump">1,256.9<span></span>
</td>
<td class="nump">1,257.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,260.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent', window );">Basic earnings per share (in euros per share)</a></td>
<td class="nump">&#8364; 6.69<span></span>
</td>
<td class="nump">&#8364; 4.97<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 9.81<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent', window );">Diluted earnings per share (in euros per share)</a></td>
<td class="nump">&#8364; 6.66<span></span>
</td>
<td class="nump">&#8364; 4.95<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 9.76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseOfRestructuringActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseOfRestructuringActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsOnDisposalsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gain on the disposal of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsOnDisposalsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a contingent consideration asset (liability) relating to a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating income. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basic Earnings (Loss) Per Share, Attributable To Owners Of Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BasicEarningsLossPerShareAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted Earnings (Loss) Per Share, Attributable To Owners Of Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income before tax and investments accounted for equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherGainsLossesAndLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The line item other gains and losses, and litigation includes the impact of material transactions of an unusual nature or amount. [note B.20.2.]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherGainsLossesAndLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455553264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated statements of comprehensive income - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Statement of comprehensive income [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">&#8364; 8,484<span></span>
</td>
<td colspan="2" class="nump">&#8364; 6,279<span></span>
</td>
<td class="nump">&#8364; 12,330<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Attributable to equity holders of Sanofi</a></td>
<td class="nump">8,371<span></span>
</td>
<td colspan="2" class="nump">6,223<span></span>
</td>
<td class="nump">12,294<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Attributable to non-controlling interests</a></td>
<td class="nump">113<span></span>
</td>
<td colspan="2" class="nump">56<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[4]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Actuarial gains/(losses)</a></td>
<td class="nump">654<span></span>
</td>
<td colspan="2" class="nump">686<span></span>
</td>
<td class="num">(267)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments', window );">Change in fair value of equity instruments included in&#160;financial assets and financial liabilities</a></td>
<td class="nump">13<span></span>
</td>
<td colspan="2" class="nump">165<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss', window );">Tax effects</a></td>
<td class="num">(216)<span></span>
</td>
<td colspan="2" class="num">(54)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax', window );">Items not subsequently reclassifiable to profit or loss</a></td>
<td class="nump">451<span></span>
</td>
<td colspan="2" class="nump">797<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax', window );">Change in fair value of debt instruments included in financial assets</a></td>
<td class="num">(77)<span></span>
</td>
<td colspan="2" class="num">(21)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax', window );">Change in fair value of cash flow hedges</a></td>
<td class="nump">7<span></span>
</td>
<td colspan="2" class="num">(6)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax', window );">Change in currency translation differences</a></td>
<td class="nump">2,278<span></span>
</td>
<td colspan="2" class="nump">2,459<span></span>
</td>
<td class="num">(3,976)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss', window );">Tax effects</a></td>
<td class="nump">105<span></span>
</td>
<td colspan="2" class="nump">78<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items subsequently reclassifiable to profit or loss</a></td>
<td class="nump">2,313<span></span>
</td>
<td colspan="2" class="nump">2,510<span></span>
</td>
<td class="num">(4,021)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income for the period, net of taxes</a></td>
<td class="nump">2,764<span></span>
</td>
<td colspan="2" class="nump">3,307<span></span>
</td>
<td class="num">(4,007)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive income</a></td>
<td class="nump">11,248<span></span>
</td>
<td colspan="2" class="nump">9,586<span></span>
</td>
<td class="nump">8,323<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Attributable to equity holders of Sanofi</a></td>
<td class="nump">11,130<span></span>
</td>
<td colspan="2" class="nump">9,519<span></span>
</td>
<td class="nump">8,307<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests', window );">Attributable to non-controlling interests</a></td>
<td class="nump">&#8364; 118<span></span>
</td>
<td colspan="2" class="nump">&#8364; 67<span></span>
</td>
<td class="nump">&#8364; 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on cash flow hedges, before tax, before reclassification adjustments. [Refer: Cash flow hedges [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_23_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, before tax, before reclassification adjustments. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) including exchange differences recognised in other comprehensive income on the fair value measurement of the entity's own equity instruments. [Refer: At fair value [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax relating to amounts recognised in other comprehensive income that will be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax relating to amounts recognised in other comprehensive income that will not be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains (Losses) On Remeasuring Debt Instruments, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435331600">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated statements of changes in equity - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2"><div>Total</div></th>
<th class="th" colspan="2"><div>Attributable to&#160;equity holders of Sanofi&#160;</div></th>
<th class="th" colspan="2"><div>Share capital</div></th>
<th class="th" colspan="2"><div>Additional paid-in capital</div></th>
<th class="th" colspan="2"><div>Treasury shares</div></th>
<th class="th" colspan="2"><div>Reserves and retained earnings</div></th>
<th class="th" colspan="2"><div>Stock options&#160;and other&#160;share- based payments</div></th>
<th class="th" colspan="2"><div>Other comprehensive income</div></th>
<th class="th" colspan="2"><div>Attributable to&#160;non- controlling interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 59,230<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 59,056<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 2,508<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 147<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 51,902<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 3,863<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 645<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 174<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income for&#160;the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,007)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(3,987)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,001)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(20)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">12,330<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,294<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,294<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,323<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">8,307<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,308<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,001)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent', window );">Dividend paid out of earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,937)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,937)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,937)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests', window );">Payment of dividends to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(44)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(44)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfTreasuryShares', window );">Share repurchase program</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(822)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(822)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(822)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareBasedPaymentPlansAbstract', window );"><strong>Share-based payment plans:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">49<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares', window );">Issuance of restricted shares and vesting of existing restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(126)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans', window );">Employee share ownership plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">174<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">174<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees', window );">Value of services obtained from employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions', window );">Tax effects of the exercise of&#160;stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity', window );">Other changes arising from issuance of restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">63,252<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">63,106<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,518<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">362<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(705)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">60,149<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,138<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(3,356)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">146<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income for&#160;the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,307<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">3,296<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,499<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,279<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">6,223<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,223<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">56<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,586<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">9,519<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,499<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">67<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent', window );">Dividend paid out of earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,008)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,008)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,008)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests', window );">Payment of dividends to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(49)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(49)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfTreasuryShares', window );">Share repurchase program</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(382)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(382)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(382)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareBasedPaymentPlansAbstract', window );"><strong>Share-based payment plans:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares', window );">Issuance of restricted shares and vesting of existing restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">148<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(148)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans', window );">Employee share ownership plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">168<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">168<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">163<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees', window );">Value of services obtained from employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">244<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">244<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">244<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions', window );">Tax effects of the exercise of&#160;stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment', window );">Other changes in non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">186<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">186<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,031<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">68,681<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,527<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">532<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(939)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">63,013<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,405<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(857)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income for&#160;the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,764<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">451<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,308<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,484<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,130<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,822<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,308<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">118<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent', window );">Dividend paid out of earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,168)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,168)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,168)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent', window );">Effect of the distribution of an exceptional supplementary dividend of 58% of the shares of EUROAPI to the equity holders of Sanofi</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="num">(793)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(793)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(793)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests', window );">Payment of dividends to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(100)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(100)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfTreasuryShares', window );">Share repurchase program</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(497)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(497)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(497)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReductionOfIssuedCapital', window );">Reduction in share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(587)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareBasedPaymentPlansAbstract', window );"><strong>Share-based payment plans:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">35<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">35<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares', window );">Issuance of restricted shares and vesting of existing restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">130<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(130)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans', window );">Employee share ownership plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">149<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees', window );">Value of services obtained from employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">245<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">245<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">245<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions', window );">Tax effects of the exercise of&#160;stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 75,152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 74,784<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 2,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 125<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (706)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 66,734<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 4,658<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,451<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 368<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="19"></td></tr>
<tr><td colspan="19"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">See Notes&#160;D.15.1., D.15.3., D.15.4. and D.15.5.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">This line includes the use of existing shares to fulfill vested rights under restricted share plans.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Issuance of restricted shares to former employees of the European Generics business subsequent to the date of divestment.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">This line includes changes in non-controlling interests arising from divestments and acquisitions.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">This amount includes the valuation of the shares distributed as a dividend in kind, at a price of &#8364;14.58 per share, as of May&#160;10, 2022 (see note&#160;D.1.).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends recognised as distributions to non-controlling interests. [Refer: Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends recognised as distributions to owners of the parent. [Refer: Parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReductionOfIssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in equity resulting from a reduction in issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReductionOfIssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exceptional Supplementary Dividends Recognised As Distributions To Owners Of Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease through changes in non-controlling interests arising from divestment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through issuance of restricted shares, equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee share ownership plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through share-based payment plans issuance of restricted shares and vesting of existing restricted shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax effects of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of services obtained from employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareBasedPaymentPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based payment plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareBasedPaymentPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442352720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated statements of changes in equity (Parenthetical) - &#8364; / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidOrdinarySharesPerShare', window );">Dividends paid, ordinary shares per share (in EUR per share)</a></td>
<td class="nump">&#8364; 3.33<span></span>
</td>
<td class="nump">&#8364; 3.20<span></span>
</td>
<td class="nump">&#8364; 3.15<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidOrdinarySharesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends paid per ordinary share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 34<br> -IssueDate 2021-01-01<br> -Paragraph 16A<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=34&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16A_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidOrdinarySharesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455810880">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated statements of cash flows - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from (used in) operating activities [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Net income attributable to equity holders of Sanofi</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 8,371<span></span>
</td>
<td class="nump">&#8364; 6,223<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 12,294<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">113<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod', window );">Share of undistributed earnings from investments accounted for using the&#160;equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(339)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset', window );">Depreciation, amortization and impairment of property, plant and equipment, right-of-use assets and intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,420<span></span>
</td>
<td class="nump">3,351<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,671<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets', window );">Gains and losses on disposals of non-current assets, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(711)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(301)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Gain on Regeneron investment arising from transaction of May 29, 2020, net&#160;of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,880)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDeferredTaxExpense', window );">Net change in deferred taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(578)<span></span>
</td>
<td class="num">(356)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(221)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities', window );">Net change in non-current provisions and other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">280<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(133)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Cost of employee benefits (stock options and other share-based payments)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">245<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue', window );">Impact of the workdown of acquired inventories remeasured at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsToReconcileProfitLoss', window );">Other profit or loss items with no cash effect on cash flows generated by operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">138<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(711)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital', window );">Operating cash flow before changes in working capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,233<span></span>
</td>
<td class="nump">9,113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,743<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to reconcile profit (loss) [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">(Increase)/decrease in inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(927)<span></span>
</td>
<td class="num">(357)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(593)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">(Increase)/decrease in accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(777)<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(134)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Increase/(decrease) in accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">452<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">86<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities', window );">Net change in other current assets and other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">545<span></span>
</td>
<td class="nump">1,130<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">316<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash provided by/(used in) operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">10,526<span></span>
</td>
<td class="nump">10,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,418<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from (used in) investing activities [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets', window );">Acquisitions of property, plant and equipment and intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,201)<span></span>
</td>
<td class="num">(2,043)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,083)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Acquisitions of consolidated undertakings and investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="num">(992)<span></span>
</td>
<td class="num">(5,594)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,336)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities', window );">Acquisitions of other equity investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(488)<span></span>
</td>
<td class="num">(311)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(137)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets', window );">Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="nump">1,488<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">918<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Disposal of consolidated undertakings and investments accounted for using the equity method, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">134<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod', window );">Net proceeds from sale of Regeneron shares on May&#160;29, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,370<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetChangeInOtherNonCurrentAssets', window );">Net change in other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(113)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash provided by/(used in) investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,075)<span></span>
</td>
<td class="num">(7,298)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,619<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from (used in) financing activities [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Issuance of Sanofi shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">188<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">203<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DividendsPaidAbstract', window );"><strong>Dividends paid:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities', window );">to shareholders of Sanofi</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,168)<span></span>
</td>
<td class="num">(4,008)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,937)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities', window );">to non-controlling interests, excluding BMS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(99)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(44)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromNoncurrentBorrowings', window );">Additional long-term debt contracted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,549<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,019<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Repayments of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,718)<span></span>
</td>
<td class="num">(2,241)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,952)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayments of lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(291)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(234)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments', window );">Net change in short-term debt and other financial instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="nump">215<span></span>
</td>
<td class="num">(414)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">282<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares', window );">Acquisitions of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(497)<span></span>
</td>
<td class="num">(382)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(822)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash provided by/(used in) financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,821)<span></span>
</td>
<td class="num">(7,056)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,485)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Impact of exchange rates on cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(64)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net change in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,638<span></span>
</td>
<td class="num">(3,817)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,488<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,098<span></span>
</td>
<td class="nump">13,915<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[12]</sup></td>
<td class="nump">9,427<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 12,736<span></span>
</td>
<td class="nump">&#8364; 10,098<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 13,915<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[12]</sup></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">(a) Includes non-current financial assets.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">(b) The gain on the sale of Regeneron shares is presented net of taxes, including deferred taxes of &#8364;115&#160;million.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">(c) This line item includes contributions paid to pension funds (see Note&#160;D.19.1.).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">(d) This line item mainly comprises unrealized foreign exchange gains and losses arising on the remeasurement of monetary items in non-functional currencies and on instruments used to hedge such items.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) Including:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:56.174%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.144%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Income tax paid</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,452)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,280)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,051)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Interest paid</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(334)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(315)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Interest received</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Dividends received from non-consolidated entities</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">(f)&#160;&#160;&#160;&#160;This line item includes payments made in respect of contingent consideration identified and recognized as a liability in business combinations. For 2022, it includes the net cash outflow on the acquisition of Amunix (see Note&#160;D.1.). For 2021, it includes the net cash outflows on the acquisitions of Kymab, Kiadis, Tidal, Translate Bio, Kadmon and Origimm (see Note&#160;D.2.1.). For 2020, it includes the net cash outflows on the acquisitions of Synthorx and Principia (see Note&#160;D.2.2.).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">For 2022, 2021 and 2020, this line item mainly comprises disposals of assets and activities related to portfolio streamlining and disposals of equity and debt instruments.</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> For 2020, it also includes the sale to Baxter of operations relating to Seprafilm</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> for a selling price (before taxes) of &#8364;311&#160;million. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(see&#160;Note&#160;D.7.1.).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">(h)&#160;&#160;&#160;&#160;For 2022, this line item includes the net cash inflows (before taxes) of &#8364;101&#160;million on the divestment of EUROAPI (see Note&#160;D.1).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top">(i)&#160;&#160;&#160;&#160;This line item includes realized foreign exchange differences on (i)&#160;cash and cash equivalents in non-functional currencies (primarily the US dollar) and (ii)&#160;derivative instruments used to manage such cash and cash equivalents.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDeferredTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDeferredTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for losses (gains) on disposal of non-current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Non-current assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 14<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_14&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for undistributed profits of investments accounted for using the equity method to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Investments accounted for using equity method; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows arising from losing control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) from the entity's operations before changes in working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A__IAS07_IE_A_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for dividends paid to equity holders of the parent, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for dividends paid to non-controlling interests, classified as financing activities. [Refer: Non-controlling interests; Dividends paid to non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAdjustmentsToReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Adjustments to reconcile profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAdjustmentsToReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire or redeem entity's shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToAcquireOrRedeemEntitysShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the disposal of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from non-current borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation, amortization and impairment of property, plant and equipment, right-of use assets and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for noncurrent provisions and other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flows From (Used In) Increase (Decrease) In Current Borrowings And Other Financial Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DividendsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends Paid [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DividendsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impact of the workdown of acquired inventories remeasured at fair value arising from business combination in accordance with IFRS 3.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other current assets and increase (decrease) in other current liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetChangeInOtherNonCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net change in other non-current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetChangeInOtherNonCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405438387472">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated statements of cash flows (Parenthetical) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income tax paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (2,452)<span></span>
</td>
<td class="num">&#8364; (1,280)<span></span>
</td>
<td class="num">&#8364; (2,051)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities', window );">Interest paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(380)<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="num">(315)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities', window );">Interest received</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">173<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities', window );">Dividends received from non-consolidated entities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets', window );">Proceeds from disposals of investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,488<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="nump">918<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Disposal of consolidated undertakings and investments accounted for using the equity method, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">134<span></span>
</td>
<td class="nump">&#8364; 42<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_EuroapiMember', window );">EUROAPI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Disposal of consolidated undertakings and investments accounted for using the equity method, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sny_SeprafilmMember', window );">Seprafilm</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets', window );">Proceeds from disposals of investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax', window );">Deferred income tax on disposal of investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 115<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">For 2022, 2021 and 2020, this line item mainly comprises disposals of assets and activities related to portfolio streamlining and disposals of equity and debt instruments.</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> For 2020, it also includes the sale to Baxter of operations relating to Seprafilm</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> for a selling price (before taxes) of &#8364;311&#160;million. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(see&#160;Note&#160;D.7.1.).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">(h)&#160;&#160;&#160;&#160;For 2022, this line item includes the net cash inflows (before taxes) of &#8364;101&#160;million on the divestment of EUROAPI (see Note&#160;D.1).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows arising from losing control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the disposal of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments For Gain (Loss) On Disposal Of Investments In Subsidiaries, Joint Ventures And Associates, Deferred Income Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends received from non-consolidated entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedCashFlowStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedCashFlowStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_EuroapiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_EuroapiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sny_SeprafilmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sny_SeprafilmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439433552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Introduction<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GeneralInformationAboutFinancialStatementsAbstract', window );"><strong>General Information About Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">Introduction</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Introduction</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi, together with its subsidiaries (collectively &#8220;Sanofi&#8221;, &#8220;the Group&#8221; or &#8220;the Company&#8221;), is a global healthcare leader engaged in the research, development and marketing of therapeutic solutions focused on patient needs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is listed in Paris (Euronext: SAN) and New&#160;York (Nasdaq: SNY).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements for the year ended December 31, 2022, and the notes thereto, were signed off by the Sanofi Board of Directors on</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> February&#160;23,&#160;2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 51<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GeneralInformationAboutFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General Information About Financial Statements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GeneralInformationAboutFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439540112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of preparation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate Information And Statement Of IFRS Compliance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of preparation</a></td>
<td class="text">Basis of preparation<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.1. International financial reporting standards (IFRS)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements cover the twelve-month periods ended December 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with Regulation No.&#160;1606/2002 of the European Parliament and Council of July&#160;19, 2002 on the application of&#160;international accounting standards, Sanofi has presented its consolidated financial statements in accordance with IFRS since&#160;January&#160;1, 2005. The term &#8220;IFRS&#8221; refers collectively to international accounting and financial reporting standards (IASs&#160;and&#160;IFRSs) and to interpretations of the interpretations committees (SIC and IFRIC) with mandatory application as of December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements of Sanofi as of December 31, 2022 have been prepared in compliance with IFRS as&#160;issued&#160;by the International Accounting Standards Board (IASB) and with IFRS as endorsed by the European Union as of December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">IFRS as endorsed by the European Union as of December 31, 2022 are available under the heading &#8220;IFRS Financial Statements&#8221; via the following web&#160;link:</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">https://www.efrag.org/Endorsement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in accordance with the IFRS general principles of fair presentation, going concern, accrual basis of accounting, consistency of presentation, materiality, and aggregation.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.2. New standards, amendments and interpretations</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">A.2.1. New standards applicable from January 1, 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following amendments are applicable from January&#160;1, 2022, and have had no material impact: &#8220;Reference to the Conceptual Framework&#8221; (amendment to IFRS&#160;3); &#8220;Proceeds before Intended Use&#8221; (amendment to IAS&#160;16); &#8220;Onerous Contracts &#8212; Cost of Fulfilling a Contract&#8221; (amendment to IAS&#160;37); and &#8220;Annual Improvements to IFRS standards 2018-2020&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As a reminder, Sanofi adopted in its consolidated financial statements for the year ended December&#160;31, 2021 the IFRS&#160;IC final agenda decision (published in the March&#160;2021 IFRS&#160;IC update) clarifying how to account for costs of configuring or customising a supplier&#8217;s application software in a Software as a Service (SaaS) arrangement, which requires such costs to be recognized as an expense.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">A.2.2. New pronouncements issued by the IASB and applicable from 2023 or later</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This note describes standards, amendments and interpretations issued by the IASB that will have mandatory application in 2023 or subsequent years, and Sanofi&#8217;s position regarding future application.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;12, 2021, the IASB issued &#8220;Disclosure of Accounting Policies&#8221;, an amendment to IAS&#160;1, and &#8220;Definition of Accounting Estimates&#8221;, an amendment to IAS&#160;8. On May&#160;7, 2021, the IASB issued an amendment to IAS&#160;12, relating to deferred tax assets and liabilities arising from a single transaction. Sanofi does not expect a material impact from those amendments, which are applicable at the earliest from January&#160;1, 2023, and will not early adopt them.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;22, 2022, the IASB issued an amendment to IFRS&#160;16 (Leases), relating to lease liabilities in a sale-and-leaseback arrangement, which is applicable at the earliest from January&#160;1, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (subject to endorsement by the European Union); it will not have a material impact on the Sanofi financial statements, and </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi will not early adopt it.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On January&#160;23, 2020, the IASB issued &#8220;Classification of Liabilities as Current or Non-current&#8221;, an amendment to IAS&#160;1, and then on&#160;October&#160;31, 2022 issued &#8220;Non-current Liabilities with Covenants&#8221;, a further amendment to IAS&#160;1. The amendments are applicable at the earliest from January&#160;1, 2024 </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(subject to endorsement by the European Union)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; they will not have a material impact on the Sanofi financial statements, and Sanofi will not early adopt them.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">IFRS&#160;17 (Insurance Contracts), issued on May&#160;18, 2017 and applicable on or after January&#160;1, 2023, will not apply to the Sanofi consolidated financial statements because the insurance activities carried on by Sanofi's captive insurance companies are internal within the Sanofi group (the sole policyholders being subsidiaries of Sanofi), and hence are eliminated on consolidation.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.3. Use of estimates and judgments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The preparation of financial statements requires management to make reasonable estimates and assumptions based on information available at the date of the finalization of the financial statements. Those estimates and assumptions may affect the reported amounts of assets, liabilities, revenues and expenses in the financial statements, and disclosures of contingent assets and contingent liabilities as of the date of the review of the financial statements. Examples of estimates and assumptions include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">amounts deducted from sales for projected sales returns, chargeback incentives, rebates and price reductions (see Notes&#160;B.13. and&#160;D.23.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">impairment of property, plant and equipment and intangible assets (see Notes&#160;B.6. and D.5.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the valuation of goodwill and the valuation and estimated useful life of acquired intangible assets (see Notes&#160;B.3.2., B.4., D.4. and&#160;D.5.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the measurement of contingent consideration receivable in connection with asset divestments (see Notes&#160;B.8.5. and&#160;D.12.) and of contingent consideration payable (see Notes&#160;B.3. and&#160;D.18.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the measurement of financial assets at amortized cost (see Note&#160;B.8.5.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of post-employment benefit obligations (see Notes&#160;B.23. and&#160;D.19.1.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of liabilities or provisions for restructuring, litigation, tax risks relating to corporate income taxes, and environmental risks (see Notes&#160;B.12., B.19., B.20., D.19. and&#160;D.22.); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of deferred tax assets resulting from tax losses available for carry-forward and deductible temporary differences (see Notes&#160;B.22. and&#160;D.14.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Actual results could differ from these estimates.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.4. Hyperinflation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, Sanofi continued to account for subsidiaries based in Venezuela using the full consolidation method, on the basis that the criteria for control as specified in IFRS&#160;10 (Consolidated Financial Statements) are still met. In 2018, following changes to the Venezuelan foreign exchange system, the &#8220;DICOM&#8221; rate was replaced by the &#8220;PETRO&#8221; rate (with a floating US dollar/bolivar parity) and the strong bolivar (&#8220;VEF&#8221;) was replaced by the sovereign bolivar (&#8220;VES&#8221;), reflecting a 1-for-100,000 devaluation. Finally, in October&#160;2021 a new currency called the &#8220;Digital Bolivar&#8221; (VED) was introduced at a rate of 1&#160;VED to 1,000,000&#160;sovereign bolivars. Consequently, the contribution of the Venezuelan subsidiaries to the consolidated financial statements is immaterial.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Argentina, the cumulative rate of inflation over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has since July&#160;1, 2018 treated Argentina as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since the beginning of 2022, inflation in Turkey has increased significantly and the cumulative inflation rate over the past three years has been above 100% since the end of February&#160;2022. Qualitative indicators following the deterioration of the economic situation and exchange controls also support the consensus conclusion that Turkey is a hyperinflationary country from 2022. Consequently, Sanofi has since January&#160;1, 2022 treated Turkey as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.5. Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;18, 2020, Sanofi and the US Department of Health and Human Services extended their research and development partnership to leverage Sanofi&#8217;s previous development work on a SARS vaccine to attempt to unlock a fast path forward for developing a COVID-19 vaccine. Under the terms of the collaboration, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the US Department of Health and Human Services, is helping to fund the research and development undertaken by Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;14, 2020, Sanofi and GlaxoSmithKline (GSK) entered into a collaboration agreement to develop a recombinant COVID-19 vaccine candidate, with Sanofi contributing its S&#8209;protein COVID-19 antigen (based on recombinant DNA technology) and GSK contributing its pandemic adjuvant technology. Sanofi is leading clinical development and the registration process for the vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On July&#160;31, 2020, the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK was selected by the US&#160;government&#8217;s Operation Warp Speed (OWS) program. Under the OWS, the US government is providing funds to support further development of the vaccine, including clinical trials and scaling-up of manufacturing capacity. Initially, the agreement also provided for the supply of 100&#160;million doses of the vaccine, with payment due at the time vaccine doses are provided. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has recognized the funding received from the US government as a deduction from the development expenses incurred, in accordance with IAS&#160;20 (Accounting for Government Grants and Disclosure of Government Assistance).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of government aid received from the US federal government and BARDA and recognized </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as a deduction from development expenses</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and other operating expenses was &#8364;265&#160;million in 2022, compared with &#8364;147&#160;million in 2021 and an immaterial amount in 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2020, Sanofi and GSK signed pre-order contracts with the Canadian and UK governments and with the European Union for doses of the vaccine candidate. During 2021, Sanofi and GSK contractualized with the Canadian and UK governments and with the European Union on the number of doses ordered.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;15, 2021, Sanofi and GSK announced positive preliminary data on their COVID-19 booster vaccine candidate and indicated that their Phase&#160;III trial was to continue, based on recommendations from an independent monitoring board.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;10, 2022, in line with the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency, the European Commission approved VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta vaccine as booster for the prevention of COVID-19 in adults aged 18&#160;years and older. Designed to provide broad protection against multiple variants, this protein-based COVID-19 booster vaccine is based on the Beta variant antigen and includes GSK&#8217;s pandemic adjuvant. VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Beta is indicated as a booster for active immunization against SARS-CoV-2 in adults who have previously received an mRNA or adenoviral COVID-19 vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;21, 2022, following the European Commission approval, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta vaccine for the prevention of COVID-19 in adults aged 18 and over within the UK.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there had been no material change in the commitments entered into by the United States in 2020, or in the pre-order arrangements with Canada, the United Kingdom and the European Union.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;15 (see Note&#160;B.13.1.), Sanofi recognizes revenue when control over the product is transferred to the customer (for vaccines, transfer of control is determined by reference to the terms of release and acceptance of batches of vaccine). Payments received subsequent to signature of vaccine pre-order contracts relating to doses not yet delivered are customer contract liabilities (i.e. an obligation for the entity to supply goods to a customer, for which consideration has been received from the customer). They are presented within &#8220;Customer contract liabilities&#8221; in the balance sheet (see Note&#160;D.19.5.), and within &#8220;Net change in other current assets and other current liabilities&#8221; in the statement of cash flows.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of&#160;December&#160;31, 2022, customer contract liabilities amounted to &#8364;264&#160;million, compared with &#8364;319&#160;million as of&#160;December&#160;31,&#160;2021 (see Note&#160;D.19.5., &#8220;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Current provisions and other current liabilities&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">). The portion of the December&#160;31, 2021 balance recognized in profit or loss during 2022 was &#8364;85&#160;million (no amounts were recognized in profit or loss during 2021).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.6. Effects of climate change</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Risks associated with climate change as assessed to date, and the commitments made by Sanofi on carbon neutrality and cutting greenhouse gas emissions, do not have a material impact on the financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Risks associated with trends in carbon costs, raw material shortages, supply chain disruption,&#160;etc. have been taken into account in the measurement of assets and liabilities.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.7. War in Ukraine</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The conflict triggered by the Russian invasion of Ukraine on February&#160;24, 2022 led to the imposition of sanctions by the European Union and other countries. While complying with those sanctions inherent to its operations, Sanofi continues to carry on commercial and industrial activities in Russia under its direct control so as to meet patient needs. In 2022, Sanofi generated net sales of &#8364;674&#160;million in Russia (compared with &#8364;575&#160;million in 2021 and &#8364;641&#160;million in 2020), representing 1.6% of consolidated net sales.</span></div>The conflict had no material direct or indirect impact on the financial statements ended December&#160;31, 2022. Sanofi will continue to monitor the situation, and will update its estimates and assumptions accordingly<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Information And Statement Of IFRS Compliance [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439424496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate Information And Statement Of IFRS Compliance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Summary of significant accounting policies</a></td>
<td class="text">Summary of significant accounting policiesBasis of consolidation<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;10 (Consolidated Financial Statements), the consolidated financial statements of Sanofi include the financial statements of entities that Sanofi controls directly or indirectly, regardless of the level of the equity interest in those entities. An entity is controlled when Sanofi has power over the entity, exposure or rights to variable returns from its involvement with the entity, and the ability to affect those returns through its power over the entity. In determining whether control exists, potential voting rights must be taken into account if those rights are substantive, in other words they can be exercised on a timely basis when decisions about the relevant activities of the entity are to be taken.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Entities consolidated by Sanofi are referred to as &#8220;subsidiaries&#8221;. Entities that Sanofi controls by means other than voting rights are referred to as &#8220;consolidated structured entities&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;11 (Joint Arrangements), Sanofi classifies its joint arrangements (i.e. arrangements in which Sanofi exercises joint control with one or more other parties) either as a joint operation (in which case, Sanofi recognizes the assets and liabilities of the operation in proportion to its rights and obligations relating to those assets and liabilities) or as a joint venture.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi exercises joint control over a joint arrangement when decisions relating to the relevant activities of the arrangement require the unanimous consent of Sanofi and the other parties with whom control is shared.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi exercises significant influence over an entity when it has the power to participate in the financial and operating policy decisions of that entity, but does not have the power to exercise control or joint control over those policies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), the equity method is used to account for joint ventures (i.e.&#160;entities over which Sanofi exercises joint control) and for associates (i.e. entities over which Sanofi exercises significant influence).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the equity method, the investment is initially recognized at cost, and subsequently adjusted to reflect changes in the net assets of the associate or joint venture. IAS&#160;28 does not specify the treatment to be adopted on first-time application of the equity method to an investee following a step acquisition. Consequently, by reference to paragraph&#160;10 of IAS&#160;28, Sanofi has opted to apply the cost method, whereby the carrying amount of the investment represents the sum of the historical cost amounts for each step in the acquisition. As of the date on which the equity method is first applied, goodwill (which is included in the carrying amount of the investment) is determined for each acquisition step. The same applies to subsequent increases in the percentage interest in the equity-accounted investment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When the criteria of IFRS&#160;5 are met, Sanofi recognizes the equity interest within the balance sheet line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The equity method is not applied to equity interests that are classified as held-for-sale assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Transactions between consolidated companies are eliminated, as are intragroup profits.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A list of the principal companies included in the consolidation in 2022 is presented in Note&#160;F.</span></div>Foreign currency translation<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.2.1. Accounting for foreign currency transactions in the financial statements of consolidated entities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Non-current assets (other than receivables) and inventories acquired in foreign currencies are translated into the functional currency using the exchange rate prevailing at the acquisition date.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the end of the reporting period. The gains and losses resulting from foreign currency translation are recorded in the income statement. However, foreign exchange gains and losses arising from the translation of advances between consolidated subsidiaries for which settlement is neither planned nor likely to occur in the foreseeable future are recognized in equity, in the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Change in currency translation differences.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.2.2. Foreign currency translation of the financial statements of foreign entities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi presents its consolidated financial statements in euros (&#8364;). In accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates), each subsidiary accounts for its transactions in the currency that is most representative of its economic environment (the functional currency).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All assets and liabilities are translated into euros using the exchange rate of the subsidiary&#8217;s functional currency prevailing at the end of the reporting period. Income statements are translated using a weighted average exchange rate for the period, except in the case of foreign subsidiaries in a hyperinflationary economy. The resulting currency translation difference is recognized as a separate component of equity in the consolidated statement of comprehensive income, and is recognized in the income statement only when the subsidiary is sold or is wholly or partially liquidated.</span></div>Business combinations and transactions with non-controlling interests<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.3.1. Accounting for business combinations, transactions with non-controlling interests and loss of control</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Business combinations are accounted for in accordance with IFRS&#160;3 (Business Combinations) and IFRS&#160;10 (Consolidated Financial Statements).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Business combinations are accounted for using the acquisition method. Under this method, the acquiree&#8217;s identifiable assets and liabilities that satisfy the recognition criteria of IFRS&#160;3 (Business Combinations) are measured initially at their fair values at the date of acquisition, except for (i)&#160;non-current assets classified as held for sale (which are measured at fair value less costs to sell) and (ii)&#160;assets and liabilities that fall within the scope of IAS&#160;12 (Income Taxes) and IAS&#160;19 (Employee Benefits). Restructuring liabilities are recognized as a liability of the acquiree only if the acquiree has an obligation as of the acquisition date to carry out the restructuring.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal accounting rules applicable to business combinations and transactions with non-controlling interests include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">acquisition-related costs are recognized as an expense, as a component of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">contingent consideration is recognized in equity if the contingent payment is settled by delivery of a fixed number of the acquirer&#8217;s equity instruments; otherwise, it is recognized in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Contingent consideration is recognized at fair value at the acquisition date irrespective of the probability of payment. If the contingent consideration was originally recognized as a financial liability, subsequent adjustments to the liability are recognized in profit or loss in the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, unless the adjustment is made within the twelve months following the acquisition date and relates to facts and circumstances existing as of that date;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">goodwill may be calculated on the basis of either (i)&#160;the entire fair value of the acquiree, or (ii)&#160;a share of the fair value of the acquiree proportionate to the interest acquired. This option is elected for each acquisition individually.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Purchase price allocations are performed under the responsibility of management, with assistance from an independent valuer in the case of major acquisitions. IFRS&#160;3 does not specify an accounting treatment for contingent consideration arising from a business combination made by an entity prior to the acquisition of control in that entity and carried as a liability in the acquired entity&#8217;s balance sheet. The accounting treatment applied by Sanofi to such a liability is to measure it at fair value as of the acquisition date and to report it in the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations and to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, with subsequent remeasurements recognized in profit or loss. This treatment is consistent with the accounting applied to contingent consideration in the books of the&#160;acquirer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, management may where it deems fit elect to apply the optional test to identify concentration of fair value permitted under IFRS&#160;3 in order to determine whether a transaction is a business combination within the meaning of IFRS&#160;3, or merely the acquisition of an asset or of a group of similar assets.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.3.2. Goodwill</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The excess of the cost of an acquisition over Sanofi&#8217;s interest in the fair value of the identifiable assets and liabilities of the acquiree is recognized as goodwill at the date of the business combination.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill arising on the acquisition of subsidiaries is shown in a separate balance sheet line item, whereas goodwill arising on the acquisition of investments accounted for using the equity method is recorded in</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Investments accounted for using the equity method.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill arising on foreign operations is expressed in the functional currency of the country concerned and translated into euros using the exchange rate prevailing at the end of the reporting period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;36 (Impairment of Assets), goodwill is carried at cost less accumulated impairment (see Note&#160;B.6.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually and whenever events or circumstances indicate that impairment might exist. Such events or circumstances include significant changes more likely than not to have an other-than-temporary impact on the substance of the original investment.</span></div>Other intangible assets<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other intangible assets are initially measured at acquisition cost or production cost, including any directly attributable costs of preparing the asset for its intended use, or (in the case of assets acquired in a business combination) at fair value as of the date of the business combination. Intangible assets are amortized on a straight line basis over their useful&#160;lives.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The useful lives of other intangible assets are reviewed at the end of each reporting period. The effect of any adjustment to useful lives is recognized prospectively as a change in accounting estimate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amortization of other intangible assets is recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Amortization of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> except for amortization charged against (i)&#160;acquired or internally-developed software and (ii)&#160;other rights of an industrial or operational nature, which is recognized in the relevant classification of expense by function.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi does not own any intangible assets with an indefinite useful life, other than goodwill.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Intangible assets (other than goodwill) are carried at cost less accumulated amortization and accumulated impairment, if any, in accordance with IAS&#160;36 (see Note&#160;B.6.).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.4.1. Research and development not acquired in a business combination</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internally generated research and development</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under IAS&#160;38, research expenses are recognized in profit or loss when incurred.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Internally generated development expenses are recognized as an intangible asset if, and only if, all the following six criteria can be demonstrated: (a)&#160;the technical feasibility of completing the development project; (b)&#160;Sanofi&#8217;s intention to complete the project; (c)&#160;Sanofi&#8217;s ability to use the project; (d)&#160;the probability that the project will generate future economic benefits; (e)&#160;the availability of adequate technical, financial and other resources to complete the project; and (f)&#160;the ability to measure the development expenditure reliably.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Due to the risks and uncertainties relating to regulatory approval and to the research and development process, the six criteria for capitalization are usually considered not to have been met until the product has obtained marketing approval from the regulatory authorities. Consequently, internally generated development expenses arising before marketing approval has been obtained, mainly the cost of clinical trials, are generally expensed as incurred within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Some industrial development expenses (such as those incurred in developing a second-generation synthesis process) are incurred after marketing approval has been obtained, in order to improve the industrial process for an active ingredient. To the extent that the six IAS&#160;38 criteria are considered as having been met, such expenses are recognized as an asset in the balance sheet within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> as incurred. Similarly, some clinical trials, for example those undertaken to obtain a geographical extension for a molecule that has already obtained marketing approval in a major market, may in certain circumstances meet the six capitalization criteria under IAS&#160;38, in which case the related expenses are recognized as an asset in the balance sheet within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Separately acquired research and development</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Payments for separately acquired research and development are capitalized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> provided that they meet the definition of an intangible asset: a resource that is (i)&#160;controlled by Sanofi, (ii)&#160;expected to provide future economic benefits for Sanofi, and (iii)&#160;identifiable (i.e.&#160;it is either separable or arises from contractual or legal rights). Under paragraph&#160;25 of&#160;IAS&#160;38, the first condition for capitalization (the probability that the expected future economic benefits from the asset will flow to the entity) is considered to be satisfied for separately acquired research and development. Consequently, upfront and milestone payments to third parties related to pharmaceutical products for which marketing approval has not yet been obtained are recognized as intangible assets, and amortized on a straight line basis over their useful lives beginning when marketing approval is&#160;obtained.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Payments under research and development arrangements relating to access to technology or to databases, and payments made to purchase generics dossiers, are also capitalized, and amortized over the useful life of the intangible asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subcontracting arrangements, payments for research and development services, and continuous payments under research and development collaborations which are unrelated to the outcome of that collaboration, are expensed over the service term.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.4.2. Other intangible assets not acquired in a business combination</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Licenses other than those related to pharmaceutical products and research projects, in particular software licenses, are capitalized at acquisition cost, including any directly attributable cost of preparing the software for its intended use. Software licenses are amortized on a straight line basis over their useful lives for Sanofi (<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTQvZnJhZzozZjc4YjJjMzg5MjM0NWI3OWUwMWQxNGFjYzI2ODQxNS90ZXh0cmVnaW9uOjNmNzhiMmMzODkyMzQ1Yjc5ZTAxZDE0YWNjMjY4NDE1XzUxMDY_a0f11f8d-0f58-4332-81c5-b171f9da546e">three</span> to five years).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Internally generated costs incurred to develop or upgrade software are capitalized if the IAS&#160;38 recognition criteria are satisfied, and amortized on a straight line basis over the useful life of the software from the date on which the software is ready for use.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.4.3. Other intangible assets acquired in a business combination</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other intangible assets acquired in a business combination (in-process research and development, technology platforms, and currently marketed products) that are reliably measurable are identified separately from goodwill, measured at fair value, and capitalized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IFRS&#160;3 (Business Combinations) and IAS&#160;38 (Intangible Assets). The related deferred tax liability is also recognized if a deductible or taxable temporary difference exists.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In-process research and development acquired in a business combination is amortized on a straight line basis over its useful life from the date of receipt of marketing approval.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Rights to technology platforms and to products currently marketed by Sanofi are amortized on a straight line basis over their useful lives, determined (in particular for marketed products) on the basis of cash flow forecasts which take into account the patent protection period of the marketed product.</span></div>Property, plant and equipment owned and leased<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.5.1. Property, plant and equipment owned</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Property, plant and equipment is initially measured and recognized at acquisition cost, including any directly attributable cost of preparing the asset for its intended use, or (in&#160;the case of assets acquired in a business combination) at fair value as of the date of the business combination. The component-based approach to accounting for property, plant and equipment is applied. Under this approach, each component of an item of property, plant and equipment with a cost which is significant in relation to the total cost of the item and which has a different useful life from the other components must be depreciated separately.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">After initial measurement, property, plant and equipment is carried at cost less accumulated depreciation and impairment, except for land which is carried at cost less impairment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subsequent costs are not recognized as assets unless (i)&#160;it is probable that future economic benefits associated with those costs will flow to Sanofi and (ii)&#160;the costs can be measured reliably.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Borrowing costs attributable to the financing of items of property, plant and equipment, and incurred during the construction period, are capitalized as part of the acquisition cost of the&#160;item.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Government grants relating to property, plant and equipment are deducted from the acquisition cost of the asset to which they&#160;relate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The depreciable amount of items of property, plant and equipment, net of any residual value, is depreciated on a straight line basis over the useful life of the asset. The useful life of an asset is usually equivalent to its economic life.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The customary useful lives of property, plant and equipment are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:49.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.671%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;to&#160;40 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixtures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10 to 20 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5 to 15 years</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 to 15 years</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Useful lives and residual values of property, plant and equipment are reviewed annually. The effect of any adjustment to useful lives or residual values is recognized prospectively as a change in accounting estimate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Depreciation of property, plant and equipment is recognized as an expense in the income statement, in the relevant classification of expense by function.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.5.2. Property, plant and equipment leased</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective from January&#160;1, 2019 leases contracted by Sanofi have been accounted for in accordance with IFRS&#160;16 (Leases). Sanofi recognizes a right-of-use asset and a lease liability for all of its lease contracts, except for (i)&#160;leases relating to low-value assets and&#160;(ii)&#160;short-term leases (12&#160;months or less). Payments made in respect of leases not recognized on the balance sheet are recognized as an operating expense on a straight line basis over the lease term.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On commencement of a lease, the liability for future lease payments is discounted at the incremental borrowing rate, which is a risk-free rate adjusted to reflect the specific risk profile of each Sanofi entity. Because lease payments are spread over the lease term, Sanofi applies a discount rate based on the duration of those payments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The payments used to determine the liability for future lease payments exclude non-lease components, but include fixed payments that Sanofi expects to make to the lessor over the estimated lease term.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">After commencement of the lease, the liability for future lease payments is reduced by the amount of the lease payments made, and increased to reflect interest on the liability. In the event of a reassessment or modification of future lease payments, the lease liability is remeasured. The right-of-use asset &#8211;&#160;which is initially measured at cost including direct costs of the lessee, prepayments made at or prior to the commencement date, less lease incentives received and restoration costs&#160;&#8211; is depreciated on a straight line basis over the lease term, and tested for impairment as required.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi recognizes deferred taxes in respect of right-of-use assets and lease liabilities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over their economic life, which is capped at the lease term as determined under&#160;IFRS&#160;16.</span></div>Impairment of property, plant and equipment, intangible assets, and&#160;investments accounted for using the equity method<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.6.1. Impairment of property, plant and equipment and intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;36 (Impairment of Assets), assets that generate separate cash flows and assets included in cash-generating units&#160;(CGUs) are assessed for impairment when events or changes in circumstances indicate that the asset or CGU may be impaired. A&#160;CGU is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under IAS&#160;36, each CGU or group of CGUs to which goodwill is allocated must (i)&#160;represent the lowest level within the entity at which the goodwill is monitored for internal management purposes, and (ii)&#160;not be larger than an operating segment determined in accordance with IFRS&#160;8 (Operating Segments), before application of the IFRS&#160;8 aggregation criteria (see Note&#160;B.26.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Quantitative and qualitative indications of impairment (primarily relating to the status of the research and development portfolio, pharmacovigilance, patent litigation, and the launch of competing products) are reviewed at the end of each reporting period. If there is any internal or external indication of impairment, Sanofi estimates the recoverable amount of the asset or CGU.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other intangible assets not yet available for use (such as capitalized in-process research and development), and CGUs or groups of CGUs that include goodwill, are tested for impairment annually whether or not there is any indication of impairment, and more frequently if any event or circumstance indicates that they might be impaired. Such assets are not amortized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When there is an internal or external indication of impairment, Sanofi estimates the recoverable amount of the asset and recognizes an impairment loss if the carrying amount of the asset exceeds its recoverable amount. The recoverable amount of the asset is the higher of its fair value less costs to sell or its value in use. To determine value in use, Sanofi uses estimates of future cash flows generated by the asset or CGU, prepared using the same methods as those used in the initial measurement of the asset or CGU on the basis of medium-term strategic plans.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of goodwill, estimates of future cash flows are based on a six-year strategic plan and a terminal value. In the case of other intrangible assets, the period used is based on the economic life of the asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Estimated cash flows are discounted at long-term market interest rates that reflect the best estimate by Sanofi of the time value of money, the risks specific to the asset or CGU, and economic conditions in the geographical regions in which the business activity associated with the asset or CGU is located.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Certain assets and liabilities that are not directly attributable to a specific CGU are allocated between CGUs on a basis that is reasonable, and consistent with the allocation of the corresponding goodwill.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Impairment losses arising on property, plant and equipment, on software and on certain rights are recognized in the relevant classification of expense by function.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Impairment losses arising on other intangible assets are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Impairment of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.6.2. Impairment of investments accounted for using the equity method</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), Sanofi determines whether investments accounted for using the equity method may be impaired based on indicators such as default in contractual payments, significant financial difficulties, probability of bankruptcy, or a prolonged or significant decline in quoted market price. If an investment is impaired, the amount of the impairment loss is determined by applying IAS&#160;36 (see Note&#160;B.6.1.) and recognized in </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.6.3. Reversals of impairment losses charged against property, plant and equipment, intangible assets, and investments accounted for using the equity method</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At the end of each reporting period, Sanofi assesses whether events or changes in circumstances indicate that an impairment loss recognized in a prior period in respect of an asset (other than goodwill) or an investment accounted for using the equity method can be reversed. If this is the case, and the recoverable amount as determined based on the revised estimates exceeds the carrying amount of the asset, Sanofi reverses the impairment loss only to the extent of the carrying amount that would have been determined had no impairment loss been recognized for the asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Reversals of impairment losses in respect of other intangible assets are recognized within the income statement line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Impairment of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, while reversals of impairment losses in respect of investments accounted for using the equity method are recognized within the income statement line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Impairment losses taken against goodwill are never reversed, unless the goodwill is part of the carrying amount of an investment accounted for using the equity method.</span></div>Assets held for sale or exchange and liabilities related to assets held for sale or exchange<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;5 (Non-Current Assets Held for Sale and Discontinued Operations), non-current assets and groups of assets are classified as held for sale in the balance sheet if their carrying amount will be recovered principally through a sale transaction rather than through continuing use. Within the meaning of IFRS&#160;5, the term &#8220;sale&#8221; also includes exchanges for other assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Non-current assets or asset groups held for sale must be available for immediate sale in their present condition, subject only to terms that are usual and customary for sales of such assets, and a sale must be highly probable. Criteria used to determine whether a sale is highly probable include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the appropriate level of management must be committed to a plan to sell;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">an active program to locate a buyer and complete the plan must have been initiated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the asset must be actively marketed for sale at a price that is reasonable in relation to its current fair value;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">completion of the sale should be foreseeable within the twelve months following the date of reclassification to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">actions required to complete the plan should indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Before initial reclassification of the non-current asset (or asset group) to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the carrying amounts of the asset (or of all the assets and liabilities in the asset group) must be measured in accordance with the applicable standards.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subsequent to reclassification to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the non-current asset (or asset group) is measured at the lower of carrying amount or fair value less costs to sell, with any write-down recognized by means of an impairment loss. Once a non-current asset has been reclassified as held for sale or exchange, it is no longer depreciated or amortized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In a disposal of an equity interest leading to loss of control, all the assets and liabilities of the entity involved are classified as held-for-sale assets or liabilities within the balance sheet line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange or Liabilities related to assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, provided that the disposal satisfies the IFRS&#160;5 classification criteria.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The profit or loss generated by a held-for-sale asset group is reported in a separate line item in the income statement for the current period and for the comparative periods presented, provided that the asset group:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">represents a separate major line of business or geographical area of operations; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">is a subsidiary acquired exclusively with a view to resale.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;10, transactions between companies that are held for sale or treated as discontinued operations and other consolidated companies are eliminated.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Events or circumstances beyond Sanofi&#8217;s control may extend the period to complete the sale or exchange beyond one year without precluding classification of the asset (or disposal group) in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> provided that there is sufficient evidence that Sanofi remains committed to the planned sale or exchange. Finally, in the event of changes to a plan of sale that requires an asset no longer to be classified as held for sale, IFRS&#160;5 specifies the following treatment:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the assets and liabilities previously classified as held for sale are reclassified to the appropriate balance sheet line items, with no restatement of comparative periods;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">each asset is measured at the lower of (a)&#160;its carrying amount before the asset was reclassified as held for sale, adjusted for any depreciation, amortization or revaluation that would have been recognized if the asset had not been reclassified as held for sale, or&#160;(b)&#160;its recoverable amount at the date of reclassification;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the backlog of depreciation, amortization and impairment not recognized while non-current assets were classified as held for sale must be reported in the same income statement line item that was used to report impairment losses arising on initial reclassification of assets as held for sale and gains or losses arising on the sale of such assets. In the consolidated income statement, those impacts are reported within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the net income of a business previously classified as discontinued or as held for sale or exchange and reported on a separate line in the income statement must be reclassified and included in net income from continuing operations, for all periods presented;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in addition, segment information relating to the income statement and the statement of cash flows (acquisitions of non-current assets) must be disclosed in the notes to the financial statements in accordance with IFRS&#160;8 (Operating Segments), and must also be restated for all prior periods presented.</span></div>Financial instruments<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.1. Non-derivative financial assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;9 (Financial Instruments) and IAS&#160;32 (Financial Instruments: Presentation), Sanofi has adopted the classification of non-derivative financial assets described below. The classification used depends on (i)&#160;the characteristics of the contractual cash flows (i.e.&#160;whether they represent interest or principal) and (ii)&#160;the business model for managing the asset applied at the time of initial recognition.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial assets at fair value through other comprehensive income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These mainly comprise:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">quoted and unquoted equity investments that Sanofi does not hold for trading purposes and that management has designated at &#8220;fair value through other comprehensive income&#8221; on initial recognition. Gains and losses arising from changes in fair value are recognized in equity within the statement of comprehensive income in the period in which they occur. When such instruments are derecognized, the previously-recognized changes in fair value remain within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, as does the gain or loss on divestment. Dividends received are recognized in profit or loss for the period, within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">debt instruments whose contractual cash flows represent payments of interest or repayments of principal, and which are managed with a view to collecting cash flows and selling the asset. Gains and losses arising from changes in fair value are recognized in equity within the statement of comprehensive income in the period in which they occur. When such assets are derecognized, the cumulative gains and losses previously recognized in equity are reclassified to profit or loss for the period within the line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial assets at fair value through profit or loss</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These mainly comprise:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">contingent consideration already carried in the books of an acquired entity or granted in connection with a business combination;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">instruments whose contractual cash flows represent payments of interest and repayments of principal, which are managed with a view to selling the asset;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">instruments that management has designated at &#8220;fair value through profit or loss&#8221; on initial recognition; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">quoted and unquoted equity investments: equity instruments that are not held for trading and which management did not designate at &#8220;fair value through other comprehensive income&#8221; on initial recognition, and instruments that do not meet the IFRS definition of &#8220;equity instruments&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Gains and losses arising from changes in fair value are recognized in profit or loss within the line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Dividends received are recognized in profit or loss for the period, within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value of equity investments in unquoted entities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On initial recognition of an equity investment in an entity not quoted in an active market, the fair value of the investment is the acquisition cost. Cost ceases to be a representative measure of the fair value of an unquoted equity investment when Sanofi identifies significant changes in the investee, or in the environment in which it operates. In such cases, an internal valuation is carried out, based mainly on growth forecasts or by reference to similar transactions contracted with third parties.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial assets measured at amortized cost</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Financial assets at amortized cost comprise instruments whose contractual cash flows represent payments of interest and repayments of principal and which are managed with a view to collecting cash flows. The main assets in this category are loans and receivables. They are presented within the line items</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Accounts receivable </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Cash and cash equivalents</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Loans with a maturity of more than 12&#160;months are presented in &#8220;Long-term loans and advances&#8221; within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. These financial assets are measured at amortized cost using the effective interest method.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of financial assets measured at amortized cost</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main assets involved are accounts receivable. Accounts receivable are initially recognized at the amount invoiced to the customer. Impairment losses on trade accounts receivable are estimated using the expected loss method, in order to take account of the risk of payment default throughout the lifetime of the receivables. The expected credit loss is estimated collectively for all accounts receivable at each reporting date using an average expected loss rate, determined primarily on the basis of historical credit loss rates. However, that average expected loss rate may be adjusted if there are indications of a likely significant increase in credit risk. If a receivable is subject to a known credit risk, a specific impairment loss is recognized for that receivable. The amount of expected losses is recognized in the balance sheet as a reduction in the gross amount of accounts receivable. Impairment losses on accounts receivable are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Selling and general expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.2. Derivative instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Derivative instruments that do not qualify for hedge accounting are initially and subsequently measured at fair value, with changes in fair value recognized in the income statement in</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, depending on the nature of the underlying economic item which is hedged.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Derivative instruments that qualify for hedge accounting are measured using the policies described in Note&#160;B.8.3. below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">IFRS&#160;13 (Fair Value Measurement) requires counterparty credit risk to be taken into account when measuring the fair value of financial instruments. That risk is estimated on the basis of observable, publicly-available statistical data.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policy on offsetting</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order for a financial asset and a financial liability to be presented as a net amount in the balance sheet under IAS&#160;32, there must be:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a) a legally enforceable right to offset; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(b) the intention either to settle on a net basis, or to realize the asset and settle the liability simultaneously.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.3. Hedging</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As part of its overall market risk management policy, Sanofi enters into various hedging transactions involving derivative or non-derivative instruments; these may include forward contracts, currency swaps or options, interest rate swaps or options, cross-currency swaps, and debt placings or issues.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Such financial instruments are designated as hedging instruments and recognized using the hedge accounting principles of&#160;IFRS&#160;9 when (a)&#160;there is formal designation and documentation of the hedging relationship, of how the effectiveness of the hedging relationship will be assessed, and of the underlying market risk management objective and strategy; (b)&#160;the hedged item and the hedging instrument are eligible for hedge accounting; and (c)&#160;there is an economic relationship between the hedged item and the hedging instrument, defined on the basis of a hedge ratio that is consistent with the underlying market risk management strategy, and the residual credit risk does not dominate the value changes that result from that economic relationship.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value hedge</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A fair value hedge is a hedge of the exposure to changes in fair value of an asset, liability or firm commitment that is attributable to one or more risk components and could affect profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in fair value of the hedging instrument and changes in fair value of the hedged item attributable to the hedged risk components are generally recognized in the income statement, within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to operating activities, or within</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to investing or financing activities.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flow hedge</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A cash flow hedge is a hedge of the exposure to variability in cash flows from an asset, liability or highly probable forecast transaction that is attributable to one or more risk components and could affect profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in fair value of the hedging instrument attributable to the effective portion of the hedge are recognized directly in equity in the consolidated statement of comprehensive income. Changes in fair value attributable to the ineffective portion of the hedge are recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">for hedges related to operating activities, and within</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to investing or financing activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Cumulative changes in fair value of the hedging instrument previously recognized in equity are reclassified to the income statement when the hedged transaction affects profit or loss. Those reclassified gains and losses are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to operating activities, and within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to investing or financing activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When a forecast transaction results in the recognition of a non-financial asset or liability, cumulative changes in the fair value of the hedging instrument previously recognized in equity are incorporated in the initial carrying amount of that asset or liability.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When the hedging instrument expires or is sold, terminated or exercised, the cumulative gain or loss previously recognized in equity remains separately recognized in equity and is not reclassified to the income statement, or recognized as an adjustment to the initial cost of the related non-financial asset or liability, until the forecast transaction occurs. However, if Sanofi no longer expects the forecast transaction to occur, the cumulative gain or loss previously recognized in equity is recognized immediately in profit or loss.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hedge of a net investment in a foreign operation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In a hedge of a net investment in a foreign operation, changes in the fair value of the hedging instrument attributable to the effective portion of the hedge are recognized directly in equity in the consolidated statement of comprehensive income. Changes in fair value attributable to the ineffective portion of the hedge are recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. When the investment in the foreign operation is sold, the changes in the fair value of the hedging instrument previously recognized in equity are reclassified to the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of hedging</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As part of its market risk management policy, Sanofi may designate currency options or interest rate options as hedging instruments, the effectiveness of which is measured on the basis of changes in intrinsic value. In such cases, the time value of the option is treated as a hedging cost and accounted for as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if the option includes a component that is not aligned on the critical features of the hedged item, the corresponding change in the time value is taken to profit or loss;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">otherwise, the change in the time value is taken to equity within the statement of comprehensive income, and then:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if the hedged item is linked to a transaction that results in the recognition of a financial asset or liability, the change in the time value is reclassified to profit or loss symmetrically with the hedged item, or</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if the hedged item is linked to a transaction that results in the recognition of a non-financial asset or liability, the change in the time value is incorporated in the initial carrying amount of that asset or liability, or</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if the hedged item is linked to a period of time, the change in time value is reclassified to profit or loss on a straight line basis over the life of the hedging relationship.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of forward contracts and foreign exchange swaps, and of cross-currency swaps that qualify for hedge accounting on the basis of changes in spot rates, Sanofi may elect for each transaction to use the option whereby the premium/discount or foreign currency basis spread are treated in the same way as the time value of an option.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinuation of hedge accounting</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Hedge accounting is discontinued when the eligibility criteria are no longer met (in particular, when the hedging instrument expires or is sold, terminated or exercised), or if there is a change in the market risk management objective of the hedging relationship.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.4. Non-derivative financial liabilities</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Borrowings and debt</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bank borrowings and debt instruments are initially measured at fair value of the consideration received, net of directly attributable transaction costs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subsequently, they are measured at amortized cost using the effective interest method. All costs related to the issuance of borrowings or debt instruments, and all differences between the issue proceeds net of transaction costs and the value on redemption, are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement over the term of the debt using the effective interest method.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities related to business combinations and to non-controlling interests</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These line items record the fair value of (i)&#160;contingent consideration payable in connection with business combinations and (ii)&#160;commitments to buy out equity holders of subsidiaries, including put options granted to non-controlling interests.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Adjustments to the fair value of commitments to buy out equity holders of subsidiaries, including put options granted to non-controlling interests, are recognized in equity.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other non-derivative financial liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other non-derivative financial liabilities include trade accounts payable, which are measured at fair value (which in most cases equates to face value) on initial recognition, and subsequently at amortized cost.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.5. Fair value of financial instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under IFRS&#160;13 (Fair Value Measurement) and IFRS&#160;7 (Financial Instruments: Disclosures), fair value measurements must be classified using a hierarchy based on the inputs used to measure the fair value of the instrument. This hierarchy has three levels:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.86pt">level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.25pt">level&#160;2: quoted prices in active markets for similar assets and liabilities, or valuation techniques in which all important inputs are derived from observable market data; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.78pt">level&#160;3: valuation techniques in which not all important inputs are derived from observable market data.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the disclosures required under IFRS&#160;7 relating to the measurement principles applied to financial instruments.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.852%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.362%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Type&#160;of financial&#160;instrument</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Measurement<br/>principle</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in<br/>fair&#160;value<br/>hierarchy</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Valuation<br/>technique</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Method used to determine fair value</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Valuation<br/>model</span></td><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market data</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exchange rate</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (quoted equity instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market&#160;price</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (quoted debt instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (unquoted equity instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cost/Approach based on comparables</span></div></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">If cost ceases to be a representative measure of fair value, an internal valuation is carried out, based mainly on comparables.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (contingent consideration receivable)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;D.7.3.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value held to meet obligations under post-employment benefit plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets designated at fair value held to meet obligations under deferred compensation plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Long-term loans and advances and other non-current receivables</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The amortized cost of long-term loans and advances and other non-current receivables at the end of the reporting period is not materially different from their fair value.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.13.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Investments in mutual funds</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Net asset value</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.13.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Negotiable debt instruments, commercial paper, instant access deposits and term deposits</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Because these instruments have a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.1.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">In the case of debt with a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.<br/>For debt with a maturity of more than 3&#160;months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.2.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The liability for future lease payments is discounted using the incremental borrowing rate.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160; year:</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid Money Market</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&gt;&#160;1&#160;year:&#160;</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid Zero Coupon</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market<br/>Spot</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160;year:</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid&#160;Money&#160;Market  and LIFFE interest rate futures</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&gt;&#160;1&#160;year: </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid&#160;Zero Coupon</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present&#160;value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market<br/>Spot</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160; year:<br/>Mid&#160;Money Market and LIFFE interest rate futures<br/>&gt;&#160;1&#160;year: <br/>Mid Zero Coupon</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.18.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Liabilities related to business combinations and to non-controlling interests (CVRs)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.18.</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Liabilities related to business combinations and to non-controlling interests (other than CVRs)</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Under IAS&#160;32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;B.8.4.</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.6. Derecognition of financial instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Financial assets are derecognized when the contractual rights to cash flows from the asset have ended or have been transferred and when Sanofi has transferred substantially all the risks and rewards of ownership of the asset. If Sanofi has neither transferred nor retained substantially all the risks and rewards of ownership of a financial asset, it is derecognized if Sanofi does not retain control of the asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A financial liability is derecognized when Sanofi&#8217;s contractual obligations in respect of the liability are discharged, cancelled or extinguished.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.7. Risks relating to financial instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Market risks in respect of non-current financial assets, cash equivalents, derivative instruments and debt are described in the discussions of risk factors presented in Item&#160;3.D. and Item&#160;11. of Sanofi&#8217;s Annual Report on Form&#160;20-F for 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Credit risk is the risk that customers may fail to pay their debts. For a description of credit risk, refer to &#8220;We are subject to the risk of non-payment by our customers&#8221; within Item&#160;3.D. and Item&#160;11. of Sanofi&#8217;s Annual Report on Form&#160;20-F for 2022.</span></div>Inventories<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inventories are measured at the lower of cost or net realizable value. Cost is calculated using the weighted average cost method or the first-in, first-out method, depending on the nature of the inventory.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The cost of finished goods inventories includes costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During the launch phase of a new product, any inventories of that product are written down to zero pending regulatory approval, other than in specific circumstances which make it possible to estimate that there is a high probability at the end of the reporting period that the carrying amount of the inventories will be recoverable. The write-down is reversed once it becomes highly probable that marketing approval will be obtained.</span></div>Cash and cash equivalentsCash and cash equivalents as shown in the consolidated balance sheet and statement of cash flows comprise cash, plus liquid short-term investments that are&#160;readily convertible into cash and are&#160;subject to an insignificant risk of changes in value in the event of movements in interest rates.Treasury sharesIn accordance with IAS&#160;32, Sanofi treasury shares are deducted from equity, irrespective of the purpose for which they are held. No gain or loss is recognized in the income statement on the purchase, sale, impairment or cancellation of treasury shares.Provisions for risks<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;37 (Provisions, Contingent Liabilities and Contingent Assets), Sanofi records a provision when it has a present obligation, whether legal or constructive, as a result of a past event; it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation; and a reliable estimate can be made of the amount of the outflow of resources.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If the obligation is expected to be settled more than twelve months after the end of the reporting period, or has no definite settlement date, the provision is recorded within Non-current provisions and other non-current liabilities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Provisions relating to the insurance programs in which Sanofi&#8217;s captive insurance company participates are based on risk exposure estimates calculated by management, with assistance from independent actuaries, using IBNR (Incurred But Not Reported) techniques. Those techniques use past claims experience, within Sanofi and in the market, to estimate future trends in the cost of&#160;claims.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Contingent liabilities are not recognized, but are disclosed in the notes to the financial statements unless the possibility of an outflow of economic resources is&#160;remote.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi estimates provisions on the basis of events and circumstances related to present obligations at the end of the reporting period and of past experience, and to the best of management&#8217;s knowledge at the date of preparation of the financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Reimbursements offsetting the probable outflow of resources are recognized as assets only if it is virtually certain that they will be received. Contingent assets are not recognized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restructuring provisions are recognized if Sanofi has a detailed, formal restructuring plan at the end of the reporting period and has announced its intention to implement this plan to those affected by it.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No provisions are recorded for future operating losses.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi records non-current provisions for certain obligations, such as legal or constructive obligations, where an outflow of resources is probable and the amount of the outflow can be reliably estimated.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of environmental risks, including at sites where operations are ongoing, Sanofi recognizes a provision where there is a violation of integrity in respect of human health or the environment resulting from past contamination at a site that requires remediation. The amount of the provision is a best estimate of the future expenditures to be incurred on the remediation plan.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Where the effect of the time value of money is material, those provisions are measured at the present value of the expenditures expected to be required to settle the obligation, calculated using a discount rate that reflects an estimate of the time value of money and the risks specific to the obligation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Increases in provisions to reflect the effects of the passage of time are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div>Revenue recognition<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.13.1. Net sales</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Revenue arising from the sale of goods is presented in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Net sales comprise revenue from sales of pharmaceutical products, consumer healthcare products, active ingredients and vaccines, net of sales returns, of customer incentives and discounts, and of certain sales-based payments paid or payable to the healthcare authorities. Analyses of net sales are provided in Note&#160;D.35.1. &#8220;Segment Information&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;15 (Revenue from Contracts with Customers), such revenue is recognized when Sanofi transfers control over the product to the customer; control of an asset refers to the ability to direct the use of, and obtain substantially all of the remaining benefits from that asset. For the vast majority of contracts, revenue is recognized when the product is physically transferred, in accordance with the delivery and acceptance terms agreed with the customer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For contracts entered into by Sanofi Pasteur, transfer of control is usually determined by reference to the terms of release (immediate or deferred) and acceptance of batches of vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of contracts with distributors, Sanofi does not recognize revenue when the product is physically transferred to the distributor if the products are sold on consignment, or if the distributor acts as agent. In such cases, revenue is recognized when control is transferred to the end customer, and the distributor&#8217;s commission is presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Selling and general expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of revenue recognized reflects the various types of price reductions or rights of return offered by Sanofi to its customers on certain products. Such price reductions and rights of return qualify as variable consideration under IFRS&#160;15.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In particular, products sold in the United States are covered by various Government and State programs (such as Medicare and Medicaid) under which products are sold at a discount. Rebates are granted to healthcare authorities, and under contractual arrangements with certain customers. Some wholesalers are entitled to chargeback incentives based on the selling price to the end customer, under specific contractual arrangements. Cash discounts may also be granted for prompt payment. Returns, discounts, incentives and rebates, as described above, are recognized in the period in which the underlying sales are recognized as a reduction of gross sales.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These amounts are calculated as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of chargeback incentives is estimated on the basis of the relevant subsidiary&#8217;s standard sales terms and conditions, and in certain cases on the basis of specific contractual arrangements with the customer;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of rebates based on attainment of sales targets is estimated and accrued as each of the underlying sales transactions is recognized;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of price reductions under Government and State programs, largely in the United States, is estimated on the basis of the specific terms of the relevant regulations or agreements, and accrued as each of the underlying sales transactions is recognized;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of sales returns is calculated on the basis of management&#8217;s best estimate of the amount of product that will ultimately be returned by customers. In countries where product returns are possible, Sanofi operates a returns policy that allows the customer to return products within a certain period either side of the expiry date (usually 12&#160;months after the expiry date). The amount recognized for returns is estimated on the basis of past experience of sales returns. Sanofi also takes into account factors such as levels of inventory in its various distribution channels, product expiry dates, information about potential discontinuation of products, the entry of competing generics into the market, and the launch of over-the-counter medicines. Most product return clauses relate solely to date-expired products, which cannot be resold and are destroyed. Sanofi does not recognize a right of return asset in the balance sheet for contracts that allow for the return of time-expired products, since those products have no value.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The estimated amounts described above are recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as a reduction of gross sales, and within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the balance sheet. They are subject to regular review and adjustment as appropriate based on the most recent data available to management. Sanofi believes that it has the ability to measure each of the above amounts reliably, using the following factors in developing its estimates:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the nature and patient profile of the underlying product;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the applicable regulations or the specific terms and conditions of contracts with governmental authorities, wholesalers and other customers;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">historical data relating to similar contracts, in the case of qualitative and quantitative rebates and chargeback incentives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">past experience and sales growth trends for the same or similar products;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">actual inventory levels in distribution channels, monitored by Sanofi using internal sales data and externally provided data;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the shelf life of Sanofi products; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">market trends including competition, pricing and demand.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of provisions for discounts, rebates and sales returns is provided in Note&#160;D.23.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.13.2. Other revenues</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">The line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other revenues</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is used to recognize all revenue that falls within the scope of IFRS&#160;15 but does not relate to sales of Sanofi products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It mainly comprises (i)&#160;royalties received from licensing intellectual property rights to third parties; (ii)&#160;VaxServe sales of products sourced from third-party manufacturers; and (iii)&#160;revenue received under agreements for Sanofi to provide manufacturing services to third parties.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Royalties received under licensing arrangements are recognized over the period during which the underlying sales are recognized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">VaxServe is a Vaccines segment entity whose operations include the distribution within the United States of vaccines and other products manufactured by third parties. VaxServe sales of products sourced from third-party manufacturers are presented within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other revenues</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div>Cost of sales<span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> consists primarily of the industrial cost of goods sold, payments made under licensing agreements, and distribution costs. The industrial cost of goods sold includes the cost of materials, depreciation of property, plant and equipment, amortization of software, personnel costs, and other expenses attributable to production.</span>Research and development<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Note&#160;B.4.1. &#8220;Research and development not acquired in a business combination&#8221; and Note&#160;B.4.3. &#8220;Other intangible assets acquired in a business combination&#8221; describe the principles applied to the recognition of research and development costs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Contributions or reimbursements received from alliance partners are recorded as a reduction of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div>Other operating income and expenses<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.16.1. Other operating income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes the share of profits that Sanofi is entitled to receive from alliance partners in respect of product marketing agreements. It also includes revenues generated under certain agreements, which may include partnership, co-promotion arrangements and licenses not included in Other revenues.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This line item also includes realized and unrealized foreign exchange gains and losses on operating activities (see Note&#160;B.8.3.), and operating gains on disposals not regarded as major disposals (see Note&#160;B.20.).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.16.2. Other operating expenses</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> mainly comprise the share of profits that alliance partners are entitled to receive from Sanofi under product marketing agreements.</span></div>Amortization and impairment of intangible assets<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.17.1. Amortization of intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The expenses recorded in this line item comprise amortization of product rights and other intangible assets (see Note&#160;D.4.), given that the benefit of those rights to Sanofi&#8217;s commercial, industrial and development functions cannot be separately identified.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amortization of software, and of other rights of an industrial or operational nature, is recognized as an expense in the income statement, in the relevant line items of expense by function.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.17.2. Impairment of intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This line item records impairment losses (other than those associated with restructuring) recognized against intangible assets (including goodwill, but excluding software and other rights of an industrial or operational nature), and any reversals of such impairment losses.</span></div>Fair value remeasurement of contingent consideration<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in the fair value of contingent consideration that was (i)&#160;already carried in the books of an acquired entity, or (ii)&#160;granted in connection with a business combination and initially recognized as a liability in accordance with IFRS&#160;3, are reported in profit or loss. Such adjustments are reported separately in the income statement, in the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This line item also includes changes in the fair value of contingent consideration receivable in connection with a divestment and classified as a financial asset at fair value through profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, it includes the effect of the unwinding of discount, and of exchange rate movements where the asset or liability is expressed in a currency other than the functional currency of the reporting entity.</span></div>Restructuring costs and similar items<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restructuring costs are expenses incurred in connection with the transformation or reorganization of Sanofi&#8217;s operations or support functions. Such costs include collective redundancy plans, compensation to third parties for early termination of contracts, and commitments made in connection with transformation or reorganization decisions. They also include accelerated depreciation charges arising from site closures (including closures of leased sites), and losses on asset disposals resulting from such decisions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, this line item includes expenses incurred in connection with programs implemented as part of the transformation strategy announced in December&#160;2019 (and previously in November&#160;2015), and intended primarily to (i)&#160;deliver a global information systems solution, further supported by the implementation in 2021 of Sanofi's new digital strategy; (ii)&#160;create a standalone Consumer Healthcare entity; and (iii)&#160;as announced on February&#160;24, 2020, create a European leader in the production and marketing to third parties of active pharmaceutical ingredients (API).</span></div>Other gains and losses, and litigation<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes the impact of material transactions of an unusual nature or amount which Sanofi believes it necessary to report separately in the income statement in order to improve the relevance of the financial statements, such as:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">gains and losses on major disposals of property, plant and equipment, of intangible assets, of assets (or groups of assets and liabilities) held for sale, or of a business within the meaning of IFRS&#160;3, other than those considered to be restructuring costs;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">impairment losses and reversals of impairment losses on assets (or groups of assets and liabilities) held for sale, other than those considered to be restructuring costs;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">gains on bargain purchases;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">costs relating to major litigation; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">pre-tax separation costs associated with the process of disinvesting from operations in the event of a major divestment.</span></div>Financial expenses and income<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.21.1. Financial expenses</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> mainly comprise interest charges on debt financing; negative changes in the fair value of certain financial instruments (where changes in fair value are recognized in profit or loss); realized and unrealized foreign exchange losses on financing and investing activities; impairment losses on financial instruments; and any reversals of impairment losses on financial instruments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> also include expenses arising from the unwinding of discount on long-term provisions, and the net interest cost related to employee benefits. This line item does not include commercial cash discounts, which are deducted from net sales.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.21.2. Financial income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes interest and dividend income; positive changes in the fair value of certain financial instruments (where changes in fair value are recognized in profit or loss); realized and unrealized foreign exchange gains on financing and investing activities; and gains on disposals of financial assets at fair value through profit or loss.</span></div>Income tax expense<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">includes all current and deferred taxes of consolidated companies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi accounts for deferred taxes in accordance with IAS&#160;12 (Income Taxes), using the methods described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred tax assets and liabilities are recognized on taxable and deductible temporary differences, and on tax loss carry-forwards. Temporary differences are differences between the carrying amount of an asset or liability in the balance sheet and its tax base;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">French business taxes include a value added based component: &#8220;CVAE&#8221; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Cotisation sur la Valeur Ajout&#233;e des Entreprises)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Given that CVAE is (i)&#160;calculated as the amount by which certain revenues exceed certain expenses and (ii)&#160;borne primarily by companies that own intellectual property rights on income derived from those rights (royalties, and margin on sales to third parties and to Sanofi entities), it is regarded as meeting the definition of income taxes specified in IAS&#160;12, paragraph&#160;2 (&#8220;taxes which are based on taxable profits&#8221;);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred tax assets and liabilities are calculated using the tax rate expected to apply in the period when the corresponding temporary differences are expected to reverse, based on tax rates enacted or substantively enacted at the end of the reporting period;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred tax assets are recognized in respect of deductible temporary differences, tax losses available for carry-forward and unused tax credits to the extent that future recovery is regarded as probable. The recoverability of deferred tax assets is assessed on a case-by-case basis, taking into account the profit forecasts contained in Sanofi&#8217;s medium-term business plan;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a deferred tax liability is recognized for temporary differences relating to interests in subsidiaries, associates and joint ventures, except in cases where Sanofi is able to control the timing of the reversal of the temporary differences. This applies in particular when Sanofi is able to control dividend policy and it is probable that the temporary differences will not reverse in the foreseeable future;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">no deferred tax is recognized on eliminations of intragroup transfers of interests in subsidiaries, associates or joint ventures;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">each tax entity calculates its own net deferred tax position. All net deferred tax asset and liability positions are then aggregated and shown in separate line items on the relevant side of the consolidated balance sheet. Deferred tax assets and liabilities are offset only if (i)&#160;Sanofi has a legally enforceable right to offset current tax assets and current tax liabilities, and (ii)&#160;the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation authority;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred taxes are not discounted, except implicitly in the case of deferred taxes on assets and liabilities which are already impacted by discounting. In addition, Sanofi has elected not to discount current taxes payable or receivable where the amounts in question are payable or receivable in the long term;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">withholding taxes on intragroup royalties and dividends, and on royalties and dividends collected from third parties, are accounted for as current income taxes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accounting for business combinations, Sanofi complies with IFRS&#160;3 as regards the recognition of deferred tax assets after the initial accounting period. Consequently, any deferred tax assets recognized by the acquiree after the end of that period in respect of temporary differences or tax loss carry-forwards existing at the acquisition date are recognized in profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The positions adopted by Sanofi in tax matters are based on its interpretation of tax laws and regulations. Some of those positions may be subject to uncertainty. In such cases, Sanofi assesses the amount of the tax liability on the basis of the following assumptions: that its position will be examined by one or more tax authorities on the basis of all relevant information; that a technical assessment is carried out with reference to legislation, case law, regulations, and established practice; and that each position is assessed individually (or collectively where appropriate), with no offset or aggregation between positions. Those assumptions are assessed on the basis of facts and circumstances existing at the end of the reporting period. When an uncertain tax liability is regarded as probable, it is measured on the basis of Sanofi&#8217;s best estimate and recognized as a liability; uncertain tax assets are not recognized. The amount of the liability includes any penalties and late payment interest. The line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Income tax expense</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes the effects of tax reassessments and tax disputes, and any penalties and late payment interest arising from such disputes that have the characteristics of income taxes within the meaning of paragraph&#160;2 of IAS&#160;12 (&#8220;taxes which are based on taxable profits&#8221;). Tax exposures relating to corporate income taxes are presented separately within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Non-current income tax liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (see Note&#160;D.19.4.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No deferred taxation is recognized on temporary differences that are liable to be subject to US global intangible low taxed income (GILTI) provisions. The related tax expense is recognized in the year in which it is declared in the tax return to the extent that it arises from the existence of non-US profits that exceed the theoretical return on investment specified in the GILTI provisions and are taxed at a rate lower than the applicable US tax rate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;1 (Presentation of Financial Statements), current income tax assets and liabilities are presented as separate line items in the consolidated balance sheet.</span></div>Employee benefit obligations<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi offers retirement benefits to employees and retirees. Such benefits are accounted for in accordance with IAS&#160;19 (Employee Benefits).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Benefits are provided in the form of either defined contribution plans or defined benefit plans. In the case of defined contribution plans, the cost is recognized immediately in the period in which it is incurred, and equates to the amount of the contributions paid by Sanofi. For defined benefit plans, Sanofi generally recognizes its obligations to pay pensions and similar benefits to employees as a liability, based on an actuarial estimate of the rights vested or currently vesting in employees and retirees, using the projected unit credit method. Estimates are performed at least once a year, and rely on financial assumptions (such as discount rates) and demographic assumptions (such as life expectancy, retirement age, employee turnover, and the rate of salary increases).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Obligations relating to other post-employment benefits (healthcare and life insurance) offered by Sanofi companies to employees are also recognized as a liability based on an actuarial estimate of the rights vested or currently vesting in employees and retirees at the end of the reporting period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Such liabilities are recognized net of the fair value of plan assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of multi-employer defined benefit plans where plan assets cannot be allocated to each participating employer with sufficient reliability, the plan is accounted for as a defined contribution plan, in accordance with paragraph&#160;34 of IAS&#160;19.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The benefit cost for the period consists primarily of current service cost, past service cost, net interest cost, gains or losses arising from plan settlements not specified in the terms of the plan, and actuarial gains or losses arising from plan curtailments. Net interest cost for the period is determined by applying the discount rate specified in IAS&#160;19 to the net liability (i.e. the amount of the obligation, net of plan assets) recognized in respect of defined benefit plans. Past service cost is recognized immediately in profit or loss in the period in which it is incurred, regardless of whether or not the rights have vested at the time of adoption (in&#160;the case of a new plan) or of amendment (in&#160;the case of an existing&#160;plan).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Actuarial gains and losses on defined benefit plans (pensions and other post-employment benefits), also referred to as&#160;&#8220;Remeasurements of the net defined benefit liability (asset)&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> arise as a result of changes in financial and demographic assumptions, experience adjustments, and the difference between the actual return and interest cost on plan assets. The impacts of those remeasurements are recognized in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, net of deferred taxes; they are not subsequently reclassifiable to profit or&#160;loss.</span></div>Share-based payment<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Share-based payment expense is recognized as a component of operating income, in the relevant classification of expense by function. In measuring the expense, the level of attainment of any performance conditions is taken into account.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.24.1. Stock option plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has granted a number of equity-settled share-based payment plans (stock option plans) to some of its employees. The terms of those plans may make the award contingent on the attainment of performance criteria for some of the grantees.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;2 (Share-Based Payment), services received from employees as consideration for stock options are recognized as an expense in the income statement, with the opposite entry recognized in equity. The expense corresponds to the fair value of the stock option plans, and is charged to income on a straight-line basis over the four-year vesting period of the plan.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of stock option plans is measured at the date of grant using the Black-Scholes valuation model, taking into account the expected life of the options. The resulting expense also takes into account the expected cancellation rate of the options. The expense is adjusted over the vesting period to reflect actual cancellation rates resulting from option-holders ceasing to be employed by Sanofi.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.24.2. Employee share ownership plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi may offer its employees the opportunity to subscribe to reserved share issues at a discount to the reference market price. Shares awarded to employees under such plans fall within the scope of IFRS&#160;2. Consequently, an expense is recognized at the subscription date, based on the value of the discount offered to employees.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.24.3. Restricted share plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi may award restricted share plans to certain of its employees. The terms of those plans may make the award contingent on the attainment of performance criteria for some of the grantees.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;2, an expense equivalent to the fair value of such plans is recognized in profit or loss on a straight line basis over the vesting period of the plan, with the opposite entry recognized in equity. The vesting period is three years.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of restricted share plans is based on the quoted market price of Sanofi shares at the date of grant, adjusted for expected dividends during the vesting period; it also takes account of any vesting conditions contingent on stock market performance, measured using the Monte-Carlo valuation model. Other vesting conditions are taken into account in the estimate of the number of shares awarded during the vesting period; that number is then definitively adjusted based on the actual number of shares awarded on the vesting date.</span></div>Earnings per share<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Basic earnings per share is calculated using the weighted average number of shares outstanding during the reporting period, adjusted on a time-weighted basis from the acquisition date to reflect the number of own shares held by Sanofi. Diluted earnings per share is calculated on the basis of the weighted average number of ordinary shares, computed using the treasury stock method.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This method assumes that (i)&#160;all outstanding dilutive options and warrants are exercised, and (ii)&#160;Sanofi acquires its own shares at the quoted market price for an amount equivalent to the cash received as consideration for the exercise of the options or warrants, plus the expense arising on unamortized stock options.</span></div>Segment information<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;8 (Operating Segments), the segment information reported by Sanofi is prepared on the basis of internal management data provided to the Chief Executive Officer, who is the chief operating decision maker. The performance of those segments is monitored individually using internal reports and common indicators. Disclosures about operating segments required under IFRS&#160;8 are presented in Note&#160;D.35. &#8220;Segment information&#8221; to the consolidated financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has three operating segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Pharmaceuticals segment comprises, for all geographical territories, the commercial operations of the following global franchises: Specialty Care (Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Neurology &amp; Immunology, Rare Diseases, Oncology, and Rare Blood Disorders) and General Medicines (Core and Non-Core Assets), together with research, development and production activities dedicated to the Pharmaceuticals segment. This segment also includes associates whose activities are related to pharmaceuticals. Following the transaction of May&#160;29, 2020, Regeneron is no longer an associate of Sanofi (see Note&#160;D.2.). Consequently, the Pharmaceuticals segment no longer includes Sanofi&#8217;s equity-accounted share of Regeneron&#8217;s profits for all the periods presented.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Vaccines segment comprises, for all geographical territories, the commercial operations of Vaccines, together with research, development and production activities dedicated to vaccines.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for Sanofi's Consumer Healthcare products, together with research, development and production activities dedicated to those products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inter-segment transactions are not material.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The costs of Sanofi&#8217;s global functions (Corporate Affairs, Finance, People &amp; Culture, Legal, Ethics &amp; Business Integrity, Information Solutions&#160;&amp; Technologies, Sanofi Business Services,&#160;etc.) are managed centrally at group-wide level, and are presented within the &#8220;Other&#8221; category. That category also includes other reconciling items such as retained commitments in respect of divested activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Information about operating segments for the years ended December 31, 2022, 2021 and 2020 is presented in Note&#160;D.35</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">., </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Segment information&#8221;.</span></div>Management of capital<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order to maintain or adjust the capital structure, Sanofi can adjust the amount of dividends paid to shareholders, repurchase its own shares, issue new shares, or issue securities giving access to its capital.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following objectives are defined under the terms of Sanofi&#8217;s share repurchase programs:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the implementation of any stock option plan giving entitlement to purchase shares in the Sanofi parent company;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the allotment or sale of shares to employees under statutory profit sharing schemes and employee savings plans;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the consideration-free allotment of shares (i.e. restricted share plans);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the cancellation of some or all of the repurchased shares;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">market-making in the secondary market by an investment services provider under a liquidity contract in compliance with the ethical code recognized by the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Autorit&#233; des march&#233;s financiers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (AMF);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the delivery of shares on the exercise of rights attached to securities giving access to the capital by redemption, conversion, exchange, presentation of a warrant or any other means;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the delivery of shares (in exchange, as payment, or otherwise) in connection with mergers and acquisitions;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the execution by an investment services provider of purchases, sales or transfers by any means, in particular via off-market trading; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">any other purpose that is or may in the future be authorized under the applicable laws and regulations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is not subject to any constraints on equity capital imposed by third parties.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Total equity includes </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Equity attributable to equity holders of Sanofi and Equity attributable to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, as shown in the consolidated balance sheet.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi defines &#8220;Net debt&#8221; as (i)&#160;the sum of short-term debt, long-term debt and interest rate derivatives and currency derivatives used to hedge debt, minus (ii)&#160;the sum of cash and cash equivalents and interest rate derivatives and currency derivatives used to hedge cash and cash equivalents.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Information And Statement Of IFRS Compliance [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439235264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal alliances<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RelatedPartyAbstract', window );"><strong>Related Party [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPrincipalAlliancesTextBlock', window );">Principal alliances</a></td>
<td class="text">Principal alliances<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.1. Alliance arrangements with Regeneron Pharmaceuticals,&#160;Inc. (Regeneron)</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Collaboration agreements on human therapeutic antibodies</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In November&#160;2007, Sanofi and Regeneron signed two agreements (amended in November&#160;2009) relating to human therapeutic antibodies: (i)&#160;the Discovery and Preclinical Development Agreement, and (ii)&#160;the License and Collaboration Agreement, relating to clinical development and commercialization. Under the License and Collaboration Agreement, Sanofi had an option to develop and commercialize antibodies discovered by Regeneron under the Discovery and Preclinical Development Agreement.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discovery and development</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Because Sanofi decided not to exercise its option to extend the Discovery and Preclinical Development Agreement, that agreement expired on December&#160;31, 2017.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As a result of Sanofi's exercise of an option with respect to an antibody under the Discovery and Preclinical Development Agreement, such antibody became a &#8220;Licensed Product&#8221; under the License and Collaboration Agreement, pursuant to which Sanofi and Regeneron co-develop the antibody with Sanofi initially being wholly responsible for funding the development program. On receipt of the first positive Phase III trial results for any antibody being developed under the License and Collaboration Agreement, the subsequent development costs for that antibody are split 80% Sanofi, 20% Regeneron. Amounts received from Regeneron under the License and Collaboration Agreement are recognized by Sanofi as a reduction in the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Co-development with Regeneron of the antibodies Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Kevzara</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and REGN3500 (SAR440340 - itepekimab) is ongoing under the License and Collaboration Agreement as of December&#160;31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Once a product begins to be commercialized, and provided that the share of quarterly results under the agreement represents a profit, Sanofi is entitled to an additional portion of Regeneron&#8217;s profit-share (capped at 20% of Regeneron&#8217;s share of quarterly profits since April&#160;1, 2022, and at 10% until March&#160;31, 2022) until Regeneron has paid 50% of the cumulative development costs incurred by the parties in the collaboration (see Note&#160;D.21.1.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On the later of (i)&#160;24 months before the scheduled launch date or (ii)&#160;the first positive Phase&#160;III trial results, Sanofi and Regeneron share the commercial expenses of the antibodies co-developed under the License and Collaboration Agreement.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercialization</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is the lead party with respect to the commercialization of all co-developed antibodies, and Regeneron has certain option rights to co-promote the antibodies. Regeneron has exercised its co-promotion rights in the United States and in certain other countries. Sanofi recognizes all sales of the antibodies. Profits and losses arising from commercial operations in the United States are split 50/50. Outside the United States, Sanofi is entitled to between 55% and 65% of profits depending on sales of the antibodies, and bears 55% of any losses. The share of profits and losses due to or from Regeneron under the agreement is recognized within the line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income or Other operating expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, which are components of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, Regeneron is entitled to receive payments contingent on the attainment of specified levels of aggregate sales on all antibodies outside the United States, on a rolling twelve-month basis. A liability for those payments is recognized on the balance sheet when it is probable that the specified level of aggregate sales will be met. The opposite entry for that liability is capitalized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> on the balance sheet. Two payments of $50&#160;million each were made in 2022, following attainment first of $2.0&#160;billion and then of $2.5&#160;billion in sales of all antibodies outside the United States on a rolling twelve-month basis. In the event that $3.0&#160;billion in sales on a rolling twelve-month basis is attained, Regeneron is entitled to a final milestone payment of $50&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amendments to the collaboration agreements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In January&#160;2018, Sanofi and Regeneron signed a set of amendments to their collaboration agreements, including an amendment that allowed for the funding of additional programs on Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and REGN3500 (SAR440340 &#8211; itepekimab) with an intended focus on extending the current range of indications, finding new indications, and improving co-morbidity between multiple pathologies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective April&#160;1, 2020, Sanofi and Regeneron signed a Cross License and Commercialization Agreement for Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, whereby Sanofi obtained sole ex-US rights to Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, and Regeneron obtained sole US rights to Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> along with a right to 5% royalties on Sanofi&#8217;s sales of Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> outside the United States. Each party is solely responsible for funding the development, manufacturing and commercialization of Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in their respective territories. Although each party has responsibility for supplying Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in its respective territory, Sanofi and Regeneron have entered into agreements to support manufacturing needs for each other.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective September&#160;30, 2021, Sanofi and Regeneron signed an amendment to their collaboration agreement in order to specify allocations of responsibilities and associated resources between the two parties in connection with the co-promotion of&#160;Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in certain countries. The terms of the collaboration relating to REGN3500 (SAR440340 &#8211; itepekimab) are unchanged.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective July&#160;1, 2022, Sanofi and Regeneron signed an amendment to their collaboration agreement in order to increase the additional portion of Regeneron&#8217;s share of quarterly profits attributable to Sanofi from 10% to 20% with retroactive impact as of April&#160;1, 2022.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Immuno-oncology (IO) collaboration agreements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On July&#160;1, 2015, Sanofi and Regeneron signed two agreements &#8211;&#160;the IO Discovery and Development Agreement and the IO License and Collaboration Agreement (IO LCA)&#160;&#8211; relating to new antibody cancer treatments in the field of immuno-oncology.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Amended IO Discovery Agreement, effective from December&#160;31, 2018, was terminated through a Letter Amendment dated March&#160;16,&#160;2021 in which Sanofi formalized its opt-out from the BCMAxCD3 and MUC16xCD3 programs. </span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(cemiplimab)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the 2015 IO LCA as amended in January&#160;2018, Sanofi and Regeneron committed funding of no more than $1,640 million, split on a&#160;50/50 basis ($820 million per company), for the development of REGN2810 (cemiplimab, trademark Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), a PD-1 inhibitor antibody. The funding was raised to $1,840&#160;million by way of amendment effective on September&#160;30, 2021. Regeneron was responsible for the commercialization of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the United States, and Sanofi in all other territories. Sanofi has exercised its option to co-promote Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the United States. In 2021, Regeneron exercised its option to co-promote Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in certain other countries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The IO LCA also provided for a one-time milestone payment of $375 million by Sanofi to Regeneron in the event that sales of a PD-1 product were to exceed, in the aggregate, $2 billion in any consecutive 12-month period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the IO LCA Sanofi and Regeneron shared equally in profits and losses generated by the commercialization of collaboration products, except that Sanofi was entitled to an additional portion of Regeneron&#8217;s profit-share (capped at 10% of Regeneron&#8217;s share of quarterly profits) until Regeneron had paid 50% of the cumulative development costs incurred by the parties under the IO Discovery Agreement, as amended.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is approved in the United States and Europe for the treatment of two types of locally advanced or metastatic skin cancer (cutaneous squamous cell carcinoma and basal cell carcinoma) and non-small cell lung cancer (NSCLC). It is also approved in Brazil and Canada as a second line treatment for recurring or metastatic cervical cancer. In the fourth quarter of 2022, it was approved in the United States in association with chemotherapy for the treatment of NSCLC, and in Europe and Japan as a second line treatment for recurring or metastatic cervical cancer. Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently approved in more than 30&#160;countries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;2022, Sanofi and Regeneron restructured their IO LCA. Under the terms of the Amended and Restated IO LCA, Regeneron holds exclusive worldwide licensing rights to Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> with effect from July&#160;1, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In July&#160;2022, Sanofi received as consideration an upfront payment of $900&#160;million (&#8364;856&#160;million), which was recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> on the date of receipt. The same line item also includes a regulatory milestone payment of $100&#160;million (&#8364;96&#160;million) following the US FDA approval in November&#160;2022 of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in combination with chemotherapy as a first line treatment for NSCLC. In addition, Sanofi is entitled to royalties of 11% and to milestone payments (&#8364;111&#160;million in 2022) linked to global net sales of Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> which are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in line with the pattern of sales . All of the cash inflows relating to the above items (&#8364;967&#160;million for the year ended December&#160;31, 2022) are presented within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net cash provided by/(used in) operating activities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amendment to the terms of the IO LCA resulted in Sanofi recognizing an accelerated amortization charge of &#8364;226&#160;million; this was allocated to the Libtayo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">product rights included within the residual carrying amount of the intangible asset recognized in July&#160;2015 to reflect rights to an antibody targeting the immune checkpoint receptor PD-1 (programmed cell death protein-1) under the Sanofi/Regeneron alliance.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The transaction also includes a time-limited transitional services agreement with Regeneron which includes manufacturing, distribution (for which Sanofi acts as agent), and promotion.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Investor agreement</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2014 and 2020, Sanofi and Regeneron amended the investor agreement entered into by the two companies in 2007. Under the terms of the amendments, Sanofi accepted various restrictions, including &#8220;standstill&#8221; provisions that contractually prohibit Sanofi from seeking to directly or indirectly exert control of Regeneron or acquiring more than 30% of Regeneron&#8217;s capital stock (consisting of the outstanding shares of common stock and the shares of Class A stock). This prohibition remains in place until the earlier of (i)&#160;the later of the fifth anniversaries of the expiration or earlier termination of the Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> collaboration agreement with Regeneron (related to the development and commercialization of Zaltrap</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) or the collaboration agreement with Regeneron on monoclonal antibodies (see &#8220;Collaboration agreements on human therapeutic antibodies&#8221; above), each as amended and (ii)&#160;other specified events.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Starting in 2018 Sanofi began to sell shares of Regeneron stock and announced on May&#160;29,&#160;2020 the closing of its sale of 13&#160;million shares of Regeneron common stock in a registered offering and a private sale to Regeneron (see Note&#160;D.2.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Pursuant to subsequent sales, as of December&#160;31, 2022 Sanofi no longer holds any shares of Regeneron stock.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.2. Alliance arrangements with Bristol-Myers Squibb (BMS)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Two of Sanofi&#8217;s products were jointly developed with BMS: the anti-hypertensive agent irbesartan (Aprovel</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Karvea</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) and the anti-atherothrombosis treatment clopidogrel bisulfate (Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Iscover</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;27, 2012, Sanofi and BMS signed an agreement relating to their alliance following the loss of exclusivity of Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in many major markets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the terms of this agreement, effective January&#160;1, 2013, BMS returned to Sanofi its rights to Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in all markets worldwide with the exception of Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the United States and Puerto Rico (&#8220;Territory&#160;B&#8221;), giving Sanofi sole control and freedom to operate commercially in respect of those products. In exchange, BMS received royalty payments on Sanofi&#8217;s sales of branded and unbranded Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> worldwide (except for Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Territory&#160;B) until 2018, and also received a payment of $200 million from Sanofi in December&#160;2018, part of which is for buying out the non-controlling interests. Rights to Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in Territory&#160;B remained unchanged and continued to be governed by the terms of the original agreement until&#160;February&#160;28, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In all of the territories managed by Sanofi (including the United States and Puerto Rico for Avapro</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">/Avalide</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) as defined in the new agreement, Sanofi recognized in its consolidated financial statements the revenue and expenses generated by its own operations. Since January&#160;2019 onwards, there has no longer been any share of profits reverting to BMS (previously presented within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to non-controlling interests </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the income statement).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Territory&#160;B for Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, which was managed by BMS, the Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> business was conducted through the Territory&#160;B partnerships, which were jointly owned by BMS and Sanofi. Sanofi recognized its share of profits and losses within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;28, 2020, Sanofi purchased all BMS&#8217;s interests (50.1%) in each of the Territory&#160;B partnerships for a cumulative purchase price of $12&#160;million. Following a transition period, Sanofi has been commercializing Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> under its own label since&#160;July&#160;1, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfPrincipalAlliancesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for principal alliances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfPrincipalAlliancesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439423024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal changes in the scope of consolidation in 2022<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock', window );">Principal changes in the scope of consolidation in 2021 and 2020</a></td>
<td class="text">Presentation of the financial statementsPrincipal changes in the scope of consolidation in 2022<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Amunix Pharmaceuticals, Inc.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;8, 2022, Sanofi acquired the entire share capital of the immuno-oncology company Amunix Pharmaceuticals, Inc. (Amunix), thereby gaining access to Amunix&#8217;s innovative Pro-XTEN</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> technology and a promising pipeline of immunotherapies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition price of Amunix comprises a fixed cash payment of &#8364;970&#160;million, plus contingent consideration in the form of milestone payments based on attainment of certain future development objectives of up to $225&#160;million, the fair value of which as of the acquisition date was &#8364;156&#160;million. In accordance with IFRS&#160;3, this contingent purchase consideration was recognized in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations and non-controlling interests </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(see Note&#160;D.18.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation led to the recognition of &#8364;609&#160;million of goodwill, determined as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:72.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">493</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred taxes, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Amunix</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">517</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,126</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Other intangible assets&#8221; comprise Pro-XTEN</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, an innovative universal protease-releasable masking technology platform for the discovery and development of transformative cytokine therapies and T-cell engager (TCE) immunotherapies for patients with cancer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill mainly represents the value of Amunix&#8217;s upstream research and development pipeline of immuno-oncology therapies based on next-generation conditionally activated biologics, especially when combined with Sanofi&#8217;s existing oncology portfolio.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition does not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amunix has no commercial operations, and has made a negative contribution of &#8364;56&#160;million to Sanofi&#8217;s consolidated net income since the acquisition date.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acquisition-related costs were recognized in profit or loss during 2021, primarily within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; the amount involved was immaterial.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a cash outflow of &#8364;852&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">EUROAPI - Loss of control and accounting implications</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On March&#160;17, 2022, the Sanofi Board of Directors approved a decision to put to a shareholder vote the proposed distribution in&#160;kind of approximately 58% of the share capital of EUROAPI, thereby confirming Sanofi&#8217;s commitment (announced in February&#160;2020) to discontinue its active pharmaceutical ingredient operations. As part of the same corporate action and on the same date, Sanofi entered into an investment agreement with EPIC Bpifrance, which undertook to acquire from Sanofi &#8211; via the French Tech Souverainet&#233; fund &#8211; a 12% equity interest in EUROAPI at a price not exceeding &#8364;150&#160;million and to be determined on the basis of the volume weighted average price (VWAP) of EUROAPI shares on the Euronext Paris regulated market over the&#160;thirty-day period starting from the date of initial listing, i.e. May&#160;6, 2022. On completion of those transactions, Sanofi holds an equity interest of 30.1% in EUROAPI, which it has undertaken to retain for at least two years from the date of the distribution, subject to the customary exceptions. With effect from that date, Sanofi exercises significant influence over EUROAPI as a result of (i)&#160;its equity interest, and (ii)&#160;having one representative on the EUROAPI Board of Directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;3, 2022, the General Meeting of Sanofi shareholders approved the decision of the Board of Directors to distribute approximately 58% of the share capital of EUROAPI in the form of an exceptional dividend in kind.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;10, 2022, the payment date of the dividend in kind in the days following the admission to listing of EUROAPI shares, those Sanofi shareholders who had retained their Sanofi shares received 1&#160;EUROAPI share per 23&#160;Sanofi shares, representing in total&#160;57.88% of the share capital of EUROAPI. As of that date, Sanofi lost control over the EUROAPI entities, based on an assessment of the criteria specified in IFRS&#160;10 (Consolidated financial statements). The assets and liabilities of EUROAPI, which since March&#160;17, 2022 had been presented as assets and liabilities held for sale within the Sanofi statement of financial position in accordance with IFRS&#160;5 (Non-Current Assets Held for Sale), were deconsolidated. In addition, because EUROAPI operations do not constitute a discontinued operation under IFRS&#160;5, the contribution from EUROAPI has not been presented within separate line items in the income statement and statement of cash flows or in information for prior comparative periods. The contribution of EUROAPI operations to the consolidated net sales of Sanofi in the year ended December&#160;31, 2021 was &#8364;486&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal consequences of the deconsolidation of EUROAPI are described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the derecognition of the carrying amount of all the assets and liabilities of EUROAPI, representing a net amount of &#8364;1,227&#160;million as of May&#160;10, 2022. This includes goodwill of &#8364;164&#160;million, determined in accordance with IAS&#160;36 (&#8220;Impairment of Assets&#8221;), which was historically allocated to the Pharmaceuticals cash generating unit (CGU), and which for the purposes of the deconsolidation was allocated using an alternative method based on the relative values of goodwill as of the date of consolidation (the &#8220;notional goodwill method&#8221;). That method was considered more appropriate to the capital-intensive nature of EUROAPI operations than the method based on the relative values of EUROAPI operations and the retained portion of the&#160;CGU;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a reduction in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Equity attributable to equity holders </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">of Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> reflecting the distribution in kind, measured at &#8364;793&#160;million based on the weighted average price of &#8364;14.58 per share as of the date of delivery of the EUROAPI shares to Sanofi shareholders and corresponding to the fair value of the distribution in accordance with IFRIC&#160;17 (Distribution of Non-Cash Assets to Owners);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a cash inflow of &#8364;150&#160;million from the divestment of 12% of the share capital of EUROAPI to EPIC Bpifrance as of the settlement date of the shares, i.e. June&#160;17, 2022;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the recognition in the statement of financial position, within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, of the retained 30.1% equity interest in EUROAPI at an amount of &#8364;413&#160;million, determined on the basis of the weighted average price of &#8364;14.58 per share and representing the fair value of the equity interest in accordance with IFRS&#160;10;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the reclassification within the net gain/loss on deconsolidation of unrealized foreign exchange losses amounting to &#8364;35&#160;million arising on EUROAPI subsidiaries, in accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the recognition of transaction-related costs and of the effects of undertakings made under agreements entered into with EUROAPI setting out the principles and terms of the legal reorganization carried out ahead of the date of deconsolidation. The principal undertakings made to EUROAPI relate to compensation for:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">environmental remediation obligations on non-operational chemical sites in France transferred to EUROAPI, amounting to&#160;&#8364;14 million, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">regulatory compliance costs relating to certain state-of-the-art active pharmaceutical ingredients of EUROAPI, capped at&#160;&#8364;15 million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These elements collectively resulted in a pre-tax loss on deconsolidation of &#8364;3&#160;million, presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement. The tax effect of the deconsolidation was a net gain of &#8364;111 million, presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the income statement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The cash impact of the deconsolidation of EUROAPI, presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Disposals of consolidated undertakings and investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the statement of cash flows, was a net cash inflow of &#8364;101&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has entered into an agreement with EUROAPI for the manufacture and supply of active pharmaceutical ingredients, intermediates and other substances, which took effect on October&#160;1, 2021 and expires five years after the loss of control. Under the terms of the agreement, Sanofi committed to target annual net sales of approximately &#8364;300&#160;million for a list of specified active ingredients until the agreement expires in 2026. As of December&#160;31, 2022, that commitment amounted to &#8364;1.1&#160;billion.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">With effect from the date of deconsolidation, the 30.1% equity interest in EUROAPI is accounted for using the equity method in accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), and the share of EUROAPI profits or losses arising from application of the equity method is excluded from &#8220;Business operating income&#8221;, the non-IFRS financial indicator used internally by&#160;Sanofi to measure the performance of its operating segments.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.2. Principal changes in the scope of consolidation in 2021 and 2020</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.2.1. Principal changes in the scope of consolidation in 2021</span></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Kymab</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;8, 2021, Sanofi acquired the entire share capital of Kymab for an upfront payment of $1.1 billion (&#8364;973 million) and up to&#160;$350 million contingent upon reaching certain development milestones.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the KY1005 project, currently in Phase&#160;II clinical development, and relating to the human monoclonal antibody OX40L, an essential regulator of the immune system) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;965 million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;932 million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Kiadis</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;2, 2020, Sanofi and Kiadis, a biopharmaceutical company developing novel "off-the-shelf" natural killer (NK) cell therapies for patients with life-threatening diseases, entered into a definitive agreement whereby Sanofi was to make a public offer to acquire the entire share capital of Kiadis, i.e. 61&#160;million shares, at a cash price of &#8364;5.45 per share.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition was approved unanimously by the Boards of Directors of Sanofi and Kiadis, and 95.03% of the share capital of Kiadis had been tendered into the offer as of April&#160;16, 2021. As of the end of the post-closing acceptance period on April&#160;29, 2021, Sanofi held&#160;97.39% of the share capital of Kiadis, and proceeded to buy out the remaining non-controlling shareholders. As of&#160;December&#160;31, 2022, Sanofi held 100% of the share capital of Kiadis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the K-NK technology platform) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;339 million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;326 million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Tidal</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;9, 2021, Sanofi acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a unique mRNA-based approach for in vivo reprogramming of immune cells. The new technology platform will expand Sanofi&#8217;s research capabilities in immuno-oncology and inflammatory diseases, and may have applicability to other disease areas as well.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Tidal Therapeutics was acquired for an upfront payment of $160&#160;million (&#8364;136&#160;million), and up to $310&#160;million contingent upon reaching certain development milestones.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the unique mRNA-based in vivo reprogramming technology) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;130&#160;million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;135&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Translate Bio</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On August&#160;3, 2021, Sanofi entered into a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutics company, under which Sanofi was to acquire all outstanding shares of Translate Bio for $38 per share. The Sanofi and Translate Bio Boards of Directors unanimously approved the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition of Translate Bio by Sanofi was completed on September&#160;14, 2021, with Sanofi holding the entire share capital of Translate&#160;Bio upon expiration of the squeeze-out procedure.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;2,118&#160;million:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:72.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(93)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shire contingent consideration liability (see Note&#160;D.18.)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(323)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Translate Bio</span></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">462</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,118</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,580</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The other intangible assets mainly comprise a messenger RNA technological platform applied to the development of vaccines and therapeutic agents.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill mainly represents the effects of expected future synergies and other benefits to be derived from the integration of Translate Bio into the Sanofi group, in particular by accelerating the delivery of development programs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Translate Bio has no commercial operations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;2,333&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the terms of the collaboration agreement between Sanofi and Translate Bio as announced on June&#160;23, 2020, Sanofi held an equity interest of approximately 5% in Translate Bio. As of the date when Sanofi obtained control of Translate Bio, that interest was remeasured at the purchase price of $38 per share. The change in fair value was recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, in accordance</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">with paragraph&#160;42 of IFRS&#160;3 </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(see Note&#160;D.7.).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Kadmon</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;8, 2021, Sanofi entered into a definitive merger agreement with Kadmon, a biopharmaceutical company that discovers, develops and markets transformative therapies for disease areas with significant unmet medical needs. Shareholders of Kadmon common stock received $9.50 per share in cash, representing a transaction valued at $1.9&#160;billion on a fully-diluted basis. The Sanofi and Kadmon Boards of Directors unanimously approved the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition of Kadmon by Sanofi was completed on November&#160;9, 2021, with Sanofi holding the entire share capital of Kadmon upon expiration of the squeeze-out procedure.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was therefore accounted for as an asset acquisition given that the principal asset (belumosudil, commercialized in the United States under the brand name Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;1,739&#160;million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the consolidated statement of cash flows is a net cash outflow of &#8364;1,575&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Origimm</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;3, 2021, Sanofi acquired the entire share capital of Origimm Biotechnology GmbH, a privately owned Austrian biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria that cause skin diseases such as acne, for an upfront payment of &#8364;55&#160;million and up to &#8364;95&#160;million contingent upon reaching certain development and regulatory milestones.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was therefore accounted for as an asset acquisition given that the principal asset (the group of Propionibacterium acnes antigens) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Nearly &#8364;55&#160;million of the acquisition price paid was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the consolidated statement of cash flows for the year ended December&#160;31, 2021 is a net cash outflow of&#160;&#8364;50&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.2.2. Principal changes in the scope of consolidation in 2020</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Principia</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On August&#160;17, 2020, Sanofi and Principia Biopharma&#160;Inc. (&#8220;Principia&#8221;), a late-stage biopharmaceutical company focused on developing treatments for autoimmune diseases, entered into a definitive agreement under which Sanofi was to acquire all the outstanding shares of Principia for $100 per share. The transaction was approved unanimously by the Boards of Directors of Sanofi and Principia. Sanofi's acquisition of Principia was completed on September&#160;28, 2020, with Sanofi holding the entire share capital of Principia upon expiration of the squeeze-out procedure. The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;912 million:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:76.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,534</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net deferred tax position</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(436)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Principia</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,246</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">912</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,158</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The other intangible assets mainly comprise:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">rilzabrutinib (PRN&#160;1008), a molecule undergoing clinical trials for various indications in immuno-inflammatory diseases and rare blood disorders; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">tolebrutinib (PRN&#160;2246/SAR442168), a molecule currently undergoing clinical trials for the treatment of multiple sclerosis and other diseases of the central nervous system.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill represents (i)&#160;the pipeline of future products in pre-clinical research and development; (ii)&#160;the capacity to draw on a specialized structure to refresh the existing product portfolio; and (iii)&#160;the competencies of Principia staff.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No material adjustment was required on completion of the final purchase price allocation.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Synthorx</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;9, 2019, Sanofi and Synthorx&#160;Inc. (&#8220;Synthorx&#8221;), a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, entered into a definitive agreement under which Sanofi was to acquire all of the outstanding shares of Synthorx for $68 per share. The transaction was unanimously approved by both the Sanofi and Synthorx Boards of Directors. On December&#160;23, 2019, Sanofi launched a public tender offer to acquire all of the outstanding ordinary shares of Synthorx for $68 per share in cash, without interest and net of any applicable withholding taxes. The acquisition of Synthorx was completed on January&#160;23, 2020, with Sanofi holding the entire share capital of Synthorx upon expiration of the squeeze-out procedure. The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;930&#160;million:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,549</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net deferred tax position</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(269)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Synthorx</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,316</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">930</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,246</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The other intangible assets mainly comprise THOR-707, a molecule currently in Phase&#160;I clinical trials that stimulates T&#160;lymphocytes, and as such has potential as a cancer immunotherapy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill represents (i)&#160;the pipeline of future products in pre-clinical research and development; (ii)&#160;the capacity to draw on a specialized structure to refresh the existing product portfolio; (iii)&#160;the competencies of Synthorx staff; (iv)&#160;benefits derived from the creation of new growth platforms; and (v)&#160;expected future synergies and other benefits from the combination of Synthorx and Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No material adjustment was required on completion of the final purchase price allocation.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transaction related to the equity-accounted investment in Regeneron</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">From the beginning of April&#160;2014, Sanofi accounted for its investment in Regeneron using the equity method. As from that date, in accordance with the Investor Agreement as amended in early 2014, Sanofi had the right to designate a member of the Regeneron Board of Directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;29, 2020, Sanofi closed the transaction announced on May&#160;25, 2020 involving the sale of its equity investment in Regeneron (with the exception of 400,000&#160;shares), through (i)&#160;a registered public offering in the United States and internationally and (ii)&#160;a share repurchase by Regeneron. Sanofi divested 13&#160;million shares of Regeneron common stock (of which&#160;10.6&#160;million were sold by Sanofi) through the public offering at a price of $515 per share, raising a total amount of&#160;$6,703&#160;million; and Regeneron repurchased 9.8&#160;million of its own shares of common stock directly from Sanofi for&#160;$5,000&#160;million, at the offer price less a subscription discount ($509.85 per share). The total sale proceeds (before transaction-related costs) amounted to &#8364;10,575&#160;million. At the same time, Sanofi as a result of this transaction lost the right to designate a member of the Regeneron Board of Directors under the amended Investor Agreement. Finally, as of May&#160;29, 2020 Sanofi retained ownership of 400,000&#160;Regeneron shares in order to continue to partially fund its commitments to invest in the development programs for cemiplimab (REGN2810) and dupilumab, in line with the 2018 Letter Agreement under which Sanofi is permitted to sell up to 1.4&#160;million shares through the end of 2020. As of December 31, 2022, Sanofi had sold 779,320&#160;Regeneron shares under that agreement. The number of Regeneron shares retained by Sanofi is 279,766 as of December&#160;31, 2021 (see&#160;Note&#160;C.1.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s equity investment in Regeneron was accounted for by the equity method until May&#160;29, 2020. As of that date, the carrying amount of the investment was &#8364;3,668&#160;million; that amount was reversed out on closing of the transaction. Before tax effects, the gain on the divestment amounted to &#8364;7,382&#160;million, including (i)&#160;a gain of &#8364;318&#160;million arising on the currency translation reserve associated with Regeneron, which was taken to profit or loss in accordance with IAS&#160;21; (ii)&#160;the deduction of transaction-related costs of &#8364;64&#160;million; and&#160;(iii)&#160;a gain of &#8364;157&#160;million on the remeasurement of the 400,000&#160;retained shares at their quoted market price as of May&#160;29, 2020 ($612.81). In accordance with IFRS&#160;9 (Financial Instruments), the retained shares were classified in the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Equity instruments at fair value through other comprehensive income&#8221; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">category on the transaction date, at a value of &#8364;221&#160;million (see Note&#160;D.7.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tax charge arising on the transaction was &#8364;502&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Given the material impact of this transaction, and to facilitate users&#8217; understanding of the financial statements, the pre-tax gain on this transaction is presented as a separate line item in the consolidated income statement, &#8220;Gain on Regeneron investment arising from the transaction of May&#160;29, 2020&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The net cash inflow from the transaction was &#8364;10,370&#160;million, which (for the reason cited above) is presented as a separate line item in the consolidated statement of cash flows, &#8220;Net proceeds from sale of Regeneron shares on May&#160;29, 2020&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;27, 2019, Sanofi entered into a definitive agreement to sell Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">to Baxter. The sale was completed on&#160;February&#160;14,&#160;2020. Sanofi recognized a pre-tax gain of &#8364;129&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this sale, reflected in the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">net of tax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> within the consolidated statement of cash flows, was a net cash inflow before tax of&#160;&#8364;311&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combinations [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for impact of changes in the scope of consolidation due to acquisitions and divestments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456184176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal changes in the scope of consolidation in 2021 and 2020<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock', window );">Principal changes in the scope of consolidation in 2021 and 2020</a></td>
<td class="text">Presentation of the financial statementsPrincipal changes in the scope of consolidation in 2022<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Amunix Pharmaceuticals, Inc.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;8, 2022, Sanofi acquired the entire share capital of the immuno-oncology company Amunix Pharmaceuticals, Inc. (Amunix), thereby gaining access to Amunix&#8217;s innovative Pro-XTEN</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> technology and a promising pipeline of immunotherapies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition price of Amunix comprises a fixed cash payment of &#8364;970&#160;million, plus contingent consideration in the form of milestone payments based on attainment of certain future development objectives of up to $225&#160;million, the fair value of which as of the acquisition date was &#8364;156&#160;million. In accordance with IFRS&#160;3, this contingent purchase consideration was recognized in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations and non-controlling interests </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(see Note&#160;D.18.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation led to the recognition of &#8364;609&#160;million of goodwill, determined as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:72.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">493</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred taxes, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Amunix</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">517</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,126</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Other intangible assets&#8221; comprise Pro-XTEN</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, an innovative universal protease-releasable masking technology platform for the discovery and development of transformative cytokine therapies and T-cell engager (TCE) immunotherapies for patients with cancer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill mainly represents the value of Amunix&#8217;s upstream research and development pipeline of immuno-oncology therapies based on next-generation conditionally activated biologics, especially when combined with Sanofi&#8217;s existing oncology portfolio.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition does not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amunix has no commercial operations, and has made a negative contribution of &#8364;56&#160;million to Sanofi&#8217;s consolidated net income since the acquisition date.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acquisition-related costs were recognized in profit or loss during 2021, primarily within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; the amount involved was immaterial.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a cash outflow of &#8364;852&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">EUROAPI - Loss of control and accounting implications</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On March&#160;17, 2022, the Sanofi Board of Directors approved a decision to put to a shareholder vote the proposed distribution in&#160;kind of approximately 58% of the share capital of EUROAPI, thereby confirming Sanofi&#8217;s commitment (announced in February&#160;2020) to discontinue its active pharmaceutical ingredient operations. As part of the same corporate action and on the same date, Sanofi entered into an investment agreement with EPIC Bpifrance, which undertook to acquire from Sanofi &#8211; via the French Tech Souverainet&#233; fund &#8211; a 12% equity interest in EUROAPI at a price not exceeding &#8364;150&#160;million and to be determined on the basis of the volume weighted average price (VWAP) of EUROAPI shares on the Euronext Paris regulated market over the&#160;thirty-day period starting from the date of initial listing, i.e. May&#160;6, 2022. On completion of those transactions, Sanofi holds an equity interest of 30.1% in EUROAPI, which it has undertaken to retain for at least two years from the date of the distribution, subject to the customary exceptions. With effect from that date, Sanofi exercises significant influence over EUROAPI as a result of (i)&#160;its equity interest, and (ii)&#160;having one representative on the EUROAPI Board of Directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;3, 2022, the General Meeting of Sanofi shareholders approved the decision of the Board of Directors to distribute approximately 58% of the share capital of EUROAPI in the form of an exceptional dividend in kind.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;10, 2022, the payment date of the dividend in kind in the days following the admission to listing of EUROAPI shares, those Sanofi shareholders who had retained their Sanofi shares received 1&#160;EUROAPI share per 23&#160;Sanofi shares, representing in total&#160;57.88% of the share capital of EUROAPI. As of that date, Sanofi lost control over the EUROAPI entities, based on an assessment of the criteria specified in IFRS&#160;10 (Consolidated financial statements). The assets and liabilities of EUROAPI, which since March&#160;17, 2022 had been presented as assets and liabilities held for sale within the Sanofi statement of financial position in accordance with IFRS&#160;5 (Non-Current Assets Held for Sale), were deconsolidated. In addition, because EUROAPI operations do not constitute a discontinued operation under IFRS&#160;5, the contribution from EUROAPI has not been presented within separate line items in the income statement and statement of cash flows or in information for prior comparative periods. The contribution of EUROAPI operations to the consolidated net sales of Sanofi in the year ended December&#160;31, 2021 was &#8364;486&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal consequences of the deconsolidation of EUROAPI are described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the derecognition of the carrying amount of all the assets and liabilities of EUROAPI, representing a net amount of &#8364;1,227&#160;million as of May&#160;10, 2022. This includes goodwill of &#8364;164&#160;million, determined in accordance with IAS&#160;36 (&#8220;Impairment of Assets&#8221;), which was historically allocated to the Pharmaceuticals cash generating unit (CGU), and which for the purposes of the deconsolidation was allocated using an alternative method based on the relative values of goodwill as of the date of consolidation (the &#8220;notional goodwill method&#8221;). That method was considered more appropriate to the capital-intensive nature of EUROAPI operations than the method based on the relative values of EUROAPI operations and the retained portion of the&#160;CGU;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a reduction in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Equity attributable to equity holders </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">of Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> reflecting the distribution in kind, measured at &#8364;793&#160;million based on the weighted average price of &#8364;14.58 per share as of the date of delivery of the EUROAPI shares to Sanofi shareholders and corresponding to the fair value of the distribution in accordance with IFRIC&#160;17 (Distribution of Non-Cash Assets to Owners);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a cash inflow of &#8364;150&#160;million from the divestment of 12% of the share capital of EUROAPI to EPIC Bpifrance as of the settlement date of the shares, i.e. June&#160;17, 2022;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the recognition in the statement of financial position, within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, of the retained 30.1% equity interest in EUROAPI at an amount of &#8364;413&#160;million, determined on the basis of the weighted average price of &#8364;14.58 per share and representing the fair value of the equity interest in accordance with IFRS&#160;10;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the reclassification within the net gain/loss on deconsolidation of unrealized foreign exchange losses amounting to &#8364;35&#160;million arising on EUROAPI subsidiaries, in accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the recognition of transaction-related costs and of the effects of undertakings made under agreements entered into with EUROAPI setting out the principles and terms of the legal reorganization carried out ahead of the date of deconsolidation. The principal undertakings made to EUROAPI relate to compensation for:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">environmental remediation obligations on non-operational chemical sites in France transferred to EUROAPI, amounting to&#160;&#8364;14 million, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">regulatory compliance costs relating to certain state-of-the-art active pharmaceutical ingredients of EUROAPI, capped at&#160;&#8364;15 million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These elements collectively resulted in a pre-tax loss on deconsolidation of &#8364;3&#160;million, presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement. The tax effect of the deconsolidation was a net gain of &#8364;111 million, presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the income statement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The cash impact of the deconsolidation of EUROAPI, presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Disposals of consolidated undertakings and investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the statement of cash flows, was a net cash inflow of &#8364;101&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has entered into an agreement with EUROAPI for the manufacture and supply of active pharmaceutical ingredients, intermediates and other substances, which took effect on October&#160;1, 2021 and expires five years after the loss of control. Under the terms of the agreement, Sanofi committed to target annual net sales of approximately &#8364;300&#160;million for a list of specified active ingredients until the agreement expires in 2026. As of December&#160;31, 2022, that commitment amounted to &#8364;1.1&#160;billion.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">With effect from the date of deconsolidation, the 30.1% equity interest in EUROAPI is accounted for using the equity method in accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), and the share of EUROAPI profits or losses arising from application of the equity method is excluded from &#8220;Business operating income&#8221;, the non-IFRS financial indicator used internally by&#160;Sanofi to measure the performance of its operating segments.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.2. Principal changes in the scope of consolidation in 2021 and 2020</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.2.1. Principal changes in the scope of consolidation in 2021</span></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Kymab</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;8, 2021, Sanofi acquired the entire share capital of Kymab for an upfront payment of $1.1 billion (&#8364;973 million) and up to&#160;$350 million contingent upon reaching certain development milestones.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the KY1005 project, currently in Phase&#160;II clinical development, and relating to the human monoclonal antibody OX40L, an essential regulator of the immune system) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;965 million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;932 million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Kiadis</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;2, 2020, Sanofi and Kiadis, a biopharmaceutical company developing novel "off-the-shelf" natural killer (NK) cell therapies for patients with life-threatening diseases, entered into a definitive agreement whereby Sanofi was to make a public offer to acquire the entire share capital of Kiadis, i.e. 61&#160;million shares, at a cash price of &#8364;5.45 per share.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition was approved unanimously by the Boards of Directors of Sanofi and Kiadis, and 95.03% of the share capital of Kiadis had been tendered into the offer as of April&#160;16, 2021. As of the end of the post-closing acceptance period on April&#160;29, 2021, Sanofi held&#160;97.39% of the share capital of Kiadis, and proceeded to buy out the remaining non-controlling shareholders. As of&#160;December&#160;31, 2022, Sanofi held 100% of the share capital of Kiadis.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the K-NK technology platform) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;339 million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;326 million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Tidal</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;9, 2021, Sanofi acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a unique mRNA-based approach for in vivo reprogramming of immune cells. The new technology platform will expand Sanofi&#8217;s research capabilities in immuno-oncology and inflammatory diseases, and may have applicability to other disease areas as well.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Tidal Therapeutics was acquired for an upfront payment of $160&#160;million (&#8364;136&#160;million), and up to $310&#160;million contingent upon reaching certain development milestones.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the unique mRNA-based in vivo reprogramming technology) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;130&#160;million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;135&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Translate Bio</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On August&#160;3, 2021, Sanofi entered into a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutics company, under which Sanofi was to acquire all outstanding shares of Translate Bio for $38 per share. The Sanofi and Translate Bio Boards of Directors unanimously approved the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition of Translate Bio by Sanofi was completed on September&#160;14, 2021, with Sanofi holding the entire share capital of Translate&#160;Bio upon expiration of the squeeze-out procedure.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;2,118&#160;million:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:72.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(93)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shire contingent consideration liability (see Note&#160;D.18.)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(323)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Translate Bio</span></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">462</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,118</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,580</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The other intangible assets mainly comprise a messenger RNA technological platform applied to the development of vaccines and therapeutic agents.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill mainly represents the effects of expected future synergies and other benefits to be derived from the integration of Translate Bio into the Sanofi group, in particular by accelerating the delivery of development programs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Translate Bio has no commercial operations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated statement of cash flows is a net cash outflow of &#8364;2,333&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the terms of the collaboration agreement between Sanofi and Translate Bio as announced on June&#160;23, 2020, Sanofi held an equity interest of approximately 5% in Translate Bio. As of the date when Sanofi obtained control of Translate Bio, that interest was remeasured at the purchase price of $38 per share. The change in fair value was recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, in accordance</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">with paragraph&#160;42 of IFRS&#160;3 </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(see Note&#160;D.7.).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Kadmon</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;8, 2021, Sanofi entered into a definitive merger agreement with Kadmon, a biopharmaceutical company that discovers, develops and markets transformative therapies for disease areas with significant unmet medical needs. Shareholders of Kadmon common stock received $9.50 per share in cash, representing a transaction valued at $1.9&#160;billion on a fully-diluted basis. The Sanofi and Kadmon Boards of Directors unanimously approved the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The acquisition of Kadmon by Sanofi was completed on November&#160;9, 2021, with Sanofi holding the entire share capital of Kadmon upon expiration of the squeeze-out procedure.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was therefore accounted for as an asset acquisition given that the principal asset (belumosudil, commercialized in the United States under the brand name Rezurock</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Of the total acquisition price paid, &#8364;1,739&#160;million was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the consolidated statement of cash flows is a net cash outflow of &#8364;1,575&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Origimm</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;3, 2021, Sanofi acquired the entire share capital of Origimm Biotechnology GmbH, a privately owned Austrian biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria that cause skin diseases such as acne, for an upfront payment of &#8364;55&#160;million and up to &#8364;95&#160;million contingent upon reaching certain development and regulatory milestones.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was therefore accounted for as an asset acquisition given that the principal asset (the group of Propionibacterium acnes antigens) concentrates substantially all of the fair value of the acquired set of activities and assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Nearly &#8364;55&#160;million of the acquisition price paid was allocated to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this acquisition as reflected within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions of consolidated undertakings and investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">in the consolidated statement of cash flows for the year ended December&#160;31, 2021 is a net cash outflow of&#160;&#8364;50&#160;million.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.2.2. Principal changes in the scope of consolidation in 2020</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Principia</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On August&#160;17, 2020, Sanofi and Principia Biopharma&#160;Inc. (&#8220;Principia&#8221;), a late-stage biopharmaceutical company focused on developing treatments for autoimmune diseases, entered into a definitive agreement under which Sanofi was to acquire all the outstanding shares of Principia for $100 per share. The transaction was approved unanimously by the Boards of Directors of Sanofi and Principia. Sanofi's acquisition of Principia was completed on September&#160;28, 2020, with Sanofi holding the entire share capital of Principia upon expiration of the squeeze-out procedure. The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;912 million:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:76.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,534</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net deferred tax position</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(436)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Principia</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,246</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">912</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,158</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The other intangible assets mainly comprise:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">rilzabrutinib (PRN&#160;1008), a molecule undergoing clinical trials for various indications in immuno-inflammatory diseases and rare blood disorders; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">tolebrutinib (PRN&#160;2246/SAR442168), a molecule currently undergoing clinical trials for the treatment of multiple sclerosis and other diseases of the central nervous system.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill represents (i)&#160;the pipeline of future products in pre-clinical research and development; (ii)&#160;the capacity to draw on a specialized structure to refresh the existing product portfolio; and (iii)&#160;the competencies of Principia staff.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No material adjustment was required on completion of the final purchase price allocation.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Synthorx</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;9, 2019, Sanofi and Synthorx&#160;Inc. (&#8220;Synthorx&#8221;), a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, entered into a definitive agreement under which Sanofi was to acquire all of the outstanding shares of Synthorx for $68 per share. The transaction was unanimously approved by both the Sanofi and Synthorx Boards of Directors. On December&#160;23, 2019, Sanofi launched a public tender offer to acquire all of the outstanding ordinary shares of Synthorx for $68 per share in cash, without interest and net of any applicable withholding taxes. The acquisition of Synthorx was completed on January&#160;23, 2020, with Sanofi holding the entire share capital of Synthorx upon expiration of the squeeze-out procedure. The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;930&#160;million:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,549</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net deferred tax position</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(269)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Synthorx</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,316</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">930</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,246</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The other intangible assets mainly comprise THOR-707, a molecule currently in Phase&#160;I clinical trials that stimulates T&#160;lymphocytes, and as such has potential as a cancer immunotherapy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill represents (i)&#160;the pipeline of future products in pre-clinical research and development; (ii)&#160;the capacity to draw on a specialized structure to refresh the existing product portfolio; (iii)&#160;the competencies of Synthorx staff; (iv)&#160;benefits derived from the creation of new growth platforms; and (v)&#160;expected future synergies and other benefits from the combination of Synthorx and Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No material adjustment was required on completion of the final purchase price allocation.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transaction related to the equity-accounted investment in Regeneron</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">From the beginning of April&#160;2014, Sanofi accounted for its investment in Regeneron using the equity method. As from that date, in accordance with the Investor Agreement as amended in early 2014, Sanofi had the right to designate a member of the Regeneron Board of Directors.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On May&#160;29, 2020, Sanofi closed the transaction announced on May&#160;25, 2020 involving the sale of its equity investment in Regeneron (with the exception of 400,000&#160;shares), through (i)&#160;a registered public offering in the United States and internationally and (ii)&#160;a share repurchase by Regeneron. Sanofi divested 13&#160;million shares of Regeneron common stock (of which&#160;10.6&#160;million were sold by Sanofi) through the public offering at a price of $515 per share, raising a total amount of&#160;$6,703&#160;million; and Regeneron repurchased 9.8&#160;million of its own shares of common stock directly from Sanofi for&#160;$5,000&#160;million, at the offer price less a subscription discount ($509.85 per share). The total sale proceeds (before transaction-related costs) amounted to &#8364;10,575&#160;million. At the same time, Sanofi as a result of this transaction lost the right to designate a member of the Regeneron Board of Directors under the amended Investor Agreement. Finally, as of May&#160;29, 2020 Sanofi retained ownership of 400,000&#160;Regeneron shares in order to continue to partially fund its commitments to invest in the development programs for cemiplimab (REGN2810) and dupilumab, in line with the 2018 Letter Agreement under which Sanofi is permitted to sell up to 1.4&#160;million shares through the end of 2020. As of December 31, 2022, Sanofi had sold 779,320&#160;Regeneron shares under that agreement. The number of Regeneron shares retained by Sanofi is 279,766 as of December&#160;31, 2021 (see&#160;Note&#160;C.1.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s equity investment in Regeneron was accounted for by the equity method until May&#160;29, 2020. As of that date, the carrying amount of the investment was &#8364;3,668&#160;million; that amount was reversed out on closing of the transaction. Before tax effects, the gain on the divestment amounted to &#8364;7,382&#160;million, including (i)&#160;a gain of &#8364;318&#160;million arising on the currency translation reserve associated with Regeneron, which was taken to profit or loss in accordance with IAS&#160;21; (ii)&#160;the deduction of transaction-related costs of &#8364;64&#160;million; and&#160;(iii)&#160;a gain of &#8364;157&#160;million on the remeasurement of the 400,000&#160;retained shares at their quoted market price as of May&#160;29, 2020 ($612.81). In accordance with IFRS&#160;9 (Financial Instruments), the retained shares were classified in the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Equity instruments at fair value through other comprehensive income&#8221; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">category on the transaction date, at a value of &#8364;221&#160;million (see Note&#160;D.7.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tax charge arising on the transaction was &#8364;502&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Given the material impact of this transaction, and to facilitate users&#8217; understanding of the financial statements, the pre-tax gain on this transaction is presented as a separate line item in the consolidated income statement, &#8220;Gain on Regeneron investment arising from the transaction of May&#160;29, 2020&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The net cash inflow from the transaction was &#8364;10,370&#160;million, which (for the reason cited above) is presented as a separate line item in the consolidated statement of cash flows, &#8220;Net proceeds from sale of Regeneron shares on May&#160;29, 2020&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;27, 2019, Sanofi entered into a definitive agreement to sell Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">to Baxter. The sale was completed on&#160;February&#160;14,&#160;2020. Sanofi recognized a pre-tax gain of &#8364;129&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of this sale, reflected in the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">net of tax</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> within the consolidated statement of cash flows, was a net cash inflow before tax of&#160;&#8364;311&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combinations [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for impact of changes in the scope of consolidation due to acquisitions and divestments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439314176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text">Property, plant and equipment<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.3.1. Property, plant and equipment owned</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Property, plant and equipment owned by Sanofi is comprised of the following items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:28.149%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.696%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Land</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Buildings</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Machinery<br/>and<br/>equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fixtures,<br/>fittings&#160;and<br/>other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Property,&#160;plant<br/>and&#160;equipment<br/>in process</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">255</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,282</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,053</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,587</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,391</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23,568</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(173)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(177)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(123)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(487)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(264)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(276)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(67)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(91)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(711)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,051)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(521)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">236</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,828</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,127</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,524</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,454</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23,169</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(80)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(314)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(839)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">240</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,170</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,648</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,655</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,097</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24,810</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,104)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,642&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,748&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(559)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,626)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(318)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">237</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,328</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,848</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,515</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,996</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23,924</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(11)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4,065)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(7,660)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,984)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(131)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(13,851)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(356)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(605)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(182)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,143)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,898)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(7,792)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,981)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(123)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(13,804)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(306)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(592)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(167)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,065)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(80)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(99)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(208)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(9)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4,190)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8,340)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,115)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(128)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14,782)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(622)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,142)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4,225)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(7,637)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,015)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(168)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14,055)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,930&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,335&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,331&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,365&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,980&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,308&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,969&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">227</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,103</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,211</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">500</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,828</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,869</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line includes in particular property, plant and equipment in process brought into service during the period, but also includes the effect of the reclassification of assets to Assets held for sale or exchange.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth acquisitions and capitalized interest by operating segment for the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,748</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,504</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,310</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Industrial facilities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">534&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">634&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Research sites</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">152&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">199&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Consumer Healthcare</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capitalized interest</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Off balance sheet commitments relating to property, plant and equipment as of December 31, 2022, 2021 and 2020 are set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Firm orders of property, plant and equipment</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Property, plant and equipment pledged as security for liabilities</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth the net impairment losses recognized in each of the last three financial periods:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net impairment losses on property, plant and equipment</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">186</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">43</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) For 2022, the amount mainly comprises an impairment loss arising from a decision to discontinue operations at an industrial facility located outside&#160;France.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.3.2. Property, plant and equipment leased &#8211; right-of-use assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Right-of-use assets relating to property, plant and equipment leased by Sanofi are analyzed in the table below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:82.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Right-of-use assets</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,583</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(121)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(85)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,711</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(91)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,745</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,872</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(283)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and impairment charged in the period</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(513)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and impairment charged in the period</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(315)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(797)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and impairment charged in the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,057)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,198</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,948</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,815</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line also includes the effect of the reclassification of assets to &#8220;Assets held for sale or exchange&#8221;.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In December&#160;2018, Sanofi signed two leases on real estate assets in the United States (at Cambridge, Massachusetts) for an initial lease term of 15 years. The first lease, relating to office space, began in April&#160;2021; Sanofi recognized a right-of-use asset of &#8364;320 million, as well as the lease liability. The second lease, relating to laboratory facilities, began on July&#160;1, 2021; Sanofi recognized a right-of-use asset of &#8364;424 million, as well as the lease liability.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Leased assets are mainly comprised of office and industrial premises (93%) and the vehicle fleet (7%) as of December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Annual lease costs on short term leases and low value asset leases amounted to &#8364;26 million in the year ended December 31, 2022, &#8364;25 million in the year ended December 31, 2021, and &#8364;27 million in the year ended December 31, 2020. Variable lease payments, sub-leasing activities, and sale-and-leaseback transactions were immaterial.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Total cash outflows on leases (excluding annual lease costs on short term leases and low value asset leases) were &#8364;389 million in&#160;the year ended December 31, 2022, &#8364;302 million in the year ended December 31, 2021, and &#8364;269 million in the year ended&#160;December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A maturity analysis of the lease liability is disclosed in Note&#160;D.17.2.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Commitments related to short-term leases and low value asset leases, including future payments for lease contracts committed but not yet commenced, are disclosed in Note&#160;D.21.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439716784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and other intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract', window );"><strong>Intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory', window );">Goodwill and other intangible assets</a></td>
<td class="text">Goodwill and other intangible assets<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in goodwill comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:82.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44,519</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions during the period</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,843&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements during the period</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,923)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44,364</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions during the period</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements during the period</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(89)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">48,056</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions during the period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements during the period</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(258)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">49,892</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line mainly comprises the amount of goodwill allocated to divested operations in accordance with paragraph&#160;86 of IAS&#160;36, and in 2022 the sale of EUROAPI (see note&#160;D.1.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Amunix Pharmaceuticals, Inc. (2022)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation for Amunix Pharmaceuticals, Inc. resulted in the recognition of intangible assets (other than goodwill) o</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">f&#160;&#8364;493&#160;million as of the acquisition date (February&#160;8, 2022), and of goodwill provisionally measured at &#8364;609&#160;million as of the acquisition date (see Note&#160;D.1.).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Translate Bio (2021)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation for Translate&#160;Bio resulted in the recognition of intangible a</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ssets (other than goodwill) of&#160;&#8364;396&#160;million as of the acquisition date (September&#160;14, 2021), and of goodwill measured at &#8364;2,118&#160;million as of the</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> acquisition date (see Note&#160;D.2.1.).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Principia (2020)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation for Principia resulted in the recognition of in</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">tangible assets (other than goodwill) of &#8364;2,534 million as of the acquisition date (September&#160;28, 2020), and of goodwill measured at &#8364;912&#160;million as of the acquisition date (se</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">e&#160;Note&#160;D.2.2.).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Synthorx (2020)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation for Synthorx resulted in the recognition of intangible a</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ssets (other than goodwill) totaling &#8364;1,549 million as of the acquisition date (January&#160;23, 2020), and of goodwill measured at &#8364;930 million as o</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">f the acquisition date (see Note&#160;D.2.2.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in other intangible assets comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.595%"><tr><td style="width:1.0%"/><td style="width:50.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.235%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.061%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquired R&amp;D</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Products,<br/>trademarks and<br/>other rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Software</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total other<br/>intangible assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at January&#160;1, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,730</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">63,953</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,613</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">71,296</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes&#160;in&#160;scope of&#160;consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,951&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,083&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(44)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(243)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(46)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(333)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(593)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,926)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,557)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(98)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December&#160;31, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,600</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">61,074</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,633</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">72,307</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,805&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,626&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(313)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(173)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(502)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(784)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2021</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,207</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">65,906</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,752</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">78,865</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(423)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(543)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,994&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,576)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,354</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">69,579</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,783</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">81,716</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at January&#160;1, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,396)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(50,314)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,077)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(54,787)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,707)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(112)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,819)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(328)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(330)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,460&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,649&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at December&#160;31, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,508)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(49,345)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,113)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(53,966)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(119)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,740)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(150)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(192)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(132)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,869)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,022)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at December&#160;31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,477)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(52,744)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,237)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(57,458)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,099)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,196)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,107)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,561&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,567)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,591)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4,128)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(54,652)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,296)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(60,076)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,092&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,729&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,341&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,730&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,162&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,407&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,226</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,927</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">487</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21,640</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement (see Note&#160;A.2.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) The &#8220;Transfers&#8221; line mainly comprises (i) acquired R&amp;D that came into commercial use during the period and (ii) reclassifications of assets as held for sale or exchange.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) The &#8220;Changes in scope of consolidation&#8221; line corresponds to the fair value of intangible assets recognized in connection with acquisitions made during the period (see Notes&#160;D.1. and&#160;D.2.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) See Note&#160;D.5.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) The amendment to the terms of the IO License and Collaboration Agreement resulted in the recognition of an amortization charge of &#8364;226&#160;million (see&#160;Note C.1.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Products, trademarks and other rights&#8221; mainly comprise:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">&#8220;marketed products&#8221;, with a carrying amount of &#8364;12.7 billion as of December 31, 2022 (versus &#8364;11.7 billion as of December 31, 2021 and &#8364;11.4 billion as of December 31, 2020) and a weighted average amortization period of approximately 10&#160;years; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">&#8220;technological platforms&#8221;, with a carrying amount of &#8364;2.2 billion as of December 31, 2022 (versus &#8364;1.2&#160;billion as of December 31, 2021 and &#8364;0.2&#160;billion as of December 31, 2020) and a weighted average amortization period of approximately 18&#160;years.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below provides information about the principal &#8220;marketed products&#8221;, which were recognized in connection with major acquisitions made by Sanofi and represented 92% of the carrying amount of that item as of December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:20.645%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>amortization&#160;&amp;<br/>impairment</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortization</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">period</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(years)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Residual</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">amortization</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">period</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(years)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,490&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,869)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Boehringer Ingelheim <br/>Consumer Healthcare</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,633&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,596)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,037&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34,684&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(34,626)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chattem</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,360&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Protein Sciences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ablynx</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(609)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,955&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,119)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,836&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,240&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kadmon</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,702&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total: principal marketed products</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">62,827</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(51,144)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,683</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,752</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,341</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Weighted averages. The amortization periods for these products vary between 1&#160;and 25&#160;years.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Weighted averages.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acquisitions of other intangible assets (excluding software) during 2022 amounted to &#8364;472 million. The main items were upfront and milestone payments within the Specialty Care GBU.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal intangible assets brought into service during 2022 were:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Enjaymo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (sutimlimab-jome), a treatment for cold agglutinin disease (gross value &#8364;854&#160;million net of impairment of &#8364;363&#160;million), with effect from the date of marketing approval (February&#160;2022); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">technology platforms (&#8364;525&#160;million).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main asset brought into service during 2021 was the Translate Bio mRNA technology platform.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During 2020, some of the acquired research and development came into commercial use, and started being amortized from the date of marketing approval; the main items involved were Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, indicated for the treatment of relapsed refractory multiple myeloma, and the meningococcal vaccine MenQuadfi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amortization of other intangible assets is recognized in the income statement within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Amortization of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, except for amortization of software and other rights of an industrial or operational nature which is recognized in the relevant classification of expense by function. An analysis of amortization of software is shown in the table below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:59.696%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">97</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">119</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">112</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement (see Note&#160;A.2.1.).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455573408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impairment of intangible assets and property, plant and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentOfAssetsAbstract', window );"><strong>Impairment Of Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock', window );">Impairment of intangible assets and property, plant and equipment</a></td>
<td class="text">Impairment of intangible assets and property, plant and equipment<div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;36, goodwill is allocated to groups of cash generating units (CGUs) at a level corresponding to the Pharmaceuticals, Consumer Healthcare and Vaccines segments. When testing goodwill annually for impairment, the recoverable amount is determined for each segment on the basis of value in use, determined using discounted estimates of the future cash flows in accordance with the policies described in Note&#160;B.6.1.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The allocation of goodwill as of December 31, 2022 is shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer Healthcare</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39,421</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,690</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,781</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">49,892</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The value in use of each segment was determined by applying an after-tax discount rate to estimated future after-tax cash flows.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A separate discount rate is used for each segment to reflect the specific economic conditions of that segment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The rates used for impairment testing in 2022 were 7.25% for the Pharmaceuticals segment, 7.00% for the Consumer Healthcare segment and 7.25% for the Vaccines segment; an identical value in use for Sanofi as a whole would be obtained by applying a uniform 7.2% rate to all three segments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The pre-tax discount rates applied to estimated pre-tax cash flows are calculated by iteration from the previously-determined value in use. Those pre-tax discount rates were 9.9% for the Pharmaceuticals segment, 9.4% for the Consumer Healthcare segment and 9.9% for the Vaccines segment, and equate to a uniform rate of 9.8% for Sanofi as a whole.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The assumptions used in testing goodwill for impairment are reviewed annually. Apart from the discount rate, the principal assumptions used in 2022 were as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the perpetual growth rates applied to future cash flows were zero for the Pharmaceuticals and Vaccines segments, and 1% for the Consumer Healthcare segment;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Sanofi also applies assumptions on the probability of success of current research and development projects, and more generally on its ability to renew the product portfolio in the longer term.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Value in use (determined as described above) is compared with the carrying amount, and this comparison is then subjected to sensitivity analyses by reference to the principal parameters, including:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">changes in the discount rate;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">changes in the perpetual growth rate; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">fluctuations in operating margin.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No impairment of goodwill would need to be recognized in the event of a reasonably possible change in the assumptions used in&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A value in use calculation for each of the segments would not result in an impairment loss using:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a discount rate up to 2.6&#160;percentage points above the rates actually used; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a perpetual growth rate up to 4.3&#160;percentage points below the rates actually used; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">an operating margin up to 6.7&#160;percentage points below the rates actually used.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No impairment losses were recognized against goodwill in the years ended December 31, 2022, 2021 or 2020.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When there is evidence that an asset may have become impaired, the asset&#8217;s value in use is calculated by applying an after-tax discount rate to the estimated future after-tax cash flows from that asset. For the purposes of impairment testing, the tax cash flows relating to the asset are determined using a notional tax rate incorporating the notional tax benefit that would result from amortizing the asset if its value in use were regarded as its depreciable amount for tax purposes. Applying after-tax discount rates&#160;to after-tax cash flows gives the same values in use as would be obtained by applying pre-tax discount rates to pre-tax cash&#160;flows.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The after-tax discount rates used in 2022 for impairment testing of other intangible assets in the Pharmaceuticals, Consumer Healthcare and Vaccines segments were obtained by adjusting Sanofi&#8217;s weighted average cost of capital to reflect specific country and business risks, giving after-tax discount rates in a range from </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">7.25% to 8.25%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In most instances, there are no market data that would enable fair value less costs to sell to be determined other than by means of developing a similar estimate based on future cash flows. Consequently, recoverable amount is in substance equal to value in use. The estimates used to determine value in use are sensitive to assumptions specific to the nature of the asset and to Sanofi's activities. Apart from the discount rate, the principal assumptions used in 2022 were as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">mid-term and long-term forecasts;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">perpetual growth or attrition rates, when applicable; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">probability of success of current research and development projects.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The assumptions used in testing intangible assets for impairment are reviewed at least annually.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, 2021 and 2020, impairment testing of other intangible assets (excluding software) resulted in the recognition of net impairment losses as shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impairment of other intangible assets, net of reversals  (excluding software)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(454)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">192</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">330</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Marketed products</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,561)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Pharmaceuticals </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1,542)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Vaccines</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Consumer Healthcare</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development projects </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a) / (b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) For 2022, these amounts mainly comprise a reversal of &#8364;2,154&#160;million of impairment losses taken against Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> and BIVV001 (assets belonging to the Eloctate franchise), consisting of &#8364;1,554&#160;million for marketed products and &#8364;600&#160;million for research and development projects respectively. In 2019, the launch of competing products for Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> led Sanofi to update its sales forecasts for products belonging to the franchise, as a result of which  impairment losses of &#8364;2.8&#160;billion were recognized against the assets in question. The reversal reflects the approval by the FDA on February 22, 2023 of the marketing authorization application for ALTUVIIIO&#8482; (the commercial name of efanesoctocog alpha, corresponding to the BIVV001 project), which was submitted in 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) For 2022, this amount mainly comprises: </span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.93pt">an impairment loss of &#8364;1,586&#160;million taken against the development project for SAR444245 (non-alpha interleukin-2), recognized following revised cash flow projections reflecting unfavorable developments in the launch schedule;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.93pt">the &#8364;600m reversal relating to the BIVV001 project (see above). </span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">     For 2021, this line relates to the discontinuation of the development of sutimlimab in the treatment of Immune Thrombocytopenic Purpura (ITP), and to the termination of various research projects in Vaccines. For 2020, this line mainly comprises impairment losses taken against R&amp;D programs within the Specialty Care GBU, and the discontinuation of certain R&amp;D programs and collaboration agreements in Diabetes.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Impairment losses taken against property, plant and equipment are disclosed in Note&#160;D.3.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for impairment of intangible assets and property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpairmentOfAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Of Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpairmentOfAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442191968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments accounted for using the equity method<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestsInOtherEntitiesAbstract', window );"><strong>Interests In Other Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory', window );">Investments accounted for using the equity method</a></td>
<td class="text">Investments accounted for using the equity method<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Investments accounted for using the equity method comprise associates and joint ventures (see Note&#160;B.1.), and are set forth below.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:49.895%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%&#160;interest</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EUROAPI</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MSP Vaccine Company</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">677</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">250</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">201</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;Following the distribution in kind and the acquisition of an equity interest by EPIC Bpifrance, Sanofi holds 30.1% of the capital of EUROAPI (see Note&#160;B.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Joint venture.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Joint venture. MSP Vaccine Company owns 100% of MCM Vaccine B.V.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows Sanofi&#8217;s overall share of (i)&#160;profit or loss and (ii)&#160;other comprehensive income from investments accounted for using the equity method, showing the split between associates and joint ventures in accordance with IFRS&#160;12 (the amounts for each individual associate or joint venture are not material):</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:28.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.562%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Joint&#160;ventures</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Associates</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Joint&#160;ventures</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Associates</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Joint&#160;ventures</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Associates</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of other comprehensive income from investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(311)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">72</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes &#8364;343&#160;million for Sanofi's share of the net income of Regeneron up to and including May&#160;29, 2020 (see Note&#160;D.2.2.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The financial statements include arm&#8217;s length commercial transactions between Sanofi and some equity-accounted investments that are classified as related parties. The principal transactions and balances with related parties are summarized below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:59.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Royalties and other income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable and other receivables</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchases and other expenses (including research expenses)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts payable and other payables</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) For 2020, these amounts include transactions between Sanofi and Regeneron for the period from January&#160;1 through May&#160;29, 2020. The table above does not include the repurchase by Regeneron of its own shares from Sanofi (see Note&#160;D.2.2.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In 2022, these items include Sanofi's transactions with EUROAPI from May&#160;10, 2022 (see Note&#160;D.1.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">There were no funding commitments to associates and joint ventures as of December 31, 2022, December 31, 2021 or December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For off balance sheet commitments of an operational nature involving joint ventures, see Note&#160;D.21.1.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestsInOtherEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interests In Other Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestsInOtherEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442192096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other non-current assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory', window );">Other non-current assets</a></td>
<td class="text">Other non-current assets<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:49.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity instruments at fair value through other comprehensive income (D.7.1.)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt instruments at fair value through other comprehensive income (D.7.2.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other financial assets at fair value through profit or loss (D.7.3.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pre-funded pension obligations (Note&#160;D.19.1.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term prepaid expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term loans and advances and other non-current receivables</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derivative financial instruments (Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,095</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,127</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,734</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) The movement in this item mainly comprises (i)&#160;the non-current portion of a $100&#160;million upfront payment made on signature of a research agreement with Exscientia on January&#160;7, 2022 to develop a portfolio of precision-engineered medicines using artificial intelligence; and (ii)&#160;the non-current portion of a $150&#160;million upfront payment made as part of a strategic partnership with IGM Biosciences signed on March&#160;29, 2022, with a view to developing targets in oncology, immunology and inflammation</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) As of December 31, 2022, this item includes a receivable under a sub-lease amounting to &#8364;164 million, or &#8364;227 million before discounting.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.7.1. Equity instruments at fair value through other comprehensive income</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quoted equity investments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line &#8220;Equity instruments at fair value through other comprehensive income&#8221; includes equity investments quoted in an active market with a carrying amount of &#8364;387 million as of December 31, 2022, &#8364;396 million as of December 31, 2021 and &#8364;439 million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main changes in quoted equity investments included in the &#8220;Equity instruments at fair value through other comprehensive income&#8221; category in the year ended December 31, 2022 are described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the sale in June&#160;2022 of the residual equity interest in Regeneron (see Note&#160;C.1.). for $174 million, the entire loss on which was recorded within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the acquisition of an equity interest in Innovent Biologics, in connection with a strategic collaboration agreement to intensify&#160;development in oncology medicines signed in August 2022, which had a fair value of &#8364;250 million as of that date and &#8364;228 million as of December&#160;31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main changes in quoted equity investments included in this category in previous years are described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in 2021, following completion of the acquisition of Translate Bio on September&#160;14, 2021 (see Note&#160;D.2.1.), the equity interest of approximately 5% in Translate Bio previously held by Sanofi ceased to be accounted for as an </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">equity instrument at fair value through other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in 2020:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">following the sale of 22.8&#160;million shares of Regeneron common stock on May&#160;29, 2020 (see Note&#160;D.2.2.), Sanofi ceased to exercise significant influence over Regeneron, and this investment ceased to be accounted for using the equity method (see Note&#160;D.6.). In accordance with IFRS&#160;9 (Financial Instruments), the 400,000&#160;shares retained by Sanofi were classified in&#160;the &#8220;Equity instruments at fair value through other comprehensive income&#8221; category as of May&#160;29, 2020, at a carrying&#160;amount of &#8364;221&#160;million. As of&#160;December 31, 2020, Sanofi held 279,766&#160;Regeneron shares with a carrying amount of &#8364;111 million,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">an equity injection was made into Translate&#160;Bio under the terms of the collaboration and license agreement announced on&#160;June&#160;23,&#160;2020, which had a carrying amount of &#8364;74 million as of December&#160;31, 2021 and represented an equity interest of approximately&#160;8% of Translate Bio as of that date,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">Sanofi owns equity interests in quoted biotechnology companies. Movements in the quoted market prices of the shares held in those companies generated a net gain of &#8364;357 million, recognized in &#8220;Equity instruments at fair value through other comprehensive income&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A 10% decline in stock prices of the quoted equity investments included within &#8220;Equity instruments at fair value through&#160;other&#160;comprehensive income&#8221; would have had a pre-tax impact of &#8364;39 million on </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as of December 31, 2022.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unquoted equity investments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line item &#8220;Equity instruments at fair value through other comprehensive income&#8221; also includes equity investments not quoted in an active market with a carrying amount of &#8364;549 million as of December 31, 2022, &#8364;427 million as of December 31, 2021 and &#8364;149 million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The change in unquoted equity investments included in the &#8220;Equity instruments at fair value through other comprehensive income&#8221; category during the year ended December 31, 2022 was mainly due to various equity stakes acquired through the Sanofi Ventures fund, partly offset by the sale in October&#160;2022 of the 19% non-controlling interest in Onduo for $175 million; the entire gain on the disposal was recognised in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.7.2. Debt instruments at fair value through other comprehensive income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The &#8220;Debt instruments at fair value through other comprehensive income&#8221; category includes quoted euro-denominated senior bonds amounting to &#8364;329 million as of December 31, 2022, including &#8364;104 million of securities obtained in exchange for financial assets held to meet obligations to employees under post-employment benefit plans.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi held &#8364;447 million of quoted senior bonds as of December&#160;31, 2021 and &#8364;426 million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As regards debt instruments held to meet obligations to employees under post-employment benefit plans, an increase of 10&#160;basis points in market interest rates as of December 31, 2022 would have had a pre-tax impact of &#8364;1 million on </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As regards other quoted debt instruments, an increase of 10&#160;basis points in market interest rates as of December 31, 2022 would have had a pre-tax impact of &#8364;1 million on </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other comprehensive income recognized in respect of &#8220;Equity instruments at fair value through other comprehensive income&#8221; and &#8220;Debt instruments at fair value through other comprehensive income&#8221; represented unrealized after-tax gains of &#8364;256 million for the year ended December 31, 2022, versus unrealized after-tax gains of &#8364;322 million for the year ended December 31, 2021 and unrealized after-tax losses of &#8364;200 million for the year ended December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of the change in gains and losses recognized in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, and of items reclassified to profit or loss, is presented in Note&#160;D.15.7.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.7.3. Other financial assets at fair value through profit or loss</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The &#8220;Other financial assets at fair value through profit or loss&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">category includes:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">contingent consideration receivable by Sanofi following the dissolution of the Sanofi Pasteur MSD (SPMSD) joint venture, based on a percentage of MSD&#8217;s future sales during the 2017-2024 period of specified products previously distributed by&#160;SPMSD (see Note&#160;D.12.).</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of the MSD contingent consideration was determined by applying the royalty percentage stipulated in the contract to discounted sales projections. A reduction of one percentage point in the discount rate would increase the fair value of the&#160;MSD&#160;contingent consideration by approximately 1%.</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in the fair value of this contingent consideration are recognized in the income statement within the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Fair value remeasurement of contingent consideration </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(see Note&#160;B.18.). As of December 31, 2022, the contingent consideration asset amounted to &#8364;303 million (including a non-current portion of &#8364;196 million), versus &#8364;378 million (non-current portion: &#8364;275 million) as of December 31, 2021 and &#8364;483 million (non current portion: &#8364;374 million) as of December 31, 2020;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a portfolio of financial investments (amounting to &#8364;512 million as of December 31, 2022) held to fund a deferred compensation plan provided to certain employees (versus &#8364;549 million as of December 31, 2021 and &#8364;453 million as of December 31, 2020);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">unquoted securities not meeting the definition of equity instruments amounting to &#8364;115 million as of December 31, 2022 (versus &#8364;78 million as of December 31, 2021 and &#8364;63 million as of December 31, 2020).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other non-current assets. [Refer: Other non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442278784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets held for sale or exchange and liabilities related to assets held for sale or exchange<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory', window );">Assets held for sale or exchange and liabilities related to assets held for sale or exchange</a></td>
<td class="text">Assets held for sale or exchange and liabilities related to&#160;assets held for sale or exchange<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Assets held for sale or exchange, and liabilities related to assets held for sale or exchange, comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:52.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.216%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets held for sale or exchange</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">85</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">89</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">83</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Liabilities related to assets held for sale or exchange</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, assets held for sale mainly related to items of property, plant and equipment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2021, assets held for sale mainly related to the divestment of a listed equity investments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2020, assets held for sale mainly related to the planned divestment of an industrial facility in North America.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of non-current assets or disposal groups classified as held for sale. [Refer: Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405457148384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">Inventories</a></td>
<td class="text">Inventories<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inventories comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.907%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.829%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Allowances</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Allowances</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Allowances</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying<br/>amount</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,474&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,663&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(678)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,985&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(554)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,025&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(542)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,856&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,748&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(247)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(218)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,024</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,064)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,960</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,619</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(904)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,715</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,188</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(836)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,352</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Allowances include write-downs of products on hand pending marketing approval, except in specific circumstances where it is possible to estimate that recovery of the value of inventories as of the end of the reporting period is highly probable.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inventories pledged as security for liabilities amounted to &#8364;3 million as of December 31, 2022 (versus &#8364;20 million as of December 31, 2021 and &#8364;17 million as of December 31, 2020).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39__IAS02_g36-39_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405457148384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfTradeReceivablesTextBlock', window );">Accounts receivable</a></td>
<td class="text">Accounts receivable<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Accounts receivable break down as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:52.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.216%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross value</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,537&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,705&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,633&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(137)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(142)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,424</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,568</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,491</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The impact of allowances against accounts receivable in 2022 was a net amount of less than &#8364;1 million (versus a net expense of&#160;&#8364;12 million in 2021 and a net expense of &#8364;30 million in 2020).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The gross value of overdue receivables was &#8364;452 million as of December 31, 2022, versus &#8364;455 million as of December 31, 2021 and &#8364;549 million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:17.123%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.532%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;accounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">gross value</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&lt;1 month</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to&#160;3&#160;months</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to&#160;6&#160;months</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6&#160;to&#160;12&#160;months</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&gt;&#160;12&#160;months</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">452</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">118</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">161</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">87</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">35</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amounts overdue by more than one month relate mainly to public-sector customers.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Some Sanofi subsidiaries have assigned receivables to factoring companies or banks without recourse. The amount of receivables&#160;derecognized was &#8364;131 million as of December 31, 2022 (&#8364;3 million as of December 31, 2021 and &#8364;18 million as of December 31, 2020). The residual guarantees relating to such transfers were immaterial as of December 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfTradeReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfTradeReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442220176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory', window );">Other current assets</a></td>
<td class="text">Other current assets<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Other current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax receivables, other than corporate income taxes</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other receivables</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate derivatives measured at fair value (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency derivatives measured at fair value (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current financial assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,532</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,571</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,737</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line mainly comprises advance payments to suppliers, and receivables relating to Sanofi's activities as agent under a transitional services agreement.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) This item includes bank loans and receivables maturing in less than one year with high-grade counterparties. For 2021, this item also includes debt instruments derived from the acquisitions of Translate Bio and Kadmon (carried out in 2021) with maturities of more than 3&#160;months at inception and less than 12&#160;months at December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other current assets. [Refer: Other current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442155664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities measured at fair value<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueMeasurementAbstract', window );"><strong>Fair Value Measurement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock', window );">Financial assets and liabilities measured at fair value</a></td>
<td class="text">Financial assets and liabilities measured at fair value<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under IFRS&#160;7 (Financial Instruments: Disclosures), fair value measurements must be classified using a fair value hierarchy with the following levels:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">level&#160;2: quoted prices in active markets for similar assets and liabilities, or valuation techniques in which all important inputs are derived from observable market data;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">level&#160;3: valuation techniques in which not all important inputs are derived from observable market data.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The valuation techniques used are described in Note&#160;B.8.5.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the balance sheet amounts of assets and liabilities measured at fair value.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:32.131%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in the fair value</span></div><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">hierarchy</span></div></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in the fair value<br/>hierarchy</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in the fair value<br/>hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial assets measured at fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Quoted equity investments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.1.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unquoted equity investments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.1.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Quoted debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.2.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unquoted debt securities not meeting the definition of equity instruments</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.3.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration relating to divestments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.3.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial assets held to meet obligations under deferred compensation plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.3.  and D.11.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.11.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mutual fund investments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.13.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,537&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,057&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total financial assets measured at fair value</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,765</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">206</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">967</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,449</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">298</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">883</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,022</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">82</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">695</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial liabilities measured at fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bayer contingent purchase consideration arising from the acquisition of Genzyme</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MSD contingent consideration (European vaccines business)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shire contingent consideration arising from the acquisition of Translate Bio</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration arising from acquisition of Amunix</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other contingent consideration arising from business combinations and acquisitions</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.19.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.19.5</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total financial liabilities measured at fair value</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">326</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">779</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">85</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">714</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">297</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">605</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No transfers between the different levels of the fair value hierarchy occurred during 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of financial assets and liabilities at fair value explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FairValueMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Measurement [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FairValueMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442160848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory', window );">Cash and cash equivalents</a></td>
<td class="text">Cash and cash equivalents<div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash equivalents</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,351&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,740&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,771&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,736</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,098</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,915</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) As of December 31, 2022, cash equivalents mainly comprised the following: (i)&#160;&#8364;9,537 million invested in euro and US dollar denominated money-market mutual funds (December 31, 2021: &#8364;5,057 million; December 31, 2020: &#8364;8,703 million); (ii)&#160;&#8364;1,167 million of term deposits (December 31, 2021: &#8364;2,768 million; December 31, 2020: &#8364;3,259 million) and (iii)&#160;nil commercial paper (December 31, 2021: &#8364;179 million; December 31, 2020: &#8364;74 million). Cash equivalents also include &#8364;439 million held by captive insurance and reinsurance companies in accordance with insurance regulations (December 31, 2021: &#8364;427 million; December 31, 2020: &#8364;425 million).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442550976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net deferred tax position<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">Net deferred tax position</a></td>
<td class="text">Net deferred tax position<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of the net deferred tax position is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:54.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred taxes on:</span></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Consolidation adjustments (intragroup margin in inventory)</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,388&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision for pensions and other employee benefits</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of other acquired intangible assets</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,269)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,079)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,083)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognition of acquired property, plant and equipment at fair value</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(27)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity interests in subsidiaries and investments in other entities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(617)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(590)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(522)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax losses available for carry-forward</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,516&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock options and other share-based payments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued expenses and provisions deductible at the time of payment</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,585&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred tax asset/(liability)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,540</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,981</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,406</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) As of December&#160;31, 2022, includes remeasurements of the acquired intangible assets of Bioverativ (&#8364;1,429 million), Principia (&#8364;625 million), Ablynx (&#8364;229 million), Genzyme (&#8364;150 million) and Amunix (&#8364;118 million).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In some countries, Sanofi is liable for withholding taxes and other tax charges when dividends are distributed. Consequently, Sanofi recognizes a deferred tax liability on the reserves of French and foreign subsidiaries (approximately &#8364;59.1 billion) which it regards as likely to be distributed in the foreseeable future. In determining the amount of the deferred tax liability as of December 31, 2022, Sanofi took into account changes in the ownership structure of certain subsidiaries, and the effects of changes in the taxation of dividends in France, following the ruling of the Court of Justice of the European Union in the Steria case and the resulting amendments to the 2015 Finance Act.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Includes deferred tax assets related to restructuring provisions, amounting to &#8364;256 million as of December 31, 2022, &#8364;307 million as of December 31, 2021, and &#8364;259 million as of December 31, 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The reserves of Sanofi subsidiaries that would be taxable if distributed but for which no distribution is planned, and for which no deferred tax liability has therefore been recognized, totaled &#8364;10.6 billion as of December 31, 2022, compared with &#8364;10.0 billion as of December 31, 2021 and &#8364;11.5 billion as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Most of Sanofi&#8217;s tax loss carry-forwards are available indefinitely. For a description of policies on the recognition of deferred tax assets, refer to Note&#160;B.22. For each tax consolidation, the recognition of deferred tax assets is determined on the basis of profit forecasts that are consistent with Sanofi&#8217;s medium-term strategic plan, and taking into consideration the tax consequences of the strategic opportunities available to Sanofi within the period of availability of tax loss carry-forwards and the specific circumstances of each tax consolidation. Deferred tax assets relating to tax loss carry-forwards as of December 31, 2022 amounted to &#8364;2,650 million, of which &#8364;1,144 million were not recognized (including &#8364;488&#160;million in respect of capital losses). This compares with &#8364;2,391 million as of December 31, 2021 (of which&#160;&#8364;875 million were not recognized) and &#8364;1,658 million as of&#160;December 31, 2020 (of which &#8364;331 million were not recognized).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows when tax losses available for carry-forward are due to expire:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:70.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Tax&#160;losses&#160;available for carry-forward</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2028 and later</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,349&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total as of December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,503</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total as of December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,644</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total as of December 31, 2020</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,515</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Excluding tax loss carry-forwards on asset disposals. Such carry-forwards amounted to &#8364;5 million as of December 31, 2022, &#8364;5 million as of&#160;December 31, 2021 and &#8364;6 million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Use of tax loss carry-forwards is limited to the entity in which they arose. In jurisdictions where tax consolidations are in place, tax losses can be netted against taxable income generated by entities in the same tax consolidation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Deferred tax assets not recognized (primarily because their future recovery was not regarded as probable given the expected results of the entities in question) amounted to &#8364;995 million in 2022, &#8364;615 million in 2021 and &#8364;346 million in 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442155664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract', window );"><strong>Share Capital, Reserves And Other Equity Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Consolidated shareholders' equity</a></td>
<td class="text">Consolidated shareholders&#8217; equity<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.1. Share capital</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, the share capital w</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as &#8364;2,521,671,464, consisting of 1,260,835,732&#160;shar</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">es with a par value of &#8364;2. Treasury shares held by Sanofi are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:49.895%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of&#160;shares </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(million)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%&#160;of&#160;share&#160;capital <br/>for the period</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.20</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.650</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="2" style="border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.02&#160;</span></td><td style="border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.872&#160;</span></td><td style="border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.658&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.002&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Treasury shares are deducted from shareholders&#8217; equity. Gains and losses on disposals of treasury shares are recorded directly in equity and are not recognized in net income for the period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in the share capital of the Sanofi parent company over the last three years are set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:33.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,253,846,111</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital&#160;increase&#160;by&#160;exercise&#160;of stock subscription options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">868,655&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by issuance of restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,666,256&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of July 28, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase reserved for employees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,590,716</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,258,971,738</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by exercise of stock subscription options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">190,076&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by issuance of restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,836,179&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of July 28, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase reserved for employees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,562,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,263,560,695</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by exercise of stock subscription options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">490,373&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by issuance of restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,499,987&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of July 27, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase reserved for employees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,027,057&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of December 14, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reduction in share capital by cancellation of <br/>treasury shares</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,742,380)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #5064a9;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,260,835,732</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Shares issued on exercise of Sanofi stock subscription options.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Shares vesting under restricted share plans and issued in the period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For the disclosures about the management of capital required under IFRS&#160;7, refer to Note&#160;B.27.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.2. Restricted share plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restricted share plans are accounted for in accordance with the policies described in Note&#160;B.24.3. The principal characteristics of those plans are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:38.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Type of plan</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Date of Board meeting approving the plan</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 3, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 14, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 27, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 28, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 28, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service period</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total number of shares awarded </span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,344,432&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">109,981&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,484,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,340,501&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73,027&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which with no market condition</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000,627&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,335&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,209,901&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,536,893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;91.19&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;79.17&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;77.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;82.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which with market condition</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,343,805&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99,646&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,274,519&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">803,608&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73,027&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded other than to the Chief Executive Officer</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;86.65&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;69.60&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;71.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;68.45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;76.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;63.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded other than to the Chief Executive Officer - additional shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;49.00&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;54.70&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded to the Chief Executive Officer</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;84.46&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;71.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;76.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value of plan at the date of grant (&#8364; million)</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">294</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">262</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">270</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Additional tranche subject to a higher level of market conditions: 114,874&#160;additional shares were awarded in May&#160;2022, and 9,066&#160;additional shares were awarded in December&#160;2022.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The total expense recognized for all restricted share plans, and the number of restricted shares not yet fully vested, are shown in the table below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:58.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total expense for restricted share plans (&#8364; million)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Number of shares not yet fully vested</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,121,573&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,507,849&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,546,612&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2022 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,206,861&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2021 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,097,531&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,364,895&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2020 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,817,181&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,014,496&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,284,558&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2019 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,128,458&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,375,717&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2018 plans</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,886,337&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.3. Capital increases</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The characteristics of the employee share ownership plans awarded in the form of a capital increase reserved for employees in&#160;2022, 2021 and 2020 are summarized in the table below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:58.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Date of Board meeting approving the plan</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 3, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 4, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 5, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Subscription price (&#8364;)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80.21&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">70.67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Subscription period</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 9-29, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 7-25, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 8-26, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Number of shares subscribed</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,909,008&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,438,590&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,467,101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Number of shares issued immediately as employer&#8217;s contribution</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118,049&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124,112&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123,615&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Subscription price representing 80% of the average of the opening quoted market prices of Sanofi shares during the 20&#160;trading days preceding June&#160;6,&#160;2022, June&#160;3,&#160;2021 and June&#160;2, 2020, respectively.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth the expense recognized for each plan:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:58.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense recognized</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which employer&#8217;s contribution</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">11&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">11&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.4. Repurchase of Sanofi shares</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Annual General Meetings of Sanofi shareholders held on May&#160;3, 2022, April&#160;30, 2021 and April&#160;28, 2020 each authorized a share repurchase program for a period of 18 months. The following repurchases have been made under those programs:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.185%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:29.25pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(in number of shares and &#8364; million)</span></div><div style="padding-right:29.25pt;text-align:justify"><span><br/></span></div><div style="padding-right:29.25pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Year of authorization</span></div></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number <br/>of shares</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number <br/>of shares</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number <br/>of shares</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022 program</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,510,000&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021 program</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,976,992&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,765,388&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020 program</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,758,569&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,685,426&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2019 program</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,982,939&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.5. Reductions in share capital</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Reductions in share capital for the accounting periods presented are described in the table included at Note&#160;D.15.1. above.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Those reductions have no impact on shareholders&#8217; equity.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.6. Currency translation differences</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Currency translation differences comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.901%"><tr><td style="width:1.0%"/><td style="width:56.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.126%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Attributable to equity holders of Sanofi</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(865)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,384)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(55)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,462</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(907)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,439)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The balance as of December 31, 2022 includes an after-tax amount of &#8364;(580) million relating to hedges of net investments in&#160;foreign operations (refer to Note&#160;B.8.3. for a description of the relevant accounting policy), compared with &#8364;(317) million as of&#160;December 31, 2021 and&#160;&#8364;(136) million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The movement in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Currency translation differences</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is mainly attributable to the US dollar.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.7. Other comprehensive income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements within other comprehensive income are shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:61.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains/(losses):</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Actuarial gains/(losses) excluding investments accounted for using the equity method (see Note&#160;D.19.1.)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(266)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity instruments included in financial assets and financial liabilities:</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;padding-right:29.25pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (excluding investments accounted for using the equity method)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (investments accounted for using the equity method, net of taxes)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Equity risk hedging instruments designated as fair value hedges</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(84)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not subsequently reclassifiable to profit or loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">451</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">797</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt instruments included in financial assets:</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (excluding investments accounted for using the equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash flow and fair value hedges:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (excluding investments accounted for using the equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (investments accounted for using the equity method, net of taxes)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#9642;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:9.29pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in currency translation differences:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,719&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,870)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Currency translation differences (investments accounted for using the&#160;equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Currency translation differences related to the investment in Regeneron and&#160;reclassified to profit or loss</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(318)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Hedges of net investments in foreign operations</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(254)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items subsequently reclassifiable to profit or loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,313</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,510</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4,021)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Amounts reclassified to profit or loss: immaterial amount in 2022, &#8364;4 million in 2021 and &#8364;5 million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Amounts reclassified to profit or loss: &#8364;2 million in 2022, &#8364;12 million in 2021 and &#8364;1 million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Amounts reclassified to profit or loss: &#8364;40 million in 2022, including &#8364;35 million relating to the deconsolidation of EUROAPI (see note&#160;D.1.). The amounts reclassified to profit and loss were immaterial in 2021 and 2020. Currency translation differences arise from the translation into euros of the financial statements of foreign subsidiaries, and are mainly due to the appreciation of the dollar against the euro.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) &#160;&#160;&#160;&#160;The amount recorded for 2020 relates to the translation reserve arising on the investment in Regeneron; the reserve was reclassified to profit or loss in accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates), including &#8364;2 million (net of tax) relating to hedges of net investments in foreign operations.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.8. Stock options</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock option plans awarded and measurement of stock option plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No stock options were awarded during 2022, 2021 or 2020.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock subscription option plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Details of the terms of exercise of stock subscription options granted under the various plans are presented below in Sanofi share equivalents. These plans were awarded to certain corporate officers and employees of Sanofi companies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table shows all Sanofi stock subscription option plans still outstanding or under which options were exercised in the year ended&#160;December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:18.961%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Source</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Date of grant</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>options<br/>granted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Start&#160;date&#160;of<br/>exercise<br/>period</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exercise<br/>price (&#8364;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of options outstanding as of 12/31/2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2012</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">814,050&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/06/2016</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2022</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56.44&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2013</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">788,725&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/06/2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72.19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">78,089&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2014</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,009,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/06/2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">506,042&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">06/24/2015</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">435,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">06/25/2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">06/24/2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">338,464&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/04/2016</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">402,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/05/2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/04/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75.90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">264,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/10/2017</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">378,040&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/11/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/10/2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">268,440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/02/2018</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/03/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/02/2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168,784&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">04/30/2019</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/02/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">04/30/2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76.71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">213,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,837,969</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The exercise of all outstanding stock subscription options would increase shareholders&#8217; equity by approximately &#8364;145 million. The exercise of each option results in the issuance of one share.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of stock option plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A summary of stock options outstanding at each balance sheet date, and of movements during the relevant periods, is presented below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:58.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of<br/>options</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted average<br/>exercise&#160;price<br/>per share (&#8364;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>(&#8364;&#160;million)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,822,020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">70.58</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">270</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,650,375&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">67.14&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">178&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(868,655)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options cancelled</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)&#160;</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(91,305)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(282,790)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,579,270</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">75.61</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">195</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,845,050&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">74.51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">137&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(190,076)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59.53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options cancelled</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)&#160;</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(51,216)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,337,968</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">77.13</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">180</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,949,184&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">78.15&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">152&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(490,373)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">71.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options cancelled</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)&#160;</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,626)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,837,969</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">78.64</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">145</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,624,569&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">78.89&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">128&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Mainly due to the grantees leaving Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below provides summary information about options outstanding and exercisable as of December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Range of exercise prices per share</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>options</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>residual&#160;life<br/>(years)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price per<br/>share (&#8364;)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>options</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price per<br/>share (&#8364;)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">From &#8364;60.00 to &#8364;70.00 per share</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168,784&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.34</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65.84&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168,784&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65.84&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">From &#8364;70.00 to &#8364;80.00 per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,062,281&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.68</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74.64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">848,881&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">From &#8364;80.00 to &#8364;90.00 per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">606,904&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.31</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">606,904&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,837,969</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,624,569</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.15.9. Number of shares used to compute diluted earnings per share</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Diluted earnings per share is computed using the number of shares outstanding plus stock options with dilutive effect and restricted shares.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.991%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Average number of shares outstanding</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,251.9&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,252.5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,253.6&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustment for stock options with dilutive effect</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustment for restricted shares</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average number of shares used to compute diluted earnings per share</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,256.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,257.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,260.1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, all stock options were taken into account in computing diluted earnings per share because they all had a dilutive effect. In both 2021 and 2020, 0.6 million&#160;stock options were not taken into account in computing diluted earnings per share because they had no dilutive effect.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Capital, Reserves And Other Equity Interest [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareCapitalReservesAndOtherEquityInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442150688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-controlling interests<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestsInOtherEntitiesAbstract', window );"><strong>Interests In Other Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory', window );">Non-controlling interests</a></td>
<td class="text">Non-controlling interestsNon-controlling interests did not represent a material component of Sanofi&#8217;s consolidated financial statements in the years ended December 31, 2022, 2021 and 2020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of non-controlling interests. [Refer: Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestsInOtherEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interests In Other Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestsInOtherEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442142128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinancialInstrumentsAbstract', window );"><strong>Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock', window );">Debt, cash and cash equivalents and lease liabilities</a></td>
<td class="text">Debt, cash and cash equivalents and lease liabilities<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.17.1. Debt, cash and cash equivalents</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in Sanofi's financial position during the period were as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.991%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,857&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,123&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,745&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,174&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,218</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,250</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,631</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,437</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,983</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,790</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Net debt does not include lease liabilities, which amounted to &#8364;2,181 million as of December 31, 2022, &#8364;2,108</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> million as of December 31, 2021, and&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">1,163&#160;million as of December 31, 2020 </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(see the maturity analysis at Note&#160;D.17.2.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Net debt&#8221; is a non-IFRS financial measure used by management and investors to measure Sanofi&#8217;s overall net indebtedness.</span></div><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Reconciliation of carrying amount to value on redemption</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"/><td style="width:25.167%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value on redemption</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustment<br/>to debt<br/>measured&#160;at<br/>fair value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,857&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,143&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,176&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,794&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion<br/>of long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,174&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,178&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(235)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,218</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,273</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,314</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,703</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,437</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,492</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a) Principal financing transactions during the year</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the movement in total debt during the period:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash&#160;flows&#160;from<br/>financing activities</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-cash items</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repayments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">New<br/>borrowings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>cash<br/>flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">translation</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">differences</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification<br/>from<br/>non-current to<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">items</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,123&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,632)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(228)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,857&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,707)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,632&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,174&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(373)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,250</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,718)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,549</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(330)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">442</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,218</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These amounts include unrealized gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the Euro zone.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) These amounts include changes in accrued interest balances, and fair value adjustments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During 2022, Sanofi carried out a bond issue of &#8364;1.5&#160;billion in April as part of its EMTN (Euro Medium Term Note) program, in two tranches:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:7.48pt">&#8364;850&#160;million bearing interest at a fixed annual rate of 0.875% and maturing April&#160;2025; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.61pt">&#8364;650&#160;million bearing interest at a fixed annual rate of 1.250% and maturing April&#160;2029; the amount of interest applicable is contingent on the attainment of a sustainability performance objective, i.e.: the cumulative number of patients (subject to a minimum of 1.5&#160;million) to which Sanofi Global Health has provided essential medicines to treat non-communicable diseases in the 40&#160;poorest countries on the planet between 2022 and 2026.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Three bond issues were redeemed in 2022:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:7.48pt">&#8364;1,000&#160;million issued September&#160;2014 and maturing March&#160;2022, early redeemed on January&#160;10, 2022;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.61pt">&#8364;850&#160;million issued March&#160;2019 and maturing March&#160;2022, early redeemed on February&#160;21, 2022; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:3.74pt">&#8364;850&#160;million issued September&#160;2016 and maturing September&#160;2022, early redeemed on June&#160;13, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 Sanofi had two&#160;syndicated credit facilities of &#8364;4&#160;billion each to provide liquidity for the purposes of current operations, each of them linked to environmental and social indicators. The maturity of one facility has been extended to&#160;December&#160;3, 2023 following the exercise of an extension option in June&#160;2022, and the maturity of the other has been extended to December&#160;6, 2027 following the exercise of an extension option in September&#160;2022. Sanofi does not have any further extension options available for either facility.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In line with Sanofi's commitment to embed sustainable development in the &#8220;Play to Win&#8221; strategy, the two&#160;revolving credit facilities build in an adjustment mechanism that links the credit spread to the attainment of two&#160;sustainable development performance indicators: Sanofi's contribution to polio eradication, and the reduction in Sanofi's carbon footprint.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show the movement in total debt during prior periods:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash&#160;flows&#160;from<br/>financing activities</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-cash items</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repayments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">New<br/>borrowings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>cash<br/>flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">translation</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">differences</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification<br/>from<br/>non-current to<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">items</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,745&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,704)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,123&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,203)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(615)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,704&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(197)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,631</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,241)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(812)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">381</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">291</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,250</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash&#160;flows&#160;from<br/>financing activities</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-cash items</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repayments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">New<br/>borrowings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>cash<br/>flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">translation</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">differences </span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification<br/>from<br/>non-current to<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">items</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,131&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(152)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,285)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,745&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,952)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(219)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24,568</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,952)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,019</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">282</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(385)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">99</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,631</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These amounts include unrealized gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the&#160;Euro zone.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) These amounts include movements in accrued interest and fair value remeasurements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b) Net debt by type, at value on redemption</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:14.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">current </span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current </span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,044&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,817&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,861&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,118&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,946&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,698&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,280&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,978&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,143</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,130</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,273</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,176</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,138</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,314</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,851</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,852</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,703</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,143</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8,651)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,492</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,176</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(7,129)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,857</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10,995)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Net debt does not include lease liabilities (see the maturity schedule in Note&#160;D.17.2.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bond issues carried out by Sanofi under the Euro Medium Term Note (EMTN) program are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.739%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issuer</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ISIN code</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issue date</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual&#160;interest&#160;rate</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364; million)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0011625433</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 2013</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0014009KS6</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0012146801</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0014009KQ0</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0012969038</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013143997</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.625&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013144003</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013201639</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013505104 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013505112</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2030</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324332</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324340</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324357</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2030</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324373</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2038</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013409844</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013409851</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2034</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bond issues carried out by Sanofi under the public bond issue program (shelf registration statement) registered with the US&#160;Securities and Exchange Commission (SEC) comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.739%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issuer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ISIN code</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issue&#160;date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual&#160;<br/>interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">($&#160;million)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US801060AC87</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US801060AD60</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2028</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.625&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The &#8220;Other borrowings&#8221; line mainly comprises participating shares issued between 1983 and 1987, of which 74,996&#160;remain outstanding, with a nominal amount of &#8364;11 million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order to manage its liquidity needs for current operations, as of December&#160;31, 2022 Sanofi has:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a syndicated credit facility of &#8364;4&#160;billion, drawable in euros and in US dollars, maturing December&#160;3,&#160;2023 following the exercise of the second extension option in June&#160;2022; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a syndicated credit facility of &#8364;4&#160;billion, drawable in euros and in US dollars, maturing December&#160;6, 2027 following the exercise of the second extension option in September&#160;2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi also has a &#8364;6&#160;billion Negotiable European Commercial Paper program in France and a $10&#160;billion Commercial Paper program in the United States. During 2022 only the US program was used, with an average drawdown of $2.3&#160;billion (versus a maximum of&#160;$4.0&#160;billion). As of December&#160;31, 2022, there were no drawdowns under any of those programs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The financing in place as of December 31, 2022 at the level of the holding company (which manages most of Sanofi&#8217;s financing needs centrally) is not subject to any financial covenants, and contains no clauses linking spreads or fees to the credit rating.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c) Debt by maturity, at value on redemption</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,861&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,817&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,684&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used <br/>to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,273</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,130</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used <br/>to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,492</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8,651)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Net debt does not include lease liabilities, which amounted to &#8364;2,181&#160;million as of December&#160;31, 2022; &#8364;2,108&#160;million as of&#160;December&#160;31, 2021; and&#160;&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">1,163&#160;million as of December&#160;31, 2020</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> (see the maturity analysis at Note&#160;D.17.2.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, the main undrawn confirmed general-purpose credit facilities at holding company level amounted to&#160;&#8364;8 billion, half of which expires in 2023 and the other half of which expires in 2027.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, no single counterparty represented more than 6% of Sanofi&#8217;s undrawn confirmed credit facilities.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,946&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,629&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,979&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,314</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,138</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,647</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">602</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,751</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,016</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(7,129)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,647</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">602</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,751</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,016</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,978&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,280&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,569&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,079&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,703</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,852</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,830</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,575</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">602</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,756</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,088</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10,995)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,836</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,575</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">602</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,756</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,088</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d) Debt by interest rate, at value on redemption</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below splits net debt between fixed and floating rate, and by maturity, as of December 31, 2022. The figures shown are values on redemption, before the effects of derivative instruments:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixed-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,861</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,817&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,684&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">16,993</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,868</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% fixed-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">98</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Floating-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">460</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,321</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,178</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(3,908)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(8,391)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,585</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8,558)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi issues debt in two currencies, the euro and the US dollar, and also invests its cash and cash equivalents in those currencies. Sanofi also operates cash pooling arrangements to manage the surplus cash and short-term liquidity needs of foreign subsidiaries located outside the euro zone.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To optimize the cost of debt or reduce the volatility of debt and manage its exposure to financial foreign exchange risk, Sanofi uses derivative instruments (interest rate swaps, currency swaps, foreign exchange swaps and forward contracts) that alter the fixed/floating rate split and the currency split of its net debt:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixed-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16,386</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,684&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">13,944</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,443</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% fixed-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">85</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Floating-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,886</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,787&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">592</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">950</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,273</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,130</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,781)</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,781)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(4,046)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(5,797)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2,155)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,492</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8,651)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the fixed/floating rate split of net debt at value on redemption after taking account of derivative instruments as of&#160;December 31, 2021 and December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:49.895%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixed-rate debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,612&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,713&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Floating-rate debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,314</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,703</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,267)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,841)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The weighted average interest rate on debt as of December 31, 2022 was 1.6% before derivative instruments and 2.5% after derivative instruments. Cash and cash equivalents were invested as of December 31, 2022 at an average rate of 3.9% before derivative instruments and 4.0% after derivative instruments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The projected full-year sensitivity of net debt to interest rate fluctuations for 2023 is as&#160;follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:53.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in short-term interest rates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact&#160;on&#160;pre-tax&#160;net<br/>income&#160;(&#8364;&#160;million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact&#160;on&#160;pre-tax<br/>income/(expense)&#160;recognized<br/>directly in equity<br/>(&#8364; million)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+100&#160;bp</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+25&#160;bp</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25&#160;bp</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-100&#160;bp</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(98)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e) Debt by currency, at value on redemption</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows net debt by currency at December 31, 2022, before and after derivative instruments contracted to convert the foreign-currency net debt of exposed entities into their functional currency:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:53.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Before&#160;derivative&#160;instruments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">After&#160;derivative&#160;instruments</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,145&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,489&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,508)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,404)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pound sterling</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexican peso</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other currencies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,585</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,492</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows net debt by currency at December 31, 2021 and 2020, after derivative instruments contracted to convert the foreign currency net debt of exposed entities into their functional currency:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:74.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,129&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,725&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(669)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,304)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other currencies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,413)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,559)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">f) Market value of net debt</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The market value of Sanofi&#8217;s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,227&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,024&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,500&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value on redemption</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,047&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,862&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of debt is determined by reference to quoted market prices at the balance sheet date in the case of quoted instruments (level&#160;1 in the IFRS&#160;7 hierarchy, see Note&#160;D.12.), and by reference to the fair value of interest rate and currency derivatives used to manage net debt (level&#160;2 in the IFRS&#160;7 hierarchy, see Note&#160;D.12.).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">g) Future contractual cash flows relating to debt and related derivatives</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:42.085%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,408</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,206</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">868</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,803</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,184</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,283</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,064</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principal</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,932&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,928&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,601&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,011&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,580&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,476&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash flows related to derivative instruments</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">209</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">60</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">38</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,617</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,230</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">928</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,841</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,215</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,314</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,089</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Future contractual cash flows are shown on the basis of the carrying amount in the balance sheet at the reporting date, without reference to any subsequent management decision that might materially alter the structure of Sanofi&#8217;s debt or its hedging policy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt as of December 31, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:42.085%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21,728</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,330</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,826</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">791</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,937</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,176</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,668</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principal</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,086&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,588&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,011&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,080&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,642&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash flows related to derivative instruments</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(51)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(59)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21,677</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,271</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,825</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">793</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,939</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,178</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,671</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:42.085%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24,339</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,943</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,019</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,808</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">791</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,937</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,841</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principal</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22,392&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,622&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,757&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,571&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,090&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,947&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash flows related to derivative instruments</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">163</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">135</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24,502</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,078</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,808</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">791</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,937</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,841</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.17.2. Lease liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A maturity analysis of lease liabilities as of December 31, 2022, 2021 and 2020 is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:41.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Undiscounted future minimum lease payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less than 1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From 1 to 3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From 3 to 5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More than 5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Discounting effect</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total lease liabilities as of December 31, 2022</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,181</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">320</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">515</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">436</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,129</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(219)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total lease liabilities as of December 31, 2021</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,108</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">314</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">476</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">362</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,184</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(228)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total lease liabilities as of December 31, 2020</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,163</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">247</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">357</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">225</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">482</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(148)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Lease liabilities as of December&#160;31, 2022 and December&#160;31, 2021 include leases relating to real estate assets located at Cambridge, MA (United States), as described in Note&#160;D.3., which have a lease term of 15 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of debt instruments issued explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442155664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities related to business combinations and to non-controlling interests<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock', window );">Liabilities related to business combinations and to non-controlling interests</a></td>
<td class="text">Liabilities related to business combinations and to non-controlling interests<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a description of the nature of the liabilities reported in the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Liabilities related to business combinations and to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, refer to Note&#160;B.8.5. The principal acquisitions are described in Notes&#160;D.1. and&#160;D.2.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The liabilities related to business combinations and to non-controlling interests shown in the table below are level&#160;3 instruments under the IFRS&#160;7 fair value hierarchy (see Note&#160;D.12.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in liabilities related to business combinations and to non-controlling interests are shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.734%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Bayer</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">contingent</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">consideration</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">arising&#160;from&#160;the</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">acquisition of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Genzyme </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MSD<br/>contingent<br/>consideration<br/>(European<br/>Vaccines<br/>business)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shire</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">contingent</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">consideration</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">arising&#160;from&#160;the</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">acquisition of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Translate Bio</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Contingent consideration arising from acquisition of Amunix</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at January 1, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">156</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">385</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">259</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">800</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(78)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(122)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(53)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">312</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">189</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">605</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New transactions</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(152)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(258)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">59</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">269</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">354</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">714</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New transactions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">204</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">380</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">165</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">779</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Portion due after more than one year: &#8364;674 million as of December 31, 2022 (&#8364;577 million as of December 31, 2021 and &#8364;387 million as of December 31, 2020); portion due within less than one year: &#8364;105 million as of December 31, 2022 (&#8364;137 million as of December 31, 2021 and &#8364;218 million as of&#160;December 31, 2020).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Amounts reported within the income statement line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">, and mainly comprising unrealized gains and losses.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Mainly corresponds to the recognition of the Shire Human Genetic Therapies&#160;Inc. (Shire) contingent consideration liability of $382 million resulting from the acquisition of Translate Bio in September&#160;2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The &#8220;Other&#8221; column mainly relates to the contingent consideration liability due to True North Therapeutics as a result of Sanofi's acquisition of Bioverativ which was settled in the first half of 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations and to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> mainly comprised:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the Bayer contingent consideration liability arising from Sanofi's acquisition of Genzyme in 2011. As of December 31, 2022, Bayer was still entitled to receive the following potential payments:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">a percentage of sales of alemtuzumab up to a maximum of $1,250 million or over a maximum period of 10&#160;years, whichever is achieved first,</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">milestone payments subject to the attainment of specified levels of worldwide sales of alemtuzumab beginning in 2021.</span></div><div style="margin-bottom:5pt;padding-left:11.25pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of this liability was measured at &#8364;26 million as of December 31, 2022, compared with &#8364;59 million as of December 31, 2021 and &#8364;104 million as of December 31, 2020. The fair value of the Bayer liability is determined by applying the contractual terms to sales projections which have been weighted to reflect the probability of success, and discounted. If the discount rate were to fall by one percentage point, the fair value of the Bayer liability would increase by approximately 1%;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the MSD contingent consideration liability arising from the 2016 acquisition of the Sanofi Pasteur activities carried on within the former Sanofi Pasteur MSD joint venture, which amounted to &#8364;204 million as of December 31, 2022, &#8364;269 million as of&#160;December 31, 2021 and &#8364;312 million as of December 31, 2020 (see Note&#160;D.12.). The fair value of this contingent consideration is determined by applying the royalty percentage stipulated in the contract to discounted sales projections. If the discount rate were to fall by one percentage point, the fair value of the MSD contingent consideration liability would increase by approximately 1%;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a contingent consideration liability towards Shire Human Genetic Therapies Inc. (Shire) arising from Sanofi's acquisition of Translate&#160;Bio in September&#160;2021. In a December&#160;2016 business combination predating the acquisition of control by Sanofi, Translate Bio (then called Rana Therapeutics, Inc.) acquired from Shire the intellectual property rights relating to the latter's Messenger RNA Therapeutics (MRT) program. As of December 31, 2022, Shire was entitled to receive the following potential payments:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">milestone payments contingent on the launch of products based on MRT technology, and on the attainment of a specified level of sales of those products, and</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">a percentage of sales of those products.</span></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-0.01pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of the Shire liability was measured at &#8364;380 million as of December 31, 2022, compared with &#8364;354 million as of&#160;December 31, 2021; it was determined by applying the contractual terms to development and sales projections which were weighted to reflect the probability of success, and discounted. If the discount rate were to fall by one percentage point, the fair value of the Shire liability would increase by approximately 13%;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the contingent consideration liability arising from the 2022 acquisition of Amunix. The fair value of the liability is determined on&#160;the basis of the nominal value of payments due subject to the attainment of specified</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> development milestones; these&#160;are&#160;weighted to reflect the probability of success, and discounted. The liability was measured at &#8364;165&#160;million as of December 31, 2022. If the discount rate were to fall by one percentage point, the fair value of the liability would increase by approximately&#160;1%.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth the maximum amount of contingent consideration payable in respect of already-marketed products:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From&#160;1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From&#160;3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commitments relating to contingent consideration&#160;in connection with business combinations</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes &#8364;0.4 billion for the Bayer contingent consideration, &#8364;0.2 billion for the MSD contingent consideration.</span></div>The nominal amount of contingent consideration was &#8364;689 million as of December 31, 2021 and &#8364;1,043 million as of December 31, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combinations [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to business combination and to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439420256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock', window );">Provisions, income tax liabilities and other liabilities</a></td>
<td class="text">Provisions, income tax liabilities and other liabilities<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Non current provisions and other non-current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comprises the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:57.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,822&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,430&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,998&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other non-current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,341</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,721</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,315</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (IAS&#160;19, Employee Benefits), </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Includes derivative financial instru</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">ments: &#8364;232 million as of De</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">cember&#160;31, 2022, &#8364;6 million as of December&#160;31, 2021, &#8364;92 million as of December&#160;31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Non-current income tax liabilities are described in Note&#160;D.19.4., and other current liabilities in Note&#160;D.19.5.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth movements in non-current provisions for the reporting periods presented:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"/><td style="width:33.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.035%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.035%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.035%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.257%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Provisions&#160;for<br/>pensions and<br/>other&#160;post-employment<br/>benefits<br/>(D.19.1.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Provisions<br/>for other<br/>long-term<br/>benefits</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Restructuring<br/>provisions<br/>(D.19.2.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>provisions<br/>(D.19.3.)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,599</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">855</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">600</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,071</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,125</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases in provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(566)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(109)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(113)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(793)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reversals of unutilized provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(226)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(245)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(518)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(369)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(64)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(421)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest related to employee benefits, and unwinding of discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(214)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains and losses on defined-benefit plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,276</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">879</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">868</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,975</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,998</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases in provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(222)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(122)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(107)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(459)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reversals of unutilized provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(145)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(200)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(370)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(425)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest related to employee benefits, and unwinding of discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains and losses on defined-benefit plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(448)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(448)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,947</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">935</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">524</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,024</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,430</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases in provisions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(528)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reversals of unutilized provisions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest related to employee benefits, and unwinding of discount</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains and losses on defined-benefit plans</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,039</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">844</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">761</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,178</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,822</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) In the case of &#8220;Provisions for pensions and other post-employment benefits&#8221;, the &#8220;Increases in provisions&#8221; line corresponds to rights vesting in employees during the period, and past service cost; the &#8220;Provisions utilized&#8221; line corresponds to contributions paid into pension funds and to beneficiaries; and the&#160;&#8220;Reversals of unutilized provisions&#8221; line corresponds to plan curtailments, settlements and amendments.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.19.1. Provisions for pensions and other post-employment benefits</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi offers its employees pension plans and other post-employment benefit plans. The specific features of the plans (benefit formulas, fund investment policy and fund assets held) vary depending on the applicable laws and regulations in each country where the employees work. These employee benefits are accounted for in accordance with IAS&#160;19 (see Note&#160;B.23.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s pension obligations in four&#160;major countries represented approximately 89% of the total value of the defined-benefit obligation and approximately 88% of the total value of plan assets as of December 31, 2022. The features of the principal defined-benefit plans in each of those four countries are described below.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">France</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Lump-sum retirement benefit plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All employees working for Sanofi in France are entitled on retirement to a lump-sum payment, the amount of which depends both on their length of service and on the rights guaranteed by collective and internal agreements. The employee&#8217;s final salary is used in calculating the amount of these lump-sum retirement benefits. These plans represent approximately 35% of Sanofi&#8217;s total obligation in France.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Defined-benefit pension plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These plans provide benefits from the date of retirement. Employees must fulfil a number of criteria to be eligible for these benefits. All of these plans are now closed. These plans represent approximately&#160;65% of Sanofi&#8217;s total obligation in France.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Germany</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Top-up defined-benefit pension plan</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The benefits offered under this pension plan are wholly funded by the employer (there are no employee contributions) via a Contractual Trust Agreement (CTA), under which benefits are estimated on the basis of a career average salary. Employees are entitled to receive an annuity under this plan if their salary exceeds the social security ceiling. The amount of the pension is calculated by reference to a range of vesting rates corresponding to salary bands. The plan also includes disability and death benefits. This plan represents approximately 62% of Sanofi&#8217;s total obligation in Germany.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi-Aventis plus (SAV plus)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A top-up pension plan (SAV plus) replaced a previous top-up defined-benefit plan. New entrants joining the plan after April&#160;1,&#160;2015 contribute to a defined-contribution plan that is partially funded via the company&#8217;s CTA.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All employees whose salary exceeds the social security ceiling are automatically covered by the plan. The employer&#8217;s contribution is 15% of the amount by which the employee&#8217;s salary exceeds the social security ceiling.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Multi-employer plan (Pensionskasse)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This is a defined-benefit plan treated as a defined-contribution plan, in accordance with the accounting policies described in&#160;Note&#160;B.23. Currently, contributions cover the level of annuities. Only the portion relating to the future revaluation of&#160;the&#160;annuities is included in the defined-benefit pension obligation. The obligation relating to this revaluation amounted to &#8364;652 million as of December 31, 2022, versus&#160;&#8364;877 million as of December 31, 2021 and &#8364;773 million as of December 31, 2020. This plan represents approximately 24% of Sanofi&#8217;s total defined-benefit obligation in Germany.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">United States</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Defined-benefit pension plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the United States, there are two types of defined-benefit plan:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">&#8220;qualified&#8221; plans within the meaning of the Employee Retirement Income Security Act of 1974 (ERISA), which provide guaranteed benefits to eligible employees during retirement, and in the event of death or disability. Employees can elect to receive a reduced annuity, in exchange for an annuity to be paid in the event of their death to a person designated by them. An annuity is also granted under the plan if the employee dies before retirement age. Eligible employees do not pay any contributions. These plans are closed to new entrants, and the vesting of rights for future service periods is partially frozen. These plans represent approximately 60% of Sanofi&#8217;s total obligation in the United States;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">&#8220;non-qualified&#8221; plans within the meaning of ERISA provide top-up retirement benefits to some eligible employees depending on the employee&#8217;s level of responsibility and subject to a salary cap. These plans represent approximately 14% of Sanofi&#8217;s total obligation in the United States.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare cover and life insurance</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi companies provide some eligible employees with healthcare cover and life insurance during the retirement period (the company&#8217;s contributions are capped at a specified level). These plans represent approximately 26% (or &#8364;409 million) of Sanofi&#8217;s total obligation and&#160;3% (or &#8364;28 million) of total plan assets in the United States.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">United Kingdom</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">Defined-benefit pension plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi operates a number of pension plans in the United Kingdom that reflect past acquisitions. The most significant arrangements are defined-benefit plans that have been closed since October&#160;1, 2015. With effect from that date, employees can no longer pay into these plans.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under these defined-benefit plans, an annuity is paid from the retirement date. This annuity is calculated on the basis of the employee&#8217;s length of service as of September&#160;30, 2015, and of the employee&#8217;s final salary (or salary on the date he or she leaves Sanofi).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The rates used for the vesting of rights vary from member to member. For most members, rights vest at the rate of 1.25% or 1.50% of final salary for each qualifying year of service giving entitlement. The notional retirement age varies according to the category to which the member belongs, but in most cases retirement is at age 65. Members may choose to retire before or after the notional retirement age (60&#160;years), in which case the amount of the annual pension is adjusted to reflect the revised estimate of the length of the retirement phase. Pensions are usually indexed to the Retail Price Index (RPI). Members paid a fixed-percentage contribution into their pension plan (the percentage varied according to the employee category), and the employer topped up the contribution to the required amount. These plans represent approximately 100% of Sanofi&#8217;s total obligation in the United Kingdom.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For service periods subsequent to October&#160;1, 2015, employees belong to a new defined-contribution plan.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Actuarial assumptions used to measure Sanofi&#8217;s obligations</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Actuarial valuations of Sanofi&#8217;s benefit obligations were computed by management with assistance from external actuaries as of&#160;December 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Those calculations were based on the following financial and demographic assumptions:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)/(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.55% to 3.75%</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.55% to 3.75%</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.90%</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.75%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.10% to 1.10%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.10% to 1.10%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.70%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.90%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">or </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.55%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">or </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.55%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.40%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.35%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">General inflation rate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.50%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.50%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.25%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.95%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.95%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.30%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.45%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.45%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.95%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pension benefit <br/>indexation</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.50%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.50%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.00%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.95%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.95%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.15%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.45%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.45%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.85%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Healthcare cost </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">inflation rate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.29%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.56%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.50%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.50%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.50% to 4.50%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retirement age</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 67</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 70</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 65</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 67</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 70</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 65</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 67</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 70</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 65</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TGH/<br/>TGF<br/>05</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Heubeck<br/>RT<br/>2018 G</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RP2012 Proj.<br/>MP2021 White Collar</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SAPS<br/>S3</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TGH/<br/>TGF<br/>05</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Heubeck<br/>RT<br/>2018 G</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RP2012 Proj.<br/>MP2020 White Collar</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SAPS<br/>S3</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TGH/<br/>TGF<br/>05</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Heubeck<br/>RT<br/>2018 G</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RP2012 Proj.<br/>G.&#160;Scale<br/>MP2019 White Collar</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SAPS<br/>S2</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The discount rates used were based on market rates for high quality corporate bonds with a duration close to that of the expected benefit payments under the plans. The benchmarks used to determine discount rates were the same for all periods presented.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The rate depends on the duration of the plan (0&#160;to 7&#160;years, 7 to 10&#160;years, or more than 10&#160;years).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Inflation for the euro zone is determined using a multi-criterion method.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;No post-employment healthcare benefits are provided in France since 2020, Germany and UK.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted average duration of obligation for pensions and other long-term benefits in principal countries</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the duration of Sanofi&#8217;s obligations in the principal countries:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:25.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(years)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted average duration</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sensitivity analysis</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the sensitivity of Sanofi&#8217;s obligations for pensions and other post-employment benefits to changes in key actuarial assumptions:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions and other post-employment benefits, <br/>by principal country</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Measurement of defined-benefit obligation</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in<br/>assumption</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.50&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+72&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+162&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+75&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+136&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">General inflation rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+306&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pension benefit indexation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Healthcare cost inflation rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">+1 year</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+61&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+51&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+74&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below reconciles the net obligation in respect of Sanofi&#8217;s pension and other post-employment benefit plans with the amounts recognized in the consolidated financial statements:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:63.065%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Measurement of the obligation:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning of period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,175&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,094&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial losses/(gains) due to changes in demographic assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(162)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial losses/(gains) due to changes in financial assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,006)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(210)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial losses/(gains) due to experience adjustments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(120)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan amendments, curtailments or settlements not specified in the terms of the plan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(938)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan settlements specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(463)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(503)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation and transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(443)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Obligation at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,651</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,175</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,456</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value of plan assets:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning of period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,651&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,651&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest income on plan assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Difference between actual return and interest income on plan assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,398)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Administration costs</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan settlements specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan settlements not specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(739)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer&#8217;s contributions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(426)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(458)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(469)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation and transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(326)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value of plan assets at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,899</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,651</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,358</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net obligation</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,752&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,098&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,770</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,539</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,099</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amounts recognized in the balance sheet:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pre-funded obligations (see Note D.7.)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(408)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(177)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Obligations provided for</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount recognized at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,770</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,539</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,099</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit cost for the period:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in&#160;the&#160;terms&#160;of the plan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(199)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest (income)/cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Administration costs and taxes paid during the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense recognized directly in profit or loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">168</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">276</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">84</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(685)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(482)</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(409)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">350</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;These amounts include the impact of applying the April&#160;2021 IFRIC agenda decision on the attribution of benefits to periods of service.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For 2020, this line mainly comprises a reduction in post-employment benefit liabilities following the announcement of voluntary redundancy programs, primarily in Europe.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;For 2022, this line includes &#8364;99&#160;million of assets in the United Kingdom (versus &#8364;220&#160;million for 2021); those amounts are not subject to any asset ceiling, in accordance with IFRIC&#160;14.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Amounts recognized in Other comprehensive income (see Note&#160;D.15.7.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show Sanofi&#8217;s net liability in respect of pension plans and other post-employment benefits by geographical region:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:25.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Measurement of obligation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,730&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,080&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,651&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,317&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,899&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">627</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">413</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">686</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(95)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">139</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,770</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:25.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Measurement of obligation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,576&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,414&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,175&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,808&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,629&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,249&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,651&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">819</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">768</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">972</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(215)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">195</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,539</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:25.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Measurement of obligation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,580&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,091&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,561&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,456&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,661&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,536&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">872</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">919</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,014</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">269</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,099</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the fair value of plan assets relating to Sanofi&#8217;s pension and other post-employment plans, split by asset category:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Securities quoted in an active market</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">84.4</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">86.9</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">94.8</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity instruments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bonds and similar instruments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commodities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15.6</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.1</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hedge funds</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Insurance policies</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has a long-term objective of maintaining or increasing the extent to which its pension obligations are covered by assets. To this end, Sanofi uses an asset-liability management strategy, matching plan assets to its pension obligations. This policy aims to ensure the best fit between the assets held on the one hand, and the associated liabilities and expected future payments to plan members on the other. To meet this aim, Sanofi operates a risk monitoring and management strategy (mainly focused on interest rate risk and inflation risk), while investing a growing proportion of assets in high-quality bonds with comparable maturities to those of the underlying obligations and in contracts entered into with leading insurance companies to fund certain post-employment benefit obligations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show the service cost for Sanofi&#8217;s pension and other post-employment benefit plans, by geographical region:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Service cost for 2022</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost/(income) including administration costs and taxes paid during the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) recognized directly in profit or loss</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">53</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">81</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">168</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(145)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(151)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(301)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">117</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(482)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Service cost for 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost/(income) including administration costs and taxes paid during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) recognized directly in profit or loss</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">80</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">52</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">84</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">54</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">276</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(106)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(113)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(157)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(236)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(73)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(685)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(26)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(61)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(73)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(230)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(19)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(409)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Service cost for 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(87)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(123)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(199)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost/(income) including administration costs and taxes paid during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) recognized directly in profit or loss</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(15)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">72</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(38)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">60</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">84</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">193</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(16)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">120</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">45</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">350</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of the &#8220;Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)&#8221; line in the preceding tables is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:19.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.108%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.335%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.421%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.421%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.108%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.421%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.574%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.421%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.429%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains/(losses) arising during the period</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(121)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(115)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprising:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">on experience adjustments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,328)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) <br/>on demographic assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) <br/>on financial assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(69)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(60)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(197)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(194)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(442)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Experience adjustments are mainly due to the effect of trends in the financial markets on plan assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The net pre-tax actuarial loss (excluding investments accounted for using the equity method) recognized directly in equity is presented below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net pre-tax actuarial loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,090)</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,738)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,423)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The present value of Sanofi&#8217;s obligations in respect of pension and other post-employment benefit plans at the end of each reporting period is shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Present value of wholly or partially funded obligations in respect of pension and other post-employment benefit plans</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,463&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,416&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,734&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Present value of unfunded obligations</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,651</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,175</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,456</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The total expense for pensions and other post-employment benefits (&#8364;168 million in 2022) is allocated between income statement line items as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating (income)/expenses, net</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(140)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">168</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">276</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">84</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The estimated amounts of employer&#8217;s contributions to plan assets in 2023 are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employer&#8217;s contributions in 2023 (estimate):</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the expected timing of benefit payments under pension and other post-employment benefit plans for future years:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated future benefit payments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2028 to 2032</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,135&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">784&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows estimates as of December 31, 2022 for the timing of future payments in respect of unfunded pension and other post-employment benefit plans:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than 1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to <br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to <br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated payments</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.19.2. Restructuring provisions</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows movements in restructuring provisions classified in non-current and current liabilities:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,118</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,499</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,390</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in non-current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in provisions recognized in profit or loss for the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(522)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(571)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(663)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unwinding of discount</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,233</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,118</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,499</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in non-current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Provisions utilized mainly correspond to payments related to employees affected by separation programs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Provisions for employee termination benefits as of December 31, 2022 amounted to &#8364;1,039 million (compared with &#8364;943&#160;million as of December 31, 2021 and &#8364;1,260 million as of December 31, 2020).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The provisions apply mainly to France, and relate to various voluntary redundancy programs:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">agreement under the Job Management and Career Paths (&#8220;GEPP&#8221;) scheme affecting several French legal entities, signed on&#160;February&#160;28, 2022 and announced in April&#160;2022 as part of the &#8220;Play to Win&#8221; strategy. The agreement provides internal transfer and outplacement opportunities for employees whose jobs are undergoing transformation, and also includes an end-of-career paid leave program and an external retraining program. The majority of the provisions charged in 2022 relate to this plan, which was implemented during 2022;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">collectively-agreed separation programs involving a number of legal entities were announced at the end of June&#160;2020 as part of the rollout of the &#8220;Play to Win&#8221; strategy; these include an end-of-career paid leave plan and an external retraining program, and were still ongoing during 2022. In addition, Sanofi-Aventis Recherche &amp;&#160;D&#233;veloppement (i)&#160;announced a voluntary redundancy program in&#160;2020 in connection with the reorganization of R&amp;D operations in France, which was implemented in&#160;2021, and (ii)&#160;signed a collectively-agreed termination program in&#160;2021 as part of the rollout of the &#8220;Play to Win&#8221; strategy; these programs, which cover support functions, include an end-of-career paid leave plan and an end-of-career transition plan;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">programs were announced in 2019 relating to (i)&#160;R&amp;D (Sanofi-Aventis Recherche &amp;&#160;D&#233;veloppement), and (ii)&#160;sales forces (the&#160;&#8220;SAF&#160;2019&#8221; plan implemented by Sanofi-Aventis France); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">collectively-agreed separation programs were announced in 2018 relating to the reorganization of support functions (&#8220;Horizon&#160;2020&#8221; plan).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The remainder of the provision for France comprises termination benefits associated with previously-announced programs (early retirement plans and end-of-career transition plans).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The provision includes the present values of:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">gross annuities for self-funded plans;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">employer&#8217;s social security charges on early retirement annuities for all plans (outsourced and self-funded); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the levy charged on those annuities under the &#8220;Fillon&#8221;&#160;law (only for plans with termination of employment contracts).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The average residual holding periods under these plans were 2.60&#160;years, 1.94&#160;year and 1.99&#160;year as of December 31, 2022, 2021 and&#160;2020, respectively.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main other countries covered by restructuring provisions are Germany, Japan and the United States.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The timing of future termination benefit payments is as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit payments by period</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employee termination benefits</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">France</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other countries</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,039</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">374</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">448</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">215</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit payments by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employee termination benefits</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">France</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other countries</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">943</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">476</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">394</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">67</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit payments by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employee termination benefits</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">France</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other countries</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,260</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">490</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">606</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">142</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.19.3. Other provisions</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other provisions</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> include provisions for risks and litigation relating to environmental, tax, commercial and product liability matters.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Environmental risks</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product liability risks, litigation and other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,652&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,374&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,178</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,024</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,975</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Provisions for environmental risks relate primarily to contingencies arising from business divestitures, and include remediation costs relating to such environmental risks.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Identified environmental risks are covered by provisions estimated on the basis of the costs Sanofi believes it will be obliged to meet over a period not exceeding (other than in exceptional cases) 30&#160;years. Sanofi expects that &#8364;96 million of those provisions will be utilized in&#160;2023, and &#8364;201 million over the period from 2024 through 2027.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Product liability risks, litigation and other&#8221; mainly comprises provisions for risks relating to product liability (including IBNR provisions as described in Note&#160;B.12.), government investigations, regulatory or antitrust law claims, contingencies arising from business divestitures (other than environmental risks), and remediation costs related to leases.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main pending legal and arbitral proceedings and government investigations are described in Note&#160;D.22.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A full risk and litigation assessment is performed with the assistance of Sanofi&#8217;s legal advisers, and provisions are recorded as required by circumstances in accordance with the principles described in Note&#160;B.12.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.19.4. Non-current income tax liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Non-current income tax liabilities </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">amounted to &#8364;1,979 million as of December 31, 2022 (versus &#8364;2,039 million as of December 31, 2021 and &#8364;1,733 million as of December 31, 2020).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The estimated tax charge on deemed repatriation attributable to the accumulated earnings of non-US operations and payable over 8&#160;years is recognized as a liability, and amounted to &#8364;1,020 million in 2022 versus &#8364;960 million in 2021 and &#8364;894 million in&#160;2020. The resulting residual tax charge generated a non-current liability of &#8364;459 million as of December 31, 2022, versus &#8364;576 million in 2021 and &#8364;569 million in 2020. In accordance with Sanofi accounting policies, this non-current liability is not discounted.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Non-current income tax liabilities include uncertainties over income tax treatments amounting to &#8364;1,520 million as of December 31, 2022, versus &#8364;1,463 million as of December 31, 2021 and &#8364;1,164 million as of December 31, 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A US legal restructuring resulted in a capital loss of &#8364;2.9&#160;billion recognized in the 2020 final tax filing. One-third of the capital loss has been used against 2020 capital gains and the remaining balance will be eligible to carry back for three years. Due to management&#8217;s judgement about potential alternative interpretations of the prevailing tax law, no tax benefit has been recognized on this transaction in accordance with IFRIC&#160;23.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.19.5. Current provisions and other current liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Current provisions and other current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes payable, other than corporate income taxes</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee-related liabilities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,158&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,042&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring provisions (see Note&#160;D.19.2.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate derivatives (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency derivatives (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity derivatives (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts payable for acquisitions of non-current assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer contract liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,899&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,112&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,021</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,217</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,132</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">See Note&#160;A.5.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">, &#8220;Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">. The year-on-year change in this item includes revenue of &#8364;85&#160;million recognized in profit or loss during 2022 that was included in the customer contract liabilities balance as of December&#160;31, 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) &#8220;Other current liabilities&#8221; mainly comprises provisions for customer rebates and returns; provisions for discounts and rebates granted to healthcare authorities and governmental programs (see Note&#160;D.23.); and the liability payable at each reporting date under the Monoclonal Antibody Alliance with Regeneron.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of provisions and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405486460240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative financial instruments and market risks<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinancialInstrumentsAbstract', window );"><strong>Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory', window );">Derivative financial instruments and market risks</a></td>
<td class="text">Derivative financial instruments and market risks<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the fair value of derivative instruments as of December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">assets</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current<br/>assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current<br/>liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current<br/>liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>liabilities</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market value at December 31, 2022 (net)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market value at December 31, 2021 (net)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market value at December 31, 2020 (net)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency derivatives</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(94)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(94)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(209)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">operating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">financial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(216)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(232)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(232)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">206</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">206</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( 232)</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( 94)</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( 326)</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( 120)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">213</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( 215)</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Objectives of the use of derivative financial instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi uses derivative instruments to manage operating exposure to movements in exchange rates, and financial exposure to movements in interest rates and exchange rates (where the debt or receivable is not contracted in the functional currency of the borrower or lender entity). On occasion, Sanofi uses equity derivatives in connection with the management of its portfolio of equity investments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi performs periodic reviews of its transactions and contractual agreements in order to identify any embedded derivatives, which are accounted for separately from the host contract in accordance with IFRS&#160;9. Sanofi had no material embedded derivatives as of December 31, 2022, 2021 or 2020.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Counterparty risk</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a description of counterparty risk, refer to &#8220;Item&#160;11. &#8212; Quantitative and Qualitative Disclosures about Market Risk&#8221;.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">a) Currency derivatives used to manage operating risk exposures</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a description of Sanofi's objectives, policies and procedures for the management of operating foreign exchange risk, refer to &#8220;Item&#160;11. &#8212; Quantitative and Qualitative Disclosures about Market Risk&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows operating currency hedging instruments in place as of December 31, 2022, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.982%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which derivatives designated as<br/>cash flow hedges</span></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which&#160;derivatives&#160;not<br/>eligible&#160;for&#160;hedge&#160;accounting</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which<br/>recognized&#160;in&#160;equity</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,403</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">49</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,403</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">49</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Korean won</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,459</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(27)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,459</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(27)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,047&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,047&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Korean won</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Taiwan dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows operating currency hedging instruments in place as of December 31, 2021, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.907%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.354%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which derivatives designated as<br/>cash flow hedges</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which&#160;derivatives&#160;not<br/>eligible&#160;for&#160;hedge&#160;accounting</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which<br/>recognized&#160;in&#160;equity</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,912</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,912</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">665&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">665&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">199&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">199&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Taiwan dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,374</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,374</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">833&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">833&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Hungarian forint</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Russian rouble</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,286</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,286</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows operating currency hedging instruments in place as of December 31, 2020, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:20.339%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.921%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which derivatives<br/>designated&#160;as&#160;cash&#160;flow&#160;hedges</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which&#160;derivatives&#160;not</span></div><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">eligible&#160;for&#160;hedge&#160;accounting </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which<br/>recognized<br/>in&#160;equity</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,477</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,477</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Mexican peso</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,932</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,932</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">580&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">580&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">571&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">571&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Russian rouble</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,409</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,409</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">b) Currency and interest rate derivatives used to manage financial exposure</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For a description of Sanofi's objectives, policies and procedures for the management of financial foreign exchange risk and interest rate risk, refer to &#8220;Item&#160;11. &#8212; Quantitative and Qualitative Disclosures about Market Risk&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows financial currency hedging instruments in place, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:22.942%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.249%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,559</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">66</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,655</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,064</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">6,114&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">5,384&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,721&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Pound sterling</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">257&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,997</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,293</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">197</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,004</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(226)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,011&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(b) (c)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">4,816&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">128&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">6,068&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(200)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(d)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(27)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,556</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">90</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16,948</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">212</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,068</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(216)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes forward sales with a notional amount of $3,615 million expiring in 2023, designated as a hedge of Sanofi&#8217;s net investment in Bioverativ. As of December 31, 2022, the fair value of these forward contracts represented an asset of &#8364;38 million; the opposite entry was recognized in "Other comprehensive income", with the impact on financial income and expense being immaterial.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Includes forward purchases with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of $1,000 million of bond issues to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of &#8364;3 million, the opposite entry for &#8364;0.6&#160;million of which was debited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting treatment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Includes receiver currency swaps with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the swaps was a liability of &#8364;2 million, the opposite entry for &#8364;1.4&#160;million of which was credited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting treatment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Includes forward purchases with a notional amount of SGD1,500 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/SGD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of&#160;&#8364;33 million, the opposite entry for &#8364;2.5&#160;million of which was credited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting treatment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows interest rate hedging instruments in place as of December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:17.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amounts by expiry date as of December 31, 2022</span></td><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="6" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>designated as<br/>fair value<br/>hedges</span></td><td colspan="9" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which designated as<br/>cash flow hedges</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>recognized<br/>in equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive 1.03%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive 1.32%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized Ester/receive 0.69%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized Ester/receive 0.92%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">850</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,584</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,434</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(232)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,434</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(232)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows interest rate hedging instruments in place as of December 31, 2021:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:17.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amounts by expiry date as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>designated as<br/>fair value<br/>hedges</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which designated as<br/>cash flow hedges</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027 and later</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>recognized<br/>in equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized EONIA/receive 0.06%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay -0.57%/receive capitalized EONIA</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive 1.03%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive 1.32%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">receive capitalized EONIA/pay 1.48%</span><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,642</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">57</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">880</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,579</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,979</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">600</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These interest rate swaps hedge fixed-rate bonds with a nominal of &#8364;99 million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within &#8220;Loans, advances and other long-term receivables&#8221; (see Note D.7.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows interest rate hedging instruments in place as of December 31, 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:17.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amounts by expiry date as of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>designated as<br/>fair value<br/>hedges</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which designated as<br/>cash flow hedges</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026 and later</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>recognized<br/>in equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized EONIA/receive 0.06%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay -0.57%/receive capitalized EONIA</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">receive capitalized Eonia/pay 1.48%</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,642</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">57</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,699</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,099</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">600</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These interest rate swaps hedge fixed-rate bonds with a nominal of &#8364;99 million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within &#8220;Loans, advances and other long-term receivables&#8221; (see Note D.7.).</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">c) Actual or potential effects of netting arrangements</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below is prepared in accordance with the accounting policies described in Note&#160;B.8.3.:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:31.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.081%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:26pt"><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>assets</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>liabilities</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross carrying amounts before offset (a)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(85)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(297)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross amounts offset (in accordance with IAS&#160;32)&#160;(b)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amounts as reported in the balance sheet (a) -&#160;(b) =&#160;(c)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">206</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(326)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">298</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(85)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">82</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(297)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effects of other netting arrangements (not fulfilling the IAS&#160;32 criteria for offsetting) (d)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial instruments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(67)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of financial collateral</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net exposure (c) + (d)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">46</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(166)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">231</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(216)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of derivative financial instruments. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456076752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Off balance sheet commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract', window );"><strong>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock', window );">Off balance sheet commitments</a></td>
<td class="text">Off balance sheet commitments<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The off balance sheet commitments presented below are shown at their nominal value.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.21.1. Off balance sheet commitments relating to operating activities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Off balance sheet commitments relating to Sanofi&#8217;s operating activities comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:48.364%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.008%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Irrevocable purchase commitments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">given</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,921&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,957&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">980&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">received</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,025)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(482)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(335)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(86)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(122)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development license agreements - commitments given</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">commitments related to R&amp;D and other commitments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">contingent milestone payments in connection with development programs in progress</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total - net commitments given</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,112</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,901</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,505</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,878</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,828</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the variable portion of future lease payments not recognized as lease liabilities as of December 31, 2022; the equivalent amount of these commitments as of December&#160;31, 2021 was &#8364;109&#160;million.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) These comprise irrevocable commitments to suppliers of (i)&#160;property, plant and equipment, net of down-payments (see Note&#160;D.3.) and (ii)&#160;goods and services. As of December 31, 2021, irrevocable commitments amounted to &#8364;8,901 million given and &#8364;1,124 million received.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Irrevocable purchase commitments given as of December 31, 2022 include &#8364;871 million of commitments to joint ventures, and the commitment to EUROAPI as described in Note&#160;D.1.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Commitments related to R&amp;D, and other commitments, amounted to &#8364;536 million as of December 31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) This line includes only contingent milestone payments on development projects in progress. The equivalent amount as of December 31, 2021 was &#8364;2,892 million.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In pursuance of its strategy, Sanofi may acquire technologies and rights to products. Such acquisitions may be made in various contractual forms: acquisitions of shares, loans, license agreements, joint development, and co-marketing. These arrangements generally involve upfront payments on signature of the agreement, development milestone payments, and royalties. Some of these complex agreements include undertakings to fund research programs in future years and payments contingent upon achieving specified development milestones, the granting of approvals or licenses, or the attainment of sales targets once a product is commercialized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The &#8220;Research and development license agreements&#8221; line comprises future service commitments to fund research and development or technology, and probable contingent milestone payments regarded as reasonably achievable (i.e. all potential milestone payments relating to projects in the development phase, for which the future financial consequences are known or probable and for which there is a sufficiently reliable estimate). This line excludes:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">commitments given relating to projects in the research phase for &#8364;18.0 billion as of December&#160;31, 2022 (&#8364;6.7 billion as of December&#160;31, 2021) and commitments given relating to contingent payments upon the attainment of sales targets once a product is commercialized for &#8364;18.5 billion as of December&#160;31, 2022 (&#8364;8.1 billion as of December&#160;31, 2021);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">commitments received amounting to &#8364;8.8 billion as of December&#160;31, 2022 (&#8364;5.8 billion as of December&#160;31, 2021), mainly&#160;comprising research, development and commercialization agreements with partners further to the acquisitions of Ablynx&#160;for&#160;&#8364;1.0 billion as of December 31, 2022 (&#8364;1.0 billion as of December&#160;31, 2021) and of Kymab for &#8364;0.2&#160;billion as of December 31, 2022 (&#8364;0.5 billion as of December&#160;31, 2021), plus contingent consideration receivable based on attainment of regulatory and&#160;sales milestones for commercialized products under the terms of licenses or rights assignment agreements amounting to &#8364;7.6&#160;billion as of December&#160;31, 2022 (&#8364;4.2&#160;billion as of December&#160;31, 2021).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The major agreements entered into by Sanofi in 2022 are described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on January&#160;7, 2022, Sanofi entered into an innovative license agreement and research collaboration with Exscientia to develop up to 15&#160;novel small molecule candidates across oncology and immunology, leveraging Exscientia&#8217;s end-to-end AI-driven platform utilizing actual patient samples. Under the terms of the agreement, Sanofi made an upfront payment of $100&#160;million and could pay up to $5.2&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on January&#160;12, 2022, Sanofi entered into a licensing and collaboration agreement with ABL Bio for the development of ABL301, a bispecific antibody targeting alpha-synuclein and intended as a treatment for alpha-synucleinopathies. Under the terms of the agreement, Sanofi paid ABL Bio $75&#160;million upfront, and could make potential milestone payments of up to approximately $985&#160;million contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on March&#160;2, 2022, Sanofi entered into a collaboration and exclusive license agreement with Adagene Inc., a company transforming the discovery and development of antibody-based therapies. Under the terms of the agreement, Sanofi made an upfront payment of $17.5&#160;million&#160;and could pay up to $2.5&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on March&#160;15, 2022, Sanofi entered into a strategic risk-sharing collaboration with Blackstone under which funds managed by Blackstone Life Sciences (BXLS) will contribute up to &#8364;300&#160;million to accelerate the global pivotal studies and clinical development program for the subcutaneous formulation and delivery of the anti-CD38 antibody Sarclisa</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, to treat patients with multiple myeloma. That amount will be paid to Sanofi on the basis of development expenses incurred. In addition, Sanofi may pay royalties on future sales of this solution;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on March&#160;29, 2022, Sanofi entered into an exclusive collaboration agreement with IGM Biosciences, Inc. to create, develop, manufacture and commercialize IgM antibody agonists against three oncology targets and three immunology/inflammation targets. Under the terms of the agreement, IGM received an upfront payment of $150&#160;million and could receive up to $6.0&#160;billion for milestones in the development, regulatory approval and sales of each target;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on July&#160;5, 2022, Sanofi entered into a collaboration agreement with Skyhawk Therapeutics, Inc. to discover and develop novel small molecules that modulate RNA splicing to address challenging oncology and immunology targets. Under the terms of the agreement, Skyhawk received an upfront payment of $54&#160;million and could receive more than $2.0&#160;billion&#160;contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on August&#160;17, 2022, Sanofi entered into a strategic research collaboration with Atomwise, that will leverage its AtomNet</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> platform to identify and synthesize up to five drug targets. Under the terms of the agreement, Atomwise received an upfront payment of $20&#160;million and could receive up to $1.0&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on September&#160;27, 2022, Sanofi entered into a research collaboration with Scribe Therapeutics, to leverage its CRISPR by&#160;Design&#8482; platform and to obtain a non-exclusive license to genome editing CasX-Editor(XE) technology for multiple oncology targets. Under the terms of the agreement, Scribe Therapeutics received an upfront payment of $25&#160;million and could receive more than $1.0&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on October&#160;4, 2022, Sanofi entered into a strategic collaboration with miRecule to accelerate the discovery and development of a Best-in-Class Antibody-RNA conjugate to treat Facioscapulohumeral Muscular Dystrophy (FSHD). Under the terms of the agreement, miRecule received an upfront payment of $20&#160;million and could receive up to $0.4&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on November&#160;8, 2022, Sanofi entered into a strategic research collaboration with Insilico Medicine to leverage Insilico Medicine's AI platform, Pharma.AI, to advance drug development candidates for up to six new targets. Under the terms of the agreement, Insilico Medicine received an upfront payment of $12.5&#160;million and could receive up to $1.2&#160;billion contingent on the attainment of certain objectives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">on December&#160;19 2022, Sanofi and Innate Pharma SA announced an expansion of their collaboration, with Sanofi licensing a natural killer (NK) cell engager program targeting B7H3 from Innate's ANKET</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Antibody-based NK Cell Engager Therapeutics) platform. Innate received an upfront payment of &#8364;25&#160;million and could receive up to &#8364;1.4&#160;billion contingent on the attainment of certain objectives.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of commitments as of December&#160;31, 2022 also includes commitments under agreements entered into by Sanofi in prior years, the principal ones of which are described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Biond Biologics (2021): license agreement for the development and commercialization of BND-22 (a humanized IgG4 antagonist antibody targeting the Ig-like transcript&#160;2 (ILT2) receptor, in development for the treatment of solid tumors);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Eureka Therapeutics and Memorial Sloan Kettering Cancer Center (MSK) (2021): license agreement with for the treatment of multiple myeloma;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Kymera (2020): agreement to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Nurix Therapeutics (2020): collaboration to develop novel targeted protein degradation therapies;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Denali Therapeutics&#160;Inc. (2018): collaboration agreement on the development of multiple molecules with the potential to treat a range of neurological and systemic inflammatory diseases. The two lead molecules are DNL747 in multiple sclerosis and amyotrophic lateral sclerosis, and DNL758 in systemic inflammatory diseases such as rheumatoid arthritis and psoriasis;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">MedImmune (a division of AstraZeneca) (2017): agreement to develop and commercialize a monoclonal antibody (MEDI8897) for the prevention of Respiratory Syncytial Virus (RSV) associated illness in newborns and infants;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Innate Pharma (2016): collaboration and licensing agreement to apply Innate Pharma&#8217;s new proprietary technology to the development of innovative bispecific antibody formats engaging natural killer (NK) cells to kill tumor cells through the activating receptor NKp46;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Eli Lilly and Company (2014): agreement to pursue regulatory approval for non-prescription Cialis</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (tadalafil).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and its alliance partners have decided to terminate the following agreements (the related commitments are no longer included in Sanofi&#8217;s off balance sheet disclosures as of December 31, 2022):</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in October&#160;2022, Sanofi and DiCE Molecules ended their global collaboration to discover potential new therapeutics for up to&#160;12&#160;targets that encompass all disease areas of strategic interest to Sanofi; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in December&#160;2022, Sanofi and Revolution Medicines agreed, after a transitional phase, to end their partnership agreement in oncology signed in 2018.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, under the collaboration agreement with Regeneron on monoclonal antibodies (see Note&#160;C.1.), Sanofi is entitled to receive an additional share of quarterly profits (capped at 10% of Regeneron&#8217;s share of quarterly profits until March&#160;31, 2022, and thereafter at 20%), until Regeneron has paid 50% of the cumulative development costs incurred by the parties to the alliance. As of December&#160;31, 2022 this represented total commitments received of &#8364;2.7 billion (versus &#8364;2.9 billion as of December&#160;31, 2021), against cumulative development costs of &#8364;8.4 billion.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi entered into an agreement with Royalty Pharma in December&#160;2014 relating to development programs under which Royalty Pharma bears a portion of the remaining development costs of the project on a quarterly basis in return for royalties on future sales. This transaction is a co-investment, whereby the partner acquires an interest in the jointly-developed product by providing funding towards the development program. Consequently, the amounts received by Sanofi are recorded as a reduction in development costs, to the extent that the development costs incurred by Sanofi are recognized in profit or loss in accordance with the policies described in Note&#160;B.4.1. The products in development under the December&#160;2014 agreement with Royalty Pharma have been launched in the United States and Europe, marking the end of the joint development programs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;27, 2017, Sanofi and Lonza announced a strategic partnership in the form of a joint venture (BioAtrium AG) to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. An initial investment of approximately &#8364;0.3 billion to finance construction of the facility, split 50/50 between the two partners, has now been made in full. In addition, Sanofi could pay BioAtrium AG in the region of &#8364;0.6 billion over the next fifteen years as its share of operating expenses and the cost of producing future batches.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2014, pursuant to the &#8220;Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits&#8221; (still effective as of December 31, 2022), Sanofi Pasteur and the World Health Organization (WHO) signed a bilateral &#8220;Standard Material Transfer Agreement&#8221; (SMTA&#160;2). This agreement stipulates that Sanofi Pasteur will, during declared pandemic periods, (i)&#160;donate 7.5% of its real-time production of pandemic vaccines against any strain with potential to cause a pandemic, and (ii)&#160;reserve a further 7.5% of such production on affordable terms. The agreement cancels and replaces all preceding commitments to donate pandemic vaccines to the WHO.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.21.2. Off balance sheet commitments relating to financing activities</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit facilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Undrawn credit facilities are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">General-purpose credit facilities</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, total credit facilities amounted to &#8364;8,000 million (versus &#8364;8,000 million as of December 31, 2021 and&#160;&#8364;8,000 million as of December 31, 2020).</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the amount of guarantees given and received:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Guarantees given:</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,815</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,794</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,291</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Guarantees provided to banks in connection with credit facilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other guarantees given</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,808&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Guarantees received</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,229)</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,149)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(964)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.21.3. Off balance sheet commitments relating to asset acquisitions and divestments, and to changes in the scope of consolidation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, Sanofi had received commitments amounting in aggregate to &#8364;1.0&#160;billion in respect of (i)&#160;divestments of assets relating to transactions not yet finalized as of that date and (ii)&#160;contingent consideration arising under past agreements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Off balance sheet commitments of a financing nature with associates and joint ventures are disclosed in N</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ote&#160;D.6.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The maximum amount of contingent consideration relating to business combinations is disclosed in Note&#160;D.18.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of off-balance sheet commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442549568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal and arbitral proceedings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract', window );"><strong>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock', window );">Legal and arbitral proceedings</a></td>
<td class="text">Legal and arbitral proceedings<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and its affiliates are involved in litigation, arbitration and other legal proceedings. These proceedings typically are related to product liability claims, intellectual property rights (particularly claims against generic companies seeking to limit the patent protection of Sanofi&#160;products), competition law and trade practices, commercial claims, employment and wrongful discharge claims, tax assessment claims, waste disposal and pollution claims, and claims under warranties or indemnification arrangements relating to business divestitures. Provisions related to legal and arbitral proceedings are recorded in accordance with the principles described in Note&#160;B.12.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Most of the issues raised by these claims are highly complex and subject to substantial uncertainties; therefore, the probability of loss and an estimation of damages are difficult to ascertain. Contingent liabilities are cases for which either we are unable to make a reasonable estimate of the expected financial effect that will result from ultimate resolution of the proceeding, or a cash outflow is not probable. In either case, a brief description of the nature of the contingent liability is disclosed and, where practicable, an estimate of its financial effect, an indication of the uncertainties relating to the amount and timing of any outflow, and the possibility of any reimbursement are provided in application of paragraph&#160;86 of IAS&#160;37.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the cases that have been settled or adjudicated, or where quantifiable fines and penalties have been assessed, we have indicated our losses or the amount of provision accrued that is the estimate of the probable loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In a limited number of ongoing cases, while we are able to make a reasonable estimate of the expected loss or range of the possible loss and have accrued a provision for such loss, we believe that publication of this information on a case-by-case basis or by class would seriously prejudice the Company&#8217;s position in the ongoing legal proceedings or in any related settlement discussions. Accordingly, in those cases, we have disclosed information with respect to the nature of the contingency but have not disclosed our estimate of the range of potential loss, in accordance with paragraph&#160;92 of IAS&#160;37.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These assessments can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. Our assessments are based on estimates and assumptions that have been deemed reasonable by management. We believe that the aggregate provisions recorded for the above matters are adequate based upon currently available information. However, given the inherent uncertainties related to these cases and involved in estimating contingent liabilities, we could in the future incur judgments that could have a material adverse effect on our net income in any particular period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Long term provisions are disclosed in Note&#160;D.19. They include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">provisions for product liability risks, litigation and other amount to &#8364;1,652 million in 2022. These provisions are mainly related to product liabilities, government investigations, competition law, regulatory claims, warranties in connection with certain contingent liabilities arising from business divestitures other than environmental matters and other claims;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">provisions for environmental risks and remediation amount to &#8364;526 million in 2022, the majority of which are related to contingencies that have arisen from business divestitures.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">a) Products</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sanofi Pasteur Hepatitis&#160;B Vaccine Product Litigation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since 1996, more than 180&#160;lawsuits have been filed in various French civil courts against Sanofi Pasteur and/or Sanofi Pasteur&#160;MSD&#160;S.N.C., the former French subsidiary of Sanofi, and the latter a joint venture company with Merck&#160;&amp; Co.,&#160;Inc. now terminated, for which past ongoing litigation is now managed by the originating party. In such lawsuits, the plaintiffs allege that they suffer from a variety of neurological disorders and autoimmune diseases, including multiple sclerosis and Guillain-Barr&#233; syndrome as a result of receiving the hepatitis&#160;B vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In January&#160;2018, the Appeal Court of Bordeaux found a causal link between hepatitis&#160;B vaccine and multiple sclerosis. In&#160;July&#160;2019, the French Supreme Court </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Cour de cassation)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> cancelled the&#160;judgment&#160;of the Appeal Court of Bordeaux and referred the&#160;case back to the Appeal Court of Toulouse. On March&#160;30, 2022, the Appeal Court of Toulouse dismissed all the plaintiff&#8217;s claims.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there were 49&#160;ongoing lawsuits related to Sanofi Pasteur hepatitis&#160;B vaccine.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxotere</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Product Litigation in the US</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, there were approximately 8,300&#160;plaintiffs in courts across the country, with approximately 700&#160;of those plaintiffs being spouses who have filed loss of consortium claims.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Lawsuits have been filed against affiliates of Sanofi under US state law for personal injuries allegedly sustained in connection with&#160;the use of Taxotere</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The actions are held in several jurisdictions, including the federal and/or state courts of Louisiana, New&#160;Jersey, California, and Delaware. To date, there have been two&#160;bellwether trials as part of a federal multi-district litigation in the Eastern District of Louisiana both resulting in jury verdicts in Sanofi's favor.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to reliably assess the outcome of these lawsuits or the potential financial impact on the Company.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxotere</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8211; Mississippi Attorney General Litigation in the US</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In October&#160;2018, the Attorney General for the State of Mississippi filed a civil action in Hinds County, Mississippi, Chancery Court against various Sanofi Defendants related to Taxotere</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The State asserts one cause of action based on the Mississippi Consumer Protection Act (&#8220;MCPA&#8221;) and seeks a permanent injunction prohibiting Defendants&#8217; conduct and civil penalties of up to $10,000 for each violation. Sanofi filed a motion to dismiss the entire action in Hinds County, Mississippi, Chancery Court, which is currently pending.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to assess reliably the outcome of this lawsuit or the potential financial impact on the Company.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Litigation in the US</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2019, the US Food and Drug Administration (&#8220;FDA&#8221;) announced it was investigating the claims of an online pharmacy&#8217;s Citizen Petition that the medication Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (the brand name for ranitidine) used for stomach heartburn contains or can generate the chemical N-Nitrosodimethylamine (&#8220;NDMA&#8221;), an alleged human carcinogen. As a precautionary measure, Sanofi initiated a voluntary recall of branded over-the-counter Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in October&#160;2019. Concurrent with FDA&#8217;s investigation, multiple personal injury lawsuits and class actions alleging that Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> causes various cancers and seeking damages for either alleged personal injuries or alleged economic injuries were filed. Most of those cases have been coordinated into a Multi-District Litigation (&#8220;MDL&#8221;) in the Southern District of Florida.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On June&#160;30 and July&#160;8, 2021, the Federal MDL Court entered orders granting in part and denying in part Defendants&#8217; motions to dismiss various aspects of Plaintiffs&#8217; amended complaints. The rulings narrowed the scope of plaintiffs&#8217; complaints and saw the dismissal of all retailers and generic manufacturers from the MDL, leaving branded manufacturers GSK, Pfizer, Boehringer Ingelheim, and Sanofi as the defendants.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;6, 2022, the MDL Court granted Sanofi and the other defendants&#8217; Daubert and Summary Judgment motions. As a result, the Court will dismiss approximately 50,000&#160;cases involving plaintiffs&#8217; five designated cancers. We expect those plaintiffs to appeal the MDL's Court's decision.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other cases are pending in various state courts. These state court cases still include numerous retail and generics manufacturing defendants in addition to branded manufacturers.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, in November&#160;2019, Sanofi received a Civil Investigative Demand (&#8220;CID&#8221;) related to this issue from the Arizona Attorney General.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;2020, the New Mexico Attorney General filed a complaint against Sanofi, the previous marketing authorization holders for branded Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, a dozen generic manufacturers, and several retailers. The complaint brings claims for alleged violations of the New Mexico Unfair Practices Act, violations of the New Mexico False Advertising Act, violations of the New Mexico Public Nuisance Statute, common law public nuisance, and negligence.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;2020, Sanofi received a notice from the US Department of Justice Civil Division and US Attorney&#8217;s Office for the Eastern District of Pennsylvania of an investigation into allegations that pharmaceutical manufacturers violated the False Claims Act,&#160;31&#160;U.S.C. &#167;&#160;3729, in relation to the drug Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and ranitidine hydrochloride through alleged failure to disclose to the federal government information about the potential presence of NDMA. The notice requests information and documents from Sanofi including applications and communications with&#160;FDA.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In November&#160;2020, the Mayor and City Council of Baltimore filed a complaint against Sanofi, the previous marketing authorization holders for branded Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, generic manufacturers, and several retailers. The complaint alleges violations of the Maryland Consumer Protection statute, public nuisance, and negligence.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In January&#160;2021, Sanofi was served with the Center for Environmental Health&#8217;s Second Amended Complaint alleging Proposition&#160;65&#160;violations. The case, which also names generic manufacturers and retailers, is pending in California Superior Court&#160;in Alameda County.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Overall between State and federal filings, there are currently 3,486&#160;product liability &#8220;complaints&#8221; filed. These complaints encompass&#160;68,355&#160;individual product liability &#8220;plaintiffs&#8221; who have all filed against Sanofi. The vast majority of these plaintiffs participated in the MDL Court&#8217;s census registry program, allege cancers that the plaintiffs&#8217; leadership decided not to designate and pursue in the MDL, and have since filed their complaints in state courts. Additional cases may be filed.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to assess reliably the outcome of these lawsuits or the potential financial impact on Sanofi.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Litigation in Canada</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Between 2019 and 2022, 7&#160;proposed class actions naming notably Sanofi Consumer Health&#160;Inc., Sanofi-Aventis Canada Inc., Chattem (Canada)&#160;Inc., Sanofi and Sanofi Pasteur Limited as Defendants, relating to ranitidine were filed in various Canadian States court on behalf of all Canadian provinces alleging they suffered personal injury, including cancer, from the ingestion of ranitidine and are seeking general special, statutory, punitive and aggravated damages in an unspecified amount as well as disgorgement of profits. Additionally, some plaintiffs seek restitution for unjust enrichment in an amount equivalent to the purchase price of Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and subrogated damages on behalf of provincial health insurers for health care costs related to ranitidine use. These actions are pending before the courts of Alberta, British Columbia, Quebec and Ontario. A Certification hearing was held in the British Columbia action in October&#160;2022 and the certification decision is under review of the Court.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to assess reliably the outcome of these lawsuits or the potential financial impact on Sanofi.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depakine</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Product Litigation in France</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Civil proceedings</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, 78&#160;families brought a civil claim involving 131&#160;people exposed in utero to sodium valproate against a French affiliate of Sanofi seeking indemnification under French law for personal injuries allegedly suffered by children in connection with the use of sodium valproate by their mothers during pregnancy to treat their epilepsy (Depakine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">). These actions are held in several jurisdictions in&#160;France.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Twenty-nine lawsuits are proceedings on the merits, the most advanced was tried at the French Supreme Court level which issued in November&#160;2019 a ruling sending the case before the Paris Appeal Court to rule on Sanofi&#8217;s argument on the compliance of the product with mandatory regulations, as well as on the question of defectiveness of the product and the assessment of damages. In January&#160;2023, the Paris Appeal Court ordered a stay in the proceedings until the second expert opinion report is handed down in the criminal investigation (see below). </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Seven first instance rulings on the merits were handed down in 2022 by the Judicial Tribunal of Nanterre. In three cases, the Court declared the judicial expert report null and void and the Court dismissed one claim in another case.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Concerning three other cases relating to births that occurred between 2005 and 2009, the Court held, on the basis of a non-fault liability, that Sanofi was liable in light of the wording of the patient information leaflet. Provisional compensation amounts were set in the range of &#8364;0.1&#160;million to &#8364;0.5&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All the judgments have been appealed.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the class action lawsuit filed in May&#160;2017 by the APESAC </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Association des Parents d&#8217;Enfants souffrant du Syndrome de l&#8217;Anti-Convulsivant)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> against the French affiliate, the Judicial Tribunal of Paris ruled on January&#160;5, 2022 that a class is admissible, retaining Sanofi&#8217;s liability between 1984 and January&#160;2006 for malformations and between 2001 and January&#160;2006 for neuro-developmental disorders (NDD). This decision is based on the conclusions of a criminal expert report within the frame of ongoing criminal proceeding, for which the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Chambre de l&#8217;Instruction</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> of the Appeal Court of Paris had ordered a counter-expertise (see&#160;below). Sanofi and its insurers appealed the Judicial Tribunal of Paris' ruling related to the class action.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On July&#160;21, 2021, a Judicial Tribunal in France dismissed a claim for damages brought against Sanofi regarding a child born in&#160;1995. The Judicial Tribunal considered that the risk of occurrence of NDD in children born to mother exposed to sodium valproate during pregnancy was not demonstrated by the state of scientific knowledge at the time of her pregnancy. This decision was appealed and the proceeding is now pending before the Appeal Court of Paris, which had ordered a stay in the proceeding until the end of the criminal investigation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In July&#160;2020, a collective redress against the French affiliate was filed by</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> 63&#160;f</span><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">amilies, seeking indemnification for a</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> prejudice of anxiety</span><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">There is no date set for the hearing on the merits in this case yet.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Criminal investigation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A criminal investigation was initiated in May&#160;2015 before the Paris Civil Court. In January&#160;2020, the French affiliate of Sanofi was indicted for aggravated deception and involuntary injuries and in July&#160;2020 for involuntary manslaughter. In July&#160;2020, a judicial supervision of the affiliate was ordered, together with the implementation of financial guarantees. In November&#160;2020, the Health Authority (</span><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">ANSM) was similarly indicted for involuntary injuries and involuntary manslaughters.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On March&#160;9, 2022, the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Chambre de l&#8217;Instruction</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> of the Appeal Court of Paris ruled that certain complaints for involuntary manslaughter and several others for aggravated deception and involuntary injuries were time-barred. The Public Prosecutor, as well as the civil parties, have brought the matter before the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Chambre Criminelle </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">of the Supreme Court. </span><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2022, the investigating judges appointed 2&#160;experts for a counter-expertise following the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Chambre de l&#8217;Instruction&#8217;s</span><span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> ruling handed down end of 2021 and in October&#160;2022 ordered 6&#160;individual medical assessments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Public compensation scheme</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2017, the French government set up a public compensation scheme to indemnify patients for damages suffered in connection with the prescription of sodium valproate and its derivatives. The scheme was further amended through the 2020 Finance Law, with notably the introduction of presumptions of default for lack of information of the mother since 1982 for malformations and since 1984 for NDD. The scheme was amended again through the&#160;2021 Finance Law in order to increase the maximum premium applicable in case of refusal to make an offer (or insufficient offer) which would be deemed unjustified by a court ruling.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The committee of the compensation scheme has issued several final opinions holding the French affiliate liable for damages either in full or in part along with the French State, and, in some cases, healthcare practitioners. The French affiliate disagreed with the committee&#8217;s conclusions and has accordingly not offered indemnification to the claimants who have received compensation from the ONIAM </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Office National d'Indemnisation des Accidents M&#233;dicaux)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The ONIAM is now seeking reimbursement from Sanofi who has filed legal actions to oppose ONIAM&#8217;s payment orders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has also been notified of 63&#160;exposed persons who have filed a request for indemnification before the public compensation scheme and who are also claimants against Sanofi in individual judicial proceedings (summary proceedings or actions on the&#160;merits).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Administrative Actions</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In July&#160;2020, March and June&#160;2021, the Montreuil Administrative Court had held the French State liable in 5&#160;administrative proceedings initiated by families against the State. In March&#160;2021, the Administrative Court did not retain any lack of information of the mother regarding the risk of neurodevelopmental disorders for births in 1999 and in 2002, based on the state of scientific knowledge at the time. However, regarding the risk of malformations, liabilities were retained against the State, the healthcare professionals and Sanofi, notably for discrepancy between the SmPC (Summary of the Product Characteristics) and the patient leaflet. In other cases involving births in 2005-2008, the liability of the State was retained for both malformations and neurodevelopmental disorders, and partially exonerated, taking into account the roles of healthcare practitioners and Sanofi. Given that the French affiliate was not a party to these administrative proceedings, its arguments (i.e. notably several requests from the French affiliate to the Health Authorities to reinforce warnings to healthcare professionals and patients in relation to Depakine</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) were not considered. All rulings were appealed by the claimants. Sanofi has filed requests for voluntary intervention in these proceedings to present its arguments before the Administrative Court of Appeal. In one proceeding, the claimants decided to withdraw their claims.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to assess reliably the outcome of these cases or the potential financial impact on the Company.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depakine</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Product Litigation in other EU countries and in the UK</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Switzerland, 10&#160;families have filed a civil claim for damages concerning 16&#160;people exposed in utero. Some of them also involve the claimants&#8217; physicians. In November&#160;2022, one action was declared time-barred by the judge. The claimant appealed this court decision on the merit. The appeal is on-going.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Spain, there are 4&#160;trials ongoing relating to 10&#160;children. In March&#160;2022, in one of the trials, the Court condemned Sanofi to indemnify 4&#160;patients. Sanofi appealed this decision. In January&#160;2023, in another trial filed by one patient, the Appeal Court confirmed the first instance's decision and dismissed the claim. The other actions are still at a preliminary stage.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Belgium, there are 2&#160;civil proceedings (currently on hold) and a criminal complaint against X and against Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Germany, there is one civil lawsuit before the Berlin Regional Court, relating to one child exposed </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">in utero</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> to valproate taken by the mother during pregnancy for bipolar disorder.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Ireland, there are 2&#160;Pre-Action Protocol cases and 2&#160;civil claims on-going.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the United Kingdom, there are 3&#160;Pre-Action Protocol cases in Great Britain and 1&#160;Pre-Action Protocol case in Northern Ireland on-going.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It is not possible, at this stage, to assess reliably the outcome of these cases or the potential financial impact on the Company.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dengvaxia</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (Philippines)</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since early 2018 up to present date, several claims were filed in the Philippines by parents of deceased children whose deaths were allegedly due to vaccination with Dengvaxia</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Early March&#160;2019, 2020 and 2022, the Philippine Department of Justice (DOJ) prosecution panel announced it had found probable cause to indict several Sanofi employees/former employees and former Government officials for &#8220;reckless imprudence&#8221; resulting in homicides. Since then, several criminal actions have been filed in court as a result of this finding. Petitions for Review to the DOJ Secretary have been filed and the said petitions remain pending. Meanwhile, the majority of the respondents have challenged the jurisdiction of the lower court where the first&#160;8&#160;cases had been assigned and this issue is now filed with the Supreme Court. There are several claims that have not yet been filed in any court despite resolutions by the DOJ that there is probable cause.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">b) Patents</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ramipril Canada Patent Litigation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi was involved in a number of legal proceedings involving companies which market generic Altace</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (ramipril) in Canada. In&#160;2004, Sanofi unsuccessfully brought Notice of Compliance proceedings (NOC proceedings) at the end of which eight manufacturers obtained marketing authorizations from the Canadian Minister of Health for generic versions of ramipril in Canada. Sanofi filed unsuccessful patent infringement actions against all those companies and ultimately Sanofi was liable for damages under Section&#160;8. Sanofi made payment in complete satisfaction of those awards.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In June&#160;2011, Apotex commenced an action in the Ontario Superior Court of Justice asserting damages under the Ontario Statute of Monopolies, the UK Statute of Monopolies, and the Trade-marks Act (the &#8220;Ontario Action&#8221;). </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At the request of the parties, in June&#160;2021, the Court ordered that the action be stayed in view of the lower court's decision in March in the Apotex vs. Lilly case. In the Lilly case, the Court dismissed Apotex's Statute of Monopolies claim by way of summary judgment. If upheld on appeal, this decision may end Apotex's claim against Sanofi, also based on the Statute of Monopolies. In November&#160;2022, Apotex filed an application for leave to appeal the Ontario Court of Appeal decision in the Lilly case with the Supreme Court of Canada. The Court will decide whether to grant the leave application in late Q1&#160;2023. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Praluent</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (alirocumab)-related Amgen Patent Litigation in the US</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2014, Amgen filed four separate complaints against Sanofi and Regeneron in the US District Court for the District of Delaware (&#8220;District Court&#8221;) asserting patent infringement relating to Sanofi and Regeneron&#8217;s Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> product. Together these complaints alleged that Praluent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> infringed seven patents for antibodies targeting PCSK9 and sought injunctive relief and unspecified damages.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2021, the Federal Circuit affirmed the District Court&#8217;s ruling invalidating the Amgen asserted patent claims. In November&#160;2021, Amgen filed a petition with the US&#160;Supreme Court, asking it to overturn the Federal Circuit decision. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;4, 2022, the US Supreme Court granted Amgen&#8217;s petition for review. Proceedings before the US Supreme Court are now underway.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dupixent</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (dupilumab)-related Amgen Patent Opposition and Revocation&#160;in Europe</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Immunex Corporation, an Amgen affiliate, is the registered proprietor of European Patent&#160;EP2292665. The claims of this patent relate to, among other things, human monoclonal antibodies that are capable of inhibiting IL-4 induced biological activity and which compete with one of four reference antibodies for binding to a cell that expresses human IL-4R. In April&#160;2016, Sanofi and Regeneron each filed an opposition in the European Patent Office (EPO) against EP2292665, seeking its revocation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The EPO rendered its decision in November&#160;2017 and revoked the patent in its entirety. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2017, Sanofi and Regeneron filed oppositions in the EPO against Amgen&#8217;s European Patent EP2990420, which is a divisional of the EP2292665 Patent discussed above.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In March&#160;2022, the European Patent Office Technical Board of Appeals (&#8220;TBA&#8221;) ruled in Sanofi and Regeneron&#8217;s favor and affirmed the invalidation of Amgen/Immunex&#8217;s EP2990420 patent. In December&#160;2022, the TBA issued its written decision in favor of Sanofi and Regeneron. Amgen/Immunex may seek review of this decision by the Enlarged Board of Appeals.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In March&#160;2022, Amgen/Immunex withdrew its appeal to the TBA for its EP2292665 patent.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jevtana</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (cabazitaxel)-related patent litigation in the US</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is currently covered by four Orange Book listed patents US&#160;7,241,907, US&#160;8,927,592, US&#160;10,583,110 and US&#160;10,716,777. In&#160;May&#160;to July&#160;2020, Sanofi filed patent infringement suits under Hatch-Waxman against 12&#160;generic filers asserting the &#8216;110&#160;patent and the&#160;&#8216;777&#160;patent in the US District Court for the District of Delaware. The '592&#160;patent was added to the suits after its amended claims issued in August&#160;2021. In January&#160;2021 and August&#160;2022, the District Court issued two claim construction decisions in favor of the defendants. In September&#160;2022, the district court issued a decision that granted the defendants&#8217; motion to dismiss in part related to the &#8216;592&#160;patent but denied the motion to dismiss in part related to the &#8216;777 and &#8216;110&#160;patents. Sanofi has reached settlement agreements with most of the defendants and the suit against the remaining defendant Sandoz is ongoing. Sanofi has voluntarily withdrawn the &#8216;110&#160;patent from the suit and a 3-day trial on the &#8216;777&#160;patent was held in January&#160;2023. Sandoz has&#160;agreed not to launch any generic cabazitaxel product until the earlier of a district court decision in favor of the defendants or&#160;120 days after the completion of the post-trial briefing.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Litigation (Commonwealth) in Australia</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In August&#160;2007, GenRX (a subsidiary of Apotex) obtained registration of a generic clopidogrel bisulfate product on the Australian Register of Therapeutic Goods. At the same time, GenRX filed a patent invalidation action with the Federal Court of Australia, seeking revocation of Sanofi&#8217;s Australian enantiomer patent claiming clopidogrel salts (a &#8220;nullity action&#8221;). In September&#160;2007, Sanofi obtained a preliminary injunction from the Federal Court preventing commercial launch of this generic clopidogrel bisulfate product until judgment on the substantive issues of patent validity and infringement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In August&#160;2008, the Australian Federal Court confirmed that the claim in Sanofi&#8217;s Australian enantiomer patent directed to clopidogrel bisulfate (the salt form in Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">) was valid and the patent infringed. On appeal, the Full Federal Court of Australia held in&#160;September&#160;2009 that all claims in the patent are invalid. Sanofi&#8217;s appeal to the Australia High Court was denied in&#160;March&#160;2010.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In April&#160;2013, the Australian Department of Health and Ageing (&#8220;Commonwealth&#8221;) filed an application before the Federal Court&#160;of&#160;Australia seeking payment of damages from Sanofi related to the Apotex preliminary injunction of up to AUD449 million (&#8364;286 million as of December 31, 2022), plus interest.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and BMS settled the patent litigation with Apotex in November&#160;2014. In April&#160;2020, the Commonwealth&#8217;s claim was dismissed. In&#160;May&#160;2020, the Commonwealth filed a Notice of Appeal to the Full Court of the Federal Court. On appeal, the Commonwealth reduced its claim to a range of AUD223.3&#160;million (&#8364;142.1&#160;million) to AUD280.2&#160;million (&#8364;178.4&#160;million) which, inclusive of interest to&#160;December&#160;31,&#160;2022, ranges from AUD343.4&#160;million (&#8364;218.6&#160;million) to AUD463.6&#160;million (&#8364;295.1&#160;million) depending on whether interest accrues from the date the Commonwealth claims the Apotex products would have been listed on the Government reimbursement scheme in the absence of the injunction (i.e. April&#160;1, 2008) or the date the Commonwealth filed its claim (i.e. April&#160;1, 2013). Appeal hearing took place in February&#160;2021 before the Full Court of the Federal Court. The ruling is expected in 2023.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">c) Other litigation</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aubagio</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (teriflunomide)-related litigation in Europe</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In October&#160;2020, Mylan Ireland&#160;Ltd (&#8220;Mylan&#8221;) brought an action before the General Court of the European Union requesting the annulment of the August&#160;18, 2020 decision of the European Medicines Agency (&#8220;EMA&#8221;) refusing to validate Mylan&#8217;s marketing authorization application for a generic version of Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (teriflunomide). Sanofi has intervened in this court case between Mylan and the EMA in order to defend Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8217;s regulatory exclusivity. Mylan submitted a request for discontinuance of the proceedings in December&#160;2022. The case is over.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (clopidogrel) &#8211; Attorney General Action in Hawaii</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In March&#160;2014, the Hawaii Attorney General (AG) filed a complaint that sets forth allegations related to the sale and marketing of and variability of response to Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The Hawaii AG specifically alleged that Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> had a diminished effect in patients of certain genetic backgrounds and that Sanofi and BMS had failed to make an earlier disclosure of this information.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2021, the Court issued its decision, imposing penalties in the total amount of $834,012,000 against both Sanofi and Bristol Myers Squibb (BMS), with $417,006,000 being apportioned to each company. In June&#160;2021, Sanofi and BMS appealed this judgment. To the extent this judgment or possibly a reduced judgment remains after the appeal, the judgment would be split evenly with BMS. On May&#160;3, 2022, the Hawaii Supreme Court granted a request to transfer the appeal directly to the Hawaii Supreme Court, thereby eliminating review by the Hawaii intermediate Court of Appeals. The Hawaii Supreme Court had oral argument in December&#160;2022 and a decision is expected in or around March&#160;2023.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(clopidogrel) - Attorney General Action in New Mexico</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2016, the New Mexico Attorney General (AG) filed a complaint, claiming that Sanofi and Bristol Meyers Squibb (BMS) engaged in unfair and deceptive practices related to the marketing and labelling of Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The New Mexico AG specifically alleged that Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> had a diminished effect in patients of certain genetic backgrounds and that the Companies failed to make an earlier disclosure of this information. This matter has been concluded and dismissed by way of a settlement by all parties that was finalized in Q4&#160;2022.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (clopidogrel)-related litigation in France</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In France, in the claim concerning allegations that Sanofi&#8217;s communication and promotional practices inhibited the entry on the&#160;market of generics of clopidogrel (the active ingredient of Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), the French Antitrust Authority issued its decision on May&#160;14,&#160;2013, imposing on Sanofi a fine of &#8364;40.6&#160;million. In December&#160;2014, the Paris Court of Appeals rejected Sanofi&#8217;s appeal and confirmed in totality the decision. As a consequence of the May&#160;2013 ruling, claims were filed by Sandoz and by Teva in 2014 before the Commercial Court of Paris for compensation of their alleged damages: loss of margin and other ancillary damages (legal fees to external counsel, image and reputation). In June&#160;and November&#160;2016 respectively, settlement agreements were entered into with Sandoz and Teva. Consequently, they subsequently withdrew their civil claims, jointly and severally. On October&#160;18, 2016, the Supreme Court confirmed the Court of Appeals&#8217; decision. Therefore, the Court of Appeals&#8217; decision became definitive. In September&#160;2017, Sanofi and its French affiliate received a summons before the Paris Commercial Court from the French</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> Caisse Nationale d&#8217;Assurance Maladie &#8211; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">CNAM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(French Social Security) claiming &#8364;115.8&#160;million for their alleged damages. On October&#160;1, 2019, the Paris Commercial Court dismissed the CNAM&#8217;s action as time barred. On February&#160;9, 2022, the Paris Court of Appeals overturned the Paris Commercial Court's ruling, finding the&#160;French</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> Caisse Nationale d'Assurance Maladie - </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">CNAM (French Social Security)'s action as not time-barred and designated an expert to determine the amount of damages. The expertise is on-going.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">340B Drug Pricing Program in the United States</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is currently involved in several matters relating to the 340B&#160;program in the US (a federal program that requires drug manufacturers to supply certain products to certain &#8220;covered entities&#8221; at reduced prices). In 2021, Sanofi filed a lawsuit against the Department of Health and Human Services (&#8220;HHS&#8221;), the Health Resources and Services Administration (&#8220;HRSA&#8221;), and certain of their administrators in the&#160;US&#160;District Court for the District of New Jersey challenging (i)&#160;HHS&#8217;s December 2020 Advisory Opinion (the &#8220;AO&#8221;) stating that drug manufacturers are legally obligated to deliver discounts under the 340B&#160;program to an unlimited number of contract pharmacies; (ii)&#160;HHS&#8217;s December&#160;2020 Administrative Dispute Resolution (&#8220;ADR&#8221;) Rule; and (iii)&#160;HRSA&#8217;s May&#160;2021 letter to Sanofi concluding that Sanofi&#8217;s 340B integrity initiative (under which Sanofi collects limited, de-identified, claims data on 340B-priced drugs dispensed by contract pharmacies) violates section&#160;340B and that Sanofi has therefore &#8220;overcharged&#8221; certain covered entities. The court issued its opinion in November&#160;2021, upholding HRSA&#8217;s conclusion in the May&#160;2021 letter, but did not impose any fines, penalties or refund obligations against Sanofi for any &#8220;overcharges&#8221;. The court also rejected Sanofi&#8217;s challenge to the ADR Rule and dismissed its challenge to the AO as moot. Sanofi appealed the court&#8217;s decision to the Third Circuit Court of Appeals and the government filed a cross-appeal. The Third Circuit issued its opinion on&#160;January&#160;30, 2023. It held that Sanofi&#8217;s restrictions on delivery to contract pharmacies do not violate Section&#160;340B. It also enjoined HHS from enforcing against Sanofi its reading of Section&#160;340B in the AO and the May&#160;2021 violation letter. As to Sanofi&#8217;s challenge to the ADR Rule, the Third Circuit held that HHS did not violate the Administrative Procedure Act&#8217;s notice-and-comment requirement in promulgating the ADR Rule.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In January&#160;2021, the National Association of Community Health Centers (&#8220;NACHC&#8221;) filed an ADR proceeding before HRSA on behalf of a number of covered entities, seeking to require Sanofi and AstraZeneca to supply contract pharmacies with 340B discounts without conditions. On August&#160;10, 2022, the ADR panel granted the motions to dismiss filed both by Sanofi and AstraZeneca, holding that the Delaware district court&#8217;s decision granting AstraZeneca&#8217;s motion for summary judgment precluded NACHC&#8217;s ADR claims against both AstraZeneca and Sanofi. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2021, HRSA referred Sanofi (as well as other manufacturers) to the HHS Office of the Inspector General (OIG) in accordance with the 340B Program Ceiling Price and Civil Monetary Penalties Final Rule.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2021, the Vermont Attorney General issued a Civil Investigative Subpoena seeking certain information about Sanofi&#8217;s participation in the 340B Drug Pricing Program. Sanofi continues to cooperate with this investigation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, in July&#160;2021, Mosaic Health Inc. and Central Virginia Health Services (covered entities) filed a nationwide antitrust class action complaint against Sanofi and three other manufacturers in the United States District Court for the Western District of New York. Plaintiffs allege that Sanofi and the other defendants conspired to eliminate favorable 340B pricing, particularly with&#160;respect to diabetes therapies. On September&#160;2, 2022, the court granted Defendants&#8217; motion to dismiss the complaint. On&#160;October&#160;3, 2022, plaintiff filed a motion for leave to file a second amended complaint. A motion to dismiss the second amended complaint is fully briefed and pending before the court.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%">d) Contingencies arising from certain mergers &amp; acquisitions transactions</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As a result of divestitures, the Company is subject to a number of ongoing contractual and legal obligations regarding the state of the sold businesses, their assets, and their liabilities, some of which may be subject to dispute.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aventis CropScience Retained Liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The sale by Aventis Agriculture S.A. and Hoechst GmbH (both legacy companies of Sanofi) of their aggregate 76% participation in Aventis CropScience Holding (ACS) to Bayer and Bayer CropScience AG (BCS), the wholly owned subsidiary of Bayer which holds the ACS shares, was effective on June&#160;3, 2002. The Stock Purchase Agreement (SPA) dated October&#160;2, 2001, contained customary representations and warranties with respect to the sold business, as well as a number of indemnifications subject to limitation periods and caps, in particular with respect to environmental liabilities for which some outstanding claims from Bayer remain unresolved.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infraserv Hoechst Retained Liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">By the Asset Contribution Agreement dated December&#160;19/20, 1996, as amended in 1997, Hoechst contributed all lands, buildings, and related assets of the Hoechst site at Frankfurt Hoechst to Infraserv GmbH &amp; Co. Hoechst KG. Infraserv Hoechst undertook to indemnify Hoechst against environmental liabilities at the Hoechst site and with respect to certain landfills. As consideration for the indemnification undertaking, Hoechst transferred to Infraserv Hoechst approximately &#8364;57&#160;million to fund reserves. In 1997, Hoechst also agreed it would reimburse current and future Infraserv Hoechst environmental expenses up to &#8364;143&#160;million. As a former operator of the land and as a former user of the landfills, Hoechst may ultimately be liable for costs of remedial action in excess of this amount.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Boehringer Ingelheim (BI) Consumer Healthcare Liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi and Boehringer Ingelheim (BI) are involved in an ICC (International Chamber of Commerce) arbitration regarding their respective indemnification obligations for liabilities connected to ongoing US court proceedings regarding Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> manufactured by BI (see above - Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Litigation in the US). The dispute arises from indemnification obligations agreed between Sanofi and BI as part of the swap of Sanofi&#8217;s Animal Health (AH) business for BI&#8217;s Consumer Health Care (CHC) business in January&#160;2017 and under a Global Settlement Agreement concluded in September&#160;2019 regarding notably the offset of respective AH and CHC claims notified under the SPAs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In February&#160;2020, BI initiated an arbitration against Sanofi seeking indemnification for losses it could incur as a result of the Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> litigation in the US. Sanofi is disputing BI&#8217;s claim for indemnification and has asserted several counterclaims under relevant agreements, including a counterclaim for indemnification of losses Sanofi and its affiliates have incurred and may incur in connection with the same US court proceedings involving Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The arbitration is expected to conclude at the earliest in&#160;March&#160;2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Legal And Arbitral Proceedings [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfLegalAndArbitralProceedingsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439558016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions for discounts, rebates and sales returns<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract', window );"><strong>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock', window );">Provisions for discounts, rebates and sales returns</a></td>
<td class="text">Provisions for discounts, rebates and sales returns<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Adjustments between gross sales and net sales, as described in Note&#160;B.13., are recognized either as provisions or as reductions in accounts receivable, depending on their nature.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows movements in these items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:28.149%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Government</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and State</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">programs</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Managed&#160;care</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and&#160;GPO</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">programs</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chargeback<br/>incentives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rebates<br/>and<br/>discounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sales<br/>returns</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>deductions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,178</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">726</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">312</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,330</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">621</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,218</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision related to current period sales</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,970&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,633&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,221&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,314&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in provision related to prior period sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(54)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(113)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(201)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,552)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,556)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,604)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,838)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(512)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(112)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(19,174)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(118)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,507</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">908</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">333</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,557</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">688</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">46</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,039</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision related to current period sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,855&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,813&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,330&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in provision related to prior period sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(136)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(152)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(242)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,561)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,979)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,828)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,291)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(697)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(105)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(19,461)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(72)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(32)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,596</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">931</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">303</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,425</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">610</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,899</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision related to current period sales</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,744&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,244&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22,141&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in provision related to prior period sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(120)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(138)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(315)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,824)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,208)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,093)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,809)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(599)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(166)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21,699)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2022</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,603</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,021</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">362</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,805</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">629</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">70</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,490</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Primarily US government programs: Medicaid (&#8364;1,307 million in 2022, &#8364;1,244 million in 2021, &#8364;1,015 million in 2020) and Medicare (&#8364;775 million in 2022, &#8364;941 million in 2021 and &#8364;726 million in 2020).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Mainly rebates and other price reductions granted to healthcare authorities in the United States (including Managed Care: &#8364;934 million in 2022, &#8364;896 million in 2021 and &#8364;692 million in 2020).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Provisions related to US net sales amounted to &#8364;4,270 million as of December 31, 2022, &#8364;4,057 million as of December 31, 2021 and &#8364;3,982 million as of&#160;December 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for provisions for discounts rebates and sales returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456076752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Personnel costs<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EmployeeBenefitsAbstract', window );"><strong>Employee Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory', window );">Personnel costs</a></td>
<td class="text">Personnel costs<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Total personnel costs (other than termination benefits, presented in Note&#160;D.27.) include the following items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Salaries</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,145&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,625&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,508&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Social security charges (including defined-contribution pension plans)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,098&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock options and other share-based payment expense</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Defined-benefit plans</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other employee benefits</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,991</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,340</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,079</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The total number of registered employees was 91,573 as of December 31, 2022, compared with 95,442 as of December 31, 2021 and&#160;99,412 as of December 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EmployeeBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Benefits [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EmployeeBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405438649872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other operating income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory', window );">Other operating income</a></td>
<td class="text">Other operating income<span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">totaled &#8364;1,969 million in 2022, versus &#8364;859 million in 2021 and &#8364;697 million in 2020.</span>Other operating income includes (i)&#160;gains from asset divestments, amounting to &#8364;655&#160;million in 2022 (versus &#8364;418 million in 2021 and &#8364;307 million in 2020); and (ii)&#160;income from Sanofi&#8217;s pharmaceutical partners, amounting to &#8364;1,178 million in 2022 (including &#8364;1,147 million from Regeneron, see Note&#160;D.26. below and Note C.1.), compared with &#8364;245 million in 2021 and &#8364;199 million in 2020. For 2021, it includes a payment of &#8364;119&#160;million from Daiichi Sankyo relating to the termination of a vaccines collaboration agreement in Japan<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other operating income. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455593472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other operating expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory', window );">Other operating expenses</a></td>
<td class="text">Other operating expenses<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> totaled &#8364;2,531 million in 2022, compared with &#8364;1,805 million in 2021 and &#8364;1,415 million in 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2022, this line item includes &#8364;2,378 million of expenses relating to the alliance with Regeneron (see Note&#160;C.1.), compared with&#160;&#8364;1,568 million for 2021 and &#8364;1,090 million for 2020 (as shown in the table below):</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income &amp; expense related to sharing of (profits)/losses under the Monoclonal Antibody Alliance</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,325)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,253)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(727)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional share of profit paid by Regeneron towards development costs </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reimbursement to Regeneron of selling expenses incurred</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(476)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(303)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(349)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total - Monoclonal Antibody Alliance</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,367)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,429)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,001)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Immuno-Oncology Alliance</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">68</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">89</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other (mainly Zaltrap</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"> and Libtayo</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,120</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(12)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other operating income/(expenses), net related to the Regeneron Alliance</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,231)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,373)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(926)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which amount presented in</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"> Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"> (Note&#160;D.25.)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">195&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">164&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Following the restructuring of the Immuno-Oncology agreement between Sanofi and Regeneron, applicable from July&#160;1, 2022 (see Note&#160;C.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) As of December 31, 2022, the commitment received by Sanofi in respect of the additional profit share payable by Regeneron towards development costs amounted to &#8364;2.7 billion, compared with &#8364;2.9&#160;billion as of December 31, 2021 (see note D.21).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Charges to provisions for litigation and environmental risks are also recorded within this line item.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other operating expense. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442611120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring costs and similar items<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock', window );">Restructuring costs and similar items</a></td>
<td class="text">Restructuring costs and similar items<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restructuring costs and similar items amounted to &#8364;1,336 million in 2022, &#8364;820 million in 2021 and &#8364;1,089 million in 2020, and were comprised of the following items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:59.696%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee-related expenses</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Charges, gains or losses on assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compensation for early termination of contracts (other than contracts of employment)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transformation programs costs</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,336</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">820</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,089</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;This line consists of impairment losses and accelerated depreciation charges related to site closures (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, the employee-related expenses of &#8364;507&#160;million related to termination benefits further to announcements made during the year, and the line &#8220;Charges, gains or losses on assets&#8221; related mainly to a strategic decision to close an industrial facility outside France. The costs of Sanofi's transformation program (as defined in Note&#160;B.19.) relate mainly to the ongoing creation of the new standalone Consumer Healthcare entity, and to the implementation of Sanofi&#8217;s new digital strategy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2021, the costs of Sanofi's transformation program were mainly related to the creation of the new standalone Consumer Healthcare entity and of EUROAPI (the new European market leader in active pharmaceutical ingredients), and to the implementation of Sanofi&#8217;s new digital strategy.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2020, employee-related expenses amounted to &#8364;697&#160;million, and consisted of termination benefits further to the announcement of plans to adapt Sanofi&#8217;s organization (primarily in Europe) in line with the new &#8220;Play to Win&#8221; strategy announced in December&#160;2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of restructuring costs and similar items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405438649872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other gains and losses, and litigation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock', window );">Other gains and losses, and litigation</a></td>
<td class="text">Other gains and losses, and litigation<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">for </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2022 represent a charge of &#8364;370&#160;million, </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">including the pre-tax loss arising on the deconsolidation of EUROAPI (see Note&#160;D.1.) and costs related to major litigation, including the estimated future defense costs which Sanofi may be exposed in connection with the Zantac</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> litigation</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2021, this line item represented a charge of &#8364;5&#160;million.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2020, this line item represented a net gain of &#8364;136 million, mainly relating to the sale of Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of other gains and losses, and litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439253408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial expenses and income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Financial expenses and income</a></td>
<td class="text">Financial expenses and income<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:57.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of debt</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(313)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(328)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cost of net debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(124)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(259)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(225)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-operating foreign exchange gains/(losses)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unwinding of discounting of provisions</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost related to employee benefits</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(44)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(57)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) on disposals of financial assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest expense on lease liabilities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net financial income/(expenses)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(234)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(328)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(335)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">comprising: Financial expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(440)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(368)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(388)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial income</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">206</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">40</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">53</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Includes net gains/(losses) on interest rate and currency derivatives used to manage debt: &#8364;(11) million in 2022, &#8364;14 million in 2021, &#8364;93 million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Includes net gains on interest rate and currency derivatives used to manage cash and cash equivalents: &#8364;68 million in 2022, &#8364;51 million in 2021, &#8364;66 million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note&#160;D.19.).</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, 2021 and 2020, the impact of the ineffective portion of hedging relationships was not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income (cost). [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405487420800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax expense<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income tax expense</a></td>
<td class="text">Income tax expense<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has elected for tax consolidations in a number of countries, principally France, Germany, the United Kingdom and the United States.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the allocation of income tax expense between current and deferred taxes:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:57.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current taxes</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,774)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,908)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,913)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,006)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,558)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,807)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income before tax and investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,422</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,798</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#23004c;padding:0 1pt"/><td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,778</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#23004c;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the standard corporate income tax rate applicable in France is explained as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(as a percentage)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Standard tax rate applicable in France</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Difference between the standard French tax rate and the rates applicable to Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Revisions to tax exposures and settlements of tax disputes</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other items</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.2</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France. For 2020, this line includes the difference between the standard French tax rate and the tax rate applicable to the gain on divestment of Regeneron shares.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In determining the amount of the deferred tax liability for 2022, 2021 and 2020, Sanofi took into account changes in the ownership structure of certain subsidiaries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For the periods presented, the amount of deferred tax assets recognized in profit or loss that were initially subject to impairment losses at the time of a business combination is immaterial.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439253408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share of profit/loss from investments accounted for using the equity method<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestsInOtherEntitiesAbstract', window );"><strong>Interests In Other Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock', window );">Share of profit/loss from investments accounted for using the equity method</a></td>
<td class="text">Share of profit/loss from investments accounted for using the equity method<span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Share of profit/(loss) from investments accounted for using the equity method </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">amounted to &#8364;68&#160;million for 2022, compared with &#8364;39&#160;million for 2021 and &#8364;359&#160;million for 2020 (including &#8364;343&#160;million for the share of Regeneron profits up to and including May&#160;29, 2020, the date on which Sanofi ceased to exercise significant influence over Regeneron: see Note&#160;D.2.).</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of share of profit loss of associates and joint ventures accounted for using equity method explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestsInOtherEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interests In Other Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestsInOtherEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439531392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net income attributable to non-controlling interests<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock', window );">Net income attributable to non-controlling interests</a></td>
<td class="text">Net income attributable to non-controlling interests<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the reporting periods presented:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of net income attributable to other non-controlling interests</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">113</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">56</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for net income attributable to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439446192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RelatedPartyAbstract', window );"><strong>Related Party [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related party transactions</a></td>
<td class="text">Related party transactions<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal related parties are companies over which Sanofi has control or significant influence, joint ventures, key management personnel, and principal shareholders.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has not entered into any material transactions with any key management personnel. Financial relations with Sanofi&#8217;s principal shareholders fall within the ordinary course of business and were immaterial in the years ended December 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Note&#160;F.1. lists the principal companies controlled by Sanofi; those companies are fully consolidated, as described in Note&#160;B.1. Transactions between those companies, and between the parent company and its subsidiaries, are eliminated when preparing the consolidated financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Transactions with companies over which Sanofi has significant influence, and with joint ventures, are presented in Note&#160;D.6.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Key management personnel include corporate officers and the members of the Executive Committee (an a</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">verage of 11&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">members in 2022, in 2021 and in 2020).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows, by type, the compensation paid to key management personnel:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:57.552%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term benefits</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Post-employment benefits</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based payment</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in profit or loss</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">52</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">55</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">57</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Compensation, employer&#8217;s social security contributions, directors&#8217; attendance fees, and any termination benefits (net of reversals of termination benefit obligations).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the aggregate obligation as of December&#160;31 for each period presented for individuals who hold or have held executive positions within Sanofi during that period.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:60.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate top-up pension obligation in favor of certain corporate officers and of Executive Committee members</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate termination benefits and lump-sum retirement benefits in favor of key management personnel</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442549568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disclosures about major customers and credit risk<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinancialInstrumentsAbstract', window );"><strong>Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExplanatory', window );">Disclosures about major customers and credit risk</a></td>
<td class="text">Disclosures about major customers and credit risk<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Credit risk is the risk that customers (wholesalers, distributors, pharmacies, hospitals, clinics or government agencies) may fail to pay their debts; for Sanofi, that risk is mainly concentrated on amounts receivable from wholesalers in the United States. Sanofi manages credit risk by vetting customers in order to set credit limits and risk levels, and asking for guarantees or insurance where necessary; performing controls; and monitoring qualitative and quantitative indicators of accounts receivable balances, such as the period of credit taken and overdue payments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sales generated by Sanofi with its biggest customers, in particular certain wholesalers in the United States, represented </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">27% of net sales in </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The three largest customers respectively accounted for approximately 12%, 8% and 7% of Sanofi's net sales in&#160;2022 (10%, 7% and 6% in 2021; 10%, 6% and 5% in 2020).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCreditRiskExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of credit risk. [Refer: Credit risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Section Credit risk<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g35A-38_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCreditRiskExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405444282400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OperatingSegmentsAbstract', window );"><strong>Operating Segments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">Segment information</a></td>
<td class="text">Segment information<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As indicated in Note&#160;B.26., Sanofi has three operating segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Pharmaceuticals segment comprises, for all geographical territories, the commercial operations of the following global franchises: Specialty Care (Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Neurology &amp; Immunology, Rare Diseases, Oncology, and Rare Blood Disorders) and General Medicines (Core and Non-Core Assets), together with research, development and production activities dedicated to the Pharmaceuticals segment. This segment also includes associates whose activities are related to pharmaceuticals. Following the transaction of May&#160;29, 2020, Regeneron is no longer an associate of Sanofi (see Note&#160;D.2.). Consequently, the Pharmaceuticals segment no longer includes Sanofi&#8217;s equity-accounted share of Regeneron&#8217;s profits for the periods presented.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Vaccines segment comprises, for all geographical territories, the commercial operations of Vaccines, together with research, development and production activities dedicated to vaccines.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for Sanofi&#8217;s Consumer Healthcare products, together with research, development and production activities dedicated to those products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inter-segment transactions are not material.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The costs of Sanofi's global support functions (Corporate Affairs, Finance, People &amp; Culture, Legal, Ethics &amp; Business Integrity, Information Solutions &amp;&#160;Technologies, Sanofi Business Services,&#160;etc.) are primarily managed centrally at the group-wide level. The costs of those functions are presented within the &#8220;Other&#8221; category. That category also includes other reconciling items such as retained commitments in respect of divested activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Following the Capital Markets Day in February&#160;2021, Sanofi changed the presentation of the net sales of the General Medicines and Consumer Healthcare GBUs, and also reallocated certain expenses. In particular, IT costs relating to Sanofi's new digital organization &#8211; previously allocated to the Pharmaceuticals, Vaccines, and Consumer Healthcare segments &#8211; are now included within the &#8220;Other&#8221; segment. The 2020 segment results presented below have been amended for comparative purposes in order to reflect those adjustments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;8, Sanofi treated the first-time application of the IFRIC agenda decisions on (i)&#160;the calculation of provisions for pensions and other post-employment benefits under IAS&#160;19 and (ii)&#160;accounting for costs of configuring or customizing a supplier&#8217;s application software in a Software as a Service (SaaS) arrangement as retrospective changes in&#160;accounting policy. The impacts are described in Note&#160;A.2.1 to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.35.1. Segment results</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.35.1.1. Analysis of net sales </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth Sanofi&#8217;s net sales for the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:7.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.491%"/><td style="width:0.1%"/></tr><tr style="height:8pt"><td colspan="6" rowspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.5pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Other<br/>countries</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</span></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Other<br/>countries</span></td><td colspan="3" rowspan="2" style="border-right:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</span></div></td><td colspan="3" rowspan="2" style="border-left:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Other<br/>countries</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2020</span></div></td></tr><tr style="height:9pt"><td colspan="42" style="display:none"/></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,157</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,694</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,837</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,688</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,201</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,484</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,285</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26,970</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,819</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,635</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,220</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25,674</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Dupixent</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.22pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">940</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,346</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,007</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,293</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">649</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,971</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">629</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,249</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">386</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,808</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">340</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,534</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Neurology &amp; Immunology</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">639</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,637</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">174</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,450</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">638</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,482</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">204</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,324</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">578</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,631</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">185</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,394</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,420&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,031&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,955&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,448&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Rare Diseases</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,104</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,367</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">974</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,445</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,069</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,142</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">915</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,126</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,010</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,122</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">879</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,011</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cerezyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fabrazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Myozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">/</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lumizyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Oncology</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">239</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">515</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">198</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">952</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">327</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">410</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">175</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">912</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">299</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">368</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">131</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">798</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Rare Blood Disorders</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">94</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">983</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">240</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,317</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">81</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">842</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">218</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,141</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">837</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">339</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,217</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Core Assets</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,917</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,653</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,819</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,389</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,868</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,315</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,585</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,768</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,759</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,413</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,409</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,581</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Non-Core Assets</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,637</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,176</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,409</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,222</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,846</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,281</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,515</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,642</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,088</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,389</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,849</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,326</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,076&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,494&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,661&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Other non-core assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4,485&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4,729&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,451&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">5,111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Industrial sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">587</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">620</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">723</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">808</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">658</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">67</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">88</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">813</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,341</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,291</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,597</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,229</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,225</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,762</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,336</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,323</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">973</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,759</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,241</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,973</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Polio/Pertussis/<br/>Hib Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,383&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,159&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,106&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Influenza Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,977&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,628&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,575&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer Healthcare</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,501</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,290</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,289</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,080</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,333</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,139</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,996</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,468</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,359</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,071</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,964</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,394</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Allergy</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Pain Care</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Digestive Wellness</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,999</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,275</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,723</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,997</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,759</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,385</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,617</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,761</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-left:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,151</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,465</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,425</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36,041</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160; For the Consumer Healthcare GBU, Sanofi has since 2021 adopted a more granular presentation by introducing new sub-categories that reflect consumer trends and the strengths and opportunities of the portfolio.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.35.1.2. Business operating income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi reports segment results on the basis of &#8220;Business operating income&#8221;. This indicator is used internally by Sanofi&#8217;s chief operating decision maker to measure the performance of each operating segment and to allocate resources.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Business operating income&#8221; is derived from </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, adjusted as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amounts reported in the line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Restructuring costs and similar items</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> relating to business combinations (IFRS&#160;3) and </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (gains and losses on major disposals of assets, asset groups ore operations, and costs related to major litigation) are eliminated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">expenses arising from the remeasurement of inventories following a business combination (IFRS&#160;3) are eliminated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">amortization and impairment losses charged against intangible assets (other than software and other rights of an industrial or operational nature) are eliminated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">upfront payments and regulatory milestone payments recognized within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and related to transactions outside the ordinary activities of Sanofi are eliminated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the share of profits/losses from investments accounted for using the equity method is added, to the extent that this relates to&#160;joint ventures and associates with which Sanofi has a strategic alliance (for 2020, excludes Regeneron up to and including&#160;May&#160;29, 2020; see Note&#160;D.2.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">acquisition-related effects and restructuring costs relating to investments accounted for using the equity method (joint ventures and associates with which Sanofi has a strategic alliance) are eliminated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">net income attributable to non-controlling interests is deducted; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">for 2020, the gain on the divestment of Regeneron shares on May&#160;29, 2020 is eliminated. This elimination does not include the gain on the remeasurement of the 400,000&#160;retained shares at market value as of that date.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows Sanofi&#8217;s segment results for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:35.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Sanofi</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,688</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,229</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,080</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,997</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,666&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,511)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,101)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,827)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,692)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,067)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(936)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(516)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,706)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,923)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(870)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,478)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,221)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,492)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income and expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,514)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,043</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,168</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,810</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,981)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,040</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">a) This caption reconciles segment financial information to total consolidated financial information.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:35.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Sanofi</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26,970</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,323</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,468</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,761</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,095&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,965)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,430)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(250)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,251)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,330)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(712)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(497)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,692)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,326)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,388)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,036)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,555)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income and expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,172)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(946)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(49)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,409</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,609</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,493</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,797)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,714</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">This caption reconciles segment financial information to total consolidated financial information.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:36.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.460%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Sanofi</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25,674</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,973</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,394</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36,041</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,982)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,312)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,528)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,106)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,171)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(682)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(524)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,530)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,927)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(789)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,419)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,256)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,391)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income and expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(487)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(561)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,207</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,336</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,410</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,194)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,759</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">2020 figures have been adjusted to take account of the reallocation of certain expenses (in particular IT costs related to Sanofi&#8217;s new digital organization) from the Pharmaceuticals, Vaccines and Consumer Healthcare operating segments to the &#8220;Other&#8221; segment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) This caption reconciles segment financial information to total consolidated financial information.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below, presented in compliance with IFRS&#160;8, shows a reconciliation between aggregated &#8220;Business operating income&#8221; for the segments and</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Income before tax and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.676%"><tr><td style="width:1.0%"/><td style="width:58.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.439%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.152%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(h)</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,040</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,714</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,759</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization and impairment of intangible assets </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,599)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,011)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expenses arising from the impact of acquisitions on inventories</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(53)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,336)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(820)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,089)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gain on divestment of Regeneron shares on May&#160;29, 2020</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,225&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income from out-licensing</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,656</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,126</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,113</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial expenses</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(368)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(388)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income before tax and investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,422</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,798</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,778</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Excludes restructuring costs relating to investments accounted for using the equity method and expenses arising from the impact of acquisitions on investments accounted for using the equity method. For the first two quarters of 2020, this line has been restated to exclude any effect of equity method accounting for the investment in Regeneron following the divestment of Sanofi's entire equity interest (with the exception of the 400,000&#160;shares retained by Sanofi) on May&#160;29, 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to non-controlling interests.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) For 2022, this line includes a reversal of &#8364;2,154&#160;million on Eloctate franchise products following FDA approval of ALTUVIIIO </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">dated February 22, 2023, partially offset by an impairment of &#8364;1,586&#160;million relating to the development project for SAR444245 (non-alpha interleukin-2).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) For 2020, this line mainly comprises the gain on the sale of operations related to the Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> activity to Baxter.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(f) This line includes the gain on the sale of (i)&#160;13&#160;million shares of Regeneron common stock in the registered public offering and (ii)&#160;the 9.8&#160;million shares repurchased by Regeneron, but does not include the gain arising from the remeasurement of the 400,000&#160;retained shares at market value as of&#160;May&#160;29,&#160;2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">)&#160;&#160;&#160;&#160;For 2022, this line includes an upfront payment of $900 million and a regulatory milestone payment of $100 million related to the out-licensing of Libtayo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> following the restructuring of the Immuno-Oncology Collaboration and License Agreement with Regeneron (see Note&#160;C.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(h) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.35.2. Other segment information</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show the split by operating segment of (i)&#160;the carrying amount of investments accounted for using the equity method, (ii)&#160;acquisitions of property, plant and equipment, and (iii)&#160;acquisitions of intangible assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal investments accounted for using the equity method in the Pharmaceuticals segment are entities majority owned by EUROAPI, MSP Vaccine Company, and Infraserv GmbH &amp; Co. H&#246;chst&#160;KG (see Note&#160;D.6.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acquisitions of intangible assets and property, plant and equipment correspond to acquisitions paid for during the period.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:48.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of other intangible assets</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:48.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investments accounted for using the equity method</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:48.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.613%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investments accounted for using the equity method</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">D.35.3. Information by geographical region</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The geographical information on net sales provided below is based on the geographical location of the customer. In accordance with&#160;IFRS&#160;8, the non-current assets reported below exclude right-of-use assets relating to leases as determined under IFRS&#160;16, investments accounted for using the equity method, other non-current assets, non-current income tax assets, and deferred tax assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:26.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.999%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">North<br/>America</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>United&#160;States</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>countries</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,997</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,999</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,296</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,984</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,275</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,014</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">property, plant and equipment owned</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,869&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,365&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,875&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,284&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,457&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">goodwill</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49,892&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#9642;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:9.29pt">other intangible assets</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,640&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,257&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,178&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:26.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.999%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></div></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">North<br/>America</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>United&#160;States</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>countries</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,761</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,759</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,256</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,075</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,385</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,927</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">property, plant and equipment owned</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,959&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,998&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">goodwill</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48,056&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,407&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,059&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,187&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:26.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.999%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></div></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">North<br/>America</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>United&#160;States</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>countries</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36,041</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,151</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,223</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,060</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,465</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,830</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">property, plant and equipment owned</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,365&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,895&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,542&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">goodwill</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44,364&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,341&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,208&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,665&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,468&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As stated in Note&#160;D.5., goodwill is not allocated by geographical region.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Segments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455668704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal accountants' fees and services<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory', window );">Principal accountants' fees and services</a></td>
<td class="text">Principal accountants&#8217; fees and services<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">PricewaterhouseCoopers Audit and Ernst&#160;&amp; Young et Autres served as independent auditors of Sanofi for the year ended December 31, 2022 and for all other reporting periods presented. The table below shows fees charged by those firms and member firms of their networks to Sanofi and consolidated subsidiaries in the years ended December 31, 2022 and 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:29.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ernst&#160;&amp;&#160;Young</span></td><td colspan="12" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PricewaterhouseCoopers</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Audit:</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> Statutory audit of separate and consolidated financial statements</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Services other than statutory audit</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Audit-related services</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.6</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.2</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes services provided by the independent auditors of the parent company and French subsidiaries: Ernst&#160;&amp; Young &#8364;7.3 million in 2022, &#8364;7.2 million in&#160;2021; PricewaterhouseCoopers &#8364;7.7 million in 2022, &#8364;7.7 million in 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Services other than statutory audit provided by Ernst&#160;&amp; Young et Autres during 2022 comprised:</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - work on share capital transactions and securities issues submitted to the Annual General Meeting (in extraordinary business) for approval;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - additional procedures to enable reports previously signed by the firm to be incorporated by reference;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - agreed-upon and audit procedures in connection with a proposed divestment; and</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - issuance of the Independent third party&#8217;s report on the consolidated statement of extra-financial performance.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      Services other than statutory audit provided by PricewaterhouseCoopers Audit during 2022 comprised:</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - work on share capital transactions and securities issues submitted to the Annual General Meeting (in extraordinary business) for approval;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - additional procedures to enable reports previously signed by the firm to be incorporated by reference;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - contractual audits, assurance engagements, agreed-upon procedures, tax compliance work, and technical consultancy.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Includes services provided by the independent auditors of the parent company and French subsidiaries: Ernst&#160;&amp; Young: &#8364;1.4 million in 2022, &#8364;2.7 million in&#160;2021; PricewaterhouseCoopers &#8364;0.3 million in 2022, &#8364;0.3 million in 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee pre-approval and procedures</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Audit Committee of Sanofi has adopted a policy and established certain procedures for the approval of audit services and for the pre-approval of other services to be provided by the independent auditors. In 2022, the Audit Committee established a limit for permitted audit-related and other services (i.e. services other than statutory audit) that can be provided by the independent auditors, and the related fees.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of compensation to the entity's auditors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAuditorsRemunerationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442611120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>List of principal companies included in the scope of consolidation during&#160;2022<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestsInOtherEntitiesAbstract', window );"><strong>Interests In Other Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory', window );">List of principal companies included in the scope of consolidation during&#160;2022</a></td>
<td class="text">List of principal companies included in the scope of&#160;consolidation during&#160;2022<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">F.1. Principal fully consolidated companies</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows Sanofi's principal subsidiaries and their country of incorporation:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:60.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hoechst GmbH</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Deutschland GmbH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">A. Nattermann &amp; Cie. GmbH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis GmbH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Belgium</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ablynx N.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Flanders BVBA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi A/S</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Spain, S.L.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Oy</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis France</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Winthrop Industrie</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Recherche &amp; D&#233;veloppement</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Groupe</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Chimie</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Participations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Biotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Mature IP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur NVL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Europe</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SECIPE SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Merieux S.A.S.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi 2015 D SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare International SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare France SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Group SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis A.E.B.E.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Greece</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Private Co, Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chinoin Private Co. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Hungary Commercial K.F.T</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carraig Insurance DAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Ireland Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Holdings (Ireland) Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi S.R.L.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Italy S.R.L.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Global Sarl</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Luxembourg Sarl</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Norge AS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Norway</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Europe B.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Foreign Participations B.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Sp. z.o.o.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Poland sp.Z.O.O</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Sp. z.o.o.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Produtos Farmaceuticos Lda</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Portugal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis, s.r.o.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Czech s.r.o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Romania SRL</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:60.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Romania S.R.L.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis UK Holdings Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Synthelabo UK Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma Holdings Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare UK Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">AO Sanofi Russia</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi AB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis (Suisse) SA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Global Sarl Baar Intellectual Property Branch</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Ilac Sanayi ve Ticaret A.S.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Asi Ticaret A.S.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Saglik Urunleri Limited Sirketi</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:60.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Therapeutic Products Limited Partnership</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi US Services Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis U.S. LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chattem, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventisub LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Corporation</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">VaxServe, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ U.S. LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ Therapeutics Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principia Biopharma Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Research Invest LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Bioverativ Holdings LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RPR US Ltd.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kadmon Holdings, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kadmon Corporation, LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amunix</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Synthorx, Inc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Translate Bio, Inc</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:57.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Countries</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis South Africa (Pty) Ltd</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Africa</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Alg&#233;rie</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Algeria</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Arabia Trading Company Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Saudi Arabia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Argentina S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme de Argentina S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Argentina S.A.U.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Healthcare Pty Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Australia Pty Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Medley Farmaceutica Ltda</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Canada Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Merieux Canada Holdings ULC (Canada)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Chile S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi (Hangzhou) Pharmaceuticals Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi (China) Investment Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi (Beijing) Pharmaceuticals Co.Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Biologies Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shenzhen Sanofi pasteur Biological Products Co, Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shanghai Rongheng Pharmaceutical Co, Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genfar S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Colombia S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Korea Co. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella healthcare Korea Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Gulf FZE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Arab Emirates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Egypt</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Egypt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Egypt LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Egypt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Hong-Kong Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi India Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">India</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Healthcare India Private Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">India</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Isra&#235;l Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi K.K.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SSP Co.,Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis (Malaysia) SDN. BHD.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Malaysia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Maroc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Morocco</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Mexico S.A. de C.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur S.A. de C.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Azteca Vacunas, S.A. de C.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Pakistan Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pakistan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Panama S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Panama</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis del Peru S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Peru</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Puerto Rico Inc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Philippines Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Philippines Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Singapore Pte. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma (Manufacturing) Pte. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Manufacturing Pte Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Taiwan Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis (Thailand) Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Venezuela S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Venezuela</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Vietnam Company Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vietnam</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Vietnam Shareholding Company Limited</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vietnam</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85.0&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">F.2. Principal investments accounted for using the equity method</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:62.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.214%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">GlaxoSmithKline Consumer Healthcare, L.P.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maphar</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Morocco</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MCM Vaccine B.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MSP Vaccine Company (formerly MCM company)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EUROAPI</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B4<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B4_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestsInOtherEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interests In Other Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestsInOtherEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405486460240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events subsequent to December 31, 2022<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Disclosure of non-adjusting events after reporting period [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Events subsequent to December 31, 2022</a></td>
<td class="text">Events subsequent to December 31, 2022<span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February 22, 2023, the US Food and Drug Administration (FDA) approved ALTUVIIIO</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. That decision resulted in the reversal, in 2022 books, of &#8364;2,154&#160;million of impairment losses against the intangible assets associated with the Eloctate franchise, in accordance with IAS 36 (Impairment of Assets); the asset had been partially written down in 2019. For more information please refer to Note D.5. to the financial statements of the present annual report. The adjustment is presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Impairment of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the consolidated income statement; the net impact after tax is &#8364;1,651&#160;million.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456431456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate Information And Statement Of IFRS Compliance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfIFRSCompliance', window );">International financial reporting standards (IFRS)</a></td>
<td class="text">International financial reporting standards (IFRS)<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements cover the twelve-month periods ended December 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with Regulation No.&#160;1606/2002 of the European Parliament and Council of July&#160;19, 2002 on the application of&#160;international accounting standards, Sanofi has presented its consolidated financial statements in accordance with IFRS since&#160;January&#160;1, 2005. The term &#8220;IFRS&#8221; refers collectively to international accounting and financial reporting standards (IASs&#160;and&#160;IFRSs) and to interpretations of the interpretations committees (SIC and IFRIC) with mandatory application as of December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements of Sanofi as of December 31, 2022 have been prepared in compliance with IFRS as&#160;issued&#160;by the International Accounting Standards Board (IASB) and with IFRS as endorsed by the European Union as of December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">IFRS as endorsed by the European Union as of December 31, 2022 are available under the heading &#8220;IFRS Financial Statements&#8221; via the following web&#160;link:</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline">https://www.efrag.org/Endorsement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in accordance with the IFRS general principles of fair presentation, going concern, accrual basis of accounting, consistency of presentation, materiality, and aggregation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations', window );">New standards, amendments and interpretations</a></td>
<td class="text">New standards, amendments and interpretations<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">A.2.1. New standards applicable from January 1, 2022</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following amendments are applicable from January&#160;1, 2022, and have had no material impact: &#8220;Reference to the Conceptual Framework&#8221; (amendment to IFRS&#160;3); &#8220;Proceeds before Intended Use&#8221; (amendment to IAS&#160;16); &#8220;Onerous Contracts &#8212; Cost of Fulfilling a Contract&#8221; (amendment to IAS&#160;37); and &#8220;Annual Improvements to IFRS standards 2018-2020&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As a reminder, Sanofi adopted in its consolidated financial statements for the year ended December&#160;31, 2021 the IFRS&#160;IC final agenda decision (published in the March&#160;2021 IFRS&#160;IC update) clarifying how to account for costs of configuring or customising a supplier&#8217;s application software in a Software as a Service (SaaS) arrangement, which requires such costs to be recognized as an expense.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations', window );">New pronouncements issued by IASB and applicable from 2023 or later</a></td>
<td class="text">New pronouncements issued by the IASB and applicable from 2023 or later<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This note describes standards, amendments and interpretations issued by the IASB that will have mandatory application in 2023 or subsequent years, and Sanofi&#8217;s position regarding future application.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;12, 2021, the IASB issued &#8220;Disclosure of Accounting Policies&#8221;, an amendment to IAS&#160;1, and &#8220;Definition of Accounting Estimates&#8221;, an amendment to IAS&#160;8. On May&#160;7, 2021, the IASB issued an amendment to IAS&#160;12, relating to deferred tax assets and liabilities arising from a single transaction. Sanofi does not expect a material impact from those amendments, which are applicable at the earliest from January&#160;1, 2023, and will not early adopt them.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On September&#160;22, 2022, the IASB issued an amendment to IFRS&#160;16 (Leases), relating to lease liabilities in a sale-and-leaseback arrangement, which is applicable at the earliest from January&#160;1, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (subject to endorsement by the European Union); it will not have a material impact on the Sanofi financial statements, and </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi will not early adopt it.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On January&#160;23, 2020, the IASB issued &#8220;Classification of Liabilities as Current or Non-current&#8221;, an amendment to IAS&#160;1, and then on&#160;October&#160;31, 2022 issued &#8220;Non-current Liabilities with Covenants&#8221;, a further amendment to IAS&#160;1. The amendments are applicable at the earliest from January&#160;1, 2024 </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(subject to endorsement by the European Union)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; they will not have a material impact on the Sanofi financial statements, and Sanofi will not early adopt them.</span></div>IFRS&#160;17 (Insurance Contracts), issued on May&#160;18, 2017 and applicable on or after January&#160;1, 2023, will not apply to the Sanofi consolidated financial statements because the insurance activities carried on by Sanofi's captive insurance companies are internal within the Sanofi group (the sole policyholders being subsidiaries of Sanofi), and hence are eliminated on consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">Use of estimates and judgments</a></td>
<td class="text">Use of estimates and judgments<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The preparation of financial statements requires management to make reasonable estimates and assumptions based on information available at the date of the finalization of the financial statements. Those estimates and assumptions may affect the reported amounts of assets, liabilities, revenues and expenses in the financial statements, and disclosures of contingent assets and contingent liabilities as of the date of the review of the financial statements. Examples of estimates and assumptions include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">amounts deducted from sales for projected sales returns, chargeback incentives, rebates and price reductions (see Notes&#160;B.13. and&#160;D.23.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">impairment of property, plant and equipment and intangible assets (see Notes&#160;B.6. and D.5.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the valuation of goodwill and the valuation and estimated useful life of acquired intangible assets (see Notes&#160;B.3.2., B.4., D.4. and&#160;D.5.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the measurement of contingent consideration receivable in connection with asset divestments (see Notes&#160;B.8.5. and&#160;D.12.) and of contingent consideration payable (see Notes&#160;B.3. and&#160;D.18.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the measurement of financial assets at amortized cost (see Note&#160;B.8.5.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of post-employment benefit obligations (see Notes&#160;B.23. and&#160;D.19.1.);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of liabilities or provisions for restructuring, litigation, tax risks relating to corporate income taxes, and environmental risks (see Notes&#160;B.12., B.19., B.20., D.19. and&#160;D.22.); and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of deferred tax assets resulting from tax losses available for carry-forward and deductible temporary differences (see Notes&#160;B.22. and&#160;D.14.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Actual results could differ from these estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory', window );">Hyperinflation</a></td>
<td class="text">Hyperinflation<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, Sanofi continued to account for subsidiaries based in Venezuela using the full consolidation method, on the basis that the criteria for control as specified in IFRS&#160;10 (Consolidated Financial Statements) are still met. In 2018, following changes to the Venezuelan foreign exchange system, the &#8220;DICOM&#8221; rate was replaced by the &#8220;PETRO&#8221; rate (with a floating US dollar/bolivar parity) and the strong bolivar (&#8220;VEF&#8221;) was replaced by the sovereign bolivar (&#8220;VES&#8221;), reflecting a 1-for-100,000 devaluation. Finally, in October&#160;2021 a new currency called the &#8220;Digital Bolivar&#8221; (VED) was introduced at a rate of 1&#160;VED to 1,000,000&#160;sovereign bolivars. Consequently, the contribution of the Venezuelan subsidiaries to the consolidated financial statements is immaterial.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Argentina, the cumulative rate of inflation over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has since July&#160;1, 2018 treated Argentina as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since the beginning of 2022, inflation in Turkey has increased significantly and the cumulative inflation rate over the past three years has been above 100% since the end of February&#160;2022. Qualitative indicators following the deterioration of the economic situation and exchange controls also support the consensus conclusion that Turkey is a hyperinflationary country from 2022. Consequently, Sanofi has since January&#160;1, 2022 treated Turkey as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock', window );">Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK</a></td>
<td class="text">Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On February&#160;18, 2020, Sanofi and the US Department of Health and Human Services extended their research and development partnership to leverage Sanofi&#8217;s previous development work on a SARS vaccine to attempt to unlock a fast path forward for developing a COVID-19 vaccine. Under the terms of the collaboration, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the US Department of Health and Human Services, is helping to fund the research and development undertaken by Sanofi.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April&#160;14, 2020, Sanofi and GlaxoSmithKline (GSK) entered into a collaboration agreement to develop a recombinant COVID-19 vaccine candidate, with Sanofi contributing its S&#8209;protein COVID-19 antigen (based on recombinant DNA technology) and GSK contributing its pandemic adjuvant technology. Sanofi is leading clinical development and the registration process for the vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On July&#160;31, 2020, the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK was selected by the US&#160;government&#8217;s Operation Warp Speed (OWS) program. Under the OWS, the US government is providing funds to support further development of the vaccine, including clinical trials and scaling-up of manufacturing capacity. Initially, the agreement also provided for the supply of 100&#160;million doses of the vaccine, with payment due at the time vaccine doses are provided. </span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has recognized the funding received from the US government as a deduction from the development expenses incurred, in accordance with IAS&#160;20 (Accounting for Government Grants and Disclosure of Government Assistance).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of government aid received from the US federal government and BARDA and recognized </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as a deduction from development expenses</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and other operating expenses was &#8364;265&#160;million in 2022, compared with &#8364;147&#160;million in 2021 and an immaterial amount in 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September&#160;2020, Sanofi and GSK signed pre-order contracts with the Canadian and UK governments and with the European Union for doses of the vaccine candidate. During 2021, Sanofi and GSK contractualized with the Canadian and UK governments and with the European Union on the number of doses ordered.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;15, 2021, Sanofi and GSK announced positive preliminary data on their COVID-19 booster vaccine candidate and indicated that their Phase&#160;III trial was to continue, based on recommendations from an independent monitoring board.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On November&#160;10, 2022, in line with the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency, the European Commission approved VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta vaccine as booster for the prevention of COVID-19 in adults aged 18&#160;years and older. Designed to provide broad protection against multiple variants, this protein-based COVID-19 booster vaccine is based on the Beta variant antigen and includes GSK&#8217;s pandemic adjuvant. VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Beta is indicated as a booster for active immunization against SARS-CoV-2 in adults who have previously received an mRNA or adenoviral COVID-19 vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On December&#160;21, 2022, following the European Commission approval, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved VidPrevtyn</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Beta vaccine for the prevention of COVID-19 in adults aged 18 and over within the UK.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there had been no material change in the commitments entered into by the United States in 2020, or in the pre-order arrangements with Canada, the United Kingdom and the European Union.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;15 (see Note&#160;B.13.1.), Sanofi recognizes revenue when control over the product is transferred to the customer (for vaccines, transfer of control is determined by reference to the terms of release and acceptance of batches of vaccine). Payments received subsequent to signature of vaccine pre-order contracts relating to doses not yet delivered are customer contract liabilities (i.e. an obligation for the entity to supply goods to a customer, for which consideration has been received from the customer). They are presented within &#8220;Customer contract liabilities&#8221; in the balance sheet (see Note&#160;D.19.5.), and within &#8220;Net change in other current assets and other current liabilities&#8221; in the statement of cash flows.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of&#160;December&#160;31, 2022, customer contract liabilities amounted to &#8364;264&#160;million, compared with &#8364;319&#160;million as of&#160;December&#160;31,&#160;2021 (see Note&#160;D.19.5., &#8220;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Current provisions and other current liabilities&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">). The portion of the December&#160;31, 2021 balance recognized in profit or loss during 2022 was &#8364;85&#160;million (no amounts were recognized in profit or loss during 2021).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock', window );">Effects of climate change</a></td>
<td class="text">Effects of climate change<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Risks associated with climate change as assessed to date, and the commitments made by Sanofi on carbon neutrality and cutting greenhouse gas emissions, do not have a material impact on the financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Risks associated with trends in carbon costs, raw material shortages, supply chain disruption,&#160;etc. have been taken into account in the measurement of assets and liabilities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock', window );">War in Ukraine</a></td>
<td class="text">War in UkraineThe conflict triggered by the Russian invasion of Ukraine on February&#160;24, 2022 led to the imposition of sanctions by the European Union and other countries. While complying with those sanctions inherent to its operations, Sanofi continues to carry on commercial and industrial activities in Russia under its direct control so as to meet patient needs. In 2022, Sanofi generated net sales of &#8364;674&#160;million in Russia (compared with &#8364;575&#160;million in 2021 and &#8364;641&#160;million in 2020), representing 1.6% of consolidated net sales.The conflict had no material direct or indirect impact on the financial statements ended December&#160;31, 2022. Sanofi will continue to monitor the situation, and will update its estimates and assumptions accordingly<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock', window );">Basis of consolidation</a></td>
<td class="text">Basis of consolidation<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;10 (Consolidated Financial Statements), the consolidated financial statements of Sanofi include the financial statements of entities that Sanofi controls directly or indirectly, regardless of the level of the equity interest in those entities. An entity is controlled when Sanofi has power over the entity, exposure or rights to variable returns from its involvement with the entity, and the ability to affect those returns through its power over the entity. In determining whether control exists, potential voting rights must be taken into account if those rights are substantive, in other words they can be exercised on a timely basis when decisions about the relevant activities of the entity are to be taken.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Entities consolidated by Sanofi are referred to as &#8220;subsidiaries&#8221;. Entities that Sanofi controls by means other than voting rights are referred to as &#8220;consolidated structured entities&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;11 (Joint Arrangements), Sanofi classifies its joint arrangements (i.e. arrangements in which Sanofi exercises joint control with one or more other parties) either as a joint operation (in which case, Sanofi recognizes the assets and liabilities of the operation in proportion to its rights and obligations relating to those assets and liabilities) or as a joint venture.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi exercises joint control over a joint arrangement when decisions relating to the relevant activities of the arrangement require the unanimous consent of Sanofi and the other parties with whom control is shared.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi exercises significant influence over an entity when it has the power to participate in the financial and operating policy decisions of that entity, but does not have the power to exercise control or joint control over those policies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), the equity method is used to account for joint ventures (i.e.&#160;entities over which Sanofi exercises joint control) and for associates (i.e. entities over which Sanofi exercises significant influence).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under the equity method, the investment is initially recognized at cost, and subsequently adjusted to reflect changes in the net assets of the associate or joint venture. IAS&#160;28 does not specify the treatment to be adopted on first-time application of the equity method to an investee following a step acquisition. Consequently, by reference to paragraph&#160;10 of IAS&#160;28, Sanofi has opted to apply the cost method, whereby the carrying amount of the investment represents the sum of the historical cost amounts for each step in the acquisition. As of the date on which the equity method is first applied, goodwill (which is included in the carrying amount of the investment) is determined for each acquisition step. The same applies to subsequent increases in the percentage interest in the equity-accounted investment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When the criteria of IFRS&#160;5 are met, Sanofi recognizes the equity interest within the balance sheet line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The equity method is not applied to equity interests that are classified as held-for-sale assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Transactions between consolidated companies are eliminated, as are intragroup profits.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A list of the principal companies included in the consolidation in 2022 is presented in Note&#160;F.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Foreign currency translation</a></td>
<td class="text">Foreign currency translation<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.2.1. Accounting for foreign currency transactions in the financial statements of consolidated entities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Non-current assets (other than receivables) and inventories acquired in foreign currencies are translated into the functional currency using the exchange rate prevailing at the acquisition date.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the end of the reporting period. The gains and losses resulting from foreign currency translation are recorded in the income statement. However, foreign exchange gains and losses arising from the translation of advances between consolidated subsidiaries for which settlement is neither planned nor likely to occur in the foreseeable future are recognized in equity, in the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Change in currency translation differences.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.2.2. Foreign currency translation of the financial statements of foreign entities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi presents its consolidated financial statements in euros (&#8364;). In accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates), each subsidiary accounts for its transactions in the currency that is most representative of its economic environment (the functional currency).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All assets and liabilities are translated into euros using the exchange rate of the subsidiary&#8217;s functional currency prevailing at the end of the reporting period. Income statements are translated using a weighted average exchange rate for the period, except in the case of foreign subsidiaries in a hyperinflationary economy. The resulting currency translation difference is recognized as a separate component of equity in the consolidated statement of comprehensive income, and is recognized in the income statement only when the subsidiary is sold or is wholly or partially liquidated.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory', window );">Business combinations and transactions with non-controlling interests</a></td>
<td class="text">Business combinations and transactions with non-controlling interests<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.3.1. Accounting for business combinations, transactions with non-controlling interests and loss of control</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Business combinations are accounted for in accordance with IFRS&#160;3 (Business Combinations) and IFRS&#160;10 (Consolidated Financial Statements).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Business combinations are accounted for using the acquisition method. Under this method, the acquiree&#8217;s identifiable assets and liabilities that satisfy the recognition criteria of IFRS&#160;3 (Business Combinations) are measured initially at their fair values at the date of acquisition, except for (i)&#160;non-current assets classified as held for sale (which are measured at fair value less costs to sell) and (ii)&#160;assets and liabilities that fall within the scope of IAS&#160;12 (Income Taxes) and IAS&#160;19 (Employee Benefits). Restructuring liabilities are recognized as a liability of the acquiree only if the acquiree has an obligation as of the acquisition date to carry out the restructuring.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The principal accounting rules applicable to business combinations and transactions with non-controlling interests include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">acquisition-related costs are recognized as an expense, as a component of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">contingent consideration is recognized in equity if the contingent payment is settled by delivery of a fixed number of the acquirer&#8217;s equity instruments; otherwise, it is recognized in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Contingent consideration is recognized at fair value at the acquisition date irrespective of the probability of payment. If the contingent consideration was originally recognized as a financial liability, subsequent adjustments to the liability are recognized in profit or loss in the line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, unless the adjustment is made within the twelve months following the acquisition date and relates to facts and circumstances existing as of that date;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">goodwill may be calculated on the basis of either (i)&#160;the entire fair value of the acquiree, or (ii)&#160;a share of the fair value of the acquiree proportionate to the interest acquired. This option is elected for each acquisition individually.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Purchase price allocations are performed under the responsibility of management, with assistance from an independent valuer in the case of major acquisitions. IFRS&#160;3 does not specify an accounting treatment for contingent consideration arising from a business combination made by an entity prior to the acquisition of control in that entity and carried as a liability in the acquired entity&#8217;s balance sheet. The accounting treatment applied by Sanofi to such a liability is to measure it at fair value as of the acquisition date and to report it in the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to business combinations and to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, with subsequent remeasurements recognized in profit or loss. This treatment is consistent with the accounting applied to contingent consideration in the books of the&#160;acquirer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, management may where it deems fit elect to apply the optional test to identify concentration of fair value permitted under IFRS&#160;3 in order to determine whether a transaction is a business combination within the meaning of IFRS&#160;3, or merely the acquisition of an asset or of a group of similar assets.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.3.2. Goodwill</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The excess of the cost of an acquisition over Sanofi&#8217;s interest in the fair value of the identifiable assets and liabilities of the acquiree is recognized as goodwill at the date of the business combination.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill arising on the acquisition of subsidiaries is shown in a separate balance sheet line item, whereas goodwill arising on the acquisition of investments accounted for using the equity method is recorded in</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Investments accounted for using the equity method.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill arising on foreign operations is expressed in the functional currency of the country concerned and translated into euros using the exchange rate prevailing at the end of the reporting period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;36 (Impairment of Assets), goodwill is carried at cost less accumulated impairment (see Note&#160;B.6.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually and whenever events or circumstances indicate that impairment might exist. Such events or circumstances include significant changes more likely than not to have an other-than-temporary impact on the substance of the original investment.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Other intangible assets</a></td>
<td class="text">Other intangible assets<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other intangible assets are initially measured at acquisition cost or production cost, including any directly attributable costs of preparing the asset for its intended use, or (in the case of assets acquired in a business combination) at fair value as of the date of the business combination. Intangible assets are amortized on a straight line basis over their useful&#160;lives.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The useful lives of other intangible assets are reviewed at the end of each reporting period. The effect of any adjustment to useful lives is recognized prospectively as a change in accounting estimate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amortization of other intangible assets is recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Amortization of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> except for amortization charged against (i)&#160;acquired or internally-developed software and (ii)&#160;other rights of an industrial or operational nature, which is recognized in the relevant classification of expense by function.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi does not own any intangible assets with an indefinite useful life, other than goodwill.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Intangible assets (other than goodwill) are carried at cost less accumulated amortization and accumulated impairment, if any, in accordance with IAS&#160;36 (see Note&#160;B.6.).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.4.1. Research and development not acquired in a business combination</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internally generated research and development</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under IAS&#160;38, research expenses are recognized in profit or loss when incurred.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Internally generated development expenses are recognized as an intangible asset if, and only if, all the following six criteria can be demonstrated: (a)&#160;the technical feasibility of completing the development project; (b)&#160;Sanofi&#8217;s intention to complete the project; (c)&#160;Sanofi&#8217;s ability to use the project; (d)&#160;the probability that the project will generate future economic benefits; (e)&#160;the availability of adequate technical, financial and other resources to complete the project; and (f)&#160;the ability to measure the development expenditure reliably.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Due to the risks and uncertainties relating to regulatory approval and to the research and development process, the six criteria for capitalization are usually considered not to have been met until the product has obtained marketing approval from the regulatory authorities. Consequently, internally generated development expenses arising before marketing approval has been obtained, mainly the cost of clinical trials, are generally expensed as incurred within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Some industrial development expenses (such as those incurred in developing a second-generation synthesis process) are incurred after marketing approval has been obtained, in order to improve the industrial process for an active ingredient. To the extent that the six IAS&#160;38 criteria are considered as having been met, such expenses are recognized as an asset in the balance sheet within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> as incurred. Similarly, some clinical trials, for example those undertaken to obtain a geographical extension for a molecule that has already obtained marketing approval in a major market, may in certain circumstances meet the six capitalization criteria under IAS&#160;38, in which case the related expenses are recognized as an asset in the balance sheet within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Separately acquired research and development</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Payments for separately acquired research and development are capitalized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> provided that they meet the definition of an intangible asset: a resource that is (i)&#160;controlled by Sanofi, (ii)&#160;expected to provide future economic benefits for Sanofi, and (iii)&#160;identifiable (i.e.&#160;it is either separable or arises from contractual or legal rights). Under paragraph&#160;25 of&#160;IAS&#160;38, the first condition for capitalization (the probability that the expected future economic benefits from the asset will flow to the entity) is considered to be satisfied for separately acquired research and development. Consequently, upfront and milestone payments to third parties related to pharmaceutical products for which marketing approval has not yet been obtained are recognized as intangible assets, and amortized on a straight line basis over their useful lives beginning when marketing approval is&#160;obtained.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Payments under research and development arrangements relating to access to technology or to databases, and payments made to purchase generics dossiers, are also capitalized, and amortized over the useful life of the intangible asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subcontracting arrangements, payments for research and development services, and continuous payments under research and development collaborations which are unrelated to the outcome of that collaboration, are expensed over the service term.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.4.2. Other intangible assets not acquired in a business combination</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Licenses other than those related to pharmaceutical products and research projects, in particular software licenses, are capitalized at acquisition cost, including any directly attributable cost of preparing the software for its intended use. Software licenses are amortized on a straight line basis over their useful lives for Sanofi (<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTQvZnJhZzozZjc4YjJjMzg5MjM0NWI3OWUwMWQxNGFjYzI2ODQxNS90ZXh0cmVnaW9uOjNmNzhiMmMzODkyMzQ1Yjc5ZTAxZDE0YWNjMjY4NDE1XzUxMDY_a0f11f8d-0f58-4332-81c5-b171f9da546e">three</span> to five years).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Internally generated costs incurred to develop or upgrade software are capitalized if the IAS&#160;38 recognition criteria are satisfied, and amortized on a straight line basis over the useful life of the software from the date on which the software is ready for use.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.4.3. Other intangible assets acquired in a business combination</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other intangible assets acquired in a business combination (in-process research and development, technology platforms, and currently marketed products) that are reliably measurable are identified separately from goodwill, measured at fair value, and capitalized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in accordance with IFRS&#160;3 (Business Combinations) and IAS&#160;38 (Intangible Assets). The related deferred tax liability is also recognized if a deductible or taxable temporary difference exists.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In-process research and development acquired in a business combination is amortized on a straight line basis over its useful life from the date of receipt of marketing approval.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Rights to technology platforms and to products currently marketed by Sanofi are amortized on a straight line basis over their useful lives, determined (in particular for marketed products) on the basis of cash flow forecasts which take into account the patent protection period of the marketed product.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment owned and leased</a></td>
<td class="text">Property, plant and equipment owned and leased<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.5.1. Property, plant and equipment owned</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Property, plant and equipment is initially measured and recognized at acquisition cost, including any directly attributable cost of preparing the asset for its intended use, or (in&#160;the case of assets acquired in a business combination) at fair value as of the date of the business combination. The component-based approach to accounting for property, plant and equipment is applied. Under this approach, each component of an item of property, plant and equipment with a cost which is significant in relation to the total cost of the item and which has a different useful life from the other components must be depreciated separately.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">After initial measurement, property, plant and equipment is carried at cost less accumulated depreciation and impairment, except for land which is carried at cost less impairment.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subsequent costs are not recognized as assets unless (i)&#160;it is probable that future economic benefits associated with those costs will flow to Sanofi and (ii)&#160;the costs can be measured reliably.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Borrowing costs attributable to the financing of items of property, plant and equipment, and incurred during the construction period, are capitalized as part of the acquisition cost of the&#160;item.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Government grants relating to property, plant and equipment are deducted from the acquisition cost of the asset to which they&#160;relate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The depreciable amount of items of property, plant and equipment, net of any residual value, is depreciated on a straight line basis over the useful life of the asset. The useful life of an asset is usually equivalent to its economic life.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The customary useful lives of property, plant and equipment are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:49.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.671%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;to&#160;40 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixtures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10 to 20 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5 to 15 years</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 to 15 years</span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Useful lives and residual values of property, plant and equipment are reviewed annually. The effect of any adjustment to useful lives or residual values is recognized prospectively as a change in accounting estimate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Depreciation of property, plant and equipment is recognized as an expense in the income statement, in the relevant classification of expense by function.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.5.2. Property, plant and equipment leased</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Effective from January&#160;1, 2019 leases contracted by Sanofi have been accounted for in accordance with IFRS&#160;16 (Leases). Sanofi recognizes a right-of-use asset and a lease liability for all of its lease contracts, except for (i)&#160;leases relating to low-value assets and&#160;(ii)&#160;short-term leases (12&#160;months or less). Payments made in respect of leases not recognized on the balance sheet are recognized as an operating expense on a straight line basis over the lease term.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On commencement of a lease, the liability for future lease payments is discounted at the incremental borrowing rate, which is a risk-free rate adjusted to reflect the specific risk profile of each Sanofi entity. Because lease payments are spread over the lease term, Sanofi applies a discount rate based on the duration of those payments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The payments used to determine the liability for future lease payments exclude non-lease components, but include fixed payments that Sanofi expects to make to the lessor over the estimated lease term.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">After commencement of the lease, the liability for future lease payments is reduced by the amount of the lease payments made, and increased to reflect interest on the liability. In the event of a reassessment or modification of future lease payments, the lease liability is remeasured. The right-of-use asset &#8211;&#160;which is initially measured at cost including direct costs of the lessee, prepayments made at or prior to the commencement date, less lease incentives received and restoration costs&#160;&#8211; is depreciated on a straight line basis over the lease term, and tested for impairment as required.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi recognizes deferred taxes in respect of right-of-use assets and lease liabilities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over their economic life, which is capped at the lease term as determined under&#160;IFRS&#160;16.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory', window );">Impairment of property, plant and equipment, intangible assets, and investments accounted for using the equity method</a></td>
<td class="text">Impairment of property, plant and equipment, intangible assets, and&#160;investments accounted for using the equity method<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.6.1. Impairment of property, plant and equipment and intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;36 (Impairment of Assets), assets that generate separate cash flows and assets included in cash-generating units&#160;(CGUs) are assessed for impairment when events or changes in circumstances indicate that the asset or CGU may be impaired. A&#160;CGU is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under IAS&#160;36, each CGU or group of CGUs to which goodwill is allocated must (i)&#160;represent the lowest level within the entity at which the goodwill is monitored for internal management purposes, and (ii)&#160;not be larger than an operating segment determined in accordance with IFRS&#160;8 (Operating Segments), before application of the IFRS&#160;8 aggregation criteria (see Note&#160;B.26.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Quantitative and qualitative indications of impairment (primarily relating to the status of the research and development portfolio, pharmacovigilance, patent litigation, and the launch of competing products) are reviewed at the end of each reporting period. If there is any internal or external indication of impairment, Sanofi estimates the recoverable amount of the asset or CGU.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other intangible assets not yet available for use (such as capitalized in-process research and development), and CGUs or groups of CGUs that include goodwill, are tested for impairment annually whether or not there is any indication of impairment, and more frequently if any event or circumstance indicates that they might be impaired. Such assets are not amortized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When there is an internal or external indication of impairment, Sanofi estimates the recoverable amount of the asset and recognizes an impairment loss if the carrying amount of the asset exceeds its recoverable amount. The recoverable amount of the asset is the higher of its fair value less costs to sell or its value in use. To determine value in use, Sanofi uses estimates of future cash flows generated by the asset or CGU, prepared using the same methods as those used in the initial measurement of the asset or CGU on the basis of medium-term strategic plans.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of goodwill, estimates of future cash flows are based on a six-year strategic plan and a terminal value. In the case of other intrangible assets, the period used is based on the economic life of the asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Estimated cash flows are discounted at long-term market interest rates that reflect the best estimate by Sanofi of the time value of money, the risks specific to the asset or CGU, and economic conditions in the geographical regions in which the business activity associated with the asset or CGU is located.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Certain assets and liabilities that are not directly attributable to a specific CGU are allocated between CGUs on a basis that is reasonable, and consistent with the allocation of the corresponding goodwill.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Impairment losses arising on property, plant and equipment, on software and on certain rights are recognized in the relevant classification of expense by function.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Impairment losses arising on other intangible assets are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Impairment of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.6.2. Impairment of investments accounted for using the equity method</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), Sanofi determines whether investments accounted for using the equity method may be impaired based on indicators such as default in contractual payments, significant financial difficulties, probability of bankruptcy, or a prolonged or significant decline in quoted market price. If an investment is impaired, the amount of the impairment loss is determined by applying IAS&#160;36 (see Note&#160;B.6.1.) and recognized in </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.6.3. Reversals of impairment losses charged against property, plant and equipment, intangible assets, and investments accounted for using the equity method</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At the end of each reporting period, Sanofi assesses whether events or changes in circumstances indicate that an impairment loss recognized in a prior period in respect of an asset (other than goodwill) or an investment accounted for using the equity method can be reversed. If this is the case, and the recoverable amount as determined based on the revised estimates exceeds the carrying amount of the asset, Sanofi reverses the impairment loss only to the extent of the carrying amount that would have been determined had no impairment loss been recognized for the asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Reversals of impairment losses in respect of other intangible assets are recognized within the income statement line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Impairment of intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, while reversals of impairment losses in respect of investments accounted for using the equity method are recognized within the income statement line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Impairment losses taken against goodwill are never reversed, unless the goodwill is part of the carrying amount of an investment accounted for using the equity method.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory', window );">Assets held for sale or exchange and liabilities related to assets held for sale or exchange</a></td>
<td class="text">Assets held for sale or exchange and liabilities related to assets held for sale or exchange<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;5 (Non-Current Assets Held for Sale and Discontinued Operations), non-current assets and groups of assets are classified as held for sale in the balance sheet if their carrying amount will be recovered principally through a sale transaction rather than through continuing use. Within the meaning of IFRS&#160;5, the term &#8220;sale&#8221; also includes exchanges for other assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Non-current assets or asset groups held for sale must be available for immediate sale in their present condition, subject only to terms that are usual and customary for sales of such assets, and a sale must be highly probable. Criteria used to determine whether a sale is highly probable include:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the appropriate level of management must be committed to a plan to sell;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">an active program to locate a buyer and complete the plan must have been initiated;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the asset must be actively marketed for sale at a price that is reasonable in relation to its current fair value;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">completion of the sale should be foreseeable within the twelve months following the date of reclassification to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">actions required to complete the plan should indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Before initial reclassification of the non-current asset (or asset group) to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the carrying amounts of the asset (or of all the assets and liabilities in the asset group) must be measured in accordance with the applicable standards.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subsequent to reclassification to </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, the non-current asset (or asset group) is measured at the lower of carrying amount or fair value less costs to sell, with any write-down recognized by means of an impairment loss. Once a non-current asset has been reclassified as held for sale or exchange, it is no longer depreciated or amortized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In a disposal of an equity interest leading to loss of control, all the assets and liabilities of the entity involved are classified as held-for-sale assets or liabilities within the balance sheet line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange or Liabilities related to assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, provided that the disposal satisfies the IFRS&#160;5 classification criteria.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The profit or loss generated by a held-for-sale asset group is reported in a separate line item in the income statement for the current period and for the comparative periods presented, provided that the asset group:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">represents a separate major line of business or geographical area of operations; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">is a subsidiary acquired exclusively with a view to resale.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;10, transactions between companies that are held for sale or treated as discontinued operations and other consolidated companies are eliminated.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Events or circumstances beyond Sanofi&#8217;s control may extend the period to complete the sale or exchange beyond one year without precluding classification of the asset (or disposal group) in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Assets held for sale or exchange</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> provided that there is sufficient evidence that Sanofi remains committed to the planned sale or exchange. Finally, in the event of changes to a plan of sale that requires an asset no longer to be classified as held for sale, IFRS&#160;5 specifies the following treatment:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the assets and liabilities previously classified as held for sale are reclassified to the appropriate balance sheet line items, with no restatement of comparative periods;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">each asset is measured at the lower of (a)&#160;its carrying amount before the asset was reclassified as held for sale, adjusted for any depreciation, amortization or revaluation that would have been recognized if the asset had not been reclassified as held for sale, or&#160;(b)&#160;its recoverable amount at the date of reclassification;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the backlog of depreciation, amortization and impairment not recognized while non-current assets were classified as held for sale must be reported in the same income statement line item that was used to report impairment losses arising on initial reclassification of assets as held for sale and gains or losses arising on the sale of such assets. In the consolidated income statement, those impacts are reported within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the net income of a business previously classified as discontinued or as held for sale or exchange and reported on a separate line in the income statement must be reclassified and included in net income from continuing operations, for all periods presented;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">in addition, segment information relating to the income statement and the statement of cash flows (acquisitions of non-current assets) must be disclosed in the notes to the financial statements in accordance with IFRS&#160;8 (Operating Segments), and must also be restated for all prior periods presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory', window );">Financial instruments</a></td>
<td class="text">Financial instruments<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.1. Non-derivative financial assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;9 (Financial Instruments) and IAS&#160;32 (Financial Instruments: Presentation), Sanofi has adopted the classification of non-derivative financial assets described below. The classification used depends on (i)&#160;the characteristics of the contractual cash flows (i.e.&#160;whether they represent interest or principal) and (ii)&#160;the business model for managing the asset applied at the time of initial recognition.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial assets at fair value through other comprehensive income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These mainly comprise:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">quoted and unquoted equity investments that Sanofi does not hold for trading purposes and that management has designated at &#8220;fair value through other comprehensive income&#8221; on initial recognition. Gains and losses arising from changes in fair value are recognized in equity within the statement of comprehensive income in the period in which they occur. When such instruments are derecognized, the previously-recognized changes in fair value remain within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, as does the gain or loss on divestment. Dividends received are recognized in profit or loss for the period, within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">debt instruments whose contractual cash flows represent payments of interest or repayments of principal, and which are managed with a view to collecting cash flows and selling the asset. Gains and losses arising from changes in fair value are recognized in equity within the statement of comprehensive income in the period in which they occur. When such assets are derecognized, the cumulative gains and losses previously recognized in equity are reclassified to profit or loss for the period within the line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial assets at fair value through profit or loss</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These mainly comprise:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">contingent consideration already carried in the books of an acquired entity or granted in connection with a business combination;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">instruments whose contractual cash flows represent payments of interest and repayments of principal, which are managed with a view to selling the asset;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">instruments that management has designated at &#8220;fair value through profit or loss&#8221; on initial recognition; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">quoted and unquoted equity investments: equity instruments that are not held for trading and which management did not designate at &#8220;fair value through other comprehensive income&#8221; on initial recognition, and instruments that do not meet the IFRS definition of &#8220;equity instruments&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Gains and losses arising from changes in fair value are recognized in profit or loss within the line items </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Dividends received are recognized in profit or loss for the period, within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value of equity investments in unquoted entities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On initial recognition of an equity investment in an entity not quoted in an active market, the fair value of the investment is the acquisition cost. Cost ceases to be a representative measure of the fair value of an unquoted equity investment when Sanofi identifies significant changes in the investee, or in the environment in which it operates. In such cases, an internal valuation is carried out, based mainly on growth forecasts or by reference to similar transactions contracted with third parties.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial assets measured at amortized cost</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Financial assets at amortized cost comprise instruments whose contractual cash flows represent payments of interest and repayments of principal and which are managed with a view to collecting cash flows. The main assets in this category are loans and receivables. They are presented within the line items</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Accounts receivable </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Cash and cash equivalents</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Loans with a maturity of more than 12&#160;months are presented in &#8220;Long-term loans and advances&#8221; within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. These financial assets are measured at amortized cost using the effective interest method.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of financial assets measured at amortized cost</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The main assets involved are accounts receivable. Accounts receivable are initially recognized at the amount invoiced to the customer. Impairment losses on trade accounts receivable are estimated using the expected loss method, in order to take account of the risk of payment default throughout the lifetime of the receivables. The expected credit loss is estimated collectively for all accounts receivable at each reporting date using an average expected loss rate, determined primarily on the basis of historical credit loss rates. However, that average expected loss rate may be adjusted if there are indications of a likely significant increase in credit risk. If a receivable is subject to a known credit risk, a specific impairment loss is recognized for that receivable. The amount of expected losses is recognized in the balance sheet as a reduction in the gross amount of accounts receivable. Impairment losses on accounts receivable are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Selling and general expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.2. Derivative instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Derivative instruments that do not qualify for hedge accounting are initially and subsequently measured at fair value, with changes in fair value recognized in the income statement in</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, depending on the nature of the underlying economic item which is hedged.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Derivative instruments that qualify for hedge accounting are measured using the policies described in Note&#160;B.8.3. below.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">IFRS&#160;13 (Fair Value Measurement) requires counterparty credit risk to be taken into account when measuring the fair value of financial instruments. That risk is estimated on the basis of observable, publicly-available statistical data.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policy on offsetting</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order for a financial asset and a financial liability to be presented as a net amount in the balance sheet under IAS&#160;32, there must be:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a) a legally enforceable right to offset; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(b) the intention either to settle on a net basis, or to realize the asset and settle the liability simultaneously.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.3. Hedging</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As part of its overall market risk management policy, Sanofi enters into various hedging transactions involving derivative or non-derivative instruments; these may include forward contracts, currency swaps or options, interest rate swaps or options, cross-currency swaps, and debt placings or issues.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Such financial instruments are designated as hedging instruments and recognized using the hedge accounting principles of&#160;IFRS&#160;9 when (a)&#160;there is formal designation and documentation of the hedging relationship, of how the effectiveness of the hedging relationship will be assessed, and of the underlying market risk management objective and strategy; (b)&#160;the hedged item and the hedging instrument are eligible for hedge accounting; and (c)&#160;there is an economic relationship between the hedged item and the hedging instrument, defined on the basis of a hedge ratio that is consistent with the underlying market risk management strategy, and the residual credit risk does not dominate the value changes that result from that economic relationship.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value hedge</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A fair value hedge is a hedge of the exposure to changes in fair value of an asset, liability or firm commitment that is attributable to one or more risk components and could affect profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in fair value of the hedging instrument and changes in fair value of the hedged item attributable to the hedged risk components are generally recognized in the income statement, within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to operating activities, or within</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to investing or financing activities.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flow hedge</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A cash flow hedge is a hedge of the exposure to variability in cash flows from an asset, liability or highly probable forecast transaction that is attributable to one or more risk components and could affect profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in fair value of the hedging instrument attributable to the effective portion of the hedge are recognized directly in equity in the consolidated statement of comprehensive income. Changes in fair value attributable to the ineffective portion of the hedge are recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">for hedges related to operating activities, and within</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to investing or financing activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Cumulative changes in fair value of the hedging instrument previously recognized in equity are reclassified to the income statement when the hedged transaction affects profit or loss. Those reclassified gains and losses are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to operating activities, and within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for hedges related to investing or financing activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When a forecast transaction results in the recognition of a non-financial asset or liability, cumulative changes in the fair value of the hedging instrument previously recognized in equity are incorporated in the initial carrying amount of that asset or liability.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">When the hedging instrument expires or is sold, terminated or exercised, the cumulative gain or loss previously recognized in equity remains separately recognized in equity and is not reclassified to the income statement, or recognized as an adjustment to the initial cost of the related non-financial asset or liability, until the forecast transaction occurs. However, if Sanofi no longer expects the forecast transaction to occur, the cumulative gain or loss previously recognized in equity is recognized immediately in profit or loss.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hedge of a net investment in a foreign operation</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In a hedge of a net investment in a foreign operation, changes in the fair value of the hedging instrument attributable to the effective portion of the hedge are recognized directly in equity in the consolidated statement of comprehensive income. Changes in fair value attributable to the ineffective portion of the hedge are recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. When the investment in the foreign operation is sold, the changes in the fair value of the hedging instrument previously recognized in equity are reclassified to the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of hedging</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As part of its market risk management policy, Sanofi may designate currency options or interest rate options as hedging instruments, the effectiveness of which is measured on the basis of changes in intrinsic value. In such cases, the time value of the option is treated as a hedging cost and accounted for as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">if the option includes a component that is not aligned on the critical features of the hedged item, the corresponding change in the time value is taken to profit or loss;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">otherwise, the change in the time value is taken to equity within the statement of comprehensive income, and then:</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if the hedged item is linked to a transaction that results in the recognition of a financial asset or liability, the change in the time value is reclassified to profit or loss symmetrically with the hedged item, or</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if the hedged item is linked to a transaction that results in the recognition of a non-financial asset or liability, the change in the time value is incorporated in the initial carrying amount of that asset or liability, or</span></div><div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt">if the hedged item is linked to a period of time, the change in time value is reclassified to profit or loss on a straight line basis over the life of the hedging relationship.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of forward contracts and foreign exchange swaps, and of cross-currency swaps that qualify for hedge accounting on the basis of changes in spot rates, Sanofi may elect for each transaction to use the option whereby the premium/discount or foreign currency basis spread are treated in the same way as the time value of an option.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinuation of hedge accounting</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Hedge accounting is discontinued when the eligibility criteria are no longer met (in particular, when the hedging instrument expires or is sold, terminated or exercised), or if there is a change in the market risk management objective of the hedging relationship.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.4. Non-derivative financial liabilities</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Borrowings and debt</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bank borrowings and debt instruments are initially measured at fair value of the consideration received, net of directly attributable transaction costs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Subsequently, they are measured at amortized cost using the effective interest method. All costs related to the issuance of borrowings or debt instruments, and all differences between the issue proceeds net of transaction costs and the value on redemption, are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement over the term of the debt using the effective interest method.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities related to business combinations and to non-controlling interests</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These line items record the fair value of (i)&#160;contingent consideration payable in connection with business combinations and (ii)&#160;commitments to buy out equity holders of subsidiaries, including put options granted to non-controlling interests.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Adjustments to the fair value of commitments to buy out equity holders of subsidiaries, including put options granted to non-controlling interests, are recognized in equity.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other non-derivative financial liabilities</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Other non-derivative financial liabilities include trade accounts payable, which are measured at fair value (which in most cases equates to face value) on initial recognition, and subsequently at amortized cost.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.5. Fair value of financial instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Under IFRS&#160;13 (Fair Value Measurement) and IFRS&#160;7 (Financial Instruments: Disclosures), fair value measurements must be classified using a hierarchy based on the inputs used to measure the fair value of the instrument. This hierarchy has three levels:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.86pt">level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.25pt">level&#160;2: quoted prices in active markets for similar assets and liabilities, or valuation techniques in which all important inputs are derived from observable market data; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.78pt">level&#160;3: valuation techniques in which not all important inputs are derived from observable market data.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the disclosures required under IFRS&#160;7 relating to the measurement principles applied to financial instruments.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.852%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.362%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Type&#160;of financial&#160;instrument</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Measurement<br/>principle</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in<br/>fair&#160;value<br/>hierarchy</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Valuation<br/>technique</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Method used to determine fair value</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Valuation<br/>model</span></td><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market data</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exchange rate</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (quoted equity instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market&#160;price</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (quoted debt instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (unquoted equity instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cost/Approach based on comparables</span></div></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">If cost ceases to be a representative measure of fair value, an internal valuation is carried out, based mainly on comparables.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (contingent consideration receivable)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;D.7.3.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value held to meet obligations under post-employment benefit plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets designated at fair value held to meet obligations under deferred compensation plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Long-term loans and advances and other non-current receivables</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The amortized cost of long-term loans and advances and other non-current receivables at the end of the reporting period is not materially different from their fair value.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.13.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Investments in mutual funds</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Net asset value</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.13.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Negotiable debt instruments, commercial paper, instant access deposits and term deposits</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Because these instruments have a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.1.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">In the case of debt with a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.<br/>For debt with a maturity of more than 3&#160;months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.2.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The liability for future lease payments is discounted using the incremental borrowing rate.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160; year:</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid Money Market</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&gt;&#160;1&#160;year:&#160;</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid Zero Coupon</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market<br/>Spot</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160;year:</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid&#160;Money&#160;Market  and LIFFE interest rate futures</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&gt;&#160;1&#160;year: </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid&#160;Zero Coupon</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present&#160;value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market<br/>Spot</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160; year:<br/>Mid&#160;Money Market and LIFFE interest rate futures<br/>&gt;&#160;1&#160;year: <br/>Mid Zero Coupon</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.18.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Liabilities related to business combinations and to non-controlling interests (CVRs)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.18.</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Liabilities related to business combinations and to non-controlling interests (other than CVRs)</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Under IAS&#160;32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;B.8.4.</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.6. Derecognition of financial instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Financial assets are derecognized when the contractual rights to cash flows from the asset have ended or have been transferred and when Sanofi has transferred substantially all the risks and rewards of ownership of the asset. If Sanofi has neither transferred nor retained substantially all the risks and rewards of ownership of a financial asset, it is derecognized if Sanofi does not retain control of the asset.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A financial liability is derecognized when Sanofi&#8217;s contractual obligations in respect of the liability are discharged, cancelled or extinguished.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.8.7. Risks relating to financial instruments</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Market risks in respect of non-current financial assets, cash equivalents, derivative instruments and debt are described in the discussions of risk factors presented in Item&#160;3.D. and Item&#160;11. of Sanofi&#8217;s Annual Report on Form&#160;20-F for 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Credit risk is the risk that customers may fail to pay their debts. For a description of credit risk, refer to &#8220;We are subject to the risk of non-payment by our customers&#8221; within Item&#160;3.D. and Item&#160;11. of Sanofi&#8217;s Annual Report on Form&#160;20-F for 2022.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories</a></td>
<td class="text">Inventories<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inventories are measured at the lower of cost or net realizable value. Cost is calculated using the weighted average cost method or the first-in, first-out method, depending on the nature of the inventory.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The cost of finished goods inventories includes costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During the launch phase of a new product, any inventories of that product are written down to zero pending regulatory approval, other than in specific circumstances which make it possible to estimate that there is a high probability at the end of the reporting period that the carrying amount of the inventories will be recoverable. The write-down is reversed once it becomes highly probable that marketing approval will be obtained.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">Cash and cash equivalentsCash and cash equivalents as shown in the consolidated balance sheet and statement of cash flows comprise cash, plus liquid short-term investments that are&#160;readily convertible into cash and are&#160;subject to an insignificant risk of changes in value in the event of movements in interest rates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory', window );">Treasury shares</a></td>
<td class="text">Treasury sharesIn accordance with IAS&#160;32, Sanofi treasury shares are deducted from equity, irrespective of the purpose for which they are held. No gain or loss is recognized in the income statement on the purchase, sale, impairment or cancellation of treasury shares.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions for risks</a></td>
<td class="text">Provisions for risks<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;37 (Provisions, Contingent Liabilities and Contingent Assets), Sanofi records a provision when it has a present obligation, whether legal or constructive, as a result of a past event; it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation; and a reliable estimate can be made of the amount of the outflow of resources.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If the obligation is expected to be settled more than twelve months after the end of the reporting period, or has no definite settlement date, the provision is recorded within Non-current provisions and other non-current liabilities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Provisions relating to the insurance programs in which Sanofi&#8217;s captive insurance company participates are based on risk exposure estimates calculated by management, with assistance from independent actuaries, using IBNR (Incurred But Not Reported) techniques. Those techniques use past claims experience, within Sanofi and in the market, to estimate future trends in the cost of&#160;claims.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Contingent liabilities are not recognized, but are disclosed in the notes to the financial statements unless the possibility of an outflow of economic resources is&#160;remote.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi estimates provisions on the basis of events and circumstances related to present obligations at the end of the reporting period and of past experience, and to the best of management&#8217;s knowledge at the date of preparation of the financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Reimbursements offsetting the probable outflow of resources are recognized as assets only if it is virtually certain that they will be received. Contingent assets are not recognized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restructuring provisions are recognized if Sanofi has a detailed, formal restructuring plan at the end of the reporting period and has announced its intention to implement this plan to those affected by it.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No provisions are recorded for future operating losses.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi records non-current provisions for certain obligations, such as legal or constructive obligations, where an outflow of resources is probable and the amount of the outflow can be reliably estimated.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of environmental risks, including at sites where operations are ongoing, Sanofi recognizes a provision where there is a violation of integrity in respect of human health or the environment resulting from past contamination at a site that requires remediation. The amount of the provision is a best estimate of the future expenditures to be incurred on the remediation plan.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Where the effect of the time value of money is material, those provisions are measured at the present value of the expenditures expected to be required to settle the obligation, calculated using a discount rate that reflects an estimate of the time value of money and the risks specific to the obligation.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Increases in provisions to reflect the effects of the passage of time are recognized within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue recognition</a></td>
<td class="text">Revenue recognition<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.13.1. Net sales</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Revenue arising from the sale of goods is presented in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Net sales comprise revenue from sales of pharmaceutical products, consumer healthcare products, active ingredients and vaccines, net of sales returns, of customer incentives and discounts, and of certain sales-based payments paid or payable to the healthcare authorities. Analyses of net sales are provided in Note&#160;D.35.1. &#8220;Segment Information&#8221;.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;15 (Revenue from Contracts with Customers), such revenue is recognized when Sanofi transfers control over the product to the customer; control of an asset refers to the ability to direct the use of, and obtain substantially all of the remaining benefits from that asset. For the vast majority of contracts, revenue is recognized when the product is physically transferred, in accordance with the delivery and acceptance terms agreed with the customer.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For contracts entered into by Sanofi Pasteur, transfer of control is usually determined by reference to the terms of release (immediate or deferred) and acceptance of batches of vaccine.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of contracts with distributors, Sanofi does not recognize revenue when the product is physically transferred to the distributor if the products are sold on consignment, or if the distributor acts as agent. In such cases, revenue is recognized when control is transferred to the end customer, and the distributor&#8217;s commission is presented within the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Selling and general expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the income statement.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The amount of revenue recognized reflects the various types of price reductions or rights of return offered by Sanofi to its customers on certain products. Such price reductions and rights of return qualify as variable consideration under IFRS&#160;15.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In particular, products sold in the United States are covered by various Government and State programs (such as Medicare and Medicaid) under which products are sold at a discount. Rebates are granted to healthcare authorities, and under contractual arrangements with certain customers. Some wholesalers are entitled to chargeback incentives based on the selling price to the end customer, under specific contractual arrangements. Cash discounts may also be granted for prompt payment. Returns, discounts, incentives and rebates, as described above, are recognized in the period in which the underlying sales are recognized as a reduction of gross sales.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">These amounts are calculated as follows:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of chargeback incentives is estimated on the basis of the relevant subsidiary&#8217;s standard sales terms and conditions, and in certain cases on the basis of specific contractual arrangements with the customer;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of rebates based on attainment of sales targets is estimated and accrued as each of the underlying sales transactions is recognized;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of price reductions under Government and State programs, largely in the United States, is estimated on the basis of the specific terms of the relevant regulations or agreements, and accrued as each of the underlying sales transactions is recognized;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the amount of sales returns is calculated on the basis of management&#8217;s best estimate of the amount of product that will ultimately be returned by customers. In countries where product returns are possible, Sanofi operates a returns policy that allows the customer to return products within a certain period either side of the expiry date (usually 12&#160;months after the expiry date). The amount recognized for returns is estimated on the basis of past experience of sales returns. Sanofi also takes into account factors such as levels of inventory in its various distribution channels, product expiry dates, information about potential discontinuation of products, the entry of competing generics into the market, and the launch of over-the-counter medicines. Most product return clauses relate solely to date-expired products, which cannot be resold and are destroyed. Sanofi does not recognize a right of return asset in the balance sheet for contracts that allow for the return of time-expired products, since those products have no value.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The estimated amounts described above are recognized in the income statement within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">as a reduction of gross sales, and within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in the balance sheet. They are subject to regular review and adjustment as appropriate based on the most recent data available to management. Sanofi believes that it has the ability to measure each of the above amounts reliably, using the following factors in developing its estimates:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the nature and patient profile of the underlying product;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the applicable regulations or the specific terms and conditions of contracts with governmental authorities, wholesalers and other customers;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">historical data relating to similar contracts, in the case of qualitative and quantitative rebates and chargeback incentives;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">past experience and sales growth trends for the same or similar products;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">actual inventory levels in distribution channels, monitored by Sanofi using internal sales data and externally provided data;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the shelf life of Sanofi products; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">market trends including competition, pricing and demand.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of provisions for discounts, rebates and sales returns is provided in Note&#160;D.23.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.13.2. Other revenues</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">The line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other revenues</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is used to recognize all revenue that falls within the scope of IFRS&#160;15 but does not relate to sales of Sanofi products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">It mainly comprises (i)&#160;royalties received from licensing intellectual property rights to third parties; (ii)&#160;VaxServe sales of products sourced from third-party manufacturers; and (iii)&#160;revenue received under agreements for Sanofi to provide manufacturing services to third parties.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Royalties received under licensing arrangements are recognized over the period during which the underlying sales are recognized.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">VaxServe is a Vaccines segment entity whose operations include the distribution within the United States of vaccines and other products manufactured by third parties. VaxServe sales of products sourced from third-party manufacturers are presented within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other revenues</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory', window );">Cost of sales</a></td>
<td class="text">Cost of sales<span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> consists primarily of the industrial cost of goods sold, payments made under licensing agreements, and distribution costs. The industrial cost of goods sold includes the cost of materials, depreciation of property, plant and equipment, amortization of software, personnel costs, and other expenses attributable to production.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory', window );">Research and development</a></td>
<td class="text">Research and development<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Note&#160;B.4.1. &#8220;Research and development not acquired in a business combination&#8221; and Note&#160;B.4.3. &#8220;Other intangible assets acquired in a business combination&#8221; describe the principles applied to the recognition of research and development costs.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Contributions or reimbursements received from alliance partners are recorded as a reduction of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock', window );">Other operating income and expenses</a></td>
<td class="text">Other operating income and expenses<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.16.1. Other operating income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes the share of profits that Sanofi is entitled to receive from alliance partners in respect of product marketing agreements. It also includes revenues generated under certain agreements, which may include partnership, co-promotion arrangements and licenses not included in Other revenues.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This line item also includes realized and unrealized foreign exchange gains and losses on operating activities (see Note&#160;B.8.3.), and operating gains on disposals not regarded as major disposals (see Note&#160;B.20.).</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.16.2. Other operating expenses</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> mainly comprise the share of profits that alliance partners are entitled to receive from Sanofi under product marketing agreements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory', window );">Amortization and impairment of intangible assets</a></td>
<td class="text">Amortization and impairment of intangible assets<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.17.1. Amortization of intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The expenses recorded in this line item comprise amortization of product rights and other intangible assets (see Note&#160;D.4.), given that the benefit of those rights to Sanofi&#8217;s commercial, industrial and development functions cannot be separately identified.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Amortization of software, and of other rights of an industrial or operational nature, is recognized as an expense in the income statement, in the relevant line items of expense by function.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.17.2. Impairment of intangible assets</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This line item records impairment losses (other than those associated with restructuring) recognized against intangible assets (including goodwill, but excluding software and other rights of an industrial or operational nature), and any reversals of such impairment losses.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock', window );">Fair value remeasurement of contingent consideration</a></td>
<td class="text">Fair value remeasurement of contingent consideration<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in the fair value of contingent consideration that was (i)&#160;already carried in the books of an acquired entity, or (ii)&#160;granted in connection with a business combination and initially recognized as a liability in accordance with IFRS&#160;3, are reported in profit or loss. Such adjustments are reported separately in the income statement, in the line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This line item also includes changes in the fair value of contingent consideration receivable in connection with a divestment and classified as a financial asset at fair value through profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Finally, it includes the effect of the unwinding of discount, and of exchange rate movements where the asset or liability is expressed in a currency other than the functional currency of the reporting entity.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock', window );">Restructuring costs and similar items</a></td>
<td class="text">Restructuring costs and similar items<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restructuring costs are expenses incurred in connection with the transformation or reorganization of Sanofi&#8217;s operations or support functions. Such costs include collective redundancy plans, compensation to third parties for early termination of contracts, and commitments made in connection with transformation or reorganization decisions. They also include accelerated depreciation charges arising from site closures (including closures of leased sites), and losses on asset disposals resulting from such decisions.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In addition, this line item includes expenses incurred in connection with programs implemented as part of the transformation strategy announced in December&#160;2019 (and previously in November&#160;2015), and intended primarily to (i)&#160;deliver a global information systems solution, further supported by the implementation in 2021 of Sanofi's new digital strategy; (ii)&#160;create a standalone Consumer Healthcare entity; and (iii)&#160;as announced on February&#160;24, 2020, create a European leader in the production and marketing to third parties of active pharmaceutical ingredients (API).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock', window );">Other gains and losses, and litigation</a></td>
<td class="text">Other gains and losses, and litigation<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes the impact of material transactions of an unusual nature or amount which Sanofi believes it necessary to report separately in the income statement in order to improve the relevance of the financial statements, such as:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">gains and losses on major disposals of property, plant and equipment, of intangible assets, of assets (or groups of assets and liabilities) held for sale, or of a business within the meaning of IFRS&#160;3, other than those considered to be restructuring costs;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">impairment losses and reversals of impairment losses on assets (or groups of assets and liabilities) held for sale, other than those considered to be restructuring costs;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">gains on bargain purchases;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">costs relating to major litigation; and</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">pre-tax separation costs associated with the process of disinvesting from operations in the event of a major divestment.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory', window );">Financial expenses and income</a></td>
<td class="text">Financial expenses and income<div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.21.1. Financial expenses</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> mainly comprise interest charges on debt financing; negative changes in the fair value of certain financial instruments (where changes in fair value are recognized in profit or loss); realized and unrealized foreign exchange losses on financing and investing activities; impairment losses on financial instruments; and any reversals of impairment losses on financial instruments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> also include expenses arising from the unwinding of discount on long-term provisions, and the net interest cost related to employee benefits. This line item does not include commercial cash discounts, which are deducted from net sales.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.21.2. Financial income</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes interest and dividend income; positive changes in the fair value of certain financial instruments (where changes in fair value are recognized in profit or loss); realized and unrealized foreign exchange gains on financing and investing activities; and gains on disposals of financial assets at fair value through profit or loss.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Income tax expense</a></td>
<td class="text">Income tax expense<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">includes all current and deferred taxes of consolidated companies.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi accounts for deferred taxes in accordance with IAS&#160;12 (Income Taxes), using the methods described below:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred tax assets and liabilities are recognized on taxable and deductible temporary differences, and on tax loss carry-forwards. Temporary differences are differences between the carrying amount of an asset or liability in the balance sheet and its tax base;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">French business taxes include a value added based component: &#8220;CVAE&#8221; </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">(Cotisation sur la Valeur Ajout&#233;e des Entreprises)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Given that CVAE is (i)&#160;calculated as the amount by which certain revenues exceed certain expenses and (ii)&#160;borne primarily by companies that own intellectual property rights on income derived from those rights (royalties, and margin on sales to third parties and to Sanofi entities), it is regarded as meeting the definition of income taxes specified in IAS&#160;12, paragraph&#160;2 (&#8220;taxes which are based on taxable profits&#8221;);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred tax assets and liabilities are calculated using the tax rate expected to apply in the period when the corresponding temporary differences are expected to reverse, based on tax rates enacted or substantively enacted at the end of the reporting period;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred tax assets are recognized in respect of deductible temporary differences, tax losses available for carry-forward and unused tax credits to the extent that future recovery is regarded as probable. The recoverability of deferred tax assets is assessed on a case-by-case basis, taking into account the profit forecasts contained in Sanofi&#8217;s medium-term business plan;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">a deferred tax liability is recognized for temporary differences relating to interests in subsidiaries, associates and joint ventures, except in cases where Sanofi is able to control the timing of the reversal of the temporary differences. This applies in particular when Sanofi is able to control dividend policy and it is probable that the temporary differences will not reverse in the foreseeable future;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">no deferred tax is recognized on eliminations of intragroup transfers of interests in subsidiaries, associates or joint ventures;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">each tax entity calculates its own net deferred tax position. All net deferred tax asset and liability positions are then aggregated and shown in separate line items on the relevant side of the consolidated balance sheet. Deferred tax assets and liabilities are offset only if (i)&#160;Sanofi has a legally enforceable right to offset current tax assets and current tax liabilities, and (ii)&#160;the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation authority;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">deferred taxes are not discounted, except implicitly in the case of deferred taxes on assets and liabilities which are already impacted by discounting. In addition, Sanofi has elected not to discount current taxes payable or receivable where the amounts in question are payable or receivable in the long term;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">withholding taxes on intragroup royalties and dividends, and on royalties and dividends collected from third parties, are accounted for as current income taxes.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accounting for business combinations, Sanofi complies with IFRS&#160;3 as regards the recognition of deferred tax assets after the initial accounting period. Consequently, any deferred tax assets recognized by the acquiree after the end of that period in respect of temporary differences or tax loss carry-forwards existing at the acquisition date are recognized in profit or loss.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The positions adopted by Sanofi in tax matters are based on its interpretation of tax laws and regulations. Some of those positions may be subject to uncertainty. In such cases, Sanofi assesses the amount of the tax liability on the basis of the following assumptions: that its position will be examined by one or more tax authorities on the basis of all relevant information; that a technical assessment is carried out with reference to legislation, case law, regulations, and established practice; and that each position is assessed individually (or collectively where appropriate), with no offset or aggregation between positions. Those assumptions are assessed on the basis of facts and circumstances existing at the end of the reporting period. When an uncertain tax liability is regarded as probable, it is measured on the basis of Sanofi&#8217;s best estimate and recognized as a liability; uncertain tax assets are not recognized. The amount of the liability includes any penalties and late payment interest. The line item</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Income tax expense</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> includes the effects of tax reassessments and tax disputes, and any penalties and late payment interest arising from such disputes that have the characteristics of income taxes within the meaning of paragraph&#160;2 of IAS&#160;12 (&#8220;taxes which are based on taxable profits&#8221;). Tax exposures relating to corporate income taxes are presented separately within </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Non-current income tax liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (see Note&#160;D.19.4.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">No deferred taxation is recognized on temporary differences that are liable to be subject to US global intangible low taxed income (GILTI) provisions. The related tax expense is recognized in the year in which it is declared in the tax return to the extent that it arises from the existence of non-US profits that exceed the theoretical return on investment specified in the GILTI provisions and are taxed at a rate lower than the applicable US tax rate.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IAS&#160;1 (Presentation of Financial Statements), current income tax assets and liabilities are presented as separate line items in the consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Employee benefit obligations</a></td>
<td class="text">Employee benefit obligations<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi offers retirement benefits to employees and retirees. Such benefits are accounted for in accordance with IAS&#160;19 (Employee Benefits).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Benefits are provided in the form of either defined contribution plans or defined benefit plans. In the case of defined contribution plans, the cost is recognized immediately in the period in which it is incurred, and equates to the amount of the contributions paid by Sanofi. For defined benefit plans, Sanofi generally recognizes its obligations to pay pensions and similar benefits to employees as a liability, based on an actuarial estimate of the rights vested or currently vesting in employees and retirees, using the projected unit credit method. Estimates are performed at least once a year, and rely on financial assumptions (such as discount rates) and demographic assumptions (such as life expectancy, retirement age, employee turnover, and the rate of salary increases).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Obligations relating to other post-employment benefits (healthcare and life insurance) offered by Sanofi companies to employees are also recognized as a liability based on an actuarial estimate of the rights vested or currently vesting in employees and retirees at the end of the reporting period.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Such liabilities are recognized net of the fair value of plan assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the case of multi-employer defined benefit plans where plan assets cannot be allocated to each participating employer with sufficient reliability, the plan is accounted for as a defined contribution plan, in accordance with paragraph&#160;34 of IAS&#160;19.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The benefit cost for the period consists primarily of current service cost, past service cost, net interest cost, gains or losses arising from plan settlements not specified in the terms of the plan, and actuarial gains or losses arising from plan curtailments. Net interest cost for the period is determined by applying the discount rate specified in IAS&#160;19 to the net liability (i.e. the amount of the obligation, net of plan assets) recognized in respect of defined benefit plans. Past service cost is recognized immediately in profit or loss in the period in which it is incurred, regardless of whether or not the rights have vested at the time of adoption (in&#160;the case of a new plan) or of amendment (in&#160;the case of an existing&#160;plan).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Actuarial gains and losses on defined benefit plans (pensions and other post-employment benefits), also referred to as&#160;&#8220;Remeasurements of the net defined benefit liability (asset)&#8221;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> arise as a result of changes in financial and demographic assumptions, experience adjustments, and the difference between the actual return and interest cost on plan assets. The impacts of those remeasurements are recognized in </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, net of deferred taxes; they are not subsequently reclassifiable to profit or&#160;loss.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payment</a></td>
<td class="text">Share-based payment<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Share-based payment expense is recognized as a component of operating income, in the relevant classification of expense by function. In measuring the expense, the level of attainment of any performance conditions is taken into account.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.24.1. Stock option plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has granted a number of equity-settled share-based payment plans (stock option plans) to some of its employees. The terms of those plans may make the award contingent on the attainment of performance criteria for some of the grantees.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;2 (Share-Based Payment), services received from employees as consideration for stock options are recognized as an expense in the income statement, with the opposite entry recognized in equity. The expense corresponds to the fair value of the stock option plans, and is charged to income on a straight-line basis over the four-year vesting period of the plan.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of stock option plans is measured at the date of grant using the Black-Scholes valuation model, taking into account the expected life of the options. The resulting expense also takes into account the expected cancellation rate of the options. The expense is adjusted over the vesting period to reflect actual cancellation rates resulting from option-holders ceasing to be employed by Sanofi.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.24.2. Employee share ownership plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi may offer its employees the opportunity to subscribe to reserved share issues at a discount to the reference market price. Shares awarded to employees under such plans fall within the scope of IFRS&#160;2. Consequently, an expense is recognized at the subscription date, based on the value of the discount offered to employees.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">B.24.3. Restricted share plans</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi may award restricted share plans to certain of its employees. The terms of those plans may make the award contingent on the attainment of performance criteria for some of the grantees.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;2, an expense equivalent to the fair value of such plans is recognized in profit or loss on a straight line basis over the vesting period of the plan, with the opposite entry recognized in equity. The vesting period is three years.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The fair value of restricted share plans is based on the quoted market price of Sanofi shares at the date of grant, adjusted for expected dividends during the vesting period; it also takes account of any vesting conditions contingent on stock market performance, measured using the Monte-Carlo valuation model. Other vesting conditions are taken into account in the estimate of the number of shares awarded during the vesting period; that number is then definitively adjusted based on the actual number of shares awarded on the vesting date.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Earnings per share</a></td>
<td class="text">Earnings per share<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Basic earnings per share is calculated using the weighted average number of shares outstanding during the reporting period, adjusted on a time-weighted basis from the acquisition date to reflect the number of own shares held by Sanofi. Diluted earnings per share is calculated on the basis of the weighted average number of ordinary shares, computed using the treasury stock method.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This method assumes that (i)&#160;all outstanding dilutive options and warrants are exercised, and (ii)&#160;Sanofi acquires its own shares at the quoted market price for an amount equivalent to the cash received as consideration for the exercise of the options or warrants, plus the expense arising on unamortized stock options.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory', window );">Segment information</a></td>
<td class="text">Segment information<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In accordance with IFRS&#160;8 (Operating Segments), the segment information reported by Sanofi is prepared on the basis of internal management data provided to the Chief Executive Officer, who is the chief operating decision maker. The performance of those segments is monitored individually using internal reports and common indicators. Disclosures about operating segments required under IFRS&#160;8 are presented in Note&#160;D.35. &#8220;Segment information&#8221; to the consolidated financial statements.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has three operating segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Pharmaceuticals segment comprises, for all geographical territories, the commercial operations of the following global franchises: Specialty Care (Dupixent</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, Neurology &amp; Immunology, Rare Diseases, Oncology, and Rare Blood Disorders) and General Medicines (Core and Non-Core Assets), together with research, development and production activities dedicated to the Pharmaceuticals segment. This segment also includes associates whose activities are related to pharmaceuticals. Following the transaction of May&#160;29, 2020, Regeneron is no longer an associate of Sanofi (see Note&#160;D.2.). Consequently, the Pharmaceuticals segment no longer includes Sanofi&#8217;s equity-accounted share of Regeneron&#8217;s profits for all the periods presented.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Vaccines segment comprises, for all geographical territories, the commercial operations of Vaccines, together with research, development and production activities dedicated to vaccines.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for Sanofi's Consumer Healthcare products, together with research, development and production activities dedicated to those products.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inter-segment transactions are not material.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The costs of Sanofi&#8217;s global functions (Corporate Affairs, Finance, People &amp; Culture, Legal, Ethics &amp; Business Integrity, Information Solutions&#160;&amp; Technologies, Sanofi Business Services,&#160;etc.) are managed centrally at group-wide level, and are presented within the &#8220;Other&#8221; category. That category also includes other reconciling items such as retained commitments in respect of divested activities.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Information about operating segments for the years ended December 31, 2022, 2021 and 2020 is presented in Note&#160;D.35</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">., </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8220;Segment information&#8221;.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory', window );">Management of capital</a></td>
<td class="text">Management of capital<div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In order to maintain or adjust the capital structure, Sanofi can adjust the amount of dividends paid to shareholders, repurchase its own shares, issue new shares, or issue securities giving access to its capital.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The following objectives are defined under the terms of Sanofi&#8217;s share repurchase programs:</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the implementation of any stock option plan giving entitlement to purchase shares in the Sanofi parent company;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the allotment or sale of shares to employees under statutory profit sharing schemes and employee savings plans;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the consideration-free allotment of shares (i.e. restricted share plans);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the cancellation of some or all of the repurchased shares;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">market-making in the secondary market by an investment services provider under a liquidity contract in compliance with the ethical code recognized by the </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Autorit&#233; des march&#233;s financiers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (AMF);</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the delivery of shares on the exercise of rights attached to securities giving access to the capital by redemption, conversion, exchange, presentation of a warrant or any other means;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the delivery of shares (in exchange, as payment, or otherwise) in connection with mergers and acquisitions;</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the execution by an investment services provider of purchases, sales or transfers by any means, in particular via off-market trading; or</span></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">any other purpose that is or may in the future be authorized under the applicable laws and regulations.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi is not subject to any constraints on equity capital imposed by third parties.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Total equity includes </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Equity attributable to equity holders of Sanofi and Equity attributable to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, as shown in the consolidated balance sheet.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi defines &#8220;Net debt&#8221; as (i)&#160;the sum of short-term debt, long-term debt and interest rate derivatives and currency derivatives used to hedge debt, minus (ii)&#160;the sum of cash and cash equivalents and interest rate derivatives and currency derivatives used to hedge cash and cash equivalents.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for business combinations and goodwill. [Refer: Business combinations [member]; Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for finance income and costs. [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for the impairment of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for non-current assets or disposal groups classified as held for sale and discontinued operations. [Refer: Discontinued operations [member]; Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 46<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 30<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_30_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the initial application of an IFRS. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial reporting in hyperinflationary economies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 29<br> -IssueDate 2021-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=29&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS29_g39-40_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfIFRSCompliance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An explicit and unreserved statement of compliance with all the requirements of IFRSs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfIFRSCompliance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreements Relating To The Recombinant Covid-19 Vaccine Candidate Developed By Sanofi In Collaboration With GSK</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Information And Statement Of IFRS Compliance [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for basis of consolidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for cost of sales explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description Of Accounting Policy For Effects Of Climate Change</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for fair value remeasurement of contingent consideration liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description Of Accounting Policy For International Conflicts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for other gains and losses, and litigation explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for other operating income and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for restructuring costs and similar items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455573280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate Information And Statement Of IFRS Compliance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock', window );">Summary of Useful Lives of Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The customary useful lives of property, plant and equipment are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:49.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.671%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;to&#160;40 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixtures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10 to 20 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5 to 15 years</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 to 15 years</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory', window );">Disclosure of Detailed Information about Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the disclosures required under IFRS&#160;7 relating to the measurement principles applied to financial instruments.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.852%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.362%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Type&#160;of financial&#160;instrument</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Measurement<br/>principle</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in<br/>fair&#160;value<br/>hierarchy</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Valuation<br/>technique</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Method used to determine fair value</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Valuation<br/>model</span></td><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market data</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exchange rate</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (quoted equity instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market&#160;price</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (quoted debt instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (unquoted equity instruments)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cost/Approach based on comparables</span></div></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">If cost ceases to be a representative measure of fair value, an internal valuation is carried out, based mainly on comparables.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value (contingent consideration receivable)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;D.7.3.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets measured at fair value held to meet obligations under post-employment benefit plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Financial assets designated at fair value held to meet obligations under deferred compensation plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.7.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Long-term loans and advances and other non-current receivables</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The amortized cost of long-term loans and advances and other non-current receivables at the end of the reporting period is not materially different from their fair value.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.13.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Investments in mutual funds</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Net asset value</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.13.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Negotiable debt instruments, commercial paper, instant access deposits and term deposits</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Because these instruments have a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.1.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">In the case of debt with a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.<br/>For debt with a maturity of more than 3&#160;months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.17.2.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amortized cost</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">The liability for future lease payments is discounted using the incremental borrowing rate.</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160; year:</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid Money Market</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&gt;&#160;1&#160;year:&#160;</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid Zero Coupon</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market<br/>Spot</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160;year:</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid&#160;Money&#160;Market  and LIFFE interest rate futures</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&gt;&#160;1&#160;year: </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid&#160;Zero Coupon</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.20.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Present&#160;value of future cash flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Mid<br/>Market<br/>Spot</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&lt;&#160;1&#160; year:<br/>Mid&#160;Money Market and LIFFE interest rate futures<br/>&gt;&#160;1&#160;year: <br/>Mid Zero Coupon</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.18.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Liabilities related to business combinations and to non-controlling interests (CVRs)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Quoted market price</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">D.18.</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Liabilities related to business combinations and to non-controlling interests (other than CVRs)</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fair value</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Revenue-based approach</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Under IAS&#160;32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;B.8.4.</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35K<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35K&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Information And Statement Of IFRS Compliance [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of estimated useful lives of property plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439459536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal changes in the scope of consolidation in 2022 (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Summary of Provisional Purchase Price Allocation</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation led to the recognition of &#8364;609&#160;million of goodwill, determined as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:72.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">493</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred taxes, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Amunix</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">517</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,126</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;2,118&#160;million:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:72.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(93)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shire contingent consideration liability (see Note&#160;D.18.)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(323)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Translate Bio</span></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">462</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,118</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,580</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;912 million:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:76.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,534</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net deferred tax position</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(436)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Principia</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,246</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">912</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,158</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;930&#160;million:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,549</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net deferred tax position</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(269)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Synthorx</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,316</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">930</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,246</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Section Disclosures application of paragraphs 59 and 61<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;doctype=Appendix&amp;subtype=B&amp;dita_xref=IFRS03_gB64-B67_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combinations [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439253120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal changes in the scope of consolidation in 2021 and 2020 (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Summary of Final Purchase Price Allocation</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation led to the recognition of &#8364;609&#160;million of goodwill, determined as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:72.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">493</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred taxes, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Amunix</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">517</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,126</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;2,118&#160;million:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:72.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(93)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shire contingent consideration liability (see Note&#160;D.18.)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(323)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Translate Bio</span></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">462</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,118</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,580</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;912 million:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:76.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,534</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net deferred tax position</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(436)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Principia</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,246</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">912</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,158</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#8364;930&#160;million:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value at acquisition date</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,549</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current and non-current assets and liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net deferred tax position</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(269)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net assets of Synthorx</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,316</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">930</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,246</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Section Disclosures application of paragraphs 59 and 61<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;doctype=Appendix&amp;subtype=B&amp;dita_xref=IFRS03_gB64-B67_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combinations [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442317872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Property, plant and equipment owned by Sanofi is comprised of the following items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:28.149%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.696%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Land</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Buildings</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Machinery<br/>and<br/>equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fixtures,<br/>fittings&#160;and<br/>other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Property,&#160;plant<br/>and&#160;equipment<br/>in process</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">255</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,282</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,053</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,587</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,391</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23,568</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(173)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(177)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(123)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(487)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(264)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(276)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(67)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(91)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(711)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,051)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(521)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">236</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,828</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,127</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,524</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,454</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23,169</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(80)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(314)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(839)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">240</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,170</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,648</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,655</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,097</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24,810</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,104)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,642&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,748&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(559)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,626)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(318)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">237</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,328</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,848</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,515</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,996</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23,924</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(11)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4,065)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(7,660)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,984)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(131)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(13,851)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(356)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(605)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(182)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,143)</span></td><td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,898)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(7,792)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,981)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(123)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(13,804)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(306)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(592)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(167)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,065)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(80)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(99)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(208)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(9)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4,190)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8,340)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,115)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(128)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14,782)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(622)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,142)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4,225)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(7,637)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,015)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(168)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14,055)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,930&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,335&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,331&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,365&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,980&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,308&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,969&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">227</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,103</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,211</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">500</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,828</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,869</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line includes in particular property, plant and equipment in process brought into service during the period, but also includes the effect of the reclassification of assets to Assets held for sale or exchange.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock', window );">Summary of Acquisitions and Capitalized Interest by Operating Segment</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth acquisitions and capitalized interest by operating segment for the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,748</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,504</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,310</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Industrial facilities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">534&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">634&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Research sites</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">152&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">199&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Consumer Healthcare</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capitalized interest</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock', window );">Summary of Off Balance Sheet Commitments Relating to Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Off balance sheet commitments relating to property, plant and equipment as of December 31, 2022, 2021 and 2020 are set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Firm orders of property, plant and equipment</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Property, plant and equipment pledged as security for liabilities</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock', window );">Summary of Impairment Losses Recognised in Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth the net impairment losses recognized in each of the last three financial periods:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net impairment losses on property, plant and equipment</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">186</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">43</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) For 2022, the amount mainly comprises an impairment loss arising from a decision to discontinue operations at an industrial facility located outside&#160;France.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Summary of Property, Plant and Equipment Leased</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Right-of-use assets relating to property, plant and equipment leased by Sanofi are analyzed in the table below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:82.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Right-of-use assets</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,583</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(121)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(85)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,711</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(91)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,745</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,872</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(283)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and impairment charged in the period</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(513)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and impairment charged in the period</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(315)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(797)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and impairment charged in the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated depreciation &amp; impairment at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,057)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,198</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,948</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,815</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line also includes the effect of the reclassification of assets to &#8220;Assets held for sale or exchange&#8221;.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In December&#160;2018, Sanofi signed two leases on real estate assets in the United States (at Cambridge, Massachusetts) for an initial lease term of 15 years. The first lease, relating to office space, began in April&#160;2021; Sanofi recognized a right-of-use asset of &#8364;320 million, as well as the lease liability. The second lease, relating to laboratory facilities, began on July&#160;1, 2021; Sanofi recognized a right-of-use asset of &#8364;424 million, as well as the lease liability.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of acquisitions of property plant and equipment by operating segments explanatory [text block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of changes in property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of Impairment Losses of Property, Plant and Equipment [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of Off-Balance Sheet Commitments of Property Plant and Equipment [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442636848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and other intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract', window );"><strong>Intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory', window );">Schedule of Movements in Goodwill</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in goodwill comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:82.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44,519</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions during the period</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,843&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements during the period</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,923)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44,364</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions during the period</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements during the period</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(89)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">48,056</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions during the period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements during the period</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(258)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">49,892</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line mainly comprises the amount of goodwill allocated to divested operations in accordance with paragraph&#160;86 of IAS&#160;36, and in 2022 the sale of EUROAPI (see note&#160;D.1.).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock', window );">Schedule of Movements in Other Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in other intangible assets comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.595%"><tr><td style="width:1.0%"/><td style="width:50.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.235%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.061%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Acquired R&amp;D</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Products,<br/>trademarks and<br/>other rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Software</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total other<br/>intangible assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at January&#160;1, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,730</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">63,953</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,613</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">71,296</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes&#160;in&#160;scope of&#160;consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,951&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,083&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(44)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(243)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(46)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(333)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(593)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,926)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,557)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(98)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December&#160;31, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,600</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">61,074</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,633</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">72,307</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,805&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,626&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(313)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(173)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(502)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(784)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2021</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,207</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">65,906</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,752</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">78,865</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and other increases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(423)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(543)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,994&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,576)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross value at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,354</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">69,579</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,783</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">81,716</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at January&#160;1, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,396)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(50,314)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,077)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(54,787)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,707)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(112)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,819)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(328)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(330)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,460&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,649&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at December&#160;31, 2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,508)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(49,345)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,113)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(53,966)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(119)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,740)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(150)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(192)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(132)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,869)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,022)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at December&#160;31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,477)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(52,744)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,237)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(57,458)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,099)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,196)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment losses, net of reversals</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,107)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,561&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Disposals and other decreases</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,567)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,591)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated amortization &amp; impairment at December 31, 2022</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4,128)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(54,652)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,296)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(60,076)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,092&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,729&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,341&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,730&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,162&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,407&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,226</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,927</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">487</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21,640</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement (see Note&#160;A.2.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) The &#8220;Transfers&#8221; line mainly comprises (i) acquired R&amp;D that came into commercial use during the period and (ii) reclassifications of assets as held for sale or exchange.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) The &#8220;Changes in scope of consolidation&#8221; line corresponds to the fair value of intangible assets recognized in connection with acquisitions made during the period (see Notes&#160;D.1. and&#160;D.2.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) See Note&#160;D.5.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) The amendment to the terms of the IO License and Collaboration Agreement resulted in the recognition of an amortization charge of &#8364;226&#160;million (see&#160;Note C.1.).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock', window );">Detailed Information for Principal Marketed Products</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below provides information about the principal &#8220;marketed products&#8221;, which were recognized in connection with major acquisitions made by Sanofi and represented 92% of the carrying amount of that item as of December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:20.645%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>amortization&#160;&amp;<br/>impairment</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortization</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">period</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(years)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Residual</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">amortization</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">period</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(years)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,490&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,869)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Boehringer Ingelheim <br/>Consumer Healthcare</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,633&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,596)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,037&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34,684&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(34,626)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chattem</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,360&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Protein Sciences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ablynx</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(609)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,955&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,119)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,836&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,240&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kadmon</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,702&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total: principal marketed products</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">62,827</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(51,144)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,683</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,752</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,341</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Weighted averages. The amortization periods for these products vary between 1&#160;and 25&#160;years.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Weighted averages.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock', window );">Amortization of Softwares Recognized in Income Statement</a></td>
<td class="text">An analysis of amortization of software is shown in the table below:<div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:59.696%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">97</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">119</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">112</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement (see Note&#160;A.2.1.).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of amortization of software and other rights by income statement line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfPrincipalMarketedProductsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of principal marketed products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfPrincipalMarketedProductsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of changes in other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455525712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impairment of intangible assets and property, plant and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentOfAssetsAbstract', window );"><strong>Impairment Of Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock', window );">Schedule of Allocation of Goodwill</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The allocation of goodwill as of December 31, 2022 is shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer Healthcare</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39,421</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,690</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,781</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">49,892</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock', window );">Summary of Net Impairment Losses of Other Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In 2022, 2021 and 2020, impairment testing of other intangible assets (excluding software) resulted in the recognition of net impairment losses as shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impairment of other intangible assets, net of reversals  (excluding software)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(454)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">192</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">330</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Marketed products</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,561)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Pharmaceuticals </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1,542)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Vaccines</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Consumer Healthcare</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development projects </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a) / (b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) For 2022, these amounts mainly comprise a reversal of &#8364;2,154&#160;million of impairment losses taken against Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> and BIVV001 (assets belonging to the Eloctate franchise), consisting of &#8364;1,554&#160;million for marketed products and &#8364;600&#160;million for research and development projects respectively. In 2019, the launch of competing products for Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> led Sanofi to update its sales forecasts for products belonging to the franchise, as a result of which  impairment losses of &#8364;2.8&#160;billion were recognized against the assets in question. The reversal reflects the approval by the FDA on February 22, 2023 of the marketing authorization application for ALTUVIIIO&#8482; (the commercial name of efanesoctocog alpha, corresponding to the BIVV001 project), which was submitted in 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span><br/></span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) For 2022, this amount mainly comprises: </span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.93pt">an impairment loss of &#8364;1,586&#160;million taken against the development project for SAR444245 (non-alpha interleukin-2), recognized following revised cash flow projections reflecting unfavorable developments in the launch schedule;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.93pt">the &#8364;600m reversal relating to the BIVV001 project (see above). </span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">     For 2021, this line relates to the discontinuation of the development of sutimlimab in the treatment of Immune Thrombocytopenic Purpura (ITP), and to the termination of various research projects in Vaccines. For 2020, this line mainly comprises impairment losses taken against R&amp;D programs within the Specialty Care GBU, and the discontinuation of certain R&amp;D programs and collaboration agreements in Diabetes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of goodwill by operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Impairment Losses Of Other Intangible Assets [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpairmentOfAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Of Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpairmentOfAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439303456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments accounted for using the equity method (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestsInOtherEntitiesAbstract', window );"><strong>Interests In Other Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock', window );">Summary of Investments in Associates and Joint Ventures</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:49.895%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%&#160;interest</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EUROAPI</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MSP Vaccine Company</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">677</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">250</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">201</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;Following the distribution in kind and the acquisition of an equity interest by EPIC Bpifrance, Sanofi holds 30.1% of the capital of EUROAPI (see Note&#160;B.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Joint venture.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Joint venture. MSP Vaccine Company owns 100% of MCM Vaccine B.V.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock', window );">Summary of Share of Profit or Loss and Other Comprehensive Income of Associates and Joint Ventures</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows Sanofi&#8217;s overall share of (i)&#160;profit or loss and (ii)&#160;other comprehensive income from investments accounted for using the equity method, showing the split between associates and joint ventures in accordance with IFRS&#160;12 (the amounts for each individual associate or joint venture are not material):</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:28.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.562%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Joint&#160;ventures</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Associates</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Joint&#160;ventures</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Associates</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Joint&#160;ventures</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Associates</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of other comprehensive income from investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(311)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">72</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes &#8364;343&#160;million for Sanofi's share of the net income of Regeneron up to and including May&#160;29, 2020 (see Note&#160;D.2.2.).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory', window );">Summary of Principal Transactions and Balances with Related Parties</a></td>
<td class="text">The principal transactions and balances with related parties are summarized below:<div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:59.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Royalties and other income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable and other receivables</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchases and other expenses (including research expenses)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts payable and other payables</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) For 2020, these amounts include transactions between Sanofi and Regeneron for the period from January&#160;1 through May&#160;29, 2020. The table above does not include the repurchase by Regeneron of its own shares from Sanofi (see Note&#160;D.2.2.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In 2022, these items include Sanofi's transactions with EUROAPI from May&#160;10, 2022 (see Note&#160;D.1.).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of investments in associates and joint ventures explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of profit or loss and other comprehensive income of associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestsInOtherEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interests In Other Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestsInOtherEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442347360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other non-current assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock', window );">Summary of Other Non-current Assets</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other non-current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:49.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity instruments at fair value through other comprehensive income (D.7.1.)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt instruments at fair value through other comprehensive income (D.7.2.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other financial assets at fair value through profit or loss (D.7.3.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pre-funded pension obligations (Note&#160;D.19.1.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term prepaid expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term loans and advances and other non-current receivables</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derivative financial instruments (Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,095</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,127</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,734</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) The movement in this item mainly comprises (i)&#160;the non-current portion of a $100&#160;million upfront payment made on signature of a research agreement with Exscientia on January&#160;7, 2022 to develop a portfolio of precision-engineered medicines using artificial intelligence; and (ii)&#160;the non-current portion of a $150&#160;million upfront payment made as part of a strategic partnership with IGM Biosciences signed on March&#160;29, 2022, with a view to developing targets in oncology, immunology and inflammation</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) As of December 31, 2022, this item includes a receivable under a sub-lease amounting to &#8364;164 million, or &#8364;227 million before discounting.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of components of other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405438642928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets held for sale or exchange and liabilities related to assets held for sale or exchange (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock', window );">Summary of Assets Held for Sale or Exchange, and Liabilities Related to Assets Held for Sale or Exchange</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Assets held for sale or exchange, and liabilities related to assets held for sale or exchange, comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:52.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.216%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets held for sale or exchange</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">85</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">89</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">83</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Liabilities related to assets held for sale or exchange</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of assets held for sale or exchange and related liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405438482544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Inventories comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.907%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.829%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Allowances</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Allowances</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Allowances</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying<br/>amount</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,474&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,663&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(678)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,985&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(554)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,025&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(542)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,856&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,748&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(247)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(218)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,024</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,064)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,960</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,619</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(904)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,715</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,188</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(836)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,352</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455846928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock', window );">Summary of Accounts Receivable</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Accounts receivable break down as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:52.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.216%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross value</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,537&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,705&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,633&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(137)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(142)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,424</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,568</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,491</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock', window );">Summary of Gross Value of Overdue Receivables</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:17.123%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.532%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;accounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Overdue&#160;by</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">gross value</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&lt;1 month</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to&#160;3&#160;months</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to&#160;6&#160;months</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6&#160;to&#160;12&#160;months</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&gt;&#160;12&#160;months</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">452</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">118</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">161</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">87</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">35</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of current trade receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfCurrentTradeReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of overdue receivables gross value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455468784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Other current assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax receivables, other than corporate income taxes</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other receivables</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate derivatives measured at fair value (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency derivatives measured at fair value (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current financial assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,532</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,571</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,737</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) This line mainly comprises advance payments to suppliers, and receivables relating to Sanofi's activities as agent under a transitional services agreement.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) This item includes bank loans and receivables maturing in less than one year with high-grade counterparties. For 2021, this item also includes debt instruments derived from the acquisitions of Translate Bio and Kadmon (carried out in 2021) with maturities of more than 3&#160;months at inception and less than 12&#160;months at December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439411200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities measured at fair value (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueMeasurementAbstract', window );"><strong>Fair Value Measurement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock', window );">Summary of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the balance sheet amounts of assets and liabilities measured at fair value.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:32.131%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in the fair value</span></div><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">hierarchy</span></div></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in the fair value<br/>hierarchy</span></td><td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level in the fair value<br/>hierarchy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial assets measured at fair value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Quoted equity investments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.1.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unquoted equity investments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.1.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Quoted debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.2.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unquoted debt securities not meeting the definition of equity instruments</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.3.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration relating to divestments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.3.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial assets held to meet obligations under deferred compensation plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.3.  and D.11.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.7.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.11.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mutual fund investments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.13.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,537&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,057&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total financial assets measured at fair value</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,765</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">206</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">967</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,449</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">298</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">883</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,022</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">82</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">695</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial liabilities measured at fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bayer contingent purchase consideration arising from the acquisition of Genzyme</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MSD contingent consideration (European vaccines business)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shire contingent consideration arising from the acquisition of Translate Bio</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration arising from acquisition of Amunix</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other contingent consideration arising from business combinations and acquisitions</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.18.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.19.</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">D.19.5</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total financial liabilities measured at fair value</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">326</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">779</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">85</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">714</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">297</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">605</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of fair value of financial assets and liabilities explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FairValueMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Measurement [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FairValueMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439437504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock', window );">Summary of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash equivalents</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,351&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,740&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,771&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,736</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,098</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,915</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) As of December 31, 2022, cash equivalents mainly comprised the following: (i)&#160;&#8364;9,537 million invested in euro and US dollar denominated money-market mutual funds (December 31, 2021: &#8364;5,057 million; December 31, 2020: &#8364;8,703 million); (ii)&#160;&#8364;1,167 million of term deposits (December 31, 2021: &#8364;2,768 million; December 31, 2020: &#8364;3,259 million) and (iii)&#160;nil commercial paper (December 31, 2021: &#8364;179 million; December 31, 2020: &#8364;74 million). Cash equivalents also include &#8364;439 million held by captive insurance and reinsurance companies in accordance with insurance regulations (December 31, 2021: &#8364;427 million; December 31, 2020: &#8364;425 million).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents details.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405457263120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net deferred tax position (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory', window );">Summary of Net Deferred Tax Position</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of the net deferred tax position is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:54.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred taxes on:</span></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Consolidation adjustments (intragroup margin in inventory)</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,388&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision for pensions and other employee benefits</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of other acquired intangible assets</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,269)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,079)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,083)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognition of acquired property, plant and equipment at fair value</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(27)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity interests in subsidiaries and investments in other entities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(617)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(590)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(522)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax losses available for carry-forward</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,516&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock options and other share-based payments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued expenses and provisions deductible at the time of payment</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,585&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ededed;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred tax asset/(liability)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,540</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,981</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,406</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) As of December&#160;31, 2022, includes remeasurements of the acquired intangible assets of Bioverativ (&#8364;1,429 million), Principia (&#8364;625 million), Ablynx (&#8364;229 million), Genzyme (&#8364;150 million) and Amunix (&#8364;118 million).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In some countries, Sanofi is liable for withholding taxes and other tax charges when dividends are distributed. Consequently, Sanofi recognizes a deferred tax liability on the reserves of French and foreign subsidiaries (approximately &#8364;59.1 billion) which it regards as likely to be distributed in the foreseeable future. In determining the amount of the deferred tax liability as of December 31, 2022, Sanofi took into account changes in the ownership structure of certain subsidiaries, and the effects of changes in the taxation of dividends in France, following the ruling of the Court of Justice of the European Union in the Steria case and the resulting amendments to the 2015 Finance Act.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Includes deferred tax assets related to restructuring provisions, amounting to &#8364;256 million as of December 31, 2022, &#8364;307 million as of December 31, 2021, and &#8364;259 million as of December 31, 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock', window );">Summary of Tax Losses Available for Carry-forward</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows when tax losses available for carry-forward are due to expire:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:70.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Tax&#160;losses&#160;available for carry-forward</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2028 and later</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,349&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total as of December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,503</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total as of December 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,644</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total as of December 31, 2020</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,515</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Excluding tax loss carry-forwards on asset disposals. Such carry-forwards amounted to &#8364;5 million as of December 31, 2022, &#8364;5 million as of&#160;December 31, 2021 and &#8364;6 million as of December 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of availability of tax losses carry forwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456255584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract', window );"><strong>Share Capital, Reserves And Other Equity Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory', window );">Summary of Treasury Shares Held</a></td>
<td class="text">Treasury shares held by Sanofi are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:49.895%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of&#160;shares </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(million)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%&#160;of&#160;share&#160;capital <br/>for the period</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.20</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.650</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="2" style="border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.02&#160;</span></td><td style="border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.872&#160;</span></td><td style="border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.658&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2020</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.002&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock', window );">Summary of Movements Share Capital</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in the share capital of the Sanofi parent company over the last three years are set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:33.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Transaction</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,253,846,111</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital&#160;increase&#160;by&#160;exercise&#160;of stock subscription options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">868,655&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by issuance of restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,666,256&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of July 28, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase reserved for employees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,590,716</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,258,971,738</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by exercise of stock subscription options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">190,076&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by issuance of restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,836,179&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of July 28, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase reserved for employees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,562,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,263,560,695</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by exercise of stock subscription options</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">490,373&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">During 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase by issuance of restricted shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,499,987&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of July 27, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital increase reserved for employees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,027,057&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Board meeting of December 14, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reduction in share capital by cancellation of <br/>treasury shares</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,742,380)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #5064a9;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,260,835,732</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Shares issued on exercise of Sanofi stock subscription options.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Shares vesting under restricted share plans and issued in the period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory', window );">Principal Characteristics of Restricted Share Plans</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restricted share plans are accounted for in accordance with the policies described in Note&#160;B.24.3. The principal characteristics of those plans are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:38.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Type of plan</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Performance<br/>share plans</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Date of Board meeting approving the plan</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 3, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 14, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 27, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 28, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 28, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service period</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total number of shares awarded </span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,344,432&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">109,981&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,484,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,340,501&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73,027&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which with no market condition</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000,627&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,335&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,209,901&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,536,893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;91.19&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;79.17&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;77.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;82.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which with market condition</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,343,805&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99,646&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,274,519&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">803,608&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73,027&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded other than to the Chief Executive Officer</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;86.65&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;69.60&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;71.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;68.45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;76.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;63.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded other than to the Chief Executive Officer - additional shares</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;49.00&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;54.70&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value per share awarded to the Chief Executive Officer</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;84.46&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;71.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;76.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value of plan at the date of grant (&#8364; million)</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">294</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">262</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">270</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Additional tranche subject to a higher level of market conditions: 114,874&#160;additional shares were awarded in May&#160;2022, and 9,066&#160;additional shares were awarded in December&#160;2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock', window );">Summary of Number of Restricted Shares Not Yet Fully Vested</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The total expense recognized for all restricted share plans, and the number of restricted shares not yet fully vested, are shown in the table below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:58.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total expense for restricted share plans (&#8364; million)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Number of shares not yet fully vested</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,121,573&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,507,849&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,546,612&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2022 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,206,861&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2021 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,097,531&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,364,895&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2020 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,817,181&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,014,496&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,284,558&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2019 plans</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,128,458&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,375,717&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Under 2018 plans</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,886,337&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock', window );">Summary of Characteristics of Employee Share Ownership Plans Awarded</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The characteristics of the employee share ownership plans awarded in the form of a capital increase reserved for employees in&#160;2022, 2021 and 2020 are summarized in the table below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:58.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Date of Board meeting approving the plan</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 3, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 4, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February 5, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Subscription price (&#8364;)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80.21&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">70.67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Subscription period</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 9-29, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 7-25, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 8-26, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Number of shares subscribed</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,909,008&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,438,590&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,467,101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Number of shares issued immediately as employer&#8217;s contribution</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118,049&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124,112&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123,615&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Subscription price representing 80% of the average of the opening quoted market prices of Sanofi shares during the 20&#160;trading days preceding June&#160;6,&#160;2022, June&#160;3,&#160;2021 and June&#160;2, 2020, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements', window );">Summary of Expenses</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth the expense recognized for each plan:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:58.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense recognized</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which employer&#8217;s contribution</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">11&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">11&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock', window );">Summary of Repurchases program</a></td>
<td class="text">The following repurchases have been made under those programs:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.185%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:29.25pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(in number of shares and &#8364; million)</span></div><div style="padding-right:29.25pt;text-align:justify"><span><br/></span></div><div style="padding-right:29.25pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Year of authorization</span></div></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number <br/>of shares</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number <br/>of shares</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number <br/>of shares</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022 program</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,510,000&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021 program</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,976,992&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,765,388&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020 program</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,758,569&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,685,426&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2019 program</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,982,939&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock', window );">Summary of Currency Translation Differences</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Currency translation differences comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.901%"><tr><td style="width:1.0%"/><td style="width:56.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.126%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Attributable to equity holders of Sanofi</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(865)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,384)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(55)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,462</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(907)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,439)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the financial statements for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock', window );">Summary of Movements within Other Comprehensive Income</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements within other comprehensive income are shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:61.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains/(losses):</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Actuarial gains/(losses) excluding investments accounted for using the equity method (see Note&#160;D.19.1.)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(266)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity instruments included in financial assets and financial liabilities:</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;padding-right:29.25pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (excluding investments accounted for using the equity method)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (investments accounted for using the equity method, net of taxes)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Equity risk hedging instruments designated as fair value hedges</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(84)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not subsequently reclassifiable to profit or loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">451</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">797</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt instruments included in financial assets:</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (excluding investments accounted for using the equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash flow and fair value hedges:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (excluding investments accounted for using the equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Change in fair value (investments accounted for using the equity method, net of taxes)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#9642;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:9.29pt">Tax effects</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in currency translation differences:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,719&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,870)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Currency translation differences (investments accounted for using the&#160;equity method)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Currency translation differences related to the investment in Regeneron and&#160;reclassified to profit or loss</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(318)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Hedges of net investments in foreign operations</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(254)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Tax effects</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items subsequently reclassifiable to profit or loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,313</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,510</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4,021)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Amounts reclassified to profit or loss: immaterial amount in 2022, &#8364;4 million in 2021 and &#8364;5 million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Amounts reclassified to profit or loss: &#8364;2 million in 2022, &#8364;12 million in 2021 and &#8364;1 million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Amounts reclassified to profit or loss: &#8364;40 million in 2022, including &#8364;35 million relating to the deconsolidation of EUROAPI (see note&#160;D.1.). The amounts reclassified to profit and loss were immaterial in 2021 and 2020. Currency translation differences arise from the translation into euros of the financial statements of foreign subsidiaries, and are mainly due to the appreciation of the dollar against the euro.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) &#160;&#160;&#160;&#160;The amount recorded for 2020 relates to the translation reserve arising on the investment in Regeneron; the reserve was reclassified to profit or loss in accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates), including &#8364;2 million (net of tax) relating to hedges of net investments in foreign operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock', window );">Disclosure of Stock Subscription Option Plan Outstanding and Option Exercised</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table shows all Sanofi stock subscription option plans still outstanding or under which options were exercised in the year ended&#160;December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:18.961%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Source</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Date of grant</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>options<br/>granted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Start&#160;date&#160;of<br/>exercise<br/>period</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exercise<br/>price (&#8364;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of options outstanding as of 12/31/2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2012</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">814,050&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/06/2016</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2022</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56.44&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2013</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">788,725&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/06/2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72.19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">78,089&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2014</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,009,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/06/2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">03/05/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">506,042&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">06/24/2015</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">435,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">06/25/2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">06/24/2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">338,464&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/04/2016</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">402,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/05/2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/04/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75.90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">264,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/10/2017</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">378,040&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/11/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/10/2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">268,440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/02/2018</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/03/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/02/2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168,784&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">04/30/2019</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">05/02/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">04/30/2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76.71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">213,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,837,969</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock', window );">Summary of Stock Options Outstanding at Each Balance Sheet Date</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A summary of stock options outstanding at each balance sheet date, and of movements during the relevant periods, is presented below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:58.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of<br/>options</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted average<br/>exercise&#160;price<br/>per share (&#8364;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>(&#8364;&#160;million)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,822,020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">70.58</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">270</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,650,375&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">67.14&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">178&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(868,655)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options cancelled</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)&#160;</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(91,305)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(282,790)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,579,270</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">75.61</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">195</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,845,050&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">74.51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">137&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(190,076)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59.53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options cancelled</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)&#160;</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(51,216)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,337,968</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">77.13</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">180</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,949,184&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">78.15&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">152&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(490,373)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">71.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options cancelled</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)&#160;</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,626)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Options outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,837,969</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">78.64</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">145</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,624,569&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">78.89&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">128&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Mainly due to the grantees leaving Sanofi.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock', window );">Summary of Options Outstanding and Exercisable</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below provides summary information about options outstanding and exercisable as of December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Range of exercise prices per share</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>options</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>residual&#160;life<br/>(years)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price per<br/>share (&#8364;)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>options</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price per<br/>share (&#8364;)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">From &#8364;60.00 to &#8364;70.00 per share</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168,784&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.34</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65.84&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168,784&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65.84&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">From &#8364;70.00 to &#8364;80.00 per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,062,281&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.68</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74.64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">848,881&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">From &#8364;80.00 to &#8364;90.00 per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">606,904&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.31</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">606,904&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,837,969</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,624,569</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock', window );">Summary of Number of Shares Used to Compute Diluted Earnings Per Share</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.991%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Average number of shares outstanding</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,251.9&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,252.5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,253.6&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustment for stock options with dilutive effect</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustment for restricted shares</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average number of shares used to compute diluted earnings per share</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,256.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,257.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,260.1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional information about share-based payment arrangements necessary to satisfy the disclosure requirements of IFRS 2. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 52<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_52&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of classes of share capital. [Refer: Share capital [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information of accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of employee stock ownership plan awarded in capital increase reserved explanatory [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of number of restricted share plans Not yet fully vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of reserve of exchange differences on translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of share based compensation shares authorized under stock option plans by exercise price range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of share repurchase program explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of shares used to compute diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of statement of changes in equity of parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of stock options outstanding at each balance sheet date and of changes during the relevant periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of stock subscription option plans under which options were exercised in the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Capital, Reserves And Other Equity Interest [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareCapitalReservesAndOtherEquityInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435298960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinancialInstrumentsAbstract', window );"><strong>Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfChangesInFinancialPositionTableTextBlock', window );">Summary of Changes in Financial Position</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Changes in Sanofi's financial position during the period were as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.991%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,857&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,123&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,745&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,174&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,218</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,250</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,631</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,437</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,983</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,790</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Net debt does not include lease liabilities, which amounted to &#8364;2,181 million as of December 31, 2022, &#8364;2,108</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> million as of December 31, 2021, and&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">1,163&#160;million as of December 31, 2020 </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(see the maturity analysis at Note&#160;D.17.2.).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock', window );">Summary of Reconciliation of Carrying Amount to Value on Redemption</a></td>
<td class="text"><div style="margin-bottom:4pt"><span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Reconciliation of carrying amount to value on redemption</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"/><td style="width:25.167%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value on redemption</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortized<br/>cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustment<br/>to debt<br/>measured&#160;at<br/>fair value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,857&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,143&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,176&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,794&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion<br/>of long-term debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,174&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,178&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(235)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,218</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,273</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,314</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,703</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,437</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,492</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory', window );">Disclosure of Movement In Total Debt</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the movement in total debt during the period:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash&#160;flows&#160;from<br/>financing activities</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-cash items</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repayments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">New<br/>borrowings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>cash<br/>flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">translation</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">differences</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification<br/>from<br/>non-current to<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">items</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,123&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,632)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(228)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,857&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,707)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,632&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,174&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(373)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,250</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,718)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,549</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(330)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">442</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,218</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These amounts include unrealized gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the Euro zone.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) These amounts include changes in accrued interest balances, and fair value adjustments.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show the movement in total debt during prior periods:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash&#160;flows&#160;from<br/>financing activities</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-cash items</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repayments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">New<br/>borrowings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>cash<br/>flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">translation</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">differences</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification<br/>from<br/>non-current to<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">items</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,745&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,704)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,123&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,203)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(615)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,704&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(197)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,631</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,241)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(812)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">381</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">291</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,250</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash&#160;flows&#160;from<br/>financing activities</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-cash items</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Repayments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">New<br/>borrowings</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>cash<br/>flows</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">translation</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">differences </span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification<br/>from<br/>non-current to<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">items</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,131&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(152)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,285)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,745&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term debt and current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,952)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(219)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24,568</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,952)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,019</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">282</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(385)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">99</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,631</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These amounts include unrealized gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the&#160;Euro zone.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) These amounts include movements in accrued interest and fair value remeasurements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock', window );">Summary of Debt by Type Valuation of Redemption</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:14.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">current </span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current </span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,044&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,817&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,861&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,118&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,946&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,698&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,280&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,978&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,143</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,130</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,273</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,176</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,138</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,314</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,851</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,852</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,703</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,143</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8,651)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,492</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,176</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(7,129)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,857</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10,995)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Net debt does not include lease liabilities (see the maturity schedule in Note&#160;D.17.2.).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock', window );">Summary of Bond Issues</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bond issues carried out by Sanofi under the Euro Medium Term Note (EMTN) program are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.739%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issuer</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ISIN code</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issue date</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual&#160;interest&#160;rate</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364; million)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0011625433</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 2013</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0014009KS6</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0012146801</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2014</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0014009KQ0</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0012969038</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013143997</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.625&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013144003</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013201639</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013505104 </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013505112</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 2030</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324332</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324340</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324357</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2030</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013324373</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2038</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013409844</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">FR0013409851</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 2034</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Bond issues carried out by Sanofi under the public bond issue program (shelf registration statement) registered with the US&#160;Securities and Exchange Commission (SEC) comprise:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:14.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.739%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issuer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ISIN code</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Issue&#160;date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual&#160;<br/>interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount </span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">($&#160;million)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US801060AC87</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US801060AD60</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 2028</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.625&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock', window );">Summary of Debt by Maturity at Value on Redemption</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,861&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,817&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,684&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used <br/>to manage debt</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,273</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,130</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used <br/>to manage cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,492</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8,651)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Net debt does not include lease liabilities, which amounted to &#8364;2,181&#160;million as of December&#160;31, 2022; &#8364;2,108&#160;million as of&#160;December&#160;31, 2021; and&#160;&#8364;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">1,163&#160;million as of December&#160;31, 2020</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> (see the maturity analysis at Note&#160;D.17.2.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, the main undrawn confirmed general-purpose credit facilities at holding company level amounted to&#160;&#8364;8 billion, half of which expires in 2023 and the other half of which expires in 2027.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of December 31, 2022, no single counterparty represented more than 6% of Sanofi&#8217;s undrawn confirmed credit facilities.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,946&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,629&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,979&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,314</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,138</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,647</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">602</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,751</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,016</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,098)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(7,129)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,647</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">602</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,751</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,016</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bond issues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,978&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,280&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,569&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,079&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other bank borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bank credit balances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,703</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,852</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,830</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,575</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">602</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,756</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,088</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,915)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate and currency derivatives used to manage cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10,995)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,836</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,575</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">602</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,756</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,088</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock', window );">Summary of Debt by Interest Rate</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below splits net debt between fixed and floating rate, and by maturity, as of December 31, 2022. The figures shown are values on redemption, before the effects of derivative instruments:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixed-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,861</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,817&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,684&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">16,993</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,868</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% fixed-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">98</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Floating-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">460</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,321</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,178</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(3,908)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(8,391)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,585</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8,558)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">To optimize the cost of debt or reduce the volatility of debt and manage its exposure to financial foreign exchange risk, Sanofi uses derivative instruments (interest rate swaps, currency swaps, foreign exchange swaps and forward contracts) that alter the fixed/floating rate split and the currency split of its net debt:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixed-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16,386</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,684&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">13,944</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,443</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% fixed-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">85</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Floating-rate debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,886</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,787&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">592</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">950</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,273</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,130</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,781)</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,781)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which euro</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(4,046)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(5,797)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2,155)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% floating-rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,492</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8,651)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">661</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,600</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,722</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock', window );">Summary of Interest Rate of Net Debt at Value on Redemption</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the fixed/floating rate split of net debt at value on redemption after taking account of derivative instruments as of&#160;December 31, 2021 and December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:49.895%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fixed-rate debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,612&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,713&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Floating-rate debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,314</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22,703</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,267)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,841)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock', window );">Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The projected full-year sensitivity of net debt to interest rate fluctuations for 2023 is as&#160;follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:53.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in short-term interest rates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact&#160;on&#160;pre-tax&#160;net<br/>income&#160;(&#8364;&#160;million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact&#160;on&#160;pre-tax<br/>income/(expense)&#160;recognized<br/>directly in equity<br/>(&#8364; million)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+100&#160;bp</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+25&#160;bp</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25&#160;bp</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-100&#160;bp</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(98)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock', window );">Summary of Debt by Currency Before and After Derivative Instrument</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows net debt by currency at December 31, 2022, before and after derivative instruments contracted to convert the foreign-currency net debt of exposed entities into their functional currency:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:53.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Before&#160;derivative&#160;instruments</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">After&#160;derivative&#160;instruments</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,145&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,489&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,508)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,404)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pound sterling</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexican peso</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other currencies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,585</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,492</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock', window );">Summary of Debt by Currency After Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows net debt by currency at December 31, 2021 and 2020, after derivative instruments contracted to convert the foreign currency net debt of exposed entities into their functional currency:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:74.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,129&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,725&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(669)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,304)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other currencies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,413)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,559)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net debt</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock', window );">Summary of Market Value of Net Debt</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The market value of Sanofi&#8217;s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Market value</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,227&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,024&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,500&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value on redemption</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,047&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,862&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock', window );">Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:42.085%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,408</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,206</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">868</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,803</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,184</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,283</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,064</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principal</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,932&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,928&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,601&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,011&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,580&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,476&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash flows related to derivative instruments</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">209</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">60</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">38</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20,617</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,230</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">928</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,841</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,215</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,314</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,089</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2022.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt as of December 31, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:42.085%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21,728</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,330</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,826</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">791</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,937</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,176</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,668</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principal</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,086&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,588&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,011&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,080&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,642&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash flows related to derivative instruments</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(51)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(59)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21,677</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,271</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,825</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">793</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,939</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,178</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,671</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2021.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:42.085%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026 and later</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24,339</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,943</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,019</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,808</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">791</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,937</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,841</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principal</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22,392&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,622&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,757&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,571&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,090&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,947&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash flows related to derivative instruments</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">163</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">135</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24,502</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,078</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,047</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,808</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">791</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,937</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,841</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock', window );">Disclosure of Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A maturity analysis of lease liabilities as of December 31, 2022, 2021 and 2020 is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:41.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Undiscounted future minimum lease payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less than 1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From 1 to 3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From 3 to 5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More than 5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Discounting effect</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total lease liabilities as of December 31, 2022</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,181</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">320</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">515</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">436</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,129</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(219)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total lease liabilities as of December 31, 2021</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,108</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">314</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">476</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">362</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,184</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(228)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total lease liabilities as of December 31, 2020</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,163</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">247</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">357</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">225</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">482</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(148)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Lease liabilities as of December&#160;31, 2022 and December&#160;31, 2021 include leases relating to real estate assets located at Cambridge, MA (United States), as described in Note&#160;D.3., which have a lease term of 15 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfChangesInFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of changes in financial position [text block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfChangesInFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of debt by currency at value of redemption after derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of debt by currency at value of redemption before and after derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of debt by interest rate at value of redemption after taking account of derivative instruments N1 N2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of debt by interest rate at value of redemption and by maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of debt by maturity at value of redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of debt net of cash and cash equivalents by type at value on redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detail Of Bonds Issued Explanatory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of market value of net debt [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfMarketValueOfNetDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of maturity analysis of future undiscounted cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Maturity Analysis Of Lease Payments [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of carrying amount to value on redemption [text block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of sensitivity analysis on long-term borrowings and debt securities assuming a 1% increase and decrease in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456033680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities related to business combinations and to non-controlling interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock', window );">Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Movements in liabilities related to business combinations and to non-controlling interests are shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:34.734%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Bayer</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">contingent</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">consideration</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">arising&#160;from&#160;the</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">acquisition of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Genzyme </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MSD<br/>contingent<br/>consideration<br/>(European<br/>Vaccines<br/>business)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shire</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">contingent</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">consideration</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">arising&#160;from&#160;the</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">acquisition of</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Translate Bio</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Contingent consideration arising from acquisition of Amunix</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at January 1, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">156</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">385</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">259</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">800</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(78)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(122)</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(53)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">312</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">189</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">605</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New transactions</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(152)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(258)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">59</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">269</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">354</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">714</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New transactions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other movements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">204</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">380</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">165</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">779</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Portion due after more than one year: &#8364;674 million as of December 31, 2022 (&#8364;577 million as of December 31, 2021 and &#8364;387 million as of December 31, 2020); portion due within less than one year: &#8364;105 million as of December 31, 2022 (&#8364;137 million as of December 31, 2021 and &#8364;218 million as of&#160;December 31, 2020).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Amounts reported within the income statement line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">Fair value remeasurement of contingent consideration</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">, and mainly comprising unrealized gains and losses.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Mainly corresponds to the recognition of the Shire Human Genetic Therapies&#160;Inc. (Shire) contingent consideration liability of $382 million resulting from the acquisition of Translate Bio in September&#160;2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The &#8220;Other&#8221; column mainly relates to the contingent consideration liability due to True North Therapeutics as a result of Sanofi's acquisition of Bioverativ which was settled in the first half of 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock', window );">Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth the maximum amount of contingent consideration payable in respect of already-marketed products:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From&#160;1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">From&#160;3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commitments relating to contingent consideration&#160;in connection with business combinations</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes &#8364;0.4 billion for the Bayer contingent consideration, &#8364;0.2 billion for the MSD contingent consideration.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combinations [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of changes in liabilities related to business combinations and to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456607024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock', window );">Summary of Non Current Provisions and Other Non-current Liabilities</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The line item </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Non current provisions and other non-current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comprises the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:57.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,822&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,430&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,998&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other non-current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,341</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,721</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,315</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (IAS&#160;19, Employee Benefits), </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Includes derivative financial instru</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">ments: &#8364;232 million as of De</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">cember&#160;31, 2022, &#8364;6 million as of December&#160;31, 2021, &#8364;92 million as of December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNoncurrentProvisionsTableTextBlock', window );">Summary of Movements in Non-current Provisions</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth movements in non-current provisions for the reporting periods presented:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"><tr><td style="width:1.0%"/><td style="width:33.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.035%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.035%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.035%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.257%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Provisions&#160;for<br/>pensions and<br/>other&#160;post-employment<br/>benefits<br/>(D.19.1.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Provisions<br/>for other<br/>long-term<br/>benefits</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Restructuring<br/>provisions<br/>(D.19.2.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>provisions<br/>(D.19.3.)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,599</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">855</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">600</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,071</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,125</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases in provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(566)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(109)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(113)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(793)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reversals of unutilized provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(226)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(245)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(518)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(369)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(64)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(421)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest related to employee benefits, and unwinding of discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(214)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains and losses on defined-benefit plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,276</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">879</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">868</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,975</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,998</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases in provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(222)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(122)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(107)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(459)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reversals of unutilized provisions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(145)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(200)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(370)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(425)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest related to employee benefits, and unwinding of discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains and losses on defined-benefit plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(448)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(448)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,947</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">935</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">524</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,024</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,430</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases in provisions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(528)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reversals of unutilized provisions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest related to employee benefits, and unwinding of discount</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains and losses on defined-benefit plans</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,039</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">844</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">761</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,178</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,822</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) In the case of &#8220;Provisions for pensions and other post-employment benefits&#8221;, the &#8220;Increases in provisions&#8221; line corresponds to rights vesting in employees during the period, and past service cost; the &#8220;Provisions utilized&#8221; line corresponds to contributions paid into pension funds and to beneficiaries; and the&#160;&#8220;Reversals of unutilized provisions&#8221; line corresponds to plan curtailments, settlements and amendments.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfActuarialAssumptionsTableTextBlock', window );">Summary of Financial and Demographic Assumptions</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Those calculations were based on the following financial and demographic assumptions:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"><tr><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)/(b)</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.55% to 3.75%</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.55% to 3.75%</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.90%</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.75%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.10% to 1.10%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.10% to 1.10%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.70%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.90%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">or </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.55%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">or </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.55%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.40%</span></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.35%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">General inflation rate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.50%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.50%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.25%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.95%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.95%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.30%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.45%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.45%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.95%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pension benefit <br/>indexation</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.50%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.50%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.00%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.95%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.95%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.15%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.45%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.45%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.85%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Healthcare cost </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">inflation rate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.29%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.56%</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.50%</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.50%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.50% to 4.50%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retirement age</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 67</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 70</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 65</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 67</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 70</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 65</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 67</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 70</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">to 65</span></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TGH/<br/>TGF<br/>05</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Heubeck<br/>RT<br/>2018 G</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RP2012 Proj.<br/>MP2021 White Collar</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SAPS<br/>S3</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TGH/<br/>TGF<br/>05</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Heubeck<br/>RT<br/>2018 G</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RP2012 Proj.<br/>MP2020 White Collar</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SAPS<br/>S3</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TGH/<br/>TGF<br/>05</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Heubeck<br/>RT<br/>2018 G</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RP2012 Proj.<br/>G.&#160;Scale<br/>MP2019 White Collar</span></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SAPS<br/>S2</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The discount rates used were based on market rates for high quality corporate bonds with a duration close to that of the expected benefit payments under the plans. The benchmarks used to determine discount rates were the same for all periods presented.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The rate depends on the duration of the plan (0&#160;to 7&#160;years, 7 to 10&#160;years, or more than 10&#160;years).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Inflation for the euro zone is determined using a multi-criterion method.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;No post-employment healthcare benefits are provided in France since 2020, Germany and UK.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock', window );">Summary of Weighted Average Duration of Obligation for Pensions and Other Long-term Benefits in Principal Countries</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the duration of Sanofi&#8217;s obligations in the principal countries:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:25.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(years)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted average duration</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory', window );">Summary of Sensitivity for Pensions and Other Post-employment Benefits to Changes in Key Actuarial Assumptions</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the sensitivity of Sanofi&#8217;s obligations for pensions and other post-employment benefits to changes in key actuarial assumptions:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions and other post-employment benefits, <br/>by principal country</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Measurement of defined-benefit obligation</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in<br/>assumption</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.50&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+72&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+162&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+75&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+136&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">General inflation rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+306&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pension benefit indexation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Healthcare cost inflation rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">+1 year</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+61&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+51&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+74&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock', window );">Reconciliation of Net Obligation in Respect of Sanofi's Pension and Other Post-Employment Benefit Plans</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below reconciles the net obligation in respect of Sanofi&#8217;s pension and other post-employment benefit plans with the amounts recognized in the consolidated financial statements:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:63.065%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Measurement of the obligation:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning of period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,175&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,094&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial losses/(gains) due to changes in demographic assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(162)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial losses/(gains) due to changes in financial assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,006)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(210)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial losses/(gains) due to experience adjustments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(120)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan amendments, curtailments or settlements not specified in the terms of the plan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(938)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan settlements specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(463)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(503)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation and transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(443)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Obligation at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,651</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,175</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,456</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value of plan assets:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning of period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,651&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,651&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest income on plan assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Difference between actual return and interest income on plan assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,398)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Administration costs</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan settlements specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan settlements not specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(739)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer&#8217;s contributions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(426)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(458)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(469)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation and transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(326)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value of plan assets at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,899</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,651</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,358</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net obligation</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,752&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,098&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,770</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,539</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,099</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amounts recognized in the balance sheet:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pre-funded obligations (see Note D.7.)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(408)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(177)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Obligations provided for</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount recognized at end of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,770</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,539</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,099</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit cost for the period:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in&#160;the&#160;terms&#160;of the plan</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(199)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest (income)/cost</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Administration costs and taxes paid during the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense recognized directly in profit or loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">168</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">276</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">84</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(685)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(482)</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(409)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">350</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;These amounts include the impact of applying the April&#160;2021 IFRIC agenda decision on the attribution of benefits to periods of service.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For 2020, this line mainly comprises a reduction in post-employment benefit liabilities following the announcement of voluntary redundancy programs, primarily in Europe.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;For 2022, this line includes &#8364;99&#160;million of assets in the United Kingdom (versus &#8364;220&#160;million for 2021); those amounts are not subject to any asset ceiling, in accordance with IFRIC&#160;14.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Amounts recognized in Other comprehensive income (see Note&#160;D.15.7.).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock', window );">Net Liability in Respect of Pension Plans and Other Post-employment Benefits by Geographical Region</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show Sanofi&#8217;s net liability in respect of pension plans and other post-employment benefits by geographical region:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:25.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Measurement of obligation</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,730&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,080&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,651&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,317&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,899&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">627</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">413</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">686</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(95)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">139</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,770</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:25.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Measurement of obligation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,576&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,414&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,175&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,808&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,629&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,249&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,651&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">819</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">768</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">972</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(215)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">195</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,539</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:25.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Measurement of obligation</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,580&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,091&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,561&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,456&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,661&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,536&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of asset ceiling</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amount shown in the balance sheet at end of period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">872</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">919</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,014</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">269</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,099</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory', window );">Fair Value of Plans Assets relating to Pension Plans and Other Post-employment Plans</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the fair value of plan assets relating to Sanofi&#8217;s pension and other post-employment plans, split by asset category:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Securities quoted in an active market</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">84.4</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">86.9</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">94.8</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity instruments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bonds and similar instruments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commodities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15.6</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.1</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.2</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hedge funds</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Insurance policies</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock', window );">Service Cost for Pension and Other post-employment Benefit Plans, by Geographical Region</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The tables below show the service cost for Sanofi&#8217;s pension and other post-employment benefit plans, by geographical region:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Service cost for 2022</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost/(income) including administration costs and taxes paid during the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) recognized directly in profit or loss</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">53</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">81</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">168</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(145)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(151)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(301)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">117</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(482)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Service cost for 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost/(income) including administration costs and taxes paid during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) recognized directly in profit or loss</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">80</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">52</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">84</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">54</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">276</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(106)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(113)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(157)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(236)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(73)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(685)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(26)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(61)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(73)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(230)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(19)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(409)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Service cost for 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current service cost</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(87)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(123)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(199)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost/(income) including administration costs and taxes paid during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from plan members</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) recognized directly in profit or loss</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(15)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">72</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(38)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">60</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">84</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expense/(gain) for the period</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">193</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(16)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">120</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">45</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">350</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock', window );">Remeasurement of Net Defined-benefit (Asset)/Liability (Actuarial Gains and Losses)</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of the &#8220;Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)&#8221; line in the preceding tables is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:19.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.108%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.335%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.421%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.421%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.108%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.421%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.574%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.421%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.429%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial gains/(losses) arising during the period</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(121)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(115)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprising:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) </span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">on experience adjustments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,328)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) <br/>on demographic assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) <br/>on financial assumptions</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(69)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(60)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(197)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(194)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(442)</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Experience adjustments are mainly due to the effect of trends in the financial markets on plan assets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock', window );">Summary of Net Pre-tax Actuarial Loss</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The net pre-tax actuarial loss (excluding investments accounted for using the equity method) recognized directly in equity is presented below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net pre-tax actuarial loss</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,090)</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,738)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,423)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock', window );">Summary of Present Value of Pension and Other Post Employement Benefits</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The present value of Sanofi&#8217;s obligations in respect of pension and other post-employment benefit plans at the end of each reporting period is shown below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Present value of wholly or partially funded obligations in respect of pension and other post-employment benefit plans</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,463&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,416&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,734&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Present value of unfunded obligations</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,651</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,175</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,456</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock', window );">Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement Line Items</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The total expense for pensions and other post-employment benefits (&#8364;168 million in 2022) is allocated between income statement line items as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating (income)/expenses, net</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(140)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">168</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">276</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">84</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock', window );">Estimated Amounts of Employer's Contributions to Plan Assets</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The estimated amounts of employer&#8217;s contributions to plan assets in 2023 are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employer&#8217;s contributions in 2023 (estimate):</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock', window );">Expected Timing of Benefit Payments under Pension and Other Post-employment Benefit Plans</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the expected timing of benefit payments under pension and other post-employment benefit plans for future years:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.337%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.163%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">France</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">UK</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated future benefit payments</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2028 to 2032</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,135&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">784&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock', window );">Timing of Future Payments in Respect of Unfunded Pension and Other Post-employment Benefit Plans</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows estimates as of December 31, 2022 for the timing of future payments in respect of unfunded pension and other post-employment benefit plans:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than 1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to <br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to <br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated payments</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfRestructuringProvisionsTableTextBlock', window );">Movements in Restructuring Provisions Classified in Non-current and Current Liabilities</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows movements in restructuring provisions classified in non-current and current liabilities:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,118</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,499</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,390</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in non-current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in provisions recognized in profit or loss for the period</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provisions utilized</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(522)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(571)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(663)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unwinding of discount</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,233</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,118</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,499</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Of which:</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in non-current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Classified in current liabilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Provisions utilized mainly correspond to payments related to employees affected by separation programs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock', window );">Timing of Future Termination Benefit Payments</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The timing of future termination benefit payments is as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit payments by period</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employee termination benefits</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">France</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other countries</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,039</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">374</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">448</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">215</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit payments by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employee termination benefits</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">France</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other countries</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">943</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">476</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">394</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">67</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Benefit payments by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Employee termination benefits</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">France</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other countries</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,260</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">490</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">606</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">142</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock', window );">Summary of Other Provisions</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other provisions</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> include provisions for risks and litigation relating to environmental, tax, commercial and product liability matters.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Environmental risks</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product liability risks, litigation and other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,652&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,374&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,178</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,024</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,975</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock', window );">Current Provisions and Other Current Liabilities</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Current provisions and other current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes payable, other than corporate income taxes</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee-related liabilities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,158&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,042&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring provisions (see Note&#160;D.19.2.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate derivatives (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency derivatives (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity derivatives (see Note&#160;D.20.)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts payable for acquisitions of non-current assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer contract liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,899&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,112&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,021</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,217</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,132</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">See Note&#160;A.5.</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">, &#8220;Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">. The year-on-year change in this item includes revenue of &#8364;85&#160;million recognized in profit or loss during 2022 that was included in the customer contract liabilities balance as of December&#160;31, 2022.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) &#8220;Other current liabilities&#8221; mainly comprises provisions for customer rebates and returns; provisions for discounts and rebates granted to healthcare authorities and governmental programs (see Note&#160;D.23.); and the liability payable at each reporting date under the Monoclonal Antibody Alliance with Regeneron.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value of defined benefit plan assets. [Refer: Plan assets [member]; Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 142<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_142&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 145<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_145&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfActuarialAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Actuarial Assumptions [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfActuarialAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of current provisions and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of estimated amounts of employer's contributions to plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expected timing of payments in respect of unfunded pension and other post employment benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expected timing of payments under pension and other post employment benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expense for pensions and other post employment benefits by income statement line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of future benefit payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of net defined benefit liability assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of net liability in respect of pension plans and other post-employment benefits by geographical region.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfNoncurrentProvisionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of noncurrent provisions explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfNoncurrentProvisionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOtherLongTermProvisionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other long term provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOtherLongTermProvisionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of pension and other post employment benefit expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Pre Tax Actuarial Loss Explanatory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of provisions and other non current liabilities explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of remeasuresment of net defined benefit liability asset by country.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfRestructuringProvisionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of restructuring provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfRestructuringProvisionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of service costs of net defined benefits by country.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of weighted average duration of defined benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442208304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative financial instruments and market risks (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinancialInstrumentsAbstract', window );"><strong>Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock', window );">Summary of Fair Value of Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the fair value of derivative instruments as of December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">assets</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current<br/>assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current<br/>liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current<br/>liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>liabilities</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market value at December 31, 2022 (net)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market value at December 31, 2021 (net)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market value at December 31, 2020 (net)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency derivatives</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(94)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(94)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(209)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">operating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">financial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(216)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(232)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(232)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">206</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">206</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( 232)</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( 94)</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( 326)</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( 120)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">213</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">( 215)</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock', window );">Summary of Operating Currency Hedging Instruments</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows operating currency hedging instruments in place as of December 31, 2022, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.982%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which derivatives designated as<br/>cash flow hedges</span></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which&#160;derivatives&#160;not<br/>eligible&#160;for&#160;hedge&#160;accounting</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which<br/>recognized&#160;in&#160;equity</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,403</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">49</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,403</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">49</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Korean won</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,459</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(27)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,459</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(27)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,047&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,047&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Korean won</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Taiwan dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,862</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows operating currency hedging instruments in place as of December 31, 2021, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.907%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.354%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which derivatives designated as<br/>cash flow hedges</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which&#160;derivatives&#160;not<br/>eligible&#160;for&#160;hedge&#160;accounting</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which<br/>recognized&#160;in&#160;equity</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,912</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,912</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">665&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">665&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">199&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">199&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Taiwan dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,374</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,374</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">833&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">833&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Hungarian forint</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Russian rouble</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,286</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8211;</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,286</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows operating currency hedging instruments in place as of December 31, 2020, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:20.339%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.921%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which derivatives<br/>designated&#160;as&#160;cash&#160;flow&#160;hedges</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which&#160;derivatives&#160;not</span></div><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">eligible&#160;for&#160;hedge&#160;accounting </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of&#160;which<br/>recognized<br/>in&#160;equity</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,477</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,477</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Mexican peso</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,932</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,932</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">580&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">580&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">571&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">571&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Russian rouble</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,409</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,409</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock', window );">Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows financial currency hedging instruments in place, with the notional amount translated into euros at the relevant closing exchange rate:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:22.942%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.249%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,559</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">66</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,655</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,064</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">6,114&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(a)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">5,384&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">3,721&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Pound sterling</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">257&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Chinese yuan renminbi</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Forward currency purchases</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,997</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,293</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">197</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,004</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(226)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which US dollar</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,011&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(b) (c)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">4,816&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">128&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">6,068&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(200)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Singapore dollar</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(d)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(27)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which Japanese yen</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,556</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">90</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16,948</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">212</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,068</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(216)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes forward sales with a notional amount of $3,615 million expiring in 2023, designated as a hedge of Sanofi&#8217;s net investment in Bioverativ. As of December 31, 2022, the fair value of these forward contracts represented an asset of &#8364;38 million; the opposite entry was recognized in "Other comprehensive income", with the impact on financial income and expense being immaterial.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Includes forward purchases with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of $1,000 million of bond issues to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of &#8364;3 million, the opposite entry for &#8364;0.6&#160;million of which was debited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting treatment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Includes receiver currency swaps with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the swaps was a liability of &#8364;2 million, the opposite entry for &#8364;1.4&#160;million of which was credited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting treatment.</span></div>(d) Includes forward purchases with a notional amount of SGD1,500 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/SGD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of&#160;&#8364;33 million, the opposite entry for &#8364;2.5&#160;million of which was credited to &#8220;Other comprehensive income&#8221; under the cost of hedging accounting treatment<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock', window );">Disclosure of Instruments</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows interest rate hedging instruments in place as of December 31, 2022:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:17.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amounts by expiry date as of December 31, 2022</span></td><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="6" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>designated as<br/>fair value<br/>hedges</span></td><td colspan="9" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which designated as<br/>cash flow hedges</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028 and later</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>recognized<br/>in equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive 1.03%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive 1.32%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized Ester/receive 0.69%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized Ester/receive 0.92%</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">850</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,584</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,434</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(232)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,434</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(232)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows interest rate hedging instruments in place as of December 31, 2021:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:17.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amounts by expiry date as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>designated as<br/>fair value<br/>hedges</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which designated as<br/>cash flow hedges</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027 and later</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>recognized<br/>in equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized EONIA/receive 0.06%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay -0.57%/receive capitalized EONIA</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive 1.03%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay SOFR USD/receive 1.32%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">receive capitalized EONIA/pay 1.48%</span><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,642</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">57</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">880</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,579</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,979</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">600</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These interest rate swaps hedge fixed-rate bonds with a nominal of &#8364;99 million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within &#8220;Loans, advances and other long-term receivables&#8221; (see Note D.7.).</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows interest rate hedging instruments in place as of December 31, 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:17.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amounts by expiry date as of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>designated as<br/>fair value<br/>hedges</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which designated as<br/>cash flow hedges</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026 and later</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional<br/>amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Of which<br/>recognized<br/>in equity</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay capitalized EONIA/receive 0.06%</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">pay -0.57%/receive capitalized EONIA</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">receive capitalized Eonia/pay 1.48%</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,642</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">57</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,699</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,099</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">600</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) These interest rate swaps hedge fixed-rate bonds with a nominal of &#8364;99 million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within &#8220;Loans, advances and other long-term receivables&#8221; (see Note D.7.).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock', window );">Disclosure of Actual or Potential Effects of Netting Arrangements</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below is prepared in accordance with the accounting policies described in Note&#160;B.8.3.:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:31.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.081%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:26pt"><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>assets</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>assets</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative<br/>financial<br/>liabilities</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross carrying amounts before offset (a)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(85)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(297)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross amounts offset (in accordance with IAS&#160;32)&#160;(b)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net amounts as reported in the balance sheet (a) -&#160;(b) =&#160;(c)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">206</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(326)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">298</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(85)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">82</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(297)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effects of other netting arrangements (not fulfilling the IAS&#160;32 criteria for offsetting) (d)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial instruments</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(67)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of financial collateral</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net exposure (c) + (d)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">46</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(166)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">231</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(216)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of actual or potential effects of netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of fair value of derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial currency hedging instruments with notional amount translated in to euros at closing exchange rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of interest rates hedging instruments with notional amount by expiry date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating currency hedging instruments with notional amount translated in to euros at closing exchange rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456185008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Off balance sheet commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract', window );"><strong>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock', window );">Summary of Off Balance Sheet Commitments Relating to Operating Activities</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Off balance sheet commitments relating to Sanofi&#8217;s operating activities comprise the following:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:48.364%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.008%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Irrevocable purchase commitments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">given</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,921&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,957&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">980&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">received</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,025)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(482)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(335)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(86)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(122)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development license agreements - commitments given</span></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">commitments related to R&amp;D and other commitments</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">contingent milestone payments in connection with development programs in progress</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total - net commitments given</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,112</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,901</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,505</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,878</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,828</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the variable portion of future lease payments not recognized as lease liabilities as of December 31, 2022; the equivalent amount of these commitments as of December&#160;31, 2021 was &#8364;109&#160;million.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) These comprise irrevocable commitments to suppliers of (i)&#160;property, plant and equipment, net of down-payments (see Note&#160;D.3.) and (ii)&#160;goods and services. As of December 31, 2021, irrevocable commitments amounted to &#8364;8,901 million given and &#8364;1,124 million received.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Irrevocable purchase commitments given as of December 31, 2022 include &#8364;871 million of commitments to joint ventures, and the commitment to EUROAPI as described in Note&#160;D.1.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) Commitments related to R&amp;D, and other commitments, amounted to &#8364;536 million as of December 31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) This line includes only contingent milestone payments on development projects in progress. The equivalent amount as of December 31, 2021 was &#8364;2,892 million.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock', window );">Summary of Undrawn Credit Facilities</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Undrawn credit facilities are as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:37.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiry</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less&#160;than<br/>1&#160;year</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1&#160;to<br/>3&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3&#160;to<br/>5&#160;years</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">More&#160;than<br/>5&#160;years</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">General-purpose credit facilities</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock', window );">Summary of Amount of Guarantees Given and Received</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the amount of guarantees given and received:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Guarantees given:</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,815</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,794</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,291</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Guarantees provided to banks in connection with credit facilities</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Other guarantees given</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,808&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Guarantees received</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,229)</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,149)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(964)</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of guarantees given and received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of off balance sheet commitments relating to operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of undrawn borrowing facilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439467168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions for discounts, rebates and sales returns (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract', window );"><strong>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock', window );">Summary of Movement in Provisions for Discounts, Rebates and Sales Returns</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows movements in these items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:28.149%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Government</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and State</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">programs</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Managed&#160;care</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and&#160;GPO</span></div><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">programs</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Chargeback<br/>incentives</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rebates<br/>and<br/>discounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sales<br/>returns</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>deductions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,178</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">726</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">312</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,330</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">621</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,218</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision related to current period sales</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,970&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,633&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,221&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20,314&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in provision related to prior period sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(54)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(113)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(201)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,552)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,556)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,604)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,838)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(512)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(112)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(19,174)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(118)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,507</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">908</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">333</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,557</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">688</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">46</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,039</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in scope of consolidation</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision related to current period sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,855&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,813&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,330&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in provision related to prior period sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(136)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(152)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(242)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,561)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,979)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,828)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,291)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(697)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(105)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(19,461)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(72)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(32)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,596</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">931</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">303</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,425</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">610</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,899</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provision related to current period sales</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,744&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,244&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22,141&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in provision related to prior period sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(120)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(138)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(315)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,824)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,208)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,093)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,809)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(599)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(166)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21,699)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance&#160;at December 31, 2022</span></td><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,603</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,021</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">362</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,805</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">629</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">70</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,490</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Primarily US government programs: Medicaid (&#8364;1,307 million in 2022, &#8364;1,244 million in 2021, &#8364;1,015 million in 2020) and Medicare (&#8364;775 million in 2022, &#8364;941 million in 2021 and &#8364;726 million in 2020).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Mainly rebates and other price reductions granted to healthcare authorities in the United States (including Managed Care: &#8364;934 million in 2022, &#8364;896 million in 2021 and &#8364;692 million in 2020).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Provisions related to US net sales amounted to &#8364;4,270 million as of December 31, 2022, &#8364;4,057 million as of December 31, 2021 and &#8364;3,982 million as of&#160;December 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of changes in provisions for discounts rebates and sales returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439401280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Personnel costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EmployeeBenefitsAbstract', window );"><strong>Employee Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock', window );">Summary of Personal Costs</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Total personnel costs (other than termination benefits, presented in Note&#160;D.27.) include the following items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Salaries</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,145&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,625&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,508&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Social security charges (including defined-contribution pension plans)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,098&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock options and other share-based payment expense</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Defined-benefit plans</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other employee benefits</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,991</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,340</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,079</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfPersonnelCostsDetailsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of personnel costs details.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfPersonnelCostsDetailsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EmployeeBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Benefits [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EmployeeBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439498480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other operating expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherOperatingExpensesTableTextBlock', window );">Schedule Other Operating Expenses</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For 2022, this line item includes &#8364;2,378 million of expenses relating to the alliance with Regeneron (see Note&#160;C.1.), compared with&#160;&#8364;1,568 million for 2021 and &#8364;1,090 million for 2020 (as shown in the table below):</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income &amp; expense related to sharing of (profits)/losses under the Monoclonal Antibody Alliance</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,325)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,253)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(727)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional share of profit paid by Regeneron towards development costs </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reimbursement to Regeneron of selling expenses incurred</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(476)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(303)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(349)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total - Monoclonal Antibody Alliance</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,367)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,429)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,001)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Immuno-Oncology Alliance</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">68</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">89</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other (mainly Zaltrap</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"> and Libtayo</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">)</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,120</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(12)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other operating income/(expenses), net related to the Regeneron Alliance</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,231)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,373)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(926)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which amount presented in</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"> Other operating income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"> (Note&#160;D.25.)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">195&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">164&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Following the restructuring of the Immuno-Oncology agreement between Sanofi and Regeneron, applicable from July&#160;1, 2022 (see Note&#160;C.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) As of December 31, 2022, the commitment received by Sanofi in respect of the additional profit share payable by Regeneron towards development costs amounted to &#8364;2.7 billion, compared with &#8364;2.9&#160;billion as of December 31, 2021 (see note D.21).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherOperatingExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Operating Expenses [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherOperatingExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456197680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring costs and similar items (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock', window );">Summary of Restructuring Costs and Similar Items</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Restructuring costs and similar items amounted to &#8364;1,336 million in 2022, &#8364;820 million in 2021 and &#8364;1,089 million in 2020, and were comprised of the following items:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:59.696%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee-related expenses</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Charges, gains or losses on assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Compensation for early termination of contracts (other than contracts of employment)</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transformation programs costs</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,336</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">820</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,089</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;This line consists of impairment losses and accelerated depreciation charges related to site closures (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of restructuring costs details.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfRestructuringCostsDetailsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439461472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial expenses and income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock', window );">Summary of Analysis of Financial Income and Expenses</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">An analysis of </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial expenses</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Financial income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> is set forth below:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:57.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of debt</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(313)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(328)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest income</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cost of net debt</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(124)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(259)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(225)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-operating foreign exchange gains/(losses)</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unwinding of discounting of provisions</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest cost related to employee benefits</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(44)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(57)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gains/(losses) on disposals of financial assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net interest expense on lease liabilities</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net financial income/(expenses)</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(234)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(328)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(335)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">comprising: Financial expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(440)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(368)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(388)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial income</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">206</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">40</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">53</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Includes net gains/(losses) on interest rate and currency derivatives used to manage debt: &#8364;(11) million in 2022, &#8364;14 million in 2021, &#8364;93 million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Includes net gains on interest rate and currency derivatives used to manage cash and cash equivalents: &#8364;68 million in 2022, &#8364;51 million in 2021, &#8364;66 million in 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note&#160;D.19.).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial income and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435567152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock', window );">Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the allocation of income tax expense between current and deferred taxes:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:57.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current taxes</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,774)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,908)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,913)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,006)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,558)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,807)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income before tax and investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,422</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,798</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#23004c;padding:0 1pt"/><td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,778</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#23004c;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock', window );">Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the standard corporate income tax rate applicable in France is explained as follows:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(as a percentage)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Standard tax rate applicable in France</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Difference between the standard French tax rate and the rates applicable to Sanofi</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Revisions to tax exposures and settlements of tax disputes</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other items</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.2</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.1</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France. For 2020, this line includes the difference between the standard French tax rate and the tax rate applicable to the gain on divestment of Regeneron shares.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) In determining the amount of the deferred tax liability for 2022, 2021 and 2020, Sanofi took into account changes in the ownership structure of certain subsidiaries.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of allocation of income tax between current and deferred taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of average effective tax rate and applicable tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439520896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net income attributable to non-controlling interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock', window );">Summary of Trends in Net Income Attributable to Non-Controlling Interests</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows </span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net income attributable to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> for the reporting periods presented:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of net income attributable to other non-controlling interests</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">113</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">56</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Information About The Amounts Attributable To Non Controlling Interests Explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441821392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RelatedPartyAbstract', window );"><strong>Related Party [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock', window );">Schedule of Compensation Paid to Key Management Personnel</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows, by type, the compensation paid to key management personnel:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:57.552%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Short-term benefits</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Post-employment benefits</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based payment</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in profit or loss</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">52</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">55</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">57</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#7802e6;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Compensation, employer&#8217;s social security contributions, directors&#8217; attendance fees, and any termination benefits (net of reversals of termination benefit obligations).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory', window );">Summary of Aggregate Amounts Payable to Key Management Personnel</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows the aggregate obligation as of December&#160;31 for each period presented for individuals who hold or have held executive positions within Sanofi during that period.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:60.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate top-up pension obligation in favor of certain corporate officers and of Executive Committee members</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate termination benefits and lump-sum retirement benefits in favor of key management personnel</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18A&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of compensation paid to key management personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456237072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OperatingSegmentsAbstract', window );"><strong>Operating Segments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock', window );">Summary of Net Sales by Segment and Geographical Area</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below sets forth Sanofi&#8217;s net sales for the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:7.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.491%"/><td style="width:0.1%"/></tr><tr style="height:8pt"><td colspan="6" rowspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.5pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Other<br/>countries</span></td><td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</span></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Other<br/>countries</span></td><td colspan="3" rowspan="2" style="border-right:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</span></div></td><td colspan="3" rowspan="2" style="border-left:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Other<br/>countries</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2020</span></div></td></tr><tr style="height:9pt"><td colspan="42" style="display:none"/></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,157</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,694</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,837</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,688</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,201</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,484</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,285</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26,970</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,819</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,635</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,220</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25,674</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Dupixent</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.22pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">940</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,346</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,007</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,293</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">649</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,971</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">629</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,249</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">386</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,808</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">340</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,534</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Neurology &amp; Immunology</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">639</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,637</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">174</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,450</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">638</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,482</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">204</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,324</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">578</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,631</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">185</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,394</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Aubagio</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,420&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,031&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,955&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,448&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Rare Diseases</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,104</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,367</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">974</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,445</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,069</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,142</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">915</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,126</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,010</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,122</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">879</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,011</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cerezyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Fabrazyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Myozyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">/</span></div><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lumizyme</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Oncology</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">239</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">515</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">198</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">952</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">327</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">410</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">175</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">912</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">299</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">368</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">131</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">798</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Jevtana</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Rare Blood Disorders</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">94</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">983</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">240</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,317</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">81</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">842</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">218</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,141</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">837</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">339</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,217</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Alprolix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Eloctate</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Core Assets</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,917</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,653</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,819</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,389</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,868</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,315</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,585</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,768</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,759</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,413</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,409</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,581</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lovenox</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Toujeo</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Plavix</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Non-Core Assets</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,637</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,176</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,409</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,222</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,846</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,281</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,515</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,642</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,088</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,389</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,849</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,326</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Lantus</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,076&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,494&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,661&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Other non-core assets</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4,485&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4,729&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,451&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">5,111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Industrial sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">587</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">620</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">723</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">808</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">658</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">67</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">88</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">813</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,341</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,291</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,597</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,229</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,225</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,762</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,336</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,323</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">973</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,759</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,241</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,973</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Polio/Pertussis/<br/>Hib Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,383&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,159&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,106&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Influenza Vaccines</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,977&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,628&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,575&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer Healthcare</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,501</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,290</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,289</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,080</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,333</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,139</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,996</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,468</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,359</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,071</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,964</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,394</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%">of which</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Allergy</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Pain Care</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Digestive Wellness</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,999</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,275</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,723</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,997</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,759</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,385</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,617</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,761</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;border-left:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,151</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,465</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,425</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36,041</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160; For the Consumer Healthcare GBU, Sanofi has since 2021 adopted a more granular presentation by introducing new sub-categories that reflect consumer trends and the strengths and opportunities of the portfolio.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Schedule of Segment Results</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows Sanofi&#8217;s segment results for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:35.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Sanofi</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,688</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,229</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,080</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,997</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,666&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,511)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,101)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,827)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,692)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,067)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(936)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(516)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,706)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,923)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(870)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,478)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,221)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,492)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income and expenses</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,514)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,043</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,168</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,810</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,981)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,040</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">a) This caption reconciles segment financial information to total consolidated financial information.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:35.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Sanofi</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26,970</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,323</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,468</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,761</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,095&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,965)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,430)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(250)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,251)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,330)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(712)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(497)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,692)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,326)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,388)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,036)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,555)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income and expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,172)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(946)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(49)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,409</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,609</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,493</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,797)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,714</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">This caption reconciles segment financial information to total consolidated financial information.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:36.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.460%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Sanofi</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25,674</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,973</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,394</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36,041</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,982)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,312)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,528)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,106)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,171)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(682)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(524)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,530)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,927)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(789)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,419)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,256)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,391)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income and expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(487)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(561)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,207</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,336</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,410</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,194)</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,759</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">2020 figures have been adjusted to take account of the reallocation of certain expenses (in particular IT costs related to Sanofi&#8217;s new digital organization) from the Pharmaceuticals, Vaccines and Consumer Healthcare operating segments to the &#8220;Other&#8221; segment.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) This caption reconciles segment financial information to total consolidated financial information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock', window );">Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below, presented in compliance with IFRS&#160;8, shows a reconciliation between aggregated &#8220;Business operating income&#8221; for the segments and</span><span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"> Income before tax and investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.676%"><tr><td style="width:1.0%"/><td style="width:58.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.439%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.152%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(h)</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,040</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,714</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,759</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit/(loss) from investments accounted for using the equity method</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization and impairment of intangible assets </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,599)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,011)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expenses arising from the impact of acquisitions on inventories</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(53)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,336)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(820)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,089)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other gains and losses, and litigation</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gain on divestment of Regeneron shares on May&#160;29, 2020</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,225&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income from out-licensing</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,656</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,126</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,113</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial expenses</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(368)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(388)</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income before tax and investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,422</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,798</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,778</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Excludes restructuring costs relating to investments accounted for using the equity method and expenses arising from the impact of acquisitions on investments accounted for using the equity method. For the first two quarters of 2020, this line has been restated to exclude any effect of equity method accounting for the investment in Regeneron following the divestment of Sanofi's entire equity interest (with the exception of the 400,000&#160;shares retained by Sanofi) on May&#160;29, 2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to non-controlling interests.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) For 2022, this line includes a reversal of &#8364;2,154&#160;million on Eloctate franchise products following FDA approval of ALTUVIIIO </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">dated February 22, 2023, partially offset by an impairment of &#8364;1,586&#160;million relating to the development project for SAR444245 (non-alpha interleukin-2).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(d) This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) For 2020, this line mainly comprises the gain on the sale of operations related to the Seprafilm</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> activity to Baxter.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(f) This line includes the gain on the sale of (i)&#160;13&#160;million shares of Regeneron common stock in the registered public offering and (ii)&#160;the 9.8&#160;million shares repurchased by Regeneron, but does not include the gain arising from the remeasurement of the 400,000&#160;retained shares at market value as of&#160;May&#160;29,&#160;2020.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">)&#160;&#160;&#160;&#160;For 2022, this line includes an upfront payment of $900 million and a regulatory milestone payment of $100 million related to the out-licensing of Libtayo</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> following the restructuring of the Immuno-Oncology Collaboration and License Agreement with Regeneron (see Note&#160;C.1.).</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(h) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock', window );">Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Acquisitions of intangible assets and property, plant and equipment correspond to acquisitions paid for during the period.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:48.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investments accounted for using the equity method</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment</span></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of other intangible assets</span></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:48.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investments accounted for using the equity method</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:48.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.613%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharmaceuticals</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consumer<br/>Healthcare</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investments accounted for using the equity method</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory', window );">Summary of Geographical Information on Net Sales and Non-Current Assets</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The geographical information on net sales provided below is based on the geographical location of the customer. In accordance with&#160;IFRS&#160;8, the non-current assets reported below exclude right-of-use assets relating to leases as determined under IFRS&#160;16, investments accounted for using the equity method, other non-current assets, non-current income tax assets, and deferred tax assets.</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:26.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.999%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>France</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">North<br/>America</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>United&#160;States</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>countries</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,997</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,999</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,296</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,984</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,275</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,014</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">property, plant and equipment owned</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,869&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,365&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,875&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,284&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,457&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">goodwill</span></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49,892&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#9642;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:9.29pt">other intangible assets</span></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,640&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,257&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14,178&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:26.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.999%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></div></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">North<br/>America</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>United&#160;States</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>countries</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,761</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,759</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,256</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15,075</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,385</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,927</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">property, plant and equipment owned</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,959&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,998&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">goodwill</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48,056&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21,407&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,059&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,187&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:26.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.999%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></div></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>France</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">North<br/>America</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of&#160;which<br/>United&#160;States</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>countries</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></div></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36,041</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,151</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,223</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,060</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,465</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,830</span><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">property, plant and equipment owned</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,365&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,895&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,542&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">goodwill</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44,364&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.34pt;text-indent:-11.34pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">other intangible assets</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,341&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,208&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,665&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,468&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of geographical information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of acquisitions of property plant and equipment and other intangible assets and carrying amount of investments in associates and joint ventures by operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of net sales by segment and geographical area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments reconciling items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Segments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405438672720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal accountants' fees and services (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AuditorsRemunerationTableTextBlock', window );">Disclosure of Accountants' Fees and Services</a></td>
<td class="text">The table below shows fees charged by those firms and member firms of their networks to Sanofi and consolidated subsidiaries in the years ended December 31, 2022 and 2021.<div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><tr><td style="width:1.0%"/><td style="width:29.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ernst&#160;&amp;&#160;Young</span></td><td colspan="12" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PricewaterhouseCoopers</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Audit:</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> Statutory audit of separate and consolidated financial statements</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Services other than statutory audit</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Audit-related services</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16.0</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16.9</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.6</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.2</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a) Includes services provided by the independent auditors of the parent company and French subsidiaries: Ernst&#160;&amp; Young &#8364;7.3 million in 2022, &#8364;7.2 million in&#160;2021; PricewaterhouseCoopers &#8364;7.7 million in 2022, &#8364;7.7 million in 2021.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(b) Services other than statutory audit provided by Ernst&#160;&amp; Young et Autres during 2022 comprised:</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - work on share capital transactions and securities issues submitted to the Annual General Meeting (in extraordinary business) for approval;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - additional procedures to enable reports previously signed by the firm to be incorporated by reference;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - agreed-upon and audit procedures in connection with a proposed divestment; and</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - issuance of the Independent third party&#8217;s report on the consolidated statement of extra-financial performance.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      Services other than statutory audit provided by PricewaterhouseCoopers Audit during 2022 comprised:</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - work on share capital transactions and securities issues submitted to the Annual General Meeting (in extraordinary business) for approval;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - additional procedures to enable reports previously signed by the firm to be incorporated by reference;</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">      - contractual audits, assurance engagements, agreed-upon procedures, tax compliance work, and technical consultancy.</span></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(c) Includes services provided by the independent auditors of the parent company and French subsidiaries: Ernst&#160;&amp; Young: &#8364;1.4 million in 2022, &#8364;2.7 million in&#160;2021; PricewaterhouseCoopers &#8364;0.3 million in 2022, &#8364;0.3 million in 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AuditorsRemunerationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditors remuneration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AuditorsRemunerationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439253408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>List of principal companies included in the scope of consolidation during&#160;2022 (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestsInOtherEntitiesAbstract', window );"><strong>Interests In Other Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory', window );">Summary of Principal Companies and their Country of Incorporation</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The table below shows Sanofi's principal subsidiaries and their country of incorporation:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:60.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hoechst GmbH</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Deutschland GmbH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">A. Nattermann &amp; Cie. GmbH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis GmbH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Belgium</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ablynx N.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Flanders BVBA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi A/S</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Spain, S.L.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Oy</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis France</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Winthrop Industrie</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Recherche &amp; D&#233;veloppement</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Groupe</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Chimie</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Participations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Biotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Mature IP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur NVL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Europe</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SECIPE SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Merieux S.A.S.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi 2015 D SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare International SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare France SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Group SAS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis A.E.B.E.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Greece</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Private Co, Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chinoin Private Co. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Hungary Commercial K.F.T</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Carraig Insurance DAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Ireland Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Holdings (Ireland) Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi S.R.L.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Italy S.R.L.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Global Sarl</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Luxembourg Sarl</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Norge AS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Norway</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Europe B.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Foreign Participations B.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Sp. z.o.o.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Poland sp.Z.O.O</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Sp. z.o.o.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Produtos Farmaceuticos Lda</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Portugal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis, s.r.o.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Czech s.r.o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Romania SRL</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:60.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Romania S.R.L.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis UK Holdings Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Synthelabo UK Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma Holdings Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare UK Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">AO Sanofi Russia</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi AB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis (Suisse) SA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Global Sarl Baar Intellectual Property Branch</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Ilac Sanayi ve Ticaret A.S.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Asi Ticaret A.S.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Saglik Urunleri Limited Sirketi</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:60.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Therapeutic Products Limited Partnership</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi US Services Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis U.S. LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chattem, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventisub LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme Corporation</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">VaxServe, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ U.S. LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Bioverativ Therapeutics Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Principia Biopharma Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Research Invest LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Bioverativ Holdings LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RPR US Ltd.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kadmon Holdings, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kadmon Corporation, LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United&#160;States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amunix</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Synthorx, Inc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Translate Bio, Inc</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:57.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Countries</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis South Africa (Pty) Ltd</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Africa</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Alg&#233;rie</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Algeria</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Arabia Trading Company Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Saudi Arabia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Argentina S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genzyme de Argentina S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Argentina S.A.U.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Healthcare Pty Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Australia Pty Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Medley Farmaceutica Ltda</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Canada Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Merieux Canada Holdings ULC (Canada)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Chile S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi (Hangzhou) Pharmaceuticals Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi (China) Investment Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi (Beijing) Pharmaceuticals Co.Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Biologies Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shenzhen Sanofi pasteur Biological Products Co, Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shanghai Rongheng Pharmaceutical Co, Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Genfar S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Colombia S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Korea Co. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella healthcare Korea Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Gulf FZE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United Arab Emirates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Egypt</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Egypt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Egypt LLC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Egypt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Hong-Kong Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi India Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">India</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Healthcare India Private Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">India</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Isra&#235;l Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi K.K.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SSP Co.,Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis (Malaysia) SDN. BHD.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Malaysia</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Maroc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Morocco</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Mexico S.A. de C.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Pasteur S.A. de C.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Azteca Vacunas, S.A. de C.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Pakistan Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pakistan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Panama S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Panama</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis del Peru S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Peru</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Puerto Rico Inc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Philippines Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella Healthcare Philippines Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Singapore Pte. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aventis Pharma (Manufacturing) Pte. Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Manufacturing Pte Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Taiwan Co., Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis (Thailand) Ltd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis de Venezuela S.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Venezuela</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi-Aventis Vietnam Company Limited</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vietnam</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi Vietnam Shareholding Company Limited</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vietnam</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85.0&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock', window );">Summary of Principal Investments Accounted for Using the Equity Method</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"><tr><td style="width:1.0%"/><td style="width:62.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.214%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial interest (%) as of December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">GlaxoSmithKline Consumer Healthcare, L.P.</span></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maphar</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Morocco</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MCM Vaccine B.V.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MSP Vaccine Company (formerly MCM company)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EUROAPI</span></td><td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of interests in subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 2<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_2_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Investments In Subsidiaries Explanatory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestsInOtherEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interests In Other Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestsInOtherEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455635232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of preparation - Additional Information (Details)<br> vaccine_dose in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>vaccine_dose</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of initial application of standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentContractLiabilities', window );">Current contract liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 264,000,000<span></span>
</td>
<td class="nump">&#8364; 319,000,000<span></span>
</td>
<td class="nump">&#8364; 252,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Contract liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,997,000,000<span></span>
</td>
<td class="nump">37,761,000,000<span></span>
</td>
<td class="nump">&#8364; 36,041,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TypesOfAgreementAxis=sny_CollaborationAgreementWithGSKMember', window );">Collaboration agreement with GSK | US Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of initial application of standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfVaccineDosesToBeSupplied', window );">Number of vaccine doses to be supplied | vaccine_dose</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses', window );">Government grant recognised as deduction from development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 265,000,000<span></span>
</td>
<td class="nump">147,000,000<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_AR', window );">Argentina</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of initial application of standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears', window );">Cumulative inflation rate over three years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_TR', window );">Turkey</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of initial application of standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears', window );">Cumulative inflation rate over three years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_RU', window );">RUSSIAN FEDERATION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of initial application of standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 674,000,000<span></span>
</td>
<td class="nump">&#8364; 575,000,000<span></span>
</td>
<td class="nump">&#8364; 641,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current contract liabilities. [Refer: Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of the entity's revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CumulativeConsumerPriceInflationOverTheLastThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative consumer price inflation rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CumulativeConsumerPriceInflationOverTheLastThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Grant Recognised As Deduction From Development Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfVaccineDosesToBeSupplied">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Vaccine Doses To Be Supplied</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfVaccineDosesToBeSupplied</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TypesOfAgreementAxis=sny_CollaborationAgreementWithGSKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TypesOfAgreementAxis=sny_CollaborationAgreementWithGSKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_USGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_USGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_TR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_TR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_RU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_RU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456218608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Other Intangible Assets not Acquired in Business Combination (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range | Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range | Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432058768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Summary of Useful Lives of Property Plant and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives or depreciation rates, property, plant and equipment (in years)</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range | Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives or depreciation rates, property, plant and equipment (in years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range | Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives or depreciation rates, property, plant and equipment (in years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range | Other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives or depreciation rates, property, plant and equipment (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives or depreciation rates, property, plant and equipment (in years)</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range | Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives or depreciation rates, property, plant and equipment (in years)</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range | Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives or depreciation rates, property, plant and equipment (in years)</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range | Other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives or depreciation rates, property, plant and equipment (in years)</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431856576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Treasury Shares (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate Information And Statement Of IFRS Compliance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainLossOnPurchaseOfTreasuryShares', window );">Gain (loss) recognized on purchase of treasury shares</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainLossOnSaleOfTreasuryShares', window );">Gain (loss) recognized on sale of treasury shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainLossOnImpairmentOfTreasuryShares', window );">Gain (loss) recognized on impairment of treasury shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainLossOnCancellationOfTreasuryShares', window );">Gain (loss) recognized on cancellation of treasury shares</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Information And Statement Of IFRS Compliance [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainLossOnCancellationOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on cancellation of treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainLossOnCancellationOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainLossOnImpairmentOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on impairment of treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainLossOnImpairmentOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainLossOnPurchaseOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on purchase of treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainLossOnPurchaseOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainLossOnSaleOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on sale of treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainLossOnSaleOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439489936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Provision for Risks (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate Information And Statement Of IFRS Compliance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsRecordedForFutureOperatingLosses', window );">Provisions recorded for future operating losses</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Information And Statement Of IFRS Compliance [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ProvisionsRecordedForFutureOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provisions recorded for future operating losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ProvisionsRecordedForFutureOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435165792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Income Tax Expense (Details) - EUR (&#8364;)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems', window );"><strong>Disclosure Of Detailed Information About Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred tax expense</a></td>
<td class="num">&#8364; (768,000,000)<span></span>
</td>
<td class="num">&#8364; (350,000,000)<span></span>
</td>
<td class="num">&#8364; (106,000,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember', window );">Temporary differences subject to GILTI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems', window );"><strong>Disclosure Of Detailed Information About Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred tax expense</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Income Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435265824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Share-Based Payment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_StockOptionPlansMember', window );">Stock option plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems', window );"><strong>Disclosure Of Detailed Information About Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OptionVestingPeriod', window );">Option vesting period (in years)</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlansMember', window );">Restricted share plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems', window );"><strong>Disclosure Of Detailed Information About Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Share-Based Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OptionVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option vesting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OptionVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_StockOptionPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_StockOptionPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439468224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Segment Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate Information And Statement Of IFRS Compliance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Information And Statement Of IFRS Compliance [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405433945424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal alliances -Collaboration agreements on human therapeutic antibodies (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th">
<div>Jul. 01, 2015 </div>
<div>agreement</div>
</th>
<th class="th">
<div>Nov. 30, 2007 </div>
<div>agreement</div>
</th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Rate</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>bond </div>
<div>Rate</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>bond </div>
<div>Rate</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 42,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 37,761<span></span>
</td>
<td class="nump">&#8364; 36,041<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 18,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 14,385<span></span>
</td>
<td class="nump">&#8364; 13,465<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfAgreementsSigned', window );">Number of agreements signed | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfSecondPartOfDevelopmentCostsFunded', window );">Phase III costs, responsibility percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty', window );">Phase III costs, responsibility percentage for Regeneron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfProfitShareOnCounterpartiesProfit', window );">Maximum additional profit-share, in percentage of Regeneron's quarterly profit (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfCumulativeDevelopmentCostsReimbursed', window );">Percentage of cumulative development costs reimbursed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared', window );">Period before scheduled launch date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPayments', window );">Number of payments | bond</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | Sales of antibodies, first achievement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PaymentRelatedToAttainmentOfGoal', window );">Payment related to attainment of goal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | Sales of antibodies, first achievement | Antibodies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | Sales of antibodies, second achievement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PaymentRelatedToAttainmentOfGoal', window );">Payment related to attainment of goal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | Sales of antibodies, second achievement | Antibodies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | Prior agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfProfitShareOnCounterpartiesProfit', window );">Maximum additional profit-share, in percentage of Regeneron's quarterly profit (in percent) | Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | New agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfProfitShareOnCounterpartiesProfit', window );">Maximum additional profit-share, in percentage of Regeneron's quarterly profit (in percent) | Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | Sales Of Antibodies, Third Achievement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PaymentRelatedToAttainmentOfGoal', window );">Payment related to attainment of goal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | Sales Of Antibodies, Third Achievement | Antibodies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations', window );">Percentage of profits and losses arising from commercial operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | Outside the United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfLossesArisingFromCommercialOperations', window );">Percentage of losses arising from commercial operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RoyaltyExpensePercentage', window );">Royalty expense, percentage (percentage)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | Outside the United States | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfProfitsArisingFromCommercialOperations', window );">Percentage of profits arising from commercial operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement | Outside the United States | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfProfitsArisingFromCommercialOperations', window );">Percentage of profits arising from commercial operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Immuno-oncology collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfAgreementsSigned', window );">Number of agreements signed | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfProfitShareOnCounterpartiesProfit', window );">Maximum additional profit-share, in percentage of Regeneron's quarterly profit (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfCumulativeDevelopmentCostsReimbursed', window );">Percentage of cumulative development costs reimbursed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr><td colspan="12"></td></tr>
<tr><td colspan="12"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about Principal Alliances [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfAgreementsSigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Agreements Signed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfAgreementsSigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PaymentRelatedToAttainmentOfGoal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment Related To Attainment Of Goal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PaymentRelatedToAttainmentOfGoal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfCumulativeDevelopmentCostsReimbursed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of cumulative development costs reimbursed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfCumulativeDevelopmentCostsReimbursed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfLossesArisingFromCommercialOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Losses Arising From Commercial Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfLossesArisingFromCommercialOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfProfitShareOnCounterpartiesProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of profit share on counter parties profit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfProfitShareOnCounterpartiesProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of profits and losses arising from commercial operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfProfitsArisingFromCommercialOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Profits Arising From Commercial Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfProfitsArisingFromCommercialOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfSecondPartOfDevelopmentCostsFunded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Second Part Of Development Costs Funded</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfSecondPartOfDevelopmentCostsFunded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of second part of development costs funded by other party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period Before Launch Date During Which Commercial Expenses Of Antibodies Co-Developed Under License Agreement Are Shared</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RoyaltyExpensePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Expense, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RoyaltyExpensePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TypesOfAgreementAxis=sny_SalesOfAntibodiesFirstAchievementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TypesOfAgreementAxis=sny_SalesOfAntibodiesFirstAchievementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sny_AntibodiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sny_AntibodiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TypesOfAgreementAxis=sny_SalesOfAntibodiesSecondAchievementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TypesOfAgreementAxis=sny_SalesOfAntibodiesSecondAchievementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TypesOfAgreementAxis=sny_PriorAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TypesOfAgreementAxis=sny_PriorAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TypesOfAgreementAxis=sny_NewAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TypesOfAgreementAxis=sny_NewAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TypesOfAgreementAxis=sny_SalesOfAntibodiesThirdAchievementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TypesOfAgreementAxis=sny_SalesOfAntibodiesThirdAchievementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_OutsideUnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_OutsideUnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PrincipalAlliancesAxis=sny_ImmunoOncologyCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PrincipalAlliancesAxis=sny_ImmunoOncologyCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435650192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal alliances - Immuno-Oncology Agreement with Regeneron Pharmaceuticals, Inc. (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2015 </div>
<div>agreement</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPrincipalAlliancesLineItems', window );"><strong>Disclosure of Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating income/(expenses), net related to the Regeneron Alliance | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (1,231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (1,373)<span></span>
</td>
<td class="num">&#8364; (926)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale', window );">Assets held for sale or exchange | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 89<span></span>
</td>
<td class="nump">&#8364; 83<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPrincipalAlliancesLineItems', window );"><strong>Disclosure of Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale', window );">Assets held for sale or exchange | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Immuno-oncology collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPrincipalAlliancesLineItems', window );"><strong>Disclosure of Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfAgreementsSigned', window );">Number of agreements signed | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfProfitShareOnCounterpartiesProfit', window );">Maximum additional profit-share, in percentage of Regeneron's quarterly profit (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfCumulativeDevelopmentCostsReimbursed', window );">Percentage of cumulative development costs reimbursed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements', window );">Upfront payments for projects under collaboration agreements | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements', window );">Regular milestone payments for projects under collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 96<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Immuno-oncology collaboration agreement | Major Collaboration Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPrincipalAlliancesLineItems', window );"><strong>Disclosure of Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements', window );">Upfront payments for projects under collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 856<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RoyaltyIncomePercentage', window );">Royalty income percentage (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating income/(expenses), net related to the Regeneron Alliance | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProceedsFromCollaborationAgreements', window );">Proceeds from collaboration agreements | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Immuno-oncology collaboration agreement | Development of cemiplimab (REGN2810)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPrincipalAlliancesLineItems', window );"><strong>Disclosure of Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PriorDevelopmentBudget', window );">Prior development budget in total | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1', window );">Contractual agreement for anti-programmed cell death protein</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5000.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany', window );">Maximum additional funding for PD1 - part of each company | $</a></td>
<td class="nump">$ 1,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment', window );">PD1 sales milestone payment from Sanofi | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment', window );">Minimum sales of PD1 in 12-month period to be achieved for milestone payment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets or disposal groups classified as held for sale. [Refer: Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 38<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_38&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Anti programmed cell death protein 1 sales milestone payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ContractualAgreementForAntiProgrammedCellDeathProtein1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual Agreement For Anti-programmed Cell Death Protein1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ContractualAgreementForAntiProgrammedCellDeathProtein1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfPrincipalAlliancesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of Principal Alliances [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfPrincipalAlliancesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum additional funding for anti programmed cell death protein 1 part of each company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum sales of anti programmed cell death protein 1 in twelve month period to be achieved for milestone payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfAgreementsSigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Agreements Signed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfAgreementsSigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfCumulativeDevelopmentCostsReimbursed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of cumulative development costs reimbursed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfCumulativeDevelopmentCostsReimbursed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfProfitShareOnCounterpartiesProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of profit share on counter parties profit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfProfitShareOnCounterpartiesProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PriorDevelopmentBudget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prior development budget.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PriorDevelopmentBudget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ProceedsFromCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Collaboration Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ProceedsFromCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regular Milestone Payments For Projects Under Collaboration Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RoyaltyIncomePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Income, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RoyaltyIncomePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront Payments For Projects Under Collaboration Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PrincipalAlliancesAxis=sny_ImmunoOncologyCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PrincipalAlliancesAxis=sny_ImmunoOncologyCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=sny_MajorCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=sny_MajorCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TypesOfAgreementAxis=sny_DevelopmentOfCemiplimabREGN2810Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TypesOfAgreementAxis=sny_DevelopmentOfCemiplimabREGN2810Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455862192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal alliances - Investor Agreement with Regeneron Pharmaceuticals, Inc. (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 29, 2020</div></th>
<th class="th"><div>Jan. 31, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SaleOfStockAxis=sny_PublicOfferingMember', window );">Public offering | Regeneron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | 2014 Amended Investment Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems', window );"><strong>Disclosure of detailed information about Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MaximumOwnershipPercentageAllowedToAcquire', window );">Maximum ownership percentage allowed to acquire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about Principal Alliances [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MaximumOwnershipPercentageAllowedToAcquire">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum ownership percentage allowed to acquire.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MaximumOwnershipPercentageAllowedToAcquire</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Number Of Shares Issued In Transaction, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockAxis=sny_PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockAxis=sny_PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PrincipalAlliancesAxis=sny_TwoThousandFourteenAmendedInvestmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PrincipalAlliancesAxis=sny_TwoThousandFourteenAmendedInvestmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435610832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal alliances - Alliance Arrangements with Bristol-Myers Squibb (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>product</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember', window );">Entities and companies managed by Bristol Mayers Squibb</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPrincipalAlliancesLineItems', window );"><strong>Disclosure of Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="nump">50.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod', window );">Purchase of interests in investments accounted for using equity method</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_BristolMyersSquibbMember', window );">Bristol-Myers Squibb</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfPrincipalAlliancesLineItems', window );"><strong>Disclosure of Principal Alliances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfProductsJointlyDeveloped', window );">Number of leading products jointly developed | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RoyaltiesPaymentsMadeBySanofi', window );">Royalty payment to be paid by Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of interests in investments accounted for using the equity method. [Refer: Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfPrincipalAlliancesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of Principal Alliances [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfPrincipalAlliancesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfProductsJointlyDeveloped">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of products jointly developed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfProductsJointlyDeveloped</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RoyaltiesPaymentsMadeBySanofi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalties payments made by sanofi.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RoyaltiesPaymentsMadeBySanofi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_BristolMyersSquibbMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_BristolMyersSquibbMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431407536">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Principal changes in the scope of consolidation in 2022 - Additional Information (Details)<br> &#8364; / shares in Units, &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 17, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 10, 2022 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th"><div>May 03, 2022</div></th>
<th class="th">
<div>Mar. 17, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Oct. 01, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Feb. 08, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Feb. 08, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 992<span></span>
</td>
<td class="nump">&#8364; 5,594<span></span>
</td>
<td class="nump">&#8364; 5,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,997<span></span>
</td>
<td class="nump">37,761<span></span>
</td>
<td class="nump">36,041<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent', window );">Exceptional supplementary dividends recognised as distributions to owners of parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 677<span></span>
</td>
<td class="nump">&#8364; 677<span></span>
</td>
<td class="nump">677<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherGainsLossesAndLitigation', window );">Other gains, (losses) and litigation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Tax expense (income)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,006)<span></span>
</td>
<td class="num">(1,558)<span></span>
</td>
<td class="num">(1,807)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Disposal of consolidated undertakings and investments accounted for using the equity method, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember', window );">Provision for decommissioning, restoration and rehabilitation costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Other provisions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_RegulatoryComplianceCostsMember', window );">Regulatory compliance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Other provisions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_EquityAttributableToOwnersOfParentMember', window );">Attributable to&#160;equity holders of Sanofi&#160;</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent', window );">Exceptional supplementary dividends recognised as distributions to owners of parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EuroapiMember', window );">EUROAPI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate (in percent)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod', window );">Ownership interest in subsidiary, minimum holding period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 413<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="nump">&#8364; 413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_EuroapiMember', window );">EUROAPI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital', window );">Exceptional supplementary dividend proposed, percentage of share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58000000.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital', window );">Exceptional supplementary dividend, percentage of share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares', window );">Number of shares received (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SpecialDistributionNumberOfSharesConverted', window );">Special Distribution, Number Of Shares Converted | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SpecialDistributionPercentageOfShareCapitalDistributed', window );">Special distribution, percentage of share capital distributed</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets', window );">Decrease through loss of control of subsidiary, net assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill', window );">Decrease through loss of control of subsidiary, intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Weighted average share price (in EUR per share) | &#8364; / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 14.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeLoss', window );">Net foreign exchange loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherGainsLossesAndLitigation', window );">Other gains, (losses) and litigation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Tax expense (income)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Disposal of consolidated undertakings and investments accounted for using the equity method, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_EuroapiMember', window );">EUROAPI | Manufacture and supply collaboration agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CollaborationAgreementPeriodAfterLossOfControl', window );">Collaboration agreement, period after loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CollaborationAgreementAnnualNetSalesTarget', window );">Collaboration agreement, annual net sales target</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CollaborationAgreementCommitmentAmount', window );">Collaboration agreement, commitment amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,100<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">&#8364; 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_EuroapiMember', window );">EUROAPI | EPIC BPIFrance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfVotingEquityInterestsDivested', window );">Percentage of voting equity interests divested</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12000000.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12000000.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ConsiderationTransferredMaximumAmount', window );">Consideration transferred, maximum amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ConsiderationTransferredValuationPeriod', window );">Consideration transferred, valuation period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_AmunixPharmaceuticalsIncMember', window );">Amunix Pharmaceuticals, Inc</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations', window );">Commitments related to milestone payments, business combinations | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossOfAcquiree', window );">Profit (loss) of acquiree since acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="14"></td></tr>
<tr><td colspan="14"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">(f)&#160;&#160;&#160;&#160;This line item includes payments made in respect of contingent consideration identified and recognized as a liability in business combinations. For 2022, it includes the net cash outflow on the acquisition of Amunix (see Note&#160;D.1.). For 2021, it includes the net cash outflows on the acquisitions of Kymab, Kiadis, Tidal, Translate Bio, Kadmon and Origimm (see Note&#160;D.2.1.). For 2020, it includes the net cash outflows on the acquisitions of Synthorx and Principia (see Note&#160;D.2.2.).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">This amount includes the valuation of the shares distributed as a dividend in kind, at a price of &#8364;14.58 per share, as of May&#160;10, 2022 (see note&#160;D.1.).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">(h)&#160;&#160;&#160;&#160;For 2022, this line item includes the net cash inflows (before taxes) of &#8364;101&#160;million on the divestment of EUROAPI (see Note&#160;D.1).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows arising from losing control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in intangible assets and goodwill resulting from the loss of control of a subsidiary. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2021-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provisions other than provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_q_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePrice2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePrice2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CollaborationAgreementAnnualNetSalesTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreement, Annual Net Sales Target</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CollaborationAgreementAnnualNetSalesTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CollaborationAgreementCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreement, Commitment Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CollaborationAgreementCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CollaborationAgreementPeriodAfterLossOfControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreement, Period After Loss Of Control</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CollaborationAgreementPeriodAfterLossOfControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Related To Milestone Payments, Business Combinations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ConsiderationTransferredMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consideration Transferred, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ConsiderationTransferredMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ConsiderationTransferredValuationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consideration Transferred, Valuation Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ConsiderationTransferredValuationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease Through Loss Of Control Of Subsidiary, Net Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExceptionalSupplementaryDividendPercentageOfShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exceptional Supplementary Dividend, Percentage Of Share Capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExceptionalSupplementaryDividendPercentageOfShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exceptional Supplementary Dividend Proposed, Percentage Of Share Capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exceptional Supplementary Dividends Recognised As Distributions To Owners Of Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherGainsLossesAndLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The line item other gains and losses, and litigation includes the impact of material transactions of an unusual nature or amount. [note B.20.2.]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherGainsLossesAndLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ownership Interest In Subsidiary, Minimum Holding Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfVotingEquityInterestsDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Voting Equity Interests Divested</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfVotingEquityInterestsDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SpecialDistributionNumberOfSharesConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Special Distribution, Number Of Shares Converted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SpecialDistributionNumberOfSharesConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SpecialDistributionPercentageOfShareCapitalDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Special Distribution, Percentage Of Share Capital Distributed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SpecialDistributionPercentageOfShareCapitalDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SpecialDistributionSharesReceivedPerConversionOfParentShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Special Distribution, Shares Received Per Conversion Of Parent Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SpecialDistributionSharesReceivedPerConversionOfParentShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_RegulatoryComplianceCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_RegulatoryComplianceCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_EquityAttributableToOwnersOfParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_EquityAttributableToOwnersOfParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EuroapiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EuroapiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_EuroapiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_EuroapiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TypesOfAgreementAxis=sny_ManufactureAndSupplyCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TypesOfAgreementAxis=sny_ManufactureAndSupplyCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_EPICBPIFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_EPICBPIFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_AmunixPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_AmunixPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455528048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Principal changes in the scope of consolidation in 2022 - Summary of Provisional Purchase Price Allocation (Details) - Amunix Pharmaceuticals, Inc<br> &#8364; in Millions</strong></div></th>
<th class="th">
<div>Feb. 08, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate', window );">Other current and non-current assets and liabilities</a></td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash equivalents</a></td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Net deferred tax position</a></td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net assets of Translate Bio</a></td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="nump">609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Purchase price</a></td>
<td class="nump">&#8364; 1,126<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other assets and liabilities as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_AmunixPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_AmunixPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405424275856">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Principal changes in the scope of consolidation in 2021 and 2020 - Additional Information (Details)<br> &#8364; / shares in Units, $ / shares in Units, &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 03, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Nov. 09, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 29, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th">
<div>May 29, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 29, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 14, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 09, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 14, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 14, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 03, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 09, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 09, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 08, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 08, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 02, 2020 </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 28, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 28, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Jun. 23, 2020</div></th>
<th class="th">
<div>May 29, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 23, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jan. 23, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 5,594<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 5,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of share capital owned (in percent)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 677<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">201<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfInvestments', window );">Gain on Regeneron investment arising from transaction of&#160;May&#160;29, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,382<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod', window );">Net proceeds from sale of Regeneron shares on May&#160;29, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,370<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfNoncurrentAssets', window );">Gains on disposal of non-current assets, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets', window );">Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 311<span></span>
</td>
<td class="nump">&#8364; 1,488<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">&#8364; 676<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">&#8364; 918<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_TranslateBioMember', window );">Translate Bio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage', window );">Investments in equity instruments designated at fair value through OCI, ownership percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentFinancialAssetsNumberOfShares', window );">Non-current financial assets, number of shares (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">279,766<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts', window );">Proceeds from sales of investments accounted for using equity method, before transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 10,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfInvestments', window );">Gain on Regeneron investment arising from transaction of&#160;May&#160;29, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SaleOfStockTransactionCosts', window );">Transaction-related costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax', window );">Gains (losses) on remeasuring available-for-sale financial assets, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_StockMarketPricePerShare', window );">Quoted stock market price per share (in USD per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 612.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome', window );">Fair value through other comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxExpenseOnDisposalOfInvestment', window );">Tax expense on disposal of investment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod', window );">Net proceeds from sale of Regeneron shares on May&#160;29, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron | Reserve of exchange differences on translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfInvestments', window );">Gain on Regeneron investment arising from transaction of&#160;May&#160;29, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron | 2018 Letter Agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts', window );">Aggregate number of Regeneron shares that could be sold for cemiplimab and dupilimab funding costs (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement', window );">Sale of stock, number of shares issued in transaction, shares agreement (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">779,320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron | Public offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in USD per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts', window );">Proceeds from sales of investments accounted for using equity method, before transaction costs | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron | Public offering | Sanofi SA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,600,000<span></span>
</td>
<td class="nump">10,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron | Repurchase from the counterpart | Regeneron Pharmaceuticals, INC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in USD per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 509.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts', window );">Proceeds from sales of investments accounted for using equity method, before transaction costs | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares agreement, sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_KymabMember', window );">Kymab</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 136<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">&#8364; 973<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements', window );">Commitments related to milestone payments for projects under collaboration agreements | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 932<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_KiadisMember', window );">Kiadis</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">326<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering', window );">Number of shares included in public offer (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationPurchasePricePerShare', window );">Purchase price (in EUR/USD per share) | &#8364; / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering', window );">Proportion of issued and outstanding share capital tendered into the public offer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_TidalTherapeuticsMember', window );">Tidal Therapeutics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements', window );">Commitments related to milestone payments for projects under collaboration agreements | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">135<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember', window );">Translate Bio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 2,333<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationPurchasePricePerShare', window );">Purchase price (in EUR/USD per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage', window );">Investments in equity instruments designated at fair value through OCI, ownership percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_KadmonMember', window );">Kadmon</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (1,575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationPurchasePricePerShare', window );">Purchase price (in EUR/USD per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis', window );">Estimated purchase price on a fully-diluted basis | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_OrigimmBiotechnologyGmbHMember', window );">Origimm Biotechnology GmbH</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements', window );">Commitments related to milestone payments for projects under collaboration agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_PrincipiaBiopharmaIncMember', window );">Principia</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationPurchasePricePerShare', window );">Purchase price (in EUR/USD per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_SynthorxMember', window );">Synthorx</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessCombinationPurchasePricePerShare', window );">Purchase price (in EUR/USD per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="29"></td></tr>
<tr><td colspan="29"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">(f)&#160;&#160;&#160;&#160;This line item includes payments made in respect of contingent consideration identified and recognized as a liability in business combinations. For 2022, it includes the net cash outflow on the acquisition of Amunix (see Note&#160;D.1.). For 2021, it includes the net cash outflows on the acquisitions of Kymab, Kiadis, Tidal, Translate Bio, Kadmon and Origimm (see Note&#160;D.2.1.). For 2020, it includes the net cash outflows on the acquisitions of Synthorx and Principia (see Note&#160;D.2.2.).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">For 2022, 2021 and 2020, this line item mainly comprises disposals of assets and activities related to portfolio streamlining and disposals of equity and debt instruments.</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> For 2020, it also includes the sale to Baxter of operations relating to Seprafilm</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> for a selling price (before taxes) of &#8364;311&#160;million. </span><span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(see&#160;Note&#160;D.7.1.).</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on remeasuring available-for-sale financial assets, net of tax, before reclassification adjustments. [Refer: Financial assets available-for-sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_91_a&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_20_a_ii&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsOnDisposalsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gain on the disposal of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsOnDisposalsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsOnDisposalsOfNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gain on disposals of non-current assets. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsOnDisposalsOfNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets at fair value through other comprehensive income. [Refer: Financial assets at fair value through other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_8_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the disposal of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of regeneron shares that could be sold for cemiplimab and dupilumab funding costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Percentage Of Voting Interests Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Estimated Purchase Price On A Fully-Diluted Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number Of Shares Included In Public Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Proportion Of Issued And Outstanding Share Capital Tendered Into The Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessCombinationPurchasePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Purchase Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessCombinationPurchasePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Related To Milestone Payments For Projects Under Collaboration Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentFinancialAssetsNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Financial Assets, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentFinancialAssetsNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sales Of Investments Accounted For Using Equity Method, Before Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Number Of Shares Issued In Transaction, Shares Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Number Of Shares Issued In Transaction, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Agreement Sale Of Stock, Number Of Shares Issued In Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_StockMarketPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock market price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_StockMarketPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TaxExpenseOnDisposalOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Expense On Disposal Of Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TaxExpenseOnDisposalOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_TranslateBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_TranslateBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PrincipalAlliancesAxis=sny_TwoThousandEighteenLetterAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PrincipalAlliancesAxis=sny_TwoThousandEighteenLetterAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockAxis=sny_PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockAxis=sny_PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sny_SanofiSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sny_SanofiSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockAxis=sny_RepurchaseFromTheCounterpartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockAxis=sny_RepurchaseFromTheCounterpartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_KymabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_KymabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_KiadisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_KiadisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_TidalTherapeuticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_TidalTherapeuticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_KadmonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_KadmonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_OrigimmBiotechnologyGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_OrigimmBiotechnologyGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_PrincipiaBiopharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_PrincipiaBiopharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_SynthorxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_SynthorxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432786032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Principal changes in the scope of consolidation in 2021 and 2020 - Summary of Purchase Price Allocation (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Sep. 14, 2021</div></th>
<th class="th"><div>Sep. 28, 2020</div></th>
<th class="th"><div>Jan. 23, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember', window );">Translate Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="num">(93)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate', window );">Other current and non-current assets and liabilities</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash equivalents</a></td>
<td class="nump">247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate', window );">Shire contingent consideration liability (see Note&#160;D.18.)</a></td>
<td class="num">(323)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net assets of Translate Bio</a></td>
<td class="nump">462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="nump">2,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PurchasePrice', window );">Purchase price</a></td>
<td class="nump">&#8364; 2,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_PrincipiaBiopharmaIncMember', window );">Principia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(436)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate', window );">Other current and non-current assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net assets of Translate Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PurchasePrice', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_SynthorxMember', window );">Synthorx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(269)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate', window );">Other current and non-current assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net assets of Translate Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">930<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PurchasePrice', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,246<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contingent liabilities recognised as of the acquisition date in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other assets and liabilities as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_PrincipiaBiopharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_PrincipiaBiopharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_SynthorxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_SynthorxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432454576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Schedule of Property, Plant and Equipment (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">&#8364; 10,028<span></span>
</td>
<td class="nump">&#8364; 9,365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions and other increases</a></td>
<td class="nump">1,748<span></span>
</td>
<td class="nump">1,504<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,310<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">9,869<span></span>
</td>
<td class="nump">10,028<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">24,810<span></span>
</td>
<td class="nump">23,169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,568<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="num">(2,104)<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions and other increases</a></td>
<td class="nump">1,748<span></span>
</td>
<td class="nump">1,504<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,310<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="num">(559)<span></span>
</td>
<td class="num">(314)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(487)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="nump">347<span></span>
</td>
<td class="nump">443<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(711)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="num">(318)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(521)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">23,924<span></span>
</td>
<td class="nump">24,810<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation &amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="num">(14,782)<span></span>
</td>
<td class="num">(13,804)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13,851)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="nump">1,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">460<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="num">(138)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">345<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">428<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation expense</a></td>
<td class="num">(1,142)<span></span>
</td>
<td class="num">(1,065)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,143)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment', window );">Impairment losses, net of reversals</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(43)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="num">(14,055)<span></span>
</td>
<td class="num">(14,782)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13,804)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land | Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">255<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions and other increases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">236<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land | Accumulated depreciation &amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment', window );">Impairment losses, net of reversals</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">2,980<span></span>
</td>
<td class="nump">2,930<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">3,103<span></span>
</td>
<td class="nump">2,980<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,930<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings | Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">7,170<span></span>
</td>
<td class="nump">6,828<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,282<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="num">(294)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions and other increases</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="num">(161)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(173)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(264)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(39)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">7,328<span></span>
</td>
<td class="nump">7,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,828<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings | Accumulated depreciation &amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="num">(4,190)<span></span>
</td>
<td class="num">(3,898)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,065)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">168<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">127<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">252<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation expense</a></td>
<td class="num">(356)<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(356)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment', window );">Impairment losses, net of reversals</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="num">(4,225)<span></span>
</td>
<td class="num">(4,190)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,898)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">3,308<span></span>
</td>
<td class="nump">3,335<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">3,211<span></span>
</td>
<td class="nump">3,308<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,335<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_MachineryAndEquipmentMember', window );">Machinery and equipment | Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">11,648<span></span>
</td>
<td class="nump">11,127<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,053<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="num">(1,480)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions and other increases</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="num">(240)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(177)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(276)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">722<span></span>
</td>
<td class="nump">453<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">484<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">10,848<span></span>
</td>
<td class="nump">11,648<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,127<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_MachineryAndEquipmentMember', window );">Machinery and equipment | Accumulated depreciation &amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="num">(8,340)<span></span>
</td>
<td class="num">(7,792)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="nump">1,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">166<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation expense</a></td>
<td class="num">(622)<span></span>
</td>
<td class="num">(592)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(605)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment', window );">Impairment losses, net of reversals</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="num">(7,637)<span></span>
</td>
<td class="num">(8,340)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,792)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures, fittings&#160;and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">543<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">540<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">543<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures, fittings&#160;and other | Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">2,655<span></span>
</td>
<td class="nump">2,524<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,587<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="num">(163)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions and other increases</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">46<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(123)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(67)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">80<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">2,515<span></span>
</td>
<td class="nump">2,655<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,524<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures, fittings&#160;and other | Accumulated depreciation &amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="num">(2,115)<span></span>
</td>
<td class="num">(1,981)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,984)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">117<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">49<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation expense</a></td>
<td class="num">(164)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(182)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment', window );">Impairment losses, net of reversals</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="num">(2,015)<span></span>
</td>
<td class="num">(2,115)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,981)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_PropertyPlantAndEquipmentInProcessMember', window );">Property,&#160;plant and&#160;equipment in process</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">2,969<span></span>
</td>
<td class="nump">2,331<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">2,828<span></span>
</td>
<td class="nump">2,969<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,331<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_PropertyPlantAndEquipmentInProcessMember', window );">Property,&#160;plant and&#160;equipment in process | Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="nump">3,097<span></span>
</td>
<td class="nump">2,454<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,391<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="num">(150)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions and other increases</a></td>
<td class="nump">1,642<span></span>
</td>
<td class="nump">1,404<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,208<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(91)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="num">(1,626)<span></span>
</td>
<td class="num">(839)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,051)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="nump">2,996<span></span>
</td>
<td class="nump">3,097<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,454<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_PropertyPlantAndEquipmentInProcessMember', window );">Property,&#160;plant and&#160;equipment in process | Accumulated depreciation &amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning balance</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(131)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Changes in scope of consolidation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and other decreases</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation differences</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment', window );">Impairment losses, net of reversals</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, ending balance</a></td>
<td class="num">&#8364; (168)<span></span>
</td>
<td class="num">&#8364; (128)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (123)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals and retirements. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised resulting from the write-down of property, plant and equipment to its recoverable amount or reversals of those write-downs. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Scope Of Consolidation Through Business Combinations, Property, Plant And Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_PropertyPlantAndEquipmentInProcessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_PropertyPlantAndEquipmentInProcessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441545696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems', window );"><strong>Disclosure of acquisitions of property plant and equipment by operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions</a></td>
<td class="nump">&#8364; 1,748<span></span>
</td>
<td class="nump">&#8364; 1,504<span></span>
</td>
<td class="nump">&#8364; 1,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestCostsCapitalised', window );">Capitalized interest</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember', window );">Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems', window );"><strong>Disclosure of acquisitions of property plant and equipment by operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions</a></td>
<td class="nump">1,049<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
<td class="nump">831<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember', window );">Pharmaceuticals | Industrial facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems', window );"><strong>Disclosure of acquisitions of property plant and equipment by operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions</a></td>
<td class="nump">597<span></span>
</td>
<td class="nump">534<span></span>
</td>
<td class="nump">634<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember', window );">Pharmaceuticals | Research sites</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems', window );"><strong>Disclosure of acquisitions of property plant and equipment by operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember', window );">Pharmaceuticals | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems', window );"><strong>Disclosure of acquisitions of property plant and equipment by operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_VaccinesMember', window );">Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems', window );"><strong>Disclosure of acquisitions of property plant and equipment by operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="nump">384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareMember', window );">Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems', window );"><strong>Disclosure of acquisitions of property plant and equipment by operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions</a></td>
<td class="nump">&#8364; 70<span></span>
</td>
<td class="nump">&#8364; 73<span></span>
</td>
<td class="nump">&#8364; 95<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestCostsCapitalised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestCostsCapitalised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of acquisitions of property plant and equipment by operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_IndustrialFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_IndustrialFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_ResearchSitesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_ResearchSitesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_VaccinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_VaccinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_ConsumerHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405433933120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Summary of Off Balance Sheet Commitments Relating to Property, Plant and Equipment (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FirmOrdersOfPropertyPlantAndEquipment', window );">Firm orders of property, plant and equipment</a></td>
<td class="nump">&#8364; 861<span></span>
</td>
<td class="nump">&#8364; 769<span></span>
</td>
<td class="nump">&#8364; 708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity', window );">Property, plant and equipment pledged as security for liabilities</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 9<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant and equipment pledged as security for liabilities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 74<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_74_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FirmOrdersOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Firm orders of property plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FirmOrdersOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456333280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Summary of Impairment Losses Recognised in Property, Plant and Equipment (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Net impairment losses on property, plant and equipment</a></td>
<td class="nump">&#8364; 186<span></span>
</td>
<td class="nump">&#8364; 39<span></span>
</td>
<td class="nump">&#8364; 43<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_v&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405424200864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Summary of Property, Plant and Equipment Leased (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>lease</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,948<span></span>
</td>
<td class="nump">&#8364; 1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,815<span></span>
</td>
<td class="nump">1,948<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,815<span></span>
</td>
<td class="nump">1,948<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,181<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,108<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_CambridgeMassachusettsMember', window );">Cambridge, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfLeaseAgreementsSigned', window );">Number of lease agreements signed | lease</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InitialLeaseTerm', window );">Initial lease term</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_OfficeSpaceCambridgeMassachusettsMember', window );">Office space, Cambridge, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_LaboratoryFacilitiesCambridgeMassachusettsMember', window );">Laboratory facilities, Cambridge, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,745<span></span>
</td>
<td class="nump">1,711<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,583<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets', window );">Changes in scope of consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets', window );">Acquisitions and other increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">963<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">340<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets', window );">Disposals and other decreases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(232)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(121)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets', window );">Currency translation differences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(85)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets', window );">Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,872<span></span>
</td>
<td class="nump">2,745<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,711<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,872<span></span>
</td>
<td class="nump">2,745<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,711<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation &amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(797)<span></span>
</td>
<td class="num">(513)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(283)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets', window );">Changes in scope of consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets', window );">Disposals and other decreases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets', window );">Currency translation differences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets', window );">Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation and impairment charged in the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(341)<span></span>
</td>
<td class="num">(315)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(299)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,057)<span></span>
</td>
<td class="num">(797)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(513)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (1,057)<span></span>
</td>
<td class="num">&#8364; (797)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (513)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (283)<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition Through Business Combinations, Property, Plant and Equipment, Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions Other Than Through Business Combinations, Property, Plant and Equipment, Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposals And Retirements, Property, Plant And Equipment, Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through Net Exchange Differences, Property, Plant and Equipment, Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through Transfers, Property, Plant and Equipment, Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InitialLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial Lease Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InitialLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfLeaseAgreementsSigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Lease Agreements Signed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfLeaseAgreementsSigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_CambridgeMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_CambridgeMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_OfficeSpaceCambridgeMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_OfficeSpaceCambridgeMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_LaboratoryFacilitiesCambridgeMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_LaboratoryFacilitiesCambridgeMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441527904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed', window );">Expense relating to short-term leases and low value assets</a></td>
<td class="nump">&#8364; 26<span></span>
</td>
<td class="nump">&#8364; 25<span></span>
</td>
<td class="nump">&#8364; 27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Cash outflow for leases, excluding short-term leases</a></td>
<td class="nump">&#8364; 389<span></span>
</td>
<td class="nump">&#8364; 302<span></span>
</td>
<td class="nump">&#8364; 269<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember', window );">Office and industrial premises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LeasedAssetsPercentage', window );">Leased assets, percentage</a></td>
<td class="nump">93.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember', window );">Vehicle fleet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LeasedAssetsPercentage', window );">Leased assets, percentage</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense Relating To Short-term Leases And Low Value Assets For Which Recognition Exemption Has Been Used</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LeasedAssetsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leased Assets, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LeasedAssetsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405424185536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and other intangible assets - Schedule of Movements in Goodwill (Details) - Goodwill - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="nump">&#8364; 48,056<span></span>
</td>
<td class="nump">&#8364; 44,364<span></span>
</td>
<td class="nump">&#8364; 44,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Acquisitions during the period</a></td>
<td class="nump">609<span></span>
</td>
<td class="nump">2,179<span></span>
</td>
<td class="nump">1,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill', window );">Other movements during the period</a></td>
<td class="num">(258)<span></span>
</td>
<td class="num">(89)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation differences</a></td>
<td class="nump">1,485<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
<td class="num">(1,923)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="nump">&#8364; 49,892<span></span>
</td>
<td class="nump">&#8364; 48,056<span></span>
</td>
<td class="nump">&#8364; 44,364<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets and goodwill resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets and goodwill resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432261360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and other intangible assets - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 08, 2022</div></th>
<th class="th"><div>Sep. 14, 2021</div></th>
<th class="th"><div>Sep. 28, 2020</div></th>
<th class="th"><div>Jan. 23, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">&#8364; 49,892<span></span>
</td>
<td class="nump">&#8364; 48,056<span></span>
</td>
<td class="nump">&#8364; 44,364<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="nump">21,640<span></span>
</td>
<td class="nump">21,407<span></span>
</td>
<td class="nump">18,341<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="nump">571<span></span>
</td>
<td class="nump">616<span></span>
</td>
<td class="nump">818<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsMember', window );">Marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="nump">&#8364; 12,700<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="nump">11,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_TechnologicalPlatformsMember', window );">Technological Platforms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="nump">&#8364; 2,200<span></span>
</td>
<td class="nump">&#8364; 1,200<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="nump">&#8364; 525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_OtherIntangibleAssetsExcludingSoftwareMember', window );">Other intangible assets excluding software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="nump">472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_EnjaymoMember', window );">Enjaymo | Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="nump">854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_EnjaymoMember', window );">Enjaymo | Accumulated impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="nump">&#8364; 363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_AmunixMember', window );">Amunix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember', window );">Translate Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_PrincipiaBiopharmaIncMember', window );">Principia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_SynthorxMember', window );">Synthorx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 930<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_TechnologicalPlatformsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_TechnologicalPlatformsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_OtherIntangibleAssetsExcludingSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_OtherIntangibleAssetsExcludingSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_EnjaymoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_EnjaymoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_AmunixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_AmunixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_PrincipiaBiopharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_PrincipiaBiopharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_SynthorxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_SynthorxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405423967376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and other intangible assets - Schedule of Movements in Other Intangible Assets (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="nump">&#8364; 21,407<span></span>
</td>
<td class="nump">&#8364; 18,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="num">(2,053)<span></span>
</td>
<td class="num">(1,580)<span></span>
</td>
<td class="num">&#8364; (1,681)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="nump">21,640<span></span>
</td>
<td class="nump">21,407<span></span>
</td>
<td class="nump">18,341<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="nump">78,865<span></span>
</td>
<td class="nump">72,307<span></span>
</td>
<td class="nump">71,296<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes&#160;in&#160;scope of&#160;consolidation</a></td>
<td class="nump">464<span></span>
</td>
<td class="nump">3,626<span></span>
</td>
<td class="nump">4,083<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="nump">571<span></span>
</td>
<td class="nump">616<span></span>
</td>
<td class="nump">818<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="num">(543)<span></span>
</td>
<td class="num">(502)<span></span>
</td>
<td class="num">(333)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="nump">2,533<span></span>
</td>
<td class="nump">2,818<span></span>
</td>
<td class="num">(3,557)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="num">(174)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="nump">81,716<span></span>
</td>
<td class="nump">78,865<span></span>
</td>
<td class="nump">72,307<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization&#160;&amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="num">(57,458)<span></span>
</td>
<td class="num">(53,966)<span></span>
</td>
<td class="num">(54,787)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes&#160;in&#160;scope of&#160;consolidation</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="num">(2,196)<span></span>
</td>
<td class="num">(1,740)<span></span>
</td>
<td class="num">(1,819)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment losses, net of reversals</a></td>
<td class="nump">454<span></span>
</td>
<td class="num">(192)<span></span>
</td>
<td class="num">(330)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="num">(1,591)<span></span>
</td>
<td class="num">(2,022)<span></span>
</td>
<td class="nump">2,649<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="num">(60,076)<span></span>
</td>
<td class="num">(57,458)<span></span>
</td>
<td class="num">(53,966)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_AcquiredRDMember', window );">Acquired R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="nump">7,730<span></span>
</td>
<td class="nump">6,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="nump">6,226<span></span>
</td>
<td class="nump">7,730<span></span>
</td>
<td class="nump">6,092<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_AcquiredRDMember', window );">Acquired R&amp;D | Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="nump">11,207<span></span>
</td>
<td class="nump">9,600<span></span>
</td>
<td class="nump">5,730<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes&#160;in&#160;scope of&#160;consolidation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,805<span></span>
</td>
<td class="nump">3,951<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">339<span></span>
</td>
<td class="nump">654<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(313)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="num">(593)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="num">(1,576)<span></span>
</td>
<td class="num">(784)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="nump">10,354<span></span>
</td>
<td class="nump">11,207<span></span>
</td>
<td class="nump">9,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_AcquiredRDMember', window );">Acquired R&amp;D | Accumulated amortization&#160;&amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="num">(3,477)<span></span>
</td>
<td class="num">(3,508)<span></span>
</td>
<td class="num">(3,396)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes&#160;in&#160;scope of&#160;consolidation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment losses, net of reversals</a></td>
<td class="num">(1,107)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="num">(328)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="nump">388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="num">(4,128)<span></span>
</td>
<td class="num">(3,477)<span></span>
</td>
<td class="num">(3,508)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsTrademarksAndOtherRightsMember', window );">Products, trademarks and other rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="nump">13,162<span></span>
</td>
<td class="nump">11,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="nump">14,927<span></span>
</td>
<td class="nump">13,162<span></span>
</td>
<td class="nump">11,729<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsTrademarksAndOtherRightsMember', window );">Products, trademarks and other rights | Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="nump">65,906<span></span>
</td>
<td class="nump">61,074<span></span>
</td>
<td class="nump">63,953<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes&#160;in&#160;scope of&#160;consolidation</a></td>
<td class="nump">499<span></span>
</td>
<td class="nump">1,821<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="num">(423)<span></span>
</td>
<td class="num">(173)<span></span>
</td>
<td class="num">(243)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="nump">1,994<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
<td class="num">(2,926)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="nump">1,408<span></span>
</td>
<td class="nump">791<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="nump">69,579<span></span>
</td>
<td class="nump">65,906<span></span>
</td>
<td class="nump">61,074<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsTrademarksAndOtherRightsMember', window );">Products, trademarks and other rights | Accumulated amortization&#160;&amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="num">(52,744)<span></span>
</td>
<td class="num">(49,345)<span></span>
</td>
<td class="num">(50,314)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes&#160;in&#160;scope of&#160;consolidation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="num">(2,099)<span></span>
</td>
<td class="num">(1,621)<span></span>
</td>
<td class="num">(1,707)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment losses, net of reversals</a></td>
<td class="nump">1,561<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="nump">411<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="num">(1,567)<span></span>
</td>
<td class="num">(1,869)<span></span>
</td>
<td class="nump">2,460<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="num">(214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="num">(54,652)<span></span>
</td>
<td class="num">(52,744)<span></span>
</td>
<td class="num">(49,345)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="nump">515<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="nump">487<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Software | Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="nump">1,752<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
<td class="nump">1,613<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes&#160;in&#160;scope of&#160;consolidation</a></td>
<td class="num">(35)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="nump">1,783<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Software | Accumulated amortization&#160;&amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, beginning balance</a></td>
<td class="num">(1,237)<span></span>
</td>
<td class="num">(1,113)<span></span>
</td>
<td class="num">(1,077)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes&#160;in&#160;scope of&#160;consolidation</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="num">(97)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment losses, net of reversals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="num">(1,296)<span></span>
</td>
<td class="num">&#8364; (1,237)<span></span>
</td>
<td class="num">&#8364; (1,113)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_IOLicenseAndCollaborationAgreementMember', window );">IO License And Collaboration Agreement | Accumulated amortization&#160;&amp; impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="num">&#8364; (226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in intangible assets other than goodwill resulting from disposals and retirements. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in other comprehensive income for intangible assets other than goodwill. [Refer: Impairment loss recognised in other comprehensive income; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 119<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_119&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Scope Of Consolidation Through Business Combination, Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_AcquiredRDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_AcquiredRDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsTrademarksAndOtherRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsTrademarksAndOtherRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_IOLicenseAndCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_IOLicenseAndCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435706448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and other intangible assets - Detailed Information for Principal Marketed Products (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 21,640<span></span>
</td>
<td class="nump">&#8364; 21,407<span></span>
</td>
<td class="nump">&#8364; 18,341<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsMember', window );">Marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ConcentrationRiskThresholdPercentage', window );">Concentration risk percentage</a></td>
<td class="nump">92.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 12,700<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="nump">11,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsMember', window );">Total: principal marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 11,683<span></span>
</td>
<td class="nump">10,752<span></span>
</td>
<td class="nump">10,341<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsGenzymeMember', window );">Genzyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 621<span></span>
</td>
<td class="nump">1,032<span></span>
</td>
<td class="nump">1,485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019', window );">Remaining amortisation period of intangible assets material to entity</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember', window );">Boehringer Ingelheim Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 2,037<span></span>
</td>
<td class="nump">2,213<span></span>
</td>
<td class="nump">2,489<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019', window );">Remaining amortisation period of intangible assets material to entity</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsAventisMember', window );">Aventis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 58<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019', window );">Remaining amortisation period of intangible assets material to entity</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsChattemMember', window );">Chattem</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 574<span></span>
</td>
<td class="nump">593<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019', window );">Remaining amortisation period of intangible assets material to entity</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsProteinSciencesMember', window );">Protein Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 498<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019', window );">Remaining amortisation period of intangible assets material to entity</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsAblynxMember', window );">Ablynx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 1,357<span></span>
</td>
<td class="nump">1,494<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019', window );">Remaining amortisation period of intangible assets material to entity</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsBioverativMember', window );">Bioverativ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 4,836<span></span>
</td>
<td class="nump">3,065<span></span>
</td>
<td class="nump">3,240<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019', window );">Remaining amortisation period of intangible assets material to entity</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsKadmonMember', window );">Kadmon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 1,702<span></span>
</td>
<td class="nump">&#8364; 1,750<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019', window );">Remaining amortisation period of intangible assets material to entity</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value | Total: principal marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 62,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value | Genzyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">10,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value | Boehringer Ingelheim Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">3,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value | Aventis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">34,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value | Chattem</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">1,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value | Protein Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value | Ablynx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">1,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value | Bioverativ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">7,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value | Kadmon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">1,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization&#160;&amp; impairment | Total: principal marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="num">(51,144)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization&#160;&amp; impairment | Genzyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="num">(9,869)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization&#160;&amp; impairment | Boehringer Ingelheim Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="num">(1,596)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization&#160;&amp; impairment | Aventis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="num">(34,626)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization&#160;&amp; impairment | Chattem</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="num">(786)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization&#160;&amp; impairment | Protein Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="num">(359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization&#160;&amp; impairment | Ablynx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="num">(609)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization&#160;&amp; impairment | Bioverativ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="num">(3,119)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization&#160;&amp; impairment | Kadmon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="num">&#8364; (180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life, intangible assets other than goodwill (in years)</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining amortisation period of individual intangible assets that are material to the entity&#8217;s financial statements. [Refer: Depreciation and amortisation expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 122<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_122_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ConcentrationRiskThresholdPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Concentration risk threshold percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ConcentrationRiskThresholdPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsGenzymeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsGenzymeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsAventisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsAventisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsChattemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsChattemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsProteinSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsProteinSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsAblynxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsAblynxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsBioverativMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsBioverativMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsKadmonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_PrincipalMarketedProductsKadmonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432986256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and other intangible assets - Amortization of Softwares Recognized in Income Statement (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="nump">&#8364; 13,695<span></span>
</td>
<td class="nump">&#8364; 12,255<span></span>
</td>
<td class="nump">&#8364; 12,159<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">6,706<span></span>
</td>
<td class="nump">5,692<span></span>
</td>
<td class="nump">5,530<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="nump">10,492<span></span>
</td>
<td class="nump">9,555<span></span>
</td>
<td class="nump">9,391<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">1,805<span></span>
</td>
<td class="nump">1,415<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="nump">2,053<span></span>
</td>
<td class="nump">1,580<span></span>
</td>
<td class="nump">1,681<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseCategoriesAxis=sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember', window );">Amortization of computer software and other rights of an industrial or operational nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="nump">&#8364; 97<span></span>
</td>
<td class="nump">&#8364; 119<span></span>
</td>
<td class="nump">&#8364; 112<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseCategoriesAxis=sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseCategoriesAxis=sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432358128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Impairment of intangible assets and property, plant and equipment - Schedule of Allocation of Goodwill (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">&#8364; 49,892<span></span>
</td>
<td class="nump">&#8364; 48,056<span></span>
</td>
<td colspan="2" class="nump">&#8364; 44,364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember', window );">Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">39,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareMember', window );">Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_VaccinesMember', window );">Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">&#8364; 3,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_ConsumerHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_VaccinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_VaccinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405433819824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impairment of intangible assets and property, plant and equipment - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss', window );">Discount rate</a></td>
<td class="nump">260.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss', window );">Perpetual growth rate</a></td>
<td class="nump">430.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss', window );">Operating margin rate</a></td>
<td class="nump">670.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill', window );">Impairment of goodwill recognized | &#8364;</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AfterTaxDiscountRates', window );">After tax discount rates</a></td>
<td class="nump">7.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AfterTaxDiscountRates', window );">After tax discount rates</a></td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember', window );">Cash-generating units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UniformPreTaxDiscountRates', window );">Uniform pre-tax discount rates</a></td>
<td class="nump">9.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember', window );">Cash-generating units | CGUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UniformImpairmentTestingPercentage', window );">Uniform impairment testing percentage</a></td>
<td class="nump">7.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections', window );">Perpetual growth rates applied to future cash flows</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Cash-generating units | CGUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentTestingPercentage', window );">Rate used for Impairment of goodwill</a></td>
<td class="nump">7.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PretaxDiscountRateAppliedForGoodwill', window );">Pre-tax discount rates</a></td>
<td class="nump">9.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareMember', window );">Consumer Healthcare | Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections', window );">Perpetual growth rates applied to future cash flows</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareMember', window );">Consumer Healthcare | Cash-generating units | CGUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentTestingPercentage', window );">Rate used for Impairment of goodwill</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PretaxDiscountRateAppliedForGoodwill', window );">Pre-tax discount rates</a></td>
<td class="nump">9.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_VaccinesMember', window );">Vaccines | Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections', window );">Perpetual growth rates applied to future cash flows</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_VaccinesMember', window );">Vaccines | Cash-generating units | CGUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentTestingPercentage', window );">Rate used for Impairment of goodwill</a></td>
<td class="nump">7.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PretaxDiscountRateAppliedForGoodwill', window );">Pre-tax discount rates</a></td>
<td class="nump">9.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_d_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph e<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_e_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_d_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AfterTaxDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>After tax discount rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AfterTaxDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpairmentTestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Testing Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpairmentTestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of discount rate above rate actually used would not cause impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of operating margin rate below rates actually used would not cause impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of perpetuity growth rate below the rates actually used would not cause impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PretaxDiscountRateAppliedForGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-tax discount rate applied for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PretaxDiscountRateAppliedForGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_UniformImpairmentTestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Uniform impairment testing percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_UniformImpairmentTestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_UniformPreTaxDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Uniform pre-tax discount rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_UniformPreTaxDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis=ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_CashGeneratingUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_CashGeneratingUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_ConsumerHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_VaccinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_VaccinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435834912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impairment of intangible assets and property, plant and equipment - Summary of Net Impairment Losses of Other Intangible Assets (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment of intangible assets</a></td>
<td class="num">&#8364; (454)<span></span>
</td>
<td class="nump">&#8364; 192<span></span>
</td>
<td class="nump">&#8364; 330<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sny_EloctateMember', window );">Eloctate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount', window );">Reversal amount</a></td>
<td class="nump">2,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">1,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sny_EloctateMember', window );">Eloctate | Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 2,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=sny_MarketedProductsMember', window );">Marketed products | Eloctate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount', window );">Reversal amount</a></td>
<td class="nump">1,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=sny_ResearchAndDevelopmentMember', window );">Research and development projects | Eloctate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount', window );">Reversal amount</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill', window );">Impairment of other intangible assets, net of reversals (excluding software)</a></td>
<td class="num">(454)<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets | Marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill', window );">Impairment of other intangible assets, net of reversals (excluding software)</a></td>
<td class="num">(1,561)<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets | Research and development projects</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill', window );">Impairment of other intangible assets, net of reversals (excluding software)</a></td>
<td class="nump">1,107<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets | SAR444245</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill', window );">Impairment of other intangible assets, net of reversals (excluding software)</a></td>
<td class="nump">1,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Other intangible assets | Marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill', window );">Impairment of other intangible assets, net of reversals (excluding software)</a></td>
<td class="num">(1,542)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember', window );">Consumer Healthcare | Other intangible assets | Marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill', window );">Impairment of other intangible assets, net of reversals (excluding software)</a></td>
<td class="num">(35)<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_VaccinesSegmentMember', window );">Vaccines | Other intangible assets | Marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill', window );">Impairment of other intangible assets, net of reversals (excluding software)</a></td>
<td class="nump">&#8364; 16<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment loss on intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Loss Recognised In Profit Or Loss, Intangible Assets Other Than Goodwill, Reversal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sny_EloctateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sny_EloctateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_MarketedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_MarketedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_SAR444245Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_SAR444245Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_VaccinesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_VaccinesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441628800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments accounted for using the equity method - Summary of Investments in Associates and Joint Ventures (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Investments in subsidiaries, joint ventures and associates</a></td>
<td class="nump">&#8364; 677<span></span>
</td>
<td class="nump">&#8364; 677<span></span>
</td>
<td class="nump">&#8364; 250<span></span>
</td>
<td class="nump">&#8364; 201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=sny_InfraservGmbhAndCoHochstKGMember', window );">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion of ownership interest in joint venture (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInJointVentures', window );">Investments in joint ventures</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">&#8364; 97<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=sny_MSPVaccineCompanyMember', window );">MSP Vaccine Company (formerly MCM company)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion of ownership interest in joint venture (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInJointVentures', window );">Investments in joint ventures</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">&#8364; 104<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion of ownership interest in joint venture (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInJointVentures', window );">Investments in joint ventures</a></td>
<td class="nump">&#8364; 84<span></span>
</td>
<td class="nump">&#8364; 84<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EuroapiMember', window );">EUROAPI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate (in percent)</a></td>
<td class="nump">30.10%<span></span>
</td>
<td class="nump">30.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInJointVentures', window );">Investments in joint ventures</a></td>
<td class="nump">&#8364; 392<span></span>
</td>
<td class="nump">&#8364; 392<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_MCMVaccineBVMember', window );">MCM Vaccine B.V. | MSP Vaccine Company (formerly MCM company)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion of ownership interest in joint venture (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in joint ventures in an entity's separate financial statements. [Refer: Joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=sny_InfraservGmbhAndCoHochstKGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=sny_InfraservGmbhAndCoHochstKGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=sny_MSPVaccineCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=sny_MSPVaccineCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EuroapiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EuroapiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_MCMVaccineBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_MCMVaccineBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sny_MSPVaccineCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sny_MSPVaccineCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431770480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments accounted for using the equity method - Summary of Share of Profit or Loss and Other Comprehensive Income of Associates and Joint Ventures (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 29, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 68<span></span>
</td>
<td class="nump">&#8364; 39<span></span>
</td>
<td class="nump">&#8364; 359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=ifrs-full_JointVenturesMember', window );">Joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax', window );">Share of other comprehensive income from investments accounted for using the equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ifrs-full_AssociatesMember', window );">Associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax', window );">Share of other comprehensive income from investments accounted for using the equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(311)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (9)<span></span>
</td>
<td class="nump">&#8364; 13<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="nump">&#8364; 343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 343<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the other comprehensive income of associates and joint ventures accounted for using the equity method, before tax. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of joint ventures accounted for using the equity method. [Refer: Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=ifrs-full_JointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=ifrs-full_JointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ifrs-full_AssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ifrs-full_AssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435328704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments accounted for using the equity method - Summary of Principal Transactions and Balances with Related Parties (Details) - Associates and joint ventures - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions', window );">Sales</a></td>
<td class="nump">&#8364; 131<span></span>
</td>
<td class="nump">&#8364; 70<span></span>
</td>
<td class="nump">&#8364; 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions', window );">Royalties and other income</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsReceivableRelatedPartyTransactions', window );">Accounts receivable and other receivables</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions', window );">Purchases and other expenses (including research expenses)</a></td>
<td class="nump">477<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Accounts payable and other payables</a></td>
<td class="nump">&#8364; 132<span></span>
</td>
<td class="nump">&#8364; 28<span></span>
</td>
<td class="nump">&#8364; 15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsReceivableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsReceivableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goods purchased by the entity in related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_21_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchasesOfGoodsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods in related party transactions. [Refer: Revenue; Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_21_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalties and other income, related party transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_AssociatesAndJointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=sny_AssociatesAndJointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455734224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments accounted for using the equity method - Additional Information (Details) - EUR (&#8364;)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_AssociatesAndJointVenturesMember', window );">Associates and joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsMadeToJointVenturesAndAssociates', window );">Funding commitments to associates and joint ventures</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsMadeToJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments made to joint ventures and associates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsMadeToJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_AssociatesAndJointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=sny_AssociatesAndJointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405433769776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other non-current assets - Summary of Other Non-current Assets (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 07, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Other financial assets at fair value through profit or loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 823<span></span>
</td>
<td class="nump">&#8364; 902<span></span>
</td>
<td class="nump">&#8364; 890<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PreFundedPensionObligations', window );">Pre-funded pension obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LongTermPrepaidExpenses', window );">Long-term prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLoansAndReceivables', window );">Long-term loans and advances and other non-current receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="nump">537<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Derivative financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,095<span></span>
</td>
<td class="nump">3,127<span></span>
</td>
<td class="nump">2,734<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinanceLeaseReceivables', window );">Non-current finance lease receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentFinanceLeaseReceivablesGross', window );">Non-current finance lease receivables, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_ExscientiaMember', window );">Exscientia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_IGMBiosciencesIncMember', window );">IGM Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment | $</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_TradingEquitySecuritiesMember', window );">Trading equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome', window );">Fair value through other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="nump">823<span></span>
</td>
<td class="nump">588<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome', window );">Fair value through other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 329<span></span>
</td>
<td class="nump">&#8364; 447<span></span>
</td>
<td class="nump">&#8364; 426<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current derivative financial assets. [Refer: Derivative financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinanceLeaseReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current finance lease receivables. [Refer: Finance lease receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinanceLeaseReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets at fair value through other comprehensive income. [Refer: Financial assets at fair value through other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_8_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLoansAndReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current loans and receivables. [Refer: Loans and receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLoansAndReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of other non-current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOtherNonCurrentAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LongTermPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LongTermPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentFinanceLeaseReceivablesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Finance Lease Receivables, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentFinanceLeaseReceivablesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PreFundedPensionObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-funded pension obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PreFundedPensionObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_UpfrontPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_UpfrontPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_ExscientiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_ExscientiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_IGMBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_IGMBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_TradingEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_TradingEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405434662656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other non-current assets - Additional Information (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 29, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Sep. 14, 2021</div></th>
<th class="th"><div>Jun. 23, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sales of investments accounted for using equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 10,370<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount', window );">Pre-tax impact on other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis=sny_FairValueOfSPMSDContingentConsiderationMember', window );">Fair value of SPMSD contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseInContingentConsideration', window );">Increase in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 10,765<span></span>
</td>
<td class="nump">6,449<span></span>
</td>
<td class="nump">10,022<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=sny_QuotedEuroDenominatedSeniorBondsMember', window );">Quoted euro denominated senior bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome', window );">Debt instruments at fair value through other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=sny_SeniorBondMember', window );">Senior bond</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HeldtomaturityInvestments', window );">Financial assets held for investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember', window );">Financial instruments held to fund deferred compensation plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinancialInvestments', window );">Financial investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="nump">453<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_TradingEquitySecuritiesMember', window );">Trading equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome', window );">Fair value through other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="nump">823<span></span>
</td>
<td class="nump">588<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_TradingEquitySecuritiesMember', window );">Trading equity securities | Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome', window );">Fair value through other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="nump">439<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_UnquotedEquityInvestmentsMember', window );">Unquoted equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome', window );">Investments in equity instruments designated at fair value through OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisposalGroupGainOnDisposal', window );">Gain on disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_UnquotedEquityInvestmentsMember', window );">Unquoted equity investments | Onduo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Proportion of ownership interests held by non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_UnquotedEquityInvestmentsMember', window );">Unquoted equity investments | Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_UnquotedEquityInvestmentsMember', window );">Unquoted equity investments | Quoted euro denominated senior bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts', window );">Exchange for financial assets held to meet obligations to employees under post-employment benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_QuotedEquitySecuritiesMember', window );">Quoted equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity', window );">Unrealized after-tax losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(256)<span></span>
</td>
<td class="num">(322)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_SPMSDContingentConsiderationAssetMember', window );">SPMSD contingent consideration asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueOfTheContingentConsideration', window );">Fair value of the contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="nump">483<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_NonCurrentAssetMember', window );">Non current asset | Fair value of SPMSD contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueOfTheContingentConsideration', window );">Fair value of the contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="nump">374<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_UnquotedDebtSecuritiesMember', window );">Unquoted debt securities not meeting the definition of equity instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_UnquotedDebtSecuritiesMember', window );">Unquoted debt securities not meeting the definition of equity instruments | Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember', window );">Increase of ten percent basis point in market interest rate | Debt instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeBeforeTax', window );">Other comprehensive income before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember', window );">Increase of ten percent basis point in market interest rate | Quoted debt instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeBeforeTax', window );">Other comprehensive income before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember', window );">Translate Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage', window );">Investments in equity instruments designated at fair value through OCI, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_TranslateBioMember', window );">Translate Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage', window );">Investments in equity instruments designated at fair value through OCI, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome', window );">Investments in equity instruments designated at fair value through OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_RegeneronMember', window );">Regeneron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome', window );">Fair value through other comprehensive income</a></td>
<td class="nump">&#8364; 221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sales of investments accounted for using equity method | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">22,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentFinancialAssetsNumberOfShares', window );">Non-current financial assets, number of shares (in shares) | shares</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279,766,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_InnoventBiologicsMember', window );">Innovent Biologics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount', window );">Investments in equity instruments designated at fair value through other comprehensive income, transaction amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=ifrs-full_AssociatesMember', window );">Associates | Trading equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome', window );">Fair value through other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="11"></td></tr>
<tr><td colspan="11"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: At fair value [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 11A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_11A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_8_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35H<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35I<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_8_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HeldtomaturityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-derivative financial assets with fixed or determinable payments and fixed maturity that an entity has the positive intention and ability to hold to maturity other than: (a) those that the entity upon initial recognition designates as at fair value through profit or loss; (b) those that the entity designates as available for sale; and (c) those that meet the definition of loans and receivables. An entity shall not classify any financial assets as held to maturity if the entity has, during the current financial year or during the two preceding financial years, sold or reclassified more than an insignificant amount of held-to-maturity investments before maturity (more than insignificant in relation to the total amount of held-to-maturity investments) other than sales or reclassifications that: (i) are so close to maturity or the financial asset&#8217;s call date (for example, less than three months before maturity) that changes in the market rate of interest would not have a significant effect on the financial asset&#8217;s fair value; (ii) occur after the entity has collected substantially all of the financial asset&#8217;s original principal through scheduled payments or prepayments; or (iii) are attributable to an isolated event that is beyond the entity&#8217;s control, is non-recurring and could not have been reasonably anticipated by the entity. [Refer: Derivative financial assets; Held-to-maturity investments; Prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_b&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HeldtomaturityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets and rights arising under insurance contracts. [Refer: Deferred tax assets; Financial instruments, class [member]; Non-current assets; Types of insurance contracts [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets at fair value through other comprehensive income. [Refer: Financial assets at fair value through other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_8_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, before tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of other non-current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOtherNonCurrentAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisposalGroupGainOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Gain On Disposal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisposalGroupGainOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Instruments At Fair Value Through Other Comprehensive Income (Loss), 10% Decline In Credit Prices, Pre-tax Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FairValueOfTheContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FairValueOfTheContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FinancialInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that are classified as financial assets available-for-sale, held-to-maturity investments or loans and receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FinancialInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseInContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseInContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income, Transaction Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentFinancialAssetsNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Financial Assets, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentFinancialAssetsNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Number Of Shares Issued In Transaction, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity instruments at fair value through other comprehensive income and Debt instruments at fair value through other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis=sny_FairValueOfSPMSDContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis=sny_FairValueOfSPMSDContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=sny_QuotedEuroDenominatedSeniorBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=sny_QuotedEuroDenominatedSeniorBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=sny_SeniorBondMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=sny_SeniorBondMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_TradingEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_TradingEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_UnquotedEquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_UnquotedEquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisposalGroupNameAxis=sny_OnduoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisposalGroupNameAxis=sny_OnduoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_QuotedEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_QuotedEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_SPMSDContingentConsiderationAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_SPMSDContingentConsiderationAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_NonCurrentAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_NonCurrentAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_UnquotedDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_UnquotedDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_DebtInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_DebtInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_QuotedDebtInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_QuotedDebtInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_TranslateBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_TranslateBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_InnoventBiologicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=sny_InnoventBiologicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=ifrs-full_AssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=ifrs-full_AssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439236976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Assets held for sale or exchange and liabilities related to assets held for sale or exchange - Summary of Assets Held for Sale or Exchange, and Liabilities Related to Assets Held for Sale or Exchange (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale', window );">Assets held for sale or exchange</a></td>
<td class="nump">&#8364; 85<span></span>
</td>
<td class="nump">&#8364; 89<span></span>
</td>
<td class="nump">&#8364; 83<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale', window );">Liabilities related to assets held for sale or exchange</a></td>
<td class="nump">&#8364; 10<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 32<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities included in disposal groups classified as held for sale. [Refer: Liabilities; Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 38<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_38&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph p<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_p&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets or disposal groups classified as held for sale. [Refer: Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 38<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_38&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441451888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Schedule of Inventories (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInventoriesLineItems', window );"><strong>Disclosure of inventories [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RawMaterials', window );">Raw materials</a></td>
<td class="nump">&#8364; 1,474<span></span>
</td>
<td class="nump">&#8364; 1,278<span></span>
</td>
<td class="nump">&#8364; 975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Work in process</a></td>
<td class="nump">4,985<span></span>
</td>
<td class="nump">5,025<span></span>
</td>
<td class="nump">4,856<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished goods</a></td>
<td class="nump">2,501<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
<td class="nump">2,521<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total</a></td>
<td class="nump">8,960<span></span>
</td>
<td class="nump">8,715<span></span>
</td>
<td class="nump">8,352<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInventoriesLineItems', window );"><strong>Disclosure of inventories [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RawMaterials', window );">Raw materials</a></td>
<td class="nump">1,613<span></span>
</td>
<td class="nump">1,344<span></span>
</td>
<td class="nump">1,051<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Work in process</a></td>
<td class="nump">5,663<span></span>
</td>
<td class="nump">5,579<span></span>
</td>
<td class="nump">5,398<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished goods</a></td>
<td class="nump">2,748<span></span>
</td>
<td class="nump">2,696<span></span>
</td>
<td class="nump">2,739<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total</a></td>
<td class="nump">10,024<span></span>
</td>
<td class="nump">9,619<span></span>
</td>
<td class="nump">9,188<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=sny_WriteDownMember', window );">Allowances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInventoriesLineItems', window );"><strong>Disclosure of inventories [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RawMaterials', window );">Raw materials</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Work in process</a></td>
<td class="nump">678<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="nump">542<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished goods</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total</a></td>
<td class="nump">&#8364; 1,064<span></span>
</td>
<td class="nump">&#8364; 904<span></span>
</td>
<td class="nump">&#8364; 836<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WorkInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WorkInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInventoriesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInventoriesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=sny_WriteDownMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=sny_WriteDownMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439622800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoriesPledgedAsSecurityForLiabilities', window );">Inventories pledged as security for liabilities</a></td>
<td class="nump">&#8364; 3<span></span>
</td>
<td class="nump">&#8364; 20<span></span>
</td>
<td class="nump">&#8364; 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoriesPledgedAsSecurityForLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventories pledged as security for liabilities. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoriesPledgedAsSecurityForLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432981792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts receivable - Summary of Accounts Receivable (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAccountsReceivableLineItems', window );"><strong>Disclosure of accounts receivable [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="nump">&#8364; 8,424<span></span>
</td>
<td class="nump">&#8364; 7,568<span></span>
</td>
<td class="nump">&#8364; 7,491<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAccountsReceivableLineItems', window );"><strong>Disclosure of accounts receivable [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="nump">8,537<span></span>
</td>
<td class="nump">7,705<span></span>
</td>
<td class="nump">7,633<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AllowanceForCreditLossesMember', window );">Allowances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAccountsReceivableLineItems', window );"><strong>Disclosure of accounts receivable [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="nump">&#8364; 113<span></span>
</td>
<td class="nump">&#8364; 137<span></span>
</td>
<td class="nump">&#8364; 142<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAccountsReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Accounts Receivable [line items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAccountsReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AllowanceForCreditLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AllowanceForCreditLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435265824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables', window );">Impairment loss recognised in profit or loss, trade receivables</a></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="nump">&#8364; 12<span></span>
</td>
<td class="nump">&#8364; 30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Gross value of overdue receivables</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">455<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerecognizedReceivables', window );">Derecognized receivables</a></td>
<td class="nump">&#8364; 131<span></span>
</td>
<td class="nump">&#8364; 3<span></span>
</td>
<td class="nump">&#8364; 18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for trade receivables. [Refer: Impairment loss recognised in profit or loss; Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DerecognizedReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derecognized receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DerecognizedReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OverdueReceivablesGrossValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Overdue receivables gross value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OverdueReceivablesGrossValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431291152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts receivable - Summary of Gross Value of Overdue Receivables (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of financial assets that are either past due or impaired [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">&#8364; 452<span></span>
</td>
<td class="nump">&#8364; 455<span></span>
</td>
<td class="nump">&#8364; 549<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember', window );">Less than 1 month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of financial assets that are either past due or impaired [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember', window );">1&#160;to&#160;3&#160;months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of financial assets that are either past due or impaired [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember', window );">3&#160;to&#160;6&#160;months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of financial assets that are either past due or impaired [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember', window );">6&#160;to&#160;12&#160;months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of financial assets that are either past due or impaired [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember', window );">Later than 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of financial assets that are either past due or impaired [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">&#8364; 51<span></span>
</td>
<td class="nump">&#8364; 56<span></span>
</td>
<td class="nump">&#8364; 95<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OverdueReceivablesGrossValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Overdue receivables gross value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OverdueReceivablesGrossValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432981952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other current assets (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax', window );">Tax receivables, other than corporate income taxes</a></td>
<td class="nump">&#8364; 658<span></span>
</td>
<td class="nump">&#8364; 802<span></span>
</td>
<td class="nump">&#8364; 687<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">714<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="nump">525<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables</a></td>
<td class="nump">1,290<span></span>
</td>
<td class="nump">805<span></span>
</td>
<td class="nump">567<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateDerivativesMeasuredAtFairValue', window );">Interest rate derivatives measured at fair value (see Note&#160;D.20.)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyDerivativesMeasuredAtFairValue', window );">Currency derivatives measured at fair value (see Note&#160;D.20.)</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Other current financial assets</a></td>
<td class="nump">664<span></span>
</td>
<td class="nump">1,054<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentAssets', window );">Total</a></td>
<td class="nump">&#8364; 3,532<span></span>
</td>
<td class="nump">&#8364; 3,571<span></span>
</td>
<td class="nump">&#8364; 2,737<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrencyDerivativesMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency derivatives measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrencyDerivativesMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateDerivativesMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate derivatives measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateDerivativesMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405434207392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and liabilities measured at fair value - Summary of Assets and Liabilities Measured at Fair Value (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_UnquotedDebtSecuritiesMember', window );">Unquoted debt securities not meeting the definition of equity instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">&#8364; 115<span></span>
</td>
<td class="nump">&#8364; 78<span></span>
</td>
<td class="nump">&#8364; 63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">10,765<span></span>
</td>
<td class="nump">6,449<span></span>
</td>
<td class="nump">10,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Bayer contingent purchase consideration arising from the acquisition of Genzyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | MSD contingent consideration (European vaccines business)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Shire contingent consideration arising from the acquisition of Translate Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Contingent consideration arising from acquisition of Amunix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Other contingent consideration arising from business combinations and acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Non-current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Quoted equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">387<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="nump">439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Unquoted equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Quoted debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">447<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Unquoted debt securities not meeting the definition of equity instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Contingent consideration relating to divestments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Financial assets held to meet obligations under deferred compensation plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">512<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Non-current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level&#160;1 | Mutual fund investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">9,537<span></span>
</td>
<td class="nump">5,057<span></span>
</td>
<td class="nump">8,703<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Bayer contingent purchase consideration arising from the acquisition of Genzyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | MSD contingent consideration (European vaccines business)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Shire contingent consideration arising from the acquisition of Translate Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Contingent consideration arising from acquisition of Amunix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Other contingent consideration arising from business combinations and acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Non-current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Quoted equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Unquoted equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Quoted debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Unquoted debt securities not meeting the definition of equity instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Contingent consideration relating to divestments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Financial assets held to meet obligations under deferred compensation plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Non-current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level&#160;2 | Mutual fund investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">967<span></span>
</td>
<td class="nump">883<span></span>
</td>
<td class="nump">695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">779<span></span>
</td>
<td class="nump">714<span></span>
</td>
<td class="nump">605<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Bayer contingent purchase consideration arising from the acquisition of Genzyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | MSD contingent consideration (European vaccines business)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Shire contingent consideration arising from the acquisition of Translate Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Contingent consideration arising from acquisition of Amunix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Other contingent consideration arising from business combinations and acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Non-current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Quoted equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Unquoted equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">549<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Quoted debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Unquoted debt securities not meeting the definition of equity instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Contingent consideration relating to divestments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Financial assets held to meet obligations under deferred compensation plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Non-current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Current derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level&#160;3 | Mutual fund investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationOnIncomeStatementLineItems', window );"><strong>Disclosure of information on income statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets measured at fair value</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35H<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35I<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInformationOnIncomeStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of information on income statement line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInformationOnIncomeStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_UnquotedDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_UnquotedDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=sny_ContingentConsiderationTranslateBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=sny_ContingentConsiderationTranslateBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=sny_NonCurrentDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=sny_NonCurrentDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=sny_CurrentDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=sny_CurrentDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_QuotedEquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_QuotedEquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_UnquotedEquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_UnquotedEquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_QuotedDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_QuotedDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_ContingentConsiderationRelatingToDivestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_ContingentConsiderationRelatingToDivestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_NonCurrentDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_NonCurrentDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_CurrentDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_CurrentDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_MutualFundInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_MutualFundInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405434185392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents (Details) - EUR (&#8364;)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">&#8364; 1,385,000,000<span></span>
</td>
<td class="nump">&#8364; 1,358,000,000<span></span>
</td>
<td class="nump">&#8364; 1,144,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">11,351,000,000<span></span>
</td>
<td class="nump">8,740,000,000<span></span>
</td>
<td class="nump">12,771,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">12,736,000,000<span></span>
</td>
<td class="nump">10,098,000,000<span></span>
</td>
<td class="nump">13,915,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td colspan="2" class="nump">&#8364; 9,427,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CashEquivalentsMoneyMarketMutualFunds', window );">Cash equivalents, money market mutual funds</a></td>
<td class="nump">9,537,000,000<span></span>
</td>
<td class="nump">5,057,000,000<span></span>
</td>
<td class="nump">8,703,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents', window );">Cash equivalents, term deposits</a></td>
<td class="nump">1,167,000,000<span></span>
</td>
<td class="nump">2,768,000,000<span></span>
</td>
<td class="nump">3,259,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CashEquivalentsCommercialPaper', window );">Cash equivalents, commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">179,000,000<span></span>
</td>
<td class="nump">74,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies', window );">Cash equivalents, captive insurance and reinsurance companies</a></td>
<td class="nump">&#8364; 439,000,000<span></span>
</td>
<td class="nump">&#8364; 427,000,000<span></span>
</td>
<td class="nump">&#8364; 425,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents captive insurance and reinsurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CashEquivalentsCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalent commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CashEquivalentsCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CashEquivalentsMoneyMarketMutualFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalent money market mutual funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CashEquivalentsMoneyMarketMutualFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431394592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Net deferred tax position - Summary of Net Deferred Tax Position (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax asset/(liability)</a></td>
<td class="nump">&#8364; 3,540<span></span>
</td>
<td class="nump">&#8364; 2,981<span></span>
</td>
<td class="nump">&#8364; 2,406<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">1,841<span></span>
</td>
<td class="nump">1,617<span></span>
</td>
<td class="nump">1,770<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture', window );">Reserves likely to be distributed in the foreseeable future</a></td>
<td class="nump">59,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">5,381<span></span>
</td>
<td class="nump">4,598<span></span>
</td>
<td class="nump">4,176<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember', window );">Consolidation adjustments (intragroup margin in inventory)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax asset/(liability)</a></td>
<td class="nump">1,388<span></span>
</td>
<td class="nump">1,292<span></span>
</td>
<td class="nump">1,142<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember', window );">Provision for pensions and other employee benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax asset/(liability)</a></td>
<td class="nump">850<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="nump">1,156<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember', window );">Remeasurement of other acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax asset/(liability)</a></td>
<td class="num">(3,269)<span></span>
</td>
<td class="num">(3,079)<span></span>
</td>
<td class="num">(3,083)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember', window );">Remeasurement of other acquired intangible assets | Bioverativ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">1,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember', window );">Remeasurement of other acquired intangible assets | Principia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember', window );">Remeasurement of other acquired intangible assets | Genzyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember', window );">Remeasurement of other acquired intangible assets | Ablynx N.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember', window );">Remeasurement of other acquired intangible assets | Amunix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember', window );">Recognition of acquired property, plant and equipment at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax asset/(liability)</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember', window );">Equity interests in subsidiaries and investments in other entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax asset/(liability)</a></td>
<td class="num">(617)<span></span>
</td>
<td class="num">(590)<span></span>
</td>
<td class="num">(522)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember', window );">Tax losses available for carry-forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax asset/(liability)</a></td>
<td class="nump">1,506<span></span>
</td>
<td class="nump">1,516<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_StockOptionsAndShareBasedPaymentsMember', window );">Stock options and other share-based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax asset/(liability)</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember', window );">Accrued expenses and provisions deductible at time of payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax asset/(liability)</a></td>
<td class="nump">1,859<span></span>
</td>
<td class="nump">1,585<span></span>
</td>
<td class="nump">1,399<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax asset/(liability)</a></td>
<td class="nump">1,755<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
<td class="nump">925<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_DeferredTaxRelatingToRestructuringProvisionsMember', window );">Deferred tax relating to restructuring provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">&#8364; 256<span></span>
</td>
<td class="nump">&#8364; 307<span></span>
</td>
<td class="nump">&#8364; 259<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ReservesLikelyToBeDistributedInTheForeseeableFuture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reserves likely to be distributed in the foreseeable future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ReservesLikelyToBeDistributedInTheForeseeableFuture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BioverativMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BioverativMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_PrincipiaBiopharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_PrincipiaBiopharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AblynxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AblynxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AmunixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AmunixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_StockOptionsAndShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_StockOptionsAndShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_DeferredTaxRelatingToRestructuringProvisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_DeferredTaxRelatingToRestructuringProvisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R131.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442587888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Net deferred tax position - Additional information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures', window );">Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax liabilities have not been recognised</a></td>
<td class="nump">&#8364; 10,600<span></span>
</td>
<td class="nump">&#8364; 10,000<span></span>
</td>
<td class="nump">&#8364; 11,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards', window );">Total deferred tax assets for tax loss carryforwards</a></td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">2,391<span></span>
</td>
<td class="nump">1,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unused tax losses for which no deferred tax asset recognised</a></td>
<td class="nump">1,144<span></span>
</td>
<td class="nump">875<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised', window );">Unused capital losses for which no deferred tax asset recognised</a></td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable', window );">Deferred tax assets not recognized as future recovery not probable</a></td>
<td class="nump">&#8364; 995<span></span>
</td>
<td class="nump">&#8364; 615<span></span>
</td>
<td class="nump">&#8364; 346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements, for which deferred tax liabilities have not been recognised as a result of satisfying both of the following conditions: (a) the parent, investor, joint venturer or joint operator is able to control the timing of the reversal of the temporary difference; and (b) it is probable that the temporary difference will not reverse in the foreseeable future. [Refer: Associates [member]; Subsidiaries [member]; Temporary differences [member]; Investments in subsidiaries reported in separate financial statements]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets not recognized as future recovery not probable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TotalDeferredTaxAssetsForTaxLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total deferred tax assets for tax loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TotalDeferredTaxAssetsForTaxLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unused Capital Losses For Which No Deferred Tax Asset Recognised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R132.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431792272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net deferred tax position - Summary of Tax Losses Available for Carry-forward (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems', window );"><strong>Disclosure of tax losses available for carryforward [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxLossesCarryforwards', window );">Tax losses available for carry-forward</a></td>
<td class="nump">&#8364; 8,503<span></span>
</td>
<td class="nump">&#8364; 7,644<span></span>
</td>
<td class="nump">&#8364; 6,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxLossCarryforwardsOnAssetDisposals', window );">Tax loss carry-forwards on asset disposals</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">&#8364; 5<span></span>
</td>
<td class="nump">&#8364; 6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Year 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems', window );"><strong>Disclosure of tax losses available for carryforward [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxLossesCarryforwards', window );">Tax losses available for carry-forward</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Year 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems', window );"><strong>Disclosure of tax losses available for carryforward [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxLossesCarryforwards', window );">Tax losses available for carry-forward</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Year 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems', window );"><strong>Disclosure of tax losses available for carryforward [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxLossesCarryforwards', window );">Tax losses available for carry-forward</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Year 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems', window );"><strong>Disclosure of tax losses available for carryforward [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxLossesCarryforwards', window );">Tax losses available for carry-forward</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Year 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems', window );"><strong>Disclosure of tax losses available for carryforward [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxLossesCarryforwards', window );">Tax losses available for carry-forward</a></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Year 5 and later</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems', window );"><strong>Disclosure of tax losses available for carryforward [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxLossesCarryforwards', window );">Tax losses available for carry-forward</a></td>
<td class="nump">&#8364; 8,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of tax losses available for carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TaxLossCarryforwardsOnAssetDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax loss carryforwards on asset disposals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TaxLossCarryforwardsOnAssetDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TaxLossesCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax losses carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TaxLossesCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R133.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432739216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Additional Information (Details) - EUR (&#8364;)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">&#8364; 2,521,671,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares (in shares)</a></td>
<td class="nump">1,260,835,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euros per share)</a></td>
<td class="nump">&#8364; 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax', window );">Hedges of net investments in foreign operations</a></td>
<td class="num">&#8364; (580,000,000)<span></span>
</td>
<td class="num">&#8364; (317,000,000)<span></span>
</td>
<td class="num">&#8364; (136,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_StockOptionsWithNoDilutiveEffect', window );">Number of stock option not taken for computing diluted earning per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AwardsDateAxis=sny_April302021Member', window );">April 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PeriodOfShareRepurchaseProgram', window );">Period of share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AwardsDateAxis=sny_April282020Member', window );">April 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PeriodOfShareRepurchaseProgram', window );">Period of share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AwardsDateAxis=sny_May32022Member', window );">May 3, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PeriodOfShareRepurchaseProgram', window );">Period of share repurchase program</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_StockSubscriptionOptionPlanMember', window );">Stock subscription option plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions', window );">Increase in shareholders equity due to exercise of stock purchase option</a></td>
<td class="nump">&#8364; 145,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesIssuedByExerciceOfEachOption', window );">Number of shares issued by exercice of each option (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Hedges of net investments in foreign operations after tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfSharesIssuedByExerciceOfEachOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Shares Issued By Exercice Of Each Option</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfSharesIssuedByExerciceOfEachOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PeriodOfShareRepurchaseProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of share repurchase program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PeriodOfShareRepurchaseProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shareholder's equity increase due to the exercise of all stock subscription options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_StockOptionsWithNoDilutiveEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock options with no dilutive effect.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_StockOptionsWithNoDilutiveEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AwardsDateAxis=sny_April302021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AwardsDateAxis=sny_April302021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AwardsDateAxis=sny_April282020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AwardsDateAxis=sny_April282020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AwardsDateAxis=sny_May32022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AwardsDateAxis=sny_May32022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_StockSubscriptionOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_StockSubscriptionOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R134.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439394464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Summary of Treasury Shares Held (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract', window );"><strong>Share Capital, Reserves And Other Equity Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesHeld', window );">Number of shares (in shares)</a></td>
<td class="nump">8,200<span></span>
</td>
<td class="nump">11,020<span></span>
</td>
<td class="nump">8,280<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfShareCapitalForThePeriod', window );">%&#160;of&#160;share&#160;capital for the period</a></td>
<td class="nump">0.65%<span></span>
</td>
<td class="nump">0.872%<span></span>
</td>
<td class="nump">0.658%<span></span>
</td>
<td class="nump">0.002%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfSharesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfSharesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfShareCapitalForThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of share capital for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfShareCapitalForThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Capital, Reserves And Other Equity Interest [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareCapitalReservesAndOtherEquityInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R135.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432722992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Summary of Movements Share Capital (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 14, 2022</div></th>
<th class="th"><div>Jul. 27, 2022</div></th>
<th class="th"><div>Jul. 28, 2021</div></th>
<th class="th"><div>Jul. 28, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,260,835,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember', window );">Share capital | Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,263,560,695<span></span>
</td>
<td class="nump">1,258,971,738<span></span>
</td>
<td class="nump">1,253,846,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions', window );">Capital&#160;increase&#160;by&#160;exercise&#160;of stock subscription options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490,373<span></span>
</td>
<td class="nump">190,076<span></span>
</td>
<td class="nump">868,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease', window );">Capital increase by issuance of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,499,987<span></span>
</td>
<td class="nump">1,836,179<span></span>
</td>
<td class="nump">1,666,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees', window );">Capital increase reserved for employees (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,027,057<span></span>
</td>
<td class="nump">2,562,702<span></span>
</td>
<td class="nump">2,590,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ReductionOfSharesByCancellationOfTreasuryShares', window );">Reduction in share capital by cancellation of treasury shares (in shares)</a></td>
<td class="num">(6,742,380)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,260,835,732<span></span>
</td>
<td class="nump">1,263,560,695<span></span>
</td>
<td class="nump">1,258,971,738<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of restricted shares issued in regards of capital increase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Share Issues In Regards To Capital increase Reserved For Employees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in regards of capital increase by exercise of stock subscription options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ReductionOfSharesByCancellationOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction Of Shares By Cancellation Of Treasury Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ReductionOfSharesByCancellationOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sny_SanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sny_SanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R136.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432579040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Principal Characteristics of Restricted Share Plans (Details)<br> &#8364; / shares in Units, &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member', window );">Restricted Share Plan 2022 | Performance share plan one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfYearsServicePeriod', window );">Service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,344,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueOfPlanAtDateOfGrant', window );">Fair value of plan at the date of grant | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member', window );">Restricted Share Plan 2022 | Performance share plan one | Without market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 91.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member', window );">Restricted Share Plan 2022 | Performance share plan one | With market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,343,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 86.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares', window );">Fair value per share awarded for three year service period, additional shares (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer', window );">Fair value per share awarded for three year service period, to chief executive officer (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 84.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member', window );">Restricted Share Plan 2022 | Performance share plan two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfYearsServicePeriod', window );">Service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueOfPlanAtDateOfGrant', window );">Fair value of plan at the date of grant | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member', window );">Restricted Share Plan 2022 | Performance share plan two | Without market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 79.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member', window );">Restricted Share Plan 2022 | Performance share plan two | With market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 69.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares', window );">Fair value per share awarded for three year service period, additional shares (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer', window );">Fair value per share awarded for three year service period, to chief executive officer (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member', window );">Restricted share plan 2021 | Performance share plan one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfYearsServicePeriod', window );">Service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,484,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueOfPlanAtDateOfGrant', window );">Fair value of plan at the date of grant | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member', window );">Restricted share plan 2021 | Performance share plan one | Without market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,209,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 77.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member', window );">Restricted share plan 2021 | Performance share plan one | With market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,274,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 71.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares', window );">Fair value per share awarded for three year service period, additional shares (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer', window );">Fair value per share awarded for three year service period, to chief executive officer (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 71.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member', window );">Restricted share plan 2021 | Performance share plan two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfYearsServicePeriod', window );">Service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueOfPlanAtDateOfGrant', window );">Fair value of plan at the date of grant | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member', window );">Restricted share plan 2021 | Performance share plan two | Without market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member', window );">Restricted share plan 2021 | Performance share plan two | With market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="nump">9,066,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 68.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares', window );">Fair value per share awarded for three year service period, additional shares (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer', window );">Fair value per share awarded for three year service period, to chief executive officer (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2020Member', window );">Restricted share plan 2020 | Performance share plan one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfYearsServicePeriod', window );">Service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,340,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueOfPlanAtDateOfGrant', window );">Fair value of plan at the date of grant | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2020Member', window );">Restricted share plan 2020 | Performance share plan one | Without market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,536,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 82.36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2020Member', window );">Restricted share plan 2020 | Performance share plan one | With market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">803,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 76.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares', window );">Fair value per share awarded for three year service period, additional shares (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer', window );">Fair value per share awarded for three year service period, to chief executive officer (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 76.11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2020Member', window );">Restricted share plan 2020 | Performance share plan two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfYearsServicePeriod', window );">Service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueOfPlanAtDateOfGrant', window );">Fair value of plan at the date of grant | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2020Member', window );">Restricted share plan 2020 | Performance share plan two | Without market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2020Member', window );">Restricted share plan 2020 | Performance share plan two | With market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total number of shares awarded (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 63.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares', window );">Fair value per share awarded for three year service period, additional shares (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer', window );">Fair value per share awarded for three year service period, to chief executive officer (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FairValueOfPlanAtDateOfGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of plan at the date of grant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FairValueOfPlanAtDateOfGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value per share awarded to a three year service period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FairValuePerShareAwardedForThreeYearServicePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Per Share Awarded For Three Year Service Period, Additional Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Per Share Awarded For Three Year Service Period, To Chief Executive Officer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfYearsServicePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Years, Service Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfYearsServicePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_PerformanceSharePlanOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_PerformanceSharePlanOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MarketConditionAxis=sny_WithoutMarketConditionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MarketConditionAxis=sny_WithoutMarketConditionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MarketConditionAxis=sny_WithMarketConditionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MarketConditionAxis=sny_WithMarketConditionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_PerformanceSharePlanTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_PerformanceSharePlanTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R137.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405433790656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharesMember', window );">Restricted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Total expense for restricted share plans</a></td>
<td class="nump">&#8364; 206<span></span>
</td>
<td class="nump">&#8364; 193<span></span>
</td>
<td class="nump">&#8364; 222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested (in shares)</a></td>
<td class="nump">9,121,573<span></span>
</td>
<td class="nump">9,507,849<span></span>
</td>
<td class="nump">10,546,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member', window );">Restricted Share Plan 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested (in shares)</a></td>
<td class="nump">3,206,861<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member', window );">Restricted share plan 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested (in shares)</a></td>
<td class="nump">3,097,531<span></span>
</td>
<td class="nump">3,364,895<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2020Member', window );">Restricted share plan 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested (in shares)</a></td>
<td class="nump">2,817,181<span></span>
</td>
<td class="nump">3,014,496<span></span>
</td>
<td class="nump">3,284,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2019Member', window );">Restricted share plan 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,128,458<span></span>
</td>
<td class="nump">3,375,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2018Member', window );">Restricted share plan 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,886,337<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from equity-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfRestrictedSharesNotYetFullyVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of restricted shares not yet fully vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfRestrictedSharesNotYetFullyVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>182
<FILENAME>R138.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435823696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Summary of Characteristics of Employee Share Ownership Plans Awarded (Details) - &#8364; / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 03, 2022</div></th>
<th class="th"><div>Feb. 04, 2021</div></th>
<th class="th"><div>Feb. 05, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfAverageOfQuotedMarketPricesOfShares', window );">Subscription price (as a percent)</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfTradingDaysPrecedingPlanApproval', window );">Number of trading days preceding plan approval</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_EmployeesShareOwnershipPlanMember', window );">Employees share ownership plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SubscriptionPricePerShare', window );">Subscription price (in euros per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 80.21<span></span>
</td>
<td class="nump">&#8364; 69.38<span></span>
</td>
<td class="nump">&#8364; 70.67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfShareSubscribed', window );">Number of shares subscribed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,909,008<span></span>
</td>
<td class="nump">2,438,590<span></span>
</td>
<td class="nump">2,467,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IssuanceOfFurtherSharesAsAnEmployersContribution', window );">Number of shares issued immediately as employer's contribution (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,049<span></span>
</td>
<td class="nump">124,112<span></span>
</td>
<td class="nump">123,615<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IssuanceOfFurtherSharesAsAnEmployersContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Further shares as an employers contribution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IssuanceOfFurtherSharesAsAnEmployersContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfShareSubscribed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares subscribed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfShareSubscribed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfTradingDaysPrecedingPlanApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Trading Days Preceding Plan Approval</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfTradingDaysPrecedingPlanApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfAverageOfQuotedMarketPricesOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of average of quoted market prices of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfAverageOfQuotedMarketPricesOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subscription price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_EmployeesShareOwnershipPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_EmployeesShareOwnershipPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R139.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405444276384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Summary of Expenses (Details) - Employees share ownership plan - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expense recognized</a></td>
<td class="nump">&#8364; 39<span></span>
</td>
<td class="nump">&#8364; 51<span></span>
</td>
<td class="nump">&#8364; 52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution', window );">Expense recognized of which employers' contribution</a></td>
<td class="nump">&#8364; 11<span></span>
</td>
<td class="nump">&#8364; 11<span></span>
</td>
<td class="nump">&#8364; 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from equity-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense recognized in equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_EmployeesShareOwnershipPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_EmployeesShareOwnershipPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R140.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432096896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Summary of Repurchases Program (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AwardsDateAxis=sny_ShareRepurchase2022ProgramMember', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesRepurchased', window );">Number of shares (in shares)</a></td>
<td class="nump">1,510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AmountOfSharesRepurchased', window );">Value</a></td>
<td class="nump">&#8364; 137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AwardsDateAxis=sny_ShareRepurchase2021ProgramMember', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesRepurchased', window );">Number of shares (in shares)</a></td>
<td class="nump">3,976,992<span></span>
</td>
<td class="nump">2,765,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AmountOfSharesRepurchased', window );">Value</a></td>
<td class="nump">&#8364; 360<span></span>
</td>
<td class="nump">&#8364; 242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AwardsDateAxis=sny_ShareRepurchase2020ProgramMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesRepurchased', window );">Number of shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,758,569<span></span>
</td>
<td class="nump">5,685,426<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AmountOfSharesRepurchased', window );">Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 140<span></span>
</td>
<td class="nump">&#8364; 461<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AwardsDateAxis=sny_ShareRepurchase2019ProgramMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesRepurchased', window );">Number of shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,982,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AmountOfSharesRepurchased', window );">Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 361<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AmountOfSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AmountOfSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AwardsDateAxis=sny_ShareRepurchase2022ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AwardsDateAxis=sny_ShareRepurchase2022ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AwardsDateAxis=sny_ShareRepurchase2021ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AwardsDateAxis=sny_ShareRepurchase2021ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AwardsDateAxis=sny_ShareRepurchase2020ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AwardsDateAxis=sny_ShareRepurchase2020ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AwardsDateAxis=sny_ShareRepurchase2019ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AwardsDateAxis=sny_ShareRepurchase2019ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>R141.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432253312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Summary of Currency Translation Differences (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Attributable to equity holders of Sanofi</a></td>
<td class="nump">&#8364; 74,784<span></span>
</td>
<td class="nump">&#8364; 68,681<span></span>
</td>
<td class="nump">&#8364; 63,106<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Attributable to non-controlling interests</a></td>
<td class="nump">368<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">75,152<span></span>
</td>
<td class="nump">69,031<span></span>
</td>
<td class="nump">63,252<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">&#8364; 59,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember', window );">Reserve of exchange differences on translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Attributable to equity holders of Sanofi</a></td>
<td class="nump">1,499<span></span>
</td>
<td class="num">(865)<span></span>
</td>
<td class="num">(3,384)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Attributable to non-controlling interests</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">&#8364; 1,462<span></span>
</td>
<td class="num">&#8364; (907)<span></span>
</td>
<td class="num">&#8364; (3,439)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Paragraph 22<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>186
<FILENAME>R142.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456272304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Summary of Movements within Other Comprehensive Income (Details) - EUR (&#8364;)<br></strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax', window );">Items not subsequently reclassifiable to profit or loss</a></td>
<td class="nump">&#8364; 451,000,000<span></span>
</td>
<td class="nump">&#8364; 797,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 14,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items subsequently reclassifiable to profit or loss</a></td>
<td class="nump">2,313,000,000<span></span>
</td>
<td class="nump">2,510,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(4,021,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items not subsequently reclassifiable to profit or loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures', window );">Actuarial gains/(losses) excluding investments accounted for using the equity method (see Note&#160;D.19.1.)</a></td>
<td class="nump">650,000,000<span></span>
</td>
<td class="nump">685,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(266,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures', window );">Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures', window );">Tax effects</a></td>
<td class="num">(212,000,000)<span></span>
</td>
<td class="num">(36,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">45,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items not subsequently reclassifiable to profit or loss | Equity instruments included in financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures', window );">Change in fair value (excluding investments accounted for using the equity method)</a></td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="nump">154,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">358,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax', window );">Change in fair value (investments accounted for using the equity method, net of taxes)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(14,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges', window );">Equity risk hedging instruments designated as fair value hedges</a></td>
<td class="nump">17,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(24,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod', window );">Tax effects</a></td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="num">(18,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(84,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax', window );">Items not subsequently reclassifiable to profit or loss</a></td>
<td class="nump">451,000,000<span></span>
</td>
<td class="nump">797,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items subsequently reclassifiable to profit or loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures', window );">Change in fair value (excluding investments accounted for using the equity method)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures', window );">Change in fair value (investments accounted for using the equity method, net of taxes)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome', window );">Tax effects</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures', window );">Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method)</a></td>
<td class="nump">2,643,000,000<span></span>
</td>
<td class="nump">2,719,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,870,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures', window );">Currency translation differences (investments accounted for using the equity method)</a></td>
<td class="num">(11,000,000)<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">32,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations', window );">Hedges of net investments in foreign operations</a></td>
<td class="num">(354,000,000)<span></span>
</td>
<td class="num">(254,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">180,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInCurrencyTranslationOnTaxEffects', window );">Tax effects</a></td>
<td class="nump">91,000,000<span></span>
</td>
<td class="nump">71,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(59,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items subsequently reclassifiable to profit or loss</a></td>
<td class="nump">2,313,000,000<span></span>
</td>
<td class="nump">2,510,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,021,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items subsequently reclassifiable to profit or loss | Regeneron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures', window );">Currency translation differences (investments accounted for using the equity method)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(318,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInCurrencyTranslationOnTaxEffects', window );">Tax effects</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items subsequently reclassifiable to profit or loss | Debt instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures', window );">Change in fair value (excluding investments accounted for using the equity method)</a></td>
<td class="num">(77,000,000)<span></span>
</td>
<td class="num">(21,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures', window );">Tax effects</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items subsequently reclassifiable to profit or loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items subsequently reclassifiable to profit or loss | Cash Flow And Fair Value Hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items subsequently reclassifiable to profit or loss</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items subsequently reclassifiable to profit or loss | Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items subsequently reclassifiable to profit or loss</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items subsequently reclassifiable to profit or loss | Foreign Currency Translation | EUROAPI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items subsequently reclassifiable to profit or loss</a></td>
<td class="nump">&#8364; 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax relating to amounts recognised in other comprehensive income in relation to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph ab<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_ab&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 90<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_90&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset excluding associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset net of tax on associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in currency translation before tax excluding associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in currency translation net of tax on associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in currency translation on hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInCurrencyTranslationOnTaxEffects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in currency translation on tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInCurrencyTranslationOnTaxEffects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value on cash flow hedges excluding associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value on cash flow hedges net of tax on associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Fair Value On Debt Instrument Excluding Associates And Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Fair Value On Equity Instruments Excluding Associates And Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Fair Value On Equity Instruments For Investments Accounted For Using The Equity Method Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Risk Hedging Instruments Designated At Fair Value Hedges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Relating To Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Net Of Tax On Associates And Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Relating To Change In Fair Value Of Debt Instrument Excluding Associates And Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Relating To Change In Fair Value Of Equity Instruments Excluding Equity Method</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassifiedItemsAxis=sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassifiedItemsAxis=sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=sny_EquityInstrumentsIncludedInFinancialAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=sny_EquityInstrumentsIncludedInFinancialAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassifiedItemsAxis=sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassifiedItemsAxis=sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=sny_DebtInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=sny_DebtInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=sny_CashFlowAndFairValueHedgeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=sny_CashFlowAndFairValueHedgeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=sny_ForeignCurrencyTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=sny_ForeignCurrencyTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EuroapiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EuroapiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>187
<FILENAME>R143.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405433860384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Disclosure of Stock Subscription Option Plan Outstanding and Option Exercised (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 02, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 10, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 04, 2016 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 24, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 05, 2014 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 05, 2013 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 05, 2012 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanMember', window );">Stock subscription option plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems', window );"><strong>Disclosure of stock subscription option plan outstanding and option exercised [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,837,969<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanThreeMember', window );">Stock subscription option plan three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems', window );"><strong>Disclosure of stock subscription option plan outstanding and option exercised [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">814,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_StockBasedCompensationStockOptionsExercisedPricePerShare', window );">Exercise price (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 56.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanFourMember', window );">Stock subscription option plan four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems', window );"><strong>Disclosure of stock subscription option plan outstanding and option exercised [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">788,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_StockBasedCompensationStockOptionsExercisedPricePerShare', window );">Exercise price (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 72.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanFiveMember', window );">Stock subscription option plan five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems', window );"><strong>Disclosure of stock subscription option plan outstanding and option exercised [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,009,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_StockBasedCompensationStockOptionsExercisedPricePerShare', window );">Exercise price (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 73.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">506,042<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanSixMember', window );">Stock subscription option plan six</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems', window );"><strong>Disclosure of stock subscription option plan outstanding and option exercised [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">435,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_StockBasedCompensationStockOptionsExercisedPricePerShare', window );">Exercise price (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 89.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">338,464<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanSevenMember', window );">Stock subscription option plan seven</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems', window );"><strong>Disclosure of stock subscription option plan outstanding and option exercised [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">402,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_StockBasedCompensationStockOptionsExercisedPricePerShare', window );">Exercise price (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 75.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanEightMember', window );">Stock subscription option plan eight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems', window );"><strong>Disclosure of stock subscription option plan outstanding and option exercised [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">378,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_StockBasedCompensationStockOptionsExercisedPricePerShare', window );">Exercise price (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 88.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268,440<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanNineMember', window );">Stock subscription option plan nine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems', window );"><strong>Disclosure of stock subscription option plan outstanding and option exercised [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_StockBasedCompensationStockOptionsExercisedPricePerShare', window );">Exercise price (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 65.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,784<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanTenMember', window );">Stock subscription option plan ten</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems', window );"><strong>Disclosure of stock subscription option plan outstanding and option exercised [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of options granted (in shares)</a></td>
<td class="nump">220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_StockBasedCompensationStockOptionsExercisedPricePerShare', window );">Exercise price (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 76.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of instruments granted in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph IG23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG23&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of stock subscription option plan outstanding and option exercised [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_StockBasedCompensationStockOptionsExercisedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock based compensation stock options exercised price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_StockBasedCompensationStockOptionsExercisedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=sny_StockSubscriptionOptionPlanTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>188
<FILENAME>R144.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432115616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Summary of Stock Options Outstanding at Each Balance Sheet Date (Details) - Total stock option plans<br> &#8364; / shares in Units, &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement', window );">Number of options, beginning balance (in shares) | shares</a></td>
<td class="nump">2,337,968<span></span>
</td>
<td class="nump">2,579,270<span></span>
</td>
<td class="nump">3,822,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of options, options exercisable (in shares) | shares</a></td>
<td class="nump">1,624,569<span></span>
</td>
<td class="nump">1,949,184<span></span>
</td>
<td class="nump">1,845,050<span></span>
</td>
<td class="nump">2,650,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of options, options exercised (in shares) | shares</a></td>
<td class="num">(490,373)<span></span>
</td>
<td class="num">(190,076)<span></span>
</td>
<td class="num">(868,655)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement', window );">Number of options, options cancelled (in shares) | shares</a></td>
<td class="num">(9,626)<span></span>
</td>
<td class="num">(51,216)<span></span>
</td>
<td class="num">(91,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Number of options, options forfeited (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(282,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement', window );">Number of options, ending balance (in shares) | shares</a></td>
<td class="nump">1,837,969<span></span>
</td>
<td class="nump">2,337,968<span></span>
</td>
<td class="nump">2,579,270<span></span>
</td>
<td class="nump">3,822,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Average exercise&#160;price per share, beginning balance (in euros per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 77.13<span></span>
</td>
<td class="nump">&#8364; 75.61<span></span>
</td>
<td class="nump">&#8364; 70.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Average exercise&#160;price per share, options exercisable (in euros per share) | &#8364; / shares</a></td>
<td class="nump">78.89<span></span>
</td>
<td class="nump">78.15<span></span>
</td>
<td class="nump">74.51<span></span>
</td>
<td class="nump">&#8364; 67.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Average exercise&#160;price per share, options exercised (in euros per share) | &#8364; / shares</a></td>
<td class="nump">71.39<span></span>
</td>
<td class="nump">59.53<span></span>
</td>
<td class="nump">59.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement', window );">Average exercise&#160;price per share, options cancelled (in euros per share) | &#8364; / shares</a></td>
<td class="nump">80.56<span></span>
</td>
<td class="nump">65.84<span></span>
</td>
<td class="nump">87.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Average exercise&#160;price per share, options forfeited (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.48<span></span>
</td>
<td class="nump">54.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Average exercise&#160;price per share, ending balance (in euros per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 78.64<span></span>
</td>
<td class="nump">&#8364; 77.13<span></span>
</td>
<td class="nump">&#8364; 75.61<span></span>
</td>
<td class="nump">&#8364; 70.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement', window );">Total, beginning balance | &#8364;</a></td>
<td class="nump">&#8364; 180<span></span>
</td>
<td class="nump">&#8364; 195<span></span>
</td>
<td class="nump">&#8364; 270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement', window );">Total, options exercisable | &#8364;</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">&#8364; 178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement', window );">Total, options exercised | &#8364;</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement', window );">Total, options cancelled | &#8364;</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement', window );">Total, options forfeited | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement', window );">Total, ending balance | &#8364;</a></td>
<td class="nump">&#8364; 145<span></span>
</td>
<td class="nump">&#8364; 180<span></span>
</td>
<td class="nump">&#8364; 195<span></span>
</td>
<td class="nump">&#8364; 270<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Share Options Cancelled In Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfShareOutstandingInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share outstanding in share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfShareOutstandingInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value Of Share Options Cancelled In Share Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of share options exercisable in share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of share options exercised in share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of share options forfeited in share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of share options outstanding in share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price Of Share Options Cancelled In Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_TotalStockOptionPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_TotalStockOptionPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>189
<FILENAME>R145.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435844192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Summary of Options Outstanding and Exercisable (Details) - Stock Option Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding, Number&#160;of options (in shares) | shares</a></td>
<td class="nump">1,837,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable, number of options (in shares) | shares</a></td>
<td class="nump">1,624,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeTwoMember', window );">Exercise price range two</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding, Number&#160;of options (in shares) | shares</a></td>
<td class="nump">168,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average residual&#160;life (years)</a></td>
<td class="text">5 years 4 months 2 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in euros per share)</a></td>
<td class="nump">&#8364; 65.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable, number of options (in shares) | shares</a></td>
<td class="nump">168,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise&#160;price per share, Options exercisable (in euros per share)</a></td>
<td class="nump">&#8364; 65.84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeThreeMember', window );">Exercise price range three</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding, Number&#160;of options (in shares) | shares</a></td>
<td class="nump">1,062,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average residual&#160;life (years)</a></td>
<td class="text">2 years 8 months 4 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in euros per share)</a></td>
<td class="nump">&#8364; 74.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable, number of options (in shares) | shares</a></td>
<td class="nump">848,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise&#160;price per share, Options exercisable (in euros per share)</a></td>
<td class="nump">&#8364; 74.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeFourMember', window );">Exercise price range four</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding, Number&#160;of options (in shares) | shares</a></td>
<td class="nump">606,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average residual&#160;life (years)</a></td>
<td class="text">3 years 3 months 21 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in euros per share)</a></td>
<td class="nump">&#8364; 89.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable, number of options (in shares) | shares</a></td>
<td class="nump">606,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise&#160;price per share, Options exercisable (in euros per share)</a></td>
<td class="nump">&#8364; 89.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range | Exercise price range two</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">60.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range | Exercise price range three</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">70.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range | Exercise price range four</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">80.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range | Exercise price range two</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">70.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range | Exercise price range three</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">80.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range | Exercise price range four</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">&#8364; 90.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of outstanding share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=sny_StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=sny_StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>190
<FILENAME>R146.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442636976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated shareholders&#8217; equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract', window );"><strong>Share Capital, Reserves And Other Equity Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Average number of shares outstanding (in shares)</a></td>
<td class="nump">1,251.9<span></span>
</td>
<td class="nump">1,252.5<span></span>
</td>
<td class="nump">1,253.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares', window );">Adjustment for stock options with dilutive effect (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares', window );">Adjustment for restricted shares (in shares)</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Average number of shares used to compute diluted earnings per share (in shares)</a></td>
<td class="nump">1,256.9<span></span>
</td>
<td class="nump">1,257.9<span></span>
</td>
<td class="nump">1,260.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dilutive effect of share options on number of restricted shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Capital, Reserves And Other Equity Interest [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareCapitalReservesAndOtherEquityInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>191
<FILENAME>R147.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442606000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Summary of Changes in Financial Position (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinancialInstrumentsAbstract', window );"><strong>Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="nump">&#8364; 14,857<span></span>
</td>
<td class="nump">&#8364; 17,123<span></span>
</td>
<td class="nump">&#8364; 19,745<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="nump">4,174<span></span>
</td>
<td class="nump">3,183<span></span>
</td>
<td class="nump">2,767<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">187<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">19,218<span></span>
</td>
<td class="nump">20,250<span></span>
</td>
<td class="nump">22,631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 24,568<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(10,098)<span></span>
</td>
<td class="num">(13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
<td class="num">(9,427)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">&#8364; 6,437<span></span>
</td>
<td class="nump">9,983<span></span>
</td>
<td class="nump">8,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,181<span></span>
</td>
<td class="nump">&#8364; 2,108<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,163<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage cash and cash equivalent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>192
<FILENAME>R148.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431848272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="nump">&#8364; 14,857<span></span>
</td>
<td class="nump">&#8364; 17,123<span></span>
</td>
<td class="nump">&#8364; 19,745<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="nump">4,174<span></span>
</td>
<td class="nump">3,183<span></span>
</td>
<td class="nump">2,767<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">187<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">19,218<span></span>
</td>
<td class="nump">20,250<span></span>
</td>
<td class="nump">22,631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 24,568<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(10,098)<span></span>
</td>
<td class="num">(13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
<td class="num">&#8364; (9,427)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">6,437<span></span>
</td>
<td class="nump">9,983<span></span>
</td>
<td class="nump">8,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AmortizedCostMember', window );">Amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AdjustmentToDebtMeasuredAtFairValueMember', window );">Adjustment to debt measured&#160;at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="num">(235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="nump">15,143<span></span>
</td>
<td class="nump">17,176<span></span>
</td>
<td class="nump">19,794<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="nump">4,178<span></span>
</td>
<td class="nump">3,183<span></span>
</td>
<td class="nump">2,767<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">19,273<span></span>
</td>
<td class="nump">20,314<span></span>
</td>
<td class="nump">22,703<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(10,098)<span></span>
</td>
<td class="num">(13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">&#8364; 6,492<span></span>
</td>
<td class="nump">&#8364; 10,047<span></span>
</td>
<td class="nump">&#8364; 8,862<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of carrying amount to value on redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage cash and cash equivalent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AmortizedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AmortizedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AdjustmentToDebtMeasuredAtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AdjustmentToDebtMeasuredAtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>193
<FILENAME>R149.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405423678384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Disclosure of Movement In Total Debt (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtLineItems', window );"><strong>Disclosure of debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings at beginning of period</a></td>
<td class="nump">&#8364; 20,250<span></span>
</td>
<td class="nump">&#8364; 22,631<span></span>
</td>
<td class="nump">&#8364; 24,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Repayments</a></td>
<td class="num">(2,718)<span></span>
</td>
<td class="num">(2,241)<span></span>
</td>
<td class="num">(3,952)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">New borrowings</a></td>
<td class="nump">1,549<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities', window );">Other cash flows</a></td>
<td class="num">(330)<span></span>
</td>
<td class="num">(812)<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ForeignCurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="nump">442<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="num">(385)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ReclassificationFromNonCurrentToCurrent', window );">Reclassification from non-current to current</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsForNoncashItems', window );">Other items</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings at end of period</a></td>
<td class="nump">19,218<span></span>
</td>
<td class="nump">20,250<span></span>
</td>
<td class="nump">22,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_LongtermBorrowingsMember', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtLineItems', window );"><strong>Disclosure of debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings at beginning of period</a></td>
<td class="nump">17,123<span></span>
</td>
<td class="nump">19,745<span></span>
</td>
<td class="nump">20,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Repayments</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">New borrowings</a></td>
<td class="nump">1,549<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities', window );">Other cash flows</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ForeignCurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="num">(152)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ReclassificationFromNonCurrentToCurrent', window );">Reclassification from non-current to current</a></td>
<td class="num">(3,632)<span></span>
</td>
<td class="num">(2,704)<span></span>
</td>
<td class="num">(2,285)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsForNoncashItems', window );">Other items</a></td>
<td class="num">(228)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings at end of period</a></td>
<td class="nump">14,857<span></span>
</td>
<td class="nump">17,123<span></span>
</td>
<td class="nump">19,745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtLineItems', window );"><strong>Disclosure of debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings at beginning of period</a></td>
<td class="nump">3,183<span></span>
</td>
<td class="nump">2,767<span></span>
</td>
<td class="nump">4,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Repayments</a></td>
<td class="num">(2,707)<span></span>
</td>
<td class="num">(2,203)<span></span>
</td>
<td class="num">(3,952)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">New borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities', window );">Other cash flows</a></td>
<td class="nump">43<span></span>
</td>
<td class="num">(615)<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ForeignCurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="num">(219)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ReclassificationFromNonCurrentToCurrent', window );">Reclassification from non-current to current</a></td>
<td class="nump">3,632<span></span>
</td>
<td class="nump">2,704<span></span>
</td>
<td class="nump">2,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsForNoncashItems', window );">Other items</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings at end of period</a></td>
<td class="nump">4,174<span></span>
</td>
<td class="nump">3,183<span></span>
</td>
<td class="nump">2,767<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtLineItems', window );"><strong>Disclosure of debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings at beginning of period</a></td>
<td class="num">(56)<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="num">(117)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Repayments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">New borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities', window );">Other cash flows</a></td>
<td class="num">(373)<span></span>
</td>
<td class="num">(197)<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ForeignCurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="nump">366<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ReclassificationFromNonCurrentToCurrent', window );">Reclassification from non-current to current</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsForNoncashItems', window );">Other items</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings at end of period</a></td>
<td class="nump">&#8364; 187<span></span>
</td>
<td class="num">&#8364; (56)<span></span>
</td>
<td class="nump">&#8364; 119<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAdjustmentsForNoncashItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAdjustmentsForNoncashItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 21<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_21&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ForeignCurrencyTranslationDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Translation Differences</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ForeignCurrencyTranslationDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ReclassificationFromNonCurrentToCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification from non current to current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ReclassificationFromNonCurrentToCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_LongtermBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_LongtermBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>194
<FILENAME>R150.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405424052704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Additional Information (Details)<br> &#8364; in Millions, patient in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>bond</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>credit_facility </div>
<div>currency </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>credit_facility </div>
<div>currency </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>EUR (&#8364;) </div>
<div>Country </div>
<div>patient </div>
<div>tranche</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>performance_indicator </div>
<div>credit_facility</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2014 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfBondIssuesRedeemed', window );">Number of bond issues redeemed | bond</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCreditFacilities', window );">Number of credit facilities | credit_facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCurrenciesDebtIsIssuedIn', window );">Number of currencies debt is issued in | currency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | Weighted average interest rate before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Bonds, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CashAndCashEquivalentsInvestedRate', window );">Cash and cash equivalents, invested rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | Weighted average interest rate after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Bonds, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CashAndCashEquivalentsInvestedRate', window );">Cash and cash equivalents, invested rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_SanofiSustainabilityLinkedCreditFacilitiesMember', window );">Sanofi sustainability-linked credit facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCreditFacilities', window );">Number of credit facilities | credit_facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSustainableDevelopmentPerformanceIndicators', window );">Number of sustainable development performance indicators | performance_indicator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_ParticipatingSharesMember', window );">1983 to 1987 participating shares issued | Sanofi Euro Medium Term Notes (EMTN) bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ParticipatingSharesNumberOutstanding', window );">Number of participating shares outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,996<span></span>
</td>
<td class="nump">74,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ParticipatingSharesCarryingAmount', window );">Participating shares carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_SyndicatedCreditFacilityOneMember', window );">Syndicated credit facility, expires in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Credit facilities, amount drawable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_SyndicatedCreditFacilityOneMember', window );">Syndicated credit facility, expires in 2022 | Sanofi Euro Medium Term Notes (EMTN) bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Credit facilities, amount drawable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_SyndicatedCreditFacilityTwoMember', window );">Syndicated credit facility, expires in December 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Credit facilities, amount drawable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_SyndicatedCreditFacilityTwoMember', window );">Syndicated credit facility, expires in December 2025 | Sanofi Euro Medium Term Notes (EMTN) bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Credit facilities, amount drawable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInFranceMember', window );">Commercial paper program in France | Sanofi Euro Medium Term Notes (EMTN) bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CommercialPapersIssued', window );">Commercial paper programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInUSAMember', window );">Commercial paper program in USA | Sanofi Euro Medium Term Notes (EMTN) bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CommercialPapersIssued', window );">Commercial paper programs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BorrowingAverageDrawdown', window );">Borrowing, average drawdown | $</a></td>
<td class="nump">$ 2,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BorrowingMaximumDrawdown', window );">Borrowing, maximum drawdown | $</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BorrowingDrawdown', window );">Borrowing, drawdown | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember', window );">Main undrawn confirmed general purpose credit facilities | Sanofi Euro Medium Term Notes (EMTN) bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Credit facilities, amount drawable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member', window );">One Billion Five Hundred Million Bonds, Issued In April 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Credit facilities, amount drawable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember', window );">Eight Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Credit facilities, amount drawable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Bonds, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember', window );">Six Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Nine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Credit facilities, amount drawable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Bonds, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PerformanceObjectiveMinimumNumberOfPatients', window );">Performance objective, minimum number of patients | patient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PerformanceObjectiveNumberOfCountries', window );">Number of countries | Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_OneBillionBondsMaturingJanuary2022Member', window );">One Billion Bonds Maturing January 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Credit facilities, amount drawable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member', window );">Eight Hundred Fifty Million Bonds Maturing February 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Credit facilities, amount drawable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_EightHundredFiftyMillionBondsMaturingJune2022Member', window );">Eight Hundred Fifty Million Bonds Maturing June 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Credit facilities, amount drawable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CommercialPapersIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of commercial paper issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CommercialPapersIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BorrowingAverageDrawdown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing, Average Drawdown</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BorrowingAverageDrawdown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BorrowingDrawdown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing, Drawdown</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BorrowingDrawdown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BorrowingMaximumDrawdown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum drawdown.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BorrowingMaximumDrawdown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CashAndCashEquivalentsInvestedRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents invested rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CashAndCashEquivalentsInvestedRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfBondIssuesRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Bond Issues Redeemed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfBondIssuesRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfCreditFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Credit Facilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfCreditFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfCurrenciesDebtIsIssuedIn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Currencies Debt Is Issued In</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfCurrenciesDebtIsIssuedIn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfSustainableDevelopmentPerformanceIndicators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Sustainable Development Performance Indicators</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfSustainableDevelopmentPerformanceIndicators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ParticipatingSharesCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Participating shares carrying amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ParticipatingSharesCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ParticipatingSharesNumberOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Participating shares number outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ParticipatingSharesNumberOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PerformanceObjectiveMinimumNumberOfPatients">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Performance Objective, Minimum Number Of Patients</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PerformanceObjectiveMinimumNumberOfPatients</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PerformanceObjectiveNumberOfCountries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Performance Objective, Number Of Countries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PerformanceObjectiveNumberOfCountries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_SanofiSustainabilityLinkedCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_SanofiSustainabilityLinkedCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_ParticipatingSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_ParticipatingSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_SyndicatedCreditFacilityOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_SyndicatedCreditFacilityOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_SyndicatedCreditFacilityTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_SyndicatedCreditFacilityTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_OneBillionBondsMaturingJanuary2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_OneBillionBondsMaturingJanuary2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_EightHundredFiftyMillionBondsMaturingJune2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_EightHundredFiftyMillionBondsMaturingJune2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>195
<FILENAME>R151.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405434301824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Summary of Net Debt by Type Valuation of Redemption (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">&#8364; 187<span></span>
</td>
<td class="num">&#8364; (56)<span></span>
</td>
<td class="nump">&#8364; 119<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">19,218<span></span>
</td>
<td class="nump">20,250<span></span>
</td>
<td class="nump">22,631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 24,568<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(10,098)<span></span>
</td>
<td class="num">(13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="num">&#8364; (9,427)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">6,437<span></span>
</td>
<td class="nump">9,983<span></span>
</td>
<td class="nump">8,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">18,861<span></span>
</td>
<td class="nump">19,946<span></span>
</td>
<td class="nump">21,978<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinanceLeaseLiabilities', window );">Finance lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">19,273<span></span>
</td>
<td class="nump">20,314<span></span>
</td>
<td class="nump">22,703<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(10,098)<span></span>
</td>
<td class="num">(13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">6,492<span></span>
</td>
<td class="nump">10,047<span></span>
</td>
<td class="nump">8,862<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">3,817<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
<td class="nump">2,280<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinanceLeaseLiabilities', window );">Finance lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">4,130<span></span>
</td>
<td class="nump">3,138<span></span>
</td>
<td class="nump">2,852<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(10,098)<span></span>
</td>
<td class="num">(13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(8,651)<span></span>
</td>
<td class="num">(7,129)<span></span>
</td>
<td class="num">(10,995)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | 1&#160;to&#160;2 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">3,629<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinanceLeaseLiabilities', window );">Finance lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">661<span></span>
</td>
<td class="nump">3,647<span></span>
</td>
<td class="nump">2,830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">661<span></span>
</td>
<td class="nump">3,647<span></span>
</td>
<td class="nump">2,836<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | 2 to 3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">3,569<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinanceLeaseLiabilities', window );">Finance lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="nump">3,575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="nump">3,575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | 3 to 4 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinanceLeaseLiabilities', window );">Finance lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | 4 to 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinanceLeaseLiabilities', window );">Finance lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,756<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,756<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">7,684<span></span>
</td>
<td class="nump">6,979<span></span>
</td>
<td class="nump">11,079<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinanceLeaseLiabilities', window );">Finance lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">7,722<span></span>
</td>
<td class="nump">7,016<span></span>
</td>
<td class="nump">11,088<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">7,722<span></span>
</td>
<td class="nump">7,016<span></span>
</td>
<td class="nump">11,088<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | Non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">15,143<span></span>
</td>
<td class="nump">17,176<span></span>
</td>
<td class="nump">19,857<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(10,098)<span></span>
</td>
<td class="num">(13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(8,651)<span></span>
</td>
<td class="num">(7,129)<span></span>
</td>
<td class="num">(10,995)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | Non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">15,044<span></span>
</td>
<td class="nump">17,118<span></span>
</td>
<td class="nump">19,698<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">15,143<span></span>
</td>
<td class="nump">17,176<span></span>
</td>
<td class="nump">19,851<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">3,817<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
<td class="nump">2,280<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">&#8364; 4,130<span></span>
</td>
<td class="nump">&#8364; 3,138<span></span>
</td>
<td class="nump">&#8364; 2,852<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that has been withdrawn from an account in excess of existing cash balances. This is considered a short-term extension of credit by the bank. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankOverdraftsClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BondsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of bonds issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BondsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of carrying amount to value on redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage cash and cash equivalent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherBankBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other bank borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherBankBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_NonCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_NonCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_CurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_CurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=sny_NoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=sny_NoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=sny_CurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=sny_CurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>196
<FILENAME>R152.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431235888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Summary of Bond Issues (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 30, 2016 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2014 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Nov. 30, 2013 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | November 2013 EMTN ISIN FR0011625433</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | April 2022 EMTN ISIN FR0014009KS6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | September 2014 EMTN ISIN FR0012146801</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | April 2022 EMTN ISIN FR0014009KQ0</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | September 2015 EMTN ISIN FR0012969038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | April 2016 EMTN ISIN FR0013143997</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | April 2016 EMTN ISIN FR0013144003</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | September 2016 EMTN ISIN FR0013201639</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | March 2020 EMTN ISIN FR0013505104</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="nump">&#8364; 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | March 2020 EMTN ISIN FR0013505112</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="nump">&#8364; 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | March 2018 EMTN ISIN FR0013324332</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | March 2018 EMTN ISIN FR0013324340</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | March 2018 EMTN ISIN FR0013324357</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | March 2018 EMTN ISIN FR0013324373</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | March 2019 EMTN ISIN FR0013409844</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember', window );">Sanofi Euro Medium Term Notes (EMTN) bonds | March 2019 EMTN ISIN FR0013409851</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_ShelfRegistrationStatementProgramMember', window );">Shelf registration statement program | June 2018 SNF ISIN US801060AC87</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtInstrumentAxis=sny_ShelfRegistrationStatementProgramMember', window );">Shelf registration statement program | June 2018 SNF ISIN US801060AD60</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Annual&#160;interest&#160;rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_November2013EMTNISINFR0011625433Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_November2013EMTNISINFR0011625433Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_April2022EMTNISINFR0014009KS6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_April2022EMTNISINFR0014009KS6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_September2014EMTNISINFR0012146801Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_September2014EMTNISINFR0012146801Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_April2022EMTNISINFR0014009KQ0Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_April2022EMTNISINFR0014009KQ0Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_September2015EMTNISINFR0012969038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_September2015EMTNISINFR0012969038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_April2016EMTNISINFR0013143997Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_April2016EMTNISINFR0013143997Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_April2016EMTNISINFR0013144003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_April2016EMTNISINFR0013144003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_September2016EMTNISINFR0013201639Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_September2016EMTNISINFR0013201639Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_March2020EMTNISINFR0013505104Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_March2020EMTNISINFR0013505104Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_March2020EMTNISINFR0013505112Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_March2020EMTNISINFR0013505112Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_March2018EMTNISINFR0013324332Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_March2018EMTNISINFR0013324332Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_March2018EMTNISINFR0013324340Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_March2018EMTNISINFR0013324340Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_March2018EMTNISINFR0013324357Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_March2018EMTNISINFR0013324357Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_March2018EMTNISINFR0013324373Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_March2018EMTNISINFR0013324373Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_March2019EMTNISINFR0013409844Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_March2019EMTNISINFR0013409844Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_March2019EMTNISINFR0013409851Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_March2019EMTNISINFR0013409851Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtInstrumentAxis=sny_ShelfRegistrationStatementProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtInstrumentAxis=sny_ShelfRegistrationStatementProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_June2018SNFISINUS801060AC87Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_June2018SNFISINUS801060AC87Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_June2018SNFISINUS801060AD60Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_June2018SNFISINUS801060AD60Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>197
<FILENAME>R153.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431434560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Maturity at Value on Redemption (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">&#8364; 187<span></span>
</td>
<td class="num">&#8364; (56)<span></span>
</td>
<td class="nump">&#8364; 119<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">19,218<span></span>
</td>
<td class="nump">20,250<span></span>
</td>
<td class="nump">22,631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 24,568<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(10,098)<span></span>
</td>
<td class="num">(13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="num">(9,427)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">6,437<span></span>
</td>
<td class="nump">9,983<span></span>
</td>
<td class="nump">8,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,181<span></span>
</td>
<td class="nump">2,108<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,163<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,129<span></span>
</td>
<td class="nump">1,184<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">18,861<span></span>
</td>
<td class="nump">19,946<span></span>
</td>
<td class="nump">21,978<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">19,273<span></span>
</td>
<td class="nump">20,314<span></span>
</td>
<td class="nump">22,703<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(10,098)<span></span>
</td>
<td class="num">(13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">6,492<span></span>
</td>
<td class="nump">10,047<span></span>
</td>
<td class="nump">8,862<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">3,817<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
<td class="nump">2,280<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">4,130<span></span>
</td>
<td class="nump">3,138<span></span>
</td>
<td class="nump">2,852<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(10,098)<span></span>
</td>
<td class="num">(13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(8,651)<span></span>
</td>
<td class="num">(7,129)<span></span>
</td>
<td class="num">(10,995)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | 1&#160;to&#160;2 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">3,629<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">661<span></span>
</td>
<td class="nump">3,647<span></span>
</td>
<td class="nump">2,830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">661<span></span>
</td>
<td class="nump">3,647<span></span>
</td>
<td class="nump">2,836<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | 2 to 3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">3,569<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="nump">3,575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="nump">3,575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | 3 to 4 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | 4 to 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,756<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,160<span></span>
</td>
<td class="nump">1,756<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="nump">7,684<span></span>
</td>
<td class="nump">6,979<span></span>
</td>
<td class="nump">11,079<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">7,722<span></span>
</td>
<td class="nump">7,016<span></span>
</td>
<td class="nump">11,088<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">&#8364; 7,722<span></span>
</td>
<td class="nump">&#8364; 7,016<span></span>
</td>
<td class="nump">&#8364; 11,088<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that has been withdrawn from an account in excess of existing cash balances. This is considered a short-term extension of credit by the bank. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankOverdraftsClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BondsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of bonds issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BondsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage cash and cash equivalent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherBankBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other bank borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherBankBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>198
<FILENAME>R154.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405429349424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Interest Rate (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">&#8364; (12,736)<span></span>
</td>
<td class="num">&#8364; (10,098)<span></span>
</td>
<td class="num">&#8364; (13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td colspan="2" class="num">&#8364; (9,427)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">6,437<span></span>
</td>
<td class="nump">&#8364; 9,983<span></span>
</td>
<td class="nump">&#8364; 8,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember', window );">Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">&#8364; 19,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtPercent', window );">Debt, percent</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">&#8364; 6,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember', window );">Value on redemption before derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">&#8364; 18,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtPercent', window );">Debt, percent</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember', window );">Value on redemption before derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">&#8364; 460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtPercent', window );">Debt, percent</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">&#8364; (12,736)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember', window );">Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">19,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtPercent', window );">Debt, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,781)<span></span>
</td>
<td class="num">&#8364; (10,267)<span></span>
</td>
<td class="num">&#8364; (13,841)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">6,492<span></span>
</td>
<td class="nump">&#8364; 10,047<span></span>
</td>
<td class="nump">&#8364; 8,862<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember', window );">Value on redemption after derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">&#8364; 16,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtPercent', window );">Debt, percent</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">87.00%<span></span>
</td>
<td class="nump">91.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember', window );">Value on redemption after derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">&#8364; 2,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtPercent', window );">Debt, percent</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Year 1 | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">&#8364; 4,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(8,558)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Year 1 | Value on redemption before derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">3,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Year 1 | Value on redemption before derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Year 1 | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">4,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,781)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(8,651)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Year 1 | Value on redemption after derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">1,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Year 1 | Value on redemption after derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">2,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Year 2 | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Year 2 | Value on redemption before derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Year 2 | Value on redemption before derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Year 2 | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Year 2 | Value on redemption after derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Year 2 | Value on redemption after derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Year 3 | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Year 3 | Value on redemption before derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Year 3 | Value on redemption before derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Year 3 | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Year 3 | Value on redemption after derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Year 3 | Value on redemption after derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Year 4 | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Year 4 | Value on redemption before derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Year 4 | Value on redemption before derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Year 4 | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Year 4 | Value on redemption after derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">4,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Year 4 | Value on redemption after derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Year 5 | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Year 5 | Value on redemption before derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Year 5 | Value on redemption before derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Year 5 | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Year 5 | Value on redemption after derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Year 5 | Value on redemption after derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Year 5 and later | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">7,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">7,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Year 5 and later | Value on redemption before derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">7,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Year 5 and later | Value on redemption before derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Year 5 and later | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">7,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">7,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Year 5 and later | Value on redemption after derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">7,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Year 5 and later | Value on redemption after derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">13,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro | Value on redemption before derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">16,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro | Value on redemption before derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(3,908)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">10,489<span></span>
</td>
<td class="nump">&#8364; 13,129<span></span>
</td>
<td class="nump">&#8364; 13,725<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro | Value on redemption after derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">13,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro | Value on redemption after derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(4,046)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">US dollar | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(6,508)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">US dollar | Value on redemption before derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">1,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">US dollar | Value on redemption before derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(8,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">US dollar | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(2,404)<span></span>
</td>
<td class="num">&#8364; (669)<span></span>
</td>
<td class="num">&#8364; (3,304)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">US dollar | Value on redemption after derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">2,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">US dollar | Value on redemption after derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfBorrowings', window );">Debt</a></td>
<td class="nump">950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(5,797)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SGD', window );">Singapore dollar | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SGD', window );">Singapore dollar | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(2,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SGD', window );">Singapore dollar | Value on redemption after derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">&#8364; (2,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Of Borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FixedInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FixedInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SGD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SGD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>199
<FILENAME>R155.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441260848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate of Net Debt at Value on Redemption (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems', window );"><strong>Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">&#8364; 19,218<span></span>
</td>
<td class="nump">&#8364; 20,250<span></span>
</td>
<td class="nump">&#8364; 22,631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 24,568<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(10,098)<span></span>
</td>
<td class="num">(13,915)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="num">&#8364; (9,427)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">6,437<span></span>
</td>
<td class="nump">9,983<span></span>
</td>
<td class="nump">8,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember', window );">Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems', window );"><strong>Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,314<span></span>
</td>
<td class="nump">22,703<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(12,781)<span></span>
</td>
<td class="num">(10,267)<span></span>
</td>
<td class="num">(13,841)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">&#8364; 6,492<span></span>
</td>
<td class="nump">&#8364; 10,047<span></span>
</td>
<td class="nump">&#8364; 8,862<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtPercent', window );">Debt, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember', window );">Value on redemption after derivative instruments | Fixed-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems', window );"><strong>Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 17,612<span></span>
</td>
<td class="nump">&#8364; 20,713<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtPercent', window );">Debt, percent</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">87.00%<span></span>
</td>
<td class="nump">91.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember', window );">Value on redemption after derivative instruments | Floating-rate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems', window );"><strong>Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,702<span></span>
</td>
<td class="nump">&#8364; 1,990<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtPercent', window );">Debt, percent</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of interest rate of debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FixedInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FixedInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>200
<FILENAME>R156.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431395008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents (Details) - Change in Euro and US dollar short-term interest rates<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=sny_PlusHundredBasisPointsMember', window );">+100&#160;bp</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems', window );"><strong>Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpactOfChangeInInterestRateOnPreTaxIncome', window );">Impact on pre-tax net income</a></td>
<td class="nump">&#8364; 98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpactOfPreTaxIncomeRecognisedInEquity', window );">Impact on pre-tax income/(expense) recognized directly in equity</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=sny_PlusTwentyFiveBasisPointsMember', window );">+25&#160;bp</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems', window );"><strong>Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpactOfChangeInInterestRateOnPreTaxIncome', window );">Impact on pre-tax net income</a></td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpactOfPreTaxIncomeRecognisedInEquity', window );">Impact on pre-tax income/(expense) recognized directly in equity</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=sny_MinusTwentyFiveBasisPointsMember', window );">-25&#160;bp</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems', window );"><strong>Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpactOfChangeInInterestRateOnPreTaxIncome', window );">Impact on pre-tax net income</a></td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpactOfPreTaxIncomeRecognisedInEquity', window );">Impact on pre-tax income/(expense) recognized directly in equity</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=sny_MinusHundredBasisPointsMember', window );">-100&#160;bp</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems', window );"><strong>Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpactOfChangeInInterestRateOnPreTaxIncome', window );">Impact on pre-tax net income</a></td>
<td class="num">(98)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpactOfPreTaxIncomeRecognisedInEquity', window );">Impact on pre-tax income/(expense) recognized directly in equity</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of interest rate of debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpactOfChangeInInterestRateOnPreTaxIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impact of change in interest rate on pre tax income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpactOfChangeInInterestRateOnPreTaxIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpactOfPreTaxIncomeRecognisedInEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impact of pre tax income recognised in equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpactOfPreTaxIncomeRecognisedInEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=sny_PlusHundredBasisPointsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=sny_PlusHundredBasisPointsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=sny_PlusTwentyFiveBasisPointsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=sny_PlusTwentyFiveBasisPointsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=sny_MinusTwentyFiveBasisPointsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=sny_MinusTwentyFiveBasisPointsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=sny_MinusHundredBasisPointsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=sny_MinusHundredBasisPointsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>201
<FILENAME>R157.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405434581968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Currency (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">&#8364; 6,437<span></span>
</td>
<td class="nump">&#8364; 9,983<span></span>
</td>
<td class="nump">&#8364; 8,790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember', window );">Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">6,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember', window );">Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">6,492<span></span>
</td>
<td class="nump">10,047<span></span>
</td>
<td class="nump">8,862<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">13,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">10,489<span></span>
</td>
<td class="nump">13,129<span></span>
</td>
<td class="nump">13,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">US dollar | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(6,508)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">US dollar | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(2,404)<span></span>
</td>
<td class="num">(669)<span></span>
</td>
<td class="num">(3,304)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SGD', window );">Singapore dollar | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SGD', window );">Singapore dollar | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(2,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_GBP', window );">Pound sterling | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_GBP', window );">Pound sterling | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_MXN', window );">Mexican peso | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_MXN', window );">Mexican peso | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=sny_OtherCurrenciesMember', window );">Other currencies | Value on redemption before derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=sny_OtherCurrenciesMember', window );">Other currencies | Value on redemption after derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtByCurrencyLineItems', window );"><strong>Disclosure Of Debt By Currency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="nump">&#8364; 105<span></span>
</td>
<td class="num">&#8364; (2,413)<span></span>
</td>
<td class="num">&#8364; (1,559)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDebtByCurrencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Debt By Currency [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDebtByCurrencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionAfterDerivativeInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SGD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SGD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_MXN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_MXN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=sny_OtherCurrenciesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=sny_OtherCurrenciesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>202
<FILENAME>R158.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441613136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Summary of Market Value of Net Debt (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">&#8364; 19,218<span></span>
</td>
<td class="nump">&#8364; 20,250<span></span>
</td>
<td class="nump">&#8364; 22,631<span></span>
</td>
<td class="nump">&#8364; 24,568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtMarketValueMember', window );">Market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">5,227<span></span>
</td>
<td class="nump">11,024<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="nump">19,273<span></span>
</td>
<td class="nump">20,314<span></span>
</td>
<td class="nump">22,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RedemptionOfDebtInstrumentIssued', window );">Total debt at redemption</a></td>
<td class="nump">&#8364; 6,492<span></span>
</td>
<td class="nump">&#8364; 10,047<span></span>
</td>
<td class="nump">&#8364; 8,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RedemptionOfDebtInstrumentIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption of debt instrument issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RedemptionOfDebtInstrumentIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AtMarketValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AtMarketValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>203
<FILENAME>R159.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431158192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Debt</a></td>
<td class="nump">&#8364; 20,408<span></span>
</td>
<td class="nump">&#8364; 21,728<span></span>
</td>
<td class="nump">&#8364; 24,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PrincipalUndiscountedCashFlow', window );">Principal</a></td>
<td class="nump">18,932<span></span>
</td>
<td class="nump">20,086<span></span>
</td>
<td class="nump">22,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestUndiscountedCashFlow', window );">Interest</a></td>
<td class="nump">1,476<span></span>
</td>
<td class="nump">1,642<span></span>
</td>
<td class="nump">1,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Net cash flows related to derivative instruments</a></td>
<td class="nump">209<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalUndiscountedCashFlow', window );">Total</a></td>
<td class="nump">20,617<span></span>
</td>
<td class="nump">21,677<span></span>
</td>
<td class="nump">24,502<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Year 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Debt</a></td>
<td class="nump">4,206<span></span>
</td>
<td class="nump">3,330<span></span>
</td>
<td class="nump">2,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PrincipalUndiscountedCashFlow', window );">Principal</a></td>
<td class="nump">3,928<span></span>
</td>
<td class="nump">3,055<span></span>
</td>
<td class="nump">2,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestUndiscountedCashFlow', window );">Interest</a></td>
<td class="nump">278<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Net cash flows related to derivative instruments</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalUndiscountedCashFlow', window );">Total</a></td>
<td class="nump">4,230<span></span>
</td>
<td class="nump">3,271<span></span>
</td>
<td class="nump">3,078<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Year 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Debt</a></td>
<td class="nump">868<span></span>
</td>
<td class="nump">3,826<span></span>
</td>
<td class="nump">3,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PrincipalUndiscountedCashFlow', window );">Principal</a></td>
<td class="nump">661<span></span>
</td>
<td class="nump">3,588<span></span>
</td>
<td class="nump">2,757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestUndiscountedCashFlow', window );">Interest</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Net cash flows related to derivative instruments</a></td>
<td class="nump">60<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalUndiscountedCashFlow', window );">Total</a></td>
<td class="nump">928<span></span>
</td>
<td class="nump">3,825<span></span>
</td>
<td class="nump">3,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Year 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Debt</a></td>
<td class="nump">2,803<span></span>
</td>
<td class="nump">791<span></span>
</td>
<td class="nump">3,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PrincipalUndiscountedCashFlow', window );">Principal</a></td>
<td class="nump">2,601<span></span>
</td>
<td class="nump">601<span></span>
</td>
<td class="nump">3,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestUndiscountedCashFlow', window );">Interest</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Net cash flows related to derivative instruments</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalUndiscountedCashFlow', window );">Total</a></td>
<td class="nump">2,841<span></span>
</td>
<td class="nump">793<span></span>
</td>
<td class="nump">3,808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Year 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Debt</a></td>
<td class="nump">3,184<span></span>
</td>
<td class="nump">1,937<span></span>
</td>
<td class="nump">791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PrincipalUndiscountedCashFlow', window );">Principal</a></td>
<td class="nump">3,011<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestUndiscountedCashFlow', window );">Interest</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Net cash flows related to derivative instruments</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalUndiscountedCashFlow', window );">Total</a></td>
<td class="nump">3,215<span></span>
</td>
<td class="nump">1,939<span></span>
</td>
<td class="nump">791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Year 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Debt</a></td>
<td class="nump">1,283<span></span>
</td>
<td class="nump">3,176<span></span>
</td>
<td class="nump">1,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PrincipalUndiscountedCashFlow', window );">Principal</a></td>
<td class="nump">1,151<span></span>
</td>
<td class="nump">3,011<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestUndiscountedCashFlow', window );">Interest</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Net cash flows related to derivative instruments</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalUndiscountedCashFlow', window );">Total</a></td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">3,178<span></span>
</td>
<td class="nump">1,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Year 5 and later</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Debt</a></td>
<td class="nump">8,064<span></span>
</td>
<td class="nump">8,668<span></span>
</td>
<td class="nump">11,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PrincipalUndiscountedCashFlow', window );">Principal</a></td>
<td class="nump">7,580<span></span>
</td>
<td class="nump">8,080<span></span>
</td>
<td class="nump">11,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestUndiscountedCashFlow', window );">Interest</a></td>
<td class="nump">484<span></span>
</td>
<td class="nump">588<span></span>
</td>
<td class="nump">751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Net cash flows related to derivative instruments</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalUndiscountedCashFlow', window );">Total</a></td>
<td class="nump">&#8364; 8,089<span></span>
</td>
<td class="nump">&#8364; 8,671<span></span>
</td>
<td class="nump">&#8364; 11,841<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to non-derivative financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestUndiscountedCashFlow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest undiscounted cash flow.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestUndiscountedCashFlow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PrincipalUndiscountedCashFlow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal undiscounted cash flow.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PrincipalUndiscountedCashFlow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TotalUndiscountedCashFlow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total undiscounted cash flow.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TotalUndiscountedCashFlow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>204
<FILENAME>R160.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455650480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt, cash and cash equivalents and lease liabilities - Lease Liabilities (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems', window );"><strong>Disclosure of maturity analysis of finance lease payments receivable [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,181<span></span>
</td>
<td class="nump">&#8364; 2,108<span></span>
</td>
<td class="nump">&#8364; 1,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LeaseLiabilitiesEffectOfDiscounting', window );">Discounting effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (219)<span></span>
</td>
<td class="num">(228)<span></span>
</td>
<td class="num">(148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_CambridgeMassachusettsMember', window );">Cambridge, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems', window );"><strong>Disclosure of maturity analysis of finance lease payments receivable [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InitialLeaseTerm', window );">Initial lease term</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems', window );"><strong>Disclosure of maturity analysis of finance lease payments receivable [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 320<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">From&#160;1&#160;to 3&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems', window );"><strong>Disclosure of maturity analysis of finance lease payments receivable [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="nump">357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">From&#160;3&#160;to 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems', window );"><strong>Disclosure of maturity analysis of finance lease payments receivable [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="nump">362<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems', window );"><strong>Disclosure of maturity analysis of finance lease payments receivable [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,129<span></span>
</td>
<td class="nump">&#8364; 1,184<span></span>
</td>
<td class="nump">&#8364; 482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InitialLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial Lease Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InitialLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LeaseLiabilitiesEffectOfDiscounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities, Effect Of Discounting</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LeaseLiabilitiesEffectOfDiscounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_CambridgeMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_CambridgeMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>205
<FILENAME>R161.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405434966496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities related to business combinations and to non-controlling interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Beginning balance</a></td>
<td class="nump">&#8364; 714<span></span>
</td>
<td class="nump">&#8364; 605<span></span>
</td>
<td class="nump">&#8364; 800<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">Payments made</a></td>
<td class="num">(136)<span></span>
</td>
<td class="num">(258)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities', window );">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherMovements', window );">Other movements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests', window );">Currency translation differences</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">New transactions</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Ending balance</a></td>
<td class="nump">779<span></span>
</td>
<td class="nump">714<span></span>
</td>
<td class="nump">605<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests', window );">Non-current liabilities related to business combinations and to non-controlling interests</a></td>
<td class="nump">674<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests', window );">Current liabilities related to business combinations and to non-controlling interests</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember', window );">Bayer contingent purchase consideration arising from the acquisition of Genzyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Beginning balance</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">Payments made</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities', window );">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherMovements', window );">Other movements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests', window );">Currency translation differences</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">New transactions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Ending balance</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember', window );">MSD contingent consideration (European vaccines business)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Beginning balance</a></td>
<td class="nump">269<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">Payments made</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities', window );">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherMovements', window );">Other movements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests', window );">Currency translation differences</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">New transactions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Ending balance</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember', window );">Shire contingent consideration arising&#160;from&#160;the acquisition of Translate Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Beginning balance</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">Payments made</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities', window );">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherMovements', window );">Other movements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests', window );">Currency translation differences</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">New transactions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Ending balance</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_AmunixMember', window );">Amunix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">Payments made</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities', window );">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherMovements', window );">Other movements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests', window );">Currency translation differences</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">New transactions</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Ending balance</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_OtherLiabilitiesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Beginning balance</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">Payments made</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(152)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities', window );">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherMovements', window );">Other movements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests', window );">Currency translation differences</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">New transactions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Ending balance</a></td>
<td class="nump">&#8364; 4<span></span>
</td>
<td class="nump">&#8364; 32<span></span>
</td>
<td class="nump">&#8364; 189<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember', window );">Translate Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ContingentConsiderationLiabilities', window );">Contingent consideration liabilities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 382<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contingent liabilities recognised in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) including exchange differences recognised in profit or loss on the fair value measurement of liabilities. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised for new contingent liabilities recognised in a business combination. [Refer: Contingent liabilities recognised in business combination]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contingent liabilities recognised in a business combination that were settled. [Refer: Contingent liabilities recognised in business combination]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ContingentConsiderationLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ContingentConsiderationLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This account includes current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes current portion of liabilities related to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease through net exchange differences business combinations and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This account includes non-current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes non-current portion of liabilities related to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherMovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other movements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherMovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_AmunixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_AmunixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_TranslateBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>206
<FILENAME>R162.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432708240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities related to business combinations and to non-controlling interests - Additional Information (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Fair value of contingent consideration payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 779<span></span>
</td>
<td class="nump">&#8364; 714<span></span>
</td>
<td class="nump">&#8364; 605<span></span>
</td>
<td class="nump">&#8364; 800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations', window );">Commitments relating to contingent consideration in connection with business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="nump">1,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_BayerScheringPharmaAGMember', window );">Bayer contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PaymentToSaleOfBusinessPeriod', window );">Payment to sale of business period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MilestonePaymentTerm', window );">Milestone payment period</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueOfContingentConsiderationPayable', window );">Fair value of contingent consideration payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 26<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageIncreaseInFairValueLiabilities', window );">Increase in fair value of liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_BayerScheringPharmaAGMember', window );">Bayer contingent consideration | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PotentialPaymentsRelatedToPercentageOfSales', window );">Potentiel payments related to percentage of sales of alemtuzumab | $</a></td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember', window );">MSD contingent consideration (European vaccines business)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueOfContingentConsiderationPayable', window );">Fair value of contingent consideration payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 204<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageIncreaseInFairValueLiabilities', window );">Increase in fair value of liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Fair value of contingent consideration payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 204<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_ShireHumanGeneticTherapiesIncMember', window );">Shire contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageIncreaseInFairValueLiabilities', window );">Increase in fair value of liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_AmunixMember', window );">Amunix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageIncreaseInFairValueLiabilities', window );">Increase in fair value of liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Fair value of contingent consideration payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 165<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contingent liabilities recognised in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Relating To Contingent Consideration In Connection With Business Combinations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FairValueOfContingentConsiderationPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the contingent consideration payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FairValueOfContingentConsiderationPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MilestonePaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone payment term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MilestonePaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PaymentToSaleOfBusinessPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment to sale of business period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PaymentToSaleOfBusinessPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageIncreaseInFairValueLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage increase in fair value liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageIncreaseInFairValueLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PotentialPaymentsRelatedToPercentageOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potentiel payments related to percentage of sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PotentialPaymentsRelatedToPercentageOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_BayerScheringPharmaAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_BayerScheringPharmaAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_ShireHumanGeneticTherapiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_ShireHumanGeneticTherapiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_AmunixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_AmunixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>207
<FILENAME>R163.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432588400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Liabilities related to business combinations and to non-controlling interests - Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems', window );"><strong>Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations', window );">Commitments relating to contingent consideration in connection with business combinations</a></td>
<td class="nump">&#8364; 604<span></span>
</td>
<td class="nump">&#8364; 689<span></span>
</td>
<td class="nump">&#8364; 1,043<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems', window );"><strong>Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations', window );">Commitments relating to contingent consideration in connection with business combinations</a></td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">From&#160;1&#160;to 3&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems', window );"><strong>Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations', window );">Commitments relating to contingent consideration in connection with business combinations</a></td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">From&#160;3&#160;to 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems', window );"><strong>Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations', window );">Commitments relating to contingent consideration in connection with business combinations</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems', window );"><strong>Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations', window );">Commitments relating to contingent consideration in connection with business combinations</a></td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_BayerScheringPharmaAGMember', window );">Bayer contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems', window );"><strong>Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer', window );">Commitments relating to contingent consideration in connection with business combinations Bayer</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember', window );">MSD contingent consideration (European vaccines business)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems', window );"><strong>Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD', window );">Commitments relating to contingent consideration in connection with business combinations MSD</a></td>
<td class="nump">&#8364; 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Relating To Contingent Consideration In Connection With Business Combinations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments relating to contingent consideration in connection with business combinations bayer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Relating To Contingent Consideration In Connection With Business Combinations MSD</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_BayerScheringPharmaAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_BayerScheringPharmaAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>208
<FILENAME>R164.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431397472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Summary of Non Current Provisions and Other Non-current Liabilities (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Provisions</a></td>
<td class="nump">&#8364; 5,822<span></span>
</td>
<td class="nump">&#8364; 6,430<span></span>
</td>
<td class="nump">&#8364; 6,998<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 7,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities', window );">Total</a></td>
<td class="nump">6,341<span></span>
</td>
<td class="nump">6,721<span></span>
</td>
<td class="nump">7,315<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">&#8364; 232<span></span>
</td>
<td class="nump">&#8364; 6<span></span>
</td>
<td class="nump">&#8364; 92<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions and non-current other liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>209
<FILENAME>R165.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405423946080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Summary of Movements in Non-current Provisions (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract', window );"><strong>Reconciliation of changes in other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Beginning balance</a></td>
<td class="nump">&#8364; 6,430<span></span>
</td>
<td class="nump">&#8364; 6,998<span></span>
</td>
<td class="nump">&#8364; 7,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions', window );">Changes in scope of consolidation</a></td>
<td class="num">(200)<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInOtherProvisions', window );">Increases in provisions</a></td>
<td class="nump">1,285<span></span>
</td>
<td class="nump">731<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(528)<span></span>
</td>
<td class="num">(459)<span></span>
</td>
<td class="num">(793)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions', window );">Reversals of unutilized provisions</a></td>
<td class="num">(288)<span></span>
</td>
<td class="num">(200)<span></span>
</td>
<td class="num">(518)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="num">(274)<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="num">(421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount', window );">Net interest related to employee benefits, and unwinding of discount</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="num">(214)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans', window );">Actuarial gains and losses on defined-benefit plans</a></td>
<td class="num">(780)<span></span>
</td>
<td class="num">(448)<span></span>
</td>
<td class="nump">266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Ending balance</a></td>
<td class="nump">5,822<span></span>
</td>
<td class="nump">6,430<span></span>
</td>
<td class="nump">6,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember', window );">Provisions for pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract', window );"><strong>Reconciliation of changes in other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Beginning balance</a></td>
<td class="nump">2,947<span></span>
</td>
<td class="nump">3,276<span></span>
</td>
<td class="nump">3,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions', window );">Changes in scope of consolidation</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInOtherProvisions', window );">Increases in provisions</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(275)<span></span>
</td>
<td class="num">(222)<span></span>
</td>
<td class="num">(566)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions', window );">Reversals of unutilized provisions</a></td>
<td class="num">(66)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="nump">10<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount', window );">Net interest related to employee benefits, and unwinding of discount</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="num">(117)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans', window );">Actuarial gains and losses on defined-benefit plans</a></td>
<td class="num">(780)<span></span>
</td>
<td class="num">(448)<span></span>
</td>
<td class="nump">266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Ending balance</a></td>
<td class="nump">2,039<span></span>
</td>
<td class="nump">2,947<span></span>
</td>
<td class="nump">3,276<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForOtherLongTermBenefitsMember', window );">Provisions for other long-term benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract', window );"><strong>Reconciliation of changes in other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Beginning balance</a></td>
<td class="nump">935<span></span>
</td>
<td class="nump">879<span></span>
</td>
<td class="nump">855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions', window );">Changes in scope of consolidation</a></td>
<td class="num">(28)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInOtherProvisions', window );">Increases in provisions</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(119)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions', window );">Reversals of unutilized provisions</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount', window );">Net interest related to employee benefits, and unwinding of discount</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans', window );">Actuarial gains and losses on defined-benefit plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Ending balance</a></td>
<td class="nump">844<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">879<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_NonCurrentRestructuringProvisionMember', window );">Restructuring provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract', window );"><strong>Reconciliation of changes in other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Beginning balance</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">868<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions', window );">Changes in scope of consolidation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInOtherProvisions', window );">Increases in provisions</a></td>
<td class="nump">521<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions', window );">Reversals of unutilized provisions</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="num">(265)<span></span>
</td>
<td class="num">(370)<span></span>
</td>
<td class="num">(369)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount', window );">Net interest related to employee benefits, and unwinding of discount</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans', window );">Actuarial gains and losses on defined-benefit plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Ending balance</a></td>
<td class="nump">761<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="nump">868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_MiscellaneousOtherProvisionsMember', window );">Other provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract', window );"><strong>Reconciliation of changes in other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Beginning balance</a></td>
<td class="nump">2,024<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
<td class="nump">2,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions', window );">Changes in scope of consolidation</a></td>
<td class="num">(76)<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInOtherProvisions', window );">Increases in provisions</a></td>
<td class="nump">531<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="nump">369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions', window );">Reversals of unutilized provisions</a></td>
<td class="num">(191)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
<td class="num">(245)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount', window );">Net interest related to employee benefits, and unwinding of discount</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans', window );">Actuarial gains and losses on defined-benefit plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Ending balance</a></td>
<td class="nump">&#8364; 2,178<span></span>
</td>
<td class="nump">&#8364; 2,024<span></span>
</td>
<td class="nump">&#8364; 1,975<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProvisionUsedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProvisionUsedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ActuarialGainsAndLossesOnDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial gains and losses on defined-benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ActuarialGainsAndLossesOnDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease of unused provision reversed, other provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through Change In Scope Of Consolidation, Other Provisions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net interest related to employees benefits and unwinding of discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForOtherLongTermBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForOtherLongTermBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_NonCurrentRestructuringProvisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_NonCurrentRestructuringProvisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_MiscellaneousOtherProvisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=ifrs-full_MiscellaneousOtherProvisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>210
<FILENAME>R166.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435154288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Additional Information (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>Country </div>
<div>age </div>
<div>plan</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCountriesIncludedInPensionPlans', window );">Number of major countries included in pension obligations | Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PensionObligationPercentageToDefinedBenefitLiability', window );">Pension obligation, percentage to defined benefit liability</a></td>
<td class="nump">89.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">89.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PensionObligationPercentageToPlanAssets', window );">Pension obligations, percentage to plan assets</a></td>
<td class="nump">88.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">88.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">&#8364; 1,039<span></span>
</td>
<td class="nump">&#8364; 943<span></span>
</td>
<td class="nump">&#8364; 1,260<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,039<span></span>
</td>
<td class="nump">&#8364; 943<span></span>
</td>
<td class="nump">&#8364; 1,260<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans', window );">Average residual holding periods</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">1 year 11 months 8 days<span></span>
</td>
<td class="text">1 year 11 months 26 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesNoncurrent', window );">Non-current income tax liabilities</a></td>
<td class="nump">&#8364; 1,979<span></span>
</td>
<td class="nump">&#8364; 2,039<span></span>
</td>
<td class="nump">&#8364; 1,733<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 1,979<span></span>
</td>
<td class="nump">2,039<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod', window );">Tax charge on deemed repatriation attributable to accumulated earnings payable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LiabilityRecognizedRepresentingEstimatedCost', window );">Liability recognized representing the estimated cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,020<span></span>
</td>
<td class="nump">960<span></span>
</td>
<td class="nump">894<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">519<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">&#8364; 317<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised', window );">Unused capital losses for which no deferred tax asset recognised</a></td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_USLegalRestructuringMember', window );">US legal restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised', window );">Unused capital losses for which no deferred tax asset recognised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CapitalLossesCarryBackPeriod', window );">Capital losses, carry back period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CapitalLossesUsedAgainstCapitalGainsPercentage', window );">Percentage of capital losses used</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember', window );">Later than 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">459<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="nump">569<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 459<span></span>
</td>
<td class="nump">&#8364; 576<span></span>
</td>
<td class="nump">&#8364; 569<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_OtherEnvironmentRelatedProvisionMember', window );">Other environment related provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod', window );">Identified environmental risks provisions estimated obligation period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths', window );">Other provisions, expected utilized amount in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive', window );">Other provisions, expected utilized amount in 2023 through 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=sny_UncertaintiesOverIncomeTaxTreatmentsMember', window );">Uncertainties over income tax treatments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesNoncurrent', window );">Non-current income tax liabilities</a></td>
<td class="nump">1,520<span></span>
</td>
<td class="nump">1,463<span></span>
</td>
<td class="nump">1,164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,520<span></span>
</td>
<td class="nump">1,463<span></span>
</td>
<td class="nump">1,164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">&#8364; 804<span></span>
</td>
<td class="nump">614<span></span>
</td>
<td class="nump">889<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 804<span></span>
</td>
<td class="nump">614<span></span>
</td>
<td class="nump">889<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfDefinedBenefitPlans', window );">Number of types of defined-benefit plan | plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RetirementAge', window );">Retirement age | age</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NotionalRetirementAge', window );">Notional retirement age | age</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DefinedBenefitPlansVestingRightsPercentage', window );">Vesting right percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DefinedBenefitPlansVestingRightsPercentage', window );">Vesting right percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_LumpSumRetirementBenefitPlansMember', window );">Lump-sum retirement benefit plans | France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PensionObligationPercentageToDefinedBenefitLiability', window );">Pension obligation, percentage to defined benefit liability</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_DefinedBenefitPensionPlansMember', window );">Defined benefit pension plans | France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PensionObligationPercentageToDefinedBenefitLiability', window );">Pension obligation, percentage to defined benefit liability</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_DefinedBenefitPensionPlansMember', window );">Defined benefit pension plans | US | Qualified defined benefit pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PensionObligationPercentageToDefinedBenefitLiability', window );">Pension obligation, percentage to defined benefit liability</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_DefinedBenefitPensionPlansMember', window );">Defined benefit pension plans | US | Non qualified defined benefit pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PensionObligationPercentageToDefinedBenefitLiability', window );">Pension obligation, percentage to defined benefit liability</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_DefinedBenefitPensionPlansMember', window );">Defined benefit pension plans | UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PensionObligationPercentageToDefinedBenefitLiability', window );">Pension obligation, percentage to defined benefit liability</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_TopUpDefinedBenefitPensionPlanMember', window );">Top-up defined-benefit pension plan | Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PensionObligationPercentageToDefinedBenefitLiability', window );">Pension obligation, percentage to defined benefit liability</a></td>
<td class="nump">62.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">62.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_SanofiaventisPlusPensionPlanMember', window );">Sanofi-Aventis Plus | Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling', window );">Employer's contribution percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=ifrs-full_MultiemployerDefinedBenefitPlansMember', window );">Multi-employer plan (Pensionskasses) | Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PensionObligationPercentageToDefinedBenefitLiability', window );">Pension obligation, percentage to defined benefit liability</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">&#8364; 652<span></span>
</td>
<td class="nump">&#8364; 877<span></span>
</td>
<td class="nump">&#8364; 773<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 652<span></span>
</td>
<td class="nump">&#8364; 877<span></span>
</td>
<td class="nump">&#8364; 773<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_HealthcareCoverAndLifeInsuranceMember', window );">Healthcare Cover And Life Insurance | US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PensionObligationPercentageToDefinedBenefitLiability', window );">Pension obligation, percentage to defined benefit liability</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">&#8364; 409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_HealthcareCoverAndLifeInsuranceMember', window );">Healthcare Cover And Life Insurance | US | Plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PensionObligationPercentageToPlanAssets', window );">Pension obligations, percentage to plan assets</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net amount shown in the balance sheet at end of period</a></td>
<td class="nump">&#8364; 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average residual holding periods under various early retirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CapitalLossesCarryBackPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Losses, Carry Back Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CapitalLossesCarryBackPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CapitalLossesUsedAgainstCapitalGainsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Losses Used Against Capital Gains, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CapitalLossesUsedAgainstCapitalGainsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DefinedBenefitPlansVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plans vesting rights percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DefinedBenefitPlansVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employer contribute percentage on amounts exceeding the social security ceiling.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identified environmental risks provisions estimated obligation period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identified environmental risks provisions expected utilized amount next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identified environmental risks provisions expected utilized amount year two to five.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LiabilityRecognizedRepresentingEstimatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability recognized representing estimated cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LiabilityRecognizedRepresentingEstimatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NotionalRetirementAge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notional retirement age.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NotionalRetirementAge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfCountriesIncludedInPensionPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of countries included in pension plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfCountriesIncludedInPensionPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PensionObligationPercentageToDefinedBenefitLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pension obligation percentage to defined benefit liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PensionObligationPercentageToDefinedBenefitLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PensionObligationPercentageToPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pension obligation percentage to plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PensionObligationPercentageToPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provisions and other non-current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RetirementAge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Retirement age.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RetirementAge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax charge on deemed repatriation attributable to accumulated earnings payable period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unused Capital Losses For Which No Deferred Tax Asset Recognised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_USLegalRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_USLegalRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_OtherEnvironmentRelatedProvisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=ifrs-full_OtherEnvironmentRelatedProvisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=sny_UncertaintiesOverIncomeTaxTreatmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=sny_UncertaintiesOverIncomeTaxTreatmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_LumpSumRetirementBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_LumpSumRetirementBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_DefinedBenefitPensionPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_DefinedBenefitPensionPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=sny_QualifiedDefinedBenefitPensionPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=sny_QualifiedDefinedBenefitPensionPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=sny_NonQualifiedDefinedBenefitPensionPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=sny_NonQualifiedDefinedBenefitPensionPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_TopUpDefinedBenefitPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_TopUpDefinedBenefitPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_SanofiaventisPlusPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_SanofiaventisPlusPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=ifrs-full_MultiemployerDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=ifrs-full_MultiemployerDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_HealthcareCoverAndLifeInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_HealthcareCoverAndLifeInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>211
<FILENAME>R167.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405434552160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Summary of Financial and Demographic Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration of defined benefit obligation</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=sny_MinimumPlan1Member', window );">Minimum Plan 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration of defined benefit obligation</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=sny_MaximumPlan1Member', window );">Maximum Plan 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration of defined benefit obligation</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=sny_MinimumPlan2Member', window );">Minimum plan 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration of defined benefit obligation</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=sny_MaximumPlan2Member', window );">Maximum plan 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration of defined benefit obligation</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation', window );">General inflation rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="nump">1.45%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases', window );">Pension benefit indexation</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates', window );">Healthcare cost inflation rate(d)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange', window );">Retirement age, bottom of range</a></td>
<td class="text">62 years<span></span>
</td>
<td class="text">62 years<span></span>
</td>
<td class="text">62 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialAssumptionOfRetirementAgeTopOfRange', window );">Retirement age, top of range</a></td>
<td class="text">67 years<span></span>
</td>
<td class="text">67 years<span></span>
</td>
<td class="text">67 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration of defined benefit obligation</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">13 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">3.55%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases', window );">Pension benefit indexation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.45%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.55%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation', window );">General inflation rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="nump">1.45%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases', window );">Pension benefit indexation</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="nump">1.45%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates', window );">Healthcare cost inflation rate(d)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialAssumptionOfRetirementAgeTopOfRange', window );">Retirement age, top of range</a></td>
<td class="text">63 years<span></span>
</td>
<td class="text">62 years<span></span>
</td>
<td class="text">62 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration of defined benefit obligation</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">16 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">3.55%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.55%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation', window );">General inflation rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases', window );">Pension benefit indexation</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange', window );">Retirement age, bottom of range</a></td>
<td class="text">55 years<span></span>
</td>
<td class="text">55 years<span></span>
</td>
<td class="text">55 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialAssumptionOfRetirementAgeTopOfRange', window );">Retirement age, top of range</a></td>
<td class="text">70 years<span></span>
</td>
<td class="text">70 years<span></span>
</td>
<td class="text">70 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration of defined benefit obligation</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">16 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates', window );">Healthcare cost inflation rate(d)</a></td>
<td class="nump">3.29%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates', window );">Healthcare cost inflation rate(d)</a></td>
<td class="nump">6.56%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">1.35%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation', window );">General inflation rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases', window );">Pension benefit indexation</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.15%<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates', window );">Healthcare cost inflation rate(d)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange', window );">Retirement age, bottom of range</a></td>
<td class="text">60 years<span></span>
</td>
<td class="text">60 years<span></span>
</td>
<td class="text">60 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialAssumptionOfRetirementAgeTopOfRange', window );">Retirement age, top of range</a></td>
<td class="text">65 years<span></span>
</td>
<td class="text">65 years<span></span>
</td>
<td class="text">65 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration of defined benefit obligation</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">18 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected rate of inflation that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected rate of increases in pension that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medical cost trend rate used as significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 147<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_147_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ActuarialAssumptionOfRetirementAgeBottomOfRange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Retirement age, bottom of range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ActuarialAssumptionOfRetirementAgeBottomOfRange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ActuarialAssumptionOfRetirementAgeTopOfRange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial assumption of retirement age top of range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ActuarialAssumptionOfRetirementAgeTopOfRange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=sny_MinimumPlan1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=sny_MinimumPlan1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=sny_MaximumPlan1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=sny_MaximumPlan1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=sny_MinimumPlan2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=sny_MinimumPlan2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=sny_MaximumPlan2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=sny_MaximumPlan2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>212
<FILENAME>R168.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441211408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Summary of Weighted Average Duration of Obligation for Pensions and Other Long-term Benefits in Principal Countries (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration in main countries</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration in main countries</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">13 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration in main countries</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">16 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration in main countries</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">16 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration in main countries</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">18 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 147<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_147_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>213
<FILENAME>R169.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441458000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Summary of Sensitivity for Pensions and Other Post-Employment Benefits to Changes in Key Actuarial Assumptions (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Possible decrease in actuarial assumption</a></td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember', window );">General inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Possible increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember', window );">Pension benefit indexation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Possible increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember', window );">Healthcare cost inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Possible increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=sny_ActuarialAssumptionOfMortalityTableMember', window );">Mortality table</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PossibleIncreaseInMortalityTableInYears', window );">Possible increase in mortality table (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_FR', window );">France | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">&#8364; 72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_FR', window );">France | General inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_FR', window );">France | Pension benefit indexation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_FR', window );">France | Healthcare cost inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_FR', window );">France | Mortality table</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_DE', window );">Germany | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_DE', window );">Germany | General inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_DE', window );">Germany | Pension benefit indexation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_DE', window );">Germany | Healthcare cost inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_DE', window );">Germany | Mortality table</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_US', window );">US | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_US', window );">US | General inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_US', window );">US | Pension benefit indexation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_US', window );">US | Healthcare cost inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_US', window );">US | Mortality table</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_GB', window );">UK | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_GB', window );">UK | General inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_GB', window );">UK | Pension benefit indexation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_GB', window );">UK | Healthcare cost inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=country_GB', window );">UK | Mortality table</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Measurement of defined-benefit obligation</a></td>
<td class="nump">&#8364; 74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PossibleIncreaseInMortalityTableInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Possible increase in mortality table in years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PossibleIncreaseInMortalityTableInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=sny_ActuarialAssumptionOfMortalityTableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=sny_ActuarialAssumptionOfMortalityTableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>214
<FILENAME>R170.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405429258976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Reconciliation of Net Amount Recognized in Respect of Pension and Other Post-employment Benefit Plans (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Actuarial losses/(gains) due to changes in financial assumptions</a></td>
<td class="nump">&#8364; 654<span></span>
</td>
<td class="nump">&#8364; 686<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">&#8364; (267)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PreFundedPensionObligations', window );">Pre-funded pension obligations</a></td>
<td class="nump">269<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Obligations provided for</a></td>
<td class="nump">5,822<span></span>
</td>
<td class="nump">6,430<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,998<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 7,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset', window );">Actuarial losses/(gains) due to changes in demographic assumptions</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Actuarial losses/(gains) due to changes in financial assumptions</a></td>
<td class="num">(1,143)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">442<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)</a></td>
<td class="num">(131)<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(115)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Beginning of period</a></td>
<td class="nump">2,539<span></span>
</td>
<td class="nump">3,099<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Interest (income)/cost</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">55<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan', window );">Plan amendments, curtailments or settlements not specified in the terms of the plan</a></td>
<td class="num">(68)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(199)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod', window );">Administration costs and taxes paid during the period</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Contributions from plan members</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan', window );">Net obligation</a></td>
<td class="nump">1,752<span></span>
</td>
<td class="nump">2,524<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,098<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PreFundedPensionObligations', window );">Pre-funded pension obligations</a></td>
<td class="nump">269<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss', window );">Expense recognized directly in profit or loss</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">84<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">End of period</a></td>
<td class="nump">1,770<span></span>
</td>
<td class="nump">2,539<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,099<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)</a></td>
<td class="num">(650)<span></span>
</td>
<td class="num">(685)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">266<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EmployeeBenefitsExpenseGain', window );">Expense/(gain) for the period</a></td>
<td class="num">(482)<span></span>
</td>
<td class="num">(409)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits | UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Beginning of period</a></td>
<td class="num">(215)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Contributions from plan members</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PreFundedPensionObligations', window );">Pre-funded pension obligations</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss', window );">Expense recognized directly in profit or loss</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">End of period</a></td>
<td class="num">(95)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)</a></td>
<td class="nump">130<span></span>
</td>
<td class="num">(236)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">115<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits | Present value of defined benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Beginning of period</a></td>
<td class="nump">12,175<span></span>
</td>
<td class="nump">12,456<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,094<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Interest (income)/cost</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">192<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset', window );">Actuarial losses/(gains) due to changes in demographic assumptions</a></td>
<td class="num">(219)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">52<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Actuarial losses/(gains) due to changes in financial assumptions</a></td>
<td class="num">(3,006)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset', window );">Actuarial losses/(gains) due to experience adjustments</a></td>
<td class="nump">177<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan', window );">Plan amendments, curtailments or settlements not specified in the terms of the plan</a></td>
<td class="num">(229)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(938)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset', window );">Plan settlements specified in the terms of the plan</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(75)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BenefitsPaidOrPayable', window );">Benefits paid</a></td>
<td class="num">(463)<span></span>
</td>
<td class="num">(503)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(545)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset', window );">Changes in scope of consolidation and transfers</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset', window );">Currency translation differences</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(443)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">End of period</a></td>
<td class="nump">8,651<span></span>
</td>
<td class="nump">12,175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,456<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits | Plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Beginning of period</a></td>
<td class="num">(9,651)<span></span>
</td>
<td class="num">(9,358)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,651)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Interest (income)/cost</a></td>
<td class="num">(163)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(138)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan', window );">Plan amendments, curtailments or settlements not specified in the terms of the plan</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">739<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset', window );">Plan settlements specified in the terms of the plan</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset', window );">Changes in scope of consolidation and transfers</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset', window );">Currency translation differences</a></td>
<td class="nump">52<span></span>
</td>
<td class="num">(344)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">326<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset', window );">Difference between actual return and interest income on plan assets</a></td>
<td class="num">(2,398)<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">696<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod', window );">Administration costs and taxes paid during the period</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Contributions from plan members</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Employer&#8217;s contributions</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">490<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset', window );">Benefits paid</a></td>
<td class="num">(426)<span></span>
</td>
<td class="num">(458)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(469)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">End of period</a></td>
<td class="num">(6,899)<span></span>
</td>
<td class="num">(9,651)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,358)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits | Effect of asset ceiling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Beginning of period</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">End of period</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember', window );">Provisions for pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Obligations provided for</a></td>
<td class="nump">2,039<span></span>
</td>
<td class="nump">2,947<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 3,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember', window );">Provisions for pensions and other post-employment benefits | Pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Obligations provided for</a></td>
<td class="nump">&#8364; 2,039<span></span>
</td>
<td class="nump">&#8364; 2,947<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 3,276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BenefitsPaidOrPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of benefits paid or payable for retirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_v&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BenefitsPaidOrPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from business combinations and disposals. [Refer: Business combinations [member]; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit in a defined benefit plan. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [member]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Administration Costs And Taxes Paid During The Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Payments In Respect Of Settlements Specified In The Terms Of The Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Plan Amendments, Curtailments Or Settlements Not Specified In The Terms Of The Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EmployeeBenefitsExpenseGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Benefits Expense / (Gain)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EmployeeBenefitsExpenseGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PreFundedPensionObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-funded pension obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PreFundedPensionObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total expense for pensions and other post-employment benefits recognized directly in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_EffectOfAssetCeilingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_EffectOfAssetCeilingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>215
<FILENAME>R171.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432661584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Net Liability in Respect of Pension Plans and Other Post-employment Benefits by Geographical Region (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Measurement of obligation</a></td>
<td class="nump">&#8364; 1,039<span></span>
</td>
<td class="nump">&#8364; 943<span></span>
</td>
<td class="nump">&#8364; 1,260<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Measurement of obligation</a></td>
<td class="nump">8,651<span></span>
</td>
<td class="nump">12,175<span></span>
</td>
<td class="nump">12,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="nump">6,899<span></span>
</td>
<td class="nump">9,651<span></span>
</td>
<td class="nump">9,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PlanAssetsEffectOfAssetCeiling', window );">Effect of asset ceiling</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net amount shown in the balance sheet at end of period</a></td>
<td class="nump">1,770<span></span>
</td>
<td class="nump">2,539<span></span>
</td>
<td class="nump">3,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Measurement of obligation</a></td>
<td class="nump">804<span></span>
</td>
<td class="nump">614<span></span>
</td>
<td class="nump">889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | Pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Measurement of obligation</a></td>
<td class="nump">1,324<span></span>
</td>
<td class="nump">1,657<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="nump">697<span></span>
</td>
<td class="nump">838<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PlanAssetsEffectOfAssetCeiling', window );">Effect of asset ceiling</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net amount shown in the balance sheet at end of period</a></td>
<td class="nump">627<span></span>
</td>
<td class="nump">819<span></span>
</td>
<td class="nump">872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany | Pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Measurement of obligation</a></td>
<td class="nump">2,730<span></span>
</td>
<td class="nump">3,576<span></span>
</td>
<td class="nump">3,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="nump">2,317<span></span>
</td>
<td class="nump">2,808<span></span>
</td>
<td class="nump">2,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PlanAssetsEffectOfAssetCeiling', window );">Effect of asset ceiling</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net amount shown in the balance sheet at end of period</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">768<span></span>
</td>
<td class="nump">919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Measurement of obligation</a></td>
<td class="nump">1,546<span></span>
</td>
<td class="nump">2,099<span></span>
</td>
<td class="nump">2,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="nump">860<span></span>
</td>
<td class="nump">1,127<span></span>
</td>
<td class="nump">1,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PlanAssetsEffectOfAssetCeiling', window );">Effect of asset ceiling</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net amount shown in the balance sheet at end of period</a></td>
<td class="nump">686<span></span>
</td>
<td class="nump">972<span></span>
</td>
<td class="nump">1,014<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK | Pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Measurement of obligation</a></td>
<td class="nump">2,080<span></span>
</td>
<td class="nump">3,414<span></span>
</td>
<td class="nump">3,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="nump">2,175<span></span>
</td>
<td class="nump">3,629<span></span>
</td>
<td class="nump">3,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PlanAssetsEffectOfAssetCeiling', window );">Effect of asset ceiling</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net amount shown in the balance sheet at end of period</a></td>
<td class="num">(95)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Measurement of obligation</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other | Pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Measurement of obligation</a></td>
<td class="nump">971<span></span>
</td>
<td class="nump">1,429<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="nump">850<span></span>
</td>
<td class="nump">1,249<span></span>
</td>
<td class="nump">1,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PlanAssetsEffectOfAssetCeiling', window );">Effect of asset ceiling</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net amount shown in the balance sheet at end of period</a></td>
<td class="nump">&#8364; 139<span></span>
</td>
<td class="nump">&#8364; 195<span></span>
</td>
<td class="nump">&#8364; 269<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PlanAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PlanAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PlanAssetsEffectOfAssetCeiling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Plan Assets, Effect Of Asset Ceiling</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PlanAssetsEffectOfAssetCeiling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>216
<FILENAME>R172.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405440690864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Fair Value of Plans Assets relating to Pension Plans and Other Post-employment Plans (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket', window );">Securities quoted in an active market</a></td>
<td class="nump">84.40%<span></span>
</td>
<td class="nump">86.90%<span></span>
</td>
<td class="nump">94.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities', window );">Other securities</a></td>
<td class="nump">15.60%<span></span>
</td>
<td class="nump">13.10%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssets', window );">Total</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket', window );">Securities quoted in an active market</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_EquityInstrumentsMember', window );">Equity instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket', window );">Securities quoted in an active market</a></td>
<td class="nump">21.70%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">24.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_BondsAndSimilarInstrumentsMember', window );">Bonds and similar instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket', window );">Securities quoted in an active market</a></td>
<td class="nump">52.40%<span></span>
</td>
<td class="nump">53.80%<span></span>
</td>
<td class="nump">59.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_RealEstateMember', window );">Real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket', window );">Securities quoted in an active market</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_DerivativesMember', window );">Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket', window );">Securities quoted in an active market</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_CommoditiesMember', window );">Commodities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket', window );">Securities quoted in an active market</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket', window );">Securities quoted in an active market</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_HedgeFundsMember', window );">Hedge funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities', window );">Other securities</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=sny_InsurancePoliciesMember', window );">Insurance policies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities', window );">Other securities</a></td>
<td class="nump">15.60%<span></span>
</td>
<td class="nump">13.10%<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageContributedToFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage contributed to fair value of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageContributedToFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Contributed To Fair Value Of Plan Assets, Other Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Contributed To Fair Value Of Plan Assets, Securities Quoted In An Active Market</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_EquityInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_EquityInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_BondsAndSimilarInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_BondsAndSimilarInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_RealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_RealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_DerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_DerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_CommoditiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_CommoditiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_InsurancePoliciesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_InsurancePoliciesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>217
<FILENAME>R173.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405434256912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Service Cost for Pension and Other post-employment Benefit Plans, by Geographical Region (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</a></td>
<td class="num">&#8364; (156)<span></span>
</td>
<td class="num">&#8364; (106)<span></span>
</td>
<td class="nump">&#8364; 23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</a></td>
<td class="num">(205)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</a></td>
<td class="num">(382)<span></span>
</td>
<td class="num">(156)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</a></td>
<td class="nump">131<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement', window );">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</a></td>
<td class="num">(68)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset', window );">Net interest cost/(income) including administration costs and taxes paid during the period</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Contributions from plan members</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss', window );">Expense/(gain) recognized directly in profit or loss</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</a></td>
<td class="nump">650<span></span>
</td>
<td class="nump">685<span></span>
</td>
<td class="num">(266)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset', window );">Expense/(gain) for the period</a></td>
<td class="num">(482)<span></span>
</td>
<td class="num">(409)<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits | France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement', window );">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</a></td>
<td class="num">(60)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset', window );">Net interest cost/(income) including administration costs and taxes paid during the period</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Contributions from plan members</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss', window );">Expense/(gain) recognized directly in profit or loss</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset', window );">Expense/(gain) for the period</a></td>
<td class="num">(145)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits | Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement', window );">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset', window );">Net interest cost/(income) including administration costs and taxes paid during the period</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Contributions from plan members</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss', window );">Expense/(gain) recognized directly in profit or loss</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset', window );">Expense/(gain) for the period</a></td>
<td class="num">(151)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits | US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement', window );">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(123)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset', window );">Net interest cost/(income) including administration costs and taxes paid during the period</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Contributions from plan members</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss', window );">Expense/(gain) recognized directly in profit or loss</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset', window );">Expense/(gain) for the period</a></td>
<td class="num">(301)<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits | UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement', window );">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset', window );">Net interest cost/(income) including administration costs and taxes paid during the period</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Contributions from plan members</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss', window );">Expense/(gain) recognized directly in profit or loss</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</a></td>
<td class="num">(130)<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="num">(115)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset', window );">Expense/(gain) for the period</a></td>
<td class="nump">117<span></span>
</td>
<td class="num">(230)<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement', window );">(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset', window );">Net interest cost/(income) including administration costs and taxes paid during the period</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Contributions from plan members</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss', window );">Expense/(gain) recognized directly in profit or loss</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset', window );">Expense/(gain) for the period</a></td>
<td class="num">&#8364; (2)<span></span>
</td>
<td class="num">&#8364; (19)<span></span>
</td>
<td class="nump">&#8364; 45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense/(gain) for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>(Gains) Losses Related To Plan Amendments, Curtailments Or Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense (Income) Including Administration Costs And Taxes Paid, Net Defined Benefit Liability (Asset)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total expense for pensions and other post-employment benefits recognized directly in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>218
<FILENAME>R174.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405440690192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Remeasurement of Net Defined-benefit (Asset)/Liability (Actuarial Gains and Losses) (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Gains/(losses) on financial assumptions</a></td>
<td class="num">&#8364; (654)<span></span>
</td>
<td class="num">&#8364; (686)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Actuarial gains/(losses) arising during the period</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(23)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments', window );">Gains/(losses) on experience adjustments</a></td>
<td class="num">(120)<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset', window );">Gains/(losses) on demographic assumptions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Gains/(losses) on financial assumptions</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(60)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Actuarial gains/(losses) arising during the period</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(121)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments', window );">Gains/(losses) on experience adjustments</a></td>
<td class="num">(620)<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset', window );">Gains/(losses) on demographic assumptions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Gains/(losses) on financial assumptions</a></td>
<td class="nump">825<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(197)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Actuarial gains/(losses) arising during the period</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments', window );">Gains/(losses) on experience adjustments</a></td>
<td class="num">(287)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset', window );">Gains/(losses) on demographic assumptions</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(42)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Gains/(losses) on financial assumptions</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(194)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Actuarial gains/(losses) arising during the period</a></td>
<td class="num">(131)<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(115)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments', window );">Gains/(losses) on experience adjustments</a></td>
<td class="num">(1,328)<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">341<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset', window );">Gains/(losses) on demographic assumptions</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Gains/(losses) on financial assumptions</a></td>
<td class="nump">&#8364; 1,143<span></span>
</td>
<td class="nump">&#8364; 77<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (442)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial gains/(losses) on experience adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>219
<FILENAME>R175.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456122576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Summary of Net Pre-tax Actuarial Loss (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity', window );">Net pre-tax actuarial loss</a></td>
<td class="num">&#8364; (2,090)<span></span>
</td>
<td class="num">&#8364; (2,738)<span></span>
</td>
<td class="num">&#8364; (3,423)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net pretax actuarial loss excluding associates and joint ventures recognized directly in equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>220
<FILENAME>R176.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442578608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Summary of Present Value of Pension and Other Post Employment Benefits (Details) - Pensions and other post-employment benefits - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net defined benefit liability (asset)</a></td>
<td class="nump">&#8364; 1,770<span></span>
</td>
<td class="nump">&#8364; 2,539<span></span>
</td>
<td class="nump">&#8364; 3,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember', window );">Present value of defined benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net defined benefit liability (asset)</a></td>
<td class="nump">8,651<span></span>
</td>
<td class="nump">12,175<span></span>
</td>
<td class="nump">12,456<span></span>
</td>
<td class="nump">&#8364; 13,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember', window );">Wholly or partly funded defined benefit plans | Present value of defined benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net defined benefit liability (asset)</a></td>
<td class="nump">7,463<span></span>
</td>
<td class="nump">10,416<span></span>
</td>
<td class="nump">10,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember', window );">Wholly unfunded defined benefit plans | Present value of defined benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net defined benefit liability (asset)</a></td>
<td class="nump">&#8364; 1,188<span></span>
</td>
<td class="nump">&#8364; 1,759<span></span>
</td>
<td class="nump">&#8364; 1,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>221
<FILENAME>R177.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432595824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="nump">&#8364; 13,695<span></span>
</td>
<td class="nump">&#8364; 12,255<span></span>
</td>
<td class="nump">&#8364; 12,159<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">6,706<span></span>
</td>
<td class="nump">5,692<span></span>
</td>
<td class="nump">5,530<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="nump">10,492<span></span>
</td>
<td class="nump">9,555<span></span>
</td>
<td class="nump">9,391<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating (income)/expenses, net</a></td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">1,373<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expenses</a></td>
<td class="nump">440<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="nump">388<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating (income)/expenses, net</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RestructuringCostsReversedAndSimilarItems', window );">Restructuring costs</a></td>
<td class="num">(61)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expenses</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss', window );">Total</a></td>
<td class="nump">&#8364; 168<span></span>
</td>
<td class="nump">&#8364; 276<span></span>
</td>
<td class="nump">&#8364; 84<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RestructuringCostsReversedAndSimilarItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Costs (Reversed) And Similar Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RestructuringCostsReversedAndSimilarItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense recognized directly in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>222
<FILENAME>R178.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405433766336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Estimated Amounts of Employer's Contributions to Plan Assets (Details) - Year 1<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan', window );">Estimate of contributions expected to be paid to plan for next annual reporting period</a></td>
<td class="nump">&#8364; 38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan', window );">Estimate of contributions expected to be paid to plan for next annual reporting period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan', window );">Estimate of contributions expected to be paid to plan for next annual reporting period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan', window );">Estimate of contributions expected to be paid to plan for next annual reporting period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">UK</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan', window );">Estimate of contributions expected to be paid to plan for next annual reporting period</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems', window );"><strong>Disclosure of fair value of plan assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan', window );">Estimate of contributions expected to be paid to plan for next annual reporting period</a></td>
<td class="nump">&#8364; 34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimate of the expected contributions to be made to a defined benefit plan for the next annual reporting period. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 147<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_147_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 148<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_148_d_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>223
<FILENAME>R179.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405430043952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Expected Timing of Benefit Payments under Pension and Other Post-employment Benefit Plans (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Year 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">&#8364; 596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Year 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Year 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">575<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Year 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">592<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Year 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember', window );">Year 6 - Year 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">3,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | Year 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | Year 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | Year 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | Year 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | Year 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | Year 6 - Year 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">505<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany | Year 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany | Year 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany | Year 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany | Year 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany | Year 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany | Year 6 - Year 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">1,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Year 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Year 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Year 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Year 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Year 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Year 6 - Year 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK | Year 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK | Year 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK | Year 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK | Year 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK | Year 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">UK | Year 6 - Year 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">784<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other | Year 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other | Year 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other | Year 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other | Year 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other | Year 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other | Year 6 - Year 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans', window );">Estimated future benefit payments under pension and other post-employment benefit plans</a></td>
<td class="nump">&#8364; 323<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated future benefit payments under pension and other post-employment benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>224
<FILENAME>R180.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455761312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Timing of Future Payments in Respect of Unfunded Pension and Other Post-employment Benefit Plans (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans', window );">Estimated payments</a></td>
<td class="nump">&#8364; 1,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans', window );">Estimated payments</a></td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">From&#160;1&#160;to 3&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans', window );">Estimated payments</a></td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">From&#160;3&#160;to 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans', window );">Estimated payments</a></td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans', window );">Estimated payments</a></td>
<td class="nump">&#8364; 859<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected timing of payments in respect of unfunded pension and other post-employment benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>225
<FILENAME>R181.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405423919584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Movements in Restructuring Provisions Classified in Non-current and Current Liabilities (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfRestructuringProvisionsLineItems', window );"><strong>Disclosure of Restructuring Provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities', window );">Balance, beginning of period</a></td>
<td class="nump">&#8364; 6,721<span></span>
</td>
<td class="nump">&#8364; 7,315<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestructuringProvisionAbstract', window );"><strong>Of which:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermRestructuringProvision', window );">Classified in current liabilities</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(528)<span></span>
</td>
<td class="num">(459)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(793)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="num">(274)<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(421)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(214)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities', window );">Balance, end of period</a></td>
<td class="nump">6,341<span></span>
</td>
<td class="nump">6,721<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,315<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember', window );">Restructuring Provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfRestructuringProvisionsLineItems', window );"><strong>Disclosure of Restructuring Provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities', window );">Balance, beginning of period</a></td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">1,499<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,390<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestructuringProvisionAbstract', window );"><strong>Of which:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermRestructuringProvision', window );">Classified in non-current liabilities</a></td>
<td class="nump">761<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">868<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermRestructuringProvision', window );">Classified in current liabilities</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod', window );">Change in provisions recognized in profit or loss for the period</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">767<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(522)<span></span>
</td>
<td class="num">(571)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(663)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UnwindingOfDiscount', window );">Unwinding of discount</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities', window );">Balance, end of period</a></td>
<td class="nump">&#8364; 1,233<span></span>
</td>
<td class="nump">&#8364; 1,118<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,499<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermRestructuringProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provision for restructuring. [Refer: Restructuring provision]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermRestructuringProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProvisionUsedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProvisionUsedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestructuringProvisionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestructuringProvisionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermRestructuringProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provision for restructuring. [Refer: Restructuring provision]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermRestructuringProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in provisions recognized in profit or loss for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfRestructuringProvisionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of restructuring provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfRestructuringProvisionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions and non-current other liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_UnwindingOfDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unwinding Of Discount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_UnwindingOfDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>226
<FILENAME>R182.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432558992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Timing of Future Termination Benefit Payments (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">&#8364; 1,039<span></span>
</td>
<td class="nump">&#8364; 943<span></span>
</td>
<td class="nump">&#8364; 1,260<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">From&#160;1&#160;to 3&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">448<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">From&#160;3&#160;to 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">804<span></span>
</td>
<td class="nump">614<span></span>
</td>
<td class="nump">889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | From&#160;1&#160;to 3&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">412<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="nump">457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | From&#160;3&#160;to 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other | From&#160;1&#160;to 3&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other | From&#160;3&#160;to 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Employee termination benefits</a></td>
<td class="nump">&#8364; 2<span></span>
</td>
<td class="nump">&#8364; 2<span></span>
</td>
<td class="nump">&#8364; 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>227
<FILENAME>R183.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441525056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Summary of Other Provisions (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsAbstract', window );"><strong>Disclosure of other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionForEnvironmentRisks', window );">Environmental risks</a></td>
<td class="nump">&#8364; 526<span></span>
</td>
<td class="nump">&#8364; 650<span></span>
</td>
<td class="nump">&#8364; 713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther', window );">Product liability risks, litigation and other</a></td>
<td class="nump">1,652<span></span>
</td>
<td class="nump">1,374<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherLongtermProvisions', window );">Total</a></td>
<td class="nump">&#8364; 2,178<span></span>
</td>
<td class="nump">&#8364; 2,024<span></span>
</td>
<td class="nump">&#8364; 1,975<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherProvisionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherProvisionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherLongtermProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherLongtermProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentProvisionForEnvironmentRisks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Environment risks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentProvisionForEnvironmentRisks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Product liability risks litigation and other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>228
<FILENAME>R184.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405424103104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions, income tax liabilities and other liabilities - Current Provisions and Other Current Liabilities (Details) - EUR (&#8364;)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax', window );">Taxes payable, other than corporate income taxes</a></td>
<td class="nump">&#8364; 420,000,000<span></span>
</td>
<td class="nump">&#8364; 428,000,000<span></span>
</td>
<td class="nump">&#8364; 347,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsAccruals', window );">Employee-related liabilities</a></td>
<td class="nump">2,158,000,000<span></span>
</td>
<td class="nump">2,126,000,000<span></span>
</td>
<td class="nump">2,042,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermRestructuringProvision', window );">Restructuring provisions (see Note&#160;D.19.2.)</a></td>
<td class="nump">472,000,000<span></span>
</td>
<td class="nump">594,000,000<span></span>
</td>
<td class="nump">631,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentInterestRateDerivativesPayable', window );">Interest rate derivatives (see Note&#160;D.20.)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentCurrencyDerivativesPayable', window );">Currency derivatives (see Note&#160;D.20.)</a></td>
<td class="nump">94,000,000<span></span>
</td>
<td class="nump">62,000,000<span></span>
</td>
<td class="nump">205,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentEquityDerivativesPayable', window );">Equity derivatives (see Note&#160;D.20.)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AmountsPayableForAcquisitionOfNonCurrentAssets', window );">Amounts payable for acquisitions of non-current assets</a></td>
<td class="nump">714,000,000<span></span>
</td>
<td class="nump">559,000,000<span></span>
</td>
<td class="nump">467,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentContractLiabilities', window );">Customer contract liabilities</a></td>
<td class="nump">264,000,000<span></span>
</td>
<td class="nump">319,000,000<span></span>
</td>
<td class="nump">252,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">7,899,000,000<span></span>
</td>
<td class="nump">7,112,000,000<span></span>
</td>
<td class="nump">6,188,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentProvisionsAndOtherCurrentLiabilities', window );">Total</a></td>
<td class="nump">12,021,000,000<span></span>
</td>
<td class="nump">11,217,000,000<span></span>
</td>
<td class="nump">&#8364; 10,132,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Contract liabilities</a></td>
<td class="nump">&#8364; 85,000,000<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current contract liabilities. [Refer: Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermRestructuringProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provision for restructuring. [Refer: Restructuring provision]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermRestructuringProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AmountsPayableForAcquisitionOfNonCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts payable for acquisitions of non-current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AmountsPayableForAcquisitionOfNonCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentCurrencyDerivativesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentCurrencyDerivativesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentEquityDerivativesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Equity Derivatives Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentEquityDerivativesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentInterestRateDerivativesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current interest rate derivatives payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentInterestRateDerivativesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentProvisionsAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions and current other liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentProvisionsAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>229
<FILENAME>R185.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405434571936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative financial instruments and market risks - Summary of Fair Value of Derivative Instruments (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of Credit Risk Exposure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Non-current assets</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 3<span></span>
</td>
<td class="nump">&#8364; 24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialAssets', window );">Current assets</a></td>
<td class="nump">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Total assets</a></td>
<td class="nump">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Non-current liabilities</a></td>
<td class="num">(232)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Current liabilities</a></td>
<td class="num">(94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Total liabilities</a></td>
<td class="num">(326)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue', window );">Market value</a></td>
<td class="num">(120)<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="num">(215)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_CurrencyDerivativesMember', window );">Currency derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of Credit Risk Exposure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Non-current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialAssets', window );">Current assets</a></td>
<td class="nump">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Total assets</a></td>
<td class="nump">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Current liabilities</a></td>
<td class="num">(94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Total liabilities</a></td>
<td class="num">(94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue', window );">Market value</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_CurrencyDerivativesOperatingMember', window );">operating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of Credit Risk Exposure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Non-current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialAssets', window );">Current assets</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Total assets</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Current liabilities</a></td>
<td class="num">(66)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Total liabilities</a></td>
<td class="num">(66)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue', window );">Market value</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_CurrencyDerivativesFinancialMember', window );">financial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of Credit Risk Exposure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Non-current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialAssets', window );">Current assets</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Total assets</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Current liabilities</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Total liabilities</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue', window );">Market value</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">212<span></span>
</td>
<td class="num">(216)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateDerivativesMember', window );">Interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of Credit Risk Exposure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Non-current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialAssets', window );">Current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Non-current liabilities</a></td>
<td class="num">(232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Total liabilities</a></td>
<td class="num">(232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue', window );">Market value</a></td>
<td class="num">(232)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_EquityDerivativesMember', window );">Equity derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of Credit Risk Exposure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Non-current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialAssets', window );">Current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue', window );">Market value</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="num">&#8364; (16)<span></span>
</td>
<td class="num">&#8364; (26)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current derivative financial assets. [Refer: Derivative financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCreditRiskExposureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial instruments designated as hedging instruments. Hedging instruments are designated derivatives or (for a hedge of the risk of changes in foreign currency exchange rates only) designated non-derivative financial assets or non-derivative financial liabilities whose fair value or cash flows are expected to offset changes in the fair value or cash flows of a designated hedged item. [Refer: At fair value [member]; Derivatives [member]; Derivative financial assets; Derivative financial liabilities; Financial instruments, class [member]; Financial assets; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 22<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_22_b&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current derivative financial assets. [Refer: Derivative financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_CurrencyDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_CurrencyDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_CurrencyDerivativesOperatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_CurrencyDerivativesOperatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_CurrencyDerivativesFinancialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_CurrencyDerivativesFinancialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_InterestRateDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_EquityDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_EquityDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>230
<FILENAME>R186.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405426555360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative financial instruments and market risks - Summary of Operating Currency Hedging Instruments (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>TWD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">&#8364; 8,862<span></span>
</td>
<td class="nump">&#8364; 6,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">5,403<span></span>
</td>
<td class="nump">3,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">2,732<span></span>
</td>
<td class="nump">1,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">576<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in Japanese Yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward Currency Sales In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales In Mexican Peso</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">3,459<span></span>
</td>
<td class="nump">2,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">2,047<span></span>
</td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">375<span></span>
</td>
<td class="nump">696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward Currency Purchased In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases in Hungarian Forint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward Currency Purchased In Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases In Russian Rouble</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases In Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales in Japanese Yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward Currency Sales In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales in Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales In Mexican Peso</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency purchases in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency purchases in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency purchases in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward Currency Purchased In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency purchases in Hungarian Forint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward Currency Purchased In Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency purchases In Russian Rouble</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency purchases In Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">8,862<span></span>
</td>
<td class="nump">6,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">5,403<span></span>
</td>
<td class="nump">3,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">2,732<span></span>
</td>
<td class="nump">1,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">576<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales in Japanese Yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward Currency Sales In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales in Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales In Mexican Peso</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">3,459<span></span>
</td>
<td class="nump">2,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency purchases in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">2,047<span></span>
</td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency purchases in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">375<span></span>
</td>
<td class="nump">696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency purchases in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward Currency Purchased In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency purchases in Hungarian Forint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward Currency Purchased In Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency purchases In Russian Rouble</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency purchases In Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in Japanese Yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward Currency Sales In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales In Mexican Peso</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(27)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward Currency Purchased In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases in Hungarian Forint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward Currency Purchased In Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases In Russian Rouble</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases In Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales in Japanese Yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward Currency Sales In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales in Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales In Mexican Peso</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency purchases in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency purchases in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency purchases in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward Currency Purchased In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency purchases in Hungarian Forint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward Currency Purchased In Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency purchases In Russian Rouble</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency purchases In Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales in Japanese Yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward Currency Sales In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales in Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales In Mexican Peso</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(27)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency purchases in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency purchases in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency purchases in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward Currency Purchased In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency purchases in Hungarian Forint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward Currency Purchased In Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency purchases In Russian Rouble</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency purchases In Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency sales in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency sales in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency sales in Japanese Yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency sales in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward Currency Sales In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency sales in Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency sales In Mexican Peso</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency purchases in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency purchases in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency purchases in Chinese Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward Currency Purchased In Korean Won</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency purchases in Hungarian Forint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward Currency Purchased In Taiwan Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency purchases In Russian Rouble</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges | Forward currency purchases In Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DerivativeFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative financial instrument</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DerivativeFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInUSDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInUSDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInChineseYuanRenminbiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInChineseYuanRenminbiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInJapaneseYenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInJapaneseYenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInSingaporeDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInSingaporeDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInKoreanWonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInKoreanWonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInTaiwanDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInTaiwanDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInMexicanPesoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInMexicanPesoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInUSDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInUSDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInSingaporeDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInSingaporeDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInKoreanWonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInKoreanWonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInHungarianForintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInHungarianForintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInTaiwanDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInTaiwanDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInRussianRoubleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInRussianRoubleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInJapaneseYenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInJapaneseYenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfHedgesAxis=ifrs-full_CashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfHedgesAxis=ifrs-full_CashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfHedgesAxis=sny_NotEligibleForHedgeAccountingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfHedgesAxis=sny_NotEligibleForHedgeAccountingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>231
<FILENAME>R187.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431246544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative financial instruments and market risks - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details)<br> &#8364; in Millions, $ in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>SGD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Derivative financial assets</a></td>
<td class="nump">&#8364; 206.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax', window );">Change in fair value of cash flow hedges</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="num">&#8364; (6.0)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 4.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInUSDollarMember', window );">Forward currency sales in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount of forward sales | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Derivative financial assets</a></td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInUSDollarMember', window );">Forward currency purchases in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount of forward sales | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Derivative financial assets</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax', window );">Change in fair value of cash flow hedges</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInSingaporeDollarMember', window );">Forward currency purchases in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount of forward sales | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Derivative financial assets</a></td>
<td class="nump">33.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax', window );">Change in fair value of cash flow hedges</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_CurrencySwapsInUSDToEURMember', window );">Currency swaps in USD to EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount of forward sales | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Derivative financial assets</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax', window );">Change in fair value of cash flow hedges</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">12,556.0<span></span>
</td>
<td class="nump">16,948.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,068.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">7,559.0<span></span>
</td>
<td class="nump">7,655.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,064.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">4,997.0<span></span>
</td>
<td class="nump">9,293.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,004.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Less&#160;than 1&#160;year | Forward currency sales in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">6,114.0<span></span>
</td>
<td class="nump">5,384.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,721.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Less&#160;than 1&#160;year | Forward Currency Sales In Pound Sterling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">384.0<span></span>
</td>
<td class="nump">309.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">257.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Less&#160;than 1&#160;year | Forward Currency Sales In Chinese Yuan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">203.0<span></span>
</td>
<td class="nump">70.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Less&#160;than 1&#160;year | Forward currency purchases in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">2,011.0<span></span>
</td>
<td class="nump">4,816.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,068.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Less&#160;than 1&#160;year | Forward currency purchases in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">2,154.0<span></span>
</td>
<td class="nump">2,910.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,250.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Less&#160;than 1&#160;year | Forward currency purchases In Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">205.0<span></span>
</td>
<td class="nump">235.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">68.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">90.0<span></span>
</td>
<td class="nump">212.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(216.0)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">66.0<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">24.0<span></span>
</td>
<td class="nump">197.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(226.0)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Less&#160;than 1&#160;year | Forward currency sales in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">59.0<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Less&#160;than 1&#160;year | Forward Currency Sales In Pound Sterling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6.0)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Less&#160;than 1&#160;year | Forward Currency Sales In Chinese Yuan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Less&#160;than 1&#160;year | Forward currency purchases in US Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="num">(4.0)<span></span>
</td>
<td class="nump">128.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(200.0)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Less&#160;than 1&#160;year | Forward currency purchases in Singapore Dollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">22.0<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27.0)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Less&#160;than 1&#160;year | Forward currency purchases In Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Financial currency hedging instruments in place</a></td>
<td class="nump">&#8364; 4.0<span></span>
</td>
<td class="num">&#8364; (2.0)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on cash flow hedges, before tax, before reclassification adjustments. [Refer: Cash flow hedges [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_23_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative financial instruments to manage financial exposure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DerivativeFinancialInstrumentsToManageFinancialExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInUSDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInUSDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInUSDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInUSDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInSingaporeDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInSingaporeDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_CurrencySwapsInUSDToEURMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_CurrencySwapsInUSDToEURMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInPoundSterlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInPoundSterlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInChineseYuanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInChineseYuanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInJapaneseYenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasedInJapaneseYenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>232
<FILENAME>R188.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405405061072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative financial instruments and market risks - Disclosure of Instruments (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">&#8364; 2,434<span></span>
</td>
<td class="nump">&#8364; 3,579<span></span>
</td>
<td class="nump">&#8364; 2,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Nominal value of interest rate swaps hedge fixed-rate bonds</a></td>
<td class="nump">8,862<span></span>
</td>
<td class="nump">6,286<span></span>
</td>
<td class="nump">5,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">2,434<span></span>
</td>
<td class="nump">2,979<span></span>
</td>
<td class="nump">2,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Nominal value of interest rate swaps hedge fixed-rate bonds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | 1&#160;to&#160;2 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | 2 to 3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">850<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | 2 to 3 years | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | 3 to 4 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | 4 to 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | More&#160;than 5&#160;years | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(232)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Nominal value of interest rate swaps hedge fixed-rate bonds</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(232)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Nominal value of interest rate swaps hedge fixed-rate bonds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Nominal value of interest rate swaps hedge fixed-rate bonds</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateSwapsInterestRate', window );">Interest rate</a></td>
<td class="nump">1.03%<span></span>
</td>
<td class="nump">1.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">&#8364; 467<span></span>
</td>
<td class="nump">&#8364; 440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Notional amount | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Notional amount | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Notional amount | 1&#160;to&#160;2 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Notional amount | 2 to 3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Notional amount | 3 to 4 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Notional amount | 4 to 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Notional amount | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Fair value | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% | Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateSwapsInterestRate', window );">Interest rate</a></td>
<td class="nump">1.32%<span></span>
</td>
<td class="nump">1.32%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">&#8364; 467<span></span>
</td>
<td class="nump">&#8364; 440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Notional amount | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Notional amount | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Notional amount | 1&#160;to&#160;2 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Notional amount | 2 to 3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Notional amount | 3 to 4 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Notional amount | 4 to 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Notional amount | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(56)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Fair value | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(56)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% | Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateSwapsInterestRate', window );">Interest rate</a></td>
<td class="nump">0.69%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">&#8364; 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Notional amount | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Notional amount | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Notional amount | 1&#160;to&#160;2 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Notional amount | 2 to 3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Notional amount | 3 to 4 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Notional amount | 4 to 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Notional amount | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Fair value | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member', window );">Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% | Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateSwapsInterestRate', window );">Interest rate</a></td>
<td class="nump">0.92%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">&#8364; 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Notional amount | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Notional amount | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Notional amount | 1&#160;to&#160;2 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Notional amount | 2 to 3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Notional amount | 3 to 4 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Notional amount | 4 to 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Notional amount | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Fair value | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member', window );">Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% | Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateSwapsInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.48%<span></span>
</td>
<td class="nump">1.48%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 99<span></span>
</td>
<td class="nump">&#8364; 99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Nominal value of interest rate swaps hedge fixed-rate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Notional amount | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Notional amount | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Notional amount | 1&#160;to&#160;2 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Notional amount | 2 to 3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Notional amount | 3 to 4 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Notional amount | 4 to 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Notional amount | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Fair value | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember', window );">Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent | Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateSwapsInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.06%<span></span>
</td>
<td class="nump">0.06%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,000<span></span>
</td>
<td class="nump">&#8364; 2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Notional amount | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Notional amount | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Notional amount | 1&#160;to&#160;2 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Notional amount | 2 to 3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Notional amount | 3 to 4 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Notional amount | 4 to 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Notional amount | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Fair value | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member', window );">Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% | Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateSwapsInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.57%)<span></span>
</td>
<td class="num">(0.57%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Notional amount | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Notional amount | Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Notional amount | 1&#160;to&#160;2 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Notional amount | 2 to 3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Notional amount | 3 to 4 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Notional amount | 4 to 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Notional amount | More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Fair value | Derivatives designated as fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember', window );">Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia | Of&#160;which recognized&#160;in&#160;equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency and interest rate derivatives used to manage debt, net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DerivativeFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative financial instrument</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DerivativeFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateSwapsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Rate Swaps, Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateSwapsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfHedgesAxis=ifrs-full_FairValueHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfHedgesAxis=ifrs-full_FairValueHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfHedgesAxis=ifrs-full_CashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfHedgesAxis=ifrs-full_CashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive069Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>233
<FILENAME>R189.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405440756832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative financial instruments and market risks - Disclosure of Actual or Potential Effects of Netting Arrangements (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=sny_DerivativeFinancialAssetsMember', window );">Derivative financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure of Offsetting of Financial Assets and Liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset', window );">Gross carrying amounts before offset</a></td>
<td class="nump">&#8364; 206<span></span>
</td>
<td class="nump">&#8364; 298<span></span>
</td>
<td class="nump">&#8364; 82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32', window );">Gross amounts offset (in accordance with IAS 32)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetAmountsAsReportedInTheBalanceSheet', window );">Net amounts as reported in the balance sheet</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetExposure', window );">Net exposure</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=sny_DerivativeFinancialAssetsMember', window );">Derivative financial assets | Effects of other netting arrangements not fulfilling the IAS 32 criteria for offsetting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure of Offsetting of Financial Assets and Liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral', window );">Fair value of financial collateral</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments', window );">Financial instruments</a></td>
<td class="num">(160)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=sny_DerivativeFinancialLiabilitiesMember', window );">Derivative financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure of Offsetting of Financial Assets and Liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset', window );">Gross carrying amounts before offset</a></td>
<td class="num">(326)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="num">(297)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32', window );">Gross amounts offset (in accordance with IAS 32)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetAmountsAsReportedInTheBalanceSheet', window );">Net amounts as reported in the balance sheet</a></td>
<td class="num">(326)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="num">(297)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetExposure', window );">Net exposure</a></td>
<td class="num">(166)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(216)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=sny_DerivativeFinancialLiabilitiesMember', window );">Derivative financial liabilities | Effects of other netting arrangements not fulfilling the IAS 32 criteria for offsetting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure of Offsetting of Financial Assets and Liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral', window );">Fair value of financial collateral</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments', window );">Financial instruments</a></td>
<td class="nump">&#8364; 160<span></span>
</td>
<td class="nump">&#8364; 67<span></span>
</td>
<td class="nump">&#8364; 81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative financial assets and liabilities gross amounts offset in accordance with IAS 32.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative financial assets and liabilities gross carrying amounts before offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of offsetting of financial assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effects of other netting arrangements not fulfilling the IAS32 criteria for offsetting fair value of financial collateral.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effects of other netting arrangements not fulfilling the IAS32 criteria for offsetting financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetAmountsAsReportedInTheBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net amounts as reported in the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetAmountsAsReportedInTheBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net exposure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=sny_DerivativeFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=sny_DerivativeFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DerivativeInstrumentAxis=sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DerivativeInstrumentAxis=sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=sny_DerivativeFinancialLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=sny_DerivativeFinancialLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>234
<FILENAME>R190.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455783088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Off balance sheet commitments - Summary of Off Balance Sheet Commitments Relating to Operating Activities (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet', window );">Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced</a></td>
<td class="nump">&#8364; 38<span></span>
</td>
<td class="nump">&#8364; 109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsGiven', window );">Irrevocable purchase commitments given</a></td>
<td class="nump">10,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsReceived', window );">Irrevocable purchase commitments received</a></td>
<td class="num">(1,025)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments', window );">Research and development license agreements - commitments related to R&amp;D and other commitments</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress', window );">Research and development license agreements - contingent milestone payments in connection with development programs in progress</a></td>
<td class="nump">2,919<span></span>
</td>
<td class="nump">2,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalOffBalanceSheetCommitments', window );">Total - net contributions given</a></td>
<td class="nump">13,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet', window );">Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsGiven', window );">Irrevocable purchase commitments given</a></td>
<td class="nump">5,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsReceived', window );">Irrevocable purchase commitments received</a></td>
<td class="num">(482)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments', window );">Research and development license agreements - commitments related to R&amp;D and other commitments</a></td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress', window );">Research and development license agreements - contingent milestone payments in connection with development programs in progress</a></td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalOffBalanceSheetCommitments', window );">Total - net contributions given</a></td>
<td class="nump">5,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">From&#160;1&#160;to 3&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet', window );">Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsGiven', window );">Irrevocable purchase commitments given</a></td>
<td class="nump">2,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsReceived', window );">Irrevocable purchase commitments received</a></td>
<td class="num">(335)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments', window );">Research and development license agreements - commitments related to R&amp;D and other commitments</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress', window );">Research and development license agreements - contingent milestone payments in connection with development programs in progress</a></td>
<td class="nump">875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalOffBalanceSheetCommitments', window );">Total - net contributions given</a></td>
<td class="nump">3,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">From&#160;3&#160;to 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet', window );">Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsGiven', window );">Irrevocable purchase commitments given</a></td>
<td class="nump">1,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsReceived', window );">Irrevocable purchase commitments received</a></td>
<td class="num">(86)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments', window );">Research and development license agreements - commitments related to R&amp;D and other commitments</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress', window );">Research and development license agreements - contingent milestone payments in connection with development programs in progress</a></td>
<td class="nump">889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalOffBalanceSheetCommitments', window );">Total - net contributions given</a></td>
<td class="nump">1,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet', window );">Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsGiven', window );">Irrevocable purchase commitments given</a></td>
<td class="nump">980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsReceived', window );">Irrevocable purchase commitments received</a></td>
<td class="num">(122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments', window );">Research and development license agreements - commitments related to R&amp;D and other commitments</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress', window );">Research and development license agreements - contingent milestone payments in connection with development programs in progress</a></td>
<td class="nump">952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalOffBalanceSheetCommitments', window );">Total - net contributions given</a></td>
<td class="nump">1,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_SuppliersMember', window );">Suppliers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsGiven', window );">Irrevocable purchase commitments given</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsReceived', window );">Irrevocable purchase commitments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (1,124)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=ifrs-full_JointVenturesMember', window );">Joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems', window );"><strong>Disclosure Of Off Balance Sheet Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IrrevocablePurchaseCommitmentsGiven', window );">Irrevocable purchase commitments given</a></td>
<td class="nump">&#8364; 871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Related To Research And Development License Agreements, Contingent Milestone Payments In Connection With Development Programs In Progress</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments related to R&amp; D licence agreements and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOffBalanceSheetCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Disclosure Of Off Balance Sheet Commitments [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOffBalanceSheetCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IrrevocablePurchaseCommitmentsGiven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Irrevocable purchase commitments given.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IrrevocablePurchaseCommitmentsGiven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IrrevocablePurchaseCommitmentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Irrevocable purchase commitments received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IrrevocablePurchaseCommitmentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short Term Leases, Low Value Asset Leases And Lease Contracts Committed But Not Started Yet</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TotalOffBalanceSheetCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TotalOffBalanceSheetCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_SuppliersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=sny_SuppliersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=ifrs-full_JointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=ifrs-full_JointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>235
<FILENAME>R191.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405427485056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Off balance sheet commitments - Additional Information (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 19, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 08, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 04, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 27, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 17, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 05, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 15, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 02, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 11, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 07, 2022 </div>
<div>USD ($) </div>
<div>molecule</div>
</th>
<th class="th">
<div>Feb. 27, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>target</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 29, 2022 </div>
<div>EUR (&#8364;) </div>
<div>target</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 08, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Feb. 28, 2014</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase', window );">Commitments related to research and development relating to projects in research phase | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets', window );">Commitments related to research and development payments contingent upon attainment of sales targets | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements', window );">Commitments related to collaboration, discovery, development and commercialization agreements | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts', window );">Commitments related to attainment of regulatory and sales milestones for commercialized products | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CumulativeDevelopmentCostsIncurred', window );">Cumulative development costs incurred | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">Total credit facilities | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments', window );">Commitments received in respect of disposals proceeds receivable and contingent consideration on divestments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_AblynxMember', window );">Sanofi Belgium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements', window );">Commitments related to collaboration, discovery, development and commercialization agreements | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_KymabMember', window );">Kymab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements', window );">Commitments related to collaboration, discovery, development and commercialization agreements | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements', window );">Commitments related to milestone payments for projects under collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_WorldHealthOrganizationMember', window );">World Health Organization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TransferPercentageOfPandemicVaccines', window );">Percentage of pandemic vaccines agreed to transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ReservePercentageOfPandemicVaccines', window );">Percentage of pandemic vaccines agreed to reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=ifrs-full_JointVenturesMember', window );">Joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty', window );">Percentage of future development expense funded by other party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5000.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_DiceMoleculesMember', window );">Dice Molecules</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfTargetsThatEncompassAllDiseasesAreas', window );">Targets that encompass all diseases areas | target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_LonzaMember', window );">Lonza | Joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInJointVentures', window );">Investments in joint ventures | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany', window );">Percentage of future development expense funded by company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AmountsPayablePartnersInCollaborationAgreements', window );">Amounts payable partners in collaboration agreements | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod', window );">Share of operating expenses and cost of production to joint partner payable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_ABLBioMember', window );">ABL Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_ABLBioMember', window );">ABL Bio | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements', window );">Commitments related to milestone payments for projects under collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 985.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_AdageneIncMember', window );">Adagene, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_AdageneIncMember', window );">Adagene, Inc | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements', window );">Commitments related to milestone payments for projects under collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_BlackstoneLifeSciencesMember', window );">Blackstone Life Sciences | Antibodies collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement', window );">Commitments related to maximum payments for projects under collaboration agreement | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_IGMBiosciencesIncMember', window );">IGM Biosciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_IGMBiosciencesIncMember', window );">IGM Biosciences, Inc | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfOncologyTargetsUnderCollaborationAgreement', window );">Number of oncology targets under collaboration agreement | target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement', window );">Number of immunology or inflammation targets under collaboration agreement | target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ContingentConsiderationCollaborationAgreements', window );">Contingent consideration collaboration agreements | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_SkyhawkTherapeuticsIncMember', window );">Skyhawk Therapeutics, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_SkyhawkTherapeuticsIncMember', window );">Skyhawk Therapeutics, Inc | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ContingentConsiderationCollaborationAgreements', window );">Contingent consideration collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_MiReculeMember', window );">miRecule</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_MiReculeMember', window );">miRecule | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ContingentConsiderationCollaborationAgreements', window );">Contingent consideration collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_InnatePharmaSAMember', window );">Innate Pharma SA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment</a></td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_InnatePharmaSAMember', window );">Innate Pharma SA | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ContingentConsiderationCollaborationAgreements', window );">Contingent consideration collaboration agreements</a></td>
<td class="nump">$ 1,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_ExscientiaMember', window );">Exscientia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_ExscientiaMember', window );">Exscientia | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement', window );">Number of novel small molecule candidates developed | molecule</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements', window );">Commitments related to milestone payments for projects under collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_AtomwiseMember', window );">Atomwise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_AtomwiseMember', window );">Atomwise | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ContingentConsiderationCollaborationAgreements', window );">Contingent consideration collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_ScribeTherapeuticsMember', window );">Scribe Therapeutics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_ScribeTherapeuticsMember', window );">Scribe Therapeutics | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ContingentConsiderationCollaborationAgreements', window );">Contingent consideration collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_InsilicoMedicineMember', window );">Insilico Medicine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_InsilicoMedicineMember', window );">Insilico Medicine | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ContingentConsiderationCollaborationAgreements', window );">Contingent consideration collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Antibodies collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems', window );"><strong>Provisions and other non-current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsReceivedForDevelopmentCosts', window );">Commitments received for development costs | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfProfitShareOnCounterpartiesProfit', window );">Maximum additional profit-share, in percentage of Regeneron's quarterly profit (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfCumulativeDevelopmentCostsReimbursed', window );">Percentage of cumulative development costs reimbursed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in joint ventures in an entity's separate financial statements. [Refer: Joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UndrawnBorrowingFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UndrawnBorrowingFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AmountsPayablePartnersInCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts payable partners in collaboration agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AmountsPayablePartnersInCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsReceivedForDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Received For Development Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsReceivedForDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Related To Attainment Of Regulatory And Sales Milestones For Commercialized Products</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Related To Collaboration, Discovery, Development And Commercialization Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Related To Maximum Payments For Projects Under Collaboration Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Related To Milestone Payments For Projects Under Collaboration Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments related to r and d payments contingent upon attainment of sales targets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Related To Research And Development Relating To Projects In Research Phase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ContingentConsiderationCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration Collaboration Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ContingentConsiderationCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CumulativeDevelopmentCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative Development Costs Incurred</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CumulativeDevelopmentCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Immunology Or Inflammation Targets Under Collaboration Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Novel Small Molecule Candidates To Be Developed Under Collaboration Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfOncologyTargetsUnderCollaborationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Oncology Targets Under Collaboration Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfOncologyTargetsUnderCollaborationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfTargetsThatEncompassAllDiseasesAreas">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Targets That Encompass All Diseases Areas</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfTargetsThatEncompassAllDiseasesAreas</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Off Balance Sheet Commitments Received In Respect Of Disposals Proceeds Receivable And Contingent Consideration On Divestments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfCumulativeDevelopmentCostsReimbursed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of cumulative development costs reimbursed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfCumulativeDevelopmentCostsReimbursed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfFutureDevelopmentExpenseFundedByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of future development expense funded by company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfFutureDevelopmentExpenseFundedByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of future development expense funded by other party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfProfitShareOnCounterpartiesProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of profit share on counter parties profit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfProfitShareOnCounterpartiesProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provisions and other non-current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ReservePercentageOfPandemicVaccines">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reserve percentage of pandemic vaccines.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ReservePercentageOfPandemicVaccines</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share of operating expenses and cost of producion to joint partner payable period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TransferPercentageOfPandemicVaccines">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer percentage of pandemic vaccines.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TransferPercentageOfPandemicVaccines</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_UpfrontPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_UpfrontPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_AblynxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_AblynxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_KymabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_KymabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_WorldHealthOrganizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=sny_WorldHealthOrganizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=ifrs-full_JointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=ifrs-full_JointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_DiceMoleculesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_DiceMoleculesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_LonzaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_LonzaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_ABLBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_ABLBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_AdageneIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_AdageneIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_BlackstoneLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_BlackstoneLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_IGMBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_IGMBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_SkyhawkTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_SkyhawkTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_MiReculeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_MiReculeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_InnatePharmaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_InnatePharmaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_ExscientiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_ExscientiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_AtomwiseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_AtomwiseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_ScribeTherapeuticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_ScribeTherapeuticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_InsilicoMedicineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_InsilicoMedicineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>236
<FILENAME>R192.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405440768304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Off balance sheet commitments - Summary of Undrawn Credit Facilities (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLineOfCreditFacilityLineItems', window );"><strong>Disclosure Of Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">General-purpose credit facilities</a></td>
<td class="nump">&#8364; 8,000<span></span>
</td>
<td class="nump">&#8364; 8,000<span></span>
</td>
<td class="nump">&#8364; 8,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less&#160;than 1&#160;year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLineOfCreditFacilityLineItems', window );"><strong>Disclosure Of Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">General-purpose credit facilities</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">From&#160;1&#160;to 3&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLineOfCreditFacilityLineItems', window );"><strong>Disclosure Of Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">General-purpose credit facilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">From&#160;3&#160;to 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLineOfCreditFacilityLineItems', window );"><strong>Disclosure Of Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">General-purpose credit facilities</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More&#160;than 5&#160;years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLineOfCreditFacilityLineItems', window );"><strong>Disclosure Of Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">General-purpose credit facilities</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UndrawnBorrowingFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UndrawnBorrowingFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfLineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of line of credit facility table line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfLineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>237
<FILENAME>R193.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405424168624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Off balance sheet commitments - Summary of Amount of Guarantees Given and Received (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_GuaranteesReceivedMember', window );">Guarantees received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfGuaranteesLineItems', window );"><strong>Disclosure of Guarantees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities', window );">Estimated financial effect of contingent liabilities</a></td>
<td class="nump">&#8364; 1,229<span></span>
</td>
<td class="nump">&#8364; 1,149<span></span>
</td>
<td class="nump">&#8364; 964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_GuaranteesGivenMember', window );">Guarantees given</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfGuaranteesLineItems', window );"><strong>Disclosure of Guarantees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities', window );">Estimated financial effect of contingent liabilities</a></td>
<td class="nump">3,815<span></span>
</td>
<td class="nump">3,794<span></span>
</td>
<td class="nump">3,291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember', window );">Guarantees provided to banks in connection with credit facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfGuaranteesLineItems', window );"><strong>Disclosure of Guarantees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities', window );">Estimated financial effect of contingent liabilities</a></td>
<td class="nump">1,007<span></span>
</td>
<td class="nump">1,042<span></span>
</td>
<td class="nump">695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_OtherGuaranteesGivenMember', window );">Other guarantees given</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfGuaranteesLineItems', window );"><strong>Disclosure of Guarantees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities', window );">Estimated financial effect of contingent liabilities</a></td>
<td class="nump">&#8364; 2,808<span></span>
</td>
<td class="nump">&#8364; 2,752<span></span>
</td>
<td class="nump">&#8364; 2,596<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the estimated financial effect of contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 86<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_86_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EstimatedFinancialEffectOfContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfGuaranteesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfGuaranteesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_GuaranteesReceivedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_GuaranteesReceivedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_GuaranteesGivenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_GuaranteesGivenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_OtherGuaranteesGivenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_OtherGuaranteesGivenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>238
<FILENAME>R194.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405403832288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal and arbitral proceedings (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="9">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
<th class="th" colspan="1">60 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>plaintiff </div>
<div>complaint</div>
</th>
<th class="th">
<div>May 14, 2013 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>medical_assessment</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>expert</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>decision</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>manufacturer</div>
</th>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>decision</div>
</th>
<th class="th">
<div>Oct. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>proceeding</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>manufacturer </div>
<div>trial </div>
<div>case </div>
<div>person </div>
<div>children </div>
<div>complaint </div>
<div>lawsuit </div>
<div>claim </div>
<div>family </div>
<div>patent</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>action</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>manufacturer </div>
<div>trial </div>
<div>case </div>
<div>person </div>
<div>children </div>
<div>complaint </div>
<div>lawsuit </div>
<div>claim </div>
<div>family</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>AUD ($) </div>
<div>manufacturer </div>
<div>trial </div>
<div>case </div>
<div>person </div>
<div>children </div>
<div>complaint </div>
<div>lawsuit </div>
<div>claim </div>
<div>family</div>
</th>
<th class="th">
<div>Dec. 06, 2022 </div>
<div>cancer </div>
<div>case</div>
</th>
<th class="th">
<div>Aug. 20, 2022 </div>
<div>ruling</div>
</th>
<th class="th">
<div>May 12, 2022 </div>
<div>ruling</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>claim </div>
<div>family</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>complaint</div>
</th>
<th class="th">
<div>Nov. 18, 2014 </div>
<div>patent</div>
</th>
<th class="th">
<div>Apr. 30, 2013 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 1997 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther', window );">Provisions for product liability risks, litigation and other</a></td>
<td class="nump">&#8364; 1,374.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,652.0<span></span>
</td>
<td class="nump">&#8364; 1,374.0<span></span>
</td>
<td class="nump">&#8364; 1,652.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,262.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionForEnvironmentRisks', window );">Environmental risks</a></td>
<td class="nump">&#8364; 650.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 526.0<span></span>
</td>
<td class="nump">&#8364; 650.0<span></span>
</td>
<td class="nump">&#8364; 526.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 713.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCasesDismissed', window );">Number of cases dismissed | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCancersAssociatedWithDismissedCases', window );">Number of cancers associated with dismissed cases | cancer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DefendantAxis=sny_ActionForWhichWeAreDefendantMember', window );">Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfFirstInstanceRulings', window );">Number of first instance rulings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DefendantAxis=sny_ActionForWhichWeAreDefendantMember', window );">Action for which we are defendant | Product liabilities | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LitigationAmountPayable', window );">Litigation amount payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DefendantAxis=sny_ActionForWhichWeAreDefendantMember', window );">Action for which we are defendant | Product liabilities | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LitigationAmountPayable', window );">Litigation amount payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_SanofiPasteurHepatitisBVaccineMember', window );">Sanofi Pasteur Hepatitis B Vaccine product litigation | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCivilIndividualActions', window );">Number of civil individual actions | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfOngoingLawsuits', window );">Number of ongoing lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_TaxotereProductLitigationInTheUSMember', window );">Taxotere product litigation in the US | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">8,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfLossConsortiumPlaintiffs', window );">Number of loss consortium plaintiffs | plaintiff</a></td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfBellweatherTrialsHeld', window );">Number of bellweather trial held | trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember', window );">Taxotere mississippi attorney general litigation in the US | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation', window );">Maximum penalty amount sought by plaintiffs for each violation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_ZantacLitigationInTheUSMember', window );">Zantac litigation in the US | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">68,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfComplaintsFiled', window );">Number of complaints filed | complaint</a></td>
<td class="nump">3,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_ZantacLitigationInCanadaMember', window );">Zantac litigation in Canada | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfClassActionLawsuits', window );">Number of class actions | action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInFranceMember', window );">Depakine product litigation In France | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCivilIndividualActions', window );">Number of civil individual actions | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPeopleExposed', window );">Number of people exposed | person</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfLawsuitsRuledOnMerit', window );">Number of lawsuits ruled on merits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfFamiliesWhoFiledACivilClaim', window );">Number of families who filed a civil claim | family</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCounterExpertiseExperts', window );">Number of experts | expert</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfMedicalAssessments', window );">Number of medical assessments | medical_assessment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification', window );">Number of people exposed who filed a request for indemnification | person</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfAdministrativeProceedings', window );">Number of administrative proceedings | proceeding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInSwitzerlandMember', window );">Depakine product litigation in Switzerland | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPeopleExposed', window );">Number of people exposed | person</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfFamiliesWhoFiledACivilClaim', window );">Number of families who filed a civil claim | family</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInSpainMember', window );">Depakine product litigation in Spain | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPeopleExposed', window );">Number of people exposed | children</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfOngoingTrials', window );">Number of ongoing trials | trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInBelgiumMember', window );">Depakine product litigation in Belgium | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCivilIndividualActions', window );">Number of civil individual actions | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInGermanyMember', window );">Depakine product litigation in Germany | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCivilIndividualActions', window );">Number of civil individual actions | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPeopleExposed', window );">Number of people exposed | children</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_DengvaxiaProductLitigationInThePhilippinesMember', window );">Dengvaxia product litigation in the Philippines | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCases', window );">Number of cases | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_RamiprilCanadaPatentLitigationMember', window );">Ramipril Canada Patent Litigation | Action for which we are a plaintiff | Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug', window );">Number of manufacturers with marketing authorization for generic version of drug | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember', window );">Praluent (Alirocumab)-related amgen patent litigation in the US | Action for which we are defendant | Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPatentActionsInitiallyFiled', window );">Number of patent actions initially filed | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPatentsAllegedlyInfringed', window );">Number of patents allegedly infringed | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_JevtanaRelatedPatentLitigationInTheUSMember', window );">Jevtana related patent litigation in the US | Action for which we are a plaintiff | Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPatentsAllegedlyInfringed', window );">Number of patents allegedly infringed | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPatentsCoveringProduct', window );">Number of patents covering product | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfDecisionsIssuedByTheDistrictCourt', window );">Number of decisions issued by the District Court | decision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing', window );">Number of days after the completion of the post-trial briefing (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">120 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_JevtanaRelatedPatentLitigationInTheUSMember', window );">Jevtana related patent litigation in the US | Action for which we are a plaintiff | Patents | Commencement of major litigation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LengthOfTrial', window );">Length of trial (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_PlavixLitigationCommonwealthInAustraliaMember', window );">Plavix litigation (Commonwealth) in Australia | Action for which we are defendant | Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo', window );">Payment of damages sought by Australian Department of Health related to the Apotex preliminary injunction, up to</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 286.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 286.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 449.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_PlavixLitigationCommonwealthInAustraliaMember', window );">Plavix litigation (Commonwealth) in Australia | Action for which we are defendant | Patents | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs', window );">Reduced amount of compensation claimed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142.1<span></span>
</td>
<td class="nump">$ 223.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded', window );">Reduced amount of compensation claimed, interest included</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218.6<span></span>
</td>
<td class="nump">343.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_PlavixLitigationCommonwealthInAustraliaMember', window );">Plavix litigation (Commonwealth) in Australia | Action for which we are defendant | Patents | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs', window );">Reduced amount of compensation claimed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178.4<span></span>
</td>
<td class="nump">280.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded', window );">Reduced amount of compensation claimed, interest included</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 295.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 295.1<span></span>
</td>
<td class="nump">$ 463.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_PlavixAttorneyGeneralActionInHawaiiMember', window );">Plavix Attorney General Action in Hawaii | Action for which we are defendant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GlobalPenaltyFeeIncurredByDefendants', window );">Total penalty fee incurred by defendants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 834,012,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PenaltyFeeIncurred', window );">Penalty fee incurred by Sanofi | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 417,006,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_PlavixRelatedLitigationInFranceMember', window );">Plavix related litigation in France | Action for which we are defendant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PenaltyFeeIncurred', window );">Penalty fee incurred by Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 40.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PaymentOfDamagesClaimedByCounterparty', window );">Payment of damages claimed by the French CNAM (French Social Security)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 115.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_A340BDrugPricingProgramInTheUnitedStatesMember', window );">340B Drug Pricing Program in the United States | Action for which we are defendant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfOtherManufacturersInvolvedInProceedings', window );">Number of other manufacturers involved in proceedings | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_AventisCropScienceRetainedLiabilitiesMember', window );">Aventis Crop Science retained liabilities | Contingencies arising from certain business divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EquityInvestmentSoldPercentage', window );">Aggregate participation percentage of legacy companies in ACS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_InfraservHoechstRetainedLiabilitiesMember', window );">Infraserv Hoechst retained liabilities | Contingencies arising from certain business divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking', window );">Fund reserves transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 57.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense', window );">Maximum amount to be reimbursed for current and future environmental expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 143.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInIrelandMember', window );">Depakine Product Litigation In Ireland | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPreActionProtocolCases', window );">Number of pre-action protocol cases | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfCivilClaimsOnGoing', window );">Number of civil claims on-going | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInGreatBritainMember', window );">Depakine Product Litigation In Great Britain | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPreActionProtocolCases', window );">Number of pre-action protocol cases | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInNorthernIrelandMember', window );">Depakine Product Litigation In Northern Ireland | Action for which we are defendant | Product liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfPreActionProtocolCases', window );">Number of pre-action protocol cases | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consideration Transferred To Fund Reserve For Indemnification Undertaking</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of legal and arbitral proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfLegalAndArbitralProceedingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EquityInvestmentSoldPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity investment sold percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EquityInvestmentSoldPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GlobalPenaltyFeeIncurredByDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Global Penalty Fee Incurred By Defendants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GlobalPenaltyFeeIncurredByDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LengthOfTrial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Length Of Trial</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LengthOfTrial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LitigationAmountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Amount Payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LitigationAmountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Amount To Be Reimbursed For Current And Future Environmental Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum penalty amount sought by plaintiffs for each violation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentProvisionForEnvironmentRisks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Environment risks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentProvisionForEnvironmentRisks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Product liability risks litigation and other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfAdministrativeProceedings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Administrative Proceedings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfAdministrativeProceedings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfBellweatherTrialsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Bellweather Trials Held</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfBellweatherTrialsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfCancersAssociatedWithDismissedCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Cancers Associated With Dismissed Cases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfCancersAssociatedWithDismissedCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Cases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfCasesDismissed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Cases Dismissed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfCasesDismissed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfCivilClaimsOnGoing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Civil Claims On-Going</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfCivilClaimsOnGoing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfCivilIndividualActions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Civil Individual Actions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfCivilIndividualActions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfComplaintsFiled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Complaints Filed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfComplaintsFiled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfCounterExpertiseExperts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Counter-Expertise Experts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfCounterExpertiseExperts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfDaysAfterCompletionOfPostTrailBriefing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Days After Completion Of Post-Trail Briefing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfDaysAfterCompletionOfPostTrailBriefing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfDecisionsIssuedByTheDistrictCourt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Decisions Issued By The District Court</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfDecisionsIssuedByTheDistrictCourt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfFamiliesWhoFiledACivilClaim">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Families Who Filed A Civil Claim</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfFamiliesWhoFiledACivilClaim</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfFirstInstanceRulings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of First Instance Rulings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfFirstInstanceRulings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfLawsuitsRuledOnMerit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Lawsuits Ruled On Merit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfLawsuitsRuledOnMerit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfLossConsortiumPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of loss consortium plaintiffs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfLossConsortiumPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Manufacturers With Marketing Authorization For Generic Version Of Drug</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfMedicalAssessments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Medical Assessments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfMedicalAssessments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfOngoingLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Ongoing Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfOngoingLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfOngoingTrials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Ongoing Trials</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfOngoingTrials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfOtherManufacturersInvolvedInProceedings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Other Manufacturers Involved In Proceedings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfOtherManufacturersInvolvedInProceedings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfPatentActionsInitiallyFiled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of patent actions initially filed .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfPatentActionsInitiallyFiled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfPatentsAllegedlyInfringed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of patents allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfPatentsAllegedlyInfringed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfPatentsCoveringProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Patents Covering Product</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfPatentsCoveringProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfPeopleExposed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of People Exposed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfPeopleExposed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of People Exposed Who Filed A Request For Indemnification</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Plaintiffs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfPreActionProtocolCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Pre-Action Protocol Cases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfPreActionProtocolCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PaymentOfDamagesClaimedByCounterparty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment Of Damages Claimed By Counterparty</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PaymentOfDamagesClaimedByCounterparty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of damages sought by australian department of health related to the apotex preliminary injunction up to.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PenaltyFeeIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Penalty Fee Incurred</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PenaltyFeeIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduced Amount Of Compensation Claimed By Filled Plaintiffs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduced Amount Of Compensation Claimed By Filled Plaintiffs, Interest Included</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DefendantAxis=sny_ActionForWhichWeAreDefendantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DefendantAxis=sny_ActionForWhichWeAreDefendantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_ProductLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_ProductLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_SanofiPasteurHepatitisBVaccineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_SanofiPasteurHepatitisBVaccineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_TaxotereProductLitigationInTheUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_TaxotereProductLitigationInTheUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_ZantacLitigationInTheUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_ZantacLitigationInTheUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_ZantacLitigationInCanadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_ZantacLitigationInCanadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInSwitzerlandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInSwitzerlandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInSpainMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInSpainMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInBelgiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInBelgiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInGermanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInGermanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_DengvaxiaProductLitigationInThePhilippinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_DengvaxiaProductLitigationInThePhilippinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_RamiprilCanadaPatentLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_RamiprilCanadaPatentLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DefendantAxis=sny_ActionForWhichWeArePlaintiffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DefendantAxis=sny_ActionForWhichWeArePlaintiffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=sny_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=sny_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_JevtanaRelatedPatentLitigationInTheUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_JevtanaRelatedPatentLitigationInTheUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_CommencementOfMajorLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_CommencementOfMajorLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_PlavixLitigationCommonwealthInAustraliaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_PlavixLitigationCommonwealthInAustraliaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_PlavixAttorneyGeneralActionInHawaiiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_PlavixAttorneyGeneralActionInHawaiiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_PlavixRelatedLitigationInFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_PlavixRelatedLitigationInFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_A340BDrugPricingProgramInTheUnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_A340BDrugPricingProgramInTheUnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_AventisCropScienceRetainedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_AventisCropScienceRetainedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_ContingenciesArisingFromCertainBusinessDivestituresMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_ContingenciesArisingFromCertainBusinessDivestituresMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_InfraservHoechstRetainedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_InfraservHoechstRetainedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInIrelandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInIrelandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInGreatBritainMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInGreatBritainMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInNorthernIrelandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_DepakineProductLitigationInNorthernIrelandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>239
<FILENAME>R195.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405404746208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions for discounts, rebates and sales returns - Summary of Movement in Provisions for Discounts, Rebates and Sales Returns (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, beginning balance</a></td>
<td class="nump">&#8364; 5,899<span></span>
</td>
<td class="nump">&#8364; 6,039<span></span>
</td>
<td class="nump">&#8364; 5,218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns', window );">Changes in scope of consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales', window );">Provision related to current period sales</a></td>
<td class="nump">22,141<span></span>
</td>
<td class="nump">19,714<span></span>
</td>
<td class="nump">20,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales', window );">Net change in provision related to prior period sales</a></td>
<td class="num">(315)<span></span>
</td>
<td class="num">(242)<span></span>
</td>
<td class="num">(201)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns', window );">Payments made</a></td>
<td class="num">(21,699)<span></span>
</td>
<td class="num">(19,461)<span></span>
</td>
<td class="num">(19,174)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns', window );">Currency translation differences</a></td>
<td class="nump">464<span></span>
</td>
<td class="num">(153)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, ending balance</a></td>
<td class="nump">6,490<span></span>
</td>
<td class="nump">5,899<span></span>
</td>
<td class="nump">6,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_GovernmentAndStateProgramsMember', window );">Government and State Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, beginning balance</a></td>
<td class="nump">2,596<span></span>
</td>
<td class="nump">2,507<span></span>
</td>
<td class="nump">2,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns', window );">Changes in scope of consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales', window );">Provision related to current period sales</a></td>
<td class="nump">6,744<span></span>
</td>
<td class="nump">5,855<span></span>
</td>
<td class="nump">5,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales', window );">Net change in provision related to prior period sales</a></td>
<td class="num">(120)<span></span>
</td>
<td class="num">(136)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns', window );">Payments made</a></td>
<td class="num">(6,824)<span></span>
</td>
<td class="num">(5,561)<span></span>
</td>
<td class="num">(5,552)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns', window );">Currency translation differences</a></td>
<td class="nump">207<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, ending balance</a></td>
<td class="nump">2,603<span></span>
</td>
<td class="nump">2,596<span></span>
</td>
<td class="nump">2,507<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_ManagedCareAndGPOProgramsMember', window );">Managed care and GPO Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, beginning balance</a></td>
<td class="nump">931<span></span>
</td>
<td class="nump">908<span></span>
</td>
<td class="nump">726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns', window );">Changes in scope of consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales', window );">Provision related to current period sales</a></td>
<td class="nump">3,246<span></span>
</td>
<td class="nump">3,037<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales', window );">Net change in provision related to prior period sales</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns', window );">Payments made</a></td>
<td class="num">(3,208)<span></span>
</td>
<td class="num">(2,979)<span></span>
</td>
<td class="num">(2,556)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns', window );">Currency translation differences</a></td>
<td class="nump">99<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, ending balance</a></td>
<td class="nump">1,021<span></span>
</td>
<td class="nump">931<span></span>
</td>
<td class="nump">908<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_ChargebackIncentivesMember', window );">Chargeback incentives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, beginning balance</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns', window );">Changes in scope of consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales', window );">Provision related to current period sales</a></td>
<td class="nump">4,147<span></span>
</td>
<td class="nump">3,813<span></span>
</td>
<td class="nump">4,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales', window );">Net change in provision related to prior period sales</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns', window );">Payments made</a></td>
<td class="num">(4,093)<span></span>
</td>
<td class="num">(3,828)<span></span>
</td>
<td class="num">(4,604)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns', window );">Currency translation differences</a></td>
<td class="nump">26<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, ending balance</a></td>
<td class="nump">362<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_RebatesAndDiscountsMember', window );">Rebates and discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, beginning balance</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="nump">1,557<span></span>
</td>
<td class="nump">1,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns', window );">Changes in scope of consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales', window );">Provision related to current period sales</a></td>
<td class="nump">7,244<span></span>
</td>
<td class="nump">6,330<span></span>
</td>
<td class="nump">6,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales', window );">Net change in provision related to prior period sales</a></td>
<td class="num">(138)<span></span>
</td>
<td class="num">(152)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns', window );">Payments made</a></td>
<td class="num">(6,809)<span></span>
</td>
<td class="num">(6,291)<span></span>
</td>
<td class="num">(5,838)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns', window );">Currency translation differences</a></td>
<td class="nump">83<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, ending balance</a></td>
<td class="nump">1,805<span></span>
</td>
<td class="nump">1,425<span></span>
</td>
<td class="nump">1,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_SalesReturnMember', window );">Sales returns</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, beginning balance</a></td>
<td class="nump">610<span></span>
</td>
<td class="nump">688<span></span>
</td>
<td class="nump">621<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns', window );">Changes in scope of consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales', window );">Provision related to current period sales</a></td>
<td class="nump">578<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales', window );">Net change in provision related to prior period sales</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns', window );">Payments made</a></td>
<td class="num">(599)<span></span>
</td>
<td class="num">(697)<span></span>
</td>
<td class="num">(512)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns', window );">Currency translation differences</a></td>
<td class="nump">48<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, ending balance</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">610<span></span>
</td>
<td class="nump">688<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_OtherDeductionsMember', window );">Other deductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, beginning balance</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns', window );">Changes in scope of consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales', window );">Provision related to current period sales</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales', window );">Net change in provision related to prior period sales</a></td>
<td class="nump">19<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns', window );">Payments made</a></td>
<td class="num">(166)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns', window );">Currency translation differences</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, ending balance</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, beginning balance</a></td>
<td class="nump">4,057<span></span>
</td>
<td class="nump">3,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, ending balance</a></td>
<td class="nump">4,270<span></span>
</td>
<td class="nump">4,057<span></span>
</td>
<td class="nump">3,982<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, beginning balance</a></td>
<td class="nump">896<span></span>
</td>
<td class="nump">692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, ending balance</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">896<span></span>
</td>
<td class="nump">692<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_MedicaidMember', window );">Medicaid | US | Government and State Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, beginning balance</a></td>
<td class="nump">1,244<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, ending balance</a></td>
<td class="nump">1,307<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_MedicareMember', window );">Medicare | US | Government and State Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, beginning balance</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns', window );">Provisions for discounts, rebates and sales returns, ending balance</a></td>
<td class="nump">&#8364; 775<span></span>
</td>
<td class="nump">&#8364; 941<span></span>
</td>
<td class="nump">&#8364; 726<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherProvisionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherProvisionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments made for discounts, rebates and sales returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net change in provisions related to prior period sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in scope of consolidation in provision for discounts rebates and sales returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency translation differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provision related to current period sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ProvisionsForDiscountsRebatesAndSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provisions for discounts, rebates and sales returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ProvisionsForDiscountsRebatesAndSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_GovernmentAndStateProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_GovernmentAndStateProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_ManagedCareAndGPOProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_ManagedCareAndGPOProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_ChargebackIncentivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_ChargebackIncentivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_RebatesAndDiscountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_RebatesAndDiscountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_SalesReturnMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_SalesReturnMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_OtherDeductionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_OtherDeductionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_ManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_ManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sny_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sny_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sny_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sny_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>240
<FILENAME>R196.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441582160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Personnel costs - Summary of Personal Costs (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EmployeeBenefitsAbstract', window );"><strong>Employee Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Salaries</a></td>
<td class="nump">&#8364; 7,145<span></span>
</td>
<td class="nump">&#8364; 6,625<span></span>
</td>
<td class="nump">&#8364; 6,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SocialSecurityContributions', window );">Social security charges (including defined-contribution pension plans)</a></td>
<td class="nump">2,098<span></span>
</td>
<td class="nump">1,929<span></span>
</td>
<td class="nump">1,874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Stock options and other share-based payment expense</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans', window );">Defined-benefit plans</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherEmployeeExpense', window );">Other employee benefits</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Total</a></td>
<td class="nump">&#8364; 9,991<span></span>
</td>
<td class="nump">&#8364; 9,340<span></span>
</td>
<td class="nump">&#8364; 9,079<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherEmployeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of employee expenses that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 5<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_5&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherEmployeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 5<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_5&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SocialSecurityContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents social security contributions. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 9<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SocialSecurityContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 9<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EmployeeBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Benefits [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EmployeeBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>241
<FILENAME>R197.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439389264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Personnel costs - Additional Information (Details) - employee<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EmployeeBenefitsAbstract', window );"><strong>Employee Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfEmployees', window );">Number of employees</a></td>
<td class="nump">91,573<span></span>
</td>
<td class="nump">95,442<span></span>
</td>
<td class="nump">99,412<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of personnel employed by the entity at a date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EmployeeBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Benefits [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EmployeeBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>242
<FILENAME>R198.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431349792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other operating income (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeLineItems', window );"><strong>Disclosure Of Other Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="nump">&#8364; 1,969<span></span>
</td>
<td class="nump">&#8364; 859<span></span>
</td>
<td class="nump">&#8364; 697<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeStatementLocationAxis=sny_OtherOperatingIncomeExpenseMember', window );">Other operating income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeLineItems', window );"><strong>Disclosure Of Other Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainsOnDivestmentOfProducts', window );">Gains on divestment of some mature products</a></td>
<td class="nump">655<span></span>
</td>
<td class="nump">418<span></span>
</td>
<td class="nump">307<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron | Other operating income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeLineItems', window );"><strong>Disclosure Of Other Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="nump">1,147<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember', window );">Other related parties | Other operating income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeLineItems', window );"><strong>Disclosure Of Other Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="nump">&#8364; 1,178<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">&#8364; 199<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_DaiichiSankyoMember', window );">Daiichi Sankyo | Other operating income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeLineItems', window );"><strong>Disclosure Of Other Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating income. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOtherOperatingIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Other Operating Income [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOtherOperatingIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainsOnDivestmentOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains on divestment of products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainsOnDivestmentOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeStatementLocationAxis=sny_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeStatementLocationAxis=sny_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_DaiichiSankyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=sny_DaiichiSankyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>243
<FILENAME>R199.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405432446992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other operating expenses - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expense</a></td>
<td class="nump">&#8364; 2,531<span></span>
</td>
<td class="nump">&#8364; 1,805<span></span>
</td>
<td class="nump">&#8364; 1,415<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>244
<FILENAME>R200.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405431854432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other operating expenses - Other Income and Expense (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="nump">&#8364; 2,531<span></span>
</td>
<td class="nump">&#8364; 1,805<span></span>
</td>
<td class="nump">&#8364; 1,415<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="nump">1,969<span></span>
</td>
<td class="nump">859<span></span>
</td>
<td class="nump">697<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating income/(expenses), net related to the Regeneron Alliance</a></td>
<td class="num">(1,231)<span></span>
</td>
<td class="num">(1,373)<span></span>
</td>
<td class="num">(926)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember', window );">Antibodies collaboration agreement | Regeneron Pharmaceuticals, INC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CommitmentsReceivedForDevelopmentCosts', window );">Commitments received for development costs</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="nump">2,378<span></span>
</td>
<td class="nump">1,568<span></span>
</td>
<td class="nump">1,090<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeStatementLocationAxis=sny_OtherOperatingIncomeExpenseMember', window );">Other operating income (expense) | Regeneron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="nump">1,147<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember', window );">Monoclonal Antibody Alliance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="nump">2,367<span></span>
</td>
<td class="nump">1,429<span></span>
</td>
<td class="nump">1,001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember', window );">Monoclonal Antibody Alliance | Share of profit or loss from commercialization of monoclonal antibodies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="nump">2,325<span></span>
</td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">727<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember', window );">Monoclonal Antibody Alliance | Share of profit or loss from commercialization of Zaltrap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember', window );">Monoclonal Antibody Alliance | Commercialization related expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="nump">476<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">349<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_ImmunooncologyAllianceMember', window );">Immuno-Oncology Alliance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_OthersCounterpartyMember', window );">Others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MiscellaneousOtherOperatingIncomeExpenses', window );">Other operating income and expenses</a></td>
<td class="nump">&#8364; 1,120<span></span>
</td>
<td class="num">&#8364; (12)<span></span>
</td>
<td class="num">&#8364; (14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating income. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CommitmentsReceivedForDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments Received For Development Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CommitmentsReceivedForDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of other operating income (expenses).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOtherOperatingIncomeExpensesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MiscellaneousOtherOperatingIncomeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other operating income and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MiscellaneousOtherOperatingIncomeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeStatementLocationAxis=sny_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeStatementLocationAxis=sny_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeStatementLocationAxis=sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeStatementLocationAxis=sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeStatementLocationAxis=sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeStatementLocationAxis=sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeStatementLocationAxis=sny_CommercializationRelatedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeStatementLocationAxis=sny_CommercializationRelatedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sny_ImmunooncologyAllianceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sny_ImmunooncologyAllianceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sny_OthersCounterpartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sny_OthersCounterpartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>245
<FILENAME>R201.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405435974160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring costs and similar items - Summary of Restructuring Costs and Similar Items (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses', window );">Employee-related expenses</a></td>
<td class="nump">&#8364; 507<span></span>
</td>
<td class="nump">&#8364; 193<span></span>
</td>
<td class="nump">&#8364; 697<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories', window );">Charges, gains or losses on assets</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts', window );">Compensation for early termination of contracts (other than contracts of employment)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts', window );">Transformation programs costs</a></td>
<td class="nump">547<span></span>
</td>
<td class="nump">463<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherRestructuringCosts', window );">Others</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Total</a></td>
<td class="nump">&#8364; 1,336<span></span>
</td>
<td class="nump">&#8364; 820<span></span>
</td>
<td class="nump">&#8364; 1,089<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseOfRestructuringActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseOfRestructuringActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Compensation for early termination of contracts (other than contracts of employment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee related expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense of restructuring activities related to property plant and equipment to inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense Of Restructuring Activities, Transformation Programs Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>246
<FILENAME>R202.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456006160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring costs and similar items - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses', window );">Increase in employee-related expenses</a></td>
<td class="nump">&#8364; 507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses', window );">Employee-related expenses</a></td>
<td class="nump">&#8364; 507<span></span>
</td>
<td class="nump">&#8364; 193<span></span>
</td>
<td class="nump">&#8364; 697<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee related expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Expense Of Restructuring Activities, Employee Related Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>247
<FILENAME>R203.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405456307888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other gains and losses, and litigation (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherGainsLossesAndLitigation', window );">Other gains, (losses) and litigation</a></td>
<td class="nump">&#8364; 370<span></span>
</td>
<td class="nump">&#8364; 5<span></span>
</td>
<td class="num">&#8364; (136)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherGainsLossesAndLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The line item other gains and losses, and litigation includes the impact of material transactions of an unusual nature or amount. [note B.20.2.]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherGainsLossesAndLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>248
<FILENAME>R204.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405434953728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial expenses and income (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems', window );"><strong>Disclosure of detailed information about finance income expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnBorrowings', window );">Cost of debt</a></td>
<td class="num">&#8364; (365)<span></span>
</td>
<td class="num">&#8364; (313)<span></span>
</td>
<td class="num">&#8364; (328)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestIncome', window );">Interest income</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CostOfDebtNet', window );">Cost of net debt</a></td>
<td class="num">(124)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
<td class="num">(225)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonOperatingForeignExchangeGainsLosses', window );">Non-operating foreign exchange gains/(losses)</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions', window );">Unwinding of discounting of provisions</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetInterestCostRelatedToEmployeeBenefits', window );">Net interest cost related to employee benefits</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets', window );">Gains/(losses) on disposals of financial assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Net interest expense on lease liabilities</a></td>
<td class="num">(40)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncomeCost', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Net financial income/(expenses)</a></td>
<td class="num">(234)<span></span>
</td>
<td class="num">(328)<span></span>
</td>
<td class="num">(335)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">comprising: Financial expenses</a></td>
<td class="num">(440)<span></span>
</td>
<td class="num">(368)<span></span>
</td>
<td class="num">(388)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">comprising: financial income</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgedItemsAxis=sny_InterestRateAndCurrencyDerivativesMember', window );">Interest rate and currency derivatives used to hedge debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems', window );"><strong>Disclosure of detailed information about finance income expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainOnDerivativesUsedToManageDebt', window );">Gain on derivatives used to manage debt</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents', window );">Gain on derivatives used to manage cash and cash equivalents</a></td>
<td class="nump">&#8364; 68<span></span>
</td>
<td class="nump">&#8364; 51<span></span>
</td>
<td class="nump">&#8364; 66<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised due to the unwinding of the discount on provisions other than provisions from employee benefits, resulting from the effect of the passage of time. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) on available-for-sale financial assets. [Refer: Financial assets available-for-sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_20_a_ii&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on borrowings. [Refer: Interest expense; Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CostOfDebtNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of debt net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CostOfDebtNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent detailed information about finance income expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainOnDerivativesUsedToManageCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain on derivatives used to manage cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainOnDerivativesUsedToManageCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainOnDerivativesUsedToManageDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain derivatives used to manage debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainOnDerivativesUsedToManageDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetInterestCostRelatedToEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net interest cost related to employee benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetInterestCostRelatedToEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonOperatingForeignExchangeGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-operating foreign exchange gains/(losses).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonOperatingForeignExchangeGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgedItemsAxis=sny_InterestRateAndCurrencyDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgedItemsAxis=sny_InterestRateAndCurrencyDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>249
<FILENAME>R205.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442136912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current taxes</a></td>
<td class="num">&#8364; (2,774)<span></span>
</td>
<td class="num">&#8364; (1,908)<span></span>
</td>
<td class="num">&#8364; (1,913)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred taxes</a></td>
<td class="nump">768<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Total</a></td>
<td class="num">(2,006)<span></span>
</td>
<td class="num">(1,558)<span></span>
</td>
<td class="num">(1,807)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments', window );">Income before tax and investments accounted for using the equity method</a></td>
<td class="nump">&#8364; 10,422<span></span>
</td>
<td class="nump">&#8364; 7,798<span></span>
</td>
<td class="nump">&#8364; 13,778<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income before tax and investments accounted for equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>250
<FILENAME>R206.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455736976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Standard tax rate applicable in France</a></td>
<td class="nump">25.80%<span></span>
</td>
<td class="nump">28.40%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfForeignTaxRates', window );">Difference between the standard French tax rate and the rates applicable to the Sanofi</a></td>
<td class="num">(6.50%)<span></span>
</td>
<td class="num">(9.50%)<span></span>
</td>
<td class="num">(18.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes', window );">Revisions to tax exposures and settlements of tax disputes</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations', window );">Fair value remeasurement of contingent considerations</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome', window );">Other items</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageEffectiveTaxRate', window );">Effective tax rate</a></td>
<td class="nump">19.20%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">13.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax rate effects, in aggregate, on the reconciliation between the average effective tax rate and the applicable tax rate that the entity does not separately disclose in the reconciliation. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfForeignTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the application of foreign tax rates. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfForeignTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Rate Effect Of Fair Value Remeasurement Of Contingent Considerations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Rate Effect Of Revisions To Tax Exposures And Settlements Of Tax Disputes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>251
<FILENAME>R207.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442793728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share of profit/loss from investments accounted for using the equity method (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 29, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 68<span></span>
</td>
<td class="nump">&#8364; 39<span></span>
</td>
<td class="nump">&#8364; 359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="nump">&#8364; 343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 343<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>252
<FILENAME>R208.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442491184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net income attributable to non-controlling interests (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems', window );"><strong>Disclosure of net income attributable to non-controlling interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="nump">&#8364; 113<span></span>
</td>
<td class="nump">&#8364; 56<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember', window );">Share of net income attributable to other non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems', window );"><strong>Disclosure of net income attributable to non-controlling interests [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="nump">&#8364; 113<span></span>
</td>
<td class="nump">&#8364; 56<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of net income attributable to noncontrolling interests [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>253
<FILENAME>R209.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439621760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions - Additional Information (Details) - executives<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RelatedPartyAbstract', window );"><strong>Related Party [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfExecutiveCommitteeMembers', window );">Average number of members of executive committee</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfExecutiveCommitteeMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of executive committee members.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfExecutiveCommitteeMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>254
<FILENAME>R210.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405455819344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions - Schedule of Compensation Paid to Key Management Personnel (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of compensation paid to key management personnel [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short-term benefits</a></td>
<td class="nump">&#8364; 31<span></span>
</td>
<td class="nump">&#8364; 33<span></span>
</td>
<td class="nump">&#8364; 36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits', window );">Post-employment benefits</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based payment</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total recognized in profit or loss</a></td>
<td class="nump">&#8364; 52<span></span>
</td>
<td class="nump">&#8364; 55<span></span>
</td>
<td class="nump">&#8364; 57<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>255
<FILENAME>R211.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441742592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions - Summary of aggregate amounts Payable to Key Management Personnel (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RelatedPartyAbstract', window );"><strong>Related Party [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee', window );">Aggregate top-up pension obligation in favor of certain corporate officers and of Executive Committee members</a></td>
<td class="nump">&#8364; 10<span></span>
</td>
<td class="nump">&#8364; 28<span></span>
</td>
<td class="nump">&#8364; 32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits', window );">Aggregate termination benefits and lump-sum retirement benefits in favor of key management personnel</a></td>
<td class="nump">&#8364; 5<span></span>
</td>
<td class="nump">&#8364; 7<span></span>
</td>
<td class="nump">&#8364; 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate pension obligation in favor of certain corporate officers and of members of the executive committee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Key management personnel compensation, termination benefits and lump sum retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>256
<FILENAME>R212.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405442707344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disclosures about major customers and credit risk (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems', window );"><strong>Disclosure of information about major customers and credit risk [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=sny_LargestCustomersMember', window );">Largest customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems', window );"><strong>Disclosure of information about major customers and credit risk [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue (in percent)</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=sny_CustomerOneMember', window );">Customer one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems', window );"><strong>Disclosure of information about major customers and credit risk [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue (in percent)</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=sny_CustomerTwoMember', window );">Customer two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems', window );"><strong>Disclosure of information about major customers and credit risk [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue (in percent)</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=sny_CustomerThreeMember', window );">Customer three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems', window );"><strong>Disclosure of information about major customers and credit risk [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue (in percent)</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of the entity's revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of information about major customers and credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=sny_LargestCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=sny_LargestCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=sny_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=sny_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=sny_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=sny_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=sny_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=sny_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>257
<FILENAME>R213.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405444224624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 29, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentFinancialAssetsNumberOfShares', window );">Non-current financial assets, number of shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279,766<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentFinancialAssetsNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Financial Assets, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentFinancialAssetsNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>258
<FILENAME>R214.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405429948672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Summary of Net Sales by Segment and Geographical Area (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">&#8364; 42,997<span></span>
</td>
<td class="nump">&#8364; 37,761<span></span>
</td>
<td class="nump">&#8364; 36,041<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">30,688<span></span>
</td>
<td class="nump">26,970<span></span>
</td>
<td class="nump">25,674<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Dupixent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">8,293<span></span>
</td>
<td class="nump">5,249<span></span>
</td>
<td class="nump">3,534<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Neurology &amp; Immunology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">2,450<span></span>
</td>
<td class="nump">2,324<span></span>
</td>
<td class="nump">2,394<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Aubagio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">2,031<span></span>
</td>
<td class="nump">1,955<span></span>
</td>
<td class="nump">2,045<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Rare Diseases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">3,445<span></span>
</td>
<td class="nump">3,126<span></span>
</td>
<td class="nump">3,011<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Cerezyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">707<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="nump">690<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Fabrazyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">938<span></span>
</td>
<td class="nump">844<span></span>
</td>
<td class="nump">817<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Myozyme/Lumizyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">958<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">948<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Oncology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">952<span></span>
</td>
<td class="nump">912<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Jevtana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">455<span></span>
</td>
<td class="nump">536<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Rare Blood Disorders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="nump">1,217<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Alprolix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Eloctate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">580<span></span>
</td>
<td class="nump">563<span></span>
</td>
<td class="nump">638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Core Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">6,389<span></span>
</td>
<td class="nump">5,768<span></span>
</td>
<td class="nump">5,581<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Lovenox</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,486<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Toujeo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,117<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="nump">933<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Plavix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">983<span></span>
</td>
<td class="nump">929<span></span>
</td>
<td class="nump">913<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Non-Core Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">7,222<span></span>
</td>
<td class="nump">7,642<span></span>
</td>
<td class="nump">8,326<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Lantus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">2,259<span></span>
</td>
<td class="nump">2,494<span></span>
</td>
<td class="nump">2,661<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Other non-core assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">4,485<span></span>
</td>
<td class="nump">4,729<span></span>
</td>
<td class="nump">5,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals | Industrial sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">620<span></span>
</td>
<td class="nump">808<span></span>
</td>
<td class="nump">813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_VaccinesSegmentMember', window );">Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">7,229<span></span>
</td>
<td class="nump">6,323<span></span>
</td>
<td class="nump">5,973<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_VaccinesSegmentMember', window );">Vaccines | Polio/Pertussis/ Hib Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">2,285<span></span>
</td>
<td class="nump">2,159<span></span>
</td>
<td class="nump">2,106<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_VaccinesSegmentMember', window );">Vaccines | Influenza Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">2,977<span></span>
</td>
<td class="nump">2,628<span></span>
</td>
<td class="nump">2,472<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember', window );">Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">5,080<span></span>
</td>
<td class="nump">4,468<span></span>
</td>
<td class="nump">4,394<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember', window );">Consumer Healthcare | Allergy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">734<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="nump">617<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember', window );">Consumer Healthcare | Pain Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">1,093<span></span>
</td>
<td class="nump">1,051<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember', window );">Consumer Healthcare | Digestive Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,318<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
<td class="nump">988<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">9,999<span></span>
</td>
<td class="nump">9,759<span></span>
</td>
<td class="nump">9,151<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">7,157<span></span>
</td>
<td class="nump">7,201<span></span>
</td>
<td class="nump">6,819<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Dupixent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">940<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="nump">386<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Neurology &amp; Immunology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">639<span></span>
</td>
<td class="nump">638<span></span>
</td>
<td class="nump">578<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Aubagio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">511<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="nump">473<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Rare Diseases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,104<span></span>
</td>
<td class="nump">1,069<span></span>
</td>
<td class="nump">1,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Cerezyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Fabrazyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Myozyme/Lumizyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Oncology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Jevtana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Rare Blood Disorders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Alprolix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Eloctate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Core Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,917<span></span>
</td>
<td class="nump">1,868<span></span>
</td>
<td class="nump">1,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Lovenox</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">658<span></span>
</td>
<td class="nump">703<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Toujeo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">374<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Plavix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Non-Core Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,637<span></span>
</td>
<td class="nump">1,846<span></span>
</td>
<td class="nump">2,088<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Lantus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="nump">537<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Other non-core assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,129<span></span>
</td>
<td class="nump">1,285<span></span>
</td>
<td class="nump">1,451<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Pharmaceuticals | Industrial sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">587<span></span>
</td>
<td class="nump">723<span></span>
</td>
<td class="nump">658<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,341<span></span>
</td>
<td class="nump">1,225<span></span>
</td>
<td class="nump">973<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Vaccines | Polio/Pertussis/ Hib Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="nump">331<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Vaccines | Influenza Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">681<span></span>
</td>
<td class="nump">729<span></span>
</td>
<td class="nump">441<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,501<span></span>
</td>
<td class="nump">1,333<span></span>
</td>
<td class="nump">1,359<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Consumer Healthcare | Allergy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Consumer Healthcare | Pain Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">555<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="nump">481<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Consumer Healthcare | Digestive Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">432<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="nump">371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">18,275<span></span>
</td>
<td class="nump">14,385<span></span>
</td>
<td class="nump">13,465<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">13,694<span></span>
</td>
<td class="nump">10,484<span></span>
</td>
<td class="nump">9,635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Dupixent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">6,346<span></span>
</td>
<td class="nump">3,971<span></span>
</td>
<td class="nump">2,808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Neurology &amp; Immunology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,637<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
<td class="nump">1,631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Aubagio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,420<span></span>
</td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">1,448<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Rare Diseases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,367<span></span>
</td>
<td class="nump">1,142<span></span>
</td>
<td class="nump">1,122<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Cerezyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Fabrazyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">471<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">406<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Myozyme/Lumizyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Oncology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">515<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Jevtana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Rare Blood Disorders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">983<span></span>
</td>
<td class="nump">842<span></span>
</td>
<td class="nump">837<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Alprolix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Eloctate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">429<span></span>
</td>
<td class="nump">445<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Core Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,653<span></span>
</td>
<td class="nump">1,315<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Lovenox</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Toujeo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">283<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Plavix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Non-Core Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">1,281<span></span>
</td>
<td class="nump">1,389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Lantus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">861<span></span>
</td>
<td class="nump">929<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Other non-core assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">412<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Pharmaceuticals | Industrial sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">3,291<span></span>
</td>
<td class="nump">2,762<span></span>
</td>
<td class="nump">2,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Vaccines | Polio/Pertussis/ Hib Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">456<span></span>
</td>
<td class="nump">470<span></span>
</td>
<td class="nump">412<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Vaccines | Influenza Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,737<span></span>
</td>
<td class="nump">1,366<span></span>
</td>
<td class="nump">1,575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,290<span></span>
</td>
<td class="nump">1,139<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Consumer Healthcare | Allergy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">439<span></span>
</td>
<td class="nump">371<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Consumer Healthcare | Pain Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Consumer Healthcare | Digestive Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">14,723<span></span>
</td>
<td class="nump">13,617<span></span>
</td>
<td class="nump">13,425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">9,837<span></span>
</td>
<td class="nump">9,285<span></span>
</td>
<td class="nump">9,220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Dupixent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,007<span></span>
</td>
<td class="nump">629<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Neurology &amp; Immunology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Aubagio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Rare Diseases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">974<span></span>
</td>
<td class="nump">915<span></span>
</td>
<td class="nump">879<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Cerezyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Fabrazyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Myozyme/Lumizyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Oncology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Jevtana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Rare Blood Disorders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">339<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Alprolix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Eloctate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Core Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">2,819<span></span>
</td>
<td class="nump">2,585<span></span>
</td>
<td class="nump">2,409<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Lovenox</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">635<span></span>
</td>
<td class="nump">754<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Toujeo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Plavix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">873<span></span>
</td>
<td class="nump">805<span></span>
</td>
<td class="nump">777<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Non-Core Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">4,409<span></span>
</td>
<td class="nump">4,515<span></span>
</td>
<td class="nump">4,849<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Lantus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,076<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Other non-core assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">2,944<span></span>
</td>
<td class="nump">3,034<span></span>
</td>
<td class="nump">3,222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Pharmaceuticals | Industrial sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">2,597<span></span>
</td>
<td class="nump">2,336<span></span>
</td>
<td class="nump">2,241<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Vaccines | Polio/Pertussis/ Hib Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">1,504<span></span>
</td>
<td class="nump">1,383<span></span>
</td>
<td class="nump">1,363<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Vaccines | Influenza Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">559<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="nump">456<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">2,289<span></span>
</td>
<td class="nump">1,996<span></span>
</td>
<td class="nump">1,964<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Consumer Healthcare | Allergy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Consumer Healthcare | Pain Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">446<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember', window );">Other countries | Consumer Healthcare | Digestive Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">&#8364; 742<span></span>
</td>
<td class="nump">&#8364; 618<span></span>
</td>
<td class="nump">&#8364; 532<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_DupixentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_DupixentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_NeurologyImmunologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_NeurologyImmunologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_AubagioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_AubagioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_RareDiseasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_RareDiseasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_CerezymeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_CerezymeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_FabrazymeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_FabrazymeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_MyozymeOrLumizymeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_MyozymeOrLumizymeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_OncologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_OncologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_JevtanaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_JevtanaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_RareBloodDisordersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_RareBloodDisordersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_AlprolixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_AlprolixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_EloctateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_EloctateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_CoreAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_CoreAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_LovenoxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_LovenoxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_ToujeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_ToujeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_PlavixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_PlavixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_NonCoreAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_NonCoreAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_LantusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_LantusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_OtherNonCoreAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_OtherNonCoreAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_IndustrialSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_IndustrialSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_VaccinesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_VaccinesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_PolioPertussisHibVaccinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_PolioPertussisHibVaccinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_InfluenzaVaccinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_InfluenzaVaccinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_AllergyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_AllergyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_PainCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_PainCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_DigestiveWellnessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_DigestiveWellnessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_OtherCountriesInSegmentResultsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>259
<FILENAME>R215.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405403729696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Schedule of Segment Results (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">&#8364; 42,997<span></span>
</td>
<td class="nump">&#8364; 37,761<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 36,041<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">2,392<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,328<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(13,695)<span></span>
</td>
<td class="num">(12,255)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,159)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(6,706)<span></span>
</td>
<td class="num">(5,692)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,530)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="num">(10,492)<span></span>
</td>
<td class="num">(9,555)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,391)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">359<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember', window );">Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">30,688<span></span>
</td>
<td class="nump">26,970<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,674<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">657<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">128<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(7,511)<span></span>
</td>
<td class="num">(6,965)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,982)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(5,067)<span></span>
</td>
<td class="num">(4,330)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,171)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="num">(5,923)<span></span>
</td>
<td class="num">(5,326)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,927)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MiscellaneousOtherOperatingIncomeExpenses', window );">Other operating income and expenses</a></td>
<td class="num">(1,800)<span></span>
</td>
<td class="num">(1,172)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(487)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(33)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessOperatingIncome', window );">Business operating income</a></td>
<td class="nump">11,043<span></span>
</td>
<td class="nump">9,409<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_VaccinesSegmentMember', window );">Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">7,229<span></span>
</td>
<td class="nump">6,323<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,973<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">1,666<span></span>
</td>
<td class="nump">1,095<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,141<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(4,101)<span></span>
</td>
<td class="num">(3,430)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,312)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(936)<span></span>
</td>
<td class="num">(712)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(682)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="num">(870)<span></span>
</td>
<td class="num">(805)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(789)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MiscellaneousOtherOperatingIncomeExpenses', window );">Other operating income and expenses</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessOperatingIncome', window );">Business operating income</a></td>
<td class="nump">3,168<span></span>
</td>
<td class="nump">2,609<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember', window );">Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">5,080<span></span>
</td>
<td class="nump">4,468<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,394<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">59<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(1,827)<span></span>
</td>
<td class="num">(1,606)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,528)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(187)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(153)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="num">(1,478)<span></span>
</td>
<td class="num">(1,388)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,419)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MiscellaneousOtherOperatingIncomeExpenses', window );">Other operating income and expenses</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessOperatingIncome', window );">Business operating income</a></td>
<td class="nump">1,810<span></span>
</td>
<td class="nump">1,493<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,410<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=ifrs-full_AllOtherSegmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(253)<span></span>
</td>
<td class="num">(250)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(284)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(516)<span></span>
</td>
<td class="num">(497)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(524)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="num">(2,221)<span></span>
</td>
<td class="num">(2,036)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,256)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MiscellaneousOtherOperatingIncomeExpenses', window );">Other operating income and expenses</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(130)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessOperatingIncome', window );">Business operating income</a></td>
<td class="num">(2,981)<span></span>
</td>
<td class="num">(2,797)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,194)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=ifrs-full_ReportableSegmentsMember', window );">Total Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">42,997<span></span>
</td>
<td class="nump">37,761<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">36,041<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">2,392<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,328<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(13,692)<span></span>
</td>
<td class="num">(12,251)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,106)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(6,706)<span></span>
</td>
<td class="num">(5,692)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,530)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="num">(10,492)<span></span>
</td>
<td class="num">(9,555)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,391)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MiscellaneousOtherOperatingIncomeExpenses', window );">Other operating income and expenses</a></td>
<td class="num">(1,514)<span></span>
</td>
<td class="num">(946)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(561)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(38)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessOperatingIncome', window );">Business operating income</a></td>
<td class="nump">&#8364; 13,040<span></span>
</td>
<td class="nump">&#8364; 10,714<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 9,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business operating income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MiscellaneousOtherOperatingIncomeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other operating income and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MiscellaneousOtherOperatingIncomeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_PharmaceuticalsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_VaccinesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_VaccinesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=ifrs-full_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=ifrs-full_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=ifrs-full_ReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=ifrs-full_ReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>260
<FILENAME>R216.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405429976736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 29, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 39<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 359<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability', window );">Fair value remeasurement of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(124)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Restructuring costs and similar items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,336)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(820)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,089)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherGainsLossesAndLitigation', window );">Other gains and losses, and litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(368)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(388)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments', window );">Income before tax and investments accounted for using the equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,798<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,778<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill', window );">Impairment of other intangible assets, net of reversals (excluding software)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(454)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 192<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">330<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets | SAR444245</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill', window );">Impairment of other intangible assets, net of reversals (excluding software)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sny_EloctateMember', window );">Eloctate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount', window );">Reversal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember', window );">Regeneron Pharmaceuticals, INC | Immuno-oncology collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements', window );">Upfront payments for projects under collaboration agreements | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements', window );">Regular milestone payments for projects under collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 96<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="nump">&#8364; 343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">343<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentFinancialAssetsNumberOfShares', window );">Non-current financial assets, number of shares (in shares) | shares</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279,766<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron | Public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron | Repurchase from the counterpart | Regeneron Pharmaceuticals, INC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares agreement, sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessOperatingIncome', window );">Business operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 10,714<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_MaterialReconcilingItemsMember', window );">Material reconciling items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(88)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">38<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill', window );">Amortization and impairment of intangible assets (c)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,599)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,772)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,011)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability', window );">Fair value remeasurement of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">124<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories', window );">Expenses arising from the impact of acquisitions on inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(53)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Restructuring costs and similar items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,336)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(820)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,089)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherGainsLossesAndLitigation', window );">Other gains and losses, and litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainOnRegeneronInvestmentSold', window );">Gain on divestment of Regeneron shares on May 29, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,225<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeResultingFromOutLicensing', window );">Income from out-licensing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseOfRestructuringActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseOfRestructuringActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a contingent consideration asset (liability) relating to a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization and impairment of intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business operating income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses arising from the impact of acquisitions on inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainOnRegeneronInvestmentSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain On Regeneron Investment Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainOnRegeneronInvestmentSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment loss on intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Loss Recognised In Profit Or Loss, Intangible Assets Other Than Goodwill, Reversal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income before tax and investments accounted for equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeResultingFromOutLicensing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Resulting From Out-Licensing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeResultingFromOutLicensing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentFinancialAssetsNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Financial Assets, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentFinancialAssetsNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherGainsLossesAndLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The line item other gains and losses, and litigation includes the impact of material transactions of an unusual nature or amount. [note B.20.2.]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherGainsLossesAndLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regular Milestone Payments For Projects Under Collaboration Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Number Of Shares Issued In Transaction, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Agreement Sale Of Stock, Number Of Shares Issued In Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront Payments For Projects Under Collaboration Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_SAR444245Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_SAR444245Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sny_EloctateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sny_EloctateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_RegeneronPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PrincipalAlliancesAxis=sny_ImmunoOncologyCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PrincipalAlliancesAxis=sny_ImmunoOncologyCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockAxis=sny_PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockAxis=sny_PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SaleOfStockAxis=sny_RepurchaseFromTheCounterpartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SaleOfStockAxis=sny_RepurchaseFromTheCounterpartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>261
<FILENAME>R217.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405403730608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember', window );">Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InvestmentsInAssociatesAndJointVentures', window );">Investments accounted for using the equity method</a></td>
<td class="nump">&#8364; 536<span></span>
</td>
<td class="nump">&#8364; 159<span></span>
</td>
<td class="nump">&#8364; 154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisitions of property, plant and equipment</a></td>
<td class="nump">1,025<span></span>
</td>
<td class="nump">1,024<span></span>
</td>
<td class="nump">755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Acquisitions of other intangible assets</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="nump">501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_VaccinesMember', window );">Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InvestmentsInAssociatesAndJointVentures', window );">Investments accounted for using the equity method</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisitions of property, plant and equipment</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="nump">404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Acquisitions of other intangible assets</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember', window );">Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InvestmentsInAssociatesAndJointVentures', window );">Investments accounted for using the equity method</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisitions of property, plant and equipment</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Acquisitions of other intangible assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=ifrs-full_ReportableSegmentsMember', window );">Reportable segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InvestmentsInAssociatesAndJointVentures', window );">Investments accounted for using the equity method</a></td>
<td class="nump">677<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisitions of property, plant and equipment</a></td>
<td class="nump">1,606<span></span>
</td>
<td class="nump">1,479<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Acquisitions of other intangible assets</a></td>
<td class="nump">&#8364; 595<span></span>
</td>
<td class="nump">&#8364; 564<span></span>
</td>
<td class="nump">&#8364; 829<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InvestmentsInAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments, joint ventures and associates in an entity's separate financial statements. Long term equity interest, significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InvestmentsInAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_PharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_VaccinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_VaccinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_ConsumerHealthcareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=ifrs-full_ReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=ifrs-full_ReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>262
<FILENAME>R218.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405440815280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">&#8364; 42,997<span></span>
</td>
<td class="nump">&#8364; 37,761<span></span>
</td>
<td class="nump">&#8364; 36,041<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment owned</a></td>
<td class="nump">9,869<span></span>
</td>
<td class="nump">10,028<span></span>
</td>
<td class="nump">9,365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">49,892<span></span>
</td>
<td class="nump">48,056<span></span>
</td>
<td class="nump">44,364<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">21,640<span></span>
</td>
<td class="nump">21,407<span></span>
</td>
<td class="nump">18,341<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_ReportableGeographicalZonesMember', window );">Reportable geographical zones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">42,997<span></span>
</td>
<td class="nump">37,761<span></span>
</td>
<td class="nump">36,041<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment owned</a></td>
<td class="nump">9,869<span></span>
</td>
<td class="nump">10,028<span></span>
</td>
<td class="nump">9,365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">49,892<span></span>
</td>
<td class="nump">48,056<span></span>
</td>
<td class="nump">44,364<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">21,640<span></span>
</td>
<td class="nump">21,407<span></span>
</td>
<td class="nump">18,341<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">9,999<span></span>
</td>
<td class="nump">9,759<span></span>
</td>
<td class="nump">9,151<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment owned</a></td>
<td class="nump">5,365<span></span>
</td>
<td class="nump">5,959<span></span>
</td>
<td class="nump">5,895<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">6,257<span></span>
</td>
<td class="nump">7,059<span></span>
</td>
<td class="nump">6,208<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">2,296<span></span>
</td>
<td class="nump">2,256<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment owned</a></td>
<td class="nump">2,875<span></span>
</td>
<td class="nump">3,253<span></span>
</td>
<td class="nump">3,189<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember', window );">North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">18,984<span></span>
</td>
<td class="nump">15,075<span></span>
</td>
<td class="nump">14,060<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment owned</a></td>
<td class="nump">3,284<span></span>
</td>
<td class="nump">2,998<span></span>
</td>
<td class="nump">2,542<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">14,178<span></span>
</td>
<td class="nump">13,187<span></span>
</td>
<td class="nump">10,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">18,275<span></span>
</td>
<td class="nump">14,385<span></span>
</td>
<td class="nump">13,465<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment owned</a></td>
<td class="nump">2,457<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
<td class="nump">1,899<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="nump">14,014<span></span>
</td>
<td class="nump">12,927<span></span>
</td>
<td class="nump">12,830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment owned</a></td>
<td class="nump">1,220<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">928<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">&#8364; 1,205<span></span>
</td>
<td class="nump">&#8364; 1,161<span></span>
</td>
<td class="nump">&#8364; 1,468<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_ReportableGeographicalZonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_ReportableGeographicalZonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>263
<FILENAME>R219.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405434958064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal accountants' fees and services (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AuditorsNameAxis=sny_ErnstAndYoungMember', window );">Ernst&#160;&amp;&#160;Young</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAuditFeesAndOtherServicesLineItems', window );"><strong>Disclosure of audit fees and other services [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationForAuditServices', window );">Statutory audit of separate and consolidated financial statements</a></td>
<td class="nump">&#8364; 14.2<span></span>
</td>
<td class="nump">&#8364; 13.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ServicesOtherThanStatutoryAudit', window );">Services other than statutory audit</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AuditorsRemunerationForAuditRelatedServices', window );">Audit-related services</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationForTaxServices', window );">Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationForOtherServices', window );">Other</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemuneration', window );">Total</a></td>
<td class="nump">&#8364; 16.0<span></span>
</td>
<td class="nump">&#8364; 16.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfAuditorRemunerationForStatutoryAudit', window );">Statutory audit of separate and consolidated financial statements, percentage</a></td>
<td class="nump">89.00%<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements', window );">Services other than statutory audit, percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfAuditorsRemuneration', window );">Total, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries', window );">Audit of the financial statements of the parent company and its French subsidiaries</a></td>
<td class="nump">&#8364; 7.3<span></span>
</td>
<td class="nump">&#8364; 7.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries', window );">Audit-related services charged to the parent company and its French subsidiaries</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AuditorsNameAxis=sny_PricewaterhousecoopersMember', window );">PricewaterhouseCoopers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAuditFeesAndOtherServicesLineItems', window );"><strong>Disclosure of audit fees and other services [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationForAuditServices', window );">Statutory audit of separate and consolidated financial statements</a></td>
<td class="nump">14.1<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ServicesOtherThanStatutoryAudit', window );">Services other than statutory audit</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AuditorsRemunerationForAuditRelatedServices', window );">Audit-related services</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationForTaxServices', window );">Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationForOtherServices', window );">Other</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemuneration', window );">Total</a></td>
<td class="nump">&#8364; 14.6<span></span>
</td>
<td class="nump">&#8364; 14.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfAuditorRemunerationForStatutoryAudit', window );">Statutory audit of separate and consolidated financial statements, percentage</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements', window );">Services other than statutory audit, percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfAuditorsRemuneration', window );">Total, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries', window );">Audit of the financial statements of the parent company and its French subsidiaries</a></td>
<td class="nump">&#8364; 7.7<span></span>
</td>
<td class="nump">&#8364; 7.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries', window );">Audit-related services charged to the parent company and its French subsidiaries</a></td>
<td class="nump">&#8364; 0.3<span></span>
</td>
<td class="nump">&#8364; 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemuneration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable to the entity's auditors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemuneration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemunerationForAuditServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable to the entity's auditors for auditing services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemunerationForAuditServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemunerationForOtherServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable to the entity's auditors for services that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemunerationForOtherServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemunerationForTaxServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable to the entity's auditors for tax services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemunerationForTaxServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit of the financial statements of the parent company and its French subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit-related services charged to the parent company and its French subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AuditorsRemunerationForAuditRelatedServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor's remuneration for audit related services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AuditorsRemunerationForAuditRelatedServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAuditFeesAndOtherServicesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of audit fees and other services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAuditFeesAndOtherServicesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfAuditorRemunerationForStatutoryAudit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of auditor remuneration for statutory audit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfAuditorRemunerationForStatutoryAudit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfAuditorsRemuneration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor's remuneration, Total Percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfAuditorsRemuneration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Services other than audit of financial statements, percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ServicesOtherThanStatutoryAudit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Services other than statutory audit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ServicesOtherThanStatutoryAudit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AuditorsNameAxis=sny_ErnstAndYoungMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AuditorsNameAxis=sny_ErnstAndYoungMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AuditorsNameAxis=sny_PricewaterhousecoopersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AuditorsNameAxis=sny_PricewaterhousecoopersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>264
<FILENAME>R220.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405427678576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>List of principal companies included in the scope of consolidation during&#160;2022 - Summary of Principal Companies and their Country of Incorporation (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_HoechstGmbHMember', window );">Hoechst GmbH | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeutschlandGmbHMember', window );">Sanofi-Aventis Deutschland GmbH | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_A.NattermannCie.GmbHMember', window );">A. Nattermann &amp; Cie. GmbH | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisGmbHMember', window );">Sanofi-Aventis GmbH | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBelgiumMember', window );">Sanofi Belgium | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AblynxMember', window );">Ablynx N.V. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeFlandersBVBAMember', window );">Genzyme Flanders BVBA | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiASMember', window );">Sanofi A/S | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSAMember', window );">Sanofi-Aventis S.A. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareSpainSLMember', window );">Opella Healthcare Spain, S.L. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiOyMember', window );">Sanofi Oy | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiMember', window );">Sanofi | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisFranceMember', window );">Sanofi-Aventis France | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiWinthropIndustriesMember', window );">Sanofi Winthrop Industrie | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisRechercheEtDeveloppementMember', window );">Sanofi-Aventis Recherche &amp; D&#233;veloppement | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisGroupeMember', window );">Sanofi-Aventis Groupe | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiChimieMember', window );">Sanofi Chimie | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisParticipationsSASMember', window );">Sanofi-Aventis Participations | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurFranceSAMember', window );">Sanofi Pasteur | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaSAFranceMember', window );">Aventis Pharma S.A. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBiotechnologyMember', window );">Sanofi Biotechnology | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiMatureIPMember', window );">Sanofi Mature IP | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurNVLMember', window );">Sanofi Pasteur NVL | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurEuropeMember', window );">Sanofi Pasteur Europe | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SECIPESASMember', window );">SECIPE SAS | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurMerieuxSASMember', window );">Sanofi Pasteur Merieux S.A.S. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_Sanofi2015DSASMember', window );">Sanofi 2015 D SAS | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareInternationalSASMember', window );">Opella Healthcare International SAS | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareFranceSASMember', window );">Opella Healthcare France SAS | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareGroupSASMember', window );">Opella Healthcare Group SAS | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiaventisAEBEMember', window );">Sanofi-Aventis A.E.B.E. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPrivateCoLtdMember', window );">Sanofi-Aventis Private Co, Ltd | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">99.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ChinoinPrivateCoLtdMember', window );">Chinoin Private Co. Ltd | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">99.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareHungaryCommercialKFTMember', window );">Opella Healthcare Hungary Commercial K.F.T | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_CarraigInsuranceDACMember', window );">Carraig Insurance DAC | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeIrelandLimitedMember', window );">Genzyme Ireland Limited | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisHoldingsIrelandLtdMember', window );">Sanofi-Aventis Holdings (Ireland) Ltd | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiSRLMember', window );">Sanofi S.R.L. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareItalySRLMember', window );">Opella Healthcare Italy S.R.L. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeGlobalSarlMember', window );">Genzyme Global Sarl | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeLuxembourgSarlMember', window );">Genzyme Luxembourg Sarl | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisNorgeASMember', window );">Sanofi-Aventis Norge AS | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeEuropeBVMember', window );">Genzyme Europe B.V. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiForeignParticipationsB.V.Member', window );">Sanofi Foreign Participations B.V. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiaventisSpZooMember', window );">Sanofi-Aventis Sp. z.o.o. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcarePolandSpZOOMember', window );">Opella Healthcare Poland sp.Z.O.O | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurSpZooMember', window );">Sanofi Pasteur Sp. z.o.o. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiProdutosFarmaceuticosLdaMember', window );">Sanofi Produtos Farmaceuticos Lda | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSROMember', window );">Sanofi-Aventis, s.r.o. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareCzechSroMember', window );">Opella Healthcare Czech s.r.o | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisRomaniaSRLMember', window );">Sanofi Romania SRL | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareRomaniaSRLMember', window );">Opella Healthcare Romania S.R.L. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisUkHoldingsLimitedMember', window );">Sanofi-Aventis UK Holdings Limited | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaLimitedMember', window );">Aventis Pharma Limited | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiSynthelaboUKLtdMember', window );">Sanofi-Synthelabo UK Ltd | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaHoldingsLtdMember', window );">Aventis Pharma Holdings Ltd | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareUKLimitedMember', window );">Opella Healthcare UK Limited | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AOSanofiRussiaMember', window );">AO Sanofi Russia | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareLLCMember', window );">Opella Healthcare LLC | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiABMember', window );">Sanofi AB | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSuisseSAMember', window );">Sanofi-Aventis (Suisse) SA | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember', window );">Genzyme Global Sarl Baar Intellectual Property Branch | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiIlacSanayiVeTicaretASMember', window );">Sanofi Ilac Sanayi ve Ticaret A.S. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurAsiTicaretASMember', window );">Sanofi Pasteur Asi Ticaret A.S. | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiSaglikUrunleriLimitedSirketiMember', window );">Sanofi Saglik Urunleri Limited Sirketi | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeTherapeuticProductsLimitedPartnershipMember', window );">Genzyme Therapeutic Products Limited Partnership | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisIncMember', window );">Aventis Inc. | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiUSServicesIncMember', window );">Sanofi US Services Inc. | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisUSLLCMember', window );">Sanofi-Aventis U.S. LLC | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ChattemIncMember', window );">Chattem, Inc. | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisubLLCMember', window );">Aventisub LLC | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeCorporationMember', window );">Genzyme Corporation | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurIncMember', window );">Sanofi Pasteur Inc. | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_VaxServeIncMember', window );">VaxServe, Inc. | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BioverativIncMember', window );">Bioverativ Inc. | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BioverativUSLLCMember', window );">Bioverativ U.S. LLC | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BioverativTherapeuticsIncMember', window );">Bioverativ Therapeutics Inc. | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_PrincipiaBiopharmaIncMember', window );">Principia Biopharma Inc. | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiResearchInvestLLCMember', window );">Sanofi Research Invest LLC | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBioverativHoldingsLLCMember', window );">Sanofi Bioverativ Holdings LLC | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_RPRUSLtdMember', window );">RPR US Ltd. | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_KadmonHoldingsIncMember', window );">Kadmon Holdings, Inc. | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_KadmonCorporationLLCMember', window );">Kadmon Corporation, LLC | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AmunixMember', window );">Amunix | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SynthorxIncMember', window );">Synthorx, Inc | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_TranslateBioIncMember', window );">Translate Bio, Inc | United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSouthAfricaPtyLtdMember', window );">Sanofi-Aventis South Africa (Pty) Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisAlgerieMember', window );">Sanofi-Aventis Alg&#233;rie | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiArabiaTradingCompanyLimitedMember', window );">Sanofi Arabia Trading Company Limited | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisArgentinaSAMember', window );">Sanofi-Aventis Argentina S.A. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeDeArgentinaSAMember', window );">Genzyme de Argentina S.A. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareArgentinaSAUMember', window );">Opella Healthcare Argentina S.A.U. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisHealthcarePtyLtdMember', window );">Sanofi-Aventis Healthcare Pty Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisAustraliaPtyLtdMember', window );">Sanofi-Aventis Australia Pty Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiMedleyFarmaceuticaLtdaMember', window );">Sanofi Medley Farmaceutica Ltda | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisCanadaIncMember', window );">Sanofi-Aventis Canada Inc. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurLimitedMember', window );">Sanofi Pasteur Limited | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_MerieuxCanadaHoldingsULCCanadaMember', window );">Merieux Canada Holdings ULC (Canada) | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeChileSAMember', window );">Sanofi-Aventis de Chile S.A. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiHangzhouPharmaceuticalsCoLtdMember', window );">Sanofi (Hangzhou) Pharmaceuticals Co., Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiChinaInvestmentCoLtdMember', window );">Sanofi (China) Investment Co., Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBeijingPharmaceuticalsCoLtdMember', window );">Sanofi (Beijing) Pharmaceuticals Co.Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurBiologiesCo.LtdMember', window );">Sanofi Pasteur Biologies Co., Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember', window );">Shenzhen Sanofi pasteur Biological Products Co, Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ShanghaiRonghengPharmaceuticalCoLtdMember', window );">Shanghai Rongheng Pharmaceutical Co, Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenfarSAMember', window );">Genfar S.A. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeColombiaSAMember', window );">Sanofi-Aventis de Colombia S.A. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisKoreaCoLtdMember', window );">Sanofi-Aventis Korea Co. Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurLtdMember', window );">Sanofi Pasteur Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareKoreaIncMember', window );">Opella healthcare Korea Inc. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisGulfFZEMember', window );">Sanofi-Aventis Gulf FZE | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiEgyptSAEMember', window );">Sanofi Egypt | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">99.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareEgyptLLCMember', window );">Opella Healthcare Egypt LLC | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiHongKongLimitedMember', window );">Sanofi Hong-Kong Limited | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiIndiaLimitedMember', window );">Sanofi India Limited | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">60.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiHealthcareIndiaPrivateLimitedMember', window );">Sanofi Healthcare India Private Limited | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">99.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisIsraelLtdMember', window );">Sanofi-Aventis Isra&#235;l Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiKKMember', window );">Sanofi K.K. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SspCoLtdMember', window );">SSP Co.,Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisMalaysiaSDNBHDMember', window );">Sanofi-Aventis (Malaysia) SDN. BHD. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisMarocMember', window );">Sanofi-Aventis Maroc | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeMexicoSADeCVMember', window );">Sanofi-Aventis de Mexico S.A. de C.V. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurS.A.deC.V.Member', window );">Sanofi Pasteur S.A. de C.V. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AztecaVacunasSADeCVMember', window );">Azteca Vacunas, S.A. de C.V. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPakistanLtdMember', window );">Sanofi-Aventis Pakistan Limited | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">52.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDePanamaSAMember', window );">Sanofi-Aventis de Panama S.A. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDelPeruSAMember', window );">Sanofi-Aventis del Peru S.A. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPuertoRicoIncMember', window );">Sanofi-Aventis Puerto Rico Inc | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPhilippinesIncMember', window );">Sanofi-Aventis Philippines Inc. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcarePhilippinesIncMember', window );">Opella Healthcare Philippines Inc. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSingaporePteLtdMember', window );">Sanofi-Aventis Singapore Pte. Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaManufacturingPTELTDMember', window );">Aventis Pharma (Manufacturing) Pte. Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiManufacturingPteLtdMember', window );">Sanofi Manufacturing Pte Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiTaiwanCoLtdMember', window );">Sanofi Taiwan Co., Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisThailandLtdMember', window );">Sanofi-Aventis (Thailand) Ltd | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeVenezuelaSAMember', window );">Sanofi-Aventis de Venezuela S.A. | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisVietnamCompanyLimitedMember', window );">Sanofi-Aventis Vietnam Company Limited | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiVietnamShareholdingCompanyLimitedMember', window );">Sanofi Vietnam Shareholding Company Limited | Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Financial interest in principal fully consolidated companies</a></td>
<td class="nump">85.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_HoechstGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_HoechstGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeutschlandGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeutschlandGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_A.NattermannCie.GmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_A.NattermannCie.GmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBelgiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBelgiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AblynxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AblynxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeFlandersBVBAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeFlandersBVBAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareSpainSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareSpainSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiOyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiOyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiWinthropIndustriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiWinthropIndustriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisRechercheEtDeveloppementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisRechercheEtDeveloppementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisGroupeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisGroupeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiChimieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiChimieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisParticipationsSASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisParticipationsSASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurFranceSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurFranceSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaSAFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaSAFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBiotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBiotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiMatureIPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiMatureIPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurNVLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurNVLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SECIPESASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SECIPESASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurMerieuxSASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurMerieuxSASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_Sanofi2015DSASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_Sanofi2015DSASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareInternationalSASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareInternationalSASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareFranceSASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareFranceSASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareGroupSASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareGroupSASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiaventisAEBEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiaventisAEBEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPrivateCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPrivateCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ChinoinPrivateCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ChinoinPrivateCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareHungaryCommercialKFTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareHungaryCommercialKFTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_CarraigInsuranceDACMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_CarraigInsuranceDACMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeIrelandLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeIrelandLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisHoldingsIrelandLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisHoldingsIrelandLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiSRLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiSRLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareItalySRLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareItalySRLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeGlobalSarlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeGlobalSarlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeLuxembourgSarlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeLuxembourgSarlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisNorgeASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisNorgeASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeEuropeBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeEuropeBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiForeignParticipationsB.V.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiForeignParticipationsB.V.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiaventisSpZooMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiaventisSpZooMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcarePolandSpZOOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcarePolandSpZOOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurSpZooMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurSpZooMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiProdutosFarmaceuticosLdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiProdutosFarmaceuticosLdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareCzechSroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareCzechSroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisRomaniaSRLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisRomaniaSRLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareRomaniaSRLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareRomaniaSRLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisUkHoldingsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisUkHoldingsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiSynthelaboUKLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiSynthelaboUKLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaHoldingsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaHoldingsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareUKLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareUKLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AOSanofiRussiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AOSanofiRussiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiABMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiABMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSuisseSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSuisseSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiIlacSanayiVeTicaretASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiIlacSanayiVeTicaretASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurAsiTicaretASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurAsiTicaretASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiSaglikUrunleriLimitedSirketiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiSaglikUrunleriLimitedSirketiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeTherapeuticProductsLimitedPartnershipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeTherapeuticProductsLimitedPartnershipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiUSServicesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiUSServicesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisUSLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisUSLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ChattemIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ChattemIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisubLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisubLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_VaxServeIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_VaxServeIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BioverativIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BioverativIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BioverativUSLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BioverativUSLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BioverativTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BioverativTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_PrincipiaBiopharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_PrincipiaBiopharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiResearchInvestLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiResearchInvestLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBioverativHoldingsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBioverativHoldingsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_RPRUSLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_RPRUSLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_KadmonHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_KadmonHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_KadmonCorporationLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_KadmonCorporationLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AmunixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AmunixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SynthorxIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SynthorxIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_TranslateBioIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_TranslateBioIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSouthAfricaPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSouthAfricaPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisAlgerieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisAlgerieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiArabiaTradingCompanyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiArabiaTradingCompanyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisArgentinaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisArgentinaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeDeArgentinaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenzymeDeArgentinaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareArgentinaSAUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareArgentinaSAUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisHealthcarePtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisHealthcarePtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisAustraliaPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisAustraliaPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiMedleyFarmaceuticaLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiMedleyFarmaceuticaLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisCanadaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisCanadaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_MerieuxCanadaHoldingsULCCanadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_MerieuxCanadaHoldingsULCCanadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeChileSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeChileSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiHangzhouPharmaceuticalsCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiHangzhouPharmaceuticalsCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiChinaInvestmentCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiChinaInvestmentCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBeijingPharmaceuticalsCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiBeijingPharmaceuticalsCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurBiologiesCo.LtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurBiologiesCo.LtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ShanghaiRonghengPharmaceuticalCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_ShanghaiRonghengPharmaceuticalCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenfarSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_GenfarSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeColombiaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeColombiaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisKoreaCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisKoreaCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareKoreaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareKoreaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisGulfFZEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisGulfFZEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiEgyptSAEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiEgyptSAEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareEgyptLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcareEgyptLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiHongKongLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiHongKongLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiIndiaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiIndiaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiHealthcareIndiaPrivateLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiHealthcareIndiaPrivateLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisIsraelLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisIsraelLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiKKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiKKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SspCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SspCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisMalaysiaSDNBHDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisMalaysiaSDNBHDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisMarocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisMarocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeMexicoSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeMexicoSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurS.A.deC.V.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiPasteurS.A.deC.V.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AztecaVacunasSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AztecaVacunasSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPakistanLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPakistanLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDePanamaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDePanamaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDelPeruSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDelPeruSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPuertoRicoIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPuertoRicoIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPhilippinesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisPhilippinesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcarePhilippinesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaHealthcarePhilippinesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSingaporePteLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisSingaporePteLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaManufacturingPTELTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_AventisPharmaManufacturingPTELTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiManufacturingPteLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiManufacturingPteLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiTaiwanCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiTaiwanCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisThailandLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisThailandLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeVenezuelaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisDeVenezuelaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisVietnamCompanyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiAventisVietnamCompanyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiVietnamShareholdingCompanyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_SanofiVietnamShareholdingCompanyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>265
<FILENAME>R221.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405441509296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>List of principal companies included in the scope of consolidation during&#160;2022 - Summary of Principal Investments Accounted for Using the Equity Method (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointOperationsAxis=sny_GlaxoSmithKlineConsumerHealthcareLPMember', window );">GlaxoSmithKline Consumer Healthcare, L.P.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointOperationsLineItems', window );"><strong>Disclosure of joint operations [line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointOperation', window );">Financial interest in principal investments accounted for using the equity method</a></td>
<td class="nump">11.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointOperationsAxis=sny_InfraservGmbhAndCoHochstKGMember', window );">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointOperationsLineItems', window );"><strong>Disclosure of joint operations [line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointOperation', window );">Financial interest in principal investments accounted for using the equity method</a></td>
<td class="nump">31.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointOperationsAxis=sny_MapharMember', window );">Maphar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointOperationsLineItems', window );"><strong>Disclosure of joint operations [line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointOperation', window );">Financial interest in principal investments accounted for using the equity method</a></td>
<td class="nump">48.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointOperationsAxis=sny_MCMVaccineBVMember', window );">MCM Vaccine B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointOperationsLineItems', window );"><strong>Disclosure of joint operations [line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointOperation', window );">Financial interest in principal investments accounted for using the equity method</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointOperationsAxis=sny_MSPVaccineCompanyMember', window );">MSP Vaccine Company (formerly MCM company)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointOperationsLineItems', window );"><strong>Disclosure of joint operations [line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointOperation', window );">Financial interest in principal investments accounted for using the equity method</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointOperationsAxis=sny_EuroapiMember', window );">EUROAPI</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointOperationsLineItems', window );"><strong>Disclosure of joint operations [line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointOperation', window );">Financial interest in principal investments accounted for using the equity method</a></td>
<td class="nump">30.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInJointOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a joint operation attributable to the entity. [Refer: Joint operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInJointOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointOperationsAxis=sny_GlaxoSmithKlineConsumerHealthcareLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointOperationsAxis=sny_GlaxoSmithKlineConsumerHealthcareLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointOperationsAxis=sny_InfraservGmbhAndCoHochstKGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointOperationsAxis=sny_InfraservGmbhAndCoHochstKGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointOperationsAxis=sny_MapharMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointOperationsAxis=sny_MapharMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointOperationsAxis=sny_MCMVaccineBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointOperationsAxis=sny_MCMVaccineBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointOperationsAxis=sny_MSPVaccineCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointOperationsAxis=sny_MSPVaccineCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointOperationsAxis=sny_EuroapiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointOperationsAxis=sny_EuroapiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>266
<FILENAME>R222.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140405439917408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events subsequent to December 31, 2022 (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment of intangible assets</a></td>
<td class="num">&#8364; (454)<span></span>
</td>
<td class="nump">&#8364; 192<span></span>
</td>
<td colspan="2" class="nump">&#8364; 330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sny_EloctateMember', window );">Eloctate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount', window );">Reversal amount</a></td>
<td class="nump">2,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">&#8364; 1,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Loss Recognised In Profit Or Loss, Intangible Assets Other Than Goodwill, Reversal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sny_EloctateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sny_EloctateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>267
<FILENAME>sny-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sny="http://www.sanofi.com/20221231"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sny-20221231.xsd" xlink:type="simple"/>
    <context id="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i51d2972f62c44302800dd88abed05207_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib8623615aa6f453286593426ee1e8b04_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">sny:AmericanDepositorySharesNASDAQGlobalSelectMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i22690d5a55c7403c964aa8af7ad10ad5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">sny:OrdinarySharesNASDAQGlobalSelectMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6beef57f0ff142ac829ee75f07d8469f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iddcaadb296914d7093323a235a8de38b_D20220510-20220510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-10</startDate>
            <endDate>2022-05-10</endDate>
        </period>
    </context>
    <context id="i9f887633b9c1418f97d4bb30260bb881_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:ErnstYoungEtAutresMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0645fdc11d9d433a8306a1a8019152d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0566192b2355417fa9d42170481d811a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8167f91dae314f4eaa1e5e23abf0fcae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7b29272f0f8e444e8185ac9de81d8964_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2180880b8f3d4518b6d13260c4b00509_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0a649176e103430588e7d82e8b4b2eae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ideadd6fc92744c689451476829e9bf88_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i30f1c21919c94f78ac899771e9dc6747_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i79431d18a64048a3a31458a8519c8577_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic7ec55dbabba4baeaa5077aa469ea0b9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i091093d5d8a34da889e3748a9b22dca7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i628f75ce25844ff8b7d482c8c7b43c78_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9fd8343fd3c47a2b272658a928ae800_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i38ee6479a7a24540a49f0870e964ced9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i918e8adb634840c39e00f014e91457f5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0555249224484a73af0282b1a26fae99_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i82a067b6228743299309f26020eedd15_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6e671cfe56146318823f0ae1232ffd4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i433315b6bd834cb68354e5a52b56773d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i37a894ed8b0d4cc88bdaa2442942a150_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ca205c9d7904bcd84d4f88ddec8328a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b7f53f9cf764e73bd0e72cef8b7390f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic46b4d1e50bc43e489fc0520c892a40d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i58dddc96bde6438a903a080d6f6acb31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i468fc46d6073421aa776f6c974d1f45d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i44a6cd71a87a4d59ad6055e7b101e7e5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0a305363936e4b86afca45f34eb6b080_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if87626104e564cce8dc2afa187c5f744_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i35c163cbd49a4859ac64117df33aca94_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i05354df582904ca187452170ab40afab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1dc0731d8fb949fe81ed2ae0a256af2b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i203e64c16cf348b2a1f3041af709228d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0475ae1c115247ef98cdcb07ea3cc9fe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46555157a0b04f06bf0709e9682eadac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifbedee479b66410dae9bbe7401f7af56_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9132ddbceaa74f6eb21b9ebb8cf0837b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id6bb87ee615b46b99718617248bfa891_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i907c3d71d3014745b11f4974adf6844d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i037c746f41544e359176f1f7ef73ab39_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if12be8423b674ce99c50f89b01868fbb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i92e8a87ffe214bca94b143308473a86c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9b77bf6a7f474a47a49a3925dd91d87e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if59ff530abc54fa08a014d04b57eaad1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8b84fb2a0f16464b8dc3f00b6942258d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3ce76960e4fc410f94b0f8b63e7fdfbf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0d0b91cd724e43e6ab4bbbc7982d3314_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibe38939ea4194d299b03b4d0b2ea279b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1fbc748bc4044c1a959e7a991c5cca4d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i57b24b05b9274679b2b5dd6df7fdac00_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i156b20e6df6a4eefa561591d7405481d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i385db0023f404198889a2d10e37da000_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i17591b56caee4f43b8f0bbb8ca58a6f4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if2835fe4d12b49b097239c6dbd3d3396_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:SeprafilmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic03c35218a744afe9fa35a7119858f22_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idfcbd6492da644e8b979ce9b73f2b1f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2c78a0e7ebc747c594c4ee6e77570478_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:TR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if7312feb82fb447ea49510fc80480c6a_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:CollaborationAgreementWithGSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:USGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i5f8e75f8110e4de1a9b126cfa19e1f6e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:CollaborationAgreementWithGSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:USGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i35c351f036c247cf83d680f6986c15c5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:CollaborationAgreementWithGSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:USGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if2c1a983cbcf45f48b7833d558393c4b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:CollaborationAgreementWithGSKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:USGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0f1d395438c74a0b8cfbd33931e2e3a4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:RU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if71752f1ad474bd485d853a961833b1f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:RU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icb6c74b8a63546e290d8ab591aaaf997_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:RU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic6d609e772664d4dabc2be8000f12dcc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i05ab760cbec74ca2a64af3ee573e8c46_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if28c01d5f14941678f17df4612ae4e2e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i394e8a86c251479586bc1a0eb8f50130_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i409bda424dac45a59c28668ef940f123_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibc5cb17ac157419a907518a7604ebc0d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i605cb1d6e0f14943b4f0ef24b77e12f7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaf712b8801ed48b59b68a97d6c1d8c34_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ica7d78006d9b4c9e8f46c61a015c748a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8675329b37394bd5b4b2fd333c7a391a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i713b01806f0b4962bdcf1fb4904578c5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie922fff56e5f419ab3f601913c0b7064_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:StockOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1cc28f89fac74c419543f702bf0f7dca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i20ae7da9383f4e3ab6826ded2379ded9_D20071101-20071130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2007-11-01</startDate>
            <endDate>2007-11-30</endDate>
        </period>
    </context>
    <context id="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia94d77530caa412a8f0882f4cd79aa5f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:NewAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2ecbe16a2f5243648f9c51e3a70306d7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:PriorAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8340ae2fb6694e37bcf4ae4303e9d61f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7b0305aa6f27497eb6fa4104c0ca63f4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OutsideUnitedStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i81e1dceb236f4caa96e65fbb39f6b94d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OutsideUnitedStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic51500ccf0de43918f2456787048ab13_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OutsideUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i61da00769f834eaa98878f6f1e9776d7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesFirstAchievementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifedcadc8c03743abbb94c99cad356d95_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesSecondAchievementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i272b0b38e1734e68a43df1ce789e2493_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:AntibodiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesFirstAchievementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i77c108aa7495480c98890a86800bc863_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:AntibodiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesSecondAchievementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4aeff9d4cfe84f959b330be0f13f0ab9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:AntibodiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesThirdAchievementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7a8c2e8daf4d45b0bcc16547962ef088_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:SalesOfAntibodiesThirdAchievementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iac784bc58da74b4aa8644c7bf23d67b9_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OutsideUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i98602d43a3714a12b2caa518ebc7b26d_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:PriorAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id427dce20c2b4d7697237ead9c24a9f7_D20150701-20150701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-07-01</startDate>
            <endDate>2015-07-01</endDate>
        </period>
    </context>
    <context id="i78b6b504abcb44898dfcb15e0cbcf437_I20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:DevelopmentOfCemiplimabREGN2810Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="ic8a9426091cb480c8f68708490b978f0_D20150101-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:DevelopmentOfCemiplimabREGN2810Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="i050c4dcdac6845d58381cc5689aef318_D20210930-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:DevelopmentOfCemiplimabREGN2810Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-30</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibc2546af5e7749c8beb48751c8dc0bf5_D20150101-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="ia4868bf0ce374326a873eb079a2f01ee_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">sny:MajorCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i8f408d44df6a499394b5c347b1c34f80_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6fbbad3af70b4c90a3eb35e084814290_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">sny:MajorCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8076a1036c53486c9cf0fadf596f4f82_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0515044855e14c60a51bff4d7c49cee9_D20140101-20140131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:TwoThousandFourteenAmendedInvestmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-01-31</endDate>
        </period>
    </context>
    <context id="id3e2037ecf8e496eaf3ae27c42505f70_D20200529-20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:SaleOfStockAxis">sny:PublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-29</startDate>
            <endDate>2020-05-29</endDate>
        </period>
    </context>
    <context id="ie8cdba1a7ee34963bcb9d8c5981f4337_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:BristolMyersSquibbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i314c45a3e1e647bcae2d4dabeea5fe4d_D20181201-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:BristolMyersSquibbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i860a838707c64bfb8b697db6c3bbeeb6_I20200228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EntitiesAndCompaniesManagedByBristolMyersSquibbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-28</instant>
        </period>
    </context>
    <context id="i9016dbf3a1c5430f9125964cc371f4de_D20200228-20200228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EntitiesAndCompaniesManagedByBristolMyersSquibbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-28</startDate>
            <endDate>2020-02-28</endDate>
        </period>
    </context>
    <context id="ia24e436ffce44c968c4694148c6aaf8d_I20220208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-08</instant>
        </period>
    </context>
    <context id="i65f4119d82404c94a1b140ad21401ade_D20220208-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-08</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8fc2b038dd1b4b99af69531ba3b92293_D20220317-20220317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-17</startDate>
            <endDate>2022-03-17</endDate>
        </period>
    </context>
    <context id="i8ae83ecb331f49f8875bcbe2fd731a7e_I20220317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:EPICBPIFranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-17</instant>
        </period>
    </context>
    <context id="i5cb73aa7ccfe4ce5ae53a260cb785a4c_D20220317-20220317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:EPICBPIFranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-17</startDate>
            <endDate>2022-03-17</endDate>
        </period>
    </context>
    <context id="id97d7b03002b4aba8b5f84d88ed212ab_D20220510-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-10</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib9f02c4c8a3b46c8b47a31e54332ecc1_D20220510-20220510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-10</startDate>
            <endDate>2022-05-10</endDate>
        </period>
    </context>
    <context id="i75540facaacb400d8502084443749f05_D20220503-20220503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="i869e6282be074d28b9a1712822c9f46b_I20220510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-10</instant>
        </period>
    </context>
    <context id="i31105a7d607d4af49033461835874947_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1363015e33be4996b0e8a89139d4895f_D20220617-20220617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:EPICBPIFranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-17</startDate>
            <endDate>2022-06-17</endDate>
        </period>
    </context>
    <context id="i50fb7abe554a4e5b9bda9e50cdfd1966_I20220617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:EPICBPIFranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-17</instant>
        </period>
    </context>
    <context id="ifc8f06a841e6428180d8121555e73740_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i67af3f0fc7dd4b2eaa2a63d60e4251a0_I20220510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-10</instant>
        </period>
    </context>
    <context id="ieddf1529368346c285a415c5ccebe6b7_I20220510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RegulatoryComplianceCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-10</instant>
        </period>
    </context>
    <context id="i34419df6f45d4271bd03deeb7650e44d_D20211001-20211001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:ManufactureAndSupplyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-01</endDate>
        </period>
    </context>
    <context id="i2b3edabed67d4c528f7b9b3aa5532b9e_I20211001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:ManufactureAndSupplyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-01</instant>
        </period>
    </context>
    <context id="i77db5a6ce6f941378dabe84d0fb99691_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:TypesOfAgreementAxis">sny:ManufactureAndSupplyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iee572facf17d4fcf8b3895371e7c97f1_I20210408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KymabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-08</instant>
        </period>
    </context>
    <context id="i4b42acc0514d4e10970ac15d3afcb8ad_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KymabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i11073bbcc0a14c62b570fb898e98d18d_I20201102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KiadisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-02</instant>
        </period>
    </context>
    <context id="ifa7ce4e64a0145088c122905f0dc3331_D20210416-20210416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KiadisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-16</startDate>
            <endDate>2021-04-16</endDate>
        </period>
    </context>
    <context id="i3392c86b77ce4ec1ae56d2c26b0f10f0_D20210429-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KiadisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="i1e3f5c0fbd854b0887ac60561bc8bbe1_I20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KiadisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-29</instant>
        </period>
    </context>
    <context id="ib1ab1eca87aa42b79b79ae7cb8a40079_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KiadisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i37e52c8c761c4a2c94bcd4c10a298624_I20210409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KymabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-09</instant>
        </period>
    </context>
    <context id="i91ee802320a44a84b28df3ca02a2a4c6_I20210409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TidalTherapeuticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-09</instant>
        </period>
    </context>
    <context id="i50186dc8e2144cf580cb8c90422239bc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TidalTherapeuticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i779663ca39724fff9eb372087b37e45b_I20210803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-03</instant>
        </period>
    </context>
    <context id="i346802ed216643f29cf03ce4f829ef06_I20210914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-14</instant>
        </period>
    </context>
    <context id="i0befa4372a524fab81e8c4d403d76062_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i81cc2b2f8e09437a9a99b63d42e7b55e_I20200623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-23</instant>
        </period>
    </context>
    <context id="i8bf9f268a35e45dbace519548e4267f3_I20211109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KadmonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-09</instant>
        </period>
    </context>
    <context id="i1e41032ba4984bdcbc1251beafa9fb22_D20211109-20211109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KadmonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-09</startDate>
            <endDate>2021-11-09</endDate>
        </period>
    </context>
    <context id="i4ba12f5a779c416ea0550b3a72a82b6c_I20211203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OrigimmBiotechnologyGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-03</instant>
        </period>
    </context>
    <context id="iab5f424031af478da77b305846219403_D20211203-20211203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OrigimmBiotechnologyGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-03</startDate>
            <endDate>2021-12-03</endDate>
        </period>
    </context>
    <context id="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:PrincipiaBiopharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-28</instant>
        </period>
    </context>
    <context id="i1818566194634dcfabc96b128a36c2bf_I20200123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:SynthorxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-23</instant>
        </period>
    </context>
    <context id="ie19b56352bc54cc6a3dff49f358c669e_I20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-29</instant>
        </period>
    </context>
    <context id="i502d25752fbb41198b743f7ae7a986d8_D20200529-20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:SaleOfStockAxis">sny:PublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-29</startDate>
            <endDate>2020-05-29</endDate>
        </period>
    </context>
    <context id="i87164f7d070f43bebcd477c11338759b_I20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:SaleOfStockAxis">sny:PublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-29</instant>
        </period>
    </context>
    <context id="i5e547fa7f10d4ba49513412e133bcd62_I20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:SaleOfStockAxis">sny:RepurchaseFromTheCounterpartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-29</instant>
        </period>
    </context>
    <context id="i169847bcb5da4bf9a458b8021feaeb0c_D20200529-20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:SaleOfStockAxis">sny:RepurchaseFromTheCounterpartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-29</startDate>
            <endDate>2020-05-29</endDate>
        </period>
    </context>
    <context id="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-29</startDate>
            <endDate>2020-05-29</endDate>
        </period>
    </context>
    <context id="i755f9def05814a168296cd241a1146d3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:TwoThousandEighteenLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f42c6e0f02b45889491a52aa65d4c26_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:TwoThousandEighteenLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7727cfd3e20341039f39e0046c5ed90b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie109280c1ab2461ab5fe2322cf084ae3_D20200529-20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-29</startDate>
            <endDate>2020-05-29</endDate>
        </period>
    </context>
    <context id="i0ae209da62af48d0802dbf6f8ad4a942_D20200214-20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <startDate>2020-02-14</startDate>
            <endDate>2020-02-14</endDate>
        </period>
    </context>
    <context id="i8a1fb47c77a7402d896ae4afa489dc32_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6fdd7a020cd743c782be74d0b156d3ff_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i44a98fba01634bd9886289ce37e699bd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie6ce85fa444d4547b8275916d66fba2e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5025c5e64e0e4238ad981ac8500d4184_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0a5f73156d8942cc9aff9b90aa0a20d9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27cf815902454458a945f8a2595eafe2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0206267cac4b43ff9378718b8008875d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa29c61d6aa54e0c83530917f533df1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibfb17be627054bbcaeb8bb573eb2dabf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9fce9fd8a39949fea1857356f2487678_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e81b12e473e49b5abc85d3e576474fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if4f8821720944d1680e7ed8837430cc6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iedff867a40194ec083a67cf71ea66917_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i87d0af8348104bf887f908169ce200b0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d6fee5315414ad1a751bc8615b564e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42c95bc466b242eba66c21cf83df94ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93db76f9896b4f74ba29861299f846f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23e8b78ba6e14985bdaf0561022d2fcb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife09bcb0dbc442368e0599e166c05925_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d532913ef384fd19661d028233c6947_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibd94ddf5b0e84f649ad3f3ba6b5cafb5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i76a1d3dce1104aa6a7d778f1999c90d9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb39c23a34044e26bef23d011e133535_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia2162c82bdeb4391aa0ecd936cefcc6c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifd00cfd5016342eaaea60535f74305b3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4b2466da63bc4da892390e4aed261abc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i476392303b7e4abba1d96716ae9615ab_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ied331c3fd4b94f45b143e83a62a935f2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ecc234cc9eb49568130c6b4fc616c68_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3f095d969a564ac0a9de8f80291ff734_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0c26e169435e4e9e9fe6193807419216_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc8a6784630a4f6dacd4f922e9fdcfda_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i10c25791faca434abad3dcc87c335545_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if76ef11240a9484db66b6a0b5b09f16b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i00ddc700bee94a3ebc732201c1d35de9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if2f730ae7e334d48893db2ae20047ece_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i472690aecacc4395b411b03484ad169e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i96cfd3c2e6874abd9afce4c2d4d64ffd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9bd6e4b32cb345028d31ec8dc75abdea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i955321bf2dce441dae3876de61625fc6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id90f926826c348e58cc61d5392337455_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i69399acab7a64ab497728ec8f97b3699_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c7e1a121231436aba2eaeb9b1fe7924_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9127d80c07874bffb0988e2f80d522b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c0b39229285466da452d51712d250f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i193fe7806c2641f3b83fb65146f5ee65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida5c0c7399ab4f90ab42e89c5e29af71_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i63729ceb65774d1b8999612861c2444c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9404661ce5304598a545950eb1e7bf70_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iba41b88a1c3648cbb1015bbea8998f1d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6fee7647f4f24f3491f03f1226afcc68_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib0f0050d932c48cbad2e4bb3e8838afa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie6326e3e444e4d0fa59364df7efee398_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8d73c6b22ae6491dbc37944b398879b4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib371a75679dd4f838651914ccd2f7845_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d233b94b150441c965315e4c2cdb970_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i460186f58d964578bb57d83f6b52c068_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a427587471c4b43b5afa2d98b323de7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7c53e563aead4f239fdd2a1346eaa2ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28edbc201159440baec039fe6f9edab4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0aae04a72c84e138d05a17aa6e4adc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i038f209f31d04ec4baba797bedf7ede2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib020c89f73574f31811c48672a7d702a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5df9065660c4e1184ba88ea30322027_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id09d5d649b4446e3a4a10a599d8c7820_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib493cbd2620f4ebeb6ea7d83ee096a61_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i29b79d594c5948f5abb69e79838735ed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2cd5556f3abe48f5a8eab0fd94631f19_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15ac112e5ca84ab9a152812eaa4b795c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:PropertyPlantAndEquipmentInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibb589cf6b30d4f85b2a6924184520710_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idb790736d7c44dc0aece34570e7aa9d1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia71d61fb176c44bc85d8a7131e07caca_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia21cdedb03d541ac8ce4c21e0f09243a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:IndustrialFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2d87c5192beb4f79a9a215eefde80519_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:IndustrialFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6e59794b9da94a948e8aa70b12c8ff88_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:IndustrialFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if815506776604f328ffbe1f64040e104_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:ResearchSitesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7903da3784d448cfb09ae68817994cc1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:ResearchSitesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie4dd16005bec44a7bfe5627a199fe9be_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:ResearchSitesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if781d7295c08487ea51c6503613eb526_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaf174122818644c48b0a0c91bb27b307_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifa82abad241d465ebfe6912fd6e39476_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i50f963fe7eb242389c52c58a27841042_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8ec69c452bde4d2e9c935c00c627ed10_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i73d9e784d85c4861808c14effc04b733_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib5d1685308d744b99b0b8ffe90f18bf9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iec6fc9c2bb8247b2b49f3c157447c542_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib8a4cde136ee4ba6867518e84f629759_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia2a9d85e3600439fa8021956ade9fb27_D20181201-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:CambridgeMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="idf46653d45ba47878e79284f8a9651fe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:OfficeSpaceCambridgeMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i521770fd159a444e8b290a2b366d3120_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:LaboratoryFacilitiesCambridgeMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9975866b6f0948c4b2dc3d5202c3a8e7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie04ea8d3bc0f4c5ba8c8a671c1dfec8a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ddd2e8b048c4aceb5e20e5ee54cfd35_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i04c2256e354744d2b996810e1b4ce23b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7d3b42ca90c45d9a60556ebff587fa1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iccfd390288694500897be21beb1f90d6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6e1d225964344fc99aa88194ac03758e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i18beae5325a24e4b91ab73391d713a14_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i805096a31a54493f98690df2512c4182_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice04a6b9957a4d6db37a912faaaaa4fb_I20220208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-08</instant>
        </period>
    </context>
    <context id="i972f543731c343078d24518f433fa726_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i479eecf06f384cd28a6d6234aded995c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib655a021196d4cdfbe4475108064a5fd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idcc8c91558474195b7619d926905f4a8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0012231543ff4a8da7fc419bff0a9e67_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2d610536ebf4dbf8b9a88106c67353f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic16020b4a1554e8a9cf89178c464111a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie7a0da2ecaa04eeb814d811ee982a0af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f1973ece55247c7bfca1df0959ed390_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i738d8bb190154e6885638cf09b03af8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i212426e60cf24241b201ace1b0732af7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6c347307f4a945aeaeb2aa62d4b9c418_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4bbdd4e400844a79a5da75e3ae604c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5fdd2720629d4afcb9cb4ca0934ff100_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id1e50048305543d09b31dcbeb40df282_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i89f73a7c69a540c59681a9b3cdc360f5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4eaa16fcabab488eaa79bd1b746613c6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58368e802e1c49819f70d00a80e9b758_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f5e538c39c74bc1bda08a15d67a3de9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i808e5c06bdd646ccbbe77ddc9e3f1433_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8053a4d07214c0c8866abb7aa242822_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie4e712c22a384fdf9a6a92f6d8363ca3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic159b371543149fe98e5dbe979df7b29_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i86724a133aba4372861b17fd7cc5dcc4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6dd35aac58414697b4cc3b232d182e78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5661f3ac3eb046019a9fd43280b32b15_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idddba6af7c6d4af7bbd01c92c017cb84_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c01ebbf5a814bd68303efe91ff455cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if22620dc4746433ea7ede1e7e434757f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4736438590b4561bf1bcf564c1f1016_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa0f7fa9eea84ac4a2c28706473cc2e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b534838cd34410bbdd454b2427db95c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2b9c32fec7247f5b6cf4d373a4bdfdc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83d587327ece400fb1dc4a4ed917f95c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief8f9ac9127344e5a1d9e4dc7468661d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5633c4724ce148ac9ddfe510b1f65f4e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredRDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i958343bdb078497db2b964d690e99d81_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaabb9095a1ff42f9a914e504f9b48258_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i425bfebf084d448791653b647ddc68bb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:IOLicenseAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i09b51cc206164edcae17c3cfc4b8be23_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i84439ea7fd4f41189f4efa5cce7f5dee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab92fc7553f84732a53070d96b07d717_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if1da231f2f58464e95b73ab82f7a6ea5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3cb82f850b314453a6ec5d1921dc1d46_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if35c01a7371643bc9842164b984ee110_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac2d7ed11f724c0ebcd3e81759fc9219_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i08203211b0d245c4b6d1cc85ee868582_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id773f103dc28473da6dce61b97b4599f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i327e5ac314c147afbbac34d3cd5154e6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie35c53e81e9249b386cd4ca320340845_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3d83b887fd184dc780e366b282c56ac1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i12436be5245a454fb08492a29387c400_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibecbd6a1102148a4b1cdae4692855a35_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8df75a742b2b432f8ed86c2c047454fd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide1da35c16a04b58969940528c31dca4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0256bda43a0b401793ad67599d6f854f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i49fae0c938264bbeade9dbd853b7285a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i340660daa522440ba21086f7ad5848cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie6daac2f7de947078866a970b9af341b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3d27352e1d547bc80849f473b0bc333_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i94646d0f821b41aa99fc727b5160ed48_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0c421b52b59042909b5e110415a07634_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i71c2f33574774918a3d21a0ac64c1257_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ief7e1240661e4b40847321005295df4b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63e0783c68d542939a2d058ea87add2d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAventisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25232be32cd74ac0a93373b678e59630_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3ce30f864e704909a1e2a6e1f5ee8e5e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4b23c81c20fc4794914a0250573bd609_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia1228690812c49ad88631d95ed6c90e1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i50b0b8ed81ed46e8be5e882078a4d6fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i026e8f42a4b84878bffe5af0996e6fd4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsChattemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf18b6d1ad6c4d90924bd6cb8c0e44bf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b24fec1ff334b3caffadd87b1917a88_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3fe69425172b4ed3b1a78c4b0afa1443_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idf8439c477204ed5bb7b9c50513f4458_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i40fb8c5a2d6649cc9bc68e43de8013db_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idc41e3bc2b9345fc876440577f2e644d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsProteinSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i041ab8c4596a46c7bb5f0667d7c6bc14_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3c5e6ecfa9074b3e8f20927944000385_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ica7f84b515f546d8bda9c71bbe43ec0e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i026473957d65465ea3db2de3e9751210_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i792f1cc45ec547c3a499357b17b066ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f4deabc2c274c3babd78470045f1453_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsAblynxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i530f7df295184dd9a99b515e6d74ca8d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i296acdd1f99f4541a48fd22b1964d943_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i708d728675864096b68be3e4e5fffa80_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie8566075f1554143b73513ddf54ad64f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i04aac2d172a44ccc919acc1227192e67_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i637119bb5a7b42f8afb86de0c5d5219f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsBioverativMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9dcc5fc52d7a4d7aba03c1b54a2a3571_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iae48efe4b3334259807bafd602c70de7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaa812a8430e74c7e8e6a760b5a84e493_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5cc7ce98c2143698b9d193c4906485d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i45f265c078e647a6a3dda117ab01eed7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0dd016314ae6400591f48c4e6f72f4f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsKadmonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iebcd0b91b7444542b0c79aa4c96b7801_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5bc35a3cbc8c4534b90c96bf47118eb5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie24b60956389422e8f541e06b844991b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iea694613587d485fa04b5eb768f73f00_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i293dc949848347408815145576461710_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:PrincipalMarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ed6aa800df24aecae7a3964ffbedd63_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i45d75dd4cd4f4947b431c2b6a34e7c1f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iae3e84046d214495840027e2c3540430_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:OtherIntangibleAssetsExcludingSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iafe00cfe38914facb60fe02e8320fc90_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:EnjaymoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib7fddf7e73a04c67bd9d437a86bbdabf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:EnjaymoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:ExpenseCategoriesAxis">sny:AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:ExpenseCategoriesAxis">sny:AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:ExpenseCategoriesAxis">sny:AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iee7cb4947a1c4854876868c8e2fb82d1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16582892e01c4bb3be453ed03f64b2ae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5146ddfb19c5499c89ad75916030806b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i21d16f2eeeb44e9abc4e0d2fff1623bc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashGeneratingUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iea1750e2b68b4202b8af152deb123cba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashGeneratingUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iacd98ed640914415ae9a8c8cb5f49656_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashGeneratingUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6291343ad8be4f14b06b056b796a9012_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashGeneratingUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib359277c5a6e4155b350cf434d57f618_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis">ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5bc6ed2a91ca4c32a13fd8fb9df67c92_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia5ad3f91fb64465ea39c823dc7f679b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie4cde3de3d25485abc32561745035697_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b27476d93554df89ad49b3ee11c7c77_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3068d0c640bc435e891dadca47642b8f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0c54b1010c23469cab4bb3eff3e7d353_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i28d5de7a4fc14b2593071a0d5fdc0a8a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2b91f780cb5b4a2ea49c0de8b0410b7b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a363d9f71a4498e9eb6d77ce4ae1ce1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibe47f0460c6443d7aac34037c1a7776f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia20f460d071c4c28a7e9a76758243fbd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5dc0f8a6677d425cbf34a6827f35eec7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if951db4e148548b0ab33c185a8187b15_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iccf65087a3c74152a1319c345dad3d4a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia45e141afabe465e85ec0f96fdaf178a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i43261e364b9346549b6c2f1839b5914b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaebb948c909c492e932578257e1ad2fc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibd554b41fcbb47338ebb6b86fee85e2c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia8cc913bbe0246f79a657a1446f40d4b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i00ff7bddddd7454291874636f6fcda0c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic32352d1a6b84884aee10c01c7d2556a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b81437bb0bc49abac2a243bae255b03_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:EloctateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib78ba3c2232f4c65ac54a211433313c6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i75a477cfdbfd407296126150806dc8ac_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4af100e170394112bab4a52fece35962_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5742d95426994746862eae78944333b8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SAR444245Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifb5a0f3994f84521ab2fd69b67690383_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i495abeb0c8ec43bd9a8672fcf415b572_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5f95cfdf0c2482a8e6ae4ea1b83aeed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i987f61ccd11547579d7e7f53a35371e8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaa479340569c4f32a4dccb3228f32e50_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifeb832a3c66e4a378f24c3a521e9cf5c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f3efa364fdd42cf927933b24fd4755d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i782f27e42e1d446bb06029d7b6d07d77_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i669940f41ad04996a28f45d5787d6ddb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i63e035f853e24b69a878f537955ad35a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82151e9cc3d943a69133a8307efdb603_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i91ae659ae5f74464822bc2b56b6fbf88_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i957f812f550347fabcd2ee14c0bc75b0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if13d5090e3fb4ebaa88f2f834e7b85d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5f292fbae704649bdd7f44efd9dc45f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i092bf3d6ba454bcd8193568dd0f4509b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:MCMVaccineBVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic49924175296420b805d168c7336e31d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i58223acf6fb24980bc8feacdb2bfeae8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1c41e8bd45074b609022a18dba83404d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id1d40d00a4f940f4b8c4db3de85057f3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i75f7fd33c99141b0834d8cd0bde8d7e4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i116430c7eca24b8ebbfa85cbe5cf6fb8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i147d77d0cdbc43f8a3861edb09fba518_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ife8c65e63c7b45eb9f4a9c39837733fd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5fab8659aed84831a2579ade0399d130_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie5ceb0532e334611ab935fb0364427b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id92cabfe863843afa6b89218300e3c36_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if09b2251983a4669a88b8ff54f8690c0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2598979394db469aaf140d5bfe9a797e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic0b1bc46ffe04f0299592c1fa440af75_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i672c84847c6c48278feb34e54f8c653e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ec71259f6414571a2d78f044395b234_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i18dfacac600544adb63df420cb892c4a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i947289ceb8754aafa7862f600d091bb9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35f0fcaaff094ff283b1ab8503932dab_D20220107-20220107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ExscientiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-07</startDate>
            <endDate>2022-01-07</endDate>
        </period>
    </context>
    <context id="i7d7acd3285a64b18bcadb39dc8467fe9_D20220329-20220329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:IGMBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-29</startDate>
            <endDate>2022-03-29</endDate>
        </period>
    </context>
    <context id="i85d4d256594b464a8880f4ff83e76312_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i747f411b1b5b4dc38fd872cb94543817_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30ef28538e274977b05fe65db2be8141_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06d47704541e4ee1a797c39f08654082_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5d0712e20c454b3c96fcf98e68a25960_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:InnoventBiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="ic0d86ac7238f4dd59ab63269350d8d09_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:InnoventBiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i57ad482a322b4fc0a81c53a3afc3d8d6_I20210914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:TranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-14</instant>
        </period>
    </context>
    <context id="i58dc338d3859459eb1381af00a929009_D20200529-20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-29</startDate>
            <endDate>2020-05-29</endDate>
        </period>
    </context>
    <context id="ib198bd6cc6604c2b9675491c47738ca5_I20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-29</instant>
        </period>
    </context>
    <context id="i7488dcfd6c2945918eaf022e244867f7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie64fc8634a414cf0b229f5f5231182b0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">sny:TranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6436922a2ad48e6aa3486427a648935_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1cb860a561454a50b32cf9b3ef5bf20a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if350acb0ea304e1380f8a7daa4bf3d34_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i58761417deb34e4789711c949bf2754c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i737d6d075cd24a3fa0a94d9a8769b9f8_D20221001-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DisposalGroupNameAxis">sny:OnduoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i4c302b94ca2e4d78b8e9a5e1966760e7_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i58d99ec61b724625ba3cf5fe5d54f353_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:QuotedEuroDenominatedSeniorBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0316f32ab41848ccaa532657cf32b68f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:QuotedEuroDenominatedSeniorBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if7bc7c1140af4531b7bb1f0aa3a64394_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:SeniorBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idbc81c6777a247f3a55a9409731b937f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:SeniorBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if636e1b1d9c94752b6e7d2f5d093ad9c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:IncreaseOfTenPercentBasisPointInMarketInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2a89cf5df5aa43cd9b53e1ca3064c250_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:IncreaseOfTenPercentBasisPointInMarketInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib26b365d63504886a705909c700dad19_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f1cbd8e523544a09df5288b9e682c8b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i187a52d9d71643088cd196df81c6809f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b47ba7fd49a4339a1546e28df0f6cc1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">sny:FairValueOfSPMSDContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia89ef6966eae49a3b34c0c5c4c087cbc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:SPMSDContingentConsiderationAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i545b36dad89549698a7358e61f470fae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">sny:FairValueOfSPMSDContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if2790c19603340069463669a1121103c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:SPMSDContingentConsiderationAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29f5271fd56c4132b303c64792c7e68b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">sny:FairValueOfSPMSDContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i008006b7cc834a49a4178a0fd6d1f590_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:SPMSDContingentConsiderationAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd6801a467d04340b8c2bbb32208b916_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">sny:FairValueOfSPMSDContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i59d2d460cf184fc7aa2916de537a8f07_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:FinancialAssetsHeldToFundDeferredCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie8b445cb2507415fb152acdc9b875a90_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:FinancialAssetsHeldToFundDeferredCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f597a89a6d040349370742d7e4695ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">sny:FinancialAssetsHeldToFundDeferredCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b12ab871b274e9aa1aa68c28cd74514_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8bbf8d410b244301ac8ff091e2c31cd3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i41f3c0f9515d4e13aa74179f5b5a3840_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib647a1698a86427cb8d4b97bbad379d5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">sny:WriteDownMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iac996783058743dc90c8e8829cd97b94_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">sny:WriteDownMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b3cc5ff69f34488be79292aa20b972d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">sny:WriteDownMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa4b63bd7db44ad5911b73e3491dd4a3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AllowanceForCreditLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05f28cd38d0841ebb218af6930d501eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AllowanceForCreditLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i032944e42df3482bbe716ed7bc4d8482_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AllowanceForCreditLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib366bca9838a4f858834d488788aa1aa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i92676380068543619922d35317997de3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51c89819a09a4a869b9cf28d9487e9a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ef2f8187cfa4407be68d0b5b25618ad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i204cf38410c44c62bd596f2773e81a5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7ba3ac339a504f58a90dc11aa1e8caef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec0ca9779e2a464985b051e55ada2803_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa0f24f6bcc446849ba76127738f68fb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id20ecec6f1584de38800aacb975d6350_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0fe124e0795a41ebac762da9097bb875_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i71a39145bca34b95ae9166213239a5c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd3ffc9d285a4ee5b56664fc9405500a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8bfa977878c49e4801932e083d9a1d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0c1337c5561d4086b729fb3b2df1d049_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2e7cdf1797e949f6abdf600757d84aa3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a92ec01ab6f4056bb7dd2fe7b28bbd6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d71f901edbb4fc9b19eac52b6dd1c63_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64bff274bc764511ad68b85e40be4102_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8bdbc198b14747a6b443e5f51b4c57c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9f35300ff6594e66a950dbb07f57d751_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i68712353db49491990d250cab1dc2b7c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9902da71fc7c466694af634d0376287c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6a2320406ec4131b78807bdb61adf57_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i868a0e34292946128d179703085f0318_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if227ca69b6764bd5aa2743a5eec6c517_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id3e0e6f2fc174daaa294b5fd344eaae5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie1c712a9f5e240d0a223b5fc4d7f3821_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie034a80e75204f5a86d6d8868b8ca40b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i57c74edeb8724bff9b4a8ade725f2f63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i57c1816e408f4146980929ba115caa65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id78484142d96470daaa4465a88fd1465_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idaf554ea45834ed891abe8817a179274_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic934f45d8eef45ffb86db0dbaebcbbb6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedEquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0e83c9ceee8d4973a9fd9afd3eb6f554_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i98d98d655e2840c6a7097e85707ab978_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0725e56c610b4ef8a9c778e1f873a5f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b13fd34daea45cb93c23eb68b1d9997_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i440fc3ad28704a76ac9e4456da1c6091_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifddadc6b0fd44b5e968e11dd8e284db1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i506eefd0acc64aa98a0ea2812e1edab1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba6ab0a538b548faafe7034677544b54_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibbdcbc2963214d8c9842c9ab0a7d99f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:QuotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if091001a8a224ba884e81e875ef8f51a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i29c615a591b8421183c5124409777d8c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic16171d1dc9b4826902326dab2989ff4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idedbd6af27cc45138105bd954312850d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66f1507ff6024854ab28cb15b8139bb7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibae8f42e29e44a80a767329003e96b3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4e1f6dffa3f4033a907e381fe585927_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icce038f9032149768e955222f2aca120_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib63df7edcf044cccad9f0d666c02d417_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:UnquotedDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6edb24c7b7614f5e8426e248ad8c0012_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie9e0f64911dd4a9591b9bc586892e8ba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia33a4f9a84e44e238ebd55018effc821_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i93162a8ef8d44ceca6e6bc7a60a8fc3d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ee383251d8a4a5db431280d0829da5b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i251a1285ee9d49388641e59f23f6241c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idbeac9cc516e4ecaa016f7b5a9919939_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i812479914b214ae5b372315aab8728a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if21f555fdb8141dc8dcdbc4a99f03044_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ContingentConsiderationRelatingToDivestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib9a5c31a587e4a009e48f3ae090ae3d4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id5b50aeecb014f088d04f8708033fed4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i865d3e2ccf184a1fa3395fe6567538b9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia5e602ade1a84742b797ec53b6d74912_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibde8b2ab03584ae4a5bca97d80502c95_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i226f7c29cfb84987a2a9deb701ed1907_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i85306855f61b45f28134e4c906e484e2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6268251951114f5db755d35912bbb195_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iefc2bf19aa14458e8c2c9dce268786a8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9510f1a95a7b43ac86ee6d4c0b128d24_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id2f822898ca84cb8a79415a6cdc45e3d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4a0738d4f3a648699d252a97ba3e6ee4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i158b44cdb3244768945b39667ddac6f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia10bc441f3d34c13ac07f05030c62cf5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1d93a2e51b44726bd0f629ca403921b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8ac539935374b558f669ee77dac8db6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia936cebd16574ca3b1b0522bc2565698_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ecabc225dcf456c8163959683eaac2f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf455571305f4064b0c27c09d9e0779e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24ce970c3de542ecacf624dcc54c068f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a85f9f5746b442bad900c30146e6957_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f9513c503d647e5864a3f1b67b93937_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6bf17373c5694449bcc60449faab13ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ac92dbfb0dc490aa7026799fe831566_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42bcfaacf8014b70b45f0bc2e3826df0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4363d5a964d4bf9a405bbc5ad84d075_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f59a0aed26e461d8f59cef0d6162389_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa6146ee4dc34054b4f2c8dd934ce7b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2a400aeea96455eac5efbbfaac85997_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i414ace804d3948748fb5516ef6e3c93d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3dd8126dfa704004be857e04a1d63621_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4bce6c62ac7e458790049ac23f730d7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55736011d7504217b288feccd10003c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a742bafd34b4be09b40358da2f7f5c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if0e53d257a5b4cfb9ef9a43db3e18a44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3df519902364806b6b4df1fa5fcaecd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:MutualFundInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4cbd6b4a3914b4bb22bc2cb56989463_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i409a2ac80199410c9d2f13738b9c1fc5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i361a9c2e95a54cbb9685b3e4db0de703_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic2b4a0233a76467f9da9303ec9617568_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a4ec58f212240f98494aef951fe0ab2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c5b69a1242e4ce3bbd8d3803a17f77b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id87ff9e380354502a2cc0a654bd50c36_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba95b079275c4adc847b0cd47a476111_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic6f8c9f62f344106bee9e868531813a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice8470e3cc6242f0b1b1e15732ab662f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0814cdc2bc444fe0a82e40cb939eaf13_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6ff19b8f7bc742c39dd5d0c627b6945b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i628eeffca97848fbbca2d84940ef2052_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i13bdffd21ca54bcdb0343b795ab7b63f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iadd128658e52488aa52e2432c171e6ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16e7a672e44841db8d883f1ef6d50e41_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idb9560b7bb344d8783c8a3d70ed140a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f86412d6fcd48e59fdae513888795c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e655abf2eff4f648351419b666b1cce_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie70a21fbce684182b63354cd9500f730_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i777128a1566043dfaae4b53b65022410_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id02c995274e4478396f61da8899c1b7a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibb908d2f93ff4a659991e90bcf70ab55_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i14178e4bb8cb402f92a63d6707574a90_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4d269e6493342a1a5a259b8a23aeeaf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7d4b6ce60161438c8fbc24e68b71336b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3234a98630243148d78d87d71b9384a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5223d477aaa341c6b4d55fe7ea7d4cea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i080f9c0694bf4d54922bdd4f999a0643_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i48e7503106404209990dfdc490c457ce_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i36ed13ff5ab544e187d2fa000ff3f53a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3edf6fd8a7cd4c6991b85fa8d8833a29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80b048bc5e924696bc290cf8e154d08d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iadeed4d1a84740f08d7f77eb1d523def_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e6725118f5948a789bfbbbf3550d8f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f777088d46d4dcd985ba538a27bed29_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationTranslateBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0baef8b28597402d8adf6cee9aa0d5d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i58e1e7cad9164a70839fa03c11e4a3cb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66f8461c0f524353bb1ff3afc8b439e3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icd997e2d59284fdcbf55f9fc4a2d1a5b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7ab76bd67b74ffc8af89529ba43e4b1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic727bbbef1ae42deb05bb6a11214c40f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3754841fd7614021b0d3d454afce5cb4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife3e8160c2604592a96fe70b98af7419_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c3722d2c71b40a5b0cd3fbdd62a14fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f77768527954a3ea0a87e7081b338cf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic866f02ab74b43c6bbab392d315c36e5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i980e5c837107458eb2f70d743a451e27_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia48366d62ce64d6e94246e1a6b554bac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2363afabce5c46a3b4c953bd0582795e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77d7a7bdcbff48a69181f857e54c25ee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ee0b2e050a04774bbcc876af9b05e2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7aebbb6cd5394ffa80a4acb7f23fbc26_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9edaf00d040343fb95831f3cc2313b2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41e7d57ea4de4fb2acde34fb25042f3c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic054a9f7342d452997b69f83837ad01d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if6c1c44bc60f4d718bf8a08c96042e61_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i391e0993fafa4e8194f1cee9bc292cb8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98a96a99ad894d939a8ef2cf79d189ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a9ba46c71214fe8bdd739e06a5e2cea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b2f10037fac4641824455bcae113474_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea19c792195c46bd9032528e794b669f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4022972c8bde4a9ca3cb288456a68271_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NonCurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i42e844a6d4cb450f9d291a2abe40dd93_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3ac22998c1824a71b163369ba9107fc3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e3b3ef271ab427b944675c91e586c90_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i90897d7067434c91a8f8652d33ff01ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a15ff2465a24f9d8f467e861eace688_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaff6099dca9e44fc83c5aa691e056e44_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i40563d22b6d240b1938338dc3cb44c4d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1dae2c57e4564bc098cf95f1a6b088e2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6370e3221d264c9283fc7256385a72e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c52f444ed0f4bda84a42b7e930f8420_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ConsolidationAdjustmentsIntragroupMarginInInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id11eb7058089436a9aff2a514b26afe8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ConsolidationAdjustmentsIntragroupMarginInInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i56a5626912de40e39e4a075cd3ebc7bc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ConsolidationAdjustmentsIntragroupMarginInInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iadbc77437f194c4b9714d27bea45d27d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ProvisionForPensionsAndOtherEmployeeBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7fed9cb1446a49ffa3cc1ec60473ea51_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ProvisionForPensionsAndOtherEmployeeBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6c1f1c7a87a147aea05b154acab7ecac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:ProvisionForPensionsAndOtherEmployeeBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if2d0541f761144ae8559c1ccc9e1c928_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if0b71582500946dba2dcb41e5a262822_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifad5fc92533e41a7aeaa856fcb32b3ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i812946d6d99c488b913e652bf22c35e2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i592524c5425b4fd687989aa3fa4c2fc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia6ac37e52785466095dc8e783f91f5bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e2dcbba0a064e75ab731959eaa3eb3c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib906ba086bbe4f30abe707134e42e386_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5535831de3647578a867ea9e090f1b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2cfc74b847364b73b4c2966e30b347c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if0499e2936c14c57a7abc3de327bb2ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i079e44824551470ebf2ecdbe82c78c53_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7470aa0bd046445ba5d903e0903f429a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:StockOptionsAndShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib9fdcded8d294930941d9b9619419474_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:StockOptionsAndShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa8eaa248f964dcc9b6c43fc5fe3997b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:StockOptionsAndShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idabd22ffeca842938dbb461d8aeb992f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i20ddd88784fd4401811a5d58a1e0998c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9380121dcb2b4c5f96096a046caefe54_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i066e7decba3b4361be385e2553f7c453_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if38e6ef7aed243b8ac91bf5307d108ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec4651d9b55449be9cc5bd98617ca794_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i443cce1a00af49c5b31e138daebd4921_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:BioverativMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4b62979a6fe9440786e1d336c8029542_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:PrincipiaBiopharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i410ae0b344fc43a3ab2cf3899b851c5e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AblynxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia53cda7c749e46b1af9080f7e52833cf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4d4bab9b0aa4d6a9547cfc9fb7b0e8d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AmunixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a265fee43744c58b5ca31c83714d579_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:DeferredTaxRelatingToRestructuringProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8f17ae20601144ea9e0f23d12022ca1a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:DeferredTaxRelatingToRestructuringProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9ca24cbf2ff42778b6960dcc8505438_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:DeferredTaxRelatingToRestructuringProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife7c44a9a1e84cb7b6b4f6fe06b1ebab_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8ea79a68514c4efeb70ef0c35a2baf70_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1f94df52faeb4018aac422ffccd0adf5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5e29bbd050a542b6994f56c5f2fafee4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i26c6820c3ece4e2aad2f35e051f8b181_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id75833e7c0144f56ab9eac0ea4d607f3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0d88a2edb81648e6afc4f83c69c424a9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia39e689409964bfa8f99f19cbd6e41c3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia196461989f240c08680cf2183a306d3_D20200728-20200728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-28</startDate>
            <endDate>2020-07-28</endDate>
        </period>
    </context>
    <context id="i36f49e4cf39f434fb5ea2349696ed58f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib03aa1724e294ec09dd7edb58b1d4e63_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie7e77578600e4c639e9d27feb554081b_D20210728-20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="i2e9f1e47319c48d5a2202f889bf79fd8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i85f3af7ddeb746839ba726053d9da1d4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifcfbe4403ae14242851e1ae3cd6f979c_D20220727-20220727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-27</startDate>
            <endDate>2022-07-27</endDate>
        </period>
    </context>
    <context id="id1f20d3235444723a9c023e3b4339f8d_D20221214-20221214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-14</startDate>
            <endDate>2022-12-14</endDate>
        </period>
    </context>
    <context id="i515ddb2455da44eaa66b43d874f42983_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib0692613954647719cf5a55f8b2600b8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iafa20f1425b74849a9afed9c64bbbccc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i93f5d73d4345431eb6e2b0feaf16ec74_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ice0df2b13649423eb9b2868f28d11017_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8c3bd86d2c1b44d7a257e61844c2fd3d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id12efe7d6a7346ab84d22f390dff95a3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idc7b7077ef674419ba3fb299aa9d4fd6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2f883da95dd949dfb22ee5967a73f21a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4abe87f00861469a8648dc66935cc3a9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idf17328999f949ebab31efd9a5ca0b93_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i91a183f0e6fb407f97a8c1b19774a395_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4923e9cc73c846eaa19bc82128326804_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5563efbc666d49d292f620bd6319cea2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iace7c690ea614bcaac762af51caa6166_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2be6784fc06342efab44ff95725d2986_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i96dc54b1575f45aa9360b1da2d463ea9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0d45edc6cd6941ef9b03d7003f0afd1f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5ad138fe89454c15a781c584d7c0212d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia5cad4f0687a4cc08c2c4b21b29e7459_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i55ee43f980e74742950602d7ecd1c557_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PerformanceSharePlanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie92c2dbc9c094b098879979d51afa004_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1cdf739ed9644e06b67f23711ab2839d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id6484d0f5c354afc941fe76a527c5cbe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i00edc5105e9f4951893c539899a4e361_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8aef65cbc35b4a7bb1424c660441fa25_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib550dc9e8fed49219de32ab81c00e68c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d14025c7c424adab3048e4636420277_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2efdc68378814672ad2455c0e7526d09_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if37df78c7cb74666ad31409c6077db06_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i98e5eb6aef8d43febb13411a27d3bb45_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i005faca79d6b45eca0b9960a7a8cccf2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4874a200b94b4652b806a566996b1830_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia63ef8082fe642f691db7df32a40dac2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19a68be4db394b5d8547b3806e810a60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e0a10794cf6434dac120f4b0fd4e858_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i175a0715b16947179dca2850b07e59eb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5952ef337321480da9d9eb91e066f493_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9eebc27712f4a14983ed16a7f0cdc1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i200a7f91a38845258783cd5f4f247240_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icd3026e0c94449659a50317d98e7f973_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i71429c4358e24efc9d002898f6394ae5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7950c585f21f43c9b757252673571f29_I20220203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-03</instant>
        </period>
    </context>
    <context id="i79da5b5df5a44ed2819eb15a236aea21_I20210204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-04</instant>
        </period>
    </context>
    <context id="i46fda90bd8224cb8aab66c2e4efa5317_I20200205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-05</instant>
        </period>
    </context>
    <context id="i66d14f14ca8849fa99dc8c0918792fb1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic1516dd6e9d447e8a114d4530d0dc9ef_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i63eadec211ae4265a25589628b710de1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeesShareOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0bcc53d1b46b433eb833bb6a2091a218_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:April302021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icceb8678190f4fc092c24a26a6eb8a8b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:May32022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib996bb209f3341dea9daa277aacec9ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:April282020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iabf63d973d864585b86699f4855bc32b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2022ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibcea4ad6a0f44a998a9b40d108e25d03_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2022ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i133ad2daf2c744769bc88969889d854c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2021ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie98122f205404008bf0c4d6ef91f8cd9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2021ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i47de2d9d1a944092a8be630f2ab66718_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2021ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7de3c0be32cc48acacb91c4afe0b5475_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2021ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id93a545773b04620ac8f01558b1daf08_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1b2461e749440a5bdbb736ccaf68050_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e27f23597f74a1c9ecae2a85d4ccc94_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i880490f8dfd74492ab0ebb0a198871b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c119e3c395a473f9ea5f13d6ebdde04_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2019ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieb20c7e9683948fcb26fb328baed1c91_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AwardsDateAxis">sny:ShareRepurchase2019ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id2b3c17bccc5485fa012a841128e0541_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i343a67603f674e36a4e9acecfd848af6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b49431edc8942d0a4afa8a40fe26c46_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf9aeb01b7384684be3ef0b4bc47fc8e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i101060c5a55146ab94a8e716c499c73b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5fbf93c7ecb84b3c99fe4d603cce5cca_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:EquityInstrumentsIncludedInFinancialAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:EquityInstrumentsIncludedInFinancialAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:EquityInstrumentsIncludedInFinancialAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaddc5f29d63d46fabf82586a2abfd3ce_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5642b66a094b41b78ecf737cf0fb29ee_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7c7268343e3c4b149282aaac720d320c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib5f0f8400faf41899e56a9f755aa798b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i84e5f74193b24fd0a09abc9140858b91_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i01a11c5677794ada9a35a69fc37af36b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4949eb4dec9442ac85100f908e6972f1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:CashFlowAndFairValueHedgeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1f6d2fa7ab6e42599794a051ecd2b89e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:CashFlowAndFairValueHedgeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icd31d9498df742b0b80e99888ab0fd03_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:CashFlowAndFairValueHedgeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib49080ce7345480abd6e11f6e27bc713_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i386bf60e102f452f92cd64f880c74114_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id5e403b7788e477a853eef59c1c0ea76_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibcee24e1452447f784500be45b06d7e8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ica78b7fc4ed34047b47a514ea2899e83_D20120305-20120305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-03-05</startDate>
            <endDate>2012-03-05</endDate>
        </period>
    </context>
    <context id="id7e65738a1c54e028a8f9ed3e5c8f6ab_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9a0dc1e4f1cb4d699ec65237a7102e35_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6fdbb4a4b5c641fc830a0a4bf600f878_D20130305-20130305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-03-05</startDate>
            <endDate>2013-03-05</endDate>
        </period>
    </context>
    <context id="i850f42283b4b45f5af5a9e3cb5bcb9fe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib7a863d7a3b84e16ada34b5dd5363074_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i70e570beee9247dd9373015a21c81447_D20140305-20140305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-03-05</startDate>
            <endDate>2014-03-05</endDate>
        </period>
    </context>
    <context id="i46fad837e04947e195c6de7464520552_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8eceb614c7954b4a9e69dda6979655f9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0423b3f235d249af9b6c602495486f3f_D20150624-20150624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-06-24</startDate>
            <endDate>2015-06-24</endDate>
        </period>
    </context>
    <context id="i761f2bdb34ff43adaab4025fbadfd268_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5e0102d8ca1542de9dd7e5b5292bff6d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9991ac00c4ee4f6795e497369e9998ea_D20160504-20160504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-04</startDate>
            <endDate>2016-05-04</endDate>
        </period>
    </context>
    <context id="ifeac6a9bfcdb48f68a24eab465620944_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9c11a2397029406fb3e60037da96b3b9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieb730a8c0b4f4f30bd170f0b73b2ae58_D20170510-20170510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-10</startDate>
            <endDate>2017-05-10</endDate>
        </period>
    </context>
    <context id="i123d774d41684985a2a86c269755103e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6ff9ac16b7da4a46b910521e9f05b3e2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b8cc6b5bfa042099e14b29e8ca19daa_D20180502-20180502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-02</startDate>
            <endDate>2018-05-02</endDate>
        </period>
    </context>
    <context id="iab81166fd8d041fd9836ffd1e59632a1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0b3f2d5eb1ab430482c82afc1c357df2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e201b70b2444c88a26affb3d73de9ad_D20190430-20190430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="iac1fbcaf85814c7a9412ccfa10736712_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2ade5b12cb694090a8bb2346378f9880_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id7761f45b2c44f4b874bfeb6104744cb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockSubscriptionOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia81dd6015449467683cda683d3e36cf4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:StockSubscriptionOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i07c7f8bc45bc439083fadaebe0c772c2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i43789de88f2946b3a8bd5af44ea50d3c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icdedad23dad54fc796d50896cba79d31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifadd309e52db44428b4ecb9771537123_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0091f830a3594684afe0ab456649287b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4927989d9967442c8996bd62b8ad73e2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:TotalStockOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i821889f0ea344561b6b623f1569dcf5a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib8bf080bbe314c159376eab8228e0259_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i96d625b90bc5415ea3c4f123b942d689_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i86600d52210546e48c0c267d156433a2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i761cd5d2d3af436abebf5b7972feb90e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ddb1db14dc74affb6c0eddc366fa6ee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if945729d6a4149c98bb12ede0a766d47_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e790c51810745d39c5f898d13e4d429_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i72ed25668eab49c2b6083a9d4b1afed6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i23039a6ebb6044c893c2b3b14a2e0be0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6c0322302b7940e2b62b4e9d6b0dd997_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifb96c4c54f0e4c9593d667cdb20954ef_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ica46b5f804e3417dad93336ac31a2ecb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if8cf06b4cc8747228729190e580e0310_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16062e084b99460599219bf6d4ffa60c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AdjustmentToDebtMeasuredAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10309ee26b644653875a9ef939afe780_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i821c164ee86d4851828efe3ab80b5250_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2ad2e7b83694c51aa8ec5759b996a3a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i610ac40ea4444926b8ca4fc00340297b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7460dad569314917928c609f43188c3e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6d1e362d6a2340b88d664b8d7109b86e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id2a418ab95d54008afcb49dc0cee1dcb_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:OneBillionFiveHundredMillionBondsIssuedInApril2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i9b7d742e8ca14e02bbba4212b5f9df28_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i63eaa2695fc84ccdbf9aa943ad509de8_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="if33294fda4e34c3097e959eb6003c057_I20140930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:OneBillionBondsMaturingJanuary2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-30</instant>
        </period>
    </context>
    <context id="ie9fabfa6d35447128880bf4259339f29_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:EightHundredFiftyMillionBondsMaturingFebruary2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i119b8f75feb74fbeabff0df24440bb94_I20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:EightHundredFiftyMillionBondsMaturingJune2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-09-30</instant>
        </period>
    </context>
    <context id="i2d6f40c3d9f341be8626293e79a24136_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SyndicatedCreditFacilityTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3c67233c3b0e4833a40cd61543f883b4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SyndicatedCreditFacilityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if95b13db708a44338258d8529b0ec6c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SanofiSustainabilityLinkedCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63e6bd162fc34a0b91feb5978e757f6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02963f181d634b7694e608faefff4b63_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5d73cdea800649ee9ff0d7d7f47de6b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i98ecbb3b780b4531b583aa429548a360_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i234aab96cb044325aa2b96beec593299_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i655df7026f214593b7b2e1587e041a19_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie7c961701531461c8f912e9bbcf2d37f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icf2f817c4f5c4ccb9efc1f90f92e9aac_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2247b882007d40f5aa3b115073c4c840_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb8cd7971d4e413399ac7063abbb76f0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a5299283064409797a6cbcb77b3b87f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5d7fb6953864b25b91382e68b89172f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8aae788d334a48228c148b2c1872c556_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:NoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i70a0c7eafe734caf82992697ac0ae048_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifdf61719dfa64d609696094dbfb37080_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id85f695673f24baba6ff5f3c480383e8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i00f6bb1b41d7431b8ba45da9f097bcd9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i607a722971b34cabb5fbb67804411532_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i023658cb94d842df8f9033585b3df0f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9db61024b8a64a5b8c29aec2980c480c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i04c2510d77e942f4ba7a8de27cabcaff_I20131130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:November2013EMTNISINFR0011625433Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-11-30</instant>
        </period>
    </context>
    <context id="i2469ac21b7364be09f669cb500520319_I20140930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:April2022EMTNISINFR0014009KS6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-30</instant>
        </period>
    </context>
    <context id="i047b177ba24344cb92a1ff94db833558_I20140930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:September2014EMTNISINFR0012146801Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-30</instant>
        </period>
    </context>
    <context id="id114c1320b834ff0b585507080df2d3e_I20140930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:April2022EMTNISINFR0014009KQ0Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-30</instant>
        </period>
    </context>
    <context id="i7f75dc1fff81450490afa0858e34619f_I20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:September2015EMTNISINFR0012969038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-09-30</instant>
        </period>
    </context>
    <context id="i199175f15b1046ac837513acb744cede_I20160430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:April2016EMTNISINFR0013143997Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-04-30</instant>
        </period>
    </context>
    <context id="i6594737bb0244237b737e165845993d7_I20160430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:April2016EMTNISINFR0013144003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-04-30</instant>
        </period>
    </context>
    <context id="i5205edb0a2ef44219261e0dd5e52acdd_I20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:September2016EMTNISINFR0013201639Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-09-30</instant>
        </period>
    </context>
    <context id="if56de4286562416281bd1e12783b1be7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2020EMTNISINFR0013505104Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id77eb5dc6f4f42379ad386e2e02634c1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2020EMTNISINFR0013505112Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id10b1bea133a4963a7fdd17e91652506_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2018EMTNISINFR0013324332Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="ia72c42b97a864e11a83f480f49ccae83_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2018EMTNISINFR0013324340Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i75cf2627ef3e4b49a60bffdc84713fe3_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2018EMTNISINFR0013324357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="iad984e38fb9c4661b085d5217e565409_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2018EMTNISINFR0013324373Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i32f8fe30afa14a24ac9c7eaceaaadef0_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2019EMTNISINFR0013409844Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i9bd94679eb80436b822cc5a86b620280_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:March2019EMTNISINFR0013409851Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic1513a029052410e867702910e46272a_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:ShelfRegistrationStatementProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:June2018SNFISINUS801060AC87Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i0e560b0683e3415f88c8eea18541347e_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:ShelfRegistrationStatementProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:June2018SNFISINUS801060AD60Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i6d556347116c4d7392f113ed4a0ab9d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:ParticipatingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i04b9380769a449a58e37ee1407a157ae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SyndicatedCreditFacilityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idee5b77afc724b18b9ed606b041a8f3c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:SyndicatedCreditFacilityTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i584b670205654f298de6bc6c82719f4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie51595be9dd743b794627696bbc95347_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1d46e42d80ad40f7be7642c3218b547b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9e52293342884ce98adab12df87659e0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7dd5166beaa6485c85ddd0224ec13658_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib184294f2a0c4d208ca2e78abb18309d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6fe6c9761ca64c7aab44286a6857190b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i41838b0e904d41fcb05555d3c2e53142_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4a3a064108104fec8f96446ec19e35c6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i21b97dca30ff4878a0d00522d024354b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9863724d6eed4da18629877e392fd908_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8115851386c448bb86584a094cd62be1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77d77717242846fd97fead9e9cab3d8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b3ff41fb31042fc9459840da1383005_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc5db8aced27474ba3858b0e92719936_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53a7d3d78c00403dae90e229c492b7a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if08e91bcc6334394ac4b4571ec9d184f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89a9437a10b6436496ce43c3ca4ffc12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a4898d404904d67b54841026f034dd5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if371f65cec7140efb6785f6076d8ef3e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6cc7bfcd54b84c8fa9042c040773a262_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib62bd4c9703147a99540e67827ebfc0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iebd2bcba58ef4b558528913b09bfaea2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i540f25e289fc4a81b2b603c1ce544e8e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i75c02dbe746a4f0c8dd0bf49930dcd0f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia7d499e8c9264feb8703281a726ff271_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4b6083f115234231b8a9cb18a0d9cf1c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i00b59f839f7a4230acf9e7674e11930f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6834ab2b35104783bf996d12d8b5b3be_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5bae5a0d6a9e4f738590405a5e507f88_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icda6c69534d246a48a04830eb613df01_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8c3e0f4218054eae8d6f0cd63d414c89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieffdd3fdeffd433ea7df1b20775e6aad_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7b5db8eab4b64e88973da38da595851d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i01fe7149c70b4165ab567b66b5f5a43e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i689114ca44ed42ee9df9e1c418d03d2e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib102efb6dc8143618a1e6b93d00e10a0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4fab70a599804fa892e143f5459a87bc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie7670912ed6048a3915926c30a98416b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic557830f381f4210be0d6833c36f65fc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8041942870dd4730b5723c5dc68d38e9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia21f3e9de40f435e9c254cf2a6cde7d5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i562d7157b7e8481a9b91191e18e64665_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7ce628e107bf47078ecfcfdb13f3e5cc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iedf903d1811b48a5b959ad28581d7e2e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i91024893bd7f4842a6956080118265db_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4c93c6fb82d542b198701a104373ae59_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ida6442fa725647e9a4886d876f008303_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie0145a96971e41eda0b8dbf9c0cc4308_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1adf194cc771430ba20e49e1d9df2cca_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e9f3675bc884686b9346c2cc4bc46d0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i82de31322c4840e9965d37b0c2de087e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i36278eb71056497db2592c9bb8341cf9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifda4536c10fc4da7bddd520da0e7f941_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie7fdb3550f04484b8bcc3e27a74136e3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if252267932914e47aa7eb646796d3c93_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i588d16a72b9a43e2ad82c0a0a94a5919_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3fc6504724b94686b7b9c04f189e7e73_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8cc8bc76c35d41f08399d789a26cfdc6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibb27d0c0e23e426ea143647091a7d102_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i26aaac9784564a11983a342fbd429be1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i891c90b7df6d4e61a27d601eeae750a6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib9aa711fcb6a40d2b80db74ac171cc0c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2a0b0e6e459f41638acacc3fc37a42fb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8fd5aa573ef4460cbfad34c55a86f731_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i49b804d9ed614704907b110f70a5cdfb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i506dffc0627c41909915d7e8817418b5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i57012484148948689f89fea0aa3009eb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id1774eefc6c64ab0af41316d805ee58e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibbcc5028550249b08609aa6bfdc653b1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i77fea54f24f24e5daa16b8e9af0ec3ba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5cedacf54d4441efb351a26b12b34b7d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3d7c1443a2d7463e82df2174db1636ee_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia5c92790c66c4fb89e2306e62a806e24_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie769b358c2a7430eaa9c327866a428af_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id275ba29b8e14859b191132d6c2cac69_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibee927ede2a140759f0c5c12d11794c0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib91f94ba7e664e9a82b38a8746af0b80_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i237bae27b00946af9d0b8a11f902a571_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i35a06cbd066c4a6385ffce5cd1bcaa31_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iab4a2932b5504a659476a2c7ba6d88ef_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibb312bd23a3443b3bd0d8c41cd9225c2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id1a1452ac88b47cdba83dde78ded377f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i57ad0dfa87a84703b12af704a04f6d7d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibf7e07a4b08c413f97b8d93e97d582ae_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idf8910c273344e81baf6be3ce9cebda0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic9ad47fc844b46bc80ec5166c7202ecf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i68a66f1fea5a498aa1aa1217323de722_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia9829d8804884a12b2a996bb924f52c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2b4aebf768c5437dbb995a69b847a59c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88fe0cc7b26a444897204bd0cd68ce16_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id463ae47153a4acca4d4ce0cd4105e45_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i017628a6bb05492681816fc312f67c17_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idd131014a277431580f16bdaa1cf4dea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iee3f28b6afc141c89ce5d05cee0c9373_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b2abede0f3b4da6acb6ca1d80672165_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i76094c0250834f1a85e51ab92e040912_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4fe1d1477b9f4783b9f56a9968687afb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2c9b9d646ff44a8a69e68756acb7765_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i44ca61b134c947c4bee18de7bfc7e7ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia15a0d49ecac416c8e39472c771744ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29b764a8ef7e489b91978a7eb7e69313_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i460a31d6345a47c1a7b3e2578b9ba86d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:WeightedAverageInterestRateBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie2b6d2511d0e4766a94389d42ac8728d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:WeightedAverageInterestRateAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic41f4a5b56624a49a78f6fe5ac261c4d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:ChangeInEuroAndUSDollarShortTermInterestRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:PlusHundredBasisPointsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5d14a3445818400e945ec968094e1c76_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:ChangeInEuroAndUSDollarShortTermInterestRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:PlusTwentyFiveBasisPointsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i16680b6fb943448fb282d180578aad71_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:ChangeInEuroAndUSDollarShortTermInterestRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:MinusTwentyFiveBasisPointsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4bfdac81298541228d40dcfd2166cf4a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:ChangeInEuroAndUSDollarShortTermInterestRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">sny:MinusHundredBasisPointsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i57bb5023f2b84d4487314592d0f4240a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6cbeba8a8bea4164a2c6d181bd02c2bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i986c2ee021b44ce3b4b179b044998da2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9fe5b918c28d40af8499fc1cc0b70c9a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifdd755aac0fc48e689e14a6274f310fb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i276f12c0b8124b55895020cdb1b4f4c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice55484dadfb417dadb944cba1425875_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0053ae4d634f454d9610544b49d8cde1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b2c283754f141868e981361c2f48440_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie96001907d3e48d1868c019e1a785aa1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if7e673112a4142d6a878b6f0f4052237_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">sny:OtherCurrenciesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibf44e1ea006f438d8d586516b03c1f93_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">sny:OtherCurrenciesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9d361595b981448ab1d50f6b03da6881_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33739fde16464d6e90fb87630cb2feca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if126614dea4c41a48da8c2ad61a16c94_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9110312ee2f64746a22d9a66d04adf9b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id9b4ea343f3047468f2f5d10fc5c9122_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">sny:OtherCurrenciesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i762332be16fa4365b2cc90d3d0037dc0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">sny:OtherCurrenciesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionAfterDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic291b624a38e421d9afc1f580652e23d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtMarketValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e4e5ad251f94a3f8a8756af248a86b1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtMarketValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iffeccf1af73449d2a5ed59864455f0d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtMarketValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1935e628d70046c1966e7d84061601fd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifeb107e71e654a8ba62720ba4f39052b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iea4dd6e2c1634f6a8d800a040260a39e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib7e3b493141f4fa09c383ab24c96a46c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i280298edcb0840438a14b90d970fec63_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if8d0defeba8840ebb20ca36929efec5f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1804f6719b7a4579ae1189ca0b6fb642_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6fda103b354c454696639116746e4ce6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i986561ae95484c06b7698d7d6959e8c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id3388b8c97b14858be97adc9fa1bb28f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34c7881faa9548c999a9a866d7049120_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib80a3cdc90b542b3872bb71805fbced2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93a3872d72bb4c82af731fdb78c50918_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5544555c01764c4b8d8f64867b09aee6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36e91efc121046df8f37594a45bf2954_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i03200b0530124cf6b744c38cef9f2c64_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82c963ffba184f95b526d153ee99815a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b10dc3381f24884b9901897b6d650eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i59dc276763734d8fa431523f6ec5e6b7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iff1ff8d4b3a145be98d0790e4617ed52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie428880947a544b49bb0e7d00760fd8c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iff9a6cfc0d3c4fb393a0f42915753ff1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i597d4960121a42bbb65d0137e78d145a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0c3121bafadb4e4f8e35a95800cbc2f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if4a75584545048bb9fe869e325a3208b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:CambridgeMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8e622d8cb4934c84ad1e319b2aff140b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5f5f52dce766446e8aa8c13efb12df1f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3a26a676a71148dbbed13648e1ad3400_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1d472a3e57b147aeb03a38a1c58e1c64_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ida0de68516d145a58b76c93f372cbcc5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idf3de6cf917a44899ea3e45a8a4818fc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8e44cd8b091f420abc8a03afa2bb16e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i96eb878aad884bb1836b938d8ed8cb7b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1bc6ab03815b40d8abfda40457a31676_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib7a524009bd4455fa39f388d2372d26c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i86bc2d12cd7842f099841197a912ae1d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0cde6022813d4c0faf7f41e7da37f957_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i276543f6767c4836beb195c81c4f8a9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia42d31397cec4401901cafed6f408fdf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b6de6418317488f82c440f54eb0498c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic709e4b4631c4e698a72e76c85ee85b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad675e551ad149f2bef90277d9fc9dfd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5321b815afeb4a57a109cf015f023977_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1c1ada8ab8e643c880ed5b7be15fcdd3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7c05c49e9a749a280011ae480cc3b0d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9028475126f24188932b789c9c3a8b88_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4be94d08066947e295889299f946ac89_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i48e232fbe36749e39b797ba6bb47d688_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24d884695eeb435a925fbec2c89281ad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic6840db205a344f3a3a3624ad1fe3d84_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2ff7c27b940f47dc8db4744efa5751f9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AmunixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibe52215125434d49876df22db77015d8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i39a7aeb71d26483d91e0c2fa09f8bace_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:TranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i61a0d34e548c452b80e7527cff0720d1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerScheringPharmaAGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i59afdb4fc3d74ad98a57783363180e8f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerScheringPharmaAGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iffd5a4bf38dc4532a6905a24f9510e2b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerScheringPharmaAGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie797eb00f7304dddbf2cde22a2826442_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerScheringPharmaAGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f26ac7c041844fa84f5ccaf51563dde_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:BayerScheringPharmaAGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8794718e5aa14c49a27eea0403dcf813_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireHumanGeneticTherapiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i532881433aa7423d869b4ec57f911c53_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i414d2c248b5a458dae7e76250a0ff9b5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i43dfdc134bf04195b896b412124e7194_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i31f290bd30874504995867d89e80c3d9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife22dbb70240483fb59abe97371c1713_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ida1b0b7fd59a4db78494bb22968fdd7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4751a46e76748978b422a63571faf77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie016f1bfac62464f88ec010a81d0e1ba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ef08d9911e24c519c5cd052d066245a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id6287d4b535a408eaad25228f5b4da0d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53403a31e97c40538e551d37a2a4daa8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87f7b547836c49bfbc71cc2d0e1e129e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93c8eb824f4249b3bfda0339bc01253c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i99f14dae6c344820b8cfd29600e3d5a5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i166b657852b1433a9e018a31616ff84f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i68ec19e5d4dd47f99a2b91bffaf44998_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i38e42cc577a14225b39b09272fa72a61_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia10e6503fcc842d0a8ec71b5c5ce2538_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:LumpSumRetirementBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1658b22a6e4540a0807eac410291250d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:DefinedBenefitPensionPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i144ca30e0cf646e2b838836778d7d0b4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:TopUpDefinedBenefitPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ief705d2690d74284bfafb92aae683ade_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:SanofiaventisPlusPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i84d47ba9760945e48ac11bae1f3b3f30_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:MultiemployerDefinedBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie22c0c0a8b924a2b9eb8114a97aa2197_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:MultiemployerDefinedBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae25acad84cd4329ab2b319e35f1cf11_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">ifrs-full:MultiemployerDefinedBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i72b834d66c174249a0c347659203c14e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:DefinedBenefitPensionPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">sny:QualifiedDefinedBenefitPensionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib27399813eb6424abd019f16bfa18111_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:DefinedBenefitPensionPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">sny:NonQualifiedDefinedBenefitPensionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07e1ed072e3e438e9fa21f2b6b669c94_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:HealthcareCoverAndLifeInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i76c3583de96148c4885a50242b9c6cbd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:HealthcareCoverAndLifeInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f22c7c899354b0cb94d9107f4fd1d7b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idce85fea541d4dca84fd5c265ae2ce3d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaa0767613c3f411ca54f05839ea4dfcd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:DefinedBenefitPensionPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie2fc70c201ea485293d21743a8c878ce_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2161c01fcdb543bf903af67ad7c742bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib109e7b8a7804e8faf5db8da9efa7002_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iad383d0b40904aa78c611003295b9f75_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i37dc156184d44185ad77a05f3d1c8e7d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d1dddd9218a466d80295b2cd0ba570a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib64132cf06b441e783c6365e8d7e0777_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d969a5687574442a05c8b81a0fdc221_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ead7b007eb34735a7448b53948b4495_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32eff8213db3483b9be806abce4ca9e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5ccc5f405134715b9e46b9feb0319b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i058d3dfb4d72464288d47993d2264238_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b87b7d69412417d8a10e4771f17da62_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11aa53d3dc864e008f9e1088d764b254_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41bece1da3a74bb9b590430977baca7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c985daced504fa199baee84c35b8e0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7848ab0fc3954d42a48de56c4b377354_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6da39a10f36d460086ee95d7fcc030b7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if2b8dfeed67443e4a6e31f8a92ee2680_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia930b4de9f06488eb2a27b3206081e50_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i61f3d4e904be4545a74ce3fa06c1a204_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib07bedf4fd5b4afd80a58bc9cb0aec36_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a09555de5d2475e921b22b01c4067e0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb0e67934e9342fe8d11bdef892de277_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia76aa13b727547f4b1f27cd2781c256a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b4ab3d8a6a24c718f4ce304e594594a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i389422a893e247e09550b1c3b9924585_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2b883217a0b47c1809f32a00d79e510_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5064ea492ff44ec88d332c35c309d9a2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">sny:MinimumPlan1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ieceff523a9144294a083d40ae6a52b9a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">sny:MaximumPlan1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie625e49612cb42ce92fe5437d2292431_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">sny:MinimumPlan2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9ed6f92d51e8497998956b0d5d310672_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">sny:MaximumPlan2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia7102fede0d146a4b433b8edd4bfc772_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibb62e344ae904638b2180924543f92ea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9847d7e6def4b7581c9458c55a23404_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2e3c25fe823d4ad6b20f9c54e9bbb046_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9a7882fdbd5e4e05aa9602a3893e9063_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e44e9528b734db79cc3d65a8189939d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9f0a85e9edb0438fafb910e5b162bdb1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic4384e1a2f0a448db27dfc68742b600e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib4a60f88d3bf4ef7820610f341e5d953_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79da83e967ea4e5e90e0bf72928c2373_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4785a07760e04fa78307171b6792c3eb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i869eae3e607c4fe0a4413a6a56efb7f1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i328a8d284f6846269cfae2148edfd6c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ccfe837400547adbd518f52980bff84_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3aaf7a0ab28f49108002d2f4290bd493_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic8f6bcd683c14b17bea138ad1208ab88_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8332aad05ed4409494a56fb553b8cf48_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if40430fe8c9b45feb6dc9b6f4a03573b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i148b4cdc5ea1410fa268363a20cffc49_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i58cc77a855b44d93866738bd3c23f42e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie526c1d298584ae8972260efcc9808b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">sny:ActuarialAssumptionOfMortalityTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i127c8206a4a849dbbb0fd4ceee30d8aa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">sny:ActuarialAssumptionOfMortalityTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i54a79349271f4e4fb33e85139f76607f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">sny:ActuarialAssumptionOfMortalityTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibaefca5f76804fce8b04f617795c3068_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">sny:ActuarialAssumptionOfMortalityTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1aeea4ef448d4878b040aca58e59cef7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46a2a2a21d77490d9398a698d3aec8c0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d7223a21f0b4cee97becbcdd1bb2efc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifda432649e3d4b16b2b65809871ae47a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i04bc92eea38a43168f452b170f5b5971_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7fcfaf4afb0a4150a2e4eb7dcb4551b3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5920c792a4ae4e7d86f79510124b3f82_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i937300c73128444c840c7f1ad48a02a2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e44f785b99b48ba805fc2c0db8dde02_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if4ae11f178054227a9f097d1bc819c0f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6201b78a9f6446cdb01a79735208e131_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia26a9a0089c24d36a14fba4dc1693ac2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:EffectOfAssetCeilingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i807618602bfb425397cffdd414a540ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:EffectOfAssetCeilingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5072e9250f7c4f3d89d1b407dd2508a4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:EffectOfAssetCeilingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3092ea35a054f4882eb46f7d877613d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie7cf90fb83ae431ca29e7217f1d29cc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i74c83face2414740ae5f9026f45db6e2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i79f5cd3d673f4efd977915e181917769_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i39d668fce64249f697434c38ca01ade9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i196a10f493ab454b9274ca3eb5246334_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia89777d1856946948f3ab287b274b7b3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d7547d361d44bc7bc51287f8d63fa39_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i735c553a649d4710a2f06d4ea8c8f3eb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9f74e0cfe57246efbeaadd68666dbd3c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9658a2abf9a5478fa9e50db338221664_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i625df457bbfd46169d9a20d074aae8b1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d15ea0bd3b14ac3b41652e59b0e1991_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icef5204976824f79a913930fb94f085b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i52f9ed0a9cdd406e836a0653d1da4b33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i372ca78f06fe4df388ba26d79d02bc31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6c3bd7580bba402387e084f56f6be553_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i385f7ed33c244c8f9865082c29418042_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1d9cb083d13740c7ac9847d70e575e46_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd245ab0bb874dd9b68d83d0e2a73768_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i132794e24a974e33a6a21b07c9e18759_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieceadb4bd3734ed687be7e86ad699c73_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied5cdd7108ef4bde8a190a1fdd725e36_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:EquityInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9322df58abf645a38feae4db48a58ebd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:EquityInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a4f3a465b6f42b98396a6e356f30a9e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:EquityInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb517efada3a407d847b0ca69894e99a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:BondsAndSimilarInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e4be19b26a049e1bf1e91bab2e11e5c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:BondsAndSimilarInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39da8a2d60674ff4ae5c11c70259b5e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:BondsAndSimilarInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a41dc31c3e74eedb023bf10eb8a0e7c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:RealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i251e98323a6443539777c4746f73c0a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:RealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6cf3f0fc2b4e4980a5a3b2ffa0064c5f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:RealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ff9752dc8ff4ccda97e1df53f25b146_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iad8a1b698baa4703b83d370174975b1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i312bbd7a70ac416b96b1efb30fc8419b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i15aa7ea7a17149d88f714ad7ee033ef2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CommoditiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iecbde7dd3ae84c15a00c868d439658cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CommoditiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ee30b965d34426b8572cbfbe3d99ab5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CommoditiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2bab82be0a94d3385be51baf05b2e8a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1a3027be885242dda3901c2d93f03d2f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i208f6ffa4b1f4aef954fb58bed015cee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4072b208f40b416c93f385cd81718d4c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7c9573f4723f496886c9527af11cd414_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib77de26cb736428ea323b4bf71486e1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45d69c6b976b4b52b4b221ada5523cf3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:InsurancePoliciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4202392dc954ef699a4858b3b2f3d28_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:InsurancePoliciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7625f2a35e3415980a56f594344ef2c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:InsurancePoliciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i78812fafeb0749c2a649f288162412a1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4f180432287e48bab7a2788e97c95000_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ief62dbe824b9481f89598dded18264cd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic96e413d27b649b6818c4939894846d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i083a34cade7349a9809e1628fbacf89d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia031999e21bb4be09427968a148fae23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1b909a4273c42b5a19aef1f040188d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie22b5bc62d6a4722a5151ce86a8d9c8b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i82dd25c00891486492e8fec0de4ec5a3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia75be383078e44f5a715dc5a129e531c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4fe5b990d9de45b49b7bf7c02a4be68c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idf679ad39d3c42948615b8c3d8c06913_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idbdcdcb4253747a694c0b2a3d28a086b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie76d9750fed74c6ab5c5827885cabb66_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i972b0ef516064ace86f839ae7759f600_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5fbc3ff0245c49bca7590dacfde5337a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idc226cab822a45fa830781a2276243b5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia144a9826d65474fa13a4d6d05757814_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3f42213a78854baf93af23eb78fbfbfa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia6a2ab1329f9438bb6a95f98aaf0e3f3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i73bcd0e9416b405280b71184e77d390e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i03a64532928a45bea416e80a24fbb2e0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieb0eb02549864f8ea6aea2b8ba55c46d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d19463a7a444bcd984e9d3b9d49979e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4105798cd2d14971b1fec1fe37a7bd83_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib06b988b7e3c4c2e94ff11744b627571_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3dbde64047a84c3ca07ea93b5743b0e4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib3fae2f714c94f67af54f0be875a5384_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia2f17bc572b546a0b59fd7c5297ae445_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i47dfa2f710b1453fb0ad595e495e2a09_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib9deef6d5e7a4bcfbd422deaf4dc5fa4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i09a717365a084772ae035c13b5a5f7f3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i22228827eb244f83a0287d5644da5318_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie01edb6a55dd423487fb757d28bf4ea0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2194e5d4a094d0582dcc78661f5b256_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3de22f04eb7e4c70949d28adf82e0abf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie18cdcaf451b4e6a822ac250b33acd0a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idf005e09f52c4e098f1b0faabc27a76e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8f2fa5376a74486b8e858119d96d0922_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i078b4c1ea24c4f69852b61428b6e2fdb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b5e5589175949ed969ff4a1ccb121bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1d087e9dddd44337a0f1832768419409_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iec7a123c92024f24b8e10eced658e625_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i475f28cce8a2420887453fd4e83fb711_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iab4710282aa04343af3461b3a5005198_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ief42aa8c7cfe4ac888627eeabf185c37_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">sny:LaterThanFiveYearsAndNotLaterThanEightYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64534b6ebaf2429c9abcfa76a80980aa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8672ddeb9f334dfaa7ff3d1ce467ff9c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9ad395b96a2a4d64958e0dd07a82a258_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5afebb992674818a78a7834ac446ae9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icb5f9e7c6185477aa7f9a156dc214f20_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i845514465d3444229b0025c52ed9385a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if7b1f1d64d014db48f48a68a6832b64a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie3a804cc972b46818508faabd25873f4_D20221231-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f39e329592f4ecf907cc503dcb00e16_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i76c0ea6a3dee45298522d8ae0b039615_D20201231-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib3ede158a1804cc89e2cbf56a9146440_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ief8448635aed42ec8bd010e6d8d33e6f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i733d9f9b2b73442f8f3ee6d411efc319_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i727bd67c94b846ec879e26bf1451a28b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib5abb9e9b2d645b687214ebf5e5b917b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4217022461624166b066799e52ed0ae2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0b14f40a60345cfbb888ce3b1583ed8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idf14e75b5e984c98bc6e960753b80f31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66df5d0d41d6428d9debc9c4c2f80889_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i54ab42bc5dab418284d3709b3f894736_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i836df9a1ca87450a9ed9f75118770f04_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i688e526d505647cca548bad7d372816f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id6d8865e8b32416f920b803df1461469_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f7f02d43ee94a4280406be5c3292239_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic901448a78764b3c9b5def1dfdd7fbee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide13b51197a24ee9b4038dac78c62afc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i158f70bc52794d319fedf9a855b45b25_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21e0cbf5e58a47feb6bd62e37f9b2bb2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f92b31b598b40a7b5f13a153bfbadba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i46f2414fec014acf824049d7ef8a26af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0593a502ce6b4cd49c8af7a40f39e801_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c31592c4cfa491e9223f6491673f1a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff57e235495f4a5589b5d11d2537313e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i370f9ca08eec4c64933f63c4154c6168_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idcc9f8081cf140aba4e01d0be09d50e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idb626ed9d7754d599f6dcb43cd6f78a7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:OtherEnvironmentRelatedProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1f1c485ac1cf4f59b3dec0c221bf9747_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">sny:UncertaintiesOverIncomeTaxTreatmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0067e056654b438e962ebd27feb406c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">sny:UncertaintiesOverIncomeTaxTreatmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if40304953a534c06a43b1715cc0c7ffa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">sny:UncertaintiesOverIncomeTaxTreatmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7182e8a5acb84acb81eb76efa4a859af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:USLegalRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b16a68d75504188ac3d7a2cb2687840_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:USLegalRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a3c0c053efb4732adcd801d2a0a398f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">sny:ActuarialAssumptionOfMortalityTableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iab27c8ba011e427586eb8baebc4580ce_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">sny:USLegalRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1ba446060ed747fd8a37852a575bc1dd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f34920cef9945fd969c11ea4e857b12_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifb00596e224b4b3eb3c4df739ff52cc1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8fc828012b3e4f69a32944391c782b1f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesOperatingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb368c61c98d4f5f804fb045a97d08e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesOperatingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifeca42fd3faa45ae94e5c1bb85088c87_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesOperatingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd45c8db737d4629b5ae31523cf4b669_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesFinancialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie9bce47aac6f476b9ddd183a1b48c82a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesFinancialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77add1a06a69418dab94e867b2a86d41_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencyDerivativesFinancialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a3dbc85683e464fa9ae058e17335a6d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i01f241b2e7334652930d2a5f3bcae23d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd6f6afab5064092a3ab474b0a93921f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad5d34f9d74d4248b507d41261086914_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:EquityDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic3c4833a597b445e8ac99a4bbe634506_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:EquityDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i579725acb4414ac980d9c04bf21d1baa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:EquityDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c02fd8df4a441dcb9995176d3a629bf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i72c3586a9fd0496ba3bc0f02039968e7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c9d5d1deb134833b4e2036bf3f18d5a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i10922d814e24467cb216f9da5b9d4241_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie786e671f2514434bb2cc23e067013a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id08df1158473419092d42e5efbd09182_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3077a750c45649c4b6777546b6550f85_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i670bfd8fbb1f496cb197f8a8d7aead50_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib47972465c6744dbb2af277f58822cc3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1515e825367145dab2111f5b97ac20ff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9a877b2db5f4ef5a898f9ab4cd8c3bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f0d14b4b851424096254509ca5ce614_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib0b930fe86134a789ba869c99ac6922a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i53b2dc71058f462a964f7f92010a94f8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6369626ceda6440e9ae77971eb0af8ce_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i31b628cae9e04ffc99774dc92b5b02b7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ed9108e10a7437da4ce7e1145d235d2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i844c3e2c764c42c38c639fff0e73a5d9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i616809455ece420c96191218acbd4402_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2600795f42b14e488938c37089a03fdc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i72fe87984bc64e35af0fdf8b4f5b3af7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i023e473680f74d54a9e6f6b0424ff693_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d190f1e3f654825a7689ee2a7e9ed59_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9ea0c8b9510b4cdd91fa96778338156d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icd085483ffc4410e9d0c190b8c42df88_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i386b0ada740d403b80ec57b202d9925f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e328aedd84b49a29a910cbaa90fbe33_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4781504261424f1e922ae06f843e805b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34e173a6429643fbb1fc2fe0c4485b3e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic08ec36e888244fc9d534271f013c502_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id22287e14b1647b7b35da64ef2a0bcd0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i554177ec4f184e20b73e2d228590a9f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2bbeb6793ff24719922e66a138d80cb6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7f8fdd2d956b482b956d8f11d789446d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i490e720986f8468298889ed58d2712f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i736a15874177466a8cdf1da7d0053f24_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3a7f408bac704d3190ff4e36dacdffd1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ff96e7abe6440fa939c031c8fda0ea9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i833ebae90f784a20b1d78388fc99a799_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i55b54f75fd784f738ba0c199ae6088a1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icc588cc6b9f54f1d963f8d24ad61d2ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i255506009ec44c939308e99a6b52e9f1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d7af22b9f714cb2ac911c16230f1007_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id027bcc05cc942509383921729fab6a8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i876113a89cb44346a3da543cb98fe7ae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34bc3f2e19ed40ab8850869c31eaaf6c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e0dfe2b1623470f91db3c18ce68dcc4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ba2fcfafbe54bd7bf7de2bb6f55eaba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i22da51d7b0254bd880ea050847a615f1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idaf9617caf734e5585971e11ab4b6606_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i35ea3b55ed754a60a864ed8442dc2c4e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia8566044ec104b54875bbc56afc2d6c6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia61ae8b4b03e49bba08e79f0b7a8f8c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8c24dfa0a78b4e9d9bc86d6f52203580_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i548e00dab5dc4ee7bdbfe1756bcb7839_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0c5b59aa68d49298a45a2a610f5c5e0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic9668fa019664db492a7ff6c75a6318d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i97148636de194a33893bec4aee4aa41c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iecc031691818425087e6d05be7c7c9bf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieff7a0389c9140eb879d380758dff38a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1d0dcd53f94b45319eafd4558d70f360_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a186c3f32f5484f8ac45bfb18dc2330_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ea8e0414ea34508ab58fd08342971ae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iee6addbe47a440138b52bf3611a17ceb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb5f65eb694a459d87948dc73311f144_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icab460a6e7e941308427a83c3d253601_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e4cadaf5b0845cba7f9cde445b6c92a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i900cd87f4c904d21a069da0f48a921a7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e3485983e3542ef8b9c5940a6e4d2cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2bd90408fdb848f4a168d4d2dcbc0549_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i614be5021c604d959a144279ba0b4526_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5bae6aad36b1448fa535c41175f48601_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7276b76a402b473f9e7c127ecbf662be_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i93c37d30370944a2826ff37e9d34e8a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i589c2dbf17b348879dc721a9525fc177_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i50449c405d664c4dbd84b341ea3b257a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ab17fcfc4d84fa99bdf75244c2ebf9a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInKoreanWonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iad4ce0de849d4cbab8c710e2aed2c4b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0d052a4d832444a98b95347523810eae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf8f1eeaa8714aa7be4e39be402dcc41_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2cfdfea2209d4ccbbc523a777b090e42_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i90a937537aa44ba09a3f7643066da725_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i48b4da387756465aa5c44aacdc958949_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i38fc2554622a4d10a204d1c010febc3f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i48e2f84695a246b1b0d8229ae8e26267_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i922eeb9c64b04920a294d8178d09fe8b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i73a34cffa66544deb36e7732558b3762_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i97c8f085dafb45a2992095d4c7dae629_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i682f1cd2c61447218a7903da70602a00_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16bad98d4d934e91a14f1d7988740778_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ideb5cf2c7c144e379dcc2ea51539478a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iee1024eeb9314f339e519f511c666ea0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a170b12241f484083d21f6e5794807e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f9c05daae0d40f886aa6ba7000ba3ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64087778cca74bc4a526a10b569636b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i20618940d10145199825568865ca8d66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i854bab973a0144a9aea65d7db2440733_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iffcabbbf635b4fd992b8a41b9510b915_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f2ea65d6c9a47f6814f3d31cd2df80c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a1f01f9052d425aa69dcfe3b06dc17c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i183f0ed5ed164cb5b4ea5ee09dc73278_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idaf0eceeae6d4eeebbc0e8defaee5b65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2fe78b5e0fa46828e0f0ab6e8f5bd07_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0dc453015c43417f8a310403dafbf8fe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07769fdb0fe34d908e96c647c0db6d12_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if36d1070ee9d4489a4cade29dd0771b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i384079b1f8bd40cca5b521eecc67173d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7d3fc2dde0f4fc1bd61c1025d30ee5a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2e1a8164b01f454a9ef85a1f93c00105_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i35ccacb194c94c69b5d085bc5ff5e589_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if4fc30d0563c4651b04f28750beea307_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc51c3a8b7fc41a092d0d1730df7f963_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7a90a0ef0ed4c3b8eb42178924b637d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i471fcc10e8564dd98a67fb349fdc3a8e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i18559c6c0cb3430ca0132b84801f9e99_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac26642cffbd4b2999baeeb3a1685db5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib23b2da676d5492e802ac4c812a506f2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5da383083c0c4afda0ee7c969ad8b27f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6dada3962cd44c1da2ef4a630f6b1ed1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i434e5e043aa94881a6a3e2eedff9adc9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if34f2b53c7d045a18844b31f4a900e41_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i894a76d0d7de48e58253294db3627dac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9c39b6d14e84ae4b1b24e007a9e3786_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc12122f258749a5bd2e6732f1d304f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida1a51f00f9f43e2addea3cff1a8fe07_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5281a2a2dd074a66a4481d353042fc10_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i930fc256127049c79f51ecf59663a752_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5f5c206bbe041ae839e26cfe2a55dd9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i837cfe78d2b645d98705c95b25994752_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ab3ed6ee531495f95aea44cf44b1526_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e0e7ef8f62a445ab7615b93e8c6e5b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ebf4555124a4b54be1588e86a3da403_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i193a8989856645a48abe7f92509a5f9e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInTaiwanDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic80c137f25e045a9822774580063fe84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia18a712428304812b70e53d9693ee063_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7109eb1c65b04a438909883fca4c7d28_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5f09375512f4606be23527c48462237_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2cbb135c3a0433ca0c3b69c5501968f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a0830338f724cbdb4b9b9bfd6adeda3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia56a7d86f76a4d05b6d08eae7ee6f6bd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if71d9bd7d43e496e93db1925af2e1b60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic2a16b777ba940a4ac181e8a001d2faf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4903495579f44e64ac57f0cc1e2d7ad9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2c01ed8a41d4db787af4ee204db1fdc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec6eb2436d6e40a0a872d2bbf400d795_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8106356ac1984ab9be68b54b74eb94cb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica7586eadbbc44c880e8d163aad962c9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i044093d165864adcae409f5f0044ffbf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i51dd419d2cd9485bae987d880a7bcdf0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5324129041d4c7a8cffd51b410c8dff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i302a876c87b44ee3a7af953022d71a40_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3825d70a3a964b628a2d61ffeb07d222_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10d98c3b5e3140ec951a12de228261fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibacaf6d36f6a46e6b159f5aa7231b80f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36c63ba9c19349b1b82e245f1b2c64d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0abd8e7f1e841f7ada74773a2015b61_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie1c9d16b1d5543db83b717cb805a3054_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie53d539627af4726a35780f1cc08e507_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id73c46ce75c74139a8bcba359c49f997_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i456a2daa913c419c8e6c1a03257e474e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifbca91ac9abf4c87a69b47abbd03d727_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3e4f8aee86404215976b9646e9d9edb6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9d14b72ec254084ba3095230da92d21_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f99799f7a8d4e2d84ecd1fff82653b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd3753fbe0a74c589d523cfd5c6b89fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i054783a0dd0a4f84aa2d451d39159d7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icad712c978144c3084e0faa45a0c85ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b8b8a03c8b14a00b47b0e84291b29d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInHungarianForintMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9928943949d54771ad5e72bd36d1e3ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6586fee6173645e78e13348b13791844_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i545bd8a737bf4fb3af3076a7c330b2c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i602ce8f41d414b48b5a84661a31d706c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i027058e0a496449eaf197cdfafc45b2c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34b226c1622a45528a50ce7d8f2d8fb5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73141eca736d4bc5afd3a96cdac8bbef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i56bcc4da86dc4c3e9d1f700ddb1fbd10_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6fbda346e6a493cb16800f488f83cc2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6ea9e1f7b784baea9d9e983ef781098_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0872c944abfa45428950a1bd06308fb9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if75a6d9165a94a1cbf4f47aa2183cdaa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia6b4d5b53fda43ea851ebdc43262033d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i95d0c7bc51184d8e8639aa78338ad663_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c5ef4bfd1f14291bfa73144e9052516_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i486d9cec4cb24d9da261820e6f2216cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib51cb586079a4e04bbd72dcec69da0bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5697cb7cf4d04dfc8add48c1c94cbbaa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34aa0682772c44b4a0ff76dc79d28958_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0a8cb6cb5af547b28dce285b9c653502_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e76f8051bde43d3a56dc6270370a1b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i147b071b30a142d6810201f12247d61b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9f071c0f18bd445eacee2517362cdc08_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i181e7ef5bdff4cf6876e51eea6ca820c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf14d2129bc34c2bb2bdb6c97085b4d8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3db42c94517e4705b4da1eed3d57e340_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i252c5890b2344a738c0f89c1f5f5c87a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4346d9e3152d432bb116ca1410c35048_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a69b4b219ce4e26a3a79c96b68b5c95_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id227c1ffc144495b9c6a929875311feb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2257aad4e93045328f47a96258ab2005_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4037de80178a4bd687c7efac29bc15d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia4f7f8938c7042c39938f0852b1bca3a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89025c2ce61749fe87850d73eded6ec2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9be9642933af42f8b0cd6d23298b5018_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ae1d237af784d4f8fa137d708f60517_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ffbb59d6cc44d84854b689b538ed0ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibae1a4d3dba24ffba6d892dbaa92e78a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d0474adac6b45b1a78fc524e09f71de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc5ec7415a4f46fd80b575baa7648a15_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief09a86e6cd4415eb08a6914a33e295b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if4ccb84c532546b9b5869e4d9f81c989_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic7b4d7c8c509402c8eca5e791875f3c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic3431bfe1daa41098f327267164dd835_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9e5de3ab1f64c9ab3bdcb2c553d1039_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27152c3f2bae46278e43f8d1a81dd8f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i840dda0508654caba7f51026ebdafdd4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d0481cacd274b2fa681c5bf9890a2b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3906596ab71d4692bfd9c38d60ea6188_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i58183268ba544f91b20e9bc30b6797b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f96ec8ab49a456fb96eb444552e80b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia344078238f4464196932e8c0a5ab334_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i68cf8057519245799cdf12687b2a6f93_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i37726d73b17249feaa902d38b48653b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c91d2ed118d4954bc375ef4b66d5e48_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e1cdda7b2be454db539353df19db57c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInMexicanPesoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5bc3cb9493e1444f82f06a80cb7a29d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idf56910613674139b60ad8c9e882447b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7a02300cd2f47f99a98237e0dd5a58f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i07e6a5b18f544c01aaa9836f457f7bd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1195cba0e9c94a3699b59f45259287a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6dda0ea5c90b4325865f424eeb8327d3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8e6703b549e47efa32fac9619c9ae51_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6bdf7cf5cfbc4d09bc7c7ce7da7a3262_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id0415e276f844457af7bd49394e36866_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99eef181a9e24ffc834f4feda4476a7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1c698af52bd241a89b377b3e2aa21704_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba0b876a446f49b586a44a97e9d18648_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iace2c7895f8f48599dab84606e9dce17_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic5e4d74fde564a0c9ea5bbbc53197031_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7921f1ac6904419daeff3fe087f5224d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i88dee4ccc2704017b2c902c331437292_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d6d099311ed413981c361852e147d39_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i47fd53236cf54f4f82c3f29a86f18f6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d03c5a45fb74275ad0ddab937a7a0c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i03f818d2869744ecb3692c1dfa0777b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87c7d8e2747146e2801b216c717facb7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib05e9a15a2a54bceb63e80175a9eb481_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2acba41953a4a5780da364938d0473f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82128cfb81e44472a2b78b3caf2eeef5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie7e05b379fae4bec9455bd5a1185a73b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f9e8576bdae4d2f82d0d3347ee01107_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i050b28520fab4a6f9bc88d51dfbef06a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ab71783130b4442bcae86e594469499_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i15ed755082ec489cb3e55190fe799c9e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2cb3114c2cfc4748bb24e171ddf88d3f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3fce9cf02c444aeaedf9dbb530518b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib880c2e4796e464d9fd6ca3f922f0c21_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6dc8281e891142dc8ce362dd453c8adb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6854f04e5b34f0a90f6a8809433364b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ide85e2c1b3c54f9b982f9dbd2e31dc36_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInRussianRoubleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c053f5646db456cb456a7f6cab34418_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i256e776c3ef949d8a602d77944076c95_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i669dc41a3e9d430285a05154e6987cfe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9f760561a25c455ca863173bc85ba050_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f736a955d6d426fa14bccb7f20423fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27e3afc8cd9a466b85b73154f1fcc426_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8b931a3e7974af8baab435cd83f842c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6ee14014d724beba49280ee27bd0579_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i079d026d077e4c1ca6b37005c231329a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6bf8f4e0a00a442d95a5b6f57d0965db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8dbfe93bcc924f1db627a13c4e7d0036_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5129bf60276249ea8a7084e5aa6f5c82_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i98b58c7d8626470da2fc804347bb6886_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2960e5bbc9504987a45ca0885c28f42e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9bbbfeca962641258e5e78ffca35be1c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2efe7553ba0c46a08b7712adb8057d20_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ea8eeea954c47c9a00eb5c671577819_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id972eac7d0f34a4a884e97419ab42e7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if037f28f69f94e49ae8653fe85139f4f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib1df7d3e3f334428885ea11342334450_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a8231394bbe4689b1cbffe0f2e8bd63_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ca8b2205d5e44f28738ffac6b5a6556_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i004c9565807d44089939621542e2100f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica05527dd8e340a49bb52e01b20aa348_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie6009351116f4a2c9676eee17f694438_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i861fbccf765e48598186ff8685f2297a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic28b8006d92e44a99432611f84570817_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8eaa77b9d15142e09240ccba86255414_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64c5dbb2401d4d34a576efb6df99ddf8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ecb8839526441e789fcc73987406208_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i94437cc84d09476a840a8eb6ec207dae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic79ef551074942af9ecbdc5716db6ce2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb40125de23e47f4b691beb3f8caaf8a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic710cde7f07241878fb45bc80807b33e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie43506936ad84ce5a6554679ac752b3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i09d9373e22c04796932fe109e2e7e74a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5ccc85c23444dce9bae65bbd26a864a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e84a1e2fa8d414cab3bdca6d9e37a42_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85aaa6f19d1c4e41892f9efb28e339cb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i55b98a7738694729859cf1f701a3036c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9cfed40ed16b475a994112d539fb98df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e141872c7da4fd0a0923c8056541885_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id35af5750eb94d1194ede73371ab7443_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i227270b1fc19499f93797d6f9434612c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie029e1cca2a447a4a3a3fab3f837ab58_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4f729e37a504044b70b5df154cba02c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7e5347dec1084a829aea7d78ec58effa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i44dc35f3195448b4a394aa1a99ee422d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ied6aa1c882654c8f9b00c1a4695ec3e0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic171ffaf34c443418e622acadcc523a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifbad1a772c8243ff9be90c4d20a4e525_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie0ec4b8e46114ca2b35eaca06a75d8c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if6f16cedceff4ae3b093541f0395f25f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInUSDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if49ca5a45afd4b6290deff09c0f6bc9b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencySwapsInUSDToEURMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i06dc5a5dfd664b289378fb47e3556afb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CurrencySwapsInUSDToEURMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i661e3141aef34374bc5a4c2b0282a005_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i11d47edbce414914a613eb9ba3ddd387_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasedInSingaporeDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i15aff7b3369844169fb17236f6500876_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i18a2fd58cbc9469c87f4b9177e7354bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i895f035f5ef54ff6a621aa415748dd18_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i069619337dbc4ccc847e26e6b2556b7c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i893adc22890b4055af537741a376b6f4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i04a837a3f9b545248b617c5023b8eca8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if03b358d41cb407d8e96408c4edd4151_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iee9d3e0b60fa489ba2e1a59ccd300754_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb30bf0b28ef4c6eb5494ffbe2ef90b3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id5ac4648736544d5be682b0545f039b8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7b24d6ead4f44d549106fd85b92a18ba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i67dfb600319c4c0e8957725369f434bf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie9cb8f93e1b846d58430281df87402c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0486b9ddaf8740c29301347caa547205_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i436fb0a145f24198b631657a4b307c84_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0cea86ea6bc459e9837c24b4130bdd6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i44734cb0c2064272a0ad777ee49ce42c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0622cdaa9da64461a96fb0292ec0eea0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34c19e263a4b4b1081b0aff21bbca864_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i426ef0ef517c427a8af20107114ef8ca_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i191f61c5f38f4bf69380a073349229ea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8474639b23494b81bb367f15d980ea45_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id5d1a7773b0f41d5865caf10d0769e53_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8899ba6d4f7742d8bef35ffd6e411f61_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i487c7bae36874cfa83dd6d27aeaaf611_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7c78a322e0c7481982834bec3a307bfd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9bef3049f3174f4daeeb2b280ca9d62a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i968d0b61e3c442b8a646491f66efac4e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9adf3d9fad074a0c935d684bd36535ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i271929f8b0414f61a36fcd512a84ce24_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b3b4a9f07684b9fad388a8d3257b3a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7006a90210804b1eba413146a647967f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8aa5a36243114d7492f0b3b84690ce01_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i784bdfbab14c473da1d2cac7e203f118_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia97eb1a29ddb48e3ac11be4d8af016e5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i480a5ccfaf0a4d619969b512824c1c9e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3446baf8e2ff432d9469238fb5dc3fb8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e35d2d09ed94351a8a81acaa3338261_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idc8c65ed2128473a8828f847b40cab4e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i60f42132b5024da096b34e23a312678e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i89aae2d2b1504df39f88a1146257c96d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ebe9e98e9c944fa9ac489f3e3801729_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive069Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6c18a7ae7ef14a598a9312096c25ded0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9fef17ad4b784d198f1d2c810f5555ca_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6852770d10664fa7aa7420995a79c7df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3b22da99f8e242f988414e346bbea953_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24369237e6074efaa812824f17d04b81_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8911505211274ebb8c960de64bb8c7f8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i415ddbc400be4e558c1b1cb09d9eae83_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib13971669f0845ea9bb525a15a7c1309_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i406525a21a61478ea46cc93649d471dc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if93b383d587447b1baa059cdf91afb22_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3bcbc6f1c89a4aee8b4962d00160fb87_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4bb05a8539e2427eadb812e81fdc182b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c645944814e426cb0a58e0b62656c9a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id99d44b83ffb41fbb20bd144d592090a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6978d30ff20b420296da0d92dac7a1e2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5762f0e8002b4b5abe902947c5d662e6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic26bcbc2c757485d8d5a38c334f0d541_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i689b9e821d364e81a6228480dd2479ff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i252e89fda19345c083603752e6118f19_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib17a33966126400e9c099f5178ff7db3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6c2f529934674b7699d9daf02407ed9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3bda9484385f4811a6cb4397402bad3c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1aea5e7d1f14480c9b4c2b380e13a8ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e1181b5e1f94eb0afab79e5ead12d84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8da9f53c8b5e4025909bce39297919f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9237a2fe49694802969f89c436b00934_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d5f45eab86f43429c18bcd68ccecdec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae24cf8f5b9643f9ba49fa85b263ed29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1cf833a38674b19a98ce0b07e1f2fbb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i892f75e2092f4191a9eb1d67b804e93d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i81056da6811b49d2aeff4320c2d985f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i231c93471cd24cd9a8425c657a55b8d0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a751e5dfe154e47bebcd411a4556b5f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ed3a0382bac4c6dbb4f81fb8b4510c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9bf5b26909214f5c88e018a134323460_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2dd4c1e5ce840daaa3939c67f591aaf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d113eb1ff7649b097238d0d21ee6615_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07fca8f6f83a40b588dc84ee11762d60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia99138c4d7234b91b3fea8b6e94fa8c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i60b7bade7cce4c9b8fd2a07220556816_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65eb896f1a3d432eae2f406e8163f8a6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i842ef60079fb4a788eb441c59eb01957_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d02dedf5e2f40de9a94dc76b5057ee4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9f0e19dd29ee4a76a46262c50b166cf6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i41c13ab9329b48849e3517bc4d5a7a56_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a6c75ffdef646cb8b9bc85acee5c836_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e04aa67c1b64442af65cb51690fb931_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0628e92d1cdb49db881f08e4556161e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9bd23edce11d47f08572dcd6cef1c475_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1160917297df4a258637aeea6cbc8408_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i513d59d537cf409284ea93c1d7ee3074_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia0be4069af744d4ebb72262d1c49c6c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7406e8367d044ac6a93b02c7fd8d0d7f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3406477180b408291805ed68b070663_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibb7e6bf403b141899b31d01fc7aad5cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia21c8f6607e84aeba3d97b89e5ac81a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i344ad243d07147ce8a36b8ded9882056_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02be206b72714d4db901c0a669d074ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3670c40f29fa41288dc623d89f7afdda_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6287e5395dae4c4ab46cabbec24ae24c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9542809101c47f08405adbf19df6a9d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iba70f10f62eb4b97a7aa7d41726b6a9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ff7d79feeaa43ff8fea8ebcd34aaf25_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29f59bc216884949bafcb1d15976757a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic2c068ebbb0a4c8c9fe94deb9daad677_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibef5d40bf8ab462bbc8e1f854f2fc952_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaadc8f4f98bd4e31ba053344ae90a5a2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida69b1ffd6a1453b8602532bc630b384_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia316589e705d4589bf786b0a1fa58345_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83bd333ecc5a45689ebc96365daf83a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i14841d0962de4dcd830a6e6ec232552e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0959357ae6d442db6998d16a60afb3b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if90289f503234a0eb212cd627281795b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0b2b67ce2434e4c9bb4553d177ba27d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i696be015b6144d53970810bcddd34f8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf406a436f8543afa2b07724b0e77498_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c3d82ed507848a7bee6b5dcfc4b9add_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9fa0165dae10416f9360d8ef68751988_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3005470a09144e07b9520bf27a0e096c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie3448b7dc78d4dcba65212215c69d18e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iccff00d7889c450492a7d84bcb6cd980_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i089150e0dfc24a74b7f19849daad27ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7500ac1bc0c9434c9d072c80aa083d52_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63d81c82ce534a6cbe657f9d4db19639_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i75edfd05889740488fd52f90caf59de4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0da07b9b35de4e45b2743100b13eaa31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2cf262c93d024154b2d0d308743e547d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib80b97abcc214e64a591648c1c81e225_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30c163ec956f41df837a5eca1f6f6b37_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i799cd607a2c24cbf8ce1dd45a6e411e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib09d73f6dafe467f9a1acd771011bef5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23f76b64e1e34fc6961e70aa8b9920f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia03794f3843a4cf3aca9226c900a741a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie16c564bf48f4da9a2d1edd6359a8bd6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i704b08a911a149928d59f0fe5f3da5dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i84049923ad77487f9fa811c3372a7764_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c40cd1979af4ea2be50a3ad38051006_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id1646cc36612494a895c40df0cbfdcd5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i47848bc2a7334009b78e12456fc26c7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibaa88d67818d446c976af2e5fbbe22d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic631820a8c0641ac9e9f460890aaec85_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i53cfa96ea5124d07b04df526798c7f66_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i513c01d3044b4f8abd4b146fe577810d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5fa3a9c279d04c76a24fbd4bca5acf08_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b48e75f4c634efc8eb26e95ef3cc591_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i063b1dc5829c4e8cb5617293416976a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5add9211f40f403aaf54c1ee281839d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieec97775a7de49ffb1a9c4cf02b086de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10ed642e6d39458d841e67fd6d9e99cf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iebbcbd554d974218a72b9914fce1e919_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9a04df3d2ef496d98b3c993e83e59f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idcac06c155c046cb8bab14fc84e911ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if2c043c8ca5b4070a8a9a79320cf0244_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7974fd34e2524ff8b37923a5ebcf26a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEoniaReceive006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9039d5a648d44eb6a6285e7a8f3ed6f5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5623b04048b44838b80378f94f84c892_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia6c8f8b2dc504670a6689c9e6cb5a9c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib968055f931a4052831d81f2d009e0dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b23561502b7467e8dedcaa04bf23cac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idbd6d8c2ec6646ddab12eb846faa1e2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11fe8f6851654698a4c3c1314f4cdb7e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i74afaf7dd9d34e35b425f2ad9ab6c04c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30a27053b6e14def8c033d7349e920eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie69dcce667cd4fea93c09d624bf405e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icc9a867ba32c4f5188edd4f852728ef7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if11a192ecef44797abf4e8a5c1ee30a1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i952a1cded8a74815937ca15f2edabb80_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i88a1b5f415cf464e89d9ca13ca302777_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPay057ReceiveCapitalizedEoniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1467f4d4b42140c2abf929b4d833c3fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e4f05d47add459ab8040ffae65ac2ba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie62d1f5008e247f0a3ea8b6ca9f80dbb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i708d051a58c54e20b95d3176a3c77084_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b68e46221cb423b913a0db767409942_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b9836c97a3149258a9dcf5b0cd2ffc0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i799d40fa5c78466998a48db7ad50c332_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i68a6cd0be59b4416bebc0edff829e3cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6efc8e80c8341db96a4ea42fb92ea80_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e72356c5a114d11bd9759a87e0029e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd430971a28b4ea0b9e3b9a41d1c2ec7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d96c431df54470d96145e5b8c4a4e5d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f30a6b3626548d68f342ca8d454fe33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i874556ffc208487cae49386049753a72_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id2bb50c6933e41bfb10adb4d6e458270_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8387da968c3a4fec95af79eb735152fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8ed54d04df74d759a8be7cbf83b103a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i273afa0ec4ce4433806daee6d20d5529_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f6050765a2747e59fe7bf091298355d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie7964ee5305d44c3802adf3c53126d12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1076d751ef0a41919289d3a7fd81eb08_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i631031048a414305b2d327250a95741d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i237b42e7bb904d21a79f9880001b2ae2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iba962d9e6d694d2b8779612e3b767372_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i155d49744d8747b49c962b6edeeeb4e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ied2d4b521a314246803eecd8ae01786c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id3db7e4575054274b9fb7995816583e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icad7c8faf49747ac89ffe01efbd20b55_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib697f784925f45fb87aef20924b4c88b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i21c5524f40ae4628ac06cf82feac300d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if160fc4f51bb485d81d5f05461afea9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32163ab576b64e3a95bbb62ebcbdb9cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia952b3d7417849c8ab7c1fd9d194c90e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d8db00ca8a8449db76cc5c3d45ca76d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DerivativeInstrumentAxis">sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">sny:DerivativeFinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifee9283d0d0f4705bf8cdb52374c5add_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:SuppliersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida98673a0c314cbbb23bda8debf1c3a2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1aecb43ad25f41bf8dc1c5d72a0787bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AblynxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34de2d5f0d404fe8b61b41f862084aa5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:AblynxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1db7d23934de4ddd846d982ab6ddd48e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KymabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51d7f3d541c8470e916d2b51d66890f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:KymabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a347be5f1b14fadbc39a77db3c13573_I20220107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ExscientiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-07</instant>
        </period>
    </context>
    <context id="i2ee3b5635d9a4570b0eaa9262220df54_D20220111-20220111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ABLBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="ia237d1ef26b2453a9066a2c6db45411a_I20220111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ABLBioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-11</instant>
        </period>
    </context>
    <context id="i5bf703c7b65f49509efae3ab1093a037_D20220302-20220302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:AdageneIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-02</startDate>
            <endDate>2022-03-02</endDate>
        </period>
    </context>
    <context id="i8577ba8bcc2641bd8f3f948974bf77da_I20220302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:AdageneIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="i4e5b18318ed54f3eb42bb7d6fc7b7b2f_D20220315-20220315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:BlackstoneLifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-15</startDate>
            <endDate>2022-03-15</endDate>
        </period>
    </context>
    <context id="iee6d0db9a6b14019a9f01106b4265553_I20220329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:IGMBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-29</instant>
        </period>
    </context>
    <context id="i44fe2a71b5884068beea16755e096330_D20220705-20220705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:SkyhawkTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-05</startDate>
            <endDate>2022-07-05</endDate>
        </period>
    </context>
    <context id="iabdcdf0ea9e54926bd844b49811591f2_I20220705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:SkyhawkTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-05</instant>
        </period>
    </context>
    <context id="i4412024b1ca64ec595944d1b8a39c157_D20220817-20220817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:AtomwiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-17</startDate>
            <endDate>2022-08-17</endDate>
        </period>
    </context>
    <context id="iefe35c5798714318b57d812dd4c261dc_I20220817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:AtomwiseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-17</instant>
        </period>
    </context>
    <context id="i4ce31d589886460a8d3fa4ad454d29e9_D20220927-20220927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ScribeTherapeuticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-27</startDate>
            <endDate>2022-09-27</endDate>
        </period>
    </context>
    <context id="i2e57da6edcd64cc0855f5deeb43a3a3e_I20220927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:ScribeTherapeuticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-27</instant>
        </period>
    </context>
    <context id="i3acc15b07f7340ec878d66dfd3f468d7_D20221004-20221004">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:MiReculeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-04</startDate>
            <endDate>2022-10-04</endDate>
        </period>
    </context>
    <context id="i28364fce90bf409d98323009a8de319e_I20221004">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:MiReculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-04</instant>
        </period>
    </context>
    <context id="i69e8fa7b0e3e42d4a5776c81a67f605c_D20221108-20221108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:InsilicoMedicineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-08</startDate>
            <endDate>2022-11-08</endDate>
        </period>
    </context>
    <context id="i627c20e57c964355b8bcb250eb638da3_I20221108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:InsilicoMedicineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-08</instant>
        </period>
    </context>
    <context id="i466e422ce31947d2b1f05591f8974461_D20221219-20221219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:InnatePharmaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-19</startDate>
            <endDate>2022-12-19</endDate>
        </period>
    </context>
    <context id="i1b248f6ef872486e91c5718d675cc163_I20221219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:InnatePharmaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-19</instant>
        </period>
    </context>
    <context id="if937d6453c6841d8b3e41feedb2e553c_D20160101-20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:DiceMoleculesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="ia86bd221eba9446a8f9f749cb46b9a8a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibf593c1decbc4ca188f74599b1b99ff6_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3ecee33decbb47918bc45c5d39b6e2d8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if08a539d4d40455d827bc164ddb96d57_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib16cb21631ad4c40a1073da4e54006b2_I20170227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:LonzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-27</instant>
        </period>
    </context>
    <context id="ie9a55e06161b4bc6ab47f39f7831c794_D20170227-20170227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:LonzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-27</startDate>
            <endDate>2017-02-27</endDate>
        </period>
    </context>
    <context id="if77c8aea29ef447792cb9de0a457cec9_D20170227-20170227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:JointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-27</startDate>
            <endDate>2017-02-27</endDate>
        </period>
    </context>
    <context id="i7297bd667dcc407e9d3a685feb63aa85_I20140228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:WorldHealthOrganizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-02-28</instant>
        </period>
    </context>
    <context id="ibf03bba2a0f04d1188d25f148f36a72d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesGivenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i939fa095546f44a393ce805aaaade10d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesGivenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7d70051b63048b482c6e8dc47988e25_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesGivenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if1de0a6f85434a9b9e97775863357700_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id1b027a016e14cfe88b71b1c3fb15eca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8bc3ba5245904e0a90bb4d29a9cc145e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0d813bb627146f2ad3035a585e98181_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:OtherGuaranteesGivenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i044e8ccf5872470daae5e14174d0c4c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:OtherGuaranteesGivenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieeeb99efde1d442fa44fecb8bdbed1f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:OtherGuaranteesGivenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ee6a60b930541f79b2560c7e63bdae3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesReceivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i214032b872604476b3988af269c27156_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesReceivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a28592851c14211acba46221b993eb6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:GuaranteesReceivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2d901acae514e5e8280c783c251f450_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:SanofiPasteurHepatitisBVaccineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide8e1ec806db4932b7eba982cc52419e_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:TaxotereProductLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9812f0f2ab434fd5b26f297a36264169_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:TaxotereProductLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3c1b80392c24483ea3270088e8c3d341_D20181001-20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:TaxotereMississippiAttorneyGeneralLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-31</endDate>
        </period>
    </context>
    <context id="id03ce38671d242c5b423a1d25f8c6f7e_I20221206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="iacdab6e288ea48229984fd6fdc5f672d_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:ZantacLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ife35047b3efb48d49565a8abefe87bdd_D20190101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:ZantacLitigationInCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i69ade77d4014436cb24fe9c6b800b42c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInFranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifd9713c0f3b84a2087189ac6adf31e26_I20220820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-20</instant>
        </period>
    </context>
    <context id="id0a6ca82125c4345addbd9134859f4dc_I20220512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-12</instant>
        </period>
    </context>
    <context id="i9a57a25d53544b7bbc8e58ad797964d3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1a12953bef7249c18a068db579937b2f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaff1b7c5dd354bbca260343d8976c984_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id8fbf1dee4e248d398715fa56ef2544a_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInFranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="iea2e083a765b4ce7902705ed5cd966e7_D20220901-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInFranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5b0489fbbf76442ab038901380310b9f_D20221001-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInFranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i82f5b65dd97e478faf4feebb1a461d65_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInFranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i38c648e7e3d449e7a4ef085d255a725f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInSwitzerlandMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5914be30840a424e9ba15aac06bfd84a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInSpainMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie3099953088a4d92b74521a460c6296a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInBelgiumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3d1a1e91d76a423db829d84274c18752_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInGermanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i31d63c85f8e441c7807a6e955b15559f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInIrelandMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icc705712fa1947ae879577c168f3f666_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInGreatBritainMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifd45fd1ec3c449df97cba0f45eef2ae9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DepakineProductLitigationInNorthernIrelandMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia799047f91fb498c88944dff7dc04fd0_D20180101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:DengvaxiaProductLitigationInThePhilippinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f6eba28b15e4c47a8864e9a6806f73c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:RamiprilCanadaPatentLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iad588bc5db4440fa968e52c2f65ca474_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i0d714fe0593a4f539299e40038a0ff5d_I20141118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-11-18</instant>
        </period>
    </context>
    <context id="i7b37c3673570484dbdc61b7e2c0bf6bd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:JevtanaRelatedPatentLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1591035a52b44bfb8ab033baa46f80a7_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:JevtanaRelatedPatentLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i53507d8a67164c8eb8d2fec1ab5c2dca_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:JevtanaRelatedPatentLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i9e06dd78a2cc45e8b38a451ebfd53f19_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:JevtanaRelatedPatentLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i9a496f537a8d429ba5d2f470f546b3d4_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeArePlaintiffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:JevtanaRelatedPatentLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:CommencementOfMajorLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i91c653975b734c3bbbb90a324b0a9e43_I20130430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixLitigationCommonwealthInAustraliaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-04-30</instant>
        </period>
    </context>
    <context id="idc6e5447243c412aa0be53b3fe522c2b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixLitigationCommonwealthInAustraliaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4fa9734152fe42adafe9a6457b51a172_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixLitigationCommonwealthInAustraliaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i94f85a2e1aab46aab17b13a49d52aa0e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixLitigationCommonwealthInAustraliaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">sny:PatentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic9db8ac12dc644388e59ef5e31d39357_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixAttorneyGeneralActionInHawaiiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="ia9903703ab204fe0a894254df0aaa506_D20130514-20130514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixRelatedLitigationInFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-14</startDate>
            <endDate>2013-05-14</endDate>
        </period>
    </context>
    <context id="if5016791206545f1a8de98c53126c448_D20170901-20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixRelatedLitigationInFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2017-09-30</endDate>
        </period>
    </context>
    <context id="if95f17244f744589bad8e963d5814997_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:A340BDrugPricingProgramInTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i3575a00a4d2941dbb8f4491a3d7966d1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:AventisCropScienceRetainedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ContingenciesArisingFromCertainBusinessDivestituresMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i14c2910d62e54d579f8a84cb7af92bab_I19971231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:InfraservHoechstRetainedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ContingenciesArisingFromCertainBusinessDivestituresMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>1997-12-31</instant>
        </period>
    </context>
    <context id="i1b692bdf75f2434fb133bc7a3bb3fdb5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2bca265b5de846a49ff7d66d365cd3f5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4c7d49c8079f45a984607afd055f6141_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9a5e4694eeae43cb9ed974f712d64133_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i616d5f0474774329bb2e1a83718aa3db_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0581727a37ae4f2d83f10871f2fa2679_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3ed9f546c418470cba11c23974e26f46_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9769bd55d48b434eb6a92677ad1f68f5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd15f26a3ce6450ca2aca80db285ee51_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0b61014391a14c5fb1683b9dc341e3d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic01ffee4e6cd43d784f593303e505e23_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0b84d1d2c5a14568bc00a2d9f3f9825d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i85baff112a0f450580f65baeb088ac0e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic3e70d031c364b549f2725ec8740c482_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i344fce21336047d085f98ba60b6a24d1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ccd90377a634c1ba0858901f0b24074_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3b2786a0eee40519674a931fd7e4b4f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63ca5f593dcd4e829883dd52c4e652e1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i64d9d93ffb0648ffbad6d150cda752c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibded5a5821924d39b6d1c07b0695c6d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i99b5e4f93c1a49cd8ea204607473a1ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia3210673a6874b43b966528be2cf0794_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i233e41249a394b40b74263dc10afafe5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b9aaaedaaea4f29a759d257cad38085_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib46e8377d3f94800bd25709bd341fc00_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib22a0224790241248f93cd93a45b1232_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8f228d50520f41bc92115db7843c0ad7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4116d4bfc3b743c3a4f8f2de755afa63_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie16e60a90d774109bacdee057e8bca89_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f6bf0d8ac1b4edb9f472e86394d3706_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i72900069921b42fea99c263ebf35ef00_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4cca6f8175204ac1bc6a07e79e2ef411_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareAndGPOProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4cdb48ddcab543e797bec062453e8560_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ChargebackIncentivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic7d6e7f31f0449ad8c055ca0af7ee098_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:RebatesAndDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iff9f3b36e4cf420295883612ede99cca_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:SalesReturnMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7f9eac0c1cdb4f5c83bcb43211427c90_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:OtherDeductionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i290ce668686b44a794845d7477734f86_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6c1eb476973a44889e6ab4746c231250_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i85bcc857ce00463eac390d699613b102_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib426e8d70a6d4415bc4d1dad51db673f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i90191c61996943178db939f24e430160_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5007c17b33544991b3dbdb064cc3f736_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:GovernmentAndStateProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8af58300a9146fc82e82e9c13c202cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i852b799422a14eaba1c477f4f3c8a31d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iebbc786d5e4e406c8d9fb17fb74e7b2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i91602956c5a04e7d8e221b1a2b3c3fd3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie12b73fd2da74dce969b70268e0ff95e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaa3510029eb8449b898dcffcb36596d8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff607e4176ca4b068613990b2582eabf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5f958208733644e1aae6fda659400f4e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaa10c8ec5cac4f29a0a9183bbd94bd99_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6e57a41f946d4ff4a313d21852bdba8b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i970b0685e8954a3aa5ddf4a490518870_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:DaiichiSankyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie13a4afd7b1b4e79b6db10af437058d8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i018625c9ec8b468a9ff0873e7d03260a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i52bffdb81007440da92ed6b97e6d9231_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5c405e8e7d324c77bfd2af173dcbb932_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i62fee9f3c5744551bbe06227b0c173fa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6fd5132ee30d4c7493ae9545f5714b73_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6d08b9ad0c254c1e8eeeba6476b35c2e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if958d5b745e54738bf294167a5124ac7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i171827e88bc74a668b2a39c3176ab65f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8348d8dee22140afbaa6845ac4456f2b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6bcd495e13694c26aed02fa8a7200ca9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7a34f2d952b641fa9a97150c939ad0be_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i55a8693d305047af919fadebbfac7084_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic2326a92e2034921aa2a51bf11bc0d93_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7ce30596c49c4242b0c04b915f6f7e57_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:ImmunooncologyAllianceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i717efcfa32c548de8e23d8e05d058bc2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:ImmunooncologyAllianceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia56a9ae0556147629310bbf5d7bcda1a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:ImmunooncologyAllianceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i622bf4fa192846ca9f1f1cdce02e4c83_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:OthersCounterpartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib7937d433de14ca7932134a404b27d2f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:OthersCounterpartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib79d267fb5b34f5cbd786c75b48c5759_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:OthersCounterpartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i088be89f9d1b4730a785c0f6445acec8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib4a2186378404e3987bb8fd7e88f511f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:IncomeStatementLocationAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i552611be812d4cebb9f4bf048999a643_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">sny:InterestRateAndCurrencyDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7ace254a2ef1455c83c5985dd96fa2cb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">sny:InterestRateAndCurrencyDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie87ee93c6896489f80ceecb2f2e91ea3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">sny:InterestRateAndCurrencyDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id4e374af20434124bd68044ee5c3132d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibed5e5583149430ea92a3d05d5060125_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45a01c0bbd2d41d7b151eaf603f54f9d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1dd1a6b04c6b4be9b142d30598f7a4f6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:LargestCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5945bf292aba43d3b3933ee4fa267f48_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i54f0c3f56ec94246b15c17488b0f280b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i043c68f74cf54dd3b12ca0cbc0859d62_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icf706ed1467c4a3396b7c74584527eea_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3f723776de7640daa8cd4b9421bfd338_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1cada9bee6d546aa93544736eadd46de_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i18e5dd1b4b0649eeb4cae77cc5f1744f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i56aabda8aa634a87b93f96b0ae541185_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if3906e38c7744d118e2d80ee3ff3beb4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib75c6578c3a84cb08fa98e7e6b8a4a4e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia960f25762194eed8ba9198f645620cf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i388b2e8292964dd488b8e5822ff441b9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i703eee8c3cf4450398c63faaf2b2713f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icb6ec4264f7b41eeb79ce7df60d9b024_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3cc915a3e8304b36b9aaea6a3b1e923a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1a0eef0b887c463b978e082705e53ff2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf8fcf146c8248ec9b16d57552fb0679_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if1b32034d89d4c5492894716caf75760_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie001d812cbaa42849ff65fc0f25fc9df_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaf451e85e36d430f80d3e0dea3554d74_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6966a3cdac584a90877a12600daac3a9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i97ab9118674344ae90b1ec5cdd6d8dc7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3fddbef245ff4118abb1ece0065f767a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0eb99c9f11e04cc6a1c3cc09537ceea1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ice90a87f313444cda4f67ec7f33659da_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia60703fcf4f34ef79aa5696b24dc5b76_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if7d5b31e23b846449b9dc6aca6c543d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1bf14ecb83e341a28f96acd5106c6361_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i38f46c66004f45f79c7d14d33e786167_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0cb348a72bfd43a8ae3327734c1b4a43_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i497f9ba9e48b486f9aabba34acb6dda3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6d31cf6a543b41fd88ed835cb7b080e1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4dd47a8ee94b4ecba12d3409c2d6307e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib4c50ff163de4a81822ecca972401b9d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7aee59f02c404957a63d2c6a84ac1bc7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7da96c92143e4cfe87cbc8ec12bb9393_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i63350fb6564e4bfab92644debffad89e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if7d1991136ac485ca3f17d7bf6664386_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic536b741856d496fbbc9ceb07260b2bd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifd98da43cc404ca08771230fbf198841_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i275946a1cae9496ca4567cbb23511dc8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NeurologyImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i925d323dd481457dbb437525932095e7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic1297a94f7ed45e493c05001e0b81533_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3e35850252ee49c29e37a747602844b1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia65102e90b134f118e220863c8b48f53_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if7e375fc233a4357934b4c0cff27f093_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i356311f03967464ebffc32cc1749c915_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3ce1b6e300ae49b8975bcd687f09500b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie8632a72e1dc41958e1a40418be2dcdf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i86bfa094225f4f33bf2caa26f75ea5df_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i05e5dbe4e5c6497f9fd313a217ef2eba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i51d60da5814d4da3b4582525b5ea5de6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i39dae50c59ff444589960d8b83241824_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id26f8eb73c594a90a9c4cd301b065133_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9fc91d54abbf41ea870eb45075d2c54f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3331011dc076449c99047a7dc1945e0e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib6399fd1af9d411d8a47300f12f1d9b3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1ba80ab3e00743088ed870250562c4c3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5351a9412414364a48f29bc495d1b51_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5755c87fa7584572873b015a8e208548_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5a6dbcefd8a4ab68267b53708933123_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i833eb11d63f9442f9f7f72021922e8f5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iadb9c19bb94841d2a79288d7aadecaa2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i42ab938545594eb992053504011e4252_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5726d6cac7a14f3ca1568529807b8c90_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib2664f2da4914ced8cdc3fc6e2aaabcc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if6654ba9bc13481fb4f6e2d9755a7d57_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i27e8629a7974464c91e36e4aecb175e6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8c4ada02638b4ae29081e603d6b495da_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4f851b224ec6401c881a9da5f983599a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i009300f656604097800d9b7ea2a83bb6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9c3c8fc92f834ca0afc1d103c341e47c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i36ab119d8f59472ca95eacef7ad659cc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id739f18cd5204257b8c191b419d8e59b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7e37e052f4f34e379c2230b24e177d6e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i02995abbcb574be98f1b4b8903dd790d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i66ebcdcc275242988ca39be9aeed1808_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CerezymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i59f7875640d940d4be71548d2d02155c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i679a528164774d5291f5852f0e21e383_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i008880cfdcf84137bd2c2e9958802471_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic75317c2c30b470f935f8f50ca516dcc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9e2f07f1f1914db2861375b158d6e829_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if482478107224ecfa98b4d25e9684b0c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5e50d845481a46298dce1596b91bb672_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i19d85e03aecd4441bc80d278e7bbeff9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9bb0c08a9b19417e99fceb3e2de828cf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice3ea0298e5348ebb9595f08b6d49ff5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7c1dd865175f445a94c92d1bf48727a9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d009dcb0eb04ef3a021faa9a7402b4f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:FabrazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i12bd9173dbaf4c49aa86481e27892395_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ied76f2bed5094e9699ba62ae5eddf190_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i530dfd00d80842dbafce7ae5cb9655ad_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia1e5d0b8029b4a8a8b1f4ac574af7ad1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icb8ac8a0ccce4b5a934f205497b715e0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i24e00e485b8e45618986356e620c908c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i885a178675c5451191389ab0cef8985d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i434b726907294409b29412431a7c19bb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i83a9ef0ccd5b487fbb118b7e76ceb612_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7205b4923fa543c7813a6878b9485c35_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i86f4b2048c414e2e9c5eb44cc0eaedcf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ee1d4e1116f4243b99c352e87d1d74c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MyozymeOrLumizymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b9df25140174f39b8d25fa4bbda653b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9c86f2f0b2854fcba45877b8058bd8e8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4c53ce511bba449da99749a8e4ce6d4d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id9f8b9f4a590449496b876034d80b8e8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ice20f96fb0cf4de0b3ca3965e622ae3a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0b81cb6976ea4348881ae7d19e9b64be_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5cc0ccf1590e4affab7ef2e75874f65e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i17ab8be945b245c6ab4bcad11716698c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9ab393d2fde64052a23ce4a484c207d8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icee2e75239b54a6691515f6280082f01_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7818bd4346ec4748b6753e13dc4eb6e9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07c0978e52b444298d8618c3d2159678_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia9a280e56f3a41af88aba2bd4cb1d48c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4288c1aa9dc6416cb56c247f3a5ea4ba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i30c4fc1b2d404bcaa190fa35d3838578_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6ef47532b8bd443d92c96e9744f3c55c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i117b2d1cc5d346c9877ebace612c1ed6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i657d3f930d0d4905af0b5e1b5dbefe0c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b3ebdaa8d354f83993ea4311de0e5ca_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i85143d1ef2a047ef8d1509cff1b4eb35_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie090a33d5f6e4860a9db0e69a9cdb4df_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia8d7968a46b648a4b7ca0e2438afd8aa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i381585a218bc4a21bc9dbccd82b92f3c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i296a8f4baeea42e78a0dd8f1a3fd6a56_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:JevtanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i51bdb13aba434060a597a9097458c3a0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f792c072bf54f60b88192d56f584272_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id67bfe76694f4de1839334ce8b69a261_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i474ddfd1c7664510913a9d53823fe524_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iecd790138e5f4caeb22913e385a783c6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3bbac3b89df045bca004b76f88dbfb78_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if58bda7003d64454ae0b3769c32c45bc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i07798b22999e4551bc98330cd328ac58_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i808feb017bbb47b2a5990030172ae9e9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ide523dbe8589413aabe48647cf02a037_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id1ac7e39036e4bb5b0a39b7b97512708_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58eaa30a28f4407f804608f379faab0d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RareBloodDisordersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if17af11c5d8a41feb31c45c868fe9eae_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib70be66dcfd54b8fa1967dc6ba0bb5eb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaf5a3b324da94b91b08eaac503473be5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7cb49f4f811244b596cd629fe1ff04e0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1b3b532d87ee4f92b20b6eca2f77a81c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4d67cad1157445109898fc8120f7683d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9e64c845eeb246f59dfd656899a27837_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i35c6e946c3624b76905a8cbf979857ba_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a4839221a9b478a8e315985b0c6c6c9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4aac4d6ed7044a869f2ab2a402ed6891_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie188b535c20b4152b071cec5896f8a8e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5193ccd45f664a6e87c2cd7ffebea135_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AlprolixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7242f99862ee418daa94f18ea3004d14_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i42189e03c07c4dc89544b5314ae6fa7f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2343ab2aad5e4a75bc999c5ed10f2dc8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idb2d3cf6268242e1a113cb343e29cbe1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id3bbdee34574428b81d52395573a7a50_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i89bbec019eba4315ac544fc5b16a8ee1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if7b892ef3d1141339a371a9d6ee5b705_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1d9408eb958d47f9970a1477c454e52b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1cefce5d6bf34ac6b51f91739b702fb3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9bc5e144c1a04076b51456626e9cd1fe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i758a45c283f3434ca1c881ffb264058b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idd17ee78068b4d03a01620b3f9a48899_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:EloctateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7534c54d521e42bfa11f4ec26a7237df_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d735f3d6a394c9cb978c28c14f66ec5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6780792481f84d549561c3ae8139f8fe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9c8ed8009e0749b5ab9de034c8837959_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1ffc44bf8e0f41e781b7e2ebbb1e69d2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3a725010cd94a3c834bc25a5093a46c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ied5995be0e4745d280c9b295e1a23e20_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i90de959467104871a3e22682cf4131f8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i22138736e8ca42b38ff8c48941f38409_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69f76298218f4254bc305200c960f426_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i52cf9837e6ed40aa85632eec92ba6f45_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i727e0782da3d46ec8fe5ab5e632fc070_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic44928021d4f4236870f0bf6d6fd1311_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib0e28c706e6d4bf18081e809b52dd3f7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id861d9b153c74477a49abd477eddc226_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i357469340a86491ab237157cde1612d1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i60d25e37a08049dcb2fb97d0a8b25b0a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57dd079515644fe69b73d21d94ac3e9d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7a1a5c473c9b4cce9650d795bfaece4c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0e76cbde32b54813adf63f05934bec59_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib446fc017cbe473c8fee4d2dad31e01b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i370d5592a1da444699977335ae0d6aa4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3025efe993694823a88967c4a6ddda1c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie718eb6f98704abebab8e41cf0bb433d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LovenoxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i30c5ee5de6db4c66bc2a5def80cb3630_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i17834d1f197042f1a682ebdde3f1bfb1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i998de8ae593247f495156ca0fd001bbf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0977ba6fd2084d8ca30b097662a249d1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9b17aab75c004d718993f2b67a67ff5c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i740678f4087c45798717797b54332317_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i49540aeddfb1476badc6b4db7a86037c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i53367ae84f81438ea1f7429170ac4341_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie9d5c0a2194149e9829332b644e91e78_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i16768b64d8324f648ba3dcd8ea1743bc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i95951b5818aa458b8d05be95e32f6f29_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib93e54f78f854e94acd0d345f631c76f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:ToujeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i92984c0d697e42b69afe6d9913419c61_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i997357ba5e0d4103a854138682dbad0c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i97f55be8ce6645d5a550bfa46ae5aefa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib18bf96fce9840e79199255e69961a1a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i16b5d5a19be44034bdb35c036e33c369_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i48989f71da6140a4beb9df8f40518550_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i343f9ebee6b943a7bf2931dd320e3aa0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i167b4765e010409db6a9ef1c2724d107_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i628fcb0013224533ae759b38ed4a9e8b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i37db7c2f8d7b469997221d1aa218fe6f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i925f6b2d5b5d40a58aa0860a22c1fbea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0aa66e4f08254a8eb5827d9da0511d7d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PlavixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib6918b42287543ffae67f45e89689571_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i83b5b2fcccc6496684aa6cb171a11b8e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iae87558939404363b5fccfefd97a00fd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i40fa65e1893444b2b1d53b7ce6e4f2ca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic8eac199a2aa4dea9ca5e52b9f0bba8a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if706c3f3b7c64218b54c47278fdff29b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i902260c2fc46471c9838a41c2d4ee190_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8fa99407fd0d465dad206a1e0d6e807e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iad567579f11c4396ad1e56f97b7462ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb3ceb86dd6c4368b68c2adc32c3298f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if613bbe5c0594318b016b497ee91c597_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3b001a8470a941d89da632e7bc9daf72_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i22153967fac6428b833321479fdb1306_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5594aa252dab4309b3116b07f116ccac_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iea483c0a6b6e49a5b4641fed43699ded_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i312af4a1d5294779ba7c9a2e218b6b4b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i578a1693685b4648b843c7591f102024_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic943869cbe084442b9752f3125562eba_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i59b03d0aa3374a76a09ad675f12ec5fd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45eb32fbd1db4afe99ef24b30301d967_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8f63b529f1744fbc83d583f5b12c35e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i866a97436e854d82a86d47a3f7c2e9cd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idf055ce7cd0d4b41b0974d84a4828176_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c2f60a295184259a5e98824572dc354_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:LantusMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7161276da0fb46c8a7f757ed66cd6b74_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i75a5f2ec92a94a89b3aae509e3a5cae0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i73a08d51def1454d9443a2bc8b6580e2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iadb91c4ffea14a4c86b46fa219e8e8e9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic496482793684b30af908ea4b53e6237_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i34ae4ee5253743af84111345f0f31775_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i466ea9984a9746c1b1788273a8e951fe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i77618a8613ca4289b3b3a2b779826d72_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id9552a01052c443f87d515d5c3a5020e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i912066ccddd243118e3de68640de9dcf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7c5c4713cc814bd7ab49ed66efb4c628_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0a90a9627ee244f28f6e326030e8fb04_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:OtherNonCoreAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i202bd69ea7354e44a25c96c53391e267_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i46f1f42e50b94bfb85ebce0b53ffcb95_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5269963529c04271bdd98254675e07ba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i95373a070bcb4ebc8e62a097d81bc07b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2f756c850c4f43a6aa9a408f9b93eb20_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i60f2bf9e9e914ea3872005fd530433e3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if6decca1f9a94e3caad98da2fcdc75d0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i085e1c70e50641f2962c6964513071a1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5ce62b370fd24f39a199e1d375dfb6d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i093e51cb9252485a94109d38a8fa4702_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i53c5d7935c7b4937a7191d5857435346_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i66e48178e270445b9442f66c6b94104d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id543945583c840488898c47cb6f44f8a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i52bb756b60e14df9a45298f4b3784a0e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i24cc0a91048b4fdebadcb26d0ef92277_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i86187c82c19c4cb9a375fa90f77d5b4a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4d424d7a10774447a1a4b8b5e0ae7689_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib056f7eee5db49e6ad47e9f71e8c6ed8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7ae926d85669499cb9afa33c7d9241d8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4e6ac042ac204ffa91527696c60c97e4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8467dbc5770446939551b7a699d503f2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifd94df2c80d743d8a13502c39a73b7ed_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i566185ab6e264c6a8db7216893997e35_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i28a1069b3bb642b693c980f6b28c3e84_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4df972df975b43f0ba3ed94f3ac9b0f0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if9c5ed55783540d9aa5ba29544a1b58e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i88db9dd7ec104b49aa9f5cad7c6b5d8f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7e5b7dc49ebf4382a4ae26de2ebc180f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5531b6cfd28445d29737a2bfa6bc7241_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1f061cdc8a4049e298e7ce678ecba5fe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9421508acd14db08ec0028a7eef9bb4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib7092d8f4e2046b9860885a474a6d5db_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i90cb244705d34e58b4ef04e3600b013d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i456fa2153dc446f5bce91beff992d477_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0bfa10bd76b546309489629a22ee1f6d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2bed6a217a124ce2832a0c652eb14a8f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iacff9073d13f4103810361e59ee490ad_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib25f8d53a5414fe19f6ae1ed1c367b75_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic25e96d4bc874fc5a518e3a62b557388_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66b75c69b5de4e3d8a0d43182fa87920_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i336524d5d81f4a39bf61ca920af300b4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3ee49f3c004543aaa32444ea5f031578_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie898ae59a55b46f0bd8bd709eb4f822a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifdd8d6dad55c4232b49ae3d7899b823e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if882abae01c8491aa97cc0f3708f8398_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie7b09c85efa64008a5815fa2c2c3a477_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id8f643c30d914f8ab4e03c092efb3091_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5e5094b910954c5f8c2098e2be4c991a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i500abf386db74b7f9515899bb2358a6d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia8336020a29448de861074ef317b627f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3d97b9f2b2384d5fb8b3e7b0afa2a5a1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i160a858a7079498f8c004e8d186d1063_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9d653af939404c578466f638984d2422_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0407751659c54020a63e3b5e93476585_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i66d6c454ffb244d98228a677f46b2fac_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6bda1c567b1c49029b875aa4febc16bc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9c22a1098e3e46b3b86d47b9cf5ba970_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i156e9e8a21b449018c4bd18d3570d698_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id5cdd431c5ae43a593b7cfa1f7bdbfd9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9a2f8c0d377e4c1283f5b111722e1ba9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9082ca4896f544149c5fa993fc76e11a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i255d9fe68622490197bffdba2a258f3f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6a047d0a5c8a445f9834ff3fbe6bb785_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib9b0bb905111472f9a11100558b1571c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c459d45e7794c9597c5651cd4ef947b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i84d4767234f44fd1b5d3a8968daa3946_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia50a50591809469c9fb3b18d4811f6c6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AllergyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i214d7e38fa714fa9b73acc2b9f341911_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia473b953f05b4b35b5b13789c70d761c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic6e4519162104b64a22cc688d15044cd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iacefe436e3af422292acb5714b1bb8b4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i259f4b387d9c42eb93ef585b678f7f77_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id551965a5ec24ec7b5833702fead3db8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i116a1c4972304262b4654d3e3720dd45_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i78407570f0dd4b788e9539bca72b8480_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9539a37f5b634f80a45b018298a7e6bf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1a60f0418a2945d6816d55ba2ee00395_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3637ba1108d64738a99a8947658367e5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4cb20a306adc460d867ea28b00dea2fc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PainCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i756f63fcc9aa4b528eaafce6b9d10810_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1680427a219746dd8d52e2b51d87bbeb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia572af328eb04f15a08f4b4be0b3c642_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i122e1cf42c504ef281c0148bcb08bfa4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i90e43d267391440f976deaffa7f1ee2c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia15f03b10746440791e34cb56493eec6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i22e0e6e055ed470d9bf214946d58ab2d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia8ac8b1054ed482a8e8960303293a8d7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i329b514f506f477d9329c03ae9d60a33_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i60bd3898aea54bd1923c045dc3905730_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i01fe34367f704a4d9280d0e481946add_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i48f608014a524624a2b5d9789797f352_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DigestiveWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6e829ee2f99a465ab88b9472b399fb82_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1d62960d62de4d168f734a97be14a478_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibf60334e241640fe96a7903ed2e9b3ad_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2f77a621c718482c8212f4c353b4d1b7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id0034d62b9984b9c819c9089b17c9dff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6a8f83aca4714f6ab0e8c9bb8b1a50a2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesInSegmentResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i013162020a33403bb8ab3a5b4d6acf5b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i86bdcc50c470440b9f04a89cc25fc25e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i10a2eadc160a461e8aa95a317634efc4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i49530103426b457c9644701cc0be276d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:ImmunoOncologyCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:RegeneronPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i029d1d8f14bf48ff95eda3b544a4736b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e9e1a94b89044af91d3720935c6c41b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib6b0b143fa7e4ffd8648c6d67f7caaa0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a2427f9f19e4111a878f552385abb20_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if3776772d55d454e9e161ef283add8c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id755af668f8b430fbfe6cc864db69bba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8feda8bd457f4a26b64959caa430dd5e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d0c0e35669c4d7aae59762151215c68_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:VaccinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ccf1608d43245e99567d6f375c33201_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:ConsumerHealthcareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i556d066cc252454daf37eb98b7987866_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i26e900f47f5a43c1af34c00b6fbd86f1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifa27b1484913467086d8717268468676_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3f6aa7c2c0a940db95a9895599a8e561_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib54fed9458034a4eac2a4487edc9c09e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3abc51abaff14a808a53308dacb0555b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0c05f2b9a58842bf9131e7d74f48ec7e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f4f45d36c37402780501202da882836_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i68c4deea6e6b470da44d7eb61f99c2c4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie7997885ee5a421a93ddf5ffca11ea96_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i54e8e37c74a24991b87c1d67d7375882_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibff824acb702445385e0da9d25b4b793_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i26f8ec3e990b4a519b49cf861ce481c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a967f1a2afd4c4aa4177d1e5ef46e32_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idc6d783c6be84509bbd905f3377753b0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idd3e8e0424b04715b821e32eeb629ba6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id92a273efd0e45db9787db6e8508d895_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:ReportableGeographicalZonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c09e143fbea445f8efdabebb4865bc8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic65c1b0f25e14bc0a163de986a44369b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AuditorsNameAxis">sny:ErnstAndYoungMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AuditorsNameAxis">sny:ErnstAndYoungMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AuditorsNameAxis">sny:PricewaterhousecoopersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AuditorsNameAxis">sny:PricewaterhousecoopersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i498c1591947b45fdadb2bb6778e0ea74_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:HoechstGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia5ae387e2cbe47c3912417d8623bf900_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDeutschlandGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4adfb7da9ccb448d9ad8c9e69d0b3cc1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:A.NattermannCie.GmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idebf15d680cb4a1184f7f35728f60030_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1051a7b1a8d549b19efe21164afc8517_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiBelgiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i63571a41cac6407491245bad0632cf43_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AblynxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ica986457aa234217a2fac7fc80955729_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeFlandersBVBAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9b7192d1177f41e6939a7a9bad74bf5a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i285cbecf53934809bfc57407935033d4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i24ec77a85f5e48ed937a7403fd09b34b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareSpainSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic074678a420e47758b62873cc4d859f6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic74f613c0cb646968c6021eb3f15c61c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibb45d02df4dc419e8ddda8153ae34b79_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie2205f57d9c8449cb0e0f24d60269bc5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiWinthropIndustriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2121a047ee3e4de3bdbdc5ce00e809ba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisRechercheEtDeveloppementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i080fdac6aa0d43588960255f9f17f975_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisGroupeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i16069c2bafd44ad0bea3a6b3957889c1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiChimieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i79acb16ef6f74dfd8a5afee5b7eaaf0b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisParticipationsSASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id75e41a2a8d44456a85dddcb895d6379_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurFranceSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia1564bffc0f94330a56e53eb941e410c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisPharmaSAFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i13936cffe69644268b73faa1e0f1222c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiBiotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if4e1d630778d4bdf98e7975d7d41370e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiMatureIPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i351193f373d14cfba556201ad238e512_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurNVLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i13a2d009465c4ed2b62b3c4ce7bedf35_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4c5bc0d0654d49e484d5bda422c95c96_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SECIPESASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0538adb5d86145d8b2614a4783bcd071_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurMerieuxSASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib51944e0d29846a1b0a6665d934c0d7a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:Sanofi2015DSASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaa2e5413dd9a4c5c8f7d90b8a94df128_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareInternationalSASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2ca8f4e855884896957fe5976fc46f0b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareFranceSASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i325731cb5882403b849f26ad9d4954b9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareGroupSASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4e5219940fdd4088915a6be208a8c941_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiaventisAEBEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibaaa67301b32448ea984ea8286dd1dd8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisPrivateCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4631c1fb362a4507ad8496f0043f8818_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:ChinoinPrivateCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icc230f3aa6da4dc1830276e62e498a05_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareHungaryCommercialKFTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i589ccb194ca14fd289b658aeea655731_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:CarraigInsuranceDACMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0941b5e1401244aeb011299f6b18762c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeIrelandLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4dfafa70e252425495ec4aa84c0b3462_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisHoldingsIrelandLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie5c98b61ee6a49c6bbe6745fbe8903f0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiSRLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4db465cfb48243f681f6c69e00a03120_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareItalySRLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifa21535e233747e191e1efe06e939f24_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeGlobalSarlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id9be7cc0cfdc4c01bd3cdefbc2db8865_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeLuxembourgSarlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic4a729e9da034ba9ba366e137ead0039_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisNorgeASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0fd91674dc3f4546ab4d9ec18c77344c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeEuropeBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iefa5c464887543849754b364afb61226_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiForeignParticipationsB.V.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i806cb8bde2da41fa864ebe59f6439f93_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiaventisSpZooMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic5677045852f43c3b14b4e3424e84806_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcarePolandSpZOOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i07d862e00e454435ba5778981fdd8d86_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurSpZooMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3d8c1c94ceb5454aaa207f9ba7d1e1d4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiProdutosFarmaceuticosLdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0a16e6db8221468eb5b3b7969c6b0832_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisSROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id426e598bb94421cb6e62308d8f1efee_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareCzechSroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3d8b86bfb5a2496495c7585dc69b8b27_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisRomaniaSRLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iecc505bcb14d4f708a5e5b413b0da850_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareRomaniaSRLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i58ff366114fa423c816fd9c7d12c6ee5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisUkHoldingsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5935a593578b42bd992125d84fde4c2b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisPharmaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5ab8aa458b2e4741896b715f331173c5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiSynthelaboUKLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iea8d1294ee8a48b2acfe1c079ae36761_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisPharmaHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7457f5f4052d410aada699fd4a19b6f6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareUKLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iba8eb10b04bf4f299d1a467e30b4255c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AOSanofiRussiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifd6d3494d7da437f8fd0c9e1b7dcbdda_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i57aa1c00eabf4f6f995aa00fe1f4cad3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiABMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i52f9faf9cfa44dc0a653f6ac823bbff6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisSuisseSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie5770860577043ba89757912c7144758_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeGlobalSarlBaarIntellectualPropertyBranchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i88db3e6c62364ad8b70611ef3579c3e0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiIlacSanayiVeTicaretASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i516dd1cd29b84843b7e8aab3e5a4c6e7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurAsiTicaretASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i005b6ed2aeb1435ea08d3315ae40197b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiSaglikUrunleriLimitedSirketiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic41db69eadcd4e9c982ed089e1167d58_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeTherapeuticProductsLimitedPartnershipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5f0515138f7c418c9bcbb13c636c695c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i08e2f2cccd464d70abbd1e5f42eed60f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiUSServicesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i60b9857f92eb49a8a8c2d24791c3ce46_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisUSLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie4d77d7546954bb39c5739590d22ed90_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:ChattemIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icdfce984527840aa9096f39e4c594c81_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisubLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idcba81032cc44b6d96e7841acb4c6f8e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia84f6147917444bc85ac41f1fe48a282_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifa9d541bb2af4c559dbbaf5d6692d189_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:VaxServeIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie5307b0935b94772a58f8ea12f188818_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:BioverativIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i08d853212613473facfe866d69b99234_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:BioverativUSLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1bbdc75c43824eb8a3de899e259da76c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:BioverativTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icb9a553ac7e54b47a1eaa3597816db8e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:PrincipiaBiopharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i37c82d3e1df445788ff372833849ae27_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiResearchInvestLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i87693c70bb4c4820b200f85cae0c40fe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiBioverativHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8482c94334704ac2a9f5d46f5b538414_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:RPRUSLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibcf097d2e4454d87b7c58b76251a2385_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:KadmonHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3b8053816d6a4e6c9e20fc4c30f781aa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:KadmonCorporationLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ide7f7e63784f41a183803f0ac8a137e7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AmunixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i718def90f99b44c1ace694608132b059_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SynthorxIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i983da08a0b754be2b43b04b0c13ea843_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:TranslateBioIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i34818f54408849b78b0de1673856f0f8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisSouthAfricaPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i825c57dbd8964e30b031dee0899ee99f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisAlgerieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5e42794c886e4988b9410e7875fa4ea3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiArabiaTradingCompanyLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i41868f27b25346e1b0eebd1483e1fc50_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisArgentinaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ica13971ef10f4193b4a67e7c1af3ebf7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenzymeDeArgentinaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i493a9c684cd24c618768ad51fe4c99b0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareArgentinaSAUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifeb9cb68f7eb4fca8a15ce101f73ec2d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisHealthcarePtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8be1a4c0cf864ca580eeff34de647013_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisAustraliaPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id38ab6ac3a3140ee8c774a6c879777f4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiMedleyFarmaceuticaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i42d8188e7be34beb9c79c609575725ce_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisCanadaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if7703f57c8434b53a13de4396f59696f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7d8105546d9a43eba6a5ba0d273ef35d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:MerieuxCanadaHoldingsULCCanadaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic71d57fdeec447afb3b584aff6e7e598_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDeChileSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i61fc86f2e0d54b88a9ae5af651e73bbf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiHangzhouPharmaceuticalsCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5762c3305eac419d9d4d578ae3517cec_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiChinaInvestmentCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if523ef2e47944973b93e0232412ed5db_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiBeijingPharmaceuticalsCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i319f41b8a18c4cf6b5f956ed40fbfa70_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurBiologiesCo.LtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i72b45e8b7e194f42be530027f55dbd36_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:ShenzhenSanofiPasteurBiologicalProductsCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic82939cbfa4e4308b5c954a528b904b3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:ShanghaiRonghengPharmaceuticalCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i21ea9e0d97b84ea8bed89d96c90b4a4c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:GenfarSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8a61deb6118546cca9152a3d19ca7ded_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDeColombiaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5b77c884d5cf4c459d41322e688941e2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisKoreaCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2d8c63a1688f487f8f48b66b144d7b14_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i235e682ab77a4e1b83eb628a686cb67d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareKoreaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i94cfec9a31f2484bbf3be22fda030c95_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisGulfFZEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9265b4b9635b4f268661bb9af41d4910_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiEgyptSAEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4ac69def9695452fa8056d9a9cf37f80_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcareEgyptLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie7215e66652242c888d9188932de83ef_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiHongKongLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icd902f48e4e0470789302c7c306a7226_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiIndiaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3427ee82661045e69654d0f7f3c81b5f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiHealthcareIndiaPrivateLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i931de8c63c0a4132b7dc27fd739de9ee_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisIsraelLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if83f0c24152340948edc3fce389f90bc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiKKMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia183f27f20164e5db33ab876c94506f6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SspCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie4658ecaa90e474bbf5ced2fcc7ac5a2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisMalaysiaSDNBHDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id812b34881814260a4fde8dbd44c51c6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisMarocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic471ab2e84ae4923a1e2dd798a44a353_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDeMexicoSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i05626dc1fd684848a779e5531a41d341_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiPasteurS.A.deC.V.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i18812706bbaf4fcd8256d1807ae64a5c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AztecaVacunasSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2dfc1df9889e46c0a941ac9f24266a01_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisPakistanLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id621d1155a9144f2a85532c3bfa7cd75_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDePanamaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i81604c6ae3a740b7ab7f5a449eff82c5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDelPeruSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1f0dab49c934466b9cc002391f7bc3f0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisPuertoRicoIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0d7249e960a449009edd04541ebb0a9a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisPhilippinesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia5941a7f40b04bed9aab3ca1870c53f3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaHealthcarePhilippinesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3aa25010b3d247be8ea308b7d38e3498_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisSingaporePteLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4036a3cf2bd8487cabda1ea457bd5fcf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:AventisPharmaManufacturingPTELTDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1d6ea91a03cb4a04ba283518cfb3a3b8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiManufacturingPteLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie8ba60949d764ee68bd5fa3cae3fd182_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiTaiwanCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5ad82677839649138379e9cf405edc11_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisThailandLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0d616d9fdf31436c85f6dd196bbba8da_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisDeVenezuelaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic3ab1d4e7a0b42c08245f856927cb942_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiAventisVietnamCompanyLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7dfc5328cd614aacab6fbc5dcd73b515_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:SanofiVietnamShareholdingCompanyLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic8a871b1ed6b455f8d1c0cea30f525e8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:GlaxoSmithKlineConsumerHealthcareLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i52895c33c77b401c852cf418dd101085_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7effbd9d99be4fa09eb11d6a24112790_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:MapharMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9db2167110a34e338dda46b7b37c973b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:MCMVaccineBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i57640986aa3c447c9a69578a8c50672a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i634adddc2f7149a6b915f960673b1b38_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointOperationsAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="vaccine_dose">
        <measure>sny:vaccine_dose</measure>
    </unit>
    <unit id="segment">
        <measure>sny:segment</measure>
    </unit>
    <unit id="agreement">
        <measure>sny:agreement</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="bond">
        <measure>sny:bond</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="product">
        <measure>sny:product</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="lease">
        <measure>sny:lease</measure>
    </unit>
    <unit id="tranche">
        <measure>sny:tranche</measure>
    </unit>
    <unit id="patient">
        <measure>sny:patient</measure>
    </unit>
    <unit id="country">
        <measure>sny:Country</measure>
    </unit>
    <unit id="credit_facility">
        <measure>sny:credit_facility</measure>
    </unit>
    <unit id="performance_indicator">
        <measure>sny:performance_indicator</measure>
    </unit>
    <unit id="currency">
        <measure>sny:currency</measure>
    </unit>
    <unit id="plan">
        <measure>sny:plan</measure>
    </unit>
    <unit id="age">
        <measure>sny:age</measure>
    </unit>
    <unit id="twd">
        <measure>iso4217:TWD</measure>
    </unit>
    <unit id="sgd">
        <measure>iso4217:SGD</measure>
    </unit>
    <unit id="molecule">
        <measure>sny:molecule</measure>
    </unit>
    <unit id="target">
        <measure>sny:target</measure>
    </unit>
    <unit id="lawsuit">
        <measure>sny:lawsuit</measure>
    </unit>
    <unit id="plaintiff">
        <measure>sny:plaintiff</measure>
    </unit>
    <unit id="trial">
        <measure>sny:trial</measure>
    </unit>
    <unit id="case">
        <measure>sny:case</measure>
    </unit>
    <unit id="cancer">
        <measure>sny:cancer</measure>
    </unit>
    <unit id="complaint">
        <measure>sny:complaint</measure>
    </unit>
    <unit id="action">
        <measure>sny:action</measure>
    </unit>
    <unit id="claim">
        <measure>sny:claim</measure>
    </unit>
    <unit id="person">
        <measure>sny:person</measure>
    </unit>
    <unit id="ruling">
        <measure>sny:ruling</measure>
    </unit>
    <unit id="family">
        <measure>sny:family</measure>
    </unit>
    <unit id="expert">
        <measure>sny:expert</measure>
    </unit>
    <unit id="medical_assessment">
        <measure>sny:medical_assessment</measure>
    </unit>
    <unit id="proceeding">
        <measure>sny:proceeding</measure>
    </unit>
    <unit id="children">
        <measure>sny:children</measure>
    </unit>
    <unit id="manufacturer">
        <measure>sny:manufacturer</measure>
    </unit>
    <unit id="patent">
        <measure>sny:patent</measure>
    </unit>
    <unit id="decision">
        <measure>sny:decision</measure>
    </unit>
    <unit id="aud">
        <measure>iso4217:AUD</measure>
    </unit>
    <unit id="employee">
        <measure>sny:employee</measure>
    </unit>
    <unit id="executives">
        <measure>sny:executives</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83L2ZyYWc6N2U3YjdiMmYwZTEyNGM0MjhlOTg0NDk2NGJlMzhlMzQvdGFibGU6OTFkYmVjN2M5YzEyNGFmODhjMmMzZTU0MGNjNWMxMzcvdGFibGVyYW5nZTo5MWRiZWM3YzljMTI0YWY4OGMyYzNlNTQwY2M1YzEzN18xLTEtMS0xLTM2NDA2MA_02aeee8d-3a9e-426f-8f20-51fbf05064b6">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83L2ZyYWc6N2U3YjdiMmYwZTEyNGM0MjhlOTg0NDk2NGJlMzhlMzQvdGFibGU6OTFkYmVjN2M5YzEyNGFmODhjMmMzZTU0MGNjNWMxMzcvdGFibGVyYW5nZTo5MWRiZWM3YzljMTI0YWY4OGMyYzNlNTQwY2M1YzEzN18yLTEtMS0xLTM2NDA2MA_599ee778-cc31-48d8-9e89-250a87caa514">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83L2ZyYWc6N2U3YjdiMmYwZTEyNGM0MjhlOTg0NDk2NGJlMzhlMzQvdGFibGU6OTFkYmVjN2M5YzEyNGFmODhjMmMzZTU0MGNjNWMxMzcvdGFibGVyYW5nZTo5MWRiZWM3YzljMTI0YWY4OGMyYzNlNTQwY2M1YzEzN18zLTEtMS0xLTM2NDA2MA_1900076c-e7c6-4829-9a30-9a47f02e4372">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83L2ZyYWc6N2U3YjdiMmYwZTEyNGM0MjhlOTg0NDk2NGJlMzhlMzQvdGFibGU6OTFkYmVjN2M5YzEyNGFmODhjMmMzZTU0MGNjNWMxMzcvdGFibGVyYW5nZTo5MWRiZWM3YzljMTI0YWY4OGMyYzNlNTQwY2M1YzEzN180LTEtMS0xLTM2NDA2MA_7cc5329d-d893-45f2-9420-aa707ee8976d">0001121404</dei:EntityCentralIndexKey>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="ic6d609e772664d4dabc2be8000f12dcc_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTQvZnJhZzozZjc4YjJjMzg5MjM0NWI3OWUwMWQxNGFjYzI2ODQxNS90ZXh0cmVnaW9uOjNmNzhiMmMzODkyMzQ1Yjc5ZTAxZDE0YWNjMjY4NDE1XzUxMDY_a0f11f8d-0f58-4332-81c5-b171f9da546e">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <sny:PossibleIncreaseInMortalityTableInYears
      contextRef="i8a3c0c053efb4732adcd801d2a0a398f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDkvZnJhZzplYzVjNDk3ZWExNjA0NjJjOTdmYTgwODhhZGJkNDRkNS90YWJsZTowM2U3MGFiZWI0Mzk0ZTg5YjdjNmQ4ZDlmM2ExY2I5Yy90YWJsZXJhbmdlOjAzZTcwYWJlYjQzOTRlODliN2M2ZDhkOWYzYTFjYjljXzItMi0xLTEtMzY0MDYw_bc0c8599-bf0e-493b-8022-b5c8397b5930">P1Y</sny:PossibleIncreaseInMortalityTableInYears>
    <sny:CapitalLossesUsedAgainstCapitalGainsPercentage
      contextRef="iab27c8ba011e427586eb8baebc4580ce_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDkvZnJhZzplYzVjNDk3ZWExNjA0NjJjOTdmYTgwODhhZGJkNDRkNS90ZXh0cmVnaW9uOmVjNWM0OTdlYTE2MDQ2MmM5N2ZhODA4OGFkYmQ0NGQ1XzE5_41efb929-a7bb-41d3-861d-893665eaddb6"
      unitRef="number">0.3333</sny:CapitalLossesUsedAgainstCapitalGainsPercentage>
    <dei:DocumentType
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTU0_e4776ca6-ad20-4a85-b9c5-d7bc41b11ccc">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6Y2NkZDRjYTIxZjcyNGNjMmI1MTQwZjVhOTk3MmJlOGIvdGFibGVyYW5nZTpjY2RkNGNhMjFmNzI0Y2MyYjUxNDBmNWE5OTcyYmU4Yl8wLTAtMS0xLTM2NDA2MA_944e3a85-5386-4ed6-94af-cb299426ac00">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6Y2NkZDRjYTIxZjcyNGNjMmI1MTQwZjVhOTk3MmJlOGIvdGFibGVyYW5nZTpjY2RkNGNhMjFmNzI0Y2MyYjUxNDBmNWE5OTcyYmU4Yl8yLTAtMS0xLTM2NDA2MA_ba46a748-d96b-49a5-ad0c-fbab95fd7784">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQx_e137de07-fd43-463a-8f4c-4e7cea309e96">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQx_9e574c33-ca9a-453c-b084-fd681f3b2b52">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6YzBhMmE4YzQ4OTZhNGU5NmJkMTM3MjE5ZWZkN2UzMDUvdGFibGVyYW5nZTpjMGEyYThjNDg5NmE0ZTk2YmQxMzcyMTllZmQ3ZTMwNV8wLTAtMS0xLTM2NDA2MA_6814a180-a6b8-4609-becc-3324fa18088b">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6YzBhMmE4YzQ4OTZhNGU5NmJkMTM3MjE5ZWZkN2UzMDUvdGFibGVyYW5nZTpjMGEyYThjNDg5NmE0ZTk2YmQxMzcyMTllZmQ3ZTMwNV8yLTAtMS0xLTM2NDA2MA_d7dd6f7f-847b-4fc4-b96c-b5d0cca317a2">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQy_9cb1ca4d-d862-46c9-b153-7f5eb5f4e9e6">001-31368</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQ2_3454d525-cff2-4ea1-8adc-2973ad62e445">Sanofi</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQz_e5fb61d7-ac70-48cf-b382-769fcea7eb96">I0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM0_adbf5d79-450c-429c-9dce-77de3ad98954">,&#160;avenue de la Grande Arm&#xe9;e</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTU1_32816357-97c3-4831-a32e-9de70f599c7c">75017</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQ0_790ade07-6a08-443f-bb75-53cd34f0464e">Paris</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQ3_5a55ddc1-cebc-45f0-9597-e77acce072ed">FR</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM3_30381c0a-3050-4d25-89f5-b81e327dee32">Roy Papatheodorou</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTU2_83652973-edd6-4f23-ad85-edf49b363d23">,&#160;avenue de la Grande Arm&#xe9;e</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM1_84112a4a-30ab-4fdc-9783-f1bf3e70e15c">75017</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTU3_c63f5f20-8846-4764-9cf2-d34557aaed94">Paris</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM4_a74fc454-d9a3-4c15-831f-8a36895f17c3">FR</dei:EntityAddressCountry>
    <dei:ContactPersonnelFaxNumber
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM5_45563b60-9420-4194-b99c-cedb15814bd3">33 1 53 77 43 03</dei:ContactPersonnelFaxNumber>
    <dei:CityAreaCode
      contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTUw_e0bc4378-7d5c-4959-a4ef-6fe09790eaee">33</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i51d2972f62c44302800dd88abed05207_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTUx_0bdb5f67-ad60-41e7-94f5-45524ea9d801">1 53 77 40 00</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ib8623615aa6f453286593426ee1e8b04_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjE4ZDQwYjE0MWI3NGMxMGE0OTU1NGYzNzY1OTE0MzIvdGFibGVyYW5nZToyMThkNDBiMTQxYjc0YzEwYTQ5NTU0ZjM3NjU5MTQzMl8xLTAtMS0xLTM2NDA2MA_6b34dfbe-f959-4893-8de5-fdf967beeb59">American&#160;Depositary&#160;Shares,&#160;each&#160;representing one half of one ordinary share, par value &#x20ac;2&#160;per&#160;share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib8623615aa6f453286593426ee1e8b04_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjE4ZDQwYjE0MWI3NGMxMGE0OTU1NGYzNzY1OTE0MzIvdGFibGVyYW5nZToyMThkNDBiMTQxYjc0YzEwYTQ5NTU0ZjM3NjU5MTQzMl8xLTEtMS0xLTUwNzYyMA_cb4a4051-9e14-47aa-85d6-f9f6b7ccc6e9">SNY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib8623615aa6f453286593426ee1e8b04_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjE4ZDQwYjE0MWI3NGMxMGE0OTU1NGYzNzY1OTE0MzIvdGFibGVyYW5nZToyMThkNDBiMTQxYjc0YzEwYTQ5NTU0ZjM3NjU5MTQzMl8xLTItMS0xLTM2NDA2MA_b691cbc5-c73a-4274-b116-1fe906aff8ac">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i22690d5a55c7403c964aa8af7ad10ad5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjE4ZDQwYjE0MWI3NGMxMGE0OTU1NGYzNzY1OTE0MzIvdGFibGVyYW5nZToyMThkNDBiMTQxYjc0YzEwYTQ5NTU0ZjM3NjU5MTQzMl8yLTAtMS0xLTM2NDA2MA_dfad37e0-33f0-4ffe-a48b-65f1a15476a6">Ordinary shares, par value &#x20ac;2&#160;per share</dei:Security12bTitle>
    <dei:SecurityExchangeName
      contextRef="i22690d5a55c7403c964aa8af7ad10ad5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjE4ZDQwYjE0MWI3NGMxMGE0OTU1NGYzNzY1OTE0MzIvdGFibGVyYW5nZToyMThkNDBiMTQxYjc0YzEwYTQ5NTU0ZjM3NjU5MTQzMl8yLTItMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjBhYTcxMjM5NTFjMjQyZTliODUzZWQ1ZGYxNTk2YzEzXzQ_aeb4e946-e6dd-4c3d-a7e0-7573ae40ec0f">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV8xMzQx_89d97625-1efb-48e3-be0c-082184b79f9d"
      unitRef="shares">1260835732</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTM2_e4ea6c9a-7d1a-4af9-8c4e-57f1b35747b3">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQw_33878abe-008e-453b-a508-f2dad37a5f3d">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTUy_6640f777-e913-4ea4-a034-2a1c051d41df">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTUz_b6a41c3e-7e32-404e-99c6-72bcf568b051">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjAwODQzMzNjMzk5NGZlNWJjNDhhNTY4ZTM4NGI0YWIvdGFibGVyYW5nZToyMDA4NDMzM2MzOTk0ZmU1YmM0OGE1NjhlMzg0YjRhYl8wLTAtMS0xLTM2NDA2MA_c1f880d9-c878-4cfe-a00b-4e32abb74e96">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6MjAwODQzMzNjMzk5NGZlNWJjNDhhNTY4ZTM4NGI0YWIvdGFibGVyYW5nZToyMDA4NDMzM2MzOTk0ZmU1YmM0OGE1NjhlMzg0YjRhYl8wLTctMS0xLTM2NDA2MA_e5a7e529-e224-4dda-a6dc-d28b38644fc5">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQ4_a48279d3-e93b-4bbd-a48b-6b8cef824cb2">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentAccountingStandard
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGFibGU6ZmNlYjI3ZTI1MDRkNDgxOGIzYzU1MTY1ZGY3Mzg0ODgvdGFibGVyYW5nZTpmY2ViMjdlMjUwNGQ0ODE4YjNjNTUxNjVkZjczODQ4OF8wLTItMS0xLTM2NDA2MA_993972a8-acb4-4946-8a67-209f4dcb96ae">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80L2ZyYWc6NzA5NjE0MzkxMDAzNDg0YTkyMThiNDdkZjFlODdjMTkvdGV4dHJlZ2lvbjo3MDk2MTQzOTEwMDM0ODRhOTIxOGI0N2RmMWU4N2MxOV80MTQ1_05dc1da0-3743-4639-8d77-3105e4e8ee27">false</dei:EntityShellCompany>
    <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl8xNzgvZnJhZzo1ZWNkYzA4ODZmOTk0ZTI3OWZmMDAyNDc2ZTk1MjkzMy90ZXh0cmVnaW9uOjVlY2RjMDg4NmY5OTRlMjc5ZmYwMDI0NzZlOTUyOTMzXzI3NDg3NzkwNzA5MDM_6d35a61e-f444-4997-bbbb-7d442b4906fd"
      unitRef="eur">101000000</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <dei:AuditorFirmId
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80MjQvZnJhZzo1Njc0ZmUxM2YwM2U0ZGZmODkxODk0YjJlMTc1Y2RkNS90ZXh0cmVnaW9uOjU2NzRmZTEzZjAzZTRkZmY4OTE4OTRiMmUxNzVjZGQ1XzE5ODU_c066f7b0-4d9d-4e3a-bf97-c948382ea865">1347</dei:AuditorFirmId>
    <dei:AuditorFirmId
      contextRef="i9f887633b9c1418f97d4bb30260bb881_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80MjQvZnJhZzo1Njc0ZmUxM2YwM2U0ZGZmODkxODk0YjJlMTc1Y2RkNS90ZXh0cmVnaW9uOjU2NzRmZTEzZjAzZTRkZmY4OTE4OTRiMmUxNzVjZGQ1XzIwMjc_f17a495d-1b3e-4d3b-9abd-51659bbb2868">1704</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i9f887633b9c1418f97d4bb30260bb881_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NjkvZnJhZzo3YWVhZTBkNDE5YjY0ZTM0YjYxM2MyYjkzNWYxOTBhZC90ZXh0cmVnaW9uOjdhZWFlMGQ0MTliNjRlMzRiNjEzYzJiOTM1ZjE5MGFkXzkwODI_f9d4c568-2e78-4c19-9586-627f8998522c">Ernst&#160;&amp; Young et Autres</dei:AuditorName>
    <dei:AuditorName
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NjkvZnJhZzo3YWVhZTBkNDE5YjY0ZTM0YjYxM2MyYjkzNWYxOTBhZC90ZXh0cmVnaW9uOjdhZWFlMGQ0MTliNjRlMzRiNjEzYzJiOTM1ZjE5MGFkXzkwODM_90b94920-5d16-4fcb-9837-f93c3e2c7b74">PricewaterhouseCoopers Audit</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i9f887633b9c1418f97d4bb30260bb881_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NjkvZnJhZzo3YWVhZTBkNDE5YjY0ZTM0YjYxM2MyYjkzNWYxOTBhZC90ZXh0cmVnaW9uOjdhZWFlMGQ0MTliNjRlMzRiNjEzYzJiOTM1ZjE5MGFkXzkwODU_97a9c5bf-0e58-48cd-b989-ceb8d44acbed">Neuilly-sur-Seine</dei:AuditorLocation>
    <dei:AuditorLocation
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NjkvZnJhZzo3YWVhZTBkNDE5YjY0ZTM0YjYxM2MyYjkzNWYxOTBhZC90ZXh0cmVnaW9uOjdhZWFlMGQ0MTliNjRlMzRiNjEzYzJiOTM1ZjE5MGFkXzkwODA_bd4bb431-903b-4e9c-bf5e-525f3df9b57c">Paris-La D&#xe9;fense</dei:AuditorLocation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEtMi0xLTEtMzY0MDYw_53c346b3-7734-412a-81d4-b853b4bdf787"
      unitRef="eur">9869000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEtMy0xLTEtMzY0MDYw_bfc25234-dad7-4ae5-89b4-9e15ac3907c0"
      unitRef="eur">10028000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEtNS0xLTEtMzY0MDYw_e1be1a81-e804-4732-bbd2-564fdf52fe38"
      unitRef="eur">9365000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzItMi0xLTEtMzY0MDYw_8adb04bb-7721-4935-92da-8132102ba5ce"
      unitRef="eur">1815000000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzItMy0xLTEtMzY0MDYw_94e73674-d819-4f0d-babb-30c6095f636b"
      unitRef="eur">1948000000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzItNS0xLTEtMzY0MDYw_c395c9a6-ee3e-41a3-a7f2-da456af52e8f"
      unitRef="eur">1198000000</ifrs-full:RightofuseAssets>
    <ifrs-full:Goodwill
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzMtMi0xLTEtMzY0MDYw_8d00049b-a1ce-466e-b4ac-761754dadc7d"
      unitRef="eur">49892000000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzMtMy0xLTEtMzY0MDYw_2acc94e6-f4cb-48ba-9947-9319ec7a3a45"
      unitRef="eur">48056000000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzMtNS0xLTEtMzY0MDYw_ff64a706-323f-41b7-8aa2-64abbc9e338c"
      unitRef="eur">44364000000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzQtMi0xLTEtMzY0MDYw_8069de26-8d1f-4b32-8cfc-621f793d0e59"
      unitRef="eur">21640000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzQtMy0xLTEtMzY0MDYw_6ebee9f6-6e57-4597-a3fb-d54cbfd6fd6d"
      unitRef="eur">21407000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzQtNS0xLTEtMzY0MDYw_ffb8d1e8-2909-41f6-ae5e-8fb6750f17e1"
      unitRef="eur">18341000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzUtMi0xLTEtMzY0MDYw_0a2c1f26-9020-45f1-a955-a7354a3a1005"
      unitRef="eur">677000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzUtMy0xLTEtMzY0MDYw_e75d8ec9-8b9d-4ac6-9d50-0fda6f971fb2"
      unitRef="eur">250000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzUtNS0xLTEtMzY0MDYw_927575f3-68ba-42ad-a314-702918da5fc8"
      unitRef="eur">201000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzYtMi0xLTEtMzY0MDYw_b055f221-a389-4054-b4e8-2309b1f8ecb3"
      unitRef="eur">3095000000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzYtMy0xLTEtMzY0MDYw_fb7507f4-517d-47d5-9da6-9f6c62bc7340"
      unitRef="eur">3127000000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzYtNS0xLTEtMzY0MDYw_0ae7ec9b-0808-4d33-ad31-74547492351f"
      unitRef="eur">2734000000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:CurrentTaxAssetsNoncurrent
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzctMi0xLTEtMzY0MDYw_752bd9c8-34cb-47fc-9f0d-130ad324013a"
      unitRef="eur">242000000</ifrs-full:CurrentTaxAssetsNoncurrent>
    <ifrs-full:CurrentTaxAssetsNoncurrent
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzctMy0xLTEtMzY0MDYw_3a1bfa4e-3552-4529-9d6d-ab57464d2d04"
      unitRef="eur">175000000</ifrs-full:CurrentTaxAssetsNoncurrent>
    <ifrs-full:CurrentTaxAssetsNoncurrent
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzctNS0xLTEtMzY0MDYw_201dbd4f-11f6-43c8-9ca5-f9512970bc4f"
      unitRef="eur">248000000</ifrs-full:CurrentTaxAssetsNoncurrent>
    <ifrs-full:DeferredTaxAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzgtMi0xLTEtMzY0MDYw_cb12f8d1-336f-42b0-accd-99138fbcab97"
      unitRef="eur">5381000000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzgtMy0xLTEtMzY0MDYw_7ac75bac-6381-4570-a9be-d258eeeb058f"
      unitRef="eur">4598000000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzgtNS0xLTEtMzY0MDYw_4989c65b-3d5e-4e45-a863-797e05effa8e"
      unitRef="eur">4176000000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzktMi0xLTEtMzY0MDYw_cc44aee7-f428-4330-aa01-a62341c260b8"
      unitRef="eur">92611000000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzktMy0xLTEtMzY0MDYw_75fe60f0-a5df-4950-974c-379b7c1c6e18"
      unitRef="eur">89589000000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzktNS0xLTEtMzY0MDYw_f304b90b-e524-4f21-8eb1-823b3262fd06"
      unitRef="eur">80627000000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Inventories
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEwLTItMS0xLTM2NDA2MA_d06f48ab-bdbf-4546-a8de-700c7d787d60"
      unitRef="eur">8960000000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEwLTMtMS0xLTM2NDA2MA_d328cfda-35c8-4b29-a264-0afdb9105451"
      unitRef="eur">8715000000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEwLTUtMS0xLTM2NDA2MA_e5c9c9f0-357f-405f-ae45-814e5df5c370"
      unitRef="eur">8352000000</ifrs-full:Inventories>
    <ifrs-full:CurrentTradeReceivables
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzExLTItMS0xLTM2NDA2MA_e7ec45bb-3d89-4bc4-9cf8-db160e7d73b1"
      unitRef="eur">8424000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzExLTMtMS0xLTM2NDA2MA_16636615-8190-4cee-8915-a4390ab43102"
      unitRef="eur">7568000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzExLTUtMS0xLTM2NDA2MA_2f978d1d-2381-44fc-9063-65875d18faaf"
      unitRef="eur">7491000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:OtherCurrentAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEyLTItMS0xLTM2NDA2MA_a9451272-394b-4244-b3bf-fed86571e4a6"
      unitRef="eur">3532000000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEyLTMtMS0xLTM2NDA2MA_abe46f97-a62c-45de-94c4-2c804f14454d"
      unitRef="eur">3571000000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEyLTUtMS0xLTM2NDA2MA_46ddbf80-0050-4426-8b6c-24dba48cfd92"
      unitRef="eur">2737000000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:CurrentTaxAssetsCurrent
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEzLTItMS0xLTM2NDA2MA_f27be8ed-5206-4203-be08-b86affb406a4"
      unitRef="eur">374000000</ifrs-full:CurrentTaxAssetsCurrent>
    <ifrs-full:CurrentTaxAssetsCurrent
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEzLTMtMS0xLTM2NDA2MA_225e643a-2965-49f8-9547-8bdd8bdba9fd"
      unitRef="eur">612000000</ifrs-full:CurrentTaxAssetsCurrent>
    <ifrs-full:CurrentTaxAssetsCurrent
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEzLTUtMS0xLTM2NDA2MA_5ee4cc7b-0628-42e2-9a04-07b791d69c0d"
      unitRef="eur">1208000000</ifrs-full:CurrentTaxAssetsCurrent>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE0LTItMS0xLTM2NDA2MA_0099939d-279e-4dfe-967d-9da6511dcb3f"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE0LTMtMS0xLTM2NDA2MA_6bbfc1f2-a8bf-4b93-a229-31329b316089"
      unitRef="eur">10098000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE0LTUtMS0xLTM2NDA2MA_5abda22f-ef3c-4f38-b583-bdf4dacc3d29"
      unitRef="eur">13915000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE1LTItMS0xLTM2NDA2MA_cf2d71be-8799-418f-8b07-b16eaafd5175"
      unitRef="eur">34026000000</ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
    <ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE1LTMtMS0xLTM2NDA2MA_a7cc9081-1fe1-4229-95da-9b60a532c33d"
      unitRef="eur">30564000000</ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
    <ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE1LTUtMS0xLTM2NDA2MA_94cb78bb-07be-4df9-9abd-d3cf5839f88a"
      unitRef="eur">33703000000</ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE2LTItMS0xLTM2NDA2MA_56ba2e9e-884e-4440-8108-dc15b98dcf66"
      unitRef="eur">85000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE2LTMtMS0xLTM2NDA2MA_b5c9bbc9-c75d-4cec-a1d2-1069bec1151c"
      unitRef="eur">89000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE2LTUtMS0xLTM2NDA2MA_3178df5e-f94d-47a9-a40f-fc62ba791e00"
      unitRef="eur">83000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:Assets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE3LTItMS0xLTM2NDA2MA_06e812df-56fb-4df6-bc64-84e396692361"
      unitRef="eur">126722000000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE3LTMtMS0xLTM2NDA2MA_1360da6d-cd04-4a32-8ccd-06cf46e7cdef"
      unitRef="eur">120242000000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE3LTUtMS0xLTM2NDA2MA_573f49c8-ea1e-458d-9c33-a9f41a087d5c"
      unitRef="eur">114413000000</ifrs-full:Assets>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEtMi0xLTEtMzY0MDYw_49ebfc94-cbbd-4de0-9d5b-edb2a9aa06da"
      unitRef="eur">74784000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEtMy0xLTEtMzY0MDYw_10fc1422-a274-4d9a-b55d-1598fb90f401"
      unitRef="eur">68681000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEtNS0xLTEtMzY0MDYw_7d7ee084-2a92-441f-bb7e-f3dfd1d51c0d"
      unitRef="eur">63106000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:NoncontrollingInterests
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzItMi0xLTEtMzY0MDYw_fa53801c-0518-4eac-a4b2-294a4a788ee7"
      unitRef="eur">368000000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzItMy0xLTEtMzY0MDYw_f751c431-c79c-46a5-af28-074d189ad087"
      unitRef="eur">350000000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzItNS0xLTEtMzY0MDYw_a425cef0-9e19-4636-b4c9-8d7457aca7e2"
      unitRef="eur">146000000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzMtMi0xLTEtMzY0MDYw_46e033f1-b432-4e62-b80d-1de76d86da3d"
      unitRef="eur">75152000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzMtMy0xLTEtMzY0MDYw_32499739-67c0-48c3-828f-62010fe2b535"
      unitRef="eur">69031000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzMtNS0xLTEtMzY0MDYw_4be8cb3c-bb9d-44c3-8eb5-28d6e296f468"
      unitRef="eur">63252000000</ifrs-full:Equity>
    <ifrs-full:LongtermBorrowings
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzQtMi0xLTEtMzY0MDYw_5512f5a6-410a-443b-8801-9114dc3d871c"
      unitRef="eur">14857000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzQtMy0xLTEtMzY0MDYw_f35b2f4c-1d4b-4206-9268-a200c309ad18"
      unitRef="eur">17123000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzQtNS0xLTEtMzY0MDYw_c2c9944f-49cf-473b-963a-80a47b9ccad9"
      unitRef="eur">19745000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzUtMi0xLTEtMzY0MDYw_6e8bdfe4-09f0-4c3f-8290-ba0dc39f07cd"
      unitRef="eur">1904000000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzUtMy0xLTEtMzY0MDYw_7b681a46-08a0-4e39-8a48-3aafa4f0eae6"
      unitRef="eur">1839000000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzUtNS0xLTEtMzY0MDYw_1b79d766-e040-4ce2-9087-b12025f05dc2"
      unitRef="eur">931000000</ifrs-full:NoncurrentLeaseLiabilities>
    <sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzYtMi0xLTEtMzY0MDYw_24b1508f-95b6-47c7-9ad8-d90abc6248d7"
      unitRef="eur">674000000</sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzYtMy0xLTEtMzY0MDYw_36c7c765-f939-44e2-b94c-3350cd528334"
      unitRef="eur">577000000</sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzYtNS0xLTEtMzY0MDYw_09466f4c-f691-4b48-87b8-9c6619c32bc6"
      unitRef="eur">387000000</sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzctMi0xLTEtMzY0MDYw_639b3696-48f5-4157-82bd-75e5a042cc97"
      unitRef="eur">6341000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzctMy0xLTEtMzY0MDYw_cc1ca1f6-24b8-4c51-b5b8-38d8691eda2d"
      unitRef="eur">6721000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzctNS0xLTEtMzY0MDYw_88a3ff41-5db5-4c72-8750-60b6b561fdc1"
      unitRef="eur">7315000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <ifrs-full:CurrentTaxLiabilitiesNoncurrent
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzgtMi0xLTEtMzY0MDYw_55202c3d-b356-4e8b-96aa-8e2283164071"
      unitRef="eur">1979000000</ifrs-full:CurrentTaxLiabilitiesNoncurrent>
    <ifrs-full:CurrentTaxLiabilitiesNoncurrent
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzgtMy0xLTEtMzY0MDYw_9fff55cf-8a91-4573-b334-c94c967ef54a"
      unitRef="eur">2039000000</ifrs-full:CurrentTaxLiabilitiesNoncurrent>
    <ifrs-full:CurrentTaxLiabilitiesNoncurrent
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzgtNS0xLTEtMzY0MDYw_9ed4f556-0f63-42a3-9ecf-c0593883b300"
      unitRef="eur">1733000000</ifrs-full:CurrentTaxLiabilitiesNoncurrent>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzktMi0xLTEtMzY0MDYw_6ec50a74-fe14-47c8-838c-c0184efa171c"
      unitRef="eur">1841000000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzktMy0xLTEtMzY0MDYw_bcc4a195-3ea3-4217-b120-9fa6c8b5c3d7"
      unitRef="eur">1617000000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzktNS0xLTEtMzY0MDYw_6ac9401c-2c5b-4d43-b1c8-59656b9f5a14"
      unitRef="eur">1770000000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEwLTItMS0xLTM2NDA2MA_017e5d13-0631-4418-b9f5-fe1d3cd7a6b1"
      unitRef="eur">27596000000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEwLTMtMS0xLTM2NDA2MA_98b8fc73-49a4-44ab-bf64-64b10f6ad665"
      unitRef="eur">29916000000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEwLTUtMS0xLTM2NDA2MA_aa53763e-ddcb-4157-8799-62448793999a"
      unitRef="eur">31881000000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzExLTItMS0xLTM2NDA2MA_4260e833-3d4e-407e-83e7-39ddefc2a08c"
      unitRef="eur">6813000000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzExLTMtMS0xLTM2NDA2MA_3bfddaac-b5f8-4241-91ff-7560955b5110"
      unitRef="eur">6180000000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzExLTUtMS0xLTM2NDA2MA_ec029af8-8e2f-4373-9f92-3f80319bb69d"
      unitRef="eur">5295000000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEyLTItMS0xLTM2NDA2MA_daa3a85e-578c-4a94-aff2-24fa17d0d2bd"
      unitRef="eur">105000000</sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEyLTMtMS0xLTM2NDA2MA_899ea4e5-4900-4ed9-a9ed-9fc4f3f47fac"
      unitRef="eur">137000000</sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEyLTUtMS0xLTM2NDA2MA_8354b5dd-7731-4c1a-a502-f93591cbc690"
      unitRef="eur">218000000</sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:CurrentProvisionsAndOtherCurrentLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEzLTItMS0xLTM2NDA2MA_b2d26eb1-ebe7-4bab-9d15-611b0435980a"
      unitRef="eur">12021000000</sny:CurrentProvisionsAndOtherCurrentLiabilities>
    <sny:CurrentProvisionsAndOtherCurrentLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEzLTMtMS0xLTM2NDA2MA_278e172f-46fe-4712-a0f0-a5199bd56bff"
      unitRef="eur">11217000000</sny:CurrentProvisionsAndOtherCurrentLiabilities>
    <sny:CurrentProvisionsAndOtherCurrentLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEzLTUtMS0xLTM2NDA2MA_5632a6c6-fe9b-4b6f-be3e-74a4762c8079"
      unitRef="eur">10132000000</sny:CurrentProvisionsAndOtherCurrentLiabilities>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE0LTItMS0xLTM2NDA2MA_f2275f31-81bb-4a4c-b914-71056cdc632b"
      unitRef="eur">574000000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE0LTMtMS0xLTM2NDA2MA_7715bf1a-4593-489c-a6d1-d93df5c07a3d"
      unitRef="eur">309000000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE0LTUtMS0xLTM2NDA2MA_c77f84c4-9b06-439c-b2c2-446f2531fab1"
      unitRef="eur">604000000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE1LTItMS0xLTM2NDA2MA_fc4a9883-2b1c-4cd5-bc37-a89c926dbf88"
      unitRef="eur">277000000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE1LTMtMS0xLTM2NDA2MA_cdf8a14f-8749-4643-8cf6-768091a80a9c"
      unitRef="eur">269000000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE1LTUtMS0xLTM2NDA2MA_3f6bc7c9-ddfd-4ea8-97a6-9560945be031"
      unitRef="eur">232000000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE2LTItMS0xLTM2NDA2MA_9f14e616-fb0a-4f28-8f1e-ead19275ad68"
      unitRef="eur">4174000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE2LTMtMS0xLTM2NDA2MA_113b2b13-6c8a-4a3e-b30f-8d9ea4ecd3b3"
      unitRef="eur">3183000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE2LTUtMS0xLTM2NDA2MA_abdea380-4305-424a-aa70-27d966ed1801"
      unitRef="eur">2767000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE3LTItMS0xLTM2NDA2MA_8660bbad-baa3-44dd-9a7f-cecae174b239"
      unitRef="eur">23964000000</ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE3LTMtMS0xLTM2NDA2MA_bcfd4e41-625f-4ad2-aa17-9af610c5fc6d"
      unitRef="eur">21295000000</ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE3LTUtMS0xLTM2NDA2MA_ee6bf62b-79dc-4852-ab0a-44f5e6cd48d9"
      unitRef="eur">19248000000</ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE4LTItMS0xLTM2NDA2MA_75d0d7ff-eac6-4dd7-97d4-ea3d2dd10211"
      unitRef="eur">10000000</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE4LTMtMS0xLTM2NDA2MA_21ce88f8-cf6c-417f-99e2-84caca945fde"
      unitRef="eur">0</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE4LTUtMS0xLTM2NDA2MA_d4a09a5b-f67e-45f7-bbbc-5112f4ccf1ac"
      unitRef="eur">32000000</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:EquityAndLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE5LTItMS0xLTM2NDA2MA_0678f0b3-8361-4607-8892-ae2e555234e5"
      unitRef="eur">126722000000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE5LTMtMS0xLTM2NDA2MA_f4c39b40-7550-46dd-94a3-95a708377473"
      unitRef="eur">120242000000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE5LTUtMS0xLTM2NDA2MA_518f424c-a583-4582-91e0-f12572c1f305"
      unitRef="eur">114413000000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEtMi0xLTEtMzY0MDYw_ecc5ab4b-8a28-4130-a701-0e0c7b90247b"
      unitRef="eur">42997000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEtMy0xLTEtMzY0MDYw_c0541969-b441-4ead-8686-b555a0861d22"
      unitRef="eur">37761000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEtNS0xLTEtMzY0MDYw_6e292d38-2475-4ad2-adc1-3bf58534aa46"
      unitRef="eur">36041000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:OtherRevenue
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzItMi0xLTEtMzY0MDYw_a5d80bf3-d40e-49cd-be43-a0b1b5fe9e6f"
      unitRef="eur">2392000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzItMy0xLTEtMzY0MDYw_51a712bb-5828-45e9-beac-7a03e9b788e7"
      unitRef="eur">1414000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzItNS0xLTEtMzY0MDYw_cf52530c-11fa-46ba-90b8-387200a923e7"
      unitRef="eur">1328000000</ifrs-full:OtherRevenue>
    <ifrs-full:CostOfSales
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMtMi0xLTEtMzY0MDYw_41e85cdb-2fd0-4382-abb6-fdbd317cd708"
      unitRef="eur">13695000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMtMy0xLTEtMzY0MDYw_e25a87f3-b89b-4a1a-9bff-5f8af37fb1f2"
      unitRef="eur">12255000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMtNS0xLTEtMzY0MDYw_19873626-8f8e-4608-b3cc-067baf62fd00"
      unitRef="eur">12159000000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzQtMi0xLTEtMzY0MDYw_b18d6717-053f-45a8-a144-3576d6785a82"
      unitRef="eur">31694000000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzQtMy0xLTEtMzY0MDYw_9ee2db1b-1b6b-4723-92e7-dd17b6d52f06"
      unitRef="eur">26920000000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzQtNS0xLTEtMzY0MDYw_6060efcb-4070-45cc-ad4c-ce7dfd6dba32"
      unitRef="eur">25210000000</ifrs-full:GrossProfit>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzUtMi0xLTEtMzY0MDYw_fb894249-711a-48cb-b285-9dfcde51d7dd"
      unitRef="eur">6706000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzUtMy0xLTEtMzY0MDYw_165f2233-ba36-4863-9d3a-8e33e1215536"
      unitRef="eur">5692000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzUtNS0xLTEtMzY0MDYw_c770a930-6359-40b0-adc4-16255141bbaa"
      unitRef="eur">5530000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzYtMi0xLTEtMzY0MDYw_2ae4a311-7c4d-4413-b3e2-fbcd73678180"
      unitRef="eur">10492000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzYtMy0xLTEtMzY0MDYw_cde29085-665d-4c41-9086-d4a25f996dcd"
      unitRef="eur">9555000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzYtNS0xLTEtMzY0MDYw_d3b3027b-8ab1-47d8-8dbe-5d66d8c882e1"
      unitRef="eur">9391000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzctMi0xLTEtMzY0MDYw_abd17a11-c4d4-4b31-ae59-f36fd401de7f"
      unitRef="eur">1969000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzctMy0xLTEtMzY0MDYw_71a4bd41-d0e8-408f-8408-6745ecd99942"
      unitRef="eur">859000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzctNS0xLTEtMzY0MDYw_ea377980-eec3-471b-8e64-babf0ac31163"
      unitRef="eur">697000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzgtMi0xLTEtMzY0MDYw_d38f5c24-4e57-44e3-bc54-1bbd70c34d60"
      unitRef="eur">2531000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzgtMy0xLTEtMzY0MDYw_83715857-2f91-45b4-a3c0-dcde15562a11"
      unitRef="eur">1805000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzgtNS0xLTEtMzY0MDYw_c52471fc-b44a-4284-bbb7-b21e467d606d"
      unitRef="eur">1415000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzktMi0xLTEtMzY0MDYw_3ad5fc37-dc42-4ae0-a97a-dd686e2fbd22"
      unitRef="eur">2053000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzktMy0xLTEtMzY0MDYw_4ae6712d-2ede-4bc4-aaf0-6a189204695e"
      unitRef="eur">1580000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzktNS0xLTEtMzY0MDYw_6cb8cfb2-5f44-49c5-b960-bd869b8ee64c"
      unitRef="eur">1681000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEwLTItMS0xLTM2NDA2MA_af43230a-fa75-4deb-98e0-c60e3469d5d5"
      unitRef="eur">-454000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEwLTMtMS0xLTM2NDA2MA_04401d69-da0f-4420-ac29-6504ce2daa1c"
      unitRef="eur">192000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEwLTUtMS0xLTM2NDA2MA_bf7d83a0-334e-40fc-815b-9b25757dca0c"
      unitRef="eur">330000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzExLTItMS0xLTM2NDA2MA_c7e2d3ab-951e-4c18-9696-540b678f759c"
      unitRef="eur">-27000000</ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability>
    <ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzExLTMtMS0xLTM2NDA2MA_38c804e3-aa54-4d6d-83e7-a857b02048d6"
      unitRef="eur">4000000</ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability>
    <ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzExLTUtMS0xLTM2NDA2MA_cf422f4c-90d8-4d65-b9f8-9da3635513d5"
      unitRef="eur">-124000000</ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEyLTItMS0xLTM2NDA2MA_638f036a-fc20-490e-bc73-ae601d35b37c"
      unitRef="eur">1336000000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEyLTMtMS0xLTM2NDA2MA_f84ce421-ab83-4ad2-8880-1975ae5bcd74"
      unitRef="eur">820000000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEyLTUtMS0xLTM2NDA2MA_f57e5083-426b-493f-be5b-89c43cd7ec16"
      unitRef="eur">1089000000</ifrs-full:ExpenseOfRestructuringActivities>
    <sny:OtherGainsLossesAndLitigation
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEzLTItMS0xLTM2NDA2MA_a01bf90d-26b5-4002-980c-87ba8c60c072"
      unitRef="eur">-370000000</sny:OtherGainsLossesAndLitigation>
    <sny:OtherGainsLossesAndLitigation
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEzLTMtMS0xLTM2NDA2MA_5f8c8838-6776-4f55-991e-55c716307f42"
      unitRef="eur">-5000000</sny:OtherGainsLossesAndLitigation>
    <sny:OtherGainsLossesAndLitigation
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEzLTUtMS0xLTM2NDA2MA_b72771e9-2b22-4bd1-a83b-77ace7d6b757"
      unitRef="eur">136000000</sny:OtherGainsLossesAndLitigation>
    <ifrs-full:GainsOnDisposalsOfInvestments
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE0LTItMS0xLTM2NDA2MA_7025bc2c-57f7-4bb3-80e2-4a3f47a75295"
      unitRef="eur">0</ifrs-full:GainsOnDisposalsOfInvestments>
    <ifrs-full:GainsOnDisposalsOfInvestments
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE0LTMtMS0xLTM2NDA2MA_a1051584-0a93-4318-a63b-866f2daea5e9"
      unitRef="eur">0</ifrs-full:GainsOnDisposalsOfInvestments>
    <ifrs-full:GainsOnDisposalsOfInvestments
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE0LTUtMS0xLTM2NDA2MA_a44438d9-b628-47fb-a335-543bf48cd46d"
      unitRef="eur">7382000000</ifrs-full:GainsOnDisposalsOfInvestments>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE1LTItMS0xLTM2NDA2MA_fa20ab29-1a7e-43a8-9632-2aecdbf3dde5"
      unitRef="eur">10656000000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE1LTMtMS0xLTM2NDA2MA_2d89a1c0-3cda-4126-a9a3-799c969e0a50"
      unitRef="eur">8126000000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE1LTUtMS0xLTM2NDA2MA_335e6c35-0a30-42ea-82ff-ae43ee8ea3aa"
      unitRef="eur">14113000000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceCosts
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE2LTItMS0xLTM2NDA2MA_fd8f181e-cdec-4233-9a08-80bcc88c7006"
      unitRef="eur">440000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE2LTMtMS0xLTM2NDA2MA_98dbe931-1abb-4ebf-97f0-fa23a69cba9d"
      unitRef="eur">368000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE2LTUtMS0xLTM2NDA2MA_1e23d4f5-79b1-4158-906a-fed081b744dd"
      unitRef="eur">388000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE3LTItMS0xLTM2NDA2MA_40570148-40d9-424d-b20d-547d415166eb"
      unitRef="eur">206000000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE3LTMtMS0xLTM2NDA2MA_7b4d036f-3b8a-48ce-b7d6-f27c4e05b9e2"
      unitRef="eur">40000000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE3LTUtMS0xLTM2NDA2MA_7b3251b8-a49d-4693-8c38-c06be8eeb196"
      unitRef="eur">53000000</ifrs-full:FinanceIncome>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE4LTItMS0xLTM2NDA2MA_a67a7535-d463-4219-99e5-91867ba0535b"
      unitRef="eur">10422000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE4LTMtMS0xLTM2NDA2MA_bc8aae17-900c-424d-9392-f27504ae5e5a"
      unitRef="eur">7798000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE4LTUtMS0xLTM2NDA2MA_cbca7a9d-da63-4a54-9d0c-49869ce7380b"
      unitRef="eur">13778000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE5LTItMS0xLTM2NDA2MA_811aef88-0caf-4e58-96c1-bdc44c33f454"
      unitRef="eur">2006000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE5LTMtMS0xLTM2NDA2MA_f9172ccc-dce0-4bfb-9a0a-169ba8c31b6e"
      unitRef="eur">1558000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE5LTUtMS0xLTM2NDA2MA_807f6c25-77e1-4ca9-83f3-d32acbeecd71"
      unitRef="eur">1807000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIwLTItMS0xLTM2NDA2MA_c2787a53-84f2-4461-bc2d-bc0a9d690abf"
      unitRef="eur">68000000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIwLTMtMS0xLTM2NDA2MA_7acb8075-cfda-4bba-8cc9-0a118fa1e1e6"
      unitRef="eur">39000000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIwLTUtMS0xLTM2NDA2MA_bb62ad5f-a735-41f9-a43f-912a735a61b5"
      unitRef="eur">359000000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLoss
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIzLTItMS0xLTM2NDA2MA_7d6f8084-a931-484f-b6c3-347a28efa325"
      unitRef="eur">8484000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIzLTMtMS0xLTM2NDA2MA_103df97f-3c26-4a40-adcf-52daa47141aa"
      unitRef="eur">6279000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIzLTUtMS0xLTM2NDA2MA_b1dd7d32-6f38-4252-800d-22bffe8f0002"
      unitRef="eur">12330000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI0LTItMS0xLTM2NDA2MA_614aace1-ca6e-40aa-8f38-05994406d0fb"
      unitRef="eur">113000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI0LTMtMS0xLTM2NDA2MA_d4a69564-bac1-4f21-aacf-979f8bd14a48"
      unitRef="eur">56000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI0LTUtMS0xLTM2NDA2MA_d0916b5d-41f1-4c2d-b244-c9d2fe8487af"
      unitRef="eur">36000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI1LTItMS0xLTM2NDA2MA_5f855f4a-2c4e-411a-95a1-5e7870e8fb0f"
      unitRef="eur">8371000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI1LTMtMS0xLTM2NDA2MA_dc8abe1c-a63c-4e5f-9628-9855b5c96788"
      unitRef="eur">6223000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI1LTUtMS0xLTM2NDA2MA_429b1ea7-b870-47ee-afaf-6f379bdc6039"
      unitRef="eur">12294000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:WeightedAverageShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI2LTItMS0xLTM2NDA2MA_1ec64694-737c-4efe-8d4c-77a786182da9"
      unitRef="shares">1251900000</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI2LTMtMS0xLTM2NDA2MA_2a710b10-bd2c-4094-9442-3b65a37c81a4"
      unitRef="shares">1252500000</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI2LTUtMS0xLTM2NDA2MA_dec78f17-eab8-4dc7-bf28-c3da212f14f4"
      unitRef="shares">1253600000</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI3LTItMS0xLTM2NDA2MA_15bcebb2-9846-4b1b-b44e-46bb861a3d58"
      unitRef="shares">1256900000</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI3LTMtMS0xLTM2NDA2MA_d87f6e4e-d005-42a6-95cf-0b64a76d46a6"
      unitRef="shares">1257900000</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI3LTUtMS0xLTM2NDA2MA_36bf6641-8869-4953-bd21-3b5bb82e56a3"
      unitRef="shares">1260100000</ifrs-full:AdjustedWeightedAverageShares>
    <sny:BasicEarningsLossPerShareAttributableToOwnersOfParent
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI4LTItMS0xLTM2NDA2MA_69a05bb5-cd34-4017-80bc-cc59072aa21b"
      unitRef="eurPerShare">6.69</sny:BasicEarningsLossPerShareAttributableToOwnersOfParent>
    <sny:BasicEarningsLossPerShareAttributableToOwnersOfParent
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI4LTMtMS0xLTM2NDA2MA_52c8c7a5-810b-449c-9055-25cacd1b5f01"
      unitRef="eurPerShare">4.97</sny:BasicEarningsLossPerShareAttributableToOwnersOfParent>
    <sny:BasicEarningsLossPerShareAttributableToOwnersOfParent
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI4LTUtMS0xLTM2NDA2MA_dcdc1738-eede-4f82-87b8-4634e2789a12"
      unitRef="eurPerShare">9.81</sny:BasicEarningsLossPerShareAttributableToOwnersOfParent>
    <sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMwLTItMS0xLTM2NDA2MA_33082f2a-97e0-4ee6-a145-f7aa75a0f018"
      unitRef="eurPerShare">6.66</sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent>
    <sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMwLTMtMS0xLTM2NDA2MA_211d2793-9591-422f-a895-283a5c7243b1"
      unitRef="eurPerShare">4.95</sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent>
    <sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMwLTUtMS0xLTM2NDA2MA_7343f7fd-6b65-4861-a0d6-934588b1df3f"
      unitRef="eurPerShare">9.76</sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent>
    <ifrs-full:ProfitLoss
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtMi0xLTEtMzY0MDYw_c18d2d94-9e98-4740-9dea-b3b5bb3e6624"
      unitRef="eur">8484000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtMy0xLTEtMzY0MDYw_15720d29-f51d-4243-a724-b51aaed82f61"
      unitRef="eur">6279000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtNS0xLTEtMzY0MDYw_de3a6b38-03fc-415d-8bd9-c7a22adf516d"
      unitRef="eur">12330000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItMi0xLTEtMzY0MDYw_a4c122bc-68a2-4d4b-88d5-dfb5a07f6f30"
      unitRef="eur">8371000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItMy0xLTEtMzY0MDYw_f6ab6b9e-394d-47cd-b041-d9ebde2baa91"
      unitRef="eur">6223000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItNS0xLTEtMzY0MDYw_2ca57e2b-4d8a-4c29-aa5a-b9735714fe38"
      unitRef="eur">12294000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtMi0xLTEtMzY0MDYw_7da84930-cdb5-4b45-a117-805b6c255aef"
      unitRef="eur">113000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtMy0xLTEtMzY0MDYw_d183fbe3-704a-461f-9c29-4665a5781c24"
      unitRef="eur">56000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtNS0xLTEtMzY0MDYw_237a3dc2-ea8e-4818-9ceb-9f36d1ecd979"
      unitRef="eur">36000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtMi0xLTEtMzY0MDYw_6d60d19f-fc47-4360-8d92-9e5d4dcfcd5c"
      unitRef="eur">-654000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtMy0xLTEtMzY0MDYw_36757908-4a31-49e1-8460-b9a6a6098871"
      unitRef="eur">-686000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtNS0xLTEtMzY0MDYw_435d1f07-5eb4-4598-9330-b197305f6473"
      unitRef="eur">267000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtMi0xLTEtMzY0MDYw_4df7fbc7-2f35-4bea-b1e3-cc5e25f82305"
      unitRef="eur">13000000</ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments>
    <ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtMy0xLTEtMzY0MDYw_5f84f4ad-c99d-4497-aad8-aeead8e33aab"
      unitRef="eur">165000000</ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments>
    <ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtNS0xLTEtMzY0MDYw_2bc5e8b8-b88f-47eb-845e-563d02b2636d"
      unitRef="eur">320000000</ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctMi0xLTEtMzY0MDYw_bb997a2b-777a-475b-b1c7-91f3063d31e4"
      unitRef="eur">216000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctMy0xLTEtMzY0MDYw_5b5cd334-de8f-4210-9dfa-e3106b3a71d0"
      unitRef="eur">54000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctNS0xLTEtMzY0MDYw_18e9fb42-cb58-4dce-bbf7-d09d691c0b1e"
      unitRef="eur">39000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtMi0xLTEtMzY0MDYw_082d0377-9d8d-4f4e-9015-65ddde6b4f31"
      unitRef="eur">451000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtMy0xLTEtMzY0MDYw_32714259-ecc6-4423-923f-e5e0eaa08e52"
      unitRef="eur">797000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtNS0xLTEtMzY0MDYw_fb721cb2-cbc5-4cdf-9e8c-d27869d08598"
      unitRef="eur">14000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktMi0xLTEtMzY0MDYw_970d131b-d7da-4ce2-b656-b245bbaa187d"
      unitRef="eur">-77000000</sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax>
    <sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktMy0xLTEtMzY0MDYw_2d1e94df-65e1-4c7e-85d2-19e5cc554ff7"
      unitRef="eur">-21000000</sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax>
    <sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktNS0xLTEtMzY0MDYw_907e71fe-0dea-4046-ab34-b67490b5d9c1"
      unitRef="eur">15000000</sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax>
    <ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTItMS0xLTM2NDA2MA_dc18bfc4-9a41-4e4d-b0db-9f28719aa0e9"
      unitRef="eur">7000000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
    <ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTMtMS0xLTM2NDA2MA_367bcc0a-3a06-4fd3-9495-15ee61eae0d8"
      unitRef="eur">-6000000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
    <ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTUtMS0xLTM2NDA2MA_50dfd5b6-6e1f-483c-8373-bc3fafbd00c5"
      unitRef="eur">4000000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTItMS0xLTM2NDA2MA_0c972dbc-8317-44f8-98de-36fd683e658a"
      unitRef="eur">2278000000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTMtMS0xLTM2NDA2MA_cd7bfc58-ac84-4fd5-a22b-ce2f411ac841"
      unitRef="eur">2459000000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTUtMS0xLTM2NDA2MA_e66fe460-ee48-4282-b2d7-bcd045c240a8"
      unitRef="eur">-3976000000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTItMS0xLTM2NDA2MA_600b1ed7-8c93-4540-87ce-b2ad34b891a8"
      unitRef="eur">-105000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTMtMS0xLTM2NDA2MA_aeb01230-3b21-4937-bdf3-3f527d689c1d"
      unitRef="eur">-78000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTUtMS0xLTM2NDA2MA_8174f1f3-2466-4f1c-8542-a62d0087c44c"
      unitRef="eur">64000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTItMS0xLTM2NDA2MA_2fdf661f-89c3-4f58-be82-b7e75ca061f3"
      unitRef="eur">2313000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTMtMS0xLTM2NDA2MA_aebab50d-8f4e-40ec-aae9-07cc65f9432c"
      unitRef="eur">2510000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTUtMS0xLTM2NDA2MA_7af04be4-34b5-46f5-a8ab-415095093659"
      unitRef="eur">-4021000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTItMS0xLTM2NDA2MA_7d3e569c-7895-4d99-b7e5-733b1a89241a"
      unitRef="eur">2764000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTMtMS0xLTM2NDA2MA_b0fd60b7-e57d-45a7-aef5-8cd1c0ea561a"
      unitRef="eur">3307000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTUtMS0xLTM2NDA2MA_d7129fd9-ad9b-4a70-973b-204286aca61a"
      unitRef="eur">-4007000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTItMS0xLTM2NDA2MA_f02c581c-13bb-4fe0-8284-f88c5c7cdba7"
      unitRef="eur">11248000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTMtMS0xLTM2NDA2MA_752d051b-3bab-45fe-976e-9867c1e053ae"
      unitRef="eur">9586000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTUtMS0xLTM2NDA2MA_41d5471b-40b4-46ab-84c7-ded290c4ae26"
      unitRef="eur">8323000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTItMS0xLTM2NDA2MA_88775fda-c370-41f7-9ef4-829643046d9d"
      unitRef="eur">11130000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTMtMS0xLTM2NDA2MA_3c5b5f3e-8f21-491f-84f6-b27988fa054c"
      unitRef="eur">9519000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTUtMS0xLTM2NDA2MA_e29579b8-4dc3-46e3-bc20-f37e964677de"
      unitRef="eur">8307000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTItMS0xLTM2NDA2MA_66962799-6bb7-4f2a-ad10-555474eaef80"
      unitRef="eur">118000000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTMtMS0xLTM2NDA2MA_6bb5bac3-ab4e-47b0-90a4-afbf89a19b46"
      unitRef="eur">67000000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTUtMS0xLTM2NDA2MA_2077b0a9-191f-434f-9f6a-2135a5630397"
      unitRef="eur">16000000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="i8167f91dae314f4eaa1e5e23abf0fcae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMS0xLTEtMzY0MDYw_e9272b1a-fe3d-426b-a99f-53e92de05eb9"
      unitRef="eur">2508000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i7b29272f0f8e444e8185ac9de81d8964_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMi0xLTEtMzY0MDYw_ac125ec7-8c00-456b-a926-eae2e5fe9e21"
      unitRef="eur">147000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i2180880b8f3d4518b6d13260c4b00509_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMy0xLTEtMzY0MDYw_98439be4-0899-45a9-8c40-1f08323f2f80"
      unitRef="eur">-9000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i0a649176e103430588e7d82e8b4b2eae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNC0xLTEtMzY0MDYw_92ac7881-3d55-420a-b4c2-2fb93c8b0d16"
      unitRef="eur">51902000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="ideadd6fc92744c689451476829e9bf88_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNS0xLTEtMzY0MDYw_85024497-8f3f-4693-bd13-5573dd0fcfc6"
      unitRef="eur">3863000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i30f1c21919c94f78ac899771e9dc6747_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNi0xLTEtMzY0MDYw_4d873dbd-5b16-420c-bc86-3b872b223384"
      unitRef="eur">645000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i79431d18a64048a3a31458a8519c8577_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNy0xLTEtMzY0MDYw_019c0649-48f9-40cf-a9ef-572100611c48"
      unitRef="eur">59056000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="ic7ec55dbabba4baeaa5077aa469ea0b9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOC0xLTEtMzY0MDYw_456437df-583f-4c00-9f6b-cd0b97e72e21"
      unitRef="eur">174000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOS0xLTEtMzY0MDYw_023a6c6b-fba0-42f8-9428-48306bc6c7ac"
      unitRef="eur">59230000000</ifrs-full:Equity>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNC0xLTEtMzY0MDYw_f8be43f1-b0d8-4be1-afb2-aee2ca1e815f"
      unitRef="eur">14000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i091093d5d8a34da889e3748a9b22dca7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNi0xLTEtMzY0MDYw_b48cb9d0-b1a6-4e2f-a0c7-3197e8992a22"
      unitRef="eur">-4001000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNy0xLTEtMzY0MDYw_c44cfc7a-13ba-4cb5-9268-ca68969a17c6"
      unitRef="eur">-3987000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i628f75ce25844ff8b7d482c8c7b43c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOC0xLTEtMzY0MDYw_17dc2a9e-c0a5-4c32-a0f2-c7461a8a0ea5"
      unitRef="eur">-20000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOS0xLTEtMzY0MDYw_96be92e2-3e8d-4f73-aa9d-01e2d758605c"
      unitRef="eur">-4007000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ProfitLoss
      contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNC0xLTEtMzY0MDYw_8375809a-87a8-4244-a166-9de316ecd262"
      unitRef="eur">12294000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNy0xLTEtMzY0MDYw_ef6cb36e-a284-4b73-9bfe-1aa48de80519"
      unitRef="eur">12294000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="i628f75ce25844ff8b7d482c8c7b43c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOC0xLTEtMzY0MDYw_697a50ed-0ca3-4e2c-9508-8d2b84920b9d"
      unitRef="eur">36000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOS0xLTEtMzY0MDYw_eb447b21-2a14-46ed-807e-30dd4a2864df"
      unitRef="eur">12330000000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNC0xLTEtMzY0MDYw_140fe7cd-ce4a-4e11-ad35-986fdf070bc4"
      unitRef="eur">12308000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i091093d5d8a34da889e3748a9b22dca7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNi0xLTEtMzY0MDYw_38cc5712-2e8d-47a4-9fb2-b23709a48d33"
      unitRef="eur">-4001000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNy0xLTEtMzY0MDYw_e8780054-fa54-4ab7-b9bd-3971d22c2a23"
      unitRef="eur">8307000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i628f75ce25844ff8b7d482c8c7b43c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOC0xLTEtMzY0MDYw_8d50453b-88c4-41cc-bb0f-46fbbd783c17"
      unitRef="eur">16000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOS0xLTEtMzY0MDYw_3ac6378f-f68a-4f1a-8888-ff27c1940bd6"
      unitRef="eur">8323000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:DividendsPaidOrdinarySharesPerShare
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzgtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246OGZiNTE4ZTgzZGNhNDg3ZGE2YzNhODJjODg0YWEyMDJfNDA_53b51296-93ad-4305-bd97-d67464345df2"
      unitRef="eurPerShare">3.15</ifrs-full:DividendsPaidOrdinarySharesPerShare>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzgtNC0xLTEtMzY0MDYw_b505bd14-40c6-45fd-a490-b968ff00c9ea"
      unitRef="eur">3937000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzgtNy0xLTEtMzY0MDYw_08351441-0982-4ab4-b80c-20d0796f1873"
      unitRef="eur">3937000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzgtOS0xLTEtMzY0MDYw_1667736a-149d-4812-9b3e-b70bc0b2058d"
      unitRef="eur">3937000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzktNy0xLTEtMzY0MDYw_128a40e2-b02d-4acf-bf75-67c837366e9f"
      unitRef="eur">0</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="i628f75ce25844ff8b7d482c8c7b43c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzktOC0xLTEtMzY0MDYw_7637a89d-eb19-4852-b9d0-07f72ef97dfe"
      unitRef="eur">44000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzktOS0xLTEtMzY0MDYw_65482607-a190-45d2-b859-3296ce4aaf3e"
      unitRef="eur">44000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="if9fd8343fd3c47a2b272658a928ae800_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTMtMS0xLTM2NDA2MA_4d3f5d84-0e38-4849-96ea-70ecac235e1f"
      unitRef="eur">822000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTctMS0xLTM2NDA2MA_3761d949-ac3c-4c18-bfca-42fb105b8059"
      unitRef="eur">822000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTktMS0xLTM2NDA2MA_5195a35a-d9e7-4bcb-999f-1d0f95a44696"
      unitRef="eur">822000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="i38ee6479a7a24540a49f0870e964ced9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTEtMS0xLTM2NDA2MA_e1f4057a-3d3e-477a-9a08-4c4524aaf0b0"
      unitRef="eur">2000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="i918e8adb634840c39e00f014e91457f5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTItMS0xLTM2NDA2MA_f9b8e3a2-a116-441b-87d1-f1c4ecc26dc4"
      unitRef="eur">49000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTctMS0xLTM2NDA2MA_a440e3b1-17e1-4af9-a70c-6a3ed6d07c76"
      unitRef="eur">51000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTktMS0xLTM2NDA2MA_9bd07696-1dde-4504-9b5e-530204637e84"
      unitRef="eur">51000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i38ee6479a7a24540a49f0870e964ced9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTEtMS0xLTM2NDA2MA_33fae6b3-9207-4d19-9d97-7ee96a7e8cb0"
      unitRef="eur">3000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i918e8adb634840c39e00f014e91457f5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTItMS0xLTM2NDA2MA_83a539ae-f2b8-47b7-9f22-1165eb4c8b79"
      unitRef="eur">-3000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="if9fd8343fd3c47a2b272658a928ae800_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTMtMS0xLTM2NDA2MA_a3cc8a2b-319d-4917-9c92-6369a3ca6160"
      unitRef="eur">126000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTQtMS0xLTM2NDA2MA_a54887eb-413f-4b98-aa4f-8a4294525ef9"
      unitRef="eur">-126000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTctMS0xLTM2NDA2MA_cf7f4845-b348-4256-9769-f70e15885bba"
      unitRef="eur">0</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTktMS0xLTM2NDA2MA_0c6b15d9-7af1-4550-b2ef-c670cd3ad5bf"
      unitRef="eur">0</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="i38ee6479a7a24540a49f0870e964ced9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTEtMS0xLTM2NDA2MA_d697ad7c-a266-4ec0-852c-7a3b8fe77e34"
      unitRef="eur">5000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="i918e8adb634840c39e00f014e91457f5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTItMS0xLTM2NDA2MA_cfaed0ab-1e26-4a37-bca1-077606cbdc5a"
      unitRef="eur">169000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTctMS0xLTM2NDA2MA_a7795b9e-f39e-4240-a4a6-e37101e11a18"
      unitRef="eur">174000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTktMS0xLTM2NDA2MA_9ac65895-eb89-4cb3-966c-6affa541fe43"
      unitRef="eur">174000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="i0555249224484a73af0282b1a26fae99_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE3LTUtMS0xLTM2NDA2MA_7b1c5b38-1a4d-468a-a4bb-a65437fc1999"
      unitRef="eur">274000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE3LTctMS0xLTM2NDA2MA_16a5feeb-10db-4601-8416-135bd79b3b01"
      unitRef="eur">274000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE3LTktMS0xLTM2NDA2MA_fe200c58-6b6b-40a0-b99d-f045bfa00339"
      unitRef="eur">274000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="i0555249224484a73af0282b1a26fae99_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE4LTUtMS0xLTM2NDA2MA_633de78a-feac-415c-8bfe-cb8803abe3c9"
      unitRef="eur">1000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE4LTctMS0xLTM2NDA2MA_1d7bc62b-ea0b-4bc5-b615-e43c329449e2"
      unitRef="eur">1000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE4LTktMS0xLTM2NDA2MA_560cabe6-dca3-454b-9702-ee86a513f240"
      unitRef="eur">1000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity
      contextRef="ifbbc0432cfa047bb928c989d4dc04347_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTQtMS0xLTM2NDA2MA_39a3dc95-e4cd-42bb-99dd-3455fc0e3fa0"
      unitRef="eur">2000000</sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity>
    <sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity
      contextRef="i20ed79569e49404fa463967cf4bdb248_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTctMS0xLTM2NDA2MA_858bc692-12bb-4cb4-803b-4d0fbb3367e6"
      unitRef="eur">2000000</sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity>
    <sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTktMS0xLTM2NDA2MA_0c77d10e-004c-46bb-8b5e-0931a9be0c1b"
      unitRef="eur">2000000</sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity>
    <ifrs-full:Equity
      contextRef="i82a067b6228743299309f26020eedd15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTEtMS0xLTM2NDA2MA_54c82653-9a92-445e-8ab8-a3b427009f86"
      unitRef="eur">2518000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="ie6e671cfe56146318823f0ae1232ffd4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTItMS0xLTM2NDA2MA_9e18e429-fe52-4c81-a708-2073d2babcf8"
      unitRef="eur">362000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i433315b6bd834cb68354e5a52b56773d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTMtMS0xLTM2NDA2MA_7ec2f7d8-f54d-4e3d-be28-978ea5def617"
      unitRef="eur">-705000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i37a894ed8b0d4cc88bdaa2442942a150_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTQtMS0xLTM2NDA2MA_100ab860-fe28-4fae-a197-702bde1a726b"
      unitRef="eur">60149000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i3ca205c9d7904bcd84d4f88ddec8328a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTUtMS0xLTM2NDA2MA_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c"
      unitRef="eur">4138000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i2b7f53f9cf764e73bd0e72cef8b7390f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTYtMS0xLTM2NDA2MA_33eaa7e7-913c-45e1-95c3-1eb2f72cee81"
      unitRef="eur">-3356000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="ic46b4d1e50bc43e489fc0520c892a40d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTctMS0xLTM2NDA2MA_8fe9842c-2530-452e-8bcb-bf5f2008673f"
      unitRef="eur">63106000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i58dddc96bde6438a903a080d6f6acb31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTgtMS0xLTM2NDA2MA_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17"
      unitRef="eur">146000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTktMS0xLTM2NDA2MA_19f875f9-870d-403b-aca5-d3d399246b17"
      unitRef="eur">63252000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i82a067b6228743299309f26020eedd15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMS0xLTEtMzY0MDYw_54c82653-9a92-445e-8ab8-a3b427009f86"
      unitRef="eur">2518000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="ie6e671cfe56146318823f0ae1232ffd4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMi0xLTEtMzY0MDYw_9e18e429-fe52-4c81-a708-2073d2babcf8"
      unitRef="eur">362000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i433315b6bd834cb68354e5a52b56773d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMy0xLTEtMzY0MDYw_7ec2f7d8-f54d-4e3d-be28-978ea5def617"
      unitRef="eur">-705000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i37a894ed8b0d4cc88bdaa2442942a150_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNC0xLTEtMzY0MDYw_100ab860-fe28-4fae-a197-702bde1a726b"
      unitRef="eur">60149000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i3ca205c9d7904bcd84d4f88ddec8328a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNS0xLTEtMzY0MDYw_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c"
      unitRef="eur">4138000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i2b7f53f9cf764e73bd0e72cef8b7390f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNi0xLTEtMzY0MDYw_33eaa7e7-913c-45e1-95c3-1eb2f72cee81"
      unitRef="eur">-3356000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="ic46b4d1e50bc43e489fc0520c892a40d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNy0xLTEtMzY0MDYw_8fe9842c-2530-452e-8bcb-bf5f2008673f"
      unitRef="eur">63106000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i58dddc96bde6438a903a080d6f6acb31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOC0xLTEtMzY0MDYw_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17"
      unitRef="eur">146000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOS0xLTEtMzY0MDYw_19f875f9-870d-403b-aca5-d3d399246b17"
      unitRef="eur">63252000000</ifrs-full:Equity>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzItNC0xLTEtMzY0MDYw_2a4ce0dd-21e6-41fb-845c-3bad46540a4d"
      unitRef="eur">797000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i468fc46d6073421aa776f6c974d1f45d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzItNi0xLTEtMzY0MDYw_952d6f6e-b244-4523-bc9a-fa323a1f8bcd"
      unitRef="eur">2499000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzItNy0xLTEtMzY0MDYw_29fcb0eb-9cd3-4cb0-a39d-aab44c8d2580"
      unitRef="eur">3296000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzItOC0xLTEtMzY0MDYw_ebdcecef-cf3d-4b48-baf8-c3234d3ee481"
      unitRef="eur">11000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzItOS0xLTEtMzY0MDYw_b0d25be0-20f6-4de9-903b-df5fad575d48"
      unitRef="eur">3307000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ProfitLoss
      contextRef="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzMtNC0xLTEtMzY0MDYw_6dd5ed10-2522-4ee9-94c0-97f2db62e876"
      unitRef="eur">6223000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzMtNy0xLTEtMzY0MDYw_39305ac1-a81a-4324-a5dc-40d727c5c32c"
      unitRef="eur">6223000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzMtOC0xLTEtMzY0MDYw_afc7158d-5a91-49f2-a308-20d2c6d5663e"
      unitRef="eur">56000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzMtOS0xLTEtMzY0MDYw_41d42015-9f3a-4b97-af8c-15e1fe711bd6"
      unitRef="eur">6279000000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzQtNC0xLTEtMzY0MDYw_e404461d-185d-468e-ad80-555443ac3b84"
      unitRef="eur">7020000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i468fc46d6073421aa776f6c974d1f45d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzQtNi0xLTEtMzY0MDYw_e3b5c4e9-2577-4225-92ba-cb11df51fb45"
      unitRef="eur">2499000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzQtNy0xLTEtMzY0MDYw_a1e4992a-0dca-4560-9f55-f42c1f7476a1"
      unitRef="eur">9519000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzQtOC0xLTEtMzY0MDYw_cf1ce047-3510-47d5-82c0-45991cbb9ea0"
      unitRef="eur">67000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzQtOS0xLTEtMzY0MDYw_ae53e442-059b-40b9-8bf6-fde9c2f551fe"
      unitRef="eur">9586000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:DividendsPaidOrdinarySharesPerShare
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246MDE3YTQzZWE0MjBlNDNmYzg0ZDNhYzM1OTNiNDNmNjFfNDA_b033f814-723e-4125-b2c9-55ba44eb1c0b"
      unitRef="eurPerShare">3.20</ifrs-full:DividendsPaidOrdinarySharesPerShare>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzUtNC0xLTEtMzY0MDYw_33779d22-3399-4229-97be-22f1d8ee7aaf"
      unitRef="eur">4008000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzUtNy0xLTEtMzY0MDYw_512cb026-71e3-4ece-881f-74199a796237"
      unitRef="eur">4008000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzUtOS0xLTEtMzY0MDYw_015696a0-9480-4cc1-a46e-7b79333f3634"
      unitRef="eur">4008000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzYtNy0xLTEtMzY0MDYw_44a9757c-2bdf-4808-9cf6-072ff7c9265a"
      unitRef="eur">0</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzYtOC0xLTEtMzY0MDYw_e865978d-de3c-4d65-b20e-f51271454727"
      unitRef="eur">49000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzYtOS0xLTEtMzY0MDYw_363a0e25-8a24-4023-8461-3ad21bb3530e"
      unitRef="eur">49000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="i44a6cd71a87a4d59ad6055e7b101e7e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctMy0xLTEtMzY0MDYw_d7773337-9244-43fc-bbaa-cfef96bffdda"
      unitRef="eur">382000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctNy0xLTEtMzY0MDYw_b3b85699-074d-4b7a-a51b-bb2b00ffeac4"
      unitRef="eur">382000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctOS0xLTEtMzY0MDYw_c02723a3-2291-4b9c-8635-75fbddffe076"
      unitRef="eur">382000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="i0a305363936e4b86afca45f34eb6b080_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTItMS0xLTM2NDA2MA_59b04cfd-6682-4d1c-a629-33077e6ffe2c"
      unitRef="eur">11000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTctMS0xLTM2NDA2MA_dece824f-4712-4939-ba41-a6b138a7be2f"
      unitRef="eur">11000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTktMS0xLTM2NDA2MA_7bc1440f-ea82-44cc-8743-b7ffed1f06ce"
      unitRef="eur">11000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="if87626104e564cce8dc2afa187c5f744_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTEtMS0xLTM2NDA2MA_d98f69dc-b0f1-4cc8-b70b-7984fd78a6c5"
      unitRef="eur">4000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i0a305363936e4b86afca45f34eb6b080_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTItMS0xLTM2NDA2MA_c4a51e91-2309-4fbe-b254-e8eb14d6d2dd"
      unitRef="eur">-4000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i44a6cd71a87a4d59ad6055e7b101e7e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTMtMS0xLTM2NDA2MA_217e0ead-39cc-4dbd-abcd-ae1f822db699"
      unitRef="eur">148000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i5d591dc5152b47c18b79ebab4710a609_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTQtMS0xLTM2NDA2MA_c0f9ae73-8f74-48e5-80b3-a5993099957c"
      unitRef="eur">-148000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTctMS0xLTM2NDA2MA_a399014e-7c97-4436-a95a-792d15aba016"
      unitRef="eur">0</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTktMS0xLTM2NDA2MA_4583d946-900e-45c5-9fef-2daede5d4639"
      unitRef="eur">0</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="if87626104e564cce8dc2afa187c5f744_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTEtMS0xLTM2NDA2MA_3708407a-51d1-4dbe-85b9-85c10719e785"
      unitRef="eur">5000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="i0a305363936e4b86afca45f34eb6b080_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTItMS0xLTM2NDA2MA_01061c07-03f6-4b1a-880a-d3f05103e41f"
      unitRef="eur">163000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTctMS0xLTM2NDA2MA_986cf489-8ff4-4209-ad3e-fe78494e8b5a"
      unitRef="eur">168000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTktMS0xLTM2NDA2MA_d2d61b17-f46d-45c7-a1c5-9aacd7ed7565"
      unitRef="eur">168000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="i35c163cbd49a4859ac64117df33aca94_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE0LTUtMS0xLTM2NDA2MA_f65494f0-c9cf-421c-8c99-a7bd42aa5db6"
      unitRef="eur">244000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE0LTctMS0xLTM2NDA2MA_2eedfe8a-ccb1-4626-af20-ec703df7fdc4"
      unitRef="eur">244000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE0LTktMS0xLTM2NDA2MA_f0a94797-76e7-4d0e-a0ba-0ab887eeee43"
      unitRef="eur">244000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="i35c163cbd49a4859ac64117df33aca94_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE1LTUtMS0xLTM2NDA2MA_7daee9c0-2866-4ccc-b2d5-0a9be3064963"
      unitRef="eur">23000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE1LTctMS0xLTM2NDA2MA_dad2a824-4a91-4283-8014-6bbb1b3ba538"
      unitRef="eur">23000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE1LTktMS0xLTM2NDA2MA_5d948728-be37-4ad8-be08-6016145492b0"
      unitRef="eur">23000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment
      contextRef="i8bf2920b7dbe41f19dbb667d93d109d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTctMS0xLTM2NDA2MA_e3abb3d3-cf48-47c9-b9e2-037b404aa01f"
      unitRef="eur">0</sny:IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment>
    <sny:IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment
      contextRef="i77e2e10ba1e44e4bad6076b155a1ca50_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTgtMS0xLTM2NDA2MA_66b952c4-dd45-40ca-b631-a61c26f81d02"
      unitRef="eur">186000000</sny:IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment>
    <sny:IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTktMS0xLTM2NDA2MA_357b481e-b9f2-4d99-9307-e25cca9bb8c8"
      unitRef="eur">186000000</sny:IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment>
    <ifrs-full:Equity
      contextRef="i05354df582904ca187452170ab40afab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTEtMS0xLTM2NDA2MA_55aabf27-33d3-4557-a185-a6a993efc283"
      unitRef="eur">2527000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i1dc0731d8fb949fe81ed2ae0a256af2b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTItMS0xLTM2NDA2MA_2cfd5a0d-a788-4aea-bdfc-d4d688b66e84"
      unitRef="eur">532000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i203e64c16cf348b2a1f3041af709228d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTMtMS0xLTM2NDA2MA_c7aae293-aadf-4df8-9461-b62dd37d0f1f"
      unitRef="eur">-939000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i0475ae1c115247ef98cdcb07ea3cc9fe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTQtMS0xLTM2NDA2MA_40ea7980-81f8-4e71-b191-dbb5b6751758"
      unitRef="eur">63013000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i46555157a0b04f06bf0709e9682eadac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTUtMS0xLTM2NDA2MA_bbc4da14-4b12-4c0a-8153-873eb8301110"
      unitRef="eur">4405000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="ifbedee479b66410dae9bbe7401f7af56_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTYtMS0xLTM2NDA2MA_e90aee12-e90b-436f-98ca-85fafd20d022"
      unitRef="eur">-857000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i9132ddbceaa74f6eb21b9ebb8cf0837b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTctMS0xLTM2NDA2MA_5440aa48-3754-4f27-98ac-66eb07135302"
      unitRef="eur">68681000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="id6bb87ee615b46b99718617248bfa891_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTgtMS0xLTM2NDA2MA_df07d499-23cf-4886-b63f-a6abbfcc3b3e"
      unitRef="eur">350000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE5LTktMS0xLTM2NDA2MA_4b1c521b-edbe-4266-bd9a-a33fb8fbcc49"
      unitRef="eur">69031000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i05354df582904ca187452170ab40afab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtMS0xLTEtMzY0MDYw_a37863dc-f973-4494-835a-06d65bbb64d5"
      unitRef="eur">2527000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i1dc0731d8fb949fe81ed2ae0a256af2b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtMi0xLTEtMzY0MDYw_ee1c2108-0e5c-4055-bb82-1cce045f346f"
      unitRef="eur">532000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i203e64c16cf348b2a1f3041af709228d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtMy0xLTEtMzY0MDYw_cab31171-0c4b-4ab5-a7d1-36f4cecaa870"
      unitRef="eur">-939000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i0475ae1c115247ef98cdcb07ea3cc9fe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtNC0xLTEtMzY0MDYw_314cb026-70be-4d26-8751-000e5db5feb6"
      unitRef="eur">63013000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i46555157a0b04f06bf0709e9682eadac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtNS0xLTEtMzY0MDYw_d377d5e5-f903-4fd1-bd58-274a0fec02cb"
      unitRef="eur">4405000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="ifbedee479b66410dae9bbe7401f7af56_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtNi0xLTEtMzY0MDYw_642afeeb-7293-42e7-a4f3-07c2ac5028bd"
      unitRef="eur">-857000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i9132ddbceaa74f6eb21b9ebb8cf0837b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtNy0xLTEtMzY0MDYw_264fb611-dbf2-4ff5-9206-140eda6a35f5"
      unitRef="eur">68681000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="id6bb87ee615b46b99718617248bfa891_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtOC0xLTEtMzY0MDYw_554a3b9b-0c04-4da7-9e86-9cf86791c8cf"
      unitRef="eur">350000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEtOS0xLTEtMzY0MDYw_ee50cff5-e1bd-45a7-9ede-11c3c5342b6f"
      unitRef="eur">69031000000</ifrs-full:Equity>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzItNC0xLTEtMzY0MDYw_f6477137-ed24-4e02-b287-edfc2d5d801f"
      unitRef="eur">451000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i907c3d71d3014745b11f4974adf6844d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzItNi0xLTEtMzY0MDYw_286c5606-6c5a-40fe-a207-bf7e5bbb21ee"
      unitRef="eur">2308000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzItNy0xLTEtMzY0MDYw_4f76faca-abc3-4e13-aca7-008a6e408ee5"
      unitRef="eur">2759000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="i037c746f41544e359176f1f7ef73ab39_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzItOC0xLTEtMzY0MDYw_d56c2fb5-461d-4d85-b7b3-7cbba47eabc9"
      unitRef="eur">5000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzItOS0xLTEtMzY0MDYw_84b746e0-d321-4e3d-837e-54ebeaab2aff"
      unitRef="eur">2764000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ProfitLoss
      contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzMtNC0xLTEtMzY0MDYw_d1fdd47a-6277-4cea-9383-715b6bce4c28"
      unitRef="eur">8371000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzMtNy0xLTEtMzY0MDYw_7ce2eab9-7444-4584-8930-ff352d55f39f"
      unitRef="eur">8371000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="i037c746f41544e359176f1f7ef73ab39_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzMtOC0xLTEtMzY0MDYw_ef434e7f-ce6f-4efb-84b8-7a86c4369849"
      unitRef="eur">113000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzMtOS0xLTEtMzY0MDYw_32c7219f-7377-431e-a015-54dc7168e554"
      unitRef="eur">8484000000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzQtNC0xLTEtMzY0MDYw_5fccd643-82eb-40e0-9025-c5ad4492e9f4"
      unitRef="eur">8822000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i907c3d71d3014745b11f4974adf6844d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzQtNi0xLTEtMzY0MDYw_5b12ce87-ec95-4150-a3d4-1055b15e5731"
      unitRef="eur">2308000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzQtNy0xLTEtMzY0MDYw_c07f9683-9d9a-4df7-a615-efc0da51836a"
      unitRef="eur">11130000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="i037c746f41544e359176f1f7ef73ab39_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzQtOC0xLTEtMzY0MDYw_375b6b6e-1509-44d4-9272-a224da7ca1bc"
      unitRef="eur">118000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzQtOS0xLTEtMzY0MDYw_4789c1f5-7615-4306-8929-98aa69107289"
      unitRef="eur">11248000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:DividendsPaidOrdinarySharesPerShare
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246NjJhNDY5NTRjMTE4NDNjYzhiNzhjN2YxYTFlMWM1NTZfNDA_a6f20625-e294-4c50-a621-7746a4ffcc68"
      unitRef="eurPerShare">3.33</ifrs-full:DividendsPaidOrdinarySharesPerShare>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzUtNC0xLTEtMzY0MDYw_945f2bd0-3b08-4d92-8d66-e3c5641b89fc"
      unitRef="eur">4168000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzUtNy0xLTEtMzY0MDYw_10cb5a44-c9d4-4ba9-a92f-80f184cba776"
      unitRef="eur">4168000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzUtOS0xLTEtMzY0MDYw_2e56355f-7f9b-43b3-9195-b5ed6d4c44ec"
      unitRef="eur">4168000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <sny:ExceptionalSupplementaryDividendPercentageOfShareCapital
      contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtMC0xLTEtNDY3Nzk3L3RleHRyZWdpb246NzI0YWYxNTJkNWQ0NDExMDkwNTY5MzI5YTljN2Y0NjdfMTk3OTEyMDkzMDAxMTM_6b7a7082-776c-478e-84e1-746d4ef6d37d"
      unitRef="number">0.58</sny:ExceptionalSupplementaryDividendPercentageOfShareCapital>
    <sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNC0xLTEtNDA0Njk0_85714117-9f74-4cd3-93b2-0175fc92848f"
      unitRef="eur">793000000</sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent>
    <sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNy0xLTEtNDA0Njk0_3f2777e7-72dd-447f-b207-67436a3ec3eb"
      unitRef="eur">793000000</sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent>
    <sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtOS0xLTEtNDA0Njk0_4f3465d3-e06d-4e0a-945e-ef98d44a023f"
      unitRef="eur">793000000</sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNy0xLTEtMzY0MDYw_0d49aed0-2a6e-4fe7-841e-ba17279d555e"
      unitRef="eur">0</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="i037c746f41544e359176f1f7ef73ab39_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtOC0xLTEtMzY0MDYw_3f13ada2-ae16-425e-a6ae-f5ca08c92892"
      unitRef="eur">100000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtOS0xLTEtMzY0MDYw_4ca7467d-adf1-4d28-b03a-ee196794df14"
      unitRef="eur">100000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="if12be8423b674ce99c50f89b01868fbb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctMy0xLTEtMzY0MDYw_843c78b6-7768-4ec0-89a4-98462d66f6a5"
      unitRef="eur">497000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctNy0xLTEtMzY0MDYw_c1ae37c7-0636-4eb5-a37d-1fe172200b6d"
      unitRef="eur">497000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctOS0xLTEtMzY0MDYw_88979adf-c420-4d86-86ac-4d172e42c928"
      unitRef="eur">497000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="i92e8a87ffe214bca94b143308473a86c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMS0xLTEtMzY0MDYw_af7b7cbd-9a7f-49a4-98d4-85e25892f5b9"
      unitRef="eur">13000000</ifrs-full:ReductionOfIssuedCapital>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="i9b77bf6a7f474a47a49a3925dd91d87e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMi0xLTEtMzY0MDYw_4fbe68a1-d00d-41d8-8219-b4f35de27b96"
      unitRef="eur">587000000</ifrs-full:ReductionOfIssuedCapital>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="if12be8423b674ce99c50f89b01868fbb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMy0xLTEtMzY0MDYw_9f35d2b3-a513-4223-921a-aba617b755fc"
      unitRef="eur">-600000000</ifrs-full:ReductionOfIssuedCapital>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtNy0xLTEtMzY0MDYw_80f47a56-a29d-4996-b77c-12bd76af1562"
      unitRef="eur">0</ifrs-full:ReductionOfIssuedCapital>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtOS0xLTEtMzY0MDYw_054eede4-8ea9-4866-aeab-74dd86e513ad"
      unitRef="eur">0</ifrs-full:ReductionOfIssuedCapital>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="i92e8a87ffe214bca94b143308473a86c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTEtMS0xLTM2NDA2MA_e5014827-23a4-4ba5-bb24-c7e7fae6dc81"
      unitRef="eur">1000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="i9b77bf6a7f474a47a49a3925dd91d87e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTItMS0xLTM2NDA2MA_dc1f79e8-2ad8-417d-98c5-247116579faa"
      unitRef="eur">34000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTctMS0xLTM2NDA2MA_93c318bd-c64d-47b6-bff2-9f2bf1368cb6"
      unitRef="eur">35000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTktMS0xLTM2NDA2MA_e12d1ed9-a847-4dcb-9553-d3ae72a6114e"
      unitRef="eur">35000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i92e8a87ffe214bca94b143308473a86c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTEtMS0xLTM2NDA2MA_3b202fd8-00e4-487b-87e9-9a7b27f67620"
      unitRef="eur">3000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i9b77bf6a7f474a47a49a3925dd91d87e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTItMS0xLTM2NDA2MA_7d7feed9-e45b-4567-ae2c-b2271c3b7e4c"
      unitRef="eur">-3000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="if12be8423b674ce99c50f89b01868fbb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTMtMS0xLTM2NDA2MA_ca2b6a8e-c22e-4f5c-b27f-219af0cd4527"
      unitRef="eur">130000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTQtMS0xLTM2NDA2MA_7ccde0a3-7066-40e2-8a3b-eaaff4071556"
      unitRef="eur">-130000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTctMS0xLTM2NDA2MA_c0c113d9-32b7-4444-a088-c2774c355f21"
      unitRef="eur">0</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTktMS0xLTM2NDA2MA_d8a8feb1-1cfa-42fb-bf37-81ef1afefc31"
      unitRef="eur">0</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="i92e8a87ffe214bca94b143308473a86c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTEtMS0xLTM2NDA2MA_74a27fce-bb34-46a6-aa1a-129f0a994827"
      unitRef="eur">4000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="i9b77bf6a7f474a47a49a3925dd91d87e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTItMS0xLTM2NDA2MA_b6549c65-de99-4001-8799-8f8e98f4e1e5"
      unitRef="eur">149000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTctMS0xLTM2NDA2MA_ea315a7f-252f-419b-8d4f-db0e553b3e76"
      unitRef="eur">153000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTktMS0xLTM2NDA2MA_2cd2613d-9aa8-490f-937a-c8d907ef0693"
      unitRef="eur">153000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="if59ff530abc54fa08a014d04b57eaad1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE1LTUtMS0xLTM2NDA2MA_41320e38-bd52-4ae1-bf36-1c98ba3d0718"
      unitRef="eur">245000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE1LTctMS0xLTM2NDA2MA_6ea40163-d42d-4e01-8854-ec00129f69d7"
      unitRef="eur">245000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE1LTktMS0xLTM2NDA2MA_ea4c839e-2cc8-4305-ab90-2102e81faee2"
      unitRef="eur">245000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="if59ff530abc54fa08a014d04b57eaad1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE2LTUtMS0xLTM2NDA2MA_27411cae-1a00-432a-acde-abb05dd8c628"
      unitRef="eur">8000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE2LTctMS0xLTM2NDA2MA_28220d62-f571-4a15-a2b0-1476cb6f72dd"
      unitRef="eur">8000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE2LTktMS0xLTM2NDA2MA_326aa980-9e02-445c-a192-c867b9a9382f"
      unitRef="eur">8000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity
      contextRef="i16ec24fb5ee747508a626f37869fdcec_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE5LTQtMS0xLTM2NDA2MA_073e41f2-61d1-487a-876c-c6881c3bff12"
      unitRef="eur">-10000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE5LTctMS0xLTM2NDA2MA_1211d7eb-a5a2-4d64-8955-7f8542ca1c54"
      unitRef="eur">-10000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzE5LTktMS0xLTM2NDA2MA_f262f3c3-0b40-4576-addb-08a41158145b"
      unitRef="eur">-10000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity>
    <ifrs-full:Equity
      contextRef="i8b84fb2a0f16464b8dc3f00b6942258d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTEtMS0xLTM2NDA2MA_07f1d734-e95e-4c4d-9a0c-6a7bdf3c06a8"
      unitRef="eur">2522000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i3ce76960e4fc410f94b0f8b63e7fdfbf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTItMS0xLTM2NDA2MA_db59833c-757d-409c-9b13-a816c227ab0b"
      unitRef="eur">125000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i0d0b91cd724e43e6ab4bbbc7982d3314_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTMtMS0xLTM2NDA2MA_7e1367bf-dd48-4dc1-800d-78a63e606d16"
      unitRef="eur">-706000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="ibe38939ea4194d299b03b4d0b2ea279b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTQtMS0xLTM2NDA2MA_668f2e6b-a4b8-4a3d-a441-18876fee97aa"
      unitRef="eur">66734000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i1fbc748bc4044c1a959e7a991c5cca4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTUtMS0xLTM2NDA2MA_6075bec9-c307-4909-b17a-e43199485d89"
      unitRef="eur">4658000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i57b24b05b9274679b2b5dd6df7fdac00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTYtMS0xLTM2NDA2MA_d6515ebf-aa00-4246-9b34-a859834ab25f"
      unitRef="eur">1451000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i156b20e6df6a4eefa561591d7405481d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTctMS0xLTM2NDA2MA_31735b82-2cd6-456c-ae3d-e07f0279727c"
      unitRef="eur">74784000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i385db0023f404198889a2d10e37da000_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTgtMS0xLTM2NDA2MA_d73550ab-e6a7-432f-89b8-d08c2c5c644b"
      unitRef="eur">368000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzIwLTktMS0xLTM2NDA2MA_89b5fc1c-1795-4378-9002-9140802f7a00"
      unitRef="eur">75152000000</ifrs-full:Equity>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzgwODE0MTA0NjQyNjcz_79da13e6-ffb2-4d20-b8ae-48887a01ac4c"
      unitRef="eurPerShare">14.58</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEtMi0xLTEtMzY0MDYw_ac47a6a1-980d-4ea8-b632-d5131f55fbeb"
      unitRef="eur">8371000000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEtMy0xLTEtMzY0MDYw_37247f4a-ac3b-4e3f-a73b-d5891c3be3aa"
      unitRef="eur">6223000000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEtNS0xLTEtMzY0MDYw_0c3db353-dc6b-4d8f-9a4e-5190e3e18604"
      unitRef="eur">12294000000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMtMi0xLTEtMzY0MDYw_da223f16-cbc9-4eb8-a179-b0fe7130ffc2"
      unitRef="eur">113000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMtMy0xLTEtMzY0MDYw_2bf655b6-4cb1-41a5-aead-a25839851d61"
      unitRef="eur">56000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMtNS0xLTEtMzY0MDYw_64118034-3ca5-4b9b-8c19-e2ae333dc82e"
      unitRef="eur">36000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQtMi0xLTEtMzY0MDYw_4c62adfa-7aa4-47ef-b4ed-ef8f8deb6391"
      unitRef="eur">48000000</ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQtMy0xLTEtMzY0MDYw_0ea5cef6-7adf-4642-8951-5933d6f9a9f8"
      unitRef="eur">15000000</ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQtNS0xLTEtMzY0MDYw_dc70927f-9041-43c6-879f-2565b16819ee"
      unitRef="eur">339000000</ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod>
    <sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzUtMi0xLTEtMzY0MDYw_e7f5be26-1ad9-48ac-9683-a3cc49deebdc"
      unitRef="eur">3420000000</sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset>
    <sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzUtMy0xLTEtMzY0MDYw_1e3cd627-d1a6-4fef-b9bc-f963354d0e72"
      unitRef="eur">3351000000</sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset>
    <sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzUtNS0xLTEtMzY0MDYw_037866be-74fb-4379-95c5-7391b8f0a643"
      unitRef="eur">3671000000</sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset>
    <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMi0xLTEtMzY0MDYw_68a96ae1-18df-4f0e-90c4-483a7863bbdd"
      unitRef="eur">-711000000</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
    <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMy0xLTEtMzY0MDYw_ebaf5874-e148-403c-83d1-a3dc652c54d9"
      unitRef="eur">-300000000</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
    <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtNS0xLTEtMzY0MDYw_659a6192-01c2-43a4-bc97-bcef7fd46f67"
      unitRef="eur">-301000000</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMi0xLTEtMzY0MDYw_d05550c3-6c5b-4a1f-a950-e57307732990"
      unitRef="eur">0</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMy0xLTEtMzY0MDYw_82231aef-55eb-412a-9b0d-2a1af2ca02af"
      unitRef="eur">0</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctNS0xLTEtMzY0MDYw_28c8f930-0ea6-4980-abbd-c6e02f40ffad"
      unitRef="eur">6880000000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:AdjustmentsForDeferredTaxExpense
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzgtMi0xLTEtMzY0MDYw_a7a4b4e6-d3d5-4fff-bce9-6d783bacccfb"
      unitRef="eur">-578000000</ifrs-full:AdjustmentsForDeferredTaxExpense>
    <ifrs-full:AdjustmentsForDeferredTaxExpense
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzgtMy0xLTEtMzY0MDYw_66ef1487-b493-40e7-90f9-949cf1d266ff"
      unitRef="eur">-356000000</ifrs-full:AdjustmentsForDeferredTaxExpense>
    <ifrs-full:AdjustmentsForDeferredTaxExpense
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzgtNS0xLTEtMzY0MDYw_42fd12c3-44d7-4452-833d-9a4e29d9f0dc"
      unitRef="eur">-221000000</ifrs-full:AdjustmentsForDeferredTaxExpense>
    <sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMi0xLTEtMzY0MDYw_a2b5688d-defb-4ded-ac13-3ba426e6f75e"
      unitRef="eur">280000000</sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities>
    <sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMy0xLTEtMzY0MDYw_b88f5582-854c-44f8-bbdc-f448e42a6399"
      unitRef="eur">-37000000</sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities>
    <sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktNS0xLTEtMzY0MDYw_753747be-20ce-4c5c-88ce-259f463a8b67"
      unitRef="eur">-133000000</sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEwLTItMS0xLTM2NDA2MA_07b667dc-64f8-4121-bb5e-32e0bf57ef1e"
      unitRef="eur">245000000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEwLTMtMS0xLTM2NDA2MA_3b2b587e-f4ec-45b8-bf14-aaf042aa28c4"
      unitRef="eur">244000000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEwLTUtMS0xLTM2NDA2MA_dc5f33b7-186d-441b-8fb1-8eb19a94a3dd"
      unitRef="eur">274000000</ifrs-full:AdjustmentsForSharebasedPayments>
    <sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzExLTItMS0xLTM2NDA2MA_fbd4c60f-cb1e-4fa6-8e54-45858457c001"
      unitRef="eur">3000000</sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue>
    <sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzExLTMtMS0xLTM2NDA2MA_b074cd7f-5d59-49b0-955b-9fb6ef90c4d2"
      unitRef="eur">4000000</sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue>
    <sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzExLTUtMS0xLTM2NDA2MA_22f5816e-e976-407b-a33f-32aeb0615a40"
      unitRef="eur">53000000</sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue>
    <ifrs-full:OtherAdjustmentsToReconcileProfitLoss
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTItMS0xLTM2NDA2MA_b807f41b-dc17-4fab-9c7a-5edc7a9ddf37"
      unitRef="eur">138000000</ifrs-full:OtherAdjustmentsToReconcileProfitLoss>
    <ifrs-full:OtherAdjustmentsToReconcileProfitLoss
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTMtMS0xLTM2NDA2MA_838ddb06-59ce-45d0-bd06-5ad48488f600"
      unitRef="eur">-57000000</ifrs-full:OtherAdjustmentsToReconcileProfitLoss>
    <ifrs-full:OtherAdjustmentsToReconcileProfitLoss
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTUtMS0xLTM2NDA2MA_9c0bd19e-35c4-4872-af6a-47f8e4217b03"
      unitRef="eur">-711000000</ifrs-full:OtherAdjustmentsToReconcileProfitLoss>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE0LTItMS0xLTM2NDA2MA_cbdd70db-b4f7-4105-bc35-7b653f9f5019"
      unitRef="eur">11233000000</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE0LTMtMS0xLTM2NDA2MA_c0b0084a-2ac0-4dea-acb0-575a24b379f0"
      unitRef="eur">9113000000</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE0LTUtMS0xLTM2NDA2MA_31c45ffd-1947-40f9-ad6a-89ca1c9f0bbd"
      unitRef="eur">7743000000</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE1LTItMS0xLTM2NDA2MA_05fcb4ae-6c81-4fc7-a631-b87158b8685b"
      unitRef="eur">-927000000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE1LTMtMS0xLTM2NDA2MA_d8ca15e3-d6b5-4a3e-a7c9-958ba121aa15"
      unitRef="eur">-357000000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE1LTUtMS0xLTM2NDA2MA_f9adf783-6975-40b3-ae86-95facc12396c"
      unitRef="eur">-593000000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE2LTItMS0xLTM2NDA2MA_9bb11f8f-99b2-4d97-98a7-e95f5fe429a1"
      unitRef="eur">-777000000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE2LTMtMS0xLTM2NDA2MA_918a2803-25c1-4f99-8de3-b30365643a9e"
      unitRef="eur">185000000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE2LTUtMS0xLTM2NDA2MA_08b6afa3-6337-4c4a-bb0a-3379dc726454"
      unitRef="eur">-134000000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE3LTItMS0xLTM2NDA2MA_c6b93155-8e17-4acb-8863-30e87341f2d2"
      unitRef="eur">452000000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE3LTMtMS0xLTM2NDA2MA_695b700c-b553-48cd-80f3-c8471e0775fd"
      unitRef="eur">451000000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE3LTUtMS0xLTM2NDA2MA_bd5603e6-aced-48de-980d-85d04fadce07"
      unitRef="eur">86000000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE4LTItMS0xLTM2NDA2MA_84b3ff75-42d3-48fc-b381-a339f9ef69cb"
      unitRef="eur">545000000</sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities>
    <sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE4LTMtMS0xLTM2NDA2MA_5b7fee67-d341-4b33-9805-1e3ce2d60710"
      unitRef="eur">1130000000</sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities>
    <sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE4LTUtMS0xLTM2NDA2MA_3784fba6-0647-4205-9f33-f3778deaae45"
      unitRef="eur">316000000</sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTItMS0xLTM2NDA2MA_adc3dc98-3752-4217-a201-9469b1c6159f"
      unitRef="eur">10526000000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTMtMS0xLTM2NDA2MA_20ba23d9-4985-4b1e-be44-744953373bd2"
      unitRef="eur">10522000000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTUtMS0xLTM2NDA2MA_f7575fc6-2ec7-4422-9290-f9eb402e6ed8"
      unitRef="eur">7418000000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIyLTItMS0xLTM2NDA2MA_83785c42-73bd-4082-89e2-28c6194a5398"
      unitRef="eur">2201000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIyLTMtMS0xLTM2NDA2MA_59cb6ba6-f2bb-4e78-b952-49b496a061ac"
      unitRef="eur">2043000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIyLTUtMS0xLTM2NDA2MA_28ccd4d4-b955-4456-a936-7c6235cf39ab"
      unitRef="eur">2083000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTItMS0xLTM2NDA2MA_14fc05d6-202f-402c-97a5-aa05fc624d48"
      unitRef="eur">992000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTMtMS0xLTM2NDA2MA_d71cb872-410e-4d33-b50f-03fc06485f4f"
      unitRef="eur">5594000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTUtMS0xLTM2NDA2MA_86f873a5-ea9d-496d-9826-7012e349d45f"
      unitRef="eur">5336000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI0LTItMS0xLTM2NDA2MA_97a09df5-497c-4388-a5a6-fb91e9c73766"
      unitRef="eur">488000000</ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI0LTMtMS0xLTM2NDA2MA_b3d0cddc-f8e7-4f5d-b9ce-06af44aa9047"
      unitRef="eur">311000000</ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI0LTUtMS0xLTM2NDA2MA_05a9ca15-42e7-4edf-8810-aed4004b5a47"
      unitRef="eur">137000000</ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTItMS0xLTM2NDA2MA_ba2d8fea-11e9-4854-8b94-0515718b611f"
      unitRef="eur">1488000000</ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTMtMS0xLTM2NDA2MA_f9534676-afa5-4f61-8123-c6c164d57420"
      unitRef="eur">676000000</ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTUtMS0xLTM2NDA2MA_4ed2c3d5-36ff-4dc1-9b89-c7736363a07b"
      unitRef="eur">918000000</ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTItMS0xLTM2NzQ3OQ_936bff2b-5c05-4544-b8a8-f59222607c67"
      unitRef="eur">134000000</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTMtMS0xLTM2NzQ3MA_47f62225-cc47-4815-8201-aeb2b6746255"
      unitRef="eur">42000000</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NzQ4Mg_2c17decc-29d6-4783-a5a8-9d236cef3b39"
      unitRef="eur">0</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTItMS0xLTM2NDA2MA_70cfa844-bdc5-4428-9af3-53d7f8c38481"
      unitRef="eur">0</ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTMtMS0xLTM2NDA2MA_7c179423-4a69-4e78-93d1-4370987efe3b"
      unitRef="eur">0</ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NDA2MA_80b331d7-f29e-4957-9b17-0946b17201e5"
      unitRef="eur">10370000000</ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod>
    <sny:NetChangeInOtherNonCurrentAssets
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI3LTItMS0xLTM2NDA2MA_2473f4a7-f976-4591-a1f4-0ede2578f74f"
      unitRef="eur">-16000000</sny:NetChangeInOtherNonCurrentAssets>
    <sny:NetChangeInOtherNonCurrentAssets
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI3LTMtMS0xLTM2NDA2MA_91d06df8-a591-4767-8ddd-b706f45fe7c3"
      unitRef="eur">-68000000</sny:NetChangeInOtherNonCurrentAssets>
    <sny:NetChangeInOtherNonCurrentAssets
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI3LTUtMS0xLTM2NDA2MA_5d91a65c-b49b-48c5-8f9f-76e35ca388c0"
      unitRef="eur">-113000000</sny:NetChangeInOtherNonCurrentAssets>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI4LTItMS0xLTM2NDA2MA_a4e43bd3-1831-40a2-9519-b92e929cff02"
      unitRef="eur">-2075000000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI4LTMtMS0xLTM2NDA2MA_0ea705da-cd61-4729-ad99-3131efdfc589"
      unitRef="eur">-7298000000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI4LTUtMS0xLTM2NDA2MA_c4db135c-f14b-48b6-90a1-2f41650c4e3b"
      unitRef="eur">3619000000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMwLTItMS0xLTM2NDA2MA_6b687395-16a4-4bdb-8059-674535549935"
      unitRef="eur">188000000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMwLTMtMS0xLTM2NDA2MA_77a60e4b-44c3-4074-9150-a4c58c695d68"
      unitRef="eur">186000000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMwLTUtMS0xLTM2NDA2MA_d97178c3-e549-40aa-89d0-58737b61a38c"
      unitRef="eur">203000000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMyLTItMS0xLTM2NDA2MA_465fbbe5-fffd-4dee-ac05-8b1cc64bef55"
      unitRef="eur">4168000000</ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMyLTMtMS0xLTM2NDA2MA_1cebe570-88c5-4066-8f35-6fee795d4bc8"
      unitRef="eur">4008000000</ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMyLTUtMS0xLTM2NDA2MA_443a4622-44ef-476a-9baf-ad2ba6cdc5ff"
      unitRef="eur">3937000000</ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMzLTItMS0xLTM2NDA2MA_5ea0b439-0539-4172-b283-7102b04691bd"
      unitRef="eur">99000000</ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMzLTMtMS0xLTM2NDA2MA_e32d9656-8411-4b4f-8e38-7a116a497de3"
      unitRef="eur">48000000</ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMzLTUtMS0xLTM2NDA2MA_63eb69a4-450d-440b-950d-c52013cdb3a4"
      unitRef="eur">44000000</ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromNoncurrentBorrowings
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM1LTItMS0xLTM2NDA2MA_efbc2543-3cb8-4046-a2e7-d100ab54709d"
      unitRef="eur">1549000000</ifrs-full:ProceedsFromNoncurrentBorrowings>
    <ifrs-full:ProceedsFromNoncurrentBorrowings
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM1LTMtMS0xLTM2NDA2MA_657dcb84-34a9-43f2-ad84-a60de8751412"
      unitRef="eur">0</ifrs-full:ProceedsFromNoncurrentBorrowings>
    <ifrs-full:ProceedsFromNoncurrentBorrowings
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM1LTUtMS0xLTM2NDA2MA_4fbb4788-3acc-4c59-93b1-ea49ead9c567"
      unitRef="eur">2019000000</ifrs-full:ProceedsFromNoncurrentBorrowings>
    <ifrs-full:RepaymentsOfNoncurrentBorrowings
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM2LTItMS0xLTM2NDA2MA_821fa717-b44a-41ea-9865-2fa9b0653e0e"
      unitRef="eur">2718000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
    <ifrs-full:RepaymentsOfNoncurrentBorrowings
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM2LTMtMS0xLTM2NDA2MA_921b84b8-1349-44cc-820c-e6af63ba40a7"
      unitRef="eur">2241000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
    <ifrs-full:RepaymentsOfNoncurrentBorrowings
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM2LTUtMS0xLTM2NDA2MA_f3b5168f-b60d-481f-b2f9-0bb8d1bf62bf"
      unitRef="eur">3952000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM3LTItMS0xLTM2NDA2MA_361f3bd1-0add-4294-a980-95467425dc6c"
      unitRef="eur">291000000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM3LTMtMS0xLTM2NDA2MA_bdfe0653-13a1-41fa-8e75-3f81a57c8cb6"
      unitRef="eur">149000000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM3LTUtMS0xLTM2NDA2MA_5d3d6b03-c339-483e-b43d-69ccb0089d93"
      unitRef="eur">234000000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTItMS0xLTM2NDA2MA_fccf220d-081e-4f3e-b8d9-b22352996dc9"
      unitRef="eur">215000000</sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments>
    <sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTMtMS0xLTM2NDA2MA_7d53f1df-0fe1-412c-8d7a-c85744a33900"
      unitRef="eur">-414000000</sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments>
    <sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTUtMS0xLTM2NDA2MA_77055e13-a439-40d7-b46e-ed1a0852390e"
      unitRef="eur">282000000</sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM5LTItMS0xLTM2NDA2MA_34e5cbbb-56a3-4acb-8e46-91f05186bd18"
      unitRef="eur">497000000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM5LTMtMS0xLTM2NDA2MA_865684c3-5be4-44ed-bf6c-15bc2ed2c1cd"
      unitRef="eur">382000000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM5LTUtMS0xLTM2NDA2MA_7dfd024d-6cb7-47b0-8d2a-309b7cafe760"
      unitRef="eur">822000000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQxLTItMS0xLTM2NDA2MA_d0777f8b-7e4d-42e2-ba40-fe960430759f"
      unitRef="eur">-5821000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQxLTMtMS0xLTM2NDA2MA_706dc5e9-0348-42a4-8269-7d3d130c3450"
      unitRef="eur">-7056000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQxLTUtMS0xLTM2NDA2MA_54ce4fb9-1abe-44c5-b71d-58f396cbf084"
      unitRef="eur">-6485000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQzLTItMS0xLTM2NDA2MA_ea621fc1-0ef2-49bd-acc7-ff045bc63c9b"
      unitRef="eur">8000000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQzLTMtMS0xLTM2NDA2MA_1290e8c8-47a5-4495-9b7e-d72cc476e205"
      unitRef="eur">15000000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQzLTUtMS0xLTM2NDA2MA_f282ed48-ec02-4893-9201-9d1039bb256a"
      unitRef="eur">-64000000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ0LTItMS0xLTM2NDA2MA_3245d7c4-2801-4e81-b582-4abf8739c9d7"
      unitRef="eur">2638000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ0LTMtMS0xLTM2NDA2MA_51cd9737-1823-467c-bcf3-ab56af4980af"
      unitRef="eur">-3817000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ0LTUtMS0xLTM2NDA2MA_ae5b4a07-2634-44a8-95cf-f6f030408c0f"
      unitRef="eur">4488000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ1LTItMS0xLTM2NDA2MA_9f3c2241-c348-48bc-b44f-7b5a1f9050b3"
      unitRef="eur">10098000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ1LTMtMS0xLTM2NDA2MA_00786d81-88ba-431a-9ed1-604c75167071"
      unitRef="eur">13915000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ1LTUtMS0xLTM2NDA2MA_ed1062a4-594a-4fc8-99f0-7c16dbf21f94"
      unitRef="eur">9427000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ2LTItMS0xLTM2NDA2MA_89c6649a-df9b-4706-a743-348b542ccbf7"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ2LTMtMS0xLTM2NDA2MA_4ebb6ed9-f40b-4613-a9dd-d539ffd3abeb"
      unitRef="eur">10098000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ2LTUtMS0xLTM2NDA2MA_b73eca4b-a452-40df-974d-91a078599ec9"
      unitRef="eur">13915000000</ifrs-full:CashAndCashEquivalents>
    <sny:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax
      contextRef="i17591b56caee4f43b8f0bbb8ca58a6f4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzQzNDMwNzA5MzA0NTI5_f4814ad5-ae53-4177-9733-aac576c1171d"
      unitRef="eur">115000000</sny:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzEtMS0xLTEtMzY0MDYw_483d6e38-d77c-47a9-b69c-8ed62754a27b"
      unitRef="eur">2452000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzEtMi0xLTEtMzY0MDYw_285523af-6f38-4af6-8784-7b813d4a011a"
      unitRef="eur">1280000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzEtMy0xLTEtMzY0MDYw_e2a5a8e4-7e90-451f-af85-17d687888e20"
      unitRef="eur">2051000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzItMS0xLTEtMzY0MDYw_40c77b41-46fb-45dc-95ae-af57471c3308"
      unitRef="eur">380000000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzItMi0xLTEtMzY0MDYw_811997fb-fda0-433f-949d-e4e1d9844c7c"
      unitRef="eur">334000000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzItMy0xLTEtMzY0MDYw_7c5b4b9e-db80-40e7-a603-f3c3bb54a5ff"
      unitRef="eur">315000000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzMtMS0xLTEtMzY0MDYw_6860a8c6-4f2c-44d8-9218-e956201a6a89"
      unitRef="eur">173000000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzMtMi0xLTEtMzY0MDYw_299c6ef8-07c7-40d5-8c5b-ea99f1618389"
      unitRef="eur">3000000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzMtMy0xLTEtMzY0MDYw_5399f2a6-ceaa-4929-87e5-630ccb958993"
      unitRef="eur">37000000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <sny:DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzQtMS0xLTEtMzY0MDYw_e4629d4e-5bd5-401b-b4aa-62a0ac0447fd"
      unitRef="eur">1000000</sny:DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities>
    <sny:DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzQtMi0xLTEtMzY0MDYw_7b127681-a142-4e10-ac37-77d185ec89b0"
      unitRef="eur">2000000</sny:DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities>
    <sny:DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTozNjM5NTY4NzA2NTE0N2Q1YjQwYTEwNDE5Yjk3MWY4NC90YWJsZXJhbmdlOjM2Mzk1Njg3MDY1MTQ3ZDViNDBhMTA0MTliOTcxZjg0XzQtMy0xLTEtMzY0MDYw_cf0eacb0-fc0b-4210-b485-9bf799687b9c"
      unitRef="eur">0</sny:DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities>
    <ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="if2835fe4d12b49b097239c6dbd3d3396_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzExMTE_742ecfce-154c-4114-a8c0-cb1ee77b13ad"
      unitRef="eur">311000000</ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="ic03c35218a744afe9fa35a7119858f22_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDE3_95b8f957-44d6-450f-98f2-21bcc45d31d1"
      unitRef="eur">101000000</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTYvZnJhZzphZmUyOTRiY2I4OGU0NjhmYTZjNTMyYzJlN2Y4NGQ4Yi90ZXh0cmVnaW9uOmFmZTI5NGJjYjg4ZTQ2OGZhNmM1MzJjMmU3Zjg0ZDhiXzQ2Nw_c342f277-3566-4db3-9166-e3e475930815">&lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%"&gt;Introduction&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi, together with its subsidiaries (collectively &#x201c;Sanofi&#x201d;, &#x201c;the Group&#x201d; or &#x201c;the Company&#x201d;), is a global healthcare leader engaged in the research, development and marketing of therapeutic solutions focused on patient needs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi is listed in Paris (Euronext: SAN) and New&#160;York (Nasdaq: SNY).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements for the year ended December 31, 2022, and the notes thereto, were signed off by the Sanofi Board of Directors on&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; February&#160;23,&#160;2023.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDg3_2528bdfa-196a-4fd9-982d-72c502963ecf">Basis of preparation&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;A.1. International financial reporting standards (IFRS)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements cover the twelve-month periods ended December 31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with Regulation No.&#160;1606/2002 of the European Parliament and Council of July&#160;19, 2002 on the application of&#160;international accounting standards, Sanofi has presented its consolidated financial statements in accordance with IFRS since&#160;January&#160;1, 2005. The term &#x201c;IFRS&#x201d; refers collectively to international accounting and financial reporting standards (IASs&#160;and&#160;IFRSs) and to interpretations of the interpretations committees (SIC and IFRIC) with mandatory application as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements of Sanofi as of December 31, 2022 have been prepared in compliance with IFRS as&#160;issued&#160;by the International Accounting Standards Board (IASB) and with IFRS as endorsed by the European Union as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;IFRS as endorsed by the European Union as of December 31, 2022 are available under the heading &#x201c;IFRS Financial Statements&#x201d; via the following web&#160;link:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;https://www.efrag.org/Endorsement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements have been prepared in accordance with the IFRS general principles of fair presentation, going concern, accrual basis of accounting, consistency of presentation, materiality, and aggregation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;A.2. New standards, amendments and interpretations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;A.2.1. New standards applicable from January 1, 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The following amendments are applicable from January&#160;1, 2022, and have had no material impact: &#x201c;Reference to the Conceptual Framework&#x201d; (amendment to IFRS&#160;3); &#x201c;Proceeds before Intended Use&#x201d; (amendment to IAS&#160;16); &#x201c;Onerous Contracts &#x2014; Cost of Fulfilling a Contract&#x201d; (amendment to IAS&#160;37); and &#x201c;Annual Improvements to IFRS standards 2018-2020&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As a reminder, Sanofi adopted in its consolidated financial statements for the year ended December&#160;31, 2021 the IFRS&#160;IC final agenda decision (published in the March&#160;2021 IFRS&#160;IC update) clarifying how to account for costs of configuring or customising a supplier&#x2019;s application software in a Software as a Service (SaaS) arrangement, which requires such costs to be recognized as an expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;A.2.2. New pronouncements issued by the IASB and applicable from 2023 or later&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;This note describes standards, amendments and interpretations issued by the IASB that will have mandatory application in 2023 or subsequent years, and Sanofi&#x2019;s position regarding future application.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On February&#160;12, 2021, the IASB issued &#x201c;Disclosure of Accounting Policies&#x201d;, an amendment to IAS&#160;1, and &#x201c;Definition of Accounting Estimates&#x201d;, an amendment to IAS&#160;8. On May&#160;7, 2021, the IASB issued an amendment to IAS&#160;12, relating to deferred tax assets and liabilities arising from a single transaction. Sanofi does not expect a material impact from those amendments, which are applicable at the earliest from January&#160;1, 2023, and will not early adopt them.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On September&#160;22, 2022, the IASB issued an amendment to IFRS&#160;16 (Leases), relating to lease liabilities in a sale-and-leaseback arrangement, which is applicable at the earliest from January&#160;1, 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (subject to endorsement by the European Union); it will not have a material impact on the Sanofi financial statements, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi will not early adopt it.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On January&#160;23, 2020, the IASB issued &#x201c;Classification of Liabilities as Current or Non-current&#x201d;, an amendment to IAS&#160;1, and then on&#160;October&#160;31, 2022 issued &#x201c;Non-current Liabilities with Covenants&#x201d;, a further amendment to IAS&#160;1. The amendments are applicable at the earliest from January&#160;1, 2024 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(subject to endorsement by the European Union)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;; they will not have a material impact on the Sanofi financial statements, and Sanofi will not early adopt them.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;IFRS&#160;17 (Insurance Contracts), issued on May&#160;18, 2017 and applicable on or after January&#160;1, 2023, will not apply to the Sanofi consolidated financial statements because the insurance activities carried on by Sanofi's captive insurance companies are internal within the Sanofi group (the sole policyholders being subsidiaries of Sanofi), and hence are eliminated on consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;A.3. Use of estimates and judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements requires management to make reasonable estimates and assumptions based on information available at the date of the finalization of the financial statements. Those estimates and assumptions may affect the reported amounts of assets, liabilities, revenues and expenses in the financial statements, and disclosures of contingent assets and contingent liabilities as of the date of the review of the financial statements. Examples of estimates and assumptions include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;amounts deducted from sales for projected sales returns, chargeback incentives, rebates and price reductions (see Notes&#160;B.13. and&#160;D.23.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;impairment of property, plant and equipment and intangible assets (see Notes&#160;B.6. and D.5.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the valuation of goodwill and the valuation and estimated useful life of acquired intangible assets (see Notes&#160;B.3.2., B.4., D.4. and&#160;D.5.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the measurement of contingent consideration receivable in connection with asset divestments (see Notes&#160;B.8.5. and&#160;D.12.) and of contingent consideration payable (see Notes&#160;B.3. and&#160;D.18.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the measurement of financial assets at amortized cost (see Note&#160;B.8.5.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of post-employment benefit obligations (see Notes&#160;B.23. and&#160;D.19.1.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of liabilities or provisions for restructuring, litigation, tax risks relating to corporate income taxes, and environmental risks (see Notes&#160;B.12., B.19., B.20., D.19. and&#160;D.22.); and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of deferred tax assets resulting from tax losses available for carry-forward and deductible temporary differences (see Notes&#160;B.22. and&#160;D.14.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Actual results could differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;A.4. Hyperinflation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2022, Sanofi continued to account for subsidiaries based in Venezuela using the full consolidation method, on the basis that the criteria for control as specified in IFRS&#160;10 (Consolidated Financial Statements) are still met. In 2018, following changes to the Venezuelan foreign exchange system, the &#x201c;DICOM&#x201d; rate was replaced by the &#x201c;PETRO&#x201d; rate (with a floating US dollar/bolivar parity) and the strong bolivar (&#x201c;VEF&#x201d;) was replaced by the sovereign bolivar (&#x201c;VES&#x201d;), reflecting a 1-for-100,000 devaluation. Finally, in October&#160;2021 a new currency called the &#x201c;Digital Bolivar&#x201d; (VED) was introduced at a rate of 1&#160;VED to 1,000,000&#160;sovereign bolivars. Consequently, the contribution of the Venezuelan subsidiaries to the consolidated financial statements is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In Argentina, the cumulative rate of inflation over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has since July&#160;1, 2018 treated Argentina as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Since the beginning of 2022, inflation in Turkey has increased significantly and the cumulative inflation rate over the past three years has been above 100% since the end of February&#160;2022. Qualitative indicators following the deterioration of the economic situation and exchange controls also support the consensus conclusion that Turkey is a hyperinflationary country from 2022. Consequently, Sanofi has since January&#160;1, 2022 treated Turkey as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;A.5. Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On February&#160;18, 2020, Sanofi and the US Department of Health and Human Services extended their research and development partnership to leverage Sanofi&#x2019;s previous development work on a SARS vaccine to attempt to unlock a fast path forward for developing a COVID-19 vaccine. Under the terms of the collaboration, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the US Department of Health and Human Services, is helping to fund the research and development undertaken by Sanofi.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On April&#160;14, 2020, Sanofi and GlaxoSmithKline (GSK) entered into a collaboration agreement to develop a recombinant COVID-19 vaccine candidate, with Sanofi contributing its S&#x2011;protein COVID-19 antigen (based on recombinant DNA technology) and GSK contributing its pandemic adjuvant technology. Sanofi is leading clinical development and the registration process for the vaccine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On July&#160;31, 2020, the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK was selected by the US&#160;government&#x2019;s Operation Warp Speed (OWS) program. Under the OWS, the US government is providing funds to support further development of the vaccine, including clinical trials and scaling-up of manufacturing capacity. Initially, the agreement also provided for the supply of 100&#160;million doses of the vaccine, with payment due at the time vaccine doses are provided. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi has recognized the funding received from the US government as a deduction from the development expenses incurred, in accordance with IAS&#160;20 (Accounting for Government Grants and Disclosure of Government Assistance).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The amount of government aid received from the US federal government and BARDA and recognized &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;as a deduction from development expenses&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; and other operating expenses was &#x20ac;265&#160;million in 2022, compared with &#x20ac;147&#160;million in 2021 and an immaterial amount in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In September&#160;2020, Sanofi and GSK signed pre-order contracts with the Canadian and UK governments and with the European Union for doses of the vaccine candidate. During 2021, Sanofi and GSK contractualized with the Canadian and UK governments and with the European Union on the number of doses ordered.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On December&#160;15, 2021, Sanofi and GSK announced positive preliminary data on their COVID-19 booster vaccine candidate and indicated that their Phase&#160;III trial was to continue, based on recommendations from an independent monitoring board.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On November&#160;10, 2022, in line with the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency, the European Commission approved VidPrevtyn&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; Beta vaccine as booster for the prevention of COVID-19 in adults aged 18&#160;years and older. Designed to provide broad protection against multiple variants, this protein-based COVID-19 booster vaccine is based on the Beta variant antigen and includes GSK&#x2019;s pandemic adjuvant. VidPrevtyn&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Beta is indicated as a booster for active immunization against SARS-CoV-2 in adults who have previously received an mRNA or adenoviral COVID-19 vaccine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On December&#160;21, 2022, following the European Commission approval, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved VidPrevtyn&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; Beta vaccine for the prevention of COVID-19 in adults aged 18 and over within the UK.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there had been no material change in the commitments entered into by the United States in 2020, or in the pre-order arrangements with Canada, the United Kingdom and the European Union.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;15 (see Note&#160;B.13.1.), Sanofi recognizes revenue when control over the product is transferred to the customer (for vaccines, transfer of control is determined by reference to the terms of release and acceptance of batches of vaccine). Payments received subsequent to signature of vaccine pre-order contracts relating to doses not yet delivered are customer contract liabilities (i.e. an obligation for the entity to supply goods to a customer, for which consideration has been received from the customer). They are presented within &#x201c;Customer contract liabilities&#x201d; in the balance sheet (see Note&#160;D.19.5.), and within &#x201c;Net change in other current assets and other current liabilities&#x201d; in the statement of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of&#160;December&#160;31, 2022, customer contract liabilities amounted to &#x20ac;264&#160;million, compared with &#x20ac;319&#160;million as of&#160;December&#160;31,&#160;2021 (see Note&#160;D.19.5., &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Current provisions and other current liabilities&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;). The portion of the December&#160;31, 2021 balance recognized in profit or loss during 2022 was &#x20ac;85&#160;million (no amounts were recognized in profit or loss during 2021).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;A.6. Effects of climate change&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Risks associated with climate change as assessed to date, and the commitments made by Sanofi on carbon neutrality and cutting greenhouse gas emissions, do not have a material impact on the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Risks associated with trends in carbon costs, raw material shortages, supply chain disruption,&#160;etc. have been taken into account in the measurement of assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;A.7. War in Ukraine&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The conflict triggered by the Russian invasion of Ukraine on February&#160;24, 2022 led to the imposition of sanctions by the European Union and other countries. While complying with those sanctions inherent to its operations, Sanofi continues to carry on commercial and industrial activities in Russia under its direct control so as to meet patient needs. In 2022, Sanofi generated net sales of &#x20ac;674&#160;million in Russia (compared with &#x20ac;575&#160;million in 2021 and &#x20ac;641&#160;million in 2020), representing 1.6% of consolidated net sales.&lt;/span&gt;&lt;/div&gt;The conflict had no material direct or indirect impact on the financial statements ended December&#160;31, 2022. Sanofi will continue to monitor the situation, and will update its estimates and assumptions accordingly</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:StatementOfIFRSCompliance
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDc0_c17d52c5-0af1-4f52-864a-cf18f084cab9">International financial reporting standards (IFRS)&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements cover the twelve-month periods ended December 31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with Regulation No.&#160;1606/2002 of the European Parliament and Council of July&#160;19, 2002 on the application of&#160;international accounting standards, Sanofi has presented its consolidated financial statements in accordance with IFRS since&#160;January&#160;1, 2005. The term &#x201c;IFRS&#x201d; refers collectively to international accounting and financial reporting standards (IASs&#160;and&#160;IFRSs) and to interpretations of the interpretations committees (SIC and IFRIC) with mandatory application as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements of Sanofi as of December 31, 2022 have been prepared in compliance with IFRS as&#160;issued&#160;by the International Accounting Standards Board (IASB) and with IFRS as endorsed by the European Union as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;IFRS as endorsed by the European Union as of December 31, 2022 are available under the heading &#x201c;IFRS Financial Statements&#x201d; via the following web&#160;link:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;https://www.efrag.org/Endorsement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements have been prepared in accordance with the IFRS general principles of fair presentation, going concern, accrual basis of accounting, consistency of presentation, materiality, and aggregation.&lt;/span&gt;&lt;/div&gt;</ifrs-full:StatementOfIFRSCompliance>
    <ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDg1_263e9a5d-5fff-48f4-82ef-f1d00e809457">New standards, amendments and interpretations&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;A.2.1. New standards applicable from January 1, 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The following amendments are applicable from January&#160;1, 2022, and have had no material impact: &#x201c;Reference to the Conceptual Framework&#x201d; (amendment to IFRS&#160;3); &#x201c;Proceeds before Intended Use&#x201d; (amendment to IAS&#160;16); &#x201c;Onerous Contracts &#x2014; Cost of Fulfilling a Contract&#x201d; (amendment to IAS&#160;37); and &#x201c;Annual Improvements to IFRS standards 2018-2020&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As a reminder, Sanofi adopted in its consolidated financial statements for the year ended December&#160;31, 2021 the IFRS&#160;IC final agenda decision (published in the March&#160;2021 IFRS&#160;IC update) clarifying how to account for costs of configuring or customising a supplier&#x2019;s application software in a Software as a Service (SaaS) arrangement, which requires such costs to be recognized as an expense.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations>
    <ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDgy_6a3f6e8f-49a3-4e12-8e85-213e59234bd5">New pronouncements issued by the IASB and applicable from 2023 or later&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;This note describes standards, amendments and interpretations issued by the IASB that will have mandatory application in 2023 or subsequent years, and Sanofi&#x2019;s position regarding future application.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On February&#160;12, 2021, the IASB issued &#x201c;Disclosure of Accounting Policies&#x201d;, an amendment to IAS&#160;1, and &#x201c;Definition of Accounting Estimates&#x201d;, an amendment to IAS&#160;8. On May&#160;7, 2021, the IASB issued an amendment to IAS&#160;12, relating to deferred tax assets and liabilities arising from a single transaction. Sanofi does not expect a material impact from those amendments, which are applicable at the earliest from January&#160;1, 2023, and will not early adopt them.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On September&#160;22, 2022, the IASB issued an amendment to IFRS&#160;16 (Leases), relating to lease liabilities in a sale-and-leaseback arrangement, which is applicable at the earliest from January&#160;1, 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (subject to endorsement by the European Union); it will not have a material impact on the Sanofi financial statements, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi will not early adopt it.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On January&#160;23, 2020, the IASB issued &#x201c;Classification of Liabilities as Current or Non-current&#x201d;, an amendment to IAS&#160;1, and then on&#160;October&#160;31, 2022 issued &#x201c;Non-current Liabilities with Covenants&#x201d;, a further amendment to IAS&#160;1. The amendments are applicable at the earliest from January&#160;1, 2024 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(subject to endorsement by the European Union)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;; they will not have a material impact on the Sanofi financial statements, and Sanofi will not early adopt them.&lt;/span&gt;&lt;/div&gt;IFRS&#160;17 (Insurance Contracts), issued on May&#160;18, 2017 and applicable on or after January&#160;1, 2023, will not apply to the Sanofi consolidated financial statements because the insurance activities carried on by Sanofi's captive insurance companies are internal within the Sanofi group (the sole policyholders being subsidiaries of Sanofi), and hence are eliminated on consolidation.</ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDc2_4028726c-0f51-4a92-ac56-3aec800190a1">Use of estimates and judgments&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements requires management to make reasonable estimates and assumptions based on information available at the date of the finalization of the financial statements. Those estimates and assumptions may affect the reported amounts of assets, liabilities, revenues and expenses in the financial statements, and disclosures of contingent assets and contingent liabilities as of the date of the review of the financial statements. Examples of estimates and assumptions include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;amounts deducted from sales for projected sales returns, chargeback incentives, rebates and price reductions (see Notes&#160;B.13. and&#160;D.23.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;impairment of property, plant and equipment and intangible assets (see Notes&#160;B.6. and D.5.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the valuation of goodwill and the valuation and estimated useful life of acquired intangible assets (see Notes&#160;B.3.2., B.4., D.4. and&#160;D.5.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the measurement of contingent consideration receivable in connection with asset divestments (see Notes&#160;B.8.5. and&#160;D.12.) and of contingent consideration payable (see Notes&#160;B.3. and&#160;D.18.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the measurement of financial assets at amortized cost (see Note&#160;B.8.5.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of post-employment benefit obligations (see Notes&#160;B.23. and&#160;D.19.1.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of liabilities or provisions for restructuring, litigation, tax risks relating to corporate income taxes, and environmental risks (see Notes&#160;B.12., B.19., B.20., D.19. and&#160;D.22.); and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of deferred tax assets resulting from tax losses available for carry-forward and deductible temporary differences (see Notes&#160;B.22. and&#160;D.14.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Actual results could differ from these estimates.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <ifrs-full:DisclosureOfHyperinflationaryReportingExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDgz_40d5112d-abb7-4af9-adce-d63ab2a5cf94">Hyperinflation&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2022, Sanofi continued to account for subsidiaries based in Venezuela using the full consolidation method, on the basis that the criteria for control as specified in IFRS&#160;10 (Consolidated Financial Statements) are still met. In 2018, following changes to the Venezuelan foreign exchange system, the &#x201c;DICOM&#x201d; rate was replaced by the &#x201c;PETRO&#x201d; rate (with a floating US dollar/bolivar parity) and the strong bolivar (&#x201c;VEF&#x201d;) was replaced by the sovereign bolivar (&#x201c;VES&#x201d;), reflecting a 1-for-100,000 devaluation. Finally, in October&#160;2021 a new currency called the &#x201c;Digital Bolivar&#x201d; (VED) was introduced at a rate of 1&#160;VED to 1,000,000&#160;sovereign bolivars. Consequently, the contribution of the Venezuelan subsidiaries to the consolidated financial statements is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In Argentina, the cumulative rate of inflation over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has since July&#160;1, 2018 treated Argentina as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Since the beginning of 2022, inflation in Turkey has increased significantly and the cumulative inflation rate over the past three years has been above 100% since the end of February&#160;2022. Qualitative indicators following the deterioration of the economic situation and exchange controls also support the consensus conclusion that Turkey is a hyperinflationary country from 2022. Consequently, Sanofi has since January&#160;1, 2022 treated Turkey as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfHyperinflationaryReportingExplanatory>
    <sny:CumulativeConsumerPriceInflationOverTheLastThreeYears
      contextRef="idfcbd6492da644e8b979ce9b73f2b1f6_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzk4MjU_8ed269c7-cf4f-4c53-b1c5-1a322a12657f"
      unitRef="number">1</sny:CumulativeConsumerPriceInflationOverTheLastThreeYears>
    <sny:CumulativeConsumerPriceInflationOverTheLastThreeYears
      contextRef="i2c78a0e7ebc747c594c4ee6e77570478_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzI2OTM4MDM0OTAzODY3_0aad7146-b3ea-4e0a-b1ae-5de7e0a5900f"
      unitRef="number">1</sny:CumulativeConsumerPriceInflationOverTheLastThreeYears>
    <sny:AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDk0_91094253-4a57-4c6e-b3c0-6f37c6bd6894">Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On February&#160;18, 2020, Sanofi and the US Department of Health and Human Services extended their research and development partnership to leverage Sanofi&#x2019;s previous development work on a SARS vaccine to attempt to unlock a fast path forward for developing a COVID-19 vaccine. Under the terms of the collaboration, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the US Department of Health and Human Services, is helping to fund the research and development undertaken by Sanofi.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On April&#160;14, 2020, Sanofi and GlaxoSmithKline (GSK) entered into a collaboration agreement to develop a recombinant COVID-19 vaccine candidate, with Sanofi contributing its S&#x2011;protein COVID-19 antigen (based on recombinant DNA technology) and GSK contributing its pandemic adjuvant technology. Sanofi is leading clinical development and the registration process for the vaccine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On July&#160;31, 2020, the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK was selected by the US&#160;government&#x2019;s Operation Warp Speed (OWS) program. Under the OWS, the US government is providing funds to support further development of the vaccine, including clinical trials and scaling-up of manufacturing capacity. Initially, the agreement also provided for the supply of 100&#160;million doses of the vaccine, with payment due at the time vaccine doses are provided. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi has recognized the funding received from the US government as a deduction from the development expenses incurred, in accordance with IAS&#160;20 (Accounting for Government Grants and Disclosure of Government Assistance).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The amount of government aid received from the US federal government and BARDA and recognized &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;as a deduction from development expenses&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; and other operating expenses was &#x20ac;265&#160;million in 2022, compared with &#x20ac;147&#160;million in 2021 and an immaterial amount in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In September&#160;2020, Sanofi and GSK signed pre-order contracts with the Canadian and UK governments and with the European Union for doses of the vaccine candidate. During 2021, Sanofi and GSK contractualized with the Canadian and UK governments and with the European Union on the number of doses ordered.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On December&#160;15, 2021, Sanofi and GSK announced positive preliminary data on their COVID-19 booster vaccine candidate and indicated that their Phase&#160;III trial was to continue, based on recommendations from an independent monitoring board.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On November&#160;10, 2022, in line with the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency, the European Commission approved VidPrevtyn&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; Beta vaccine as booster for the prevention of COVID-19 in adults aged 18&#160;years and older. Designed to provide broad protection against multiple variants, this protein-based COVID-19 booster vaccine is based on the Beta variant antigen and includes GSK&#x2019;s pandemic adjuvant. VidPrevtyn&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Beta is indicated as a booster for active immunization against SARS-CoV-2 in adults who have previously received an mRNA or adenoviral COVID-19 vaccine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On December&#160;21, 2022, following the European Commission approval, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved VidPrevtyn&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; Beta vaccine for the prevention of COVID-19 in adults aged 18 and over within the UK.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there had been no material change in the commitments entered into by the United States in 2020, or in the pre-order arrangements with Canada, the United Kingdom and the European Union.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;15 (see Note&#160;B.13.1.), Sanofi recognizes revenue when control over the product is transferred to the customer (for vaccines, transfer of control is determined by reference to the terms of release and acceptance of batches of vaccine). Payments received subsequent to signature of vaccine pre-order contracts relating to doses not yet delivered are customer contract liabilities (i.e. an obligation for the entity to supply goods to a customer, for which consideration has been received from the customer). They are presented within &#x201c;Customer contract liabilities&#x201d; in the balance sheet (see Note&#160;D.19.5.), and within &#x201c;Net change in other current assets and other current liabilities&#x201d; in the statement of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of&#160;December&#160;31, 2022, customer contract liabilities amounted to &#x20ac;264&#160;million, compared with &#x20ac;319&#160;million as of&#160;December&#160;31,&#160;2021 (see Note&#160;D.19.5., &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Current provisions and other current liabilities&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;). The portion of the December&#160;31, 2021 balance recognized in profit or loss during 2022 was &#x20ac;85&#160;million (no amounts were recognized in profit or loss during 2021).&lt;/span&gt;&lt;/div&gt;</sny:AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock>
    <sny:NumberOfVaccineDosesToBeSupplied
      contextRef="if7312feb82fb447ea49510fc80480c6a_D20200701-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzEzMzc4_dab4f8c6-f694-432f-b8c8-3665a8fbc470"
      unitRef="vaccine_dose">100000000</sny:NumberOfVaccineDosesToBeSupplied>
    <sny:GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses
      contextRef="i5f8e75f8110e4de1a9b126cfa19e1f6e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDky_a54cb222-c750-41eb-aa17-23b85261bba3"
      unitRef="eur">265000000</sny:GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses>
    <sny:GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses
      contextRef="i35c351f036c247cf83d680f6986c15c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzEzODM3_ea23bc32-98d3-44e7-b1d5-dd60a286b9ed"
      unitRef="eur">147000000</sny:GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses>
    <sny:GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses
      contextRef="if2c1a983cbcf45f48b7833d558393c4b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MTA1_ae6f7867-e7c0-4212-a8d7-b0b67e979cef"
      unitRef="eur">0</sny:GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses>
    <ifrs-full:CurrentContractLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDA0_cdb8fa35-319c-4f7b-b7c1-0dd9092ec52c"
      unitRef="eur">264000000</ifrs-full:CurrentContractLiabilities>
    <ifrs-full:CurrentContractLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDMx_b2f36e0d-b721-4cef-99b4-89063148f5a4"
      unitRef="eur">319000000</ifrs-full:CurrentContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDQ1_2cf56e9f-16cd-49a5-a61e-3a4d32b8474f"
      unitRef="eur">85000000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE5NzkxMjA5MzQwMDMy_379a742f-d611-431f-8945-15356431fc2e"
      unitRef="eur">0</ifrs-full:ContractLiabilities>
    <sny:DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzE3MDg4_54118667-8498-4ade-aeb6-4356f46b88ab">Effects of climate change&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Risks associated with climate change as assessed to date, and the commitments made by Sanofi on carbon neutrality and cutting greenhouse gas emissions, do not have a material impact on the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Risks associated with trends in carbon costs, raw material shortages, supply chain disruption,&#160;etc. have been taken into account in the measurement of assets and liabilities.&lt;/span&gt;&lt;/div&gt;</sny:DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock>
    <sny:DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzI2OTM4MDM0OTAzODcz_789aaac8-9652-4d03-96c1-0d4e7482ada2">War in UkraineThe conflict triggered by the Russian invasion of Ukraine on February&#160;24, 2022 led to the imposition of sanctions by the European Union and other countries. While complying with those sanctions inherent to its operations, Sanofi continues to carry on commercial and industrial activities in Russia under its direct control so as to meet patient needs. In 2022, Sanofi generated net sales of &#x20ac;674&#160;million in Russia (compared with &#x20ac;575&#160;million in 2021 and &#x20ac;641&#160;million in 2020), representing 1.6% of consolidated net sales.The conflict had no material direct or indirect impact on the financial statements ended December&#160;31, 2022. Sanofi will continue to monitor the situation, and will update its estimates and assumptions accordingly</sny:DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i0f1d395438c74a0b8cfbd33931e2e3a4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDU4_626e74ba-d88c-48ab-b24e-fc05f7f01d0b"
      unitRef="eur">674000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if71752f1ad474bd485d853a961833b1f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDcy_cdcc0992-adc0-44e8-ab2a-c4bbb342f006"
      unitRef="eur">575000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="icb6c74b8a63546e290d8ab591aaaf997_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgwODE0MTA0Njk3Mjkw_ce7483e3-dbd3-4bd9-8850-ae80f39d9b9b"
      unitRef="eur">641000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="i0f1d395438c74a0b8cfbd33931e2e3a4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTkvZnJhZzo0YmU1MmUyZmI4ZTU0YjJkYWZkOWI5NWRjYWIwZjIzZi90ZXh0cmVnaW9uOjRiZTUyZTJmYjhlNTRiMmRhZmQ5Yjk1ZGNhYjBmMjNmXzgzMDEzMTI3OTM3MDg2_152e6378-b741-4c8e-b8e3-71a4e7607c16"
      unitRef="number">0.016</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MDIvZnJhZzphNWExM2U0OTQ1MmY0YjYxOTljYWNjM2EwY2UzMzgwNS90ZXh0cmVnaW9uOmE1YTEzZTQ5NDUyZjRiNjE5OWNhY2MzYTBjZTMzODA1XzUx_ea46b2f7-6886-43a1-bbc5-f403aa38cf3a">Summary of significant accounting policiesBasis of consolidation&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;10 (Consolidated Financial Statements), the consolidated financial statements of Sanofi include the financial statements of entities that Sanofi controls directly or indirectly, regardless of the level of the equity interest in those entities. An entity is controlled when Sanofi has power over the entity, exposure or rights to variable returns from its involvement with the entity, and the ability to affect those returns through its power over the entity. In determining whether control exists, potential voting rights must be taken into account if those rights are substantive, in other words they can be exercised on a timely basis when decisions about the relevant activities of the entity are to be taken.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Entities consolidated by Sanofi are referred to as &#x201c;subsidiaries&#x201d;. Entities that Sanofi controls by means other than voting rights are referred to as &#x201c;consolidated structured entities&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;11 (Joint Arrangements), Sanofi classifies its joint arrangements (i.e. arrangements in which Sanofi exercises joint control with one or more other parties) either as a joint operation (in which case, Sanofi recognizes the assets and liabilities of the operation in proportion to its rights and obligations relating to those assets and liabilities) or as a joint venture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi exercises joint control over a joint arrangement when decisions relating to the relevant activities of the arrangement require the unanimous consent of Sanofi and the other parties with whom control is shared.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi exercises significant influence over an entity when it has the power to participate in the financial and operating policy decisions of that entity, but does not have the power to exercise control or joint control over those policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), the equity method is used to account for joint ventures (i.e.&#160;entities over which Sanofi exercises joint control) and for associates (i.e. entities over which Sanofi exercises significant influence).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under the equity method, the investment is initially recognized at cost, and subsequently adjusted to reflect changes in the net assets of the associate or joint venture. IAS&#160;28 does not specify the treatment to be adopted on first-time application of the equity method to an investee following a step acquisition. Consequently, by reference to paragraph&#160;10 of IAS&#160;28, Sanofi has opted to apply the cost method, whereby the carrying amount of the investment represents the sum of the historical cost amounts for each step in the acquisition. As of the date on which the equity method is first applied, goodwill (which is included in the carrying amount of the investment) is determined for each acquisition step. The same applies to subsequent increases in the percentage interest in the equity-accounted investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;When the criteria of IFRS&#160;5 are met, Sanofi recognizes the equity interest within the balance sheet line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. The equity method is not applied to equity interests that are classified as held-for-sale assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Transactions between consolidated companies are eliminated, as are intragroup profits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A list of the principal companies included in the consolidation in 2022 is presented in Note&#160;F.&lt;/span&gt;&lt;/div&gt;Foreign currency translation&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.2.1. Accounting for foreign currency transactions in the financial statements of consolidated entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Non-current assets (other than receivables) and inventories acquired in foreign currencies are translated into the functional currency using the exchange rate prevailing at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the end of the reporting period. The gains and losses resulting from foreign currency translation are recorded in the income statement. However, foreign exchange gains and losses arising from the translation of advances between consolidated subsidiaries for which settlement is neither planned nor likely to occur in the foreseeable future are recognized in equity, in the line item&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Change in currency translation differences.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.2.2. Foreign currency translation of the financial statements of foreign entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi presents its consolidated financial statements in euros (&#x20ac;). In accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates), each subsidiary accounts for its transactions in the currency that is most representative of its economic environment (the functional currency).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;All assets and liabilities are translated into euros using the exchange rate of the subsidiary&#x2019;s functional currency prevailing at the end of the reporting period. Income statements are translated using a weighted average exchange rate for the period, except in the case of foreign subsidiaries in a hyperinflationary economy. The resulting currency translation difference is recognized as a separate component of equity in the consolidated statement of comprehensive income, and is recognized in the income statement only when the subsidiary is sold or is wholly or partially liquidated.&lt;/span&gt;&lt;/div&gt;Business combinations and transactions with non-controlling interests&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.3.1. Accounting for business combinations, transactions with non-controlling interests and loss of control&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Business combinations are accounted for in accordance with IFRS&#160;3 (Business Combinations) and IFRS&#160;10 (Consolidated Financial Statements).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Business combinations are accounted for using the acquisition method. Under this method, the acquiree&#x2019;s identifiable assets and liabilities that satisfy the recognition criteria of IFRS&#160;3 (Business Combinations) are measured initially at their fair values at the date of acquisition, except for (i)&#160;non-current assets classified as held for sale (which are measured at fair value less costs to sell) and (ii)&#160;assets and liabilities that fall within the scope of IAS&#160;12 (Income Taxes) and IAS&#160;19 (Employee Benefits). Restructuring liabilities are recognized as a liability of the acquiree only if the acquiree has an obligation as of the acquisition date to carry out the restructuring.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The principal accounting rules applicable to business combinations and transactions with non-controlling interests include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;acquisition-related costs are recognized as an expense, as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;contingent consideration is recognized in equity if the contingent payment is settled by delivery of a fixed number of the acquirer&#x2019;s equity instruments; otherwise, it is recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liabilities related to business combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Contingent consideration is recognized at fair value at the acquisition date irrespective of the probability of payment. If the contingent consideration was originally recognized as a financial liability, subsequent adjustments to the liability are recognized in profit or loss in the line item&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Fair value remeasurement of contingent consideration&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, unless the adjustment is made within the twelve months following the acquisition date and relates to facts and circumstances existing as of that date;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;goodwill may be calculated on the basis of either (i)&#160;the entire fair value of the acquiree, or (ii)&#160;a share of the fair value of the acquiree proportionate to the interest acquired. This option is elected for each acquisition individually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Purchase price allocations are performed under the responsibility of management, with assistance from an independent valuer in the case of major acquisitions. IFRS&#160;3 does not specify an accounting treatment for contingent consideration arising from a business combination made by an entity prior to the acquisition of control in that entity and carried as a liability in the acquired entity&#x2019;s balance sheet. The accounting treatment applied by Sanofi to such a liability is to measure it at fair value as of the acquisition date and to report it in the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liabilities related to business combinations and to non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, with subsequent remeasurements recognized in profit or loss. This treatment is consistent with the accounting applied to contingent consideration in the books of the&#160;acquirer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Finally, management may where it deems fit elect to apply the optional test to identify concentration of fair value permitted under IFRS&#160;3 in order to determine whether a transaction is a business combination within the meaning of IFRS&#160;3, or merely the acquisition of an asset or of a group of similar assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.3.2. Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The excess of the cost of an acquisition over Sanofi&#x2019;s interest in the fair value of the identifiable assets and liabilities of the acquiree is recognized as goodwill at the date of the business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Goodwill arising on the acquisition of subsidiaries is shown in a separate balance sheet line item, whereas goodwill arising on the acquisition of investments accounted for using the equity method is recorded in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Investments accounted for using the equity method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Goodwill arising on foreign operations is expressed in the functional currency of the country concerned and translated into euros using the exchange rate prevailing at the end of the reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;36 (Impairment of Assets), goodwill is carried at cost less accumulated impairment (see Note&#160;B.6.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment annually and whenever events or circumstances indicate that impairment might exist. Such events or circumstances include significant changes more likely than not to have an other-than-temporary impact on the substance of the original investment.&lt;/span&gt;&lt;/div&gt;Other intangible assets&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Other intangible assets are initially measured at acquisition cost or production cost, including any directly attributable costs of preparing the asset for its intended use, or (in the case of assets acquired in a business combination) at fair value as of the date of the business combination. Intangible assets are amortized on a straight line basis over their useful&#160;lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The useful lives of other intangible assets are reviewed at the end of each reporting period. The effect of any adjustment to useful lives is recognized prospectively as a change in accounting estimate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Amortization of other intangible assets is recognized in the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; except for amortization charged against (i)&#160;acquired or internally-developed software and (ii)&#160;other rights of an industrial or operational nature, which is recognized in the relevant classification of expense by function.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi does not own any intangible assets with an indefinite useful life, other than goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Intangible assets (other than goodwill) are carried at cost less accumulated amortization and accumulated impairment, if any, in accordance with IAS&#160;36 (see Note&#160;B.6.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.4.1. Research and development not acquired in a business combination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Internally generated research and development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under IAS&#160;38, research expenses are recognized in profit or loss when incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Internally generated development expenses are recognized as an intangible asset if, and only if, all the following six criteria can be demonstrated: (a)&#160;the technical feasibility of completing the development project; (b)&#160;Sanofi&#x2019;s intention to complete the project; (c)&#160;Sanofi&#x2019;s ability to use the project; (d)&#160;the probability that the project will generate future economic benefits; (e)&#160;the availability of adequate technical, financial and other resources to complete the project; and (f)&#160;the ability to measure the development expenditure reliably.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Due to the risks and uncertainties relating to regulatory approval and to the research and development process, the six criteria for capitalization are usually considered not to have been met until the product has obtained marketing approval from the regulatory authorities. Consequently, internally generated development expenses arising before marketing approval has been obtained, mainly the cost of clinical trials, are generally expensed as incurred within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Some industrial development expenses (such as those incurred in developing a second-generation synthesis process) are incurred after marketing approval has been obtained, in order to improve the industrial process for an active ingredient. To the extent that the six IAS&#160;38 criteria are considered as having been met, such expenses are recognized as an asset in the balance sheet within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; as incurred. Similarly, some clinical trials, for example those undertaken to obtain a geographical extension for a molecule that has already obtained marketing approval in a major market, may in certain circumstances meet the six capitalization criteria under IAS&#160;38, in which case the related expenses are recognized as an asset in the balance sheet within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Separately acquired research and development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Payments for separately acquired research and development are capitalized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; provided that they meet the definition of an intangible asset: a resource that is (i)&#160;controlled by Sanofi, (ii)&#160;expected to provide future economic benefits for Sanofi, and (iii)&#160;identifiable (i.e.&#160;it is either separable or arises from contractual or legal rights). Under paragraph&#160;25 of&#160;IAS&#160;38, the first condition for capitalization (the probability that the expected future economic benefits from the asset will flow to the entity) is considered to be satisfied for separately acquired research and development. Consequently, upfront and milestone payments to third parties related to pharmaceutical products for which marketing approval has not yet been obtained are recognized as intangible assets, and amortized on a straight line basis over their useful lives beginning when marketing approval is&#160;obtained.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Payments under research and development arrangements relating to access to technology or to databases, and payments made to purchase generics dossiers, are also capitalized, and amortized over the useful life of the intangible asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Subcontracting arrangements, payments for research and development services, and continuous payments under research and development collaborations which are unrelated to the outcome of that collaboration, are expensed over the service term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.4.2. Other intangible assets not acquired in a business combination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Licenses other than those related to pharmaceutical products and research projects, in particular software licenses, are capitalized at acquisition cost, including any directly attributable cost of preparing the software for its intended use. Software licenses are amortized on a straight line basis over their useful lives for Sanofi (&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTQvZnJhZzozZjc4YjJjMzg5MjM0NWI3OWUwMWQxNGFjYzI2ODQxNS90ZXh0cmVnaW9uOjNmNzhiMmMzODkyMzQ1Yjc5ZTAxZDE0YWNjMjY4NDE1XzUxMDY_a0f11f8d-0f58-4332-81c5-b171f9da546e"&gt;three&lt;/span&gt; to five years).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Internally generated costs incurred to develop or upgrade software are capitalized if the IAS&#160;38 recognition criteria are satisfied, and amortized on a straight line basis over the useful life of the software from the date on which the software is ready for use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.4.3. Other intangible assets acquired in a business combination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Other intangible assets acquired in a business combination (in-process research and development, technology platforms, and currently marketed products) that are reliably measurable are identified separately from goodwill, measured at fair value, and capitalized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in accordance with IFRS&#160;3 (Business Combinations) and IAS&#160;38 (Intangible Assets). The related deferred tax liability is also recognized if a deductible or taxable temporary difference exists.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In-process research and development acquired in a business combination is amortized on a straight line basis over its useful life from the date of receipt of marketing approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Rights to technology platforms and to products currently marketed by Sanofi are amortized on a straight line basis over their useful lives, determined (in particular for marketed products) on the basis of cash flow forecasts which take into account the patent protection period of the marketed product.&lt;/span&gt;&lt;/div&gt;Property, plant and equipment owned and leased&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.5.1. Property, plant and equipment owned&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is initially measured and recognized at acquisition cost, including any directly attributable cost of preparing the asset for its intended use, or (in&#160;the case of assets acquired in a business combination) at fair value as of the date of the business combination. The component-based approach to accounting for property, plant and equipment is applied. Under this approach, each component of an item of property, plant and equipment with a cost which is significant in relation to the total cost of the item and which has a different useful life from the other components must be depreciated separately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;After initial measurement, property, plant and equipment is carried at cost less accumulated depreciation and impairment, except for land which is carried at cost less impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Subsequent costs are not recognized as assets unless (i)&#160;it is probable that future economic benefits associated with those costs will flow to Sanofi and (ii)&#160;the costs can be measured reliably.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Borrowing costs attributable to the financing of items of property, plant and equipment, and incurred during the construction period, are capitalized as part of the acquisition cost of the&#160;item.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Government grants relating to property, plant and equipment are deducted from the acquisition cost of the asset to which they&#160;relate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The depreciable amount of items of property, plant and equipment, net of any residual value, is depreciated on a straight line basis over the useful life of the asset. The useful life of an asset is usually equivalent to its economic life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The customary useful lives of property, plant and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;to&#160;40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10 to 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5 to 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 to 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Useful lives and residual values of property, plant and equipment are reviewed annually. The effect of any adjustment to useful lives or residual values is recognized prospectively as a change in accounting estimate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Depreciation of property, plant and equipment is recognized as an expense in the income statement, in the relevant classification of expense by function.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.5.2. Property, plant and equipment leased&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Effective from January&#160;1, 2019 leases contracted by Sanofi have been accounted for in accordance with IFRS&#160;16 (Leases). Sanofi recognizes a right-of-use asset and a lease liability for all of its lease contracts, except for (i)&#160;leases relating to low-value assets and&#160;(ii)&#160;short-term leases (12&#160;months or less). Payments made in respect of leases not recognized on the balance sheet are recognized as an operating expense on a straight line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On commencement of a lease, the liability for future lease payments is discounted at the incremental borrowing rate, which is a risk-free rate adjusted to reflect the specific risk profile of each Sanofi entity. Because lease payments are spread over the lease term, Sanofi applies a discount rate based on the duration of those payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The payments used to determine the liability for future lease payments exclude non-lease components, but include fixed payments that Sanofi expects to make to the lessor over the estimated lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;After commencement of the lease, the liability for future lease payments is reduced by the amount of the lease payments made, and increased to reflect interest on the liability. In the event of a reassessment or modification of future lease payments, the lease liability is remeasured. The right-of-use asset &#x2013;&#160;which is initially measured at cost including direct costs of the lessee, prepayments made at or prior to the commencement date, less lease incentives received and restoration costs&#160;&#x2013; is depreciated on a straight line basis over the lease term, and tested for impairment as required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi recognizes deferred taxes in respect of right-of-use assets and lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are depreciated over their economic life, which is capped at the lease term as determined under&#160;IFRS&#160;16.&lt;/span&gt;&lt;/div&gt;Impairment of property, plant and equipment, intangible assets, and&#160;investments accounted for using the equity method&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.6.1. Impairment of property, plant and equipment and intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;36 (Impairment of Assets), assets that generate separate cash flows and assets included in cash-generating units&#160;(CGUs) are assessed for impairment when events or changes in circumstances indicate that the asset or CGU may be impaired. A&#160;CGU is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under IAS&#160;36, each CGU or group of CGUs to which goodwill is allocated must (i)&#160;represent the lowest level within the entity at which the goodwill is monitored for internal management purposes, and (ii)&#160;not be larger than an operating segment determined in accordance with IFRS&#160;8 (Operating Segments), before application of the IFRS&#160;8 aggregation criteria (see Note&#160;B.26.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Quantitative and qualitative indications of impairment (primarily relating to the status of the research and development portfolio, pharmacovigilance, patent litigation, and the launch of competing products) are reviewed at the end of each reporting period. If there is any internal or external indication of impairment, Sanofi estimates the recoverable amount of the asset or CGU.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Other intangible assets not yet available for use (such as capitalized in-process research and development), and CGUs or groups of CGUs that include goodwill, are tested for impairment annually whether or not there is any indication of impairment, and more frequently if any event or circumstance indicates that they might be impaired. Such assets are not amortized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;When there is an internal or external indication of impairment, Sanofi estimates the recoverable amount of the asset and recognizes an impairment loss if the carrying amount of the asset exceeds its recoverable amount. The recoverable amount of the asset is the higher of its fair value less costs to sell or its value in use. To determine value in use, Sanofi uses estimates of future cash flows generated by the asset or CGU, prepared using the same methods as those used in the initial measurement of the asset or CGU on the basis of medium-term strategic plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the case of goodwill, estimates of future cash flows are based on a six-year strategic plan and a terminal value. In the case of other intrangible assets, the period used is based on the economic life of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Estimated cash flows are discounted at long-term market interest rates that reflect the best estimate by Sanofi of the time value of money, the risks specific to the asset or CGU, and economic conditions in the geographical regions in which the business activity associated with the asset or CGU is located.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities that are not directly attributable to a specific CGU are allocated between CGUs on a basis that is reasonable, and consistent with the allocation of the corresponding goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Impairment losses arising on property, plant and equipment, on software and on certain rights are recognized in the relevant classification of expense by function.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Impairment losses arising on other intangible assets are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the income statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.6.2. Impairment of investments accounted for using the equity method&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), Sanofi determines whether investments accounted for using the equity method may be impaired based on indicators such as default in contractual payments, significant financial difficulties, probability of bankruptcy, or a prolonged or significant decline in quoted market price. If an investment is impaired, the amount of the impairment loss is determined by applying IAS&#160;36 (see Note&#160;B.6.1.) and recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.6.3. Reversals of impairment losses charged against property, plant and equipment, intangible assets, and investments accounted for using the equity method&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;At the end of each reporting period, Sanofi assesses whether events or changes in circumstances indicate that an impairment loss recognized in a prior period in respect of an asset (other than goodwill) or an investment accounted for using the equity method can be reversed. If this is the case, and the recoverable amount as determined based on the revised estimates exceeds the carrying amount of the asset, Sanofi reverses the impairment loss only to the extent of the carrying amount that would have been determined had no impairment loss been recognized for the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Reversals of impairment losses in respect of other intangible assets are recognized within the income statement line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, while reversals of impairment losses in respect of investments accounted for using the equity method are recognized within the income statement line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Impairment losses taken against goodwill are never reversed, unless the goodwill is part of the carrying amount of an investment accounted for using the equity method.&lt;/span&gt;&lt;/div&gt;Assets held for sale or exchange and liabilities related to assets held for sale or exchange&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;5 (Non-Current Assets Held for Sale and Discontinued Operations), non-current assets and groups of assets are classified as held for sale in the balance sheet if their carrying amount will be recovered principally through a sale transaction rather than through continuing use. Within the meaning of IFRS&#160;5, the term &#x201c;sale&#x201d; also includes exchanges for other assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Non-current assets or asset groups held for sale must be available for immediate sale in their present condition, subject only to terms that are usual and customary for sales of such assets, and a sale must be highly probable. Criteria used to determine whether a sale is highly probable include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the appropriate level of management must be committed to a plan to sell;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;an active program to locate a buyer and complete the plan must have been initiated;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the asset must be actively marketed for sale at a price that is reasonable in relation to its current fair value;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;completion of the sale should be foreseeable within the twelve months following the date of reclassification to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;actions required to complete the plan should indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Before initial reclassification of the non-current asset (or asset group) to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, the carrying amounts of the asset (or of all the assets and liabilities in the asset group) must be measured in accordance with the applicable standards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Subsequent to reclassification to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, the non-current asset (or asset group) is measured at the lower of carrying amount or fair value less costs to sell, with any write-down recognized by means of an impairment loss. Once a non-current asset has been reclassified as held for sale or exchange, it is no longer depreciated or amortized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In a disposal of an equity interest leading to loss of control, all the assets and liabilities of the entity involved are classified as held-for-sale assets or liabilities within the balance sheet line items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange or Liabilities related to assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, provided that the disposal satisfies the IFRS&#160;5 classification criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The profit or loss generated by a held-for-sale asset group is reported in a separate line item in the income statement for the current period and for the comparative periods presented, provided that the asset group:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;represents a separate major line of business or geographical area of operations; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;is a subsidiary acquired exclusively with a view to resale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;10, transactions between companies that are held for sale or treated as discontinued operations and other consolidated companies are eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Events or circumstances beyond Sanofi&#x2019;s control may extend the period to complete the sale or exchange beyond one year without precluding classification of the asset (or disposal group) in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; provided that there is sufficient evidence that Sanofi remains committed to the planned sale or exchange. Finally, in the event of changes to a plan of sale that requires an asset no longer to be classified as held for sale, IFRS&#160;5 specifies the following treatment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the assets and liabilities previously classified as held for sale are reclassified to the appropriate balance sheet line items, with no restatement of comparative periods;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;each asset is measured at the lower of (a)&#160;its carrying amount before the asset was reclassified as held for sale, adjusted for any depreciation, amortization or revaluation that would have been recognized if the asset had not been reclassified as held for sale, or&#160;(b)&#160;its recoverable amount at the date of reclassification;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the backlog of depreciation, amortization and impairment not recognized while non-current assets were classified as held for sale must be reported in the same income statement line item that was used to report impairment losses arising on initial reclassification of assets as held for sale and gains or losses arising on the sale of such assets. In the consolidated income statement, those impacts are reported within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other gains and losses, and litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the net income of a business previously classified as discontinued or as held for sale or exchange and reported on a separate line in the income statement must be reclassified and included in net income from continuing operations, for all periods presented;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;in addition, segment information relating to the income statement and the statement of cash flows (acquisitions of non-current assets) must be disclosed in the notes to the financial statements in accordance with IFRS&#160;8 (Operating Segments), and must also be restated for all prior periods presented.&lt;/span&gt;&lt;/div&gt;Financial instruments&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.1. Non-derivative financial assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;9 (Financial Instruments) and IAS&#160;32 (Financial Instruments: Presentation), Sanofi has adopted the classification of non-derivative financial assets described below. The classification used depends on (i)&#160;the characteristics of the contractual cash flows (i.e.&#160;whether they represent interest or principal) and (ii)&#160;the business model for managing the asset applied at the time of initial recognition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial assets at fair value through other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;These mainly comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;quoted and unquoted equity investments that Sanofi does not hold for trading purposes and that management has designated at &#x201c;fair value through other comprehensive income&#x201d; on initial recognition. Gains and losses arising from changes in fair value are recognized in equity within the statement of comprehensive income in the period in which they occur. When such instruments are derecognized, the previously-recognized changes in fair value remain within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, as does the gain or loss on divestment. Dividends received are recognized in profit or loss for the period, within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;debt instruments whose contractual cash flows represent payments of interest or repayments of principal, and which are managed with a view to collecting cash flows and selling the asset. Gains and losses arising from changes in fair value are recognized in equity within the statement of comprehensive income in the period in which they occur. When such assets are derecognized, the cumulative gains and losses previously recognized in equity are reclassified to profit or loss for the period within the line items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial assets at fair value through profit or loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;These mainly comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;contingent consideration already carried in the books of an acquired entity or granted in connection with a business combination;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;instruments whose contractual cash flows represent payments of interest and repayments of principal, which are managed with a view to selling the asset;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;instruments that management has designated at &#x201c;fair value through profit or loss&#x201d; on initial recognition; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;quoted and unquoted equity investments: equity instruments that are not held for trading and which management did not designate at &#x201c;fair value through other comprehensive income&#x201d; on initial recognition, and instruments that do not meet the IFRS definition of &#x201c;equity instruments&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Gains and losses arising from changes in fair value are recognized in profit or loss within the line items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Dividends received are recognized in profit or loss for the period, within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair value of equity investments in unquoted entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On initial recognition of an equity investment in an entity not quoted in an active market, the fair value of the investment is the acquisition cost. Cost ceases to be a representative measure of the fair value of an unquoted equity investment when Sanofi identifies significant changes in the investee, or in the environment in which it operates. In such cases, an internal valuation is carried out, based mainly on growth forecasts or by reference to similar transactions contracted with third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial assets measured at amortized cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Financial assets at amortized cost comprise instruments whose contractual cash flows represent payments of interest and repayments of principal and which are managed with a view to collecting cash flows. The main assets in this category are loans and receivables. They are presented within the line items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Other non-current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Accounts receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Loans with a maturity of more than 12&#160;months are presented in &#x201c;Long-term loans and advances&#x201d; within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other non-current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. These financial assets are measured at amortized cost using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of financial assets measured at amortized cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The main assets involved are accounts receivable. Accounts receivable are initially recognized at the amount invoiced to the customer. Impairment losses on trade accounts receivable are estimated using the expected loss method, in order to take account of the risk of payment default throughout the lifetime of the receivables. The expected credit loss is estimated collectively for all accounts receivable at each reporting date using an average expected loss rate, determined primarily on the basis of historical credit loss rates. However, that average expected loss rate may be adjusted if there are indications of a likely significant increase in credit risk. If a receivable is subject to a known credit risk, a specific impairment loss is recognized for that receivable. The amount of expected losses is recognized in the balance sheet as a reduction in the gross amount of accounts receivable. Impairment losses on accounts receivable are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Selling and general expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the income statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.2. Derivative instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Derivative instruments that do not qualify for hedge accounting are initially and subsequently measured at fair value, with changes in fair value recognized in the income statement in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, depending on the nature of the underlying economic item which is hedged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Derivative instruments that qualify for hedge accounting are measured using the policies described in Note&#160;B.8.3. below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;IFRS&#160;13 (Fair Value Measurement) requires counterparty credit risk to be taken into account when measuring the fair value of financial instruments. That risk is estimated on the basis of observable, publicly-available statistical data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Policy on offsetting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In order for a financial asset and a financial liability to be presented as a net amount in the balance sheet under IAS&#160;32, there must be:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(a) a legally enforceable right to offset; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(b) the intention either to settle on a net basis, or to realize the asset and settle the liability simultaneously.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.3. Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As part of its overall market risk management policy, Sanofi enters into various hedging transactions involving derivative or non-derivative instruments; these may include forward contracts, currency swaps or options, interest rate swaps or options, cross-currency swaps, and debt placings or issues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Such financial instruments are designated as hedging instruments and recognized using the hedge accounting principles of&#160;IFRS&#160;9 when (a)&#160;there is formal designation and documentation of the hedging relationship, of how the effectiveness of the hedging relationship will be assessed, and of the underlying market risk management objective and strategy; (b)&#160;the hedged item and the hedging instrument are eligible for hedge accounting; and (c)&#160;there is an economic relationship between the hedged item and the hedging instrument, defined on the basis of a hedge ratio that is consistent with the underlying market risk management strategy, and the residual credit risk does not dominate the value changes that result from that economic relationship.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair value hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A fair value hedge is a hedge of the exposure to changes in fair value of an asset, liability or firm commitment that is attributable to one or more risk components and could affect profit or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Changes in fair value of the hedging instrument and changes in fair value of the hedged item attributable to the hedged risk components are generally recognized in the income statement, within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for hedges related to operating activities, or within&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for hedges related to investing or financing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash flow hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A cash flow hedge is a hedge of the exposure to variability in cash flows from an asset, liability or highly probable forecast transaction that is attributable to one or more risk components and could affect profit or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Changes in fair value of the hedging instrument attributable to the effective portion of the hedge are recognized directly in equity in the consolidated statement of comprehensive income. Changes in fair value attributable to the ineffective portion of the hedge are recognized in the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;for hedges related to operating activities, and within&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for hedges related to investing or financing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Cumulative changes in fair value of the hedging instrument previously recognized in equity are reclassified to the income statement when the hedged transaction affects profit or loss. Those reclassified gains and losses are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for hedges related to operating activities, and within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for hedges related to investing or financing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;When a forecast transaction results in the recognition of a non-financial asset or liability, cumulative changes in the fair value of the hedging instrument previously recognized in equity are incorporated in the initial carrying amount of that asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;When the hedging instrument expires or is sold, terminated or exercised, the cumulative gain or loss previously recognized in equity remains separately recognized in equity and is not reclassified to the income statement, or recognized as an adjustment to the initial cost of the related non-financial asset or liability, until the forecast transaction occurs. However, if Sanofi no longer expects the forecast transaction to occur, the cumulative gain or loss previously recognized in equity is recognized immediately in profit or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Hedge of a net investment in a foreign operation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In a hedge of a net investment in a foreign operation, changes in the fair value of the hedging instrument attributable to the effective portion of the hedge are recognized directly in equity in the consolidated statement of comprehensive income. Changes in fair value attributable to the ineffective portion of the hedge are recognized in the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. When the investment in the foreign operation is sold, the changes in the fair value of the hedging instrument previously recognized in equity are reclassified to the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cost of hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As part of its market risk management policy, Sanofi may designate currency options or interest rate options as hedging instruments, the effectiveness of which is measured on the basis of changes in intrinsic value. In such cases, the time value of the option is treated as a hedging cost and accounted for as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;if the option includes a component that is not aligned on the critical features of the hedged item, the corresponding change in the time value is taken to profit or loss;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;otherwise, the change in the time value is taken to equity within the statement of comprehensive income, and then:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;if the hedged item is linked to a transaction that results in the recognition of a financial asset or liability, the change in the time value is reclassified to profit or loss symmetrically with the hedged item, or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;if the hedged item is linked to a transaction that results in the recognition of a non-financial asset or liability, the change in the time value is incorporated in the initial carrying amount of that asset or liability, or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;if the hedged item is linked to a period of time, the change in time value is reclassified to profit or loss on a straight line basis over the life of the hedging relationship.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the case of forward contracts and foreign exchange swaps, and of cross-currency swaps that qualify for hedge accounting on the basis of changes in spot rates, Sanofi may elect for each transaction to use the option whereby the premium/discount or foreign currency basis spread are treated in the same way as the time value of an option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Discontinuation of hedge accounting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Hedge accounting is discontinued when the eligibility criteria are no longer met (in particular, when the hedging instrument expires or is sold, terminated or exercised), or if there is a change in the market risk management objective of the hedging relationship.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.4. Non-derivative financial liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Borrowings and debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Bank borrowings and debt instruments are initially measured at fair value of the consideration received, net of directly attributable transaction costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Subsequently, they are measured at amortized cost using the effective interest method. All costs related to the issuance of borrowings or debt instruments, and all differences between the issue proceeds net of transaction costs and the value on redemption, are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the income statement over the term of the debt using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities related to business combinations and to non-controlling interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;These line items record the fair value of (i)&#160;contingent consideration payable in connection with business combinations and (ii)&#160;commitments to buy out equity holders of subsidiaries, including put options granted to non-controlling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Adjustments to the fair value of commitments to buy out equity holders of subsidiaries, including put options granted to non-controlling interests, are recognized in equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other non-derivative financial liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Other non-derivative financial liabilities include trade accounts payable, which are measured at fair value (which in most cases equates to face value) on initial recognition, and subsequently at amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.5. Fair value of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under IFRS&#160;13 (Fair Value Measurement) and IFRS&#160;7 (Financial Instruments: Disclosures), fair value measurements must be classified using a hierarchy based on the inputs used to measure the fair value of the instrument. This hierarchy has three levels:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.86pt"&gt;level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.25pt"&gt;level&#160;2: quoted prices in active markets for similar assets and liabilities, or valuation techniques in which all important inputs are derived from observable market data; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;c.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.78pt"&gt;level&#160;3: valuation techniques in which not all important inputs are derived from observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the disclosures required under IFRS&#160;7 relating to the measurement principles applied to financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Type&#160;of financial&#160;instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Measurement&lt;br/&gt;principle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level in&lt;br/&gt;fair&#160;value&lt;br/&gt;hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Valuation&lt;br/&gt;technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Method used to determine fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Valuation&lt;br/&gt;model&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Market data&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (quoted equity instruments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market&#160;price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (quoted debt instruments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (unquoted equity instruments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Cost/Approach based on comparables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;If cost ceases to be a representative measure of fair value, an internal valuation is carried out, based mainly on comparables.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (contingent consideration receivable)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Revenue-based approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;D.7.3.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value held to meet obligations under post-employment benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets designated at fair value held to meet obligations under deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Long-term loans and advances and other non-current receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;The amortized cost of long-term loans and advances and other non-current receivables at the end of the reporting period is not materially different from their fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.13.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Net asset value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.13.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Negotiable debt instruments, commercial paper, instant access deposits and term deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Because these instruments have a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.17.1.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;In the case of debt with a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.&lt;br/&gt;For debt with a maturity of more than 3&#160;months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.17.2.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;The liability for future lease payments is discounted using the incremental borrowing rate.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.20.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Present value of future cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&lt;br/&gt;Market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;lt;&#160;1&#160; year:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid Money Market&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;gt;&#160;1&#160;year:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid Zero Coupon&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.20.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Revenue-based approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Present value of future cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&lt;br/&gt;Market&lt;br/&gt;Spot&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;lt;&#160;1&#160;year:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&#160;Money&#160;Market  and LIFFE interest rate futures&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;gt;&#160;1&#160;year: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&#160;Zero Coupon&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.20.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Present&#160;value of future cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&lt;br/&gt;Market&lt;br/&gt;Spot&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;lt;&#160;1&#160; year:&lt;br/&gt;Mid&#160;Money Market and LIFFE interest rate futures&lt;br/&gt;&amp;gt;&#160;1&#160;year: &lt;br/&gt;Mid Zero Coupon&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Liabilities related to business combinations and to non-controlling interests (CVRs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Liabilities related to business combinations and to non-controlling interests (other than CVRs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Revenue-based approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Under IAS&#160;32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;B.8.4.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.6. Derecognition of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Financial assets are derecognized when the contractual rights to cash flows from the asset have ended or have been transferred and when Sanofi has transferred substantially all the risks and rewards of ownership of the asset. If Sanofi has neither transferred nor retained substantially all the risks and rewards of ownership of a financial asset, it is derecognized if Sanofi does not retain control of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A financial liability is derecognized when Sanofi&#x2019;s contractual obligations in respect of the liability are discharged, cancelled or extinguished.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.7. Risks relating to financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Market risks in respect of non-current financial assets, cash equivalents, derivative instruments and debt are described in the discussions of risk factors presented in Item&#160;3.D. and Item&#160;11. of Sanofi&#x2019;s Annual Report on Form&#160;20-F for 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Credit risk is the risk that customers may fail to pay their debts. For a description of credit risk, refer to &#x201c;We are subject to the risk of non-payment by our customers&#x201d; within Item&#160;3.D. and Item&#160;11. of Sanofi&#x2019;s Annual Report on Form&#160;20-F for 2022.&lt;/span&gt;&lt;/div&gt;Inventories&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Inventories are measured at the lower of cost or net realizable value. Cost is calculated using the weighted average cost method or the first-in, first-out method, depending on the nature of the inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The cost of finished goods inventories includes costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;During the launch phase of a new product, any inventories of that product are written down to zero pending regulatory approval, other than in specific circumstances which make it possible to estimate that there is a high probability at the end of the reporting period that the carrying amount of the inventories will be recoverable. The write-down is reversed once it becomes highly probable that marketing approval will be obtained.&lt;/span&gt;&lt;/div&gt;Cash and cash equivalentsCash and cash equivalents as shown in the consolidated balance sheet and statement of cash flows comprise cash, plus liquid short-term investments that are&#160;readily convertible into cash and are&#160;subject to an insignificant risk of changes in value in the event of movements in interest rates.Treasury sharesIn accordance with IAS&#160;32, Sanofi treasury shares are deducted from equity, irrespective of the purpose for which they are held. No gain or loss is recognized in the income statement on the purchase, sale, impairment or cancellation of treasury shares.Provisions for risks&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;37 (Provisions, Contingent Liabilities and Contingent Assets), Sanofi records a provision when it has a present obligation, whether legal or constructive, as a result of a past event; it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation; and a reliable estimate can be made of the amount of the outflow of resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;If the obligation is expected to be settled more than twelve months after the end of the reporting period, or has no definite settlement date, the provision is recorded within Non-current provisions and other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Provisions relating to the insurance programs in which Sanofi&#x2019;s captive insurance company participates are based on risk exposure estimates calculated by management, with assistance from independent actuaries, using IBNR (Incurred But Not Reported) techniques. Those techniques use past claims experience, within Sanofi and in the market, to estimate future trends in the cost of&#160;claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Contingent liabilities are not recognized, but are disclosed in the notes to the financial statements unless the possibility of an outflow of economic resources is&#160;remote.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi estimates provisions on the basis of events and circumstances related to present obligations at the end of the reporting period and of past experience, and to the best of management&#x2019;s knowledge at the date of preparation of the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Reimbursements offsetting the probable outflow of resources are recognized as assets only if it is virtually certain that they will be received. Contingent assets are not recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Restructuring provisions are recognized if Sanofi has a detailed, formal restructuring plan at the end of the reporting period and has announced its intention to implement this plan to those affected by it.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;No provisions are recorded for future operating losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi records non-current provisions for certain obligations, such as legal or constructive obligations, where an outflow of resources is probable and the amount of the outflow can be reliably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the case of environmental risks, including at sites where operations are ongoing, Sanofi recognizes a provision where there is a violation of integrity in respect of human health or the environment resulting from past contamination at a site that requires remediation. The amount of the provision is a best estimate of the future expenditures to be incurred on the remediation plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Where the effect of the time value of money is material, those provisions are measured at the present value of the expenditures expected to be required to settle the obligation, calculated using a discount rate that reflects an estimate of the time value of money and the risks specific to the obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Increases in provisions to reflect the effects of the passage of time are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;Revenue recognition&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.13.1. Net sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Revenue arising from the sale of goods is presented in the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net sales&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Net sales comprise revenue from sales of pharmaceutical products, consumer healthcare products, active ingredients and vaccines, net of sales returns, of customer incentives and discounts, and of certain sales-based payments paid or payable to the healthcare authorities. Analyses of net sales are provided in Note&#160;D.35.1. &#x201c;Segment Information&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;15 (Revenue from Contracts with Customers), such revenue is recognized when Sanofi transfers control over the product to the customer; control of an asset refers to the ability to direct the use of, and obtain substantially all of the remaining benefits from that asset. For the vast majority of contracts, revenue is recognized when the product is physically transferred, in accordance with the delivery and acceptance terms agreed with the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For contracts entered into by Sanofi Pasteur, transfer of control is usually determined by reference to the terms of release (immediate or deferred) and acceptance of batches of vaccine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the case of contracts with distributors, Sanofi does not recognize revenue when the product is physically transferred to the distributor if the products are sold on consignment, or if the distributor acts as agent. In such cases, revenue is recognized when control is transferred to the end customer, and the distributor&#x2019;s commission is presented within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Selling and general expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the income statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The amount of revenue recognized reflects the various types of price reductions or rights of return offered by Sanofi to its customers on certain products. Such price reductions and rights of return qualify as variable consideration under IFRS&#160;15.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In particular, products sold in the United States are covered by various Government and State programs (such as Medicare and Medicaid) under which products are sold at a discount. Rebates are granted to healthcare authorities, and under contractual arrangements with certain customers. Some wholesalers are entitled to chargeback incentives based on the selling price to the end customer, under specific contractual arrangements. Cash discounts may also be granted for prompt payment. Returns, discounts, incentives and rebates, as described above, are recognized in the period in which the underlying sales are recognized as a reduction of gross sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;These amounts are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of chargeback incentives is estimated on the basis of the relevant subsidiary&#x2019;s standard sales terms and conditions, and in certain cases on the basis of specific contractual arrangements with the customer;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of rebates based on attainment of sales targets is estimated and accrued as each of the underlying sales transactions is recognized;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of price reductions under Government and State programs, largely in the United States, is estimated on the basis of the specific terms of the relevant regulations or agreements, and accrued as each of the underlying sales transactions is recognized;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of sales returns is calculated on the basis of management&#x2019;s best estimate of the amount of product that will ultimately be returned by customers. In countries where product returns are possible, Sanofi operates a returns policy that allows the customer to return products within a certain period either side of the expiry date (usually 12&#160;months after the expiry date). The amount recognized for returns is estimated on the basis of past experience of sales returns. Sanofi also takes into account factors such as levels of inventory in its various distribution channels, product expiry dates, information about potential discontinuation of products, the entry of competing generics into the market, and the launch of over-the-counter medicines. Most product return clauses relate solely to date-expired products, which cannot be resold and are destroyed. Sanofi does not recognize a right of return asset in the balance sheet for contracts that allow for the return of time-expired products, since those products have no value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The estimated amounts described above are recognized in the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net sales&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;as a reduction of gross sales, and within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the balance sheet. They are subject to regular review and adjustment as appropriate based on the most recent data available to management. Sanofi believes that it has the ability to measure each of the above amounts reliably, using the following factors in developing its estimates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the nature and patient profile of the underlying product;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the applicable regulations or the specific terms and conditions of contracts with governmental authorities, wholesalers and other customers;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;historical data relating to similar contracts, in the case of qualitative and quantitative rebates and chargeback incentives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;past experience and sales growth trends for the same or similar products;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;actual inventory levels in distribution channels, monitored by Sanofi using internal sales data and externally provided data;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the shelf life of Sanofi products; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;market trends including competition, pricing and demand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;An analysis of provisions for discounts, rebates and sales returns is provided in Note&#160;D.23.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.13.2. Other revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;The line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; is used to recognize all revenue that falls within the scope of IFRS&#160;15 but does not relate to sales of Sanofi products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;It mainly comprises (i)&#160;royalties received from licensing intellectual property rights to third parties; (ii)&#160;VaxServe sales of products sourced from third-party manufacturers; and (iii)&#160;revenue received under agreements for Sanofi to provide manufacturing services to third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Royalties received under licensing arrangements are recognized over the period during which the underlying sales are recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;VaxServe is a Vaccines segment entity whose operations include the distribution within the United States of vaccines and other products manufactured by third parties. VaxServe sales of products sourced from third-party manufacturers are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;Cost of sales&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of sales&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; consists primarily of the industrial cost of goods sold, payments made under licensing agreements, and distribution costs. The industrial cost of goods sold includes the cost of materials, depreciation of property, plant and equipment, amortization of software, personnel costs, and other expenses attributable to production.&lt;/span&gt;Research and development&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Note&#160;B.4.1. &#x201c;Research and development not acquired in a business combination&#x201d; and Note&#160;B.4.3. &#x201c;Other intangible assets acquired in a business combination&#x201d; describe the principles applied to the recognition of research and development costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Contributions or reimbursements received from alliance partners are recorded as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;Other operating income and expenses&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.16.1. Other operating income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; includes the share of profits that Sanofi is entitled to receive from alliance partners in respect of product marketing agreements. It also includes revenues generated under certain agreements, which may include partnership, co-promotion arrangements and licenses not included in Other revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;This line item also includes realized and unrealized foreign exchange gains and losses on operating activities (see Note&#160;B.8.3.), and operating gains on disposals not regarded as major disposals (see Note&#160;B.20.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.16.2. Other operating expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; mainly comprise the share of profits that alliance partners are entitled to receive from Sanofi under product marketing agreements.&lt;/span&gt;&lt;/div&gt;Amortization and impairment of intangible assets&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.17.1. Amortization of intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The expenses recorded in this line item comprise amortization of product rights and other intangible assets (see Note&#160;D.4.), given that the benefit of those rights to Sanofi&#x2019;s commercial, industrial and development functions cannot be separately identified.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Amortization of software, and of other rights of an industrial or operational nature, is recognized as an expense in the income statement, in the relevant line items of expense by function.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.17.2. Impairment of intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;This line item records impairment losses (other than those associated with restructuring) recognized against intangible assets (including goodwill, but excluding software and other rights of an industrial or operational nature), and any reversals of such impairment losses.&lt;/span&gt;&lt;/div&gt;Fair value remeasurement of contingent consideration&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of contingent consideration that was (i)&#160;already carried in the books of an acquired entity, or (ii)&#160;granted in connection with a business combination and initially recognized as a liability in accordance with IFRS&#160;3, are reported in profit or loss. Such adjustments are reported separately in the income statement, in the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair value remeasurement of contingent consideration&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;This line item also includes changes in the fair value of contingent consideration receivable in connection with a divestment and classified as a financial asset at fair value through profit or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Finally, it includes the effect of the unwinding of discount, and of exchange rate movements where the asset or liability is expressed in a currency other than the functional currency of the reporting entity.&lt;/span&gt;&lt;/div&gt;Restructuring costs and similar items&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Restructuring costs are expenses incurred in connection with the transformation or reorganization of Sanofi&#x2019;s operations or support functions. Such costs include collective redundancy plans, compensation to third parties for early termination of contracts, and commitments made in connection with transformation or reorganization decisions. They also include accelerated depreciation charges arising from site closures (including closures of leased sites), and losses on asset disposals resulting from such decisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In addition, this line item includes expenses incurred in connection with programs implemented as part of the transformation strategy announced in December&#160;2019 (and previously in November&#160;2015), and intended primarily to (i)&#160;deliver a global information systems solution, further supported by the implementation in 2021 of Sanofi's new digital strategy; (ii)&#160;create a standalone Consumer Healthcare entity; and (iii)&#160;as announced on February&#160;24, 2020, create a European leader in the production and marketing to third parties of active pharmaceutical ingredients (API).&lt;/span&gt;&lt;/div&gt;Other gains and losses, and litigation&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other gains and losses, and litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; includes the impact of material transactions of an unusual nature or amount which Sanofi believes it necessary to report separately in the income statement in order to improve the relevance of the financial statements, such as:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;gains and losses on major disposals of property, plant and equipment, of intangible assets, of assets (or groups of assets and liabilities) held for sale, or of a business within the meaning of IFRS&#160;3, other than those considered to be restructuring costs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;impairment losses and reversals of impairment losses on assets (or groups of assets and liabilities) held for sale, other than those considered to be restructuring costs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;gains on bargain purchases;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;costs relating to major litigation; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;pre-tax separation costs associated with the process of disinvesting from operations in the event of a major divestment.&lt;/span&gt;&lt;/div&gt;Financial expenses and income&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.21.1. Financial expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; mainly comprise interest charges on debt financing; negative changes in the fair value of certain financial instruments (where changes in fair value are recognized in profit or loss); realized and unrealized foreign exchange losses on financing and investing activities; impairment losses on financial instruments; and any reversals of impairment losses on financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; also include expenses arising from the unwinding of discount on long-term provisions, and the net interest cost related to employee benefits. This line item does not include commercial cash discounts, which are deducted from net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.21.2. Financial income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; includes interest and dividend income; positive changes in the fair value of certain financial instruments (where changes in fair value are recognized in profit or loss); realized and unrealized foreign exchange gains on financing and investing activities; and gains on disposals of financial assets at fair value through profit or loss.&lt;/span&gt;&lt;/div&gt;Income tax expense&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income tax expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;includes all current and deferred taxes of consolidated companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi accounts for deferred taxes in accordance with IAS&#160;12 (Income Taxes), using the methods described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;deferred tax assets and liabilities are recognized on taxable and deductible temporary differences, and on tax loss carry-forwards. Temporary differences are differences between the carrying amount of an asset or liability in the balance sheet and its tax base;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;French business taxes include a value added based component: &#x201c;CVAE&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Cotisation sur la Valeur Ajout&#xe9;e des Entreprises)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Given that CVAE is (i)&#160;calculated as the amount by which certain revenues exceed certain expenses and (ii)&#160;borne primarily by companies that own intellectual property rights on income derived from those rights (royalties, and margin on sales to third parties and to Sanofi entities), it is regarded as meeting the definition of income taxes specified in IAS&#160;12, paragraph&#160;2 (&#x201c;taxes which are based on taxable profits&#x201d;);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;deferred tax assets and liabilities are calculated using the tax rate expected to apply in the period when the corresponding temporary differences are expected to reverse, based on tax rates enacted or substantively enacted at the end of the reporting period;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;deferred tax assets are recognized in respect of deductible temporary differences, tax losses available for carry-forward and unused tax credits to the extent that future recovery is regarded as probable. The recoverability of deferred tax assets is assessed on a case-by-case basis, taking into account the profit forecasts contained in Sanofi&#x2019;s medium-term business plan;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;a deferred tax liability is recognized for temporary differences relating to interests in subsidiaries, associates and joint ventures, except in cases where Sanofi is able to control the timing of the reversal of the temporary differences. This applies in particular when Sanofi is able to control dividend policy and it is probable that the temporary differences will not reverse in the foreseeable future;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;no deferred tax is recognized on eliminations of intragroup transfers of interests in subsidiaries, associates or joint ventures;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;each tax entity calculates its own net deferred tax position. All net deferred tax asset and liability positions are then aggregated and shown in separate line items on the relevant side of the consolidated balance sheet. Deferred tax assets and liabilities are offset only if (i)&#160;Sanofi has a legally enforceable right to offset current tax assets and current tax liabilities, and (ii)&#160;the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation authority;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;deferred taxes are not discounted, except implicitly in the case of deferred taxes on assets and liabilities which are already impacted by discounting. In addition, Sanofi has elected not to discount current taxes payable or receivable where the amounts in question are payable or receivable in the long term;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;withholding taxes on intragroup royalties and dividends, and on royalties and dividends collected from third parties, are accounted for as current income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accounting for business combinations, Sanofi complies with IFRS&#160;3 as regards the recognition of deferred tax assets after the initial accounting period. Consequently, any deferred tax assets recognized by the acquiree after the end of that period in respect of temporary differences or tax loss carry-forwards existing at the acquisition date are recognized in profit or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The positions adopted by Sanofi in tax matters are based on its interpretation of tax laws and regulations. Some of those positions may be subject to uncertainty. In such cases, Sanofi assesses the amount of the tax liability on the basis of the following assumptions: that its position will be examined by one or more tax authorities on the basis of all relevant information; that a technical assessment is carried out with reference to legislation, case law, regulations, and established practice; and that each position is assessed individually (or collectively where appropriate), with no offset or aggregation between positions. Those assumptions are assessed on the basis of facts and circumstances existing at the end of the reporting period. When an uncertain tax liability is regarded as probable, it is measured on the basis of Sanofi&#x2019;s best estimate and recognized as a liability; uncertain tax assets are not recognized. The amount of the liability includes any penalties and late payment interest. The line item&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Income tax expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; includes the effects of tax reassessments and tax disputes, and any penalties and late payment interest arising from such disputes that have the characteristics of income taxes within the meaning of paragraph&#160;2 of IAS&#160;12 (&#x201c;taxes which are based on taxable profits&#x201d;). Tax exposures relating to corporate income taxes are presented separately within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-current income tax liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (see Note&#160;D.19.4.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;No deferred taxation is recognized on temporary differences that are liable to be subject to US global intangible low taxed income (GILTI) provisions. The related tax expense is recognized in the year in which it is declared in the tax return to the extent that it arises from the existence of non-US profits that exceed the theoretical return on investment specified in the GILTI provisions and are taxed at a rate lower than the applicable US tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;1 (Presentation of Financial Statements), current income tax assets and liabilities are presented as separate line items in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;Employee benefit obligations&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi offers retirement benefits to employees and retirees. Such benefits are accounted for in accordance with IAS&#160;19 (Employee Benefits).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Benefits are provided in the form of either defined contribution plans or defined benefit plans. In the case of defined contribution plans, the cost is recognized immediately in the period in which it is incurred, and equates to the amount of the contributions paid by Sanofi. For defined benefit plans, Sanofi generally recognizes its obligations to pay pensions and similar benefits to employees as a liability, based on an actuarial estimate of the rights vested or currently vesting in employees and retirees, using the projected unit credit method. Estimates are performed at least once a year, and rely on financial assumptions (such as discount rates) and demographic assumptions (such as life expectancy, retirement age, employee turnover, and the rate of salary increases).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Obligations relating to other post-employment benefits (healthcare and life insurance) offered by Sanofi companies to employees are also recognized as a liability based on an actuarial estimate of the rights vested or currently vesting in employees and retirees at the end of the reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Such liabilities are recognized net of the fair value of plan assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the case of multi-employer defined benefit plans where plan assets cannot be allocated to each participating employer with sufficient reliability, the plan is accounted for as a defined contribution plan, in accordance with paragraph&#160;34 of IAS&#160;19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The benefit cost for the period consists primarily of current service cost, past service cost, net interest cost, gains or losses arising from plan settlements not specified in the terms of the plan, and actuarial gains or losses arising from plan curtailments. Net interest cost for the period is determined by applying the discount rate specified in IAS&#160;19 to the net liability (i.e. the amount of the obligation, net of plan assets) recognized in respect of defined benefit plans. Past service cost is recognized immediately in profit or loss in the period in which it is incurred, regardless of whether or not the rights have vested at the time of adoption (in&#160;the case of a new plan) or of amendment (in&#160;the case of an existing&#160;plan).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Actuarial gains and losses on defined benefit plans (pensions and other post-employment benefits), also referred to as&#160;&#x201c;Remeasurements of the net defined benefit liability (asset)&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; arise as a result of changes in financial and demographic assumptions, experience adjustments, and the difference between the actual return and interest cost on plan assets. The impacts of those remeasurements are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, net of deferred taxes; they are not subsequently reclassifiable to profit or&#160;loss.&lt;/span&gt;&lt;/div&gt;Share-based payment&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Share-based payment expense is recognized as a component of operating income, in the relevant classification of expense by function. In measuring the expense, the level of attainment of any performance conditions is taken into account.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.24.1. Stock option plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi has granted a number of equity-settled share-based payment plans (stock option plans) to some of its employees. The terms of those plans may make the award contingent on the attainment of performance criteria for some of the grantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;2 (Share-Based Payment), services received from employees as consideration for stock options are recognized as an expense in the income statement, with the opposite entry recognized in equity. The expense corresponds to the fair value of the stock option plans, and is charged to income on a straight-line basis over the four-year vesting period of the plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The fair value of stock option plans is measured at the date of grant using the Black-Scholes valuation model, taking into account the expected life of the options. The resulting expense also takes into account the expected cancellation rate of the options. The expense is adjusted over the vesting period to reflect actual cancellation rates resulting from option-holders ceasing to be employed by Sanofi.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.24.2. Employee share ownership plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi may offer its employees the opportunity to subscribe to reserved share issues at a discount to the reference market price. Shares awarded to employees under such plans fall within the scope of IFRS&#160;2. Consequently, an expense is recognized at the subscription date, based on the value of the discount offered to employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.24.3. Restricted share plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi may award restricted share plans to certain of its employees. The terms of those plans may make the award contingent on the attainment of performance criteria for some of the grantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;2, an expense equivalent to the fair value of such plans is recognized in profit or loss on a straight line basis over the vesting period of the plan, with the opposite entry recognized in equity. The vesting period is three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The fair value of restricted share plans is based on the quoted market price of Sanofi shares at the date of grant, adjusted for expected dividends during the vesting period; it also takes account of any vesting conditions contingent on stock market performance, measured using the Monte-Carlo valuation model. Other vesting conditions are taken into account in the estimate of the number of shares awarded during the vesting period; that number is then definitively adjusted based on the actual number of shares awarded on the vesting date.&lt;/span&gt;&lt;/div&gt;Earnings per share&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated using the weighted average number of shares outstanding during the reporting period, adjusted on a time-weighted basis from the acquisition date to reflect the number of own shares held by Sanofi. Diluted earnings per share is calculated on the basis of the weighted average number of ordinary shares, computed using the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;This method assumes that (i)&#160;all outstanding dilutive options and warrants are exercised, and (ii)&#160;Sanofi acquires its own shares at the quoted market price for an amount equivalent to the cash received as consideration for the exercise of the options or warrants, plus the expense arising on unamortized stock options.&lt;/span&gt;&lt;/div&gt;Segment information&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;8 (Operating Segments), the segment information reported by Sanofi is prepared on the basis of internal management data provided to the Chief Executive Officer, who is the chief operating decision maker. The performance of those segments is monitored individually using internal reports and common indicators. Disclosures about operating segments required under IFRS&#160;8 are presented in Note&#160;D.35. &#x201c;Segment information&#x201d; to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi has three operating segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Pharmaceuticals segment comprises, for all geographical territories, the commercial operations of the following global franchises: Specialty Care (Dupixent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, Neurology &amp;amp; Immunology, Rare Diseases, Oncology, and Rare Blood Disorders) and General Medicines (Core and Non-Core Assets), together with research, development and production activities dedicated to the Pharmaceuticals segment. This segment also includes associates whose activities are related to pharmaceuticals. Following the transaction of May&#160;29, 2020, Regeneron is no longer an associate of Sanofi (see Note&#160;D.2.). Consequently, the Pharmaceuticals segment no longer includes Sanofi&#x2019;s equity-accounted share of Regeneron&#x2019;s profits for all the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Vaccines segment comprises, for all geographical territories, the commercial operations of Vaccines, together with research, development and production activities dedicated to vaccines.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for Sanofi's Consumer Healthcare products, together with research, development and production activities dedicated to those products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Inter-segment transactions are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The costs of Sanofi&#x2019;s global functions (Corporate Affairs, Finance, People &amp;amp; Culture, Legal, Ethics &amp;amp; Business Integrity, Information Solutions&#160;&amp;amp; Technologies, Sanofi Business Services,&#160;etc.) are managed centrally at group-wide level, and are presented within the &#x201c;Other&#x201d; category. That category also includes other reconciling items such as retained commitments in respect of divested activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Information about operating segments for the years ended December 31, 2022, 2021 and 2020 is presented in Note&#160;D.35&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x201c;Segment information&#x201d;.&lt;/span&gt;&lt;/div&gt;Management of capital&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In order to maintain or adjust the capital structure, Sanofi can adjust the amount of dividends paid to shareholders, repurchase its own shares, issue new shares, or issue securities giving access to its capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The following objectives are defined under the terms of Sanofi&#x2019;s share repurchase programs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the implementation of any stock option plan giving entitlement to purchase shares in the Sanofi parent company;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the allotment or sale of shares to employees under statutory profit sharing schemes and employee savings plans;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the consideration-free allotment of shares (i.e. restricted share plans);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the cancellation of some or all of the repurchased shares;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;market-making in the secondary market by an investment services provider under a liquidity contract in compliance with the ethical code recognized by the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Autorit&#xe9; des march&#xe9;s financiers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (AMF);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the delivery of shares on the exercise of rights attached to securities giving access to the capital by redemption, conversion, exchange, presentation of a warrant or any other means;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the delivery of shares (in exchange, as payment, or otherwise) in connection with mergers and acquisitions;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the execution by an investment services provider of purchases, sales or transfers by any means, in particular via off-market trading; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;any other purpose that is or may in the future be authorized under the applicable laws and regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi is not subject to any constraints on equity capital imposed by third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Total equity includes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity attributable to equity holders of Sanofi and Equity attributable to non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, as shown in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi defines &#x201c;Net debt&#x201d; as (i)&#160;the sum of short-term debt, long-term debt and interest rate derivatives and currency derivatives used to hedge debt, minus (ii)&#160;the sum of cash and cash equivalents and interest rate derivatives and currency derivatives used to hedge cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <sny:DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MDUvZnJhZzo1ZDZhNjNmNDM2Y2U0Yjg4OTI3NzI3MDdiZjJmNWZlOS90ZXh0cmVnaW9uOjVkNmE2M2Y0MzZjZTRiODg5Mjc3MjcwN2JmMmY1ZmU5XzMzOTc_e4b4b3a8-d63a-4289-a3db-b97754ee8d20">Basis of consolidation&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;10 (Consolidated Financial Statements), the consolidated financial statements of Sanofi include the financial statements of entities that Sanofi controls directly or indirectly, regardless of the level of the equity interest in those entities. An entity is controlled when Sanofi has power over the entity, exposure or rights to variable returns from its involvement with the entity, and the ability to affect those returns through its power over the entity. In determining whether control exists, potential voting rights must be taken into account if those rights are substantive, in other words they can be exercised on a timely basis when decisions about the relevant activities of the entity are to be taken.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Entities consolidated by Sanofi are referred to as &#x201c;subsidiaries&#x201d;. Entities that Sanofi controls by means other than voting rights are referred to as &#x201c;consolidated structured entities&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;11 (Joint Arrangements), Sanofi classifies its joint arrangements (i.e. arrangements in which Sanofi exercises joint control with one or more other parties) either as a joint operation (in which case, Sanofi recognizes the assets and liabilities of the operation in proportion to its rights and obligations relating to those assets and liabilities) or as a joint venture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi exercises joint control over a joint arrangement when decisions relating to the relevant activities of the arrangement require the unanimous consent of Sanofi and the other parties with whom control is shared.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi exercises significant influence over an entity when it has the power to participate in the financial and operating policy decisions of that entity, but does not have the power to exercise control or joint control over those policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), the equity method is used to account for joint ventures (i.e.&#160;entities over which Sanofi exercises joint control) and for associates (i.e. entities over which Sanofi exercises significant influence).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under the equity method, the investment is initially recognized at cost, and subsequently adjusted to reflect changes in the net assets of the associate or joint venture. IAS&#160;28 does not specify the treatment to be adopted on first-time application of the equity method to an investee following a step acquisition. Consequently, by reference to paragraph&#160;10 of IAS&#160;28, Sanofi has opted to apply the cost method, whereby the carrying amount of the investment represents the sum of the historical cost amounts for each step in the acquisition. As of the date on which the equity method is first applied, goodwill (which is included in the carrying amount of the investment) is determined for each acquisition step. The same applies to subsequent increases in the percentage interest in the equity-accounted investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;When the criteria of IFRS&#160;5 are met, Sanofi recognizes the equity interest within the balance sheet line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. The equity method is not applied to equity interests that are classified as held-for-sale assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Transactions between consolidated companies are eliminated, as are intragroup profits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A list of the principal companies included in the consolidation in 2022 is presented in Note&#160;F.&lt;/span&gt;&lt;/div&gt;</sny:DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MDgvZnJhZzo4NWRhZDgwOWE5NDk0YTgyOGIzMzQ1OTBmZTM4Mzg5My90ZXh0cmVnaW9uOjg1ZGFkODA5YTk0OTRhODI4YjMzNDU5MGZlMzgzODkzXzE4NTA_0310b73a-3c8f-459f-8393-42cfc3833dfd">Foreign currency translation&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.2.1. Accounting for foreign currency transactions in the financial statements of consolidated entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Non-current assets (other than receivables) and inventories acquired in foreign currencies are translated into the functional currency using the exchange rate prevailing at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the end of the reporting period. The gains and losses resulting from foreign currency translation are recorded in the income statement. However, foreign exchange gains and losses arising from the translation of advances between consolidated subsidiaries for which settlement is neither planned nor likely to occur in the foreseeable future are recognized in equity, in the line item&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Change in currency translation differences.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.2.2. Foreign currency translation of the financial statements of foreign entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi presents its consolidated financial statements in euros (&#x20ac;). In accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates), each subsidiary accounts for its transactions in the currency that is most representative of its economic environment (the functional currency).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;All assets and liabilities are translated into euros using the exchange rate of the subsidiary&#x2019;s functional currency prevailing at the end of the reporting period. Income statements are translated using a weighted average exchange rate for the period, except in the case of foreign subsidiaries in a hyperinflationary economy. The resulting currency translation difference is recognized as a separate component of equity in the consolidated statement of comprehensive income, and is recognized in the income statement only when the subsidiary is sold or is wholly or partially liquidated.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTEvZnJhZzphZTJkZDk0ODI4MGY0YzFhYTM1ZDczZjA1OGMyMjQ2ZS90ZXh0cmVnaW9uOmFlMmRkOTQ4MjgwZjRjMWFhMzVkNzNmMDU4YzIyNDZlXzQ0NDc_52739c07-69c7-431c-b412-d1b9f236b1fd">Business combinations and transactions with non-controlling interests&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.3.1. Accounting for business combinations, transactions with non-controlling interests and loss of control&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Business combinations are accounted for in accordance with IFRS&#160;3 (Business Combinations) and IFRS&#160;10 (Consolidated Financial Statements).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Business combinations are accounted for using the acquisition method. Under this method, the acquiree&#x2019;s identifiable assets and liabilities that satisfy the recognition criteria of IFRS&#160;3 (Business Combinations) are measured initially at their fair values at the date of acquisition, except for (i)&#160;non-current assets classified as held for sale (which are measured at fair value less costs to sell) and (ii)&#160;assets and liabilities that fall within the scope of IAS&#160;12 (Income Taxes) and IAS&#160;19 (Employee Benefits). Restructuring liabilities are recognized as a liability of the acquiree only if the acquiree has an obligation as of the acquisition date to carry out the restructuring.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The principal accounting rules applicable to business combinations and transactions with non-controlling interests include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;acquisition-related costs are recognized as an expense, as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;contingent consideration is recognized in equity if the contingent payment is settled by delivery of a fixed number of the acquirer&#x2019;s equity instruments; otherwise, it is recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liabilities related to business combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Contingent consideration is recognized at fair value at the acquisition date irrespective of the probability of payment. If the contingent consideration was originally recognized as a financial liability, subsequent adjustments to the liability are recognized in profit or loss in the line item&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Fair value remeasurement of contingent consideration&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, unless the adjustment is made within the twelve months following the acquisition date and relates to facts and circumstances existing as of that date;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;goodwill may be calculated on the basis of either (i)&#160;the entire fair value of the acquiree, or (ii)&#160;a share of the fair value of the acquiree proportionate to the interest acquired. This option is elected for each acquisition individually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Purchase price allocations are performed under the responsibility of management, with assistance from an independent valuer in the case of major acquisitions. IFRS&#160;3 does not specify an accounting treatment for contingent consideration arising from a business combination made by an entity prior to the acquisition of control in that entity and carried as a liability in the acquired entity&#x2019;s balance sheet. The accounting treatment applied by Sanofi to such a liability is to measure it at fair value as of the acquisition date and to report it in the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liabilities related to business combinations and to non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, with subsequent remeasurements recognized in profit or loss. This treatment is consistent with the accounting applied to contingent consideration in the books of the&#160;acquirer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Finally, management may where it deems fit elect to apply the optional test to identify concentration of fair value permitted under IFRS&#160;3 in order to determine whether a transaction is a business combination within the meaning of IFRS&#160;3, or merely the acquisition of an asset or of a group of similar assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.3.2. Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The excess of the cost of an acquisition over Sanofi&#x2019;s interest in the fair value of the identifiable assets and liabilities of the acquiree is recognized as goodwill at the date of the business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Goodwill arising on the acquisition of subsidiaries is shown in a separate balance sheet line item, whereas goodwill arising on the acquisition of investments accounted for using the equity method is recorded in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Investments accounted for using the equity method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Goodwill arising on foreign operations is expressed in the functional currency of the country concerned and translated into euros using the exchange rate prevailing at the end of the reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;36 (Impairment of Assets), goodwill is carried at cost less accumulated impairment (see Note&#160;B.6.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment annually and whenever events or circumstances indicate that impairment might exist. Such events or circumstances include significant changes more likely than not to have an other-than-temporary impact on the substance of the original investment.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTQvZnJhZzozZjc4YjJjMzg5MjM0NWI3OWUwMWQxNGFjYzI2ODQxNS90ZXh0cmVnaW9uOjNmNzhiMmMzODkyMzQ1Yjc5ZTAxZDE0YWNjMjY4NDE1XzYzMzU_ad532899-428c-4d23-9903-edc1b5cc718c">Other intangible assets&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Other intangible assets are initially measured at acquisition cost or production cost, including any directly attributable costs of preparing the asset for its intended use, or (in the case of assets acquired in a business combination) at fair value as of the date of the business combination. Intangible assets are amortized on a straight line basis over their useful&#160;lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The useful lives of other intangible assets are reviewed at the end of each reporting period. The effect of any adjustment to useful lives is recognized prospectively as a change in accounting estimate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Amortization of other intangible assets is recognized in the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; except for amortization charged against (i)&#160;acquired or internally-developed software and (ii)&#160;other rights of an industrial or operational nature, which is recognized in the relevant classification of expense by function.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi does not own any intangible assets with an indefinite useful life, other than goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Intangible assets (other than goodwill) are carried at cost less accumulated amortization and accumulated impairment, if any, in accordance with IAS&#160;36 (see Note&#160;B.6.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.4.1. Research and development not acquired in a business combination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Internally generated research and development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under IAS&#160;38, research expenses are recognized in profit or loss when incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Internally generated development expenses are recognized as an intangible asset if, and only if, all the following six criteria can be demonstrated: (a)&#160;the technical feasibility of completing the development project; (b)&#160;Sanofi&#x2019;s intention to complete the project; (c)&#160;Sanofi&#x2019;s ability to use the project; (d)&#160;the probability that the project will generate future economic benefits; (e)&#160;the availability of adequate technical, financial and other resources to complete the project; and (f)&#160;the ability to measure the development expenditure reliably.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Due to the risks and uncertainties relating to regulatory approval and to the research and development process, the six criteria for capitalization are usually considered not to have been met until the product has obtained marketing approval from the regulatory authorities. Consequently, internally generated development expenses arising before marketing approval has been obtained, mainly the cost of clinical trials, are generally expensed as incurred within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Some industrial development expenses (such as those incurred in developing a second-generation synthesis process) are incurred after marketing approval has been obtained, in order to improve the industrial process for an active ingredient. To the extent that the six IAS&#160;38 criteria are considered as having been met, such expenses are recognized as an asset in the balance sheet within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; as incurred. Similarly, some clinical trials, for example those undertaken to obtain a geographical extension for a molecule that has already obtained marketing approval in a major market, may in certain circumstances meet the six capitalization criteria under IAS&#160;38, in which case the related expenses are recognized as an asset in the balance sheet within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Separately acquired research and development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Payments for separately acquired research and development are capitalized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; provided that they meet the definition of an intangible asset: a resource that is (i)&#160;controlled by Sanofi, (ii)&#160;expected to provide future economic benefits for Sanofi, and (iii)&#160;identifiable (i.e.&#160;it is either separable or arises from contractual or legal rights). Under paragraph&#160;25 of&#160;IAS&#160;38, the first condition for capitalization (the probability that the expected future economic benefits from the asset will flow to the entity) is considered to be satisfied for separately acquired research and development. Consequently, upfront and milestone payments to third parties related to pharmaceutical products for which marketing approval has not yet been obtained are recognized as intangible assets, and amortized on a straight line basis over their useful lives beginning when marketing approval is&#160;obtained.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Payments under research and development arrangements relating to access to technology or to databases, and payments made to purchase generics dossiers, are also capitalized, and amortized over the useful life of the intangible asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Subcontracting arrangements, payments for research and development services, and continuous payments under research and development collaborations which are unrelated to the outcome of that collaboration, are expensed over the service term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.4.2. Other intangible assets not acquired in a business combination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Licenses other than those related to pharmaceutical products and research projects, in particular software licenses, are capitalized at acquisition cost, including any directly attributable cost of preparing the software for its intended use. Software licenses are amortized on a straight line basis over their useful lives for Sanofi (&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTQvZnJhZzozZjc4YjJjMzg5MjM0NWI3OWUwMWQxNGFjYzI2ODQxNS90ZXh0cmVnaW9uOjNmNzhiMmMzODkyMzQ1Yjc5ZTAxZDE0YWNjMjY4NDE1XzUxMDY_a0f11f8d-0f58-4332-81c5-b171f9da546e"&gt;three&lt;/span&gt; to five years).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Internally generated costs incurred to develop or upgrade software are capitalized if the IAS&#160;38 recognition criteria are satisfied, and amortized on a straight line basis over the useful life of the software from the date on which the software is ready for use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.4.3. Other intangible assets acquired in a business combination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Other intangible assets acquired in a business combination (in-process research and development, technology platforms, and currently marketed products) that are reliably measurable are identified separately from goodwill, measured at fair value, and capitalized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in accordance with IFRS&#160;3 (Business Combinations) and IAS&#160;38 (Intangible Assets). The related deferred tax liability is also recognized if a deductible or taxable temporary difference exists.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In-process research and development acquired in a business combination is amortized on a straight line basis over its useful life from the date of receipt of marketing approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Rights to technology platforms and to products currently marketed by Sanofi are amortized on a straight line basis over their useful lives, determined (in particular for marketed products) on the basis of cash flow forecasts which take into account the patent protection period of the marketed product.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="i05ab760cbec74ca2a64af3ee573e8c46_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTQvZnJhZzozZjc4YjJjMzg5MjM0NWI3OWUwMWQxNGFjYzI2ODQxNS90ZXh0cmVnaW9uOjNmNzhiMmMzODkyMzQ1Yjc5ZTAxZDE0YWNjMjY4NDE1XzUxMTI_80411f39-331c-4740-bf0e-933e397e4a8c">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90ZXh0cmVnaW9uOjFiN2IxYjM0N2M2YjQ5OGI4ZGI0NDQ2MTBjOWUzODk4XzM5OTY_2dac0a13-6212-4d6c-90d2-b1602e0a290a">Property, plant and equipment owned and leased&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.5.1. Property, plant and equipment owned&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is initially measured and recognized at acquisition cost, including any directly attributable cost of preparing the asset for its intended use, or (in&#160;the case of assets acquired in a business combination) at fair value as of the date of the business combination. The component-based approach to accounting for property, plant and equipment is applied. Under this approach, each component of an item of property, plant and equipment with a cost which is significant in relation to the total cost of the item and which has a different useful life from the other components must be depreciated separately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;After initial measurement, property, plant and equipment is carried at cost less accumulated depreciation and impairment, except for land which is carried at cost less impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Subsequent costs are not recognized as assets unless (i)&#160;it is probable that future economic benefits associated with those costs will flow to Sanofi and (ii)&#160;the costs can be measured reliably.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Borrowing costs attributable to the financing of items of property, plant and equipment, and incurred during the construction period, are capitalized as part of the acquisition cost of the&#160;item.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Government grants relating to property, plant and equipment are deducted from the acquisition cost of the asset to which they&#160;relate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The depreciable amount of items of property, plant and equipment, net of any residual value, is depreciated on a straight line basis over the useful life of the asset. The useful life of an asset is usually equivalent to its economic life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The customary useful lives of property, plant and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;to&#160;40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10 to 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5 to 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 to 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Useful lives and residual values of property, plant and equipment are reviewed annually. The effect of any adjustment to useful lives or residual values is recognized prospectively as a change in accounting estimate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Depreciation of property, plant and equipment is recognized as an expense in the income statement, in the relevant classification of expense by function.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.5.2. Property, plant and equipment leased&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Effective from January&#160;1, 2019 leases contracted by Sanofi have been accounted for in accordance with IFRS&#160;16 (Leases). Sanofi recognizes a right-of-use asset and a lease liability for all of its lease contracts, except for (i)&#160;leases relating to low-value assets and&#160;(ii)&#160;short-term leases (12&#160;months or less). Payments made in respect of leases not recognized on the balance sheet are recognized as an operating expense on a straight line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On commencement of a lease, the liability for future lease payments is discounted at the incremental borrowing rate, which is a risk-free rate adjusted to reflect the specific risk profile of each Sanofi entity. Because lease payments are spread over the lease term, Sanofi applies a discount rate based on the duration of those payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The payments used to determine the liability for future lease payments exclude non-lease components, but include fixed payments that Sanofi expects to make to the lessor over the estimated lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;After commencement of the lease, the liability for future lease payments is reduced by the amount of the lease payments made, and increased to reflect interest on the liability. In the event of a reassessment or modification of future lease payments, the lease liability is remeasured. The right-of-use asset &#x2013;&#160;which is initially measured at cost including direct costs of the lessee, prepayments made at or prior to the commencement date, less lease incentives received and restoration costs&#160;&#x2013; is depreciated on a straight line basis over the lease term, and tested for impairment as required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi recognizes deferred taxes in respect of right-of-use assets and lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are depreciated over their economic life, which is capped at the lease term as determined under&#160;IFRS&#160;16.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <sny:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90ZXh0cmVnaW9uOjFiN2IxYjM0N2M2YjQ5OGI4ZGI0NDQ2MTBjOWUzODk4XzM5OTM_28318561-848b-4c49-b93c-e6997b273b9b">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The customary useful lives of property, plant and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;to&#160;40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10 to 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5 to 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 to 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="if28c01d5f14941678f17df4612ae4e2e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzAtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246OTNkMjllOGUwNjA2NDhkOGE5YjRiZDk1NWU1NTU5YmRfNA_72eab562-ccfe-48e3-bbe9-8a8928b5d689">P15Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="i394e8a86c251479586bc1a0eb8f50130_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzAtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246OTNkMjllOGUwNjA2NDhkOGE5YjRiZDk1NWU1NTU5YmRfMTA_485e371f-21fd-4916-988e-90403189cc49">P40Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="i409bda424dac45a59c28668ef940f123_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzEtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDU4NDFiNzg2MDhkNDg1NGEwZDYzZGM3MWY3OTM2YWNfNA_d1053e80-0221-4dfb-ba5c-d7bb83ea3a8a">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="ibc5cb17ac157419a907518a7604ebc0d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzEtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDU4NDFiNzg2MDhkNDg1NGEwZDYzZGM3MWY3OTM2YWNfMTA_b7928de2-72a8-44a8-bda0-ae9b7ef9ca65">P20Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="i605cb1d6e0f14943b4f0ef24b77e12f7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzItMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ODE3NjZjMzZhYTExNDAxNmIxYWZkZmI5N2I3Mzg0ZDdfNA_38110661-a5b0-4855-a107-d491907f5095">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="iaf712b8801ed48b59b68a97d6c1d8c34_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzItMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ODE3NjZjMzZhYTExNDAxNmIxYWZkZmI5N2I3Mzg0ZDdfMTA_44c5a949-d148-4482-8160-0a0ea9d4d268">P15Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="ica7d78006d9b4c9e8f46c61a015c748a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzMtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246MTQ3MzU4YmIwNGI5NGI3ZTgzMWIxYTNmMmRhZGY2ZDhfNA_ad869bc8-0602-4cd6-8ac4-a93c513d0c10">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="i8675329b37394bd5b4b2fd333c7a391a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MTcvZnJhZzoxYjdiMWIzNDdjNmI0OThiOGRiNDQ0NjEwYzllMzg5OC90YWJsZTo0NGJmOTJhMTg0ZDk0NDA4OGRkN2NkZjVhM2ZmNGJmOC90YWJsZXJhbmdlOjQ0YmY5MmExODRkOTQ0MDg4ZGQ3Y2RmNWEzZmY0YmY4XzMtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246MTQ3MzU4YmIwNGI5NGI3ZTgzMWIxYTNmMmRhZGY2ZDhfMTA_64382695-1762-4725-8054-c32d90f1158a">P15Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MjAvZnJhZzoyY2M5ZDkyOTEzYmI0MzZkYmI2NTQxMjFjNzg5MzQ1ZS90ZXh0cmVnaW9uOjJjYzlkOTI5MTNiYjQzNmRiYjY1NDEyMWM3ODkzNDVlXzUzMzk_60c2ac33-aa41-4bf3-8e6d-f2c25a826194">Impairment of property, plant and equipment, intangible assets, and&#160;investments accounted for using the equity method&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.6.1. Impairment of property, plant and equipment and intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;36 (Impairment of Assets), assets that generate separate cash flows and assets included in cash-generating units&#160;(CGUs) are assessed for impairment when events or changes in circumstances indicate that the asset or CGU may be impaired. A&#160;CGU is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under IAS&#160;36, each CGU or group of CGUs to which goodwill is allocated must (i)&#160;represent the lowest level within the entity at which the goodwill is monitored for internal management purposes, and (ii)&#160;not be larger than an operating segment determined in accordance with IFRS&#160;8 (Operating Segments), before application of the IFRS&#160;8 aggregation criteria (see Note&#160;B.26.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Quantitative and qualitative indications of impairment (primarily relating to the status of the research and development portfolio, pharmacovigilance, patent litigation, and the launch of competing products) are reviewed at the end of each reporting period. If there is any internal or external indication of impairment, Sanofi estimates the recoverable amount of the asset or CGU.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Other intangible assets not yet available for use (such as capitalized in-process research and development), and CGUs or groups of CGUs that include goodwill, are tested for impairment annually whether or not there is any indication of impairment, and more frequently if any event or circumstance indicates that they might be impaired. Such assets are not amortized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;When there is an internal or external indication of impairment, Sanofi estimates the recoverable amount of the asset and recognizes an impairment loss if the carrying amount of the asset exceeds its recoverable amount. The recoverable amount of the asset is the higher of its fair value less costs to sell or its value in use. To determine value in use, Sanofi uses estimates of future cash flows generated by the asset or CGU, prepared using the same methods as those used in the initial measurement of the asset or CGU on the basis of medium-term strategic plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the case of goodwill, estimates of future cash flows are based on a six-year strategic plan and a terminal value. In the case of other intrangible assets, the period used is based on the economic life of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Estimated cash flows are discounted at long-term market interest rates that reflect the best estimate by Sanofi of the time value of money, the risks specific to the asset or CGU, and economic conditions in the geographical regions in which the business activity associated with the asset or CGU is located.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities that are not directly attributable to a specific CGU are allocated between CGUs on a basis that is reasonable, and consistent with the allocation of the corresponding goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Impairment losses arising on property, plant and equipment, on software and on certain rights are recognized in the relevant classification of expense by function.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Impairment losses arising on other intangible assets are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the income statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.6.2. Impairment of investments accounted for using the equity method&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), Sanofi determines whether investments accounted for using the equity method may be impaired based on indicators such as default in contractual payments, significant financial difficulties, probability of bankruptcy, or a prolonged or significant decline in quoted market price. If an investment is impaired, the amount of the impairment loss is determined by applying IAS&#160;36 (see Note&#160;B.6.1.) and recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.6.3. Reversals of impairment losses charged against property, plant and equipment, intangible assets, and investments accounted for using the equity method&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;At the end of each reporting period, Sanofi assesses whether events or changes in circumstances indicate that an impairment loss recognized in a prior period in respect of an asset (other than goodwill) or an investment accounted for using the equity method can be reversed. If this is the case, and the recoverable amount as determined based on the revised estimates exceeds the carrying amount of the asset, Sanofi reverses the impairment loss only to the extent of the carrying amount that would have been determined had no impairment loss been recognized for the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Reversals of impairment losses in respect of other intangible assets are recognized within the income statement line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, while reversals of impairment losses in respect of investments accounted for using the equity method are recognized within the income statement line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Impairment losses taken against goodwill are never reversed, unless the goodwill is part of the carrying amount of an investment accounted for using the equity method.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MjMvZnJhZzo0ZGM1OTNkZjlhOTI0NDk1OWU4YWYzYjRjYWVkODlkYy90ZXh0cmVnaW9uOjRkYzU5M2RmOWE5MjQ0OTU5ZThhZjNiNGNhZWQ4OWRjXzUwNTM_36422c2a-3f52-46e1-8a1f-7d38910ebf0d">Assets held for sale or exchange and liabilities related to assets held for sale or exchange&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;5 (Non-Current Assets Held for Sale and Discontinued Operations), non-current assets and groups of assets are classified as held for sale in the balance sheet if their carrying amount will be recovered principally through a sale transaction rather than through continuing use. Within the meaning of IFRS&#160;5, the term &#x201c;sale&#x201d; also includes exchanges for other assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Non-current assets or asset groups held for sale must be available for immediate sale in their present condition, subject only to terms that are usual and customary for sales of such assets, and a sale must be highly probable. Criteria used to determine whether a sale is highly probable include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the appropriate level of management must be committed to a plan to sell;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;an active program to locate a buyer and complete the plan must have been initiated;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the asset must be actively marketed for sale at a price that is reasonable in relation to its current fair value;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;completion of the sale should be foreseeable within the twelve months following the date of reclassification to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;actions required to complete the plan should indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Before initial reclassification of the non-current asset (or asset group) to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, the carrying amounts of the asset (or of all the assets and liabilities in the asset group) must be measured in accordance with the applicable standards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Subsequent to reclassification to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, the non-current asset (or asset group) is measured at the lower of carrying amount or fair value less costs to sell, with any write-down recognized by means of an impairment loss. Once a non-current asset has been reclassified as held for sale or exchange, it is no longer depreciated or amortized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In a disposal of an equity interest leading to loss of control, all the assets and liabilities of the entity involved are classified as held-for-sale assets or liabilities within the balance sheet line items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange or Liabilities related to assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, provided that the disposal satisfies the IFRS&#160;5 classification criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The profit or loss generated by a held-for-sale asset group is reported in a separate line item in the income statement for the current period and for the comparative periods presented, provided that the asset group:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;represents a separate major line of business or geographical area of operations; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;is a subsidiary acquired exclusively with a view to resale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;10, transactions between companies that are held for sale or treated as discontinued operations and other consolidated companies are eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Events or circumstances beyond Sanofi&#x2019;s control may extend the period to complete the sale or exchange beyond one year without precluding classification of the asset (or disposal group) in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; provided that there is sufficient evidence that Sanofi remains committed to the planned sale or exchange. Finally, in the event of changes to a plan of sale that requires an asset no longer to be classified as held for sale, IFRS&#160;5 specifies the following treatment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the assets and liabilities previously classified as held for sale are reclassified to the appropriate balance sheet line items, with no restatement of comparative periods;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;each asset is measured at the lower of (a)&#160;its carrying amount before the asset was reclassified as held for sale, adjusted for any depreciation, amortization or revaluation that would have been recognized if the asset had not been reclassified as held for sale, or&#160;(b)&#160;its recoverable amount at the date of reclassification;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the backlog of depreciation, amortization and impairment not recognized while non-current assets were classified as held for sale must be reported in the same income statement line item that was used to report impairment losses arising on initial reclassification of assets as held for sale and gains or losses arising on the sale of such assets. In the consolidated income statement, those impacts are reported within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other gains and losses, and litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the net income of a business previously classified as discontinued or as held for sale or exchange and reported on a separate line in the income statement must be reclassified and included in net income from continuing operations, for all periods presented;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;in addition, segment information relating to the income statement and the statement of cash flows (acquisitions of non-current assets) must be disclosed in the notes to the financial statements in accordance with IFRS&#160;8 (Operating Segments), and must also be restated for all prior periods presented.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MjYvZnJhZzozMzA5OTAxM2I1Y2U0ZGJlOWNkNmI3YmJlZDlkYmEyNi90ZXh0cmVnaW9uOjMzMDk5MDEzYjVjZTRkYmU5Y2Q2YjdiYmVkOWRiYTI2XzE2MTIw_955b83ed-715d-4f47-8962-217ec934fb46">Financial instruments&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.1. Non-derivative financial assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;9 (Financial Instruments) and IAS&#160;32 (Financial Instruments: Presentation), Sanofi has adopted the classification of non-derivative financial assets described below. The classification used depends on (i)&#160;the characteristics of the contractual cash flows (i.e.&#160;whether they represent interest or principal) and (ii)&#160;the business model for managing the asset applied at the time of initial recognition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial assets at fair value through other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;These mainly comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;quoted and unquoted equity investments that Sanofi does not hold for trading purposes and that management has designated at &#x201c;fair value through other comprehensive income&#x201d; on initial recognition. Gains and losses arising from changes in fair value are recognized in equity within the statement of comprehensive income in the period in which they occur. When such instruments are derecognized, the previously-recognized changes in fair value remain within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, as does the gain or loss on divestment. Dividends received are recognized in profit or loss for the period, within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;debt instruments whose contractual cash flows represent payments of interest or repayments of principal, and which are managed with a view to collecting cash flows and selling the asset. Gains and losses arising from changes in fair value are recognized in equity within the statement of comprehensive income in the period in which they occur. When such assets are derecognized, the cumulative gains and losses previously recognized in equity are reclassified to profit or loss for the period within the line items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial assets at fair value through profit or loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;These mainly comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;contingent consideration already carried in the books of an acquired entity or granted in connection with a business combination;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;instruments whose contractual cash flows represent payments of interest and repayments of principal, which are managed with a view to selling the asset;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;instruments that management has designated at &#x201c;fair value through profit or loss&#x201d; on initial recognition; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;quoted and unquoted equity investments: equity instruments that are not held for trading and which management did not designate at &#x201c;fair value through other comprehensive income&#x201d; on initial recognition, and instruments that do not meet the IFRS definition of &#x201c;equity instruments&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Gains and losses arising from changes in fair value are recognized in profit or loss within the line items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Dividends received are recognized in profit or loss for the period, within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair value of equity investments in unquoted entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On initial recognition of an equity investment in an entity not quoted in an active market, the fair value of the investment is the acquisition cost. Cost ceases to be a representative measure of the fair value of an unquoted equity investment when Sanofi identifies significant changes in the investee, or in the environment in which it operates. In such cases, an internal valuation is carried out, based mainly on growth forecasts or by reference to similar transactions contracted with third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial assets measured at amortized cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Financial assets at amortized cost comprise instruments whose contractual cash flows represent payments of interest and repayments of principal and which are managed with a view to collecting cash flows. The main assets in this category are loans and receivables. They are presented within the line items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Other non-current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Accounts receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Loans with a maturity of more than 12&#160;months are presented in &#x201c;Long-term loans and advances&#x201d; within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other non-current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. These financial assets are measured at amortized cost using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of financial assets measured at amortized cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The main assets involved are accounts receivable. Accounts receivable are initially recognized at the amount invoiced to the customer. Impairment losses on trade accounts receivable are estimated using the expected loss method, in order to take account of the risk of payment default throughout the lifetime of the receivables. The expected credit loss is estimated collectively for all accounts receivable at each reporting date using an average expected loss rate, determined primarily on the basis of historical credit loss rates. However, that average expected loss rate may be adjusted if there are indications of a likely significant increase in credit risk. If a receivable is subject to a known credit risk, a specific impairment loss is recognized for that receivable. The amount of expected losses is recognized in the balance sheet as a reduction in the gross amount of accounts receivable. Impairment losses on accounts receivable are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Selling and general expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the income statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.2. Derivative instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Derivative instruments that do not qualify for hedge accounting are initially and subsequently measured at fair value, with changes in fair value recognized in the income statement in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, depending on the nature of the underlying economic item which is hedged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Derivative instruments that qualify for hedge accounting are measured using the policies described in Note&#160;B.8.3. below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;IFRS&#160;13 (Fair Value Measurement) requires counterparty credit risk to be taken into account when measuring the fair value of financial instruments. That risk is estimated on the basis of observable, publicly-available statistical data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Policy on offsetting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In order for a financial asset and a financial liability to be presented as a net amount in the balance sheet under IAS&#160;32, there must be:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(a) a legally enforceable right to offset; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(b) the intention either to settle on a net basis, or to realize the asset and settle the liability simultaneously.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.3. Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As part of its overall market risk management policy, Sanofi enters into various hedging transactions involving derivative or non-derivative instruments; these may include forward contracts, currency swaps or options, interest rate swaps or options, cross-currency swaps, and debt placings or issues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Such financial instruments are designated as hedging instruments and recognized using the hedge accounting principles of&#160;IFRS&#160;9 when (a)&#160;there is formal designation and documentation of the hedging relationship, of how the effectiveness of the hedging relationship will be assessed, and of the underlying market risk management objective and strategy; (b)&#160;the hedged item and the hedging instrument are eligible for hedge accounting; and (c)&#160;there is an economic relationship between the hedged item and the hedging instrument, defined on the basis of a hedge ratio that is consistent with the underlying market risk management strategy, and the residual credit risk does not dominate the value changes that result from that economic relationship.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair value hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A fair value hedge is a hedge of the exposure to changes in fair value of an asset, liability or firm commitment that is attributable to one or more risk components and could affect profit or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Changes in fair value of the hedging instrument and changes in fair value of the hedged item attributable to the hedged risk components are generally recognized in the income statement, within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for hedges related to operating activities, or within&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for hedges related to investing or financing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash flow hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A cash flow hedge is a hedge of the exposure to variability in cash flows from an asset, liability or highly probable forecast transaction that is attributable to one or more risk components and could affect profit or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Changes in fair value of the hedging instrument attributable to the effective portion of the hedge are recognized directly in equity in the consolidated statement of comprehensive income. Changes in fair value attributable to the ineffective portion of the hedge are recognized in the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;for hedges related to operating activities, and within&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for hedges related to investing or financing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Cumulative changes in fair value of the hedging instrument previously recognized in equity are reclassified to the income statement when the hedged transaction affects profit or loss. Those reclassified gains and losses are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for hedges related to operating activities, and within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for hedges related to investing or financing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;When a forecast transaction results in the recognition of a non-financial asset or liability, cumulative changes in the fair value of the hedging instrument previously recognized in equity are incorporated in the initial carrying amount of that asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;When the hedging instrument expires or is sold, terminated or exercised, the cumulative gain or loss previously recognized in equity remains separately recognized in equity and is not reclassified to the income statement, or recognized as an adjustment to the initial cost of the related non-financial asset or liability, until the forecast transaction occurs. However, if Sanofi no longer expects the forecast transaction to occur, the cumulative gain or loss previously recognized in equity is recognized immediately in profit or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Hedge of a net investment in a foreign operation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In a hedge of a net investment in a foreign operation, changes in the fair value of the hedging instrument attributable to the effective portion of the hedge are recognized directly in equity in the consolidated statement of comprehensive income. Changes in fair value attributable to the ineffective portion of the hedge are recognized in the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. When the investment in the foreign operation is sold, the changes in the fair value of the hedging instrument previously recognized in equity are reclassified to the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cost of hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As part of its market risk management policy, Sanofi may designate currency options or interest rate options as hedging instruments, the effectiveness of which is measured on the basis of changes in intrinsic value. In such cases, the time value of the option is treated as a hedging cost and accounted for as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;if the option includes a component that is not aligned on the critical features of the hedged item, the corresponding change in the time value is taken to profit or loss;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;otherwise, the change in the time value is taken to equity within the statement of comprehensive income, and then:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;if the hedged item is linked to a transaction that results in the recognition of a financial asset or liability, the change in the time value is reclassified to profit or loss symmetrically with the hedged item, or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;if the hedged item is linked to a transaction that results in the recognition of a non-financial asset or liability, the change in the time value is incorporated in the initial carrying amount of that asset or liability, or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;if the hedged item is linked to a period of time, the change in time value is reclassified to profit or loss on a straight line basis over the life of the hedging relationship.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the case of forward contracts and foreign exchange swaps, and of cross-currency swaps that qualify for hedge accounting on the basis of changes in spot rates, Sanofi may elect for each transaction to use the option whereby the premium/discount or foreign currency basis spread are treated in the same way as the time value of an option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Discontinuation of hedge accounting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Hedge accounting is discontinued when the eligibility criteria are no longer met (in particular, when the hedging instrument expires or is sold, terminated or exercised), or if there is a change in the market risk management objective of the hedging relationship.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.4. Non-derivative financial liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Borrowings and debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Bank borrowings and debt instruments are initially measured at fair value of the consideration received, net of directly attributable transaction costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Subsequently, they are measured at amortized cost using the effective interest method. All costs related to the issuance of borrowings or debt instruments, and all differences between the issue proceeds net of transaction costs and the value on redemption, are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the income statement over the term of the debt using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities related to business combinations and to non-controlling interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;These line items record the fair value of (i)&#160;contingent consideration payable in connection with business combinations and (ii)&#160;commitments to buy out equity holders of subsidiaries, including put options granted to non-controlling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Adjustments to the fair value of commitments to buy out equity holders of subsidiaries, including put options granted to non-controlling interests, are recognized in equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other non-derivative financial liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Other non-derivative financial liabilities include trade accounts payable, which are measured at fair value (which in most cases equates to face value) on initial recognition, and subsequently at amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.5. Fair value of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under IFRS&#160;13 (Fair Value Measurement) and IFRS&#160;7 (Financial Instruments: Disclosures), fair value measurements must be classified using a hierarchy based on the inputs used to measure the fair value of the instrument. This hierarchy has three levels:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.86pt"&gt;level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.25pt"&gt;level&#160;2: quoted prices in active markets for similar assets and liabilities, or valuation techniques in which all important inputs are derived from observable market data; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;c.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:4.78pt"&gt;level&#160;3: valuation techniques in which not all important inputs are derived from observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the disclosures required under IFRS&#160;7 relating to the measurement principles applied to financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Type&#160;of financial&#160;instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Measurement&lt;br/&gt;principle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level in&lt;br/&gt;fair&#160;value&lt;br/&gt;hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Valuation&lt;br/&gt;technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Method used to determine fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Valuation&lt;br/&gt;model&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Market data&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (quoted equity instruments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market&#160;price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (quoted debt instruments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (unquoted equity instruments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Cost/Approach based on comparables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;If cost ceases to be a representative measure of fair value, an internal valuation is carried out, based mainly on comparables.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (contingent consideration receivable)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Revenue-based approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;D.7.3.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value held to meet obligations under post-employment benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets designated at fair value held to meet obligations under deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Long-term loans and advances and other non-current receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;The amortized cost of long-term loans and advances and other non-current receivables at the end of the reporting period is not materially different from their fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.13.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Net asset value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.13.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Negotiable debt instruments, commercial paper, instant access deposits and term deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Because these instruments have a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.17.1.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;In the case of debt with a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.&lt;br/&gt;For debt with a maturity of more than 3&#160;months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.17.2.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;The liability for future lease payments is discounted using the incremental borrowing rate.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.20.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Present value of future cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&lt;br/&gt;Market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;lt;&#160;1&#160; year:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid Money Market&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;gt;&#160;1&#160;year:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid Zero Coupon&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.20.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Revenue-based approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Present value of future cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&lt;br/&gt;Market&lt;br/&gt;Spot&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;lt;&#160;1&#160;year:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&#160;Money&#160;Market  and LIFFE interest rate futures&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;gt;&#160;1&#160;year: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&#160;Zero Coupon&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.20.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Present&#160;value of future cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&lt;br/&gt;Market&lt;br/&gt;Spot&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;lt;&#160;1&#160; year:&lt;br/&gt;Mid&#160;Money Market and LIFFE interest rate futures&lt;br/&gt;&amp;gt;&#160;1&#160;year: &lt;br/&gt;Mid Zero Coupon&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Liabilities related to business combinations and to non-controlling interests (CVRs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Liabilities related to business combinations and to non-controlling interests (other than CVRs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Revenue-based approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Under IAS&#160;32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;B.8.4.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.6. Derecognition of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Financial assets are derecognized when the contractual rights to cash flows from the asset have ended or have been transferred and when Sanofi has transferred substantially all the risks and rewards of ownership of the asset. If Sanofi has neither transferred nor retained substantially all the risks and rewards of ownership of a financial asset, it is derecognized if Sanofi does not retain control of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A financial liability is derecognized when Sanofi&#x2019;s contractual obligations in respect of the liability are discharged, cancelled or extinguished.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.8.7. Risks relating to financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Market risks in respect of non-current financial assets, cash equivalents, derivative instruments and debt are described in the discussions of risk factors presented in Item&#160;3.D. and Item&#160;11. of Sanofi&#x2019;s Annual Report on Form&#160;20-F for 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Credit risk is the risk that customers may fail to pay their debts. For a description of credit risk, refer to &#x201c;We are subject to the risk of non-payment by our customers&#x201d; within Item&#160;3.D. and Item&#160;11. of Sanofi&#x2019;s Annual Report on Form&#160;20-F for 2022.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MjYvZnJhZzozMzA5OTAxM2I1Y2U0ZGJlOWNkNmI3YmJlZDlkYmEyNi90ZXh0cmVnaW9uOjMzMDk5MDEzYjVjZTRkYmU5Y2Q2YjdiYmVkOWRiYTI2XzE2MTIx_72509bb0-a33a-4882-9fa8-91dd87e27ecb">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the disclosures required under IFRS&#160;7 relating to the measurement principles applied to financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Type&#160;of financial&#160;instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Measurement&lt;br/&gt;principle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level in&lt;br/&gt;fair&#160;value&lt;br/&gt;hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Valuation&lt;br/&gt;technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Method used to determine fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Valuation&lt;br/&gt;model&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Market data&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (quoted equity instruments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market&#160;price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (quoted debt instruments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (unquoted equity instruments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Cost/Approach based on comparables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;If cost ceases to be a representative measure of fair value, an internal valuation is carried out, based mainly on comparables.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value (contingent consideration receivable)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Revenue-based approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;D.7.3.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets measured at fair value held to meet obligations under post-employment benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Financial assets designated at fair value held to meet obligations under deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Long-term loans and advances and other non-current receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;The amortized cost of long-term loans and advances and other non-current receivables at the end of the reporting period is not materially different from their fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.13.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Net asset value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.13.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Negotiable debt instruments, commercial paper, instant access deposits and term deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Because these instruments have a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.17.1.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;In the case of debt with a maturity of less than 3&#160;months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.&lt;br/&gt;For debt with a maturity of more than 3&#160;months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.17.2.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;The liability for future lease payments is discounted using the incremental borrowing rate.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.20.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Present value of future cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&lt;br/&gt;Market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;lt;&#160;1&#160; year:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid Money Market&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;gt;&#160;1&#160;year:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid Zero Coupon&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.20.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Revenue-based approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Present value of future cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&lt;br/&gt;Market&lt;br/&gt;Spot&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;lt;&#160;1&#160;year:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&#160;Money&#160;Market  and LIFFE interest rate futures&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;gt;&#160;1&#160;year: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&#160;Zero Coupon&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.20.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Present&#160;value of future cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Mid&lt;br/&gt;Market&lt;br/&gt;Spot&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&amp;lt;&#160;1&#160; year:&lt;br/&gt;Mid&#160;Money Market and LIFFE interest rate futures&lt;br/&gt;&amp;gt;&#160;1&#160;year: &lt;br/&gt;Mid Zero Coupon&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Liabilities related to business combinations and to non-controlling interests (CVRs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Quoted market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Liabilities related to business combinations and to non-controlling interests (other than CVRs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Revenue-based approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Under IAS&#160;32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note&#160;B.8.4.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s).&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MjkvZnJhZzo5ZjYyOWI3NDNmOTg0NWI0YTNiZjBkNjEwZGQ4N2ExZS90ZXh0cmVnaW9uOjlmNjI5Yjc0M2Y5ODQ1YjRhM2JmMGQ2MTBkZDg3YTFlXzEwMjI_a5f0174e-9664-4863-8aa8-108b9dacb4ce">Inventories&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Inventories are measured at the lower of cost or net realizable value. Cost is calculated using the weighted average cost method or the first-in, first-out method, depending on the nature of the inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The cost of finished goods inventories includes costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;During the launch phase of a new product, any inventories of that product are written down to zero pending regulatory approval, other than in specific circumstances which make it possible to estimate that there is a high probability at the end of the reporting period that the carrying amount of the inventories will be recoverable. The write-down is reversed once it becomes highly probable that marketing approval will be obtained.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzIvZnJhZzowMjVkZWRmNDFjYTc0OTZlOTZiNjkzMDE5YmM0N2ZmNi90ZXh0cmVnaW9uOjAyNWRlZGY0MWNhNzQ5NmU5NmI2OTMwMTliYzQ3ZmY2XzMzMQ_4b4c85ca-f520-404a-900a-0a05da4cd71b">Cash and cash equivalentsCash and cash equivalents as shown in the consolidated balance sheet and statement of cash flows comprise cash, plus liquid short-term investments that are&#160;readily convertible into cash and are&#160;subject to an insignificant risk of changes in value in the event of movements in interest rates.</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzUvZnJhZzplMjBkNTBlMDVjMzQ0YmIzOGIwZGM4ZmRkYjM3ZjgxYS90ZXh0cmVnaW9uOmUyMGQ1MGUwNWMzNDRiYjM4YjBkYzhmZGRiMzdmODFhXzI4Mg_0bd10e2f-925b-4db3-a6ee-7a6ef23b0912">Treasury sharesIn accordance with IAS&#160;32, Sanofi treasury shares are deducted from equity, irrespective of the purpose for which they are held. No gain or loss is recognized in the income statement on the purchase, sale, impairment or cancellation of treasury shares.</ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory>
    <sny:GainLossOnPurchaseOfTreasuryShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzUvZnJhZzplMjBkNTBlMDVjMzQ0YmIzOGIwZGM4ZmRkYjM3ZjgxYS90ZXh0cmVnaW9uOmUyMGQ1MGUwNWMzNDRiYjM4YjBkYzhmZGRiMzdmODFhXzE1Ng_13958afe-8258-447d-bcde-4a094c528520"
      unitRef="eur">0</sny:GainLossOnPurchaseOfTreasuryShares>
    <sny:GainLossOnSaleOfTreasuryShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzUvZnJhZzplMjBkNTBlMDVjMzQ0YmIzOGIwZGM4ZmRkYjM3ZjgxYS90ZXh0cmVnaW9uOmUyMGQ1MGUwNWMzNDRiYjM4YjBkYzhmZGRiMzdmODFhXzE1Ng_4deaf6b2-37c8-4dd2-8ff5-d39837919005"
      unitRef="eur">0</sny:GainLossOnSaleOfTreasuryShares>
    <sny:GainLossOnImpairmentOfTreasuryShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzUvZnJhZzplMjBkNTBlMDVjMzQ0YmIzOGIwZGM4ZmRkYjM3ZjgxYS90ZXh0cmVnaW9uOmUyMGQ1MGUwNWMzNDRiYjM4YjBkYzhmZGRiMzdmODFhXzE1Ng_b1ce71f5-489b-41e3-8747-811d72b05718"
      unitRef="eur">0</sny:GainLossOnImpairmentOfTreasuryShares>
    <sny:GainLossOnCancellationOfTreasuryShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzUvZnJhZzplMjBkNTBlMDVjMzQ0YmIzOGIwZGM4ZmRkYjM3ZjgxYS90ZXh0cmVnaW9uOmUyMGQ1MGUwNWMzNDRiYjM4YjBkYzhmZGRiMzdmODFhXzE1Ng_b334f1ca-2054-4c3c-9f64-bd0f5aaccf5f"
      unitRef="eur">0</sny:GainLossOnCancellationOfTreasuryShares>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzgvZnJhZzpmMTMzNWIwNDkxNGE0MGU2OTJiNWU2ZmUxYTM1OWI1ZC90ZXh0cmVnaW9uOmYxMzM1YjA0OTE0YTQwZTY5MmI1ZTZmZTFhMzU5YjVkXzI5NDE_2ff3ff4d-414b-437c-b0f6-14bda8e3da78">Provisions for risks&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;37 (Provisions, Contingent Liabilities and Contingent Assets), Sanofi records a provision when it has a present obligation, whether legal or constructive, as a result of a past event; it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation; and a reliable estimate can be made of the amount of the outflow of resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;If the obligation is expected to be settled more than twelve months after the end of the reporting period, or has no definite settlement date, the provision is recorded within Non-current provisions and other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Provisions relating to the insurance programs in which Sanofi&#x2019;s captive insurance company participates are based on risk exposure estimates calculated by management, with assistance from independent actuaries, using IBNR (Incurred But Not Reported) techniques. Those techniques use past claims experience, within Sanofi and in the market, to estimate future trends in the cost of&#160;claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Contingent liabilities are not recognized, but are disclosed in the notes to the financial statements unless the possibility of an outflow of economic resources is&#160;remote.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi estimates provisions on the basis of events and circumstances related to present obligations at the end of the reporting period and of past experience, and to the best of management&#x2019;s knowledge at the date of preparation of the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Reimbursements offsetting the probable outflow of resources are recognized as assets only if it is virtually certain that they will be received. Contingent assets are not recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Restructuring provisions are recognized if Sanofi has a detailed, formal restructuring plan at the end of the reporting period and has announced its intention to implement this plan to those affected by it.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;No provisions are recorded for future operating losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi records non-current provisions for certain obligations, such as legal or constructive obligations, where an outflow of resources is probable and the amount of the outflow can be reliably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the case of environmental risks, including at sites where operations are ongoing, Sanofi recognizes a provision where there is a violation of integrity in respect of human health or the environment resulting from past contamination at a site that requires remediation. The amount of the provision is a best estimate of the future expenditures to be incurred on the remediation plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Where the effect of the time value of money is material, those provisions are measured at the present value of the expenditures expected to be required to settle the obligation, calculated using a discount rate that reflects an estimate of the time value of money and the risks specific to the obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Increases in provisions to reflect the effects of the passage of time are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <sny:ProvisionsRecordedForFutureOperatingLosses
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81MzgvZnJhZzpmMTMzNWIwNDkxNGE0MGU2OTJiNWU2ZmUxYTM1OWI1ZC90ZXh0cmVnaW9uOmYxMzM1YjA0OTE0YTQwZTY5MmI1ZTZmZTFhMzU5YjVkXzE4NzQ_ad8950c9-2aa2-48c0-a344-cf2a1ddea724"
      unitRef="eur">0</sny:ProvisionsRecordedForFutureOperatingLosses>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NDEvZnJhZzo0N2E2Mzc2NzkwMTM0NjQzYTZiODIzYjM1N2NlMzA3ZS90ZXh0cmVnaW9uOjQ3YTYzNzY3OTAxMzQ2NDNhNmI4MjNiMzU3Y2UzMDdlXzYwNDk_a8cd2b2e-6170-401b-95d6-7e4a6d0fe91d">Revenue recognition&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.13.1. Net sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Revenue arising from the sale of goods is presented in the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net sales&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Net sales comprise revenue from sales of pharmaceutical products, consumer healthcare products, active ingredients and vaccines, net of sales returns, of customer incentives and discounts, and of certain sales-based payments paid or payable to the healthcare authorities. Analyses of net sales are provided in Note&#160;D.35.1. &#x201c;Segment Information&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;15 (Revenue from Contracts with Customers), such revenue is recognized when Sanofi transfers control over the product to the customer; control of an asset refers to the ability to direct the use of, and obtain substantially all of the remaining benefits from that asset. For the vast majority of contracts, revenue is recognized when the product is physically transferred, in accordance with the delivery and acceptance terms agreed with the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For contracts entered into by Sanofi Pasteur, transfer of control is usually determined by reference to the terms of release (immediate or deferred) and acceptance of batches of vaccine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the case of contracts with distributors, Sanofi does not recognize revenue when the product is physically transferred to the distributor if the products are sold on consignment, or if the distributor acts as agent. In such cases, revenue is recognized when control is transferred to the end customer, and the distributor&#x2019;s commission is presented within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Selling and general expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the income statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The amount of revenue recognized reflects the various types of price reductions or rights of return offered by Sanofi to its customers on certain products. Such price reductions and rights of return qualify as variable consideration under IFRS&#160;15.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In particular, products sold in the United States are covered by various Government and State programs (such as Medicare and Medicaid) under which products are sold at a discount. Rebates are granted to healthcare authorities, and under contractual arrangements with certain customers. Some wholesalers are entitled to chargeback incentives based on the selling price to the end customer, under specific contractual arrangements. Cash discounts may also be granted for prompt payment. Returns, discounts, incentives and rebates, as described above, are recognized in the period in which the underlying sales are recognized as a reduction of gross sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;These amounts are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of chargeback incentives is estimated on the basis of the relevant subsidiary&#x2019;s standard sales terms and conditions, and in certain cases on the basis of specific contractual arrangements with the customer;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of rebates based on attainment of sales targets is estimated and accrued as each of the underlying sales transactions is recognized;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of price reductions under Government and State programs, largely in the United States, is estimated on the basis of the specific terms of the relevant regulations or agreements, and accrued as each of the underlying sales transactions is recognized;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amount of sales returns is calculated on the basis of management&#x2019;s best estimate of the amount of product that will ultimately be returned by customers. In countries where product returns are possible, Sanofi operates a returns policy that allows the customer to return products within a certain period either side of the expiry date (usually 12&#160;months after the expiry date). The amount recognized for returns is estimated on the basis of past experience of sales returns. Sanofi also takes into account factors such as levels of inventory in its various distribution channels, product expiry dates, information about potential discontinuation of products, the entry of competing generics into the market, and the launch of over-the-counter medicines. Most product return clauses relate solely to date-expired products, which cannot be resold and are destroyed. Sanofi does not recognize a right of return asset in the balance sheet for contracts that allow for the return of time-expired products, since those products have no value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The estimated amounts described above are recognized in the income statement within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net sales&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;as a reduction of gross sales, and within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the balance sheet. They are subject to regular review and adjustment as appropriate based on the most recent data available to management. Sanofi believes that it has the ability to measure each of the above amounts reliably, using the following factors in developing its estimates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the nature and patient profile of the underlying product;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the applicable regulations or the specific terms and conditions of contracts with governmental authorities, wholesalers and other customers;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;historical data relating to similar contracts, in the case of qualitative and quantitative rebates and chargeback incentives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;past experience and sales growth trends for the same or similar products;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;actual inventory levels in distribution channels, monitored by Sanofi using internal sales data and externally provided data;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the shelf life of Sanofi products; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;market trends including competition, pricing and demand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;An analysis of provisions for discounts, rebates and sales returns is provided in Note&#160;D.23.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.13.2. Other revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;The line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; is used to recognize all revenue that falls within the scope of IFRS&#160;15 but does not relate to sales of Sanofi products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;It mainly comprises (i)&#160;royalties received from licensing intellectual property rights to third parties; (ii)&#160;VaxServe sales of products sourced from third-party manufacturers; and (iii)&#160;revenue received under agreements for Sanofi to provide manufacturing services to third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Royalties received under licensing arrangements are recognized over the period during which the underlying sales are recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;VaxServe is a Vaccines segment entity whose operations include the distribution within the United States of vaccines and other products manufactured by third parties. VaxServe sales of products sourced from third-party manufacturers are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <sny:DescriptionOfAccountingPolicyForCostOfSalesExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NDQvZnJhZzpiOWE3MzdmODU1MDM0NGI0YjBmZDM5NGY4MmI5MDg4Zi90ZXh0cmVnaW9uOmI5YTczN2Y4NTUwMzQ0YjRiMGZkMzk0ZjgyYjkwODhmXzM2Ng_4cf3aa24-0de3-4409-9873-f99b98ac8eef">Cost of sales&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of sales&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; consists primarily of the industrial cost of goods sold, payments made under licensing agreements, and distribution costs. The industrial cost of goods sold includes the cost of materials, depreciation of property, plant and equipment, amortization of software, personnel costs, and other expenses attributable to production.&lt;/span&gt;</sny:DescriptionOfAccountingPolicyForCostOfSalesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NDcvZnJhZzo2NDg3MmE3MjVmMGU0OGNjOTZjODYzNTM4MGUzMWRmNC90ZXh0cmVnaW9uOjY0ODcyYTcyNWYwZTQ4Y2M5NmM4NjM1MzgwZTMxZGY0XzQwNg_c338753e-fc9e-492c-9a36-7f18ba996691">Research and development&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Note&#160;B.4.1. &#x201c;Research and development not acquired in a business combination&#x201d; and Note&#160;B.4.3. &#x201c;Other intangible assets acquired in a business combination&#x201d; describe the principles applied to the recognition of research and development costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Contributions or reimbursements received from alliance partners are recorded as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
    <sny:DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NTAvZnJhZzo2ODM1ZTdhMWExY2Q0MGY3ODBmZjRjYjI2YTNiYzg2Mi90ZXh0cmVnaW9uOjY4MzVlN2ExYTFjZDQwZjc4MGZmNGNiMjZhM2JjODYyXzc2Nw_ab8e112a-09be-42f0-8aba-78b8393a1fa7">Other operating income and expenses&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.16.1. Other operating income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; includes the share of profits that Sanofi is entitled to receive from alliance partners in respect of product marketing agreements. It also includes revenues generated under certain agreements, which may include partnership, co-promotion arrangements and licenses not included in Other revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;This line item also includes realized and unrealized foreign exchange gains and losses on operating activities (see Note&#160;B.8.3.), and operating gains on disposals not regarded as major disposals (see Note&#160;B.20.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.16.2. Other operating expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; mainly comprise the share of profits that alliance partners are entitled to receive from Sanofi under product marketing agreements.&lt;/span&gt;&lt;/div&gt;</sny:DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NTMvZnJhZzo2YjcyY2ZjNTkyMjI0NWYxOGEwZTQyOGY3NzNhZWYwMS90ZXh0cmVnaW9uOjZiNzJjZmM1OTIyMjQ1ZjE4YTBlNDI4Zjc3M2FlZjAxXzg2NA_25838b34-e09d-4efb-ab5b-26a00c3e3fcc">Amortization and impairment of intangible assets&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.17.1. Amortization of intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The expenses recorded in this line item comprise amortization of product rights and other intangible assets (see Note&#160;D.4.), given that the benefit of those rights to Sanofi&#x2019;s commercial, industrial and development functions cannot be separately identified.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Amortization of software, and of other rights of an industrial or operational nature, is recognized as an expense in the income statement, in the relevant line items of expense by function.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.17.2. Impairment of intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;This line item records impairment losses (other than those associated with restructuring) recognized against intangible assets (including goodwill, but excluding software and other rights of an industrial or operational nature), and any reversals of such impairment losses.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory>
    <sny:DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NTYvZnJhZzo3ZWU4N2U1NTYwMDM0M2NlODU1N2ZjYzJhZWUxNzQyZS90ZXh0cmVnaW9uOjdlZTg3ZTU1NjAwMzQzY2U4NTU3ZmNjMmFlZTE3NDJlXzg4Nw_2059bea1-6436-4c7e-83a9-0a6b29c4c776">Fair value remeasurement of contingent consideration&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of contingent consideration that was (i)&#160;already carried in the books of an acquired entity, or (ii)&#160;granted in connection with a business combination and initially recognized as a liability in accordance with IFRS&#160;3, are reported in profit or loss. Such adjustments are reported separately in the income statement, in the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair value remeasurement of contingent consideration&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;This line item also includes changes in the fair value of contingent consideration receivable in connection with a divestment and classified as a financial asset at fair value through profit or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Finally, it includes the effect of the unwinding of discount, and of exchange rate movements where the asset or liability is expressed in a currency other than the functional currency of the reporting entity.&lt;/span&gt;&lt;/div&gt;</sny:DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock>
    <sny:DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NTkvZnJhZzoxMDJiOGIxOWE3YWY0OThkOTAxNGEwMTU4MzljNmMyYi90ZXh0cmVnaW9uOjEwMmI4YjE5YTdhZjQ5OGQ5MDE0YTAxNTgzOWM2YzJiXzExNDA_9d2a8fbb-9c66-49b7-b76b-eb7f779f9c1d">Restructuring costs and similar items&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Restructuring costs are expenses incurred in connection with the transformation or reorganization of Sanofi&#x2019;s operations or support functions. Such costs include collective redundancy plans, compensation to third parties for early termination of contracts, and commitments made in connection with transformation or reorganization decisions. They also include accelerated depreciation charges arising from site closures (including closures of leased sites), and losses on asset disposals resulting from such decisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In addition, this line item includes expenses incurred in connection with programs implemented as part of the transformation strategy announced in December&#160;2019 (and previously in November&#160;2015), and intended primarily to (i)&#160;deliver a global information systems solution, further supported by the implementation in 2021 of Sanofi's new digital strategy; (ii)&#160;create a standalone Consumer Healthcare entity; and (iii)&#160;as announced on February&#160;24, 2020, create a European leader in the production and marketing to third parties of active pharmaceutical ingredients (API).&lt;/span&gt;&lt;/div&gt;</sny:DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock>
    <sny:DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NjIvZnJhZzpmMzc1OTNhNmFkMWU0OGExOGMxNTMwNjExYWNkM2M2Yy90ZXh0cmVnaW9uOmYzNzU5M2E2YWQxZTQ4YTE4YzE1MzA2MTFhY2QzYzZjXzk2Mw_410c9dca-f0fe-4448-baa1-23d5134036ec">Other gains and losses, and litigation&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other gains and losses, and litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; includes the impact of material transactions of an unusual nature or amount which Sanofi believes it necessary to report separately in the income statement in order to improve the relevance of the financial statements, such as:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;gains and losses on major disposals of property, plant and equipment, of intangible assets, of assets (or groups of assets and liabilities) held for sale, or of a business within the meaning of IFRS&#160;3, other than those considered to be restructuring costs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;impairment losses and reversals of impairment losses on assets (or groups of assets and liabilities) held for sale, other than those considered to be restructuring costs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;gains on bargain purchases;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;costs relating to major litigation; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;pre-tax separation costs associated with the process of disinvesting from operations in the event of a major divestment.&lt;/span&gt;&lt;/div&gt;</sny:DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NjUvZnJhZzpjY2M3MTEyMzdkMDM0ZWE4OWUzYzI2NjA2ZWZhZDIyYS90ZXh0cmVnaW9uOmNjYzcxMTIzN2QwMzRlYTg5ZTNjMjY2MDZlZmFkMjJhXzExMDM_be0d72b6-dfa0-401f-8c8e-38e32a568e46">Financial expenses and income&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.21.1. Financial expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; mainly comprise interest charges on debt financing; negative changes in the fair value of certain financial instruments (where changes in fair value are recognized in profit or loss); realized and unrealized foreign exchange losses on financing and investing activities; impairment losses on financial instruments; and any reversals of impairment losses on financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; also include expenses arising from the unwinding of discount on long-term provisions, and the net interest cost related to employee benefits. This line item does not include commercial cash discounts, which are deducted from net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.21.2. Financial income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; includes interest and dividend income; positive changes in the fair value of certain financial instruments (where changes in fair value are recognized in profit or loss); realized and unrealized foreign exchange gains on financing and investing activities; and gains on disposals of financial assets at fair value through profit or loss.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NjgvZnJhZzoyZWU3ZDdhNjI1OWQ0NzRjYjM5ZDI1NjYxMzY2YzUxZi90ZXh0cmVnaW9uOjJlZTdkN2E2MjU5ZDQ3NGNiMzlkMjU2NjEzNjZjNTFmXzU2NDA_118d5c21-37d3-4e69-95cc-2fa427e29572">Income tax expense&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income tax expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;includes all current and deferred taxes of consolidated companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi accounts for deferred taxes in accordance with IAS&#160;12 (Income Taxes), using the methods described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;deferred tax assets and liabilities are recognized on taxable and deductible temporary differences, and on tax loss carry-forwards. Temporary differences are differences between the carrying amount of an asset or liability in the balance sheet and its tax base;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;French business taxes include a value added based component: &#x201c;CVAE&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Cotisation sur la Valeur Ajout&#xe9;e des Entreprises)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Given that CVAE is (i)&#160;calculated as the amount by which certain revenues exceed certain expenses and (ii)&#160;borne primarily by companies that own intellectual property rights on income derived from those rights (royalties, and margin on sales to third parties and to Sanofi entities), it is regarded as meeting the definition of income taxes specified in IAS&#160;12, paragraph&#160;2 (&#x201c;taxes which are based on taxable profits&#x201d;);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;deferred tax assets and liabilities are calculated using the tax rate expected to apply in the period when the corresponding temporary differences are expected to reverse, based on tax rates enacted or substantively enacted at the end of the reporting period;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;deferred tax assets are recognized in respect of deductible temporary differences, tax losses available for carry-forward and unused tax credits to the extent that future recovery is regarded as probable. The recoverability of deferred tax assets is assessed on a case-by-case basis, taking into account the profit forecasts contained in Sanofi&#x2019;s medium-term business plan;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;a deferred tax liability is recognized for temporary differences relating to interests in subsidiaries, associates and joint ventures, except in cases where Sanofi is able to control the timing of the reversal of the temporary differences. This applies in particular when Sanofi is able to control dividend policy and it is probable that the temporary differences will not reverse in the foreseeable future;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;no deferred tax is recognized on eliminations of intragroup transfers of interests in subsidiaries, associates or joint ventures;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;each tax entity calculates its own net deferred tax position. All net deferred tax asset and liability positions are then aggregated and shown in separate line items on the relevant side of the consolidated balance sheet. Deferred tax assets and liabilities are offset only if (i)&#160;Sanofi has a legally enforceable right to offset current tax assets and current tax liabilities, and (ii)&#160;the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation authority;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;deferred taxes are not discounted, except implicitly in the case of deferred taxes on assets and liabilities which are already impacted by discounting. In addition, Sanofi has elected not to discount current taxes payable or receivable where the amounts in question are payable or receivable in the long term;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;withholding taxes on intragroup royalties and dividends, and on royalties and dividends collected from third parties, are accounted for as current income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accounting for business combinations, Sanofi complies with IFRS&#160;3 as regards the recognition of deferred tax assets after the initial accounting period. Consequently, any deferred tax assets recognized by the acquiree after the end of that period in respect of temporary differences or tax loss carry-forwards existing at the acquisition date are recognized in profit or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The positions adopted by Sanofi in tax matters are based on its interpretation of tax laws and regulations. Some of those positions may be subject to uncertainty. In such cases, Sanofi assesses the amount of the tax liability on the basis of the following assumptions: that its position will be examined by one or more tax authorities on the basis of all relevant information; that a technical assessment is carried out with reference to legislation, case law, regulations, and established practice; and that each position is assessed individually (or collectively where appropriate), with no offset or aggregation between positions. Those assumptions are assessed on the basis of facts and circumstances existing at the end of the reporting period. When an uncertain tax liability is regarded as probable, it is measured on the basis of Sanofi&#x2019;s best estimate and recognized as a liability; uncertain tax assets are not recognized. The amount of the liability includes any penalties and late payment interest. The line item&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Income tax expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; includes the effects of tax reassessments and tax disputes, and any penalties and late payment interest arising from such disputes that have the characteristics of income taxes within the meaning of paragraph&#160;2 of IAS&#160;12 (&#x201c;taxes which are based on taxable profits&#x201d;). Tax exposures relating to corporate income taxes are presented separately within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-current income tax liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (see Note&#160;D.19.4.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;No deferred taxation is recognized on temporary differences that are liable to be subject to US global intangible low taxed income (GILTI) provisions. The related tax expense is recognized in the year in which it is declared in the tax return to the extent that it arises from the existence of non-US profits that exceed the theoretical return on investment specified in the GILTI provisions and are taxed at a rate lower than the applicable US tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;1 (Presentation of Financial Statements), current income tax assets and liabilities are presented as separate line items in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="i713b01806f0b4962bdcf1fb4904578c5_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NjgvZnJhZzoyZWU3ZDdhNjI1OWQ0NzRjYjM5ZDI1NjYxMzY2YzUxZi90ZXh0cmVnaW9uOjJlZTdkN2E2MjU5ZDQ3NGNiMzlkMjU2NjEzNjZjNTFmXzUwMDU_d9203262-c271-4fbe-9795-a43507d35295"
      unitRef="eur">0</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NzEvZnJhZzo5YzFmMmI0NTYyNzk0ZDEzYjE1MzFhN2M4ZDZjMjc0Ni90ZXh0cmVnaW9uOjljMWYyYjQ1NjI3OTRkMTNiMTUzMWE3YzhkNmMyNzQ2XzI4NDI_7409e4df-6dc4-4ed2-a73d-9f09f4c4ff8d">Employee benefit obligations&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi offers retirement benefits to employees and retirees. Such benefits are accounted for in accordance with IAS&#160;19 (Employee Benefits).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Benefits are provided in the form of either defined contribution plans or defined benefit plans. In the case of defined contribution plans, the cost is recognized immediately in the period in which it is incurred, and equates to the amount of the contributions paid by Sanofi. For defined benefit plans, Sanofi generally recognizes its obligations to pay pensions and similar benefits to employees as a liability, based on an actuarial estimate of the rights vested or currently vesting in employees and retirees, using the projected unit credit method. Estimates are performed at least once a year, and rely on financial assumptions (such as discount rates) and demographic assumptions (such as life expectancy, retirement age, employee turnover, and the rate of salary increases).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Obligations relating to other post-employment benefits (healthcare and life insurance) offered by Sanofi companies to employees are also recognized as a liability based on an actuarial estimate of the rights vested or currently vesting in employees and retirees at the end of the reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Such liabilities are recognized net of the fair value of plan assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the case of multi-employer defined benefit plans where plan assets cannot be allocated to each participating employer with sufficient reliability, the plan is accounted for as a defined contribution plan, in accordance with paragraph&#160;34 of IAS&#160;19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The benefit cost for the period consists primarily of current service cost, past service cost, net interest cost, gains or losses arising from plan settlements not specified in the terms of the plan, and actuarial gains or losses arising from plan curtailments. Net interest cost for the period is determined by applying the discount rate specified in IAS&#160;19 to the net liability (i.e. the amount of the obligation, net of plan assets) recognized in respect of defined benefit plans. Past service cost is recognized immediately in profit or loss in the period in which it is incurred, regardless of whether or not the rights have vested at the time of adoption (in&#160;the case of a new plan) or of amendment (in&#160;the case of an existing&#160;plan).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Actuarial gains and losses on defined benefit plans (pensions and other post-employment benefits), also referred to as&#160;&#x201c;Remeasurements of the net defined benefit liability (asset)&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; arise as a result of changes in financial and demographic assumptions, experience adjustments, and the difference between the actual return and interest cost on plan assets. The impacts of those remeasurements are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, net of deferred taxes; they are not subsequently reclassifiable to profit or&#160;loss.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NzQvZnJhZzozZjhlMzlmOGM0Mzc0OGM2YjlhYjVjZGRkNTNkOTNlNy90ZXh0cmVnaW9uOjNmOGUzOWY4YzQzNzQ4YzZiOWFiNWNkZGQ1M2Q5M2U3XzI2NTc_1160521d-1054-4c8d-94fe-487f4b28915c">Share-based payment&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Share-based payment expense is recognized as a component of operating income, in the relevant classification of expense by function. In measuring the expense, the level of attainment of any performance conditions is taken into account.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.24.1. Stock option plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi has granted a number of equity-settled share-based payment plans (stock option plans) to some of its employees. The terms of those plans may make the award contingent on the attainment of performance criteria for some of the grantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;2 (Share-Based Payment), services received from employees as consideration for stock options are recognized as an expense in the income statement, with the opposite entry recognized in equity. The expense corresponds to the fair value of the stock option plans, and is charged to income on a straight-line basis over the four-year vesting period of the plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The fair value of stock option plans is measured at the date of grant using the Black-Scholes valuation model, taking into account the expected life of the options. The resulting expense also takes into account the expected cancellation rate of the options. The expense is adjusted over the vesting period to reflect actual cancellation rates resulting from option-holders ceasing to be employed by Sanofi.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.24.2. Employee share ownership plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi may offer its employees the opportunity to subscribe to reserved share issues at a discount to the reference market price. Shares awarded to employees under such plans fall within the scope of IFRS&#160;2. Consequently, an expense is recognized at the subscription date, based on the value of the discount offered to employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;B.24.3. Restricted share plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi may award restricted share plans to certain of its employees. The terms of those plans may make the award contingent on the attainment of performance criteria for some of the grantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;2, an expense equivalent to the fair value of such plans is recognized in profit or loss on a straight line basis over the vesting period of the plan, with the opposite entry recognized in equity. The vesting period is three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The fair value of restricted share plans is based on the quoted market price of Sanofi shares at the date of grant, adjusted for expected dividends during the vesting period; it also takes account of any vesting conditions contingent on stock market performance, measured using the Monte-Carlo valuation model. Other vesting conditions are taken into account in the estimate of the number of shares awarded during the vesting period; that number is then definitively adjusted based on the actual number of shares awarded on the vesting date.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <sny:OptionVestingPeriod
      contextRef="ie922fff56e5f419ab3f601913c0b7064_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NzQvZnJhZzozZjhlMzlmOGM0Mzc0OGM2YjlhYjVjZGRkNTNkOTNlNy90ZXh0cmVnaW9uOjNmOGUzOWY4YzQzNzQ4YzZiOWFiNWNkZGQ1M2Q5M2U3XzI2NjI_6c03d95c-9ca5-493c-8787-9d006f5a37ff">P4Y</sny:OptionVestingPeriod>
    <sny:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod
      contextRef="i1cc28f89fac74c419543f702bf0f7dca_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NzQvZnJhZzozZjhlMzlmOGM0Mzc0OGM2YjlhYjVjZGRkNTNkOTNlNy90ZXh0cmVnaW9uOjNmOGUzOWY4YzQzNzQ4YzZiOWFiNWNkZGQ1M2Q5M2U3XzIxNTk_06b3aeea-1f0c-4ae4-a957-6b4a07a78648">P3Y</sny:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod>
    <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81NzcvZnJhZzo1ZTEzNjgwOTliYjM0ZTI1OGMzNGViZTNmMjE4NGZhMi90ZXh0cmVnaW9uOjVlMTM2ODA5OWJiMzRlMjU4YzM0ZWJlM2YyMTg0ZmEyXzczMw_6d49d8ce-1eae-4121-aeb0-efcb762a8f9a">Earnings per share&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated using the weighted average number of shares outstanding during the reporting period, adjusted on a time-weighted basis from the acquisition date to reflect the number of own shares held by Sanofi. Diluted earnings per share is calculated on the basis of the weighted average number of ordinary shares, computed using the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;This method assumes that (i)&#160;all outstanding dilutive options and warrants are exercised, and (ii)&#160;Sanofi acquires its own shares at the quoted market price for an amount equivalent to the cash received as consideration for the exercise of the options or warrants, plus the expense arising on unamortized stock options.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODAvZnJhZzplNDg4OTc4Y2Y4MDk0ZmMxYmFiZDllMGM5ZGYxOTA4Ny90ZXh0cmVnaW9uOmU0ODg5NzhjZjgwOTRmYzFiYWJkOWUwYzlkZjE5MDg3XzMxNTg_4e85080b-c774-4d64-864e-757e7d710799">Segment information&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IFRS&#160;8 (Operating Segments), the segment information reported by Sanofi is prepared on the basis of internal management data provided to the Chief Executive Officer, who is the chief operating decision maker. The performance of those segments is monitored individually using internal reports and common indicators. Disclosures about operating segments required under IFRS&#160;8 are presented in Note&#160;D.35. &#x201c;Segment information&#x201d; to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi has three operating segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Pharmaceuticals segment comprises, for all geographical territories, the commercial operations of the following global franchises: Specialty Care (Dupixent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, Neurology &amp;amp; Immunology, Rare Diseases, Oncology, and Rare Blood Disorders) and General Medicines (Core and Non-Core Assets), together with research, development and production activities dedicated to the Pharmaceuticals segment. This segment also includes associates whose activities are related to pharmaceuticals. Following the transaction of May&#160;29, 2020, Regeneron is no longer an associate of Sanofi (see Note&#160;D.2.). Consequently, the Pharmaceuticals segment no longer includes Sanofi&#x2019;s equity-accounted share of Regeneron&#x2019;s profits for all the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Vaccines segment comprises, for all geographical territories, the commercial operations of Vaccines, together with research, development and production activities dedicated to vaccines.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for Sanofi's Consumer Healthcare products, together with research, development and production activities dedicated to those products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Inter-segment transactions are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The costs of Sanofi&#x2019;s global functions (Corporate Affairs, Finance, People &amp;amp; Culture, Legal, Ethics &amp;amp; Business Integrity, Information Solutions&#160;&amp;amp; Technologies, Sanofi Business Services,&#160;etc.) are managed centrally at group-wide level, and are presented within the &#x201c;Other&#x201d; category. That category also includes other reconciling items such as retained commitments in respect of divested activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Information about operating segments for the years ended December 31, 2022, 2021 and 2020 is presented in Note&#160;D.35&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x201c;Segment information&#x201d;.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory>
    <sny:NumberOfOperatingSegments
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODAvZnJhZzplNDg4OTc4Y2Y4MDk0ZmMxYmFiZDllMGM5ZGYxOTA4Ny90ZXh0cmVnaW9uOmU0ODg5NzhjZjgwOTRmYzFiYWJkOWUwYzlkZjE5MDg3XzUyNw_9184c7a1-f49c-4d22-a851-b4dc86a3131b"
      unitRef="segment">3</sny:NumberOfOperatingSegments>
    <ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODMvZnJhZzpiNDNlMWI2ZWQ5Njc0NTI1YjlhZjhmZGFiYmQ1YjI0Yi90ZXh0cmVnaW9uOmI0M2UxYjZlZDk2NzQ1MjViOWFmOGZkYWJiZDViMjRiXzE5NzI_364a5418-7161-414b-9062-79ed10648555">Management of capital&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In order to maintain or adjust the capital structure, Sanofi can adjust the amount of dividends paid to shareholders, repurchase its own shares, issue new shares, or issue securities giving access to its capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The following objectives are defined under the terms of Sanofi&#x2019;s share repurchase programs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the implementation of any stock option plan giving entitlement to purchase shares in the Sanofi parent company;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the allotment or sale of shares to employees under statutory profit sharing schemes and employee savings plans;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the consideration-free allotment of shares (i.e. restricted share plans);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the cancellation of some or all of the repurchased shares;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;market-making in the secondary market by an investment services provider under a liquidity contract in compliance with the ethical code recognized by the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Autorit&#xe9; des march&#xe9;s financiers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (AMF);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the delivery of shares on the exercise of rights attached to securities giving access to the capital by redemption, conversion, exchange, presentation of a warrant or any other means;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the delivery of shares (in exchange, as payment, or otherwise) in connection with mergers and acquisitions;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the execution by an investment services provider of purchases, sales or transfers by any means, in particular via off-market trading; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;any other purpose that is or may in the future be authorized under the applicable laws and regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi is not subject to any constraints on equity capital imposed by third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Total equity includes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity attributable to equity holders of Sanofi and Equity attributable to non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, as shown in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi defines &#x201c;Net debt&#x201d; as (i)&#160;the sum of short-term debt, long-term debt and interest rate derivatives and currency derivatives used to hedge debt, minus (ii)&#160;the sum of cash and cash equivalents and interest rate derivatives and currency derivatives used to hedge cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory>
    <sny:DisclosureOfPrincipalAlliancesTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzEzNDY4_247009db-901d-4c55-bd72-f57ed1d29059">Principal alliances&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;C.1. Alliance arrangements with Regeneron Pharmaceuticals,&#160;Inc. (Regeneron)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaboration agreements on human therapeutic antibodies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In November&#160;2007, Sanofi and Regeneron signed two agreements (amended in November&#160;2009) relating to human therapeutic antibodies: (i)&#160;the Discovery and Preclinical Development Agreement, and (ii)&#160;the License and Collaboration Agreement, relating to clinical development and commercialization. Under the License and Collaboration Agreement, Sanofi had an option to develop and commercialize antibodies discovered by Regeneron under the Discovery and Preclinical Development Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Discovery and development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Because Sanofi decided not to exercise its option to extend the Discovery and Preclinical Development Agreement, that agreement expired on December&#160;31, 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As a result of Sanofi's exercise of an option with respect to an antibody under the Discovery and Preclinical Development Agreement, such antibody became a &#x201c;Licensed Product&#x201d; under the License and Collaboration Agreement, pursuant to which Sanofi and Regeneron co-develop the antibody with Sanofi initially being wholly responsible for funding the development program. On receipt of the first positive Phase III trial results for any antibody being developed under the License and Collaboration Agreement, the subsequent development costs for that antibody are split 80% Sanofi, 20% Regeneron. Amounts received from Regeneron under the License and Collaboration Agreement are recognized by Sanofi as a reduction in the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Co-development with Regeneron of the antibodies Dupixent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, Kevzara&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; and REGN3500 (SAR440340 - itepekimab) is ongoing under the License and Collaboration Agreement as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Once a product begins to be commercialized, and provided that the share of quarterly results under the agreement represents a profit, Sanofi is entitled to an additional portion of Regeneron&#x2019;s profit-share (capped at 20% of Regeneron&#x2019;s share of quarterly profits since April&#160;1, 2022, and at 10% until March&#160;31, 2022) until Regeneron has paid 50% of the cumulative development costs incurred by the parties in the collaboration (see Note&#160;D.21.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On the later of (i)&#160;24 months before the scheduled launch date or (ii)&#160;the first positive Phase&#160;III trial results, Sanofi and Regeneron share the commercial expenses of the antibodies co-developed under the License and Collaboration Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commercialization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi is the lead party with respect to the commercialization of all co-developed antibodies, and Regeneron has certain option rights to co-promote the antibodies. Regeneron has exercised its co-promotion rights in the United States and in certain other countries. Sanofi recognizes all sales of the antibodies. Profits and losses arising from commercial operations in the United States are split 50/50. Outside the United States, Sanofi is entitled to between 55% and 65% of profits depending on sales of the antibodies, and bears 55% of any losses. The share of profits and losses due to or from Regeneron under the agreement is recognized within the line items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income or Other operating expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, which are components of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In addition, Regeneron is entitled to receive payments contingent on the attainment of specified levels of aggregate sales on all antibodies outside the United States, on a rolling twelve-month basis. A liability for those payments is recognized on the balance sheet when it is probable that the specified level of aggregate sales will be met. The opposite entry for that liability is capitalized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; on the balance sheet. Two payments of $50&#160;million each were made in 2022, following attainment first of $2.0&#160;billion and then of $2.5&#160;billion in sales of all antibodies outside the United States on a rolling twelve-month basis. In the event that $3.0&#160;billion in sales on a rolling twelve-month basis is attained, Regeneron is entitled to a final milestone payment of $50&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amendments to the collaboration agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In January&#160;2018, Sanofi and Regeneron signed a set of amendments to their collaboration agreements, including an amendment that allowed for the funding of additional programs on Dupixent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; and REGN3500 (SAR440340 &#x2013; itepekimab) with an intended focus on extending the current range of indications, finding new indications, and improving co-morbidity between multiple pathologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Effective April&#160;1, 2020, Sanofi and Regeneron signed a Cross License and Commercialization Agreement for Praluent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, whereby Sanofi obtained sole ex-US rights to Praluent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, and Regeneron obtained sole US rights to Praluent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; along with a right to 5% royalties on Sanofi&#x2019;s sales of Praluent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; outside the United States. Each party is solely responsible for funding the development, manufacturing and commercialization of Praluent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in their respective territories. Although each party has responsibility for supplying Praluent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in its respective territory, Sanofi and Regeneron have entered into agreements to support manufacturing needs for each other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Effective September&#160;30, 2021, Sanofi and Regeneron signed an amendment to their collaboration agreement in order to specify allocations of responsibilities and associated resources between the two parties in connection with the co-promotion of&#160;Dupixent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in certain countries. The terms of the collaboration relating to REGN3500 (SAR440340 &#x2013; itepekimab) are unchanged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Effective July&#160;1, 2022, Sanofi and Regeneron signed an amendment to their collaboration agreement in order to increase the additional portion of Regeneron&#x2019;s share of quarterly profits attributable to Sanofi from 10% to 20% with retroactive impact as of April&#160;1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Immuno-oncology (IO) collaboration agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On July&#160;1, 2015, Sanofi and Regeneron signed two agreements &#x2013;&#160;the IO Discovery and Development Agreement and the IO License and Collaboration Agreement (IO LCA)&#160;&#x2013; relating to new antibody cancer treatments in the field of immuno-oncology.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Amended IO Discovery Agreement, effective from December&#160;31, 2018, was terminated through a Letter Amendment dated March&#160;16,&#160;2021 in which Sanofi formalized its opt-out from the BCMAxCD3 and MUC16xCD3 programs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Libtayo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(cemiplimab)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under the 2015 IO LCA as amended in January&#160;2018, Sanofi and Regeneron committed funding of no more than $1,640 million, split on a&#160;50/50 basis ($820 million per company), for the development of REGN2810 (cemiplimab, trademark Libtayo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;), a PD-1 inhibitor antibody. The funding was raised to $1,840&#160;million by way of amendment effective on September&#160;30, 2021. Regeneron was responsible for the commercialization of Libtayo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the United States, and Sanofi in all other territories. Sanofi has exercised its option to co-promote Libtayo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the United States. In 2021, Regeneron exercised its option to co-promote Libtayo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in certain other countries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The IO LCA also provided for a one-time milestone payment of $375 million by Sanofi to Regeneron in the event that sales of a PD-1 product were to exceed, in the aggregate, $2 billion in any consecutive 12-month period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under the IO LCA Sanofi and Regeneron shared equally in profits and losses generated by the commercialization of collaboration products, except that Sanofi was entitled to an additional portion of Regeneron&#x2019;s profit-share (capped at 10% of Regeneron&#x2019;s share of quarterly profits) until Regeneron had paid 50% of the cumulative development costs incurred by the parties under the IO Discovery Agreement, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Libtayo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; is approved in the United States and Europe for the treatment of two types of locally advanced or metastatic skin cancer (cutaneous squamous cell carcinoma and basal cell carcinoma) and non-small cell lung cancer (NSCLC). It is also approved in Brazil and Canada as a second line treatment for recurring or metastatic cervical cancer. In the fourth quarter of 2022, it was approved in the United States in association with chemotherapy for the treatment of NSCLC, and in Europe and Japan as a second line treatment for recurring or metastatic cervical cancer. Libtayo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; is currently approved in more than 30&#160;countries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In June&#160;2022, Sanofi and Regeneron restructured their IO LCA. Under the terms of the Amended and Restated IO LCA, Regeneron holds exclusive worldwide licensing rights to Libtayo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; with effect from July&#160;1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In July&#160;2022, Sanofi received as consideration an upfront payment of $900&#160;million (&#x20ac;856&#160;million), which was recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; on the date of receipt. The same line item also includes a regulatory milestone payment of $100&#160;million (&#x20ac;96&#160;million) following the US FDA approval in November&#160;2022 of Libtayo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in combination with chemotherapy as a first line treatment for NSCLC. In addition, Sanofi is entitled to royalties of 11% and to milestone payments (&#x20ac;111&#160;million in 2022) linked to global net sales of Libtayo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; which are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;in line with the pattern of sales . All of the cash inflows relating to the above items (&#x20ac;967&#160;million for the year ended December&#160;31, 2022) are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net cash provided by/(used in) operating activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the consolidated statement of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The amendment to the terms of the IO LCA resulted in Sanofi recognizing an accelerated amortization charge of &#x20ac;226&#160;million; this was allocated to the Libtayo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;product rights included within the residual carrying amount of the intangible asset recognized in July&#160;2015 to reflect rights to an antibody targeting the immune checkpoint receptor PD-1 (programmed cell death protein-1) under the Sanofi/Regeneron alliance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The transaction also includes a time-limited transitional services agreement with Regeneron which includes manufacturing, distribution (for which Sanofi acts as agent), and promotion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investor agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2014 and 2020, Sanofi and Regeneron amended the investor agreement entered into by the two companies in 2007. Under the terms of the amendments, Sanofi accepted various restrictions, including &#x201c;standstill&#x201d; provisions that contractually prohibit Sanofi from seeking to directly or indirectly exert control of Regeneron or acquiring more than 30% of Regeneron&#x2019;s capital stock (consisting of the outstanding shares of common stock and the shares of Class A stock). This prohibition remains in place until the earlier of (i)&#160;the later of the fifth anniversaries of the expiration or earlier termination of the Zaltrap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; collaboration agreement with Regeneron (related to the development and commercialization of Zaltrap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;) or the collaboration agreement with Regeneron on monoclonal antibodies (see &#x201c;Collaboration agreements on human therapeutic antibodies&#x201d; above), each as amended and (ii)&#160;other specified events.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Starting in 2018 Sanofi began to sell shares of Regeneron stock and announced on May&#160;29,&#160;2020 the closing of its sale of 13&#160;million shares of Regeneron common stock in a registered offering and a private sale to Regeneron (see Note&#160;D.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Pursuant to subsequent sales, as of December&#160;31, 2022 Sanofi no longer holds any shares of Regeneron stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;C.2. Alliance arrangements with Bristol-Myers Squibb (BMS)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Two of Sanofi&#x2019;s products were jointly developed with BMS: the anti-hypertensive agent irbesartan (Aprovel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;/Avapro&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;/Karvea&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;) and the anti-atherothrombosis treatment clopidogrel bisulfate (Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;/Iscover&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On September&#160;27, 2012, Sanofi and BMS signed an agreement relating to their alliance following the loss of exclusivity of Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; and Avapro&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;/Avalide&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in many major markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under the terms of this agreement, effective January&#160;1, 2013, BMS returned to Sanofi its rights to Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; and Avapro&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;/Avalide&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in all markets worldwide with the exception of Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the United States and Puerto Rico (&#x201c;Territory&#160;B&#x201d;), giving Sanofi sole control and freedom to operate commercially in respect of those products. In exchange, BMS received royalty payments on Sanofi&#x2019;s sales of branded and unbranded Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; and Avapro&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;/Avalide&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; worldwide (except for Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in Territory&#160;B) until 2018, and also received a payment of $200 million from Sanofi in December&#160;2018, part of which is for buying out the non-controlling interests. Rights to Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in Territory&#160;B remained unchanged and continued to be governed by the terms of the original agreement until&#160;February&#160;28, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In all of the territories managed by Sanofi (including the United States and Puerto Rico for Avapro&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;/Avalide&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;) as defined in the new agreement, Sanofi recognized in its consolidated financial statements the revenue and expenses generated by its own operations. Since January&#160;2019 onwards, there has no longer been any share of profits reverting to BMS (previously presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net income attributable to non-controlling interests &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;in the income statement).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In Territory&#160;B for Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, which was managed by BMS, the Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; business was conducted through the Territory&#160;B partnerships, which were jointly owned by BMS and Sanofi. Sanofi recognized its share of profits and losses within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On February&#160;28, 2020, Sanofi purchased all BMS&#x2019;s interests (50.1%) in each of the Territory&#160;B partnerships for a cumulative purchase price of $12&#160;million. Following a transition period, Sanofi has been commercializing Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; under its own label since&#160;July&#160;1, 2020.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfPrincipalAlliancesTextBlock>
    <sny:NumberOfAgreementsSigned
      contextRef="i20ae7da9383f4e3ab6826ded2379ded9_D20071101-20071130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzIwNw_74d85d24-4b1c-45f4-a86e-1be5145bb1bb"
      unitRef="agreement">2</sny:NumberOfAgreementsSigned>
    <sny:PercentageOfSecondPartOfDevelopmentCostsFunded
      contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzEzOTU_59c1deca-6b3c-4b6e-bf16-e7e4b7841964"
      unitRef="number">0.80</sny:PercentageOfSecondPartOfDevelopmentCostsFunded>
    <sny:PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty
      contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE0MDY_dd07ae63-9ab6-4aa9-8a3b-c834652f1895"
      unitRef="number">0.20</sny:PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty>
    <sny:PercentageOfProfitShareOnCounterpartiesProfit
      contextRef="ia94d77530caa412a8f0882f4cd79aa5f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTIy_269a96ca-a005-42df-9e76-bf239371dda0"
      unitRef="rate">0.20</sny:PercentageOfProfitShareOnCounterpartiesProfit>
    <sny:PercentageOfProfitShareOnCounterpartiesProfit
      contextRef="i2ecbe16a2f5243648f9c51e3a70306d7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTI4_d8f688e7-b08d-4a72-8e7b-e057fa8501a0"
      unitRef="rate">0.10</sny:PercentageOfProfitShareOnCounterpartiesProfit>
    <sny:PercentageOfCumulativeDevelopmentCostsReimbursed
      contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNzA5_e3abce9d-f99a-43d0-ba23-e63b4d32fcc2"
      unitRef="number">0.50</sny:PercentageOfCumulativeDevelopmentCostsReimbursed>
    <sny:PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared
      contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzIyOTY_73ed3b2c-5e36-4fa9-88bd-e56eadd0b183">P24M</sny:PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared>
    <sny:PercentageOfProfitsAndLossesArisingFromCommercialOperations
      contextRef="i8340ae2fb6694e37bcf4ae4303e9d61f_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI5Mjk_9bff84c1-f928-42e6-9fcc-f9a0fb9ae5c2"
      unitRef="number">0.50</sny:PercentageOfProfitsAndLossesArisingFromCommercialOperations>
    <sny:PercentageOfProfitsArisingFromCommercialOperations
      contextRef="i7b0305aa6f27497eb6fa4104c0ca63f4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI5OTM_9d362c51-27a7-458d-a630-f23c0fd351fe"
      unitRef="number">0.55</sny:PercentageOfProfitsArisingFromCommercialOperations>
    <sny:PercentageOfProfitsArisingFromCommercialOperations
      contextRef="i81e1dceb236f4caa96e65fbb39f6b94d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzMwMDA_0d6dc57d-bd58-4c53-ba28-f51877a79774"
      unitRef="number">0.65</sny:PercentageOfProfitsArisingFromCommercialOperations>
    <sny:PercentageOfLossesArisingFromCommercialOperations
      contextRef="ic51500ccf0de43918f2456787048ab13_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzMwNjI_1824c53e-d43d-4c55-8f02-135022bb0303"
      unitRef="number">0.55</sny:PercentageOfLossesArisingFromCommercialOperations>
    <sny:NumberOfPayments
      contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTYz_6610d018-eb84-4945-82f2-1f61601ead30"
      unitRef="bond">2</sny:NumberOfPayments>
    <sny:PaymentRelatedToAttainmentOfGoal
      contextRef="i61da00769f834eaa98878f6f1e9776d7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNTg0_e8ff34c4-1c43-41e6-a31b-de932508ccae"
      unitRef="usd">50000000</sny:PaymentRelatedToAttainmentOfGoal>
    <sny:PaymentRelatedToAttainmentOfGoal
      contextRef="ifedcadc8c03743abbb94c99cad356d95_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNTg0_f9d135ef-0093-48e3-a903-ae98b76b3517"
      unitRef="usd">50000000</sny:PaymentRelatedToAttainmentOfGoal>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i272b0b38e1734e68a43df1ce789e2493_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNjc1_bd743a4e-b1d8-4afb-9a94-3494312c7216"
      unitRef="usd">2000000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i77c108aa7495480c98890a86800bc863_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNjkw_e51fc43a-9716-4fed-aeb5-bbf659e64ca0"
      unitRef="usd">2500000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4aeff9d4cfe84f959b330be0f13f0ab9_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTM0_d056fc91-b0e2-4446-b4e7-395b81b8d823"
      unitRef="usd">3000000000</ifrs-full:RevenueFromSaleOfGoods>
    <sny:PaymentRelatedToAttainmentOfGoal
      contextRef="i7a8c2e8daf4d45b0bcc16547962ef088_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTQ4_ad55794f-2ec2-4925-8dde-76c38457969a"
      unitRef="usd">50000000</sny:PaymentRelatedToAttainmentOfGoal>
    <sny:RoyaltyExpensePercentage
      contextRef="iac784bc58da74b4aa8644c7bf23d67b9_D20200401-20200401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzQ1NDg_dc8dba95-69df-4739-9d1a-41f8bd66e534"
      unitRef="number">0.05</sny:RoyaltyExpensePercentage>
    <sny:PercentageOfProfitShareOnCounterpartiesProfit
      contextRef="i98602d43a3714a12b2caa518ebc7b26d_D20220401-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzUzODI4_dab501c3-fe7a-45f1-b1b7-7c82d92e0800"
      unitRef="rate">0.10</sny:PercentageOfProfitShareOnCounterpartiesProfit>
    <sny:PercentageOfProfitShareOnCounterpartiesProfit
      contextRef="ia94d77530caa412a8f0882f4cd79aa5f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzUzODM0_7f53bded-4546-4269-891d-6734ab4960e7"
      unitRef="rate">0.20</sny:PercentageOfProfitShareOnCounterpartiesProfit>
    <sny:NumberOfAgreementsSigned
      contextRef="id427dce20c2b4d7697237ead9c24a9f7_D20150701-20150701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzUzOTg_15653a7a-0982-4701-b4f4-e55200d07f2f"
      unitRef="agreement">2</sny:NumberOfAgreementsSigned>
    <sny:PriorDevelopmentBudget
      contextRef="i78b6b504abcb44898dfcb15e0cbcf437_I20151231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzU5MzM_804bce63-a897-4103-b5ec-388cadaaf214"
      unitRef="usd">1640000000</sny:PriorDevelopmentBudget>
    <sny:ContractualAgreementForAntiProgrammedCellDeathProtein1
      contextRef="i78b6b504abcb44898dfcb15e0cbcf437_I20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzU5NDg_cf811249-bfce-464a-bba3-d4cd9d802c7f"
      unitRef="number">50</sny:ContractualAgreementForAntiProgrammedCellDeathProtein1>
    <sny:MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany
      contextRef="ic8a9426091cb480c8f68708490b978f0_D20150101-20151231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzU5NjI_e2590d91-d848-4176-a89a-75a646807fc0"
      unitRef="usd">820000000</sny:MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany>
    <sny:MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany
      contextRef="i050c4dcdac6845d58381cc5689aef318_D20210930-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzYwOTg_2759cd81-f1e6-413e-b064-18833e2a86f2"
      unitRef="usd">1840000000</sny:MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany>
    <sny:AntiProgrammedCellDeathProtein1SalesMilestonePayment
      contextRef="ic8a9426091cb480c8f68708490b978f0_D20150101-20151231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzY1MDU_877cfcf9-675a-4051-b08a-6abb3d005807"
      unitRef="usd">375000000</sny:AntiProgrammedCellDeathProtein1SalesMilestonePayment>
    <sny:MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment
      contextRef="ic8a9426091cb480c8f68708490b978f0_D20150101-20151231"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzY2MDc_512f5b60-1f3d-4862-9269-c5496815d394"
      unitRef="usd">2000000000</sny:MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment>
    <sny:PercentageOfProfitShareOnCounterpartiesProfit
      contextRef="ibc2546af5e7749c8beb48751c8dc0bf5_D20150101-20151231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzY4ODM_cf3f59d6-ba38-4192-bb3f-e209487954d6"
      unitRef="number">0.10</sny:PercentageOfProfitShareOnCounterpartiesProfit>
    <sny:PercentageOfCumulativeDevelopmentCostsReimbursed
      contextRef="ibc2546af5e7749c8beb48751c8dc0bf5_D20150101-20151231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzY5NTQ_b4fda46f-659c-470d-a175-3481798b0235"
      unitRef="number">0.50</sny:PercentageOfCumulativeDevelopmentCostsReimbursed>
    <sny:UpfrontPaymentsForProjectsUnderCollaborationAgreements
      contextRef="ia4868bf0ce374326a873eb079a2f01ee_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzgzMDEzMTI3OTQxMTY2_b18673cb-b4a4-4c27-b68d-04eada2fc553"
      unitRef="usd">900000000</sny:UpfrontPaymentsForProjectsUnderCollaborationAgreements>
    <sny:UpfrontPaymentsForProjectsUnderCollaborationAgreements
      contextRef="ia4868bf0ce374326a873eb079a2f01ee_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTc0_8bf6b6f0-bf88-4869-9bda-cd67bcc7276a"
      unitRef="eur">856000000</sny:UpfrontPaymentsForProjectsUnderCollaborationAgreements>
    <sny:RegularMilestonePaymentsForProjectsUnderCollaborationAgreements
      contextRef="i8f408d44df6a499394b5c347b1c34f80_D20220601-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzgzMDEzMTI3OTQxMTkz_395c0c27-f414-4d03-ab76-e66a66dfafcd"
      unitRef="usd">100000000</sny:RegularMilestonePaymentsForProjectsUnderCollaborationAgreements>
    <sny:RegularMilestonePaymentsForProjectsUnderCollaborationAgreements
      contextRef="i8f408d44df6a499394b5c347b1c34f80_D20220601-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MTg5_11d048e5-1137-4f85-b25e-d663935a090e"
      unitRef="eur">96000000</sny:RegularMilestonePaymentsForProjectsUnderCollaborationAgreements>
    <sny:RoyaltyIncomePercentage
      contextRef="ia4868bf0ce374326a873eb079a2f01ee_D20220701-20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzgwODE0MTA0Njk1Mzg5_7e7482fc-a061-4358-89eb-203a738bbd38"
      unitRef="number">0.11</sny:RoyaltyIncomePercentage>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="i6fbbad3af70b4c90a3eb35e084814290_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzU0MzA1_771cb001-b822-4916-849f-194bb8da7baa"
      unitRef="eur">111000000</ifrs-full:OtherOperatingIncomeExpense>
    <sny:ProceedsFromCollaborationAgreements
      contextRef="i6fbbad3af70b4c90a3eb35e084814290_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzE5NzkxMjA5MzQ0MjAy_1ce0f82e-3a1b-41cb-9e88-7c4c35841d7d"
      unitRef="eur">967000000</sny:ProceedsFromCollaborationAgreements>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale
      contextRef="i8076a1036c53486c9cf0fadf596f4f82_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzgzMDEzMTI3OTQxMjIw_f40ea14d-e24c-4c6f-9eb4-7442a6489855"
      unitRef="eur">226000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
    <sny:MaximumOwnershipPercentageAllowedToAcquire
      contextRef="i0515044855e14c60a51bff4d7c49cee9_D20140101-20140131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNzI0_80c55718-eacf-4ef0-bd62-4059f64383df"
      unitRef="number">0.30</sny:MaximumOwnershipPercentageAllowedToAcquire>
    <sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal
      contextRef="id3e2037ecf8e496eaf3ae27c42505f70_D20200529-20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzI2OTM4MDM0OTEwNzI5_1c839b55-f561-419a-a74d-673f711bdf96"
      unitRef="shares">13000000</sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal>
    <sny:NumberOfProductsJointlyDeveloped
      contextRef="ie8cdba1a7ee34963bcb9d8c5981f4337_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzExMjcw_7152f01a-9032-4495-9d5a-4388ec5aac1b"
      unitRef="product">2</sny:NumberOfProductsJointlyDeveloped>
    <sny:RoyaltiesPaymentsMadeBySanofi
      contextRef="i314c45a3e1e647bcae2d4dabeea5fe4d_D20181201-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzEyMTkx_2357e523-2a04-467f-b447-50addedaa203"
      unitRef="usd">200000000</sny:RoyaltiesPaymentsMadeBySanofi>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="i860a838707c64bfb8b697db6c3bbeeb6_I20200228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzEzMjcz_eea54d08-2fb2-4453-9033-9b5267078c5a"
      unitRef="number">0.501</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod
      contextRef="i9016dbf3a1c5430f9125964cc371f4de_D20200228-20200228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODYvZnJhZzo2YjMxOTE3YTliNDc0ZDU1OWMxZmZmNDg0MzI5ZjA3ZC90ZXh0cmVnaW9uOjZiMzE5MTdhOWI0NzRkNTU5YzFmZmY0ODQzMjlmMDdkXzEzMzUy_c9ab7b42-e7f6-4ee4-8139-9d2ce7bb652f"
      unitRef="usd">12000000</ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod>
    <sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81ODkvZnJhZzpkZTFkOWJkNDYxMmI0NmNiYjM1NDRkNmMwZjU2NDAzYS90ZXh0cmVnaW9uOmRlMWQ5YmQ0NjEyYjQ2Y2JiMzU0NGQ2YzBmNTY0MDNhXzQ4_7b7ecc7a-5b12-4a0c-9811-aaef33156844">Presentation of the financial statementsPrincipal changes in the scope of consolidation in 2022&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Amunix Pharmaceuticals, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On February&#160;8, 2022, Sanofi acquired the entire share capital of the immuno-oncology company Amunix Pharmaceuticals, Inc. (Amunix), thereby gaining access to Amunix&#x2019;s innovative Pro-XTEN&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; technology and a promising pipeline of immunotherapies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The acquisition price of Amunix comprises a fixed cash payment of &#x20ac;970&#160;million, plus contingent consideration in the form of milestone payments based on attainment of certain future development objectives of up to $225&#160;million, the fair value of which as of the acquisition date was &#x20ac;156&#160;million. In accordance with IFRS&#160;3, this contingent purchase consideration was recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liabilities related to business combinations and non-controlling interests &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(see Note&#160;D.18.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation led to the recognition of &#x20ac;609&#160;million of goodwill, determined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value at acquisition date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;493&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current and non-current assets and liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;118&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net assets of Amunix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;517&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;609&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,126&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x201c;Other intangible assets&#x201d; comprise Pro-XTEN&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, an innovative universal protease-releasable masking technology platform for the discovery and development of transformative cytokine therapies and T-cell engager (TCE) immunotherapies for patients with cancer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Goodwill mainly represents the value of Amunix&#x2019;s upstream research and development pipeline of immuno-oncology therapies based on next-generation conditionally activated biologics, especially when combined with Sanofi&#x2019;s existing oncology portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The goodwill generated on this acquisition does not give rise to any deduction for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Amunix has no commercial operations, and has made a negative contribution of &#x20ac;56&#160;million to Sanofi&#x2019;s consolidated net income since the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Acquisition-related costs were recognized in profit or loss during 2021, primarily within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;; the amount involved was immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The impact of this acquisition as reflected within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions of consolidated undertakings and investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the consolidated statement of cash flows is a cash outflow of &#x20ac;852&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;EUROAPI - Loss of control and accounting implications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On March&#160;17, 2022, the Sanofi Board of Directors approved a decision to put to a shareholder vote the proposed distribution in&#160;kind of approximately 58% of the share capital of EUROAPI, thereby confirming Sanofi&#x2019;s commitment (announced in February&#160;2020) to discontinue its active pharmaceutical ingredient operations. As part of the same corporate action and on the same date, Sanofi entered into an investment agreement with EPIC Bpifrance, which undertook to acquire from Sanofi &#x2013; via the French Tech Souverainet&#xe9; fund &#x2013; a 12% equity interest in EUROAPI at a price not exceeding &#x20ac;150&#160;million and to be determined on the basis of the volume weighted average price (VWAP) of EUROAPI shares on the Euronext Paris regulated market over the&#160;thirty-day period starting from the date of initial listing, i.e. May&#160;6, 2022. On completion of those transactions, Sanofi holds an equity interest of 30.1% in EUROAPI, which it has undertaken to retain for at least two years from the date of the distribution, subject to the customary exceptions. With effect from that date, Sanofi exercises significant influence over EUROAPI as a result of (i)&#160;its equity interest, and (ii)&#160;having one representative on the EUROAPI Board of Directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On May&#160;3, 2022, the General Meeting of Sanofi shareholders approved the decision of the Board of Directors to distribute approximately 58% of the share capital of EUROAPI in the form of an exceptional dividend in kind.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On May&#160;10, 2022, the payment date of the dividend in kind in the days following the admission to listing of EUROAPI shares, those Sanofi shareholders who had retained their Sanofi shares received 1&#160;EUROAPI share per 23&#160;Sanofi shares, representing in total&#160;57.88% of the share capital of EUROAPI. As of that date, Sanofi lost control over the EUROAPI entities, based on an assessment of the criteria specified in IFRS&#160;10 (Consolidated financial statements). The assets and liabilities of EUROAPI, which since March&#160;17, 2022 had been presented as assets and liabilities held for sale within the Sanofi statement of financial position in accordance with IFRS&#160;5 (Non-Current Assets Held for Sale), were deconsolidated. In addition, because EUROAPI operations do not constitute a discontinued operation under IFRS&#160;5, the contribution from EUROAPI has not been presented within separate line items in the income statement and statement of cash flows or in information for prior comparative periods. The contribution of EUROAPI operations to the consolidated net sales of Sanofi in the year ended December&#160;31, 2021 was &#x20ac;486&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The principal consequences of the deconsolidation of EUROAPI are described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the derecognition of the carrying amount of all the assets and liabilities of EUROAPI, representing a net amount of &#x20ac;1,227&#160;million as of May&#160;10, 2022. This includes goodwill of &#x20ac;164&#160;million, determined in accordance with IAS&#160;36 (&#x201c;Impairment of Assets&#x201d;), which was historically allocated to the Pharmaceuticals cash generating unit (CGU), and which for the purposes of the deconsolidation was allocated using an alternative method based on the relative values of goodwill as of the date of consolidation (the &#x201c;notional goodwill method&#x201d;). That method was considered more appropriate to the capital-intensive nature of EUROAPI operations than the method based on the relative values of EUROAPI operations and the retained portion of the&#160;CGU;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;a reduction in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity attributable to equity holders &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;of Sanofi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; reflecting the distribution in kind, measured at &#x20ac;793&#160;million based on the weighted average price of &#x20ac;14.58 per share as of the date of delivery of the EUROAPI shares to Sanofi shareholders and corresponding to the fair value of the distribution in accordance with IFRIC&#160;17 (Distribution of Non-Cash Assets to Owners);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;a cash inflow of &#x20ac;150&#160;million from the divestment of 12% of the share capital of EUROAPI to EPIC Bpifrance as of the settlement date of the shares, i.e. June&#160;17, 2022;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the recognition in the statement of financial position, within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, of the retained 30.1% equity interest in EUROAPI at an amount of &#x20ac;413&#160;million, determined on the basis of the weighted average price of &#x20ac;14.58 per share and representing the fair value of the equity interest in accordance with IFRS&#160;10;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the reclassification within the net gain/loss on deconsolidation of unrealized foreign exchange losses amounting to &#x20ac;35&#160;million arising on EUROAPI subsidiaries, in accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the recognition of transaction-related costs and of the effects of undertakings made under agreements entered into with EUROAPI setting out the principles and terms of the legal reorganization carried out ahead of the date of deconsolidation. The principal undertakings made to EUROAPI relate to compensation for:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;environmental remediation obligations on non-operational chemical sites in France transferred to EUROAPI, amounting to&#160;&#x20ac;14 million, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;regulatory compliance costs relating to certain state-of-the-art active pharmaceutical ingredients of EUROAPI, capped at&#160;&#x20ac;15 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;These elements collectively resulted in a pre-tax loss on deconsolidation of &#x20ac;3&#160;million, presented within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other gains and losses, and litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the income statement. The tax effect of the deconsolidation was a net gain of &#x20ac;111 million, presented within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income tax expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;in the income statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The cash impact of the deconsolidation of EUROAPI, presented within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disposals of consolidated undertakings and investments accounted for using the equity method &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;in the statement of cash flows, was a net cash inflow of &#x20ac;101&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi has entered into an agreement with EUROAPI for the manufacture and supply of active pharmaceutical ingredients, intermediates and other substances, which took effect on October&#160;1, 2021 and expires five years after the loss of control. Under the terms of the agreement, Sanofi committed to target annual net sales of approximately &#x20ac;300&#160;million for a list of specified active ingredients until the agreement expires in 2026. As of December&#160;31, 2022, that commitment amounted to &#x20ac;1.1&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;With effect from the date of deconsolidation, the 30.1% equity interest in EUROAPI is accounted for using the equity method in accordance with IAS&#160;28 (Investments in Associates and Joint Ventures), and the share of EUROAPI profits or losses arising from application of the equity method is excluded from &#x201c;Business operating income&#x201d;, the non-IFRS financial indicator used internally by&#160;Sanofi to measure the performance of its operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;D.2. Principal changes in the scope of consolidation in 2021 and 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.2.1. Principal changes in the scope of consolidation in 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Kymab&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On April&#160;8, 2021, Sanofi acquired the entire share capital of Kymab for an upfront payment of $1.1 billion (&#x20ac;973 million) and up to&#160;$350 million contingent upon reaching certain development milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the KY1005 project, currently in Phase&#160;II clinical development, and relating to the human monoclonal antibody OX40L, an essential regulator of the immune system) concentrates substantially all of the fair value of the acquired set of activities and assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Of the total acquisition price paid, &#x20ac;965 million was allocated to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The impact of this acquisition as reflected within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions of consolidated undertakings and investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the consolidated statement of cash flows is a net cash outflow of &#x20ac;932 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Kiadis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On November&#160;2, 2020, Sanofi and Kiadis, a biopharmaceutical company developing novel "off-the-shelf" natural killer (NK) cell therapies for patients with life-threatening diseases, entered into a definitive agreement whereby Sanofi was to make a public offer to acquire the entire share capital of Kiadis, i.e. 61&#160;million shares, at a cash price of &#x20ac;5.45 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The acquisition was approved unanimously by the Boards of Directors of Sanofi and Kiadis, and 95.03% of the share capital of Kiadis had been tendered into the offer as of April&#160;16, 2021. As of the end of the post-closing acceptance period on April&#160;29, 2021, Sanofi held&#160;97.39% of the share capital of Kiadis, and proceeded to buy out the remaining non-controlling shareholders. As of&#160;December&#160;31, 2022, Sanofi held 100% of the share capital of Kiadis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the K-NK technology platform) concentrates substantially all of the fair value of the acquired set of activities and assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Of the total acquisition price paid, &#x20ac;339 million was allocated to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The impact of this acquisition as reflected within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions of consolidated undertakings and investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the consolidated statement of cash flows is a net cash outflow of &#x20ac;326 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Tidal&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On April&#160;9, 2021, Sanofi acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a unique mRNA-based approach for in vivo reprogramming of immune cells. The new technology platform will expand Sanofi&#x2019;s research capabilities in immuno-oncology and inflammatory diseases, and may have applicability to other disease areas as well.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Tidal Therapeutics was acquired for an upfront payment of $160&#160;million (&#x20ac;136&#160;million), and up to $310&#160;million contingent upon reaching certain development milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was accounted for as an asset acquisition given that the principal asset (the unique mRNA-based in vivo reprogramming technology) concentrates substantially all of the fair value of the acquired set of activities and assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Of the total acquisition price paid, &#x20ac;130&#160;million was allocated to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The impact of this acquisition as reflected within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions of consolidated undertakings and investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the consolidated statement of cash flows is a net cash outflow of &#x20ac;135&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Translate Bio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On August&#160;3, 2021, Sanofi entered into a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutics company, under which Sanofi was to acquire all outstanding shares of Translate Bio for $38 per share. The Sanofi and Translate Bio Boards of Directors unanimously approved the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The acquisition of Translate Bio by Sanofi was completed on September&#160;14, 2021, with Sanofi holding the entire share capital of Translate&#160;Bio upon expiration of the squeeze-out procedure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#x20ac;2,118&#160;million:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value at acquisition date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;396&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current and non-current assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;247&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shire contingent consideration liability (see Note&#160;D.18.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(323)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net assets of Translate Bio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;462&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,118&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,580&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The other intangible assets mainly comprise a messenger RNA technological platform applied to the development of vaccines and therapeutic agents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Goodwill mainly represents the effects of expected future synergies and other benefits to be derived from the integration of Translate Bio into the Sanofi group, in particular by accelerating the delivery of development programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Translate Bio has no commercial operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The impact of this acquisition as reflected within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions of consolidated undertakings and investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the consolidated statement of cash flows is a net cash outflow of &#x20ac;2,333&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under the terms of the collaboration agreement between Sanofi and Translate Bio as announced on June&#160;23, 2020, Sanofi held an equity interest of approximately 5% in Translate Bio. As of the date when Sanofi obtained control of Translate Bio, that interest was remeasured at the purchase price of $38 per share. The change in fair value was recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, in accordance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;with paragraph&#160;42 of IFRS&#160;3 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(see Note&#160;D.7.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Kadmon&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On September&#160;8, 2021, Sanofi entered into a definitive merger agreement with Kadmon, a biopharmaceutical company that discovers, develops and markets transformative therapies for disease areas with significant unmet medical needs. Shareholders of Kadmon common stock received $9.50 per share in cash, representing a transaction valued at $1.9&#160;billion on a fully-diluted basis. The Sanofi and Kadmon Boards of Directors unanimously approved the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The acquisition of Kadmon by Sanofi was completed on November&#160;9, 2021, with Sanofi holding the entire share capital of Kadmon upon expiration of the squeeze-out procedure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was therefore accounted for as an asset acquisition given that the principal asset (belumosudil, commercialized in the United States under the brand name Rezurock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;) concentrates substantially all of the fair value of the acquired set of activities and assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Of the total acquisition price paid, &#x20ac;1,739&#160;million was allocated to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The impact of this acquisition as reflected within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions of consolidated undertakings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;investments accounted for using the equity method &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;in the consolidated statement of cash flows is a net cash outflow of &#x20ac;1,575&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Origimm&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On December&#160;3, 2021, Sanofi acquired the entire share capital of Origimm Biotechnology GmbH, a privately owned Austrian biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria that cause skin diseases such as acne, for an upfront payment of &#x20ac;55&#160;million and up to &#x20ac;95&#160;million contingent upon reaching certain development and regulatory milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi elected to apply the optional test to identify concentration of fair value under paragraph&#160;B7A of IFRS&#160;3. The transaction was therefore accounted for as an asset acquisition given that the principal asset (the group of Propionibacterium acnes antigens) concentrates substantially all of the fair value of the acquired set of activities and assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Nearly &#x20ac;55&#160;million of the acquisition price paid was allocated to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in accordance with IAS&#160;38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed as part of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The impact of this acquisition as reflected within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions of consolidated undertakings and investments accounted for using the equity method &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;in the consolidated statement of cash flows for the year ended December&#160;31, 2021 is a net cash outflow of&#160;&#x20ac;50&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.2.2. Principal changes in the scope of consolidation in 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisition of Principia&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On August&#160;17, 2020, Sanofi and Principia Biopharma&#160;Inc. (&#x201c;Principia&#x201d;), a late-stage biopharmaceutical company focused on developing treatments for autoimmune diseases, entered into a definitive agreement under which Sanofi was to acquire all the outstanding shares of Principia for $100 per share. The transaction was approved unanimously by the Boards of Directors of Sanofi and Principia. Sanofi's acquisition of Principia was completed on September&#160;28, 2020, with Sanofi holding the entire share capital of Principia upon expiration of the squeeze-out procedure. The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#x20ac;912 million:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value at acquisition date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,534&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current and non-current assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;186&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net deferred tax position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(436)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net assets of Principia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,246&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;912&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,158&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The other intangible assets mainly comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;rilzabrutinib (PRN&#160;1008), a molecule undergoing clinical trials for various indications in immuno-inflammatory diseases and rare blood disorders; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;tolebrutinib (PRN&#160;2246/SAR442168), a molecule currently undergoing clinical trials for the treatment of multiple sclerosis and other diseases of the central nervous system.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Goodwill represents (i)&#160;the pipeline of future products in pre-clinical research and development; (ii)&#160;the capacity to draw on a specialized structure to refresh the existing product portfolio; and (iii)&#160;the competencies of Principia staff.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;No material adjustment was required on completion of the final purchase price allocation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisition of Synthorx&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On December&#160;9, 2019, Sanofi and Synthorx&#160;Inc. (&#x201c;Synthorx&#x201d;), a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, entered into a definitive agreement under which Sanofi was to acquire all of the outstanding shares of Synthorx for $68 per share. The transaction was unanimously approved by both the Sanofi and Synthorx Boards of Directors. On December&#160;23, 2019, Sanofi launched a public tender offer to acquire all of the outstanding ordinary shares of Synthorx for $68 per share in cash, without interest and net of any applicable withholding taxes. The acquisition of Synthorx was completed on January&#160;23, 2020, with Sanofi holding the entire share capital of Synthorx upon expiration of the squeeze-out procedure. The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#x20ac;930&#160;million:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value at acquisition date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,549&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current and non-current assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net deferred tax position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net assets of Synthorx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,316&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;930&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,246&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The other intangible assets mainly comprise THOR-707, a molecule currently in Phase&#160;I clinical trials that stimulates T&#160;lymphocytes, and as such has potential as a cancer immunotherapy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Goodwill represents (i)&#160;the pipeline of future products in pre-clinical research and development; (ii)&#160;the capacity to draw on a specialized structure to refresh the existing product portfolio; (iii)&#160;the competencies of Synthorx staff; (iv)&#160;benefits derived from the creation of new growth platforms; and (v)&#160;expected future synergies and other benefits from the combination of Synthorx and Sanofi.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The goodwill generated on this acquisition did not give rise to any deduction for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;No material adjustment was required on completion of the final purchase price allocation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Transaction related to the equity-accounted investment in Regeneron&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;From the beginning of April&#160;2014, Sanofi accounted for its investment in Regeneron using the equity method. As from that date, in accordance with the Investor Agreement as amended in early 2014, Sanofi had the right to designate a member of the Regeneron Board of Directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On May&#160;29, 2020, Sanofi closed the transaction announced on May&#160;25, 2020 involving the sale of its equity investment in Regeneron (with the exception of 400,000&#160;shares), through (i)&#160;a registered public offering in the United States and internationally and (ii)&#160;a share repurchase by Regeneron. Sanofi divested 13&#160;million shares of Regeneron common stock (of which&#160;10.6&#160;million were sold by Sanofi) through the public offering at a price of $515 per share, raising a total amount of&#160;$6,703&#160;million; and Regeneron repurchased 9.8&#160;million of its own shares of common stock directly from Sanofi for&#160;$5,000&#160;million, at the offer price less a subscription discount ($509.85 per share). The total sale proceeds (before transaction-related costs) amounted to &#x20ac;10,575&#160;million. At the same time, Sanofi as a result of this transaction lost the right to designate a member of the Regeneron Board of Directors under the amended Investor Agreement. Finally, as of May&#160;29, 2020 Sanofi retained ownership of 400,000&#160;Regeneron shares in order to continue to partially fund its commitments to invest in the development programs for cemiplimab (REGN2810) and dupilumab, in line with the 2018 Letter Agreement under which Sanofi is permitted to sell up to 1.4&#160;million shares through the end of 2020. As of December 31, 2022, Sanofi had sold 779,320&#160;Regeneron shares under that agreement. The number of Regeneron shares retained by Sanofi is 279,766 as of December&#160;31, 2021 (see&#160;Note&#160;C.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi&#x2019;s equity investment in Regeneron was accounted for by the equity method until May&#160;29, 2020. As of that date, the carrying amount of the investment was &#x20ac;3,668&#160;million; that amount was reversed out on closing of the transaction. Before tax effects, the gain on the divestment amounted to &#x20ac;7,382&#160;million, including (i)&#160;a gain of &#x20ac;318&#160;million arising on the currency translation reserve associated with Regeneron, which was taken to profit or loss in accordance with IAS&#160;21; (ii)&#160;the deduction of transaction-related costs of &#x20ac;64&#160;million; and&#160;(iii)&#160;a gain of &#x20ac;157&#160;million on the remeasurement of the 400,000&#160;retained shares at their quoted market price as of May&#160;29, 2020 ($612.81). In accordance with IFRS&#160;9 (Financial Instruments), the retained shares were classified in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x201c;Equity instruments at fair value through other comprehensive income&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;category on the transaction date, at a value of &#x20ac;221&#160;million (see Note&#160;D.7.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The tax charge arising on the transaction was &#x20ac;502&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Given the material impact of this transaction, and to facilitate users&#x2019; understanding of the financial statements, the pre-tax gain on this transaction is presented as a separate line item in the consolidated income statement, &#x201c;Gain on Regeneron investment arising from the transaction of May&#160;29, 2020&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The net cash inflow from the transaction was &#x20ac;10,370&#160;million, which (for the reason cited above) is presented as a separate line item in the consolidated statement of cash flows, &#x201c;Net proceeds from sale of Regeneron shares on May&#160;29, 2020&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Sale of Seprafilm&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On November&#160;27, 2019, Sanofi entered into a definitive agreement to sell Seprafilm&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;to Baxter. The sale was completed on&#160;February&#160;14,&#160;2020. Sanofi recognized a pre-tax gain of &#x20ac;129&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The impact of this sale, reflected in the line item&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; within the consolidated statement of cash flows, was a net cash inflow before tax of&#160;&#x20ac;311&#160;million.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock>
    <ifrs-full:CashTransferred
      contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDU1_43992b91-26fb-48ab-9ae4-8d59b551f218"
      unitRef="eur">970000000</ifrs-full:CashTransferred>
    <sny:CommitmentsRelatedToMilestonePaymentsBusinessCombinations
      contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDYz_787b690d-5a5f-4958-8316-bbeb758c655d"
      unitRef="usd">225000000</sny:CommitmentsRelatedToMilestonePaymentsBusinessCombinations>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDcw_934fbad8-b30f-4113-9655-5507078f3e63"
      unitRef="eur">156000000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzI2OTM4MDM0OTEyMTMz_74b8526d-ef3d-4aa4-9fa5-42392850c720">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation led to the recognition of &#x20ac;609&#160;million of goodwill, determined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value at acquisition date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;493&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current and non-current assets and liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;118&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net assets of Amunix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;517&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;609&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,126&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#x20ac;2,118&#160;million:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value at acquisition date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;396&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current and non-current assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;247&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shire contingent consideration liability (see Note&#160;D.18.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(323)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net assets of Translate Bio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;462&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,118&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,580&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#x20ac;912 million:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value at acquisition date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,534&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current and non-current assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;186&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net deferred tax position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(436)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net assets of Principia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,246&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;912&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,158&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of &#x20ac;930&#160;million:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value at acquisition date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,549&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current and non-current assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net deferred tax position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net assets of Synthorx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,316&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;930&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,246&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDc4_0e0bffe2-ee22-4124-82a4-d4de7e767f9d"
      unitRef="eur">609000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzEtMS0xLTEtNDExMjM0_1cf60165-8398-46a6-8aee-fa3be6913c62"
      unitRef="eur">493000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <sny:OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate
      contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzQtMS0xLTEtNDExMjQ0_2666674e-6a28-4a9f-a6b1-556e70032b86"
      unitRef="eur">-13000000</sny:OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzUtMS0xLTEtNDExMjQ0_7a4fd7e8-cc57-46d3-b713-ad8c7e121bf5"
      unitRef="eur">118000000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzYtMS0xLTEtNDExMjQ0_a7a4162c-5357-497a-8b5e-1a85eee9b265"
      unitRef="eur">81000000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzctMS0xLTEtNDExMjQ0_52a4efab-806b-403e-9072-fac0f6b215cc"
      unitRef="eur">517000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzgtMS0xLTEtNDExMjQ0_eebca1a0-183c-40db-ac65-ebd768a2359d"
      unitRef="eur">609000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="ia24e436ffce44c968c4694148c6aaf8d_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90YWJsZToyYTU0MGZiZDdiNGE0YTY5OWI5ZTljMzc2ZDMxYjQwYS90YWJsZXJhbmdlOjJhNTQwZmJkN2I0YTRhNjk5YjllOWMzNzZkMzFiNDBhXzktMS0xLTEtNDExMjQ0_e43da90e-55fa-461a-836f-f635d67e75da"
      unitRef="eur">1126000000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="i65f4119d82404c94a1b140ad21401ade_D20220208-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDg2_e24ec0f0-4bda-4c1f-ab5f-b27ea1d19a4c"
      unitRef="eur">-56000000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="i65f4119d82404c94a1b140ad21401ade_D20220208-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzI3MDk1_efdd6b68-197d-4966-90d1-c1bb7bf16e29"
      unitRef="eur">852000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <sny:ExceptionalSupplementaryDividendProposedPercentageOfShareCapital
      contextRef="i8fc2b038dd1b4b99af69531ba3b92293_D20220317-20220317"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTMzODQ_99d23af7-4392-4928-9d51-9010d4e74d59"
      unitRef="number">580000</sny:ExceptionalSupplementaryDividendProposedPercentageOfShareCapital>
    <sny:PercentageOfVotingEquityInterestsDivested
      contextRef="i8ae83ecb331f49f8875bcbe2fd731a7e_I20220317"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTMzODg_77b64eb9-9eb3-46fd-8f51-c822ff4f2413"
      unitRef="number">120000</sny:PercentageOfVotingEquityInterestsDivested>
    <sny:ConsiderationTransferredMaximumAmount
      contextRef="i5cb73aa7ccfe4ce5ae53a260cb785a4c_D20220317-20220317"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTMzOTI_ac9b5544-090e-4d28-963b-ad92eba6c45f"
      unitRef="eur">150000000</sny:ConsiderationTransferredMaximumAmount>
    <sny:ConsiderationTransferredValuationPeriod
      contextRef="i5cb73aa7ccfe4ce5ae53a260cb785a4c_D20220317-20220317"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzI2OTM4MDM0OTEyMTE3_f7ac03ba-feab-4d1d-a1a4-ec5427e6fe12">P30D</sny:ConsiderationTransferredValuationPeriod>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="id97d7b03002b4aba8b5f84d88ed212ab_D20220510-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzgwODE0MTA0NjkyMzkz_1f8e9100-9167-4f1e-91d4-a0901aaf46a9"
      unitRef="number">0.301</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <sny:OwnershipInterestInSubsidiaryMinimumHoldingPeriod
      contextRef="ib9f02c4c8a3b46c8b47a31e54332ecc1_D20220510-20220510"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzI2OTM4MDM0OTEyMTE4_c0103bd6-ea6f-4b69-88e7-395fb375f33e">P2Y</sny:OwnershipInterestInSubsidiaryMinimumHoldingPeriod>
    <sny:ExceptionalSupplementaryDividendPercentageOfShareCapital
      contextRef="i75540facaacb400d8502084443749f05_D20220503-20220503"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0MjE_4659817a-21d2-4c08-be47-b2a50c5a8ffb"
      unitRef="number">0.58</sny:ExceptionalSupplementaryDividendPercentageOfShareCapital>
    <sny:SpecialDistributionSharesReceivedPerConversionOfParentShares
      contextRef="i869e6282be074d28b9a1712822c9f46b_I20220510"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzMxNzUx_f1c4062d-ff10-4542-9e1c-38aafcc33648"
      unitRef="shares">1</sny:SpecialDistributionSharesReceivedPerConversionOfParentShares>
    <sny:SpecialDistributionNumberOfSharesConverted
      contextRef="i869e6282be074d28b9a1712822c9f46b_I20220510"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzE5NzkxMjA5MzMxNzU0_9ab304be-f7be-4f6e-a145-6d1f3f707b8b"
      unitRef="shares">23</sny:SpecialDistributionNumberOfSharesConverted>
    <sny:SpecialDistributionPercentageOfShareCapitalDistributed
      contextRef="i869e6282be074d28b9a1712822c9f46b_I20220510"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0MjY_1ebcb667-e462-4c5c-92ac-03e6f128f51e"
      unitRef="number">0.5788</sny:SpecialDistributionPercentageOfShareCapitalDistributed>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i31105a7d607d4af49033461835874947_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0MzA_7d23d005-5925-407c-8ed5-a4ba0c9744fc"
      unitRef="eur">486000000</ifrs-full:RevenueFromSaleOfGoods>
    <sny:DecreaseThroughLossOfControlOfSubsidiaryNetAssets
      contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0NDI_fa3925cc-ca67-4b46-940b-e93809551e6f"
      unitRef="eur">1227000000</sny:DecreaseThroughLossOfControlOfSubsidiaryNetAssets>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill
      contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0NTQ_b1c49a6e-5c76-4677-83cd-b5ad54f02cf5"
      unitRef="eur">164000000</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill>
    <sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="ib7243c961f6042ffa9e07051ace68d7b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0NjY_5f4b2acc-6827-4003-b32c-0acf77491343"
      unitRef="eur">793000000</sny:ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0OTI_65dfeff8-ff7c-4b8f-b214-1d617ed037d3"
      unitRef="eurPerShare">14.58</ifrs-full:WeightedAverageSharePrice2019>
    <sny:ConsiderationTransferredMaximumAmount
      contextRef="i1363015e33be4996b0e8a89139d4895f_D20220617-20220617"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM0OTY_a1575755-ffa9-47da-afdb-6f4bc7cd67e2"
      unitRef="eur">150000000</sny:ConsiderationTransferredMaximumAmount>
    <sny:PercentageOfVotingEquityInterestsDivested
      contextRef="i50fb7abe554a4e5b9bda9e50cdfd1966_I20220617"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1MDg_05ae8655-a056-4a08-a8b5-95a58147931c"
      unitRef="number">120000</sny:PercentageOfVotingEquityInterestsDivested>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="id97d7b03002b4aba8b5f84d88ed212ab_D20220510-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1MTI_2ccba3da-50d2-4152-be2f-ca5f04a06ae6"
      unitRef="number">0.301</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="ifc8f06a841e6428180d8121555e73740_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1MTY_2f63d3ee-1b85-408d-b82e-04b476c952e0"
      unitRef="eur">413000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1Mjg_33dde466-16dd-48e4-a728-f60429e6bd32"
      unitRef="eurPerShare">14.58</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1MzI_9e87a9d9-9029-449d-80ec-d4f13de95e5a"
      unitRef="eur">35000000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:OtherProvisions
      contextRef="i67af3f0fc7dd4b2eaa2a63d60e4251a0_I20220510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1NDY_cf8e3c2c-3f3e-4085-9ca2-50d6e2934129"
      unitRef="eur">14000000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="ieddf1529368346c285a415c5ccebe6b7_I20220510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1NTg_1375f2d0-51f9-496c-96a8-3b3e90ad1e27"
      unitRef="eur">15000000</ifrs-full:OtherProvisions>
    <sny:OtherGainsLossesAndLitigation
      contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzI2OTM4MDM0OTEyMTIw_bd174f10-ba50-4b1d-995c-75443492b02e"
      unitRef="eur">3000000</sny:OtherGainsLossesAndLitigation>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1ODI_0e57aa25-e39b-4b43-a0a1-5cc5081c0201"
      unitRef="eur">-111000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="iddcaadb296914d7093323a235a8de38b_D20220510-20220510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM1OTQ_6d35a61e-f444-4997-bbbb-7d442b4906fd"
      unitRef="eur">101000000</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <sny:CollaborationAgreementPeriodAfterLossOfControl
      contextRef="i34419df6f45d4271bd03deeb7650e44d_D20211001-20211001"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzQzNDMwNzA5MzI4Nzc3_780555bd-367c-4420-83b4-38db314a8f78">P5Y</sny:CollaborationAgreementPeriodAfterLossOfControl>
    <sny:CollaborationAgreementAnnualNetSalesTarget
      contextRef="i2b3edabed67d4c528f7b9b3aa5532b9e_I20211001"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM2MTA_e0103040-0fdb-43ae-a8c6-dea069b036e8"
      unitRef="eur">300000000</sny:CollaborationAgreementAnnualNetSalesTarget>
    <sny:CollaborationAgreementCommitmentAmount
      contextRef="i77db5a6ce6f941378dabe84d0fb99691_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM2MjI_1ba7bf8b-9ebf-4648-9d21-f1091d29c214"
      unitRef="eur">1100000000</sny:CollaborationAgreementCommitmentAmount>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="id97d7b03002b4aba8b5f84d88ed212ab_D20220510-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTIvZnJhZzo2MGYwYTYyOWRhZDU0NDM0YjA5Y2RhZDc5MDc5NjBiNy90ZXh0cmVnaW9uOjYwZjBhNjI5ZGFkNTQ0MzRiMDljZGFkNzkwNzk2MGI3XzY1OTcwNjk3OTM2MzQ_93defab6-944e-45f2-8ec3-40715744e80f"
      unitRef="number">0.301</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:CashTransferred
      contextRef="iee572facf17d4fcf8b3895371e7c97f1_I20210408"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEwMDIz_8f2c923a-dc45-4224-a67a-a14dc0e15ca9"
      unitRef="usd">1100000000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="iee572facf17d4fcf8b3895371e7c97f1_I20210408"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEwMDI4_10f13e63-0116-450b-84ca-b37a624c6eca"
      unitRef="eur">973000000</ifrs-full:CashTransferred>
    <sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements
      contextRef="iee572facf17d4fcf8b3895371e7c97f1_I20210408"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEwMDQz_f0b0b282-61ea-4182-941e-c41f21604662"
      unitRef="usd">350000000</sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="iee572facf17d4fcf8b3895371e7c97f1_I20210408"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEwNjAx_52080e36-9af5-4ab5-bb92-86c9c31dcf79"
      unitRef="eur">965000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="i4b42acc0514d4e10970ac15d3afcb8ad_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTExMDU3_66654add-78bf-4a28-ab57-7439c94f1327"
      unitRef="eur">932000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <sny:BusinessCombinationNumberOfSharesIncludedInPublicOffering
      contextRef="i11073bbcc0a14c62b570fb898e98d18d_I20201102"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTExMzk1_df5706a4-64af-4e5d-8f96-98d4b53d8593"
      unitRef="shares">61000000</sny:BusinessCombinationNumberOfSharesIncludedInPublicOffering>
    <sny:BusinessCombinationPurchasePricePerShare
      contextRef="i11073bbcc0a14c62b570fb898e98d18d_I20201102"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTExNDI3_1c58b627-a7e5-4686-893a-f67ee34d0b19"
      unitRef="eurPerShare">5.45</sny:BusinessCombinationPurchasePricePerShare>
    <sny:BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering
      contextRef="ifa7ce4e64a0145088c122905f0dc3331_D20210416-20210416"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTExNTM2_6b127592-fa3e-48e4-b10a-6b414f154fba"
      unitRef="number">0.9503</sny:BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i3392c86b77ce4ec1ae56d2c26b0f10f0_D20210429-20210429"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTExNzA5_49a4f9cf-176c-4f74-91af-29e4b2880811"
      unitRef="number">0.9739</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <sny:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzgzMDEzMTI3OTI4NDc3_9e205536-7685-4f1f-85e6-a9e69b52a506"
      unitRef="number">1</sny:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="i1e3f5c0fbd854b0887ac60561bc8bbe1_I20210429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEyMjA1_e1571cf2-9cfe-4078-b35f-2b646a8f74df"
      unitRef="eur">339000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="ib1ab1eca87aa42b79b79ae7cb8a40079_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTEyNjYx_ce46836b-ea03-408f-a94e-a339845226a0"
      unitRef="eur">326000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashTransferred
      contextRef="i37e52c8c761c4a2c94bcd4c10a298624_I20210409"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjM1_19cf4c9a-e446-4ad4-a60e-2400bf5babee"
      unitRef="usd">160000000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="i37e52c8c761c4a2c94bcd4c10a298624_I20210409"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjQy_4edbd46e-05b1-4a6d-b03b-dca8d8fbac32"
      unitRef="eur">136000000</ifrs-full:CashTransferred>
    <sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements
      contextRef="i91ee802320a44a84b28df3ca02a2a4c6_I20210409"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjUx_12e8fe2d-fa58-4e8e-b6fe-5f525d4c0c61"
      unitRef="usd">310000000</sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="i91ee802320a44a84b28df3ca02a2a4c6_I20210409"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjYx_a1ae24a5-a040-49da-a51a-f024ab97b9a6"
      unitRef="eur">130000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="i50186dc8e2144cf580cb8c90422239bc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjgx_5c0cb9df-9975-431e-9486-051ea60e98a1"
      unitRef="eur">135000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <sny:BusinessCombinationPurchasePricePerShare
      contextRef="i779663ca39724fff9eb372087b37e45b_I20210803"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMTk0_58a98f32-3581-49ce-b782-93f4531544ba"
      unitRef="usdPerShare">0.38</sny:BusinessCombinationPurchasePricePerShare>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjAw_9b2fab91-aa10-4c52-86df-14e14d47e832"
      unitRef="eur">2118000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzEtMS0xLTEtNDQ5Mzg5_9621582e-b9f2-45ed-8b10-e841d0a4e248"
      unitRef="eur">396000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzItMS0xLTEtNDQ5Mzg5_46e46ae6-dfbf-47e7-9e8b-cd6c1ca887a3"
      unitRef="eur">93000000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <sny:OtherAssetsAndLiabilitiesAsOfAcquisitionDate
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzMtMS0xLTEtNDQ5Mzg5_85840ab3-24cc-447c-adea-42357acb2f13"
      unitRef="eur">235000000</sny:OtherAssetsAndLiabilitiesAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzQtMS0xLTEtNDQ5Mzg5_669ef288-7fc8-4862-9a58-1055fac55b86"
      unitRef="eur">247000000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzUtMS0xLTEtNDQ5Mzg5_adb05b92-6cbf-489f-93ff-c2310d1f0f04"
      unitRef="eur">323000000</ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzctMS0xLTEtNDQ5Mzg5_ff871faf-ce58-4695-a1bb-a412c38c2f5f"
      unitRef="eur">462000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzgtMS0xLTEtNDQ5Mzgx_afaca4b7-f970-4563-b54f-fe0a8b8715d5"
      unitRef="eur">2118000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <sny:PurchasePrice
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTowYjk4ZTkzMDExNTU0NmIwODA5ZTQ3MTY4MjZjZjUxMS90YWJsZXJhbmdlOjBiOThlOTMwMTE1NTQ2YjA4MDllNDcxNjgyNmNmNTExXzktMS0xLTEtNDY5NzYx_a7ec53a4-294e-45f1-980a-c70bf0d82ceb"
      unitRef="eur">2580000000</sny:PurchasePrice>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="i0befa4372a524fab81e8c4d403d76062_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjEz_759b5977-5754-4ebc-86bb-2cdc7e4a78de"
      unitRef="eur">2333000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage
      contextRef="i81cc2b2f8e09437a9a99b63d42e7b55e_I20200623"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjIx_815f4766-f73e-47ee-bbd6-ad5454f79056"
      unitRef="number">0.05</sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage>
    <sny:BusinessCombinationPurchasePricePerShare
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzU5MzczNjI3OTMxMjI2_026797ba-f2d2-462b-9e98-aeb53c20c7b1"
      unitRef="usdPerShare">0.38</sny:BusinessCombinationPurchasePricePerShare>
    <sny:BusinessCombinationPurchasePricePerShare
      contextRef="i8bf9f268a35e45dbace519548e4267f3_I20211109"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNDAw_852d9783-c386-4ffd-a5c3-e423ecc06fbb"
      unitRef="usdPerShare">9.50</sny:BusinessCombinationPurchasePricePerShare>
    <sny:BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis
      contextRef="i8bf9f268a35e45dbace519548e4267f3_I20211109"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExMzgw_5ae75765-9540-42c0-b957-e33e10344e1f"
      unitRef="usd">1900000000</sny:BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="i8bf9f268a35e45dbace519548e4267f3_I20211109"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNTE5_e3b807fb-f87d-47dd-8078-246bd17c3e4b"
      unitRef="eur">1739000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="i1e41032ba4984bdcbc1251beafa9fb22_D20211109-20211109"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNDg3_90bc85ee-7a40-442f-94b8-c4eb36100e91"
      unitRef="eur">-1575000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashTransferred
      contextRef="i4ba12f5a779c416ea0550b3a72a82b6c_I20211203"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNDMy_9dda7ca3-176e-4e9c-9f21-0003060cd991"
      unitRef="eur">55000000</ifrs-full:CashTransferred>
    <sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements
      contextRef="i4ba12f5a779c416ea0550b3a72a82b6c_I20211203"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNDU4_b83a64e4-c71a-4bea-aab9-37d749ccd64a"
      unitRef="eur">95000000</sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="i4ba12f5a779c416ea0550b3a72a82b6c_I20211203"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNTQ4_aeaa83cb-efae-4746-8c80-f3bb8bae1999"
      unitRef="eur">55000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="iab5f424031af478da77b305846219403_D20211203-20211203"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExMzIy_9ef62650-eadf-4d2d-9efc-caf917688e87"
      unitRef="eur">-50000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <sny:BusinessCombinationPurchasePricePerShare
      contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNDEz_377eb56a-d3aa-4c39-a5b9-500d0f9320bc"
      unitRef="usdPerShare">100</sny:BusinessCombinationPurchasePricePerShare>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMDk2OTU0_1e535492-bdef-48c9-acbe-6f7ce25f54c9"
      unitRef="eur">912000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzEtMS0xLTEtNDA0NTE2_235a2fa3-7c57-4244-9456-63196103174c"
      unitRef="eur">2534000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <sny:OtherAssetsAndLiabilitiesAsOfAcquisitionDate
      contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzQtMS0xLTEtNDA0NTE2_70791c00-8f17-43c8-b5e6-01c1fb77ef22"
      unitRef="eur">-38000000</sny:OtherAssetsAndLiabilitiesAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzUtMS0xLTEtNDA0NTE2_e3b4f165-e945-4989-9ff5-5f3d36712fe7"
      unitRef="eur">186000000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzYtMS0xLTEtNDA0NTE2_7cdf5bc8-1907-415d-84c0-a5072a65c887"
      unitRef="eur">436000000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzctMS0xLTEtNDA0NTE2_f7f6253a-03a4-409a-8678-8b7a9b11b09b"
      unitRef="eur">2246000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzgtMS0xLTEtNDA0NTE2_7bfc2bbe-2b2a-45cf-80ea-bdbc9bdecaf5"
      unitRef="eur">912000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <sny:PurchasePrice
      contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTphZWM3ODE3YjgzM2M0OTliYWRjNTcyMGIwNjQzZjE3ZS90YWJsZXJhbmdlOmFlYzc4MTdiODMzYzQ5OWJhZGM1NzIwYjA2NDNmMTdlXzktMS0xLTEtNDUyMTU0_31d537d5-6aee-4b01-a932-25c10a0d82aa"
      unitRef="eur">3158000000</sny:PurchasePrice>
    <sny:BusinessCombinationPurchasePricePerShare
      contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMDk4MTA2_2cd353b1-e3d0-4aa9-81d3-60af2493868e"
      unitRef="usdPerShare">68</sny:BusinessCombinationPurchasePricePerShare>
    <sny:BusinessCombinationPurchasePricePerShare
      contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMDk4MzQx_ae591721-0bf8-4886-bf9c-558051e31e51"
      unitRef="usdPerShare">68</sny:BusinessCombinationPurchasePricePerShare>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI5MTM3MDU4MTY3MTk1_3a149b95-7898-406f-aeb7-24995359d3df"
      unitRef="eur">930000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzEtMS0xLTEtNDQ5NDI4_48b73196-5f85-43e3-a6cd-27d345887d45"
      unitRef="eur">1549000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <sny:OtherAssetsAndLiabilitiesAsOfAcquisitionDate
      contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzItMS0xLTEtNDQ5NDI4_99494c61-9fb8-4fda-847b-400e2d8b384f"
      unitRef="eur">36000000</sny:OtherAssetsAndLiabilitiesAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzMtMS0xLTEtNDQ5NDI4_bba3fd62-51a2-48ed-a2ac-91e53925f4cc"
      unitRef="eur">269000000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzQtMS0xLTEtNDQ5NDI4_7441df28-0cee-403f-b5ef-daa7bb7dd3a7"
      unitRef="eur">1316000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzUtMS0xLTEtNDQ5NDI4_e02016ba-cd22-4041-a4d5-b16c4acdcc89"
      unitRef="eur">930000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <sny:PurchasePrice
      contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90YWJsZTplM2I0MjMzMDVjY2I0OGU5YjhlZDA4ZTg3ZWY2ZjU4OS90YWJsZXJhbmdlOmUzYjQyMzMwNWNjYjQ4ZTliOGVkMDhlODdlZjZmNTg5XzYtMS0xLTEtNDQ5NDI4_8a1c5646-35c8-4e20-9874-911e62a62434"
      unitRef="eur">2246000000</sny:PurchasePrice>
    <sny:NonCurrentFinancialAssetsNumberOfShares
      contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMDk5OTgx_b1899b5b-a606-4d8a-aab2-62839945c45f"
      unitRef="shares">400000</sny:NonCurrentFinancialAssetsNumberOfShares>
    <sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal
      contextRef="id3e2037ecf8e496eaf3ae27c42505f70_D20200529-20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwMTM0_f8b89553-d6a9-4804-9744-b719ce6da231"
      unitRef="shares">13000000</sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal>
    <sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal
      contextRef="i502d25752fbb41198b743f7ae7a986d8_D20200529-20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzI2OTM4MDM0OTExNTg2_cfd6aa17-dd36-4694-9216-84b1472f7fb2"
      unitRef="shares">10600000</sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal>
    <sny:SaleOfStockPricePerShare
      contextRef="i87164f7d070f43bebcd477c11338759b_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwMjQ5_833fc7e9-8a53-4030-8531-2e3963fd22ec"
      unitRef="usdPerShare">515</sny:SaleOfStockPricePerShare>
    <sny:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts
      contextRef="id3e2037ecf8e496eaf3ae27c42505f70_D20200529-20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwMjkw_4dce3a3b-8cf1-497b-8066-a19ac1143a1a"
      unitRef="usd">6703000000</sny:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts>
    <sny:SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i5e547fa7f10d4ba49513412e133bcd62_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwMzIx_ad8df81a-ba9d-4fcb-8483-e840576c6a58"
      unitRef="shares">9800000</sny:SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction>
    <sny:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts
      contextRef="i169847bcb5da4bf9a458b8021feaeb0c_D20200529-20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwMzg0_0cab1d9d-5486-4eb2-8238-d780757d5487"
      unitRef="usd">5000000000</sny:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts>
    <sny:SaleOfStockPricePerShare
      contextRef="i5e547fa7f10d4ba49513412e133bcd62_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwNDM4_86f76ab8-3145-4c5e-8083-5021ef025ffe"
      unitRef="usdPerShare">509.85</sny:SaleOfStockPricePerShare>
    <sny:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts
      contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwNTI1_3308150f-7bf8-4587-b7f4-be4814ed274f"
      unitRef="eur">10575000000</sny:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts>
    <sny:NonCurrentFinancialAssetsNumberOfShares
      contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwNzU1_36cecce9-6635-43eb-a752-baa5d0b946a4"
      unitRef="shares">400000</sny:NonCurrentFinancialAssetsNumberOfShares>
    <sny:AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts
      contextRef="i755f9def05814a168296cd241a1146d3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAwOTk1_ef31ac62-f95d-4a57-9e4b-544cd471489d"
      unitRef="shares">1400000</sny:AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts>
    <sny:SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement
      contextRef="i0f42c6e0f02b45889491a52aa65d4c26_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxMDU4_bedbfe75-6f88-4ff1-b247-081a76208d15"
      unitRef="shares">779320</sny:SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement>
    <sny:NonCurrentFinancialAssetsNumberOfShares
      contextRef="i7727cfd3e20341039f39e0046c5ed90b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxMTU0_2de8647d-96c7-4c3f-a7cd-2d3481452561"
      unitRef="shares">279766</sny:NonCurrentFinancialAssetsNumberOfShares>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxMzU3_9ab6b756-4ddf-4c76-8f0f-0d5ddc36e952"
      unitRef="eur">3668000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:GainsOnDisposalsOfInvestments
      contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxNDgx_32642316-75cb-46b4-a5bf-3611365d4c32"
      unitRef="eur">7382000000</ifrs-full:GainsOnDisposalsOfInvestments>
    <ifrs-full:GainsOnDisposalsOfInvestments
      contextRef="ie109280c1ab2461ab5fe2322cf084ae3_D20200529-20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxNTEw_1e5ce08d-369f-475c-aa7f-b6afb2785521"
      unitRef="eur">318000000</ifrs-full:GainsOnDisposalsOfInvestments>
    <sny:SaleOfStockTransactionCosts
      contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxNjk3_97981743-334a-409f-86c0-a089356e0394"
      unitRef="eur">64000000</sny:SaleOfStockTransactionCosts>
    <ifrs-full:GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax
      contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxNzIy_9796f7ab-4da6-4246-9f55-f3112af75c50"
      unitRef="eur">157000000</ifrs-full:GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax>
    <sny:NonCurrentFinancialAssetsNumberOfShares
      contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxNzU0_384b16b5-662c-44bb-8f27-b3cc6d07c652"
      unitRef="shares">400000</sny:NonCurrentFinancialAssetsNumberOfShares>
    <sny:StockMarketPricePerShare
      contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAxODI0_8d57304e-5c50-4d02-9997-f872a559d33b"
      unitRef="usdPerShare">612.81</sny:StockMarketPricePerShare>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAyMDQy_26308644-4d34-4581-b360-dd0e0c2fed8e"
      unitRef="eur">221000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <sny:TaxExpenseOnDisposalOfInvestment
      contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAyMTEw_b19a0ca2-d982-488f-b99a-37203d750ae1"
      unitRef="eur">502000000</sny:TaxExpenseOnDisposalOfInvestment>
    <ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod
      contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAyNDYz_d35c058e-41fe-4a38-8070-b6ec06da3216"
      unitRef="eur">10370000000</ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:GainsOnDisposalsOfNoncurrentAssets
      contextRef="i0ae209da62af48d0802dbf6f8ad4a942_D20200214-20200214"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAyODQw_b21db766-f934-484a-a152-9dd1c0b2ae15"
      unitRef="eur">129000000</ifrs-full:GainsOnDisposalsOfNoncurrentAssets>
    <ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="i0ae209da62af48d0802dbf6f8ad4a942_D20200214-20200214"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTUvZnJhZzo4MmM0MmYxMjYzZmE0MWZlOGJkNTYyNDUxMTQ5YjAwZC90ZXh0cmVnaW9uOjgyYzQyZjEyNjNmYTQxZmU4YmQ1NjI0NTExNDliMDBkXzM1MTg0MzcyMTAzMTAw_328acd91-3475-4dad-93b6-9c37ca5a3baa"
      unitRef="eur">311000000</ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0MzI_e3e3e60a-23a8-4fdc-a9ab-8889fd14d38e">Property, plant and equipment&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.3.1. Property, plant and equipment owned&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment owned by Sanofi is comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Machinery&lt;br/&gt;and&lt;br/&gt;equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fixtures,&lt;br/&gt;fittings&#160;and&lt;br/&gt;other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Property,&#160;plant&lt;br/&gt;and&#160;equipment&lt;br/&gt;in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;255&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,282&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,053&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,587&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,391&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;23,568&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(487)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(711)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;236&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,828&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,127&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,524&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,454&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;23,169&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(839)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;240&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,170&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,648&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,655&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,097&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24,810&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,328&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,848&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,515&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,996&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;23,924&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(7,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,984)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(13,851)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(7,792)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(13,804)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(592)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(8,340)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,115)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(14,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(622)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4,225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(7,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(14,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Carrying amount at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Carrying amount at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;227&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,103&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,211&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;500&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,828&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,869&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) This line includes in particular property, plant and equipment in process brought into service during the period, but also includes the effect of the reclassification of assets to Assets held for sale or exchange.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth acquisitions and capitalized interest by operating segment for the years ended December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,748&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,504&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,310&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Industrial facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Research sites&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Consumer Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Off balance sheet commitments relating to property, plant and equipment as of December 31, 2022, 2021 and 2020 are set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Firm orders of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment pledged as security for liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth the net impairment losses recognized in each of the last three financial periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net impairment losses on property, plant and equipment&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;186&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;43&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) For 2022, the amount mainly comprises an impairment loss arising from a decision to discontinue operations at an industrial facility located outside&#160;France.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.3.2. Property, plant and equipment leased &#x2013; right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Right-of-use assets relating to property, plant and equipment leased by Sanofi are analyzed in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,583&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,711&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,745&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,872&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and impairment charged in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and impairment charged in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(797)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and impairment charged in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,198&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,948&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,815&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) This line also includes the effect of the reclassification of assets to &#x201c;Assets held for sale or exchange&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) In December&#160;2018, Sanofi signed two leases on real estate assets in the United States (at Cambridge, Massachusetts) for an initial lease term of 15 years. The first lease, relating to office space, began in April&#160;2021; Sanofi recognized a right-of-use asset of &#x20ac;320 million, as well as the lease liability. The second lease, relating to laboratory facilities, began on July&#160;1, 2021; Sanofi recognized a right-of-use asset of &#x20ac;424 million, as well as the lease liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Leased assets are mainly comprised of office and industrial premises (93%) and the vehicle fleet (7%) as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Annual lease costs on short term leases and low value asset leases amounted to &#x20ac;26 million in the year ended December 31, 2022, &#x20ac;25 million in the year ended December 31, 2021, and &#x20ac;27 million in the year ended December 31, 2020. Variable lease payments, sub-leasing activities, and sale-and-leaseback transactions were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Total cash outflows on leases (excluding annual lease costs on short term leases and low value asset leases) were &#x20ac;389 million in&#160;the year ended December 31, 2022, &#x20ac;302 million in the year ended December 31, 2021, and &#x20ac;269 million in the year ended&#160;December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A maturity analysis of the lease liability is disclosed in Note&#160;D.17.2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Commitments related to short-term leases and low value asset leases, including future payments for lease contracts committed but not yet commenced, are disclosed in Note&#160;D.21.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <sny:DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0Mjk_e72a92f1-8b7d-466b-b782-d8234d5e6e9e">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment owned by Sanofi is comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.691%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Machinery&lt;br/&gt;and&lt;br/&gt;equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fixtures,&lt;br/&gt;fittings&#160;and&lt;br/&gt;other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Property,&#160;plant&lt;br/&gt;and&#160;equipment&lt;br/&gt;in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;255&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,282&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,053&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,587&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,391&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;23,568&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(487)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(711)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;236&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,828&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,127&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,524&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,454&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;23,169&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(839)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;240&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,170&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,648&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,655&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,097&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24,810&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,328&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,848&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,515&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,996&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;23,924&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(7,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,984)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(13,851)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(7,792)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(13,804)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(592)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(8,340)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,115)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(14,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(622)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4,225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(7,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(14,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Carrying amount at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Carrying amount at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;227&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,103&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,211&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;500&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,828&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,869&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) This line includes in particular property, plant and equipment in process brought into service during the period, but also includes the effect of the reclassification of assets to Assets held for sale or exchange.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i8a1fb47c77a7402d896ae4afa489dc32_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtMS0xLTEtMzY0MDYw_4da496cf-2c04-4e1a-9bc4-6fbdd5419a41"
      unitRef="eur">255000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i6fdd7a020cd743c782be74d0b156d3ff_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtMi0xLTEtMzY0MDYw_d854734a-14a0-47d8-9638-960f1c4bfabc"
      unitRef="eur">7282000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i44a98fba01634bd9886289ce37e699bd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtMy0xLTEtMzY0MDYw_daa88773-4064-4002-8570-35ddce21d16c"
      unitRef="eur">11053000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ie6ce85fa444d4547b8275916d66fba2e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtNC0xLTEtMzY0MDYw_01dfc3e7-c9d1-4885-9f6e-093ebbcec3e2"
      unitRef="eur">2587000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i5025c5e64e0e4238ad981ac8500d4184_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtNS0xLTEtMzY0MDYw_70b7d39d-fca0-4dca-b37f-2433f8deabbb"
      unitRef="eur">2391000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i0a5f73156d8942cc9aff9b90aa0a20d9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEtNi0xLTEtMzY0MDYw_7f4da517-342f-4f09-bbe5-cc97f77fbce8"
      unitRef="eur">23568000000</ifrs-full:PropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItMS0xLTEtMzY0MDYw_5320a566-eea0-4482-958b-f65f12bdc02d"
      unitRef="eur">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItMi0xLTEtMzY0MDYw_3a1a5dbb-ba49-4285-b27b-4fb086c780b0"
      unitRef="eur">6000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItMy0xLTEtMzY0MDYw_b0b5e278-8351-4aad-94cf-19c2c5cd95e8"
      unitRef="eur">3000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItNC0xLTEtMzY0MDYw_d202d6f7-90e4-469a-b6ef-7797c53996f4"
      unitRef="eur">1000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItNS0xLTEtMzY0MDYw_fdabb729-8747-480f-9a67-2e42ad0a6bde"
      unitRef="eur">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzItNi0xLTEtMzY0MDYw_1d91a09d-bd44-463a-af39-d7f678a7d439"
      unitRef="eur">10000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtMS0xLTEtMzY0MDYw_8318bc79-b136-4cb1-b3ce-b8338e3f1360"
      unitRef="eur">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtMi0xLTEtMzY0MDYw_e51506df-bde9-449f-94c5-98871c8eacc9"
      unitRef="eur">16000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtMy0xLTEtMzY0MDYw_25680853-73d0-48f1-8b2e-81cd31b9c245"
      unitRef="eur">40000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtNC0xLTEtMzY0MDYw_5885382e-b10d-44ab-a58d-d385196e8e38"
      unitRef="eur">46000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtNS0xLTEtMzY0MDYw_2d9df0eb-b0d0-4182-8695-d07787ee218a"
      unitRef="eur">1208000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMtNi0xLTEtMzY0MDYw_86a78dcd-6953-406e-8bf0-191337c20879"
      unitRef="eur">1310000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtMS0xLTEtMzY0MDYw_c159a07e-e234-4c66-93f1-a790f3df64fd"
      unitRef="eur">11000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtMi0xLTEtMzY0MDYw_25f37730-f043-48c5-8e47-adbc5b450ca6"
      unitRef="eur">173000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtMy0xLTEtMzY0MDYw_4a3704e2-e259-42b8-8e51-9b7ee97519f0"
      unitRef="eur">177000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtNC0xLTEtMzY0MDYw_a7f7c662-0c70-428b-b645-f9cbedef8a91"
      unitRef="eur">123000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtNS0xLTEtMzY0MDYw_fffae85a-40f0-4313-b218-5c7ff3712ff8"
      unitRef="eur">3000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQtNi0xLTEtMzY0MDYw_9e3f9e43-bfa7-43d8-b083-d93ca68353e4"
      unitRef="eur">487000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtMS0xLTEtMzY0MDYw_946452d0-fed9-4243-85f5-3331ffcd98ca"
      unitRef="eur">-13000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtMi0xLTEtMzY0MDYw_519affd0-9c73-4f53-96de-cac0fd08d853"
      unitRef="eur">-264000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtMy0xLTEtMzY0MDYw_e736ae54-c553-49a5-9b1c-1cf94f6e012d"
      unitRef="eur">-276000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtNC0xLTEtMzY0MDYw_e6444707-d742-4485-8644-724d740f930f"
      unitRef="eur">-67000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtNS0xLTEtMzY0MDYw_0b7cfbac-14aa-4e6c-b49b-1d93f1484e4f"
      unitRef="eur">-91000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzUtNi0xLTEtMzY0MDYw_ccb15c7c-203d-4090-9fbb-8e6603b659ba"
      unitRef="eur">-711000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i1fef38f8cd664e0d93dec1e25aa4fefa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtMS0xLTEtMzY0MDYw_f6d5f156-593d-449c-a4dc-cc5b6cf2d081"
      unitRef="eur">5000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="iead1ab8881944cdbb6661ec9aef1d770_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtMi0xLTEtMzY0MDYw_6cac7890-18f7-41fc-8ad8-a54b9ffd84ff"
      unitRef="eur">-39000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="ia730d71ee6774d83a2758dd17e64836b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtMy0xLTEtMzY0MDYw_5fe7ed59-afaa-48d6-b586-0e3aa57b1f2b"
      unitRef="eur">484000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i3a314acc74994064b7645fe94f4d33f9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtNC0xLTEtMzY0MDYw_eba5d412-d747-4a6b-9008-370bb2645f02"
      unitRef="eur">80000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i65d62f86d07340bea3ebbedc37b04737_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtNS0xLTEtMzY0MDYw_baefcd4c-376f-4e32-8746-5f454c441ce2"
      unitRef="eur">-1051000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzYtNi0xLTEtMzY0MDYw_be352fa3-e725-432d-8c6e-0b0c24c24b73"
      unitRef="eur">-521000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i0206267cac4b43ff9378718b8008875d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctMS0xLTEtMzY0MDYw_0d8289dd-4ec4-47bb-9451-026dc2ce05d5"
      unitRef="eur">236000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="iaa29c61d6aa54e0c83530917f533df1f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctMi0xLTEtMzY0MDYw_9ce613dd-f1d9-4ed6-90c2-71be6cec9244"
      unitRef="eur">6828000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ibfb17be627054bbcaeb8bb573eb2dabf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctMy0xLTEtMzY0MDYw_d8b1eedb-f6d4-4112-acab-b158ff9c24f9"
      unitRef="eur">11127000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i9fce9fd8a39949fea1857356f2487678_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctNC0xLTEtMzY0MDYw_4e294f9f-6271-4c57-ba8a-e21488393344"
      unitRef="eur">2524000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i8e81b12e473e49b5abc85d3e576474fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctNS0xLTEtMzY0MDYw_9ca00068-4344-43cf-b77b-6fcca45dec55"
      unitRef="eur">2454000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzctNi0xLTEtMzY0MDYw_e4057e6d-9af8-48f5-8ea7-0288b2faa9f1"
      unitRef="eur">23169000000</ifrs-full:PropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtMS0xLTEtMzY0MDYw_34331169-fd1f-4e08-8c7e-36e89b34176c"
      unitRef="eur">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtMi0xLTEtMzY0MDYw_81df6555-f679-4c01-a6cf-34029dd1644c"
      unitRef="eur">11000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtMy0xLTEtMzY0MDYw_d43f5d57-701d-4327-adc5-0fb59c1dc0b3"
      unitRef="eur">15000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtNC0xLTEtMzY0MDYw_6e87e30c-cb79-43e0-b0cf-18eb0aa9e809"
      unitRef="eur">2000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtNS0xLTEtMzY0MDYw_f2bb8380-9c85-4f85-8ba8-ed46a816e886"
      unitRef="eur">2000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzgtNi0xLTEtMzY0MDYw_e0064f2c-a9b2-4eaf-8fa1-750c7c22693c"
      unitRef="eur">30000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktMS0xLTEtMzY0MDYw_4ec3caf4-0b47-43c4-8274-0427fffecc3b"
      unitRef="eur">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktMi0xLTEtMzY0MDYw_4e8685b0-0c1a-4dae-b568-6cba1cb9a46e"
      unitRef="eur">10000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktMy0xLTEtMzY0MDYw_057b6693-af5b-4fc7-ac68-9257b805f44e"
      unitRef="eur">51000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktNC0xLTEtMzY0MDYw_a83c7bc3-d8b7-4710-9aa6-b82f51a8d80e"
      unitRef="eur">39000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktNS0xLTEtMzY0MDYw_c0dccb4f-e97c-4691-b007-09e20e74b479"
      unitRef="eur">1404000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzktNi0xLTEtMzY0MDYw_5839c9c3-af1e-4eb7-b1ce-33ea0cda7145"
      unitRef="eur">1504000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTEtMS0xLTM2NDA2MA_32dd0b2d-9b90-4274-bc62-1237a3a86235"
      unitRef="eur">3000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTItMS0xLTM2NDA2MA_f244cfcb-2da0-4e6b-8819-6190c870bbeb"
      unitRef="eur">75000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTMtMS0xLTM2NDA2MA_766c49d1-917f-4202-b8c1-6c5f61503593"
      unitRef="eur">153000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTQtMS0xLTM2NDA2MA_29f96b3a-00b2-4fec-808f-3c41c1c70917"
      unitRef="eur">80000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTUtMS0xLTM2NDA2MA_e4777174-a0d9-49a0-9cf6-dfe2785ae173"
      unitRef="eur">3000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEwLTYtMS0xLTM2NDA2MA_5ef5bdb3-f15d-4e3e-8d6c-cbf6d9cb39f9"
      unitRef="eur">314000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTEtMS0xLTM2NDA2MA_5c27c11a-2bda-41af-9590-9fee9dcaed42"
      unitRef="eur">6000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTItMS0xLTM2NDA2MA_aa571b4e-4741-40ba-a05a-4a92d578dfef"
      unitRef="eur">169000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTMtMS0xLTM2NDA2MA_14cb1e02-1b94-46bb-a7db-2e9544050396"
      unitRef="eur">155000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTQtMS0xLTM2NDA2MA_b3e399c0-4065-415b-b549-3239a58e46a7"
      unitRef="eur">34000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTUtMS0xLTM2NDA2MA_8c17361c-c1d3-48ce-b32b-2d77b8502aec"
      unitRef="eur">79000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzExLTYtMS0xLTM2NDA2MA_f6e2b6b7-d934-4876-bf38-2068e538c165"
      unitRef="eur">443000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i055e27b6b33d480cb5b87d142e86fe3d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTEtMS0xLTM2NDA2MA_c2b9e904-7ddc-4f00-9ed4-1e1049b377d5"
      unitRef="eur">1000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="idc5a020df73045ea9fbf5696e86eb0fb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTItMS0xLTM2NDA2MA_3b44edc7-8000-4316-bee8-3d4dcd67e7d8"
      unitRef="eur">227000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i345278edd1ea429aab3fad6324b5e530_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTMtMS0xLTM2NDA2MA_964c852b-a681-47eb-913a-bec9ab00e6a2"
      unitRef="eur">453000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i3f164c1112af417eb3c7299a8e8e0afd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTQtMS0xLTM2NDA2MA_7df18321-e583-4ea3-ad30-a888db527e07"
      unitRef="eur">136000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i3c21e1c6b27e4b9891ad16c7d8e79276_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTUtMS0xLTM2NDA2MA_29f59a7c-c2a3-4d7f-b2eb-2ce7db94af37"
      unitRef="eur">-839000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEyLTYtMS0xLTM2NDA2MA_718e7b79-cdde-4078-be62-51cbe34ef62c"
      unitRef="eur">-22000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i87d0af8348104bf887f908169ce200b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTEtMS0xLTM2NDA2MA_13b0698c-3994-4c55-8807-cbaa1fb268c6"
      unitRef="eur">240000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i7d6fee5315414ad1a751bc8615b564e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTItMS0xLTM2NDA2MA_f350ecc8-56ff-4e84-92b3-7c49cd36ff53"
      unitRef="eur">7170000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i42c95bc466b242eba66c21cf83df94ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTMtMS0xLTM2NDA2MA_cfbd6869-236b-4cee-9cd3-7d717ffc5a2d"
      unitRef="eur">11648000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i93db76f9896b4f74ba29861299f846f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTQtMS0xLTM2NDA2MA_fe2d393c-8e54-48e6-a4cf-f265c4860359"
      unitRef="eur">2655000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i23e8b78ba6e14985bdaf0561022d2fcb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTUtMS0xLTM2NDA2MA_1333981a-5466-43d8-a23c-87f45cee80ee"
      unitRef="eur">3097000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzEzLTYtMS0xLTM2NDA2MA_ff970d05-9d7a-43e0-adea-1c9353476650"
      unitRef="eur">24810000000</ifrs-full:PropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTEtMS0xLTM2NDA2MA_6743cc59-b77d-4ba4-9350-91b14c4e49eb"
      unitRef="eur">-17000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTItMS0xLTM2NDA2MA_b8027b1d-7727-4a71-9c22-afd136aef1fa"
      unitRef="eur">-294000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTMtMS0xLTM2NDA2MA_2a7cbbb9-78cc-4033-a571-59bcc05cc9a7"
      unitRef="eur">-1480000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTQtMS0xLTM2NDA2MA_3eb84ef4-2556-4612-b62d-240ee3a52ef3"
      unitRef="eur">-163000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTUtMS0xLTM2NDA2MA_ddae99a8-ed56-4933-bb29-858ebdddcd43"
      unitRef="eur">-150000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE0LTYtMS0xLTM2NDA2MA_f6dca72f-59f7-498b-aa41-62c434d56c6b"
      unitRef="eur">-2104000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTEtMS0xLTM2NDA2MA_04928677-60ed-40b4-89ec-95fdf1bc9dc4"
      unitRef="eur">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTItMS0xLTM2NDA2MA_2d5d4571-0c35-453c-9f56-68ef5c65a5fa"
      unitRef="eur">11000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTMtMS0xLTM2NDA2MA_b9045a50-5a62-4cac-bf26-8c53a95c0ba2"
      unitRef="eur">54000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTQtMS0xLTM2NDA2MA_18f2ae3b-f744-4b99-a0f7-92ef8d1b6820"
      unitRef="eur">41000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTUtMS0xLTM2NDA2MA_cd3dc8ae-b2ff-4881-9396-68a9e5cf6617"
      unitRef="eur">1642000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE1LTYtMS0xLTM2NDA2MA_0d140fc4-b944-47cc-92fe-97852ff4e3a5"
      unitRef="eur">1748000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTEtMS0xLTM2NDA2MA_08c44645-ea48-4a00-8903-221164a4de32"
      unitRef="eur">1000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTItMS0xLTM2NDA2MA_37dddaf3-f129-4919-9401-75cb4f9817a1"
      unitRef="eur">161000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTMtMS0xLTM2NDA2MA_d16d1166-9577-4050-a093-538345514243"
      unitRef="eur">240000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTQtMS0xLTM2NDA2MA_3fb17c90-fef4-4dc7-a368-d5d017035333"
      unitRef="eur">155000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTUtMS0xLTM2NDA2MA_c2e2b97c-7a06-4a7f-b402-d7fa4d46c0de"
      unitRef="eur">2000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE2LTYtMS0xLTM2NDA2MA_fe0ebd19-6700-48dc-837c-c4a209eba8e2"
      unitRef="eur">559000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTEtMS0xLTM2NDA2MA_21fdf05e-d229-4ecf-8f5b-539f2d74098b"
      unitRef="eur">17000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTItMS0xLTM2NDA2MA_4b5435ef-bda5-49f2-9831-f2ee02ece4e2"
      unitRef="eur">122000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTMtMS0xLTM2NDA2MA_b5f80075-959a-48b0-9085-cfed3c43715d"
      unitRef="eur">144000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTQtMS0xLTM2NDA2MA_baffa1db-c018-40bd-b845-f4db7b1399c3"
      unitRef="eur">29000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTUtMS0xLTM2NDA2MA_0c6bdeea-bd1f-4ff3-9427-c254ccaee056"
      unitRef="eur">35000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE3LTYtMS0xLTM2NDA2MA_4caa233e-0f8d-4921-9732-146482ef7e56"
      unitRef="eur">347000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i669308cc8ab24d1db8e25e1d1b38b9ac_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTEtMS0xLTM2NDA2MA_d734f179-7976-489f-a192-c5d820654aeb"
      unitRef="eur">-2000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i344fada3b0b646059fe1d9aeb6732cf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTItMS0xLTM2NDA2MA_9d237119-dfb3-4567-b277-7f90a94d5973"
      unitRef="eur">480000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i219819057719437a98830f8b3e8fbf3c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTMtMS0xLTM2NDA2MA_5f54a9f0-e55a-4015-9521-7c2161ebc7e3"
      unitRef="eur">722000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i1b20332b9ccd41cb8bea2cc971b07de2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTQtMS0xLTM2NDA2MA_51749472-c062-4715-b291-887ccb115040"
      unitRef="eur">108000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i9db1e72abd4040c1876c363d946b1a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTUtMS0xLTM2NDA2MA_318463cb-236e-4355-86ea-98b63f3c740f"
      unitRef="eur">-1626000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE4LTYtMS0xLTM2NDA2MA_2ca5e56b-dd23-40f9-8be0-57a8d8b8d9db"
      unitRef="eur">-318000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ibd94ddf5b0e84f649ad3f3ba6b5cafb5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTEtMS0xLTM2NDA2MA_cda2f4b9-bce5-4d40-a432-6c9c4fc18e85"
      unitRef="eur">237000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i76a1d3dce1104aa6a7d778f1999c90d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTItMS0xLTM2NDA2MA_e077180b-f163-459f-a5d9-d3bb96c18418"
      unitRef="eur">7328000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="icb39c23a34044e26bef23d011e133535_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTMtMS0xLTM2NDA2MA_68ccd3fc-bee4-464a-8dd7-46abc143e679"
      unitRef="eur">10848000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ia2162c82bdeb4391aa0ecd936cefcc6c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTQtMS0xLTM2NDA2MA_2cf6fa7b-8188-4b5f-90e9-56ce832b712f"
      unitRef="eur">2515000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ifd00cfd5016342eaaea60535f74305b3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTUtMS0xLTM2NDA2MA_5ce31576-d967-4d16-bbcb-050abc923045"
      unitRef="eur">2996000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzE5LTYtMS0xLTM2NDA2MA_91705b79-ea80-4095-8c73-9d461c675c48"
      unitRef="eur">23924000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i476392303b7e4abba1d96716ae9615ab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTEtMS0xLTM2NDA2MA_56b9a94e-fe1f-4e8a-a37b-f66aeeedae50"
      unitRef="eur">-11000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ied331c3fd4b94f45b143e83a62a935f2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTItMS0xLTM2NDA2MA_c741cdbb-02c1-48de-ab0a-907d6807b52d"
      unitRef="eur">-4065000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i1ecc234cc9eb49568130c6b4fc616c68_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTMtMS0xLTM2NDA2MA_b9e88dfd-f4e5-4d50-a315-9e986aa3228b"
      unitRef="eur">-7660000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i3f095d969a564ac0a9de8f80291ff734_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTQtMS0xLTM2NDA2MA_57417325-f18a-4acb-b578-41134afcb0b9"
      unitRef="eur">-1984000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i0c26e169435e4e9e9fe6193807419216_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTUtMS0xLTM2NDA2MA_0bf11cea-bbd8-4d8d-9a02-32d483b8a98b"
      unitRef="eur">-131000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="idc8a6784630a4f6dacd4f922e9fdcfda_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIwLTYtMS0xLTM2NDA2MA_5c69fd58-8ab3-40c9-8371-506544c8b646"
      unitRef="eur">-13851000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationExpense
      contextRef="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTEtMS0xLTM2NDA2MA_063aa6cf-3e1b-4c65-9a66-c7d27a1c8285"
      unitRef="eur">0</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTItMS0xLTM2NDA2MA_af8ece7c-b908-40b7-964c-1e980cd4b290"
      unitRef="eur">356000000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTMtMS0xLTM2NDA2MA_f6b56c5a-7e83-4e97-9944-e0a909dc59c0"
      unitRef="eur">605000000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="i10c25791faca434abad3dcc87c335545_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTQtMS0xLTM2NDA2MA_4e5ed22b-9ff6-41df-a368-f687f0a33e1c"
      unitRef="eur">182000000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTUtMS0xLTM2NDA2MA_8d7f409a-1fcf-4adc-820b-a3c04a3734ff"
      unitRef="eur">0</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIxLTYtMS0xLTM2NDA2MA_80de3432-d092-44dc-8937-4b7c40c6b1b4"
      unitRef="eur">1143000000</ifrs-full:DepreciationExpense>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTEtMS0xLTM2NDA2MA_9d2b7bb6-49e3-408e-b72b-524dd03007f9"
      unitRef="eur">0</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTItMS0xLTM2NDA2MA_6311f764-c9d9-44be-a3dc-bb637360a79b"
      unitRef="eur">24000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTMtMS0xLTM2NDA2MA_7ad8c0d6-cfb1-4735-86bb-88f96c3ed4f4"
      unitRef="eur">12000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="i10c25791faca434abad3dcc87c335545_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTQtMS0xLTM2NDA2MA_9c90655d-766b-4dbf-9132-a5c4b89921a0"
      unitRef="eur">7000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTUtMS0xLTM2NDA2MA_2bfc6fa8-b8ca-4faf-9df6-9f5b7ddb754b"
      unitRef="eur">0</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIyLTYtMS0xLTM2NDA2MA_9bcb2e60-9582-4cca-b26b-3367f7d4fea3"
      unitRef="eur">43000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTEtMS0xLTM2NDA2MA_41335db2-8d95-4a96-a7ef-6065da0a32a6"
      unitRef="eur">-1000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTItMS0xLTM2NDA2MA_2070a8ee-1b1a-4921-b709-0caec072bd8a"
      unitRef="eur">-168000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTMtMS0xLTM2NDA2MA_961b565b-9b94-49a8-84d4-0e0be6095a17"
      unitRef="eur">-166000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i10c25791faca434abad3dcc87c335545_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTQtMS0xLTM2NDA2MA_0832775f-f243-4aed-ad99-335a9b1ddc02"
      unitRef="eur">-117000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTUtMS0xLTM2NDA2MA_fb4bf8c5-3732-4fb6-8724-f2fbcf46fce0"
      unitRef="eur">-8000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzIzLTYtMS0xLTM2NDA2MA_f24d2da7-301f-42da-969f-38f78aa2fef1"
      unitRef="eur">-460000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTEtMS0xLTM2NDA2MA_90b11200-4813-4636-959d-046106655fc6"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTItMS0xLTM2NDA2MA_0346ef62-d161-4151-a970-8cc0cf7db3a1"
      unitRef="eur">127000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTMtMS0xLTM2NDA2MA_870ee7e2-8940-44d4-b064-152bf020eae7"
      unitRef="eur">169000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i10c25791faca434abad3dcc87c335545_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTQtMS0xLTM2NDA2MA_74fec814-c91c-4b69-8a1d-68138f19903d"
      unitRef="eur">49000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTUtMS0xLTM2NDA2MA_c2c3a224-adf8-4888-82b2-0b10e6f039bd"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI0LTYtMS0xLTM2NDA2MA_a49d385f-32dd-45fd-ae6b-e4b1bff54f65"
      unitRef="eur">345000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i74b073687d5d4189bb745d03d4e8e99e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTEtMS0xLTM2NDA2MA_a1306f01-f166-4945-9af8-88d964538012"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="ic01386edfd94418e8392fb23c4f0bd16_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTItMS0xLTM2NDA2MA_4a3bb2cb-b1cb-48bc-b59e-8f28004679fc"
      unitRef="eur">252000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="id5c8ca8ec37b44e7a6cf60eb34dcab49_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTMtMS0xLTM2NDA2MA_627a377a-7266-42c9-9500-dc1821abad5e"
      unitRef="eur">150000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i10c25791faca434abad3dcc87c335545_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTQtMS0xLTM2NDA2MA_ba3c166a-7bee-48f4-aea2-96d56da562d7"
      unitRef="eur">26000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="ib9eccd14ecb84a4da2779295460bdd59_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTUtMS0xLTM2NDA2MA_3bb8a6b7-f7a6-4bc0-b493-bfd0bd8e4404"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI1LTYtMS0xLTM2NDA2MA_d36f16f0-952c-4619-9f45-11beb80c399b"
      unitRef="eur">428000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="if76ef11240a9484db66b6a0b5b09f16b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTEtMS0xLTM2NDA2MA_767f0538-41fb-4575-b6e3-bfa6868bc3dd"
      unitRef="eur">-10000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i00ddc700bee94a3ebc732201c1d35de9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTItMS0xLTM2NDA2MA_63b5adad-418d-4fe0-8566-e812b6a9060d"
      unitRef="eur">-3898000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="if2f730ae7e334d48893db2ae20047ece_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTMtMS0xLTM2NDA2MA_1dc05371-f58d-467a-bc68-decff48bd7c8"
      unitRef="eur">-7792000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i472690aecacc4395b411b03484ad169e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTQtMS0xLTM2NDA2MA_88952879-c1a0-43c7-9ddb-59aa0e939e99"
      unitRef="eur">-1981000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i96cfd3c2e6874abd9afce4c2d4d64ffd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTUtMS0xLTM2NDA2MA_2b891024-a427-45da-a629-7333d1471845"
      unitRef="eur">-123000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i9bd6e4b32cb345028d31ec8dc75abdea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI2LTYtMS0xLTM2NDA2MA_f0cf31b8-b743-448e-bfef-c214b04b9740"
      unitRef="eur">-13804000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationExpense
      contextRef="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTEtMS0xLTM2NDA2MA_e7a42a26-fb93-41c3-bbad-9975f0cf422e"
      unitRef="eur">0</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="i955321bf2dce441dae3876de61625fc6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTItMS0xLTM2NDA2MA_1849ce5d-7f4e-4ee7-9ae4-bc04aa7db12d"
      unitRef="eur">306000000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTMtMS0xLTM2NDA2MA_2ada9bde-7af4-439b-8651-efe29733c758"
      unitRef="eur">592000000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTQtMS0xLTM2NDA2MA_9458697b-dd55-4638-b7f1-11ac47eb4077"
      unitRef="eur">167000000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTUtMS0xLTM2NDA2MA_c1545a39-b558-49bb-ba23-9b1e9b1faa8b"
      unitRef="eur">0</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI3LTYtMS0xLTM2NDA2MA_f798e361-6b6d-4cbe-a6bc-12b3f097c785"
      unitRef="eur">1065000000</ifrs-full:DepreciationExpense>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTEtMS0xLTM2NDA2MA_93d26328-7380-4f0e-87ae-76ff9cd21bf2"
      unitRef="eur">0</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="i955321bf2dce441dae3876de61625fc6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTItMS0xLTM2NDA2MA_ffb30e19-54fc-472c-a80c-831e9598669b"
      unitRef="eur">3000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTMtMS0xLTM2NDA2MA_180c31f6-a403-442b-b8a6-222edffad65e"
      unitRef="eur">22000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTQtMS0xLTM2NDA2MA_bd64edd0-d9b2-49fd-9f9d-68853b17e396"
      unitRef="eur">2000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTUtMS0xLTM2NDA2MA_f2ccd079-0788-4a82-8d98-584131b1d4a2"
      unitRef="eur">12000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI4LTYtMS0xLTM2NDA2MA_f5cc62ea-7dac-4e1c-b85b-56c01c947a35"
      unitRef="eur">39000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTEtMS0xLTM2NDA2MA_86f1975c-7f31-4cdc-8110-2e8817dc7cbb"
      unitRef="eur">0</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i955321bf2dce441dae3876de61625fc6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTItMS0xLTM2NDA2MA_c1407297-71fd-4fbc-b4f7-8b106c5f5299"
      unitRef="eur">-74000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTMtMS0xLTM2NDA2MA_dd9f352c-6311-4cdc-9923-f738426877ab"
      unitRef="eur">-149000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTQtMS0xLTM2NDA2MA_2f359739-1b16-4841-9883-99d6a41f6886"
      unitRef="eur">-75000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTUtMS0xLTM2NDA2MA_fbca4d1f-96ad-4632-9e43-2e041c7bd2f1"
      unitRef="eur">-1000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzI5LTYtMS0xLTM2NDA2MA_8febc712-16e8-4652-b3e8-bcb585464d29"
      unitRef="eur">-299000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTEtMS0xLTM2NDA2MA_31daf529-6109-4856-b1a6-e5e52a291ac0"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i955321bf2dce441dae3876de61625fc6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTItMS0xLTM2NDA2MA_71e16f2b-52dc-4a3d-82ff-8feabd5db0e0"
      unitRef="eur">-80000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTMtMS0xLTM2NDA2MA_e72b8b9d-6a1b-4c8e-b800-35e2241d7b8e"
      unitRef="eur">-99000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTQtMS0xLTM2NDA2MA_2a5498e5-024c-454f-a085-6bc962e53757"
      unitRef="eur">-29000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTUtMS0xLTM2NDA2MA_277cfccf-dde8-46cf-b606-13baf8fee169"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMwLTYtMS0xLTM2NDA2MA_20fd9fd3-7127-4008-9231-d6cb25fd3eed"
      unitRef="eur">-208000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="ie85752d1be384fad9fd39c1717bec8c7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTEtMS0xLTM2NDA2MA_d670f4f1-0f89-45df-9cdc-5faf45570eca"
      unitRef="eur">1000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i955321bf2dce441dae3876de61625fc6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTItMS0xLTM2NDA2MA_7f8e801f-acfc-4082-965d-fa498e411f31"
      unitRef="eur">23000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i72e0ead726a4475ba78622861c4923c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTMtMS0xLTM2NDA2MA_9ab41ae0-406f-46e1-9b32-67bf91c179dd"
      unitRef="eur">16000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i3b4cd92232ba413b81602cb77218b7fb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTQtMS0xLTM2NDA2MA_f5906743-98c8-423e-b488-e948390110de"
      unitRef="eur">-11000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i17f68f519a00404ea3052984ca288a6b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTUtMS0xLTM2NDA2MA_3c7d1327-b9d3-495e-931d-ab9409177e59"
      unitRef="eur">6000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMxLTYtMS0xLTM2NDA2MA_b439abe0-c1a3-40f0-94de-cd095b1eaddb"
      unitRef="eur">35000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i69399acab7a64ab497728ec8f97b3699_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTEtMS0xLTM2NDA2MA_78bd68db-db67-4d0e-8c95-1a442f366110"
      unitRef="eur">-9000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i3c7e1a121231436aba2eaeb9b1fe7924_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTItMS0xLTM2NDA2MA_c60a3d1c-857c-4776-9b12-8a7230cb262d"
      unitRef="eur">-4190000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i9127d80c07874bffb0988e2f80d522b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTMtMS0xLTM2NDA2MA_c75e62b3-6c42-4389-a546-9540cbc2eac4"
      unitRef="eur">-8340000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i3c0b39229285466da452d51712d250f6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTQtMS0xLTM2NDA2MA_c5ebbf6e-c3f6-45ec-99b9-d129c26c40e9"
      unitRef="eur">-2115000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i193fe7806c2641f3b83fb65146f5ee65_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTUtMS0xLTM2NDA2MA_22ad6adc-9177-4641-9aaa-e79a318aacea"
      unitRef="eur">-128000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ida5c0c7399ab4f90ab42e89c5e29af71_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMyLTYtMS0xLTM2NDA2MA_ad1acd31-6103-40f7-8d50-9440d66824a5"
      unitRef="eur">-14782000000</ifrs-full:PropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTEtMS0xLTUwMjA4NQ_e43da565-9843-42a0-9e41-9f92566bdde6"
      unitRef="eur">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTItMS0xLTUwMjA4NQ_b6ec57c4-b70f-4ea6-b22d-0354c7a86638"
      unitRef="eur">201000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTMtMS0xLTUwMjA4NQ_f03f10b1-879b-40fb-9185-cd7aa2172006"
      unitRef="eur">1202000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTQtMS0xLTUwMjA4NQ_a03f091e-d063-4cd4-af66-776f54bdb101"
      unitRef="eur">130000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTUtMS0xLTUwMjA4NQ_0f3915a7-e34d-484a-aa27-78952b53ae67"
      unitRef="eur">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTYtMS0xLTUwMjA4NQ_c86e07ec-7a0d-489f-bf42-b2a4e1651932"
      unitRef="eur">1533000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DepreciationExpense
      contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTEtMS0xLTM2NDA2MA_304b82f9-bfed-4ce9-b8c2-bcac1257da69"
      unitRef="eur">0</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTItMS0xLTM2NDA2MA_499a2e20-31d1-4d42-8e63-82660f14128c"
      unitRef="eur">356000000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTMtMS0xLTM2NDA2MA_4010bd48-94f6-4657-9508-7a1b835c9bcb"
      unitRef="eur">622000000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTQtMS0xLTM2NDA2MA_63dac130-5de1-4e89-8f4f-75b245a06c68"
      unitRef="eur">164000000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTUtMS0xLTM2NDA2MA_31c10179-ba27-479a-a37c-6249809183c4"
      unitRef="eur">0</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzMzLTYtMS0xLTM2NDA2MA_0539bc57-0a26-4ad6-ada5-160a6dcf778f"
      unitRef="eur">1142000000</ifrs-full:DepreciationExpense>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTEtMS0xLTM2NDA2MA_87c217c3-68a7-4e72-8489-219eb9a09292"
      unitRef="eur">1000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTItMS0xLTM2NDA2MA_1214b7c7-ea00-415f-84fa-e51762c844b8"
      unitRef="eur">50000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTMtMS0xLTM2NDA2MA_226332cb-6441-492a-a40f-ba9385cfe6e0"
      unitRef="eur">58000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTQtMS0xLTM2NDA2MA_9ee89e70-8a96-4efc-9c5e-4caf9b4146e8"
      unitRef="eur">2000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTUtMS0xLTM2NDA2MA_466f2f63-5e99-4920-9164-652e13eaf3d2"
      unitRef="eur">75000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM0LTYtMS0xLTM2NDA2MA_2226c940-b365-42aa-807f-f98ad5131604"
      unitRef="eur">186000000</ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTEtMS0xLTM2NDA2MA_eba8a025-6acc-4bef-87ec-97ae62b0bd75"
      unitRef="eur">0</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTItMS0xLTM2NDA2MA_0818a9e0-50e2-49f5-b04a-1844b3dabab7"
      unitRef="eur">-133000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTMtMS0xLTM2NDA2MA_25977e4d-268a-4061-9cac-6b568608e7a8"
      unitRef="eur">-201000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTQtMS0xLTM2NDA2MA_c2da7e94-d073-4858-9e09-74e6c9c758ce"
      unitRef="eur">-153000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTUtMS0xLTM2NDA2MA_7830d79c-9fd6-48bd-b88b-2ea49aff9605"
      unitRef="eur">-31000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM1LTYtMS0xLTM2NDA2MA_1e1ca1aa-fa4b-409f-9368-7f055bb2aa70"
      unitRef="eur">-518000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTEtMS0xLTM2NDA2MA_ed2ebe1e-7510-4c03-8973-df5b4eac5d75"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTItMS0xLTM2NDA2MA_4cc4e6f7-a0ca-44fd-aa10-1165ae8ef30b"
      unitRef="eur">-52000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTMtMS0xLTM2NDA2MA_99292a26-8202-4b99-abd7-83ca738c778b"
      unitRef="eur">-69000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTQtMS0xLTM2NDA2MA_0fc02111-9c1c-4495-a6ab-df9a23b82fa8"
      unitRef="eur">-22000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTUtMS0xLTM2NDA2MA_37a00827-70ab-4680-b987-0f88edebed05"
      unitRef="eur">5000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM2LTYtMS0xLTM2NDA2MA_b686f1cd-ec4b-4816-ba13-5d8230eea961"
      unitRef="eur">-138000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i327d18f4b4c1426db0742d38574dd969_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTEtMS0xLTM2NDA2MA_5c80f11c-6b95-48f9-8d57-779adfa5214b"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="idbcee8b841bd4b938d21ba6adeac65dc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTItMS0xLTM2NDA2MA_bbce6c32-651f-42bc-88db-dd682b3c0f2d"
      unitRef="eur">89000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="id9b3fbf7d252444fae20507fdaaac1a0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTMtMS0xLTM2NDA2MA_2113bbff-f885-433d-89aa-5db6c39305fb"
      unitRef="eur">49000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="iede1d2e525a54a3db88578aa065c81d4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTQtMS0xLTM2NDA2MA_fc0787d9-06e8-47cd-87cd-2b71083ba054"
      unitRef="eur">5000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="ic648643950304042bf94a1d3afbbbc5c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTUtMS0xLTM2NDA2MA_77896b47-c4a7-4c50-8a5f-1cd534dd4b3c"
      unitRef="eur">-1000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM3LTYtMS0xLTM2NDA2MA_dcdeb7f5-8ca7-4b0d-8aed-31a36da54d2a"
      unitRef="eur">142000000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i9404661ce5304598a545950eb1e7bf70_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTEtMS0xLTM2NDA2MA_0352783f-0644-408d-a85f-bf5970bed209"
      unitRef="eur">-10000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="iba41b88a1c3648cbb1015bbea8998f1d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTItMS0xLTM2NDA2MA_f4f70720-b7b2-4260-9912-4ae8eaa605cb"
      unitRef="eur">-4225000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i6fee7647f4f24f3491f03f1226afcc68_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTMtMS0xLTM2NDA2MA_a9a05cf6-2a6f-4fce-9bdb-db569c0c8997"
      unitRef="eur">-7637000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ib0f0050d932c48cbad2e4bb3e8838afa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTQtMS0xLTM2NDA2MA_9a091e3a-ae30-4e53-b45d-6c63c7120314"
      unitRef="eur">-2015000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ie6326e3e444e4d0fa59364df7efee398_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTUtMS0xLTM2NDA2MA_3737293c-01bf-4e06-a625-9709d46071ee"
      unitRef="eur">-168000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i8d73c6b22ae6491dbc37944b398879b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM4LTYtMS0xLTM2NDA2MA_f35307bc-bff1-47ab-b49f-5a3fe788b9c5"
      unitRef="eur">-14055000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ib371a75679dd4f838651914ccd2f7845_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTEtMS0xLTM2NDA2MA_609d6d12-b0fc-423f-9cc4-293b76955da7"
      unitRef="eur">226000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i6d233b94b150441c965315e4c2cdb970_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTItMS0xLTM2NDA2MA_e3b545d5-ace1-459c-8db8-00ea08c606e9"
      unitRef="eur">2930000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i460186f58d964578bb57d83f6b52c068_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTMtMS0xLTM2NDA2MA_546d7cce-3edc-455d-b919-7d2087026040"
      unitRef="eur">3335000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i8a427587471c4b43b5afa2d98b323de7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTQtMS0xLTM2NDA2MA_3817b5af-29ab-4e02-8817-10eafa1c548d"
      unitRef="eur">543000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i7c53e563aead4f239fdd2a1346eaa2ca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTUtMS0xLTM2NDA2MA_adc11436-556b-438a-bfea-7583c81ff215"
      unitRef="eur">2331000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzM5LTYtMS0xLTM2NDA2MA_d8ab62ad-555d-4f94-b02b-7caadfcbb224"
      unitRef="eur">9365000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i28edbc201159440baec039fe6f9edab4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTEtMS0xLTM2NDA2MA_4471c65e-9998-42ac-9836-47c36230d829"
      unitRef="eur">231000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ib0aae04a72c84e138d05a17aa6e4adc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTItMS0xLTM2NDA2MA_77fc7201-c3e7-4931-b223-30470945ba94"
      unitRef="eur">2980000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i038f209f31d04ec4baba797bedf7ede2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTMtMS0xLTM2NDA2MA_9b03e304-2e62-49db-8d93-10d73bd9444b"
      unitRef="eur">3308000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ib020c89f73574f31811c48672a7d702a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTQtMS0xLTM2NDA2MA_709d5f7b-127d-463c-a2d6-ffe668c585fb"
      unitRef="eur">540000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ie5df9065660c4e1184ba88ea30322027_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTUtMS0xLTM2NDA2MA_9dbde3c0-5b8e-4417-bc65-ec139518fe6b"
      unitRef="eur">2969000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQwLTYtMS0xLTM2NDA2MA_9709295c-ec82-4b5c-b225-aa858df54a81"
      unitRef="eur">10028000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="id09d5d649b4446e3a4a10a599d8c7820_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTEtMS0xLTM2NDA2MA_bc42daa6-b9af-4042-9bbc-866f03fbc4f8"
      unitRef="eur">227000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ib493cbd2620f4ebeb6ea7d83ee096a61_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTItMS0xLTM2NDA2MA_1609c986-dc55-419c-bcba-29c354f4ea16"
      unitRef="eur">3103000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i29b79d594c5948f5abb69e79838735ed_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTMtMS0xLTM2NDA2MA_af5170f4-7d29-4a80-b74f-0e04b8489592"
      unitRef="eur">3211000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i2cd5556f3abe48f5a8eab0fd94631f19_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTQtMS0xLTM2NDA2MA_f5a6dc78-d761-4fbb-ae93-4e0ef59d58c5"
      unitRef="eur">500000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i15ac112e5ca84ab9a152812eaa4b795c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTUtMS0xLTM2NDA2MA_9c007f27-27ce-423e-9388-301432337a61"
      unitRef="eur">2828000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTpjZjc4ZjgzNGY1OTg0MGYzYjQwNmJiZDZmY2JjMGExNS90YWJsZXJhbmdlOmNmNzhmODM0ZjU5ODQwZjNiNDA2YmJkNmZjYmMwYTE1XzQxLTYtMS0xLTM2NDA2MA_013abe6d-aa89-4bed-b487-23b27fbfbffe"
      unitRef="eur">9869000000</ifrs-full:PropertyPlantAndEquipment>
    <sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0MzA_9c94e656-8015-40bf-90b9-ea91dd9f769e">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth acquisitions and capitalized interest by operating segment for the years ended December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,748&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,504&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,310&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Industrial facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Research sites&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Consumer Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzEtMS0xLTEtMzY0MDYw_cd042b01-2996-4531-b5f9-3a720839cc81"
      unitRef="eur">1748000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzEtMi0xLTEtMzY0MDYw_9e2fa8b2-a700-49b3-8ea4-1c099e5a8266"
      unitRef="eur">1504000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzEtMy0xLTEtMzY0MDYw_b7b1a843-ac53-4d59-bdc8-d7315bea89fa"
      unitRef="eur">1310000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="ibb589cf6b30d4f85b2a6924184520710_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzItMS0xLTEtMzY0MDYw_81598f4d-8935-4a87-bec2-1a47cfbf792f"
      unitRef="eur">1049000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="idb790736d7c44dc0aece34570e7aa9d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzItMi0xLTEtMzY0MDYw_3a00b9c0-64cf-4b4c-a9b9-58edb4e0b93b"
      unitRef="eur">1007000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="ia71d61fb176c44bc85d8a7131e07caca_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzItMy0xLTEtMzY0MDYw_794c5167-42f7-47b4-964b-9a63f0a4fc7c"
      unitRef="eur">831000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="ia21cdedb03d541ac8ce4c21e0f09243a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzMtMS0xLTEtMzY0MDYw_f525bd6b-20a8-4fc6-882a-87353e040d8a"
      unitRef="eur">597000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i2d87c5192beb4f79a9a215eefde80519_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzMtMi0xLTEtMzY0MDYw_8a8cf781-bbbf-4210-9e98-a70f41c1961f"
      unitRef="eur">534000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i6e59794b9da94a948e8aa70b12c8ff88_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzMtMy0xLTEtMzY0MDYw_98a9047b-6da9-4384-b885-d36b3f7746d0"
      unitRef="eur">634000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="if815506776604f328ffbe1f64040e104_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzQtMS0xLTEtMzY0MDYw_83ea8241-cc5c-4cad-b6e4-a32c1bf525cb"
      unitRef="eur">153000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i7903da3784d448cfb09ae68817994cc1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzQtMi0xLTEtMzY0MDYw_8929108a-1144-4c19-937d-b7db4e311749"
      unitRef="eur">277000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="ie4dd16005bec44a7bfe5627a199fe9be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzQtMy0xLTEtMzY0MDYw_85cdf173-f308-4d1a-a69a-494504d8a899"
      unitRef="eur">152000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="if781d7295c08487ea51c6503613eb526_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzUtMS0xLTEtMzY0MDYw_5fafee69-3971-4f94-9d3c-6bf614754d6f"
      unitRef="eur">299000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="iaf174122818644c48b0a0c91bb27b307_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzUtMi0xLTEtMzY0MDYw_acc14838-2b59-49ee-9382-a51ca32bbc14"
      unitRef="eur">199000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="ifa82abad241d465ebfe6912fd6e39476_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzUtMy0xLTEtMzY0MDYw_fee1dcf9-6c83-4c15-837c-baffe79295ed"
      unitRef="eur">45000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i50f963fe7eb242389c52c58a27841042_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzYtMS0xLTEtMzY0MDYw_88939c40-1844-42fc-af2f-269d25b46ce2"
      unitRef="eur">629000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i8ec69c452bde4d2e9c935c00c627ed10_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzYtMi0xLTEtMzY0MDYw_750bbc46-380f-4bc3-b118-d11d1ea3005d"
      unitRef="eur">421000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="i73d9e784d85c4861808c14effc04b733_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzYtMy0xLTEtMzY0MDYw_bec3163b-50b3-490c-acba-2f1e755d6bda"
      unitRef="eur">384000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="ib5d1685308d744b99b0b8ffe90f18bf9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzctMS0xLTEtMzY0MDYw_b6b2e1a0-3cae-40e8-95d9-2221790f3bce"
      unitRef="eur">70000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="iec6fc9c2bb8247b2b49f3c157447c542_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzctMi0xLTEtMzY0MDYw_a9c4a2ce-6b3b-4b4e-a74c-9a87e99fc1d0"
      unitRef="eur">73000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="ib8a4cde136ee4ba6867518e84f629759_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzctMy0xLTEtMzY0MDYw_7e62adc0-6248-42a6-b5d2-fe81eb3bdb4d"
      unitRef="eur">95000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:InterestCostsCapitalised
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzgtMS0xLTEtMzY0MDYw_682f6156-6eea-494a-adb2-c0379db6ce80"
      unitRef="eur">17000000</ifrs-full:InterestCostsCapitalised>
    <ifrs-full:InterestCostsCapitalised
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzgtMi0xLTEtMzY0MDYw_b6af0878-3682-4bc5-a79e-bbbe4aa1c033"
      unitRef="eur">14000000</ifrs-full:InterestCostsCapitalised>
    <ifrs-full:InterestCostsCapitalised
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo2ZWY3OGM1N2U4NTU0ZmRlYWU1YjBiYzkwOTI1NmFmNC90YWJsZXJhbmdlOjZlZjc4YzU3ZTg1NTRmZGVhZTViMGJjOTA5MjU2YWY0XzgtMy0xLTEtMzY0MDYw_46dacd4e-245a-45ca-91db-26aba51ef7b2"
      unitRef="eur">11000000</ifrs-full:InterestCostsCapitalised>
    <sny:DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0MjU_ce848da2-e280-4859-af7a-cda42e02e378">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Off balance sheet commitments relating to property, plant and equipment as of December 31, 2022, 2021 and 2020 are set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Firm orders of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment pledged as security for liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock>
    <sny:FirmOrdersOfPropertyPlantAndEquipment
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzEtMS0xLTEtMzY0MDYw_83930a6e-4229-43a5-9fb0-a4fb88d030ee"
      unitRef="eur">861000000</sny:FirmOrdersOfPropertyPlantAndEquipment>
    <sny:FirmOrdersOfPropertyPlantAndEquipment
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzEtMi0xLTEtMzY0MDYw_2e1f1f60-8dfe-4dfd-90f8-e580e32a9306"
      unitRef="eur">769000000</sny:FirmOrdersOfPropertyPlantAndEquipment>
    <sny:FirmOrdersOfPropertyPlantAndEquipment
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzEtMy0xLTEtMzY0MDYw_ccda5be4-23db-4416-a53f-f0f8f7d48b54"
      unitRef="eur">708000000</sny:FirmOrdersOfPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzItMS0xLTEtMzY0MDYw_16de73a0-01b7-4f97-a5bc-f0f9fa7f5f3e"
      unitRef="eur">0</ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity>
    <ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzItMi0xLTEtMzY0MDYw_1dde16d7-65f5-4d31-9d7a-b8a5ea26d4f8"
      unitRef="eur">9000000</ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity>
    <ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTowMzY0MzQ3YmVkMWU0NWQ0YWJhNmY2NmQwYzkxYWExZS90YWJsZXJhbmdlOjAzNjQzNDdiZWQxZTQ1ZDRhYmE2ZjY2ZDBjOTFhYTFlXzItMy0xLTEtMzY0MDYw_2474e40d-29ae-4547-b40c-4ff86fde8bfe"
      unitRef="eur">0</ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity>
    <sny:DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0MjE_d7ac26d2-2692-45cd-b462-5ed487c02f36">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth the net impairment losses recognized in each of the last three financial periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net impairment losses on property, plant and equipment&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;186&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;43&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) For 2022, the amount mainly comprises an impairment loss arising from a decision to discontinue operations at an industrial facility located outside&#160;France.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo4NTBiOTlkOGIyZDk0NzI1OWY3MThiNzUxYTBmZDdhYS90YWJsZXJhbmdlOjg1MGI5OWQ4YjJkOTQ3MjU5ZjcxOGI3NTFhMGZkN2FhXzEtMS0xLTEtMzY0MDYw_75c35830-bb95-4a31-a39f-c621caf79084"
      unitRef="eur">186000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo4NTBiOTlkOGIyZDk0NzI1OWY3MThiNzUxYTBmZDdhYS90YWJsZXJhbmdlOjg1MGI5OWQ4YjJkOTQ3MjU5ZjcxOGI3NTFhMGZkN2FhXzEtMi0xLTEtMzY0MDYw_bed4c3d5-8c03-4e32-86a4-a98686ec299a"
      unitRef="eur">39000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo4NTBiOTlkOGIyZDk0NzI1OWY3MThiNzUxYTBmZDdhYS90YWJsZXJhbmdlOjg1MGI5OWQ4YjJkOTQ3MjU5ZjcxOGI3NTFhMGZkN2FhXzEtMy0xLTEtMzY0MDYw_66952fdb-a6cd-49aa-80ed-62cf587193bd"
      unitRef="eur">43000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzI0Mjg_120e07da-364c-435d-a5e3-8e7563500adc">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Right-of-use assets relating to property, plant and equipment leased by Sanofi are analyzed in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,583&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,711&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,745&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,872&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and impairment charged in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and impairment charged in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(797)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and impairment charged in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation &amp;amp; impairment at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,198&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,948&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,815&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) This line also includes the effect of the reclassification of assets to &#x201c;Assets held for sale or exchange&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) In December&#160;2018, Sanofi signed two leases on real estate assets in the United States (at Cambridge, Massachusetts) for an initial lease term of 15 years. The first lease, relating to office space, began in April&#160;2021; Sanofi recognized a right-of-use asset of &#x20ac;320 million, as well as the lease liability. The second lease, relating to laboratory facilities, began on July&#160;1, 2021; Sanofi recognized a right-of-use asset of &#x20ac;424 million, as well as the lease liability.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <ifrs-full:RightofuseAssets
      contextRef="i0a5f73156d8942cc9aff9b90aa0a20d9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzEtMS0xLTEtMzY0MDYw_62f0aa7b-1a38-428e-b2e6-1c0d24bce007"
      unitRef="eur">1583000000</ifrs-full:RightofuseAssets>
    <sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzItMS0xLTEtMzcxNDIy_7c248326-2f7b-4669-9753-e36367c8e976"
      unitRef="eur">15000000</sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets>
    <sny:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMtMS0xLTEtMzcxNDIy_120d65ca-caf9-4b18-80e4-3791c4edfaba"
      unitRef="eur">340000000</sny:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets>
    <sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzItMS0xLTEtMzY0MDYw_68e3c346-d4ec-4e49-b97c-1e50c8abcfd2"
      unitRef="eur">121000000</sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMtMS0xLTEtMzY0MDYw_1e2268af-9b3a-433d-8c8a-1d730e8cac48"
      unitRef="eur">-85000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzQtMS0xLTEtMzY0MDYw_c571ed77-b123-4409-8780-a4a692ff841c"
      unitRef="eur">-21000000</sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzUtMS0xLTEtMzY0MDYw_c7d8bb25-0627-4782-b2fb-fb815679a09f"
      unitRef="eur">1711000000</ifrs-full:RightofuseAssets>
    <sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzYtMS0xLTEtMzY0MDYw_b3c119cc-ba0b-4f7c-9428-5ea8f5547fc0"
      unitRef="eur">93000000</sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets>
    <sny:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzctMS0xLTEtMzY0MDYw_3df5017d-8a1b-466a-a79e-dbd12e1188a5"
      unitRef="eur">963000000</sny:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets>
    <sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzgtMS0xLTEtMzY0MDYw_d709a49c-3d0f-496c-b58f-355e6e67b2b9"
      unitRef="eur">91000000</sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzktMS0xLTEtMzY0MDYw_1457ca71-53d6-4583-beca-35a1b19a98e4"
      unitRef="eur">76000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzEwLTEtMS0xLTM2NDA2MA_15ac10ed-328a-47af-bd7d-128946e77f81"
      unitRef="eur">-7000000</sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzExLTEtMS0xLTM2NDA2MA_a493ce94-cde1-4b0e-86a8-85c9dc83fc07"
      unitRef="eur">2745000000</ifrs-full:RightofuseAssets>
    <sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzEyLTEtMS0xLTM2NDA2MA_48bf5c5d-3741-45ba-9f81-931edfdcd797"
      unitRef="eur">-26000000</sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets>
    <sny:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzEzLTEtMS0xLTM2NDA2MA_cb274697-2dfc-401d-aa3d-c13cb1ca7b6e"
      unitRef="eur">292000000</sny:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets>
    <sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE0LTEtMS0xLTM2NDA2MA_16d19a1d-65ce-4055-b8eb-7011473a2e6e"
      unitRef="eur">232000000</sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE1LTEtMS0xLTM2NDA2MA_e69dcb61-75c0-4c70-a22c-da3352ab3d8e"
      unitRef="eur">101000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE2LTEtMS0xLTM2NDA2MA_554a3144-f03c-4289-8c64-07b97508bc63"
      unitRef="eur">-8000000</sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE3LTEtMS0xLTM2NDA2MA_859b8b76-3249-432a-acd2-a7298da0dc78"
      unitRef="eur">2872000000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="idc8a6784630a4f6dacd4f922e9fdcfda_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE4LTEtMS0xLTM2NDA2MA_ad9acaa5-5cc6-4b23-894b-5aec9d3e4beb"
      unitRef="eur">-283000000</ifrs-full:RightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIyLTEtMS0xLTM3MTQyMg_c5265486-13c8-4137-8680-27432de5a46e"
      unitRef="eur">299000000</ifrs-full:DepreciationRightofuseAssets>
    <sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIzLTEtMS0xLTM3MTQyMg_6a5ecdee-3a31-4dd1-a729-042040f4bdfc"
      unitRef="eur">-44000000</sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzE5LTEtMS0xLTM2NDA2MA_bb51dc90-06e9-4782-98a6-55df2bfd207b"
      unitRef="eur">22000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIwLTEtMS0xLTM2NDA2MA_c9564eef-2538-4555-bcb0-fd42d392549c"
      unitRef="eur">3000000</sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="i9bd6e4b32cb345028d31ec8dc75abdea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIxLTEtMS0xLTM2NDA2MA_fc398901-ab13-45bf-8d0b-3f1a848d6afd"
      unitRef="eur">-513000000</ifrs-full:RightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIyLTEtMS0xLTM2NDA2MA_2be94f0e-ddf6-4b86-a86a-a9fefbde56ba"
      unitRef="eur">315000000</ifrs-full:DepreciationRightofuseAssets>
    <sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzIzLTEtMS0xLTM2NDA2MA_388786c9-15b2-44d6-8684-e30a07ebc8d4"
      unitRef="eur">-40000000</sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI0LTEtMS0xLTM2NDA2MA_8e78dc7f-7256-4ede-b5c5-e6ca9cd53093"
      unitRef="eur">-15000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI1LTEtMS0xLTM2NDA2MA_64f46f01-4c44-48e3-a389-99656402e7fc"
      unitRef="eur">6000000</sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="ida5c0c7399ab4f90ab42e89c5e29af71_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI2LTEtMS0xLTM2NDA2MA_d5ac50d3-6985-42e4-988d-8c47656a2308"
      unitRef="eur">-797000000</ifrs-full:RightofuseAssets>
    <sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMzLTEtMS0xLTM3MTQyMg_ac868b18-ddc7-4a22-8e31-6d033c05b853"
      unitRef="eur">14000000</sny:AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI3LTEtMS0xLTM2NDA2MA_1b38e35c-1327-4a76-bdfc-b3b76a8bb6b0"
      unitRef="eur">341000000</ifrs-full:DepreciationRightofuseAssets>
    <sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI4LTEtMS0xLTM2NDA2MA_449de399-568f-4efe-8794-193264102aed"
      unitRef="eur">-82000000</sny:DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzI5LTEtMS0xLTM2NDA2MA_4c56990c-d030-43fb-9f15-c5e84b13e308"
      unitRef="eur">-17000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets>
    <sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMwLTEtMS0xLTM2NDA2MA_273b2f05-c9fe-4dd7-971b-8f265a3343c1"
      unitRef="eur">2000000</sny:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="i8d73c6b22ae6491dbc37944b398879b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMxLTEtMS0xLTM2NDA2MA_212e14bd-abef-414c-80a8-3f19743db289"
      unitRef="eur">-1057000000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMyLTEtMS0xLTM2NDA2MA_992e0fe5-e96a-4974-af3e-46a8c2cf1da2"
      unitRef="eur">1198000000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzMzLTEtMS0xLTM2NDA2MA_51997faa-861e-4a1f-b012-b1411f9c1cf0"
      unitRef="eur">1948000000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90YWJsZTo3NzllZjQzMGQ2OTE0NWRiYTgwMzNmNGM5ZDQzZjczNS90YWJsZXJhbmdlOjc3OWVmNDMwZDY5MTQ1ZGJhODAzM2Y0YzlkNDNmNzM1XzM0LTEtMS0xLTM2NDA2MA_bf08c373-aa60-4dbf-b241-da6aa4128268"
      unitRef="eur">1815000000</ifrs-full:RightofuseAssets>
    <sny:NumberOfLeaseAgreementsSigned
      contextRef="ia2a9d85e3600439fa8021956ade9fb27_D20181201-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzExOTA_93f8956e-3716-439f-97b8-e45092aff0a4"
      unitRef="lease">2</sny:NumberOfLeaseAgreementsSigned>
    <sny:InitialLeaseTerm
      contextRef="ia2a9d85e3600439fa8021956ade9fb27_D20181201-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzEzMDI_c847bb5f-edc4-415b-ae61-473a1c8d5b49">P15Y</sny:InitialLeaseTerm>
    <ifrs-full:RightofuseAssets
      contextRef="idf46653d45ba47878e79284f8a9651fe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE0MTI_06c43500-f176-43a3-b9e0-1a201c71ae94"
      unitRef="eur">320000000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities
      contextRef="idf46653d45ba47878e79284f8a9651fe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE0MTI_3636b328-499e-485e-b5a9-61207b66884b"
      unitRef="eur">320000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:RightofuseAssets
      contextRef="i521770fd159a444e8b290a2b366d3120_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE1NjY_7a43ea13-b5d6-412c-9a7b-0c5074d25bba"
      unitRef="eur">424000000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities
      contextRef="i521770fd159a444e8b290a2b366d3120_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE1NjY_84e80aae-ea0d-44f5-88de-b47d16cd2aed"
      unitRef="eur">424000000</ifrs-full:LeaseLiabilities>
    <sny:LeasedAssetsPercentage
      contextRef="i9975866b6f0948c4b2dc3d5202c3a8e7_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE2NzM_cc40e9b7-d382-4809-8240-8b9f17599254"
      unitRef="number">0.93</sny:LeasedAssetsPercentage>
    <sny:LeasedAssetsPercentage
      contextRef="ie04ea8d3bc0f4c5ba8c8a671c1dfec8a_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE3MDA_811a5ffe-5e24-4fc9-9857-5ce861f41f53"
      unitRef="number">0.07</sny:LeasedAssetsPercentage>
    <sny:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE3OTM_8d09dddc-3887-47e6-a21d-657ce3447b61"
      unitRef="eur">26000000</sny:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <sny:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE4MTg_7b73e03d-ceeb-4ea8-8036-30751d3cc7ba"
      unitRef="eur">25000000</sny:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <sny:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzE4NDc_c89cac2b-4170-40d5-9fc9-8ad18fe5d2a3"
      unitRef="eur">27000000</sny:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:CashOutflowForLeases
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzIwOTU_dfc2ea75-8368-4aa7-9c6f-6db63be2a1c3"
      unitRef="eur">389000000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzIxMjA_2d99b079-f4c6-4b9d-a0c3-8f5cae9572be"
      unitRef="eur">302000000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl81OTgvZnJhZzo3ZGE0YjdjMDdiMjI0MzUzYjc0NzJmMWEyMThlMzVlMi90ZXh0cmVnaW9uOjdkYTRiN2MwN2IyMjQzNTNiNzQ3MmYxYTIxOGUzNWUyXzIxNDk_88540ffe-2840-4d64-9fc7-88f7957e0ed2"
      unitRef="eur">269000000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2OTM4MDM0ODkyMTQw_8d5f4c61-b2c9-4dc0-88d7-927c608dbc1e">Goodwill and other intangible assets&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Movements in goodwill comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;44,519&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements during the period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;44,364&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements during the period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;48,056&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements during the period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;49,892&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) This line mainly comprises the amount of goodwill allocated to divested operations in accordance with paragraph&#160;86 of IAS&#160;36, and in 2022 the sale of EUROAPI (see note&#160;D.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisition of Amunix Pharmaceuticals, Inc. (2022)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation for Amunix Pharmaceuticals, Inc. resulted in the recognition of intangible assets (other than goodwill) o&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;f&#160;&#x20ac;493&#160;million as of the acquisition date (February&#160;8, 2022), and of goodwill provisionally measured at &#x20ac;609&#160;million as of the acquisition date (see Note&#160;D.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisition of Translate Bio (2021)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation for Translate&#160;Bio resulted in the recognition of intangible a&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;ssets (other than goodwill) of&#160;&#x20ac;396&#160;million as of the acquisition date (September&#160;14, 2021), and of goodwill measured at &#x20ac;2,118&#160;million as of the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; acquisition date (see Note&#160;D.2.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisition of Principia (2020)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation for Principia resulted in the recognition of in&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;tangible assets (other than goodwill) of &#x20ac;2,534 million as of the acquisition date (September&#160;28, 2020), and of goodwill measured at &#x20ac;912&#160;million as of the acquisition date (se&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;e&#160;Note&#160;D.2.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisition of Synthorx (2020)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation for Synthorx resulted in the recognition of intangible a&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;ssets (other than goodwill) totaling &#x20ac;1,549 million as of the acquisition date (January&#160;23, 2020), and of goodwill measured at &#x20ac;930 million as o&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;f the acquisition date (see Note&#160;D.2.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Movements in other intangible assets comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.595%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.061%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Acquired R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Products,&lt;br/&gt;trademarks and&lt;br/&gt;other rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total other&lt;br/&gt;intangible assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at January&#160;1, 2020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,730&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;63,953&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,613&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;71,296&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes&#160;in&#160;scope of&#160;consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(333)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(593)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,926)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,600&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;61,074&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,633&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;72,307&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(313)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(502)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(784)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,207&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;65,906&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,752&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;78,865&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,354&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;69,579&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,783&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;81,716&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated amortization &amp;amp; impairment at January&#160;1, 2020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(50,314)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,077)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(54,787)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated amortization &amp;amp; impairment at December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,508)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(49,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(53,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,740)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated amortization &amp;amp; impairment at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(52,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(57,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt; (e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated amortization &amp;amp; impairment at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(54,652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(60,076)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Carrying amount at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Carrying amount at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,226&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,927&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;487&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21,640&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement (see Note&#160;A.2.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) The &#x201c;Transfers&#x201d; line mainly comprises (i) acquired R&amp;amp;D that came into commercial use during the period and (ii) reclassifications of assets as held for sale or exchange.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) The &#x201c;Changes in scope of consolidation&#x201d; line corresponds to the fair value of intangible assets recognized in connection with acquisitions made during the period (see Notes&#160;D.1. and&#160;D.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d) See Note&#160;D.5.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(e) The amendment to the terms of the IO License and Collaboration Agreement resulted in the recognition of an amortization charge of &#x20ac;226&#160;million (see&#160;Note C.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x201c;Products, trademarks and other rights&#x201d; mainly comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;&#x201c;marketed products&#x201d;, with a carrying amount of &#x20ac;12.7 billion as of December 31, 2022 (versus &#x20ac;11.7 billion as of December 31, 2021 and &#x20ac;11.4 billion as of December 31, 2020) and a weighted average amortization period of approximately 10&#160;years; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;&#x201c;technological platforms&#x201d;, with a carrying amount of &#x20ac;2.2 billion as of December 31, 2022 (versus &#x20ac;1.2&#160;billion as of December 31, 2021 and &#x20ac;0.2&#160;billion as of December 31, 2020) and a weighted average amortization period of approximately 18&#160;years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below provides information about the principal &#x201c;marketed products&#x201d;, which were recognized in connection with major acquisitions made by Sanofi and represented 92% of the carrying amount of that item as of December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;amortization&#160;&amp;amp;&lt;br/&gt;impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(years)&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Residual&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;amortization&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(years)&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Boehringer Ingelheim &lt;br/&gt;Consumer Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(34,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Chattem&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Protein Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ablynx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bioverativ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Kadmon&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total: principal marketed products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;62,827&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(51,144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,683&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,752&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,341&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Weighted averages. The amortization periods for these products vary between 1&#160;and 25&#160;years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Weighted averages.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Acquisitions of other intangible assets (excluding software) during 2022 amounted to &#x20ac;472 million. The main items were upfront and milestone payments within the Specialty Care GBU.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The principal intangible assets brought into service during 2022 were:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;Enjaymo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (sutimlimab-jome), a treatment for cold agglutinin disease (gross value &#x20ac;854&#160;million net of impairment of &#x20ac;363&#160;million), with effect from the date of marketing approval (February&#160;2022); and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;technology platforms (&#x20ac;525&#160;million).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The main asset brought into service during 2021 was the Translate Bio mRNA technology platform.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;During 2020, some of the acquired research and development came into commercial use, and started being amortized from the date of marketing approval; the main items involved were Sarclisa&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, indicated for the treatment of relapsed refractory multiple myeloma, and the meningococcal vaccine MenQuadfi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Amortization of other intangible assets is recognized in the income statement within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, except for amortization of software and other rights of an industrial or operational nature which is recognized in the relevant classification of expense by function. An analysis of amortization of software is shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and general expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;112&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement (see Note&#160;A.2.1.).&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzM5NzU_7774da56-e2be-4fc3-b30f-63470ab42d3d">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Movements in goodwill comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;44,519&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements during the period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;44,364&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements during the period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;48,056&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements during the period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;49,892&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) This line mainly comprises the amount of goodwill allocated to divested operations in accordance with paragraph&#160;86 of IAS&#160;36, and in 2022 the sale of EUROAPI (see note&#160;D.1.).&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="i0ddd2e8b048c4aceb5e20e5ee54cfd35_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzEtMS0xLTEtMzY0MDYw_15bb4f78-cf63-4cc4-9b62-b2e969fb5833"
      unitRef="eur">44519000000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="i04c2256e354744d2b996810e1b4ce23b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzItMS0xLTEtMzY0MDYw_10aa8690-827b-4e5e-a901-5dc4b5bf8046"
      unitRef="eur">1843000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill
      contextRef="i04c2256e354744d2b996810e1b4ce23b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzMtMS0xLTEtMzY0MDYw_14d51b47-233f-4207-8a53-e7223da8f044"
      unitRef="eur">-75000000</ifrs-full:IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="i04c2256e354744d2b996810e1b4ce23b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzQtMS0xLTEtMzY0MDYw_5e8dd783-ada4-435c-bb73-2a9511fa8108"
      unitRef="eur">-1923000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="ic7d3b42ca90c45d9a60556ebff587fa1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzUtMS0xLTEtMzY0MDYw_ec53260d-921c-4525-ab49-ab992199b2ba"
      unitRef="eur">44364000000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="iccfd390288694500897be21beb1f90d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzYtMS0xLTEtMzY0MDYw_f70941a5-02f7-4f49-a2a3-6790ca22ded2"
      unitRef="eur">2179000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill
      contextRef="iccfd390288694500897be21beb1f90d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzctMS0xLTEtMzY0MDYw_54e6db24-07eb-420b-9d0a-add014002004"
      unitRef="eur">-89000000</ifrs-full:IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="iccfd390288694500897be21beb1f90d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzgtMS0xLTEtMzY0MDYw_306d7572-a387-475b-b8fa-ff94b5218384"
      unitRef="eur">1602000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="i6e1d225964344fc99aa88194ac03758e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzktMS0xLTEtMzY0MDYw_5bd537b5-f1f8-4960-87e5-dfeb106c3049"
      unitRef="eur">48056000000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="i18beae5325a24e4b91ab73391d713a14_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzEwLTEtMS0xLTM2NDA2MA_10b4e3bb-b95a-4a09-bb35-6911574bb791"
      unitRef="eur">609000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill
      contextRef="i18beae5325a24e4b91ab73391d713a14_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzExLTEtMS0xLTM2NDA2MA_5f4d0ddd-9b92-4e2b-83eb-dc5bd85d60fc"
      unitRef="eur">-258000000</ifrs-full:IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="i18beae5325a24e4b91ab73391d713a14_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzEyLTEtMS0xLTM2NDA2MA_0c3c79a4-dba7-4bda-9f44-2ba0eddab01a"
      unitRef="eur">1485000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="i805096a31a54493f98690df2512c4182_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTozNDc0YTg1YmVmNDk0YjIyOTEwNjliMjRiM2Y0N2Q4NC90YWJsZXJhbmdlOjM0NzRhODViZWY0OTRiMjI5MTA2OWIyNGIzZjQ3ZDg0XzEzLTEtMS0xLTM2NDA2MA_2e610b1e-4b87-49e6-96db-52cba51fd63c"
      unitRef="eur">49892000000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="ice04a6b9957a4d6db37a912faaaaa4fb_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzYwNDczMTM5NTc0MTQ_de356b15-f5b9-419e-ac39-1a88606c1ef8"
      unitRef="eur">493000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:Goodwill
      contextRef="ice04a6b9957a4d6db37a912faaaaa4fb_I20220208"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2OTM4MDM0ODkyMTM4_50a36537-84dd-4e0c-8971-fa936669b616"
      unitRef="eur">609000000</ifrs-full:Goodwill>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzM3NQ_eb93f39b-a604-499d-8947-c05b79acd879"
      unitRef="eur">396000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:Goodwill
      contextRef="i346802ed216643f29cf03ce4f829ef06_I20210914"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzQ3OA_cd4a3974-123c-4e67-bc7e-4e2e7dcc7163"
      unitRef="eur">2118000000</ifrs-full:Goodwill>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzY4OQ_98928fb7-0f64-428b-a96b-000cdbe856b0"
      unitRef="eur">2534000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:Goodwill
      contextRef="i726362910e9b4dfc9dbaeb1583ce65cf_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzc3MA_5dcdce4a-c559-40a8-9a4f-1fc8d92f9be9"
      unitRef="eur">912000000</ifrs-full:Goodwill>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzk4Nw_212a5874-0168-4bca-81d4-e8bd58b298c6"
      unitRef="eur">1549000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:Goodwill
      contextRef="i1818566194634dcfabc96b128a36c2bf_I20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzEwNjU_3058177f-bae7-443a-9f2b-4ddf2ed3c812"
      unitRef="eur">930000000</ifrs-full:Goodwill>
    <sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzM5Nzc_f09607c5-96e9-417f-93fe-5cf9ef22f98e">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Movements in other intangible assets comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.595%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.061%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Acquired R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Products,&lt;br/&gt;trademarks and&lt;br/&gt;other rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total other&lt;br/&gt;intangible assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at January&#160;1, 2020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,730&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;63,953&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,613&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;71,296&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes&#160;in&#160;scope of&#160;consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(333)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(593)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,926)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,600&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;61,074&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,633&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;72,307&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(313)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(502)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(784)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,207&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;65,906&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,752&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;78,865&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions and other increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross value at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,354&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;69,579&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,783&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;81,716&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated amortization &amp;amp; impairment at January&#160;1, 2020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(50,314)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,077)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(54,787)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated amortization &amp;amp; impairment at December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,508)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(49,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(53,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,740)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated amortization &amp;amp; impairment at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(52,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(57,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt; (e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Impairment losses, net of reversals&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Disposals and other decreases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated amortization &amp;amp; impairment at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(54,652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(60,076)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Carrying amount at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Carrying amount at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,226&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,927&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;487&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21,640&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement (see Note&#160;A.2.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) The &#x201c;Transfers&#x201d; line mainly comprises (i) acquired R&amp;amp;D that came into commercial use during the period and (ii) reclassifications of assets as held for sale or exchange.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) The &#x201c;Changes in scope of consolidation&#x201d; line corresponds to the fair value of intangible assets recognized in connection with acquisitions made during the period (see Notes&#160;D.1. and&#160;D.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d) See Note&#160;D.5.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(e) The amendment to the terms of the IO License and Collaboration Agreement resulted in the recognition of an amortization charge of &#x20ac;226&#160;million (see&#160;Note C.1.).&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i972f543731c343078d24518f433fa726_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEtMS0xLTEtMzY0MDYw_90cd4c54-c9e9-46ff-ac92-dd1a4d433987"
      unitRef="eur">5730000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i479eecf06f384cd28a6d6234aded995c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEtMi0xLTEtMzY0MDYw_cb7b380d-cb56-4329-9c8a-006e11c33453"
      unitRef="eur">63953000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="ib655a021196d4cdfbe4475108064a5fd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEtMy0xLTEtMzY0MDYw_839d4dd7-bdf1-4b91-8596-55eca74f6af3"
      unitRef="eur">1613000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i0a5f73156d8942cc9aff9b90aa0a20d9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEtNS0xLTEtMzY0MDYw_3b8cfb4b-a000-4de5-9523-313b66250511"
      unitRef="eur">71296000000</ifrs-full:OtherIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzItMS0xLTEtMzY0MDYw_f948768b-f431-4e7f-9e92-13de33ebb687"
      unitRef="eur">3951000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="idcc8c91558474195b7619d926905f4a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzItMi0xLTEtMzY0MDYw_bda135fb-01f4-42b7-85db-7d2f34b969a9"
      unitRef="eur">132000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzItMy0xLTEtMzY0MDYw_bab677bc-a243-402f-92a1-f094b868623d"
      unitRef="eur">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzItNS0xLTEtMzY0MDYw_2c49a438-5b48-491b-965c-b4887832ed44"
      unitRef="eur">4083000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMtMS0xLTEtMzY0MDYw_37eaf158-be34-4b30-8ac5-876f120aa232"
      unitRef="eur">654000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="idcc8c91558474195b7619d926905f4a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMtMi0xLTEtMzY0MDYw_9009d31b-98ed-4fa7-a948-3023613d012b"
      unitRef="eur">58000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMtMy0xLTEtMzY0MDYw_48b3c6b2-36db-4aa3-8814-7183d1c49b4d"
      unitRef="eur">106000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMtNS0xLTEtMzY0MDYw_2a694e23-a9f8-4975-9f24-8d0acc76fe4b"
      unitRef="eur">818000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQtMS0xLTEtMzY0MDYw_eeaf9e56-90c8-4b11-97a0-4262c73ec605"
      unitRef="eur">44000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="idcc8c91558474195b7619d926905f4a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQtMi0xLTEtMzY0MDYw_a0153541-27fb-49da-aea0-c09fd39e0712"
      unitRef="eur">243000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQtMy0xLTEtMzY0MDYw_62e394b6-8e97-4bfb-bda3-9728f511d92d"
      unitRef="eur">46000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQtNS0xLTEtMzY0MDYw_47d715b1-cb6c-4c80-af85-cfc1ae5b5fd3"
      unitRef="eur">333000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzUtMS0xLTEtMzY0MDYw_d946e3f1-1f5f-4297-b42b-2a9f3ea62381"
      unitRef="eur">-593000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="idcc8c91558474195b7619d926905f4a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzUtMi0xLTEtMzY0MDYw_963e31d1-b7cc-4812-8425-5622631261d3"
      unitRef="eur">-2926000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzUtMy0xLTEtMzY0MDYw_6ecebe3d-b25e-439a-ac31-680c262eb6ab"
      unitRef="eur">-38000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzUtNS0xLTEtMzY0MDYw_7be7d891-94a8-449b-9615-58a505c8b34f"
      unitRef="eur">-3557000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="i0d6057f8a88a4ab19a6114164ea4c04f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzYtMS0xLTEtMzY0MDYw_ac0db332-c592-4cb4-9b54-dab398d333d4"
      unitRef="eur">-98000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="idcc8c91558474195b7619d926905f4a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzYtMi0xLTEtMzY0MDYw_683e6749-c4c8-4ba6-a20b-896cd5102696"
      unitRef="eur">100000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="ic185381f05c942b3b0f16f94502954ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzYtMy0xLTEtMzY0MDYw_49404a8c-0aef-456b-ac20-ecb67f0ace3f"
      unitRef="eur">-2000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="i27cf815902454458a945f8a2595eafe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzYtNS0xLTEtMzY0MDYw_6db206a0-f47d-48bb-ab15-d643ad6035df"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i0012231543ff4a8da7fc419bff0a9e67_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzctMS0xLTEtMzY0MDYw_327af381-070d-408b-9e03-972a361a7e14"
      unitRef="eur">9600000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="ic2d610536ebf4dbf8b9a88106c67353f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzctMi0xLTEtMzY0MDYw_79c33281-8415-47b6-af39-9efd64017e87"
      unitRef="eur">61074000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="ic16020b4a1554e8a9cf89178c464111a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzctMy0xLTEtMzY0MDYw_73dacd03-8a1a-485e-997f-1f4347a2478a"
      unitRef="eur">1633000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzctNS0xLTEtMzY0MDYw_6e49198e-0aae-458d-9546-c974f9f837d6"
      unitRef="eur">72307000000</ifrs-full:OtherIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzgtMS0xLTEtMzY0MDYw_80e20218-2d9a-4145-86e3-79abdc7fdb04"
      unitRef="eur">1805000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzgtMi0xLTEtMzY0MDYw_2d7dd2f2-1a98-4e27-97e0-fb6acc6fa79b"
      unitRef="eur">1821000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzgtMy0xLTEtMzY0MDYw_98ffab46-5c9a-4bac-a023-e73b16c4f60e"
      unitRef="eur">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzgtNS0xLTEtMzY0MDYw_f1f34ff0-2ae6-49ea-b05a-ca312575c373"
      unitRef="eur">3626000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzktMS0xLTEtMzY0MDYw_60910940-1ef2-4a6a-83e9-368d789265c2"
      unitRef="eur">339000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzktMi0xLTEtMzY0MDYw_9bd9bf8a-f761-411b-80ec-063376558285"
      unitRef="eur">159000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzktMy0xLTEtMzY0MDYw_0ba10264-3235-4fda-b055-89f71784827a"
      unitRef="eur">118000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzktNS0xLTEtMzY0MDYw_5097892f-8a76-4f63-b55b-4993ae1bae20"
      unitRef="eur">616000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEwLTEtMS0xLTM2NDA2MA_5120710b-19d9-4e07-b5b9-7dea8a010bca"
      unitRef="eur">313000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEwLTItMS0xLTM2NDA2MA_972e08a9-6947-4e66-a05c-a800498ed181"
      unitRef="eur">173000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEwLTMtMS0xLTM2NDA2MA_a16f94b0-af1f-4347-97d1-9b8d7fcc5e9e"
      unitRef="eur">16000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEwLTUtMS0xLTM2NDA2MA_8f644319-4f30-4bf1-89c2-4d947b70efab"
      unitRef="eur">502000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzExLTEtMS0xLTM2NDA2MA_7d485f7c-45ea-4687-878e-d5416910d27d"
      unitRef="eur">560000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzExLTItMS0xLTM2NDA2MA_8102bb04-5021-46cc-8806-15e67f72788d"
      unitRef="eur">2234000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzExLTMtMS0xLTM2NDA2MA_de7ff90f-5f06-4405-b8df-80e4abd399f8"
      unitRef="eur">24000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzExLTUtMS0xLTM2NDA2MA_d88ad1e9-675a-4e4c-92eb-cdeff9c9f83a"
      unitRef="eur">2818000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="ic67faeaa9c1d443d9219de6a0a9705f9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEyLTEtMS0xLTM2NDA2MA_7899ce1c-53b3-4270-b934-dc95fb04dff4"
      unitRef="eur">-784000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="i7113fc31712f43b4a8013e68c271e09e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEyLTItMS0xLTM2NDA2MA_5b3722f7-8461-4801-9876-b920c1dd3656"
      unitRef="eur">791000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="ic1d21b37ca8c483c8ffc317559dd291e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEyLTMtMS0xLTM2NDA2MA_d5bf01e8-8be6-4995-8163-6628cdf66840"
      unitRef="eur">-7000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="iedff867a40194ec083a67cf71ea66917_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEyLTUtMS0xLTM2NDA2MA_b9703ab7-101e-4792-a542-16573ec61a92"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherIntangibleAssets
      contextRef="ie7a0da2ecaa04eeb814d811ee982a0af_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEzLTEtMS0xLTM2NDA2MA_1e892f7c-62a1-4c2c-b254-b0929b37a7ee"
      unitRef="eur">11207000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i3f1973ece55247c7bfca1df0959ed390_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEzLTItMS0xLTM2NDA2MA_20bbdfdb-607b-426c-9290-fda2605f4bb4"
      unitRef="eur">65906000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i738d8bb190154e6885638cf09b03af8a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEzLTMtMS0xLTM2NDA2MA_36100dc9-cda3-4e88-9686-c8a7f98e4d37"
      unitRef="eur">1752000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzEzLTUtMS0xLTM2NDA2MA_5ac2e5a8-94e0-42df-89ec-7acfcfddbb31"
      unitRef="eur">78865000000</ifrs-full:OtherIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE0LTEtMS0xLTM2NDA2MA_c0d77a61-8c65-4204-a84f-e6e38586f0d5"
      unitRef="eur">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="i212426e60cf24241b201ace1b0732af7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE0LTItMS0xLTM2NDA2MA_117ea130-ebfe-48e9-9be6-797151fdcae1"
      unitRef="eur">499000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE0LTMtMS0xLTM2NDA2MA_bafa3e30-45e0-4dd9-bc9e-0dda4a90ffe0"
      unitRef="eur">-35000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE0LTUtMS0xLTM2NDA2MA_511eacc1-990b-4360-aafa-a65dc27f32d6"
      unitRef="eur">464000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE1LTEtMS0xLTM2NDA2MA_27ae6585-2250-4536-b091-1c3cb43cca3c"
      unitRef="eur">277000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="i212426e60cf24241b201ace1b0732af7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE1LTItMS0xLTM2NDA2MA_ddb101a7-eafa-48ad-8da4-ca33ca370944"
      unitRef="eur">195000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE1LTMtMS0xLTM2NDA2MA_513dedac-05c8-4856-b3bc-3f88434b3afe"
      unitRef="eur">99000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE1LTUtMS0xLTM2NDA2MA_0888f9ec-9435-4bd8-9c85-c764856f8c38"
      unitRef="eur">571000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE2LTEtMS0xLTM2NDA2MA_51ead8ec-f391-47e4-ad22-c8007559b03e"
      unitRef="eur">72000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="i212426e60cf24241b201ace1b0732af7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE2LTItMS0xLTM2NDA2MA_96feb6fa-716b-4309-9e98-2b5e30486581"
      unitRef="eur">423000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE2LTMtMS0xLTM2NDA2MA_11da7be6-d768-4394-bb6c-65df1b9bc6d7"
      unitRef="eur">48000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE2LTUtMS0xLTM2NDA2MA_694e1972-b8ae-4136-84f3-fe26e0a2a5a1"
      unitRef="eur">543000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE3LTEtMS0xLTM2NDA2MA_b99974ca-47e0-4e23-af5d-906e50c1136d"
      unitRef="eur">518000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="i212426e60cf24241b201ace1b0732af7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE3LTItMS0xLTM2NDA2MA_44a3e4c2-0294-4acf-ad37-007ddab1f694"
      unitRef="eur">1994000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE3LTMtMS0xLTM2NDA2MA_877a73a5-b1c9-4f6c-9465-79181a19c855"
      unitRef="eur">21000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE3LTUtMS0xLTM2NDA2MA_f2067bce-2fc7-4f24-858f-26712790f54c"
      unitRef="eur">2533000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="ia5ddeea93268432fa85ae10e23aa14b2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE4LTEtMS0xLTM2NDA2MA_f8818442-acb0-4018-b519-71c626b8c0fe"
      unitRef="eur">-1576000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="i212426e60cf24241b201ace1b0732af7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE4LTItMS0xLTM2NDA2MA_ee72955b-cc31-4f18-b1ca-251242b3e59d"
      unitRef="eur">1408000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="i05d5251355fc4f41aa9be8fbb43e8b6c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE4LTMtMS0xLTM2NDA2MA_b515e084-0b39-492a-8bcb-3f7f13d26a7d"
      unitRef="eur">-6000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="i9d532913ef384fd19661d028233c6947_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE4LTUtMS0xLTM2NDA2MA_a9c698be-260f-46d0-80e8-fc4174f48e69"
      unitRef="eur">-174000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i6c347307f4a945aeaeb2aa62d4b9c418_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE5LTEtMS0xLTM2NDA2MA_9155e974-3d8d-4471-9d37-0f16e4fb6da0"
      unitRef="eur">10354000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="id4bbdd4e400844a79a5da75e3ae604c9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE5LTItMS0xLTM2NDA2MA_f5712864-d914-401c-80d0-53928f93dd44"
      unitRef="eur">69579000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i5fdd2720629d4afcb9cb4ca0934ff100_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE5LTMtMS0xLTM2NDA2MA_c86817e6-1ef2-43dc-b088-2faad3c56113"
      unitRef="eur">1783000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzE5LTUtMS0xLTM2NDA2MA_8ae6d3c3-9a64-460b-9087-eac25c16eeca"
      unitRef="eur">81716000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="id1e50048305543d09b31dcbeb40df282_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIwLTEtMS0xLTM2NDA2MA_a6be4950-ef2f-4629-a73d-b482936222c5"
      unitRef="eur">-3396000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i89f73a7c69a540c59681a9b3cdc360f5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIwLTItMS0xLTM2NDA2MA_8ed245fe-d7e7-4f29-8178-4e15b86cb22f"
      unitRef="eur">-50314000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i4eaa16fcabab488eaa79bd1b746613c6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIwLTMtMS0xLTM2NDA2MA_deeb5c21-6468-42cc-af32-7fbb27dde0ed"
      unitRef="eur">-1077000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="idc8a6784630a4f6dacd4f922e9fdcfda_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIwLTUtMS0xLTM2NDA2MA_bb2a39ce-d533-4520-b4a3-051e3cfc2e5d"
      unitRef="eur">-54787000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIyLTEtMS0xLTM2NDA2MA_c1c599e4-9829-47b4-b5d9-6f8bb1c4cfb0"
      unitRef="eur">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIyLTItMS0xLTM2NDA2MA_5a674c5d-73db-493d-9d9c-75b24ed4b880"
      unitRef="eur">1707000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIyLTMtMS0xLTM2NDA2MA_0f2a0a4f-7f16-4e67-bf0d-5a3cf2ad26ef"
      unitRef="eur">112000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIyLTUtMS0xLTM2NDA2MA_3ec56732-2cc8-4e48-8579-25ca4ea4393e"
      unitRef="eur">1819000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIzLTEtMS0xLTM2NDA2MA_dfde0544-d221-40e6-a018-dc10ac482b5a"
      unitRef="eur">328000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIzLTItMS0xLTM2NDA2MA_fbc03c23-654c-4585-a407-d9b73d3bb677"
      unitRef="eur">2000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIzLTMtMS0xLTM2NDA2MA_7e493f60-2317-43dd-a67a-41b62e7dec68"
      unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzIzLTUtMS0xLTM2NDA2MA_a4b721fc-7404-48c7-a5ee-7741487de04c"
      unitRef="eur">330000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI0LTEtMS0xLTM2NDA2MA_f1452a7f-8ff7-45cf-b5af-ed089b8f8592"
      unitRef="eur">-44000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI0LTItMS0xLTM2NDA2MA_189d06ab-edc6-41a6-b18f-b19426bb1ff9"
      unitRef="eur">-232000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI0LTMtMS0xLTM2NDA2MA_85dae13f-32a1-46f5-bf57-1054c2387209"
      unitRef="eur">-45000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI0LTUtMS0xLTM2NDA2MA_7b1f974d-4db5-4d91-9359-a9942831aff4"
      unitRef="eur">-321000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI1LTEtMS0xLTM2NDA2MA_f7e9f87e-7216-4fe9-92eb-0dbd259d0597"
      unitRef="eur">158000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI1LTItMS0xLTM2NDA2MA_200c8e14-2c0f-4303-adb4-258e9c28b970"
      unitRef="eur">2460000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI1LTMtMS0xLTM2NDA2MA_c41c65f4-9ac7-4130-a360-16cffa989863"
      unitRef="eur">31000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI1LTUtMS0xLTM2NDA2MA_fc070d13-be78-475c-80c4-39675cfde509"
      unitRef="eur">2649000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="idd0e1dbb7467421f8c6887eb0d8e7e65_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI2LTEtMS0xLTM2NDA2MA_23db2ce5-b785-46a6-8b1e-d919d93902b2"
      unitRef="eur">14000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="i010b8e3b7bbf42b08f4149fcb73d1b19_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI2LTItMS0xLTM2NDA2MA_d67efe6e-6b87-4a45-9376-914bd5f3d407"
      unitRef="eur">-14000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="if735cc24a59246cba9540dc9f95873d7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI2LTMtMS0xLTM2NDA2MA_afe67313-b4c0-4474-83a1-6773bea6bab0"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="iecdc12e357fe4e1e9af47ab8e4843ec5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI2LTUtMS0xLTM2NDA2MA_9e27af3b-c296-4f47-9263-850d10f72fa9"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i58368e802e1c49819f70d00a80e9b758_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI3LTEtMS0xLTM2NDA2MA_1985f5b8-a5aa-46c2-87fc-e6de95396189"
      unitRef="eur">-3508000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i3f5e538c39c74bc1bda08a15d67a3de9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI3LTItMS0xLTM2NDA2MA_4006da26-7d92-4953-8e71-dff2abed0791"
      unitRef="eur">-49345000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i808e5c06bdd646ccbbe77ddc9e3f1433_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI3LTMtMS0xLTM2NDA2MA_bea15288-ddbc-4bb2-9e41-ac12886434e3"
      unitRef="eur">-1113000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i9bd6e4b32cb345028d31ec8dc75abdea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI3LTUtMS0xLTM2NDA2MA_2ad86cb1-ecd8-4b9f-8345-2af017005f79"
      unitRef="eur">-53966000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="ia8053a4d07214c0c8866abb7aa242822_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI5LTEtMS0xLTM2NDA2MA_b22d0ea4-0a9d-4696-9236-e08464d8be20"
      unitRef="eur">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="ie4e712c22a384fdf9a6a92f6d8363ca3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI5LTItMS0xLTM2NDA2MA_62f95f71-0561-4a97-a622-4dd48534c7ee"
      unitRef="eur">1621000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="ic159b371543149fe98e5dbe979df7b29_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI5LTMtMS0xLTM2NDA2MA_405e57cb-eeb9-44b1-a33f-6fc448239122"
      unitRef="eur">119000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzI5LTUtMS0xLTM2NDA2MA_d98767bc-b072-4cb5-a377-90ba442cb224"
      unitRef="eur">1740000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="ia8053a4d07214c0c8866abb7aa242822_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMwLTEtMS0xLTM2NDA2MA_9f9178ed-8d4d-429b-be02-167d394969eb"
      unitRef="eur">150000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="ie4e712c22a384fdf9a6a92f6d8363ca3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMwLTItMS0xLTM2NDA2MA_9d06050a-d785-43a4-ae10-f10e287bb1e6"
      unitRef="eur">42000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="ic159b371543149fe98e5dbe979df7b29_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMwLTMtMS0xLTM2NDA2MA_27d632da-bcb3-4955-bd9a-f9d6e7e67c7d"
      unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMwLTUtMS0xLTM2NDA2MA_022f81bf-a97c-4f02-b6ee-0d54a3f7f038"
      unitRef="eur">192000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="ia8053a4d07214c0c8866abb7aa242822_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMxLTEtMS0xLTM2NDA2MA_84cea413-2bb5-4071-afe5-67086e8ac7fb"
      unitRef="eur">-313000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="ie4e712c22a384fdf9a6a92f6d8363ca3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMxLTItMS0xLTM2NDA2MA_d2f762f7-43d9-4d81-be7e-c116ed2cbeab"
      unitRef="eur">-133000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="ic159b371543149fe98e5dbe979df7b29_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMxLTMtMS0xLTM2NDA2MA_20592696-2a4b-4d15-b9f5-1852f3ed42b6"
      unitRef="eur">-16000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMxLTUtMS0xLTM2NDA2MA_e8876e43-a7f8-4e6f-b486-7907c1a1857a"
      unitRef="eur">-462000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="ia8053a4d07214c0c8866abb7aa242822_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMyLTEtMS0xLTM2NDA2MA_b6c230e2-8801-4eff-8131-cc975bb0c79c"
      unitRef="eur">-132000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="ie4e712c22a384fdf9a6a92f6d8363ca3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMyLTItMS0xLTM2NDA2MA_4b42403a-efe3-45f3-adf8-86a2f35dab87"
      unitRef="eur">-1869000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="ic159b371543149fe98e5dbe979df7b29_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMyLTMtMS0xLTM2NDA2MA_78df9375-2b00-4a7a-b384-a9a66d88a7f8"
      unitRef="eur">-21000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="id90f926826c348e58cc61d5392337455_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzMyLTUtMS0xLTM2NDA2MA_26f40618-aa58-4c4b-928b-1f2c84905f46"
      unitRef="eur">-2022000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i86724a133aba4372861b17fd7cc5dcc4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM0LTEtMS0xLTM2NDA2MA_89a4f0b4-0589-4f80-8cfa-19c3dceeffcb"
      unitRef="eur">-3477000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i6dd35aac58414697b4cc3b232d182e78_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM0LTItMS0xLTM2NDA2MA_b41bee2e-d813-48c3-8ca2-1d7077904c9b"
      unitRef="eur">-52744000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i5661f3ac3eb046019a9fd43280b32b15_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM0LTMtMS0xLTM2NDA2MA_0d3c717b-2b7d-4746-9cb8-dfd343e34905"
      unitRef="eur">-1237000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="ida5c0c7399ab4f90ab42e89c5e29af71_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM0LTUtMS0xLTM2NDA2MA_887ff2b2-891e-4b82-9f04-e1a90ccabd45"
      unitRef="eur">-57458000000</ifrs-full:OtherIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM1LTEtMS0xLTM2NDA2MA_bad1c812-f79a-4592-9b42-3e5e513912a2"
      unitRef="eur">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM1LTItMS0xLTM2NDA2MA_c361422a-7fcf-4d07-ad0c-94198ad2001a"
      unitRef="eur">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM1LTMtMS0xLTM2NDA2MA_4b8326ff-1325-4ec1-8732-e560468b2c5f"
      unitRef="eur">11000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM1LTUtMS0xLTM2NDA2MA_21d2cd9f-c36c-404f-b299-0a9e1429df89"
      unitRef="eur">11000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM2LTEtMS0xLTM2NDA2MA_fdcb693b-c44c-4f6a-9e97-04d98325d4b5"
      unitRef="eur">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM2LTItMS0xLTM2NDA2MA_85d59d8f-abec-4462-890c-0449aba3dd81"
      unitRef="eur">2099000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM2LTMtMS0xLTM2NDA2MA_4419d26b-4be5-4db1-b3a1-93a3d6a1bc17"
      unitRef="eur">97000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM2LTUtMS0xLTM2NDA2MA_1800e6ae-573e-44c8-a6eb-95c15e38d124"
      unitRef="eur">2196000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM3LTEtMS0xLTM2NDA2MA_e6bd8328-bf6f-4884-b6e6-b4fb0a216ad7"
      unitRef="eur">1107000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM3LTItMS0xLTM2NDA2MA_804ac66d-112a-40de-9be0-a451c39059ce"
      unitRef="eur">-1561000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM3LTMtMS0xLTM2NDA2MA_f81a913c-e036-4d92-8832-1909f904b3c4"
      unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM3LTUtMS0xLTM2NDA2MA_6ac96976-724a-4101-9b23-9061228262d6"
      unitRef="eur">-454000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM4LTEtMS0xLTM2NDA2MA_8ce920fd-03a2-4965-b654-2458751d4cab"
      unitRef="eur">-75000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM4LTItMS0xLTM2NDA2MA_4dff4284-84b7-4783-bef1-38f60d325e97"
      unitRef="eur">-411000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM4LTMtMS0xLTM2NDA2MA_737712ad-06b9-4f27-9e67-12b7e2c3ca86"
      unitRef="eur">-39000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM4LTUtMS0xLTM2NDA2MA_1ca11e1a-09d9-4402-a7e3-d1dad447bd7b"
      unitRef="eur">-525000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM5LTEtMS0xLTM2NDA2MA_b5ac6f69-a99c-4c34-a5a9-8f5f38ce929a"
      unitRef="eur">-7000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM5LTItMS0xLTM2NDA2MA_e35c9fdb-5c4f-4766-ab87-1454393ec188"
      unitRef="eur">-1567000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM5LTMtMS0xLTM2NDA2MA_19ad8c7a-d1fe-48c8-a8ed-c70e84a51e1f"
      unitRef="eur">-17000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzM5LTUtMS0xLTM2NDA2MA_a03afb44-c3ff-4744-80a3-4d0c95dc40cc"
      unitRef="eur">-1591000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="ie2e07c52dec84f09af1207fa2cf71265_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQwLTEtMS0xLTM2NDA2MA_ecd8d9fb-0fbf-48f0-98ad-5e3f16d14e2b"
      unitRef="eur">388000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="i26eb7f7c31cd45a7a630f58e4a97eda2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQwLTItMS0xLTM2NDA2MA_f85e793e-e371-4953-9606-0542f93b0b77"
      unitRef="eur">-214000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="i27e1bddc40414adc8dfb48360e0078ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQwLTMtMS0xLTM2NDA2MA_5ab88cc9-757d-4959-a2a7-5468c5ca55e6"
      unitRef="eur">5000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="i63729ceb65774d1b8999612861c2444c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQwLTUtMS0xLTM2NDA2MA_612df526-b176-4ed1-a8d2-341c982abd46"
      unitRef="eur">179000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherIntangibleAssets
      contextRef="idddba6af7c6d4af7bbd01c92c017cb84_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQxLTEtMS0xLTM2NDA2MA_fd6cf54c-9bb7-4c30-bd2b-b78116e320eb"
      unitRef="eur">-4128000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i5c01ebbf5a814bd68303efe91ff455cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQxLTItMS0xLTM2NDA2MA_ff8443c2-5960-4aff-a8ec-2d8a179e6f85"
      unitRef="eur">-54652000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="if22620dc4746433ea7ede1e7e434757f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQxLTMtMS0xLTM2NDA2MA_2e6d3188-3b04-4286-8dd6-655e0d2fbbe6"
      unitRef="eur">-1296000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i8d73c6b22ae6491dbc37944b398879b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQxLTUtMS0xLTM2NDA2MA_05edf979-f166-4789-a9b3-24b27e0fe8ed"
      unitRef="eur">-60076000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="ia4736438590b4561bf1bcf564c1f1016_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQyLTEtMS0xLTM2NDA2MA_33d92f17-c968-492c-a51c-2c440c3bc85f"
      unitRef="eur">6092000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="iaa0f7fa9eea84ac4a2c28706473cc2e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQyLTItMS0xLTM2NDA2MA_f95ba211-dc63-46d0-920a-263478804b5f"
      unitRef="eur">11729000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i2b534838cd34410bbdd454b2427db95c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQyLTMtMS0xLTM2NDA2MA_ae5c886d-2207-4147-95b8-9d89882eae27"
      unitRef="eur">520000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQyLTUtMS0xLTM2NDA2MA_315f804f-eb47-492a-8efa-c771b339c57e"
      unitRef="eur">18341000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="ia2b9c32fec7247f5b6cf4d373a4bdfdc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQzLTEtMS0xLTM2NDA2MA_161a92b1-ce19-4d3a-9ebc-fb32bab9c542"
      unitRef="eur">7730000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i83d587327ece400fb1dc4a4ed917f95c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQzLTItMS0xLTM2NDA2MA_629bf263-6b39-4a90-bc0b-95f6a402a425"
      unitRef="eur">13162000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="ief8f9ac9127344e5a1d9e4dc7468661d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQzLTMtMS0xLTM2NDA2MA_7e9e5cff-adab-42c9-9b1e-628b89fa98d5"
      unitRef="eur">515000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQzLTUtMS0xLTM2NDA2MA_af37197b-cd54-4e67-b1a5-fca859f2daac"
      unitRef="eur">21407000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i5633c4724ce148ac9ddfe510b1f65f4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQ0LTEtMS0xLTM2NDA2MA_0001f479-15b4-4b9d-8112-07c147a89f57"
      unitRef="eur">6226000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i958343bdb078497db2b964d690e99d81_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQ0LTItMS0xLTM2NDA2MA_3e9236f0-b372-4fd8-8837-543714b73a3b"
      unitRef="eur">14927000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="iaabb9095a1ff42f9a914e504f9b48258_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQ0LTMtMS0xLTM2NDA2MA_bbdcf47f-ed12-4920-a8a0-c58349558794"
      unitRef="eur">487000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTplODgxYWIyMWQ3Zjk0ZGJhYWU3OWFkZWU3ZGU4ZThiNC90YWJsZXJhbmdlOmU4ODFhYjIxZDdmOTRkYmFhZTc5YWRlZTdkZThlOGI0XzQ0LTUtMS0xLTM2NDA2MA_b4beb061-497d-4987-9b3c-717fad92a85e"
      unitRef="eur">21640000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="i425bfebf084d448791653b647ddc68bb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzgxMzYzODYwNDY3ODE3_08c50c64-6e2d-4d47-af15-d1d94234cd84"
      unitRef="eur">226000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i09b51cc206164edcae17c3cfc4b8be23_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzE4MjY_c2d127d9-f093-456b-a598-aecdac88d874"
      unitRef="eur">12700000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i84439ea7fd4f41189f4efa5cce7f5dee_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzE4NDY_f1f542ec-3909-4be6-afc7-385a23b30dfb"
      unitRef="eur">11700000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="iab92fc7553f84732a53070d96b07d717_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzE4NjI_8bc322ed-f422-46d4-bb8f-907edadc5ee9"
      unitRef="eur">11400000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="if1da231f2f58464e95b73ab82f7a6ea5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzE5MzU_cd6f409f-172f-4bb8-87e9-c0d1d2e4215e">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i3cb82f850b314453a6ec5d1921dc1d46_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzE5OTk_91318b90-cd2b-4723-b842-e34e1b271d97"
      unitRef="eur">2200000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="if35c01a7371643bc9842164b984ee110_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzIwMjA_e3789c20-e571-4f93-8fa7-c0787ef2231c"
      unitRef="eur">1200000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="iac2d7ed11f724c0ebcd3e81759fc9219_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzIwNDU_fb909aa2-0617-438e-a7f2-548281605920"
      unitRef="eur">200000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="i08203211b0d245c4b6d1cc85ee868582_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzIxMjY_7822f91a-201d-41c3-badb-72552a895886">P18Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <sny:DisclosureOfPrincipalMarketedProductsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzM5Nzk_9ec75072-98b8-4b7c-85fe-b87a31f8e522">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below provides information about the principal &#x201c;marketed products&#x201d;, which were recognized in connection with major acquisitions made by Sanofi and represented 92% of the carrying amount of that item as of December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;amortization&#160;&amp;amp;&lt;br/&gt;impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(years)&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Residual&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;amortization&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(years)&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Boehringer Ingelheim &lt;br/&gt;Consumer Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(34,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Chattem&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Protein Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ablynx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bioverativ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Kadmon&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total: principal marketed products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;62,827&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(51,144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,683&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,752&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,341&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Weighted averages. The amortization periods for these products vary between 1&#160;and 25&#160;years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Weighted averages.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfPrincipalMarketedProductsTableTextBlock>
    <sny:ConcentrationRiskThresholdPercentage
      contextRef="if1da231f2f58464e95b73ab82f7a6ea5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI0Njk_746f7dbe-6787-46c0-8aa4-435558bcc794"
      unitRef="number">0.92</sny:ConcentrationRiskThresholdPercentage>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="id773f103dc28473da6dce61b97b4599f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtMS0xLTEtMzY0MDYw_319a125d-7358-41e0-bde8-b931e7328d94"
      unitRef="eur">10490000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i327e5ac314c147afbbac34d3cd5154e6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtMi0xLTEtMzY0MDYw_436fe5f4-c0b9-42af-a300-f4555dc06529"
      unitRef="eur">-9869000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ie35c53e81e9249b386cd4ca320340845_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtMy0xLTEtMzY0MDYw_f6ca07b5-4461-4558-a234-c6b9789488a6"
      unitRef="eur">621000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="i3d83b887fd184dc780e366b282c56ac1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtNC0xLTEtMzY0MDYw_ece487c3-1213-4da4-a818-cbbecd8a0369">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019
      contextRef="i3d83b887fd184dc780e366b282c56ac1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtNS0xLTEtMzY0MDYw_23521890-4df3-480a-a2a8-12a2aee88bbe">P2Y</ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i12436be5245a454fb08492a29387c400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtNi0xLTEtMzY0MDYw_7d3d36ad-ebb5-4238-92c0-7543361932fe"
      unitRef="eur">1032000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ibecbd6a1102148a4b1cdae4692855a35_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzEtNy0xLTEtMzY0MDYw_8f5f3bd4-6338-4e97-a742-fe3b4381944d"
      unitRef="eur">1485000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i8df75a742b2b432f8ed86c2c047454fd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItMS0xLTEtMzY0MDYw_20c5f7f0-9d58-4a1e-819a-1cf36e392f65"
      unitRef="eur">3633000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ide1da35c16a04b58969940528c31dca4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItMi0xLTEtMzY0MDYw_86cdfd73-d1d0-4af1-ae26-e9ea4bec5cff"
      unitRef="eur">-1596000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i0256bda43a0b401793ad67599d6f854f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItMy0xLTEtMzY0MDYw_05460c80-e40c-4897-a6c6-d84d15805c35"
      unitRef="eur">2037000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="i49fae0c938264bbeade9dbd853b7285a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItNC0xLTEtMzY0MDYw_a5cbfb2f-b3d6-4e25-96c5-0d98540d2088">P17Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019
      contextRef="i49fae0c938264bbeade9dbd853b7285a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItNS0xLTEtMzY0MDYw_9f88e682-19e8-4de1-a866-e2d1da00fff0">P12Y</ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i340660daa522440ba21086f7ad5848cd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItNi0xLTEtMzY0MDYw_9410fb0c-3251-42aa-9db7-60e4116c9ac6"
      unitRef="eur">2213000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ie6daac2f7de947078866a970b9af341b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzItNy0xLTEtMzY0MDYw_e31d28a8-4849-4181-af4e-2140d496a6ff"
      unitRef="eur">2489000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ib3d27352e1d547bc80849f473b0bc333_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtMS0xLTEtMzY0MDYw_63f19ba7-bbce-4af8-a66f-f970c2900b8b"
      unitRef="eur">34684000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i94646d0f821b41aa99fc727b5160ed48_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtMi0xLTEtMzY0MDYw_9369694f-f725-4e6b-a2d8-c1b2dc196c21"
      unitRef="eur">-34626000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i0c421b52b59042909b5e110415a07634_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtMy0xLTEtMzY0MDYw_1e61d39d-ce30-4844-82d7-e39c6249b3b3"
      unitRef="eur">58000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="i71c2f33574774918a3d21a0ac64c1257_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtNC0xLTEtMzY0MDYw_fef21846-b9aa-49dc-94f8-2b189170dcd8">P9Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019
      contextRef="i71c2f33574774918a3d21a0ac64c1257_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtNS0xLTEtMzY0MDYw_4fe57d7a-ce9d-41d1-9ec4-20a1c943c85f">P10Y</ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ief7e1240661e4b40847321005295df4b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtNi0xLTEtMzY0MDYw_85ba2f70-f6a5-4ce7-a1e7-77ae63f13dc3"
      unitRef="eur">73000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i63e0783c68d542939a2d058ea87add2d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzMtNy0xLTEtMzY0MDYw_d8e0045a-0bfd-4923-805a-35e86a9a21bb"
      unitRef="eur">110000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i25232be32cd74ac0a93373b678e59630_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtMS0xLTEtMzY0MDYw_4f39d7e0-443c-4193-a13a-c7dd83a80ac2"
      unitRef="eur">1360000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i3ce30f864e704909a1e2a6e1f5ee8e5e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtMi0xLTEtMzY0MDYw_b495a437-1ec2-4e9c-bb0f-364dd42d6128"
      unitRef="eur">-786000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i4b23c81c20fc4794914a0250573bd609_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtMy0xLTEtMzY0MDYw_a1efaf08-855a-44fd-a529-e4784dc97791"
      unitRef="eur">574000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="ia1228690812c49ad88631d95ed6c90e1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtNC0xLTEtMzY0MDYw_0e3274dc-480a-49d5-9328-b4d3e3b3fbb0">P23Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019
      contextRef="ia1228690812c49ad88631d95ed6c90e1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtNS0xLTEtMzY0MDYw_ce82bf3e-6cdc-424b-a1ac-a5c3ad960128">P11Y</ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i50b0b8ed81ed46e8be5e882078a4d6fa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtNi0xLTEtMzY0MDYw_96be96f5-8259-46b7-8b93-3539169c69fb"
      unitRef="eur">593000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i026e8f42a4b84878bffe5af0996e6fd4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzQtNy0xLTEtMzY0MDYw_7dd65d29-9ab3-465e-bf23-df5445c5d5dd"
      unitRef="eur">602000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="icf18b6d1ad6c4d90924bd6cb8c0e44bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtMS0xLTEtMzY0MDYw_d9d1ad81-475f-49b0-961d-a6d1bfe5cbf9"
      unitRef="eur">857000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i0b24fec1ff334b3caffadd87b1917a88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtMi0xLTEtMzY0MDYw_dd15c1bd-04c2-43de-b670-be8bf714cddf"
      unitRef="eur">-359000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i3fe69425172b4ed3b1a78c4b0afa1443_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtMy0xLTEtMzY0MDYw_4cbd97f8-2f64-4834-bcc9-8be7482f581e"
      unitRef="eur">498000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="idf8439c477204ed5bb7b9c50513f4458_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtNC0xLTEtMzY0MDYw_10aca48a-049b-4f79-ab1a-6618854f6159">P13Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019
      contextRef="idf8439c477204ed5bb7b9c50513f4458_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtNS0xLTEtMzY0MDYw_aad864a6-9a72-4e78-b05e-8a748ef02952">P8Y</ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i40fb8c5a2d6649cc9bc68e43de8013db_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtNi0xLTEtMzY0MDYw_9234f44c-b730-4097-a7a4-d2696e517fae"
      unitRef="eur">532000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="idc41e3bc2b9345fc876440577f2e644d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzUtNy0xLTEtMzY0MDYw_9de507ed-5a74-4299-9f3b-dd8b4b308feb"
      unitRef="eur">554000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i041ab8c4596a46c7bb5f0667d7c6bc14_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtMS0xLTEtMzY0MDYw_cb8ed3c0-8cd4-4dff-a340-c74937a8c6e7"
      unitRef="eur">1966000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i3c5e6ecfa9074b3e8f20927944000385_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtMi0xLTEtMzY0MDYw_b54d6ee8-3bf3-4386-b778-c12fa299325c"
      unitRef="eur">-609000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ica7f84b515f546d8bda9c71bbe43ec0e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtMy0xLTEtMzY0MDYw_b798094d-dc8b-43b7-9dd4-2c80216545be"
      unitRef="eur">1357000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="i026473957d65465ea3db2de3e9751210_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtNC0xLTEtMzY0MDYw_f865f4ad-0e18-4208-b18a-60232e77e654">P14Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019
      contextRef="i026473957d65465ea3db2de3e9751210_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtNS0xLTEtMzY0MDYw_8a8c8558-30d0-42fd-8240-87e36d9df2ba">P10Y</ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i792f1cc45ec547c3a499357b17b066ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtNi0xLTEtMzY0MDYw_0371c8db-cd9b-43b7-b27d-a14d30109a75"
      unitRef="eur">1494000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i5f4deabc2c274c3babd78470045f1453_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzYtNy0xLTEtMzY0MDYw_e653dc6a-8b68-48e3-93e8-519b2c8368b4"
      unitRef="eur">1861000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i530f7df295184dd9a99b515e6d74ca8d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctMS0xLTEtMzY0MDYw_f06d8d01-2a79-498b-b264-0026d302a765"
      unitRef="eur">7955000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i296acdd1f99f4541a48fd22b1964d943_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctMi0xLTEtMzY0MDYw_7957d3c4-c636-4ccd-9dba-791db650a51b"
      unitRef="eur">-3119000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i708d728675864096b68be3e4e5fffa80_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctMy0xLTEtMzY0MDYw_a01c4b32-e508-4a79-984b-38d65a786b3b"
      unitRef="eur">4836000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="ie8566075f1554143b73513ddf54ad64f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctNC0xLTEtMzY0MDYw_e2f078e6-02a2-4ec6-99af-480173887687">P13Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019
      contextRef="ie8566075f1554143b73513ddf54ad64f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctNS0xLTEtMzY0MDYw_58913a3e-b2a3-4eb6-9060-7059c6b8ccb5">P9Y</ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i04aac2d172a44ccc919acc1227192e67_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctNi0xLTEtMzY0MDYw_891590ef-9916-479e-8655-7d1bb8094355"
      unitRef="eur">3065000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i637119bb5a7b42f8afb86de0c5d5219f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzctNy0xLTEtMzY0MDYw_a32bc5ee-0d77-4044-9e23-eadbd0f4bdb8"
      unitRef="eur">3240000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i9dcc5fc52d7a4d7aba03c1b54a2a3571_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtMS0xLTEtMzY0MDYw_a5795b89-1610-4d3e-abdc-445f0a4e5cf3"
      unitRef="eur">1882000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="iae48efe4b3334259807bafd602c70de7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtMi0xLTEtMzY0MDYw_73bb02da-9d88-4a20-b93e-d55857eea537"
      unitRef="eur">-180000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="iaa812a8430e74c7e8e6a760b5a84e493_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtMy0xLTEtMzY0MDYw_3f03d75c-e829-4eb3-b24e-eec23ff78ef4"
      unitRef="eur">1702000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="ic5cc7ce98c2143698b9d193c4906485d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtNC0xLTEtMzY0MDYw_759cedf7-a136-4813-b7d6-fa1d2d5962fa">P12Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019
      contextRef="ic5cc7ce98c2143698b9d193c4906485d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtNS0xLTEtMzY0MDYw_a0dd2be1-19d7-4051-8017-f2cb8b1e0fe0">P11Y</ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i45f265c078e647a6a3dda117ab01eed7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtNi0xLTEtMzY0MDYw_5690e2f9-48da-4628-8861-537c7eeb1c5f"
      unitRef="eur">1750000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i0dd016314ae6400591f48c4e6f72f4f1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzgtNy0xLTEtMzY0MDYw_a5a0322c-f318-497c-b718-9dff93088400"
      unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="iebcd0b91b7444542b0c79aa4c96b7801_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzktMS0xLTEtMzY0MDYw_35bbb34e-32be-4aff-ae54-89717fadeb4e"
      unitRef="eur">62827000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i5bc35a3cbc8c4534b90c96bf47118eb5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzktMi0xLTEtMzY0MDYw_291d9c60-2b77-4b91-aeb9-0abe7825ef2e"
      unitRef="eur">-51144000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ie24b60956389422e8f541e06b844991b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzktMy0xLTEtMzY0MDYw_29f03bfb-8ede-4223-a2e9-0ce584ac9efe"
      unitRef="eur">11683000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="iea694613587d485fa04b5eb768f73f00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzktNi0xLTEtMzY0MDYw_3650a1bc-cf74-4ff4-8bf6-23532d2fb6fe"
      unitRef="eur">10752000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i293dc949848347408815145576461710_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTo0YmJhOTNjMzAzNTQ0NjUzODg5Y2NhMjY2MzIxNDE0Ny90YWJsZXJhbmdlOjRiYmE5M2MzMDM1NDQ2NTM4ODljY2EyNjYzMjE0MTQ3XzktNy0xLTEtMzY0MDYw_e994af00-fb2b-4b66-a6c2-0c57374c41f4"
      unitRef="eur">10341000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="i9ed6aa800df24aecae7a3964ffbedd63_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2MDA_83dbd3d8-9311-4a3d-a36d-ac4dc8498aed">P1Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="i45d75dd4cd4f4947b431c2b6a34e7c1f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2MDc_44442340-9b03-4ad8-9afc-7aa15212ab23">P25Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="iae3e84046d214495840027e2c3540430_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI3MjQ_4fd11477-a1b1-4806-86e1-443a3428967f"
      unitRef="eur">472000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="iafe00cfe38914facb60fe02e8320fc90_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2OTM4MDM0ODkyMTQz_1d5f048d-51e5-4079-8fb5-7e778045cd1e"
      unitRef="eur">854000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="ib7fddf7e73a04c67bd9d437a86bbdabf_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2OTM4MDM0ODkyMTU3_e3b2ba94-754e-4c54-bc26-5ee0a60d50db"
      unitRef="eur">363000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="i08203211b0d245c4b6d1cc85ee868582_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzI2OTM4MDM0ODkyMTcx_09f91ac0-d79b-4285-a889-c1ac070eebbc"
      unitRef="eur">525000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <sny:DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90ZXh0cmVnaW9uOjJkNmEzNWI2ZDFkODRjMzZiYjVlNmEyYjBkZjM3YWEzXzM5ODU_1740dfbb-cc69-4433-8061-c9736a00077a">An analysis of amortization of software is shown in the table below:&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and general expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;112&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement (see Note&#160;A.2.1.).&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock>
    <ifrs-full:CostOfSales
      contextRef="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzEtMS0xLTEtMzY0MDYw_9fd719a5-c653-46ae-937a-13cf12a76508"
      unitRef="eur">10000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzEtMi0xLTEtMzY0MDYw_99f0bd62-38c0-4213-ad4a-6a769c75c286"
      unitRef="eur">18000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzEtNC0xLTEtMzY0MDYw_4674dd1c-0c1d-466c-8372-7d3b7e45036c"
      unitRef="eur">19000000</ifrs-full:CostOfSales>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzItMS0xLTEtMzY0MDYw_217f9c60-4ceb-484b-83e3-4febebc5ea6d"
      unitRef="eur">1000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzItMi0xLTEtMzY0MDYw_eb86d8a6-2b26-45f8-9519-889a4c5c9586"
      unitRef="eur">3000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzItNC0xLTEtMzY0MDYw_7f85dc5f-f1e3-4a29-a2a3-ca9b04b121b1"
      unitRef="eur">2000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzMtMS0xLTEtMzY0MDYw_c4191548-47aa-4a6a-a9e9-de653ca37b7f"
      unitRef="eur">82000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzMtMi0xLTEtMzY0MDYw_56489b91-ec04-4466-af4d-4ddb819adf64"
      unitRef="eur">98000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzMtNC0xLTEtMzY0MDYw_1017b008-57f4-4ed2-a7c5-30fe9769ea51"
      unitRef="eur">87000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzQtMS0xLTEtMzY0MDYw_e32d4697-d74f-47b3-a57a-a32cafc5b26b"
      unitRef="eur">4000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzQtMi0xLTEtMzY0MDYw_90a333e1-0723-4b45-be7d-985aa991163f"
      unitRef="eur">0</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzQtNC0xLTEtMzY0MDYw_b745722e-8837-4f69-aca3-7443040c2ece"
      unitRef="eur">4000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzUtMS0xLTEtMzY0MDYw_8aa7c397-cdc5-4f54-a021-b1136a9f869d"
      unitRef="eur">97000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="i6322e2c8a62b452f922d4ea2f63025fc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzUtMi0xLTEtMzY0MDYw_d44af548-5636-4f6d-9695-09dd755bbfc9"
      unitRef="eur">119000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="i3bfd2850813b46f48ecfef80ba508fc7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDEvZnJhZzoyZDZhMzViNmQxZDg0YzM2YmI1ZTZhMmIwZGYzN2FhMy90YWJsZTphN2U4YzI0NDQ4ZGI0NTUzYjdjNWMyOTUxZjlmNWNhOC90YWJsZXJhbmdlOmE3ZThjMjQ0NDhkYjQ1NTNiN2M1YzI5NTFmOWY1Y2E4XzUtNC0xLTEtMzY0MDYw_f51467a8-67aa-4344-8196-947f99409cd7"
      unitRef="eur">112000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <sny:DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzU3NzE_f0e7ddf3-dc53-4de4-94fc-659c16928f52">Impairment of intangible assets and property, plant and equipment&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;36, goodwill is allocated to groups of cash generating units (CGUs) at a level corresponding to the Pharmaceuticals, Consumer Healthcare and Vaccines segments. When testing goodwill annually for impairment, the recoverable amount is determined for each segment on the basis of value in use, determined using discounted estimates of the future cash flows in accordance with the policies described in Note&#160;B.6.1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The allocation of goodwill as of December 31, 2022 is shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;39,421&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,690&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,781&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;49,892&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The value in use of each segment was determined by applying an after-tax discount rate to estimated future after-tax cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A separate discount rate is used for each segment to reflect the specific economic conditions of that segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The rates used for impairment testing in 2022 were 7.25% for the Pharmaceuticals segment, 7.00% for the Consumer Healthcare segment and 7.25% for the Vaccines segment; an identical value in use for Sanofi as a whole would be obtained by applying a uniform 7.2% rate to all three segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The pre-tax discount rates applied to estimated pre-tax cash flows are calculated by iteration from the previously-determined value in use. Those pre-tax discount rates were 9.9% for the Pharmaceuticals segment, 9.4% for the Consumer Healthcare segment and 9.9% for the Vaccines segment, and equate to a uniform rate of 9.8% for Sanofi as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The assumptions used in testing goodwill for impairment are reviewed annually. Apart from the discount rate, the principal assumptions used in 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the perpetual growth rates applied to future cash flows were zero for the Pharmaceuticals and Vaccines segments, and 1% for the Consumer Healthcare segment;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;Sanofi also applies assumptions on the probability of success of current research and development projects, and more generally on its ability to renew the product portfolio in the longer term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Value in use (determined as described above) is compared with the carrying amount, and this comparison is then subjected to sensitivity analyses by reference to the principal parameters, including:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;changes in the discount rate;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;changes in the perpetual growth rate; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;fluctuations in operating margin.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;No impairment of goodwill would need to be recognized in the event of a reasonably possible change in the assumptions used in&#160;2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A value in use calculation for each of the segments would not result in an impairment loss using:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;a discount rate up to 2.6&#160;percentage points above the rates actually used; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;a perpetual growth rate up to 4.3&#160;percentage points below the rates actually used; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;an operating margin up to 6.7&#160;percentage points below the rates actually used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;No impairment losses were recognized against goodwill in the years ended December 31, 2022, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;When there is evidence that an asset may have become impaired, the asset&#x2019;s value in use is calculated by applying an after-tax discount rate to the estimated future after-tax cash flows from that asset. For the purposes of impairment testing, the tax cash flows relating to the asset are determined using a notional tax rate incorporating the notional tax benefit that would result from amortizing the asset if its value in use were regarded as its depreciable amount for tax purposes. Applying after-tax discount rates&#160;to after-tax cash flows gives the same values in use as would be obtained by applying pre-tax discount rates to pre-tax cash&#160;flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The after-tax discount rates used in 2022 for impairment testing of other intangible assets in the Pharmaceuticals, Consumer Healthcare and Vaccines segments were obtained by adjusting Sanofi&#x2019;s weighted average cost of capital to reflect specific country and business risks, giving after-tax discount rates in a range from &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;7.25% to 8.25%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In most instances, there are no market data that would enable fair value less costs to sell to be determined other than by means of developing a similar estimate based on future cash flows. Consequently, recoverable amount is in substance equal to value in use. The estimates used to determine value in use are sensitive to assumptions specific to the nature of the asset and to Sanofi's activities. Apart from the discount rate, the principal assumptions used in 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;mid-term and long-term forecasts;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;perpetual growth or attrition rates, when applicable; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;probability of success of current research and development projects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The assumptions used in testing intangible assets for impairment are reviewed at least annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2022, 2021 and 2020, impairment testing of other intangible assets (excluding software) resulted in the recognition of net impairment losses as shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Impairment of other intangible assets, net of reversals  (excluding software)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;192&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;330&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Marketed products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Consumer Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development projects &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a) / (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) For 2022, these amounts mainly comprise a reversal of &#x20ac;2,154&#160;million of impairment losses taken against Eloctate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; and BIVV001 (assets belonging to the Eloctate franchise), consisting of &#x20ac;1,554&#160;million for marketed products and &#x20ac;600&#160;million for research and development projects respectively. In 2019, the launch of competing products for Eloctate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; led Sanofi to update its sales forecasts for products belonging to the franchise, as a result of which  impairment losses of &#x20ac;2.8&#160;billion were recognized against the assets in question. The reversal reflects the approval by the FDA on February 22, 2023 of the marketing authorization application for ALTUVIIIO&#x2122; (the commercial name of efanesoctocog alpha, corresponding to the BIVV001 project), which was submitted in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) For 2022, this amount mainly comprises: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.93pt"&gt;an impairment loss of &#x20ac;1,586&#160;million taken against the development project for SAR444245 (non-alpha interleukin-2), recognized following revised cash flow projections reflecting unfavorable developments in the launch schedule;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.93pt"&gt;the &#x20ac;600m reversal relating to the BIVV001 project (see above). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;     For 2021, this line relates to the discontinuation of the development of sutimlimab in the treatment of Immune Thrombocytopenic Purpura (ITP), and to the termination of various research projects in Vaccines. For 2020, this line mainly comprises impairment losses taken against R&amp;amp;D programs within the Specialty Care GBU, and the discontinuation of certain R&amp;amp;D programs and collaboration agreements in Diabetes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Impairment losses taken against property, plant and equipment are disclosed in Note&#160;D.3.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock>
    <sny:DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzU3NzI_b17464e5-e781-44e1-a416-b58e14d58fbb">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The allocation of goodwill as of December 31, 2022 is shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;39,421&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,690&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,781&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;49,892&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock>
    <ifrs-full:Goodwill
      contextRef="iee7cb4947a1c4854876868c8e2fb82d1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZToxYzI2NDc2ZDZiYzU0ZDVlOTc1OWQyOWUxNTcyNzczZS90YWJsZXJhbmdlOjFjMjY0NzZkNmJjNTRkNWU5NzU5ZDI5ZTE1NzI3NzNlXzEtMS0xLTEtMzY0MDYw_04de8e17-138e-4e12-8a39-b9ec19fb4bd7"
      unitRef="eur">39421000000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i16582892e01c4bb3be453ed03f64b2ae_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZToxYzI2NDc2ZDZiYzU0ZDVlOTc1OWQyOWUxNTcyNzczZS90YWJsZXJhbmdlOjFjMjY0NzZkNmJjNTRkNWU5NzU5ZDI5ZTE1NzI3NzNlXzEtMi0xLTEtMzY0MDYw_2fe4f157-19f7-434b-9acb-c45f04c77b94"
      unitRef="eur">6690000000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i5146ddfb19c5499c89ad75916030806b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZToxYzI2NDc2ZDZiYzU0ZDVlOTc1OWQyOWUxNTcyNzczZS90YWJsZXJhbmdlOjFjMjY0NzZkNmJjNTRkNWU5NzU5ZDI5ZTE1NzI3NzNlXzEtMy0xLTEtMzY0MDYw_e5b85969-c505-4398-8051-48b57c4a7e43"
      unitRef="eur">3781000000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZToxYzI2NDc2ZDZiYzU0ZDVlOTc1OWQyOWUxNTcyNzczZS90YWJsZXJhbmdlOjFjMjY0NzZkNmJjNTRkNWU5NzU5ZDI5ZTE1NzI3NzNlXzEtNC0xLTEtMzY0MDYw_55272030-f228-4a53-8cc0-c5c682d0b255"
      unitRef="eur">49892000000</ifrs-full:Goodwill>
    <sny:ImpairmentTestingPercentage
      contextRef="i21d16f2eeeb44e9abc4e0d2fff1623bc_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg2Mg_a34e577e-4871-4cdc-b9d2-fb308b613761"
      unitRef="number">0.0725</sny:ImpairmentTestingPercentage>
    <sny:ImpairmentTestingPercentage
      contextRef="iea1750e2b68b4202b8af152deb123cba_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg5OA_88649644-37c8-41a1-87ff-80b8f681acb1"
      unitRef="number">0.0700</sny:ImpairmentTestingPercentage>
    <sny:ImpairmentTestingPercentage
      contextRef="iacd98ed640914415ae9a8c8cb5f49656_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzk0MQ_fb5105b3-002c-4e60-aecf-a4d56dd616d0"
      unitRef="number">0.0725</sny:ImpairmentTestingPercentage>
    <sny:UniformImpairmentTestingPercentage
      contextRef="i6291343ad8be4f14b06b056b796a9012_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzEwNTg_46af8c3e-11d5-4717-9370-76220e4b2125"
      unitRef="number">0.072</sny:UniformImpairmentTestingPercentage>
    <sny:NumberOfOperatingSegments
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzEwNzM_7a8da66c-fe00-46f1-a865-120b71e46db1"
      unitRef="segment">3</sny:NumberOfOperatingSegments>
    <sny:PretaxDiscountRateAppliedForGoodwill
      contextRef="i21d16f2eeeb44e9abc4e0d2fff1623bc_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzEyNjA_3e2235ac-df3f-4ebb-9114-4a06d6e519cb"
      unitRef="number">0.099</sny:PretaxDiscountRateAppliedForGoodwill>
    <sny:PretaxDiscountRateAppliedForGoodwill
      contextRef="iea1750e2b68b4202b8af152deb123cba_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzEyOTY_67ef812f-0dbe-4aad-9cb2-47c074796ef4"
      unitRef="number">0.094</sny:PretaxDiscountRateAppliedForGoodwill>
    <sny:PretaxDiscountRateAppliedForGoodwill
      contextRef="iacd98ed640914415ae9a8c8cb5f49656_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzEzMzk_996dc5e9-5409-4818-be7f-025dba7b31b1"
      unitRef="number">0.099</sny:PretaxDiscountRateAppliedForGoodwill>
    <sny:UniformPreTaxDiscountRates
      contextRef="ib359277c5a6e4155b350cf434d57f618_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzE0MDA_c4e7acaf-ce36-4342-9380-7fef01917e5c"
      unitRef="number">0.098</sny:UniformPreTaxDiscountRates>
    <ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections
      contextRef="i5bc6ed2a91ca4c32a13fd8fb9df67c92_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzE2NTE_7f14cec7-2562-4096-9e58-653fcf8ee7a0"
      unitRef="number">0</ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections>
    <ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections
      contextRef="ia5ad3f91fb64465ea39c823dc7f679b2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzE2NTE_d0e71173-3946-483f-8232-6ddf50bdb309"
      unitRef="number">0</ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections>
    <ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections
      contextRef="ie4cde3de3d25485abc32561745035697_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzE3MDU_decaefac-0d87-4660-a8cb-e713164c70ac"
      unitRef="number">0.01</ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections>
    <sny:PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI0OTQ_5387a2b6-4b85-4437-b45d-73cd5d6b878b"
      unitRef="number">2.6</sny:PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss>
    <sny:PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI1Nzk_f8afd2aa-4208-4be4-95ee-8e9ecd7fef87"
      unitRef="number">4.3</sny:PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss>
    <sny:PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI2NjA_1f2b0a00-ec4b-47c5-9cab-cbb90e9b9645"
      unitRef="number">6.7</sny:PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI3MTI_17a4f826-e99f-410c-8ce7-9e36f2f83bbe"
      unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI3MTI_29d48d0c-556d-46df-b67d-a6b5f35c0a0a"
      unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzI3MTI_cd2a4772-6529-48d6-8aec-df327d641cd6"
      unitRef="eur">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill>
    <sny:AfterTaxDiscountRates
      contextRef="i9ed6aa800df24aecae7a3964ffbedd63_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzM3OTY_413581e6-fad0-4b08-8f64-12dfbc016ae0"
      unitRef="number">0.0725</sny:AfterTaxDiscountRates>
    <sny:AfterTaxDiscountRates
      contextRef="i45d75dd4cd4f4947b431c2b6a34e7c1f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzM4MDI_e6492bcb-2700-498b-a534-61126e13aa4e"
      unitRef="number">0.0825</sny:AfterTaxDiscountRates>
    <sny:DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzU3NzQ_885aa201-b60e-49f0-85cd-0216cc0188d7">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2022, 2021 and 2020, impairment testing of other intangible assets (excluding software) resulted in the recognition of net impairment losses as shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Impairment of other intangible assets, net of reversals  (excluding software)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;192&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;330&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Marketed products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Consumer Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development projects &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a) / (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) For 2022, these amounts mainly comprise a reversal of &#x20ac;2,154&#160;million of impairment losses taken against Eloctate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; and BIVV001 (assets belonging to the Eloctate franchise), consisting of &#x20ac;1,554&#160;million for marketed products and &#x20ac;600&#160;million for research and development projects respectively. In 2019, the launch of competing products for Eloctate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; led Sanofi to update its sales forecasts for products belonging to the franchise, as a result of which  impairment losses of &#x20ac;2.8&#160;billion were recognized against the assets in question. The reversal reflects the approval by the FDA on February 22, 2023 of the marketing authorization application for ALTUVIIIO&#x2122; (the commercial name of efanesoctocog alpha, corresponding to the BIVV001 project), which was submitted in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) For 2022, this amount mainly comprises: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.93pt"&gt;an impairment loss of &#x20ac;1,586&#160;million taken against the development project for SAR444245 (non-alpha interleukin-2), recognized following revised cash flow projections reflecting unfavorable developments in the launch schedule;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.93pt"&gt;the &#x20ac;600m reversal relating to the BIVV001 project (see above). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;     For 2021, this line relates to the discontinuation of the development of sutimlimab in the treatment of Immune Thrombocytopenic Purpura (ITP), and to the termination of various research projects in Vaccines. For 2020, this line mainly comprises impairment losses taken against R&amp;amp;D programs within the Specialty Care GBU, and the discontinuation of certain R&amp;amp;D programs and collaboration agreements in Diabetes.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="i1b27476d93554df89ad49b3ee11c7c77_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzEtMS0xLTEtMzY0MDYw_96db8429-ba10-4be5-903c-5f9a1bb20d4f"
      unitRef="eur">-454000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="i3068d0c640bc435e891dadca47642b8f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzEtMi0xLTEtMzY0MDYw_7f483d2c-56c2-4b05-b7da-d338251ec290"
      unitRef="eur">192000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="i0c54b1010c23469cab4bb3eff3e7d353_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzEtMy0xLTEtMzY0MDYw_0b3f4258-fd47-4ff2-96b4-42b2de4b6fcc"
      unitRef="eur">330000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="i28d5de7a4fc14b2593071a0d5fdc0a8a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzItMS0xLTEtMzY0MDYw_4b45dccf-d0ee-4da9-98d0-ad35c059de10"
      unitRef="eur">-1561000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="i2b91f780cb5b4a2ea49c0de8b0410b7b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzItMi0xLTEtMzY0MDYw_4daeb53d-c57e-48d7-9ad2-3fdb9c2f90e6"
      unitRef="eur">42000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="i8a363d9f71a4498e9eb6d77ce4ae1ce1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzItMy0xLTEtMzY0MDYw_8ed141bd-8e23-4a58-ae3d-1d001e0b2852"
      unitRef="eur">2000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="ibe47f0460c6443d7aac34037c1a7776f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzMtMS0xLTEtMzY0MDYw_4a4d662a-b26d-4e3f-a1fa-4c73e4009f94"
      unitRef="eur">-1542000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="ia20f460d071c4c28a7e9a76758243fbd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzMtMi0xLTEtMzY0MDYw_89bbddf4-e347-4017-94d9-59eb5199bbd8"
      unitRef="eur">1000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="i5dc0f8a6677d425cbf34a6827f35eec7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzMtMy0xLTEtMzY0MDYw_e92d9a4a-b030-4f7f-894c-dd4bdaf4b732"
      unitRef="eur">2000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="if951db4e148548b0ab33c185a8187b15_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzQtMS0xLTEtMzY0MDYw_07becc26-3a55-491d-a90b-33daeed411ec"
      unitRef="eur">16000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="iccf65087a3c74152a1319c345dad3d4a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzQtMi0xLTEtMzY0MDYw_9c1f789a-6dd6-4d45-9377-54737effc1bb"
      unitRef="eur">0</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="ia45e141afabe465e85ec0f96fdaf178a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzQtMy0xLTEtMzY0MDYw_22a05771-0849-42de-851c-e950ed1d5fdd"
      unitRef="eur">0</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="i43261e364b9346549b6c2f1839b5914b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzUtMS0xLTEtMzY0MDYw_75a9866a-54d2-4a9f-aca9-1b1fb19f55cf"
      unitRef="eur">-35000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="iaebb948c909c492e932578257e1ad2fc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzUtMi0xLTEtMzY0MDYw_dc6356ff-4459-402c-8a0d-689168640bbd"
      unitRef="eur">41000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="ibd554b41fcbb47338ebb6b86fee85e2c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzUtMy0xLTEtMzY0MDYw_1ef15eec-910c-473c-9f0c-ed0d4397c296"
      unitRef="eur">0</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="ia8cc913bbe0246f79a657a1446f40d4b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzYtMS0xLTEtMzY0MDYw_231afb34-b6b0-4af5-b904-d1306e3b1d16"
      unitRef="eur">1107000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="i00ff7bddddd7454291874636f6fcda0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzYtMi0xLTEtMzY0MDYw_5cf3983d-fcbb-4e48-a1f5-40b0c4ac3f53"
      unitRef="eur">150000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="ic32352d1a6b84884aee10c01c7d2556a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90YWJsZTpkYzc2ZTU0MGEyYzc0OTkwOTlkYjdlMzhjZjg0MmY3ZC90YWJsZXJhbmdlOmRjNzZlNTQwYTJjNzQ5OTA5OWRiN2UzOGNmODQyZjdkXzYtMy0xLTEtMzY0MDYw_96d7e8cc-3fdf-40ad-8176-1f8f6112b4a0"
      unitRef="eur">328000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount
      contextRef="i9b81437bb0bc49abac2a243bae255b03_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNDYz_0b63a886-0edf-4d1b-be45-6942b18eb9a5"
      unitRef="eur">2154000000</sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount>
    <sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount
      contextRef="ib78ba3c2232f4c65ac54a211433313c6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNDc5_4a51708c-7e59-4635-ad36-6aa9f1476d76"
      unitRef="eur">1554000000</sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount>
    <sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount
      contextRef="i75a477cfdbfd407296126150806dc8ac_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNDk1_fdd07481-065e-48b4-804d-53e401716982"
      unitRef="eur">600000000</sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="i4af100e170394112bab4a52fece35962_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNTA5_4e69a0b9-d3d1-44b5-b096-c382ebae0f0b"
      unitRef="eur">2800000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="i5742d95426994746862eae78944333b8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNTIz_09980f05-7ae4-41d1-b2f8-ba0d855baeec"
      unitRef="eur">1586000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount
      contextRef="i75a477cfdbfd407296126150806dc8ac_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDQvZnJhZzpiYjQ5OGYxZTJkMGM0YWUxODc5N2NhZTk4OTMyZDE0MS90ZXh0cmVnaW9uOmJiNDk4ZjFlMmQwYzRhZTE4Nzk3Y2FlOTg5MzJkMTQxXzg1NzYxOTA2OTkwNTM5_e4dbee23-37f0-4e81-8f24-a55b00ebe3a5"
      unitRef="eur">600000000</sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount>
    <ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzM1MzM_6f01cc64-bff5-4d28-8d43-79f615f557b1">Investments accounted for using the equity method&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Investments accounted for using the equity method comprise associates and joint ventures (see Note&#160;B.1.), and are set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&#160;interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;EUROAPI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Infraserv GmbH&#160;&amp;amp; Co. H&#xf6;chst KG&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MSP Vaccine Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;677&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;250&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;201&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) &#160;&#160;&#160;&#160;Following the distribution in kind and the acquisition of an equity interest by EPIC Bpifrance, Sanofi holds 30.1% of the capital of EUROAPI (see Note&#160;B.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Joint venture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;Joint venture. MSP Vaccine Company owns 100% of MCM Vaccine B.V.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows Sanofi&#x2019;s overall share of (i)&#160;profit or loss and (ii)&#160;other comprehensive income from investments accounted for using the equity method, showing the split between associates and joint ventures in accordance with IFRS&#160;12 (the amounts for each individual associate or joint venture are not material):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Joint&#160;ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Associates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Joint&#160;ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Associates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Joint&#160;ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Associates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of other comprehensive income from investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes &#x20ac;343&#160;million for Sanofi's share of the net income of Regeneron up to and including May&#160;29, 2020 (see Note&#160;D.2.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The financial statements include arm&#x2019;s length commercial transactions between Sanofi and some equity-accounted investments that are classified as related parties. The principal transactions and balances with related parties are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Royalties and other income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts receivable and other receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Purchases and other expenses (including research expenses)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts payable and other payables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) For 2020, these amounts include transactions between Sanofi and Regeneron for the period from January&#160;1 through May&#160;29, 2020. The table above does not include the repurchase by Regeneron of its own shares from Sanofi (see Note&#160;D.2.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) In 2022, these items include Sanofi's transactions with EUROAPI from May&#160;10, 2022 (see Note&#160;D.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;There were no funding commitments to associates and joint ventures as of December 31, 2022, December 31, 2021 or December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For off balance sheet commitments of an operational nature involving joint ventures, see Note&#160;D.21.1.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory>
    <sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzM1MzI_23834684-babd-4f93-9ccd-24cbeb27ab5a">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&#160;interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;EUROAPI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Infraserv GmbH&#160;&amp;amp; Co. H&#xf6;chst KG&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MSP Vaccine Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;677&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;250&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;201&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) &#160;&#160;&#160;&#160;Following the distribution in kind and the acquisition of an equity interest by EPIC Bpifrance, Sanofi holds 30.1% of the capital of EUROAPI (see Note&#160;B.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Joint venture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;Joint venture. MSP Vaccine Company owns 100% of MCM Vaccine B.V.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="ifb5a0f3994f84521ab2fd69b67690383_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzEtMS0xLTEtMzY0MDYw_524cad5e-069b-48f2-b06d-ce86a37d1894"
      unitRef="number">0.301</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="ifc8f06a841e6428180d8121555e73740_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzEtMi0xLTEtMzY0MDYw_ccfae5a9-11e9-4357-b08d-5104a15b8f70"
      unitRef="eur">392000000</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="i495abeb0c8ec43bd9a8672fcf415b572_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzEtMy0xLTEtMzY0MDYw_a54fab54-c519-4874-b197-8b5ef5e94826"
      unitRef="eur">0</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="ic5f95cfdf0c2482a8e6ae4ea1b83aeed_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzEtNC0xLTEtMzY0MDYw_9fa03aaa-fb79-4daa-87bf-a9eefe8af117"
      unitRef="eur">0</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="i987f61ccd11547579d7e7f53a35371e8_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzItMS0xLTEtMzY0MDYw_8e2423f0-42a7-4afe-9373-2f3c8030f2da"
      unitRef="number">0.312</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="iaa479340569c4f32a4dccb3228f32e50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzItMi0xLTEtMzY0MDYw_8ed02ad7-c6a5-414e-811e-1e91408df931"
      unitRef="eur">97000000</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="ifeb832a3c66e4a378f24c3a521e9cf5c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzItMy0xLTEtMzY0MDYw_b2bfe838-58fa-4fb6-87e9-a9100d17446e"
      unitRef="eur">80000000</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="i0f3efa364fdd42cf927933b24fd4755d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzItNC0xLTEtMzY0MDYw_d7691ec4-5800-4b4d-b9a2-dc7f967f118f"
      unitRef="eur">72000000</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="i782f27e42e1d446bb06029d7b6d07d77_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzMtMS0xLTEtMzY0MDYw_3628131f-0008-44d4-9d74-7048dee029a1"
      unitRef="number">0.500</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="i669940f41ad04996a28f45d5787d6ddb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzMtMi0xLTEtMzY0MDYw_e732125c-77d5-415b-9b53-f1033747b538"
      unitRef="eur">104000000</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="i63e035f853e24b69a878f537955ad35a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzMtMy0xLTEtMzY0MDYw_86746ed6-3b52-48e0-8453-e23233046f07"
      unitRef="eur">88000000</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="i82151e9cc3d943a69133a8307efdb603_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzMtNC0xLTEtMzY0MDYw_8da7d189-3be9-4f14-90c8-f6dad8d75f72"
      unitRef="eur">44000000</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="i91ae659ae5f74464822bc2b56b6fbf88_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzUtMS0xLTEtMzY0MDYw_78940cd6-82d9-4f0f-99c9-2ee925573abb"
      unitRef="number">0</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="i957f812f550347fabcd2ee14c0bc75b0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzUtMi0xLTEtMzY0MDYw_694ba275-bf3a-4b2b-a80f-15e66f05ab48"
      unitRef="eur">84000000</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="if13d5090e3fb4ebaa88f2f834e7b85d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzUtMy0xLTEtMzY0MDYw_e81b6151-5900-4d7c-851f-dbe1a434c75f"
      unitRef="eur">82000000</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="ib5f292fbae704649bdd7f44efd9dc45f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzUtNC0xLTEtMzY0MDYw_2ce3bd12-2423-407d-82a5-261459e42132"
      unitRef="eur">85000000</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzYtMi0xLTEtMzY0MDYw_1ebfc6e1-96cc-4e9c-97ec-36d1e3f1588b"
      unitRef="eur">677000000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzYtMy0xLTEtMzY0MDYw_6cddcc95-7063-4e1e-bff0-404084ef17ca"
      unitRef="eur">250000000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTozMzI0NTk1NTEyNzI0MGZlYWQ4ODVkOTk0OWU1NGVmNy90YWJsZXJhbmdlOjMzMjQ1OTU1MTI3MjQwZmVhZDg4NWQ5OTQ5ZTU0ZWY3XzYtNC0xLTEtMzY0MDYw_cd4221ee-eb5d-4a11-9792-ffacef313132"
      unitRef="eur">201000000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="ifb5a0f3994f84521ab2fd69b67690383_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzE5NzkxMjA5MzA4Mjc0_6dcd314c-0d64-4267-8197-9781245b6567"
      unitRef="number">0.301</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="i092bf3d6ba454bcd8193568dd0f4509b_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzY4OA_4dddd127-c1ac-425e-a7b6-77cf4a75a2c2"
      unitRef="number">1</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <sny:DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzM1MTg_419503d3-17f3-4978-b407-dfcc15db7e86">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows Sanofi&#x2019;s overall share of (i)&#160;profit or loss and (ii)&#160;other comprehensive income from investments accounted for using the equity method, showing the split between associates and joint ventures in accordance with IFRS&#160;12 (the amounts for each individual associate or joint venture are not material):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Joint&#160;ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Associates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Joint&#160;ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Associates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Joint&#160;ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Associates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of other comprehensive income from investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes &#x20ac;343&#160;million for Sanofi's share of the net income of Regeneron up to and including May&#160;29, 2020 (see Note&#160;D.2.2.).&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod
      contextRef="ic49924175296420b805d168c7336e31d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItMS0xLTEtMzY0MDYw_4209a86d-8598-4212-9da9-f5bd54f59d51"
      unitRef="eur">74000000</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod
      contextRef="i58223acf6fb24980bc8feacdb2bfeae8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItMi0xLTEtMzY0MDYw_de246952-9758-47e2-bc90-ff8763ec223d"
      unitRef="eur">-6000000</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod
      contextRef="i1c41e8bd45074b609022a18dba83404d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItMy0xLTEtMzY0MDYw_991b9af5-a5a0-4e37-a1bc-6a7b73907f63"
      unitRef="eur">26000000</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod
      contextRef="id1d40d00a4f940f4b8c4db3de85057f3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItNC0xLTEtMzY0MDYw_591955f8-edb1-4603-ac00-605884918802"
      unitRef="eur">13000000</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod
      contextRef="i75f7fd33c99141b0834d8cd0bde8d7e4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItNi0xLTEtMzY0MDYw_419b873d-92b1-4dcd-9cf8-3241610864e2"
      unitRef="eur">4000000</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod
      contextRef="i116430c7eca24b8ebbfa85cbe5cf6fb8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzItNy0xLTEtMzY0MDYw_837908a1-13b9-4028-b7c2-cb0dacd29605"
      unitRef="eur">355000000</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax
      contextRef="ic49924175296420b805d168c7336e31d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtMS0xLTEtMzY0MDYw_fa8cb7e3-ba35-40f3-9e70-59f2b56fdf90"
      unitRef="eur">-2000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax>
    <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax
      contextRef="i58223acf6fb24980bc8feacdb2bfeae8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtMi0xLTEtMzY0MDYw_639a6185-5326-4f2b-b8c1-5c8837a58fe7"
      unitRef="eur">-3000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax>
    <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax
      contextRef="i1c41e8bd45074b609022a18dba83404d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtMy0xLTEtMzY0MDYw_3001f552-c9ba-4d32-945c-9830cdfbfc28"
      unitRef="eur">-6000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax>
    <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax
      contextRef="id1d40d00a4f940f4b8c4db3de85057f3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtNC0xLTEtMzY0MDYw_559fa731-d7f5-40d9-b724-f6cde39d04df"
      unitRef="eur">0</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax>
    <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax
      contextRef="i75f7fd33c99141b0834d8cd0bde8d7e4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtNi0xLTEtMzY0MDYw_49f290f1-d5e7-47bb-b874-fcf563f94290"
      unitRef="eur">8000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax>
    <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax
      contextRef="i116430c7eca24b8ebbfa85cbe5cf6fb8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzMtNy0xLTEtMzY0MDYw_14fe17e9-0ee9-4b61-a923-b44b54e229c7"
      unitRef="eur">-311000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax>
    <sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures
      contextRef="ic49924175296420b805d168c7336e31d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtMS0xLTEtMzY0MDYw_e807bc78-e132-45e3-90a1-4aeeb7a8de17"
      unitRef="eur">72000000</sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures>
    <sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures
      contextRef="i58223acf6fb24980bc8feacdb2bfeae8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtMi0xLTEtMzY0MDYw_896d8095-f736-4785-a2bc-ffc79a494390"
      unitRef="eur">-9000000</sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures>
    <sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures
      contextRef="i1c41e8bd45074b609022a18dba83404d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtMy0xLTEtMzY0MDYw_593d28b9-a0b4-4a6a-8414-33ec5b8c236a"
      unitRef="eur">20000000</sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures>
    <sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures
      contextRef="id1d40d00a4f940f4b8c4db3de85057f3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtNC0xLTEtMzY0MDYw_acd2ff1f-00fe-4045-89b9-bb5b2d514ea7"
      unitRef="eur">13000000</sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures>
    <sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures
      contextRef="i75f7fd33c99141b0834d8cd0bde8d7e4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtNi0xLTEtMzY0MDYw_f57b357e-cdb5-4b14-8540-7a07e5ecf581"
      unitRef="eur">12000000</sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures>
    <sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures
      contextRef="i116430c7eca24b8ebbfa85cbe5cf6fb8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTphYTM2ZWVlZWJhY2U0YWU1YjE5ZjU0Y2ZlN2JlNjk4YS90YWJsZXJhbmdlOmFhMzZlZWVlYmFjZTRhZTViMTlmNTRjZmU3YmU2OThhXzQtNy0xLTEtMzY0MDYw_00f34ab8-8ca6-4c3c-850a-0cf873ac78da"
      unitRef="eur">44000000</sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="ie57d3ecdaba24bb899bd154519fbadc9_D20200529-20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzI4MDM3NTQ2NTE0MDg3_0817bb62-ab7d-4846-a3e6-a9c5e306f2c5"
      unitRef="eur">343000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzM1Mjg_12b12ad3-8e70-4a32-8f3d-9a5b24bb0c41">The principal transactions and balances with related parties are summarized below:&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Royalties and other income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts receivable and other receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Purchases and other expenses (including research expenses)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts payable and other payables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) For 2020, these amounts include transactions between Sanofi and Regeneron for the period from January&#160;1 through May&#160;29, 2020. The table above does not include the repurchase by Regeneron of its own shares from Sanofi (see Note&#160;D.2.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) In 2022, these items include Sanofi's transactions with EUROAPI from May&#160;10, 2022 (see Note&#160;D.1.).&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions
      contextRef="i147d77d0cdbc43f8a3861edb09fba518_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzEtMS0xLTEtMzY0MDYw_b753e88f-78a2-40d3-b461-9343a26c51f5"
      unitRef="eur">131000000</ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions>
    <ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions
      contextRef="ife8c65e63c7b45eb9f4a9c39837733fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzEtMi0xLTEtMzY0MDYw_cbd1f385-4b26-4367-8649-2c9420d716d5"
      unitRef="eur">70000000</ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions>
    <ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions
      contextRef="i5fab8659aed84831a2579ade0399d130_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzEtMy0xLTEtMzY0MDYw_6a59ef34-a6a2-4ce3-97ce-83b827ae78cb"
      unitRef="eur">75000000</ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions>
    <sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions
      contextRef="i147d77d0cdbc43f8a3861edb09fba518_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzItMS0xLTEtMzY0MDYw_5439b33c-fe37-4ad8-b07c-6adb877b93c7"
      unitRef="eur">81000000</sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions>
    <sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions
      contextRef="ife8c65e63c7b45eb9f4a9c39837733fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzItMi0xLTEtMzY0MDYw_fbc9b612-de07-4e18-8aff-696378c6064b"
      unitRef="eur">66000000</sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions>
    <sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions
      contextRef="i5fab8659aed84831a2579ade0399d130_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzItMy0xLTEtMzY0MDYw_b54a2056-4947-43e7-bbe6-875357401a1c"
      unitRef="eur">97000000</sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="ie5ceb0532e334611ab935fb0364427b6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzMtMS0xLTEtMzY0MDYw_32f593c5-83e5-48f9-b008-10bf83ce0973"
      unitRef="eur">174000000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="id92cabfe863843afa6b89218300e3c36_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzMtMi0xLTEtMzY0MDYw_ce666fd1-97cd-48f7-9ff6-7560d54833c1"
      unitRef="eur">116000000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="if09b2251983a4669a88b8ff54f8690c0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzMtMy0xLTEtMzY0MDYw_544a5429-c85d-4858-b7f3-a5fac258b348"
      unitRef="eur">50000000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:PurchasesOfGoodsRelatedPartyTransactions
      contextRef="i147d77d0cdbc43f8a3861edb09fba518_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzQtMS0xLTEtMzY0MDYw_bca8baeb-846d-4d30-b2bb-0d86d38c9030"
      unitRef="eur">477000000</ifrs-full:PurchasesOfGoodsRelatedPartyTransactions>
    <ifrs-full:PurchasesOfGoodsRelatedPartyTransactions
      contextRef="ife8c65e63c7b45eb9f4a9c39837733fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzQtMi0xLTEtMzY0MDYw_f81ae4b3-a103-440a-b6f6-62b5f07dfe90"
      unitRef="eur">178000000</ifrs-full:PurchasesOfGoodsRelatedPartyTransactions>
    <ifrs-full:PurchasesOfGoodsRelatedPartyTransactions
      contextRef="i5fab8659aed84831a2579ade0399d130_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzQtMy0xLTEtMzY0MDYw_f9b398eb-ad86-4bb2-983e-243e42d87157"
      unitRef="eur">747000000</ifrs-full:PurchasesOfGoodsRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="ie5ceb0532e334611ab935fb0364427b6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzUtMS0xLTEtMzY0MDYw_a3d071db-8198-41ff-b3cf-1b06bdadbec3"
      unitRef="eur">132000000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="id92cabfe863843afa6b89218300e3c36_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzUtMi0xLTEtMzY0MDYw_a0e8d722-53a4-4a9c-9e85-ac77ab617e5c"
      unitRef="eur">28000000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="if09b2251983a4669a88b8ff54f8690c0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90YWJsZTo4YmE5M2Y2Njc1MDY0M2NhOTk2YzU4ODJmMGVkMTkwYi90YWJsZXJhbmdlOjhiYTkzZjY2NzUwNjQzY2E5OTZjNTg4MmYwZWQxOTBiXzUtMy0xLTEtMzY0MDYw_0443a01c-ebbb-4d1f-bce0-e95a81a21622"
      unitRef="eur">15000000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <sny:CommitmentsMadeToJointVenturesAndAssociates
      contextRef="id92cabfe863843afa6b89218300e3c36_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzIwMDc_378827c3-60b0-4a73-a654-ed7cd87b168a"
      unitRef="eur">0</sny:CommitmentsMadeToJointVenturesAndAssociates>
    <sny:CommitmentsMadeToJointVenturesAndAssociates
      contextRef="ie5ceb0532e334611ab935fb0364427b6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzIwMDc_9fd4d7a1-5813-4c9f-8379-7487de4fa757"
      unitRef="eur">0</sny:CommitmentsMadeToJointVenturesAndAssociates>
    <sny:CommitmentsMadeToJointVenturesAndAssociates
      contextRef="if09b2251983a4669a88b8ff54f8690c0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MDcvZnJhZzpiYjM2ZjNlN2Q3ZGQ0NGZhYTRkNzQ4MDMxOGZmYzExZC90ZXh0cmVnaW9uOmJiMzZmM2U3ZDdkZDQ0ZmFhNGQ3NDgwMzE4ZmZjMTFkXzIwMDc_bef6f79c-6073-41f9-9f17-772bfc4c80c0"
      unitRef="eur">0</sny:CommitmentsMadeToJointVenturesAndAssociates>
    <ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY3NjU_bf0d5c6f-39ce-4659-955b-a2f1d1b81db6">Other non-current assets&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other non-current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity instruments at fair value through other comprehensive income (D.7.1.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt instruments at fair value through other comprehensive income (D.7.2.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other financial assets at fair value through profit or loss (D.7.3.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pre-funded pension obligations (Note&#160;D.19.1.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term prepaid expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term loans and advances and other non-current receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Derivative financial instruments (Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,095&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,127&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,734&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) The movement in this item mainly comprises (i)&#160;the non-current portion of a $100&#160;million upfront payment made on signature of a research agreement with Exscientia on January&#160;7, 2022 to develop a portfolio of precision-engineered medicines using artificial intelligence; and (ii)&#160;the non-current portion of a $150&#160;million upfront payment made as part of a strategic partnership with IGM Biosciences signed on March&#160;29, 2022, with a view to developing targets in oncology, immunology and inflammation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) As of December 31, 2022, this item includes a receivable under a sub-lease amounting to &#x20ac;164 million, or &#x20ac;227 million before discounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.7.1. Equity instruments at fair value through other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Quoted equity investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The line &#x201c;Equity instruments at fair value through other comprehensive income&#x201d; includes equity investments quoted in an active market with a carrying amount of &#x20ac;387 million as of December 31, 2022, &#x20ac;396 million as of December 31, 2021 and &#x20ac;439 million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The main changes in quoted equity investments included in the &#x201c;Equity instruments at fair value through other comprehensive income&#x201d; category in the year ended December 31, 2022 are described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the sale in June&#160;2022 of the residual equity interest in Regeneron (see Note&#160;C.1.). for $174 million, the entire loss on which was recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the acquisition of an equity interest in Innovent Biologics, in connection with a strategic collaboration agreement to intensify&#160;development in oncology medicines signed in August 2022, which had a fair value of &#x20ac;250 million as of that date and &#x20ac;228 million as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The main changes in quoted equity investments included in this category in previous years are described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;in 2021, following completion of the acquisition of Translate Bio on September&#160;14, 2021 (see Note&#160;D.2.1.), the equity interest of approximately 5% in Translate Bio previously held by Sanofi ceased to be accounted for as an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;equity instrument at fair value through other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;in 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;following the sale of 22.8&#160;million shares of Regeneron common stock on May&#160;29, 2020 (see Note&#160;D.2.2.), Sanofi ceased to exercise significant influence over Regeneron, and this investment ceased to be accounted for using the equity method (see Note&#160;D.6.). In accordance with IFRS&#160;9 (Financial Instruments), the 400,000&#160;shares retained by Sanofi were classified in&#160;the &#x201c;Equity instruments at fair value through other comprehensive income&#x201d; category as of May&#160;29, 2020, at a carrying&#160;amount of &#x20ac;221&#160;million. As of&#160;December 31, 2020, Sanofi held 279,766&#160;Regeneron shares with a carrying amount of &#x20ac;111 million,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;an equity injection was made into Translate&#160;Bio under the terms of the collaboration and license agreement announced on&#160;June&#160;23,&#160;2020, which had a carrying amount of &#x20ac;74 million as of December&#160;31, 2021 and represented an equity interest of approximately&#160;8% of Translate Bio as of that date,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;Sanofi owns equity interests in quoted biotechnology companies. Movements in the quoted market prices of the shares held in those companies generated a net gain of &#x20ac;357 million, recognized in &#x201c;Equity instruments at fair value through other comprehensive income&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A 10% decline in stock prices of the quoted equity investments included within &#x201c;Equity instruments at fair value through&#160;other&#160;comprehensive income&#x201d; would have had a pre-tax impact of &#x20ac;39 million on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unquoted equity investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The line item &#x201c;Equity instruments at fair value through other comprehensive income&#x201d; also includes equity investments not quoted in an active market with a carrying amount of &#x20ac;549 million as of December 31, 2022, &#x20ac;427 million as of December 31, 2021 and &#x20ac;149 million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The change in unquoted equity investments included in the &#x201c;Equity instruments at fair value through other comprehensive income&#x201d; category during the year ended December 31, 2022 was mainly due to various equity stakes acquired through the Sanofi Ventures fund, partly offset by the sale in October&#160;2022 of the 19% non-controlling interest in Onduo for $175 million; the entire gain on the disposal was recognised in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.7.2. Debt instruments at fair value through other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The &#x201c;Debt instruments at fair value through other comprehensive income&#x201d; category includes quoted euro-denominated senior bonds amounting to &#x20ac;329 million as of December 31, 2022, including &#x20ac;104 million of securities obtained in exchange for financial assets held to meet obligations to employees under post-employment benefit plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi held &#x20ac;447 million of quoted senior bonds as of December&#160;31, 2021 and &#x20ac;426 million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As regards debt instruments held to meet obligations to employees under post-employment benefit plans, an increase of 10&#160;basis points in market interest rates as of December 31, 2022 would have had a pre-tax impact of &#x20ac;1 million on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As regards other quoted debt instruments, an increase of 10&#160;basis points in market interest rates as of December 31, 2022 would have had a pre-tax impact of &#x20ac;1 million on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Other comprehensive income recognized in respect of &#x201c;Equity instruments at fair value through other comprehensive income&#x201d; and &#x201c;Debt instruments at fair value through other comprehensive income&#x201d; represented unrealized after-tax gains of &#x20ac;256 million for the year ended December 31, 2022, versus unrealized after-tax gains of &#x20ac;322 million for the year ended December 31, 2021 and unrealized after-tax losses of &#x20ac;200 million for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;An analysis of the change in gains and losses recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, and of items reclassified to profit or loss, is presented in Note&#160;D.15.7.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.7.3. Other financial assets at fair value through profit or loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The &#x201c;Other financial assets at fair value through profit or loss&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;category includes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;contingent consideration receivable by Sanofi following the dissolution of the Sanofi Pasteur MSD (SPMSD) joint venture, based on a percentage of MSD&#x2019;s future sales during the 2017-2024 period of specified products previously distributed by&#160;SPMSD (see Note&#160;D.12.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The fair value of the MSD contingent consideration was determined by applying the royalty percentage stipulated in the contract to discounted sales projections. A reduction of one percentage point in the discount rate would increase the fair value of the&#160;MSD&#160;contingent consideration by approximately 1%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of this contingent consideration are recognized in the income statement within the line item&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Fair value remeasurement of contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(see Note&#160;B.18.). As of December 31, 2022, the contingent consideration asset amounted to &#x20ac;303 million (including a non-current portion of &#x20ac;196 million), versus &#x20ac;378 million (non-current portion: &#x20ac;275 million) as of December 31, 2021 and &#x20ac;483 million (non current portion: &#x20ac;374 million) as of December 31, 2020;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;a portfolio of financial investments (amounting to &#x20ac;512 million as of December 31, 2022) held to fund a deferred compensation plan provided to certain employees (versus &#x20ac;549 million as of December 31, 2021 and &#x20ac;453 million as of December 31, 2020);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;unquoted securities not meeting the definition of equity instruments amounting to &#x20ac;115 million as of December 31, 2022 (versus &#x20ac;78 million as of December 31, 2021 and &#x20ac;63 million as of December 31, 2020).&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory>
    <sny:DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY3Njc_1df1193c-7cc6-4026-937f-60820a001807">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other non-current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity instruments at fair value through other comprehensive income (D.7.1.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt instruments at fair value through other comprehensive income (D.7.2.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other financial assets at fair value through profit or loss (D.7.3.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pre-funded pension obligations (Note&#160;D.19.1.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term prepaid expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term loans and advances and other non-current receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Derivative financial instruments (Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,095&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,127&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,734&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) The movement in this item mainly comprises (i)&#160;the non-current portion of a $100&#160;million upfront payment made on signature of a research agreement with Exscientia on January&#160;7, 2022 to develop a portfolio of precision-engineered medicines using artificial intelligence; and (ii)&#160;the non-current portion of a $150&#160;million upfront payment made as part of a strategic partnership with IGM Biosciences signed on March&#160;29, 2022, with a view to developing targets in oncology, immunology and inflammation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) As of December 31, 2022, this item includes a receivable under a sub-lease amounting to &#x20ac;164 million, or &#x20ac;227 million before discounting.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="i2598979394db469aaf140d5bfe9a797e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzMtMS0xLTEtMzY0MDYw_7c02a43a-5166-424b-a708-a23ce83c8cb1"
      unitRef="eur">936000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="ic0b1bc46ffe04f0299592c1fa440af75_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzMtMi0xLTEtMzY0MDYw_b94404cb-0a4e-43e0-98d1-74d0f2f04b1b"
      unitRef="eur">823000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="i672c84847c6c48278feb34e54f8c653e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzMtMy0xLTEtMzY0MDYw_371177ec-7380-4701-9886-4c39e5cac914"
      unitRef="eur">588000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="i0ec71259f6414571a2d78f044395b234_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzQtMS0xLTEtMzY0MDYw_34ac499c-f03c-4450-be8d-9b92d8714ed7"
      unitRef="eur">329000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="i18dfacac600544adb63df420cb892c4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzQtMi0xLTEtMzY0MDYw_c0c514e6-0d87-4950-b266-d08580e5abec"
      unitRef="eur">447000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="i947289ceb8754aafa7862f600d091bb9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzQtMy0xLTEtMzY0MDYw_a2713d99-fb0c-4d5a-817e-082348f9507c"
      unitRef="eur">426000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzUtMS0xLTEtMzY0MDYw_505b0043-8ed4-4acc-beb5-e73a73006783"
      unitRef="eur">823000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzUtMi0xLTEtMzY0MDYw_f1d7638b-b605-4d4b-9ae7-5253da74e566"
      unitRef="eur">902000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzUtMy0xLTEtMzY0MDYw_8bfcd556-05bc-481f-a810-5b4ffc07eb62"
      unitRef="eur">890000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <sny:PreFundedPensionObligations
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzYtMS0xLTEtMzY0MDYw_5c002d40-13c9-4ac9-a295-78e982f1c2a0"
      unitRef="eur">269000000</sny:PreFundedPensionObligations>
    <sny:PreFundedPensionObligations
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzYtMi0xLTEtMzY0MDYw_d1f92528-5577-4a29-9d83-5e7d0139760a"
      unitRef="eur">408000000</sny:PreFundedPensionObligations>
    <sny:PreFundedPensionObligations
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzYtMy0xLTEtMzY0MDYw_38f38a9e-80b5-4a7e-b06e-099f9831a089"
      unitRef="eur">177000000</sny:PreFundedPensionObligations>
    <sny:LongTermPrepaidExpenses
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzctMS0xLTEtMzY0MDYw_38ca9cb0-a381-4f01-8ba8-e41948d7db4a"
      unitRef="eur">286000000</sny:LongTermPrepaidExpenses>
    <sny:LongTermPrepaidExpenses
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzctMi0xLTEtMzY0MDYw_316796b8-3522-424a-868f-007e4c1bec14"
      unitRef="eur">59000000</sny:LongTermPrepaidExpenses>
    <sny:LongTermPrepaidExpenses
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzctMy0xLTEtMzY0MDYw_a383904a-3dce-41da-ba08-2c4c74ae3754"
      unitRef="eur">92000000</sny:LongTermPrepaidExpenses>
    <ifrs-full:NoncurrentLoansAndReceivables
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzgtMS0xLTEtMzY0MDYw_90c0abe3-2047-4f9d-9f4c-98871d6b7cfc"
      unitRef="eur">452000000</ifrs-full:NoncurrentLoansAndReceivables>
    <ifrs-full:NoncurrentLoansAndReceivables
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzgtMi0xLTEtMzY0MDYw_02d11a00-a2d2-4f4c-8ed8-72d1c9c4a2ac"
      unitRef="eur">485000000</ifrs-full:NoncurrentLoansAndReceivables>
    <ifrs-full:NoncurrentLoansAndReceivables
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzgtMy0xLTEtMzY0MDYw_70449306-1f84-4f66-a1c7-3a0a547b280c"
      unitRef="eur">537000000</ifrs-full:NoncurrentLoansAndReceivables>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzktMS0xLTEtMzY0MDYw_a05e3cc9-3160-4536-97b6-db9abd97d095"
      unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzktMi0xLTEtMzY0MDYw_6d748c46-c1cd-49a7-91c4-df3f5e86504f"
      unitRef="eur">3000000</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzktMy0xLTEtMzY0MDYw_3fb7bee7-b5c0-4961-9479-20a5bee19fe7"
      unitRef="eur">24000000</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzEwLTEtMS0xLTM2NDA2MA_c6abc20c-da9a-47db-be14-7af2e0f90937"
      unitRef="eur">3095000000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzEwLTItMS0xLTM2NDA2MA_d8ac6f40-d472-4002-888e-31fc5e1d2699"
      unitRef="eur">3127000000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90YWJsZTpkYTNjYmNiNWE4MDc0OGUyYTZkNDMyY2ZmOTA0NWI0OS90YWJsZXJhbmdlOmRhM2NiY2I1YTgwNzQ4ZTJhNmQ0MzJjZmY5MDQ1YjQ5XzEwLTMtMS0xLTM2NDA2MA_4621d40a-7a5a-4980-80a0-2326f151b2b9"
      unitRef="eur">2734000000</ifrs-full:OtherNoncurrentAssets>
    <sny:UpfrontPayments
      contextRef="i35f0fcaaff094ff283b1ab8503932dab_D20220107-20220107"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzgyNDYzMzcyMTY5OTM_84d4db1a-6877-46d6-943a-c0503bf7fb2f"
      unitRef="usd">100000000</sny:UpfrontPayments>
    <sny:UpfrontPayments
      contextRef="i7d7acd3285a64b18bcadb39dc8467fe9_D20220329-20220329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzgyNDYzMzcyMTY5OTk_2f660362-f612-4292-bfb3-ba5108b42f88"
      unitRef="usd">150000000</sny:UpfrontPayments>
    <ifrs-full:NoncurrentFinanceLeaseReceivables
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzgyNDYzMzcyMTcwMDU_b8bed4cd-e378-419f-a7ab-2a5420955572"
      unitRef="eur">164000000</ifrs-full:NoncurrentFinanceLeaseReceivables>
    <sny:NonCurrentFinanceLeaseReceivablesGross
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzgyNDYzMzcyMTcwMTE_223c1733-43b3-442f-ba07-c99a7549748b"
      unitRef="eur">227000000</sny:NonCurrentFinanceLeaseReceivablesGross>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="i85d4d256594b464a8880f4ff83e76312_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzMzMw_d14677d8-cdf8-4e61-a85d-1601f0a68eca"
      unitRef="eur">387000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="i747f411b1b5b4dc38fd872cb94543817_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzM0Ng_d1827eae-fdb2-4b3c-82b9-3ba2d59613e3"
      unitRef="eur">396000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="i30ef28538e274977b05fe65db2be8141_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzM2Mg_0db27619-ba5c-4b74-9d5b-c3d97f21baad"
      unitRef="eur">439000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod
      contextRef="i06d47704541e4ee1a797c39f08654082_D20220601-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNTAyMDY_d839b636-5478-4442-ab19-6be0e98a36d8"
      unitRef="usd">174000000</ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod>
    <sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount
      contextRef="i5d0712e20c454b3c96fcf98e68a25960_I20220831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNTE0NDg_6ecad852-0e19-4c18-b774-62879d7d3e01"
      unitRef="eur">250000000</sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount>
    <sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount
      contextRef="ic0d86ac7238f4dd59ab63269350d8d09_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNjEyODY_4d68eb1b-f13e-4a46-8e70-4dd31720dced"
      unitRef="eur">228000000</sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount>
    <sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage
      contextRef="i57ad482a322b4fc0a81c53a3afc3d8d6_I20210914"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY5OQ_80f345fe-420f-4999-b043-65087a2037ed"
      unitRef="number">0.05</sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage>
    <sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal
      contextRef="i58dc338d3859459eb1381af00a929009_D20200529-20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzEwODk_2591b0e2-dbe2-4180-a74f-62e69d2301f4"
      unitRef="shares">22800000</sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal>
    <sny:NonCurrentFinancialAssetsNumberOfShares
      contextRef="ib198bd6cc6604c2b9675491c47738ca5_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzEzNDk_a51317ac-810d-4913-b2b3-e5458a6f4a5e"
      unitRef="shares">400000</sny:NonCurrentFinancialAssetsNumberOfShares>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="ib198bd6cc6604c2b9675491c47738ca5_I20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE1MjQ_83779e7d-125b-4517-922b-5991d4668b55"
      unitRef="eur">221000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <sny:NonCurrentFinancialAssetsNumberOfShares
      contextRef="i7488dcfd6c2945918eaf022e244867f7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE1NTA_6ff61fcf-e1f5-4bd1-8712-b4760a0ddb83"
      unitRef="shares">279766000000</sny:NonCurrentFinancialAssetsNumberOfShares>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="i7488dcfd6c2945918eaf022e244867f7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE1OTc_a1907fec-dc95-4da0-ad15-614258ca6bdb"
      unitRef="eur">111000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome
      contextRef="ie64fc8634a414cf0b229f5f5231182b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE3NjM_fdd0fb49-151c-4ef8-ba38-79793e060cdc"
      unitRef="eur">74000000</ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome>
    <sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage
      contextRef="ie64fc8634a414cf0b229f5f5231182b0_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE4Mjg_34b78e9a-bfb5-4543-9edb-9891f2047549"
      unitRef="number">0.08</sny:InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="if6436922a2ad48e6aa3486427a648935_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzIwMzA_674e687b-bd21-4d9e-bb9d-fcc4a151ea47"
      unitRef="eur">357000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <sny:EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzMzMDc_07bcac62-1606-48f5-abbc-bd0fee35f565"
      unitRef="eur">39000000</sny:EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount>
    <ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome
      contextRef="i1cb860a561454a50b32cf9b3ef5bf20a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzM1NTI_775acdce-9cdd-4d0d-8a6e-8d85869f07a9"
      unitRef="eur">549000000</ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome
      contextRef="if350acb0ea304e1380f8a7daa4bf3d34_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzM1NjU_cb1a1215-b9f1-4281-aafb-93228309fc85"
      unitRef="eur">427000000</ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome
      contextRef="i58761417deb34e4789711c949bf2754c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzM1ODE_2cf131a4-8ef9-4a7b-acbb-c14d199d253f"
      unitRef="eur">149000000</ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="i737d6d075cd24a3fa0a94d9a8769b9f8_D20221001-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzE5NzkxMjA5MzIzMDA5_d14e922d-77b8-4dcd-bd09-704f754abe8a"
      unitRef="number">0.19</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <sny:DisposalGroupGainOnDisposal
      contextRef="i4c302b94ca2e4d78b8e9a5e1966760e7_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNjE3NTI_6a64ee1f-322f-4619-bfb8-494f4246e89f"
      unitRef="eur">175000000</sny:DisposalGroupGainOnDisposal>
    <ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="i58d99ec61b724625ba3cf5fe5d54f353_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzQxOTk_621f0d50-4fea-4ca9-b261-afc5e3a92d47"
      unitRef="eur">329000000</ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts
      contextRef="i0316f32ab41848ccaa532657cf32b68f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzQyMjI_526287c8-6ff0-4de0-abec-604baabd793a"
      unitRef="eur">104000000</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts>
    <ifrs-full:HeldtomaturityInvestments
      contextRef="if7bc7c1140af4531b7bb1f0aa3a64394_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNjE3NzE_73b61a86-58f4-429f-a78a-718acde8ccce"
      unitRef="eur">447000000</ifrs-full:HeldtomaturityInvestments>
    <ifrs-full:HeldtomaturityInvestments
      contextRef="idbc81c6777a247f3a55a9409731b937f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzQzNjg_0c4f0cfb-2590-4042-b331-832457daa20b"
      unitRef="eur">426000000</ifrs-full:HeldtomaturityInvestments>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="if636e1b1d9c94752b6e7d2f5d093ad9c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzQ2MjM_ac99ec7d-d780-4ef1-a18d-342430bc6d0a"
      unitRef="eur">1000000</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="i2a89cf5df5aa43cd9b53e1ca3064c250_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzQ3OTk_91c70b96-e8ae-49b5-af6b-8229c3a530fc"
      unitRef="eur">1000000</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <sny:UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity
      contextRef="ib26b365d63504886a705909c700dad19_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzUwNjk_6837ac19-1b8b-46b8-a5c2-1059097a1fbf"
      unitRef="eur">256000000</sny:UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity>
    <sny:UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity
      contextRef="i0f1cbd8e523544a09df5288b9e682c8b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzUxMzI_352d67c1-cd97-4eff-886d-587118748abc"
      unitRef="eur">322000000</sny:UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity>
    <sny:UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity
      contextRef="i187a52d9d71643088cd196df81c6809f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzUxOTM_c422270e-f716-4635-ac76-7c0345b4c882"
      unitRef="eur">-200000000</sny:UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity>
    <sny:IncreaseInContingentConsideration
      contextRef="i8b47ba7fd49a4339a1546e28df0f6cc1_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzYxMDA_5f3f649a-b6aa-43fc-883d-71cf78a6f634"
      unitRef="number">0.01</sny:IncreaseInContingentConsideration>
    <sny:FairValueOfTheContingentConsideration
      contextRef="ia89ef6966eae49a3b34c0c5c4c087cbc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzYzNTE_ba676f0c-e2dd-468e-89f0-e73b904c9aa7"
      unitRef="eur">303000000</sny:FairValueOfTheContingentConsideration>
    <sny:FairValueOfTheContingentConsideration
      contextRef="i545b36dad89549698a7358e61f470fae_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzYzOTA_eb8a6312-6232-48ce-994d-64a034acee79"
      unitRef="eur">196000000</sny:FairValueOfTheContingentConsideration>
    <sny:FairValueOfTheContingentConsideration
      contextRef="if2790c19603340069463669a1121103c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY0MDI_ed4863c4-733e-44bf-b945-993df47c4efe"
      unitRef="eur">378000000</sny:FairValueOfTheContingentConsideration>
    <sny:FairValueOfTheContingentConsideration
      contextRef="i29f5271fd56c4132b303c64792c7e68b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY0Mjc_62944752-0fff-4b7b-a8ad-70ff7ad8b3fe"
      unitRef="eur">275000000</sny:FairValueOfTheContingentConsideration>
    <sny:FairValueOfTheContingentConsideration
      contextRef="i008006b7cc834a49a4178a0fd6d1f590_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY0NDQ_fcaa6a56-5fa3-44ee-af2b-db72e71773e0"
      unitRef="eur">483000000</sny:FairValueOfTheContingentConsideration>
    <sny:FairValueOfTheContingentConsideration
      contextRef="icd6801a467d04340b8c2bbb32208b916_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzU0OTc1NTgxNjE3OTE_5d122117-88ce-426d-bd46-c4eddcd605b7"
      unitRef="eur">374000000</sny:FairValueOfTheContingentConsideration>
    <sny:FinancialInvestments
      contextRef="i59d2d460cf184fc7aa2916de537a8f07_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY1MDk_27508308-60e7-422b-8731-94b9970b0a68"
      unitRef="eur">512000000</sny:FinancialInvestments>
    <sny:FinancialInvestments
      contextRef="ie8b445cb2507415fb152acdc9b875a90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY2MDI_744c9b1f-e874-4d99-82f8-c034bb7096d0"
      unitRef="eur">549000000</sny:FinancialInvestments>
    <sny:FinancialInvestments
      contextRef="i6f597a89a6d040349370742d7e4695ac_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY2MTg_8570c02b-2f65-42b5-aa26-4f9b79f26be2"
      unitRef="eur">453000000</sny:FinancialInvestments>
    <ifrs-full:FinancialAssets
      contextRef="i0b12ab871b274e9aa1aa68c28cd74514_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY3MTQ_bb876a43-b09a-4b9a-a76b-3d5f4eff9acd"
      unitRef="eur">115000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i8bbf8d410b244301ac8ff091e2c31cd3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY3MzQ_f08ac728-e37b-400a-b21b-fc44927fa36d"
      unitRef="eur">78000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i41f3c0f9515d4e13aa74179f5b5a3840_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTAvZnJhZzphOWE1ZDJiMzVhZjM0OGFkYjgzYjhiYTc1ZWU0Y2UwNC90ZXh0cmVnaW9uOmE5YTVkMmIzNWFmMzQ4YWRiODNiOGJhNzVlZTRjZTA0XzY3NTA_0aa1d648-e420-481b-a582-d16e833631a8"
      unitRef="eur">63000000</ifrs-full:FinancialAssets>
    <ifrs-full:DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90ZXh0cmVnaW9uOjIzYzQ2NGI3ZGExYzRlNmZiMjNkNmNhYzAyYjcxNTkyXzY3Mg_abec95f2-ec1a-462b-abcb-ee850dd2069a">Assets held for sale or exchange and liabilities related to&#160;assets held for sale or exchange&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Assets held for sale or exchange, and liabilities related to assets held for sale or exchange, comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;89&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;83&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Liabilities related to assets held for sale or exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, assets held for sale mainly related to items of property, plant and equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, assets held for sale mainly related to the divestment of a listed equity investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, assets held for sale mainly related to the planned divestment of an industrial facility in North America.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory>
    <sny:DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90ZXh0cmVnaW9uOjIzYzQ2NGI3ZGExYzRlNmZiMjNkNmNhYzAyYjcxNTkyXzY3MA_78dd802b-a452-48b5-95e2-47329574ba78">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Assets held for sale or exchange, and liabilities related to assets held for sale or exchange, comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assets held for sale or exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;89&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;83&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Liabilities related to assets held for sale or exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzEtMS0xLTEtMzY0MDYw_3878eb6f-cfd8-40b7-ae97-6c8f2f1975cf"
      unitRef="eur">85000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzEtMi0xLTEtMzY0MDYw_6d7b69ae-513d-4f1f-9302-7828ada5efc7"
      unitRef="eur">89000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzEtMy0xLTEtMzY0MDYw_2436de90-5f5c-4c35-b1bb-e3c40dead1ac"
      unitRef="eur">83000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzItMS0xLTEtMzY0MDYw_4e0c8005-c07f-4932-8506-c32784886ea5"
      unitRef="eur">10000000</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzItMi0xLTEtMzY0MDYw_301e6d0f-2265-4fe7-ba3d-e2d8e4467cd2"
      unitRef="eur">0</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTMvZnJhZzoyM2M0NjRiN2RhMWM0ZTZmYjIzZDZjYWMwMmI3MTU5Mi90YWJsZToxNzJkOGIwYjRhMzg0NzVjOGVhYTVhN2FiZjFkZTQ3Yi90YWJsZXJhbmdlOjE3MmQ4YjBiNGEzODQ3NWM4ZWFhNWE3YWJmMWRlNDdiXzItMy0xLTEtMzY0MDYw_81768e65-12be-4acf-855a-6cc155ff341c"
      unitRef="eur">32000000</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:DisclosureOfInventoriesExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90ZXh0cmVnaW9uOjNlYTFlYjQ5NjEyZTRkYjU4NGUyOGIyZTJmY2E2Y2YzXzQxNw_830180ac-e7a1-4f8f-a071-84af95bcc47f">Inventories&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Inventories comprise the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(554)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(542)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,024&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,960&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,619&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,715&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,188&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,352&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Allowances include write-downs of products on hand pending marketing approval, except in specific circumstances where it is possible to estimate that recovery of the value of inventories as of the end of the reporting period is highly probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Inventories pledged as security for liabilities amounted to &#x20ac;3 million as of December 31, 2022 (versus &#x20ac;20 million as of December 31, 2021 and &#x20ac;17 million as of December 31, 2020).&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfInventoriesExplanatory>
    <sny:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90ZXh0cmVnaW9uOjNlYTFlYjQ5NjEyZTRkYjU4NGUyOGIyZTJmY2E2Y2YzXzQxNA_9ce76fee-0c53-4901-9a8d-384e45ee7759">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Inventories comprise the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(554)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(542)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,024&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,960&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,619&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,715&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,188&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,352&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock>
    <ifrs-full:RawMaterials
      contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItMS0xLTEtMzY0MDYw_9d2731b3-cb2e-49fc-bc9a-4c8c84957008"
      unitRef="eur">1613000000</ifrs-full:RawMaterials>
    <ifrs-full:RawMaterials
      contextRef="ib647a1698a86427cb8d4b97bbad379d5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItMi0xLTEtMzY0MDYw_c21f1c96-912f-4a43-8a06-ad1fb4a63e6e"
      unitRef="eur">139000000</ifrs-full:RawMaterials>
    <ifrs-full:RawMaterials
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItMy0xLTEtMzY0MDYw_4545bc30-98aa-44d2-8f8d-aa92644857b9"
      unitRef="eur">1474000000</ifrs-full:RawMaterials>
    <ifrs-full:RawMaterials
      contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItNC0xLTEtMzY0MDYw_e726de21-d857-47d1-8c2f-36d7f0a01d2d"
      unitRef="eur">1344000000</ifrs-full:RawMaterials>
    <ifrs-full:RawMaterials
      contextRef="iac996783058743dc90c8e8829cd97b94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItNS0xLTEtMzY0MDYw_d9319ef0-9848-42f9-965d-fff42f391035"
      unitRef="eur">66000000</ifrs-full:RawMaterials>
    <ifrs-full:RawMaterials
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItNi0xLTEtMzY0MDYw_9e796864-072e-4e9b-9a74-d83345a64908"
      unitRef="eur">1278000000</ifrs-full:RawMaterials>
    <ifrs-full:RawMaterials
      contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItNy0xLTEtMzY0MDYw_46624b20-d558-40b5-82a0-b4b748e865cf"
      unitRef="eur">1051000000</ifrs-full:RawMaterials>
    <ifrs-full:RawMaterials
      contextRef="i1b3cc5ff69f34488be79292aa20b972d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItOC0xLTEtMzY0MDYw_a0a6f703-fd4a-4c4f-b007-72659eedd66c"
      unitRef="eur">76000000</ifrs-full:RawMaterials>
    <ifrs-full:RawMaterials
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzItOS0xLTEtMzY0MDYw_3fef5778-35ae-4be8-83db-8159ffbcc0b1"
      unitRef="eur">975000000</ifrs-full:RawMaterials>
    <ifrs-full:WorkInProgress
      contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtMS0xLTEtMzY0MDYw_b6339f82-059d-4f00-8f45-22ba06be023d"
      unitRef="eur">5663000000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress
      contextRef="ib647a1698a86427cb8d4b97bbad379d5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtMi0xLTEtMzY0MDYw_5788e2f6-c9a1-41da-b444-6bd7677594c5"
      unitRef="eur">678000000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtMy0xLTEtMzY0MDYw_4f009353-9c62-420a-ad95-a868b124abaf"
      unitRef="eur">4985000000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress
      contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtNC0xLTEtMzY0MDYw_05aef563-c747-4602-bdf7-62c7fbc60784"
      unitRef="eur">5579000000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress
      contextRef="iac996783058743dc90c8e8829cd97b94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtNS0xLTEtMzY0MDYw_57e65adc-d25e-40a8-a95b-f491bc305ab2"
      unitRef="eur">554000000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtNi0xLTEtMzY0MDYw_e46025d4-7399-408a-9ddb-871b2deed3ed"
      unitRef="eur">5025000000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress
      contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtNy0xLTEtMzY0MDYw_8bef61d9-697a-4ffa-a868-c8997a911463"
      unitRef="eur">5398000000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress
      contextRef="i1b3cc5ff69f34488be79292aa20b972d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtOC0xLTEtMzY0MDYw_9a97140b-3bc3-4699-a0d3-aedf8773d2e7"
      unitRef="eur">542000000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzMtOS0xLTEtMzY0MDYw_84a197ac-259f-445b-b29c-275173dd9db2"
      unitRef="eur">4856000000</ifrs-full:WorkInProgress>
    <ifrs-full:FinishedGoods
      contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtMS0xLTEtMzY0MDYw_008128e1-fe74-4ae5-95c9-aa0f5780219b"
      unitRef="eur">2748000000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods
      contextRef="ib647a1698a86427cb8d4b97bbad379d5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtMi0xLTEtMzY0MDYw_fb2bb2e9-12d6-42a1-a165-cc2808998b46"
      unitRef="eur">247000000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtMy0xLTEtMzY0MDYw_ef3f5824-28f0-4eaa-abf7-0d3c2744a9aa"
      unitRef="eur">2501000000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods
      contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtNC0xLTEtMzY0MDYw_6567dc9b-8334-4242-96c1-4b362805c27c"
      unitRef="eur">2696000000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods
      contextRef="iac996783058743dc90c8e8829cd97b94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtNS0xLTEtMzY0MDYw_17a3e7b3-4467-4aad-8952-d4f57b947e5d"
      unitRef="eur">284000000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtNi0xLTEtMzY0MDYw_b443e2f9-e66b-42de-8071-1dca53034941"
      unitRef="eur">2412000000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods
      contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtNy0xLTEtMzY0MDYw_4d5d1f9f-2a00-4bcf-9be7-8c516dc0471f"
      unitRef="eur">2739000000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods
      contextRef="i1b3cc5ff69f34488be79292aa20b972d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtOC0xLTEtMzY0MDYw_6a79adae-1d23-4a01-a067-cd83962542f2"
      unitRef="eur">218000000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzQtOS0xLTEtMzY0MDYw_14ed9e12-d360-4430-8c42-36e89c867748"
      unitRef="eur">2521000000</ifrs-full:FinishedGoods>
    <ifrs-full:Inventories
      contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtMS0xLTEtMzY0MDYw_6c610045-fa13-464b-9c7f-8c67506cee12"
      unitRef="eur">10024000000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="ib647a1698a86427cb8d4b97bbad379d5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtMi0xLTEtMzY0MDYw_60fc8a0c-2816-488d-8e7a-6c5f87cf8853"
      unitRef="eur">1064000000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtMy0xLTEtMzY0MDYw_7fa67f09-3616-4140-a65e-5f22d871db96"
      unitRef="eur">8960000000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtNC0xLTEtMzY0MDYw_a6c37a61-effc-43c6-8aeb-659f1d8212de"
      unitRef="eur">9619000000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="iac996783058743dc90c8e8829cd97b94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtNS0xLTEtMzY0MDYw_469b86f1-8ff7-4bdc-a6f3-78eb7b30bd25"
      unitRef="eur">904000000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtNi0xLTEtMzY0MDYw_7357dd3a-6c9e-4c5d-b0d3-71ad4ac1d454"
      unitRef="eur">8715000000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtNy0xLTEtMzY0MDYw_69604a27-5582-4361-806b-bb1e822ad526"
      unitRef="eur">9188000000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="i1b3cc5ff69f34488be79292aa20b972d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtOC0xLTEtMzY0MDYw_2f3ac7ef-85ec-40e2-8e04-35a7cf6b5588"
      unitRef="eur">836000000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90YWJsZTpjOWM0ODQzZTlkNjU0MDJlYTFkYmE1MmM2YzNiMzAxMC90YWJsZXJhbmdlOmM5YzQ4NDNlOWQ2NTQwMmVhMWRiYTUyYzZjM2IzMDEwXzUtOS0xLTEtMzY0MDYw_8ed50d71-adaa-4ca0-96ae-2a8d5b63ecad"
      unitRef="eur">8352000000</ifrs-full:Inventories>
    <ifrs-full:InventoriesPledgedAsSecurityForLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90ZXh0cmVnaW9uOjNlYTFlYjQ5NjEyZTRkYjU4NGUyOGIyZTJmY2E2Y2YzXzM2NQ_077027f8-6159-4028-90f6-7120e133f3dd"
      unitRef="eur">3000000</ifrs-full:InventoriesPledgedAsSecurityForLiabilities>
    <ifrs-full:InventoriesPledgedAsSecurityForLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90ZXh0cmVnaW9uOjNlYTFlYjQ5NjEyZTRkYjU4NGUyOGIyZTJmY2E2Y2YzXzM4NQ_850801af-5dfd-46af-948b-9bcf95b36e02"
      unitRef="eur">20000000</ifrs-full:InventoriesPledgedAsSecurityForLiabilities>
    <ifrs-full:InventoriesPledgedAsSecurityForLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTYvZnJhZzozZWExZWI0OTYxMmU0ZGI1ODRlMjhiMmUyZmNhNmNmMy90ZXh0cmVnaW9uOjNlYTFlYjQ5NjEyZTRkYjU4NGUyOGIyZTJmY2E2Y2YzXzQwMQ_6ec236bc-291f-4f25-be18-bf8ea1c1ab3a"
      unitRef="eur">17000000</ifrs-full:InventoriesPledgedAsSecurityForLiabilities>
    <sny:DisclosureOfTradeReceivablesTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzY3MQ_6262d5ff-dd37-4ebb-8b22-6a9929bac9a0">Accounts receivable&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Accounts receivable break down as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,424&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,568&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,491&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The impact of allowances against accounts receivable in 2022 was a net amount of less than &#x20ac;1 million (versus a net expense of&#160;&#x20ac;12 million in 2021 and a net expense of &#x20ac;30 million in 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The gross value of overdue receivables was &#x20ac;452 million as of December 31, 2022, versus &#x20ac;455 million as of December 31, 2021 and &#x20ac;549 million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;by&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;by&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;by&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;by&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;by&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;gross value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&amp;lt;1 month&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&#160;3&#160;months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&#160;6&#160;months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&#160;to&#160;12&#160;months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&amp;gt;&#160;12&#160;months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;452&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;118&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;87&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Amounts overdue by more than one month relate mainly to public-sector customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Some Sanofi subsidiaries have assigned receivables to factoring companies or banks without recourse. The amount of receivables&#160;derecognized was &#x20ac;131 million as of December 31, 2022 (&#x20ac;3 million as of December 31, 2021 and &#x20ac;18 million as of December 31, 2020). The residual guarantees relating to such transfers were immaterial as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfTradeReceivablesTextBlock>
    <sny:DisclosureOfCurrentTradeReceivablesTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzY3Mw_d0a7fcab-03af-48cb-b592-50b8f21486b0">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Accounts receivable break down as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,424&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,568&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,491&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfCurrentTradeReceivablesTableTextBlock>
    <ifrs-full:CurrentTradeReceivables
      contextRef="i4b2466da63bc4da892390e4aed261abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzEtMS0xLTEtMzY0MDYw_ba485b8f-2e62-4419-abfb-3c5bb49ee5de"
      unitRef="eur">8537000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="ife09bcb0dbc442368e0599e166c05925_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzEtMi0xLTEtMzY0MDYw_787d46c8-044e-4a07-be4b-1a3077753a1f"
      unitRef="eur">7705000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="if4f8821720944d1680e7ed8837430cc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzEtMy0xLTEtMzY0MDYw_0c4edec7-1db3-48f0-b622-48b0d3747d6f"
      unitRef="eur">7633000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="iaa4b63bd7db44ad5911b73e3491dd4a3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzItMS0xLTEtMzY0MDYw_926b76eb-7709-4c1c-b452-e51de83c7af2"
      unitRef="eur">113000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="i05f28cd38d0841ebb218af6930d501eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzItMi0xLTEtMzY0MDYw_92d788cb-a952-440b-b611-74a76a675f1a"
      unitRef="eur">137000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="i032944e42df3482bbe716ed7bc4d8482_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzItMy0xLTEtMzY0MDYw_68b4efc5-1376-493d-bc7f-4c427b7a5bc6"
      unitRef="eur">142000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzMtMS0xLTEtMzY0MDYw_762dfb53-c866-475f-9d99-2202473c6ded"
      unitRef="eur">8424000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzMtMi0xLTEtMzY0MDYw_47e7c91a-1620-4368-b229-9559d738f0aa"
      unitRef="eur">7568000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTo3NGQ5NWM1MjhiYTI0YjVjOWVmOTljOWEzNTM5ZDQ3OC90YWJsZXJhbmdlOjc0ZDk1YzUyOGJhMjRiNWM5ZWY5OWM5YTM1MzlkNDc4XzMtMy0xLTEtMzY0MDYw_021e94be-685d-43bf-8cf5-43aea2be501d"
      unitRef="eur">7491000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzE1Ng_328abd81-326b-4f4d-bd36-ea041991adbc"
      unitRef="eur">1000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzE4NA_4b63ee18-feaa-41a6-855d-55ffeee419a9"
      unitRef="eur">12000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzIxMQ_b94e96bb-5449-4429-b4cd-d5b7a79ccad0"
      unitRef="eur">30000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <sny:OverdueReceivablesGrossValue
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzI2Ng_2ec3e5e9-2989-4a40-91f3-c50ce834a3c9"
      unitRef="eur">452000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzI5NA_dde1bb7b-7d0c-41da-8c19-5d0e9ff21377"
      unitRef="eur">455000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzMxMQ_ab4fbeb3-b8e2-4ed0-bce1-9dd5b40f034c"
      unitRef="eur">549000000</sny:OverdueReceivablesGrossValue>
    <sny:DisclosureOfOverdueReceivablesGrossValueTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzY3NQ_e84d8606-119b-4403-9b46-4efcd4038440">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;by&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;by&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;by&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;by&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Overdue&#160;by&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;gross value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&amp;lt;1 month&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&#160;3&#160;months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&#160;6&#160;months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&#160;to&#160;12&#160;months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&amp;gt;&#160;12&#160;months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;452&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;118&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;87&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfOverdueReceivablesGrossValueTableTextBlock>
    <sny:OverdueReceivablesGrossValue
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItMS0xLTEtMzY0MDYw_2ec3e5e9-2989-4a40-91f3-c50ce834a3c9"
      unitRef="eur">452000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="ib366bca9838a4f858834d488788aa1aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItMi0xLTEtMzY0MDYw_71bd357b-3749-43be-8457-00981420c567"
      unitRef="eur">118000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i92676380068543619922d35317997de3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItMy0xLTEtMzY0MDYw_ef6f552d-a2b1-4767-b2e8-0de9b275a50c"
      unitRef="eur">161000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i51c89819a09a4a869b9cf28d9487e9a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItNC0xLTEtMzY0MDYw_df1f5aa3-cf7b-4c80-a730-380502dc15b7"
      unitRef="eur">87000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i4ef2f8187cfa4407be68d0b5b25618ad_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItNS0xLTEtMzY0MDYw_c3ea3436-2ccd-4b24-92d5-d22e25d1f913"
      unitRef="eur">35000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i204cf38410c44c62bd596f2773e81a5b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzItNi0xLTEtMzY0MDYw_2ad1f60a-19bf-4dc4-931e-44dba2574af4"
      unitRef="eur">51000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtMS0xLTEtMzY0MDYw_dde1bb7b-7d0c-41da-8c19-5d0e9ff21377"
      unitRef="eur">455000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i7ba3ac339a504f58a90dc11aa1e8caef_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtMi0xLTEtMzY0MDYw_42dee4a4-c54b-45a1-948c-c0be7b943625"
      unitRef="eur">169000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="iec0ca9779e2a464985b051e55ada2803_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtMy0xLTEtMzY0MDYw_b79efcc6-29b5-4968-9619-dc8b6e7a445a"
      unitRef="eur">151000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="iaa0f24f6bcc446849ba76127738f68fb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtNC0xLTEtMzY0MDYw_941363d3-990b-493c-8524-d3633bc7a974"
      unitRef="eur">67000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="id20ecec6f1584de38800aacb975d6350_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtNS0xLTEtMzY0MDYw_e00c05c4-95e6-40b1-9095-7274f7343988"
      unitRef="eur">12000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i0fe124e0795a41ebac762da9097bb875_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzMtNi0xLTEtMzY0MDYw_814865bf-b153-404f-8fe8-0632c0f884c9"
      unitRef="eur">56000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtMS0xLTEtMzY0MDYw_ab4fbeb3-b8e2-4ed0-bce1-9dd5b40f034c"
      unitRef="eur">549000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i71a39145bca34b95ae9166213239a5c9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtMi0xLTEtMzY0MDYw_bd560c87-9fc2-41fa-9e5b-ea6f5de009e7"
      unitRef="eur">271000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="ifd3ffc9d285a4ee5b56664fc9405500a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtMy0xLTEtMzY0MDYw_fc4b24a5-f3ff-42b1-b524-fc6fef886f08"
      unitRef="eur">97000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="id8bfa977878c49e4801932e083d9a1d9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtNC0xLTEtMzY0MDYw_ab96a703-9c32-4c90-9ae9-c189956018e7"
      unitRef="eur">52000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i0c1337c5561d4086b729fb3b2df1d049_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtNS0xLTEtMzY0MDYw_0d16cffc-518d-4e97-af14-98d60dc99931"
      unitRef="eur">34000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="i2e7cdf1797e949f6abdf600757d84aa3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90YWJsZTowZWZlMjk3NzI5ZDA0NjgzYmJhYjdiMjViNWFhMWFlOS90YWJsZXJhbmdlOjBlZmUyOTc3MjlkMDQ2ODNiYmFiN2IyNWI1YWExYWU5XzQtNi0xLTEtMzY0MDYw_341c01bb-7bd1-44cf-a122-535373e12c64"
      unitRef="eur">95000000</sny:OverdueReceivablesGrossValue>
    <sny:DerecognizedReceivables
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzU1MQ_2c25f668-faa5-495b-b87c-0baf3caa7ab7"
      unitRef="eur">131000000</sny:DerecognizedReceivables>
    <sny:DerecognizedReceivables
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzU2NA_70eea285-9b15-4254-940e-b010ccfb1d72"
      unitRef="eur">3000000</sny:DerecognizedReceivables>
    <sny:DerecognizedReceivables
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MTkvZnJhZzo3NTJhMjY2MTdhYWU0MGY0OTAxMDU5NDY2NzFiYjdjNi90ZXh0cmVnaW9uOjc1MmEyNjYxN2FhZTQwZjQ5MDEwNTk0NjY3MWJiN2M2XzU4MA_2d082f1c-cc58-41c5-a96f-c8a059c13434"
      unitRef="eur">18000000</sny:DerecognizedReceivables>
    <ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90ZXh0cmVnaW9uOmUyNzBjNGI1ODE5YjQwZGRiY2M0ZDEwYzEzZTU3ZGIxXzY4NA_d8ba05f0-fe39-4040-bd2e-826134d704e9">Other current assets&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;An analysis of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Other current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax receivables, other than corporate income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate derivatives measured at fair value (see Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency derivatives measured at fair value (see Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current financial assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,532&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,571&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,737&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) This line mainly comprises advance payments to suppliers, and receivables relating to Sanofi's activities as agent under a transitional services agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) This item includes bank loans and receivables maturing in less than one year with high-grade counterparties. For 2021, this item also includes debt instruments derived from the acquisitions of Translate Bio and Kadmon (carried out in 2021) with maturities of more than 3&#160;months at inception and less than 12&#160;months at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory>
    <sny:DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90ZXh0cmVnaW9uOmUyNzBjNGI1ODE5YjQwZGRiY2M0ZDEwYzEzZTU3ZGIxXzY4Mg_21cb74e8-11a7-4a81-b6f5-44170dd47eea">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;An analysis of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Other current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax receivables, other than corporate income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate derivatives measured at fair value (see Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency derivatives measured at fair value (see Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current financial assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,532&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,571&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,737&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) This line mainly comprises advance payments to suppliers, and receivables relating to Sanofi's activities as agent under a transitional services agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) This item includes bank loans and receivables maturing in less than one year with high-grade counterparties. For 2021, this item also includes debt instruments derived from the acquisitions of Translate Bio and Kadmon (carried out in 2021) with maturities of more than 3&#160;months at inception and less than 12&#160;months at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock>
    <ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzEtMS0xLTEtMzY0MDYw_c1cadad4-ec85-4da9-806e-b03dff7a1165"
      unitRef="eur">658000000</ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax>
    <ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzEtMi0xLTEtMzY0MDYw_b3b58d2f-8d78-40b0-84f0-cd771eff4504"
      unitRef="eur">802000000</ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax>
    <ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzEtMy0xLTEtMzY0MDYw_e7da15bb-8c97-4ce7-86dd-2a85ee815604"
      unitRef="eur">687000000</ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzItMS0xLTEtMzY0MDYw_209bce85-7f0b-4af5-8531-e21e695363fd"
      unitRef="eur">714000000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzItMi0xLTEtMzY0MDYw_c5f8b754-8ed9-4307-86bb-a6ec51fb8795"
      unitRef="eur">615000000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzItMy0xLTEtMzY0MDYw_882447e9-16d3-40dd-95e8-f5d4bab811c9"
      unitRef="eur">525000000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:OtherCurrentReceivables
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzMtMS0xLTEtMzY0MDYw_8c85bc85-ae95-48b2-a9da-db72e07b268d"
      unitRef="eur">1290000000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzMtMi0xLTEtMzY0MDYw_403d2fff-8392-4793-bd1d-e7df804852f2"
      unitRef="eur">805000000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzMtMy0xLTEtMzY0MDYw_efc9c680-4a42-4dc2-9492-ac947021bca4"
      unitRef="eur">567000000</ifrs-full:OtherCurrentReceivables>
    <sny:InterestRateDerivativesMeasuredAtFairValue
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzQtMS0xLTEtMzY0MDYw_a16dc7b5-72b9-4a2d-9de1-6d47fb317d6d"
      unitRef="eur">0</sny:InterestRateDerivativesMeasuredAtFairValue>
    <sny:InterestRateDerivativesMeasuredAtFairValue
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzQtMi0xLTEtMzY0MDYw_71a05d12-cfe1-47a2-a99b-69238123bf7e"
      unitRef="eur">11000000</sny:InterestRateDerivativesMeasuredAtFairValue>
    <sny:InterestRateDerivativesMeasuredAtFairValue
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzQtMy0xLTEtMzY0MDYw_9508fa6c-b8a0-4690-aaf5-746305001dd3"
      unitRef="eur">0</sny:InterestRateDerivativesMeasuredAtFairValue>
    <sny:CurrencyDerivativesMeasuredAtFairValue
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzUtMS0xLTEtMzY0MDYw_ad9f71ff-edf5-4232-a988-5f8d131ff250"
      unitRef="eur">206000000</sny:CurrencyDerivativesMeasuredAtFairValue>
    <sny:CurrencyDerivativesMeasuredAtFairValue
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzUtMi0xLTEtMzY0MDYw_bd688798-8660-4b34-ab7a-6b4a951bba1d"
      unitRef="eur">284000000</sny:CurrencyDerivativesMeasuredAtFairValue>
    <sny:CurrencyDerivativesMeasuredAtFairValue
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzUtMy0xLTEtMzY0MDYw_461cdb6e-e7ab-4c21-a92d-30e8151443aa"
      unitRef="eur">58000000</sny:CurrencyDerivativesMeasuredAtFairValue>
    <ifrs-full:OtherCurrentFinancialAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzYtMS0xLTEtMzY0MDYw_c737f46f-86f5-407a-a12a-1c0d78e70df2"
      unitRef="eur">664000000</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzYtMi0xLTEtMzY0MDYw_d25a2395-814f-44df-acc4-c5458ade7a20"
      unitRef="eur">1054000000</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzYtMy0xLTEtMzY0MDYw_edfb4957-094b-4b2d-b55c-ebead607ed0b"
      unitRef="eur">900000000</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzctMS0xLTEtMzY0MDYw_7f945e72-e1ca-4dac-a4e1-9b6a1bb0aed5"
      unitRef="eur">3532000000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzctMi0xLTEtMzY0MDYw_ce2d4b93-e715-4249-b5e9-f99ead381cd3"
      unitRef="eur">3571000000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjIvZnJhZzplMjcwYzRiNTgxOWI0MGRkYmNjNGQxMGMxM2U1N2RiMS90YWJsZTplYjM3Yzc5OTViMDY0MzI4OWJjNDdkNzEzYjhjYzE4ZS90YWJsZXJhbmdlOmViMzdjNzk5NWIwNjQzMjg5YmM0N2Q3MTNiOGNjMThlXzctMy0xLTEtMzY0MDYw_f4abbf97-5248-4ce8-9769-4a7105e5e1d8"
      unitRef="eur">2737000000</ifrs-full:OtherCurrentAssets>
    <sny:DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90ZXh0cmVnaW9uOmNmNzI1N2QyMmRhZjQ4YjRiODM3YjNiN2I3ZDI3ZGZjXzg2MQ_0add67a5-34ab-419e-82d3-d238434755a8">Financial assets and liabilities measured at fair value&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under IFRS&#160;7 (Financial Instruments: Disclosures), fair value measurements must be classified using a fair value hierarchy with the following levels:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;level&#160;2: quoted prices in active markets for similar assets and liabilities, or valuation techniques in which all important inputs are derived from observable market data;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;level&#160;3: valuation techniques in which not all important inputs are derived from observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The valuation techniques used are described in Note&#160;B.8.5.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the balance sheet amounts of assets and liabilities measured at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level in the fair value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;hierarchy&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level in the fair value&lt;br/&gt;hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level in the fair value&lt;br/&gt;hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Quoted equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.1.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unquoted equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.1.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Quoted debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.2.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unquoted debt securities not meeting the definition of equity instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.3.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contingent consideration relating to divestments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.3.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Financial assets held to meet obligations under deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.3.  and D.11.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-current derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.11.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mutual fund investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.13.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total financial assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,765&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;967&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,449&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;298&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;883&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,022&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;695&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bayer contingent purchase consideration arising from the acquisition of Genzyme&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MSD contingent consideration (European vaccines business)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shire contingent consideration arising from the acquisition of Translate Bio&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contingent consideration arising from acquisition of Amunix&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other contingent consideration arising from business combinations and acquisitions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-current derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.19.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.19.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total financial liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;326&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;779&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;714&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;297&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;605&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;No transfers between the different levels of the fair value hierarchy occurred during 2022.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock>
    <sny:DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90ZXh0cmVnaW9uOmNmNzI1N2QyMmRhZjQ4YjRiODM3YjNiN2I3ZDI3ZGZjXzg2Mg_332610bd-9614-4021-89c5-fe9d68d9b7f3">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the balance sheet amounts of assets and liabilities measured at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level in the fair value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;hierarchy&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level in the fair value&lt;br/&gt;hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level in the fair value&lt;br/&gt;hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Quoted equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.1.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unquoted equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.1.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Quoted debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.2.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unquoted debt securities not meeting the definition of equity instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.3.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contingent consideration relating to divestments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.3.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Financial assets held to meet obligations under deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.3.  and D.11.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-current derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.7.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.11.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mutual fund investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.13.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total financial assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,765&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;967&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,449&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;298&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;883&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,022&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;695&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bayer contingent purchase consideration arising from the acquisition of Genzyme&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MSD contingent consideration (European vaccines business)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shire contingent consideration arising from the acquisition of Translate Bio&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contingent consideration arising from acquisition of Amunix&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other contingent consideration arising from business combinations and acquisitions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.18.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-current derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.19.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;D.19.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total financial liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;326&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;779&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;714&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;297&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;605&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock>
    <ifrs-full:FinancialAssets
      contextRef="i5a92ec01ab6f4056bb7dd2fe7b28bbd6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtMi0xLTEtMzY0MDYw_13c28d8e-aed8-4de5-8fd2-4339277250fb"
      unitRef="eur">387000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i4d71f901edbb4fc9b19eac52b6dd1c63_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtMy0xLTEtMzY0MDYw_34f1c016-97d1-422b-b9bc-0a5129dc77c9"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i64bff274bc764511ad68b85e40be4102_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtNC0xLTEtMzY0MDYw_82857db4-0476-4314-b70f-300138763818"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i8bdbc198b14747a6b443e5f51b4c57c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtNS0xLTEtMzY0MDYw_d13c85ec-0c80-4c04-891a-8f854a6a82c7"
      unitRef="eur">396000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i9f35300ff6594e66a950dbb07f57d751_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtNi0xLTEtMzY0MDYw_84a29bf8-17dd-4da2-be4b-0e6a75aab197"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i68712353db49491990d250cab1dc2b7c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtNy0xLTEtMzY0MDYw_b2ac1392-6ffb-44f0-b142-bb2ed50b7314"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i9902da71fc7c466694af634d0376287c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtOC0xLTEtMzY0MDYw_ae50b8df-d197-4d77-b441-89c29596b205"
      unitRef="eur">439000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ie6a2320406ec4131b78807bdb61adf57_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtOS0xLTEtMzY0MDYw_c214b67f-f27a-43a7-a0b1-de3c601878d8"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i868a0e34292946128d179703085f0318_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzQtMTAtMS0xLTM2NDA2MA_f43a6c51-e9ae-465e-9b7f-644673cfa92e"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="if227ca69b6764bd5aa2743a5eec6c517_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtMi0xLTEtMzY0MDYw_6af5b48a-3e85-4148-b0fe-cedeedd086a2"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="id3e0e6f2fc174daaa294b5fd344eaae5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtMy0xLTEtMzY0MDYw_6f80feb3-838a-4f66-bc96-92744d19bfac"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ie1c712a9f5e240d0a223b5fc4d7f3821_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtNC0xLTEtMzY0MDYw_ab2c3b7d-933b-4e8a-9909-827af535b0eb"
      unitRef="eur">549000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ie034a80e75204f5a86d6d8868b8ca40b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtNS0xLTEtMzY0MDYw_d042b241-faae-4219-a2e4-ba15ae1165d6"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i57c74edeb8724bff9b4a8ade725f2f63_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtNi0xLTEtMzY0MDYw_edafbd26-9ba8-4ca7-995f-faae13ee408f"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i57c1816e408f4146980929ba115caa65_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtNy0xLTEtMzY0MDYw_7f23c20c-bb18-4180-a6ae-f794d096e723"
      unitRef="eur">427000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="id78484142d96470daaa4465a88fd1465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtOC0xLTEtMzY0MDYw_6efc2a4f-8361-42c6-9964-b9234cd4ee2b"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="idaf554ea45834ed891abe8817a179274_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtOS0xLTEtMzY0MDYw_5eed6e60-8d09-49f1-bb50-861a41f6f5f6"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ic934f45d8eef45ffb86db0dbaebcbbb6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzUtMTAtMS0xLTM2NDA2MA_c77f4e76-fac7-4466-afcd-728d99970248"
      unitRef="eur">149000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i0e83c9ceee8d4973a9fd9afd3eb6f554_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtMi0xLTEtMzY0MDYw_a2a113b3-b34e-4cb0-bc2c-1f1a19c6fb00"
      unitRef="eur">329000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i98d98d655e2840c6a7097e85707ab978_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtMy0xLTEtMzY0MDYw_ec9fb390-0d03-4da2-bac4-ee1a702905ca"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i0725e56c610b4ef8a9c778e1f873a5f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtNC0xLTEtMzY0MDYw_02ce0d06-f08b-4e0c-ab0b-cdaf6e3e4d2c"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i6b13fd34daea45cb93c23eb68b1d9997_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtNS0xLTEtMzY0MDYw_5a4d6808-74d3-429f-813f-dabf87eb8ec2"
      unitRef="eur">447000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i440fc3ad28704a76ac9e4456da1c6091_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtNi0xLTEtMzY0MDYw_acd21c49-dfac-4ad3-b6a6-b51a0b2de1d1"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ifddadc6b0fd44b5e968e11dd8e284db1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtNy0xLTEtMzY0MDYw_d0c0dc40-f6a5-4da2-95d5-5255815ddc54"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i506eefd0acc64aa98a0ea2812e1edab1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtOC0xLTEtMzY0MDYw_67fd7eb9-7417-46e7-a5b3-a3ca000fe998"
      unitRef="eur">426000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="iba6ab0a538b548faafe7034677544b54_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtOS0xLTEtMzY0MDYw_a62d7e92-4649-429a-9249-35ccd27d4c83"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ibbdcbc2963214d8c9842c9ab0a7d99f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzYtMTAtMS0xLTM2NDA2MA_e1e7a699-01da-4438-9a9c-94cc347373b0"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="if091001a8a224ba884e81e875ef8f51a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctMi0xLTEtMzY0MDYw_696f6d4f-eb63-4477-8182-795a4b8e1c9d"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i29c615a591b8421183c5124409777d8c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctMy0xLTEtMzY0MDYw_eada40a0-6f72-44a6-a7d7-7f6b94b5e65c"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ic16171d1dc9b4826902326dab2989ff4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctNC0xLTEtMzY0MDYw_6420c57d-bdb2-475a-b841-eb0704015f09"
      unitRef="eur">115000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="idedbd6af27cc45138105bd954312850d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctNS0xLTEtMzY0MDYw_f2ba9270-7fef-4efe-ba47-339051eef48c"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i66f1507ff6024854ab28cb15b8139bb7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctNi0xLTEtMzY0MDYw_05ced425-921f-4a6b-93fe-763dec741390"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ibae8f42e29e44a80a767329003e96b3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctNy0xLTEtMzY0MDYw_cad75de7-0bc0-4c01-83ba-4c45f06a9b25"
      unitRef="eur">78000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ib4e1f6dffa3f4033a907e381fe585927_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctOC0xLTEtMzY0MDYw_d3593af8-d476-428f-ae3d-02bc985bc6cb"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="icce038f9032149768e955222f2aca120_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctOS0xLTEtMzY0MDYw_630f7f18-d977-406d-bb82-581aa97331c5"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ib63df7edcf044cccad9f0d666c02d417_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzctMTAtMS0xLTM2NDA2MA_143f6404-f970-46b0-a7b0-94f05fb49e4a"
      unitRef="eur">63000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i6edb24c7b7614f5e8426e248ad8c0012_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtMi0xLTEtMzY0MDYw_ceba465e-1718-40c4-8493-75bd644edbe7"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ie9e0f64911dd4a9591b9bc586892e8ba_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtMy0xLTEtMzY0MDYw_a6773677-b94d-4cd1-9768-9dc2a6d77545"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ia33a4f9a84e44e238ebd55018effc821_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtNC0xLTEtMzY0MDYw_7dc1e6cb-b849-40f0-947f-5974acbe161c"
      unitRef="eur">303000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i93162a8ef8d44ceca6e6bc7a60a8fc3d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtNS0xLTEtMzY0MDYw_727cc77a-c5bc-4d84-87ba-29682e3d9ba5"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i6ee383251d8a4a5db431280d0829da5b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtNi0xLTEtMzY0MDYw_5b36ec2b-8860-484a-9b57-c1bfe191f5d7"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i251a1285ee9d49388641e59f23f6241c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtNy0xLTEtMzY0MDYw_fdd9fa33-1dd8-4d94-9155-f471354cdeed"
      unitRef="eur">378000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="idbeac9cc516e4ecaa016f7b5a9919939_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtOC0xLTEtMzY0MDYw_8ed6e1ad-4ff6-497a-81f2-979660c94728"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i812479914b214ae5b372315aab8728a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtOS0xLTEtMzY0MDYw_5d402828-3e66-4705-9909-0e3ab9ceae31"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="if21f555fdb8141dc8dcdbc4a99f03044_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzgtMTAtMS0xLTM2NDA2MA_6dd6f286-1b39-4d6d-b795-7cca7d365ff9"
      unitRef="eur">483000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ib9a5c31a587e4a009e48f3ae090ae3d4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTItMS0xLTM2NDA2MA_08665703-0bed-4ad7-b920-5d17e673caef"
      unitRef="eur">512000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="id5b50aeecb014f088d04f8708033fed4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTMtMS0xLTM2NDA2MA_50d95f50-7b87-48a7-9ff4-005b5bff1aa6"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i865d3e2ccf184a1fa3395fe6567538b9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTQtMS0xLTM2NDA2MA_04bed21d-a4ec-4869-bc67-fe01189436fe"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ia5e602ade1a84742b797ec53b6d74912_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTUtMS0xLTM2NDA2MA_0ed4e605-dc06-4d48-8e36-fcb500d7035f"
      unitRef="eur">549000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ibde8b2ab03584ae4a5bca97d80502c95_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTYtMS0xLTM2NDA2MA_f1af5433-6f79-4c51-a922-5ff25d32ff94"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i226f7c29cfb84987a2a9deb701ed1907_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTctMS0xLTM2NDA2MA_d294464c-a354-46f1-bd39-5794d948a0ae"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i85306855f61b45f28134e4c906e484e2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTgtMS0xLTM2NDA2MA_5cc88baf-21a7-4165-8a1e-2e6f9740b1b8"
      unitRef="eur">454000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i6268251951114f5db755d35912bbb195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTktMS0xLTM2NDA2MA_f2a9cc7e-4567-4036-9e0b-9cfd0d763adc"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="iefc2bf19aa14458e8c2c9dce268786a8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEwLTEwLTEtMS0zNjQwNjA_eccd2913-de86-4552-930e-44389ff9c9b1"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i9510f1a95a7b43ac86ee6d4c0b128d24_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTItMS0xLTM2NDA2MA_f1808a89-0b88-4102-afd2-4c1f22b2159f"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="id2f822898ca84cb8a79415a6cdc45e3d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTMtMS0xLTM2NDA2MA_12f07d63-8e63-4fd8-a887-895a98b5cf9c"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i4a0738d4f3a648699d252a97ba3e6ee4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTQtMS0xLTM2NDA2MA_64c9b9b0-f1d2-40db-83f1-348fbb6e9917"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i158b44cdb3244768945b39667ddac6f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTUtMS0xLTM2NDA2MA_f10fb49e-8658-4fd5-a014-b6908f67f710"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ia10bc441f3d34c13ac07f05030c62cf5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTYtMS0xLTM2NDA2MA_3a657545-7be5-4808-93b3-07a68417224f"
      unitRef="eur">3000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ic1d93a2e51b44726bd0f629ca403921b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTctMS0xLTM2NDA2MA_602902fe-1b76-44f6-b4d7-c613853d0b70"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ie8ac539935374b558f669ee77dac8db6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTgtMS0xLTM2NDA2MA_2bf7e328-d7a7-4812-a520-7dfa592e23c2"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ia936cebd16574ca3b1b0522bc2565698_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTktMS0xLTM2NDA2MA_782d6542-1883-4741-b7d8-47a76cdee126"
      unitRef="eur">24000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i3ecabc225dcf456c8163959683eaac2f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzExLTEwLTEtMS0zNjQwNjA_fdb26c98-0c1f-4ed2-9290-9f974f7336c5"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="iaf455571305f4064b0c27c09d9e0779e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTItMS0xLTM2NDA2MA_0a647aae-a11a-4cd5-a04c-78a3039fc253"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i24ce970c3de542ecacf624dcc54c068f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTMtMS0xLTM2NDA2MA_90790c44-9ed1-4aa1-83a3-722a419a9a15"
      unitRef="eur">206000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i7a85f9f5746b442bad900c30146e6957_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTQtMS0xLTM2NDA2MA_9834a0a6-93ee-4691-ba84-9de15cb8d710"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i6f9513c503d647e5864a3f1b67b93937_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTUtMS0xLTM2NDA2MA_d9ceb6ce-9af2-470a-b653-74e62af3814a"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i6bf17373c5694449bcc60449faab13ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTYtMS0xLTM2NDA2MA_ee0bcd2c-966a-4cdc-a9a4-82563afdec61"
      unitRef="eur">295000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i6ac92dbfb0dc490aa7026799fe831566_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTctMS0xLTM2NDA2MA_a8bdd122-7b7c-4a8e-bae4-0e6f6ec8d8ce"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i42bcfaacf8014b70b45f0bc2e3826df0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTgtMS0xLTM2NDA2MA_ce1fbc73-e6f0-4ea9-8f49-df398994aa65"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ic4363d5a964d4bf9a405bbc5ad84d075_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTktMS0xLTM2NDA2MA_d7202889-6ad0-4624-b368-3187f46b569f"
      unitRef="eur">58000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i5f59a0aed26e461d8f59cef0d6162389_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEyLTEwLTEtMS0zNjQwNjA_43566088-ae41-4afd-9cc5-4c07cd193fb6"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ifa6146ee4dc34054b4f2c8dd934ce7b6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTItMS0xLTM2NDA2MA_fc8e815c-928c-419c-bcf2-fa56dc8e4427"
      unitRef="eur">9537000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ib2a400aeea96455eac5efbbfaac85997_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTMtMS0xLTM2NDA2MA_9eff7090-a27f-4a18-8c05-fb0f705c3454"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i414ace804d3948748fb5516ef6e3c93d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTQtMS0xLTM2NDA2MA_4d98cba2-3c1b-4df7-9048-2c1333747ebd"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i3dd8126dfa704004be857e04a1d63621_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTUtMS0xLTM2NDA2MA_dede5724-0134-4ab0-a211-6bd8bfdf0500"
      unitRef="eur">5057000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i4bce6c62ac7e458790049ac23f730d7b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTYtMS0xLTM2NDA2MA_40fccc97-af2e-4fc4-a5ba-478c8e9f75f7"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i55736011d7504217b288feccd10003c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTctMS0xLTM2NDA2MA_2c148deb-71ad-44b6-8e13-d9a1d61e8a4e"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i1a742bafd34b4be09b40358da2f7f5c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTgtMS0xLTM2NDA2MA_3a30fbff-9bc2-4265-b249-c351e93c9808"
      unitRef="eur">8703000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="if0e53d257a5b4cfb9ef9a43db3e18a44_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTktMS0xLTM2NDA2MA_e3c3c2cc-b907-4e7e-b43e-3d30d00ef073"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ie3df519902364806b6b4df1fa5fcaecd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzEzLTEwLTEtMS0zNjQwNjA_23679208-dea0-44bd-b5ed-ba536411aba3"
      unitRef="eur">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ib4cbd6b4a3914b4bb22bc2cb56989463_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTItMS0xLTM2NDA2MA_fd71d711-ec92-4914-9733-ca2108eb3d12"
      unitRef="eur">10765000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i409a2ac80199410c9d2f13738b9c1fc5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTMtMS0xLTM2NDA2MA_fcaf47de-4bc2-4bbf-82d9-0a37dd81d802"
      unitRef="eur">206000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i361a9c2e95a54cbb9685b3e4db0de703_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTQtMS0xLTM2NDA2MA_237e69a1-a462-4ba1-ac36-607fec210d9e"
      unitRef="eur">967000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ic2b4a0233a76467f9da9303ec9617568_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTUtMS0xLTM2NDA2MA_7b90cc66-62a4-49c1-8a17-82a0db021235"
      unitRef="eur">6449000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i5a4ec58f212240f98494aef951fe0ab2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTYtMS0xLTM2NDA2MA_4ecb19e1-a612-4be5-a5e0-5677fdd52b16"
      unitRef="eur">298000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="i8c5b69a1242e4ce3bbd8d3803a17f77b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTctMS0xLTM2NDA2MA_0d4e2b6a-88e9-4dea-9f3b-18183bdcdcf1"
      unitRef="eur">883000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="id87ff9e380354502a2cc0a654bd50c36_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTgtMS0xLTM2NDA2MA_7f3f5017-89e6-47b4-bc24-fae3f6bdfcb2"
      unitRef="eur">10022000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="iba95b079275c4adc847b0cd47a476111_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTktMS0xLTM2NDA2MA_e3287ea4-efa6-4da2-b6b6-a99633390974"
      unitRef="eur">82000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="ic6f8c9f62f344106bee9e868531813a0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE0LTEwLTEtMS0zNjQwNjA_83a39ff3-ecf2-4b31-ac4d-29f13c716336"
      unitRef="eur">695000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialLiabilities
      contextRef="ice8470e3cc6242f0b1b1e15732ab662f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTItMS0xLTM2NDA2MA_02a563ea-981f-40b1-90fb-7680db9bbece"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i0814cdc2bc444fe0a82e40cb939eaf13_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTMtMS0xLTM2NDA2MA_771624fa-92af-41ce-a20d-517079bc57e3"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i6ff19b8f7bc742c39dd5d0c627b6945b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTQtMS0xLTM2NDA2MA_678b9fca-bc32-44fe-bcb7-5fea5e2362b1"
      unitRef="eur">26000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i628eeffca97848fbbca2d84940ef2052_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTUtMS0xLTM2NDA2MA_b8975d1d-1c7d-4356-862a-6f1c040054f8"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i13bdffd21ca54bcdb0343b795ab7b63f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTYtMS0xLTM2NDA2MA_d2c63e1e-39d1-452a-9f9b-0a0485cfe138"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="iadd128658e52488aa52e2432c171e6ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTctMS0xLTM2NDA2MA_ccf0a1ba-8ade-4e1e-8a7b-1ceb98f3e01d"
      unitRef="eur">59000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i16e7a672e44841db8d883f1ef6d50e41_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTgtMS0xLTM2NDA2MA_b0257415-381b-474c-8b8d-de1322114588"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="idb9560b7bb344d8783c8a3d70ed140a3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTktMS0xLTM2NDA2MA_d7d99c5f-609a-4791-8d85-a6bef25b57b8"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i2f86412d6fcd48e59fdae513888795c1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE3LTEwLTEtMS0zNjQwNjA_90b82aa5-8b88-407e-b7aa-d9ef3a051ed3"
      unitRef="eur">104000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i3e655abf2eff4f648351419b666b1cce_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTItMS0xLTM2NDA2MA_673bfc22-4258-494c-883f-54236f2befcc"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ie70a21fbce684182b63354cd9500f730_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTMtMS0xLTM2NDA2MA_6270179b-022a-447b-8ffd-437c02f45940"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i777128a1566043dfaae4b53b65022410_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTQtMS0xLTM2NDA2MA_e00e7de9-5b92-47a2-a87a-82cb517da490"
      unitRef="eur">204000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="id02c995274e4478396f61da8899c1b7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTUtMS0xLTM2NDA2MA_85773405-1600-47c6-afc6-51774cf8155b"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ibb908d2f93ff4a659991e90bcf70ab55_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTYtMS0xLTM2NDA2MA_5aacf577-f5f9-45b3-b5b4-7e1ab1fa28cc"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i14178e4bb8cb402f92a63d6707574a90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTctMS0xLTM2NDA2MA_73944095-f6d9-475c-9569-94fb3680de22"
      unitRef="eur">269000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ia4d269e6493342a1a5a259b8a23aeeaf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTgtMS0xLTM2NDA2MA_72839751-e814-4af1-bd36-fc556a8761af"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i7d4b6ce60161438c8fbc24e68b71336b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTktMS0xLTM2NDA2MA_44d6e8c7-128b-4c20-bd4f-e421bf552d4a"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ib3234a98630243148d78d87d71b9384a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE4LTEwLTEtMS0zNjQwNjA_18de8e0d-5394-4c64-b3a0-bae400220526"
      unitRef="eur">312000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i5223d477aaa341c6b4d55fe7ea7d4cea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTItMS0xLTM2NDA2MA_fda5d318-4c8c-4bf9-8889-168bbc95b16b"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i080f9c0694bf4d54922bdd4f999a0643_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTMtMS0xLTM2NDA2MA_9a25acc9-10ac-47ac-a9aa-b8d2e1b81a0d"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i48e7503106404209990dfdc490c457ce_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTQtMS0xLTM2NDA2MA_ef14dcad-1970-49a9-890a-a99dbed8f983"
      unitRef="eur">380000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i36ed13ff5ab544e187d2fa000ff3f53a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTUtMS0xLTM2NDA2MA_37aa6942-fce2-4b0b-8a89-a642c9897319"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i3edf6fd8a7cd4c6991b85fa8d8833a29_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTYtMS0xLTM2NDA2MA_83155df6-5d38-4bc8-91d4-8258943fa65d"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i80b048bc5e924696bc290cf8e154d08d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTctMS0xLTM2NDA2MA_11373976-e987-4928-8bae-36123486f648"
      unitRef="eur">354000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="iadeed4d1a84740f08d7f77eb1d523def_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTgtMS0xLTM2NDA2MA_565efc8d-3e42-4a73-8025-76d0286bec49"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i8e6725118f5948a789bfbbbf3550d8f1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTktMS0xLTM2NDA2MA_9e595b5b-0f1c-43a9-b74b-0c9545152d24"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i8f777088d46d4dcd985ba538a27bed29_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzE5LTEwLTEtMS0zNjQwNjA_d4e8346d-2cc2-4dd5-bf77-eb15411842ab"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i0baef8b28597402d8adf6cee9aa0d5d6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTItMS0xLTM5OTU5Ng_9e409116-1471-42ab-aca8-4881e08fc820"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i58e1e7cad9164a70839fa03c11e4a3cb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTMtMS0xLTM5OTU5Ng_b425e8e6-e1b8-477c-9978-45b504960e9e"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i66f8461c0f524353bb1ff3afc8b439e3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTQtMS0xLTM5OTU5Ng_67e4247d-84c8-4635-89a6-70e97abd8ae8"
      unitRef="eur">165000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="icd997e2d59284fdcbf55f9fc4a2d1a5b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTUtMS0xLTM5OTU5Ng_1c518434-e33f-424e-bb92-1d67f65c29bb"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ie7ab76bd67b74ffc8af89529ba43e4b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTYtMS0xLTM5OTU5Ng_f9de913c-4792-4b08-9350-ed6e3c0eeb71"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ic727bbbef1ae42deb05bb6a11214c40f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTctMS0xLTM5OTU5Ng_4583ca49-1354-42c8-94c6-f3585e68e658"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i3754841fd7614021b0d3d454afce5cb4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTgtMS0xLTM5OTU5Ng_82445190-158c-459a-80e3-44a0485bdfb8"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ife3e8160c2604592a96fe70b98af7419_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTktMS0xLTM5OTU5Ng_be5e6e8a-9f97-4b63-94d7-603d822dc37f"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i2c3722d2c71b40a5b0cd3fbdd62a14fb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTEwLTEtMS0zOTk1OTY_2b2026c6-f946-41a7-b0cd-c47c43f91c1d"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i4f77768527954a3ea0a87e7081b338cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTItMS0xLTM2NDA2MA_490bd8d3-dfac-4382-87c8-f091173b7896"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ic866f02ab74b43c6bbab392d315c36e5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTMtMS0xLTM2NDA2MA_60220498-f5d1-4a20-9022-b2f6a1d14027"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i980e5c837107458eb2f70d743a451e27_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTQtMS0xLTM2NDA2MA_b601a1a5-7355-46ac-8506-3cc50525ef83"
      unitRef="eur">4000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ia48366d62ce64d6e94246e1a6b554bac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTUtMS0xLTM2NDA2MA_57e54ffc-8418-4734-a72f-487b1ed5cf08"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i2363afabce5c46a3b4c953bd0582795e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTYtMS0xLTM2NDA2MA_02719ac8-2569-4bb7-99b7-1a911f564c03"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i77d7a7bdcbff48a69181f857e54c25ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTctMS0xLTM2NDA2MA_20328a1b-4aff-41f8-bd09-e8c14e7ac6f5"
      unitRef="eur">32000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i8ee0b2e050a04774bbcc876af9b05e2e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTgtMS0xLTM2NDA2MA_b552154f-146a-4843-9e22-85ae12e5efaa"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i7aebbb6cd5394ffa80a4acb7f23fbc26_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTktMS0xLTM2NDA2MA_ddf4b1e5-2906-4d68-929d-27f0769763ca"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i9edaf00d040343fb95831f3cc2313b2e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIwLTEwLTEtMS0zNjQwNjA_6629c44d-30cf-44d2-a36e-f71aee69901e"
      unitRef="eur">189000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i41e7d57ea4de4fb2acde34fb25042f3c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTItMS0xLTM2NDA2MA_54f930aa-8878-447e-a6bf-6d753d2ab4ea"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ic054a9f7342d452997b69f83837ad01d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTMtMS0xLTM2NDA2MA_cfad54e1-10f2-4a6b-9c9e-21a00ef0e312"
      unitRef="eur">232000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="if6c1c44bc60f4d718bf8a08c96042e61_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTQtMS0xLTM2NDA2MA_0055d47f-f21e-4cfc-a0d3-faaf92bf4829"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i391e0993fafa4e8194f1cee9bc292cb8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTUtMS0xLTM2NDA2MA_eb1238ed-54a5-44e4-b194-b7806eea9704"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i98a96a99ad894d939a8ef2cf79d189ca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTYtMS0xLTM2NDA2MA_4da75b66-d992-48d3-8b1b-e2ff5387e364"
      unitRef="eur">6000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i6a9ba46c71214fe8bdd739e06a5e2cea_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTctMS0xLTM2NDA2MA_3eb7f162-61cb-4e04-ad29-bf3376e8f2c0"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i9b2f10037fac4641824455bcae113474_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTgtMS0xLTM2NDA2MA_4eb950a9-4220-4e65-82a7-40903fbb44b1"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="iea19c792195c46bd9032528e794b669f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTktMS0xLTM2NDA2MA_cb132576-8ee1-4e9f-aef3-28216ba989e9"
      unitRef="eur">92000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i4022972c8bde4a9ca3cb288456a68271_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIyLTEwLTEtMS0zNjQwNjA_8b6d325f-ddc6-4ecc-aba5-c919df023713"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i42e844a6d4cb450f9d291a2abe40dd93_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTItMS0xLTM2NDA2MA_c62da4d8-5f62-4126-b5d1-4debeecc5932"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i3ac22998c1824a71b163369ba9107fc3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTMtMS0xLTM2NDA2MA_f50195f5-d1fb-4f16-9df9-e08892e031e2"
      unitRef="eur">94000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i8e3b3ef271ab427b944675c91e586c90_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTQtMS0xLTM2NDA2MA_32a7013d-194e-4a8e-a4e0-cc414aac084c"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i90897d7067434c91a8f8652d33ff01ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTUtMS0xLTM2NDA2MA_0947e2fa-f8b8-4701-b299-93329f6b4b47"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i9a15ff2465a24f9d8f467e861eace688_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTYtMS0xLTM2NDA2MA_ea774bcc-15d9-43ea-986f-535fb166e062"
      unitRef="eur">79000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="iaff6099dca9e44fc83c5aa691e056e44_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTctMS0xLTM2NDA2MA_ca1544b8-ca69-4c4c-96e2-bb65d83c44b1"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i40563d22b6d240b1938338dc3cb44c4d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTgtMS0xLTM2NDA2MA_304ec7d2-760a-4175-bfc7-ffb8ca4b6987"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i1dae2c57e4564bc098cf95f1a6b088e2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTktMS0xLTM2NDA2MA_cd6a6e2b-d611-4b25-8adc-8e33c8692280"
      unitRef="eur">205000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i6370e3221d264c9283fc7256385a72e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzIzLTEwLTEtMS0zNjQwNjA_9fcb5d10-70d7-4206-876f-24e4594ab883"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ib4cbd6b4a3914b4bb22bc2cb56989463_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTItMS0xLTM2NDA2MA_55cd3956-9b71-4af8-96b2-50ac771d4135"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i409a2ac80199410c9d2f13738b9c1fc5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTMtMS0xLTM2NDA2MA_3db5927b-8e15-4a16-bd2a-5cee394f3ed8"
      unitRef="eur">326000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i361a9c2e95a54cbb9685b3e4db0de703_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTQtMS0xLTM2NDA2MA_e7f1129a-7e5f-4332-b472-598fa8e60d74"
      unitRef="eur">779000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ic2b4a0233a76467f9da9303ec9617568_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTUtMS0xLTM2NDA2MA_65927e9f-a56a-406a-bf10-febe04593acf"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i5a4ec58f212240f98494aef951fe0ab2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTYtMS0xLTM2NDA2MA_6e232a7a-f5f8-4a47-a215-2d2e4d7dbdbc"
      unitRef="eur">85000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="i8c5b69a1242e4ce3bbd8d3803a17f77b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTctMS0xLTM2NDA2MA_9bd30e49-fb1c-40b7-a510-be4e92fdf895"
      unitRef="eur">714000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="id87ff9e380354502a2cc0a654bd50c36_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTgtMS0xLTM2NDA2MA_948b0d35-88d4-4bc7-9020-326a1f4bedd2"
      unitRef="eur">0</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="iba95b079275c4adc847b0cd47a476111_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTktMS0xLTM2NDA2MA_f1d0f648-3d4b-49ad-962d-f2bbfc88286f"
      unitRef="eur">297000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="ic6f8c9f62f344106bee9e868531813a0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjUvZnJhZzpjZjcyNTdkMjJkYWY0OGI0YjgzN2IzYjdiN2QyN2RmYy90YWJsZTo2OWM0OTlhNGQxZWU0ZDQwYmQ4OTBkZTJkZmE3ODk1Ny90YWJsZXJhbmdlOjY5YzQ5OWE0ZDFlZTRkNDBiZDg5MGRlMmRmYTc4OTU3XzI0LTEwLTEtMS0zNjQwNjA_8a6f59fb-1bc3-40dd-ba0c-3ff032e1ba67"
      unitRef="eur">605000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzQzMg_6450ea22-f6cc-4683-9619-1d8bba9c6e04">Cash and cash equivalents&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,736&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,098&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,915&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) As of December 31, 2022, cash equivalents mainly comprised the following: (i)&#160;&#x20ac;9,537 million invested in euro and US dollar denominated money-market mutual funds (December 31, 2021: &#x20ac;5,057 million; December 31, 2020: &#x20ac;8,703 million); (ii)&#160;&#x20ac;1,167 million of term deposits (December 31, 2021: &#x20ac;2,768 million; December 31, 2020: &#x20ac;3,259 million) and (iii)&#160;nil commercial paper (December 31, 2021: &#x20ac;179 million; December 31, 2020: &#x20ac;74 million). Cash equivalents also include &#x20ac;439 million held by captive insurance and reinsurance companies in accordance with insurance regulations (December 31, 2021: &#x20ac;427 million; December 31, 2020: &#x20ac;425 million).&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <sny:DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzQzNA_2f0a4428-0812-4654-aba8-38f8a5757007">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,736&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,098&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,915&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) As of December 31, 2022, cash equivalents mainly comprised the following: (i)&#160;&#x20ac;9,537 million invested in euro and US dollar denominated money-market mutual funds (December 31, 2021: &#x20ac;5,057 million; December 31, 2020: &#x20ac;8,703 million); (ii)&#160;&#x20ac;1,167 million of term deposits (December 31, 2021: &#x20ac;2,768 million; December 31, 2020: &#x20ac;3,259 million) and (iii)&#160;nil commercial paper (December 31, 2021: &#x20ac;179 million; December 31, 2020: &#x20ac;74 million). Cash equivalents also include &#x20ac;439 million held by captive insurance and reinsurance companies in accordance with insurance regulations (December 31, 2021: &#x20ac;427 million; December 31, 2020: &#x20ac;425 million).&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock>
    <ifrs-full:Cash
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzEtMS0xLTEtMzY0MDYw_ed6f60b5-5f80-4a73-acb1-94c6d2807d2d"
      unitRef="eur">1385000000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzEtMi0xLTEtMzY0MDYw_b507b2ea-a30f-4c17-99d1-83b2b2bfbe82"
      unitRef="eur">1358000000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzEtMy0xLTEtMzY0MDYw_2df42c2f-5e42-41c9-a700-2f9b2c4dad52"
      unitRef="eur">1144000000</ifrs-full:Cash>
    <ifrs-full:CashEquivalents
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzItMS0xLTEtMzY0MDYw_12214515-2174-4bf7-b32a-73a9677e1c8b"
      unitRef="eur">11351000000</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzItMi0xLTEtMzY0MDYw_3884d353-12c0-403a-aa77-abd3568cf897"
      unitRef="eur">8740000000</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzItMy0xLTEtMzY0MDYw_9b12a380-4ee3-452f-a90b-dbec2c27b7ef"
      unitRef="eur">12771000000</ifrs-full:CashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzMtMS0xLTEtMzY0MDYw_b6121274-ac30-40e1-bedc-da10ff439c2c"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzMtMi0xLTEtMzY0MDYw_c31ee7f5-a5b4-4950-8974-3dcc33c33a90"
      unitRef="eur">10098000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90YWJsZTo4N2Q5OGU1ZTI3Y2Y0ODk3YTM4OTRkNmMwM2I1OWNjNS90YWJsZXJhbmdlOjg3ZDk4ZTVlMjdjZjQ4OTdhMzg5NGQ2YzAzYjU5Y2M1XzMtMy0xLTEtMzY0MDYw_6d7a6bb6-a7c9-4a1d-8b57-e584b1ecaebc"
      unitRef="eur">13915000000</ifrs-full:CashAndCashEquivalents>
    <sny:CashEquivalentsMoneyMarketMutualFunds
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzEwNg_9d95b272-12a9-49f2-867e-2c8c80c333eb"
      unitRef="eur">9537000000</sny:CashEquivalentsMoneyMarketMutualFunds>
    <sny:CashEquivalentsMoneyMarketMutualFunds
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzE4Mw_bd960a59-83e3-4502-b059-d551c842fe48"
      unitRef="eur">5057000000</sny:CashEquivalentsMoneyMarketMutualFunds>
    <sny:CashEquivalentsMoneyMarketMutualFunds
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzE5MQ_e07a5376-e868-4d72-b360-cf93223c152b"
      unitRef="eur">8703000000</sny:CashEquivalentsMoneyMarketMutualFunds>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzIwMQ_280f896a-9ce3-4cac-9ccc-e858f8d40c8b"
      unitRef="eur">1167000000</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzIyNg_260bdbb3-1ed0-4e76-8051-6d6c13437ac6"
      unitRef="eur">2768000000</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzIzNA_83f725fb-3cd9-43a6-b1a2-9f8d2d7463dc"
      unitRef="eur">3259000000</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <sny:CashEquivalentsCommercialPaper
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzYwNDczMTM5NTMyNDQ_19e4be7b-79c6-4fcc-a983-778291a43cba"
      unitRef="eur">0</sny:CashEquivalentsCommercialPaper>
    <sny:CashEquivalentsCommercialPaper
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzI3Ng_3eb6ee70-c0a4-4fc6-82ae-8c2d7b9eceb7"
      unitRef="eur">179000000</sny:CashEquivalentsCommercialPaper>
    <sny:CashEquivalentsCommercialPaper
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzI4NA_a674be11-4bf0-4696-b903-9d9988e4f4e1"
      unitRef="eur">74000000</sny:CashEquivalentsCommercialPaper>
    <sny:CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzMxOQ_ffa90ddd-57a9-4b7e-a67f-6f1f4e3435cd"
      unitRef="eur">439000000</sny:CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies>
    <sny:CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzQyMA_3fc2c75f-7132-4c45-81f4-7efa5beee278"
      unitRef="eur">427000000</sny:CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies>
    <sny:CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MjgvZnJhZzpkZDBlOWVhOTMwOTQ0M2RlYTQzNjVjZDg0NTY0ZDczMS90ZXh0cmVnaW9uOmRkMGU5ZWE5MzA5NDQzZGVhNDM2NWNkODQ1NjRkNzMxXzQyOA_02a586cc-074c-4d22-a645-bbeacb9b5cb7"
      unitRef="eur">425000000</sny:CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies>
    <ifrs-full:DisclosureOfDeferredTaxesExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4NDc_f8e4076f-64c5-4cd3-aff1-702e028e36bc">Net deferred tax position&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;An analysis of the net deferred tax position is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred taxes on:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Consolidation adjustments (intragroup margin in inventory)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provision for pensions and other employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Remeasurement of other acquired intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognition of acquired property, plant and equipment at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity interests in subsidiaries and investments in other entities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(590)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(522)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax losses available for carry-forward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Stock options and other share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accrued expenses and provisions deductible at the time of payment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred tax asset/(liability)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,540&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,981&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,406&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) As of December&#160;31, 2022, includes remeasurements of the acquired intangible assets of Bioverativ (&#x20ac;1,429 million), Principia (&#x20ac;625 million), Ablynx (&#x20ac;229 million), Genzyme (&#x20ac;150 million) and Amunix (&#x20ac;118 million).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) In some countries, Sanofi is liable for withholding taxes and other tax charges when dividends are distributed. Consequently, Sanofi recognizes a deferred tax liability on the reserves of French and foreign subsidiaries (approximately &#x20ac;59.1 billion) which it regards as likely to be distributed in the foreseeable future. In determining the amount of the deferred tax liability as of December 31, 2022, Sanofi took into account changes in the ownership structure of certain subsidiaries, and the effects of changes in the taxation of dividends in France, following the ruling of the Court of Justice of the European Union in the Steria case and the resulting amendments to the 2015 Finance Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Includes deferred tax assets related to restructuring provisions, amounting to &#x20ac;256 million as of December 31, 2022, &#x20ac;307 million as of December 31, 2021, and &#x20ac;259 million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The reserves of Sanofi subsidiaries that would be taxable if distributed but for which no distribution is planned, and for which no deferred tax liability has therefore been recognized, totaled &#x20ac;10.6 billion as of December 31, 2022, compared with &#x20ac;10.0 billion as of December 31, 2021 and &#x20ac;11.5 billion as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Most of Sanofi&#x2019;s tax loss carry-forwards are available indefinitely. For a description of policies on the recognition of deferred tax assets, refer to Note&#160;B.22. For each tax consolidation, the recognition of deferred tax assets is determined on the basis of profit forecasts that are consistent with Sanofi&#x2019;s medium-term strategic plan, and taking into consideration the tax consequences of the strategic opportunities available to Sanofi within the period of availability of tax loss carry-forwards and the specific circumstances of each tax consolidation. Deferred tax assets relating to tax loss carry-forwards as of December 31, 2022 amounted to &#x20ac;2,650 million, of which &#x20ac;1,144 million were not recognized (including &#x20ac;488&#160;million in respect of capital losses). This compares with &#x20ac;2,391 million as of December 31, 2021 (of which&#160;&#x20ac;875 million were not recognized) and &#x20ac;1,658 million as of&#160;December 31, 2020 (of which &#x20ac;331 million were not recognized).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows when tax losses available for carry-forward are due to expire:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Tax&#160;losses&#160;available for carry-forward&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,503&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,644&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,515&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Excluding tax loss carry-forwards on asset disposals. Such carry-forwards amounted to &#x20ac;5 million as of December 31, 2022, &#x20ac;5 million as of&#160;December 31, 2021 and &#x20ac;6 million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Use of tax loss carry-forwards is limited to the entity in which they arose. In jurisdictions where tax consolidations are in place, tax losses can be netted against taxable income generated by entities in the same tax consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Deferred tax assets not recognized (primarily because their future recovery was not regarded as probable given the expected results of the entities in question) amounted to &#x20ac;995 million in 2022, &#x20ac;615 million in 2021 and &#x20ac;346 million in 2020.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDeferredTaxesExplanatory>
    <ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4NDQ_7a12724f-2892-4243-87e2-b7d4f68463ca">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;An analysis of the net deferred tax position is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred taxes on:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Consolidation adjustments (intragroup margin in inventory)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provision for pensions and other employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Remeasurement of other acquired intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognition of acquired property, plant and equipment at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity interests in subsidiaries and investments in other entities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(590)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(522)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax losses available for carry-forward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Stock options and other share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accrued expenses and provisions deductible at the time of payment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred tax asset/(liability)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,540&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,981&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,406&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) As of December&#160;31, 2022, includes remeasurements of the acquired intangible assets of Bioverativ (&#x20ac;1,429 million), Principia (&#x20ac;625 million), Ablynx (&#x20ac;229 million), Genzyme (&#x20ac;150 million) and Amunix (&#x20ac;118 million).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) In some countries, Sanofi is liable for withholding taxes and other tax charges when dividends are distributed. Consequently, Sanofi recognizes a deferred tax liability on the reserves of French and foreign subsidiaries (approximately &#x20ac;59.1 billion) which it regards as likely to be distributed in the foreseeable future. In determining the amount of the deferred tax liability as of December 31, 2022, Sanofi took into account changes in the ownership structure of certain subsidiaries, and the effects of changes in the taxation of dividends in France, following the ruling of the Court of Justice of the European Union in the Steria case and the resulting amendments to the 2015 Finance Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Includes deferred tax assets related to restructuring provisions, amounting to &#x20ac;256 million as of December 31, 2022, &#x20ac;307 million as of December 31, 2021, and &#x20ac;259 million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i5c52f444ed0f4bda84a42b7e930f8420_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzItMS0xLTEtMzY0MDYw_17f83391-885c-41fd-a5ed-8f445054a296"
      unitRef="eur">-1388000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="id11eb7058089436a9aff2a514b26afe8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzItMy0xLTEtMzY0MDYw_858305f7-aa9f-446f-bf36-18f4a7976b22"
      unitRef="eur">-1292000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i56a5626912de40e39e4a075cd3ebc7bc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzItNS0xLTEtMzY0MDYw_6497fd40-38be-4b55-b6cb-a29b439dcae0"
      unitRef="eur">-1142000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="iadbc77437f194c4b9714d27bea45d27d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzMtMS0xLTEtMzY0MDYw_b62eba11-e83f-4a5f-87d7-546c65d53a82"
      unitRef="eur">-850000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i7fed9cb1446a49ffa3cc1ec60473ea51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzMtMy0xLTEtMzY0MDYw_0855df8d-2784-4ee8-a8ca-8c46a2247f61"
      unitRef="eur">-1117000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i6c1f1c7a87a147aea05b154acab7ecac_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzMtNS0xLTEtMzY0MDYw_dbd086a2-582c-442e-836b-68caa45f9374"
      unitRef="eur">-1156000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="if2d0541f761144ae8559c1ccc9e1c928_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzQtMS0xLTEtMzY0MDYw_17cfc751-f9a3-475d-83df-489a7723529c"
      unitRef="eur">3269000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="if0b71582500946dba2dcb41e5a262822_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzQtMy0xLTEtMzY0MDYw_ca06f600-e95c-48ec-b468-acbe49cf8421"
      unitRef="eur">3079000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="ifad5fc92533e41a7aeaa856fcb32b3ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzQtNS0xLTEtMzY0MDYw_7fb2074f-aea6-45df-b04b-c9e0925f1bd1"
      unitRef="eur">3083000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i812946d6d99c488b913e652bf22c35e2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzUtMS0xLTEtMzY0MDYw_a52875bc-1d29-4536-8739-e5802ab59b62"
      unitRef="eur">24000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i592524c5425b4fd687989aa3fa4c2fc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzUtMy0xLTEtMzY0MDYw_b5360592-2383-4de6-933b-d9734873eaab"
      unitRef="eur">26000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="ia6ac37e52785466095dc8e783f91f5bf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzUtNS0xLTEtMzY0MDYw_10d778a1-25c6-4149-926e-2499c36597b8"
      unitRef="eur">27000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i6e2dcbba0a064e75ab731959eaa3eb3c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzYtMS0xLTEtMzY0MDYw_20bcfd1d-5310-4579-a244-af6318643f0b"
      unitRef="eur">617000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="ib906ba086bbe4f30abe707134e42e386_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzYtMy0xLTEtMzY0MDYw_655f1815-17fe-44f9-9389-166e4d36c70f"
      unitRef="eur">590000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="ie5535831de3647578a867ea9e090f1b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzYtNS0xLTEtMzY0MDYw_4f764654-a961-43ca-a71d-474faf22dff9"
      unitRef="eur">522000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i2cfc74b847364b73b4c2966e30b347c9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzctMS0xLTEtMzY0MDYw_ca77588d-1836-4682-a6f4-76720d355212"
      unitRef="eur">-1506000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="if0499e2936c14c57a7abc3de327bb2ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzctMy0xLTEtMzY0MDYw_1ddb940d-c3e8-4e28-918c-f41769fe94d9"
      unitRef="eur">-1516000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i079e44824551470ebf2ecdbe82c78c53_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzctNS0xLTEtMzY0MDYw_913e193a-4396-45c7-8b35-ee37fcc94990"
      unitRef="eur">-1327000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i7470aa0bd046445ba5d903e0903f429a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzgtMS0xLTEtMzY0MDYw_7b9c479f-d5f8-4a87-a650-1ef31fe30836"
      unitRef="eur">-92000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="ib9fdcded8d294930941d9b9619419474_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzgtMy0xLTEtMzY0MDYw_17fc2c2e-696f-4c9e-88fe-a731ee9bed53"
      unitRef="eur">-88000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="iaa8eaa248f964dcc9b6c43fc5fe3997b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzgtNS0xLTEtMzY0MDYw_2678f55d-8890-42dd-9dba-dac453302eea"
      unitRef="eur">-89000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="idabd22ffeca842938dbb461d8aeb992f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzktMS0xLTEtMzY0MDYw_61004333-7f13-4d74-b28e-69db17402810"
      unitRef="eur">-1859000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i20ddd88784fd4401811a5d58a1e0998c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzktMy0xLTEtMzY0MDYw_87cebf53-2bb6-40aa-b626-fd4dc006db52"
      unitRef="eur">-1585000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i9380121dcb2b4c5f96096a046caefe54_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzktNS0xLTEtMzY0MDYw_248d8165-b9db-47cd-94b9-91597c949213"
      unitRef="eur">-1399000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i066e7decba3b4361be385e2553f7c453_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzEwLTEtMS0xLTM2NDA2MA_7886fb94-811c-407e-ba0c-39d5454c603c"
      unitRef="eur">-1755000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="if38e6ef7aed243b8ac91bf5307d108ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzEwLTMtMS0xLTM2NDA2MA_9fad063e-8eac-459a-abd3-b0b6b66ac59a"
      unitRef="eur">-1078000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="iec4651d9b55449be9cc5bd98617ca794_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzEwLTUtMS0xLTM2NDA2MA_f6e96ba8-e1e1-46ea-8e02-63af56fb079c"
      unitRef="eur">-925000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzExLTEtMS0xLTM2NDA2MA_3bfff951-f3cf-4148-945d-8cb37ffad1d9"
      unitRef="eur">-3540000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzExLTMtMS0xLTM2NDA2MA_74e92651-66b2-46a2-882a-2b9d24ae5ab4"
      unitRef="eur">-2981000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo5NTg1YWFlYjU4NTg0YzEyYTcxOTBiNjE4YzBhZDQyMi90YWJsZXJhbmdlOjk1ODVhYWViNTg1ODRjMTJhNzE5MGI2MThjMGFkNDIyXzExLTUtMS0xLTM2NDA2MA_5e4a568b-0337-46b1-8fe6-988f72dceda2"
      unitRef="eur">-2406000000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="i443cce1a00af49c5b31e138daebd4921_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIwNg_0c9946cf-68b0-42a6-887e-5c09c6d859b0"
      unitRef="eur">1429000000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="i4b62979a6fe9440786e1d336c8029542_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIyMw_07633816-9ef8-4a51-982e-f5c6e55a3d83"
      unitRef="eur">625000000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="i410ae0b344fc43a3ab2cf3899b851c5e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE3MDQyNDMwMjMzNTQz_943a420e-bd6e-4a35-b4c0-944fe0cb6583"
      unitRef="eur">229000000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="ia53cda7c749e46b1af9080f7e52833cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI0NQ_5d197259-e2d9-4312-9099-63c7699b4d21"
      unitRef="eur">150000000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="id4d4bab9b0aa4d6a9547cfc9fb7b0e8d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE3MDQyNDMwMjMzNjE2_cd42b59b-e073-45c1-b11b-39a592e144f7"
      unitRef="eur">118000000</ifrs-full:DeferredTaxLiabilities>
    <sny:ReservesLikelyToBeDistributedInTheForeseeableFuture
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzUxOA_24d4b7e3-0b10-4c04-9749-acddc700a9d5"
      unitRef="eur">59100000000</sny:ReservesLikelyToBeDistributedInTheForeseeableFuture>
    <ifrs-full:DeferredTaxAssets
      contextRef="i7a265fee43744c58b5ca31c83714d579_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEwMzU_127d7b1e-51a9-414a-9fd3-2afd7e28125a"
      unitRef="eur">256000000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="i8f17ae20601144ea9e0f23d12022ca1a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEwNDg_c3c81a8a-d8f2-445c-a680-e41448d5dacd"
      unitRef="eur">307000000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="ib9ca24cbf2ff42778b6960dcc8505438_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEwNjU_568119a2-20db-47e4-ac78-ceeb28273292"
      unitRef="eur">259000000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEyODA_4fc8d0bc-665c-4250-b7bb-8952a036db14"
      unitRef="eur">10600000000</ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures>
    <ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEzMDc_d9ffab0e-f193-4670-b080-ec40959bd58f"
      unitRef="eur">10000000000</ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures>
    <ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzEzMjM_ab6d086d-4352-4a60-a985-0bfa42a53c8d"
      unitRef="eur">11500000000</ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures>
    <sny:TotalDeferredTaxAssetsForTaxLossCarryforwards
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE5NzI_a7f60a73-6640-47e4-af45-ae6a522a1e9a"
      unitRef="eur">2650000000</sny:TotalDeferredTaxAssetsForTaxLossCarryforwards>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE5ODU_75793b59-1af5-4e88-9155-205ef7c0f997"
      unitRef="eur">1144000000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <sny:UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE3MDQyNDMwMjMzNDc2_e7667e04-dac9-4663-aac9-8d4bf35b8050"
      unitRef="eur">488000000</sny:UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised>
    <sny:TotalDeferredTaxAssetsForTaxLossCarryforwards
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIwNzI_bf45bb8f-3d28-4817-b14a-ad9b494e2c85"
      unitRef="eur">2391000000</sny:TotalDeferredTaxAssetsForTaxLossCarryforwards>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIwOTQ_4f4dc85d-2de6-41fe-a174-96733e715ea1"
      unitRef="eur">875000000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <sny:TotalDeferredTaxAssetsForTaxLossCarryforwards
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIxMjI_845d574f-39f0-45f3-8836-30d4731215a8"
      unitRef="eur">1658000000</sny:TotalDeferredTaxAssetsForTaxLossCarryforwards>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIxNDQ_b30b8b5e-2769-425b-91ab-c51926b280af"
      unitRef="eur">331000000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <sny:DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4NDY_aec5ac0d-41e9-4da9-812f-2a2357f47b02">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows when tax losses available for carry-forward are due to expire:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Tax&#160;losses&#160;available for carry-forward&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,503&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,644&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,515&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Excluding tax loss carry-forwards on asset disposals. Such carry-forwards amounted to &#x20ac;5 million as of December 31, 2022, &#x20ac;5 million as of&#160;December 31, 2021 and &#x20ac;6 million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock>
    <sny:TaxLossesCarryforwards
      contextRef="ife7c44a9a1e84cb7b6b4f6fe06b1ebab_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzEtMS0xLTEtMzY0MDYw_59d9c0b6-0e4c-45ea-aeae-2632bce2f2c8"
      unitRef="eur">0</sny:TaxLossesCarryforwards>
    <sny:TaxLossesCarryforwards
      contextRef="i8ea79a68514c4efeb70ef0c35a2baf70_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzItMS0xLTEtMzY0MDYw_fef837b6-54c0-439f-9c6e-83480a80f4ee"
      unitRef="eur">3000000</sny:TaxLossesCarryforwards>
    <sny:TaxLossesCarryforwards
      contextRef="i1f94df52faeb4018aac422ffccd0adf5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzMtMS0xLTEtMzY0MDYw_462bdcb9-1904-4880-90e0-d24f004325be"
      unitRef="eur">21000000</sny:TaxLossesCarryforwards>
    <sny:TaxLossesCarryforwards
      contextRef="i5e29bbd050a542b6994f56c5f2fafee4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzQtMS0xLTEtMzY0MDYw_69e0b2db-7dd7-4716-bff2-24b316cc0095"
      unitRef="eur">28000000</sny:TaxLossesCarryforwards>
    <sny:TaxLossesCarryforwards
      contextRef="i26c6820c3ece4e2aad2f35e051f8b181_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzUtMS0xLTEtMzY0MDYw_199a28d9-6782-4900-9650-8f21a03d3a94"
      unitRef="eur">102000000</sny:TaxLossesCarryforwards>
    <sny:TaxLossesCarryforwards
      contextRef="id75833e7c0144f56ab9eac0ea4d607f3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzYtMS0xLTEtMzY0MDYw_d9bbc3e2-6318-45aa-972f-e234595355d7"
      unitRef="eur">8349000000</sny:TaxLossesCarryforwards>
    <sny:TaxLossesCarryforwards
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzctMS0xLTEtMzY0MDYw_7432df65-1968-4e69-94b0-4d57165e4452"
      unitRef="eur">8503000000</sny:TaxLossesCarryforwards>
    <sny:TaxLossesCarryforwards
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzgtMS0xLTEtMzY0MDYw_b0d2a4a0-024c-4c73-b1d0-d406246f7a8f"
      unitRef="eur">7644000000</sny:TaxLossesCarryforwards>
    <sny:TaxLossesCarryforwards
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90YWJsZTo1MDk5YjBmMWI4NTI0MTY1OWM1OGFkMWUzMmE1YTcxOC90YWJsZXJhbmdlOjUwOTliMGYxYjg1MjQxNjU5YzU4YWQxZTMyYTVhNzE4XzktMS0xLTEtMzY0MDYw_567c46c5-c1d5-40a3-a380-442c9bcd89d2"
      unitRef="eur">6515000000</sny:TaxLossesCarryforwards>
    <sny:TaxLossCarryforwardsOnAssetDisposals
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIzNDY_fd763d99-1f62-4700-aea5-2562098486fe"
      unitRef="eur">5000000</sny:TaxLossCarryforwardsOnAssetDisposals>
    <sny:TaxLossCarryforwardsOnAssetDisposals
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzE3MDQyNDMwMjMzNDA2_d9cf247d-3d95-4a5f-8ec9-be28e8ee1f01"
      unitRef="eur">5000000</sny:TaxLossCarryforwardsOnAssetDisposals>
    <sny:TaxLossCarryforwardsOnAssetDisposals
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzIzOTA_24cb6d64-ac86-478b-b81d-347ecd474004"
      unitRef="eur">6000000</sny:TaxLossCarryforwardsOnAssetDisposals>
    <sny:DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4MTE_064b8ebb-a097-44e7-9dae-714d71dffa89"
      unitRef="eur">995000000</sny:DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable>
    <sny:DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4MjE_2524f41a-c4de-44fc-9d7d-0c888ad86243"
      unitRef="eur">615000000</sny:DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable>
    <sny:DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzEvZnJhZzpiYzk1ZDc5N2E4OWY0MDNkYmY3OTc4ZTk2OTI4NjEwMy90ZXh0cmVnaW9uOmJjOTVkNzk3YTg5ZjQwM2RiZjc5NzhlOTY5Mjg2MTAzXzI4MzQ_917085b9-dd83-4ab2-a323-447cb0ad99d6"
      unitRef="eur">346000000</sny:DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwOTM_ea7f81ba-646a-4deb-83bf-b81da135674b">Consolidated shareholders&#x2019; equity&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.15.1. Share capital&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, the share capital w&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;as &#x20ac;2,521,671,464, consisting of 1,260,835,732&#160;shar&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;es with a par value of &#x20ac;2. Treasury shares held by Sanofi are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number&#160;of&#160;shares &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(million)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&#160;of&#160;share&#160;capital &lt;br/&gt;for the period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8.20&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.650&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Treasury shares are deducted from shareholders&#x2019; equity. Gains and losses on disposals of treasury shares are recorded directly in equity and are not recognized in net income for the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Movements in the share capital of the Sanofi parent company over the last three years are set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Transaction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,253,846,111&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital&#160;increase&#160;by&#160;exercise&#160;of stock subscription options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;868,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase by issuance of restricted shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,666,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Board meeting of July 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase reserved for employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,590,716&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,258,971,738&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase by exercise of stock subscription options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;190,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase by issuance of restricted shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,836,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Board meeting of July 28, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase reserved for employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,562,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,263,560,695&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase by exercise of stock subscription options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;490,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase by issuance of restricted shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,499,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Board meeting of July 27, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase reserved for employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,027,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Board meeting of December 14, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reduction in share capital by cancellation of &lt;br/&gt;treasury shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,742,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #5064a9;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,260,835,732&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Shares issued on exercise of Sanofi stock subscription options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Shares vesting under restricted share plans and issued in the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For the disclosures about the management of capital required under IFRS&#160;7, refer to Note&#160;B.27.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.15.2. Restricted share plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Restricted share plans are accounted for in accordance with the policies described in Note&#160;B.24.3. The principal characteristics of those plans are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Type of plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Date of Board meeting approving the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 3, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 14, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total number of shares awarded &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,344,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;109,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,484,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,340,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Of which with no market condition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,209,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,536,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value per share awarded&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;91.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;79.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;77.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;82.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Of which with market condition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,343,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,274,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;803,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value per share awarded other than to the Chief Executive Officer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;86.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;69.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;71.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;68.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;76.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;63.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value per share awarded other than to the Chief Executive Officer - additional shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;49.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;54.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value per share awarded to the Chief Executive Officer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;84.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;71.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;76.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value of plan at the date of grant (&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;294&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;262&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Additional tranche subject to a higher level of market conditions: 114,874&#160;additional shares were awarded in May&#160;2022, and 9,066&#160;additional shares were awarded in December&#160;2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The total expense recognized for all restricted share plans, and the number of restricted shares not yet fully vested, are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total expense for restricted share plans (&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Number of shares not yet fully vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,121,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,507,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,546,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Under 2022 plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,206,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Under 2021 plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,097,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,364,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Under 2020 plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,817,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,014,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,284,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Under 2019 plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,128,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,375,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Under 2018 plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,886,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.15.3. Capital increases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The characteristics of the employee share ownership plans awarded in the form of a capital increase reserved for employees in&#160;2022, 2021 and 2020 are summarized in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Date of Board meeting approving the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;February 3, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;February 4, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;February 5, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Subscription price (&#x20ac;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;69.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;70.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Subscription period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 9-29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 7-25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 8-26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Number of shares subscribed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,909,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,438,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,467,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Number of shares issued immediately as employer&#x2019;s contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;123,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Subscription price representing 80% of the average of the opening quoted market prices of Sanofi shares during the 20&#160;trading days preceding June&#160;6,&#160;2022, June&#160;3,&#160;2021 and June&#160;2, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth the expense recognized for each plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expense recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which employer&#x2019;s contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.15.4. Repurchase of Sanofi shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Annual General Meetings of Sanofi shareholders held on May&#160;3, 2022, April&#160;30, 2021 and April&#160;28, 2020 each authorized a share repurchase program for a period of 18 months. The following repurchases have been made under those programs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-right:29.25pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(in number of shares and &#x20ac; million)&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:29.25pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:29.25pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Year of authorization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number &lt;br/&gt;of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number &lt;br/&gt;of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number &lt;br/&gt;of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022 program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,510,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021 program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,976,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,765,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020 program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,758,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,685,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2019 program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,982,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.15.5. Reductions in share capital&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Reductions in share capital for the accounting periods presented are described in the table included at Note&#160;D.15.1. above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Those reductions have no impact on shareholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.15.6. Currency translation differences&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Currency translation differences comprise the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.901%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Attributable to equity holders of Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(865)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,462&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The balance as of December 31, 2022 includes an after-tax amount of &#x20ac;(580) million relating to hedges of net investments in&#160;foreign operations (refer to Note&#160;B.8.3. for a description of the relevant accounting policy), compared with &#x20ac;(317) million as of&#160;December 31, 2021 and&#160;&#x20ac;(136) million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The movement in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Currency translation differences&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; is mainly attributable to the US dollar.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.15.7. Other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Movements within other comprehensive income are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial gains/(losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Actuarial gains/(losses) excluding investments accounted for using the equity method (see Note&#160;D.19.1.)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Tax effects&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity instruments included in financial assets and financial liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;padding-right:29.25pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Change in fair value (excluding investments accounted for using the equity method)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Change in fair value (investments accounted for using the equity method, net of taxes)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Equity risk hedging instruments designated as fair value hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Tax effects&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Items not subsequently reclassifiable to profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;451&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;797&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt instruments included in financial assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Change in fair value (excluding investments accounted for using the equity method)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Tax effects&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash flow and fair value hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Change in fair value (excluding investments accounted for using the equity method)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Change in fair value (investments accounted for using the equity method, net of taxes)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:9.29pt"&gt;Tax effects&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Change in currency translation differences:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Currency translation differences (investments accounted for using the&#160;equity method)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Currency translation differences related to the investment in Regeneron and&#160;reclassified to profit or loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Hedges of net investments in foreign operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Tax effects&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Items subsequently reclassifiable to profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,313&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,510&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Amounts reclassified to profit or loss: immaterial amount in 2022, &#x20ac;4 million in 2021 and &#x20ac;5 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Amounts reclassified to profit or loss: &#x20ac;2 million in 2022, &#x20ac;12 million in 2021 and &#x20ac;1 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d) Amounts reclassified to profit or loss: &#x20ac;40 million in 2022, including &#x20ac;35 million relating to the deconsolidation of EUROAPI (see note&#160;D.1.). The amounts reclassified to profit and loss were immaterial in 2021 and 2020. Currency translation differences arise from the translation into euros of the financial statements of foreign subsidiaries, and are mainly due to the appreciation of the dollar against the euro.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(e) &#160;&#160;&#160;&#160;The amount recorded for 2020 relates to the translation reserve arising on the investment in Regeneron; the reserve was reclassified to profit or loss in accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates), including &#x20ac;2 million (net of tax) relating to hedges of net investments in foreign operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.15.8. Stock options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock option plans awarded and measurement of stock option plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;No stock options were awarded during 2022, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock subscription option plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Details of the terms of exercise of stock subscription options granted under the various plans are presented below in Sanofi share equivalents. These plans were awarded to certain corporate officers and employees of Sanofi companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table shows all Sanofi stock subscription option plans still outstanding or under which options were exercised in the year ended&#160;December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Source&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Date of grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;options&lt;br/&gt;granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Start&#160;date&#160;of&lt;br/&gt;exercise&lt;br/&gt;period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiry date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Exercise&lt;br/&gt;price (&#x20ac;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number of options outstanding as of 12/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2012&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;814,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/06/2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;788,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/06/2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;78,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,009,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/06/2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;506,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;06/24/2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;435,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;06/25/2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;06/24/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;338,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/04/2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;402,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/05/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/04/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;264,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/10/2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;378,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/11/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/10/2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;268,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/02/2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;220,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/03/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/02/2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;04/30/2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;220,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/02/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;04/30/2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;213,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,837,969&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The exercise of all outstanding stock subscription options would increase shareholders&#x2019; equity by approximately &#x20ac;145 million. The exercise of each option results in the issuance of one share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Summary of stock option plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A summary of stock options outstanding at each balance sheet date, and of movements during the relevant periods, is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted average&lt;br/&gt;exercise&#160;price&lt;br/&gt;per share (&#x20ac;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;(&#x20ac;&#160;million)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Options outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,822,020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;70.58&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,650,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;67.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(868,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options cancelled&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(91,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(282,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Options outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,579,270&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;75.61&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;195&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,845,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;74.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(190,076)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options cancelled&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(51,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Options outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,337,968&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;77.13&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;180&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,949,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;78.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(490,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;71.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options cancelled&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Options outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,837,969&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;78.64&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;145&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,624,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;78.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Mainly due to the grantees leaving Sanofi.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below provides summary information about options outstanding and exercisable as of December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Range of exercise prices per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;residual&#160;life&lt;br/&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price per&lt;br/&gt;share (&#x20ac;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price per&lt;br/&gt;share (&#x20ac;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;From &#x20ac;60.00 to &#x20ac;70.00 per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;From &#x20ac;70.00 to &#x20ac;80.00 per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,062,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;848,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;From &#x20ac;80.00 to &#x20ac;90.00 per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;606,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;606,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,837,969&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,624,569&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.15.9. Number of shares used to compute diluted earnings per share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share is computed using the number of shares outstanding plus stock options with dilutive effect and restricted shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Average number of shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,251.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,252.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,253.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Adjustment for stock options with dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Adjustment for restricted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Average number of shares used to compute diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,256.9&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,257.9&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,260.1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2022, all stock options were taken into account in computing diluted earnings per share because they all had a dilutive effect. In both 2021 and 2020, 0.6 million&#160;stock options were not taken into account in computing diluted earnings per share because they had no dilutive effect.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:IssuedCapital
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3Xzk5_418b552a-dff2-4baf-81fc-da33daa5d8f8"
      unitRef="eur">2521671464</ifrs-full:IssuedCapital>
    <ifrs-full:NumberOfSharesIssued
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzExNw_0a5322e3-ee4b-4bae-acae-421b0f0c2a67"
      unitRef="shares">1260835732</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE0Nw_76c00511-412f-453b-baf5-4033e9af717c"
      unitRef="eurPerShare">2</ifrs-full:ParValuePerShare>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwODg_e1374ea0-996b-4258-abe2-1449405980dd">Treasury shares held by Sanofi are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number&#160;of&#160;shares &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(million)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&#160;of&#160;share&#160;capital &lt;br/&gt;for the period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8.20&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.650&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.25pt solid #0e32e1;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #0e32e1;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <sny:NumberOfSharesHeld
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzEtMS0xLTEtMzY0MDYw_e22c0451-c8e7-4cbe-ad9a-d4c1c9097891"
      unitRef="shares">8200000</sny:NumberOfSharesHeld>
    <sny:PercentageOfShareCapitalForThePeriod
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzEtMi0xLTEtMzY0MDYw_63bd5c88-a85c-430a-ab21-af7c55cfbe43"
      unitRef="number">0.00650</sny:PercentageOfShareCapitalForThePeriod>
    <sny:NumberOfSharesHeld
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzItMS0xLTEtMzY0MDYw_f8448724-3d86-4241-8891-090081e10ecb"
      unitRef="shares">11020000.00</sny:NumberOfSharesHeld>
    <sny:PercentageOfShareCapitalForThePeriod
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzItMi0xLTEtMzY0MDYw_92aabe91-8e1a-4e66-aa4b-df6c33f43aa7"
      unitRef="number">0.00872</sny:PercentageOfShareCapitalForThePeriod>
    <sny:NumberOfSharesHeld
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzMtMS0xLTEtMzY0MDYw_ba5b6836-3a42-4e18-b2a6-c405325e78d8"
      unitRef="shares">8280000</sny:NumberOfSharesHeld>
    <sny:PercentageOfShareCapitalForThePeriod
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzMtMi0xLTEtMzY0MDYw_0adc9624-a007-4fd2-a732-c7b5a86b364b"
      unitRef="number">0.00658</sny:PercentageOfShareCapitalForThePeriod>
    <sny:NumberOfSharesHeld
      contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzQtMS0xLTEtMzY0MDYw_aa1a26f0-c614-4fd6-af45-a11ecd28e30b"
      unitRef="shares">20000.00</sny:NumberOfSharesHeld>
    <sny:PercentageOfShareCapitalForThePeriod
      contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo4YzQ2YzJmM2NmYjc0NTJhYjE0YWJlYjU3ZDZkNThhNC90YWJsZXJhbmdlOjhjNDZjMmYzY2ZiNzQ1MmFiMTRhYmViNTdkNmQ1OGE0XzQtMi0xLTEtMzY0MDYw_710d55f9-e042-4189-8d93-1fb5c0322ca5"
      unitRef="number">0.00002</sny:PercentageOfShareCapitalForThePeriod>
    <sny:DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMDA_45dbf072-9d87-49f2-8110-d597b78bcfcd">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Movements in the share capital of the Sanofi parent company over the last three years are set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Transaction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,253,846,111&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital&#160;increase&#160;by&#160;exercise&#160;of stock subscription options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;868,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase by issuance of restricted shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,666,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Board meeting of July 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase reserved for employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,590,716&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,258,971,738&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase by exercise of stock subscription options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;190,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase by issuance of restricted shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,836,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Board meeting of July 28, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase reserved for employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,562,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,263,560,695&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase by exercise of stock subscription options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;490,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;During 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase by issuance of restricted shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,499,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Board meeting of July 27, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Capital increase reserved for employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,027,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Board meeting of December 14, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reduction in share capital by cancellation of &lt;br/&gt;treasury shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,742,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #5064a9;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,260,835,732&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Shares issued on exercise of Sanofi stock subscription options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Shares vesting under restricted share plans and issued in the period.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock>
    <ifrs-full:NumberOfSharesIssued
      contextRef="i0d88a2edb81648e6afc4f83c69c424a9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzEtMi0xLTEtMzY0MDYw_92b8355b-6649-474e-bdaa-366d4886272e"
      unitRef="shares">1253846111</ifrs-full:NumberOfSharesIssued>
    <sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions
      contextRef="ia39e689409964bfa8f99f19cbd6e41c3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzItMi0xLTEtMzY0MDYw_4681579c-bb96-49f8-b923-1cc83bf08a30"
      unitRef="shares">868655</sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions>
    <sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease
      contextRef="ia39e689409964bfa8f99f19cbd6e41c3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzMtMi0xLTEtMzY0MDYw_49cffeb6-4c7e-4383-8121-9b2e4c856774"
      unitRef="shares">1666256</sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease>
    <sny:NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees
      contextRef="ia196461989f240c08680cf2183a306d3_D20200728-20200728"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzQtMi0xLTEtMzk1NTAz_d4ea581e-9b45-488a-b50d-644aee5e443a"
      unitRef="shares">2590716</sny:NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees>
    <ifrs-full:NumberOfSharesIssued
      contextRef="i36f49e4cf39f434fb5ea2349696ed58f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzQtMi0xLTEtMzY0MDYw_0ef230bb-60b9-4bcc-8bc4-afb8cf4bb99a"
      unitRef="shares">1258971738</ifrs-full:NumberOfSharesIssued>
    <sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions
      contextRef="ib03aa1724e294ec09dd7edb58b1d4e63_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzUtMi0xLTEtMzY0MDYw_b8d7cd16-bc66-4e11-aec8-8450412607d0"
      unitRef="shares">190076</sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions>
    <sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease
      contextRef="ib03aa1724e294ec09dd7edb58b1d4e63_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzYtMi0xLTEtMzY0MDYw_ce017cef-6072-4871-815a-35e18da63505"
      unitRef="shares">1836179</sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease>
    <sny:NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees
      contextRef="ie7e77578600e4c639e9d27feb554081b_D20210728-20210728"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzctMi0xLTEtMzY0MDYw_22deb393-2d6f-4485-a568-749ca6b961a6"
      unitRef="shares">2562702</sny:NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees>
    <ifrs-full:NumberOfSharesIssued
      contextRef="i2e9f1e47319c48d5a2202f889bf79fd8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzgtMi0xLTEtMzY0MDYw_bd468d72-d3fb-4250-9653-79b1df0d8c59"
      unitRef="shares">1263560695</ifrs-full:NumberOfSharesIssued>
    <sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions
      contextRef="i85f3af7ddeb746839ba726053d9da1d4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzktMi0xLTEtMzY0MDYw_272533e1-8646-45e2-8839-c301c0206613"
      unitRef="shares">490373</sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions>
    <sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease
      contextRef="i85f3af7ddeb746839ba726053d9da1d4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzEwLTItMS0xLTM2NDA2MA_2a12cbb6-39a6-4b00-b18d-af41020c7114"
      unitRef="shares">1499987</sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease>
    <sny:NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees
      contextRef="ifcfbe4403ae14242851e1ae3cd6f979c_D20220727-20220727"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzExLTItMS0xLTM2NDA2MA_bebe9edc-43e5-41ce-a9fc-c13aeaae9a03"
      unitRef="shares">2027057</sny:NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees>
    <sny:ReductionOfSharesByCancellationOfTreasuryShares
      contextRef="id1f20d3235444723a9c023e3b4339f8d_D20221214-20221214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzEzLTItMS0xLTQ3Nzg1MA_80d5af3d-1484-4615-a936-ffbcd847ba5a"
      unitRef="shares">6742380</sny:ReductionOfSharesByCancellationOfTreasuryShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="i515ddb2455da44eaa66b43d874f42983_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTowOWZlZWE3YjY0ZjU0NTAzODlmMjczMDQ4ZDM2ODE1Ni90YWJsZXJhbmdlOjA5ZmVlYTdiNjRmNTQ1MDM4OWYyNzMwNDhkMzY4MTU2XzEyLTItMS0xLTM2NDA2MA_c940d8e3-1911-4a53-9266-2bf99d2a300f"
      unitRef="shares">1260835732</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwODU_33394fb6-6f55-4c8a-8f9a-f84f1a3985f4">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Restricted share plans are accounted for in accordance with the policies described in Note&#160;B.24.3. The principal characteristics of those plans are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Type of plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;share plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Date of Board meeting approving the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 3, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 14, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total number of shares awarded &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,344,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;109,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,484,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,340,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Of which with no market condition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,209,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,536,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value per share awarded&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;91.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;79.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;77.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;82.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Of which with market condition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,343,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,274,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;803,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value per share awarded other than to the Chief Executive Officer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;86.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;69.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;71.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;68.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;76.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;63.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value per share awarded other than to the Chief Executive Officer - additional shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;49.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;54.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value per share awarded to the Chief Executive Officer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;84.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;71.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x20ac;76.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value of plan at the date of grant (&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;294&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;262&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Additional tranche subject to a higher level of market conditions: 114,874&#160;additional shares were awarded in May&#160;2022, and 9,066&#160;additional shares were awarded in December&#160;2022.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory>
    <sny:NumberOfYearsServicePeriod
      contextRef="ib0692613954647719cf5a55f8b2600b8_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtMS0xLTEtMzY0MDYw_3ce541bd-6a5b-49be-a515-be85c66f2e79">P3Y</sny:NumberOfYearsServicePeriod>
    <sny:NumberOfYearsServicePeriod
      contextRef="iafa20f1425b74849a9afed9c64bbbccc_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtMi0xLTEtMzY0MDYw_3484c73c-22ca-471b-b0df-e1141d34eb2f">P3Y</sny:NumberOfYearsServicePeriod>
    <sny:NumberOfYearsServicePeriod
      contextRef="i93f5d73d4345431eb6e2b0feaf16ec74_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtMy0xLTEtMzY0MDYw_6e79fc16-281d-4425-8771-f823a1e737e8">P3Y</sny:NumberOfYearsServicePeriod>
    <sny:NumberOfYearsServicePeriod
      contextRef="ice0df2b13649423eb9b2868f28d11017_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtNC0xLTEtMzY0MDYw_8eefed22-3f53-4636-a520-32ade46be827">P3Y</sny:NumberOfYearsServicePeriod>
    <sny:NumberOfYearsServicePeriod
      contextRef="i8c3bd86d2c1b44d7a257e61844c2fd3d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtNS0xLTEtMzY0MDYw_c7629477-a93b-4478-9b84-83cb2a556b4f">P3Y</sny:NumberOfYearsServicePeriod>
    <sny:NumberOfYearsServicePeriod
      contextRef="id12efe7d6a7346ab84d22f390dff95a3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzMtNi0xLTEtMzY4Mzk3_a92af788-0267-4402-ac92-bdcc293c64d5">P3Y</sny:NumberOfYearsServicePeriod>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="ib0692613954647719cf5a55f8b2600b8_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtMS0xLTEtMzY0MDYw_a5f0d03d-d82d-4a47-8803-87adb401e593"
      unitRef="shares">3344432</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="iafa20f1425b74849a9afed9c64bbbccc_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtMi0xLTEtMzY0MDYw_4a7a427f-ed10-436b-847c-033eb32ef124"
      unitRef="shares">109981</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i93f5d73d4345431eb6e2b0feaf16ec74_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtMy0xLTEtMzY0MDYw_f72411fb-f040-4f8f-9293-56b45e0a4855"
      unitRef="shares">3484420</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="ice0df2b13649423eb9b2868f28d11017_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtNC0xLTEtMzY0MDYw_b832c117-a40e-4f3e-999e-de8ce3d0605b"
      unitRef="shares">13521</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i8c3bd86d2c1b44d7a257e61844c2fd3d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtNS0xLTEtMzY0MDYw_ba6bd90c-1934-42d3-85f2-3c0f6036e954"
      unitRef="shares">3340501</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="id12efe7d6a7346ab84d22f390dff95a3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzQtNi0xLTEtMzY4Mzk3_0a6755a7-685f-4c0a-8cba-8d132f25d866"
      unitRef="shares">73027</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="idc7b7077ef674419ba3fb299aa9d4fd6_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtMS0xLTEtMzY0MDYw_d2661032-190d-4011-adda-86066055f3a2"
      unitRef="shares">2000627</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i2f883da95dd949dfb22ee5967a73f21a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtMi0xLTEtMzY0MDYw_fcfb65b2-bbed-4dec-8479-f01e2e05877f"
      unitRef="shares">10335</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i4abe87f00861469a8648dc66935cc3a9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtMy0xLTEtMzY0MDYw_0230508f-f233-4ca7-a475-741195efd7b8"
      unitRef="shares">2209901</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="idf17328999f949ebab31efd9a5ca0b93_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtNC0xLTEtMzY0MDYw_1d3c6eff-e7e3-4e01-a8c8-03529a71eb04"
      unitRef="shares">0</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i91a183f0e6fb407f97a8c1b19774a395_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtNS0xLTEtMzY0MDYw_3043abe5-5487-48a6-9848-9966c95f9e83"
      unitRef="shares">2536893</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i4923e9cc73c846eaa19bc82128326804_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzUtNi0xLTEtMzY4NDA0_016bb663-f58c-49e3-b4f8-3a653c45fbed"
      unitRef="shares">0</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="idc7b7077ef674419ba3fb299aa9d4fd6_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtMS0xLTEtMzY0MDYw_fb799b27-e987-40d5-9c15-c845d0c1f606"
      unitRef="eurPerShare">91.19</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="i2f883da95dd949dfb22ee5967a73f21a_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtMi0xLTEtMzY0MDYw_8219bb3d-71c2-4d09-ba8e-52d52d443db5"
      unitRef="eurPerShare">79.17</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="i4abe87f00861469a8648dc66935cc3a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtMy0xLTEtMzY0MDYw_9314b56f-835a-4c75-ad84-8d2ae981a886"
      unitRef="eurPerShare">77.27</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="idf17328999f949ebab31efd9a5ca0b93_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtNC0xLTEtMzY0MDYw_53cffe01-334f-47cf-874e-713b1c790d8d"
      unitRef="eurPerShare">0</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="i91a183f0e6fb407f97a8c1b19774a395_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtNS0xLTEtMzY0MDYw_815a9bf5-85b5-42e6-a413-923bd2105476"
      unitRef="eurPerShare">82.36</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="i4923e9cc73c846eaa19bc82128326804_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzYtNi0xLTEtMzY4NDA0_54f74076-09ef-422c-986f-5e44ecac7b3f"
      unitRef="eurPerShare">0</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i5563efbc666d49d292f620bd6319cea2_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctMS0xLTEtMzY0MDYw_1beffd84-6c21-4538-b9bf-34438576ab4b"
      unitRef="shares">1343805</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="iace7c690ea614bcaac762af51caa6166_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctMi0xLTEtMzY0MDYw_2c15af45-60e4-4865-af31-1641fb8bfafc"
      unitRef="shares">99646</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i2be6784fc06342efab44ff95725d2986_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctMy0xLTEtMzY0MDYw_3a8d6a65-f4cc-4b68-b76d-7e1e5ee31306"
      unitRef="shares">1274519</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i96dc54b1575f45aa9360b1da2d463ea9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctNC0xLTEtMzY0MDYw_4c6cd786-3c63-4be8-a124-07d88f98c8ae"
      unitRef="shares">13521</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i0d45edc6cd6941ef9b03d7003f0afd1f_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctNS0xLTEtMzY0MDYw_209884da-6a14-43ca-9ab8-07aa51db1b86"
      unitRef="shares">803608</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i5ad138fe89454c15a781c584d7c0212d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzctNi0xLTEtMzY4NDA0_9ad9828d-e451-41b2-be6b-2222866e471f"
      unitRef="shares">73027</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="i5563efbc666d49d292f620bd6319cea2_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtMS0xLTEtMzY0MDYw_63991653-b753-437d-a285-7963ad37d8fb"
      unitRef="eurPerShare">86.65</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="iace7c690ea614bcaac762af51caa6166_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtMi0xLTEtMzY0MDYw_74851841-1074-423f-930f-4c5a741965b0"
      unitRef="eurPerShare">69.60</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="i2be6784fc06342efab44ff95725d2986_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtMy0xLTEtMzY0MDYw_7e1b6630-0b4e-4540-9af9-fb61fc6c05e5"
      unitRef="eurPerShare">71.30</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="i96dc54b1575f45aa9360b1da2d463ea9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtNC0xLTEtMzY0MDYw_c87b1620-a8f4-4e15-a216-6f5f1316f52b"
      unitRef="eurPerShare">68.45</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="i0d45edc6cd6941ef9b03d7003f0afd1f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtNS0xLTEtMzY0MDYw_c838eb44-5371-4966-88c1-bc596386c8f7"
      unitRef="eurPerShare">76.11</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="i5ad138fe89454c15a781c584d7c0212d_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzgtNi0xLTEtMzY4NDA0_ea90f322-85c9-4062-923e-823f5addbf6c"
      unitRef="eurPerShare">63.18</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares
      contextRef="i5563efbc666d49d292f620bd6319cea2_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMS0xLTEtMzY4NTc5_e5ea31d1-a533-4dcc-b34f-796b6f6188ef"
      unitRef="eurPerShare">49.00</sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares
      contextRef="iace7c690ea614bcaac762af51caa6166_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMi0xLTEtMzY4NjQy_9237a9ff-95a6-42c9-8052-0549d6b68e50"
      unitRef="eurPerShare">54.70</sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares
      contextRef="i2be6784fc06342efab44ff95725d2986_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMy0xLTEtMzY4NTkz_c80e901a-7893-4cac-a4b0-7bf25f27ea38"
      unitRef="eurPerShare">0</sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares
      contextRef="i96dc54b1575f45aa9360b1da2d463ea9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNC0xLTEtMzY4NTkz_02808123-abee-40b0-9cd5-489dcfadbfa6"
      unitRef="eurPerShare">0</sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares
      contextRef="i0d45edc6cd6941ef9b03d7003f0afd1f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNS0xLTEtMzY4NTkz_212aa8cd-b12b-4d51-be12-38886890bb4a"
      unitRef="eurPerShare">0</sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares
      contextRef="i5ad138fe89454c15a781c584d7c0212d_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNi0xLTEtMzY4NTkz_a7920edc-bfd5-417c-9ebb-d370047707b0"
      unitRef="eurPerShare">0</sny:FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer
      contextRef="i5563efbc666d49d292f620bd6319cea2_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTEtMS0xLTM2ODU3OQ_38d1d2dc-30c7-4253-b9ae-3747b70bcdba"
      unitRef="eurPerShare">84.46</sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer
      contextRef="iace7c690ea614bcaac762af51caa6166_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTItMS0xLTM2ODY0Mg_5f99d03e-c0f0-4d50-a76e-1f847513cc13"
      unitRef="eurPerShare">0</sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer
      contextRef="i2be6784fc06342efab44ff95725d2986_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTMtMS0xLTM2ODU5Mw_56f8dd48-faa3-4ada-8455-b97e73ece5f6"
      unitRef="eurPerShare">71.30</sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer
      contextRef="i96dc54b1575f45aa9360b1da2d463ea9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTQtMS0xLTM2ODU5Mw_ede11c11-7ce6-4d01-a4c3-0455c891413a"
      unitRef="eurPerShare">0</sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer
      contextRef="i0d45edc6cd6941ef9b03d7003f0afd1f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTUtMS0xLTM2ODU5Mw_bd828d76-5cb8-439d-9ff6-7f7174c38cfc"
      unitRef="eurPerShare">76.11</sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer
      contextRef="i5ad138fe89454c15a781c584d7c0212d_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzEwLTYtMS0xLTM2ODU5Mw_dae5dc3d-b561-408b-ad48-66655a556455"
      unitRef="eurPerShare">0</sny:FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer>
    <sny:FairValueOfPlanAtDateOfGrant
      contextRef="ib0692613954647719cf5a55f8b2600b8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMS0xLTEtMzY0MDYw_c522ae3c-04dd-41e0-b175-719c3e2a7f67"
      unitRef="eur">294000000</sny:FairValueOfPlanAtDateOfGrant>
    <sny:FairValueOfPlanAtDateOfGrant
      contextRef="iafa20f1425b74849a9afed9c64bbbccc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMi0xLTEtMzY0MDYw_4aede710-bac9-4da7-bda3-ef561c7cadac"
      unitRef="eur">8000000</sny:FairValueOfPlanAtDateOfGrant>
    <sny:FairValueOfPlanAtDateOfGrant
      contextRef="i93f5d73d4345431eb6e2b0feaf16ec74_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktMy0xLTEtMzY0MDYw_2a5a8ca0-e4f3-4b94-9751-4736cf891ca3"
      unitRef="eur">262000000</sny:FairValueOfPlanAtDateOfGrant>
    <sny:FairValueOfPlanAtDateOfGrant
      contextRef="ice0df2b13649423eb9b2868f28d11017_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNC0xLTEtMzY0MDYw_1d595479-02e3-4f7b-9d5e-a468d7c34412"
      unitRef="eur">1000000</sny:FairValueOfPlanAtDateOfGrant>
    <sny:FairValueOfPlanAtDateOfGrant
      contextRef="i8c3bd86d2c1b44d7a257e61844c2fd3d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNS0xLTEtMzY0MDYw_5efe19b5-3040-41b5-86ea-93d5567129cd"
      unitRef="eur">270000000</sny:FairValueOfPlanAtDateOfGrant>
    <sny:FairValueOfPlanAtDateOfGrant
      contextRef="id12efe7d6a7346ab84d22f390dff95a3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpkYWY0MGE3NzRmZDQ0NjhjYjY2YjMyNjFjMDg2NzBkOS90YWJsZXJhbmdlOmRhZjQwYTc3NGZkNDQ2OGNiNjZiMzI2MWMwODY3MGQ5XzktNi0xLTEtMzY4NDEx_61a71d58-2fcb-4a78-a494-7dc346665444"
      unitRef="eur">5000000</sny:FairValueOfPlanAtDateOfGrant>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="ia5cad4f0687a4cc08c2c4b21b29e7459_D20220501-20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzU0OTc1NTgxNDQ1Mzg_310b9b29-ad97-4a65-a7fb-1312fe528b93"
      unitRef="shares">114874</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="i55ee43f980e74742950602d7ecd1c557_D20221201-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzU0OTc1NTgxNDU1Njc_d76a2986-5003-487c-998b-a0f9f70aa653"
      unitRef="shares">9066000000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <sny:DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMDQ_dd476e77-ca8c-4726-9053-ed10c2084ae3">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The total expense recognized for all restricted share plans, and the number of restricted shares not yet fully vested, are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total expense for restricted share plans (&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Number of shares not yet fully vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,121,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,507,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,546,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Under 2022 plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,206,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Under 2021 plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,097,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,364,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Under 2020 plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,817,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,014,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,284,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Under 2019 plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,128,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,375,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Under 2018 plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,886,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="ie92c2dbc9c094b098879979d51afa004_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzEtMS0xLTEtMzY0MDYw_dfeb630a-e68d-48e8-9efd-39705ed1e14c"
      unitRef="eur">206000000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="i1cdf739ed9644e06b67f23711ab2839d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzEtMi0xLTEtMzY0MDYw_ae8b6cad-281f-441f-8a8a-27e1c9f7b217"
      unitRef="eur">193000000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="id6484d0f5c354afc941fe76a527c5cbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzEtMy0xLTEtMzY0MDYw_1d75edfd-03b3-461d-aaca-8695f1da1fa6"
      unitRef="eur">222000000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i00edc5105e9f4951893c539899a4e361_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzItMS0xLTEtMzY0MDYw_c45b2a8f-f3ba-428f-b1ca-569cef0978f9"
      unitRef="shares">9121573</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i8aef65cbc35b4a7bb1424c660441fa25_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzItMi0xLTEtMzY0MDYw_3db3c469-1bc8-4e1d-a931-0185dc199c08"
      unitRef="shares">9507849</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="ib550dc9e8fed49219de32ab81c00e68c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzItMy0xLTEtMzY0MDYw_b821e39d-45b1-40ab-a3c2-10e7da22f834"
      unitRef="shares">10546612</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i4d14025c7c424adab3048e4636420277_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMS0xLTEtMzY5MDQ2_887a7947-d631-45f6-a679-5e3516f108f9"
      unitRef="shares">3206861</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i2efdc68378814672ad2455c0e7526d09_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMi0xLTEtMzY5MDQ2_3e0413e1-5e2f-49eb-87ac-b912383e59a8"
      unitRef="shares">0</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="if37df78c7cb74666ad31409c6077db06_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMy0xLTEtMzY5MDQ2_b3627bcf-ae66-4151-a630-155098428a17"
      unitRef="shares">0</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i98e5eb6aef8d43febb13411a27d3bb45_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMS0xLTEtMzY0MDYw_90e29848-bf1f-49ac-85bd-9a04f0b2e2d9"
      unitRef="shares">3097531</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i005faca79d6b45eca0b9960a7a8cccf2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMi0xLTEtMzY0MDYw_cc60340e-a6ae-4cd9-8f15-9617966b6de3"
      unitRef="shares">3364895</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i4874a200b94b4652b806a566996b1830_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzMtMy0xLTEtMzY0MDYw_a05d9903-75e3-4f1c-8da3-308ebb246e85"
      unitRef="shares">0</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="ia63ef8082fe642f691db7df32a40dac2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzQtMS0xLTEtMzY0MDYw_06d6f5e1-e2ee-4037-9834-8c33f1b65717"
      unitRef="shares">2817181</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i19a68be4db394b5d8547b3806e810a60_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzQtMi0xLTEtMzY0MDYw_0f24ed48-8e10-46a8-aa9a-f3edcc71da7c"
      unitRef="shares">3014496</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i9e0a10794cf6434dac120f4b0fd4e858_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzQtMy0xLTEtMzY0MDYw_303aa621-afc6-4702-8353-1234c2bf3580"
      unitRef="shares">3284558</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i175a0715b16947179dca2850b07e59eb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzUtMS0xLTEtMzY0MDYw_47d98ad3-767d-42f6-a7ac-d061242e4112"
      unitRef="shares">0</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i5952ef337321480da9d9eb91e066f493_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzUtMi0xLTEtMzY0MDYw_6fc92364-a934-41da-99fc-e43528d0fc6b"
      unitRef="shares">3128458</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="id9eebc27712f4a14983ed16a7f0cdc1e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzUtMy0xLTEtMzY0MDYw_e8a9d85e-a335-4a66-bb21-0b4c5dbc305a"
      unitRef="shares">3375717</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i200a7f91a38845258783cd5f4f247240_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzYtMS0xLTEtMzY0MDYw_adb98ca5-3327-4bd2-8461-bdd13b73c8d3"
      unitRef="shares">0</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="icd3026e0c94449659a50317d98e7f973_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzYtMi0xLTEtMzY0MDYw_7416db85-8cfa-492a-a755-d5a3a22edb1c"
      unitRef="shares">0</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="i71429c4358e24efc9d002898f6394ae5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2ODlmYmI0NmYyNTE0ZGRjYWEyMjQ2Y2E0ZGFmZTM0Yy90YWJsZXJhbmdlOjY4OWZiYjQ2ZjI1MTRkZGNhYTIyNDZjYTRkYWZlMzRjXzYtMy0xLTEtMzY0MDYw_9a8eb8b7-c7e8-45bd-9123-7eaf1ea9bd1a"
      unitRef="shares">3886337</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMTU_d21e47db-afcf-4dcf-81f5-4f7e5c7bad13">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The characteristics of the employee share ownership plans awarded in the form of a capital increase reserved for employees in&#160;2022, 2021 and 2020 are summarized in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Date of Board meeting approving the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;February 3, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;February 4, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;February 5, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Subscription price (&#x20ac;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;69.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;70.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Subscription period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 9-29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 7-25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 8-26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Number of shares subscribed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,909,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,438,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,467,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Number of shares issued immediately as employer&#x2019;s contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;123,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Subscription price representing 80% of the average of the opening quoted market prices of Sanofi shares during the 20&#160;trading days preceding June&#160;6,&#160;2022, June&#160;3,&#160;2021 and June&#160;2, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock>
    <sny:SubscriptionPricePerShare
      contextRef="i7950c585f21f43c9b757252673571f29_I20220203"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzItMS0xLTEtMzY4MDc3_7370faea-b476-4676-ac1e-2b95ded608fe"
      unitRef="eurPerShare">80.21</sny:SubscriptionPricePerShare>
    <sny:SubscriptionPricePerShare
      contextRef="i79da5b5df5a44ed2819eb15a236aea21_I20210204"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzItMS0xLTEtMzY0MDYw_bdde49dc-1453-467f-b02e-6f2d3cba0ae9"
      unitRef="eurPerShare">69.38</sny:SubscriptionPricePerShare>
    <sny:SubscriptionPricePerShare
      contextRef="i46fda90bd8224cb8aab66c2e4efa5317_I20200205"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzItMi0xLTEtMzY0MDYw_897e92f6-eb1d-4072-96b4-fd6b291c25d2"
      unitRef="eurPerShare">70.67</sny:SubscriptionPricePerShare>
    <sny:NumberOfShareSubscribed
      contextRef="i7950c585f21f43c9b757252673571f29_I20220203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzQtMS0xLTEtMzY4MDc3_972c6905-1994-4154-a4f9-05f31784c679"
      unitRef="shares">1909008</sny:NumberOfShareSubscribed>
    <sny:NumberOfShareSubscribed
      contextRef="i79da5b5df5a44ed2819eb15a236aea21_I20210204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzQtMS0xLTEtMzY0MDYw_c2e95562-1719-44fc-893a-d053f4ee54eb"
      unitRef="shares">2438590</sny:NumberOfShareSubscribed>
    <sny:NumberOfShareSubscribed
      contextRef="i46fda90bd8224cb8aab66c2e4efa5317_I20200205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzQtMi0xLTEtMzY0MDYw_65ffbc29-5921-43d9-8fac-53a0888f6b7f"
      unitRef="shares">2467101</sny:NumberOfShareSubscribed>
    <sny:IssuanceOfFurtherSharesAsAnEmployersContribution
      contextRef="i7950c585f21f43c9b757252673571f29_I20220203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzUtMS0xLTEtMzY4MDc3_53d37f2f-71c1-43a4-980f-117cc66ea690"
      unitRef="shares">118049</sny:IssuanceOfFurtherSharesAsAnEmployersContribution>
    <sny:IssuanceOfFurtherSharesAsAnEmployersContribution
      contextRef="i79da5b5df5a44ed2819eb15a236aea21_I20210204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzUtMS0xLTEtMzY0MDYw_d9658c8e-4192-4dc5-9b49-cb82a34e1f96"
      unitRef="shares">124112</sny:IssuanceOfFurtherSharesAsAnEmployersContribution>
    <sny:IssuanceOfFurtherSharesAsAnEmployersContribution
      contextRef="i46fda90bd8224cb8aab66c2e4efa5317_I20200205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTplNDNlMmQ1NzEyMjk0NGY1YmNiMDJiYTE4MDE0YTcxNC90YWJsZXJhbmdlOmU0M2UyZDU3MTIyOTQ0ZjViY2IwMmJhMTgwMTRhNzE0XzUtMi0xLTEtMzY0MDYw_eb60a898-45ed-4848-b1e5-9e68e5a8a41f"
      unitRef="shares">123615</sny:IssuanceOfFurtherSharesAsAnEmployersContribution>
    <sny:PercentageOfAverageOfQuotedMarketPricesOfShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE2OTI_9a0cc83d-a4d9-4500-9884-5db9f13c6023"
      unitRef="number">0.80</sny:PercentageOfAverageOfQuotedMarketPricesOfShares>
    <sny:PercentageOfAverageOfQuotedMarketPricesOfShares
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE2OTI_a466f3f2-51aa-4740-8ae6-f613ead44bdf"
      unitRef="number">0.80</sny:PercentageOfAverageOfQuotedMarketPricesOfShares>
    <sny:PercentageOfAverageOfQuotedMarketPricesOfShares
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE2OTI_aa71aacb-6f9f-4207-a2c5-33f2d2ceb79c"
      unitRef="number">0.80</sny:PercentageOfAverageOfQuotedMarketPricesOfShares>
    <sny:NumberOfTradingDaysPrecedingPlanApproval
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE3NzQ_8e2e2726-220a-4550-86e5-8c8c4139e70a">P20D</sny:NumberOfTradingDaysPrecedingPlanApproval>
    <sny:NumberOfTradingDaysPrecedingPlanApproval
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE3NzQ_8f06e9fc-e117-4467-acd4-886bc63928dd">P20D</sny:NumberOfTradingDaysPrecedingPlanApproval>
    <sny:NumberOfTradingDaysPrecedingPlanApproval
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzE3NzQ_eea1a3e2-6e54-41df-9df2-3d85e0bca6c6">P20D</sny:NumberOfTradingDaysPrecedingPlanApproval>
    <ifrs-full:AdditionalInformationAboutSharebasedPaymentArrangements
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwODc_ebcc1b93-2a7b-4cdc-b89f-b8f8e1fbe735">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth the expense recognized for each plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expense recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which employer&#x2019;s contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:AdditionalInformationAboutSharebasedPaymentArrangements>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="i66d14f14ca8849fa99dc8c0918792fb1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzEtMS0xLTEtMzY4MzM3_7fc5b944-ea46-4664-921a-d24924e984b3"
      unitRef="eur">39000000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="ic1516dd6e9d447e8a114d4530d0dc9ef_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzEtMS0xLTEtMzY0MDYw_0f3c1846-a8af-4cdd-8f74-7fdc0b8a0a59"
      unitRef="eur">51000000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="i63eadec211ae4265a25589628b710de1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzEtMi0xLTEtMzY0MDYw_2f6abcfe-4544-43b7-968a-1908c6cb2cb1"
      unitRef="eur">52000000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <sny:ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution
      contextRef="i66d14f14ca8849fa99dc8c0918792fb1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzItMS0xLTEtMzY4MzM3_552a7a2b-d2c3-454a-b25d-e9ab77751f33"
      unitRef="eur">11000000</sny:ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution>
    <sny:ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution
      contextRef="ic1516dd6e9d447e8a114d4530d0dc9ef_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzItMS0xLTEtMzY0MDYw_85b9b7ed-4d5c-4bcd-a2e0-e066c2bc4bc6"
      unitRef="eur">11000000</sny:ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution>
    <sny:ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution
      contextRef="i63eadec211ae4265a25589628b710de1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozMTJiOGNiM2I1M2I0YzhkOWY1ZWM4NGYzOThiZjEyMC90YWJsZXJhbmdlOjMxMmI4Y2IzYjUzYjRjOGQ5ZjVlYzg0ZjM5OGJmMTIwXzItMi0xLTEtMzY0MDYw_b0fd2f40-fcba-4980-bd65-d2e8518ddc4b"
      unitRef="eur">11000000</sny:ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution>
    <sny:PeriodOfShareRepurchaseProgram
      contextRef="i0bcc53d1b46b433eb833bb6a2091a218_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzIxMzA_007ad1ee-b5e3-46d8-8bf3-f2fa195ef6e4">P18M</sny:PeriodOfShareRepurchaseProgram>
    <sny:PeriodOfShareRepurchaseProgram
      contextRef="icceb8678190f4fc092c24a26a6eb8a8b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzIxMzA_9ddadcd5-06af-4398-9afe-bd4fca3cdbd1">P18M</sny:PeriodOfShareRepurchaseProgram>
    <sny:PeriodOfShareRepurchaseProgram
      contextRef="ib996bb209f3341dea9daa277aacec9ee_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzIxMzA_a7958b90-a2b0-4624-9407-c1714d25601b">P18M</sny:PeriodOfShareRepurchaseProgram>
    <sny:DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMTE_c46cbf0f-9437-4c33-9be9-772c32db90b5">The following repurchases have been made under those programs:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-right:29.25pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(in number of shares and &#x20ac; million)&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:29.25pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:29.25pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Year of authorization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number &lt;br/&gt;of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number &lt;br/&gt;of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number &lt;br/&gt;of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022 program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,510,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021 program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,976,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,765,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020 program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,758,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,685,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2019 program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,982,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock>
    <sny:NumberOfSharesRepurchased
      contextRef="iabf63d973d864585b86699f4855bc32b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzItMS0xLTEtMzY0MDYw_0e81900e-d2f6-404d-80a7-ef0924e276c6"
      unitRef="shares">1510000</sny:NumberOfSharesRepurchased>
    <sny:AmountOfSharesRepurchased
      contextRef="ibcea4ad6a0f44a998a9b40d108e25d03_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzItMi0xLTEtMzY0MDYw_31bd78bd-5634-466d-94d1-c2ff72912aaf"
      unitRef="eur">137000000</sny:AmountOfSharesRepurchased>
    <sny:NumberOfSharesRepurchased
      contextRef="i133ad2daf2c744769bc88969889d854c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzMtMS0xLTEtMzY0MDYw_3cc9dc4a-a1a4-4386-8ee4-31f5515855c0"
      unitRef="shares">3976992</sny:NumberOfSharesRepurchased>
    <sny:AmountOfSharesRepurchased
      contextRef="ie98122f205404008bf0c4d6ef91f8cd9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzMtMi0xLTEtMzY0MDYw_c445a0db-1c71-43e9-860a-87b0b4cb2939"
      unitRef="eur">360000000</sny:AmountOfSharesRepurchased>
    <sny:NumberOfSharesRepurchased
      contextRef="i47de2d9d1a944092a8be630f2ab66718_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzMtMy0xLTEtMzY0MDYw_c2610c6d-c5aa-41ad-b57c-7972c16340ae"
      unitRef="shares">2765388</sny:NumberOfSharesRepurchased>
    <sny:AmountOfSharesRepurchased
      contextRef="i7de3c0be32cc48acacb91c4afe0b5475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzMtNC0xLTEtMzY0MDYw_5a35545b-4a9c-45a9-b3d6-564e9f603468"
      unitRef="eur">242000000</sny:AmountOfSharesRepurchased>
    <sny:NumberOfSharesRepurchased
      contextRef="id93a545773b04620ac8f01558b1daf08_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzQtMy0xLTEtMzY0MDYw_a4966e08-a945-44e1-ab28-30fc2f50ad28"
      unitRef="shares">1758569</sny:NumberOfSharesRepurchased>
    <sny:AmountOfSharesRepurchased
      contextRef="ic1b2461e749440a5bdbb736ccaf68050_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzQtNC0xLTEtMzY0MDYw_0caeba7d-c544-4248-a4eb-4d937cf59fb5"
      unitRef="eur">140000000</sny:AmountOfSharesRepurchased>
    <sny:NumberOfSharesRepurchased
      contextRef="i7e27f23597f74a1c9ecae2a85d4ccc94_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzQtNS0xLTEtMzY0MDYw_629f9129-fe40-46fa-8e54-747fba5d986a"
      unitRef="shares">5685426</sny:NumberOfSharesRepurchased>
    <sny:AmountOfSharesRepurchased
      contextRef="i880490f8dfd74492ab0ebb0a198871b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzQtNi0xLTEtMzY0MDYw_2f1e3d7e-ded3-4451-9869-bc41159c8860"
      unitRef="eur">461000000</sny:AmountOfSharesRepurchased>
    <sny:NumberOfSharesRepurchased
      contextRef="i5c119e3c395a473f9ea5f13d6ebdde04_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzUtNS0xLTEtMzY0MDYw_2fe8c300-74ce-416c-baf4-73b8154810d5"
      unitRef="shares">3982939</sny:NumberOfSharesRepurchased>
    <sny:AmountOfSharesRepurchased
      contextRef="ieb20c7e9683948fcb26fb328baed1c91_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZTY1ZTRjM2ZhMjU0YWFkODVkYmJmM2IzNjgwZjU3Yi90YWJsZXJhbmdlOmFlNjVlNGMzZmEyNTRhYWQ4NWRiYmYzYjM2ODBmNTdiXzUtNi0xLTEtMzY0MDYw_6aa9ed20-ee13-4fde-9c0a-80822d67b0f2"
      unitRef="eur">361000000</sny:AmountOfSharesRepurchased>
    <sny:DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwOTY_f485523d-d7ae-4e68-ae47-4bca9e37236a">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Currency translation differences comprise the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.901%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Attributable to equity holders of Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(865)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,462&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="id2b3c17bccc5485fa012a841128e0541_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzEtMS0xLTEtMzY0MDYw_07261486-cc30-4f35-8626-7bf33e28225e"
      unitRef="eur">1499000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="i343a67603f674e36a4e9acecfd848af6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzEtMi0xLTEtMzY0MDYw_e75cdad0-30f8-4340-a70d-9970990a6e2c"
      unitRef="eur">-865000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="i7b49431edc8942d0a4afa8a40fe26c46_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzEtNC0xLTEtMzY0MDYw_29b6941c-f89e-4a4b-862d-d853ae402f05"
      unitRef="eur">-3384000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:NoncontrollingInterests
      contextRef="id2b3c17bccc5485fa012a841128e0541_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzItMS0xLTEtMzY0MDYw_8d19c363-1c67-4bfb-86a3-8039db4336d6"
      unitRef="eur">-37000000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="i343a67603f674e36a4e9acecfd848af6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzItMi0xLTEtMzY0MDYw_3f14a047-c356-4e81-9e02-9c2ebb65f56c"
      unitRef="eur">-42000000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="i7b49431edc8942d0a4afa8a40fe26c46_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzItNC0xLTEtMzY0MDYw_6e31f648-7a84-4794-be23-b3a35b648a38"
      unitRef="eur">-55000000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="id2b3c17bccc5485fa012a841128e0541_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzMtMS0xLTEtMzY0MDYw_9ab3d3d7-5cfd-4fdc-afb4-ce4128a2c6a4"
      unitRef="eur">1462000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i343a67603f674e36a4e9acecfd848af6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzMtMi0xLTEtMzY0MDYw_94af7ca9-7b27-4f89-ac5e-5b3fe6fa4e3a"
      unitRef="eur">-907000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="i7b49431edc8942d0a4afa8a40fe26c46_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTpiZWI5MmVkMzE5YTA0ZWQ5ODBhZjlkYThjNzg1ZTg1Mi90YWJsZXJhbmdlOmJlYjkyZWQzMTlhMDRlZDk4MGFmOWRhOGM3ODVlODUyXzMtNC0xLTEtMzY0MDYw_44dcb68d-32f8-45b2-89ef-17408af223df"
      unitRef="eur">-3439000000</ifrs-full:Equity>
    <sny:HedgesOfNetInvestmentsInForeignOperationsAfterTax
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzI2NTk_68f48a22-dcf3-4d01-a51f-721d4294f1ee"
      unitRef="eur">580000000</sny:HedgesOfNetInvestmentsInForeignOperationsAfterTax>
    <sny:HedgesOfNetInvestmentsInForeignOperationsAfterTax
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzI4MDY_b411a196-3749-48fb-b9f1-f507a42a31cb"
      unitRef="eur">317000000</sny:HedgesOfNetInvestmentsInForeignOperationsAfterTax>
    <sny:HedgesOfNetInvestmentsInForeignOperationsAfterTax
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzI4MjM_7fbcf48b-1a26-4cd5-bda8-807d6e68080c"
      unitRef="eur">136000000</sny:HedgesOfNetInvestmentsInForeignOperationsAfterTax>
    <sny:DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwOTI_527f51c6-37c3-4acb-a1e8-3bb36ea128d0">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Movements within other comprehensive income are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial gains/(losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Actuarial gains/(losses) excluding investments accounted for using the equity method (see Note&#160;D.19.1.)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Tax effects&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity instruments included in financial assets and financial liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;padding-right:29.25pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Change in fair value (excluding investments accounted for using the equity method)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Change in fair value (investments accounted for using the equity method, net of taxes)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Equity risk hedging instruments designated as fair value hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Tax effects&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Items not subsequently reclassifiable to profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;451&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;797&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt instruments included in financial assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Change in fair value (excluding investments accounted for using the equity method)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Tax effects&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash flow and fair value hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Change in fair value (excluding investments accounted for using the equity method)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Change in fair value (investments accounted for using the equity method, net of taxes)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:9.29pt"&gt;Tax effects&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Change in currency translation differences:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Currency translation differences (investments accounted for using the&#160;equity method)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Currency translation differences related to the investment in Regeneron and&#160;reclassified to profit or loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Hedges of net investments in foreign operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Tax effects&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Items subsequently reclassifiable to profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,313&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,510&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Amounts reclassified to profit or loss: immaterial amount in 2022, &#x20ac;4 million in 2021 and &#x20ac;5 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Amounts reclassified to profit or loss: &#x20ac;2 million in 2022, &#x20ac;12 million in 2021 and &#x20ac;1 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d) Amounts reclassified to profit or loss: &#x20ac;40 million in 2022, including &#x20ac;35 million relating to the deconsolidation of EUROAPI (see note&#160;D.1.). The amounts reclassified to profit and loss were immaterial in 2021 and 2020. Currency translation differences arise from the translation into euros of the financial statements of foreign subsidiaries, and are mainly due to the appreciation of the dollar against the euro.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(e) &#160;&#160;&#160;&#160;The amount recorded for 2020 relates to the translation reserve arising on the investment in Regeneron; the reserve was reclassified to profit or loss in accordance with IAS&#160;21 (The Effects of Changes in Foreign Exchange Rates), including &#x20ac;2 million (net of tax) relating to hedges of net investments in foreign operations.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock>
    <sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures
      contextRef="iaf9aeb01b7384684be3ef0b4bc47fc8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzMtMS0xLTEtMzY0MDYw_8cedfbad-783a-4912-8771-04f8d7af8dee"
      unitRef="eur">650000000</sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures>
    <sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures
      contextRef="i101060c5a55146ab94a8e716c499c73b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzMtMi0xLTEtMzY0MDYw_07c3319e-2983-4ef5-897d-986d36309d48"
      unitRef="eur">685000000</sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures>
    <sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures
      contextRef="i5fbf93c7ecb84b3c99fe4d603cce5cca_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzMtNC0xLTEtMzY0MDYw_39db9822-34ea-41c9-a5b5-df8c03850dda"
      unitRef="eur">-266000000</sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures>
    <sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures
      contextRef="iaf9aeb01b7384684be3ef0b4bc47fc8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzQtMS0xLTEtMzY0MDYw_6541319e-1f68-4b80-914f-be9eec30f5b7"
      unitRef="eur">4000000</sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures>
    <sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures
      contextRef="i101060c5a55146ab94a8e716c499c73b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzQtMi0xLTEtMzY0MDYw_b34a1a48-335c-430c-87e1-031f775829f4"
      unitRef="eur">1000000</sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures>
    <sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures
      contextRef="i5fbf93c7ecb84b3c99fe4d603cce5cca_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzQtNC0xLTEtMzY0MDYw_e70ac79f-84c8-4c53-a2de-7a5bcd63fbe3"
      unitRef="eur">-1000000</sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures>
    <sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures
      contextRef="iaf9aeb01b7384684be3ef0b4bc47fc8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzUtMS0xLTEtMzY0MDYw_509c3275-f5fe-4490-958f-d116b2329976"
      unitRef="eur">212000000</sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures>
    <sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures
      contextRef="i101060c5a55146ab94a8e716c499c73b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzUtMi0xLTEtMzY0MDYw_ae1db31e-dfc1-4755-bd36-b0dd60c307c3"
      unitRef="eur">36000000</sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures>
    <sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures
      contextRef="i5fbf93c7ecb84b3c99fe4d603cce5cca_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzUtNC0xLTEtMzY0MDYw_a0f66aaf-1510-46cc-8994-b30caf5d3458"
      unitRef="eur">-45000000</sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures
      contextRef="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzctMS0xLTEtMzY0MDYw_739d992e-0906-4f85-b825-c1c87df37081"
      unitRef="eur">-4000000</sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures
      contextRef="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzctMi0xLTEtMzY0MDYw_09c9cbed-02c1-41e3-98f2-c846c961317f"
      unitRef="eur">154000000</sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures
      contextRef="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzctNC0xLTEtMzY0MDYw_b1cd2988-a67e-49ef-9765-818418209a84"
      unitRef="eur">358000000</sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax
      contextRef="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzgtMS0xLTEtMzY0MDYw_7ebd3ef1-d903-4062-9f13-3b7a563c5586"
      unitRef="eur">0</sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax>
    <sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax
      contextRef="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzgtMi0xLTEtMzY0MDYw_3953a8e6-c350-4648-820d-93c2d7225e46"
      unitRef="eur">0</sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax>
    <sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax
      contextRef="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzgtNC0xLTEtMzY0MDYw_9c317d28-0869-48c9-b01f-c081ecaa91d0"
      unitRef="eur">-14000000</sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax>
    <sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges
      contextRef="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzktMS0xLTEtMzY0MDYw_849d738a-05ff-4a6e-a935-1187fdf4c79c"
      unitRef="eur">17000000</sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges>
    <sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges
      contextRef="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzktMi0xLTEtMzY0MDYw_0e902d50-75a3-4e2b-8506-adc22bd8896c"
      unitRef="eur">11000000</sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges>
    <sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges
      contextRef="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzktNC0xLTEtMzY0MDYw_2b867f47-f290-4d96-ba75-3c50fa228ee6"
      unitRef="eur">-24000000</sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges>
    <sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod
      contextRef="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEwLTEtMS0xLTM2NDA2MA_8b391452-7f61-40ea-b282-9ba77cced18d"
      unitRef="eur">4000000</sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod>
    <sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod
      contextRef="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEwLTItMS0xLTM2NDA2MA_c70e40d1-e783-4acc-bbde-f017265b287c"
      unitRef="eur">18000000</sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod>
    <sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod
      contextRef="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEwLTQtMS0xLTM2NDA2MA_8835bbea-ac90-4625-9031-0559b425d71d"
      unitRef="eur">84000000</sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="ie6ecd02fb2694313ab1d1852406932c6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzExLTEtMS0xLTM2NDA2MA_e8224b6d-64e0-4dc3-966c-e277b362aad4"
      unitRef="eur">451000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="id16147e7ee824a1083893ecebcef8ac8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzExLTItMS0xLTM2NDA2MA_e00fff7f-cf1f-4886-8fd9-42c14d427087"
      unitRef="eur">797000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i51fdd6e6a4a4492a91386cc665982eb6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzExLTQtMS0xLTM2NDA2MA_8eccda5e-44ae-4de8-a275-76492260088b"
      unitRef="eur">14000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures
      contextRef="iaddc5f29d63d46fabf82586a2abfd3ce_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEzLTEtMS0xLTM2NDA2MA_e849a6cf-e7c1-419f-9cfa-eaac192e6a0e"
      unitRef="eur">-77000000</sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures
      contextRef="i5642b66a094b41b78ecf737cf0fb29ee_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEzLTItMS0xLTM2NDA2MA_7dd71570-103e-417a-8b5a-f454182836c3"
      unitRef="eur">-21000000</sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures
      contextRef="i7c7268343e3c4b149282aaac720d320c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzEzLTQtMS0xLTM2NDA2MA_101471cf-cafd-4cbc-bf6b-21d42ef47f4f"
      unitRef="eur">15000000</sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures>
    <sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures
      contextRef="iaddc5f29d63d46fabf82586a2abfd3ce_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE1LTEtMS0xLTM2NDA2MA_ef82f4e2-eb57-49df-af38-6c88cb11d609"
      unitRef="eur">-15000000</sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures>
    <sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures
      contextRef="i5642b66a094b41b78ecf737cf0fb29ee_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE1LTItMS0xLTM2NDA2MA_556ddd27-1794-4531-810b-92d4980b7625"
      unitRef="eur">-5000000</sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures>
    <sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures
      contextRef="i7c7268343e3c4b149282aaac720d320c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE1LTQtMS0xLTM2NDA2MA_f24faeff-12de-4abe-8c0a-64bc773e8d4f"
      unitRef="eur">3000000</sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures
      contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE3LTEtMS0xLTM2NDA2MA_66d31765-33da-4091-8fc3-10927f25d4c1"
      unitRef="eur">5000000</sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures
      contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE3LTItMS0xLTM2NDA2MA_bed5f1c1-1bca-46b6-8e1e-c9ab8faecac0"
      unitRef="eur">-6000000</sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures
      contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE3LTQtMS0xLTM2NDA2MA_ab940607-9505-4269-9018-6cafaee5d7f3"
      unitRef="eur">4000000</sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures
      contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE4LTEtMS0xLTM2NDA2MA_698c1168-2b9a-4c7d-b00a-4956cc11f793"
      unitRef="eur">2000000</sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures
      contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE4LTItMS0xLTM2NDA2MA_609ab456-a33a-4daf-9647-92f8ce727253"
      unitRef="eur">0</sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures
      contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE4LTQtMS0xLTM2NDA2MA_d8b6264d-d7a0-4e90-b2f1-e631cdd5c248"
      unitRef="eur">0</sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures>
    <ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome
      contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE5LTEtMS0xLTM2NDA2MA_753e877d-0588-479f-a21c-f0712cc9b130"
      unitRef="eur">1000000</ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome>
    <ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome
      contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE5LTItMS0xLTM2NDA2MA_3bdb327e-9684-4ac6-b0f1-d94039a58779"
      unitRef="eur">-2000000</ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome>
    <ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome
      contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzE5LTQtMS0xLTM2NDA2MA_5849bfca-b109-4c96-b2f1-4cc2fea2b4b1"
      unitRef="eur">2000000</ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome>
    <sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures
      contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIxLTEtMS0xLTM2NDA2MA_4ba88330-34e4-40eb-8668-f59ed823da27"
      unitRef="eur">2643000000</sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures
      contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIxLTItMS0xLTM2NDA2MA_d98cc138-df88-44e9-9bb5-1ad8a8a438a9"
      unitRef="eur">2719000000</sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures
      contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIxLTQtMS0xLTM2NDA2MA_51553870-e817-4ed6-88ef-5ee69113238b"
      unitRef="eur">-3870000000</sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures
      contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIyLTEtMS0xLTM2NDA2MA_bd79e645-bfd4-4c97-84f1-f8d0230fb11b"
      unitRef="eur">-11000000</sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures
      contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIyLTItMS0xLTM2NDA2MA_cb8a9f0b-02a9-4200-917c-5607519e7de3"
      unitRef="eur">-6000000</sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures
      contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIyLTQtMS0xLTM2NDA2MA_96289aad-19a1-4b28-83ca-40961b1c76f2"
      unitRef="eur">32000000</sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures
      contextRef="ib5f0f8400faf41899e56a9f755aa798b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIzLTEtMS0xLTM2NDA2MA_e9dc0283-d456-4257-a339-93989d39a587"
      unitRef="eur">0</sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures
      contextRef="i84e5f74193b24fd0a09abc9140858b91_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIzLTItMS0xLTM2NDA2MA_a30a1480-37f8-4e13-86fd-0738eb5425ad"
      unitRef="eur">0</sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures
      contextRef="i01a11c5677794ada9a35a69fc37af36b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzIzLTQtMS0xLTM2NDA2MA_769afd39-a0b7-4de2-921d-c80ecff473c9"
      unitRef="eur">-318000000</sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations
      contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI0LTEtMS0xLTM2NDA2MA_1c937a55-a77d-4b6f-a608-531e6cf13f5e"
      unitRef="eur">-354000000</sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations>
    <sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations
      contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI0LTItMS0xLTM2NDA2MA_6a156640-136a-496c-ad80-2b8b5a042c6f"
      unitRef="eur">-254000000</sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations>
    <sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations
      contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI0LTQtMS0xLTM2NDA2MA_d6faad74-9794-4b7e-9eba-450285b59e5d"
      unitRef="eur">180000000</sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations>
    <sny:ChangeInCurrencyTranslationOnTaxEffects
      contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI1LTEtMS0xLTM2NDA2MA_147803d8-0ffb-47dd-9aa5-3606005cbcb7"
      unitRef="eur">-91000000</sny:ChangeInCurrencyTranslationOnTaxEffects>
    <sny:ChangeInCurrencyTranslationOnTaxEffects
      contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI1LTItMS0xLTM2NDA2MA_1fdfc6db-f56a-4524-9d7a-485c92e26939"
      unitRef="eur">-71000000</sny:ChangeInCurrencyTranslationOnTaxEffects>
    <sny:ChangeInCurrencyTranslationOnTaxEffects
      contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI1LTQtMS0xLTM2NDA2MA_3594a39d-180f-416d-a8ca-d2095eb3e5ef"
      unitRef="eur">59000000</sny:ChangeInCurrencyTranslationOnTaxEffects>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i0ca9f37db3d8483bbe6cea19086d40fe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI2LTEtMS0xLTM2NDA2MA_07065861-fb9c-46e8-ac09-df59e7bc29b6"
      unitRef="eur">2313000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="ia2e9b712ca9f4de0bbdc660b1e72de78_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI2LTItMS0xLTM2NDA2MA_1e75fcac-8d14-4695-a46c-85b60770cb48"
      unitRef="eur">2510000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i81ff754d95d044eb9f65cc5bdce4ec38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTphZjc1NDFjMzkzNWE0Yjk0YjA3NGMxMGNhY2RlMTZlYy90YWJsZXJhbmdlOmFmNzU0MWMzOTM1YTRiOTRiMDc0YzEwY2FjZGUxNmVjXzI2LTQtMS0xLTM2NDA2MA_7cdd4d71-8bfd-4284-874f-bebd13e1a1dc"
      unitRef="eur">-4021000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="iaddc5f29d63d46fabf82586a2abfd3ce_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzgzMDEzMTI3OTA4Mzk1_35f82b36-24ee-43e1-aabc-606829314a4b"
      unitRef="eur">0</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i5642b66a094b41b78ecf737cf0fb29ee_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzMwODc_67d23729-bed8-4ba8-a3f0-0f66c2e25afd"
      unitRef="eur">4000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i7c7268343e3c4b149282aaac720d320c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzU0OTc1NTgxNDQyMDI_2b52e643-e4e2-40f6-ac3c-f1e815a333f3"
      unitRef="eur">5000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i4949eb4dec9442ac85100f908e6972f1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzMxNTc_8a0d56ba-fe66-4f74-a2b4-df5fc76d730f"
      unitRef="eur">2000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i1f6d2fa7ab6e42599794a051ecd2b89e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzMxNjc_bfb42ea0-aa2b-48c4-8430-b1c6b46f0e82"
      unitRef="eur">12000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="icd31d9498df742b0b80e99888ab0fd03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzMxODE_2a38726e-ecc9-4ed6-9140-0304b8ae286b"
      unitRef="eur">1000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="ib49080ce7345480abd6e11f6e27bc713_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzU0OTc1NTgxNDk0MTc_cefb9c7d-5734-46d0-a9a6-e6b6d63b7089"
      unitRef="eur">40000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="i386bf60e102f452f92cd64f880c74114_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzU0OTc1NTgxNDk5NjU_96585e7b-6d18-4667-b598-a66fbb9a48ce"
      unitRef="eur">35000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="id5e403b7788e477a853eef59c1c0ea76_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzgzMDEzMTI3OTA4NDEx_b36d5e85-822e-46ad-ac12-ba566cc512d7"
      unitRef="eur">0</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="ibcee24e1452447f784500be45b06d7e8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzgzMDEzMTI3OTA4NDEx_e8b7d323-f167-4f89-aa90-bbf13397b112"
      unitRef="eur">0</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <sny:ChangeInCurrencyTranslationOnTaxEffects
      contextRef="i01a11c5677794ada9a35a69fc37af36b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzMzOTg_5a40dd16-c533-457a-871f-9a74c9ed4199"
      unitRef="eur">2000000</sny:ChangeInCurrencyTranslationOnTaxEffects>
    <sny:DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwOTg_7d50b029-bd26-415c-9965-b7c0810b7273">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table shows all Sanofi stock subscription option plans still outstanding or under which options were exercised in the year ended&#160;December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Source&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Date of grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;options&lt;br/&gt;granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Start&#160;date&#160;of&lt;br/&gt;exercise&lt;br/&gt;period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiry date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Exercise&lt;br/&gt;price (&#x20ac;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number of options outstanding as of 12/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2012&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;814,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/06/2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;788,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/06/2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;78,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,009,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/06/2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;03/05/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;506,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;06/24/2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;435,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;06/25/2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;06/24/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;338,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/04/2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;402,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/05/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/04/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;264,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/10/2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;378,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/11/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/10/2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;268,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/02/2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;220,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/03/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/02/2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;04/30/2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;220,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;05/02/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;04/30/2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;213,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,837,969&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="ica78b7fc4ed34047b47a514ea2899e83_D20120305-20120305"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzItMi0xLTEtMzY0MDYw_7a86eb66-2b21-40ee-b0b3-a4132afbf8b0"
      unitRef="shares">814050</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <sny:StockBasedCompensationStockOptionsExercisedPricePerShare
      contextRef="id7e65738a1c54e028a8f9ed3e5c8f6ab_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzItNS0xLTEtMzY0MDYw_68390af0-9323-46ac-a5c0-a91cb1aa2109"
      unitRef="eurPerShare">56.44</sny:StockBasedCompensationStockOptionsExercisedPricePerShare>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="i9a0dc1e4f1cb4d699ec65237a7102e35_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzItNi0xLTEtMzY0MDYw_b7ec5fe6-57a0-47ae-9fbb-b18c14661154"
      unitRef="shares">0</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="i6fdbb4a4b5c641fc830a0a4bf600f878_D20130305-20130305"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzMtMi0xLTEtMzY0MDYw_8c43a68c-6f3d-479d-ae11-26cb004694a1"
      unitRef="shares">788725</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <sny:StockBasedCompensationStockOptionsExercisedPricePerShare
      contextRef="i850f42283b4b45f5af5a9e3cb5bcb9fe_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzMtNS0xLTEtMzY0MDYw_e63beb41-f3ec-47ea-a779-845a4ecd54dc"
      unitRef="eurPerShare">72.19</sny:StockBasedCompensationStockOptionsExercisedPricePerShare>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="ib7a863d7a3b84e16ada34b5dd5363074_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzMtNi0xLTEtMzY0MDYw_2fc90ddb-8c6d-41ba-87cf-34c02904e644"
      unitRef="shares">78089</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="i70e570beee9247dd9373015a21c81447_D20140305-20140305"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzQtMi0xLTEtMzY0MDYw_66ee8ac2-1ffd-4ed4-8982-efcf854abe5a"
      unitRef="shares">1009250</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <sny:StockBasedCompensationStockOptionsExercisedPricePerShare
      contextRef="i46fad837e04947e195c6de7464520552_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzQtNS0xLTEtMzY0MDYw_4d2acc42-b861-4d98-9684-48dd3537bc46"
      unitRef="eurPerShare">73.48</sny:StockBasedCompensationStockOptionsExercisedPricePerShare>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="i8eceb614c7954b4a9e69dda6979655f9_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzQtNi0xLTEtMzY0MDYw_d086f313-867a-41c4-9282-2c6a639dcfcf"
      unitRef="shares">506042</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="i0423b3f235d249af9b6c602495486f3f_D20150624-20150624"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzUtMi0xLTEtMzY0MDYw_1bb9a619-d5f7-4b9b-9d4e-44e54ca8e5ef"
      unitRef="shares">435000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <sny:StockBasedCompensationStockOptionsExercisedPricePerShare
      contextRef="i761f2bdb34ff43adaab4025fbadfd268_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzUtNS0xLTEtMzY0MDYw_a08aa46b-1d86-461e-9118-8c8ad39031ee"
      unitRef="eurPerShare">89.38</sny:StockBasedCompensationStockOptionsExercisedPricePerShare>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="i5e0102d8ca1542de9dd7e5b5292bff6d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzUtNi0xLTEtMzY0MDYw_a0b0e043-3b09-4fac-aacb-f735470e48af"
      unitRef="shares">338464</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="i9991ac00c4ee4f6795e497369e9998ea_D20160504-20160504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzYtMi0xLTEtMzY0MDYw_37ea4cf4-41d1-4d55-af8e-14422bc163b5"
      unitRef="shares">402750</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <sny:StockBasedCompensationStockOptionsExercisedPricePerShare
      contextRef="ifeac6a9bfcdb48f68a24eab465620944_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzYtNS0xLTEtMzY0MDYw_7cb08dca-86b6-4396-9a43-93275af9f9cf"
      unitRef="eurPerShare">75.90</sny:StockBasedCompensationStockOptionsExercisedPricePerShare>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="i9c11a2397029406fb3e60037da96b3b9_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzYtNi0xLTEtMzY0MDYw_1c3b915b-0a10-46a4-91df-99cb1f673f29"
      unitRef="shares">264750</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="ieb730a8c0b4f4f30bd170f0b73b2ae58_D20170510-20170510"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzctMi0xLTEtMzY0MDYw_b1b10db6-d827-4408-87a1-fd713ead7a42"
      unitRef="shares">378040</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <sny:StockBasedCompensationStockOptionsExercisedPricePerShare
      contextRef="i123d774d41684985a2a86c269755103e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzctNS0xLTEtMzY0MDYw_2dbbbe0f-61a9-4575-838b-7eef9b89a5c3"
      unitRef="eurPerShare">88.97</sny:StockBasedCompensationStockOptionsExercisedPricePerShare>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="i6ff9ac16b7da4a46b910521e9f05b3e2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzctNi0xLTEtMzY0MDYw_395fdb0c-626c-4e7d-af17-5d0e192d7428"
      unitRef="shares">268440</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="i6b8cc6b5bfa042099e14b29e8ca19daa_D20180502-20180502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzgtMi0xLTEtMzY0MDYw_4cb1ed76-3c4c-4cc6-bfaf-7b018efc387a"
      unitRef="shares">220000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <sny:StockBasedCompensationStockOptionsExercisedPricePerShare
      contextRef="iab81166fd8d041fd9836ffd1e59632a1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzgtNS0xLTEtMzY0MDYw_073950cb-8037-4c71-8d23-68b044b8ca24"
      unitRef="eurPerShare">65.84</sny:StockBasedCompensationStockOptionsExercisedPricePerShare>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="i0b3f2d5eb1ab430482c82afc1c357df2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzgtNi0xLTEtMzY0MDYw_a5a3a897-cde4-4723-bc54-869cbe259d1d"
      unitRef="shares">168784</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
      contextRef="i3e201b70b2444c88a26affb3d73de9ad_D20190430-20190430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzktMi0xLTEtMzY0MDYw_7c5b7184-13f4-4264-960e-0cddff9ee604"
      unitRef="shares">220000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
    <sny:StockBasedCompensationStockOptionsExercisedPricePerShare
      contextRef="iac1fbcaf85814c7a9412ccfa10736712_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzktNS0xLTEtMzY0MDYw_3792e7c6-25b2-4ea7-9e6a-edfc58e42646"
      unitRef="eurPerShare">76.71</sny:StockBasedCompensationStockOptionsExercisedPricePerShare>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="i2ade5b12cb694090a8bb2346378f9880_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzktNi0xLTEtMzY0MDYw_dbbea1a5-9365-43c3-b2b2-49a0bec2e3c8"
      unitRef="shares">213400</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="id7761f45b2c44f4b874bfeb6104744cb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZToxMmY1YjQ4NDg2MjQ0NjU3YWYyNzczNzI4NWM1OGVhOS90YWJsZXJhbmdlOjEyZjViNDg0ODYyNDQ2NTdhZjI3NzM3Mjg1YzU4ZWE5XzEwLTYtMS0xLTM2NDA2MA_22780b32-0256-4d34-9d33-c586be87ac2e"
      unitRef="shares">1837969</ifrs-full:NumberOfOutstandingShareOptions>
    <sny:ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions
      contextRef="ia81dd6015449467683cda683d3e36cf4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzQzMjM_24697294-36af-4793-9880-cc335b9c858f"
      unitRef="eur">145000000</sny:ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions>
    <sny:NumberOfSharesIssuedByExerciceOfEachOption
      contextRef="ia81dd6015449467683cda683d3e36cf4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzQzODI_9ab2352a-ca75-4ae8-9a6a-01224bb953ec"
      unitRef="shares">1</sny:NumberOfSharesIssuedByExerciceOfEachOption>
    <sny:DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwODI_37a32b12-e5be-40dd-870b-6679843389c4">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A summary of stock options outstanding at each balance sheet date, and of movements during the relevant periods, is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted average&lt;br/&gt;exercise&#160;price&lt;br/&gt;per share (&#x20ac;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;(&#x20ac;&#160;million)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Options outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,822,020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;70.58&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,650,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;67.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(868,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options cancelled&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(91,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(282,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Options outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,579,270&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;75.61&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;195&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,845,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;74.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(190,076)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options cancelled&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(51,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Options outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,337,968&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;77.13&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;180&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,949,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;78.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(490,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;71.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options cancelled&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Options outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,837,969&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;78.64&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;145&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,624,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;78.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Mainly due to the grantees leaving Sanofi.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock>
    <sny:NumberOfShareOutstandingInShareBasedPaymentArrangement
      contextRef="i07c7f8bc45bc439083fadaebe0c772c2_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEtMS0xLTEtMzY0MDYw_a24af7da-5a51-49ff-8599-72992a72dfb3"
      unitRef="shares">3822020</sny:NumberOfShareOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="i07c7f8bc45bc439083fadaebe0c772c2_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEtMi0xLTEtMzY0MDYw_acc493e5-7526-4d00-a303-867bcf99f223"
      unitRef="eurPerShare">70.58</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement
      contextRef="i07c7f8bc45bc439083fadaebe0c772c2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEtMy0xLTEtMzY0MDYw_3c0fd04d-4108-4308-a492-43901bd51647"
      unitRef="eur">270000000</sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="i07c7f8bc45bc439083fadaebe0c772c2_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzItMS0xLTEtMzY0MDYw_3f74ce6c-3e99-4d8f-a37d-173a8767b7c5"
      unitRef="shares">2650375</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="i07c7f8bc45bc439083fadaebe0c772c2_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzItMi0xLTEtMzY0MDYw_6c06c9b7-2aea-4996-9fe1-e0b1d6db5ea2"
      unitRef="eurPerShare">67.14</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement
      contextRef="i43789de88f2946b3a8bd5af44ea50d3c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzItMy0xLTEtMzY0MDYw_6a9008af-44fc-47d6-a23b-22ebc787d830"
      unitRef="eur">178000000</sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzQtMS0xLTEtMzY0MDYw_f1bcb20b-fb44-4886-99fe-f435afe5096f"
      unitRef="shares">868655</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzQtMi0xLTEtMzY0MDYw_bda6ae14-d0f2-4760-bd4b-26132b6c3861"
      unitRef="eurPerShare">59.20</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsExercisedInShareBasedPaymentArrangement
      contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzQtMy0xLTEtMzY0MDYw_63fef895-df11-4613-ad83-cf559fa16f53"
      unitRef="eur">52000000</sny:ValueOfShareOptionsExercisedInShareBasedPaymentArrangement>
    <sny:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzUtMS0xLTEtMzY0MDYw_c4352302-ef27-4236-ae75-bcd6013e16f8"
      unitRef="shares">91305</sny:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <sny:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzUtMi0xLTEtMzY0MDYw_00cbe009-f58e-4aaf-8bb9-7e335fe6ca6c"
      unitRef="eurPerShare">87.73</sny:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <sny:ValueOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzUtMy0xLTEtMzY0MDYw_86215ce1-55bc-4482-8b85-29d36813b8e8"
      unitRef="eur">8000000</sny:ValueOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzYtMS0xLTEtMzY0MDYw_5d96ff10-e94c-48da-833a-b3294bc45580"
      unitRef="shares">282790</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzYtMi0xLTEtMzY0MDYw_d31b18ec-2c67-4e54-8d01-be7afe96bfbd"
      unitRef="eurPerShare">54.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement
      contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzYtMy0xLTEtMzY0MDYw_3a488251-ab12-4f86-8239-c4790b6222ca"
      unitRef="eur">15000000</sny:ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement>
    <sny:NumberOfShareOutstandingInShareBasedPaymentArrangement
      contextRef="icdedad23dad54fc796d50896cba79d31_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzctMS0xLTEtMzY0MDYw_21755bab-92cf-4eda-a069-f8c0ccae55c3"
      unitRef="shares">2579270</sny:NumberOfShareOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="icdedad23dad54fc796d50896cba79d31_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzctMi0xLTEtMzY0MDYw_796b065c-f7f3-4770-a4ec-7d72642d35db"
      unitRef="eurPerShare">75.61</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement
      contextRef="icdedad23dad54fc796d50896cba79d31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzctMy0xLTEtMzY0MDYw_583d51fe-668d-40cf-a95a-df271879f0e4"
      unitRef="eur">195000000</sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="icdedad23dad54fc796d50896cba79d31_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzgtMS0xLTEtMzY0MDYw_ee110978-727f-4960-ad33-e69743b3cbed"
      unitRef="shares">1845050</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="icdedad23dad54fc796d50896cba79d31_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzgtMi0xLTEtMzY0MDYw_60375af8-d1c1-47bf-9cb6-d07959b1c5d8"
      unitRef="eurPerShare">74.51</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement
      contextRef="i8fa64a21f2c54b59a4595dde4a7d8059_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzgtMy0xLTEtMzY0MDYw_7440778e-4a5d-44cd-be1a-b5f6bebbe028"
      unitRef="eur">137000000</sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEwLTEtMS0xLTM2NDA2MA_bd8ee6dd-9389-49d2-9842-85bd1f36c9c8"
      unitRef="shares">190076</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEwLTItMS0xLTM2NDA2MA_e79b1aec-18a1-40a1-a16d-c165c1dac9d1"
      unitRef="eurPerShare">59.53</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsExercisedInShareBasedPaymentArrangement
      contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEwLTMtMS0xLTM2NDA2MA_eacac365-3fa9-450a-8d96-9510a3af157e"
      unitRef="eur">11000000</sny:ValueOfShareOptionsExercisedInShareBasedPaymentArrangement>
    <sny:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzExLTEtMS0xLTM2NDA2MA_e568d7f0-f3ce-4208-ab98-cd2dcb67aa83"
      unitRef="shares">51216</sny:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <sny:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzExLTItMS0xLTM2NDA2MA_641131a7-91e4-4398-9f5f-596ffe85fdc7"
      unitRef="eurPerShare">65.84</sny:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <sny:ValueOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzExLTMtMS0xLTM2NDA2MA_e5bf1407-bb1f-4c24-9ce5-470dbd06a291"
      unitRef="eur">3000000</sny:ValueOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEyLTEtMS0xLTM2NDA2MA_d3fc7a63-a381-4093-bfa6-c8e3463bfc7c"
      unitRef="shares">10</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEyLTItMS0xLTM2NDA2MA_f772bdf5-a5ff-4d9e-b123-542f35f9186c"
      unitRef="eurPerShare">50.48</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement
      contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEyLTMtMS0xLTM2NDA2MA_5fa08cb4-693a-4921-a2f3-79d1c91030e7"
      unitRef="eur">0</sny:ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement>
    <sny:NumberOfShareOutstandingInShareBasedPaymentArrangement
      contextRef="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEzLTEtMS0xLTM2NDA2MA_18a4da42-335c-42de-817f-f7588a29e0fd"
      unitRef="shares">2337968</sny:NumberOfShareOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEzLTItMS0xLTM2NDA2MA_4f7eef6a-6826-48c7-b908-195ef7bc3b17"
      unitRef="eurPerShare">77.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement
      contextRef="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzEzLTMtMS0xLTM2NDA2MA_1d88df0b-8ab2-48a4-9226-502edcd13192"
      unitRef="eur">180000000</sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE0LTEtMS0xLTM2NDA2MA_495767e7-c4bb-4658-9aeb-fe856c404804"
      unitRef="shares">1949184</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="ib674dc57206c4a22a57a7b59b48c8b5d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE0LTItMS0xLTM2NDA2MA_899e2afb-7010-45f0-b356-298e673c7b02"
      unitRef="eurPerShare">78.15</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement
      contextRef="ifadd309e52db44428b4ecb9771537123_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE0LTMtMS0xLTM2NDA2MA_1ed3a38a-7eb2-44fe-b521-ee93026405f1"
      unitRef="eur">152000000</sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE2LTEtMS0xLTM2NDA2MA_618a2a89-48f3-4385-b77c-b173257f4e4d"
      unitRef="shares">490373</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE2LTItMS0xLTM2NDA2MA_6d746b55-e558-4c45-aa60-7db9f3bfbf8a"
      unitRef="eurPerShare">71.39</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsExercisedInShareBasedPaymentArrangement
      contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE2LTMtMS0xLTM2NDA2MA_d8f9f26d-f1de-469d-930a-ffb602677edc"
      unitRef="eur">35000000</sny:ValueOfShareOptionsExercisedInShareBasedPaymentArrangement>
    <sny:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE3LTEtMS0xLTM2NDA2MA_20dd5356-a91f-446a-9a92-cb5516194872"
      unitRef="shares">9626</sny:NumberOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <sny:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE3LTItMS0xLTM2NDA2MA_745c3532-a2e0-4fe5-8dea-e3b928564468"
      unitRef="eurPerShare">80.56</sny:WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <sny:ValueOfShareOptionsCancelledInShareBasedPaymentArrangement
      contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE3LTMtMS0xLTM2NDA2MA_56fc5d19-2c04-4ba8-a55c-92fa3b3de3d1"
      unitRef="eur">1000000</sny:ValueOfShareOptionsCancelledInShareBasedPaymentArrangement>
    <sny:NumberOfShareOutstandingInShareBasedPaymentArrangement
      contextRef="i4927989d9967442c8996bd62b8ad73e2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE5LTEtMS0xLTM2NDA2MA_b172710b-29b8-4419-9495-ea6b95d73bbe"
      unitRef="shares">1837969</sny:NumberOfShareOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="i4927989d9967442c8996bd62b8ad73e2_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE5LTItMS0xLTM2NDA2MA_577f3e8a-089c-4e8d-a3c3-c114df976445"
      unitRef="eurPerShare">78.64</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement
      contextRef="i4927989d9967442c8996bd62b8ad73e2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzE5LTMtMS0xLTM2NDA2MA_5d6da6d1-ced9-490f-a984-27fe6d5e0317"
      unitRef="eur">145000000</sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="i4927989d9967442c8996bd62b8ad73e2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzIwLTEtMS0xLTM2NDA2MA_6b91dd2c-8208-486d-8b6d-9a64d2f5fbc1"
      unitRef="shares">1624569</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="i4927989d9967442c8996bd62b8ad73e2_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzIwLTItMS0xLTM2NDA2MA_91b37958-3668-4cac-abb1-bcaa6108ea5f"
      unitRef="eurPerShare">78.89</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement
      contextRef="i0091f830a3594684afe0ab456649287b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo0MTIwMTQxZTAyYjA0ZjZiYjgzZmUxOTdhZTc4ZWUyNi90YWJsZXJhbmdlOjQxMjAxNDFlMDJiMDRmNmJiODNmZTE5N2FlNzhlZTI2XzIwLTMtMS0xLTM2NDA2MA_56025b1e-2d51-4870-8d3c-2954419f437b"
      unitRef="eur">128000000</sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement>
    <sny:DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMTM_4476738e-2c8f-4c04-acf7-73bec2634989">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below provides summary information about options outstanding and exercisable as of December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Range of exercise prices per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;residual&#160;life&lt;br/&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price per&lt;br/&gt;share (&#x20ac;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price per&lt;br/&gt;share (&#x20ac;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;From &#x20ac;60.00 to &#x20ac;70.00 per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;From &#x20ac;70.00 to &#x20ac;80.00 per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,062,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;848,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;From &#x20ac;80.00 to &#x20ac;90.00 per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;606,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;606,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,837,969&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,624,569&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="i821889f0ea344561b6b623f1569dcf5a_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZWY3MzBhNjVlNGNmNDEwYmFjOGZlNjJiM2ZjZDRhYzRfOQ_862c8543-d354-41fb-9da5-43b0ae227f3e"
      unitRef="eurPerShare">60.00</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="ib8bf080bbe314c159376eab8228e0259_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZWY3MzBhNjVlNGNmNDEwYmFjOGZlNjJiM2ZjZDRhYzRfMTU_b709f97a-d8f4-4d67-aafe-858daa92d5c2"
      unitRef="eurPerShare">70.00</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="i96d625b90bc5415ea3c4f123b942d689_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtMS0xLTEtMzY0MDYw_f7b3e950-65d3-4c13-86e9-cacb2bff28d5"
      unitRef="shares">168784</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="i86600d52210546e48c0c267d156433a2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtMi0xLTEtMzY0MDYw_e1214ba9-2040-40ba-9fdd-4ac78cd7287c">P5Y4M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="i96d625b90bc5415ea3c4f123b942d689_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtMy0xLTEtMzY0MDYw_0e1346b4-abed-4782-b115-a5e8e16c08d6"
      unitRef="eurPerShare">65.84</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="i96d625b90bc5415ea3c4f123b942d689_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtNC0xLTEtMzY0MDYw_321e9346-c229-46a5-b495-c625554228a6"
      unitRef="shares">168784</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="i96d625b90bc5415ea3c4f123b942d689_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzMtNS0xLTEtMzY0MDYw_3e1aaa70-6833-4ce1-b00c-1563a4ea7d15"
      unitRef="eurPerShare">65.84</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="i761cd5d2d3af436abebf5b7972feb90e_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246MTdiY2Y5MGEyMDk5NGYyYzk1Y2JjMTcwZGI2ZWRjZmVfOQ_c3c8bff2-ce4e-4495-ae11-15d9451f08b8"
      unitRef="eurPerShare">70.00</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="i8ddb1db14dc74affb6c0eddc366fa6ee_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246MTdiY2Y5MGEyMDk5NGYyYzk1Y2JjMTcwZGI2ZWRjZmVfMTU_456cb995-e87f-4cf2-9369-5aab3fb28472"
      unitRef="eurPerShare">80.00</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="if945729d6a4149c98bb12ede0a766d47_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtMS0xLTEtMzY0MDYw_e5c3ede7-fd6c-43a3-b81f-e7c5facf8a24"
      unitRef="shares">1062281</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="i9e790c51810745d39c5f898d13e4d429_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtMi0xLTEtMzY0MDYw_ee3f30bc-bb49-4f12-9e45-63f9ab38fcb9">P2Y8M4D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="if945729d6a4149c98bb12ede0a766d47_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtMy0xLTEtMzY0MDYw_caeca737-8380-46b9-b7c6-b37799bfda06"
      unitRef="eurPerShare">74.64</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="if945729d6a4149c98bb12ede0a766d47_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtNC0xLTEtMzY0MDYw_5ea6017c-653d-4291-8250-2a6d1c68adae"
      unitRef="shares">848881</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="if945729d6a4149c98bb12ede0a766d47_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzQtNS0xLTEtMzY0MDYw_eaf129a1-6bce-41c6-984e-336b7867ecfc"
      unitRef="eurPerShare">74.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="i72ed25668eab49c2b6083a9d4b1afed6_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZjQ1MmQ3MmRjNjUzNGU0MGFiYTJhYzc2M2RmZGFkOTBfOQ_5db01ac6-a447-4d36-af18-d5517b0d4c94"
      unitRef="eurPerShare">80.00</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="i23039a6ebb6044c893c2b3b14a2e0be0_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZjQ1MmQ3MmRjNjUzNGU0MGFiYTJhYzc2M2RmZGFkOTBfMTU_eecac07c-4bea-4278-b5c5-f799e342de01"
      unitRef="eurPerShare">90.00</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="i6c0322302b7940e2b62b4e9d6b0dd997_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtMS0xLTEtMzY0MDYw_548ad9d1-893c-4d7d-8051-28f46529514d"
      unitRef="shares">606904</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="ifb96c4c54f0e4c9593d667cdb20954ef_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtMi0xLTEtMzY0MDYw_5b628944-f486-4900-8f73-467364e6a119">P3Y3M21D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="i6c0322302b7940e2b62b4e9d6b0dd997_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtMy0xLTEtMzY0MDYw_4dd1784d-b1b0-40c4-a48b-13dd5f562183"
      unitRef="eurPerShare">89.20</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="i6c0322302b7940e2b62b4e9d6b0dd997_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtNC0xLTEtMzY0MDYw_f339505e-0e64-482a-acb2-34ae1d33c805"
      unitRef="shares">606904</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="i6c0322302b7940e2b62b4e9d6b0dd997_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzUtNS0xLTEtMzY0MDYw_befdb047-f8c6-4889-8b83-aa22cd5b8957"
      unitRef="eurPerShare">89.20</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="ica46b5f804e3417dad93336ac31a2ecb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzYtMS0xLTEtMzY0MDYw_44c764f5-5c10-43eb-bbf1-5a8b69391c53"
      unitRef="shares">1837969</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="ica46b5f804e3417dad93336ac31a2ecb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTozNTEyNDQxMjc0OTI0MDAxODY3NDg3ZGMwNTdiZGY1MS90YWJsZXJhbmdlOjM1MTI0NDEyNzQ5MjQwMDE4Njc0ODdkYzA1N2JkZjUxXzYtNC0xLTEtMzY0MDYw_6e4d6db5-af10-4132-9f31-40bb1d0aba41"
      unitRef="shares">1624569</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <sny:DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUxMTQ_cf693272-00b1-45b5-a4fb-d2e091fe8d29">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Average number of shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,251.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,252.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,253.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Adjustment for stock options with dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Adjustment for restricted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Average number of shares used to compute diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,256.9&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,257.9&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,260.1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock>
    <ifrs-full:WeightedAverageShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzEtMS0xLTEtMzY0MDYw_0b152aba-40fd-4f13-8e38-f755c847a167"
      unitRef="shares">1251900000</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzEtMi0xLTEtMzY0MDYw_cf294736-0a9d-402e-8494-9ad7fd3e800a"
      unitRef="shares">1252500000</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzEtMy0xLTEtMzY0MDYw_978caa82-e63e-437d-a77e-a97db2d0da76"
      unitRef="shares">1253600000</ifrs-full:WeightedAverageShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzItMS0xLTEtMzY0MDYw_52ff95e0-e2c6-40cb-8b7c-aa4eec4e8764"
      unitRef="shares">300000</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzItMi0xLTEtMzY0MDYw_5581577e-612f-405f-8a88-85b2d678239b"
      unitRef="shares">300000</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzItMy0xLTEtMzY0MDYw_f46cef83-eebb-459b-9ccf-ebb0ff2793bd"
      unitRef="shares">400000</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzMtMS0xLTEtMzY0MDYw_65beeafe-8997-405f-bbcb-63f271a970b8"
      unitRef="shares">4700000</sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares>
    <sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzMtMi0xLTEtMzY0MDYw_44c257ed-d142-4441-ae9a-3a31d0b55ab0"
      unitRef="shares">5100000</sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares>
    <sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzMtMy0xLTEtMzY0MDYw_0a71d660-bf8a-47e7-96f9-7abd0e5b86f1"
      unitRef="shares">6100000</sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzQtMS0xLTEtMzY0MDYw_96a1f892-4388-4d76-8268-79571cf56f2b"
      unitRef="shares">1256900000</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzQtMi0xLTEtMzY0MDYw_13fdfe50-8b53-45e7-a157-d4a0e7817605"
      unitRef="shares">1257900000</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90YWJsZTo2MWQ5ODQ4NjU5NDM0YjBjYTFlNzAxMjc4N2JhZjQxOS90YWJsZXJhbmdlOjYxZDk4NDg2NTk0MzRiMGNhMWU3MDEyNzg3YmFmNDE5XzQtMy0xLTEtMzY0MDYw_6c9b5752-f453-4898-b3f4-fa0d2d5ed5ec"
      unitRef="shares">1260100000</ifrs-full:AdjustedWeightedAverageShares>
    <sny:StockOptionsWithNoDilutiveEffect
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwNTg_135319df-eafe-4dbc-ac15-412aaaf3b02e"
      unitRef="shares">600000</sny:StockOptionsWithNoDilutiveEffect>
    <sny:StockOptionsWithNoDilutiveEffect
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzQvZnJhZzpkMmIxMzAzYzUyZWM0MWFkYWQwMmVmYWJiYjE1MWE4Ny90ZXh0cmVnaW9uOmQyYjEzMDNjNTJlYzQxYWRhZDAyZWZhYmJiMTUxYTg3XzUwNTg_6278f938-6f62-4b45-aaad-2e8d279670eb"
      unitRef="shares">600000</sny:StockOptionsWithNoDilutiveEffect>
    <ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82MzcvZnJhZzphZWY0M2FmZThiM2M0NzBmODdlMzE3ZDU4NjYzOTgzNy90ZXh0cmVnaW9uOmFlZjQzYWZlOGIzYzQ3MGY4N2UzMTdkNTg2NjM5ODM3XzE4MA_1bc65263-9950-40e2-9a1b-1fac4222ea70">Non-controlling interestsNon-controlling interests did not represent a material component of Sanofi&#x2019;s consolidated financial statements in the years ended December 31, 2022, 2021 and 2020</ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory>
    <sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NDk_7b0bba59-b6bd-47bc-ac2e-3de98c8b53bc">Debt, cash and cash equivalents and lease liabilities&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.17.1. Debt, cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Changes in Sanofi's financial position during the period were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term debt and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,218&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,250&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,631&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,437&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,983&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,790&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Net debt does not include lease liabilities, which amounted to &#x20ac;2,181 million as of December 31, 2022, &#x20ac;2,108&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; million as of December 31, 2021, and&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x20ac;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;1,163&#160;million as of December 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(see the maturity analysis at Note&#160;D.17.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x201c;Net debt&#x201d; is a non-IFRS financial measure used by management and investors to measure Sanofi&#x2019;s overall net indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Reconciliation of carrying amount to value on redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.167%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Value on redemption&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;br/&gt;to debt&lt;br/&gt;measured&#160;at&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term debt and current portion&lt;br/&gt;of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,218&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,273&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,314&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,703&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,437&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,492&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;a) Principal financing transactions during the year&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the movement in total debt during the period:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash&#160;flows&#160;from&lt;br/&gt;financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-cash items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;New&lt;br/&gt;borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;cash&lt;br/&gt;flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;differences&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reclassification&lt;br/&gt;from&lt;br/&gt;non-current to&lt;br/&gt;current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;items&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term debt and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,250&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,549&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;442&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,218&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) These amounts include unrealized gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the Euro zone.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) These amounts include changes in accrued interest balances, and fair value adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;During 2022, Sanofi carried out a bond issue of &#x20ac;1.5&#160;billion in April as part of its EMTN (Euro Medium Term Note) program, in two tranches:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:7.48pt"&gt;&#x20ac;850&#160;million bearing interest at a fixed annual rate of 0.875% and maturing April&#160;2025; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.61pt"&gt;&#x20ac;650&#160;million bearing interest at a fixed annual rate of 1.250% and maturing April&#160;2029; the amount of interest applicable is contingent on the attainment of a sustainability performance objective, i.e.: the cumulative number of patients (subject to a minimum of 1.5&#160;million) to which Sanofi Global Health has provided essential medicines to treat non-communicable diseases in the 40&#160;poorest countries on the planet between 2022 and 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Three bond issues were redeemed in 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:7.48pt"&gt;&#x20ac;1,000&#160;million issued September&#160;2014 and maturing March&#160;2022, early redeemed on January&#160;10, 2022;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.61pt"&gt;&#x20ac;850&#160;million issued March&#160;2019 and maturing March&#160;2022, early redeemed on February&#160;21, 2022; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;iii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:3.74pt"&gt;&#x20ac;850&#160;million issued September&#160;2016 and maturing September&#160;2022, early redeemed on June&#160;13, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 Sanofi had two&#160;syndicated credit facilities of &#x20ac;4&#160;billion each to provide liquidity for the purposes of current operations, each of them linked to environmental and social indicators. The maturity of one facility has been extended to&#160;December&#160;3, 2023 following the exercise of an extension option in June&#160;2022, and the maturity of the other has been extended to December&#160;6, 2027 following the exercise of an extension option in September&#160;2022. Sanofi does not have any further extension options available for either facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In line with Sanofi's commitment to embed sustainable development in the &#x201c;Play to Win&#x201d; strategy, the two&#160;revolving credit facilities build in an adjustment mechanism that links the credit spread to the attainment of two&#160;sustainable development performance indicators: Sanofi's contribution to polio eradication, and the reduction in Sanofi's carbon footprint.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The tables below show the movement in total debt during prior periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash&#160;flows&#160;from&lt;br/&gt;financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-cash items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;New&lt;br/&gt;borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;cash&lt;br/&gt;flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;differences&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reclassification&lt;br/&gt;from&lt;br/&gt;non-current to&lt;br/&gt;current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;items&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term debt and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,631&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;381&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;291&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,250&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash&#160;flows&#160;from&lt;br/&gt;financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-cash items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;New&lt;br/&gt;borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;cash&lt;br/&gt;flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;differences &lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reclassification&lt;br/&gt;from&lt;br/&gt;non-current to&lt;br/&gt;current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;items&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,285)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term debt and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24,568&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,019&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;282&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,631&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) These amounts include unrealized gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the&#160;Euro zone.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) These amounts include movements in accrued interest and fair value remeasurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;b) Net debt by type, at value on redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;current &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-&lt;br/&gt;current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-&lt;br/&gt;current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bond issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other bank borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bank credit balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,143&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,130&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,273&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,176&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,138&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,314&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,851&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,852&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,703&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,143&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(8,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,492&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,176&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(7,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,857&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Net debt does not include lease liabilities (see the maturity schedule in Note&#160;D.17.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Bond issues carried out by Sanofi under the Euro Medium Term Note (EMTN) program are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Issuer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;ISIN code&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Issue date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Annual&#160;interest&#160;rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0011625433&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0014009KS6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0012146801&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0014009KQ0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0012969038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013143997&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013144003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013201639&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013505104 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013505112&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013324332&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013324340&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013324357&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013324373&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013409844&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013409851&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Bond issues carried out by Sanofi under the public bond issue program (shelf registration statement) registered with the US&#160;Securities and Exchange Commission (SEC) comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Issuer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;ISIN code&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Issue&#160;date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Annual&#160;&lt;br/&gt;interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;($&#160;million)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;US801060AC87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;US801060AD60&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The &#x201c;Other borrowings&#x201d; line mainly comprises participating shares issued between 1983 and 1987, of which 74,996&#160;remain outstanding, with a nominal amount of &#x20ac;11 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In order to manage its liquidity needs for current operations, as of December&#160;31, 2022 Sanofi has:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;a syndicated credit facility of &#x20ac;4&#160;billion, drawable in euros and in US dollars, maturing December&#160;3,&#160;2023 following the exercise of the second extension option in June&#160;2022; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;a syndicated credit facility of &#x20ac;4&#160;billion, drawable in euros and in US dollars, maturing December&#160;6, 2027 following the exercise of the second extension option in September&#160;2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi also has a &#x20ac;6&#160;billion Negotiable European Commercial Paper program in France and a $10&#160;billion Commercial Paper program in the United States. During 2022 only the US program was used, with an average drawdown of $2.3&#160;billion (versus a maximum of&#160;$4.0&#160;billion). As of December&#160;31, 2022, there were no drawdowns under any of those programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The financing in place as of December 31, 2022 at the level of the holding company (which manages most of Sanofi&#x2019;s financing needs centrally) is not subject to any financial covenants, and contains no clauses linking spreads or fees to the credit rating.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;c) Debt by maturity, at value on redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bond issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other bank borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bank credit balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used &lt;br/&gt;to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,273&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,130&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used &lt;br/&gt;to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,492&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(8,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Net debt does not include lease liabilities, which amounted to &#x20ac;2,181&#160;million as of December&#160;31, 2022; &#x20ac;2,108&#160;million as of&#160;December&#160;31, 2021; and&#160;&#x20ac;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;1,163&#160;million as of December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; (see the maturity analysis at Note&#160;D.17.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, the main undrawn confirmed general-purpose credit facilities at holding company level amounted to&#160;&#x20ac;8 billion, half of which expires in 2023 and the other half of which expires in 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, no single counterparty represented more than 6% of Sanofi&#x2019;s undrawn confirmed credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bond issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other bank borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bank credit balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,314&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,138&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,647&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;602&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,751&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,016&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(7,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,647&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;602&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,751&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,016&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bond issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other bank borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bank credit balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,703&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,852&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,830&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,575&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;602&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,756&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,088&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,836&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,575&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;602&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,756&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,088&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;d) Debt by interest rate, at value on redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below splits net debt between fixed and floating rate, and by maturity, as of December 31, 2022. The figures shown are values on redemption, before the effects of derivative instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fixed-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,861&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;16,993&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,868&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% fixed-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;98&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Floating-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;460&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% floating-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,321&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,178&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(3,908)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(8,391)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% floating-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,585&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(8,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi issues debt in two currencies, the euro and the US dollar, and also invests its cash and cash equivalents in those currencies. Sanofi also operates cash pooling arrangements to manage the surplus cash and short-term liquidity needs of foreign subsidiaries located outside the euro zone.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;To optimize the cost of debt or reduce the volatility of debt and manage its exposure to financial foreign exchange risk, Sanofi uses derivative instruments (interest rate swaps, currency swaps, foreign exchange swaps and forward contracts) that alter the fixed/floating rate split and the currency split of its net debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fixed-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;13,944&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,443&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% fixed-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Floating-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,886&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;592&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;950&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% floating-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,273&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,130&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,781)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(4,046)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(5,797)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2,155)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% floating-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,492&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(8,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the fixed/floating rate split of net debt at value on redemption after taking account of derivative instruments as of&#160;December 31, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fixed-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Floating-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,314&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,703&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The weighted average interest rate on debt as of December 31, 2022 was 1.6% before derivative instruments and 2.5% after derivative instruments. Cash and cash equivalents were invested as of December 31, 2022 at an average rate of 3.9% before derivative instruments and 4.0% after derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The projected full-year sensitivity of net debt to interest rate fluctuations for 2023 is as&#160;follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Change in short-term interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Impact&#160;on&#160;pre-tax&#160;net&lt;br/&gt;income&#160;(&#x20ac;&#160;million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Impact&#160;on&#160;pre-tax&lt;br/&gt;income/(expense)&#160;recognized&lt;br/&gt;directly in equity&lt;br/&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+100&#160;bp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+25&#160;bp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;-25&#160;bp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;-100&#160;bp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;e) Debt by currency, at value on redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows net debt by currency at December 31, 2022, before and after derivative instruments contracted to convert the foreign-currency net debt of exposed entities into their functional currency:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Before&#160;derivative&#160;instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;After&#160;derivative&#160;instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,508)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pound sterling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mexican peso&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other currencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,585&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,492&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows net debt by currency at December 31, 2021 and 2020, after derivative instruments contracted to convert the foreign currency net debt of exposed entities into their functional currency:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(669)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other currencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;f) Market value of net debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The market value of Sanofi&#x2019;s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Value on redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The fair value of debt is determined by reference to quoted market prices at the balance sheet date in the case of quoted instruments (level&#160;1 in the IFRS&#160;7 hierarchy, see Note&#160;D.12.), and by reference to the fair value of interest rate and currency derivatives used to manage net debt (level&#160;2 in the IFRS&#160;7 hierarchy, see Note&#160;D.12.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;g) Future contractual cash flows relating to debt and related derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,408&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,206&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;868&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,803&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,184&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,283&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,064&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net cash flows related to derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;209&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;60&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,617&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,230&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;928&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,841&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,215&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,314&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,089&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Future contractual cash flows are shown on the basis of the carrying amount in the balance sheet at the reporting date, without reference to any subsequent management decision that might materially alter the structure of Sanofi&#x2019;s debt or its hedging policy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The tables below show the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt as of December 31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21,728&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,330&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,826&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;791&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,937&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,176&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,668&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net cash flows related to derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21,677&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,271&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,825&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;793&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,939&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,178&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,671&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24,339&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,943&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,019&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,808&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;791&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,937&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,841&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net cash flows related to derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;163&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;135&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;28&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24,502&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,078&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,808&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;791&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,937&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,841&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.17.2. Lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A maturity analysis of lease liabilities as of December 31, 2022, 2021 and 2020 is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Undiscounted future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less than 1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;From 1 to 3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;From 3 to 5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More than 5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Discounting effect&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Total lease liabilities as of December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,181&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;320&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;515&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;436&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,129&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Total lease liabilities as of December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,108&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;314&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;476&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;362&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,184&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Total lease liabilities as of December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,163&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;247&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;357&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;225&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;482&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Lease liabilities as of December&#160;31, 2022 and December&#160;31, 2021 include leases relating to real estate assets located at Cambridge, MA (United States), as described in Note&#160;D.3., which have a lease term of 15 years.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock>
    <sny:DisclosureOfChangesInFinancialPositionTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NDA_b2206ed3-3554-49c4-8e6f-e9ac0e8e78f7">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Changes in Sanofi's financial position during the period were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term debt and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,218&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,250&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,631&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,437&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,983&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,790&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Net debt does not include lease liabilities, which amounted to &#x20ac;2,181 million as of December 31, 2022, &#x20ac;2,108&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; million as of December 31, 2021, and&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x20ac;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;1,163&#160;million as of December 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(see the maturity analysis at Note&#160;D.17.2.).&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfChangesInFinancialPositionTableTextBlock>
    <ifrs-full:LongtermBorrowings
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEtMS0xLTEtMzY0MDYw_9015aba1-9533-41eb-a9f3-5c3b22c4ac05"
      unitRef="eur">14857000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEtMi0xLTEtMzY0MDYw_7cfec027-d23a-4256-8baf-19a13553dee8"
      unitRef="eur">17123000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEtMy0xLTEtMzY0MDYw_393bc6be-91be-40f1-917c-d32209e983ca"
      unitRef="eur">19745000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzItMS0xLTEtMzY0MDYw_0e897f2b-97ad-45e0-831d-00c2045067f1"
      unitRef="eur">4174000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzItMi0xLTEtMzY0MDYw_e9452bee-4ba3-4dc7-9a94-05d48b36dcec"
      unitRef="eur">3183000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzItMy0xLTEtMzY0MDYw_a853510d-71e8-429a-84f9-0203acdc45dc"
      unitRef="eur">2767000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzUtMS0xLTEtMzY0MDYw_bf36b04b-e283-4c81-ba19-2ff93506e1d8"
      unitRef="eur">-187000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzUtMi0xLTEtMzY0MDYw_90f88140-6c0a-46b7-a111-607e31ffc389"
      unitRef="eur">56000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzUtMy0xLTEtMzY0MDYw_ea74365b-5c35-43ae-a1d8-d7873e7202b0"
      unitRef="eur">-119000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <ifrs-full:Borrowings
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzYtMS0xLTEtMzY0MDYw_8401dba6-3835-43ef-ba61-6a06c90c045e"
      unitRef="eur">19218000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzYtMi0xLTEtMzY0MDYw_eb01bfbe-4e22-4819-95be-34e16b3c1bda"
      unitRef="eur">20250000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzYtMy0xLTEtMzY0MDYw_aa188621-5c42-4a72-9453-b502da990748"
      unitRef="eur">22631000000</ifrs-full:Borrowings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzctMS0xLTEtMzY0MDYw_4d7fdc52-7dfa-48c2-87f5-031234999b44"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzctMi0xLTEtMzY0MDYw_6a92f465-8298-419e-8d8b-ec4d28962034"
      unitRef="eur">10098000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzctMy0xLTEtMzY0MDYw_586efd43-d3a1-4ae3-ac49-deefe927104b"
      unitRef="eur">13915000000</ifrs-full:CashAndCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEwLTEtMS0xLTM2NDA2MA_226c2bc4-6c0b-4b12-820f-3aede0604a47"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEwLTItMS0xLTM2NDA2MA_bad73e32-5814-49de-af8d-1d8ba02e0a8b"
      unitRef="eur">169000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzEwLTMtMS0xLTM2NDA2MA_73fedef2-f81f-498a-9e09-36ccaf8f886f"
      unitRef="eur">-74000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzExLTEtMS0xLTM2NDA2MA_e7b4c969-bada-4dc2-b5a7-3563672ef7fd"
      unitRef="eur">6437000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzExLTItMS0xLTM2NDA2MA_b3c8c444-001f-47bd-8be8-fde0cd4ebb98"
      unitRef="eur">9983000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMGQ0ZDUxYmUxNDg0NDI4ODg3MTZkZGI4MTg1MDg1Ni90YWJsZXJhbmdlOmQwZDRkNTFiZTE0ODQ0Mjg4ODcxNmRkYjgxODUwODU2XzExLTMtMS0xLTM2NDA2MA_76d04335-67d3-497e-a9f6-e10f7d987d31"
      unitRef="eur">8790000000</sny:DebtNetOfCashAndCashEquivalents>
    <ifrs-full:LeaseLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzI0OA_b8e77a0b-c18d-4dbc-85e1-81d8f3177f99"
      unitRef="eur">2181000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzI3Nw_d1d52ba2-bea1-468f-a41e-38055b097ad9"
      unitRef="eur">2108000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzMxOA_3c3d855a-863a-4ea4-ab6d-9f7f955c321c"
      unitRef="eur">1163000000</ifrs-full:LeaseLiabilities>
    <sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MjE_bc83a01d-b676-4d1d-8d88-7f42cc206b5e">&lt;div style="margin-bottom:4pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Reconciliation of carrying amount to value on redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.167%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Value on redemption&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Carrying amount at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;br/&gt;to debt&lt;br/&gt;measured&#160;at&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term debt and current portion&lt;br/&gt;of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,218&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,273&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,314&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,703&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,437&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,492&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock>
    <ifrs-full:LongtermBorrowings
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItMS0xLTEtMzY0MDYw_553f7409-219d-4d4c-9a63-1427dc1b54e3"
      unitRef="eur">14857000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="if8cf06b4cc8747228729190e580e0310_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItMi0xLTEtMzY0MDYw_ac8f2587-bfa5-4a4b-adfd-afc766b6e85b"
      unitRef="eur">51000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItMy0xLTEtMzY0MDYw_7dc6aea8-a4a8-4c02-aa8c-3d3380ee1730"
      unitRef="eur">235000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItNC0xLTEtMzY0MDYw_b94c615a-fc69-4411-b817-56fb030f1e53"
      unitRef="eur">15143000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItNS0xLTEtMzY0MDYw_33091410-7555-4380-ab5d-876fdd6e1fbd"
      unitRef="eur">17176000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzItNi0xLTEtMzY0MDYw_54500de2-ff3c-4ddd-ae7e-6d1375847f36"
      unitRef="eur">19794000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtMS0xLTEtMzY0MDYw_d5b15c80-7ac5-46eb-994d-7b055d62f41e"
      unitRef="eur">4174000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="if8cf06b4cc8747228729190e580e0310_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtMi0xLTEtMzY0MDYw_c6ec1e94-da64-494a-b062-1490dddd061c"
      unitRef="eur">0</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtMy0xLTEtMzY0MDYw_e12c7a01-4893-4e28-82f6-cd9c2a3a0640"
      unitRef="eur">4000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtNC0xLTEtMzY0MDYw_8d5d4781-4c23-43ac-aed9-14af61c3bcd8"
      unitRef="eur">4178000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtNS0xLTEtMzY0MDYw_68029c6a-6e1c-4321-9752-15f68dcfbafd"
      unitRef="eur">3183000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzMtNi0xLTEtMzY0MDYw_e879decd-e1f6-43ee-9982-38f122ad7889"
      unitRef="eur">2767000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtMS0xLTEtMzY0MDYw_3b175121-4bcd-4586-810e-d1925912fcea"
      unitRef="eur">-187000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="if8cf06b4cc8747228729190e580e0310_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtMi0xLTEtMzY0MDYw_d1c46244-bf67-4523-a71a-2d75fd36a1b4"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtMy0xLTEtMzY0MDYw_cca3ded6-9c0b-43a6-ab34-9c35ca6386e2"
      unitRef="eur">235000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtNC0xLTEtMzY0MDYw_6e853cf1-36e2-4b9f-970e-2e782cd5570c"
      unitRef="eur">48000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtNS0xLTEtMzY0MDYw_170d94d4-56e2-4e0a-82c7-ef946eb74be8"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzQtNi0xLTEtMzY0MDYw_deff0117-21b9-458c-a358-de267d0c9917"
      unitRef="eur">-142000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <ifrs-full:Borrowings
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtMS0xLTEtMzY0MDYw_3f616b31-31ab-405f-9e82-c93f5d5ef537"
      unitRef="eur">19218000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="if8cf06b4cc8747228729190e580e0310_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtMi0xLTEtMzY0MDYw_fa7db2b1-de65-4666-8ea6-45dbd286dc8d"
      unitRef="eur">51000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtMy0xLTEtMzY0MDYw_8abd6b66-71b8-4184-92bf-87f9832e87ea"
      unitRef="eur">4000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtNC0xLTEtMzY0MDYw_0c7d8518-3593-42a6-b34b-6f0927461f07"
      unitRef="eur">19273000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtNS0xLTEtMzY0MDYw_f7bd72d2-41a5-4f09-ba09-315eebc4581f"
      unitRef="eur">20314000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzUtNi0xLTEtMzY0MDYw_249538b5-227c-4dbd-a6ba-d0e6702b186f"
      unitRef="eur">22703000000</ifrs-full:Borrowings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtMS0xLTEtMzY0MDYw_dc50d0f5-ce0d-44c6-8890-fdacd999776a"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="if8cf06b4cc8747228729190e580e0310_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtMi0xLTEtMzY0MDYw_630ccf6e-9ec1-485c-82f0-7744f4a5e9f4"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtMy0xLTEtMzY0MDYw_5acdc92a-6351-44f7-99d8-12b1166e6337"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtNC0xLTEtMzY0MDYw_577371e3-c301-4331-b1ff-6347d63cdb39"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtNS0xLTEtMzY0MDYw_dac7a3c0-f22a-45d4-8e7c-b296eacb0c3c"
      unitRef="eur">10098000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzYtNi0xLTEtMzY0MDYw_9d22acf3-0d0d-4b38-8a50-f454393cdf88"
      unitRef="eur">13915000000</ifrs-full:CashAndCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctMS0xLTEtMzY0MDYw_b9180c1a-6aee-4a24-9c7f-91fa7eed3775"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="if8cf06b4cc8747228729190e580e0310_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctMi0xLTEtMzY0MDYw_30d5bf9e-9b9d-46ac-9d45-f1e9da4007f5"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctMy0xLTEtMzY0MDYw_785e5e2d-e9e8-4371-9479-f9d72721dfae"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctNC0xLTEtMzY0MDYw_e943e645-af92-4e09-a362-5a73dfa6bf4d"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctNS0xLTEtMzY0MDYw_44d5c143-233e-4384-b5da-6bc15655c474"
      unitRef="eur">169000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzctNi0xLTEtMzY0MDYw_7d7d6dcd-9536-4d31-b05c-71ad52c59139"
      unitRef="eur">-74000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtMS0xLTEtMzY0MDYw_8feaad52-9c4d-4661-8e01-aa6b5b9ee6af"
      unitRef="eur">6437000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="if8cf06b4cc8747228729190e580e0310_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtMi0xLTEtMzY0MDYw_19653435-e9b9-4739-a8b7-e61e7c352742"
      unitRef="eur">51000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i16062e084b99460599219bf6d4ffa60c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtMy0xLTEtMzY0MDYw_a12e3704-f036-4e24-8ac3-8e05a3125a63"
      unitRef="eur">4000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtNC0xLTEtMzY0MDYw_eac25ac3-1643-493d-b331-e4406975bab5"
      unitRef="eur">6492000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtNS0xLTEtMzY0MDYw_e3473a9e-d4cc-45c0-b44f-2981ad39250c"
      unitRef="eur">10047000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3N2FiYTFiYTUwOTY0YTlkYTRkNmY3MzNiYjQ1NzIxYi90YWJsZXJhbmdlOjc3YWJhMWJhNTA5NjRhOWRhNGQ2ZjczM2JiNDU3MjFiXzgtNi0xLTEtMzY0MDYw_630992e5-b732-4d76-b4ac-fec6c3c4c960"
      unitRef="eur">8862000000</sny:DebtNetOfCashAndCashEquivalents>
    <ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MTc_f10b5a11-3a05-4698-b996-41692d680b6a">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the movement in total debt during the period:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash&#160;flows&#160;from&lt;br/&gt;financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-cash items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;New&lt;br/&gt;borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;cash&lt;br/&gt;flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;differences&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reclassification&lt;br/&gt;from&lt;br/&gt;non-current to&lt;br/&gt;current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;items&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term debt and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,250&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,549&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;442&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,218&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) These amounts include unrealized gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the Euro zone.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) These amounts include changes in accrued interest balances, and fair value adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The tables below show the movement in total debt during prior periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash&#160;flows&#160;from&lt;br/&gt;financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-cash items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;New&lt;br/&gt;borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;cash&lt;br/&gt;flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;differences&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reclassification&lt;br/&gt;from&lt;br/&gt;non-current to&lt;br/&gt;current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;items&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term debt and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,631&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;381&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;291&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,250&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash&#160;flows&#160;from&lt;br/&gt;financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-cash items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;New&lt;br/&gt;borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;cash&lt;br/&gt;flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;differences &lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reclassification&lt;br/&gt;from&lt;br/&gt;non-current to&lt;br/&gt;current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;items&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,285)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term debt and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24,568&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,019&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;282&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,631&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) These amounts include unrealized gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the&#160;Euro zone.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) These amounts include movements in accrued interest and fair value remeasurements.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory>
    <ifrs-full:Borrowings
      contextRef="i10309ee26b644653875a9ef939afe780_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItMS0xLTEtMzY0MDYw_c6b71bbb-a9e1-4446-bfa3-2b9bc27a5e6b"
      unitRef="eur">17123000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItMi0xLTEtMzY0MDYw_7f970ed1-721f-469d-aec0-3fbfa6ad78e1"
      unitRef="eur">11000000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItMy0xLTEtMzY0MDYw_61d137e1-e768-4d8e-bd76-01c4ec1e4b57"
      unitRef="eur">1549000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItNC0xLTEtMzY0MDYw_eb237c39-4c49-4d71-a7d6-0ba2bd2a66b3"
      unitRef="eur">0</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItNS0xLTEtMzY0MDYw_c38df5e5-7fd3-45d9-b377-9995699d2487"
      unitRef="eur">56000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="i821c164ee86d4851828efe3ab80b5250_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItNi0xLTEtMzY0MDYw_d8add52c-0cac-4ce6-9b9d-1ca5242951ab"
      unitRef="eur">-3632000000</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="ic2786fc862fd4e6b828e206f948d0719_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItNy0xLTEtMzY0MDYw_0a60828b-866d-4205-b86d-8992c1d87bc2"
      unitRef="eur">-228000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="i821c164ee86d4851828efe3ab80b5250_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzItOC0xLTEtMzY0MDYw_6b1b6200-56bf-4093-ad5f-a32b9d48a635"
      unitRef="eur">14857000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="ib2ad2e7b83694c51aa8ec5759b996a3a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtMS0xLTEtMzY0MDYw_92f7e6f9-29c3-40de-b212-5a3b6028a976"
      unitRef="eur">3183000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtMi0xLTEtMzY0MDYw_e6282f50-e25c-4482-b443-df46535c08da"
      unitRef="eur">2707000000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtMy0xLTEtMzY0MDYw_690fbc3b-42bf-4f02-bd24-f0d88645b406"
      unitRef="eur">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtNC0xLTEtMzY0MDYw_ecce8c1c-2d58-4f3e-bd3c-58729fc302d3"
      unitRef="eur">43000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtNS0xLTEtMzY0MDYw_b52c86d5-4934-4943-9321-91ed86f60d22"
      unitRef="eur">20000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="i610ac40ea4444926b8ca4fc00340297b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtNi0xLTEtMzY0MDYw_fdde88c7-d3dd-4b13-90f9-466784ecbddf"
      unitRef="eur">3632000000</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="ie663a4903b0a4e3a995677c46569cdae_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtNy0xLTEtMzY0MDYw_7e123edd-5fbf-4445-9210-add6955f5b99"
      unitRef="eur">3000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="i610ac40ea4444926b8ca4fc00340297b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzMtOC0xLTEtMzY0MDYw_ed1e31a9-bb49-40f7-b24e-8b8e5054c5cb"
      unitRef="eur">4174000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i7460dad569314917928c609f43188c3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtMS0xLTEtMzY0MDYw_be1314a0-bdda-40e5-9c23-5640651cd666"
      unitRef="eur">-56000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtMi0xLTEtMzY0MDYw_a7ae6c84-1cff-4b37-b178-f07f0d2285a5"
      unitRef="eur">0</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtMy0xLTEtMzY0MDYw_70483524-8abd-4039-a5ea-3d10da6e84dd"
      unitRef="eur">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtNC0xLTEtMzY0MDYw_60d951b4-3133-4fd3-ab06-a8db93d6daae"
      unitRef="eur">-373000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtNS0xLTEtMzY0MDYw_036a4712-0ff8-4c22-a909-8c0d5a31e4fd"
      unitRef="eur">366000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="i6d1e362d6a2340b88d664b8d7109b86e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtNi0xLTEtMzY0MDYw_90e98eaf-4892-486c-a3ce-14f0debb777e"
      unitRef="eur">7000000</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="i748e10744fe04b3fa1b02bd10e6e8977_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtNy0xLTEtMzY0MDYw_4325e992-f44e-4e29-9395-d9d89cb5ab8c"
      unitRef="eur">243000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="i6d1e362d6a2340b88d664b8d7109b86e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzQtOC0xLTEtMzY0MDYw_c1246bd0-ad69-4ea4-92ab-08e673788245"
      unitRef="eur">187000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtMS0xLTEtMzY0MDYw_c1f2b1c1-c057-4295-95a7-e1240e97e42a"
      unitRef="eur">20250000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtMi0xLTEtMzY0MDYw_c2464cea-b413-4146-a80f-5d8ca0517c62"
      unitRef="eur">2718000000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtMy0xLTEtMzY0MDYw_288328d3-a5c7-4e9e-ab19-1005fda8b28f"
      unitRef="eur">1549000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtNC0xLTEtMzY0MDYw_dff45f31-5d9a-4546-ad60-617a25ea417c"
      unitRef="eur">-330000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtNS0xLTEtMzY0MDYw_f9f95d60-0785-4b92-a6e2-358f5896c331"
      unitRef="eur">442000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtNi0xLTEtMzY0MDYw_c4cbf72d-1861-4acc-89e5-1885e68993b7"
      unitRef="eur">7000000</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtNy0xLTEtMzY0MDYw_cf922671-81ae-42f4-82fe-d7900037d4a5"
      unitRef="eur">18000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo1YTY2MmMzNTBiMTY0MDQ0YmFhMmIyYWY4YzkxYmEyOC90YWJsZXJhbmdlOjVhNjYyYzM1MGIxNjQwNDRiYWEyYjJhZjhjOTFiYTI4XzUtOC0xLTEtMzY0MDYw_47567617-764e-4a76-af24-fbbd571cf427"
      unitRef="eur">19218000000</ifrs-full:Borrowings>
    <ifrs-full:NotionalAmount
      contextRef="id2a418ab95d54008afcb49dc0cee1dcb_I20220430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMDUx_f0f944ac-14a6-4805-a6bf-bfb84c2f9779"
      unitRef="eur">1500000000</ifrs-full:NotionalAmount>
    <sny:NumberOfTranches
      contextRef="id2a418ab95d54008afcb49dc0cee1dcb_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTY0_75eb8824-e7e9-42f4-a154-68d959b9d04f"
      unitRef="tranche">2</sny:NumberOfTranches>
    <ifrs-full:NotionalAmount
      contextRef="i9b7d742e8ca14e02bbba4212b5f9df28_I20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMDY5_355208c4-acf4-4832-9412-3ce3758dc5de"
      unitRef="eur">850000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i9b7d742e8ca14e02bbba4212b5f9df28_I20220430"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwNDczMTM5Njg2MzY_43b30086-6865-43cd-8c59-3f8541e839b7"
      unitRef="number">0.00875</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i63eaa2695fc84ccdbf9aa943ad509de8_I20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMDg3_f7bd5c80-e512-4681-ad20-a8f9bd1b27f7"
      unitRef="eur">650000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i63eaa2695fc84ccdbf9aa943ad509de8_I20220430"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwNDczMTM5Njg2NDk_01bdf4d3-6b40-40a2-92fc-31cef4178fe0"
      unitRef="number">0.01250</ifrs-full:BorrowingsInterestRate>
    <sny:PerformanceObjectiveMinimumNumberOfPatients
      contextRef="i63eaa2695fc84ccdbf9aa943ad509de8_I20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMDM0_987fa52c-d6bc-4d2d-8557-eef783fc88e9"
      unitRef="patient">1500000</sny:PerformanceObjectiveMinimumNumberOfPatients>
    <sny:PerformanceObjectiveNumberOfCountries
      contextRef="i63eaa2695fc84ccdbf9aa943ad509de8_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwNDczMTM5Njg2ODQ_dc96e5c7-887a-47bb-8b95-b2e128df1a2f"
      unitRef="country">40</sny:PerformanceObjectiveNumberOfCountries>
    <sny:NumberOfBondIssuesRedeemed
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTcy_effe5a0d-72ab-4564-a4a8-96269eeadd9f"
      unitRef="bond">3</sny:NumberOfBondIssuesRedeemed>
    <ifrs-full:NotionalAmount
      contextRef="if33294fda4e34c3097e959eb6003c057_I20140930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTAy_4a838fcd-6484-4cc5-a57b-e65ed8c812a6"
      unitRef="eur">1000000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="ie9fabfa6d35447128880bf4259339f29_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTE5_8b2a4fbd-78e8-41f9-8be8-eea4dec5b45f"
      unitRef="eur">850000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="i119b8f75feb74fbeabff0df24440bb94_I20160930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTM3_96d3eb21-6693-4df4-b1a9-5f8d4afcbfe1"
      unitRef="eur">850000000</ifrs-full:NotionalAmount>
    <sny:NumberOfCreditFacilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwNDczMTM5Njg2ODI_c13d6d0a-11d4-482b-8a33-2595e8f7f699"
      unitRef="credit_facility">2</sny:NumberOfCreditFacilities>
    <ifrs-full:NotionalAmount
      contextRef="i2d6f40c3d9f341be8626293e79a24136_I20221231"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTUz_1647124c-739c-4cef-a216-e702780ff746"
      unitRef="eur">4000000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="i3c67233c3b0e4833a40cd61543f883b4_I20221231"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzgzMDEzMTI3OTEzMTUz_2716150c-fe51-4e05-b156-75c95b64f1ce"
      unitRef="eur">4000000000</ifrs-full:NotionalAmount>
    <sny:NumberOfCreditFacilities
      contextRef="if95b13db708a44338258d8529b0ec6c2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzE4OTg_76d0ff0f-2869-456e-9078-cfb70c5e36f7"
      unitRef="credit_facility">2</sny:NumberOfCreditFacilities>
    <sny:NumberOfSustainableDevelopmentPerformanceIndicators
      contextRef="if95b13db708a44338258d8529b0ec6c2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzIwMTI_bd87b97b-c214-49ea-bf7d-cdf54a45301b"
      unitRef="performance_indicator">2</sny:NumberOfSustainableDevelopmentPerformanceIndicators>
    <ifrs-full:Borrowings
      contextRef="i63e6bd162fc34a0b91feb5978e757f6a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItMS0xLTEtMzY0MDYw_e1e6a850-6136-4d67-a052-c1cfccdead76"
      unitRef="eur">19745000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="i02963f181d634b7694e608faefff4b63_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItMi0xLTEtMzY0MDYw_bc425201-2f0c-4f35-9726-c91fa96eae61"
      unitRef="eur">38000000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="i02963f181d634b7694e608faefff4b63_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItMy0xLTEtMzY0MDYw_69ea1178-f52b-4b9b-a84d-afaef137e3c0"
      unitRef="eur">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="i02963f181d634b7694e608faefff4b63_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItNC0xLTEtMzY0MDYw_e7d9abe9-badb-4673-87b3-893f7e2ac83d"
      unitRef="eur">0</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="i02963f181d634b7694e608faefff4b63_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItNS0xLTEtMzY0MDYw_7573906e-8609-44f0-8902-420f20bbb830"
      unitRef="eur">124000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="i10309ee26b644653875a9ef939afe780_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItNi0xLTEtMzY0MDYw_2ee40688-b4dc-4389-92c5-9bb0ed3a5c35"
      unitRef="eur">-2704000000</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="i02963f181d634b7694e608faefff4b63_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItNy0xLTEtMzY0MDYw_a2b4c185-768e-4021-bd1b-f31fed06eb7b"
      unitRef="eur">-4000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="i10309ee26b644653875a9ef939afe780_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzItOC0xLTEtMzY0MDYw_7a57c320-9da7-4b19-a3c8-7f48945b3cd0"
      unitRef="eur">17123000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i5d73cdea800649ee9ff0d7d7f47de6b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtMS0xLTEtMzY0MDYw_e77e0337-9594-4ccb-a0a0-63a98632663b"
      unitRef="eur">2767000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtMi0xLTEtMzY0MDYw_1cc7d484-1011-460e-85ee-a80c267d1d53"
      unitRef="eur">2203000000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtMy0xLTEtMzY0MDYw_560d44cd-8bed-46cc-9222-187d903841f0"
      unitRef="eur">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtNC0xLTEtMzY0MDYw_548c2574-ab86-447e-b081-7c56d48181b2"
      unitRef="eur">-615000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtNS0xLTEtMzY0MDYw_bfcad15c-526b-4412-91f1-25551eddad3b"
      unitRef="eur">248000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="ib2ad2e7b83694c51aa8ec5759b996a3a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtNi0xLTEtMzY0MDYw_6399bc36-9f91-4406-8a74-c5d3a5ed27f6"
      unitRef="eur">2704000000</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="i13ea4121a99c4fd7848e225d536257cb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtNy0xLTEtMzY0MDYw_9a22af56-8a29-47c6-82ca-6f61c56b9181"
      unitRef="eur">282000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="ib2ad2e7b83694c51aa8ec5759b996a3a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzMtOC0xLTEtMzY0MDYw_e78d182e-64ac-4003-aca6-47faabd58466"
      unitRef="eur">3183000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i98ecbb3b780b4531b583aa429548a360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtMS0xLTEtMzY0MDYw_7779e944-0d36-4ac7-9269-a27efaf63996"
      unitRef="eur">119000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="i234aab96cb044325aa2b96beec593299_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtMi0xLTEtMzY0MDYw_b96907e7-d4e3-4d06-8ba6-160880dd86af"
      unitRef="eur">0</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="i234aab96cb044325aa2b96beec593299_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtMy0xLTEtMzY0MDYw_be75bb20-ef92-400e-93ef-731989b3f5ec"
      unitRef="eur">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="i234aab96cb044325aa2b96beec593299_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtNC0xLTEtMzY0MDYw_bdf8355a-3ff0-4110-86e1-e23511979676"
      unitRef="eur">-197000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="i234aab96cb044325aa2b96beec593299_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtNS0xLTEtMzY0MDYw_e54d720e-4438-4ef1-ab21-7097ea651d51"
      unitRef="eur">9000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="i7460dad569314917928c609f43188c3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtNi0xLTEtMzY0MDYw_95cba3ae-110e-4873-8b76-942d3302e189"
      unitRef="eur">0</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="i234aab96cb044325aa2b96beec593299_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtNy0xLTEtMzY0MDYw_d142bbcf-1c46-4c04-9770-58a936528e8d"
      unitRef="eur">13000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="i7460dad569314917928c609f43188c3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzQtOC0xLTEtMzY0MDYw_f2b59f3a-0ae7-4745-bb2f-688a0b89176a"
      unitRef="eur">-56000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtMS0xLTEtMzY0MDYw_96b3453d-b539-43ef-9d3b-6caec4756657"
      unitRef="eur">22631000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtMi0xLTEtMzY0MDYw_d71ee087-c18b-4a34-b62f-d88e123793ae"
      unitRef="eur">2241000000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtMy0xLTEtMzY0MDYw_2a2ea1a3-f98c-4e94-b7ed-9e6c623d8f9b"
      unitRef="eur">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtNC0xLTEtMzY0MDYw_1382b20e-d8d0-4123-9216-7518e18b547e"
      unitRef="eur">-812000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtNS0xLTEtMzY0MDYw_cb72bb50-0899-4bec-bb17-dff1c9359e93"
      unitRef="eur">381000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtNi0xLTEtMzY0MDYw_c811f5cf-278a-4d53-bde7-869dcf83ff08"
      unitRef="eur">0</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtNy0xLTEtMzY0MDYw_f324c65e-5569-4c78-9e9e-6e555d24ca54"
      unitRef="eur">291000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpkMDg3MzQxYmJlZTA0NDEyYjRiMzRhZjRlNGQ1NzVhZi90YWJsZXJhbmdlOmQwODczNDFiYmVlMDQ0MTJiNGIzNGFmNGU0ZDU3NWFmXzUtOC0xLTEtMzY0MDYw_ad2efe85-565a-40fd-bf98-b7d5521e1ed5"
      unitRef="eur">20250000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i655df7026f214593b7b2e1587e041a19_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItMS0xLTEtMzY0MDYw_f67a17cd-215a-4cdb-87af-d4c23ed5dde7"
      unitRef="eur">20131000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItMi0xLTEtMzY0MDYw_f0155db5-6a0a-40f7-a21c-06d1c9aaf624"
      unitRef="eur">0</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItMy0xLTEtMzY0MDYw_c12b53a9-1d36-4343-959b-674668c7bbd0"
      unitRef="eur">2019000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItNC0xLTEtMzY0MDYw_684539d6-b814-4165-a20f-442a5bd155b7"
      unitRef="eur">0</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItNS0xLTEtMzY0MDYw_d205687c-cda5-4805-a82e-68f0988dda45"
      unitRef="eur">-152000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="i63e6bd162fc34a0b91feb5978e757f6a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItNi0xLTEtMzY0MDYw_f01eddab-8b82-4d81-bb8d-b42fee3928ee"
      unitRef="eur">-2285000000</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="i1adffa39b0664e39a204361b14240fc4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItNy0xLTEtMzY0MDYw_c167dacf-61ef-47a1-a6d8-3ecd37c82f59"
      unitRef="eur">32000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="i63e6bd162fc34a0b91feb5978e757f6a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzItOC0xLTEtMzY0MDYw_f125bf33-012e-4250-8b62-38a1cbbb8ff7"
      unitRef="eur">19745000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="ie7c961701531461c8f912e9bbcf2d37f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtMS0xLTEtMzY0MDYw_e1a40089-80ce-4735-8d8b-d4b06ea796ca"
      unitRef="eur">4554000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtMi0xLTEtMzY0MDYw_e78baa08-c494-4482-a699-5b70776518b2"
      unitRef="eur">3952000000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtMy0xLTEtMzY0MDYw_f08dac6f-51a0-4997-8051-c78786b62115"
      unitRef="eur">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtNC0xLTEtMzY0MDYw_bc294136-de8d-4584-be66-41e137d2d95d"
      unitRef="eur">86000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtNS0xLTEtMzY0MDYw_dadaf89b-3a44-41ab-b3b0-22fdbf6571d4"
      unitRef="eur">-219000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="i5d73cdea800649ee9ff0d7d7f47de6b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtNi0xLTEtMzY0MDYw_9ccc6e55-de20-498f-bdab-e848edf9653d"
      unitRef="eur">2285000000</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="iefc2aa57ece845d58d6ca47a2a162ed4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtNy0xLTEtMzY0MDYw_72742048-546a-433f-b26b-d8f7be56f1d3"
      unitRef="eur">13000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="i5d73cdea800649ee9ff0d7d7f47de6b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzMtOC0xLTEtMzY0MDYw_699f871e-39b0-4b54-8af2-0418e0c27dfe"
      unitRef="eur">2767000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="icf2f817c4f5c4ccb9efc1f90f92e9aac_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtMS0xLTEtMzY0MDYw_daece9f0-22bf-46f2-8e10-4c68229aad0c"
      unitRef="eur">-117000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtMi0xLTEtMzY0MDYw_c3f5518c-27ec-43c6-bfdb-d90642524a8a"
      unitRef="eur">0</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtMy0xLTEtMzY0MDYw_2344b60c-11ea-4543-9cff-63e81c3bb5d9"
      unitRef="eur">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtNC0xLTEtMzY0MDYw_5e23db0b-b5c8-4021-a371-38f58af4cf75"
      unitRef="eur">196000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtNS0xLTEtMzY0MDYw_40386945-5db6-4a39-a57b-43565b344080"
      unitRef="eur">-14000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="i98ecbb3b780b4531b583aa429548a360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtNi0xLTEtMzY0MDYw_8888b535-2348-4821-a5ff-c2d6f22cbca5"
      unitRef="eur">0</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="if999fc197dcb4ab4a299360f27ef9085_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtNy0xLTEtMzY0MDYw_95252c75-63f8-48ea-a405-23c983751a3b"
      unitRef="eur">54000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="i98ecbb3b780b4531b583aa429548a360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzQtOC0xLTEtMzY0MDYw_b389c8ca-0ea3-464f-943a-ad14ec810ffb"
      unitRef="eur">119000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtMS0xLTEtMzY0MDYw_4f428d07-ccdf-4473-82be-84cd68d19a67"
      unitRef="eur">24568000000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtMi0xLTEtMzY0MDYw_0fc08320-b098-49d1-ac93-1b03c1bf60fc"
      unitRef="eur">3952000000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtMy0xLTEtMzY0MDYw_fe1e2365-d5bb-4aa5-b6d4-1022e5b6e26b"
      unitRef="eur">2019000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtNC0xLTEtMzY0MDYw_9b7bf689-257e-492f-86de-edd45e39dd85"
      unitRef="eur">282000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <sny:ForeignCurrencyTranslationDifferences
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtNS0xLTEtMzY0MDYw_a6a34187-c441-473f-9758-b82fe6e1a514"
      unitRef="eur">-385000000</sny:ForeignCurrencyTranslationDifferences>
    <sny:ReclassificationFromNonCurrentToCurrent
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtNi0xLTEtMzY0MDYw_88b4d46b-3e6f-42b6-98f4-c1988b941116"
      unitRef="eur">0</sny:ReclassificationFromNonCurrentToCurrent>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtNy0xLTEtMzY0MDYw_7d3d2a77-0735-4aff-bd41-4a5652934155"
      unitRef="eur">99000000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:Borrowings
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo5ZWQ0ZTBiNzVkMTY0MWE5Yjc3ZDBmNWY1YTk4NzRiYy90YWJsZXJhbmdlOjllZDRlMGI3NWQxNjQxYTliNzdkMGY1ZjVhOTg3NGJjXzUtOC0xLTEtMzY0MDYw_4350382e-636f-4918-bada-1fbaf11e2ced"
      unitRef="eur">22631000000</ifrs-full:Borrowings>
    <sny:DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0Mjg_54c430ac-40e2-427b-9c0e-753f4bbaba2e">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;current &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-&lt;br/&gt;current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-&lt;br/&gt;current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bond issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other bank borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bank credit balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,143&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,130&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,273&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,176&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,138&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,314&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,851&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,852&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,703&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,143&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(8,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,492&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,176&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(7,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,857&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Net debt does not include lease liabilities (see the maturity schedule in Note&#160;D.17.2.).&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock>
    <ifrs-full:BondsIssued
      contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItMS0xLTEtMzY0MDYw_b7c83e4e-3a2a-44c7-b5a0-6f526771cc6d"
      unitRef="eur">15044000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItMi0xLTEtMzY0MDYw_51ab703e-71f7-4fc5-b6b2-5ad3b316a7a5"
      unitRef="eur">3817000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItMy0xLTEtMzY0MDYw_db767b6f-cf5f-4130-9771-23efda8944b6"
      unitRef="eur">18861000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItNC0xLTEtMzY0MDYw_2b052424-5a64-4b9f-9bfc-4983780d8acc"
      unitRef="eur">17118000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItNS0xLTEtMzY0MDYw_fef0604d-ab53-43b0-8c57-54ec72cfc786"
      unitRef="eur">2828000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItNi0xLTEtMzY0MDYw_608c83ea-ae05-47dd-bc1f-c5554745eeb3"
      unitRef="eur">19946000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i8aae788d334a48228c148b2c1872c556_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItNy0xLTEtMzY0MDYw_ffff1c2e-6b1f-4f99-9100-579667a83789"
      unitRef="eur">19698000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItOC0xLTEtMzY0MDYw_f954ad88-a19d-4324-b469-e7108571f10f"
      unitRef="eur">2280000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzItOS0xLTEtMzY0MDYw_8d945110-4791-4346-9a6a-4c439550f8d3"
      unitRef="eur">21978000000</ifrs-full:BondsIssued>
    <sny:OtherBankBorrowings
      contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtMS0xLTEtMzY0MDYw_55846f49-34ef-4605-b871-62ed02f2274a"
      unitRef="eur">99000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtMi0xLTEtMzY0MDYw_0a87fcb0-e7f8-46fd-bc3d-9a1424351e39"
      unitRef="eur">187000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtMy0xLTEtMzY0MDYw_78eec03e-600e-4425-aadc-a9a669f8f101"
      unitRef="eur">286000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtNC0xLTEtMzY0MDYw_5d4cd030-57f4-4768-b8b9-cbeb6c2f08d5"
      unitRef="eur">21000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtNS0xLTEtMzY0MDYw_6bf2926e-2ddf-47bf-97f2-3a8e3d430bea"
      unitRef="eur">163000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtNi0xLTEtMzY0MDYw_1d5de94f-b599-4302-9721-96e0aeab6ec7"
      unitRef="eur">184000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i8aae788d334a48228c148b2c1872c556_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtNy0xLTEtMzY0MDYw_3cde9e8d-4690-44cf-ad25-cd3e55ee06b0"
      unitRef="eur">96000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtOC0xLTEtMzY0MDYw_917961d6-84c3-4d14-8a68-15fedde78684"
      unitRef="eur">200000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzMtOS0xLTEtMzY0MDYw_ed8da3c2-c5fd-4d31-9463-270582cae86b"
      unitRef="eur">296000000</sny:OtherBankBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtMS0xLTEtMzY0MDYw_b7bacf8a-8b8e-47a2-a93f-80ab95ecf0a8"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtMi0xLTEtMzY0MDYw_0c111266-0b15-4105-8f58-54a656ce5b1a"
      unitRef="eur">6000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtMy0xLTEtMzY0MDYw_72ed17d9-ebcb-4ae2-a598-2e1f4467a12c"
      unitRef="eur">6000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtNC0xLTEtMzY0MDYw_57dfb632-05b5-4227-be96-63016b3ad7db"
      unitRef="eur">37000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtNS0xLTEtMzY0MDYw_e13f2d4a-3837-47a5-845b-353623ff9047"
      unitRef="eur">3000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtNi0xLTEtMzY0MDYw_c0bd0000-1fb9-4e62-b7af-b9c8391a7f7b"
      unitRef="eur">40000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i8aae788d334a48228c148b2c1872c556_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtNy0xLTEtMzY0MDYw_e9b964e1-efcb-4535-88af-9881d1ebedbf"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtOC0xLTEtMzY0MDYw_6177f6fb-c5ec-4eba-9ff7-fc53b7908540"
      unitRef="eur">2000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzQtOS0xLTEtMzY0MDYw_d3b5925d-4340-4675-b195-83eead03c099"
      unitRef="eur">2000000</ifrs-full:OtherBorrowings>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtMS0xLTEtMzY0MDYw_1d3f7429-eabf-4526-86e3-233edf94dac3"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtMi0xLTEtMzY0MDYw_caf27dbb-5b32-48ef-8c7c-3825aa0ad350"
      unitRef="eur">168000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtMy0xLTEtMzY0MDYw_7ccc4617-95bb-491a-b5c7-82b6f0407f1c"
      unitRef="eur">168000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtNC0xLTEtMzY0MDYw_52c0220e-05ac-4a7d-a728-5675ca26cb73"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtNS0xLTEtMzY0MDYw_4641113a-edca-4ecd-960d-17db15fdbda0"
      unitRef="eur">189000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtNi0xLTEtMzY0MDYw_164d8577-989e-48a6-8840-89dd9716fd9f"
      unitRef="eur">189000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i8aae788d334a48228c148b2c1872c556_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtNy0xLTEtMzY0MDYw_6c964dfd-bc28-439f-8bc8-59bd181cd98c"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtOC0xLTEtMzY0MDYw_fd31f6d8-45df-45fd-985c-6cbcc9f36af4"
      unitRef="eur">285000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzUtOS0xLTEtMzY0MDYw_fd8a011b-cc82-43fd-b44f-e8d98614d6e8"
      unitRef="eur">285000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtMS0xLTEtMzY0MDYw_f6f8d778-f8ce-486b-8125-aade0619c5dd"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtMi0xLTEtMzY0MDYw_3e91093b-8eb2-4a80-97be-c8e05a664622"
      unitRef="eur">48000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtMy0xLTEtMzY0MDYw_93fbc22c-2dc3-4e7c-b497-146b81564e66"
      unitRef="eur">48000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtNC0xLTEtMzY0MDYw_1697c42a-d8b5-467a-b04f-13c5046459ab"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtNS0xLTEtMzY0MDYw_1a31902f-3a62-4ceb-9bfb-c26565122db5"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtNi0xLTEtMzY0MDYw_dfb2b536-efa6-4eae-a792-a8ea3c8430bc"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i8aae788d334a48228c148b2c1872c556_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtNy0xLTEtMzY0MDYw_c677b9c1-1a9f-4b71-8c48-274937d99e51"
      unitRef="eur">-57000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtOC0xLTEtMzY0MDYw_79255d73-2a5a-4dd6-9e5d-d35fee7176a3"
      unitRef="eur">-85000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzYtOS0xLTEtMzY0MDYw_627e1d58-081d-41fa-81d3-2a4f331cfa92"
      unitRef="eur">-142000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <ifrs-full:Borrowings
      contextRef="i2247b882007d40f5aa3b115073c4c840_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctMS0xLTEtMzY0MDYw_17635627-95d6-4a84-b10c-c1ed705da7ef"
      unitRef="eur">15143000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="idb8cd7971d4e413399ac7063abbb76f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctMi0xLTEtMzY0MDYw_3d657d26-9109-42ce-8e35-7ce55b5fcfb9"
      unitRef="eur">4130000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctMy0xLTEtMzY0MDYw_ae0fd05c-64e1-4ab4-bcf8-bec1fced4382"
      unitRef="eur">19273000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i6a5299283064409797a6cbcb77b3b87f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctNC0xLTEtMzY0MDYw_1712cadc-8655-415a-885e-105cbc747636"
      unitRef="eur">17176000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="ic5d7fb6953864b25b91382e68b89172f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctNS0xLTEtMzY0MDYw_75051dc0-85f9-44a7-a643-19207375a581"
      unitRef="eur">3138000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctNi0xLTEtMzY0MDYw_13699f8d-c2da-41ad-ba57-b26b3a4113c1"
      unitRef="eur">20314000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i8aae788d334a48228c148b2c1872c556_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctNy0xLTEtMzY0MDYw_9693f25f-dbd2-4654-a9c2-d498f9aefeb4"
      unitRef="eur">19851000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i70a0c7eafe734caf82992697ac0ae048_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctOC0xLTEtMzY0MDYw_eb1aa707-91e3-4088-85be-bef684779437"
      unitRef="eur">2852000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzctOS0xLTEtMzY0MDYw_85a283db-c9ba-4bf2-a8d9-e325ba03ebe7"
      unitRef="eur">22703000000</ifrs-full:Borrowings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="ifdf61719dfa64d609696094dbfb37080_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtMS0xLTEtMzY0MDYw_b1a7be3c-d47d-4f72-9ab4-85fb8548f0a0"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="id85f695673f24baba6ff5f3c480383e8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtMi0xLTEtMzY0MDYw_2a439fbf-baae-4582-97c1-27bddee16f11"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtMy0xLTEtMzY0MDYw_b8999b10-5c51-4326-8a37-4191d747db10"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i00f6bb1b41d7431b8ba45da9f097bcd9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtNC0xLTEtMzY0MDYw_0f4c85dd-0613-4b63-a885-a675b87822a2"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i607a722971b34cabb5fbb67804411532_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtNS0xLTEtMzY0MDYw_a316c02e-6178-4dd6-aadb-69297dd9c0f1"
      unitRef="eur">10098000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtNi0xLTEtMzY0MDYw_fdee9727-7bd0-498b-af01-8b59ea45c792"
      unitRef="eur">10098000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i023658cb94d842df8f9033585b3df0f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtNy0xLTEtMzY0MDYw_f660d87a-c9f1-4f11-8715-e0c6d4f51328"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i9db61024b8a64a5b8c29aec2980c480c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtOC0xLTEtMzY0MDYw_b5e32099-7948-41f4-aa7b-9ce3bfc3135f"
      unitRef="eur">13915000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzgtOS0xLTEtMzY0MDYw_f1ec94dd-2bdf-45f4-b76d-31474892ffef"
      unitRef="eur">13915000000</ifrs-full:CashAndCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="ifdf61719dfa64d609696094dbfb37080_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktMS0xLTEtMzY0MDYw_58b2efe4-4d9b-4381-9eae-1f2c23d6e4cf"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="id85f695673f24baba6ff5f3c480383e8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktMi0xLTEtMzY0MDYw_a4e674ab-4f29-4b91-9d06-8f308240ecb6"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktMy0xLTEtMzY0MDYw_63dfe671-b3f4-46e1-a287-a58a5dcc26c0"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i00f6bb1b41d7431b8ba45da9f097bcd9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktNC0xLTEtMzY0MDYw_d09d70c2-a574-462e-9bde-7e2b5ba3f198"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i607a722971b34cabb5fbb67804411532_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktNS0xLTEtMzY0MDYw_0e01ec02-bb83-4f0d-83cc-e85f7bb56948"
      unitRef="eur">169000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktNi0xLTEtMzY0MDYw_f7a9b51e-2203-4a55-a3f5-215758368d2a"
      unitRef="eur">169000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i023658cb94d842df8f9033585b3df0f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktNy0xLTEtMzY0MDYw_8e7310fb-95da-4dea-9318-ca00704d9e07"
      unitRef="eur">-6000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i9db61024b8a64a5b8c29aec2980c480c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktOC0xLTEtMzY0MDYw_0c6b6429-0178-4a83-9687-e4b0760ea5ed"
      unitRef="eur">-68000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzktOS0xLTEtMzY0MDYw_8996642b-89f1-4d91-a145-e6c32783a9b3"
      unitRef="eur">-74000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ifdf61719dfa64d609696094dbfb37080_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTEtMS0xLTM2NDA2MA_4699028a-4ea6-41d3-9f44-6c00665dcea8"
      unitRef="eur">15143000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="id85f695673f24baba6ff5f3c480383e8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTItMS0xLTM2NDA2MA_fe8b58d7-bbb3-4264-8c15-45c3718af3e2"
      unitRef="eur">-8651000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTMtMS0xLTM2NDA2MA_f5b13b10-929b-4807-a40e-a2a0a8a71558"
      unitRef="eur">6492000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i00f6bb1b41d7431b8ba45da9f097bcd9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTQtMS0xLTM2NDA2MA_2104946c-be3c-476a-8e72-42053bf509a6"
      unitRef="eur">17176000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i607a722971b34cabb5fbb67804411532_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTUtMS0xLTM2NDA2MA_b2e7ff7b-c0c9-4129-b302-aa46de322a60"
      unitRef="eur">-7129000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTYtMS0xLTM2NDA2MA_1de6edc8-2530-4b7c-b0a3-9ec65f6244a5"
      unitRef="eur">10047000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i023658cb94d842df8f9033585b3df0f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTctMS0xLTM2NDA2MA_06c889d3-e59f-4b1b-9608-db917f7e0768"
      unitRef="eur">19857000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i9db61024b8a64a5b8c29aec2980c480c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTgtMS0xLTM2NDA2MA_46876bdf-212e-4856-9359-6150ea7b108d"
      unitRef="eur">-10995000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MDE5OTNkNTViMTY0NDYwOWVlMTQxYTcwNjkxODA0Ny90YWJsZXJhbmdlOjgwMTk5M2Q1NWIxNjQ0NjA5ZWUxNDFhNzA2OTE4MDQ3XzEwLTktMS0xLTM2NDA2MA_47471bee-f96d-43ac-8afd-d82db67eae43"
      unitRef="eur">8862000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MzQ_ded9ae65-8825-4404-a16c-420a07523947">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Bond issues carried out by Sanofi under the Euro Medium Term Note (EMTN) program are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Issuer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;ISIN code&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Issue date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Annual&#160;interest&#160;rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0011625433&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0014009KS6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0012146801&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0014009KQ0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0012969038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013143997&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013144003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013201639&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013505104 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013505112&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013324332&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013324340&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013324357&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013324373&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013409844&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;FR0013409851&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Bond issues carried out by Sanofi under the public bond issue program (shelf registration statement) registered with the US&#160;Securities and Exchange Commission (SEC) comprise:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Issuer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;ISIN code&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Issue&#160;date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Annual&#160;&lt;br/&gt;interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;($&#160;million)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;US801060AC87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;US801060AD60&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i04c2510d77e942f4ba7a8de27cabcaff_I20131130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEtNC0xLTEtMzY0MDYw_bf4da51b-297a-453b-9099-abe144005b4b"
      unitRef="number">0.025</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i04c2510d77e942f4ba7a8de27cabcaff_I20131130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEtNS0xLTEtMzY0MDYw_457709ca-120f-4915-b766-54b2013c0473"
      unitRef="eur">1000000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i2469ac21b7364be09f669cb500520319_I20140930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzItNC0xLTEtMzY0MDYw_767b5af8-cb58-4c95-bb90-6e0cae576fee"
      unitRef="number">0.00875</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i2469ac21b7364be09f669cb500520319_I20140930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzItNS0xLTEtMzY0MDYw_20e2b9b1-388b-4462-9577-1e88179e727e"
      unitRef="eur">850000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i047b177ba24344cb92a1ff94db833558_I20140930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzMtNC0xLTEtMzY0MDYw_661903f5-e657-4f24-8504-36ef160edc6d"
      unitRef="number">0.0175</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i047b177ba24344cb92a1ff94db833558_I20140930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzMtNS0xLTEtMzY0MDYw_fa955846-11f0-4f63-bd1f-323ca7c892da"
      unitRef="eur">1510000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="id114c1320b834ff0b585507080df2d3e_I20140930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzQtNC0xLTEtNTAzNjEw_abfe9091-e639-4e7c-8ce0-b6199ebe60c0"
      unitRef="number">0.0125</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="id114c1320b834ff0b585507080df2d3e_I20140930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzQtNS0xLTEtNTAzNjEw_cc358cfe-4587-4d19-a831-e86378facc6c"
      unitRef="eur">650000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i7f75dc1fff81450490afa0858e34619f_I20150930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzQtNC0xLTEtMzY0MDYw_924c2521-f516-4f45-9b06-825f87e8c9d4"
      unitRef="number">0.015</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i7f75dc1fff81450490afa0858e34619f_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzQtNS0xLTEtMzY0MDYw_92b5ad22-caea-43dd-a93c-33da7f73afab"
      unitRef="eur">750000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i199175f15b1046ac837513acb744cede_I20160430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzUtNC0xLTEtMzY0MDYw_c1e2af42-4369-4cfa-8d8a-8fc75e43ef8f"
      unitRef="number">0.00625</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i199175f15b1046ac837513acb744cede_I20160430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzUtNS0xLTEtMzY0MDYw_3c2c376f-98c6-40cd-a034-c3c8dbec8b51"
      unitRef="eur">600000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i6594737bb0244237b737e165845993d7_I20160430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzYtNC0xLTEtMzY0MDYw_41af32f3-81d8-46fd-ab85-0322fce473d9"
      unitRef="number">0.01125</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i6594737bb0244237b737e165845993d7_I20160430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzYtNS0xLTEtMzY0MDYw_5ec23789-3f4c-4054-ab17-2bee3a51876a"
      unitRef="eur">700000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i5205edb0a2ef44219261e0dd5e52acdd_I20160930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzgtNC0xLTEtMzY0MDYw_ab47b968-7e18-4aac-8149-3271d8e8d1cb"
      unitRef="number">0.005</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i5205edb0a2ef44219261e0dd5e52acdd_I20160930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzgtNS0xLTEtMzY0MDYw_436d8e70-1bc6-4527-9a1e-d7f3dedfbb16"
      unitRef="eur">1150000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="if56de4286562416281bd1e12783b1be7_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzktNC0xLTEtMzY0MDYw_ed717c5a-70a5-40d6-b652-4a3dbb921b11"
      unitRef="number">0.01</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="if56de4286562416281bd1e12783b1be7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzktNS0xLTEtMzY0MDYw_e819b782-f864-4800-996a-c34758ca0386"
      unitRef="eur">1000000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="id77eb5dc6f4f42379ad386e2e02634c1_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEwLTQtMS0xLTM2NDA2MA_38b98e49-e38e-4114-9f21-a0b4d32a0d65"
      unitRef="number">0.015</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="id77eb5dc6f4f42379ad386e2e02634c1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEwLTUtMS0xLTM2NDA2MA_a97d692c-9f7b-4862-93e9-11c0877905f7"
      unitRef="eur">1000000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="id10b1bea133a4963a7fdd17e91652506_I20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzExLTQtMS0xLTM2NDA2MA_0f18809b-120c-4c95-a44d-82c822ededc9"
      unitRef="number">0.005</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="id10b1bea133a4963a7fdd17e91652506_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzExLTUtMS0xLTM2NDA2MA_e190a718-5f8a-4481-af2b-7da6e8a08e8f"
      unitRef="eur">1750000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="ia72c42b97a864e11a83f480f49ccae83_I20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEyLTQtMS0xLTM2NDA2MA_290f9759-1426-461e-87e8-f1ca7d191a93"
      unitRef="number">0.01</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="ia72c42b97a864e11a83f480f49ccae83_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEyLTUtMS0xLTM2NDA2MA_32dfe7b1-ae73-40a0-a739-f46e92cc9203"
      unitRef="eur">1500000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i75cf2627ef3e4b49a60bffdc84713fe3_I20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEzLTQtMS0xLTM2NDA2MA_9ec97e8a-5907-4c64-a0d8-4701f1d88a13"
      unitRef="number">0.01375</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i75cf2627ef3e4b49a60bffdc84713fe3_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzEzLTUtMS0xLTM2NDA2MA_61033d8a-1e7f-4668-91a8-34875392d7d1"
      unitRef="eur">2000000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="iad984e38fb9c4661b085d5217e565409_I20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE0LTQtMS0xLTM2NDA2MA_83749745-9fdb-4f2c-9a85-1d256db02516"
      unitRef="number">0.01875</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="iad984e38fb9c4661b085d5217e565409_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE0LTUtMS0xLTM2NDA2MA_a432ef5f-191c-4a15-ad49-9460d05e5f19"
      unitRef="eur">1250000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i32f8fe30afa14a24ac9c7eaceaaadef0_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE2LTQtMS0xLTM2NDA2MA_518f8459-564d-4031-b259-fa906438175b"
      unitRef="number">0.00875</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i32f8fe30afa14a24ac9c7eaceaaadef0_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE2LTUtMS0xLTM2NDA2MA_fffbd1ff-de25-4746-823b-f9321896c405"
      unitRef="eur">650000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i9bd94679eb80436b822cc5a86b620280_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE3LTQtMS0xLTM2NDA2MA_c25b494d-7d03-4971-9ebb-b21a3c281f26"
      unitRef="number">0.0125</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i9bd94679eb80436b822cc5a86b620280_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4ZTI2MGU5M2E2ODU0NjhlYmM1NDMyNzg5MTI1ODhkOS90YWJsZXJhbmdlOjhlMjYwZTkzYTY4NTQ2OGViYzU0MzI3ODkxMjU4OGQ5XzE3LTUtMS0xLTM2NDA2MA_f9255896-b925-4ab7-b7c5-0b620ac430e3"
      unitRef="eur">500000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="ic1513a029052410e867702910e46272a_I20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjMzU4N2M2MmUxZDM0Njc0YmM0NzgxYTc3ZDgzMzNjMC90YWJsZXJhbmdlOmMzNTg3YzYyZTFkMzQ2NzRiYzQ3ODFhNzdkODMzM2MwXzItNC0xLTEtMzY0MDYw_11704b27-15df-4786-b5e5-f81a0f5b0464"
      unitRef="number">0.03375</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="ic1513a029052410e867702910e46272a_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjMzU4N2M2MmUxZDM0Njc0YmM0NzgxYTc3ZDgzMzNjMC90YWJsZXJhbmdlOmMzNTg3YzYyZTFkMzQ2NzRiYzQ3ODFhNzdkODMzM2MwXzItNS0xLTEtMzY0MDYw_131a3922-d78e-4e81-813f-c1cba2d80f65"
      unitRef="usd">1000000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i0e560b0683e3415f88c8eea18541347e_I20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjMzU4N2M2MmUxZDM0Njc0YmM0NzgxYTc3ZDgzMzNjMC90YWJsZXJhbmdlOmMzNTg3YzYyZTFkMzQ2NzRiYzQ3ODFhNzdkODMzM2MwXzMtNC0xLTEtMzY0MDYw_56789251-81d0-46f9-8576-c49ce858e8b4"
      unitRef="number">0.03625</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:NotionalAmount
      contextRef="i0e560b0683e3415f88c8eea18541347e_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjMzU4N2M2MmUxZDM0Njc0YmM0NzgxYTc3ZDgzMzNjMC90YWJsZXJhbmdlOmMzNTg3YzYyZTFkMzQ2NzRiYzQ3ODFhNzdkODMzM2MwXzMtNS0xLTEtMzY0MDYw_15965ff8-edc7-4ecb-9540-80c5cd329900"
      unitRef="usd">1000000000</ifrs-full:NotionalAmount>
    <sny:ParticipatingSharesNumberOutstanding
      contextRef="i6d556347116c4d7392f113ed4a0ab9d6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzMwMDk_e18506d3-df73-40ac-834e-ad01876d9fd7"
      unitRef="shares">74996</sny:ParticipatingSharesNumberOutstanding>
    <sny:ParticipatingSharesCarryingAmount
      contextRef="i6d556347116c4d7392f113ed4a0ab9d6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzMwNTc_b9890f27-1433-40e2-89a5-2044532ea966"
      unitRef="eur">11000000</sny:ParticipatingSharesCarryingAmount>
    <ifrs-full:NotionalAmount
      contextRef="i04b9380769a449a58e37ee1407a157ae_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzMxOTI_058219c8-4edd-4ada-ae83-18995cb242d4"
      unitRef="eur">4000000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="idee5b77afc724b18b9ed606b041a8f3c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM0NTg_f0d65564-4229-4514-960b-f6dc7b003593"
      unitRef="eur">4000000000</ifrs-full:NotionalAmount>
    <ifrs-full:CommercialPapersIssued
      contextRef="i584b670205654f298de6bc6c82719f4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM3MDk_5ec60ed8-9a8f-4629-8af0-4cb077a65245"
      unitRef="eur">6000000000</ifrs-full:CommercialPapersIssued>
    <ifrs-full:CommercialPapersIssued
      contextRef="ie51595be9dd743b794627696bbc95347_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM3NzM_90c67a90-6a3f-47c5-9171-bd99796e32da"
      unitRef="usd">10000000000</ifrs-full:CommercialPapersIssued>
    <sny:BorrowingAverageDrawdown
      contextRef="i1d46e42d80ad40f7be7642c3218b547b_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM4OTE_23d22a61-0652-4d54-8a1f-8a6081db4dfc"
      unitRef="usd">2300000000</sny:BorrowingAverageDrawdown>
    <sny:BorrowingMaximumDrawdown
      contextRef="i1d46e42d80ad40f7be7642c3218b547b_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM5MTU_ee54a2c6-b19b-49ca-86d5-6e741716dde3"
      unitRef="usd">4000000000</sny:BorrowingMaximumDrawdown>
    <sny:BorrowingDrawdown
      contextRef="ie51595be9dd743b794627696bbc95347_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzM5NTY_5a520fab-bfe6-4fad-b127-6283e2d24993"
      unitRef="usd">0</sny:BorrowingDrawdown>
    <sny:DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NTM_de417125-292c-46f2-8c6b-92a0df87a82e">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bond issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other bank borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bank credit balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used &lt;br/&gt;to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,273&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,130&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used &lt;br/&gt;to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,492&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(8,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Net debt does not include lease liabilities, which amounted to &#x20ac;2,181&#160;million as of December&#160;31, 2022; &#x20ac;2,108&#160;million as of&#160;December&#160;31, 2021; and&#160;&#x20ac;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;1,163&#160;million as of December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; (see the maturity analysis at Note&#160;D.17.2.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, the main undrawn confirmed general-purpose credit facilities at holding company level amounted to&#160;&#x20ac;8 billion, half of which expires in 2023 and the other half of which expires in 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, no single counterparty represented more than 6% of Sanofi&#x2019;s undrawn confirmed credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bond issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other bank borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bank credit balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,314&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,138&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,647&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;602&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,751&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,016&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(7,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,647&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;602&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,751&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,016&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bond issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other bank borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bank credit balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,703&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,852&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,830&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,575&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;602&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,756&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,088&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,836&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,575&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;602&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,756&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,088&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock>
    <ifrs-full:BondsIssued
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItMS0xLTEtMzY0MDYw_169ec2c4-69a3-4adc-be2e-a93474b392fa"
      unitRef="eur">18861000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i9e52293342884ce98adab12df87659e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItMi0xLTEtMzY0MDYw_3c56dd6d-8aa3-4d0d-9aee-726b0d01d7f1"
      unitRef="eur">3817000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItMy0xLTEtMzY0MDYw_24c1e071-c61e-4f1e-bf32-59317721a9c2"
      unitRef="eur">600000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItNC0xLTEtMzY0MDYw_49d1f67d-3aa6-40ae-88c1-00b3e72fd519"
      unitRef="eur">2600000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItNS0xLTEtMzY0MDYw_e874e246-5335-4a5e-97d8-b4928ad8c06c"
      unitRef="eur">4160000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItNi0xLTEtMzY0MDYw_9f17ee04-9777-46ce-b76c-1feb9ce3a2e9"
      unitRef="eur">0</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzItNy0xLTEtMzY0MDYw_82722205-5303-4f81-aa6f-6f47a5d5a832"
      unitRef="eur">7684000000</ifrs-full:BondsIssued>
    <sny:OtherBankBorrowings
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtMS0xLTEtMzY0MDYw_bfc4b0e4-0932-45eb-8acd-d2a9ae183f88"
      unitRef="eur">286000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i9e52293342884ce98adab12df87659e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtMi0xLTEtMzY0MDYw_521147a2-c32d-41b9-8265-a2c6c4d19534"
      unitRef="eur">187000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtMy0xLTEtMzY0MDYw_6c281604-92f7-41bc-a287-713820b7ae9a"
      unitRef="eur">61000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtNC0xLTEtMzY0MDYw_611e342d-ff2c-4c03-a2fc-88b1b32d45e5"
      unitRef="eur">0</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtNS0xLTEtMzY0MDYw_50bd4921-0018-49c6-8936-28ad1a3f1ee4"
      unitRef="eur">0</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtNi0xLTEtMzY0MDYw_aedb30f9-da46-4cf5-99e3-a3ac9505d2d7"
      unitRef="eur">0</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzMtNy0xLTEtMzY0MDYw_747ae667-449b-4416-8051-0ac40bcf48e1"
      unitRef="eur">38000000</sny:OtherBankBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtMS0xLTEtMzY0MDYw_8e4c1192-61f6-4cb9-9b7e-ae39ac600d80"
      unitRef="eur">6000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i9e52293342884ce98adab12df87659e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtMi0xLTEtMzY0MDYw_641088b0-527e-4854-9881-2ad462db741f"
      unitRef="eur">6000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtMy0xLTEtMzY0MDYw_2a6e6deb-7a42-41eb-a431-88a36dab8558"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtNC0xLTEtMzY0MDYw_d771547d-fdb0-4fe3-9696-5205dea66f4e"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtNS0xLTEtMzY0MDYw_06126523-0b45-49e9-9c5d-71638f3f7657"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtNi0xLTEtMzY0MDYw_aef46794-21a4-44ee-9ed5-bda1de0ed639"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzQtNy0xLTEtMzY0MDYw_abc2263b-1e53-4ca9-a3a4-317739acec64"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtMS0xLTEtMzY0MDYw_919745f9-e511-4192-b587-4e4fade7a6e2"
      unitRef="eur">168000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i9e52293342884ce98adab12df87659e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtMi0xLTEtMzY0MDYw_1182cea1-31d8-4bb8-9583-9e0805315eac"
      unitRef="eur">168000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtMy0xLTEtMzY0MDYw_f7b0ec5d-0b39-47e2-a247-e8a4c702a07c"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtNC0xLTEtMzY0MDYw_6133453f-982d-464c-a4ea-aed7a8d45145"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtNS0xLTEtMzY0MDYw_9e2c196b-ae96-499c-8e2f-af3413323bb3"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtNi0xLTEtMzY0MDYw_feed7db5-da5d-4cd0-a8f0-073f0d0a8f40"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzUtNy0xLTEtMzY0MDYw_8196b72c-d890-4687-9426-60ab78e8a889"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtMS0xLTEtMzY0MDYw_fed3bd52-8dd4-4bda-b21b-cf22b8b7b473"
      unitRef="eur">48000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i9e52293342884ce98adab12df87659e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtMi0xLTEtMzY0MDYw_51b6a39f-aa68-4c68-937e-216dc7571729"
      unitRef="eur">48000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtMy0xLTEtMzY0MDYw_465a4a52-49e6-4f9c-9ee2-e2564aeeb8ff"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtNC0xLTEtMzY0MDYw_9172e4dd-b760-43c0-9add-7585a2c0f585"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtNS0xLTEtMzY0MDYw_f8202930-adc4-4f28-b7b3-c5e4b1ca39de"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtNi0xLTEtMzY0MDYw_d9eefe3e-6daf-4239-8372-90177bc850ed"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzYtNy0xLTEtMzY0MDYw_1aa22722-88fb-411c-9349-022daf73001c"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <ifrs-full:Borrowings
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctMS0xLTEtMzY0MDYw_68cd24d3-e7de-4f89-9f9e-824580637e82"
      unitRef="eur">19273000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i9e52293342884ce98adab12df87659e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctMi0xLTEtMzY0MDYw_fda2f55c-148c-4e98-8ba1-0c2227cfffab"
      unitRef="eur">4130000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctMy0xLTEtMzY0MDYw_b7e97ac8-107c-4715-a0af-3734f72e073f"
      unitRef="eur">661000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctNC0xLTEtMzY0MDYw_6e5ee047-9c5d-4565-a1a2-8ad0c3107ff2"
      unitRef="eur">2600000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctNS0xLTEtMzY0MDYw_417b5794-a0d7-46d4-ba30-48699caccf4b"
      unitRef="eur">4160000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctNi0xLTEtMzY0MDYw_f7eae6c7-36a9-4c41-b310-4df5c420cf77"
      unitRef="eur">0</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzctNy0xLTEtMzY0MDYw_00600620-2a36-4969-93f7-3096b6b0dca4"
      unitRef="eur">7722000000</ifrs-full:Borrowings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtMS0xLTEtMzY0MDYw_e8a6bf73-5343-48f5-8875-4172da6b9a46"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i9e52293342884ce98adab12df87659e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtMi0xLTEtMzY0MDYw_f57fb9f8-655a-4ad9-a56b-bdbeb599dd45"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtMy0xLTEtMzY0MDYw_e66183be-5a55-4b2a-91c1-6fdb00c9bd40"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtNC0xLTEtMzY0MDYw_a9742d81-be13-44ca-a8d6-f83897814b56"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtNS0xLTEtMzY0MDYw_feeae699-cb85-4a56-8d5c-9a49648311c2"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtNi0xLTEtMzY0MDYw_4ccb6000-7e36-46d4-8a50-41e46e630b2d"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzgtNy0xLTEtMzY0MDYw_1078632b-b826-49dd-93d8-539155d21a5b"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktMS0xLTEtMzY0MDYw_50345479-9001-4af6-b005-4f9abad9b6c9"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i9e52293342884ce98adab12df87659e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktMi0xLTEtMzY0MDYw_f2791f23-5cbb-4ac5-93ef-b6ed6fcc43d0"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktMy0xLTEtMzY0MDYw_3417e534-1934-45ed-9f6c-1c9a0894a112"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktNC0xLTEtMzY0MDYw_751c64ff-47e6-4277-b3d8-ed3e98b540ae"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktNS0xLTEtMzY0MDYw_db07658c-7d68-4988-8583-b7e6ecd9da72"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktNi0xLTEtMzY0MDYw_f4b27b0e-2ee6-4744-adcd-010ff8dfb379"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzktNy0xLTEtMzY0MDYw_848e8678-9d1b-4667-8739-9721ed4deaa5"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i7ddf467d5bf64c9f8ba8fb8967dcea35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTEtMS0xLTM2NDA2MA_a7749556-3a34-4d33-ac39-ad71fd6ef4af"
      unitRef="eur">6492000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i9e52293342884ce98adab12df87659e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTItMS0xLTM2NDA2MA_3e261f56-ba23-418b-bb9b-7ace6e8124d5"
      unitRef="eur">-8651000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i7dd5166beaa6485c85ddd0224ec13658_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTMtMS0xLTM2NDA2MA_b1385cf3-e462-4f3b-96ea-be48d3e5f541"
      unitRef="eur">661000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ib184294f2a0c4d208ca2e78abb18309d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTQtMS0xLTM2NDA2MA_79e5eda7-c733-4217-9b52-c544f2ca2e94"
      unitRef="eur">2600000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i6fe6c9761ca64c7aab44286a6857190b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTUtMS0xLTM2NDA2MA_e2140fd7-541d-4641-9c04-5c8c03e843ea"
      unitRef="eur">4160000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i41838b0e904d41fcb05555d3c2e53142_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTYtMS0xLTM2NDA2MA_4cb5c432-c274-4af2-9316-bbf1cf824af1"
      unitRef="eur">0</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i4a3a064108104fec8f96446ec19e35c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpiZTczN2U4YzFiNzg0ZWZjOTE3MjAxMjk4ZjgyNjA5Ni90YWJsZXJhbmdlOmJlNzM3ZThjMWI3ODRlZmM5MTcyMDEyOThmODI2MDk2XzEwLTctMS0xLTM2NDA2MA_ecd29dc0-8b5c-4fb3-9de8-a04d2cbef563"
      unitRef="eur">7722000000</sny:DebtNetOfCashAndCashEquivalents>
    <ifrs-full:LeaseLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzQzNTI_b8e77a0b-c18d-4dbc-85e1-81d8f3177f99"
      unitRef="eur">2181000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzQ0MTM_d1d52ba2-bea1-468f-a41e-38055b097ad9"
      unitRef="eur">2108000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzQ0NTQ_3c3d855a-863a-4ea4-ab6d-9f7f955c321c"
      unitRef="eur">1163000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:NotionalAmount
      contextRef="i21b97dca30ff4878a0d00522d024354b_I20221231"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzQ2NDI_78fe0718-ed74-4e22-9c59-6f9887d2677f"
      unitRef="eur">8000000000</ifrs-full:NotionalAmount>
    <ifrs-full:BondsIssued
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItMS0xLTEtMzY0MDYw_4a358627-fcf4-4c85-ae44-f1876a5d248a"
      unitRef="eur">19946000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i9863724d6eed4da18629877e392fd908_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItMi0xLTEtMzY0MDYw_ab435ab3-c738-4fe8-bab5-d30a2e147024"
      unitRef="eur">2828000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i8115851386c448bb86584a094cd62be1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItMy0xLTEtMzY0MDYw_76e11d23-b6e1-4ac1-b5b0-05284fad7756"
      unitRef="eur">3629000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItNC0xLTEtMzY0MDYw_29dbf800-902c-4ab8-ba91-cd4d49b8da4a"
      unitRef="eur">600000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItNS0xLTEtMzY0MDYw_baed3913-da55-4065-b328-491fc374f9fa"
      unitRef="eur">1750000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="icc5db8aced27474ba3858b0e92719936_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItNi0xLTEtMzY0MDYw_601b76bc-cd97-438b-94ca-948a0696ee16"
      unitRef="eur">4160000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzItNy0xLTEtMzY0MDYw_b1ac13a1-cb54-4b6c-8480-7b1590300da0"
      unitRef="eur">6979000000</ifrs-full:BondsIssued>
    <sny:OtherBankBorrowings
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtMS0xLTEtMzY0MDYw_2df76bad-65f1-42ac-ae9d-b4b14969192e"
      unitRef="eur">184000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i9863724d6eed4da18629877e392fd908_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtMi0xLTEtMzY0MDYw_534e6fd2-e97d-4c7e-aa0f-9bedcfe9cf3c"
      unitRef="eur">163000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i8115851386c448bb86584a094cd62be1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtMy0xLTEtMzY0MDYw_917d8330-e9a4-4428-9207-3d50569867d6"
      unitRef="eur">18000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtNC0xLTEtMzY0MDYw_812aead1-4719-4106-87b0-e6909c958404"
      unitRef="eur">2000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtNS0xLTEtMzY0MDYw_945524d1-6212-42f0-98de-0ae31a8c10b5"
      unitRef="eur">1000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="icc5db8aced27474ba3858b0e92719936_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtNi0xLTEtMzY0MDYw_e1b2e8e5-79f7-4f85-8192-eef316b13934"
      unitRef="eur">0</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzMtNy0xLTEtMzY0MDYw_4129578c-5b1d-44ce-8158-27d5e5e0ff94"
      unitRef="eur">0</sny:OtherBankBorrowings>
    <sny:FinanceLeaseLiabilities
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtMS0xLTEtMzY0MDYw_5aa54dbc-65b7-4a9c-a91f-88b51bc2d517"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="i9863724d6eed4da18629877e392fd908_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtMi0xLTEtMzY0MDYw_9d8db104-a305-4281-910a-64fcf800fd54"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="i8115851386c448bb86584a094cd62be1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtMy0xLTEtMzY0MDYw_9f7a9790-3b8e-4cd0-8c67-ac93b4b04dee"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtNC0xLTEtMzY0MDYw_993b9516-11f7-429e-b6a7-db20f677215d"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtNS0xLTEtMzY0MDYw_cde3d241-9712-47f5-8500-1cd5e8857591"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="icc5db8aced27474ba3858b0e92719936_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtNi0xLTEtMzY0MDYw_26b6ba37-1062-48af-b93b-127dcd007c58"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzQtNy0xLTEtMzY0MDYw_0cd37399-7313-45a1-abd0-13554a827a32"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <ifrs-full:OtherBorrowings
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtMS0xLTEtMzY0MDYw_98ed9f9f-07aa-4951-8208-2edbaeaefad5"
      unitRef="eur">40000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i9863724d6eed4da18629877e392fd908_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtMi0xLTEtMzY0MDYw_2251c336-46fb-4cce-b317-c2602bbde88b"
      unitRef="eur">3000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i8115851386c448bb86584a094cd62be1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtMy0xLTEtMzY0MDYw_5ad26c2b-5b79-4f18-bf1c-c7305caa7091"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtNC0xLTEtMzY0MDYw_528f796e-1b2b-4a6a-a23a-505cfb52e1cd"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtNS0xLTEtMzY0MDYw_2520d9a8-fae2-423b-9176-50860298d857"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="icc5db8aced27474ba3858b0e92719936_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtNi0xLTEtMzY0MDYw_8df95209-041b-4eff-a9a1-06999cb1fd00"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzUtNy0xLTEtMzY0MDYw_f4f8ab55-3da9-4cdb-8f85-2d2686fa5990"
      unitRef="eur">37000000</ifrs-full:OtherBorrowings>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtMS0xLTEtMzY0MDYw_24a799d2-9770-483c-ba4c-832951f5f24d"
      unitRef="eur">189000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i9863724d6eed4da18629877e392fd908_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtMi0xLTEtMzY0MDYw_5d2ed8dd-eb5b-4f6c-b987-3ef8149f24a6"
      unitRef="eur">189000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i8115851386c448bb86584a094cd62be1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtMy0xLTEtMzY0MDYw_9b2dac3d-1de3-4ba6-b7d2-4a46aea122ca"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtNC0xLTEtMzY0MDYw_fc49bb86-25a8-45a3-ba8d-37c02f181de1"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtNS0xLTEtMzY0MDYw_47e84651-2505-42ae-ad49-ab3d07a23540"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="icc5db8aced27474ba3858b0e92719936_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtNi0xLTEtMzY0MDYw_56308a0c-2cb9-4f50-913a-e020b05e9935"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzYtNy0xLTEtMzY0MDYw_253c1605-e262-4c73-990f-702363878e3b"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctMS0xLTEtMzY0MDYw_713cecc3-7e4f-45a4-a9c4-6e3bd84f6fbd"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i9863724d6eed4da18629877e392fd908_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctMi0xLTEtMzY0MDYw_36f54e48-1fbc-4fae-8552-7428da9fa8c0"
      unitRef="eur">45000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i8115851386c448bb86584a094cd62be1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctMy0xLTEtMzY0MDYw_1605ba18-ceff-4b0d-aca7-f5c679fa24a5"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctNC0xLTEtMzY0MDYw_e9745682-aa63-4be6-88e7-5aae2eac6eac"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctNS0xLTEtMzY0MDYw_ac6941b7-6115-4159-a2fc-4e1075ab9d4a"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="icc5db8aced27474ba3858b0e92719936_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctNi0xLTEtMzY0MDYw_13677760-604e-4cd6-a442-8ccc8e1d2f38"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzctNy0xLTEtMzY0MDYw_3896aadd-954c-4df7-afba-fb2a351e1940"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <ifrs-full:Borrowings
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtMS0xLTEtMzY0MDYw_c75b91b1-c66e-4c04-9921-62012cc25513"
      unitRef="eur">20314000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i9863724d6eed4da18629877e392fd908_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtMi0xLTEtMzY0MDYw_830a184e-3c79-4096-a04d-7eab9c6926bb"
      unitRef="eur">3138000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i8115851386c448bb86584a094cd62be1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtMy0xLTEtMzY0MDYw_b0489310-f292-41a6-be58-1b95eb3fe516"
      unitRef="eur">3647000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtNC0xLTEtMzY0MDYw_39000786-0e95-4dd9-9dfe-713b48f1db17"
      unitRef="eur">602000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtNS0xLTEtMzY0MDYw_8fd5bfd6-17d8-4c3f-bc1b-59d2213bea18"
      unitRef="eur">1751000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="icc5db8aced27474ba3858b0e92719936_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtNi0xLTEtMzY0MDYw_7b21667f-b314-45a5-bf0f-f46285df7de0"
      unitRef="eur">4160000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzgtNy0xLTEtMzY0MDYw_475b1085-f680-46bc-b948-b4df1b1903d3"
      unitRef="eur">7016000000</ifrs-full:Borrowings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktMS0xLTEtMzY0MDYw_35504233-8a89-403a-9a07-8db51bbf4e35"
      unitRef="eur">10098000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i9863724d6eed4da18629877e392fd908_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktMi0xLTEtMzY0MDYw_764a51bf-b168-4c60-9464-4770f0d1520a"
      unitRef="eur">10098000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i8115851386c448bb86584a094cd62be1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktMy0xLTEtMzY0MDYw_5c37a19e-8f53-416f-ab81-cccacd69b732"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktNC0xLTEtMzY0MDYw_cf039ae6-fd74-40ac-af08-c4d2920511cf"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktNS0xLTEtMzY0MDYw_30c392d2-c7b2-4a66-85bf-fb3abe9789ac"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="icc5db8aced27474ba3858b0e92719936_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktNi0xLTEtMzY0MDYw_cb3a8e96-cd51-4908-ac26-b4a9e2b104a5"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzktNy0xLTEtMzY0MDYw_4b86d609-9110-45f2-9c91-60d3c9a8e8cc"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTEtMS0xLTM2NDA2MA_1a5eb32e-efe9-4ab2-aa69-bd36c606f27d"
      unitRef="eur">169000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i9863724d6eed4da18629877e392fd908_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTItMS0xLTM2NDA2MA_13a633bf-fe26-4b0f-9911-91e3632d2767"
      unitRef="eur">169000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i8115851386c448bb86584a094cd62be1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTMtMS0xLTM2NDA2MA_e70c0bff-0e33-4040-9d1c-810a0d71771e"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTQtMS0xLTM2NDA2MA_20a25683-f479-4132-8520-545a9530a459"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTUtMS0xLTM2NDA2MA_14f60a74-f40c-4a25-bf9a-47cf489be129"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="icc5db8aced27474ba3858b0e92719936_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTYtMS0xLTM2NDA2MA_752451e6-f8d8-4de5-898a-3869837ccd09"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzEwLTctMS0xLTM2NDA2MA_dddfebea-4381-4434-a203-7d9e7103da56"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i9dd9d077d0d74b84a86388ebba38fe7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTEtMS0xLTM2NDA2MA_ec77c50c-437e-47d7-9aa0-add1a0f2e9dd"
      unitRef="eur">10047000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i9863724d6eed4da18629877e392fd908_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTItMS0xLTM2NDA2MA_1c063115-c1a9-4522-891c-c5209420076f"
      unitRef="eur">-7129000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i8115851386c448bb86584a094cd62be1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTMtMS0xLTM2NDA2MA_5bb2f028-db31-48fd-924c-bbc4029255a7"
      unitRef="eur">3647000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i77d77717242846fd97fead9e9cab3d8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTQtMS0xLTM2NDA2MA_184149b6-deac-469a-874d-969fad0983c0"
      unitRef="eur">602000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i6b3ff41fb31042fc9459840da1383005_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTUtMS0xLTM2NDA2MA_f086e290-a6c2-4699-a13f-775bacacb5b2"
      unitRef="eur">1751000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="icc5db8aced27474ba3858b0e92719936_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTYtMS0xLTM2NDA2MA_d4597b9f-e331-42a3-b145-a9befb7da6a6"
      unitRef="eur">4160000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i53a7d3d78c00403dae90e229c492b7a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozM2Q5Zjg4MzI4ODQ0MzQ3YTVmMjZhOGNhMGVmYTQxNS90YWJsZXJhbmdlOjMzZDlmODgzMjg4NDQzNDdhNWYyNmE4Y2EwZWZhNDE1XzExLTctMS0xLTM2NDA2MA_18565560-d4e3-4e8d-80de-f5a5554a7eaa"
      unitRef="eur">7016000000</sny:DebtNetOfCashAndCashEquivalents>
    <ifrs-full:BondsIssued
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItMS0xLTEtMzY0MDYw_e865051b-43b4-4160-9d94-7fb1d479cdbc"
      unitRef="eur">21978000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItMi0xLTEtMzY0MDYw_46e5e310-03a0-4a7b-89d4-8f3a678446b4"
      unitRef="eur">2280000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItMy0xLTEtMzY0MDYw_6fb639c4-41f5-4586-9252-0b086f1f4fd4"
      unitRef="eur">2700000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i3a4898d404904d67b54841026f034dd5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItNC0xLTEtMzY0MDYw_ca7f1d64-44a7-44e2-84da-96e45ed1d354"
      unitRef="eur">3569000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItNS0xLTEtMzY0MDYw_6192bd99-6066-403b-ab24-1f311f3af82b"
      unitRef="eur">600000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItNi0xLTEtMzY0MDYw_c15bf1f1-81b6-4b09-81ab-829905797eef"
      unitRef="eur">1750000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzItNy0xLTEtMzY0MDYw_a49d65cb-9056-4cb4-ae94-d23dc26814bc"
      unitRef="eur">11079000000</ifrs-full:BondsIssued>
    <sny:OtherBankBorrowings
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtMS0xLTEtMzY0MDYw_de3e206a-fa84-467b-b2b7-3e6da4e23a3d"
      unitRef="eur">296000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtMi0xLTEtMzY0MDYw_cacaa558-8e8e-4443-a216-67ebe5159b28"
      unitRef="eur">200000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtMy0xLTEtMzY0MDYw_6bbdaa3c-0171-4636-8794-f8df432a0510"
      unitRef="eur">73000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i3a4898d404904d67b54841026f034dd5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtNC0xLTEtMzY0MDYw_44d0938e-3550-4818-b48d-32469e8c1f2c"
      unitRef="eur">6000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtNS0xLTEtMzY0MDYw_4d89de60-b14b-4976-9195-3365b8eef4a6"
      unitRef="eur">2000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtNi0xLTEtMzY0MDYw_d08ed7e8-3a1b-4702-9843-542ecba51f2a"
      unitRef="eur">6000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzMtNy0xLTEtMzY0MDYw_ffb60373-c6ef-4d79-8c8b-12c2f42ca4a1"
      unitRef="eur">9000000</sny:OtherBankBorrowings>
    <sny:FinanceLeaseLiabilities
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtMS0xLTEtMzY0MDYw_d65980b6-e107-4cc9-84d4-e237367aeb2c"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtMi0xLTEtMzY0MDYw_5424fb9e-00ad-43e6-a144-54155dd0c541"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtMy0xLTEtMzY0MDYw_7f0b8f6b-1757-43a3-a47c-6358e3c2f6e1"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="i3a4898d404904d67b54841026f034dd5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtNC0xLTEtMzY0MDYw_029aee0b-c67c-4ca8-81a8-efe3c90dadd9"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtNS0xLTEtMzY0MDYw_29cbd171-2013-4687-9388-c409465d4b86"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtNi0xLTEtMzY0MDYw_fd4c1bf0-7191-4bbe-97b1-9d3bc806d23a"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <sny:FinanceLeaseLiabilities
      contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzQtNy0xLTEtMzY0MDYw_90f5a98f-0c0c-4927-ba56-348912121774"
      unitRef="eur">0</sny:FinanceLeaseLiabilities>
    <ifrs-full:OtherBorrowings
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtMS0xLTEtMzY0MDYw_0b284583-cd50-4c42-9be5-b773f2443d42"
      unitRef="eur">2000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtMi0xLTEtMzY0MDYw_f942f115-37be-4aba-83c9-a015063e5240"
      unitRef="eur">2000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtMy0xLTEtMzY0MDYw_e6571478-5770-45a1-9010-2acff46cde10"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i3a4898d404904d67b54841026f034dd5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtNC0xLTEtMzY0MDYw_938aa0c2-dde9-45b4-b491-c32ba6807db7"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtNS0xLTEtMzY0MDYw_84af5600-3d0e-4c9a-9328-cd2ffa12a28f"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtNi0xLTEtMzY0MDYw_8c91614f-5935-4ad3-a371-068228411e26"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzUtNy0xLTEtMzY0MDYw_3187ff2a-c4f2-4066-bd13-31e297720619"
      unitRef="eur">0</ifrs-full:OtherBorrowings>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtMS0xLTEtMzY0MDYw_e2fdc3c9-456e-4fdd-998b-048bee03f122"
      unitRef="eur">285000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtMi0xLTEtMzY0MDYw_a0ffbd03-f6c8-40ca-8ca8-fd71ed8fc05a"
      unitRef="eur">285000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtMy0xLTEtMzY0MDYw_b1cb2d0f-0301-4be4-b467-4de1201ca542"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i3a4898d404904d67b54841026f034dd5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtNC0xLTEtMzY0MDYw_51d6e2a6-ef22-45c2-ae02-bb5a569115ce"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtNS0xLTEtMzY0MDYw_db3f2a5f-7b77-4743-aca7-36f922c4b58b"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtNi0xLTEtMzY0MDYw_aaf84e27-d6cb-45d2-91a7-36fa69a5a2d2"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzYtNy0xLTEtMzY0MDYw_d55bb8d6-8568-43a4-998d-15a51557cc79"
      unitRef="eur">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctMS0xLTEtMzY0MDYw_7572af89-1ec0-4e72-bf80-dbd7e32dfc7f"
      unitRef="eur">-142000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctMi0xLTEtMzY0MDYw_43bce636-91f3-4d60-a3b3-81589f53e4d6"
      unitRef="eur">-85000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctMy0xLTEtMzY0MDYw_60e2bab6-f0fd-4fa9-8b3e-ec7930abd136"
      unitRef="eur">-57000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i3a4898d404904d67b54841026f034dd5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctNC0xLTEtMzY0MDYw_662d5da6-a3d9-4d02-9380-5c766ab791e2"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctNS0xLTEtMzY0MDYw_2a190514-9216-4dff-bcc9-687fa9a86389"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctNi0xLTEtMzY0MDYw_78273028-e1cb-4b35-ae88-4386966734b2"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzctNy0xLTEtMzY0MDYw_fb6c7a6c-b66c-4fee-8fce-f019e6710da0"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <ifrs-full:Borrowings
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtMS0xLTEtMzY0MDYw_77ca57d0-851a-4b33-bfae-73e55755bb78"
      unitRef="eur">22703000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtMi0xLTEtMzY0MDYw_f7344dca-a671-437e-a3d7-6666ba15e67d"
      unitRef="eur">2852000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtMy0xLTEtMzY0MDYw_9fe7e43e-53c8-4584-8e45-9cfc5b90aba5"
      unitRef="eur">2830000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i3a4898d404904d67b54841026f034dd5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtNC0xLTEtMzY0MDYw_ea144e93-a981-456a-8ff5-fcb08cd77c2d"
      unitRef="eur">3575000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtNS0xLTEtMzY0MDYw_cbfbcf90-ccb5-4a63-af57-e28446d83447"
      unitRef="eur">602000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtNi0xLTEtMzY0MDYw_09b5818b-52e0-463b-9688-73de25630f07"
      unitRef="eur">1756000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzgtNy0xLTEtMzY0MDYw_c2f9dea7-c3ef-4a30-bd0a-f6121abfd75a"
      unitRef="eur">11088000000</ifrs-full:Borrowings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktMS0xLTEtMzY0MDYw_07b566b4-c11e-4bb4-a623-b28c71a2ad24"
      unitRef="eur">13915000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktMi0xLTEtMzY0MDYw_15fa7384-8865-496b-857a-716f16ee3a52"
      unitRef="eur">13915000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktMy0xLTEtMzY0MDYw_d2293a68-934e-4cfe-aae9-605f41db0f43"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i3a4898d404904d67b54841026f034dd5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktNC0xLTEtMzY0MDYw_18373d8c-30a4-4457-9500-5b93f85f8765"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktNS0xLTEtMzY0MDYw_493c50e9-384d-49e1-a4d2-e87db5f773c9"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktNi0xLTEtMzY0MDYw_cfde3a7c-1d64-4066-9cf0-ba66868060dd"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzktNy0xLTEtMzY0MDYw_39469798-c6ba-42e9-bae0-d2114482ee7a"
      unitRef="eur">0</ifrs-full:CashAndCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTEtMS0xLTM2NDA2MA_7890b55b-e24e-403a-a5b3-4a85daf28ecf"
      unitRef="eur">-74000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTItMS0xLTM2NDA2MA_7f6bc09c-3e64-4948-9b56-c2c9c7b4bcc7"
      unitRef="eur">-68000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTMtMS0xLTM2NDA2MA_5ccfad3b-ac1c-4180-9667-854db09f7608"
      unitRef="eur">-6000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i3a4898d404904d67b54841026f034dd5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTQtMS0xLTM2NDA2MA_7060ecd8-e7bf-4c07-b522-21af9c59661e"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTUtMS0xLTM2NDA2MA_54f0de86-abfe-40de-858b-0bef953f17c4"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTYtMS0xLTM2NDA2MA_93f4a2ab-8bd1-4b34-8459-069e74c521cd"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzEwLTctMS0xLTM2NDA2MA_a5c81e21-2949-4e99-bbc5-5fa0a884241f"
      unitRef="eur">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i0bdf2d2b3add4e3eaa1d007185ed82e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTEtMS0xLTM2NDA2MA_d1fc4765-72b5-46e3-b3e5-cb243ce522d4"
      unitRef="eur">8862000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="if08e91bcc6334394ac4b4571ec9d184f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTItMS0xLTM2NDA2MA_3bd23d46-e5b1-404d-8a0a-7cfcc32d4840"
      unitRef="eur">-10995000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i89a9437a10b6436496ce43c3ca4ffc12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTMtMS0xLTM2NDA2MA_19b18f32-303f-4282-b330-0c277d1bcad3"
      unitRef="eur">2836000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i3a4898d404904d67b54841026f034dd5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTQtMS0xLTM2NDA2MA_e392715f-d776-4703-8a10-ded46dbdf586"
      unitRef="eur">3575000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="if371f65cec7140efb6785f6076d8ef3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTUtMS0xLTM2NDA2MA_db8d6e20-8fd2-4d7a-97fe-3f354259dd73"
      unitRef="eur">602000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i6cc7bfcd54b84c8fa9042c040773a262_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTYtMS0xLTM2NDA2MA_dbe7c3a1-afba-4ff0-9685-d21393eac329"
      unitRef="eur">1756000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ib62bd4c9703147a99540e67827ebfc0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjZDMyOTc4ZDkzNDc0MDg4OTRiNTc1Yzg3NzU5M2UwOC90YWJsZXJhbmdlOmNkMzI5NzhkOTM0NzQwODg5NGI1NzVjODc3NTkzZTA4XzExLTctMS0xLTM2NDA2MA_33e1ae4b-2d79-419a-95ac-a437de08ddd7"
      unitRef="eur">11088000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NTQ_be3b5962-1632-49e7-92a8-15875a282c8f">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below splits net debt between fixed and floating rate, and by maturity, as of December 31, 2022. The figures shown are values on redemption, before the effects of derivative instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fixed-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,861&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;16,993&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,868&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% fixed-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;98&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Floating-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;460&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% floating-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,321&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,178&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(3,908)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(8,391)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% floating-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,585&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(8,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;To optimize the cost of debt or reduce the volatility of debt and manage its exposure to financial foreign exchange risk, Sanofi uses derivative instruments (interest rate swaps, currency swaps, foreign exchange swaps and forward contracts) that alter the fixed/floating rate split and the currency split of its net debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fixed-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;13,944&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,443&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% fixed-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Floating-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,886&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;592&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;950&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% floating-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19,273&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,130&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,781)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(4,046)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(5,797)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2,155)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;% floating-rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,492&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(8,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;661&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,600&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,722&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="iebd2bcba58ef4b558528913b09bfaea2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtMS0xLTEtMzY0MDYw_648bae0e-8ad8-4007-9b05-0afcc3a5c87b"
      unitRef="eur">18861000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i540f25e289fc4a81b2b603c1ce544e8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtMi0xLTEtMzY0MDYw_a70242e3-6190-4cfd-92f4-ad602c17b0a0"
      unitRef="eur">3817000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i75c02dbe746a4f0c8dd0bf49930dcd0f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtMy0xLTEtMzY0MDYw_8fe3d5e9-7c95-408a-ab80-a1b4f8853149"
      unitRef="eur">600000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ia7d499e8c9264feb8703281a726ff271_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtNC0xLTEtMzY0MDYw_a2f7c529-398a-45e2-abc7-5c6045ed5da2"
      unitRef="eur">2600000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i4b6083f115234231b8a9cb18a0d9cf1c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtNS0xLTEtMzY0MDYw_9a2e816c-d3c1-443e-b557-a6a2856c5a23"
      unitRef="eur">4160000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i00b59f839f7a4230acf9e7674e11930f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtNi0xLTEtMzY0MDYw_2696504d-afcb-43ba-98e9-544299ef40c8"
      unitRef="eur">0</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i6834ab2b35104783bf996d12d8b5b3be_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEtNy0xLTEtMzY0MDYw_18d1a0ee-6c14-4b53-8b27-4d6ea8e5ab08"
      unitRef="eur">7684000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i5bae5a0d6a9e4f738590405a5e507f88_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzItMS0xLTEtMzY0MDYw_7ad3a5ee-024f-4cc1-bb0c-8b5858640783"
      unitRef="eur">16993000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="icda6c69534d246a48a04830eb613df01_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzMtMS0xLTEtMzY0MDYw_14038f16-ff70-4a2c-ba43-83ea3a21ba23"
      unitRef="eur">1868000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:DebtPercent
      contextRef="i8c3e0f4218054eae8d6f0cd63d414c89_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzQtMS0xLTEtMzY0MDYw_5144f6c0-38b7-453f-9459-44cc700afb7c"
      unitRef="number">0.98</sny:DebtPercent>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ieffdd3fdeffd433ea7df1b20775e6aad_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtMS0xLTEtMzY0MDYw_623e7b51-cf8d-4808-a131-97f041113f25"
      unitRef="eur">460000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i7b5db8eab4b64e88973da38da595851d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtMi0xLTEtMzY0MDYw_d3d3092e-6dbf-46d3-958b-629336d8083f"
      unitRef="eur">361000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i01fe7149c70b4165ab567b66b5f5a43e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtMy0xLTEtMzY0MDYw_5a3ea233-2aff-4b67-a265-a9626a910dd5"
      unitRef="eur">61000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i689114ca44ed42ee9df9e1c418d03d2e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtNC0xLTEtMzY0MDYw_96d07a67-052b-4aeb-bbf2-fc6da10225bb"
      unitRef="eur">0</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ib102efb6dc8143618a1e6b93d00e10a0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtNS0xLTEtMzY0MDYw_e820ddcc-c3fb-4818-9dfe-6505eff360bb"
      unitRef="eur">0</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i4fab70a599804fa892e143f5459a87bc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtNi0xLTEtMzY0MDYw_ef804c31-1a2b-4817-a00d-21c8e0e274cc"
      unitRef="eur">0</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ie7670912ed6048a3915926c30a98416b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzUtNy0xLTEtMzY0MDYw_7d71ca41-d78d-487f-a239-8883e956c394"
      unitRef="eur">38000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ic557830f381f4210be0d6833c36f65fc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzYtMS0xLTEtMzY0MDYw_026c0bf8-71fe-4989-a7f9-7fb021e73301"
      unitRef="eur">60000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i8041942870dd4730b5723c5dc68d38e9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzctMS0xLTEtMzY0MDYw_4cdf1f17-8454-4f5e-b041-fdbde2b21826"
      unitRef="eur">15000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:DebtPercent
      contextRef="ia21f3e9de40f435e9c254cf2a6cde7d5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzgtMS0xLTEtMzY0MDYw_36080f29-db18-4c40-b02f-89cf46ad336c"
      unitRef="number">0.02</sny:DebtPercent>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i562d7157b7e8481a9b91191e18e64665_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktMS0xLTEtMzY0MDYw_e8690146-1bc3-42f3-b6b3-289315436473"
      unitRef="eur">19321000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i7ce628e107bf47078ecfcfdb13f3e5cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktMi0xLTEtMzY0MDYw_a9d16508-3f7e-43e0-b80c-292d788e1d00"
      unitRef="eur">4178000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="iedf903d1811b48a5b959ad28581d7e2e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktMy0xLTEtMzY0MDYw_9d10a7f5-0582-4570-b979-b49aac6147da"
      unitRef="eur">661000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i91024893bd7f4842a6956080118265db_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktNC0xLTEtMzY0MDYw_b7b55e07-c9e5-419b-8b72-8fd58199c8de"
      unitRef="eur">2600000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i4c93c6fb82d542b198701a104373ae59_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktNS0xLTEtMzY0MDYw_5d7f8ede-4e5e-488f-8943-56eb797ea581"
      unitRef="eur">4160000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ida6442fa725647e9a4886d876f008303_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktNi0xLTEtMzY0MDYw_dc434fbd-0d6f-4996-8a02-1c712a1de151"
      unitRef="eur">0</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ie0145a96971e41eda0b8dbf9c0cc4308_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzktNy0xLTEtMzY0MDYw_51dc987e-b06f-4d95-9969-0178351fc2c5"
      unitRef="eur">7722000000</sny:IncreaseDecreaseOfBorrowings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="ia21f3e9de40f435e9c254cf2a6cde7d5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEwLTEtMS0xLTM2NDA2MA_7373dd70-934d-4160-a586-f0481e9eac0b"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i1adf194cc771430ba20e49e1d9df2cca_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEwLTItMS0xLTM2NDA2MA_10411ba5-2fbf-4de9-9725-9d34522f5018"
      unitRef="eur">12736000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i8e9f3675bc884686b9346c2cc4bc46d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzExLTEtMS0xLTM2NDA2MA_f118371b-7d11-4382-b798-ce4441b6a9f1"
      unitRef="eur">3908000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i82de31322c4840e9965d37b0c2de087e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEyLTEtMS0xLTM2NDA2MA_c020b014-6922-4b7b-8611-53bfa39731cf"
      unitRef="eur">8391000000</ifrs-full:CashAndCashEquivalents>
    <sny:DebtPercent
      contextRef="i36278eb71056497db2592c9bb8341cf9_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzEzLTEtMS0xLTM2NDA2MA_6274d345-648a-47c2-8a04-aa58424a3fdb"
      unitRef="number">1</sny:DebtPercent>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i36278eb71056497db2592c9bb8341cf9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTEtMS0xLTM2NDA2MA_d449c973-c45f-4035-98f5-d0134fe81621"
      unitRef="eur">6585000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ifda4536c10fc4da7bddd520da0e7f941_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTItMS0xLTM2NDA2MA_ee01ec3e-2f90-488f-86cc-664f8d52f4dc"
      unitRef="eur">-8558000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ie7fdb3550f04484b8bcc3e27a74136e3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTMtMS0xLTM2NDA2MA_e4d46faf-184f-4c41-bff4-260e9546ef64"
      unitRef="eur">661000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="if252267932914e47aa7eb646796d3c93_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTQtMS0xLTM2NDA2MA_0bb5e494-6938-4b5a-bbac-234baeb5ce93"
      unitRef="eur">2600000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i588d16a72b9a43e2ad82c0a0a94a5919_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTUtMS0xLTM2NDA2MA_40bc0a48-207a-4a77-b763-86f1f2d8b18b"
      unitRef="eur">4160000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i3fc6504724b94686b7b9c04f189e7e73_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTYtMS0xLTM2NDA2MA_ff59fd42-66d2-47cd-a9c9-94366b2df536"
      unitRef="eur">0</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i8cc8bc76c35d41f08399d789a26cfdc6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzNiZmY0NWU0Y2M0MmNmOGY5MDAwYWE1MzczNDM0MS90YWJsZXJhbmdlOjczM2JmZjQ1ZTRjYzQyY2Y4ZjkwMDBhYTUzNzM0MzQxXzE0LTctMS0xLTM2NDA2MA_034a3cb3-6599-486a-ba46-d9367f2546b0"
      unitRef="eur">7722000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:NumberOfCurrenciesDebtIsIssuedIn
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzUwNjI_0529f9f4-fb89-4156-89ae-efe5077269f1"
      unitRef="currency">2</sny:NumberOfCurrenciesDebtIsIssuedIn>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ibb27d0c0e23e426ea143647091a7d102_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtMS0xLTEtMzY0MDYw_4bd91f68-724d-4ec9-bc3a-afb5427e5f38"
      unitRef="eur">16386000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i26aaac9784564a11983a342fbd429be1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtMi0xLTEtMzY0MDYw_94a3ae52-2dd4-4508-b2f3-a6236f548298"
      unitRef="eur">1342000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i891c90b7df6d4e61a27d601eeae750a6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtMy0xLTEtMzY0MDYw_76605fbe-d408-4b16-92a1-fe09e337786b"
      unitRef="eur">600000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ib9aa711fcb6a40d2b80db74ac171cc0c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtNC0xLTEtMzY0MDYw_dcb2b79f-d016-4967-8a95-f395fd1bb5df"
      unitRef="eur">2600000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i2a0b0e6e459f41638acacc3fc37a42fb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtNS0xLTEtMzY0MDYw_168a3528-17e8-40c4-a145-caaf58f3cf7f"
      unitRef="eur">4160000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i8fd5aa573ef4460cbfad34c55a86f731_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtNi0xLTEtMzY0MDYw_5db5c161-1114-4e25-8df7-ccfe62ec38dd"
      unitRef="eur">0</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i49b804d9ed614704907b110f70a5cdfb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEtNy0xLTEtMzY0MDYw_c8ef0f8a-3ded-4dc8-b026-adb36c54b243"
      unitRef="eur">7684000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i506dffc0627c41909915d7e8817418b5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzItMS0xLTEtMzY0MDYw_090a01e3-6dd1-4d46-9c60-b51d82ffbd71"
      unitRef="eur">13944000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i57012484148948689f89fea0aa3009eb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzMtMS0xLTEtMzY0MDYw_9e4c273c-bb56-475b-b9cd-d8046b9596fe"
      unitRef="eur">2443000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:DebtPercent
      contextRef="id1774eefc6c64ab0af41316d805ee58e_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzQtMS0xLTEtMzY0MDYw_fe7aed12-6363-4a13-a970-c197a492fa5f"
      unitRef="number">0.85</sny:DebtPercent>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ibbcc5028550249b08609aa6bfdc653b1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtMS0xLTEtMzY0MDYw_98801f3f-40d9-4c30-86f8-6dc8855736ff"
      unitRef="eur">2886000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i77fea54f24f24e5daa16b8e9af0ec3ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtMi0xLTEtMzY0MDYw_9122b30f-d86f-4e4b-a088-095c5024aaf0"
      unitRef="eur">2787000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i5cedacf54d4441efb351a26b12b34b7d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtMy0xLTEtMzY0MDYw_eb72b39e-d58f-4a7f-bc01-2d928cb565f7"
      unitRef="eur">61000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i3d7c1443a2d7463e82df2174db1636ee_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtNC0xLTEtMzY0MDYw_172ecff2-ac5d-410b-8308-512eece20ede"
      unitRef="eur">0</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ia5c92790c66c4fb89e2306e62a806e24_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtNS0xLTEtMzY0MDYw_c5f7ee3c-140d-437d-9696-8716c4ff4da1"
      unitRef="eur">0</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ie769b358c2a7430eaa9c327866a428af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtNi0xLTEtMzY0MDYw_4e239301-25f2-425f-be42-15e598f8ea7e"
      unitRef="eur">0</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="id275ba29b8e14859b191132d6c2cac69_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzUtNy0xLTEtMzY0MDYw_a5dffa21-46ee-4079-a305-af249f8d1e46"
      unitRef="eur">38000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ibee927ede2a140759f0c5c12d11794c0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzYtMS0xLTEtMzY0MDYw_090d1ef7-de1a-4ca6-9b49-2222c56f20bb"
      unitRef="eur">592000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ib91f94ba7e664e9a82b38a8746af0b80_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzctMS0xLTEtMzY0MDYw_9b255f82-64a7-43ac-937f-5f7775193e16"
      unitRef="eur">950000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:DebtPercent
      contextRef="i237bae27b00946af9d0b8a11f902a571_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzktMS0xLTEtMzY0MDYw_abcfdfd0-9c86-4ad3-85dd-4e5ed3ca3a46"
      unitRef="number">0.15</sny:DebtPercent>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i35a06cbd066c4a6385ffce5cd1bcaa31_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTEtMS0xLTM2NDA2MA_8b5d8dd0-cdc9-406c-b65a-1c19413acca4"
      unitRef="eur">19273000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="iab4a2932b5504a659476a2c7ba6d88ef_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTItMS0xLTM2NDA2MA_0a690999-c585-44a5-ac58-9078ce2a6b3c"
      unitRef="eur">4130000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ibb312bd23a3443b3bd0d8c41cd9225c2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTMtMS0xLTM2NDA2MA_039edddf-770b-4c01-aac7-294a85640885"
      unitRef="eur">661000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="id1a1452ac88b47cdba83dde78ded377f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTQtMS0xLTM2NDA2MA_02f5a02d-73d4-488c-9113-d64dbff57a07"
      unitRef="eur">2600000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="i57ad0dfa87a84703b12af704a04f6d7d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTUtMS0xLTM2NDA2MA_d89e4e53-544b-4e6d-aa18-d5439d061a0e"
      unitRef="eur">4160000000</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="ibf7e07a4b08c413f97b8d93e97d582ae_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTYtMS0xLTM2NDA2MA_c59a3aff-7629-470b-9fa1-4800e25bb362"
      unitRef="eur">0</sny:IncreaseDecreaseOfBorrowings>
    <sny:IncreaseDecreaseOfBorrowings
      contextRef="idf8910c273344e81baf6be3ce9cebda0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEwLTctMS0xLTM2NDA2MA_e08a8a57-6b3c-4225-af6d-3b92f0ca5bf9"
      unitRef="eur">7722000000</sny:IncreaseDecreaseOfBorrowings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="ic9ad47fc844b46bc80ec5166c7202ecf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzExLTEtMS0xLTM2NDA2MA_ef651a9f-e526-4051-8a0d-5990defe51ef"
      unitRef="eur">12781000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i68a66f1fea5a498aa1aa1217323de722_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzExLTItMS0xLTM2NDA2MA_1d3ff2a5-e5ba-42a5-933a-014a2de0e260"
      unitRef="eur">12781000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="ia9829d8804884a12b2a996bb924f52c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEyLTEtMS0xLTM2NDA2MA_330875e7-4af9-492d-b9a7-74ac443700dd"
      unitRef="eur">4046000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i2b4aebf768c5437dbb995a69b847a59c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzEzLTEtMS0xLTM2NDA2MA_f4e135da-7273-4d17-8fae-aa0a1dd7b14c"
      unitRef="eur">5797000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i88fe0cc7b26a444897204bd0cd68ce16_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE0LTEtMS0xLTM2NDA2MA_687cf67e-da4d-4aa6-955f-a624dc4738c6"
      unitRef="eur">2155000000</ifrs-full:CashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ic9ad47fc844b46bc80ec5166c7202ecf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTEtMS0xLTM2NDA2MA_1f89ffc7-c526-4f47-abd2-dd48ba6fdf17"
      unitRef="eur">6492000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i68a66f1fea5a498aa1aa1217323de722_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTItMS0xLTM2NDA2MA_11ef185d-2732-4824-9b1a-2e98007eea02"
      unitRef="eur">-8651000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="id463ae47153a4acca4d4ce0cd4105e45_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTMtMS0xLTM2NDA2MA_bea3b645-95e7-4f47-a802-e7724d65dc4f"
      unitRef="eur">661000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i017628a6bb05492681816fc312f67c17_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTQtMS0xLTM2NDA2MA_69951e8c-d4a0-419f-aa85-7f6fb70aac72"
      unitRef="eur">2600000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="idd131014a277431580f16bdaa1cf4dea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTUtMS0xLTM2NDA2MA_8e7ced6c-5bc9-4a1c-aa3e-06fe35bdf2a3"
      unitRef="eur">4160000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="iee3f28b6afc141c89ce5d05cee0c9373_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTYtMS0xLTM2NDA2MA_a8510381-66f0-43c8-8a4a-c80320b7d2ad"
      unitRef="eur">0</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i1b2abede0f3b4da6acb6ca1d80672165_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplMGFlYzJjMTQ0OTQ0YWM4YWMwYWNiYWI0OGY2ODRhYy90YWJsZXJhbmdlOmUwYWVjMmMxNDQ5NDRhYzhhYzBhY2JhYjQ4ZjY4NGFjXzE2LTctMS0xLTM2NDA2MA_ea7cbb41-8dd9-4377-9384-5d2703de3dff"
      unitRef="eur">7722000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MTk_f61095fc-802b-47ae-9a18-9d111bf84998">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the fixed/floating rate split of net debt at value on redemption after taking account of derivative instruments as of&#160;December 31, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fixed-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Floating-rate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,314&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22,703&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock>
    <ifrs-full:Borrowings
      contextRef="i76094c0250834f1a85e51ab92e040912_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzEtMS0xLTEtMzY0MDYw_05c507c9-e099-418e-9451-999b575e6829"
      unitRef="eur">17612000000</ifrs-full:Borrowings>
    <sny:DebtPercent
      contextRef="i76094c0250834f1a85e51ab92e040912_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzEtMi0xLTEtMzY0MDYw_75a0cee8-7acb-4ac9-8b90-ce88add9e3a9"
      unitRef="number">0.87</sny:DebtPercent>
    <ifrs-full:Borrowings
      contextRef="i4fe1d1477b9f4783b9f56a9968687afb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzEtMy0xLTEtMzY0MDYw_7f4a7f64-112a-44b7-aa29-f42372366012"
      unitRef="eur">20713000000</ifrs-full:Borrowings>
    <sny:DebtPercent
      contextRef="i4fe1d1477b9f4783b9f56a9968687afb_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzEtNC0xLTEtMzY0MDYw_053a0743-f993-4bfb-9c44-66b63f5ac3f2"
      unitRef="number">0.91</sny:DebtPercent>
    <ifrs-full:Borrowings
      contextRef="ib2c9b9d646ff44a8a69e68756acb7765_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzItMS0xLTEtMzY0MDYw_d61b5ffc-07e6-4706-aa29-aa96fb18b1e1"
      unitRef="eur">2702000000</ifrs-full:Borrowings>
    <sny:DebtPercent
      contextRef="ib2c9b9d646ff44a8a69e68756acb7765_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzItMi0xLTEtMzY0MDYw_b3ff1fc5-04d7-4618-b427-b2b5937b822b"
      unitRef="number">0.13</sny:DebtPercent>
    <ifrs-full:Borrowings
      contextRef="i44ca61b134c947c4bee18de7bfc7e7ca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzItMy0xLTEtMzY0MDYw_84651845-7774-44a6-a6fe-4ff9f0f08c3f"
      unitRef="eur">1990000000</ifrs-full:Borrowings>
    <sny:DebtPercent
      contextRef="i44ca61b134c947c4bee18de7bfc7e7ca_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzItNC0xLTEtMzY0MDYw_4625e2ff-a034-495d-8f69-228addfa3ab0"
      unitRef="number">0.09</sny:DebtPercent>
    <ifrs-full:Borrowings
      contextRef="ia15a0d49ecac416c8e39472c771744ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzMtMS0xLTEtMzY0MDYw_2ece6cad-e474-4692-a87a-a6e23a250ab2"
      unitRef="eur">20314000000</ifrs-full:Borrowings>
    <sny:DebtPercent
      contextRef="ia15a0d49ecac416c8e39472c771744ae_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzMtMi0xLTEtMzY0MDYw_e459241b-a430-4afd-9d34-5c1489110b16"
      unitRef="number">1</sny:DebtPercent>
    <ifrs-full:Borrowings
      contextRef="i29b764a8ef7e489b91978a7eb7e69313_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzMtMy0xLTEtMzY0MDYw_25671a01-c8f7-4af7-9f0b-83244ce930a5"
      unitRef="eur">22703000000</ifrs-full:Borrowings>
    <sny:DebtPercent
      contextRef="i29b764a8ef7e489b91978a7eb7e69313_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzMtNC0xLTEtMzY0MDYw_5472c20b-cc08-44ea-82ae-8c32614f1bd3"
      unitRef="number">1</sny:DebtPercent>
    <ifrs-full:CashAndCashEquivalents
      contextRef="ia15a0d49ecac416c8e39472c771744ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzQtMS0xLTEtMzY0MDYw_bfa11b8f-1260-4891-8102-d744ad6fce71"
      unitRef="eur">10267000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="i29b764a8ef7e489b91978a7eb7e69313_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzQtMy0xLTEtMzY0MDYw_86b7598c-0dcf-416c-a684-fcdf6d8f24f7"
      unitRef="eur">13841000000</ifrs-full:CashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ia15a0d49ecac416c8e39472c771744ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzUtMS0xLTEtMzY0MDYw_12bc8cec-392c-4d03-a598-f8859d99ddf0"
      unitRef="eur">10047000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i29b764a8ef7e489b91978a7eb7e69313_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3MzY5NTU2MTRlNTE0OWRlYWQwMzdkNzVmMjNiMWY0ZC90YWJsZXJhbmdlOjczNjk1NTYxNGU1MTQ5ZGVhZDAzN2Q3NWYyM2IxZjRkXzUtMy0xLTEtMzY0MDYw_1500b85d-593d-427a-80de-c58eb715e7a1"
      unitRef="eur">8862000000</sny:DebtNetOfCashAndCashEquivalents>
    <ifrs-full:BorrowingsInterestRate
      contextRef="i460a31d6345a47c1a7b3e2578b9ba86d_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzU4Nzk_ec7292da-9a15-46c2-b25f-57924014ff03"
      unitRef="number">0.016</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate
      contextRef="ie2b6d2511d0e4766a94389d42ac8728d_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzU5MTY_63ce711d-a588-4222-a9d8-caa762a11684"
      unitRef="number">0.025</ifrs-full:BorrowingsInterestRate>
    <sny:CashAndCashEquivalentsInvestedRate
      contextRef="i460a31d6345a47c1a7b3e2578b9ba86d_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwMjA_3cb0acdd-ec51-4ebb-87b9-8c3c793e511d"
      unitRef="number">0.039</sny:CashAndCashEquivalentsInvestedRate>
    <sny:CashAndCashEquivalentsInvestedRate
      contextRef="ie2b6d2511d0e4766a94389d42ac8728d_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3XzYwNTc_81402b4c-d6b9-4cd3-ba0e-43a6d8c2172b"
      unitRef="number">0.040</sny:CashAndCashEquivalentsInvestedRate>
    <sny:DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NDg_d915fdbc-c35e-44b9-b932-600785ec6264">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The projected full-year sensitivity of net debt to interest rate fluctuations for 2023 is as&#160;follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Change in short-term interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Impact&#160;on&#160;pre-tax&#160;net&lt;br/&gt;income&#160;(&#x20ac;&#160;million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Impact&#160;on&#160;pre-tax&lt;br/&gt;income/(expense)&#160;recognized&lt;br/&gt;directly in equity&lt;br/&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+100&#160;bp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+25&#160;bp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;-25&#160;bp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;-100&#160;bp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock>
    <sny:ImpactOfChangeInInterestRateOnPreTaxIncome
      contextRef="ic41f4a5b56624a49a78f6fe5ac261c4d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzEtMS0xLTEtMzY0MDYw_273a688c-cf72-45d8-a9a6-9a2397530ef8"
      unitRef="eur">98000000</sny:ImpactOfChangeInInterestRateOnPreTaxIncome>
    <sny:ImpactOfPreTaxIncomeRecognisedInEquity
      contextRef="ic41f4a5b56624a49a78f6fe5ac261c4d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzEtMi0xLTEtMzY0MDYw_dd94ee74-d762-4d0f-9029-00ac6772ef3f"
      unitRef="eur">0</sny:ImpactOfPreTaxIncomeRecognisedInEquity>
    <sny:ImpactOfChangeInInterestRateOnPreTaxIncome
      contextRef="i5d14a3445818400e945ec968094e1c76_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzItMS0xLTEtMzY0MDYw_1bf498be-dd53-4ac9-9c23-5670e2bdea01"
      unitRef="eur">25000000</sny:ImpactOfChangeInInterestRateOnPreTaxIncome>
    <sny:ImpactOfPreTaxIncomeRecognisedInEquity
      contextRef="i5d14a3445818400e945ec968094e1c76_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzItMi0xLTEtMzY0MDYw_703d9ca3-5203-4aa9-89d0-842f268d7588"
      unitRef="eur">0</sny:ImpactOfPreTaxIncomeRecognisedInEquity>
    <sny:ImpactOfChangeInInterestRateOnPreTaxIncome
      contextRef="i16680b6fb943448fb282d180578aad71_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzMtMS0xLTEtMzY0MDYw_5dc4a21b-6c0e-4b40-b0ed-746b3ed56d22"
      unitRef="eur">-25000000</sny:ImpactOfChangeInInterestRateOnPreTaxIncome>
    <sny:ImpactOfPreTaxIncomeRecognisedInEquity
      contextRef="i16680b6fb943448fb282d180578aad71_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzMtMi0xLTEtMzY0MDYw_11110e6b-4153-442f-8c9d-8e89304b6b0f"
      unitRef="eur">0</sny:ImpactOfPreTaxIncomeRecognisedInEquity>
    <sny:ImpactOfChangeInInterestRateOnPreTaxIncome
      contextRef="i4bfdac81298541228d40dcfd2166cf4a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzQtMS0xLTEtMzY0MDYw_a1847c74-aab8-4dd4-b194-e583f863d4cf"
      unitRef="eur">-98000000</sny:ImpactOfChangeInInterestRateOnPreTaxIncome>
    <sny:ImpactOfPreTaxIncomeRecognisedInEquity
      contextRef="i4bfdac81298541228d40dcfd2166cf4a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTozMjJmNDI3OTFiZGY0YWVmOGM3YTRjMTZjYzQzNTkzZi90YWJsZXJhbmdlOjMyMmY0Mjc5MWJkZjRhZWY4YzdhNGMxNmNjNDM1OTNmXzQtMi0xLTEtMzY0MDYw_b23b597a-82e3-41bf-bf48-09dc1e79f5da"
      unitRef="eur">0</sny:ImpactOfPreTaxIncomeRecognisedInEquity>
    <sny:DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MjU_e2231678-b1eb-4017-aea8-8f4552a267f3">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows net debt by currency at December 31, 2022, before and after derivative instruments contracted to convert the foreign-currency net debt of exposed entities into their functional currency:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Before&#160;derivative&#160;instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;After&#160;derivative&#160;instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,508)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pound sterling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mexican peso&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other currencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,585&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,492&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i57bb5023f2b84d4487314592d0f4240a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzEtMS0xLTEtMzY0MDYw_e8bfc9d4-aecd-44fd-9202-b4cbcbb3b349"
      unitRef="eur">13145000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i6cbeba8a8bea4164a2c6d181bd02c2bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzEtMi0xLTEtMzY0MDYw_39357a1c-44f7-475d-89a9-826441796b79"
      unitRef="eur">10489000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i986c2ee021b44ce3b4b179b044998da2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzItMS0xLTEtMzY0MDYw_5b3e9999-a928-402e-81b9-42a615a47c48"
      unitRef="eur">-6508000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i9fe5b918c28d40af8499fc1cc0b70c9a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzItMi0xLTEtMzY0MDYw_a501bfa6-da68-4b04-855c-84523e2bcc18"
      unitRef="eur">-2404000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ifdd755aac0fc48e689e14a6274f310fb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzMtMS0xLTEtMzY0MDYw_6caec28e-5266-4370-9d1c-cd7e02239ef9"
      unitRef="eur">0</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i276f12c0b8124b55895020cdb1b4f4c9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzMtMi0xLTEtMzY0MDYw_04292484-c4bf-4d69-a0c9-f6a33686a4e0"
      unitRef="eur">-2155000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ice55484dadfb417dadb944cba1425875_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzQtMS0xLTEtMzY0MDYw_6264002d-a449-4d4a-a63e-e55f0fe9a3c4"
      unitRef="eur">0</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i0053ae4d634f454d9610544b49d8cde1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzQtMi0xLTEtMzY0MDYw_0047723e-985f-4c70-a74c-887ed4ae05fa"
      unitRef="eur">359000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i8b2c283754f141868e981361c2f48440_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzUtMS0xLTEtMzY0MDYw_60c929a5-bcaa-4433-80a8-296100b94352"
      unitRef="eur">0</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ie96001907d3e48d1868c019e1a785aa1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzUtMi0xLTEtMzY0MDYw_895f1585-31cd-4029-930c-34cbf5e8a61a"
      unitRef="eur">98000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="if7e673112a4142d6a878b6f0f4052237_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzYtMS0xLTEtMzY0MDYw_bb1e417c-8f54-4310-b993-d0629a3b511d"
      unitRef="eur">-52000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ibf44e1ea006f438d8d586516b03c1f93_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzYtMi0xLTEtMzY0MDYw_bdef3f9b-8679-493f-9254-88ad9ba894a4"
      unitRef="eur">105000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i36278eb71056497db2592c9bb8341cf9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzctMS0xLTEtMzY0MDYw_e9c5fa3e-ad6b-4a2c-9402-a67ce14057e0"
      unitRef="eur">6585000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ic9ad47fc844b46bc80ec5166c7202ecf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTplNmJkZmZhMzA1ZDA0MGJkYjA2NWUzM2JkYWY4NGY3NC90YWJsZXJhbmdlOmU2YmRmZmEzMDVkMDQwYmRiMDY1ZTMzYmRhZjg0Zjc0XzctMi0xLTEtMzY0MDYw_4b14c7d3-14e4-4bd0-9683-ececf84c9079"
      unitRef="eur">6492000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MzA_6ecd03fb-21f2-4fac-8fc5-3a6606396c27">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows net debt by currency at December 31, 2021 and 2020, after derivative instruments contracted to convert the foreign currency net debt of exposed entities into their functional currency:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(669)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other currencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i9d361595b981448ab1d50f6b03da6881_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzEtMS0xLTEtMzY0MDYw_5b9fa8a6-1ca1-46c2-adc9-d6db2bca6723"
      unitRef="eur">13129000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i33739fde16464d6e90fb87630cb2feca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzEtMi0xLTEtMzY0MDYw_a743a2fb-48ba-4a63-8d97-7b04b79d29cf"
      unitRef="eur">13725000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="if126614dea4c41a48da8c2ad61a16c94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzItMS0xLTEtMzY0MDYw_97c421a1-d346-4828-b8c6-4728ae91a764"
      unitRef="eur">-669000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i9110312ee2f64746a22d9a66d04adf9b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzItMi0xLTEtMzY0MDYw_1a416b9c-67d5-4491-8628-8acddcdf42d3"
      unitRef="eur">-3304000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="id9b4ea343f3047468f2f5d10fc5c9122_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzMtMS0xLTEtMzY0MDYw_a3586376-5733-41b6-99fa-3c3a0ca2d47b"
      unitRef="eur">-2413000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i762332be16fa4365b2cc90d3d0037dc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzMtMi0xLTEtMzY0MDYw_190168ba-6aba-43c1-a299-d883ae37860f"
      unitRef="eur">-1559000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="ia15a0d49ecac416c8e39472c771744ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzQtMS0xLTEtMzY0MDYw_230c58d2-b55b-413e-9fa7-759dac955ad9"
      unitRef="eur">10047000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="i29b764a8ef7e489b91978a7eb7e69313_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo3YmY0ZTA0Nzg3MDg0ZjJlYjA0ZDZlNWUzYmVmODc3Ni90YWJsZXJhbmdlOjdiZjRlMDQ3ODcwODRmMmViMDRkNmU1ZTNiZWY4Nzc2XzQtMi0xLTEtMzY0MDYw_0306a906-1846-4bb0-a41b-1615ccf963cd"
      unitRef="eur">8862000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DisclosureOfMarketValueOfNetDebtTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MzE_87980e6a-0b98-48f2-9fd0-ed7a5713ff01">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The market value of Sanofi&#x2019;s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Market value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Value on redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfMarketValueOfNetDebtTableTextBlock>
    <ifrs-full:Borrowings
      contextRef="ic291b624a38e421d9afc1f580652e23d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzEtMS0xLTEtMzY0MDYw_0af36ffd-4371-4bcf-b60a-7422f319e900"
      unitRef="eur">5227000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="i9e4e5ad251f94a3f8a8756af248a86b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzEtMi0xLTEtMzY0MDYw_e8d96f1b-e2fd-46ad-84a7-6b3cc33b1e2e"
      unitRef="eur">11024000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="iffeccf1af73449d2a5ed59864455f0d9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzEtMy0xLTEtMzY0MDYw_6c391f3c-5338-4775-9fab-b5a65df0d1b7"
      unitRef="eur">10500000000</ifrs-full:Borrowings>
    <sny:RedemptionOfDebtInstrumentIssued
      contextRef="i1935e628d70046c1966e7d84061601fd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzItMS0xLTEtMzY0MDYw_23ad0adc-1a8f-4079-ae7a-201b04389eac"
      unitRef="eur">6492000000</sny:RedemptionOfDebtInstrumentIssued>
    <sny:RedemptionOfDebtInstrumentIssued
      contextRef="ifeb107e71e654a8ba62720ba4f39052b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzItMi0xLTEtMzY0MDYw_0993b5bc-2f03-4a70-928f-5ca75943fc4b"
      unitRef="eur">10047000000</sny:RedemptionOfDebtInstrumentIssued>
    <sny:RedemptionOfDebtInstrumentIssued
      contextRef="iea4dd6e2c1634f6a8d800a040260a39e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo4MjI0ZWFiMTk2MTA0ZmQ4YWE0YzgxYTNmZGI3YjRlNi90YWJsZXJhbmdlOjgyMjRlYWIxOTYxMDRmZDhhYTRjODFhM2ZkYjdiNGU2XzItMy0xLTEtMzY0MDYw_3f686dc6-1ffa-4249-a200-27f64ff3e9e1"
      unitRef="eur">8862000000</sny:RedemptionOfDebtInstrumentIssued>
    <sny:DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MzI_c28c9f48-48a6-4ce5-bc32-250e084f33b8">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,408&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,206&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;868&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,803&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,184&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,283&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,064&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net cash flows related to derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;209&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;60&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20,617&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,230&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;928&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,841&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,215&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,314&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,089&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The tables below show the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt as of December 31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21,728&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,330&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,826&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;791&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,937&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,176&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,668&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net cash flows related to derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21,677&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,271&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,825&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;793&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,939&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,178&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,671&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026 and later&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24,339&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,943&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,019&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,808&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;791&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,937&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,841&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net cash flows related to derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;163&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;135&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;28&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24,502&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,078&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,047&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,808&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;791&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,937&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,841&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItMS0xLTEtMzY0MDYw_b5a2e5d0-07d3-4b93-abde-d61c738c7a45"
      unitRef="eur">20408000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItMi0xLTEtMzY0MDYw_a026854c-d938-4f1c-a703-b59e399bac09"
      unitRef="eur">4206000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i280298edcb0840438a14b90d970fec63_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItMy0xLTEtMzY0MDYw_7d98acf1-28db-48b7-a532-68aff532d153"
      unitRef="eur">868000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItNC0xLTEtMzY0MDYw_ec98bc7e-06d3-4b27-9bfd-073949967356"
      unitRef="eur">2803000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItNS0xLTEtMzY0MDYw_9d93e7ec-29b6-4289-9ca9-d659486ceb1e"
      unitRef="eur">3184000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItNi0xLTEtMzY0MDYw_8e2b8214-882e-409f-b86b-0f1209bf04cd"
      unitRef="eur">1283000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzItNy0xLTEtMzY0MDYw_05f22478-ccf0-4228-83cf-f223d42f019b"
      unitRef="eur">8064000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtMS0xLTEtMzY0MDYw_a3a71aef-36b2-448e-903d-ad11a9492309"
      unitRef="eur">18932000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtMi0xLTEtMzY0MDYw_4ce0f98e-c107-4f7b-adcf-b73e540733c0"
      unitRef="eur">3928000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i280298edcb0840438a14b90d970fec63_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtMy0xLTEtMzY0MDYw_b29dae0a-3f3b-4b3c-9944-e32135427207"
      unitRef="eur">661000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtNC0xLTEtMzY0MDYw_643b8878-4142-4d92-b58a-1611b08075f8"
      unitRef="eur">2601000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtNS0xLTEtMzY0MDYw_913e7d25-12f4-4715-9aed-c2d3b4659e66"
      unitRef="eur">3011000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtNi0xLTEtMzY0MDYw_776d33c1-efff-48f1-ab23-2f91e68a8a39"
      unitRef="eur">1151000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzMtNy0xLTEtMzY0MDYw_99569fe7-351d-44da-aed2-c5f4573c5da4"
      unitRef="eur">7580000000</sny:PrincipalUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtMS0xLTEtMzY0MDYw_4017cf29-ec23-4297-ac44-2e24c91351c0"
      unitRef="eur">1476000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtMi0xLTEtMzY0MDYw_bcca52d7-9d1d-46c2-ae68-5e690ac2b51f"
      unitRef="eur">278000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i280298edcb0840438a14b90d970fec63_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtMy0xLTEtMzY0MDYw_78a407aa-4403-4232-b536-e4b266d55a46"
      unitRef="eur">207000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtNC0xLTEtMzY0MDYw_013d113e-c40d-4d3b-a963-feb2e86f94aa"
      unitRef="eur">202000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtNS0xLTEtMzY0MDYw_58e93f44-9522-481d-8f43-d88b8990a399"
      unitRef="eur">173000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtNi0xLTEtMzY0MDYw_d44e8503-6768-4587-a164-273867769c0c"
      unitRef="eur">132000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzQtNy0xLTEtMzY0MDYw_3b891eeb-c7fe-473d-9e00-539cf6022d92"
      unitRef="eur">484000000</sny:InterestUndiscountedCashFlow>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtMS0xLTEtMzY0MDYw_8f2edd10-c608-4ecf-bb75-f398f172d01e"
      unitRef="eur">209000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtMi0xLTEtMzY0MDYw_1af3c2c0-5bcd-4a6a-8768-ca779abb9cc8"
      unitRef="eur">24000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i280298edcb0840438a14b90d970fec63_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtMy0xLTEtMzY0MDYw_be61181e-387a-422b-bc3b-938697546156"
      unitRef="eur">60000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtNC0xLTEtMzY0MDYw_fc9bcdcb-3554-42df-9da5-f73a5f3cf450"
      unitRef="eur">38000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtNS0xLTEtMzY0MDYw_8ee1c570-57a9-4f3a-95a4-16b6bd3b7c95"
      unitRef="eur">31000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtNi0xLTEtMzY0MDYw_df6b589c-637e-469e-b8ec-f5f611f632b2"
      unitRef="eur">31000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzUtNy0xLTEtMzY0MDYw_3f5d1996-497d-4234-8a35-ea55c730d69b"
      unitRef="eur">25000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <sny:TotalUndiscountedCashFlow
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtMS0xLTEtMzY0MDYw_2f768023-a8fe-4ba1-9665-d13b502ee265"
      unitRef="eur">20617000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtMi0xLTEtMzY0MDYw_92ca7aeb-78fc-4061-8408-6dbd2b5f2813"
      unitRef="eur">4230000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i280298edcb0840438a14b90d970fec63_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtMy0xLTEtMzY0MDYw_cd10ed6e-354c-43d4-a340-e99815266380"
      unitRef="eur">928000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtNC0xLTEtMzY0MDYw_a4479faf-b797-445e-8510-73fcb70244b7"
      unitRef="eur">2841000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtNS0xLTEtMzY0MDYw_50fff844-b9a1-431e-84db-0908978edd95"
      unitRef="eur">3215000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtNi0xLTEtMzY0MDYw_59e277f5-9d73-4806-bf1e-fe82df533b76"
      unitRef="eur">1314000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZToyOTk0NGZiNzIyNzk0OTkwYTY3YjkzOTg4MjFlMjYyZC90YWJsZXJhbmdlOjI5OTQ0ZmI3MjI3OTQ5OTBhNjdiOTM5ODgyMWUyNjJkXzYtNy0xLTEtMzY0MDYw_34bd24cf-90bf-425f-a110-94b9e1b34a59"
      unitRef="eur">8089000000</sny:TotalUndiscountedCashFlow>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItMS0xLTEtMzY0MDYw_b2298e64-e5a3-4d92-bfe6-9170ba9dc281"
      unitRef="eur">21728000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItMi0xLTEtMzY0MDYw_6ad5fcd3-9293-4c28-8e20-1d7fb76dc0f7"
      unitRef="eur">3330000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="id3388b8c97b14858be97adc9fa1bb28f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItMy0xLTEtMzY0MDYw_b58e30d7-548d-45bf-8db0-d46b38863645"
      unitRef="eur">3826000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItNC0xLTEtMzY0MDYw_e9948a8b-2a4a-497a-88f7-a44cd2dba85b"
      unitRef="eur">791000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i34c7881faa9548c999a9a866d7049120_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItNS0xLTEtMzY0MDYw_2d3a08e8-48fd-44ea-9b0d-0865065d3ead"
      unitRef="eur">1937000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="ib80a3cdc90b542b3872bb71805fbced2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItNi0xLTEtMzY0MDYw_5d0e54f1-fe50-489f-a068-e10423c189e3"
      unitRef="eur">3176000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzItNy0xLTEtMzY0MDYw_f01b8f55-80ae-408d-b46d-4ed6a65155eb"
      unitRef="eur">8668000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtMS0xLTEtMzY0MDYw_68bb017b-8c9a-4696-90d7-f65afa83fe93"
      unitRef="eur">20086000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtMi0xLTEtMzY0MDYw_4f281383-bc64-46c6-b14e-210730d514d1"
      unitRef="eur">3055000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="id3388b8c97b14858be97adc9fa1bb28f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtMy0xLTEtMzY0MDYw_c06e47c8-c2c7-4857-885c-939939ee8abc"
      unitRef="eur">3588000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtNC0xLTEtMzY0MDYw_737a7201-08b0-494d-a1cb-aa9761514922"
      unitRef="eur">601000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i34c7881faa9548c999a9a866d7049120_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtNS0xLTEtMzY0MDYw_46e8e701-68e6-497a-a133-56887b69c3db"
      unitRef="eur">1751000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="ib80a3cdc90b542b3872bb71805fbced2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtNi0xLTEtMzY0MDYw_d0d3c434-8391-4b4d-97ea-960ad93794c7"
      unitRef="eur">3011000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzMtNy0xLTEtMzY0MDYw_9df2feeb-3449-49b6-a2f3-2a334eb0d172"
      unitRef="eur">8080000000</sny:PrincipalUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtMS0xLTEtMzY0MDYw_23431727-6926-4083-9b09-a1b9a4eba6c7"
      unitRef="eur">1642000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtMi0xLTEtMzY0MDYw_60e55f3d-19ac-46a3-a396-cec0f8cc9098"
      unitRef="eur">275000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="id3388b8c97b14858be97adc9fa1bb28f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtMy0xLTEtMzY0MDYw_f770b6ac-7a81-411f-8b35-4d9ba654f87e"
      unitRef="eur">238000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtNC0xLTEtMzY0MDYw_4c34a227-3481-4380-9e55-e007f3bab0ff"
      unitRef="eur">190000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i34c7881faa9548c999a9a866d7049120_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtNS0xLTEtMzY0MDYw_ae0680ce-d7ef-4501-b148-95885f91c66e"
      unitRef="eur">186000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="ib80a3cdc90b542b3872bb71805fbced2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtNi0xLTEtMzY0MDYw_4d869f16-bb49-492e-9d3a-525ccf37684b"
      unitRef="eur">165000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzQtNy0xLTEtMzY0MDYw_f63e6123-c388-4b51-a940-4f991a460737"
      unitRef="eur">588000000</sny:InterestUndiscountedCashFlow>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtMS0xLTEtMzY0MDYw_48781990-f825-4b29-b04b-e9fdba7274d1"
      unitRef="eur">-51000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtMi0xLTEtMzY0MDYw_889a943f-0998-403a-b7f5-030339ff7d74"
      unitRef="eur">-59000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="id3388b8c97b14858be97adc9fa1bb28f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtMy0xLTEtMzY0MDYw_4d68863b-577b-46d1-9c48-da78951712d9"
      unitRef="eur">-1000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtNC0xLTEtMzY0MDYw_63953b4c-e508-4765-85f2-2d4e31d94e97"
      unitRef="eur">2000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i34c7881faa9548c999a9a866d7049120_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtNS0xLTEtMzY0MDYw_328bfca8-f383-4e81-a333-99637203cfa5"
      unitRef="eur">2000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="ib80a3cdc90b542b3872bb71805fbced2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtNi0xLTEtMzY0MDYw_33fe1584-1e63-4715-a427-1ebf7d4f274f"
      unitRef="eur">2000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzUtNy0xLTEtMzY0MDYw_1ff4b673-0a63-4f80-9551-8f027620f2b6"
      unitRef="eur">3000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <sny:TotalUndiscountedCashFlow
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtMS0xLTEtMzY0MDYw_0afbdd8a-56fb-45b4-b569-ceb97cfc8180"
      unitRef="eur">21677000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtMi0xLTEtMzY0MDYw_016ad58b-b92d-46bc-8786-a4c94e688b32"
      unitRef="eur">3271000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="id3388b8c97b14858be97adc9fa1bb28f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtMy0xLTEtMzY0MDYw_4d643e10-03c1-4a09-ba25-b23d1be28a21"
      unitRef="eur">3825000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i2710cfccacb4408bbbb8f9be6c03ad39_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtNC0xLTEtMzY0MDYw_8b991661-bd9f-4d60-96c0-26a120032c7c"
      unitRef="eur">793000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i34c7881faa9548c999a9a866d7049120_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtNS0xLTEtMzY0MDYw_bb7a0142-b334-407c-967a-2a4b597ef5f4"
      unitRef="eur">1939000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="ib80a3cdc90b542b3872bb71805fbced2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtNi0xLTEtMzY0MDYw_5322c9a5-400d-453f-b9da-74e01db9ad67"
      unitRef="eur">3178000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTo0NDljMWFmNTVlMmE0ZmI0YTUwYjJiYjFhYzIzOTQwYi90YWJsZXJhbmdlOjQ0OWMxYWY1NWUyYTRmYjRhNTBiMmJiMWFjMjM5NDBiXzYtNy0xLTEtMzY0MDYw_93d114b1-b843-4057-a63e-b1771ec142b7"
      unitRef="eur">8671000000</sny:TotalUndiscountedCashFlow>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItMS0xLTEtMzY0MDYw_5fd85f8a-4ab8-4d1c-99d5-9086d3f308f1"
      unitRef="eur">24339000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItMi0xLTEtMzY0MDYw_edf647f5-230d-49ac-9bc2-45e1359acd66"
      unitRef="eur">2943000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i36e91efc121046df8f37594a45bf2954_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItMy0xLTEtMzY0MDYw_e0901b30-fd3e-4f6b-ae2c-d19113a93e5c"
      unitRef="eur">3019000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i03200b0530124cf6b744c38cef9f2c64_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItNC0xLTEtMzY0MDYw_44771a9e-6ba5-40f5-9f4b-3182dd6b7387"
      unitRef="eur">3808000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i82c963ffba184f95b526d153ee99815a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItNS0xLTEtMzY0MDYw_d4152568-ebd1-4b15-902e-41202c573330"
      unitRef="eur">791000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i4b10dc3381f24884b9901897b6d650eb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItNi0xLTEtMzY0MDYw_883f7d88-b3fc-4ba2-aee2-5ca0937f01a0"
      unitRef="eur">1937000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzItNy0xLTEtMzY0MDYw_6dcd24ec-4e38-4ab9-867a-2d9c75adb549"
      unitRef="eur">11841000000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtMS0xLTEtMzY0MDYw_b05be9e0-c65e-49d1-98a2-01d0b9f1eea5"
      unitRef="eur">22392000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtMi0xLTEtMzY0MDYw_d6f3af33-bf08-4b25-b39b-051d18a938c9"
      unitRef="eur">2622000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i36e91efc121046df8f37594a45bf2954_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtMy0xLTEtMzY0MDYw_af024a20-3bc6-415a-bddc-bd48264b933b"
      unitRef="eur">2757000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i03200b0530124cf6b744c38cef9f2c64_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtNC0xLTEtMzY0MDYw_8f0e280f-bf28-424f-98b9-0472b31441ec"
      unitRef="eur">3571000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i82c963ffba184f95b526d153ee99815a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtNS0xLTEtMzY0MDYw_60278f6d-e28c-4e40-b3c4-a4c3399a3a53"
      unitRef="eur">601000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i4b10dc3381f24884b9901897b6d650eb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtNi0xLTEtMzY0MDYw_cad541b2-97c8-4544-8679-d32c2b1dba8a"
      unitRef="eur">1751000000</sny:PrincipalUndiscountedCashFlow>
    <sny:PrincipalUndiscountedCashFlow
      contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzMtNy0xLTEtMzY0MDYw_75d5742f-7041-4c31-9251-044a8348b816"
      unitRef="eur">11090000000</sny:PrincipalUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtMS0xLTEtMzY0MDYw_77069e50-efa9-4244-8728-f33df5a24d69"
      unitRef="eur">1947000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtMi0xLTEtMzY0MDYw_e8f2fe82-1dce-4c27-ae24-4db202220f11"
      unitRef="eur">321000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i36e91efc121046df8f37594a45bf2954_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtMy0xLTEtMzY0MDYw_c7207367-cf7b-4889-a471-4c344f8aa1cc"
      unitRef="eur">262000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i03200b0530124cf6b744c38cef9f2c64_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtNC0xLTEtMzY0MDYw_3f796c4f-346c-4d83-b768-cf7ca9588221"
      unitRef="eur">237000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i82c963ffba184f95b526d153ee99815a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtNS0xLTEtMzY0MDYw_f49e43b0-f401-4f79-a861-d872fa21ba96"
      unitRef="eur">190000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i4b10dc3381f24884b9901897b6d650eb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtNi0xLTEtMzY0MDYw_0c24e3b5-4c34-4ce8-a049-5de8f68ebba4"
      unitRef="eur">186000000</sny:InterestUndiscountedCashFlow>
    <sny:InterestUndiscountedCashFlow
      contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzQtNy0xLTEtMzY0MDYw_d7f6eaaa-94a8-45b2-b8b9-438db62913af"
      unitRef="eur">751000000</sny:InterestUndiscountedCashFlow>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtMS0xLTEtMzY0MDYw_2fcd766d-71fc-487e-8d53-401b03f95db2"
      unitRef="eur">163000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtMi0xLTEtMzY0MDYw_59342d32-a33f-4a3c-bc39-a213c76e653a"
      unitRef="eur">135000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i36e91efc121046df8f37594a45bf2954_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtMy0xLTEtMzY0MDYw_b950facb-047d-4790-b944-f0f4a83afaaa"
      unitRef="eur">28000000</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i03200b0530124cf6b744c38cef9f2c64_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtNC0xLTEtMzY0MDYw_7322b9a9-f9b2-443e-9b99-c3fb0a012f6c"
      unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i82c963ffba184f95b526d153ee99815a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtNS0xLTEtMzY0MDYw_fc62d33c-bb76-4bc4-aca5-549708d8b046"
      unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i4b10dc3381f24884b9901897b6d650eb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtNi0xLTEtMzY0MDYw_9b597ce8-5ba1-4981-9a55-7a671e6223d0"
      unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzUtNy0xLTEtMzY0MDYw_ba452e3b-114e-4da1-ae85-c93122264ae7"
      unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows>
    <sny:TotalUndiscountedCashFlow
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtMS0xLTEtMzY0MDYw_1ec8ce94-2d3c-4118-87ef-812077db8b8d"
      unitRef="eur">24502000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtMi0xLTEtMzY0MDYw_93a2babd-a1c1-4d74-a53d-b8a4594fa11c"
      unitRef="eur">3078000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i36e91efc121046df8f37594a45bf2954_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtMy0xLTEtMzY0MDYw_5c33e404-bb7d-455d-b7d9-67fa690e6622"
      unitRef="eur">3047000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i03200b0530124cf6b744c38cef9f2c64_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtNC0xLTEtMzY0MDYw_93b7f7a2-bcc1-4ef9-b0ab-9de068b02f93"
      unitRef="eur">3808000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i82c963ffba184f95b526d153ee99815a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtNS0xLTEtMzY0MDYw_de37c91c-2729-4295-87bc-db619c2d95d5"
      unitRef="eur">791000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i4b10dc3381f24884b9901897b6d650eb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtNi0xLTEtMzY0MDYw_c61448be-7685-4b5f-95e7-0fe21b5cc010"
      unitRef="eur">1937000000</sny:TotalUndiscountedCashFlow>
    <sny:TotalUndiscountedCashFlow
      contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpjYzkyMjExOGJlY2Q0YjQzYWEyMmQ5MjcxZjY0ODIzZi90YWJsZXJhbmdlOmNjOTIyMTE4YmVjZDRiNDNhYTIyZDkyNzFmNjQ4MjNmXzYtNy0xLTEtMzY0MDYw_d479f991-4bce-478b-9182-e557467a2624"
      unitRef="eur">11841000000</sny:TotalUndiscountedCashFlow>
    <sny:DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0NDQ_6ca0a21a-ac08-4cfa-8764-19cdaa601757">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A maturity analysis of lease liabilities as of December 31, 2022, 2021 and 2020 is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Undiscounted future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less than 1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;From 1 to 3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;From 3 to 5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More than 5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Discounting effect&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Total lease liabilities as of December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,181&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;320&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;515&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;436&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,129&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Total lease liabilities as of December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,108&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;314&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;476&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;362&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,184&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Total lease liabilities as of December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,163&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;247&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;357&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;225&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;482&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Lease liabilities as of December&#160;31, 2022 and December&#160;31, 2021 include leases relating to real estate assets located at Cambridge, MA (United States), as described in Note&#160;D.3., which have a lease term of 15 years.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock>
    <ifrs-full:LeaseLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItMS0xLTEtMzY0MDYw_b8e77a0b-c18d-4dbc-85e1-81d8f3177f99"
      unitRef="eur">2181000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItMi0xLTEtMzY0MDYw_12f71e1b-3004-4e78-89e5-37763b334dfb"
      unitRef="eur">320000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItMy0xLTEtMzY0MDYw_56f77361-6675-4ddc-9f05-5fe5a83ce3f4"
      unitRef="eur">515000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItNC0xLTEtMzY0MDYw_4f5a9e42-0aef-42fc-8cdc-1d9e8503ee4c"
      unitRef="eur">436000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItNS0xLTEtMzY0MDYw_40c6c0dd-b76b-4652-9a38-2b22ee052183"
      unitRef="eur">1129000000</ifrs-full:LeaseLiabilities>
    <sny:LeaseLiabilitiesEffectOfDiscounting
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzItNi0xLTEtMzY0MDYw_e6d8c852-7a68-41c3-9a0a-a4b41bd4974e"
      unitRef="eur">219000000</sny:LeaseLiabilitiesEffectOfDiscounting>
    <ifrs-full:LeaseLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtMS0xLTEtMzY0MDYw_d1d52ba2-bea1-468f-a41e-38055b097ad9"
      unitRef="eur">2108000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtMi0xLTEtMzY0MDYw_27445614-80c7-469c-813e-6677ba104926"
      unitRef="eur">314000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="ie428880947a544b49bb0e7d00760fd8c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtMy0xLTEtMzY0MDYw_afff8fe2-851f-42a7-900a-6421e72c01bd"
      unitRef="eur">476000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="iff9a6cfc0d3c4fb393a0f42915753ff1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtNC0xLTEtMzY0MDYw_2e1079f7-90d5-45b2-b03a-63c59111735a"
      unitRef="eur">362000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtNS0xLTEtMzY0MDYw_e17d27b5-7c66-4040-ae06-d8b16db0244f"
      unitRef="eur">1184000000</ifrs-full:LeaseLiabilities>
    <sny:LeaseLiabilitiesEffectOfDiscounting
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzMtNi0xLTEtMzY0MDYw_b450820b-6226-4d78-ab78-2dbf7591ddad"
      unitRef="eur">228000000</sny:LeaseLiabilitiesEffectOfDiscounting>
    <ifrs-full:LeaseLiabilities
      contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtMS0xLTEtMzY0MDYw_3c3d855a-863a-4ea4-ab6d-9f7f955c321c"
      unitRef="eur">1163000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtMi0xLTEtMzY0MDYw_262199c3-5aec-4153-b1d8-da3219a3f58a"
      unitRef="eur">247000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="i597d4960121a42bbb65d0137e78d145a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtMy0xLTEtMzY0MDYw_d0b55ad5-9952-41fc-9bfd-acc784c13b60"
      unitRef="eur">357000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="i0c3121bafadb4e4f8e35a95800cbc2f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtNC0xLTEtMzY0MDYw_b1ae5f0e-457d-4892-95f2-ca779cc9bafd"
      unitRef="eur">225000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtNS0xLTEtMzY0MDYw_965dfc1e-eed4-44ae-ac64-cfed3328f8ab"
      unitRef="eur">482000000</ifrs-full:LeaseLiabilities>
    <sny:LeaseLiabilitiesEffectOfDiscounting
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90YWJsZTpmYjE0MzJlMmFmOTU0N2I5OTI4NzhmYjQ5YWZjYzA5ZS90YWJsZXJhbmdlOmZiMTQzMmUyYWY5NTQ3Yjk5Mjg3OGZiNDlhZmNjMDllXzQtNi0xLTEtMzY0MDYw_1800c3b8-b545-4b8b-87af-d6d4e3b0d5de"
      unitRef="eur">148000000</sny:LeaseLiabilitiesEffectOfDiscounting>
    <sny:InitialLeaseTerm
      contextRef="if4a75584545048bb9fe869e325a3208b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDAvZnJhZzo2NTg2Y2E0MDE0YjU0YWI5ODI1YjNlNDc1NTFmZTIxNy90ZXh0cmVnaW9uOjY1ODZjYTQwMTRiNTRhYjk4MjViM2U0NzU1MWZlMjE3Xzg0MTM_ceeeef49-d5f4-4b3b-afc6-e66481a63653">P15Y</sny:InitialLeaseTerm>
    <sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ2OTU_1906634f-ffe1-40c8-85c1-355094cd55c7">Liabilities related to business combinations and to non-controlling interests&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For a description of the nature of the liabilities reported in the line item&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Liabilities related to business combinations and to non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, refer to Note&#160;B.8.5. The principal acquisitions are described in Notes&#160;D.1. and&#160;D.2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The liabilities related to business combinations and to non-controlling interests shown in the table below are level&#160;3 instruments under the IFRS&#160;7 fair value hierarchy (see Note&#160;D.12.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Movements in liabilities related to business combinations and to non-controlling interests are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Bayer&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;contingent&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;arising&#160;from&#160;the&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;acquisition of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Genzyme &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MSD&lt;br/&gt;contingent&lt;br/&gt;consideration&lt;br/&gt;(European&lt;br/&gt;Vaccines&lt;br/&gt;business)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shire&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;contingent&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;arising&#160;from&#160;the&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;acquisition of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Translate Bio&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Contingent consideration arising from acquisition of Amunix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance&#160;at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;385&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;259&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance&#160;at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;189&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;605&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;New transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance&#160;at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;269&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;354&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;714&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;New transactions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance&#160;at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;204&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;380&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;165&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;779&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Portion due after more than one year: &#x20ac;674 million as of December 31, 2022 (&#x20ac;577 million as of December 31, 2021 and &#x20ac;387 million as of December 31, 2020); portion due within less than one year: &#x20ac;105 million as of December 31, 2022 (&#x20ac;137 million as of December 31, 2021 and &#x20ac;218 million as of&#160;December 31, 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Amounts reported within the income statement line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair value remeasurement of contingent consideration&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;, and mainly comprising unrealized gains and losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Mainly corresponds to the recognition of the Shire Human Genetic Therapies&#160;Inc. (Shire) contingent consideration liability of $382 million resulting from the acquisition of Translate Bio in September&#160;2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d)&#160;&#160;&#160;&#160;The &#x201c;Other&#x201d; column mainly relates to the contingent consideration liability due to True North Therapeutics as a result of Sanofi's acquisition of Bioverativ which was settled in the first half of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liabilities related to business combinations and to non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; mainly comprised:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the Bayer contingent consideration liability arising from Sanofi's acquisition of Genzyme in 2011. As of December 31, 2022, Bayer was still entitled to receive the following potential payments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;a percentage of sales of alemtuzumab up to a maximum of $1,250 million or over a maximum period of 10&#160;years, whichever is achieved first,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;milestone payments subject to the attainment of specified levels of worldwide sales of alemtuzumab beginning in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:11.25pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The fair value of this liability was measured at &#x20ac;26 million as of December 31, 2022, compared with &#x20ac;59 million as of December 31, 2021 and &#x20ac;104 million as of December 31, 2020. The fair value of the Bayer liability is determined by applying the contractual terms to sales projections which have been weighted to reflect the probability of success, and discounted. If the discount rate were to fall by one percentage point, the fair value of the Bayer liability would increase by approximately 1%;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the MSD contingent consideration liability arising from the 2016 acquisition of the Sanofi Pasteur activities carried on within the former Sanofi Pasteur MSD joint venture, which amounted to &#x20ac;204 million as of December 31, 2022, &#x20ac;269 million as of&#160;December 31, 2021 and &#x20ac;312 million as of December 31, 2020 (see Note&#160;D.12.). The fair value of this contingent consideration is determined by applying the royalty percentage stipulated in the contract to discounted sales projections. If the discount rate were to fall by one percentage point, the fair value of the MSD contingent consideration liability would increase by approximately 1%;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;a contingent consideration liability towards Shire Human Genetic Therapies Inc. (Shire) arising from Sanofi's acquisition of Translate&#160;Bio in September&#160;2021. In a December&#160;2016 business combination predating the acquisition of control by Sanofi, Translate Bio (then called Rana Therapeutics, Inc.) acquired from Shire the intellectual property rights relating to the latter's Messenger RNA Therapeutics (MRT) program. As of December 31, 2022, Shire was entitled to receive the following potential payments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;milestone payments contingent on the launch of products based on MRT technology, and on the attainment of a specified level of sales of those products, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.68pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:5.99pt"&gt;a percentage of sales of those products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-0.01pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The fair value of the Shire liability was measured at &#x20ac;380 million as of December 31, 2022, compared with &#x20ac;354 million as of&#160;December 31, 2021; it was determined by applying the contractual terms to development and sales projections which were weighted to reflect the probability of success, and discounted. If the discount rate were to fall by one percentage point, the fair value of the Shire liability would increase by approximately 13%;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the contingent consideration liability arising from the 2022 acquisition of Amunix. The fair value of the liability is determined on&#160;the basis of the nominal value of payments due subject to the attainment of specified&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; development milestones; these&#160;are&#160;weighted to reflect the probability of success, and discounted. The liability was measured at &#x20ac;165&#160;million as of December 31, 2022. If the discount rate were to fall by one percentage point, the fair value of the liability would increase by approximately&#160;1%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth the maximum amount of contingent consideration payable in respect of already-marketed products:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;From&#160;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;From&#160;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Commitments relating to contingent consideration&#160;in connection with business combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes &#x20ac;0.4 billion for the Bayer contingent consideration, &#x20ac;0.2 billion for the MSD contingent consideration.&lt;/span&gt;&lt;/div&gt;The nominal amount of contingent consideration was &#x20ac;689 million as of December 31, 2021 and &#x20ac;1,043 million as of December 31, 2020.</sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock>
    <sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ2OTc_389c12a9-4383-4aff-9e38-daf0cff3cbcd">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Movements in liabilities related to business combinations and to non-controlling interests are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Bayer&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;contingent&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;arising&#160;from&#160;the&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;acquisition of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Genzyme &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MSD&lt;br/&gt;contingent&lt;br/&gt;consideration&lt;br/&gt;(European&lt;br/&gt;Vaccines&lt;br/&gt;business)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shire&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;contingent&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;arising&#160;from&#160;the&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;acquisition of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Translate Bio&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Contingent consideration arising from acquisition of Amunix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance&#160;at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;385&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;259&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance&#160;at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;189&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;605&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;New transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance&#160;at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;269&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;354&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;714&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;New transactions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other movements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance&#160;at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;204&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;380&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;165&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;779&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Portion due after more than one year: &#x20ac;674 million as of December 31, 2022 (&#x20ac;577 million as of December 31, 2021 and &#x20ac;387 million as of December 31, 2020); portion due within less than one year: &#x20ac;105 million as of December 31, 2022 (&#x20ac;137 million as of December 31, 2021 and &#x20ac;218 million as of&#160;December 31, 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Amounts reported within the income statement line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair value remeasurement of contingent consideration&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;, and mainly comprising unrealized gains and losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Mainly corresponds to the recognition of the Shire Human Genetic Therapies&#160;Inc. (Shire) contingent consideration liability of $382 million resulting from the acquisition of Translate Bio in September&#160;2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d)&#160;&#160;&#160;&#160;The &#x201c;Other&#x201d; column mainly relates to the contingent consideration liability due to True North Therapeutics as a result of Sanofi's acquisition of Bioverativ which was settled in the first half of 2021.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i8e622d8cb4934c84ad1e319b2aff140b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtMy0xLTEtMzY0MDYw_864f85ba-e6a6-4e6e-ae25-c68028b6a33b"
      unitRef="eur">156000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i5f5f52dce766446e8aa8c13efb12df1f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtNC0xLTEtMzY0MDYw_a074a991-faf0-4808-adc2-6aae956cf571"
      unitRef="eur">385000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i3a26a676a71148dbbed13648e1ad3400_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtNS0xLTEtMzY0MDYw_da9d7056-b0b2-47b7-8d21-257563e5d50f"
      unitRef="eur">0</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i1d472a3e57b147aeb03a38a1c58e1c64_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtNi0xLTEtMzY4NTUx_4d68a5e7-307d-4e3b-86d6-4eaf37ec60fc"
      unitRef="eur">0</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="ida0de68516d145a58b76c93f372cbcc5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtNi0xLTEtMzY0MDYw_3d378bb3-f9b8-4616-ada6-0fb37fec1e19"
      unitRef="eur">259000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEtNy0xLTEtMzY0MDYw_33757cf2-b02b-4f25-82d6-59f5f7e2699e"
      unitRef="eur">800000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="idf3de6cf917a44899ea3e45a8a4818fc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtMy0xLTEtMzY0MDYw_ac6074a5-5b08-4775-ac0c-f48e39ebd0d6"
      unitRef="eur">42000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i8e44cd8b091f420abc8a03afa2bb16e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtNC0xLTEtMzY0MDYw_c478391c-09ee-4de7-bbc8-70191c0e3bd4"
      unitRef="eur">78000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i96eb878aad884bb1836b938d8ed8cb7b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtNS0xLTEtMzY0MDYw_5de641bb-3245-4f02-8c43-204db0daafc4"
      unitRef="eur">0</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i1bc6ab03815b40d8abfda40457a31676_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtNi0xLTEtMzY4NTUx_a6ae532e-a0f9-4c85-b0ff-20db826b2ae4"
      unitRef="eur">0</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="ib7a524009bd4455fa39f388d2372d26c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtNi0xLTEtMzY0MDYw_7001e341-7ae8-4139-ac54-700cf019b075"
      unitRef="eur">2000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzMtNy0xLTEtMzY0MDYw_8558c5f3-320f-41f5-9601-cac98a102bcd"
      unitRef="eur">122000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="idf3de6cf917a44899ea3e45a8a4818fc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtMy0xLTEtMzY0MDYw_9da23b8a-0c81-418d-ac5f-a553919d954e"
      unitRef="eur">9000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i8e44cd8b091f420abc8a03afa2bb16e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtNC0xLTEtMzY0MDYw_7e0e1996-265f-4e16-9fbe-58f2423e6078"
      unitRef="eur">9000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i96eb878aad884bb1836b938d8ed8cb7b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtNS0xLTEtMzY0MDYw_d05daa93-aa77-478a-b44f-3ab105fae92d"
      unitRef="eur">0</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i1bc6ab03815b40d8abfda40457a31676_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtNi0xLTEtMzY4NTUx_2181415d-6ec5-4f14-b511-411490030dad"
      unitRef="eur">0</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="ib7a524009bd4455fa39f388d2372d26c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtNi0xLTEtMzY0MDYw_3db2d6b7-b346-45b3-8203-2a62d7d47782"
      unitRef="eur">-53000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzQtNy0xLTEtMzY0MDYw_caec917a-274e-48f7-8c30-a2796ed70d96"
      unitRef="eur">-35000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <sny:OtherMovements
      contextRef="idf3de6cf917a44899ea3e45a8a4818fc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtMy0xLTEtMzY0MDYw_26c7f212-7ab3-4161-a864-f972d56c0ec5"
      unitRef="eur">8000000</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="i8e44cd8b091f420abc8a03afa2bb16e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtNC0xLTEtMzY0MDYw_5ea851d6-18bd-436a-9d5b-601a73f87c0e"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="i96eb878aad884bb1836b938d8ed8cb7b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtNS0xLTEtMzY0MDYw_3e0ddf2d-5fee-4e3e-a9d3-ebdfaee7e82e"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="i1bc6ab03815b40d8abfda40457a31676_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtNi0xLTEtMzY4NTUx_6902ef38-e4e6-4c8b-bc92-a7524e971490"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="ib7a524009bd4455fa39f388d2372d26c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtNi0xLTEtMzY0MDYw_3cb95fcb-ca67-4658-9a44-cb9cd0fdf26a"
      unitRef="eur">2000000</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzUtNy0xLTEtMzY0MDYw_f13964cc-e963-4df3-a783-1eec4334be5b"
      unitRef="eur">10000000</sny:OtherMovements>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="idf3de6cf917a44899ea3e45a8a4818fc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtMy0xLTEtMzY0MDYw_2bb748a4-c0f2-49ba-aea0-f025fc6ac237"
      unitRef="eur">-11000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i8e44cd8b091f420abc8a03afa2bb16e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtNC0xLTEtMzY0MDYw_3b2bd1c1-8c4c-42bb-8e3d-8d8a9ed9caa8"
      unitRef="eur">-4000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i96eb878aad884bb1836b938d8ed8cb7b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtNS0xLTEtMzY0MDYw_49d16387-5a2d-4fa8-befc-8a2b3f6519ee"
      unitRef="eur">0</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i1bc6ab03815b40d8abfda40457a31676_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtNi0xLTEtMzY4NTUx_bc546579-54ba-4235-9369-33b4d162545e"
      unitRef="eur">0</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="ib7a524009bd4455fa39f388d2372d26c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtNi0xLTEtMzY0MDYw_fcb53924-8fc3-4fda-9287-27c193fdd590"
      unitRef="eur">-13000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzYtNy0xLTEtMzY0MDYw_780f08fa-b88c-4c43-98b5-ba27dbca5ab1"
      unitRef="eur">-28000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i86bc2d12cd7842f099841197a912ae1d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctMy0xLTEtMzY0MDYw_d5275e43-f4c8-45fc-93f8-dbce4be74b86"
      unitRef="eur">104000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i0cde6022813d4c0faf7f41e7da37f957_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctNC0xLTEtMzY0MDYw_016cce6f-5805-42a4-a750-5db266d14a85"
      unitRef="eur">312000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i276543f6767c4836beb195c81c4f8a9d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctNS0xLTEtMzY0MDYw_29e7c270-6928-4dfb-91d0-9889a4c6852a"
      unitRef="eur">0</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="ia42d31397cec4401901cafed6f408fdf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctNi0xLTEtMzY4NTUx_cad39c42-fce2-40cf-9db5-7edb0b0eaca0"
      unitRef="eur">0</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i0b6de6418317488f82c440f54eb0498c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctNi0xLTEtMzY0MDYw_27d9cc0c-8769-4a7c-86de-0a842ec36521"
      unitRef="eur">189000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzctNy0xLTEtMzY0MDYw_09b4966e-8707-40c7-b0b1-6b40188a24fd"
      unitRef="eur">605000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtMy0xLTEtMzY0MDYw_eabc2328-ba3a-4ba2-9da2-8ed9f4ff395a"
      unitRef="eur">0</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtNC0xLTEtMzY0MDYw_dcd3e3d1-ae6f-4c0c-b977-1b669a65b779"
      unitRef="eur">0</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtNS0xLTEtMzY0MDYw_117fa85c-1730-4294-9f60-4b2ac3af38ca"
      unitRef="eur">323000000</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtNi0xLTEtMzY4NTUx_f0a0f686-4044-484f-a0ee-49801aa228dc"
      unitRef="eur">0</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtNi0xLTEtMzY0MDYw_432e37a1-07a3-4dff-adae-6df588fa1b65"
      unitRef="eur">37000000</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzgtNy0xLTEtMzY0MDYw_20d62c48-9b64-474f-b913-efe03111f905"
      unitRef="eur">360000000</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktMy0xLTEtMzY0MDYw_6d211872-39f9-40dd-9868-6f28545c58ef"
      unitRef="eur">31000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktNC0xLTEtMzY0MDYw_13bdd5df-d01e-4ed9-9920-7cd9742d7a7a"
      unitRef="eur">75000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktNS0xLTEtMzY0MDYw_e69fc51e-e257-4618-b96b-c96b23786d63"
      unitRef="eur">0</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktNi0xLTEtMzY4NTUx_610b497d-47a7-4bc8-83c1-34d92dba9b9b"
      unitRef="eur">0</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktNi0xLTEtMzY0MDYw_821aff80-76a9-4022-964d-4e48ce16e096"
      unitRef="eur">152000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzktNy0xLTEtMzY0MDYw_b6a20192-aeb4-45c8-b049-61f250e8f15f"
      unitRef="eur">258000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTMtMS0xLTM2NDA2MA_3e3af05f-484c-45e4-a90e-979f92a99f65"
      unitRef="eur">-18000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTQtMS0xLTM2NDA2MA_bcc7ca44-e77d-4332-be8c-6722902a6b50"
      unitRef="eur">26000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTUtMS0xLTM2NDA2MA_d06178de-8748-4bf9-86ad-934e85c0f653"
      unitRef="eur">19000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTYtMS0xLTM2ODU1MQ_c8ce024f-36fc-43f1-a98b-54281a806abe"
      unitRef="eur">0</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTYtMS0xLTM2NDA2MA_2bb05acf-788f-4af2-bc2d-10887d4af2c4"
      unitRef="eur">-31000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEwLTctMS0xLTM2NDA2MA_3e3b334b-152d-496a-8392-e59cfdc1d447"
      unitRef="eur">-4000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <sny:OtherMovements
      contextRef="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTMtMS0xLTM2NDA2MA_b451d8df-ace7-4871-b164-ba190bada6bf"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTQtMS0xLTM2NDA2MA_48bd68a5-7cd3-43d0-a996-8bc38bf078af"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTUtMS0xLTM2NDA2MA_cf5ddbcb-3d46-4072-88c8-411d72bf0a33"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTYtMS0xLTM2ODU1MQ_8fde67cf-441f-4f2a-bf79-a978cc32230b"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTYtMS0xLTM2NDA2MA_1b50b038-909d-41d1-8d5f-b70a2d0a1146"
      unitRef="eur">14000000</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzExLTctMS0xLTM2NDA2MA_4c8ab710-aec5-41a7-8ead-c51757034b7c"
      unitRef="eur">14000000</sny:OtherMovements>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i68dbcd4a19554ffa8c5f94423bd0f790_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTMtMS0xLTM2NDA2MA_331b29a0-2474-4f99-aaab-ebe87e65c89a"
      unitRef="eur">4000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i38ea31baf0b143c895bedacbdef96542_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTQtMS0xLTM2NDA2MA_bf694492-afdf-4632-a4ae-232f78e7f38a"
      unitRef="eur">6000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i9c9d5adbb8d945d39d408ad415c196e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTUtMS0xLTM2NDA2MA_315d7b72-01de-4fae-896d-9262d4110979"
      unitRef="eur">12000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="ie92fdc29398f434baa9ad21f5fdc71f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTYtMS0xLTM2ODU1MQ_507cf090-cd30-4600-a312-5c050b95f983"
      unitRef="eur">0</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i362cbb07a08e45bfa2bcf658f57b1f87_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTYtMS0xLTM2NDA2MA_ad5a4788-4959-4225-81ab-6571928835d4"
      unitRef="eur">3000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEyLTctMS0xLTM2NDA2MA_12bdf705-dd49-4b50-8b7d-805e64a33386"
      unitRef="eur">25000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="ic709e4b4631c4e698a72e76c85ee85b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTMtMS0xLTM2NDA2MA_9fc3bbff-b7cd-47ab-86be-0ec47c1b4c1e"
      unitRef="eur">59000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="iad675e551ad149f2bef90277d9fc9dfd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTQtMS0xLTM2NDA2MA_b8bee069-42dd-4e92-b7aa-678b78ac54f2"
      unitRef="eur">269000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i5321b815afeb4a57a109cf015f023977_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTUtMS0xLTM2NDA2MA_fcd7f0be-2095-4734-b99e-f4106e207597"
      unitRef="eur">354000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i1c1ada8ab8e643c880ed5b7be15fcdd3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTYtMS0xLTM2ODU1MQ_382a898d-4b8c-462f-af6a-b92127c09182"
      unitRef="eur">0</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="if7c05c49e9a749a280011ae480cc3b0d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTYtMS0xLTM2NDA2MA_9741cc09-cb16-4a7b-be98-8883486eb365"
      unitRef="eur">32000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzEzLTctMS0xLTM2NDA2MA_e8fc4a99-e1a6-4e5c-82c3-d4d60dcebb58"
      unitRef="eur">714000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTMtMS0xLTM2NDA2MA_69173e29-b782-4068-8795-afb9fa2fb722"
      unitRef="eur">0</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i9028475126f24188932b789c9c3a8b88_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTQtMS0xLTM2NDA2MA_12651448-6b41-4973-ac2c-7883f1af9118"
      unitRef="eur">0</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i4be94d08066947e295889299f946ac89_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTUtMS0xLTM2NDA2MA_6e215f5a-7c79-473c-be25-478101386e80"
      unitRef="eur">0</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTYtMS0xLTM2ODU1MQ_c27de62b-56f9-437a-842e-6a71745ed83d"
      unitRef="eur">156000000</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTYtMS0xLTM2NDA2MA_c38ae769-c8fe-447f-a701-eec738393cff"
      unitRef="eur">0</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE0LTctMS0xLTM2NDA2MA_bf752413-9a60-4aa3-80ac-b90740558115"
      unitRef="eur">156000000</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTMtMS0xLTM2NDA2MA_518a10f0-3a08-4a52-b444-0c787b5522c2"
      unitRef="eur">29000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i9028475126f24188932b789c9c3a8b88_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTQtMS0xLTM2NDA2MA_9b094508-6437-4439-9f90-f383c0f8a4e8"
      unitRef="eur">79000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i4be94d08066947e295889299f946ac89_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTUtMS0xLTM2NDA2MA_1c98d84f-036c-46c3-a98f-2650602f4c24"
      unitRef="eur">0</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTYtMS0xLTM2ODU1MQ_5dcda018-1bee-4d3c-82c4-eda34f96dc16"
      unitRef="eur">0</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTYtMS0xLTM2NDA2MA_5a8354c8-2468-4fd5-b483-02ba1ede2ea1"
      unitRef="eur">28000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE1LTctMS0xLTM2NDA2MA_69eb603b-fce7-4987-a888-2250131d7509"
      unitRef="eur">136000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTMtMS0xLTM2NDA2MA_979252e5-c538-4279-b62d-b3cb42e82fcf"
      unitRef="eur">-9000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i9028475126f24188932b789c9c3a8b88_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTQtMS0xLTM2NDA2MA_01d4addd-0bb5-488d-8c99-d2d390ebc96c"
      unitRef="eur">14000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i4be94d08066947e295889299f946ac89_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTUtMS0xLTM2NDA2MA_41e9e8be-0f0a-414d-8418-045b263547ea"
      unitRef="eur">2000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTYtMS0xLTM2ODU1MQ_ecbe9757-59f8-435e-9d64-c7446361988b"
      unitRef="eur">-2000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTYtMS0xLTM2NDA2MA_eb202f53-fd26-4792-847f-06c1dec981a2"
      unitRef="eur">0</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE2LTctMS0xLTM2NDA2MA_477c9579-11e8-465d-b1b5-baff9c9e43be"
      unitRef="eur">5000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <sny:OtherMovements
      contextRef="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTMtMS0xLTM2NDA2MA_d9b77763-44ca-4719-978a-803dff33b2ae"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="i9028475126f24188932b789c9c3a8b88_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTQtMS0xLTM2NDA2MA_e6eca165-003d-4e2f-a361-db621cac1e6d"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="i4be94d08066947e295889299f946ac89_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTUtMS0xLTM2NDA2MA_a076f157-4fba-4d56-a6fa-84be28615fb0"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTYtMS0xLTM2ODU1MQ_f0270c6a-aa11-4a43-b3ae-f5e9ab47528a"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTYtMS0xLTM2NDA2MA_db4e7b05-c9dc-4a29-bba3-ffeed29cde0b"
      unitRef="eur">0</sny:OtherMovements>
    <sny:OtherMovements
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE3LTctMS0xLTM2NDA2MA_f7d7c066-bb38-4edb-bba2-3f8901532d5d"
      unitRef="eur">0</sny:OtherMovements>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i5f26dd6e86e649b5b00b8c4103262142_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTMtMS0xLTM2NDA2MA_d4cb292d-8f0f-4e61-8a19-ae7e8c69a6e7"
      unitRef="eur">5000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i9028475126f24188932b789c9c3a8b88_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTQtMS0xLTM2NDA2MA_f4eae446-a171-4c4f-8c7c-5ef89722cbb7"
      unitRef="eur">0</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i4be94d08066947e295889299f946ac89_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTUtMS0xLTM2NDA2MA_eb6bcf78-7cfa-4fd7-96db-32d8f79b5b17"
      unitRef="eur">24000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="ie7a496b82f924022805cae2c2e05693e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTYtMS0xLTM2ODU1MQ_e4ecb6dd-8855-4927-8206-76ceef6c461d"
      unitRef="eur">11000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="i9d9e533b893a423080bb61ebaf14a1b1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTYtMS0xLTM2NDA2MA_5c99b7e7-532d-4e0c-b809-308068997df2"
      unitRef="eur">0</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE4LTctMS0xLTM2NDA2MA_bd4fc3ef-d603-48db-9139-dff7e4518e63"
      unitRef="eur">40000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i48e232fbe36749e39b797ba6bb47d688_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTMtMS0xLTM2NDA2MA_e67951ae-b12b-449a-8b6f-50ca613d16c5"
      unitRef="eur">26000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i24d884695eeb435a925fbec2c89281ad_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTQtMS0xLTM2NDA2MA_a1b15adb-c762-44ab-849c-dd549bd2e7a4"
      unitRef="eur">204000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="ic6840db205a344f3a3a3624ad1fe3d84_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTUtMS0xLTM2NDA2MA_34031972-d0b6-49ab-bfff-688b6e969805"
      unitRef="eur">380000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i2ff7c27b940f47dc8db4744efa5751f9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTYtMS0xLTM2ODU1MQ_bab830cf-e552-4442-b5f2-8553b9a3102b"
      unitRef="eur">165000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="ibe52215125434d49876df22db77015d8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTYtMS0xLTM2NDA2MA_17293478-cbb2-4401-8620-d24071ea43aa"
      unitRef="eur">4000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo4YWU2YTBjMjc0YjE0ZGY2ODI0MWJkZDcyZjRiMDhkOS90YWJsZXJhbmdlOjhhZTZhMGMyNzRiMTRkZjY4MjQxYmRkNzJmNGIwOGQ5XzE5LTctMS0xLTM2NDA2MA_67d88858-3eb2-4a4b-8a56-9d0ccca359c3"
      unitRef="eur">779000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzEwNTI_401ba9a6-3730-4187-acc0-f087552db9c9"
      unitRef="eur">674000000</sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzEwNjU_acec6b26-dead-4913-98ab-7388bf7d0d93"
      unitRef="eur">577000000</sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzEwODE_1e7e0ac4-a448-4077-98ee-cb916e4ac096"
      unitRef="eur">387000000</sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzExMzQ_fc5d8ecc-8843-4a7a-bc40-6e77e8f4027f"
      unitRef="eur">105000000</sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzExNDc_003b1ea7-ad24-4276-a42e-b3ad303c6a86"
      unitRef="eur">137000000</sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzExNjM_f48d7e38-ca4b-4ba3-ae6d-8551688adb9f"
      unitRef="eur">218000000</sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:ContingentConsiderationLiabilities
      contextRef="i39a7aeb71d26483d91e0c2fa09f8bace_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzE0NzE_1cf43d24-5e66-4c2b-a562-b6bb54cd272a"
      unitRef="usd">382000000</sny:ContingentConsiderationLiabilities>
    <sny:PotentialPaymentsRelatedToPercentageOfSales
      contextRef="i61a0d34e548c452b80e7527cff0720d1_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIwOTE_901c6b35-5427-40ee-8a2e-38261f5b0817"
      unitRef="usd">1250000000</sny:PotentialPaymentsRelatedToPercentageOfSales>
    <sny:PaymentToSaleOfBusinessPeriod
      contextRef="i59afdb4fc3d74ad98a57783363180e8f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIxMjI_299e0450-e83c-48e9-b6e7-05fe819c306e">P10Y</sny:PaymentToSaleOfBusinessPeriod>
    <sny:MilestonePaymentTerm
      contextRef="i59afdb4fc3d74ad98a57783363180e8f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIyNzM_e3bc0a4d-b42d-44ec-9713-a4dc51627025">2021</sny:MilestonePaymentTerm>
    <sny:FairValueOfContingentConsiderationPayable
      contextRef="iffd5a4bf38dc4532a6905a24f9510e2b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIzMjY_563b059e-54c5-4f2b-8a98-ba05db11225b"
      unitRef="eur">26000000</sny:FairValueOfContingentConsiderationPayable>
    <sny:FairValueOfContingentConsiderationPayable
      contextRef="ie797eb00f7304dddbf2cde22a2826442_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIzNTM_261462af-b6cf-41c5-9d0f-190ac80f1036"
      unitRef="eur">59000000</sny:FairValueOfContingentConsiderationPayable>
    <sny:FairValueOfContingentConsiderationPayable
      contextRef="i5f26ac7c041844fa84f5ccaf51563dde_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzIzNjk_0c05b441-3950-4a13-a8c3-ef3da7a0314b"
      unitRef="eur">104000000</sny:FairValueOfContingentConsiderationPayable>
    <sny:PercentageIncreaseInFairValueLiabilities
      contextRef="iffd5a4bf38dc4532a6905a24f9510e2b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzI2OTc_af6290b6-b34e-4fc6-a9db-46b3f8c2f39b"
      unitRef="number">0.01</sny:PercentageIncreaseInFairValueLiabilities>
    <sny:FairValueOfContingentConsiderationPayable
      contextRef="i24d884695eeb435a925fbec2c89281ad_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzI4OTM_efb8ba29-edbe-47ae-a85e-a820a20d353a"
      unitRef="eur">204000000</sny:FairValueOfContingentConsiderationPayable>
    <sny:FairValueOfContingentConsiderationPayable
      contextRef="iad675e551ad149f2bef90277d9fc9dfd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzI5MDY_d5913984-bd9a-4ec4-9f14-15ec654a0b16"
      unitRef="eur">269000000</sny:FairValueOfContingentConsiderationPayable>
    <sny:FairValueOfContingentConsiderationPayable
      contextRef="i0cde6022813d4c0faf7f41e7da37f957_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzI5MjI_19dda148-acad-4224-a5c3-7649f2fc17c7"
      unitRef="eur">312000000</sny:FairValueOfContingentConsiderationPayable>
    <sny:PercentageIncreaseInFairValueLiabilities
      contextRef="i24d884695eeb435a925fbec2c89281ad_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzMyNjA_edebfb2e-967f-46ac-85be-58db9daa38b7"
      unitRef="number">0.01</sny:PercentageIncreaseInFairValueLiabilities>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="ic6840db205a344f3a3a3624ad1fe3d84_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQwMDc_e6c4b39b-17d0-42ca-9e99-09b8d520abce"
      unitRef="eur">380000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i5321b815afeb4a57a109cf015f023977_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzMwMjM2NTY5NzcwMTU3_d8771181-852e-4b55-b8ee-d34fdf87a205"
      unitRef="eur">354000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <sny:PercentageIncreaseInFairValueLiabilities
      contextRef="i8794718e5aa14c49a27eea0403dcf813_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQzMTM_6e3a6d6b-b558-4d80-95fb-044cbb82aba2"
      unitRef="number">0.13</sny:PercentageIncreaseInFairValueLiabilities>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="i2ff7c27b940f47dc8db4744efa5751f9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzEwOTk1MTE2MzMzMTM_1fbe394c-a9d3-40ed-a832-d1abb2861011"
      unitRef="eur">165000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <sny:PercentageIncreaseInFairValueLiabilities
      contextRef="i2ff7c27b940f47dc8db4744efa5751f9_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzEwOTk1MTE2MzMzMTc_787d4943-ee3e-472c-8239-c007bc817457"
      unitRef="number">0.01</sny:PercentageIncreaseInFairValueLiabilities>
    <sny:DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ2OTI_3524b7fc-381b-4edc-892a-ca0f3de459c7">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth the maximum amount of contingent consideration payable in respect of already-marketed products:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;From&#160;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;From&#160;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Commitments relating to contingent consideration&#160;in connection with business combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes &#x20ac;0.4 billion for the Bayer contingent consideration, &#x20ac;0.2 billion for the MSD contingent consideration.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock>
    <sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo3MjBkNTU5MmJiZmY0YTg4YWVhZjFlMGMwMTYwYWEyYi90YWJsZXJhbmdlOjcyMGQ1NTkyYmJmZjRhODhhZWFmMWUwYzAxNjBhYTJiXzItMS0xLTEtMzY0MDYw_03d9ca83-c22a-446d-8957-e7ea2979a8b5"
      unitRef="eur">604000000</sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations>
    <sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo3MjBkNTU5MmJiZmY0YTg4YWVhZjFlMGMwMTYwYWEyYi90YWJsZXJhbmdlOjcyMGQ1NTkyYmJmZjRhODhhZWFmMWUwYzAxNjBhYTJiXzItMi0xLTEtMzY0MDYw_fa90781a-86e4-4593-8786-a5ca73c66aa1"
      unitRef="eur">104000000</sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations>
    <sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations
      contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo3MjBkNTU5MmJiZmY0YTg4YWVhZjFlMGMwMTYwYWEyYi90YWJsZXJhbmdlOjcyMGQ1NTkyYmJmZjRhODhhZWFmMWUwYzAxNjBhYTJiXzItMy0xLTEtMzY0MDYw_9a883b95-7dae-4967-8791-b94be16558c0"
      unitRef="eur">145000000</sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations>
    <sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations
      contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo3MjBkNTU5MmJiZmY0YTg4YWVhZjFlMGMwMTYwYWEyYi90YWJsZXJhbmdlOjcyMGQ1NTkyYmJmZjRhODhhZWFmMWUwYzAxNjBhYTJiXzItNC0xLTEtMzY0MDYw_bcc4baf2-1073-4062-af65-76c7b78ec8bb"
      unitRef="eur">0</sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations>
    <sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90YWJsZTo3MjBkNTU5MmJiZmY0YTg4YWVhZjFlMGMwMTYwYWEyYi90YWJsZXJhbmdlOjcyMGQ1NTkyYmJmZjRhODhhZWFmMWUwYzAxNjBhYTJiXzItNS0xLTEtMzY0MDYw_5a4168fb-2be4-4ead-a29a-5702f7d42afc"
      unitRef="eur">355000000</sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations>
    <sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer
      contextRef="iffd5a4bf38dc4532a6905a24f9510e2b_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ0MTU_c2200a78-3a62-49ae-ad1f-f6b041cf712d"
      unitRef="eur">400000000</sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer>
    <sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD
      contextRef="i24d884695eeb435a925fbec2c89281ad_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ0NjE_2f40c29b-d956-4f9f-ad8f-126eaebd222a"
      unitRef="eur">200000000</sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD>
    <sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ1NTQ_de4d7fcb-e942-4a24-9bcb-cc35c6ae7e55"
      unitRef="eur">689000000</sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations>
    <sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDMvZnJhZzpjNzdkNjY3OTA5ZjI0Yjc1ODlmOGFmMjZmNzQwM2VjOC90ZXh0cmVnaW9uOmM3N2Q2Njc5MDlmMjRiNzU4OWY4YWYyNmY3NDAzZWM4XzQ1NzA_edc31492-b7a4-408a-a289-20065c3c935d"
      unitRef="eur">1043000000</sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations>
    <sny:DisclosureOfProvisionsAndOtherLiabilitiesTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NTA5_f3c99a14-7b90-41d7-a4e8-3e1c1a8a4e8b">Provisions, income tax liabilities and other liabilities&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non current provisions and other non-current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; comprises the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,341&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,721&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,315&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (IAS&#160;19, Employee Benefits), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Includes derivative financial instru&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;ments: &#x20ac;232 million as of De&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;cember&#160;31, 2022, &#x20ac;6 million as of December&#160;31, 2021, &#x20ac;92 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Non-current income tax liabilities are described in Note&#160;D.19.4., and other current liabilities in Note&#160;D.19.5.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth movements in non-current provisions for the reporting periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Provisions&#160;for&lt;br/&gt;pensions and&lt;br/&gt;other&#160;post-employment&lt;br/&gt;benefits&lt;br/&gt;(D.19.1.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Provisions&lt;br/&gt;for other&lt;br/&gt;long-term&lt;br/&gt;benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Restructuring&lt;br/&gt;provisions&lt;br/&gt;(D.19.2.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;provisions&lt;br/&gt;(D.19.3.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,599&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;855&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;600&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,071&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,125&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases in provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provisions utilized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(566)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(793)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reversals of unutilized provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(518)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest related to employee benefits, and unwinding of discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial gains and losses on defined-benefit plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,276&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;879&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;868&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,975&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,998&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases in provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provisions utilized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(222)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(459)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reversals of unutilized provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(425)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest related to employee benefits, and unwinding of discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial gains and losses on defined-benefit plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,947&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;935&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;524&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,024&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,430&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases in provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provisions utilized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reversals of unutilized provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest related to employee benefits, and unwinding of discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial gains and losses on defined-benefit plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,039&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;844&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;761&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,178&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,822&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) In the case of &#x201c;Provisions for pensions and other post-employment benefits&#x201d;, the &#x201c;Increases in provisions&#x201d; line corresponds to rights vesting in employees during the period, and past service cost; the &#x201c;Provisions utilized&#x201d; line corresponds to contributions paid into pension funds and to beneficiaries; and the&#160;&#x201c;Reversals of unutilized provisions&#x201d; line corresponds to plan curtailments, settlements and amendments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.19.1. Provisions for pensions and other post-employment benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi offers its employees pension plans and other post-employment benefit plans. The specific features of the plans (benefit formulas, fund investment policy and fund assets held) vary depending on the applicable laws and regulations in each country where the employees work. These employee benefits are accounted for in accordance with IAS&#160;19 (see Note&#160;B.23.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi&#x2019;s pension obligations in four&#160;major countries represented approximately 89% of the total value of the defined-benefit obligation and approximately 88% of the total value of plan assets as of December 31, 2022. The features of the principal defined-benefit plans in each of those four countries are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;France&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lump-sum retirement benefit plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;All employees working for Sanofi in France are entitled on retirement to a lump-sum payment, the amount of which depends both on their length of service and on the rights guaranteed by collective and internal agreements. The employee&#x2019;s final salary is used in calculating the amount of these lump-sum retirement benefits. These plans represent approximately 35% of Sanofi&#x2019;s total obligation in France.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Defined-benefit pension plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;These plans provide benefits from the date of retirement. Employees must fulfil a number of criteria to be eligible for these benefits. All of these plans are now closed. These plans represent approximately&#160;65% of Sanofi&#x2019;s total obligation in France.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Germany&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Top-up defined-benefit pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The benefits offered under this pension plan are wholly funded by the employer (there are no employee contributions) via a Contractual Trust Agreement (CTA), under which benefits are estimated on the basis of a career average salary. Employees are entitled to receive an annuity under this plan if their salary exceeds the social security ceiling. The amount of the pension is calculated by reference to a range of vesting rates corresponding to salary bands. The plan also includes disability and death benefits. This plan represents approximately 62% of Sanofi&#x2019;s total obligation in Germany.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sanofi-Aventis plus (SAV plus)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A top-up pension plan (SAV plus) replaced a previous top-up defined-benefit plan. New entrants joining the plan after April&#160;1,&#160;2015 contribute to a defined-contribution plan that is partially funded via the company&#x2019;s CTA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;All employees whose salary exceeds the social security ceiling are automatically covered by the plan. The employer&#x2019;s contribution is 15% of the amount by which the employee&#x2019;s salary exceeds the social security ceiling.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Multi-employer plan (Pensionskasse)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;This is a defined-benefit plan treated as a defined-contribution plan, in accordance with the accounting policies described in&#160;Note&#160;B.23. Currently, contributions cover the level of annuities. Only the portion relating to the future revaluation of&#160;the&#160;annuities is included in the defined-benefit pension obligation. The obligation relating to this revaluation amounted to &#x20ac;652 million as of December 31, 2022, versus&#160;&#x20ac;877 million as of December 31, 2021 and &#x20ac;773 million as of December 31, 2020. This plan represents approximately 24% of Sanofi&#x2019;s total defined-benefit obligation in Germany.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Defined-benefit pension plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the United States, there are two types of defined-benefit plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;&#x201c;qualified&#x201d; plans within the meaning of the Employee Retirement Income Security Act of 1974 (ERISA), which provide guaranteed benefits to eligible employees during retirement, and in the event of death or disability. Employees can elect to receive a reduced annuity, in exchange for an annuity to be paid in the event of their death to a person designated by them. An annuity is also granted under the plan if the employee dies before retirement age. Eligible employees do not pay any contributions. These plans are closed to new entrants, and the vesting of rights for future service periods is partially frozen. These plans represent approximately 60% of Sanofi&#x2019;s total obligation in the United States;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;&#x201c;non-qualified&#x201d; plans within the meaning of ERISA provide top-up retirement benefits to some eligible employees depending on the employee&#x2019;s level of responsibility and subject to a salary cap. These plans represent approximately 14% of Sanofi&#x2019;s total obligation in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Healthcare cover and life insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi companies provide some eligible employees with healthcare cover and life insurance during the retirement period (the company&#x2019;s contributions are capped at a specified level). These plans represent approximately 26% (or &#x20ac;409 million) of Sanofi&#x2019;s total obligation and&#160;3% (or &#x20ac;28 million) of total plan assets in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;United Kingdom&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Defined-benefit pension plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi operates a number of pension plans in the United Kingdom that reflect past acquisitions. The most significant arrangements are defined-benefit plans that have been closed since October&#160;1, 2015. With effect from that date, employees can no longer pay into these plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Under these defined-benefit plans, an annuity is paid from the retirement date. This annuity is calculated on the basis of the employee&#x2019;s length of service as of September&#160;30, 2015, and of the employee&#x2019;s final salary (or salary on the date he or she leaves Sanofi).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The rates used for the vesting of rights vary from member to member. For most members, rights vest at the rate of 1.25% or 1.50% of final salary for each qualifying year of service giving entitlement. The notional retirement age varies according to the category to which the member belongs, but in most cases retirement is at age 65. Members may choose to retire before or after the notional retirement age (60&#160;years), in which case the amount of the annual pension is adjusted to reflect the revised estimate of the length of the retirement phase. Pensions are usually indexed to the Retail Price Index (RPI). Members paid a fixed-percentage contribution into their pension plan (the percentage varied according to the employee category), and the employer topped up the contribution to the required amount. These plans represent approximately 100% of Sanofi&#x2019;s total obligation in the United Kingdom.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For service periods subsequent to October&#160;1, 2015, employees belong to a new defined-contribution plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Actuarial assumptions used to measure Sanofi&#x2019;s obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Actuarial valuations of Sanofi&#x2019;s benefit obligations were computed by management with assistance from external actuaries as of&#160;December 31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Those calculations were based on the following financial and demographic assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)/(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.55% to 3.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.55% to 3.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.90%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.10% to 1.10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.10% to 1.10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.70%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.90%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;or &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;or &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.40%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.35%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;General inflation rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.30%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pension benefit &lt;br/&gt;indexation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.15%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.85%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Healthcare cost &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;inflation rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.29%&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6.56%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.50% to 4.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Retirement age&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 70&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 65&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 70&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 65&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 70&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 65&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mortality table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;TGH/&lt;br/&gt;TGF&lt;br/&gt;05&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Heubeck&lt;br/&gt;RT&lt;br/&gt;2018 G&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;RP2012 Proj.&lt;br/&gt;MP2021 White Collar&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;SAPS&lt;br/&gt;S3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;TGH/&lt;br/&gt;TGF&lt;br/&gt;05&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Heubeck&lt;br/&gt;RT&lt;br/&gt;2018 G&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;RP2012 Proj.&lt;br/&gt;MP2020 White Collar&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;SAPS&lt;br/&gt;S3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;TGH/&lt;br/&gt;TGF&lt;br/&gt;05&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Heubeck&lt;br/&gt;RT&lt;br/&gt;2018 G&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;RP2012 Proj.&lt;br/&gt;G.&#160;Scale&lt;br/&gt;MP2019 White Collar&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;SAPS&lt;br/&gt;S2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;The discount rates used were based on market rates for high quality corporate bonds with a duration close to that of the expected benefit payments under the plans. The benchmarks used to determine discount rates were the same for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;The rate depends on the duration of the plan (0&#160;to 7&#160;years, 7 to 10&#160;years, or more than 10&#160;years).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Inflation for the euro zone is determined using a multi-criterion method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d)&#160;&#160;&#160;&#160;No post-employment healthcare benefits are provided in France since 2020, Germany and UK.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted average duration of obligation for pensions and other long-term benefits in principal countries&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the duration of Sanofi&#x2019;s obligations in the principal countries:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted average duration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Sensitivity analysis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the sensitivity of Sanofi&#x2019;s obligations for pensions and other post-employment benefits to changes in key actuarial assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions and other post-employment benefits, &lt;br/&gt;by principal country&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Measurement of defined-benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Change in&lt;br/&gt;assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;-0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;General inflation rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pension benefit indexation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Healthcare cost inflation rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mortality table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;+1 year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below reconciles the net obligation in respect of Sanofi&#x2019;s pension and other post-employment benefit plans with the amounts recognized in the consolidated financial statements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Measurement of the obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial losses/(gains) due to changes in demographic assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial losses/(gains) due to changes in financial assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(210)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial losses/(gains) due to experience adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan amendments, curtailments or settlements not specified in the terms of the plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(938)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan settlements specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation and transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Obligation at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,651&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,175&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,456&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value of plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest income on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Difference between actual return and interest income on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Administration costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan settlements specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan settlements not specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(739)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contributions from plan members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employer&#x2019;s contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(469)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation and transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value of plan assets at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,899&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,651&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,358&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount shown in the balance sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Effect of asset ceiling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount shown in the balance sheet at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,770&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,539&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amounts recognized in the balance sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pre-funded obligations (see Note D.7.)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Obligations provided for&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount recognized at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,770&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,539&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Benefit cost for the period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Gains)/losses related to plan amendments, curtailments or settlements not specified in&#160;the&#160;terms&#160;of the plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest (income)/cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contributions from plan members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Administration costs and taxes paid during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense recognized directly in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;168&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;276&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(685)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(409)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;350&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;These amounts include the impact of applying the April&#160;2021 IFRIC agenda decision on the attribution of benefits to periods of service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;For 2020, this line mainly comprises a reduction in post-employment benefit liabilities following the announcement of voluntary redundancy programs, primarily in Europe.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;For 2022, this line includes &#x20ac;99&#160;million of assets in the United Kingdom (versus &#x20ac;220&#160;million for 2021); those amounts are not subject to any asset ceiling, in accordance with IFRIC&#160;14.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d)&#160;&#160;&#160;&#160;Amounts recognized in Other comprehensive income (see Note&#160;D.15.7.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The tables below show Sanofi&#x2019;s net liability in respect of pension plans and other post-employment benefits by geographical region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Measurement of obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Effect of asset ceiling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount shown in the balance sheet at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;627&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;413&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;686&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;139&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,770&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Measurement of obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Effect of asset ceiling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount shown in the balance sheet at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;819&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;768&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;972&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;195&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,539&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Measurement of obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Effect of asset ceiling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount shown in the balance sheet at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;872&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;919&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,014&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;269&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the fair value of plan assets relating to Sanofi&#x2019;s pension and other post-employment plans, split by asset category:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Securities quoted in an active market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;84.4&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;86.9&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;94.8&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bonds and similar instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Commodities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15.6&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13.1&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5.2&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hedge funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi has a long-term objective of maintaining or increasing the extent to which its pension obligations are covered by assets. To this end, Sanofi uses an asset-liability management strategy, matching plan assets to its pension obligations. This policy aims to ensure the best fit between the assets held on the one hand, and the associated liabilities and expected future payments to plan members on the other. To meet this aim, Sanofi operates a risk monitoring and management strategy (mainly focused on interest rate risk and inflation risk), while investing a growing proportion of assets in high-quality bonds with comparable maturities to those of the underlying obligations and in contracts entered into with leading insurance companies to fund certain post-employment benefit obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The tables below show the service cost for Sanofi&#x2019;s pension and other post-employment benefit plans, by geographical region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Service cost for 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest cost/(income) including administration costs and taxes paid during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contributions from plan members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) recognized directly in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;168&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Service cost for 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest cost/(income) including administration costs and taxes paid during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contributions from plan members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) recognized directly in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;80&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;54&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;276&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(685)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(409)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Service cost for 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest cost/(income) including administration costs and taxes paid during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contributions from plan members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) recognized directly in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;60&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;350&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;An analysis of the &#x201c;Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)&#x201d; line in the preceding tables is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial gains/(losses) arising during the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Comprising:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gains/(losses) &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;on experience adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gains/(losses) &lt;br/&gt;on demographic assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gains/(losses) &lt;br/&gt;on financial assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(442)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Experience adjustments are mainly due to the effect of trends in the financial markets on plan assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The net pre-tax actuarial loss (excluding investments accounted for using the equity method) recognized directly in equity is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net pre-tax actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,090)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The present value of Sanofi&#x2019;s obligations in respect of pension and other post-employment benefit plans at the end of each reporting period is shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Present value of wholly or partially funded obligations in respect of pension and other post-employment benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Present value of unfunded obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,651&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,175&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,456&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The total expense for pensions and other post-employment benefits (&#x20ac;168 million in 2022) is allocated between income statement line items as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and general expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other operating (income)/expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Financial expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;168&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;276&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The estimated amounts of employer&#x2019;s contributions to plan assets in 2023 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Employer&#x2019;s contributions in 2023 (estimate):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the expected timing of benefit payments under pension and other post-employment benefit plans for future years:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated future benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2028 to 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows estimates as of December 31, 2022 for the timing of future payments in respect of unfunded pension and other post-employment benefit plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than 1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to &lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to &lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.19.2. Restructuring provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows movements in restructuring provisions classified in non-current and current liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,499&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,390&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Of which:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Classified in non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Classified in current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Change in provisions recognized in profit or loss for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provisions utilized&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(571)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(663)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unwinding of discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,233&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,499&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Of which:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Classified in non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Classified in current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Provisions utilized mainly correspond to payments related to employees affected by separation programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Provisions for employee termination benefits as of December 31, 2022 amounted to &#x20ac;1,039 million (compared with &#x20ac;943&#160;million as of December 31, 2021 and &#x20ac;1,260 million as of December 31, 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The provisions apply mainly to France, and relate to various voluntary redundancy programs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;agreement under the Job Management and Career Paths (&#x201c;GEPP&#x201d;) scheme affecting several French legal entities, signed on&#160;February&#160;28, 2022 and announced in April&#160;2022 as part of the &#x201c;Play to Win&#x201d; strategy. The agreement provides internal transfer and outplacement opportunities for employees whose jobs are undergoing transformation, and also includes an end-of-career paid leave program and an external retraining program. The majority of the provisions charged in 2022 relate to this plan, which was implemented during 2022;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;collectively-agreed separation programs involving a number of legal entities were announced at the end of June&#160;2020 as part of the rollout of the &#x201c;Play to Win&#x201d; strategy; these include an end-of-career paid leave plan and an external retraining program, and were still ongoing during 2022. In addition, Sanofi-Aventis Recherche &amp;amp;&#160;D&#xe9;veloppement (i)&#160;announced a voluntary redundancy program in&#160;2020 in connection with the reorganization of R&amp;amp;D operations in France, which was implemented in&#160;2021, and (ii)&#160;signed a collectively-agreed termination program in&#160;2021 as part of the rollout of the &#x201c;Play to Win&#x201d; strategy; these programs, which cover support functions, include an end-of-career paid leave plan and an end-of-career transition plan;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;programs were announced in 2019 relating to (i)&#160;R&amp;amp;D (Sanofi-Aventis Recherche &amp;amp;&#160;D&#xe9;veloppement), and (ii)&#160;sales forces (the&#160;&#x201c;SAF&#160;2019&#x201d; plan implemented by Sanofi-Aventis France); and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;collectively-agreed separation programs were announced in 2018 relating to the reorganization of support functions (&#x201c;Horizon&#160;2020&#x201d; plan).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The remainder of the provision for France comprises termination benefits associated with previously-announced programs (early retirement plans and end-of-career transition plans).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The provision includes the present values of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;gross annuities for self-funded plans;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;employer&#x2019;s social security charges on early retirement annuities for all plans (outsourced and self-funded); and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the levy charged on those annuities under the &#x201c;Fillon&#x201d;&#160;law (only for plans with termination of employment contracts).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The average residual holding periods under these plans were 2.60&#160;years, 1.94&#160;year and 1.99&#160;year as of December 31, 2022, 2021 and&#160;2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The main other countries covered by restructuring provisions are Germany, Japan and the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The timing of future termination benefit payments is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Benefit payments by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Employee termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;France&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Other countries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,039&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;374&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;448&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;215&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Benefit payments by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Employee termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;France&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Other countries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;943&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;476&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;67&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Benefit payments by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Employee termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;France&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Other countries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,260&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;490&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;606&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.19.3. Other provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other provisions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; include provisions for risks and litigation relating to environmental, tax, commercial and product liability matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Environmental risks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Product liability risks, litigation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,178&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,024&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,975&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Provisions for environmental risks relate primarily to contingencies arising from business divestitures, and include remediation costs relating to such environmental risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Identified environmental risks are covered by provisions estimated on the basis of the costs Sanofi believes it will be obliged to meet over a period not exceeding (other than in exceptional cases) 30&#160;years. Sanofi expects that &#x20ac;96 million of those provisions will be utilized in&#160;2023, and &#x20ac;201 million over the period from 2024 through 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x201c;Product liability risks, litigation and other&#x201d; mainly comprises provisions for risks relating to product liability (including IBNR provisions as described in Note&#160;B.12.), government investigations, regulatory or antitrust law claims, contingencies arising from business divestitures (other than environmental risks), and remediation costs related to leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The main pending legal and arbitral proceedings and government investigations are described in Note&#160;D.22.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A full risk and litigation assessment is performed with the assistance of Sanofi&#x2019;s legal advisers, and provisions are recorded as required by circumstances in accordance with the principles described in Note&#160;B.12.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.19.4. Non-current income tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-current income tax liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;amounted to &#x20ac;1,979 million as of December 31, 2022 (versus &#x20ac;2,039 million as of December 31, 2021 and &#x20ac;1,733 million as of December 31, 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The estimated tax charge on deemed repatriation attributable to the accumulated earnings of non-US operations and payable over 8&#160;years is recognized as a liability, and amounted to &#x20ac;1,020 million in 2022 versus &#x20ac;960 million in 2021 and &#x20ac;894 million in&#160;2020. The resulting residual tax charge generated a non-current liability of &#x20ac;459 million as of December 31, 2022, versus &#x20ac;576 million in 2021 and &#x20ac;569 million in 2020. In accordance with Sanofi accounting policies, this non-current liability is not discounted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Non-current income tax liabilities include uncertainties over income tax treatments amounting to &#x20ac;1,520 million as of December 31, 2022, versus &#x20ac;1,463 million as of December 31, 2021 and &#x20ac;1,164 million as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A US legal restructuring resulted in a capital loss of &#x20ac;2.9&#160;billion recognized in the 2020 final tax filing. One-third of the capital loss has been used against 2020 capital gains and the remaining balance will be eligible to carry back for three years. Due to management&#x2019;s judgement about potential alternative interpretations of the prevailing tax law, no tax benefit has been recognized on this transaction in accordance with IFRIC&#160;23.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.19.5. Current provisions and other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Current provisions and other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; comprise the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Taxes payable, other than corporate income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee-related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Restructuring provisions (see Note&#160;D.19.2.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate derivatives (see Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency derivatives (see Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity derivatives (see Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amounts payable for acquisitions of non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Customer contract liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,021&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,217&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,132&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;See Note&#160;A.5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &#x201c;Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;. The year-on-year change in this item includes revenue of &#x20ac;85&#160;million recognized in profit or loss during 2022 that was included in the customer contract liabilities balance as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) &#x201c;Other current liabilities&#x201d; mainly comprises provisions for customer rebates and returns; provisions for discounts and rebates granted to healthcare authorities and governmental programs (see Note&#160;D.23.); and the liability payable at each reporting date under the Monoclonal Antibody Alliance with Regeneron.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfProvisionsAndOtherLiabilitiesTextBlock>
    <sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDkx_5bab8f81-5f0d-4c5f-9992-f75a882bc9b0">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non current provisions and other non-current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; comprises the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,341&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,721&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,315&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (IAS&#160;19, Employee Benefits), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Includes derivative financial instru&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;ments: &#x20ac;232 million as of De&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;cember&#160;31, 2022, &#x20ac;6 million as of December&#160;31, 2021, &#x20ac;92 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock>
    <ifrs-full:NoncurrentProvisions
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzEtMS0xLTEtMzY0MDYw_eecc902c-32f8-4020-86be-9d56836987b4"
      unitRef="eur">5822000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzEtMi0xLTEtMzY0MDYw_d5d1c1b8-e0c9-44c2-9fd0-e1bb4179b3fc"
      unitRef="eur">6430000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzEtNC0xLTEtMzY0MDYw_3107fec1-0c76-4b9b-aaa3-6fa749c47a5f"
      unitRef="eur">6998000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzItMS0xLTEtMzY0MDYw_fd3a1a74-5c33-4d60-a56e-3f93410b5d96"
      unitRef="eur">519000000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzItMi0xLTEtMzY0MDYw_444c798c-4a84-413f-b38a-99e8e384bc43"
      unitRef="eur">291000000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzItNC0xLTEtMzY0MDYw_25fd113b-2055-47df-b54f-482513dc3f0f"
      unitRef="eur">317000000</ifrs-full:OtherNoncurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzQtMS0xLTEtMzY0MDYw_4e70fea6-bf6e-4acd-85c8-361a6b15cd21"
      unitRef="eur">6341000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzQtMi0xLTEtMzY0MDYw_9438c858-24b8-41b1-96cb-f3f67eb83d38"
      unitRef="eur">6721000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphYWIzMDY3NjcxN2Y0ZGZjYTA4MDBiNzYwZTYwZDM5Zi90YWJsZXJhbmdlOmFhYjMwNjc2NzE3ZjRkZmNhMDgwMGI3NjBlNjBkMzlmXzQtNC0xLTEtMzY0MDYw_09619340-c2e5-4677-bfdf-bdaeb8f32cc9"
      unitRef="eur">7315000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzM3Mw_57673396-fcfa-4c61-888e-881441994671"
      unitRef="eur">232000000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQwMQ_f683d53b-0d67-4c9a-bb8a-483b0ad76f4d"
      unitRef="eur">6000000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQyOQ_634b2654-9b9c-46fe-8dcc-b6adc2a6f114"
      unitRef="eur">92000000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <sny:DisclosureOfNoncurrentProvisionsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDcz_e2ee3871-db9d-4dc5-9baa-ef0694f753ac">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth movements in non-current provisions for the reporting periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.667%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Provisions&#160;for&lt;br/&gt;pensions and&lt;br/&gt;other&#160;post-employment&lt;br/&gt;benefits&lt;br/&gt;(D.19.1.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Provisions&lt;br/&gt;for other&lt;br/&gt;long-term&lt;br/&gt;benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Restructuring&lt;br/&gt;provisions&lt;br/&gt;(D.19.2.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;provisions&lt;br/&gt;(D.19.3.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,599&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;855&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;600&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,071&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,125&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases in provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provisions utilized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(566)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(793)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reversals of unutilized provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(518)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest related to employee benefits, and unwinding of discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial gains and losses on defined-benefit plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,276&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;879&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;868&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,975&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,998&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases in provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provisions utilized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(222)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(459)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reversals of unutilized provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(425)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest related to employee benefits, and unwinding of discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial gains and losses on defined-benefit plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,947&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;935&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;524&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,024&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,430&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases in provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provisions utilized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reversals of unutilized provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest related to employee benefits, and unwinding of discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial gains and losses on defined-benefit plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,039&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;844&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;761&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,178&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,822&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) In the case of &#x201c;Provisions for pensions and other post-employment benefits&#x201d;, the &#x201c;Increases in provisions&#x201d; line corresponds to rights vesting in employees during the period, and past service cost; the &#x201c;Provisions utilized&#x201d; line corresponds to contributions paid into pension funds and to beneficiaries; and the&#160;&#x201c;Reversals of unutilized provisions&#x201d; line corresponds to plan curtailments, settlements and amendments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfNoncurrentProvisionsTableTextBlock>
    <ifrs-full:NoncurrentProvisions
      contextRef="i532881433aa7423d869b4ec57f911c53_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEtMS0xLTEtMzY0MDYw_c832c633-c70e-460e-80bd-38a0f82e660c"
      unitRef="eur">3599000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i414d2c248b5a458dae7e76250a0ff9b5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEtMy0xLTEtMzY0MDYw_721ffca4-2a2e-4964-99fb-49afabb7e298"
      unitRef="eur">855000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i43dfdc134bf04195b896b412124e7194_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEtNC0xLTEtMzY0MDYw_87ded9ff-f4e9-4e16-845e-8f9a6be628e8"
      unitRef="eur">600000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i31f290bd30874504995867d89e80c3d9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEtNS0xLTEtMzY0MDYw_c498582b-924f-44d9-95e0-5bf37d11fb1b"
      unitRef="eur">2071000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEtNy0xLTEtMzY0MDYw_204645dc-fb34-4385-91b2-4b7c8c20e299"
      unitRef="eur">7125000000</ifrs-full:NoncurrentProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzItMS0xLTEtMzY0MDYw_f9a0bc30-9336-44dd-84d8-92419481aabd"
      unitRef="eur">-3000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzItMy0xLTEtMzY0MDYw_6efe33ed-780d-40b1-ad66-3d3361d3860a"
      unitRef="eur">0</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzItNC0xLTEtMzY0MDYw_0fcb36f9-43bd-405c-b47f-dfa01eb56f4e"
      unitRef="eur">0</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzItNS0xLTEtMzY0MDYw_d41feecd-a67a-444e-93a2-267c47744d17"
      unitRef="eur">8000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzItNy0xLTEtMzY0MDYw_ad436c08-f512-424b-9a65-b01ec0c26549"
      unitRef="eur">5000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMtMS0xLTEtMzY0MDYw_80e0a31b-b93f-44e9-b614-119a99786ee7"
      unitRef="eur">256000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMtMy0xLTEtMzY0MDYw_42ea2bd7-9e7b-4096-a823-c4160e7caa10"
      unitRef="eur">169000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMtNC0xLTEtMzY0MDYw_daa7c230-815f-4b63-8565-7649a2e3eaf9"
      unitRef="eur">688000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMtNS0xLTEtMzY0MDYw_20aabc4a-f771-4cc8-9070-2e25e0ae97e4"
      unitRef="eur">369000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMtNy0xLTEtMzY0MDYw_682aa1a9-33b3-49a7-946d-11ba78a76a18"
      unitRef="eur">1482000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzQtMS0xLTEtMzY0MDYw_fcbd5b78-a43b-4a35-99d8-535b0f085c94"
      unitRef="eur">566000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzQtMy0xLTEtMzY0MDYw_c51cb54d-8c12-4dab-b55b-713a4a7a3e74"
      unitRef="eur">109000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzQtNC0xLTEtMzY0MDYw_4edfe764-0a35-4075-8ab6-3c9ee22c148b"
      unitRef="eur">5000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzQtNS0xLTEtMzY0MDYw_eeecf75e-1f81-47df-bc49-919338e63c71"
      unitRef="eur">113000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzQtNy0xLTEtMzY0MDYw_83e1a4c4-675a-4e8c-aed8-2e446a5c91d3"
      unitRef="eur">793000000</ifrs-full:ProvisionUsedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzUtMS0xLTEtMzY0MDYw_6d91acb8-cb4d-40d2-b1c7-e8c9263539ac"
      unitRef="eur">226000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzUtMy0xLTEtMzY0MDYw_ccb1d753-7ed2-4dda-afb3-9bd2765e8149"
      unitRef="eur">5000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzUtNC0xLTEtMzY0MDYw_e3b39b45-eee4-4b86-8308-d110f49dc5bb"
      unitRef="eur">42000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzUtNS0xLTEtMzY0MDYw_94dad0a1-62f6-4ff7-86a6-9305f3c7d749"
      unitRef="eur">245000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzUtNy0xLTEtMzY0MDYw_ae84d9b0-574c-43db-9d4a-a20bbb5d35cb"
      unitRef="eur">518000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzYtMS0xLTEtMzY0MDYw_c5adcfff-b545-47a3-8fea-29fe922fb2bd"
      unitRef="eur">12000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzYtMy0xLTEtMzY0MDYw_e8f778f2-94c7-4723-aefb-d7e048cd8551"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzYtNC0xLTEtMzY0MDYw_feef1df7-bbd3-492e-b789-7c9eb7e6dc8e"
      unitRef="eur">-369000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzYtNS0xLTEtMzY0MDYw_d29798b8-15e3-4368-b13c-dc948638a739"
      unitRef="eur">-64000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzYtNy0xLTEtMzY0MDYw_ecb9776c-cc62-41fb-a614-0c9657f1b014"
      unitRef="eur">-421000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzctMS0xLTEtMzY0MDYw_23b5838b-a6cd-48d4-8d10-89adcf046493"
      unitRef="eur">55000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzctMy0xLTEtMzY0MDYw_bd2c51b7-09dc-4fec-9ad0-53b16ee86ba0"
      unitRef="eur">2000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzctNC0xLTEtMzY0MDYw_b6f99202-928d-4398-b080-4b387970068f"
      unitRef="eur">1000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzctNS0xLTEtMzY0MDYw_ffeda01c-13da-440e-ba3e-69b7c5cd86a1"
      unitRef="eur">8000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzctNy0xLTEtMzY0MDYw_da484cbf-1ec8-4c9f-84dd-742f48e673b5"
      unitRef="eur">66000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzktMS0xLTEtMzY0MDYw_6f6f0723-1963-43fd-a1be-edd5063bc1ea"
      unitRef="eur">-117000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzktMy0xLTEtMzY0MDYw_b8d6b6d3-09b0-4567-b7d3-1e4f1b7d25d2"
      unitRef="eur">-33000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzktNC0xLTEtMzY0MDYw_6d386825-a19f-4721-b2a4-1c0fe1940a41"
      unitRef="eur">-5000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzktNS0xLTEtMzY0MDYw_97ea44d4-e50c-41b5-905a-ac0819dc9b2c"
      unitRef="eur">-59000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzktNy0xLTEtMzY0MDYw_31f5c6c6-e3a0-4106-958c-1256c4ee4e8b"
      unitRef="eur">-214000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i5fef6934b6954089afe4656d38520c7f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEwLTEtMS0xLTM2NDA2MA_176aa4eb-5dd8-4c63-a365-31db6b5cf5bb"
      unitRef="eur">266000000</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i35404bf880174b80a7d3d4c6991893fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEwLTMtMS0xLTM2NDA2MA_ee4e7de6-bec2-4077-8036-29d99923ba68"
      unitRef="eur">0</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i4b2d714b21c448a381bae1093ce9b650_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEwLTQtMS0xLTM2NDA2MA_83205df8-b295-4507-8d91-f855abfd37be"
      unitRef="eur">0</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="ife22dbb70240483fb59abe97371c1713_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEwLTUtMS0xLTM2NDA2MA_5722e34f-e8ab-4563-85a8-9047c841691a"
      unitRef="eur">0</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEwLTctMS0xLTM2NDA2MA_95c7b8c9-bc38-4f6a-8b43-4a829038e26b"
      unitRef="eur">266000000</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <ifrs-full:NoncurrentProvisions
      contextRef="ida1b0b7fd59a4db78494bb22968fdd7a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzExLTEtMS0xLTM2NDA2MA_8dc9c749-139b-4227-b591-483de3994210"
      unitRef="eur">3276000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="ie4751a46e76748978b422a63571faf77_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzExLTMtMS0xLTM2NDA2MA_0083b0ba-0936-4d64-9dc7-da488b61c98c"
      unitRef="eur">879000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="ie016f1bfac62464f88ec010a81d0e1ba_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzExLTQtMS0xLTM2NDA2MA_81d518a8-c21b-43e2-b181-217066818e91"
      unitRef="eur">868000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i2ef08d9911e24c519c5cd052d066245a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzExLTUtMS0xLTM2NDA2MA_cc009da1-6745-4e89-b8fc-e156310a4104"
      unitRef="eur">1975000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzExLTctMS0xLTM2NDA2MA_989c3ae2-4402-4025-aeea-3b6b54df3698"
      unitRef="eur">6998000000</ifrs-full:NoncurrentProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEyLTEtMS0xLTM2NDA2MA_15d5ba77-1384-4b8b-b4f1-d48932148926"
      unitRef="eur">-2000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEyLTMtMS0xLTM2NDA2MA_e7300188-c95b-4915-98cd-751fae3aee27"
      unitRef="eur">0</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEyLTQtMS0xLTM2NDA2MA_aa7463f2-a271-4bd4-b367-d12a492403d4"
      unitRef="eur">0</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEyLTUtMS0xLTM2NDA2MA_088c3da8-c90b-44f0-bdbb-2d084e7eb170"
      unitRef="eur">37000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEyLTctMS0xLTM2NDA2MA_821da38a-c1a6-44e7-b237-8c5a3fff72d5"
      unitRef="eur">35000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEzLTEtMS0xLTM2NDA2MA_810e6779-fa05-4375-b941-a0a762e5421c"
      unitRef="eur">247000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEzLTMtMS0xLTM2NDA2MA_96732961-4a3f-4489-b8f2-e04f26b9dc66"
      unitRef="eur">156000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEzLTQtMS0xLTM2NDA2MA_5bdebb08-436d-4626-86e5-4eebfd061bbb"
      unitRef="eur">67000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEzLTUtMS0xLTM2NDA2MA_a5398270-cec4-44f8-97f4-ef35e7dac0e5"
      unitRef="eur">261000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzEzLTctMS0xLTM2NDA2MA_e042d544-df23-499e-a011-30c38135b878"
      unitRef="eur">731000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE0LTEtMS0xLTM2NDA2MA_969705f6-65dc-4418-a5e1-3d3dccbd54c5"
      unitRef="eur">222000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE0LTMtMS0xLTM2NDA2MA_ac0037d1-1dd7-45d7-a3c2-d2e2863281f1"
      unitRef="eur">122000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE0LTQtMS0xLTM2NDA2MA_847675ec-bb30-4468-b9bb-fa4f9dadb363"
      unitRef="eur">8000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE0LTUtMS0xLTM2NDA2MA_e436f1b5-ac67-455b-9488-065599fa1740"
      unitRef="eur">107000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE0LTctMS0xLTM2NDA2MA_bc5ec9b8-fc0d-4b8d-9e31-800658910359"
      unitRef="eur">459000000</ifrs-full:ProvisionUsedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE1LTEtMS0xLTM2NDA2MA_b8202c6a-9422-413e-a070-ec422b3a705b"
      unitRef="eur">13000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE1LTMtMS0xLTM2NDA2MA_4eb5dd66-b874-4fdf-8927-3ac8651b7679"
      unitRef="eur">7000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE1LTQtMS0xLTM2NDA2MA_2df43353-9f40-4a1c-bf73-a0e9058b88ed"
      unitRef="eur">35000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE1LTUtMS0xLTM2NDA2MA_f60242d2-bede-47d5-b7be-a57e1f1af4de"
      unitRef="eur">145000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE1LTctMS0xLTM2NDA2MA_dfe984c2-076c-4dd4-984b-8f81c158511b"
      unitRef="eur">200000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE2LTEtMS0xLTM2NDA2MA_59008b37-a870-4cce-b262-7e505bdb986b"
      unitRef="eur">-13000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE2LTMtMS0xLTM2NDA2MA_dc027f15-d9c4-494d-86bb-82679183d80b"
      unitRef="eur">-3000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE2LTQtMS0xLTM2NDA2MA_4bec4a6f-93bf-450e-b786-148a50898280"
      unitRef="eur">-370000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE2LTUtMS0xLTM2NDA2MA_1a9460b4-33dc-4602-814e-8af4bfad6b0e"
      unitRef="eur">-39000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE2LTctMS0xLTM2NDA2MA_afe6b7b7-fc62-4a55-a0c7-62826f3994fa"
      unitRef="eur">-425000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE3LTEtMS0xLTM2NDA2MA_427624c6-98b4-4fb4-a754-29c2efe8fc5d"
      unitRef="eur">42000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE3LTMtMS0xLTM2NDA2MA_22bee1a9-64ba-41e0-bacd-11840a5d7583"
      unitRef="eur">2000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE3LTQtMS0xLTM2NDA2MA_49c41768-657e-41bc-b198-4e87de72999c"
      unitRef="eur">0</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE3LTUtMS0xLTM2NDA2MA_81574b01-d3b1-4cdc-b364-873ce1688b02"
      unitRef="eur">9000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE3LTctMS0xLTM2NDA2MA_276e22dc-70a2-49a2-b57e-59de049382ba"
      unitRef="eur">53000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE5LTEtMS0xLTM2NDA2MA_e6390930-51e6-48b0-bc18-5ae012ac66ae"
      unitRef="eur">80000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE5LTMtMS0xLTM2NDA2MA_5c5348ae-96ed-4af2-ad67-4c6f3a51c9e7"
      unitRef="eur">30000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE5LTQtMS0xLTM2NDA2MA_5e92bff8-223e-453c-9813-7a8e4e8975ae"
      unitRef="eur">2000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE5LTUtMS0xLTM2NDA2MA_332ab806-a116-47d6-aba6-4b64bb2c4673"
      unitRef="eur">33000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzE5LTctMS0xLTM2NDA2MA_edb29b42-d04e-4df1-b131-adfff40448f1"
      unitRef="eur">145000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i5397bc267bd54109b96ba70a4fe2c7bb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIwLTEtMS0xLTM2NDA2MA_9d03d0d0-dab6-44dd-b4db-98265bea65b5"
      unitRef="eur">-448000000</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i74af08f65a164c0fbd56e7d88060f2a6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIwLTMtMS0xLTM2NDA2MA_306963a7-e83f-4394-a61b-2534202fe05f"
      unitRef="eur">0</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i51ebd9041a584c77881d558fe55f35e7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIwLTQtMS0xLTM2NDA2MA_d8663bee-0297-441e-aa04-d5073a89f9f7"
      unitRef="eur">0</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i2f6a6daa2282425c989154f4396a2770_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIwLTUtMS0xLTM2NDA2MA_83f04657-f557-44b1-9921-ecd71610b25f"
      unitRef="eur">0</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIwLTctMS0xLTM2NDA2MA_544c960b-f198-4561-aeaf-6e23ebb4045b"
      unitRef="eur">-448000000</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <ifrs-full:NoncurrentProvisions
      contextRef="id6287d4b535a408eaad25228f5b4da0d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIxLTEtMS0xLTM2NDA2MA_7e4ca96a-7b43-44fe-9bd0-ce4084f0e231"
      unitRef="eur">2947000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i53403a31e97c40538e551d37a2a4daa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIxLTMtMS0xLTM2NDA2MA_479003b8-9c2c-4f07-95c9-5eecaea28fe4"
      unitRef="eur">935000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i87f7b547836c49bfbc71cc2d0e1e129e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIxLTQtMS0xLTM2NDA2MA_d4a3abe7-1cc1-4eca-b94b-38afff040dbb"
      unitRef="eur">524000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i93c8eb824f4249b3bfda0339bc01253c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIxLTUtMS0xLTM2NDA2MA_dc7f2487-5e56-4d7b-8540-43c85b65aeed"
      unitRef="eur">2024000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIxLTctMS0xLTM2NDA2MA_3b8ec918-5ee6-4adf-8a8f-a896bc264b21"
      unitRef="eur">6430000000</ifrs-full:NoncurrentProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIyLTEtMS0xLTM2NDA2MA_81e35e29-7393-48f4-a3a6-7fc8f16fdff2"
      unitRef="eur">-96000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIyLTMtMS0xLTM2NDA2MA_4b533926-74ce-4587-a584-d0560ff8e7be"
      unitRef="eur">-28000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIyLTQtMS0xLTM2NDA2MA_43bca423-e034-4785-bb9b-2f06e81c2eeb"
      unitRef="eur">0</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIyLTUtMS0xLTM2NDA2MA_7615b53b-0c93-4df9-930d-1ddadb68802b"
      unitRef="eur">-76000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIyLTctMS0xLTM2NDA2MA_a0c26ae8-ddd6-4b63-a8ef-fc6152cdc3e4"
      unitRef="eur">-200000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIzLTEtMS0xLTM2NDA2MA_2b9a2d90-1300-4ad2-a389-d008a32dfadd"
      unitRef="eur">193000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIzLTMtMS0xLTM2NDA2MA_1d81b0d2-2522-44c9-8fc9-8a83b65cdcd8"
      unitRef="eur">40000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIzLTQtMS0xLTM2NDA2MA_87affa8d-cc44-48ba-9783-58f6267b9be9"
      unitRef="eur">521000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIzLTUtMS0xLTM2NDA2MA_99d49956-64be-4524-a491-323da4e42151"
      unitRef="eur">531000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzIzLTctMS0xLTM2NDA2MA_f214bc1d-5e93-4f5d-bee3-05b3ee9edba0"
      unitRef="eur">1285000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI0LTEtMS0xLTM2NDA2MA_abe5c8e1-a9ae-4f05-bfe7-8ff7fab6fe54"
      unitRef="eur">275000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI0LTMtMS0xLTM2NDA2MA_fcaf9ec3-ae93-4ce3-8016-7dc197ceb0fc"
      unitRef="eur">119000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI0LTQtMS0xLTM2NDA2MA_df1b151f-d3ae-4360-80cb-3b1f47886539"
      unitRef="eur">12000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI0LTUtMS0xLTM2NDA2MA_5cae471b-9dfc-4e7d-9ca7-34565ac77077"
      unitRef="eur">122000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI0LTctMS0xLTM2NDA2MA_a70e1a7f-88ca-4f36-b1d1-6a6e233ef534"
      unitRef="eur">528000000</ifrs-full:ProvisionUsedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI1LTEtMS0xLTM2NDA2MA_3fe2a891-c619-4e59-a204-755dc61aefef"
      unitRef="eur">66000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI1LTMtMS0xLTM2NDA2MA_aa1b323d-b347-49ae-ae7e-71fef38f2eb3"
      unitRef="eur">20000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI1LTQtMS0xLTM2NDA2MA_388cb8be-807d-4783-9794-4f59dc9e4566"
      unitRef="eur">11000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI1LTUtMS0xLTM2NDA2MA_1e7a94e0-e231-4a31-83ff-2e239adcfeba"
      unitRef="eur">191000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI1LTctMS0xLTM2NDA2MA_9bdf58ea-f8f8-4836-9282-5548a16aedcb"
      unitRef="eur">288000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI2LTEtMS0xLTM2NDA2MA_28c76548-6d64-4cbe-a8fc-7f4863a1e555"
      unitRef="eur">10000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI2LTMtMS0xLTM2NDA2MA_06d4418c-352e-4600-b189-607d5b884ab9"
      unitRef="eur">4000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI2LTQtMS0xLTM2NDA2MA_c6d0a5f9-125f-4b8b-99e2-6e849a140452"
      unitRef="eur">-265000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI2LTUtMS0xLTM2NDA2MA_f771d09e-b9d3-42a7-b625-5b70dd873156"
      unitRef="eur">-23000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI2LTctMS0xLTM2NDA2MA_5404cb80-3ef2-4dca-a27c-db0a97483844"
      unitRef="eur">-274000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI3LTEtMS0xLTM2NDA2MA_620f1280-6152-43c3-a451-3304510821bd"
      unitRef="eur">43000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI3LTMtMS0xLTM2NDA2MA_5b834f77-9761-4583-ae83-7e4055d2077c"
      unitRef="eur">4000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI3LTQtMS0xLTM2NDA2MA_7932dce8-b0e1-4576-a84b-125165609e86"
      unitRef="eur">5000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI3LTUtMS0xLTM2NDA2MA_667c7c18-077f-43eb-8609-d1b4cfeab136"
      unitRef="eur">12000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI3LTctMS0xLTM2NDA2MA_3d367b56-15e9-41d4-9d76-ec661246543f"
      unitRef="eur">64000000</sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI5LTEtMS0xLTM2NDA2MA_107f10e3-a0c8-424d-ab08-4bec263aa2b7"
      unitRef="eur">63000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI5LTMtMS0xLTM2NDA2MA_6201ee62-7eb8-4068-bbfb-870751cee16d"
      unitRef="eur">28000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI5LTQtMS0xLTM2NDA2MA_69da9819-68ad-4c63-aa8f-f25909ff87ae"
      unitRef="eur">-1000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI5LTUtMS0xLTM2NDA2MA_dab75740-ffdb-4202-a808-78d9e44afd10"
      unitRef="eur">23000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzI5LTctMS0xLTM2NDA2MA_ff13e7c2-f942-499f-a933-141ba5eb8025"
      unitRef="eur">113000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i97b92f394953493d8e22d9d82ab95e5d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMwLTEtMS0xLTM2NDA2MA_910d106a-b281-40f8-8449-fc10e691d086"
      unitRef="eur">-780000000</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i65f2342c6fe1414da96f11bcabd67923_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMwLTMtMS0xLTM2NDA2MA_c067cb3d-98bc-4361-b24e-5c8192a339df"
      unitRef="eur">0</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="iccd3cbc6e5fd45c584792269fa098678_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMwLTQtMS0xLTM2NDA2MA_7097aad3-ef13-47d0-b62c-2d64028e5dc0"
      unitRef="eur">0</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="i7b2262ed3adc40b5a52de3ee9d3c1cff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMwLTUtMS0xLTM2NDA2MA_30705515-1ae6-4898-a01f-cbdc3ceea473"
      unitRef="eur">0</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <sny:ActuarialGainsAndLossesOnDefinedBenefitPlans
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMwLTctMS0xLTM2NDA2MA_944e3dfd-0f36-423f-80c3-1814d26b55bc"
      unitRef="eur">-780000000</sny:ActuarialGainsAndLossesOnDefinedBenefitPlans>
    <ifrs-full:NoncurrentProvisions
      contextRef="i99f14dae6c344820b8cfd29600e3d5a5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMxLTEtMS0xLTM2NDA2MA_8a314f38-0efb-47e4-a134-8fcba3121888"
      unitRef="eur">2039000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i166b657852b1433a9e018a31616ff84f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMxLTMtMS0xLTM2NDA2MA_da868be0-189b-42ad-9b5b-13e70abaebf8"
      unitRef="eur">844000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i68ec19e5d4dd47f99a2b91bffaf44998_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMxLTQtMS0xLTM2NDA2MA_3db26947-54b6-458e-a8a9-240955aa9ed2"
      unitRef="eur">761000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i38e42cc577a14225b39b09272fa72a61_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMxLTUtMS0xLTM2NDA2MA_50b356ac-82dc-4f3b-aa69-1ca3c54fa900"
      unitRef="eur">2178000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MGY2NjdmOGU5NTc0N2E4YTk3OWMxNzE4OTgyNzNiNC90YWJsZXJhbmdlOjYwZjY2N2Y4ZTk1NzQ3YThhOTc5YzE3MTg5ODI3M2I0XzMxLTctMS0xLTM2NDA2MA_45b14449-45bb-4c50-adf1-e1d940e64eae"
      unitRef="eur">5822000000</ifrs-full:NoncurrentProvisions>
    <sny:NumberOfCountriesIncludedInPensionPlans
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE5MjE_405d121d-e674-4d60-a36d-ea58eef28d90"
      unitRef="country">4</sny:NumberOfCountriesIncludedInPensionPlans>
    <sny:PensionObligationPercentageToDefinedBenefitLiability
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE5NjY_420c145b-fe42-4275-8e17-37de9d47e811"
      unitRef="number">0.89</sny:PensionObligationPercentageToDefinedBenefitLiability>
    <sny:PensionObligationPercentageToPlanAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzIwNDA_86553942-7972-4b02-a38b-a8ca9039fa34"
      unitRef="number">0.88</sny:PensionObligationPercentageToPlanAssets>
    <sny:PensionObligationPercentageToDefinedBenefitLiability
      contextRef="ia10e6503fcc842d0a8ec71b5c5ce2538_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzI1OTE_1c0346c5-0fec-49b1-9aed-55d6311b0562"
      unitRef="number">0.35</sny:PensionObligationPercentageToDefinedBenefitLiability>
    <sny:PensionObligationPercentageToDefinedBenefitLiability
      contextRef="i1658b22a6e4540a0807eac410291250d_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzI5NDA_f7211e5c-b6f7-48cb-8c26-eb916f4512a9"
      unitRef="number">0.65</sny:PensionObligationPercentageToDefinedBenefitLiability>
    <sny:PensionObligationPercentageToDefinedBenefitLiability
      contextRef="i144ca30e0cf646e2b838836778d7d0b4_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzM1NzY_2880d3c1-05cb-4ce2-9400-17485c162797"
      unitRef="number">0.62</sny:PensionObligationPercentageToDefinedBenefitLiability>
    <sny:EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling
      contextRef="ief705d2690d74284bfafb92aae683ade_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQwMDY_cab7c6e4-3604-4f53-88c2-9e3c18bdcd44"
      unitRef="number">0.15</sny:EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i84d47ba9760945e48ac11bae1f3b3f30_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQ1MDA_81de10b5-3dca-4406-aa19-41b0b0e472b3"
      unitRef="eur">652000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ie22c0c0a8b924a2b9eb8114a97aa2197_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQ1MjA_62d43cb9-3679-4ad6-a262-ce450f459377"
      unitRef="eur">877000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="iae25acad84cd4329ab2b319e35f1cf11_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQ1MzY_32bc6f2d-ddff-4c35-b1da-214a3c81524a"
      unitRef="eur">773000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <sny:PensionObligationPercentageToDefinedBenefitLiability
      contextRef="i84d47ba9760945e48ac11bae1f3b3f30_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQ1ODQ_9db3a088-897b-4d43-bc1c-a7160e80a8b3"
      unitRef="number">0.24</sny:PensionObligationPercentageToDefinedBenefitLiability>
    <sny:NumberOfDefinedBenefitPlans
      contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzQ3MjA_a5b3cba5-8c73-4b47-8eb9-5d68f62ea76d"
      unitRef="plan">2</sny:NumberOfDefinedBenefitPlans>
    <sny:PensionObligationPercentageToDefinedBenefitLiability
      contextRef="i72b834d66c174249a0c347659203c14e_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzU0MDU_f74c9c32-2885-463c-b30b-ca492d3bc5d8"
      unitRef="number">0.60</sny:PensionObligationPercentageToDefinedBenefitLiability>
    <sny:PensionObligationPercentageToDefinedBenefitLiability
      contextRef="ib27399813eb6424abd019f16bfa18111_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzU2ODg_5ddf27a0-e650-4340-bb61-069b84c7f3b5"
      unitRef="number">0.14</sny:PensionObligationPercentageToDefinedBenefitLiability>
    <sny:PensionObligationPercentageToDefinedBenefitLiability
      contextRef="i07e1ed072e3e438e9fa21f2b6b669c94_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzU5OTY_048a1535-fbdb-4f57-bc26-f3f4f5ab30ab"
      unitRef="number">0.26</sny:PensionObligationPercentageToDefinedBenefitLiability>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i07e1ed072e3e438e9fa21f2b6b669c94_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzYwMDM_6641327c-d326-4af3-acff-88ccbad9fcd7"
      unitRef="eur">409000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <sny:PensionObligationPercentageToPlanAssets
      contextRef="i76c3583de96148c4885a50242b9c6cbd_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzYwNDA_24720741-59fb-4d60-9b92-68a836e1be78"
      unitRef="number">0.03</sny:PensionObligationPercentageToPlanAssets>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i76c3583de96148c4885a50242b9c6cbd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzYwNDc_d28e8cc2-0366-44a1-82f9-9e7875cbed51"
      unitRef="eur">28000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <sny:DefinedBenefitPlansVestingRightsPercentage
      contextRef="i6f22c7c899354b0cb94d9107f4fd1d7b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzY3OTQ_a9f39446-6064-4097-93f6-f781c5d9e88b"
      unitRef="number">0.0125</sny:DefinedBenefitPlansVestingRightsPercentage>
    <sny:DefinedBenefitPlansVestingRightsPercentage
      contextRef="idce85fea541d4dca84fd5c265ae2ce3d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzY4MDE_3b46ce38-3641-44fc-9af5-91252a8a7110"
      unitRef="number">0.0150</sny:DefinedBenefitPlansVestingRightsPercentage>
    <sny:RetirementAge
      contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzcwMDU_82af764c-7c57-4694-8bab-d5159a2f4dcb"
      unitRef="age">65</sny:RetirementAge>
    <sny:NotionalRetirementAge
      contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzcwODM_b0ee3d9e-84dd-4c8e-a1ce-61a3a335bad2"
      unitRef="age">60</sny:NotionalRetirementAge>
    <sny:PensionObligationPercentageToDefinedBenefitLiability
      contextRef="iaa0767613c3f411ca54f05839ea4dfcd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzc1MTk_20086845-20d7-4e99-af01-19cd805eeb27"
      unitRef="number">1</sny:PensionObligationPercentageToDefinedBenefitLiability>
    <sny:DisclosureOfActuarialAssumptionsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDc0_3f6cfbbe-4389-4e2e-8380-aced9645db89">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Those calculations were based on the following financial and demographic assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)/(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.55% to 3.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.55% to 3.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.90%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.10% to 1.10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.10% to 1.10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.70%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.90%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;or &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;or &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.40%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.35%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;General inflation rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.30%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pension benefit &lt;br/&gt;indexation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.15%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.85%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Healthcare cost &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;inflation rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.29%&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6.56%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.50% to 4.50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Retirement age&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 70&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 65&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 70&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 65&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 70&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;to 65&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mortality table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;TGH/&lt;br/&gt;TGF&lt;br/&gt;05&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Heubeck&lt;br/&gt;RT&lt;br/&gt;2018 G&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;RP2012 Proj.&lt;br/&gt;MP2021 White Collar&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;SAPS&lt;br/&gt;S3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;TGH/&lt;br/&gt;TGF&lt;br/&gt;05&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Heubeck&lt;br/&gt;RT&lt;br/&gt;2018 G&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;RP2012 Proj.&lt;br/&gt;MP2020 White Collar&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;SAPS&lt;br/&gt;S3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;TGH/&lt;br/&gt;TGF&lt;br/&gt;05&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Heubeck&lt;br/&gt;RT&lt;br/&gt;2018 G&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;RP2012 Proj.&lt;br/&gt;G.&#160;Scale&lt;br/&gt;MP2019 White Collar&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;SAPS&lt;br/&gt;S2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;The discount rates used were based on market rates for high quality corporate bonds with a duration close to that of the expected benefit payments under the plans. The benchmarks used to determine discount rates were the same for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;The rate depends on the duration of the plan (0&#160;to 7&#160;years, 7 to 10&#160;years, or more than 10&#160;years).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Inflation for the euro zone is determined using a multi-criterion method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d)&#160;&#160;&#160;&#160;No post-employment healthcare benefits are provided in France since 2020, Germany and UK.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfActuarialAssumptionsTableTextBlock>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="ie2fc70c201ea485293d21743a8c878ce_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZmYwMWE5MDQ3OGViNGY2MThiOGQwNGY2MGY5ZmE2OTVfNzY5NjU4MTM5NDQ3OQ_0112498c-1e34-45fb-9c90-3ff61836b321"
      unitRef="number">0.0355</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i2161c01fcdb543bf903af67ad7c742bc_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZmYwMWE5MDQ3OGViNGY2MThiOGQwNGY2MGY5ZmE2OTVfNzY5NjU4MTM5NDQ4Nw_119de001-b2b6-4702-9c47-f8dad193287b"
      unitRef="number">0.0375</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="ib109e7b8a7804e8faf5db8da9efa7002_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMi0xLTEtMzY0MDYwL3RleHRyZWdpb246MGIyMzI4OWZiMWZjNGJlMzlhM2QzZTRhMGQwNWNiYTBfNzY5NjU4MTM5NDQ3OQ_d7f45f0c-095b-490b-af47-27ff66cc3ee7"
      unitRef="number">0.0355</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="iad383d0b40904aa78c611003295b9f75_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMi0xLTEtMzY0MDYwL3RleHRyZWdpb246MGIyMzI4OWZiMWZjNGJlMzlhM2QzZTRhMGQwNWNiYTBfNzY5NjU4MTM5NDQ4Nw_7ea0f94e-abb2-4f0b-a460-d4cde87486cb"
      unitRef="number">0.0375</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItNC0xLTEtMzY0MDYwL3RleHRyZWdpb246NDhiOTAwOTc2ZWY0NDNlOGIzZDU5MjQ5ZmYyY2NjNTFfNzY5NjU4MTM5NDQ1Ng_038a7d83-1328-4700-accc-89e5d8cb73ff"
      unitRef="number">0.0490</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i37dc156184d44185ad77a05f3d1c8e7d_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItNS0xLTEtMzY0MDYwL3RleHRyZWdpb246NmE4ODczMjg0YmY5NDY5ZGExZmVjYTc4MzI3NWY1MmVfNzY5NjU4MTM5NDQ1OA_425f3ed4-c42d-4519-8657-16cbff406318"
      unitRef="number">0.0475</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i7d1dddd9218a466d80295b2cd0ba570a_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItNy0xLTEtMzY0MDYwL3RleHRyZWdpb246MjdlOTdlM2NkMTdlNDRlZDlmYzkyMDM0YzA2YzU4MWFfNzY5NjU4MTM5NDQ3Nw_e7b110bd-5f94-48b4-8df1-03f9c890f2cc"
      unitRef="number">0.0010</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="ib64132cf06b441e783c6365e8d7e0777_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItNy0xLTEtMzY0MDYwL3RleHRyZWdpb246MjdlOTdlM2NkMTdlNDRlZDlmYzkyMDM0YzA2YzU4MWFfNzY5NjU4MTM5NDQ4NQ_16fc138b-336d-4096-b8cd-afcf5ccd14e4"
      unitRef="number">0.0110</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i5d969a5687574442a05c8b81a0fdc221_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItOC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZGI5MTZlMzY1ZmNhNGI5ZTg5NjlmMjU5MjMyZTA4OGZfNzY5NjU4MTM5NDQ3Nw_9332e296-f0b3-41f1-814f-6ff82e345ddb"
      unitRef="number">0.0010</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i9ead7b007eb34735a7448b53948b4495_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItOC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZGI5MTZlMzY1ZmNhNGI5ZTg5NjlmMjU5MjMyZTA4OGZfNzY5NjU4MTM5NDQ4NQ_2b18660d-d4a9-403b-a554-fec61d891db2"
      unitRef="number">0.0110</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjJkOWE1MDQ3NmE5OTRmN2FiYzA0NDJmMjBkYjAwYTg5Xzc2OTY1ODEzOTQ0NTY_169424cc-b658-44c7-96ce-413ec54f5459"
      unitRef="number">0.0270</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="ib5ccc5f405134715b9e46b9feb0319b6_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjFlODk1ZmI2NjQ0YTQ3YjRiM2M0YzViZTMzYzVlYjM4Xzc2OTY1ODEzOTQ0NTg_cdb2bf0b-8d45-4854-9376-0b5b4b2c9700"
      unitRef="number">0.0190</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i058d3dfb4d72464288d47993d2264238_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjc2ZjM2ODRiYWYwMDRjMjdiZmNkNjJhYjRmMDUyM2VmXzE5NzkxMjA5MzAwMDUz_297f44f8-b8c4-4d87-a3ba-fd8debe0ef55"
      unitRef="number">0.0000</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i3b87b7d69412417d8a10e4771f17da62_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjc2ZjM2ODRiYWYwMDRjMjdiZmNkNjJhYjRmMDUyM2VmXzc2OTY1ODEzOTQ0ODQ_758e38b3-3579-4b09-a07c-6fa46643dbda"
      unitRef="number">0.0055</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i11aa53d3dc864e008f9e1088d764b254_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjE0YTM4MWRiZDA3MDRjYTdhNmYxZDZjYzdhNDkwMmI1XzE5NzkxMjA5MzAwMDUz_61ff054f-eb6d-42f0-bc94-58f9f03859b3"
      unitRef="number">0.0000</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i41bece1da3a74bb9b590430977baca7c_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjE0YTM4MWRiZDA3MDRjYTdhNmYxZDZjYzdhNDkwMmI1Xzc2OTY1ODEzOTQ0ODQ_4def06f3-a522-47c6-92ae-28b9a001cbcc"
      unitRef="number">0.0055</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjA5NWUyYjJkMjU0MjQ0Njk5Y2Q0OTcwMDY5ZDdlNmFkXzc2OTY1ODEzOTQ0NTQ_54ac2428-2c19-4ddb-a7c7-fba2abb2faf9"
      unitRef="number">0.0240</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="i7848ab0fc3954d42a48de56c4b377354_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzItMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmI5NDEwZmI5OTMzYTQyMjBiY2Y1MWY5MDk4NjcxYTA4Xzc2OTY1ODEzOTQ0NTY_7a9db231-889e-49e2-9687-dda26446fc7f"
      unitRef="number">0.0135</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246MzU0ZGNjZTQ3Y2NiNDg3YTk5YjBjZGI0OTczM2FkZmZfNzY5NjU4MTM5NDQ2Mg_5f2a9d00-d19b-41a0-a09a-0ded83b9f5a8"
      unitRef="number">0.0250</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="if2b8dfeed67443e4a6e31f8a92ee2680_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMi0xLTEtMzY0MDYwL3RleHRyZWdpb246NzQ3MzlmMzZkMzM3NDgxNWJkYTcyOWY5ZTkyNDZlNzBfNzY5NjU4MTM5NDQ1OA_10ff06c4-34be-41ef-be86-f70518077207"
      unitRef="number">0.0250</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246OGMwNDY3OTBjNzQzNGY4N2I1ZGQ1NTI5ZmI2M2NmMGRfNzY5NjU4MTM5NDQzOA_54e819e5-c317-43b9-82e8-aedec662e345"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="i37dc156184d44185ad77a05f3d1c8e7d_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtNS0xLTEtMzY0MDYwL3RleHRyZWdpb246NDRmMzBmMjgyYjlkNDAyNWI0MTJjYWUyNTY2NTQ0NmVfNzY5NjU4MTM5NDQ1OA_1668a450-6f15-4fb1-b892-aeb1e8f545d5"
      unitRef="number">0.0325</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtNy0xLTEtMzY0MDYwL3RleHRyZWdpb246NDYyMjVhZTcyNDIyNDZmZThkMWZlMzkzMzM3ZTE5YmNfNzY5NjU4MTM5NDQ2MA_ae44c805-50b5-4d7b-80e8-9284465ed023"
      unitRef="number">0.0195</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="i61f3d4e904be4545a74ce3fa06c1a204_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtOC0xLTEtMzY0MDYwL3RleHRyZWdpb246Y2ZmZjk4ZTYyZGE0NDQ2NWFjN2E5ZWI3MzU2MjhmNTFfNzY5NjU4MTM5NDQ2MA_e7053d7d-482e-449a-98de-e69a696c223b"
      unitRef="number">0.0195</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmZiZDM1NTdkODg2ZDQ0ZjE4Nzc1NjNiNTU2ODI3NmFjXzc2OTY1ODEzOTQ0Mzg_c2238722-4a06-44fc-88e6-fe35e0420eb1"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="ib5ccc5f405134715b9e46b9feb0319b6_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjI5YjM0OTc5M2Q4ZDRkNDM4MTNjZDAwMTE3Y2ViMjA1Xzc2OTY1ODEzOTQ0NTg_8252ada3-3c86-4531-bb5e-9bd797d27790"
      unitRef="number">0.0330</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjQ5OTI1YzdlMzU4MjRjNTViNWI2Y2ZmZGZjY2Y5NWNlXzc2OTY1ODEzOTQ0NTg_c8fb3918-ed06-4e80-b45a-f55a29ef344c"
      unitRef="number">0.0145</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="ib07bedf4fd5b4afd80a58bc9cb0aec36_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjM1ZTY2OGZjNjdmZTRmZDQ5MDAyOWQ3OGRmMWIxN2JmXzc2OTY1ODEzOTQ0NTg_1c91789e-f45a-4f36-8354-065e99dc1851"
      unitRef="number">0.0145</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjcwN2VjYTIyOTk5YjQwNDA5YjZiZjBhMDMxMmRkMTBhXzc2OTY1ODEzOTQ0NDI_7a229fd0-fa1d-4f5e-afcd-49520aff5538"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="i7848ab0fc3954d42a48de56c4b377354_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzMtMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjYzZWY0N2FmYjkxODRhZjhiMTY4NTU1NGY4ZGRlNWUwXzc2OTY1ODEzOTQ0NjA_be35fdd1-a771-417d-9fc2-3848d6b42304"
      unitRef="number">0.0295</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246NThkYmYxN2QyMjVjNGY0NmEyNDBiNjc0MWY1ZTljYmNfNzY5NjU4MTM5NDQ1Ng_2c58987e-2345-4cee-a6fd-ebf5876561ec"
      unitRef="number">0.0250</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="if2b8dfeed67443e4a6e31f8a92ee2680_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMi0xLTEtMzY0MDYwL3RleHRyZWdpb246N2FhYjFjMWJlYjUwNDViOGJlYmU2ODkzY2MxNTY1YTRfNzY5NjU4MTM5NDQ1OA_22c59fe0-b33b-4d09-8745-02eef5dd99c1"
      unitRef="number">0.0250</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246NjE0MTcwZWYwNmY0NGJlNzhlNTFhMzkwMzljZDY1MWZfNzY5NjU4MTM5NDQzOA_452fbf91-cdd2-44bb-9f59-26c4382fd8b7"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="i37dc156184d44185ad77a05f3d1c8e7d_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtNS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZGI3NzljMDQzZmQ2NDYyNThlYWJjOTEzNWMzODdjZThfNzY5NjU4MTM5NDQ1Ng_e3781d83-535f-4cc8-9719-d4f720ade10f"
      unitRef="number">0.0300</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtNy0xLTEtMzY0MDYwL3RleHRyZWdpb246NzY1MzA1NTQ1NTFiNDE0NWE2YjRiZDZiZDA4MzY5MjBfNzY5NjU4MTM5NDQ1Ng_f2921123-f2ea-4876-83e1-baf4011a8b75"
      unitRef="number">0.0195</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="i61f3d4e904be4545a74ce3fa06c1a204_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtOC0xLTEtMzY0MDYwL3RleHRyZWdpb246NmFkZDcwMDAxYzE4NDFhM2EwZTA2ZjAwOTMyNWY1NDdfNzY5NjU4MTM5NDQ2MA_f6f7ad48-5137-43fc-a9eb-b4f2deb95586"
      unitRef="number">0.0195</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjJhZjIzYjgzNzcxMDQ4MjhhYzNiZmExMWE1NzU4ZTNmXzc2OTY1ODEzOTQ0Mzg_05efd7b9-8db7-4f61-8b02-939138fad262"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="ib5ccc5f405134715b9e46b9feb0319b6_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmNkMzZkYjQzNTViNTRmNmM4MDJhM2UwYzdmMzY1MzdiXzc2OTY1ODEzOTQ0NjA_4c3e1d54-8436-4e36-9841-61fb5b42ff41"
      unitRef="number">0.0315</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="i058d3dfb4d72464288d47993d2264238_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmU4ZDI0NmNhN2NkMjQ3ZjY5MTQwOTk3YWJlZDFiZjQ2Xzc2OTY1ODEzOTQ0NzY_7213dd93-8c45-4ff1-9311-99787290756c"
      unitRef="number">0.0145</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="ib07bedf4fd5b4afd80a58bc9cb0aec36_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjJhZDQ0MTg1MDYzZjQ2NzRiZDM5ZWIyZDY5YzA2YjQ2Xzc2OTY1ODEzOTQ0NTg_602e5949-5be3-4b5d-89f8-424d180bdee2"
      unitRef="number">0.0145</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjcxMmQ3YmRjYWI5MTQzZWU5MmQzMjdlNDZkMWE3NGE3Xzc2OTY1ODEzOTQ0Mzg_b10a6de6-e027-433f-9a42-f25a3bb27091"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="i7848ab0fc3954d42a48de56c4b377354_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzQtMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjEzYWI4OGQ4OWViZDQ4MmY4MjdmY2IzZDViNmYxNjhmXzc2OTY1ODEzOTQ0NTg_4e72b1f3-5f3e-4db1-b409-d6e1c4b6e26e"
      unitRef="number">0.0285</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246NjkzN2RmYzA4ZDhlNDYxMTgzYzQ3MGJjY2QwNDBhZTZfNzY5NjU4MTM5NDQzOA_0632aa31-b88f-481c-ab40-1973d5c32919"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="if2b8dfeed67443e4a6e31f8a92ee2680_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMi0xLTEtMzY0MDYwL3RleHRyZWdpb246NmY2NzgzNTA1ZGUyNDcxNzhhZTM3NGRhNDI5ODA5YjdfNzY5NjU4MTM5NDQzOA_3877f138-5904-4d2e-a13a-9735911947a1"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="i5a09555de5d2475e921b22b01c4067e0_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDBmMzM4Y2MzOTRmNGVmMmI3ZTdjNTAzZTlkZjFlZDRfNzY5NjU4MTM5NDQ1NQ_1c8e5c2f-64b3-463a-bc68-bc670d705002"
      unitRef="number">0.0329</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="idb0e67934e9342fe8d11bdef892de277_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDBmMzM4Y2MzOTRmNGVmMmI3ZTdjNTAzZTlkZjFlZDRfNzY5NjU4MTM5NDQ2Mw_97359474-be04-4878-89e6-be59d5bcd362"
      unitRef="number">0.0656</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="i37dc156184d44185ad77a05f3d1c8e7d_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtNS0xLTEtMzY0MDYwL3RleHRyZWdpb246ZTAwMWExZjVjN2ZjNDIyMzkzOTdkMTNhZDBkMWQ0MTVfNzY5NjU4MTM5NDQzOA_afdfe770-40ec-426b-bc88-40e9398eb3f4"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtNy0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDBiOWM2ZTkzNmQ2NDliMDhhZDM3NTNhZmRjNGZhNGFfNzY5NjU4MTM5NDQzOA_aaba7211-96ab-45fc-9c5c-d948317efd32"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="i61f3d4e904be4545a74ce3fa06c1a204_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtOC0xLTEtMzY0MDYwL3RleHRyZWdpb246OWFjMWRjNjA4OTVjNGZiYjkyMTEzYzFkZDViZjA0ZDJfNzY5NjU4MTM5NDQzOA_b8448b7c-02f9-4749-b565-4a6d92c7ac5a"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="ia76aa13b727547f4b1f27cd2781c256a_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjdlNWRiNzhmODdhNTRlMWI5YTcxNTA3MThmNDMwMmUwXzQ_00ab34ad-3cf3-4983-8e8f-07c9fff6ac33"
      unitRef="number">0.0350</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="i4b4ab3d8a6a24c718f4ce304e594594a_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjdlNWRiNzhmODdhNTRlMWI5YTcxNTA3MThmNDMwMmUwXzEw_59ff9374-d7fa-4c43-bed1-7a0ea62f3c1c"
      unitRef="number">0.0450</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="ib5ccc5f405134715b9e46b9feb0319b6_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjA4YjEyNjZhNTZjODQ5ZDRhNGRiOTg2ZmRmZmM0ZmNmXzc2OTY1ODEzOTQ0Mzg_4432cefa-172d-4436-b57c-d1a457f22f59"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmJlMzUyNDE1ZDFkMDQ0YjdiYjc2YzIxMGVlMDViMGRmXzc2OTY1ODEzOTQ0Mzg_b0f5fb3e-a22f-408c-98f7-b165d7e82bbc"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="ib07bedf4fd5b4afd80a58bc9cb0aec36_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjgyMTgwNzE2YmJjYTQ4MWNiMTYwZThjMzlkYmE2MzU5Xzc2OTY1ODEzOTQ0Mzg_a0a64011-36f6-4a01-a258-31fa698b6f2b"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="i389422a893e247e09550b1c3b9924585_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjRhZjBkOGE4YTE4NzRkYjA4MDU4ZWU1MDc5MjVjYTJjXzc2OTY1ODEzOTQ0Njc_f40570d9-1969-4fc0-83b7-daacacbb8f45"
      unitRef="number">0.0350</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="ib2b883217a0b47c1809f32a00d79e510_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjRhZjBkOGE4YTE4NzRkYjA4MDU4ZWU1MDc5MjVjYTJjXzc2OTY1ODEzOTQ0NzU_e5db6924-5c1d-44e0-9f49-8c1e941389d3"
      unitRef="number">0.0450</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates
      contextRef="i7848ab0fc3954d42a48de56c4b377354_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzUtMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmIyZmEzOGM4ZTZmYTRhMTg4OTQ0MDUyMjk3ODlhZDRiXzc2OTY1ODEzOTQ0Mzg_a0e1be6f-4a38-420a-8569-d9959dcb8394"
      unitRef="number">0</ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates>
    <sny:ActuarialAssumptionOfRetirementAgeBottomOfRange
      contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246YWQyMGFlODU4MjViNGE4ZGFiNWQxYmYwOWMyMDA1OGZfNzY5NjU4MTM5NDQ0Ng_fa8e5c68-8a9c-47ea-adf8-c0aa771c4330">P62Y</sny:ActuarialAssumptionOfRetirementAgeBottomOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMS0xLTEtMzY0MDYwL3RleHRyZWdpb246YWQyMGFlODU4MjViNGE4ZGFiNWQxYmYwOWMyMDA1OGZfNzY5NjU4MTM5NDQ1MQ_6e5c4722-a3b9-41e7-a60e-479a0fbc2f9f">P67Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMi0xLTEtMzY0MDYwL3RleHRyZWdpb246ODUyNmU2Y2Q0YzFkNGNkMDk5MjI3ODgzYWU3MmYyZTFfNzY5NjU4MTM5NDQ0MA_8dac44c0-19d6-4b85-aa98-e09d09c72260">P63Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeBottomOfRange
      contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDBlNjgyNGQ4YTY5NDBmMDhmYzY1MjQ4MTAxYjU4NTBfNzY5NjU4MTM5NDQ1NA_a0929c8d-7741-4db0-94fc-bd8da698b442">P55Y</sny:ActuarialAssumptionOfRetirementAgeBottomOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZDBlNjgyNGQ4YTY5NDBmMDhmYzY1MjQ4MTAxYjU4NTBfNzY5NjU4MTM5NDQ1OQ_e47ce5a7-412b-48b7-9aa8-e79a4aa5add5">P70Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeBottomOfRange
      contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNS0xLTEtMzY0MDYwL3RleHRyZWdpb246MDVlNmQ4MTY2MWMyNDQ5ZWEwZGIwMDY0NGQwOGM5MGZfNzY5NjU4MTM5NDQ0Ng_d28d7555-26a9-4f86-995e-d70469114934">P60Y</sny:ActuarialAssumptionOfRetirementAgeBottomOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNS0xLTEtMzY0MDYwL3RleHRyZWdpb246MDVlNmQ4MTY2MWMyNDQ5ZWEwZGIwMDY0NGQwOGM5MGZfNzY5NjU4MTM5NDQ1Mg_afbee218-5f1b-4722-9044-e89f90b902b6">P65Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeBottomOfRange
      contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNy0xLTEtMzY0MDYwL3RleHRyZWdpb246Mjk1MGRhYWE3ZWE0NGI0OGJhYWQ0ZGZjNDllOWMwMjJfNzY5NjU4MTM5NDQ0NQ_547604ec-55c2-4b9f-bd08-964507f90dc1">P62Y</sny:ActuarialAssumptionOfRetirementAgeBottomOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtNy0xLTEtMzY0MDYwL3RleHRyZWdpb246Mjk1MGRhYWE3ZWE0NGI0OGJhYWQ0ZGZjNDllOWMwMjJfNzY5NjU4MTM5NDQ0OQ_b56f4dd8-ea4f-41a0-ab8f-63f13e39f9f4">P67Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtOC0xLTEtMzY0MDYwL3RleHRyZWdpb246YzU4ZjBkNTFlYTMzNDdjOGI1MDNiY2JmNWZmZTlhOTRfNzY5NjU4MTM5NDQ0OA_a1f2cb3f-f848-439b-be06-efcb4f5ea7c7">P62Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeBottomOfRange
      contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmFjYjYwYTVlY2Y4ZTQ5MTU5ODI3ZmExZTExNGFiZWUwXzc2OTY1ODEzOTQ0NDU_889148f0-4a02-450a-a3b5-8b05a51db378">P55Y</sny:ActuarialAssumptionOfRetirementAgeBottomOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTAtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOmFjYjYwYTVlY2Y4ZTQ5MTU5ODI3ZmExZTExNGFiZWUwXzc2OTY1ODEzOTQ0NDk_54256b45-7726-4102-a28e-50e31787f263">P70Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeBottomOfRange
      contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjhhM2E4MjZiOGFkMzQzNDk4OGQ0MzdlMzNlYjYyMjBhXzc2OTY1ODEzOTQ0NDU_56910bcb-6977-4c4a-bda3-9389204a1a5f">P60Y</sny:ActuarialAssumptionOfRetirementAgeBottomOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTEtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjhhM2E4MjZiOGFkMzQzNDk4OGQ0MzdlMzNlYjYyMjBhXzc2OTY1ODEzOTQ0NDk_4970ca96-6307-4c83-8dc9-51ef8634e82f">P65Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeBottomOfRange
      contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjgxNWM0M2YyNjM5ODRjODU4YzhmYmRmZGM5NDhiYjIxXzc2OTY1ODEzOTQ0NDU_8926fbf1-b00f-4b5d-8c10-035b32200aec">P62Y</sny:ActuarialAssumptionOfRetirementAgeBottomOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTMtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjgxNWM0M2YyNjM5ODRjODU4YzhmYmRmZGM5NDhiYjIxXzc2OTY1ODEzOTQ0NDk_4bfdb18d-0252-4985-b8b2-3b1dc6be01c4">P67Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTQtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjJjNmEwZDQ4NzI5ZDQ5OWQ5MTE0OTEwNjVlMGI0MjNjXzc2OTY1ODEzOTQ0NDg_39d7431f-ee47-4a66-b132-b44ce293e12a">P62Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeBottomOfRange
      contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjZhN2UzMzJkNDA2YTQ1OTM4OTAwMjA5Yzc2NzYzMjg1Xzc2OTY1ODEzOTQ0NDU_f790f46e-cd59-4b40-a14f-9c63f1a70246">P55Y</sny:ActuarialAssumptionOfRetirementAgeBottomOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTYtMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjZhN2UzMzJkNDA2YTQ1OTM4OTAwMjA5Yzc2NzYzMjg1Xzc2OTY1ODEzOTQ0NDg_243b61df-37dd-42fb-8447-f560731e8ac9">P70Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeBottomOfRange
      contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjVhZmVjN2FmYzA5MzQ3YjA4Y2VkYTYwZTI4YjY1MmZiXzc2OTY1ODEzOTQ0NDU_5e56a837-b99f-486f-b3fb-fb5489878910">P60Y</sny:ActuarialAssumptionOfRetirementAgeBottomOfRange>
    <sny:ActuarialAssumptionOfRetirementAgeTopOfRange
      contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NTA0Yzc4ZTE3NDA0ODFmYTgwMTM4YjNiMmM3MmI5Ni90YWJsZXJhbmdlOjU1MDRjNzhlMTc0MDQ4MWZhODAxMzhiM2IyYzcyYjk2XzYtMTctMS0xLTM2NDA2MC90ZXh0cmVnaW9uOjVhZmVjN2FmYzA5MzQ3YjA4Y2VkYTYwZTI4YjY1MmZiXzc2OTY1ODEzOTQ0NDk_6fcb3d00-3386-44ca-b762-a27025419a20">P65Y</sny:ActuarialAssumptionOfRetirementAgeTopOfRange>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="i5064ea492ff44ec88d332c35c309d9a2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgyNzQ_52eedd2e-0071-41fb-a6bd-689143ac5ae0">P0Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="ieceff523a9144294a083d40ae6a52b9a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgyODA_7e3e51c7-b964-40bd-a146-40145736f8ab">P7Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="ie625e49612cb42ce92fe5437d2292431_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgyOTA_c427204b-3c8e-4930-bd72-fac9d6937de6">P7Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="i9ed6f92d51e8497998956b0d5d310672_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgyOTY_2c4e6086-2cb9-45d3-b122-cf8fe0a280e7">P10Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgzMTk_9b2c70ba-91c4-45c1-8848-886754cd7808">P10Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <sny:DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDgx_3c490f9f-9fae-41e1-9763-08090a13ed28">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the duration of Sanofi&#x2019;s obligations in the principal countries:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted average duration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMS0xLTEtMzY0MDYw_8a287a84-8032-4e2e-a6e1-1b9cb3416e63">P10Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMi0xLTEtMzY0MDYw_2a734250-f61f-425b-8227-077c0ca55470">P12Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMy0xLTEtMzY0MDYw_76231227-3e77-4143-904d-5f0209dc5622">P11Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItNC0xLTEtMzY0MDYw_7e5d32ac-79d1-4a1e-9da2-d648649990bb">P13Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItNS0xLTEtMzY0MDYw_8c1091b3-5380-469d-817f-31a21bb6e9a0">P12Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItNi0xLTEtMzY0MDYw_aaddc364-8a67-474a-a3a9-40bf545e6612">P16Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItNy0xLTEtMzY0MDYw_646ea2ea-6bde-438b-a252-90a0686a6b3d">P15Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItOC0xLTEtMzY0MDYw_c3cc7c2c-4100-4590-a402-94d5e5cbca7d">P17Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItOS0xLTEtMzY0MDYw_a73e2ffd-908a-4bbf-ad41-f9f44a4f458e">P13Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMTAtMS0xLTM2NDA2MA_9d0c1782-0cc7-42c3-9318-743bd3c07718">P16Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMTEtMS0xLTM2NDA2MA_e564ebdc-3128-422b-ab01-187ac0567f09">P16Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyYTJlZGNiOWIyMDc0YzlkOTU1YzllZTgyNGRmNjFkZS90YWJsZXJhbmdlOjJhMmVkY2I5YjIwNzRjOWQ5NTVjOWVlODI0ZGY2MWRlXzItMTItMS0xLTM2NDA2MA_d08e33b9-43cc-422d-99aa-4e75bc0ffc21">P18Y</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDgy_f5590636-7634-4206-afe7-18f9863d1f86">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the sensitivity of Sanofi&#x2019;s obligations for pensions and other post-employment benefits to changes in key actuarial assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions and other post-employment benefits, &lt;br/&gt;by principal country&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Measurement of defined-benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Change in&lt;br/&gt;assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;-0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;General inflation rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pension benefit indexation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Healthcare cost inflation rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mortality table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;+1 year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;+74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="ia7102fede0d146a4b433b8edd4bfc772_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzItMS0xLTEtMzY0MDYw_8b1c4d5f-9b7d-4cd5-b484-6745c073be5b"
      unitRef="number">0.0050</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="ibb62e344ae904638b2180924543f92ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzItMi0xLTEtMzY0MDYw_50f34523-3c98-4250-a9a1-d19595e422cf"
      unitRef="eur">72000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="id9847d7e6def4b7581c9458c55a23404_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzItMy0xLTEtMzY0MDYw_2e786f47-915b-446b-ab83-013dbafdba4a"
      unitRef="eur">162000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i2e3c25fe823d4ad6b20f9c54e9bbb046_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzItNC0xLTEtMzY0MDYw_ebc64601-5935-4e2f-9738-c78f64aef9b2"
      unitRef="eur">75000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i9a7882fdbd5e4e05aa9602a3893e9063_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzItNS0xLTEtMzY0MDYw_11de42d4-a8ab-4524-84d5-4d5e96dfd958"
      unitRef="eur">136000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i8e44e9528b734db79cc3d65a8189939d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzMtMS0xLTEtMzY0MDYw_71cd65cc-85ee-4f13-80d9-2e54606a7505"
      unitRef="number">0.0050</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i9f0a85e9edb0438fafb910e5b162bdb1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzMtMi0xLTEtMzY0MDYw_7f02f8ad-7ffa-437e-acaf-6fae13a2e773"
      unitRef="eur">47000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="ic4384e1a2f0a448db27dfc68742b600e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzMtMy0xLTEtMzY0MDYw_2cc37d18-1936-472c-aaf2-5a3068399244"
      unitRef="eur">306000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="ib4a60f88d3bf4ef7820610f341e5d953_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzMtNC0xLTEtMzY0MDYw_8eaf51d0-e384-4ec2-881c-e70afdde4ee0"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i79da83e967ea4e5e90e0bf72928c2373_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzMtNS0xLTEtMzY0MDYw_29372358-9d69-432a-a466-35ae7fddffca"
      unitRef="eur">75000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i4785a07760e04fa78307171b6792c3eb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzQtMS0xLTEtMzY0MDYw_cd5f5a2e-649a-449a-a328-b69e2b5c5e43"
      unitRef="number">0.0050</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i869eae3e607c4fe0a4413a6a56efb7f1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzQtMi0xLTEtMzY0MDYw_9416df45-d20f-4f5c-b2b7-790a2f43b774"
      unitRef="eur">51000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i328a8d284f6846269cfae2148edfd6c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzQtMy0xLTEtMzY0MDYw_0c9f5f34-5dc9-4968-abc4-3108573a09f8"
      unitRef="eur">200000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i5ccfe837400547adbd518f52980bff84_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzQtNC0xLTEtMzY0MDYw_02b98ab4-5278-4a35-8e11-678e1a25863e"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i3aaf7a0ab28f49108002d2f4290bd493_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzQtNS0xLTEtMzY0MDYw_c1c5e069-fd41-4506-9fd1-5f1ff5165154"
      unitRef="eur">53000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="ic8f6bcd683c14b17bea138ad1208ab88_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzUtMS0xLTEtMzY0MDYw_874ca71f-198b-4c4b-af62-c068de7e218c"
      unitRef="number">0.0050</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i8332aad05ed4409494a56fb553b8cf48_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzUtMi0xLTEtMzY0MDYw_9b0732a6-7c68-4f9a-8062-d9e12a42e659"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="if40430fe8c9b45feb6dc9b6f4a03573b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzUtMy0xLTEtMzY0MDYw_60e51618-7544-4ce7-8d38-575513fa39b3"
      unitRef="eur">2000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i148b4cdc5ea1410fa268363a20cffc49_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzUtNC0xLTEtMzY0MDYw_7fc34155-19be-4fa9-8c5a-baa3dcf097d2"
      unitRef="eur">6000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i58cc77a855b44d93866738bd3c23f42e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzUtNS0xLTEtMzY0MDYw_07275cdd-9dc4-45e6-955f-bb1ab5c7c9e7"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="ie526c1d298584ae8972260efcc9808b6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzYtMi0xLTEtMzY0MDYw_8bdb10e0-c339-46c5-aced-a78a9f05c269"
      unitRef="eur">61000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i127c8206a4a849dbbb0fd4ceee30d8aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzYtMy0xLTEtMzY0MDYw_8b291982-4da2-4b4d-a3fc-eb4d812bc874"
      unitRef="eur">51000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="i54a79349271f4e4fb33e85139f76607f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzYtNC0xLTEtMzY0MDYw_554d976f-7a3e-47be-8233-f28ba56dd076"
      unitRef="eur">19000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="ibaefca5f76804fce8b04f617795c3068_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4ZmNlZTNmYWYzMTM0NTVhYjczYTJlODg5NGIwNTFiZS90YWJsZXJhbmdlOjhmY2VlM2ZhZjMxMzQ1NWFiNzNhMmU4ODk0YjA1MWJlXzYtNS0xLTEtMzY0MDYw_a9f6767d-cd3d-4880-927b-b647e062cf95"
      unitRef="eur">74000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <sny:DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDc1_e0bd3331-8a40-4651-b470-80d7c8f47018">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below reconciles the net obligation in respect of Sanofi&#x2019;s pension and other post-employment benefit plans with the amounts recognized in the consolidated financial statements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Measurement of the obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial losses/(gains) due to changes in demographic assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial losses/(gains) due to changes in financial assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(210)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial losses/(gains) due to experience adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan amendments, curtailments or settlements not specified in the terms of the plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(938)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan settlements specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation and transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Obligation at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,651&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,175&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,456&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value of plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest income on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Difference between actual return and interest income on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Administration costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan settlements specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan settlements not specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(739)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contributions from plan members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employer&#x2019;s contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(469)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation and transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value of plan assets at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,899&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,651&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,358&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount shown in the balance sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Effect of asset ceiling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount shown in the balance sheet at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,770&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,539&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amounts recognized in the balance sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pre-funded obligations (see Note D.7.)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Obligations provided for&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount recognized at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,770&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,539&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Benefit cost for the period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Gains)/losses related to plan amendments, curtailments or settlements not specified in&#160;the&#160;terms&#160;of the plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest (income)/cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contributions from plan members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Administration costs and taxes paid during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense recognized directly in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;168&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;276&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(685)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(409)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;350&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;These amounts include the impact of applying the April&#160;2021 IFRIC agenda decision on the attribution of benefits to periods of service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;For 2020, this line mainly comprises a reduction in post-employment benefit liabilities following the announcement of voluntary redundancy programs, primarily in Europe.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;For 2022, this line includes &#x20ac;99&#160;million of assets in the United Kingdom (versus &#x20ac;220&#160;million for 2021); those amounts are not subject to any asset ceiling, in accordance with IFRIC&#160;14.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d)&#160;&#160;&#160;&#160;Amounts recognized in Other comprehensive income (see Note&#160;D.15.7.).&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i1aeea4ef448d4878b040aca58e59cef7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMtMS0xLTEtMzY0MDYw_06209289-c303-49e1-a6b9-7a7cd86a1933"
      unitRef="eur">12175000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i46a2a2a21d77490d9398a698d3aec8c0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMtMi0xLTEtMzY0MDYw_ed6a70c1-b7aa-4ff5-9da1-701319ce30ef"
      unitRef="eur">12456000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i0d7223a21f0b4cee97becbcdd1bb2efc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMtNC0xLTEtMzY0MDYw_bea8e7b6-a310-4ff7-bcf8-a0902b40bbb8"
      unitRef="eur">13094000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQtMS0xLTEtMzY0MDYw_213c9443-62c3-4d24-b6c3-60ddd643eeec"
      unitRef="eur">193000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQtMi0xLTEtMzY0MDYw_189d62f9-14fd-4bdc-8357-4ca159d1fb8f"
      unitRef="eur">227000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQtNC0xLTEtMzY0MDYw_24c89d2f-f639-471d-b8f3-0a0b3d38025f"
      unitRef="eur">221000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzUtMS0xLTEtMzY0MDYw_380ad16c-9446-4160-b21d-da268368d55b"
      unitRef="eur">206000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzUtMi0xLTEtMzY0MDYw_c1346325-0cde-4799-a5ef-b59a8cace873"
      unitRef="eur">148000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzUtNC0xLTEtMzY0MDYw_a8709277-9a50-429e-acfb-dae70066bd24"
      unitRef="eur">192000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzYtMS0xLTEtMzY0MDYw_cbb42974-fceb-4e66-8b1f-f59ebbedcc05"
      unitRef="eur">219000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzYtMi0xLTEtMzY0MDYw_e691eca9-13d4-4322-8d0d-9e93d0951a17"
      unitRef="eur">162000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzYtNC0xLTEtMzY0MDYw_3c386825-2d3d-4d75-aa33-511b1fef3058"
      unitRef="eur">-52000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzctMS0xLTEtMzY0MDYw_e5f2fb6f-ae22-4fe0-9f23-50bafac635ca"
      unitRef="eur">3006000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzctMi0xLTEtMzY0MDYw_752b2a83-5d49-4048-8fa9-8a7981f66a71"
      unitRef="eur">210000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzctNC0xLTEtMzY0MDYw_40f2aec5-018f-4ce9-850b-aa886cfeb0b0"
      unitRef="eur">-936000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
      contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzgtMS0xLTEtMzY0MDYw_838b2955-1c48-42c4-9c8e-85bf5a8d5a6d"
      unitRef="eur">-177000000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
      contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzgtMi0xLTEtMzY0MDYw_ffefec78-95dc-48bb-80e3-36280005f8b5"
      unitRef="eur">120000000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
      contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzgtNC0xLTEtMzY0MDYw_715ecd84-fa53-4aba-9f69-86d8ead2cd17"
      unitRef="eur">26000000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan
      contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzktMS0xLTEtMzY0MDYw_3fa7f510-d919-4f06-84d4-bcc6141d5125"
      unitRef="eur">229000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan
      contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzktMi0xLTEtMzY0MDYw_60348bf9-f844-4fb0-b804-61682121cfd3"
      unitRef="eur">4000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan
      contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzktNC0xLTEtMzY0MDYw_f5aa0464-3887-49e6-8a7a-35db6b92a89d"
      unitRef="eur">938000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset
      contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEwLTEtMS0xLTM2NDA2MA_a5cf4848-e1d4-4b89-8714-0d953bfdc7a7"
      unitRef="eur">84000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset
      contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEwLTItMS0xLTM2NDA2MA_ea33086b-1cac-4a90-869d-38c6a45879a7"
      unitRef="eur">66000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset
      contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEwLTQtMS0xLTM2NDA2MA_5c9d55a5-6524-435a-810f-851076364d08"
      unitRef="eur">75000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzExLTEtMS0xLTM2NDA2MA_26d78a1e-1cb0-494d-9e80-148ed1ba6e2d"
      unitRef="eur">463000000</ifrs-full:BenefitsPaidOrPayable>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzExLTItMS0xLTM2NDA2MA_1dd16a43-5b19-4fa0-9842-28e0ed5aee78"
      unitRef="eur">503000000</ifrs-full:BenefitsPaidOrPayable>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzExLTQtMS0xLTM2NDA2MA_ee51c892-0eae-45da-8449-d231a9f35452"
      unitRef="eur">545000000</ifrs-full:BenefitsPaidOrPayable>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset
      contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEyLTEtMS0xLTM2NDA2MA_24815b57-5119-4144-9ac7-1568bae6b278"
      unitRef="eur">-114000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset
      contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEyLTItMS0xLTM2NDA2MA_828479d8-4793-44e9-9c47-ed6b831e294e"
      unitRef="eur">-8000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset
      contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEyLTQtMS0xLTM2NDA2MA_5b957ff2-449e-4797-b527-b3a720a9286b"
      unitRef="eur">-12000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset
      contextRef="ifc22eaafb3314fb6a28a57826709fbca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEzLTEtMS0xLTM2NDA2MA_7279977a-b92c-49b4-9cf1-7c01c9bd6b79"
      unitRef="eur">15000000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset
      contextRef="i1fc1d41620a54dd2ae9108d2177a767b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEzLTItMS0xLTM2NDA2MA_6e7cd805-03c9-4944-9cf5-a55cb63cf280"
      unitRef="eur">417000000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset
      contextRef="ib27da8790ad74a2f8fe63dd792002eac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzEzLTQtMS0xLTM2NDA2MA_77cc4a60-c44d-481b-9fdc-1269d996b1c3"
      unitRef="eur">-443000000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="ifda432649e3d4b16b2b65809871ae47a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE0LTEtMS0xLTM2NDA2MA_976a7b56-faab-45a3-973a-d1e867803012"
      unitRef="eur">8651000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i1aeea4ef448d4878b040aca58e59cef7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE0LTItMS0xLTM2NDA2MA_f0f9a0d9-b715-4a1d-b0ed-586e0de94039"
      unitRef="eur">12175000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i46a2a2a21d77490d9398a698d3aec8c0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE0LTQtMS0xLTM2NDA2MA_d73227bf-54ff-45f6-9a9f-60e2556b202f"
      unitRef="eur">12456000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i04bc92eea38a43168f452b170f5b5971_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE2LTEtMS0xLTM2NDA2MA_6e558f6d-9033-404f-a6e4-71a4643acfb7"
      unitRef="eur">-9651000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i7fcfaf4afb0a4150a2e4eb7dcb4551b3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE2LTItMS0xLTM2NDA2MA_0e746b79-740d-44fd-9c74-a739905e1216"
      unitRef="eur">-9358000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i5920c792a4ae4e7d86f79510124b3f82_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE2LTQtMS0xLTM2NDA2MA_e121d077-2b85-424e-9811-1e3f8d712697"
      unitRef="eur">-9651000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE3LTEtMS0xLTM2NDA2MA_32e84bff-1114-484c-b751-bdf9fbb73658"
      unitRef="eur">-163000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE3LTItMS0xLTM2NDA2MA_707f4609-5930-4daf-bb73-d891d2de9db2"
      unitRef="eur">-106000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE3LTQtMS0xLTM2NDA2MA_147a5dd0-4d4a-42fa-b474-12c12bd06805"
      unitRef="eur">-138000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset
      contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE4LTEtMS0xLTM2NDA2MA_660012b6-3413-4ed5-b3e6-86ceb2640ff8"
      unitRef="eur">-2398000000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset
      contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE4LTItMS0xLTM2NDA2MA_77906760-5103-4a70-9226-7d1c2ecfc347"
      unitRef="eur">207000000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset
      contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE4LTQtMS0xLTM2NDA2MA_6b2494fb-c8b8-4309-959d-dac0eea904f5"
      unitRef="eur">696000000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod
      contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE5LTEtMS0xLTM2NDA2MA_5f901a43-63f8-40b3-b6a4-25b5f7420bcb"
      unitRef="eur">-6000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod
      contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE5LTItMS0xLTM2NDA2MA_f1eb88aa-8267-4147-a792-781e859f36b8"
      unitRef="eur">-7000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod
      contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzE5LTQtMS0xLTM2NDA2MA_eb1e7057-7aed-4918-bfb9-903c9ae26765"
      unitRef="eur">-14000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset
      contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIwLTEtMS0xLTM2NDA2MA_48664848-164f-41fc-bfab-abce69060eff"
      unitRef="eur">-84000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset
      contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIwLTItMS0xLTM2NDA2MA_cb650ca7-cb94-4d61-bf8c-f9487a3fbba7"
      unitRef="eur">-66000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset
      contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIwLTQtMS0xLTM2NDA2MA_e7fc83d6-d6c1-4953-a932-ce728af41982"
      unitRef="eur">-75000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan
      contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIxLTEtMS0xLTM2NDA2MA_590a71cd-b0c1-4b72-bbf3-5731337ed44b"
      unitRef="eur">-161000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan
      contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIxLTItMS0xLTM2NDA2MA_cf2062bf-df13-4f63-be45-6d17a741c96d"
      unitRef="eur">-9000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan
      contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIxLTQtMS0xLTM2NDA2MA_bbc1f207-56da-419f-8f69-bdf9106609cf"
      unitRef="eur">-739000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIyLTEtMS0xLTM2NDA2MA_1b979238-de5f-4f5e-bc44-01410440b63f"
      unitRef="eur">6000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIyLTItMS0xLTM2NDA2MA_d9949aad-6692-4a2e-9dc2-4a2647af6a1a"
      unitRef="eur">6000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIyLTQtMS0xLTM2NDA2MA_ac08cc1b-0e29-4cfa-bdf7-d8486590dcbc"
      unitRef="eur">6000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIzLTEtMS0xLTM2NDA2MA_df951f4a-ad0e-46ae-8671-1d43be56e5bd"
      unitRef="eur">238000000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIzLTItMS0xLTM2NDA2MA_caf6fc3c-0b7b-41a9-994b-4e2b6b9515ec"
      unitRef="eur">176000000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzIzLTQtMS0xLTM2NDA2MA_d8d567e0-817f-4576-8cee-9771b56301d4"
      unitRef="eur">490000000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset
      contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI0LTEtMS0xLTM2NDA2MA_e63c0499-4a11-44b4-aff1-e3423fe91731"
      unitRef="eur">-426000000</ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset>
    <ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset
      contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI0LTItMS0xLTM2NDA2MA_8414e2a9-ec5d-4d22-a580-d8d2df64de59"
      unitRef="eur">-458000000</ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset>
    <ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset
      contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI0LTQtMS0xLTM2NDA2MA_7be0e38d-dfab-4ce3-bbea-5a40e3358961"
      unitRef="eur">-469000000</ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset
      contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI1LTEtMS0xLTM2NDA2MA_603d521c-42c5-4f65-bec0-7ce608eeefb3"
      unitRef="eur">32000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset
      contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI1LTItMS0xLTM2NDA2MA_bd4f3f8e-5c3b-4d13-8ec9-cb97aa3e46cb"
      unitRef="eur">6000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset
      contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI1LTQtMS0xLTM2NDA2MA_f1a65221-3469-44be-9ebc-c15d8f36de91"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset
      contextRef="i173ba77be5064b3e920e7737557abdf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI2LTEtMS0xLTM2NDA2MA_0e31c386-75e9-415f-8c8a-d6d3384e67ef"
      unitRef="eur">52000000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset
      contextRef="i45593de6fda94e9285ac19b2b662916b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI2LTItMS0xLTM2NDA2MA_0c1a8995-234f-45b6-b1dc-00f9bcf557e8"
      unitRef="eur">-344000000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset
      contextRef="ie3ae67c368134154916bc3eada16dfbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI2LTQtMS0xLTM2NDA2MA_0843dcec-fdd2-4bf8-b42d-6795ad9dd630"
      unitRef="eur">326000000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i937300c73128444c840c7f1ad48a02a2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI3LTEtMS0xLTM2NDA2MA_feae442b-c905-4f31-8088-0fc1a951e8e0"
      unitRef="eur">-6899000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i04bc92eea38a43168f452b170f5b5971_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI3LTItMS0xLTM2NDA2MA_2252aead-94b2-4338-a7c1-020d885e31ba"
      unitRef="eur">-9651000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i7fcfaf4afb0a4150a2e4eb7dcb4551b3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI3LTQtMS0xLTM2NDA2MA_dfcb4a2b-a2aa-40e7-bb07-9ae9c96356e7"
      unitRef="eur">-9358000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan
      contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI5LTEtMS0xLTM2NDA2MA_258d1c75-eebb-43b6-8af8-376295c3c8e3"
      unitRef="eur">1752000000</ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan
      contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI5LTItMS0xLTM2NDA2MA_308ae90c-58b7-4bd4-8b31-5297566930e9"
      unitRef="eur">2524000000</ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan
      contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzI5LTQtMS0xLTM2NDA2MA_72a8ba96-4e9c-4afd-9487-fbdb717b77da"
      unitRef="eur">3098000000</ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="ia26a9a0089c24d36a14fba4dc1693ac2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMwLTEtMS0xLTM2NDA2MA_ecced113-e36f-4c42-92e4-11a3e5b34217"
      unitRef="eur">18000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i807618602bfb425397cffdd414a540ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMwLTItMS0xLTM2NDA2MA_4674cc50-6e1e-4865-ae53-946d7413e401"
      unitRef="eur">15000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i5072e9250f7c4f3d89d1b407dd2508a4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMwLTQtMS0xLTM2NDA2MA_4da5ecc9-ce3a-4c49-ab61-d8d7e469014d"
      unitRef="eur">1000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMxLTEtMS0xLTM2NDA2MA_67a8dfdd-799f-4922-a032-c4a495a55dc3"
      unitRef="eur">1770000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMxLTItMS0xLTM2NDA2MA_ae5b4e2a-e20e-46ad-8051-97ac77ab603d"
      unitRef="eur">2539000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMxLTQtMS0xLTM2NDA2MA_57316272-5f77-4f1e-adb6-14e97d45eb32"
      unitRef="eur">3099000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <sny:PreFundedPensionObligations
      contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMzLTEtMS0xLTM2NDA2MA_ab0255f0-c0e8-4eb8-ae75-bb951b8c94ac"
      unitRef="eur">269000000</sny:PreFundedPensionObligations>
    <sny:PreFundedPensionObligations
      contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMzLTItMS0xLTM2NDA2MA_c425db18-e1e8-4393-be27-c34b40c248ec"
      unitRef="eur">408000000</sny:PreFundedPensionObligations>
    <sny:PreFundedPensionObligations
      contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzMzLTQtMS0xLTM2NDA2MA_39be06e5-fba7-46da-9f04-91aaf12a9ceb"
      unitRef="eur">177000000</sny:PreFundedPensionObligations>
    <ifrs-full:NoncurrentProvisions
      contextRef="ie3092ea35a054f4882eb46f7d877613d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM0LTEtMS0xLTM2NDA2MA_5a129ced-014d-4a3b-948a-680682b5868b"
      unitRef="eur">2039000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="ie7cf90fb83ae431ca29e7217f1d29cc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM0LTItMS0xLTM2NDA2MA_1d04ad3e-aa78-4fe4-a684-b58a63ad71d6"
      unitRef="eur">2947000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="i74c83face2414740ae5f9026f45db6e2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM0LTQtMS0xLTM2NDA2MA_fb37a420-f72a-43b5-b8e2-23b4001c51b8"
      unitRef="eur">3276000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM1LTEtMS0xLTM2NDA2MA_04636b69-149a-4e67-9ca2-2779b27dade5"
      unitRef="eur">1770000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM1LTItMS0xLTM2NDA2MA_7b3a2573-ce0c-4620-af67-88d202959521"
      unitRef="eur">2539000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM1LTQtMS0xLTM2NDA2MA_1f12346d-de2f-4789-9895-e0dd0c2751da"
      unitRef="eur">3099000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM3LTEtMS0xLTM2NDA2MA_e1a20542-33f5-4b14-b108-99724fd6e6ef"
      unitRef="eur">193000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM3LTItMS0xLTM2NDA2MA_886f4645-f6a4-4a0a-8b8e-7f0ab846fce7"
      unitRef="eur">227000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM3LTQtMS0xLTM2NDA2MA_93a6c22c-2755-4ee5-9715-37a971fa9d6d"
      unitRef="eur">221000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM4LTEtMS0xLTM2NDA2MA_f4c131fd-a24c-4cd2-8948-92584ede4b62"
      unitRef="eur">68000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM4LTItMS0xLTM2NDA2MA_cc4f4607-34f8-42cc-aa8f-9a06d819ee02"
      unitRef="eur">-5000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM4LTQtMS0xLTM2NDA2MA_067eb1d3-798e-4332-9337-f2bfe6c4183d"
      unitRef="eur">199000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM5LTEtMS0xLTM2NDA2MA_9fcc09a6-0dd6-4c67-a31c-ed99b37bc66c"
      unitRef="eur">43000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM5LTItMS0xLTM2NDA2MA_8b270076-bdb7-4641-95a0-29ab5055ad15"
      unitRef="eur">42000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzM5LTQtMS0xLTM2NDA2MA_3cf9f52c-f9fc-41a1-bdee-63dae56447ff"
      unitRef="eur">55000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQwLTEtMS0xLTM2NDA2MA_faa5a5a0-3c39-4655-9038-f06b2832676e"
      unitRef="eur">6000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQwLTItMS0xLTM2NDA2MA_1e5b7ea2-7b8c-4f68-b5df-b1dbfaea82c6"
      unitRef="eur">6000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQwLTQtMS0xLTM2NDA2MA_4277bcfe-5e24-49c7-9447-e06a2b6ccd71"
      unitRef="eur">7000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQxLTEtMS0xLTM2NDA2MA_2c6704e3-cda0-4b69-a949-f059340933a5"
      unitRef="eur">-6000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQxLTItMS0xLTM2NDA2MA_06cec28f-a941-4edc-93bf-3fb2ebf57ad4"
      unitRef="eur">-7000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQxLTQtMS0xLTM2NDA2MA_c8a19af4-5c74-4fd2-9eb3-020ec87b2f4c"
      unitRef="eur">-14000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQyLTEtMS0xLTM2NDA2MA_6e3a8adf-e3fb-4ee4-b767-9046dfd083de"
      unitRef="eur">168000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQyLTItMS0xLTM2NDA2MA_ef11d54c-8a95-401f-a049-536f3c038d0c"
      unitRef="eur">276000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQyLTQtMS0xLTM2NDA2MA_85e7007c-e477-4678-a48a-71dbfdc1dc91"
      unitRef="eur">84000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQzLTEtMS0xLTM2NDA2MA_114ac67e-f498-40d7-92b8-05a01c900f1d"
      unitRef="eur">-650000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQzLTItMS0xLTM2NDA2MA_ce8650db-39ca-4add-9404-2a9d454728ae"
      unitRef="eur">-685000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQzLTQtMS0xLTM2NDA2MA_13a3b2fb-ddb3-4cf6-bc03-3e6c8a5dea75"
      unitRef="eur">266000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <sny:EmployeeBenefitsExpenseGain
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQ0LTEtMS0xLTM2NDA2MA_a02199f5-714e-43cf-b196-4a974789e16c"
      unitRef="eur">-482000000</sny:EmployeeBenefitsExpenseGain>
    <sny:EmployeeBenefitsExpenseGain
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQ0LTItMS0xLTM2NDA2MA_7c06866d-a2f1-4231-8382-d08b363f5c64"
      unitRef="eur">-409000000</sny:EmployeeBenefitsExpenseGain>
    <sny:EmployeeBenefitsExpenseGain
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0NjRiZDEwNTE0Mzc0NTAyOWZlZWQzMDQzNmUyNjQzMy90YWJsZXJhbmdlOjQ2NGJkMTA1MTQzNzQ1MDI5ZmVlZDMwNDM2ZTI2NDMzXzQ0LTQtMS0xLTM2NDA2MA_4b367d72-2568-41b5-836d-aa9972bc728b"
      unitRef="eur">350000000</sny:EmployeeBenefitsExpenseGain>
    <sny:PreFundedPensionObligations
      contextRef="i39d668fce64249f697434c38ca01ade9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgwODE0MTA0Njc1MjAz_9698621e-de27-4938-82ba-2b6a00d026e8"
      unitRef="eur">99000000</sny:PreFundedPensionObligations>
    <sny:PreFundedPensionObligations
      contextRef="i196a10f493ab454b9274ca3eb5246334_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzgwODE0MTA0Njc1MjE2_a7557bd2-883f-4753-a88b-fedc2659e86a"
      unitRef="eur">220000000</sny:PreFundedPensionObligations>
    <sny:DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NTA2_20d0b398-2e4a-44ef-8448-301e4e23fdb7">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The tables below show Sanofi&#x2019;s net liability in respect of pension plans and other post-employment benefits by geographical region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Measurement of obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Effect of asset ceiling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount shown in the balance sheet at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;627&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;413&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;686&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;139&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,770&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Measurement of obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Effect of asset ceiling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount shown in the balance sheet at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;819&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;768&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;972&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;195&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,539&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Measurement of obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Effect of asset ceiling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amount shown in the balance sheet at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;872&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;919&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,014&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;269&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ia89777d1856946948f3ab287b274b7b3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItMS0xLTEtMzY0MDYw_70c1ff39-d25b-4c62-a5a7-a880aed9bbce"
      unitRef="eur">1324000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i7d7547d361d44bc7bc51287f8d63fa39_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItMi0xLTEtMzY0MDYw_64a3096a-0013-4cb8-aa5f-aa5d68a69790"
      unitRef="eur">2730000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i735c553a649d4710a2f06d4ea8c8f3eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItMy0xLTEtMzY0MDYw_9f995357-58b5-4084-a5f4-af08b0aa2f22"
      unitRef="eur">1546000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i39d668fce64249f697434c38ca01ade9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItNC0xLTEtMzY0MDYw_d1ee2a32-dba9-41ad-abfc-3bb02d77b0db"
      unitRef="eur">2080000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i9f74e0cfe57246efbeaadd68666dbd3c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItNS0xLTEtMzY0MDYw_700f09d8-d40f-4d88-a58a-24355de273e9"
      unitRef="eur">971000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzItNi0xLTEtMzY0MDYw_a2e40eef-304e-4fb6-a706-3cff6b3b2211"
      unitRef="eur">8651000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="ia89777d1856946948f3ab287b274b7b3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtMS0xLTEtMzY0MDYw_ef971d66-5589-4697-a35d-88137c9f6fd0"
      unitRef="eur">697000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i7d7547d361d44bc7bc51287f8d63fa39_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtMi0xLTEtMzY0MDYw_b8f44844-5a80-4958-8385-5794cccf991b"
      unitRef="eur">2317000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i735c553a649d4710a2f06d4ea8c8f3eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtMy0xLTEtMzY0MDYw_f63249c8-c6f2-4efd-8644-fefcc1470c58"
      unitRef="eur">860000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i39d668fce64249f697434c38ca01ade9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtNC0xLTEtMzY0MDYw_85d46873-39c2-4093-a444-e8adc5718728"
      unitRef="eur">2175000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i9f74e0cfe57246efbeaadd68666dbd3c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtNS0xLTEtMzY0MDYw_16128a7b-2da4-4e9f-99c8-0f517f7eb1a5"
      unitRef="eur">850000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzMtNi0xLTEtMzY0MDYw_e7cc22ae-53e4-4d5a-8ad6-d9928afe1a0d"
      unitRef="eur">6899000000</ifrs-full:PlanAssetsAtFairValue>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="ia89777d1856946948f3ab287b274b7b3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtMS0xLTEtMzY0MDYw_5a06b6df-beca-4b39-a8f3-0699d274d161"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i7d7547d361d44bc7bc51287f8d63fa39_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtMi0xLTEtMzY0MDYw_f8d43fbb-4fb9-4e71-9ce7-91d8dbdd0aa8"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i735c553a649d4710a2f06d4ea8c8f3eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtMy0xLTEtMzY0MDYw_70ed9df2-c15a-4f29-b703-3d9adb46ddae"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i39d668fce64249f697434c38ca01ade9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtNC0xLTEtMzY0MDYw_30f06237-9af2-44a4-b5aa-dc2069e8a550"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i9f74e0cfe57246efbeaadd68666dbd3c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtNS0xLTEtMzY0MDYw_fc7e63f7-9c9a-478f-a3c9-3a3e3be77b3c"
      unitRef="eur">-18000000</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzQtNi0xLTEtMzY0MDYw_8b1d554b-e024-4f87-ae78-8b4e43f6a017"
      unitRef="eur">-18000000</sny:PlanAssetsEffectOfAssetCeiling>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="ia89777d1856946948f3ab287b274b7b3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtMS0xLTEtMzY0MDYw_5e6cdf6d-98cc-41d7-8a24-9f0515b2791a"
      unitRef="eur">627000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i7d7547d361d44bc7bc51287f8d63fa39_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtMi0xLTEtMzY0MDYw_f0165368-efc8-4f38-b133-da3ef2102638"
      unitRef="eur">413000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i735c553a649d4710a2f06d4ea8c8f3eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtMy0xLTEtMzY0MDYw_8994a0dd-1f97-4119-83e6-5bc25f5f120c"
      unitRef="eur">686000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i39d668fce64249f697434c38ca01ade9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtNC0xLTEtMzY0MDYw_0bffe4b0-6845-4bd5-ab6b-c57f82185dab"
      unitRef="eur">-95000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i9f74e0cfe57246efbeaadd68666dbd3c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtNS0xLTEtMzY0MDYw_16063033-50a1-4aad-9bbc-1418ee0e6ab4"
      unitRef="eur">139000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i3e44f785b99b48ba805fc2c0db8dde02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo4YWM1ZjU0YTJmNTU0OGY2OTM5M2VjNTBmNjQwMDAzNy90YWJsZXJhbmdlOjhhYzVmNTRhMmY1NTQ4ZjY5MzkzZWM1MGY2NDAwMDM3XzUtNi0xLTEtMzY0MDYw_ee4a4f81-1744-4c46-a56e-d96129c303a2"
      unitRef="eur">1770000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i9658a2abf9a5478fa9e50db338221664_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItMS0xLTEtMzY0MDYw_16f32bad-b6c8-4492-b2f8-0c5177e4b161"
      unitRef="eur">1657000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i625df457bbfd46169d9a20d074aae8b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItMi0xLTEtMzY0MDYw_babfa98e-df7e-4c14-9dd0-093e5639742a"
      unitRef="eur">3576000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i6d15ea0bd3b14ac3b41652e59b0e1991_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItMy0xLTEtMzY0MDYw_35bba39a-d32d-4991-916f-6335af77cba4"
      unitRef="eur">2099000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i196a10f493ab454b9274ca3eb5246334_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItNC0xLTEtMzY0MDYw_8302c802-2289-4401-9c0c-4d5d791dd4af"
      unitRef="eur">3414000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="icef5204976824f79a913930fb94f085b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItNS0xLTEtMzY0MDYw_a35ec3d2-4b93-4747-8f0d-8c883d44da3b"
      unitRef="eur">1429000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzItNi0xLTEtMzY0MDYw_13a91501-6780-49aa-af0b-7a25225d2111"
      unitRef="eur">12175000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i9658a2abf9a5478fa9e50db338221664_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtMS0xLTEtMzY0MDYw_d092c0b0-797f-4916-8eaa-88348f67951b"
      unitRef="eur">838000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i625df457bbfd46169d9a20d074aae8b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtMi0xLTEtMzY0MDYw_b64c78ec-69d2-4cfb-853a-363f552394d4"
      unitRef="eur">2808000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i6d15ea0bd3b14ac3b41652e59b0e1991_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtMy0xLTEtMzY0MDYw_8761f720-2939-4e03-85e4-6fc7402aceca"
      unitRef="eur">1127000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i196a10f493ab454b9274ca3eb5246334_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtNC0xLTEtMzY0MDYw_d3b715c7-c407-4756-b8f4-1f9ccce136c0"
      unitRef="eur">3629000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="icef5204976824f79a913930fb94f085b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtNS0xLTEtMzY0MDYw_f2020000-5237-407f-b0f3-2ff76171ede9"
      unitRef="eur">1249000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzMtNi0xLTEtMzY0MDYw_b5712db8-38f3-4e73-985a-2ef66dbd2d8e"
      unitRef="eur">9651000000</ifrs-full:PlanAssetsAtFairValue>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i9658a2abf9a5478fa9e50db338221664_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtMS0xLTEtMzY0MDYw_71256e63-a22f-4534-9f1f-f6fb06c11f64"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i625df457bbfd46169d9a20d074aae8b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtMi0xLTEtMzY0MDYw_5c533c21-d44d-4602-b420-7a3c4b610ae8"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i6d15ea0bd3b14ac3b41652e59b0e1991_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtMy0xLTEtMzY0MDYw_6253127c-60c9-4819-86a9-afa75ba249fb"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i196a10f493ab454b9274ca3eb5246334_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtNC0xLTEtMzY0MDYw_4c7f20f1-f11d-4071-8f47-878815c7a900"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="icef5204976824f79a913930fb94f085b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtNS0xLTEtMzY0MDYw_2a3ac2e7-2355-4bee-9a16-1690e8f40e93"
      unitRef="eur">-15000000</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzQtNi0xLTEtMzY0MDYw_7821496c-5c6a-4363-8e15-fc522a6a75f4"
      unitRef="eur">-15000000</sny:PlanAssetsEffectOfAssetCeiling>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i9658a2abf9a5478fa9e50db338221664_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtMS0xLTEtMzY0MDYw_729e98ba-8dda-4995-8860-507dfd67b1d9"
      unitRef="eur">819000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i625df457bbfd46169d9a20d074aae8b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtMi0xLTEtMzY0MDYw_c5ef01ba-dff4-41ae-b5d5-e9ebe9ec4110"
      unitRef="eur">768000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i6d15ea0bd3b14ac3b41652e59b0e1991_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtMy0xLTEtMzY0MDYw_63d3f69b-b64c-4080-8bea-705f51b624fe"
      unitRef="eur">972000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i196a10f493ab454b9274ca3eb5246334_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtNC0xLTEtMzY0MDYw_5cd7dc72-2053-48ee-bcc2-2e325bcbdd15"
      unitRef="eur">-215000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="icef5204976824f79a913930fb94f085b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtNS0xLTEtMzY0MDYw_cc0b8e39-cf11-4849-bf14-1bea7581c7e0"
      unitRef="eur">195000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="if4ae11f178054227a9f097d1bc819c0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowMGNlZTU3NjA0NGY0MTA5YjYwNDBlY2RjZjcyYTgyOC90YWJsZXJhbmdlOjAwY2VlNTc2MDQ0ZjQxMDliNjA0MGVjZGNmNzJhODI4XzUtNi0xLTEtMzY0MDYw_c435a484-00eb-4c09-a2ff-3161a99bc1e0"
      unitRef="eur">2539000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i52f9ed0a9cdd406e836a0653d1da4b33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItMS0xLTEtMzY0MDYw_3b3968ea-8ff6-4b3d-be88-ff811b1bba2a"
      unitRef="eur">1778000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i372ca78f06fe4df388ba26d79d02bc31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItMi0xLTEtMzY0MDYw_2301c8db-c487-4297-8842-57204414684a"
      unitRef="eur">3580000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i6c3bd7580bba402387e084f56f6be553_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItMy0xLTEtMzY0MDYw_dd11161a-ca61-4765-850c-b395509479b1"
      unitRef="eur">2091000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i385f7ed33c244c8f9865082c29418042_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItNC0xLTEtMzY0MDYw_f02069e5-3f96-485c-841f-12e3552f1f04"
      unitRef="eur">3561000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i1d9cb083d13740c7ac9847d70e575e46_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItNS0xLTEtMzY0MDYw_d758503b-9784-4f86-a93e-b2255d6dad0a"
      unitRef="eur">1446000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzItNi0xLTEtMzY0MDYw_afba1cc7-2e69-4859-9c35-2af45cb7e8ce"
      unitRef="eur">12456000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i52f9ed0a9cdd406e836a0653d1da4b33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtMS0xLTEtMzY0MDYw_4b02009d-a2b9-4234-9aab-2ed22e182bef"
      unitRef="eur">906000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i372ca78f06fe4df388ba26d79d02bc31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtMi0xLTEtMzY0MDYw_b2fa87c9-7bfd-482a-a97c-bf95f0be9832"
      unitRef="eur">2661000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i6c3bd7580bba402387e084f56f6be553_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtMy0xLTEtMzY0MDYw_5a6812e5-ea3f-4964-8795-b866a21d5270"
      unitRef="eur">1077000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i385f7ed33c244c8f9865082c29418042_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtNC0xLTEtMzY0MDYw_2858eadd-f252-4327-b6ff-f5e51bd7d7cd"
      unitRef="eur">3536000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i1d9cb083d13740c7ac9847d70e575e46_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtNS0xLTEtMzY0MDYw_614e2565-648a-4663-b921-d2037047cdd7"
      unitRef="eur">1178000000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzMtNi0xLTEtMzY0MDYw_07486100-cdb1-4207-8662-2f25dec7d325"
      unitRef="eur">9358000000</ifrs-full:PlanAssetsAtFairValue>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i52f9ed0a9cdd406e836a0653d1da4b33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtMS0xLTEtMzY0MDYw_54c796f1-13cd-4449-8957-edd2f9db75c6"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i372ca78f06fe4df388ba26d79d02bc31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtMi0xLTEtMzY0MDYw_3043481b-4c66-4938-b2a3-767f69b861d7"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i6c3bd7580bba402387e084f56f6be553_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtMy0xLTEtMzY0MDYw_62afb695-e70f-404d-b09b-3befd1124637"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i385f7ed33c244c8f9865082c29418042_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtNC0xLTEtMzY0MDYw_ef81ea41-4d95-4a1f-930e-bb412458e403"
      unitRef="eur">0</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i1d9cb083d13740c7ac9847d70e575e46_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtNS0xLTEtMzY0MDYw_77724349-8968-48a5-b767-b2f80ba26b8a"
      unitRef="eur">-1000000</sny:PlanAssetsEffectOfAssetCeiling>
    <sny:PlanAssetsEffectOfAssetCeiling
      contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzQtNi0xLTEtMzY0MDYw_4679be78-f0ea-4e5b-9549-f8249c75519d"
      unitRef="eur">-1000000</sny:PlanAssetsEffectOfAssetCeiling>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i52f9ed0a9cdd406e836a0653d1da4b33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtMS0xLTEtMzY0MDYw_0a76e5b8-0398-4395-b44c-02e0b3b642fd"
      unitRef="eur">872000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i372ca78f06fe4df388ba26d79d02bc31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtMi0xLTEtMzY0MDYw_28654821-1528-4236-9cb5-ff97942548c9"
      unitRef="eur">919000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i6c3bd7580bba402387e084f56f6be553_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtMy0xLTEtMzY0MDYw_37480cc5-251e-4df1-b210-4b451ea308bf"
      unitRef="eur">1014000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i385f7ed33c244c8f9865082c29418042_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtNC0xLTEtMzY0MDYw_9ed04fa3-401f-4be7-b281-9e77dface17f"
      unitRef="eur">25000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i1d9cb083d13740c7ac9847d70e575e46_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtNS0xLTEtMzY0MDYw_1b40ca09-9b10-407a-9e02-2d8bb2312d8d"
      unitRef="eur">269000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i6201b78a9f6446cdb01a79735208e131_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjOTAzM2VhMDM0NmI0NDkxYjAzM2Q4NGU0YmI1NWJhNi90YWJsZXJhbmdlOmM5MDMzZWEwMzQ2YjQ0OTFiMDMzZDg0ZTRiYjU1YmE2XzUtNi0xLTEtMzY0MDYw_c1b49d0e-6b1a-480c-aefb-29c05de21d28"
      unitRef="eur">3099000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDg3_bf9b35f9-e523-4e6b-9c9d-2fb77eea6849">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the fair value of plan assets relating to Sanofi&#x2019;s pension and other post-employment plans, split by asset category:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Securities quoted in an active market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;84.4&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;86.9&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;94.8&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bonds and similar instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Commodities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15.6&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13.1&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5.2&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hedge funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEtMS0xLTEtMzY0MDYw_746f6108-2fc1-478f-82a3-48206cb8f55c"
      unitRef="number">0.844</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEtMi0xLTEtMzY0MDYw_5166acc9-3297-42e7-9026-286520c95bd6"
      unitRef="number">0.869</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEtMy0xLTEtMzY0MDYw_f40f21fc-9a6c-4730-958c-e40543f5ac06"
      unitRef="number">0.948</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="ifd245ab0bb874dd9b68d83d0e2a73768_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzItMS0xLTEtMzY0MDYw_7c48db73-f03e-4696-bd74-93ee16eb3877"
      unitRef="number">0.007</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i132794e24a974e33a6a21b07c9e18759_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzItMi0xLTEtMzY0MDYw_40f51bb2-defe-4a84-9a63-8ff12f63f15a"
      unitRef="number">0.007</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="ieceadb4bd3734ed687be7e86ad699c73_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzItMy0xLTEtMzY0MDYw_f293992f-4f2c-439e-b929-158ab8029c1c"
      unitRef="number">0.035</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="ied5cdd7108ef4bde8a190a1fdd725e36_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzMtMS0xLTEtMzY0MDYw_01c34209-d475-4e49-a730-aabc2c4d2a13"
      unitRef="number">0.217</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i9322df58abf645a38feae4db48a58ebd_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzMtMi0xLTEtMzY0MDYw_74f89b60-2987-44e8-bbb2-99b3c51d4277"
      unitRef="number">0.250</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i9a4f3a465b6f42b98396a6e356f30a9e_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzMtMy0xLTEtMzY0MDYw_515aa140-ecd6-4877-8ced-eba18071e213"
      unitRef="number">0.248</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="ibb517efada3a407d847b0ca69894e99a_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzQtMS0xLTEtMzY0MDYw_92633469-4d40-4943-bd7c-f29fde707745"
      unitRef="number">0.524</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i9e4be19b26a049e1bf1e91bab2e11e5c_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzQtMi0xLTEtMzY0MDYw_d4c2e4ce-bc90-44cb-aaa1-adf42356d5b8"
      unitRef="number">0.538</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i39da8a2d60674ff4ae5c11c70259b5e3_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzQtMy0xLTEtMzY0MDYw_1552f843-eed8-44bd-a096-9238c8783442"
      unitRef="number">0.599</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i5a41dc31c3e74eedb023bf10eb8a0e7c_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzUtMS0xLTEtMzY0MDYw_5216744a-79d6-4576-a02e-7e6ae514fa04"
      unitRef="number">0.040</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i251e98323a6443539777c4746f73c0a1_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzUtMi0xLTEtMzY0MDYw_2fee1f1b-e18a-4073-85e6-95ec83cabe65"
      unitRef="number">0.040</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i6cf3f0fc2b4e4980a5a3b2ffa0064c5f_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzUtMy0xLTEtMzY0MDYw_c12c9abe-7b34-440e-8e58-fccf4a6a4c2c"
      unitRef="number">0.034</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i6ff9752dc8ff4ccda97e1df53f25b146_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMS0xLTEtNTA2MTgy_7f4ae856-9a18-471b-8137-291b3c2f5a9a"
      unitRef="number">0.001</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i6ff9752dc8ff4ccda97e1df53f25b146_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMS0xLTEtNTA2MTgy_a076ff94-81dc-4eea-ad38-6924a7dea22e"
      unitRef="number">0.001</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="iad8a1b698baa4703b83d370174975b1c_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMi0xLTEtNTA2MTgy_cff35af6-dd2e-423b-a973-4c544eac4ad6"
      unitRef="number">0</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="iad8a1b698baa4703b83d370174975b1c_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMi0xLTEtNTA2MTgy_df4b63a7-e065-4994-9471-de52fdacbbd2"
      unitRef="number">0</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i312bbd7a70ac416b96b1efb30fc8419b_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMy0xLTEtNTA2MTgy_711e2d7b-2543-4907-83ba-1c019961437a"
      unitRef="number">0</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i312bbd7a70ac416b96b1efb30fc8419b_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMy0xLTEtNTA2MTgy_bbfa285e-3f8a-4fed-abc6-ed4daa48afff"
      unitRef="number">0</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i15aa7ea7a17149d88f714ad7ee033ef2_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMS0xLTEtMzY0MDYw_a1394c2f-13fa-4bd9-af92-abf81d9f3c5c"
      unitRef="number">0.009</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="iecbde7dd3ae84c15a00c868d439658cd_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMi0xLTEtMzY0MDYw_2c2f6df0-5976-449e-9b37-d775c13e442f"
      unitRef="number">0.010</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i9ee30b965d34426b8572cbfbe3d99ab5_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzctMy0xLTEtMzY0MDYw_a4d1cf87-f953-4ba0-a266-eb47dd172074"
      unitRef="number">0.009</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="ic2bab82be0a94d3385be51baf05b2e8a_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzgtMS0xLTEtMzY0MDYw_bb290631-e1de-4dd1-aa70-6d90405c8686"
      unitRef="number">0.046</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i1a3027be885242dda3901c2d93f03d2f_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzgtMi0xLTEtMzY0MDYw_8af0a127-8259-4461-be3b-575a969bbaf2"
      unitRef="number">0.024</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket
      contextRef="i208f6ffa4b1f4aef954fb58bed015cee_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzgtMy0xLTEtMzY0MDYw_cb4604b2-b560-4f16-af83-d669a692c9f9"
      unitRef="number">0.023</sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket>
    <sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzktMS0xLTEtMzY0MDYw_88a4f154-8713-4a51-a740-427beccc6714"
      unitRef="number">0.156</sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities>
    <sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzktMi0xLTEtMzY0MDYw_e6a97c58-2f8d-4530-8ccd-06a0c0e7659c"
      unitRef="number">0.131</sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities>
    <sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzktMy0xLTEtMzY0MDYw_4cd4e8d5-2a9b-4151-a2bc-b9cf8e975e70"
      unitRef="number">0.052</sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities>
    <sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities
      contextRef="i4072b208f40b416c93f385cd81718d4c_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEwLTEtMS0xLTM2NDA2MA_d348f751-7c2d-42be-81eb-7e3a16ede825"
      unitRef="number">0</sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities>
    <sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities
      contextRef="i7c9573f4723f496886c9527af11cd414_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEwLTItMS0xLTM2NDA2MA_f7efbc9f-c477-4e5b-accb-cf66a80b92d3"
      unitRef="number">0</sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities>
    <sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities
      contextRef="ib77de26cb736428ea323b4bf71486e1f_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEwLTMtMS0xLTM2NDA2MA_edd3a910-1182-4e8e-b5de-8c363feec768"
      unitRef="number">0.004</sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities>
    <sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities
      contextRef="i45d69c6b976b4b52b4b221ada5523cf3_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzExLTEtMS0xLTM2NDA2MA_e05f04b7-69ad-4839-99c3-21803fe7df77"
      unitRef="number">0.156</sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities>
    <sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities
      contextRef="ia4202392dc954ef699a4858b3b2f3d28_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzExLTItMS0xLTM2NDA2MA_6db4799e-d520-4dff-b226-35fcf123a087"
      unitRef="number">0.131</sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities>
    <sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities
      contextRef="ie7625f2a35e3415980a56f594344ef2c_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzExLTMtMS0xLTM2NDA2MA_74aaefae-ffa1-465a-a3e3-e3645d4d47b7"
      unitRef="number">0.048</sny:PercentageContributedToFairValueOfPlanAssetsOtherSecurities>
    <sny:PercentageContributedToFairValueOfPlanAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEyLTEtMS0xLTM2NDA2MA_c211c6f7-1351-4b6d-83d1-1cb04f9862e4"
      unitRef="number">1.000</sny:PercentageContributedToFairValueOfPlanAssets>
    <sny:PercentageContributedToFairValueOfPlanAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEyLTItMS0xLTM2NDA2MA_341eee2a-1f35-4028-88fa-f1626cc84c65"
      unitRef="number">1.000</sny:PercentageContributedToFairValueOfPlanAssets>
    <sny:PercentageContributedToFairValueOfPlanAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2N2JlMGRjN2M5ZjE0YzhiODcxNjNhZDMzZWZkNDNmOS90YWJsZXJhbmdlOjY3YmUwZGM3YzlmMTRjOGI4NzE2M2FkMzNlZmQ0M2Y5XzEyLTMtMS0xLTM2NDA2MA_acfce9c2-07cf-4da2-8efa-93cd3d226cb2"
      unitRef="number">1.000</sny:PercentageContributedToFairValueOfPlanAssets>
    <sny:DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDc2_04e19dd2-30ca-4d29-9fe4-b7d6caa7cb9b">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The tables below show the service cost for Sanofi&#x2019;s pension and other post-employment benefit plans, by geographical region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Service cost for 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest cost/(income) including administration costs and taxes paid during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contributions from plan members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) recognized directly in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;168&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Service cost for 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest cost/(income) including administration costs and taxes paid during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contributions from plan members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) recognized directly in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;80&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;54&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;276&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(685)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(409)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pensions&#160;and&#160;other&#160;post-employment benefits&#160;by&#160;geographical&#160;region&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Service cost for 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest cost/(income) including administration costs and taxes paid during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contributions from plan members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) recognized directly in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;60&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expense/(gain) for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;350&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItMS0xLTEtMzY0MDYw_e8d9ab9c-6e0d-4b1d-b778-2b8816eba2df"
      unitRef="eur">61000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItMi0xLTEtMzY0MDYw_6835c0bb-6868-4708-bdcc-66070ff3a62e"
      unitRef="eur">44000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItMy0xLTEtMzY0MDYw_3142d79e-0e1e-40da-99f4-715f69f97665"
      unitRef="eur">50000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItNC0xLTEtMzY0MDYw_9a73500b-0a79-4f90-91e7-a7b4cb65dadc"
      unitRef="eur">0</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItNS0xLTEtMzY0MDYw_4c99b46f-3fe1-4bdc-bfbb-efe325adf47b"
      unitRef="eur">38000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzItNi0xLTEtMzY0MDYw_4aca1107-5b8b-46f2-a0a3-5d27dc3feda6"
      unitRef="eur">193000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtMS0xLTEtMzY0MDYw_39e17a8c-b82c-4c13-b578-87ed00e1ae4b"
      unitRef="eur">60000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtMi0xLTEtMzY0MDYw_1238e3d7-0653-4419-9495-08c4c3b8aa53"
      unitRef="eur">-2000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtMy0xLTEtMzY0MDYw_0a5ad5a8-4f6a-47cb-b390-f70cc734b981"
      unitRef="eur">-1000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtNC0xLTEtMzY0MDYw_25a300f8-2248-4634-a6a1-9b102929ff1c"
      unitRef="eur">6000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtNS0xLTEtMzY0MDYw_3f79e7d1-f072-4195-be41-d558f620c59c"
      unitRef="eur">5000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzMtNi0xLTEtMzY0MDYw_99605f32-8854-44fa-87a4-1a3bacb343fb"
      unitRef="eur">68000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtMS0xLTEtMzY0MDYw_523633dc-14bd-4e64-98cd-d1ab7d4f4448"
      unitRef="eur">10000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtMi0xLTEtMzY0MDYw_d0ed0a40-4a0c-4b3f-95f6-a71eebd47176"
      unitRef="eur">7000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtMy0xLTEtMzY0MDYw_4d96d421-71a5-4df6-a8f0-68e120ffbc28"
      unitRef="eur">30000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtNC0xLTEtMzY0MDYw_c2d98f77-881d-497e-bc57-5e42097df676"
      unitRef="eur">-7000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtNS0xLTEtMzY0MDYw_4a0e3a5e-4e1b-431a-bb55-2622ff158f4f"
      unitRef="eur">9000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzQtNi0xLTEtMzY0MDYw_799898c1-b28b-43b7-b853-795fa4f10750"
      unitRef="eur">49000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtMS0xLTEtMzY0MDYw_f4bb68c2-a038-4cb4-9ead-4f105ce4f92d"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtMi0xLTEtMzY0MDYw_c4581fff-a033-40eb-bbd4-85796fcf3216"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtMy0xLTEtMzY0MDYw_5ca1f0fe-3122-4e41-bd42-c73a873220d6"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtNC0xLTEtMzY0MDYw_3f0f84f6-f6b4-437d-a022-39b423969fc1"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtNS0xLTEtMzY0MDYw_c6be478d-2123-463f-92d1-0c9d0d5b67a2"
      unitRef="eur">6000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzUtNi0xLTEtMzY0MDYw_0475598d-9d70-4141-950b-3f8c613bcb81"
      unitRef="eur">6000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtMS0xLTEtMzY0MDYw_11f29e3e-7591-449b-a332-282b7b5dafe4"
      unitRef="eur">11000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtMi0xLTEtMzY0MDYw_544350ae-f3fe-4ee6-b406-5bb80f199bf5"
      unitRef="eur">53000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtMy0xLTEtMzY0MDYw_fff940ec-e508-44f6-a757-9f91bdf765e9"
      unitRef="eur">81000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtNC0xLTEtMzY0MDYw_29dbfa54-453d-4c84-80cb-72120cd6d1e3"
      unitRef="eur">-13000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtNS0xLTEtMzY0MDYw_a2d1196c-c66b-4389-a873-61da0dd313f8"
      unitRef="eur">36000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzYtNi0xLTEtMzY0MDYw_1d9fde55-5b88-41ae-88b1-aad4ba3cf0d5"
      unitRef="eur">168000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctMS0xLTEtMzY0MDYw_bcb2dc5f-b935-4ec5-a25b-bbc1dec0eb6f"
      unitRef="eur">-156000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctMi0xLTEtMzY0MDYw_7787cd8a-d99b-4263-8c94-633fe01fd7a4"
      unitRef="eur">-204000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctMy0xLTEtMzY0MDYw_203baa89-49dc-4c8f-935c-b0ad47ae42f9"
      unitRef="eur">-382000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctNC0xLTEtMzY0MDYw_608fb498-07d4-42f0-b3c0-d529985f9acf"
      unitRef="eur">130000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctNS0xLTEtMzY0MDYw_68799654-4875-4486-b703-c543fd185608"
      unitRef="eur">-38000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzctNi0xLTEtMzY0MDYw_7b2e045a-b941-4f02-8310-848a23919aa6"
      unitRef="eur">-650000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="ia9cb53ff1a2b474897c9ccaaedc9fca3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtMS0xLTEtMzY0MDYw_f0e51322-0ab3-424d-8d61-9e60611d4aa5"
      unitRef="eur">-145000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="i78812fafeb0749c2a649f288162412a1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtMi0xLTEtMzY0MDYw_9697c73d-62fd-47c4-be4b-b7525778daa3"
      unitRef="eur">-151000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="i4f180432287e48bab7a2788e97c95000_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtMy0xLTEtMzY0MDYw_39901f1b-5d7f-4533-bf87-54c3ded074d6"
      unitRef="eur">-301000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="i2e19e967b59c466a9f72536064a4c71c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtNC0xLTEtMzY0MDYw_2dd628a2-737e-4957-b028-846519288970"
      unitRef="eur">117000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="if02bf6e613f9439895688c25863b7a1f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtNS0xLTEtMzY0MDYw_4c612cfe-8441-441a-984d-7380b9f25dcb"
      unitRef="eur">-2000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjODY5ODI3MzAyNzE0YzM5ODViMWQxMzYyMDhkODZmMS90YWJsZXJhbmdlOmM4Njk4MjczMDI3MTRjMzk4NWIxZDEzNjIwOGQ4NmYxXzgtNi0xLTEtMzY0MDYw_57ca5850-c72a-45a3-bd70-0fde534b0db9"
      unitRef="eur">-482000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItMS0xLTEtMzY0MDYw_ce1d0828-815f-4b9b-abee-486467dd3e42"
      unitRef="eur">72000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItMi0xLTEtMzY0MDYw_1fcfb2ea-3103-4681-934d-852e42db519a"
      unitRef="eur">47000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItMy0xLTEtMzY0MDYw_0b173751-25ce-4c33-95b3-4d045a50fb9d"
      unitRef="eur">57000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItNC0xLTEtMzY0MDYw_f46c392e-17ae-4128-8cc5-5a1e836c9a2b"
      unitRef="eur">0</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItNS0xLTEtMzY0MDYw_99ecb3ce-09b7-406b-9022-11f3aad0ed11"
      unitRef="eur">51000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzItNi0xLTEtMzY0MDYw_da401f09-b0b6-44ac-b46f-f68a229d8ba1"
      unitRef="eur">227000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtMS0xLTEtMzY0MDYw_3959128e-0a8b-40e4-a1f6-0c26b17758f4"
      unitRef="eur">-2000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtMi0xLTEtMzY0MDYw_9101a84b-2587-4635-b8da-69f6e6c15051"
      unitRef="eur">0</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtMy0xLTEtMzY0MDYw_f02e483b-f907-431d-9c9f-0df722844cf3"
      unitRef="eur">0</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtNC0xLTEtMzY0MDYw_e7cbca62-e47c-4f4b-896e-e49ddda5ed6b"
      unitRef="eur">-3000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtNS0xLTEtMzY0MDYw_0d8647a5-1ffe-4929-b54e-edd28329cf04"
      unitRef="eur">0</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzMtNi0xLTEtMzY0MDYw_fdf4cd65-665a-4576-a675-9f1eea36ab32"
      unitRef="eur">-5000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtMS0xLTEtMzY0MDYw_94a8d7f7-7425-4f11-9b84-33e4155e4fb5"
      unitRef="eur">5000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtMi0xLTEtMzY0MDYw_fb26ab72-4821-4095-b7e7-90cc4e3ecf96"
      unitRef="eur">5000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtMy0xLTEtMzY0MDYw_686e4776-fe11-4295-8a66-c45534e67193"
      unitRef="eur">27000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtNC0xLTEtMzY0MDYw_b105ecf6-6b61-4c25-8e48-38081f425ce5"
      unitRef="eur">3000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtNS0xLTEtMzY0MDYw_2dee84ba-46f3-4039-864c-20dd4d9241f6"
      unitRef="eur">9000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzQtNi0xLTEtMzY0MDYw_ac981142-60a4-4e2c-ac6d-94062e9b1e3c"
      unitRef="eur">49000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtMS0xLTEtMzY0MDYw_f98287e0-0d14-4998-a6a2-701533248edc"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtMi0xLTEtMzY0MDYw_b358d448-577c-45e8-9b8b-cb12045df159"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtMy0xLTEtMzY0MDYw_e387c458-2f9d-4f5c-a0c3-5f79ccb2dbe3"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtNC0xLTEtMzY0MDYw_e4fc121e-cb79-454d-aa77-df4e99ab1e6f"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtNS0xLTEtMzY0MDYw_e58c9aa8-a297-4d57-a9da-5f060178580d"
      unitRef="eur">6000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzUtNi0xLTEtMzY0MDYw_9b80e233-6201-4c63-9c78-1a4c791774a0"
      unitRef="eur">6000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtMS0xLTEtMzY0MDYw_b5693b8f-739f-4a8b-9929-621359afaf5a"
      unitRef="eur">80000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtMi0xLTEtMzY0MDYw_ccbd56fb-c68a-47a3-88d3-6b5c3e95e2fe"
      unitRef="eur">52000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtMy0xLTEtMzY0MDYw_4b95734d-a38a-4571-9d11-78415dd4579b"
      unitRef="eur">84000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtNC0xLTEtMzY0MDYw_1ddf01e3-6cdf-4702-ab00-8edb43ec2ea1"
      unitRef="eur">6000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtNS0xLTEtMzY0MDYw_9e5c9c4f-e03d-4ea7-a3ef-82d624bb13e5"
      unitRef="eur">54000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzYtNi0xLTEtMzY0MDYw_fe6773a0-eed1-4357-92fe-31417459f9aa"
      unitRef="eur">276000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctMS0xLTEtMzY0MDYw_84f700f4-7c49-454f-ad18-1ebbb94b95bd"
      unitRef="eur">-106000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctMi0xLTEtMzY0MDYw_b90b9cfb-abc2-421b-ae68-db4925fc3e43"
      unitRef="eur">-113000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctMy0xLTEtMzY0MDYw_3de18229-9020-4018-a3dd-40b706e1b597"
      unitRef="eur">-157000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctNC0xLTEtMzY0MDYw_df163dab-ccd8-4737-b731-0e82de171674"
      unitRef="eur">-236000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctNS0xLTEtMzY0MDYw_3eff4f22-c767-4eb4-a889-8efbffc02a96"
      unitRef="eur">-73000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzctNi0xLTEtMzY0MDYw_c4ab98d1-2240-46a9-9c88-7150fffe24cc"
      unitRef="eur">-685000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="ief62dbe824b9481f89598dded18264cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtMS0xLTEtMzY0MDYw_53d4c9de-5a34-41ba-a9ec-5e931108f198"
      unitRef="eur">-26000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="ibfca4cf8f3ff46d98045c5292fb649a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtMi0xLTEtMzY0MDYw_496ab505-05d5-4056-b7f8-6436cc3da67e"
      unitRef="eur">-61000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="i9b0e36671c874183b8b51bb844d3757e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtMy0xLTEtMzY0MDYw_b187f711-2215-4e86-a295-0236aae11de5"
      unitRef="eur">-73000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="i28884d8cf6e449cd8d272ffe72982da3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtNC0xLTEtMzY0MDYw_56bc9d2d-7765-425c-8e19-4d7cfbe28861"
      unitRef="eur">-230000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="i3b4703d9b5c24d149d6f4a09101507b8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtNS0xLTEtMzY0MDYw_fd20ecb2-2e1d-4b8a-90d0-4cba53a0c29f"
      unitRef="eur">-19000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTphMzVjN2RlY2VhMWE0NmRlODgyMjE4OWNkZjI2NjFlOC90YWJsZXJhbmdlOmEzNWM3ZGVjZWExYTQ2ZGU4ODIyMTg5Y2RmMjY2MWU4XzgtNi0xLTEtMzY0MDYw_e90da40e-02be-47c0-b170-09fc8d6a248c"
      unitRef="eur">-409000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItMS0xLTEtMzY0MDYw_d55aba65-84e3-4d09-8cc5-c54f129e0402"
      unitRef="eur">65000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItMi0xLTEtMzY0MDYw_b815884f-328c-4468-a7cc-15eeba9c77e1"
      unitRef="eur">49000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItMy0xLTEtMzY0MDYw_45e4ca9e-8ea1-4243-96ba-4c53732265bc"
      unitRef="eur">51000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItNC0xLTEtMzY0MDYw_607459f8-f7e3-4605-938f-b8ca5592be6a"
      unitRef="eur">0</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItNS0xLTEtMzY0MDYw_c7568487-6685-4a07-9535-20429503a2cc"
      unitRef="eur">56000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzItNi0xLTEtMzY0MDYw_fb2992db-483a-47a1-af88-fab728a3f20d"
      unitRef="eur">221000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtMS0xLTEtMzY0MDYw_b0c9ca2b-4440-46c6-9b63-c33018645d1a"
      unitRef="eur">87000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtMi0xLTEtMzY0MDYw_c8fe78ac-b6e8-47b1-b797-abe86cc75539"
      unitRef="eur">-10000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtMy0xLTEtMzY0MDYw_6d6ec3a8-0c3a-48eb-a668-702cc261de29"
      unitRef="eur">123000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtNC0xLTEtMzY0MDYw_f9b1093b-0d7c-4da6-b924-2c60a610112a"
      unitRef="eur">0</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtNS0xLTEtMzY0MDYw_4fdda480-3bdd-4726-8399-0bb9a3be0ae4"
      unitRef="eur">-1000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzMtNi0xLTEtMzY0MDYw_e9bebc14-883f-40a9-bc24-92f59fd8adac"
      unitRef="eur">199000000</sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtMS0xLTEtMzY0MDYw_c87feee4-7e2f-4e85-95f6-33799efb4736"
      unitRef="eur">7000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtMi0xLTEtMzY0MDYw_2ae37870-60a1-4b12-b77f-48e9747f15ab"
      unitRef="eur">13000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtMy0xLTEtMzY0MDYw_a17fe582-9505-408e-a097-fd8a53f8f39f"
      unitRef="eur">34000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtNC0xLTEtMzY0MDYw_dec336c6-549e-4909-872d-ecd549ff1ceb"
      unitRef="eur">5000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtNS0xLTEtMzY0MDYw_6fb9bfb7-03e7-4a07-8749-f21426b0076d"
      unitRef="eur">10000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzQtNi0xLTEtMzY0MDYw_a213348c-deb1-4a04-8438-070284102184"
      unitRef="eur">69000000</sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtMS0xLTEtMzY0MDYw_f16b4d5d-82de-4ab4-a7e3-a65a5e5399a1"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtMi0xLTEtMzY0MDYw_a44165d8-c82a-49c4-bfcb-4e25b467be2c"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtMy0xLTEtMzY0MDYw_a6c7055f-b5a7-4a49-84a4-680fce39e7f9"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtNC0xLTEtMzY0MDYw_5bdad3a6-d39a-470d-9eda-2f8dde7f48ac"
      unitRef="eur">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtNS0xLTEtMzY0MDYw_7d6f3de5-df35-4abf-b130-e9a199976239"
      unitRef="eur">7000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzUtNi0xLTEtMzY0MDYw_a9a283d7-9b17-43fa-b98d-aed20563a0b2"
      unitRef="eur">7000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtMS0xLTEtMzY0MDYw_2337c7b7-c55b-41a2-a04d-f98951f8d195"
      unitRef="eur">-15000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtMi0xLTEtMzY0MDYw_e5d1f757-10f7-47e0-ab6c-e2025cfda2f5"
      unitRef="eur">72000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtMy0xLTEtMzY0MDYw_10d504ef-cc43-4e94-829e-05eea84c876f"
      unitRef="eur">-38000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtNC0xLTEtMzY0MDYw_bad6570e-93b6-481c-bbf2-8aab2df459c2"
      unitRef="eur">5000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtNS0xLTEtMzY0MDYw_ab718552-8beb-4c96-bace-334b9f3a2d6c"
      unitRef="eur">60000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzYtNi0xLTEtMzY0MDYw_9de8d113-b327-471e-b92d-f3dd65f7a52b"
      unitRef="eur">84000000</sny:TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctMS0xLTEtMzY0MDYw_08683b12-050c-463e-91ba-bc899227d035"
      unitRef="eur">23000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctMi0xLTEtMzY0MDYw_e1c73d87-9d91-4692-b8ca-c52a7203ee6e"
      unitRef="eur">121000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctMy0xLTEtMzY0MDYw_03b989d2-db2a-414f-83b4-3907b69e9489"
      unitRef="eur">22000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctNC0xLTEtMzY0MDYw_33b94172-f7b6-4694-b2b2-f9f2d93bcbe5"
      unitRef="eur">115000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctNS0xLTEtMzY0MDYw_2027ddbe-a833-4b5b-b548-539a4564623a"
      unitRef="eur">-15000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzctNi0xLTEtMzY0MDYw_babd6350-f3b3-4669-a8c2-6e6b2755dd6b"
      unitRef="eur">266000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="ic96e413d27b649b6818c4939894846d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtMS0xLTEtMzY0MDYw_8d38d507-011a-4c81-b67f-44e46282dfe2"
      unitRef="eur">8000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="id6b20fe6e1db4ee5a9e4e6edf34a454d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtMi0xLTEtMzY0MDYw_3c2a7d44-cda7-4ee6-9fa5-f921bab34b16"
      unitRef="eur">193000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="ia3b0eae77ecc41b7bb8d25d224025ee8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtMy0xLTEtMzY0MDYw_d0e2e03e-1442-4f0a-b780-14c4c5789c82"
      unitRef="eur">-16000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="i6d1173e32b0546fa9d3dc5b3ad07d75f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtNC0xLTEtMzY0MDYw_605bbdcb-7bc7-4ad7-9f54-709ae8f6e214"
      unitRef="eur">120000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="i03d32a43bff046bcb7fd3720263aba91_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtNS0xLTEtMzY0MDYw_6d8b884d-6312-4a06-b3f7-5f236ccd64ea"
      unitRef="eur">45000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MWMxNzA2YmJhOWU0YTM3YjM3MDFlN2ZiNTYzYTExZC90YWJsZXJhbmdlOjYxYzE3MDZiYmE5ZTRhMzdiMzcwMWU3ZmI1NjNhMTFkXzgtNi0xLTEtMzY0MDYw_9aefcf06-9246-47e6-a929-c623fb8c2e65"
      unitRef="eur">350000000</sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset>
    <sny:DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDky_77e09dac-f77e-49a6-97b1-fd3a4744af52">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;An analysis of the &#x201c;Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)&#x201d; line in the preceding tables is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial gains/(losses) arising during the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Comprising:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gains/(losses) &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;on experience adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gains/(losses) &lt;br/&gt;on demographic assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gains/(losses) &lt;br/&gt;on financial assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(442)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Experience adjustments are mainly due to the effect of trends in the financial markets on plan assets.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMS0xLTEtMzY0MDYw_96d0ff15-c894-40d9-b020-3e3d0b3809e6"
      unitRef="eur">156000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMi0xLTEtMzY0MDYw_1779c551-6ec0-4040-bb77-3dd731cc1795"
      unitRef="eur">205000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMy0xLTEtMzY0MDYw_839c2b08-e49b-487e-8863-b3b59722ef2e"
      unitRef="eur">382000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItNC0xLTEtMzY0MDYw_70eaef3c-4b64-488e-9dbf-9687ed75ebc3"
      unitRef="eur">-131000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItNS0xLTEtMzY0MDYw_b895bf4c-ed60-4900-ae3d-4221d965197b"
      unitRef="eur">106000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItNi0xLTEtMzY0MDYw_7ac8f415-35e1-41de-8153-db4f63572a4a"
      unitRef="eur">113000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItNy0xLTEtMzY0MDYw_b357cad6-66b1-4684-8cee-390fa8bdce4d"
      unitRef="eur">156000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItOC0xLTEtMzY0MDYw_53d1d089-ad19-4be2-93ce-0baa915bcb77"
      unitRef="eur">237000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItOS0xLTEtMzY0MDYw_6f4deab7-5790-4799-ab93-6ac3528e5108"
      unitRef="eur">-23000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMTAtMS0xLTM2NDA2MA_9b4a71af-7819-44c1-a4e3-b375ad3f5dff"
      unitRef="eur">-121000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMTEtMS0xLTM2NDA2MA_1cc35ea3-26c0-474a-9cb4-11bde4be958c"
      unitRef="eur">-22000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzItMTItMS0xLTM2NDA2MA_27e00337-500f-4036-bf49-c1026b658050"
      unitRef="eur">-115000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMS0xLTEtMzY0MDYw_dec5a405-0829-48c7-ad8e-6193e170495c"
      unitRef="eur">-120000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMi0xLTEtMzY0MDYw_7e8efe19-b0e3-446f-9151-5c25d4b9514d"
      unitRef="eur">-620000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMy0xLTEtMzY0MDYw_be64f15a-f870-499d-9072-b7b4995fa7e5"
      unitRef="eur">-287000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtNC0xLTEtMzY0MDYw_a931a608-3d98-4fa5-aa03-48ab99e2e52c"
      unitRef="eur">-1328000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtNS0xLTEtMzY0MDYw_03a79167-6fde-4d53-8b47-0eae7dc1fe6b"
      unitRef="eur">60000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtNi0xLTEtMzY0MDYw_2d7e635b-781f-4d5f-bf66-c083c3c2b39c"
      unitRef="eur">182000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtNy0xLTEtMzY0MDYw_f67f9f73-37be-49ac-b3a2-47349f8c36d9"
      unitRef="eur">23000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtOC0xLTEtMzY0MDYw_cc4b7d29-7df8-48e5-9883-8f0b9dca1775"
      unitRef="eur">35000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtOS0xLTEtMzY0MDYw_37c2f726-84ca-4462-a2cc-bc9f8083f342"
      unitRef="eur">28000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMTAtMS0xLTM2NDA2MA_8ada40e4-482d-492f-98b1-0b7ce48bfd74"
      unitRef="eur">76000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMTEtMS0xLTM2NDA2MA_11dd6919-9509-40bd-99fa-7e80be869da8"
      unitRef="eur">214000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments
      contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzQtMTItMS0xLTM2NDA2MA_16dad7f4-e533-4ed3-b0ae-910676d00d71"
      unitRef="eur">341000000</sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMS0xLTEtMzY0MDYw_225fb376-e0e6-4725-84b6-8f21fbd7680d"
      unitRef="eur">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMi0xLTEtMzY0MDYw_24a8d514-6e9d-4512-a8b0-916a9184fa3c"
      unitRef="eur">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMy0xLTEtMzY0MDYw_c42bdabb-76d0-416c-a5a8-dd48b74ad426"
      unitRef="eur">129000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtNC0xLTEtMzY0MDYw_8e62956a-65ac-4b1f-822f-cedd334b108b"
      unitRef="eur">54000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtNS0xLTEtMzY0MDYw_6e467a58-9370-4e7d-8460-ee0484d09558"
      unitRef="eur">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtNi0xLTEtMzY0MDYw_d57cfbaf-da03-453c-84fd-d48fbb7f5c9f"
      unitRef="eur">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtNy0xLTEtMzY0MDYw_8bc2be18-3d9b-4a15-8d95-025e82108c66"
      unitRef="eur">51000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtOC0xLTEtMzY0MDYw_bfc37c06-e1fe-4ae3-b313-eed5dbb5b48a"
      unitRef="eur">125000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtOS0xLTEtMzY0MDYw_32bd8a21-0243-483f-ae43-f3843643b345"
      unitRef="eur">9000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMTAtMS0xLTM2NDA2MA_f6f67363-b83e-400a-8d4a-9cf618f2d9db"
      unitRef="eur">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMTEtMS0xLTM2NDA2MA_dc3dd56b-f094-4fe6-8f8d-adee3d922e77"
      unitRef="eur">-42000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzUtMTItMS0xLTM2NDA2MA_7d91731c-c898-4f32-8d7e-cdfdba113cff"
      unitRef="eur">-14000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMS0xLTEtMzY0MDYw_d15d8db3-9670-427e-b172-fb7092b0974a"
      unitRef="eur">276000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i6057b0dc112e49d5b42134c2ff5e6583_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMi0xLTEtMzY0MDYw_9edbb084-6f0d-4a49-a435-dbb601d8db0f"
      unitRef="eur">825000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMy0xLTEtMzY0MDYw_4ee0836e-cdc8-4d6c-95fc-0eae00e6713d"
      unitRef="eur">540000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i8fd90fa81dab4765bb2919a06b8314be_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtNC0xLTEtMzY0MDYw_27b867d6-d014-43d5-9a48-59d7f728dc91"
      unitRef="eur">1143000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtNS0xLTEtMzY0MDYw_3e84a49e-8adc-4489-8f3c-84097db7c5c0"
      unitRef="eur">46000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="iae5be8a3f7d240a98cafbe72f2a10c36_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtNi0xLTEtMzY0MDYw_e1c6da3a-e8d9-4aae-8421-44ddb76b38a5"
      unitRef="eur">-69000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtNy0xLTEtMzY0MDYw_17753287-c8fd-4b0a-8f32-225147b47831"
      unitRef="eur">82000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="ib172fe9ce7ea4e86b04a4b04b41a190f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtOC0xLTEtMzY0MDYw_3934bb9c-011b-471b-acab-5ba4c9d7cad1"
      unitRef="eur">77000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtOS0xLTEtMzY0MDYw_fccc3733-331c-4370-9529-1c4bdd43cac0"
      unitRef="eur">-60000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i3dae4e2648ad46c2879a97a0d0f2edb8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMTAtMS0xLTM2NDA2MA_cdd7a2ab-965b-48b1-bf2e-ac9bd100aa57"
      unitRef="eur">-197000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMTEtMS0xLTM2NDA2MA_87091a32-95e7-4ef1-94be-d3872df85e14"
      unitRef="eur">-194000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="i61f10605aa6041ffadfa3eee48ace5a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2MTJmMDc3MjkzZWI0M2E5YmM0NTAwMTk1YTAwZGI3Yi90YWJsZXJhbmdlOjYxMmYwNzcyOTNlYjQzYTliYzQ1MDAxOTVhMDBkYjdiXzYtMTItMS0xLTM2NDA2MA_053dc864-0fc1-4bc7-912f-45937c744827"
      unitRef="eur">-442000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <sny:DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDY5_c3eac020-627d-48e6-942c-9ef3791da5cc">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The net pre-tax actuarial loss (excluding investments accounted for using the equity method) recognized directly in equity is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net pre-tax actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,090)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock>
    <sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2NDE5MGM3ZGYwMjA0ZDQxOThlNmRlMjFkMzg0YmE4OS90YWJsZXJhbmdlOjY0MTkwYzdkZjAyMDRkNDE5OGU2ZGUyMWQzODRiYTg5XzEtMS0xLTEtMzY0MDYw_38ee8639-3199-40e9-a2f0-a90d18e810ca"
      unitRef="eur">-2090000000</sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity>
    <sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2NDE5MGM3ZGYwMjA0ZDQxOThlNmRlMjFkMzg0YmE4OS90YWJsZXJhbmdlOjY0MTkwYzdkZjAyMDRkNDE5OGU2ZGUyMWQzODRiYTg5XzEtMi0xLTEtMzY0MDYw_7c65bb8c-237b-4817-b567-c9fefec9557b"
      unitRef="eur">-2738000000</sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity>
    <sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2NDE5MGM3ZGYwMjA0ZDQxOThlNmRlMjFkMzg0YmE4OS90YWJsZXJhbmdlOjY0MTkwYzdkZjAyMDRkNDE5OGU2ZGUyMWQzODRiYTg5XzEtMy0xLTEtMzY0MDYw_78bb7caf-c916-452a-9f58-72fdd477afa6"
      unitRef="eur">-3423000000</sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity>
    <sny:DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDcw_9f4f3a6a-e833-4b59-8a65-277bd8d51662">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The present value of Sanofi&#x2019;s obligations in respect of pension and other post-employment benefit plans at the end of each reporting period is shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Present value of wholly or partially funded obligations in respect of pension and other post-employment benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Present value of unfunded obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,651&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,175&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,456&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i083a34cade7349a9809e1628fbacf89d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzEtMS0xLTEtMzY0MDYw_74d0effd-773b-4a47-8fc1-97cc1ee7bba5"
      unitRef="eur">7463000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="ia031999e21bb4be09427968a148fae23_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzEtMi0xLTEtMzY0MDYw_b9df7866-e783-4f90-9c4d-2f6eb7da79ac"
      unitRef="eur">10416000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="ia1b909a4273c42b5a19aef1f040188d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzEtMy0xLTEtMzY0MDYw_1d3b55d1-19b6-4385-a08a-78de1aa466ec"
      unitRef="eur">10734000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="ie22b5bc62d6a4722a5151ce86a8d9c8b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzItMS0xLTEtMzY0MDYw_2a4a746c-14bb-4df9-9c65-c4d892d9ec5b"
      unitRef="eur">1188000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i82dd25c00891486492e8fec0de4ec5a3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzItMi0xLTEtMzY0MDYw_b86d0dca-0bde-4d3c-b2f8-efd17d012c52"
      unitRef="eur">1759000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="ia75be383078e44f5a715dc5a129e531c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzItMy0xLTEtMzY0MDYw_b0269547-284f-4daa-b582-7bd6e515dd87"
      unitRef="eur">1722000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="ifda432649e3d4b16b2b65809871ae47a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzMtMS0xLTEtMzY0MDYw_0b78e9ba-4b04-42f0-894d-659f7a52d2b0"
      unitRef="eur">8651000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i1aeea4ef448d4878b040aca58e59cef7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzMtMi0xLTEtMzY0MDYw_3fdb975e-01b2-4309-8f00-45bc925e5550"
      unitRef="eur">12175000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="i46a2a2a21d77490d9398a698d3aec8c0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYmJmOTlkYjNhZWY0YmQwYmMwZWEyOTYyYjIwY2NhZS90YWJsZXJhbmdlOmNiYmY5OWRiM2FlZjRiZDBiYzBlYTI5NjJiMjBjY2FlXzMtMy0xLTEtMzY0MDYw_147cdd19-9836-4c53-a5fc-ca7209f21d26"
      unitRef="eur">12456000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <sny:DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDg4_d2fcc33c-d87e-41ca-ab97-8468bb311e4b">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The total expense for pensions and other post-employment benefits (&#x20ac;168 million in 2022) is allocated between income statement line items as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and general expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other operating (income)/expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Financial expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;168&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;276&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock>
    <sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzEyMDQ0_364e8433-a188-4af3-b6ad-ca6efd1f50be"
      unitRef="eur">168000000</sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <ifrs-full:CostOfSales
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzEtMS0xLTEtMzY0MDYw_f09a3a15-51d8-4b1b-8678-48f04308a549"
      unitRef="eur">55000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzEtMi0xLTEtMzY0MDYw_93de8606-139e-4ed1-a3e1-d0a9cc66dcd6"
      unitRef="eur">77000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzEtMy0xLTEtMzY0MDYw_307aa9a2-9a80-4e13-9c18-d52a015329e7"
      unitRef="eur">77000000</ifrs-full:CostOfSales>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzItMS0xLTEtMzY0MDYw_e807c59a-234e-436b-9d6b-2054df1f6bc3"
      unitRef="eur">52000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzItMi0xLTEtMzY0MDYw_fbe6432a-6b91-4e52-8e9f-484645280292"
      unitRef="eur">65000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzItMy0xLTEtMzY0MDYw_01fe286f-7ba5-42dc-beeb-0cef7ce2c9b3"
      unitRef="eur">63000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzMtMS0xLTEtMzY0MDYw_929b364c-8a19-490a-9c80-0c0acd2937b7"
      unitRef="eur">81000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzMtMi0xLTEtMzY0MDYw_4814c835-be1d-4b32-a8a1-9098dcff978f"
      unitRef="eur">87000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzMtMy0xLTEtMzY0MDYw_dc33a484-6375-4df7-88b6-583cc1bd85b2"
      unitRef="eur">88000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzQtMS0xLTEtMzY0MDYw_53c3458c-8bb5-4359-a98b-299f25de76c6"
      unitRef="eur">2000000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzQtMi0xLTEtMzY0MDYw_05a90957-8da3-4c47-86ae-1d97a3eab96f"
      unitRef="eur">1000000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzQtMy0xLTEtMzY0MDYw_28cf8047-7e3c-4b7a-96a0-d5bb300b80d0"
      unitRef="eur">140000000</ifrs-full:OtherOperatingIncomeExpense>
    <sny:RestructuringCostsReversedAndSimilarItems
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzUtMS0xLTEtMzY0MDYw_308160e6-ed7f-4fe5-b8d0-d3b9833c2888"
      unitRef="eur">-61000000</sny:RestructuringCostsReversedAndSimilarItems>
    <sny:RestructuringCostsReversedAndSimilarItems
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzUtMi0xLTEtMzY0MDYw_835a7b04-1cd6-4dc6-9773-22cae3299c5b"
      unitRef="eur">6000000</sny:RestructuringCostsReversedAndSimilarItems>
    <sny:RestructuringCostsReversedAndSimilarItems
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzUtMy0xLTEtMzY0MDYw_27b2e7e5-e570-48c0-b504-74357cb99c05"
      unitRef="eur">-59000000</sny:RestructuringCostsReversedAndSimilarItems>
    <ifrs-full:FinanceCosts
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzYtMS0xLTEtMzY0MDYw_6b0b4029-313c-48d4-9544-4129d48f497c"
      unitRef="eur">43000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzYtMi0xLTEtMzY0MDYw_a746cc41-f952-4e14-8ebe-39ab86ce71c7"
      unitRef="eur">42000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzYtMy0xLTEtMzY0MDYw_134b0e39-d079-4ebe-84df-0f7856178ebe"
      unitRef="eur">55000000</ifrs-full:FinanceCosts>
    <sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i0ee8ed8118074d36831eff9b53238052_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzctMS0xLTEtMzY0MDYw_a384fa2e-46ca-4d95-bb62-61d4e215200a"
      unitRef="eur">168000000</sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="i79f5cd3d673f4efd977915e181917769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzctMi0xLTEtMzY0MDYw_e6b30f36-4de5-426c-91ca-125f8ca4a68f"
      unitRef="eur">276000000</sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss
      contextRef="ie20ad39aa4394b54aa9c6e13af42225e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo0Y2MyMjZhZmNiZTY0ZTc0YjlmNWU1OWU4ZWMyYmIyMS90YWJsZXJhbmdlOjRjYzIyNmFmY2JlNjRlNzRiOWY1ZTU5ZThlYzJiYjIxXzctMy0xLTEtMzY0MDYw_e0ff83aa-cdd5-47f8-ab8c-5fe5028dec4a"
      unitRef="eur">84000000</sny:TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss>
    <sny:DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDc4_6093c014-97df-470c-a0f6-4dadcaad04d2">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The estimated amounts of employer&#x2019;s contributions to plan assets in 2023 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Employer&#x2019;s contributions in 2023 (estimate):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock>
    <ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan
      contextRef="i4fe5b990d9de45b49b7bf7c02a4be68c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItMS0xLTEtMzY0MDYw_a546fa73-a3c1-4cac-971b-4226d4f31ad6"
      unitRef="eur">0</ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan>
    <ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan
      contextRef="idf679ad39d3c42948615b8c3d8c06913_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItMi0xLTEtMzY0MDYw_229ffb37-d555-4959-80e6-61c9f77c4b51"
      unitRef="eur">0</ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan>
    <ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan
      contextRef="idbdcdcb4253747a694c0b2a3d28a086b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItMy0xLTEtMzY0MDYw_36d86b68-0782-4aaf-8bbc-3c692cf0bb31"
      unitRef="eur">0</ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan>
    <ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan
      contextRef="ie76d9750fed74c6ab5c5827885cabb66_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItNC0xLTEtMzY0MDYw_62096114-6c6d-4fec-b502-38771ff498ea"
      unitRef="eur">4000000</ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan>
    <ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan
      contextRef="i972b0ef516064ace86f839ae7759f600_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItNS0xLTEtMzY0MDYw_170fc918-4d22-4fb2-9d19-26b6d2779ef7"
      unitRef="eur">34000000</ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan>
    <ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan
      contextRef="ife7c44a9a1e84cb7b6b4f6fe06b1ebab_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo1NGQ0MjUyNDdlZTY0MzFkOTNiM2EwOTkyY2RhZWU2ZS90YWJsZXJhbmdlOjU0ZDQyNTI0N2VlNjQzMWQ5M2IzYTA5OTJjZGFlZTZlXzItNi0xLTEtMzY0MDYw_a093cd2a-6e92-4972-a658-830ce0519fb7"
      unitRef="eur">38000000</ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan>
    <sny:DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NTAw_872bc6dc-1af9-49b6-95a2-e36fce33b863">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the expected timing of benefit payments under pension and other post-employment benefit plans for future years:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated future benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2028 to 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i5fbc3ff0245c49bca7590dacfde5337a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItMS0xLTEtMzY0MDYw_038d603e-87e9-48a2-aba3-a975e0693a7b"
      unitRef="eur">99000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="idc226cab822a45fa830781a2276243b5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItMi0xLTEtMzY0MDYw_beca77d0-db23-4614-8a0b-3332585ec305"
      unitRef="eur">195000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ia144a9826d65474fa13a4d6d05757814_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItMy0xLTEtMzY0MDYw_e26da371-5069-4819-bf29-4290df35bd21"
      unitRef="eur">118000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i3f42213a78854baf93af23eb78fbfbfa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItNC0xLTEtMzY0MDYw_bd0a049b-b400-454d-b3f0-d569f9d90799"
      unitRef="eur">125000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ia6a2ab1329f9438bb6a95f98aaf0e3f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItNS0xLTEtMzY0MDYw_bcfd4305-425f-4f3b-a7aa-a3465e220ca2"
      unitRef="eur">59000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzItNi0xLTEtMzY0MDYw_8b1d432c-4cab-43e1-b463-00c6b1ce6627"
      unitRef="eur">596000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i73bcd0e9416b405280b71184e77d390e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtMS0xLTEtMzY0MDYw_d8705b7d-e356-4b7e-ba1b-8bd8031bbdf4"
      unitRef="eur">67000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i03a64532928a45bea416e80a24fbb2e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtMi0xLTEtMzY0MDYw_765a4d30-8223-4b23-9dc3-8320590801d3"
      unitRef="eur">203000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ieb0eb02549864f8ea6aea2b8ba55c46d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtMy0xLTEtMzY0MDYw_0cbba03c-3577-4139-a2a8-4a43b35c10d7"
      unitRef="eur">106000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i2d19463a7a444bcd984e9d3b9d49979e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtNC0xLTEtMzY0MDYw_b7885495-643c-4519-ad9d-bb240d3cfa7e"
      unitRef="eur">129000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i4105798cd2d14971b1fec1fe37a7bd83_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtNS0xLTEtMzY0MDYw_26a60672-cfe3-40a7-bb95-6537765150bd"
      unitRef="eur">53000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i280298edcb0840438a14b90d970fec63_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzMtNi0xLTEtMzY0MDYw_afafece7-da03-4ec8-8221-0f3b4ab60c60"
      unitRef="eur">558000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ib06b988b7e3c4c2e94ff11744b627571_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtMS0xLTEtMzY0MDYw_f1a27323-1883-4f7f-abc0-5b932addf8d8"
      unitRef="eur">72000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i3dbde64047a84c3ca07ea93b5743b0e4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtMi0xLTEtMzY0MDYw_03cd517f-a50b-4f2a-a5e2-49b6128eb344"
      unitRef="eur">209000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ib3fae2f714c94f67af54f0be875a5384_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtMy0xLTEtMzY0MDYw_9ba7ead8-2643-4cf1-b07c-745a3a37c735"
      unitRef="eur">107000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ia2f17bc572b546a0b59fd7c5297ae445_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtNC0xLTEtMzY0MDYw_72aaf5c4-89b2-4ff9-aff2-dd17c9eee0dc"
      unitRef="eur">134000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i47dfa2f710b1453fb0ad595e495e2a09_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtNS0xLTEtMzY0MDYw_8d6f75d8-cf39-4637-adf8-a742e5820192"
      unitRef="eur">53000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="if8d0defeba8840ebb20ca36929efec5f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzQtNi0xLTEtMzY0MDYw_88373036-eece-4d02-add0-18873383749a"
      unitRef="eur">575000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ib9deef6d5e7a4bcfbd422deaf4dc5fa4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtMS0xLTEtMzY0MDYw_79369f53-55de-436a-b02c-2aff8fd2d3d8"
      unitRef="eur">75000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i09a717365a084772ae035c13b5a5f7f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtMi0xLTEtMzY0MDYw_92840b0e-e288-4840-b8fd-38de3f88e996"
      unitRef="eur">212000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i22228827eb244f83a0287d5644da5318_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtMy0xLTEtMzY0MDYw_3df068db-b484-4246-9247-b70981045bbe"
      unitRef="eur">110000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ie01edb6a55dd423487fb757d28bf4ea0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtNC0xLTEtMzY0MDYw_9db96e10-7a64-4303-9255-2edc671a0617"
      unitRef="eur">138000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ib2194e5d4a094d0582dcc78661f5b256_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtNS0xLTEtMzY0MDYw_0210c794-10ef-44df-bf0e-88ab2886a29a"
      unitRef="eur">57000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i1804f6719b7a4579ae1189ca0b6fb642_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzUtNi0xLTEtMzY0MDYw_dce5121a-98ae-4d78-984a-72b2a295babc"
      unitRef="eur">592000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i3de22f04eb7e4c70949d28adf82e0abf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtMS0xLTEtMzY0MDYw_58b0118a-ce48-4df9-bf04-c33eb53f20b7"
      unitRef="eur">94000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ie18cdcaf451b4e6a822ac250b33acd0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtMi0xLTEtMzY0MDYw_95f0b22d-b5fc-46d2-900e-1dbef890da3a"
      unitRef="eur">219000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="idf005e09f52c4e098f1b0faabc27a76e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtMy0xLTEtMzY0MDYw_46abbe63-97bf-4786-b288-b83eb4eb4aea"
      unitRef="eur">100000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i8f2fa5376a74486b8e858119d96d0922_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtNC0xLTEtMzY0MDYw_c1ae3a4c-5551-4b92-b6a1-f0b168f36aab"
      unitRef="eur">142000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i078b4c1ea24c4f69852b61428b6e2fdb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtNS0xLTEtMzY0MDYw_7770d1f3-17d8-48e6-aeab-d96307b549ba"
      unitRef="eur">59000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ic32a24fa2fc9470d8f2994fd9d629dac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzYtNi0xLTEtMzY0MDYw_db73d532-2455-4d89-afa1-5ca210c0dc60"
      unitRef="eur">614000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i8b5e5589175949ed969ff4a1ccb121bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctMS0xLTEtMzY0MDYw_40166270-734a-443b-bb65-8b9d8e4c1325"
      unitRef="eur">505000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i1d087e9dddd44337a0f1832768419409_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctMi0xLTEtMzY0MDYw_f074fab1-1648-4c6f-ac2d-f76d5d85f772"
      unitRef="eur">1135000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="iec7a123c92024f24b8e10eced658e625_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctMy0xLTEtMzY0MDYw_468de13d-fbfd-442f-ad71-4a848166ce69"
      unitRef="eur">499000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="i475f28cce8a2420887453fd4e83fb711_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctNC0xLTEtMzY0MDYw_09fcb59d-aa7d-4242-8a96-458cfbc745fb"
      unitRef="eur">784000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="iab4710282aa04343af3461b3a5005198_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctNS0xLTEtMzY0MDYw_8a0127af-8942-4210-b9fa-129f5f4ad578"
      unitRef="eur">323000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans
      contextRef="ief42aa8c7cfe4ac888627eeabf185c37_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTplMWEyMmJhOGE5MTE0N2JjOTcwODIxZTQxNWM4NzA5Mi90YWJsZXJhbmdlOmUxYTIyYmE4YTkxMTQ3YmM5NzA4MjFlNDE1Yzg3MDkyXzctNi0xLTEtMzY0MDYw_55f4e277-06cb-4723-841d-03b22d708cee"
      unitRef="eur">3246000000</sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans>
    <sny:DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDg0_a6edd403-5ce2-4140-a1c8-aa0bc530b632">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows estimates as of December 31, 2022 for the timing of future payments in respect of unfunded pension and other post-employment benefit plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than 1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to &lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to &lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock>
    <sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjNjhkMTM3NzQ1NzQ0ZjYwYjdkZWJmMGRjZmE0YjBmZC90YWJsZXJhbmdlOmM2OGQxMzc3NDU3NDRmNjBiN2RlYmYwZGNmYTRiMGZkXzItMS0xLTEtMzY0MDYw_3ab7d573-849e-4889-898e-1be3dbd2fbd8"
      unitRef="eur">1188000000</sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans>
    <sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans
      contextRef="ife7c44a9a1e84cb7b6b4f6fe06b1ebab_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjNjhkMTM3NzQ1NzQ0ZjYwYjdkZWJmMGRjZmE0YjBmZC90YWJsZXJhbmdlOmM2OGQxMzc3NDU3NDRmNjBiN2RlYmYwZGNmYTRiMGZkXzItMi0xLTEtMzY0MDYw_cc622f84-b2a7-4f8b-bb51-3fe9ef4a1654"
      unitRef="eur">74000000</sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans>
    <sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans
      contextRef="i64534b6ebaf2429c9abcfa76a80980aa_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjNjhkMTM3NzQ1NzQ0ZjYwYjdkZWJmMGRjZmE0YjBmZC90YWJsZXJhbmdlOmM2OGQxMzc3NDU3NDRmNjBiN2RlYmYwZGNmYTRiMGZkXzItMy0xLTEtMzY0MDYw_4bbce661-a028-43c8-95db-8dd6acb52f51"
      unitRef="eur">116000000</sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans>
    <sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans
      contextRef="i8672ddeb9f334dfaa7ff3d1ce467ff9c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjNjhkMTM3NzQ1NzQ0ZjYwYjdkZWJmMGRjZmE0YjBmZC90YWJsZXJhbmdlOmM2OGQxMzc3NDU3NDRmNjBiN2RlYmYwZGNmYTRiMGZkXzItNC0xLTEtMzY0MDYw_b997430f-d5bf-4d6e-9ccd-d515ddba2560"
      unitRef="eur">139000000</sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans>
    <sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans
      contextRef="id75833e7c0144f56ab9eac0ea4d607f3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjNjhkMTM3NzQ1NzQ0ZjYwYjdkZWJmMGRjZmE0YjBmZC90YWJsZXJhbmdlOmM2OGQxMzc3NDU3NDRmNjBiN2RlYmYwZGNmYTRiMGZkXzItNS0xLTEtMzY0MDYw_b859242d-a0c8-4b5a-b8dc-3bf9f4686933"
      unitRef="eur">859000000</sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans>
    <sny:DisclosureOfRestructuringProvisionsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDcx_a045b86e-6f96-4371-be9c-2ecb904ca424">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows movements in restructuring provisions classified in non-current and current liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,499&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,390&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Of which:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Classified in non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Classified in current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Change in provisions recognized in profit or loss for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provisions utilized&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(571)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(663)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unwinding of discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,233&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,499&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Of which:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Classified in non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Classified in current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Provisions utilized mainly correspond to payments related to employees affected by separation programs.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfRestructuringProvisionsTableTextBlock>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEtMS0xLTEtMzY0MDYw_279863d8-64ee-4328-a81d-490c6cdb71a2"
      unitRef="eur">1118000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="id5afebb992674818a78a7834ac446ae9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEtMi0xLTEtMzY0MDYw_5c03b1cb-e643-4365-87ac-441a7c17db5e"
      unitRef="eur">1499000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="icb5f9e7c6185477aa7f9a156dc214f20_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEtMy0xLTEtMzY0MDYw_2dd4d0c5-ec54-448b-a5d9-44e3bf5d6eee"
      unitRef="eur">1390000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <ifrs-full:LongtermRestructuringProvision
      contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzMtMS0xLTEtMzY0MDYw_f5286cb0-2cd8-4000-b10a-ae7fbbad3537"
      unitRef="eur">524000000</ifrs-full:LongtermRestructuringProvision>
    <ifrs-full:LongtermRestructuringProvision
      contextRef="id5afebb992674818a78a7834ac446ae9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzMtMi0xLTEtMzY0MDYw_d116c766-522c-4ac0-b375-24670976e8fa"
      unitRef="eur">868000000</ifrs-full:LongtermRestructuringProvision>
    <ifrs-full:LongtermRestructuringProvision
      contextRef="icb5f9e7c6185477aa7f9a156dc214f20_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzMtMy0xLTEtMzY0MDYw_82796eeb-0ea2-4940-84c0-a6295a6b16d8"
      unitRef="eur">600000000</ifrs-full:LongtermRestructuringProvision>
    <ifrs-full:ShorttermRestructuringProvision
      contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzQtMS0xLTEtMzY0MDYw_e371a4f8-5ea9-4fd3-9f13-16d288bb3622"
      unitRef="eur">594000000</ifrs-full:ShorttermRestructuringProvision>
    <ifrs-full:ShorttermRestructuringProvision
      contextRef="id5afebb992674818a78a7834ac446ae9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzQtMi0xLTEtMzY0MDYw_82b8eda8-b675-4291-a53a-421770da7e48"
      unitRef="eur">631000000</ifrs-full:ShorttermRestructuringProvision>
    <ifrs-full:ShorttermRestructuringProvision
      contextRef="icb5f9e7c6185477aa7f9a156dc214f20_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzQtMy0xLTEtMzY0MDYw_29e8895c-6cac-4f70-8bf2-c34772c3fd69"
      unitRef="eur">790000000</ifrs-full:ShorttermRestructuringProvision>
    <sny:ChangeInProvisionsRecognizedInProfitOrLossForThePeriod
      contextRef="i845514465d3444229b0025c52ed9385a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzUtMS0xLTEtMzY0MDYw_f7797baa-fde3-4513-8cb9-d6fa072ed1ad"
      unitRef="eur">636000000</sny:ChangeInProvisionsRecognizedInProfitOrLossForThePeriod>
    <sny:ChangeInProvisionsRecognizedInProfitOrLossForThePeriod
      contextRef="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzUtMi0xLTEtMzY0MDYw_335accc7-b955-491a-994a-92707dbe8867"
      unitRef="eur">183000000</sny:ChangeInProvisionsRecognizedInProfitOrLossForThePeriod>
    <sny:ChangeInProvisionsRecognizedInProfitOrLossForThePeriod
      contextRef="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzUtMy0xLTEtMzY0MDYw_f23136d1-c0eb-4812-83ad-f2f5ea3fa735"
      unitRef="eur">767000000</sny:ChangeInProvisionsRecognizedInProfitOrLossForThePeriod>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i845514465d3444229b0025c52ed9385a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzYtMS0xLTEtMzY0MDYw_3c3982dd-4af7-4ae6-a662-fd7133ab2cc1"
      unitRef="eur">522000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzYtMi0xLTEtMzY0MDYw_90b9995c-42e7-425b-8467-66292d7f66be"
      unitRef="eur">571000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzYtMy0xLTEtMzY0MDYw_51c54cee-e378-471a-acbe-0c704960cf55"
      unitRef="eur">663000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i845514465d3444229b0025c52ed9385a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzctMS0xLTEtMzY0MDYw_39d6170d-dcaa-4c65-9500-134479d289d5"
      unitRef="eur">0</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzctMi0xLTEtMzY0MDYw_f14227f7-a2c6-43c3-8bfb-f1e9a4098042"
      unitRef="eur">1000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzctMy0xLTEtMzY0MDYw_7d257689-b6f3-4754-b928-b36e3c755a48"
      unitRef="eur">20000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <sny:UnwindingOfDiscount
      contextRef="i845514465d3444229b0025c52ed9385a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzgtMS0xLTEtMzY0MDYw_08c7b0c7-31f0-4597-bc8c-9955355ca014"
      unitRef="eur">5000000</sny:UnwindingOfDiscount>
    <sny:UnwindingOfDiscount
      contextRef="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzgtMi0xLTEtMzY0MDYw_c4400605-80cb-4f24-8259-027a442e1f37"
      unitRef="eur">0</sny:UnwindingOfDiscount>
    <sny:UnwindingOfDiscount
      contextRef="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzgtMy0xLTEtMzY0MDYw_ae2edede-33a7-4b51-b914-568e4035717e"
      unitRef="eur">1000000</sny:UnwindingOfDiscount>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i845514465d3444229b0025c52ed9385a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzktMS0xLTEtMzY0MDYw_d5aa977c-e52a-41a2-99bf-5a3503ccd853"
      unitRef="eur">-4000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="i462fc960f7f34d938c94bcc42fab0948_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzktMi0xLTEtMzY0MDYw_3ab9014c-d073-42c5-b837-e91f18935c92"
      unitRef="eur">6000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="ib9add433ac594e459d40d54c04ff99fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzktMy0xLTEtMzY0MDYw_b6a04c0a-9485-48e3-832f-3faab0b3f65c"
      unitRef="eur">-16000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="if7b1f1d64d014db48f48a68a6832b64a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEwLTEtMS0xLTM2NDA2MA_6662044c-b039-4ab8-9757-db336d6272fe"
      unitRef="eur">1233000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEwLTItMS0xLTM2NDA2MA_51030fc4-70dc-4ab3-a93f-092230b813e0"
      unitRef="eur">1118000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities
      contextRef="id5afebb992674818a78a7834ac446ae9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEwLTMtMS0xLTM2NDA2MA_82497fd9-7244-47b2-b3d5-d33a5ad14467"
      unitRef="eur">1499000000</sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities>
    <ifrs-full:LongtermRestructuringProvision
      contextRef="if7b1f1d64d014db48f48a68a6832b64a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEyLTEtMS0xLTM2NDA2MA_de41c0e6-6330-4a2c-a55a-4d749e0600ca"
      unitRef="eur">761000000</ifrs-full:LongtermRestructuringProvision>
    <ifrs-full:LongtermRestructuringProvision
      contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEyLTItMS0xLTM2NDA2MA_2b34a08d-73d7-45be-bf8b-285466fc71f3"
      unitRef="eur">524000000</ifrs-full:LongtermRestructuringProvision>
    <ifrs-full:LongtermRestructuringProvision
      contextRef="id5afebb992674818a78a7834ac446ae9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEyLTMtMS0xLTM2NDA2MA_b058f4c3-bcc1-44d0-ace7-8be1f429135b"
      unitRef="eur">868000000</ifrs-full:LongtermRestructuringProvision>
    <ifrs-full:ShorttermRestructuringProvision
      contextRef="if7b1f1d64d014db48f48a68a6832b64a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEzLTEtMS0xLTM2NDA2MA_ccb6f6fb-a41f-43d3-9ffe-4a484566140d"
      unitRef="eur">472000000</ifrs-full:ShorttermRestructuringProvision>
    <ifrs-full:ShorttermRestructuringProvision
      contextRef="i9ad395b96a2a4d64958e0dd07a82a258_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEzLTItMS0xLTM2NDA2MA_d52cae02-3e07-4b8d-a4d7-1b492025ea59"
      unitRef="eur">594000000</ifrs-full:ShorttermRestructuringProvision>
    <ifrs-full:ShorttermRestructuringProvision
      contextRef="id5afebb992674818a78a7834ac446ae9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo5MzI1MzQxZjkyZDg0MWZkYTEzZDBhNmY2NzAzM2M3Ni90YWJsZXJhbmdlOjkzMjUzNDFmOTJkODQxZmRhMTNkMGE2ZjY3MDMzYzc2XzEzLTMtMS0xLTM2NDA2MA_a468852a-cd3f-4a39-9e0c-9d26f865092b"
      unitRef="eur">631000000</ifrs-full:ShorttermRestructuringProvision>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzEyNzAz_f2701bc5-7621-4d15-aaec-5ce735919baf"
      unitRef="eur">1039000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzEyNzIy_28230593-7625-4126-b399-fa5cd086a9f7"
      unitRef="eur">943000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzEyNzQ2_2af8f237-8868-42fc-bbdf-2f117084efde"
      unitRef="eur">1260000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <sny:AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans
      contextRef="ie3a804cc972b46818508faabd25873f4_D20221231-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE0NjE1_3f565ab0-ed0c-4c33-bb8c-4fa94f22b1e7">P2Y7M6D</sny:AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans>
    <sny:AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans
      contextRef="i0f39e329592f4ecf907cc503dcb00e16_D20211231-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE0NjI1_51ed3385-df47-46fc-9931-a0cc3e190208">P1Y11M8D</sny:AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans>
    <sny:AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans
      contextRef="i76c0ea6a3dee45298522d8ae0b039615_D20201231-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE0NjM4_ae0e2e02-8d17-490b-83a6-b983b19d5dcc">P1Y11M26D</sny:AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans>
    <sny:DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NTAy_ee7e0837-06ad-4dc7-8a6c-774c8f315520">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The timing of future termination benefit payments is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Benefit payments by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Employee termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;France&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Other countries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,039&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;374&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;448&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;215&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Benefit payments by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Employee termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;France&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Other countries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;943&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;476&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;67&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Benefit payments by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Employee termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;France&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Other countries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,260&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;490&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;606&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;border-bottom:0.5pt solid #5064a9;border-top:0.5pt solid #5064a9;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzMtMS0xLTEtMzY0MDYw_0eedf25a-0d86-45d5-94e4-6be3baf2c4d1"
      unitRef="eur">804000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i5fbc3ff0245c49bca7590dacfde5337a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzMtMi0xLTEtMzY0MDYw_0bdad2d8-e9f3-47a9-8f8e-07738bde6201"
      unitRef="eur">185000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ib3ede158a1804cc89e2cbf56a9146440_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzMtMy0xLTEtMzY0MDYw_5e831766-e154-451e-94af-f536c177961b"
      unitRef="eur">412000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ief8448635aed42ec8bd010e6d8d33e6f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzMtNC0xLTEtMzY0MDYw_1be2ac9a-c657-40f3-ba3c-55d9c7199099"
      unitRef="eur">207000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i733d9f9b2b73442f8f3ee6d411efc319_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzMtNS0xLTEtMzY0MDYw_6e280b3d-fb37-4ddf-bbeb-bbbc6b34be68"
      unitRef="eur">0</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i727bd67c94b846ec879e26bf1451a28b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzQtMS0xLTEtMzY0MDYw_0b37cb09-4047-40d8-ac71-ff4d82bd3294"
      unitRef="eur">235000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ia6a2ab1329f9438bb6a95f98aaf0e3f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzQtMi0xLTEtMzY0MDYw_9bbde57a-4347-4d54-bf1b-20616ca9edba"
      unitRef="eur">189000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ib5abb9e9b2d645b687214ebf5e5b917b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzQtMy0xLTEtMzY0MDYw_a05de612-258d-4d5f-bb4b-0e6ba0cfb834"
      unitRef="eur">36000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i4217022461624166b066799e52ed0ae2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzQtNC0xLTEtMzY0MDYw_4c040117-8775-4622-adcf-2abde7600c47"
      unitRef="eur">8000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ia0b14f40a60345cfbb888ce3b1583ed8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzQtNS0xLTEtMzY0MDYw_ae5d3d95-7710-4d79-a537-0c5d12ce2995"
      unitRef="eur">2000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzUtMS0xLTEtMzY0MDYw_f2701bc5-7621-4d15-aaec-5ce735919baf"
      unitRef="eur">1039000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzUtMi0xLTEtMzY0MDYw_74544c8f-0079-43ab-8daf-bf7cf7b5f79a"
      unitRef="eur">374000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzUtMy0xLTEtMzY0MDYw_dcddeb96-e4e0-4725-8331-4265f8f50fcb"
      unitRef="eur">448000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzUtNC0xLTEtMzY0MDYw_797dbc01-aea3-493a-9668-95a4d63b1a7f"
      unitRef="eur">215000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTo2Nzk0YjBlZGU4NWQ0ZDU2YTVlNDE4Y2YzYWFlNTIxYi90YWJsZXJhbmdlOjY3OTRiMGVkZTg1ZDRkNTZhNWU0MThjZjNhYWU1MjFiXzUtNS0xLTEtMzY0MDYw_9c90cae9-5569-43e3-816c-75cb5d1daafa"
      unitRef="eur">2000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzMtMS0xLTEtMzY0MDYw_73d808f2-ca0e-4e51-bf58-784ecf230752"
      unitRef="eur">614000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="idf14e75b5e984c98bc6e960753b80f31_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzMtMi0xLTEtMzY0MDYw_2ebf0132-05c0-4e38-9a75-1cc1be299634"
      unitRef="eur">269000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i66df5d0d41d6428d9debc9c4c2f80889_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzMtMy0xLTEtMzY0MDYw_1a5e4a4f-ba58-435c-ae2e-67ce56e418e9"
      unitRef="eur">288000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i54ab42bc5dab418284d3709b3f894736_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzMtNC0xLTEtMzY0MDYw_2bad719b-9154-4dae-bdca-c757b327ae1e"
      unitRef="eur">53000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i836df9a1ca87450a9ed9f75118770f04_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzMtNS0xLTEtMzY0MDYw_e6decf4d-8f6d-4361-bae6-cd0e0f823216"
      unitRef="eur">4000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i688e526d505647cca548bad7d372816f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzQtMS0xLTEtMzY0MDYw_5603a17f-2eb9-4d72-9e3d-2b3a5c7c9f98"
      unitRef="eur">329000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="id6d8865e8b32416f920b803df1461469_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzQtMi0xLTEtMzY0MDYw_5734dcdc-19a8-4629-87ca-3258cc5bee8f"
      unitRef="eur">207000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i2f7f02d43ee94a4280406be5c3292239_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzQtMy0xLTEtMzY0MDYw_276aec8d-bec1-4713-a576-5abd31bf41a3"
      unitRef="eur">106000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ic901448a78764b3c9b5def1dfdd7fbee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzQtNC0xLTEtMzY0MDYw_0e898bfd-2b26-4936-a47c-ba58d37de4b2"
      unitRef="eur">14000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ide13b51197a24ee9b4038dac78c62afc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzQtNS0xLTEtMzY0MDYw_77651c21-d6f0-4c2a-a10f-c4e7599d96a2"
      unitRef="eur">2000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzUtMS0xLTEtMzY0MDYw_28230593-7625-4126-b399-fa5cd086a9f7"
      unitRef="eur">943000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i986561ae95484c06b7698d7d6959e8c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzUtMi0xLTEtMzY0MDYw_d04c204d-82d5-4d43-8036-e878769b9eae"
      unitRef="eur">476000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="ie428880947a544b49bb0e7d00760fd8c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzUtMy0xLTEtMzY0MDYw_1b38e344-f40f-4d18-8961-9a325c383aad"
      unitRef="eur">394000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="iff9a6cfc0d3c4fb393a0f42915753ff1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzUtNC0xLTEtMzY0MDYw_33189e31-2afd-450d-9f40-ea65d3d04082"
      unitRef="eur">67000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i93a3872d72bb4c82af731fdb78c50918_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToxMGRmNmVjZjUwMDE0NmUxYTljNDFlYmQ3ZmZjNDYyYi90YWJsZXJhbmdlOjEwZGY2ZWNmNTAwMTQ2ZTFhOWM0MWViZDdmZmM0NjJiXzUtNS0xLTEtMzY0MDYw_54124d99-1f2b-4ef4-9523-967eb4ec65cd"
      unitRef="eur">6000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzMtMS0xLTEtMzY0MDYw_3776a788-962c-4eb6-a8aa-8b7fe1745362"
      unitRef="eur">889000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i158f70bc52794d319fedf9a855b45b25_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzMtMi0xLTEtMzY0MDYw_dfe27176-304c-4028-b967-a9111c1f13e2"
      unitRef="eur">295000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i21e0cbf5e58a47feb6bd62e37f9b2bb2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzMtMy0xLTEtMzY0MDYw_55e8cc12-d0f6-48c2-94f6-b640a4693137"
      unitRef="eur">457000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i2f92b31b598b40a7b5f13a153bfbadba_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzMtNC0xLTEtMzY0MDYw_20e752fd-06ec-4fb1-ab86-67219fd79a49"
      unitRef="eur">124000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i46f2414fec014acf824049d7ef8a26af_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzMtNS0xLTEtMzY0MDYw_783562ec-d635-4d00-b3df-489187c5c285"
      unitRef="eur">13000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i0593a502ce6b4cd49c8af7a40f39e801_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzQtMS0xLTEtMzY0MDYw_bd9b5272-eea4-47e9-b7d2-10db7a1ec502"
      unitRef="eur">371000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i3c31592c4cfa491e9223f6491673f1a2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzQtMi0xLTEtMzY0MDYw_09c34b3e-717d-4afa-b3f3-b813f673fc3a"
      unitRef="eur">195000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="iff57e235495f4a5589b5d11d2537313e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzQtMy0xLTEtMzY0MDYw_c7255553-56e7-4ee3-90cd-f7bb6605d0f7"
      unitRef="eur">149000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i370f9ca08eec4c64933f63c4154c6168_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzQtNC0xLTEtMzY0MDYw_4a34b7a6-ff11-4e37-87e7-c004616c3fde"
      unitRef="eur">18000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="idcc9f8081cf140aba4e01d0be09d50e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzQtNS0xLTEtMzY0MDYw_3def6656-1959-4c26-b4aa-a42578b84342"
      unitRef="eur">9000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzUtMS0xLTEtMzY0MDYw_2af8f237-8868-42fc-bbdf-2f117084efde"
      unitRef="eur">1260000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i5544555c01764c4b8d8f64867b09aee6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzUtMi0xLTEtMzY0MDYw_3f400685-e8e7-4d78-bb72-d01524db3b6d"
      unitRef="eur">490000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i597d4960121a42bbb65d0137e78d145a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzUtMy0xLTEtMzY0MDYw_37ffe98b-6b30-4575-9836-6dc63c5b9bed"
      unitRef="eur">606000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i0c3121bafadb4e4f8e35a95800cbc2f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzUtNC0xLTEtMzY0MDYw_d6bdd2b2-a53a-432a-a6ce-dafee0573cc8"
      unitRef="eur">142000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="i9c0fb0f1741b4e32bed337f19bd37e61_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTpjYTZmMDBkYzU4NDQ0M2JlODI1YTRkYWJiNzg0NGJiOS90YWJsZXJhbmdlOmNhNmYwMGRjNTg0NDQzYmU4MjVhNGRhYmI3ODQ0YmI5XzUtNS0xLTEtMzY0MDYw_f2b2bd5e-d0d0-4cdc-a9cd-79554ae2ca1a"
      unitRef="eur">22000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <sny:DisclosureOfOtherLongTermProvisionsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NDg5_0c8f5d4f-0301-4e66-9b2b-d726ac73c2ab">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other provisions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; include provisions for risks and litigation relating to environmental, tax, commercial and product liability matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Environmental risks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Product liability risks, litigation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,178&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,024&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,975&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfOtherLongTermProvisionsTableTextBlock>
    <sny:NonCurrentProvisionForEnvironmentRisks
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzEtMS0xLTEtMzY0MDYw_eee19e01-7706-48aa-b28e-a68adf913fcd"
      unitRef="eur">526000000</sny:NonCurrentProvisionForEnvironmentRisks>
    <sny:NonCurrentProvisionForEnvironmentRisks
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzEtMi0xLTEtMzY0MDYw_07f08726-9a4f-40b9-bb74-ee22c8f0ba6d"
      unitRef="eur">650000000</sny:NonCurrentProvisionForEnvironmentRisks>
    <sny:NonCurrentProvisionForEnvironmentRisks
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzEtMy0xLTEtMzY0MDYw_c3ae2f77-7c2e-4456-99d7-6a8c900b720c"
      unitRef="eur">713000000</sny:NonCurrentProvisionForEnvironmentRisks>
    <sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzItMS0xLTEtMzY0MDYw_72d66f83-a30c-4d63-84a1-7c83733bdacb"
      unitRef="eur">1652000000</sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther>
    <sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzItMi0xLTEtMzY0MDYw_9b3c2333-e14d-40dc-9ea8-ae8bbec8eb75"
      unitRef="eur">1374000000</sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther>
    <sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzItMy0xLTEtMzY0MDYw_8fe2631c-0c21-4a11-b185-e836184da4e5"
      unitRef="eur">1262000000</sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther>
    <ifrs-full:OtherLongtermProvisions
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzMtMS0xLTEtMzY0MDYw_b4e4cdc9-c0b1-4583-a9f8-f2521af0b93b"
      unitRef="eur">2178000000</ifrs-full:OtherLongtermProvisions>
    <ifrs-full:OtherLongtermProvisions
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzMtMi0xLTEtMzY0MDYw_999f0a96-4505-4167-8122-1fac91582534"
      unitRef="eur">2024000000</ifrs-full:OtherLongtermProvisions>
    <ifrs-full:OtherLongtermProvisions
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZToyNGY1OTU5MmM0NjQ0Y2MwOGU0M2Q1MWE2YTY4MGQyZC90YWJsZXJhbmdlOjI0ZjU5NTkyYzQ2NDRjYzA4ZTQzZDUxYTZhNjgwZDJkXzMtMy0xLTEtMzY0MDYw_9e0234ea-37a3-4e4e-b7a9-b301d80c8fc8"
      unitRef="eur">1975000000</ifrs-full:OtherLongtermProvisions>
    <sny:IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod
      contextRef="idb626ed9d7754d599f6dcb43cd6f78a7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE1Nzkw_448c641c-3ec8-45be-80fb-881e374c511f">P30Y</sny:IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod>
    <sny:IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths
      contextRef="idb626ed9d7754d599f6dcb43cd6f78a7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE1ODIw_83786039-c90f-4078-b919-f4ab41dcbdb4"
      unitRef="eur">96000000</sny:IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths>
    <sny:IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive
      contextRef="idb626ed9d7754d599f6dcb43cd6f78a7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE1ODcx_97045856-8595-4c7d-b111-2fd97fd2c634"
      unitRef="eur">201000000</sny:IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive>
    <ifrs-full:CurrentTaxLiabilitiesNoncurrent
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2Njgw_e4f510ed-55e3-4f7a-97f0-8cd86614b244"
      unitRef="eur">1979000000</ifrs-full:CurrentTaxLiabilitiesNoncurrent>
    <ifrs-full:CurrentTaxLiabilitiesNoncurrent
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2NzAx_0351b7a0-d048-4586-aa3c-58e6f1fa8104"
      unitRef="eur">2039000000</ifrs-full:CurrentTaxLiabilitiesNoncurrent>
    <ifrs-full:CurrentTaxLiabilitiesNoncurrent
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2NzE4_434e824d-7efd-4872-891e-4d7b636aeadb"
      unitRef="eur">1733000000</ifrs-full:CurrentTaxLiabilitiesNoncurrent>
    <sny:TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2ODU5_6ba3c51b-afb1-47d0-b63f-d92d65ec4d8e">P8Y</sny:TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod>
    <sny:LiabilityRecognizedRepresentingEstimatedCost
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2OTE0_0801ef6a-9f92-49fb-900e-e3588fcb4a67"
      unitRef="eur">1020000000</sny:LiabilityRecognizedRepresentingEstimatedCost>
    <sny:LiabilityRecognizedRepresentingEstimatedCost
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2OTMw_4ec2f0f0-ea60-4e85-8b09-338336fb071f"
      unitRef="eur">960000000</sny:LiabilityRecognizedRepresentingEstimatedCost>
    <sny:LiabilityRecognizedRepresentingEstimatedCost
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE2OTQ0_eb965910-16b9-448b-b76a-6d49aa76b65f"
      unitRef="eur">894000000</sny:LiabilityRecognizedRepresentingEstimatedCost>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="i204cf38410c44c62bd596f2773e81a5b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3MDI1_431c4cf1-936f-41ce-b23b-b0dbdbddedfc"
      unitRef="eur">459000000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="i0fe124e0795a41ebac762da9097bb875_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3MDQ1_ba235c91-5670-4bb8-b0f9-b5fab927a721"
      unitRef="eur">576000000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="i2e7cdf1797e949f6abdf600757d84aa3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3MDU4_15efc7d9-8eb2-4d4b-9631-1986525bd930"
      unitRef="eur">569000000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:CurrentTaxLiabilitiesNoncurrent
      contextRef="i1f1c485ac1cf4f59b3dec0c221bf9747_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3MjU4_1e938802-1baa-44be-8a44-797ca9ead20d"
      unitRef="eur">1520000000</ifrs-full:CurrentTaxLiabilitiesNoncurrent>
    <ifrs-full:CurrentTaxLiabilitiesNoncurrent
      contextRef="i0067e056654b438e962ebd27feb406c1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3Mjc4_c781b469-786f-4da6-8538-25f23f0a9c34"
      unitRef="eur">1463000000</ifrs-full:CurrentTaxLiabilitiesNoncurrent>
    <ifrs-full:CurrentTaxLiabilitiesNoncurrent
      contextRef="if40304953a534c06a43b1715cc0c7ffa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3Mjk0_cbf415dc-4ee8-43c8-9d9b-316398189b9e"
      unitRef="eur">1164000000</ifrs-full:CurrentTaxLiabilitiesNoncurrent>
    <sny:UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="i7182e8a5acb84acb81eb76efa4a859af_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3MzYz_35b3b670-99fe-4221-a83b-7a27291e08bc"
      unitRef="eur">2900000000</sny:UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised>
    <sny:CapitalLossesCarryBackPeriod
      contextRef="i3b16a68d75504188ac3d7a2cb2687840_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE3NTQ3_d6100ff0-7e50-430c-9552-03a64a931a20">P3Y</sny:CapitalLossesCarryBackPeriod>
    <sny:DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE4NTA4_a58d39b9-9190-4e76-8699-9f00e55224d7">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Current provisions and other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; comprise the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Taxes payable, other than corporate income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee-related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Restructuring provisions (see Note&#160;D.19.2.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate derivatives (see Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency derivatives (see Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity derivatives (see Note&#160;D.20.)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amounts payable for acquisitions of non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Customer contract liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,021&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,217&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,132&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;See Note&#160;A.5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &#x201c;Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;. The year-on-year change in this item includes revenue of &#x20ac;85&#160;million recognized in profit or loss during 2022 that was included in the customer contract liabilities balance as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) &#x201c;Other current liabilities&#x201d; mainly comprises provisions for customer rebates and returns; provisions for discounts and rebates granted to healthcare authorities and governmental programs (see Note&#160;D.23.); and the liability payable at each reporting date under the Monoclonal Antibody Alliance with Regeneron.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock>
    <ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEtMS0xLTEtMzY0MDYw_35e81fe9-8b7c-4212-9ba3-33ba57664fb3"
      unitRef="eur">420000000</ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEtMi0xLTEtMzY0MDYw_ff3b0075-0af6-421a-bf36-73009292d719"
      unitRef="eur">428000000</ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEtMy0xLTEtMzY0MDYw_8386b0fe-922c-4248-ba89-3b8992160a98"
      unitRef="eur">347000000</ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzItMS0xLTEtMzY0MDYw_8c7d4973-96ad-40ef-95e7-9b79d9666759"
      unitRef="eur">2158000000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzItMi0xLTEtMzY0MDYw_66c7140f-0005-4eb4-b043-75b92f104cbe"
      unitRef="eur">2126000000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzItMy0xLTEtMzY0MDYw_3fade880-0454-4a81-9e02-577607a996ed"
      unitRef="eur">2042000000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermRestructuringProvision
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzMtMS0xLTEtMzY0MDYw_2f563ec7-83be-4c98-aecf-b557e69e7bd2"
      unitRef="eur">472000000</ifrs-full:ShorttermRestructuringProvision>
    <ifrs-full:ShorttermRestructuringProvision
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzMtMi0xLTEtMzY0MDYw_7d601789-8ef7-45f2-bc9c-214a6b87d66e"
      unitRef="eur">594000000</ifrs-full:ShorttermRestructuringProvision>
    <ifrs-full:ShorttermRestructuringProvision
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzMtMy0xLTEtMzY0MDYw_d4f1c130-6a11-49f7-b140-8f0bc7361a66"
      unitRef="eur">631000000</ifrs-full:ShorttermRestructuringProvision>
    <sny:CurrentInterestRateDerivativesPayable
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzQtMS0xLTEtMzY0MDYw_0b1844d0-17ca-4ac8-ba25-1445e870d9f7"
      unitRef="eur">0</sny:CurrentInterestRateDerivativesPayable>
    <sny:CurrentInterestRateDerivativesPayable
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzQtMi0xLTEtMzY0MDYw_ca5f2962-e72c-4102-ae33-ff820ac69cfd"
      unitRef="eur">1000000</sny:CurrentInterestRateDerivativesPayable>
    <sny:CurrentInterestRateDerivativesPayable
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzQtMy0xLTEtMzY0MDYw_30946100-172e-451a-80a6-7d9a10f40bfa"
      unitRef="eur">0</sny:CurrentInterestRateDerivativesPayable>
    <sny:CurrentCurrencyDerivativesPayable
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzUtMS0xLTEtMzY0MDYw_1912ac6e-567d-4ece-8535-e5d616ff191c"
      unitRef="eur">94000000</sny:CurrentCurrencyDerivativesPayable>
    <sny:CurrentCurrencyDerivativesPayable
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzUtMi0xLTEtMzY0MDYw_9798a2f6-208f-47f5-9f23-1703b36898a1"
      unitRef="eur">62000000</sny:CurrentCurrencyDerivativesPayable>
    <sny:CurrentCurrencyDerivativesPayable
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzUtMy0xLTEtMzY0MDYw_fb71ad32-f15c-48eb-882d-f13a901d7964"
      unitRef="eur">205000000</sny:CurrentCurrencyDerivativesPayable>
    <sny:CurrentEquityDerivativesPayable
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzYtMS0xLTEtMzY0MDYw_d28e4822-40a7-4bf1-975e-90844616f4fb"
      unitRef="eur">0</sny:CurrentEquityDerivativesPayable>
    <sny:CurrentEquityDerivativesPayable
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzYtMi0xLTEtMzY0MDYw_2b693102-fcd7-4995-a748-edbbb5f2c2ef"
      unitRef="eur">16000000</sny:CurrentEquityDerivativesPayable>
    <sny:CurrentEquityDerivativesPayable
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzYtMy0xLTEtMzY0MDYw_0651660d-00b3-4d43-bd42-8396d6b5d4e1"
      unitRef="eur">0</sny:CurrentEquityDerivativesPayable>
    <sny:AmountsPayableForAcquisitionOfNonCurrentAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzctMS0xLTEtMzY0MDYw_78dac1f7-2ad5-4ab1-908c-55ff40bf2d7c"
      unitRef="eur">714000000</sny:AmountsPayableForAcquisitionOfNonCurrentAssets>
    <sny:AmountsPayableForAcquisitionOfNonCurrentAssets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzctMi0xLTEtMzY0MDYw_adc4526d-4081-459f-a42f-00a3ff2696a0"
      unitRef="eur">559000000</sny:AmountsPayableForAcquisitionOfNonCurrentAssets>
    <sny:AmountsPayableForAcquisitionOfNonCurrentAssets
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzctMy0xLTEtMzY0MDYw_f291f243-535a-4a0d-8915-a2bd96e9742d"
      unitRef="eur">467000000</sny:AmountsPayableForAcquisitionOfNonCurrentAssets>
    <ifrs-full:CurrentContractLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzgtMS0xLTEtMzY0MDYw_44980c80-8f71-4fc7-9642-68dfb56700ac"
      unitRef="eur">264000000</ifrs-full:CurrentContractLiabilities>
    <ifrs-full:CurrentContractLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzgtMi0xLTEtMzY0MDYw_9679bcb4-1851-4bdc-8a88-5fd53c894211"
      unitRef="eur">319000000</ifrs-full:CurrentContractLiabilities>
    <ifrs-full:CurrentContractLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzgtMy0xLTEtMzY0MDYw_a61ee222-bb66-4ffb-a4e6-fd548575bdfe"
      unitRef="eur">252000000</ifrs-full:CurrentContractLiabilities>
    <ifrs-full:OtherCurrentLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzktMS0xLTEtMzY0MDYw_df337933-e9c4-47a9-a069-da78a5c4d668"
      unitRef="eur">7899000000</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:OtherCurrentLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzktMi0xLTEtMzY0MDYw_a382f895-053d-4966-83d7-24f46f6a9f0d"
      unitRef="eur">7112000000</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:OtherCurrentLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzktMy0xLTEtMzY0MDYw_3f0d28c8-fcb6-4079-a035-053ad5700d2b"
      unitRef="eur">6188000000</ifrs-full:OtherCurrentLiabilities>
    <sny:CurrentProvisionsAndOtherCurrentLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEwLTEtMS0xLTM2NDA2MA_ca5600d7-89a8-4dfe-b8df-c48fed798a2f"
      unitRef="eur">12021000000</sny:CurrentProvisionsAndOtherCurrentLiabilities>
    <sny:CurrentProvisionsAndOtherCurrentLiabilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEwLTItMS0xLTM2NDA2MA_270e80dc-4e0b-4e53-b6e9-85fbf11c4cfb"
      unitRef="eur">11217000000</sny:CurrentProvisionsAndOtherCurrentLiabilities>
    <sny:CurrentProvisionsAndOtherCurrentLiabilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90YWJsZTowZjgzNWMwNjE1OWE0YzEyYTUyYmYzMDg1YWRjYzk1Yi90YWJsZXJhbmdlOjBmODM1YzA2MTU5YTRjMTJhNTJiZjMwODVhZGNjOTViXzEwLTMtMS0xLTM2NDA2MA_2a0bc318-9cfe-403d-ad7e-bad5e4f8c5a1"
      unitRef="eur">10132000000</sny:CurrentProvisionsAndOtherCurrentLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NDYvZnJhZzplOTA5YTA4NWZkNzQ0MDk2YTViZTMwNjE2NzlhNmI3MC90ZXh0cmVnaW9uOmU5MDlhMDg1ZmQ3NDQwOTZhNWJlMzA2MTY3OWE2YjcwXzE5NzkxMjA5MzI1NTI4_e30c2949-05f2-486e-93da-248dc2cdb0e9"
      unitRef="eur">85000000</ifrs-full:ContractLiabilities>
    <ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MjQ_710c5d95-74a8-4a71-9003-85bef9e110b9">Derivative financial instruments and market risks&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the fair value of derivative instruments as of December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;br/&gt;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-current&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Market value at December 31, 2022 (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Market value at December 31, 2021 (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Market value at December 31, 2020 (net)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;financial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;( 232)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;( 94)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;( 326)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;( 120)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;( 215)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Objectives of the use of derivative financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi uses derivative instruments to manage operating exposure to movements in exchange rates, and financial exposure to movements in interest rates and exchange rates (where the debt or receivable is not contracted in the functional currency of the borrower or lender entity). On occasion, Sanofi uses equity derivatives in connection with the management of its portfolio of equity investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi performs periodic reviews of its transactions and contractual agreements in order to identify any embedded derivatives, which are accounted for separately from the host contract in accordance with IFRS&#160;9. Sanofi had no material embedded derivatives as of December 31, 2022, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Counterparty risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For a description of counterparty risk, refer to &#x201c;Item&#160;11. &#x2014; Quantitative and Qualitative Disclosures about Market Risk&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a) Currency derivatives used to manage operating risk exposures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For a description of Sanofi's objectives, policies and procedures for the management of operating foreign exchange risk, refer to &#x201c;Item&#160;11. &#x2014; Quantitative and Qualitative Disclosures about Market Risk&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows operating currency hedging instruments in place as of December 31, 2022, with the notional amount translated into euros at the relevant closing exchange rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which derivatives designated as&lt;br/&gt;cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&#160;derivatives&#160;not&lt;br/&gt;eligible&#160;for&#160;hedge&#160;accounting&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&lt;br/&gt;recognized&#160;in&#160;equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,403&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,403&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Japanese yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Korean won&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,459&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,459&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Korean won&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Taiwan dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows operating currency hedging instruments in place as of December 31, 2021, with the notional amount translated into euros at the relevant closing exchange rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which derivatives designated as&lt;br/&gt;cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&#160;derivatives&#160;not&lt;br/&gt;eligible&#160;for&#160;hedge&#160;accounting&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&lt;br/&gt;recognized&#160;in&#160;equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,912&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,912&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Japanese yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Taiwan dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,374&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,374&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Hungarian forint&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Russian rouble&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,286&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,286&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows operating currency hedging instruments in place as of December 31, 2020, with the notional amount translated into euros at the relevant closing exchange rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.339%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.304%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which derivatives&lt;br/&gt;designated&#160;as&#160;cash&#160;flow&#160;hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&#160;derivatives&#160;not&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;eligible&#160;for&#160;hedge&#160;accounting &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&lt;br/&gt;recognized&lt;br/&gt;in&#160;equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,477&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,477&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Japanese yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Mexican peso&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,932&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,932&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Russian rouble&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Japanese yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,409&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,409&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b) Currency and interest rate derivatives used to manage financial exposure&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For a description of Sanofi's objectives, policies and procedures for the management of financial foreign exchange risk and interest rate risk, refer to &#x201c;Item&#160;11. &#x2014; Quantitative and Qualitative Disclosures about Market Risk&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows financial currency hedging instruments in place, with the notional amount translated into euros at the relevant closing exchange rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiry&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiry&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiry&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,559&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,655&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,064&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;6,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;5,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Pound sterling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,997&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,293&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;197&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,004&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%"&gt;(b) (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;4,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;6,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Japanese yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,556&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;90&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16,948&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;212&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,068&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes forward sales with a notional amount of $3,615 million expiring in 2023, designated as a hedge of Sanofi&#x2019;s net investment in Bioverativ. As of December 31, 2022, the fair value of these forward contracts represented an asset of &#x20ac;38 million; the opposite entry was recognized in "Other comprehensive income", with the impact on financial income and expense being immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Includes forward purchases with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of $1,000 million of bond issues to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of &#x20ac;3 million, the opposite entry for &#x20ac;0.6&#160;million of which was debited to &#x201c;Other comprehensive income&#x201d; under the cost of hedging accounting treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Includes receiver currency swaps with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the swaps was a liability of &#x20ac;2 million, the opposite entry for &#x20ac;1.4&#160;million of which was credited to &#x201c;Other comprehensive income&#x201d; under the cost of hedging accounting treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d) Includes forward purchases with a notional amount of SGD1,500 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/SGD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of&#160;&#x20ac;33 million, the opposite entry for &#x20ac;2.5&#160;million of which was credited to &#x201c;Other comprehensive income&#x201d; under the cost of hedging accounting treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows interest rate hedging instruments in place as of December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amounts by expiry date as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;designated as&lt;br/&gt;fair value&lt;br/&gt;hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which designated as&lt;br/&gt;cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;recognized&lt;br/&gt;in equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay SOFR USD/receive 1.03%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay SOFR USD/receive 1.32%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay capitalized Ester/receive 0.69%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay capitalized Ester/receive 0.92%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;850&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,584&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,434&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,434&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows interest rate hedging instruments in place as of December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amounts by expiry date as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;designated as&lt;br/&gt;fair value&lt;br/&gt;hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which designated as&lt;br/&gt;cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027 and later&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;recognized&lt;br/&gt;in equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay capitalized EONIA/receive 0.06%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay -0.57%/receive capitalized EONIA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay SOFR USD/receive 1.03%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay SOFR USD/receive 1.32%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;receive capitalized EONIA/pay 1.48%&lt;/span&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,642&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;57&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;880&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,579&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,979&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;600&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) These interest rate swaps hedge fixed-rate bonds with a nominal of &#x20ac;99 million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within &#x201c;Loans, advances and other long-term receivables&#x201d; (see Note D.7.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows interest rate hedging instruments in place as of December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amounts by expiry date as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;designated as&lt;br/&gt;fair value&lt;br/&gt;hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which designated as&lt;br/&gt;cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026 and later&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;recognized&lt;br/&gt;in equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay capitalized EONIA/receive 0.06%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay -0.57%/receive capitalized EONIA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;receive capitalized Eonia/pay 1.48%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,642&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;57&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,699&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,099&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;600&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) These interest rate swaps hedge fixed-rate bonds with a nominal of &#x20ac;99 million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within &#x201c;Loans, advances and other long-term receivables&#x201d; (see Note D.7.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;c) Actual or potential effects of netting arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below is prepared in accordance with the accounting policies described in Note&#160;B.8.3.:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross carrying amounts before offset (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(297)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross amounts offset (in accordance with IAS&#160;32)&#160;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amounts as reported in the balance sheet (a) -&#160;(b) =&#160;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;298&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(297)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effects of other netting arrangements (not fulfilling the IAS&#160;32 criteria for offsetting) (d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of financial collateral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net exposure (c) + (d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;231&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory>
    <sny:DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MTI_60599b81-97d8-4e88-9f20-83220cef8070">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the fair value of derivative instruments as of December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;br/&gt;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-current&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Market value at December 31, 2022 (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Market value at December 31, 2021 (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Market value at December 31, 2020 (net)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;financial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;( 232)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;( 94)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;( 326)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;( 120)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;( 215)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtMS0xLTEtMzY0MDYw_d0e5fe5e-5b93-4086-be34-575ca47b9213"
      unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:CurrentDerivativeFinancialAssets
      contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtMi0xLTEtMzY0MDYw_bdb5fa81-9a31-4581-ab4d-d7095e980d37"
      unitRef="eur">206000000</ifrs-full:CurrentDerivativeFinancialAssets>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtMy0xLTEtMzY0MDYw_1cd7ab1e-3f5b-4539-ae90-60462b9442f4"
      unitRef="eur">206000000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtNC0xLTEtMzY0MDYw_4b92781f-376b-4015-a680-42441794dffe"
      unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtNS0xLTEtMzY0MDYw_6530e223-2093-4e7f-8ad2-e9e4f99de3cc"
      unitRef="eur">94000000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtNi0xLTEtMzY0MDYw_d7128bec-3458-490f-91e2-4489b07dae5b"
      unitRef="eur">94000000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="i1ba446060ed747fd8a37852a575bc1dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtNy0xLTEtMzY0MDYw_e4953e57-4407-4b07-a5f7-5f5cb66f9003"
      unitRef="eur">112000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="i6f34920cef9945fd969c11ea4e857b12_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtOC0xLTEtMzY0MDYw_57b15a0a-cd47-42eb-9297-204ae9986827"
      unitRef="eur">222000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="ifb00596e224b4b3eb3c4df739ff52cc1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzEtOS0xLTEtMzY0MDYw_645bfa2e-ebb5-4c22-a912-21f498acc75e"
      unitRef="eur">-209000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItMS0xLTEtMzY0MDYw_d4accf9e-30e3-49dd-a88e-3caef5f2bbd8"
      unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:CurrentDerivativeFinancialAssets
      contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItMi0xLTEtMzY0MDYw_9615722f-2655-47a3-b8a0-dab9de005c9c"
      unitRef="eur">88000000</ifrs-full:CurrentDerivativeFinancialAssets>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItMy0xLTEtMzY0MDYw_a2f0308c-973d-4d6a-9a23-8021c04e5117"
      unitRef="eur">88000000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItNC0xLTEtMzY0MDYw_9e6eea81-9d98-4f84-82a3-52843d9c1781"
      unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItNS0xLTEtMzY0MDYw_0421354e-7728-40b3-aeb8-29dd9868acf1"
      unitRef="eur">66000000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItNi0xLTEtMzY0MDYw_8b0ed034-bd59-4aad-8470-236b0dd68dcb"
      unitRef="eur">66000000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="i8fc828012b3e4f69a32944391c782b1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItNy0xLTEtMzY0MDYw_baf68674-a4b1-458f-bf45-0b3a7eada100"
      unitRef="eur">22000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="icb368c61c98d4f5f804fb045a97d08e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItOC0xLTEtMzY0MDYw_3f22f5d2-fc96-4703-a687-03c9594d6048"
      unitRef="eur">10000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="ifeca42fd3faa45ae94e5c1bb85088c87_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzItOS0xLTEtMzY0MDYw_2c8306c1-6f3e-49cc-902c-e4e6c29140a2"
      unitRef="eur">7000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtMS0xLTEtMzY0MDYw_0eaaf037-26cb-41fc-8ae9-00b7538fde2c"
      unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:CurrentDerivativeFinancialAssets
      contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtMi0xLTEtMzY0MDYw_07c93871-a1f6-4ef4-9a9a-9627942eca66"
      unitRef="eur">118000000</ifrs-full:CurrentDerivativeFinancialAssets>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtMy0xLTEtMzY0MDYw_2909acce-bc10-4041-97a8-d80f08a41421"
      unitRef="eur">118000000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtNC0xLTEtMzY0MDYw_cb21b8ca-969f-4f07-a299-0f70b139685e"
      unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtNS0xLTEtMzY0MDYw_ab87accb-57a3-41f3-ae42-04bc7b5e9dae"
      unitRef="eur">28000000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtNi0xLTEtMzY0MDYw_8ce2756b-9c33-42d6-ad74-dd206a0df9df"
      unitRef="eur">28000000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="ibd45c8db737d4629b5ae31523cf4b669_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtNy0xLTEtMzY0MDYw_be7f5e49-8c22-4f72-a212-f3057027d400"
      unitRef="eur">90000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="ie9bce47aac6f476b9ddd183a1b48c82a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtOC0xLTEtMzY0MDYw_d7623634-205e-46d5-872a-2d4741d08fe3"
      unitRef="eur">212000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="i77add1a06a69418dab94e867b2a86d41_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzMtOS0xLTEtMzY0MDYw_866d627e-8c32-4516-86e0-5d5aac1fbce5"
      unitRef="eur">-216000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtMS0xLTEtMzY0MDYw_a32b773c-ecbc-4269-ac79-3b0c2dcc8402"
      unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:CurrentDerivativeFinancialAssets
      contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtMi0xLTEtMzY0MDYw_4361f526-0c7e-4986-8c52-4fbcd778f727"
      unitRef="eur">0</ifrs-full:CurrentDerivativeFinancialAssets>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtMy0xLTEtMzY0MDYw_23ee5341-0644-479f-ac71-9234c3ca7c42"
      unitRef="eur">0</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtNC0xLTEtMzY0MDYw_fcf38aaf-50f1-4569-ab52-68b6551dab92"
      unitRef="eur">232000000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtNS0xLTEtMzY0MDYw_f6d5aa9e-a62d-4e37-8a81-3e67fe698b68"
      unitRef="eur">0</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtNi0xLTEtMzY0MDYw_02af7f1b-0ae1-407c-8efe-9c912444d118"
      unitRef="eur">232000000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="i3a3dbc85683e464fa9ae058e17335a6d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtNy0xLTEtMzY0MDYw_fd05f50d-5380-4f61-8433-4551bffb06a4"
      unitRef="eur">-232000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="i01f241b2e7334652930d2a5f3bcae23d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtOC0xLTEtMzY0MDYw_94734b79-0f2b-4c32-ba80-0510249f6781"
      unitRef="eur">7000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="idd6f6afab5064092a3ab474b0a93921f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzQtOS0xLTEtMzY0MDYw_a0ce1199-5ad4-4968-9014-c5cdd191a3a3"
      unitRef="eur">20000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="iad5d34f9d74d4248b507d41261086914_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtMS0xLTEtMzY0MDYw_2f886ec0-cc1a-4eaf-9c2e-016f18fc346b"
      unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:CurrentDerivativeFinancialAssets
      contextRef="iad5d34f9d74d4248b507d41261086914_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtMi0xLTEtMzY0MDYw_4144e595-302a-46ef-87f9-199b23ebbc56"
      unitRef="eur">0</ifrs-full:CurrentDerivativeFinancialAssets>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="iad5d34f9d74d4248b507d41261086914_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtMy0xLTEtMzY0MDYw_8d3acf6b-6515-4c37-9388-353413212c56"
      unitRef="eur">0</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="iad5d34f9d74d4248b507d41261086914_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtNC0xLTEtMzY0MDYw_595e0139-b461-4d4f-8fa6-f413e9d51256"
      unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="iad5d34f9d74d4248b507d41261086914_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtNS0xLTEtMzY0MDYw_a189ebd8-c6f6-4fc7-8f1d-538f305e82f3"
      unitRef="eur">0</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="iad5d34f9d74d4248b507d41261086914_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtNi0xLTEtMzY0MDYw_42ffe352-bc08-496c-80e1-5abc4487dbdb"
      unitRef="eur">0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="iad5d34f9d74d4248b507d41261086914_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtNy0xLTEtMzY0MDYw_acf820f0-e23e-4dd4-b25f-0c95a4c53213"
      unitRef="eur">0</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="ic3c4833a597b445e8ac99a4bbe634506_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtOC0xLTEtMzY0MDYw_6a73e091-3d7a-4b6a-adc2-9bb3cfeb3306"
      unitRef="eur">-16000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="i579725acb4414ac980d9c04bf21d1baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzUtOS0xLTEtMzY0MDYw_29aa9c95-8d8a-4553-8462-82842afc232d"
      unitRef="eur">-26000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtMS0xLTEtMzY0MDYw_8bde0361-7a26-4177-b9c2-03a5ea2412da"
      unitRef="eur">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:CurrentDerivativeFinancialAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtMi0xLTEtMzY0MDYw_6aaa09b8-c831-4fa3-aa0e-d16059d765f0"
      unitRef="eur">206000000</ifrs-full:CurrentDerivativeFinancialAssets>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtMy0xLTEtMzY0MDYw_1980a7e3-ad69-491c-81eb-ca9e98eaeb01"
      unitRef="eur">206000000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtNC0xLTEtMzY0MDYw_3de40d4e-d971-40c5-b3c6-cf0de47f1380"
      unitRef="eur">232000000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtNS0xLTEtMzY0MDYw_d63a1899-6339-4ce2-980d-394bf55372c3"
      unitRef="eur">94000000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtNi0xLTEtMzY0MDYw_846802c8-e9b1-4ade-8817-6664dcfff03b"
      unitRef="eur">326000000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtNy0xLTEtMzY0MDYw_9fbc0d2a-2225-4f15-a1ad-19b9125c71da"
      unitRef="eur">-120000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtOC0xLTEtMzY0MDYw_3b185e4c-a2e7-426b-aadb-be560a0857ec"
      unitRef="eur">213000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2MTI2OTYwZWYzZTQ0YmMxOGM2NjNjMGY2NTgzMjY3Mi90YWJsZXJhbmdlOjYxMjY5NjBlZjNlNDRiYzE4YzY2M2MwZjY1ODMyNjcyXzYtOS0xLTEtMzY0MDYw_81e16cdf-382f-4566-8b41-135d15a9b9dc"
      unitRef="eur">-215000000</ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue>
    <sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MTM_3fdf7a64-77ae-4210-a75a-bd084dac6f7b">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows operating currency hedging instruments in place as of December 31, 2022, with the notional amount translated into euros at the relevant closing exchange rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which derivatives designated as&lt;br/&gt;cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&#160;derivatives&#160;not&lt;br/&gt;eligible&#160;for&#160;hedge&#160;accounting&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&lt;br/&gt;recognized&#160;in&#160;equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,403&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,403&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Japanese yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Korean won&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,459&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,459&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Korean won&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Taiwan dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,862&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;22&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows operating currency hedging instruments in place as of December 31, 2021, with the notional amount translated into euros at the relevant closing exchange rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which derivatives designated as&lt;br/&gt;cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&#160;derivatives&#160;not&lt;br/&gt;eligible&#160;for&#160;hedge&#160;accounting&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&lt;br/&gt;recognized&#160;in&#160;equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,912&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,912&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Japanese yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Taiwan dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,374&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,374&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Hungarian forint&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Russian rouble&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,286&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,286&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows operating currency hedging instruments in place as of December 31, 2020, with the notional amount translated into euros at the relevant closing exchange rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.339%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.304%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which derivatives&lt;br/&gt;designated&#160;as&#160;cash&#160;flow&#160;hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&#160;derivatives&#160;not&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;eligible&#160;for&#160;hedge&#160;accounting &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of&#160;which&lt;br/&gt;recognized&lt;br/&gt;in&#160;equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,477&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,477&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Japanese yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Mexican peso&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,932&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,932&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Russian rouble&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Japanese yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,409&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,409&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock>
    <sny:DerivativeFinancialInstruments
      contextRef="i2c02fd8df4a441dcb9995176d3a629bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItMS0xLTEtMzY0MDYw_0c11a5db-8808-42e5-8a5b-cc72ab67d456"
      unitRef="eur">5403000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i72c3586a9fd0496ba3bc0f02039968e7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItMi0xLTEtMzY0MDYw_64dd074f-db48-40fc-a4f0-e2ed9809219e"
      unitRef="eur">49000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i5c9d5d1deb134833b4e2036bf3f18d5a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItMy0xLTEtMzY0MDYw_be48beda-601b-40bb-8a6f-2e97493e6e11"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i10922d814e24467cb216f9da5b9d4241_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItNC0xLTEtMzY0MDYw_2e0a6888-54dd-4a8a-b7c0-477e3b2aee83"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ie786e671f2514434bb2cc23e067013a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItNS0xLTEtMzY0MDYw_a5d7ae3c-7681-49ed-891b-d5a97226d1c0"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id08df1158473419092d42e5efbd09182_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItNi0xLTEtMzY0MDYw_60bbf029-7126-443c-a85d-db80c1253ec5"
      unitRef="eur">5403000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i3077a750c45649c4b6777546b6550f85_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzItNy0xLTEtMzY0MDYw_e21a0288-81d0-464e-b41f-7274355b08fe"
      unitRef="eur">49000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i670bfd8fbb1f496cb197f8a8d7aead50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtMS0xLTEtMzY0MDYw_c104684c-756c-46b3-a247-9a56b7e8df42"
      unitRef="eur">2732000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ib47972465c6744dbb2af277f58822cc3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtMi0xLTEtMzY0MDYw_158ae203-5e9b-41d3-8e6b-8d11de336248"
      unitRef="eur">56000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i1515e825367145dab2111f5b97ac20ff_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtMy0xLTEtMzY0MDYw_e1f45f7c-a4e6-4f62-abf6-52a344820fb5"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id9a877b2db5f4ef5a898f9ab4cd8c3bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtNC0xLTEtMzY0MDYw_a2254856-1e56-4673-adc5-1c9daef415f4"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i5f0d14b4b851424096254509ca5ce614_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtNS0xLTEtMzY0MDYw_da8b2f79-2112-4564-b0bc-b0ccf9e7ac3c"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ib0b930fe86134a789ba869c99ac6922a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtNi0xLTEtMzY0MDYw_eb74a006-b2be-4b85-b967-7685ab91a557"
      unitRef="eur">2732000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i53b2dc71058f462a964f7f92010a94f8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzMtNy0xLTEtMzY0MDYw_d3384851-4749-4375-8b48-66e777a93b01"
      unitRef="eur">56000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i6369626ceda6440e9ae77971eb0af8ce_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtMS0xLTEtMzY0MDYw_5fdf6448-65a0-4a48-bd67-abaea4d96460"
      unitRef="eur">576000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i31b628cae9e04ffc99774dc92b5b02b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtMi0xLTEtMzY0MDYw_b8fced98-b7ea-4499-a380-d6c9d9dd5102"
      unitRef="eur">2000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i1ed9108e10a7437da4ce7e1145d235d2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtMy0xLTEtMzY0MDYw_7c910789-c111-44ee-8cb1-765238217f4d"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i844c3e2c764c42c38c639fff0e73a5d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtNC0xLTEtMzY0MDYw_e6083e14-f7e4-4ec1-8b18-271df11268eb"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i616809455ece420c96191218acbd4402_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtNS0xLTEtMzY0MDYw_53cd5252-4c9f-406d-a5dc-cb2d948ff700"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2600795f42b14e488938c37089a03fdc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtNi0xLTEtMzY0MDYw_626fdf2d-9992-4bd0-b50b-180ddb78d2ba"
      unitRef="eur">576000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i72fe87984bc64e35af0fdf8b4f5b3af7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzQtNy0xLTEtMzY0MDYw_500475f5-aaa1-404f-9dd3-609624563637"
      unitRef="eur">2000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i023e473680f74d54a9e6f6b0424ff693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtMS0xLTEtMzY0MDYw_28ad8575-cff2-4bde-8d7a-14adb76064d3"
      unitRef="eur">240000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2d190f1e3f654825a7689ee2a7e9ed59_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtMi0xLTEtMzY0MDYw_86aabbbb-ee99-4851-aad9-378540c1d1e6"
      unitRef="eur">-5000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i9ea0c8b9510b4cdd91fa96778338156d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtMy0xLTEtMzY0MDYw_9b2018c7-f83d-4799-b894-2bef3e91eb53"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="icd085483ffc4410e9d0c190b8c42df88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtNC0xLTEtMzY0MDYw_66400ddd-0e0e-41a7-9cbc-f201135f8e0e"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i386b0ada740d403b80ec57b202d9925f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtNS0xLTEtMzY0MDYw_ad12712c-388e-4ca7-8e3f-ff8b3025ce07"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i8e328aedd84b49a29a910cbaa90fbe33_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtNi0xLTEtMzY0MDYw_89c81acf-2127-441b-b187-1ea3ac18d6f8"
      unitRef="eur">240000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i4781504261424f1e922ae06f843e805b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzUtNy0xLTEtMzY0MDYw_b0defa29-0673-4b5b-ab88-03dbaddd84c2"
      unitRef="eur">-5000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i34e173a6429643fbb1fc2fe0c4485b3e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtMS0xLTEtMzY0MDYw_f2332907-c946-42e2-8881-b2cafd83e148"
      unitRef="eur">180000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ic08ec36e888244fc9d534271f013c502_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtMi0xLTEtMzY0MDYw_0cea637f-1786-44b1-892d-f30a1410af50"
      unitRef="eur">1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id22287e14b1647b7b35da64ef2a0bcd0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtMy0xLTEtMzY0MDYw_ba584c9b-fd12-45a0-829e-a3dd91412ddc"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i554177ec4f184e20b73e2d228590a9f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtNC0xLTEtMzY0MDYw_f038ca30-e768-4599-a9f7-b431dad8cdbe"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2bbeb6793ff24719922e66a138d80cb6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtNS0xLTEtMzY0MDYw_3349b646-6cd2-42fc-9278-4263fd8e200e"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i7f8fdd2d956b482b956d8f11d789446d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtNi0xLTEtMzY0MDYw_7e4321ba-4c6c-4925-8cce-22d8efe8f53b"
      unitRef="eur">180000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i490e720986f8468298889ed58d2712f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzYtNy0xLTEtMzY0MDYw_180613bd-f649-44f4-ba3b-2a1781d6ad7b"
      unitRef="eur">1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i736a15874177466a8cdf1da7d0053f24_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctMS0xLTEtMzY0MDYw_b92d7c54-508d-4eb1-8538-da76bbdf3791"
      unitRef="eur">179000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i3a7f408bac704d3190ff4e36dacdffd1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctMi0xLTEtMzY0MDYw_c415844c-fcac-4e56-9152-05adfb4242a1"
      unitRef="eur">-14000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i0ff96e7abe6440fa939c031c8fda0ea9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctMy0xLTEtMzY0MDYw_07fc7cd6-5a3a-41d7-b5e4-84496b5c87cb"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i833ebae90f784a20b1d78388fc99a799_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctNC0xLTEtMzY0MDYw_f1b5a810-8233-4eed-9ae0-6a37f3758b6d"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i55b54f75fd784f738ba0c199ae6088a1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctNS0xLTEtMzY0MDYw_b8850004-3675-44f5-9c9d-29769095bf7c"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="icc588cc6b9f54f1d963f8d24ad61d2ac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctNi0xLTEtMzY0MDYw_3815cab6-503c-438e-907a-4ff965c7bfee"
      unitRef="eur">179000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i255506009ec44c939308e99a6b52e9f1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzctNy0xLTEtMzY0MDYw_65c24928-2c27-4e27-9f21-606728407bc3"
      unitRef="eur">-14000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i7d7af22b9f714cb2ac911c16230f1007_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtMS0xLTEtMzY0MDYw_ddfb059b-bd58-492b-9da5-8a1b2e0e120c"
      unitRef="eur">3459000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id027bcc05cc942509383921729fab6a8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtMi0xLTEtMzY0MDYw_44533952-40d2-4088-af20-3246326fb781"
      unitRef="eur">-27000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i876113a89cb44346a3da543cb98fe7ae_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtMy0xLTEtMzY0MDYw_ce07cc35-a54e-4931-96f3-90724d66df16"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i34bc3f2e19ed40ab8850869c31eaaf6c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtNC0xLTEtMzY0MDYw_5e7b6d16-44ed-4a74-9909-0340d228d7e7"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i9e0dfe2b1623470f91db3c18ce68dcc4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtNS0xLTEtMzY0MDYw_b01de91f-f484-4299-8615-f74d1d719c78"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i8ba2fcfafbe54bd7bf7de2bb6f55eaba_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtNi0xLTEtMzY0MDYw_5eb31ea8-5337-4c9f-a644-65e09f097cd7"
      unitRef="eur">3459000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i22da51d7b0254bd880ea050847a615f1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzgtNy0xLTEtMzY0MDYw_b51e7741-38d3-4ec9-b4d5-6315209eb339"
      unitRef="eur">-27000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="idaf9617caf734e5585971e11ab4b6606_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktMS0xLTEtMzY0MDYw_33550caa-3129-4258-8ab7-1ea1ea727153"
      unitRef="eur">2047000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i35ea3b55ed754a60a864ed8442dc2c4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktMi0xLTEtMzY0MDYw_0268def0-9960-442b-a149-6938d669204a"
      unitRef="eur">-21000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ia8566044ec104b54875bbc56afc2d6c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktMy0xLTEtMzY0MDYw_06bb3d11-d912-415f-9db7-fdf5467519e2"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ia61ae8b4b03e49bba08e79f0b7a8f8c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktNC0xLTEtMzY0MDYw_2a1f0bfa-49b0-477a-a635-2fcfad65938f"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i8c24dfa0a78b4e9d9bc86d6f52203580_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktNS0xLTEtMzY0MDYw_5d02db16-e0cf-4545-93f4-f66f5696131a"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i548e00dab5dc4ee7bdbfe1756bcb7839_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktNi0xLTEtMzY0MDYw_3e62940a-c900-460c-bbfe-eed8a4f2764d"
      unitRef="eur">2047000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ia0c5b59aa68d49298a45a2a610f5c5e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzktNy0xLTEtMzY0MDYw_83f18dbf-227c-4f42-a0f3-bdab6925d278"
      unitRef="eur">-21000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ic9668fa019664db492a7ff6c75a6318d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTEtMS0xLTM2NDA2MA_57673d05-8dce-48e2-8a13-e9ba18f28ad1"
      unitRef="eur">375000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i97148636de194a33893bec4aee4aa41c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTItMS0xLTM2NDA2MA_2193c325-874f-4c90-b346-9d1b6e66975f"
      unitRef="eur">-7000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="iecc031691818425087e6d05be7c7c9bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTMtMS0xLTM2NDA2MA_0ba37539-da0c-49d9-bdca-c90127a8a4b1"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ieff7a0389c9140eb879d380758dff38a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTQtMS0xLTM2NDA2MA_9bd0c6e6-77ff-40e8-81c1-2bc2f77517b2"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i1d0dcd53f94b45319eafd4558d70f360_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTUtMS0xLTM2NDA2MA_d6d8dcfe-e3bb-4f6f-9837-3c0be7c37fc2"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i6a186c3f32f5484f8ac45bfb18dc2330_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTYtMS0xLTM2NDA2MA_75ebf7a3-3a9d-46a8-acaa-c0f320576095"
      unitRef="eur">375000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i1ea8e0414ea34508ab58fd08342971ae_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEwLTctMS0xLTM2NDA2MA_11412cfe-1711-4c39-9f2e-be3b7b7bf1a2"
      unitRef="eur">-7000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="iee6addbe47a440138b52bf3611a17ceb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTEtMS0xLTM2NDA2MA_c55f6b0b-dbed-4078-8f4d-ce2858066b1c"
      unitRef="eur">142000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="idb5f65eb694a459d87948dc73311f144_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTItMS0xLTM2NDA2MA_414a236f-7ec0-4786-a96c-cbd55f69cd79"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="icab460a6e7e941308427a83c3d253601_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTMtMS0xLTM2NDA2MA_eabc7b42-c9cb-4ee9-be57-b988584de3a1"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i9e4cadaf5b0845cba7f9cde445b6c92a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTQtMS0xLTM2NDA2MA_0c719e44-63be-4b90-98c5-bc536e09ce01"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i900cd87f4c904d21a069da0f48a921a7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTUtMS0xLTM2NDA2MA_ece14a2f-9a49-48c5-9f45-7659ab83559c"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i8e3485983e3542ef8b9c5940a6e4d2cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTYtMS0xLTM2NDA2MA_a3f4728f-6d94-4afe-8804-0dbc5e68faa3"
      unitRef="eur">142000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2bd90408fdb848f4a168d4d2dcbc0549_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzExLTctMS0xLTM2NDA2MA_22c7be0f-2d01-476b-9251-ae2103ceac71"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i614be5021c604d959a144279ba0b4526_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTEtMS0xLTM2NDA2MA_51f8425f-4ebd-4cdd-b4d7-39e88c3728a4"
      unitRef="eur">130000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i5bae6aad36b1448fa535c41175f48601_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTItMS0xLTM2NDA2MA_182c69f7-b9d6-49f3-834f-8eac227113b2"
      unitRef="eur">4000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i7276b76a402b473f9e7c127ecbf662be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTMtMS0xLTM2NDA2MA_0b05cf09-109e-4117-a6f2-4b8d63d86a20"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i93c37d30370944a2826ff37e9d34e8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTQtMS0xLTM2NDA2MA_0cb07e7f-f71d-49be-88c3-1903fd46a5e4"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i589c2dbf17b348879dc721a9525fc177_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTUtMS0xLTM2NDA2MA_7c2667bd-813f-4ab4-98fb-458c0e70e9b5"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i50449c405d664c4dbd84b341ea3b257a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTYtMS0xLTM2NDA2MA_2840739d-6f90-4650-b6a9-bbcefddd8332"
      unitRef="eur">130000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i5ab17fcfc4d84fa99bdf75244c2ebf9a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEyLTctMS0xLTM2NDA2MA_d1acc2bb-6bf2-447c-bd61-578ca6663afb"
      unitRef="eur">4000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="iad4ce0de849d4cbab8c710e2aed2c4b2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTEtMS0xLTM2NDA2MA_4f35967d-8ecd-47cc-a457-8dddda3f6f32"
      unitRef="eur">84000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i0d052a4d832444a98b95347523810eae_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTItMS0xLTM2NDA2MA_ccbc00d5-71c6-412f-b5b0-3c0d22b3b518"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="iaf8f1eeaa8714aa7be4e39be402dcc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTMtMS0xLTM2NDA2MA_22ebfbb3-a0c6-46a3-b462-27508b6c2468"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2cfdfea2209d4ccbbc523a777b090e42_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTQtMS0xLTM2NDA2MA_e823b13b-994a-4e98-bb71-5a7fb7a3e0ec"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i90a937537aa44ba09a3f7643066da725_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTUtMS0xLTM2NDA2MA_37521cc5-08ed-480c-80af-1f606c3b763b"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i48b4da387756465aa5c44aacdc958949_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTYtMS0xLTM2NDA2MA_31310fbf-a2eb-4875-a768-939e9368631d"
      unitRef="eur">84000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i38fc2554622a4d10a204d1c010febc3f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzEzLTctMS0xLTM2NDA2MA_820f6036-2c8f-48c3-bfa5-c45fe398a357"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i48e2f84695a246b1b0d8229ae8e26267_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTEtMS0xLTM2NDA2MA_f9ee8548-3515-4cf9-9191-d22ae09bed1f"
      unitRef="eur">8862000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i922eeb9c64b04920a294d8178d09fe8b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTItMS0xLTM2NDA2MA_c1e14887-407f-444e-8075-2c183a7d4437"
      unitRef="eur">22000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i73a34cffa66544deb36e7732558b3762_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTMtMS0xLTM2NDA2MA_be4cda09-52ec-44d8-b328-5b28324aa435"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i97c8f085dafb45a2992095d4c7dae629_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTQtMS0xLTM2NDA2MA_6c0e237b-9c42-4ecb-bcac-15caeb4362c4"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i682f1cd2c61447218a7903da70602a00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTUtMS0xLTM2NDA2MA_3780ec94-8ec1-4bf1-a330-09fd6a8abdfe"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i16bad98d4d934e91a14f1d7988740778_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTYtMS0xLTM2NDA2MA_9417c64c-81dc-4085-96d2-b22cd27fbaa3"
      unitRef="eur">8862000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ideb5cf2c7c144e379dcc2ea51539478a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo1ODU1ZmMzMDNmZDM0NzNkYjg1MzNkNjkxNGZlMDIzNi90YWJsZXJhbmdlOjU4NTVmYzMwM2ZkMzQ3M2RiODUzM2Q2OTE0ZmUwMjM2XzE0LTctMS0xLTM2NDA2MA_997d2e8d-57a4-423c-ad6f-9b96f58de2ad"
      unitRef="eur">22000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="iee1024eeb9314f339e519f511c666ea0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItMS0xLTEtMzY0MDYw_b1cbc8b9-a752-41f3-b6b8-3f6a90793327"
      unitRef="eur">3912000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i5a170b12241f484083d21f6e5794807e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItMi0xLTEtMzY0MDYw_18f2d657-73c1-41e2-9a5e-53cc0d2cfbf0"
      unitRef="eur">4000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i1f9c05daae0d40f886aa6ba7000ba3ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItMy0xLTEtMzY0MDYw_eb281d51-0b17-47eb-a229-fa8a62bb0b43"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i64087778cca74bc4a526a10b569636b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItNC0xLTEtMzY0MDYw_4d5cd652-4886-498e-80f9-bd6ee8953d02"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i20618940d10145199825568865ca8d66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItNS0xLTEtMzY0MDYw_0b2822a5-bc20-4ae6-b7d3-c2be35e22b34"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i854bab973a0144a9aea65d7db2440733_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItNi0xLTEtMzY0MDYw_70bb02f4-cec3-42bf-a5b5-ed09ae4801e1"
      unitRef="eur">3912000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="iffcabbbf635b4fd992b8a41b9510b915_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzItNy0xLTEtMzY0MDYw_dc285cff-3df5-409b-be0e-8b08ba969170"
      unitRef="eur">4000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i4f2ea65d6c9a47f6814f3d31cd2df80c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtMS0xLTEtMzY0MDYw_15b7e78f-bdb2-43cc-ae3d-87980c44df8e"
      unitRef="eur">1392000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i0a1f01f9052d425aa69dcfe3b06dc17c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtMi0xLTEtMzY0MDYw_0fcf9673-fe58-4ddb-a3a7-bb870f501f40"
      unitRef="eur">5000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i183f0ed5ed164cb5b4ea5ee09dc73278_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtMy0xLTEtMzY0MDYw_1e797b30-4c34-4f2a-aef5-504ace6769be"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="idaf0eceeae6d4eeebbc0e8defaee5b65_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtNC0xLTEtMzY0MDYw_395029d8-61a1-45ba-b532-63b3a8fb324d"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ie2fe78b5e0fa46828e0f0ab6e8f5bd07_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtNS0xLTEtMzY0MDYw_1f8f08cd-2e01-4b2b-a0a4-0f965517d00d"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i0dc453015c43417f8a310403dafbf8fe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtNi0xLTEtMzY0MDYw_ebcd3854-a485-407c-bfbf-95ac9e4f2d4f"
      unitRef="eur">1392000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i07769fdb0fe34d908e96c647c0db6d12_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzMtNy0xLTEtMzY0MDYw_3328280a-e608-4cfa-a51c-7f8116eda95b"
      unitRef="eur">5000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="if36d1070ee9d4489a4cade29dd0771b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtMS0xLTEtMzY0MDYw_3d25df61-f925-411c-bb0e-707504babc82"
      unitRef="eur">665000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i384079b1f8bd40cca5b521eecc67173d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtMi0xLTEtMzY0MDYw_f2cbdfe6-6bcb-4d37-a0b2-4f3aa34ca178"
      unitRef="eur">-2000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id7d3fc2dde0f4fc1bd61c1025d30ee5a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtMy0xLTEtMzY0MDYw_d4219776-16d1-4dba-a8ed-85403e346c00"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2e1a8164b01f454a9ef85a1f93c00105_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtNC0xLTEtMzY0MDYw_1e0390b9-a7c8-4e43-ac0f-438573a80908"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i35ccacb194c94c69b5d085bc5ff5e589_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtNS0xLTEtMzY0MDYw_ab15fb6d-2d2f-48de-b089-3d771f97fc1d"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="if4fc30d0563c4651b04f28750beea307_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtNi0xLTEtMzY0MDYw_1ffcd02f-6947-40b7-bd0f-cd3ce3ec37ec"
      unitRef="eur">665000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="icc51c3a8b7fc41a092d0d1730df7f963_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzQtNy0xLTEtMzY0MDYw_0bdfafcd-2714-4498-949c-f26ba6ae12ff"
      unitRef="eur">-2000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ib7a90a0ef0ed4c3b8eb42178924b637d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtMS0xLTEtMzY0MDYw_6bc34a48-16e5-44ff-a2ba-bc1de485b959"
      unitRef="eur">355000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i471fcc10e8564dd98a67fb349fdc3a8e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtMi0xLTEtMzY0MDYw_036cc176-807d-4339-8798-a0a19449a9ab"
      unitRef="eur">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i18559c6c0cb3430ca0132b84801f9e99_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtMy0xLTEtMzY0MDYw_722d2143-137e-47be-81fa-3e84bc4d9830"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="iac26642cffbd4b2999baeeb3a1685db5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtNC0xLTEtMzY0MDYw_9b8d0817-11cf-46eb-bd90-4dd01ca76b4b"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ib23b2da676d5492e802ac4c812a506f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtNS0xLTEtMzY0MDYw_9c0c79ea-7bd9-4904-a944-f811726e602e"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i5da383083c0c4afda0ee7c969ad8b27f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtNi0xLTEtMzY0MDYw_b5d79e8e-f134-426a-81df-d2a98d17f1ad"
      unitRef="eur">355000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i6dada3962cd44c1da2ef4a630f6b1ed1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzUtNy0xLTEtMzY0MDYw_33a2a508-308d-4f1e-ad4e-90a2649008ca"
      unitRef="eur">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i434e5e043aa94881a6a3e2eedff9adc9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtMS0xLTEtMzY0MDYw_e109d0f3-71e6-4305-9660-8927dc6169ad"
      unitRef="eur">199000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="if34f2b53c7d045a18844b31f4a900e41_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtMi0xLTEtMzY0MDYw_74e71daa-622c-49cb-84af-ad581cc3cd06"
      unitRef="eur">3000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i894a76d0d7de48e58253294db3627dac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtMy0xLTEtMzY0MDYw_01f98019-4887-4405-bb0a-482615c47cae"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id9c39b6d14e84ae4b1b24e007a9e3786_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtNC0xLTEtMzY0MDYw_ba80d230-03aa-4710-ad07-88c3aec792b4"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="icc12122f258749a5bd2e6732f1d304f7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtNS0xLTEtMzY0MDYw_5be5407d-7234-4891-a126-ebd28d04c8c7"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ida1a51f00f9f43e2addea3cff1a8fe07_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtNi0xLTEtMzY0MDYw_5407fc5b-4c6e-45a2-ae0a-701e21bb493b"
      unitRef="eur">199000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i5281a2a2dd074a66a4481d353042fc10_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzYtNy0xLTEtMzY0MDYw_416ec122-783f-45ae-a2ce-5b79a5d0db99"
      unitRef="eur">3000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i930fc256127049c79f51ecf59663a752_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctMS0xLTEtMzY0MDYw_8ca0aa18-26c9-4cc9-936b-9e646d5eb66f"
      unitRef="twd">122000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id5f5c206bbe041ae839e26cfe2a55dd9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctMi0xLTEtMzY0MDYw_202c5923-f380-4037-931d-e7321d625675"
      unitRef="twd">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i837cfe78d2b645d98705c95b25994752_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctMy0xLTEtMzY0MDYw_07f6d2c3-f149-4cb9-97ef-e92db5573d1a"
      unitRef="twd">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i7ab3ed6ee531495f95aea44cf44b1526_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctNC0xLTEtMzY0MDYw_4d43a1ad-f848-4b92-988e-fc05f5272ad4"
      unitRef="twd">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i6e0e7ef8f62a445ab7615b93e8c6e5b5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctNS0xLTEtMzY0MDYw_ee5dff43-55df-406a-9e10-051e0e4ae088"
      unitRef="twd">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i3ebf4555124a4b54be1588e86a3da403_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctNi0xLTEtMzY0MDYw_358825be-26c0-4fe9-bff4-13f29a0c5d97"
      unitRef="twd">122000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i193a8989856645a48abe7f92509a5f9e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzctNy0xLTEtMzY0MDYw_242bd023-7ba6-45a9-a9e5-3a59012891dd"
      unitRef="twd">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ic80c137f25e045a9822774580063fe84_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtMS0xLTEtMzY0MDYw_2e8e6778-077e-42db-87d2-db86cab97522"
      unitRef="eur">2374000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ia18a712428304812b70e53d9693ee063_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtMi0xLTEtMzY0MDYw_9d405723-19ea-4195-b49e-db87c748bbcc"
      unitRef="eur">6000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i7109eb1c65b04a438909883fca4c7d28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtMy0xLTEtMzY0MDYw_5c6da555-937d-41be-873c-872f8930f7ac"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ic5f09375512f4606be23527c48462237_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtNC0xLTEtMzY0MDYw_5bc38de3-9d66-4fd0-9fde-15b022d39242"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="if2cbb135c3a0433ca0c3b69c5501968f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtNS0xLTEtMzY0MDYw_619126c6-da6b-45e6-a141-f0c967afdcca"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2a0830338f724cbdb4b9b9bfd6adeda3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtNi0xLTEtMzY0MDYw_8bd86792-ad47-4ae8-9cda-b329530e76aa"
      unitRef="eur">2374000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ia56a7d86f76a4d05b6d08eae7ee6f6bd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzgtNy0xLTEtMzY0MDYw_067cc671-d4e3-4d26-88eb-d3eefad9698b"
      unitRef="eur">6000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="if71d9bd7d43e496e93db1925af2e1b60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktMS0xLTEtMzY0MDYw_46d39f2c-6f0b-4b10-9c0f-446d77735a13"
      unitRef="eur">833000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ic2a16b777ba940a4ac181e8a001d2faf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktMi0xLTEtMzY0MDYw_122165cc-4476-4fef-8781-6b87c76a1729"
      unitRef="eur">-2000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i4903495579f44e64ac57f0cc1e2d7ad9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktMy0xLTEtMzY0MDYw_4a7f37c9-0f30-46c6-8fd0-a66a0bb1ba62"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="if2c01ed8a41d4db787af4ee204db1fdc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktNC0xLTEtMzY0MDYw_1e3a16ed-0f35-451c-bd84-ef732d00464d"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="iec6eb2436d6e40a0a872d2bbf400d795_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktNS0xLTEtMzY0MDYw_e45b82f8-9497-4222-b3ad-a2ddb1caebeb"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i8106356ac1984ab9be68b54b74eb94cb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktNi0xLTEtMzY0MDYw_5f76e0eb-fb04-45ff-9a00-08f791b251f2"
      unitRef="eur">833000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ica7586eadbbc44c880e8d163aad962c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzktNy0xLTEtMzY0MDYw_23fe358e-f669-4c3f-b9e0-95e6a0bbf824"
      unitRef="eur">-2000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i044093d165864adcae409f5f0044ffbf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTEtMS0xLTM2NDA2MA_147a067c-8329-4b72-8d11-da68a6bd8ad4"
      unitRef="eur">696000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i51dd419d2cd9485bae987d880a7bcdf0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTItMS0xLTM2NDA2MA_8a9efba9-605b-4b0f-9eb5-17ecb3fb2b3c"
      unitRef="eur">7000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ia5324129041d4c7a8cffd51b410c8dff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTMtMS0xLTM2NDA2MA_ca84f517-12e7-47a8-b6d1-9379daa7cca9"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i302a876c87b44ee3a7af953022d71a40_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTQtMS0xLTM2NDA2MA_961b6ad8-51f3-4d79-bb55-383732406636"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i3825d70a3a964b628a2d61ffeb07d222_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTUtMS0xLTM2NDA2MA_ef3cfacb-6cd7-4073-a54b-9a745a659473"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i10d98c3b5e3140ec951a12de228261fc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTYtMS0xLTM2NDA2MA_24556685-c5e7-466d-b050-b64c7aa787f4"
      unitRef="eur">696000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ibacaf6d36f6a46e6b159f5aa7231b80f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEwLTctMS0xLTM2NDA2MA_5db95563-a05a-4301-8990-6f30373356f5"
      unitRef="eur">7000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i36c63ba9c19349b1b82e245f1b2c64d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTEtMS0xLTM2NDA2MA_870c8315-2ade-44bb-b678-fdb00fee230d"
      unitRef="eur">255000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id0abd8e7f1e841f7ada74773a2015b61_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTItMS0xLTM2NDA2MA_fff29a34-9b77-4080-8d19-3232e3272f09"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ie1c9d16b1d5543db83b717cb805a3054_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTMtMS0xLTM2NDA2MA_e0f5c36c-3cb0-46e6-aa81-5c33373145e2"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ie53d539627af4726a35780f1cc08e507_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTQtMS0xLTM2NDA2MA_ad1dde83-4d3a-42ca-924e-f41c109e8423"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id73c46ce75c74139a8bcba359c49f997_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTUtMS0xLTM2NDA2MA_33b2952a-8230-490c-a268-06b69843c784"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i456a2daa913c419c8e6c1a03257e474e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTYtMS0xLTM2NDA2MA_58ae4ede-95a8-4787-8836-cfba94bf39a9"
      unitRef="eur">255000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ifbca91ac9abf4c87a69b47abbd03d727_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzExLTctMS0xLTM2NDA2MA_74a3dd69-3906-4bcf-9be9-f7c1d8cec4a6"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i3e4f8aee86404215976b9646e9d9edb6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTEtMS0xLTM2NDA2MA_308daaf9-9029-4d5b-b14d-25fd2ca9691e"
      unitRef="eur">77000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ib9d14b72ec254084ba3095230da92d21_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTItMS0xLTM2NDA2MA_65539509-fa37-436a-915c-d630077e43aa"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i4f99799f7a8d4e2d84ecd1fff82653b5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTMtMS0xLTM2NDA2MA_3c46a1d2-c2d4-4eb4-be34-07408f5c911b"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ibd3753fbe0a74c589d523cfd5c6b89fc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTQtMS0xLTM2NDA2MA_54ce0978-aa9a-4c2d-88ed-7f2281431650"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i054783a0dd0a4f84aa2d451d39159d7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTUtMS0xLTM2NDA2MA_b432b6f6-c481-4b10-9a48-cc9ca69ccf23"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="icad712c978144c3084e0faa45a0c85ef_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTYtMS0xLTM2NDA2MA_ed8a8be0-e983-4182-ab0f-9dbac495a965"
      unitRef="eur">77000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i4b8b8a03c8b14a00b47b0e84291b29d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEyLTctMS0xLTM2NDA2MA_057df03b-e4ad-4610-af6d-628c25d46bfd"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i9928943949d54771ad5e72bd36d1e3ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTEtMS0xLTM2NDA2MA_6eb966cf-d40d-49bf-b56d-6fa7f1efed4f"
      unitRef="eur">72000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i6586fee6173645e78e13348b13791844_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTItMS0xLTM2NDA2MA_6f1dda37-5be5-4c55-a70d-fe0d8b9d912d"
      unitRef="eur">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i545bd8a737bf4fb3af3076a7c330b2c0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTMtMS0xLTM2NDA2MA_c083adc2-f633-4d4a-94d1-17e9a7c217e9"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i602ce8f41d414b48b5a84661a31d706c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTQtMS0xLTM2NDA2MA_7cc6a5db-d5f6-4fe9-b077-a654c6487683"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i027058e0a496449eaf197cdfafc45b2c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTUtMS0xLTM2NDA2MA_f9c1f160-f239-46af-961e-81ecdad89238"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i34b226c1622a45528a50ce7d8f2d8fb5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTYtMS0xLTM2NDA2MA_2f352d43-2ae6-489b-847d-ea188042f009"
      unitRef="eur">72000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i73141eca736d4bc5afd3a96cdac8bbef_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzEzLTctMS0xLTM2NDA2MA_25d6211d-154f-4a9d-a213-deee9a3095f8"
      unitRef="eur">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i56bcc4da86dc4c3e9d1f700ddb1fbd10_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTEtMS0xLTM2NDA2MA_a1d9cf27-c10d-496e-a71c-4c225c80707a"
      unitRef="eur">6286000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ic6fbda346e6a493cb16800f488f83cc2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTItMS0xLTM2NDA2MA_0a983f28-2576-4b90-bcd3-5b8c40cf30c3"
      unitRef="eur">10000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ib6ea9e1f7b784baea9d9e983ef781098_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTMtMS0xLTM2NDA2MA_2f0478fd-f63d-42fa-8b6b-a58e11d13636"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i0872c944abfa45428950a1bd06308fb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTQtMS0xLTM2NDA2MA_a5e87aea-b23f-4de0-9a4c-1603c85390f1"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="if75a6d9165a94a1cbf4f47aa2183cdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTUtMS0xLTM2NDA2MA_c447af7a-e383-438a-926e-6a9bb478af55"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ia6b4d5b53fda43ea851ebdc43262033d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTYtMS0xLTM2NDA2MA_2daa2880-db3f-4847-ba08-26f51452a523"
      unitRef="eur">6286000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i95d0c7bc51184d8e8639aa78338ad663_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTpjMDEyOGQzODk4MWI0Y2VhYjAyNjA5NzA2NzFlZWRmZC90YWJsZXJhbmdlOmMwMTI4ZDM4OTgxYjRjZWFiMDI2MDk3MDY3MWVlZGZkXzE0LTctMS0xLTM2NDA2MA_3013f870-b639-492d-95c2-9c7548ff4709"
      unitRef="eur">10000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i4c5ef4bfd1f14291bfa73144e9052516_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItMS0xLTEtMzY0MDYw_2266e871-d443-49a4-b708-178ad48eb90e"
      unitRef="eur">3477000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i486d9cec4cb24d9da261820e6f2216cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItMi0xLTEtMzY0MDYw_2ab0ee7b-de8d-47b8-b5cb-fc9991309222"
      unitRef="eur">7000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ib51cb586079a4e04bbd72dcec69da0bd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItMy0xLTEtMzY0MDYw_b0a8648c-3c93-4220-acda-9b633f1acfc5"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i5697cb7cf4d04dfc8add48c1c94cbbaa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItNC0xLTEtMzY0MDYw_ce743d45-e0ee-444f-a711-4c40b8cbc1ff"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i34aa0682772c44b4a0ff76dc79d28958_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItNS0xLTEtMzY0MDYw_167cf99b-e7e6-4b64-a000-760bc271f9ea"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i0a8cb6cb5af547b28dce285b9c653502_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItNi0xLTEtMzY0MDYw_13392a45-8936-47fa-bc3b-39a948a9e2be"
      unitRef="eur">3477000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i3e76f8051bde43d3a56dc6270370a1b2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzItNy0xLTEtMzY0MDYw_5bda88c1-1294-4743-9720-0dfae47f0760"
      unitRef="eur">7000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i147b071b30a142d6810201f12247d61b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtMS0xLTEtMzY0MDYw_defa79d7-339c-4b26-9720-3542f5165be4"
      unitRef="eur">1367000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i9f071c0f18bd445eacee2517362cdc08_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtMi0xLTEtMzY0MDYw_8fd5327b-4ab5-44b8-8f6d-16098d9780de"
      unitRef="eur">10000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i181e7ef5bdff4cf6876e51eea6ca820c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtMy0xLTEtMzY0MDYw_34bdd684-8c94-4247-8966-134bd7062a63"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ibf14d2129bc34c2bb2bdb6c97085b4d8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtNC0xLTEtMzY0MDYw_288a6228-24c0-4b14-b7a4-400bcfe4d9b8"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i3db42c94517e4705b4da1eed3d57e340_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtNS0xLTEtMzY0MDYw_0b178518-a45a-4b53-97f2-2afbfdcca55a"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i252c5890b2344a738c0f89c1f5f5c87a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtNi0xLTEtMzY0MDYw_43f52bc1-b91c-494a-85f0-fab31a19edeb"
      unitRef="eur">1367000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i4346d9e3152d432bb116ca1410c35048_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzMtNy0xLTEtMzY0MDYw_f3019df0-39c2-42c4-9eff-5cd1ca10f862"
      unitRef="eur">10000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2a69b4b219ce4e26a3a79c96b68b5c95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtMS0xLTEtMzY0MDYw_01012951-b434-415d-b54e-768a15c5a621"
      unitRef="eur">521000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id227c1ffc144495b9c6a929875311feb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtMi0xLTEtMzY0MDYw_f0541911-d20f-4acc-bc56-a01a5927f137"
      unitRef="eur">2000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2257aad4e93045328f47a96258ab2005_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtMy0xLTEtMzY0MDYw_129be358-7ef6-45b3-85d0-341a95967711"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i4037de80178a4bd687c7efac29bc15d5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtNC0xLTEtMzY0MDYw_79949615-cb7c-4463-8fd5-dd27912746da"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ia4f7f8938c7042c39938f0852b1bca3a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtNS0xLTEtMzY0MDYw_0bcd07d2-c9fd-4686-bd55-c6ecd14bd329"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i89025c2ce61749fe87850d73eded6ec2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtNi0xLTEtMzY0MDYw_e083c84b-3137-44e3-883d-9c422e474015"
      unitRef="eur">521000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i9be9642933af42f8b0cd6d23298b5018_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzQtNy0xLTEtMzY0MDYw_8a7622f8-b12d-41f9-832c-2918bff56042"
      unitRef="eur">2000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i4ae1d237af784d4f8fa137d708f60517_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtMS0xLTEtMzY0MDYw_ae393912-0414-4665-b084-9320cddf8c4a"
      unitRef="eur">287000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i1ffbb59d6cc44d84854b689b538ed0ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtMi0xLTEtMzY0MDYw_48832345-8279-42e9-a024-aa285f092779"
      unitRef="eur">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ibae1a4d3dba24ffba6d892dbaa92e78a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtMy0xLTEtMzY0MDYw_bf16c9a6-2766-481e-b6a1-3da49587467c"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2d0474adac6b45b1a78fc524e09f71de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtNC0xLTEtMzY0MDYw_1c062039-5962-4906-96c6-78f504e3cd95"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ibc5ec7415a4f46fd80b575baa7648a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtNS0xLTEtMzY0MDYw_098ed3b7-0562-4bdb-a1a5-6c5fe4645551"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ief09a86e6cd4415eb08a6914a33e295b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtNi0xLTEtMzY0MDYw_1f10bb6d-03aa-4395-8334-4774d4e41fd9"
      unitRef="eur">287000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="if4ccb84c532546b9b5869e4d9f81c989_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzUtNy0xLTEtMzY0MDYw_7b87bf72-d55d-4e9d-a0e4-f6d491b6e3b7"
      unitRef="eur">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ic7b4d7c8c509402c8eca5e791875f3c9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtMS0xLTEtMzY0MDYw_b64219f2-99bf-426c-8211-c3ce75340d12"
      unitRef="eur">143000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ic3431bfe1daa41098f327267164dd835_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtMi0xLTEtMzY0MDYw_a102bc23-bae3-4a31-ba1d-147e5b15a77f"
      unitRef="eur">1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ia9e5de3ab1f64c9ab3bdcb2c553d1039_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtMy0xLTEtMzY0MDYw_c6e7995e-e1cb-4678-bf0e-cc8df8a8aa8b"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i27152c3f2bae46278e43f8d1a81dd8f1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtNC0xLTEtMzY0MDYw_9f550ccf-e088-42bb-8bb7-ac630c0385b0"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i840dda0508654caba7f51026ebdafdd4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtNS0xLTEtMzY0MDYw_ec6f9527-f0c5-4fa1-b78a-73b79fee5ac6"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i6d0481cacd274b2fa681c5bf9890a2b7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtNi0xLTEtMzY0MDYw_54fad63d-93b7-447b-8309-1c5b591a599f"
      unitRef="eur">143000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i3906596ab71d4692bfd9c38d60ea6188_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzYtNy0xLTEtMzY0MDYw_cdb6d7ad-7194-40ea-97ca-614823fc6ed2"
      unitRef="eur">1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i58183268ba544f91b20e9bc30b6797b1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctMS0xLTEtMzY0MDYw_5e53268d-0d76-45b2-9821-89ec43061812"
      unitRef="eur">121000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i1f96ec8ab49a456fb96eb444552e80b7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctMi0xLTEtMzY0MDYw_751e9c53-a222-4d88-921b-3f54ec025441"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ia344078238f4464196932e8c0a5ab334_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctMy0xLTEtMzY0MDYw_f3406888-3228-4f8a-b485-e08cfeb78dfb"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i68cf8057519245799cdf12687b2a6f93_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctNC0xLTEtMzY0MDYw_25a20743-5dc5-41fb-9208-814a3be55317"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i37726d73b17249feaa902d38b48653b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctNS0xLTEtMzY0MDYw_287c9197-14c2-44f8-8187-1ec15bd86bac"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2c91d2ed118d4954bc375ef4b66d5e48_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctNi0xLTEtMzY0MDYw_a0250001-e75d-4fff-b306-683a4506d037"
      unitRef="eur">121000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i7e1cdda7b2be454db539353df19db57c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzctNy0xLTEtMzY0MDYw_4aa0cd72-80c2-4899-8296-8696bfbae461"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i5bc3cb9493e1444f82f06a80cb7a29d5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtMS0xLTEtMzY0MDYw_d5ced4b5-f7b5-4594-b7a6-a7d34369245c"
      unitRef="eur">1932000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="idf56910613674139b60ad8c9e882447b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtMi0xLTEtMzY0MDYw_33a71c5a-ceaa-4c44-a771-e3fdffb6d6a0"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id7a02300cd2f47f99a98237e0dd5a58f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtMy0xLTEtMzY0MDYw_5c39f8c3-23a3-4dd7-9d28-5392ce7954eb"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i07e6a5b18f544c01aaa9836f457f7bd1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtNC0xLTEtMzY0MDYw_4d90c5df-98fa-4270-aa22-da2a54a8c222"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i1195cba0e9c94a3699b59f45259287a5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtNS0xLTEtMzY0MDYw_7610cc37-ee46-424b-b589-b403646e2355"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i6dda0ea5c90b4325865f424eeb8327d3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtNi0xLTEtMzY0MDYw_8e9cd712-ab7c-4b92-9fe2-8604d2929049"
      unitRef="eur">1932000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ia8e6703b549e47efa32fac9619c9ae51_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzgtNy0xLTEtMzY0MDYw_e439df81-fb0f-47b3-821b-ffc9e200e3f2"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i6bdf7cf5cfbc4d09bc7c7ce7da7a3262_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktMS0xLTEtMzY0MDYw_b04554be-998e-413d-8b92-e27c3ac1684b"
      unitRef="eur">580000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id0415e276f844457af7bd49394e36866_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktMi0xLTEtMzY0MDYw_9daa001b-0a21-4f42-83a8-ae4f3c0795a5"
      unitRef="eur">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i99eef181a9e24ffc834f4feda4476a7a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktMy0xLTEtMzY0MDYw_6633d993-706a-48ce-abe5-cffa9ca95372"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i1c698af52bd241a89b377b3e2aa21704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktNC0xLTEtMzY0MDYw_58df45a8-7527-43c3-8cff-759abde8efef"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="iba0b876a446f49b586a44a97e9d18648_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktNS0xLTEtMzY0MDYw_c4dfd284-bfa5-4df9-994e-0de8fa40447c"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="iace2c7895f8f48599dab84606e9dce17_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktNi0xLTEtMzY0MDYw_1ecfc684-526d-40e6-ae28-bc2e4c1fe137"
      unitRef="eur">580000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ic5e4d74fde564a0c9ea5bbbc53197031_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzktNy0xLTEtMzY0MDYw_8a7690e8-0571-4f29-85ea-3c5ed81f3f8d"
      unitRef="eur">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i7921f1ac6904419daeff3fe087f5224d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTEtMS0xLTM2NDA2MA_844c1248-fcdc-44c5-8c32-dbef052abe26"
      unitRef="eur">571000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i88dee4ccc2704017b2c902c331437292_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTItMS0xLTM2NDA2MA_04f52af3-45cd-4866-9b3e-8cd723132735"
      unitRef="eur">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i8d6d099311ed413981c361852e147d39_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTMtMS0xLTM2NDA2MA_ef8e2c9e-83a3-4a26-a5fe-d3096f045230"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i47fd53236cf54f4f82c3f29a86f18f6c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTQtMS0xLTM2NDA2MA_1d53dce9-2ae9-4756-a712-4fa08d8e5a6c"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i3d03c5a45fb74275ad0ddab937a7a0c9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTUtMS0xLTM2NDA2MA_ed1092e7-d81a-4fb1-89b5-087699186a43"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i03f818d2869744ecb3692c1dfa0777b2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTYtMS0xLTM2NDA2MA_66b03b94-34d8-4081-9b06-30aced9329f4"
      unitRef="eur">571000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i87c7d8e2747146e2801b216c717facb7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEwLTctMS0xLTM2NDA2MA_43864e9a-8455-47e9-9680-dd5c6611a387"
      unitRef="eur">-1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ib05e9a15a2a54bceb63e80175a9eb481_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTEtMS0xLTM2NDA2MA_35eb77f2-59e4-435d-a96e-e69b96012217"
      unitRef="eur">286000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ib2acba41953a4a5780da364938d0473f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTItMS0xLTM2NDA2MA_6eb0ff43-a368-4497-9f5f-b2aba8166a6c"
      unitRef="eur">1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i82128cfb81e44472a2b78b3caf2eeef5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTMtMS0xLTM2NDA2MA_64590731-7b1e-42c3-8f4f-7b91ca0c5519"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ie7e05b379fae4bec9455bd5a1185a73b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTQtMS0xLTM2NDA2MA_5f1e5b85-c26e-4920-9919-fa924f8e7f61"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i5f9e8576bdae4d2f82d0d3347ee01107_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTUtMS0xLTM2NDA2MA_917ddcfd-0e9a-4326-abb9-a511e309b4ea"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i050b28520fab4a6f9bc88d51dfbef06a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTYtMS0xLTM2NDA2MA_1e5b92c7-7a21-4b7a-844a-7d5ae3fdd8e1"
      unitRef="eur">286000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i3ab71783130b4442bcae86e594469499_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzExLTctMS0xLTM2NDA2MA_835c10c9-5bda-4d47-985a-4d36180857f0"
      unitRef="eur">1000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i15ed755082ec489cb3e55190fe799c9e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTEtMS0xLTM2NDA2MA_033ccdc6-1f2a-45c2-ad7d-18b4b6464824"
      unitRef="eur">61000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2cb3114c2cfc4748bb24e171ddf88d3f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTItMS0xLTM2NDA2MA_d4759c1d-80b6-48df-a835-7b1bbdb238c2"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ib3fce9cf02c444aeaedf9dbb530518b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTMtMS0xLTM2NDA2MA_ff96b6f7-35ea-4dbb-819c-3a480dbaf655"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ib880c2e4796e464d9fd6ca3f922f0c21_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTQtMS0xLTM2NDA2MA_6a43fb6b-9024-4858-8b4d-4119afad0167"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i6dc8281e891142dc8ce362dd453c8adb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTUtMS0xLTM2NDA2MA_a2ce5bb3-7b8d-4c3b-96d4-0d9c9fadb073"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id6854f04e5b34f0a90f6a8809433364b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTYtMS0xLTM2NDA2MA_7947d3c7-b142-49f3-8e14-0b87f2d5709a"
      unitRef="eur">61000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="ide85e2c1b3c54f9b982f9dbd2e31dc36_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEyLTctMS0xLTM2NDA2MA_a7750089-4231-4fae-9ed6-1e775d063cf8"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2c053f5646db456cb456a7f6cab34418_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTEtMS0xLTM2NDA2MA_43f17dd7-6113-40ea-8422-0b33a48184a3"
      unitRef="eur">55000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i256e776c3ef949d8a602d77944076c95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTItMS0xLTM2NDA2MA_b452a82f-a347-4b33-b7b2-8394743a96a5"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i669dc41a3e9d430285a05154e6987cfe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTMtMS0xLTM2NDA2MA_3fa7db3a-ff61-422e-996d-83e26c4f655d"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i9f760561a25c455ca863173bc85ba050_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTQtMS0xLTM2NDA2MA_1530ab67-13ef-4457-aa28-822376384e2c"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i1f736a955d6d426fa14bccb7f20423fd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTUtMS0xLTM2NDA2MA_783601f9-815b-4a4e-9a42-dae01655d4c8"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i27e3afc8cd9a466b85b73154f1fcc426_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTYtMS0xLTM2NDA2MA_2a96f860-1ac7-4430-957f-7a5aa0eff95f"
      unitRef="eur">55000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id8b931a3e7974af8baab435cd83f842c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzEzLTctMS0xLTM2NDA2MA_07e92dba-a12c-4ffe-b344-d23d9239ab33"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="id6ee14014d724beba49280ee27bd0579_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTEtMS0xLTM2NDA2MA_dd029795-767a-4427-8508-cd0b6dfab56f"
      unitRef="eur">5409000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i079d026d077e4c1ca6b37005c231329a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTItMS0xLTM2NDA2MA_055c9a93-0e6c-4c90-8f66-7aca45cfe4e7"
      unitRef="eur">7000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i6bf8f4e0a00a442d95a5b6f57d0965db_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTMtMS0xLTM2NDA2MA_1470878b-15d9-484c-b167-e7f0eef1b16f"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i8dbfe93bcc924f1db627a13c4e7d0036_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTQtMS0xLTM2NDA2MA_158fa0b1-c423-4606-a98e-94aab68bb686"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i5129bf60276249ea8a7084e5aa6f5c82_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTUtMS0xLTM2NDA2MA_6eb47db2-bbe9-4b7d-8a5e-66349634510f"
      unitRef="eur">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i98b58c7d8626470da2fc804347bb6886_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTYtMS0xLTM2NDA2MA_b9c1a386-7d66-4c61-a210-907e3a7ca7f4"
      unitRef="eur">5409000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="i2960e5bbc9504987a45ca0885c28f42e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTphYWQxMmZlMWYxNDA0NGUwYmRhMjIxZTEwMjg1NTNkNC90YWJsZXJhbmdlOmFhZDEyZmUxZjE0MDQ0ZTBiZGEyMjFlMTAyODU1M2Q0XzE0LTctMS0xLTM2NDA2MA_5a49cf8f-2cfb-4de9-9ac1-c9cf6fd0f5eb"
      unitRef="eur">7000000</sny:DerivativeFinancialInstruments>
    <sny:DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MTQ_8603fb9e-3f3e-47e1-aa42-f8b17cab2dbf">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows financial currency hedging instruments in place, with the notional amount translated into euros at the relevant closing exchange rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiry&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiry&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiry&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,559&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,655&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,064&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;6,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;5,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;3,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Pound sterling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Chinese yuan renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Forward currency purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,997&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,293&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;197&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,004&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which US dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%"&gt;(b) (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;4,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;6,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Singapore dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which Japanese yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,556&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;90&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16,948&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;212&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,068&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes forward sales with a notional amount of $3,615 million expiring in 2023, designated as a hedge of Sanofi&#x2019;s net investment in Bioverativ. As of December 31, 2022, the fair value of these forward contracts represented an asset of &#x20ac;38 million; the opposite entry was recognized in "Other comprehensive income", with the impact on financial income and expense being immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Includes forward purchases with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of $1,000 million of bond issues to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of &#x20ac;3 million, the opposite entry for &#x20ac;0.6&#160;million of which was debited to &#x201c;Other comprehensive income&#x201d; under the cost of hedging accounting treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Includes receiver currency swaps with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the swaps was a liability of &#x20ac;2 million, the opposite entry for &#x20ac;1.4&#160;million of which was credited to &#x201c;Other comprehensive income&#x201d; under the cost of hedging accounting treatment.&lt;/span&gt;&lt;/div&gt;(d) Includes forward purchases with a notional amount of SGD1,500 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/SGD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of&#160;&#x20ac;33 million, the opposite entry for &#x20ac;2.5&#160;million of which was credited to &#x201c;Other comprehensive income&#x201d; under the cost of hedging accounting treatment</sny:DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i2c02fd8df4a441dcb9995176d3a629bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItMS0xLTEtMzY0MDYw_0853c04e-4ae0-4385-b032-6d0d7236bde9"
      unitRef="eur">7559000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i72c3586a9fd0496ba3bc0f02039968e7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItMy0xLTEtMzY0MDYw_7537530a-8c94-4b7f-bdc5-69be8eb53b43"
      unitRef="eur">66000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="iee1024eeb9314f339e519f511c666ea0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItNS0xLTEtMzY0MDYw_4d986e78-cce8-477e-ad06-c1fe907cddb7"
      unitRef="eur">7655000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i5a170b12241f484083d21f6e5794807e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItNi0xLTEtMzY0MDYw_6b0b5916-b207-4bff-a543-27abb0f9cace"
      unitRef="eur">15000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i4c5ef4bfd1f14291bfa73144e9052516_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItOC0xLTEtMzY0MDYw_dd7a881a-3808-4dec-bc86-ac029ed3784f"
      unitRef="eur">5064000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i486d9cec4cb24d9da261820e6f2216cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzItOS0xLTEtMzY0MDYw_d27f4099-082e-40cc-83e9-a90b5dcd8349"
      unitRef="eur">10000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i9bbbfeca962641258e5e78ffca35be1c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtMS0xLTEtMzY0MDYw_a4b59e0d-e19e-4648-9aea-c8ca774c4644"
      unitRef="eur">6114000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i2efe7553ba0c46a08b7712adb8057d20_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtMy0xLTEtMzY0MDYw_fabaa311-955f-4975-bc47-edcec02c650a"
      unitRef="eur">59000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i8ea8eeea954c47c9a00eb5c671577819_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtNS0xLTEtMzY0MDYw_a6868c96-0b99-4e12-a2e7-9b5665e7efae"
      unitRef="eur">5384000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="id972eac7d0f34a4a884e97419ab42e7b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtNi0xLTEtMzY0MDYw_349bb58e-d49b-49a1-8c9d-46fc2df85517"
      unitRef="eur">23000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="if037f28f69f94e49ae8653fe85139f4f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtOC0xLTEtMzY0MDYw_ae2e7580-2e54-4b98-a542-f33aa1cfdaf4"
      unitRef="eur">3721000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ib1df7d3e3f334428885ea11342334450_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzMtOS0xLTEtMzY0MDYw_645786f6-dde5-48c4-9e7e-3ad9fc9423b7"
      unitRef="eur">20000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i6a8231394bbe4689b1cbffe0f2e8bd63_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtMS0xLTEtMzY0MDYw_2cd38e3f-f532-472e-b178-ba2c37f37427"
      unitRef="eur">384000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i1ca8b2205d5e44f28738ffac6b5a6556_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtMy0xLTEtMzY0MDYw_94b46dcb-02d2-47e6-afc2-7caf2c3fd706"
      unitRef="eur">7000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i004c9565807d44089939621542e2100f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtNS0xLTEtMzY0MDYw_da8d8cf9-0d45-4f37-8cb9-38189ed9b888"
      unitRef="eur">309000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ica05527dd8e340a49bb52e01b20aa348_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtNi0xLTEtMzY0MDYw_895166c1-49e9-4733-8858-79ef8be97fa1"
      unitRef="eur">-2000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ie6009351116f4a2c9676eee17f694438_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtOC0xLTEtMzY0MDYw_612ba90c-2436-4f42-8d77-13c86b52af3d"
      unitRef="eur">257000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i861fbccf765e48598186ff8685f2297a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzQtOS0xLTEtMzY0MDYw_28fcbfab-2c85-4f01-926c-8f1ec995a9c5"
      unitRef="eur">-6000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ic28b8006d92e44a99432611f84570817_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtMS0xLTEtMzY0MDYw_02d94db3-2758-4b9a-a86a-b04ea7cfab3d"
      unitRef="eur">203000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i8eaa77b9d15142e09240ccba86255414_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtMy0xLTEtMzY0MDYw_efb5cb7e-0ea9-41b3-8787-4325129784f1"
      unitRef="eur">2000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i64c5dbb2401d4d34a576efb6df99ddf8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtNS0xLTEtMzY0MDYw_141fd8b5-8ab6-4664-9996-a6acc035e269"
      unitRef="eur">70000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i6ecb8839526441e789fcc73987406208_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtNi0xLTEtMzY0MDYw_95499462-8990-4251-b604-a4667181ae18"
      unitRef="eur">-2000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i94437cc84d09476a840a8eb6ec207dae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtOC0xLTEtMzY0MDYw_ff668bb1-57d4-48d3-b9b6-f2c624de6309"
      unitRef="eur">26000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ic79ef551074942af9ecbdc5716db6ce2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzUtOS0xLTEtMzY0MDYw_2600052d-32d3-470a-a914-aee575c49fd4"
      unitRef="eur">0</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i7d7af22b9f714cb2ac911c16230f1007_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtMS0xLTEtMzY0MDYw_6b77bcf5-ff5e-43fe-a918-0b03050e4d23"
      unitRef="eur">4997000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="id027bcc05cc942509383921729fab6a8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtMy0xLTEtMzY0MDYw_b3be0f1c-d1ca-4629-a0fe-4737017ffa12"
      unitRef="eur">24000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ic80c137f25e045a9822774580063fe84_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtNS0xLTEtMzY0MDYw_7670dc1e-d157-4405-932e-4f318d2f5d60"
      unitRef="eur">9293000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ia18a712428304812b70e53d9693ee063_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtNi0xLTEtMzY0MDYw_6f12f799-bb03-4505-8e5b-0ad97b195c4a"
      unitRef="eur">197000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i5bc3cb9493e1444f82f06a80cb7a29d5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtOC0xLTEtMzY0MDYw_d0af4cd4-be2c-4f37-880a-6ce3d1bd1a0e"
      unitRef="eur">9004000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="idf56910613674139b60ad8c9e882447b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzYtOS0xLTEtMzY0MDYw_e79af7a2-6bf0-4ce0-8dd4-52a39b07159a"
      unitRef="eur">-226000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ieb40125de23e47f4b691beb3f8caaf8a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctMS0xLTEtMzY0MDYw_bf758038-7d0c-455e-a927-a2aed24202f7"
      unitRef="eur">2011000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ic710cde7f07241878fb45bc80807b33e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctMy0xLTEtMzY0MDYw_13ea73ca-fdd7-4290-bd32-2ee1ec458d24"
      unitRef="eur">-4000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ie43506936ad84ce5a6554679ac752b3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctNS0xLTEtMzY0MDYw_126fa42a-5d13-43c1-b900-b01be1fc61d3"
      unitRef="eur">4816000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i09d9373e22c04796932fe109e2e7e74a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctNi0xLTEtMzY0MDYw_e0291ea9-37bd-453d-96b9-1a864c415f8b"
      unitRef="eur">128000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ie5ccc85c23444dce9bae65bbd26a864a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctOC0xLTEtMzY0MDYw_fa207fb0-c335-4833-b361-98bbba27e4a4"
      unitRef="eur">6068000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i9e84a1e2fa8d414cab3bdca6d9e37a42_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzctOS0xLTEtMzY0MDYw_aa937e54-bd29-42bc-941c-ee977b63d17a"
      unitRef="eur">-200000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i85aaa6f19d1c4e41892f9efb28e339cb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtMS0xLTEtMzY0MDYw_ba777cab-deda-4f34-8314-4c4447e702fa"
      unitRef="eur">2154000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i55b98a7738694729859cf1f701a3036c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtMy0xLTEtMzY0MDYw_cd429bb1-38c8-42aa-8c12-5b0c4f4576cb"
      unitRef="eur">22000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i9cfed40ed16b475a994112d539fb98df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtNS0xLTEtMzY0MDYw_458f6ed5-03c6-4285-84c0-5bc55cb40074"
      unitRef="eur">2910000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i7e141872c7da4fd0a0923c8056541885_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtNi0xLTEtMzY0MDYw_d9697297-551b-48c7-af9a-66c7b30bb44e"
      unitRef="eur">75000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="id35af5750eb94d1194ede73371ab7443_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtOC0xLTEtMzY0MDYw_a69f4689-36eb-4381-b38b-7f9bf3c0b356"
      unitRef="eur">2250000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i227270b1fc19499f93797d6f9434612c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzgtOS0xLTEtMzY0MDYw_aa5b10e1-7dae-4223-8f04-06ca757c0bf1"
      unitRef="eur">-27000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ie029e1cca2a447a4a3a3fab3f837ab58_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktMS0xLTEtMzY0MDYw_4e472ef4-cb1d-4936-81d4-906efbb8b771"
      unitRef="eur">205000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="id4f729e37a504044b70b5df154cba02c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktMy0xLTEtMzY0MDYw_8de6d4e2-39dd-41e6-8789-05edd947c919"
      unitRef="eur">4000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i7e5347dec1084a829aea7d78ec58effa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktNS0xLTEtMzY0MDYw_fbca9e15-9b09-4dd6-9e3d-fc0b6a194954"
      unitRef="eur">235000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i44dc35f3195448b4a394aa1a99ee422d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktNi0xLTEtMzY0MDYw_57af6035-298d-4f36-b97c-63dbc100fcff"
      unitRef="eur">-2000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ied6aa1c882654c8f9b00c1a4695ec3e0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktOC0xLTEtMzY0MDYw_bd97c3ca-3e4d-42f3-855f-ce4342fee9f5"
      unitRef="eur">68000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ic171ffaf34c443418e622acadcc523a5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzktOS0xLTEtMzY0MDYw_052f3d2e-af55-4e21-93f0-31ad71dc0db0"
      unitRef="eur">0</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i48e2f84695a246b1b0d8229ae8e26267_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTEtMS0xLTM2NDA2MA_dc35abed-13d4-4f31-9f13-1fafd03b9077"
      unitRef="eur">12556000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i922eeb9c64b04920a294d8178d09fe8b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTMtMS0xLTM2NDA2MA_5c618631-6205-4fdb-bf6e-6ed38002baac"
      unitRef="eur">90000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i56bcc4da86dc4c3e9d1f700ddb1fbd10_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTUtMS0xLTM2NDA2MA_e93b6090-254c-4f2e-a8fa-f065eddb8515"
      unitRef="eur">16948000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="ic6fbda346e6a493cb16800f488f83cc2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTYtMS0xLTM2NDA2MA_491106aa-e272-4c58-b095-abbcde6adcc3"
      unitRef="eur">212000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="id6ee14014d724beba49280ee27bd0579_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTgtMS0xLTM2NDA2MA_69652966-829f-44c5-b928-e0d5d8f9b182"
      unitRef="eur">14068000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="i079d026d077e4c1ca6b37005c231329a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo4N2E1Yzk0N2IxYTg0NTI4YTM0MWI1ZWE5MGM3ZDk5Ny90YWJsZXJhbmdlOjg3YTVjOTQ3YjFhODQ1MjhhMzQxYjVlYTkwYzdkOTk3XzEwLTktMS0xLTM2NDA2MA_5f01f3ae-9fe5-436f-896d-ef281486032e"
      unitRef="eur">-216000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <ifrs-full:NotionalAmount
      contextRef="ifbad1a772c8243ff9be90c4d20a4e525_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzIzMDc_f2948394-323e-42eb-8dd1-2d025bb851df"
      unitRef="usd">3615000000</ifrs-full:NotionalAmount>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="ifbad1a772c8243ff9be90c4d20a4e525_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzI0NjY_f10d64e6-9dfa-4723-b9cd-fd4400752c03"
      unitRef="eur">38000000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:NotionalAmount
      contextRef="ie0ec4b8e46114ca2b35eaca06a75d8c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM0MDI_096ca510-c685-4292-9d6d-f763cab38c5a"
      unitRef="usd">1000000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="ie0ec4b8e46114ca2b35eaca06a75d8c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM0NzQ_096ca510-c685-4292-9d6d-f763cab38c5a"
      unitRef="usd">1000000000</ifrs-full:NotionalAmount>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="ie0ec4b8e46114ca2b35eaca06a75d8c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM1OTM_7d1275d7-7bee-4852-8795-5f489e2b1b55"
      unitRef="eur">3000000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax
      contextRef="if6f16cedceff4ae3b093541f0395f25f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzgwODE0MTA0NjUxMDE3_1bee202e-996d-4923-8991-f0202719b3d2"
      unitRef="eur">600000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
    <ifrs-full:NotionalAmount
      contextRef="if49ca5a45afd4b6290deff09c0f6bc9b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM3ODA_2be33d06-2a7c-4d21-9d95-ba1248b19cbe"
      unitRef="usd">1000000000</ifrs-full:NotionalAmount>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="if49ca5a45afd4b6290deff09c0f6bc9b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM5MzQ_4e2d9292-cbe1-4185-b17d-4e029b996978"
      unitRef="eur">2000000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax
      contextRef="i06dc5a5dfd664b289378fb47e3556afb_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzE5NzkxMjA5MzA3MTM2_9402f37b-895f-4745-b5f1-41c44027c931"
      unitRef="eur">1400000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
    <ifrs-full:NotionalAmount
      contextRef="i661e3141aef34374bc5a4c2b0282a005_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzM5OTg_8c814ac9-1b6b-4f43-b835-05ae21d91e3b"
      unitRef="sgd">1500000000</ifrs-full:NotionalAmount>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="i661e3141aef34374bc5a4c2b0282a005_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzQyMjI_ad1955fb-2b65-4339-b4fd-c577bcd7e37e"
      unitRef="eur">33000000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax
      contextRef="i11d47edbce414914a613eb9ba3ddd387_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzE5NzkxMjA5MzA3MTUw_60df2c78-9362-40fd-a8cf-8cc4aa859239"
      unitRef="eur">2500000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
    <sny:DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MTA_f2dec5a5-9b1e-4f5b-8ab9-b74bed31c28b">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows interest rate hedging instruments in place as of December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amounts by expiry date as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;designated as&lt;br/&gt;fair value&lt;br/&gt;hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#e3e3e3;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which designated as&lt;br/&gt;cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028 and later&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;recognized&lt;br/&gt;in equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay SOFR USD/receive 1.03%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay SOFR USD/receive 1.32%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay capitalized Ester/receive 0.69%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay capitalized Ester/receive 0.92%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;850&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,584&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,434&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,434&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows interest rate hedging instruments in place as of December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amounts by expiry date as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;designated as&lt;br/&gt;fair value&lt;br/&gt;hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which designated as&lt;br/&gt;cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027 and later&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;recognized&lt;br/&gt;in equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay capitalized EONIA/receive 0.06%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay -0.57%/receive capitalized EONIA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay SOFR USD/receive 1.03%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay SOFR USD/receive 1.32%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;receive capitalized EONIA/pay 1.48%&lt;/span&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,642&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;57&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;880&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,579&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,979&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;600&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) These interest rate swaps hedge fixed-rate bonds with a nominal of &#x20ac;99 million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within &#x201c;Loans, advances and other long-term receivables&#x201d; (see Note D.7.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows interest rate hedging instruments in place as of December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amounts by expiry date as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;designated as&lt;br/&gt;fair value&lt;br/&gt;hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which designated as&lt;br/&gt;cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026 and later&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Of which&lt;br/&gt;recognized&lt;br/&gt;in equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay capitalized EONIA/receive 0.06%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;pay -0.57%/receive capitalized EONIA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;receive capitalized Eonia/pay 1.48%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,642&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;57&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,699&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,099&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;600&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) These interest rate swaps hedge fixed-rate bonds with a nominal of &#x20ac;99 million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within &#x201c;Loans, advances and other long-term receivables&#x201d; (see Note D.7.).&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock>
    <sny:InterestRateSwapsInterestRate
      contextRef="i15aff7b3369844169fb17236f6500876_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246NjcxYTRlNzZjM2E5NDI0NDhjMWU0YzQ5ZThkZjg3OTZfMTk3OTEyMDkzMDAwNjY_b82dccda-2b64-40a1-957a-fe4623d263aa"
      unitRef="number">0.0103</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i18a2fd58cbc9469c87f4b9177e7354bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMS0xLTEtMzY0MDYw_ccc98bf2-6a7e-4769-95b4-25f4b1dfa4fb"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i895f035f5ef54ff6a621aa415748dd18_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMi0xLTEtMzY0MDYw_f04c5c9d-6d94-4cdd-9d6b-c002b0ae2e67"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i069619337dbc4ccc847e26e6b2556b7c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMy0xLTEtMzY0MDYw_2a2796ac-1a9f-4e45-8601-d7312c405180"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i893adc22890b4055af537741a376b6f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtNC0xLTEtMzY0MDYw_ee32c9a4-2497-4515-8eb8-c1d0239b0fb1"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i04a837a3f9b545248b617c5023b8eca8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtNS0xLTEtMzY0MDYw_6ffca81c-6a1a-4328-ad6d-bb92ac668ec8"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="if03b358d41cb407d8e96408c4edd4151_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtNi0xLTEtMzY0MDYw_cd745a89-042f-4ef6-a756-8b757eefb2fb"
      unitRef="eur">467000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="iee9d3e0b60fa489ba2e1a59ccd300754_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtNy0xLTEtMzY0MDYw_ff59c573-e243-449a-b58f-60372f08266e"
      unitRef="eur">467000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="idb30bf0b28ef4c6eb5494ffbe2ef90b3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtOC0xLTEtMzY0MDYw_244efd3e-698d-4b96-9475-a851b105e208"
      unitRef="eur">-62000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="id5ac4648736544d5be682b0545f039b8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtOS0xLTEtMzY0MDYw_f502674c-554b-4805-943c-3ba4d21fdbc8"
      unitRef="eur">467000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i7b24d6ead4f44d549106fd85b92a18ba_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMTAtMS0xLTM2NDA2MA_a6dc809f-a7fe-453e-bc8c-55e319211214"
      unitRef="eur">-62000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i67dfb600319c4c0e8957725369f434bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMTEtMS0xLTM2NDA2MA_60698be4-eaeb-4d3a-acc8-dc70eff3270c"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ie9cb8f93e1b846d58430281df87402c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMTItMS0xLTM2NDA2MA_4e467aeb-d844-4b7d-bc75-3668aa256e78"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i0486b9ddaf8740c29301347caa547205_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzMtMTMtMS0xLTM2NDA2MA_66cb1137-b680-49bb-b420-8664bd361dbd"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:InterestRateSwapsInterestRate
      contextRef="i436fb0a145f24198b631657a4b307c84_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ODM1M2UxNzlkMjNhNGI0M2FmZTdiZGI0NDYzZDE0MzFfMTk3OTEyMDkzMDAwNjg_1d1a39d8-dbe8-4518-99fb-4d6e2058da87"
      unitRef="number">0.0132</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ia0cea86ea6bc459e9837c24b4130bdd6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMS0xLTEtMzY0MDYw_372c18d6-340b-4724-bfad-096bba7e1a9b"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i44734cb0c2064272a0ad777ee49ce42c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMi0xLTEtMzY0MDYw_a29ed738-7f6a-4080-bc61-072676a87e5f"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i0622cdaa9da64461a96fb0292ec0eea0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMy0xLTEtMzY0MDYw_86005fd4-f227-4e52-bea7-e198cede15bf"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i34c19e263a4b4b1081b0aff21bbca864_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtNC0xLTEtMzY0MDYw_3ff0783a-297c-4a0b-b9c1-478161ab69c4"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i426ef0ef517c427a8af20107114ef8ca_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtNS0xLTEtMzY0MDYw_4c713d47-0415-4d7f-9ae0-5156725bd89a"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i191f61c5f38f4bf69380a073349229ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtNi0xLTEtMzY0MDYw_5ef33e35-6005-40e2-aa33-dd852f96eefa"
      unitRef="eur">467000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8474639b23494b81bb367f15d980ea45_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtNy0xLTEtMzY0MDYw_d91f9897-7690-4068-a51b-da2aeffacfd9"
      unitRef="eur">467000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="id5d1a7773b0f41d5865caf10d0769e53_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtOC0xLTEtMzY0MDYw_382ca98b-e499-4805-9efb-5e4dc4cb312c"
      unitRef="eur">-56000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8899ba6d4f7742d8bef35ffd6e411f61_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtOS0xLTEtMzY0MDYw_b775ae1d-0a01-4e2c-ae67-fb1491263156"
      unitRef="eur">467000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i487c7bae36874cfa83dd6d27aeaaf611_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMTAtMS0xLTM2NDA2MA_2f850134-46c1-4c15-be02-787901e7a81a"
      unitRef="eur">-56000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i7c78a322e0c7481982834bec3a307bfd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMTEtMS0xLTM2NDA2MA_a84d0772-418a-48d9-9683-ddaf960bc7b8"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i9bef3049f3174f4daeeb2b280ca9d62a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMTItMS0xLTM2NDA2MA_a69e3087-9ee0-4973-a529-f459c06c8f5b"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i968d0b61e3c442b8a646491f66efac4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzQtMTMtMS0xLTM2NDA2MA_bb4d0d20-a813-4fb0-8666-b4f7e4f21554"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:InterestRateSwapsInterestRate
      contextRef="i9adf3d9fad074a0c935d684bd36535ec_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246NjRmY2QwMDc0MWQ3NDNmYmEwOTY5M2U3M2Y0Njc1NGVfMTk3OTEyMDkzMDAwNDA_1dd5aee9-df0b-4c35-bd1a-3a161cf624bb"
      unitRef="number">0.0069</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i271929f8b0414f61a36fcd512a84ce24_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMS0xLTEtMzY0MDYw_b6233f52-612f-4f71-8bd3-59c0553bbfe3"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i1b3b4a9f07684b9fad388a8d3257b3a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMi0xLTEtMzY0MDYw_caf395c4-b257-4a3e-a23d-8f4986bcdb03"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i7006a90210804b1eba413146a647967f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMy0xLTEtMzY0MDYw_190607b8-c594-4633-ba5b-b0abc236b381"
      unitRef="eur">850000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8aa5a36243114d7492f0b3b84690ce01_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtNC0xLTEtMzY0MDYw_a992b980-8f0d-43dc-a6ed-f83fa8d7489d"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i784bdfbab14c473da1d2cac7e203f118_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtNS0xLTEtMzY0MDYw_066803f8-2785-4f56-a473-1911d78b3bff"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ia97eb1a29ddb48e3ac11be4d8af016e5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtNi0xLTEtMzY0MDYw_491acc6b-bbbc-4b12-a86f-f4f73b7fa95c"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i480a5ccfaf0a4d619969b512824c1c9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtNy0xLTEtMzY0MDYw_b7edca09-ab36-4a8a-8c02-effd7f59fa7a"
      unitRef="eur">850000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i3446baf8e2ff432d9469238fb5dc3fb8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtOC0xLTEtMzY0MDYw_6087f393-b9f9-4e45-b609-a05f8581873b"
      unitRef="eur">-43000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8e35d2d09ed94351a8a81acaa3338261_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtOS0xLTEtMzY0MDYw_c810db6c-cd9f-4950-b2fe-3631c00b118a"
      unitRef="eur">850000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="idc8c65ed2128473a8828f847b40cab4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMTAtMS0xLTM2NDA2MA_946cfc40-8cb1-479d-b599-a6c829be37df"
      unitRef="eur">-43000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i60f42132b5024da096b34e23a312678e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMTEtMS0xLTM2NDA2MA_b5721471-c0ea-409a-a953-2eebb8233a8e"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i89aae2d2b1504df39f88a1146257c96d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMTItMS0xLTM2NDA2MA_cc8d19f6-722f-4d53-acd4-5089101d66d6"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8ebe9e98e9c944fa9ac489f3e3801729_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzUtMTMtMS0xLTM2NDA2MA_6a05d4ce-3fc5-41a5-a842-3144b30fa6ea"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:InterestRateSwapsInterestRate
      contextRef="i6c18a7ae7ef14a598a9312096c25ded0_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246Y2YxZDI5NzJjZGZkNDdkNzhiZDgyOWU5NDE2YTlhMWRfMTk3OTEyMDkzMDAwNDM_926622af-e382-42f2-b587-a0b57955c87f"
      unitRef="number">0.0092</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i9fef17ad4b784d198f1d2c810f5555ca_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMS0xLTEtMzY0MDYw_936995ad-b957-4728-b9ca-91283620f301"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i6852770d10664fa7aa7420995a79c7df_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMi0xLTEtMzY0MDYw_34b2ffb2-b406-4df1-b43d-e93d6baca667"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i3b22da99f8e242f988414e346bbea953_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMy0xLTEtMzY0MDYw_22b743e1-28c5-43d0-8250-1550b4d8b5d9"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i24369237e6074efaa812824f17d04b81_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtNC0xLTEtMzY0MDYw_f695d599-150e-4677-8b4b-6361042ee4be"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8911505211274ebb8c960de64bb8c7f8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtNS0xLTEtMzY0MDYw_2ddd15de-67b6-437e-84b4-7e6af0b2b3d8"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i415ddbc400be4e558c1b1cb09d9eae83_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtNi0xLTEtMzY0MDYw_4b4db35f-138b-4d6e-8a73-583502543f48"
      unitRef="eur">650000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ib13971669f0845ea9bb525a15a7c1309_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtNy0xLTEtMzY0MDYw_4dd12a05-d707-4d35-b24c-b9a0006e36c5"
      unitRef="eur">650000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i406525a21a61478ea46cc93649d471dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtOC0xLTEtMzY0MDYw_e12eecdb-928f-4343-89a0-3562a91c5823"
      unitRef="eur">-71000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="if93b383d587447b1baa059cdf91afb22_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtOS0xLTEtMzY0MDYw_da085b75-a2ec-4265-a732-d9eba0e6ef28"
      unitRef="eur">650000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i3bcbc6f1c89a4aee8b4962d00160fb87_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMTAtMS0xLTM2NDA2MA_e7c83bfb-ea1a-45e9-b2fd-f6c599b602fd"
      unitRef="eur">-71000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i4bb05a8539e2427eadb812e81fdc182b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMTEtMS0xLTM2NDA2MA_e452ce98-189f-4a22-9280-624cc1e24b97"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i9c645944814e426cb0a58e0b62656c9a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMTItMS0xLTM2NDA2MA_2cb2e67c-c6f3-49b7-8ec2-a38d74162c12"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="id99d44b83ffb41fbb20bd144d592090a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzYtMTMtMS0xLTM2NDA2MA_5354f10a-0e96-406e-b9f9-48e6372d2a6e"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i6978d30ff20b420296da0d92dac7a1e2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMS0xLTEtMzY0MDYw_2ccf7c64-12eb-4892-8d6f-669fb20fa6b3"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i5762f0e8002b4b5abe902947c5d662e6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMi0xLTEtMzY0MDYw_1c7cba19-a17d-4cf5-914f-2e368521ed67"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ic26bcbc2c757485d8d5a38c334f0d541_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMy0xLTEtMzY0MDYw_4c9cd14d-9c82-4758-bc63-e756719dce56"
      unitRef="eur">850000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i689b9e821d364e81a6228480dd2479ff_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtNC0xLTEtMzY0MDYw_8d85662b-b4ea-42e2-97a5-10c46a6f6bdb"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i252e89fda19345c083603752e6118f19_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtNS0xLTEtMzY0MDYw_62497395-bae1-412b-bb86-e4264f06834c"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ib17a33966126400e9c099f5178ff7db3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtNi0xLTEtMzY0MDYw_b475faf3-eb65-4918-8189-e2f069551584"
      unitRef="eur">1584000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i48e2f84695a246b1b0d8229ae8e26267_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtNy0xLTEtMzY0MDYw_7ba968e5-5ddc-4472-8efe-c8aeb692dedf"
      unitRef="eur">2434000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i922eeb9c64b04920a294d8178d09fe8b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtOC0xLTEtMzY0MDYw_96882a58-4e38-4ead-916c-1847a2f235dd"
      unitRef="eur">-232000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i6c2f529934674b7699d9daf02407ed9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtOS0xLTEtMzY0MDYw_3fb8a811-3227-4cbb-ae2e-af4e4d03859c"
      unitRef="eur">2434000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i3bda9484385f4811a6cb4397402bad3c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMTAtMS0xLTM2NDA2MA_ac3a4a2c-ebbe-4b33-a279-91e04f66865a"
      unitRef="eur">-232000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i73a34cffa66544deb36e7732558b3762_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMTEtMS0xLTM2NDA2MA_4423e6ba-88f5-4e0b-be7f-dcb492a673c3"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i97c8f085dafb45a2992095d4c7dae629_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMTItMS0xLTM2NDA2MA_42ba49d6-e29c-4bb4-aeb3-b7cc4173a0d7"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i682f1cd2c61447218a7903da70602a00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTozZmFhMzE2NWFkMTY0NTEwYThkMjliMDk0YTRmNDNmMy90YWJsZXJhbmdlOjNmYWEzMTY1YWQxNjQ1MTBhOGQyOWIwOTRhNGY0M2YzXzgtMTMtMS0xLTM2NDA2MA_80b58ba2-5f09-4770-a10b-af441daaa9b0"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:InterestRateSwapsInterestRate
      contextRef="i1aea5e7d1f14480c9b4c2b380e13a8ad_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246Y2Y1OGM4MDVjMTQzNDBkYjhhY2NkMWVjM2FhZGUzYWRfMTk3OTEyMDkzMDAwNzA_d16f40c8-5175-4c14-9822-0268f6a218f3"
      unitRef="number">0.0006</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i9e1181b5e1f94eb0afab79e5ead12d84_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMS0xLTEtMzY0MDYw_ab30d9d4-79e9-4ea7-a0e2-72334f9a1f23"
      unitRef="eur">2000000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8da9f53c8b5e4025909bce39297919f7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMi0xLTEtMzY0MDYw_78bc0648-9f7b-4d33-b959-1d61e011376b"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i9237a2fe49694802969f89c436b00934_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMy0xLTEtMzY0MDYw_d801555b-bbda-465f-bcd9-f450acb254a2"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8d5f45eab86f43429c18bcd68ccecdec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtNC0xLTEtMzY0MDYw_447f3250-dc35-4ff0-ad39-30ec22d33f02"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="iae24cf8f5b9643f9ba49fa85b263ed29_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtNS0xLTEtMzY0MDYw_bad0f580-350e-4151-9add-ab4db1c18b62"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ic1cf833a38674b19a98ce0b07e1f2fbb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtNi0xLTEtMzY0MDYw_5ac8f1ae-bb85-4c09-b009-6bd32c01356b"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i892f75e2092f4191a9eb1d67b804e93d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtNy0xLTEtMzY0MDYw_4188efd9-612b-4d95-9ca6-0edb43de4b99"
      unitRef="eur">2000000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i81056da6811b49d2aeff4320c2d985f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtOC0xLTEtMzY0MDYw_0c327da9-b4ae-4cf1-9b05-158944679507"
      unitRef="eur">10000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i231c93471cd24cd9a8425c657a55b8d0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtOS0xLTEtMzY0MDYw_3e31bcc3-3960-496c-af4b-ec13a47732d1"
      unitRef="eur">2000000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i6a751e5dfe154e47bebcd411a4556b5f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMTAtMS0xLTM2NDA2MA_61b81499-d8bd-4071-9e40-a335aef5a30c"
      unitRef="eur">10000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8ed3a0382bac4c6dbb4f81fb8b4510c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMTEtMS0xLTM2NDA2MA_315f0399-50a9-443e-952a-0273af253d9a"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i9bf5b26909214f5c88e018a134323460_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMTItMS0xLTM2NDA2MA_9ab0a6e2-c593-420f-9a04-91429b4738f6"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ie2dd4c1e5ce840daaa3939c67f591aaf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzMtMTMtMS0xLTM2NDA2MA_ebc79425-6f36-43b3-a4a7-a876e78c5097"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:InterestRateSwapsInterestRate
      contextRef="i6d113eb1ff7649b097238d0d21ee6615_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMC0xLTEtNDc1OTE3L3RleHRyZWdpb246OGRmNmQ0MTE2ZWIwNDY1YTk1Y2U1ODM2ZDQzZjljMWRfMTk3OTEyMDkzMDAwMTY_d7853de8-c4d5-4762-b9ba-fd566e77977d"
      unitRef="number">-0.0057</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i07fca8f6f83a40b588dc84ee11762d60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMS0xLTEtNDUzODcz_b9416b92-0bc5-456c-82cc-3c2a43bd256b"
      unitRef="eur">600000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ia99138c4d7234b91b3fea8b6e94fa8c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMi0xLTEtNDUzODcz_43ea24ec-e4e3-47a9-98e5-c3bf6bf4db56"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i60b7bade7cce4c9b8fd2a07220556816_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMy0xLTEtNDUzODcz_23289a0b-885b-4436-8fec-d1968e732db6"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i65eb896f1a3d432eae2f406e8163f8a6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNC0xLTEtNDUzODcz_6fc3494e-a32d-48da-92d1-e93652f2ccc5"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i842ef60079fb4a788eb441c59eb01957_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNS0xLTEtNDUzODcz_205a2f14-e357-4386-bba2-5d63ba3627f2"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i6d02dedf5e2f40de9a94dc76b5057ee4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNi0xLTEtNDUzODcz_951a9a44-432a-4f6e-add2-73dc63d934bd"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i9f0e19dd29ee4a76a46262c50b166cf6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNy0xLTEtNDUzODcz_9610d743-84ed-4904-810c-d95be3552641"
      unitRef="eur">600000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i41c13ab9329b48849e3517bc4d5a7a56_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtOC0xLTEtNDUzODcz_5c10a270-ed5f-4195-97f4-678dab6f1b3b"
      unitRef="eur">1000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i4a6c75ffdef646cb8b9bc85acee5c836_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtOS0xLTEtNDUzODcz_e65c33af-aa95-4401-8c66-d980d0e19d02"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i0e04aa67c1b64442af65cb51690fb931_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTAtMS0xLTQ1Mzg3Mw_d5cff796-1782-40e8-8a81-1233f70518e1"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i0628e92d1cdb49db881f08e4556161e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTEtMS0xLTQ1Mzg3Mw_f6f269de-14f6-48fe-9f5d-7a5778c1f923"
      unitRef="eur">600000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i9bd23edce11d47f08572dcd6cef1c475_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTItMS0xLTQ1Mzg3Mw_eb164489-2a3c-45f8-9cab-c5837f773d40"
      unitRef="eur">1000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i1160917297df4a258637aeea6cbc8408_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTMtMS0xLTQ1Mzg3Mw_bc02cfcc-1f5f-45fd-be09-865014dd51f3"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:InterestRateSwapsInterestRate
      contextRef="i513d59d537cf409284ea93c1d7ee3074_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMC0xLTEtNDc1OTI0L3RleHRyZWdpb246MzAzNmZiNjZjZDliNGIxZjhkZTVmMjljM2NjNDVmNmNfMTk3OTEyMDkzMDAwMDU_2e12dd20-3c80-4bce-a67e-e60e1e3433f5"
      unitRef="number">0.0103</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ia0be4069af744d4ebb72262d1c49c6c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMS0xLTEtNDUzOTg2_e454afc5-c8f5-42b1-b39a-3d4be318d4b2"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i7406e8367d044ac6a93b02c7fd8d0d7f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMi0xLTEtNDUzOTg2_03dc1aac-5912-41b9-aa5b-13da166db72f"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ic3406477180b408291805ed68b070663_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMy0xLTEtNDUzOTg2_74f4415c-e5d1-4f1d-a7f1-dff7fbb690df"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ibb7e6bf403b141899b31d01fc7aad5cd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNC0xLTEtNDUzOTg2_840db47f-7b4b-4080-87dc-c7a1c7206633"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ia21c8f6607e84aeba3d97b89e5ac81a7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNS0xLTEtNDUzOTg2_112a4f18-e788-4688-87d2-4d4214657f5c"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i344ad243d07147ce8a36b8ded9882056_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNi0xLTEtNDUzOTg2_5315b4d7-2f59-46ae-ae1b-db5144fbcdc4"
      unitRef="eur">440000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i02be206b72714d4db901c0a669d074ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNy0xLTEtNDUzOTg2_e62b03c0-f576-4fc0-bb0d-35974eeae619"
      unitRef="eur">440000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i3670c40f29fa41288dc623d89f7afdda_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtOC0xLTEtNDUzOTg2_046d3eb0-d8b0-4d1a-b45f-1cba039763b4"
      unitRef="eur">-5000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i6287e5395dae4c4ab46cabbec24ae24c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtOS0xLTEtNDUzOTg2_fc6edc6f-b249-49c9-9a71-11f07b2335a4"
      unitRef="eur">440000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ic9542809101c47f08405adbf19df6a9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTAtMS0xLTQ1Mzk4Ng_95e71008-0e1f-4d22-bfe4-aade4e88d13e"
      unitRef="eur">-5000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="iba70f10f62eb4b97a7aa7d41726b6a9f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTEtMS0xLTQ1Mzk4Ng_8f972299-a257-4bdb-93ff-861e0924bc55"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i6ff7d79feeaa43ff8fea8ebcd34aaf25_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTItMS0xLTQ1Mzk4Ng_8f7c8c1e-b52b-4ad1-b0f6-e77a17acf5d7"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i29f59bc216884949bafcb1d15976757a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTMtMS0xLTQ1Mzk4Ng_348343ae-9310-45fc-a014-422b773392ea"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:InterestRateSwapsInterestRate
      contextRef="ic2c068ebbb0a4c8c9fe94deb9daad677_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246YTQ4MzY3Yzk3MDI0NGJlYTg1NmE2YjhiOWY3MzY1MTJfMTk3OTEyMDkzMDAwNjE_e3d37d1a-14c2-4fed-8250-d08bb25b06d8"
      unitRef="number">0.0132</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ibef5d40bf8ab462bbc8e1f854f2fc952_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMS0xLTEtMzY0MDYw_93134084-6f76-444b-a32a-fabaa1a7c0cb"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="iaadc8f4f98bd4e31ba053344ae90a5a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMi0xLTEtMzY0MDYw_66f69a38-3887-48b7-9a01-5321da5b295b"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ida69b1ffd6a1453b8602532bc630b384_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMy0xLTEtMzY0MDYw_bdd1f043-b9f6-4381-9b5e-226eef1c6e87"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ia316589e705d4589bf786b0a1fa58345_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNC0xLTEtMzY0MDYw_84e05611-cb69-4870-abbf-7072937cefb4"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i83bd333ecc5a45689ebc96365daf83a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNS0xLTEtMzY0MDYw_0221c9ce-4373-4f5b-93b6-c85c0252897b"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i14841d0962de4dcd830a6e6ec232552e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNi0xLTEtMzY0MDYw_af955210-6f1e-472d-ba3b-eec1a8d57104"
      unitRef="eur">440000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ib0959357ae6d442db6998d16a60afb3b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtNy0xLTEtMzY0MDYw_ebc83329-364a-4be7-a7b8-90c4aad309ad"
      unitRef="eur">440000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="if90289f503234a0eb212cd627281795b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtOC0xLTEtMzY0MDYw_05712e9c-2e88-4044-b57e-6d88f757c42e"
      unitRef="eur">3000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ib0b2b67ce2434e4c9bb4553d177ba27d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtOS0xLTEtMzY0MDYw_266c6825-46f1-4d52-8495-a2f1ff2fde45"
      unitRef="eur">440000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i696be015b6144d53970810bcddd34f8a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTAtMS0xLTM2NDA2MA_9d1d3b54-fc6e-42ad-ae2a-4bfd2d0181fc"
      unitRef="eur">3000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="idf406a436f8543afa2b07724b0e77498_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTEtMS0xLTM2NDA2MA_f190a789-be94-4e48-82c6-2ecf9d82e711"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i5c3d82ed507848a7bee6b5dcfc4b9add_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTItMS0xLTM2NDA2MA_4c08e0f0-fb2d-4183-a3bc-9c7b40cfa9f0"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i9fa0165dae10416f9360d8ef68751988_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzQtMTMtMS0xLTM2NDA2MA_7d35b50c-aa2e-406d-961c-248585e44ce1"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:InterestRateSwapsInterestRate
      contextRef="i3005470a09144e07b9520bf27a0e096c_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZjA0NjcxMDRjYTYwNDdlOTk3OWQ4ZDIwMTRhOTY3MmFfMTk3OTEyMDkzMDAwMTg_7b4eda44-eab8-4970-b00a-7ee8d8d89c60"
      unitRef="number">0.0148</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ie3448b7dc78d4dcba65212215c69d18e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMS0xLTEtMzY0MDYw_db6c779f-ac81-42cb-99b6-4d3afcd6a78f"
      unitRef="eur">42000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="iccff00d7889c450492a7d84bcb6cd980_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMi0xLTEtMzY0MDYw_62c01ec6-91c3-4c73-a17c-f1cf7ba0183c"
      unitRef="eur">57000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i089150e0dfc24a74b7f19849daad27ef_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMy0xLTEtMzY0MDYw_75647770-4f3b-4203-b6ea-f0d4788526c7"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i7500ac1bc0c9434c9d072c80aa083d52_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNC0xLTEtMzY0MDYw_4abdddaf-9b05-4cff-a5e8-2097810572b1"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i63d81c82ce534a6cbe657f9d4db19639_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNS0xLTEtMzY0MDYw_f19c9a61-0d2e-46a3-93a9-39a3a1560c47"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i75edfd05889740488fd52f90caf59de4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNi0xLTEtMzY0MDYw_ec5559bf-ffec-41f3-bf2c-d6a596456c8a"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i0da07b9b35de4e45b2743100b13eaa31_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtNy0xLTEtMzY0MDYw_bb40069d-cf98-4f49-a06d-23c005e9a6cb"
      unitRef="eur">99000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i2cf262c93d024154b2d0d308743e547d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtOC0xLTEtMzY0MDYw_128ecd26-1f9c-495b-ac35-7a44d07cc4b3"
      unitRef="eur">-3000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ib80b97abcc214e64a591648c1c81e225_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtOS0xLTEtMzY0MDYw_d16e4774-9f88-486d-abe8-b83b943a15c3"
      unitRef="eur">99000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i30c163ec956f41df837a5eca1f6f6b37_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTAtMS0xLTM2NDA2MA_02aee0f2-ff84-4f6d-8dc4-0e5ba3883d79"
      unitRef="eur">-3000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i799cd607a2c24cbf8ce1dd45a6e411e8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTEtMS0xLTM2NDA2MA_b14a3fbf-ac06-460b-9327-2bbc754bba01"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ib09d73f6dafe467f9a1acd771011bef5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTItMS0xLTM2NDA2MA_69a6bd47-cafc-4c01-9770-a26b5104c1b5"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i23f76b64e1e34fc6961e70aa8b9920f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzUtMTMtMS0xLTM2NDA2MA_4416f910-4589-40ae-b9fe-0f5bccb3f2a2"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ia03794f3843a4cf3aca9226c900a741a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMS0xLTEtMzY0MDYw_86de4f1a-6c8e-49fb-8d70-1850cc0b6b51"
      unitRef="eur">2642000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ie16c564bf48f4da9a2d1edd6359a8bd6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMi0xLTEtMzY0MDYw_873fde71-c2fa-4a2d-833e-d91a93234105"
      unitRef="eur">57000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i704b08a911a149928d59f0fe5f3da5dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMy0xLTEtMzY0MDYw_5abd82b7-1208-4957-823e-7b27ae4176a8"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i84049923ad77487f9fa811c3372a7764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtNC0xLTEtMzY0MDYw_3d40a69f-54ac-4605-804f-12431d0ce4ae"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i3c40cd1979af4ea2be50a3ad38051006_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtNS0xLTEtMzY0MDYw_05e79b34-8360-4925-b26e-a316d04d6626"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="id1646cc36612494a895c40df0cbfdcd5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtNi0xLTEtMzY0MDYw_59d3afe2-cec2-4033-a269-b403c03d037a"
      unitRef="eur">880000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i56bcc4da86dc4c3e9d1f700ddb1fbd10_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtNy0xLTEtMzY0MDYw_53fb8874-e61e-4b9d-ae5a-9df928583065"
      unitRef="eur">3579000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ic6fbda346e6a493cb16800f488f83cc2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtOC0xLTEtMzY0MDYw_22437664-8e2e-48a1-8140-3838c0874985"
      unitRef="eur">7000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i47848bc2a7334009b78e12456fc26c7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtOS0xLTEtMzY0MDYw_ae58770b-f661-4e65-896e-5dfc1bc1124a"
      unitRef="eur">2979000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ibaa88d67818d446c976af2e5fbbe22d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMTAtMS0xLTM2NDA2MA_e3792463-3c2e-4696-81cd-fb7ffce86834"
      unitRef="eur">6000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ib6ea9e1f7b784baea9d9e983ef781098_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMTEtMS0xLTM2NDA2MA_dbdb0fe0-c0bd-4862-8dd6-d77abbbee787"
      unitRef="eur">600000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i0872c944abfa45428950a1bd06308fb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMTItMS0xLTM2NDA2MA_fadcbe96-cf82-4fda-92a6-e6370164795d"
      unitRef="eur">1000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="if75a6d9165a94a1cbf4f47aa2183cdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo2ODY3NTk2N2JjNjU0MDhjYTcwOWM4ZWJmNGUzODQ1OS90YWJsZXJhbmdlOjY4Njc1OTY3YmM2NTQwOGNhNzA5YzhlYmY0ZTM4NDU5XzYtMTMtMS0xLTM2NDA2MA_f91ec6a6-ff09-4a05-9de4-3b83d51e8bb4"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:DerivativeFinancialInstruments
      contextRef="i0da07b9b35de4e45b2743100b13eaa31_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzQ4MTM_fd1fb8b1-1779-4f23-81b3-83604d8317f8"
      unitRef="eur">99000000</sny:DerivativeFinancialInstruments>
    <sny:InterestRateSwapsInterestRate
      contextRef="ic631820a8c0641ac9e9f460890aaec85_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246ZGQ0OTNmYzMxNDQ0NGE1OGE2ZTZiOWJmMDg2NTdjY2JfMTk3OTEyMDkzMDAwMzQ_262061eb-b499-41c3-a277-1cbb72499632"
      unitRef="number">0.0006</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i53cfa96ea5124d07b04df526798c7f66_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMS0xLTEtMzY0MDYw_fa21fa6e-8ec4-43f2-8bc7-eaee3588daed"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i513c01d3044b4f8abd4b146fe577810d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMi0xLTEtMzY0MDYw_82308659-fab1-4cfb-bf1d-f312131fbd65"
      unitRef="eur">2000000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i5fa3a9c279d04c76a24fbd4bca5acf08_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMy0xLTEtMzY0MDYw_da1eb69f-8b50-43e3-904f-365c919709bd"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8b48e75f4c634efc8eb26e95ef3cc591_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtNC0xLTEtMzY0MDYw_ef756d96-719a-456f-a66f-d8f5f0e7df8f"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i063b1dc5829c4e8cb5617293416976a0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtNS0xLTEtMzY0MDYw_f55bb0cf-c5b4-4c2d-b492-24e73c32e5b9"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i5add9211f40f403aaf54c1ee281839d6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtNi0xLTEtMzY0MDYw_babdf979-9a31-4426-ab60-ac8994a48759"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ieec97775a7de49ffb1a9c4cf02b086de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtNy0xLTEtMzY0MDYw_5ca2ffcb-ec2b-43a8-bf77-943519928096"
      unitRef="eur">2000000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i10ed642e6d39458d841e67fd6d9e99cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtOC0xLTEtMzY0MDYw_7d86fbfe-6114-41b6-8d7d-23aba3760179"
      unitRef="eur">23000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="iebbcbd554d974218a72b9914fce1e919_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtOS0xLTEtMzY0MDYw_f67247b9-5873-45a5-8b11-c39e811337f8"
      unitRef="eur">2000000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ia9a04df3d2ef496d98b3c993e83e59f8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMTAtMS0xLTM2NDA2MA_ca6b4b8c-3cab-4c70-895f-f92a8dcccb37"
      unitRef="eur">23000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="idcac06c155c046cb8bab14fc84e911ed_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMTEtMS0xLTM2NDA2MA_52e690de-be3f-4030-863c-9516c6e14d28"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="if2c043c8ca5b4070a8a9a79320cf0244_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMTItMS0xLTM2NDA2MA_463399c2-8429-4bce-9987-ca5a440c622c"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i7974fd34e2524ff8b37923a5ebcf26a2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzMtMTMtMS0xLTM2NDA2MA_122ed4e4-8aa5-4a93-8912-714c046caa17"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:InterestRateSwapsInterestRate
      contextRef="i9039d5a648d44eb6a6285e7a8f3ed6f5_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMC0xLTEtMzY0MDYwL3RleHRyZWdpb246OTNjYjkxZTZmNTcyNDgyMWFjZTJkY2VkMzk2MGM4NGNfMTk3OTEyMDkzMDAwNjA_2b047e5b-a0dd-4947-b899-fa0bf09ffb4c"
      unitRef="number">-0.0057</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i5623b04048b44838b80378f94f84c892_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMS0xLTEtMzY0MDYw_952ed1d7-73b3-475f-826b-ff88f3f13929"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ia6c8f8b2dc504670a6689c9e6cb5a9c9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMi0xLTEtMzY0MDYw_b486bb81-3e58-4dfb-ab7e-fe762020d9ea"
      unitRef="eur">600000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ib968055f931a4052831d81f2d009e0dd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMy0xLTEtMzY0MDYw_e4ea7dd8-3978-4bdb-8ba9-0c0fd0e1aa92"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i4b23561502b7467e8dedcaa04bf23cac_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtNC0xLTEtMzY0MDYw_5f69cc46-3956-4ae8-8489-31e9a1b7392a"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="idbd6d8c2ec6646ddab12eb846faa1e2e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtNS0xLTEtMzY0MDYw_ae8ccc68-d2a1-4d8d-98e5-19091b5f4521"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i11fe8f6851654698a4c3c1314f4cdb7e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtNi0xLTEtMzY0MDYw_fbb0eae1-d412-4241-b135-56a9db5b174c"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i74afaf7dd9d34e35b425f2ad9ab6c04c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtNy0xLTEtMzY0MDYw_e87c3549-b67d-4f38-839f-e4f244038ff6"
      unitRef="eur">600000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i30a27053b6e14def8c033d7349e920eb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtOC0xLTEtMzY0MDYw_b4d894b3-8125-43c6-919c-00f235252029"
      unitRef="eur">1000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ie69dcce667cd4fea93c09d624bf405e8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtOS0xLTEtMzY0MDYw_fcee3c44-b002-43f4-8a41-66db2feb7c74"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="icc9a867ba32c4f5188edd4f852728ef7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMTAtMS0xLTM2NDA2MA_766bfab7-d629-4fdb-8911-1b6d9dca795e"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="if11a192ecef44797abf4e8a5c1ee30a1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMTEtMS0xLTM2NDA2MA_e2512480-a9a7-495b-89a4-1cd2108d5b9b"
      unitRef="eur">600000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i952a1cded8a74815937ca15f2edabb80_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMTItMS0xLTM2NDA2MA_656318dc-fd2e-4bb6-965e-a087ee0123a1"
      unitRef="eur">1000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i88a1b5f415cf464e89d9ca13ca302777_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzQtMTMtMS0xLTM2NDA2MA_9d518329-94ff-415e-a026-f8d2bd304653"
      unitRef="eur">1000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:InterestRateSwapsInterestRate
      contextRef="i1467f4d4b42140c2abf929b4d833c3fb_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMC0xLTEtMzY0MDYwL3RleHRyZWdpb246OGYwNjFmYjUxYTU2NDU5MGEyN2ZmY2Q0YzY3YTg1MTNfMTk3OTEyMDkzMDAwMTA_bf04b65a-525e-4a7e-af70-b19686e80697"
      unitRef="number">0.0148</sny:InterestRateSwapsInterestRate>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i5e4f05d47add459ab8040ffae65ac2ba_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMS0xLTEtMzY0MDYw_20b3af42-1e84-4631-bedf-1ac1e0bd4ff2"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ie62d1f5008e247f0a3ea8b6ca9f80dbb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMi0xLTEtMzY0MDYw_c53826ad-828b-403e-a77d-d82d0e71f0b1"
      unitRef="eur">42000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i708d051a58c54e20b95d3176a3c77084_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMy0xLTEtMzY0MDYw_0fce17c8-eafd-4724-83bd-bae17ff1292b"
      unitRef="eur">57000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i7b68e46221cb423b913a0db767409942_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctNC0xLTEtMzY0MDYw_ea783484-b098-45ac-be6b-fbcdb25ca806"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i6b9836c97a3149258a9dcf5b0cd2ffc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctNS0xLTEtMzY0MDYw_5472b657-8b39-4cc6-b4e4-9f9fe7cea8ab"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i799d40fa5c78466998a48db7ad50c332_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctNi0xLTEtMzY0MDYw_1d436331-3259-419f-8756-ae0bec8844a7"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i68a6cd0be59b4416bebc0edff829e3cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctNy0xLTEtMzY0MDYw_a8eaf688-47e0-40bc-9e41-43ee3ae96453"
      unitRef="eur">99000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="id6efc8e80c8341db96a4ea42fb92ea80_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctOC0xLTEtMzY0MDYw_45db9431-0142-4a45-a265-2d3f3a9c3085"
      unitRef="eur">-4000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i3e72356c5a114d11bd9759a87e0029e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctOS0xLTEtMzY0MDYw_ded89375-c61f-49ac-9bb0-bc27057ffeb4"
      unitRef="eur">99000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="idd430971a28b4ea0b9e3b9a41d1c2ec7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMTAtMS0xLTM2NDA2MA_0563c772-f646-4fb6-9659-71cacbfd0400"
      unitRef="eur">-4000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8d96c431df54470d96145e5b8c4a4e5d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMTEtMS0xLTM2NDA2MA_f9a89278-5832-4d5f-8e3b-143311556fda"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i7f30a6b3626548d68f342ca8d454fe33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMTItMS0xLTM2NDA2MA_367f62fb-5947-453a-8fe3-3a7cd56e3a88"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i874556ffc208487cae49386049753a72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzctMTMtMS0xLTM2NDA2MA_efd4511e-3dfa-4b11-a845-c4fff26250fe"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="id2bb50c6933e41bfb10adb4d6e458270_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMS0xLTEtMzY0MDYw_87dc511c-65ca-4f9f-8c02-38444ef98549"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8387da968c3a4fec95af79eb735152fd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMi0xLTEtMzY0MDYw_61168d49-7575-4a3b-a076-ca1db97b4319"
      unitRef="eur">2642000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ib8ed54d04df74d759a8be7cbf83b103a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMy0xLTEtMzY0MDYw_f9bb65e6-2318-4d5c-9530-1af690bb7dfe"
      unitRef="eur">57000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i273afa0ec4ce4433806daee6d20d5529_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtNC0xLTEtMzY0MDYw_417e7b0b-de20-4aa9-9320-1570a71b0ea2"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i5f6050765a2747e59fe7bf091298355d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtNS0xLTEtMzY0MDYw_6d2c77a4-95ab-47cb-ac83-b106b71c4c27"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="ie7964ee5305d44c3802adf3c53126d12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtNi0xLTEtMzY0MDYw_61c29638-4cd7-4c00-8778-adaa4c5bf42f"
      unitRef="eur">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="id6ee14014d724beba49280ee27bd0579_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtNy0xLTEtMzY0MDYw_f42f53c2-1c9a-47b7-a73d-b95603d4d1ce"
      unitRef="eur">2699000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i079d026d077e4c1ca6b37005c231329a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtOC0xLTEtMzY0MDYw_b4f8f548-2336-4a58-b0b6-e8fe2ab160f4"
      unitRef="eur">20000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i1076d751ef0a41919289d3a7fd81eb08_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtOS0xLTEtMzY0MDYw_eca79f5c-f106-4dee-9a91-e5c841625be7"
      unitRef="eur">2099000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i631031048a414305b2d327250a95741d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMTAtMS0xLTM2NDA2MA_3f6aedd4-b5cc-4900-a05a-229bcd352889"
      unitRef="eur">19000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i6bf8f4e0a00a442d95a5b6f57d0965db_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMTEtMS0xLTM2NDA2MA_3c36a38a-1ca2-4d58-9cda-60909485132f"
      unitRef="eur">600000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i8dbfe93bcc924f1db627a13c4e7d0036_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMTItMS0xLTM2NDA2MA_7f81cfaa-8f24-4dc8-9fbc-62ae7ccb9efb"
      unitRef="eur">1000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="i5129bf60276249ea8a7084e5aa6f5c82_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo5ZjQzMzMyYzk4MTU0MjBhOTk2ZTg5NGE1MWFkYTNlOS90YWJsZXJhbmdlOjlmNDMzMzJjOTgxNTQyMGE5OTZlODk0YTUxYWRhM2U5XzgtMTMtMS0xLTM2NDA2MA_dc697623-9a03-454c-b054-46c5fe154659"
      unitRef="eur">1000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:DerivativeFinancialInstruments
      contextRef="i68a6cd0be59b4416bebc0edff829e3cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzQ5Njc_7234f045-d95f-427d-8ddf-4eb4c2e35347"
      unitRef="eur">99000000</sny:DerivativeFinancialInstruments>
    <sny:DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90ZXh0cmVnaW9uOmZkYWVhOGEzOWJmOTRmNjFiODg2OWZjYjYyODJmMzkxXzU0MjU_4aed4753-e824-4910-803b-8760c33245f5">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below is prepared in accordance with the accounting policies described in Note&#160;B.8.3.:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative&lt;br/&gt;financial&lt;br/&gt;liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross carrying amounts before offset (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(297)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross amounts offset (in accordance with IAS&#160;32)&#160;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net amounts as reported in the balance sheet (a) -&#160;(b) =&#160;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;298&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(297)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effects of other netting arrangements (not fulfilling the IAS&#160;32 criteria for offsetting) (d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of financial collateral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net exposure (c) + (d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;231&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset
      contextRef="i237b42e7bb904d21a79f9880001b2ae2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItMS0xLTEtMzY0MDYw_b2e6cd0e-d513-42b8-abbc-0fd5ac9aed13"
      unitRef="eur">206000000</sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset
      contextRef="iba962d9e6d694d2b8779612e3b767372_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItMi0xLTEtMzY0MDYw_fe4aef89-ccd4-4474-bed9-c34aa757620f"
      unitRef="eur">-326000000</sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset
      contextRef="i155d49744d8747b49c962b6edeeeb4e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItMy0xLTEtMzY0MDYw_f05ffade-abb5-47f0-a03c-df2544982f8d"
      unitRef="eur">298000000</sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset
      contextRef="ied2d4b521a314246803eecd8ae01786c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItNC0xLTEtMzY0MDYw_5d44e913-0397-4287-916a-8405b0100851"
      unitRef="eur">-85000000</sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset
      contextRef="id3db7e4575054274b9fb7995816583e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItNS0xLTEtMzY0MDYw_84489ebf-6e3e-4b78-8799-ec28af907c9e"
      unitRef="eur">82000000</sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset
      contextRef="icad7c8faf49747ac89ffe01efbd20b55_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzItNi0xLTEtMzY0MDYw_4a596ddb-7670-47bc-b336-817ff37c3627"
      unitRef="eur">-297000000</sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32
      contextRef="i237b42e7bb904d21a79f9880001b2ae2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtMS0xLTEtMzY0MDYw_dc2c6a10-3fc4-4ebf-aca1-2432bd7d3aa5"
      unitRef="eur">0</sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32
      contextRef="iba962d9e6d694d2b8779612e3b767372_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtMi0xLTEtMzY0MDYw_1843ee26-8b7e-49d2-8a12-b14eeca9a25e"
      unitRef="eur">0</sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32
      contextRef="i155d49744d8747b49c962b6edeeeb4e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtMy0xLTEtMzY0MDYw_faf2ebd2-88e8-452b-9e77-6c1c9fd6d078"
      unitRef="eur">0</sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32
      contextRef="ied2d4b521a314246803eecd8ae01786c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtNC0xLTEtMzY0MDYw_40856321-1b96-418c-bb8a-a576203ca7d4"
      unitRef="eur">0</sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32
      contextRef="id3db7e4575054274b9fb7995816583e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtNS0xLTEtMzY0MDYw_7ab2ca67-3149-44ad-9c9d-9545bd410bea"
      unitRef="eur">0</sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32>
    <sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32
      contextRef="icad7c8faf49747ac89ffe01efbd20b55_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzMtNi0xLTEtMzY0MDYw_7e15f64f-e1a0-4d48-9eea-15a6707f96c1"
      unitRef="eur">0</sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32>
    <sny:NetAmountsAsReportedInTheBalanceSheet
      contextRef="i237b42e7bb904d21a79f9880001b2ae2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtMS0xLTEtMzY0MDYw_be3cd153-d70a-4355-b159-bf25663e706c"
      unitRef="eur">206000000</sny:NetAmountsAsReportedInTheBalanceSheet>
    <sny:NetAmountsAsReportedInTheBalanceSheet
      contextRef="iba962d9e6d694d2b8779612e3b767372_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtMi0xLTEtMzY0MDYw_2db27cd0-b25b-4f0b-b0eb-aef1579b3355"
      unitRef="eur">-326000000</sny:NetAmountsAsReportedInTheBalanceSheet>
    <sny:NetAmountsAsReportedInTheBalanceSheet
      contextRef="i155d49744d8747b49c962b6edeeeb4e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtMy0xLTEtMzY0MDYw_a4a3beff-3ddf-41f8-80fc-e6e2c19a4608"
      unitRef="eur">298000000</sny:NetAmountsAsReportedInTheBalanceSheet>
    <sny:NetAmountsAsReportedInTheBalanceSheet
      contextRef="ied2d4b521a314246803eecd8ae01786c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtNC0xLTEtMzY0MDYw_899e694e-523a-4164-9c16-04b0f27d6ace"
      unitRef="eur">-85000000</sny:NetAmountsAsReportedInTheBalanceSheet>
    <sny:NetAmountsAsReportedInTheBalanceSheet
      contextRef="id3db7e4575054274b9fb7995816583e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtNS0xLTEtMzY0MDYw_28a1f243-783f-4c21-afbd-7ad3a55ea883"
      unitRef="eur">82000000</sny:NetAmountsAsReportedInTheBalanceSheet>
    <sny:NetAmountsAsReportedInTheBalanceSheet
      contextRef="icad7c8faf49747ac89ffe01efbd20b55_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzQtNi0xLTEtMzY0MDYw_624ac1d5-22fc-40e7-88e4-80fcef4d997c"
      unitRef="eur">-297000000</sny:NetAmountsAsReportedInTheBalanceSheet>
    <sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral
      contextRef="ib697f784925f45fb87aef20924b4c88b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzUtMS0xLTEtMzY0MDYw_60526792-479a-45c5-a349-c6ce1329d8dc"
      unitRef="eur">0</sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral>
    <sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral
      contextRef="i21c5524f40ae4628ac06cf82feac300d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzUtMi0xLTEtMzY0MDYw_d8150d80-85c3-4d89-a658-e6b5fcad6288"
      unitRef="eur">0</sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral>
    <sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments
      contextRef="ib697f784925f45fb87aef20924b4c88b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtMS0xLTEtMzY0MDYw_e501b49f-affd-44df-ba2f-1bf343b5e7c1"
      unitRef="eur">-160000000</sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments>
    <sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments
      contextRef="i21c5524f40ae4628ac06cf82feac300d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtMi0xLTEtMzY0MDYw_76101cd9-c529-4671-bad7-0402d79d2a04"
      unitRef="eur">160000000</sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments>
    <sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments
      contextRef="if160fc4f51bb485d81d5f05461afea9a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtMy0xLTEtMzY0MDYw_166be067-b7cb-46a8-a1ff-a15576e2731e"
      unitRef="eur">-67000000</sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments>
    <sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments
      contextRef="i32163ab576b64e3a95bbb62ebcbdb9cc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtNC0xLTEtMzY0MDYw_f8610a9e-2605-4b6b-8e35-b8d0cb03e516"
      unitRef="eur">67000000</sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments>
    <sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments
      contextRef="ia952b3d7417849c8ab7c1fd9d194c90e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtNS0xLTEtMzY0MDYw_71a4a876-8ff1-4e63-a53b-153be399f79c"
      unitRef="eur">-81000000</sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments>
    <sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments
      contextRef="i0d8db00ca8a8449db76cc5c3d45ca76d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzYtNi0xLTEtMzY0MDYw_07c1e8e2-a0ec-4821-befd-65b6342c8bb8"
      unitRef="eur">81000000</sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments>
    <sny:NetExposure
      contextRef="i237b42e7bb904d21a79f9880001b2ae2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtMS0xLTEtMzY0MDYw_a2f19d9a-d878-46ee-98c0-a700645fa16c"
      unitRef="eur">46000000</sny:NetExposure>
    <sny:NetExposure
      contextRef="iba962d9e6d694d2b8779612e3b767372_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtMi0xLTEtMzY0MDYw_0812a9fd-fb62-48ef-afba-cd7db3455ef8"
      unitRef="eur">-166000000</sny:NetExposure>
    <sny:NetExposure
      contextRef="i155d49744d8747b49c962b6edeeeb4e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtMy0xLTEtMzY0MDYw_4889ec13-edea-49d2-8b32-d5ed04d06f7e"
      unitRef="eur">231000000</sny:NetExposure>
    <sny:NetExposure
      contextRef="ied2d4b521a314246803eecd8ae01786c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtNC0xLTEtMzY0MDYw_b455cd05-2e44-4e48-bbce-7242d5d888ea"
      unitRef="eur">-18000000</sny:NetExposure>
    <sny:NetExposure
      contextRef="id3db7e4575054274b9fb7995816583e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtNS0xLTEtMzY0MDYw_f17f72d7-b633-48e4-88b7-b4052af4d6e5"
      unitRef="eur">1000000</sny:NetExposure>
    <sny:NetExposure
      contextRef="icad7c8faf49747ac89ffe01efbd20b55_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTIvZnJhZzpmZGFlYThhMzliZjk0ZjYxYjg4NjlmY2I2MjgyZjM5MS90YWJsZTo0YmI4OGM2Y2JjMmY0N2JiOTI5Y2RjY2I3ZmUxYTRlOC90YWJsZXJhbmdlOjRiYjg4YzZjYmMyZjQ3YmI5MjljZGNjYjdmZTFhNGU4XzgtNi0xLTEtMzY0MDYw_10c64c6d-1619-4023-ab8e-29b6039aeadd"
      unitRef="eur">-216000000</sny:NetExposure>
    <sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEzODYy_eda640d8-d0dc-483b-b9ca-b6b7641814fd">Off balance sheet commitments&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The off balance sheet commitments presented below are shown at their nominal value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.21.1. Off balance sheet commitments relating to operating activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Off balance sheet commitments relating to Sanofi&#x2019;s operating activities comprise the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Irrevocable purchase commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;given&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;received&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development license agreements - commitments given&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;commitments related to R&amp;amp;D and other commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;contingent milestone payments in connection with development programs in progress&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(f)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total - net commitments given&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(g)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,112&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,901&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,505&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,878&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,828&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the variable portion of future lease payments not recognized as lease liabilities as of December 31, 2022; the equivalent amount of these commitments as of December&#160;31, 2021 was &#x20ac;109&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) These comprise irrevocable commitments to suppliers of (i)&#160;property, plant and equipment, net of down-payments (see Note&#160;D.3.) and (ii)&#160;goods and services. As of December 31, 2021, irrevocable commitments amounted to &#x20ac;8,901 million given and &#x20ac;1,124 million received.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Irrevocable purchase commitments given as of December 31, 2022 include &#x20ac;871 million of commitments to joint ventures, and the commitment to EUROAPI as described in Note&#160;D.1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d) Commitments related to R&amp;amp;D, and other commitments, amounted to &#x20ac;536 million as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(e) This line includes only contingent milestone payments on development projects in progress. The equivalent amount as of December 31, 2021 was &#x20ac;2,892 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In pursuance of its strategy, Sanofi may acquire technologies and rights to products. Such acquisitions may be made in various contractual forms: acquisitions of shares, loans, license agreements, joint development, and co-marketing. These arrangements generally involve upfront payments on signature of the agreement, development milestone payments, and royalties. Some of these complex agreements include undertakings to fund research programs in future years and payments contingent upon achieving specified development milestones, the granting of approvals or licenses, or the attainment of sales targets once a product is commercialized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The &#x201c;Research and development license agreements&#x201d; line comprises future service commitments to fund research and development or technology, and probable contingent milestone payments regarded as reasonably achievable (i.e. all potential milestone payments relating to projects in the development phase, for which the future financial consequences are known or probable and for which there is a sufficiently reliable estimate). This line excludes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;commitments given relating to projects in the research phase for &#x20ac;18.0 billion as of December&#160;31, 2022 (&#x20ac;6.7 billion as of December&#160;31, 2021) and commitments given relating to contingent payments upon the attainment of sales targets once a product is commercialized for &#x20ac;18.5 billion as of December&#160;31, 2022 (&#x20ac;8.1 billion as of December&#160;31, 2021);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;commitments received amounting to &#x20ac;8.8 billion as of December&#160;31, 2022 (&#x20ac;5.8 billion as of December&#160;31, 2021), mainly&#160;comprising research, development and commercialization agreements with partners further to the acquisitions of Ablynx&#160;for&#160;&#x20ac;1.0 billion as of December 31, 2022 (&#x20ac;1.0 billion as of December&#160;31, 2021) and of Kymab for &#x20ac;0.2&#160;billion as of December 31, 2022 (&#x20ac;0.5 billion as of December&#160;31, 2021), plus contingent consideration receivable based on attainment of regulatory and&#160;sales milestones for commercialized products under the terms of licenses or rights assignment agreements amounting to &#x20ac;7.6&#160;billion as of December&#160;31, 2022 (&#x20ac;4.2&#160;billion as of December&#160;31, 2021).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The major agreements entered into by Sanofi in 2022 are described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;on January&#160;7, 2022, Sanofi entered into an innovative license agreement and research collaboration with Exscientia to develop up to 15&#160;novel small molecule candidates across oncology and immunology, leveraging Exscientia&#x2019;s end-to-end AI-driven platform utilizing actual patient samples. Under the terms of the agreement, Sanofi made an upfront payment of $100&#160;million and could pay up to $5.2&#160;billion contingent on the attainment of certain objectives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;on January&#160;12, 2022, Sanofi entered into a licensing and collaboration agreement with ABL Bio for the development of ABL301, a bispecific antibody targeting alpha-synuclein and intended as a treatment for alpha-synucleinopathies. Under the terms of the agreement, Sanofi paid ABL Bio $75&#160;million upfront, and could make potential milestone payments of up to approximately $985&#160;million contingent on the attainment of certain objectives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;on March&#160;2, 2022, Sanofi entered into a collaboration and exclusive license agreement with Adagene Inc., a company transforming the discovery and development of antibody-based therapies. Under the terms of the agreement, Sanofi made an upfront payment of $17.5&#160;million&#160;and could pay up to $2.5&#160;billion contingent on the attainment of certain objectives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;on March&#160;15, 2022, Sanofi entered into a strategic risk-sharing collaboration with Blackstone under which funds managed by Blackstone Life Sciences (BXLS) will contribute up to &#x20ac;300&#160;million to accelerate the global pivotal studies and clinical development program for the subcutaneous formulation and delivery of the anti-CD38 antibody Sarclisa&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, to treat patients with multiple myeloma. That amount will be paid to Sanofi on the basis of development expenses incurred. In addition, Sanofi may pay royalties on future sales of this solution;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;on March&#160;29, 2022, Sanofi entered into an exclusive collaboration agreement with IGM Biosciences, Inc. to create, develop, manufacture and commercialize IgM antibody agonists against three oncology targets and three immunology/inflammation targets. Under the terms of the agreement, IGM received an upfront payment of $150&#160;million and could receive up to $6.0&#160;billion for milestones in the development, regulatory approval and sales of each target;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;on July&#160;5, 2022, Sanofi entered into a collaboration agreement with Skyhawk Therapeutics, Inc. to discover and develop novel small molecules that modulate RNA splicing to address challenging oncology and immunology targets. Under the terms of the agreement, Skyhawk received an upfront payment of $54&#160;million and could receive more than $2.0&#160;billion&#160;contingent on the attainment of certain objectives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;on August&#160;17, 2022, Sanofi entered into a strategic research collaboration with Atomwise, that will leverage its AtomNet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; platform to identify and synthesize up to five drug targets. Under the terms of the agreement, Atomwise received an upfront payment of $20&#160;million and could receive up to $1.0&#160;billion contingent on the attainment of certain objectives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;on September&#160;27, 2022, Sanofi entered into a research collaboration with Scribe Therapeutics, to leverage its CRISPR by&#160;Design&#x2122; platform and to obtain a non-exclusive license to genome editing CasX-Editor(XE) technology for multiple oncology targets. Under the terms of the agreement, Scribe Therapeutics received an upfront payment of $25&#160;million and could receive more than $1.0&#160;billion contingent on the attainment of certain objectives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;on October&#160;4, 2022, Sanofi entered into a strategic collaboration with miRecule to accelerate the discovery and development of a Best-in-Class Antibody-RNA conjugate to treat Facioscapulohumeral Muscular Dystrophy (FSHD). Under the terms of the agreement, miRecule received an upfront payment of $20&#160;million and could receive up to $0.4&#160;billion contingent on the attainment of certain objectives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;on November&#160;8, 2022, Sanofi entered into a strategic research collaboration with Insilico Medicine to leverage Insilico Medicine's AI platform, Pharma.AI, to advance drug development candidates for up to six new targets. Under the terms of the agreement, Insilico Medicine received an upfront payment of $12.5&#160;million and could receive up to $1.2&#160;billion contingent on the attainment of certain objectives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;on December&#160;19 2022, Sanofi and Innate Pharma SA announced an expansion of their collaboration, with Sanofi licensing a natural killer (NK) cell engager program targeting B7H3 from Innate's ANKET&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (Antibody-based NK Cell Engager Therapeutics) platform. Innate received an upfront payment of &#x20ac;25&#160;million and could receive up to &#x20ac;1.4&#160;billion contingent on the attainment of certain objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The amount of commitments as of December&#160;31, 2022 also includes commitments under agreements entered into by Sanofi in prior years, the principal ones of which are described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;Biond Biologics (2021): license agreement for the development and commercialization of BND-22 (a humanized IgG4 antagonist antibody targeting the Ig-like transcript&#160;2 (ILT2) receptor, in development for the treatment of solid tumors);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;Eureka Therapeutics and Memorial Sloan Kettering Cancer Center (MSK) (2021): license agreement with for the treatment of multiple myeloma;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;Kymera (2020): agreement to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;Nurix Therapeutics (2020): collaboration to develop novel targeted protein degradation therapies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;Denali Therapeutics&#160;Inc. (2018): collaboration agreement on the development of multiple molecules with the potential to treat a range of neurological and systemic inflammatory diseases. The two lead molecules are DNL747 in multiple sclerosis and amyotrophic lateral sclerosis, and DNL758 in systemic inflammatory diseases such as rheumatoid arthritis and psoriasis;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;MedImmune (a division of AstraZeneca) (2017): agreement to develop and commercialize a monoclonal antibody (MEDI8897) for the prevention of Respiratory Syncytial Virus (RSV) associated illness in newborns and infants;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;Innate Pharma (2016): collaboration and licensing agreement to apply Innate Pharma&#x2019;s new proprietary technology to the development of innovative bispecific antibody formats engaging natural killer (NK) cells to kill tumor cells through the activating receptor NKp46;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;Eli Lilly and Company (2014): agreement to pursue regulatory approval for non-prescription Cialis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (tadalafil).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi and its alliance partners have decided to terminate the following agreements (the related commitments are no longer included in Sanofi&#x2019;s off balance sheet disclosures as of December 31, 2022):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;in October&#160;2022, Sanofi and DiCE Molecules ended their global collaboration to discover potential new therapeutics for up to&#160;12&#160;targets that encompass all disease areas of strategic interest to Sanofi; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;in December&#160;2022, Sanofi and Revolution Medicines agreed, after a transitional phase, to end their partnership agreement in oncology signed in 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In addition, under the collaboration agreement with Regeneron on monoclonal antibodies (see Note&#160;C.1.), Sanofi is entitled to receive an additional share of quarterly profits (capped at 10% of Regeneron&#x2019;s share of quarterly profits until March&#160;31, 2022, and thereafter at 20%), until Regeneron has paid 50% of the cumulative development costs incurred by the parties to the alliance. As of December&#160;31, 2022 this represented total commitments received of &#x20ac;2.7 billion (versus &#x20ac;2.9 billion as of December&#160;31, 2021), against cumulative development costs of &#x20ac;8.4 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi entered into an agreement with Royalty Pharma in December&#160;2014 relating to development programs under which Royalty Pharma bears a portion of the remaining development costs of the project on a quarterly basis in return for royalties on future sales. This transaction is a co-investment, whereby the partner acquires an interest in the jointly-developed product by providing funding towards the development program. Consequently, the amounts received by Sanofi are recorded as a reduction in development costs, to the extent that the development costs incurred by Sanofi are recognized in profit or loss in accordance with the policies described in Note&#160;B.4.1. The products in development under the December&#160;2014 agreement with Royalty Pharma have been launched in the United States and Europe, marking the end of the joint development programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On February&#160;27, 2017, Sanofi and Lonza announced a strategic partnership in the form of a joint venture (BioAtrium AG) to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. An initial investment of approximately &#x20ac;0.3 billion to finance construction of the facility, split 50/50 between the two partners, has now been made in full. In addition, Sanofi could pay BioAtrium AG in the region of &#x20ac;0.6 billion over the next fifteen years as its share of operating expenses and the cost of producing future batches.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In February&#160;2014, pursuant to the &#x201c;Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits&#x201d; (still effective as of December 31, 2022), Sanofi Pasteur and the World Health Organization (WHO) signed a bilateral &#x201c;Standard Material Transfer Agreement&#x201d; (SMTA&#160;2). This agreement stipulates that Sanofi Pasteur will, during declared pandemic periods, (i)&#160;donate 7.5% of its real-time production of pandemic vaccines against any strain with potential to cause a pandemic, and (ii)&#160;reserve a further 7.5% of such production on affordable terms. The agreement cancels and replaces all preceding commitments to donate pandemic vaccines to the WHO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.21.2. Off balance sheet commitments relating to financing activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Credit facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Undrawn credit facilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiry&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;General-purpose credit facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, total credit facilities amounted to &#x20ac;8,000 million (versus &#x20ac;8,000 million as of December 31, 2021 and&#160;&#x20ac;8,000 million as of December 31, 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the amount of guarantees given and received:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Guarantees given:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,815&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,794&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,291&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Guarantees provided to banks in connection with credit facilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Other guarantees given&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Guarantees received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(964)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.21.3. Off balance sheet commitments relating to asset acquisitions and divestments, and to changes in the scope of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, Sanofi had received commitments amounting in aggregate to &#x20ac;1.0&#160;billion in respect of (i)&#160;divestments of assets relating to transactions not yet finalized as of that date and (ii)&#160;contingent consideration arising under past agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Off balance sheet commitments of a financing nature with associates and joint ventures are disclosed in N&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;ote&#160;D.6.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The maximum amount of contingent consideration relating to business combinations is disclosed in Note&#160;D.18.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock>
    <sny:DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEzODU1_abebb698-837d-4c73-9022-58f480e89e2f">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Off balance sheet commitments relating to Sanofi&#x2019;s operating activities comprise the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Payments due by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Irrevocable purchase commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;given&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;received&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development license agreements - commitments given&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;commitments related to R&amp;amp;D and other commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;contingent milestone payments in connection with development programs in progress&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(f)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total - net commitments given&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(g)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,112&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,901&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,505&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,878&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,828&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the variable portion of future lease payments not recognized as lease liabilities as of December 31, 2022; the equivalent amount of these commitments as of December&#160;31, 2021 was &#x20ac;109&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) These comprise irrevocable commitments to suppliers of (i)&#160;property, plant and equipment, net of down-payments (see Note&#160;D.3.) and (ii)&#160;goods and services. As of December 31, 2021, irrevocable commitments amounted to &#x20ac;8,901 million given and &#x20ac;1,124 million received.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Irrevocable purchase commitments given as of December 31, 2022 include &#x20ac;871 million of commitments to joint ventures, and the commitment to EUROAPI as described in Note&#160;D.1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d) Commitments related to R&amp;amp;D, and other commitments, amounted to &#x20ac;536 million as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(e) This line includes only contingent milestone payments on development projects in progress. The equivalent amount as of December 31, 2021 was &#x20ac;2,892 million.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock>
    <sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzItMS0xLTEtMzY0MDYw_432ddc24-6dfb-4bd4-9549-cf20e7b3c9ac"
      unitRef="eur">38000000</sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet>
    <sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzItMi0xLTEtMzY0MDYw_78781de7-f64a-4dd3-8644-3641c60933ab"
      unitRef="eur">26000000</sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet>
    <sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet
      contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzItMy0xLTEtMzY0MDYw_f6a3e99c-e082-4637-9b9d-6622ab2e6265"
      unitRef="eur">4000000</sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet>
    <sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet
      contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzItNC0xLTEtMzY0MDYw_899b6cde-3fe9-4a7e-a3b4-1ce3bdf8215c"
      unitRef="eur">3000000</sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet>
    <sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzItNS0xLTEtMzY0MDYw_cc9acf4d-7fa1-473d-b3de-b221963d0241"
      unitRef="eur">5000000</sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet>
    <sny:IrrevocablePurchaseCommitmentsGiven
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzQtMS0xLTEtMzY0MDYw_32436e75-be44-4fa5-ad85-8852c50b4679"
      unitRef="eur">10921000000</sny:IrrevocablePurchaseCommitmentsGiven>
    <sny:IrrevocablePurchaseCommitmentsGiven
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzQtMi0xLTEtMzY0MDYw_1d43a0ba-104d-4c8f-9258-8563ed2cb4b3"
      unitRef="eur">5957000000</sny:IrrevocablePurchaseCommitmentsGiven>
    <sny:IrrevocablePurchaseCommitmentsGiven
      contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzQtMy0xLTEtMzY0MDYw_a6a7d5a6-c17a-468f-969c-01881ea68920"
      unitRef="eur">2922000000</sny:IrrevocablePurchaseCommitmentsGiven>
    <sny:IrrevocablePurchaseCommitmentsGiven
      contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzQtNC0xLTEtMzY0MDYw_f77a26cf-48c6-47c3-a014-17c1893e0a3c"
      unitRef="eur">1062000000</sny:IrrevocablePurchaseCommitmentsGiven>
    <sny:IrrevocablePurchaseCommitmentsGiven
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzQtNS0xLTEtMzY0MDYw_bc7718bd-fdf5-4de9-af80-a5bb2d944567"
      unitRef="eur">980000000</sny:IrrevocablePurchaseCommitmentsGiven>
    <sny:IrrevocablePurchaseCommitmentsReceived
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzUtMS0xLTEtMzY0MDYw_e38b36af-c918-4234-b6c9-c86914f93f81"
      unitRef="eur">1025000000</sny:IrrevocablePurchaseCommitmentsReceived>
    <sny:IrrevocablePurchaseCommitmentsReceived
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzUtMi0xLTEtMzY0MDYw_c7d05510-c877-4c45-8e9b-0a030ba5ae48"
      unitRef="eur">482000000</sny:IrrevocablePurchaseCommitmentsReceived>
    <sny:IrrevocablePurchaseCommitmentsReceived
      contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzUtMy0xLTEtMzY0MDYw_d1a60b93-d4a3-4a87-8251-ed18f27be50c"
      unitRef="eur">335000000</sny:IrrevocablePurchaseCommitmentsReceived>
    <sny:IrrevocablePurchaseCommitmentsReceived
      contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzUtNC0xLTEtMzY0MDYw_3f6d179b-b5f7-41c8-9589-6699a1a8fc79"
      unitRef="eur">86000000</sny:IrrevocablePurchaseCommitmentsReceived>
    <sny:IrrevocablePurchaseCommitmentsReceived
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzUtNS0xLTEtMzY0MDYw_b278cd63-9501-44b2-952b-3a89c75a4b76"
      unitRef="eur">122000000</sny:IrrevocablePurchaseCommitmentsReceived>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzctMS0xLTEtMzY0MDYw_ed0aa7e5-02c8-4bbd-a14e-05a353c1272f"
      unitRef="eur">259000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzctMi0xLTEtMzY0MDYw_81bab1ac-f85f-4ef4-8bfc-9db2a467926f"
      unitRef="eur">197000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments
      contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzctMy0xLTEtMzY0MDYw_139b8ede-7214-4322-b2aa-5a2eef99310a"
      unitRef="eur">39000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments
      contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzctNC0xLTEtMzY0MDYw_dd4365fc-4927-408b-b069-07e931a799fa"
      unitRef="eur">10000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzctNS0xLTEtMzY0MDYw_5dc89916-2ffc-41b5-8e1d-84fb1a392773"
      unitRef="eur">13000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzgtMS0xLTEtMzY0MDYw_7a1bcfd4-837d-4b4b-8863-b8bad45adc97"
      unitRef="eur">2919000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzgtMi0xLTEtMzY0MDYw_720c98d4-ef02-43e2-b7f1-60d8b4d4b5e6"
      unitRef="eur">203000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress
      contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzgtMy0xLTEtMzY0MDYw_b132bfca-4469-4c18-aa1e-a34a2d092c11"
      unitRef="eur">875000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress
      contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzgtNC0xLTEtMzY0MDYw_997e844b-2ad7-4186-9a4d-8b3e8110b20e"
      unitRef="eur">889000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzgtNS0xLTEtMzY0MDYw_b87f8852-9b42-4ec5-995c-894478a0d000"
      unitRef="eur">952000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress>
    <sny:TotalOffBalanceSheetCommitments
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzktMS0xLTEtMzY0MDYw_e8da3516-1ce3-475a-952b-78d753d83572"
      unitRef="eur">13112000000</sny:TotalOffBalanceSheetCommitments>
    <sny:TotalOffBalanceSheetCommitments
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzktMi0xLTEtMzY0MDYw_6461ebf3-57a9-4713-8563-7496907a4690"
      unitRef="eur">5901000000</sny:TotalOffBalanceSheetCommitments>
    <sny:TotalOffBalanceSheetCommitments
      contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzktMy0xLTEtMzY0MDYw_f8441ea6-c10f-4727-94e3-8407e406ebc8"
      unitRef="eur">3505000000</sny:TotalOffBalanceSheetCommitments>
    <sny:TotalOffBalanceSheetCommitments
      contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzktNC0xLTEtMzY0MDYw_04f26e1a-ffb6-4ef7-b65f-3145619cca86"
      unitRef="eur">1878000000</sny:TotalOffBalanceSheetCommitments>
    <sny:TotalOffBalanceSheetCommitments
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNzk0OWE3ZDYxYzM0YzU2YmRmOWZlZDM3NDliYmJjNC90YWJsZXJhbmdlOjI3OTQ5YTdkNjFjMzRjNTZiZGY5ZmVkMzc0OWJiYmM0XzktNS0xLTEtMzY0MDYw_26afa4de-8748-417d-8568-f1f941e53a6a"
      unitRef="eur">1828000000</sny:TotalOffBalanceSheetCommitments>
    <sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI5Njg2ODEzOTc4Njc4_2fe92697-161b-4766-909b-ebbe16a0e050"
      unitRef="eur">109000000</sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet>
    <sny:IrrevocablePurchaseCommitmentsGiven
      contextRef="ifee9283d0d0f4705bf8cdb52374c5add_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2Xzg1Mw_c42f92bf-eadb-41e7-8a6a-67927d5ca9e3"
      unitRef="eur">8901000000</sny:IrrevocablePurchaseCommitmentsGiven>
    <sny:IrrevocablePurchaseCommitmentsReceived
      contextRef="ifee9283d0d0f4705bf8cdb52374c5add_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2Xzg2Nw_1171beae-6dd9-412b-9528-b629f3307941"
      unitRef="eur">1124000000</sny:IrrevocablePurchaseCommitmentsReceived>
    <sny:IrrevocablePurchaseCommitmentsGiven
      contextRef="ida98673a0c314cbbb23bda8debf1c3a2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2Xzk0MQ_1261ce8d-3029-4406-ae9a-1704896aa6ab"
      unitRef="eur">871000000</sny:IrrevocablePurchaseCommitmentsGiven>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwNDY_69af29da-7485-4e4f-b0be-2698d825cd6d"
      unitRef="eur">536000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments>
    <sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyMTM_0d36fd4b-610b-48a9-beb2-34ffae11ce28"
      unitRef="eur">2892000000</sny:CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress>
    <sny:CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMTg1Mjg_ec79ef45-8b5b-4555-bc50-525e2192994d"
      unitRef="eur">18000000000</sny:CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase>
    <sny:CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMTg1NDA_867c77a5-9eb1-4f1e-827c-041ebbf68b07"
      unitRef="eur">6700000000</sny:CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase>
    <sny:CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMTg2NDc_4076bb57-5625-4d78-8bed-f227623e19ab"
      unitRef="eur">18500000000</sny:CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets>
    <sny:CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMTg2NTk_91e3a305-78ca-4e64-91fe-92a87281a47b"
      unitRef="eur">8100000000</sny:CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets>
    <sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjIxNjM_f06bc195-2ce5-4d8e-b201-d9f628035586"
      unitRef="eur">8800000000</sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements>
    <sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjIxOTE_7cf00a3a-d4ab-480b-aed4-ddc8ef58114c"
      unitRef="eur">5800000000</sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements>
    <sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements
      contextRef="i1aecb43ad25f41bf8dc1c5d72a0787bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjIzNDc_6660a8fe-8c8b-4e79-b801-a534a423250e"
      unitRef="eur">1000000000</sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements>
    <sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements
      contextRef="i34de2d5f0d404fe8b61b41f862084aa5_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjIzNjI_a02895cb-f24f-44c1-a12a-78cb5f1d74f2"
      unitRef="eur">1000000000</sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements>
    <sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements
      contextRef="i1db7d23934de4ddd846d982ab6ddd48e_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjI0MDU_eb28093e-c813-43db-937e-bf374d4d78ef"
      unitRef="eur">200000000</sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements>
    <sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements
      contextRef="i51d7f3d541c8470e916d2b51d66890f0_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjI0Mjk_cd66f872-e732-4154-8e8b-f5974f80e0dd"
      unitRef="eur">500000000</sny:CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements>
    <sny:CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjI2NjU_c218884e-1e98-4c3e-92be-5f1f12a53672"
      unitRef="eur">7600000000</sny:CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts>
    <sny:CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjI3MDY_bf14a477-3d65-4d55-8751-bdc8d9bfd95b"
      unitRef="eur">4200000000</sny:CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts>
    <sny:NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement
      contextRef="i9a347be5f1b14fadbc39a77db3c13573_I20220107"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI5MTM3MDU4MTcwNTYz_4b71c851-5078-4b94-8d58-bfdc79179b24"
      unitRef="molecule">15</sny:NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement>
    <sny:UpfrontPayments
      contextRef="i35f0fcaaff094ff283b1ab8503932dab_D20220107-20220107"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4MDE_84d4db1a-6877-46d6-943a-c0503bf7fb2f"
      unitRef="usd">100000000</sny:UpfrontPayments>
    <sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements
      contextRef="i9a347be5f1b14fadbc39a77db3c13573_I20220107"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4MDc_c098a23a-3720-46b4-8bd3-c6b01b0178c2"
      unitRef="usd">5200000000</sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements>
    <sny:UpfrontPayments
      contextRef="i2ee3b5635d9a4570b0eaa9262220df54_D20220111-20220111"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4MTM_c282dedc-aad1-4a97-871c-d6544031f1bb"
      unitRef="usd">75000000</sny:UpfrontPayments>
    <sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements
      contextRef="ia237d1ef26b2453a9066a2c6db45411a_I20220111"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4MTk_dfc13684-c18e-44ad-860e-2019b95103c7"
      unitRef="usd">985000000</sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements>
    <sny:UpfrontPayments
      contextRef="i5bf703c7b65f49509efae3ab1093a037_D20220302-20220302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4Mjc_480d3159-f400-41dc-add4-822fcd9d32a6"
      unitRef="usd">17500000</sny:UpfrontPayments>
    <sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements
      contextRef="i8577ba8bcc2641bd8f3f948974bf77da_I20220302"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4MzM_98fc8a53-13f6-43d4-8b5d-dc90eda2a32d"
      unitRef="usd">2500000000</sny:CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements>
    <sny:CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement
      contextRef="i4e5b18318ed54f3eb42bb7d6fc7b7b2f_D20220315-20220315"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4NDA_61e58b73-eed9-4bb9-977a-7497f808a4a0"
      unitRef="eur">300000000</sny:CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement>
    <sny:NumberOfOncologyTargetsUnderCollaborationAgreement
      contextRef="iee6d0db9a6b14019a9f01106b4265553_I20220329"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzQwNjgxOTMwMjUzNjEw_c889bbb7-4f8b-404f-ad42-7144e2532e76"
      unitRef="target">3</sny:NumberOfOncologyTargetsUnderCollaborationAgreement>
    <sny:NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement
      contextRef="iee6d0db9a6b14019a9f01106b4265553_I20220329"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzgwODE0MTA0NjgwNTEw_9a84af18-b284-451a-910b-10f93cef8b92"
      unitRef="target">3</sny:NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement>
    <sny:UpfrontPayments
      contextRef="i7d7acd3285a64b18bcadb39dc8467fe9_D20220329-20220329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4NDc_2f660362-f612-4292-bfb3-ba5108b42f88"
      unitRef="usd">150000000</sny:UpfrontPayments>
    <sny:ContingentConsiderationCollaborationAgreements
      contextRef="iee6d0db9a6b14019a9f01106b4265553_I20220329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDQ4NTM_28bff37f-3ce6-432e-9c1a-dceb78734ea7"
      unitRef="eur">6000000000.0</sny:ContingentConsiderationCollaborationAgreements>
    <sny:UpfrontPayments
      contextRef="i44fe2a71b5884068beea16755e096330_D20220705-20220705"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTA0Nzk_51459437-9b27-47ed-9313-c5db5edaa058"
      unitRef="usd">54000000</sny:UpfrontPayments>
    <sny:ContingentConsiderationCollaborationAgreements
      contextRef="iabdcdf0ea9e54926bd844b49811591f2_I20220705"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTA1MzA_53cee153-4432-4f31-bbf5-104ba95c111f"
      unitRef="usd">2000000000.0</sny:ContingentConsiderationCollaborationAgreements>
    <sny:UpfrontPayments
      contextRef="i4412024b1ca64ec595944d1b8a39c157_D20220817-20220817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTk0Nzk_c8030514-c2e6-4cf1-80ef-4328d9926127"
      unitRef="usd">20000000</sny:UpfrontPayments>
    <sny:ContingentConsiderationCollaborationAgreements
      contextRef="iefe35c5798714318b57d812dd4c261dc_I20220817"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTk1MzA_1cfc4a9f-86b2-46ef-9042-d0657059c03b"
      unitRef="usd">1000000000.0</sny:ContingentConsiderationCollaborationAgreements>
    <sny:UpfrontPayments
      contextRef="i4ce31d589886460a8d3fa4ad454d29e9_D20220927-20220927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTk5NTc_2f4169b0-30c6-40a4-aad1-3fb4140c0b41"
      unitRef="usd">25000000</sny:UpfrontPayments>
    <sny:ContingentConsiderationCollaborationAgreements
      contextRef="i2e57da6edcd64cc0855f5deeb43a3a3e_I20220927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NjAwMDg_97b03108-0165-4ed1-b4c2-baac32767ebe"
      unitRef="usd">1000000000.0</sny:ContingentConsiderationCollaborationAgreements>
    <sny:UpfrontPayments
      contextRef="i3acc15b07f7340ec878d66dfd3f468d7_D20221004-20221004"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTE3NTM_d67cc577-9fb2-41c7-b8ee-9356fa457cce"
      unitRef="usd">20000000</sny:UpfrontPayments>
    <sny:ContingentConsiderationCollaborationAgreements
      contextRef="i28364fce90bf409d98323009a8de319e_I20221004"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTE4MDQ_5c5d6a6d-eff1-4fbc-9434-9311c98b0363"
      unitRef="usd">400000000</sny:ContingentConsiderationCollaborationAgreements>
    <sny:UpfrontPayments
      contextRef="i69e8fa7b0e3e42d4a5776c81a67f605c_D20221108-20221108"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NjEzNzU_31bfc390-0ffa-4c1e-ae82-8954031440f5"
      unitRef="usd">12500000</sny:UpfrontPayments>
    <sny:ContingentConsiderationCollaborationAgreements
      contextRef="i627c20e57c964355b8bcb250eb638da3_I20221108"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NjE0MjY_7520241e-a326-4215-bc46-c23c91293d73"
      unitRef="usd">1200000000</sny:ContingentConsiderationCollaborationAgreements>
    <sny:UpfrontPayments
      contextRef="i466e422ce31947d2b1f05591f8974461_D20221219-20221219"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTQxMDg_79b98536-265b-4f0e-bd97-a238c2492551"
      unitRef="usd">25000000</sny:UpfrontPayments>
    <sny:ContingentConsiderationCollaborationAgreements
      contextRef="i1b248f6ef872486e91c5718d675cc163_I20221219"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NTQxNTY_a00a3d8d-2a93-4108-bdc2-925e748142a6"
      unitRef="usd">1400000000</sny:ContingentConsiderationCollaborationAgreements>
    <sny:NumberOfTargetsThatEncompassAllDiseasesAreas
      contextRef="if937d6453c6841d8b3e41feedb2e553c_D20160101-20161231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEwOTk1MTE2NDg5NzA_d6b51964-1096-4c7c-a161-6b9751c187e8"
      unitRef="target">12</sny:NumberOfTargetsThatEncompassAllDiseasesAreas>
    <sny:PercentageOfProfitShareOnCounterpartiesProfit
      contextRef="ia86bd221eba9446a8f9f749cb46b9a8a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzgwODE0MTA0NzQ4ODAx_d36a7bd8-7e2b-4bcf-9b78-7da0235c2537"
      unitRef="number">0.10</sny:PercentageOfProfitShareOnCounterpartiesProfit>
    <sny:PercentageOfProfitShareOnCounterpartiesProfit
      contextRef="ibf593c1decbc4ca188f74599b1b99ff6_D20220401-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzgwODE0MTA0NzQ4ODEx_fff19d15-7c72-42f0-8aa2-c5b98d6531e1"
      unitRef="number">0.20</sny:PercentageOfProfitShareOnCounterpartiesProfit>
    <sny:PercentageOfCumulativeDevelopmentCostsReimbursed
      contextRef="i5ac3d72e4d4b4421bbf3911c50584e74_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzgwODE0MTA0NzQ4ODA2_fed51c52-1a00-47fb-857c-bb23f0bae766"
      unitRef="number">0.50</sny:PercentageOfCumulativeDevelopmentCostsReimbursed>
    <sny:CommitmentsReceivedForDevelopmentCosts
      contextRef="i3ecee33decbb47918bc45c5d39b6e2d8_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjM4Mzg_45bd72c3-09a0-431f-8ff4-6fd4ca49e814"
      unitRef="eur">2700000000</sny:CommitmentsReceivedForDevelopmentCosts>
    <sny:CommitmentsReceivedForDevelopmentCosts
      contextRef="if08a539d4d40455d827bc164ddb96d57_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjM4NTE_fca51858-5835-42ba-82d7-b54ea9c4d61f"
      unitRef="eur">2900000000</sny:CommitmentsReceivedForDevelopmentCosts>
    <sny:CumulativeDevelopmentCostsIncurred
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI3NDg3NzkxMjM5MTQ_753daca0-e9dd-4136-b593-41ba7f2e422a"
      unitRef="eur">8400000000</sny:CumulativeDevelopmentCostsIncurred>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="ib16cb21631ad4c40a1073da4e54006b2_I20170227"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzExNzE3_f75066b9-cdb4-4639-8662-a355f9a00737"
      unitRef="eur">300000000</ifrs-full:InvestmentsInJointVentures>
    <sny:PercentageOfFutureDevelopmentExpenseFundedByCompany
      contextRef="ie9a55e06161b4bc6ab47f39f7831c794_D20170227-20170227"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzExNzY3_b69d7826-27e2-4d86-810b-1b86e574edce"
      unitRef="number">0.50</sny:PercentageOfFutureDevelopmentExpenseFundedByCompany>
    <sny:PercentageOfFutureDevelopmentExpenseFundedByOtherParty
      contextRef="if77c8aea29ef447792cb9de0a457cec9_D20170227-20170227"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzExNzcw_815ce034-ccc3-471f-9dcb-ee99bf94374a"
      unitRef="number">50</sny:PercentageOfFutureDevelopmentExpenseFundedByOtherParty>
    <sny:AmountsPayablePartnersInCollaborationAgreements
      contextRef="ib16cb21631ad4c40a1073da4e54006b2_I20170227"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzExODc5_383f2ad1-cc29-467d-b79b-11c7172f9336"
      unitRef="eur">600000000</sny:AmountsPayablePartnersInCollaborationAgreements>
    <sny:ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod
      contextRef="ie9a55e06161b4bc6ab47f39f7831c794_D20170227-20170227"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzExODk2_9572e5d0-2774-4c14-8963-327704f43da6">P15Y</sny:ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod>
    <sny:TransferPercentageOfPandemicVaccines
      contextRef="i7297bd667dcc407e9d3a685feb63aa85_I20140228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyMzg4_8b4c308e-9fcf-41d0-8f1b-dcf8368e9e7a"
      unitRef="number">0.075</sny:TransferPercentageOfPandemicVaccines>
    <sny:ReservePercentageOfPandemicVaccines
      contextRef="i7297bd667dcc407e9d3a685feb63aa85_I20140228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyNTIy_c2440964-c278-481a-ad56-4870b98b750d"
      unitRef="number">0.075</sny:ReservePercentageOfPandemicVaccines>
    <sny:DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEzODU4_58c53636-bee3-4692-814b-c2d64b938ed1">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Undrawn credit facilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiry&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&#160;than&lt;br/&gt;1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1&#160;to&lt;br/&gt;3&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3&#160;to&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;More&#160;than&lt;br/&gt;5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;General-purpose credit facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock>
    <ifrs-full:UndrawnBorrowingFacilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToxZmM5YjhmY2IzYTc0ZWViYjU2NjkwZTE3NDI3MDc1YS90YWJsZXJhbmdlOjFmYzliOGZjYjNhNzRlZWJiNTY2OTBlMTc0MjcwNzVhXzItMS0xLTEtMzY0MDYw_9e7134af-4669-455a-a507-107ae33e6be7"
      unitRef="eur">8000000000</ifrs-full:UndrawnBorrowingFacilities>
    <ifrs-full:UndrawnBorrowingFacilities
      contextRef="ib7e3b493141f4fa09c383ab24c96a46c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToxZmM5YjhmY2IzYTc0ZWViYjU2NjkwZTE3NDI3MDc1YS90YWJsZXJhbmdlOjFmYzliOGZjYjNhNzRlZWJiNTY2OTBlMTc0MjcwNzVhXzItMi0xLTEtMzY0MDYw_de6714a5-1eb6-4981-b10b-0688c4430982"
      unitRef="eur">4000000000</ifrs-full:UndrawnBorrowingFacilities>
    <ifrs-full:UndrawnBorrowingFacilities
      contextRef="i59dc276763734d8fa431523f6ec5e6b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToxZmM5YjhmY2IzYTc0ZWViYjU2NjkwZTE3NDI3MDc1YS90YWJsZXJhbmdlOjFmYzliOGZjYjNhNzRlZWJiNTY2OTBlMTc0MjcwNzVhXzItMy0xLTEtMzY0MDYw_dae89307-754a-419a-95ea-e9ebaf2d24ac"
      unitRef="eur">0</ifrs-full:UndrawnBorrowingFacilities>
    <ifrs-full:UndrawnBorrowingFacilities
      contextRef="iff1ff8d4b3a145be98d0790e4617ed52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToxZmM5YjhmY2IzYTc0ZWViYjU2NjkwZTE3NDI3MDc1YS90YWJsZXJhbmdlOjFmYzliOGZjYjNhNzRlZWJiNTY2OTBlMTc0MjcwNzVhXzItNC0xLTEtMzY0MDYw_c5945dec-0f80-4fbd-9e62-b8baf18a2738"
      unitRef="eur">4000000000</ifrs-full:UndrawnBorrowingFacilities>
    <ifrs-full:UndrawnBorrowingFacilities
      contextRef="i6fda103b354c454696639116746e4ce6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToxZmM5YjhmY2IzYTc0ZWViYjU2NjkwZTE3NDI3MDc1YS90YWJsZXJhbmdlOjFmYzliOGZjYjNhNzRlZWJiNTY2OTBlMTc0MjcwNzVhXzItNS0xLTEtMzY0MDYw_de8ffea5-9e74-4e45-b0e7-1272b68d6052"
      unitRef="eur">0</ifrs-full:UndrawnBorrowingFacilities>
    <ifrs-full:UndrawnBorrowingFacilities
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyODQ1_ce47020d-3760-4f44-aead-2b253269910e"
      unitRef="eur">8000000000</ifrs-full:UndrawnBorrowingFacilities>
    <ifrs-full:UndrawnBorrowingFacilities
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyODU2_d6f5af07-0cc7-475b-bc40-24e7be4c05f9"
      unitRef="eur">8000000000</ifrs-full:UndrawnBorrowingFacilities>
    <ifrs-full:UndrawnBorrowingFacilities
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEyODcy_ec4cff75-dee7-4761-856a-8722d8f58efc"
      unitRef="eur">8000000000</ifrs-full:UndrawnBorrowingFacilities>
    <sny:DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzEzODY3_95ebbf2d-b2dd-4bec-a196-78fb1969c0a7">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the amount of guarantees given and received:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Guarantees given:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,815&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,794&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,291&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Guarantees provided to banks in connection with credit facilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;Other guarantees given&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Guarantees received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(964)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="ibf03bba2a0f04d1188d25f148f36a72d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzEtMS0xLTEtMzY0MDYw_5dbb1e2f-d7b8-4a1c-99e7-3fdf25b6c713"
      unitRef="eur">3815000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="i939fa095546f44a393ce805aaaade10d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzEtMi0xLTEtMzY0MDYw_a54e6a48-1f48-4e99-8d2e-43f510a20e8d"
      unitRef="eur">3794000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="ie7d70051b63048b482c6e8dc47988e25_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzEtMy0xLTEtMzY0MDYw_190ef15f-6984-4ea1-9b43-98f37bf664a5"
      unitRef="eur">3291000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="if1de0a6f85434a9b9e97775863357700_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzItMS0xLTEtMzY0MDYw_2b7d625d-3356-4f40-8e81-95e578008ad0"
      unitRef="eur">1007000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="id1b027a016e14cfe88b71b1c3fb15eca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzItMi0xLTEtMzY0MDYw_ff4f4e31-0d3a-4def-b22a-954d28aea9a5"
      unitRef="eur">1042000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="i8bc3ba5245904e0a90bb4d29a9cc145e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzItMy0xLTEtMzY0MDYw_f9536780-3e10-4325-a188-a9e7f8f14159"
      unitRef="eur">695000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="ia0d813bb627146f2ad3035a585e98181_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzMtMS0xLTEtMzY0MDYw_0be7929f-f486-4d94-b6fb-491f3dfc1c14"
      unitRef="eur">2808000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="i044e8ccf5872470daae5e14174d0c4c0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzMtMi0xLTEtMzY0MDYw_6bee93d2-b8e1-4e33-b793-7b79b672c3e9"
      unitRef="eur">2752000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="ieeeb99efde1d442fa44fecb8bdbed1f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzMtMy0xLTEtMzY0MDYw_bdf8f012-7fbf-44b2-8e62-d26f711d82e7"
      unitRef="eur">2596000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="i2ee6a60b930541f79b2560c7e63bdae3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzQtMS0xLTEtMzY0MDYw_e3d8dbcc-5857-4e48-ba45-155bfd2f5ec2"
      unitRef="eur">1229000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="i214032b872604476b3988af269c27156_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzQtMi0xLTEtMzY0MDYw_8994e359-4e65-47f7-9b4d-2c3b69669908"
      unitRef="eur">1149000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="i6a28592851c14211acba46221b993eb6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90YWJsZToyNTg4MjE1Y2M2ODY0ODQ1YWQ5YzliNTg5ZjI0MTgwOS90YWJsZXJhbmdlOjI1ODgyMTVjYzY4NjQ4NDVhZDljOWI1ODlmMjQxODA5XzQtMy0xLTEtMzY0MDYw_34f72064-73a9-465a-82c1-521df9c1f55a"
      unitRef="eur">964000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <sny:OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTUvZnJhZzpjYTk5ZTQ3MzUyNzY0YjUzOGJjZTFjZmFjZDkxMGFiNi90ZXh0cmVnaW9uOmNhOTllNDczNTI3NjRiNTM4YmNlMWNmYWNkOTEwYWI2XzI5Njg2ODE0MDQ5MDA3_55a84cea-4aa6-4b1e-b5d9-92b34386b046"
      unitRef="usd">1000000000.0</sny:OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments>
    <sny:DisclosureOfLegalAndArbitralProceedingsTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzM3MDE5_f65db3d1-b56e-4f8c-88e2-66fa81fb65e3">Legal and arbitral proceedings&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi and its affiliates are involved in litigation, arbitration and other legal proceedings. These proceedings typically are related to product liability claims, intellectual property rights (particularly claims against generic companies seeking to limit the patent protection of Sanofi&#160;products), competition law and trade practices, commercial claims, employment and wrongful discharge claims, tax assessment claims, waste disposal and pollution claims, and claims under warranties or indemnification arrangements relating to business divestitures. Provisions related to legal and arbitral proceedings are recorded in accordance with the principles described in Note&#160;B.12.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Most of the issues raised by these claims are highly complex and subject to substantial uncertainties; therefore, the probability of loss and an estimation of damages are difficult to ascertain. Contingent liabilities are cases for which either we are unable to make a reasonable estimate of the expected financial effect that will result from ultimate resolution of the proceeding, or a cash outflow is not probable. In either case, a brief description of the nature of the contingent liability is disclosed and, where practicable, an estimate of its financial effect, an indication of the uncertainties relating to the amount and timing of any outflow, and the possibility of any reimbursement are provided in application of paragraph&#160;86 of IAS&#160;37.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the cases that have been settled or adjudicated, or where quantifiable fines and penalties have been assessed, we have indicated our losses or the amount of provision accrued that is the estimate of the probable loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In a limited number of ongoing cases, while we are able to make a reasonable estimate of the expected loss or range of the possible loss and have accrued a provision for such loss, we believe that publication of this information on a case-by-case basis or by class would seriously prejudice the Company&#x2019;s position in the ongoing legal proceedings or in any related settlement discussions. Accordingly, in those cases, we have disclosed information with respect to the nature of the contingency but have not disclosed our estimate of the range of potential loss, in accordance with paragraph&#160;92 of IAS&#160;37.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;These assessments can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. Our assessments are based on estimates and assumptions that have been deemed reasonable by management. We believe that the aggregate provisions recorded for the above matters are adequate based upon currently available information. However, given the inherent uncertainties related to these cases and involved in estimating contingent liabilities, we could in the future incur judgments that could have a material adverse effect on our net income in any particular period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Long term provisions are disclosed in Note&#160;D.19. They include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;provisions for product liability risks, litigation and other amount to &#x20ac;1,652 million in 2022. These provisions are mainly related to product liabilities, government investigations, competition law, regulatory claims, warranties in connection with certain contingent liabilities arising from business divestitures other than environmental matters and other claims;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;provisions for environmental risks and remediation amount to &#x20ac;526 million in 2022, the majority of which are related to contingencies that have arisen from business divestitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a) Products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sanofi Pasteur Hepatitis&#160;B Vaccine Product Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Since 1996, more than 180&#160;lawsuits have been filed in various French civil courts against Sanofi Pasteur and/or Sanofi Pasteur&#160;MSD&#160;S.N.C., the former French subsidiary of Sanofi, and the latter a joint venture company with Merck&#160;&amp;amp; Co.,&#160;Inc. now terminated, for which past ongoing litigation is now managed by the originating party. In such lawsuits, the plaintiffs allege that they suffer from a variety of neurological disorders and autoimmune diseases, including multiple sclerosis and Guillain-Barr&#xe9; syndrome as a result of receiving the hepatitis&#160;B vaccine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In January&#160;2018, the Appeal Court of Bordeaux found a causal link between hepatitis&#160;B vaccine and multiple sclerosis. In&#160;July&#160;2019, the French Supreme Court &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Cour de cassation)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; cancelled the&#160;judgment&#160;of the Appeal Court of Bordeaux and referred the&#160;case back to the Appeal Court of Toulouse. On March&#160;30, 2022, the Appeal Court of Toulouse dismissed all the plaintiff&#x2019;s claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there were 49&#160;ongoing lawsuits related to Sanofi Pasteur hepatitis&#160;B vaccine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Taxotere&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Product Litigation in the US&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, there were approximately 8,300&#160;plaintiffs in courts across the country, with approximately 700&#160;of those plaintiffs being spouses who have filed loss of consortium claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Lawsuits have been filed against affiliates of Sanofi under US state law for personal injuries allegedly sustained in connection with&#160;the use of Taxotere&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. The actions are held in several jurisdictions, including the federal and/or state courts of Louisiana, New&#160;Jersey, California, and Delaware. To date, there have been two&#160;bellwether trials as part of a federal multi-district litigation in the Eastern District of Louisiana both resulting in jury verdicts in Sanofi's favor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;It is not possible, at this stage, to reliably assess the outcome of these lawsuits or the potential financial impact on the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Taxotere&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2013; Mississippi Attorney General Litigation in the US&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In October&#160;2018, the Attorney General for the State of Mississippi filed a civil action in Hinds County, Mississippi, Chancery Court against various Sanofi Defendants related to Taxotere&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. The State asserts one cause of action based on the Mississippi Consumer Protection Act (&#x201c;MCPA&#x201d;) and seeks a permanent injunction prohibiting Defendants&#x2019; conduct and civil penalties of up to $10,000 for each violation. Sanofi filed a motion to dismiss the entire action in Hinds County, Mississippi, Chancery Court, which is currently pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;It is not possible, at this stage, to assess reliably the outcome of this lawsuit or the potential financial impact on the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zantac&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Litigation in the US&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In September&#160;2019, the US Food and Drug Administration (&#x201c;FDA&#x201d;) announced it was investigating the claims of an online pharmacy&#x2019;s Citizen Petition that the medication Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (the brand name for ranitidine) used for stomach heartburn contains or can generate the chemical N-Nitrosodimethylamine (&#x201c;NDMA&#x201d;), an alleged human carcinogen. As a precautionary measure, Sanofi initiated a voluntary recall of branded over-the-counter Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in October&#160;2019. Concurrent with FDA&#x2019;s investigation, multiple personal injury lawsuits and class actions alleging that Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; causes various cancers and seeking damages for either alleged personal injuries or alleged economic injuries were filed. Most of those cases have been coordinated into a Multi-District Litigation (&#x201c;MDL&#x201d;) in the Southern District of Florida.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On June&#160;30 and July&#160;8, 2021, the Federal MDL Court entered orders granting in part and denying in part Defendants&#x2019; motions to dismiss various aspects of Plaintiffs&#x2019; amended complaints. The rulings narrowed the scope of plaintiffs&#x2019; complaints and saw the dismissal of all retailers and generic manufacturers from the MDL, leaving branded manufacturers GSK, Pfizer, Boehringer Ingelheim, and Sanofi as the defendants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On December&#160;6, 2022, the MDL Court granted Sanofi and the other defendants&#x2019; Daubert and Summary Judgment motions. As a result, the Court will dismiss approximately 50,000&#160;cases involving plaintiffs&#x2019; five designated cancers. We expect those plaintiffs to appeal the MDL's Court's decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Other cases are pending in various state courts. These state court cases still include numerous retail and generics manufacturing defendants in addition to branded manufacturers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In addition, in November&#160;2019, Sanofi received a Civil Investigative Demand (&#x201c;CID&#x201d;) related to this issue from the Arizona Attorney General.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In June&#160;2020, the New Mexico Attorney General filed a complaint against Sanofi, the previous marketing authorization holders for branded Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, a dozen generic manufacturers, and several retailers. The complaint brings claims for alleged violations of the New Mexico Unfair Practices Act, violations of the New Mexico False Advertising Act, violations of the New Mexico Public Nuisance Statute, common law public nuisance, and negligence.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In June&#160;2020, Sanofi received a notice from the US Department of Justice Civil Division and US Attorney&#x2019;s Office for the Eastern District of Pennsylvania of an investigation into allegations that pharmaceutical manufacturers violated the False Claims Act,&#160;31&#160;U.S.C. &#xa7;&#160;3729, in relation to the drug Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; and ranitidine hydrochloride through alleged failure to disclose to the federal government information about the potential presence of NDMA. The notice requests information and documents from Sanofi including applications and communications with&#160;FDA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In November&#160;2020, the Mayor and City Council of Baltimore filed a complaint against Sanofi, the previous marketing authorization holders for branded Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, generic manufacturers, and several retailers. The complaint alleges violations of the Maryland Consumer Protection statute, public nuisance, and negligence.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In January&#160;2021, Sanofi was served with the Center for Environmental Health&#x2019;s Second Amended Complaint alleging Proposition&#160;65&#160;violations. The case, which also names generic manufacturers and retailers, is pending in California Superior Court&#160;in Alameda County.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Overall between State and federal filings, there are currently 3,486&#160;product liability &#x201c;complaints&#x201d; filed. These complaints encompass&#160;68,355&#160;individual product liability &#x201c;plaintiffs&#x201d; who have all filed against Sanofi. The vast majority of these plaintiffs participated in the MDL Court&#x2019;s census registry program, allege cancers that the plaintiffs&#x2019; leadership decided not to designate and pursue in the MDL, and have since filed their complaints in state courts. Additional cases may be filed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;It is not possible, at this stage, to assess reliably the outcome of these lawsuits or the potential financial impact on Sanofi.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zantac&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Litigation in Canada&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Between 2019 and 2022, 7&#160;proposed class actions naming notably Sanofi Consumer Health&#160;Inc., Sanofi-Aventis Canada Inc., Chattem (Canada)&#160;Inc., Sanofi and Sanofi Pasteur Limited as Defendants, relating to ranitidine were filed in various Canadian States court on behalf of all Canadian provinces alleging they suffered personal injury, including cancer, from the ingestion of ranitidine and are seeking general special, statutory, punitive and aggravated damages in an unspecified amount as well as disgorgement of profits. Additionally, some plaintiffs seek restitution for unjust enrichment in an amount equivalent to the purchase price of Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; and subrogated damages on behalf of provincial health insurers for health care costs related to ranitidine use. These actions are pending before the courts of Alberta, British Columbia, Quebec and Ontario. A Certification hearing was held in the British Columbia action in October&#160;2022 and the certification decision is under review of the Court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;It is not possible, at this stage, to assess reliably the outcome of these lawsuits or the potential financial impact on Sanofi.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Depakine&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Product Litigation in France&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Civil proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, 78&#160;families brought a civil claim involving 131&#160;people exposed in utero to sodium valproate against a French affiliate of Sanofi seeking indemnification under French law for personal injuries allegedly suffered by children in connection with the use of sodium valproate by their mothers during pregnancy to treat their epilepsy (Depakine&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;). These actions are held in several jurisdictions in&#160;France.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Twenty-nine lawsuits are proceedings on the merits, the most advanced was tried at the French Supreme Court level which issued in November&#160;2019 a ruling sending the case before the Paris Appeal Court to rule on Sanofi&#x2019;s argument on the compliance of the product with mandatory regulations, as well as on the question of defectiveness of the product and the assessment of damages. In January&#160;2023, the Paris Appeal Court ordered a stay in the proceedings until the second expert opinion report is handed down in the criminal investigation (see below). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Seven first instance rulings on the merits were handed down in 2022 by the Judicial Tribunal of Nanterre. In three cases, the Court declared the judicial expert report null and void and the Court dismissed one claim in another case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Concerning three other cases relating to births that occurred between 2005 and 2009, the Court held, on the basis of a non-fault liability, that Sanofi was liable in light of the wording of the patient information leaflet. Provisional compensation amounts were set in the range of &#x20ac;0.1&#160;million to &#x20ac;0.5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;All the judgments have been appealed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the class action lawsuit filed in May&#160;2017 by the APESAC &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Association des Parents d&#x2019;Enfants souffrant du Syndrome de l&#x2019;Anti-Convulsivant)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; against the French affiliate, the Judicial Tribunal of Paris ruled on January&#160;5, 2022 that a class is admissible, retaining Sanofi&#x2019;s liability between 1984 and January&#160;2006 for malformations and between 2001 and January&#160;2006 for neuro-developmental disorders (NDD). This decision is based on the conclusions of a criminal expert report within the frame of ongoing criminal proceeding, for which the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chambre de l&#x2019;Instruction&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; of the Appeal Court of Paris had ordered a counter-expertise (see&#160;below). Sanofi and its insurers appealed the Judicial Tribunal of Paris' ruling related to the class action.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On July&#160;21, 2021, a Judicial Tribunal in France dismissed a claim for damages brought against Sanofi regarding a child born in&#160;1995. The Judicial Tribunal considered that the risk of occurrence of NDD in children born to mother exposed to sodium valproate during pregnancy was not demonstrated by the state of scientific knowledge at the time of her pregnancy. This decision was appealed and the proceeding is now pending before the Appeal Court of Paris, which had ordered a stay in the proceeding until the end of the criminal investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In July&#160;2020, a collective redress against the French affiliate was filed by&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; 63&#160;f&lt;/span&gt;&lt;span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;amilies, seeking indemnification for a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; prejudice of anxiety&lt;/span&gt;&lt;span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;There is no date set for the hearing on the merits in this case yet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Criminal investigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;A criminal investigation was initiated in May&#160;2015 before the Paris Civil Court. In January&#160;2020, the French affiliate of Sanofi was indicted for aggravated deception and involuntary injuries and in July&#160;2020 for involuntary manslaughter. In July&#160;2020, a judicial supervision of the affiliate was ordered, together with the implementation of financial guarantees. In November&#160;2020, the Health Authority (&lt;/span&gt;&lt;span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;ANSM) was similarly indicted for involuntary injuries and involuntary manslaughters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On March&#160;9, 2022, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chambre de l&#x2019;Instruction&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; of the Appeal Court of Paris ruled that certain complaints for involuntary manslaughter and several others for aggravated deception and involuntary injuries were time-barred. The Public Prosecutor, as well as the civil parties, have brought the matter before the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chambre Criminelle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;of the Supreme Court. &lt;/span&gt;&lt;span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In September&#160;2022, the investigating judges appointed 2&#160;experts for a counter-expertise following the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chambre de l&#x2019;Instruction&#x2019;s&lt;/span&gt;&lt;span style="background-color:#fefefe;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; ruling handed down end of 2021 and in October&#160;2022 ordered 6&#160;individual medical assessments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Public compensation scheme&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2017, the French government set up a public compensation scheme to indemnify patients for damages suffered in connection with the prescription of sodium valproate and its derivatives. The scheme was further amended through the 2020 Finance Law, with notably the introduction of presumptions of default for lack of information of the mother since 1982 for malformations and since 1984 for NDD. The scheme was amended again through the&#160;2021 Finance Law in order to increase the maximum premium applicable in case of refusal to make an offer (or insufficient offer) which would be deemed unjustified by a court ruling.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The committee of the compensation scheme has issued several final opinions holding the French affiliate liable for damages either in full or in part along with the French State, and, in some cases, healthcare practitioners. The French affiliate disagreed with the committee&#x2019;s conclusions and has accordingly not offered indemnification to the claimants who have received compensation from the ONIAM &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Office National d'Indemnisation des Accidents M&#xe9;dicaux)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. The ONIAM is now seeking reimbursement from Sanofi who has filed legal actions to oppose ONIAM&#x2019;s payment orders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi has also been notified of 63&#160;exposed persons who have filed a request for indemnification before the public compensation scheme and who are also claimants against Sanofi in individual judicial proceedings (summary proceedings or actions on the&#160;merits).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Administrative Actions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In July&#160;2020, March and June&#160;2021, the Montreuil Administrative Court had held the French State liable in 5&#160;administrative proceedings initiated by families against the State. In March&#160;2021, the Administrative Court did not retain any lack of information of the mother regarding the risk of neurodevelopmental disorders for births in 1999 and in 2002, based on the state of scientific knowledge at the time. However, regarding the risk of malformations, liabilities were retained against the State, the healthcare professionals and Sanofi, notably for discrepancy between the SmPC (Summary of the Product Characteristics) and the patient leaflet. In other cases involving births in 2005-2008, the liability of the State was retained for both malformations and neurodevelopmental disorders, and partially exonerated, taking into account the roles of healthcare practitioners and Sanofi. Given that the French affiliate was not a party to these administrative proceedings, its arguments (i.e. notably several requests from the French affiliate to the Health Authorities to reinforce warnings to healthcare professionals and patients in relation to Depakine&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;) were not considered. All rulings were appealed by the claimants. Sanofi has filed requests for voluntary intervention in these proceedings to present its arguments before the Administrative Court of Appeal. In one proceeding, the claimants decided to withdraw their claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;It is not possible, at this stage, to assess reliably the outcome of these cases or the potential financial impact on the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Depakine&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Product Litigation in other EU countries and in the UK&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In Switzerland, 10&#160;families have filed a civil claim for damages concerning 16&#160;people exposed in utero. Some of them also involve the claimants&#x2019; physicians. In November&#160;2022, one action was declared time-barred by the judge. The claimant appealed this court decision on the merit. The appeal is on-going.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In Spain, there are 4&#160;trials ongoing relating to 10&#160;children. In March&#160;2022, in one of the trials, the Court condemned Sanofi to indemnify 4&#160;patients. Sanofi appealed this decision. In January&#160;2023, in another trial filed by one patient, the Appeal Court confirmed the first instance's decision and dismissed the claim. The other actions are still at a preliminary stage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In Belgium, there are 2&#160;civil proceedings (currently on hold) and a criminal complaint against X and against Sanofi.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In Germany, there is one civil lawsuit before the Berlin Regional Court, relating to one child exposed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;in utero&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; to valproate taken by the mother during pregnancy for bipolar disorder.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In Ireland, there are 2&#160;Pre-Action Protocol cases and 2&#160;civil claims on-going.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In the United Kingdom, there are 3&#160;Pre-Action Protocol cases in Great Britain and 1&#160;Pre-Action Protocol case in Northern Ireland on-going.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;It is not possible, at this stage, to assess reliably the outcome of these cases or the potential financial impact on the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dengvaxia&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; (Philippines)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Since early 2018 up to present date, several claims were filed in the Philippines by parents of deceased children whose deaths were allegedly due to vaccination with Dengvaxia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. Early March&#160;2019, 2020 and 2022, the Philippine Department of Justice (DOJ) prosecution panel announced it had found probable cause to indict several Sanofi employees/former employees and former Government officials for &#x201c;reckless imprudence&#x201d; resulting in homicides. Since then, several criminal actions have been filed in court as a result of this finding. Petitions for Review to the DOJ Secretary have been filed and the said petitions remain pending. Meanwhile, the majority of the respondents have challenged the jurisdiction of the lower court where the first&#160;8&#160;cases had been assigned and this issue is now filed with the Supreme Court. There are several claims that have not yet been filed in any court despite resolutions by the DOJ that there is probable cause.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b) Patents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ramipril Canada Patent Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi was involved in a number of legal proceedings involving companies which market generic Altace&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (ramipril) in Canada. In&#160;2004, Sanofi unsuccessfully brought Notice of Compliance proceedings (NOC proceedings) at the end of which eight manufacturers obtained marketing authorizations from the Canadian Minister of Health for generic versions of ramipril in Canada. Sanofi filed unsuccessful patent infringement actions against all those companies and ultimately Sanofi was liable for damages under Section&#160;8. Sanofi made payment in complete satisfaction of those awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In June&#160;2011, Apotex commenced an action in the Ontario Superior Court of Justice asserting damages under the Ontario Statute of Monopolies, the UK Statute of Monopolies, and the Trade-marks Act (the &#x201c;Ontario Action&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;At the request of the parties, in June&#160;2021, the Court ordered that the action be stayed in view of the lower court's decision in March in the Apotex vs. Lilly case. In the Lilly case, the Court dismissed Apotex's Statute of Monopolies claim by way of summary judgment. If upheld on appeal, this decision may end Apotex's claim against Sanofi, also based on the Statute of Monopolies. In November&#160;2022, Apotex filed an application for leave to appeal the Ontario Court of Appeal decision in the Lilly case with the Supreme Court of Canada. The Court will decide whether to grant the leave application in late Q1&#160;2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Praluent&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; (alirocumab)-related Amgen Patent Litigation in the US&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2014, Amgen filed four separate complaints against Sanofi and Regeneron in the US District Court for the District of Delaware (&#x201c;District Court&#x201d;) asserting patent infringement relating to Sanofi and Regeneron&#x2019;s Praluent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; product. Together these complaints alleged that Praluent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; infringed seven patents for antibodies targeting PCSK9 and sought injunctive relief and unspecified damages.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In February&#160;2021, the Federal Circuit affirmed the District Court&#x2019;s ruling invalidating the Amgen asserted patent claims. In November&#160;2021, Amgen filed a petition with the US&#160;Supreme Court, asking it to overturn the Federal Circuit decision. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On November&#160;4, 2022, the US Supreme Court granted Amgen&#x2019;s petition for review. Proceedings before the US Supreme Court are now underway.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dupixent&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; (dupilumab)-related Amgen Patent Opposition and Revocation&#160;in Europe&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Immunex Corporation, an Amgen affiliate, is the registered proprietor of European Patent&#160;EP2292665. The claims of this patent relate to, among other things, human monoclonal antibodies that are capable of inhibiting IL-4 induced biological activity and which compete with one of four reference antibodies for binding to a cell that expresses human IL-4R. In April&#160;2016, Sanofi and Regeneron each filed an opposition in the European Patent Office (EPO) against EP2292665, seeking its revocation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The EPO rendered its decision in November&#160;2017 and revoked the patent in its entirety. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In September&#160;2017, Sanofi and Regeneron filed oppositions in the EPO against Amgen&#x2019;s European Patent EP2990420, which is a divisional of the EP2292665 Patent discussed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In March&#160;2022, the European Patent Office Technical Board of Appeals (&#x201c;TBA&#x201d;) ruled in Sanofi and Regeneron&#x2019;s favor and affirmed the invalidation of Amgen/Immunex&#x2019;s EP2990420 patent. In December&#160;2022, the TBA issued its written decision in favor of Sanofi and Regeneron. Amgen/Immunex may seek review of this decision by the Enlarged Board of Appeals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In March&#160;2022, Amgen/Immunex withdrew its appeal to the TBA for its EP2292665 patent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jevtana&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; (cabazitaxel)-related patent litigation in the US&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Jevtana&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; is currently covered by four Orange Book listed patents US&#160;7,241,907, US&#160;8,927,592, US&#160;10,583,110 and US&#160;10,716,777. In&#160;May&#160;to July&#160;2020, Sanofi filed patent infringement suits under Hatch-Waxman against 12&#160;generic filers asserting the &#x2018;110&#160;patent and the&#160;&#x2018;777&#160;patent in the US District Court for the District of Delaware. The '592&#160;patent was added to the suits after its amended claims issued in August&#160;2021. In January&#160;2021 and August&#160;2022, the District Court issued two claim construction decisions in favor of the defendants. In September&#160;2022, the district court issued a decision that granted the defendants&#x2019; motion to dismiss in part related to the &#x2018;592&#160;patent but denied the motion to dismiss in part related to the &#x2018;777 and &#x2018;110&#160;patents. Sanofi has reached settlement agreements with most of the defendants and the suit against the remaining defendant Sandoz is ongoing. Sanofi has voluntarily withdrawn the &#x2018;110&#160;patent from the suit and a 3-day trial on the &#x2018;777&#160;patent was held in January&#160;2023. Sandoz has&#160;agreed not to launch any generic cabazitaxel product until the earlier of a district court decision in favor of the defendants or&#160;120 days after the completion of the post-trial briefing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Litigation (Commonwealth) in Australia&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In August&#160;2007, GenRX (a subsidiary of Apotex) obtained registration of a generic clopidogrel bisulfate product on the Australian Register of Therapeutic Goods. At the same time, GenRX filed a patent invalidation action with the Federal Court of Australia, seeking revocation of Sanofi&#x2019;s Australian enantiomer patent claiming clopidogrel salts (a &#x201c;nullity action&#x201d;). In September&#160;2007, Sanofi obtained a preliminary injunction from the Federal Court preventing commercial launch of this generic clopidogrel bisulfate product until judgment on the substantive issues of patent validity and infringement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In August&#160;2008, the Australian Federal Court confirmed that the claim in Sanofi&#x2019;s Australian enantiomer patent directed to clopidogrel bisulfate (the salt form in Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;) was valid and the patent infringed. On appeal, the Full Federal Court of Australia held in&#160;September&#160;2009 that all claims in the patent are invalid. Sanofi&#x2019;s appeal to the Australia High Court was denied in&#160;March&#160;2010.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In April&#160;2013, the Australian Department of Health and Ageing (&#x201c;Commonwealth&#x201d;) filed an application before the Federal Court&#160;of&#160;Australia seeking payment of damages from Sanofi related to the Apotex preliminary injunction of up to AUD449 million (&#x20ac;286 million as of December 31, 2022), plus interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi and BMS settled the patent litigation with Apotex in November&#160;2014. In April&#160;2020, the Commonwealth&#x2019;s claim was dismissed. In&#160;May&#160;2020, the Commonwealth filed a Notice of Appeal to the Full Court of the Federal Court. On appeal, the Commonwealth reduced its claim to a range of AUD223.3&#160;million (&#x20ac;142.1&#160;million) to AUD280.2&#160;million (&#x20ac;178.4&#160;million) which, inclusive of interest to&#160;December&#160;31,&#160;2022, ranges from AUD343.4&#160;million (&#x20ac;218.6&#160;million) to AUD463.6&#160;million (&#x20ac;295.1&#160;million) depending on whether interest accrues from the date the Commonwealth claims the Apotex products would have been listed on the Government reimbursement scheme in the absence of the injunction (i.e. April&#160;1, 2008) or the date the Commonwealth filed its claim (i.e. April&#160;1, 2013). Appeal hearing took place in February&#160;2021 before the Full Court of the Federal Court. The ruling is expected in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;c) Other litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Aubagio&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; (teriflunomide)-related litigation in Europe&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In October&#160;2020, Mylan Ireland&#160;Ltd (&#x201c;Mylan&#x201d;) brought an action before the General Court of the European Union requesting the annulment of the August&#160;18, 2020 decision of the European Medicines Agency (&#x201c;EMA&#x201d;) refusing to validate Mylan&#x2019;s marketing authorization application for a generic version of Aubagio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (teriflunomide). Sanofi has intervened in this court case between Mylan and the EMA in order to defend Aubagio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x2019;s regulatory exclusivity. Mylan submitted a request for discontinuance of the proceedings in December&#160;2022. The case is over.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; (clopidogrel) &#x2013; Attorney General Action in Hawaii&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In March&#160;2014, the Hawaii Attorney General (AG) filed a complaint that sets forth allegations related to the sale and marketing of and variability of response to Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. The Hawaii AG specifically alleged that Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; had a diminished effect in patients of certain genetic backgrounds and that Sanofi and BMS had failed to make an earlier disclosure of this information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In February&#160;2021, the Court issued its decision, imposing penalties in the total amount of $834,012,000 against both Sanofi and Bristol Myers Squibb (BMS), with $417,006,000 being apportioned to each company. In June&#160;2021, Sanofi and BMS appealed this judgment. To the extent this judgment or possibly a reduced judgment remains after the appeal, the judgment would be split evenly with BMS. On May&#160;3, 2022, the Hawaii Supreme Court granted a request to transfer the appeal directly to the Hawaii Supreme Court, thereby eliminating review by the Hawaii intermediate Court of Appeals. The Hawaii Supreme Court had oral argument in December&#160;2022 and a decision is expected in or around March&#160;2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(clopidogrel) - Attorney General Action in New Mexico&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In September&#160;2016, the New Mexico Attorney General (AG) filed a complaint, claiming that Sanofi and Bristol Meyers Squibb (BMS) engaged in unfair and deceptive practices related to the marketing and labelling of Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. The New Mexico AG specifically alleged that Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; had a diminished effect in patients of certain genetic backgrounds and that the Companies failed to make an earlier disclosure of this information. This matter has been concluded and dismissed by way of a settlement by all parties that was finalized in Q4&#160;2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; (clopidogrel)-related litigation in France&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In France, in the claim concerning allegations that Sanofi&#x2019;s communication and promotional practices inhibited the entry on the&#160;market of generics of clopidogrel (the active ingredient of Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;), the French Antitrust Authority issued its decision on May&#160;14,&#160;2013, imposing on Sanofi a fine of &#x20ac;40.6&#160;million. In December&#160;2014, the Paris Court of Appeals rejected Sanofi&#x2019;s appeal and confirmed in totality the decision. As a consequence of the May&#160;2013 ruling, claims were filed by Sandoz and by Teva in 2014 before the Commercial Court of Paris for compensation of their alleged damages: loss of margin and other ancillary damages (legal fees to external counsel, image and reputation). In June&#160;and November&#160;2016 respectively, settlement agreements were entered into with Sandoz and Teva. Consequently, they subsequently withdrew their civil claims, jointly and severally. On October&#160;18, 2016, the Supreme Court confirmed the Court of Appeals&#x2019; decision. Therefore, the Court of Appeals&#x2019; decision became definitive. In September&#160;2017, Sanofi and its French affiliate received a summons before the Paris Commercial Court from the French&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt; Caisse Nationale d&#x2019;Assurance Maladie &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;CNAM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(French Social Security) claiming &#x20ac;115.8&#160;million for their alleged damages. On October&#160;1, 2019, the Paris Commercial Court dismissed the CNAM&#x2019;s action as time barred. On February&#160;9, 2022, the Paris Court of Appeals overturned the Paris Commercial Court's ruling, finding the&#160;French&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt; Caisse Nationale d'Assurance Maladie - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;CNAM (French Social Security)'s action as not time-barred and designated an expert to determine the amount of damages. The expertise is on-going.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;340B Drug Pricing Program in the United States&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi is currently involved in several matters relating to the 340B&#160;program in the US (a federal program that requires drug manufacturers to supply certain products to certain &#x201c;covered entities&#x201d; at reduced prices). In 2021, Sanofi filed a lawsuit against the Department of Health and Human Services (&#x201c;HHS&#x201d;), the Health Resources and Services Administration (&#x201c;HRSA&#x201d;), and certain of their administrators in the&#160;US&#160;District Court for the District of New Jersey challenging (i)&#160;HHS&#x2019;s December 2020 Advisory Opinion (the &#x201c;AO&#x201d;) stating that drug manufacturers are legally obligated to deliver discounts under the 340B&#160;program to an unlimited number of contract pharmacies; (ii)&#160;HHS&#x2019;s December&#160;2020 Administrative Dispute Resolution (&#x201c;ADR&#x201d;) Rule; and (iii)&#160;HRSA&#x2019;s May&#160;2021 letter to Sanofi concluding that Sanofi&#x2019;s 340B integrity initiative (under which Sanofi collects limited, de-identified, claims data on 340B-priced drugs dispensed by contract pharmacies) violates section&#160;340B and that Sanofi has therefore &#x201c;overcharged&#x201d; certain covered entities. The court issued its opinion in November&#160;2021, upholding HRSA&#x2019;s conclusion in the May&#160;2021 letter, but did not impose any fines, penalties or refund obligations against Sanofi for any &#x201c;overcharges&#x201d;. The court also rejected Sanofi&#x2019;s challenge to the ADR Rule and dismissed its challenge to the AO as moot. Sanofi appealed the court&#x2019;s decision to the Third Circuit Court of Appeals and the government filed a cross-appeal. The Third Circuit issued its opinion on&#160;January&#160;30, 2023. It held that Sanofi&#x2019;s restrictions on delivery to contract pharmacies do not violate Section&#160;340B. It also enjoined HHS from enforcing against Sanofi its reading of Section&#160;340B in the AO and the May&#160;2021 violation letter. As to Sanofi&#x2019;s challenge to the ADR Rule, the Third Circuit held that HHS did not violate the Administrative Procedure Act&#x2019;s notice-and-comment requirement in promulgating the ADR Rule.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In January&#160;2021, the National Association of Community Health Centers (&#x201c;NACHC&#x201d;) filed an ADR proceeding before HRSA on behalf of a number of covered entities, seeking to require Sanofi and AstraZeneca to supply contract pharmacies with 340B discounts without conditions. On August&#160;10, 2022, the ADR panel granted the motions to dismiss filed both by Sanofi and AstraZeneca, holding that the Delaware district court&#x2019;s decision granting AstraZeneca&#x2019;s motion for summary judgment precluded NACHC&#x2019;s ADR claims against both AstraZeneca and Sanofi. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In September&#160;2021, HRSA referred Sanofi (as well as other manufacturers) to the HHS Office of the Inspector General (OIG) in accordance with the 340B Program Ceiling Price and Civil Monetary Penalties Final Rule.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In February&#160;2021, the Vermont Attorney General issued a Civil Investigative Subpoena seeking certain information about Sanofi&#x2019;s participation in the 340B Drug Pricing Program. Sanofi continues to cooperate with this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In addition, in July&#160;2021, Mosaic Health Inc. and Central Virginia Health Services (covered entities) filed a nationwide antitrust class action complaint against Sanofi and three other manufacturers in the United States District Court for the Western District of New York. Plaintiffs allege that Sanofi and the other defendants conspired to eliminate favorable 340B pricing, particularly with&#160;respect to diabetes therapies. On September&#160;2, 2022, the court granted Defendants&#x2019; motion to dismiss the complaint. On&#160;October&#160;3, 2022, plaintiff filed a motion for leave to file a second amended complaint. A motion to dismiss the second amended complaint is fully briefed and pending before the court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Serif',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d) Contingencies arising from certain mergers &amp;amp; acquisitions transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As a result of divestitures, the Company is subject to a number of ongoing contractual and legal obligations regarding the state of the sold businesses, their assets, and their liabilities, some of which may be subject to dispute.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Aventis CropScience Retained Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The sale by Aventis Agriculture S.A. and Hoechst GmbH (both legacy companies of Sanofi) of their aggregate 76% participation in Aventis CropScience Holding (ACS) to Bayer and Bayer CropScience AG (BCS), the wholly owned subsidiary of Bayer which holds the ACS shares, was effective on June&#160;3, 2002. The Stock Purchase Agreement (SPA) dated October&#160;2, 2001, contained customary representations and warranties with respect to the sold business, as well as a number of indemnifications subject to limitation periods and caps, in particular with respect to environmental liabilities for which some outstanding claims from Bayer remain unresolved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Infraserv Hoechst Retained Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;By the Asset Contribution Agreement dated December&#160;19/20, 1996, as amended in 1997, Hoechst contributed all lands, buildings, and related assets of the Hoechst site at Frankfurt Hoechst to Infraserv GmbH &amp;amp; Co. Hoechst KG. Infraserv Hoechst undertook to indemnify Hoechst against environmental liabilities at the Hoechst site and with respect to certain landfills. As consideration for the indemnification undertaking, Hoechst transferred to Infraserv Hoechst approximately &#x20ac;57&#160;million to fund reserves. In 1997, Hoechst also agreed it would reimburse current and future Infraserv Hoechst environmental expenses up to &#x20ac;143&#160;million. As a former operator of the land and as a former user of the landfills, Hoechst may ultimately be liable for costs of remedial action in excess of this amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:11.34pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Boehringer Ingelheim (BI) Consumer Healthcare Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi and Boehringer Ingelheim (BI) are involved in an ICC (International Chamber of Commerce) arbitration regarding their respective indemnification obligations for liabilities connected to ongoing US court proceedings regarding Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; manufactured by BI (see above - Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; Litigation in the US). The dispute arises from indemnification obligations agreed between Sanofi and BI as part of the swap of Sanofi&#x2019;s Animal Health (AH) business for BI&#x2019;s Consumer Health Care (CHC) business in January&#160;2017 and under a Global Settlement Agreement concluded in September&#160;2019 regarding notably the offset of respective AH and CHC claims notified under the SPAs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In February&#160;2020, BI initiated an arbitration against Sanofi seeking indemnification for losses it could incur as a result of the Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; litigation in the US. Sanofi is disputing BI&#x2019;s claim for indemnification and has asserted several counterclaims under relevant agreements, including a counterclaim for indemnification of losses Sanofi and its affiliates have incurred and may incur in connection with the same US court proceedings involving Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. The arbitration is expected to conclude at the earliest in&#160;March&#160;2023.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfLegalAndArbitralProceedingsTextBlock>
    <sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzMwMzU_72d66f83-a30c-4d63-84a1-7c83733bdacb"
      unitRef="eur">1652000000</sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther>
    <sny:NonCurrentProvisionForEnvironmentRisks
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzMzNzY_eee19e01-7706-48aa-b28e-a68adf913fcd"
      unitRef="eur">526000000</sny:NonCurrentProvisionForEnvironmentRisks>
    <sny:NumberOfCivilIndividualActions
      contextRef="ia2d901acae514e5e8280c783c251f450_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzM1NzA_d8ec0ae3-0711-42af-947a-b40b9c565628"
      unitRef="lawsuit">180</sny:NumberOfCivilIndividualActions>
    <sny:NumberOfOngoingLawsuits
      contextRef="ia2d901acae514e5e8280c783c251f450_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzQ1MzI_f7fda773-380e-4621-b80d-f0396ca365df"
      unitRef="lawsuit">49</sny:NumberOfOngoingLawsuits>
    <sny:NumberOfPlaintiffs
      contextRef="ide8e1ec806db4932b7eba982cc52419e_D20211231-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzQ2NzM_d8f6c213-4369-42fb-bb68-840ec6ef1ee0"
      unitRef="plaintiff">8300</sny:NumberOfPlaintiffs>
    <sny:NumberOfLossConsortiumPlaintiffs
      contextRef="ide8e1ec806db4932b7eba982cc52419e_D20211231-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzQ3MzY_c66b99ea-03c8-4340-97c2-1b45a7282893"
      unitRef="plaintiff">700</sny:NumberOfLossConsortiumPlaintiffs>
    <sny:NumberOfBellweatherTrialsHeld
      contextRef="i9812f0f2ab434fd5b26f297a36264169_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzUxMzc_ff62b064-bd1f-456e-98b6-f4fff8065ccf"
      unitRef="trial">2</sny:NumberOfBellweatherTrialsHeld>
    <sny:MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation
      contextRef="i3c1b80392c24483ea3270088e8c3d341_D20181001-20181031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzU4Njg_51ef3a19-0ebc-4755-b832-85dc5d82a3f9"
      unitRef="usd">10000</sny:MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation>
    <sny:NumberOfCasesDismissed
      contextRef="id03ce38671d242c5b423a1d25f8c6f7e_I20221206"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzA5_e35cb0b7-dec8-4251-8d4f-0e8ef8d23838"
      unitRef="case">50000</sny:NumberOfCasesDismissed>
    <sny:NumberOfCancersAssociatedWithDismissedCases
      contextRef="id03ce38671d242c5b423a1d25f8c6f7e_I20221206"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzE2_dae3b78c-36a8-4547-91c8-1e27e725ee96"
      unitRef="cancer">5</sny:NumberOfCancersAssociatedWithDismissedCases>
    <sny:NumberOfComplaintsFiled
      contextRef="iacdab6e288ea48229984fd6fdc5f672d_D20211231-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzk2OTM_295e5e1e-6b5c-4867-8ec0-966ef87ee859"
      unitRef="complaint">3486</sny:NumberOfComplaintsFiled>
    <sny:NumberOfPlaintiffs
      contextRef="iacdab6e288ea48229984fd6fdc5f672d_D20211231-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzk3NjE_beb9bcce-1ec8-406c-92cf-80ce7a32a780"
      unitRef="plaintiff">68355</sny:NumberOfPlaintiffs>
    <sny:NumberOfClassActionLawsuits
      contextRef="ife35047b3efb48d49565a8abefe87bdd_D20190101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzEwMDUz_7eb700dd-c3b5-46ae-bb5d-fd7719901f86"
      unitRef="action">7</sny:NumberOfClassActionLawsuits>
    <sny:NumberOfCivilIndividualActions
      contextRef="i69ade77d4014436cb24fe9c6b800b42c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzExMDgy_83f465fb-249e-46a3-be77-26a544625355"
      unitRef="claim">78</sny:NumberOfCivilIndividualActions>
    <sny:NumberOfPeopleExposed
      contextRef="i69ade77d4014436cb24fe9c6b800b42c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzExMTI2_30870ad4-3c1e-4ec7-9603-e0817fc82b48"
      unitRef="person">131</sny:NumberOfPeopleExposed>
    <sny:NumberOfLawsuitsRuledOnMerit
      contextRef="i69ade77d4014436cb24fe9c6b800b42c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzExNDgx_146e2002-caec-4734-bc5b-13279a1f95e6"
      unitRef="lawsuit">29</sny:NumberOfLawsuitsRuledOnMerit>
    <sny:NumberOfFirstInstanceRulings
      contextRef="ifd9713c0f3b84a2087189ac6adf31e26_I20220820"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzI2_067d7bb6-073f-4ef3-9b88-4351469f7ade"
      unitRef="ruling">7</sny:NumberOfFirstInstanceRulings>
    <sny:NumberOfFirstInstanceRulings
      contextRef="id0a6ca82125c4345addbd9134859f4dc_I20220512"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzI2_4a0ec77e-46c2-4d00-9f05-ab9e21888d1b"
      unitRef="ruling">7</sny:NumberOfFirstInstanceRulings>
    <sny:NumberOfFirstInstanceRulings
      contextRef="i9a57a25d53544b7bbc8e58ad797964d3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzI3_fb50fd6f-7ce0-4ae7-beb7-a029ab49c5b2"
      unitRef="case">3</sny:NumberOfFirstInstanceRulings>
    <sny:NumberOfFirstInstanceRulings
      contextRef="i9a57a25d53544b7bbc8e58ad797964d3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzI1_55580f9c-6e01-49bb-9394-6d704e632689"
      unitRef="case">3</sny:NumberOfFirstInstanceRulings>
    <sny:LitigationAmountPayable
      contextRef="i1a12953bef7249c18a068db579937b2f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4Mzc4_55698535-d39a-4571-b75c-4b642b66ca61"
      unitRef="eur">100000</sny:LitigationAmountPayable>
    <sny:LitigationAmountPayable
      contextRef="iaff1b7c5dd354bbca260343d8976c984_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4MzMw_952f6ccc-b1ee-4ee8-b150-af15888693ff"
      unitRef="eur">500000</sny:LitigationAmountPayable>
    <sny:NumberOfFamiliesWhoFiledACivilClaim
      contextRef="id8fbf1dee4e248d398715fa56ef2544a_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzEzOTg2_4f0387d6-9f7a-472f-a9ce-78dd041bb38e"
      unitRef="family">63</sny:NumberOfFamiliesWhoFiledACivilClaim>
    <sny:NumberOfCounterExpertiseExperts
      contextRef="iea2e083a765b4ce7902705ed5cd966e7_D20220901-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4Mzg0_46ca6c25-e1da-499e-b030-6438c40bdf02"
      unitRef="expert">2</sny:NumberOfCounterExpertiseExperts>
    <sny:NumberOfMedicalAssessments
      contextRef="i5b0489fbbf76442ab038901380310b9f_D20221001-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4Mzkz_1d40247b-7374-4e7f-814b-eba9f5a26595"
      unitRef="medical_assessment">6</sny:NumberOfMedicalAssessments>
    <sny:NumberOfPeopleExposedWhoFiledARequestForIndemnification
      contextRef="i69ade77d4014436cb24fe9c6b800b42c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE2MzUx_6fa6f2e5-92a3-4d80-a4dd-1e1c615ed984"
      unitRef="person">63</sny:NumberOfPeopleExposedWhoFiledARequestForIndemnification>
    <sny:NumberOfAdministrativeProceedings
      contextRef="i82f5b65dd97e478faf4feebb1a461d65_D20200701-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE2NjM3_dd2df685-7202-4c73-b533-507080c70180"
      unitRef="proceeding">5</sny:NumberOfAdministrativeProceedings>
    <sny:NumberOfFamiliesWhoFiledACivilClaim
      contextRef="i38c648e7e3d449e7a4ef085d255a725f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE3ODI2_f3a898f9-6e22-4779-8251-04578a45f909"
      unitRef="family">10</sny:NumberOfFamiliesWhoFiledACivilClaim>
    <sny:NumberOfPeopleExposed
      contextRef="i38c648e7e3d449e7a4ef085d255a725f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE3ODg2_b476b047-3dd0-4fb9-b22d-5933806637e6"
      unitRef="person">16</sny:NumberOfPeopleExposed>
    <sny:NumberOfOngoingTrials
      contextRef="i5914be30840a424e9ba15aac06bfd84a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE3OTg3_f52c78a5-899b-48ee-bf65-64b4747b3685"
      unitRef="trial">4</sny:NumberOfOngoingTrials>
    <sny:NumberOfPeopleExposed
      contextRef="i5914be30840a424e9ba15aac06bfd84a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE4MDE3_b4650236-0ae0-460c-8ee8-081f48b785d0"
      unitRef="children">10</sny:NumberOfPeopleExposed>
    <sny:NumberOfCivilIndividualActions
      contextRef="ie3099953088a4d92b74521a460c6296a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE4MDUy_15c6026d-2ec7-4780-acb1-81255c25463f"
      unitRef="complaint">2</sny:NumberOfCivilIndividualActions>
    <sny:NumberOfCivilIndividualActions
      contextRef="i3d1a1e91d76a423db829d84274c18752_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE4MTY5_5713effc-7a33-44b6-b575-dfe181534cd0"
      unitRef="lawsuit">1</sny:NumberOfCivilIndividualActions>
    <sny:NumberOfPeopleExposed
      contextRef="i3d1a1e91d76a423db829d84274c18752_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE4MjMy_721a3c98-fa9c-407c-81dc-ac18cc1421cd"
      unitRef="children">1</sny:NumberOfPeopleExposed>
    <sny:NumberOfPreActionProtocolCases
      contextRef="i31d63c85f8e441c7807a6e955b15559f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4Mzk2_b68e0a01-1336-42b1-84f5-8a3b6339db45"
      unitRef="case">2</sny:NumberOfPreActionProtocolCases>
    <sny:NumberOfCivilClaimsOnGoing
      contextRef="i31d63c85f8e441c7807a6e955b15559f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4Mzk5_060f4c9e-09fc-4dd4-b38f-89de3420afdd"
      unitRef="claim">2</sny:NumberOfCivilClaimsOnGoing>
    <sny:NumberOfPreActionProtocolCases
      contextRef="icc705712fa1947ae879577c168f3f666_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDAy_f28866a5-0c37-4c90-a987-671439a1f4ab"
      unitRef="case">3</sny:NumberOfPreActionProtocolCases>
    <sny:NumberOfPreActionProtocolCases
      contextRef="ifd45fd1ec3c449df97cba0f45eef2ae9_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDA1_3e5674bd-0651-4290-95b2-bb89760b7fd0"
      unitRef="case">1</sny:NumberOfPreActionProtocolCases>
    <sny:NumberOfCases
      contextRef="ia799047f91fb498c88944dff7dc04fd0_D20180101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE5MzU5_ed11e9e2-a957-45f4-8e2f-8133ecb2ba72"
      unitRef="case">8</sny:NumberOfCases>
    <sny:NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug
      contextRef="i0f6eba28b15e4c47a8864e9a6806f73c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzE5ODEy_b2a740c7-af64-40b4-95fb-7d8def6a15c1"
      unitRef="manufacturer">8</sny:NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug>
    <sny:NumberOfPatentActionsInitiallyFiled
      contextRef="iad588bc5db4440fa968e52c2f65ca474_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzIxMjI0_fc929289-f0bd-48d7-92b3-806b66c48674"
      unitRef="complaint">4</sny:NumberOfPatentActionsInitiallyFiled>
    <sny:NumberOfPatentsAllegedlyInfringed
      contextRef="i0d714fe0593a4f539299e40038a0ff5d_I20141118"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzIxNDky_e4870e5a-a486-4c9b-8f9d-8ee3f87e2e37"
      unitRef="patent">7</sny:NumberOfPatentsAllegedlyInfringed>
    <sny:NumberOfPatentsCoveringProduct
      contextRef="i7b37c3673570484dbdc61b7e2c0bf6bd_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI0NTA1_42c2a90a-1c4f-4a41-9171-f702e2197b48"
      unitRef="patent">4</sny:NumberOfPatentsCoveringProduct>
    <sny:NumberOfPatentsAllegedlyInfringed
      contextRef="i1591035a52b44bfb8ab033baa46f80a7_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI0Njgz_64272a63-5d8f-44ec-a6d0-c0f7229c4c53"
      unitRef="claim">12</sny:NumberOfPatentsAllegedlyInfringed>
    <sny:NumberOfDecisionsIssuedByTheDistrictCourt
      contextRef="i53507d8a67164c8eb8d2fec1ab5c2dca_D20220801-20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDA3_4ae50562-05b7-4cd7-ac8e-d93ba990408e"
      unitRef="decision">2</sny:NumberOfDecisionsIssuedByTheDistrictCourt>
    <sny:NumberOfDecisionsIssuedByTheDistrictCourt
      contextRef="i9e06dd78a2cc45e8b38a451ebfd53f19_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDA3_5e9166ad-929d-4489-bf90-4435133f4417"
      unitRef="decision">2</sny:NumberOfDecisionsIssuedByTheDistrictCourt>
    <sny:LengthOfTrial
      contextRef="i9a496f537a8d429ba5d2f470f546b3d4_D20230101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDM0_af699e82-8f8d-42b5-a215-1848c7cd19a7">P3D</sny:LengthOfTrial>
    <sny:NumberOfDaysAfterCompletionOfPostTrailBriefing
      contextRef="i7b37c3673570484dbdc61b7e2c0bf6bd_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzgwODE0MTA0Njk4NDEx_28e4abc2-e42f-4aec-a355-e477a73ef254">P120D</sny:NumberOfDaysAfterCompletionOfPostTrailBriefing>
    <sny:PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo
      contextRef="i91c653975b734c3bbbb90a324b0a9e43_I20130430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI2OTc1_906e73c7-6209-4bf5-b4bd-61a2cdade5ff"
      unitRef="aud">449000000</sny:PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo>
    <sny:PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo
      contextRef="idc6e5447243c412aa0be53b3fe522c2b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI2OTc5_c6710569-f6ea-4e97-bfe3-3d6f86efff2d"
      unitRef="eur">286000000</sny:PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo>
    <sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs
      contextRef="i4fa9734152fe42adafe9a6457b51a172_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mjkz_099d1cf3-ed39-4f07-8a8b-0aad8ade72a7"
      unitRef="aud">223300000</sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs>
    <sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs
      contextRef="i4fa9734152fe42adafe9a6457b51a172_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mjk3_04efd6ff-923e-47ce-88d8-1ddb3403d45b"
      unitRef="eur">142100000</sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs>
    <sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs
      contextRef="i94f85a2e1aab46aab17b13a49d52aa0e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3MzA0_c861fd3e-3220-4ee2-916a-ab80b40134bf"
      unitRef="aud">280200000</sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs>
    <sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs
      contextRef="i94f85a2e1aab46aab17b13a49d52aa0e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3MzA4_9af0a169-0c8e-4ec1-946c-d60e4f9a679b"
      unitRef="eur">178400000</sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffs>
    <sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded
      contextRef="i4fa9734152fe42adafe9a6457b51a172_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mzc1_0ad4e017-5924-443d-801f-de60b4774cce"
      unitRef="aud">343400000</sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded>
    <sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded
      contextRef="i4fa9734152fe42adafe9a6457b51a172_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mzc5_b6555416-8f40-469a-90ac-e3b3856e1b4f"
      unitRef="eur">218600000</sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded>
    <sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded
      contextRef="i94f85a2e1aab46aab17b13a49d52aa0e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mzg2_e3c50c51-53f4-4448-b7e4-d7f0cb443ca3"
      unitRef="aud">463600000</sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded>
    <sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded
      contextRef="i94f85a2e1aab46aab17b13a49d52aa0e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI3Mzkw_2e856eee-4a6f-49c5-99bf-1fea2804c17d"
      unitRef="eur">295100000</sny:ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded>
    <sny:GlobalPenaltyFeeIncurredByDefendants
      contextRef="ic9db8ac12dc644388e59ef5e31d39357_D20210201-20210228"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI4ODkx_1c635ed0-3f71-456a-bb05-8423d9a23f71"
      unitRef="usd">834012000</sny:GlobalPenaltyFeeIncurredByDefendants>
    <sny:PenaltyFeeIncurred
      contextRef="ic9db8ac12dc644388e59ef5e31d39357_D20210201-20210228"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzI4OTUx_6479b466-2033-4b4b-b387-e0c11d495700"
      unitRef="usd">417006000</sny:PenaltyFeeIncurred>
    <sny:PenaltyFeeIncurred
      contextRef="ia9903703ab204fe0a894254df0aaa506_D20130514-20130514"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzMwMDI1_a2ed6326-04cb-4b00-b503-b3815ca161f7"
      unitRef="eur">40600000</sny:PenaltyFeeIncurred>
    <sny:PaymentOfDamagesClaimedByCounterparty
      contextRef="if5016791206545f1a8de98c53126c448_D20170901-20170930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzMwOTMz_8d44a837-e7bd-418c-9e29-8b3aaee6ec63"
      unitRef="eur">115800000</sny:PaymentOfDamagesClaimedByCounterparty>
    <sny:NumberOfOtherManufacturersInvolvedInProceedings
      contextRef="if95f17244f744589bad8e963d5814997_D20210701-20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzMzNjQ3_ca6a8577-8352-4296-a298-18deee45dcaa"
      unitRef="manufacturer">3</sny:NumberOfOtherManufacturersInvolvedInProceedings>
    <sny:EquityInvestmentSoldPercentage
      contextRef="i3575a00a4d2941dbb8f4491a3d7966d1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzM0NTMw_9a9196a8-b42f-43c5-9b30-e1bc15bcd810"
      unitRef="number">0.76</sny:EquityInvestmentSoldPercentage>
    <sny:ConsiderationTransferredToFundReserveForIndemnificationUndertaking
      contextRef="i14c2910d62e54d579f8a84cb7af92bab_I19971231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzM1NTc3_4fc210d4-8353-4b4d-8ac8-dcaac1eeca75"
      unitRef="eur">57000000</sny:ConsiderationTransferredToFundReserveForIndemnificationUndertaking>
    <sny:MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense
      contextRef="i14c2910d62e54d579f8a84cb7af92bab_I19971231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NTgvZnJhZzo2OWYzNmRkMGIzMjI0ZjA0YTIwOGNmNmM5N2Q5M2NmYi90ZXh0cmVnaW9uOjY5ZjM2ZGQwYjMyMjRmMDRhMjA4Y2Y2Yzk3ZDkzY2ZiXzM1NzEy_e189a25e-cc5a-4785-8310-ac9f1eba1cf6"
      unitRef="eur">143000000</sny:MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense>
    <sny:DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzY3NA_87e2a09b-3db9-410b-ab9c-2587b8089d75">Provisions for discounts, rebates and sales returns&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Adjustments between gross sales and net sales, as described in Note&#160;B.13., are recognized either as provisions or as reductions in accounts receivable, depending on their nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows movements in these items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;and State&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;programs&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Managed&#160;care&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;and&#160;GPO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;programs&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Chargeback&lt;br/&gt;incentives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Rebates&lt;br/&gt;and&lt;br/&gt;discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sales&lt;br/&gt;returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,178&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;726&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,330&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;621&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,218&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provision related to current period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net change in provision related to prior period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(19,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,507&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;908&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;333&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,557&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;688&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,039&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provision related to current period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net change in provision related to prior period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,561)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(697)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(19,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,596&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;931&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;303&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,425&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;610&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,899&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provision related to current period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net change in provision related to prior period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,809)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(599)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance&#160;at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,603&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,021&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;362&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,805&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;629&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,490&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Primarily US government programs: Medicaid (&#x20ac;1,307 million in 2022, &#x20ac;1,244 million in 2021, &#x20ac;1,015 million in 2020) and Medicare (&#x20ac;775 million in 2022, &#x20ac;941 million in 2021 and &#x20ac;726 million in 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Mainly rebates and other price reductions granted to healthcare authorities in the United States (including Managed Care: &#x20ac;934 million in 2022, &#x20ac;896 million in 2021 and &#x20ac;692 million in 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Provisions related to US net sales amounted to &#x20ac;4,270 million as of December 31, 2022, &#x20ac;4,057 million as of December 31, 2021 and &#x20ac;3,982 million as of&#160;December 31, 2020.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock>
    <sny:DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzY3NQ_8c4707b5-20ae-4e65-8ac6-fcd5c748c0ad">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows movements in these items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;and State&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;programs&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Managed&#160;care&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;and&#160;GPO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;programs&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Chargeback&lt;br/&gt;incentives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Rebates&lt;br/&gt;and&lt;br/&gt;discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sales&lt;br/&gt;returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,178&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;726&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,330&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;621&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,218&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provision related to current period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net change in provision related to prior period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(19,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,507&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;908&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;333&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,557&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;688&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,039&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Changes in scope of consolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provision related to current period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net change in provision related to prior period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,561)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(697)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(19,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,596&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;931&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;303&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,425&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;610&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,899&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Provision related to current period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net change in provision related to prior period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,809)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(599)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(21,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance&#160;at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,603&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,021&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;362&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,805&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;629&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,490&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Primarily US government programs: Medicaid (&#x20ac;1,307 million in 2022, &#x20ac;1,244 million in 2021, &#x20ac;1,015 million in 2020) and Medicare (&#x20ac;775 million in 2022, &#x20ac;941 million in 2021 and &#x20ac;726 million in 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Mainly rebates and other price reductions granted to healthcare authorities in the United States (including Managed Care: &#x20ac;934 million in 2022, &#x20ac;896 million in 2021 and &#x20ac;692 million in 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Provisions related to US net sales amounted to &#x20ac;4,270 million as of December 31, 2022, &#x20ac;4,057 million as of December 31, 2021 and &#x20ac;3,982 million as of&#160;December 31, 2020.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i1b692bdf75f2434fb133bc7a3bb3fdb5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtMi0xLTEtMzY0MDYw_ed553d6c-bab8-4061-87ce-2c1af2e93144"
      unitRef="eur">2178000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i2bca265b5de846a49ff7d66d365cd3f5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtMy0xLTEtMzY0MDYw_2cef449f-4e23-4fc8-88f7-826dd74c0f3b"
      unitRef="eur">726000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i4c7d49c8079f45a984607afd055f6141_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtNC0xLTEtMzY0MDYw_66134d41-7593-4eaf-9743-568ca5916e67"
      unitRef="eur">312000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i9a5e4694eeae43cb9ed974f712d64133_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtNS0xLTEtMzY0MDYw_76b0a5b5-7393-4fa6-8395-7b7fb14dbe3c"
      unitRef="eur">1330000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i616d5f0474774329bb2e1a83718aa3db_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtNi0xLTEtMzY0MDYw_fe05c9be-436e-4f24-a1fc-bd2efd3acb55"
      unitRef="eur">621000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i0581727a37ae4f2d83f10871f2fa2679_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtNy0xLTEtMzY0MDYw_d64e4bd1-36c0-4e27-9d8f-3cd7b30f9b54"
      unitRef="eur">51000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="icfa0f3ae5e6c414a899ba5e892823a0e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEtOC0xLTEtMzY0MDYw_db3361e4-a4c8-4abf-b96a-76ccd7882055"
      unitRef="eur">5218000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i3ed9f546c418470cba11c23974e26f46_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtMi0xLTEtMzY0MDYw_23ecaabe-f07a-4157-abac-63e1b9c1fc28"
      unitRef="eur">5970000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i9769bd55d48b434eb6a92677ad1f68f5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtMy0xLTEtMzY0MDYw_c6227033-7956-40c6-8719-db8977df57df"
      unitRef="eur">2752000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="ibd15f26a3ce6450ca2aca80db285ee51_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtNC0xLTEtMzY0MDYw_d9b5cb11-1b1a-419b-bbc6-8e1b877d2b4c"
      unitRef="eur">4633000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i0b61014391a14c5fb1683b9dc341e3d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtNS0xLTEtMzY0MDYw_be2fe26b-7e24-46a5-bbb0-b7bd14de27b2"
      unitRef="eur">6221000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="ic01ffee4e6cd43d784f593303e505e23_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtNi0xLTEtMzY0MDYw_e61e26fa-9452-4127-897e-fcb3b9ceba70"
      unitRef="eur">628000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i0b84d1d2c5a14568bc00a2d9f3f9825d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtNy0xLTEtMzY0MDYw_a3c9b5c3-fd7c-41a8-a4b2-336230c14bd2"
      unitRef="eur">110000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzMtOC0xLTEtMzY0MDYw_49cd1bd5-e7f3-493b-afbd-0b7bb22f6ff2"
      unitRef="eur">20314000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i3ed9f546c418470cba11c23974e26f46_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtMi0xLTEtMzY0MDYw_19d21a7f-b729-4e59-bb43-0590679bb468"
      unitRef="eur">-54000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i9769bd55d48b434eb6a92677ad1f68f5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtMy0xLTEtMzY0MDYw_caf596d3-d26a-4c12-8ef7-dab401ba87b6"
      unitRef="eur">0</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="ibd15f26a3ce6450ca2aca80db285ee51_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtNC0xLTEtMzY0MDYw_338eae15-a1dc-4ef0-8493-3e7e63c1ff12"
      unitRef="eur">0</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i0b61014391a14c5fb1683b9dc341e3d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtNS0xLTEtMzY0MDYw_5579a0c1-2b33-418b-952f-61a486e7435c"
      unitRef="eur">-113000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="ic01ffee4e6cd43d784f593303e505e23_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtNi0xLTEtMzY0MDYw_642b47c6-0bc1-44f1-8181-33a2d7d42b63"
      unitRef="eur">-34000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i0b84d1d2c5a14568bc00a2d9f3f9825d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtNy0xLTEtMzY0MDYw_ad876468-80cd-44ba-a0b9-b9ee226c7c53"
      unitRef="eur">0</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzQtOC0xLTEtMzY0MDYw_4f3e1e31-cb1a-473f-bd4f-5ce7e077616c"
      unitRef="eur">-201000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i3ed9f546c418470cba11c23974e26f46_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtMi0xLTEtMzY0MDYw_ac67d305-ae7c-4b3d-bf51-fb09e189f828"
      unitRef="eur">5552000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i9769bd55d48b434eb6a92677ad1f68f5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtMy0xLTEtMzY0MDYw_4a6c4a21-1145-4cca-95f7-2254d9325c23"
      unitRef="eur">2556000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ibd15f26a3ce6450ca2aca80db285ee51_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtNC0xLTEtMzY0MDYw_be1f4597-9d71-4c90-a7a7-7f5b7db473f6"
      unitRef="eur">4604000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i0b61014391a14c5fb1683b9dc341e3d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtNS0xLTEtMzY0MDYw_3f0d0d65-2fb5-46cb-88ca-3d6507d2b6e6"
      unitRef="eur">5838000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ic01ffee4e6cd43d784f593303e505e23_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtNi0xLTEtMzY0MDYw_1fbd49a0-11ed-408c-9ad5-3653e18d0b2f"
      unitRef="eur">512000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i0b84d1d2c5a14568bc00a2d9f3f9825d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtNy0xLTEtMzY0MDYw_b1dabb49-0e9a-4760-8332-236366b5f628"
      unitRef="eur">112000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzUtOC0xLTEtMzY0MDYw_fcd048ec-b216-48a3-b8e1-e17c08542861"
      unitRef="eur">19174000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i3ed9f546c418470cba11c23974e26f46_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtMi0xLTEtMzY0MDYw_319a4583-e79e-4e00-88eb-e986a2b6fbfa"
      unitRef="eur">-35000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i9769bd55d48b434eb6a92677ad1f68f5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtMy0xLTEtMzY0MDYw_3a7544af-e77a-479f-a4f7-88b82401d6f8"
      unitRef="eur">-14000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ibd15f26a3ce6450ca2aca80db285ee51_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtNC0xLTEtMzY0MDYw_337e2441-b7f7-4e9f-b6cd-1ed1c0c3dd69"
      unitRef="eur">-8000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i0b61014391a14c5fb1683b9dc341e3d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtNS0xLTEtMzY0MDYw_ea34a3ee-c186-4017-9d8e-a0d517dbbf26"
      unitRef="eur">-43000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ic01ffee4e6cd43d784f593303e505e23_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtNi0xLTEtMzY0MDYw_f76570b7-2de6-4710-9737-cd14ed37897e"
      unitRef="eur">-15000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i0b84d1d2c5a14568bc00a2d9f3f9825d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtNy0xLTEtMzY0MDYw_cfa3d1a3-ef22-4beb-aeb1-4ea81f306fe4"
      unitRef="eur">-3000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzYtOC0xLTEtMzY0MDYw_0bff03c3-2344-4da9-bb20-4a6bc4c94757"
      unitRef="eur">-118000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i85baff112a0f450580f65baeb088ac0e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctMi0xLTEtMzY0MDYw_6349913f-a4a3-4432-b697-480565dca664"
      unitRef="eur">2507000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ic3e70d031c364b549f2725ec8740c482_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctMy0xLTEtMzY0MDYw_54e1c3ce-756f-40c6-b789-a66278a08393"
      unitRef="eur">908000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i344fce21336047d085f98ba60b6a24d1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctNC0xLTEtMzY0MDYw_bdeb6fa3-6e74-4e23-bc34-b1d839da88f9"
      unitRef="eur">333000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i4ccd90377a634c1ba0858901f0b24074_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctNS0xLTEtMzY0MDYw_b5d0196c-0fee-4e43-aca1-ffec6bd3061f"
      unitRef="eur">1557000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ie3b2786a0eee40519674a931fd7e4b4f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctNi0xLTEtMzY0MDYw_8a35bf82-5190-44cd-b2f1-ccd6d8b13321"
      unitRef="eur">688000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i63ca5f593dcd4e829883dd52c4e652e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctNy0xLTEtMzY0MDYw_db7bd200-1ee1-490c-aa4f-f16602a87999"
      unitRef="eur">46000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzctOC0xLTEtMzY0MDYw_118b62fd-706e-4e93-9e8a-0eeb887ee61c"
      unitRef="eur">6039000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns
      contextRef="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtMi0xLTEtNDkyMTA5_cc3cf844-8720-430f-9e53-10bc7f650b0d"
      unitRef="eur">3000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns
      contextRef="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtMy0xLTEtNDkyMTA5_9fa02d6b-1c85-45a1-98c2-b7b1a044aa7f"
      unitRef="eur">0</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns
      contextRef="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNC0xLTEtNDkyMTA5_b409f6b5-b117-4e58-9fde-b3abb7901479"
      unitRef="eur">0</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns
      contextRef="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNS0xLTEtNDkyMTA5_2b1546ef-10b8-49ac-ad20-94306a0737ba"
      unitRef="eur">-2000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns
      contextRef="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNi0xLTEtNDkyMTA5_619a6a08-1a0b-48df-9814-60e068f18176"
      unitRef="eur">1000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns
      contextRef="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNy0xLTEtNDkyMTA5_9e5e160a-ca22-4478-9efb-96e164d95d3c"
      unitRef="eur">0</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtOC0xLTEtNDkyMTA5_5f02edee-8b35-4e24-afff-d639fa3be398"
      unitRef="eur">2000000</sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtMi0xLTEtMzY0MDYw_31335799-cbdb-4887-aaf8-fd1b7817947c"
      unitRef="eur">5855000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtMy0xLTEtMzY0MDYw_b6c2d3aa-7050-4794-832b-e452ec7df61e"
      unitRef="eur">3037000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNC0xLTEtMzY0MDYw_3dd55cf5-3b5d-4651-9c27-65f02473b88b"
      unitRef="eur">3813000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNS0xLTEtMzY0MDYw_3f9b014f-3092-47f3-a57c-b0d0b09b9e4c"
      unitRef="eur">6330000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNi0xLTEtMzY0MDYw_17a098d2-902c-47bf-9157-00b6bc29d962"
      unitRef="eur">582000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtNy0xLTEtMzY0MDYw_8952a83c-f74e-4af1-91d0-51bd94446ac1"
      unitRef="eur">97000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzgtOC0xLTEtMzY0MDYw_0c25a4f0-8b90-4236-b91c-6a1355a2a7b1"
      unitRef="eur">19714000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktMi0xLTEtMzY0MDYw_d885624a-61ca-42e2-884b-d5fec672491a"
      unitRef="eur">-136000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktMy0xLTEtMzY0MDYw_5fac7d07-1018-404d-a48a-460fadb76990"
      unitRef="eur">-3000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktNC0xLTEtMzY0MDYw_2f61a305-f543-45cf-84d4-dce998abaf9f"
      unitRef="eur">-4000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktNS0xLTEtMzY0MDYw_7ce32378-bac8-485d-b5fe-c573c6107257"
      unitRef="eur">-152000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktNi0xLTEtMzY0MDYw_b69c4469-0c90-40a5-8f77-53df5a2b52cd"
      unitRef="eur">56000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktNy0xLTEtMzY0MDYw_69f4b88a-d8d2-4c33-83c2-fbe175b3b6da"
      unitRef="eur">-3000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzktOC0xLTEtMzY0MDYw_0b37fa06-5f54-4e9a-b08e-c4c4f580a8d8"
      unitRef="eur">-242000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTItMS0xLTM2NDA2MA_484aedee-7267-446c-b678-a2d45d6afbcb"
      unitRef="eur">5561000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTMtMS0xLTM2NDA2MA_9b74ea78-ad71-4678-836b-13c000847e18"
      unitRef="eur">2979000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTQtMS0xLTM2NDA2MA_5993ca24-4258-4d38-beb9-8f13938c1998"
      unitRef="eur">3828000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTUtMS0xLTM2NDA2MA_e9be9634-fe00-45cb-99e0-7f2af927a115"
      unitRef="eur">6291000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTYtMS0xLTM2NDA2MA_efb42f58-7a28-4c9c-81b9-cefef692ed99"
      unitRef="eur">697000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTctMS0xLTM2NDA2MA_baecd370-8f89-4f2f-8e0a-ab1767277ad0"
      unitRef="eur">105000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEwLTgtMS0xLTM2NDA2MA_ece9fd54-c62b-4a7c-b0c4-01dc62093921"
      unitRef="eur">19461000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ib8549f99e93a4c8f88351f78efd55034_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTItMS0xLTM2NDA2MA_26f6f36e-3966-4e6b-8359-61cb5f0a446c"
      unitRef="eur">-72000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i1664b98afc6e46598a52e279b2f3ee89_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTMtMS0xLTM2NDA2MA_6104fd5a-ab83-4ea0-9b4a-bb791674795e"
      unitRef="eur">-32000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i2044a45bb63a47f9bcac2359abf74ab6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTQtMS0xLTM2NDA2MA_4dcb5851-b6ef-43b0-b5ab-8b2b97eec0b1"
      unitRef="eur">-11000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i054c72ff34994f06a7a458ad33789d88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTUtMS0xLTM2NDA2MA_f18051ad-afb8-445b-943b-b6f5d3535be5"
      unitRef="eur">-17000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i3345089bf2e74afaa45a6894a98dd5aa_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTYtMS0xLTM2NDA2MA_cd76afe9-2068-4eba-aaaf-c0dc2b110bbe"
      unitRef="eur">-20000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="if045fdf55f86441b8b1b494b410a33d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTctMS0xLTM2NDA2MA_f95e8b60-5474-4fb5-83e5-ac42c2869839"
      unitRef="eur">-1000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzExLTgtMS0xLTM2NDA2MA_f6cafbb7-e1e2-40f5-8ec6-8816482571a2"
      unitRef="eur">-153000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i64d9d93ffb0648ffbad6d150cda752c8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTItMS0xLTM2NDA2MA_91f76e43-1483-4d90-9a3b-92b7447bf290"
      unitRef="eur">2596000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ibded5a5821924d39b6d1c07b0695c6d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTMtMS0xLTM2NDA2MA_f47fb9de-ab8a-4aa8-9fa6-2ed0fddb0610"
      unitRef="eur">931000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i99b5e4f93c1a49cd8ea204607473a1ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTQtMS0xLTM2NDA2MA_3603996b-509f-4a3a-bbd0-13452b97be7e"
      unitRef="eur">303000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ia3210673a6874b43b966528be2cf0794_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTUtMS0xLTM2NDA2MA_7e85b44a-4fa3-4c82-bedf-fa78813bba33"
      unitRef="eur">1425000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i233e41249a394b40b74263dc10afafe5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTYtMS0xLTM2NDA2MA_0886c12c-7cd8-4b09-aaae-88f77df033da"
      unitRef="eur">610000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i9b9aaaedaaea4f29a759d257cad38085_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTctMS0xLTM2NDA2MA_e28fe6a7-c16b-4944-963e-e0008705b7ec"
      unitRef="eur">34000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzEyLTgtMS0xLTM2NDA2MA_84b6fa95-80ef-4393-b3c2-3162981c5d72"
      unitRef="eur">5899000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="ib46e8377d3f94800bd25709bd341fc00_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTItMS0xLTM2NDA2MA_c050d3fb-ff4a-47cc-80e5-4d91c7768235"
      unitRef="eur">6744000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="ib22a0224790241248f93cd93a45b1232_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTMtMS0xLTM2NDA2MA_feacab69-9821-454e-8f48-08955eecade6"
      unitRef="eur">3246000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i8f228d50520f41bc92115db7843c0ad7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTQtMS0xLTM2NDA2MA_6c9942cc-5129-4212-be61-746683ecaf23"
      unitRef="eur">4147000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i4116d4bfc3b743c3a4f8f2de755afa63_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTUtMS0xLTM2NDA2MA_c1c7569a-c718-493e-b951-d63a05202f9f"
      unitRef="eur">7244000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="ie16e60a90d774109bacdee057e8bca89_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTYtMS0xLTM2NDA2MA_8261af9f-a889-4528-a8dd-453af32c3ea7"
      unitRef="eur">578000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="i0f6bf0d8ac1b4edb9f472e86394d3706_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTctMS0xLTM2NDA2MA_97b37c7a-fb45-4c47-8b2b-3ef1071cf202"
      unitRef="eur">182000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE0LTgtMS0xLTM2NDA2MA_5ca409dd-037a-40d4-baaa-86dcd57c4aa0"
      unitRef="eur">22141000000</sny:IncreaseThroughNewProvisionRelatedToCurrentPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="ib46e8377d3f94800bd25709bd341fc00_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTItMS0xLTM2NDA2MA_caaf661d-99a5-4c93-909f-33f3750546e5"
      unitRef="eur">-120000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="ib22a0224790241248f93cd93a45b1232_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTMtMS0xLTM2NDA2MA_c2fa035b-180f-4425-b088-96fabdcc2d48"
      unitRef="eur">-47000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i8f228d50520f41bc92115db7843c0ad7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTQtMS0xLTM2NDA2MA_e85dcad0-9e38-4c88-b496-63469839b9ed"
      unitRef="eur">-21000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i4116d4bfc3b743c3a4f8f2de755afa63_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTUtMS0xLTM2NDA2MA_7c516330-b739-44e0-a45c-9257713cece3"
      unitRef="eur">-138000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="ie16e60a90d774109bacdee057e8bca89_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTYtMS0xLTM2NDA2MA_07ae8d94-91bc-4188-b592-1e79d8b85530"
      unitRef="eur">-8000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="i0f6bf0d8ac1b4edb9f472e86394d3706_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTctMS0xLTM2NDA2MA_3aba5625-39fa-4ab0-9048-0e54e69f0957"
      unitRef="eur">19000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE1LTgtMS0xLTM2NDA2MA_d90b4d6e-10fb-4c1e-8e65-a8e1492d566b"
      unitRef="eur">-315000000</sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ib46e8377d3f94800bd25709bd341fc00_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTItMS0xLTM2NDA2MA_91381890-f70a-4591-8d3d-014e233b8a15"
      unitRef="eur">6824000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ib22a0224790241248f93cd93a45b1232_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTMtMS0xLTM2NDA2MA_2fdbd6ef-0364-48d8-8155-508393681c28"
      unitRef="eur">3208000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i8f228d50520f41bc92115db7843c0ad7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTQtMS0xLTM2NDA2MA_044e173c-5be4-4b4b-afd5-ff151fd00727"
      unitRef="eur">4093000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i4116d4bfc3b743c3a4f8f2de755afa63_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTUtMS0xLTM2NDA2MA_f860af74-7a49-4c64-b80c-00b2d487f45c"
      unitRef="eur">6809000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ie16e60a90d774109bacdee057e8bca89_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTYtMS0xLTM2NDA2MA_b8dc0af1-2c16-4ff4-bc48-b296466c5d5d"
      unitRef="eur">599000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i0f6bf0d8ac1b4edb9f472e86394d3706_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTctMS0xLTM2NDA2MA_742acaae-c58b-42ee-b3fc-f7cf3d061a2e"
      unitRef="eur">166000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE2LTgtMS0xLTM2NDA2MA_193527e4-5f5f-4b1a-b365-9c22c687f7f2"
      unitRef="eur">21699000000</sny:DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ib46e8377d3f94800bd25709bd341fc00_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTItMS0xLTM2NDA2MA_811cbb81-0daf-4811-8ba6-70fe942e4b82"
      unitRef="eur">207000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ib22a0224790241248f93cd93a45b1232_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTMtMS0xLTM2NDA2MA_e6482af2-c92d-4796-a1f8-f98fc150e899"
      unitRef="eur">99000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i8f228d50520f41bc92115db7843c0ad7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTQtMS0xLTM2NDA2MA_d1a1d52e-63ec-4693-b455-f9a9c5777c2a"
      unitRef="eur">26000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i4116d4bfc3b743c3a4f8f2de755afa63_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTUtMS0xLTM2NDA2MA_ee3a27f0-1644-4df0-80a6-dc59b822d906"
      unitRef="eur">83000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ie16e60a90d774109bacdee057e8bca89_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTYtMS0xLTM2NDA2MA_059200a9-28da-43b9-bab3-abd8297005e8"
      unitRef="eur">48000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i0f6bf0d8ac1b4edb9f472e86394d3706_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTctMS0xLTM2NDA2MA_da0b5977-5f45-417e-9fbb-a67300a41f6c"
      unitRef="eur">1000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE3LTgtMS0xLTM2NDA2MA_b686b791-aec0-4312-a005-7121c77c3ede"
      unitRef="eur">464000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i72900069921b42fea99c263ebf35ef00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTItMS0xLTM2NDA2MA_4f6938d4-31a2-4ed8-be8f-3d8e6ae60128"
      unitRef="eur">2603000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i4cca6f8175204ac1bc6a07e79e2ef411_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTMtMS0xLTM2NDA2MA_4e7ce593-6f55-45a9-b58a-04e2c8503679"
      unitRef="eur">1021000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i4cdb48ddcab543e797bec062453e8560_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTQtMS0xLTM2NDA2MA_32fe24ca-cec3-4614-9bb0-9c2ca835319c"
      unitRef="eur">362000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ic7d6e7f31f0449ad8c055ca0af7ee098_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTUtMS0xLTM2NDA2MA_f5a27ac0-a91d-4c9a-92ce-df2e9a24e8f8"
      unitRef="eur">1805000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="iff9f3b36e4cf420295883612ede99cca_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTYtMS0xLTM2NDA2MA_32926516-a797-439d-819c-c324735b01aa"
      unitRef="eur">629000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i7f9eac0c1cdb4f5c83bcb43211427c90_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTctMS0xLTM2NDA2MA_b92cf2e3-5817-40cb-99b7-80831099cbea"
      unitRef="eur">70000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90YWJsZTowOTVmMGYxNDE3ODE0YWJhYjI0YjExNmVhY2I0MDZlYS90YWJsZXJhbmdlOjA5NWYwZjE0MTc4MTRhYmFiMjRiMTE2ZWFjYjQwNmVhXzE4LTgtMS0xLTM2NDA2MA_dd9e953b-b469-4866-9ff9-44af3314204b"
      unitRef="eur">6490000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i290ce668686b44a794845d7477734f86_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzM0MA_403be3f5-119c-400d-89a3-7990366f4893"
      unitRef="eur">1307000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i6c1eb476973a44889e6ab4746c231250_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzM1MA_e8394013-426e-4cc8-8b14-652f8c38e8da"
      unitRef="eur">1244000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i85bcc857ce00463eac390d699613b102_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzM2MA_c498f4a8-3161-48e9-aea3-8370b5fbaaa7"
      unitRef="eur">1015000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="ib426e8d70a6d4415bc4d1dad51db673f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzM4NA_c7e96dfb-b737-4b4c-b21c-bb7a6b5cad62"
      unitRef="eur">775000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i90191c61996943178db939f24e430160_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzM5NA_1e241076-9989-41f7-abfe-f8c72f1a3310"
      unitRef="eur">941000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i5007c17b33544991b3dbdb064cc3f736_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzQwOQ_58cb6ad2-7483-4d38-9e1e-bb73a0b522b2"
      unitRef="eur">726000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="if8af58300a9146fc82e82e9c13c202cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzU0Ng_3093252e-e425-4502-858d-2cfe7d04c486"
      unitRef="eur">934000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i852b799422a14eaba1c477f4f3c8a31d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzU1Ng_151f57c2-ed92-476b-bffe-d0777b800207"
      unitRef="eur">896000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="iebbc786d5e4e406c8d9fb17fb74e7b2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzU3MA_8081b180-2e3d-499d-bcc8-0f5b180ef9e0"
      unitRef="eur">692000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzYzMg_2e00136c-8024-467b-aedb-20ad4021175c"
      unitRef="eur">4270000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzY0NQ_5db7eb89-11e6-413e-93c2-662869bf2135"
      unitRef="eur">4057000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <sny:ProvisionsForDiscountsRebatesAndSalesReturns
      contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjEvZnJhZzphZDhlZjRhOTc5NjI0NTQyYjgxYjlhNDk3ZGRmMDVkNC90ZXh0cmVnaW9uOmFkOGVmNGE5Nzk2MjQ1NDJiODFiOWE0OTdkZGYwNWQ0XzY2MQ_6eb16252-b5e7-4fe4-9165-eafbcfdcb81a"
      unitRef="eur">3982000000</sny:ProvisionsForDiscountsRebatesAndSalesReturns>
    <ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90ZXh0cmVnaW9uOjYwMDIwZjE3ZGE1YTQxNjE4NGVkYTI0YTRmNjM4YTJiXzM3Mg_c5852b7a-48d2-44c6-be16-e8724012d605">Personnel costs&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Total personnel costs (other than termination benefits, presented in Note&#160;D.27.) include the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Salaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Social security charges (including defined-contribution pension plans)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Stock options and other share-based payment expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Defined-benefit plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,991&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,340&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,079&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The total number of registered employees was 91,573 as of December 31, 2022, compared with 95,442 as of December 31, 2021 and&#160;99,412 as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory>
    <sny:DisclosureOfPersonnelCostsDetailsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90ZXh0cmVnaW9uOjYwMDIwZjE3ZGE1YTQxNjE4NGVkYTI0YTRmNjM4YTJiXzM3NA_e14d46ed-2acb-43d7-917a-41cc2663c102">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Total personnel costs (other than termination benefits, presented in Note&#160;D.27.) include the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Salaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Social security charges (including defined-contribution pension plans)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Stock options and other share-based payment expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Defined-benefit plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,991&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,340&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,079&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfPersonnelCostsDetailsTableTextBlock>
    <ifrs-full:WagesAndSalaries
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzEtMS0xLTEtMzY0MDYw_8c76f2f6-2c85-4078-be6a-f0fa12f7ae0c"
      unitRef="eur">7145000000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzEtMi0xLTEtMzY0MDYw_60c7f908-691f-4146-809d-c9b7816d5309"
      unitRef="eur">6625000000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzEtMy0xLTEtMzY0MDYw_0edb5767-83cc-4196-bf77-94f76ae5cd41"
      unitRef="eur">6508000000</ifrs-full:WagesAndSalaries>
    <ifrs-full:SocialSecurityContributions
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzItMS0xLTEtMzY0MDYw_d0a58a40-36ad-4757-aed4-72f3b228730e"
      unitRef="eur">2098000000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:SocialSecurityContributions
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzItMi0xLTEtMzY0MDYw_277386b3-e39e-4b37-816a-dc0b70c80b8d"
      unitRef="eur">1929000000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:SocialSecurityContributions
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzItMy0xLTEtMzY0MDYw_2680ed88-2585-4ebe-b132-b7d2a311fa08"
      unitRef="eur">1874000000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzMtMS0xLTEtMzY0MDYw_2ca28ad5-feb6-411d-a700-d13d3b967d43"
      unitRef="eur">245000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzMtMi0xLTEtMzY0MDYw_cac2a9cb-8424-44de-968e-383859f27ee2"
      unitRef="eur">244000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzMtMy0xLTEtMzY0MDYw_43dcaec8-8c8e-4158-b8bf-431fc8979a37"
      unitRef="eur">274000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzQtMS0xLTEtMzY0MDYw_93371163-079d-47df-9b23-9a29fdbd91b5"
      unitRef="eur">236000000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzQtMi0xLTEtMzY0MDYw_1e69dd88-3854-438f-9b0f-57628860bf6d"
      unitRef="eur">273000000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzQtMy0xLTEtMzY0MDYw_74459905-6a9b-494b-8358-56c96e214a55"
      unitRef="eur">162000000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:OtherEmployeeExpense
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzUtMS0xLTEtMzY0MDYw_3b3d11cc-fa31-45e3-ab78-1b545e124fce"
      unitRef="eur">267000000</ifrs-full:OtherEmployeeExpense>
    <ifrs-full:OtherEmployeeExpense
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzUtMi0xLTEtMzY0MDYw_40d1aa0b-756a-4afd-8a68-62dc5dde294d"
      unitRef="eur">269000000</ifrs-full:OtherEmployeeExpense>
    <ifrs-full:OtherEmployeeExpense
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzUtMy0xLTEtMzY0MDYw_1067d848-fffc-4941-abbb-52dd4ae5d907"
      unitRef="eur">261000000</ifrs-full:OtherEmployeeExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzYtMS0xLTEtMzY0MDYw_b1658044-d85d-462d-9885-29390fcf5f9d"
      unitRef="eur">9991000000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzYtMi0xLTEtMzY0MDYw_fc16bfce-0401-43fd-acd9-a329546a64f3"
      unitRef="eur">9340000000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90YWJsZTpjYmFmNzYzMWJmNjc0MmJkOTZiYjRmMWVkYWFjNGJjZC90YWJsZXJhbmdlOmNiYWY3NjMxYmY2NzQyYmQ5NmJiNGYxZWRhYWM0YmNkXzYtMy0xLTEtMzY0MDYw_3c90f967-5fe1-4e9b-88b7-30d61ff92530"
      unitRef="eur">9079000000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:NumberOfEmployees
      contextRef="i6beef57f0ff142ac829ee75f07d8469f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90ZXh0cmVnaW9uOjYwMDIwZjE3ZGE1YTQxNjE4NGVkYTI0YTRmNjM4YTJiXzMxNw_acff51a6-7c32-4126-9288-21faa50dc1cc"
      unitRef="employee">91573</ifrs-full:NumberOfEmployees>
    <ifrs-full:NumberOfEmployees
      contextRef="i0645fdc11d9d433a8306a1a8019152d7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90ZXh0cmVnaW9uOjYwMDIwZjE3ZGE1YTQxNjE4NGVkYTI0YTRmNjM4YTJiXzM0NA_9f293b5d-a448-495f-bd63-24dc56d70a63"
      unitRef="employee">95442</ifrs-full:NumberOfEmployees>
    <ifrs-full:NumberOfEmployees
      contextRef="i0566192b2355417fa9d42170481d811a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjQvZnJhZzo2MDAyMGYxN2RhNWE0MTYxODRlZGEyNGE0ZjYzOGEyYi90ZXh0cmVnaW9uOjYwMDIwZjE3ZGE1YTQxNjE4NGVkYTI0YTRmNjM4YTJiXzM2MA_a29de26d-20eb-408b-9aba-0cef95d6a83e"
      unitRef="employee">99412</ifrs-full:NumberOfEmployees>
    <ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzY5MA_bf4df5d6-fffd-46b3-8e6f-40c12a644eb9">Other operating income&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;totaled &#x20ac;1,969 million in 2022, versus &#x20ac;859 million in 2021 and &#x20ac;697 million in 2020.&lt;/span&gt;Other operating income includes (i)&#160;gains from asset divestments, amounting to &#x20ac;655&#160;million in 2022 (versus &#x20ac;418 million in 2021 and &#x20ac;307 million in 2020); and (ii)&#160;income from Sanofi&#x2019;s pharmaceutical partners, amounting to &#x20ac;1,178 million in 2022 (including &#x20ac;1,147 million from Regeneron, see Note&#160;D.26. below and Note C.1.), compared with &#x20ac;245 million in 2021 and &#x20ac;199 million in 2020. For 2021, it includes a payment of &#x20ac;119&#160;million from Daiichi Sankyo relating to the termination of a vaccines collaboration agreement in Japan</ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzY1_b191e594-33fb-4884-a292-fe8b76af4d2f"
      unitRef="eur">1969000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzgy_9903c0ed-2563-4c6e-97fc-a40e1ca46c63"
      unitRef="eur">859000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzk1_bcf60734-3181-499e-b4fe-85fded705b9a"
      unitRef="eur">697000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <sny:GainsOnDivestmentOfProducts
      contextRef="i91602956c5a04e7d8e221b1a2b3c3fd3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzE4NQ_bd64b51a-1d7a-4f4e-8218-39e32d12843b"
      unitRef="eur">655000000</sny:GainsOnDivestmentOfProducts>
    <sny:GainsOnDivestmentOfProducts
      contextRef="ie12b73fd2da74dce969b70268e0ff95e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzIxMQ_8b6b28a7-f5b8-449d-9e9c-308bb49019fc"
      unitRef="eur">418000000</sny:GainsOnDivestmentOfProducts>
    <sny:GainsOnDivestmentOfProducts
      contextRef="iaa3510029eb8449b898dcffcb36596d8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzIyNQ_f016af0d-991a-4642-b571-392ee2538582"
      unitRef="eur">307000000</sny:GainsOnDivestmentOfProducts>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="iff607e4176ca4b068613990b2582eabf_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzMwMQ_714ffda2-059b-4bcc-922a-b3e356ce86a9"
      unitRef="eur">1178000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i5f958208733644e1aae6fda659400f4e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzMyMg_e7f15133-9139-4c01-b904-4b5195704129"
      unitRef="eur">1147000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="iaa10c8ec5cac4f29a0a9183bbd94bd99_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzM3OQ_26284c0c-5831-49e7-a8a9-45d78c708b5f"
      unitRef="eur">245000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i6e57a41f946d4ff4a313d21852bdba8b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzM5Mw_4c68b7b2-5e1d-4e19-891c-35276ce233ab"
      unitRef="eur">199000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i970b0685e8954a3aa5ddf4a490518870_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NjcvZnJhZzpkMzBlMTZkZDJmNDM0NzZmYmRjYjIzMTAyOGVmMmNkZi90ZXh0cmVnaW9uOmQzMGUxNmRkMmY0MzQ3NmZiZGNiMjMxMDI4ZWYyY2RmXzQ1OA_58dbaea8-ac41-4fee-a215-63ad47699c44"
      unitRef="eur">119000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzM4NQ_c3755847-14f3-49cf-99b4-9e92667e5773">Other operating expenses&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; totaled &#x20ac;2,531 million in 2022, compared with &#x20ac;1,805 million in 2021 and &#x20ac;1,415 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For 2022, this line item includes &#x20ac;2,378 million of expenses relating to the alliance with Regeneron (see Note&#160;C.1.), compared with&#160;&#x20ac;1,568 million for 2021 and &#x20ac;1,090 million for 2020 (as shown in the table below):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income &amp;amp; expense related to sharing of (profits)/losses under the Monoclonal Antibody Alliance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additional share of profit paid by Regeneron towards development costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reimbursement to Regeneron of selling expenses incurred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total - Monoclonal Antibody Alliance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,001)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Immuno-Oncology Alliance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;89&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other (mainly Zaltrap&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt; and Libtayo&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,120&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other operating income/(expenses), net related to the Regeneron Alliance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(926)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which amount presented in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt; Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt; (Note&#160;D.25.)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Following the restructuring of the Immuno-Oncology agreement between Sanofi and Regeneron, applicable from July&#160;1, 2022 (see Note&#160;C.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) As of December 31, 2022, the commitment received by Sanofi in respect of the additional profit share payable by Regeneron towards development costs amounted to &#x20ac;2.7 billion, compared with &#x20ac;2.9&#160;billion as of December 31, 2021 (see note D.21).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Charges to provisions for litigation and environmental risks are also recorded within this line item.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzY5_a35b8fe1-a495-4c29-a9f8-cc1f021f28cb"
      unitRef="eur">2531000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4Xzkz_2abf9cca-162b-4e3c-ae56-9a4420f1a290"
      unitRef="eur">1805000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzEwNg_46b1a524-4dc1-49a5-84e1-9ce493db541c"
      unitRef="eur">1415000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <sny:OtherOperatingExpensesTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzM4Ng_f329ca90-1a8c-4136-8e88-91c3706b640d">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For 2022, this line item includes &#x20ac;2,378 million of expenses relating to the alliance with Regeneron (see Note&#160;C.1.), compared with&#160;&#x20ac;1,568 million for 2021 and &#x20ac;1,090 million for 2020 (as shown in the table below):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income &amp;amp; expense related to sharing of (profits)/losses under the Monoclonal Antibody Alliance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additional share of profit paid by Regeneron towards development costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reimbursement to Regeneron of selling expenses incurred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total - Monoclonal Antibody Alliance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,001)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Immuno-Oncology Alliance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;89&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other (mainly Zaltrap&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt; and Libtayo&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,120&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other operating income/(expenses), net related to the Regeneron Alliance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(926)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which amount presented in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt; Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt; (Note&#160;D.25.)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Following the restructuring of the Immuno-Oncology agreement between Sanofi and Regeneron, applicable from July&#160;1, 2022 (see Note&#160;C.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) As of December 31, 2022, the commitment received by Sanofi in respect of the additional profit share payable by Regeneron towards development costs amounted to &#x20ac;2.7 billion, compared with &#x20ac;2.9&#160;billion as of December 31, 2021 (see note D.21).&lt;/span&gt;&lt;/div&gt;</sny:OtherOperatingExpensesTableTextBlock>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="ie13a4afd7b1b4e79b6db10af437058d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzE0OA_d7fd3e11-73c1-4c92-982a-26d6168c72a0"
      unitRef="eur">2378000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i018625c9ec8b468a9ff0873e7d03260a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzIyNw_3c8f0334-f6f7-4480-a1c0-21f97c95d3dc"
      unitRef="eur">1568000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i17591b56caee4f43b8f0bbb8ca58a6f4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzI0MQ_4aca79f6-b9ab-401c-bfb6-8bd82c15323a"
      unitRef="eur">1090000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i52bffdb81007440da92ed6b97e6d9231_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzEtMS0xLTEtMzY0MDYw_b0a77f30-9b43-4e97-9d5f-144d0e1b4075"
      unitRef="eur">2325000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i5c405e8e7d324c77bfd2af173dcbb932_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzEtMi0xLTEtMzY0MDYw_cbc9452b-90c6-4d8d-b9c6-fa24fb745eb5"
      unitRef="eur">1253000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i62fee9f3c5744551bbe06227b0c173fa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzEtMy0xLTEtMzY0MDYw_424a90e7-9fb6-4213-a551-a017845a4a6b"
      unitRef="eur">727000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i6fd5132ee30d4c7493ae9545f5714b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzItMS0xLTEtMzY0MDYw_133f210e-f9cf-4bd2-b94b-e9a58f341455"
      unitRef="eur">434000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i6d08b9ad0c254c1e8eeeba6476b35c2e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzItMi0xLTEtMzY0MDYw_521200b5-dee9-4e23-9a2b-f3a3c0d25e05"
      unitRef="eur">127000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="if958d5b745e54738bf294167a5124ac7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzItMy0xLTEtMzY0MDYw_a2927634-3e39-4623-aefc-0adfda5b0722"
      unitRef="eur">75000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i171827e88bc74a668b2a39c3176ab65f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzMtMS0xLTEtMzY0MDYw_8cbfac5b-5e88-45af-8274-9fb5b451066e"
      unitRef="eur">476000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i8348d8dee22140afbaa6845ac4456f2b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzMtMi0xLTEtMzY0MDYw_c01499dd-78b8-4248-b4d1-f8d97dbc27e4"
      unitRef="eur">303000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i6bcd495e13694c26aed02fa8a7200ca9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzMtMy0xLTEtMzY0MDYw_a656e90c-df55-4f73-81da-9f7c8e77bb36"
      unitRef="eur">349000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i7a34f2d952b641fa9a97150c939ad0be_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzQtMS0xLTEtMzY0MDYw_c5c752c0-aa2a-422f-9022-8ac17f96629d"
      unitRef="eur">2367000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="i55a8693d305047af919fadebbfac7084_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzQtMi0xLTEtMzY0MDYw_b3199a1a-36ae-43d8-b49b-442882535e13"
      unitRef="eur">1429000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="ic2326a92e2034921aa2a51bf11bc0d93_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzQtMy0xLTEtMzY0MDYw_779d9ead-b13e-4f77-a796-6cac98c72eed"
      unitRef="eur">1001000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i7ce30596c49c4242b0c04b915f6f7e57_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzUtMS0xLTEtMzY0MDYw_874b544a-ad3a-4c7f-aa94-8d7d8edb0f83"
      unitRef="eur">16000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i717efcfa32c548de8e23d8e05d058bc2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzUtMi0xLTEtMzY0MDYw_b1c6dc83-9be3-413e-83f1-5a2aaf18a9f9"
      unitRef="eur">68000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="ia56a9ae0556147629310bbf5d7bcda1a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzUtMy0xLTEtMzY0MDYw_ecbeeb72-be36-4c45-84a6-5980ea44d57b"
      unitRef="eur">89000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="i622bf4fa192846ca9f1f1cdce02e4c83_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzYtMS0xLTEtMzY0MDYw_9af87101-4db0-4a6f-b66c-bc4b31b19b00"
      unitRef="eur">1120000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="ib7937d433de14ca7932134a404b27d2f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzYtMi0xLTEtMzY0MDYw_4c2134ed-705f-495a-ab20-0383a5511f11"
      unitRef="eur">-12000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="ib79d267fb5b34f5cbd786c75b48c5759_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzYtMy0xLTEtMzY0MDYw_589d4b12-1bf8-4e75-9ad2-28e392c55bfd"
      unitRef="eur">-14000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzctMS0xLTEtMzY0MDYw_9d6936ba-4ea8-45cb-8738-60808ba8bf77"
      unitRef="eur">-1231000000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzctMi0xLTEtMzY0MDYw_c8be0fe8-b442-4b40-b5b0-d166129d2f94"
      unitRef="eur">-1373000000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzctMy0xLTEtMzY0MDYw_bde7f6df-9cf4-4964-96d6-163c79378855"
      unitRef="eur">-926000000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i5f958208733644e1aae6fda659400f4e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzgtMS0xLTEtMzY0MDYw_e7f15133-9139-4c01-b904-4b5195704129"
      unitRef="eur">1147000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="i088be89f9d1b4730a785c0f6445acec8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzgtMi0xLTEtMzY0MDYw_cda29c72-9c77-4e32-a5e7-d44d071fb8d5"
      unitRef="eur">195000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="ib4a2186378404e3987bb8fd7e88f511f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90YWJsZTpjYjg4YzJlNzZhMzY0ZGVkODE2NWU4ZTJlZGJkM2E3NC90YWJsZXJhbmdlOmNiODhjMmU3NmEzNjRkZWQ4MTY1ZThlMmVkYmQzYTc0XzgtMy0xLTEtMzY0MDYw_6a6881f6-08ca-42e0-9ebc-d90adbc8b796"
      unitRef="eur">164000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <sny:CommitmentsReceivedForDevelopmentCosts
      contextRef="i3ecee33decbb47918bc45c5d39b6e2d8_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzQyODgwOTUzNDg1MDY5_fd23bae1-f6dc-4b39-a120-cea15d90ac47"
      unitRef="eur">2700000000</sny:CommitmentsReceivedForDevelopmentCosts>
    <sny:CommitmentsReceivedForDevelopmentCosts
      contextRef="if08a539d4d40455d827bc164ddb96d57_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzAvZnJhZzphYmFmM2JmNWVmZTU0YzYwOTE2Yjg4YTBjOTk0ZDU0OC90ZXh0cmVnaW9uOmFiYWYzYmY1ZWZlNTRjNjA5MTZiODhhMGM5OTRkNTQ4XzQyODgwOTUzNDg1MDI2_656acfd2-5e80-4b22-91f7-71e6c9c3ac40"
      unitRef="eur">2900000000</sny:CommitmentsReceivedForDevelopmentCosts>
    <sny:DisclosureOfRestructuringCostsAndSimilarItemsTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzEyMjg_e304e081-f3ad-4039-bfb5-499776d69f1a">Restructuring costs and similar items&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Restructuring costs and similar items amounted to &#x20ac;1,336 million in 2022, &#x20ac;820 million in 2021 and &#x20ac;1,089 million in 2020, and were comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee-related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Charges, gains or losses on assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Compensation for early termination of contracts (other than contracts of employment)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transformation programs costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,336&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;820&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,089&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;This line consists of impairment losses and accelerated depreciation charges related to site closures (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2022, the employee-related expenses of &#x20ac;507&#160;million related to termination benefits further to announcements made during the year, and the line &#x201c;Charges, gains or losses on assets&#x201d; related mainly to a strategic decision to close an industrial facility outside France. The costs of Sanofi's transformation program (as defined in Note&#160;B.19.) relate mainly to the ongoing creation of the new standalone Consumer Healthcare entity, and to the implementation of Sanofi&#x2019;s new digital strategy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2021, the costs of Sanofi's transformation program were mainly related to the creation of the new standalone Consumer Healthcare entity and of EUROAPI (the new European market leader in active pharmaceutical ingredients), and to the implementation of Sanofi&#x2019;s new digital strategy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2020, employee-related expenses amounted to &#x20ac;697&#160;million, and consisted of termination benefits further to the announcement of plans to adapt Sanofi&#x2019;s organization (primarily in Europe) in line with the new &#x201c;Play to Win&#x201d; strategy announced in December&#160;2019.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfRestructuringCostsAndSimilarItemsTextBlock>
    <sny:DisclosureOfRestructuringCostsDetailsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzEyMzE_7f062f66-ae41-4570-8a4d-21d48e1046b0">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Restructuring costs and similar items amounted to &#x20ac;1,336 million in 2022, &#x20ac;820 million in 2021 and &#x20ac;1,089 million in 2020, and were comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee-related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Charges, gains or losses on assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Compensation for early termination of contracts (other than contracts of employment)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Transformation programs costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,336&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;820&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,089&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;This line consists of impairment losses and accelerated depreciation charges related to site closures (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfRestructuringCostsDetailsTableTextBlock>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzEwMA_cea2a219-23b6-4ba9-9009-496db4e59314"
      unitRef="eur">1336000000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzExOQ_537ab77f-3b4f-4619-9f98-5803e1ae8863"
      unitRef="eur">820000000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzE0MQ_31075019-f6f8-48ac-8e0a-d5a0a6947249"
      unitRef="eur">1089000000</ifrs-full:ExpenseOfRestructuringActivities>
    <sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzEtMS0xLTEtMzY0MDYw_10c1aff9-cf99-406f-b3b1-e5670c2539d0"
      unitRef="eur">507000000</sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses>
    <sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzEtMi0xLTEtMzY0MDYw_0f4ef0a6-8084-47a5-81ba-99cccadcc45e"
      unitRef="eur">193000000</sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses>
    <sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzEtNC0xLTEtMzY0MDYw_969df51b-7962-4389-a4e5-879b882a7e88"
      unitRef="eur">697000000</sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses>
    <sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzItMS0xLTEtMzY0MDYw_ec0217d7-0ac2-4db9-906d-74d0fd724492"
      unitRef="eur">261000000</sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories>
    <sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzItMi0xLTEtMzY0MDYw_73547244-178a-4958-82a0-15fa3fffa679"
      unitRef="eur">110000000</sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories>
    <sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzItNC0xLTEtMzY0MDYw_6cb42d54-5a9e-4322-b8e8-109962da6388"
      unitRef="eur">149000000</sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories>
    <sny:ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzMtMS0xLTEtMzY0MDYw_7fdce263-eed4-4f8f-b667-04a7a010f3ba"
      unitRef="eur">1000000</sny:ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts>
    <sny:ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzMtMi0xLTEtMzY0MDYw_d5f60b61-9c08-490b-beea-1c4fc829a031"
      unitRef="eur">34000000</sny:ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts>
    <sny:ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzMtNC0xLTEtMzY0MDYw_2dfee850-7e93-4b30-b045-e96a70f07e7e"
      unitRef="eur">40000000</sny:ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts>
    <sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzUtMS0xLTEtMzY0MDYw_37e824dd-79a5-4ac1-a757-fa9d991d7389"
      unitRef="eur">547000000</sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts>
    <sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzUtMi0xLTEtMzY0MDYw_b725c0b8-68d6-41e2-b2d4-a1aef562e05e"
      unitRef="eur">463000000</sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts>
    <sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzUtNC0xLTEtMzY0MDYw_8ef8f2fc-9b59-44a4-aa4c-34522f8e5885"
      unitRef="eur">191000000</sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts>
    <sny:OtherRestructuringCosts
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzYtMS0xLTEtMzY0MDYw_ea2167b6-72bf-403e-9baa-f356579d0027"
      unitRef="eur">20000000</sny:OtherRestructuringCosts>
    <sny:OtherRestructuringCosts
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzYtMi0xLTEtMzY0MDYw_972eca47-e939-4f33-856c-f5a2ec82ab78"
      unitRef="eur">20000000</sny:OtherRestructuringCosts>
    <sny:OtherRestructuringCosts
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzYtNC0xLTEtMzY0MDYw_66d4f4e4-b006-4b16-a840-e2c83e533adc"
      unitRef="eur">12000000</sny:OtherRestructuringCosts>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzctMS0xLTEtMzY0MDYw_cea2a219-23b6-4ba9-9009-496db4e59314"
      unitRef="eur">1336000000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzctMi0xLTEtMzY0MDYw_537ab77f-3b4f-4619-9f98-5803e1ae8863"
      unitRef="eur">820000000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90YWJsZTowYTk4Yjg1ODI0ZmU0YmRkOGI2M2UyOWU2MWQzYjZiNS90YWJsZXJhbmdlOjBhOThiODU4MjRmZTRiZGQ4YjYzZTI5ZTYxZDNiNmI1XzctNC0xLTEtMzY0MDYw_31075019-f6f8-48ac-8e0a-d5a0a6947249"
      unitRef="eur">1089000000</ifrs-full:ExpenseOfRestructuringActivities>
    <sny:IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzgwODE0MTA0NjQ4NjM3_282609b1-37c5-44eb-8bfb-ef2a42c480bd"
      unitRef="eur">507000000</sny:IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses>
    <sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzMvZnJhZzo2ZDg1ZjMyMGZiMDI0MzUxODg5Y2QyM2ZmOWEzNWU0MS90ZXh0cmVnaW9uOjZkODVmMzIwZmIwMjQzNTE4ODljZDIzZmY5YTM1ZTQxXzc2OTY1ODEzOTc5Mjk_66b130f6-b9c3-4344-aa32-c2d2f3e4b54c"
      unitRef="eur">697000000</sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses>
    <sny:DisclosureOfOtherGainsAndLossesAndLitigationTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzYvZnJhZzowMTNiOWZlNGE3YWE0NjYxOTBmNWUxYTU2MDc3M2M3MS90ZXh0cmVnaW9uOjAxM2I5ZmU0YTdhYTQ2NjE5MGY1ZTFhNTYwNzczYzcxXzMzNg_e7e79bcd-be7e-4678-b2e7-9b456a8090b4">Other gains and losses, and litigation&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other gains and losses, and litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;for &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;2022 represent a charge of &#x20ac;370&#160;million, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;including the pre-tax loss arising on the deconsolidation of EUROAPI (see Note&#160;D.1.) and costs related to major litigation, including the estimated future defense costs which Sanofi may be exposed in connection with the Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; litigation&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For 2021, this line item represented a charge of &#x20ac;5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For 2020, this line item represented a net gain of &#x20ac;136 million, mainly relating to the sale of Seprafilm&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfOtherGainsAndLossesAndLitigationTextBlock>
    <sny:OtherGainsLossesAndLitigation
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzYvZnJhZzowMTNiOWZlNGE3YWE0NjYxOTBmNWUxYTU2MDc3M2M3MS90ZXh0cmVnaW9uOjAxM2I5ZmU0YTdhYTQ2NjE5MGY1ZTFhNTYwNzczYzcxXzI5Njg2ODEzOTUwNjA0_a01bf90d-26b5-4002-980c-87ba8c60c072"
      unitRef="eur">-370000000</sny:OtherGainsLossesAndLitigation>
    <sny:OtherGainsLossesAndLitigation
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzYvZnJhZzowMTNiOWZlNGE3YWE0NjYxOTBmNWUxYTU2MDc3M2M3MS90ZXh0cmVnaW9uOjAxM2I5ZmU0YTdhYTQ2NjE5MGY1ZTFhNTYwNzczYzcxXzE3Ng_54232797-b400-4cb8-870b-694fe08fd1df"
      unitRef="eur">-5000000</sny:OtherGainsLossesAndLitigation>
    <sny:OtherGainsLossesAndLitigation
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzYvZnJhZzowMTNiOWZlNGE3YWE0NjYxOTBmNWUxYTU2MDc3M2M3MS90ZXh0cmVnaW9uOjAxM2I5ZmU0YTdhYTQ2NjE5MGY1ZTFhNTYwNzczYzcxXzI3OA_9b0bfbe3-b435-4094-abec-45bb11801f2a"
      unitRef="eur">136000000</sny:OtherGainsLossesAndLitigation>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2Xzc0Nw_ca03df23-1c20-4a4c-ae5d-08be5e4657b2">Financial expenses and income&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;An analysis of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(313)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cost of net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-operating foreign exchange gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unwinding of discounting of provisions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest cost related to employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gains/(losses) on disposals of financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest expense on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net financial income/(expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;comprising: Financial expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Includes net gains/(losses) on interest rate and currency derivatives used to manage debt: &#x20ac;(11) million in 2022, &#x20ac;14 million in 2021, &#x20ac;93 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Includes net gains on interest rate and currency derivatives used to manage cash and cash equivalents: &#x20ac;68 million in 2022, &#x20ac;51 million in 2021, &#x20ac;66 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d)&#160;&#160;&#160;&#160;Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note&#160;D.19.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In 2022, 2021 and 2020, the impact of the ineffective portion of hedging relationships was not material.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2Xzc0OQ_568987f4-6917-4329-a040-6a2a553e1131">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;An analysis of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(313)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cost of net debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-operating foreign exchange gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unwinding of discounting of provisions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest cost related to employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gains/(losses) on disposals of financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net interest expense on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net financial income/(expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;comprising: Financial expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Includes net gains/(losses) on interest rate and currency derivatives used to manage debt: &#x20ac;(11) million in 2022, &#x20ac;14 million in 2021, &#x20ac;93 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Includes net gains on interest rate and currency derivatives used to manage cash and cash equivalents: &#x20ac;68 million in 2022, &#x20ac;51 million in 2021, &#x20ac;66 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d)&#160;&#160;&#160;&#160;Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note&#160;D.19.).&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock>
    <ifrs-full:InterestExpenseOnBorrowings
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEtMS0xLTEtMzY0MDYw_aee91495-4cb0-49a7-b72f-417dfab0ec9e"
      unitRef="eur">365000000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestExpenseOnBorrowings
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEtMi0xLTEtMzY0MDYw_f385b02e-e05d-4ff1-b140-400fe4cee5fe"
      unitRef="eur">313000000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestExpenseOnBorrowings
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEtNC0xLTEtMzY0MDYw_bcd15c76-07fb-4c7c-83fc-09905889f43c"
      unitRef="eur">328000000</ifrs-full:InterestExpenseOnBorrowings>
    <sny:InterestIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzItMS0xLTEtMzY0MDYw_0ce3655b-db09-4666-8f81-5cc788f92d40"
      unitRef="eur">241000000</sny:InterestIncome>
    <sny:InterestIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzItMi0xLTEtMzY0MDYw_1de8cd58-a407-4626-822f-3348314e87ed"
      unitRef="eur">54000000</sny:InterestIncome>
    <sny:InterestIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzItNC0xLTEtMzY0MDYw_9979f8a1-9b51-4fe9-ae4b-f134a198f762"
      unitRef="eur">103000000</sny:InterestIncome>
    <sny:CostOfDebtNet
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzMtMS0xLTEtMzY0MDYw_b1fe12af-c957-487e-8c9e-d93874e857bd"
      unitRef="eur">124000000</sny:CostOfDebtNet>
    <sny:CostOfDebtNet
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzMtMi0xLTEtMzY0MDYw_36aa0586-358b-412f-883d-9e7e042712c0"
      unitRef="eur">259000000</sny:CostOfDebtNet>
    <sny:CostOfDebtNet
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzMtNC0xLTEtMzY0MDYw_795ac924-1edb-45f5-8326-2da07fc552e3"
      unitRef="eur">225000000</sny:CostOfDebtNet>
    <sny:NonOperatingForeignExchangeGainsLosses
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzQtMS0xLTEtMzY0MDYw_041d795c-d44c-4866-87a6-747011c55677"
      unitRef="eur">-4000000</sny:NonOperatingForeignExchangeGainsLosses>
    <sny:NonOperatingForeignExchangeGainsLosses
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzQtMi0xLTEtMzY0MDYw_19a70c5e-be35-400e-b811-3dc70fc67e91"
      unitRef="eur">2000000</sny:NonOperatingForeignExchangeGainsLosses>
    <sny:NonOperatingForeignExchangeGainsLosses
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzQtNC0xLTEtMzY0MDYw_8e3bdd44-296f-4835-96f4-c63cc0ca64eb"
      unitRef="eur">-6000000</sny:NonOperatingForeignExchangeGainsLosses>
    <ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzUtMS0xLTEtMzY0MDYw_03ecd5ec-52f0-4898-9371-59d630a6b1b0"
      unitRef="eur">20000000</ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions>
    <ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzUtMi0xLTEtMzY0MDYw_0a441d1a-9f65-4003-a99f-2497b7cd6f5f"
      unitRef="eur">11000000</ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions>
    <ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzUtNC0xLTEtMzY0MDYw_cd07c76e-90a5-43b0-ab4a-6ac851acc1d1"
      unitRef="eur">11000000</ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions>
    <sny:NetInterestCostRelatedToEmployeeBenefits
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzYtMS0xLTEtMzY0MDYw_a47a0b09-0fec-47e4-a797-b63c749bfe34"
      unitRef="eur">47000000</sny:NetInterestCostRelatedToEmployeeBenefits>
    <sny:NetInterestCostRelatedToEmployeeBenefits
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzYtMi0xLTEtMzY0MDYw_ad44dce5-6115-4c56-a526-3e85afc086c6"
      unitRef="eur">44000000</sny:NetInterestCostRelatedToEmployeeBenefits>
    <sny:NetInterestCostRelatedToEmployeeBenefits
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzYtNC0xLTEtMzY0MDYw_93c48a91-94f5-4907-8df7-203b2958cefe"
      unitRef="eur">57000000</sny:NetInterestCostRelatedToEmployeeBenefits>
    <ifrs-full:GainsLossesOnAvailableforsaleFinancialAssets
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzctMS0xLTEtMzY0MDYw_82a66839-b7fa-4fa5-82b1-cd41fc5caa4c"
      unitRef="eur">1000000</ifrs-full:GainsLossesOnAvailableforsaleFinancialAssets>
    <ifrs-full:GainsLossesOnAvailableforsaleFinancialAssets
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzctMi0xLTEtMzY0MDYw_20bacd78-6a59-4302-aa18-657c47d40830"
      unitRef="eur">3000000</ifrs-full:GainsLossesOnAvailableforsaleFinancialAssets>
    <ifrs-full:GainsLossesOnAvailableforsaleFinancialAssets
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzctNC0xLTEtMzY0MDYw_8d8bd101-debc-45c7-8e25-89f8d670bf58"
      unitRef="eur">6000000</ifrs-full:GainsLossesOnAvailableforsaleFinancialAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzktMS0xLTEtMzY0MDYw_b0638f7c-5186-4959-a597-f23411ac9f47"
      unitRef="eur">40000000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzktMi0xLTEtMzY0MDYw_74f21294-6762-443b-b5c4-2c20c89f346d"
      unitRef="eur">35000000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzktNC0xLTEtMzY0MDYw_9de96676-bef7-4f22-b3d0-ea2afa92820d"
      unitRef="eur">38000000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:OtherFinanceIncomeCost
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEwLTEtMS0xLTM2NDA2MA_cdc3de45-67b7-49fb-ae05-e15229a20078"
      unitRef="eur">0</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:OtherFinanceIncomeCost
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEwLTItMS0xLTM2NDA2MA_5a9718fc-31a4-441d-9c67-e992285b8fd2"
      unitRef="eur">16000000</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:OtherFinanceIncomeCost
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEwLTQtMS0xLTM2NDA2MA_26e79b81-2463-4345-ab84-0abef96aaa24"
      unitRef="eur">-4000000</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzExLTEtMS0xLTM2NDA2MA_6fc7e2fc-2e4f-40d6-be3f-96a6049a47dd"
      unitRef="eur">-234000000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzExLTItMS0xLTM2NDA2MA_5e263f4a-9891-4765-b3ce-6016e72fe5cd"
      unitRef="eur">-328000000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzExLTQtMS0xLTM2NDA2MA_0d645955-b426-4186-a5b8-7a41b17954f4"
      unitRef="eur">-335000000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceCosts
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEyLTEtMS0xLTM2NDA2MA_d65c8421-37de-46a8-9f0f-6f86e86aa882"
      unitRef="eur">440000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEyLTItMS0xLTM2NDA2MA_18db40b5-9e82-41bb-9518-43c54708c003"
      unitRef="eur">368000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEyLTQtMS0xLTM2NDA2MA_ff2e696b-5c56-41cc-b889-bae1bd32ebb0"
      unitRef="eur">388000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEzLTEtMS0xLTM2NDA2MA_b545b726-dfef-4ddd-a394-7afdc59267d3"
      unitRef="eur">206000000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEzLTItMS0xLTM2NDA2MA_eb5770b9-cdde-409d-8904-9c0c1eced34c"
      unitRef="eur">40000000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90YWJsZTpiNDE3ZDk1MTZiNDg0NjFlOWFjYzA3MzVkM2NlZWYzYy90YWJsZXJhbmdlOmI0MTdkOTUxNmI0ODQ2MWU5YWNjMDczNWQzY2VlZjNjXzEzLTQtMS0xLTM2NDA2MA_9a616d49-a647-4b1f-86b5-35afb5ef2ff2"
      unitRef="eur">53000000</ifrs-full:FinanceIncome>
    <sny:GainOnDerivativesUsedToManageDebt
      contextRef="i552611be812d4cebb9f4bf048999a643_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzIwNA_da6833b2-fb8c-467c-a01f-1362e255c727"
      unitRef="eur">-11000000</sny:GainOnDerivativesUsedToManageDebt>
    <sny:GainOnDerivativesUsedToManageDebt
      contextRef="i7ace254a2ef1455c83c5985dd96fa2cb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzIxNA_9230e99c-c4a4-471f-9689-30fb3cb4ac39"
      unitRef="eur">14000000</sny:GainOnDerivativesUsedToManageDebt>
    <sny:GainOnDerivativesUsedToManageDebt
      contextRef="ie87ee93c6896489f80ceecb2f2e91ea3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzIyNw_74c266fa-abfe-4aa2-a324-fd87464848fe"
      unitRef="eur">93000000</sny:GainOnDerivativesUsedToManageDebt>
    <sny:GainOnDerivativesUsedToManageCashAndCashEquivalents
      contextRef="i552611be812d4cebb9f4bf048999a643_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzM0NA_1866e69a-17fa-445c-88b0-b98d90ce2ddb"
      unitRef="eur">68000000</sny:GainOnDerivativesUsedToManageCashAndCashEquivalents>
    <sny:GainOnDerivativesUsedToManageCashAndCashEquivalents
      contextRef="i7ace254a2ef1455c83c5985dd96fa2cb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzM1NA_9765a032-5f82-4ca1-ac20-eca7d9f67b3f"
      unitRef="eur">51000000</sny:GainOnDerivativesUsedToManageCashAndCashEquivalents>
    <sny:GainOnDerivativesUsedToManageCashAndCashEquivalents
      contextRef="ie87ee93c6896489f80ceecb2f2e91ea3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82NzkvZnJhZzpmMGU2ODc5YTUyYjE0NGNmYTcxN2E3NGNkZDY5NTBhNi90ZXh0cmVnaW9uOmYwZTY4NzlhNTJiMTQ0Y2ZhNzE3YTc0Y2RkNjk1MGE2XzM2Nw_20c2de5e-f78d-4efa-bd93-4ea7eb913f3d"
      unitRef="eur">66000000</sny:GainOnDerivativesUsedToManageCashAndCashEquivalents>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90ZXh0cmVnaW9uOjljZjRiNTI0NjQ4MzQ4N2JhZjQ4MmQyYzFmZWNkM2JhXzEyODc_d1ca08fb-e669-4287-b2e3-b38eec7531c7">Income tax expense&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi has elected for tax consolidations in a number of countries, principally France, Germany, the United Kingdom and the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the allocation of income tax expense between current and deferred taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Income before tax and investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,422&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,798&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#23004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,778&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The difference between the effective tax rate and the standard corporate income tax rate applicable in France is explained as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(as a percentage)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Standard tax rate applicable in France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Difference between the standard French tax rate and the rates applicable to Sanofi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Revisions to tax exposures and settlements of tax disputes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value remeasurement of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19.2&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20.0&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13.1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France. For 2020, this line includes the difference between the standard French tax rate and the tax rate applicable to the gain on divestment of Regeneron shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) In determining the amount of the deferred tax liability for 2022, 2021 and 2020, Sanofi took into account changes in the ownership structure of certain subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;For the periods presented, the amount of deferred tax assets recognized in profit or loss that were initially subject to impairment losses at the time of a business combination is immaterial.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90ZXh0cmVnaW9uOjljZjRiNTI0NjQ4MzQ4N2JhZjQ4MmQyYzFmZWNkM2JhXzEyODg_1b199f1f-07f5-4bfa-9cc1-07781b9e8799">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the allocation of income tax expense between current and deferred taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Income before tax and investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,422&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,798&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#23004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,778&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzEtMS0xLTEtMzY0MDYw_3a5deadc-eaf1-460e-9e0f-bf30fcdc614f"
      unitRef="eur">2774000000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzEtMi0xLTEtMzY0MDYw_c5893c05-73f0-4ad5-8f7e-d18183dd17a2"
      unitRef="eur">1908000000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzEtNC0xLTEtMzY0MDYw_dfbee5de-e634-4211-8130-f943a64af90c"
      unitRef="eur">1913000000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzItMS0xLTEtMzY0MDYw_3ce2ee0b-954e-49ce-8dc1-8facfb66d9b8"
      unitRef="eur">-768000000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzItMi0xLTEtMzY0MDYw_9ec94c23-2156-4aef-8682-a4ac12685514"
      unitRef="eur">-350000000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzItNC0xLTEtMzY0MDYw_6781424f-117e-42e0-9cea-fcab769782d0"
      unitRef="eur">-106000000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzMtMS0xLTEtMzY0MDYw_3a96d870-3425-42ea-90d8-fe603f43de1f"
      unitRef="eur">2006000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzMtMi0xLTEtMzY0MDYw_1d6d3705-6a85-40c5-9bd8-25cf11ae54bd"
      unitRef="eur">1558000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzMtNC0xLTEtMzY0MDYw_7fe1df2c-5b7b-4f2b-9ba8-20651967fee9"
      unitRef="eur">1807000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzQtMS0xLTEtMzY0MDYw_c0b3c9bd-37a6-48ee-bd86-5400f1b4aba4"
      unitRef="eur">10422000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzQtMi0xLTEtMzY0MDYw_3e0fbc47-c8c8-4ae1-a5fb-8af4331ab86e"
      unitRef="eur">7798000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZToxYjg5OWQ4NjUyMzg0ODcwOTk4MGYzZjJmMWI2YjhiNy90YWJsZXJhbmdlOjFiODk5ZDg2NTIzODQ4NzA5OTgwZjNmMmYxYjZiOGI3XzQtNC0xLTEtMzY0MDYw_7ba2f528-3f1f-4786-a2d6-ae9f56a684af"
      unitRef="eur">13778000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90ZXh0cmVnaW9uOjljZjRiNTI0NjQ4MzQ4N2JhZjQ4MmQyYzFmZWNkM2JhXzEyODU_b1fd8024-a54f-4d3a-b748-10a08ab8980c">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The difference between the effective tax rate and the standard corporate income tax rate applicable in France is explained as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(as a percentage)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Standard tax rate applicable in France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Difference between the standard French tax rate and the rates applicable to Sanofi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Revisions to tax exposures and settlements of tax disputes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value remeasurement of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;19.2&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20.0&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13.1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France. For 2020, this line includes the difference between the standard French tax rate and the tax rate applicable to the gain on divestment of Regeneron shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) In determining the amount of the deferred tax liability for 2022, 2021 and 2020, Sanofi took into account changes in the ownership structure of certain subsidiaries.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock>
    <ifrs-full:ApplicableTaxRate
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzEtMS0xLTEtMzY0MDYw_8aedf0fd-f8ab-403c-b1fb-e9a23cfe7c43"
      unitRef="number">0.258</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzEtMi0xLTEtMzY0MDYw_494adf40-4f02-469c-9fd1-641adf5ab8fa"
      unitRef="number">0.284</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzEtMy0xLTEtMzY0MDYw_5f0822d9-230a-4fd9-a097-86b1c554776c"
      unitRef="number">0.320</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxRateEffectOfForeignTaxRates
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzItMS0xLTEtMzY0MDYw_5b5ec54d-34d1-461f-b570-c2038351ead6"
      unitRef="number">-0.065</ifrs-full:TaxRateEffectOfForeignTaxRates>
    <ifrs-full:TaxRateEffectOfForeignTaxRates
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzItMi0xLTEtMzY0MDYw_f3a4a992-587c-406f-bee1-8067afd8dff9"
      unitRef="number">-0.095</ifrs-full:TaxRateEffectOfForeignTaxRates>
    <ifrs-full:TaxRateEffectOfForeignTaxRates
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzItMy0xLTEtMzY0MDYw_acc731f1-112c-41d9-8c0e-68d9bec7a312"
      unitRef="number">-0.182</ifrs-full:TaxRateEffectOfForeignTaxRates>
    <sny:TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzMtMS0xLTEtMzY0MDYw_d93e32be-7f5f-4a1d-8815-f90197b209a4"
      unitRef="number">-0.008</sny:TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes>
    <sny:TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzMtMi0xLTEtMzY0MDYw_1cfcbf3b-827d-43e0-93fd-20b3f399dda3"
      unitRef="number">0.010</sny:TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes>
    <sny:TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzMtMy0xLTEtMzY0MDYw_aae2df70-a261-489e-b923-3e72f74ea8f2"
      unitRef="number">0.005</sny:TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes>
    <sny:TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzUtMS0xLTEtMzY0MDYw_93b42ca7-a311-4da2-af8f-599d273ceb24"
      unitRef="number">-0.002</sny:TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations>
    <sny:TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzUtMi0xLTEtMzY0MDYw_c08374a1-7eaf-469d-a9d1-a2d2f058f325"
      unitRef="number">0</sny:TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations>
    <sny:TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzUtMy0xLTEtMzY0MDYw_8cc65213-874f-4b88-9d01-56ead0ef3933"
      unitRef="number">0</sny:TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations>
    <ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzYtMS0xLTEtMzY0MDYw_b556105d-f3f4-4e2a-a1ea-040510f1e056"
      unitRef="number">0.009</ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzYtMi0xLTEtMzY0MDYw_9d1a3ad5-1402-46fd-8391-247a0cf7720b"
      unitRef="number">0.001</ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzYtMy0xLTEtMzY0MDYw_97a270ba-5299-4c7c-beba-e6ce2cd07ced"
      unitRef="number">-0.012</ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzctMS0xLTEtMzY0MDYw_8dde86a0-5c46-4ea4-bbec-932262eee8bd"
      unitRef="number">0.192</ifrs-full:AverageEffectiveTaxRate>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzctMi0xLTEtMzY0MDYw_cf16c9cb-baac-4271-ab14-10c65abe1c3b"
      unitRef="number">0.200</ifrs-full:AverageEffectiveTaxRate>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODIvZnJhZzo5Y2Y0YjUyNDY0ODM0ODdiYWY0ODJkMmMxZmVjZDNiYS90YWJsZTo4ZGY0NGE3NjgxZTU0NWMyOTI1NjZlYjhmYWYwNDVhMS90YWJsZXJhbmdlOjhkZjQ0YTc2ODFlNTQ1YzI5MjU2NmViOGZhZjA0NWExXzctMy0xLTEtMzY0MDYw_4f32887e-fbef-4b6f-b6de-6eaba5544e42"
      unitRef="number">0.131</ifrs-full:AverageEffectiveTaxRate>
    <sny:DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODUvZnJhZzphMGZiZTc2NjM4NDQ0NjZjODc3MGZkMTZjNGIyZDU2Mi90ZXh0cmVnaW9uOmEwZmJlNzY2Mzg0NDQ2NmM4NzcwZmQxNmM0YjJkNTYyXzg2Nw_4c9d7ebe-563c-490c-9b7d-c6598aa49a20">Share of profit/loss from investments accounted for using the equity method&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The line item&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Share of profit/(loss) from investments accounted for using the equity method &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;amounted to &#x20ac;68&#160;million for 2022, compared with &#x20ac;39&#160;million for 2021 and &#x20ac;359&#160;million for 2020 (including &#x20ac;343&#160;million for the share of Regeneron profits up to and including May&#160;29, 2020, the date on which Sanofi ceased to exercise significant influence over Regeneron: see Note&#160;D.2.).&lt;/span&gt;</sny:DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODUvZnJhZzphMGZiZTc2NjM4NDQ0NjZjODc3MGZkMTZjNGIyZDU2Mi90ZXh0cmVnaW9uOmEwZmJlNzY2Mzg0NDQ2NmM4NzcwZmQxNmM0YjJkNTYyXzIxNDQwNDc2NzQ1MDkx_9bad1c50-bf0f-4d13-909f-8b8c5fdcb538"
      unitRef="eur">68000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODUvZnJhZzphMGZiZTc2NjM4NDQ0NjZjODc3MGZkMTZjNGIyZDU2Mi90ZXh0cmVnaW9uOmEwZmJlNzY2Mzg0NDQ2NmM4NzcwZmQxNmM0YjJkNTYyXzIxNDQwNDc2NzQ1MDg2_0efb3c11-1922-4efc-b0f7-9f2de3c112e5"
      unitRef="eur">39000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODUvZnJhZzphMGZiZTc2NjM4NDQ0NjZjODc3MGZkMTZjNGIyZDU2Mi90ZXh0cmVnaW9uOmEwZmJlNzY2Mzg0NDQ2NmM4NzcwZmQxNmM0YjJkNTYyXzIxNDQwNDc2NzQ1MDgx_23f25e7e-34c4-457e-acbf-c1c23e8a990d"
      unitRef="eur">359000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i17591b56caee4f43b8f0bbb8ca58a6f4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODUvZnJhZzphMGZiZTc2NjM4NDQ0NjZjODc3MGZkMTZjNGIyZDU2Mi90ZXh0cmVnaW9uOmEwZmJlNzY2Mzg0NDQ2NmM4NzcwZmQxNmM0YjJkNTYyXzgwODE0MTA0NjQ0OTk5_2dbff976-f10b-4e9b-8948-502da2f3f8de"
      unitRef="eur">343000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <sny:DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90ZXh0cmVnaW9uOjFmYmI2YzY5OWVjMjRhYmZiYjdiYWZhMGY4N2Y4YzBkXzE3Nw_13c4481f-4efa-4bb3-8ea8-a377706d7aee">Net income attributable to non-controlling interests&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for the reporting periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of net income attributable to other non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;56&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock>
    <sny:DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90ZXh0cmVnaW9uOjFmYmI2YzY5OWVjMjRhYmZiYjdiYWZhMGY4N2Y4YzBkXzE3OQ_dc97f678-1e40-46c9-b4d5-ba4330b20ef3">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; for the reporting periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of net income attributable to other non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;56&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sny:DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="id4e374af20434124bd68044ee5c3132d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzItMS0xLTEtMzY0MDYw_d3152081-2519-484c-9454-4533674d4cd9"
      unitRef="eur">113000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="ibed5e5583149430ea92a3d05d5060125_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzItMi0xLTEtMzY0MDYw_cc326dec-7a4f-4fee-bdb7-d13ec73339ea"
      unitRef="eur">56000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i45a01c0bbd2d41d7b151eaf603f54f9d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzItMy0xLTEtMzY0MDYw_942a5ad9-f136-449e-8e88-1ca3fe93a2f3"
      unitRef="eur">36000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzMtMS0xLTEtMzY0MDYw_5f493780-c56c-470c-b26b-5a05ec2490e6"
      unitRef="eur">113000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzMtMi0xLTEtMzY0MDYw_9a352a25-3531-4ef1-a4bf-e2e0dd31a334"
      unitRef="eur">56000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82ODgvZnJhZzoxZmJiNmM2OTllYzI0YWJmYmI3YmFmYTBmODdmOGMwZC90YWJsZTowMjc1M2U4OWMyZjg0ZWY3OWZmOGIxZTY4MjAxNzRlMS90YWJsZXJhbmdlOjAyNzUzZTg5YzJmODRlZjc5ZmY4YjFlNjgyMDE3NGUxXzMtMy0xLTEtMzY0MDYw_87582a4d-896c-4918-a9e2-4983f2bda3ab"
      unitRef="eur">36000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5XzE4ODQ_27192e19-36fb-4281-b294-11f50dffa050">Related party transactions&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The principal related parties are companies over which Sanofi has control or significant influence, joint ventures, key management personnel, and principal shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi has not entered into any material transactions with any key management personnel. Financial relations with Sanofi&#x2019;s principal shareholders fall within the ordinary course of business and were immaterial in the years ended December 31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Note&#160;F.1. lists the principal companies controlled by Sanofi; those companies are fully consolidated, as described in Note&#160;B.1. Transactions between those companies, and between the parent company and its subsidiaries, are eliminated when preparing the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Transactions with companies over which Sanofi has significant influence, and with joint ventures, are presented in Note&#160;D.6.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Key management personnel include corporate officers and the members of the Executive Committee (an a&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;verage of 11&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;members in 2022, in 2021 and in 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows, by type, the compensation paid to key management personnel:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.552%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Post-employment benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share-based payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;57&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Compensation, employer&#x2019;s social security contributions, directors&#x2019; attendance fees, and any termination benefits (net of reversals of termination benefit obligations).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the aggregate obligation as of December&#160;31 for each period presented for individuals who hold or have held executive positions within Sanofi during that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aggregate top-up pension obligation in favor of certain corporate officers and of Executive Committee members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aggregate termination benefits and lump-sum retirement benefits in favor of key management personnel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021).&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <sny:NumberOfExecutiveCommitteeMembers
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5Xzk3NQ_a047d7eb-404d-4537-9a09-2cffd41de250"
      unitRef="executives">11</sny:NumberOfExecutiveCommitteeMembers>
    <sny:NumberOfExecutiveCommitteeMembers
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5Xzk3NQ_d156f4f2-5448-42ff-9165-57f04a10571a"
      unitRef="executives">11</sny:NumberOfExecutiveCommitteeMembers>
    <sny:NumberOfExecutiveCommitteeMembers
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5Xzk3NQ_f1ab576b-c6f0-472f-b9de-d5a07c526c94"
      unitRef="executives">11</sny:NumberOfExecutiveCommitteeMembers>
    <sny:DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5XzE4ODc_97dcbe14-4e9e-4a79-951d-c497f06ba61f">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows, by type, the compensation paid to key management personnel:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.552%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Short-term benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Post-employment benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share-based payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;57&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Compensation, employer&#x2019;s social security contributions, directors&#x2019; attendance fees, and any termination benefits (net of reversals of termination benefit obligations).&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzEtMS0xLTEtMzY0MDYw_db3c9225-57e3-4967-8648-f9a67101506f"
      unitRef="eur">31000000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzEtMi0xLTEtMzY0MDYw_43e4009b-ce87-48a0-b6f1-be9edd093de2"
      unitRef="eur">33000000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzEtNC0xLTEtMzY0MDYw_53779d61-7ee4-4b38-9488-1468b5c8ad60"
      unitRef="eur">36000000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzItMS0xLTEtMzY0MDYw_40b72c78-651b-4285-a0f8-b72db18d8fff"
      unitRef="eur">2000000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzItMi0xLTEtMzY0MDYw_1ee99e38-3cc8-435b-ba51-2eaba3d94bee"
      unitRef="eur">2000000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzItNC0xLTEtMzY0MDYw_f0f10380-3b3e-4410-a18b-ebbb84bce745"
      unitRef="eur">3000000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzMtMS0xLTEtMzY0MDYw_e6f3c4c3-735a-4c8a-9cc9-db084c1375b2"
      unitRef="eur">19000000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzMtMi0xLTEtMzY0MDYw_87bd132f-e4b3-4cba-9e2f-053234f7042d"
      unitRef="eur">20000000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzMtNC0xLTEtMzY0MDYw_73f8cdd7-eed7-45ff-b5d5-f05402887164"
      unitRef="eur">18000000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzQtMS0xLTEtMzY0MDYw_12ebe864-272c-4484-b282-cac8dfb185f8"
      unitRef="eur">52000000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzQtMi0xLTEtMzY0MDYw_f7ace87c-992d-44cb-bb48-f5a965bc14f8"
      unitRef="eur">55000000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTo3YmFiZGVjMWVlMzM0NmUwYWMwNGQ0NTk0MzBjOWI5ZC90YWJsZXJhbmdlOjdiYWJkZWMxZWUzMzQ2ZTBhYzA0ZDQ1OTQzMGM5YjlkXzQtNC0xLTEtMzY0MDYw_cc173227-6705-4314-82ef-790225360013"
      unitRef="eur">57000000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90ZXh0cmVnaW9uOmI4NzVmODhkNmU5ZTRmNjY4MTU4NzE2MGVmYTBhYmE5XzE4ODg_4eb27318-1c0c-4a1c-8e70-7cfce7126eb8">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows the aggregate obligation as of December&#160;31 for each period presented for individuals who hold or have held executive positions within Sanofi during that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aggregate top-up pension obligation in favor of certain corporate officers and of Executive Committee members&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aggregate termination benefits and lump-sum retirement benefits in favor of key management personnel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021).&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory>
    <sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzEtMS0xLTEtMzY0MDYw_7a9befbd-f111-4d8b-a485-11308f2a74a1"
      unitRef="eur">10000000</sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee>
    <sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzEtMi0xLTEtMzY0MDYw_4e80ca10-f33d-4ba1-9690-a3919d009129"
      unitRef="eur">28000000</sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee>
    <sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzEtNC0xLTEtMzY0MDYw_f86ea3c2-b1bf-4edc-96e0-3c4008acd29f"
      unitRef="eur">32000000</sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee>
    <sny:KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzItMS0xLTEtMzY0MDYw_7fa72954-90eb-4521-8326-242e6e260679"
      unitRef="eur">5000000</sny:KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits>
    <sny:KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzItMi0xLTEtMzY0MDYw_1c24f363-8ab9-45c9-895e-6c596280e8c0"
      unitRef="eur">7000000</sny:KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits>
    <sny:KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTEvZnJhZzpiODc1Zjg4ZDZlOWU0ZjY2ODE1ODcxNjBlZmEwYWJhOS90YWJsZTpjYjM2MDE4M2EyZTA0YTBiYmQwNmM0NmQ2MjIxNGYwYS90YWJsZXJhbmdlOmNiMzYwMTgzYTJlMDRhMGJiZDA2YzQ2ZDYyMjE0ZjBhXzItNC0xLTEtMzY0MDYw_c0608a2e-dc03-4e23-8415-9cb10bbba85a"
      unitRef="eur">5000000</sny:KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits>
    <ifrs-full:DisclosureOfCreditRiskExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2XzkzNA_1e436275-5fa9-4eed-9095-dc53eb19e309">Disclosures about major customers and credit risk&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Credit risk is the risk that customers (wholesalers, distributors, pharmacies, hospitals, clinics or government agencies) may fail to pay their debts; for Sanofi, that risk is mainly concentrated on amounts receivable from wholesalers in the United States. Sanofi manages credit risk by vetting customers in order to set credit limits and risk levels, and asking for guarantees or insurance where necessary; performing controls; and monitoring qualitative and quantitative indicators of accounts receivable balances, such as the period of credit taken and overdue payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sales generated by Sanofi with its biggest customers, in particular certain wholesalers in the United States, represented &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;27% of net sales in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The three largest customers respectively accounted for approximately 12%, 8% and 7% of Sanofi's net sales in&#160;2022 (10%, 7% and 6% in 2021; 10%, 6% and 5% in 2020).&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfCreditRiskExplanatory>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="i1dd1a6b04c6b4be9b142d30598f7a4f6_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzc1Nw_2bcef9b9-4ecf-4a2e-ad32-de4feee8544b"
      unitRef="number">0.27</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="i5945bf292aba43d3b3933ee4fa267f48_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzg0OQ_eea8950c-25ba-4103-9f1a-d9072840506f"
      unitRef="number">0.12</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="i54f0c3f56ec94246b15c17488b0f280b_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzg1Mw_bb05483e-daa9-4074-973f-a0e1644eb5fd"
      unitRef="number">0.08</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="i043c68f74cf54dd3b12ca0cbc0859d62_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzg2MA_36135593-d434-4bf3-b28d-5b40c6c2d89d"
      unitRef="number">0.07</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="icf706ed1467c4a3396b7c74584527eea_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzg5Mg_324c7319-855f-4475-a9b4-49b01bb289d4"
      unitRef="number">0.10</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="i3f723776de7640daa8cd4b9421bfd338_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2Xzg5Ng_ca521d10-79e8-4153-a87f-c4dc1cb7b89f"
      unitRef="number">0.07</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="i1cada9bee6d546aa93544736eadd46de_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2XzkwMw_fe120e47-b01f-4b36-9d40-b09bdbd574f1"
      unitRef="number">0.06</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="i18e5dd1b4b0649eeb4cae77cc5f1744f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2XzkxMw_1d8420e2-b612-44aa-bf5b-9d5e2848aba5"
      unitRef="number">0.10</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="i56aabda8aa634a87b93f96b0ae541185_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2XzkxNw_34dd29e5-34f9-4d31-b462-8eba15746ac5"
      unitRef="number">0.06</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTQvZnJhZzowMzAxY2ViMzdhNmI0OTE1OGUxZjkyN2E1NjkxNGE4Ni90ZXh0cmVnaW9uOjAzMDFjZWIzN2E2YjQ5MTU4ZTFmOTI3YTU2OTE0YTg2XzkyNA_e9f32b12-8e62-4086-b74c-7330f434eb6e"
      unitRef="number">0.05</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDUw_3da0b584-b344-4f2b-995a-e3c8402d173e">Segment information&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As indicated in Note&#160;B.26., Sanofi has three operating segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Pharmaceuticals segment comprises, for all geographical territories, the commercial operations of the following global franchises: Specialty Care (Dupixent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, Neurology &amp;amp; Immunology, Rare Diseases, Oncology, and Rare Blood Disorders) and General Medicines (Core and Non-Core Assets), together with research, development and production activities dedicated to the Pharmaceuticals segment. This segment also includes associates whose activities are related to pharmaceuticals. Following the transaction of May&#160;29, 2020, Regeneron is no longer an associate of Sanofi (see Note&#160;D.2.). Consequently, the Pharmaceuticals segment no longer includes Sanofi&#x2019;s equity-accounted share of Regeneron&#x2019;s profits for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Vaccines segment comprises, for all geographical territories, the commercial operations of Vaccines, together with research, development and production activities dedicated to vaccines.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for Sanofi&#x2019;s Consumer Healthcare products, together with research, development and production activities dedicated to those products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Inter-segment transactions are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The costs of Sanofi's global support functions (Corporate Affairs, Finance, People &amp;amp; Culture, Legal, Ethics &amp;amp; Business Integrity, Information Solutions &amp;amp;&#160;Technologies, Sanofi Business Services,&#160;etc.) are primarily managed centrally at the group-wide level. The costs of those functions are presented within the &#x201c;Other&#x201d; category. That category also includes other reconciling items such as retained commitments in respect of divested activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Following the Capital Markets Day in February&#160;2021, Sanofi changed the presentation of the net sales of the General Medicines and Consumer Healthcare GBUs, and also reallocated certain expenses. In particular, IT costs relating to Sanofi's new digital organization &#x2013; previously allocated to the Pharmaceuticals, Vaccines, and Consumer Healthcare segments &#x2013; are now included within the &#x201c;Other&#x201d; segment. The 2020 segment results presented below have been amended for comparative purposes in order to reflect those adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;In accordance with IAS&#160;8, Sanofi treated the first-time application of the IFRIC agenda decisions on (i)&#160;the calculation of provisions for pensions and other post-employment benefits under IAS&#160;19 and (ii)&#160;accounting for costs of configuring or customizing a supplier&#x2019;s application software in a Software as a Service (SaaS) arrangement as retrospective changes in&#160;accounting policy. The impacts are described in Note&#160;A.2.1 to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.35.1. Segment results&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;D.35.1.1. Analysis of net sales &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth Sanofi&#x2019;s net sales for the years ended December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.491%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="6" rowspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.5pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;United&lt;br/&gt;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-right:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;United&lt;br/&gt;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="42" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,157&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,694&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,837&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;30,688&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,201&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,484&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,285&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;26,970&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,819&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,635&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,220&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;25,674&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Dupixent&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.22pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;940&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,346&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,007&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,293&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;649&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,971&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;629&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,249&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;386&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,808&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;340&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,534&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Neurology &amp;amp; Immunology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;639&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,637&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;174&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,450&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;638&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,482&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;204&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,324&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;578&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,631&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;185&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,394&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Aubagio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Rare Diseases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,104&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,367&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;974&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,445&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,069&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,142&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;915&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,126&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,010&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,122&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;879&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,011&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Cerezyme&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fabrazyme&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Myozyme&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Lumizyme&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;239&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;515&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;198&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;952&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;410&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;912&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;299&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;368&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;131&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;798&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Jevtana&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Rare Blood Disorders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;983&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;240&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,317&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;842&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,141&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;837&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;339&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,217&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Alprolix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Eloctate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Core Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,917&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,653&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,819&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,389&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,868&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,315&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,585&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,768&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,759&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,413&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,409&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,581&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Lovenox&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Toujeo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Non-Core Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,637&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,176&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,409&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,222&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,846&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,281&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,515&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,642&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,088&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,389&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,849&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,326&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Lantus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Other non-core assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;4,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;4,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;5,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Industrial sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;587&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;620&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;723&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;808&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;658&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;67&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;88&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;813&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,341&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,291&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,597&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,229&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,225&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,762&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,336&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,323&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;973&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,759&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,241&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,973&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Polio/Pertussis/&lt;br/&gt;Hib Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Influenza Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer Healthcare&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,501&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,290&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,289&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,080&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,333&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,139&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,996&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,468&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,359&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,071&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,964&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,394&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Allergy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Pain Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Digestive Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,999&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,275&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,723&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;42,997&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,759&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,385&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,617&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;37,761&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-left:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,151&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,465&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,425&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36,041&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160; For the Consumer Healthcare GBU, Sanofi has since 2021 adopted a more granular presentation by introducing new sub-categories that reflect consumer trends and the strengths and opportunities of the portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;D.35.1.2. Business operating income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Sanofi reports segment results on the basis of &#x201c;Business operating income&#x201d;. This indicator is used internally by Sanofi&#x2019;s chief operating decision maker to measure the performance of each operating segment and to allocate resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;&#x201c;Business operating income&#x201d; is derived from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, adjusted as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the amounts reported in the line items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restructuring costs and similar items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair value remeasurement of contingent consideration&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; relating to business combinations (IFRS&#160;3) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other gains and losses, and litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; (gains and losses on major disposals of assets, asset groups ore operations, and costs related to major litigation) are eliminated;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;expenses arising from the remeasurement of inventories following a business combination (IFRS&#160;3) are eliminated;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;amortization and impairment losses charged against intangible assets (other than software and other rights of an industrial or operational nature) are eliminated;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;upfront payments and regulatory milestone payments recognized within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;and related to transactions outside the ordinary activities of Sanofi are eliminated;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;the share of profits/losses from investments accounted for using the equity method is added, to the extent that this relates to&#160;joint ventures and associates with which Sanofi has a strategic alliance (for 2020, excludes Regeneron up to and including&#160;May&#160;29, 2020; see Note&#160;D.2.);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;acquisition-related effects and restructuring costs relating to investments accounted for using the equity method (joint ventures and associates with which Sanofi has a strategic alliance) are eliminated;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;net income attributable to non-controlling interests is deducted; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt"&gt;for 2020, the gain on the divestment of Regeneron shares on May&#160;29, 2020 is eliminated. This elimination does not include the gain on the remeasurement of the 400,000&#160;retained shares at market value as of that date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows Sanofi&#x2019;s segment results for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;30,688&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,229&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,080&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;42,997&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and general expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other operating income and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Business operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,043&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,168&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,810&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,040&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;a) This caption reconciles segment financial information to total consolidated financial information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;26,970&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,323&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,468&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;37,761&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,251)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(712)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(497)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and general expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,326)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(805)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other operating income and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(946)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Business operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,409&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,609&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,493&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,714&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;This caption reconciles segment financial information to total consolidated financial information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;25,674&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,973&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,394&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36,041&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(682)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(524)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and general expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(789)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,419)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other operating income and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(487)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Business operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,207&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,336&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,410&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,759&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 figures have been adjusted to take account of the reallocation of certain expenses (in particular IT costs related to Sanofi&#x2019;s new digital organization) from the Pharmaceuticals, Vaccines and Consumer Healthcare operating segments to the &#x201c;Other&#x201d; segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) This caption reconciles segment financial information to total consolidated financial information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below, presented in compliance with IFRS&#160;8, shows a reconciliation between aggregated &#x201c;Business operating income&#x201d; for the segments and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Income before tax and investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.676%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(h)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Business operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,040&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,714&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,759&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization and impairment of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value remeasurement of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expenses arising from the impact of acquisitions on inventories&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Restructuring costs and similar items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(820)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other gains and losses, and litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gain on divestment of Regeneron shares on May&#160;29, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(f)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income from out-licensing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(g)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,656&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,126&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,113&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Financial expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Financial income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Income before tax and investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,422&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,798&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,778&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Excludes restructuring costs relating to investments accounted for using the equity method and expenses arising from the impact of acquisitions on investments accounted for using the equity method. For the first two quarters of 2020, this line has been restated to exclude any effect of equity method accounting for the investment in Regeneron following the divestment of Sanofi's entire equity interest (with the exception of the 400,000&#160;shares retained by Sanofi) on May&#160;29, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to non-controlling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) For 2022, this line includes a reversal of &#x20ac;2,154&#160;million on Eloctate franchise products following FDA approval of ALTUVIIIO &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;TM &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;dated February 22, 2023, partially offset by an impairment of &#x20ac;1,586&#160;million relating to the development project for SAR444245 (non-alpha interleukin-2).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d) This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(e) For 2020, this line mainly comprises the gain on the sale of operations related to the Seprafilm&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; activity to Baxter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(f) This line includes the gain on the sale of (i)&#160;13&#160;million shares of Regeneron common stock in the registered public offering and (ii)&#160;the 9.8&#160;million shares repurchased by Regeneron, but does not include the gain arising from the remeasurement of the 400,000&#160;retained shares at market value as of&#160;May&#160;29,&#160;2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(g&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;)&#160;&#160;&#160;&#160;For 2022, this line includes an upfront payment of $900 million and a regulatory milestone payment of $100 million related to the out-licensing of Libtayo&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; following the restructuring of the Immuno-Oncology Collaboration and License Agreement with Regeneron (see Note&#160;C.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(h) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.35.2. Other segment information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The tables below show the split by operating segment of (i)&#160;the carrying amount of investments accounted for using the equity method, (ii)&#160;acquisitions of property, plant and equipment, and (iii)&#160;acquisitions of intangible assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The principal investments accounted for using the equity method in the Pharmaceuticals segment are entities majority owned by EUROAPI, MSP Vaccine Company, and Infraserv GmbH &amp;amp; Co. H&#xf6;chst&#160;KG (see Note&#160;D.6.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Acquisitions of intangible assets and property, plant and equipment correspond to acquisitions paid for during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Investments accounted for using the equity method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;D.35.3. Information by geographical region&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The geographical information on net sales provided below is based on the geographical location of the customer. In accordance with&#160;IFRS&#160;8, the non-current assets reported below exclude right-of-use assets relating to leases as determined under IFRS&#160;16, investments accounted for using the equity method, other non-current assets, non-current income tax assets, and deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;North&lt;br/&gt;America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;42,997&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,999&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,296&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,984&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,275&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,014&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;property, plant and equipment owned&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:9.29pt"&gt;other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;North&lt;br/&gt;America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;37,761&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,759&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,256&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,075&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,385&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,927&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;property, plant and equipment owned&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;North&lt;br/&gt;America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36,041&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,151&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,223&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,060&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,465&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,830&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;property, plant and equipment owned&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;As stated in Note&#160;D.5., goodwill is not allocated by geographical region.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <sny:NumberOfOperatingSegments
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzcw_31ee15d4-cfda-429f-b4f8-a51f2f5f62a0"
      unitRef="segment">3</sny:NumberOfOperatingSegments>
    <sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDUx_823eda64-f8e7-4aaa-901a-f9e51b6e0371">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below sets forth Sanofi&#x2019;s net sales for the years ended December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.491%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="6" rowspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.5pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;United&lt;br/&gt;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-right:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;United&lt;br/&gt;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="42" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,157&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,694&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,837&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;30,688&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,201&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,484&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,285&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;26,970&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,819&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,635&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,220&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;25,674&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Dupixent&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.22pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;940&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,346&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,007&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,293&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;649&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,971&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;629&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,249&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;386&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,808&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;340&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,534&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Neurology &amp;amp; Immunology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;639&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,637&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;174&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,450&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;638&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,482&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;204&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,324&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;578&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,631&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;185&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,394&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Aubagio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Rare Diseases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,104&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,367&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;974&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,445&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,069&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,142&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;915&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,126&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,010&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,122&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;879&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,011&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Cerezyme&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Fabrazyme&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Myozyme&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Lumizyme&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;239&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;515&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;198&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;952&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;410&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;912&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;299&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;368&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;131&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;798&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Jevtana&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Rare Blood Disorders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;983&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;240&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,317&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;842&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,141&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;837&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;339&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,217&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Alprolix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Eloctate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Core Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,917&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,653&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,819&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,389&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,868&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,315&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,585&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,768&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,759&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,413&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,409&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,581&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Lovenox&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Toujeo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Non-Core Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,637&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,176&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,409&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,222&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,846&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,281&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,515&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,642&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,088&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,389&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,849&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,326&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Lantus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.22pt;font-weight:400;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Other non-core assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;4,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;4,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;5,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Industrial sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;587&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;620&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;723&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;808&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;658&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;67&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;88&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;813&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,341&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,291&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,597&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,229&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,225&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,762&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,336&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,323&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;973&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,759&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,241&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,973&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Polio/Pertussis/&lt;br/&gt;Hib Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Influenza Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer Healthcare&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,501&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,290&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,289&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,080&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,333&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,139&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,996&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,468&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,359&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,071&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,964&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,394&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Allergy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Pain Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;Digestive Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,999&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,275&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,723&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;42,997&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,759&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,385&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,617&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;37,761&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;border-left:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,151&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,465&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,425&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36,041&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160; For the Consumer Healthcare GBU, Sanofi has since 2021 adopted a more granular presentation by introducing new sub-categories that reflect consumer trends and the strengths and opportunities of the portfolio.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if3906e38c7744d118e2d80ee3ff3beb4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMi0xLTEtMzY0MDYw_b97e8a32-dfd4-416a-b80f-6de885bbe998"
      unitRef="eur">7157000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib75c6578c3a84cb08fa98e7e6b8a4a4e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMy0xLTEtMzY0MDYw_4a305407-45b3-4bca-ba53-41aa54322f75"
      unitRef="eur">13694000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia960f25762194eed8ba9198f645620cf_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItNC0xLTEtMzY0MDYw_a8f33037-57de-4817-b519-8b059dccfa99"
      unitRef="eur">9837000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItNS0xLTEtMzY0MDYw_82279507-94e9-4849-bebb-2e2b96edcb9a"
      unitRef="eur">30688000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i388b2e8292964dd488b8e5822ff441b9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItNi0xLTEtMzY0MDYw_0bb830f2-3965-4f4c-90cf-3992af5beb54"
      unitRef="eur">7201000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i703eee8c3cf4450398c63faaf2b2713f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItNy0xLTEtMzY0MDYw_8fb9c14c-69be-4b2d-9e39-8e8c7f0f6c4a"
      unitRef="eur">10484000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="icb6ec4264f7b41eeb79ce7df60d9b024_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItOC0xLTEtMzY0MDYw_2192236b-19e0-4eb8-b0eb-753334648af2"
      unitRef="eur">9285000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItOS0xLTEtMzY0MDYw_f9b19460-9e75-4abc-9d9c-b70867bad2d3"
      unitRef="eur">26970000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3cc915a3e8304b36b9aaea6a3b1e923a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMTAtMS0xLTM2NDA2MA_0d66ecda-720b-4517-af43-d5dc44fb0932"
      unitRef="eur">6819000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1a0eef0b887c463b978e082705e53ff2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMTEtMS0xLTM2NDA2MA_60ddb69d-57c4-4514-b1bb-05a7503d2bed"
      unitRef="eur">9635000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ibf8fcf146c8248ec9b16d57552fb0679_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMTItMS0xLTM2NDA2MA_bf6cd19d-eb1d-4390-8472-71b460d3b305"
      unitRef="eur">9220000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzItMTMtMS0xLTM2NDA2MA_fcb5abbb-b2ea-4351-8e3b-ead11370f811"
      unitRef="eur">25674000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if1b32034d89d4c5492894716caf75760_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMi0xLTEtMzY0MDYw_9f83357c-aec1-4d9f-a81a-9bbc581f506b"
      unitRef="eur">940000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie001d812cbaa42849ff65fc0f25fc9df_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMy0xLTEtMzY0MDYw_353e0400-eac8-4bec-88d0-acbc63995555"
      unitRef="eur">6346000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iaf451e85e36d430f80d3e0dea3554d74_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtNC0xLTEtMzY0MDYw_0ae76523-66a2-4f09-9f9d-85eac3aa4164"
      unitRef="eur">1007000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i6966a3cdac584a90877a12600daac3a9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtNS0xLTEtMzY0MDYw_0ab6862e-1371-44b4-b422-746504d5ebcd"
      unitRef="eur">8293000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i97ab9118674344ae90b1ec5cdd6d8dc7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtNi0xLTEtMzY0MDYw_4f274ee2-c0ac-4b67-ba6d-bfa0a7803928"
      unitRef="eur">649000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3fddbef245ff4118abb1ece0065f767a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtNy0xLTEtMzY0MDYw_9dce022d-d76e-4027-a115-ec4404f82bda"
      unitRef="eur">3971000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i0eb99c9f11e04cc6a1c3cc09537ceea1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtOC0xLTEtMzY0MDYw_f5fd5a11-aef0-4fb4-969f-373d16242254"
      unitRef="eur">629000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ice90a87f313444cda4f67ec7f33659da_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtOS0xLTEtMzY0MDYw_d01c89ef-c496-4af0-843e-c47b9e25aab3"
      unitRef="eur">5249000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia60703fcf4f34ef79aa5696b24dc5b76_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMTAtMS0xLTM2NDA2MA_1380bd74-d7c2-40b6-bea7-c2d60fb6844a"
      unitRef="eur">386000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if7d5b31e23b846449b9dc6aca6c543d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMTEtMS0xLTM2NDA2MA_662c6759-f6bf-4dcb-8dc3-560507171ab7"
      unitRef="eur">2808000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1bf14ecb83e341a28f96acd5106c6361_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMTItMS0xLTM2NDA2MA_83829967-d4f7-457e-8972-f0a6f3d9eff2"
      unitRef="eur">340000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i38f46c66004f45f79c7d14d33e786167_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzMtMTMtMS0xLTM2NDA2MA_a98edb63-5e7f-4c17-bc84-54f1da756da1"
      unitRef="eur">3534000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i0cb348a72bfd43a8ae3327734c1b4a43_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMi0xLTEtNDYyMDYy_4b816aad-0f02-4d27-95d7-eaf36579abcc"
      unitRef="eur">639000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i497f9ba9e48b486f9aabba34acb6dda3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMy0xLTEtNDYyMDY5_ea5109b0-c704-4d86-99a4-fb40136da09e"
      unitRef="eur">1637000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i6d31cf6a543b41fd88ed835cb7b080e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNC0xLTEtNDYyMDc0_748ce22b-8300-4671-88bd-abe0330bd1b9"
      unitRef="eur">174000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4dd47a8ee94b4ecba12d3409c2d6307e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNS0xLTEtNDYyMDc5_450ecac6-c13a-44fa-a86f-09ef8619404d"
      unitRef="eur">2450000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib4c50ff163de4a81822ecca972401b9d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNi0xLTEtNDYyNDQ1_440309ef-f250-4040-bc3c-a98dded21cd8"
      unitRef="eur">638000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7aee59f02c404957a63d2c6a84ac1bc7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNy0xLTEtNDYyNDUz_4ba7b878-e8f6-4e19-81b3-1627e3e9d17a"
      unitRef="eur">1482000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7da96c92143e4cfe87cbc8ec12bb9393_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtOC0xLTEtNDYyNDYx_926bb249-af14-4a4d-9743-f0a1e778177e"
      unitRef="eur">204000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i63350fb6564e4bfab92644debffad89e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtOS0xLTEtNDYyNDY5_89a521f4-e0fd-4da1-b9b2-7578ff530802"
      unitRef="eur">2324000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if7d1991136ac485ca3f17d7bf6664386_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTAtMS0xLTQ2MjQ3Nw_881e86ea-6514-42c2-9cff-6a5af16a5318"
      unitRef="eur">578000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ic536b741856d496fbbc9ceb07260b2bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTEtMS0xLTQ2MjQ4NQ_6814985c-3e31-4eb9-bfdd-1e53869e85f5"
      unitRef="eur">1631000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ifd98da43cc404ca08771230fbf198841_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTItMS0xLTQ2MjQ5Mw_1a842320-7e80-4236-8ada-0b8d469c077e"
      unitRef="eur">185000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i275946a1cae9496ca4567cbb23511dc8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTMtMS0xLTQ2MjUwNw_0b518fde-1da4-4446-880a-023988113362"
      unitRef="eur">2394000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i925d323dd481457dbb437525932095e7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMi0xLTEtMzY0MDYw_175fb1cf-cce9-45f3-a9dd-a90e6639781d"
      unitRef="eur">511000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ic1297a94f7ed45e493c05001e0b81533_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMy0xLTEtMzY0MDYw_18840608-004e-444c-b98f-cc187f7efaf8"
      unitRef="eur">1420000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3e35850252ee49c29e37a747602844b1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNC0xLTEtMzY0MDYw_3138a40f-30f1-4104-a0d9-0044c87418ed"
      unitRef="eur">100000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia65102e90b134f118e220863c8b48f53_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNS0xLTEtMzY0MDYw_a0937d1a-fe3e-44bc-b47e-5916bac10263"
      unitRef="eur">2031000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if7e375fc233a4357934b4c0cff27f093_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNi0xLTEtMzY0MDYw_283f55bc-1492-42d4-9351-d0b1643981f5"
      unitRef="eur">512000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i356311f03967464ebffc32cc1749c915_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtNy0xLTEtMzY0MDYw_ca0607eb-2d8f-411c-a276-87aafa7ff7f2"
      unitRef="eur">1312000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3ce1b6e300ae49b8975bcd687f09500b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtOC0xLTEtMzY0MDYw_7f419d66-9556-4397-9cd0-6f5e7ace7ff5"
      unitRef="eur">131000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie8632a72e1dc41958e1a40418be2dcdf_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtOS0xLTEtMzY0MDYw_50aad779-70cb-4732-a08f-cc9d172e734f"
      unitRef="eur">1955000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i86bfa094225f4f33bf2caa26f75ea5df_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTAtMS0xLTM2NDA2MA_d2f59a9c-98fb-4d1a-8dd0-3c6ae0d8f22b"
      unitRef="eur">473000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i05e5dbe4e5c6497f9fd313a217ef2eba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTEtMS0xLTM2NDA2MA_24f867b3-0d15-4429-a16d-984148359412"
      unitRef="eur">1448000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i51d60da5814d4da3b4582525b5ea5de6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTItMS0xLTM2NDA2MA_5a8457a0-4089-4a12-b713-e33b90e3ff26"
      unitRef="eur">124000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i39dae50c59ff444589960d8b83241824_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzQtMTMtMS0xLTM2NDA2MA_2938c5f6-a323-4801-a220-9082af7bb2d9"
      unitRef="eur">2045000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id26f8eb73c594a90a9c4cd301b065133_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMi0xLTEtNDYyMTA1_f03da9d3-be7d-49fc-8adf-9d282efe53f4"
      unitRef="eur">1104000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9fc91d54abbf41ea870eb45075d2c54f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMy0xLTEtNDYyMTEw_57c72fc1-ec0c-45c8-8f8c-0a2b45bc96de"
      unitRef="eur">1367000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3331011dc076449c99047a7dc1945e0e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNC0xLTEtNDYyMTE4_c62d89c1-0a11-4065-b9ea-fb0871c7c814"
      unitRef="eur">974000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib6399fd1af9d411d8a47300f12f1d9b3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNS0xLTEtNDYyMTI2_9574377f-3e7e-4b39-88de-659bad7f7e37"
      unitRef="eur">3445000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1ba80ab3e00743088ed870250562c4c3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNi0xLTEtNDYyNTE1_e5474ddb-ecf6-4644-b40c-b3a29e3e72e8"
      unitRef="eur">1069000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if5351a9412414364a48f29bc495d1b51_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNy0xLTEtNDYyNTIz_6099d859-f774-4bd0-8676-0e9873aa9b90"
      unitRef="eur">1142000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5755c87fa7584572873b015a8e208548_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOC0xLTEtNDYyNTMx_ee04f904-acd0-419b-a45f-fe411d42518b"
      unitRef="eur">915000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if5a6dbcefd8a4ab68267b53708933123_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOS0xLTEtNDYyNTM5_68e4ecdc-e743-4b60-bff2-edf55ce98c94"
      unitRef="eur">3126000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i833eb11d63f9442f9f7f72021922e8f5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTAtMS0xLTQ2MjU1Mg_75226293-ef23-48ce-9340-7de3665744b3"
      unitRef="eur">1010000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iadb9c19bb94841d2a79288d7aadecaa2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTEtMS0xLTQ2MjU2MA_1ed01b24-296b-4376-824d-802a1cb9f072"
      unitRef="eur">1122000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i42ab938545594eb992053504011e4252_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTItMS0xLTQ2MjU2OA_ab3b3803-5c5e-47e7-87de-00802314e45c"
      unitRef="eur">879000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5726d6cac7a14f3ca1568529807b8c90_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTMtMS0xLTQ2MjU3Ng_6f7b294e-f53c-41b9-a870-48444ce30648"
      unitRef="eur">3011000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib2664f2da4914ced8cdc3fc6e2aaabcc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMi0xLTEtNDYxNzMx_8c538481-a3f3-4b0a-b47a-e2199de0d32d"
      unitRef="eur">239000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if6654ba9bc13481fb4f6e2d9755a7d57_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMy0xLTEtNDYxNzMx_bcfc2aee-6e97-48e8-87fb-e5cc9bbb3071"
      unitRef="eur">194000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i27e8629a7974464c91e36e4aecb175e6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNC0xLTEtNDYxNzMx_6ffb4969-916b-4318-ad38-be1e65d54bb9"
      unitRef="eur">274000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i8c4ada02638b4ae29081e603d6b495da_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNS0xLTEtNDYxNzMx_a6a585d0-16e1-423c-b249-d7f06de3bb4e"
      unitRef="eur">707000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4f851b224ec6401c881a9da5f983599a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNi0xLTEtNDYxNzMx_a89db706-ccfd-4b13-8df7-882e8c0c9845"
      unitRef="eur">244000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i009300f656604097800d9b7ea2a83bb6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNy0xLTEtNDYxNzMx_46dbc7aa-8460-42fa-ae93-1a857f3e8916"
      unitRef="eur">173000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9c3c8fc92f834ca0afc1d103c341e47c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOC0xLTEtNDYxNzMx_6ecc6c51-0d14-4352-8050-bb47beb91e1e"
      unitRef="eur">266000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i36ab119d8f59472ca95eacef7ad659cc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOS0xLTEtNDYxNzMx_0417ca65-467c-45d6-b22e-adea1a04dc34"
      unitRef="eur">683000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id739f18cd5204257b8c191b419d8e59b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTAtMS0xLTQ2MTczMQ_e6c9432d-9738-4737-8941-5ee315d3b3c6"
      unitRef="eur">249000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7e37e052f4f34e379c2230b24e177d6e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTEtMS0xLTQ2MTczMQ_45d19d80-b2c8-47f4-aad7-849371193507"
      unitRef="eur">177000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i02995abbcb574be98f1b4b8903dd790d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTItMS0xLTQ2MTczMQ_03583e47-9848-4c94-8153-e060bc7174b3"
      unitRef="eur">264000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i66ebcdcc275242988ca39be9aeed1808_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTMtMS0xLTQ2MTczMQ_1b838af8-2114-4f1f-8744-6a6de4cfb002"
      unitRef="eur">690000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i59f7875640d940d4be71548d2d02155c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMi0xLTEtNDYxNzY2_7a46477f-7aed-45e2-b33f-70ad6c4587e3"
      unitRef="eur">228000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i679a528164774d5291f5852f0e21e383_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMy0xLTEtNDYxNzY2_290f8e09-4cb5-4ab7-b087-33dd03db82da"
      unitRef="eur">471000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i008880cfdcf84137bd2c2e9958802471_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNC0xLTEtNDYxNzY2_80886a74-1f44-4bd3-a736-4ba42a7ccea1"
      unitRef="eur">239000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ic75317c2c30b470f935f8f50ca516dcc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNS0xLTEtNDYxNzY2_caed303f-e325-4c13-92fb-e36166c0c15a"
      unitRef="eur">938000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9e2f07f1f1914db2861375b158d6e829_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNi0xLTEtNDYxNzY2_f194d220-a1e5-4a80-9efe-a55faa056634"
      unitRef="eur">223000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if482478107224ecfa98b4d25e9684b0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNy0xLTEtNDYxNzY2_2209de95-3a98-4965-adbb-94a647f20ed0"
      unitRef="eur">395000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5e50d845481a46298dce1596b91bb672_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctOC0xLTEtNDYxNzY2_11e783d4-90e1-42f1-88e9-8edfe4739f20"
      unitRef="eur">226000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i19d85e03aecd4441bc80d278e7bbeff9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctOS0xLTEtNDYxNzY2_063bb02f-b528-447f-8c2d-00356569df54"
      unitRef="eur">844000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9bb0c08a9b19417e99fceb3e2de828cf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTAtMS0xLTQ2MTc2Ng_bf4f91be-1f77-4ed6-9d5b-6f8223fce1f8"
      unitRef="eur">200000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ice3ea0298e5348ebb9595f08b6d49ff5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTEtMS0xLTQ2MTc2Ng_ff7b434d-25eb-4fd7-aeeb-d1cc95550729"
      unitRef="eur">406000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7c1dd865175f445a94c92d1bf48727a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTItMS0xLTQ2MTc2Ng_a0e20b31-ba38-4d3d-b6ef-606b4cebfa80"
      unitRef="eur">211000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3d009dcb0eb04ef3a021faa9a7402b4f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTMtMS0xLTQ2MTc2Ng_607f875b-6ece-4a52-a76d-5b5b57a5c9c9"
      unitRef="eur">817000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i12bd9173dbaf4c49aa86481e27892395_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMi0xLTEtNDYxNzk1_54b5cb80-7cda-43ec-9537-162d4b70bad7"
      unitRef="eur">408000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ied76f2bed5094e9699ba62ae5eddf190_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMy0xLTEtNDYxNzk1_ddf46d0e-9533-4745-bfa1-bcdf9cadc8f9"
      unitRef="eur">318000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i530dfd00d80842dbafce7ae5cb9655ad_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNC0xLTEtNDYxNzk1_8ec2cf1d-d97c-4de4-acb3-6044b6ac00f9"
      unitRef="eur">232000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia1e5d0b8029b4a8a8b1f4ac574af7ad1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNS0xLTEtNDYxNzk1_197889b8-a0ba-4ec5-81c7-2043e47dbbfc"
      unitRef="eur">958000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="icb8ac8a0ccce4b5a934f205497b715e0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNi0xLTEtNDYxNzk1_ff793b6e-9852-43c9-92a4-1615cbe74d71"
      unitRef="eur">410000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i24e00e485b8e45618986356e620c908c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNy0xLTEtNDYxNzk1_31dda82b-f4d5-4d95-8cf8-ab2f84f7c68b"
      unitRef="eur">373000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i885a178675c5451191389ab0cef8985d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtOC0xLTEtNDYxNzk1_ba98fc0c-2572-4a36-9efa-ccf1d0efccd5"
      unitRef="eur">220000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i434b726907294409b29412431a7c19bb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtOS0xLTEtNDYxNzk1_b7314644-cdb5-4b34-9356-be6121fe6dcd"
      unitRef="eur">1003000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i83a9ef0ccd5b487fbb118b7e76ceb612_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTAtMS0xLTQ2MTc5NQ_7ecee8df-8710-48d0-9760-f569e932af9c"
      unitRef="eur">389000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7205b4923fa543c7813a6878b9485c35_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTEtMS0xLTQ2MTc5NQ_efb207bc-5331-4a62-afe3-f41d48b1d1d5"
      unitRef="eur">359000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i86f4b2048c414e2e9c5eb44cc0eaedcf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTItMS0xLTQ2MTc5NQ_6493c6c3-6b4f-4145-8fdd-3106af38156c"
      unitRef="eur">200000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i2ee1d4e1116f4243b99c352e87d1d74c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTMtMS0xLTQ2MTc5NQ_477b581e-c4f5-4cde-92ca-c26c679112b3"
      unitRef="eur">948000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9b9df25140174f39b8d25fa4bbda653b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTItMS0xLTQ2MjE4MQ_6e4488fa-01c9-4882-be9b-b062cfde31f1"
      unitRef="eur">239000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9c86f2f0b2854fcba45877b8058bd8e8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTMtMS0xLTQ2MjE3Mw_acb16ae4-e517-4f14-85a7-e3f964a101c9"
      unitRef="eur">515000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4c53ce511bba449da99749a8e4ce6d4d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTQtMS0xLTQ2MjIxNA_4b8b46ec-1ed7-4a0d-be94-19fde8655180"
      unitRef="eur">198000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id9f8b9f4a590449496b876034d80b8e8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTUtMS0xLTQ2MjIxOA_4eeec340-01dc-4c34-8279-da1c62e0a462"
      unitRef="eur">952000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ice20f96fb0cf4de0b3ca3965e622ae3a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTYtMS0xLTQ2MjU4NA_da596d62-21f0-40db-8cce-ea84a0b23cde"
      unitRef="eur">327000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i0b81cb6976ea4348881ae7d19e9b64be_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTctMS0xLTQ2MjU5Mg_976fe8aa-440c-4188-8d3a-415beff7334f"
      unitRef="eur">410000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5cc0ccf1590e4affab7ef2e75874f65e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTgtMS0xLTQ2MjYwMA_3c57861f-cfa1-4b3f-a454-7685e5fd2dd4"
      unitRef="eur">175000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i17ab8be945b245c6ab4bcad11716698c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTktMS0xLTQ2MjYwOQ_7139ba3b-6b61-4e3d-ba6e-952e91a6578b"
      unitRef="eur">912000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9ab393d2fde64052a23ce4a484c207d8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTEwLTEtMS00NjI2MjI_a0e05552-1042-4363-b41e-30040a50e1b9"
      unitRef="eur">299000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="icee2e75239b54a6691515f6280082f01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTExLTEtMS00NjI2MzA_f988b2c1-b5b0-41b2-9191-c16e78373451"
      unitRef="eur">368000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7818bd4346ec4748b6753e13dc4eb6e9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTEyLTEtMS00NjI2Mzg_d0b07ddc-0d27-46ad-8645-2ffe62e79603"
      unitRef="eur">131000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i07c0978e52b444298d8618c3d2159678_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEwLTEzLTEtMS00NjI2NDY_6e9b590f-0dd3-4a5e-b211-5ba5c041bdf7"
      unitRef="eur">798000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia9a280e56f3a41af88aba2bd4cb1d48c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTItMS0xLTQ2MjIyOQ_fef55e52-d397-4454-9885-891b67230e34"
      unitRef="eur">33000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4288c1aa9dc6416cb56c247f3a5ea4ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTMtMS0xLTQ2MjIzMw_3050d05a-e55c-44d6-8375-7a991604ce64"
      unitRef="eur">275000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i30c4fc1b2d404bcaa190fa35d3838578_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTQtMS0xLTQ2MjIzNw_82ad148a-13a4-4e40-b3dd-41948f0b7edd"
      unitRef="eur">83000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i6ef47532b8bd443d92c96e9744f3c55c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTUtMS0xLTQ2MjI0MQ_87ffae6b-c66e-4e9f-86c2-5de20b6635d2"
      unitRef="eur">391000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i117b2d1cc5d346c9877ebace612c1ed6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTYtMS0xLTQ2MjY1NA_a92dc3a2-1d88-46e8-9ad4-9df88fcdbd25"
      unitRef="eur">112000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i657d3f930d0d4905af0b5e1b5dbefe0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTctMS0xLTQ2MjY1OA_fea4049b-15c8-4fdb-a38f-b069caf458ea"
      unitRef="eur">253000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7b3ebdaa8d354f83993ea4311de0e5ca_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTgtMS0xLTQ2MjY2Mw_212956c3-4470-4a5f-918f-3cdbe9b72495"
      unitRef="eur">90000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i85143d1ef2a047ef8d1509cff1b4eb35_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTktMS0xLTQ2MjY2OA_3ead38a1-8a66-48ef-a375-071a9cb5790f"
      unitRef="eur">455000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie090a33d5f6e4860a9db0e69a9cdb4df_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTEwLTEtMS00NjI2NzI_75cbcd43-e490-433a-8677-01e64d4cab20"
      unitRef="eur">187000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia8d7968a46b648a4b7ca0e2438afd8aa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTExLTEtMS00NjI2NzY_46cf8734-c4f0-4a59-9a4b-f1a146bf9a0e"
      unitRef="eur">246000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i381585a218bc4a21bc9dbccd82b92f3c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTEyLTEtMS00NjI2ODA_239c5dfd-67a0-466f-9ba5-f1858c63864b"
      unitRef="eur">103000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i296a8f4baeea42e78a0dd8f1a3fd6a56_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzExLTEzLTEtMS00NjI2ODU_7bdd8455-3a24-432d-9145-71e5a119656b"
      unitRef="eur">536000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i51bdb13aba434060a597a9097458c3a0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTItMS0xLTQ2MjI0NQ_8794e66c-8f89-4ba1-9227-d8d09ea0f91d"
      unitRef="eur">94000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i0f792c072bf54f60b88192d56f584272_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTMtMS0xLTQ2MjI1NQ_748b6b9c-609a-4772-b03d-c97619e77027"
      unitRef="eur">983000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id67bfe76694f4de1839334ce8b69a261_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTQtMS0xLTQ2MjI2Mw_a3a2e02a-de6f-416f-91b5-51be57b25161"
      unitRef="eur">240000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i474ddfd1c7664510913a9d53823fe524_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTUtMS0xLTQ2MjI3Mg_c5466c30-fdf8-4cf3-a2c0-3116ddf09afd"
      unitRef="eur">1317000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iecd790138e5f4caeb22913e385a783c6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTYtMS0xLTQ2MjY4OQ_11c54b3a-e8df-42b9-948c-0590ffdacfcb"
      unitRef="eur">81000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3bbac3b89df045bca004b76f88dbfb78_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTctMS0xLTQ2MjY5Nw_e2270855-6d10-4e44-bc2c-0410ee67e1ab"
      unitRef="eur">842000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if58bda7003d64454ae0b3769c32c45bc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTgtMS0xLTQ2MjcwNw_96e8fc40-d677-4a79-b94e-ca5c35bdd7ee"
      unitRef="eur">218000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i07798b22999e4551bc98330cd328ac58_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTktMS0xLTQ2MjcxNQ_632dd5ef-f6bc-4fd8-8eab-4be7696464c5"
      unitRef="eur">1141000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i808feb017bbb47b2a5990030172ae9e9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTEwLTEtMS00NjI3MjQ_b9c4c489-6389-49db-9df5-7f9a0483e025"
      unitRef="eur">41000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ide523dbe8589413aabe48647cf02a037_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTExLTEtMS00NjI3MzM_7fbabb6b-c645-429a-ab1e-7f4de611dbc4"
      unitRef="eur">837000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id1ac7e39036e4bb5b0a39b7b97512708_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTEyLTEtMS00NjI3NDU_7d2a6643-8cae-4999-9cf6-d56dce0d5fcf"
      unitRef="eur">339000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i58eaa30a28f4407f804608f379faab0d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEyLTEzLTEtMS00NjI3NTQ_2ee60c7c-f8d1-44ef-a5fc-fcb0915996f9"
      unitRef="eur">1217000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if17af11c5d8a41feb31c45c868fe9eae_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTItMS0xLTQ2MjI4Mg_3cb4b592-10a3-4081-9260-156c7ecadc18"
      unitRef="eur">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib70be66dcfd54b8fa1967dc6ba0bb5eb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTMtMS0xLTQ2MjI4OQ_be7a236a-ec33-4550-ac8d-b47c8c72bc59"
      unitRef="eur">406000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iaf5a3b324da94b91b08eaac503473be5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTQtMS0xLTQ2MjI5NQ_1c35793c-49bc-4a99-8ff3-2e2332ed81df"
      unitRef="eur">98000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7cb49f4f811244b596cd629fe1ff04e0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTUtMS0xLTQ2MjMwMA_35aff350-eb2a-49f2-bdc2-3e0aaea9dc7a"
      unitRef="eur">504000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1b3b532d87ee4f92b20b6eca2f77a81c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTYtMS0xLTQ2MzU1OA_15dbb682-b1bf-4f8e-9d36-f79bc37b3181"
      unitRef="eur">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4d67cad1157445109898fc8120f7683d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTctMS0xLTQ2MzU3MQ_792bf262-0ead-4cef-b91d-3ebbef3b67f8"
      unitRef="eur">332000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9e64c845eeb246f59dfd656899a27837_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTgtMS0xLTQ2MzU4Mg_d68f64a5-e4a6-42dc-9aec-d59670558d71"
      unitRef="eur">82000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i35c6e946c3624b76905a8cbf979857ba_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTktMS0xLTQ2MzU5MA_3b453a32-36ac-4a44-82cd-3c9d7fc1f7b2"
      unitRef="eur">414000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i8a4839221a9b478a8e315985b0c6c6c9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTEwLTEtMS00NjM2MDQ_9010250e-61ea-4d73-87b1-e991224e5ee7"
      unitRef="eur">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4aac4d6ed7044a869f2ab2a402ed6891_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTExLTEtMS00NjM2MzQ_f627d2e1-c252-4648-8968-060d1faa9f0d"
      unitRef="eur">320000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie188b535c20b4152b071cec5896f8a8e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTEyLTEtMS00NjM2NTU_850bd83f-f26c-409b-981f-ea8bd7cc4378"
      unitRef="eur">146000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5193ccd45f664a6e87c2cd7ffebea135_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzEzLTEzLTEtMS00NjM2Njk_1d10efbc-fbfb-4836-b59a-8cb6532b1b53"
      unitRef="eur">466000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7242f99862ee418daa94f18ea3004d14_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTItMS0xLTQ2MjMxNQ_d4c1ab46-1b0f-4123-8e10-5b1272793cef"
      unitRef="eur">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i42189e03c07c4dc89544b5314ae6fa7f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTMtMS0xLTQ2MjMyNA_5ad3b986-c796-40b7-8cf6-69665f0eeaea"
      unitRef="eur">450000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i2343ab2aad5e4a75bc999c5ed10f2dc8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTQtMS0xLTQ2MjMzMg_1aba6845-2d40-44db-9a82-4f7f3db67cc4"
      unitRef="eur">130000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="idb2d3cf6268242e1a113cb343e29cbe1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTUtMS0xLTQ2MjM0Mg_274fbee2-78f1-4717-bab2-82865f7153e8"
      unitRef="eur">580000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id3bbdee34574428b81d52395573a7a50_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTYtMS0xLTQ2MzY4OQ_5a84598f-6489-42c2-b009-a7ffd7c1027f"
      unitRef="eur">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i89bbec019eba4315ac544fc5b16a8ee1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTctMS0xLTQ2MzcwNQ_587ba7aa-0861-48a9-83aa-fdc36a06f70e"
      unitRef="eur">429000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if7b892ef3d1141339a371a9d6ee5b705_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTgtMS0xLTQ2MzcxMA_44821602-17f4-4ee3-9401-1b27d88646d9"
      unitRef="eur">134000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1d9408eb958d47f9970a1477c454e52b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTktMS0xLTQ2MzcxNg_ac59cd5a-65a6-42f5-8407-cdfa0b6ad114"
      unitRef="eur">563000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1cefce5d6bf34ac6b51f91739b702fb3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTEwLTEtMS00NjM3MjM_5ed6c1b3-b5c2-4cac-b014-f715ac7a2d6f"
      unitRef="eur">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9bc5e144c1a04076b51456626e9cd1fe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTExLTEtMS00NjM3MzY_2d51173c-c8a1-4a41-8096-1536f4566547"
      unitRef="eur">445000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i758a45c283f3434ca1c881ffb264058b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTEyLTEtMS00NjM3NDA_17ab8a40-6b8e-4670-80e0-e08a0de579fa"
      unitRef="eur">193000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="idd17ee78068b4d03a01620b3f9a48899_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE0LTEzLTEtMS00NjM3NDQ_b6aea295-c4ce-4760-813c-a18633dec312"
      unitRef="eur">638000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7534c54d521e42bfa11f4ec26a7237df_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTItMS0xLTQ2MjM2MA_9240fba2-426c-44ed-b952-90d0158cd6c8"
      unitRef="eur">1917000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9d735f3d6a394c9cb978c28c14f66ec5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTMtMS0xLTQ2MjM3NA_058d4c04-d669-4c5b-b054-7dfaf1ce37fe"
      unitRef="eur">1653000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i6780792481f84d549561c3ae8139f8fe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTQtMS0xLTQ2MjM3OA_b8a33333-bd27-47e4-be6d-ae7c516ed1c6"
      unitRef="eur">2819000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9c8ed8009e0749b5ab9de034c8837959_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTUtMS0xLTQ2MjM4Mw_6cd93b46-e6ec-4243-a1c1-85cea26c7a4f"
      unitRef="eur">6389000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1ffc44bf8e0f41e781b7e2ebbb1e69d2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTYtMS0xLTQ2Mzc1OA_61fdd937-11c5-41f4-9f19-46e9a3cde5f9"
      unitRef="eur">1868000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id3a725010cd94a3c834bc25a5093a46c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTctMS0xLTQ2Mzc3Mg_c7ddeead-0582-4785-a840-64863051b8c0"
      unitRef="eur">1315000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ied5995be0e4745d280c9b295e1a23e20_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTgtMS0xLTQ2Mzc4NQ_f6c1b0ec-5b35-484f-a2fd-3e908b0fd81c"
      unitRef="eur">2585000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i90de959467104871a3e22682cf4131f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTktMS0xLTQ2Mzc5MQ_022ba761-737e-4bc6-a19f-5ce1ab7d40b3"
      unitRef="eur">5768000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i22138736e8ca42b38ff8c48941f38409_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEwLTEtMS00NjM3OTY_29185188-f7de-40c9-a959-9a0a748e9d90"
      unitRef="eur">1759000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i69f76298218f4254bc305200c960f426_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTExLTEtMS00NjM4MDU_430f8edf-f1b1-4156-b0f4-4b49eaab405c"
      unitRef="eur">1413000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i52cf9837e6ed40aa85632eec92ba6f45_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEyLTEtMS00NjM4MTc_9088bf6d-d34b-43e5-bd3d-7b9eca518fac"
      unitRef="eur">2409000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i727e0782da3d46ec8fe5ab5e632fc070_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEzLTEtMS00NjM4MjU_e501eb26-9071-4263-80c8-0a35146b80ba"
      unitRef="eur">5581000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ic44928021d4f4236870f0bf6d6fd1311_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTItMS0xLTQ2MTg5MA_7c48f438-a4a5-4ae2-8614-2ced81514154"
      unitRef="eur">658000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib0e28c706e6d4bf18081e809b52dd3f7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTMtMS0xLTQ2MTg5MA_cf638c9f-6f9a-41db-9cc1-5f0d02557ce6"
      unitRef="eur">17000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id861d9b153c74477a49abd477eddc226_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTQtMS0xLTQ2MTg5MA_d73dd7d4-208c-44f2-a014-dfbe74c3a1dd"
      unitRef="eur">635000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i357469340a86491ab237157cde1612d1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTUtMS0xLTQ2MTg5MA_d7b6a502-c1a9-4092-b67d-7143b3f88422"
      unitRef="eur">1310000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i60d25e37a08049dcb2fb97d0a8b25b0a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTYtMS0xLTQ2MTg5MA_e4032fb6-5b04-41bd-9591-e4074eecfdbf"
      unitRef="eur">703000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i57dd079515644fe69b73d21d94ac3e9d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTctMS0xLTQ2MTg5MA_9cba9f71-41a2-4547-8f86-faa82fe175b8"
      unitRef="eur">29000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7a1a5c473c9b4cce9650d795bfaece4c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTgtMS0xLTQ2MTg5MA_60e4023e-1bcd-4e82-a6bd-d1d8ea3a7061"
      unitRef="eur">754000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i0e76cbde32b54813adf63f05934bec59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTktMS0xLTQ2MTg5MA_3e69c75e-bb95-4e13-8cee-4c3e951b24fd"
      unitRef="eur">1486000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib446fc017cbe473c8fee4d2dad31e01b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEwLTEtMS00NjE4OTA_89167ad7-cc04-4920-bdc7-f4e59b34cb3a"
      unitRef="eur">656000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i370d5592a1da444699977335ae0d6aa4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTExLTEtMS00NjE4OTA_29bf8062-5137-4917-8535-56f9daea0a7c"
      unitRef="eur">30000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3025efe993694823a88967c4a6ddda1c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEyLTEtMS00NjE4OTA_f9413eb4-9670-4fc8-b655-ef3f77213ea6"
      unitRef="eur">665000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie718eb6f98704abebab8e41cf0bb433d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE1LTEzLTEtMS00NjE4OTA_6b742ea7-b380-495f-aba8-55d3d4b058b1"
      unitRef="eur">1351000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i30c5ee5de6db4c66bc2a5def80cb3630_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMi0xLTEtMzY0MDYw_1d715b42-d115-4da1-b753-82f4c9a3557c"
      unitRef="eur">421000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i17834d1f197042f1a682ebdde3f1bfb1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMy0xLTEtMzY0MDYw_38585ed6-09bc-489f-be9f-2ef30b9f1a7d"
      unitRef="eur">283000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i998de8ae593247f495156ca0fd001bbf_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtNC0xLTEtMzY0MDYw_6b6f1ec3-abd0-42e3-b8a1-eeb9cb4defbb"
      unitRef="eur">413000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i0977ba6fd2084d8ca30b097662a249d1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtNS0xLTEtMzY0MDYw_827d400e-4e79-437f-90b7-190ae7966117"
      unitRef="eur">1117000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9b17aab75c004d718993f2b67a67ff5c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtNi0xLTEtMzY0MDYw_38f7a98a-5650-4c18-891a-7ef37101d4f0"
      unitRef="eur">394000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i740678f4087c45798717797b54332317_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtNy0xLTEtMzY0MDYw_870b597d-8db0-461c-8201-a15c9cd8fd16"
      unitRef="eur">259000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i49540aeddfb1476badc6b4db7a86037c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtOC0xLTEtMzY0MDYw_e56cf475-cd32-4087-bbf2-01fe4c0724ed"
      unitRef="eur">316000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i53367ae84f81438ea1f7429170ac4341_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtOS0xLTEtMzY0MDYw_725d0584-4857-4466-92ee-73d1c5439d4d"
      unitRef="eur">969000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie9d5c0a2194149e9829332b644e91e78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMTAtMS0xLTM2NDA2MA_f739e2e3-d14a-4366-b6f8-5ed4955b83ca"
      unitRef="eur">374000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i16768b64d8324f648ba3dcd8ea1743bc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMTEtMS0xLTM2NDA2MA_c563b137-0fe8-4d81-acfa-f9ddb04e362f"
      unitRef="eur">267000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i95951b5818aa458b8d05be95e32f6f29_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMTItMS0xLTM2NDA2MA_7a73415a-2630-4187-94aa-1139f003b089"
      unitRef="eur">292000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib93e54f78f854e94acd0d345f631c76f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzUtMTMtMS0xLTM2NDA2MA_49b9d7e2-e732-40f6-9e08-8e0ed5d002bb"
      unitRef="eur">933000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i92984c0d697e42b69afe6d9913419c61_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMi0xLTEtMzY0MDYw_c671ff36-6d6d-434a-847a-1c7082d5d70d"
      unitRef="eur">101000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i997357ba5e0d4103a854138682dbad0c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMy0xLTEtMzY0MDYw_cc4ebd98-26b1-48a5-a5a6-4da5e6e4e57c"
      unitRef="eur">9000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i97f55be8ce6645d5a550bfa46ae5aefa_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNC0xLTEtMzY0MDYw_67dc1afe-adaf-40b9-960e-f07894bc6813"
      unitRef="eur">873000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib18bf96fce9840e79199255e69961a1a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNS0xLTEtMzY0MDYw_e2a0c96f-1229-4d52-8cdd-ccf592a11950"
      unitRef="eur">983000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i16b5d5a19be44034bdb35c036e33c369_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNi0xLTEtMzY0MDYw_3a885f74-210e-4284-b314-c6ec34e324e1"
      unitRef="eur">115000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i48989f71da6140a4beb9df8f40518550_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtNy0xLTEtMzY0MDYw_ff29adac-be89-47f6-b220-6c43f4cc14d9"
      unitRef="eur">9000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i343f9ebee6b943a7bf2931dd320e3aa0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOC0xLTEtMzY0MDYw_216fb187-6868-4c74-aff2-5f89b0f09bc5"
      unitRef="eur">805000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i167b4765e010409db6a9ef1c2724d107_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtOS0xLTEtMzY0MDYw_6e5e0ef5-19ec-469b-bbfe-022b19511dcf"
      unitRef="eur">929000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i628fcb0013224533ae759b38ed4a9e8b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTAtMS0xLTM2NDA2MA_52c60ae0-51fc-4a3b-8fdf-1a7347ecb9d9"
      unitRef="eur">126000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i37db7c2f8d7b469997221d1aa218fe6f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTEtMS0xLTM2NDA2MA_01a8a55b-cc46-4ef8-b267-b001d74e399c"
      unitRef="eur">10000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i925f6b2d5b5d40a58aa0860a22c1fbea_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTItMS0xLTM2NDA2MA_a4c48339-402e-459d-8123-878efb342760"
      unitRef="eur">777000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i0aa66e4f08254a8eb5827d9da0511d7d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzYtMTMtMS0xLTM2NDA2MA_f4d156c9-1e71-4b19-a80a-4ca5a732e1f5"
      unitRef="eur">913000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib6918b42287543ffae67f45e89689571_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTItMS0xLTQ2MjM4Nw_53b1539c-81d6-409b-99f1-7c11af1aaf8f"
      unitRef="eur">1637000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i83b5b2fcccc6496684aa6cb171a11b8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTMtMS0xLTQ2MjM5MQ_c093a846-ea2a-4834-8b5d-0bc41a31e13d"
      unitRef="eur">1176000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iae87558939404363b5fccfefd97a00fd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTQtMS0xLTQ2MjM5NQ_61b489fd-7a9b-4889-9f8b-4df12b686558"
      unitRef="eur">4409000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i40fa65e1893444b2b1d53b7ce6e4f2ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTUtMS0xLTQ2MjM5OQ_9606c3d7-1b8c-4df8-b5e8-10d8297dc98f"
      unitRef="eur">7222000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ic8eac199a2aa4dea9ca5e52b9f0bba8a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTYtMS0xLTQ2MzgzNA_c294d4c1-4fe0-42fb-a638-3da7b63de3a3"
      unitRef="eur">1846000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if706c3f3b7c64218b54c47278fdff29b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTctMS0xLTQ2MzgzOA_8e435b0d-9270-4178-a7fd-00940d86ee72"
      unitRef="eur">1281000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i902260c2fc46471c9838a41c2d4ee190_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTgtMS0xLTQ2Mzg0NQ_47896fda-7fde-42e7-8069-f67cc0e324f8"
      unitRef="eur">4515000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i8fa99407fd0d465dad206a1e0d6e807e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTktMS0xLTQ2Mzg1MA_77935b2f-7813-488f-950b-54e8c1295086"
      unitRef="eur">7642000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iad567579f11c4396ad1e56f97b7462ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEwLTEtMS00NjM4NTk_2df6779b-49f8-4d72-ba40-ee38f8ad923d"
      unitRef="eur">2088000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="idb3ceb86dd6c4368b68c2adc32c3298f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTExLTEtMS00NjM4NjM_ab2f9574-92c2-4eec-82be-ffab6e501d73"
      unitRef="eur">1389000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if613bbe5c0594318b016b497ee91c597_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEyLTEtMS00NjM4Njc_800e3597-e098-4c66-acbf-26694e6f7ff0"
      unitRef="eur">4849000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3b001a8470a941d89da632e7bc9daf72_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEzLTEtMS00NjM4ODM_2cc1bfad-c7c3-4ef5-a6fa-d7e3dd93360e"
      unitRef="eur">8326000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i22153967fac6428b833321479fdb1306_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMi0xLTEtMzY0MDYw_501e6a8a-f576-4c95-9c71-fde571623d0e"
      unitRef="eur">426000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5594aa252dab4309b3116b07f116ccac_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMy0xLTEtMzY0MDYw_3684b8a9-39bf-4ce1-bc95-5f2e62330e0a"
      unitRef="eur">757000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iea483c0a6b6e49a5b4641fed43699ded_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNC0xLTEtMzY0MDYw_df73d29c-2a2e-4676-8e2e-2e7bd63f584a"
      unitRef="eur">1076000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i312af4a1d5294779ba7c9a2e218b6b4b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNS0xLTEtMzY0MDYw_a5843817-5555-4923-8075-2b6efdaeca35"
      unitRef="eur">2259000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i578a1693685b4648b843c7591f102024_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNi0xLTEtMzY0MDYw_7043517e-c431-4937-9ccc-07c5d4e8fed9"
      unitRef="eur">474000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ic943869cbe084442b9752f3125562eba_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctNy0xLTEtMzY0MDYw_32ada888-77ad-4066-aa7c-40f591f852cd"
      unitRef="eur">861000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i59b03d0aa3374a76a09ad675f12ec5fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctOC0xLTEtMzY0MDYw_4a16bfed-fcde-485a-b8b4-a977094722ea"
      unitRef="eur">1159000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i45eb32fbd1db4afe99ef24b30301d967_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctOS0xLTEtMzY0MDYw_b288210f-736f-4db4-9e18-26c42d2015ee"
      unitRef="eur">2494000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i8f63b529f1744fbc83d583f5b12c35e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTAtMS0xLTM2NDA2MA_5ae21775-e8d6-452e-9f8e-986bbff314e2"
      unitRef="eur">537000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i866a97436e854d82a86d47a3f7c2e9cd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTEtMS0xLTM2NDA2MA_17c52c40-77f5-4d61-a5cf-3682f983b42f"
      unitRef="eur">929000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="idf055ce7cd0d4b41b0974d84a4828176_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTItMS0xLTM2NDA2MA_c4844dfe-c41a-4e78-aefe-2fceaebc024c"
      unitRef="eur">1195000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1c2f60a295184259a5e98824572dc354_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzctMTMtMS0xLTM2NDA2MA_cf0a91fb-c152-4c17-9273-503d8a6c748d"
      unitRef="eur">2661000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7161276da0fb46c8a7f757ed66cd6b74_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMi0xLTEtMzY0MDYw_14bfad69-5805-4e9a-91fa-a7d557f17d90"
      unitRef="eur">1129000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i75a5f2ec92a94a89b3aae509e3a5cae0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMy0xLTEtMzY0MDYw_b388f720-0008-4b4e-a444-f2e8dc55d70f"
      unitRef="eur">412000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i73a08d51def1454d9443a2bc8b6580e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNC0xLTEtMzY0MDYw_020645af-048b-4c3e-b612-40d0ae324dc7"
      unitRef="eur">2944000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iadb91c4ffea14a4c86b46fa219e8e8e9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNS0xLTEtMzY0MDYw_b39d7e13-b53b-405d-8f90-1526ac95217c"
      unitRef="eur">4485000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ic496482793684b30af908ea4b53e6237_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNi0xLTEtMzY0MDYw_5e5f328a-9ca5-4d24-b047-3151da9a8da8"
      unitRef="eur">1285000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i34ae4ee5253743af84111345f0f31775_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtNy0xLTEtMzY0MDYw_643803cf-26de-4590-9614-b47052b55bc7"
      unitRef="eur">410000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i466ea9984a9746c1b1788273a8e951fe_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtOC0xLTEtMzY0MDYw_aff30f27-e70f-4dba-aa39-ade6d01e844b"
      unitRef="eur">3034000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i77618a8613ca4289b3b3a2b779826d72_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtOS0xLTEtMzY0MDYw_f1009bac-4ce9-4ed0-b838-1bc051cb3858"
      unitRef="eur">4729000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id9552a01052c443f87d515d5c3a5020e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTAtMS0xLTM2NDA2MA_68c64e56-1554-45db-84cf-b84cb0d03f6b"
      unitRef="eur">1451000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i912066ccddd243118e3de68640de9dcf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTEtMS0xLTM2NDA2MA_47837a1d-a3fb-4e4d-945e-67775d666d8b"
      unitRef="eur">438000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7c5c4713cc814bd7ab49ed66efb4c628_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTItMS0xLTM2NDA2MA_3959f33d-3942-4875-887f-bbc20c938816"
      unitRef="eur">3222000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i0a90a9627ee244f28f6e326030e8fb04_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzgtMTMtMS0xLTM2NDA2MA_c2db954c-97b5-4de1-bff8-23596d49300a"
      unitRef="eur">5111000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i202bd69ea7354e44a25c96c53391e267_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTItMS0xLTM2NDA2MA_8be88853-ceae-424b-b603-1d3180e982e9"
      unitRef="eur">587000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i46f1f42e50b94bfb85ebce0b53ffcb95_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTMtMS0xLTM2NDA2MA_56549dc5-7a4b-48d9-a1d8-33b7eeb891ae"
      unitRef="eur">17000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5269963529c04271bdd98254675e07ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTQtMS0xLTM2NDA2MA_17897731-46b4-4d2f-bd75-551890dd89b9"
      unitRef="eur">16000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i95373a070bcb4ebc8e62a097d81bc07b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTUtMS0xLTM2NDA2MA_0be1f62a-eaa7-4834-9371-74140e0359e4"
      unitRef="eur">620000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i2f756c850c4f43a6aa9a408f9b93eb20_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTYtMS0xLTM2NDA2MA_43c8359b-0a05-4d2e-a6ff-8c9a0096f95c"
      unitRef="eur">723000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i60f2bf9e9e914ea3872005fd530433e3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTctMS0xLTM2NDA2MA_ea905a63-88fa-4419-b72e-232e1e34cf06"
      unitRef="eur">41000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if6decca1f9a94e3caad98da2fcdc75d0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTgtMS0xLTM2NDA2MA_7072de35-7dc0-4525-873a-ef1d5bbf8b8c"
      unitRef="eur">44000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i085e1c70e50641f2962c6964513071a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTktMS0xLTM2NDA2MA_e4d961e8-fcd0-4db3-a420-957b7adfb612"
      unitRef="eur">808000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5ce62b370fd24f39a199e1d375dfb6d3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEwLTEtMS0zNjQwNjA_f095989f-1406-4e48-982e-aa0d1e42350c"
      unitRef="eur">658000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i093e51cb9252485a94109d38a8fa4702_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTExLTEtMS0zNjQwNjA_f8e256ba-0a06-4c65-b5a1-5ab464dbfe3e"
      unitRef="eur">67000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i53c5d7935c7b4937a7191d5857435346_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEyLTEtMS0zNjQwNjA_961b7293-a616-43f2-a68b-5cb3bd72af88"
      unitRef="eur">88000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i66e48178e270445b9442f66c6b94104d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzE5LTEzLTEtMS0zNjQwNjA_23c4e482-eed2-4662-ae94-95ff1eac331f"
      unitRef="eur">813000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id543945583c840488898c47cb6f44f8a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTItMS0xLTM2NDA2MA_17882816-5d1b-4089-875a-3e6f35488519"
      unitRef="eur">1341000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i52bb756b60e14df9a45298f4b3784a0e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTMtMS0xLTM2NDA2MA_c0ec759a-ebcc-405a-8c51-e54983a55593"
      unitRef="eur">3291000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i24cc0a91048b4fdebadcb26d0ef92277_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTQtMS0xLTM2NDA2MA_c3f13f66-e67e-4084-9634-8460f4d910a9"
      unitRef="eur">2597000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTUtMS0xLTM2NDA2MA_dc5134ac-a426-4875-bc62-f0e5720e93a3"
      unitRef="eur">7229000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i86187c82c19c4cb9a375fa90f77d5b4a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTYtMS0xLTM2NDA2MA_b716f14e-446e-4e4c-8111-b8b8662466a1"
      unitRef="eur">1225000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4d424d7a10774447a1a4b8b5e0ae7689_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTctMS0xLTM2NDA2MA_eb8f4f0e-a95e-4d67-89e4-66f14e1b2de0"
      unitRef="eur">2762000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib056f7eee5db49e6ad47e9f71e8c6ed8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTgtMS0xLTM2NDA2MA_2b7c8b06-1856-418e-9068-7f7ad4ee47c4"
      unitRef="eur">2336000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTktMS0xLTM2NDA2MA_57eeabd1-5ba1-428c-8c5e-6c747050ebbd"
      unitRef="eur">6323000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7ae926d85669499cb9afa33c7d9241d8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTEwLTEtMS0zNjQwNjA_fbbe973d-8c0b-4480-b062-3449fcd9537f"
      unitRef="eur">973000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4e6ac042ac204ffa91527696c60c97e4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTExLTEtMS0zNjQwNjA_b12ee929-6a65-4626-afcf-7553c13703c1"
      unitRef="eur">2759000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i8467dbc5770446939551b7a699d503f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTEyLTEtMS0zNjQwNjA_a2dc9e01-94e2-4d3c-8e5a-e08ca4725e1a"
      unitRef="eur">2241000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIwLTEzLTEtMS0zNjQwNjA_8deb9e40-2f4d-4682-95de-cd922547f851"
      unitRef="eur">5973000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ifd94df2c80d743d8a13502c39a73b7ed_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTItMS0xLTM2NDA2MA_2c8e6708-e29c-4b58-a10b-d4eee1666873"
      unitRef="eur">325000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i566185ab6e264c6a8db7216893997e35_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTMtMS0xLTM2NDA2MA_432de92d-8b21-4d04-953e-3a0553a0fb2b"
      unitRef="eur">456000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i28a1069b3bb642b693c980f6b28c3e84_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTQtMS0xLTM2NDA2MA_a8570d6c-c01b-4944-92c3-a6261eabfc7f"
      unitRef="eur">1504000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4df972df975b43f0ba3ed94f3ac9b0f0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTUtMS0xLTM2NDA2MA_6e861720-8ae4-4f01-b4ac-19c840ff16d6"
      unitRef="eur">2285000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if9c5ed55783540d9aa5ba29544a1b58e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTYtMS0xLTM2NDA2MA_aa9ef3a6-646e-48b8-9f4a-5980d4a09f73"
      unitRef="eur">306000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i88db9dd7ec104b49aa9f5cad7c6b5d8f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTctMS0xLTM2NDA2MA_57805d4c-5ef5-48fb-b4af-c5d0e7e01482"
      unitRef="eur">470000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7e5b7dc49ebf4382a4ae26de2ebc180f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTgtMS0xLTM2NDA2MA_bdbd3514-8597-4e5a-ba80-3407cce22836"
      unitRef="eur">1383000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5531b6cfd28445d29737a2bfa6bc7241_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTktMS0xLTM2NDA2MA_33dd0c91-4305-4520-99f1-430e26f4847e"
      unitRef="eur">2159000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1f061cdc8a4049e298e7ce678ecba5fe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTEwLTEtMS0zNjQwNjA_88038089-2339-432d-8bd6-9edd3e67114d"
      unitRef="eur">331000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if9421508acd14db08ec0028a7eef9bb4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTExLTEtMS0zNjQwNjA_68f82b94-a577-4282-b4ae-699fc8923f7e"
      unitRef="eur">412000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib7092d8f4e2046b9860885a474a6d5db_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTEyLTEtMS0zNjQwNjA_132a982b-09c9-48ce-9970-0ae8119329ff"
      unitRef="eur">1363000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i90cb244705d34e58b4ef04e3600b013d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIxLTEzLTEtMS0zNjQwNjA_32390585-31a5-409e-92c7-c25379cfd021"
      unitRef="eur">2106000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i456fa2153dc446f5bce91beff992d477_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTItMS0xLTM2NDA2MA_6f14a330-ac60-4d22-9834-052aa32deb59"
      unitRef="eur">681000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i0bfa10bd76b546309489629a22ee1f6d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTMtMS0xLTM2NDA2MA_59aa4702-6ebb-4b57-a551-4fcc32c92284"
      unitRef="eur">1737000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i2bed6a217a124ce2832a0c652eb14a8f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTQtMS0xLTM2NDA2MA_82a17500-42f2-4ee5-88f9-6ffa9c863800"
      unitRef="eur">559000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iacff9073d13f4103810361e59ee490ad_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTUtMS0xLTM2NDA2MA_2cbb3625-08a8-4074-96ad-08a4dc69da7e"
      unitRef="eur">2977000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib25f8d53a5414fe19f6ae1ed1c367b75_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTYtMS0xLTM2NDA2MA_2c0d245a-0fcf-42e7-9ea5-1028a8bc065b"
      unitRef="eur">729000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ic25e96d4bc874fc5a518e3a62b557388_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTctMS0xLTM2NDA2MA_2919d59f-9c61-4979-98e9-f9e45e0f55d9"
      unitRef="eur">1366000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i66b75c69b5de4e3d8a0d43182fa87920_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTgtMS0xLTM2NDA2MA_bfe03901-0254-446f-a60a-fa7bab398a3a"
      unitRef="eur">533000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i336524d5d81f4a39bf61ca920af300b4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTktMS0xLTM2NDA2MA_0aaa6bc6-9aa3-4f4b-8624-b3bb199610c8"
      unitRef="eur">2628000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3ee49f3c004543aaa32444ea5f031578_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTEwLTEtMS0zNjQwNjA_452069a4-c548-476f-995c-ee3a8fa79152"
      unitRef="eur">441000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie898ae59a55b46f0bd8bd709eb4f822a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTExLTEtMS0zNjQwNjA_9f7d40cd-f1cb-4c1f-91ad-1cbe7b03da63"
      unitRef="eur">1575000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ifdd8d6dad55c4232b49ae3d7899b823e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTEyLTEtMS0zNjQwNjA_bced7836-beb2-41ea-a93b-4a58eb02a4bb"
      unitRef="eur">456000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if882abae01c8491aa97cc0f3708f8398_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIyLTEzLTEtMS0zNjQwNjA_1bc8bed1-d144-4c9a-95fe-e378ec7526c5"
      unitRef="eur">2472000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie7b09c85efa64008a5815fa2c2c3a477_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTItMS0xLTM2NDA2MA_3f425707-1e86-4e6a-b2a9-80f529abc09d"
      unitRef="eur">1501000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id8f643c30d914f8ab4e03c092efb3091_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTMtMS0xLTM2NDA2MA_200c56dd-9775-4e6e-9479-21993c96f584"
      unitRef="eur">1290000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5e5094b910954c5f8c2098e2be4c991a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTQtMS0xLTM2NDA2MA_461b22f0-b286-4891-a928-810359bc188c"
      unitRef="eur">2289000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTUtMS0xLTM2NDA2MA_6f67d165-10c7-43cc-9f2b-f9fa291fc3a6"
      unitRef="eur">5080000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i500abf386db74b7f9515899bb2358a6d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTYtMS0xLTM2NDA2MA_49f74b39-4c4c-4132-9c70-97635e24f0ef"
      unitRef="eur">1333000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia8336020a29448de861074ef317b627f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTctMS0xLTM2NDA2MA_73170083-0587-4e32-881d-76b9efc54730"
      unitRef="eur">1139000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3d97b9f2b2384d5fb8b3e7b0afa2a5a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTgtMS0xLTM2NDA2MA_06f68d1a-c7e2-46d2-ac09-23e1307fd7af"
      unitRef="eur">1996000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTktMS0xLTM2NDA2MA_43984402-6685-49a8-9fb6-4ff9cc74562b"
      unitRef="eur">4468000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9d653af939404c578466f638984d2422_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTEwLTEtMS0zNjQwNjA_9d094161-b5fb-4013-b6fb-972641fd6720"
      unitRef="eur">1359000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i0407751659c54020a63e3b5e93476585_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTExLTEtMS0zNjQwNjA_ec128ea3-e0ac-400c-8d3d-1381a130371c"
      unitRef="eur">1071000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i66d6c454ffb244d98228a677f46b2fac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTEyLTEtMS0zNjQwNjA_dc576981-f767-49df-93a6-8efe50496bed"
      unitRef="eur">1964000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzIzLTEzLTEtMS0zNjQwNjA_15bc771f-6f5d-41f6-8772-a85cafb76b2c"
      unitRef="eur">4394000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i6bda1c567b1c49029b875aa4febc16bc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTItMS0xLTM2NDA2MA_9aa847e6-8675-4e32-8651-c83491db1bf4"
      unitRef="eur">55000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9c22a1098e3e46b3b86d47b9cf5ba970_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTMtMS0xLTM2NDA2MA_98e517d2-c0ed-4200-b682-17d8c836fce8"
      unitRef="eur">439000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i156e9e8a21b449018c4bd18d3570d698_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTQtMS0xLTM2NDA2MA_80dbd5d6-574d-48c2-8b71-54269154afb1"
      unitRef="eur">240000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id5cdd431c5ae43a593b7cfa1f7bdbfd9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTUtMS0xLTM2NDA2MA_053390ca-26e5-4d88-9e9d-dacabc7bd8e6"
      unitRef="eur">734000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9a2f8c0d377e4c1283f5b111722e1ba9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTYtMS0xLTM2NDA2MA_30ae4b3e-b919-4567-bc4f-6a523b2d545f"
      unitRef="eur">49000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9082ca4896f544149c5fa993fc76e11a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTctMS0xLTM2NDA2MA_0d5e248b-9d19-4587-a669-8649181cf100"
      unitRef="eur">371000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i255d9fe68622490197bffdba2a258f3f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTgtMS0xLTM2NDA2MA_d0e54343-5bde-433e-8b27-644122df39f2"
      unitRef="eur">192000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i6a047d0a5c8a445f9834ff3fbe6bb785_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTktMS0xLTM2NDA2MA_8d3cf92c-2837-4aa5-8412-9eb9ab5b81fe"
      unitRef="eur">612000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib9b0bb905111472f9a11100558b1571c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTEwLTEtMS0zNjQwNjA_8503e47a-50ec-4ecd-931e-1b4501dd8f75"
      unitRef="eur">51000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5c459d45e7794c9597c5651cd4ef947b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTExLTEtMS0zNjQwNjA_fa78812f-c188-4d59-8c5a-1ebbe4e60cb9"
      unitRef="eur">361000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i84d4767234f44fd1b5d3a8968daa3946_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTEyLTEtMS0zNjQwNjA_f6cf35fc-bc43-4b64-9049-2f986f9d3191"
      unitRef="eur">205000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia50a50591809469c9fb3b18d4811f6c6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI0LTEzLTEtMS0zNjQwNjA_7c70ef2c-1f0a-4f68-9a4b-6fe7e96fbb14"
      unitRef="eur">617000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i214d7e38fa714fa9b73acc2b9f341911_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTItMS0xLTM2NDA2MA_5fd9589e-b231-4d60-a09f-012040ba31ec"
      unitRef="eur">555000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia473b953f05b4b35b5b13789c70d761c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTMtMS0xLTM2NDA2MA_89b4f2c4-a930-484e-ab11-88ecfd04c057"
      unitRef="eur">212000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ic6e4519162104b64a22cc688d15044cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTQtMS0xLTM2NDA2MA_703b96fc-0610-45fd-a88e-84da36639bff"
      unitRef="eur">446000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iacefe436e3af422292acb5714b1bb8b4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTUtMS0xLTM2NDA2MA_93295a7c-9567-46b1-801d-37b6630570fe"
      unitRef="eur">1213000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i259f4b387d9c42eb93ef585b678f7f77_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTYtMS0xLTM2NDA2MA_0414d2bc-5942-46f6-82a1-fb51bc1dba2a"
      unitRef="eur">515000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id551965a5ec24ec7b5833702fead3db8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTctMS0xLTM2NDA2MA_488945f5-e9ac-4ed3-96c1-4e1c9c2708f2"
      unitRef="eur">196000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i116a1c4972304262b4654d3e3720dd45_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTgtMS0xLTM2NDA2MA_7e9021ad-592f-4c58-a661-3535df9c3cf2"
      unitRef="eur">382000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i78407570f0dd4b788e9539bca72b8480_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTktMS0xLTM2NDA2MA_d7f38d03-e791-4640-afed-1a5735d7ed24"
      unitRef="eur">1093000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9539a37f5b634f80a45b018298a7e6bf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTEwLTEtMS0zNjQwNjA_c07d9e79-1f4d-4071-90ef-64f7b249cec8"
      unitRef="eur">481000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1a60f0418a2945d6816d55ba2ee00395_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTExLTEtMS0zNjQwNjA_d65e040d-e3f0-4389-b1bf-8ea049edd420"
      unitRef="eur">181000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3637ba1108d64738a99a8947658367e5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTEyLTEtMS0zNjQwNjA_846d1a9c-e266-4bc1-97cd-ae9520882233"
      unitRef="eur">389000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4cb20a306adc460d867ea28b00dea2fc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI1LTEzLTEtMS0zNjQwNjA_a2743b46-e692-4d60-b13d-24fdcdb06256"
      unitRef="eur">1051000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i756f63fcc9aa4b528eaafce6b9d10810_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTItMS0xLTM2NDA2MA_de870741-0c7f-41b0-b052-2c4fd7fffcc7"
      unitRef="eur">432000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1680427a219746dd8d52e2b51d87bbeb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTMtMS0xLTM2NDA2MA_5ff179e9-65a5-4e4e-a8ce-5b59f1646d86"
      unitRef="eur">144000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia572af328eb04f15a08f4b4be0b3c642_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTQtMS0xLTM2NDA2MA_9fecec74-a157-40de-abab-40a66de210e7"
      unitRef="eur">742000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i122e1cf42c504ef281c0148bcb08bfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTUtMS0xLTM2NDA2MA_ee093325-8ad3-4a24-bdb7-75ead3909bba"
      unitRef="eur">1318000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i90e43d267391440f976deaffa7f1ee2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTYtMS0xLTM2NDA2MA_8be36a96-da86-44b5-a387-1233f22d63f3"
      unitRef="eur">389000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia15f03b10746440791e34cb56493eec6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTctMS0xLTM2NDA2MA_00bf775d-aac0-47ae-909d-d80011daa126"
      unitRef="eur">124000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i22e0e6e055ed470d9bf214946d58ab2d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTgtMS0xLTM2NDA2MA_5443c9c2-c688-478a-9c4f-c933aebddbdb"
      unitRef="eur">618000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ia8ac8b1054ed482a8e8960303293a8d7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTktMS0xLTM2NDA2MA_8451a1c1-cf96-4627-9553-dd35f4512373"
      unitRef="eur">1131000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i329b514f506f477d9329c03ae9d60a33_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTEwLTEtMS0zNjQwNjA_3c81612e-f84d-409f-816a-3e898cab732b"
      unitRef="eur">371000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i60bd3898aea54bd1923c045dc3905730_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTExLTEtMS0zNjQwNjA_e5c2ad31-1f11-43e2-8529-50e063b54bf1"
      unitRef="eur">85000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i01fe34367f704a4d9280d0e481946add_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTEyLTEtMS0zNjQwNjA_d7245dff-2b61-4fdc-9dd4-88419e7827a3"
      unitRef="eur">532000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i48f608014a524624a2b5d9789797f352_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI2LTEzLTEtMS0zNjQwNjA_3ae0a806-d1e4-4264-906e-3554b942d9ed"
      unitRef="eur">988000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i6e829ee2f99a465ab88b9472b399fb82_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTItMS0xLTM2NDA2MA_75378073-89a8-4475-8236-c594ccf4217b"
      unitRef="eur">9999000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTMtMS0xLTM2NDA2MA_f2c0cd6c-e60d-4f5d-ba61-5a8381d2d8bc"
      unitRef="eur">18275000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i1d62960d62de4d168f734a97be14a478_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTQtMS0xLTM2NDA2MA_a51da84c-d8ea-401b-af4a-4ebff1f2ff59"
      unitRef="eur">14723000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTUtMS0xLTM2NDA2MA_996427fa-d5ac-4dbe-82d8-e91f43f9ae54"
      unitRef="eur">42997000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ibf60334e241640fe96a7903ed2e9b3ad_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTYtMS0xLTM2NDA2MA_b30340b1-ad54-47c5-a033-fa7c18c08a55"
      unitRef="eur">9759000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTctMS0xLTM2NDA2MA_c45bb618-e953-4a57-8c4f-c0775f7ce441"
      unitRef="eur">14385000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i2f77a621c718482c8212f4c353b4d1b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTgtMS0xLTM2NDA2MA_2ff1d6ed-15bb-4870-8cc5-8bad0fe52ef3"
      unitRef="eur">13617000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTktMS0xLTM2NDA2MA_513a695b-2342-419b-aeb0-1249364dc542"
      unitRef="eur">37761000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id0034d62b9984b9c819c9089b17c9dff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTEwLTEtMS0zNjQwNjA_eab9b3d6-044a-4bd4-81ec-50c09c3b8fa8"
      unitRef="eur">9151000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTExLTEtMS0zNjQwNjA_2a8a9c97-4957-4dba-91cd-4061118237da"
      unitRef="eur">13465000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i6a8f83aca4714f6ab0e8c9bb8b1a50a2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTEyLTEtMS0zNjQwNjA_c0d4f3b2-c809-441e-8837-829d458a15b0"
      unitRef="eur">13425000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo1OTQ4MWE1Y2U5MTQ0YzQ0YTI3OTcxZDFjYjdlZGZhYy90YWJsZXJhbmdlOjU5NDgxYTVjZTkxNDRjNDRhMjc5NzFkMWNiN2VkZmFjXzI3LTEzLTEtMS0zNjQwNjA_1abd459e-e8d7-441b-bcaf-5e7137029f7b"
      unitRef="eur">36041000000</ifrs-full:RevenueFromSaleOfGoods>
    <sny:NonCurrentFinancialAssetsNumberOfShares
      contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzYxMDg_651fa2c9-5787-4f81-961d-09b98e016c80"
      unitRef="shares">400000</sny:NonCurrentFinancialAssetsNumberOfShares>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDU5_e5a958b4-db1f-4a94-a56a-4e98d11a252e">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows Sanofi&#x2019;s segment results for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;30,688&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,229&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,080&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;42,997&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and general expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10,492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other operating income and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Business operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,043&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,168&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,810&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,040&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;a) This caption reconciles segment financial information to total consolidated financial information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;26,970&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,323&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,468&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;37,761&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,251)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(712)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(497)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and general expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,326)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(805)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other operating income and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(946)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Business operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,409&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,609&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,493&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(2,797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,714&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;This caption reconciles segment financial information to total consolidated financial information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;25,674&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,973&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,394&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36,041&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(682)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(524)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and general expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(789)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,419)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other operating income and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(487)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Business operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,207&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,336&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,410&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,759&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 figures have been adjusted to take account of the reallocation of certain expenses (in particular IT costs related to Sanofi&#x2019;s new digital organization) from the Pharmaceuticals, Vaccines and Consumer Healthcare operating segments to the &#x201c;Other&#x201d; segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;Includes the impact of the April&#160;2021 IFRIC agenda decision on the allocation of benefits to service periods, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) This caption reconciles segment financial information to total consolidated financial information.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzItMS0xLTEtMzY0MDYw_daf4398d-4775-4c8e-ac92-26a1bf60d45a"
      unitRef="eur">30688000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzItMi0xLTEtMzY0MDYw_4a6513ef-6957-4184-a15c-4f794095c073"
      unitRef="eur">7229000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzItMy0xLTEtMzY0MDYw_796abecd-0da9-47c6-bc2e-2f1236ee537d"
      unitRef="eur">5080000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzItNC0xLTEtMzY0MDYw_7db22e56-2de3-4295-9ce4-8ca1ef9c62b6"
      unitRef="eur">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzItNS0xLTEtMzY0MDYw_ed0de674-2607-486f-9dda-f17cdda760b8"
      unitRef="eur">42997000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:OtherRevenue
      contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzMtMS0xLTEtMzY0MDYw_1173e3f8-da66-4026-88ca-c26504162f6c"
      unitRef="eur">657000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzMtMi0xLTEtMzY0MDYw_033dee1f-62ab-4c37-a9dd-cdea918f1df3"
      unitRef="eur">1666000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzMtMy0xLTEtMzY0MDYw_73c1cf8f-3a1e-42b9-ac2e-a10e7e8a524d"
      unitRef="eur">62000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzMtNC0xLTEtMzY0MDYw_d7764683-48d3-4087-b614-90f264699d3c"
      unitRef="eur">7000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzMtNS0xLTEtMzY0MDYw_c501555f-940c-4391-9c23-1ce0082eae8d"
      unitRef="eur">2392000000</ifrs-full:OtherRevenue>
    <ifrs-full:CostOfSales
      contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzQtMS0xLTEtMzY0MDYw_64e81359-dfd8-4a0f-9339-2925daa30580"
      unitRef="eur">7511000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzQtMi0xLTEtMzY0MDYw_3fa2d7cd-ef35-4ffe-a937-f29c5d92682d"
      unitRef="eur">4101000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzQtMy0xLTEtMzY0MDYw_7660f46e-8866-4215-8879-4060ca21a687"
      unitRef="eur">1827000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzQtNC0xLTEtMzY0MDYw_fdbb9e13-8510-41e9-b454-0778276d78ed"
      unitRef="eur">253000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzQtNS0xLTEtMzY0MDYw_270a8e40-57f6-45a1-9294-1f196cd91116"
      unitRef="eur">13692000000</ifrs-full:CostOfSales>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzUtMS0xLTEtMzY0MDYw_3eb03316-e4c3-4ad6-aeef-07ff3f451438"
      unitRef="eur">5067000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzUtMi0xLTEtMzY0MDYw_41987df5-f681-4202-ae47-b2044804126e"
      unitRef="eur">936000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzUtMy0xLTEtMzY0MDYw_5070edaf-b256-4e46-9964-0ac64dacc90d"
      unitRef="eur">187000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzUtNC0xLTEtMzY0MDYw_278de198-c574-46cc-99d0-108e64f7cac9"
      unitRef="eur">516000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzUtNS0xLTEtMzY0MDYw_568f617a-f3fc-40b9-bca8-13ed6cdd79e7"
      unitRef="eur">6706000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzYtMS0xLTEtMzY0MDYw_2871905b-3ba2-4123-a14f-ed4582e88899"
      unitRef="eur">5923000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzYtMi0xLTEtMzY0MDYw_ffd5b6e6-25cb-4add-a311-aff4b6aadb23"
      unitRef="eur">870000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzYtMy0xLTEtMzY0MDYw_ee80536f-1199-4591-814c-05d1f5436045"
      unitRef="eur">1478000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzYtNC0xLTEtMzY0MDYw_cf619c5b-b70e-46a4-a1e3-21803a02271e"
      unitRef="eur">2221000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzYtNS0xLTEtMzY0MDYw_bca4fa10-a24e-4118-ab9e-2551de1e7761"
      unitRef="eur">10492000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzctMS0xLTEtMzY0MDYw_f56cefe6-b7e6-4f00-ba08-36005483e543"
      unitRef="eur">-1800000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzctMi0xLTEtMzY0MDYw_eeca744a-a5f0-4759-972b-f7a3ec5eec0b"
      unitRef="eur">132000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzctMy0xLTEtMzY0MDYw_d7a5ec4e-8761-4ff5-a0b2-dbd99d7baf96"
      unitRef="eur">152000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzctNC0xLTEtMzY0MDYw_bcaea117-f09f-4ba3-abd1-1932882a6325"
      unitRef="eur">2000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzctNS0xLTEtMzY0MDYw_dfaa0a19-8196-47cf-abd7-24c0aeb24cfd"
      unitRef="eur">-1514000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzgtMS0xLTEtMzY0MDYw_10b0fab6-fe7f-428e-be4b-c4c29187658d"
      unitRef="eur">28000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzgtMi0xLTEtMzY0MDYw_93747d48-ea92-451a-a8ce-c259f9a42d98"
      unitRef="eur">48000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzgtMy0xLTEtMzY0MDYw_d27e0966-a06c-4e3c-8534-e0c354b21626"
      unitRef="eur">12000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzgtNC0xLTEtMzY0MDYw_8a29a972-69db-4995-8643-b604a7272894"
      unitRef="eur">0</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzgtNS0xLTEtMzY0MDYw_52277fe5-6f3c-4f46-a9e9-2217f0ae8095"
      unitRef="eur">88000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzktMS0xLTEtMzY0MDYw_a59dfdec-a5ca-4f0f-bfe9-b8867504f6ba"
      unitRef="eur">-29000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzktMi0xLTEtMzY0MDYw_776f5fb5-8755-49f2-a2b0-795fc88847f0"
      unitRef="eur">0</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzktMy0xLTEtMzY0MDYw_da4b950c-f8e0-4157-9b44-71a8eb68e670"
      unitRef="eur">-4000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzktNC0xLTEtMzY0MDYw_afd9894f-122f-4a4f-bbf1-211d0c66032d"
      unitRef="eur">0</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzktNS0xLTEtMzY0MDYw_29de6495-cc68-4ee2-a785-3f69d8354f37"
      unitRef="eur">-33000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <sny:BusinessOperatingIncome
      contextRef="ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzEwLTEtMS0xLTM2NDA2MA_2f0d549b-6571-4548-a5b5-28ceb031b161"
      unitRef="eur">11043000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="i4a78337d06d8433b9637916651d1c25c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzEwLTItMS0xLTM2NDA2MA_2e669a06-33c8-4af9-83c0-4963b822f535"
      unitRef="eur">3168000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzEwLTMtMS0xLTM2NDA2MA_102210b0-c308-469a-b91d-543b03642c2f"
      unitRef="eur">1810000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="i3400db5fdada4a398d6f6f4ad940cf0e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzEwLTQtMS0xLTM2NDA2MA_d9501d51-667e-48ec-96f0-81b7d44b3210"
      unitRef="eur">-2981000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTozZjViNzM1NmNjMjY0MjA2YTM3ODUzNmI5ZWZlYmJjOC90YWJsZXJhbmdlOjNmNWI3MzU2Y2MyNjQyMDZhMzc4NTM2YjllZmViYmM4XzEwLTUtMS0xLTM2NDA2MA_edb3a615-66da-4e3a-91e8-4e9f7d4c39b3"
      unitRef="eur">13040000000</sny:BusinessOperatingIncome>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzItMS0xLTEtMzY0MDYw_722683e4-c937-446c-8444-a2712e971112"
      unitRef="eur">26970000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzItMi0xLTEtMzY0MDYw_9967ab85-b928-4af8-9c10-17c58f023dc8"
      unitRef="eur">6323000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzItMy0xLTEtMzY0MDYw_daa0aa1c-f3ec-4fa7-9956-1b839f8b0c2f"
      unitRef="eur">4468000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzItNC0xLTEtMzY0MDYw_5254a5e6-a867-488b-9c5e-815e20ddfa6d"
      unitRef="eur">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzItNS0xLTEtMzY0MDYw_3e561c49-09c0-470a-ba6f-be44ed11540b"
      unitRef="eur">37761000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:OtherRevenue
      contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzMtMS0xLTEtMzY0MDYw_03dca851-9864-4a08-b516-9234303f2c90"
      unitRef="eur">264000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzMtMi0xLTEtMzY0MDYw_a5fa83c8-aa7e-4199-92f8-a92200f2e696"
      unitRef="eur">1095000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzMtMy0xLTEtMzY0MDYw_1a0345af-f5e0-4ed5-a303-dad4af9cc08a"
      unitRef="eur">55000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzMtNC0xLTEtMzY0MDYw_efdabf40-6224-4391-b35b-503335cbec16"
      unitRef="eur">0</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzMtNS0xLTEtMzY0MDYw_b9a7ec3a-5e63-4f89-b95b-5f87c67e7813"
      unitRef="eur">1414000000</ifrs-full:OtherRevenue>
    <ifrs-full:CostOfSales
      contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzQtMS0xLTEtMzY0MDYw_d95b92cd-24c4-4d8c-af99-1539b423234d"
      unitRef="eur">6965000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzQtMi0xLTEtMzY0MDYw_be56f4f3-fcb4-443f-9278-a7ca7f2962a9"
      unitRef="eur">3430000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzQtMy0xLTEtMzY0MDYw_e4bd7265-fddb-4cc1-a364-d92bd7168d2d"
      unitRef="eur">1606000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzQtNC0xLTEtMzY0MDYw_4730fa24-e060-4267-89d6-b94735d9c14c"
      unitRef="eur">250000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzQtNS0xLTEtMzY0MDYw_d80fa903-57a9-4058-8051-3efab3897a2a"
      unitRef="eur">12251000000</ifrs-full:CostOfSales>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzUtMS0xLTEtMzY0MDYw_07834c5b-a2cb-4705-af08-56824f44cdee"
      unitRef="eur">4330000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzUtMi0xLTEtMzY0MDYw_cb9f5eee-8e06-4706-8a83-d0480a320138"
      unitRef="eur">712000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzUtMy0xLTEtMzY0MDYw_15c3a473-3864-4849-96a7-187092b5669b"
      unitRef="eur">153000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzUtNC0xLTEtMzY0MDYw_16015e3a-057b-4419-b627-450096a6b2bb"
      unitRef="eur">497000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzUtNS0xLTEtMzY0MDYw_5f9f9a9b-54e6-445a-ae2d-6c1401ac05fc"
      unitRef="eur">5692000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzYtMS0xLTEtMzY0MDYw_a0e85aa6-ee2f-4a4d-b32c-9f6269f7a949"
      unitRef="eur">5326000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzYtMi0xLTEtMzY0MDYw_2fa7102c-548d-4de4-ab20-e19aa789bdfd"
      unitRef="eur">805000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzYtMy0xLTEtMzY0MDYw_100780e8-cc39-4b3c-87cd-6579ccbb1d43"
      unitRef="eur">1388000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzYtNC0xLTEtMzY0MDYw_6c19fa01-7960-489f-8f66-80b90c0ce068"
      unitRef="eur">2036000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzYtNS0xLTEtMzY0MDYw_8145dae8-41d7-4f6b-bffa-3cf4c0841676"
      unitRef="eur">9555000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzctMS0xLTEtMzY0MDYw_dc6d1699-c042-44a9-bfec-518e34756faf"
      unitRef="eur">-1172000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzctMi0xLTEtMzY0MDYw_da314ea3-da27-4d05-9eae-f238c73e1158"
      unitRef="eur">128000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzctMy0xLTEtMzY0MDYw_4168934f-7a6c-4685-a290-40dcd7e74dde"
      unitRef="eur">111000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzctNC0xLTEtMzY0MDYw_53ee4fd7-12bc-4c0b-9042-4722edadd36e"
      unitRef="eur">-13000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzctNS0xLTEtMzY0MDYw_2f03848d-3e2b-4738-bc80-f9824b48452b"
      unitRef="eur">-946000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzgtMS0xLTEtMzY0MDYw_d6d8e2cc-c2b3-4830-8714-320afeb05c67"
      unitRef="eur">17000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzgtMi0xLTEtMzY0MDYw_40f94fbb-2bef-4f56-9881-128bf23d6199"
      unitRef="eur">11000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzgtMy0xLTEtMzY0MDYw_8d241f9b-1597-40d9-aa38-f1a43a253252"
      unitRef="eur">11000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzgtNC0xLTEtMzY0MDYw_00c6844c-ed7a-455a-a0c0-36090ec256a8"
      unitRef="eur">0</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzgtNS0xLTEtMzY0MDYw_4dea8a8a-37b6-4d29-8382-a96fde10b2b1"
      unitRef="eur">39000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzktMS0xLTEtMzY0MDYw_2f5341bd-477e-46d7-825e-24997cd69fb5"
      unitRef="eur">-49000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzktMi0xLTEtMzY0MDYw_5e024f6a-20e5-4fc6-b0f0-1f6d41060412"
      unitRef="eur">-1000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzktMy0xLTEtMzY0MDYw_e027e0ca-30e2-4725-8f42-ba39f0cc43a6"
      unitRef="eur">-5000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzktNC0xLTEtMzY0MDYw_63cabbdb-c752-4da1-8291-9a60ef658506"
      unitRef="eur">-1000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzktNS0xLTEtMzY0MDYw_9e340624-7770-489a-8c32-f467d0e9ac2c"
      unitRef="eur">-56000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <sny:BusinessOperatingIncome
      contextRef="i5a3f1ed6666e461ab7862353f667c7d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzEwLTEtMS0xLTM2NDA2MA_d3fae6af-9b22-4c1f-9880-4114a2e4c119"
      unitRef="eur">9409000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="i40febd3d66474776a524d16537fa2dd4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzEwLTItMS0xLTM2NDA2MA_b3c3d801-86c1-4525-a9df-d1801217ba0c"
      unitRef="eur">2609000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzEwLTMtMS0xLTM2NDA2MA_4ce35214-8354-491e-aaaf-f045ce36b062"
      unitRef="eur">1493000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="ic2aaaaf75d834101a3050927ae17d2c8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzEwLTQtMS0xLTM2NDA2MA_8276c4c1-1522-4a2e-abaa-e9156f4e6c0b"
      unitRef="eur">-2797000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpmZGVkYjY5ZGI0Yjk0N2U4YTgzNTZmMTk3OTFkZGEwMS90YWJsZXJhbmdlOmZkZWRiNjlkYjRiOTQ3ZThhODM1NmYxOTc5MWRkYTAxXzEwLTUtMS0xLTM2NDA2MA_738c98a8-8563-4f02-b654-bc19ccc2ac0e"
      unitRef="eur">10714000000</sny:BusinessOperatingIncome>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzItMS0xLTEtMzY0MDYw_fc0baa6d-7fc4-4027-9a74-434212b14893"
      unitRef="eur">25674000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzItMi0xLTEtMzY0MDYw_46cda69b-53ce-4a93-9242-8bf31cdde069"
      unitRef="eur">5973000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzItMy0xLTEtMzY0MDYw_774aef60-0b28-4fef-aee5-20a6425fdec4"
      unitRef="eur">4394000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzItNC0xLTEtMzY0MDYw_aefd9867-2e92-474c-aff0-ec1327574caf"
      unitRef="eur">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzItNS0xLTEtMzY0MDYw_593dee01-210b-4ad2-9f93-1c6a9861f8ce"
      unitRef="eur">36041000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:OtherRevenue
      contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzMtMS0xLTEtMzY0MDYw_7e71cff7-0252-4475-893f-f3c46ac95253"
      unitRef="eur">128000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzMtMi0xLTEtMzY0MDYw_6aa53a96-9f71-420a-ae82-3793cfddc69e"
      unitRef="eur">1141000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzMtMy0xLTEtMzY0MDYw_608dc93e-2d9f-467f-bd1f-76d9a1601505"
      unitRef="eur">59000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzMtNC0xLTEtMzY0MDYw_4a6bfb59-a593-421c-8317-20b25d6dd3be"
      unitRef="eur">0</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzMtNS0xLTEtMzY0MDYw_1bbe6b9d-6b0c-45f6-b512-e42ab5d8c345"
      unitRef="eur">1328000000</ifrs-full:OtherRevenue>
    <ifrs-full:CostOfSales
      contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzQtMS0xLTEtMzY0MDYw_a1483f78-9f36-42a1-b5d7-7771a2bcb8da"
      unitRef="eur">6982000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzQtMi0xLTEtMzY0MDYw_2109ee5e-31cb-46e7-9b83-ea58b55f5894"
      unitRef="eur">3312000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzQtMy0xLTEtMzY0MDYw_913b76cb-da03-465d-8eb6-e3af163f5da9"
      unitRef="eur">1528000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzQtNC0xLTEtMzY0MDYw_36c7de2d-fdc5-4a96-bd3e-ca04af947da9"
      unitRef="eur">284000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzQtNS0xLTEtMzY0MDYw_2f663c60-8e03-4755-8559-dfc0cc10f6b7"
      unitRef="eur">12106000000</ifrs-full:CostOfSales>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzUtMS0xLTEtMzY0MDYw_c6b78802-f713-44ce-9367-04881d55ee26"
      unitRef="eur">4171000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzUtMi0xLTEtMzY0MDYw_5684ecda-d65b-4e54-b110-cee63a3e9305"
      unitRef="eur">682000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzUtMy0xLTEtMzY0MDYw_44812421-c3f4-47fb-bf05-493c370dd23e"
      unitRef="eur">153000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzUtNC0xLTEtMzY0MDYw_541d7668-a28c-47e6-8de6-5a4d3b4dce77"
      unitRef="eur">524000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzUtNS0xLTEtMzY0MDYw_7d465ccf-76e2-4aa9-84ad-b95988d2ff1c"
      unitRef="eur">5530000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzYtMS0xLTEtMzY0MDYw_5bfcc1d1-7e02-4f7d-b930-55a2da2fc772"
      unitRef="eur">4927000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzYtMi0xLTEtMzY0MDYw_bb67ccf7-d6d4-4230-b3d9-48aefe05c026"
      unitRef="eur">789000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzYtMy0xLTEtMzY0MDYw_b524df3a-ea54-4f48-bee0-817b0754d7c2"
      unitRef="eur">1419000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzYtNC0xLTEtMzY0MDYw_0cbf6db5-7560-4b9d-a30c-e5b02edd14f7"
      unitRef="eur">2256000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzYtNS0xLTEtMzY0MDYw_f23137aa-1f13-4d57-85b8-89e556cf1638"
      unitRef="eur">9391000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzctMS0xLTEtMzY0MDYw_36d20614-7dc6-4b70-b3b1-e61a5eb4cb66"
      unitRef="eur">-487000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzctMi0xLTEtMzY0MDYw_a099af1e-36a4-45d6-8a6f-0b1255f8f65a"
      unitRef="eur">3000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzctMy0xLTEtMzY0MDYw_caaff323-956f-47e1-84fd-659b7c8194a4"
      unitRef="eur">53000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzctNC0xLTEtMzY0MDYw_80484aa4-d0fb-4c01-b764-7ad23fa623f3"
      unitRef="eur">-130000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzctNS0xLTEtMzY0MDYw_90e6c902-15e0-495a-911b-f1c35606219e"
      unitRef="eur">-561000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzgtMS0xLTEtMzY0MDYw_81448c33-cd29-4e2f-b684-7e8911e6e170"
      unitRef="eur">5000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzgtMi0xLTEtMzY0MDYw_539a39cd-588d-41a1-aee3-c6cacecef19f"
      unitRef="eur">2000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzgtMy0xLTEtMzY0MDYw_d566bc8f-ba6d-4990-bafa-73070857611e"
      unitRef="eur">9000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzgtNC0xLTEtMzY0MDYw_70b84172-0271-4691-b857-a02c02080d9c"
      unitRef="eur">0</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzgtNS0xLTEtMzY0MDYw_591eb7d7-86bd-4e18-ba54-9874247a7c1b"
      unitRef="eur">16000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzktMS0xLTEtMzY0MDYw_45635301-25bc-41aa-b469-34dda2880462"
      unitRef="eur">-33000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzktMi0xLTEtMzY0MDYw_80570e53-62ad-47c6-8b9d-81e0283a0e93"
      unitRef="eur">0</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzktMy0xLTEtMzY0MDYw_7b83e069-c7c0-45f8-ba3d-05ed6f09e83a"
      unitRef="eur">-5000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzktNC0xLTEtMzY0MDYw_0f29a7e3-cda5-4e62-ab0e-f0055040c1a8"
      unitRef="eur">0</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzktNS0xLTEtMzY0MDYw_780ad07f-895e-406d-9569-a60854389cd9"
      unitRef="eur">-38000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <sny:BusinessOperatingIncome
      contextRef="i14159df791e342a8b0cb4b7dae15cad1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzEwLTEtMS0xLTM2NDA2MA_82a350d8-5229-42d8-9b41-c8b0816a7164"
      unitRef="eur">9207000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="iaff535bbab1e42a9b480947c1fc358d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzEwLTItMS0xLTM2NDA2MA_67a2930b-921f-423d-971f-e46c952fac54"
      unitRef="eur">2336000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzEwLTMtMS0xLTM2NDA2MA_43eaf992-22bc-4d66-8804-66755b71ceac"
      unitRef="eur">1410000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="ib188812bb76c43d7857e0ec6dc6f46be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzEwLTQtMS0xLTM2NDA2MA_40fd3c2b-6944-4069-84ba-70bb7fd10d96"
      unitRef="eur">-3194000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTpiYzZhYzBlNjM5Mjc0NjMxYTU5MmZhMjU2NzExNzYxNy90YWJsZXJhbmdlOmJjNmFjMGU2MzkyNzQ2MzFhNTkyZmEyNTY3MTE3NjE3XzEwLTUtMS0xLTM2NDA2MA_b6dd9495-6876-47b1-8a5f-3f0d0395d8b3"
      unitRef="eur">9759000000</sny:BusinessOperatingIncome>
    <sny:DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDU0_f48b2bd0-d7b2-4bbb-8ce9-c5ffb2247d71">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below, presented in compliance with IFRS&#160;8, shows a reconciliation between aggregated &#x201c;Business operating income&#x201d; for the segments and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt; Income before tax and investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.676%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(h)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Business operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,040&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,714&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,759&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization and impairment of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value remeasurement of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expenses arising from the impact of acquisitions on inventories&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Restructuring costs and similar items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(820)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other gains and losses, and litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gain on divestment of Regeneron shares on May&#160;29, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(f)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income from out-licensing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(g)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,656&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,126&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,113&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Financial expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Financial income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Income before tax and investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,422&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,798&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,778&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Excludes restructuring costs relating to investments accounted for using the equity method and expenses arising from the impact of acquisitions on investments accounted for using the equity method. For the first two quarters of 2020, this line has been restated to exclude any effect of equity method accounting for the investment in Regeneron following the divestment of Sanofi's entire equity interest (with the exception of the 400,000&#160;shares retained by Sanofi) on May&#160;29, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to non-controlling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) For 2022, this line includes a reversal of &#x20ac;2,154&#160;million on Eloctate franchise products following FDA approval of ALTUVIIIO &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;TM &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;dated February 22, 2023, partially offset by an impairment of &#x20ac;1,586&#160;million relating to the development project for SAR444245 (non-alpha interleukin-2).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(d) This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(e) For 2020, this line mainly comprises the gain on the sale of operations related to the Seprafilm&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; activity to Baxter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(f) This line includes the gain on the sale of (i)&#160;13&#160;million shares of Regeneron common stock in the registered public offering and (ii)&#160;the 9.8&#160;million shares repurchased by Regeneron, but does not include the gain arising from the remeasurement of the 400,000&#160;retained shares at market value as of&#160;May&#160;29,&#160;2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(g&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;)&#160;&#160;&#160;&#160;For 2022, this line includes an upfront payment of $900 million and a regulatory milestone payment of $100 million related to the out-licensing of Libtayo&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt; following the restructuring of the Immuno-Oncology Collaboration and License Agreement with Regeneron (see Note&#160;C.1.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(h) Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock>
    <sny:BusinessOperatingIncome
      contextRef="i013162020a33403bb8ab3a5b4d6acf5b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEtMS0xLTEtMzY0MDYw_3a8d6eb1-8890-4286-b3bf-7f3bb7977849"
      unitRef="eur">13040000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="i86bdcc50c470440b9f04a89cc25fc25e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEtMi0xLTEtMzY0MDYw_db4c0258-50f9-4efc-a8ab-bd0ce71b71c8"
      unitRef="eur">10714000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="i10a2eadc160a461e8aa95a317634efc4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEtNC0xLTEtMzY0MDYw_3f383401-851f-43e0-8b83-f5dcac27d942"
      unitRef="eur">9759000000</sny:BusinessOperatingIncome>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzItMS0xLTEtMzY0MDYw_2720d3cb-f6bd-4ed1-854f-bec48a6e5791"
      unitRef="eur">-88000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzItMi0xLTEtMzY0MDYw_5e4126e2-11a1-459b-b7a7-1734e1e04c1e"
      unitRef="eur">-39000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzItNC0xLTEtMzY0MDYw_91f1e052-f0a0-4cd6-a105-d57456e0e2f6"
      unitRef="eur">-16000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzMtMS0xLTEtMzY0MDYw_9a1424c5-b300-4b87-9f1b-255b8bb5c71a"
      unitRef="eur">33000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzMtMi0xLTEtMzY0MDYw_ac1fca66-0366-48c1-8674-1aa0a194c6f6"
      unitRef="eur">56000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzMtNC0xLTEtMzY0MDYw_71dea521-721b-4e98-bdad-adf2df295a4b"
      unitRef="eur">38000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill
      contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzQtMS0xLTEtMzY0MDYw_f3698bad-331f-4905-8a07-b3904f8792cb"
      unitRef="eur">1599000000</sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill>
    <sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill
      contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzQtMi0xLTEtMzY0MDYw_dd5d947c-2cb3-414e-be03-965fc38babf8"
      unitRef="eur">1772000000</sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill>
    <sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill
      contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzQtNC0xLTEtMzY0MDYw_4ad5657a-ac1d-4aaf-a628-ef222aaaae17"
      unitRef="eur">2011000000</sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability
      contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzUtMS0xLTEtMzY0MDYw_ffd332fb-09e3-4ab1-b8b3-81c88fe45781"
      unitRef="eur">27000000</ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability>
    <ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability
      contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzUtMi0xLTEtMzY0MDYw_110495ec-116d-496a-b69d-84f3ebc4ed45"
      unitRef="eur">-4000000</ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability>
    <ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability
      contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzUtNC0xLTEtMzY0MDYw_feeca2c3-c6d6-4de2-b717-2f0a176995dd"
      unitRef="eur">124000000</ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability>
    <sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories
      contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzYtMS0xLTEtMzY0MDYw_a4bfa685-64ee-4e81-a0fa-1c508c6dedb3"
      unitRef="eur">3000000</sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories>
    <sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories
      contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzYtMi0xLTEtMzY0MDYw_03f298d9-8520-4f8f-90fa-c8816303ae53"
      unitRef="eur">4000000</sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories>
    <sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories
      contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzYtNC0xLTEtMzY0MDYw_9ef15954-d8ac-480e-9ab3-c791a33d0a8a"
      unitRef="eur">53000000</sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzctMS0xLTEtMzY0MDYw_ea7b8733-1919-4d64-9e15-afd5c5e77ef4"
      unitRef="eur">1336000000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzctMi0xLTEtMzY0MDYw_dd0af69a-e284-4dca-8c3e-42a2cde5145b"
      unitRef="eur">820000000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzctNC0xLTEtMzY0MDYw_2960f8d1-17b8-4d70-886d-0da17abab1c0"
      unitRef="eur">1089000000</ifrs-full:ExpenseOfRestructuringActivities>
    <sny:OtherGainsLossesAndLitigation
      contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzktMS0xLTEtMzY0MDYw_32eda327-8dae-4df0-9bad-7e36e06a0283"
      unitRef="eur">-370000000</sny:OtherGainsLossesAndLitigation>
    <sny:OtherGainsLossesAndLitigation
      contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzktMi0xLTEtMzY0MDYw_56b273c4-5153-494f-8328-54a1e7f96452"
      unitRef="eur">-5000000</sny:OtherGainsLossesAndLitigation>
    <sny:OtherGainsLossesAndLitigation
      contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzktNC0xLTEtMzY0MDYw_25a1452f-953c-4a2b-8d7c-dedda92ec7eb"
      unitRef="eur">136000000</sny:OtherGainsLossesAndLitigation>
    <sny:GainOnRegeneronInvestmentSold
      contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEwLTEtMS0xLTM2NDA2MA_e42a20ce-0253-4a7f-b5e0-c84d4fafcc8f"
      unitRef="eur">0</sny:GainOnRegeneronInvestmentSold>
    <sny:GainOnRegeneronInvestmentSold
      contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEwLTItMS0xLTM2NDA2MA_daee5277-47d6-4bed-9f1b-298fd2393464"
      unitRef="eur">0</sny:GainOnRegeneronInvestmentSold>
    <sny:GainOnRegeneronInvestmentSold
      contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEwLTQtMS0xLTM2NDA2MA_79cce99f-e962-48af-b57e-f827847f9d15"
      unitRef="eur">7225000000</sny:GainOnRegeneronInvestmentSold>
    <sny:IncomeResultingFromOutLicensing
      contextRef="i2bd0a70846ce4eb28ba590eb8c1430ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTEtMS0xLTQ0NzkwOA_76c8981a-8eb6-4fa8-b698-e0d6d3d1fb57"
      unitRef="eur">952000000</sny:IncomeResultingFromOutLicensing>
    <sny:IncomeResultingFromOutLicensing
      contextRef="i9f03479b2b8b405ab38882e4ff07b4e6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTItMS0xLTQ0NzkwOA_fbb12f5a-b8a6-4243-98da-5a3167f9d6d4"
      unitRef="eur">0</sny:IncomeResultingFromOutLicensing>
    <sny:IncomeResultingFromOutLicensing
      contextRef="ia972a79408e243f5b76125dd64d24bc8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTQtMS0xLTQ0NzkxNg_980e21af-44a5-4f43-af5d-0b34276f50e9"
      unitRef="eur">0</sny:IncomeResultingFromOutLicensing>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTEtMS0xLTM2NDA2MA_99498100-fc0b-4375-862f-849e9c29e184"
      unitRef="eur">10656000000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTItMS0xLTM2NDA2MA_b58d4478-534e-451f-a3d4-0e37d34e8ba1"
      unitRef="eur">8126000000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzExLTQtMS0xLTM2NDA2MA_e5374ccc-2d88-49cf-9981-17c21b8f6b01"
      unitRef="eur">14113000000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceCosts
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEyLTEtMS0xLTM2NDA2MA_7a406d8a-594e-442b-8b6d-9d5528bee57f"
      unitRef="eur">440000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEyLTItMS0xLTM2NDA2MA_2128e605-50e8-419f-a501-1c0e3f378d18"
      unitRef="eur">368000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEyLTQtMS0xLTM2NDA2MA_a8392b1a-9940-4b5c-85f6-43da1ccd5946"
      unitRef="eur">388000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncome
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEzLTEtMS0xLTM2NDA2MA_a60a5950-7f61-4746-b594-13e97cff0d91"
      unitRef="eur">206000000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEzLTItMS0xLTM2NDA2MA_d86a2cf4-ad14-472a-b436-d909039011ab"
      unitRef="eur">40000000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzEzLTQtMS0xLTM2NDA2MA_69a16d2d-08bd-463d-9f14-13e5a197d647"
      unitRef="eur">53000000</ifrs-full:FinanceIncome>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzE0LTEtMS0xLTM2NDA2MA_1557d4c8-31da-4675-a490-f386f8fb734b"
      unitRef="eur">10422000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="i6d52ff5a0d014d5d839511defb54a786_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzE0LTItMS0xLTM2NDA2MA_dd8bd87a-8c5d-47fb-86e0-f3a53a00568c"
      unitRef="eur">7798000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo4ZmUxNjkzMzFiYzQ0NWM2OGQxOTM1MWQ0ZTg1YThiNC90YWJsZXJhbmdlOjhmZTE2OTMzMWJjNDQ1YzY4ZDE5MzUxZDRlODVhOGI0XzE0LTQtMS0xLTM2NDA2MA_441554ba-9109-4313-9428-397598f7123b"
      unitRef="eur">13778000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:NonCurrentFinancialAssetsNumberOfShares
      contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzc3NTg_0b8cffe7-cefc-4d16-85be-35b1551a23c0"
      unitRef="shares">400000</sny:NonCurrentFinancialAssetsNumberOfShares>
    <sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount
      contextRef="i9b81437bb0bc49abac2a243bae255b03_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEyMzY5NTA1ODE1Mzg1OQ_4ae5ea8a-913b-45b3-8fd9-79b15ff7fbde"
      unitRef="eur">2154000000</sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount>
    <sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill
      contextRef="i5742d95426994746862eae78944333b8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEyMzY5NTA1ODE1Mzg3NQ_436b699c-711a-4a9b-8e3c-43f2a099a52e"
      unitRef="eur">1586000000</sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill>
    <sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal
      contextRef="id3e2037ecf8e496eaf3ae27c42505f70_D20200529-20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzgyOTQ_d5c046e3-6f1c-4259-901b-8b549aa0285a"
      unitRef="shares">13000000</sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal>
    <sny:SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i5e547fa7f10d4ba49513412e133bcd62_I20200529"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzgzODU_31db2bfc-7133-4e0a-9c71-a902ff7215f1"
      unitRef="shares">9800000</sny:SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction>
    <sny:NonCurrentFinancialAssetsNumberOfShares
      contextRef="ie19b56352bc54cc6a3dff49f358c669e_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzg0OTc_353373fa-0310-4c4e-bb9a-2fe027e893c1"
      unitRef="shares">400000</sny:NonCurrentFinancialAssetsNumberOfShares>
    <sny:UpfrontPaymentsForProjectsUnderCollaborationAgreements
      contextRef="i49530103426b457c9644701cc0be276d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzE5NzkxMjA5MzE0MTE3_456a88dc-12f8-4a53-a24d-a0f5570aa6eb"
      unitRef="usd">900000000</sny:UpfrontPaymentsForProjectsUnderCollaborationAgreements>
    <sny:RegularMilestonePaymentsForProjectsUnderCollaborationAgreements
      contextRef="i49530103426b457c9644701cc0be276d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzE5NzkxMjA5MzE0MTI2_296f92c4-803b-4ffd-89b8-f13a2aee5f80"
      unitRef="usd">100000000</sny:RegularMilestonePaymentsForProjectsUnderCollaborationAgreements>
    <sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDYx_ae277f57-5771-477a-a8eb-f57f34c448b5">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;Acquisitions of intangible assets and property, plant and equipment correspond to acquisitions paid for during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Investments accounted for using the equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vaccines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consumer&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Investments accounted for using the equity method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisitions of other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="iee7cb4947a1c4854876868c8e2fb82d1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzItMS0xLTEtMzY0MDYw_c43b7916-74c8-41fe-b747-cae73b7ece7f"
      unitRef="eur">536000000</sny:InvestmentsInAssociatesAndJointVentures>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="i5146ddfb19c5499c89ad75916030806b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzItMi0xLTEtMzY0MDYw_8de2bd3b-7873-419c-aea8-f0fe6c36b17a"
      unitRef="eur">104000000</sny:InvestmentsInAssociatesAndJointVentures>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="i029d1d8f14bf48ff95eda3b544a4736b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzItMy0xLTEtMzY0MDYw_4d974c37-a7b8-4a85-88c7-8e6ee45c2eee"
      unitRef="eur">37000000</sny:InvestmentsInAssociatesAndJointVentures>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="i3e9e1a94b89044af91d3720935c6c41b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzItNC0xLTEtMzY0MDYw_85172159-f761-41e9-890d-b34d0d1ac7d2"
      unitRef="eur">677000000</sny:InvestmentsInAssociatesAndJointVentures>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="ibb589cf6b30d4f85b2a6924184520710_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzMtMS0xLTEtMzY0MDYw_fcf08fc6-85e8-407d-8626-98715d59b2e1"
      unitRef="eur">1025000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="i50f963fe7eb242389c52c58a27841042_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzMtMi0xLTEtMzY0MDYw_48ad60e5-e956-4eba-958c-a0221cd5bf07"
      unitRef="eur">504000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzMtMy0xLTEtMzY0MDYw_f5f9f2e4-4c1e-4891-b7d2-ea024074dfe8"
      unitRef="eur">77000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzMtNC0xLTEtMzY0MDYw_e0f822a2-f978-4181-b7d9-dfa132664d92"
      unitRef="eur">1606000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="ibb589cf6b30d4f85b2a6924184520710_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzQtMS0xLTEtMzY0MDYw_c9609d00-e3a1-4ce3-9969-7b5768355af5"
      unitRef="eur">463000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="i50f963fe7eb242389c52c58a27841042_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzQtMi0xLTEtMzY0MDYw_503cab0a-0b01-4b28-9975-fed901dd2464"
      unitRef="eur">111000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="i22a56d976f5940dc9a2128c2d82dcfa4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzQtMy0xLTEtMzY0MDYw_9115d069-a4ac-40ec-aa84-48a2c8a87ec3"
      unitRef="eur">21000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="id607765fd9a24117aba1b6f91c3728cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTo5MmMzNTIzMzQ1ODI0NjEzYTcyODE5NDA2MDZhYmZmZC90YWJsZXJhbmdlOjkyYzM1MjMzNDU4MjQ2MTNhNzI4MTk0MDYwNmFiZmZkXzQtNC0xLTEtMzY0MDYw_b01a1ec6-7ff8-435f-8be7-5db0213aabe5"
      unitRef="eur">595000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="ib6b0b143fa7e4ffd8648c6d67f7caaa0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzItMS0xLTEtMzY0MDYw_572db3c4-60ce-4b57-a534-b7832472ed34"
      unitRef="eur">159000000</sny:InvestmentsInAssociatesAndJointVentures>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="i2a2427f9f19e4111a878f552385abb20_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzItMi0xLTEtMzY0MDYw_3b6c6f22-cdbb-4f74-9c62-7a6a3a43ffb5"
      unitRef="eur">91000000</sny:InvestmentsInAssociatesAndJointVentures>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="if3776772d55d454e9e161ef283add8c7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzItMy0xLTEtMzY0MDYw_6b46391f-8b61-4b12-bcee-be341c00fe72"
      unitRef="eur">0</sny:InvestmentsInAssociatesAndJointVentures>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="id755af668f8b430fbfe6cc864db69bba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzItNC0xLTEtMzY0MDYw_9c315893-134d-4594-8c3d-da478d5026cd"
      unitRef="eur">250000000</sny:InvestmentsInAssociatesAndJointVentures>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="idb790736d7c44dc0aece34570e7aa9d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzMtMS0xLTEtMzY0MDYw_8bbb39ee-af92-41ad-87aa-a275065fa902"
      unitRef="eur">1024000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="i8ec69c452bde4d2e9c935c00c627ed10_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzMtMi0xLTEtMzY0MDYw_b43050ea-5693-4813-a79a-37013803bbcc"
      unitRef="eur">382000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzMtMy0xLTEtMzY0MDYw_5b021c05-7c7d-42c2-89a5-8a797aa2a858"
      unitRef="eur">73000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzMtNC0xLTEtMzY0MDYw_18cd10f6-036c-462f-bc6d-e212be5a27b4"
      unitRef="eur">1479000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="idb790736d7c44dc0aece34570e7aa9d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzQtMS0xLTEtMzY0MDYw_29741985-2e92-47d1-9db6-f289c8a85cf7"
      unitRef="eur">450000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="i8ec69c452bde4d2e9c935c00c627ed10_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzQtMi0xLTEtMzY0MDYw_6505e110-754f-484c-a390-93823bae4713"
      unitRef="eur">108000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="i160a858a7079498f8c004e8d186d1063_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzQtMy0xLTEtMzY0MDYw_cbeba79a-2a02-44cf-998a-b101fbbff928"
      unitRef="eur">6000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="i81650437d58f40b488b1451b5a16cdc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTowYWU5NTYxMjBmZmM0NWE5YmYxNjU0Yzc2NDFiNmFjZC90YWJsZXJhbmdlOjBhZTk1NjEyMGZmYzQ1YTliZjE2NTRjNzY0MWI2YWNkXzQtNC0xLTEtMzY0MDYw_86beaa86-0d54-4834-99c1-ea3558b54fb5"
      unitRef="eur">564000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="i8feda8bd457f4a26b64959caa430dd5e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzItMS0xLTEtMzY0MDYw_59127c34-65b6-4849-8743-e754cd1a770e"
      unitRef="eur">154000000</sny:InvestmentsInAssociatesAndJointVentures>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="i2d0c0e35669c4d7aae59762151215c68_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzItMi0xLTEtMzY0MDYw_1d480def-e76d-4bc8-a099-bd5ca8ca21f2"
      unitRef="eur">47000000</sny:InvestmentsInAssociatesAndJointVentures>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="i5ccf1608d43245e99567d6f375c33201_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzItMy0xLTEtMzY0MDYw_7861f038-13ea-4b00-a6f3-33c7565d76d2"
      unitRef="eur">0</sny:InvestmentsInAssociatesAndJointVentures>
    <sny:InvestmentsInAssociatesAndJointVentures
      contextRef="i556d066cc252454daf37eb98b7987866_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzItNC0xLTEtMzY0MDYw_a89c8a33-3eb6-4676-a34b-522979901f1a"
      unitRef="eur">201000000</sny:InvestmentsInAssociatesAndJointVentures>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="ia71d61fb176c44bc85d8a7131e07caca_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzMtMS0xLTEtMzY0MDYw_c138eec0-dc40-45db-b496-1c74f76406d5"
      unitRef="eur">755000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="i73d9e784d85c4861808c14effc04b733_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzMtMi0xLTEtMzY0MDYw_cb79ec92-37fb-41b1-9f17-c0156e7e55cb"
      unitRef="eur">404000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzMtMy0xLTEtMzY0MDYw_7b4c34de-8009-434a-ad34-041b5fb6705d"
      unitRef="eur">95000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzMtNC0xLTEtMzY0MDYw_c8431713-f5bf-4b5d-ab0c-2899da4280e9"
      unitRef="eur">1254000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="ia71d61fb176c44bc85d8a7131e07caca_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzQtMS0xLTEtMzY0MDYw_11305a88-3265-4f0a-b26c-f6ab0e755612"
      unitRef="eur">501000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="i73d9e784d85c4861808c14effc04b733_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzQtMi0xLTEtMzY0MDYw_b80231c5-d0cc-41df-9a85-88b4532ecb1f"
      unitRef="eur">322000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="i57a7ca4c5da9411a80915285fb4c4b9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzQtMy0xLTEtMzY0MDYw_68250a8c-a622-4a86-8a36-eb84ccb6728b"
      unitRef="eur">6000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="i80508da7ee2146948d2dcc7c182982d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTphYjI0MWZiMWY2ZGM0NjNhOTA1NzdlZDY2ZDQ2MWZhNy90YWJsZXJhbmdlOmFiMjQxZmIxZjZkYzQ2M2E5MDU3N2VkNjZkNDYxZmE3XzQtNC0xLTEtMzY0MDYw_271ccb50-5999-4e7d-859e-88f2b76c0374"
      unitRef="eur">829000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:DisclosureOfGeographicalAreasExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90ZXh0cmVnaW9uOmQzZGJmNmJlMDhjYzQ0YjVhYjM4ZjI5MzhhMWJjMGViXzEwNDU2_c2a538fa-7bb9-4d3f-ac0d-483920564df1">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The geographical information on net sales provided below is based on the geographical location of the customer. In accordance with&#160;IFRS&#160;8, the non-current assets reported below exclude right-of-use assets relating to leases as determined under IFRS&#160;16, investments accounted for using the equity method, other non-current assets, non-current income tax assets, and deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="background-color:#e7e7e8;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;North&lt;br/&gt;America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;42,997&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,999&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,296&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,984&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,275&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,014&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;property, plant and equipment owned&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:9.29pt"&gt;other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;North&lt;br/&gt;America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;37,761&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,759&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,256&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;15,075&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,385&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,927&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;property, plant and equipment owned&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;North&lt;br/&gt;America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;of&#160;which&lt;br/&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;countries&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36,041&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,151&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,223&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,060&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,465&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,830&lt;/span&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;property, plant and equipment owned&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.34pt;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt"&gt;other intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes the impact of the IFRIC agenda decision of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfGeographicalAreasExplanatory>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i26e900f47f5a43c1af34c00b6fbd86f1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItMS0xLTEtMzY0MDYw_943563e0-729a-4b0e-a757-bc113a350684"
      unitRef="eur">42997000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i6e829ee2f99a465ab88b9472b399fb82_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItMi0xLTEtMzY0MDYw_ef2c8e51-db52-4a80-b443-387831cbc0b6"
      unitRef="eur">9999000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItMy0xLTEtMzY0MDYw_e15fc2ff-7d61-4aa3-a333-13f26ed8001b"
      unitRef="eur">2296000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ifa27b1484913467086d8717268468676_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItNC0xLTEtMzY0MDYw_eea6a661-b930-4be0-9ae2-b76c0aafca9c"
      unitRef="eur">18984000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="idb3eafcc3cb44db6bf1aa226b7ff8263_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItNS0xLTEtMzY0MDYw_0d136949-1f82-4766-a16f-9eecc638be54"
      unitRef="eur">18275000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i3f6aa7c2c0a940db95a9895599a8e561_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzItNi0xLTEtMzY0MDYw_b968b8b2-5284-469c-981a-0feeedbbc76a"
      unitRef="eur">14014000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ib54fed9458034a4eac2a4487edc9c09e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtMS0xLTEtMzY0MDYw_77f56a30-55c8-4efa-8b35-1147c511d6a4"
      unitRef="eur">9869000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i3abc51abaff14a808a53308dacb0555b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtMi0xLTEtMzY0MDYw_d64bedae-e4ee-4238-ab09-c8ca37c9c14a"
      unitRef="eur">5365000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtMy0xLTEtMzY0MDYw_7b30aac9-307f-4fd6-bf76-092a1c5d1d4b"
      unitRef="eur">2875000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i0c05f2b9a58842bf9131e7d74f48ec7e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtNC0xLTEtMzY0MDYw_9407c50f-119a-4398-998a-e26bc4db4e2e"
      unitRef="eur">3284000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtNS0xLTEtMzY0MDYw_7102aa47-b287-4643-b423-6d2fa24bea79"
      unitRef="eur">2457000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i727bd67c94b846ec879e26bf1451a28b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzQtNi0xLTEtMzY0MDYw_8dc00d94-0048-420c-bf05-0fe24a9e38ae"
      unitRef="eur">1220000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="ib54fed9458034a4eac2a4487edc9c09e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtMS0xLTEtMzY0MDYw_1db10087-5c48-40de-bb48-5e4897c69257"
      unitRef="eur">49892000000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i3abc51abaff14a808a53308dacb0555b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtMi0xLTEtMzY0MDYw_97c9801f-66ab-4932-82f1-b8db1389d4ea"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtMy0xLTEtMzY0MDYw_eee0776a-05bc-4753-8c60-38a0560e4c55"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i0c05f2b9a58842bf9131e7d74f48ec7e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtNC0xLTEtMzY0MDYw_a01d01f0-6352-4e21-af63-7d74d707b838"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtNS0xLTEtMzY0MDYw_119e9e2d-4f7e-47c5-b40f-796e9b8c7365"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i727bd67c94b846ec879e26bf1451a28b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzUtNi0xLTEtMzY0MDYw_43a61532-d9f3-4363-b320-e603ae6c0e30"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ib54fed9458034a4eac2a4487edc9c09e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtMS0xLTEtMzY0MDYw_df162ec4-bf68-4d49-b8ca-930a651ee844"
      unitRef="eur">21640000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i3abc51abaff14a808a53308dacb0555b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtMi0xLTEtMzY0MDYw_f9d28ed6-9d10-467a-a346-14a1f92ddc37"
      unitRef="eur">6257000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i6da39a10f36d460086ee95d7fcc030b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtMy0xLTEtMzY0MDYw_cbb71be9-a51c-4f0d-b35a-2c338c1fd62c"
      unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i0c05f2b9a58842bf9131e7d74f48ec7e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtNC0xLTEtMzY0MDYw_0a517cdc-163f-42d9-b1cb-7d0449c96d83"
      unitRef="eur">14178000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i56fa30ecd5c442d1ae753d82f6f509a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtNS0xLTEtMzY0MDYw_8ceff476-05ae-4063-bdee-95e8c9f33bd7"
      unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i727bd67c94b846ec879e26bf1451a28b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNDg1NDhhMzhiYjM0ZGZlOTE1Zjg2MjAzMzAxZWY4Ni90YWJsZXJhbmdlOmU0ODU0OGEzOGJiMzRkZmU5MTVmODYyMDMzMDFlZjg2XzYtNi0xLTEtMzY0MDYw_4f006701-40ac-4468-8425-32c8a2bafa76"
      unitRef="eur">1205000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5f4f45d36c37402780501202da882836_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItMS0xLTEtMzY0MDYw_cb0ceed1-bf41-4d50-aa07-8a7183bb6111"
      unitRef="eur">37761000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ibf60334e241640fe96a7903ed2e9b3ad_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItMi0xLTEtMzY0MDYw_caafbfd9-06e0-4adb-9c87-127501047b9e"
      unitRef="eur">9759000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id1c7bf876bd34221a7192285d1f86a2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItMy0xLTEtMzY0MDYw_95d6c1bd-b0b9-41b6-8bb1-78565e93e161"
      unitRef="eur">2256000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i68c4deea6e6b470da44d7eb61f99c2c4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItNC0xLTEtMzY0MDYw_333ec188-76b8-4a2e-a8f4-7eba4119e678"
      unitRef="eur">15075000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i5c7b958e2aac40bca8b1ee792ca34900_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItNS0xLTEtMzY0MDYw_ed62f046-1966-4d79-8b5f-55f1a7b2f355"
      unitRef="eur">14385000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie7997885ee5a421a93ddf5ffca11ea96_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzItNi0xLTEtMzY0MDYw_a954c580-317e-4847-b2a8-1868f6f2559a"
      unitRef="eur">12927000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i54e8e37c74a24991b87c1d67d7375882_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtMS0xLTEtMzY0MDYw_82fdf7b6-baab-495f-b0e2-be2af0889266"
      unitRef="eur">10028000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ibff824acb702445385e0da9d25b4b793_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtMi0xLTEtMzY0MDYw_877da7e5-ac40-4fbe-8c19-b72218919114"
      unitRef="eur">5959000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtMy0xLTEtMzY0MDYw_be7d61d1-d890-417b-b236-06ef7735fb81"
      unitRef="eur">3253000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i26f8ec3e990b4a519b49cf861ce481c7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtNC0xLTEtMzY0MDYw_4726be24-05e2-439c-9ab4-76e07ba590e5"
      unitRef="eur">2998000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtNS0xLTEtMzY0MDYw_4da80c93-5a85-448b-a701-52afff545cc2"
      unitRef="eur">2234000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i688e526d505647cca548bad7d372816f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzQtNi0xLTEtMzY0MDYw_ec34ab25-d026-4411-a026-93315c2d8561"
      unitRef="eur">1071000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="i54e8e37c74a24991b87c1d67d7375882_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtMS0xLTEtMzY0MDYw_05d9e189-fcd2-41d9-a552-3369017c1694"
      unitRef="eur">48056000000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="ibff824acb702445385e0da9d25b4b793_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtMi0xLTEtMzY0MDYw_285ca39d-b3c4-4e2f-b050-64f67d750c93"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtMy0xLTEtMzY0MDYw_ae3573b1-c78d-4ecd-9c05-f47caefe10dc"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i26f8ec3e990b4a519b49cf861ce481c7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtNC0xLTEtMzY0MDYw_bccb12b2-7b84-471f-9f97-bfac4d9fd489"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtNS0xLTEtMzY0MDYw_1baf56f4-63a0-4320-97e5-e2bc269b5e9e"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i688e526d505647cca548bad7d372816f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzUtNi0xLTEtMzY0MDYw_8c2c810b-ca25-4c93-adc7-dcc4d719518b"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i54e8e37c74a24991b87c1d67d7375882_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtMS0xLTEtMzY0MDYw_bf436342-82ce-44cc-a209-28b9166beb14"
      unitRef="eur">21407000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ibff824acb702445385e0da9d25b4b793_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtMi0xLTEtMzY0MDYw_8e2f321d-86b2-4c6d-8e45-e29b50f79779"
      unitRef="eur">7059000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ia930b4de9f06488eb2a27b3206081e50_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtMy0xLTEtMzY0MDYw_f3868593-dae5-400a-b198-eaf62ace8874"
      unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i26f8ec3e990b4a519b49cf861ce481c7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtNC0xLTEtMzY0MDYw_22fc7eb1-ee78-48fc-9274-d0ee2b17aed5"
      unitRef="eur">13187000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i32eff8213db3483b9be806abce4ca9e8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtNS0xLTEtMzY0MDYw_667d4d04-2bd4-4112-865f-7cd998e3d4cc"
      unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i688e526d505647cca548bad7d372816f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZTplNzJiMzIzNWFhMWI0MTIyYTI3N2IxMTEyNzc2ZDBjNy90YWJsZXJhbmdlOmU3MmIzMjM1YWExYjQxMjJhMjc3YjExMTI3NzZkMGM3XzYtNi0xLTEtMzY0MDYw_f2843d9c-e205-4c8c-b766-8d03b6823ea1"
      unitRef="eur">1161000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i2a967f1a2afd4c4aa4177d1e5ef46e32_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItMS0xLTEtMzY0MDYw_8412e481-cd3c-40d8-8766-e72ac27d08de"
      unitRef="eur">36041000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="id0034d62b9984b9c819c9089b17c9dff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItMi0xLTEtMzY0MDYw_f7007cf0-197a-4e88-a02f-592bc16b1a90"
      unitRef="eur">9151000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="i7c2b14b0dfd84a9db235eec59fec66d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItMy0xLTEtMzY0MDYw_b849d3d8-9a58-4f66-845d-ab6b4b8595ed"
      unitRef="eur">2223000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="idc6d783c6be84509bbd905f3377753b0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItNC0xLTEtMzY0MDYw_ad9c02c4-58d1-419d-bee1-992b9bf21faa"
      unitRef="eur">14060000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="ie65cc2a8edfc4ac38f59844bedc29d03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItNS0xLTEtMzY0MDYw_1aace4d6-6e72-434d-95b0-89f9101abbde"
      unitRef="eur">13465000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="idd3e8e0424b04715b821e32eeb629ba6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzItNi0xLTEtMzY0MDYw_512358e6-a208-485b-b41f-44f2d2866184"
      unitRef="eur">12830000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="id92a273efd0e45db9787db6e8508d895_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtMS0xLTEtMzY0MDYw_68ef52cf-bdc1-48ac-a915-893cd97ab5d5"
      unitRef="eur">9365000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i4c09e143fbea445f8efdabebb4865bc8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtMi0xLTEtMzY0MDYw_5c74c652-c09e-48ae-a918-f211b50167f2"
      unitRef="eur">5895000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtMy0xLTEtMzY0MDYw_c2ea144a-31a0-40ed-b6d2-ef9f915340f1"
      unitRef="eur">3189000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="ic65c1b0f25e14bc0a163de986a44369b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtNC0xLTEtMzY0MDYw_580379a0-100d-4347-9a5b-e868e022944d"
      unitRef="eur">2542000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtNS0xLTEtMzY0MDYw_9c729f81-1832-471f-870e-913b7e2b7c00"
      unitRef="eur">1899000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="i0593a502ce6b4cd49c8af7a40f39e801_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzQtNi0xLTEtMzY0MDYw_f282965c-b93f-4391-acf7-0a3ec5709df0"
      unitRef="eur">928000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="id92a273efd0e45db9787db6e8508d895_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtMS0xLTEtMzY0MDYw_1b264649-1f17-40bd-8253-e7018e501275"
      unitRef="eur">44364000000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i4c09e143fbea445f8efdabebb4865bc8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtMi0xLTEtMzY0MDYw_42b2f66f-9d92-4abd-b123-82c77e90b045"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtMy0xLTEtMzY0MDYw_e4b77d01-b775-475e-9c8b-83cc57e9bd06"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="ic65c1b0f25e14bc0a163de986a44369b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtNC0xLTEtMzY0MDYw_a901b492-b08a-477c-acba-91fff14c1226"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtNS0xLTEtMzY0MDYw_c271b896-b952-4d12-80e4-1e74ad402b5e"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="i0593a502ce6b4cd49c8af7a40f39e801_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzUtNi0xLTEtMzY0MDYw_0edf24a3-4f1d-47f5-8353-961b80b2fdd7"
      unitRef="eur">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="id92a273efd0e45db9787db6e8508d895_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtMS0xLTEtMzY0MDYw_bdfde6d5-09f2-4a72-8eae-cab5483704b9"
      unitRef="eur">18341000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i4c09e143fbea445f8efdabebb4865bc8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtMi0xLTEtMzY0MDYw_46debe73-6d76-4c25-ba64-7f100f84e027"
      unitRef="eur">6208000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i71c87579faa14f7da7aad3b6cb02cdc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtMy0xLTEtMzY0MDYw_fab00b47-6817-4827-85f9-2b96123fa138"
      unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="ic65c1b0f25e14bc0a163de986a44369b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtNC0xLTEtMzY0MDYw_2732fe9c-bb56-4a75-add3-fe21a2a9ae8d"
      unitRef="eur">10665000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i3c985daced504fa199baee84c35b8e0c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtNS0xLTEtMzY0MDYw_9748f979-abe3-4707-aaed-04df36316e3f"
      unitRef="eur">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="i0593a502ce6b4cd49c8af7a40f39e801_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl82OTcvZnJhZzpkM2RiZjZiZTA4Y2M0NGI1YWIzOGYyOTM4YTFiYzBlYi90YWJsZToxOGNlNDBlOThkODA0ODVlYTBlNDIyNDdkMzkwMjFjMi90YWJsZXJhbmdlOjE4Y2U0MGU5OGQ4MDQ4NWVhMGU0MjI0N2QzOTAyMWMyXzYtNi0xLTEtMzY0MDYw_3e34189b-f8e7-49c4-82e0-4406eafdd298"
      unitRef="eur">1468000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfAuditorsRemunerationExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzIyMjQ_38c38042-c314-4ad9-80a8-d933bd747860">Principal accountants&#x2019; fees and services&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;PricewaterhouseCoopers Audit and Ernst&#160;&amp;amp; Young et Autres served as independent auditors of Sanofi for the year ended December 31, 2022 and for all other reporting periods presented. The table below shows fees charged by those firms and member firms of their networks to Sanofi and consolidated subsidiaries in the years ended December 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ernst&#160;&amp;amp;&#160;Young&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PricewaterhouseCoopers&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Audit:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt; Statutory audit of separate and consolidated financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Services other than statutory audit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Audit-related services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16.0&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16.9&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14.6&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14.2&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes services provided by the independent auditors of the parent company and French subsidiaries: Ernst&#160;&amp;amp; Young &#x20ac;7.3 million in 2022, &#x20ac;7.2 million in&#160;2021; PricewaterhouseCoopers &#x20ac;7.7 million in 2022, &#x20ac;7.7 million in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Services other than statutory audit provided by Ernst&#160;&amp;amp; Young et Autres during 2022 comprised:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - work on share capital transactions and securities issues submitted to the Annual General Meeting (in extraordinary business) for approval;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - additional procedures to enable reports previously signed by the firm to be incorporated by reference;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - agreed-upon and audit procedures in connection with a proposed divestment; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - issuance of the Independent third party&#x2019;s report on the consolidated statement of extra-financial performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      Services other than statutory audit provided by PricewaterhouseCoopers Audit during 2022 comprised:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - work on share capital transactions and securities issues submitted to the Annual General Meeting (in extraordinary business) for approval;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - additional procedures to enable reports previously signed by the firm to be incorporated by reference;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - contractual audits, assurance engagements, agreed-upon procedures, tax compliance work, and technical consultancy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Includes services provided by the independent auditors of the parent company and French subsidiaries: Ernst&#160;&amp;amp; Young: &#x20ac;1.4 million in 2022, &#x20ac;2.7 million in&#160;2021; PricewaterhouseCoopers &#x20ac;0.3 million in 2022, &#x20ac;0.3 million in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Audit Committee pre-approval and procedures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The Audit Committee of Sanofi has adopted a policy and established certain procedures for the approval of audit services and for the pre-approval of other services to be provided by the independent auditors. In 2022, the Audit Committee established a limit for permitted audit-related and other services (i.e. services other than statutory audit) that can be provided by the independent auditors, and the related fees.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfAuditorsRemunerationExplanatory>
    <sny:AuditorsRemunerationTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzIyMjc_496f62df-2e26-47a0-a7c0-2149be1a2434">The table below shows fees charged by those firms and member firms of their networks to Sanofi and consolidated subsidiaries in the years ended December 31, 2022 and 2021.&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ernst&#160;&amp;amp;&#160;Young&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PricewaterhouseCoopers&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(&#x20ac; million)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Audit:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt; Statutory audit of separate and consolidated financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Services other than statutory audit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Audit-related services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e3e3e3;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e3e3e3;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e3e3e3;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16.0&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;16.9&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14.6&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14.2&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a) Includes services provided by the independent auditors of the parent company and French subsidiaries: Ernst&#160;&amp;amp; Young &#x20ac;7.3 million in 2022, &#x20ac;7.2 million in&#160;2021; PricewaterhouseCoopers &#x20ac;7.7 million in 2022, &#x20ac;7.7 million in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b) Services other than statutory audit provided by Ernst&#160;&amp;amp; Young et Autres during 2022 comprised:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - work on share capital transactions and securities issues submitted to the Annual General Meeting (in extraordinary business) for approval;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - additional procedures to enable reports previously signed by the firm to be incorporated by reference;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - agreed-upon and audit procedures in connection with a proposed divestment; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - issuance of the Independent third party&#x2019;s report on the consolidated statement of extra-financial performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      Services other than statutory audit provided by PricewaterhouseCoopers Audit during 2022 comprised:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - work on share capital transactions and securities issues submitted to the Annual General Meeting (in extraordinary business) for approval;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - additional procedures to enable reports previously signed by the firm to be incorporated by reference;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;      - contractual audits, assurance engagements, agreed-upon procedures, tax compliance work, and technical consultancy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"&gt;(c) Includes services provided by the independent auditors of the parent company and French subsidiaries: Ernst&#160;&amp;amp; Young: &#x20ac;1.4 million in 2022, &#x20ac;2.7 million in&#160;2021; PricewaterhouseCoopers &#x20ac;0.3 million in 2022, &#x20ac;0.3 million in 2021.&lt;/span&gt;&lt;/div&gt;</sny:AuditorsRemunerationTableTextBlock>
    <ifrs-full:AuditorsRemunerationForAuditServices
      contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtMS0xLTEtMzY0MDYw_8701bbb0-41f4-4178-b846-9ae633d10488"
      unitRef="eur">14200000</ifrs-full:AuditorsRemunerationForAuditServices>
    <sny:PercentageOfAuditorRemunerationForStatutoryAudit
      contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtMi0xLTEtMzY0MDYw_33667420-99f7-4b6a-bcee-dd91d570c6c1"
      unitRef="number">0.89</sny:PercentageOfAuditorRemunerationForStatutoryAudit>
    <ifrs-full:AuditorsRemunerationForAuditServices
      contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtMy0xLTEtMzY0MDYw_fc226134-ea56-461e-b141-70d196ebc2d9"
      unitRef="eur">13900000</ifrs-full:AuditorsRemunerationForAuditServices>
    <sny:PercentageOfAuditorRemunerationForStatutoryAudit
      contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtNC0xLTEtMzY0MDYw_674722c4-d8a7-41d9-b55b-c8644e67eac0"
      unitRef="number">0.82</sny:PercentageOfAuditorRemunerationForStatutoryAudit>
    <ifrs-full:AuditorsRemunerationForAuditServices
      contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtNS0xLTEtMzY0MDYw_59f30fff-1cdc-4605-b07e-624d4e1523a1"
      unitRef="eur">14100000</ifrs-full:AuditorsRemunerationForAuditServices>
    <sny:PercentageOfAuditorRemunerationForStatutoryAudit
      contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtNi0xLTEtMzY0MDYw_7b429ca8-aecd-4850-a3e6-bd058be58969"
      unitRef="number">0.97</sny:PercentageOfAuditorRemunerationForStatutoryAudit>
    <ifrs-full:AuditorsRemunerationForAuditServices
      contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtNy0xLTEtMzY0MDYw_d8f98a3e-5ac7-432c-864e-a091cbae727e"
      unitRef="eur">13800000</ifrs-full:AuditorsRemunerationForAuditServices>
    <sny:PercentageOfAuditorRemunerationForStatutoryAudit
      contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzQtOC0xLTEtMzY0MDYw_b199d46d-6d39-49aa-bc14-21ed9b18859a"
      unitRef="number">0.97</sny:PercentageOfAuditorRemunerationForStatutoryAudit>
    <sny:ServicesOtherThanStatutoryAudit
      contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtMS0xLTEtMzY0MDYw_527be519-353a-4c7f-9e57-3da5da63dfaf"
      unitRef="eur">1800000</sny:ServicesOtherThanStatutoryAudit>
    <sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements
      contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtMi0xLTEtMzY0MDYw_5c5d94da-af9d-4c73-b9e4-75e8b989c7d5"
      unitRef="number">0.11</sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements>
    <sny:ServicesOtherThanStatutoryAudit
      contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtMy0xLTEtMzY0MDYw_d65843bf-6b9d-4745-9b81-ef594600b2d9"
      unitRef="eur">3000000.0</sny:ServicesOtherThanStatutoryAudit>
    <sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements
      contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtNC0xLTEtMzY0MDYw_84e15b0b-b1c8-45e8-b59b-914be9f2d996"
      unitRef="number">0.18</sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements>
    <sny:ServicesOtherThanStatutoryAudit
      contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtNS0xLTEtMzY0MDYw_bcd58b35-9b2b-4bdd-b23c-d8921719a6d6"
      unitRef="eur">500000</sny:ServicesOtherThanStatutoryAudit>
    <sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements
      contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtNi0xLTEtMzY0MDYw_9e59d9c1-0f24-46a8-9217-16cb73efd748"
      unitRef="number">0.03</sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements>
    <sny:ServicesOtherThanStatutoryAudit
      contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtNy0xLTEtMzY0MDYw_c2c80ab4-4007-4ca8-960c-eebb4c59403a"
      unitRef="eur">400000</sny:ServicesOtherThanStatutoryAudit>
    <sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements
      contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzUtOC0xLTEtMzY0MDYw_cc8737df-e4a0-471d-b330-c8286e3f4685"
      unitRef="number">0.03</sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements>
    <sny:AuditorsRemunerationForAuditRelatedServices
      contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzYtMS0xLTEtMzY0MDYw_379fc932-316a-40be-8ead-b73321948b7f"
      unitRef="eur">1500000</sny:AuditorsRemunerationForAuditRelatedServices>
    <sny:AuditorsRemunerationForAuditRelatedServices
      contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzYtMy0xLTEtMzY0MDYw_c9c6da4f-c7fe-4d18-abe9-3ce0cf8cd3ba"
      unitRef="eur">2800000</sny:AuditorsRemunerationForAuditRelatedServices>
    <sny:AuditorsRemunerationForAuditRelatedServices
      contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzYtNS0xLTEtMzY0MDYw_fbb63151-6fe8-47fa-a777-70aa093e01d9"
      unitRef="eur">500000</sny:AuditorsRemunerationForAuditRelatedServices>
    <sny:AuditorsRemunerationForAuditRelatedServices
      contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzYtNy0xLTEtMzY0MDYw_44c96965-3e19-4051-beb9-7aaf9f4edd07"
      unitRef="eur">400000</sny:AuditorsRemunerationForAuditRelatedServices>
    <ifrs-full:AuditorsRemunerationForTaxServices
      contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzctMS0xLTEtMzY0MDYw_b10ab91a-ea85-4f53-a5c5-a5abc3639143"
      unitRef="eur">0.0</ifrs-full:AuditorsRemunerationForTaxServices>
    <ifrs-full:AuditorsRemunerationForTaxServices
      contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzctMy0xLTEtMzY0MDYw_05d31709-2af7-4519-b29a-b4fac75ed959"
      unitRef="eur">0</ifrs-full:AuditorsRemunerationForTaxServices>
    <ifrs-full:AuditorsRemunerationForTaxServices
      contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzctNS0xLTEtMzY0MDYw_aebe8f8f-6bf8-4650-8e87-069c7cc42e64"
      unitRef="eur">0.0</ifrs-full:AuditorsRemunerationForTaxServices>
    <ifrs-full:AuditorsRemunerationForTaxServices
      contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzctNy0xLTEtMzY0MDYw_3df24d20-f114-4260-a1ef-0d9f691b245b"
      unitRef="eur">0</ifrs-full:AuditorsRemunerationForTaxServices>
    <ifrs-full:AuditorsRemunerationForOtherServices
      contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzgtMS0xLTEtMzY0MDYw_4cab4e23-cc8d-4dd5-9770-cc1144f2f568"
      unitRef="eur">300000</ifrs-full:AuditorsRemunerationForOtherServices>
    <ifrs-full:AuditorsRemunerationForOtherServices
      contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzgtMy0xLTEtMzY0MDYw_6e5bd2f2-fb73-49af-a307-4493906bd339"
      unitRef="eur">200000</ifrs-full:AuditorsRemunerationForOtherServices>
    <ifrs-full:AuditorsRemunerationForOtherServices
      contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzgtNS0xLTEtMzY0MDYw_7108ef10-a870-45ac-a938-5c8200a902bd"
      unitRef="eur">0</ifrs-full:AuditorsRemunerationForOtherServices>
    <ifrs-full:AuditorsRemunerationForOtherServices
      contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzgtNy0xLTEtMzY0MDYw_59e5c237-3795-4736-83f7-e0477554b829"
      unitRef="eur">0</ifrs-full:AuditorsRemunerationForOtherServices>
    <ifrs-full:AuditorsRemuneration
      contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktMS0xLTEtMzY0MDYw_25d968cf-175b-4e1c-90a1-0f7c4ecf8f6a"
      unitRef="eur">16000000.0</ifrs-full:AuditorsRemuneration>
    <sny:PercentageOfAuditorsRemuneration
      contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktMi0xLTEtMzY0MDYw_6070cec2-c658-4a25-9a25-9b5b5c91853d"
      unitRef="number">1</sny:PercentageOfAuditorsRemuneration>
    <ifrs-full:AuditorsRemuneration
      contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktMy0xLTEtMzY0MDYw_cbe0b0fc-c655-4590-be2e-c031b0ed6550"
      unitRef="eur">16900000</ifrs-full:AuditorsRemuneration>
    <sny:PercentageOfAuditorsRemuneration
      contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktNC0xLTEtMzY0MDYw_f37a2161-7dfc-4fa9-8bcb-0fb6f387f2ae"
      unitRef="number">1</sny:PercentageOfAuditorsRemuneration>
    <ifrs-full:AuditorsRemuneration
      contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktNS0xLTEtMzY0MDYw_3edcaa4e-e5b3-4b34-bf5a-210b8a2af30a"
      unitRef="eur">14600000</ifrs-full:AuditorsRemuneration>
    <sny:PercentageOfAuditorsRemuneration
      contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktNi0xLTEtMzY0MDYw_6bf38a97-b78c-4383-aca0-a59dbc5886b7"
      unitRef="number">1</sny:PercentageOfAuditorsRemuneration>
    <ifrs-full:AuditorsRemuneration
      contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktNy0xLTEtMzY0MDYw_3f3238bd-09c9-40ce-9595-fa5bcf0d5e8d"
      unitRef="eur">14200000</ifrs-full:AuditorsRemuneration>
    <sny:PercentageOfAuditorsRemuneration
      contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90YWJsZTozZDY4NDEwOWJmM2Q0MDRiOWYzNDA4MmJkMjhiOTIyMi90YWJsZXJhbmdlOjNkNjg0MTA5YmYzZDQwNGI5ZjM0MDgyYmQyOGI5MjIyXzktOC0xLTEtMzY0MDYw_62dc9d15-2a4f-4e88-8a13-b6e38a826289"
      unitRef="number">1</sny:PercentageOfAuditorsRemuneration>
    <sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries
      contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzQ5Mw_861bd31b-dafb-430b-8190-d48749f02011"
      unitRef="eur">7300000</sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries>
    <sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries
      contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzUwMw_3b1de4da-3f7d-49fe-a25d-3e818d06d29f"
      unitRef="eur">7200000</sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries>
    <sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries
      contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzUzNg_fc64dd08-a2c7-48f3-a8c0-a93ca7581362"
      unitRef="eur">7700000</sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries>
    <sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries
      contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzU0Ng_0c99ce6b-3592-4f19-9609-e6ee4807e615"
      unitRef="eur">7700000</sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries>
    <sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries
      contextRef="ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzE3MDE_dbbebaa7-945d-45dc-b921-2c8452de870e"
      unitRef="eur">1400000</sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries>
    <sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries
      contextRef="i6b3be0e5582b49eda3d0644660da08f1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzE3MTE_7bf0ce04-7c90-4433-a099-924b76a3aaec"
      unitRef="eur">2700000</sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries>
    <sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries
      contextRef="i12a68318ba074d1bb1ff3e71a9600ebc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzE3NDQ_861f93b7-4a74-436e-b800-c14731dabd97"
      unitRef="eur">300000</sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries>
    <sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries
      contextRef="i5dd36edf242044c3bb117c147cd095b7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDAvZnJhZzo4ZTk4MGZjODlhN2I0ZDc2ODIxODU0ZDYwMjk2YTJhMy90ZXh0cmVnaW9uOjhlOTgwZmM4OWE3YjRkNzY4MjE4NTRkNjAyOTZhMmEzXzE3NTQ_1278e474-1584-4762-80da-713d47d39e83"
      unitRef="eur">300000</sny:AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries>
    <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90ZXh0cmVnaW9uOjgzZjJjZTY0YWFkNDQyOWNiMzA3OTYwMjc5MWEzZDQ1XzI4Ng_d95792da-ca4d-4f57-b8ad-09a427373851">List of principal companies included in the scope of&#160;consolidation during&#160;2022&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;F.1. Principal fully consolidated companies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows Sanofi's principal subsidiaries and their country of incorporation:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial interest (%) as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hoechst GmbH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Deutschland GmbH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;A. Nattermann &amp;amp; Cie. GmbH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis GmbH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Austria&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Belgium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Belgium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ablynx N.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Belgium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Flanders BVBA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Belgium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi A/S&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Denmark&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Spain, S.L.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Oy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Finland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Winthrop Industrie&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Recherche &amp;amp; D&#xe9;veloppement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Groupe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Chimie&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Participations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis Pharma S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Biotechnology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Mature IP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur NVL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;SECIPE SAS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Merieux S.A.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi 2015 D SAS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare International SAS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare France SAS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Group SAS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis A.E.B.E.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Greece&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Private Co, Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hungary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Chinoin Private Co. Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hungary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Hungary Commercial K.F.T&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hungary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Carraig Insurance DAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Ireland Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Holdings (Ireland) Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi S.R.L.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Italy S.R.L.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Global Sarl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Luxembourg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Luxembourg Sarl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Luxembourg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Norge AS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Norway&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Europe B.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Netherlands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Foreign Participations B.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Netherlands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Sp. z.o.o.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Poland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Poland sp.Z.O.O&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Poland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Sp. z.o.o.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Poland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Produtos Farmaceuticos Lda&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Portugal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis, s.r.o.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Czech Republic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Czech s.r.o&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Czech Republic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Romania SRL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Romania&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial interest (%) as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Romania S.R.L.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Romania&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis UK Holdings Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis Pharma Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Synthelabo UK Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis Pharma Holdings Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare UK Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;AO Sanofi Russia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Russia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Russia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi AB&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sweden&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis (Suisse) SA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Global Sarl Baar Intellectual Property Branch&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Ilac Sanayi ve Ticaret A.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Turkey&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Asi Ticaret A.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Turkey&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Saglik Urunleri Limited Sirketi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Turkey&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial interest (%) as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Therapeutic Products Limited Partnership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi US Services Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis U.S. LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Chattem, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventisub LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;VaxServe, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bioverativ Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bioverativ U.S. LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bioverativ Therapeutics Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Principia Biopharma Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Research Invest LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Bioverativ Holdings LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;RPR US Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Kadmon Holdings, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Kadmon Corporation, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amunix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Synthorx, Inc&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Translate Bio, Inc&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other Countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial interest (%) as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis South Africa (Pty) Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;South Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Alg&#xe9;rie&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Algeria&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Arabia Trading Company Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Saudi Arabia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Argentina S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Argentina&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme de Argentina S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Argentina&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Argentina S.A.U.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Argentina&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Healthcare Pty Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Australia Pty Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Medley Farmaceutica Ltda&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Brazil&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Canada Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Merieux Canada Holdings ULC (Canada)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis de Chile S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Chile&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi (Hangzhou) Pharmaceuticals Co., Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi (China) Investment Co., Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi (Beijing) Pharmaceuticals Co.Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Biologies Co., Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shenzhen Sanofi pasteur Biological Products Co, Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shanghai Rongheng Pharmaceutical Co, Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genfar S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Colombia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis de Colombia S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Colombia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Korea Co. Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella healthcare Korea Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Gulf FZE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Arab Emirates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Egypt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Egypt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Egypt LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Egypt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Hong-Kong Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hong Kong&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi India Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;India&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Healthcare India Private Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;India&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Isra&#xeb;l Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi K.K.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;SSP Co.,Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis (Malaysia) SDN. BHD.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Maroc&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Morocco&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis de Mexico S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Azteca Vacunas, S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Pakistan Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pakistan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis de Panama S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Panama&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis del Peru S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Peru&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Puerto Rico Inc&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Philippines Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Philippines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Philippines Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Philippines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Singapore Pte. Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Singapore&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis Pharma (Manufacturing) Pte. Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Singapore&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Manufacturing Pte Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Singapore&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Taiwan Co., Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Taiwan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis (Thailand) Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Thailand&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis de Venezuela S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Venezuela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Vietnam Company Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vietnam&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Vietnam Shareholding Company Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vietnam&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;85.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;F.2. Principal investments accounted for using the equity method&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial interest (%) as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;GlaxoSmithKline Consumer Healthcare, L.P.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Infraserv GmbH&#160;&amp;amp; Co. H&#xf6;chst KG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maphar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Morocco&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MCM Vaccine B.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Netherlands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MSP Vaccine Company (formerly MCM company)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;EUROAPI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
    <ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90ZXh0cmVnaW9uOjgzZjJjZTY0YWFkNDQyOWNiMzA3OTYwMjc5MWEzZDQ1XzI4OA_e5a7a44a-69ba-4711-a547-80796fdf0db5">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;The table below shows Sanofi's principal subsidiaries and their country of incorporation:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial interest (%) as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hoechst GmbH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Deutschland GmbH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;A. Nattermann &amp;amp; Cie. GmbH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis GmbH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Austria&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Belgium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Belgium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ablynx N.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Belgium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Flanders BVBA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Belgium&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi A/S&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Denmark&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Spain, S.L.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Oy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Finland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Winthrop Industrie&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Recherche &amp;amp; D&#xe9;veloppement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Groupe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Chimie&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Participations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis Pharma S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Biotechnology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Mature IP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur NVL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;SECIPE SAS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Merieux S.A.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi 2015 D SAS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare International SAS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare France SAS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Group SAS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis A.E.B.E.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Greece&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Private Co, Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hungary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Chinoin Private Co. Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hungary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Hungary Commercial K.F.T&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hungary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Carraig Insurance DAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Ireland Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Holdings (Ireland) Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi S.R.L.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Italy S.R.L.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Global Sarl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Luxembourg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Luxembourg Sarl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Luxembourg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Norge AS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Norway&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Europe B.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Netherlands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Foreign Participations B.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Netherlands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Sp. z.o.o.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Poland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Poland sp.Z.O.O&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Poland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Sp. z.o.o.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Poland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Produtos Farmaceuticos Lda&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Portugal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis, s.r.o.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Czech Republic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Czech s.r.o&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Czech Republic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Romania SRL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Romania&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial interest (%) as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Romania S.R.L.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Romania&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis UK Holdings Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis Pharma Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Synthelabo UK Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis Pharma Holdings Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare UK Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;AO Sanofi Russia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Russia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Russia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi AB&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sweden&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis (Suisse) SA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Global Sarl Baar Intellectual Property Branch&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Ilac Sanayi ve Ticaret A.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Turkey&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Asi Ticaret A.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Turkey&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Saglik Urunleri Limited Sirketi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Turkey&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial interest (%) as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Therapeutic Products Limited Partnership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi US Services Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis U.S. LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Chattem, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventisub LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;VaxServe, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bioverativ Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bioverativ U.S. LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Bioverativ Therapeutics Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Principia Biopharma Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Research Invest LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Bioverativ Holdings LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;RPR US Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Kadmon Holdings, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#4c4d4f;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Kadmon Corporation, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United&#160;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amunix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Synthorx, Inc&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Translate Bio, Inc&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other Countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial interest (%) as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis South Africa (Pty) Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;South Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Alg&#xe9;rie&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Algeria&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Arabia Trading Company Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Saudi Arabia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Argentina S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Argentina&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genzyme de Argentina S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Argentina&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Argentina S.A.U.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Argentina&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Healthcare Pty Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Australia Pty Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Medley Farmaceutica Ltda&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Brazil&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Canada Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Merieux Canada Holdings ULC (Canada)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis de Chile S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Chile&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi (Hangzhou) Pharmaceuticals Co., Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi (China) Investment Co., Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi (Beijing) Pharmaceuticals Co.Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Biologies Co., Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shenzhen Sanofi pasteur Biological Products Co, Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shanghai Rongheng Pharmaceutical Co, Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Genfar S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Colombia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis de Colombia S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Colombia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Korea Co. Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella healthcare Korea Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Gulf FZE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United Arab Emirates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Egypt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Egypt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Egypt LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Egypt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Hong-Kong Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hong Kong&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi India Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;India&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Healthcare India Private Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;India&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Isra&#xeb;l Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi K.K.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;SSP Co.,Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis (Malaysia) SDN. BHD.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Maroc&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Morocco&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis de Mexico S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Pasteur S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Azteca Vacunas, S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Pakistan Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Pakistan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis de Panama S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Panama&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis del Peru S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Peru&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Puerto Rico Inc&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Philippines Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Philippines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Opella Healthcare Philippines Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Philippines&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Singapore Pte. Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Singapore&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aventis Pharma (Manufacturing) Pte. Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Singapore&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Manufacturing Pte Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Singapore&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Taiwan Co., Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Taiwan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis (Thailand) Ltd&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Thailand&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis de Venezuela S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Venezuela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi-Aventis Vietnam Company Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vietnam&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Sanofi Vietnam Shareholding Company Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vietnam&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;85.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i498c1591947b45fdadb2bb6778e0ea74_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzEtMi0xLTEtMzY0MDYw_a1bdc4f1-b1f3-4320-b823-f55be80e19a8"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ia5ae387e2cbe47c3912417d8623bf900_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzItMi0xLTEtMzY0MDYw_dcdf7343-b82b-4151-b6fa-516f75b38c64"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i4adfb7da9ccb448d9ad8c9e69d0b3cc1_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzMtMi0xLTEtMzY0MDYw_8ea9677b-5a15-4b69-86e8-66d0ea4ca827"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="idebf15d680cb4a1184f7f35728f60030_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzUtMi0xLTEtMzY0MDYw_fa5fe58c-0e51-43f7-862c-f8441e25a1f3"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i1051a7b1a8d549b19efe21164afc8517_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYtMi0xLTEtMzY0MDYw_0f144380-693c-4a66-a31f-5821b7b3060d"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i63571a41cac6407491245bad0632cf43_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzctMi0xLTEtMzY0MDYw_eae7724f-121e-4a32-bc11-1b373271d406"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ica986457aa234217a2fac7fc80955729_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzgtMi0xLTEtMzY0MDYw_0961db18-8ed1-4bbd-a10f-fc6134680f38"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i9b7192d1177f41e6939a7a9bad74bf5a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzktMi0xLTEtMzY0MDYw_2389afa0-626d-431f-be46-453dc253ba8b"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i285cbecf53934809bfc57407935033d4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzEwLTItMS0xLTM2NDA2MA_ef30e111-1b73-4d21-bc85-5b9145642525"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i24ec77a85f5e48ed937a7403fd09b34b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzEwLTItMS0xLTQyNjQwOA_ad96454b-fcd6-4207-990a-54841909fbc6"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ic074678a420e47758b62873cc4d859f6_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzExLTItMS0xLTM2NDA2MA_170c7078-a900-44d5-bbf7-29553feb962c"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ic74f613c0cb646968c6021eb3f15c61c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzEyLTItMS0xLTM2NDA2MA_776c41c0-c122-4e0c-ba52-24205ead7e92"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ibb45d02df4dc419e8ddda8153ae34b79_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzEzLTItMS0xLTM2NDA2MA_d27c038c-2c7b-4630-98e3-913274852f6a"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ie2205f57d9c8449cb0e0f24d60269bc5_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzE0LTItMS0xLTM2NDA2MA_837fa627-c16e-4806-9d44-710acd00b729"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i2121a047ee3e4de3bdbdc5ce00e809ba_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzE1LTItMS0xLTM2NDA2MA_ad419e0e-eb9f-41b8-a9b8-da7ef19528a3"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i080fdac6aa0d43588960255f9f17f975_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzE2LTItMS0xLTM2NDA2MA_9422e1ef-f35d-4901-8d65-75c30b4081a3"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i16069c2bafd44ad0bea3a6b3957889c1_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzE3LTItMS0xLTM2NDA2MA_34c395d1-8d14-4498-aaac-c56e8a9235a1"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i79acb16ef6f74dfd8a5afee5b7eaaf0b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzE5LTItMS0xLTM2NDA2MA_850dc33f-7604-4400-afdd-5a4b33290fc6"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="id75e41a2a8d44456a85dddcb895d6379_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzIxLTItMS0xLTM2NDA2MA_40694094-4a95-4544-b8e9-d8b7c33db519"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ia1564bffc0f94330a56e53eb941e410c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzIyLTItMS0xLTM2NDA2MA_76d706c7-e457-4725-95b5-c3d1ce390a48"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i13936cffe69644268b73faa1e0f1222c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzIzLTItMS0xLTM2NDA2MA_7f432ff9-9088-4810-8853-2589f02a1e0d"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="if4e1d630778d4bdf98e7975d7d41370e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzI0LTItMS0xLTM2NDA2MA_709076be-eeea-44c1-ae6c-c575783aa644"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i351193f373d14cfba556201ad238e512_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzI1LTItMS0xLTM2NDA2MA_a6bbce61-6afd-4384-8415-002b27fd7bea"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i13a2d009465c4ed2b62b3c4ce7bedf35_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzI3LTItMS0xLTM2NDA2MA_bdcae1a5-cd07-424c-a7d8-e43032af7134"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i4c5bc0d0654d49e484d5bda422c95c96_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzI4LTItMS0xLTM2NDA2MA_fd21e103-3133-432f-bfcb-7fd3d05906e7"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i0538adb5d86145d8b2614a4783bcd071_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzI5LTItMS0xLTM2NDA2MA_680fd991-2761-4359-8e8e-b9069745202c"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ib51944e0d29846a1b0a6665d934c0d7a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzMwLTItMS0xLTM2NDA2MA_d961bfd5-255d-4701-ae72-67203b360590"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="iaa2e5413dd9a4c5c8f7d90b8a94df128_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzMxLTItMS0xLTM2NDA2MA_2f33d593-6b21-458b-a986-09de8f274cf3"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i2ca8f4e855884896957fe5976fc46f0b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzMyLTItMS0xLTM2NDA2MA_d29a643c-863f-485d-a2f3-1c6a9919499b"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i325731cb5882403b849f26ad9d4954b9_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzMxLTItMS0xLTQ2NjA1OA_91f0cbde-6ffa-486e-9bc7-9e6f319efe0e"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i4e5219940fdd4088915a6be208a8c941_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzM1LTItMS0xLTM2NDA2MA_740bdf41-4fb4-48cc-bc99-9a0c917230bc"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ibaaa67301b32448ea984ea8286dd1dd8_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzM2LTItMS0xLTM2NDA2MA_9f9797ea-b961-4793-ba79-74665f7f53a5"
      unitRef="number">0.996</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i4631c1fb362a4507ad8496f0043f8818_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzM3LTItMS0xLTM2NDA2MA_2730666d-d90c-4255-9340-9652008ec653"
      unitRef="number">0.996</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="icc230f3aa6da4dc1830276e62e498a05_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzM1LTItMS0xLTM3MDEyNQ_5589e406-f27c-4ddb-be91-316853a059ba"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i589ccb194ca14fd289b658aeea655731_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQwLTItMS0xLTM2NDA2MA_7cb22c93-f010-45fa-b366-91ba8049ee54"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i0941b5e1401244aeb011299f6b18762c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQyLTItMS0xLTM2NDA2MA_ac0c710f-076c-455d-a2f9-c8215f59bcc1"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i4dfafa70e252425495ec4aa84c0b3462_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ0LTItMS0xLTM2NDA2MA_08d0ca98-3880-4620-bb10-b679809d1d84"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ie5c98b61ee6a49c6bbe6745fbe8903f0_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ1LTItMS0xLTM2NDA2MA_1d2bcda3-a90d-47ce-8a5a-335406b799c6"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i4db465cfb48243f681f6c69e00a03120_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQyLTItMS0xLTM3MDEzNA_fa1e9ae6-3a02-4849-bfb6-8857aa080fd7"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ifa21535e233747e191e1efe06e939f24_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ3LTItMS0xLTM2NDA2MA_8565c2d4-aebc-4f58-91b5-efeb9e8de770"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="id9be7cc0cfdc4c01bd3cdefbc2db8865_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ4LTItMS0xLTM2NDA2MA_2b62dfdd-01f7-4ff6-9efe-4c65268ea7fa"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ic4a729e9da034ba9ba366e137ead0039_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ3LTItMS0xLTQyNjQ1Nw_942431bc-505a-47f2-8cd0-827c47a6630b"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i0fd91674dc3f4546ab4d9ec18c77344c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzQ5LTItMS0xLTM2NDA2MA_84e1bffd-317f-42bd-ab5b-4f02cda77eb1"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="iefa5c464887543849754b364afb61226_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzUwLTItMS0xLTM2NDA2MA_9796034b-8ed0-4482-9455-ad0cb463371e"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i806cb8bde2da41fa864ebe59f6439f93_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzUzLTItMS0xLTM2NDA2MA_0d2a2709-cb1c-4634-8765-04ca7e201680"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ic5677045852f43c3b14b4e3424e84806_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzUxLTItMS0xLTM3MDE2Ng_b384d50f-175e-465b-a389-b2161f878f3e"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i07d862e00e454435ba5778981fdd8d86_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzUwLTItMS0xLTQ2NjIyMA_06057847-6c79-4143-b5ce-ad290481c767"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i3d8c1c94ceb5454aaa207f9ba7d1e1d4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU0LTItMS0xLTM2NDA2MA_975386ab-acc8-4985-8782-710de279cf0e"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i0a16e6db8221468eb5b3b7969c6b0832_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU1LTItMS0xLTM2NDA2MA_cbb8137c-70aa-408b-b801-a8a00119b892"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="id426e598bb94421cb6e62308d8f1efee_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU1LTItMS0xLTQyNjQ3OQ_affb8c49-d188-4dbc-aa39-099e0a4bf86b"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i3d8b86bfb5a2496495c7585dc69b8b27_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU2LTItMS0xLTM2NDA2MA_b9d23717-5cc4-493b-a235-e08b7def395e"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="iecc505bcb14d4f708a5e5b413b0da850_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU1LTItMS0xLTM3MDE4Mg_599ff3c3-efa0-4315-8960-b9fb96cadcb1"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i58ff366114fa423c816fd9c7d12c6ee5_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU3LTItMS0xLTM2NDA2MA_c4ddefed-621a-4bc8-9a9a-8d782de05b96"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i5935a593578b42bd992125d84fde4c2b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzU5LTItMS0xLTM2NDA2MA_d8af0b96-17be-456b-8d53-323692229df9"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i5ab8aa458b2e4741896b715f331173c5_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYwLTItMS0xLTM2NDA2MA_f17ac460-85e8-44fe-a3fe-bee0de3b9df3"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="iea8d1294ee8a48b2acfe1c079ae36761_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYyLTItMS0xLTM2NDA2MA_799b0d82-ce5f-4442-9b29-5eb44c04fd2e"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i7457f5f4052d410aada699fd4a19b6f6_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYzLTItMS0xLTQyNjUyMw_cc70251f-3b65-4f44-b8bc-7edce6fdace8"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="iba8eb10b04bf4f299d1a467e30b4255c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYzLTItMS0xLTM2NDA2MA_f869f91c-0925-4f25-9d79-568e87f65841"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ifd6d3494d7da437f8fd0c9e1b7dcbdda_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzYzLTItMS0xLTM3MDE5OA_fb5e3a55-0d22-45d2-9383-6f8acc940a18"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i57aa1c00eabf4f6f995aa00fe1f4cad3_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzY2LTItMS0xLTM2NDA2MA_cd17a42a-62aa-4fb9-9bbf-bdbdc3f61ac1"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i52f9faf9cfa44dc0a653f6ac823bbff6_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzY3LTItMS0xLTM2NDA2MA_f542694f-4d13-40e3-bceb-f5c0b9ab09fe"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ie5770860577043ba89757912c7144758_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzY4LTItMS0xLTM2NDA2MA_7eb2a706-63c6-4b49-b976-b8874008dc0a"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i88db3e6c62364ad8b70611ef3579c3e0_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzY5LTItMS0xLTM2NDA2MA_570db97a-c173-474e-a8c4-ced68e9e45db"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i516dd1cd29b84843b7e8aab3e5a4c6e7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzcwLTItMS0xLTM2NDA2MA_46ec5b00-9aa4-47b7-93ec-c9ec850ba021"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i005b6ed2aeb1435ea08d3315ae40197b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozZGVjMzE5MjU4N2M0M2NjYWU2YzYzZjgxYjc2Mjk5ZC90YWJsZXJhbmdlOjNkZWMzMTkyNTg3YzQzY2NhZTZjNjNmODFiNzYyOTlkXzcxLTItMS0xLTM2NDA2MA_edf86d24-0343-4811-8de6-6bc72de75c38"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ic41db69eadcd4e9c982ed089e1167d58_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzEtMi0xLTEtMzY0MDYw_0b5d1132-57e8-4aea-816e-f3a80beeee78"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i5f0515138f7c418c9bcbb13c636c695c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzItMi0xLTEtMzY0MDYw_4198d1bc-42b6-4e89-ac68-93fa7c059e98"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i08e2f2cccd464d70abbd1e5f42eed60f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzMtMi0xLTEtMzY0MDYw_b8537a54-7210-4f1f-9189-f2541db8e4ce"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i60b9857f92eb49a8a8c2d24791c3ce46_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzQtMi0xLTEtMzY0MDYw_124bf1a5-e2d5-40d0-bdb0-7447c81380ee"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ie4d77d7546954bb39c5739590d22ed90_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzUtMi0xLTEtMzY0MDYw_8879d4ab-ae1b-4532-87bb-492c449169c3"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="icdfce984527840aa9096f39e4c594c81_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzYtMi0xLTEtMzY0MDYw_cefccf46-c51a-4eeb-b9b1-c418239a407c"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="idcba81032cc44b6d96e7841acb4c6f8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzctMi0xLTEtMzY0MDYw_23a54c31-85f5-4f71-8324-11a0f1596825"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ia84f6147917444bc85ac41f1fe48a282_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzgtMi0xLTEtMzY0MDYw_f4a7787b-778c-4c4a-abe3-b577d838a2eb"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ifa9d541bb2af4c559dbbaf5d6692d189_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzktMi0xLTEtMzY0MDYw_ee7d808f-02d4-4960-91c4-25f5480bdd23"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ie5307b0935b94772a58f8ea12f188818_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzEwLTItMS0xLTM2NDA2MA_197544fa-4999-4c88-8817-f30e1ba42932"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i08d853212613473facfe866d69b99234_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzExLTItMS0xLTM2NDA2MA_c06315d4-60ef-49df-9aa7-3793711819a4"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i1bbdc75c43824eb8a3de899e259da76c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzEyLTItMS0xLTM2NDA2MA_2a2a952f-d342-400f-9b43-3d9d3381d71b"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="icb9a553ac7e54b47a1eaa3597816db8e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzEzLTItMS0xLTM2NDA2MA_235a9436-449d-4c66-b249-cb95426dfe1f"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i37c82d3e1df445788ff372833849ae27_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzE0LTItMS0xLTM2NDA2MA_5f6876f1-4c33-4473-adc7-43b10161928c"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i87693c70bb4c4820b200f85cae0c40fe_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzE3LTItMS0xLTM2NDA2MA_78b06525-4d0d-4eaa-91bc-5408fbf98482"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i8482c94334704ac2a9f5d46f5b538414_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzE4LTItMS0xLTM2NDA2MA_0f5052ea-5657-4df9-bead-44a3740d0964"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ibcf097d2e4454d87b7c58b76251a2385_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzE5LTItMS0xLTM2NDA2MA_c6105b99-c00c-43fc-9c4a-892d9390d8d0"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i3b8053816d6a4e6c9e20fc4c30f781aa_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzIwLTItMS0xLTM2NDA2MA_b2725efc-c45b-4d3f-8692-e9b93303d85e"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ide7f7e63784f41a183803f0ac8a137e7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzIxLTItMS0xLTM3MDIyMA_82cd595b-f2b0-4a5f-a598-365220f4912f"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i718def90f99b44c1ace694608132b059_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzIyLTItMS0xLTQyNjUzNQ_746d77df-06bd-42b9-a229-777197af5d3c"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i983da08a0b754be2b43b04b0c13ea843_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozYTM4YzM5ZTUzYTc0ODFmOGUyYjIxYzQyNzlmZWY2My90YWJsZXJhbmdlOjNhMzhjMzllNTNhNzQ4MWY4ZTJiMjFjNDI3OWZlZjYzXzIzLTItMS0xLTQyNjUzNQ_2bf38286-6fc1-4eee-8c75-8a4deadce2fd"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i34818f54408849b78b0de1673856f0f8_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzEtMi0xLTEtMzY0MDYw_755bcaf1-97a5-4ccb-9d35-2e5fbddcac05"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i825c57dbd8964e30b031dee0899ee99f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzItMi0xLTEtMzY0MDYw_8cb8190e-32af-4c35-9021-5440b7f69c97"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i5e42794c886e4988b9410e7875fa4ea3_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzMtMi0xLTEtMzY0MDYw_aee6f569-ee5b-4a83-9622-8905b00b3210"
      unitRef="number">0.750</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i41868f27b25346e1b0eebd1483e1fc50_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQtMi0xLTEtMzY0MDYw_5cb1c123-9543-4e9b-9a6c-31d4cf2a0d29"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ica13971ef10f4193b4a67e7c1af3ebf7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzUtMi0xLTEtMzY0MDYw_d57986c8-09d7-4953-b950-328f62d9ce39"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i493a9c684cd24c618768ad51fe4c99b0_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzgtMi0xLTEtMzcwMjcw_043aa1f4-8dab-4b31-860c-6b3dcc001978"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ifeb9cb68f7eb4fca8a15ce101f73ec2d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzYtMi0xLTEtMzY0MDYw_0b84dc98-895b-4e75-a57c-c5efb41eb0a5"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i8be1a4c0cf864ca580eeff34de647013_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzctMi0xLTEtMzY0MDYw_f93a854b-38cc-46ca-95f0-43d0babce02a"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="id38ab6ac3a3140ee8c774a6c879777f4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzgtMi0xLTEtMzY0MDYw_99ae46cf-3787-4844-95f7-65d6aea1f346"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i42d8188e7be34beb9c79c609575725ce_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzktMi0xLTEtMzY0MDYw_3a17a2a6-54ad-47ed-9d71-793ee6bb5521"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="if7703f57c8434b53a13de4396f59696f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzEwLTItMS0xLTM2NDA2MA_c8b9b5ec-932d-4796-a561-c36b3433a1a1"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i7d8105546d9a43eba6a5ba0d273ef35d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE0LTItMS0xLTM3MDI4Ng_a06bd14b-d03a-4177-889a-5711b481b26d"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ic71d57fdeec447afb3b584aff6e7e598_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzExLTItMS0xLTM2NDA2MA_b48a5359-9942-49b2-8614-82aca7d4efa4"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i61fc86f2e0d54b88a9ae5af651e73bbf_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzEyLTItMS0xLTM2NDA2MA_59b771c7-074b-4cb6-b955-d69f7eb9b56e"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i5762c3305eac419d9d4d578ae3517cec_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzEzLTItMS0xLTM2NDA2MA_230829ff-2f95-4f5c-9e58-89e3d50330be"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="if523ef2e47944973b93e0232412ed5db_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE0LTItMS0xLTM2NDA2MA_a8eb0cba-d0ea-475e-b048-6dcd5c03ed35"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i319f41b8a18c4cf6b5f956ed40fbfa70_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE1LTItMS0xLTM2NDA2MA_7112c9dc-dd35-4c18-bd1f-9379f68bb682"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i72b45e8b7e194f42be530027f55dbd36_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE2LTItMS0xLTM2NDA2MA_be0ade73-6948-46ee-ae82-9b22f4ee7d7d"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ic82939cbfa4e4308b5c954a528b904b3_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE3LTItMS0xLTM2NDA2MA_40131075-4610-48c6-a13d-33baa44001ca"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i21ea9e0d97b84ea8bed89d96c90b4a4c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE4LTItMS0xLTM2NDA2MA_8799e3eb-2db8-483a-83f9-c17314ef3f3d"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i8a61deb6118546cca9152a3d19ca7ded_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzE5LTItMS0xLTM2NDA2MA_d1cbd4f7-c82a-425c-98cf-0e9b458bead2"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i5b77c884d5cf4c459d41322e688941e2_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzIwLTItMS0xLTM2NDA2MA_70494314-f76a-4e56-8973-c4cdea9348c7"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i2d8c63a1688f487f8f48b66b144d7b14_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzIxLTItMS0xLTM2NDA2MA_e8a64329-09c7-47e1-a186-9797726a46c4"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i235e682ab77a4e1b83eb628a686cb67d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI2LTItMS0xLTQ2NjMwMw_b76f96d5-903e-490f-a435-76cfdf83dd72"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i94cfec9a31f2484bbf3be22fda030c95_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzIyLTItMS0xLTM2NDA2MA_d9208233-2448-49ac-b52b-7c53ef50f288"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i9265b4b9635b4f268661bb9af41d4910_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzIzLTItMS0xLTM2NDA2MA_faf82cdc-ba55-4d11-b312-ba324f2a0f6b"
      unitRef="number">0.998</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i4ac69def9695452fa8056d9a9cf37f80_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI5LTItMS0xLTQ2NjM0OQ_9bfc8b80-2783-4f8e-b661-21817044b18f"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ie7215e66652242c888d9188932de83ef_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI0LTItMS0xLTM2NDA2MA_3be12934-cfc9-4750-b70a-e7051f8897dc"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="icd902f48e4e0470789302c7c306a7226_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI1LTItMS0xLTM2NDA2MA_80ee68e0-58fa-4a3b-b598-ec59217c23f5"
      unitRef="number">0.604</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i3427ee82661045e69654d0f7f3c81b5f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI2LTItMS0xLTM2NDA2MA_67f1133a-06c7-4c3e-b04e-bca9ccb7dad6"
      unitRef="number">0.999</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i931de8c63c0a4132b7dc27fd739de9ee_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI4LTItMS0xLTM2NDA2MA_f48c33dc-2d85-490a-8cfc-6b2f27e181a2"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="if83f0c24152340948edc3fce389f90bc_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzI5LTItMS0xLTM2NDA2MA_66ea2f32-5858-4b2b-9157-6771ff4203b0"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ia183f27f20164e5db33ab876c94506f6_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzMwLTItMS0xLTM2NDA2MA_dc7e7c25-c57c-4d41-953d-6da1bbf45184"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ie4658ecaa90e474bbf5ced2fcc7ac5a2_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzMyLTItMS0xLTM2NDA2MA_1cc52738-6d0a-411a-afc9-39a5779f6cec"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="id812b34881814260a4fde8dbd44c51c6_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzMzLTItMS0xLTM2NDA2MA_02825bb4-9a57-4002-a13f-1241fcb5aeae"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ic471ab2e84ae4923a1e2dd798a44a353_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzM0LTItMS0xLTM2NDA2MA_bc81fd7a-58ed-4cad-8271-4dbc7f93e5a3"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i05626dc1fd684848a779e5531a41d341_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzM2LTItMS0xLTM2NDA2MA_b99ee4e9-5522-44a9-b9f2-2db4be78ad4b"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i18812706bbaf4fcd8256d1807ae64a5c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzM3LTItMS0xLTM2NDA2MA_7ddf1a36-869a-4c4c-8e37-18ce11dfce5a"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i2dfc1df9889e46c0a941ac9f24266a01_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzM4LTItMS0xLTM2NDA2MA_fa9ec489-414e-4fde-99c6-fd2ef81d0d2e"
      unitRef="number">0.529</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="id621d1155a9144f2a85532c3bfa7cd75_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzM5LTItMS0xLTM2NDA2MA_d7c056aa-c16e-4bb0-b252-57931df1e2f6"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i81604c6ae3a740b7ab7f5a449eff82c5_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ0LTItMS0xLTM3MDMzMQ_49112d14-c93a-4b1f-b270-df3d05d82a98"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i1f0dab49c934466b9cc002391f7bc3f0_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQwLTItMS0xLTM2NDA2MA_1d9067af-f1fe-4bfb-9f9f-88ff6567bea9"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i0d7249e960a449009edd04541ebb0a9a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQxLTItMS0xLTM2NDA2MA_b9bebf58-f16d-4e0c-ac3a-e22824b622fc"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ia5941a7f40b04bed9aab3ca1870c53f3_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ4LTItMS0xLTM3MDM1NQ_fd52d311-12c3-4641-8aae-19eef67e7eb3"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i3aa25010b3d247be8ea308b7d38e3498_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQzLTItMS0xLTM2NDA2MA_ae8aec65-90a9-46f2-8341-a928f8b40e14"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i4036a3cf2bd8487cabda1ea457bd5fcf_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ0LTItMS0xLTM2NDA2MA_802fec89-731c-447d-90f5-2f426b1ff698"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i1d6ea91a03cb4a04ba283518cfb3a3b8_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzUxLTItMS0xLTM3MDQ1NA_6e5c07ad-e391-4c5c-850d-a06e7a6b4efd"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ie8ba60949d764ee68bd5fa3cae3fd182_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ1LTItMS0xLTM2NDA2MA_f355e0de-d824-4312-84e8-630fd3b1a12a"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i5ad82677839649138379e9cf405edc11_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ2LTItMS0xLTM2NDA2MA_4c2ab2b2-04a7-4507-823b-562992fe2cc3"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i0d616d9fdf31436c85f6dd196bbba8da_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ3LTItMS0xLTM2NDA2MA_54e6a954-60dd-4f29-83f2-71c18c2b3ca9"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="ic3ab1d4e7a0b42c08245f856927cb942_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ4LTItMS0xLTM2NDA2MA_0b04c542-67c4-48dd-9884-52032ca6f09b"
      unitRef="number">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="i7dfc5328cd614aacab6fbc5dcd73b515_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozM2Y2MTFkNjM3ZjQ0ODQwYmMwYjk4YjNiZmFjYWJhYi90YWJsZXJhbmdlOjMzZjYxMWQ2MzdmNDQ4NDBiYzBiOThiM2JmYWNhYmFiXzQ5LTItMS0xLTM2NDA2MA_aa69c3f0-76e1-4a87-86b8-ab68c7c743bb"
      unitRef="number">0.850</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <sny:DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90ZXh0cmVnaW9uOjgzZjJjZTY0YWFkNDQyOWNiMzA3OTYwMjc5MWEzZDQ1XzI5MA_cdc5ea8e-93f0-4dea-b5db-b74e23856158">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.820%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial interest (%) as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;GlaxoSmithKline Consumer Healthcare, L.P.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Infraserv GmbH&#160;&amp;amp; Co. H&#xf6;chst KG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maphar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Morocco&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MCM Vaccine B.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Netherlands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MSP Vaccine Company (formerly MCM company)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;EUROAPI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#262626;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock>
    <ifrs-full:ProportionOfOwnershipInterestInJointOperation
      contextRef="ic8a871b1ed6b455f8d1c0cea30f525e8_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzItMi0xLTEtMzY0MDYw_051ec10e-65ba-4ae6-a181-e9489aa0ba3a"
      unitRef="number">0.117</ifrs-full:ProportionOfOwnershipInterestInJointOperation>
    <ifrs-full:ProportionOfOwnershipInterestInJointOperation
      contextRef="i52895c33c77b401c852cf418dd101085_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzMtMi0xLTEtMzY0MDYw_755f7172-639e-4787-826e-0a8d00349d4b"
      unitRef="number">0.312</ifrs-full:ProportionOfOwnershipInterestInJointOperation>
    <ifrs-full:ProportionOfOwnershipInterestInJointOperation
      contextRef="i7effbd9d99be4fa09eb11d6a24112790_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzQtMi0xLTEtMzY0MDYw_f49bf7fc-33a3-46ab-9270-c1d905af36f4"
      unitRef="number">0.483</ifrs-full:ProportionOfOwnershipInterestInJointOperation>
    <ifrs-full:ProportionOfOwnershipInterestInJointOperation
      contextRef="i9db2167110a34e338dda46b7b37c973b_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzUtMi0xLTEtMzY0MDYw_b7a8c548-e9c1-48dd-9919-f454af64f2b3"
      unitRef="number">0.500</ifrs-full:ProportionOfOwnershipInterestInJointOperation>
    <ifrs-full:ProportionOfOwnershipInterestInJointOperation
      contextRef="i57640986aa3c447c9a69578a8c50672a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzYtMi0xLTEtMzY0MDYw_3485eaaf-4cbf-4ad7-bd43-6bc5fe065577"
      unitRef="number">0.500</ifrs-full:ProportionOfOwnershipInterestInJointOperation>
    <ifrs-full:ProportionOfOwnershipInterestInJointOperation
      contextRef="i634adddc2f7149a6b915f960673b1b38_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDMvZnJhZzo4M2YyY2U2NGFhZDQ0MjljYjMwNzk2MDI3OTFhM2Q0NS90YWJsZTozMjMxODk4ZTIzZDI0Y2E0YjFjM2VjNTIwNGY0NjhmNC90YWJsZXJhbmdlOjMyMzE4OThlMjNkMjRjYTRiMWMzZWM1MjA0ZjQ2OGY0XzctMi0xLTEtMzcwNDQx_1989f73e-ca4e-41a7-85da-d288802b5c81"
      unitRef="number">0.301</ifrs-full:ProportionOfOwnershipInterestInJointOperation>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory
      contextRef="if15c8e82a1264626929110026e2a5d8e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDYvZnJhZzoxNTVhYzA5MWUzODA0MTYwODRhODJmNTgyZTM5M2Y2Zi90ZXh0cmVnaW9uOjE1NWFjMDkxZTM4MDQxNjA4NGE4MmY1ODJlMzkzZjZmXzExNDA_c0c08821-8a32-46fe-bfc5-6739efdbfba1">Events subsequent to December 31, 2022&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;On February 22, 2023, the US Food and Drug Administration (FDA) approved ALTUVIIIO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. That decision resulted in the reversal, in 2022 books, of &#x20ac;2,154&#160;million of impairment losses against the intangible assets associated with the Eloctate franchise, in accordance with IAS 36 (Impairment of Assets); the asset had been partially written down in 2019. For more information please refer to Note D.5. to the financial statements of the present annual report. The adjustment is presented within the line item &lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt; in the consolidated income statement; the net impact after tax is &#x20ac;1,651&#160;million.&lt;/span&gt;</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount
      contextRef="i9b81437bb0bc49abac2a243bae255b03_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDYvZnJhZzoxNTVhYzA5MWUzODA0MTYwODRhODJmNTgyZTM5M2Y2Zi90ZXh0cmVnaW9uOjE1NWFjMDkxZTM4MDQxNjA4NGE4MmY1ODJlMzkzZjZmXzg1NzYxOTA2OTcyNjc2_4534771f-739f-4e27-9528-6fbfec58880a"
      unitRef="eur">2154000000</sny:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="i9b81437bb0bc49abac2a243bae255b03_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl83MDYvZnJhZzoxNTVhYzA5MWUzODA0MTYwODRhODJmNTgyZTM5M2Y2Zi90ZXh0cmVnaW9uOjE1NWFjMDkxZTM4MDQxNjA4NGE4MmY1ODJlMzkzZjZmXzg1NzYxOTA2OTcyNjky_9d05fb3d-f939-47a9-bb91-3e909cc364b1"
      unitRef="eur">1651000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTMtMS0xLTM2NDA2MA_217e0ead-39cc-4dbd-abcd-ae1f822db699"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTMtMS0xLTM2NDA2MA_217e0ead-39cc-4dbd-abcd-ae1f822db699"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This line includes the use of existing shares to fulfill vested rights under restricted share plans.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTMtMS0xLTM2NDA2MA_217e0ead-39cc-4dbd-abcd-ae1f822db699"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See Notes&#160;D.15.1., D.15.3., D.15.4. and D.15.5.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTMtMS0xLTM2NDA2MA_217e0ead-39cc-4dbd-abcd-ae1f822db699"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTctMS0xLTM2NDA2MA_c0c113d9-32b7-4444-a088-c2774c355f21"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTctMS0xLTM2NDA2MA_c0c113d9-32b7-4444-a088-c2774c355f21"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTctMS0xLTM2NDA2MA_c0c113d9-32b7-4444-a088-c2774c355f21"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTctMS0xLTM2NDA2MA_c0c113d9-32b7-4444-a088-c2774c355f21"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTMtMS0xLTM2NDA2MA_a3cc8a2b-319d-4917-9c92-6369a3ca6160"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTMtMS0xLTM2NDA2MA_a3cc8a2b-319d-4917-9c92-6369a3ca6160"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTMtMS0xLTM2NDA2MA_a3cc8a2b-319d-4917-9c92-6369a3ca6160"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTMtMS0xLTM2NDA2MA_a3cc8a2b-319d-4917-9c92-6369a3ca6160"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTQtMS0xLTM2NDA2MA_a54887eb-413f-4b98-aa4f-8a4294525ef9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTQtMS0xLTM2NDA2MA_a54887eb-413f-4b98-aa4f-8a4294525ef9"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTQtMS0xLTM2NDA2MA_a54887eb-413f-4b98-aa4f-8a4294525ef9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTQtMS0xLTM2NDA2MA_a54887eb-413f-4b98-aa4f-8a4294525ef9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTQtMS0xLTM2NDA2MA_c0f9ae73-8f74-48e5-80b3-a5993099957c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTQtMS0xLTM2NDA2MA_c0f9ae73-8f74-48e5-80b3-a5993099957c"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTQtMS0xLTM2NDA2MA_c0f9ae73-8f74-48e5-80b3-a5993099957c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTQtMS0xLTM2NDA2MA_c0f9ae73-8f74-48e5-80b3-a5993099957c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktNS0xLTEtMzY0MDYw_753747be-20ce-4c5c-88ce-259f463a8b67"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktNS0xLTEtMzY0MDYw_753747be-20ce-4c5c-88ce-259f463a8b67"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(j)&#160;&#160;&#160;&#160;Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktNS0xLTEtMzY0MDYw_753747be-20ce-4c5c-88ce-259f463a8b67"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQz_4413e2d3-0704-4581-a253-6ac595b10cd5" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQz_4413e2d3-0704-4581-a253-6ac595b10cd5" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(c) This line item includes contributions paid to pension funds (see Note&#160;D.19.1.).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktNS0xLTEtMzY0MDYw_753747be-20ce-4c5c-88ce-259f463a8b67"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQz_4413e2d3-0704-4581-a253-6ac595b10cd5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTUtMS0xLTM2NDA2MA_f7575fc6-2ec7-4422-9290-f9eb402e6ed8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTUtMS0xLTM2NDA2MA_f7575fc6-2ec7-4422-9290-f9eb402e6ed8"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTUtMS0xLTM2NDA2MA_f7575fc6-2ec7-4422-9290-f9eb402e6ed8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ1_51450c7d-26aa-43d2-ada2-6a14149956df" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ1_51450c7d-26aa-43d2-ada2-6a14149956df" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(e) Including:</xhtml:span></xhtml:div><xhtml:div style="margin-bottom:5pt;text-align:justify"><xhtml:table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.973%"><xhtml:tr><xhtml:td style="width:1.0%"/><xhtml:td style="width:56.174%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:13.141%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:13.141%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:13.144%"/><xhtml:td style="width:0.1%"/></xhtml:tr><xhtml:tr><xhtml:td colspan="3" style="padding:0 1pt"/><xhtml:td
              colspan="3"
              style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</xhtml:span></xhtml:td><xhtml:td
              colspan="3"
              style="padding:2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</xhtml:span></xhtml:td><xhtml:td
              colspan="3"
              style="padding:2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#21004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</xhtml:span></xhtml:td></xhtml:tr><xhtml:tr><xhtml:td
              colspan="3"
              style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:div style="padding-left:11.34pt;text-indent:-11.34pt"><xhtml:span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#x2022;</xhtml:span><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Income tax paid</xhtml:span></xhtml:div></xhtml:td><xhtml:td
              colspan="2"
              style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,452)</xhtml:span></xhtml:td><xhtml:td style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td
              colspan="2"
              style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,280)</xhtml:span></xhtml:td><xhtml:td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td
              colspan="2"
              style="border-top:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,051)</xhtml:span></xhtml:td><xhtml:td style="border-top:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr><xhtml:tr><xhtml:td
              colspan="3"
              style="padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:div style="padding-left:11.34pt;text-indent:-11.34pt"><xhtml:span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#x2022;</xhtml:span><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Interest paid</xhtml:span></xhtml:div></xhtml:td><xhtml:td
              colspan="2"
              style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(380)</xhtml:span></xhtml:td><xhtml:td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td
              colspan="2"
              style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(334)</xhtml:span></xhtml:td><xhtml:td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td
              colspan="2"
              style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(315)</xhtml:span></xhtml:td><xhtml:td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr><xhtml:tr><xhtml:td
              colspan="3"
              style="padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:div style="padding-left:11.34pt;text-indent:-11.34pt"><xhtml:span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#x2022;</xhtml:span><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Interest received</xhtml:span></xhtml:div></xhtml:td><xhtml:td
              colspan="2"
              style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td
              colspan="2"
              style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</xhtml:span></xhtml:td><xhtml:td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td
              colspan="2"
              style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</xhtml:span></xhtml:td><xhtml:td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr><xhtml:tr><xhtml:td
              colspan="3"
              style="border-bottom:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:div style="padding-left:11.34pt;text-indent:-11.34pt"><xhtml:span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#x2022;</xhtml:span><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;padding-left:8.95pt">Dividends received from non-consolidated entities</xhtml:span></xhtml:div></xhtml:td><xhtml:td
              colspan="2"
              style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#e7e7e8;border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td
              colspan="2"
              style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</xhtml:span></xhtml:td><xhtml:td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td
              colspan="2"
              style="border-bottom:0.5pt solid #21004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#x2014;&#160;</xhtml:span></xhtml:td><xhtml:td style="border-bottom:0.5pt solid #21004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr></xhtml:table></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTUtMS0xLTM2NDA2MA_f7575fc6-2ec7-4422-9290-f9eb402e6ed8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ1_51450c7d-26aa-43d2-ada2-6a14149956df"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTctMS0xLTM2NDA2MA_cf7f4845-b348-4256-9769-f70e15885bba"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTctMS0xLTM2NDA2MA_cf7f4845-b348-4256-9769-f70e15885bba"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTctMS0xLTM2NDA2MA_cf7f4845-b348-4256-9769-f70e15885bba"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTctMS0xLTM2NDA2MA_cf7f4845-b348-4256-9769-f70e15885bba"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTUtMS0xLTM2NDA2MA_9c0bd19e-35c4-4872-af6a-47f8e4217b03"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTUtMS0xLTM2NDA2MA_9c0bd19e-35c4-4872-af6a-47f8e4217b03"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTUtMS0xLTM2NDA2MA_9c0bd19e-35c4-4872-af6a-47f8e4217b03"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ0_06a9dadf-45f8-44b4-82fa-41db2fe39be6" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ0_06a9dadf-45f8-44b4-82fa-41db2fe39be6" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(d) This line item mainly comprises unrealized foreign exchange gains and losses arising on the remeasurement of monetary items in non-functional currencies and on instruments used to hedge such items.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTUtMS0xLTM2NDA2MA_9c0bd19e-35c4-4872-af6a-47f8e4217b03"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ0_06a9dadf-45f8-44b4-82fa-41db2fe39be6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTktMS0xLTM2NDA2MA_4583d946-900e-45c5-9fef-2daede5d4639"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTktMS0xLTM2NDA2MA_4583d946-900e-45c5-9fef-2daede5d4639"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTktMS0xLTM2NDA2MA_4583d946-900e-45c5-9fef-2daede5d4639"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTktMS0xLTM2NDA2MA_4583d946-900e-45c5-9fef-2daede5d4639"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTktMS0xLTM2NDA2MA_d8a8feb1-1cfa-42fb-bf37-81ef1afefc31"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTktMS0xLTM2NDA2MA_d8a8feb1-1cfa-42fb-bf37-81ef1afefc31"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTktMS0xLTM2NDA2MA_d8a8feb1-1cfa-42fb-bf37-81ef1afefc31"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTktMS0xLTM2NDA2MA_d8a8feb1-1cfa-42fb-bf37-81ef1afefc31"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtNS0xLTEtMzY0MDYw_659a6192-01c2-43a4-bc97-bcef7fd46f67"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtNS0xLTEtMzY0MDYw_659a6192-01c2-43a4-bc97-bcef7fd46f67"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQx_05e590d1-51db-4ca8-b860-337a3c2ef7a6" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQx_05e590d1-51db-4ca8-b860-337a3c2ef7a6" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(a) Includes non-current financial assets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtNS0xLTEtMzY0MDYw_659a6192-01c2-43a4-bc97-bcef7fd46f67"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQx_05e590d1-51db-4ca8-b860-337a3c2ef7a6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtNS0xLTEtMzY0MDYw_659a6192-01c2-43a4-bc97-bcef7fd46f67"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTQtMS0xLTM2NDA2MA_7ccde0a3-7066-40e2-8a3b-eaaff4071556"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTQtMS0xLTM2NDA2MA_7ccde0a3-7066-40e2-8a3b-eaaff4071556"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTQtMS0xLTM2NDA2MA_7ccde0a3-7066-40e2-8a3b-eaaff4071556"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTQtMS0xLTM2NDA2MA_7ccde0a3-7066-40e2-8a3b-eaaff4071556"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTEtMS0xLTM2NDA2MA_d98f69dc-b0f1-4cc8-b70b-7984fd78a6c5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTEtMS0xLTM2NDA2MA_d98f69dc-b0f1-4cc8-b70b-7984fd78a6c5"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTEtMS0xLTM2NDA2MA_d98f69dc-b0f1-4cc8-b70b-7984fd78a6c5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTEtMS0xLTM2NDA2MA_d98f69dc-b0f1-4cc8-b70b-7984fd78a6c5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTUtMS0xLTM2NDA2MA_86f873a5-ea9d-496d-9826-7012e349d45f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTUtMS0xLTM2NDA2MA_86f873a5-ea9d-496d-9826-7012e349d45f"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTUtMS0xLTM2NDA2MA_86f873a5-ea9d-496d-9826-7012e349d45f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ2_7c2dd840-1374-4610-964f-c966ea4bc4b5" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ2_7c2dd840-1374-4610-964f-c966ea4bc4b5" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(f)&#160;&#160;&#160;&#160;This line item includes payments made in respect of contingent consideration identified and recognized as a liability in business combinations. For 2022, it includes the net cash outflow on the acquisition of Amunix (see Note&#160;D.1.). For 2021, it includes the net cash outflows on the acquisitions of Kymab, Kiadis, Tidal, Translate Bio, Kadmon and Origimm (see Note&#160;D.2.1.). For 2020, it includes the net cash outflows on the acquisitions of Synthorx and Principia (see Note&#160;D.2.2.).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTUtMS0xLTM2NDA2MA_86f873a5-ea9d-496d-9826-7012e349d45f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ2_7c2dd840-1374-4610-964f-c966ea4bc4b5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTUtMS0xLTM2NDA2MA_4ed2c3d5-36ff-4dc1-9b89-c7736363a07b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTUtMS0xLTM2NDA2MA_4ed2c3d5-36ff-4dc1-9b89-c7736363a07b"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTUtMS0xLTM2NDA2MA_4ed2c3d5-36ff-4dc1-9b89-c7736363a07b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ3_eca3b69e-ddc5-40c4-8c60-b88736c10615" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ3_eca3b69e-ddc5-40c4-8c60-b88736c10615" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(g</xhtml:span><xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">)&#160;&#160;&#160;&#160;</xhtml:span><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">For 2022, 2021 and 2020, this line item mainly comprises disposals of assets and activities related to portfolio streamlining and disposals of equity and debt instruments.</xhtml:span><xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> For 2020, it also includes the sale to Baxter of operations relating to Seprafilm</xhtml:span><xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#xae;</xhtml:span><xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> for a selling price (before taxes) of &#x20ac;311&#160;million. </xhtml:span><xhtml:span style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(see&#160;Note&#160;D.7.1.).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTUtMS0xLTM2NDA2MA_4ed2c3d5-36ff-4dc1-9b89-c7736363a07b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ3_eca3b69e-ddc5-40c4-8c60-b88736c10615"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTktMS0xLTM2NDA2MA_0c6b15d9-7af1-4550-b2ef-c670cd3ad5bf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTktMS0xLTM2NDA2MA_0c6b15d9-7af1-4550-b2ef-c670cd3ad5bf"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTktMS0xLTM2NDA2MA_0c6b15d9-7af1-4550-b2ef-c670cd3ad5bf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTktMS0xLTM2NDA2MA_0c6b15d9-7af1-4550-b2ef-c670cd3ad5bf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctNS0xLTEtMzY0MDYw_28c8f930-0ea6-4980-abbd-c6e02f40ffad"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctNS0xLTEtMzY0MDYw_28c8f930-0ea6-4980-abbd-c6e02f40ffad"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQy_cf6c8d9b-a5aa-4ad1-a1e9-53e2186cf56f" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQy_cf6c8d9b-a5aa-4ad1-a1e9-53e2186cf56f" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(b) The gain on the sale of Regeneron shares is presented net of taxes, including deferred taxes of &#x20ac;115&#160;million.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctNS0xLTEtMzY0MDYw_28c8f930-0ea6-4980-abbd-c6e02f40ffad"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQy_cf6c8d9b-a5aa-4ad1-a1e9-53e2186cf56f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctNS0xLTEtMzY0MDYw_28c8f930-0ea6-4980-abbd-c6e02f40ffad"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTEtMS0xLTM2NDA2MA_3b202fd8-00e4-487b-87e9-9a7b27f67620"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTEtMS0xLTM2NDA2MA_3b202fd8-00e4-487b-87e9-9a7b27f67620"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTEtMS0xLTM2NDA2MA_3b202fd8-00e4-487b-87e9-9a7b27f67620"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTEtMS0xLTM2NDA2MA_3b202fd8-00e4-487b-87e9-9a7b27f67620"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTItMS0xLTM2NDA2MA_83a539ae-f2b8-47b7-9f22-1165eb4c8b79"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTItMS0xLTM2NDA2MA_83a539ae-f2b8-47b7-9f22-1165eb4c8b79"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTItMS0xLTM2NDA2MA_83a539ae-f2b8-47b7-9f22-1165eb4c8b79"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTItMS0xLTM2NDA2MA_83a539ae-f2b8-47b7-9f22-1165eb4c8b79"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NzQ4Mg_2c17decc-29d6-4783-a5a8-9d236cef3b39"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NzQ4Mg_2c17decc-29d6-4783-a5a8-9d236cef3b39"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ4_35ca4623-8801-4945-8e8e-9bd5409bc25f" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ4_35ca4623-8801-4945-8e8e-9bd5409bc25f" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(h)&#160;&#160;&#160;&#160;For 2022, this line item includes the net cash inflows (before taxes) of &#x20ac;101&#160;million on the divestment of EUROAPI (see Note&#160;D.1).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NzQ4Mg_2c17decc-29d6-4783-a5a8-9d236cef3b39"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ4_35ca4623-8801-4945-8e8e-9bd5409bc25f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NzQ4Mg_2c17decc-29d6-4783-a5a8-9d236cef3b39"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTctMS0xLTM2NDA2MA_a399014e-7c97-4436-a95a-792d15aba016"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTctMS0xLTM2NDA2MA_a399014e-7c97-4436-a95a-792d15aba016"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTctMS0xLTM2NDA2MA_a399014e-7c97-4436-a95a-792d15aba016"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTctMS0xLTM2NDA2MA_a399014e-7c97-4436-a95a-792d15aba016"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTUtMS0xLTM2NDA2MA_77055e13-a439-40d7-b46e-ed1a0852390e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTUtMS0xLTM2NDA2MA_77055e13-a439-40d7-b46e-ed1a0852390e"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTUtMS0xLTM2NDA2MA_77055e13-a439-40d7-b46e-ed1a0852390e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ5_a854f423-a49a-4d25-83ec-b6c61a89c384" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ5_a854f423-a49a-4d25-83ec-b6c61a89c384" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(i)&#160;&#160;&#160;&#160;This line item includes realized foreign exchange differences on (i)&#160;cash and cash equivalents in non-functional currencies (primarily the US dollar) and (ii)&#160;derivative instruments used to manage such cash and cash equivalents.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTUtMS0xLTM2NDA2MA_77055e13-a439-40d7-b46e-ed1a0852390e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ5_a854f423-a49a-4d25-83ec-b6c61a89c384"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTEtMS0xLTM2NDA2MA_33fae6b3-9207-4d19-9d97-7ee96a7e8cb0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTEtMS0xLTM2NDA2MA_33fae6b3-9207-4d19-9d97-7ee96a7e8cb0"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTEtMS0xLTM2NDA2MA_33fae6b3-9207-4d19-9d97-7ee96a7e8cb0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE0LTEtMS0xLTM2NDA2MA_33fae6b3-9207-4d19-9d97-7ee96a7e8cb0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTItMS0xLTM2NDA2MA_7d7feed9-e45b-4567-ae2c-b2271c3b7e4c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTItMS0xLTM2NDA2MA_7d7feed9-e45b-4567-ae2c-b2271c3b7e4c"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTItMS0xLTM2NDA2MA_7d7feed9-e45b-4567-ae2c-b2271c3b7e4c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTItMS0xLTM2NDA2MA_7d7feed9-e45b-4567-ae2c-b2271c3b7e4c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTItMS0xLTM2NDA2MA_c4a51e91-2309-4fbe-b254-e8eb14d6d2dd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTItMS0xLTM2NDA2MA_c4a51e91-2309-4fbe-b254-e8eb14d6d2dd"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTItMS0xLTM2NDA2MA_c4a51e91-2309-4fbe-b254-e8eb14d6d2dd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzExLTItMS0xLTM2NDA2MA_c4a51e91-2309-4fbe-b254-e8eb14d6d2dd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTMtMS0xLTM2NDA2MA_ca2b6a8e-c22e-4f5c-b27f-219af0cd4527"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTMtMS0xLTM2NDA2MA_ca2b6a8e-c22e-4f5c-b27f-219af0cd4527"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTMtMS0xLTM2NDA2MA_ca2b6a8e-c22e-4f5c-b27f-219af0cd4527"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzExLTMtMS0xLTM2NDA2MA_ca2b6a8e-c22e-4f5c-b27f-219af0cd4527"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzNg_b0b2e7dd-daa6-4be9-94c6-ea1cb98b13c3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTItMS0xLTM2NzQ3OQ_936bff2b-5c05-4544-b8a8-f59222607c67"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTItMS0xLTM2NzQ3OQ_936bff2b-5c05-4544-b8a8-f59222607c67"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTMtMS0xLTM2NzQ3MA_47f62225-cc47-4815-8201-aeb2b6746255"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTMtMS0xLTM2NzQ3MA_47f62225-cc47-4815-8201-aeb2b6746255"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTItMS0xLTM2NzQ3OQ_936bff2b-5c05-4544-b8a8-f59222607c67"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ4_35ca4623-8801-4945-8e8e-9bd5409bc25f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTMtMS0xLTM2NzQ3MA_47f62225-cc47-4815-8201-aeb2b6746255"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ4_35ca4623-8801-4945-8e8e-9bd5409bc25f"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM2LTUtMS0xLTM2NDA2MA_f3b5168f-b60d-481f-b2f9-0bb8d1bf62bf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM2LTUtMS0xLTM2NDA2MA_f3b5168f-b60d-481f-b2f9-0bb8d1bf62bf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM3LTUtMS0xLTM2NDA2MA_5d3d6b03-c339-483e-b43d-69ccb0089d93"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM3LTUtMS0xLTM2NDA2MA_5d3d6b03-c339-483e-b43d-69ccb0089d93"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQxLTUtMS0xLTM2NDA2MA_54ce4fb9-1abe-44c5-b71d-58f396cbf084"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQxLTUtMS0xLTM2NDA2MA_54ce4fb9-1abe-44c5-b71d-58f396cbf084"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ2LTUtMS0xLTM2NDA2MA_b73eca4b-a452-40df-974d-91a078599ec9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ2LTUtMS0xLTM2NDA2MA_b73eca4b-a452-40df-974d-91a078599ec9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NDA2MA_80b331d7-f29e-4957-9b17-0946b17201e5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NDA2MA_80b331d7-f29e-4957-9b17-0946b17201e5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMtNS0xLTEtMzY0MDYw_64118034-3ca5-4b9b-8c19-e2ae333dc82e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMtNS0xLTEtMzY0MDYw_64118034-3ca5-4b9b-8c19-e2ae333dc82e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI4LTUtMS0xLTM2NDA2MA_c4db135c-f14b-48b6-90a1-2f41650c4e3b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI4LTUtMS0xLTM2NDA2MA_c4db135c-f14b-48b6-90a1-2f41650c4e3b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM1LTUtMS0xLTM2NDA2MA_4fbb4788-3acc-4c59-93b1-ea49ead9c567"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM1LTUtMS0xLTM2NDA2MA_4fbb4788-3acc-4c59-93b1-ea49ead9c567"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMyLTUtMS0xLTM2NDA2MA_443a4622-44ef-476a-9baf-ad2ba6cdc5ff"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMyLTUtMS0xLTM2NDA2MA_443a4622-44ef-476a-9baf-ad2ba6cdc5ff"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ0LTUtMS0xLTM2NDA2MA_ae5b4a07-2634-44a8-95cf-f6f030408c0f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ0LTUtMS0xLTM2NDA2MA_ae5b4a07-2634-44a8-95cf-f6f030408c0f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE1LTUtMS0xLTM2NDA2MA_f9adf783-6975-40b3-ae86-95facc12396c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE1LTUtMS0xLTM2NDA2MA_f9adf783-6975-40b3-ae86-95facc12396c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzUtNS0xLTEtMzY0MDYw_037866be-74fb-4379-95c5-7391b8f0a643"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzUtNS0xLTEtMzY0MDYw_037866be-74fb-4379-95c5-7391b8f0a643"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI0LTUtMS0xLTM2NDA2MA_05a9ca15-42e7-4edf-8810-aed4004b5a47"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI0LTUtMS0xLTM2NDA2MA_05a9ca15-42e7-4edf-8810-aed4004b5a47"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ1LTUtMS0xLTM2NDA2MA_ed1062a4-594a-4fc8-99f0-7c16dbf21f94"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ1LTUtMS0xLTM2NDA2MA_ed1062a4-594a-4fc8-99f0-7c16dbf21f94"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMzLTUtMS0xLTM2NDA2MA_63eb69a4-450d-440b-950d-c52013cdb3a4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMzLTUtMS0xLTM2NDA2MA_63eb69a4-450d-440b-950d-c52013cdb3a4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzgtNS0xLTEtMzY0MDYw_42fd12c3-44d7-4452-833d-9a4e29d9f0dc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzgtNS0xLTEtMzY0MDYw_42fd12c3-44d7-4452-833d-9a4e29d9f0dc"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIyLTUtMS0xLTM2NDA2MA_28ccd4d4-b955-4456-a936-7c6235cf39ab"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIyLTUtMS0xLTM2NDA2MA_28ccd4d4-b955-4456-a936-7c6235cf39ab"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE2LTUtMS0xLTM2NDA2MA_08b6afa3-6337-4c4a-bb0a-3379dc726454"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE2LTUtMS0xLTM2NDA2MA_08b6afa3-6337-4c4a-bb0a-3379dc726454"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE0LTUtMS0xLTM2NDA2MA_31c45ffd-1947-40f9-ad6a-89ca1c9f0bbd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE0LTUtMS0xLTM2NDA2MA_31c45ffd-1947-40f9-ad6a-89ca1c9f0bbd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQtNS0xLTEtMzY0MDYw_dc70927f-9041-43c6-879f-2565b16819ee"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQtNS0xLTEtMzY0MDYw_dc70927f-9041-43c6-879f-2565b16819ee"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE3LTUtMS0xLTM2NDA2MA_bd5603e6-aced-48de-980d-85d04fadce07"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE3LTUtMS0xLTM2NDA2MA_bd5603e6-aced-48de-980d-85d04fadce07"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMwLTUtMS0xLTM2NDA2MA_d97178c3-e549-40aa-89d0-58737b61a38c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMwLTUtMS0xLTM2NDA2MA_d97178c3-e549-40aa-89d0-58737b61a38c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzExLTUtMS0xLTM2NDA2MA_22f5816e-e976-407b-a33f-32aeb0615a40"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzExLTUtMS0xLTM2NDA2MA_22f5816e-e976-407b-a33f-32aeb0615a40"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQzLTUtMS0xLTM2NDA2MA_f282ed48-ec02-4893-9201-9d1039bb256a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQzLTUtMS0xLTM2NDA2MA_f282ed48-ec02-4893-9201-9d1039bb256a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE4LTUtMS0xLTM2NDA2MA_3784fba6-0647-4205-9f33-f3778deaae45"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE4LTUtMS0xLTM2NDA2MA_3784fba6-0647-4205-9f33-f3778deaae45"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM5LTUtMS0xLTM2NDA2MA_7dfd024d-6cb7-47b0-8d2a-309b7cafe760"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM5LTUtMS0xLTM2NDA2MA_7dfd024d-6cb7-47b0-8d2a-309b7cafe760"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEwLTUtMS0xLTM2NDA2MA_dc5f33b7-186d-441b-8fb1-8eb19a94a3dd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEwLTUtMS0xLTM2NDA2MA_dc5f33b7-186d-441b-8fb1-8eb19a94a3dd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI3LTUtMS0xLTM2NDA2MA_5d91a65c-b49b-48c5-8f9f-76e35ca388c0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI3LTUtMS0xLTM2NDA2MA_5d91a65c-b49b-48c5-8f9f-76e35ca388c0"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM2LTUtMS0xLTM2NDA2MA_f3b5168f-b60d-481f-b2f9-0bb8d1bf62bf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM3LTUtMS0xLTM2NDA2MA_5d3d6b03-c339-483e-b43d-69ccb0089d93"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQxLTUtMS0xLTM2NDA2MA_54ce4fb9-1abe-44c5-b71d-58f396cbf084"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ2LTUtMS0xLTM2NDA2MA_b73eca4b-a452-40df-974d-91a078599ec9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI2LTUtMS0xLTM2NDA2MA_80b331d7-f29e-4957-9b17-0946b17201e5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMtNS0xLTEtMzY0MDYw_64118034-3ca5-4b9b-8c19-e2ae333dc82e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI4LTUtMS0xLTM2NDA2MA_c4db135c-f14b-48b6-90a1-2f41650c4e3b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM1LTUtMS0xLTM2NDA2MA_4fbb4788-3acc-4c59-93b1-ea49ead9c567"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMyLTUtMS0xLTM2NDA2MA_443a4622-44ef-476a-9baf-ad2ba6cdc5ff"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ0LTUtMS0xLTM2NDA2MA_ae5b4a07-2634-44a8-95cf-f6f030408c0f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE1LTUtMS0xLTM2NDA2MA_f9adf783-6975-40b3-ae86-95facc12396c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzUtNS0xLTEtMzY0MDYw_037866be-74fb-4379-95c5-7391b8f0a643"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI0LTUtMS0xLTM2NDA2MA_05a9ca15-42e7-4edf-8810-aed4004b5a47"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQ1LTUtMS0xLTM2NDA2MA_ed1062a4-594a-4fc8-99f0-7c16dbf21f94"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMzLTUtMS0xLTM2NDA2MA_63eb69a4-450d-440b-950d-c52013cdb3a4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzgtNS0xLTEtMzY0MDYw_42fd12c3-44d7-4452-833d-9a4e29d9f0dc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIyLTUtMS0xLTM2NDA2MA_28ccd4d4-b955-4456-a936-7c6235cf39ab"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE2LTUtMS0xLTM2NDA2MA_08b6afa3-6337-4c4a-bb0a-3379dc726454"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE0LTUtMS0xLTM2NDA2MA_31c45ffd-1947-40f9-ad6a-89ca1c9f0bbd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQtNS0xLTEtMzY0MDYw_dc70927f-9041-43c6-879f-2565b16819ee"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE3LTUtMS0xLTM2NDA2MA_bd5603e6-aced-48de-980d-85d04fadce07"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzMwLTUtMS0xLTM2NDA2MA_d97178c3-e549-40aa-89d0-58737b61a38c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzExLTUtMS0xLTM2NDA2MA_22f5816e-e976-407b-a33f-32aeb0615a40"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzQzLTUtMS0xLTM2NDA2MA_f282ed48-ec02-4893-9201-9d1039bb256a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzE4LTUtMS0xLTM2NDA2MA_3784fba6-0647-4205-9f33-f3778deaae45"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM5LTUtMS0xLTM2NDA2MA_7dfd024d-6cb7-47b0-8d2a-309b7cafe760"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEwLTUtMS0xLTM2NDA2MA_dc5f33b7-186d-441b-8fb1-8eb19a94a3dd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI3LTUtMS0xLTM2NDA2MA_5d91a65c-b49b-48c5-8f9f-76e35ca388c0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDUw_317d8c8e-0940-4d0f-8c04-9d2cd127e5c2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTMtMS0xLTM2NDA2MA_367bcc0a-3a06-4fd3-9495-15ee61eae0d8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTMtMS0xLTM2NDA2MA_367bcc0a-3a06-4fd3-9495-15ee61eae0d8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTUtMS0xLTM2NDA2MA_e66fe460-ee48-4282-b2d7-bcd045c240a8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTUtMS0xLTM2NDA2MA_e66fe460-ee48-4282-b2d7-bcd045c240a8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktNS0xLTEtMzY0MDYw_907e71fe-0dea-4046-ab34-b67490b5d9c1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktNS0xLTEtMzY0MDYw_907e71fe-0dea-4046-ab34-b67490b5d9c1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItNS0xLTEtMzY0MDYw_2ca57e2b-4d8a-4c29-aa5a-b9735714fe38"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItNS0xLTEtMzY0MDYw_2ca57e2b-4d8a-4c29-aa5a-b9735714fe38"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtNS0xLTEtMzY0MDYw_fb721cb2-cbc5-4cdf-9e8c-d27869d08598"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtNS0xLTEtMzY0MDYw_fb721cb2-cbc5-4cdf-9e8c-d27869d08598"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtMy0xLTEtMzY0MDYw_15720d29-f51d-4243-a724-b51aaed82f61"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtMy0xLTEtMzY0MDYw_15720d29-f51d-4243-a724-b51aaed82f61"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTMtMS0xLTM2NDA2MA_6bb5bac3-ab4e-47b0-90a4-afbf89a19b46"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTMtMS0xLTM2NDA2MA_6bb5bac3-ab4e-47b0-90a4-afbf89a19b46"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTUtMS0xLTM2NDA2MA_7af04be4-34b5-46f5-a8ab-415095093659"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTUtMS0xLTM2NDA2MA_7af04be4-34b5-46f5-a8ab-415095093659"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTMtMS0xLTM2NDA2MA_cd7bfc58-ac84-4fd5-a22b-ce2f411ac841"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTMtMS0xLTM2NDA2MA_cd7bfc58-ac84-4fd5-a22b-ce2f411ac841"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtNS0xLTEtMzY0MDYw_2bc5e8b8-b88f-47eb-845e-563d02b2636d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtNS0xLTEtMzY0MDYw_2bc5e8b8-b88f-47eb-845e-563d02b2636d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTMtMS0xLTM2NDA2MA_752d051b-3bab-45fe-976e-9867c1e053ae"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTMtMS0xLTM2NDA2MA_752d051b-3bab-45fe-976e-9867c1e053ae"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTMtMS0xLTM2NDA2MA_b0fd60b7-e57d-45a7-aef5-8cd1c0ea561a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTMtMS0xLTM2NDA2MA_b0fd60b7-e57d-45a7-aef5-8cd1c0ea561a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktMy0xLTEtMzY0MDYw_2d1e94df-65e1-4c7e-85d2-19e5cc554ff7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktMy0xLTEtMzY0MDYw_2d1e94df-65e1-4c7e-85d2-19e5cc554ff7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTMtMS0xLTM2NDA2MA_3c5b5f3e-8f21-491f-84f6-b27988fa054c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTMtMS0xLTM2NDA2MA_3c5b5f3e-8f21-491f-84f6-b27988fa054c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTMtMS0xLTM2NDA2MA_aebab50d-8f4e-40ec-aae9-07cc65f9432c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTMtMS0xLTM2NDA2MA_aebab50d-8f4e-40ec-aae9-07cc65f9432c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTUtMS0xLTM2NDA2MA_50dfd5b6-6e1f-483c-8373-bc3fafbd00c5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTUtMS0xLTM2NDA2MA_50dfd5b6-6e1f-483c-8373-bc3fafbd00c5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtMy0xLTEtMzY0MDYw_d183fbe3-704a-461f-9c29-4665a5781c24"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtMy0xLTEtMzY0MDYw_d183fbe3-704a-461f-9c29-4665a5781c24"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTUtMS0xLTM2NDA2MA_e29579b8-4dc3-46e3-bc20-f37e964677de"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTUtMS0xLTM2NDA2MA_e29579b8-4dc3-46e3-bc20-f37e964677de"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTUtMS0xLTM2NDA2MA_41d5471b-40b4-46ab-84c7-ded290c4ae26"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTUtMS0xLTM2NDA2MA_41d5471b-40b4-46ab-84c7-ded290c4ae26"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTUtMS0xLTM2NDA2MA_d7129fd9-ad9b-4a70-973b-204286aca61a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTUtMS0xLTM2NDA2MA_d7129fd9-ad9b-4a70-973b-204286aca61a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtMy0xLTEtMzY0MDYw_32714259-ecc6-4423-923f-e5e0eaa08e52"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtMy0xLTEtMzY0MDYw_32714259-ecc6-4423-923f-e5e0eaa08e52"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctMy0xLTEtMzY0MDYw_5b5cd334-de8f-4210-9dfa-e3106b3a71d0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctMy0xLTEtMzY0MDYw_5b5cd334-de8f-4210-9dfa-e3106b3a71d0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTUtMS0xLTM2NDA2MA_2077b0a9-191f-434f-9f6a-2135a5630397"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTUtMS0xLTM2NDA2MA_2077b0a9-191f-434f-9f6a-2135a5630397"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtNS0xLTEtMzY0MDYw_435d1f07-5eb4-4598-9330-b197305f6473"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtNS0xLTEtMzY0MDYw_435d1f07-5eb4-4598-9330-b197305f6473"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtMy0xLTEtMzY0MDYw_5f84f4ad-c99d-4497-aad8-aeead8e33aab"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtMy0xLTEtMzY0MDYw_5f84f4ad-c99d-4497-aad8-aeead8e33aab"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTMtMS0xLTM2NDA2MA_aeb01230-3b21-4937-bdf3-3f527d689c1d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTMtMS0xLTM2NDA2MA_aeb01230-3b21-4937-bdf3-3f527d689c1d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtNS0xLTEtMzY0MDYw_237a3dc2-ea8e-4818-9ceb-9f36d1ecd979"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtNS0xLTEtMzY0MDYw_237a3dc2-ea8e-4818-9ceb-9f36d1ecd979"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctNS0xLTEtMzY0MDYw_18e9fb42-cb58-4dce-bbf7-d09d691c0b1e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctNS0xLTEtMzY0MDYw_18e9fb42-cb58-4dce-bbf7-d09d691c0b1e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtNS0xLTEtMzY0MDYw_de3a6b38-03fc-415d-8bd9-c7a22adf516d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtNS0xLTEtMzY0MDYw_de3a6b38-03fc-415d-8bd9-c7a22adf516d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTUtMS0xLTM2NDA2MA_8174f1f3-2466-4f1c-8542-a62d0087c44c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTUtMS0xLTM2NDA2MA_8174f1f3-2466-4f1c-8542-a62d0087c44c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItMy0xLTEtMzY0MDYw_f6ab6b9e-394d-47cd-b041-d9ebde2baa91"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItMy0xLTEtMzY0MDYw_f6ab6b9e-394d-47cd-b041-d9ebde2baa91"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtMy0xLTEtMzY0MDYw_36757908-4a31-49e1-8460-b9a6a6098871"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtMy0xLTEtMzY0MDYw_36757908-4a31-49e1-8460-b9a6a6098871"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTMtMS0xLTM2NDA2MA_367bcc0a-3a06-4fd3-9495-15ee61eae0d8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTUtMS0xLTM2NDA2MA_e66fe460-ee48-4282-b2d7-bcd045c240a8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktNS0xLTEtMzY0MDYw_907e71fe-0dea-4046-ab34-b67490b5d9c1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItNS0xLTEtMzY0MDYw_2ca57e2b-4d8a-4c29-aa5a-b9735714fe38"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtNS0xLTEtMzY0MDYw_fb721cb2-cbc5-4cdf-9e8c-d27869d08598"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtMy0xLTEtMzY0MDYw_15720d29-f51d-4243-a724-b51aaed82f61"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTMtMS0xLTM2NDA2MA_6bb5bac3-ab4e-47b0-90a4-afbf89a19b46"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTUtMS0xLTM2NDA2MA_7af04be4-34b5-46f5-a8ab-415095093659"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzExLTMtMS0xLTM2NDA2MA_cd7bfc58-ac84-4fd5-a22b-ce2f411ac841"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtNS0xLTEtMzY0MDYw_2bc5e8b8-b88f-47eb-845e-563d02b2636d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTMtMS0xLTM2NDA2MA_752d051b-3bab-45fe-976e-9867c1e053ae"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTMtMS0xLTM2NDA2MA_b0fd60b7-e57d-45a7-aef5-8cd1c0ea561a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzktMy0xLTEtMzY0MDYw_2d1e94df-65e1-4c7e-85d2-19e5cc554ff7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTMtMS0xLTM2NDA2MA_3c5b5f3e-8f21-491f-84f6-b27988fa054c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEzLTMtMS0xLTM2NDA2MA_aebab50d-8f4e-40ec-aae9-07cc65f9432c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEwLTUtMS0xLTM2NDA2MA_50dfd5b6-6e1f-483c-8373-bc3fafbd00c5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtMy0xLTEtMzY0MDYw_d183fbe3-704a-461f-9c29-4665a5781c24"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE2LTUtMS0xLTM2NDA2MA_e29579b8-4dc3-46e3-bc20-f37e964677de"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE1LTUtMS0xLTM2NDA2MA_41d5471b-40b4-46ab-84c7-ded290c4ae26"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE0LTUtMS0xLTM2NDA2MA_d7129fd9-ad9b-4a70-973b-204286aca61a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzgtMy0xLTEtMzY0MDYw_32714259-ecc6-4423-923f-e5e0eaa08e52"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctMy0xLTEtMzY0MDYw_5b5cd334-de8f-4210-9dfa-e3106b3a71d0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzE3LTUtMS0xLTM2NDA2MA_2077b0a9-191f-434f-9f6a-2135a5630397"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtNS0xLTEtMzY0MDYw_435d1f07-5eb4-4598-9330-b197305f6473"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzYtMy0xLTEtMzY0MDYw_5f84f4ad-c99d-4497-aad8-aeead8e33aab"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTMtMS0xLTM2NDA2MA_aeb01230-3b21-4937-bdf3-3f527d689c1d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzMtNS0xLTEtMzY0MDYw_237a3dc2-ea8e-4818-9ceb-9f36d1ecd979"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzctNS0xLTEtMzY0MDYw_18e9fb42-cb58-4dce-bbf7-d09d691c0b1e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEtNS0xLTEtMzY0MDYw_de3a6b38-03fc-415d-8bd9-c7a22adf516d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzEyLTUtMS0xLTM2NDA2MA_8174f1f3-2466-4f1c-8542-a62d0087c44c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzItMy0xLTEtMzY0MDYw_f6ab6b9e-394d-47cd-b041-d9ebde2baa91"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90YWJsZTo5OTA0ZWM0ZjhkOGM0M2U2ODk2MTk3NmIyYjdhNjY5MC90YWJsZXJhbmdlOjk5MDRlYzRmOGQ4YzQzZTY4OTYxOTc2YjJiN2E2NjkwXzUtMy0xLTEtMzY0MDYw_36757908-4a31-49e1-8460-b9a6a6098871"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODQvZnJhZzo0MzNiYTZlYmYwYjY0NTU2YTNkOGZiMmMwN2RiYzYwMy90ZXh0cmVnaW9uOjQzM2JhNmViZjBiNjQ1NTZhM2Q4ZmIyYzA3ZGJjNjAzXzU5_0b96e689-99c0-4258-916b-c27846d3fa36"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTQtMS0xLTM2NDA2MA_39a3dc95-e4cd-42bb-99dd-3455fc0e3fa0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTQtMS0xLTM2NDA2MA_39a3dc95-e4cd-42bb-99dd-3455fc0e3fa0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTktMS0xLTM2NDA2MA_0c77d10e-004c-46bb-8b5e-0931a9be0c1b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTktMS0xLTM2NDA2MA_0c77d10e-004c-46bb-8b5e-0931a9be0c1b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTctMS0xLTM2NDA2MA_858bc692-12bb-4cb4-803b-4d0fbb3367e6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTctMS0xLTM2NDA2MA_858bc692-12bb-4cb4-803b-4d0fbb3367e6"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMQ_b6e1becc-c779-46d0-aceb-3700af176d39" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMQ_b6e1becc-c779-46d0-aceb-3700af176d39" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Issuance of restricted shares to former employees of the European Generics business subsequent to the date of divestment.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTQtMS0xLTM2NDA2MA_39a3dc95-e4cd-42bb-99dd-3455fc0e3fa0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMQ_b6e1becc-c779-46d0-aceb-3700af176d39"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTktMS0xLTM2NDA2MA_0c77d10e-004c-46bb-8b5e-0931a9be0c1b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMQ_b6e1becc-c779-46d0-aceb-3700af176d39"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE5LTctMS0xLTM2NDA2MA_858bc692-12bb-4cb4-803b-4d0fbb3367e6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMQ_b6e1becc-c779-46d0-aceb-3700af176d39"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTMtMS0xLTM2NDA2MA_20ba23d9-4985-4b1e-be44-744953373bd2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTMtMS0xLTM2NDA2MA_20ba23d9-4985-4b1e-be44-744953373bd2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTItMS0xLTM2NDA2MA_adc3dc98-3752-4217-a201-9469b1c6159f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTItMS0xLTM2NDA2MA_adc3dc98-3752-4217-a201-9469b1c6159f"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTMtMS0xLTM2NDA2MA_20ba23d9-4985-4b1e-be44-744953373bd2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ1_51450c7d-26aa-43d2-ada2-6a14149956df"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIwLTItMS0xLTM2NDA2MA_adc3dc98-3752-4217-a201-9469b1c6159f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ1_51450c7d-26aa-43d2-ada2-6a14149956df"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI3LTUtMS0xLTM2NDA2MA_36bf6641-8869-4953-bd21-3b5bb82e56a3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI3LTUtMS0xLTM2NDA2MA_36bf6641-8869-4953-bd21-3b5bb82e56a3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzQtNS0xLTEtMzY0MDYw_6060efcb-4070-45cc-ad4c-ce7dfd6dba32"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzQtNS0xLTEtMzY0MDYw_6060efcb-4070-45cc-ad4c-ce7dfd6dba32"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIzLTUtMS0xLTM2NDA2MA_b1dd7d32-6f38-4252-800d-22bffe8f0002"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIzLTUtMS0xLTM2NDA2MA_b1dd7d32-6f38-4252-800d-22bffe8f0002"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEyLTUtMS0xLTM2NDA2MA_f57e5083-426b-493f-be5b-89c43cd7ec16"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEyLTUtMS0xLTM2NDA2MA_f57e5083-426b-493f-be5b-89c43cd7ec16"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE1LTUtMS0xLTM2NDA2MA_335e6c35-0a30-42ea-82ff-ae43ee8ea3aa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE1LTUtMS0xLTM2NDA2MA_335e6c35-0a30-42ea-82ff-ae43ee8ea3aa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIwLTUtMS0xLTM2NDA2MA_bb62ad5f-a735-41f9-a43f-912a735a61b5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIwLTUtMS0xLTM2NDA2MA_bb62ad5f-a735-41f9-a43f-912a735a61b5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEwLTUtMS0xLTM2NDA2MA_bf7d83a0-334e-40fc-815b-9b25757dca0c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEwLTUtMS0xLTM2NDA2MA_bf7d83a0-334e-40fc-815b-9b25757dca0c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzUtNS0xLTEtMzY0MDYw_c770a930-6359-40b0-adc4-16255141bbaa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzUtNS0xLTEtMzY0MDYw_c770a930-6359-40b0-adc4-16255141bbaa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE3LTUtMS0xLTM2NDA2MA_7b3251b8-a49d-4693-8c38-c06be8eeb196"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE3LTUtMS0xLTM2NDA2MA_7b3251b8-a49d-4693-8c38-c06be8eeb196"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI0LTUtMS0xLTM2NDA2MA_d0916b5d-41f1-4c2d-b244-c9d2fe8487af"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI0LTUtMS0xLTM2NDA2MA_d0916b5d-41f1-4c2d-b244-c9d2fe8487af"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzgtNS0xLTEtMzY0MDYw_c52471fc-b44a-4284-bbb7-b21e467d606d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzgtNS0xLTEtMzY0MDYw_c52471fc-b44a-4284-bbb7-b21e467d606d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE5LTUtMS0xLTM2NDA2MA_807f6c25-77e1-4ca9-83f3-d32acbeecd71"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE5LTUtMS0xLTM2NDA2MA_807f6c25-77e1-4ca9-83f3-d32acbeecd71"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE4LTUtMS0xLTM2NDA2MA_cbca7a9d-da63-4a54-9d0c-49869ce7380b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE4LTUtMS0xLTM2NDA2MA_cbca7a9d-da63-4a54-9d0c-49869ce7380b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEtNS0xLTEtMzY0MDYw_6e292d38-2475-4ad2-adc1-3bf58534aa46"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEtNS0xLTEtMzY0MDYw_6e292d38-2475-4ad2-adc1-3bf58534aa46"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI4LTUtMS0xLTM2NDA2MA_dcdc1738-eede-4f82-87b8-4634e2789a12"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI4LTUtMS0xLTM2NDA2MA_dcdc1738-eede-4f82-87b8-4634e2789a12"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzYtNS0xLTEtMzY0MDYw_d3b3027b-8ab1-47d8-8dbe-5d66d8c882e1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzYtNS0xLTEtMzY0MDYw_d3b3027b-8ab1-47d8-8dbe-5d66d8c882e1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEzLTUtMS0xLTM2NDA2MA_b72771e9-2b22-4bd1-a83b-77ace7d6b757"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEzLTUtMS0xLTM2NDA2MA_b72771e9-2b22-4bd1-a83b-77ace7d6b757"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzctNS0xLTEtMzY0MDYw_ea377980-eec3-471b-8e64-babf0ac31163"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzctNS0xLTEtMzY0MDYw_ea377980-eec3-471b-8e64-babf0ac31163"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzExLTUtMS0xLTM2NDA2MA_cf422f4c-90d8-4d65-b9f8-9da3635513d5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzExLTUtMS0xLTM2NDA2MA_cf422f4c-90d8-4d65-b9f8-9da3635513d5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI2LTUtMS0xLTM2NDA2MA_dec78f17-eab8-4dc7-bf28-c3da212f14f4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI2LTUtMS0xLTM2NDA2MA_dec78f17-eab8-4dc7-bf28-c3da212f14f4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI1LTUtMS0xLTM2NDA2MA_429b1ea7-b870-47ee-afaf-6f379bdc6039"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI1LTUtMS0xLTM2NDA2MA_429b1ea7-b870-47ee-afaf-6f379bdc6039"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMtNS0xLTEtMzY0MDYw_19873626-8f8e-4608-b3cc-067baf62fd00"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMtNS0xLTEtMzY0MDYw_19873626-8f8e-4608-b3cc-067baf62fd00"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzktNS0xLTEtMzY0MDYw_6cb8cfb2-5f44-49c5-b960-bd869b8ee64c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzktNS0xLTEtMzY0MDYw_6cb8cfb2-5f44-49c5-b960-bd869b8ee64c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMwLTUtMS0xLTM2NDA2MA_7343f7fd-6b65-4861-a0d6-934588b1df3f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMwLTUtMS0xLTM2NDA2MA_7343f7fd-6b65-4861-a0d6-934588b1df3f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE2LTUtMS0xLTM2NDA2MA_1e23d4f5-79b1-4158-906a-fed081b744dd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE2LTUtMS0xLTM2NDA2MA_1e23d4f5-79b1-4158-906a-fed081b744dd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE0LTUtMS0xLTM2NDA2MA_a44438d9-b628-47fb-a335-543bf48cd46d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE0LTUtMS0xLTM2NDA2MA_a44438d9-b628-47fb-a335-543bf48cd46d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzItNS0xLTEtMzY0MDYw_cf52530c-11fa-46ba-90b8-387200a923e7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzItNS0xLTEtMzY0MDYw_cf52530c-11fa-46ba-90b8-387200a923e7"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI3LTUtMS0xLTM2NDA2MA_36bf6641-8869-4953-bd21-3b5bb82e56a3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzQtNS0xLTEtMzY0MDYw_6060efcb-4070-45cc-ad4c-ce7dfd6dba32"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIzLTUtMS0xLTM2NDA2MA_b1dd7d32-6f38-4252-800d-22bffe8f0002"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEyLTUtMS0xLTM2NDA2MA_f57e5083-426b-493f-be5b-89c43cd7ec16"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE1LTUtMS0xLTM2NDA2MA_335e6c35-0a30-42ea-82ff-ae43ee8ea3aa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzIwLTUtMS0xLTM2NDA2MA_bb62ad5f-a735-41f9-a43f-912a735a61b5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEwLTUtMS0xLTM2NDA2MA_bf7d83a0-334e-40fc-815b-9b25757dca0c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzUtNS0xLTEtMzY0MDYw_c770a930-6359-40b0-adc4-16255141bbaa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE3LTUtMS0xLTM2NDA2MA_7b3251b8-a49d-4693-8c38-c06be8eeb196"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI0LTUtMS0xLTM2NDA2MA_d0916b5d-41f1-4c2d-b244-c9d2fe8487af"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzgtNS0xLTEtMzY0MDYw_c52471fc-b44a-4284-bbb7-b21e467d606d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE5LTUtMS0xLTM2NDA2MA_807f6c25-77e1-4ca9-83f3-d32acbeecd71"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE4LTUtMS0xLTM2NDA2MA_cbca7a9d-da63-4a54-9d0c-49869ce7380b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEtNS0xLTEtMzY0MDYw_6e292d38-2475-4ad2-adc1-3bf58534aa46"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI4LTUtMS0xLTM2NDA2MA_dcdc1738-eede-4f82-87b8-4634e2789a12"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzYtNS0xLTEtMzY0MDYw_d3b3027b-8ab1-47d8-8dbe-5d66d8c882e1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzEzLTUtMS0xLTM2NDA2MA_b72771e9-2b22-4bd1-a83b-77ace7d6b757"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzctNS0xLTEtMzY0MDYw_ea377980-eec3-471b-8e64-babf0ac31163"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzExLTUtMS0xLTM2NDA2MA_cf422f4c-90d8-4d65-b9f8-9da3635513d5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI2LTUtMS0xLTM2NDA2MA_dec78f17-eab8-4dc7-bf28-c3da212f14f4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzI1LTUtMS0xLTM2NDA2MA_429b1ea7-b870-47ee-afaf-6f379bdc6039"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMtNS0xLTEtMzY0MDYw_19873626-8f8e-4608-b3cc-067baf62fd00"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzktNS0xLTEtMzY0MDYw_6cb8cfb2-5f44-49c5-b960-bd869b8ee64c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzMwLTUtMS0xLTM2NDA2MA_7343f7fd-6b65-4861-a0d6-934588b1df3f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE2LTUtMS0xLTM2NDA2MA_1e23d4f5-79b1-4158-906a-fed081b744dd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzE0LTUtMS0xLTM2NDA2MA_a44438d9-b628-47fb-a335-543bf48cd46d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90YWJsZToyZTZiNWM3MmI4ZmQ0YzFkOGExNzc5ZWMzN2M0OTM1Zi90YWJsZXJhbmdlOjJlNmI1YzcyYjhmZDRjMWQ4YTE3NzllYzM3YzQ5MzVmXzItNS0xLTEtMzY0MDYw_cf52530c-11fa-46ba-90b8-387200a923e7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODEvZnJhZzplNmQ4NjRlY2I4NDY0Y2NjOGFhNzI1YTU4MTY4ZTc5Yy90ZXh0cmVnaW9uOmU2ZDg2NGVjYjg0NjRjY2M4YWE3MjVhNTgxNjhlNzljXzIzOA_f931cc72-8567-4ffd-9528-ce84a9be84c9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMy0xLTEtMzY0MDYw_82231aef-55eb-412a-9b0d-2a1af2ca02af"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMy0xLTEtMzY0MDYw_82231aef-55eb-412a-9b0d-2a1af2ca02af"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMi0xLTEtMzY0MDYw_d05550c3-6c5b-4a1f-a950-e57307732990"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMi0xLTEtMzY0MDYw_d05550c3-6c5b-4a1f-a950-e57307732990"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMy0xLTEtMzY0MDYw_82231aef-55eb-412a-9b0d-2a1af2ca02af"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQy_cf6c8d9b-a5aa-4ad1-a1e9-53e2186cf56f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzctMi0xLTEtMzY0MDYw_d05550c3-6c5b-4a1f-a950-e57307732990"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQy_cf6c8d9b-a5aa-4ad1-a1e9-53e2186cf56f"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtOS0xLTEtNDA0Njk0_4f3465d3-e06d-4e0a-945e-ef98d44a023f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtOS0xLTEtNDA0Njk0_4f3465d3-e06d-4e0a-945e-ef98d44a023f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNC0xLTEtNDA0Njk0_85714117-9f74-4cd3-93b2-0175fc92848f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNC0xLTEtNDA0Njk0_85714117-9f74-4cd3-93b2-0175fc92848f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNy0xLTEtNDA0Njk0_3f2777e7-72dd-447f-b207-67436a3ec3eb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNy0xLTEtNDA0Njk0_3f2777e7-72dd-447f-b207-67436a3ec3eb"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzI2OTM4MDM0ODgxNjE2_fe6723a9-d270-4eed-8051-fedf99786726" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzI2OTM4MDM0ODgxNjE2_fe6723a9-d270-4eed-8051-fedf99786726" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This amount includes the valuation of the shares distributed as a dividend in kind, at a price of &#x20ac;14.58 per share, as of May&#160;10, 2022 (see note&#160;D.1.).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtOS0xLTEtNDA0Njk0_4f3465d3-e06d-4e0a-945e-ef98d44a023f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzI2OTM4MDM0ODgxNjE2_fe6723a9-d270-4eed-8051-fedf99786726"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNC0xLTEtNDA0Njk0_85714117-9f74-4cd3-93b2-0175fc92848f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzI2OTM4MDM0ODgxNjE2_fe6723a9-d270-4eed-8051-fedf99786726"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzYtNy0xLTEtNDA0Njk0_3f2777e7-72dd-447f-b207-67436a3ec3eb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzI2OTM4MDM0ODgxNjE2_fe6723a9-d270-4eed-8051-fedf99786726"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTItMS0xLTM2NDA2MA_ba2d8fea-11e9-4854-8b94-0515718b611f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTItMS0xLTM2NDA2MA_ba2d8fea-11e9-4854-8b94-0515718b611f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTMtMS0xLTM2NDA2MA_f9534676-afa5-4f61-8123-c6c164d57420"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTMtMS0xLTM2NDA2MA_f9534676-afa5-4f61-8123-c6c164d57420"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTItMS0xLTM2NDA2MA_ba2d8fea-11e9-4854-8b94-0515718b611f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ3_eca3b69e-ddc5-40c4-8c60-b88736c10615"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzI1LTMtMS0xLTM2NDA2MA_f9534676-afa5-4f61-8123-c6c164d57420"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ3_eca3b69e-ddc5-40c4-8c60-b88736c10615"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMi0xLTEtMzY0MDYw_68a96ae1-18df-4f0e-90c4-483a7863bbdd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMi0xLTEtMzY0MDYw_68a96ae1-18df-4f0e-90c4-483a7863bbdd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMy0xLTEtMzY0MDYw_ebaf5874-e148-403c-83d1-a3dc652c54d9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMy0xLTEtMzY0MDYw_ebaf5874-e148-403c-83d1-a3dc652c54d9"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMi0xLTEtMzY0MDYw_68a96ae1-18df-4f0e-90c4-483a7863bbdd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQx_05e590d1-51db-4ca8-b860-337a3c2ef7a6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzYtMy0xLTEtMzY0MDYw_ebaf5874-e148-403c-83d1-a3dc652c54d9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQx_05e590d1-51db-4ca8-b860-337a3c2ef7a6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEwLTUtMS0xLTM2NDA2MA_aa53763e-ddcb-4157-8799-62448793999a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEwLTUtMS0xLTM2NDA2MA_aa53763e-ddcb-4157-8799-62448793999a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE0LTUtMS0xLTM2NDA2MA_c77f84c4-9b06-439c-b2c2-446f2531fab1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE0LTUtMS0xLTM2NDA2MA_c77f84c4-9b06-439c-b2c2-446f2531fab1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE3LTUtMS0xLTM2NDA2MA_ee6bf62b-79dc-4852-ab0a-44f5e6cd48d9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE3LTUtMS0xLTM2NDA2MA_ee6bf62b-79dc-4852-ab0a-44f5e6cd48d9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE1LTUtMS0xLTM2NDA2MA_3f6bc7c9-ddfd-4ea8-97a6-9560945be031"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE1LTUtMS0xLTM2NDA2MA_3f6bc7c9-ddfd-4ea8-97a6-9560945be031"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzMtNS0xLTEtMzY0MDYw_4be8cb3c-bb9d-44c3-8eb5-28d6e296f468"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzMtNS0xLTEtMzY0MDYw_4be8cb3c-bb9d-44c3-8eb5-28d6e296f468"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE4LTUtMS0xLTM2NDA2MA_d4a09a5b-f67e-45f7-bbbc-5112f4ccf1ac"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE4LTUtMS0xLTM2NDA2MA_d4a09a5b-f67e-45f7-bbbc-5112f4ccf1ac"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEtNS0xLTEtMzY0MDYw_7d7ee084-2a92-441f-bb7e-f3dfd1d51c0d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEtNS0xLTEtMzY0MDYw_7d7ee084-2a92-441f-bb7e-f3dfd1d51c0d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzYtNS0xLTEtMzY0MDYw_09466f4c-f691-4b48-87b8-9c6619c32bc6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzYtNS0xLTEtMzY0MDYw_09466f4c-f691-4b48-87b8-9c6619c32bc6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzItNS0xLTEtMzY0MDYw_a425cef0-9e19-4636-b4c9-8d7457aca7e2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzItNS0xLTEtMzY0MDYw_a425cef0-9e19-4636-b4c9-8d7457aca7e2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzctNS0xLTEtMzY0MDYw_88a3ff41-5db5-4c72-8750-60b6b561fdc1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzctNS0xLTEtMzY0MDYw_88a3ff41-5db5-4c72-8750-60b6b561fdc1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEzLTUtMS0xLTM2NDA2MA_5632a6c6-fe9b-4b6f-be3e-74a4762c8079"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEzLTUtMS0xLTM2NDA2MA_5632a6c6-fe9b-4b6f-be3e-74a4762c8079"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzUtNS0xLTEtMzY0MDYw_1b79d766-e040-4ce2-9087-b12025f05dc2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzUtNS0xLTEtMzY0MDYw_1b79d766-e040-4ce2-9087-b12025f05dc2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE2LTUtMS0xLTM2NDA2MA_abdea380-4305-424a-aa70-27d966ed1801"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE2LTUtMS0xLTM2NDA2MA_abdea380-4305-424a-aa70-27d966ed1801"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEyLTUtMS0xLTM2NDA2MA_8354b5dd-7731-4c1a-a502-f93591cbc690"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEyLTUtMS0xLTM2NDA2MA_8354b5dd-7731-4c1a-a502-f93591cbc690"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzktNS0xLTEtMzY0MDYw_6ac9401c-2c5b-4d43-b1c8-59656b9f5a14"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzktNS0xLTEtMzY0MDYw_6ac9401c-2c5b-4d43-b1c8-59656b9f5a14"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzQtNS0xLTEtMzY0MDYw_c2c9944f-49cf-473b-963a-80a47b9ccad9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzQtNS0xLTEtMzY0MDYw_c2c9944f-49cf-473b-963a-80a47b9ccad9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzExLTUtMS0xLTM2NDA2MA_ec029af8-8e2f-4373-9f92-3f80319bb69d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzExLTUtMS0xLTM2NDA2MA_ec029af8-8e2f-4373-9f92-3f80319bb69d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzgtNS0xLTEtMzY0MDYw_9ed4f556-0f63-42a3-9ecf-c0593883b300"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzgtNS0xLTEtMzY0MDYw_9ed4f556-0f63-42a3-9ecf-c0593883b300"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE5LTUtMS0xLTM2NDA2MA_518f424c-a583-4582-91e0-f12572c1f305"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE5LTUtMS0xLTM2NDA2MA_518f424c-a583-4582-91e0-f12572c1f305"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEwLTUtMS0xLTM2NDA2MA_aa53763e-ddcb-4157-8799-62448793999a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE0LTUtMS0xLTM2NDA2MA_c77f84c4-9b06-439c-b2c2-446f2531fab1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE3LTUtMS0xLTM2NDA2MA_ee6bf62b-79dc-4852-ab0a-44f5e6cd48d9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE1LTUtMS0xLTM2NDA2MA_3f6bc7c9-ddfd-4ea8-97a6-9560945be031"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzMtNS0xLTEtMzY0MDYw_4be8cb3c-bb9d-44c3-8eb5-28d6e296f468"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE4LTUtMS0xLTM2NDA2MA_d4a09a5b-f67e-45f7-bbbc-5112f4ccf1ac"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEtNS0xLTEtMzY0MDYw_7d7ee084-2a92-441f-bb7e-f3dfd1d51c0d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzYtNS0xLTEtMzY0MDYw_09466f4c-f691-4b48-87b8-9c6619c32bc6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzItNS0xLTEtMzY0MDYw_a425cef0-9e19-4636-b4c9-8d7457aca7e2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzctNS0xLTEtMzY0MDYw_88a3ff41-5db5-4c72-8750-60b6b561fdc1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEzLTUtMS0xLTM2NDA2MA_5632a6c6-fe9b-4b6f-be3e-74a4762c8079"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzUtNS0xLTEtMzY0MDYw_1b79d766-e040-4ce2-9087-b12025f05dc2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE2LTUtMS0xLTM2NDA2MA_abdea380-4305-424a-aa70-27d966ed1801"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzEyLTUtMS0xLTM2NDA2MA_8354b5dd-7731-4c1a-a502-f93591cbc690"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzktNS0xLTEtMzY0MDYw_6ac9401c-2c5b-4d43-b1c8-59656b9f5a14"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzQtNS0xLTEtMzY0MDYw_c2c9944f-49cf-473b-963a-80a47b9ccad9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzExLTUtMS0xLTM2NDA2MA_ec029af8-8e2f-4373-9f92-3f80319bb69d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzgtNS0xLTEtMzY0MDYw_9ed4f556-0f63-42a3-9ecf-c0593883b300"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90YWJsZTo4MjE3NzZlNzkyYTI0NWNhOTAxZWQ4NjYxNGU4YzU1Ny90YWJsZXJhbmdlOjgyMTc3NmU3OTJhMjQ1Y2E5MDFlZDg2NjE0ZThjNTU3XzE5LTUtMS0xLTM2NDA2MA_518f424c-a583-4582-91e0-f12572c1f305"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzgvZnJhZzo1Y2UwMjI3MDM1ZmU0OWI0OGM0YWZiNDFkNmYyOGI2My90ZXh0cmVnaW9uOjVjZTAyMjcwMzVmZTQ5YjQ4YzRhZmI0MWQ2ZjI4YjYzXzY3_6c65cf9f-8657-4f28-9ae8-406c3770793e"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTMtMS0xLTM2NDA2MA_d71cb872-410e-4d33-b50f-03fc06485f4f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTMtMS0xLTM2NDA2MA_d71cb872-410e-4d33-b50f-03fc06485f4f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTItMS0xLTM2NDA2MA_14fc05d6-202f-402c-97a5-aa05fc624d48"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTItMS0xLTM2NDA2MA_14fc05d6-202f-402c-97a5-aa05fc624d48"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTMtMS0xLTM2NDA2MA_d71cb872-410e-4d33-b50f-03fc06485f4f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ2_7c2dd840-1374-4610-964f-c966ea4bc4b5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzIzLTItMS0xLTM2NDA2MA_14fc05d6-202f-402c-97a5-aa05fc624d48"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ2_7c2dd840-1374-4610-964f-c966ea4bc4b5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMy0xLTEtMzY0MDYw_b88f5582-854c-44f8-bbdc-f448e42a6399"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMy0xLTEtMzY0MDYw_b88f5582-854c-44f8-bbdc-f448e42a6399"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMi0xLTEtMzY0MDYw_a2b5688d-defb-4ded-ac13-3ba426e6f75e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMi0xLTEtMzY0MDYw_a2b5688d-defb-4ded-ac13-3ba426e6f75e"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMy0xLTEtMzY0MDYw_b88f5582-854c-44f8-bbdc-f448e42a6399"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQz_4413e2d3-0704-4581-a253-6ac595b10cd5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzktMi0xLTEtMzY0MDYw_a2b5688d-defb-4ded-ac13-3ba426e6f75e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQz_4413e2d3-0704-4581-a253-6ac595b10cd5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTItMS0xLTM2NDA2MA_b807f41b-dc17-4fab-9c7a-5edc7a9ddf37"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTItMS0xLTM2NDA2MA_b807f41b-dc17-4fab-9c7a-5edc7a9ddf37"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTMtMS0xLTM2NDA2MA_838ddb06-59ce-45d0-bd06-5ad48488f600"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTMtMS0xLTM2NDA2MA_838ddb06-59ce-45d0-bd06-5ad48488f600"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTItMS0xLTM2NDA2MA_b807f41b-dc17-4fab-9c7a-5edc7a9ddf37"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ0_06a9dadf-45f8-44b4-82fa-41db2fe39be6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzEzLTMtMS0xLTM2NDA2MA_838ddb06-59ce-45d0-bd06-5ad48488f600"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ0_06a9dadf-45f8-44b4-82fa-41db2fe39be6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTctMS0xLTM2NDA2MA_e3abb3d3-cf48-47c9-b9e2-037b404aa01f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTctMS0xLTM2NDA2MA_e3abb3d3-cf48-47c9-b9e2-037b404aa01f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTgtMS0xLTM2NDA2MA_66b952c4-dd45-40ca-b631-a61c26f81d02"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTgtMS0xLTM2NDA2MA_66b952c4-dd45-40ca-b631-a61c26f81d02"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTktMS0xLTM2NDA2MA_357b481e-b9f2-4d99-9307-e25cca9bb8c8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTktMS0xLTM2NDA2MA_357b481e-b9f2-4d99-9307-e25cca9bb8c8"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMQ_98bd5f86-b9de-4fe0-8b4c-07b961a7f844" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMQ_98bd5f86-b9de-4fe0-8b4c-07b961a7f844" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This line includes changes in non-controlling interests arising from divestments and acquisitions.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTctMS0xLTM2NDA2MA_e3abb3d3-cf48-47c9-b9e2-037b404aa01f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMQ_98bd5f86-b9de-4fe0-8b4c-07b961a7f844"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTgtMS0xLTM2NDA2MA_66b952c4-dd45-40ca-b631-a61c26f81d02"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMQ_98bd5f86-b9de-4fe0-8b4c-07b961a7f844"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzE4LTktMS0xLTM2NDA2MA_357b481e-b9f2-4d99-9307-e25cca9bb8c8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMQ_98bd5f86-b9de-4fe0-8b4c-07b961a7f844"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTctMS0xLTM2NDA2MA_ea315a7f-252f-419b-8d4f-db0e553b3e76"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTctMS0xLTM2NDA2MA_ea315a7f-252f-419b-8d4f-db0e553b3e76"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctNy0xLTEtMzY0MDYw_b3b85699-074d-4b7a-a51b-bb2b00ffeac4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctNy0xLTEtMzY0MDYw_b3b85699-074d-4b7a-a51b-bb2b00ffeac4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTktMS0xLTM2NDA2MA_e12d1ed9-a847-4dcb-9553-d3ae72a6114e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTktMS0xLTM2NDA2MA_e12d1ed9-a847-4dcb-9553-d3ae72a6114e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTEtMS0xLTM2NDA2MA_d697ad7c-a266-4ec0-852c-7a3b8fe77e34"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTEtMS0xLTM2NDA2MA_d697ad7c-a266-4ec0-852c-7a3b8fe77e34"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTctMS0xLTM2NDA2MA_dece824f-4712-4939-ba41-a6b138a7be2f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTctMS0xLTM2NDA2MA_dece824f-4712-4939-ba41-a6b138a7be2f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTktMS0xLTM2NDA2MA_d2d61b17-f46d-45c7-a1c5-9aacd7ed7565"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTktMS0xLTM2NDA2MA_d2d61b17-f46d-45c7-a1c5-9aacd7ed7565"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTItMS0xLTM2NDA2MA_b6549c65-de99-4001-8799-8f8e98f4e1e5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTItMS0xLTM2NDA2MA_b6549c65-de99-4001-8799-8f8e98f4e1e5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTktMS0xLTM2NDA2MA_5195a35a-d9e7-4bcb-999f-1d0f95a44696"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTktMS0xLTM2NDA2MA_5195a35a-d9e7-4bcb-999f-1d0f95a44696"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTItMS0xLTM2NDA2MA_59b04cfd-6682-4d1c-a629-33077e6ffe2c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTItMS0xLTM2NDA2MA_59b04cfd-6682-4d1c-a629-33077e6ffe2c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctOS0xLTEtMzY0MDYw_c02723a3-2291-4b9c-8635-75fbddffe076"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctOS0xLTEtMzY0MDYw_c02723a3-2291-4b9c-8635-75fbddffe076"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMi0xLTEtMzY0MDYw_4fbe68a1-d00d-41d8-8219-b4f35de27b96"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMi0xLTEtMzY0MDYw_4fbe68a1-d00d-41d8-8219-b4f35de27b96"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTEtMS0xLTM2NDA2MA_3708407a-51d1-4dbe-85b9-85c10719e785"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTEtMS0xLTM2NDA2MA_3708407a-51d1-4dbe-85b9-85c10719e785"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTEtMS0xLTM2NDA2MA_e1f4057a-3d3e-477a-9a08-4c4524aaf0b0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTEtMS0xLTM2NDA2MA_e1f4057a-3d3e-477a-9a08-4c4524aaf0b0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtOS0xLTEtMzY0MDYw_054eede4-8ea9-4866-aeab-74dd86e513ad"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtOS0xLTEtMzY0MDYw_054eede4-8ea9-4866-aeab-74dd86e513ad"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTItMS0xLTM2NDA2MA_cfaed0ab-1e26-4a37-bca1-077606cbdc5a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTItMS0xLTM2NDA2MA_cfaed0ab-1e26-4a37-bca1-077606cbdc5a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTItMS0xLTM2NDA2MA_f9b8e3a2-a116-441b-87d1-f1c4ecc26dc4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTItMS0xLTM2NDA2MA_f9b8e3a2-a116-441b-87d1-f1c4ecc26dc4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMS0xLTEtMzY0MDYw_af7b7cbd-9a7f-49a4-98d4-85e25892f5b9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMS0xLTEtMzY0MDYw_af7b7cbd-9a7f-49a4-98d4-85e25892f5b9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctOS0xLTEtMzY0MDYw_88979adf-c420-4d86-86ac-4d172e42c928"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctOS0xLTEtMzY0MDYw_88979adf-c420-4d86-86ac-4d172e42c928"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctMy0xLTEtMzY0MDYw_d7773337-9244-43fc-bbaa-cfef96bffdda"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctMy0xLTEtMzY0MDYw_d7773337-9244-43fc-bbaa-cfef96bffdda"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTctMS0xLTM2NDA2MA_a440e3b1-17e1-4af9-a70c-6a3ed6d07c76"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTctMS0xLTM2NDA2MA_a440e3b1-17e1-4af9-a70c-6a3ed6d07c76"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtNy0xLTEtMzY0MDYw_80f47a56-a29d-4996-b77c-12bd76af1562"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtNy0xLTEtMzY0MDYw_80f47a56-a29d-4996-b77c-12bd76af1562"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTktMS0xLTM2NDA2MA_9ac65895-eb89-4cb3-966c-6affa541fe43"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTktMS0xLTM2NDA2MA_9ac65895-eb89-4cb3-966c-6affa541fe43"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTktMS0xLTM2NDA2MA_9bd07696-1dde-4504-9b5e-530204637e84"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTktMS0xLTM2NDA2MA_9bd07696-1dde-4504-9b5e-530204637e84"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctMy0xLTEtMzY0MDYw_843c78b6-7768-4ec0-89a4-98462d66f6a5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctMy0xLTEtMzY0MDYw_843c78b6-7768-4ec0-89a4-98462d66f6a5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTktMS0xLTM2NDA2MA_2cd2613d-9aa8-490f-937a-c8d907ef0693"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTktMS0xLTM2NDA2MA_2cd2613d-9aa8-490f-937a-c8d907ef0693"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTItMS0xLTM2NDA2MA_dc1f79e8-2ad8-417d-98c5-247116579faa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTItMS0xLTM2NDA2MA_dc1f79e8-2ad8-417d-98c5-247116579faa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTEtMS0xLTM2NDA2MA_e5014827-23a4-4ba5-bb24-c7e7fae6dc81"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTEtMS0xLTM2NDA2MA_e5014827-23a4-4ba5-bb24-c7e7fae6dc81"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTctMS0xLTM2NDA2MA_93c318bd-c64d-47b6-bff2-9f2bf1368cb6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTctMS0xLTM2NDA2MA_93c318bd-c64d-47b6-bff2-9f2bf1368cb6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTctMS0xLTM2NDA2MA_a7795b9e-f39e-4240-a4a6-e37101e11a18"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTctMS0xLTM2NDA2MA_a7795b9e-f39e-4240-a4a6-e37101e11a18"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctNy0xLTEtMzY0MDYw_c1ae37c7-0636-4eb5-a37d-1fe172200b6d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctNy0xLTEtMzY0MDYw_c1ae37c7-0636-4eb5-a37d-1fe172200b6d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTEtMS0xLTM2NDA2MA_74a27fce-bb34-46a6-aa1a-129f0a994827"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTEtMS0xLTM2NDA2MA_74a27fce-bb34-46a6-aa1a-129f0a994827"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTMtMS0xLTM2NDA2MA_4d3f5d84-0e38-4849-96ea-70ecac235e1f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTMtMS0xLTM2NDA2MA_4d3f5d84-0e38-4849-96ea-70ecac235e1f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTItMS0xLTM2NDA2MA_01061c07-03f6-4b1a-880a-d3f05103e41f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTItMS0xLTM2NDA2MA_01061c07-03f6-4b1a-880a-d3f05103e41f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMy0xLTEtMzY0MDYw_9f35d2b3-a513-4223-921a-aba617b755fc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMy0xLTEtMzY0MDYw_9f35d2b3-a513-4223-921a-aba617b755fc"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTctMS0xLTM2NDA2MA_986cf489-8ff4-4209-ad3e-fe78494e8b5a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTctMS0xLTM2NDA2MA_986cf489-8ff4-4209-ad3e-fe78494e8b5a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTctMS0xLTM2NDA2MA_3761d949-ac3c-4c18-bfca-42fb105b8059"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTctMS0xLTM2NDA2MA_3761d949-ac3c-4c18-bfca-42fb105b8059"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTktMS0xLTM2NDA2MA_7bc1440f-ea82-44cc-8743-b7ffed1f06ce"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTktMS0xLTM2NDA2MA_7bc1440f-ea82-44cc-8743-b7ffed1f06ce"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTctMS0xLTM2NDA2MA_ea315a7f-252f-419b-8d4f-db0e553b3e76"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctNy0xLTEtMzY0MDYw_b3b85699-074d-4b7a-a51b-bb2b00ffeac4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTktMS0xLTM2NDA2MA_e12d1ed9-a847-4dcb-9553-d3ae72a6114e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTEtMS0xLTM2NDA2MA_d697ad7c-a266-4ec0-852c-7a3b8fe77e34"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTctMS0xLTM2NDA2MA_dece824f-4712-4939-ba41-a6b138a7be2f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTktMS0xLTM2NDA2MA_d2d61b17-f46d-45c7-a1c5-9aacd7ed7565"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTItMS0xLTM2NDA2MA_b6549c65-de99-4001-8799-8f8e98f4e1e5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTktMS0xLTM2NDA2MA_5195a35a-d9e7-4bcb-999f-1d0f95a44696"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTItMS0xLTM2NDA2MA_59b04cfd-6682-4d1c-a629-33077e6ffe2c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctOS0xLTEtMzY0MDYw_c02723a3-2291-4b9c-8635-75fbddffe076"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMi0xLTEtMzY0MDYw_4fbe68a1-d00d-41d8-8219-b4f35de27b96"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTEtMS0xLTM2NDA2MA_3708407a-51d1-4dbe-85b9-85c10719e785"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTEtMS0xLTM2NDA2MA_e1f4057a-3d3e-477a-9a08-4c4524aaf0b0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtOS0xLTEtMzY0MDYw_054eede4-8ea9-4866-aeab-74dd86e513ad"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTItMS0xLTM2NDA2MA_cfaed0ab-1e26-4a37-bca1-077606cbdc5a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTItMS0xLTM2NDA2MA_f9b8e3a2-a116-441b-87d1-f1c4ecc26dc4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMS0xLTEtMzY0MDYw_af7b7cbd-9a7f-49a4-98d4-85e25892f5b9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctOS0xLTEtMzY0MDYw_88979adf-c420-4d86-86ac-4d172e42c928"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzctMy0xLTEtMzY0MDYw_d7773337-9244-43fc-bbaa-cfef96bffdda"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTctMS0xLTM2NDA2MA_a440e3b1-17e1-4af9-a70c-6a3ed6d07c76"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtNy0xLTEtMzY0MDYw_80f47a56-a29d-4996-b77c-12bd76af1562"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTktMS0xLTM2NDA2MA_9ac65895-eb89-4cb3-966c-6affa541fe43"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEzLTktMS0xLTM2NDA2MA_9bd07696-1dde-4504-9b5e-530204637e84"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctMy0xLTEtMzY0MDYw_843c78b6-7768-4ec0-89a4-98462d66f6a5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTktMS0xLTM2NDA2MA_2cd2613d-9aa8-490f-937a-c8d907ef0693"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTItMS0xLTM2NDA2MA_dc1f79e8-2ad8-417d-98c5-247116579faa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTEtMS0xLTM2NDA2MA_e5014827-23a4-4ba5-bb24-c7e7fae6dc81"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEwLTctMS0xLTM2NDA2MA_93c318bd-c64d-47b6-bff2-9f2bf1368cb6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzE1LTctMS0xLTM2NDA2MA_a7795b9e-f39e-4240-a4a6-e37101e11a18"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzctNy0xLTEtMzY0MDYw_c1ae37c7-0636-4eb5-a37d-1fe172200b6d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzEzLTEtMS0xLTM2NDA2MA_74a27fce-bb34-46a6-aa1a-129f0a994827"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTMtMS0xLTM2NDA2MA_4d3f5d84-0e38-4849-96ea-70ecac235e1f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTItMS0xLTM2NDA2MA_01061c07-03f6-4b1a-880a-d3f05103e41f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo5NzZhZWE5MWZiYjQ0OTZiYTRiZGNlZDA2YjQxODE2MC90YWJsZXJhbmdlOjk3NmFlYTkxZmJiNDQ5NmJhNGJkY2VkMDZiNDE4MTYwXzgtMy0xLTEtMzY0MDYw_9f35d2b3-a513-4223-921a-aba617b755fc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEzLTctMS0xLTM2NDA2MA_986cf489-8ff4-4209-ad3e-fe78494e8b5a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEwLTctMS0xLTM2NDA2MA_3761d949-ac3c-4c18-bfca-42fb105b8059"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEwLTktMS0xLTM2NDA2MA_7bc1440f-ea82-44cc-8743-b7ffed1f06ce"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYzMA_0dc9f220-6075-4a72-a2ec-31b4a7c47d46"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzYtNS0xLTEtMzY0MDYw_0ae7ec9b-0808-4d33-ad31-74547492351f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzYtNS0xLTEtMzY0MDYw_0ae7ec9b-0808-4d33-ad31-74547492351f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE0LTUtMS0xLTM2NDA2MA_5abda22f-ef3c-4f38-b583-bdf4dacc3d29"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE0LTUtMS0xLTM2NDA2MA_5abda22f-ef3c-4f38-b583-bdf4dacc3d29"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzMtNS0xLTEtMzY0MDYw_ff64a706-323f-41b7-8aa2-64abbc9e338c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzMtNS0xLTEtMzY0MDYw_ff64a706-323f-41b7-8aa2-64abbc9e338c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzUtNS0xLTEtMzY0MDYw_927575f3-68ba-42ad-a314-702918da5fc8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzUtNS0xLTEtMzY0MDYw_927575f3-68ba-42ad-a314-702918da5fc8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEtNS0xLTEtMzY0MDYw_e1be1a81-e804-4732-bbd2-564fdf52fe38"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEtNS0xLTEtMzY0MDYw_e1be1a81-e804-4732-bbd2-564fdf52fe38"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE1LTUtMS0xLTM2NDA2MA_94cb78bb-07be-4df9-9abd-d3cf5839f88a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE1LTUtMS0xLTM2NDA2MA_94cb78bb-07be-4df9-9abd-d3cf5839f88a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE2LTUtMS0xLTM2NDA2MA_3178df5e-f94d-47a9-a40f-fc62ba791e00"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE2LTUtMS0xLTM2NDA2MA_3178df5e-f94d-47a9-a40f-fc62ba791e00"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzgtNS0xLTEtMzY0MDYw_4989c65b-3d5e-4e45-a863-797e05effa8e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzgtNS0xLTEtMzY0MDYw_4989c65b-3d5e-4e45-a863-797e05effa8e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzQtNS0xLTEtMzY0MDYw_ffb8d1e8-2909-41f6-ae5e-8fb6750f17e1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzQtNS0xLTEtMzY0MDYw_ffb8d1e8-2909-41f6-ae5e-8fb6750f17e1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzktNS0xLTEtMzY0MDYw_f304b90b-e524-4f21-8eb1-823b3262fd06"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzktNS0xLTEtMzY0MDYw_f304b90b-e524-4f21-8eb1-823b3262fd06"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzctNS0xLTEtMzY0MDYw_201dbd4f-11f6-43c8-9ca5-f9512970bc4f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzctNS0xLTEtMzY0MDYw_201dbd4f-11f6-43c8-9ca5-f9512970bc4f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE3LTUtMS0xLTM2NDA2MA_573f49c8-ea1e-458d-9c33-a9f41a087d5c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE3LTUtMS0xLTM2NDA2MA_573f49c8-ea1e-458d-9c33-a9f41a087d5c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEwLTUtMS0xLTM2NDA2MA_e5c9c9f0-357f-405f-ae45-814e5df5c370"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEwLTUtMS0xLTM2NDA2MA_e5c9c9f0-357f-405f-ae45-814e5df5c370"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzExLTUtMS0xLTM2NDA2MA_2f978d1d-2381-44fc-9063-65875d18faaf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzExLTUtMS0xLTM2NDA2MA_2f978d1d-2381-44fc-9063-65875d18faaf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEyLTUtMS0xLTM2NDA2MA_46ddbf80-0050-4426-8b6c-24dba48cfd92"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEyLTUtMS0xLTM2NDA2MA_46ddbf80-0050-4426-8b6c-24dba48cfd92"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEzLTUtMS0xLTM2NDA2MA_5ee4cc7b-0628-42e2-9a04-07b791d69c0d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEzLTUtMS0xLTM2NDA2MA_5ee4cc7b-0628-42e2-9a04-07b791d69c0d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzItNS0xLTEtMzY0MDYw_c395c9a6-ee3e-41a3-a7f2-da456af52e8f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzItNS0xLTEtMzY0MDYw_c395c9a6-ee3e-41a3-a7f2-da456af52e8f"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzYtNS0xLTEtMzY0MDYw_0ae7ec9b-0808-4d33-ad31-74547492351f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE0LTUtMS0xLTM2NDA2MA_5abda22f-ef3c-4f38-b583-bdf4dacc3d29"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzMtNS0xLTEtMzY0MDYw_ff64a706-323f-41b7-8aa2-64abbc9e338c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzUtNS0xLTEtMzY0MDYw_927575f3-68ba-42ad-a314-702918da5fc8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEtNS0xLTEtMzY0MDYw_e1be1a81-e804-4732-bbd2-564fdf52fe38"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE1LTUtMS0xLTM2NDA2MA_94cb78bb-07be-4df9-9abd-d3cf5839f88a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE2LTUtMS0xLTM2NDA2MA_3178df5e-f94d-47a9-a40f-fc62ba791e00"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzgtNS0xLTEtMzY0MDYw_4989c65b-3d5e-4e45-a863-797e05effa8e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzQtNS0xLTEtMzY0MDYw_ffb8d1e8-2909-41f6-ae5e-8fb6750f17e1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzktNS0xLTEtMzY0MDYw_f304b90b-e524-4f21-8eb1-823b3262fd06"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzctNS0xLTEtMzY0MDYw_201dbd4f-11f6-43c8-9ca5-f9512970bc4f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzE3LTUtMS0xLTM2NDA2MA_573f49c8-ea1e-458d-9c33-a9f41a087d5c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEwLTUtMS0xLTM2NDA2MA_e5c9c9f0-357f-405f-ae45-814e5df5c370"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzExLTUtMS0xLTM2NDA2MA_2f978d1d-2381-44fc-9063-65875d18faaf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEyLTUtMS0xLTM2NDA2MA_46ddbf80-0050-4426-8b6c-24dba48cfd92"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzEzLTUtMS0xLTM2NDA2MA_5ee4cc7b-0628-42e2-9a04-07b791d69c0d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90YWJsZTo1Njk1OThiMzdmZDk0YzI4Yjk2MmRlODAzZjRiYWM2OC90YWJsZXJhbmdlOjU2OTU5OGIzN2ZkOTRjMjhiOTYyZGU4MDNmNGJhYzY4XzItNS0xLTEtMzY0MDYw_c395c9a6-ee3e-41a3-a7f2-da456af52e8f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80NzUvZnJhZzo5N2NhNDA5MzM4ZjM0ZDQ4OTZmYjhiODk3N2YzMmQzZS90ZXh0cmVnaW9uOjk3Y2E0MDkzMzhmMzRkNDg5NmZiOGI4OTc3ZjMyZDNlXzMzMg_966368d5-ad78-4262-8e7e-25251eefd93c"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOS0xLTEtMzY0MDYw_96be92e2-3e8d-4f73-aa9d-01e2d758605c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOS0xLTEtMzY0MDYw_96be92e2-3e8d-4f73-aa9d-01e2d758605c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTQtMS0xLTM2NDA2MA_100ab860-fe28-4fae-a197-702bde1a726b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTQtMS0xLTM2NDA2MA_100ab860-fe28-4fae-a197-702bde1a726b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNS0xLTEtMzY0MDYw_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNS0xLTEtMzY0MDYw_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNi0xLTEtMzY0MDYw_38cc5712-2e8d-47a4-9fb2-b23709a48d33"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNi0xLTEtMzY0MDYw_38cc5712-2e8d-47a4-9fb2-b23709a48d33"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMS0xLTEtMzY0MDYw_e9272b1a-fe3d-426b-a99f-53e92de05eb9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMS0xLTEtMzY0MDYw_e9272b1a-fe3d-426b-a99f-53e92de05eb9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTUtMS0xLTM2NDA2MA_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTUtMS0xLTM2NDA2MA_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMy0xLTEtMzY0MDYw_98439be4-0899-45a9-8c40-1f08323f2f80"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMy0xLTEtMzY0MDYw_98439be4-0899-45a9-8c40-1f08323f2f80"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTMtMS0xLTM2NDA2MA_7ec2f7d8-f54d-4e3d-be28-978ea5def617"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTMtMS0xLTM2NDA2MA_7ec2f7d8-f54d-4e3d-be28-978ea5def617"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMi0xLTEtMzY0MDYw_9e18e429-fe52-4c81-a708-2073d2babcf8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMi0xLTEtMzY0MDYw_9e18e429-fe52-4c81-a708-2073d2babcf8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNy0xLTEtMzY0MDYw_e8780054-fa54-4ab7-b9bd-3971d22c2a23"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNy0xLTEtMzY0MDYw_e8780054-fa54-4ab7-b9bd-3971d22c2a23"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNy0xLTEtMzY0MDYw_c44cfc7a-13ba-4cb5-9268-ca68969a17c6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNy0xLTEtMzY0MDYw_c44cfc7a-13ba-4cb5-9268-ca68969a17c6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNy0xLTEtMzY0MDYw_019c0649-48f9-40cf-a9ef-572100611c48"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNy0xLTEtMzY0MDYw_019c0649-48f9-40cf-a9ef-572100611c48"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTYtMS0xLTM2NDA2MA_33eaa7e7-913c-45e1-95c3-1eb2f72cee81"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTYtMS0xLTM2NDA2MA_33eaa7e7-913c-45e1-95c3-1eb2f72cee81"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNS0xLTEtMzY0MDYw_85024497-8f3f-4693-bd13-5573dd0fcfc6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNS0xLTEtMzY0MDYw_85024497-8f3f-4693-bd13-5573dd0fcfc6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOS0xLTEtMzY0MDYw_023a6c6b-fba0-42f8-9428-48306bc6c7ac"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOS0xLTEtMzY0MDYw_023a6c6b-fba0-42f8-9428-48306bc6c7ac"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNy0xLTEtMzY0MDYw_ef6cb36e-a284-4b73-9bfe-1aa48de80519"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNy0xLTEtMzY0MDYw_ef6cb36e-a284-4b73-9bfe-1aa48de80519"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNC0xLTEtMzY0MDYw_8375809a-87a8-4244-a166-9de316ecd262"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNC0xLTEtMzY0MDYw_8375809a-87a8-4244-a166-9de316ecd262"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOC0xLTEtMzY0MDYw_17dc2a9e-c0a5-4c32-a0f2-c7461a8a0ea5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOC0xLTEtMzY0MDYw_17dc2a9e-c0a5-4c32-a0f2-c7461a8a0ea5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMi0xLTEtMzY0MDYw_ac125ec7-8c00-456b-a926-eae2e5fe9e21"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMi0xLTEtMzY0MDYw_ac125ec7-8c00-456b-a926-eae2e5fe9e21"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTgtMS0xLTM2NDA2MA_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTgtMS0xLTM2NDA2MA_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOS0xLTEtMzY0MDYw_3ac6378f-f68a-4f1a-8888-ff27c1940bd6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOS0xLTEtMzY0MDYw_3ac6378f-f68a-4f1a-8888-ff27c1940bd6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNy0xLTEtMzY0MDYw_8fe9842c-2530-452e-8bcb-bf5f2008673f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNy0xLTEtMzY0MDYw_8fe9842c-2530-452e-8bcb-bf5f2008673f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOC0xLTEtMzY0MDYw_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOC0xLTEtMzY0MDYw_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMy0xLTEtMzY0MDYw_7ec2f7d8-f54d-4e3d-be28-978ea5def617"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMy0xLTEtMzY0MDYw_7ec2f7d8-f54d-4e3d-be28-978ea5def617"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOS0xLTEtMzY0MDYw_eb447b21-2a14-46ed-807e-30dd4a2864df"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOS0xLTEtMzY0MDYw_eb447b21-2a14-46ed-807e-30dd4a2864df"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMS0xLTEtMzY0MDYw_54c82653-9a92-445e-8ab8-a3b427009f86"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMS0xLTEtMzY0MDYw_54c82653-9a92-445e-8ab8-a3b427009f86"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTktMS0xLTM2NDA2MA_19f875f9-870d-403b-aca5-d3d399246b17"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTktMS0xLTM2NDA2MA_19f875f9-870d-403b-aca5-d3d399246b17"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTItMS0xLTM2NDA2MA_9e18e429-fe52-4c81-a708-2073d2babcf8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTItMS0xLTM2NDA2MA_9e18e429-fe52-4c81-a708-2073d2babcf8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNi0xLTEtMzY0MDYw_b48cb9d0-b1a6-4e2f-a0c7-3197e8992a22"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNi0xLTEtMzY0MDYw_b48cb9d0-b1a6-4e2f-a0c7-3197e8992a22"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOC0xLTEtMzY0MDYw_456437df-583f-4c00-9f6b-cd0b97e72e21"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOC0xLTEtMzY0MDYw_456437df-583f-4c00-9f6b-cd0b97e72e21"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTEtMS0xLTM2NDA2MA_54c82653-9a92-445e-8ab8-a3b427009f86"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTEtMS0xLTM2NDA2MA_54c82653-9a92-445e-8ab8-a3b427009f86"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNC0xLTEtMzY0MDYw_92ac7881-3d55-420a-b4c2-2fb93c8b0d16"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNC0xLTEtMzY0MDYw_92ac7881-3d55-420a-b4c2-2fb93c8b0d16"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNC0xLTEtMzY0MDYw_f8be43f1-b0d8-4be1-afb2-aee2ca1e815f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNC0xLTEtMzY0MDYw_f8be43f1-b0d8-4be1-afb2-aee2ca1e815f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNC0xLTEtMzY0MDYw_140fe7cd-ce4a-4e11-ad35-986fdf070bc4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNC0xLTEtMzY0MDYw_140fe7cd-ce4a-4e11-ad35-986fdf070bc4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTctMS0xLTM2NDA2MA_8fe9842c-2530-452e-8bcb-bf5f2008673f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTctMS0xLTM2NDA2MA_8fe9842c-2530-452e-8bcb-bf5f2008673f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOS0xLTEtMzY0MDYw_19f875f9-870d-403b-aca5-d3d399246b17"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOS0xLTEtMzY0MDYw_19f875f9-870d-403b-aca5-d3d399246b17"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNi0xLTEtMzY0MDYw_4d873dbd-5b16-420c-bc86-3b872b223384"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNi0xLTEtMzY0MDYw_4d873dbd-5b16-420c-bc86-3b872b223384"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOC0xLTEtMzY0MDYw_697a50ed-0ca3-4e2c-9508-8d2b84920b9d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOC0xLTEtMzY0MDYw_697a50ed-0ca3-4e2c-9508-8d2b84920b9d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNC0xLTEtMzY0MDYw_100ab860-fe28-4fae-a197-702bde1a726b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNC0xLTEtMzY0MDYw_100ab860-fe28-4fae-a197-702bde1a726b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNi0xLTEtMzY0MDYw_33eaa7e7-913c-45e1-95c3-1eb2f72cee81"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNi0xLTEtMzY0MDYw_33eaa7e7-913c-45e1-95c3-1eb2f72cee81"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOC0xLTEtMzY0MDYw_8d50453b-88c4-41cc-bb0f-46fbbd783c17"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOC0xLTEtMzY0MDYw_8d50453b-88c4-41cc-bb0f-46fbbd783c17"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service, as described in Note&#160;A.2.1. to the consolidated financial statements for the year ended December&#160;31, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOS0xLTEtMzY0MDYw_96be92e2-3e8d-4f73-aa9d-01e2d758605c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTQtMS0xLTM2NDA2MA_100ab860-fe28-4fae-a197-702bde1a726b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNS0xLTEtMzY0MDYw_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNi0xLTEtMzY0MDYw_38cc5712-2e8d-47a4-9fb2-b23709a48d33"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMS0xLTEtMzY0MDYw_e9272b1a-fe3d-426b-a99f-53e92de05eb9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTUtMS0xLTM2NDA2MA_67c7e1a8-e7a1-4a02-bdd5-1d984963c36c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMy0xLTEtMzY0MDYw_98439be4-0899-45a9-8c40-1f08323f2f80"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTMtMS0xLTM2NDA2MA_7ec2f7d8-f54d-4e3d-be28-978ea5def617"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMi0xLTEtMzY0MDYw_9e18e429-fe52-4c81-a708-2073d2babcf8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNy0xLTEtMzY0MDYw_e8780054-fa54-4ab7-b9bd-3971d22c2a23"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNy0xLTEtMzY0MDYw_c44cfc7a-13ba-4cb5-9268-ca68969a17c6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNy0xLTEtMzY0MDYw_019c0649-48f9-40cf-a9ef-572100611c48"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTYtMS0xLTM2NDA2MA_33eaa7e7-913c-45e1-95c3-1eb2f72cee81"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNS0xLTEtMzY0MDYw_85024497-8f3f-4693-bd13-5573dd0fcfc6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOS0xLTEtMzY0MDYw_023a6c6b-fba0-42f8-9428-48306bc6c7ac"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNy0xLTEtMzY0MDYw_ef6cb36e-a284-4b73-9bfe-1aa48de80519"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtNC0xLTEtMzY0MDYw_8375809a-87a8-4244-a166-9de316ecd262"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtOC0xLTEtMzY0MDYw_17dc2a9e-c0a5-4c32-a0f2-c7461a8a0ea5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtMi0xLTEtMzY0MDYw_ac125ec7-8c00-456b-a926-eae2e5fe9e21"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTgtMS0xLTM2NDA2MA_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOS0xLTEtMzY0MDYw_3ac6378f-f68a-4f1a-8888-ff27c1940bd6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNy0xLTEtMzY0MDYw_8fe9842c-2530-452e-8bcb-bf5f2008673f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOC0xLTEtMzY0MDYw_ba8a9c03-7ffa-4e05-a2e5-d36d41ef3d17"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMy0xLTEtMzY0MDYw_7ec2f7d8-f54d-4e3d-be28-978ea5def617"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOS0xLTEtMzY0MDYw_eb447b21-2a14-46ed-807e-30dd4a2864df"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtMS0xLTEtMzY0MDYw_54c82653-9a92-445e-8ab8-a3b427009f86"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTktMS0xLTM2NDA2MA_19f875f9-870d-403b-aca5-d3d399246b17"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTItMS0xLTM2NDA2MA_9e18e429-fe52-4c81-a708-2073d2babcf8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNi0xLTEtMzY0MDYw_b48cb9d0-b1a6-4e2f-a0c7-3197e8992a22"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtOC0xLTEtMzY0MDYw_456437df-583f-4c00-9f6b-cd0b97e72e21"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTEtMS0xLTM2NDA2MA_54c82653-9a92-445e-8ab8-a3b427009f86"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNC0xLTEtMzY0MDYw_92ac7881-3d55-420a-b4c2-2fb93c8b0d16"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzUtNC0xLTEtMzY0MDYw_f8be43f1-b0d8-4be1-afb2-aee2ca1e815f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctNC0xLTEtMzY0MDYw_140fe7cd-ce4a-4e11-ad35-986fdf070bc4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzIyLTctMS0xLTM2NDA2MA_8fe9842c-2530-452e-8bcb-bf5f2008673f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtOS0xLTEtMzY0MDYw_19f875f9-870d-403b-aca5-d3d399246b17"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzEtNi0xLTEtMzY0MDYw_4d873dbd-5b16-420c-bc86-3b872b223384"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzYtOC0xLTEtMzY0MDYw_697a50ed-0ca3-4e2c-9508-8d2b84920b9d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNC0xLTEtMzY0MDYw_100ab860-fe28-4fae-a197-702bde1a726b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZToxNTc4OGM1NWZiZmU0NGQ2YmY4MGM0OWE4NTM5MDJlOS90YWJsZXJhbmdlOjE1Nzg4YzU1ZmJmZTQ0ZDZiZjgwYzQ5YTg1MzkwMmU5XzEtNi0xLTEtMzY0MDYw_33eaa7e7-913c-45e1-95c3-1eb2f72cee81"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90YWJsZTo4NzI4NDVlZDNhOGQ0ZWY1YjA0ZTBlODU1YzUwOGU0Yi90YWJsZXJhbmdlOjg3Mjg0NWVkM2E4ZDRlZjViMDRlMGU4NTVjNTA4ZTRiXzctOC0xLTEtMzY0MDYw_8d50453b-88c4-41cc-bb0f-46fbbd783c17"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80ODcvZnJhZzozMTU2OWE5ODFiMmY0Nzk4YWYzMTc0OGQ3ZGU1NDk4ZC90ZXh0cmVnaW9uOjMxNTY5YTk4MWIyZjQ3OThhZjMxNzQ4ZDdkZTU0OThkXzYyMw_3b164bf3-3409-47f6-9238-ae34454be6b8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTItMS0xLTM2NDA2MA_fccf220d-081e-4f3e-b8d9-b22352996dc9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTItMS0xLTM2NDA2MA_fccf220d-081e-4f3e-b8d9-b22352996dc9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTMtMS0xLTM2NDA2MA_7d53f1df-0fe1-412c-8d7a-c85744a33900"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTMtMS0xLTM2NDA2MA_7d53f1df-0fe1-412c-8d7a-c85744a33900"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTItMS0xLTM2NDA2MA_fccf220d-081e-4f3e-b8d9-b22352996dc9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ5_a854f423-a49a-4d25-83ec-b6c61a89c384"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90YWJsZTo4N2IxNzdjNzgwNGE0NThlYjYwZDExYmEyN2ZlN2JkNy90YWJsZXJhbmdlOjg3YjE3N2M3ODA0YTQ1OGViNjBkMTFiYTI3ZmU3YmQ3XzM4LTMtMS0xLTM2NDA2MA_7d53f1df-0fe1-412c-8d7a-c85744a33900"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjUyZjU3MTcyYTlkNzQ0MzU4MDM0NmMyZDhmMzljZDJiL3NlYzo1MmY1NzE3MmE5ZDc0NDM1ODAzNDZjMmQ4ZjM5Y2QyYl80OTAvZnJhZzo0YjQyOTAyYjI3ODU0Y2E4ODFiOGIyYmEwY2JiNGI5ZS90ZXh0cmVnaW9uOjRiNDI5MDJiMjc4NTRjYTg4MWI4YjJiYTBjYmI0YjllXzgwODE0MTA0NjU1MDQ5_a854f423-a49a-4d25-83ec-b6c61a89c384"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>268
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MA[UQ^.9H$-@![H[/&;_5&\?$/LJEE-?VY"0][ 66$<]Y8BP$@X\;/N%Y;I&
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MSB06T,H@K6 +R+H/#$B O2Z)O5_$N,B#S:LL8:):],=0W>C,]C;5>=40UHK
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M006Y,A)8OQ[@#*K**&F./VO1P*UI'+?;&_4+&[P.Y@Y+../5#U*H<AP, U3
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MH\.!OCY$5T&[CN*UK5IW7.D::)NE_NL 829H^Y)SM>F8!=Q_3/8,4$L#!!0
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M=P%'^-AR.2,QMN*W86D6I9E)   +8G.83#V>>Q@8E"-V"JTN,=92-"6'0R=
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M@IX L#@+J-4K !@EEA[W^.R)?="CQ"WK?A3U\D*]\36:\QE8@R5 _3!,([,
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MG,UYHP'J^X50Q.TN] /VO[>X_1]02P,$%     @ +5-85MF1KN2>"   82H
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M#E2<F-MC[D+%H4F%WPD_%9,#%1.OE0<0:+Q<UTRL6<D$S;TL3!QK-XBL_>^
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M:KY;P@;3@HL76TCTZZBN7^\6]W<SM(*L)T>P*<LE14N6<7TOI<9\T/^Y:>L
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M'>/K1>:?#_(;+3)[W'TOM!:)O=P 0SUM#/#Y2B CQ8WIH/R(,_L74$L#!!0
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M *5CVQ8^QK/YXO>_^_KZ^O$+/$E55G!_UM-'5R^2Y29I$Y;=60,@\ZGAF6:
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M<"&IW+YZMJ1J(?#I\S+2$X8+4?LP>O7P&E5YD61 J#^)7;0:SF#4A1A9G/V
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M-'95AJ5852Q<3$(0Z7 U;E:-#@SMX;>D?U;Y,-E[SL=*RB]SOP/@.3F[FMM
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M99X>WFB993IADC*>$!EA*+/*8U@P&YU;%N!?UUHO;^#7"/8!9@:' @/ LE9
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M45>H(DN'#\ON.I"S#R;S-FP/,'?S^3Z,'D+Y1NMA1Y#D72QM!C&F*97KI5<
MM1G*QJ>6W<&Y"&HG<-)Q(*YI3D;&EY*RC=QA"49)_:E.$' 3"E_6EB7W'&J*
M2(M<1<%()?<]4.-0=,>QIY[^G'&$9X:,,'[&$TZ3\UGC)%+S%-/YY/C3SC^-
M07,.'W\:GYZ)JPUNR\&3>G:P?>=,F1A,QI/V*:GF;I[.QO[L#W.N=5QJ'$WG
M(]I'?8 QYLB0.RLEP<!@C@O/(9$F6D]$H,K!&X(<?F-;IYZNP89AFME:;ZO+
M8 LXYWO/B:6@K(P5,+*RYDABN<]5L4X;E9>%RA5ERVW#>D&]JJXL@,GJM9?X
M)A-=8&R4:EWH>D=U=G0.:5)GLD EQ<@WL]EK7K-ODVD<FF(_7G[<D:1T^<DG
MDIKKN>M@TO\SOS:.)A/?)G6P?(:5:+G01D"\N[)PY*!7("1H3ZO J]3:,YZT
M\FR4=>@_/=#J.:>#!(TIPI0,'YC=>(+TPK3JN)[H5=N[$I)R,_*9V+";C(!J
MTV0@SN]Z1M,W@J<7O %NG;$U\F(,*1H4M3$M>T9N>]M7/!0_'7LDWK"'9WC$
MMIWAE,LM%E5#-]FNTQP&): ;Z[ YA4GA,>].AW)?NCGS6496]4L3DN&IE;)]
M[+.9"&W&931Q> RCSD$5!!:8$RK7*FPMO@I;[?SJ4<LQ25GIY+UOTG]P/IR.
M@JZI-"<-Z339AG$.[2C)Q(-X>.[J4J@08'HAV#A9IEE-IS>Q@ZN#EPQ!GQ4H
MF3'O0$@NN7W^J?C(S/%QP.B+B$I1J-2*NF8_2WP*<*W>ZK*&?8X"]V%/B>([
MOX+VP&]7%<6BM3.GBX+P$IZ6>ZO^K N4QF^_B<\ N'U9\6MT]E>2\6OT]'$T
M/3L<P[XITG6ZW:*O\,6!3RGIVX&><%;1Y/Q>;A<_]N0C(5+&YF70Q47C<>M(
MS,GW]$][2&H3WB6 *#HM:@PD!-Y! (M+"@TCT9'5+0@-LQHU :@%=&E.$"Y@
MQ^E\$W?4T,D<&L F#T$'^5(.F>0JNB/=9^M;07>JR^[9$N3TTU)\7'YWO8E?
M7,;O<]M6_",%%CCQ9:%W\%)J=JK>TDZ4;A__[2;SM9*%;_<*]C<<IF-%_[*7
M_W?LI6UTO//LV'U&U;<<<9/6)[=IC=H&V0P#1LHG%,V1B&9_@G_PB07DYEXG
MT\_F'O!'L:3 ^.?$U7\.X/B53FIS;B;H<, +4<RND+[7E38UGX_K3_BP5"5)
M<&^ZTB^<4I7Q:-2.R#I%BG^IQ<#-9PWP?Y1M-.Y)NB-1.9[;7?Q8(.Z'_^*3
ME.?Q^-^0HAQ'T\GI)U[#-)G?>0W3?$9YQ&68 '7'@P>GDUD[S^@W8QR-3V<^
M7X=+;^48)U$\G7],CM&?)2W2[$^Y*$ SP1N*P>7;U]B>,2<EWFHPMH!_6)76
MFJ"$+>XBKLI81:]ED8*PVP95LKZ^EMI;/F7X@?*WR&!A^'=P5A!9/W*')^A0
M#%#0)&X,O'AX=?'V]'0<SUID^N[#>PAFSV/,##)[6V<5GG4!(YJI0N/Y*)_;
M=#3;9!7A LP+%->X;&XW##*J02H5KVH@.!)<XV32J*! F%<L^?Z?H&Q^Z"ZH
M1WRW Y$@P4N:2O.RD#><)'!PEMQ247-W/=UZL8)!-ZS\]@8G,[^_P.F1O3_"
M3H(G;2H "6G;((*U7*W^UY*KK[&KC.\K$G+YS]H<%N34EX$;NGN9R+TVJ1.D
M7.US<//%;2-*H;1&?-[PB>[!AB.T?PW]8*NRUA^&!'X0-B73H+IT:GB): @\
MBK7;F;WZ;Z<T"6N-*,YUI/-=9 PS&TZ3->MS>DW#X'['Z;A#?G/6262VW69O
M<@K<Y@+4+RP+-#C?XT^'C7WC)'"P<9FL\V2CEKX[D3OSNDV*!U8(; 2! B/V
M(4OU&3_TPN@P70Z8/(J)#O*]:QTQ%TLX1XUW]?7FY-RD'1#P=YGS54V33X4
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M+UTE7>AZO2$C@O=_K$%S"=N$!P^"K&ZS;,+9'W,CB[T;U=Z=9JYE1%-E!1#
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M?8".(@"TBAR^Z:  _!K\2\FG@JT:^R.=ZFDC_!ZF&.O=QO6XO:5GW#3-Z!U
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ML-+FX6V&>)@)6Q71=BV>G%_A$]RKHYVFPY%LWALJ%I4F2]ML5\'*?,Y&H6H
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MC_8W_C-VT:(RC"B7QCKO27:)3KD'?7 OHDU]]%"7O,;C(Q]&Y(UFM "F]\$
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M V5D(3]@'M ^3,^1=X3CPZD]VIL0]6)W;[@/Q?VM#IOW-^&[/U=0[G')1#0
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MA>8=#R7IV[HKH(K3*Q2MJ]SS("R&C85=%QN_N96T8YW6*$FX:8B\"#B6"PE
MNR[I^*]_SJ;1 (>8<UN/?8M $[&4F?$>K0F)V(L#S4&E,QJM@)H7?7_[YIKZ
MTELQ-35'?XYE9-14^^ CW]9JM]!&_@@C4ZR8[?AT_<_/7[[>WMY^ /KQ.2+_
MR$^_ND""@+XI-)$B7%_../()UM;0AG%5+7BR_WJ[B;WHX.,D&HWN/-$-"^E<
M=[ZC%.HF#%VZAP:ZE2ZQEZ3IY;Y9;B-@SR=M#&[FBN]KNT$8KI:N/X['X^'X
ME!V5NGSN5:1R)HP2]3=9/A\>)UUGA@Y'BE.1I^;0TH-&KN\;T8_A-<&,W^O
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M/X/A7"Y5TVIN$&R-L%&".I7+[?5P"6X)W1+ Y/V[(LZ2#U2'0M!93N&S5L;
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M::@= _TOE;([PBD8'WZK?P%02P,$%     @ +5-85M<142H !   @ @  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C0N>&ULG59M;^,V#/XKA ^XM4 6OR1Q
M<FT2H"\;=ACNKKAVVX=A'VB;B87*DD^2F^;?CY+=-(>UQ38@L"6+?,B'%,DL
M=]K<VYK(P6,CE5U%M7/M61S;LJ8&[5BWI/ADHTV#CK=F&]O6$%9!J9%QEB1Y
MW*!0T7H9OMV8]5)W3@I%-P9LUS1H]I<D]6X5I='3AZ]B6SO_(5XO6]S2+;G?
MVAO#N_B 4HF&E!5:@:'-*KI(SRZG7CX(_"YH9X_6X)D46M_[S<=J%27>(9)4
M.H^ _'J@*Y+2 [$;WP;,Z&#2*QZOG]!_#MR92X&6KK3\0U2N7D6+""K:8"?=
M5[W[A08^,X]7:FG#$W:];)Y'4';6Z6909@\:H?HW/@YQ.%)8)*\H9(-"%OSN
M#04OK]'A>FGT#HR79C2_"%2#-CLGE$_*K3-\*EC/K;^XF@P;,H:4 [26G%W&
MCI']>5P.*)<]2O8*2IK!)ZU<;>$G55'U/4#,+AW\RI[\NLS>1+RF<@R3= 19
MDF5OX$T./"<!;_(*WFU7E)+IB8THT=\'"WHS\!V!%%@(*9P@"Z@JH&]=O_D3
M"^L,7YV_7@I*;W+ZLDE?3F>VQ9)6$=>+)?- T?K]NS1/SM\@-#T0FKZ%_J\3
M]]]1X(*+1:'<6Q&"]*(,'_$;N"NX&@I?VV=P\O[=8I)/S_F>2LDA/@W)\X_4
M/Q*XPT<NY)+$ Q:2..XZ0+L:%93:M-J@(Q"JU V!PT=.0#Y;P"+)(%_,X<90
MBX*S\\@MR?+A/)U"GLY@ELT&+X_0X01/(1UE'Q(&8)E\#A^5(\Z$@V"G(L.B
MOBE8: AM9Z@"9$XH##R@[ A.+!%\UBQ\/<Z2\2DPPRS-SB%-#\NK$)AR_[_P
MLB2';#$%9OE]F#="H2H%RJ> GQ2GD.=39I3,IO AX6AJQ\>3T6R2^>><@SR:
M3^:!]UW-"?+)!M^8Y9[#V[1&^*!A]<#(!"WNN;DRLM/<DMM6"C*<$G_]CZ-H
M2#(GM?5BMZCT1OQ@^UXZE O_MM[CCBO?  *7"[=L7V+LG;_UHO1B6T/D[8T#
MD^"?<-3X;,NN8HD"U3U(S<K_\(&;;V>\#T(![VU_8S2SVQ,:[IA\!VMNOS]N
M#5;$7#N?Z!:-]W ,W+[#)1RQWI-9E%8_VZZH<+SC4N_ZF(1<<OHV1C>L1<R8
M6T)/*Q3%G6<I_36Z%#HX_"M6#8^9DQ*-$:S*$]#[ZPV?]B[V-$+4&*'1AGHB
M$UZ'YHE>HZ2VGU>,^4R6.^RS$#=':@J.]M @T_%+#24^F@H-F6V8?;:/3C\@
M#E\/X_6BGRK/XOUL_H1FR^%A?S:LFHSGLPA,/^_ZC=-MF#&%=CRQPK+FOPAD
MO "?;S1?^F'C#1S^=*S_!E!+ P04    "  M4UA6X4P=D;T%   U$0  &0
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M!6DSGY VBP7[ASL[B683>A+/YCARPIX@WP5OV"\D7\H"#KU@HV@RCED:+>9
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MBKV=5FD:5B-RAT-JN]]_BT*:CS@*XSU*Q:<3\/"2T4':#$*[U_;,G!8&"8F
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MA![ ?3JQW/R@ =JW4;[X'U!+ P04    "  M4UA65+[;_9<)  !=(   &0
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MS@]:A]W@D(Y^76<I"[(P+"V=P: +:"KDD_"&@SYJ3@L7Z(\Q".U;4941KTD
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M&$2 G=,+F !4<$$4T WN5/PBD:5:"81I@6 %"1<(G-0RJB6:>6A;@A);(@4
MK&4.J-L"[0&_GG !.U$DKH@?%D^BQ?D+QN4ROP-(X&O43ZX;P^R^K^ .$2#/
M!8@N@;I9C0)X#[X;*]FB:A#5. : 4<KEN0)(;(#J@'68<D@E_1=_LYAC1["
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MW\!8X\I<DX0NKQK)J^_6W0^**):9BW<U(?M_MNO->;-= W+:O):[K"@NBV)
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M#W<3<_;XR[H 8"FR!=HL3!P]Y-6VT;>,V8,Y!"6/2%14A8WXK<I+X]@21NY
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M6>R8S"*0\#Y3OLL@=!ZK6AKGZ)2&2&=^F*CWAEO5(0U3,\')21?\5!=9V$]
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M!WCU0T<'ZDWGC:E2CD%I.%82/VF,G%PCWG;)QD&1N Z9NS0^Q\R8]>3PD6I
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M>U(V)#-GI,=/_^*3 _0#4J\./1%X;*OIV3=H9Z7?:?&$#<]/JCB3E.),6.Y
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MVOI#6VUP2'S8&N"?W@+R8"5X ?Q^5P%2U >< )__1N"]^G]02P,$%     @
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M0>*O=ZIZ$"J)#HOT$/^(\^O#*.>0A^*D(,0ER@+%UC^N0T$X+ /=Q).1!$^
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M%4PE;"C0Q]!F"&U%.7ST@)H:$)1:<N+VX[DP&4*X@Y(P8&YAATN\I1*&.$_
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MD"RE:&AO%+H57I%&,)%U^R""UOL8H%?-$M? FU$P;,F682-!H"=^0T4R;[$
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MZ9KR!6"ZG%\,3E^\H'J'>U-*7=G^Y7,#!I</T44\4QXM9"0SL.\QO9 FA#B
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M_D&QJ0BARFY,:0&0L#GCNFHAT]X)5H*>L %. /G %D8RU89FJ13OK,50C\1
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M9$S/?F$"T8]D\&0_HA*1(K0M,1+;"N%GCABD+F]J9X3;0@>6 RG3TO?/)&"
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M"G?_C]9N<$GT45N[IK^N:+PWW@"_+RQ^:(W_@2]XL,U7VMX/_P502P,$%
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M)(>";04^J_TG:/,9.5ZFA/%?LF]\AS$EV=:@JMI@JZ#BLOFS0WL.)P&3\$)
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M@X[_6]%DB=H9T/>=HHCT+VZ#<5;=_ 502P,$%     @ +5-85HK5_,^@!0
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M.9B_?I4>)*<O )_UP&<O1?_YBOV"L/3_9HG*K&LO"_*&7K\ZFA[,3M.]Z?0
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MTF)+#Z(VI1I#4ZWGF1'YK-6P3>M5-EWG^9V4=EW35[%<VV@9@U1J=)^\+4%
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MG*ETH:1$'&F4"35MO6!+9HFO;>.M9C>@M=5-KM>JJA[IQJHFYP']P"B+YG%
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M1U#B4JR5NZ/V,V[R&7J^@I0-([2=[S"/H%A;1_4&S IJJ;NO>-Z<PP[@/#D
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MU#4V*HY]BXY/5CXTBG@;UGEL ZHJ*34V+R:3L[Q1QF7+>9+=A>7<=V2-P[L
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MVS1<2D\<F+2L^=L @US@\Y7WM-N(@?W7QO)?4$L#!!0    ( "U36%9NY>P
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M*6+3+*M-="_4)#LU43/-:<EN$(+5Y_8ABK$Q)9&!CG$*B-*<Z?4F+V]%+]>
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MCP=B6.9XD9-E IPOC/'=#U;0O_%G?P%02P,$%     @ +5-85A%@4EF6"0
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MMB7^_5]YM<%+3=ORX-&4-AWFL\K^_*<G9V</GN.S],_3Y\A:BP;?N21.>5O
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MY03^^Q#^]Q7\[]BD5G"9@')T^8Y,R#P'<R87+6U6E+=T=\B34U42*B#63#,
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M\3[#U-])"+9"48-O@->M\7+3J8K]?_B13?#NW13+M9#:8B.G/GIV%*SN\H_
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M:,P&-^&H/.:3CO6[H9H?S(FC &]BDX&WA9=G2]Y] 1]JBZ6X(XY*>-NN/5K
M>KR9T\[J=:'6\.D9>EV(6WS :ETA#?SF:7;TFHJ."\PPHY)CI(3WOBQX(%7Z
M;$^_WYIS0<Z:65+9^_"&891<%DI !^@KH"X4:$YK-S7)0C"+QD$B-AL,VCD@
M#O17?!7V,,0:"),^(=^C5'\G=\OPH]ADBT7%K^:W$^X>JKI'B]@'PD'EC5:>
MV.\T41SE >F5Y+F7%"(ZO!P4JT^H6%IJK#NY +ME$@V/@KC'<_:&WI6XKK(;
M3LJCK.@>C9X(N7P.66U\>T:,F*R$&XH^+%6T)'_LRE&M; VH*8-=B]^/^2E@
MH%US.>S@*@2]U"[%Q'M'V%=G@&^L=>L\A@IZ+[%EH*?_$!:/R0V'02Q,L,0)
M]YPVRR9$FBGFC#@VPD"OV8IA@N,$S,$V<Y;\DARF6 Y$J6N485(VL\V*D_-;
MCI"1JA><T?C[0.KFT$* DRM4ZI:S#9-,5$6.NA4;1,B,-6P%F^AHHL>1*.&1
MN2D[Y\TT&?V)BW\(0V+M2WQ+:J=/&0^M7BN9:IE+TI6&H=;;<KY!(IIF[S;-
MC+*\&5D$/JQG3OH"4T!L&=21S8G<<.E6&4@X(-A,#"Q#*B*2F>"TV*:O.*_R
M?U#:KTVUG:IP'?B#\\HSW. 9UEK^)/7U4,12#,!2ET(H9(VEL;KW?B-](F?E
M(QM,>2 ZRJ&8\AY8"PH&:R?R$4HQ26J=ZO<+X4]RA>)1^Y>U49EVUV=:X[(O
MK\2G3^5*93>\__?BJC+<N& 3NG'L*F(J?98>,R>A_[ ['/5GY%47DO>HQ<%O
M.B[=Y,+7]<>V+X\<*H&#;T*F00Y]W+%Y4:S08=[Q=8QC 'Q7L:0++S+&-EDE
MW3*P;-6%8FQW8&OTD7>=W4:Y'1B<I[1=JCD41[JE!^1>P^#:ZR3E.]Z+H6\I
M<^=7$.]:P<)D^KUK@+>1X''JAD4Y>X$QJZM<E<N\,3<SH_9D/RJ;_<"> )?K
M,1.84[KA[BT8]^H5VO9]^D-&>HBBW^>Y ^,ZX!@-$;52.^F6IQRG'L1=:',B
M#P&&;.N[BET%9LZ/! TD<!3-;N>[2A?Z'#.I!A$&[Z1\<]\!TMN@WI&0A$<"
MZQ-ZI-K@84AY?8Q &"9 $)B+>="B#W8WW=N!E/3DG3\&XR:"UN)0SK$+C"$K
M4DG 852VM& \AH# "8<Q?'W"8P3[^=$-A+Q"3?+PDYP ?05; GTPZ#7.J"B$
M8)=B%4@+;L0C&(99H>N+-:1I=HF29'P(SOSRX68-^E+&B/J%,=" 0KN3NIQ<
MDHA.\)N3@'P4)P)*WE&H*5>=UX?H=KF* C[VZ6X$ZU^)/PY0QI+.G\\:*1O[
MG,-EZ@OP%KF_MLP*&RTXT8]\:7!>;4,>7=YQ03=Q.X,U9BQ"4YV)3ZO/N%1\
MZDVK^FFLD^E\740H+3Z.1W6+_>SR37)_ IP9Y95A,3F1*/% T<(E0ZYL H;<
M;=&RWN0_P??7.\Z"T0#Y!!PW(-TY'0 J.(>/!-76FS((X^#?'(L3.$HU!Y<"
M4!+*0IQ^HGFIT^R"M\'4@;%E'.:H%2'?'W0XG',WY?YAQBB<6R4>FC]&'>0K
MI-8&0-8GH3[?\+'-H<2KD&0NEO8NO;IN@GR /[E2R8'7#A=J>5:S <"K^#Q0
M55:I,D0+1L&+!SG<"+9GV'XAN.3"XQ5.?(*@,OT411\EGF/GX%[Q$.V_U'\E
M9,<$W2ZPAM%"=Q17??&"Z(FGTQC\P]>34X[!WLNO#2V0F87\]5$L#G;3TI2>
M3,)CH79]GS."L].DL'^:?GNZ*C[E%.N?.>PCQS[$A3A!JU@BF^J%:,M/P0DL
MB;#S8E57A'E1S)]E1SG[!0A#@_)R%L#FG=%,50M%%T"8'- ,(X0^SXZNCE-*
M;Z49D3)&H7XE^=5L\"N7?8Q5-O'C\^.!7\I0\N0I3IS7W=6PKH4,!3*RA<$*
M'DP@$&VU8%;_<T-ZA^['I)\XR"RA:.M-,Y-*C.3RB(DLY#5A76KF]C>3#G]>
MTH2Q2AZDXQ:K_LV?PFB1."H6U3<=,+9@U4HN9Q/*=;725XU:<8F,0 8Q\@G'
M(2*B863(->+3V=UND+>P,J>F*(7:@PI%M4:@7V<H)Y:Z+U2.2MEF5SA[^,TJ
M;SX6:NGR="TYP*]%L'TH<3+.=2OO<:E8NY>>%XE76Y&FS@^MYK+R^7!<DN9A
M3B:T']*6!1Z5]]&MU;NO\FR4?]DD@>6C)'1")OG8$?M0T$&)6:7V'BS^\NA+
M+9+^_$1VAC+4MA4LIN4J>SSS8]'R9(1\@87MAVV.-^A+;M0AXMQF[R%U<NUF
M!P]<P[M*<B=_J,7P(2>(76@D0F:]@19)# 6"RZEY#A\ID]N$?4N[^:@PSU2R
MFQS3J#K<.FY^R2X#I,$6CVQ %N359&AF.28'[H3)*+2/Z(4H:LK.I%_3/K1:
M>)R#I;(L9INE&$(4&%IB'\/MSDM$X[*CDK^=D-,'LU68<_1L):KXLKL?7W?;
M_DTD#Z,<>E5N.+GK#]K^*4*TD+L!=5*5]J,\S6K+*;IXGU^RNB.;$&[OV+P,
MGTB)=QOV<Q[UKDA(\6<$N\7"Q-)?4%MU]4#F/9VP5LH](XH(9&-,U-'J]=>B
MU\(0D<>)<[<Y)B7A MZO*\[P1,Y92"&1@YHA/:>X)B!C5) MA3OD&Y\]T@@K
MD@PG.&%F+G*ETLKK>P1W-"KE;>'CJU7IP61&Z@#6G*L$9#_VL;E>F9-PHC9'
MT4MQ7=R'8OI":;.&>0@^$G )L)*P4F6M!$ES*9NY548XQ_0:#)=5/BLV';&#
MM0>'X?LVPIL5[R#BT8DK.*!?:>KUV6:LPQLEA3?%CH+(=Y@/S$]VW$)7%N25
M',25:'D7#?@MX]@'8@HA)HPLRG:<PB6XNQI&(HE8SEH$BVC+HA$Q3GAC[NH/
M]D9KW7I8\!+OBC86W5-7>EUH.]R")F%N C*>WH36D 1#ZX -%MVL#]S%"&:N
M=>UC-I6C.O)?;3JRPC7BV -DI&QJU6UL'V1^! #"9MK9=)11'FBE_0P#DOQP
MMJ@6(>Z])QQBE<T07;PE:<4E01MT\YNAOY17308\/^'C.MRA-?1GV1M3+JUI
MZ,6E$_I"UY+C^ME1QNB\2?.3W6^F_3DT2/28KX&+S]WD^YLD"12BIR4SCZA$
M4QGKO5E-ZIZ%K31 O4%!2.ATAJP#M26. !1,H^?C-'H ?7[!3X_*ZD15XK$K
M._%L;0T$CY%M90"<2H7.6.*R[*HCRC_.K)!"S4>Q-3FJU(0P$[JZ@G2C;51?
MSV0D[TI>?[A2])G)>$Q)1\XQ);$*S3U=BH'G^AQ$@63BX-XKLPA(A*+.P&_R
ML9X&4IV,SIJ]!W7(@9?MP>2.7,&3>X^\%UP,L>XX!Z$O8Q%(1$O 4_2C;@!C
ME E2BHN4/Y_[3'R=U%',>A=FDD2TV\]:,; @BL3!7YW*+K2?LJ@JG-3%O!,_
MAH+,L1=<F4;_E3LC,Z$WX>GN/H'O=K:HJ>\TZD>86/-DP.9KO@!XVR-TDQ[R
MJ]W/1"66@2/T0#Z_KHC\3PSY?+AQF>J"1T@W#B,N@00U 7IWRR)M9U?$*< Z
MGM1.1-F.:#!B%DN]KQV2-,V@G;7X0UQH*SHT>V3)Y5MW6H:I*BR^B^.S.,0-
MP[@*<^S2W$G!;F36 ;]ACN4;@FD4Q,TTNR /DY"7AQV:[-^_O4$(>ZD&(7S@
MP06+EF&58\.&7Y(FKPD_(6T5U=F>>X-I4I('T8HO%6+YBD4.92*/&:\#$"A2
M>OF%D27KRNS)(:#NR59]_'9E@R?Y1=TTTMZ%5^!OI);&L:>;4VJ0&-J]E#=1
MA$U6( 58K),R#LI##MPXH6:W$4K[,*P<"'/JL8RO&>_8FX5[^H4U1:_3V:[W
M,2^"04VEW(KNP3Q!R8P4'BL8/G3'L-9<(K*@6U".HVI95&,<[LUG*<AB?7X8
M?AO<;ZUY\'%>\/(B $\98>+/A <2+!^J2OUP]?Y=SS4MMGV6O=B42Q0.+8)<
MPNL>/A (V1_*3PQ*</H /S_3S]\"2X15-]O>P/1K&(.?8B7T//KL-S]1L0K=
M5A\X^1!QE_25>X;5V;:/WONED?97GL7M7<2P!LO2Z\>B[U;M>-]H-:H?9_O4
M#U%5N*P0@P'#=I^G3_FIUKR-D7(:(DR'U?^XYK331#E\SN[+DWIQLE% %K93
M>]UKV8C$(*N4(O+7!D(Z*'Z1143]<.N[$U5#+,V/>#B!^9V@VJR_.SH]T[QR
M\K2VK4=,)9<6276B'YR3_*XGE^J4JSWIFA] L!_ ?W@/V/WSJV#12=-LSK&D
M!R:2E>LW4L0@#V#N+&2 9:O'*GY?0DS [^$679D<:[@7A;4*I@CIR0)]'13]
M3:%^D'. .Z?-Z'F.V2\+RZ-1N!(!LWH!Q@>216^:Y-98HVLAM14!"ET (');
M5";ID@ZW&F2FJP&NW6ND>,=<?8IH:<FSA^XJ$";EPF%FLU*M*FP,<*/9<ES=
M$ES5#G6*O>^M=7_5Z@P@S-K#@%G#3$\;K/7UR<.V[5X$0GU%"T-XC!$[>H_C
M-3$=17I=.7JPW-RZBF= V92TG%LC9?PYXHKR[!%W:AXQQ>2$)VY6D:?",L<E
M52O!A2@OXO1YYE!+4LEXI+D$P\M@'=L 9H.'A+4=9')Y#I)+ZIXK'H@.B=%3
M29_E-826KQZUG,1KI]U,^-4Z^WOK-/XBD=LBG5!JO8GG*;;N741<V>PXY7"O
MVV!'1X"G&4F.&RP.EA!W8 #1JH(K)-*?)M[*6*\#3PN+Q)4XAXG+F3]]O--/
M$3I+G^YN!?WF\,:ZD[$ T;TSLY/NCO_ >5*.V2G<]R_N/GS__&OY(7%9RUH*
M-?*&F)T)[&<1BBO)XX%/6'8'+&Y3H5YR]/+'WR2OPX"0>Y>'(G4N<SH@.^S*
MPPZF$?P&7J+E9SPPWL,+^K@4W*<5MKI$WN2CS59TD5I\RXM&] %<MKFTEYC.
MB6ENKCQ+$^W]#TB99)>$HGDU_$;7['OJ4_L>B]\%YZW/$M@%[&&P 'VBO!2?
M8>;%1E)+#:J"KW9]5Y 7 >% 7;V*EEUU+E+A!Q9 6%-G.5[C*W?6FV9=6WB3
M]$;4]JYD@R18%JER;7'-C#QPF#%%^4EV%,IK+_EW2*62,96 +).?Y=?7B(8:
M1WY\$N<997'^]P9Q.@7. Q?PSV';1T7@\\4&()W ]BR7VP%N(=HL&Q-RX^EM
MH%J##5K6$XT;UK?E=4D*\41]Q[ZSLP(8+G,P;FXT#9(][L%I??^4;*Z=Y;B4
MY/'R&5.ND/P[[$2\$:95!C1@7O4,A4_/%]&_JKNCLI@X$'>#1L%H6691S&]_
M8$1:"] -BJX?WRE*<A%U,\2=".MD=^6(EHK!UY1L&._DV*91$D9-\4(#!.04
M9-7MXLH1XWFA"?-6RDXB5G?)FV/)^13=UIA) &?3*?Y;SCKRT/-;PSYR@;0R
MS23<'8^"9FPQ9TRAX1LU$K=[)B(";F#?N$R>LG-VX3ADXOGG[X%'4;CV@S=W
M_%>V0QNT><,V!3W<B<\0\%:;P5T-T8J;PD-O$7X?*PAM2+3<N-JOA <[=?$&
MH2UL:;E9L:7/:=C7H"NBEM&:T:%!CG ]]BP0"=!U1&[+3R?H!NN]0-P:O)WJ
MD1J\U$HWFKY^19$VCJOQ3O0Z,$6:;\\=^=K,PMZT8W-_65?7O#<<L@L66A.N
MI+?FK_ [W1W?S8'?+GW^I-@2)&PA+;,XG=I\ 5HX'=$%*7VZ)LM9,Y2!*'$3
M.TG*=T&Z6U1)<'6W"1]_CURP<R6K%]/LI21K[L(U4=:3#K51>QI;)([/:4ZJ
MP2C2&O-J"J&%]O.</-'6%0YE&4C#>F4KQ@^UCPU7WY,]ZNI-8F;DDK+K:I^Z
MC[G+OCZG#KFL$=3UEY;<[)SC[N(L>[7H?+'2G\R12/E?IV21G/4MDOL;-E\/
M8ECKD)03MR:+[S^KGLT0.(AK_*V*!QCQ^69)T4N?>!I\*S[$&>HT,&2)^09X
M2R9]().KO/J([5&P=QZE6,/WR'4**@SS \Z+&5<R5Z"IUIVE6C,(!6ES!M%K
M87-9UB3AFAK(XGY?+2J\QUU+UD&=3H_[(7B8V:5B='#QT;='./2QH/[?^W"8
M]LZQU JD>XMM7&-E7.Y$O[[NWV6K7^S7LH/SE6W?0*OWMG<3^E.\^;EXSD0H
MQDXFB[:EB^JX(L)1SV$[(!'>ALZG4)NB;%7C8DA[-6 2:EKL;8KD-QHS^&=0
M-E05W*<S.IQAFE>;)'BJ5.NB@H\ZK8_2]M_5F^7<A7O<M*5O2_\%VF)-CTBA
M$$4'V4/4\?'=C]>G&+F#(=DG"LA-N-1C/7"&][\^GS7WK\UAAA*6:V*4ESBH
M",1EOZ7T9J;V")C)NTY\$D&"3C_CHNWTO#X)GM<G.SV:>T&S^SJ=2W'.]_PV
MZ6#]OS>=T3XAC[(CA'G61GHRAY]TG$O"]ZZX<;6T1YJ'[N:H?B10!/$'?;_>
M"(IXF&VRZH@MXK(9T W1UI7Q4 K6"XP>E01R(YR<A_;@-3!QE[C.C\G*R$F+
M=NW?QV%L'K'N0$:0MH:!5VAC0<IPM9:VNON<\NT]G],4N'8MW^K>Q?NCJ5NQ
M*ZA<H<E*GNFPB66CV,/!,"(<-RK#-49/?4'-3J&<$TEDUH02?7G+4#/F4Y%<
M\7ABZ$Y8;BV?"BPD*TX;Q$8#L!!/N^W_.AO %)*HP'0\.&A<KS5T\N!),I69
MM'/FN\'FM7@R DY;*'F$0<%67'$. &D8F*VXI6XF\UX%,0Y%KPFBCYT-\+;G
M\63I+.W8-(W$LEWM9/$ !#MM:-KUDP/+D![L7#8>:)%+PH/!1^]H;TA>7\70
MV@=BY;DDY]A.@_GLY5I<;!W )K79CJ2&#DJT<8-EMCV@&4Z-J@(T3)?$CQ$=
MA@92-D'A5-(WM";=?XO;,&_R.TR387>Z^H\&*Y8]'3 ]T".CVWM\T-Y,4C*Q
MC90W&ABYJ. 'C+@;%!/.ST!)ST''#H2 W"I%&455>YXWV%3P,FKV^UE'/SET
MKPAL-\3,-4[#C8[[&D.SVU6I\('5-KM#!G0R1V .IUB%OER+A!&!F3((8IB8
MMN\3O$.0N1U0,-&J)M\9+"@*2S?>)XT2&OUMZ[K-ES*W?B>099'/+5DI F*>
M[".0.NJ,)NWFY@?V]J <)S?8_HXD[7[J@'^/  #NU68FP[K>L'5:T=2&*-BC
MOH-) V&*P!M!@T0.Z3RU(1*))$:-!JX:G!8=#@KZF JOUH^2F%BIVKU)<CUH
M.!)1]+7K8)+: C>W(#==OQ\W0:X_IVFBVT5=H1@1\HY3( \"J Y0:\_Q&1W;
M*??HUZZNJ8" >E[2_JG@Y;,IY+FO/H<\;FJ@L)B85]6RT)44? P',C?#L]S1
M/>]!#QD]-+W0GC.F-PVHE# D^2[-O=;LX.H"5LE![7&FV>L1'+6K8@L*7A^I
M12%%T9M'IOS<1P?Z$G=PNV10+(NF. 7N"^)7(^>2-*:T5 S<W2ZC,OAJ/S\8
MT#-'Y]H-^@NIW6V!WU>J)IE38T6]3"*=3T4\NB/Z+W*XFV4OC<RI$*(UHMZ;
M:W& *"T.*B$P=BY3WR$7)LJ*Q.,O_,EI6HH]^FRH1@[Y.<(/EO6F19R7'<)(
MG KA"8VE.$UZC(5/%$J<\L=ZK1YZC"DHH P6K''&4;&.V$:DR_;$N^0S!'*Z
MHURRG1MKR:2,9+*-*DTF,?@5)7VC[B!J3,J7%9<HAJFP8ZL[0 G@JJBKXY$P
M;1\&M*]=Q8;$53[[N*S)!MVQL+B@II]HS!ZLA*U._>AW49!JD5[261!VAV>*
M=S8/F;$*!+PKAK-+[PY +ST21V\#L0 1X/&0@<5%)FR(K'H./$RW%Q ?@I=4
M_Z)LA-."PK(YDZ/?7FDB]U>S6++XA"N*I6J%ORN5&[WEL61I=FJA$IB06=<)
M165$1PE'[U_.Z;J6YN;F;B DXDSQ7=(U/7^@R(2=0!5J;MX*28TJ*RR1Y4WK
M9Q@-)JR>]9A;A9#VD4<&Q^^&%R*83;C%<'J!XN%*!?-RK(73O9*W*/T%7T=^
MHZM"&>T\;)<+8;A-V^D ?1H<H$]WMYFS-;A>"$G/Y6>,D[V8/L'4371TS6'^
MMRPO'&#;>&(F[MG3["B,^R:,ZXK1ST8>>9:]L^94=74<-=/4CI]T]0<\IMHS
MV7G1@NEP1<%YH"@IP(J'(7['F9 4ME=T?PS+8;E,@PT$9@ZL.L1./:D2[H_Z
MR3HN<E.O7LB,;X+?T_5:B=(;5O6\6$IM=Y5?QR6]"F(N HDR,BAZ87Q882.F
MKN^.LN*H=E>]J:'HM-\."G>K+12WC9XH6^?BDT NP^C)'V8"AUB&U_Y"[]]:
MN!]L)JFHFHXI3"'OO*/PA@)MZ#W*);=%G+GW6H]Z?6/!%3;LQYU-]ER<TU=
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M5N(3FM*:7,)S7'-Y$[D$2"S-%*8P% 8$EY'#)*DWL&F<I24\'+Z_!CL,N%;
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MX8B#DJ91\"X'.C*B1>"8)2=QQI#PW/8ZJHU/>__?%^7J"A5]A=TRS FYL<P
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MFKR12?2$1!L,CZ<6I'O/# ]$3"H6P;;2PXK<K+V"B=*"#ITJH8]MN?1I[(3
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M:]VN:Y <JJR%FG&*-[KO_9AG#Z94O@@D<S8D&:.IT2]ZVMX.ZDG?U%%*4A.
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M\5CLY$,[# V)HQ,Y6^#W;^Q."0ED9]^[O;O$Y%*=4EMJD.G:VB33A\XU[!D
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M ^OD-92+\)+CVVR?2)V#&75@W(8\&VA&V9NG=FNT[I5VW/LRA)XZ]]^_.)0
M%3X2=:O=)[:C\&7I;GOX/H<TA[$6+)KBZ&3T F^K)GSS"C=.5_X[4Z2=TX6_
MS$@B>KP!SU,-]S<WK*#[\'CX-U!+ P04    "  M4UA6SR,B?=@#   !"@
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M1^F3:?9$HJ?R3DG>-R4F3L8G\A*G%W!;<HWN[+*<3C5"<L<8+U!WQ=J!/<#
M(,)711QNSJ/)^1D,DCAYGKX[S:01CNB2*TBS^#&+K7+/\A@/QY/1^ZE(<$GZ
MQA).)B=+>))YJL5QCFK5!35(D^RY%-V%P1E%%:?9HQ!3.MB?R9 ,H_'D_62(
MAN-T^C89DI,TXVSZG.;M UU12N_):1(=LTQ&_TTVZ?#2,1X>7<L5ZJU_?!BJ
MQ$;:]H;N9_OWS55[K3]N;Q]'7YC><KJ$!&[(='1^0<\)W3XXVH%5M;_DU\K2
MD\%_EO1&0^TVT/I&48EW ^>@?_4M_@502P,$%     @ +5-85LUAB K7 P
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M*14H@S)\((]#0R<Q:?A$B*,:Q3H )G)XY))&0S^&+D/:R'$3:-=W8HA[7*.
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M9BE/V8VV2P,K;T\HU# A#(GF(9Q^',;X"(+@F$!!SA%E-$L@9+B)*7UX492
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MM8C #*^#8>)T%V[D7#NZW\.PH0<5&B] ^Y6F"ALG_H#C$VW[+U!+ P04
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MA?K%ATKBQPWJFI:_6#!#-)R$'Z9AC\SW=.P5Y<M?+8\Y6AQ4^TS:&P:->\?
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M0K6@:;N.+M/SJYF3]P)_"-J;DS4X)H52]V[SN5I'B3.())76(2"_'NB:I'1
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MJ$?RM(]#9T%H#RS ^P6XPET;JE#>$D7F4\%W2.C9H$V_5*Y6JP$<*W12[I6
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M"5Q.1'U]J3\4WU17AB57< &I7E.X\5&A)\#_%8?]>/^A#31WR/G_4$L#!!0
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M5/?:C8].'G'*[-:W*D-D>VF']WS<';OAS= $CN9#*_W*])9T@, -N<97TR(
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M+T9'-_!>QMQ&Q#4/86SSL'\(;1'V],S+2-ANT+]\S/L1XQRR(HX[/@,6!EY
M6!)ZED\A7FLC<EPK<*).%[-,5RI';C>PD;92]O)ND\LUN_HFTST576!GC;6M
M%<!T_ ;(TKJ'(+8#IQ>/VV[_$$2VUW<+ YOSOL6U>?2_Q=ASEF1:-["B+EJD
M/;->C*RQ>_ ].W3&ZI_\/<O8=ZC)L[W@<*U[#3UZV2GG</H.,))639H9?[]%
MZM>RA1G-^C1=Q!Z+F C@*O!>A_G**#]I$X(3IX^BB7&S"=(65/IO%+ &0;/\
M+L]DF34(2CNI(#?3P9Q&=N'&Q ^E@7^JBIK>KF1[+V7)%OF2K0?!,@D@14T,
M4ONFHT2U)B7@=0&'K3)9J"BUR#%T^W\L ^SG<K JU(ME2AG]?O5OC"4;2-@&
M(F+!"WDG579_Z*F( 1P0&X7>A('>RY%)Y1J@"8LM)7)L.4%PQJ@>RFGH7.0.
M^\@=GEL7#27%8<1N*$JR?T'6#_L":=<?DK0\%<%G)YNNIBGFMBH@T#J5*G=+
MJ]LR_R^SD$E1G,AIM.YH.8=8<IQ(EN#]@0HJQ?N=XMW29=:FNB^[;*BE/9.N
MWCJ,Y8_X(Z9.)%D3'NH L!%1! @>%6U3K,$6N."6CP0Z1H0+4<'%%+)\%'(!
M%^QWE>0I!O6<+N(8HE; CV"M[\K[KDX<(LBI !K 5&/_N+-C.@LKXJ'%5?AU
M8-=>'-!<",0^*O:N.Z*0[M[1<<%^9'GH@CE"Y+N(A7WGZ*#S,"B* D3ED,W8
M=-3;='2N34^DHU>F&##)Z.?[4M;-)M_IM)1=:F>;,N[Y6<F.)S-&V=<?QE2J
M?DJ32 [^3;TIV:.125]M/%758*"&$K74Y!-J&96)*UTH7SK#SL].+S_(5:VV
M:[H<LW_A&2[Z%WZ7,XZK& WKG;<L];:"8V,<L@M4YZ%C!^'!$)UK_K8O)8N?
MB]A,K)[#Y\(W\ZKGZ+D(S+1'/F>J*4K_.;(_("\R)X%T,Z*] _HK@-4C*SP:
MV55/VZW,<F@*+HO\WRQ#;?9@&XH'@(;57B=O/+(<<F#A61S>RP52-:[#](1&
M:JF L51ZCYR?.PM*[F2=W,KND?;YJ<=?^XH08QPKF^-@.0I[4 A"6T:/6?+0
M8 @"BGI4>M-*@R&I)W=D4.J%MC!4#:!*(15I4/$P%X7BWF/C<SWV2H/L9'TX
M2V0FN@P63SMKC=E:4YXY'7)D@FR<#/W%)*(_\IFK8Q)NS'S.?$'RZ,S^*2,Q
M_V94R9WAD, Y5YG7<K>O 4K0)Y:Z0IJTG3P3F"5X6K&Z]"7KJ4<3;6"LT#92
MP&V22;,I80IGS0,2I070Z+@ A*$=J?M?*!D5'.Y! TBF-UP.%L'XZA\JU3S]
MH*.F9@+>[R.LHBA$&14^62+H*&J&NE8<!E8<"^8&!!EAX%MN!!CQQ-1 IQ]X
MV,BMT ?N!  (#]F[%40^RMR >0$WL?7$P., &D?"BF%Y;C!O1Z/#)GYV&-W7
MM2S3![T%;?:\WN?KM:37T\[Z!/6>9#LBF0TDU4YY3=MA[=C2SG!(@M;+5GN7
M\GPD[^9@S!R7C2!2[3"R113X"$)(6"+O>'!9E<^5OX(),O;<G"PAW7-##/,$
M?O@@H--$D$0]MHB=4)'TW%C'MX]E6NPS2$8"Y5LX5-OA^<</UQ_?,0!\F26H
ME-*\,9N*J.2 'DJV2H?OM**)T02.UOFMAG9 ECY^S!L3L(L\U2IMJG5[3YG
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M$DQE;X=Z_'LY39?$!;G'WVUKQ]G-+S_%@2<.K()3SP6<=F C?2+<CS3T5&*
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MHGYHJYWZ[F]5M6VU57]N9(*J@3J@?5VAK#</-$'_)>B;_P902P,$%     @
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MD"A<T)E#S?Q=FI$?V3#\+9K>-DVX$37.8*<M/(6(HJ"APCL#=C%*7U.T>ZW
MJ1AL!<]YQE6K8+<5O2BB;3Y]]K<8TPL-1ML %+5@^"Z?G@U9N5"*8K;40:PS
M&WQP!E4;6LCHMR'7N6?>A4!2*=I6"%I-!Z+AKR=':H40,]3*-_QY0Y3@< ;:
M*/Z$4A)GF$-X_:%V)/W0*)>SRZ,+M^VV,@2L:WB,&HW>U2[5"H%DH)5P:Y6D
MH1WC+-:;:9K,$*_K)HV'F)1+F2Z L6X36LA1X*=!>J?F/OS G-TGU5)U]ML-
M5&I&OH+\+P60=]]U7LPN\]4*_:OJZ,V[RU,XF154H)3'N9[:V?Q+S\W\=@-K
MMWW[XA+PY&^;3.KY,%=0&&&F<4O1FE97OCW0*D0K;7BZU4B8B)HP$1V+,)M!
MQM6A%>Y1&L,AI%^PJG&CRA'-==^-:\2C/32Y(F7GRIB4GU!24MD$YJO81I\:
M<&KT29X+60K^ C#Y=H,D LL'@!P&FX0R"6WZO)<^U9\B["-.0IK[WM_]'$2?
M6ZCS@$Z.05D[,/. WG<*WT$-.7V?[Y%H0)-[R&+:GEKX'S/.+81X0.^[:VV
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MUN28FA;"+2[P+_H5%D0%L4,;#UI171#[!59$Y3!0\H*CK$?7OTPQS J%FA8
M\UIO?#4M83AJ/KMEKO\M\PE<JG3YAYN,J635A2T2@+]/ "/)!K?;W8KVL>E&
M(X0O$,+@AL31+H>SB]Z"_QIQ%$"L'OA45O=29FR1?(=L51T_S2%NX N:"[T(
M >9JQ&/M0U]ZG721W&X(+= 2:::*66I%H-S>B&.![$)# <GD8B%G>HFBG6O
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M,5"? @_\> #A* :T2^ 'Q^TSB ]AY'EPPQ:U;PJ6<NA&00^ZPU%O@[Y++_P
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M,2YX;6S-7%MSVT:R_BM3VLHN6:8IS. N)ZZ2Y4N\L1.59&<?3IT'B(1$;$B
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M,+.BQ ,H7 P*;<\M'^(H%S%)J8",Q:L;H,O(&;HC!-43GP.X^XA4;*O+)(5
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MJQTL<SY'*1__$!M6>1)^HR 1T@G00K54G<Y;G(XXDS&&+H\[>F-/,$.I4\X
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MV5RX((\*^<6Q,;]T=?DHI3!MBN8E88&2W3H5<" !H,M^I4OVW+9PE91<YJ0
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M-8<6C"'W;@/"B!1H09L/<4;"\"BA%HBA\VDC)5(1Q09313ALD7I8IZ+ <J(
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M1T3H\]SZH2I*=89Z7E15L5:W*\X67"  C"\+"([Z 1F80_5G_P502P,$%
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;)U7;6_;-A#^*P</*&Q
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M)&U76#E#/@>I9CS9Z66]M,?RC%90LHV29<CC/C;.TP)=6 1,I14DMR@L()^
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M<307]U(9\2RK%BB@(-F&KY-0C0ZEQRNFLLK)A/J#"6! FTN3].-P_QVN&*'
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M'TR"9H]J9LI4K25;:'7&J_AH=F] !@DA5J7WC>2EF54Z"&Y0SA+S2V,:L/[
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MCUP[L[<?P=9Q3I[9@*D[D@5^YK"3"SB?6QNZ#U&P^>$T_0M02P,$%     @
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M"$=OP!0"P/Y"2E.\((/RHOOT_U!+ P04    "  M4UA682E?H6T&  ";)
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M"ZAH^N!FHGAI>\^EK7AVF.MO!Q!F@WZ><JY6$^.@^QJ9_@902P,$%     @
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M'<E)3BF*K^+HZB]_,D>]OW65&XG9).:0F$MB'HGY)!:06$AB$80IU3A85^-
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MR*&6)RC-@-),*,V"TFPHS8'27"C-@])\%*U]-6B\4=K/?JB3!C5%06DZE&9
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MXE0MY.FR?"W.4YJ+$Z/\N&!TRK@L(+Z?I>( U NR@O6[M&[^"U!+ P04
M"  M4UA665TW+C0#  !8"@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y-2YX
M;6S%5FUOVC 0_BM6)DVMU)&0\-8.D"C=M$YC0JVV?9CVP82#6'7LU'9(*^W'
M[^R$%":(U EI?""Q<_?</4]\EQL64CWH!,"0IY0+/?(28[(KW]=Q BG5+9F!
MP"<KJ5)J<*G6OLX4T*5S2KD?!D'/3RD3WGCH]N9J/)2YX4S 7!&=IRE5S]?
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M2)5I5UDQ,BL2D;4TE-84Q1WM4E2V WW?2&E.%3M G?Q._P502P,$%     @
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MSJ8H6K=/1]NQJO;E.E<6B[]OEOC:@G8+<'ZME'WJN!>@?[^SWU!+ P04
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M?R5<9T7YAK"Y>)>4,Z55=8?R]INLW*R[/ZH!OF2K/S?;\?W_ U!+ P04
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M:AE,4 ESU US[]5>E'];\66+MBT4P2Z".(+)0G/^@EFL119O),51-\5]W -
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M,9?,FP^L 1PQ%,ZQS<2@E!"1N=&3(:*7-+.,PG*)H+G[%;)S+)S#E749> N
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M ;]!4?R:8][,&26B4.@NULC_FXC<\5F.+P:_8.K+G%$,:H1I]Q2I%R)"8[G
M@0\N@V&G,9EUX*-$=2$#85W&$=$!@5T&;GQ\K?!DSL@IA1U]AXPA2*P7$%,-
M$X%Y $1C(RLE9@PY0] 8@H1[ 12":,#""J?&<$F!Q5/"QA L;@PL#R@":P\0
MC37Q"A8.Q(XY^!4 $MD%/GV#&N;6&&XH&#@0(6;LS'^$$)WY6FR"J@@89B$J
MFV=*;!;B#CWB@0QW-TAU" := BH#![M:9+8!RB8$BO&5@B8#,4-^)W]\7$[G
MZYGH*T33MP&]:=?VQ=I__/CAUX^3X+Y:EO.@?! Y4?9MHQB3]B-2H?E4-M/'
M;7-,0TH"4</[RZ9UN[4ANIS[ZF'=]!E8-\%TW7;U0EPN/I:KU;R:;I^*MK[O
MGDJ!1^MVPT5!&7QY_JIL^T^BX:^F//CI2UE^^3DHFZ;OWC:5<=-JWP=O5TTU
MARDINZZI[M:;NPC5'5_R^TJDK:L#4>95/=LDL]V:?]'?3.3$5%RR3<<_ZXYO
MC;Y]15^15_UU6P>?NU*AZ[-G*1[P>=!VXHL^56T@T&ZC_,[+IJ]"0O>>3_GB
MCC=;@Q%Y$?0I?87U8]?M(^?=^[(K;V\6O'G@$SX7/=2T7B^[OF8HWXK'[[XO
MZ-=OZ=4U^/X=>?V!(-]/Z.OWF)[1UQ^P[T5%ZBW%F*V^DO6_;:Z[ELF]O5F)
M.B.JB."J-ICS>Y'T\%5_8DI3/3SN/W3U2M39J^"N[D3EV/SYR,L9;WJ!^/V^
M%H6P^]#?X*EN_MQDS^W_ %!+ P04    "  M4UA6/DEJ5JT$   O'0  &@
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M7)K>C-(&F.^9$'H[L3^HNWW\#U!+ P04    "  M4UA6![9BY)@"   -!P
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MLS+O%4J;8,9G0NAUQT[0OX#9/U!+ P04    "  M4UA6W"N,@9H)  "N30
M&@   'AL+W=O<FMS:&5E=',O<VAE970Q,#4N>&ULS5Q=;]LX%OTKA <H6B")
M+4K^2I, 2115 ::S0;.S^S#8!UJF;6)DR4/*R038'[^DI%BFR#!6]QK(2VO)
MEX?4/5<TSXG$B^><_RE6E!;H[W6:B<O>JB@VY_V^2%9T3<19OJ&9_&:1\S4I
MY"%?]L6&4S(O&ZW3/AX,1OTU85GOZJ(\]\"O+O)MD;*,/G DMNLUX2\W-,V?
M+WM>[_7$#[9<%>I$_^IB0Y;TD1:_;QZX/.KO4.9L33/!\@QQNKCL77OG<3!4
M#<J(?S'Z+/8^(W4ILSS_4QW<SR][ S4BFM*D4!!$_O=$;VF:*B0YCK]JT-ZN
M3]5P__,K>E1>O+R8&1'T-D__S>;%ZK(WZ:$Y79!M6OS(GV-:7U YP"1/1?DO
M>JYC!SV4;$61K^O&<@1KEE7_D[_K1.PUP&\UP'4#W&Z WVC@UPW\0QL$=8.@
MU<#SWV@PK!L,#^UA5#<8'=K#N&XP/K2'2=U@4K);T5%R&9*"7%WP_!EQ%2W1
MU(>R(,K6DD*6J=I]++C\ELEVQ=4#E[<!+UY.T"8E68%(-D?TKRW;R/HLT"EZ
MK&H:Y0O4A#[L0N]VH;]264%S]#FD!6&I^((^_3+Q1\%7Q#+TG:6I+%1QT2_D
MD%7'_:0>WDTU//S&\#ST/<^*E4!WV9S.+>UOWVF/'0!]F:M=PO!KPFZP$S&D
MR1GRO1.$!]X$I>JJ;<,Z& 1C=/?[#_2Y3M<7"UAX.)CW+EAT.-C@7;#X\%Q-
M76 :$_ZN=/T2W7\+G8DDS<664U6=\[+N9 6RK)K1RYEQ)J=KM''6^!\*%[&"
MKL5_; 5:#2*P#T+]M)R+#4GH94_^=@C*GVCOZM,OWFCPU586D& A)%@$"18#
M@6EE$>S*(G"A7Y4_OZ?YXG0K*")"T$(@4J 97;(L8]E2%8LL!Y;;II,;)W97
MMBNP40FF%A%/5]XTF%STG_99M 1YTU;0G?N2__!LE1M!7DL,!*91.MQ1.OP9
M2JF\CYUD.E&[DEF!#?=YFGC#%IF6((/Q:'@ X]_<&;$S'@-=L$;2:$?2J"M)
M-DZ<(%TY&9F9-#D9'<*))<CDQ)V -S@!NF"-D_&.D[%S2.6B#*6,S%C*"D:M
MC#@ANC(""1:.#5*PY+?%G"UHT&(N'EMNN9&_"]*2.]DE=^),[BU9SSB;+^D)
M^B[KG20K6?F%O>J=2%US# D60H)%D& Q$)C&[73'[?0CK"VGD&4!"19"@D60
M8#$0F%86WJ"1RP/G3?_;=CVC7!5%*?T067)*%=<"";;,9(W\]TU1>%-C:W.5
M/E'=NKOORB(H6@2*%D.AZ43N^1Z>D\C[3/X@DK2FL:!\;67,#>(-T0LEW#;E
MW_Y\T]#=M#-MD&@Q%)I.&VYHP\ZT_6.Q8 E%91<GJ,M/L!NXZV0+BA:"HD6@
M:#$4FDYX8_)X'\+E\4!M'E"T$!0M D6+H=#TZFB\'N^89H\;O#/III/CXT%+
MC()V&8&BQ5!H.I>-R>,=Q^5QPW9F$1(M]$Q#R*B)"+3+& I-9[%Q@3P0&\B-
MTIDT2+30,\T@"VF07<90:#IIC4WD ?A$;HS.E($Z19[I EDH@^PRAD+3*6O,
M)\_M/OTJ5SV<%#E_00N2U+1U7!&#NE*@:"$H6@2*%D.AZ<PWUI3W(;PI#]2<
M D4+0=$B4+08"DU_.J$QJ+#;H/K_5L1N\*ZD8]/O"G#06A&#=AF!HL50:#J7
MC4>%W1[1SZZ(W;"=681$"VLT9TU$H%W&4&@ZBXUEA=V6U8$K8C=*9]) _:D:
M[1W20&TG*#2=M,9VPD[CXK 5L1NC,V6@IE&-]@YEH%X0%)I.6>,%8;<7](WG
M0J GDFZM?WQQM^Y,%B1:"(H6@:+%4&@ZJXTKA(<?8;6+04TD4+00%"T"18NA
MT/3J:-PFW-EMZK+:!36AL&D;X7'0?AK)$N6-O?9#+;:HX<1O/=4"-7X]^8UK
MA-VNT>V*9$LJU!/>(I$WGTIVDF<B3]F\O#.M.0=UD;#I^YSB43OE9M#4;R?<
MC&D_2!9##5U/=^/X8+?C<YW(V4PPE5A1SFYYL:)<9C_A:K%B7Z& 6CPUFE;A
M4]S.MADT'1GI-H/\8-#.]S%\%MSX+-BIU-4OSR87)-U/]IRZD@WJF-1H>FG[
M1K8M45-C-K$$>=AKI_L8QH7?&!>^V[BXW7).L^0%%9QD(JU^VN=LL:#JM#WC
M;LC.#^>;=H4W:&4IM 2-6Q-.9(DYG;1G$ZBQZ^ENO 7?[2W\4V59YM:>5U #
MP3<E_VG[*7A;S+B=5DN,4<500]?3VHA]O[/8/\BR<<-VSKBIU_%DW)X[;%'&
M@B6R1)D+EAAJ_'K:]UX%<LOU ST6-TKG+)L2VY9E2Y0ERV:4+<N6J/UEH9Z]
M1CG[;N5\G23;]59.N5)8S:F\](15T^\GLMY\16R](8PK&67-*:BN!D4+0=$B
M4+08"DWGO-'5_H?0U3ZHK@9%"T'1(E"T& I-KXY&5_O'U-5N\,ZDFUKX=#P=
MMZ=92]30:^L.6Q0V=#74^/7D-[K:/X*N=F-VSKE%#K?_< ?:8P2*%D.AZ0PV
M4MUW2_7.TM&-UYD]4UU/C&6)&=,6X)$M)FC?*\<0Z7XCTGVW2/\IU0BJTWV;
MN#9F)UN0L08T@S!NI_L8(CUH1'K@%NE.U>ANV_GEZ7=?E@DM(6TI;@EIS_90
MP]93V@CQP"W$P_T%MYHNFN4V2E:$+\M5&9)SB.NU=5#!'EB$MA^TG1!KE%'4
MMB@\G;8Y.(9J#QK5'AQ'M;MA.Z?=5-JGWF#8GDML8<9Z*+)%&>NA&.H"]+PW
MLCT D>UNE,YIKM!&[Z79$F9)LR7*DF9+%'Y+MP=*M^MG&E47O+LOP'V6I-NY
M7#ZJ&4/-)8DL9EG%ZO ^^G%_BQ8L(RDB2UG>1"U+F"C_I"!COA.>K*K,E9O)
MY-6\D^2BPI"KT 5;;GFI 'B]/Y%L+@_)9I.RI)K%1+XHGHE4EEM135X$/;Z>
M(D(=28[4:UR?'PEY_(((YVK%6TYYI+KGKC><I>9(2%%P-MN6O<BH&<WH@LFQ
M%7E]EY;#%!7\B>I,9B*13:IQ_)87M *]/L-GWIEJ5UW@Z^I:QJGT9(EZ-U 4
M\D3U<J=4Q66D>F=/S0LR+J0)52^#5H"O&_"<V6Z,_MX&36LJIW2U69>0W6ZS
MHMIA87=VMR'8=;D-5NO\K7?^S;.<#_'YG2T^PN??;.>O@^ \#@+K-\/7O<CZ
MS5"KG<QD>4C])U!*%W+8@[.Q+$9>;0Y6'13YIMQJ:I87LC#*CRM*YI2K /G]
M(I<$U >J@]T6;5?_ U!+ P04    "  M4UA6D7W22*4#  "U#P  &@   'AL
M+W=O<FMS:&5E=',O<VAE970Q,#8N>&ULS5=-;]LX$/TKA H4+9!&'[9E.[4-
M)%$66V"##5*T>UCL@9%&%E%*5$G*3O_]#BE%L1Q92  =FD-,4C./\]Z0 \YJ
M+^0/E0%H\ICS0JV=3.ORPG55G$%.U;DHH< OJ9 YU3B56U>5$FABG7+N!IX7
MNCEEA;-9V;4[N5F)2G-6P)TDJLIS*G]= 1?[M>,[3POW;)MIL^!N5B7=PE?0
MW\H[B3.W14E8#H5BHB 2TK5SZ5]$OG6P%M\9[-7!F!@J#T+\,),OR=KQ3$3
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M9_[ 4I$&F"2<(0'KA7<?WA69P5O %P)[>31&1LD+YU_-Y,]JX04F(*!0*L.
M]=\.5D"I(=)A?.LYO6%+XW@\/K#_;K5K+2]8PHK3OTFEZH67>:B"-6ZI>N+[
M/Z#7DQB^DE-I?]&^QP8>*ENI>-,[ZP@:PKI__+W/PY%#F%YPB'J':.P07W"8
M] Z3USK$O4-L,]-)L7DHL,+Y7/ ]$@:MV<S )M-Z:_F$F;(_*Z%7B?93^2?.
MJSVA%&%6(:YJ$(@PA=F&O%! 6$I0$MV@9_VY5:VV\#5ZX#O0A==VPM#@_ZX
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MA-(B*(U":0Q%,]75^1>N=>!YJP&^CN/U<IUR_2B47*ZX+)8BJWK5!?4GH+0
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MD&= TA/[!OY!,C%#-88P2!:.;5)BD@"9G0"/3,XSB.^8?O\TH!)HI7L&B$;
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M2ULM^Y>K/%2M: #]QR>>SGC="<3?YY4(]/I+=X#-&X!N_@]02P,$%     @
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M#4>RAD.SQINT>.1-H?#CJ$M0RH"J12@UU;C.]1"3488#I0RH6H124UV7E.'
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MZ%#[>@XBA=(BK<$00<JRZC_^50MQ H!$[8!A#1B^%!#4@."E@%$-&#T%!,\
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MRY=(KJM?<FI\/8<DI38R;\ 80<Y$_4^?FCQT 'YT!A T@* /",\ )@U@\E9
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M@&HAJDE4BU MIC2S:]KD?&(_!YRY\]'CO>NC-X<$DJO>R-"^.@>W%QJQHYI
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M0:)Q%)I*JI P8>(S.J$*!8K&46@JT4*AA&1BCHK.U!Z=5A-.FJC^"6$0TL)
M3YPG1B8)ZKQ@D&@<A:82*I1(F/F,3*CR@*)Q%)I*M% >(;VQ HK,W!Z95A-.
MFJBE#"+AC^B$7XO,?QZ*24[E(7UD=F?+0VAHY]H%Z.8$"DVE5>B,B/FL$8$*
M""@:1Z&I1 L!$=&[))^\:7W$EX,JRI9:<)J,\E0+3X-1'.5G E0J-J(3=RU
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M'?FIR,I3'PT'Z3BICD+=28-1ICV<@!MLPGQYQDF1GZ>3\_/03W<^?4'.C[B
MYO8H-/5FB-P^]9G;I]#<'HK&46@JT2*W3WVT'*3V!-]NPDD3U3^1X*>3$_P0
MW:!/G]IY64$E  I-I5U(@-2G!$BA$@"*QE%H*M'2(Y=\-"6D]J8$NPDG353_
M1/J?3D__/33HTU?CO-*@:@*%IMX)H292GVHBA:H)*!I'H:E$"S61^NAF2.W=
M#'833IJH#S 3:F(YN9LAQ#?HTR=W75A0-(Y"4XD7"F?IL]]A"54O4#2.0E.)
M%NIEZ=;O\'$1O!RW*N@1;#?AI(GJGQ -R\GM#J&W!GWZFIS7&[1""86FW@\A
M<I8^NR264%D#1>,H-)5H(6N6;ET2'QG8]E8)NPDG353_A)I83FZ5"-V*1VA@
MYT4#+3E"H:FD2D]L]=DKL80J%"@:1Z&I1 N%LO3QZ-CEN,TAC/0"+X.1WFEH
M,,G/?!._%-I@.;E;(IQ>1$*#.J\9:,$1"DU]V+ 0(YG/OH<,*CZ@:!R%IA(M
MQ$?FXTFPV;AM(8^UV#38+/7:2X--N$C,T9F)O#^;W  1NO;IT]#.2P>Z1X%"
M4VD5<B/SV>F0074$%(VCT%2BA8[(9NYTR.R=#G833IJHKHG,/9O<Z1"Z=^C3
MX,YK!KH!@4)3B162(?/9N9!!9004C:/05**%C,AF[ES([(]LM9MPTD1U31KY
M,+EG(73JT*=QG9<+=!<!A:9R*I1"YK-E(8,J""@:1Z&I,SV$@LAG;EG([2T+
M=A-.FJBNB9P]=RJ)FK4WG[X4UQ4&1>,H-/4V"%F1^RR&RJ%" XK&46@JT4)H
MY#,W.N3V.BB["2=-5-=$:I\[U4$A>O/I,SHO).@^ 0I-95NHC=QG^5,.51]0
M-(Y"4XD6ZB.?N0,BMU<^V4TX::*Z)O+]W*GR:>;>?/IBG-<8=%L!A:;>"*%.
M<I^%3SE4LD#1. I-)5H:CS=S&T5NKWFRFW#21!LX)T^<<ZIZ<MA:M2"[+ADL
M'(?!:<Q*(^86/LN:7L\&8QNJ1&!P&MNAQ/;,SW)]/0$Y.LA@$VEA:K()SSP^
M@RVDT7(+I^*FB5NL%E3W98.=(H>"TUB5YL@M?)8HO9X-QC94?,#@-+:EJ7:+
MF9_F^GH"NB/1:)7K[7HFJR0[%ZC2P+B%4[&20^^^!=E]^6#GPZ'@-&:E"7$+
MGQ5+KV>#L0T5%S XC6UI7MUBYD>\OIZ _D2U#[RF;33_I+%PB\DU2Y'Y\K&C
MWJ!P' :G35"6E(/?8=7@:=7@<=4SS:N6!U;/_'Q69I@SG:?Z,S5,5EDVRG$-
M5FE^IDZ)R6.K+7.K47.YQRGX4J^UNC%:L7CDZM@J/5>2Q>11T?2(9.7MQT]?
MO^6*W$,,JP7F&2DMSY1F7K4 /<+:G6VL%D#!:6Q+6L RXAH5ZH94?Z0'#$:)
M7GII,NH5T[E E_0 /3A9#W1HJ[_EW.Z+#*L8YADI+<^49EX5 SW"VIUMK&)
MP6EL2XK!,N(:%=*&3H>%7DUMM$K'06T8,\'.M#LP>:8T/4M9#^JY^_\ME^.^
M\K!:9);!TTR:/,U"KUJ$'G3MS#84CL/@-+8E+6(9A V*\W L(J)L] 6!R2H9
M9>D&JW-?$4@#IAD]6%F/<O C 2QG=U]FT)HG&)S&OJ200I_]%8P><NW.-E;]
MH. TMB7U8QF"C0KJ<9,$2Y-14-N[+6@;S4U)=M#3F/60]O., ,M%N:\]:*T4
M#$Z[*9)$"GTV:S!Z8+8[VUA1A(+3V)9$D66@-BK2#7,B1G$^MM%[EKG)B&5G
M9I\R:<PUH\<[ZZ'N4MJ"'6J-A>,P.(U92?V$/ILX&#U&VYUMK+A!P:EL2U.V
MF67,-BA>(WL_QP0;3MMH3DJ:@I[U/$JU)P8J=KHU%H[#X#16)0$3^6S18/0\
M;7>VL8(%!:>Q+0D6R[AM5*#:NS4FV'#:1G-2T@GTQ&<]4)T>)F#!=E] V#V1
M669=,VG8-8M\]F<P>K:V.]M8U8&"T]B65(=E />G;ZE']BZ-"3:<MM'\D_)\
M>@:T'JF.SQ:PH+NO'NQFQRSSKYDT )M%/MLO&#UOVYUMK.) P6EL2XK#,HX;
M$*OC]HG1[,,;DU4<ZB-E3%8L/J=8I6'7C![R?.:S=<(#!RS SLL'.]H:!J<1
M*ZF+V&LO!CU+VYUMK.I P6EL2ZK#,G#[TX,UGM"+8;?AM(WFGY3GTY.=SWZP
MSO'\ <NUN*\U[+;%+#.PF30$F\5>B[;HF=ON;&,%"@I.8UL2*);!W(#(-E19
ML='^D,%JJ8^4,AFE9^:Z,6GD-:-'/4_>]'5X)('EE.[+"KLC,<OL:R8-OV:Q
MUS(M>M:V.]M8Y8*"T]B6E(ME%#<@B U558MH%,0&*T,4CZWB[&P82XJ!'@FM
MA_',SRFP7(W[FL/N8<PR/IM)\[-9XK5 BQ[7[<PV%([#X#2V);ECF>G]Z1&>
M4/54KZQ9;3AMH_DG"0QZLO2G[.QBYVECX3@,3F-6DC:)UYHK>H*W.]M8\8*"
MT]B6Q(MES#<@3JV%5#<3;#AMH_DGR05ZT/3';NIB1VMCX3@,3F-5$BB)UVHI
M>IBW.]M8;8*"T]B6M(EET#<@1NT/N)U@PVD;S3])#=!#J$?M20Z/*\".WL;"
M<1B<QJRD0!*O55+TL&]WMK$* P6GLBW- F>.P\#=X_1X@I2*4[L-IVT._EVV
MC[WLY$577%\]%0_ENZ)YJ'KMN2[O^V,67PU#E)KJX?'THJN?>CHN@MNZZ^K-
M_M?'LN@_2 >#_O_OZ[I[?7'9X[_4S6_[<US_'U!+ P04    "  N4UA6-"GE
M0><$  "2$P  &@   'AL+W=O<FMS:&5E=',O<VAE970Q,CDN>&UL[5A-;]LX
M$/TKA L4"9"UOBS)5AT#:5Q[<]A%D:"[AZ('6J)L;B51):FX_?<[I!35B::N
M$Q38R^;@B*-Y,YPWPQ')^5[(SVK'F"9?RZ)2EZ.=UG7B."K=L9*JL:A9!6]R
M(4NJ82BWCJHEHYD%E87CNV[DE)17H\7<RM[+Q5PTNN 5>R^):LJ2RF]O62'V
MER-O]""XY=N=-@)G,:_IEMTQ_:%^+V'D]%8R7K)*<5$1R?++T967K#T+L!I_
M<;97!\_$A+(1XK,9W&27(]?,B!4LU<8$A7_W[)H5A;$$\_C2&1WU/@WP\/G!
M^LH&#\%LJ&+7HOB;9WIW.9J.2,9RVA3Z5NQ_9UU H;&7BD+97[+O=-T121NE
M1=F!808EK]K_]&M'Q $ [.  OP/XIP*"#A"<"IAT@,E30/ #0-@!PE,]1!T@
M.M5#W %BFZR679N:)=5T,9=B3Z31!FOFP>;7HB$CO#*E>*<EO.6 TXMKJG:$
M5AE)S0/[TO![6K!**W*V9)KR0IV3W\B[#[?D[/6K:1!-WIS/'0V.#=Q).R=O
M6R?^#YPL63HF@7=!?-?W$?CUZ7 /@2]/A[L(?'4RW)LA\/5Q^$?OTV.0 QGJ
MT^3W:?*ME> '5NZ:35I0I7C.4VK6L"(B)R!@6EV0@M,-+[CF3-E<FC3:P4>Z
M45K"<O^$):UU.<%=FAZ8J)JF['($34XQ><]&B]>OO,A]@Z7P5QI;_DICJU]D
M[%'>@CYOP3'K=GEAU+>HR*+,U^)^X073T+5_<^?^D%A,-9QBJDM$U9M,,-75
MT6F_D)1)3\KDIZ0<MAJ,H-9"^"B4(/10AH:ZT[B+^BE#B%D_CE&SJZ-!O)"B
ML*<H_#E%6%O&N JQH(((Y0K1==T97DZ(;C#ST"I]=SP<:((7'WVL":W"0<W.
M)G[\Q,<C#J.>P^A9979!2E&Q;_#UE)]ACU<VNJ$%R9LJ0UF-!M'/PN#IQ%I2
MAZJA&Z*JRZ'J-'8#M/Z.1O?"^HM[[N)G<J>9+&&/5PO%\2J,D14;X7P-5?TX
MPFMPJ!KXX0SEZVA$+^1KVO,U?29?J2A+)E,.)5;3FDF,LND@N*=,#36\&(U^
M.=2,\<Y_-) 7TC3K:9H]ER9:F[,(X95J)*U29KN>9-_'0&1-*]C-8 S.!MUC
M$J#\7".:@S;3,HEIHDUO=338%U+IF:/:8\G!7M[[69L]^^>\=3'\O:G2HLE@
M5ZAWP#>0FFJ[BS3#F]7MS37)>07E"B?0*J.PUE.N'G::?U"9[EHS9A-.X!!I
M8*E0K8U45#G?-I)76R)D=W !. QI71?=II4HD>L]E8PTBF60<T+)W8.(*C,"
MEC@D_>R.TKMS0B74P);!T5?;N@!/5[7DQ7 F5&O)-XWU EH;5K$<&A71@L#B
MXR*STU2M^0OC#)A( =+.XT^A66OT:NR/O;'!M0%62A0\HQKT##V57=%*@Z"T
MQZ0<PC6:WQB5!(@#/3@QL'+#9&OPX> RA@_@_RGX;U. K3OGX/ ,'7MK[T44
MN&TJW2V^7MQ>OBR]Y)V]HW@B7_G)VL?D0;(.,/DD64\P>9BL0TP>)>L(D\?)
M.L;DTV0]Q>2S9#U#Y%>>FZRA_V!O^OLFYSM'[6T5U.46NC4I6 Y\N>,8OD&R
MO0!J!UK4]OYA(S14I'W<,9HQ:13@?2X@\]W ..BOX1;_ E!+ P04    "  N
M4UA6EEKK#%X)  !/1P  &@   'AL+W=O<FMS:&5E=',O<VAE970Q,S N>&UL
M[5QM;]LX$OXKA!=8M$ 36V]^R28!4C.[UP_M!<GNWH>@'VB9=GB5)2U%._'A
M?OR1DFR:$LV+@@G.'PXH&DD>/B2',T,^XE"7SQG_43Q1*M#+*DF+J]Z3$/E%
MOU_$3W1%BO,LIZG\99'Q%1'REB_[1<XIF9>%5DG?'PR&_15A:>_ZLGQVQZ\O
ML[5(6$KO."K6JQ7AV\\TR9ZO>EYO]^">+9^$>M"_OLS)DCY0\4=^Q^5=?X\R
M9RN:%BQ+$:>+J]Z-=W$;!:I *?$GH\_%P35279EEV0]U\V5^U1NH%M&$QD)!
M$/EG0Z<T2122;,=?-6AO7Z<J>'B]0_^U[+SLS(P4=)HE_V!S\735&_?0G"[(
M.A'WV?/?:-VA2.'%65*4_Z/G6G;00_&Z$-FJ+BQ;L&)I]9>\U(HX*."%1PKX
M=0'_M06"ND#PV@)A72!L%@B.%(CJ F77^U7?2\5A(LCU)<^>$5?2$DU=E-HO
M2TM]L509RH/@\E<FRXGK;](6I5XIYW2.!'E!>5:P<@C/T$-E/"A;("6&=V*_
M2[&[G=@'3 5A2?%1%KC]XQY]^/FG<3 ,?_F(Z@O$4O25)8D4+B[[0K99U=R/
MZ_9]KMKG'VD?IO$Y"KQ/R!_XOJ7X]/7%/4MQ_/KB [-X7RIZKVU_KVV_Q N.
MX;$B3K)BS:E2JJ"K/.-*PW.VD+JE:4P_H76Z+NJQD*(%+1!)YX=/8SD&3!3H
M4:$C)E&*[S;%5DT)[4U1 >BBR$E,KWHRPA24;VCO^N>?O.'@%YN:(<$P$)@Q
M!,%^" (7>MO@B=2QZ'](&)FQA(GM1YLN*\QAB:EB[^8ZB$)I$9M#';6%_,G8
M,X6P12@<#/="1I_"?9]"9Y_P87]V'6'4ZFX54G10OS<.&XV<6H2&WJC1$XO0
M:-30R:V[X8_>=\>01OON1TZ4^\I("MGU'S39(I&A&94^50C.9FLA]2)#D'BB
M2,ZK4I2262*OUT*ZH4U#4:M?T<0;- ?;V:2N#@$$9FAON-?>\/7&4SJ#U6Z&
M;:T$3>.>MH7":#)NV(U%R!L-&W;C;O.C[[*;T;[G(R?*5,Y(6<+FI%JRS/\I
MIUNY!I*A]0-+!2=+GJUS.=GRI;2?\M]&_IIQ>XAPUM4UW$*"82 P0\?CO8['
MIS/CC2&' !(, X$90S#9#\'D'6:\23NZ!^.&*T\M0O[$;_B[1<@+??N,YPWT
MNG7@[-4=SS:LI"LRJJ.\HBZ5Y60RUG,D32W)MI3*N2"E"V:/:NY*NIH,*!J&
M0C,5?$ ,O-/QW+HM4., B8:AT,QQT)3!<RZ'W^B^->BAUXVCYAK&(N1YK76>
M52HZLF3U]#K<<R_$[^F*$F5>:LI5)E:Y+8G_6C->KMD$29=,K=6.KTK<=72V
M&T@T#(5FZE=S B\\(?]UKO,[CP,D&H9",\=!DQ//S4[>Z+]M%G(6^,-)TX-M
M8H/1I.G"5K%Q<,2'-77PW.OPSCZ,_HT^LVQ#N5QS;ZS]=E;8V9 @T3 4FJEL
MS5:\T0DY-"B= 47#4&CF.&A&XSE7ZYW>MM10QMP9^BTO!N4:4&BF>C3;\-QT
MXRTQX8ZS-&8Y(U8=.NOK;(J0:!@*S7R;K$F0/SB=D."#<B50- R%9HZ#YDJ^
MDP-T"@DUU&%(&/I1(R*XZ^NLG?=@,/[!IH>;P;PE(OQ&TW]M5];WL^[:.MLA
M[,[&>VQM^)I3^<$)Q0-0[@6*AJ'0S''0W,N'VY#Q+?LH+:;NKJ^S=MZ#$?F:
M$?G_;;^F>SRXF27;] 5].__SW*I$R.V8*2@:AD(SM:TYFC\\H9@ 2M] T3 4
MFCD.FK[Y[MVF3C%AU(H)?HLUN.OKK)WW(%6^)E6^FU2]*2:LUBE[L>H/="<(
M% U#H9F*UO3,GYQ0. "E;J!H& K-S$+1U"UP[U]U"0<UE/D&OKD7YZZOJW:@
MT$SM:$(5N G5/8VS95IEF$DSW8>!G&<YY6+[">4)D8%"V265O^5EV" "+0CC
M:$.2M94ZN&OM:H^@:!@*S=2X)FG!":6F!: 4#A0-0Z&9XW"0GO8N^6E!^P6_
M'S8CA$UHV,Q/LPF-[!L%@29$@9L0W4H?%5LUBTM;*J2%L!05ZUG!YHQP5AN2
MRJ_99>#(W^MM_%0<CXN@NTZ@:!@*S52XYEA!=$+N#,J^0-$P%)HY#II]!>X=
MLC>Z<SM'[JR5@#FU24630=.A;5+^D?R;0-.9P$UG?C^PF@UA2954F7$4$\ZW
M9_+JF?"YM7.@6TN@:!@*S52J9D'!"67+!: D"10-0Z&9XZ!)4O >*7.!)=,M
M&@R;7FN3\EK3L"W_[M@\'&K6$;I9QX/(XA\HRT4C6:YX(IR>J1,W<HU-MN4<
M;,T>!]T# D7#4&BF:C5E"4\H7RX$)3*@:!@*S1P'363"]\B7"]M);LU$UJE%
MIID1BVTRDR->JSE!Z.8$-W',U[(W]$7EN=96D^\28 O9W?DZ%M7+,8$$6Y4F
MZ/1CT+T;4#0,A68J^^ LS0GES86@# 84#4.AF>.@&4SX'GES83O3S1M'S5?G
M-JEH'#5]V2(53(YYLZ8$H9L2_%W-N-:V@VZ>@*)A*#139YIMA">4^Q:"$A10
M- R%9HZ#)BBA>YOFC4YIR8(;1<V<%YO48-2:8-M2DX/T&;-?>L$?NA?\QMMX
M3A,B6+I4!PG5VRHN)]<U5P_TG&OM)NAN!R@:AD(S#VAJWA&=4*):!$I20-$P
M%)HY#IJD1!T2U8X?JZA1C%/*49/(6H2"0?/PB!7IR!0:J36^^40OD2/W$OG1
M^_XEC9/U7)J-.NK+5E*+TE:4M<G;+[_>?YFB!4M)@LB2IG,BPUA<+Y^ES%?"
MXZ=*S^I+ 2BK#@S'65%AQ%FZ8,LJ"*AW7.6'&61Q>4OR/&%Q=8:TR!;B63)I
M5-HL2Q%!#[M'I%!W<D193-&'!T(>/B+".4F7U9YW2<87Z";G+&FWA(CJ,'.]
M(;8[TZ9"5$XYR^9E,XL*_I.J3&HBED6J=GS+!*U ;\[]<^]<E:LZN#L"*^64
M>M*821450CZH7L2K5WI*<DN)>ADOJ0;"-*:K&>45X.[K"N>/_O^'X'\\!+88
MT3_X.,B*\F7Y599"5KM.1?79A/W3ZLLOV+NX+3^0TGA^$_D7MY%O_278?2RF
MKZNH/C7SM3P^7:"$+F1U@_.1G+EY]?66ZD9D>?EYDEDFY("6ET^4S"E7 O+W
M12855]^H"O;?T+G^#U!+ P04    "  N4UA6D.&"=VX#  "Q"@  &@   'AL
M+W=O<FMS:&5E=',O<VAE970Q,S$N>&ULK5;;;MLX$/T50@6*%FBCN^RDMH T
MWL7VH8L@;78?%GV@I+'%EB)5DK;2_?H=2HIJRXK7!?)B\W+.:,[A#,%%(]4W
M70(8\E!QH9=.:4Q]Y;HZ+Z&B^D+6('!G+55%#4[5QM6U EJTI(J[@><E;D69
M<-)%NW:KTH7<&LX$W"JBMU5%U8_WP&6S='SG<>&.;4IC%]QT4=,-? )S7]\J
MG+E#E()5(#23@BA8+YUK_VHUL_@6\!>#1N^-B5622?G-3CX42\>S"0&'W-@(
M%/]V< .<VT"8QO<^IC-\TA+WQX_1?V^UHY:,:KB1_&]6F'+IS!U2P)INN;F3
MS1_0ZXEMO%QRW?Z2IL=Z#LFWVLBJ)V,&%1/=/WWH?=@C^-$3A* G!.<2PIX0
MGDN(>D+4.M-):7U844/3A9(-41:-T>R@-;-EHWPF[+%_,@IW&?),^B=6%MH$
M2D%!#'T@M=2L/9&WY+HHVB'EA(FNPNS&JQ48RKA^C9#?[N_(JY<OYF$2O7M-
M^@&BR4?&.8+UPC68I?V6F_<9O>\R"I[(: 7Y!0G]-R3P@F""?G,^W9^@K\ZG
M>X=T%ZT=_ T&?X,V7OA$O \BEQ60S_0!-/GG.M-&8:E_F;*E"Q1-![+M?Z5K
MFL/2P?[6H';@I"]?^(GW;LJDYPRV>J9@!P:&@X'AJ>CI9ZAJJ?!&(@5;8YV"
MR-%)JK7,&358M TS)5;<#K3!Z\AH6WUZFVE6,*H8Z#<D4U3@=8DL4?QD=E,F
M#,;4'>VKQ"FA"O$;Z()AV9.F9'EYV"6<T8QQ[ X,4](=$"$-R0#L59C+C6 :
MBJDS[K0FK59[(^]2WTL\++3=_N%-H;PQ:C6!\N,]U('=T6!W=-IN:;#=#[2B
M8] [T4J76I,<3?J!*PU5Q62/=U^)]Y(+DGBL<P(47OHCF<<@/XGGTRKC065\
M4N6]V.K'DT0YL'_.0D[(_Y]CC8]S]*-HI/88-)_%([''F##TI[4F@];D'*TY
MK9D]VF?1FQRE&<WG([DGL_K5&^B9@AT8.!L,G)TT<#71#+;=>XO^!7NID/76
M;!6TBSO V\HB:B4SFG&8LG!VU+V7EZ-JN#G&)/ZX8HXQ892,*L;=>Q_8Q]Q'
MJC9,:,)AC2SO8H8GJ;H'4C<QLFZ?#)DT^ !IAR6^*4%9 .ZOI32/$_L*&5ZI
MZ7]02P,$%     @ +E-85OBCK+%J!   I!X  !H   !X;"]W;W)K<VAE971S
M+W-H965T,3,R+GAM;+V9:V_;-A2&_PJA D4+K-%==E+;0&QVZ(!E"))>, S[
MP%BT+502/9*VTW\_4I(ET5;4&#GQET07GH<\+_4R/.%HQ_@/L:)4HL<LS<78
M6DFYOK)M,5_1C(@+MJ:Y>K-@/"-2W?*E+=:<DK@(RE+;<YS(SDB26Y-1\>R6
M3T9L(],DI[<<B4V6$?YS2E.V&UNNM7]PERQ74C^P)Z,U6=)[*K^N;[FZLVM*
MG&0T%PG+$:>+L77M7F'/UP%%BV\)W8G6-=*I/##V0]_\$8\M1X^(IG0N-8*H
M7ULZHVFJ26H<_U50J^Y3![:O]_3?B^15,@]$T!E+OR>Q7(VMH85BNB";5-ZQ
MW6=:)11JWIREHOB)=E5;QT+SC9 LJX+5"+(D+W^3QTJ(5H ;/1'@50'>84#P
M1(!?!?C/#0BJ@*!0IDRET $3228CSG:(Z]:*IB\*,8MHE7Z2ZWF_EUR]352<
MG/RE/BTE$^6<QDB21[1F(BEFY .Z+[\%Q!;HBWKS)Q.""G2])4E*'E**U%>'
M9H3SGQ_4U8[P&+W#5*JWXKV*_O3U#KU[^V;H1\'']ZBZ0$F.;I(T51V(D2U5
M GH8]KP:[+0<K/?$8%T/W;!<K@3ZE,<T-@&VRKQ.W]NG/_5ZB9C.+Y#O_H8\
MQ_,Z!C1[?KC;$8Z?'^[T9./7D^D7//\I7B+F*1,;3O6<Z=E,RSDCQIS-]9SM
MI^P?#4&)I)GXMVM&RAZ#[A[UJG0EUF1.QY9:=@3E6VI-WKYQ(^=CEYJ0, P$
M,Y0.:J6#/OKD2Z^V>S]TZ5ERHX*K%^7M9!@Z_LC>MG4Z;C2(@L!LA(\;1:$;
MUHV,O,(ZK_!9>9EY"*17:)6M6BL2H58(DG:ZMV2'K1&%!XF%1V,^:(&/6T3=
M*45U2E%O2G]3PE&7.:>]<:=^VI P# 0S]!K4>@W.OH@,()6&A&$@F*'TL%9Z
M^$J+R/#(:,Z!T7I[/E4D()@ATF4MTN6O[=OUIWG:&W?J1P4)PT P0R_7:79T
MSMD-7'4))#8H#4/13+E;&VCWE5Q<@=LV/MP(]/=]LE) -%,IKU'*^[65_4XE
M>@-/_KP@:1B*9HK6;.G=\^_I7=!-/2@-0]%,N9M]O?M:&_L*W':SK@E-._=V
M?K)40#13JJ94</MKA<+.0:<4O8$G?U^0- Q%,T5KBA$W.K^=00L94!J&HIER
M-[6,V[N!?XF=!\=V'A[:&;04@:*94C7%B-M?C11V#CNE@"PF9J T#$4S16N*
M$_?R_'8&+6Q :1B*9OZSMBEMO-Z]_ OL7(';=G8=[\#/_;V?JA44S=2JJ4N\
M_KJD]#,B>8Q2(BGO5 6RO)B!TC 4S92O*58\[^S.]D#+'% :AJ*9<C=ECM>[
MKW^)L_WC_ZC[P>6AM4&+%"A:*9;=.K[+*%\6QZ "S=DFE^515OVT/FJ]+@X8
M#YY/W2M<'I@VF/+\]H;P99(+E-*%0CH7 [40\O)(M+R1;%T<$CXP*5E67*XH
MB2G7#=3[!6-R?Z,[J ^F)_\#4$L#!!0    ( "Y36%:=I#D8[@0  %8<   :
M    >&PO=V]R:W-H965T<R]S:&5E=#$S,RYX;6R]F5UOHS@4AO^*Q4BCCK13
M,"0D[221FC"KZ4575:O9O5CMA0,GB57 C&V2]M^O^0B$E+C-R&HO&@,^KWT>
ML'V./=DQ_B0V !(])W$JIM9&RNS:MD6X@82(2Y9!JIZL&$^(5)=\;8N, XE*
MHR2V7<?Q[830U)I-RGOW?#9AN8QI"O<<B3Q)"'^90\QV4PM;^QL/=+V1Q0U[
M-LG(&AY!_LSNN;JR&Y6()I *RE+$836U;O!UX)8&98V_*>S$01D5KBP9>RHN
M;J.IY10]@AA"64@0];.%!<1QH:3Z\:L6M9HV"\/#\E[]S])YY<R2"%BP^!\:
MR<W4&ELH@A7)8_G =C^@=FA8Z(4L%N5_M*OK.A8*<R%94ANK'B0TK7[)<PWB
MP #[)PS<VL ]-AB<,/!J ^^]!H/:8%"2J5PI.01$DMF$LQWB16VE5A1*F*6U
M<I^FQ7M_E%P]I<I.SA8L%2RF$9$0(;$A'#8LCH"+SY_&+AY]0_ KI_(%?44W
M442+5T5B=)M6'USQXBX"D(3&XHNJ\OWG [I0AIX_^/9E8DO5OZ(5.ZS[,J_Z
MXI[H"W;1'4OE1J#O:0115\!6CC7>N7OOYJY6,8#P$GGX#^0ZKMO3H<7[S7&/
M>?!^<T?CC=>\*Z_4\T[I41'&3.0<$%NA,"9"@"B*Y7M#(<FH5&_GW\(.40F)
M^*_O)52-#/H;*>:9:Y&1$*:6FD@$\"U8L\^?L.]\ZP-H4BPP)-:!.VC@#G3J
ML\=#AGW8*G._-"]FT^W,';K8'^&!/YC8VT,HVI;.A6)(K -EV$ 9:J'\E2=+
MX,TG)M %3>MB[_BNU(8'C+#K.V-O./+<(T;:AL]E9$BLP\AO&/E:1O>$HRV)
M<T"90E4-Q0(3Y)R)]EXO+__U-W6$2=OVN9@,B74PC1I,(RVF'Q"MJ]DJ5=$,
M3;<@I(H?I%!EI)83M4"G2(4SO%Q61!^MT2M:7X=CI_H[PM93U<.COJI!3U7L
M^4=5.RZ/&Y?'[QT]DH5/RKMRQ4R91)(\0>DV"EF2Y9*F:Q31."]682 \+:Z[
MGY-FU&E[<>Z$/GXUA/T^:F]6ZQ"[:HA=:8G=9)S&R'-.KKASK?VYOIH4"PR)
M=;AAIPWCG(^(#>I6#/$UJA:84NL2/@B4L7Z>!TY9U"+ED.4\W*B< V6<K3E)
M>H%J1<\&JN\B'J.D#*![\1GJ21>?V^)SWS&TW7%?-%RCT@J<C<JD6F!*K0NO
M#?SQAT3^V&CH;U0M,*76)=Q&_U@?_O_FZ#89Z2^,J@5O.'QBKNCB:_,$K$\4
M[L@+\DZFV7.]]=F<C.8.IM2ZY-KL ?L?,K1-)@H+HVJ!*;4NX3;QP/K,XS>'
MMEY4M]0N]+9GXS.DUL77)C%8G\4\EKF+R)<BY+3*8.I$)HM)VHO.:$)B5"TP
MI=:%V>8W^.I#1KO1-,BH6F!*K;OAVR9"KC8-F-VF(8=B;.]SYGH_>[^1'>6
M)$/P##RD MKLO)D4JJ^[#WO=].%> 1X,>S<@]+T\EZDIM2[3-O5Q]7G%JVU
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M970Q,S4N>&ULO9EK;Z,X%(;_BL5(HQEII^$2;ITDTC1 V)5&JAKM[H?5?G#
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MA9DRD/UK2L7+@QJ@OO^:_P]02P,$%     @ +E-85BZ?@6A7!   &!8  !H
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MYR:L-RF_8^H]TT^$[V@N4 I;A<2CB4J*U]N0]8ED1;4+MF%2LJPZW -)@.L
M]?V6,?ERHB=H-X.7_P)02P,$%     @ +E-85BGMH:/: @  R <  !H   !X
M;"]W;W)K<VAE971S+W-H965T,3,Y+GAM;*U5;4_;,!#^*Z<@,9 V\M(7&+21
M:,.T?4!"(+8/TSZXR;6Q<.Q@.PWLU\]VTJR%MF,27Q+[?,_CY\[VW:@6\D'E
MB!J>"L;5V,NU+L]]7Z4Y%D2=B!*Y69D+61!MIG+AJU(BR1RH8'X4!$._()1[
M\<C9;F0\$I5FE..-!%45!9'/$V2B'GNAMS+<TD6NK<&/1R59X!WJ^_)&FIG?
ML62T0*ZHX"!Q/O8NP_-D8/V=PW>*M5H;@XUD)L2#G7S+QEY@!2'#5%L&8GY+
MG")CELC(>&PYO6Y+"UP?K]B_N-A-+#.B<"K8#YKI?.R=>9#AG%1,WXKZ*[;Q
M.(&I8,I]H6Y] P_22FE1M&"CH*"\^9.G-@]K@'"X Q"U@.@EH+\#T&L!O;<"
M^BV@[S+3A.+RD!!-XI$4-4CK;=CLP"73H4WXE-MCO]/2K%*#T_%4<"48S8C&
M#%1.).:"92C5X<%9%)Y> #Y65#_#)[AK+@:(.5P]F5NG4,%1@II0IH[-^E51
M,O&,QNIH0-3<T.2TA)(1;AWN;^'(T/:&_8MC: = .5Q3QLP=4"-?FXBL+C]M
MU4\:]=$.]6$$UX+K7,$5SS#;)/!-*KI\1*M\3**]C FF)] +/T(41-$60=.W
MP\,M\.3M\&!/-+WN='N.K[>+CZJ4"579XYA#RHBRIV:&S1&EI*2:,/AI<4 U
M%NK7MD-H-NEOW\06IG-5DA3'GJD\"N42O?CP(!P&%]L2^)YDR3N1;22WWR6W
MOX\];E^!*7ZI6'#Z^^7]:W+7< P=AZW!R[CW>>0OUS/RVF40;KHD6URBSF5#
M_:!3/_A/]?9>U#E-<\#F*4OU 5+SO"2=5;9(;PMO\$I8^$+[]-\NR5Z7)CQ_
MK<85*!>N5RBCK^*Z>=Z=M6M'EZX*O[!/3)MJNLI?FJ;'71.YH%P!P[FA#$Y.
MC2S9](UFHD7I*NE,:%.7W3 WK1:E=3#K<R'T:F(WZ)IW_ =02P,$%     @
M+E-85LT=[),'!   $A<  !H   !X;"]W;W)K<VAE971S+W-H965T,30P+GAM
M;+U876^C.!3]*Q8CC5IIMV"^ FT2:1)F-?/05=5J9A]6^^""$ZPQ.&.;IO/O
MUP9*0D*8IK*:A\3 /8=[#_CFZ$ZWC/\0.<82/!>T%#,KEW)S;=LBS7&!Q!7;
MX%)=63%>(*D.^=H6&XY15H,*:KN.$]H%(J4UG];G[OA\RBI)28GO.!!542#^
M:X$IV\XL:+V<N"?K7.H3]GRZ06O\@.6WS1U71W;'DI$"EX*P$G"\FEF?X'4"
M(PVH([X3O!5[:Z!+>63LAS[XFLTL1V>$*4ZEID#JYPDO,:6:2>7QLR6UNGMJ
MX/[ZA?VONGA5S",2>,GH/R23^<R*+)#A%:JHO&?;+[@M*-!\*:.B_@;;-M:Q
M0%H)R8H6K#(H2-G\HN=6B#T #$\ W!;@'@+\$P"O!7BO!?@MP*^5:4JI=4B0
M1/,I9UO =;1BTXM:S!JMRB>E?NX/DJNK1.'D?,E*P2C)D,09$#GB.&<TPUQ\
M_!"Y<'(#\,^*R%_@3_#0O!F K< ]WE0\S97< MQQMN:H !<)EHA0<:E"/W^[
M!Q>*P O]FTO0+@ IP2VA5#UM,;6EREUG8*=MGHLF3_=$GM %MZR4N0"?RPQG
M?0);%=U5[KY4OG!'&1.<7@$/_@%<QW4'$EJ^'@X'X,GKX<Y(-5[W'+V:SS_!
M=Z*(Q2A*-Y5KL4$IGEFJ:PC,G[ U__@!AL[-D"(FR1)#9#VU_$XMOV;W3JE/
M1$J9J#C6KW-*D="OLEK6.P"D:$,DHN!?C0-$XD+\-R2N;U)<DV2)(;*>N$$G
M;C#Z*OY=%8^8=VH*<*%V?K.\'%*Q80MJ-OTW]32' 7349VH_[0LT>M=S!3)$
MUA,H[ 0*1P7ZCFB%AY1H8.&^$M[D0(51ZG-5,$364V'2J3#Y7<<:ZIN+4=2Y
MF\HD66*(K*=6U*D5O4?'BDR*:Y(L,436$S?NQ(V-=JSXJ&-Y\22,8_=@KQ['
MN9,P\**H'Y>,9O?&VJ&S<X#.V]I1B]OO1UYXV)4'@ES_0(AD/(.W5KCG<>'O
M6HTS6. H[-SM8)0M,<76E\S=2>:^1[]I[V)*89-LB2FVOL([PP[''?NY36><
M[FPIO6/7-0FB((P/M^YQ8!!&@>^&76!?@)T'AZ,N=*3O&/75+5O/5?G.897'
M07X(3U2X,\)PW F[#HP'"S1I99=&V1)3;'W)=M88AN_2=TS:Y*51ML046U_A
MG>V&X[[[[+YCU) ;94M:MKX3B]S8BT]LW9W=AJ.&<Z0Y&;701MF2EJUOV Z[
MF+TW+"PP7]=#5P%25I6RF9YU9[O![J=ZG'EP?J$'OO40<D?33(MO$5^34@"*
M5XK2N9JH!\2; 6QS(-FF'DD^,BE942]SC#+,=8"ZOF),OASH&W1C\/G_4$L#
M!!0    ( "Y36%;YG4 3( 4  /P5   :    >&PO=V]R:W-H965T<R]S:&5E
M=#$T,2YX;6SM6$UOVS@0_2N$"Q0)T%C?DJTZ!M(X=G/HHHC;W4/1 RU1-E&)
M=$DZ3O[]#B5%L65&<+/N[F4O"3F:-QR^&<Z8'&VY^"%7A"CT4.1,7O962JUC
MRY+)BA18]OF:,/B2<5%@!5.QM.1:$)R6H"*W7-L.K0)3UAN/2MEG,1[QC<HI
M(Y\%DINBP.+Q \GY]K+G])X$=W2Y4EI@C4=KO"1SHKZN/PN868V5E!:$2<H9
M$B2[[%TY\<QQ-:#4^).2K=P9([V5!><_].0VO>S9VB.2DT1I$QC^W9-KDN?:
M$OCQLS;::];4P-WQD_5IN7G8S )+<LWSOVBJ5I>]00^E),.;7-WQ[4=2;RC0
M]A*>R_(OVM:Z=@\E&ZEX48/!@X*RZC]^J(G8 3C^"P"W!KC' KP:X!T+\&N
MWP9X+P""&A <NT)8 \)C5XAJ0%0&JV*W#,T$*SP>";Y%0FN#-3THXUNB(2*4
MZ52<*P%?*>#4^)HSR7.:8D52)%=8D!7/4R+DVS<#UXG>(_)S0]4CND#S*ED1
MS]#U1@C"DD?T16 F<UPFU81F&=%B(M'9A"A,<WD.N)NO=^@,K'FA__X<U0-$
M&?I$\QR <F0IV(AVQTIJIS]43KLO.#TA21]YSCODVJYK@%\?#W<,\,GQ<-L
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M"O ]XY 3]40OT#SXCO\&4$L#!!0    ( "Y36%8(8UDK$0D  'P\   :
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M@VH<J@FH)J&:0FG-<-7%.;E0<6YV>^<$6IQ#-0K5&#DOISUW;-M/=M,<.JN
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MU2144RBM&:ZZ./<N5)Q[Y^5TVV[ZQCQ_[P1 _VDY5&-0C4,U =4D5%,HK9F
MD__Z_+6*<_-$O4\=T.(<JE&HQJ :AVH"JDFHIKSSXGPZ&4[MV<F?CAU*7:)[
M%RS1S7;O0$!+=*A&H1J#:ARJ":@FH9KR6DITQ_7LIR7Z*%UIG05A%LZO-CJY
MTS=ZO4ZM1;S?Y@.+W?OQJU:B;XL/&'WW@0Q&^<CZX?.K77BG/X7)792G8JUO
M\Z'V<)I/GA2_\?YX(XMW!6E]C;,LWI175SI<ZJ1X0'[_;1QGCS>*"1[BY%MY
M>//_ 5!+ P04    "  N4UA62QO:"/ %   \'@  &@   'AL+W=O<FMS:&5E
M=',O<VAE970Q-#0N>&ULM9G;CMLV$(9?A7" ( &RDDB=-UX#\5I%>Y$FR#;M
M1=$+VJ9M(9+HD/3N!NC#ESJL9%$T8:M.+K*R_'/(^3B:X5C3)\J^\1TA CSG
M6<'O)CLA]K>VS5<[DF-NT3TIY#<;RG(LY$>VM?F>$;RN!N69C1PGL'.<%I/9
MM+KWF<VF]""RM""?&>"'/,?LQYQD].EN B<O-[ZDVYTH;]BSZ1YOR0,17_>?
MF?QDMU;6:4X*GM(",+*YFWR MPFJ!E2*/U/RQ(^N0>G*DM)OY8??UG<3IUP1
MR<A*E":P_/-([DF6E9;D.KXW1B?MG.7 X^L7Z[]4SDMGEIB3>YK]E:[%[FX2
M3<":;/ A$U_HTZ^D<<@O[:UHQJO_P5.C=29@=>""YLU@N8(\+>J_^+D!<33
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MMXURMYK5/35KRE<9Y0=&RO 5A.4<R(@%*RK#MHYB>;^:[J9,.VNPQS]D.A0
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M=K<7J[V8X -8L3UT9@B)U!^_XP\\[F)/B L1-V ;SYGW'+]S'@P>K[FXEPL
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M$-D)^O,9YVJSDTU0/1LS^0]02P,$%     @ +E-85M?@K9]@!   K@P  !H
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M_N 0MCCOUK?P^QEQ^HTX_?/B)/]@/L,:HPG6-X*I+7XBHC3U0F'6TQE)3-K
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M>/CV-<,_%" - +^G D6N!V:!YB_*Y%]02P,$%     @ +E-85L+%W2DN!0
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M!UF NUKRD1*!@#B0@\L/S694&(5/=[ N)-&3?TY-9_/W=W1^<73\WQOD%X?
M=B X.P] &17+XFU/PK2;7)DK5M5KW@_'^.*Z>&:K]4_TNZ*E_PKK ?N(]_04
MZ3Q/;1XR(=Q+!I%/Z0+,<+L1')+"O V:AN+KXFEJQA4$NOA<40)ECA: \04'
M0LN&GJ!ZH1W^"U!+ P04    "  N4UA6C>$Y/$0(  "N.P  &@   'AL+W=O
M<FMS:&5E=',O<VAE970Q-#@N>&UL[5M?;]NV'OTJA <,+=#$(BE+5I88R.RJ
M-\#=4"1;]Q#T@99I6YO^>!2=K/?37U)2+(ND6=M@MC[LI;6DW^^0/(>D>"+R
M^KED?U1K2CGX*\^*ZF:PYGQS-1Q6R9KFI+HL-[003Y8ERPD7EVPUK#:,DD6=
ME&=#Y'G!,"=I,9A<U_<^LLEUN>596M"/#%3;/"?LRX\T*Y]O!G#P<N,^7:VY
MO#&<7&_(BCY0_NOF(Q-7PQW*(LUI4:5E 1A=W@QNX=4'/)8)=<2GE#Y7>[^!
M;,J\+/^0%W>+FX$G:T0SFG )0<1_3W1*LTPBB7K\V8(.=F7*Q/W?+^AQW7C1
MF#FIZ+3,?DL7?'TS& _ @B[)-N/WY?-_:-N@D<1+RJRJ_P7/;:PW ,FVXF7>
M)HL:Y&G1_$_^:HG82X#^@034)J!C$W";@(]-\-L$7TW !Q)&;<+HV!*"-B$X
MMH2P30AKL1IV:VEFA)/)-2N? 9/1 DW^J/6MLX4B:2&[X@-GXFDJ\OAD1N?\
M'4A(M0:D6#0_Z)_;](EDM.!5?3.C0FN0I62>9BE/:04NP$/3=4&Y!/<T*8M$
M/")UYQ)WIH2Q+VFQ K=YN2TXX"7X1+(M!>+Q/5W0?%-'OIE13M*L>BOPWO]Z
M#]Y\_]T8!_X/;T'[ Z0%^"G-,A%<70^Y:*ZL]#!IF_9CTS1TL&G))<#P'4 >
M0H;TZ?'IT) ^.S[=,Z3'1Z?#J)\^%!+O=$8[G5&-AP_AI562E=6642D0TR1+
M7B0C.\F>7B1CG62/$A>DG.;59Y,B325\<R7DM'I5;4A";P9BWJPH>Z*#R???
MP<#[P:2/2["92[#8$5A/2;Q3$MO0)_\MB]4%IRP7,^Z<FT1H\H,Z7[Z*GB;0
M'X_"Z^'3/KN&J! BW(^:&:*BT!_UH][;:_P(37TEMB:=2:*_(]&W5NEA73+>
ML=C,?5O&Q)P'-N)1.RJRKW+=%#/:X\>'H:]0K0=A.%:9UH-0&"BBO;>WZ@#1
MUJ0SB1[MB!Y9JW17"/IHQ0$CG.[1G'P1E#+QFI$KD0IL*[J0<TY."K$ .LCV
M2.,(CM5^K<=<C *%:P..G&7W8V)KN\YD+=BQ%EA9^Z7D)#O(0J#7/D)PK/"@
M1XDWT<A3F#!$H0!#A8M FP60/PJZ$GN-#'>-#*V-G!Y:=)C:'.JJ0A1B1=BI
M*<SS(H6;F2D,1U"=UNSU?T2?WSUBXX@+-;XN(A\I/?7#5^$M/6F\(WG\"N/O
MX'K0),U8)U-]04P-,3!01MQ,#U)GTMC:V#,'9;2C,K)2^;,PAH>&9*15/?"Q
M.C/I05&DO0;TH'$8*:,VME;T3!J@UUD&STJ$6-6+-^3_1(])RLI(AQW@U'6@
M4[294[38%5I?BCWW!K^%97U;"U=ZND2;.46+7:'U]>Q<&K1:AR,6]RW _@0Q
M4E[74WLA)Q/LU#JY0NL3W)DG:/<BSA;^;3G[.GBJ#(X<3BN#2[38%5I?ALY^
M0;M3<6L+H.Z=-"T<F:!6"Y=HL2NTOA:=0X-VBV8W&U#W2OI\X\@KM>2Z1(M=
MH?7)[8P<M#NYDTP.U-V8UH^MQ9U,M4NTV!5:G^K.3D*[8?H;K [4C:,FD+62
M)POD$BUVA=87J+.BT.Y%;08*ZN9/GV8<N;^66I=HL2NT/K6=-85V;WJ[^'U;
M\9PV2_QZ99-3(GW!HBF%<+ D*6M6_T8!''G*5BJ7:#.G:+$KM/YWF,X](^];
ML&S(J05WBC9SBA:[0NOKV5EP9+6$1UBV%J#W1U:L_H7,7LK)##LUQ:[0^@SO
M?;JTFV)GG@WIWEG]5&.ORLDRN/WJ^!K6&776&=FMLUO/AG3_?&$8%4XMM%.T
MV!5:7X[.0B.[A;;;-F3X,*ERZ]02.T6+7:'UN>TL,;);XI-<&](=LFH*[,6=
M3+53@^P*K4]U9Y"1W2#_#:X-?=U6VRMYLD!.;;4KM+Y G:U&=EMM<VU(]\/:
M+./4#SM%BUVA]9GM_#"R^^%/^K+>2+)+HSIUBC9SBA:[0NOKT9EH%'T3SLRI
MTW:*-G.*%KM"Z^^3ZYPVMG^G/F*GG*=OI1E!7_DF/S6%A3!4=Q69PJ(P4O<P
MV&M]+BN=7\5VO^K,36'=UOHP5+<A&:(,F]\,4?KNM]C>LG.9ZWPHMOM0MP8(
MZV;TPM?8,P6-5/+T(.@CE;M7V;.ZMVG5;A[M;@7K9A!&*-3&H1Z&/ Q]E0]#
M& H]K#+R&OX-=_X-V_W;21X#ZW;.N/_-&&?8 &>,TW? Q?8VG,M1Y\/P:^P>
M/<D<8,-^46W[FBE(W[]FB-(VL-D;?"ZAG=O"=K=E6\QC?9=GX$=(I4*/$AW,
M#U4N]+#Q.- FI=>P-EA:F_Z=;DF.[4OR1_CYKDBR[4+T*KX6J[A<%,\K^4*4
MEW?Q_=T4+--"S&6BIQ4+(MA,4GDNJX[YB;!DW510GAJ1"T.9)K?)U<_%BG*9
MKK9,+B)+UI[O$>ER3;G99&G2K#6K<LF?B5B&UAT[+0 !#R^W2"6O!!5I0L&;
M!T(>W@*Q+B7%BM:??V2_%R7=;EB:Z34AG+-TOGUYR<]I09>IJ)L8/!LQH,I%
M7<VJ@7\G"Q-,)"*EJ<?/):<-Z.TENH27,J]I8%&56;H0HW11TR,6SH*BBHL;
M>7V.:"F:*R._4,* ($[$S6A"\SEE#>#+29O+1_3YS>]OFYOZO_^J\P^K@_\=
M(/^P!*:I;[AW C"G;%4?[JQ$L<*G-J=B=G>; Z0S>/6^/F>IW(_AU0?3_5L<
M7GW H?')^.4LZK KNCG)*N1>I4+YC"Y%-;S+4+S]6',XM+G@Y:8^FS@ON1"Z
M_KFF1+S;98!XOBP%H>V%+&!W1'?R?U!+ P04    "  N4UA6557/#YL&  !@
M)P  &@   'AL+W=O<FMS:&5E=',O<VAE970Q-#DN>&ULM9I=;]LV%(;_"N$"
M10O4M4C*LIPF!IJH0PNL6Y&NV\6P"\:F;:&2Z(JTT_[[41\1+?)(3F#E)I'E
MET?G/13)QQ(O[T7^76XY5^AGFF3R:K15:G<QF<CEEJ=,OA4[GNEOUB)/F=(?
M\\U$[G+.5F6C-)D0SPLF*8NST>*R//<E7UR*O4KBC'_)D=RG*<M_7?-$W%^-
M\.CAQ&V\V:KBQ&1QN6,;_I6K;[LON?XT::*LXI1G,A89ROGZ:O0>7T1^V:!4
M_!WS>WETC HK=T)\+SY\6EV-O"(CGO"E*D(P_>_ ;WB2%)%T'C_JH*/FFD7#
MX^.'Z+^5YK69.R;YC4C^B5=J>S4*1VC%UVR?J%MQ_Y'7AJ9%O*5(9/D7W==:
M;X26>ZE$6C?6&:1Q5OUG/^M"'#7 04<#4C<@=@._HP&M&]#'-O#K!GY9F<I*
M68>(*;:XS,4]R@NUCE8<E,4L6VO[<5;T^U>5ZV]CW4XM(GZGWJ EDUO$LE5U
MP'_LXP-+>*9D>3+ANK HB=E=G,0JYA*-413+92+D/N=(K-%G<>#Z9E#H4X;^
M$HHEJ(B+7D5<L3B1KW6##]]NT:N7+T(:^.]>H_H Q1GZ'">)O@/DY41I/T56
MDV6=^W65.^G('1-]X4QM)?J0K?BJ'6"B"]%4@SQ4XYKT1HSX\BVB^ TB'B%
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M:K.7"5/M/?O,<KW82)3PM0[IO9WI^N;5=J[J@Q*[<H/3G5!*I.7AEC,-4X5
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M-GM0+8)J!*I1J,:@&H=J J799XF8LC#H[7T>#Z E(E2+H!J!:A2J,:C&H9I
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MV7KD#]</.'"@:3FJ%:@F4$VBFD(UC6JFT?8.'/'>@>-K!.)1FXA'WN#0=^!
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MYH:GGV$L0=30>3:C4:O1F*UHX\X3O.CBP/BFX@2=-\UZS]RBHIX;QZ$K3RZ
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M7U,_!&V02;2AAS"BLH*ZWP(2A?)534!$YHHMQ^ .3W"'AW/'% CS5%*0LR!
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M5]K4%)'\!WCR?P*."M3$7[%2*Z%Z"<.;:FJE8(< 9P>,HP)@;PTPUE05,-:
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M 3#IDC'. /AW'[K\0&DUE"91-+N0O0$H9S0 )=0 0&DUE"91-+N*O0$HIQF
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M0$[79,_UG3C^1NN (LN7":[<)SC6MM #V5YI4=1@XT'!RNJ;?*L3<0) \0L
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M2HD6O8F27)1$6O0 BM"4P-&'Y^A#9_0?9!.2BPF6/C2#9[$6U0( 14Q+, -
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M_EZ]9;Z\C>NO-!]U:S[KLR! I^%$GYD *)Q2??0-H(9,-8Y<23[JEGQ.#J+
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M(R]GXNW-\>:$X@YY\\EPF_RW]AHEX)H61ET]&8ZV 7RRQ5[9$E]LW2:5UBI
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MJ0M%Q%THNE]R/8JU^3['#6P;1%!: $H+06D1%,T6NJY*$?Q:YRP$M+(%2@M
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M@&9(2.2Q9,B*XF35$P<?KG*&@R&5R\& RLO!U) -Q9=ISG,P=1=3Z)A-;0^
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M$MDKZ)#*F8UC0-69C5L3HY/WW[:R7#?O$59!TR/:][V.OQ[?57S7O*%G_?Y
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MNR&>NKX]^3"Y1#'5$J6'>C-EG2%2TPUQNR&>NNI]J>%2Q=0M54Q98(CQX1S
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M((MK($NM@4ZTL<&"1!*6GFD ):Z[0IB9*:Z[JEO=E]6=@SMJ*56QNLM<3]8
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M&5LM9?9/-MB0"I'B(1 E2D$71$EAM;KJ?:GA8L7^6X@5&]C&YDAC3@:).XD
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MW/)"_&555CEKQ-MJ/:VW%6?+KE&>35$01-.<I<5D?MY]=E7-S\M=DZ4%OZI
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M-Y".6"%Z)]<*\;B$.B5J$!+YD'LST]\*T7=T?'4$8CU*4Q1'QGB9HAD<^/Z
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ML0F0!+:+CP)(X@;(/\%-Q,0WG9OV2ZA3TJV,@D#BAD!OW&0R7:0GEB&-SOR
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M$R@W@,AX_,V5/^S645%A]&,\=11!ZPL-T@=4F!@V@ \GV9Q0Y!CU2BP>0$P
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M$&=GY8(MY!:KC+L1*M?2%&!P]]*$A;Y3>8BJC7-TA_&=SA4<I\O\$#4[:EV
MLS6GL3D2+"6G#YNL%X4JTKCRE179)1NFR.F_ZLY4)$)EDH_C!Y,D)ST;H $<
M:+O<P52PF$98*ERY/H14#=FV!@OEKD8^$\P!T2>GX(*$)'D@/"=\.<$<V-*J
MLW<ZG1"^S+XC$*K;32KSXXQ=Z^Y;A;/LA+[6?@Z/+Z&E?8Z.+VSX !U?VMK/
MT%0]F-J>N,.7SR2<<JCY1Q9J>2SU<75,%FK8P\%8[56>?[>0WTBVSL[9'YA4
M"R.[7!$<$:X!ZOF"J0DH;G0'NZ]'9O\#4$L#!!0    ( "Y36%:%CLDEL0(
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M,1G/W+3S?]KZ'^SQWP_(@ZATH<A=E4&V2^!B,OJ,!)N,3(-W&1-(STCHGY#
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M4*CY9HR*XA-MRUC'0K.UD"PMP6H'*<EVW_B^+,0!P V> '@EP#L5X)< _U1
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M<!V@KB\8D_N)/B:K#E['_P%02P,$%     @ +E-85I'1^$J-!0  MQ4  !H
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M,T?E-MCG"RG-;N("U+U^]!]02P,$%     @ +E-85O\#..P$"   JU   !H
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MNTP&LHB471:\1V!^6!C2>CQTH6]E 6Q<D&N#4T"0 P4Y"JFCBB,<BR,1#G$
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MU>!Q?'_H"31,Z'W6A *9"2 SF8S/FE@N>HT=O$D F D.S.WT ZRQP0/X5AB
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MWI3]L+3O)JC< ;N_D-+<3UR"[FTG^Q]02P,$%     @ +E-85C*;+IN!!@
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M,?WR!#Z\?S?P O_31U \:*#/-(XU_E5'*A;T6CIAL>+;?,7HR(HA4I&G<B7
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MT-GO&QUY>O WHI]TY05NI?P%M4I:-^HALR^W& V"@9FLO7KWWBTSNKKZ4H[
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MD6CW^N'MIZC>3C"L:XX13F&%T_G](2XB63U'5 TM"GO?7@B- ;6?&V!XT!L
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MK[)MD@6%@]IF,>U9+P?%"8;SM%=>3C)[.*@M$7Z?9VT5%"<8KB]#JFR5=*;
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M\O!F7GXUT%(ETQ(\'/B>;R"/1[L4H6H&I6;/Q8!M51(S"%100(.J&92:[?P
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MX@\-NO_^?K/9]W^Y[O2_;+:_'?MX\R]02P,$%     @ +E-85KPC]2FO!
M:1H  !H   !X;"]W;W)K<VAE971S+W-H965T,3@Y+GAM;,59:V_;-A3]*X0*
M% FP1J+D^)':!M*HZ0JL6Y"@VX=A'QB9LHE0HD?2=@KLQX^D%3TL6DXR>OEB
MZW'OT3WG\G$@C3>,/X@%QA(\9C07$V\AY?+"]T6RP!D29VR)<W4G93Q#4IWR
MN2^6'*.92<JH'P9!W\\0R;WIV%R[X=,Q6TE*<GS#@5AE&>(_/F'*-A,/>D\7
M;LE\(?4%?SI>HCF^P_+[\H:K,[]$F9$,YX*P''"<3KQ+>!&')L%$_$[P1M2.
M@:9RS]B#/ODZFWB!K@A3G$@-@=3?&E]A2C62JN/O M0KGZD3Z\=/Z->&O")S
MCP2^8O0/,I.+B3?TP RG:$7E+=O\C M"YQHO85287[ I8@,/)"LA658DJPHR
MDF__T6,A1"T!]O8DA$5"^-R$J$B(GIO0*Q)Z1IDM%:-#C"2:CCG; *ZC%9H^
M,&*:;$6?Y+KO=Y*KNT3ER6F,.5DCK3U(28[RA" *2"XD7ZGN2@%0/E//XP]J
M"'(B'@3X &(B$LK$BF/ 4G"9R)7*81S<,*E2-,#G-%5]%?KVKUA*DL_!)><H
MG^,MZ$F,)2)4G"JTS]]OP<G[=\.HW_MX"HH#50+X1BA50T.,?:F(ZG+]I"#U
M:4LJW$LJ.0,1_ F$01A:TJ^>GPXMZ?'STX-FNJ^Z4[8H+%L4&KS>2UJ$A,#2
M*DTGF%Y&+L02)7CBJ75"8+[&WO3].]@//MJ$<@D6.P)KB!B5(D8&/=HG8F/,
M_I:FHAB7ZNRZ5/72J&K&_"\$W1-*),$"_*G1 )$X$W_9)(]<2NX2+'8$UI"\
M5TK>ZQRW7S@3 B2(\Q]::)2QE9[[]UCM5KH+N@4V-;>H?8.JMZWU- SZ8W]=
M%\D2,QHV8^)VS# L0QJ,SDM&Y\]@]$1DRP"<$+U[)8S/U"#":OF6"_#U\@Y$
MX:F-W?8)Y[6J@AUN!R/BKH@&L7Y)K-])3"W2)2TDU'Z^9%SBF5Z%Y0*KC94:
M;F:;L9'JMPIJM\P2TVI9.V9?RP8EL\%!9OAQ:6:^K?)!ZXF]W<+;(6$$=PIO
MQT![W<.R[N%K%WWP3WU_9:I!'.3%:H;JNVS.)$A7--7[J+JG.[D=F"#A:C'C
M! $U%8MQK--M G66^=*US258[ BLT9Y1V9[1VVTG(Y>2NP2+'8$U)(=!956#
MSCEQC0@':T171O1J6B@/3)$:SXA:K6)P<,7M?NY+17*%UE2I9NAAMTHV&V\5
M!K:$^:"JV-7&$M4?["Q_MJ#AGA405KX7OL+XTFHB64DYM;].T6)7:$TY*P<,
MW] "0Z<>V"E:[ JMJ7ME@^%Q?' !VYA44;CK3FQ1P_/=^6D)"D>#/1.TLL/P
M^'X8'C;$AT/BSI FN\H3P^.:8MAVL[;^6:+:_;,$[>]?Y8WA?S/'L&UKU0[1
M8F"+VG7VMJ 0]O<PJ%PR?(5-KFT1_Z]7[B[VQ8N@4[?L"JW9J,HOPS<TS-"I
M8W:*%KM":[XZK#QS> S/'![VS-W/??&KP6-XYK#RS*$CSUS@U%\JM2VS):CE
MF"TQ+</LUU[KZX\PWQ"?J_H Q:E*"LX&JC]\^UUC>R+9TKSIOV=2LLP<+C":
M8:X#U/V4,?ETHC\>E%^7IO\"4$L#!!0    ( "Y36%8\3<JXLP8  +8Q   :
M    >&PO=V]R:W-H965T<R]S:&5E=#$Y,"YX;6S5F^]OFS@8Q_\5*Y.F35H7
M;).$;&VDK;UI.VW:U-[N7ISNA4N<! TP9SOI^M^?^5$,F+@K@3;WIH5@/_C[
M]6/[$T-.;QC_(3:42O S"F-Q-MI(F;P9CX6_H1$1KUE"8W5EQ7A$I#KEZ[%(
M."7+K%(4CI'C3,<1">+1XC3[[!M?G+*M#(.8?N- ;*.(\-OW-&0W9R,XNOO@
M,EAO9/K!>'&:D#6]HO)[\HVKLW$991E$-!8!BP&GJ[/1._CFW)VE%;(2?P;T
M1E2.02KEFK$?Z<FGY=G(25M$0^K+- 11_W;TG(9A&DFUX]\BZ*B\9UJQ>GP7
M_4,F7HFY)H*>L_"O8"DW9R-O!)9T1;:AO&0W'VDA:)+&\UDHLK_@IBCKC("_
M%9)%1675@BB(\__D9V%$I0)T]U1 107TJQ5P40%G0O.69;(NB"2+4\YN $]+
MJVCI0>9-5ENI">*T&Z\D5U<#54\NOJY6RH:0Q#X%>=[X+(H"J7I*"G "KO+N
M!6P%TJ+OBZ)76='S2M%+&A(9Q&L@&?B:4)Z?O$M[*9 !%>#%!94D",5+%?6W
M[Y?@Q?-G'IZZ;U^"X@ $,?@2A*'J77$ZEDI<VL2Q7PAYGPM!>X1<4/\UP/ 5
M0 Y"+=7/?[TZK%<?*TM+7U'I*\KBX7WQ N&'3&PY5;[=8]W?GU5E\$G22/S3
M)CR_D]M^IW2<OQ$)\>G92 UD0?F.CA;/G\&I\[;-AIZ"U4S!I2G8%GWQF:H!
M)U2&RPT@0%(>I7D54B& W) 80 0B%LN-> 74] )V)-Q20(10?H5Y51(O\T.5
MIK'D:A(01<)*N@376PEB)L%MD<94^;UL<S1OYC1K9CK1[1;8.QWOJCZ91: S
M+\O4Y+NE?-<J_Q/G=,=\<AU2D&RYO\EUZ$18JQDM;FMO'G=2;TR:I[4F6^_>
ML6LGI;;)8=HX]:F2U]H=$T/>"730I"'/VH".\J:EO*E5WJ6*2)2J+ &7=*>6
MOR35!<+ 5VN:RM(UI_1NTJSK5O.BRDTU+5X^)U'R]B*+P>2&\FK!-E^FAB]H
M,F^X8I:9X&E[GLY*L;->Q<;I5)]>CP(UEB53DUE";O/K:DY7!>)BT<Y&?C5B
MPMF:DR@KEQVKN:#-B9GIQ!PVK6@IY,U1NQ=>Z85G]>(/)DFH5,;9E**FG$!-
M,ND*M7^P>N9@Q1"B1F.MM^V8S?-2U/R>>5B(/%@^[>;'MZK3V_188SUT^>DI
M6$TV=#3L.(^V*A>WZLF7OJ+5C:E0(/Q_K,Q%.VN#>-H8.G8M7;W29 >MC'3
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M'-4*2A.C<"BD.3M_Q[E1M+ &U514TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4
MU4)4BU M1K4$U5)4RU M1[6"TL3$' IKSJ2W]T,K2M&B&E13-YHP>WKR<IFE
MAHZIHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@6HUJ":BFJ9:B6HUI!:6("
M#@4T9_("&FNQ*+M*"6_+=EXJR9>= 8<VT*":BFH:JNFH9J":B6H6JMFHYJ":
MBVH>JOFH%J!:B&H1JL6HEJ!:BFH9JN6H5E":$(3G0U7-^='[39Z>HP4VJ*:B
MFH9J.JH9J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6H1J,:HEJ):B6H9J.:H5E"8F
MYE!@<RZ]W7^?A:4;05R\>2K./GZ5#W-PO*%M,ZBFHYJ!:B:J6:AFHYJ#:BZJ
M>:CFHUJ :B&J1:@6HUJ":BFJ9:B6HUI!:6*\C8=XD[?-O)P9E2\PE6,'G_&A
MM3*HIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:C&H)JJ6HEJ%:CFH%
MI8F1.+3/G!^_XQPI6E>#:BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J
M1:@6HUJ":BFJ9:B6HUI!:6)B#G4U_4/9222RP'0SAC"+.MI:Q?E5OBL'1R"I
M::BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@6HUJ":BFJ9:B6HUI!:6($
M#OTSY_+^&>W/Y:3NHZTN=V8;6CV#:BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>:CF
MHUJ :B&J1:@6HUJ":BFJ9:B6HUI!:6($#ATUYV?O.&^*5MF@FHIJ&JKIJ&:@
MFHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J):@6HIJ&:KEJ%90FIB80Y7-N?3&
M_[W6EJ(%-:BFHIJ&:CJJ&:AFHIJ%:C:J.:CF;C3Q"L'+"P0>.J:/:@&JA:@6
MH5J,:@FJI:B6H5J.:@6EB?DV%,^<RXMGADG1-Y:5HMTRJ*:BFH9J.JH9J&:B
MFH5J-JHYJ.:BFH=J/JH%J!:B6H1J,:HEJ):B6H9J.:H5E":&X=!!<W[YCM.C
M:%D-JJFHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:C&H)JJ6HEJ%:
MCFH%I0F)>3&4U5Q(;^V_\N_GW_J,;*[[F/Q>S93EO)S-E'DS>_@HC$D?H_6T
M[/JXG%;]SYN[:MJ?9S[^?%=LR@<\-#91344U#=5T5#-0S40U"]5L5'-0S=UH
MI\\G4U^45GCHB#ZJ!:@6HEJ$:C&J):B6HEJ&:CFJ%90FAN'00W,A[Z'YVLSG
M=;>^>T)IJUD?>U.E:Y1Y/:N67=.?+&XN(BZ5ZZ95[MKFG]6D_^)^,>TC])#[
M,.3[<7!&HK4WJ*:AFHYJ!JJ9J&:AFHUJ#JJY%SN:G4['6Y<<T4%]5 M0+42U
M"-5B5$M0+46U#-5R5"LH38S)\1"3\CZ;+UTS_U$O=Y_]H>TUJ*:BFH9J.JH9
MJ&:BFH5J-JHYJ.:BFH=J/JH%J!:B6H1J,:HEJ):B6H9J.:H5E"8&X-!><_&.
M[347:'L-JJFHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:C&H)JJ6H
MEJ%:CFH%I8F).;37] ]EIXQ[W(4A%P[.05)344U#-7VCB<WH+V;/#'1($]4L
M5+-1S4$U%]4\5/-1+4"U$-4B5(M1+4&U%-4R5,M1K: T,=Z&9IH+>3/-XXRH
M_!8,.7)PPJ$--:BFH9J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H5J,:@FJ
MI:B6H5J.:@6EB5$X--1<O&-#S07:4(-J*JIIJ*:CFH%J)JI9J&:CFH-J+JIY
MJ.:C6H!J(:I%J!:C6H)J*:IEJ):C6D%I8F(.#347\H8:I-E;/L;!28EVV*":
MAFKZQ>Z^DZWY4[2<!M4L5+-1S4$U%]4\5/-1+4"U$-4B5(M1+4&U%-4R5,M1
MK: T,0*'$IL+>8E-,FGK;Y62]N>*Y5UUW]63W2&'=MB@FHIJ&JKIJ&:@FHEJ
M%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J):@6HIJ&:KEJ%90FIB%0X?-Q3MVV%R@
M'3:HIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):A&HQJB6HEJ):AFHY
MJA64)B3FY=!A<RGOL-EC<:E<.#0'44U%-6VCB<M!7W2.Z.B0!JJ9J&:AFHUJ
M#JJYJ.:AFH]J :J%J!:A6HQJ":JEJ):A6HYJ!:6)\3:TTES*6VEV3([*UYG*
MO8/##FV7034-U714,U#-1#4+U6Q4<U#-134/U7Q4"U M1+4(U6)42U M1;4,
MU7)4*RA-3,7QD(KC]YLFO41;:U!-134-U714,U#-1#4+U6Q4<U#-134/U7Q4
M"U M1+4(U6)42U M1;4,U7)4*RA-3,RAM>92>H\_L\Y4/L;!28FVU:":MM'>
M6!FJHX,:J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6H1J,:HEJ):B6H9J.:H5E"9&
MX%!#TS^41:#5Q]ZLGC2*5TWK2?_#G1$G-0Z..%)344U#-1W5#%0S4<U"-1O5
M'%1S4<U#-1_5 E0+42U"M1C5$E1+42U#M1S5"DH3DW!HK+D\?<?I4[38!M54
M5--034<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0+4:U!-525,M0+4>U@M+$
MQ!R*;2ZE-0![K3)%ZVHVVDCX]+CQQQ=K.55T4 W5=%0S4,U$-0O5;%1S4,U%
M-0_5?%0+4"U$M0C58E1+4"U%M0S5<E0K*$T,N*&'YE+>0[,U.?K&*E.T<0;5
M5%334$U'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4"U&M0354E3+4"U'M8+2
MQ$P<BFDN+]YQFA2MKT$U%=4T5--1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B
M5(M1+4&U%-4R5,M1K: T,3&'^II+Z<W^T"I3M+9FHXDK.;<^85Q%!]5034<U
M ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0+4:U!-525,M0+4>U@M*$"!P=#84T
MJ\>R$(RK/@"KML^Y\+9LY_U0J]OVR]GR%\7RORK_4K[T(?FMF:[.&E_)Q5VQ
M^,:PA^8BRZDLI[&<SG(&RYDL9[&<S7(.R[DLY[&<SW(!RX4L%[%<S'()RZ4L
ME[%<SG(%QKW(U-&S3!V]WU3LXV!8DJ(E.2RGL9S.<@;+F2QGL9S-<@[+N2SG
ML9S/<@'+A2P7L5S,<@G+I2R7L5S.<@7&O4C2\;,DE18-7'UMYO.Z6T^^*FTU
MJ>KOU52Y;EIE6GVO9LW=_&'R=MFM>N;^^I>+X[.37;_)[V^,<WB(HKTY+*>Q
MG,YR!LN9+&>QG,UR#LNY+.>QG,]R <N%+!>Q7/S(G3V[CC0^?WD=*6%'37>.
M>OERU(P=-6>Y N->A-[QL]"3M]]L5K(JY71:KV9:RYERUS;7=?>/Y6W95K\H
M]4*YJ]I)GWWE3:4TU\K3).Y_+I7_N2_;KFIG/S<;*7\;GO[WW=F(%N6PG,IR
M&LOI+&>PG,ER%LO9+.>PG,MR'LOYC]SELW?:HX\C\8TVV/VLL?BLD-VUB.5B
MEDM8+F6YC.5REBLP[D4RGCQ+QA-I,H9"ZDWNY_>SLNO/"7><#K95/?]VWRZK
MZ>[,DPYT>.:1G,IR&LOI+&>PG,ER%LO9+.>PG,MR'LOY+!>P7/C(B5G[X@[H
MB!TT9KF$Y5*6RU@N9[D"XQ["\=/RMJHZM>S*J\_SJKVIOE:SV6H%SOVBYU<3
MJ$_?[:/N>I6=OWX9?_BT]?UP]&LT6GW_T\!<?;[K(]0KVYMZL51FU75/'GT\
M/_V@M/7-[=,777/7Q_,'Y5O3=<U\_?"V*J=5NWI"__/KIND>OU@-\*-I_UCO
M]M7_!5!+ P04    "  N4UA68EKW588#  !P%0  &@   'AL+W=O<FMS:&5E
M=',O<VAE970Q.3(N>&ULO9A=3]LP%$#_BI5)"*1!/EL*M)$&&1L2" 1B>YCV
M8-*;UL*),]MMX=_/3D+:K"5MD=<7:B>^Q_:);XC=GS'^+,8 $KVD-!,#:RQE
M?FK;(AY#BL41RR%3=Q+&4RQ5E8]LD7/ PR(HI;;G.%T[Q22SPGYQ[8Z'?3:1
ME&1PQY&8I"GFK^= V6Q@N=;;A7LR&DM]P0[[.1[! \C'_(ZKFEU3AB2%3!"6
M(0[)P/KBGD9N1P<4+7X0F(F%,M)3>6+L65>NA@/+T2,""K'4"*Q^IG !E&J2
M&L>?"FK5?>K Q?(;_;*8O)K,$Q9PP>A/,I3C@=6ST! 2/*'RGLV^0S6A8H Q
MHZ+XBV956\="\41(EE;!:@0IR<I?_%*)6 AP@W<"O"K VS3 KP+\30."*B H
MS)13*3Q$6.*PS]D,<=U:T72AD%E$J^F33#_W!\G57:+B9'B;),H;Q5D,J%QH
M,4M3(M6CE0(=HH=R/2"6H,=LR/$L0Q<<AD2B2QP32B0!@?8CD)A0<: "OC[>
MH_V]3SV_&YP=H*J 2(9N"*7J28N^+=6X=>]V7(WQO!RC]\X8(XB/D.]^1I[C
M>2O"+S8/=U>$1YN'.\UP6\FNC7NU<:_@^>_QB(@I$Q,.Z#9!U^JNEMN4^HI^
M%3>N)*3B]RIC91_!ZC[TR^)4Y#B&@:7>!@+X%*QP[Y/;=<Y6^3,)BPS!&F[]
MVJW?1@^_008<T\-\PG,F ,6EU:1>JJM4ELAN@=2OR6G8<QSUI*>+BC9I%*UI
MU)A24$\I:)W2-0A1^I%CG"&W++\"YJOFTLK:=EF8A$6&8 V'G=IA9P<IUS'I
MUB0L,@1KN.W6;KOF4ZY$=A82)5A.N=9^MU5D"-90=%PK.FY5=,E96L*J[)4,
M^?,\7FFHE;CM8C,)BPS!&B9[M<G>#A*Y9]*M25AD"-9P>U*[/3&?R"=+B?QO
M%K=VNJT?0["&']>9?RH[&^:Q7^=Q9TT>MR.W76Q&:9$I6E/GPL[#W4$R5YV8
M$FR2%IFB-07/-QINZ[?VQS*Z8J[YW]S>\]:>_L>>P9UO&MSV7<,-X[#PB;TV
MI5MI6Z\XD[3(%*UI<KY7<8-=I+3178Q16F2*UA0\W\BXK=_R'TSISM*^="F?
MC>Y'3-%*2?;"Z98^B[S!?$0R@2@D"N\<':O>>'F\5U8DRXL#KR<F)4N+XACP
M$+ANH.XGC,FWBCY#JP]9P[]02P,$%     @ +E-85I^((3&> P  )A(  !H
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M3R[.=@L\FNB':A*JR:BFH)J*:AJJZ:AFH)J):A:JV:@V0C4'U5Q4\U#-1[4
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M[/[Y*]WZQWYU T!J(JI)J":CFH)J*JIIJ*:CFH%J)JI9J&9OM+[9U!$ZHG/
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M%JK9J#9"-0?57%3S4,U'M0#50E2+4"T^>YK[>-)=*TK0 5-4RRBM4^O/VXS
M\X,S N_G_H6ZOA<WQ55=Y,O9]:+^^W]=Z.__=5^5[Q_@M54>U414DU!-1C4%
MU514TU!-1S4#U4Q4LU#-1K41JCFHYJ*:AVH^J@6H%J):A&HQJB7G3V,JS[L]
M0XH.F%%:M\JW(83G_2&$>O&URF>Y\'"]P!^[4N#@&PO[C^;5+0$:.XAJ$JK)
MJ*:@FHIJ&JKIJ&:@FHEJ%JK9J#9"-0?57%3S4,U'M0#50E2+4"U&M0354E3+
M**W;/0S;[N$-8P?/T=A!5!-134(U&=445%-134,U'=4,5#-1S4(U&]5&J.:@
MFHMJ'JKYJ!:@6HAJ$:K%J):@6HIJ&:5U>X,V=O#\T-C!_O6#\20OIWO[ 32-
M$-5$5)-0348U!=545--034<U ]5,5+-0S4:U$:HYJ.:BFH=J/JH%J!:B6G3^
M-&%R,.S.T<?HB FJI:B645JWRK=QA/7#UU7Y\?QKT13WQW<UZKU$H%=_=8TG
M-1'5)%2344U!-175-%334<U -1/5+%2S-UK/I50C=$ 'U5Q4\U#-1[4 U4)4
MBU M1K4$U5)4RRBM6^+;],#SW@2BK1)_58S+Y?WU_LOEJO[K_<N/];4!8KFL
M%F5=ZC_/5XNFX#]LN+?DH_F!J":BFH1J,JHI&VW[!7VGAU;1 354TU\^? ,=
MT$0U"]5L5!NAFH-J+JIYJ.:C6H!J(:I%J!:C6H)J*:IEE-:MXVW2W_FA27]7
M^8^ED%]7];.F?*]OU2NJ38A?\YF[^;+Z9UW2\XGP95$6U\V?\S^5L_6.?]];
MU-%(/U0344U"-1G5%%1344U#-1W5#%0S4<U"-?N%EXC!\&C].[ZW+T"C_E#-
M134/U7Q4"U M1+4(U6)42U M1;6,TKI]01L@>-X?(/@7W@)0/_H\GTZ+V;B8
M-N8Z9?B_ZUVW\/^<%DU?LO^20#1:$-5$5)-0348U!=545--034<U ]5,5+-0
MS4:U$:HYJ.:BFH=J/JH%J!:B6H1J,:HEJ):B6D9IW4ZCC18\?\-HP7,T6A#5
M1%234$U&-0755%334$U'-0/53%2S4,U&M1&J.:CFHIJ':CZJ!:@6HEJ$:C&J
M):B6HEI&:=W>H(T6/.^/%C2+V4UUNUZ 6*\[]"\WH/F!J":^\'4>/S?!*J&'
M(:.:@FHJJFFHIJ.:@6HFJEFH9J/:"-4<5'-1S4,U']4"5 M1+4*U&-425$M1
M+:.T3IF_:%,%+_I3!9U)_K7\OCW__U.S0C"??2OR277[]V:MX=-JV<P&E/F?
M?V^B_J-Y;:. :B*J2:@FHYJ":BJJ::BFHYJ!:B:J6:AFH]H(U1Q4<U'-0S4?
MU0)4"U$M0K48U1)42U$MH[1N]]"F%5X,WFX!X0+-(D0U$=4D5)-134$U%=4T
M5--1S4 U$]4L5+-1;81J#JJYJ.:AFH]J :J%J!:A6HQJ":JEJ)916K<W&+:]
M06^>T4<G__%PC>%5/LUOBJ6PG*]N;JOF+L7'*869(!9W^:)ZV%1=3SL\7OM8
MS==7.GZZFU?%=Z$^SDDY+6?YHHDL^N_5;#T9\0]A=5=ON+>E0",,44U$-0G5
M9%134$U%-0W5=%0S4,U$-0O5[(UVMM8VMX]>G.T$&J!#.H<,Z:)#>JCFHUJ
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MZ29\N76GTC1@DG#2R32ON.G53?ARZV96XR9Q#W%.!T6''1L7.^.\A$3$O$Y
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M('7SX"@J<GN>VYFHC7MS\Q;5UQZ[6=+L2$\<2AR#110:X[,FU  5;[?O(0^
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MU@&?EQ)%;C?V@.ZS:?8#4$L#!!0    ( "Y36%9N"NZ.'@<  ,,K   :
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M"1)/)DH+:M'4T]"4&FCA08*'211U0D&9#+*NWWO065?-+6<2'C0Q<R&H?AT
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MX(*)A+.4P$^<?!HT86).N$AD!N1L"H;Q5)^3"W+_Y9&<O7TSB@>]]^>D^(%
M\I&G*=9<7P<& [)N@Z08_"X?/&H8G$;DHQ1FI<F]F,/\V$& 3$HZT8[.7=3J
M<0I)E\3T'8G"*/($-#G=G'K,IZ>;ARULXK(XL?,7-_GC.DFEWB@@<H'3W]8"
M;''R!<(UV@R[GRQ<%6%7MJ*4Y.M?Z) \&,CT-U]U\M%[_M'M$G6EURR!FPZN
M01K4,W3&;]_00?C>E]G7=#9])6='6>^56>^U>1]/I#9YOF?&E[7<>N"L[3K\
M/+Z(!_WKX/DP&SX0C8]!4Q\H&I6@H^C[9?3]UN@?A ',B2GF@H] [J!_,&S4
MHY7XZYA^KQ)]'4+#V!_\H Q^<%+J!>Z03>D?U(:]H%$EMHD'%/4O*P1\H*CO
M9S L&0Q;&7R2X@)W<87=*98$^Q1W*H$-F:R86 )9XM:M@S-L:EQISWWTAO6@
MJN3JD*C"S.-DX.<U*GF-6GE]$5LNYI:3[0Q<E^1&F.)QK>0SUTU;P,B3Y;#"
MR(.AE1DY;<<<D;HL25VV%PMLFQ3]DMBYIR!E!I=8(PEDZU2^ ) 9"%APXR5W
MZ:G6L$+.AZGVD@?3'_K)T7"_M8>M]/XXFFP$=PLLW%IJEFI;MD6Y]3,$^/D5
M(QPU>86>!U)=YSR0ANE(#W0+/;UVNPT/*:: LI&DG,UXR@T'/RWJJ4EU4OI
M<;]*S0=J6,)IM"<7M9+[VZQ >0./:L/5PJY#Z* :=1USL,H<![T7*[1U5W85
MV<^I?/L)SG:RTKO8%1Z/%X>XNM[Y4(?[9,')AXH;EG.Z%P.T70T@B[7"U4TL
MKTA=+'M)]7P-7RN3!Q4/:J1\J%$%=?\+"E_IMQ991/?*@K9+B\-45 OM381'
M:(2#:A[JH&JNIAY,/Z[FH#WV7^1@+U!HNT(IY17N\.".2LE&*1#)"PH6Q9^9
M/?=JLM'Y)K*".>[Z35*F?:S?%>"OZFWZ6MZ.\[R7473XOQY]:*N,^^W4OZ:W
MZ6MY.T[]7NG1=JEG98,3"Y[YG#'!VB;T"4)NX@'1JA[R8"X;SA9TK_9HN]P[
M@5C"]"KO:OL#?FP0F()H$$>7M?-;=0&?>##]JK+U^6G01Y$5?\=O]HHI:E=,
MN 0^B"3=S)$VZ@O",YQ$QDE!^_CPX?%AXMH)!>$2Q)QAHI)<UUO,1Z:253[-
M[.V(3:0UL[+9?4^D6/#E1KE#@2KNKMQN0=AZG?(D[UHM%V;+L*U=YK$@C#SM
M7C%MGW!"<VSHLR?&GLX)4\J>G#(L@BL,CG2+NU!:CX09H_ALXT9!U$ZVV^KB
M@8S+N0M3Y^[?V<$P$PF:Y'%\D@9RI[?=J$N[UBXG*+1,^=R="_;;GC;XPD:E
M[2G/(5^ *0+V)HM,(8%L!BIWN+M1ZOKZ,SBXO,M +=VMJ2;N@)4?^\NWY<WL
MK;N/K+R_HU?WU/-^&EW=^_"W48@?0N^7\O(WV(>47QWC-%CBL0)U]@+#"[M#
M[%&5W\;F#T:NW77C3!J< .[G"ACVG 7@]X7$1!</=H#R3GS\'U!+ P04
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M<H_DY+CD$>/&BLQX".$N@8T;K'?I;G9Y[YYDG$+0(IYS0]RVZS8D-#D?[C3
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MEB008<KMUBW^W\ERLBL76F3%)+(4&B]%\1CC, S2..#OD4#QJX4)4(_7HW\
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M0%D#_#Z7TCQ-[ ;5O2G^#U!+ P04    "  N4UA6"(#6&0\#   U"   &@
M 'AL+W=O<FMS:&5E=',O<VAE970R,3$N>&ULK5;;3MM $/V5D9$02 4GS@4$
MB:5 J%I52!&(]J'JP\8>)ROVXNYN$OC[SJX=$T)(>> EV5W/.9XYLSF3P4J;
M1SM'=/ DA;+#:.Y<>1''-INC9/94EZCH2:&-9(ZV9A;;TB#+ TB*.&FU^K%D
M7$7I()Q-3#K0"R>XPHD!NY"2F><K%'HUC-K1^N".S^;.'\3IH&0SO$?W4$X,
M[>*&)><2E>5:@<%B&(W:%^.>CP\!/SFN[,8:?"53K1_]YGL^C%H^(128.<_
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M".M&I=NEE>YC0QWUH1X[D8::O0R@XV44VI3&47-WF:T>'52!0]$\"FW*[:C
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M0:8X)T*F"+T@5A"=0E6P^;Y<%9FP&!JDJ"0I)CHOF76AX,Y>&5 X#X-CO-*
MQ\PF$X/.> 2'/&;1]33F,9UUJ+2>"0TBECLA+^4J?@M<K"IB'WHT3%%)4TRT
MWBD9& K\_ 4"'7W#X!B]1-6;S/X3 TZ !$= YLF I"&0Z21$K0-#YTC)'UR[
M%*OXCEM>JJ)[W[$S(-I9R5I,=& J&D.!G;\PH&-P&!RCE:AYD]F&8L")D.!(
MR#R9D#04,IV,J'5>:" 19*=0Y6P3=)Z U44[CPAG)7LQT7F)R P%=?ZZ@([
M87 L^9J(>9O9KV*P*9%8. ^#8P0359].2U0:SX9.$\=MEU*1"4>=4E4;,3@;
MDL9HE#A&;=1Y0I*&\A+SUP@X(3W+/)QD1AJ;V=%BL#F26#@/@V,$$V&?SE/4
MFC#THO#-@"ZEHI:;6J2B,F(;,R2MT2AQC:G;?(EL#05V_JK SL%1<(Q6HN5M
M9FN+P89*8N$\#(X13%1].EQ1:[O0EL+M+2?4^'0->^]$,"O!C8F>2Z5M*+#S
MEP1V_(V"8[02%6\S.UH,-F42"^=A<%."2="D2:<M*CWG0B-*T'-ZC4_7L/=.
MM+*2Y)BZIY?>[E5!GKTJH' >!L>8)2+>Y;:T8+,GL7 >!L<()A(^G<&HM5UH
M0S%=L(>Y6-8&SXN+9?0A!G821"8K08^)_DOD<BBH\Y<&=NB-@F.L$O7N<OM9
ML$F46#@/@V,$$QV?3F34>D^(P0E"MJ6J)@C9EK$B3FI#(A^-DOF8:+QX6(<"
M.G]98$?>*#A&*E'P+K>5!1M.B87S,#A&,-'RZ9!&K>^$;4UL8.,4JERP$[-8
MU41V2#$D!=(H,9")OHMG>"B@LY<%%,[#X!BI1,67N7TLV,A*+)R'P3&"B9A/
M1S<J?5<*>3G\\;M+L<KP1&ZQ*A8R8$@VI%'"(5//#NG9'@KZ_/6!G7:CX!B[
M1,:7N6TLV#A++)R'P3&"B:)/QSIJ#2AL@%*[X&)/*FM+'@HGE=DBMKF#(=&1
M1LF.3%WL13,_%-#Y*P,[\4;!,5*)D"]S^UBP*9=8. ^#8P0349].>]1:+_2>
ME+8..D^H:@+-*515+G8_G<1)&B5/,N4@.S4(1'F-^:L$.P1'P4TY)I&7ILKM
M:L$F86+A/ R.$4PT?CH14FG#2C2L!'XRJ2S8"MJ+965L-Q9#4B>-$CN9Z,13
M D(4^/EK!#L21\$Q>HG(KW*[6K!IF5@X#X-C!!.=GTZ-U)HP]*)4;:!"A:HF
M?)Y!J*(S5'8&1$@KN91?.C"UN[H",G\98,??*#A&(A'R56X;"S8L$POG87",
M8"+JTZ&16I^%]A/CRF#@(I59&W[8";N^1!]8)[F41@FF##KMU^2)*"\R?Z%@
M!^(H.$8RD?95;G,+-E,3"^=A<%."2:RF26=+*IU8AZ84QSOL4JPJ@K&+5.5B
MFI.$5QHEO5+JP]-"1A3DV6L#"N=A<(Q9HN;KW!:7&JOGH7 >!L<()GH^'3.I
M-5]H2JFY0?I2J@IC(*6J,NJC)CF61@FR_-)\)R:/*'CS5P1V#HZ"8WP2^5[G
M=K9@0S:Q<!X&QP@FTCX=-JFUG+"W2A7>ZI/*''_*R,ME45<9";0T2J)EJNO2
MB20*\OSE@1V&H^ 8LT34U[D=+MA03BR<A\$Q@HF@3X=3:OTGA "%<E.PP80?
M> )2[/..1%\:)?M2Z;QD3(F"/7MI0.$\#(YQ2X1\D]OE@DWGQ,)Y&!PCF.CY
M=$JETGM-Z$RIPN:3JD*7BU!5MM'V(X)9R<%4VN^T[!+E1>8O$^P0' 7'2"::
MOLEM=L&F=V+A/ R.$4Q$?CK%4NM#83<69X,^3._&\GRJ0E43[4.BHI6<S!_?
MRV\=._6&PGD8'&.-R/8FMY4%&]R)A?,P.$8P4>_I $NML83DG]8VX4><4%>Z
M\"ZZ5.?*NHJU%Q')2E#FC^]/BS11<.:O!^QP&P4WY9'D=9HVMVD%F^")A?,P
M.$8PD>SI)$NEX5K!9N+J<",(J:XHV\ _)M1UM8OU&\G+-$I@IM1O2KZ) CE_
M96!'VR@X1BE1ZFUNJPHVU1,+YV%PC&"BTM/IEEKK"?82QZW0EU*9ZYI@$Q:A
MS+9%S*U"$C2-$J$9:;QY:2?*B\Q?*=B1-PJ.D4S$>IO;S8)-^\3">1@<(YCH
M^G3JI=:*@DU%>'A!*BO;8$\R&2UV24>2-8T2K1EIQ53H21IQ_K+ CKI1<(Q1
MHN+;W-X5;"HH%L[#X*8$DV!0DT['5/JN"_TFIK3!WBQ2F0OW A31RMA'($G@
M-$H$9Z3O],R3-.[LQ0&%\S XQBO1]%UN\PHV,!0+YV%PC&"B\-/!F5KW"3NJ
MN#KXU)/*ABX-ND\JLS;6?41%*^F<D>Y+YIVD(>>O"^QT&P7'*"6:OLMM8<%F
MAV+A/ R.$4ST?#I#4VL\P702CERDJB8PL(A5L0?V2$BG45(Z(UV7SCI)8\Y?
M%=C9-PJ.<4KT>Y?;N8)-#<7">1@<(YC(^71ZIM9V@BF%#U(NI2K7!3<6)*PB
MLD>$)>F<5DGGC+3=*3DG"O3<Q8&%\S X1JTAU&;VKEAL@B@6SL/@&,&6$'R&
M=^7YX$E?&;XCF5@5?.B)53'3IB41G5:)Z(QT7RKC1(&<ORB@,W 8'*.T))1F
M=JI8;' H%L[#X!C!%2'X#*?*\\%)+]BE5!6F"TE5KHZ,5RQ)YK1*,F>DZQ+Y
M)@KB_#4!G7;#X!BC#6$TLXO%8@-#L7 >!L<(;@G!9[A8G@^>W(L+/"QB515^
MU E5951H=N0,YOM79H2;*/#S%PAT[@V#F])+XD*MR6QKL=C<4"R<A\$Q@HF:
M3P=G*AUH!!M*RR.&I*HV&&R*5;$MD2P)YK1*,&?L;EXBVT2!G+\HH/-N&!RC
ME.AWD]G18K%9H5@X#X-C!!,UGP[+U+HN]*"4_"'S2ZG*<?.T%ZML)&W!DC!.
MJX1Q1KHNE6ZB0,Y?%-!A-PR.44KTN\EL7K'8G% LG(?!,8*)G$\'96I=%]I-
MRHK?0Q>K@F?0Q:HRXMZT)(C3*D&<L7MXZ2UO%=3YZP(Z[H;!,5:)AC>9W2L6
MFQ.*A?,PN"G!)"?4IH,RE<:S@M^DYE=PEV*9"Y['$\M*$]D$R9(L3JMD<49Z
M+Y%MHB#.7A90. ^#8XP2Y6XS^U8L-AH4"^=A<(Q@HN/3V9A:WTE)0$'7A47A
MQYU0Y&(:DP1O6B5X,])Q\5 3!7#^>L#.N%%PC% BVFUFOXK%AH)BX3P,CA%,
M)'PZ%5-KN-!C8L-IBE15A2TG5-6Q:0I)W;1*ZF:DY^*!)@K@_"6!'7&CX!BA
M1++;S&85BPT%Q<)Y&!PCF*CW="JFUG.AP81O)7U"C9=J3.PCC@1N6B5P,_94
MD)YCHB#/7A90. ^#8\P2N>YRVU2PJ:!8. ^#8P03]9Z.Q53ZSDD104TPQ)3*
M;!"-+I;1/2#821"%K"1OQB[JHADF"N#\58&=;*/@&*%$L[O</A5L("@6SL/@
M&,%$PZ<3,;6V"[TE315<U E5;1TV75C5V6C/$9&L)&[&W&&GYI<H^/-7"';,
MC8)C_!()[W*[5K#9H%@X#X-C!!-)GP['U%I0" CB#]E=RE6!54RJ<C&K& G?
MM$KX9J0%3PDN4:#G+P[LK!L%-Z66I(+:,K=C!9L0BH7S,#A&,!'VZ8A,I?M*
M88.5X/-/*.*9"UXJB@Y82/ZF5?(W'UHOM56[ C#_]X\=:J/@&(%$LI>YS2G8
M!% LG(?!,8*)A$]'8&H-)AE*.O[XCU1FFSJPIXAET4<02,JF55(V)VWV:^)*
ME!>8OTJPHVX4'".8J/@RMUL%FP:*A?,P.$8PD?'I.$RM#26W2C!>D:J:0&5*
M52;RQ+DE<9M6B=OD/7A:5(F".G]=8.?=*#C&*M'N96ZW"C;_$POG87!3@DG^
MITT'8"J-5PG^DB;8XT@L<S5/"A++JB;F%",9FU;)V'SHO1.32A2LV0L""N=A
M<(Q+(MFKW#X5;-@G%L[#X!C!1-*GTRZUCA-\*K8+G)E2F7'!C3RIK(AM%&U)
MH*95 C5C'9=.*5%0YR\-[+@;!<=8)3J^RFU9P0: 8N$\#(X13'1\.@%3Z[W0
M9E+RGKJ4JERPM:9854<;CPAE)6$ST7C)D!(%=_[*P(ZY47",5R+?J]S.%6SB
M)Q;.P^ 8P43)IR,OM=8+'2<VO(\@5)DNE)E"52RDQ))(3:M$:B9:[[2 $N4%
M9B\1*)R'P3&"B8RO<[M8L,&?6#@/@V,$$VU?G^-BJ07?2<EW&!.K+-_27:IJ
M8Q=Z)%C3*L&:C[?-K[;WF\-N%3L-[, ;"N=A<(Q"HMSKW)X5;-0G%L[#X!C!
M1,2GLRZU)@M])J9L;&",ENH& =D$C2;5E3;::T0K*XF:K-=.2RY10.<O#NR<
M&P7'2"7RO<YM5\$&?6+A/ R.$4QT?#KI4NN^T&+2M>$\4RJS05"07!9]WIR$
M:5HE3%-M/27$1,&?OTBP0V\4W)1?DO9IF]RV%6SD)Q;.P^ 8P43)IS,OE2YL
MI%R@(NA"H:P.'\<3JEP9ZT$2JFF54,U3>G!>GHGRBO,7#78PCH)CC!-QW^3V
MNF #0+%P'@;'"";2/YV J75EZ$XQ37#Y)U39(KC\D["BUW\D8=,J"9NG-&4B
MV42!G[] L.-Q%!RCETC^)K?-!9L4BH7S,#A&,)'_Z:A,K0.%#* BN/4G5;G@
M_H-41<8T[ R(OE:B.$_I0#7C1'F1^<L$.RM'P3&2B?YO<KM>L &B6#@/@YL2
M3 )$;3I!4^G#-O2I=.$GH505[M B5+5-S/))$CJMDM!Y2A^FTDX4_-DK! KG
M87",7R+_V]PV&&R0*!;.P^ 8P43MIY,TM184=F(16E"H"FUG8E7LHY D=5HE
MJ?.4%DQ&GR@O,'^)8"?I*#A&,%'[;6X[##9!% OG87",8*+WTQ&:6@\*NZZ$
M=ABIRH8]*%29V#UY$M%IE8C.4WKPI!R4].O,7RG8L3H*CO%,9'^;VQZ##17%
MPGD8'".82/YTJJ;6BH(]AF]_>RE6\6!,+U85L8$I2>VT2FKG*:V8#$5)X\]>
M(5 X#X-C_!+%W^5VQV"31;%P'@;'"":2/QVMJ;1@)_A>NB"*2*KB*0Y>K(IE
M/5L2W6F5Z,Y36C"5D)*&G[] L/-S%!RCEPC^+K=U!ALQBH7S,#A&,!'\Z8Q-
MK0.%C5P"WXQ0Q)^>\%*1*6*[YI($3ZLD>)X\'#TE+"7]6O/7"G:4CH)C7!/E
MW^5VTF"#1[%P'@;'"":2/YV\J36C%#$4W*N0JGA^GY>JG(O-2$FRIU62/4^Z
M6YA*3DGCSU\AV"DZ"F["KR.YHZ[(;*-QV/11+)R'P3&"#2'X#!O-\\%3,QOK
M0*FHY1M32$4FEA?F2+BG4\(]3VG 5(B*@C]_?4!GZ# XQJ\C_&9VS#AL$"D6
MSL/@&,$E(?@,Q\SSP=/+./X9*%=QQXQ8U44DJ2-)GTY)^CSI/F%Z\UWE)>8O
M$N@4'0;'**X)Q9E=,PZ;3(J%\S X1G!#"#[#-?-\\'2C></O4XAE5>#I%LO*
M(B)&'4G_=$KZYRF-F(A74>#GKQ'H_!P&Q^CM"+V9+3,.&TZ*A?,PN"G!))S4
MI=,YE28TH<VE=CR]5JIJJN"C4,*J(^911](_G9+^>4H'QN-6%/39ZP,*YV%P
MC%VB]4UFPXS#YI1BX3P,CA%,Q'XZJ%-KP-#D0H/ GCD1LHL,OUDO5=DNLD6:
M(T&@3@D"/:4!X]DK"OK\]0$=GL/@&+M$Z9O,;AF'C2S%PGD8'".8Z/QT9J?6
M@*'#I6W"!A2JBD"$"E5-$]F.UY%,4*=D@I[T3).>QJ*\S/R% IV<P^ 8S43J
MF\QF&8?-,,7">1@<(YB(_72(I]:)H<&EI)=PSZ0(955@X!;+VC)V04AR0IV2
M$WK2!6$TFD5!G[U$H' >!L?8)6+?9G;+.&R>*1;.P^ 8P43OIP,]E1ZT@L.E
M"!*1Q#(3Y/_)95WLDI!DACHE,_0DS]JI42W*B\U?,=AA.@J.D4WDO\ULGW'8
MQ%,LG(?!,8+)%4 Z\E-KR=#T8KM@?R>IS!7A_0JIS-K812))%75*JN@I+7E*
M=(OR.O,7"W:HCH)C/)-K 9O9/^.P6:A8. ^#8P23JX!T&*C6C:'GA0]B+J4B
MWK!>*FHCJ4F.)(TZ)6DT[,/4/O8*VOS%@)V>H^"F;)+H4^=R6V6P":A8. ^#
M8P03O9^. %6ZS84&%UMU?,<9L<RY8#XJE=DRXM]V)&74*2FC\9[[-:$NRJO-
M7S+8@3H*CK%-Q+_+[9[!QJ-BX3P,CA%,!'\Z'U3K2<'Q4O&M9"[%,L=]WUXN
MJV,&&A)!ZI0(TF1/GA;RHKS$_'6"':RCX!C%1/*[W 8:;$@J%L[#X!C!1.NG
M4T*U1@PM+Q6?P5R*52YLPW12$SL#(J:5%-*P"T^,>U& YR\-["@=!<>()3+?
MY?;-8"-2L7 >!C<EF$2DNG1&J-)[9>AUL;8-FD\H,UVP\[U<%MOJPI$84J?$
MD)[4?NGL%^4E9J\3*)R'P3&*B?8O<_MGL%&J6#@/@V,$$[F?SA+5&E'PO 3/
M,TE5I@L>IY"PBMC="I)5ZI2LTE.[,!D$H[S(_&6"':*CX!C)1.^7N6TTV"Q5
M+)R'P3&"B=I/AXEJ?2AD,)7!8%2H<N%C36)5[,X]"2MU2ECIJ7UX6BJ,\FKS
MUPMVCHZ"8VP3Z5_F=M-@,U:Q<!X&QP@FEP#ID%&M(1\/KDD3-27?>D:JJH,'
M?:6JRL7N&3Z$F+(?$<6J1(+^P_SSV\W5^OYZZ,^A71>KVX'#P_ZXA([??ONG
M'[Z]7'Q<;8ZKZ*;?7"\7U_W5:K\:&OE8\]UR=_7ID65;6+/8;AX.N]KN'S&N
MMIN/JYO[W6ISL]@.?PON]X?M[7#X\.WR[FX]K,[# +78;S\>/A__&-SO^^O%
M\*F\7+Q__M&P<H?OAM_GZJI?_/;]<OG^=\."WBTW-_UMOSDLEIOKXRN]N=NM
MUN$[61Z&OST?[A]>9:CZT&_ZCZOAO1VVB[M^M]I>/[S-_2/\[X\O-C!Q-1SR
M^#Z^WQ[Z1] W+^U+\_)XW.,);O;;]>IZ>1CJCO1LKA[NLAZ?T#R^J_WBXW"Z
MQ\I?^N5N,1 WU/G^JK_]T.\> 9WY_>+X3E]*R_-B_ZGO#WYY6+Y^-?R]O.DO
MA[^,^\>_I<>_U.2GBUW_<?A%FZ_>V!<7P<^_,5^]-<+/O?WJK50_+)CBJ[?'
M127^FSG^VP/>Q?BV7K^Z&];&L!1N5L.J6/<?A[=8O#SNTKQ;W7SZ\LUA>_?U
MBV$U?M@>AD7P\.6G?GG=[XX%P[]_W YD/WUS?('/V]V_'FAX_?]02P,$%
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M#WVT+^IBU?PPQ7U1RXG1_+D0\4R42B#?GQ=R #8OU =L?V[EZG]02P,$%
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MJ[&0!:FTQEF3_)LZ>=B3O _!>UJ*%0=WY9S,VP1CV8E].^!3.]Y )V-"L@N
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MI@#R^P65C6X.U 7V_T=@^B]02P,$%     @ +E-85JQL.*'V!   [1<  !H
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M!+O#T8:X"CK9A3*8=O!6-J,=F]".==)@G3BQGFLTGSA)R^1N:\\&;V*!-^K
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MF*C*Y]79<C60K"B/9Q^8E"PK+Q."8\*U@7J^8DQN!WJ"YH1_^1]02P,$%
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M]J26Q3M9%O+ +8M+UMA(H61!"(<CZW D-VO'EL7F<CZR8)&C[&4;G_AP+TL
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M3_4/HHE/^KE[,GV=IY,DFY;!HXU4'CL?11Q7:%UJ9I$*%HHJ#/Z$\T]D3 E
M)][!J.*P$P?M9).2CSH?79M!'2.U+BES007+014&@\(Y*#*N!* '[RQ4<>B)
M@WKRDZB\BNN)>0D$T1@J3D-1L$A481 IG)$BHTP  O&.114#HB@'$67[R/%7
MFM\T;YW$1>K@4$&Z0H9'41J6B2H(*44Q5(J2B2;'5X7VSD45XZ(H!QAEJXIW
MR^]F?I,OBZF/,B#='R.E* T+1Q6$GZ(80$7)G!. ,KP#4L5H*<J!2]E[$/T[
M+Z8F<+R)XABS=7&9#6I8/*H@,!7%:"I*AIX E.&]J%,Q=(IRL%.V]XS-&KY+
M)\1,'J\UTI!Y'^'"40A+13&8BI*9)\=7!?E3+ADY13G0*9N&Y%5>F&2:[6\8
M<XM$'KYUG3GX$DB^A#@BPZTHF8H"$(E_'LK8*LH!5]GG6RTZP8].7O_GT :D
M"62\%46X3!1"8E$,Q:)D8@I &_Z9*..N* =XY6$'>YVOPM%RT?E/YT/G@T,C
MD#Z0,5D4X=)1")Y%,3Z+DC$J 'BN?SK*8"S*06/96S+L>_^01VU=7F:.(2X1
MA7!:% .U*)FG M"&?R(:<ORS5R)Z7>239967P:MF9^K8+.O'D/I/[R:Q0R.0
MOI 16U2(2TDA@!;%""U*!JD -.*?DC(<BW+P6/[Y_/$D*#N%^^8!:0L9GT6%
MN'04@FI1C-6B9*0*0!C^Z2@#LR@'F>7AP\?5#S.>K07BX+1#&D0&;%$]7$X*
M8;@H!G%1,FOE^/KH^>>DC-BB',B6C;E\S.?UE>-@]%'>RNH8KG5=F1OV<!$I
MA."B>OR4A!-'I#W_B)3Q6I0#V/+PIK'3A\>[;O+@K:O,S+"'RTHA<!?%Z"Y*
MAK  ).*?E3*4BW*P7/8"C\]O[8H.KS4_\O"M3P%AQACAHE,(]$4QZHN2X2S'
M%TGD'YU&S ,CV0/W8#I>PI"';%U;YH@1+BZ%\%\4 \ HF=,"$(9_7,IH+\J!
M>]G</4;W634S:7R3-S<0Y_HO>=#6U>5'!P'/#H*X(B/"*!G< I"&?UK*\"_*
MP7_9NV=85W&J ](1,BB,BG Y*001HQ@C1LDH%\#A4OXY*0/"* <1YN&3:7/C
M\/$5>>#6%69FV,=%I1!DC&+,&"6C70#R\(]*&2!&.0@Q%Q^";4.[+,O$D8S*
M@[6N*K/!/BX9A1!D%$/(*)GT I"$?S+:YX?F';I^]-T[QTX5><36I64>V,<%
MHQ"$C&(,&26C7@"Z\ ]&&3!&.8@QVU/)+AWG%$):/0:-40-<" IAR"@&D5$R
MZ^7X6ACXAZ",&*,<R)B],./1:)F4I7D<C.13"QW#MJXO\[L!+@R%,&04@\@H
MF?4"$(=_&,J(,<J!C/G9^O++."Y6R)XT->-J67_ZNA%)4=T'E\UVR)E#-Y!>
MD!%FU "7D$(H,VK CY@]<4(Z\$](&5-&.: R&X-YD\;CYJ$TOD^".Q-\2IIG
MD"IPHN <P[<^(I<YY!"7D$*H,XIA9Y1,ASF^2(;^"2ECS"@'9&9OW<]%F1R@
M$'GLUD5FOCG$1:40#(UB'!HEXV( "O&/2AET1CFH,]O]D/$T3;X&GXMEEIHB
MV64>HZ3X:BKYR#S')5K7FGGH$!><0K@TBH%IE,R/ 0C%/SAE%!KEP-!LGU,^
MS4P1+U;+P]9KQL:5?4^N6;V>F:*<)8M:,I^SM8:J>M*_F"KFG'9^4#OPI';,
M4>W\K/93'];N?UH[H]1H!Z5FV_>\R<8='U4XQFM=6,UFC#NP'<*GT8Q/HV6(
M#$ 5_H>V,Q*-=I!H-L;S>12,ZB(D8W.(0!"]I69\&MW%G>8. =5H!JK1,DT&
M(!#_$]T9DD8[D#3[2T":Y]5UMNHA$,CY[@Q4H[NX$]XAO!K->#5:ALH !.(=
ML6I&IM$.,LW5+*[J*C[QOV_( [:M+*/4: 5+6S4$3Z,9GD;+#)GCRT)YIZV:
M@6BT T2SN6$L;[SO%O* K2O+O%#!<E8-H=1H1JG1,DH&( OOG%4S'HUV\&BV
M_<M57BSR8K6]UD\<B/Y0,T*-5K P=3OTL2?/?%#&R #$X1VF:L:BT0X6S5Y.
MYF\HD!:0T6FTAH6H&@*JT0Q4HV6:S/'%H;U#5,V0--J!I/D2?V]:%'/ @X8\
M8NO2,A/4L.A40S UFF%JM,R2 >C".SK5#$BC'4":RR2_,XV3W!T@#$CSQ_ T
M6L.B4@VAU&A&J=$R2@8@#.^H5#,>C7;P:)@P#NI:Y6%;UY?9H(:EH1H"J]$,
M5J-EHLSQQ4'^:2C#TF@'EH:)@T7I!X1?\OBM"\W\D'#I*(16HQFM1LM(&8!*
M_--1QJ71#B[-]7I"2=R<#KQ8KU7W5PBD)62X&DVX>!3"K-&,6:-EL Q (?[Q
M**/3: >=9KL0N:Y!7(QGM3KNFJGZ>HT\>NLR,Y,D7$(*8=9HQJS1,E@&H!'_
MA)31:;2#3F,/&-]:CMWOXJD3^0IM2\W0-3K$1:80?HUF_!HM0V:.KY/0/S)E
MI!KM(-5\O/[8O!'WKIKX&8P\7.NZ,GL,<8$I!%BC&;!&RU09@"C\ U.&IM$.
M-,W;>#+/L]T=XX#T0QZX=869-X:XR!2"K=$,6Z-EM@Q 'OZ1*0/4: >@9B,/
M%J<_\3<52*_(L#6ZAXM-(=P:S;@U6H;+'%\@/?_8E!%JM(-0<S%?9LEW+SW(
M([4N*3/ 'BXNA2!K-$/6:)DK ]"#?US*X#3: :=9[<;/B^\K(_&3!:059* :
MW<.%I1!,C6:8&BVS9 "R\ ]+&9!&.X TGXHX*]/FO,"Z33E &Y 6D!%J= ^7
ME4+H-)K1:;2,D#F^-B+_K)1Q:+2#0[.//<Z7U2RXN"V2<1P\NJ[NMX<Z?:AF
MIJAGN,RJXI<SA/2"$?/#"!>;1A"#9-0:+:-E (+QCTT9GT8[^#3[!Q:GT]_^
MI8G^K*OL*Q-(=\C8-3K"9:<0@HUF!!LM8V8 ,O'/3AFK1CM8-=O-V45\D\1!
M[4!-A]N<0UK/Y)[Q/KP$ ^D7&=%&1[@@%0*UT0QJHV7R#$ P#X/4;J??^X5F
M&,%&.P@V^[>68MI\D#7,PHN.IU;D2[0M-^/;Z#XN3(40;C0CW&@90W-\K?3]
MPU3&LM$.ELUVH>'$M!0)I)]DE!O=QX6K$.:-9LP;+8-I "+Q#U<9W48[Z#8/
ML3'_U,IG;[5 VDP&P-%]7-8*(>%H1L+1,JX&H!;_K)4Q;[2#>;-_N"T[ZJ.Z
M/Z 'DB_3MMZ,BJ,'N-P5@LK1#)6C99[-\<4R\,]=&11'.Z X^P\JR[(JXK1^
MSCU,*_)56I>;^>@ E\E"R#F:D7.TC+<!:,4_DV6,'.U@Y&P:H?=FDII[?O)'
MW"@E]I4*I.UD#!T]P.6T$%B.9K <+1-M %+QSVD9%D<[L#A[MY6K.(LGNS5I
M7BJ!])J,F*,'N,060LO1C):C9:3-\54R]$]L&1='.[@X>QMI#HM2Y+%;%YE9
MYQ 7T4)H.9K1<K2,M $HQ#^B95P<[>#BO#=U/9??MS>0W8*TS^^N@D?K3S[V
MU0NDV63P'#W$9;40:(YFT!PMDVT >O'/:AD>1SOP.'N^,S'!U2Q)S2&)BGR%
MUJ5FWCG$1;001(YFB!PM<VP .O%>ZTH,AD,.&,[&>1Z]CK/ICUF^?+Q!O&^>
M9]/ZD27O//%O@!S7:UEX8MP<ZL+"6H(@=(@A=$CFW!Q=-=OK>:F&V#2]SJ=Z
M5-]3LMIWUHOHY_6MYF"U(#I.8CP=ZL)26X+P=(CQ=$B&W@#4XIW:$B/GD(.<
MLU7+I4G^IWYH^>DMY@#)(#I/8H0=ZL*B6X(0=H@1=DC&X  DXQW=$F/ID(.E
ML]<0729YFD^;"A]Z?T$TH,1H.Z1@T2U!N#O$N#LDPW&.+Q;E'=T2(^R0@[ S
MFIGL1_UK>\K$XI^J&:]!T&ODXE5^B'SD"[?^"3"C5; TER!\'F)\'I(A.@#Y
M>*>YQ$@\Y"#QC&;UL^\L;H[;K'\WV73/GP[5#*)#)8;L(06+=0F"[2&&[2&9
MK0/0C'>L2PS00PY SU\FNXV+ [IIQX"M*\LL5<%R7(( >X@!>TBFZAQ?%MH[
MQR6&YB$'FN<GJ4MM0?.;Y)"E+(Z+M*XV,U0-"W0)PO AQO A&;0#D(IWH$N,
MUD,.6L^>5-[FA8F;I]L#G$:^0NM2,^?4L""7($@?8D@?DKD[ )UX![G$X#WD
M@/?LOS7DKPY(J\EX/J1A\2U!F#[$F#XD@W< ZO"/;QF]AQSTGLV"N)E=VK2^
MD?B_P>RX0MM2,[0/$2ZPA5!]B%%]2$;O'%\GY!_8,GX/.?@]>V[SUS*]#5[]
MYZ6O1""=)./Z$.%26@C6AQC6AV3V#D B_BDM _B0 ^"S,9J7T_M%Y:L+2+?(
M:#Y$N"@6@O(AAO(AF;<#T,7Z>DUL6-E=',/AX%?B8';H(/<\7'B]ULD:7>"E
M%4@+R:@^%.*26 C.AQC.AV3FSO&U$OHGL0S<0PYPS^8>\CK/IK^_K?]WV$HF
MQ^BMR\QL,L3%K1"Z#S&Z#\D('H!&_.-6QO$A!\=G>P)?5E?V4'U >D8&]Z$0
M%ZU"\#[$\#XD,W@ ^NC_S&^B;O@KD3!O=-!\MC<2ZS=KO5P7R5T#/3A0-Y!N
MDE%_*,1EKQ#J#S'J#\EHGN/K9G.]!\\IPU_HAD%^R 'YV>MSWI1%W&QE[_V9
M'I"<R-=H77%FHSU<_@J! A&# I%,[@'(Q3]_9?@?<N!_-G>8MYVWOD&)/&#K
MRC+G[.'B5@@4B!@4B&1R#T 6_G$KP_^0 _\S&EVOUI@<<+> ])$,!40]7,X*
MX0$1XP&1#.T!R,(_9V7D'W*0?_;/HG\?I_%]F<2/@]&+OSO!Y>L7OG<1^4)M
M*\[H0!3AXE8(#8@BYHS1B>/6R#]N9=P?<G!_]N3R/B[RL:\^(&TD@P%1A,M:
M(1@@8A@@DED] 'WX9ZT,^$,.X,_#=0+OS?=DG*]7"33+!CI?O&\HD+Z288$H
MPH6P$ P0,0P0R:P>@&#\U\,RX \Y@#][[P*WD0FDC60D(.KC\E<( 8@8 8AD
M3,_Q9=+WSU\9ZX<<K)^+'Y49Q\&7>+S,XO))&YW(5VA=:N:=?5P&"X$ $8,
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MO\WS:ON'Y@+?\N+K:GK/_Q]02P,$%     @ +E-85MS,)R[3 P  S!   !H
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M@C03\/Y*"/W2,0M4?V!,_@=02P,$%     @ +E-85DZ Y.(P!   K X  !H
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M=GH/#['/;\J*,E7:/81Z,V&H6+$E!T*U!M.[*QK"Q!':(_UQ?C8<#:?^XZY
MSYW"BVC?9_'<)XZ#SF<OG5&7SNA@.BF7F:$&^N(^B'SK C@FV>)(9'N*)9UB
MR?^TX9)CZGU,LL61R/;T/N_T/C^X0N]15*4I)[24M3!]PC4$HYU]$87/-MC!
M6=XJR)'(]@09=X*,CWT"C9\?+LDH?"+0P5G?*M"1R/8$NO">&,+@;_\3'-0,
MO[4W(N-U#IJ8-6Y"U###G8H"VN'-I_N;:U(P89?9"D1.L0W-F.V3G<\M5=FZ
MB<^V"@1[7PO+I&XX,BD*MJJ5W>Q2M1T=PG%(JXJSC+I^6<O";"@>'+6&W/92
ME#QL353;$2K!,B G#Y0^G!*J%-867*FIR.U,EY5B_'DDU!C%EK6;!;V6(*!@
M&!NV><WAX\+4#?T'.QDJD2&DB>,?:: AO1Q$@W!@<4V"0DO.<OQ Y$X>D3&4
M2-LO1NF..KS$.,\_0!4!V]9U?65#N&VO!GV%]7=:VA+4RMTE-$Z+&[TM;V?N
M+BR7KDU_8K^R%YD>^R*>I'&??3A)AWWVT20=]=F329KTV<\GZ7F??3Q)QSWV
MRXM)>M%G#X/M3<S_JT1SC\/5MV*X$#D4J$HP.,>33C57HV9@9.5Z_Z4TN.[<
MXQJODZ"L [XO)-:W'=@)N@OJ_#]02P,$%     @ +E-85EENQUMX P  L1<
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M]/"'%Z#B<(, A69BQS\<?ZC1T_YV 0K-Q Z >#7Z\.4I(9@ H=@1$  TOI6
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M;^JO?@)02P$"% ,4    "  M4UA6!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( "U36%;.QDQL[@
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( "U36%:97)PC$ 8  )PG   3              "  <P!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ +5-85M*ZA>['!@  XB$  !@
M             ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( "U36%9M<I^'J (  -,(   8              " @0H/  !X;"]W
M;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  M4UA6M(KIV#4)  ![
M,0  &               @('H$0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL
M4$L! A0#%     @ +5-85MF1KN2>"   82H  !@              ("!4QL
M 'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( "U36%:R"Q@]
M_P8  'PA   8              " @2<D  !X;"]W;W)K<VAE971S+W-H965T
M-2YX;6Q02P$"% ,4    "  M4UA6",=G:# 0  #FB@  &
M@(%<*P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ +5-8
M5GQ3[ U- @  ?@4  !@              ("!PCL  'AL+W=O<FMS:&5E=',O
M<VAE970W+GAM;%!+ 0(4 Q0    ( "U36%8/M:CCIPT   M!   8
M      " @44^  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M"  M4UA6"S^6BXP%  #0&0  &               @($B3   >&PO=V]R:W-H
M965T<R]S:&5E=#DN>&UL4$L! A0#%     @ +5-85DG/8#(I P  H@8  !D
M             ("!Y%$  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"
M% ,4    "  M4UA6@3XE6JX4  #Z.0  &0              @(%$50  >&PO
M=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( "U36%;(D*:>Y"0
M /V%   9              " @2EJ  !X;"]W;W)K<VAE971S+W-H965T,3(N
M>&UL4$L! A0#%     @ +5-85N9W<]>:$P  H3H  !D              ("!
M1(\  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  M4UA6
MF(8TC. =  "N;0  &0              @($5HP  >&PO=V]R:W-H965T<R]S
M:&5E=#$T+GAM;%!+ 0(4 Q0    ( "U36%8]VCC8WQT  +=M   9
M      " @2S!  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%
M  @ +5-85DJ>62SN"@  5"(  !D              ("!0M\  'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "  M4UA6]Z-H9 T-  #F)@
M&0              @(%GZ@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+
M 0(4 Q0    ( "U36%;+E# OA L  $@@   9              " @:OW  !X
M;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ +5-85B*,X"\9
M!@  Y0X  !D              ("!9@,! 'AL+W=O<FMS:&5E=',O<VAE970Q
M.2YX;6Q02P$"% ,4    "  M4UA6_C0BAJ0+  !!)@  &0
M@(&V"0$ >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( "U3
M6%;.G\F;V0(  !\(   9              " @9$5 0!X;"]W;W)K<VAE971S
M+W-H965T,C$N>&UL4$L! A0#%     @ +5-85AW*%L'! P  "@@  !D
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M=#(V+GAM;%!+ 0(4 Q0    ( "U36%8@3)\\* D  " 7   9
M  " @:4N 0!X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @
M+5-85D=@2$NA$P  V3L  !D              ("!!#@! 'AL+W=O<FMS:&5E
M=',O<VAE970R."YX;6Q02P$"% ,4    "  M4UA6GWYINUX"  !H!0  &0
M            @('<2P$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4
M Q0    ( "U36%8M + &TQ<  )E2   9              " @7%. 0!X;"]W
M;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ +5-85E2^V_V7"0
M72   !D              ("!>V8! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX
M;6Q02P$"% ,4    "  M4UA6@DG=!)(F  "@@@  &0              @(%)
M< $ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( "U36%9
M:/.)#0T  ,,T   9              " @1*7 0!X;"]W;W)K<VAE971S+W-H
M965T,S,N>&UL4$L! A0#%     @ +5-85G)%J$D8%@  LT$  !D
M     ("!5J0! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "U36%:[?9+HKP0  +<*   9              "
M@43U 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ +5-8
M5HK5_,^@!0  90T  !D              ("!*OH! 'AL+W=O<FMS:&5E=',O
M<VAE970T,"YX;6Q02P$"% ,4    "  M4UA65*B53OX"  #W!@  &0
M        @($!  ( >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0
M   ( "U36%:F_90MEP0  )0*   9              " @38# @!X;"]W;W)K
M<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ +5-85KO(J^7 !0  R0P
M !D              ("!! @" 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q0
M2P$"% ,4    "  M4UA6;JV!8=<"  #H!@  &0              @('[#0(
M>&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( "U36%:\W<^G
M> (  !D&   9              " @0D1 @!X;"]W;W)K<VAE971S+W-H965T
M-#4N>&UL4$L! A0#%     @ +5-85O9_/?1O!0  O0T  !D
M ("!N!," 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    "  M
M4UA6YL)9GL$#  !Y"   &0              @(%>&0( >&PO=V]R:W-H965T
M<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( "U36%9NY>P U1<   %(   9
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M970U,BYX;6Q02P$"% ,4    "  M4UA60. 19 @'  "$%   &0
M    @('ZL0( >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    (
M "U36%;/(R)]V ,   $*   9              " @3FY @!X;"]W;W)K<VAE
M971S+W-H965T-30N>&UL4$L! A0#%     @ +5-85LUAB K7 P  ! H  !D
M             ("!2+T" 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"
M% ,4    "  M4UA6./].8C\*  #O(   &0              @(%6P0( >&PO
M=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( "U36%;!OSR5+0H
M "8<   9              " @<S+ @!X;"]W;W)K<VAE971S+W-H965T-3<N
M>&UL4$L! A0#%     @ +5-85O)BB\(2!@  70X  !D              ("!
M,-8" 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    "  M4UA6
M]SF,5,4%   Y#@  &0              @(%YW ( >&PO=V]R:W-H965T<R]S
M:&5E=#4Y+GAM;%!+ 0(4 Q0    ( "U36%;$<2WV@ 0  *X)   9
M      " @77B @!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%
M  @ +5-85F]UD#66 @  DP8  !D              ("!+.<" 'AL+W=O<FMS
M:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    "  M4UA69\ 9] P#  !M!@
M&0              @('YZ0( >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+
M 0(4 Q0    ( "U36%8]4]49&0,  (8'   9              " @3SM @!X
M;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ +5-85@-#Y-X3
M!   @ @  !D              ("!C/ " 'AL+W=O<FMS:&5E=',O<VAE970V
M-"YX;6Q02P$"% ,4    "  M4UA6+V=<<L,$  !/#@  &0
M@('6] ( >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( "U3
M6%;YMDTM= ,  "\(   9              " @=#Y @!X;"]W;W)K<VAE971S
M+W-H965T-C8N>&UL4$L! A0#%     @ +5-85NY9CND(!P  A1   !D
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M=#<Q+GAM;%!+ 0(4 Q0    ( "U36%;[SIB=P0L  & O   9
M  " @:=* P!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @
M+5-85@_R_ 0,!@  +0\  !D              ("!GU8# 'AL+W=O<FMS:&5E
M=',O<VAE970W,RYX;6Q02P$"% ,4    "  M4UA6,!VN1G8%   C#0  &0
M            @('B7 , >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4
M Q0    ( "U36%9Y^^A4>0,  !T'   9              " @8]B P!X;"]W
M;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ +5-85CP_5NQS!
MO@D  !D              ("!/V8# 'AL+W=O<FMS:&5E=',O<VAE970W-BYX
M;6Q02P$"% ,4    "  M4UA6$(13WDH$   0"0  &0              @('I
M:@, >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( "U36%9E
M_\1?? 0  "T*   9              " @6IO P!X;"]W;W)K<VAE971S+W-H
M965T-S@N>&UL4$L! A0#%     @ +5-85DBKGLEI!0  >PP  !D
M     ("!'70# 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "U36%;=I^K5D0D  /0>   9              "
M@3N9 P!X;"]W;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ +5-8
M5F$I7Z%M!@  FR0  !D              ("! Z,# 'AL+W=O<FMS:&5E=',O
M<VAE970X-2YX;6Q02P$"% ,4    "  M4UA6EPAFO T#  "9#   &0
M        @(&GJ0, >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0
M   ( "U36%9N(#P3OP,  *@6   9              " @>NL P!X;"]W;W)K
M<VAE971S+W-H965T.#<N>&UL4$L! A0#%     @ +5-85G?'K3VJ @  V08
M !D              ("!X; # 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q0
M2P$"% ,4    "  M4UA6\@+7T6L"   '!0  &0              @('"LP,
M>&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( "U36%9%:7ZF
M_P(  *X*   9              " @62V P!X;"]W;W)K<VAE971S+W-H965T
M.3 N>&UL4$L! A0#%     @ +5-85IF:BRZ7 @  Q0<  !D
M ("!FKD# 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX;6Q02P$"% ,4    "  M
M4UA6D)@,XU "  #N!   &0              @(%HO , >&PO=V]R:W-H965T
M<R]S:&5E=#DR+GAM;%!+ 0(4 Q0    ( "U36%8[K+;'*@\  //,   9
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M970Y-RYX;6Q02P$"% ,4    "  M4UA6=61]J!D#  #+!P  &0
M    @(&L] , >&PO=V]R:W-H965T<R]S:&5E=#DX+GAM;%!+ 0(4 Q0    (
M "U36%:ICX;3S"D  $[P @ 9              " @?SW P!X;"]W;W)K<VAE
M971S+W-H965T.3DN>&UL4$L! A0#%     @ +5-85ARY8X-9!0  U2,  !H
M             ("!_R$$ 'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&UL4$L!
M A0#%     @ +5-85L@^2IZ#$0  ?Y,  !H              ("!D"<$ 'AL
M+W=O<FMS:&5E=',O<VAE970Q,#$N>&UL4$L! A0#%     @ +5-85CY):E:M
M!   +QT  !H              ("!2SD$ 'AL+W=O<FMS:&5E=',O<VAE970Q
M,#(N>&UL4$L! A0#%     @ +5-85AJ&_H// @  ^0<  !H
M ("!,#X$ 'AL+W=O<FMS:&5E=',O<VAE970Q,#,N>&UL4$L! A0#%     @
M+5-85@>V8N28 @  #0<  !H              ("!-T$$ 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#0N>&UL4$L! A0#%     @ +5-85MPKC(&:"0  KDT  !H
M             ("!!T0$ 'AL+W=O<FMS:&5E=',O<VAE970Q,#4N>&UL4$L!
M A0#%     @ +5-85I%]TDBE P  M0\  !H              ("!V4T$ 'AL
M+W=O<FMS:&5E=',O<VAE970Q,#8N>&UL4$L! A0#%     @ +5-85M'QT-I9
M P  *0H  !H              ("!ME$$ 'AL+W=O<FMS:&5E=',O<VAE970Q
M,#<N>&UL4$L! A0#%     @ +5-85K8TFA'@"0  S6H  !H
M ("!1U4$ 'AL+W=O<FMS:&5E=',O<VAE970Q,#@N>&UL4$L! A0#%     @
M+5-85N9@,2^B#0  #6@  !H              ("!7U\$ 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#DN>&UL4$L! A0#%     @ +5-85M]DD/S1#0  +I0  !H
M             ("!.6T$ 'AL+W=O<FMS:&5E=',O<VAE970Q,3 N>&UL4$L!
M A0#%     @ +5-85L_?G>A)!0  =10  !H              ("!0GL$ 'AL
M+W=O<FMS:&5E=',O<VAE970Q,3$N>&UL4$L! A0#%     @ +5-85M\*-L^_
M!   $Q4  !H              ("!PX $ 'AL+W=O<FMS:&5E=',O<VAE970Q
M,3(N>&UL4$L! A0#%     @ +5-85@\*8KB>!@  :S8  !H
M ("!NH4$ 'AL+W=O<FMS:&5E=',O<VAE970Q,3,N>&UL4$L! A0#%     @
M+5-85O+M=V*W!P  W$   !H              ("!D(P$ 'AL+W=O<FMS:&5E
M=',O<VAE970Q,30N>&UL4$L! A0#%     @ +5-85BR(-ZAF!0  720  !H
M             ("!?Y0$ 'AL+W=O<FMS:&5E=',O<VAE970Q,34N>&UL4$L!
M A0#%     @ +5-85O,WW!J)!   ZQH  !H              ("!'9H$ 'AL
M+W=O<FMS:&5E=',O<VAE970Q,38N>&UL4$L! A0#%     @ +5-85C?-P=)\
M P  > H  !H              ("!WIX$ 'AL+W=O<FMS:&5E=',O<VAE970Q
M,3<N>&UL4$L! A0#%     @ +5-85AU^;K^. @  C@<  !H
M ("!DJ($ 'AL+W=O<FMS:&5E=',O<VAE970Q,3@N>&UL4$L! A0#%     @
M+5-85D)CG@//!@  PBL  !H              ("!6*4$ 'AL+W=O<FMS:&5E
M=',O<VAE970Q,3DN>&UL4$L! A0#%     @ +5-85G: 49%P$@  PO<  !H
M             ("!7ZP$ 'AL+W=O<FMS:&5E=',O<VAE970Q,C N>&UL4$L!
M A0#%     @ +5-85LUOQZ+! P  "PP  !H              ("!![\$ 'AL
M+W=O<FMS:&5E=',O<VAE970Q,C$N>&UL4$L! A0#%     @ +5-85FX8_&(E
M!0  _A4  !H              ("! ,,$ 'AL+W=O<FMS:&5E=',O<VAE970Q
M,C(N>&UL4$L! A0#%     @ +5-85G3FR0UF @  - 8  !H
M ("!7<@$ 'AL+W=O<FMS:&5E=',O<VAE970Q,C,N>&UL4$L! A0#%     @
M+5-85K-=^Q;Z P  ; \  !H              ("!^\H$ 'AL+W=O<FMS:&5E
M=',O<VAE970Q,C0N>&UL4$L! A0#%     @ +E-85KZH4?W] @  A@@  !H
M             ("!+<\$ 'AL+W=O<FMS:&5E=',O<VAE970Q,C4N>&UL4$L!
M A0#%     @ +E-85GY"ENGZ P  +A@  !H              ("!8M($ 'AL
M+W=O<FMS:&5E=',O<VAE970Q,C8N>&UL4$L! A0#%     @ +E-85@>Y%7M\
M!   OPT  !H              ("!E-8$ 'AL+W=O<FMS:&5E=',O<VAE970Q
M,C<N>&UL4$L! A0#%     @ +E-85H-DBDU"$   Z,<  !H
M ("!2-L$ 'AL+W=O<FMS:&5E=',O<VAE970Q,C@N>&UL4$L! A0#%     @
M+E-85C0IY4'G!   DA,  !H              ("!PNL$ 'AL+W=O<FMS:&5E
M=',O<VAE970Q,CDN>&UL4$L! A0#%     @ +E-85I9:ZPQ>"0  3T<  !H
M             ("!X? $ 'AL+W=O<FMS:&5E=',O<VAE970Q,S N>&UL4$L!
M A0#%     @ +E-85I#A@G=N P  L0H  !H              ("!=_H$ 'AL
M+W=O<FMS:&5E=',O<VAE970Q,S$N>&UL4$L! A0#%     @ +E-85OBCK+%J
M!   I!X  !H              ("!'?X$ 'AL+W=O<FMS:&5E=',O<VAE970Q
M,S(N>&UL4$L! A0#%     @ +E-85IVD.1CN!   5AP  !H
M ("!OP(% 'AL+W=O<FMS:&5E=',O<VAE970Q,S,N>&UL4$L! A0#%     @
M+E-85AIK\6K1 @  -@@  !H              ("!Y0<% 'AL+W=O<FMS:&5E
M=',O<VAE970Q,S0N>&UL4$L! A0#%     @ +E-85@I%ZP'/!   IQT  !H
M             ("![@H% 'AL+W=O<FMS:&5E=',O<VAE970Q,S4N>&UL4$L!
M A0#%     @ +E-85NJ$YS$Y#0  <+0  !H              ("!]0\% 'AL
M+W=O<FMS:&5E=',O<VAE970Q,S8N>&UL4$L! A0#%     @ +E-85DJ;A467
M!   "QL  !H              ("!9AT% 'AL+W=O<FMS:&5E=',O<VAE970Q
M,S<N>&UL4$L! A0#%     @ +E-85BZ?@6A7!   &!8  !H
M ("!-2(% 'AL+W=O<FMS:&5E=',O<VAE970Q,S@N>&UL4$L! A0#%     @
M+E-85BGMH:/: @  R <  !H              ("!Q"8% 'AL+W=O<FMS:&5E
M=',O<VAE970Q,SDN>&UL4$L! A0#%     @ +E-85LT=[),'!   $A<  !H
M             ("!UBD% 'AL+W=O<FMS:&5E=',O<VAE970Q-# N>&UL4$L!
M A0#%     @ +E-85OF=0!,@!0  _!4  !H              ("!%2X% 'AL
M+W=O<FMS:&5E=',O<VAE970Q-#$N>&UL4$L! A0#%     @ +E-85@AC62L1
M"0  ?#P  !H              ("!;3,% 'AL+W=O<FMS:&5E=',O<VAE970Q
M-#(N>&UL4$L! A0#%     @ +E-85B'IA3N="0  SXT  !H
M ("!MCP% 'AL+W=O<FMS:&5E=',O<VAE970Q-#,N>&UL4$L! A0#%     @
M+E-85DL;V@CP!0  /!X  !H              ("!BT8% 'AL+W=O<FMS:&5E
M=',O<VAE970Q-#0N>&UL4$L! A0#%     @ +E-85N&P&"=T!0  )R,  !H
M             ("!LTP% 'AL+W=O<FMS:&5E=',O<VAE970Q-#4N>&UL4$L!
M A0#%     @ +E-85M?@K9]@!   K@P  !H              ("!7U(% 'AL
M+W=O<FMS:&5E=',O<VAE970Q-#8N>&UL4$L! A0#%     @ +E-85L+%W2DN
M!0  K14  !H              ("!]U8% 'AL+W=O<FMS:&5E=',O<VAE970Q
M-#<N>&UL4$L! A0#%     @ +E-85HWA.3Q$"   KCL  !H
M ("!75P% 'AL+W=O<FMS:&5E=',O<VAE970Q-#@N>&UL4$L! A0#%     @
M+E-85E55SP^;!@  8"<  !H              ("!V60% 'AL+W=O<FMS:&5E
M=',O<VAE970Q-#DN>&UL4$L! A0#%     @ +E-85N4AAM^>#@  _L0  !H
M             ("!K&L% 'AL+W=O<FMS:&5E=',O<VAE970Q-3 N>&UL4$L!
M A0#%     @ +E-85I=A56-V$   C)D  !H              ("!@GH% 'AL
M+W=O<FMS:&5E=',O<VAE970Q-3$N>&UL4$L! A0#%     @ +E-85ME%UY;>
M#0  YN8  !H              ("!,(L% 'AL+W=O<FMS:&5E=',O<VAE970Q
M-3(N>&UL4$L! A0#%     @ +E-85H7V)?_2#0  X'<  !H
M ("!1ID% 'AL+W=O<FMS:&5E=',O<VAE970Q-3,N>&UL4$L! A0#%     @
M+E-85E+#.V<[&P  K& ! !H              ("!4*<% 'AL+W=O<FMS:&5E
M=',O<VAE970Q-30N>&UL4$L! A0#%     @ +E-85C9\M3X3!@  V"$  !H
M             ("!P\(% 'AL+W=O<FMS:&5E=',O<VAE970Q-34N>&UL4$L!
M A0#%     @ +E-85GC R7:3 P  W0X  !H              ("!#LD% 'AL
M+W=O<FMS:&5E=',O<VAE970Q-38N>&UL4$L! A0#%     @ +E-85LV>6J91
M!@  =CH  !H              ("!V<P% 'AL+W=O<FMS:&5E=',O<VAE970Q
M-3<N>&UL4$L! A0#%     @ +E-85J<81=&X P  CA$  !H
M ("!8M,% 'AL+W=O<FMS:&5E=',O<VAE970Q-3@N>&UL4$L! A0#%     @
M+E-85L^+(LV.!P  \#   !H              ("!4M<% 'AL+W=O<FMS:&5E
M=',O<VAE970Q-3DN>&UL4$L! A0#%     @ +E-85A)R4X\5!0  PR4  !H
M             ("!&-\% 'AL+W=O<FMS:&5E=',O<VAE970Q-C N>&UL4$L!
M A0#%     @ +E-85BTZH!?D"@  /%,  !H              ("!9>0% 'AL
M+W=O<FMS:&5E=',O<VAE970Q-C$N>&UL4$L! A0#%     @ +E-85G69#Q9(
M!@  LC$  !H              ("!@>\% 'AL+W=O<FMS:&5E=',O<VAE970Q
M-C(N>&UL4$L! A0#%     @ +E-85AB9,B*I!   FR$  !H
M ("! ?8% 'AL+W=O<FMS:&5E=',O<VAE970Q-C,N>&UL4$L! A0#%     @
M+E-85G6]TU$>!   )PT  !H              ("!XOH% 'AL+W=O<FMS:&5E
M=',O<VAE970Q-C0N>&UL4$L! A0#%     @ +E-85OBPO:P,"0  Y3D  !H
M             ("!./\% 'AL+W=O<FMS:&5E=',O<VAE970Q-C4N>&UL4$L!
M A0#%     @ +E-85@&??J#*#P  IJ@  !H              ("!? @& 'AL
M+W=O<FMS:&5E=',O<VAE970Q-C8N>&UL4$L! A0#%     @ +E-85K3=<A)L
M"   *$X  !H              ("!?A@& 'AL+W=O<FMS:&5E=',O<VAE970Q
M-C<N>&UL4$L! A0#%     @ +E-85MGXE!W- P  2Q8  !H
M ("!(B$& 'AL+W=O<FMS:&5E=',O<VAE970Q-C@N>&UL4$L! A0#%     @
M+E-85AQ@QVO;!@   CD  !H              ("!)R4& 'AL+W=O<FMS:&5E
M=',O<VAE970Q-CDN>&UL4$L! A0#%     @ +E-85E65JA5[#0  A6,  !H
M             ("!.BP& 'AL+W=O<FMS:&5E=',O<VAE970Q-S N>&UL4$L!
M A0#%     @ +E-85EPA&*X6!P  (#(  !H              ("![3D& 'AL
M+W=O<FMS:&5E=',O<VAE970Q-S$N>&UL4$L! A0#%     @ +E-85DG-8LY@
M!0  2R<  !H              ("!.T$& 'AL+W=O<FMS:&5E=',O<VAE970Q
M-S(N>&UL4$L! A0#%     @ +E-85G\.5VS."0  H4H  !H
M ("!TT8& 'AL+W=O<FMS:&5E=',O<VAE970Q-S,N>&UL4$L! A0#%     @
M+E-85D(XL;&+!@  22(  !H              ("!V5 & 'AL+W=O<FMS:&5E
M=',O<VAE970Q-S0N>&UL4$L! A0#%     @ +E-85H6.R26Q @  "@<  !H
M             ("!G%<& 'AL+W=O<FMS:&5E=',O<VAE970Q-S4N>&UL4$L!
M A0#%     @ +E-85JCL<0W@ P  A!4  !H              ("!A5H& 'AL
M+W=O<FMS:&5E=',O<VAE970Q-S8N>&UL4$L! A0#%     @ +E-85I'1^$J-
M!0  MQ4  !H              ("!G5X& 'AL+W=O<FMS:&5E=',O<VAE970Q
M-S<N>&UL4$L! A0#%     @ +E-85DFI9I&! P  ]P\  !H
M ("!8F0& 'AL+W=O<FMS:&5E=',O<VAE970Q-S@N>&UL4$L! A0#%     @
M+E-85O\#..P$"   JU   !H              ("!&V@& 'AL+W=O<FMS:&5E
M=',O<VAE970Q-SDN>&UL4$L! A0#%     @ +E-85OFR@=)9 P  ^0P  !H
M             ("!5W & 'AL+W=O<FMS:&5E=',O<VAE970Q.# N>&UL4$L!
M A0#%     @ +E-85C*;+IN!!@  Z"   !H              ("!Z',& 'AL
M+W=O<FMS:&5E=',O<VAE970Q.#$N>&UL4$L! A0#%     @ +E-85H:"-E92
M!@  !S<  !H              ("!H7H& 'AL+W=O<FMS:&5E=',O<VAE970Q
M.#(N>&UL4$L! A0#%     @ +E-85KAV/C&Y @  S <  !H
M ("!*X$& 'AL+W=O<FMS:&5E=',O<VAE970Q.#,N>&UL4$L! A0#%     @
M+E-85@0S,HDI!0  (!(  !H              ("!'(0& 'AL+W=O<FMS:&5E
M=',O<VAE970Q.#0N>&UL4$L! A0#%     @ +E-85IEMTG@"!P  ;#T  !H
M             ("!?8D& 'AL+W=O<FMS:&5E=',O<VAE970Q.#4N>&UL4$L!
M A0#%     @ +E-85B""Z &O)0  T8@" !H              ("!MY & 'AL
M+W=O<FMS:&5E=',O<VAE970Q.#8N>&UL4$L! A0#%     @ +E-85K^8&<-F
M#0  XIL  !H              ("!GK8& 'AL+W=O<FMS:&5E=',O<VAE970Q
M.#<N>&UL4$L! A0#%     @ +E-85@,;Y[HR'@  YM8! !H
M ("!/,0& 'AL+W=O<FMS:&5E=',O<VAE970Q.#@N>&UL4$L! A0#%     @
M+E-85KPC]2FO!   :1H  !H              ("!IN(& 'AL+W=O<FMS:&5E
M=',O<VAE970Q.#DN>&UL4$L! A0#%     @ +E-85CQ-RKBS!@  MC$  !H
M             ("!C><& 'AL+W=O<FMS:&5E=',O<VAE970Q.3 N>&UL4$L!
M A0#%     @ +E-85BK32?3_(@  M-\" !H              ("!>.X& 'AL
M+W=O<FMS:&5E=',O<VAE970Q.3$N>&UL4$L! A0#%     @ +E-85F):]U6&
M P  <!4  !H              ("!KQ$' 'AL+W=O<FMS:&5E=',O<VAE970Q
M.3(N>&UL4$L! A0#%     @ +E-85I^((3&> P  )A(  !H
M ("!;14' 'AL+W=O<FMS:&5E=',O<VAE970Q.3,N>&UL4$L! A0#%     @
M+E-85E;;.#_X+0  DZT# !H              ("!0QD' 'AL+W=O<FMS:&5E
M=',O<VAE970Q.30N>&UL4$L! A0#%     @ +E-85K(=WB_%"@  -%8  !H
M             ("!<T<' 'AL+W=O<FMS:&5E=',O<VAE970Q.34N>&UL4$L!
M A0#%     @ +E-85C[GK31L P  M@H  !H              ("!<%(' 'AL
M+W=O<FMS:&5E=',O<VAE970Q.38N>&UL4$L! A0#%     @ +E-85EI@"K\Y
M @  Z 4  !H              ("!%%8' 'AL+W=O<FMS:&5E=',O<VAE970Q
M.3<N>&UL4$L! A0#%     @ +E-85GC'K3_B!   G1<  !H
M ("!A5@' 'AL+W=O<FMS:&5E=',O<VAE970Q.3@N>&UL4$L! A0#%     @
M+E-85@0Q6UR$ P  0@D  !H              ("!GUT' 'AL+W=O<FMS:&5E
M=',O<VAE970Q.3DN>&UL4$L! A0#%     @ +E-85FX*[HX>!P  PRL  !H
M             ("!6V$' 'AL+W=O<FMS:&5E=',O<VAE970R,# N>&UL4$L!
M A0#%     @ +E-85C);AOZ !   = T  !H              ("!L6@' 'AL
M+W=O<FMS:&5E=',O<VAE970R,#$N>&UL4$L! A0#%     @ +E-85KL:K[JY
M @  [P<  !H              ("!:6T' 'AL+W=O<FMS:&5E=',O<VAE970R
M,#(N>&UL4$L! A0#%     @ +E-85F0&6"N$ P  0 D  !H
M ("!6G ' 'AL+W=O<FMS:&5E=',O<VAE970R,#,N>&UL4$L! A0#%     @
M+E-85DZ\0R?L!0  'Q<  !H              ("!%G0' 'AL+W=O<FMS:&5E
M=',O<VAE970R,#0N>&UL4$L! A0#%     @ +E-85O0$F>DI!    @P  !H
M             ("!.GH' 'AL+W=O<FMS:&5E=',O<VAE970R,#4N>&UL4$L!
M A0#%     @ +E-85HZ*QHZ? P  O L  !H              ("!FWX' 'AL
M+W=O<FMS:&5E=',O<VAE970R,#8N>&UL4$L! A0#%     @ +E-85K@(E_P.
M P  FPP  !H              ("!<H(' 'AL+W=O<FMS:&5E=',O<VAE970R
M,#<N>&UL4$L! A0#%     @ +E-85FZ\=^KW P  :@\  !H
M ("!N(4' 'AL+W=O<FMS:&5E=',O<VAE970R,#@N>&UL4$L! A0#%     @
M+E-85NVR*[QS @  J@8  !H              ("!YXD' 'AL+W=O<FMS:&5E
M=',O<VAE970R,#DN>&UL4$L! A0#%     @ +E-85I?#:,$G P  0PD  !H
M             ("!DHP' 'AL+W=O<FMS:&5E=',O<VAE970R,3 N>&UL4$L!
M A0#%     @ +E-85@B UAD/ P  -0@  !H              ("!\8\' 'AL
M+W=O<FMS:&5E=',O<VAE970R,3$N>&UL4$L! A0#%     @ +E-85GJR[HB9
M P   Q8  !H              ("!.),' 'AL+W=O<FMS:&5E=',O<VAE970R
M,3(N>&UL4$L! A0#%     @ +E-85NR,"JSH @  G H  !H
M ("!"9<' 'AL+W=O<FMS:&5E=',O<VAE970R,3,N>&UL4$L! A0#%     @
M+E-85AAA4:#%(0  _I<! !H              ("!*9H' 'AL+W=O<FMS:&5E
M=',O<VAE970R,30N>&UL4$L! A0#%     @ +E-85DSP68FN"@  >D4  !H
M             ("!)KP' 'AL+W=O<FMS:&5E=',O<VAE970R,34N>&UL4$L!
M A0#%     @ +E-85K [G !C#0  (WT  !H              ("!#,<' 'AL
M+W=O<FMS:&5E=',O<VAE970R,38N>&UL4$L! A0#%     @ +E-85A,V]R;"
M!   TQD  !H              ("!I]0' 'AL+W=O<FMS:&5E=',O<VAE970R
M,3<N>&UL4$L! A0#%     @ +E-85N1>7(#6!P  +S   !H
M ("!H=D' 'AL+W=O<FMS:&5E=',O<VAE970R,3@N>&UL4$L! A0#%     @
M+E-85JQL.*'V!   [1<  !H              ("!K^$' 'AL+W=O<FMS:&5E
M=',O<VAE970R,3DN>&UL4$L! A0#%     @ +E-85LU$2#EK&@  H2@! !H
M             ("!W>8' 'AL+W=O<FMS:&5E=',O<VAE970R,C N>&UL4$L!
M A0#%     @ +E-85MS,)R[3 P  S!   !H              ("!@ $( 'AL
M+W=O<FMS:&5E=',O<VAE970R,C$N>&UL4$L! A0#%     @ +E-85DZ Y.(P
M!   K X  !H              ("!BP4( 'AL+W=O<FMS:&5E=',O<VAE970R
M,C(N>&UL4$L! A0#%     @ +E-85EENQUMX P  L1<   T
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;72YX;6Q02P4&     .8 Y@#\/P  (R4(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>269
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>270
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>271
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2693</ContextCount>
  <ElementCount>916</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>634</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>46</UnitCount>
  <MyReports>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Coverpage</Role>
      <ShortName>Cover page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated balance sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Consolidatedbalancesheets</Role>
      <ShortName>Consolidated balance sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated income statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Consolidatedincomestatements</Role>
      <ShortName>Consolidated income statements</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated statements of comprehensive income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome</Role>
      <ShortName>Consolidated statements of comprehensive income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated statements of changes in equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity</Role>
      <ShortName>Consolidated statements of changes in equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated statements of changes in equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical</Role>
      <ShortName>Consolidated statements of changes in equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated statements of cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Consolidatedstatementsofcashflows</Role>
      <ShortName>Consolidated statements of cash flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated statements of cash flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical</Role>
      <ShortName>Consolidated statements of cash flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Introduction</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Introduction</Role>
      <ShortName>Introduction</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Basis of preparation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Basisofpreparation</Role>
      <ShortName>Basis of preparation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Summary of significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Summaryofsignificantaccountingpolicies</Role>
      <ShortName>Summary of significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Principal alliances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Principalalliances</Role>
      <ShortName>Principal alliances</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Principal changes in the scope of consolidation in 2022</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022</Role>
      <ShortName>Principal changes in the scope of consolidation in 2022</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020</Role>
      <ShortName>Principal changes in the scope of consolidation in 2021 and 2020</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Property, plant and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Propertyplantandequipment</Role>
      <ShortName>Property, plant and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Goodwill and other intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Goodwillandotherintangibleassets</Role>
      <ShortName>Goodwill and other intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Impairment of intangible assets and property, plant and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Impairmentofintangibleassetsandpropertyplantandequipment</Role>
      <ShortName>Impairment of intangible assets and property, plant and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Investments accounted for using the equity method</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Investmentsaccountedforusingtheequitymethod</Role>
      <ShortName>Investments accounted for using the equity method</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Other non-current assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Othernoncurrentassets</Role>
      <ShortName>Other non-current assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Assets held for sale or exchange and liabilities related to assets held for sale or exchange</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Assetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchange</Role>
      <ShortName>Assets held for sale or exchange and liabilities related to assets held for sale or exchange</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Accounts receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Accountsreceivable</Role>
      <ShortName>Accounts receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Other current assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Othercurrentassets</Role>
      <ShortName>Other current assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Financial assets and liabilities measured at fair value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Financialassetsandliabilitiesmeasuredatfairvalue</Role>
      <ShortName>Financial assets and liabilities measured at fair value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Cash and cash equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Cashandcashequivalents</Role>
      <ShortName>Cash and cash equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Net deferred tax position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Netdeferredtaxposition</Role>
      <ShortName>Net deferred tax position</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Consolidated shareholders??? equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Consolidatedshareholdersequity</Role>
      <ShortName>Consolidated shareholders??? equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Non-controlling interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Noncontrollinginterests</Role>
      <ShortName>Non-controlling interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Debt, cash and cash equivalents and lease liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Debtcashandcashequivalentsandleaseliabilities</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Liabilities related to business combinations and to non-controlling interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Liabilitiesrelatedtobusinesscombinationsandtononcontrollinginterests</Role>
      <ShortName>Liabilities related to business combinations and to non-controlling interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Provisions, income tax liabilities and other liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Provisionsincometaxliabilitiesandotherliabilities</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Derivative financial instruments and market risks</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Derivativefinancialinstrumentsandmarketrisks</Role>
      <ShortName>Derivative financial instruments and market risks</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Off balance sheet commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Offbalancesheetcommitments</Role>
      <ShortName>Off balance sheet commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Legal and arbitral proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Legalandarbitralproceedings</Role>
      <ShortName>Legal and arbitral proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Provisions for discounts, rebates and sales returns</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Provisionsfordiscountsrebatesandsalesreturns</Role>
      <ShortName>Provisions for discounts, rebates and sales returns</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Personnel costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Personnelcosts</Role>
      <ShortName>Personnel costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Other operating income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Otheroperatingincome</Role>
      <ShortName>Other operating income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Other operating expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Otheroperatingexpenses</Role>
      <ShortName>Other operating expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Restructuring costs and similar items</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Restructuringcostsandsimilaritems</Role>
      <ShortName>Restructuring costs and similar items</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Other gains and losses, and litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Othergainsandlossesandlitigation</Role>
      <ShortName>Other gains and losses, and litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Financial expenses and income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Financialexpensesandincome</Role>
      <ShortName>Financial expenses and income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Income tax expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Incometaxexpense</Role>
      <ShortName>Income tax expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Share of profit/loss from investments accounted for using the equity method</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Shareofprofitlossfrominvestmentsaccountedforusingtheequitymethod</Role>
      <ShortName>Share of profit/loss from investments accounted for using the equity method</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Net income attributable to non-controlling interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Netincomeattributabletononcontrollinginterests</Role>
      <ShortName>Net income attributable to non-controlling interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Related party transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Relatedpartytransactions</Role>
      <ShortName>Related party transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Disclosures about major customers and credit risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Disclosuresaboutmajorcustomersandcreditrisk</Role>
      <ShortName>Disclosures about major customers and credit risk</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Segment information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Segmentinformation</Role>
      <ShortName>Segment information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Principal accountants' fees and services</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Principalaccountantsfeesandservices</Role>
      <ShortName>Principal accountants' fees and services</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - List of principal companies included in the scope of consolidation during??2022</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022</Role>
      <ShortName>List of principal companies included in the scope of consolidation during??2022</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Events subsequent to December 31, 2022</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/EventssubsequenttoDecember312022</Role>
      <ShortName>Events subsequent to December 31, 2022</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Summary of significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies</Role>
      <ShortName>Summary of significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Summary of significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTables</Role>
      <ShortName>Summary of significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Summaryofsignificantaccountingpolicies</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Principal changes in the scope of consolidation in 2022 (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022Tables</Role>
      <ShortName>Principal changes in the scope of consolidation in 2022 (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020 (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020Tables</Role>
      <ShortName>Principal changes in the scope of consolidation in 2021 and 2020 (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Property, plant and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PropertyplantandequipmentTables</Role>
      <ShortName>Property, plant and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Propertyplantandequipment</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Goodwill and other intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/GoodwillandotherintangibleassetsTables</Role>
      <ShortName>Goodwill and other intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Goodwillandotherintangibleassets</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Impairment of intangible assets and property, plant and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentTables</Role>
      <ShortName>Impairment of intangible assets and property, plant and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Impairmentofintangibleassetsandpropertyplantandequipment</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Investments accounted for using the equity method (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodTables</Role>
      <ShortName>Investments accounted for using the equity method (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Investmentsaccountedforusingtheequitymethod</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Other non-current assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OthernoncurrentassetsTables</Role>
      <ShortName>Other non-current assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Othernoncurrentassets</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Assets held for sale or exchange and liabilities related to assets held for sale or exchange (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeTables</Role>
      <ShortName>Assets held for sale or exchange and liabilities related to assets held for sale or exchange (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Assetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchange</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Inventories</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Accounts receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/AccountsreceivableTables</Role>
      <ShortName>Accounts receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Accountsreceivable</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Other current assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OthercurrentassetsTables</Role>
      <ShortName>Other current assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Othercurrentassets</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Financial assets and liabilities measured at fair value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueTables</Role>
      <ShortName>Financial assets and liabilities measured at fair value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Financialassetsandliabilitiesmeasuredatfairvalue</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Cash and cash equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/CashandcashequivalentsTables</Role>
      <ShortName>Cash and cash equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Cashandcashequivalents</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Net deferred tax position (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/NetdeferredtaxpositionTables</Role>
      <ShortName>Net deferred tax position (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Netdeferredtaxposition</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Consolidated shareholders??? equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequityTables</Role>
      <ShortName>Consolidated shareholders??? equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Consolidatedshareholdersequity</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Debt, cash and cash equivalents and lease liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Debtcashandcashequivalentsandleaseliabilities</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Liabilities related to business combinations and to non-controlling interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsTables</Role>
      <ShortName>Liabilities related to business combinations and to non-controlling interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Liabilitiesrelatedtobusinesscombinationsandtononcontrollinginterests</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Provisions, income tax liabilities and other liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Provisionsincometaxliabilitiesandotherliabilities</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Derivative financial instruments and market risks (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksTables</Role>
      <ShortName>Derivative financial instruments and market risks (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Derivativefinancialinstrumentsandmarketrisks</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Off balance sheet commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OffbalancesheetcommitmentsTables</Role>
      <ShortName>Off balance sheet commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Offbalancesheetcommitments</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Provisions for discounts, rebates and sales returns (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsTables</Role>
      <ShortName>Provisions for discounts, rebates and sales returns (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Provisionsfordiscountsrebatesandsalesreturns</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Personnel costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PersonnelcostsTables</Role>
      <ShortName>Personnel costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Personnelcosts</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Other operating expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OtheroperatingexpensesTables</Role>
      <ShortName>Other operating expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Otheroperatingexpenses</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Restructuring costs and similar items (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/RestructuringcostsandsimilaritemsTables</Role>
      <ShortName>Restructuring costs and similar items (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Restructuringcostsandsimilaritems</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Financial expenses and income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/FinancialexpensesandincomeTables</Role>
      <ShortName>Financial expenses and income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Financialexpensesandincome</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Income tax expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/IncometaxexpenseTables</Role>
      <ShortName>Income tax expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Incometaxexpense</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Net income attributable to non-controlling interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsTables</Role>
      <ShortName>Net income attributable to non-controlling interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Netincomeattributabletononcontrollinginterests</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Related party transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/RelatedpartytransactionsTables</Role>
      <ShortName>Related party transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Relatedpartytransactions</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Segment information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SegmentinformationTables</Role>
      <ShortName>Segment information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Segmentinformation</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Principal accountants' fees and services (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesTables</Role>
      <ShortName>Principal accountants' fees and services (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Principalaccountantsfeesandservices</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - List of principal companies included in the scope of consolidation during??2022 (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022Tables</Role>
      <ShortName>List of principal companies included in the scope of consolidation during??2022 (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Basis of preparation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails</Role>
      <ShortName>Basis of preparation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Summary of significant accounting policies - Other Intangible Assets not Acquired in Business Combination (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails</Role>
      <ShortName>Summary of significant accounting policies - Other Intangible Assets not Acquired in Business Combination (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Summary of significant accounting policies - Summary of Useful Lives of Property Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails</Role>
      <ShortName>Summary of significant accounting policies - Summary of Useful Lives of Property Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Summary of significant accounting policies - Treasury Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTreasurySharesDetails</Role>
      <ShortName>Summary of significant accounting policies - Treasury Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Summary of significant accounting policies - Provision for Risks (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesProvisionforRisksDetails</Role>
      <ShortName>Summary of significant accounting policies - Provision for Risks (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Summary of significant accounting policies - Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails</Role>
      <ShortName>Summary of significant accounting policies - Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - Summary of significant accounting policies - Share-Based Payment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails</Role>
      <ShortName>Summary of significant accounting policies - Share-Based Payment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Summary of significant accounting policies - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSegmentInformationDetails</Role>
      <ShortName>Summary of significant accounting policies - Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Principal alliances -Collaboration agreements on human therapeutic antibodies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails</Role>
      <ShortName>Principal alliances -Collaboration agreements on human therapeutic antibodies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - Principal alliances - Immuno-Oncology Agreement with Regeneron Pharmaceuticals, Inc. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails</Role>
      <ShortName>Principal alliances - Immuno-Oncology Agreement with Regeneron Pharmaceuticals, Inc. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Principal alliances - Investor Agreement with Regeneron Pharmaceuticals, Inc. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails</Role>
      <ShortName>Principal alliances - Investor Agreement with Regeneron Pharmaceuticals, Inc. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Principal alliances - Alliance Arrangements with Bristol-Myers Squibb (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails</Role>
      <ShortName>Principal alliances - Alliance Arrangements with Bristol-Myers Squibb (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Principal changes in the scope of consolidation in 2022 - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails</Role>
      <ShortName>Principal changes in the scope of consolidation in 2022 - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Principal changes in the scope of consolidation in 2022 - Summary of Provisional Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails</Role>
      <ShortName>Principal changes in the scope of consolidation in 2022 - Summary of Provisional Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020 - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails</Role>
      <ShortName>Principal changes in the scope of consolidation in 2021 and 2020 - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020 - Summary of Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails</Role>
      <ShortName>Principal changes in the scope of consolidation in 2021 and 2020 - Summary of Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - Property, plant and equipment - Schedule of Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails</Role>
      <ShortName>Property, plant and equipment - Schedule of Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0000102 - Disclosure - Property, plant and equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails</Role>
      <ShortName>Property, plant and equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0000103 - Disclosure - Property, plant and equipment - Summary of Off Balance Sheet Commitments Relating to Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PropertyplantandequipmentSummaryofOffBalanceSheetCommitmentsRelatingtoPropertyPlantandEquipmentDetails</Role>
      <ShortName>Property, plant and equipment - Summary of Off Balance Sheet Commitments Relating to Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0000104 - Disclosure - Property, plant and equipment - Summary of Impairment Losses Recognised in Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PropertyplantandequipmentSummaryofImpairmentLossesRecognisedinPropertyPlantandEquipmentDetails</Role>
      <ShortName>Property, plant and equipment - Summary of Impairment Losses Recognised in Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>0000105 - Disclosure - Property, plant and equipment - Summary of Property, Plant and Equipment Leased (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails</Role>
      <ShortName>Property, plant and equipment - Summary of Property, Plant and Equipment Leased (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>0000106 - Disclosure - Property, plant and equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails</Role>
      <ShortName>Property, plant and equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>0000107 - Disclosure - Goodwill and other intangible assets - Schedule of Movements in Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails</Role>
      <ShortName>Goodwill and other intangible assets - Schedule of Movements in Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>0000108 - Disclosure - Goodwill and other intangible assets - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails</Role>
      <ShortName>Goodwill and other intangible assets - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>0000109 - Disclosure - Goodwill and other intangible assets - Schedule of Movements in Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and other intangible assets - Schedule of Movements in Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>0000110 - Disclosure - Goodwill and other intangible assets - Detailed Information for Principal Marketed Products (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails</Role>
      <ShortName>Goodwill and other intangible assets - Detailed Information for Principal Marketed Products (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>0000111 - Disclosure - Goodwill and other intangible assets - Amortization of Softwares Recognized in Income Statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails</Role>
      <ShortName>Goodwill and other intangible assets - Amortization of Softwares Recognized in Income Statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>0000112 - Disclosure - Impairment of intangible assets and property, plant and equipment - Schedule of Allocation of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails</Role>
      <ShortName>Impairment of intangible assets and property, plant and equipment - Schedule of Allocation of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>0000113 - Disclosure - Impairment of intangible assets and property, plant and equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails</Role>
      <ShortName>Impairment of intangible assets and property, plant and equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>0000114 - Disclosure - Impairment of intangible assets and property, plant and equipment - Summary of Net Impairment Losses of Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails</Role>
      <ShortName>Impairment of intangible assets and property, plant and equipment - Summary of Net Impairment Losses of Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>0000115 - Disclosure - Investments accounted for using the equity method - Summary of Investments in Associates and Joint Ventures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails</Role>
      <ShortName>Investments accounted for using the equity method - Summary of Investments in Associates and Joint Ventures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>0000116 - Disclosure - Investments accounted for using the equity method - Summary of Share of Profit or Loss and Other Comprehensive Income of Associates and Joint Ventures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails</Role>
      <ShortName>Investments accounted for using the equity method - Summary of Share of Profit or Loss and Other Comprehensive Income of Associates and Joint Ventures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>0000117 - Disclosure - Investments accounted for using the equity method - Summary of Principal Transactions and Balances with Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails</Role>
      <ShortName>Investments accounted for using the equity method - Summary of Principal Transactions and Balances with Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>0000118 - Disclosure - Investments accounted for using the equity method - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails</Role>
      <ShortName>Investments accounted for using the equity method - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>0000119 - Disclosure - Other non-current assets - Summary of Other Non-current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails</Role>
      <ShortName>Other non-current assets - Summary of Other Non-current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>0000120 - Disclosure - Other non-current assets - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails</Role>
      <ShortName>Other non-current assets - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>0000121 - Disclosure - Assets held for sale or exchange and liabilities related to assets held for sale or exchange - Summary of Assets Held for Sale or Exchange, and Liabilities Related to Assets Held for Sale or Exchange (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeSummaryofAssetsHeldforSaleorExchangeandLiabilitiesRelatedtoAssetsHeldforSaleorExchangeDetails</Role>
      <ShortName>Assets held for sale or exchange and liabilities related to assets held for sale or exchange - Summary of Assets Held for Sale or Exchange, and Liabilities Related to Assets Held for Sale or Exchange (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>0000122 - Disclosure - Inventories - Schedule of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails</Role>
      <ShortName>Inventories - Schedule of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>0000123 - Disclosure - Inventories - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/InventoriesAdditionalInformationDetails</Role>
      <ShortName>Inventories - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>0000124 - Disclosure - Accounts receivable - Summary of Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails</Role>
      <ShortName>Accounts receivable - Summary of Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>124</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>0000125 - Disclosure - Accounts receivable - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/AccountsreceivableAdditionalInformationDetails</Role>
      <ShortName>Accounts receivable - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>0000126 - Disclosure - Accounts receivable - Summary of Gross Value of Overdue Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails</Role>
      <ShortName>Accounts receivable - Summary of Gross Value of Overdue Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>0000127 - Disclosure - Other current assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OthercurrentassetsDetails</Role>
      <ShortName>Other current assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/OthercurrentassetsTables</ParentRole>
      <Position>127</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>0000128 - Disclosure - Financial assets and liabilities measured at fair value - Summary of Assets and Liabilities Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails</Role>
      <ShortName>Financial assets and liabilities measured at fair value - Summary of Assets and Liabilities Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>128</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>0000129 - Disclosure - Cash and cash equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/CashandcashequivalentsDetails</Role>
      <ShortName>Cash and cash equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/CashandcashequivalentsTables</ParentRole>
      <Position>129</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>0000130 - Disclosure - Net deferred tax position - Summary of Net Deferred Tax Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails</Role>
      <ShortName>Net deferred tax position - Summary of Net Deferred Tax Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>130</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R131.htm</HtmlFileName>
      <LongName>0000131 - Disclosure - Net deferred tax position - Additional information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/NetdeferredtaxpositionAdditionalinformationDetails</Role>
      <ShortName>Net deferred tax position - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>131</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R132.htm</HtmlFileName>
      <LongName>0000132 - Disclosure - Net deferred tax position - Summary of Tax Losses Available for Carry-forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails</Role>
      <ShortName>Net deferred tax position - Summary of Tax Losses Available for Carry-forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>132</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R133.htm</HtmlFileName>
      <LongName>0000133 - Disclosure - Consolidated shareholders??? equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>133</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R134.htm</HtmlFileName>
      <LongName>0000134 - Disclosure - Consolidated shareholders??? equity - Summary of Treasury Shares Held (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofTreasurySharesHeldDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Summary of Treasury Shares Held (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>134</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R135.htm</HtmlFileName>
      <LongName>0000135 - Disclosure - Consolidated shareholders??? equity - Summary of Movements Share Capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Summary of Movements Share Capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>135</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R136.htm</HtmlFileName>
      <LongName>0000136 - Disclosure - Consolidated shareholders??? equity - Principal Characteristics of Restricted Share Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Principal Characteristics of Restricted Share Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>136</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R137.htm</HtmlFileName>
      <LongName>0000137 - Disclosure - Consolidated shareholders??? equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>137</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R138.htm</HtmlFileName>
      <LongName>0000138 - Disclosure - Consolidated shareholders??? equity - Summary of Characteristics of Employee Share Ownership Plans Awarded (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Summary of Characteristics of Employee Share Ownership Plans Awarded (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>138</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R139.htm</HtmlFileName>
      <LongName>0000139 - Disclosure - Consolidated shareholders??? equity - Summary of Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Summary of Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>139</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R140.htm</HtmlFileName>
      <LongName>0000140 - Disclosure - Consolidated shareholders??? equity - Summary of Repurchases Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Summary of Repurchases Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>140</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R141.htm</HtmlFileName>
      <LongName>0000141 - Disclosure - Consolidated shareholders??? equity - Summary of Currency Translation Differences (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Summary of Currency Translation Differences (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>141</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R142.htm</HtmlFileName>
      <LongName>0000142 - Disclosure - Consolidated shareholders??? equity - Summary of Movements within Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Summary of Movements within Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>142</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R143.htm</HtmlFileName>
      <LongName>0000143 - Disclosure - Consolidated shareholders??? equity - Disclosure of Stock Subscription Option Plan Outstanding and Option Exercised (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Disclosure of Stock Subscription Option Plan Outstanding and Option Exercised (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>143</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R144.htm</HtmlFileName>
      <LongName>0000144 - Disclosure - Consolidated shareholders??? equity - Summary of Stock Options Outstanding at Each Balance Sheet Date (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Summary of Stock Options Outstanding at Each Balance Sheet Date (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>144</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R145.htm</HtmlFileName>
      <LongName>0000145 - Disclosure - Consolidated shareholders??? equity - Summary of Options Outstanding and Exercisable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Summary of Options Outstanding and Exercisable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>145</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R146.htm</HtmlFileName>
      <LongName>0000146 - Disclosure - Consolidated shareholders??? equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails</Role>
      <ShortName>Consolidated shareholders??? equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>146</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R147.htm</HtmlFileName>
      <LongName>0000147 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Changes in Financial Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Summary of Changes in Financial Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>147</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R148.htm</HtmlFileName>
      <LongName>0000148 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>148</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R149.htm</HtmlFileName>
      <LongName>0000149 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Disclosure of Movement In Total Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Disclosure of Movement In Total Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>149</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R150.htm</HtmlFileName>
      <LongName>0000150 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>150</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R151.htm</HtmlFileName>
      <LongName>0000151 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Net Debt by Type Valuation of Redemption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Summary of Net Debt by Type Valuation of Redemption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>151</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R152.htm</HtmlFileName>
      <LongName>0000152 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Bond Issues (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Summary of Bond Issues (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>152</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R153.htm</HtmlFileName>
      <LongName>0000153 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Maturity at Value on Redemption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Maturity at Value on Redemption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>153</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R154.htm</HtmlFileName>
      <LongName>0000154 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Interest Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Interest Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>154</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R155.htm</HtmlFileName>
      <LongName>0000155 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate of Net Debt at Value on Redemption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate of Net Debt at Value on Redemption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>155</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R156.htm</HtmlFileName>
      <LongName>0000156 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>156</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R157.htm</HtmlFileName>
      <LongName>0000157 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Currency (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Currency (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>157</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R158.htm</HtmlFileName>
      <LongName>0000158 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Market Value of Net Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Summary of Market Value of Net Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>158</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R159.htm</HtmlFileName>
      <LongName>0000159 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>159</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R160.htm</HtmlFileName>
      <LongName>0000160 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails</Role>
      <ShortName>Debt, cash and cash equivalents and lease liabilities - Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>160</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R161.htm</HtmlFileName>
      <LongName>0000161 - Disclosure - Liabilities related to business combinations and to non-controlling interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails</Role>
      <ShortName>Liabilities related to business combinations and to non-controlling interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>161</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R162.htm</HtmlFileName>
      <LongName>0000162 - Disclosure - Liabilities related to business combinations and to non-controlling interests - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails</Role>
      <ShortName>Liabilities related to business combinations and to non-controlling interests - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>162</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R163.htm</HtmlFileName>
      <LongName>0000163 - Disclosure - Liabilities related to business combinations and to non-controlling interests - Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails</Role>
      <ShortName>Liabilities related to business combinations and to non-controlling interests - Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>163</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R164.htm</HtmlFileName>
      <LongName>0000164 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Non Current Provisions and Other Non-current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Summary of Non Current Provisions and Other Non-current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>164</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R165.htm</HtmlFileName>
      <LongName>0000165 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Movements in Non-current Provisions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Summary of Movements in Non-current Provisions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>165</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R166.htm</HtmlFileName>
      <LongName>0000166 - Disclosure - Provisions, income tax liabilities and other liabilities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>166</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R167.htm</HtmlFileName>
      <LongName>0000167 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Financial and Demographic Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Summary of Financial and Demographic Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>167</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R168.htm</HtmlFileName>
      <LongName>0000168 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Weighted Average Duration of Obligation for Pensions and Other Long-term Benefits in Principal Countries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Summary of Weighted Average Duration of Obligation for Pensions and Other Long-term Benefits in Principal Countries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>168</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R169.htm</HtmlFileName>
      <LongName>0000169 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Sensitivity for Pensions and Other Post-Employment Benefits to Changes in Key Actuarial Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Summary of Sensitivity for Pensions and Other Post-Employment Benefits to Changes in Key Actuarial Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>169</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R170.htm</HtmlFileName>
      <LongName>0000170 - Disclosure - Provisions, income tax liabilities and other liabilities - Reconciliation of Net Amount Recognized in Respect of Pension and Other Post-employment Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Reconciliation of Net Amount Recognized in Respect of Pension and Other Post-employment Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>170</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R171.htm</HtmlFileName>
      <LongName>0000171 - Disclosure - Provisions, income tax liabilities and other liabilities - Net Liability in Respect of Pension Plans and Other Post-employment Benefits by Geographical Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Net Liability in Respect of Pension Plans and Other Post-employment Benefits by Geographical Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>171</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R172.htm</HtmlFileName>
      <LongName>0000172 - Disclosure - Provisions, income tax liabilities and other liabilities - Fair Value of Plans Assets relating to Pension Plans and Other Post-employment Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Fair Value of Plans Assets relating to Pension Plans and Other Post-employment Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>172</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R173.htm</HtmlFileName>
      <LongName>0000173 - Disclosure - Provisions, income tax liabilities and other liabilities - Service Cost for Pension and Other post-employment Benefit Plans, by Geographical Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Service Cost for Pension and Other post-employment Benefit Plans, by Geographical Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>173</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R174.htm</HtmlFileName>
      <LongName>0000174 - Disclosure - Provisions, income tax liabilities and other liabilities - Remeasurement of Net Defined-benefit (Asset)/Liability (Actuarial Gains and Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Remeasurement of Net Defined-benefit (Asset)/Liability (Actuarial Gains and Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>174</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R175.htm</HtmlFileName>
      <LongName>0000175 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Net Pre-tax Actuarial Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNetPretaxActuarialLossDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Summary of Net Pre-tax Actuarial Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>175</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R176.htm</HtmlFileName>
      <LongName>0000176 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Present Value of Pension and Other Post Employment Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Summary of Present Value of Pension and Other Post Employment Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>176</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R177.htm</HtmlFileName>
      <LongName>0000177 - Disclosure - Provisions, income tax liabilities and other liabilities - Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>177</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R178.htm</HtmlFileName>
      <LongName>0000178 - Disclosure - Provisions, income tax liabilities and other liabilities - Estimated Amounts of Employer's Contributions to Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Estimated Amounts of Employer's Contributions to Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>178</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R179.htm</HtmlFileName>
      <LongName>0000179 - Disclosure - Provisions, income tax liabilities and other liabilities - Expected Timing of Benefit Payments under Pension and Other Post-employment Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Expected Timing of Benefit Payments under Pension and Other Post-employment Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>179</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R180.htm</HtmlFileName>
      <LongName>0000180 - Disclosure - Provisions, income tax liabilities and other liabilities - Timing of Future Payments in Respect of Unfunded Pension and Other Post-employment Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Timing of Future Payments in Respect of Unfunded Pension and Other Post-employment Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>180</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R181.htm</HtmlFileName>
      <LongName>0000181 - Disclosure - Provisions, income tax liabilities and other liabilities - Movements in Restructuring Provisions Classified in Non-current and Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Movements in Restructuring Provisions Classified in Non-current and Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>181</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R182.htm</HtmlFileName>
      <LongName>0000182 - Disclosure - Provisions, income tax liabilities and other liabilities - Timing of Future Termination Benefit Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Timing of Future Termination Benefit Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>182</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R183.htm</HtmlFileName>
      <LongName>0000183 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Other Provisions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Summary of Other Provisions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>183</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R184.htm</HtmlFileName>
      <LongName>0000184 - Disclosure - Provisions, income tax liabilities and other liabilities - Current Provisions and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Provisions, income tax liabilities and other liabilities - Current Provisions and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>184</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R185.htm</HtmlFileName>
      <LongName>0000185 - Disclosure - Derivative financial instruments and market risks - Summary of Fair Value of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails</Role>
      <ShortName>Derivative financial instruments and market risks - Summary of Fair Value of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>185</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R186.htm</HtmlFileName>
      <LongName>0000186 - Disclosure - Derivative financial instruments and market risks - Summary of Operating Currency Hedging Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails</Role>
      <ShortName>Derivative financial instruments and market risks - Summary of Operating Currency Hedging Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>186</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R187.htm</HtmlFileName>
      <LongName>0000187 - Disclosure - Derivative financial instruments and market risks - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails</Role>
      <ShortName>Derivative financial instruments and market risks - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>187</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R188.htm</HtmlFileName>
      <LongName>0000188 - Disclosure - Derivative financial instruments and market risks - Disclosure of Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails</Role>
      <ShortName>Derivative financial instruments and market risks - Disclosure of Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>188</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R189.htm</HtmlFileName>
      <LongName>0000189 - Disclosure - Derivative financial instruments and market risks - Disclosure of Actual or Potential Effects of Netting Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails</Role>
      <ShortName>Derivative financial instruments and market risks - Disclosure of Actual or Potential Effects of Netting Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>189</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R190.htm</HtmlFileName>
      <LongName>0000190 - Disclosure - Off balance sheet commitments - Summary of Off Balance Sheet Commitments Relating to Operating Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails</Role>
      <ShortName>Off balance sheet commitments - Summary of Off Balance Sheet Commitments Relating to Operating Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>190</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R191.htm</HtmlFileName>
      <LongName>0000191 - Disclosure - Off balance sheet commitments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails</Role>
      <ShortName>Off balance sheet commitments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>191</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R192.htm</HtmlFileName>
      <LongName>0000192 - Disclosure - Off balance sheet commitments - Summary of Undrawn Credit Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails</Role>
      <ShortName>Off balance sheet commitments - Summary of Undrawn Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>192</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R193.htm</HtmlFileName>
      <LongName>0000193 - Disclosure - Off balance sheet commitments - Summary of Amount of Guarantees Given and Received (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails</Role>
      <ShortName>Off balance sheet commitments - Summary of Amount of Guarantees Given and Received (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>193</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R194.htm</HtmlFileName>
      <LongName>0000194 - Disclosure - Legal and arbitral proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/LegalandarbitralproceedingsDetails</Role>
      <ShortName>Legal and arbitral proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Legalandarbitralproceedings</ParentRole>
      <Position>194</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R195.htm</HtmlFileName>
      <LongName>0000195 - Disclosure - Provisions for discounts, rebates and sales returns - Summary of Movement in Provisions for Discounts, Rebates and Sales Returns (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails</Role>
      <ShortName>Provisions for discounts, rebates and sales returns - Summary of Movement in Provisions for Discounts, Rebates and Sales Returns (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>195</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R196.htm</HtmlFileName>
      <LongName>0000196 - Disclosure - Personnel costs - Summary of Personal Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails</Role>
      <ShortName>Personnel costs - Summary of Personal Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>196</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R197.htm</HtmlFileName>
      <LongName>0000197 - Disclosure - Personnel costs - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PersonnelcostsAdditionalInformationDetails</Role>
      <ShortName>Personnel costs - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>197</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R198.htm</HtmlFileName>
      <LongName>0000198 - Disclosure - Other operating income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OtheroperatingincomeDetails</Role>
      <ShortName>Other operating income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Otheroperatingincome</ParentRole>
      <Position>198</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R199.htm</HtmlFileName>
      <LongName>0000199 - Disclosure - Other operating expenses - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OtheroperatingexpensesAdditionalInformationDetails</Role>
      <ShortName>Other operating expenses - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>199</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R200.htm</HtmlFileName>
      <LongName>0000200 - Disclosure - Other operating expenses - Other Income and Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails</Role>
      <ShortName>Other operating expenses - Other Income and Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>200</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R201.htm</HtmlFileName>
      <LongName>0000201 - Disclosure - Restructuring costs and similar items - Summary of Restructuring Costs and Similar Items (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails</Role>
      <ShortName>Restructuring costs and similar items - Summary of Restructuring Costs and Similar Items (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>201</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R202.htm</HtmlFileName>
      <LongName>0000202 - Disclosure - Restructuring costs and similar items - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/RestructuringcostsandsimilaritemsAdditionalInformationDetails</Role>
      <ShortName>Restructuring costs and similar items - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>202</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R203.htm</HtmlFileName>
      <LongName>0000203 - Disclosure - Other gains and losses, and litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/OthergainsandlossesandlitigationDetails</Role>
      <ShortName>Other gains and losses, and litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Othergainsandlossesandlitigation</ParentRole>
      <Position>203</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R204.htm</HtmlFileName>
      <LongName>0000204 - Disclosure - Financial expenses and income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/FinancialexpensesandincomeDetails</Role>
      <ShortName>Financial expenses and income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/FinancialexpensesandincomeTables</ParentRole>
      <Position>204</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R205.htm</HtmlFileName>
      <LongName>0000205 - Disclosure - Income tax expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails</Role>
      <ShortName>Income tax expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>205</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R206.htm</HtmlFileName>
      <LongName>0000206 - Disclosure - Income tax expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails</Role>
      <ShortName>Income tax expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>206</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R207.htm</HtmlFileName>
      <LongName>0000207 - Disclosure - Share of profit/loss from investments accounted for using the equity method (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails</Role>
      <ShortName>Share of profit/loss from investments accounted for using the equity method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Shareofprofitlossfrominvestmentsaccountedforusingtheequitymethod</ParentRole>
      <Position>207</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R208.htm</HtmlFileName>
      <LongName>0000208 - Disclosure - Net income attributable to non-controlling interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails</Role>
      <ShortName>Net income attributable to non-controlling interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsTables</ParentRole>
      <Position>208</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R209.htm</HtmlFileName>
      <LongName>0000209 - Disclosure - Related party transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/RelatedpartytransactionsAdditionalInformationDetails</Role>
      <ShortName>Related party transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>209</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R210.htm</HtmlFileName>
      <LongName>0000210 - Disclosure - Related party transactions - Schedule of Compensation Paid to Key Management Personnel (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails</Role>
      <ShortName>Related party transactions - Schedule of Compensation Paid to Key Management Personnel (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>210</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R211.htm</HtmlFileName>
      <LongName>0000211 - Disclosure - Related party transactions - Summary of aggregate amounts Payable to Key Management Personnel (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/RelatedpartytransactionsSummaryofaggregateamountsPayabletoKeyManagementPersonnelDetails</Role>
      <ShortName>Related party transactions - Summary of aggregate amounts Payable to Key Management Personnel (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>211</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R212.htm</HtmlFileName>
      <LongName>0000212 - Disclosure - Disclosures about major customers and credit risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails</Role>
      <ShortName>Disclosures about major customers and credit risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/Disclosuresaboutmajorcustomersandcreditrisk</ParentRole>
      <Position>212</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R213.htm</HtmlFileName>
      <LongName>0000213 - Disclosure - Segment information - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails</Role>
      <ShortName>Segment information - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>213</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R214.htm</HtmlFileName>
      <LongName>0000214 - Disclosure - Segment information - Summary of Net Sales by Segment and Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails</Role>
      <ShortName>Segment information - Summary of Net Sales by Segment and Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>214</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R215.htm</HtmlFileName>
      <LongName>0000215 - Disclosure - Segment information - Schedule of Segment Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails</Role>
      <ShortName>Segment information - Schedule of Segment Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>215</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R216.htm</HtmlFileName>
      <LongName>0000216 - Disclosure - Segment information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails</Role>
      <ShortName>Segment information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>216</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R217.htm</HtmlFileName>
      <LongName>0000217 - Disclosure - Segment information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails</Role>
      <ShortName>Segment information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>217</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R218.htm</HtmlFileName>
      <LongName>0000218 - Disclosure - Segment information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails</Role>
      <ShortName>Segment information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>218</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R219.htm</HtmlFileName>
      <LongName>0000219 - Disclosure - Principal accountants' fees and services (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails</Role>
      <ShortName>Principal accountants' fees and services (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesTables</ParentRole>
      <Position>219</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R220.htm</HtmlFileName>
      <LongName>0000220 - Disclosure - List of principal companies included in the scope of consolidation during??2022 - Summary of Principal Companies and their Country of Incorporation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails</Role>
      <ShortName>List of principal companies included in the scope of consolidation during??2022 - Summary of Principal Companies and their Country of Incorporation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>220</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R221.htm</HtmlFileName>
      <LongName>0000221 - Disclosure - List of principal companies included in the scope of consolidation during??2022 - Summary of Principal Investments Accounted for Using the Equity Method (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails</Role>
      <ShortName>List of principal companies included in the scope of consolidation during??2022 - Summary of Principal Investments Accounted for Using the Equity Method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>221</Position>
    </Report>
    <Report instance="sny-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R222.htm</HtmlFileName>
      <LongName>0000222 - Disclosure - Events subsequent to December 31, 2022 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sanofi.com/role/EventssubsequenttoDecember312022Details</Role>
      <ShortName>Events subsequent to December 31, 2022 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sanofi.com/role/EventssubsequenttoDecember312022</ParentRole>
      <Position>222</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill, sny:CapitalLossesUsedAgainstCapitalGainsPercentage, sny:PossibleIncreaseInMortalityTableInYears -  sny-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="20-F" original="sny-20221231.htm">sny-20221231.htm</File>
    <File>a2022-exhibit11.htm</File>
    <File>a2022-exhibit12.htm</File>
    <File>a2022-exhibit121.htm</File>
    <File>a2022-exhibit122.htm</File>
    <File>a2022-exhibit131.htm</File>
    <File>a2022-exhibit132.htm</File>
    <File>a2022-exhibit22.htm</File>
    <File>a2022-exhibit231.htm</File>
    <File>a2022-exhibit232.htm</File>
    <File>a2022-exhibit233.htm</File>
    <File>sny-20221231.xsd</File>
    <File>sny-20221231_cal.xml</File>
    <File>sny-20221231_def.xml</File>
    <File>sny-20221231_lab.xml</File>
    <File>sny-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>sny-20221231_g1.jpg</File>
    <File>sny-20221231_g10.jpg</File>
    <File>sny-20221231_g11.jpg</File>
    <File>sny-20221231_g12.jpg</File>
    <File>sny-20221231_g13.jpg</File>
    <File>sny-20221231_g14.jpg</File>
    <File>sny-20221231_g15.jpg</File>
    <File>sny-20221231_g16.jpg</File>
    <File>sny-20221231_g17.jpg</File>
    <File>sny-20221231_g18.jpg</File>
    <File>sny-20221231_g19.jpg</File>
    <File>sny-20221231_g2.jpg</File>
    <File>sny-20221231_g20.jpg</File>
    <File>sny-20221231_g21.jpg</File>
    <File>sny-20221231_g22.jpg</File>
    <File>sny-20221231_g23.jpg</File>
    <File>sny-20221231_g24.jpg</File>
    <File>sny-20221231_g25.jpg</File>
    <File>sny-20221231_g26.jpg</File>
    <File>sny-20221231_g27.jpg</File>
    <File>sny-20221231_g28.jpg</File>
    <File>sny-20221231_g3.jpg</File>
    <File>sny-20221231_g4.jpg</File>
    <File>sny-20221231_g5.jpg</File>
    <File>sny-20221231_g6.jpg</File>
    <File>sny-20221231_g7.gif</File>
    <File>sny-20221231_g8.gif</File>
    <File>sny-20221231_g9.gif</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3656">http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full</BaseTaxonomy>
    <BaseTaxonomy items="47">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>274
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sny-20221231.htm": {
   "axisCustom": 13,
   "axisStandard": 51,
   "baseTaxonomies": {
    "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full": 3656,
    "http://xbrl.sec.gov/dei/2021q4": 47
   },
   "contextCount": 2693,
   "dts": {
    "calculationLink": {
     "local": [
      "sny-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sny-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sny-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sny-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sny-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sny-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 1837,
   "entityCount": 1,
   "hidden": {
    "http://www.sanofi.com/20221231": 2,
    "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full": 1,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 7
   },
   "keyCustom": 505,
   "keyStandard": 411,
   "memberCustom": 513,
   "memberStandard": 93,
   "nsprefix": "sny",
   "nsuri": "http://www.sanofi.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.sanofi.com/role/Coverpage",
     "shortName": "Cover page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Introduction",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.sanofi.com/role/Introduction",
     "shortName": "Introduction",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i346802ed216643f29cf03ce4f829ef06_I20210914",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020 - Summary of Purchase Price Allocation (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails",
     "shortName": "Principal changes in the scope of consolidation in 2021 and 2020 - Summary of Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i346802ed216643f29cf03ce4f829ef06_I20210914",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0645fdc11d9d433a8306a1a8019152d7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Property, plant and equipment - Schedule of Property, Plant and Equipment (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
     "shortName": "Property, plant and equipment - Schedule of Property, Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0a5f73156d8942cc9aff9b90aa0a20d9_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - Property, plant and equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails",
     "shortName": "Property, plant and equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:InterestCostsCapitalised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:FirmOrdersOfPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - Property, plant and equipment - Summary of Off Balance Sheet Commitments Relating to Property, Plant and Equipment (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofOffBalanceSheetCommitmentsRelatingtoPropertyPlantandEquipmentDetails",
     "shortName": "Property, plant and equipment - Summary of Off Balance Sheet Commitments Relating to Property, Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:FirmOrdersOfPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - Property, plant and equipment - Summary of Impairment Losses Recognised in Property, Plant and Equipment (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofImpairmentLossesRecognisedinPropertyPlantandEquipmentDetails",
     "shortName": "Property, plant and equipment - Summary of Impairment Losses Recognised in Property, Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0645fdc11d9d433a8306a1a8019152d7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RightofuseAssets",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000105 - Disclosure - Property, plant and equipment - Summary of Property, Plant and Equipment Leased (Details)",
     "menuCat": "Details",
     "order": "105",
     "role": "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails",
     "shortName": "Property, plant and equipment - Summary of Property, Plant and Equipment Leased (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ia2a9d85e3600439fa8021956ade9fb27_D20181201-20181231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "sny:NumberOfLeaseAgreementsSigned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000106 - Disclosure - Property, plant and equipment - Additional Information (Details)",
     "menuCat": "Details",
     "order": "106",
     "role": "http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails",
     "shortName": "Property, plant and equipment - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6e1d225964344fc99aa88194ac03758e_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:IntangibleAssetsAndGoodwill",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000107 - Disclosure - Goodwill and other intangible assets - Schedule of Movements in Goodwill (Details)",
     "menuCat": "Details",
     "order": "107",
     "role": "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails",
     "shortName": "Goodwill and other intangible assets - Schedule of Movements in Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0ddd2e8b048c4aceb5e20e5ee54cfd35_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:IntangibleAssetsAndGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Goodwill",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000108 - Disclosure - Goodwill and other intangible assets - Additional Information (Details)",
     "menuCat": "Details",
     "order": "108",
     "role": "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
     "shortName": "Goodwill and other intangible assets - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i3cb82f850b314453a6ec5d1921dc1d46_I20221231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0645fdc11d9d433a8306a1a8019152d7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:OtherIntangibleAssets",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000109 - Disclosure - Goodwill and other intangible assets - Schedule of Movements in Other Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "109",
     "role": "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails",
     "shortName": "Goodwill and other intangible assets - Schedule of Movements in Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:OtherIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Basis of preparation",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.sanofi.com/role/Basisofpreparation",
     "shortName": "Basis of preparation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000110 - Disclosure - Goodwill and other intangible assets - Detailed Information for Principal Marketed Products (Details)",
     "menuCat": "Details",
     "order": "110",
     "role": "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
     "shortName": "Goodwill and other intangible assets - Detailed Information for Principal Marketed Products (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "sny:DisclosureOfPrincipalMarketedProductsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if1da231f2f58464e95b73ab82f7a6ea5_D20220101-20221231",
      "decimals": "2",
      "lang": "en-US",
      "name": "sny:ConcentrationRiskThresholdPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CostOfSales",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000111 - Disclosure - Goodwill and other intangible assets - Amortization of Softwares Recognized in Income Statement (Details)",
     "menuCat": "Details",
     "order": "111",
     "role": "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails",
     "shortName": "Goodwill and other intangible assets - Amortization of Softwares Recognized in Income Statement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i8c6d9f3a64b248be9b5d547fabfe27ba_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:CostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Goodwill",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000112 - Disclosure - Impairment of intangible assets and property, plant and equipment - Schedule of Allocation of Goodwill (Details)",
     "menuCat": "Details",
     "order": "112",
     "role": "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails",
     "shortName": "Impairment of intangible assets and property, plant and equipment - Schedule of Allocation of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "iee7cb4947a1c4854876868c8e2fb82d1_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000113 - Disclosure - Impairment of intangible assets and property, plant and equipment - Additional Information (Details)",
     "menuCat": "Details",
     "order": "113",
     "role": "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
     "shortName": "Impairment of intangible assets and property, plant and equipment - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "sny:PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000114 - Disclosure - Impairment of intangible assets and property, plant and equipment - Summary of Net Impairment Losses of Other Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "114",
     "role": "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
     "shortName": "Impairment of intangible assets and property, plant and equipment - Summary of Net Impairment Losses of Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "sny:DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i4af100e170394112bab4a52fece35962_D20190101-20191231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000115 - Disclosure - Investments accounted for using the equity method - Summary of Investments in Associates and Joint Ventures (Details)",
     "menuCat": "Details",
     "order": "115",
     "role": "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
     "shortName": "Investments accounted for using the equity method - Summary of Investments in Associates and Joint Ventures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0645fdc11d9d433a8306a1a8019152d7_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000116 - Disclosure - Investments accounted for using the equity method - Summary of Share of Profit or Loss and Other Comprehensive Income of Associates and Joint Ventures (Details)",
     "menuCat": "Details",
     "order": "116",
     "role": "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails",
     "shortName": "Investments accounted for using the equity method - Summary of Share of Profit or Loss and Other Comprehensive Income of Associates and Joint Ventures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ic49924175296420b805d168c7336e31d_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i147d77d0cdbc43f8a3861edb09fba518_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000117 - Disclosure - Investments accounted for using the equity method - Summary of Principal Transactions and Balances with Related Parties (Details)",
     "menuCat": "Details",
     "order": "117",
     "role": "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails",
     "shortName": "Investments accounted for using the equity method - Summary of Principal Transactions and Balances with Related Parties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i147d77d0cdbc43f8a3861edb09fba518_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "sny:CommitmentsMadeToJointVenturesAndAssociates",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ie5ceb0532e334611ab935fb0364427b6_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:CommitmentsMadeToJointVenturesAndAssociates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000118 - Disclosure - Investments accounted for using the equity method - Additional Information (Details)",
     "menuCat": "Details",
     "order": "118",
     "role": "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails",
     "shortName": "Investments accounted for using the equity method - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "sny:CommitmentsMadeToJointVenturesAndAssociates",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ie5ceb0532e334611ab935fb0364427b6_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:CommitmentsMadeToJointVenturesAndAssociates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000119 - Disclosure - Other non-current assets - Summary of Other Non-current Assets (Details)",
     "menuCat": "Details",
     "order": "119",
     "role": "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails",
     "shortName": "Other non-current assets - Summary of Other Non-current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Summary of significant accounting policies",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.sanofi.com/role/Summaryofsignificantaccountingpolicies",
     "shortName": "Summary of significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000120 - Disclosure - Other non-current assets - Additional Information (Details)",
     "menuCat": "Details",
     "order": "120",
     "role": "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
     "shortName": "Other non-current assets - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000121 - Disclosure - Assets held for sale or exchange and liabilities related to assets held for sale or exchange - Summary of Assets Held for Sale or Exchange, and Liabilities Related to Assets Held for Sale or Exchange (Details)",
     "menuCat": "Details",
     "order": "121",
     "role": "http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeSummaryofAssetsHeldforSaleorExchangeandLiabilitiesRelatedtoAssetsHeldforSaleorExchangeDetails",
     "shortName": "Assets held for sale or exchange and liabilities related to assets held for sale or exchange - Summary of Assets Held for Sale or Exchange, and Liabilities Related to Assets Held for Sale or Exchange (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000122 - Disclosure - Inventories - Schedule of Inventories (Details)",
     "menuCat": "Details",
     "order": "122",
     "role": "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails",
     "shortName": "Inventories - Schedule of Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:InventoriesPledgedAsSecurityForLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000123 - Disclosure - Inventories - Additional Information (Details)",
     "menuCat": "Details",
     "order": "123",
     "role": "http://www.sanofi.com/role/InventoriesAdditionalInformationDetails",
     "shortName": "Inventories - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:InventoriesPledgedAsSecurityForLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R124": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfCurrentTradeReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CurrentTradeReceivables",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000124 - Disclosure - Accounts receivable - Summary of Accounts Receivable (Details)",
     "menuCat": "Details",
     "order": "124",
     "role": "http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails",
     "shortName": "Accounts receivable - Summary of Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfCurrentTradeReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i4b2466da63bc4da892390e4aed261abc_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:CurrentTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R125": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000125 - Disclosure - Accounts receivable - Additional Information (Details)",
     "menuCat": "Details",
     "order": "125",
     "role": "http://www.sanofi.com/role/AccountsreceivableAdditionalInformationDetails",
     "shortName": "Accounts receivable - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R126": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfOverdueReceivablesGrossValueTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:OverdueReceivablesGrossValue",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000126 - Disclosure - Accounts receivable - Summary of Gross Value of Overdue Receivables (Details)",
     "menuCat": "Details",
     "order": "126",
     "role": "http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails",
     "shortName": "Accounts receivable - Summary of Gross Value of Overdue Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfOverdueReceivablesGrossValueTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ib366bca9838a4f858834d488788aa1aa_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:OverdueReceivablesGrossValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R127": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000127 - Disclosure - Other current assets (Details)",
     "menuCat": "Details",
     "order": "127",
     "role": "http://www.sanofi.com/role/OthercurrentassetsDetails",
     "shortName": "Other current assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R128": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0b12ab871b274e9aa1aa68c28cd74514_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:FinancialAssets",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000128 - Disclosure - Financial assets and liabilities measured at fair value - Summary of Assets and Liabilities Measured at Fair Value (Details)",
     "menuCat": "Details",
     "order": "128",
     "role": "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
     "shortName": "Financial assets and liabilities measured at fair value - Summary of Assets and Liabilities Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ib4cbd6b4a3914b4bb22bc2cb56989463_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:FinancialLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R129": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000129 - Disclosure - Cash and cash equivalents (Details)",
     "menuCat": "Details",
     "order": "129",
     "role": "http://www.sanofi.com/role/CashandcashequivalentsDetails",
     "shortName": "Cash and cash equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfPrincipalAlliancesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Principal alliances",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.sanofi.com/role/Principalalliances",
     "shortName": "Principal alliances",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfPrincipalAlliancesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R130": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DeferredTaxLiabilityAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000130 - Disclosure - Net deferred tax position - Summary of Net Deferred Tax Position (Details)",
     "menuCat": "Details",
     "order": "130",
     "role": "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails",
     "shortName": "Net deferred tax position - Summary of Net Deferred Tax Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DeferredTaxLiabilityAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R131": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000131 - Disclosure - Net deferred tax position - Additional information (Details)",
     "menuCat": "Details",
     "order": "131",
     "role": "http://www.sanofi.com/role/NetdeferredtaxpositionAdditionalinformationDetails",
     "shortName": "Net deferred tax position - Additional information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R132": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:TaxLossesCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000132 - Disclosure - Net deferred tax position - Summary of Tax Losses Available for Carry-forward (Details)",
     "menuCat": "Details",
     "order": "132",
     "role": "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails",
     "shortName": "Net deferred tax position - Summary of Tax Losses Available for Carry-forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:TaxLossesCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R133": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:IssuedCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000133 - Disclosure - Consolidated shareholders\u2019 equity - Additional Information (Details)",
     "menuCat": "Details",
     "order": "133",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:IssuedCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R134": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-4",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfSharesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000134 - Disclosure - Consolidated shareholders\u2019 equity - Summary of Treasury Shares Held (Details)",
     "menuCat": "Details",
     "order": "134",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofTreasurySharesHeldDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Summary of Treasury Shares Held (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-4",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfSharesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R135": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NumberOfSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000135 - Disclosure - Consolidated shareholders\u2019 equity - Summary of Movements Share Capital (Details)",
     "menuCat": "Details",
     "order": "135",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Summary of Movements Share Capital (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0d88a2edb81648e6afc4f83c69c424a9_I20191231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ifrs-full:NumberOfSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R136": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ib0692613954647719cf5a55f8b2600b8_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfYearsServicePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000136 - Disclosure - Consolidated shareholders\u2019 equity - Principal Characteristics of Restricted Share Plans (Details)",
     "menuCat": "Details",
     "order": "136",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Principal Characteristics of Restricted Share Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ib0692613954647719cf5a55f8b2600b8_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfYearsServicePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R137": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ie92c2dbc9c094b098879979d51afa004_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000137 - Disclosure - Consolidated shareholders\u2019 equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details)",
     "menuCat": "Details",
     "order": "137",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ie92c2dbc9c094b098879979d51afa004_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R138": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "sny:DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "sny:PercentageOfAverageOfQuotedMarketPricesOfShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000138 - Disclosure - Consolidated shareholders\u2019 equity - Summary of Characteristics of Employee Share Ownership Plans Awarded (Details)",
     "menuCat": "Details",
     "order": "138",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Summary of Characteristics of Employee Share Ownership Plans Awarded (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "sny:DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "sny:PercentageOfAverageOfQuotedMarketPricesOfShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R139": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:AdditionalInformationAboutSharebasedPaymentArrangements",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i66d14f14ca8849fa99dc8c0918792fb1_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000139 - Disclosure - Consolidated shareholders\u2019 equity - Summary of Expenses (Details)",
     "menuCat": "Details",
     "order": "139",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Summary of Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:AdditionalInformationAboutSharebasedPaymentArrangements",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i66d14f14ca8849fa99dc8c0918792fb1_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Principal changes in the scope of consolidation in 2022",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022",
     "shortName": "Principal changes in the scope of consolidation in 2022",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R140": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "iabf63d973d864585b86699f4855bc32b_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfSharesRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000140 - Disclosure - Consolidated shareholders\u2019 equity - Summary of Repurchases Program (Details)",
     "menuCat": "Details",
     "order": "140",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Summary of Repurchases Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "iabf63d973d864585b86699f4855bc32b_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfSharesRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R141": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EquityAttributableToOwnersOfParent",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000141 - Disclosure - Consolidated shareholders\u2019 equity - Summary of Currency Translation Differences (Details)",
     "menuCat": "Details",
     "order": "141",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Summary of Currency Translation Differences (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "id2b3c17bccc5485fa012a841128e0541_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:EquityAttributableToOwnersOfParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R142": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000142 - Disclosure - Consolidated shareholders\u2019 equity - Summary of Movements within Other Comprehensive Income (Details)",
     "menuCat": "Details",
     "order": "142",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Summary of Movements within Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "iaf9aeb01b7384684be3ef0b4bc47fc8e_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R143": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "id7761f45b2c44f4b874bfeb6104744cb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000143 - Disclosure - Consolidated shareholders\u2019 equity - Disclosure of Stock Subscription Option Plan Outstanding and Option Exercised (Details)",
     "menuCat": "Details",
     "order": "143",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Disclosure of Stock Subscription Option Plan Outstanding and Option Exercised (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "id7761f45b2c44f4b874bfeb6104744cb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R144": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ib674dc57206c4a22a57a7b59b48c8b5d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfShareOutstandingInShareBasedPaymentArrangement",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000144 - Disclosure - Consolidated shareholders\u2019 equity - Summary of Stock Options Outstanding at Each Balance Sheet Date (Details)",
     "menuCat": "Details",
     "order": "144",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Summary of Stock Options Outstanding at Each Balance Sheet Date (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i4927989d9967442c8996bd62b8ad73e2_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R145": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ica46b5f804e3417dad93336ac31a2ecb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000145 - Disclosure - Consolidated shareholders\u2019 equity - Summary of Options Outstanding and Exercisable (Details)",
     "menuCat": "Details",
     "order": "145",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Summary of Options Outstanding and Exercisable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ica46b5f804e3417dad93336ac31a2ecb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R146": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:WeightedAverageShares",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000146 - Disclosure - Consolidated shareholders\u2019 equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "146",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails",
     "shortName": "Consolidated shareholders\u2019 equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R147": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:LongtermBorrowings",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000147 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Changes in Financial Position (Details)",
     "menuCat": "Details",
     "order": "147",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Summary of Changes in Financial Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R148": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:LongtermBorrowings",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000148 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details)",
     "menuCat": "Details",
     "order": "148",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if8cf06b4cc8747228729190e580e0310_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:LongtermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R149": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfChangesInFinancialPositionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0645fdc11d9d433a8306a1a8019152d7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000149 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Disclosure of Movement In Total Debt (Details)",
     "menuCat": "Details",
     "order": "149",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Disclosure of Movement In Total Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020",
     "shortName": "Principal changes in the scope of consolidation in 2021 and 2020",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R150": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfBondIssuesRedeemed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "bond",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000150 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Additional Information (Details)",
     "menuCat": "Details",
     "order": "150",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfBondIssuesRedeemed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "bond",
      "xsiNil": "false"
     }
    },
    "R151": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:InterestRateAndCurrencyDerivativesUsedToManageDebt",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000151 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Net Debt by Type Valuation of Redemption (Details)",
     "menuCat": "Details",
     "order": "151",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Summary of Net Debt by Type Valuation of Redemption (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i9dd9d077d0d74b84a86388ebba38fe7d_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:FinanceLeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R152": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i04c2510d77e942f4ba7a8de27cabcaff_I20131130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:BorrowingsInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000152 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Bond Issues (Details)",
     "menuCat": "Details",
     "order": "152",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Summary of Bond Issues (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i04c2510d77e942f4ba7a8de27cabcaff_I20131130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:BorrowingsInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R153": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:InterestRateAndCurrencyDerivativesUsedToManageDebt",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000153 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Maturity at Value on Redemption (Details)",
     "menuCat": "Details",
     "order": "153",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Maturity at Value on Redemption (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R154": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000154 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Interest Rate (Details)",
     "menuCat": "Details",
     "order": "154",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Interest Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i562d7157b7e8481a9b91191e18e64665_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:IncreaseDecreaseOfBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R155": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000155 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate of Net Debt at Value on Redemption (Details)",
     "menuCat": "Details",
     "order": "155",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate of Net Debt at Value on Redemption (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ia15a0d49ecac416c8e39472c771744ae_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R156": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ic41f4a5b56624a49a78f6fe5ac261c4d_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:ImpactOfChangeInInterestRateOnPreTaxIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000156 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents (Details)",
     "menuCat": "Details",
     "order": "156",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ic41f4a5b56624a49a78f6fe5ac261c4d_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:ImpactOfChangeInInterestRateOnPreTaxIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R157": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfChangesInFinancialPositionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:DebtNetOfCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000157 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Currency (Details)",
     "menuCat": "Details",
     "order": "157",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Summary of Debt by Currency (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ice55484dadfb417dadb944cba1425875_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:DebtNetOfCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R158": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000158 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Summary of Market Value of Net Debt (Details)",
     "menuCat": "Details",
     "order": "158",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Summary of Market Value of Net Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfMarketValueOfNetDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ic291b624a38e421d9afc1f580652e23d_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R159": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000159 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt (Details)",
     "menuCat": "Details",
     "order": "159",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Property, plant and equipment",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.sanofi.com/role/Propertyplantandequipment",
     "shortName": "Property, plant and equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R160": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "sny:DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0645fdc11d9d433a8306a1a8019152d7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:LeaseLiabilities",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000160 - Disclosure - Debt, cash and cash equivalents and lease liabilities - Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "160",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
     "shortName": "Debt, cash and cash equivalents and lease liabilities - Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:LeaseLiabilitiesEffectOfDiscounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R161": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0645fdc11d9d433a8306a1a8019152d7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000161 - Disclosure - Liabilities related to business combinations and to non-controlling interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)",
     "menuCat": "Details",
     "order": "161",
     "role": "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails",
     "shortName": "Liabilities related to business combinations and to non-controlling interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R162": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000162 - Disclosure - Liabilities related to business combinations and to non-controlling interests - Additional Information (Details)",
     "menuCat": "Details",
     "order": "162",
     "role": "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
     "shortName": "Liabilities related to business combinations and to non-controlling interests - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i59afdb4fc3d74ad98a57783363180e8f_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "sny:PaymentToSaleOfBusinessPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R163": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000163 - Disclosure - Liabilities related to business combinations and to non-controlling interests - Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests (Details)",
     "menuCat": "Details",
     "order": "163",
     "role": "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails",
     "shortName": "Liabilities related to business combinations and to non-controlling interests - Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ib7e3b493141f4fa09c383ab24c96a46c_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R164": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNoncurrentProvisionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentProvisions",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000164 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Non Current Provisions and Other Non-current Liabilities (Details)",
     "menuCat": "Details",
     "order": "164",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Summary of Non Current Provisions and Other Non-current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R165": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNoncurrentProvisionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0645fdc11d9d433a8306a1a8019152d7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentProvisions",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000165 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Movements in Non-current Provisions (Details)",
     "menuCat": "Details",
     "order": "165",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Summary of Movements in Non-current Provisions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNoncurrentProvisionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R166": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfCountriesIncludedInPensionPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "country",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000166 - Disclosure - Provisions, income tax liabilities and other liabilities - Additional Information (Details)",
     "menuCat": "Details",
     "order": "166",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfCountriesIncludedInPensionPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "country",
      "xsiNil": "false"
     }
    },
    "R167": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "sny:DisclosureOfActuarialAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000167 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Financial and Demographic Assumptions (Details)",
     "menuCat": "Details",
     "order": "167",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Summary of Financial and Demographic Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "sny:DisclosureOfActuarialAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i5064ea492ff44ec88d332c35c309d9a2_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R168": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "sny:DisclosureOfActuarialAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000168 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Weighted Average Duration of Obligation for Pensions and Other Long-term Benefits in Principal Countries (Details)",
     "menuCat": "Details",
     "order": "168",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Summary of Weighted Average Duration of Obligation for Pensions and Other Long-term Benefits in Principal Countries (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R169": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ia7102fede0d146a4b433b8edd4bfc772_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000169 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Sensitivity for Pensions and Other Post-Employment Benefits to Changes in Key Actuarial Assumptions (Details)",
     "menuCat": "Details",
     "order": "169",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Summary of Sensitivity for Pensions and Other Post-Employment Benefits to Changes in Key Actuarial Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ia7102fede0d146a4b433b8edd4bfc772_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Goodwill and other intangible assets",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.sanofi.com/role/Goodwillandotherintangibleassets",
     "shortName": "Goodwill and other intangible assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R170": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000170 - Disclosure - Provisions, income tax liabilities and other liabilities - Reconciliation of Net Amount Recognized in Respect of Pension and Other Post-employment Benefit Plans (Details)",
     "menuCat": "Details",
     "order": "170",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Reconciliation of Net Amount Recognized in Respect of Pension and Other Post-employment Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0ee8ed8118074d36831eff9b53238052_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R171": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DefinedBenefitObligationAtPresentValue",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000171 - Disclosure - Provisions, income tax liabilities and other liabilities - Net Liability in Respect of Pension Plans and Other Post-employment Benefits by Geographical Region (Details)",
     "menuCat": "Details",
     "order": "171",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Net Liability in Respect of Pension Plans and Other Post-employment Benefits by Geographical Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i3e44f785b99b48ba805fc2c0db8dde02_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:DefinedBenefitObligationAtPresentValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R172": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000172 - Disclosure - Provisions, income tax liabilities and other liabilities - Fair Value of Plans Assets relating to Pension Plans and Other Post-employment Plans (Details)",
     "menuCat": "Details",
     "order": "172",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Fair Value of Plans Assets relating to Pension Plans and Other Post-employment Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "sny:PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R173": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000173 - Disclosure - Provisions, income tax liabilities and other liabilities - Service Cost for Pension and Other post-employment Benefit Plans, by Geographical Region (Details)",
     "menuCat": "Details",
     "order": "173",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Service Cost for Pension and Other post-employment Benefit Plans, by Geographical Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0ee8ed8118074d36831eff9b53238052_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R174": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000174 - Disclosure - Provisions, income tax liabilities and other liabilities - Remeasurement of Net Defined-benefit (Asset)/Liability (Actuarial Gains and Losses) (Details)",
     "menuCat": "Details",
     "order": "174",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Remeasurement of Net Defined-benefit (Asset)/Liability (Actuarial Gains and Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "idbf9dc84bfe14bfe82d15821bafebc7f_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R175": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000175 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Net Pre-tax Actuarial Loss (Details)",
     "menuCat": "Details",
     "order": "175",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNetPretaxActuarialLossDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Summary of Net Pre-tax Actuarial Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R176": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i3e44f785b99b48ba805fc2c0db8dde02_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000176 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Present Value of Pension and Other Post Employment Benefits (Details)",
     "menuCat": "Details",
     "order": "176",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Summary of Present Value of Pension and Other Post Employment Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i083a34cade7349a9809e1628fbacf89d_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R177": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CostOfSales",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000177 - Disclosure - Provisions, income tax liabilities and other liabilities - Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement (Details)",
     "menuCat": "Details",
     "order": "177",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0ee8ed8118074d36831eff9b53238052_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:CostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R178": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ife7c44a9a1e84cb7b6b4f6fe06b1ebab_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000178 - Disclosure - Provisions, income tax liabilities and other liabilities - Estimated Amounts of Employer's Contributions to Plan Assets (Details)",
     "menuCat": "Details",
     "order": "178",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Estimated Amounts of Employer's Contributions to Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ife7c44a9a1e84cb7b6b4f6fe06b1ebab_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R179": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ib7e3b493141f4fa09c383ab24c96a46c_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000179 - Disclosure - Provisions, income tax liabilities and other liabilities - Expected Timing of Benefit Payments under Pension and Other Post-employment Benefit Plans (Details)",
     "menuCat": "Details",
     "order": "179",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Expected Timing of Benefit Payments under Pension and Other Post-employment Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ib7e3b493141f4fa09c383ab24c96a46c_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Impairment of intangible assets and property, plant and equipment",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.sanofi.com/role/Impairmentofintangibleassetsandpropertyplantandequipment",
     "shortName": "Impairment of intangible assets and property, plant and equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R180": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000180 - Disclosure - Provisions, income tax liabilities and other liabilities - Timing of Future Payments in Respect of Unfunded Pension and Other Post-employment Benefit Plans (Details)",
     "menuCat": "Details",
     "order": "180",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Timing of Future Payments in Respect of Unfunded Pension and Other Post-employment Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R181": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0645fdc11d9d433a8306a1a8019152d7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000181 - Disclosure - Provisions, income tax liabilities and other liabilities - Movements in Restructuring Provisions Classified in Non-current and Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "181",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Movements in Restructuring Provisions Classified in Non-current and Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfRestructuringProvisionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "icb5f9e7c6185477aa7f9a156dc214f20_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:NonCurrentProvisionsAndOtherNoncurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R182": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DefinedBenefitObligationAtPresentValue",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000182 - Disclosure - Provisions, income tax liabilities and other liabilities - Timing of Future Termination Benefit Payments (Details)",
     "menuCat": "Details",
     "order": "182",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Timing of Future Termination Benefit Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ib7e3b493141f4fa09c383ab24c96a46c_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:DefinedBenefitObligationAtPresentValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R183": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:NonCurrentProvisionForEnvironmentRisks",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000183 - Disclosure - Provisions, income tax liabilities and other liabilities - Summary of Other Provisions (Details)",
     "menuCat": "Details",
     "order": "183",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Summary of Other Provisions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfOtherLongTermProvisionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:OtherLongtermProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R184": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000184 - Disclosure - Provisions, income tax liabilities and other liabilities - Current Provisions and Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "184",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails",
     "shortName": "Provisions, income tax liabilities and other liabilities - Current Provisions and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R185": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentDerivativeFinancialAssets",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000185 - Disclosure - Derivative financial instruments and market risks - Summary of Fair Value of Derivative Instruments (Details)",
     "menuCat": "Details",
     "order": "185",
     "role": "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails",
     "shortName": "Derivative financial instruments and market risks - Summary of Fair Value of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:CurrentDerivativeFinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R186": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i48e2f84695a246b1b0d8229ae8e26267_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:DerivativeFinancialInstruments",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000186 - Disclosure - Derivative financial instruments and market risks - Summary of Operating Currency Hedging Instruments (Details)",
     "menuCat": "Details",
     "order": "186",
     "role": "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails",
     "shortName": "Derivative financial instruments and market risks - Summary of Operating Currency Hedging Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i2c02fd8df4a441dcb9995176d3a629bf_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:DerivativeFinancialInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R187": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DerivativeFinancialAssets",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000187 - Disclosure - Derivative financial instruments and market risks - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details)",
     "menuCat": "Details",
     "order": "187",
     "role": "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
     "shortName": "Derivative financial instruments and market risks - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "sny:DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ifbad1a772c8243ff9be90c4d20a4e525_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:NotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R188": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i48e2f84695a246b1b0d8229ae8e26267_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000188 - Disclosure - Derivative financial instruments and market risks - Disclosure of Instruments (Details)",
     "menuCat": "Details",
     "order": "188",
     "role": "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
     "shortName": "Derivative financial instruments and market risks - Disclosure of Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i48e2f84695a246b1b0d8229ae8e26267_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R189": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i237b42e7bb904d21a79f9880001b2ae2_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000189 - Disclosure - Derivative financial instruments and market risks - Disclosure of Actual or Potential Effects of Netting Arrangements (Details)",
     "menuCat": "Details",
     "order": "189",
     "role": "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails",
     "shortName": "Derivative financial instruments and market risks - Disclosure of Actual or Potential Effects of Netting Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i237b42e7bb904d21a79f9880001b2ae2_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Investments accounted for using the equity method",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.sanofi.com/role/Investmentsaccountedforusingtheequitymethod",
     "shortName": "Investments accounted for using the equity method",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R190": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000190 - Disclosure - Off balance sheet commitments - Summary of Off Balance Sheet Commitments Relating to Operating Activities (Details)",
     "menuCat": "Details",
     "order": "190",
     "role": "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails",
     "shortName": "Off balance sheet commitments - Summary of Off Balance Sheet Commitments Relating to Operating Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R191": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "sny:CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000191 - Disclosure - Off balance sheet commitments - Additional Information (Details)",
     "menuCat": "Details",
     "order": "191",
     "role": "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
     "shortName": "Off balance sheet commitments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "sny:CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R192": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:UndrawnBorrowingFacilities",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000192 - Disclosure - Off balance sheet commitments - Summary of Undrawn Credit Facilities (Details)",
     "menuCat": "Details",
     "order": "192",
     "role": "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails",
     "shortName": "Off balance sheet commitments - Summary of Undrawn Credit Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ib7e3b493141f4fa09c383ab24c96a46c_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:UndrawnBorrowingFacilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R193": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i2ee6a60b930541f79b2560c7e63bdae3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EstimatedFinancialEffectOfContingentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000193 - Disclosure - Off balance sheet commitments - Summary of Amount of Guarantees Given and Received (Details)",
     "menuCat": "Details",
     "order": "193",
     "role": "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails",
     "shortName": "Off balance sheet commitments - Summary of Amount of Guarantees Given and Received (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i2ee6a60b930541f79b2560c7e63bdae3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EstimatedFinancialEffectOfContingentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R194": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfOtherLongTermProvisionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0645fdc11d9d433a8306a1a8019152d7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:NonCurrentProvisionForProductLiabilityRisksLitigationAndOther",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000194 - Disclosure - Legal and arbitral proceedings (Details)",
     "menuCat": "Details",
     "order": "194",
     "role": "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
     "shortName": "Legal and arbitral proceedings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "id03ce38671d242c5b423a1d25f8c6f7e_I20221206",
      "decimals": "0",
      "lang": "en-US",
      "name": "sny:NumberOfCasesDismissed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R195": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0645fdc11d9d433a8306a1a8019152d7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:ProvisionsForDiscountsRebatesAndSalesReturns",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000195 - Disclosure - Provisions for discounts, rebates and sales returns - Summary of Movement in Provisions for Discounts, Rebates and Sales Returns (Details)",
     "menuCat": "Details",
     "order": "195",
     "role": "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails",
     "shortName": "Provisions for discounts, rebates and sales returns - Summary of Movement in Provisions for Discounts, Rebates and Sales Returns (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "icfa0f3ae5e6c414a899ba5e892823a0e_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:ProvisionsForDiscountsRebatesAndSalesReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R196": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfPersonnelCostsDetailsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:WagesAndSalaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000196 - Disclosure - Personnel costs - Summary of Personal Costs (Details)",
     "menuCat": "Details",
     "order": "196",
     "role": "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails",
     "shortName": "Personnel costs - Summary of Personal Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfPersonnelCostsDetailsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:WagesAndSalaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R197": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NumberOfEmployees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "employee",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000197 - Disclosure - Personnel costs - Additional Information (Details)",
     "menuCat": "Details",
     "order": "197",
     "role": "http://www.sanofi.com/role/PersonnelcostsAdditionalInformationDetails",
     "shortName": "Personnel costs - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NumberOfEmployees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "employee",
      "xsiNil": "false"
     }
    },
    "R198": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:MiscellaneousOtherOperatingIncome",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000198 - Disclosure - Other operating income (Details)",
     "menuCat": "Details",
     "order": "198",
     "role": "http://www.sanofi.com/role/OtheroperatingincomeDetails",
     "shortName": "Other operating income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i91602956c5a04e7d8e221b1a2b3c3fd3_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:GainsOnDivestmentOfProducts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R199": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:MiscellaneousOtherOperatingExpense",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000199 - Disclosure - Other operating expenses - Additional Information (Details)",
     "menuCat": "Details",
     "order": "199",
     "role": "http://www.sanofi.com/role/OtheroperatingexpensesAdditionalInformationDetails",
     "shortName": "Other operating expenses - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.sanofi.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Other non-current assets",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.sanofi.com/role/Othernoncurrentassets",
     "shortName": "Other non-current assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R200": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:MiscellaneousOtherOperatingExpense",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000200 - Disclosure - Other operating expenses - Other Income and Expense (Details)",
     "menuCat": "Details",
     "order": "200",
     "role": "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
     "shortName": "Other operating expenses - Other Income and Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "sny:OtherOperatingExpensesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ie13a4afd7b1b4e79b6db10af437058d8_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:MiscellaneousOtherOperatingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R201": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfRestructuringCostsDetailsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000201 - Disclosure - Restructuring costs and similar items - Summary of Restructuring Costs and Similar Items (Details)",
     "menuCat": "Details",
     "order": "201",
     "role": "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails",
     "shortName": "Restructuring costs and similar items - Summary of Restructuring Costs and Similar Items (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfRestructuringCostsDetailsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R202": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000202 - Disclosure - Restructuring costs and similar items - Additional Information (Details)",
     "menuCat": "Details",
     "order": "202",
     "role": "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsAdditionalInformationDetails",
     "shortName": "Restructuring costs and similar items - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R203": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:OtherGainsLossesAndLitigation",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000203 - Disclosure - Other gains and losses, and litigation (Details)",
     "menuCat": "Details",
     "order": "203",
     "role": "http://www.sanofi.com/role/OthergainsandlossesandlitigationDetails",
     "shortName": "Other gains and losses, and litigation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R204": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:InterestExpenseOnBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000204 - Disclosure - Financial expenses and income (Details)",
     "menuCat": "Details",
     "order": "204",
     "role": "http://www.sanofi.com/role/FinancialexpensesandincomeDetails",
     "shortName": "Financial expenses and income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:InterestExpenseOnBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R205": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000205 - Disclosure - Income tax expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details)",
     "menuCat": "Details",
     "order": "205",
     "role": "http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails",
     "shortName": "Income tax expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R206": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000206 - Disclosure - Income tax expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)",
     "menuCat": "Details",
     "order": "206",
     "role": "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails",
     "shortName": "Income tax expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R207": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000207 - Disclosure - Share of profit/loss from investments accounted for using the equity method (Details)",
     "menuCat": "Details",
     "order": "207",
     "role": "http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails",
     "shortName": "Share of profit/loss from investments accounted for using the equity method (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R208": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProfitLossAttributableToNoncontrollingInterests",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000208 - Disclosure - Net income attributable to non-controlling interests (Details)",
     "menuCat": "Details",
     "order": "208",
     "role": "http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails",
     "shortName": "Net income attributable to non-controlling interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "id4e374af20434124bd68044ee5c3132d_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:ProfitLossAttributableToNoncontrollingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R209": {
     "firstAnchor": {
      "ancestors": [
       "sny:NumberOfExecutiveCommitteeMembers",
       "sny:NumberOfExecutiveCommitteeMembers",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfExecutiveCommitteeMembers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "executives",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000209 - Disclosure - Related party transactions - Additional Information (Details)",
     "menuCat": "Details",
     "order": "209",
     "role": "http://www.sanofi.com/role/RelatedpartytransactionsAdditionalInformationDetails",
     "shortName": "Related party transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "sny:NumberOfExecutiveCommitteeMembers",
       "sny:NumberOfExecutiveCommitteeMembers",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfExecutiveCommitteeMembers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "executives",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Assets held for sale or exchange and liabilities related to assets held for sale or exchange",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.sanofi.com/role/Assetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchange",
     "shortName": "Assets held for sale or exchange and liabilities related to assets held for sale or exchange",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R210": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000210 - Disclosure - Related party transactions - Schedule of Compensation Paid to Key Management Personnel (Details)",
     "menuCat": "Details",
     "order": "210",
     "role": "http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails",
     "shortName": "Related party transactions - Schedule of Compensation Paid to Key Management Personnel (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R211": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000211 - Disclosure - Related party transactions - Summary of aggregate amounts Payable to Key Management Personnel (Details)",
     "menuCat": "Details",
     "order": "211",
     "role": "http://www.sanofi.com/role/RelatedpartytransactionsSummaryofaggregateamountsPayabletoKeyManagementPersonnelDetails",
     "shortName": "Related party transactions - Summary of aggregate amounts Payable to Key Management Personnel (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R212": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i9bd446f69aac4af6a08e76344c48905b_D20200101-20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PercentageOfEntitysRevenue",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000212 - Disclosure - Disclosures about major customers and credit risk (Details)",
     "menuCat": "Details",
     "order": "212",
     "role": "http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails",
     "shortName": "Disclosures about major customers and credit risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i1dd1a6b04c6b4be9b142d30598f7a4f6_D20220101-20221231",
      "decimals": "2",
      "lang": "en-US",
      "name": "ifrs-full:PercentageOfEntitysRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R213": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000213 - Disclosure - Segment information - Additional Information (Details)",
     "menuCat": "Details",
     "order": "213",
     "role": "http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails",
     "shortName": "Segment information - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R214": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000214 - Disclosure - Segment information - Summary of Net Sales by Segment and Geographical Area (Details)",
     "menuCat": "Details",
     "order": "214",
     "role": "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails",
     "shortName": "Segment information - Summary of Net Sales by Segment and Geographical Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6966a3cdac584a90877a12600daac3a9_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R215": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000215 - Disclosure - Segment information - Schedule of Segment Results (Details)",
     "menuCat": "Details",
     "order": "215",
     "role": "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails",
     "shortName": "Segment information - Schedule of Segment Results (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ie07e1cda02804dfeb4f408dfe335f092_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:OtherRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R216": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000216 - Disclosure - Segment information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details)",
     "menuCat": "Details",
     "order": "216",
     "role": "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
     "shortName": "Segment information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i013162020a33403bb8ab3a5b4d6acf5b_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:BusinessOperatingIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R217": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "iee7cb4947a1c4854876868c8e2fb82d1_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:InvestmentsInAssociatesAndJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000217 - Disclosure - Segment information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details)",
     "menuCat": "Details",
     "order": "217",
     "role": "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails",
     "shortName": "Segment information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "iee7cb4947a1c4854876868c8e2fb82d1_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sny:InvestmentsInAssociatesAndJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R218": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000218 - Disclosure - Segment information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details)",
     "menuCat": "Details",
     "order": "218",
     "role": "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails",
     "shortName": "Segment information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i26e900f47f5a43c1af34c00b6fbd86f1_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R219": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:AuditorsRemunerationForAuditServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000219 - Disclosure - Principal accountants' fees and services (Details)",
     "menuCat": "Details",
     "order": "219",
     "role": "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails",
     "shortName": "Principal accountants' fees and services (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ief744f78b1a64242b3f89bb00929ce9d_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:AuditorsRemunerationForAuditServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.sanofi.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R220": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i498c1591947b45fdadb2bb6778e0ea74_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000220 - Disclosure - List of principal companies included in the scope of consolidation during\u00a02022 - Summary of Principal Companies and their Country of Incorporation (Details)",
     "menuCat": "Details",
     "order": "220",
     "role": "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
     "shortName": "List of principal companies included in the scope of consolidation during\u00a02022 - Summary of Principal Companies and their Country of Incorporation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i498c1591947b45fdadb2bb6778e0ea74_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R221": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ic8a871b1ed6b455f8d1c0cea30f525e8_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProportionOfOwnershipInterestInJointOperation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000221 - Disclosure - List of principal companies included in the scope of consolidation during\u00a02022 - Summary of Principal Investments Accounted for Using the Equity Method (Details)",
     "menuCat": "Details",
     "order": "221",
     "role": "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails",
     "shortName": "List of principal companies included in the scope of consolidation during\u00a02022 - Summary of Principal Investments Accounted for Using the Equity Method (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ic8a871b1ed6b455f8d1c0cea30f525e8_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProportionOfOwnershipInterestInJointOperation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R222": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000222 - Disclosure - Events subsequent to December 31, 2022 (Details)",
     "menuCat": "Details",
     "order": "222",
     "role": "http://www.sanofi.com/role/EventssubsequenttoDecember312022Details",
     "shortName": "Events subsequent to December 31, 2022 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfTradeReceivablesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Accounts receivable",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.sanofi.com/role/Accountsreceivable",
     "shortName": "Accounts receivable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfTradeReceivablesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Other current assets",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.sanofi.com/role/Othercurrentassets",
     "shortName": "Other current assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Financial assets and liabilities measured at fair value",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.sanofi.com/role/Financialassetsandliabilitiesmeasuredatfairvalue",
     "shortName": "Financial assets and liabilities measured at fair value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Cash and cash equivalents",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.sanofi.com/role/Cashandcashequivalents",
     "shortName": "Cash and cash equivalents",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Net deferred tax position",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.sanofi.com/role/Netdeferredtaxposition",
     "shortName": "Net deferred tax position",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Consolidated shareholders\u2019 equity",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://www.sanofi.com/role/Consolidatedshareholdersequity",
     "shortName": "Consolidated shareholders\u2019 equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Non-controlling interests",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://www.sanofi.com/role/Noncontrollinginterests",
     "shortName": "Non-controlling interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated balance sheets",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.sanofi.com/role/Consolidatedbalancesheets",
     "shortName": "Consolidated balance sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:CurrentTaxAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Debt, cash and cash equivalents and lease liabilities",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://www.sanofi.com/role/Debtcashandcashequivalentsandleaseliabilities",
     "shortName": "Debt, cash and cash equivalents and lease liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Liabilities related to business combinations and to non-controlling interests",
     "menuCat": "Notes",
     "order": "31",
     "role": "http://www.sanofi.com/role/Liabilitiesrelatedtobusinesscombinationsandtononcontrollinginterests",
     "shortName": "Liabilities related to business combinations and to non-controlling interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfProvisionsAndOtherLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Provisions, income tax liabilities and other liabilities",
     "menuCat": "Notes",
     "order": "32",
     "role": "http://www.sanofi.com/role/Provisionsincometaxliabilitiesandotherliabilities",
     "shortName": "Provisions, income tax liabilities and other liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfProvisionsAndOtherLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Derivative financial instruments and market risks",
     "menuCat": "Notes",
     "order": "33",
     "role": "http://www.sanofi.com/role/Derivativefinancialinstrumentsandmarketrisks",
     "shortName": "Derivative financial instruments and market risks",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Off balance sheet commitments",
     "menuCat": "Notes",
     "order": "34",
     "role": "http://www.sanofi.com/role/Offbalancesheetcommitments",
     "shortName": "Off balance sheet commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfLegalAndArbitralProceedingsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Legal and arbitral proceedings",
     "menuCat": "Notes",
     "order": "35",
     "role": "http://www.sanofi.com/role/Legalandarbitralproceedings",
     "shortName": "Legal and arbitral proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfLegalAndArbitralProceedingsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Provisions for discounts, rebates and sales returns",
     "menuCat": "Notes",
     "order": "36",
     "role": "http://www.sanofi.com/role/Provisionsfordiscountsrebatesandsalesreturns",
     "shortName": "Provisions for discounts, rebates and sales returns",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Personnel costs",
     "menuCat": "Notes",
     "order": "37",
     "role": "http://www.sanofi.com/role/Personnelcosts",
     "shortName": "Personnel costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Other operating income",
     "menuCat": "Notes",
     "order": "38",
     "role": "http://www.sanofi.com/role/Otheroperatingincome",
     "shortName": "Other operating income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Other operating expenses",
     "menuCat": "Notes",
     "order": "39",
     "role": "http://www.sanofi.com/role/Otheroperatingexpenses",
     "shortName": "Other operating expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated income statements",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.sanofi.com/role/Consolidatedincomestatements",
     "shortName": "Consolidated income statements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfRestructuringCostsAndSimilarItemsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Restructuring costs and similar items",
     "menuCat": "Notes",
     "order": "40",
     "role": "http://www.sanofi.com/role/Restructuringcostsandsimilaritems",
     "shortName": "Restructuring costs and similar items",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfRestructuringCostsAndSimilarItemsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfOtherGainsAndLossesAndLitigationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Other gains and losses, and litigation",
     "menuCat": "Notes",
     "order": "41",
     "role": "http://www.sanofi.com/role/Othergainsandlossesandlitigation",
     "shortName": "Other gains and losses, and litigation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfOtherGainsAndLossesAndLitigationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Financial expenses and income",
     "menuCat": "Notes",
     "order": "42",
     "role": "http://www.sanofi.com/role/Financialexpensesandincome",
     "shortName": "Financial expenses and income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Income tax expense",
     "menuCat": "Notes",
     "order": "43",
     "role": "http://www.sanofi.com/role/Incometaxexpense",
     "shortName": "Income tax expense",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Share of profit/loss from investments accounted for using the equity method",
     "menuCat": "Notes",
     "order": "44",
     "role": "http://www.sanofi.com/role/Shareofprofitlossfrominvestmentsaccountedforusingtheequitymethod",
     "shortName": "Share of profit/loss from investments accounted for using the equity method",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Net income attributable to non-controlling interests",
     "menuCat": "Notes",
     "order": "45",
     "role": "http://www.sanofi.com/role/Netincomeattributabletononcontrollinginterests",
     "shortName": "Net income attributable to non-controlling interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Related party transactions",
     "menuCat": "Notes",
     "order": "46",
     "role": "http://www.sanofi.com/role/Relatedpartytransactions",
     "shortName": "Related party transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCreditRiskExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Disclosures about major customers and credit risk",
     "menuCat": "Notes",
     "order": "47",
     "role": "http://www.sanofi.com/role/Disclosuresaboutmajorcustomersandcreditrisk",
     "shortName": "Disclosures about major customers and credit risk",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCreditRiskExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Segment information",
     "menuCat": "Notes",
     "order": "48",
     "role": "http://www.sanofi.com/role/Segmentinformation",
     "shortName": "Segment information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Principal accountants' fees and services",
     "menuCat": "Notes",
     "order": "49",
     "role": "http://www.sanofi.com/role/Principalaccountantsfeesandservices",
     "shortName": "Principal accountants' fees and services",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated statements of comprehensive income",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome",
     "shortName": "Consolidated statements of comprehensive income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - List of principal companies included in the scope of consolidation during\u00a02022",
     "menuCat": "Notes",
     "order": "50",
     "role": "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022",
     "shortName": "List of principal companies included in the scope of consolidation during\u00a02022",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Events subsequent to December 31, 2022",
     "menuCat": "Notes",
     "order": "51",
     "role": "http://www.sanofi.com/role/EventssubsequenttoDecember312022",
     "shortName": "Events subsequent to December 31, 2022",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:StatementOfIFRSCompliance",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Summary of significant accounting policies (Policies)",
     "menuCat": "Policies",
     "order": "52",
     "role": "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies",
     "shortName": "Summary of significant accounting policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:StatementOfIFRSCompliance",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Summary of significant accounting policies (Tables)",
     "menuCat": "Tables",
     "order": "53",
     "role": "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTables",
     "shortName": "Summary of significant accounting policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Principal changes in the scope of consolidation in 2022 (Tables)",
     "menuCat": "Tables",
     "order": "54",
     "role": "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022Tables",
     "shortName": "Principal changes in the scope of consolidation in 2022 (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020 (Tables)",
     "menuCat": "Tables",
     "order": "55",
     "role": "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020Tables",
     "shortName": "Principal changes in the scope of consolidation in 2021 and 2020 (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Property, plant and equipment (Tables)",
     "menuCat": "Tables",
     "order": "56",
     "role": "http://www.sanofi.com/role/PropertyplantandequipmentTables",
     "shortName": "Property, plant and equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Goodwill and other intangible assets (Tables)",
     "menuCat": "Tables",
     "order": "57",
     "role": "http://www.sanofi.com/role/GoodwillandotherintangibleassetsTables",
     "shortName": "Goodwill and other intangible assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Impairment of intangible assets and property, plant and equipment (Tables)",
     "menuCat": "Tables",
     "order": "58",
     "role": "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentTables",
     "shortName": "Impairment of intangible assets and property, plant and equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Investments accounted for using the equity method (Tables)",
     "menuCat": "Tables",
     "order": "59",
     "role": "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodTables",
     "shortName": "Investments accounted for using the equity method (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "icfa0f3ae5e6c414a899ba5e892823a0e_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated statements of changes in equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity",
     "shortName": "Consolidated statements of changes in equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i79431d18a64048a3a31458a8519c8577_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Other non-current assets (Tables)",
     "menuCat": "Tables",
     "order": "60",
     "role": "http://www.sanofi.com/role/OthernoncurrentassetsTables",
     "shortName": "Other non-current assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Assets held for sale or exchange and liabilities related to assets held for sale or exchange (Tables)",
     "menuCat": "Tables",
     "order": "61",
     "role": "http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeTables",
     "shortName": "Assets held for sale or exchange and liabilities related to assets held for sale or exchange (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "62",
     "role": "http://www.sanofi.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfCurrentTradeReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Accounts receivable (Tables)",
     "menuCat": "Tables",
     "order": "63",
     "role": "http://www.sanofi.com/role/AccountsreceivableTables",
     "shortName": "Accounts receivable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfCurrentTradeReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Other current assets (Tables)",
     "menuCat": "Tables",
     "order": "64",
     "role": "http://www.sanofi.com/role/OthercurrentassetsTables",
     "shortName": "Other current assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Financial assets and liabilities measured at fair value (Tables)",
     "menuCat": "Tables",
     "order": "65",
     "role": "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueTables",
     "shortName": "Financial assets and liabilities measured at fair value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Cash and cash equivalents (Tables)",
     "menuCat": "Tables",
     "order": "66",
     "role": "http://www.sanofi.com/role/CashandcashequivalentsTables",
     "shortName": "Cash and cash equivalents (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Net deferred tax position (Tables)",
     "menuCat": "Tables",
     "order": "67",
     "role": "http://www.sanofi.com/role/NetdeferredtaxpositionTables",
     "shortName": "Net deferred tax position (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Consolidated shareholders\u2019 equity (Tables)",
     "menuCat": "Tables",
     "order": "68",
     "role": "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables",
     "shortName": "Consolidated shareholders\u2019 equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfChangesInFinancialPositionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Debt, cash and cash equivalents and lease liabilities (Tables)",
     "menuCat": "Tables",
     "order": "69",
     "role": "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables",
     "shortName": "Debt, cash and cash equivalents and lease liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfChangesInFinancialPositionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DividendsPaidOrdinarySharesPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated statements of changes in equity (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical",
     "shortName": "Consolidated statements of changes in equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DividendsPaidOrdinarySharesPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Liabilities related to business combinations and to non-controlling interests (Tables)",
     "menuCat": "Tables",
     "order": "70",
     "role": "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsTables",
     "shortName": "Liabilities related to business combinations and to non-controlling interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Provisions, income tax liabilities and other liabilities (Tables)",
     "menuCat": "Tables",
     "order": "71",
     "role": "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables",
     "shortName": "Provisions, income tax liabilities and other liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Derivative financial instruments and market risks (Tables)",
     "menuCat": "Tables",
     "order": "72",
     "role": "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksTables",
     "shortName": "Derivative financial instruments and market risks (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Off balance sheet commitments (Tables)",
     "menuCat": "Tables",
     "order": "73",
     "role": "http://www.sanofi.com/role/OffbalancesheetcommitmentsTables",
     "shortName": "Off balance sheet commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Provisions for discounts, rebates and sales returns (Tables)",
     "menuCat": "Tables",
     "order": "74",
     "role": "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsTables",
     "shortName": "Provisions for discounts, rebates and sales returns (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfPersonnelCostsDetailsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Personnel costs (Tables)",
     "menuCat": "Tables",
     "order": "75",
     "role": "http://www.sanofi.com/role/PersonnelcostsTables",
     "shortName": "Personnel costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfPersonnelCostsDetailsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:OtherOperatingExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Other operating expenses (Tables)",
     "menuCat": "Tables",
     "order": "76",
     "role": "http://www.sanofi.com/role/OtheroperatingexpensesTables",
     "shortName": "Other operating expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:OtherOperatingExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfRestructuringCostsDetailsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Restructuring costs and similar items (Tables)",
     "menuCat": "Tables",
     "order": "77",
     "role": "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsTables",
     "shortName": "Restructuring costs and similar items (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfRestructuringCostsDetailsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Financial expenses and income (Tables)",
     "menuCat": "Tables",
     "order": "78",
     "role": "http://www.sanofi.com/role/FinancialexpensesandincomeTables",
     "shortName": "Financial expenses and income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Income tax expense (Tables)",
     "menuCat": "Tables",
     "order": "79",
     "role": "http://www.sanofi.com/role/IncometaxexpenseTables",
     "shortName": "Income tax expense (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated statements of cash flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.sanofi.com/role/Consolidatedstatementsofcashflows",
     "shortName": "Consolidated statements of cash flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Net income attributable to non-controlling interests (Tables)",
     "menuCat": "Tables",
     "order": "80",
     "role": "http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsTables",
     "shortName": "Net income attributable to non-controlling interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Related party transactions (Tables)",
     "menuCat": "Tables",
     "order": "81",
     "role": "http://www.sanofi.com/role/RelatedpartytransactionsTables",
     "shortName": "Related party transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Segment information (Tables)",
     "menuCat": "Tables",
     "order": "82",
     "role": "http://www.sanofi.com/role/SegmentinformationTables",
     "shortName": "Segment information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:AuditorsRemunerationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Principal accountants' fees and services (Tables)",
     "menuCat": "Tables",
     "order": "83",
     "role": "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesTables",
     "shortName": "Principal accountants' fees and services (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:AuditorsRemunerationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - List of principal companies included in the scope of consolidation during\u00a02022 (Tables)",
     "menuCat": "Tables",
     "order": "84",
     "role": "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022Tables",
     "shortName": "List of principal companies included in the scope of consolidation during\u00a02022 (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CurrentContractLiabilities",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Basis of preparation - Additional Information (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails",
     "shortName": "Basis of preparation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if7312feb82fb447ea49510fc80480c6a_D20200701-20200731",
      "decimals": "-6",
      "lang": "en-US",
      "name": "sny:NumberOfVaccineDosesToBeSupplied",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vaccine_dose",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "sny:DisclosureOfPrincipalMarketedProductsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i9ed6aa800df24aecae7a3964ffbedd63_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Summary of significant accounting policies - Other Intangible Assets not Acquired in Business Combination (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails",
     "shortName": "Summary of significant accounting policies - Other Intangible Assets not Acquired in Business Combination (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i05ab760cbec74ca2a64af3ee573e8c46_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if28c01d5f14941678f17df4612ae4e2e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Summary of significant accounting policies - Summary of Useful Lives of Property Plant and Equipment (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails",
     "shortName": "Summary of significant accounting policies - Summary of Useful Lives of Property Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if28c01d5f14941678f17df4612ae4e2e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:GainLossOnPurchaseOfTreasuryShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Summary of significant accounting policies - Treasury Shares (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTreasurySharesDetails",
     "shortName": "Summary of significant accounting policies - Treasury Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:GainLossOnPurchaseOfTreasuryShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:ProvisionsRecordedForFutureOperatingLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Summary of significant accounting policies - Provision for Risks (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesProvisionforRisksDetails",
     "shortName": "Summary of significant accounting policies - Provision for Risks (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:ProvisionsRecordedForFutureOperatingLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "link:footnote",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Consolidated statements of cash flows (Parenthetical)",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
     "shortName": "Consolidated statements of cash flows (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "link:footnote",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DeferredTaxExpenseIncome",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Summary of significant accounting policies - Income Tax Expense (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails",
     "shortName": "Summary of significant accounting policies - Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i713b01806f0b4962bdcf1fb4904578c5_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ifrs-full:DeferredTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ie922fff56e5f419ab3f601913c0b7064_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:OptionVestingPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Summary of significant accounting policies - Share-Based Payment (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails",
     "shortName": "Summary of significant accounting policies - Share-Based Payment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ie922fff56e5f419ab3f601913c0b7064_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sny:OptionVestingPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Summary of significant accounting policies - Segment Information (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSegmentInformationDetails",
     "shortName": "Summary of significant accounting policies - Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Principal alliances -Collaboration agreements on human therapeutic antibodies (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
     "shortName": "Principal alliances -Collaboration agreements on human therapeutic antibodies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i20ae7da9383f4e3ab6826ded2379ded9_D20071101-20071130",
      "decimals": "INF",
      "lang": "en-US",
      "name": "sny:NumberOfAgreementsSigned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "agreement",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sny:OtherOperatingExpensesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:OtherOperatingIncomeExpense",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Principal alliances - Immuno-Oncology Agreement with Regeneron Pharmaceuticals, Inc. (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
     "shortName": "Principal alliances - Immuno-Oncology Agreement with Regeneron Pharmaceuticals, Inc. (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i8076a1036c53486c9cf0fadf596f4f82_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "id3e2037ecf8e496eaf3ae27c42505f70_D20200529-20200529",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sny:SaleOfStockNumberOfSharesIssuedInTransactionTotal",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Principal alliances - Investor Agreement with Regeneron Pharmaceuticals, Inc. (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
     "shortName": "Principal alliances - Investor Agreement with Regeneron Pharmaceuticals, Inc. (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i0515044855e14c60a51bff4d7c49cee9_D20140101-20140131",
      "decimals": "INF",
      "lang": "en-US",
      "name": "sny:MaximumOwnershipPercentageAllowedToAcquire",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i860a838707c64bfb8b697db6c3bbeeb6_I20200228",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Principal alliances - Alliance Arrangements with Bristol-Myers Squibb (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
     "shortName": "Principal alliances - Alliance Arrangements with Bristol-Myers Squibb (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i860a838707c64bfb8b697db6c3bbeeb6_I20200228",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Principal changes in the scope of consolidation in 2022 - Additional Information (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
     "shortName": "Principal changes in the scope of consolidation in 2022 - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i67af3f0fc7dd4b2eaa2a63d60e4251a0_I20220510",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:OtherProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ia24e436ffce44c968c4694148c6aaf8d_I20220208",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Principal changes in the scope of consolidation in 2022 - Summary of Provisional Purchase Price Allocation (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails",
     "shortName": "Principal changes in the scope of consolidation in 2022 - Summary of Provisional Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "ia24e436ffce44c968c4694148c6aaf8d_I20220208",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "if15c8e82a1264626929110026e2a5d8e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Principal changes in the scope of consolidation in 2021 and 2020 - Additional Information (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
     "shortName": "Principal changes in the scope of consolidation in 2021 and 2020 - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sny-20221231.htm",
      "contextRef": "i6beef57f0ff142ac829ee75f07d8469f_I20221231",
      "decimals": "2",
      "lang": "en-US",
      "name": "sny:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 634,
   "tag": {
    "country_AR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ARGENTINA",
        "terseLabel": "Argentina"
       }
      }
     },
     "localname": "AR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "Germany"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FRANCE",
        "terseLabel": "France"
       }
      }
     },
     "localname": "FR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "UK"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_RU": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RUSSIAN FEDERATION",
        "terseLabel": "RUSSIAN FEDERATION"
       }
      }
     },
     "localname": "RU",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_TR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TURKEY",
        "terseLabel": "Turkey"
       }
      }
     },
     "localname": "TR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "US",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "Pound sterling"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_MXN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mexico, Pesos",
        "terseLabel": "Mexican peso"
       }
      }
     },
     "localname": "MXN",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SGD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Singapore, Dollars",
        "terseLabel": "Singapore dollar"
       }
      }
     },
     "localname": "SGD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "US dollar"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]",
        "terseLabel": "Auditor [Line Items]"
       }
      }
     },
     "localname": "AuditorLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/AuditInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]",
        "terseLabel": "Auditor [Table]"
       }
      }
     },
     "localname": "AuditorTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/AuditInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]",
        "terseLabel": "Business Contact"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelFaxNumber": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fax Number of contact personnel.",
        "label": "Contact Personnel Fax Number",
        "terseLabel": "Contact Personnel Fax Number"
       }
      }
     },
     "localname": "ContactPersonnelFaxNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name",
        "terseLabel": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard",
        "terseLabel": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement",
        "terseLabel": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report",
        "terseLabel": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]",
        "terseLabel": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": {
     "auth_ref": [
      "r67",
      "r74",
      "r142",
      "r156",
      "r159"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation, amortisation and impairment. [Refer: Impairment loss; Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated depreciation, amortisation and impairment [member]",
        "terseLabel": "Accumulated depreciation &amp; impairment",
        "verboseLabel": "Accumulated amortization\u00a0&amp; impairment"
       }
      }
     },
     "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AccumulatedImpairmentMember": {
     "auth_ref": [
      "r238",
      "r251",
      "r353",
      "r375",
      "r380",
      "r404",
      "r417",
      "r424",
      "r425"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated impairment. [Refer: Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated impairment [member]",
        "terseLabel": "Accumulated impairment"
       }
      }
     },
     "localname": "AccumulatedImpairmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income [member]",
        "terseLabel": "Other comprehensive income",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails",
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Consideration transferred, acquisition-date fair value",
        "terseLabel": "Purchase price"
       }
      }
     },
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r418"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, intangible assets and goodwill",
        "terseLabel": "Acquisitions during the period"
       }
      }
     },
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRates": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "ActuarialAssumptionOfDiscountRates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRatesMember": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the discount rates used as actuarial assumptions. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates [member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "ActuarialAssumptionOfDiscountRatesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected rate of inflation that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of inflation",
        "terseLabel": "General inflation rate"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfInflation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the expected rates of inflation used as actuarial assumptions. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of inflation [member]",
        "terseLabel": "General inflation rate"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfInflationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected rate of increases in pension that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of pension increases",
        "terseLabel": "Pension benefit indexation"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreases",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the expected rates of pension increases used as actuarial assumptions. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of pension increases [member]",
        "terseLabel": "Pension benefit indexation"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Medical cost trend rate used as significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of medical cost trend rates",
        "terseLabel": "Healthcare cost inflation rate(d)"
       }
      }
     },
     "localname": "ActuarialAssumptionOfMedicalCostTrendRates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the medical cost trend rates used as actuarial assumptions. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of medical cost trend rates [member]",
        "terseLabel": "Healthcare cost inflation rate"
       }
      }
     },
     "localname": "ActuarialAssumptionOfMedicalCostTrendRatesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialAssumptionsAxis": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumptions [axis]",
        "terseLabel": "Actuarial assumptions [axis]"
       }
      }
     },
     "localname": "ActuarialAssumptionsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ActuarialAssumptionsMember": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all actuarial assumptions. Actuarial assumptions are the entity\u2019s unbiased and mutually compatible best estimates of the demographic and financial variables that will determine the ultimate cost of providing post-employment benefits. It also represents the standard value for the 'Actuarial assumptions' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumptions [member]",
        "terseLabel": "Actuarial assumptions [member]"
       }
      }
     },
     "localname": "ActuarialAssumptionsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions",
        "negatedLabel": "Actuarial losses/(gains) due to changes in demographic assumptions",
        "verboseLabel": "Gains/(losses) on demographic assumptions"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions",
        "negatedLabel": "Actuarial losses/(gains) due to changes in financial assumptions",
        "negatedTerseLabel": "Actuarial gains/(losses)",
        "verboseLabel": "Gains/(losses) on financial assumptions"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments",
        "negatedLabel": "Actuarial losses/(gains) due to experience adjustments"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionalInformationAboutSharebasedPaymentArrangements": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Additional information about share-based payment arrangements necessary to satisfy the disclosure requirements of IFRS 2. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additional information about share-based payment arrangements [text block]",
        "terseLabel": "Summary of Expenses"
       }
      }
     },
     "localname": "AdditionalInformationAboutSharebasedPaymentArrangements",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_AdditionalPaidinCapitalMember": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for amounts received from issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders."
       }
      },
      "en-us": {
       "role": {
        "label": "Additional paid-in capital [member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidinCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, intangible assets other than goodwill",
        "terseLabel": "Acquisitions and other increases"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, property, plant and equipment",
        "terseLabel": "Acquisitions and other increases",
        "verboseLabel": "Acquisitions"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share",
        "terseLabel": "Average number of shares after dilution (in shares)",
        "totalLabel": "Average number of shares used to compute diluted earnings per share (in shares)"
       }
      }
     },
     "localname": "AdjustedWeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in inventories",
        "terseLabel": "(Increase)/decrease in inventories"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in trade accounts receivable",
        "terseLabel": "(Increase)/decrease in accounts receivable"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDeferredTaxExpense": {
     "auth_ref": [
      "r431"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for deferred tax expense",
        "terseLabel": "Net change in deferred taxes"
       }
      }
     },
     "localname": "AdjustmentsForDeferredTaxExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "auth_ref": [
      "r431"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates",
        "negatedTerseLabel": "Gain on Regeneron investment arising from transaction of May 29, 2020, net\u00a0of tax"
       }
      }
     },
     "localname": "AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade accounts payable",
        "terseLabel": "Increase/(decrease) in accounts payable"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for losses (gains) on disposal of non-current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Non-current assets; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for losses (gains) on disposal of non-current assets",
        "terseLabel": "Gains and losses on disposals of non-current assets, net of tax"
       }
      }
     },
     "localname": "AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss) [abstract]",
        "terseLabel": "Adjustments to reconcile profit (loss) [abstract]"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "auth_ref": [
      "r430"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "terseLabel": "Cost of employee benefits (stock options and other share-based payments)"
       }
      }
     },
     "localname": "AdjustmentsForSharebasedPayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r431"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for undistributed profits of investments accounted for using the equity method to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Investments accounted for using equity method; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for undistributed profits of investments accounted for using equity method",
        "negatedLabel": "Share of undistributed earnings from investments accounted for using the\u00a0equity method"
       }
      }
     },
     "localname": "AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember": {
     "auth_ref": [
      "r187",
      "r290",
      "r294"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the aggregation of associates that are individually immaterial. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated individually immaterial associates [member]",
        "terseLabel": "Other investments",
        "verboseLabel": "Share of net income attributable to other non-controlling interests"
       }
      }
     },
     "localname": "AggregatedIndividuallyImmaterialAssociatesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AggregatedMeasurementMember": {
     "auth_ref": [
      "r154",
      "r158",
      "r199"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated measurement [member]",
        "terseLabel": "Aggregated measurement"
       }
      }
     },
     "localname": "AggregatedMeasurementMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "auth_ref": [
      "r28",
      "r209",
      "r216",
      "r217",
      "r244",
      "r282",
      "r283",
      "r284",
      "r285",
      "r321",
      "r357",
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated time bands [member]",
        "terseLabel": "Aggregated time bands"
       }
      }
     },
     "localname": "AggregatedTimeBandsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllLevelsOfFairValueHierarchyMember": {
     "auth_ref": [
      "r91",
      "r200"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "All levels of fair value hierarchy [member]",
        "terseLabel": "All levels of fair value hierarchy [member]"
       }
      }
     },
     "localname": "AllLevelsOfFairValueHierarchyMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllOtherSegmentsMember": {
     "auth_ref": [
      "r207",
      "r267"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for business activities and operating segments that are not reportable."
       }
      },
      "en-us": {
       "role": {
        "label": "All other segments [member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllowanceForCreditLossesMember": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an allowance account used to record impairments to financial assets due to credit losses."
       }
      },
      "en-us": {
       "role": {
        "label": "Allowance for credit losses [member]",
        "terseLabel": "Allowances"
       }
      }
     },
     "localname": "AllowanceForCreditLossesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 5.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amortisation, intangible assets other than goodwill",
        "negatedLabel": "Amortization of intangible assets",
        "negatedTerseLabel": "Amortization expense",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmountsPayableRelatedPartyTransactions": {
     "auth_ref": [
      "r108",
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amounts payable, related party transactions",
        "terseLabel": "Accounts payable and other payables"
       }
      }
     },
     "localname": "AmountsPayableRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmountsReceivableRelatedPartyTransactions": {
     "auth_ref": [
      "r108",
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amounts receivable, related party transactions",
        "terseLabel": "Accounts receivable and other receivables"
       }
      }
     },
     "localname": "AmountsReceivableRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AnalysisOfIncomeAndExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Analysis of income and expense [abstract]",
        "terseLabel": "Analysis of income and expense [abstract]"
       }
      }
     },
     "localname": "AnalysisOfIncomeAndExpenseAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ApplicableTaxRate": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_AverageEffectiveTaxRate",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      },
      "en-us": {
       "role": {
        "label": "Applicable tax rate",
        "terseLabel": "Standard tax rate applicable in France"
       }
      }
     },
     "localname": "ApplicableTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r24",
      "r199",
      "r200",
      "r203",
      "r270",
      "r273"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AssociatesMember": {
     "auth_ref": [
      "r111",
      "r120",
      "r122",
      "r198",
      "r289",
      "r293"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entities over which the investor has significant influence."
       }
      },
      "en-us": {
       "role": {
        "label": "Associates [member]",
        "terseLabel": "Associates"
       }
      }
     },
     "localname": "AssociatesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AtFairValueMember": {
     "auth_ref": [
      "r154",
      "r158",
      "r199"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for measurement based on fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date."
       }
      },
      "en-us": {
       "role": {
        "label": "At fair value [member]",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "AtFairValueMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AuditorsRemuneration": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors."
       }
      },
      "en-us": {
       "role": {
        "label": "Auditor's remuneration",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AuditorsRemuneration",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AuditorsRemunerationForAuditServices": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_AuditorsRemuneration",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors for auditing services."
       }
      },
      "en-us": {
       "role": {
        "label": "Auditor's remuneration for audit services",
        "terseLabel": "Statutory audit of separate and consolidated financial statements"
       }
      }
     },
     "localname": "AuditorsRemunerationForAuditServices",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AuditorsRemunerationForOtherServices": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails": {
       "order": 3.0,
       "parentTag": "sny_ServicesOtherThanStatutoryAudit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors for services that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Auditor's remuneration for other services",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "AuditorsRemunerationForOtherServices",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AuditorsRemunerationForTaxServices": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails": {
       "order": 2.0,
       "parentTag": "sny_ServicesOtherThanStatutoryAudit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors for tax services."
       }
      },
      "en-us": {
       "role": {
        "label": "Auditor's remuneration for tax services",
        "terseLabel": "Tax"
       }
      }
     },
     "localname": "AuditorsRemunerationForTaxServices",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AverageEffectiveTaxRate": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Average effective tax rate",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "AverageEffectiveTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_BankOverdraftsClassifiedAsCashEquivalents": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that has been withdrawn from an account in excess of existing cash balances. This is considered a short-term extension of credit by the bank. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Bank overdrafts",
        "terseLabel": "Bank credit balances"
       }
      }
     },
     "localname": "BankOverdraftsClassifiedAsCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BenefitsPaidOrPayable": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of benefits paid or payable for retirement benefit plans."
       }
      },
      "en-us": {
       "role": {
        "label": "Benefits paid or payable",
        "negatedLabel": "Benefits paid"
       }
      }
     },
     "localname": "BenefitsPaidOrPayable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BondsIssued": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of bonds issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Bonds issued",
        "terseLabel": "Bond issues"
       }
      }
     },
     "localname": "BondsIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Borrowings": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails": {
       "order": 1.0,
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings",
        "periodEndLabel": "Borrowings at end of period",
        "periodStartLabel": "Borrowings at beginning of period",
        "terseLabel": "Total debt",
        "totalLabel": "Total debt",
        "verboseLabel": "Total debt"
       }
      }
     },
     "localname": "Borrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]",
        "terseLabel": "Borrowings by name [axis]"
       }
      }
     },
     "localname": "BorrowingsByNameAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsByNameMember": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings by name [member]",
        "terseLabel": "Borrowings by name [member]"
       }
      }
     },
     "localname": "BorrowingsByNameMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BorrowingsInterestRate": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings, interest rate",
        "terseLabel": "Annual\u00a0interest\u00a0rate",
        "verboseLabel": "Bonds, interest rate (in percent)"
       }
      }
     },
     "localname": "BorrowingsInterestRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_BottomOfRangeMember": {
     "auth_ref": [
      "r205",
      "r225",
      "r284",
      "r342",
      "r344",
      "r436"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Bottom of range [member]",
        "terseLabel": "Bottom of range"
       }
      }
     },
     "localname": "BottomOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BuildingsMember": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Buildings [member]",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BusinessCombinationsAxis": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Business combinations [axis]",
        "terseLabel": "Business Combinations [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "auth_ref": [
      "r67",
      "r71",
      "r142",
      "r148",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r238",
      "r251",
      "r252",
      "r438",
      "r439"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]",
        "terseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      }
     },
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CarryingAmountMember": {
     "auth_ref": [
      "r71",
      "r148",
      "r155",
      "r157",
      "r158",
      "r238",
      "r251",
      "r252",
      "r375",
      "r379"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount [member]",
        "terseLabel": "Carrying amount"
       }
      }
     },
     "localname": "CarryingAmountMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Cash": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://www.sanofi.com/role/CashandcashequivalentsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/CashandcashequivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r17",
      "r171",
      "r192"
     ],
     "calculation": {
      "http://www.sanofi.com/role/CashandcashequivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 5.0,
       "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails": {
       "order": 2.0,
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "negatedLabel": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/CashandcashequivalentsDetails",
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r433"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents recognised as of acquisition date",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashEquivalents": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://www.sanofi.com/role/CashandcashequivalentsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash equivalents",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/CashandcashequivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowHedgesMember": {
     "auth_ref": [
      "r153",
      "r245",
      "r246",
      "r247"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for hedges of the exposure to variability in cash flows that (a) are attributable to a particular risk associated with a recognised asset or liability (such as all or some future interest payments on variable rate debt) or a highly probable forecast transaction; and (b) could affect profit or loss. [Refer: Hedges [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flow hedges [member]",
        "terseLabel": "Cash flow hedges"
       }
      }
     },
     "localname": "CashFlowHedgesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate cash flows arising from losing control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from losing control of subsidiaries or other businesses, classified as investing activities",
        "terseLabel": "Disposal of consolidated undertakings and investments accounted for using the equity method, net of tax"
       }
      }
     },
     "localname": "CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows",
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r160",
      "r173"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 4.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash provided by/(used in) financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities [abstract]",
        "terseLabel": "Cash flows from (used in) financing activities [abstract]"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r160",
      "r173"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash provided by/(used in) investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities [abstract]",
        "terseLabel": "Cash flows from (used in) investing activities [abstract]"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "auth_ref": [
      "r160",
      "r173"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Net cash provided by/(used in) operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities [abstract]",
        "terseLabel": "Cash flows from (used in) operating activities [abstract]"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital": {
     "auth_ref": [
      "r338",
      "r431"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow (outflow) from the entity's operations before changes in working capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operations before changes in working capital",
        "totalLabel": "Operating cash flow before changes in working capital"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities",
        "negatedLabel": "Acquisitions of consolidated undertakings and investments accounted for using the equity method",
        "terseLabel": "Net cash flow on acquisition"
       }
      }
     },
     "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashOutflowForLeases": {
     "auth_ref": [
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash outflow for leases",
        "terseLabel": "Cash outflow for leases, excluding short-term leases"
       }
      }
     },
     "localname": "CashOutflowForLeases",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashTransferred": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash transferred",
        "terseLabel": "Cash transferred"
       }
      }
     },
     "localname": "CashTransferred",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CategoriesOfFinancialAssetsAxis": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of financial assets [axis]",
        "terseLabel": "Categories of Financial Assets [Axis]"
       }
      }
     },
     "localname": "CategoriesOfFinancialAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]",
        "terseLabel": "Categories of Related Parties [Axis]"
       }
      }
     },
     "localname": "CategoriesOfRelatedPartiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails",
      "http://www.sanofi.com/role/OtheroperatingincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ChangesInOtherProvisions": {
     "auth_ref": [
      "r137"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in other provisions. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in other provisions",
        "terseLabel": "Increases in provisions"
       }
      }
     },
     "localname": "ChangesInOtherProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "auth_ref": [
      "r127",
      "r128",
      "r204",
      "r215"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]",
        "terseLabel": "Classes of assets [axis]"
       }
      }
     },
     "localname": "ClassesOfAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "auth_ref": [
      "r127",
      "r204",
      "r215"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets [member]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "ClassesOfAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfContingentLiabilitiesAxis": {
     "auth_ref": [
      "r139",
      "r236"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of contingent liabilities [axis]",
        "terseLabel": "Classes of Contingent Liabilities [Axis]"
       }
      }
     },
     "localname": "ClassesOfContingentLiabilitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "auth_ref": [
      "r259",
      "r260",
      "r281",
      "r286",
      "r287",
      "r288"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]",
        "terseLabel": "Classes of financial assets [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsAxis": {
     "auth_ref": [
      "r251",
      "r253",
      "r254",
      "r255"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [axis]",
        "terseLabel": "Classes of financial instruments [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsMember": {
     "auth_ref": [
      "r251",
      "r253",
      "r254",
      "r255"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial instruments, class [member]",
        "terseLabel": "Financial instruments, class [member]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of intangible assets and goodwill [axis]",
        "terseLabel": "Classes of intangible assets and goodwill [axis]"
       }
      }
     },
     "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]",
        "terseLabel": "Classes of intangible assets other than goodwill [axis]"
       }
      }
     },
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfLiabilitiesAxis": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of liabilities [axis]",
        "terseLabel": "Classes of liabilities [axis]"
       }
      }
     },
     "localname": "ClassesOfLiabilitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]",
        "terseLabel": "Classes of property, plant and equipment [axis]"
       }
      }
     },
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfProvisionsAxis": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of other provisions [axis]",
        "terseLabel": "Classes of other provisions [axis]"
       }
      }
     },
     "localname": "ClassesOfProvisionsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CommencementOfMajorLitigationMember": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the commencement of major litigation."
       }
      },
      "en-us": {
       "role": {
        "label": "Commencement of major litigation [member]",
        "terseLabel": "Commencement of major litigation [member]"
       }
      }
     },
     "localname": "CommencementOfMajorLitigationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CommercialPapersIssued": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of commercial paper issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Commercial papers issued",
        "terseLabel": "Commercial paper programs"
       }
      }
     },
     "localname": "CommercialPapersIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]",
        "terseLabel": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity",
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r2",
      "r38",
      "r177",
      "r179",
      "r190",
      "r340"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity",
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r2",
      "r41"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome_1": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to non-controlling interests",
        "terseLabel": "Attributable to non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "auth_ref": [
      "r2",
      "r42"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome_1": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to owners of parent",
        "terseLabel": "Attributable to equity holders of Sanofi"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComputerSoftwareMember": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Computer software [member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "ComputerSoftwareMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Contingent consideration recognised as of acquisition date",
        "terseLabel": "Contingent consideration recognised as of acquisition date"
       }
      }
     },
     "localname": "ContingentConsiderationRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContingentLiabilitiesMember": {
     "auth_ref": [
      "r140",
      "r236"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity; or, present obligations that arise from past events but are not recognised because (a) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligations; or (b) the amount of the obligations cannot be measured with sufficient reliability. It also represents the standard value for the 'Classes of contingent liabilities' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Contingent liabilities [member]",
        "terseLabel": "Contingent liabilities [member]"
       }
      }
     },
     "localname": "ContingentLiabilitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r350",
      "r352"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contingent liabilities recognised as of the acquisition date in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Contingent liabilities recognised as of acquisition date",
        "negatedTerseLabel": "Shire contingent consideration liability (see Note\u00a0D.18.)"
       }
      }
     },
     "localname": "ContingentLiabilitiesRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contingent liabilities recognised in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Contingent liabilities recognised in business combination",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Fair value of contingent consideration payable"
       }
      }
     },
     "localname": "ContingentLiabilitiesRecognisedInBusinessCombination",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContractLiabilities": {
     "auth_ref": [
      "r206",
      "r208"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of an entity\u2019s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer."
       }
      },
      "en-us": {
       "role": {
        "label": "Contract liabilities",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer",
        "terseLabel": "Employer\u2019s contributions"
       }
      }
     },
     "localname": "ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants",
        "negatedLabel": "Contributions from plan members",
        "terseLabel": "Contributions from plan members"
       }
      }
     },
     "localname": "ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CostOfSales": {
     "auth_ref": [
      "r0",
      "r53"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 3.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0
      },
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails": {
       "order": 5.0,
       "parentTag": "sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails": {
       "order": 3.0,
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "negatedLabel": "Cost of sales",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSales",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CounterpartiesAxis": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Counterparties [axis]",
        "terseLabel": "Counterparties [axis]"
       }
      }
     },
     "localname": "CounterpartiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails",
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CounterpartiesMember": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Counterparties [member]",
        "terseLabel": "Counterparties"
       }
      }
     },
     "localname": "CounterpartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails",
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Cumulative effect at date of initial application [axis]",
        "terseLabel": "Cumulative effect at date of initial application [axis]"
       }
      }
     },
     "localname": "CumulativeEffectAtDateOfInitialApplicationAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Current assets; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale; Non-current assets or disposal groups classified as held for distribution to owners]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners",
        "totalLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current borrowings and current portion of non-current borrowings",
        "verboseLabel": "Short-term debt and current portion of long-term debt"
       }
      }
     },
     "localname": "CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentContractLiabilities": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "sny_CurrentProvisionsAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current contract liabilities. [Refer: Contract liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current contract liabilities",
        "terseLabel": "Current contract liabilities",
        "verboseLabel": "Customer contract liabilities"
       }
      }
     },
     "localname": "CurrentContractLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentDerivativeFinancialAssets": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_DerivativeFinancialAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current derivative financial assets. [Refer: Derivative financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current derivative financial assets",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentDerivativeFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentDerivativeFinancialLiabilities": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_DerivativeFinancialLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current derivative financial liabilities",
        "negatedTerseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentDerivativeFinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current lease liabilities",
        "terseLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "CurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 3.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current liabilities other than liabilities included in disposal groups classified as held for sale. [Refer: Current liabilities; Disposal groups classified as held for sale [member]; Liabilities included in disposal groups classified as held for sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities other than liabilities included in disposal groups classified as held for sale",
        "totalLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": {
     "auth_ref": [
      "r400"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "sny_CurrentProvisionsAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current payables on social security and taxes other than income tax",
        "terseLabel": "Taxes payable, other than corporate income taxes"
       }
      }
     },
     "localname": "CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/OthercurrentassetsDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepaid expenses",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "CurrentPrepaidExpenses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthercurrentassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax": {
     "auth_ref": [
      "r399"
     ],
     "calculation": {
      "http://www.sanofi.com/role/OthercurrentassetsDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_OtherCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current receivables from taxes other than income tax",
        "terseLabel": "Tax receivables, other than corporate income taxes"
       }
      }
     },
     "localname": "CurrentReceivablesFromTaxesOtherThanIncomeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthercurrentassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase in net defined benefit liability (asset) resulting from current service cost",
        "terseLabel": "Current service cost"
       }
      }
     },
     "localname": "CurrentServiceCostNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxAssetsCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of current tax assets. [Refer: Current tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax assets, current",
        "terseLabel": "Current income tax assets"
       }
      }
     },
     "localname": "CurrentTaxAssetsCurrent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxAssetsNoncurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The non-current amount of current tax assets. [Refer: Current tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax assets, non-current",
        "terseLabel": "Non-current income tax assets"
       }
      }
     },
     "localname": "CurrentTaxAssetsNoncurrent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "auth_ref": [
      "r314"
     ],
     "calculation": {
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax expense (income)",
        "negatedLabel": "Current taxes"
       }
      }
     },
     "localname": "CurrentTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxLiabilitiesCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 6.0,
       "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax liabilities, current",
        "terseLabel": "Current income tax liabilities"
       }
      }
     },
     "localname": "CurrentTaxLiabilitiesCurrent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxLiabilitiesNoncurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The non-current amount of current tax liabilities. [Refer: Current tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax liabilities, non-current",
        "terseLabel": "Non-current income tax liabilities"
       }
      }
     },
     "localname": "CurrentTaxLiabilitiesNoncurrent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTradeReceivables": {
     "auth_ref": [
      "r306",
      "r308"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current trade receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "CurrentTradeReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails",
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DebtSecuritiesMember": {
     "auth_ref": [
      "r341",
      "r343"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for instruments held by the entity that represent indebtedness."
       }
      },
      "en-us": {
       "role": {
        "label": "Debt securities [member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in intangible assets and goodwill resulting from the loss of control of a subsidiary. [Refer: Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease through loss of control of subsidiary, intangible assets and goodwill",
        "terseLabel": "Decrease through loss of control of subsidiary, intangible assets and goodwill"
       }
      }
     },
     "localname": "DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssetsAndGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxAssets": {
     "auth_ref": [
      "r20",
      "r25",
      "r62"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax expense (income)",
        "negatedLabel": "Deferred taxes",
        "terseLabel": "Deferred tax expense"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "auth_ref": [
      "r20",
      "r25",
      "r62"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r433"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities recognised as of acquisition date",
        "negatedLabel": "Net deferred tax position",
        "negatedTerseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liability (asset)",
        "negatedLabel": "Net deferred tax asset/(liability)"
       }
      }
     },
     "localname": "DeferredTaxLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DefinedBenefitObligationAtPresentValue": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_LiabilityAssetOfDefinedBenefitPlans",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]"
       }
      },
      "en-us": {
       "role": {
        "label": "Defined benefit obligation, at present value",
        "terseLabel": "Employee termination benefits",
        "verboseLabel": "Measurement of obligation"
       }
      }
     },
     "localname": "DefinedBenefitObligationAtPresentValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DefinedBenefitPlansAxis": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Defined benefit plans [axis]",
        "terseLabel": "Defined benefit plans [axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DefinedBenefitPlansMember": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Defined benefit plans [member]",
        "terseLabel": "Defined benefit plans [member]"
       }
      }
     },
     "localname": "DefinedBenefitPlansMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_DepreciationExpense": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "negatedTerseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "DepreciationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, right-of-use assets",
        "negatedTerseLabel": "Depreciation and impairment charged in the period"
       }
      }
     },
     "localname": "DepreciationRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DerivativeFinancialAssets": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Derivative financial assets",
        "terseLabel": "Derivative financial assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "DerivativeFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DerivativeFinancialLiabilities": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Derivative financial liabilities",
        "negatedTotalLabel": "Total liabilities"
       }
      }
     },
     "localname": "DerivativeFinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DerivativeFinancialLiabilitiesUndiscountedCashFlows": {
     "auth_ref": [
      "r257"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails": {
       "order": 2.0,
       "parentTag": "sny_TotalUndiscountedCashFlow",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Derivative financial liabilities, undiscounted cash flows",
        "terseLabel": "Net cash flows related to derivative instruments"
       }
      }
     },
     "localname": "DerivativeFinancialLiabilitiesUndiscountedCashFlows",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DerivativesMember": {
     "auth_ref": [
      "r341",
      "r343",
      "r354",
      "r367"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for financial instruments or other contracts within the scope of IFRS 9 with all three of the following characteristics: (a) Their value changes in response to the change in a specified interest rate, financial instrument price, commodity price, foreign exchange rate, index of prices or rates, credit rating or credit index, or other variable, provided in the case of a non-financial variable that the variable is not specific to a party to the contract (sometimes called the \u2018underlying\u2019); (b) They require no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; (c) They are settled at a future date. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Derivatives [member]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for business combinations and goodwill. [Refer: Business combinations [member]; Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for business combinations and goodwill [text block]",
        "terseLabel": "Business combinations and transactions with non-controlling interests"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for earnings per share [text block]",
        "terseLabel": "Earnings per share"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for employee benefits [text block]",
        "terseLabel": "Employee benefit obligations"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for finance income and costs. [Refer: Finance income (cost)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for finance income and costs [text block]",
        "terseLabel": "Financial expenses and income"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for financial instruments [text block]",
        "terseLabel": "Financial instruments"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for foreign currency translation."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for foreign currency translation [text block]",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for the impairment of assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for impairment of assets [text block]",
        "terseLabel": "Impairment of property, plant and equipment, intangible assets, and investments accounted for using the equity method"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for income tax."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for income tax [text block]",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for intangible assets and goodwill [text block]",
        "terseLabel": "Amortization and impairment of intangible assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for intangible assets other than goodwill [text block]",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for issued capital. [Refer: Issued capital]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for issued capital [text block]",
        "terseLabel": "Management of capital"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for measuring inventories [text block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for non-current assets or disposal groups classified as held for sale and discontinued operations. [Refer: Discontinued operations [member]; Non-current assets or disposal groups classified as held for sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for non-current assets or disposal groups classified as held for sale and discontinued operations [text block]",
        "terseLabel": "Assets held for sale or exchange and liabilities related to assets held for sale or exchange"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment owned and leased"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for provisions. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for provisions [text block]",
        "terseLabel": "Provisions for risks"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for recognition of revenue [text block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for research and development expense [text block]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for segment reporting."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for segment reporting [text block]",
        "terseLabel": "Segment information"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for share-based payment transactions [text block]",
        "terseLabel": "Share-based payment"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for treasury shares. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for treasury shares [text block]",
        "terseLabel": "Treasury shares"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForTreasurySharesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]",
        "terseLabel": "New pronouncements issued by IASB and applicable from 2023 or later"
       }
      }
     },
     "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections": {
     "auth_ref": [
      "r130",
      "r131"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Growth rate used to extrapolate cash flow projections",
        "terseLabel": "Perpetual growth rates applied to future cash flows"
       }
      }
     },
     "localname": "DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the initial application of an IFRS. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of initial application of standards or interpretations [text block]",
        "terseLabel": "New standards, amendments and interpretations"
       }
      }
     },
     "localname": "DescriptionOfInitialApplicationOfStandardsOrInterpretations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares": {
     "auth_ref": [
      "r415"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_AdjustedWeightedAverageShares",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options."
       }
      },
      "en-us": {
       "role": {
        "label": "Dilutive effect of share options on number of ordinary shares",
        "terseLabel": "Adjustment for stock options with dilutive effect (in shares)"
       }
      }
     },
     "localname": "DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of accounting judgements and estimates [text block]",
        "terseLabel": "Use of estimates and judgments"
       }
      }
     },
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block]",
        "terseLabel": "Summary of Aggregate Amounts Payable to Key Management Personnel"
       }
      }
     },
     "localname": "DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/RelatedpartytransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of analysis of other comprehensive income by item [line items]",
        "terseLabel": "Disclosure of analysis of other comprehensive income by item [line items]"
       }
      }
     },
     "localname": "DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the analysis of other comprehensive income by item."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of analysis of other comprehensive income by item [table]",
        "terseLabel": "Disclosure of analysis of other comprehensive income by item [table]"
       }
      }
     },
     "localname": "DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfAuditorsRemunerationExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of compensation to the entity's auditors."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of auditors' remuneration [text block]",
        "terseLabel": "Principal accountants' fees and services"
       }
      }
     },
     "localname": "DisclosureOfAuditorsRemunerationExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalaccountantsfeesandservices"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for the preparation of the financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of basis of preparation of financial statements [text block]",
        "terseLabel": "Basis of preparation"
       }
      }
     },
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Basisofpreparation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBusinessCombinationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [line items]",
        "terseLabel": "Disclosure of detailed information about business combination [line items]"
       }
      }
     },
     "localname": "DisclosureOfBusinessCombinationsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfBusinessCombinationsTable": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of business combinations."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [table]",
        "terseLabel": "Disclosure of detailed information about business combination [table]"
       }
      }
     },
     "localname": "DisclosureOfBusinessCombinationsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of cash and cash equivalents [text block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Cashandcashequivalents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [text block]",
        "terseLabel": "Summary of Treasury Shares Held"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [line items]",
        "terseLabel": "Disclosure of classes of share capital [line items]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [table]",
        "terseLabel": "Disclosure of classes of share capital [table]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfCreditRiskExplanatory": {
     "auth_ref": [
      "r266",
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of credit risk. [Refer: Credit risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of credit risk [text block]",
        "terseLabel": "Disclosures about major customers and credit risk"
       }
      }
     },
     "localname": "DisclosureOfCreditRiskExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Disclosuresaboutmajorcustomersandcreditrisk"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfCreditRiskExposureLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of credit risk exposure [line items]",
        "terseLabel": "Disclosure of Credit Risk Exposure [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfCreditRiskExposureLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfCreditRiskExposureTable": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the credit risk exposure."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of credit risk exposure [table]",
        "terseLabel": "Disclosure of Credit Risk Exposure [Table]"
       }
      }
     },
     "localname": "DisclosureOfCreditRiskExposureTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDeferredTaxesExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of deferred taxes [text block]",
        "terseLabel": "Net deferred tax position"
       }
      }
     },
     "localname": "DisclosureOfDeferredTaxesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Netdeferredtaxposition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [line items]",
        "terseLabel": "Disclosure of defined benefit plans [line items]"
       }
      }
     },
     "localname": "DisclosureOfDefinedBenefitPlansLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansTable": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to defined benefit plans."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [table]",
        "terseLabel": "Disclosure of defined benefit plans [table]"
       }
      }
     },
     "localname": "DisclosureOfDefinedBenefitPlansTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of derivative financial instruments. [Refer: Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of derivative financial instruments [text block]",
        "terseLabel": "Derivative financial instruments and market risks"
       }
      }
     },
     "localname": "DisclosureOfDerivativeFinancialInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Derivativefinancialinstrumentsandmarketrisks"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [text block]",
        "terseLabel": "Disclosure of Movement In Total Debt"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [line items]",
        "terseLabel": "Disclosure of detailed information about borrowings [line items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [table]",
        "terseLabel": "Disclosure of detailed information about borrowings [table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [text block]",
        "terseLabel": "Summary of Provisional Purchase Price Allocation",
        "verboseLabel": "Summary of Final Purchase Price Allocation"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020Tables",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r250",
      "r253",
      "r261"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about financial instruments. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [text block]",
        "terseLabel": "Disclosure of Detailed Information about Financial Instruments"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of entity's operating segments [text block]",
        "terseLabel": "Segment information"
       }
      }
     },
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Segmentinformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of events after reporting period [text block]",
        "terseLabel": "Events subsequent to December 31, 2022"
       }
      }
     },
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/EventssubsequenttoDecember312022"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value of defined benefit plan assets. [Refer: Plan assets [member]; Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of fair value of plan assets [text block]",
        "terseLabel": "Fair Value of Plans Assets relating to Pension Plans and Other Post-employment Plans"
       }
      }
     },
     "localname": "DisclosureOfFairValueOfPlanAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFairValueOfPlanAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of fair value of plan assets [line items]",
        "terseLabel": "Disclosure of fair value of plan assets [line items]"
       }
      }
     },
     "localname": "DisclosureOfFairValueOfPlanAssetsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFairValueOfPlanAssetsTable": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the fair value of defined benefit plan assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of fair value of plan assets [table]",
        "terseLabel": "Disclosure of fair value of plan assets [table]"
       }
      }
     },
     "localname": "DisclosureOfFairValueOfPlanAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of finance income (cost) [text block]",
        "terseLabel": "Financial expenses and income"
       }
      }
     },
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Financialexpensesandincome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets that are either past due or impaired [line items]",
        "terseLabel": "Disclosure of financial assets that are either past due or impaired [line items]"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets that are either past due or impaired."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets that are either past due or impaired [table]",
        "terseLabel": "Disclosure of financial assets that are either past due or impaired [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments by type of interest rate [line items]",
        "terseLabel": "Disclosure of financial instruments by type of interest rate [line items]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial instruments, by type of interest rate."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments by type of interest rate [table]",
        "terseLabel": "Disclosure of financial instruments by type of interest rate [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [line items]",
        "terseLabel": "Disclosure of detailed information about financial instruments [line items]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsTable": {
     "auth_ref": [
      "r250",
      "r253",
      "r261"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [table]",
        "terseLabel": "Disclosure of detailed information about financial instruments [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of general information about financial statements [text block]",
        "terseLabel": "Introduction"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Introduction"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasExplanatory": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of geographical information."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [text block]",
        "terseLabel": "Summary of Geographical Information on Net Sales and Non-Current Assets"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [line items]",
        "terseLabel": "Disclosure of geographical areas [line items]"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasTable": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to geographical areas."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [table]",
        "terseLabel": "Disclosure of geographical areas [table]"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial reporting in hyperinflationary economies."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of hyperinflationary reporting [text block]",
        "terseLabel": "Hyperinflation"
       }
      }
     },
     "localname": "DisclosureOfHyperinflationaryReportingExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of impairment loss and reversal of impairment loss [line items]",
        "terseLabel": "Disclosure of impairment loss and reversal of impairment loss [line items]"
       }
      }
     },
     "localname": "DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to impairment loss and the reversal of impairment loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of impairment loss and reversal of impairment loss [table]",
        "terseLabel": "Disclosure of impairment loss and reversal of impairment loss [table]"
       }
      }
     },
     "localname": "DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of income tax [text block]",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Incometaxexpense"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of information about credit exposures designated as measured at fair value through profit or loss [line items]",
        "terseLabel": "Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to credit exposures designated as measured at fair value through profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of information about credit exposures designated as measured at fair value through profit or loss [table]",
        "terseLabel": "Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Table]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of information about employees."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of information about employees [text block]",
        "terseLabel": "Personnel costs"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutEmployeesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Personnelcosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]",
        "terseLabel": "Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the terms and conditions of hedging instruments and how they affect future cash flows."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [table]",
        "terseLabel": "Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Table]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of initial application of standards or interpretations [line items]",
        "terseLabel": "Disclosure of initial application of standards or interpretations [line items]"
       }
      }
     },
     "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the initial application of standards or interpretations."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of initial application of standards or interpretations [table]",
        "terseLabel": "Disclosure of initial application of standards or interpretations [table]"
       }
      }
     },
     "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets and goodwill [text block]",
        "terseLabel": "Goodwill and other intangible assets"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Goodwillandotherintangibleassets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [line items]",
        "terseLabel": "Disclosure of detailed information about intangible assets [line items]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]",
        "terseLabel": "Disclosure of detailed information about intangible assets [table]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of interests in subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of interests in subsidiaries [text block]",
        "terseLabel": "Summary of Principal Companies and their Country of Incorporation"
       }
      }
     },
     "localname": "DisclosureOfInterestsInSubsidiariesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of inventories [text block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DisclosureOfInventoriesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of investments accounted for using equity method [text block]",
        "terseLabel": "Investments accounted for using the equity method"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Investmentsaccountedforusingtheequitymethod"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfJointOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of joint operations [line items]",
        "terseLabel": "Disclosure of joint operations [line Items]"
       }
      }
     },
     "localname": "DisclosureOfJointOperationsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfJointOperationsTable": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to joint operations."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of joint operations [table]",
        "terseLabel": "Disclosure of Joint Operations [Table]"
       }
      }
     },
     "localname": "DisclosureOfJointOperationsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for derivative financial liabilities [line items]",
        "terseLabel": "Disclosure of maturity analysis for derivative financial liabilities [line items]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis for derivative financial liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for derivative financial liabilities [table]",
        "terseLabel": "Disclosure of maturity analysis for derivative financial liabilities [table]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of finance lease payments receivable [line items]",
        "terseLabel": "Disclosure of maturity analysis of finance lease payments receivable [line items]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis of finance lease payments receivable."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of finance lease payments receivable [table]",
        "terseLabel": "Disclosure of maturity analysis of finance lease payments receivable [table]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [line items]",
        "terseLabel": "Disclosure of net defined benefit liability (asset) [line items]"
       }
      }
     },
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the net defined benefit liability (asset)."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [table]",
        "terseLabel": "Disclosure of net defined benefit liability (asset) [table]"
       }
      }
     },
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [abstract]",
        "terseLabel": "Disclosure of non-adjusting events after reporting period [text block]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [line items]",
        "terseLabel": "Disclosure of non-adjusting events after reporting period [line items]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/EventssubsequenttoDecember312022Details"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]",
        "terseLabel": "Description of nature of non-adjusting event after reporting period"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/EventssubsequenttoDecember312022Details"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of non-controlling interests. [Refer: Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-controlling interests [text block]",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "DisclosureOfNoncontrollingInterestsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Noncontrollinginterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of non-current assets or disposal groups classified as held for sale. [Refer: Non-current assets or disposal groups classified as held for sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-current assets or disposal groups classified as held for sale [text block]",
        "terseLabel": "Assets held for sale or exchange and liabilities related to assets held for sale or exchange"
       }
      }
     },
     "localname": "DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Assetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchange"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [text block]",
        "terseLabel": "Schedule of Segment Results"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [line items]",
        "terseLabel": "Disclosure of operating segments [line items]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsTable": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [table]",
        "terseLabel": "Disclosure of operating segments [table]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of other current assets. [Refer: Other current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other current assets [text block]",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "DisclosureOfOtherCurrentAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Othercurrentassets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of other non-current assets. [Refer: Other non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other non-current assets [text block]",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "DisclosureOfOtherNoncurrentAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Othernoncurrentassets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of other operating expense. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other operating expense [text block]",
        "terseLabel": "Other operating expenses"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Otheroperatingexpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of other operating income. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other operating income [text block]",
        "terseLabel": "Other operating income"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingIncomeExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Otheroperatingincome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOtherProvisionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of other provisions [abstract]",
        "terseLabel": "Disclosure of other provisions [abstract]"
       }
      }
     },
     "localname": "DisclosureOfOtherProvisionsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOtherProvisionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other provisions [line items]",
        "terseLabel": "Disclosure of other provisions [line items]"
       }
      }
     },
     "localname": "DisclosureOfOtherProvisionsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOtherProvisionsTable": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to other provisions."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other provisions [table]",
        "terseLabel": "Disclosure of other provisions [table]"
       }
      }
     },
     "localname": "DisclosureOfOtherProvisionsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Propertyplantandequipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [line items]",
        "terseLabel": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]",
        "terseLabel": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [text block]",
        "terseLabel": "Summary of Property, Plant and Equipment Leased"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in goodwill [text block]",
        "terseLabel": "Schedule of Movements in Goodwill"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in goodwill [line items]",
        "terseLabel": "Disclosure of reconciliation of changes in goodwill [line items]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in goodwill [table]",
        "terseLabel": "Disclosure of reconciliation of changes in goodwill [table]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of related party [text block]",
        "terseLabel": "Related party transactions"
       }
      }
     },
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Relatedpartytransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [text block]",
        "terseLabel": "Summary of Sensitivity for Pensions and Other Post-employment Benefits to Changes in Key Actuarial Assumptions"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [line items]",
        "terseLabel": "Disclosure of sensitivity analysis for actuarial assumptions [line items]"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the sensitivity analysis for actuarial assumptions."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [table]",
        "terseLabel": "Disclosure of sensitivity analysis for actuarial assumptions [table]"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "terseLabel": "Consolidated shareholders' equity"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedshareholdersequity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of associates [line items]",
        "terseLabel": "Disclosure of associates [line items]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable": {
     "auth_ref": [
      "r120",
      "r122",
      "r198"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to associates."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of associates [table]",
        "terseLabel": "Disclosure of associates [table]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": {
     "auth_ref": [
      "r120",
      "r122",
      "r195"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [text block]",
        "terseLabel": "List of principal companies included in the scope of consolidation during\u00a02022"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [line items]",
        "terseLabel": "Disclosure of subsidiaries [line items]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": {
     "auth_ref": [
      "r120",
      "r122",
      "r195"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to subsidiaries."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [table]",
        "terseLabel": "Disclosure of Subsidiaries [Table]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [text block]",
        "terseLabel": "Summary of significant accounting policies"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Summaryofsignificantaccountingpolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]",
        "terseLabel": "Summary of Net Deferred Tax Position"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]",
        "terseLabel": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]",
        "terseLabel": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [text block]",
        "terseLabel": "Principal Characteristics of Restricted Share Plans"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]",
        "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [line items]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]",
        "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [abstract]",
        "terseLabel": "Disclosure of compensation paid to key management personnel [abstract]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [text block]",
        "terseLabel": "Summary of Principal Transactions and Balances with Related Parties"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [line items]",
        "terseLabel": "Disclosure of transactions between related parties [line items]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [table]",
        "terseLabel": "Disclosure of transactions between related parties [table]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in intangible assets other than goodwill resulting from disposals and retirements. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals and retirements, intangible assets other than goodwill",
        "negatedTerseLabel": "Disposals and other decreases"
       }
      }
     },
     "localname": "DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals and retirements. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals and retirements, property, plant and equipment",
        "negatedLabel": "Disposals and other decreases"
       }
      }
     },
     "localname": "DisposalsAndRetirementsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsPaidOrdinarySharesPerShare": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends paid per ordinary share."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends paid, ordinary shares per share",
        "terseLabel": "Dividends paid, ordinary shares per share (in EUR per share)"
       }
      }
     },
     "localname": "DividendsPaidOrdinarySharesPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid to equity holders of the parent, classified as financing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends paid to equity holders of parent, classified as financing activities",
        "negatedLabel": "to shareholders of Sanofi"
       }
      }
     },
     "localname": "DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid to non-controlling interests, classified as financing activities. [Refer: Non-controlling interests; Dividends paid to non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends paid to non-controlling interests, classified as financing activities",
        "negatedLabel": "to non-controlling interests, excluding BMS"
       }
      }
     },
     "localname": "DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to non-controlling interests. [Refer: Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends recognised as distributions to non-controlling interests",
        "negatedLabel": "Payment of dividends to non-controlling interests"
       }
      }
     },
     "localname": "DividendsRecognisedAsDistributionsToNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to owners of the parent. [Refer: Parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends recognised as distributions to owners of parent",
        "negatedLabel": "Dividend paid out of earnings"
       }
      }
     },
     "localname": "DividendsRecognisedAsDistributionsToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EffectOfAssetCeilingMember": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the effect of asset ceiling in a defined benefit plan. Asset ceiling is the present value of any economic benefits available in the form of refunds from the defined benefit plan or reductions in future contributions to the defined benefit plan. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of asset ceiling [member]",
        "terseLabel": "Effect of asset ceiling"
       }
      }
     },
     "localname": "EffectOfAssetCeilingMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "auth_ref": [
      "r164",
      "r165"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 5.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "terseLabel": "Impact of exchange rates on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EliminationOfIntersegmentAmountsMember": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the elimination of intersegment amounts in the reconciliations of total segment amounts to amounts recognised in the entity's financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Elimination of intersegment amounts [member]",
        "terseLabel": "Elimination of inter-segment amounts"
       }
      }
     },
     "localname": "EliminationOfIntersegmentAmountsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EmployeeBenefitsExpense": {
     "auth_ref": [
      "r1",
      "r53",
      "r303"
     ],
     "calculation": {
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment."
       }
      },
      "en-us": {
       "role": {
        "label": "Employee benefits expense",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EmployeeBenefitsExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EntitysTotalForAssociatesMember": {
     "auth_ref": [
      "r120",
      "r122",
      "r198",
      "r291",
      "r295"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Associates' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for associates [member]",
        "terseLabel": "Entity's total for associates"
       }
      }
     },
     "localname": "EntitysTotalForAssociatesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails",
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/OtheroperatingincomeDetails",
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForBusinessCombinationsMember": {
     "auth_ref": [
      "r234",
      "r239"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for business combinations [member]",
        "terseLabel": "Entity's total for business combinations"
       }
      }
     },
     "localname": "EntitysTotalForBusinessCombinationsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForCashgeneratingUnitsMember": {
     "auth_ref": [
      "r132",
      "r134"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Cash-generating units' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for cash-generating units [member]",
        "terseLabel": "Entity's total for cash-generating units [member]"
       }
      }
     },
     "localname": "EntitysTotalForCashgeneratingUnitsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForJointOperationsMember": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Joint operations' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for joint operations [member]",
        "terseLabel": "Entity's Total for Joint Operations [Member]"
       }
      }
     },
     "localname": "EntitysTotalForJointOperationsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForJointVenturesMember": {
     "auth_ref": [
      "r120",
      "r122",
      "r196",
      "r291",
      "r295"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Joint ventures' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for joint ventures [member]",
        "terseLabel": "Entity's total for joint ventures"
       }
      }
     },
     "localname": "EntitysTotalForJointVenturesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]",
        "terseLabel": "Entity's total for related parties"
       }
      }
     },
     "localname": "EntitysTotalForRelatedPartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails",
      "http://www.sanofi.com/role/OtheroperatingincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSegmentConsolidationItemsMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for segment consolidation items [member]",
        "terseLabel": "Entity's total for segment consolidation items [member]"
       }
      }
     },
     "localname": "EntitysTotalForSegmentConsolidationItemsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSubsidiariesMember": {
     "auth_ref": [
      "r120",
      "r122",
      "r195"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for subsidiaries [member]",
        "terseLabel": "Entity's total for subsidiaries"
       }
      }
     },
     "localname": "EntitysTotalForSubsidiariesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical",
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r24",
      "r32",
      "r176",
      "r178",
      "r199",
      "r200",
      "r203"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails",
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total equity and liabilities"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and liabilities [abstract]",
        "terseLabel": "Equity and liabilities"
       }
      }
     },
     "localname": "EquityAndLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent",
        "terseLabel": "Attributable to equity holders of Sanofi",
        "verboseLabel": "Equity attributable to equity holders of Sanofi"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParentMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity attributable to the owners of the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent [member]",
        "terseLabel": "Attributable to\u00a0equity holders of Sanofi"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity",
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EquityInvestmentsMember": {
     "auth_ref": [
      "r354",
      "r367"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for investments in equity instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity investments [member]",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquityInvestmentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [member]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity",
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan": {
     "auth_ref": [
      "r94",
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The estimate of the expected contributions to be made to a defined benefit plan for the next annual reporting period. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Estimate of contributions expected to be paid to plan for next annual reporting period",
        "terseLabel": "Estimate of contributions expected to be paid to plan for next annual reporting period"
       }
      }
     },
     "localname": "EstimateOfContributionsExpectedToBePaidToPlan",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EstimatedFinancialEffectOfContingentLiabilities": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the estimated financial effect of contingent liabilities. [Refer: Contingent liabilities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Estimated financial effect of contingent liabilities",
        "terseLabel": "Estimated financial effect of contingent liabilities"
       }
      }
     },
     "localname": "EstimatedFinancialEffectOfContingentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The exercise price of outstanding share options."
       }
      },
      "en-us": {
       "role": {
        "label": "Exercise price of outstanding share options",
        "terseLabel": "Exercise price of outstanding options (in euros per share)"
       }
      }
     },
     "localname": "ExercisePriceOfOutstandingShareOptions2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense recognised due to the unwinding of the discount on provisions other than provisions from employee benefits, resulting from the effect of the passage of time. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense arising from passage of time on other provisions",
        "negatedLabel": "Unwinding of discounting of provisions"
       }
      }
     },
     "localname": "ExpenseDueToUnwindingOfDiscountOnProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from equity-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from equity-settled share-based payment transactions",
        "netLabel": "Total expense for restricted share plans",
        "terseLabel": "Expense recognized"
       }
      }
     },
     "localname": "ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions with employees",
        "terseLabel": "Stock options and other share-based payment expense"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseOfRestructuringActivities": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 8.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense of restructuring activities",
        "negatedLabel": "Restructuring costs and similar items",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "ExpenseOfRestructuringActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FairValueHedgesMember": {
     "auth_ref": [
      "r152",
      "r245",
      "r246",
      "r247"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for hedges of the exposure to changes in fair value of a recognised asset or liability or an unrecognised firm commitment, or an identified portion of such an asset, liability or firm commitment, that is attributable to a particular risk and could affect profit or loss. [Refer: Hedges [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Fair value hedges [member]",
        "terseLabel": "Derivatives designated as fair value hedges"
       }
      }
     },
     "localname": "FairValueHedgesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [
      "r242",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: At fair value [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in equity instruments designated at fair value through other comprehensive income",
        "terseLabel": "Investments in equity instruments designated at fair value through OCI"
       }
      }
     },
     "localname": "FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceCosts": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 2.0,
       "parentTag": "sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments",
       "weight": -1.0
      },
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails_1": {
       "order": 1.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      },
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails": {
       "order": 2.0,
       "parentTag": "sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance costs",
        "negatedLabel": "comprising: Financial expenses",
        "negatedTerseLabel": "Financial expenses",
        "terseLabel": "Financial expenses"
       }
      }
     },
     "localname": "FinanceCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncome": {
     "auth_ref": [
      "r401"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 3.0,
       "parentTag": "sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails_1": {
       "order": 2.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income",
        "terseLabel": "comprising: financial income",
        "verboseLabel": "Financial income"
       }
      }
     },
     "localname": "FinanceIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncomeCost": {
     "auth_ref": [
      "r401"
     ],
     "calculation": {
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income (cost)",
        "totalLabel": "Net financial income/(expenses)"
       }
      }
     },
     "localname": "FinanceIncomeCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssets": {
     "auth_ref": [
      "r249",
      "r251",
      "r252",
      "r254",
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets",
        "terseLabel": "Total financial assets measured at fair value"
       }
      }
     },
     "localname": "FinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial assets at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets at fair value through other comprehensive income",
        "terseLabel": "Debt instruments at fair value through other comprehensive income"
       }
      }
     },
     "localname": "FinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsCategoryMember": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, category [member]",
        "terseLabel": "Financial assets, category [member]"
       }
      }
     },
     "localname": "FinancialAssetsCategoryMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsMember": {
     "auth_ref": [
      "r259",
      "r260",
      "r281",
      "r286",
      "r287",
      "r288"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, class [member]",
        "terseLabel": "Financial assets, class"
       }
      }
     },
     "localname": "FinancialAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of financial instruments designated as hedging instruments. Hedging instruments are designated derivatives or (for a hedge of the risk of changes in foreign currency exchange rates only) designated non-derivative financial assets or non-derivative financial liabilities whose fair value or cash flows are expected to offset changes in the fair value or cash flows of a designated hedged item. [Refer: At fair value [member]; Derivatives [member]; Derivative financial assets; Derivative financial liabilities; Financial instruments, class [member]; Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial instruments designated as hedging instruments, at fair value",
        "totalLabel": "Market value"
       }
      }
     },
     "localname": "FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [axis]",
        "terseLabel": "Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [axis]"
       }
      }
     },
     "localname": "FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for financial instruments measured at fair value through profit or loss, because a credit derivative is used to manage the credit risk of these instruments. It also represents the standard value for the 'Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk' axis if no other member is used. [Refer: Financial instruments, class [member]; Credit risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [member]",
        "terseLabel": "Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [member]"
       }
      }
     },
     "localname": "FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialLiabilities": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities",
        "terseLabel": "Total financial liabilities measured at fair value"
       }
      }
     },
     "localname": "FinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinishedGoods": {
     "auth_ref": [
      "r309",
      "r413"
     ],
     "calculation": {
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current finished goods",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "FinishedGoods",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FixedInterestRateMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a fixed interest rate. [Refer: Interest rate risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Fixed interest rate [member]",
        "terseLabel": "Fixed-rate debt"
       }
      }
     },
     "localname": "FixedInterestRateMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FixturesAndFittingsMember": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Fixtures and fittings [member]",
        "terseLabel": "Fixtures, fittings\u00a0and other",
        "verboseLabel": "Fixtures"
       }
      }
     },
     "localname": "FixturesAndFittingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FloatingInterestRateMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a non-fixed interest rate. [Refer: Interest rate risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Floating interest rate [member]",
        "terseLabel": "Floating-rate debt"
       }
      }
     },
     "localname": "FloatingInterestRateMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Funding arrangements of defined benefit plans [axis]",
        "terseLabel": "Funding arrangements of defined benefit plans [axis]"
       }
      }
     },
     "localname": "FundingArrangementsOfDefinedBenefitPlansAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all defined benefit plans when disaggregated by funding arrangements of defined benefits plans. It also represents the standard value for the 'Funding arrangements of defined benefits plans' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Funding arrangements of defined benefit plans [member]",
        "terseLabel": "Funding arrangements of defined benefit plans [member]"
       }
      }
     },
     "localname": "FundingArrangementsOfDefinedBenefitPlansMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails": {
       "order": 2.0,
       "parentTag": "sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income",
        "negatedLabel": "Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses)",
        "terseLabel": "Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses)",
        "verboseLabel": "Actuarial gains/(losses) arising during the period"
       }
      }
     },
     "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets": {
     "auth_ref": [
      "r296"
     ],
     "calculation": {
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) on available-for-sale financial assets. [Refer: Financial assets available-for-sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on available-for-sale financial assets",
        "terseLabel": "Gains/(losses) on disposals of financial assets"
       }
      }
     },
     "localname": "GainsLossesOnAvailableforsaleFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax": {
     "auth_ref": [
      "r48",
      "r299"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in other comprehensive income on cash flow hedges, before tax, before reclassification adjustments. [Refer: Cash flow hedges [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on cash flow hedges, before tax",
        "terseLabel": "Change in fair value of cash flow hedges"
       }
      }
     },
     "localname": "GainsLossesOnCashFlowHedgesBeforeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, before tax, before reclassification adjustments. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on exchange differences on translation of foreign operations, before tax",
        "terseLabel": "Change in currency translation differences"
       }
      }
     },
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationBeforeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax": {
     "auth_ref": [
      "r292",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in other comprehensive income on remeasuring available-for-sale financial assets, net of tax, before reclassification adjustments. [Refer: Financial assets available-for-sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on remeasuring available-for-sale financial assets, net of tax",
        "terseLabel": "Gains (losses) on remeasuring available-for-sale financial assets, net of tax"
       }
      }
     },
     "localname": "GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments": {
     "auth_ref": [
      "r202"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) including exchange differences recognised in other comprehensive income on the fair value measurement of the entity's own equity instruments. [Refer: At fair value [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) recognised in other comprehensive income including exchange differences, fair value measurement, entity's own equity instruments",
        "terseLabel": "Change in fair value of equity instruments included in\u00a0financial assets and financial liabilities"
       }
      }
     },
     "localname": "GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) including exchange differences recognised in profit or loss on the fair value measurement of liabilities. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, liabilities",
        "terseLabel": "Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)"
       }
      }
     },
     "localname": "GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsOnDisposalsOfInvestments": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 9.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gain on the disposal of investments."
       }
      },
      "en-us": {
       "role": {
        "label": "Gains on disposals of investments",
        "terseLabel": "Gain on Regeneron investment arising from transaction of\u00a0May\u00a029, 2020"
       }
      }
     },
     "localname": "GainsOnDisposalsOfInvestments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsOnDisposalsOfNoncurrentAssets": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gain on disposals of non-current assets. [Refer: Non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains on disposals of non-current assets",
        "terseLabel": "Gains on disposal of non-current assets, net of tax"
       }
      }
     },
     "localname": "GainsOnDisposalsOfNoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeographicalAreasAxis": {
     "auth_ref": [
      "r278",
      "r318",
      "r346",
      "r371"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]",
        "terseLabel": "Geographical areas [axis]"
       }
      }
     },
     "localname": "GeographicalAreasAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails",
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GeographicalAreasMember": {
     "auth_ref": [
      "r278",
      "r318",
      "r346",
      "r371"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [member]",
        "terseLabel": "Geographical areas [member]"
       }
      }
     },
     "localname": "GeographicalAreasMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails",
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Goodwill": {
     "auth_ref": [
      "r13",
      "r129",
      "r133",
      "r238"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GoodwillMember": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goodwill [member]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goodwill recognised as of acquisition date",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "auth_ref": [
      "r67",
      "r142",
      "r156",
      "r159",
      "r238",
      "r252",
      "r254",
      "r353",
      "r438",
      "r439"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]",
        "terseLabel": "Gross value"
       }
      }
     },
     "localname": "GrossCarryingAmountMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GrossProfit": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_HedgedItemsAxis": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Hedged items [axis]",
        "terseLabel": "Hedged items [axis]"
       }
      }
     },
     "localname": "HedgedItemsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_HedgedItemsMember": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for hedged items. A hedged item can be a recognised asset or liability, an unrecognised firm commitment, a forecast transaction or a net investment in a foreign operation. The hedged item can be: (a) a single item; or (b) a group of items (subject to paragraphs 6.6.1\u20136.6.6 and B6.6.1\u2013B6.6.16 of IFRS 9). A hedged item can also be a component of such an item or group of items (see paragraphs 6.3.7 and B6.3.7\u2013B6.3.25 of IFRS 9). This member also represents the standard value for the 'Hedged items' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Hedged items [member]",
        "terseLabel": "Hedged items [member]"
       }
      }
     },
     "localname": "HedgedItemsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_HedgingInstrumentsAxis": {
     "auth_ref": [
      "r243",
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Hedging instruments [axis]",
        "terseLabel": "Hedging instruments [axis]"
       }
      }
     },
     "localname": "HedgingInstrumentsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_HedgingInstrumentsMember": {
     "auth_ref": [
      "r243",
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for hedging instruments. A hedging instrument can be a designated: (a) derivative measured at fair value through profit or loss, except for some written options (see paragraph B6.2.4 of IFRS 9); (b) non-derivative financial asset or non-derivative financial liability measured at fair value through profit or loss, unless it is a financial liability designated as at fair value through profit or loss for which the amount of its change in fair value that is attributable to changes in the credit risk of that liability is presented in other comprehensive income in accordance with paragraph 5.7.7 of IFRS 9. For a hedge of foreign currency risk, the foreign currency risk component of a non-derivative financial asset or a non-derivative financial liability may be designated as a hedging instrument provided that it is not an investment in an equity instrument for which an entity has elected to present changes in fair value in other comprehensive income in accordance with paragraph 5.7.5 of IFRS 9. This member also represents the standard value for the 'Hedging instruments' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Hedging instruments [member]",
        "terseLabel": "Hedging instruments [member]"
       }
      }
     },
     "localname": "HedgingInstrumentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_HeldtomaturityInvestments": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-derivative financial assets with fixed or determinable payments and fixed maturity that an entity has the positive intention and ability to hold to maturity other than: (a) those that the entity upon initial recognition designates as at fair value through profit or loss; (b) those that the entity designates as available for sale; and (c) those that meet the definition of loans and receivables. An entity shall not classify any financial assets as held to maturity if the entity has, during the current financial year or during the two preceding financial years, sold or reclassified more than an insignificant amount of held-to-maturity investments before maturity (more than insignificant in relation to the total amount of held-to-maturity investments) other than sales or reclassifications that: (i) are so close to maturity or the financial asset\u2019s call date (for example, less than three months before maturity) that changes in the market rate of interest would not have a significant effect on the financial asset\u2019s fair value; (ii) occur after the entity has collected substantially all of the financial asset\u2019s original principal through scheduled payments or prepayments; or (iii) are attributable to an isolated event that is beyond the entity\u2019s control, is non-recurring and could not have been reasonably anticipated by the entity. [Refer: Derivative financial assets; Held-to-maturity investments; Prepayments]"
       }
      },
      "en-us": {
       "role": {
        "label": "Held-to-maturity investments",
        "terseLabel": "Financial assets held for investments"
       }
      }
     },
     "localname": "HeldtomaturityInvestments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": {
     "auth_ref": [
      "r350",
      "r352"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Identifiable assets acquired (liabilities assumed)",
        "terseLabel": "Net assets of Translate Bio",
        "totalLabel": "Net assets of Translate Bio"
       }
      }
     },
     "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r350",
      "r352"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Identifiable intangible assets recognised as of acquisition date",
        "netLabel": "Identifiable intangible assets recognised as of acquisition date",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in other comprehensive income for intangible assets other than goodwill. [Refer: Impairment loss recognised in other comprehensive income; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in other comprehensive income, intangible assets other than goodwill",
        "negatedTerseLabel": "Impairment losses, net of reversals"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in profit or loss, goodwill",
        "terseLabel": "Impairment of goodwill recognized"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInProfitOrLossGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 7.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in profit or loss, intangible assets other than goodwill",
        "negatedLabel": "Impairment of intangible assets",
        "terseLabel": "Impairment of intangible assets"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/EventssubsequenttoDecember312022Details",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": {
     "auth_ref": [
      "r50",
      "r69"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in profit or loss, property, plant and equipment",
        "verboseLabel": "Net impairment losses on property, plant and equipment"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofImpairmentLossesRecognisedinPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for trade receivables. [Refer: Impairment loss recognised in profit or loss; Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in profit or loss, trade receivables",
        "terseLabel": "Impairment loss recognised in profit or loss, trade receivables"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInProfitOrLossTradeReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "auth_ref": [
      "r45",
      "r56",
      "r58",
      "r59",
      "r117",
      "r193",
      "r269"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      },
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income)",
        "negatedLabel": "Income tax expense",
        "negatedTerseLabel": "Tax expense (income)",
        "negatedTotalLabel": "Total"
       }
      }
     },
     "localname": "IncomeTaxExpenseContinuingOperations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome": {
     "auth_ref": [
      "r46",
      "r57"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income tax relating to cash flow hedges included in other comprehensive income",
        "negatedTerseLabel": "Tax effects"
       }
      }
     },
     "localname": "IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income that will be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income tax relating to components of other comprehensive income that will be reclassified to profit or loss",
        "negatedLabel": "Tax effects"
       }
      }
     },
     "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income that will not be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss",
        "negatedLabel": "Tax effects"
       }
      }
     },
     "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r167",
      "r329"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes paid (refund), classified as operating activities",
        "negatedTerseLabel": "Income tax paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the financial effect of changes in accounting policy for cumulative effect adjustment in the financial statements at the date of initial application of a new or amended IFRS Standard. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) due to changes in accounting policy required by IFRSs, cumulative effect at date of initial application [member]",
        "terseLabel": "Impact of applying IFRIC agenda decision on IAS 19"
       }
      }
     },
     "localname": "IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "auth_ref": [
      "r171"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 6.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a contingent consideration asset (liability) relating to a business combination."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in contingent consideration asset (liability)",
        "negatedLabel": "Fair value remeasurement of contingent consideration",
        "terseLabel": "Fair value remeasurement of contingent consideration"
       }
      }
     },
     "localname": "IncreaseDecreaseInContingentConsiderationAssetLiability",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption",
        "terseLabel": "Measurement of defined-benefit obligation"
       }
      }
     },
     "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from business combinations and disposals. [Refer: Business combinations [member]; Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from business combinations and disposals",
        "terseLabel": "Changes in scope of consolidation and transfers"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset)",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of options, equity",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets and goodwill resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, intangible assets and goodwill",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, other provisions",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, property, plant and equipment",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets and goodwill resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through other changes, intangible assets and goodwill",
        "terseLabel": "Other movements during the period"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity": {
     "auth_ref": [
      "r5"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Equity]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through other changes, equity",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in other provisions resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers and other changes, other provisions",
        "terseLabel": "Transfers"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers, intangible assets other than goodwill",
        "terseLabel": "Transfers"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers, property, plant and equipment",
        "terseLabel": "Transfers"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash-generating units [axis]",
        "terseLabel": "Cash-generating units [axis]"
       }
      }
     },
     "localname": "IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash-generating units [member]",
        "terseLabel": "Cash-generating units"
       }
      }
     },
     "localname": "IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_IntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "IntangibleAssetsAndGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsAndGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill [abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsAndGoodwillAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IntangibleAssetsAndGoodwillMember": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill [member]",
        "terseLabel": "Intangible assets and goodwill [member]"
       }
      }
     },
     "localname": "IntangibleAssetsAndGoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinGoodwillDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r13",
      "r148"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 5.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill",
        "terseLabel": "Intangible assets other than goodwill",
        "verboseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "auth_ref": [
      "r149",
      "r324",
      "r347"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [member]",
        "terseLabel": "Intangible assets other than goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestCostsCapitalised": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest costs capitalised",
        "terseLabel": "Capitalized interest"
       }
      }
     },
     "localname": "InterestCostsCapitalised",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)",
        "terseLabel": "Interest (income)/cost"
       }
      }
     },
     "localname": "InterestExpenseIncomeNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseOnBorrowings": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails": {
       "order": 1.0,
       "parentTag": "sny_CostOfDebtNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense on borrowings. [Refer: Interest expense; Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense on borrowings",
        "negatedLabel": "Cost of debt"
       }
      }
     },
     "localname": "InterestExpenseOnBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense on lease liabilities",
        "negatedTerseLabel": "Net interest expense on lease liabilities"
       }
      }
     },
     "localname": "InterestExpenseOnLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestPaidClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as operating activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest paid, classified as operating activities",
        "negatedLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidClassifiedAsOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestRateTypesMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest rate types [member]",
        "terseLabel": "Interest rate types [member]"
       }
      }
     },
     "localname": "InterestRateTypesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as operating activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest received, classified as operating activities",
        "terseLabel": "Interest received"
       }
      }
     },
     "localname": "InterestReceivedClassifiedAsOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Inventories": {
     "auth_ref": [
      "r16",
      "r100",
      "r306"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current inventories",
        "terseLabel": "Inventories",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "Inventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InventoriesPledgedAsSecurityForLiabilities": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of inventories pledged as security for liabilities. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Inventories pledged as security for liabilities",
        "terseLabel": "Inventories pledged as security for liabilities"
       }
      }
     },
     "localname": "InventoriesPledgedAsSecurityForLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InventoriesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r15",
      "r194",
      "r271"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 8.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments accounted for using equity method",
        "terseLabel": "Investments accounted for using the equity method"
       }
      }
     },
     "localname": "InvestmentAccountedForUsingEquityMethod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in equity instruments designated at fair value through other comprehensive income [axis]",
        "terseLabel": "Investments in equity instruments designated at fair value through other comprehensive income [axis]"
       }
      }
     },
     "localname": "InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r242",
      "r263"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for investments in equity instruments that the entity has designated at fair value through other comprehensive income. It also represents the standard value for the 'Investments in equity instruments designated at fair value through other comprehensive income' axis if no other member is used. [Refer: At fair value [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in equity instruments designated at fair value through other comprehensive income [member]",
        "terseLabel": "Investments in equity instruments designated at fair value through other comprehensive income [member]"
       }
      }
     },
     "localname": "InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InvestmentsInJointVentures": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in joint ventures in an entity's separate financial statements. [Refer: Joint ventures [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in joint ventures reported in separate financial statements",
        "terseLabel": "Investments in joint ventures"
       }
      }
     },
     "localname": "InvestmentsInJointVentures",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in subsidiaries, joint ventures and associates reported in separate financial statements",
        "terseLabel": "Investments in subsidiaries, joint ventures and associates"
       }
      }
     },
     "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapital": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "IssuedCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapitalMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital [member]",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "IssuedCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails",
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_JointOperationsAxis": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Joint operations [axis]",
        "terseLabel": "Joint Operations [Axis]"
       }
      }
     },
     "localname": "JointOperationsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_JointVenturesAxis": {
     "auth_ref": [
      "r120",
      "r122",
      "r196",
      "r291",
      "r295"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Joint ventures [axis]",
        "terseLabel": "Joint ventures [axis]"
       }
      }
     },
     "localname": "JointVenturesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_JointVenturesMember": {
     "auth_ref": [
      "r120",
      "r122",
      "r196",
      "r289",
      "r293"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for joint arrangements whereby the parties that have joint control of the arrangement have rights to the net assets of the arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Joint ventures [member]",
        "terseLabel": "Joint ventures"
       }
      }
     },
     "localname": "JointVenturesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation",
        "totalLabel": "Total recognized in profit or loss"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, post-employment benefits",
        "terseLabel": "Post-employment benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, share-based payment",
        "terseLabel": "Share-based payment"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, short-term employee benefits",
        "terseLabel": "Short-term benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/RelatedpartytransactionsScheduleofCompensationPaidtoKeyManagementPersonnelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LandAndBuildingsMember": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing land and depreciable buildings and similar structures for use in operations. [Refer: Buildings; Land; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Land and buildings [member]",
        "terseLabel": "Office and industrial premises"
       }
      }
     },
     "localname": "LandAndBuildingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LandMember": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing land held by the entity for use in operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Land [member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "auth_ref": [
      "r216",
      "r217",
      "r285",
      "r357",
      "r364",
      "r366"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than five years [member]",
        "terseLabel": "More\u00a0than 5\u00a0years",
        "verboseLabel": "Year 5 and later"
       }
      }
     },
     "localname": "LaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r216",
      "r217",
      "r285",
      "r357",
      "r366",
      "r395"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than four years and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than four years and not later than five years [member]",
        "terseLabel": "4 to 5 years",
        "verboseLabel": "Year 5"
       }
      }
     },
     "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember": {
     "auth_ref": [
      "r356",
      "r359",
      "r366"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one month and not later than three months."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one month and not later than three months [member]",
        "terseLabel": "1\u00a0to\u00a03\u00a0months"
       }
      }
     },
     "localname": "LaterThanOneMonthAndNotLaterThanThreeMonthsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": {
     "auth_ref": [
      "r357",
      "r362",
      "r366"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than three years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one year and not later than three years [member]",
        "terseLabel": "From\u00a01\u00a0to 3\u00a0years"
       }
      }
     },
     "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": {
     "auth_ref": [
      "r216",
      "r217",
      "r285",
      "r357",
      "r366",
      "r395"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than two years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one year and not later than two years [member]",
        "terseLabel": "1\u00a0to\u00a02 years",
        "verboseLabel": "Year 2"
       }
      }
     },
     "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearMember": {
     "auth_ref": [
      "r27",
      "r374",
      "r378"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one year [member]",
        "verboseLabel": "Later than 12 months"
       }
      }
     },
     "localname": "LaterThanOneYearMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember": {
     "auth_ref": [
      "r357",
      "r361",
      "r366",
      "r374",
      "r377"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than six months and not later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than six months and not later than one year [member]",
        "terseLabel": "6\u00a0to\u00a012\u00a0months"
       }
      }
     },
     "localname": "LaterThanSixMonthsAndNotLaterThanOneYearMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember": {
     "auth_ref": [
      "r357",
      "r360",
      "r366",
      "r374",
      "r376"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three months and not later than six months."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than three months and not later than six months [member]",
        "terseLabel": "3\u00a0to\u00a06\u00a0months"
       }
      }
     },
     "localname": "LaterThanThreeMonthsAndNotLaterThanSixMonthsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r357",
      "r363",
      "r366"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three years and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than three years and not later than five years [member]",
        "terseLabel": "From\u00a03\u00a0to 5\u00a0years"
       }
      }
     },
     "localname": "LaterThanThreeYearsAndNotLaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember": {
     "auth_ref": [
      "r216",
      "r217",
      "r285",
      "r357",
      "r366",
      "r395"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three years and not later than four years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than three years and not later than four years [member]",
        "terseLabel": "3 to 4 years",
        "verboseLabel": "Year 4"
       }
      }
     },
     "localname": "LaterThanThreeYearsAndNotLaterThanFourYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember": {
     "auth_ref": [
      "r216",
      "r217",
      "r285",
      "r357",
      "r366",
      "r395"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than two years and not later than three years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than two years and not later than three years [member]",
        "terseLabel": "2 to 3 years",
        "verboseLabel": "Year 3"
       }
      }
     },
     "localname": "LaterThanTwoYearsAndNotLaterThanThreeYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseLiabilities": {
     "auth_ref": [
      "r210"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Level1OfFairValueHierarchyMember": {
     "auth_ref": [
      "r91",
      "r200"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 1 of fair value hierarchy [member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "Level1OfFairValueHierarchyMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 2 of fair value hierarchy [member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "Level2OfFairValueHierarchyMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 3 of fair value hierarchy [member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "Level3OfFairValueHierarchyMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "auth_ref": [
      "r91",
      "r200"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]",
        "terseLabel": "Levels of fair value hierarchy [axis]"
       }
      }
     },
     "localname": "LevelsOfFairValueHierarchyAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale": {
     "auth_ref": [
      "r21",
      "r241"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 4.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities included in disposal groups classified as held for sale. [Refer: Liabilities; Disposal groups classified as held for sale [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities included in disposal groups classified as held for sale",
        "terseLabel": "Liabilities related to assets held for sale or exchange"
       }
      }
     },
     "localname": "LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeSummaryofAssetsHeldforSaleorExchangeandLiabilitiesRelatedtoAssetsHeldforSaleorExchangeDetails",
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesMember": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities [member]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset)",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period",
        "terseLabel": "Net amount shown in the balance sheet at end of period",
        "totalLabel": "Net amount shown in the balance sheet at end of period",
        "verboseLabel": "Net defined benefit liability (asset)"
       }
      }
     },
     "localname": "LiabilityAssetOfDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LongtermBorrowings": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current portion of non-current borrowings",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongtermBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LongtermBorrowingsMember": {
     "auth_ref": [
      "r336",
      "r339"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for long-term borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Long-term borrowings [member]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongtermBorrowingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LongtermRestructuringProvision": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current provision for restructuring. [Refer: Restructuring provision]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current restructuring provision",
        "terseLabel": "Classified in non-current liabilities"
       }
      }
     },
     "localname": "LongtermRestructuringProvision",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MajorCustomersAxis": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Major customers [axis]",
        "terseLabel": "Major customers [axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MajorCustomersMember": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Customers [member]",
        "terseLabel": "Customers [member]"
       }
      }
     },
     "localname": "MajorCustomersMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for material adjustments used to reconcile items in the entity's financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Material reconciling items [member]",
        "terseLabel": "Material reconciling items"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MaturityAxis": {
     "auth_ref": [
      "r28",
      "r209",
      "r216",
      "r217",
      "r244",
      "r258",
      "r282",
      "r283",
      "r284",
      "r285",
      "r321",
      "r357"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Maturity [axis]",
        "terseLabel": "Maturity [axis]"
       }
      }
     },
     "localname": "MaturityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MeasurementAxis": {
     "auth_ref": [
      "r154",
      "r158",
      "r199"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Measurement [axis]",
        "terseLabel": "Measurement [axis]"
       }
      }
     },
     "localname": "MeasurementAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MiscellaneousOtherOperatingExpense": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 4.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Miscellaneous other operating expense",
        "negatedLabel": "Other operating expenses",
        "terseLabel": "Other operating expense",
        "verboseLabel": "Other operating expenses"
       }
      }
     },
     "localname": "MiscellaneousOtherOperatingExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesAdditionalInformationDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MiscellaneousOtherOperatingIncome": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 10.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other operating income. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Miscellaneous other operating income",
        "terseLabel": "Other operating income"
       }
      }
     },
     "localname": "MiscellaneousOtherOperatingIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/OtheroperatingincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MiscellaneousOtherProvisionsMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for miscellaneous other provisions. [Refer: Other provisions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Miscellaneous other provisions [member]",
        "terseLabel": "Other provisions"
       }
      }
     },
     "localname": "MiscellaneousOtherProvisionsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MultiemployerDefinedBenefitPlansMember": {
     "auth_ref": [
      "r97",
      "r98"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for defined benefit plans (other than state plans) that: (a) pool the assets contributed by various entities that are not under common control; and (b) use those assets to provide benefits to employees of more than one entity, on the basis that contribution and benefit levels are determined without regard to the identity of the entity that employs the employees. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Multi-employer defined benefit plans [member]",
        "terseLabel": "Multi-employer plan (Pensionskasses)"
       }
      }
     },
     "localname": "MultiemployerDefinedBenefitPlansMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetAxis": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset) [axis]",
        "terseLabel": "Net defined benefit liability (asset) [axis]"
       }
      }
     },
     "localname": "NetDefinedBenefitLiabilityAssetAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetMember": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the net defined benefit liability (asset). It also represents the standard value for the 'Net defined benefit liability (asset)' axis if no other member is used. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset) [member]",
        "terseLabel": "Net defined benefit liability (asset) [member]"
       }
      }
     },
     "localname": "NetDefinedBenefitLiabilityAssetMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NetForeignExchangeLoss": {
     "auth_ref": [
      "r397",
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net foreign exchange loss",
        "terseLabel": "Net foreign exchange loss"
       }
      }
     },
     "localname": "NetForeignExchangeLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised for new contingent liabilities recognised in a business combination. [Refer: Contingent liabilities recognised in business combination]"
       }
      },
      "en-us": {
       "role": {
        "label": "New liabilities, contingent liabilities recognised in business combination",
        "terseLabel": "New transactions"
       }
      }
     },
     "localname": "NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]",
        "terseLabel": "Non-adjusting events after reporting period [axis]"
       }
      }
     },
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NonadjustingEventsMember": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [member]",
        "terseLabel": "Non-adjusting events after reporting period [member]"
       }
      }
     },
     "localname": "NonadjustingEventsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncontrollingInterests": {
     "auth_ref": [
      "r22",
      "r180",
      "r183"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests",
        "terseLabel": "Attributable to non-controlling interests",
        "verboseLabel": "Equity attributable to non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests [member]",
        "terseLabel": "Attributable to\u00a0non- controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r29",
      "r188",
      "r340"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale": {
     "auth_ref": [
      "r241"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 3.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current assets or disposal groups classified as held for sale. [Refer: Disposal groups classified as held for sale [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets or disposal groups classified as held for sale",
        "terseLabel": "Assets held for sale or exchange"
       }
      }
     },
     "localname": "NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeSummaryofAssetsHeldforSaleorExchangeandLiabilitiesRelatedtoAssetsHeldforSaleorExchangeDetails",
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets and rights arising under insurance contracts. [Refer: Deferred tax assets; Financial instruments, class [member]; Non-current assets; Types of insurance contracts [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts",
        "terseLabel": "Exchange for financial assets held to meet obligations to employees under post-employment benefit plans"
       }
      }
     },
     "localname": "NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentDerivativeFinancialAssets": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_DerivativeFinancialAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current derivative financial assets. [Refer: Derivative financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current derivative financial assets",
        "terseLabel": "Derivative financial instruments",
        "verboseLabel": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentDerivativeFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentDerivativeFinancialLiabilities": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_DerivativeFinancialLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current derivative financial liabilities",
        "negatedTerseLabel": "Non-current liabilities",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentDerivativeFinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentFinanceLeaseReceivables": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current finance lease receivables. [Refer: Finance lease receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current finance lease receivables",
        "terseLabel": "Non-current finance lease receivables"
       }
      }
     },
     "localname": "NoncurrentFinanceLeaseReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets at fair value through other comprehensive income. [Refer: Financial assets at fair value through other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current financial assets at fair value through other comprehensive income",
        "terseLabel": "Fair value through other comprehensive income"
       }
      }
     },
     "localname": "NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current financial assets at fair value through profit or loss",
        "terseLabel": "Other financial assets at fair value through profit or loss"
       }
      }
     },
     "localname": "NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities",
        "terseLabel": "Non-current lease liabilities"
       }
      }
     },
     "localname": "NoncurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilities": {
     "auth_ref": [
      "r30",
      "r189",
      "r340"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "totalLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLoansAndReceivables": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current loans and receivables. [Refer: Loans and receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current loans and receivables",
        "terseLabel": "Long-term loans and advances and other non-current receivables"
       }
      }
     },
     "localname": "NoncurrentLoansAndReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentProvisions": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current provisions",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Provisions",
        "verboseLabel": "Obligations provided for"
       }
      }
     },
     "localname": "NoncurrentProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails": {
       "order": 1.0,
       "parentTag": "sny_TotalUndiscountedCashFlow",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to non-derivative financial liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-derivative financial liabilities, undiscounted cash flows",
        "totalLabel": "Debt"
       }
      }
     },
     "localname": "NonderivativeFinancialLiabilitiesUndiscountedCashFlows",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NotLaterThanOneMonthMember": {
     "auth_ref": [
      "r355",
      "r358",
      "r366"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one month."
       }
      },
      "en-us": {
       "role": {
        "label": "Not later than one month [member]",
        "terseLabel": "Less than 1 month"
       }
      }
     },
     "localname": "NotLaterThanOneMonthMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "auth_ref": [
      "r26",
      "r216",
      "r217",
      "r285",
      "r357",
      "r366"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Not later than one year [member]",
        "terseLabel": "Less\u00a0than 1\u00a0year",
        "verboseLabel": "Year 1"
       }
      }
     },
     "localname": "NotLaterThanOneYearMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NotionalAmount": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      },
      "en-us": {
       "role": {
        "label": "Notional amount",
        "netLabel": "Notional amount of forward sales",
        "terseLabel": "Credit facilities, amount drawable",
        "verboseLabel": "Amount"
       }
      }
     },
     "localname": "NotionalAmount",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NumberOfEmployees": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of personnel employed by the entity at a date."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of employees",
        "terseLabel": "Number of employees"
       }
      }
     },
     "localname": "NumberOfEmployees",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PersonnelcostsAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r348",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of instruments granted in share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of instruments granted in share-based payment arrangement",
        "terseLabel": "Number of options granted (in shares)"
       }
      }
     },
     "localname": "NumberOfInstrumentsGrantedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "auth_ref": [
      "r218",
      "r222",
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options outstanding in share-based payment arrangement",
        "terseLabel": "Number of options outstanding (in shares)",
        "verboseLabel": "Outstanding, Number\u00a0of options (in shares)"
       }
      }
     },
     "localname": "NumberOfOutstandingShareOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options exercisable in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options exercisable in share-based payment arrangement",
        "terseLabel": "Exercisable, number of options (in shares)",
        "verboseLabel": "Number of options, options exercisable (in shares)"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options exercised in share-based payment arrangement",
        "negatedLabel": "Number of options, options exercised (in shares)"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options forfeited in share-based payment arrangement",
        "negatedLabel": "Number of options, options forfeited (in shares)"
       }
      }
     },
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options granted in share-based payment arrangement",
        "netLabel": "Total number of shares awarded (in shares)"
       }
      }
     },
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfSharesIssued": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Number of shares (in shares)"
       }
      }
     },
     "localname": "NumberOfSharesIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member indicates the opening balance before the cumulative effect adjustment in the financial statements at the date of initial application of a new or amended IFRS Standard. It also represents the standard value for the \u2018Cumulative effect at date of initial application\u2019 axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Opening balance before adjustment, cumulative effect at date of initial application [member]",
        "terseLabel": "Opening balance before adjustment, cumulative effect at date of initial application [member]"
       }
      }
     },
     "localname": "OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OperatingSegmentsMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for operating segments. An operating segment is a component of an entity: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity); (b) whose operating results are regularly reviewed by the entity\u2019s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance; and (c) for which discrete financial information is available. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Operating segments [member]",
        "terseLabel": "Operating segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherAdjustmentsForNoncashItems": {
     "auth_ref": [
      "r430"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other adjustments for non-cash items",
        "terseLabel": "Other items"
       }
      }
     },
     "localname": "OtherAdjustmentsForNoncashItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherAdjustmentsToReconcileProfitLoss": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 11.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Adjustments to reconcile profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other adjustments to reconcile profit (loss)",
        "terseLabel": "Other profit or loss items with no cash effect on cash flows generated by operating activities"
       }
      }
     },
     "localname": "OtherAdjustmentsToReconcileProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherAssetsMember": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for assets that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other assets [member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherBorrowings": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other borrowings",
        "terseLabel": "Other borrowings"
       }
      }
     },
     "localname": "OtherBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "auth_ref": [
      "r4",
      "r37",
      "r47",
      "r191"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income",
        "terseLabel": "Other comprehensive income for\u00a0the period",
        "totalLabel": "Other comprehensive income for the period, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity",
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income [abstract]",
        "terseLabel": "Other comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, before tax. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, before tax",
        "terseLabel": "Other comprehensive income before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": {
     "auth_ref": [
      "r311",
      "r312"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax",
        "totalLabel": "Items subsequently reclassifiable to profit or loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails",
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax": {
     "auth_ref": [
      "r311",
      "r312"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income that will not be reclassified to profit or loss, net of tax",
        "totalLabel": "Items not subsequently reclassifiable to profit or loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails",
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentAssets": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/OthercurrentassetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current assets",
        "terseLabel": "Other current assets",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherCurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/OthercurrentassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentFinancialAssets": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.sanofi.com/role/OthercurrentassetsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current financial assets",
        "terseLabel": "Other current financial assets"
       }
      }
     },
     "localname": "OtherCurrentFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthercurrentassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentLiabilities": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "sny_CurrentProvisionsAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentReceivables": {
     "auth_ref": [
      "r308"
     ],
     "calculation": {
      "http://www.sanofi.com/role/OthercurrentassetsDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current receivables",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherCurrentReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthercurrentassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherEmployeeExpense": {
     "auth_ref": [
      "r410"
     ],
     "calculation": {
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of employee expenses that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other employee expense",
        "terseLabel": "Other employee benefits"
       }
      }
     },
     "localname": "OtherEmployeeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherEnvironmentRelatedProvisionMember": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an environment-related provision that the entity does not separately disclose in the same statement or note. [Refer: Other provisions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other environment related provision [member]",
        "terseLabel": "Other environment related provision"
       }
      }
     },
     "localname": "OtherEnvironmentRelatedProvisionMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherFinanceIncomeCost": {
     "auth_ref": [
      "r401"
     ],
     "calculation": {
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails": {
       "order": 7.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other finance income (cost)",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherFinanceIncomeCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r163"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other inflows (outflows) of cash, classified as financing activities",
        "terseLabel": "Other cash flows"
       }
      }
     },
     "localname": "OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherIntangibleAssets": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other intangible assets",
        "periodEndLabel": "Other intangible assets, ending balance",
        "periodStartLabel": "Other intangible assets, beginning balance"
       }
      }
     },
     "localname": "OtherIntangibleAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherIntangibleAssetsMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other intangible assets [member]",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherLongtermProvisions": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current provisions",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherLongtermProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current assets",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current liabilities",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "auth_ref": [
      "r401"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails": {
       "order": 1.0,
       "parentTag": "sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other operating income (expense)",
        "negatedLabel": "Other operating (income)/expenses, net",
        "terseLabel": "Other operating income/(expenses), net related to the Regeneron Alliance"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherPropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other property, plant and equipment [member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherPropertyPlantAndEquipmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherProvisions": {
     "auth_ref": [
      "r31",
      "r135"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of provisions other than provisions for employee benefits. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other provisions",
        "terseLabel": "Other provisions"
       }
      }
     },
     "localname": "OtherProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherProvisionsMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other provisions [member]",
        "terseLabel": "Other provisions [member]"
       }
      }
     },
     "localname": "OtherProvisionsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherRelatedPartiesMember": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for related parties that the entity does not separately disclose in the same statement or note. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other related parties [member]",
        "terseLabel": "Other related parties"
       }
      }
     },
     "localname": "OtherRelatedPartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherRevenue": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 2.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails": {
       "order": 2.0,
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other revenue",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "OtherRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_AverageEffectiveTaxRate",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "Tax rate effects, in aggregate, on the reconciliation between the average effective tax rate and the applicable tax rate that the entity does not separately disclose in the reconciliation. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other tax rate effects for reconciliation between accounting profit and tax expense (income)",
        "terseLabel": "Other items"
       }
      }
     },
     "localname": "OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_OtherTemporaryDifferencesMember": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences that the entity does not separately disclose in the same statement or note. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other temporary differences [member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherTemporaryDifferencesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ParValuePerShare": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Par value per share",
        "terseLabel": "Par value per share (in euros per share)"
       }
      }
     },
     "localname": "ParValuePerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries": {
     "auth_ref": [
      "r169",
      "r170"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for changes in ownership interests in subsidiaries that do not result in a loss of control. [Refer: Subsidiaries [member]]"
       }
      }
     },
     "localname": "PaymentsFromChangesInOwnershipInterestsInSubsidiaries",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from payments from plan",
        "terseLabel": "Benefits paid"
       }
      }
     },
     "localname": "PaymentsFromPlanNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedTerseLabel": "Repayments of lease liabilities"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": {
     "auth_ref": [
      "r332"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to acquire or redeem entity's shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Payments to acquire or redeem entity's shares",
        "negatedLabel": "Acquisitions of treasury shares"
       }
      }
     },
     "localname": "PaymentsToAcquireOrRedeemEntitysShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PercentageOfEntitysRevenue": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of the entity's revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of entity's revenue",
        "terseLabel": "Percentage of entity's revenue (in percent)"
       }
      }
     },
     "localname": "PercentageOfEntitysRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails",
      "http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of reasonably possible decrease in actuarial assumption",
        "negatedTerseLabel": "Possible decrease in actuarial assumption"
       }
      }
     },
     "localname": "PercentageOfReasonablyPossibleDecreaseInActuarialAssumption",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of reasonably possible increase in actuarial assumption",
        "terseLabel": "Possible increase in actuarial assumption"
       }
      }
     },
     "localname": "PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of voting equity interests acquired",
        "terseLabel": "Percentage of voting equity interests acquired"
       }
      }
     },
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PlanAssetsAtFairValue": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_LiabilityAssetOfDefinedBenefitPlans",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Plan assets, at fair value",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "PlanAssetsAtFairValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PlanAssetsMember": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for defined benefit plan assets. Plan assets comprise: (a) assets held by a long-term employee benefit fund; and (b) qualifying insurance policies."
       }
      },
      "en-us": {
       "role": {
        "label": "Plan assets [member]",
        "terseLabel": "Plan assets"
       }
      }
     },
     "localname": "PlanAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans": {
     "auth_ref": [
      "r406",
      "r410"
     ],
     "calculation": {
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Post-employment benefit expense in profit or loss, defined benefit plans",
        "terseLabel": "Defined-benefit plans"
       }
      }
     },
     "localname": "PostemploymentBenefitExpenseDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PresentValueOfDefinedBenefitObligationMember": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the present value of a defined benefit obligation. The present value of a defined benefit obligation is the present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods."
       }
      },
      "en-us": {
       "role": {
        "label": "Present value of defined benefit obligation [member]",
        "terseLabel": "Present value of defined benefit obligation"
       }
      }
     },
     "localname": "PresentValueOfDefinedBenefitObligationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from borrowings, classified as financing activities",
        "terseLabel": "New borrowings"
       }
      }
     },
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the disposal of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets",
        "netLabel": "Proceeds from disposals of investments",
        "terseLabel": "Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets, net of tax"
       }
      }
     },
     "localname": "ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows",
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issuing shares",
        "terseLabel": "Issuance of Sanofi shares"
       }
      }
     },
     "localname": "ProceedsFromIssuingShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromNoncurrentBorrowings": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from non-current borrowings obtained. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from non-current borrowings",
        "terseLabel": "Additional long-term debt contracted"
       }
      }
     },
     "localname": "ProceedsFromNoncurrentBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from sales of investments accounted for using equity method",
        "terseLabel": "Net proceeds from sale of Regeneron shares on May\u00a029, 2020",
        "verboseLabel": "Proceeds from sales of investments accounted for using equity method"
       }
      }
     },
     "localname": "ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "auth_ref": [
      "r276",
      "r345"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Products and services [axis]",
        "terseLabel": "Products and services [axis]"
       }
      }
     },
     "localname": "ProductsAndServicesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProductsAndServicesMember": {
     "auth_ref": [
      "r276",
      "r345"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Products and services [member]",
        "terseLabel": "Products and services [member]"
       }
      }
     },
     "localname": "ProductsAndServicesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r36",
      "r161",
      "r177",
      "r179",
      "r270",
      "r272",
      "r340",
      "r370",
      "r373"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sanofi.com/role/Consolidatedincomestatements_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss)",
        "totalLabel": "Net income",
        "verboseLabel": "Net income for the period"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity",
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) [abstract]",
        "terseLabel": "Profit (loss) [abstract]"
       }
      }
     },
     "localname": "ProfitLossAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r39",
      "r182"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements_1": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": 8.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails": {
       "order": 8.0,
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to non-controlling interests",
        "terseLabel": "Attributable to non-controlling interests",
        "verboseLabel": "Net income attributable to non-controlling interests"
       }
      }
     },
     "localname": "ProfitLossAttributableToNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows",
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome",
      "http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share",
        "terseLabel": "Net income attributable to equity holders of Sanofi"
       }
      }
     },
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements_1": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to owners of parent",
        "terseLabel": "Attributable to equity holders of Sanofi",
        "verboseLabel": "Net income attributable to equity holders of Sanofi"
       }
      }
     },
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "auth_ref": [
      "r323",
      "r401"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 1.0,
       "parentTag": "sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "ProfitLossFromOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossOfAcquiree": {
     "auth_ref": [
      "r233"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) of acquiree since acquisition date",
        "negatedTerseLabel": "Profit (loss) of acquiree since acquisition date"
       }
      }
     },
     "localname": "ProfitLossOfAcquiree",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r12",
      "r71"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 6.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "periodEndLabel": "Property, plant and equipment, ending balance",
        "periodStartLabel": "Property, plant and equipment, beginning balance",
        "terseLabel": "Property, plant and equipment",
        "verboseLabel": "Property, plant and equipment owned"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [abstract]",
        "terseLabel": "Property, plant and equipment [abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r72",
      "r324",
      "r347"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [member]",
        "terseLabel": "Property, plant and equipment [member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of property, plant and equipment pledged as security for liabilities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment, pledged as security",
        "terseLabel": "Property, plant and equipment pledged as security for liabilities"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPledgedAsSecurity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofOffBalanceSheetCommitmentsRelatingtoPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInAssociate": {
     "auth_ref": [
      "r119",
      "r121",
      "r186"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in associate",
        "terseLabel": "Proportion of ownership interest in associate (in percent)",
        "verboseLabel": "Proportion of ownership interest in associate (in percent)"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInAssociate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInJointOperation": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a joint operation attributable to the entity. [Refer: Joint operations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in joint operation",
        "terseLabel": "Financial interest in principal investments accounted for using the equity method"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInJointOperation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInJointVenture": {
     "auth_ref": [
      "r119",
      "r121",
      "r186"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Joint ventures [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in joint venture",
        "terseLabel": "Proportion of ownership interest in joint venture (in percent)"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInJointVenture",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "auth_ref": [
      "r119",
      "r121",
      "r184"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in subsidiary",
        "terseLabel": "Financial interest in principal fully consolidated companies"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interests held by non-controlling interests",
        "terseLabel": "Proportion of ownership interests held by non-controlling interests"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember": {
     "auth_ref": [
      "r326",
      "r327"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a provision relating to decommissioning, restoration and rehabilitation costs. [Refer: Other provisions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Provision for decommissioning, restoration and rehabilitation costs [member]",
        "terseLabel": "Provision for decommissioning, restoration and rehabilitation costs"
       }
      }
     },
     "localname": "ProvisionForDecommissioningRestorationAndRehabilitationCostsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProvisionUsedOtherProvisions": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Provision used, other provisions",
        "negatedLabel": "Provisions utilized"
       }
      }
     },
     "localname": "ProvisionUsedOtherProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of financial instruments. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of financial instruments, classified as investing activities",
        "negatedLabel": "Acquisitions of other equity investments"
       }
      }
     },
     "localname": "PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of intangible assets, classified as investing activities",
        "terseLabel": "Acquisitions of other intangible assets"
       }
      }
     },
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of interests in investments accounted for using the equity method. [Refer: Investments accounted for using equity method]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of interests in investments accounted for using equity method",
        "terseLabel": "Purchase of interests in investments accounted for using equity method"
       }
      }
     },
     "localname": "PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "terseLabel": "Acquisitions of property, plant and equipment"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets",
        "negatedLabel": "Acquisitions of property, plant and equipment and intangible assets"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfTreasuryShares": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of treasury shares",
        "negatedLabel": "Share repurchase program"
       }
      }
     },
     "localname": "PurchaseOfTreasuryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchasesOfGoodsRelatedPartyTransactions": {
     "auth_ref": [
      "r322"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of goods purchased by the entity in related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchases of goods, related party transactions",
        "terseLabel": "Purchases and other expenses (including research expenses)"
       }
      }
     },
     "localname": "PurchasesOfGoodsRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RangeAxis": {
     "auth_ref": [
      "r205",
      "r225",
      "r284",
      "r342",
      "r344",
      "r436"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Range [axis]",
        "terseLabel": "Range [axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesMember": {
     "auth_ref": [
      "r205",
      "r225",
      "r284",
      "r342",
      "r344",
      "r436"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges [member]",
        "terseLabel": "Ranges"
       }
      }
     },
     "localname": "RangesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [axis]",
        "terseLabel": "Ranges of exercise prices for outstanding share options [axis]"
       }
      }
     },
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [member]",
        "terseLabel": "Ranges of exercise prices for outstanding share options [member]"
       }
      }
     },
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RawMaterials": {
     "auth_ref": [
      "r309",
      "r413"
     ],
     "calculation": {
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current raw materials",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "RawMaterials",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReclassifiedItemsAxis": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Reclassified items [axis]",
        "terseLabel": "Reclassified items [axis]"
       }
      }
     },
     "localname": "ReclassifiedItemsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ReclassifiedItemsMember": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for items that have been reclassified when the entity changes their presentation or classification in its financial statements. It also represents the standard value for the 'Reclassified items' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Reclassified items [member]",
        "terseLabel": "Reclassified items"
       }
      }
     },
     "localname": "ReclassifiedItemsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deficit in a defined benefit plan. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability",
        "terseLabel": "Net obligation"
       }
      }
     },
     "localname": "RecognisedLiabilitiesDefinedBenefitPlan",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of changes in other provisions [abstract]",
        "terseLabel": "Reconciliation of changes in other provisions [abstract]"
       }
      }
     },
     "localname": "ReconciliationOfChangesInOtherProvisionsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ReductionOfIssuedCapital": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in equity resulting from a reduction in issued capital. [Refer: Issued capital]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reduction of issued capital",
        "negatedTerseLabel": "Reduction in share capital"
       }
      }
     },
     "localname": "ReductionOfIssuedCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The remaining amortisation period of individual intangible assets that are material to the entity\u2019s financial statements. [Refer: Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Remaining amortisation period of intangible assets material to entity",
        "terseLabel": "Remaining amortisation period of intangible assets material to entity"
       }
      }
     },
     "localname": "RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r334"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Repayments of borrowings, classified as financing activities",
        "negatedLabel": "Repayments"
       }
      }
     },
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RepaymentsOfNoncurrentBorrowings": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Repayments of non-current borrowings",
        "negatedLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfNoncurrentBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReportableSegmentsMember": {
     "auth_ref": [
      "r207",
      "r270",
      "r319",
      "r372"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for operating segments for which IFRS 8 requires information to be disclosed. The entity shall report separately information about an operating segment that meets any of the following quantitative thresholds: (a) reported revenue, including both sales to external customers and intersegment sales or transfers, is 10 per cent or more of the combined revenue, internal and external, of all operating segments; (b) the absolute amount of its reported profit or loss is 10 per cent or more of the greater, in absolute amount, of (i) the combined reported profit of all operating segments that did not report a loss and (ii) the combined reported loss of all operating segments that reported a loss; or (c) assets are 10 per cent or more of the combined assets of all operating segments. Additionally operating segments that do not meet any of the quantitative thresholds may be considered reportable, and separately disclosed, if management believes that information about the segment would be useful to users of the financial statements. [Refer: Operating segments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reportable segments [member]",
        "terseLabel": "Reportable segments",
        "verboseLabel": "Total Sanofi"
       }
      }
     },
     "localname": "ReportableSegmentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 11.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails": {
       "order": 3.0,
       "parentTag": "sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails": {
       "order": 4.0,
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Research and development expense",
        "negatedLabel": "Research and development expenses",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "auth_ref": [
      "r103",
      "r305"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation [member]",
        "terseLabel": "Reserve of exchange differences on translation"
       }
      }
     },
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCurrencyTranslationDifferencesDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ReserveOfSharebasedPaymentsMember": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from share-based payments."
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of share-based payments [member]",
        "terseLabel": "Stock options\u00a0and other\u00a0share- based payments"
       }
      }
     },
     "localname": "ReserveOfSharebasedPaymentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RestructuringProvisionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring provision [abstract]",
        "terseLabel": "Of which:"
       }
      }
     },
     "localname": "RestructuringProvisionAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RestructuringProvisionMember": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a provision for restructuring, such as the sale or termination of a line of business; closure of business locations in a country or region or relocation of activities from one country or region to another; changes in management structure; and fundamental reorganisations that have a material effect on the nature and focus of the entity's operations. [Refer: Other provisions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Restructuring provision [member]",
        "terseLabel": "Restructuring Provision"
       }
      }
     },
     "localname": "RestructuringProvisionMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r6",
      "r305"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Reserves and retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity",
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [member]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense",
        "terseLabel": "Difference between actual return and interest income on plan assets"
       }
      }
     },
     "localname": "ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromSaleOfGoods": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 1.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails": {
       "order": 1.0,
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the sale of goods. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from sale of goods",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromSaleOfGoods",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails",
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions": {
     "auth_ref": [
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the sale of goods in related party transactions. [Refer: Revenue; Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from sale of goods, related party transactions",
        "terseLabel": "Sales"
       }
      }
     },
     "localname": "RevenueFromSaleOfGoodsRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssets": {
     "auth_ref": [
      "r214"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 7.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "periodEndLabel": "Right-of-use assets at end of period",
        "periodStartLabel": "Right-of-use assets at beginning of period",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SegmentConsolidationItemsAxis": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segment consolidation items [axis]",
        "terseLabel": "Segment consolidation items [axis]"
       }
      }
     },
     "localname": "SegmentConsolidationItemsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsAxis": {
     "auth_ref": [
      "r128",
      "r207",
      "r270",
      "r319",
      "r372"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segments [axis]",
        "terseLabel": "Segments [axis]"
       }
      }
     },
     "localname": "SegmentsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsMember": {
     "auth_ref": [
      "r128",
      "r207",
      "r275",
      "r319",
      "r372"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Segments [member]",
        "terseLabel": "Segments [member]"
       }
      }
     },
     "localname": "SegmentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r401"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails": {
       "order": 4.0,
       "parentTag": "sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails": {
       "order": 5.0,
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expense",
        "negatedLabel": "Selling and general expenses",
        "terseLabel": "Selling and general expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contingent liabilities recognised in a business combination that were settled. [Refer: Contingent liabilities recognised in business combination]"
       }
      },
      "en-us": {
       "role": {
        "label": "Settled liabilities, contingent liabilities recognised in business combination",
        "negatedLabel": "Payments made"
       }
      }
     },
     "localname": "SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax": {
     "auth_ref": [
      "r48",
      "r290"
     ],
     "calculation": {
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails": {
       "order": 2.0,
       "parentTag": "sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The entity's share of the other comprehensive income of associates and joint ventures accounted for using the equity method, before tax. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share of other comprehensive income of associates and joint ventures accounted for using equity method, before tax",
        "terseLabel": "Share of other comprehensive income from investments accounted for using the equity method"
       }
      }
     },
     "localname": "ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r401"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share of profit (loss) of associates accounted for using equity method",
        "terseLabel": "Share of profit/(loss) from investments accounted for using the equity method"
       }
      }
     },
     "localname": "ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r44",
      "r268",
      "r274",
      "r290"
     ],
     "calculation": {
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": 10.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails": {
       "order": 7.0,
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method",
        "terseLabel": "Share of profit/(loss) from investments accounted for using the equity method"
       }
      }
     },
     "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails",
      "http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r401"
     ],
     "calculation": {
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails": {
       "order": 1.0,
       "parentTag": "sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The entity's share of the profit (loss) of joint ventures accounted for using the equity method. [Refer: Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share of profit (loss) of joint ventures accounted for using equity method",
        "terseLabel": "Share of profit/(loss) from investments accounted for using the equity method"
       }
      }
     },
     "localname": "ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]",
        "terseLabel": "Stock options and other share-based payment [Member]"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term deposits, classified as cash equivalents",
        "terseLabel": "Cash equivalents, term deposits"
       }
      }
     },
     "localname": "ShorttermDepositsClassifiedAsCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/CashandcashequivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShorttermEmployeeBenefitsAccruals": {
     "auth_ref": [
      "r400"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "sny_CurrentProvisionsAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term employee benefits accruals",
        "terseLabel": "Employee-related liabilities"
       }
      }
     },
     "localname": "ShorttermEmployeeBenefitsAccruals",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShorttermRestructuringProvision": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "sny_CurrentProvisionsAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current provision for restructuring. [Refer: Restructuring provision]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current restructuring provision",
        "terseLabel": "Restructuring provisions (see Note\u00a0D.19.2.)",
        "verboseLabel": "Classified in current liabilities"
       }
      }
     },
     "localname": "ShorttermRestructuringProvision",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SignificantInvestmentsInAssociatesAxis": {
     "auth_ref": [
      "r120",
      "r122",
      "r198",
      "r291",
      "r295"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Associates [axis]",
        "terseLabel": "Associates [axis]"
       }
      }
     },
     "localname": "SignificantInvestmentsInAssociatesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails",
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/OtheroperatingincomeDetails",
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "auth_ref": [
      "r120",
      "r122",
      "r195"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]",
        "terseLabel": "Subsidiaries [axis]"
       }
      }
     },
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical",
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SocialSecurityContributions": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents social security contributions. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Social security contributions",
        "terseLabel": "Social security charges (including defined-contribution pension plans)"
       }
      }
     },
     "localname": "SocialSecurityContributions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]",
        "terseLabel": "Statement of cash flows [abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [abstract]",
        "terseLabel": "Statement of changes in equity [abstract]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]",
        "terseLabel": "Statement of changes in equity [line items]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity",
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]",
        "terseLabel": "Statement of changes in equity [table]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity",
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of comprehensive income [abstract]",
        "terseLabel": "Statement of comprehensive income [abstract]"
       }
      }
     },
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]",
        "terseLabel": "Statement of financial position [abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfIFRSCompliance": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "An explicit and unreserved statement of compliance with all the requirements of IFRSs."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of IFRS compliance [text block]",
        "terseLabel": "International financial reporting standards (IFRS)"
       }
      }
     },
     "localname": "StatementOfIFRSCompliance",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subclassifications of assets, liabilities and equities [abstract]",
        "terseLabel": "Subclassifications of assets, liabilities and equities [abstract]"
       }
      }
     },
     "localname": "SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TaxRateEffectOfForeignTaxRates": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_AverageEffectiveTaxRate",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the application of foreign tax rates. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax rate effect of foreign tax rates",
        "terseLabel": "Difference between the standard French tax rate and the rates applicable to the Sanofi"
       }
      }
     },
     "localname": "TaxRateEffectOfForeignTaxRates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]",
        "terseLabel": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [member]",
        "terseLabel": "Temporary difference, unused tax losses and unused tax credits [member]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount of temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements, for which deferred tax liabilities have not been recognised as a result of satisfying both of the following conditions: (a) the parent, investor, joint venturer or joint operator is able to control the timing of the reversal of the temporary difference; and (b) it is probable that the temporary difference will not reverse in the foreseeable future. [Refer: Associates [member]; Subsidiaries [member]; Temporary differences [member]; Investments in subsidiaries reported in separate financial statements]"
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax liabilities have not been recognised",
        "terseLabel": "Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax liabilities have not been recognised"
       }
      }
     },
     "localname": "TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TopOfRangeMember": {
     "auth_ref": [
      "r205",
      "r225",
      "r284",
      "r342",
      "r344",
      "r436"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Top of range [member]",
        "terseLabel": "Top of range"
       }
      }
     },
     "localname": "TopOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "auth_ref": [
      "r307",
      "r400"
     ],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 5.0,
       "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current trade payables",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradingEquitySecuritiesMember": {
     "auth_ref": [
      "r341",
      "r343"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that (a) are acquired or incurred principally for the purpose of selling or repurchasing it in the near term; or (b) on initial recognition are part of a portfolio of identified financial instruments that are managed together and for which there is evidence of a recent actual pattern of short-term profit-taking."
       }
      },
      "en-us": {
       "role": {
        "label": "Trading equity securities [member]",
        "terseLabel": "Trading equity securities"
       }
      }
     },
     "localname": "TradingEquitySecuritiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TreasurySharesMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      },
      "en-us": {
       "role": {
        "label": "Treasury shares [member]",
        "terseLabel": "Treasury shares"
       }
      }
     },
     "localname": "TreasurySharesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfHedgesAxis": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r298"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of hedges [axis]",
        "terseLabel": "Types of Hedges [Axis]"
       }
      }
     },
     "localname": "TypesOfHedgesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfHedgesMember": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r298"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of hedges. It also represents the standard value for the 'Types of hedges' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Hedges [member]",
        "terseLabel": "Hedges [member]"
       }
      }
     },
     "localname": "TypesOfHedgesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfInterestRatesAxis": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of interest rates [axis]",
        "terseLabel": "Types of interest rates [axis]"
       }
      }
     },
     "localname": "TypesOfInterestRatesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]",
        "terseLabel": "Types of share-based payment arrangements [axis]"
       }
      }
     },
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_UndrawnBorrowingFacilities": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]"
       }
      },
      "en-us": {
       "role": {
        "label": "Undrawn borrowing facilities",
        "terseLabel": "General-purpose credit facilities",
        "verboseLabel": "Total credit facilities"
       }
      }
     },
     "localname": "UndrawnBorrowingFacilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Unused tax losses for which no deferred tax asset recognised",
        "terseLabel": "Unused tax losses for which no deferred tax asset recognised"
       }
      }
     },
     "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_UnusedTaxLossesMember": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit."
       }
      },
      "en-us": {
       "role": {
        "label": "Unused tax losses [member]",
        "terseLabel": "Tax losses available for carry-forward"
       }
      }
     },
     "localname": "UnusedTaxLossesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Useful life measured as period of time, intangible assets other than goodwill",
        "terseLabel": "Useful life, intangible assets other than goodwill (in years)"
       }
      }
     },
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesOtherIntangibleAssetsnotAcquiredinBusinessCombinationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Useful life measured as period of time, property, plant and equipment",
        "terseLabel": "Useful lives or depreciation rates, property, plant and equipment (in years)"
       }
      }
     },
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_VehiclesMember": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Vehicles [member]",
        "terseLabel": "Vehicle fleet"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_WagesAndSalaries": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Wages and salaries",
        "terseLabel": "Salaries"
       }
      }
     },
     "localname": "WagesAndSalaries",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PersonnelcostsSummaryofPersonalCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average duration of defined benefit obligation",
        "terseLabel": "Weighted average duration of defined benefit obligation",
        "verboseLabel": "Weighted average duration in main countries"
       }
      }
     },
     "localname": "WeightedAverageDurationOfDefinedBenefitObligation2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofWeightedAverageDurationofObligationforPensionsandOtherLongtermBenefitsinPrincipalCountriesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement",
        "terseLabel": "Weighted average exercise\u00a0price per share, Options exercisable (in euros per share)",
        "verboseLabel": "Average exercise\u00a0price per share, options exercisable (in euros per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercised in share-based payment arrangement",
        "terseLabel": "Average exercise\u00a0price per share, options exercised (in euros per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options forfeited in share-based payment arrangement",
        "terseLabel": "Average exercise\u00a0price per share, options forfeited (in euros per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r218",
      "r222"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement",
        "periodEndLabel": "Average exercise\u00a0price per share, ending balance (in euros per share)",
        "periodStartLabel": "Average exercise\u00a0price per share, beginning balance (in euros per share)",
        "terseLabel": "Weighted average exercise price of share options outstanding in share-based payment arrangement (in euros per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life of outstanding share options",
        "terseLabel": "Weighted average residual\u00a0life (years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_WeightedAverageSharePrice2019": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average share price. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average share price",
        "terseLabel": "Weighted average share price (in EUR per share)"
       }
      }
     },
     "localname": "WeightedAverageSharePrice2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageShares": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_AdjustedWeightedAverageShares",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share",
        "terseLabel": "Average number of shares outstanding (in shares)",
        "verboseLabel": "Average number of shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for wholly funded or partly funded defined benefit plans. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Wholly or partly funded defined benefit plans [member]",
        "terseLabel": "Wholly or partly funded defined benefit plans"
       }
      }
     },
     "localname": "WhollyOrPartlyFundedDefinedBenefitPlansMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_WhollyUnfundedDefinedBenefitPlansMember": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for wholly unfunded defined benefit plans. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Wholly unfunded defined benefit plans [member]",
        "terseLabel": "Wholly unfunded defined benefit plans"
       }
      }
     },
     "localname": "WhollyUnfundedDefinedBenefitPlansMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_WorkInProgress": {
     "auth_ref": [
      "r309",
      "r413"
     ],
     "calculation": {
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current work in progress",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "WorkInProgress",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised resulting from the write-down of property, plant and equipment to its recoverable amount or reversals of those write-downs. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Write-downs (reversals of write-downs) of property, plant and equipment",
        "negatedTerseLabel": "Impairment losses, net of reversals"
       }
      }
     },
     "localname": "WritedownsReversalsOfPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_A.NattermannCie.GmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A. Nattermann &amp; Cie. GmbH [Member]",
        "label": "A. Nattermann &amp; Cie. GmbH [Member]",
        "terseLabel": "A. Nattermann &amp; Cie. GmbH"
       }
      }
     },
     "localname": "A.NattermannCie.GmbHMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_A340BDrugPricingProgramInTheUnitedStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "340B Drug Pricing Program In The United States",
        "label": "340B Drug Pricing Program In The United States [Member]",
        "terseLabel": "340B Drug Pricing Program in the United States"
       }
      }
     },
     "localname": "A340BDrugPricingProgramInTheUnitedStatesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ABLBioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ABL Bio",
        "label": "ABL Bio [Member]",
        "terseLabel": "ABL Bio"
       }
      }
     },
     "localname": "ABLBioMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AOSanofiRussiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AO Sanofi Russia.",
        "label": "AO Sanofi Russia [member]",
        "terseLabel": "AO Sanofi Russia"
       }
      }
     },
     "localname": "AOSanofiRussiaMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AblynxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ablynx.",
        "label": "Ablynx [member]",
        "terseLabel": "Sanofi Belgium",
        "verboseLabel": "Ablynx N.V."
       }
      }
     },
     "localname": "AblynxMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses and provisions deductible at time of payments.",
        "label": "Accrued Expenses And Provisions Deductible At Time Of Payments [member]",
        "terseLabel": "Accrued expenses and provisions deductible at time of payments"
       }
      }
     },
     "localname": "AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AcquiredRDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired R&amp;D",
        "label": "Acquired R&amp;D [Member]",
        "terseLabel": "Acquired R&amp;D"
       }
      }
     },
     "localname": "AcquiredRDMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Through Business Combinations, Property, Plant and Equipment, Right Of Use Assets",
        "label": "Acquisition Through Business Combinations, Property, Plant and Equipment, Right Of Use Assets",
        "terseLabel": "Changes in scope of consolidation"
       }
      }
     },
     "localname": "AcquisitionThroughBusinessCombinationsPropertyPlantAndEquipmentRightOfUseAssets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ActionForWhichWeAreDefendantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Action for which we are defendant.",
        "label": "Action For Which We Are Defendant [member]",
        "terseLabel": "Action for which we are defendant"
       }
      }
     },
     "localname": "ActionForWhichWeAreDefendantMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ActionForWhichWeArePlaintiffMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Action For Which We Are a Plaintiff.",
        "label": "Action For Which We Are a Plaintiff [member]",
        "terseLabel": "Action for which we are a plaintiff"
       }
      }
     },
     "localname": "ActionForWhichWeArePlaintiffMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ActuarialAssumptionOfMortalityTableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actuarial assumption of mortality table.",
        "label": "Actuarial Assumption Of Mortality Table [Member]",
        "terseLabel": "Mortality table"
       }
      }
     },
     "localname": "ActuarialAssumptionOfMortalityTableMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ActuarialAssumptionOfRetirementAgeBottomOfRange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement age, bottom of range.",
        "label": "Actuarial Assumption Of Retirement Age Bottom Of Range",
        "terseLabel": "Retirement age, bottom of range"
       }
      }
     },
     "localname": "ActuarialAssumptionOfRetirementAgeBottomOfRange",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_ActuarialAssumptionOfRetirementAgeTopOfRange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actuarial assumption of retirement age top of range.",
        "label": "Actuarial Assumption Of Retirement Age Top Of Range",
        "terseLabel": "Retirement age, top of range"
       }
      }
     },
     "localname": "ActuarialAssumptionOfRetirementAgeTopOfRange",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_ActuarialGainsAndLossesOnDefinedBenefitPlans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actuarial gains and losses on defined-benefit plans.",
        "label": "Actuarial Gains And Losses On Defined Benefit Plans",
        "terseLabel": "Actuarial gains and losses on defined-benefit plans"
       }
      }
     },
     "localname": "ActuarialGainsAndLossesOnDefinedBenefitPlans",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset excluding associates and joint ventures.",
        "label": "Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Excluding Associates And Joint Ventures",
        "terseLabel": "Actuarial gains/(losses) excluding investments accounted for using the equity method (see Note\u00a0D.19.1.)"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset net of tax on associates and joint ventures.",
        "label": "Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Net Of Tax On Associates And Joint Ventures",
        "terseLabel": "Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AdageneIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adagene, Inc",
        "label": "Adagene, Inc [Member]",
        "terseLabel": "Adagene, Inc"
       }
      }
     },
     "localname": "AdageneIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions Other Than Through Business Combinations, Property, Plant and Equipment, Right Of Use Assets",
        "label": "Additions Other Than Through Business Combinations, Property, Plant and Equipment, Right Of Use Assets",
        "terseLabel": "Acquisitions and other increases"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantandEquipmentRightOfUseAssets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AdjustmentToDebtMeasuredAtFairValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to debt measured at fair value.",
        "label": "Adjustment To Debt Measured At Fair Value [Member]",
        "terseLabel": "Adjustment to debt measured\u00a0at fair value"
       }
      }
     },
     "localname": "AdjustmentToDebtMeasuredAtFairValueMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation, amortization and impairment of property, plant and equipment, right-of use assets and intangible assets.",
        "label": "Adjustments For Depreciation And Amortisation Expense And Impairment Loss Reversal Of Impairment Loss Of Property Plant And Equipment Right-of Use Assets And Intangible Asset",
        "verboseLabel": "Depreciation, amortization and impairment of property, plant and equipment, right-of-use assets and intangible assets"
       }
      }
     },
     "localname": "AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments For Gain (Loss) On Disposal Of Investments In Subsidiaries, Joint Ventures And Associates, Deferred Income Tax",
        "label": "Adjustments For Gain (Loss) On Disposal Of Investments In Subsidiaries, Joint Ventures And Associates, Deferred Income Tax",
        "terseLabel": "Deferred income tax on disposal of investments"
       }
      }
     },
     "localname": "AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesDeferredIncomeTax",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for noncurrent provisions and other noncurrent liabilities.",
        "label": "Adjustments For Non-current Provisions And Other Non-current Liabilities",
        "terseLabel": "Net change in non-current provisions and other non-current liabilities"
       }
      }
     },
     "localname": "AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AfterTaxDiscountRates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "After tax discount rates.",
        "label": "After Tax Discount Rates",
        "terseLabel": "After tax discount rates"
       }
      }
     },
     "localname": "AfterTaxDiscountRates",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of regeneron shares that could be sold for cemiplimab and dupilumab funding costs.",
        "label": "Aggregate Number Of Regeneron Shares That Could Be Sold For Cemiplimab And Dupilumab Funding Costs",
        "terseLabel": "Aggregate number of Regeneron shares that could be sold for cemiplimab and dupilimab funding costs (in shares)"
       }
      }
     },
     "localname": "AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate pension obligation in favor of certain corporate officers and of members of the executive committee.",
        "label": "Aggregate Pension Obligation In Favor Of Certain Corporate Officers And Of Members Of The Executive Committee",
        "terseLabel": "Aggregate top-up pension obligation in favor of certain corporate officers and of Executive Committee members"
       }
      }
     },
     "localname": "AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/RelatedpartytransactionsSummaryofaggregateamountsPayabletoKeyManagementPersonnelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreements Relating To The Recombinant Covid-19 Vaccine Candidate Developed By Sanofi In Collaboration With GSK",
        "label": "Agreements Relating To The Recombinant Covid-19 Vaccine Candidate Developed By Sanofi In Collaboration With GSK [Policy Text Block]",
        "terseLabel": "Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK"
       }
      }
     },
     "localname": "AgreementsRelatingToTheRecombinantCovid19VaccineCandidateDevelopedBySanofiInCollaborationWithGSKPolicyTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_AllergyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allergy, Cough And Cold [Member]",
        "label": "Allergy [Member]",
        "terseLabel": "Allergy"
       }
      }
     },
     "localname": "AllergyMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AlprolixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alprolix",
        "label": "Alprolix [Member]",
        "terseLabel": "Alprolix"
       }
      }
     },
     "localname": "AlprolixMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AmericanDepositorySharesNASDAQGlobalSelectMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depository Shares, NASDAQ Global Select Market [Member]",
        "label": "American Depository Shares, NASDAQ Global Select Market [Member]",
        "terseLabel": "American\u00a0Depositary\u00a0Shares,\u00a0each\u00a0representing one half of one ordinary share, par value \u20ac2\u00a0per\u00a0share"
       }
      }
     },
     "localname": "AmericanDepositorySharesNASDAQGlobalSelectMarketMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": 7.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization and impairment of intangible assets other than goodwill.",
        "label": "Amortization And Impairment Of Intangible Assets Other Than Goodwill",
        "negatedLabel": "Amortization and impairment of intangible assets (c)"
       }
      }
     },
     "localname": "AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of computer software and other rights of an industrial or operational nature.",
        "label": "Amortization Of Computer Software And Other Rights Of An Industrial Or Operational Nature [member]",
        "terseLabel": "Amortization of computer software and other rights of an industrial or operational nature"
       }
      }
     },
     "localname": "AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AmortizedCostMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost.",
        "label": "Amortized Cost Member [member]",
        "terseLabel": "Amortized cost"
       }
      }
     },
     "localname": "AmortizedCostMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AmountOfSharesRepurchased": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of shares repurchased.",
        "label": "Amount Of Shares Repurchased",
        "terseLabel": "Value"
       }
      }
     },
     "localname": "AmountOfSharesRepurchased",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AmountsPayableForAcquisitionOfNonCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "sny_CurrentProvisionsAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts payable for acquisitions of non-current assets.",
        "label": "Amounts Payable For Acquisition Of Non-current Assets",
        "terseLabel": "Amounts payable for acquisitions of non-current assets"
       }
      }
     },
     "localname": "AmountsPayableForAcquisitionOfNonCurrentAssets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AmountsPayablePartnersInCollaborationAgreements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts payable partners in collaboration agreements.",
        "label": "Amounts Payable Partners In Collaboration Agreements",
        "terseLabel": "Amounts payable partners in collaboration agreements"
       }
      }
     },
     "localname": "AmountsPayablePartnersInCollaborationAgreements",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AmunixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amunix",
        "label": "Amunix [Member]",
        "terseLabel": "Amunix"
       }
      }
     },
     "localname": "AmunixMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails",
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AmunixPharmaceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amunix Pharmaceuticals, Inc",
        "label": "Amunix Pharmaceuticals, Inc [Member]",
        "terseLabel": "Amunix Pharmaceuticals, Inc"
       }
      }
     },
     "localname": "AmunixPharmaceuticalsIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AntiProgrammedCellDeathProtein1SalesMilestonePayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anti programmed cell death protein 1 sales milestone payment.",
        "label": "Anti Programmed Cell Death Protein 1 Sales Milestone Payment",
        "terseLabel": "PD1 sales milestone payment from Sanofi"
       }
      }
     },
     "localname": "AntiProgrammedCellDeathProtein1SalesMilestonePayment",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AntibodiesAllianceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Antibodies Alliance [Member]",
        "label": "Antibodies Alliance [Member]",
        "terseLabel": "Monoclonal Antibody Alliance"
       }
      }
     },
     "localname": "AntibodiesAllianceMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AntibodiesCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Antibodies collaboration agreement.",
        "label": "Antibodies Collaboration Agreement [Member]",
        "terseLabel": "Antibodies collaboration agreement"
       }
      }
     },
     "localname": "AntibodiesCollaborationAgreementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AntibodiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Antibodies",
        "label": "Antibodies [Member]",
        "terseLabel": "Antibodies"
       }
      }
     },
     "localname": "AntibodiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AnticipatedDurationOfAppealsProcess": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anticipated Duration Of Appeals Process",
        "label": "Anticipated Duration Of Appeals Process",
        "terseLabel": "Anticipated duration of appeals process"
       }
      }
     },
     "localname": "AnticipatedDurationOfAppealsProcess",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_April2016EMTNISINFR0013143997Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 2016 EMTN ISIN FR0013143997.",
        "label": "April 2016 EMTNISINFR0013143997 [Member]",
        "terseLabel": "April 2016 EMTN ISIN FR0013143997"
       }
      }
     },
     "localname": "April2016EMTNISINFR0013143997Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_April2016EMTNISINFR0013144003Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 2016 EMTN ISIN FR0013144003.",
        "label": "April 2016 EMTNISINFR0013144003 [Member]",
        "terseLabel": "April 2016 EMTN ISIN FR0013144003"
       }
      }
     },
     "localname": "April2016EMTNISINFR0013144003Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_April2022EMTNISINFR0014009KQ0Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 2022 EMTN ISIN FR0014009KQ0",
        "label": "April 2022 EMTN ISIN FR0014009KQ0 [Member]",
        "terseLabel": "April 2022 EMTN ISIN FR0014009KQ0"
       }
      }
     },
     "localname": "April2022EMTNISINFR0014009KQ0Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_April2022EMTNISINFR0014009KS6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "September 2014 EMTN ISIN FR0012146777.",
        "label": "April 2022 EMTN ISIN FR0014009KS6 [Member]",
        "verboseLabel": "April 2022 EMTN ISIN FR0014009KS6"
       }
      }
     },
     "localname": "April2022EMTNISINFR0014009KS6Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_April282020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 28, 2020",
        "label": "April 28, 2020 [Member]",
        "terseLabel": "April 28, 2020"
       }
      }
     },
     "localname": "April282020Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_April302021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 30, 2021",
        "label": "April 30, 2021 [Member]",
        "terseLabel": "April 30, 2021"
       }
      }
     },
     "localname": "April302021Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AssociatesAndJointVenturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Associates and Joint Ventures.",
        "label": "Associates And Joint Ventures [Member]",
        "terseLabel": "Associates and joint ventures"
       }
      }
     },
     "localname": "AssociatesAndJointVenturesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AtMarketValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At market value.",
        "label": "At Market Value [member]",
        "terseLabel": "Market value"
       }
      }
     },
     "localname": "AtMarketValueMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AtNotionalAmountMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At notional amount.",
        "label": "At Notional Amount [member]",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "AtNotionalAmountMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AtomwiseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Atomwise",
        "label": "Atomwise [Member]",
        "terseLabel": "Atomwise"
       }
      }
     },
     "localname": "AtomwiseMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AubagioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aubagio.",
        "label": "Aubagio [Member]",
        "terseLabel": "Aubagio"
       }
      }
     },
     "localname": "AubagioMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit of the financial statements of the parent company and its French subsidiaries.",
        "label": "Audit Of The Financial Statements Of The Parent Company And Its French Subsidiaries",
        "terseLabel": "Audit of the financial statements of the parent company and its French subsidiaries"
       }
      }
     },
     "localname": "AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit-related services charged to the parent company and its French subsidiaries.",
        "label": "Audit Related Services Charged To The Parent Company And Its French Subsidiaries",
        "terseLabel": "Audit-related services charged to the parent company and its French subsidiaries"
       }
      }
     },
     "localname": "AuditRelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information",
        "label": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_AuditorsNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditors Name [Axis]",
        "label": "Auditors Name [Axis]",
        "terseLabel": "Auditors Name [Axis]"
       }
      }
     },
     "localname": "AuditorsNameAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_AuditorsNameMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditors Name [Member]",
        "label": "Auditors Name [Member]",
        "terseLabel": "Auditors Name [Member]"
       }
      }
     },
     "localname": "AuditorsNameMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AuditorsRemunerationForAuditRelatedServices": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails": {
       "order": 1.0,
       "parentTag": "sny_ServicesOtherThanStatutoryAudit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor's remuneration for audit related services.",
        "label": "Auditor's Remuneration For Audit Related Services",
        "terseLabel": "Audit-related services"
       }
      }
     },
     "localname": "AuditorsRemunerationForAuditRelatedServices",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_AuditorsRemunerationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditors remuneration.",
        "label": "Auditors Remuneration [Table Text Block]",
        "terseLabel": "Disclosure of Accountants' Fees and Services"
       }
      }
     },
     "localname": "AuditorsRemunerationTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_AventisCropScienceRetainedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aventis crop science retained liabilities.",
        "label": "Aventis Crop Science Retained Liabilities [member]",
        "terseLabel": "Aventis Crop Science retained liabilities"
       }
      }
     },
     "localname": "AventisCropScienceRetainedLiabilitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AventisIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aventis Inc.",
        "label": "Aventis Inc [member]",
        "terseLabel": "Aventis Inc."
       }
      }
     },
     "localname": "AventisIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AventisPharmaHoldingsLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aventis Pharma Holdings Ltd",
        "label": "Aventis Pharma Holdings Ltd [Member]",
        "terseLabel": "Aventis Pharma Holdings Ltd"
       }
      }
     },
     "localname": "AventisPharmaHoldingsLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AventisPharmaLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aventis Pharma Limited.",
        "label": "Aventis Pharma Limited [member]",
        "terseLabel": "Aventis Pharma Limited"
       }
      }
     },
     "localname": "AventisPharmaLimitedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AventisPharmaManufacturingPTELTDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aventis Pharma (Manufacturing) PTE LTD.",
        "label": "Aventis Pharma Manufacturing PTE LTD [Member]",
        "terseLabel": "Aventis Pharma (Manufacturing) Pte. Ltd"
       }
      }
     },
     "localname": "AventisPharmaManufacturingPTELTDMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AventisPharmaSAFranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aventis Pharma S.A. France.",
        "label": "Aventis Pharma S.A. France [member]",
        "terseLabel": "Aventis Pharma S.A."
       }
      }
     },
     "localname": "AventisPharmaSAFranceMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AventisubLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aventisub LLC.",
        "label": "Aventisub LLC [Member]",
        "terseLabel": "Aventisub LLC"
       }
      }
     },
     "localname": "AventisubLLCMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average residual holding periods under various early retirement plans.",
        "label": "Average Residual Holding Periods Under Various Early Retirement Plans",
        "terseLabel": "Average residual holding periods"
       }
      }
     },
     "localname": "AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_AwardsDateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Awards Date 1 [Axis]",
        "label": "Awards Date [Axis]",
        "terseLabel": "Awards Date [Axis]"
       }
      }
     },
     "localname": "AwardsDateAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_AwardsDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Awards Date [Domain]",
        "label": "Awards Date [Domain]",
        "terseLabel": "Awards Date [Domain]"
       }
      }
     },
     "localname": "AwardsDateDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_AztecaVacunasSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Azteca Vacunas, S.A. De C.V",
        "label": "Azteca Vacunas, S.A. De C.V [Member]",
        "terseLabel": "Azteca Vacunas, S.A. de C.V."
       }
      }
     },
     "localname": "AztecaVacunasSADeCVMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_BasicEarningsLossPerShareAttributableToOwnersOfParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basic Earnings (Loss) Per Share, Attributable To Owners Of Parent",
        "label": "Basic Earnings (Loss) Per Share, Attributable To Owners Of Parent",
        "verboseLabel": "Basic earnings per share (in euros per share)"
       }
      }
     },
     "localname": "BasicEarningsLossPerShareAttributableToOwnersOfParent",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements"
     ],
     "xbrltype": "perShareItemType"
    },
    "sny_BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bayer contingent purchase consideration arising from the acquisition of Genzyme.",
        "label": "Bayer Contingent Consideration Arising From The Acquisition Of Genzyme [Member]",
        "terseLabel": "Bayer contingent purchase consideration arising from the acquisition of Genzyme"
       }
      }
     },
     "localname": "BayerContingentConsiderationArisingFromTheAcquisitionOfGenzymeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_BayerScheringPharmaAGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bayer Schering Pharma AG.",
        "label": "Bayer Schering Pharma AG [member]",
        "terseLabel": "Bayer contingent consideration"
       }
      }
     },
     "localname": "BayerScheringPharmaAGMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_BioverativIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bioverativ Inc.",
        "label": "Bioverativ Inc. [member]",
        "terseLabel": "Bioverativ Inc."
       }
      }
     },
     "localname": "BioverativIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_BioverativMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bioverativ.",
        "label": "Bioverativ [member]",
        "terseLabel": "Bioverativ"
       }
      }
     },
     "localname": "BioverativMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_BioverativTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bioverativ Therapeutics Inc.",
        "label": "Bioverativ Therapeutics Inc. [member]",
        "terseLabel": "Bioverativ Therapeutics Inc."
       }
      }
     },
     "localname": "BioverativTherapeuticsIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_BioverativUSLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bioverativ US LLC.",
        "label": "Bioverativ US LLC [member]",
        "terseLabel": "Bioverativ U.S. LLC"
       }
      }
     },
     "localname": "BioverativUSLLCMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_BlackstoneLifeSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blackstone Life Sciences",
        "label": "Blackstone Life Sciences [Member]",
        "terseLabel": "Blackstone Life Sciences"
       }
      }
     },
     "localname": "BlackstoneLifeSciencesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_BondsAndSimilarInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds and similar instruments.",
        "label": "Bonds And Similar Instruments [member]",
        "terseLabel": "Bonds and similar instruments"
       }
      }
     },
     "localname": "BondsAndSimilarInstrumentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_BorrowingAverageDrawdown": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing, Average Drawdown",
        "label": "Borrowing, Average Drawdown",
        "terseLabel": "Borrowing, average drawdown"
       }
      }
     },
     "localname": "BorrowingAverageDrawdown",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_BorrowingDrawdown": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing, Drawdown",
        "label": "Borrowing, Drawdown",
        "terseLabel": "Borrowing, drawdown"
       }
      }
     },
     "localname": "BorrowingDrawdown",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_BorrowingMaximumDrawdown": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum drawdown.",
        "label": "Borrowing, Maximum Drawdown",
        "terseLabel": "Borrowing, maximum drawdown"
       }
      }
     },
     "localname": "BorrowingMaximumDrawdown",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_BristolMyersSquibbMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bristol-Myers Squibb.",
        "label": "Bristol-Myers Squibb [Member]",
        "terseLabel": "Bristol-Myers Squibb"
       }
      }
     },
     "localname": "BristolMyersSquibbMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Percentage Of Voting Interests Acquired",
        "label": "Business Acquisition, Percentage Of Voting Interests Acquired",
        "terseLabel": "Percentage of share capital owned (in percent)"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "sny_BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Estimated Purchase Price On A Fully-Diluted Basis",
        "label": "Business Combination, Estimated Purchase Price On A Fully-Diluted Basis",
        "terseLabel": "Estimated purchase price on a fully-diluted basis"
       }
      }
     },
     "localname": "BusinessCombinationEstimatedPurchasePriceOnAFullyDilutedBasis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_BusinessCombinationNumberOfSharesIncludedInPublicOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number Of Shares Included In Public Offering",
        "label": "Business Combination, Number Of Shares Included In Public Offering",
        "terseLabel": "Number of shares included in public offer (in shares)"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfSharesIncludedInPublicOffering",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Proportion Of Issued And Outstanding Share Capital Tendered Into The Offering",
        "label": "Business Combination, Proportion Of Issued And Outstanding Share Capital Tendered Into The Offering",
        "terseLabel": "Proportion of issued and outstanding share capital tendered into the public offer"
       }
      }
     },
     "localname": "BusinessCombinationProportionOfIssuedAndOutstandingShareCapitalTenderedIntoTheOffering",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_BusinessCombinationPurchasePricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Purchase Price Per Share",
        "label": "Business Combination, Purchase Price Per Share",
        "terseLabel": "Purchase price (in EUR/USD per share)"
       }
      }
     },
     "localname": "BusinessCombinationPurchasePricePerShare",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "sny_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combinations [Abstract]",
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations 1 [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_BusinessOperatingIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business operating income.",
        "label": "Business Operating Income",
        "terseLabel": "Business operating income",
        "totalLabel": "Business operating income"
       }
      }
     },
     "localname": "BusinessOperatingIncome",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CaissePrimaireDassuranceMaladieMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Caisse Primaire D Assurance Maladie.",
        "label": "Caisse Primaire DAssurance Maladie [Member]",
        "terseLabel": "Caisse Primaire D Assurance Maladie"
       }
      }
     },
     "localname": "CaissePrimaireDassuranceMaladieMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CambridgeMassachusettsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cambridge, Massachusetts",
        "label": "Cambridge, Massachusetts [Member]",
        "terseLabel": "Cambridge, Massachusetts"
       }
      }
     },
     "localname": "CambridgeMassachusettsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CapitalLossesCarryBackPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Losses, Carry Back Period",
        "label": "Capital Losses, Carry Back Period",
        "terseLabel": "Capital losses, carry back period"
       }
      }
     },
     "localname": "CapitalLossesCarryBackPeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_CapitalLossesUsedAgainstCapitalGainsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Losses Used Against Capital Gains, Percentage",
        "label": "Capital Losses Used Against Capital Gains, Percentage",
        "terseLabel": "Percentage of capital losses used"
       }
      }
     },
     "localname": "CapitalLossesUsedAgainstCapitalGainsPercentage",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_CarraigInsuranceDACMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carraig Insurance DAC.",
        "label": "Carraig Insurance DAC [member]",
        "terseLabel": "Carraig Insurance DAC"
       }
      }
     },
     "localname": "CarraigInsuranceDACMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CashAndCashEquivalentsInvestedRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalents invested rate.",
        "label": "Cash And Cash Equivalents, Invested Rate",
        "terseLabel": "Cash and cash equivalents, invested rate"
       }
      }
     },
     "localname": "CashAndCashEquivalentsInvestedRate",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalents.",
        "label": "Cash And Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalents captive insurance and reinsurance companies.",
        "label": "Cash Equivalents, Captive Insurance And Reinsurance Companies",
        "terseLabel": "Cash equivalents, captive insurance and reinsurance companies"
       }
      }
     },
     "localname": "CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/CashandcashequivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CashEquivalentsCommercialPaper": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalent commercial paper.",
        "label": "Cash Equivalents, Commercial Paper",
        "terseLabel": "Cash equivalents, commercial paper"
       }
      }
     },
     "localname": "CashEquivalentsCommercialPaper",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/CashandcashequivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CashEquivalentsMoneyMarketMutualFunds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalent money market mutual funds.",
        "label": "Cash Equivalents, Money Market Mutual Funds",
        "terseLabel": "Cash equivalents, money market mutual funds"
       }
      }
     },
     "localname": "CashEquivalentsMoneyMarketMutualFunds",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/CashandcashequivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CashFlowAndFairValueHedgeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow And Fair Value Hedge",
        "label": "Cash Flow And Fair Value Hedge [Member]",
        "terseLabel": "Cash Flow And Fair Value Hedge"
       }
      }
     },
     "localname": "CashFlowAndFairValueHedgeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flows From (Used In) Increase (Decrease) In Current Borrowings And Other Financial Instruments",
        "label": "Cash Flows From (Used In) Increase (Decrease) In Current Borrowings And Other Financial Instruments",
        "terseLabel": "Net change in short-term debt and other financial instruments"
       }
      }
     },
     "localname": "CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CashGeneratingUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Generating Units [member]",
        "label": "Cash Generating Units [member]",
        "terseLabel": "CGUs"
       }
      }
     },
     "localname": "CashGeneratingUnitsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CashInflowsFromExchangeOfBusinessInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "localname": "CashInflowsFromExchangeOfBusinessInvestingActivities",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "monetaryItemType"
    },
    "sny_CerezymeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cerezyme.",
        "label": "Cerezyme [Member]",
        "terseLabel": "Cerezyme"
       }
      }
     },
     "localname": "CerezymeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in currency translation before tax excluding associates and joint ventures.",
        "label": "Change In Currency Translation Before Tax Excluding Associates And Joint Ventures",
        "terseLabel": "Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method)"
       }
      }
     },
     "localname": "ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in currency translation net of tax on associates and joint ventures.",
        "label": "Change In Currency Translation Net Of Tax On Associates And Joint Ventures",
        "terseLabel": "Currency translation differences (investments accounted for using the equity method)"
       }
      }
     },
     "localname": "ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in currency translation on hedges of net investments in foreign operations.",
        "label": "Change In Currency Translation On Hedges Of Net Investments In Foreign Operations",
        "terseLabel": "Hedges of net investments in foreign operations"
       }
      }
     },
     "localname": "ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChangeInCurrencyTranslationOnTaxEffects": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in currency translation on tax effects.",
        "label": "Change In Currency Translation On Tax Effects",
        "negatedLabel": "Tax effects"
       }
      }
     },
     "localname": "ChangeInCurrencyTranslationOnTaxEffects",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChangeInEuroAndUSDollarShortTermInterestRatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Euro and US dollar short-term interest rates.",
        "label": "Change In Euro And US Dollar Short-term Interest Rates [Member]",
        "terseLabel": "Change in Euro and US dollar short-term interest rates"
       }
      }
     },
     "localname": "ChangeInEuroAndUSDollarShortTermInterestRatesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 9.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value on cash flow hedges excluding associates and joint ventures.",
        "label": "Change In Fair Value On Cash Flow Hedges Excluding Associates And Joint Ventures",
        "terseLabel": "Change in fair value (excluding investments accounted for using the equity method)"
       }
      }
     },
     "localname": "ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 8.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value on cash flow hedges net of tax on associates and joint ventures.",
        "label": "Change In Fair Value On Cash Flow Hedges Net Of Tax On Associates And Joint Ventures",
        "terseLabel": "Change in fair value (investments accounted for using the equity method, net of taxes)"
       }
      }
     },
     "localname": "ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Fair Value On Debt Instrument Excluding Associates And Joint Ventures",
        "label": "Change In Fair Value On Debt Instrument Excluding Associates And Joint Ventures",
        "terseLabel": "Change in fair value (excluding investments accounted for using the equity method)"
       }
      }
     },
     "localname": "ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Fair Value On Equity Instruments Excluding Associates And Joint Ventures",
        "label": "Change In Fair Value On Equity Instruments Excluding Associates And Joint Ventures",
        "terseLabel": "Change in fair value (excluding investments accounted for using the equity method)"
       }
      }
     },
     "localname": "ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 7.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Fair Value On Equity Instruments For Investments Accounted For Using The Equity Method Net Of Tax",
        "label": "Change In Fair Value On Equity Instruments For Investments Accounted For Using The Equity Method Net Of Tax",
        "terseLabel": "Change in fair value (investments accounted for using the equity method, net of taxes)"
       }
      }
     },
     "localname": "ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChangeInProvisionsRecognizedInProfitOrLossForThePeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in provisions recognized in profit or loss for the period.",
        "label": "Change In Provisions Recognized In Profit Or Loss For The Period",
        "terseLabel": "Change in provisions recognized in profit or loss for the period"
       }
      }
     },
     "localname": "ChangeInProvisionsRecognizedInProfitOrLossForThePeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Scope Of Consolidation Through Business Combination, Intangible Assets",
        "label": "Change In Scope Of Consolidation Through Business Combination, Intangible Assets",
        "terseLabel": "Changes\u00a0in\u00a0scope of\u00a0consolidation"
       }
      }
     },
     "localname": "ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Scope Of Consolidation Through Business Combinations, Property, Plant And Equipment",
        "label": "Change In Scope Of Consolidation Through Business Combinations, Property, Plant And Equipment",
        "terseLabel": "Changes in scope of consolidation"
       }
      }
     },
     "localname": "ChangeInScopeOfConsolidationThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ChargebackIncentivesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chargeback incentives.",
        "label": "Chargeback Incentives [Member]",
        "terseLabel": "Chargeback incentives"
       }
      }
     },
     "localname": "ChargebackIncentivesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ChattemIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chattem, Inc.",
        "label": "Chattem Inc [member]",
        "terseLabel": "Chattem, Inc."
       }
      }
     },
     "localname": "ChattemIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ChinoinPrivateCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chinoin Private Co. Ltd.",
        "label": "Chinoin Private Co. Ltd [member]",
        "terseLabel": "Chinoin Private Co. Ltd"
       }
      }
     },
     "localname": "ChinoinPrivateCoLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CollaborationAgreementAnnualNetSalesTarget": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Agreement, Annual Net Sales Target",
        "label": "Collaboration Agreement, Annual Net Sales Target",
        "terseLabel": "Collaboration agreement, annual net sales target"
       }
      }
     },
     "localname": "CollaborationAgreementAnnualNetSalesTarget",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CollaborationAgreementCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Agreement, Commitment Amount",
        "label": "Collaboration Agreement, Commitment Amount",
        "terseLabel": "Collaboration agreement, commitment amount"
       }
      }
     },
     "localname": "CollaborationAgreementCommitmentAmount",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CollaborationAgreementPeriodAfterLossOfControl": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Agreement, Period After Loss Of Control",
        "label": "Collaboration Agreement, Period After Loss Of Control",
        "terseLabel": "Collaboration agreement, period after loss of control"
       }
      }
     },
     "localname": "CollaborationAgreementPeriodAfterLossOfControl",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_CollaborationAgreementWithGSKMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Agreement With GSK",
        "label": "Collaboration Agreement With GSK [Member]",
        "terseLabel": "Collaboration agreement with GSK"
       }
      }
     },
     "localname": "CollaborationAgreementWithGSKMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CommercialPaperProgramInFranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial paper program In France.",
        "label": "Commercial Paper Program In France [Member]",
        "terseLabel": "Commercial paper program in France"
       }
      }
     },
     "localname": "CommercialPaperProgramInFranceMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CommercialPaperProgramInUSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial paper program in USA.",
        "label": "Commercial Paper Program In USA [Member]",
        "terseLabel": "Commercial paper program in USA"
       }
      }
     },
     "localname": "CommercialPaperProgramInUSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CommercializationRelatedExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercialization related expenses.",
        "label": "Commercialization Related Expenses [Member]",
        "terseLabel": "Commercialization related expenses"
       }
      }
     },
     "localname": "CommercializationRelatedExpensesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CommitmentsMadeToJointVenturesAndAssociates": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments made to joint ventures and associates.",
        "label": "Commitments Made To Joint Ventures And Associates",
        "terseLabel": "Funding commitments to associates and joint ventures"
       }
      }
     },
     "localname": "CommitmentsMadeToJointVenturesAndAssociates",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsReceivedForDevelopmentCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments Received For Development Costs",
        "label": "Commitments Received For Development Costs",
        "terseLabel": "Commitments received for development costs"
       }
      }
     },
     "localname": "CommitmentsReceivedForDevelopmentCosts",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments Related To Attainment Of Regulatory And Sales Milestones For Commercialized Products",
        "label": "Commitments Related To Attainment Of Regulatory And Sales Milestones For Commercialized Products",
        "terseLabel": "Commitments related to attainment of regulatory and sales milestones for commercialized products"
       }
      }
     },
     "localname": "CommitmentsRelatedToAttainmentOfRegulatoryAndSalesMilestonesForCommercializedProducts",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments Related To Collaboration, Discovery, Development And Commercialization Agreements",
        "label": "Commitments Related To Collaboration, Discovery, Development And Commercialization Agreements",
        "terseLabel": "Commitments related to collaboration, discovery, development and commercialization agreements"
       }
      }
     },
     "localname": "CommitmentsRelatedToCollaborationDiscoveryDevelopmentAndCommercializationAgreements",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments Related To Maximum Payments For Projects Under Collaboration Agreement",
        "label": "Commitments Related To Maximum Payments For Projects Under Collaboration Agreement",
        "terseLabel": "Commitments related to maximum payments for projects under collaboration agreement"
       }
      }
     },
     "localname": "CommitmentsRelatedToMaximumPaymentsForProjectsUnderCollaborationAgreement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatedToMilestonePaymentsBusinessCombinations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments Related To Milestone Payments, Business Combinations",
        "label": "Commitments Related To Milestone Payments, Business Combinations",
        "terseLabel": "Commitments related to milestone payments, business combinations"
       }
      }
     },
     "localname": "CommitmentsRelatedToMilestonePaymentsBusinessCombinations",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments Related To Milestone Payments For Projects Under Collaboration Agreements",
        "label": "Commitments Related To Milestone Payments For Projects Under Collaboration Agreements",
        "terseLabel": "Commitments related to milestone payments for projects under collaboration agreements"
       }
      }
     },
     "localname": "CommitmentsRelatedToMilestonePaymentsForProjectsUnderCollaborationAgreements",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments Related To Research And Development License Agreements, Contingent Milestone Payments In Connection With Development Programs In Progress",
        "label": "Commitments Related To Research And Development License Agreements, Contingent Milestone Payments In Connection With Development Programs In Progress",
        "terseLabel": "Research and development license agreements - contingent milestone payments in connection with development programs in progress"
       }
      }
     },
     "localname": "CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsContingentMilestonePaymentsInConnectionWithDevelopmentProgramsInProgress",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments related to R&amp; D licence agreements and other commitments.",
        "label": "Commitments Related To Research And Development License Agreements, Other Commitments",
        "terseLabel": "Research and development license agreements - commitments related to R&amp;D and other commitments"
       }
      }
     },
     "localname": "CommitmentsRelatedToResearchAndDevelopmentLicenseAgreementsOtherCommitments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments related to r and d payments contingent upon attainment of sales targets.",
        "label": "Commitments Related To Research And Development Payments Contingent Upon Attainment Of Sales Targets",
        "terseLabel": "Commitments related to research and development payments contingent upon attainment of sales targets"
       }
      }
     },
     "localname": "CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments Related To Research And Development Relating To Projects In Research Phase",
        "label": "Commitments Related To Research And Development Relating To Projects In Research Phase",
        "terseLabel": "Commitments related to research and development relating to projects in research phase"
       }
      }
     },
     "localname": "CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments Relating To Contingent Consideration In Connection With Business Combinations",
        "label": "Commitments Relating To Contingent Consideration In Connection With Business Combinations",
        "terseLabel": "Commitments relating to contingent consideration in connection with business combinations"
       }
      }
     },
     "localname": "CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments relating to contingent consideration in connection with business combinations bayer.",
        "label": "Commitments Relating To Contingent Consideration In Connection With Business Combinations Bayer",
        "terseLabel": "Commitments relating to contingent consideration in connection with business combinations Bayer"
       }
      }
     },
     "localname": "CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments Relating To Contingent Consideration In Connection With Business Combinations MSD",
        "label": "Commitments Relating To Contingent Consideration In Connection With Business Combinations MSD",
        "terseLabel": "Commitments relating to contingent consideration in connection with business combinations MSD"
       }
      }
     },
     "localname": "CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsMSD",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CommoditiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commodities.",
        "label": "Commodities [Member]",
        "terseLabel": "Commodities"
       }
      }
     },
     "localname": "CommoditiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ConcentrationRiskThresholdPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration risk threshold percentage.",
        "label": "Concentration Risk Threshold Percentage",
        "terseLabel": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskThresholdPercentage",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_ConsiderationTransferredMaximumAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consideration Transferred, Maximum Amount",
        "label": "Consideration Transferred, Maximum Amount",
        "terseLabel": "Consideration transferred, maximum amount"
       }
      }
     },
     "localname": "ConsiderationTransferredMaximumAmount",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ConsiderationTransferredToFundReserveForIndemnificationUndertaking": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consideration Transferred To Fund Reserve For Indemnification Undertaking",
        "label": "Consideration Transferred To Fund Reserve For Indemnification Undertaking",
        "terseLabel": "Fund reserves transferred"
       }
      }
     },
     "localname": "ConsiderationTransferredToFundReserveForIndemnificationUndertaking",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ConsiderationTransferredValuationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consideration Transferred, Valuation Period",
        "label": "Consideration Transferred, Valuation Period",
        "terseLabel": "Consideration transferred, valuation period"
       }
      }
     },
     "localname": "ConsiderationTransferredValuationPeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_ConsolidationAdjustmentsIntragroupMarginInInventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidation adjustments intragroup margin In Inventory.",
        "label": "Consolidation Adjustments Intragroup Margin In Inventory [Member]",
        "terseLabel": "Consolidation adjustments (intragroup margin in inventory)"
       }
      }
     },
     "localname": "ConsolidationAdjustmentsIntragroupMarginInInventoryMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ConsumerHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumer Healthcare.",
        "label": "Consumer Healthcare [Member]",
        "terseLabel": "Consumer Healthcare"
       }
      }
     },
     "localname": "ConsumerHealthcareMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ConsumerHealthcareSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumer Healthcare segment.",
        "label": "Consumer Healthcare Segment [Member]",
        "terseLabel": "Consumer Healthcare"
       }
      }
     },
     "localname": "ConsumerHealthcareSegmentMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ContingenciesArisingFromCertainBusinessDivestituresMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingencies Arising From Certain Business Divestitures [Member]",
        "label": "Contingencies Arising From Certain Business Divestitures [Member]",
        "terseLabel": "Contingencies arising from certain business divestitures"
       }
      }
     },
     "localname": "ContingenciesArisingFromCertainBusinessDivestituresMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration Arising From The Acquisition Of Amunix",
        "label": "Contingent Consideration Arising From The Acquisition Of Amunix [Member]",
        "terseLabel": "Contingent consideration arising from acquisition of Amunix"
       }
      }
     },
     "localname": "ContingentConsiderationArisingFromTheAcquisitionOfAmunixMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ContingentConsiderationCollaborationAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration Collaboration Agreements",
        "label": "Contingent Consideration Collaboration Agreements",
        "terseLabel": "Contingent consideration collaboration agreements"
       }
      }
     },
     "localname": "ContingentConsiderationCollaborationAgreements",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ContingentConsiderationLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration liabilities.",
        "label": "Contingent Consideration Liabilities",
        "terseLabel": "Contingent consideration liabilities"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilities",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ContingentConsiderationRelatingToDivestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration relating to divestments.",
        "label": "Contingent Consideration Relating To Divestments [Member]",
        "terseLabel": "Contingent consideration relating to divestments"
       }
      }
     },
     "localname": "ContingentConsiderationRelatingToDivestmentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ContingentConsiderationTranslateBioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration Translate Bio",
        "label": "Contingent Consideration Translate Bio [Member]",
        "terseLabel": "Shire contingent consideration arising from the acquisition of Translate Bio"
       }
      }
     },
     "localname": "ContingentConsiderationTranslateBioMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ContractualAgreementForAntiProgrammedCellDeathProtein1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual Agreement For Anti-programmed Cell Death Protein1",
        "label": "Contractual Agreement For Anti-programmed Cell Death Protein1",
        "terseLabel": "Contractual agreement for anti-programmed cell death protein"
       }
      }
     },
     "localname": "ContractualAgreementForAntiProgrammedCellDeathProtein1",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_CoreAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Core Assets",
        "label": "Core Assets [Member]",
        "terseLabel": "Core Assets"
       }
      }
     },
     "localname": "CoreAssetsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CorporateInformationAndStatementOfIFRSComplianceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Information And Statement Of IFRS Compliance [Abstract]",
        "label": "Corporate Information And Statement Of IFRS Compliance [Abstract]",
        "terseLabel": "Corporate Information And Statement Of IFRS Compliance [Abstract]"
       }
      }
     },
     "localname": "CorporateInformationAndStatementOfIFRSComplianceAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_CostOfDebtNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of debt net.",
        "label": "Cost Of Debt Net",
        "negatedTotalLabel": "Cost of net debt"
       }
      }
     },
     "localname": "CostOfDebtNet",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CumulativeConsumerPriceInflationOverTheLastThreeYears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative consumer price inflation rate.",
        "label": "Cumulative Consumer Price Inflation Over The Last Three Years",
        "terseLabel": "Cumulative inflation rate over three years"
       }
      }
     },
     "localname": "CumulativeConsumerPriceInflationOverTheLastThreeYears",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_CumulativeDevelopmentCostsIncurred": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Development Costs Incurred",
        "label": "Cumulative Development Costs Incurred",
        "terseLabel": "Cumulative development costs incurred"
       }
      }
     },
     "localname": "CumulativeDevelopmentCostsIncurred",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency and interest rate derivatives used to manage debt, net of cash and cash equivalents.",
        "label": "Currency And Interest Rate Derivatives Used To Manage Debt Net Of Cash And Cash Equivalents",
        "terseLabel": "Currency and interest rate derivatives"
       }
      }
     },
     "localname": "CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CurrencyDerivativesFinancialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency derivatives, financial.",
        "label": "Currency Derivatives Financial [Member]",
        "terseLabel": "financial"
       }
      }
     },
     "localname": "CurrencyDerivativesFinancialMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CurrencyDerivativesMeasuredAtFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/OthercurrentassetsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency derivatives measured at fair value.",
        "label": "Currency Derivatives Measured At Fair Value",
        "terseLabel": "Currency derivatives measured at fair value (see Note\u00a0D.20.)"
       }
      }
     },
     "localname": "CurrencyDerivativesMeasuredAtFairValue",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthercurrentassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CurrencyDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency derivatives.",
        "label": "Currency Derivatives [member]",
        "terseLabel": "Currency derivatives"
       }
      }
     },
     "localname": "CurrencyDerivativesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CurrencyDerivativesOperatingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency derivatives, operating.",
        "label": "Currency Derivatives Operating [Member]",
        "terseLabel": "operating"
       }
      }
     },
     "localname": "CurrencyDerivativesOperatingMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CurrencySwapsInUSDToEURMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency Swaps In USD to EUR",
        "label": "Currency Swaps In USD to EUR [Member]",
        "terseLabel": "Currency swaps in USD to EUR"
       }
      }
     },
     "localname": "CurrencySwapsInUSDToEURMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current assets.",
        "label": "Current Assets [Member]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentAssetsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CurrentCurrencyDerivativesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "sny_CurrentProvisionsAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency derivatives.",
        "label": "Current Currency Derivatives Payable",
        "terseLabel": "Currency derivatives (see Note\u00a0D.20.)"
       }
      }
     },
     "localname": "CurrentCurrencyDerivativesPayable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CurrentDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current derivatives.",
        "label": "Current Derivatives [Member]",
        "terseLabel": "Current derivatives",
        "verboseLabel": "Current derivatives"
       }
      }
     },
     "localname": "CurrentDerivativesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CurrentEquityDerivativesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "sny_CurrentProvisionsAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Equity Derivatives Payable",
        "label": "Current Equity Derivatives Payable",
        "verboseLabel": "Equity derivatives (see Note\u00a0D.20.)"
       }
      }
     },
     "localname": "CurrentEquityDerivativesPayable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CurrentInterestRateDerivativesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "sny_CurrentProvisionsAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current interest rate derivatives payable.",
        "label": "Current Interest Rate Derivatives Payable",
        "terseLabel": "Interest rate derivatives (see Note\u00a0D.20.)"
       }
      }
     },
     "localname": "CurrentInterestRateDerivativesPayable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current liabilities.",
        "label": "Current Liabilities [Member]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentLiabilitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This account includes current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes current portion of liabilities related to non-controlling interests.",
        "label": "Current Liabilities Related To Business Combinations And To Non-Controlling Interests",
        "terseLabel": "Current liabilities related to business combinations and to non-controlling interests"
       }
      }
     },
     "localname": "CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CurrentProvisionsAndOtherCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current provisions and current other liabilities that the entity does not separately disclose in the same statement or note.",
        "label": "Current Provisions And Other Current Liabilities",
        "terseLabel": "Current provisions and other current liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CurrentProvisionsAndOtherCurrentLiabilities",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesCurrentProvisionsandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_CustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer one.",
        "label": "Customer One [member]",
        "terseLabel": "Customer one"
       }
      }
     },
     "localname": "CustomerOneMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer three.",
        "label": "Customer Three [member]",
        "terseLabel": "Customer three"
       }
      }
     },
     "localname": "CustomerThreeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_CustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer two.",
        "label": "Customer Two [member]",
        "terseLabel": "Customer two"
       }
      }
     },
     "localname": "CustomerTwoMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DaiichiSankyoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Daiichi Sankyo",
        "label": "Daiichi Sankyo [Member]",
        "terseLabel": "Daiichi Sankyo"
       }
      }
     },
     "localname": "DaiichiSankyoMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DebtInstrumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument 1.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DebtInstrumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument [Domain]",
        "label": "Debt Instrument [Domain]",
        "terseLabel": "Debt Instrument [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DebtInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instruments.",
        "label": "Debt Instruments [Member]",
        "terseLabel": "Debt instruments"
       }
      }
     },
     "localname": "DebtInstrumentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DebtNetOfCashAndCashEquivalents": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt net of cash and cash equivalents.",
        "label": "Debt, Net Of Cash And Cash Equivalents",
        "terseLabel": "Net debt",
        "totalLabel": "Net debt"
       }
      }
     },
     "localname": "DebtNetOfCashAndCashEquivalents",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DebtPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt percent.",
        "label": "Debt, Percent",
        "terseLabel": "Debt, percent"
       }
      }
     },
     "localname": "DebtPercent",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actuarial gains/(losses) on experience adjustments.",
        "label": "Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Actuarial Gains (Losses) On Experience Adjustments",
        "terseLabel": "Gains/(losses) on experience adjustments"
       }
      }
     },
     "localname": "DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromActuarialGainsLossesOnExperienceAdjustments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesRemeasurementofNetDefinedbenefitAssetLiabilityActuarialGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Administration Costs And Taxes Paid During The Period",
        "label": "Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Administration Costs And Taxes Paid During The Period",
        "terseLabel": "Administration costs and taxes paid during the period"
       }
      }
     },
     "localname": "DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsAndTaxesPaidDuringThePeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Payments In Respect Of Settlements Specified In The Terms Of The Plan",
        "label": "Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Payments In Respect Of Settlements Specified In The Terms Of The Plan Net Defined Benefit Liability (Asset)",
        "negatedLabel": "Plan settlements specified in the terms of the plan"
       }
      }
     },
     "localname": "DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Plan Amendments, Curtailments Or Settlements Not Specified In The Terms Of The Plan",
        "label": "Decrease (Increase) In Net Defined Benefit Liability (Asset) Resulting From Plan Amendments, Curtailments Or Settlements Not Specified In The Terms Of The Plan",
        "negatedLabel": "Plan amendments, curtailments or settlements not specified in the terms of the plan"
       }
      }
     },
     "localname": "DecreaseIncreaseInNetDefinedBenefitLiabilityAssetResultingFromPlanAmendmentsCurtailmentsOrSettlementsNotSpecifiedInTheTermsOfThePlan",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DecreaseThroughLossOfControlOfSubsidiaryNetAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease Through Loss Of Control Of Subsidiary, Net Assets",
        "label": "Decrease Through Loss Of Control Of Subsidiary, Net Assets",
        "terseLabel": "Decrease through loss of control of subsidiary, net assets"
       }
      }
     },
     "localname": "DecreaseThroughLossOfControlOfSubsidiaryNetAssets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments made for discounts, rebates and sales returns.",
        "label": "Decrease Through Payments Made Provisions For Discounts Rebates And Sales Returns",
        "negatedTerseLabel": "Payments made"
       }
      }
     },
     "localname": "DecreaseThroughPaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DefendantAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defendant [Axis]",
        "label": "Defendant [Axis]",
        "terseLabel": "Defendant [Axis]"
       }
      }
     },
     "localname": "DefendantAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DefendantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defendant.",
        "label": "Defendants [Member]",
        "terseLabel": "Defendants [Member]"
       }
      }
     },
     "localname": "DefendantsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets not recognized as future recovery not probable.",
        "label": "Deferred Tax Assets Not Recognized As Future Recovery Not Probable",
        "terseLabel": "Deferred tax assets not recognized as future recovery not probable"
       }
      }
     },
     "localname": "DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DeferredTaxRelatingToRestructuringProvisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax relating to restructuring provisions.",
        "label": "Deferred Tax Relating To Restructuring Provisions [member]",
        "terseLabel": "Deferred tax relating to restructuring provisions"
       }
      }
     },
     "localname": "DeferredTaxRelatingToRestructuringProvisionsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DefinedBenefitPensionPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit pension plans.",
        "label": "Defined Benefit Pension Plans [Member]",
        "terseLabel": "Defined benefit pension plans"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlansMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DefinedBenefitPlansVestingRightsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plans vesting rights percentage.",
        "label": "Defined Benefit Plans Vesting Rights Percentage",
        "terseLabel": "Vesting right percentage"
       }
      }
     },
     "localname": "DefinedBenefitPlansVestingRightsPercentage",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_DengvaxiaProductLitigationInThePhilippinesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dengvaxia Product Litigation In The Philippines",
        "label": "Dengvaxia Product Litigation In The Philippines [Member]",
        "terseLabel": "Dengvaxia product litigation in the Philippines"
       }
      }
     },
     "localname": "DengvaxiaProductLitigationInThePhilippinesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DepakineProductLitigationInBelgiumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depakine Product Litigation In Belgium",
        "label": "Depakine Product Litigation In Belgium [Member]",
        "terseLabel": "Depakine product litigation in Belgium"
       }
      }
     },
     "localname": "DepakineProductLitigationInBelgiumMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DepakineProductLitigationInFranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depakine Product Litigation In France",
        "label": "Depakine Product Litigation In France [Member]",
        "terseLabel": "Depakine product litigation In France"
       }
      }
     },
     "localname": "DepakineProductLitigationInFranceMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DepakineProductLitigationInGermanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depakine Product Litigation In Germany",
        "label": "Depakine Product Litigation In Germany [Member]",
        "terseLabel": "Depakine product litigation in Germany"
       }
      }
     },
     "localname": "DepakineProductLitigationInGermanyMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DepakineProductLitigationInGreatBritainMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depakine Product Litigation In Great Britain",
        "label": "Depakine Product Litigation In Great Britain [Member]",
        "verboseLabel": "Depakine Product Litigation In Great Britain"
       }
      }
     },
     "localname": "DepakineProductLitigationInGreatBritainMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DepakineProductLitigationInIrelandMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depakine Product Litigation In Ireland",
        "label": "Depakine Product Litigation In Ireland [Member]",
        "terseLabel": "Depakine Product Litigation In Ireland"
       }
      }
     },
     "localname": "DepakineProductLitigationInIrelandMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DepakineProductLitigationInNorthernIrelandMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depakine Product Litigation In Northern Ireland",
        "label": "Depakine Product Litigation In Northern Ireland [Member]",
        "terseLabel": "Depakine Product Litigation In Northern Ireland"
       }
      }
     },
     "localname": "DepakineProductLitigationInNorthernIrelandMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DepakineProductLitigationInSpainMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depakine Product Litigation In Spain",
        "label": "Depakine Product Litigation In Spain [Member]",
        "terseLabel": "Depakine product litigation in Spain"
       }
      }
     },
     "localname": "DepakineProductLitigationInSpainMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DepakineProductLitigationInSwitzerlandMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depakine Product Litigation In Switzerland",
        "label": "Depakine Product Litigation In Switzerland [Member]",
        "terseLabel": "Depakine product litigation in Switzerland"
       }
      }
     },
     "localname": "DepakineProductLitigationInSwitzerlandMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DerecognizedReceivables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derecognized receivables.",
        "label": "Derecognized Receivables",
        "terseLabel": "Derecognized receivables"
       }
      }
     },
     "localname": "DerecognizedReceivables",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails": {
       "order": 2.0,
       "parentTag": "sny_NetAmountsAsReportedInTheBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative financial assets and liabilities gross amounts offset in accordance with IAS 32.",
        "label": "Derivative Financial Assets And Liabilities, Gross Amounts Offset In Accordance With IAS 32",
        "terseLabel": "Gross amounts offset (in accordance with IAS 32)"
       }
      }
     },
     "localname": "DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails": {
       "order": 1.0,
       "parentTag": "sny_NetAmountsAsReportedInTheBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative financial assets and liabilities gross carrying amounts before offset.",
        "label": "Derivative Financial Assets And Liabilities, Gross Carrying Amounts Before Offset",
        "terseLabel": "Gross carrying amounts before offset"
       }
      }
     },
     "localname": "DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DerivativeFinancialAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative financial assets.",
        "label": "Derivative Financial Assets [member]",
        "terseLabel": "Derivative financial assets"
       }
      }
     },
     "localname": "DerivativeFinancialAssetsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DerivativeFinancialInstruments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative financial instrument",
        "label": "Derivative Financial Instruments",
        "terseLabel": "Operating currency hedging instruments in place",
        "verboseLabel": "Nominal value of interest rate swaps hedge fixed-rate bonds"
       }
      }
     },
     "localname": "DerivativeFinancialInstruments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DerivativeFinancialInstrumentsToManageFinancialExposure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative financial instruments to manage financial exposure.",
        "label": "Derivative Financial Instruments To Manage Financial Exposure",
        "terseLabel": "Financial currency hedging instruments in place"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsToManageFinancialExposure",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DerivativeFinancialLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative financial liabilities.",
        "label": "Derivative Financial Liabilities [Member]",
        "terseLabel": "Derivative financial liabilities"
       }
      }
     },
     "localname": "DerivativeFinancialLiabilitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DerivativeInstrumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DerivativeInstrumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of derivative instrument.",
        "label": "Derivative Instrument [Domain]",
        "terseLabel": "Derivative Instrument [Domain]"
       }
      }
     },
     "localname": "DerivativeInstrumentDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for basis of consolidation.",
        "label": "Description Of Accounting Policy For Basis Of Consolidation [Policy Text Block]",
        "terseLabel": "Basis of consolidation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DescriptionOfAccountingPolicyForCostOfSalesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of accounting policy for cost of sales explanatory.",
        "label": "Description Of Accounting Policy For Cost Of Sales [Policy Text Block]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForCostOfSalesExplanatory",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description Of Accounting Policy For Effects Of Climate Change",
        "label": "Description Of Accounting Policy For Effects Of Climate Change [Policy Text Block]",
        "terseLabel": "Effects of climate change"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEffectsOfClimateChangePolicyTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for fair value remeasurement of contingent consideration liabilities.",
        "label": "Description Of Accounting Policy For Fair Value Remeasurement Of Contingent Consideration Liabilities Explanatory [Policy Text Block]",
        "terseLabel": "Fair value remeasurement of contingent consideration"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFairValueRemeasurementOfContingentConsiderationLiabilitiesExplanatoryPolicyTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description Of Accounting Policy For International Conflicts",
        "label": "Description Of Accounting Policy For International Conflicts [Policy Text Block]",
        "terseLabel": "War in Ukraine"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForInternationalConflictsPolicyTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of accounting policy for other gains and losses, and litigation explanatory.",
        "label": "Description Of Accounting Policy For Other Gains And Losses And Litigation Explanatory [Policy Text Block]",
        "terseLabel": "Other gains and losses, and litigation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatoryPolicyTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for other operating income and expenses.",
        "label": "Description Of Accounting Policy For Other Operating Income And Expenses Explanatory [Policy Text Block]",
        "terseLabel": "Other operating income and expenses"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatoryPolicyTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for restructuring costs and similar items.",
        "label": "Description Of Accounting Policy For Restructuring Costs And Similar Items [Policy Text Block]",
        "terseLabel": "Restructuring costs and similar items"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsPolicyTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DevelopmentOfCemiplimabREGN2810Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development of cemiplimab (REGN2810).",
        "label": "Development Of Cemiplimab (REGN2810) [Member]",
        "terseLabel": "Development of cemiplimab (REGN2810)"
       }
      }
     },
     "localname": "DevelopmentOfCemiplimabREGN2810Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DiceMoleculesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dice molecules.",
        "label": "DiCE Molecules [Member]",
        "terseLabel": "Dice Molecules"
       }
      }
     },
     "localname": "DiceMoleculesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DigestiveWellnessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Digestive [Member]",
        "label": "Digestive Wellness [Member]",
        "terseLabel": "Digestive Wellness"
       }
      }
     },
     "localname": "DigestiveWellnessMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diluted Earnings (Loss) Per Share, Attributable To Owners Of Parent",
        "label": "Diluted Earnings (Loss) Per Share, Attributable To Owners Of Parent",
        "terseLabel": "Diluted earnings per share (in euros per share)"
       }
      }
     },
     "localname": "DilutedEarningsLossPerShareAttributableToOwnersOfParent",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements"
     ],
     "xbrltype": "perShareItemType"
    },
    "sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_AdjustedWeightedAverageShares",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dilutive effect of share options on number of restricted shares.",
        "label": "Dilutive Effect Of Share Options On Number Of Restricted Shares",
        "terseLabel": "Adjustment for restricted shares (in shares)"
       }
      }
     },
     "localname": "DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofSharesUsedtoComputeDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_DisclosureOfAccountsReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Accounts Receivable [line items]",
        "label": "Disclosure Of Accounts Receivable [line items]",
        "terseLabel": "Disclosure of accounts receivable [line items]"
       }
      }
     },
     "localname": "DisclosureOfAccountsReceivableLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfAccountsReceivableTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Accounts receivable Table.",
        "label": "Disclosure Of Accounts Receivable [Table]",
        "terseLabel": "Disclosure of accounts receivable [Table]"
       }
      }
     },
     "localname": "DisclosureOfAccountsReceivableTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableSummaryofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information of accumulated other comprehensive income.",
        "label": "Disclosure Of Accumulated Other Comprehensive Income Explanatory [Table Text Block]",
        "terseLabel": "Summary of Movements within Other Comprehensive Income"
       }
      }
     },
     "localname": "DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of acquisitions of property plant and equipment and other intangible assets and carrying amount of investments in associates and joint ventures by operating segment.",
        "label": "Disclosure Of Acquisitions Of Property Plant And Equipment And Other Intangible Assets And Carrying Amount Of Investments In Associates And Joint Ventures By Operating Segment [Table Text Block]",
        "terseLabel": "Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment"
       }
      }
     },
     "localname": "DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of acquisitions of property plant and equipment by operating segments explanatory [text block]",
        "label": "Disclosure Of Acquisitions Of Property Plant And Equipment By Operating Segments Explanatory [Table Text Block]",
        "terseLabel": "Summary of Acquisitions and Capitalized Interest by Operating Segment"
       }
      }
     },
     "localname": "DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of acquisitions of property plant and equipment by operating segments.",
        "label": "Disclosure Of Acquisitions Of Property Plant And Equipment By Operating Segments [Line Items]",
        "terseLabel": "Disclosure of acquisitions of property plant and equipment by operating segments [line items]"
       }
      }
     },
     "localname": "DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Acquisitions Of Property Plant And Equipment By Operating Segments",
        "label": "Disclosure Of Acquisitions Of Property Plant And Equipment By Operating Segments [Table]",
        "terseLabel": "Disclosure of acquisitions of property plant and equipment by operating segments [table]"
       }
      }
     },
     "localname": "DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of actual or potential effects of netting arrangements.",
        "label": "Disclosure Of Actual Or Potential Effects Of Netting Arrangements [Table Text Block]",
        "terseLabel": "Disclosure of Actual or Potential Effects of Netting Arrangements"
       }
      }
     },
     "localname": "DisclosureOfActualOrPotentialEffectsOfNettingArrangementsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfActuarialAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Actuarial Assumptions [Table Text Block]",
        "label": "Disclosure Of Actuarial Assumptions [Table Text Block]",
        "terseLabel": "Summary of Financial and Demographic Assumptions"
       }
      }
     },
     "localname": "DisclosureOfActuarialAssumptionsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of allocation of income tax between current and deferred taxes.",
        "label": "Disclosure Of Allocation Of Income Tax Between Current And Deferred Taxes [Table Text Block]",
        "terseLabel": "Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes"
       }
      }
     },
     "localname": "DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/IncometaxexpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of amortization of software and other rights by income statement line.",
        "label": "Disclosure Of Amortization Of Software And Other Rights By Income Statement Line [Table Text Block]",
        "terseLabel": "Amortization of Softwares Recognized in Income Statement"
       }
      }
     },
     "localname": "DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of assets held for sale or exchange and related liabilities.",
        "label": "Disclosure Of Assets Held For Sale Or Exchange And Related Liabilities [Table Text Block]",
        "terseLabel": "Summary of Assets Held for Sale or Exchange, and Liabilities Related to Assets Held for Sale or Exchange"
       }
      }
     },
     "localname": "DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/AssetsheldforsaleorexchangeandliabilitiesrelatedtoassetsheldforsaleorexchangeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfAuditFeesAndOtherServicesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of audit fees and other services.",
        "label": "Disclosure Of Audit Fees And Other Services [Line Items]",
        "terseLabel": "Disclosure of audit fees and other services [line items]"
       }
      }
     },
     "localname": "DisclosureOfAuditFeesAndOtherServicesLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfAuditFeesAndOtherServicesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of audit fees and other services [Table]",
        "label": "Disclosure Of Audit Fees And Other Services [Table]",
        "terseLabel": "Disclosure of audit fees and other services [Table]"
       }
      }
     },
     "localname": "DisclosureOfAuditFeesAndOtherServicesTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of availability of tax losses carry forwards.",
        "label": "Disclosure Of Availability Of Tax Losses Carry Forwards [Table Text Block]",
        "terseLabel": "Summary of Tax Losses Available for Carry-forward"
       }
      }
     },
     "localname": "DisclosureOfAvailabilityOfTaxLossesCarryForwardsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents details.",
        "label": "Disclosure Of Cash And Cash Equivalents Details [Table Text Block]",
        "terseLabel": "Summary of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "DisclosureOfCashAndCashEquivalentsDetailsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/CashandcashequivalentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfChangesInFinancialPositionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of changes in financial position [text block]",
        "label": "Disclosure Of Changes In Financial Position [Table Text Block]",
        "terseLabel": "Summary of Changes in Financial Position"
       }
      }
     },
     "localname": "DisclosureOfChangesInFinancialPositionTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of changes in liabilities related to business combinations and to non-controlling interests.",
        "label": "Disclosure Of Changes In Liabilities Related To Business Combinations And To Noncontrolling Interests [Table Text Block]",
        "terseLabel": "Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests"
       }
      }
     },
     "localname": "DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of changes in property, plant and equipment.",
        "label": "Disclosure Of Changes In Property, Plant And Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "DisclosureOfChangesInPropertyPlantAndEquipmentTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of changes in provisions for discounts rebates and sales returns.",
        "label": "Disclosure Of Changes In Provisions For Discounts Rebates And Sales Returns [Table Text Block]",
        "terseLabel": "Summary of Movement in Provisions for Discounts, Rebates and Sales Returns"
       }
      }
     },
     "localname": "DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of compensation paid to key management personnel.",
        "label": "Disclosure Of Compensation Paid To Key Management Personnel [Table Text Block]",
        "terseLabel": "Schedule of Compensation Paid to Key Management Personnel"
       }
      }
     },
     "localname": "DisclosureOfCompensationPaidToKeyManagementPersonnelTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/RelatedpartytransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of components of other noncurrent assets.",
        "label": "Disclosure Of Components Of Other Noncurrent Assets [Table Text Block]",
        "terseLabel": "Summary of Other Non-current Assets"
       }
      }
     },
     "localname": "DisclosureOfComponentsOfOtherNoncurrentAssetsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of current provisions and other current liabilities.",
        "label": "Disclosure Of Current Provisions And Other Current Liabilities [Table Text Block]",
        "terseLabel": "Current Provisions and Other Current Liabilities"
       }
      }
     },
     "localname": "DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfCurrentTradeReceivablesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of current trade receivables.",
        "label": "Disclosure Of Current Trade Receivables [Table Text Block]",
        "terseLabel": "Summary of Accounts Receivable"
       }
      }
     },
     "localname": "DisclosureOfCurrentTradeReceivablesTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of debt by currency at value of redemption after derivative instruments.",
        "label": "Disclosure Of Debt By Currency At Value Of Redemption After Derivative Instruments [Table Text Block]",
        "terseLabel": "Summary of Debt by Currency After Derivative Instruments"
       }
      }
     },
     "localname": "DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of debt by currency at value of redemption before and after derivative instruments.",
        "label": "Disclosure Of Debt By Currency At Value Of Redemption Before And After Derivative Instruments [Table Text Block]",
        "terseLabel": "Summary of Debt by Currency Before and After Derivative Instrument"
       }
      }
     },
     "localname": "DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfDebtByCurrencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Debt By Currency [Line Items]",
        "label": "Disclosure Of Debt By Currency [Line Items]",
        "terseLabel": "Disclosure Of Debt By Currency [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfDebtByCurrencyLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfDebtByCurrencyTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Debt By Currency [Table]",
        "label": "Disclosure Of Debt By Currency [Table]",
        "terseLabel": "Disclosure Of Debt By Currency [Table]"
       }
      }
     },
     "localname": "DisclosureOfDebtByCurrencyTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of debt by interest rate at value of redemption after taking account of derivative instruments N1 N2.",
        "label": "Disclosure Of Debt By Interest Rate At Value Of Redemption After Taking Account Of Derivative Instruments N1N2 [Table Text Block]",
        "terseLabel": "Summary of Interest Rate of Net Debt at Value on Redemption"
       }
      }
     },
     "localname": "DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of debt by interest rate at value of redemption and by maturity.",
        "label": "Disclosure Of Debt By Interest Rate At Value Of Redemption And By Maturity Explanatory [Table Text Block]",
        "terseLabel": "Summary of Debt by Interest Rate"
       }
      }
     },
     "localname": "DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of debt by maturity at value of redemption.",
        "label": "Disclosure Of Debt By Maturity At Value Of Redemption Explanatory [Table Text Block]",
        "terseLabel": "Summary of Debt by Maturity at Value on Redemption"
       }
      }
     },
     "localname": "DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of debt instruments issued explanatory.",
        "label": "Disclosure Of Debt Instruments Issued Explanatory [Text Block]",
        "terseLabel": "Debt, cash and cash equivalents and lease liabilities"
       }
      }
     },
     "localname": "DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Debtcashandcashequivalentsandleaseliabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Debt",
        "label": "Disclosure Of Debt [Line Items]",
        "terseLabel": "Disclosure of debt [line items]"
       }
      }
     },
     "localname": "DisclosureOfDebtLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of debt net of cash and cash equivalents by type at value on redemption.",
        "label": "Disclosure Of Debt Net Of Cash And Cash Equivalents By Type At Value On Redemption Explanatory [Table Text Block]",
        "terseLabel": "Summary of Debt by Type Valuation of Redemption"
       }
      }
     },
     "localname": "DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfDebtTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of debt [Table]",
        "label": "Disclosure Of Debt [Table]",
        "terseLabel": "Disclosure Of Debt [Table]"
       }
      }
     },
     "localname": "DisclosureOfDebtTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Detail Of Bonds Issued Explanatory",
        "label": "Disclosure Of Detail Of Bonds Issued Explanatory [Table Text Block]",
        "terseLabel": "Summary of Bond Issues"
       }
      }
     },
     "localname": "DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent detailed information about finance income expense.",
        "label": "Disclosure Of Detailed Information About Finance Income Expense [Line Items]",
        "terseLabel": "Disclosure of detailed information about finance income expense [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to details of finance income (expense).",
        "label": "Disclosure Of Detailed Information About Finance Income Expense [table]",
        "terseLabel": "Disclosure Of Detailed Information About Finance Income Expense [table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfDetailedInformationAboutIncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Detailed Information About Income Taxes",
        "label": "Disclosure Of Detailed Information About Income Taxes [Line Items]",
        "terseLabel": "Disclosure Of Detailed Information About Income Taxes [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutIncomeTaxesLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfDetailedInformationAboutIncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Detailed Information About Income Taxes",
        "label": "Disclosure Of Detailed Information About Income Taxes [Table]",
        "terseLabel": "Disclosure Of Detailed Information About Income Taxes [Table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutIncomeTaxesTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about inventories.",
        "label": "Disclosure Of Detailed Information About Inventories [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutInventoriesTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about Principal Alliances [Line Items]",
        "label": "Disclosure Of Detailed Information About Principal Alliances [Line Items]",
        "terseLabel": "Disclosure of detailed information about Principal Alliances [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Detailed Information About Share-Based Payment",
        "label": "Disclosure Of Detailed Information About Share-Based Payment [Line Items]",
        "terseLabel": "Disclosure Of Detailed Information About Share-Based Payment [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutShareBasedPaymentLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfDetailedInformationAboutShareBasedPaymentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Detailed Information About Share-Based Payment",
        "label": "Disclosure Of Detailed Information About Share-Based Payment [Table]",
        "terseLabel": "Disclosure Of Detailed Information About Share-Based Payment [Table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutShareBasedPaymentTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information of other current assets.",
        "label": "Disclosure Of Detailed Information Of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthercurrentassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of employee stock ownership plan awarded in capital increase reserved explanatory [Text Block]",
        "label": "Disclosure Of Employee Stock Ownership Plan Awarded In Capital Increase Reserved Explanatory [Table Text Block]",
        "terseLabel": "Summary of Characteristics of Employee Share Ownership Plans Awarded"
       }
      }
     },
     "localname": "DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of estimated amounts of employer's contributions to plan assets.",
        "label": "Disclosure Of Estimated Amounts Of Employer's Contributions To Plan Assets [Table Text Block]",
        "terseLabel": "Estimated Amounts of Employer's Contributions to Plan Assets"
       }
      }
     },
     "localname": "DisclosureOfEstimatedAmountsOfEmployersContributionsToPlanAssetsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of estimated useful lives of property plant and equipment.",
        "label": "Disclosure Of Estimated Useful Lives Of Property Plant And Equipment Explanatory [Table Text Block]",
        "terseLabel": "Summary of Useful Lives of Property, Plant and Equipment"
       }
      }
     },
     "localname": "DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of expected timing of payments in respect of unfunded pension and other post employment benefit plans.",
        "label": "Disclosure Of Expected Timing Of Payments In Respect Of Unfunded Pension And Other Post Employment Benefit Plans Explanatory [Table Text Block]",
        "terseLabel": "Timing of Future Payments in Respect of Unfunded Pension and Other Post-employment Benefit Plans"
       }
      }
     },
     "localname": "DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of expected timing of payments under pension and other post employment benefit plans.",
        "label": "Disclosure Of Expected Timing Of Payments Under Pension And Other Post Employment Benefit Plans [Table Text Block]",
        "terseLabel": "Expected Timing of Benefit Payments under Pension and Other Post-employment Benefit Plans"
       }
      }
     },
     "localname": "DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of expense for pensions and other post employment benefits by income statement line.",
        "label": "Disclosure Of Expense For Pensions And Other Post Employment Benefits By Income Statement Line Explanatory [Table Text Block]",
        "terseLabel": "Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement Line Items"
       }
      }
     },
     "localname": "DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of fair value measurement of assets and liabilities.",
        "label": "Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]",
        "terseLabel": "Disclosure of Fair Value Measurement of Assets and Liabilities [Table]"
       }
      }
     },
     "localname": "DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of fair value of derivative instruments.",
        "label": "Disclosure Of Fair Value Of Derivative Instruments [Table Text Block]",
        "terseLabel": "Summary of Fair Value of Derivative Instruments"
       }
      }
     },
     "localname": "DisclosureOfFairValueOfDerivativeInstrumentsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of fair value of financial assets and liabilities explanatory.",
        "label": "Disclosure Of Fair Value Of Financial Assets And Liabilities Explanatory [Table Text Block]",
        "terseLabel": "Summary of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of financial assets and liabilities at fair value explanatory.",
        "label": "Disclosure Of Financial Assets And Liabilities At Fair Value Explanatory [Text Block]",
        "terseLabel": "Financial assets and liabilities measured at fair value"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Financialassetsandliabilitiesmeasuredatfairvalue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of financial currency hedging instruments with notional amount translated in to euros at closing exchange rate.",
        "label": "Disclosure Of Financial Currency Hedging Instruments With Notional Amount Translated In To Euros At Closing Exchange Rate Explanatory [Table Text Block]",
        "terseLabel": "Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated"
       }
      }
     },
     "localname": "DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial income and expenses.",
        "label": "Disclosure Of Financial Income And Expenses Explanatory [Table Text Block]",
        "terseLabel": "Summary of Analysis of Financial Income and Expenses"
       }
      }
     },
     "localname": "DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of future benefit payments.",
        "label": "Disclosure Of Future Benefit Payments Explanatory [Table Text Block]",
        "terseLabel": "Timing of Future Termination Benefit Payments"
       }
      }
     },
     "localname": "DisclosureOfFutureBenefitPaymentsExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of goodwill by operating segments.",
        "label": "Disclosure Of Goodwill By Operating Segments Explanatory [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Goodwill"
       }
      }
     },
     "localname": "DisclosureOfGoodwillByOperatingSegmentsExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of guarantees given and received.",
        "label": "Disclosure Of Guarantees Given And Received Explanatory [Table Text Block]",
        "terseLabel": "Summary of Amount of Guarantees Given and Received"
       }
      }
     },
     "localname": "DisclosureOfGuaranteesGivenAndReceivedExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfGuaranteesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of guarantees.",
        "label": "Disclosure Of Guarantees [Line Items]",
        "terseLabel": "Disclosure of Guarantees [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfGuaranteesLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfGuaranteesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Guarantees [Table]",
        "label": "Disclosure Of Guarantees [Table]",
        "terseLabel": "Disclosure Of Guarantees [Table]"
       }
      }
     },
     "localname": "DisclosureOfGuaranteesTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for impact of changes in the scope of consolidation due to acquisitions and divestments.",
        "label": "Disclosure Of Impact Of Changes In The Scope Of Consolidation Due To Acquisitions And Divestments Explanatory [Text Block]",
        "verboseLabel": "Principal changes in the scope of consolidation in 2021 and 2020"
       }
      }
     },
     "localname": "DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Impairment Losses Of Other Intangible Assets [Text Block]",
        "label": "Disclosure Of Impairment Losses Of Other Intangible Assets [Table Text Block]",
        "terseLabel": "Summary of Net Impairment Losses of Other Intangible Assets"
       }
      }
     },
     "localname": "DisclosureOfImpairmentLossesOfOtherIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Impairment Losses of Property, Plant and Equipment [Text Block]",
        "label": "Disclosure Of Impairment Losses of Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Impairment Losses Recognised in Property, Plant and Equipment"
       }
      }
     },
     "localname": "DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for impairment of intangible assets and property, plant and equipment.",
        "label": "Disclosure Of Impairment Of Intangible Assets And Property Plant And Equipment Explanatory [Text Block]",
        "terseLabel": "Impairment of intangible assets and property, plant and equipment"
       }
      }
     },
     "localname": "DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Impairmentofintangibleassetsandpropertyplantandequipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about major customers and credit risk.",
        "label": "Disclosure Of Information About Major Customers And Credit Risk [Line Items]",
        "terseLabel": "Disclosure of information about major customers and credit risk [line items]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about major customers and credit risk.",
        "label": "Disclosure Of Information About Major Customers And Credit Risk [Table]",
        "terseLabel": "Disclosure of Information About Major Customers and Credit Risk [Table]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Information About The Amounts Attributable To Non Controlling Interests Explanatory.",
        "label": "Disclosure Of Information About The Amounts Attributable To Non Controlling Interests Explanatory [Table Text Block]",
        "terseLabel": "Summary of Trends in Net Income Attributable to Non-Controlling Interests"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfInformationOnIncomeStatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information on income statement line items.",
        "label": "Disclosure Of Information On Income Statement [Line Items]",
        "terseLabel": "Disclosure of information on income statement [line items]"
       }
      }
     },
     "localname": "DisclosureOfInformationOnIncomeStatementLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of interest rate of debt net of cash and cash equivalents.",
        "label": "Disclosure Of Interest Rate Of Debt Net of Cash And Cash Equivalent [Line Items]",
        "terseLabel": "Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of interest rate of debt net of cash and cash equivalent.",
        "label": "Disclosure Of Interest Rate Of Debt NetOf Cash And Cash Equivalent [Table]",
        "terseLabel": "Disclosure Of Interest Rate Of Debt Net Of Cash And Cash Equivalent [Table]"
       }
      }
     },
     "localname": "DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of interest rates hedging instruments with notional amount by expiry date.",
        "label": "Disclosure Of Interest Rates Hedging Instruments With Notional Amount By Expiry Date Explanatory [Table Text Block]",
        "terseLabel": "Disclosure of Instruments"
       }
      }
     },
     "localname": "DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfInventoriesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventories.",
        "label": "Disclosure Of Inventories [Line Items]",
        "terseLabel": "Disclosure of inventories [line items]"
       }
      }
     },
     "localname": "DisclosureOfInventoriesLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfInventoriesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventories.",
        "label": "Disclosure Of Inventories [Table]",
        "terseLabel": "Disclosure of inventories [table]"
       }
      }
     },
     "localname": "DisclosureOfInventoriesTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of investments in associates and joint ventures explanatory.",
        "label": "Disclosure Of Investments In Associates And Joint Ventures [Table Text Block]",
        "terseLabel": "Summary of Investments in Associates and Joint Ventures"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Investments In Subsidiaries Explanatory",
        "label": "Disclosure Of Investments In Subsidiaries Explanatory [Table Text Block]",
        "terseLabel": "Summary of Principal Investments Accounted for Using the Equity Method"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsInSubsidiariesExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfLegalAndArbitralProceedingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of legal and arbitral proceedings.",
        "label": "Disclosure Of Legal And Arbitral Proceedings [Line Items]",
        "terseLabel": "Disclosure of Legal and Arbitral Proceedings [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfLegalAndArbitralProceedingsLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfLegalAndArbitralProceedingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of legal and arbitral proceedings.",
        "label": "Disclosure Of Legal And Arbitral Proceedings [Table]",
        "terseLabel": "Disclosure of Legal and Arbitral Proceedings [Table]"
       }
      }
     },
     "localname": "DisclosureOfLegalAndArbitralProceedingsTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfLegalAndArbitralProceedingsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Legal And Arbitral Proceedings [Text Block]",
        "label": "Disclosure Of Legal And Arbitral Proceedings [Text Block]",
        "terseLabel": "Legal and arbitral proceedings"
       }
      }
     },
     "localname": "DisclosureOfLegalAndArbitralProceedingsTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Legalandarbitralproceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for liabilities related to business combination and to non-controlling interests.",
        "label": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests Explanatory [Text Block]",
        "terseLabel": "Liabilities related to business combinations and to non-controlling interests"
       }
      }
     },
     "localname": "DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Liabilitiesrelatedtobusinesscombinationsandtononcontrollinginterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]",
        "label": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]",
        "terseLabel": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]"
       }
      }
     },
     "localname": "DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests Table",
        "label": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Table]",
        "terseLabel": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Table]"
       }
      }
     },
     "localname": "DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfLineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of line of credit facility table line items.",
        "label": "Disclosure Of Line Of Credit Facility [Line Items]",
        "terseLabel": "Disclosure Of Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfLineOfCreditFacilityLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfLineOfCreditFacilityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of line of credit facility table.",
        "label": "Disclosure Of Line Of Credit Facility [Table]",
        "terseLabel": "Disclosure Of Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "DisclosureOfLineOfCreditFacilityTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofUndrawnCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfMarketValueOfNetDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of market value of net debt [Text Block]",
        "label": "Disclosure Of Market Value Of Net Debt [Table Text Block]",
        "terseLabel": "Summary of Market Value of Net Debt"
       }
      }
     },
     "localname": "DisclosureOfMarketValueOfNetDebtTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of maturity analysis of future undiscounted cash flows.",
        "label": "Disclosure Of Maturity Analysis Of Future Undiscounted Cash Flows Explanatory [Table Text Block]",
        "terseLabel": "Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Maturity Analysis Of Lease Payments [Table Text Block]",
        "label": "Disclosure Of Maturity Analysis Of Lease Payments [Table Text Block]",
        "terseLabel": "Disclosure of Lease Liabilities"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests explanatory.",
        "label": "Disclosure Of Maximum Amount Of Contingent Consideration Payable And Firm Commitments To Buy Out Non-controlling Interests Explanatory [Table Text Block]",
        "terseLabel": "Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests"
       }
      }
     },
     "localname": "DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]",
        "label": "Disclosure Of Maximum Amount Of Contingent Consideration Payable And Firm Commitments To Buy Out Non-controlling Interests [Line Items]",
        "terseLabel": "Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests Table",
        "label": "Disclosure Of Maximum Amount Of Contingent Consideration Payable And Firm Commitments To Buy Out Non-controlling Interests [Table]",
        "terseLabel": "Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Table]"
       }
      }
     },
     "localname": "DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInterestsTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of net defined benefit liability assets.",
        "label": "Disclosure Of Net Defined Benefit Liability Assets Explanatory [Table Text Block]",
        "terseLabel": "Reconciliation of Net Obligation in Respect of Sanofi's Pension and Other Post-Employment Benefit Plans"
       }
      }
     },
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of net income attributable to noncontrolling interests [Line Items]",
        "label": "Disclosure Of Net Income Attributable To Non-controlling Interests [Line Items]",
        "terseLabel": "Disclosure of net income attributable to non-controlling interests [line items]"
       }
      }
     },
     "localname": "DisclosureOfNetIncomeAttributableToNonControllingInterestsLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfNetIncomeAttributableToNonControllingInterestsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of net income attributable to Non-controlling Interests [Table]",
        "label": "Disclosure Of Net Income Attributable To Non-controlling Interests [Table]",
        "terseLabel": "Disclosure of net income attributable to Non-controlling Interests [Table]"
       }
      }
     },
     "localname": "DisclosureOfNetIncomeAttributableToNonControllingInterestsTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetincomeattributabletononcontrollinginterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of net liability in respect of pension plans and other post-employment benefits by geographical region.",
        "label": "Disclosure Of Net Liability In Respect Of Pension Plans And Other Post-employment Benefits By Geographical Region [Table Text Block]",
        "terseLabel": "Net Liability in Respect of Pension Plans and Other Post-employment Benefits by Geographical Region"
       }
      }
     },
     "localname": "DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostEmploymentBenefitsByGeographicalRegionTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of net sales by segment and geographical area.",
        "label": "Disclosure Of Net Sales By Segment And Geographical Area [Table Text Block]",
        "terseLabel": "Summary of Net Sales by Segment and Geographical Area"
       }
      }
     },
     "localname": "DisclosureOfNetSalesBySegmentAndGeographicalAreaTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfNoncurrentProvisionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Non-current Provisions [line items]",
        "label": "Disclosure Of Noncurrent Provisions [line items]",
        "terseLabel": "Disclosure Of Non-current Provisions [line items]"
       }
      }
     },
     "localname": "DisclosureOfNoncurrentProvisionsLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfNoncurrentProvisionsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Noncurrent Provisions [Table]",
        "label": "Disclosure Of Noncurrent Provisions [Table]",
        "terseLabel": "Disclosure Of Noncurrent Provisions [Table]"
       }
      }
     },
     "localname": "DisclosureOfNoncurrentProvisionsTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfNoncurrentProvisionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of noncurrent provisions explanatory.",
        "label": "Disclosure Of Noncurrent Provisions [Table Text Block]",
        "terseLabel": "Summary of Movements in Non-current Provisions"
       }
      }
     },
     "localname": "DisclosureOfNoncurrentProvisionsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of number of restricted share plans Not yet fully vested.",
        "label": "Disclosure Of Number Of Restricted Share Plans Not Yet Fully Vested [Table Text Block]",
        "terseLabel": "Summary of Number of Restricted Shares Not Yet Fully Vested"
       }
      }
     },
     "localname": "DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of off-balance sheet commitments.",
        "label": "Disclosure Of Off-Balance Sheet Commitments Explanatory [Text Block]",
        "terseLabel": "Off balance sheet commitments"
       }
      }
     },
     "localname": "DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Offbalancesheetcommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfOffBalanceSheetCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Disclosure Of Off Balance Sheet Commitments [Table]",
        "label": "Disclosure Of Off Balance Sheet Commitments [Line Items]",
        "terseLabel": "Disclosure Of Off Balance Sheet Commitments [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfOffBalanceSheetCommitmentsLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Off-Balance Sheet Commitments of Property Plant and Equipment [Text Block]",
        "label": "Disclosure Of Off-Balance Sheet Commitments Of Property Plant And Equipment [Table Text Block]",
        "terseLabel": "Summary of Off Balance Sheet Commitments Relating to Property, Plant and Equipment"
       }
      }
     },
     "localname": "DisclosureOfOffBalanceSheetCommitmentsOfPropertyPlantAndEquipmentTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of off balance sheet commitments relating to operating activities.",
        "label": "Disclosure Of Off Balance Sheet Commitments Relating To Operating Activities [Table Text Block]",
        "terseLabel": "Summary of Off Balance Sheet Commitments Relating to Operating Activities"
       }
      }
     },
     "localname": "DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfOffBalanceSheetCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Off Balance Sheet Commitments [Table]",
        "label": "Disclosure Of Off Balance Sheet Commitments [Table]",
        "terseLabel": "Disclosure Of Off Balance Sheet Commitments [Table]"
       }
      }
     },
     "localname": "DisclosureOfOffBalanceSheetCommitmentsTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of offsetting of financial assets and liabilities.",
        "label": "Disclosure Of Off Setting Of Financial Assets And Liabilities [Line Items]",
        "terseLabel": "Disclosure of Offsetting of Financial Assets and Liabilities [line items]"
       }
      }
     },
     "localname": "DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Off Setting Of Financial Assets And Liabilities [table].",
        "label": "Disclosure Of Off Setting Of Financial Assets And Liabilities [table]",
        "terseLabel": "Disclosure Of Off Setting Of Financial Assets And Liabilities [table]"
       }
      }
     },
     "localname": "DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of operating currency hedging instruments with notional amount translated in to euros at closing exchange rate.",
        "label": "Disclosure Of Operating Currency Hedging Instruments With Notional Amount Translated In To Euros At Closing Exchange Rate [Table Text Block]",
        "terseLabel": "Summary of Operating Currency Hedging Instruments"
       }
      }
     },
     "localname": "DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of operating segments reconciling items.",
        "label": "Disclosure Of Operating Segments Reconciling Items [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of other gains and losses, and litigation.",
        "label": "Disclosure Of Other Gains And Losses, And Litigation [Text Block]",
        "terseLabel": "Other gains and losses, and litigation"
       }
      }
     },
     "localname": "DisclosureOfOtherGainsAndLossesAndLitigationTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Othergainsandlossesandlitigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfOtherLongTermProvisionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of other long term provisions.",
        "label": "Disclosure Of Other Long Term Provisions [Table Text Block]",
        "terseLabel": "Summary of Other Provisions"
       }
      }
     },
     "localname": "DisclosureOfOtherLongTermProvisionsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfOtherNonCurrentAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of other non-current assets.",
        "label": "Disclosure Of Other Non Current Assets [Line Items]",
        "terseLabel": "Disclosure Of Other Non Current Assets [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfOtherNonCurrentAssetsLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfOtherNoncurrentAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to other non-current assets.",
        "label": "Disclosure Of Other Non-current Assets [Table]",
        "terseLabel": "Disclosure Of Other Non-current Assets [Table]"
       }
      }
     },
     "localname": "DisclosureOfOtherNoncurrentAssetsTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfOtherOperatingIncomeExpensesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of other operating income (expenses).",
        "label": "Disclosure Of Other Operating Income Expenses [Line Items]",
        "terseLabel": "Disclosure Of Other Operating Income Expenses [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingIncomeExpensesLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfOtherOperatingIncomeExpensesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of other operating income expenses.",
        "label": "Disclosure Of Other Operating Income Expenses [Table]",
        "terseLabel": "Disclosure of Other Operating Income Expenses [Table]"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingIncomeExpensesTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfOtherOperatingIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Other Operating Income [Line Items]",
        "label": "Disclosure Of Other Operating Income [Line Items]",
        "terseLabel": "Disclosure Of Other Operating Income [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingIncomeLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfOtherOperatingIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Other Operating Income [Table]",
        "label": "Disclosure Of Other Operating Income [Table]",
        "terseLabel": "Disclosure Of Other Operating Income [Table]"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingIncomeTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of overdue receivables gross value.",
        "label": "Disclosure Of Overdue Receivables Gross Value [Table Text Block]",
        "terseLabel": "Summary of Gross Value of Overdue Receivables"
       }
      }
     },
     "localname": "DisclosureOfOverdueReceivablesGrossValueTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of pension and other post employment benefit expense.",
        "label": "Disclosure Of Pension And Other Post Employment Benefit Expense [Table Text Block]",
        "terseLabel": "Summary of Present Value of Pension and Other Post Employement Benefits"
       }
      }
     },
     "localname": "DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfPersonnelCostsDetailsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of personnel costs details.",
        "label": "Disclosure Of Personnel Costs Details [Table Text Block]",
        "terseLabel": "Summary of Personal Costs"
       }
      }
     },
     "localname": "DisclosureOfPersonnelCostsDetailsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PersonnelcostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Pre Tax Actuarial Loss Explanatory",
        "label": "Disclosure Of Pre Tax Actuarial Loss Explanatory [Table Text Block]",
        "terseLabel": "Summary of Net Pre-tax Actuarial Loss"
       }
      }
     },
     "localname": "DisclosureOfPreTaxActuarialLossExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfPrincipalAlliancesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Principal Alliances [Line Items]",
        "label": "Disclosure Of Principal Alliances [Line Items]",
        "terseLabel": "Disclosure of Principal Alliances [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfPrincipalAlliancesLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfPrincipalAlliancesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for principal alliances.",
        "label": "Disclosure Of Principal Alliances [Text Block]",
        "terseLabel": "Principal alliances"
       }
      }
     },
     "localname": "DisclosureOfPrincipalAlliancesTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalalliances"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfPrincipalMarketedProductsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of principal marketed products.",
        "label": "Disclosure Of Principal Marketed Products [Table Text Block]",
        "terseLabel": "Detailed Information for Principal Marketed Products"
       }
      }
     },
     "localname": "DisclosureOfPrincipalMarketedProductsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for net income attributable to non-controlling interests.",
        "label": "Disclosure Of Profit Loss Attributable To Noncontrolling Interests [Text Block]",
        "terseLabel": "Net income attributable to non-controlling interests"
       }
      }
     },
     "localname": "DisclosureOfProfitLossAttributableToNoncontrollingInterestsTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Netincomeattributabletononcontrollinginterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of profit or loss and other comprehensive income of associates and joint ventures.",
        "label": "Disclosure Of Profit Or Loss And Other Comprehensive Income Of Associates And Joint Ventures [Table Text Block]",
        "terseLabel": "Summary of Share of Profit or Loss and Other Comprehensive Income of Associates and Joint Ventures"
       }
      }
     },
     "localname": "DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfProvisionsAndOtherLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of provisions and other liabilities.",
        "label": "Disclosure Of Provisions And Other Liabilities [Text Block]",
        "terseLabel": "Provisions, income tax liabilities and other liabilities"
       }
      }
     },
     "localname": "DisclosureOfProvisionsAndOtherLiabilitiesTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Provisionsincometaxliabilitiesandotherliabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of provisions and other non current liabilities explanatory.",
        "label": "Disclosure Of Provisions And Other Non Current Liabilities Explanatory [Table Text Block]",
        "terseLabel": "Summary of Non Current Provisions and Other Non-current Liabilities"
       }
      }
     },
     "localname": "DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for provisions for discounts rebates and sales returns.",
        "label": "Disclosure Of Provisions For Discounts Rebates And Sales Returns [Text Block]",
        "terseLabel": "Provisions for discounts, rebates and sales returns"
       }
      }
     },
     "localname": "DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Provisionsfordiscountsrebatesandsalesreturns"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reconciliation of average effective tax rate and applicable tax rate.",
        "label": "Disclosure Of Reconciliation Of Average Effective Tax Rate And Applicable Tax Rate Explanatory [Table Text Block]",
        "terseLabel": "Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/IncometaxexpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reconciliation of carrying amount to value on redemption.",
        "label": "Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Line Items]",
        "terseLabel": "Disclosure of reconciliation of carrying amount to value on redemption [line items]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption",
        "label": "Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Table]",
        "terseLabel": "Disclosure of reconciliation of carrying amount to value on redemption [table]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reconciliation of carrying amount to value on redemption [text block]",
        "label": "Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Table Text Block]",
        "terseLabel": "Summary of Reconciliation of Carrying Amount to Value on Redemption"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reconciliation of changes in other intangible assets.",
        "label": "Disclosure Of Reconciliation Of Changes In Other Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Movements in Other Intangible Assets"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of remeasuresment of net defined benefit liability asset by country.",
        "label": "Disclosure Of Remeasurement Of Net Defined Benefit Liability Asset By Country [Table Text Block]",
        "terseLabel": "Remeasurement of Net Defined-benefit (Asset)/Liability (Actuarial Gains and Losses)"
       }
      }
     },
     "localname": "DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetByCountryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of reserve of exchange differences on translation.",
        "label": "Disclosure Of Reserve Of Exchange Differences On Translation [Table Text Block]",
        "terseLabel": "Summary of Currency Translation Differences"
       }
      }
     },
     "localname": "DisclosureOfReserveOfExchangeDifferencesOnTranslationTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfRestructuringCostsAndSimilarItemsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of restructuring costs and similar items.",
        "label": "Disclosure Of Restructuring Costs And Similar Items [Text Block]",
        "terseLabel": "Restructuring costs and similar items"
       }
      }
     },
     "localname": "DisclosureOfRestructuringCostsAndSimilarItemsTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Restructuringcostsandsimilaritems"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfRestructuringCostsDetailsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of restructuring costs details.",
        "label": "Disclosure Of Restructuring Costs Details [Table Text Block]",
        "terseLabel": "Summary of Restructuring Costs and Similar Items"
       }
      }
     },
     "localname": "DisclosureOfRestructuringCostsDetailsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfRestructuringProvisionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of restructuring provisions.",
        "label": "Disclosure Of Restructuring Provisions [Line Items]",
        "terseLabel": "Disclosure of Restructuring Provisions [line items]"
       }
      }
     },
     "localname": "DisclosureOfRestructuringProvisionsLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfRestructuringProvisionsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Restructuring provisions [Table]",
        "label": "Disclosure Of Restructuring Provisions [Table]",
        "terseLabel": "Disclosure of Restructuring provisions [Table]"
       }
      }
     },
     "localname": "DisclosureOfRestructuringProvisionsTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfRestructuringProvisionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of restructuring provisions.",
        "label": "Disclosure Of Restructuring Provisions [Table Text Block]",
        "terseLabel": "Movements in Restructuring Provisions Classified in Non-current and Current Liabilities"
       }
      }
     },
     "localname": "DisclosureOfRestructuringProvisionsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of sensitivity analysis on long-term borrowings and debt securities assuming a 1% increase and decrease in interest rates.",
        "label": "Disclosure Of sensitivity Analysis On Long-term Borrowings And Debt Securities Assuming A 1% Increase And Decrease In Interest Rates [Table Text Block]",
        "terseLabel": "Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of service costs of net defined benefits by country.",
        "label": "Disclosure Of Service Costs Of Net Defined Benefits By Country [Table Text Block]",
        "terseLabel": "Service Cost for Pension and Other post-employment Benefit Plans, by Geographical Region"
       }
      }
     },
     "localname": "DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of share based compensation shares authorized under stock option plans by exercise price range.",
        "label": "Disclosure Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table Text Block]",
        "terseLabel": "Summary of Options Outstanding and Exercisable"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of share of profit loss of associates and joint ventures accounted for using equity method explanatory.",
        "label": "Disclosure Of Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method [Text Block]",
        "terseLabel": "Share of profit/loss from investments accounted for using the equity method"
       }
      }
     },
     "localname": "DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Shareofprofitlossfrominvestmentsaccountedforusingtheequitymethod"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of share repurchase program explanatory.",
        "label": "Disclosure Of Share Repurchase Program Explanatory [Table Text Block]",
        "terseLabel": "Summary of Repurchases program"
       }
      }
     },
     "localname": "DisclosureOfShareRepurchaseProgramExplanatoryTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of shares used to compute diluted earnings per share.",
        "label": "Disclosure Of Shares Used To Compute Diluted Earnings Per Share [Table Text Block]",
        "terseLabel": "Summary of Number of Shares Used to Compute Diluted Earnings Per Share"
       }
      }
     },
     "localname": "DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of statement of changes in equity of parent.",
        "label": "Disclosure Of Statement Of Changes In Equity Of Parent [Table Text Block]",
        "terseLabel": "Summary of Movements Share Capital"
       }
      }
     },
     "localname": "DisclosureOfStatementOfChangesInEquityOfParentTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of stock options outstanding at each balance sheet date and of changes during the relevant periods.",
        "label": "Disclosure Of Stock Options Outstanding At Each Balance Sheet Date And Of Changes During The Relevant Periods [Table Text Block]",
        "terseLabel": "Summary of Stock Options Outstanding at Each Balance Sheet Date"
       }
      }
     },
     "localname": "DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of stock subscription option plan outstanding and option exercised [Line Items]",
        "label": "Disclosure Of Stock Subscription Option Plan Outstanding And Option Exercised [Line Items]",
        "terseLabel": "Disclosure of stock subscription option plan outstanding and option exercised [line items]"
       }
      }
     },
     "localname": "DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of stock subscription option plan outstanding and option exercised [Table]",
        "label": "Disclosure Of Stock Subscription Option Plan Outstanding And Option Exercised [Table]",
        "terseLabel": "Disclosure of stock subscription option plan outstanding and option exercised [Table]"
       }
      }
     },
     "localname": "DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of stock subscription option plans under which options were exercised in the year.",
        "label": "Disclosure Of Stock Subscription Option Plans Under Which Options Were Exercised In The Year [Table Text Block]",
        "terseLabel": "Disclosure of Stock Subscription Option Plan Outstanding and Option Exercised"
       }
      }
     },
     "localname": "DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfTaxLossesAvailableForCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of tax losses available for carryforward.",
        "label": "Disclosure Of Tax Losses Available For Carryforward [Line Items]",
        "terseLabel": "Disclosure of tax losses available for carryforward [line items]"
       }
      }
     },
     "localname": "DisclosureOfTaxLossesAvailableForCarryforwardLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfTaxLossesAvailableForCarryforwardTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Tax Losses Available For Carryforward [Table]",
        "label": "Disclosure Of Tax Losses Available For Carryforward [Table]",
        "terseLabel": "Disclosure Of Tax Losses Available For Carryforward [Table]"
       }
      }
     },
     "localname": "DisclosureOfTaxLossesAvailableForCarryforwardTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisclosureOfTradeReceivablesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of trade receivables.",
        "label": "Disclosure Of Trade Receivables [Text Block]",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "DisclosureOfTradeReceivablesTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Accountsreceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of undrawn borrowing facilities.",
        "label": "Disclosure Of Undrawn Borrowing Facilities [Table Text Block]",
        "terseLabel": "Summary of Undrawn Credit Facilities"
       }
      }
     },
     "localname": "DisclosureOfUndrawnBorrowingFacilitiesTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of weighted average duration of defined benefit obligation.",
        "label": "Disclosure Of Weighted Average Duration Of Defined Benefit Obligation [Table Text Block]",
        "terseLabel": "Summary of Weighted Average Duration of Obligation for Pensions and Other Long-term Benefits in Principal Countries"
       }
      }
     },
     "localname": "DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_DisposalGroupGainOnDisposal": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Gain On Disposal",
        "label": "Disposal Group, Gain On Disposal",
        "terseLabel": "Gain on disposal"
       }
      }
     },
     "localname": "DisposalGroupGainOnDisposal",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DisposalGroupNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Name",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "DisposalGroupNameAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DisposalGroupNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Name [Domain]",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupNameDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposals And Retirements, Property, Plant And Equipment, Right Of Use Assets",
        "label": "Disposals And Retirements, Property, Plant And Equipment, Right Of Use Assets",
        "negatedTerseLabel": "Disposals and other decreases"
       }
      }
     },
     "localname": "DisposalsAndRetirementsPropertyPlantAndEquipmentRightOfUseAssets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DividendsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends Paid [Abstract]",
        "label": "Dividends Paid [Abstract]",
        "terseLabel": "Dividends paid:"
       }
      }
     },
     "localname": "DividendsPaidAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends received from non-consolidated entities.",
        "label": "Dividends Received from Non-consolidated Entities Classified As Operating Activities",
        "verboseLabel": "Dividends received from non-consolidated entities"
       }
      }
     },
     "localname": "DividendsReceivedFromNonConsolidatedEntitiesClassifiedAsOperatingActivities",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_DupixentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dupixent [member]",
        "label": "Dupixent [Member]",
        "terseLabel": "Dupixent"
       }
      }
     },
     "localname": "DupixentMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EPICBPIFranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EPIC BPIFrance",
        "label": "EPIC BPIFrance [Member]",
        "terseLabel": "EPIC BPIFrance"
       }
      }
     },
     "localname": "EPICBPIFranceMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails": {
       "order": 2.0,
       "parentTag": "sny_NetExposure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effects of other netting arrangements not fulfilling the IAS32 criteria for offsetting fair value of financial collateral.",
        "label": "Effects Of Other Netting Arrangements Not Fulfilling The IAS 32 Criteria For Offsetting Fair Value Of Financial Collateral",
        "terseLabel": "Fair value of financial collateral"
       }
      }
     },
     "localname": "EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails": {
       "order": 1.0,
       "parentTag": "sny_NetExposure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effects of other netting arrangements not fulfilling the IAS32 criteria for offsetting financial instruments.",
        "label": "Effects Of Other Netting Arrangements Not Fulfilling The IAS 32 Criteria For Offsetting Financial Instruments",
        "verboseLabel": "Financial instruments"
       }
      }
     },
     "localname": "EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effects of other netting arrangements not fulfilling the IAS 32 criteria for offsetting.",
        "label": "Effects Of Other Netting Arrangements Not Fulfilling The IAS 32 Criteria For Offsetting [Member]",
        "terseLabel": "Effects of other netting arrangements not fulfilling the IAS 32 criteria for offsetting"
       }
      }
     },
     "localname": "EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eight Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Five",
        "label": "Eight Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Five [Member]",
        "terseLabel": "Eight Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Five"
       }
      }
     },
     "localname": "EightHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyFiveMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EightHundredFiftyMillionBondsMaturingFebruary2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eight Hundred Fifty Million Bonds Maturing February 2022",
        "label": "Eight Hundred Fifty Million Bonds Maturing February 2022 [Member]",
        "terseLabel": "Eight Hundred Fifty Million Bonds Maturing February 2022"
       }
      }
     },
     "localname": "EightHundredFiftyMillionBondsMaturingFebruary2022Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EightHundredFiftyMillionBondsMaturingJune2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eight Hundred Fifty Million Bonds Maturing June 2022",
        "label": "Eight Hundred Fifty Million Bonds Maturing June 2022 [Member]",
        "terseLabel": "Eight Hundred Fifty Million Bonds Maturing June 2022"
       }
      }
     },
     "localname": "EightHundredFiftyMillionBondsMaturingJune2022Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EloctateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eloctate [Member]",
        "label": "Eloctate [Member]",
        "terseLabel": "Eloctate"
       }
      }
     },
     "localname": "EloctateMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/EventssubsequenttoDecember312022Details",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EmployeeBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Benefits [Abstract]",
        "label": "Employee Benefits [Abstract]",
        "terseLabel": "Employee Benefits [Abstract]"
       }
      }
     },
     "localname": "EmployeeBenefitsAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_EmployeeBenefitsExpenseGain": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Benefits Expense / (Gain)",
        "label": "Employee Benefits Expense / (Gain)",
        "terseLabel": "Expense/(gain) for the period"
       }
      }
     },
     "localname": "EmployeeBenefitsExpenseGain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_EmployeesShareOwnershipPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees share ownership plan.",
        "label": "Employees Share Ownership Plan [member]",
        "terseLabel": "Employees share ownership plan"
       }
      }
     },
     "localname": "EmployeesShareOwnershipPlanMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employer contribute percentage on amounts exceeding the social security ceiling.",
        "label": "Employer Contribute Percentage On Amounts Exceeding The Social Security Ceiling",
        "terseLabel": "Employer's contribution percentage"
       }
      }
     },
     "localname": "EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_EnjaymoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Enjaymo",
        "label": "Enjaymo [Member]",
        "terseLabel": "Enjaymo"
       }
      }
     },
     "localname": "EnjaymoMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EntitiesAndCompaniesManagedByBristolMyersSquibbMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entities and companies managed by bristol myers squibb.",
        "label": "Entities And Companies Managed By Bristol Myers Squibb [Member]",
        "terseLabel": "Entities and companies managed by Bristol Mayers Squibb"
       }
      }
     },
     "localname": "EntitiesAndCompaniesManagedByBristolMyersSquibbMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EquityDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Derivatives [Member]",
        "label": "Equity Derivatives [Member]",
        "terseLabel": "Equity derivatives"
       }
      }
     },
     "localname": "EquityDerivativesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Instruments At Fair Value Through Other Comprehensive Income (Loss), 10% Decline In Credit Prices, Pre-tax Amount",
        "label": "Equity Instruments At Fair Value Through Other Comprehensive Income (Loss), 10% Decline In Credit Prices, Pre-tax Amount",
        "terseLabel": "Pre-tax impact on other comprehensive income"
       }
      }
     },
     "localname": "EquityInstrumentsAtFairValueThroughOtherComprehensiveIncomeLoss10DeclineInCreditPricesPreTaxAmount",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_EquityInstrumentsIncludedInFinancialAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Instruments Included In Financial Asset",
        "label": "Equity Instruments Included In Financial Asset [Member]",
        "terseLabel": "Equity instruments included in financial assets"
       }
      }
     },
     "localname": "EquityInstrumentsIncludedInFinancialAssetMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EquityInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity instruments.",
        "label": "Equity Instruments [Member]",
        "terseLabel": "Equity instruments"
       }
      }
     },
     "localname": "EquityInstrumentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity interests in subsidiaries and investments in other entities.",
        "label": "Equity Interests In Subsidiaries And Investments In Other Entities [member]",
        "terseLabel": "Equity interests in subsidiaries and investments in other entities"
       }
      }
     },
     "localname": "EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EquityInvestmentSoldPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investment sold percentage.",
        "label": "Equity Investment Sold Percentage",
        "terseLabel": "Aggregate participation percentage of legacy companies in ACS"
       }
      }
     },
     "localname": "EquityInvestmentSoldPercentage",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Risk Hedging Instruments Designated At Fair Value Hedges",
        "label": "Equity Risk Hedging Instruments Designated At Fair Value Hedges",
        "terseLabel": "Equity risk hedging instruments designated as fair value hedges"
       }
      }
     },
     "localname": "EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ErnstAndYoungMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ernst And Young.",
        "label": "Ernst And Young [Member]",
        "terseLabel": "Ernst\u00a0&amp;\u00a0Young"
       }
      }
     },
     "localname": "ErnstAndYoungMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ErnstYoungEtAutresMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ernst &amp; Young Et Autres",
        "label": "Ernst &amp; Young Et Autres [Member]",
        "terseLabel": "Ernst &amp; Young et Autres"
       }
      }
     },
     "localname": "ErnstYoungEtAutresMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/AuditInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated future benefit payments under pension and other post-employment benefit plans.",
        "label": "Estimated Future Benefit Payments Under Pension And Other Postemployment Benefit Plans",
        "terseLabel": "Estimated future benefit payments under pension and other post-employment benefit plans"
       }
      }
     },
     "localname": "EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_EuroapiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euroapi",
        "label": "Euroapi [Member]",
        "terseLabel": "EUROAPI"
       }
      }
     },
     "localname": "EuroapiMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails",
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_EvotecMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evotec.",
        "label": "Evotec [Member]",
        "terseLabel": "Evotec"
       }
      }
     },
     "localname": "EvotecMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ExceptionalSupplementaryDividendPercentageOfShareCapital": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exceptional Supplementary Dividend, Percentage Of Share Capital",
        "label": "Exceptional Supplementary Dividend, Percentage Of Share Capital",
        "terseLabel": "Exceptional supplementary dividend, percentage of share capital"
       }
      }
     },
     "localname": "ExceptionalSupplementaryDividendPercentageOfShareCapital",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofchangesinequityParenthetical",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_ExceptionalSupplementaryDividendProposedPercentageOfShareCapital": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exceptional Supplementary Dividend Proposed, Percentage Of Share Capital",
        "label": "Exceptional Supplementary Dividend Proposed, Percentage Of Share Capital",
        "terseLabel": "Exceptional supplementary dividend proposed, percentage of share capital"
       }
      }
     },
     "localname": "ExceptionalSupplementaryDividendProposedPercentageOfShareCapital",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exceptional Supplementary Dividends Recognised As Distributions To Owners Of Parent",
        "label": "Exceptional Supplementary Dividends Recognised As Distributions To Owners Of Parent",
        "negatedTerseLabel": "Effect of the distribution of an exceptional supplementary dividend of 58% of the shares of EUROAPI to the equity holders of Sanofi",
        "terseLabel": "Exceptional supplementary dividends recognised as distributions to owners of parent"
       }
      }
     },
     "localname": "ExceptionalSupplementaryDividendsRecognisedAsDistributionsToOwnersOfParent",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ExercisePriceRangeFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Four [Member]",
        "label": "Exercise Price Range Four [Member]",
        "terseLabel": "Exercise price range four"
       }
      }
     },
     "localname": "ExercisePriceRangeFourMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ExercisePriceRangeThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Three [Member]",
        "label": "Exercise Price Range Three [Member]",
        "terseLabel": "Exercise price range three"
       }
      }
     },
     "localname": "ExercisePriceRangeThreeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ExercisePriceRangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range Two [Member]",
        "label": "Exercise Price Range Two [Member]",
        "terseLabel": "Exercise price range two"
       }
      }
     },
     "localname": "ExercisePriceRangeTwoMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected timing of payments in respect of unfunded pension and other post-employment benefit plans.",
        "label": "Expected Timing Of Payments In Respect Of Unfunded Pension And Other Post-employment Benefit Plans",
        "terseLabel": "Estimated payments"
       }
      }
     },
     "localname": "ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlans",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFuturePaymentsinRespectofUnfundedPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": 11.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses arising from the impact of acquisitions on inventories.",
        "label": "Expense Arising From The Impact Of Acquisitions On Inventories",
        "negatedLabel": "Expenses arising from the impact of acquisitions on inventories"
       }
      }
     },
     "localname": "ExpenseArisingFromTheImpactOfAcquisitionsOnInventories",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ExpenseCategoriesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense Categories [Axis]",
        "label": "Expense Categories [Axis]",
        "terseLabel": "Expense Categories [Axis]"
       }
      }
     },
     "localname": "ExpenseCategoriesAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_ExpenseCategoriesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense Categories [Domain]",
        "label": "Expense Categories [Domain]",
        "terseLabel": "Expense Categories [Domain]"
       }
      }
     },
     "localname": "ExpenseCategoriesDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAmortizationofSoftwaresRecognizedinIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense recognized in equity.",
        "label": "Expense From Equity-Settled Share-Based Payment Transactions Of Which Goods Or Services Received Did Not Qualify For Recognition As Assets Employer Contribution",
        "terseLabel": "Expense recognized of which employers' contribution"
       }
      }
     },
     "localname": "ExpenseFromEquitySettledShareBasedPaymentTransactionsOfWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense/(gain) for the period.",
        "label": "Expense Gain For The Period Net Defined Benefit Liability Asset",
        "totalLabel": "Expense/(gain) for the period"
       }
      }
     },
     "localname": "ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_ExpenseOfRestructuringActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation for early termination of contracts (other than contracts of employment).",
        "label": "Expense Of Restructuring Activities, Compensation For Early Termination Of Contracts",
        "terseLabel": "Compensation for early termination of contracts (other than contracts of employment)"
       }
      }
     },
     "localname": "ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_ExpenseOfRestructuringActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee related expenses.",
        "label": "Expense Of Restructuring Activities, Employee Related Expenses",
        "terseLabel": "Employee-related expenses"
       }
      }
     },
     "localname": "ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsAdditionalInformationDetails",
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_ExpenseOfRestructuringActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense of restructuring activities related to property plant and equipment to inventories.",
        "label": "Expense Of Restructuring Activities, Related To Property Plant And Equipment And To Inventories",
        "terseLabel": "Charges, gains or losses on assets"
       }
      }
     },
     "localname": "ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_ExpenseOfRestructuringActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense Of Restructuring Activities, Transformation Programs Costs",
        "label": "Expense Of Restructuring Activities, Transformation Programs Costs",
        "terseLabel": "Transformation programs costs"
       }
      }
     },
     "localname": "ExpenseOfRestructuringActivitiesTransformationProgramsCosts",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense Relating To Short-term Leases And Low Value Assets For Which Recognition Exemption Has Been Used",
        "label": "Expense Relating To Short-term Leases And Low Value Assets For Which Recognition Exemption Has Been Used",
        "terseLabel": "Expense relating to short-term leases and low value assets"
       }
      }
     },
     "localname": "ExpenseRelatingToShortTermLeasesAndLowValueAssetsForWhichRecognitionExemptionHasBeenUsed",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ExscientiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exscientia",
        "label": "Exscientia [Member]",
        "terseLabel": "Exscientia"
       }
      }
     },
     "localname": "ExscientiaMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_FabrazymeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fabrazyme [Member]",
        "label": "Fabrazyme [Member]",
        "terseLabel": "Fabrazyme"
       }
      }
     },
     "localname": "FabrazymeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_FairValueMeasurementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Measurement [Abstract]",
        "label": "Fair Value Measurement [Abstract]",
        "terseLabel": "Fair Value Measurement [Abstract]"
       }
      }
     },
     "localname": "FairValueMeasurementAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_FairValueOfContingentConsiderationPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the contingent consideration payable",
        "label": "Fair Value Of Contingent Consideration Payable",
        "terseLabel": "Fair value of contingent consideration payable"
       }
      }
     },
     "localname": "FairValueOfContingentConsiderationPayable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_FairValueOfPlanAtDateOfGrant": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of plan at the date of grant.",
        "label": "Fair Value Of Plan At Date Of Grant",
        "terseLabel": "Fair value of plan at the date of grant"
       }
      }
     },
     "localname": "FairValueOfPlanAtDateOfGrant",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_FairValueOfSPMSDContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of SPMSD contingent consideration.",
        "label": "Fair Value Of SPMSD Contingent Consideration [Member]",
        "terseLabel": "Fair value of SPMSD contingent consideration"
       }
      }
     },
     "localname": "FairValueOfSPMSDContingentConsiderationMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_FairValueOfTheContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the contingent consideration.",
        "label": "Fair Value Of The Contingent Consideration",
        "terseLabel": "Fair value of the contingent consideration"
       }
      }
     },
     "localname": "FairValueOfTheContingentConsideration",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_FairValuePerShareAwardedForThreeYearServicePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value per share awarded to a three year service period.",
        "label": "Fair Value Per Share Awarded For Three Year Service Period",
        "terseLabel": "Fair value per share awarded (in euros per share)"
       }
      }
     },
     "localname": "FairValuePerShareAwardedForThreeYearServicePeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "sny_FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Per Share Awarded For Three Year Service Period, Additional Shares",
        "label": "Fair Value Per Share Awarded For Three Year Service Period, Additional Shares",
        "terseLabel": "Fair value per share awarded for three year service period, additional shares (in euros per share)"
       }
      }
     },
     "localname": "FairValuePerShareAwardedForThreeYearServicePeriodAdditionalShares",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "sny_FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Per Share Awarded For Three Year Service Period, To Chief Executive Officer",
        "label": "Fair Value Per Share Awarded For Three Year Service Period, To Chief Executive Officer",
        "terseLabel": "Fair value per share awarded for three year service period, to chief executive officer (in euros per share)"
       }
      }
     },
     "localname": "FairValuePerShareAwardedForThreeYearServicePeriodToChiefExecutiveOfficer",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "sny_FinanceLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Liabilities",
        "label": "Finance Lease Liabilities",
        "terseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilities",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_FinancialAssetsHeldToFundDeferredCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Assets Held To Fund Deferred Compensation Plan",
        "label": "Financial Assets Held To Fund Deferred Compensation Plan [Member]",
        "terseLabel": "Financial instruments held to fund deferred compensation plan"
       }
      }
     },
     "localname": "FinancialAssetsHeldToFundDeferredCompensationPlanMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial assets held to meet obligations under deferred compensation plans.",
        "label": "Financial Assets Held To Meet Obligations Under Deferred Compensation Plans [Member]",
        "terseLabel": "Financial assets held to meet obligations under deferred compensation plans"
       }
      }
     },
     "localname": "FinancialAssetsHeldToMeetObligationsUnderDeferredCompensationPlansMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_FinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Instruments [Abstract]",
        "label": "Financial Instruments [Abstract]",
        "terseLabel": "Financial Instruments [Abstract]"
       }
      }
     },
     "localname": "FinancialInstrumentsAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_FinancialInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of financial assets that are classified as financial assets available-for-sale, held-to-maturity investments or loans and receivables.",
        "label": "Financial Investments",
        "terseLabel": "Financial investments"
       }
      }
     },
     "localname": "FinancialInvestments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_FirmOrdersOfPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Firm orders of property plant and equipment.",
        "label": "Firm Orders Of Property Plant And Equipment",
        "terseLabel": "Firm orders of property, plant and equipment"
       }
      }
     },
     "localname": "FirmOrdersOfPropertyPlantAndEquipment",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofOffBalanceSheetCommitmentsRelatingtoPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ForeignCurrencyTranslationDifferences": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Translation Differences",
        "label": "Foreign Currency Translation Differences",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationDifferences",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ForeignCurrencyTranslationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Translation",
        "label": "Foreign Currency Translation [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencyPurchasedInChineseYuanRenminbiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward currency purchases in Chinese Yuan Renminbi.",
        "label": "Forward Currency Purchased In Chinese Yuan Renminbi [member]",
        "terseLabel": "Forward currency purchases in Chinese Yuan Renminbi"
       }
      }
     },
     "localname": "ForwardCurrencyPurchasedInChineseYuanRenminbiMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencyPurchasedInHungarianForintMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward currency purchases in Hungarian Forint.",
        "label": "Forward Currency Purchased In Hungarian Forint [Member]",
        "terseLabel": "Forward currency purchases in Hungarian Forint"
       }
      }
     },
     "localname": "ForwardCurrencyPurchasedInHungarianForintMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencyPurchasedInJapaneseYenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Purchased In Japanese yen",
        "label": "Forward Currency Purchased In Japanese yen [Member]",
        "terseLabel": "Forward currency purchases In Japanese yen"
       }
      }
     },
     "localname": "ForwardCurrencyPurchasedInJapaneseYenMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencyPurchasedInKoreanWonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Purchased In Korean Won",
        "label": "Forward Currency Purchased In Korean Won [Member]",
        "terseLabel": "Forward Currency Purchased In Korean Won"
       }
      }
     },
     "localname": "ForwardCurrencyPurchasedInKoreanWonMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencyPurchasedInRussianRoubleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Purchased In Russian Rouble [Member]",
        "label": "Forward Currency Purchased In Russian Rouble [Member]",
        "terseLabel": "Forward currency purchases In Russian Rouble"
       }
      }
     },
     "localname": "ForwardCurrencyPurchasedInRussianRoubleMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencyPurchasedInSingaporeDollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward currency purchases in Singapore Dollar.",
        "label": "Forward Currency Purchased In Singapore Dollar [member]",
        "terseLabel": "Forward currency purchases in Singapore Dollar"
       }
      }
     },
     "localname": "ForwardCurrencyPurchasedInSingaporeDollarMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencyPurchasedInTaiwanDollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Purchased In Taiwan Dollar",
        "label": "Forward Currency Purchased In Taiwan Dollar [Member]",
        "terseLabel": "Forward Currency Purchased In Taiwan Dollar"
       }
      }
     },
     "localname": "ForwardCurrencyPurchasedInTaiwanDollarMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencyPurchasedInUSDollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward currency purchases in USD.",
        "label": "Forward Currency Purchased In US Dollar [Member]",
        "terseLabel": "Forward currency purchases in US Dollar"
       }
      }
     },
     "localname": "ForwardCurrencyPurchasedInUSDollarMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencyPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward currency purchases.",
        "label": "Forward Currency Purchases [Member]",
        "terseLabel": "Forward currency purchases"
       }
      }
     },
     "localname": "ForwardCurrencyPurchasesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencySalesInChineseYuanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Sales In Chinese Yuan",
        "label": "Forward Currency Sales In Chinese Yuan [Member]",
        "terseLabel": "Forward Currency Sales In Chinese Yuan"
       }
      }
     },
     "localname": "ForwardCurrencySalesInChineseYuanMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencySalesInChineseYuanRenminbiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward currency sales in Chinese Yuan Renminbi.",
        "label": "Forward Currency Sales In Chinese Yuan Renminbi [member]",
        "terseLabel": "Forward currency sales in Chinese Yuan Renminbi"
       }
      }
     },
     "localname": "ForwardCurrencySalesInChineseYuanRenminbiMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencySalesInJapaneseYenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward currency sales in Japanese Yen.",
        "label": "Forward Currency Sales In Japanese Yen [Member]",
        "terseLabel": "Forward currency sales in Japanese Yen"
       }
      }
     },
     "localname": "ForwardCurrencySalesInJapaneseYenMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencySalesInKoreanWonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Sales In Korean Won",
        "label": "Forward Currency Sales In Korean Won [Member]",
        "terseLabel": "Forward Currency Sales In Korean Won"
       }
      }
     },
     "localname": "ForwardCurrencySalesInKoreanWonMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencySalesInMexicanPesoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Sales In Mexican Peso",
        "label": "Forward Currency Sales In Mexican Peso [Member]",
        "terseLabel": "Forward currency sales In Mexican Peso"
       }
      }
     },
     "localname": "ForwardCurrencySalesInMexicanPesoMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencySalesInPoundSterlingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Sales In Pound Sterling",
        "label": "Forward Currency Sales In Pound Sterling [Member]",
        "terseLabel": "Forward Currency Sales In Pound Sterling"
       }
      }
     },
     "localname": "ForwardCurrencySalesInPoundSterlingMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencySalesInSingaporeDollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward currency sales in Singapore Dollar.",
        "label": "Forward Currency Sales In Singapore Dollar [member]",
        "terseLabel": "Forward currency sales in Singapore Dollar"
       }
      }
     },
     "localname": "ForwardCurrencySalesInSingaporeDollarMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencySalesInTaiwanDollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Sales In Taiwan Dollar",
        "label": "Forward Currency Sales In Taiwan Dollar [Member]",
        "terseLabel": "Forward currency sales in Taiwan Dollar"
       }
      }
     },
     "localname": "ForwardCurrencySalesInTaiwanDollarMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencySalesInUSDollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward currency sales in USD.",
        "label": "Forward Currency Sales In US Dollar [Member]",
        "terseLabel": "Forward currency sales in US Dollar"
       }
      }
     },
     "localname": "ForwardCurrencySalesInUSDollarMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ForwardCurrencySalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward currency sales.",
        "label": "Forward Currency Sales [Member]",
        "terseLabel": "Forward currency sales"
       }
      }
     },
     "localname": "ForwardCurrencySalesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofFinancialCurrencyHedgingInstrumentsinPlacewithNotionalAmountTranslatedDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GainLossOnCancellationOfTreasuryShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) on cancellation of treasury shares.",
        "label": "Gain (Loss) On Cancellation Of Treasury Shares",
        "terseLabel": "Gain (loss) recognized on cancellation of treasury shares"
       }
      }
     },
     "localname": "GainLossOnCancellationOfTreasuryShares",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTreasurySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GainLossOnImpairmentOfTreasuryShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) on impairment of treasury shares.",
        "label": "Gain (Loss) On Impairment Of Treasury Shares",
        "terseLabel": "Gain (loss) recognized on impairment of treasury shares"
       }
      }
     },
     "localname": "GainLossOnImpairmentOfTreasuryShares",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTreasurySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GainLossOnPurchaseOfTreasuryShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) on purchase of treasury shares.",
        "label": "Gain (Loss) On Purchase Of Treasury Shares",
        "terseLabel": "Gain (loss) recognized on purchase of treasury shares"
       }
      }
     },
     "localname": "GainLossOnPurchaseOfTreasuryShares",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTreasurySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GainLossOnSaleOfTreasuryShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) on sale of treasury shares.",
        "label": "Gain (Loss) On Sale Of Treasury Shares",
        "terseLabel": "Gain (loss) recognized on sale of treasury shares"
       }
      }
     },
     "localname": "GainLossOnSaleOfTreasuryShares",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesTreasurySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GainOnDerivativesUsedToManageCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain on derivatives used to manage cash and cash equivalents.",
        "label": "Gain On Derivatives Used To Manage Cash And Cash Equivalents",
        "terseLabel": "Gain on derivatives used to manage cash and cash equivalents"
       }
      }
     },
     "localname": "GainOnDerivativesUsedToManageCashAndCashEquivalents",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GainOnDerivativesUsedToManageDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain derivatives used to manage debt.",
        "label": "Gain On Derivatives Used To Manage Debt",
        "terseLabel": "Gain on derivatives used to manage debt"
       }
      }
     },
     "localname": "GainOnDerivativesUsedToManageDebt",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GainOnRegeneronInvestmentSold": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain On Regeneron Investment Sold",
        "label": "Gain On Regeneron Investment Sold",
        "terseLabel": "Gain on divestment of Regeneron shares on May 29, 2020"
       }
      }
     },
     "localname": "GainOnRegeneronInvestmentSold",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gains (Losses) On Remeasuring Debt Instruments, Before Tax",
        "label": "Gains (Losses) On Remeasuring Debt Instruments, Before Tax",
        "terseLabel": "Change in fair value of debt instruments included in financial assets"
       }
      }
     },
     "localname": "GainsLossesOnRemeasuringDebtInstrumentsBeforeTax",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcomprehensiveincome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "(Gains) Losses Related To Plan Amendments, Curtailments Or Settlement",
        "label": "(Gains) Losses Related To Plan Amendments, Curtailments Or Settlement",
        "negatedTerseLabel": "(Gains)/losses related to plan amendments, curtailments or settlements not specified in the terms of the plan"
       }
      }
     },
     "localname": "GainsLossesRelatedToPlanAmendmentsCurtailmentsOrSettlement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GainsOnDivestmentOfProducts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gains on divestment of products.",
        "label": "Gains On Divestment Of Products",
        "terseLabel": "Gains on divestment of some mature products"
       }
      }
     },
     "localname": "GainsOnDivestmentOfProducts",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GeneralInformationAboutFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General Information About Financial Statements [Abstract]",
        "label": "General Information About Financial Statements [Abstract]",
        "terseLabel": "General Information About Financial Statements [Abstract]"
       }
      }
     },
     "localname": "GeneralInformationAboutFinancialStatementsAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_GenfarSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genfar S.A.",
        "label": "Genfar S A [Member]",
        "terseLabel": "Genfar S.A."
       }
      }
     },
     "localname": "GenfarSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GenzymeCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genzyme Corporation.",
        "label": "Genzyme Corporation [Member]",
        "terseLabel": "Genzyme Corporation"
       }
      }
     },
     "localname": "GenzymeCorporationMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GenzymeDeArgentinaSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genzyme de Argentina SA.",
        "label": "Genzyme De Argentina SA [Member]",
        "terseLabel": "Genzyme de Argentina S.A."
       }
      }
     },
     "localname": "GenzymeDeArgentinaSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GenzymeEuropeBVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genzyme Europe BV.",
        "label": "Genzyme Europe BV [member]",
        "terseLabel": "Genzyme Europe B.V."
       }
      }
     },
     "localname": "GenzymeEuropeBVMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GenzymeFlandersBVBAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genzyme Flanders BVBA.",
        "label": "Genzyme Flanders BVBA [member]",
        "terseLabel": "Genzyme Flanders BVBA"
       }
      }
     },
     "localname": "GenzymeFlandersBVBAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GenzymeGlobalSarlBaarIntellectualPropertyBranchMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genzyme Global Sarl Baar Intellectual Property Branch",
        "label": "Genzyme Global Sarl Baar Intellectual Property Branch [Member]",
        "terseLabel": "Genzyme Global Sarl Baar Intellectual Property Branch"
       }
      }
     },
     "localname": "GenzymeGlobalSarlBaarIntellectualPropertyBranchMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GenzymeGlobalSarlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genzyme Global Sarl.",
        "label": "Genzyme Global Sarl [member]",
        "terseLabel": "Genzyme Global Sarl"
       }
      }
     },
     "localname": "GenzymeGlobalSarlMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GenzymeIrelandLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genzyme Ireland Limited.",
        "label": "Genzyme Ireland Limited [member]",
        "terseLabel": "Genzyme Ireland Limited"
       }
      }
     },
     "localname": "GenzymeIrelandLimitedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GenzymeLuxembourgSarlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genzyme Luxembourg Sarl",
        "label": "Genzyme Luxembourg Sarl [Member]",
        "terseLabel": "Genzyme Luxembourg Sarl"
       }
      }
     },
     "localname": "GenzymeLuxembourgSarlMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GenzymeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genzyme.",
        "label": "Genzyme [Member]",
        "terseLabel": "Genzyme"
       }
      }
     },
     "localname": "GenzymeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GenzymeTherapeuticProductsLimitedPartnershipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genzyme Therapeutic Products Limited Partnership [Member]",
        "label": "Genzyme Therapeutic Products Limited Partnership [Member]",
        "terseLabel": "Genzyme Therapeutic Products Limited Partnership"
       }
      }
     },
     "localname": "GenzymeTherapeuticProductsLimitedPartnershipMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GlaxoSmithKlineConsumerHealthcareLPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Glaxo Smith Kline Consumer Health Care L P.",
        "label": "Glaxo Smith Kline Consumer Healthcare L P [Member]",
        "terseLabel": "GlaxoSmithKline Consumer Healthcare, L.P."
       }
      }
     },
     "localname": "GlaxoSmithKlineConsumerHealthcareLPMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GlobalPenaltyFeeIncurredByDefendants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Penalty Fee Incurred By Defendants",
        "label": "Global Penalty Fee Incurred By Defendants",
        "terseLabel": "Total penalty fee incurred by defendants"
       }
      }
     },
     "localname": "GlobalPenaltyFeeIncurredByDefendants",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GovernmentAndStateProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government and state programs.",
        "label": "Government And State Programs [Member]",
        "terseLabel": "Government and State Programs"
       }
      }
     },
     "localname": "GovernmentAndStateProgramsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grant Recognised As Deduction From Development Expenses",
        "label": "Government Grant Recognised As Deduction From Development Expenses",
        "terseLabel": "Government grant recognised as deduction from development expenses"
       }
      }
     },
     "localname": "GovernmentGrantRecognisedAsDeductionFromDevelopmentExpenses",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_GuaranteesGivenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantees given.",
        "label": "Guarantees Given [member]",
        "terseLabel": "Guarantees given"
       }
      }
     },
     "localname": "GuaranteesGivenMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantees provided to banks in connection with credit facilities.",
        "label": "Guarantees Provided To Banks In Connection With Credit Facilities [Member]",
        "terseLabel": "Guarantees provided to banks in connection with credit facilities"
       }
      }
     },
     "localname": "GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_GuaranteesReceivedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantees received.",
        "label": "Guarantees Received [Member]",
        "terseLabel": "Guarantees received"
       }
      }
     },
     "localname": "GuaranteesReceivedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_HealthcareCoverAndLifeInsuranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Cover And Life Insurance [Member]",
        "label": "Healthcare Cover And Life Insurance [Member]",
        "terseLabel": "Healthcare Cover And Life Insurance"
       }
      }
     },
     "localname": "HealthcareCoverAndLifeInsuranceMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_HedgeFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge funds.",
        "label": "Hedge Funds [Member]",
        "terseLabel": "Hedge funds"
       }
      }
     },
     "localname": "HedgeFundsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_HedgesOfNetInvestmentsInForeignOperationsAfterTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of net investments in foreign operations after tax.",
        "label": "Hedges Of Net Investments In Foreign Operations After Tax",
        "negatedTerseLabel": "Hedges of net investments in foreign operations"
       }
      }
     },
     "localname": "HedgesOfNetInvestmentsInForeignOperationsAfterTax",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_HoechstGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hoechst GmbH.",
        "label": "Hoechst Gmbh [member]",
        "terseLabel": "Hoechst GmbH"
       }
      }
     },
     "localname": "HoechstGmbHMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_IGMBiosciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IGM Biosciences, Inc",
        "label": "IGM Biosciences, Inc [Member]",
        "terseLabel": "IGM Biosciences, Inc"
       }
      }
     },
     "localname": "IGMBiosciencesIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_IOLicenseAndCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IO License And Collaboration Agreement",
        "label": "IO License And Collaboration Agreement [Member]",
        "terseLabel": "IO License And Collaboration Agreement"
       }
      }
     },
     "localname": "IOLicenseAndCollaborationAgreementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified environmental risks provisions estimated obligation period.",
        "label": "Identified Environmental Risks Provisions Estimated Obligation Period",
        "terseLabel": "Identified environmental risks provisions estimated obligation period"
       }
      }
     },
     "localname": "IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified environmental risks provisions expected utilized amount next twelve months.",
        "label": "Identified Environmental Risks Provisions Expected Utilized Amount Next Twelve Months",
        "terseLabel": "Other provisions, expected utilized amount in 2022"
       }
      }
     },
     "localname": "IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified environmental risks provisions expected utilized amount year two to five.",
        "label": "Identified Environmental Risks Provisions Expected Utilized Amount Year Two To Five",
        "terseLabel": "Other provisions, expected utilized amount in 2023 through 2026"
       }
      }
     },
     "localname": "IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ImmunoOncologyCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immuno oncology collaboration agreement.",
        "label": "Immuno Oncology Collaboration Agreement [Member]",
        "terseLabel": "Immuno-oncology collaboration agreement"
       }
      }
     },
     "localname": "ImmunoOncologyCollaborationAgreementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ImmunooncologyAllianceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immuno-oncology Alliance [Member]",
        "label": "Immuno-oncology Alliance [Member]",
        "terseLabel": "Immuno-Oncology Alliance"
       }
      }
     },
     "localname": "ImmunooncologyAllianceMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ImpactOfChangeInInterestRateOnPreTaxIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of change in interest rate on pre tax income.",
        "label": "Impact Of Change In Interest Rate On Pre Tax Income",
        "terseLabel": "Impact on pre-tax net income"
       }
      }
     },
     "localname": "ImpactOfChangeInInterestRateOnPreTaxIncome",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ImpactOfPreTaxIncomeRecognisedInEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of pre tax income recognised in equity.",
        "label": "Impact Of Pre Tax Income Recognised In Equity",
        "terseLabel": "Impact on pre-tax income/(expense) recognized directly in equity"
       }
      }
     },
     "localname": "ImpactOfPreTaxIncomeRecognisedInEquity",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of the workdown of acquired inventories remeasured at fair value arising from business combination in accordance with IFRS 3.",
        "label": "Impact Of The Workdown Of Acquired Inventories Remeasured At Fair Value",
        "verboseLabel": "Impact of the workdown of acquired inventories remeasured at fair value"
       }
      }
     },
     "localname": "ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ImpairmentLossOnIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment loss on intangible assets other than goodwill.",
        "label": "Impairment Loss On Intangible Assets Other Than Goodwill",
        "terseLabel": "Impairment of other intangible assets, net of reversals (excluding software)"
       }
      }
     },
     "localname": "ImpairmentLossOnIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Loss Recognised In Profit Or Loss, Intangible Assets Other Than Goodwill, Reversal Amount",
        "label": "Impairment Loss Recognised In Profit Or Loss, Intangible Assets Other Than Goodwill, Reversal Amount",
        "terseLabel": "Reversal amount"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillReversalAmount",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/EventssubsequenttoDecember312022Details",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ImpairmentOfAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Of Assets [Abstract]",
        "label": "Impairment Of Assets [Abstract]",
        "terseLabel": "Impairment Of Assets [Abstract]"
       }
      }
     },
     "localname": "ImpairmentOfAssetsAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_ImpairmentTestingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Testing Percentage",
        "label": "Impairment Testing Percentage",
        "terseLabel": "Rate used for Impairment of goodwill"
       }
      }
     },
     "localname": "ImpairmentTestingPercentage",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income before tax and investments accounted for equity method investments.",
        "label": "Income Before Tax And Investments Accounted For Equity Method Investments",
        "terseLabel": "Income before tax and investments accounted for using the equity method",
        "totalLabel": "Income before tax and investments accounted for using the equity method"
       }
      }
     },
     "localname": "IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofAllocationofIncomeTaxExpenseBetweenCurrentandDeferredTaxesDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncomeResultingFromOutLicensing": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Resulting From Out-Licensing",
        "label": "Income Resulting From Out-Licensing",
        "terseLabel": "Income from out-licensing"
       }
      }
     },
     "localname": "IncomeResultingFromOutLicensing",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncomeStatementLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Statement Location",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/OtheroperatingincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Statement Location",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/OtheroperatingincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Relating To Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Net Of Tax On Associates And Joint Ventures",
        "label": "Income Tax Relating To Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Net Of Tax On Associates And Joint Ventures",
        "negatedTerseLabel": "Tax effects"
       }
      }
     },
     "localname": "IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 7.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Relating To Change In Fair Value Of Debt Instrument Excluding Associates And Joint Ventures",
        "label": "Income Tax Relating To Change In Fair Value Of Debt Instrument Excluding Associates And Joint Ventures",
        "negatedTerseLabel": "Tax effects"
       }
      }
     },
     "localname": "IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Relating To Change In Fair Value Of Equity Instruments Excluding Equity Method",
        "label": "Income Tax Relating To Change In Fair Value Of Equity Instruments Excluding Equity Method",
        "negatedTerseLabel": "Tax effects"
       }
      }
     },
     "localname": "IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncomeTaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Abstract]",
        "label": "Income Taxes [Abstract]",
        "terseLabel": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxesAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Expense Of Restructuring Activities, Employee Related Expenses",
        "label": "Increase (Decrease) In Expense Of Restructuring Activities, Employee Related Expenses",
        "terseLabel": "Increase in employee-related expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInExpenseOfRestructuringActivitiesEmployeeRelatedExpenses",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net change in provisions related to prior period sales.",
        "label": "Increase (Decrease) In Provisions Related To Prior Period Sales",
        "terseLabel": "Net change in provision related to prior period sales"
       }
      }
     },
     "localname": "IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate and currency derivatives used to manage debt.",
        "label": "Increase (Decrease) Interest Rate And Currency Derivatives Used To Manage Debt [Member]",
        "terseLabel": "Interest rate and currency derivatives used to manage debt"
       }
      }
     },
     "localname": "IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_IncreaseDecreaseOfBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) Of Borrowings",
        "label": "Increase (Decrease) Of Borrowings",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "IncreaseDecreaseOfBorrowings",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease of unused provision reversed, other provisions.",
        "label": "Increase (Decrease) Of Unused Provision Reversed, Other Provisions",
        "negatedLabel": "Reversals of unutilized provisions"
       }
      }
     },
     "localname": "IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in scope of consolidation in provision for discounts rebates and sales returns.",
        "label": "Increase (Decrease) Through Change In Scope Of Consolidation In Provision For Discounts Rebates And Sales Returns",
        "terseLabel": "Changes in scope of consolidation"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) Through Change In Scope Of Consolidation, Other Provisions",
        "label": "Increase (Decrease) Through Change In Scope Of Consolidation, Other Provisions",
        "terseLabel": "Changes in scope of consolidation"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughChangeInScopeOfConsolidationOtherProvisions",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease through changes in non-controlling interests arising from divestment.",
        "label": "Increase (Decrease) Through Changes In Non-controlling Interests Arising From Divestment",
        "terseLabel": "Other changes in non-controlling interests"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughChangesInNonControllingInterestsArisingFromDivestment",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) through issuance of restricted shares, equity.",
        "label": "Increase (Decrease) Through Issuance Of Restricted Shares, Equity",
        "terseLabel": "Other changes arising from issuance of restricted shares"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease through net exchange differences business combinations and noncontrolling interests.",
        "label": "Increase (Decrease) Through Net Exchange Differences Business Combinations And Noncontrolling Interests",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) Through Net Exchange Differences, Property, Plant and Equipment, Right Of Use Assets",
        "label": "Increase (Decrease) Through Net Exchange Differences, Property, Plant and Equipment, Right Of Use Assets",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantandEquipmentRightOfUseAssets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency translation differences.",
        "label": "Increase (Decrease) Through Net Exchange Differences Provisions For Discounts Rebates And Sales Returns",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee share ownership plans.",
        "label": "Increase (Decrease) Through Share-Based Payment Plans Employee Share Ownership Plans",
        "terseLabel": "Employee share ownership plan"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) through share-based payment plans issuance of restricted shares and vesting of existing restricted shares.",
        "label": "Increase (Decrease) Through Share-Based Payment Plans Issuance Of Restricted Shares And Vesting Of Existing Restricted Shares",
        "terseLabel": "Issuance of restricted shares and vesting of existing restricted shares"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax effects of the exercise of stock options.",
        "label": "Increase (Decrease) Through Share-Based Payment Plans Tax Effects Of The Exercise Of Stock Options",
        "terseLabel": "Tax effects of the exercise of\u00a0stock options"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of services obtained from employees.",
        "label": "Increase (Decrease) Through Share-Based Payment Plans Value Of Services Obtained From Employees",
        "terseLabel": "Value of services obtained from employees"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) Through Transfers, Property, Plant and Equipment, Right Of Use Assets",
        "label": "Increase (Decrease) Through Transfers, Property, Plant and Equipment, Right Of Use Assets",
        "terseLabel": "Transfers"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersPropertyPlantAndEquipmentRightOfUseAssets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IncreaseInContingentConsideration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in contingent consideration.",
        "label": "Increase In Contingent Consideration",
        "terseLabel": "Increase in contingent consideration"
       }
      }
     },
     "localname": "IncreaseInContingentConsideration",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_IncreaseOfTenPercentBasisPointInMarketInterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction of ten percent basis point in market interest rate.",
        "label": "Increase Of Ten Percent Basis Point In Market Interest Rate [Member]",
        "terseLabel": "Increase of ten percent basis point in market interest rate"
       }
      }
     },
     "localname": "IncreaseOfTenPercentBasisPointInMarketInterestRateMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_IncreaseThroughNewProvisionRelatedToCurrentPeriodSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision related to current period sales.",
        "label": "Increase Through New Provision Related To Current Period Sales",
        "terseLabel": "Provision related to current period sales"
       }
      }
     },
     "localname": "IncreaseThroughNewProvisionRelatedToCurrentPeriodSales",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IndustrialFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Industrial facilities.",
        "label": "Industrial Facilities [Member]",
        "terseLabel": "Industrial facilities"
       }
      }
     },
     "localname": "IndustrialFacilitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_IndustrialSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Industrial Sales",
        "label": "Industrial Sales [Member]",
        "terseLabel": "Industrial sales"
       }
      }
     },
     "localname": "IndustrialSalesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InfluenzaVaccinesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Influenza Vaccines.",
        "label": "Influenza Vaccines [Member]",
        "terseLabel": "Influenza Vaccines"
       }
      }
     },
     "localname": "InfluenzaVaccinesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InfraservGmbhAndCoHochstKGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infraserv GmbH and Co. Hochst KG.",
        "label": "Infraserv Gmbh And Co Hochst KG [member]",
        "verboseLabel": "Infraserv GmbH\u00a0&amp; Co. H\u00f6chst KG"
       }
      }
     },
     "localname": "InfraservGmbhAndCoHochstKGMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InfraservHoechstRetainedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infraserv Hoechst retained liabilities.",
        "label": "Infraserv Hoechst Retained Liabilities [member]",
        "terseLabel": "Infraserv Hoechst retained liabilities"
       }
      }
     },
     "localname": "InfraservHoechstRetainedLiabilitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InitialLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Lease Term",
        "label": "Initial Lease Term",
        "terseLabel": "Initial lease term"
       }
      }
     },
     "localname": "InitialLeaseTerm",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_InnatePharmaSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Innate Pharma SA",
        "label": "Innate Pharma SA [Member]",
        "terseLabel": "Innate Pharma SA"
       }
      }
     },
     "localname": "InnatePharmaSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InnoventBiologicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Innovent Biologics",
        "label": "Innovent Biologics [Member]",
        "terseLabel": "Innovent Biologics"
       }
      }
     },
     "localname": "InnoventBiologicsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InsilicoMedicineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insilico Medicine",
        "label": "Insilico Medicine [Member]",
        "terseLabel": "Insilico Medicine"
       }
      }
     },
     "localname": "InsilicoMedicineMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InsurancePoliciesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance policies.",
        "label": "Insurance Policies [Member]",
        "terseLabel": "Insurance policies"
       }
      }
     },
     "localname": "InsurancePoliciesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expense (Income) Including Administration Costs And Taxes Paid, Net Defined Benefit Liability (Asset)",
        "label": "Interest Expense (Income) Including Administration Costs And Taxes Paid, Net Defined Benefit Liability (Asset)",
        "terseLabel": "Net interest cost/(income) including administration costs and taxes paid during the period"
       }
      }
     },
     "localname": "InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_InterestIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails": {
       "order": 2.0,
       "parentTag": "sny_CostOfDebtNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Income",
        "label": "Interest Income",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncome",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_InterestRateAndCurrencyDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate and currency derivatives used to hedge debt.",
        "label": "Interest Rate And Currency Derivatives [Member]",
        "terseLabel": "Interest rate and currency derivatives used to hedge debt"
       }
      }
     },
     "localname": "InterestRateAndCurrencyDerivativesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails": {
       "order": 3.0,
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate and currency derivatives used to manage cash and cash equivalent.",
        "label": "Interest Rate And Currency Derivatives Used To Manage Cash And Cash Equivalent",
        "negatedLabel": "Interest rate and currency derivatives used to manage cash and cash equivalents"
       }
      }
     },
     "localname": "InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_InterestRateAndCurrencyDerivativesUsedToManageDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": -1.0
      },
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate and currency derivatives used to manage debt.",
        "label": "Interest Rate And Currency Derivatives Used To Manage Debt",
        "negatedLabel": "Interest rate and currency derivatives used to manage debt"
       }
      }
     },
     "localname": "InterestRateAndCurrencyDerivativesUsedToManageDebt",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofChangesinFinancialPositionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_InterestRateDerivativesMeasuredAtFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/OthercurrentassetsDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_OtherCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate derivatives measured at fair value.",
        "label": "Interest Rate Derivatives Measured At Fair Value",
        "terseLabel": "Interest rate derivatives measured at fair value (see Note\u00a0D.20.)"
       }
      }
     },
     "localname": "InterestRateDerivativesMeasuredAtFairValue",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthercurrentassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_InterestRateDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate derivatives.",
        "label": "Interest Rate Derivatives [Member]",
        "terseLabel": "Interest rate derivatives"
       }
      }
     },
     "localname": "InterestRateDerivativesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InterestRateSwapsInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swaps, Interest Rate",
        "label": "Interest Rate Swaps, Interest Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "InterestRateSwapsInterestRate",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_InterestRateSwapsPay057ReceiveCapitalizedEoniaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate swaps pay -0.57% / receivecapitalized Eonia",
        "label": "Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia [Member]",
        "verboseLabel": "Interest Rate Swaps Pay -0.57% / Receive Capitalized Eonia"
       }
      }
     },
     "localname": "InterestRateSwapsPay057ReceiveCapitalizedEoniaMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InterestRateSwapsPayCapitalizedEoniaReceive006Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate swaps pay capitalized Eonia / receive 0.06%.",
        "label": "Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06% [Member]",
        "verboseLabel": "Interest Rate Swaps Pay Capitalized Eonia / Receive 0.06%"
       }
      }
     },
     "localname": "InterestRateSwapsPayCapitalizedEoniaReceive006Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InterestRateSwapsPayCapitalizedEsterReceive069Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swaps Pay Capitalized Ester / Receive 0.69%",
        "label": "Interest Rate Swaps Pay Capitalized Ester / Receive 0.69% [Member]",
        "terseLabel": "Interest Rate Swaps Pay Capitalized Ester / Receive 0.69%"
       }
      }
     },
     "localname": "InterestRateSwapsPayCapitalizedEsterReceive069Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92%",
        "label": "Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92% [Member]",
        "terseLabel": "Interest Rate Swaps Pay Capitalized USD SOFR / Receive 0.92%"
       }
      }
     },
     "localname": "InterestRateSwapsPayCapitalizedUSDSOFRReceive092Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03%",
        "label": "Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03% [Member]",
        "verboseLabel": "Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.03%"
       }
      }
     },
     "localname": "InterestRateSwapsPayCapitalizedUSDSOFRReceive103Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32%",
        "label": "Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32% [Member]",
        "terseLabel": "Interest Rate Swaps Pay Capitalized USD SOFR / Receive 1.32%"
       }
      }
     },
     "localname": "InterestRateSwapsPayCapitalizedUSDSOFRReceive132Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate swaps receive capitalized Eonia / pay 1.48%.",
        "label": "Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent [Member]",
        "verboseLabel": "Interest Rate Swaps Receive Capitalized Eonia / Pay 1.48 Percent"
       }
      }
     },
     "localname": "InterestRateSwapsReceiveCapitalizedEoniaPay148PercentMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_InterestUndiscountedCashFlow": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest undiscounted cash flow.",
        "label": "Interest Undiscounted Cash Flow",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestUndiscountedCashFlow",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_InterestsInOtherEntitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interests In Other Entities [Abstract]",
        "label": "Interests In Other Entities [Abstract]",
        "terseLabel": "Interests In Other Entities [Abstract]"
       }
      }
     },
     "localname": "InterestsInOtherEntitiesAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_InvestmentsInAssociatesAndJointVentures": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of investments, joint ventures and associates in an entity's separate financial statements. Long term equity interest, significant influence.",
        "label": "Investments In Associates And Joint Ventures",
        "terseLabel": "Investments accounted for using the equity method"
       }
      }
     },
     "localname": "InvestmentsInAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income, Ownership Percentage",
        "label": "Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income, Ownership Percentage",
        "terseLabel": "Investments in equity instruments designated at fair value through OCI, ownership percentage"
       }
      }
     },
     "localname": "InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeOwnershipPercentage",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income, Transaction Amount",
        "label": "Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income, Transaction Amount",
        "terseLabel": "Investments in equity instruments designated at fair value through other comprehensive income, transaction amount"
       }
      }
     },
     "localname": "InvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncomeTransactionAmount",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IrrevocablePurchaseCommitmentsGiven": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Irrevocable purchase commitments given.",
        "label": "Irrevocable Purchase Commitments Given",
        "terseLabel": "Irrevocable purchase commitments given"
       }
      }
     },
     "localname": "IrrevocablePurchaseCommitmentsGiven",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IrrevocablePurchaseCommitmentsReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Irrevocable purchase commitments received.",
        "label": "Irrevocable Purchase Commitments Received",
        "negatedLabel": "Irrevocable purchase commitments received"
       }
      }
     },
     "localname": "IrrevocablePurchaseCommitmentsReceived",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_IssuanceOfFurtherSharesAsAnEmployersContribution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Further shares as an employers contribution.",
        "label": "Issuance Of Further Shares As An Employers Contribution",
        "terseLabel": "Number of shares issued immediately as employer's contribution (in shares)"
       }
      }
     },
     "localname": "IssuanceOfFurtherSharesAsAnEmployersContribution",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items not subsequently reclassifiable to profit or loss.",
        "label": "Items Not Subsequently Reclassifiable To Profit Or Loss [Member]",
        "terseLabel": "Items not subsequently reclassifiable to profit or loss"
       }
      }
     },
     "localname": "ItemsNotSubsequentlyReclassifiableToProfitOrLossMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items subsequently reclassifiable to profit or loss.",
        "label": "Items Subsequently Reclassifiable To Profit Or Loss [Member]",
        "terseLabel": "Items subsequently reclassifiable to profit or loss"
       }
      }
     },
     "localname": "ItemsSubsequentlyReclassifiableToProfitOrLossMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_JevtanaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Jevtana.",
        "label": "Jevtana [Member]",
        "terseLabel": "Jevtana"
       }
      }
     },
     "localname": "JevtanaMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_JevtanaRelatedPatentLitigationInTheUSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Jevtana Related Patent Litigation In The US",
        "label": "Jevtana Related Patent Litigation In The US [Member]",
        "terseLabel": "Jevtana related patent litigation in the US"
       }
      }
     },
     "localname": "JevtanaRelatedPatentLitigationInTheUSMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_June2018SNFISINUS801060AC87Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2018SNFISINUS801060AC87.",
        "label": "June 2018 SNFISINUS801060AC87 [member]",
        "terseLabel": "June 2018 SNF ISIN US801060AC87"
       }
      }
     },
     "localname": "June2018SNFISINUS801060AC87Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_June2018SNFISINUS801060AD60Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2018SNFISINUS801060AD60.",
        "label": "June 2018 SNFISINUS801060AD60 [member]",
        "terseLabel": "June 2018 SNF ISIN US801060AD60"
       }
      }
     },
     "localname": "June2018SNFISINUS801060AD60Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_KadmonCorporationLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kadmon Corporation, LLC",
        "label": "Kadmon Corporation, LLC [Member]",
        "terseLabel": "Kadmon Corporation, LLC"
       }
      }
     },
     "localname": "KadmonCorporationLLCMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_KadmonHoldingsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kadmon Holdings, Inc",
        "label": "Kadmon Holdings, Inc [Member]",
        "terseLabel": "Kadmon Holdings, Inc."
       }
      }
     },
     "localname": "KadmonHoldingsIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_KadmonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kadmon",
        "label": "Kadmon [Member]",
        "terseLabel": "Kadmon"
       }
      }
     },
     "localname": "KadmonMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Key management personnel compensation, termination benefits and lump sum retirement benefits.",
        "label": "Key Management Personnel Compensation Termination Benefits And LumpSum Retirement Benefits",
        "terseLabel": "Aggregate termination benefits and lump-sum retirement benefits in favor of key management personnel"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/RelatedpartytransactionsSummaryofaggregateamountsPayabletoKeyManagementPersonnelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_KiadisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kiadis",
        "label": "Kiadis [Member]",
        "terseLabel": "Kiadis"
       }
      }
     },
     "localname": "KiadisMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_KymabMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kymab",
        "label": "Kymab [Member]",
        "terseLabel": "Kymab"
       }
      }
     },
     "localname": "KymabMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_LaboratoryFacilitiesCambridgeMassachusettsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory Facilities, Cambridge, Massachusetts",
        "label": "Laboratory Facilities, Cambridge, Massachusetts [Member]",
        "terseLabel": "Laboratory facilities, Cambridge, Massachusetts"
       }
      }
     },
     "localname": "LaboratoryFacilitiesCambridgeMassachusettsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_LantusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lantus.",
        "label": "Lantus [Member]",
        "terseLabel": "Lantus"
       }
      }
     },
     "localname": "LantusMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_LargestCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Largest Customers",
        "label": "Largest Customers [Member]",
        "terseLabel": "Largest customers"
       }
      }
     },
     "localname": "LargestCustomersMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DisclosuresaboutmajorcustomersandcreditriskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_LaterThanFiveYearsAndNotLaterThanEightYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Later Than Five Years And Not Later Than Eight Years",
        "label": "Later Than Five Years And Not Later Than Eight Years [Member]",
        "verboseLabel": "Year 6 - Year 10"
       }
      }
     },
     "localname": "LaterThanFiveYearsAndNotLaterThanEightYearsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_LeaseLiabilitiesEffectOfDiscounting": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities, Effect Of Discounting",
        "label": "Lease Liabilities, Effect Of Discounting",
        "negatedTerseLabel": "Discounting effect"
       }
      }
     },
     "localname": "LeaseLiabilitiesEffectOfDiscounting",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_LeasedAssetsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leased Assets, Percentage",
        "label": "Leased Assets, Percentage",
        "terseLabel": "Leased assets, percentage"
       }
      }
     },
     "localname": "LeasedAssetsPercentage",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_LegalAndArbitralProceedingsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal And Arbitral Proceedings [Axis]",
        "label": "Legal And Arbitral Proceedings [Axis]",
        "terseLabel": "Legal And Arbitral Proceedings [Axis]"
       }
      }
     },
     "localname": "LegalAndArbitralProceedingsAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_LegalAndArbitralProceedingsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Legal And Arbitral Proceedings [Axis]",
        "label": "Legal And Arbitral Proceedings [Domain]",
        "terseLabel": "Legal And Arbitral Proceedings [Domain]"
       }
      }
     },
     "localname": "LegalAndArbitralProceedingsDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_LengthOfTrial": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Length Of Trial",
        "label": "Length Of Trial",
        "terseLabel": "Length of trial (in days)"
       }
      }
     },
     "localname": "LengthOfTrial",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_LiabilityRecognizedRepresentingEstimatedCost": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability recognized representing estimated cost.",
        "label": "Liability Recognized Representing Estimated Cost",
        "terseLabel": "Liability recognized representing the estimated cost"
       }
      }
     },
     "localname": "LiabilityRecognizedRepresentingEstimatedCost",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_LitigationAmountPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Amount Payable.",
        "label": "Litigation Amount Payable",
        "terseLabel": "Litigation amount payable"
       }
      }
     },
     "localname": "LitigationAmountPayable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_LongTermPrepaidExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term prepaid expenses.",
        "label": "Long Term Prepaid Expenses",
        "terseLabel": "Long-term prepaid expenses"
       }
      }
     },
     "localname": "LongTermPrepaidExpenses",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_LonzaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lonza.",
        "label": "Lonza [member]",
        "terseLabel": "Lonza"
       }
      }
     },
     "localname": "LonzaMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_LovenoxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lovenox.",
        "label": "Lovenox [Member]",
        "terseLabel": "Lovenox"
       }
      }
     },
     "localname": "LovenoxMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_LumpSumRetirementBenefitPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lump-sum retirement benefit plans.",
        "label": "Lump-sum Retirement Benefit Plans [Member]",
        "terseLabel": "Lump-sum retirement benefit plans"
       }
      }
     },
     "localname": "LumpSumRetirementBenefitPlansMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MCMVaccineBVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MCM Vaccine BV.",
        "label": "MCM Vaccine BV [Member]",
        "terseLabel": "MCM Vaccine B.V."
       }
      }
     },
     "localname": "MCMVaccineBVMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MSD contingent consideration European vaccines business.",
        "label": "MSD Contingent Consideration (European Vaccines Business) [Member]",
        "terseLabel": "MSD contingent consideration (European vaccines business)"
       }
      }
     },
     "localname": "MSDContingentConsiderationEuropeanVaccinesBusinessMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMaximumAmountofContingentConsiderationPayableandFirmCommitmentstoBuyOutNonControllingInterestsDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MSPVaccineCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MSP Vaccine Company",
        "label": "MSP Vaccine Company [Member]",
        "terseLabel": "MSP Vaccine Company (formerly MCM company)"
       }
      }
     },
     "localname": "MSPVaccineCompanyMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofInvestmentsinAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Machinery And Equipment",
        "label": "Machinery And Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSummaryofUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Main undrawn confirmed general purpose credit facilities.",
        "label": "Main Undrawn Confirmed General Purpose Credit Facilities [member]",
        "terseLabel": "Main undrawn confirmed general purpose credit facilities"
       }
      }
     },
     "localname": "MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MajorCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major Collaboration Agreement",
        "label": "Major Collaboration Agreement [Member]",
        "terseLabel": "Major Collaboration Agreement"
       }
      }
     },
     "localname": "MajorCollaborationAgreementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ManagedCareAndGPOProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Managed Care And GPO Programs [Member]",
        "label": "Managed Care And GPO Programs [Member]",
        "terseLabel": "Managed care and GPO Programs"
       }
      }
     },
     "localname": "ManagedCareAndGPOProgramsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ManagedCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Managed care [Member]",
        "label": "Managed Care [Member]",
        "terseLabel": "Managed care"
       }
      }
     },
     "localname": "ManagedCareMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ManufactureAndSupplyCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacture And Supply Collaboration Agreement",
        "label": "Manufacture And Supply Collaboration Agreement [Member]",
        "terseLabel": "Manufacture and supply collaboration agreement"
       }
      }
     },
     "localname": "ManufactureAndSupplyCollaborationAgreementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MapharMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maphar.",
        "label": "Maphar [Member]",
        "terseLabel": "Maphar"
       }
      }
     },
     "localname": "MapharMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_March2018EMTNISINFR0013324332Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2018 EMTN ISIN FR 0013324332.",
        "label": "March 2018 EMTN ISIN FR0013324332 [Member]",
        "terseLabel": "March 2018 EMTN ISIN FR0013324332"
       }
      }
     },
     "localname": "March2018EMTNISINFR0013324332Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_March2018EMTNISINFR0013324340Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2018 EMTN ISIN FR 0013324340.",
        "label": "March 2018 EMTN ISIN FR0013324340 [Member]",
        "terseLabel": "March 2018 EMTN ISIN FR0013324340"
       }
      }
     },
     "localname": "March2018EMTNISINFR0013324340Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_March2018EMTNISINFR0013324357Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2018 EMTN ISIN FR 0013324357.",
        "label": "March 2018 EMTN ISIN FR0013324357 [Member]",
        "terseLabel": "March 2018 EMTN ISIN FR0013324357"
       }
      }
     },
     "localname": "March2018EMTNISINFR0013324357Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_March2018EMTNISINFR0013324373Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2018 EMTN ISIN FR 0013324373.",
        "label": "March 2018 EMTN ISIN FR0013324373 [Member]",
        "terseLabel": "March 2018 EMTN ISIN FR0013324373"
       }
      }
     },
     "localname": "March2018EMTNISINFR0013324373Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_March2019EMTNISINFR0013409844Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2019 EMTN ISIN FR0013409844 [Member]",
        "label": "March 2019 EMTN ISIN FR0013409844 [Member]",
        "terseLabel": "March 2019 EMTN ISIN FR0013409844"
       }
      }
     },
     "localname": "March2019EMTNISINFR0013409844Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_March2019EMTNISINFR0013409851Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2019 EMTN ISIN FR0013409851 [Member]",
        "label": "March 2019 EMTN ISIN FR0013409851 [Member]",
        "terseLabel": "March 2019 EMTN ISIN FR0013409851"
       }
      }
     },
     "localname": "March2019EMTNISINFR0013409851Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_March2020EMTNISINFR0013505104Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2020 EMTNISINFR0013505104",
        "label": "March 2020 EMTNISINFR0013505104 [Member]",
        "terseLabel": "March 2020 EMTN ISIN FR0013505104"
       }
      }
     },
     "localname": "March2020EMTNISINFR0013505104Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_March2020EMTNISINFR0013505112Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2020 EMTNISINFR0013505112",
        "label": "March 2020 EMTNISINFR0013505112 [Member]",
        "terseLabel": "March 2020 EMTN ISIN FR0013505112"
       }
      }
     },
     "localname": "March2020EMTNISINFR0013505112Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MarketConditionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Condition",
        "label": "Market Condition [Axis]",
        "terseLabel": "Market Condition [Axis]"
       }
      }
     },
     "localname": "MarketConditionAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_MarketConditionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Condition [Domain]",
        "label": "Market Condition [Domain]",
        "terseLabel": "Market Condition [Domain]"
       }
      }
     },
     "localname": "MarketConditionDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MarketedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketed products.",
        "label": "Marketed Products [Member]",
        "terseLabel": "Marketed products"
       }
      }
     },
     "localname": "MarketedProductsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MarketedProductsTrademarksAndOtherRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketed products trademarks and other rights.",
        "label": "Marketed Products Trademarks And Other Rights [Member]",
        "terseLabel": "Products, trademarks and other rights"
       }
      }
     },
     "localname": "MarketedProductsTrademarksAndOtherRightsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsScheduleofMovementsinOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum additional funding for anti programmed cell death protein 1 part of each company.",
        "label": "Maximum Additional Funding For Anti Programmed Cell Death Protein 1 Part Of Each Company",
        "terseLabel": "Maximum additional funding for PD1 - part of each company"
       }
      }
     },
     "localname": "MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Amount To Be Reimbursed For Current And Future Environmental Expense",
        "label": "Maximum Amount To Be Reimbursed For Current And Future Environmental Expense",
        "terseLabel": "Maximum amount to be reimbursed for current and future environmental expense"
       }
      }
     },
     "localname": "MaximumAmountToBeReimbursedForCurrentAndFutureEnvironmentalExpense",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_MaximumOwnershipPercentageAllowedToAcquire": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum ownership percentage allowed to acquire.",
        "label": "Maximum Ownership Percentage Allowed To Acquire",
        "terseLabel": "Maximum ownership percentage allowed to acquire"
       }
      }
     },
     "localname": "MaximumOwnershipPercentageAllowedToAcquire",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum penalty amount sought by plaintiffs for each violation",
        "label": "Maximum Penalty Amount Sought By Plaintiffs For Each Violation",
        "terseLabel": "Maximum penalty amount sought by plaintiffs for each violation"
       }
      }
     },
     "localname": "MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_MaximumPlan1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Plan 1",
        "label": "Maximum Plan 1 [Member]",
        "terseLabel": "Maximum Plan 1"
       }
      }
     },
     "localname": "MaximumPlan1Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MaximumPlan2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Plan 2",
        "label": "Maximum Plan 2 [Member]",
        "terseLabel": "Maximum plan 2"
       }
      }
     },
     "localname": "MaximumPlan2Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_May32022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2, 2018 [Member]",
        "label": "May 3, 2022 [Member]",
        "verboseLabel": "May 3, 2022"
       }
      }
     },
     "localname": "May32022Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid [Member]",
        "label": "Medicaid [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "MedicaidMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MedicareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare [Member]",
        "label": "Medicare [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "MedicareMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MerieuxCanadaHoldingsULCCanadaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merieux Canada Holdings ULC (Canada)",
        "label": "Merieux Canada Holdings ULC (Canada) [Member]",
        "terseLabel": "Merieux Canada Holdings ULC (Canada)"
       }
      }
     },
     "localname": "MerieuxCanadaHoldingsULCCanadaMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MiReculeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "miRecule",
        "label": "miRecule [Member]",
        "terseLabel": "miRecule"
       }
      }
     },
     "localname": "MiReculeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MilestonePaymentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone payment term.",
        "label": "Milestone Payment Term",
        "terseLabel": "Milestone payment period"
       }
      }
     },
     "localname": "MilestonePaymentTerm",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "sny_MilestoneTypesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Types",
        "label": "Milestone Types [Axis]",
        "terseLabel": "Milestone Types [Axis]"
       }
      }
     },
     "localname": "MilestoneTypesAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_MilestoneTypesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Types [Domain]",
        "label": "Milestone Types [Domain]",
        "terseLabel": "Milestone Types [Domain]"
       }
      }
     },
     "localname": "MilestoneTypesDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MinimumPlan1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Plan 1",
        "label": "Minimum Plan 1 [Member]",
        "terseLabel": "Minimum Plan 1"
       }
      }
     },
     "localname": "MinimumPlan1Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MinimumPlan2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Plan 2",
        "label": "Minimum Plan 2 [Member]",
        "terseLabel": "Minimum plan 2"
       }
      }
     },
     "localname": "MinimumPlan2Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofFinancialandDemographicAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum sales of anti programmed cell death protein 1 in twelve month period to be achieved for milestone payment.",
        "label": "Minimum Sales Of Anti Programmed Cell Death Protein 1 In Twelve Month Period To Be Achieved For Milestone Payment",
        "terseLabel": "Minimum sales of PD1 in 12-month period to be achieved for milestone payment"
       }
      }
     },
     "localname": "MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_MinusHundredBasisPointsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minus hundred basis points.",
        "label": "Minus Hundred Basis Points [Member]",
        "terseLabel": "-100\u00a0bp"
       }
      }
     },
     "localname": "MinusHundredBasisPointsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MinusTwentyFiveBasisPointsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minus twenty five basis points.",
        "label": "Minus Twenty Five Basis Points [Member]",
        "terseLabel": "-25\u00a0bp"
       }
      }
     },
     "localname": "MinusTwentyFiveBasisPointsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MiscellaneousOtherOperatingIncomeExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails": {
       "order": 6.0,
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other operating income and expenses.",
        "label": "Miscellaneous Other Operating Income (Expenses)",
        "terseLabel": "Other operating income and expenses"
       }
      }
     },
     "localname": "MiscellaneousOtherOperatingIncomeExpenses",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_MutualFundInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mutual fund investments.",
        "label": "Mutual Fund Investments [Member]",
        "terseLabel": "Mutual fund investments"
       }
      }
     },
     "localname": "MutualFundInvestmentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_MyozymeOrLumizymeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Myozyme or Lumizyme [Member]",
        "label": "Myozyme Or Lumizyme [Member]",
        "terseLabel": "Myozyme/Lumizyme"
       }
      }
     },
     "localname": "MyozymeOrLumizymeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NetAmountsAsReportedInTheBalanceSheet": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails": {
       "order": 3.0,
       "parentTag": "sny_NetExposure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net amounts as reported in the balance sheet.",
        "label": "Net Amounts As Reported In The Balance Sheet",
        "totalLabel": "Net amounts as reported in the balance sheet"
       }
      }
     },
     "localname": "NetAmountsAsReportedInTheBalanceSheet",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other current assets and increase (decrease) in other current liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities.",
        "label": "Net Change In Other Current Assets And Other Current Liabilities",
        "terseLabel": "Net change in other current assets and other current liabilities"
       }
      }
     },
     "localname": "NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NetChangeInOtherNonCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net change in other non-current assets.",
        "label": "Net Change In Other Non-current Assets",
        "verboseLabel": "Net change in other non-current assets"
       }
      }
     },
     "localname": "NetChangeInOtherNonCurrentAssets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofcashflows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NetExposure": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net exposure",
        "label": "Net Exposure",
        "totalLabel": "Net exposure"
       }
      }
     },
     "localname": "NetExposure",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofActualorPotentialEffectsofNettingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NetInterestCostRelatedToEmployeeBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net interest cost related to employee benefits.",
        "label": "Net Interest Cost Related To Employee Benefits",
        "negatedLabel": "Net interest cost related to employee benefits"
       }
      }
     },
     "localname": "NetInterestCostRelatedToEmployeeBenefits",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net interest related to employees benefits and unwinding of discount.",
        "label": "Net Interest Related To Employees Benefits And Unwinding Of Discount",
        "terseLabel": "Net interest related to employee benefits, and unwinding of discount"
       }
      }
     },
     "localname": "NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net pretax actuarial loss excluding associates and joint ventures recognized directly in equity.",
        "label": "Net Pretax Actuarial Loss Excluding Associates And Joint Ventures Recognized Directly In Equity",
        "terseLabel": "Net pre-tax actuarial loss"
       }
      }
     },
     "localname": "NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNetPretaxActuarialLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NeurologyImmunologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Neurology &amp; Immunology",
        "label": "Neurology &amp; Immunology [Member]",
        "terseLabel": "Neurology &amp; Immunology"
       }
      }
     },
     "localname": "NeurologyImmunologyMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NewAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Agreement",
        "label": "New Agreement [Member]",
        "terseLabel": "New agreement"
       }
      }
     },
     "localname": "NewAgreementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NewBusinessModelRolloutInVariousGeographiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Business Model, Rollout In Various Geographies",
        "label": "New Business Model, Rollout In Various Geographies [Member]",
        "terseLabel": "New business model, rollout in various geographies"
       }
      }
     },
     "localname": "NewBusinessModelRolloutInVariousGeographiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NonCoreAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Core Assets",
        "label": "Non-Core Assets [Member]",
        "terseLabel": "Non-Core Assets"
       }
      }
     },
     "localname": "NonCoreAssetsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NonCurrentAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-current asset.",
        "label": "Non Current Asset [Member]",
        "terseLabel": "Non current asset"
       }
      }
     },
     "localname": "NonCurrentAssetMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NonCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-current assets.",
        "label": "Non-current Assets [Member]",
        "terseLabel": "Non-current"
       }
      }
     },
     "localname": "NonCurrentAssetsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NonCurrentDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-current derivatives.",
        "label": "Non-current Derivatives [Member]",
        "terseLabel": "Non-current derivatives",
        "verboseLabel": "Non-current derivatives"
       }
      }
     },
     "localname": "NonCurrentDerivativesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NonCurrentFinanceLeaseReceivablesGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Current Finance Lease Receivables, Gross",
        "label": "Non-Current Finance Lease Receivables, Gross",
        "terseLabel": "Non-current finance lease receivables, gross"
       }
      }
     },
     "localname": "NonCurrentFinanceLeaseReceivablesGross",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NonCurrentFinancialAssetsNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Current Financial Assets, Number Of Shares",
        "label": "Non-Current Financial Assets, Number Of Shares",
        "terseLabel": "Non-current financial assets, number of shares (in shares)"
       }
      }
     },
     "localname": "NonCurrentFinancialAssetsNumberOfShares",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 6.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This account includes non-current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes non-current portion of liabilities related to non-controlling interests.",
        "label": "Non-current Liabilities Related To Business Combinations And To Non-controlling Interests",
        "terseLabel": "Non-current liabilities related to business combinations and to non-controlling interests"
       }
      }
     },
     "localname": "NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NonCurrentProvisionForEnvironmentRisks": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherLongtermProvisions",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environment risks.",
        "label": "Non-Current Provision For Environment Risks",
        "terseLabel": "Environmental risks"
       }
      }
     },
     "localname": "NonCurrentProvisionForEnvironmentRisks",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NonCurrentProvisionForProductLiabilityRisksLitigationAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherLongtermProvisions",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability risks litigation and other.",
        "label": "Non-Current Provision For Product Liability Risks Litigation And Other",
        "terseLabel": "Product liability risks, litigation and other",
        "verboseLabel": "Provisions for product liability risks, litigation and other"
       }
      }
     },
     "localname": "NonCurrentProvisionForProductLiabilityRisksLitigationAndOther",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofOtherProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NonCurrentProvisionsAndOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedbalancesheets": {
       "order": 5.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non-current provisions and non-current other liabilities that the entity does not separately disclose in the same statement or note.",
        "label": "Non-current Provisions And Other Noncurrent Liabilities",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "totalLabel": "Total",
        "verboseLabel": "Non-current provisions and other non-current liabilities"
       }
      }
     },
     "localname": "NonCurrentProvisionsAndOtherNoncurrentLiabilities",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedbalancesheets",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofNonCurrentProvisionsandOtherNoncurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NonCurrentRestructuringProvisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring provisions.",
        "label": "Non-current Restructuring Provision [Member]",
        "terseLabel": "Restructuring provisions"
       }
      }
     },
     "localname": "NonCurrentRestructuringProvisionMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NonOperatingForeignExchangeGainsLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-operating foreign exchange gains/(losses).",
        "label": "Non-Operating Foreign Exchange Gains (Losses)",
        "terseLabel": "Non-operating foreign exchange gains/(losses)"
       }
      }
     },
     "localname": "NonOperatingForeignExchangeGainsLosses",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialexpensesandincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_NonQualifiedDefinedBenefitPensionPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non qualified defined benefit pension plans.",
        "label": "Non Qualified Defined Benefit Pension Plans [member]",
        "terseLabel": "Non qualified defined benefit pension plans"
       }
      }
     },
     "localname": "NonQualifiedDefinedBenefitPensionPlansMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-current liabilities.",
        "label": "Non-current Liabilities [member]",
        "terseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentLiabilitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NotEligibleForHedgeAccountingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Not eligible for hedge accounting.",
        "label": "Not Eligible For Hedge Accounting [Member]",
        "terseLabel": "Not eligible for hedge accounting"
       }
      }
     },
     "localname": "NotEligibleForHedgeAccountingMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NotionalRetirementAge": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notional retirement age.",
        "label": "Notional Retirement Age",
        "terseLabel": "Notional retirement age"
       }
      }
     },
     "localname": "NotionalRetirementAge",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_November2013EMTNISINFR0011625433Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2013 EMTN ISIN FR0011625433.",
        "label": "November 2013 EMTNISINFR0011625433 [Member]",
        "terseLabel": "November 2013 EMTN ISIN FR0011625433"
       }
      }
     },
     "localname": "November2013EMTNISINFR0011625433Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_NumberOfAdministrativeProceedings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Administrative Proceedings",
        "label": "Number Of Administrative Proceedings",
        "terseLabel": "Number of administrative proceedings"
       }
      }
     },
     "localname": "NumberOfAdministrativeProceedings",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfAgreementsSigned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Agreements Signed",
        "label": "Number Of Agreements Signed",
        "terseLabel": "Number of agreements signed"
       }
      }
     },
     "localname": "NumberOfAgreementsSigned",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfBellweatherTrialsHeld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Bellweather Trials Held",
        "label": "Number Of Bellweather Trials Held",
        "terseLabel": "Number of bellweather trial held"
       }
      }
     },
     "localname": "NumberOfBellweatherTrialsHeld",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfBondIssuesRedeemed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Bond Issues Redeemed",
        "label": "Number Of Bond Issues Redeemed",
        "terseLabel": "Number of bond issues redeemed"
       }
      }
     },
     "localname": "NumberOfBondIssuesRedeemed",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfCancersAssociatedWithDismissedCases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Cancers Associated With Dismissed Cases",
        "label": "Number Of Cancers Associated With Dismissed Cases",
        "terseLabel": "Number of cancers associated with dismissed cases"
       }
      }
     },
     "localname": "NumberOfCancersAssociatedWithDismissedCases",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfCases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Cases",
        "label": "Number Of Cases",
        "terseLabel": "Number of cases"
       }
      }
     },
     "localname": "NumberOfCases",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfCasesDismissed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Cases Dismissed",
        "label": "Number Of Cases Dismissed",
        "terseLabel": "Number of cases dismissed"
       }
      }
     },
     "localname": "NumberOfCasesDismissed",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfCivilClaimsOnGoing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Civil Claims On-Going",
        "label": "Number Of Civil Claims On-Going",
        "terseLabel": "Number of civil claims on-going"
       }
      }
     },
     "localname": "NumberOfCivilClaimsOnGoing",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfCivilIndividualActions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Civil Individual Actions",
        "label": "Number Of Civil Individual Actions",
        "terseLabel": "Number of civil individual actions"
       }
      }
     },
     "localname": "NumberOfCivilIndividualActions",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfClaimsInvalid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Claims Invalid",
        "label": "Number Of Claims Invalid",
        "terseLabel": "Number of claims invalid"
       }
      }
     },
     "localname": "NumberOfClaimsInvalid",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfClassActionLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Class Action Lawsuits",
        "label": "Number Of Class Action Lawsuits",
        "terseLabel": "Number of class actions"
       }
      }
     },
     "localname": "NumberOfClassActionLawsuits",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfComplaintsFiled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Complaints Filed",
        "label": "Number Of Complaints Filed",
        "terseLabel": "Number of complaints filed"
       }
      }
     },
     "localname": "NumberOfComplaintsFiled",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfCounterExpertiseExperts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Counter-Expertise Experts",
        "label": "Number Of Counter-Expertise Experts",
        "terseLabel": "Number of experts"
       }
      }
     },
     "localname": "NumberOfCounterExpertiseExperts",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfCountriesIncludedInPensionPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of countries included in pension plans.",
        "label": "Number Of Countries Included In Pension Plans",
        "terseLabel": "Number of major countries included in pension obligations"
       }
      }
     },
     "localname": "NumberOfCountriesIncludedInPensionPlans",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "sny_NumberOfCreditFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Credit Facilities",
        "label": "Number Of Credit Facilities",
        "terseLabel": "Number of credit facilities"
       }
      }
     },
     "localname": "NumberOfCreditFacilities",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfCurrenciesDebtIsIssuedIn": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Currencies Debt Is Issued In",
        "label": "Number Of Currencies Debt Is Issued In",
        "terseLabel": "Number of currencies debt is issued in"
       }
      }
     },
     "localname": "NumberOfCurrenciesDebtIsIssuedIn",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfDaysAfterCompletionOfPostTrailBriefing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Days After Completion Of Post-Trail Briefing",
        "label": "Number Of Days After Completion Of Post-Trail Briefing",
        "terseLabel": "Number of days after the completion of the post-trial briefing (in days)"
       }
      }
     },
     "localname": "NumberOfDaysAfterCompletionOfPostTrailBriefing",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_NumberOfDecisionsIssuedByTheDistrictCourt": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Decisions Issued By The District Court",
        "label": "Number Of Decisions Issued By The District Court",
        "terseLabel": "Number of decisions issued by the District Court"
       }
      }
     },
     "localname": "NumberOfDecisionsIssuedByTheDistrictCourt",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfDefinedBenefitPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of defined benefit plans.",
        "label": "Number Of Defined Benefit Plans",
        "terseLabel": "Number of types of defined-benefit plan"
       }
      }
     },
     "localname": "NumberOfDefinedBenefitPlans",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfExecutiveCommitteeMembers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of executive committee members.",
        "label": "Number Of Executive Committee Members",
        "terseLabel": "Average number of members of executive committee"
       }
      }
     },
     "localname": "NumberOfExecutiveCommitteeMembers",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/RelatedpartytransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfFamiliesWhoFiledACivilClaim": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Families Who Filed A Civil Claim",
        "label": "Number Of Families Who Filed A Civil Claim",
        "terseLabel": "Number of families who filed a civil claim"
       }
      }
     },
     "localname": "NumberOfFamiliesWhoFiledACivilClaim",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfFirstInstanceRulings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of First Instance Rulings",
        "label": "Number Of First Instance Rulings",
        "terseLabel": "Number of first instance rulings"
       }
      }
     },
     "localname": "NumberOfFirstInstanceRulings",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Immunology Or Inflammation Targets Under Collaboration Agreement",
        "label": "Number Of Immunology Or Inflammation Targets Under Collaboration Agreement",
        "terseLabel": "Number of immunology or inflammation targets under collaboration agreement"
       }
      }
     },
     "localname": "NumberOfImmunologyOrInflammationTargetsUnderCollaborationAgreement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfLawsuitsRuledOnMerit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Lawsuits Ruled On Merit",
        "label": "Number Of Lawsuits Ruled On Merit",
        "terseLabel": "Number of lawsuits ruled on merits"
       }
      }
     },
     "localname": "NumberOfLawsuitsRuledOnMerit",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfLeaseAgreementsSigned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Lease Agreements Signed",
        "label": "Number Of Lease Agreements Signed",
        "terseLabel": "Number of lease agreements signed"
       }
      }
     },
     "localname": "NumberOfLeaseAgreementsSigned",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfLossConsortiumPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of loss consortium plaintiffs.",
        "label": "Number Of Loss Consortium Plaintiffs",
        "terseLabel": "Number of loss consortium plaintiffs"
       }
      }
     },
     "localname": "NumberOfLossConsortiumPlaintiffs",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Manufacturers With Marketing Authorization For Generic Version Of Drug",
        "label": "Number Of Manufacturers With Marketing Authorization For Generic Version Of Drug",
        "terseLabel": "Number of manufacturers with marketing authorization for generic version of drug"
       }
      }
     },
     "localname": "NumberOfManufacturersWithMarketingAuthorizationForGenericVersionOfDrug",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfMedicalAssessments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Medical Assessments",
        "label": "Number Of Medical Assessments",
        "terseLabel": "Number of medical assessments"
       }
      }
     },
     "localname": "NumberOfMedicalAssessments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Novel Small Molecule Candidates To Be Developed Under Collaboration Agreement",
        "label": "Number Of Novel Small Molecule Candidates To Be Developed Under Collaboration Agreement",
        "terseLabel": "Number of novel small molecule candidates developed"
       }
      }
     },
     "localname": "NumberOfNovelSmallMoleculeCandidatesToBeDevelopedUnderCollaborationAgreement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfOncologyTargetsUnderCollaborationAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Oncology Targets Under Collaboration Agreement",
        "label": "Number Of Oncology Targets Under Collaboration Agreement",
        "terseLabel": "Number of oncology targets under collaboration agreement"
       }
      }
     },
     "localname": "NumberOfOncologyTargetsUnderCollaborationAgreement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfOngoingLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Ongoing Lawsuits",
        "label": "Number Of Ongoing Lawsuits",
        "terseLabel": "Number of ongoing lawsuits"
       }
      }
     },
     "localname": "NumberOfOngoingLawsuits",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfOngoingTrials": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Ongoing Trials",
        "label": "Number Of Ongoing Trials",
        "terseLabel": "Number of ongoing trials"
       }
      }
     },
     "localname": "NumberOfOngoingTrials",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfOperatingSegments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments.",
        "label": "Number Of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails",
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesSegmentInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfOtherManufacturersInvolvedInProceedings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Other Manufacturers Involved In Proceedings",
        "label": "Number Of Other Manufacturers Involved In Proceedings",
        "terseLabel": "Number of other manufacturers involved in proceedings"
       }
      }
     },
     "localname": "NumberOfOtherManufacturersInvolvedInProceedings",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfPatentActionsInitiallyFiled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of patent actions initially filed .",
        "label": "Number Of Patent Actions Initially Filed",
        "terseLabel": "Number of patent actions initially filed"
       }
      }
     },
     "localname": "NumberOfPatentActionsInitiallyFiled",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfPatentsAllegedlyInfringed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of patents allegedly infringed.",
        "label": "Number Of Patents Allegedly Infringed",
        "terseLabel": "Number of patents allegedly infringed"
       }
      }
     },
     "localname": "NumberOfPatentsAllegedlyInfringed",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfPatentsCoveringProduct": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Patents Covering Product",
        "label": "Number Of Patents Covering Product",
        "terseLabel": "Number of patents covering product"
       }
      }
     },
     "localname": "NumberOfPatentsCoveringProduct",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfPayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Payments",
        "label": "Number Of Payments",
        "terseLabel": "Number of payments"
       }
      }
     },
     "localname": "NumberOfPayments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfPeopleExposed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of People Exposed",
        "label": "Number Of People Exposed",
        "terseLabel": "Number of people exposed"
       }
      }
     },
     "localname": "NumberOfPeopleExposed",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfPeopleExposedWhoFiledARequestForIndemnification": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of People Exposed Who Filed A Request For Indemnification",
        "label": "Number Of People Exposed Who Filed A Request For Indemnification",
        "terseLabel": "Number of people exposed who filed a request for indemnification"
       }
      }
     },
     "localname": "NumberOfPeopleExposedWhoFiledARequestForIndemnification",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Plaintiffs.",
        "label": "Number Of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "NumberOfPlaintiffs",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfPreActionProtocolCases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Pre-Action Protocol Cases",
        "label": "Number Of Pre-Action Protocol Cases",
        "terseLabel": "Number of pre-action protocol cases"
       }
      }
     },
     "localname": "NumberOfPreActionProtocolCases",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfProductsJointlyDeveloped": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of products jointly developed.",
        "label": "Number Of Products Jointly Developed",
        "terseLabel": "Number of leading products jointly developed"
       }
      }
     },
     "localname": "NumberOfProductsJointlyDeveloped",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of restricted shares issued in regards of capital increase.",
        "label": "Number Of Restricted Shares Issued In Regards Of Capital Increase",
        "terseLabel": "Capital increase by issuance of restricted shares (in shares)"
       }
      }
     },
     "localname": "NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_NumberOfRestrictedSharesNotYetFullyVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of restricted shares not yet fully vested.",
        "label": "Number Of Restricted Shares Not Yet Fully Vested",
        "terseLabel": "Number of shares not yet fully vested (in shares)"
       }
      }
     },
     "localname": "NumberOfRestrictedSharesNotYetFullyVested",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Share Issues In Regards To Capital increase Reserved For Employees",
        "label": "Number Of Share Issues In Regards To Capital increase Reserved For Employees",
        "terseLabel": "Capital increase reserved for employees (in shares)"
       }
      }
     },
     "localname": "NumberOfShareIssuesInRegardsToCapitalincreaseReservedForEmployees",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_NumberOfShareOptionsCancelledInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Share Options Cancelled In Share-Based Payment Arrangement",
        "label": "Number Of Share Options Cancelled In Share-Based Payment Arrangement",
        "negatedLabel": "Number of options, options cancelled (in shares)"
       }
      }
     },
     "localname": "NumberOfShareOptionsCancelledInShareBasedPaymentArrangement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "sny_NumberOfShareOutstandingInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share outstanding in share based payment arrangement.",
        "label": "Number Of Share Outstanding In Share Based Payment Arrangement",
        "periodEndLabel": "Number of options, ending balance (in shares)",
        "periodStartLabel": "Number of options, beginning balance (in shares)"
       }
      }
     },
     "localname": "NumberOfShareOutstandingInShareBasedPaymentArrangement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "sny_NumberOfShareSubscribed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares subscribed.",
        "label": "Number Of Share Subscribed",
        "terseLabel": "Number of shares subscribed (in shares)"
       }
      }
     },
     "localname": "NumberOfShareSubscribed",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_NumberOfSharesHeld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares held.",
        "label": "Number Of Shares Held",
        "terseLabel": "Number of shares (in shares)"
       }
      }
     },
     "localname": "NumberOfSharesHeld",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofTreasurySharesHeldDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_NumberOfSharesIssuedByExerciceOfEachOption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Shares Issued By Exercice Of Each Option",
        "label": "Number Of Shares Issued By Exercice Of Each Option",
        "terseLabel": "Number of shares issued by exercice of each option (in shares)"
       }
      }
     },
     "localname": "NumberOfSharesIssuedByExerciceOfEachOption",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in regards of capital increase by exercise of stock subscription options.",
        "label": "Number Of Shares Issued In Regards Of Capital Increase By Exercise Of Stock Subscription Options",
        "terseLabel": "Capital\u00a0increase\u00a0by\u00a0exercise\u00a0of stock subscription options (in shares)"
       }
      }
     },
     "localname": "NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_NumberOfSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares repurchased.",
        "label": "Number Of Shares Repurchased",
        "terseLabel": "Number of shares (in shares)"
       }
      }
     },
     "localname": "NumberOfSharesRepurchased",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_NumberOfSustainableDevelopmentPerformanceIndicators": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Sustainable Development Performance Indicators",
        "label": "Number Of Sustainable Development Performance Indicators",
        "terseLabel": "Number of sustainable development performance indicators"
       }
      }
     },
     "localname": "NumberOfSustainableDevelopmentPerformanceIndicators",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfTargetsThatEncompassAllDiseasesAreas": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Targets That Encompass All Diseases Areas",
        "label": "Number Of Targets That Encompass All Diseases Areas",
        "terseLabel": "Targets that encompass all diseases areas"
       }
      }
     },
     "localname": "NumberOfTargetsThatEncompassAllDiseasesAreas",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfTradingDaysPrecedingPlanApproval": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Trading Days Preceding Plan Approval",
        "label": "Number Of Trading Days Preceding Plan Approval",
        "terseLabel": "Number of trading days preceding plan approval"
       }
      }
     },
     "localname": "NumberOfTradingDaysPrecedingPlanApproval",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_NumberOfTranches": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Tranches",
        "label": "Number Of Tranches",
        "terseLabel": "Number of tranches"
       }
      }
     },
     "localname": "NumberOfTranches",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfVaccineDosesToBeSupplied": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Vaccine Doses To Be Supplied",
        "label": "Number Of Vaccine Doses To Be Supplied",
        "terseLabel": "Number of vaccine doses to be supplied"
       }
      }
     },
     "localname": "NumberOfVaccineDosesToBeSupplied",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_NumberOfYearsServicePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Years, Service Period",
        "label": "Number Of Years, Service Period",
        "terseLabel": "Service period"
       }
      }
     },
     "localname": "NumberOfYearsServicePeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Off Balance Sheet Commitments Received In Respect Of Disposals Proceeds Receivable And Contingent Consideration On Divestments",
        "label": "Off Balance Sheet Commitments Received In Respect Of Disposals Proceeds Receivable And Contingent Consideration On Divestments",
        "terseLabel": "Commitments received in respect of disposals proceeds receivable and contingent consideration on divestments"
       }
      }
     },
     "localname": "OffBalanceSheetCommitmentsReceivedInRespectOfDisposalsProceedsReceivableAndContingentConsiderationOnDivestments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_OfficeSpaceCambridgeMassachusettsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office Space, Cambridge, Massachusetts",
        "label": "Office Space, Cambridge, Massachusetts [Member]",
        "terseLabel": "Office space, Cambridge, Massachusetts"
       }
      }
     },
     "localname": "OfficeSpaceCambridgeMassachusettsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofPropertyPlantandEquipmentLeasedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OncologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oncology",
        "label": "Oncology [Member]",
        "terseLabel": "Oncology"
       }
      }
     },
     "localname": "OncologyMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OnduoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Onduo",
        "label": "Onduo [Member]",
        "terseLabel": "Onduo"
       }
      }
     },
     "localname": "OnduoMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OneBillionBondsMaturingJanuary2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Billion Bonds Maturing January 2022",
        "label": "One Billion Bonds Maturing January 2022 [Member]",
        "terseLabel": "One Billion Bonds Maturing January 2022"
       }
      }
     },
     "localname": "OneBillionBondsMaturingJanuary2022Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OneBillionFiveHundredMillionBondsIssuedInApril2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Billion Five Hundred Million Bonds, Issued In April 2022",
        "label": "One Billion Five Hundred Million Bonds, Issued In April 2022 [Member]",
        "terseLabel": "One Billion Five Hundred Million Bonds, Issued In April 2022"
       }
      }
     },
     "localname": "OneBillionFiveHundredMillionBondsIssuedInApril2022Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareArgentinaSAUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare Argentina S.A.U.",
        "label": "Opella Healthcare Argentina S.A.U. [Member]",
        "terseLabel": "Opella Healthcare Argentina S.A.U."
       }
      }
     },
     "localname": "OpellaHealthcareArgentinaSAUMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareCzechSroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare Czech s.r.o",
        "label": "Opella Healthcare Czech s.r.o [Member]",
        "terseLabel": "Opella Healthcare Czech s.r.o"
       }
      }
     },
     "localname": "OpellaHealthcareCzechSroMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareEgyptLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare Egypt LLC",
        "label": "Opella Healthcare Egypt LLC [Member]",
        "terseLabel": "Opella Healthcare Egypt LLC"
       }
      }
     },
     "localname": "OpellaHealthcareEgyptLLCMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareFranceSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare France SAS",
        "label": "Opella Healthcare France SAS [Member]",
        "terseLabel": "Opella Healthcare France SAS"
       }
      }
     },
     "localname": "OpellaHealthcareFranceSASMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareGroupSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare Group SAS",
        "label": "Opella Healthcare Group SAS [Member]",
        "terseLabel": "Opella Healthcare Group SAS"
       }
      }
     },
     "localname": "OpellaHealthcareGroupSASMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareHungaryCommercialKFTMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare Hungary Commercial K.F.T",
        "label": "Opella Healthcare Hungary Commercial K.F.T [Member]",
        "terseLabel": "Opella Healthcare Hungary Commercial K.F.T"
       }
      }
     },
     "localname": "OpellaHealthcareHungaryCommercialKFTMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareInternationalSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare International SAS",
        "label": "Opella Healthcare International SAS [Member]",
        "terseLabel": "Opella Healthcare International SAS"
       }
      }
     },
     "localname": "OpellaHealthcareInternationalSASMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareItalySRLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare Italy S.R.L.",
        "label": "Opella Healthcare Italy S.R.L. [Member]",
        "terseLabel": "Opella Healthcare Italy S.R.L."
       }
      }
     },
     "localname": "OpellaHealthcareItalySRLMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareKoreaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella healthcare Korea Inc.",
        "label": "Opella healthcare Korea Inc. [Member]",
        "terseLabel": "Opella healthcare Korea Inc."
       }
      }
     },
     "localname": "OpellaHealthcareKoreaIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare LLC",
        "label": "Opella Healthcare LLC [Member]",
        "terseLabel": "Opella Healthcare LLC"
       }
      }
     },
     "localname": "OpellaHealthcareLLCMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcarePhilippinesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare Philippines Inc.",
        "label": "Opella Healthcare Philippines Inc. [Member]",
        "terseLabel": "Opella Healthcare Philippines Inc."
       }
      }
     },
     "localname": "OpellaHealthcarePhilippinesIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcarePolandSpZOOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare Poland sp.Z.O.O",
        "label": "Opella Healthcare Poland sp.Z.O.O [Member]",
        "terseLabel": "Opella Healthcare Poland sp.Z.O.O"
       }
      }
     },
     "localname": "OpellaHealthcarePolandSpZOOMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareRomaniaSRLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare Romania S.R.L.",
        "label": "Opella Healthcare Romania S.R.L. [Member]",
        "terseLabel": "Opella Healthcare Romania S.R.L."
       }
      }
     },
     "localname": "OpellaHealthcareRomaniaSRLMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareSpainSLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare Spain, S.L.",
        "label": "Opella Healthcare Spain, S.L. [Member]",
        "terseLabel": "Opella Healthcare Spain, S.L."
       }
      }
     },
     "localname": "OpellaHealthcareSpainSLMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OpellaHealthcareUKLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opella Healthcare UK Limited",
        "label": "Opella Healthcare UK Limited [Member]",
        "terseLabel": "Opella Healthcare UK Limited"
       }
      }
     },
     "localname": "OpellaHealthcareUKLimitedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OperatingSegmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Segments [Abstract]",
        "label": "Operating Segments [Abstract]",
        "terseLabel": "Operating Segments [Abstract]"
       }
      }
     },
     "localname": "OperatingSegmentsAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_OptionVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option vesting period.",
        "label": "Option Vesting Period",
        "terseLabel": "Option vesting period (in years)"
       }
      }
     },
     "localname": "OptionVestingPeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_OrdinarySharesNASDAQGlobalSelectMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Shares, NASDAQ Global Select Market [Member]",
        "label": "Ordinary Shares, NASDAQ Global Select Market [Member]",
        "terseLabel": "Ordinary shares, par value \u20ac2\u00a0per share"
       }
      }
     },
     "localname": "OrdinarySharesNASDAQGlobalSelectMarketMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Coverpage"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OrigimmBiotechnologyGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Origimm Biotechnology GmbH",
        "label": "Origimm Biotechnology GmbH [Member]",
        "terseLabel": "Origimm Biotechnology GmbH"
       }
      }
     },
     "localname": "OrigimmBiotechnologyGmbHMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherAssetsAndLiabilitiesAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other assets and liabilities as of acquisition date.",
        "label": "Other Assets And Liabilities As Of Acquisition Date",
        "terseLabel": "Other current and non-current assets and liabilities"
       }
      }
     },
     "localname": "OtherAssetsAndLiabilitiesAsOfAcquisitionDate",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_OtherBankBorrowings": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other bank borrowings.",
        "label": "Other Bank Borrowings",
        "terseLabel": "Other bank borrowings"
       }
      }
     },
     "localname": "OtherBankBorrowings",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_OtherContingentConsiderationArisingFromBusinessCombinationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other contingent consideration arising from business combinations.",
        "label": "Other Contingent Consideration Arising From Business Combinations [Member]",
        "terseLabel": "Other contingent consideration arising from business combinations and acquisitions"
       }
      }
     },
     "localname": "OtherContingentConsiderationArisingFromBusinessCombinationsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherCountriesInSegmentResultsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other countries in segement results.",
        "label": "Other Countries In Segment Results [Member]",
        "terseLabel": "Other countries"
       }
      }
     },
     "localname": "OtherCountriesInSegmentResultsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other countries.",
        "label": "Other Countries [member]",
        "terseLabel": "Other",
        "verboseLabel": "Other countries"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesEstimatedAmountsofEmployersContributionstoPlanAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesExpectedTimingofBenefitPaymentsunderPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTimingofFutureTerminationBenefitPaymentsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherCurrenciesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Currencies [Member]",
        "label": "Other Currencies [Member]",
        "terseLabel": "Other currencies"
       }
      }
     },
     "localname": "OtherCurrenciesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other assets and liabilities as of acquisition date.",
        "label": "Other Current Assets And Current Liabilities As Of Acquisition Date",
        "terseLabel": "Other current and non-current assets and liabilities"
       }
      }
     },
     "localname": "OtherCurrentAssetsAndCurrentLiabilitiesAsOfAcquisitionDate",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022SummaryofProvisionalPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_OtherDeductionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other deductions.",
        "label": "Other Deductions [Member]",
        "terseLabel": "Other deductions"
       }
      }
     },
     "localname": "OtherDeductionsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherGainsLossesAndLitigation": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/Consolidatedincomestatements": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      },
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": 9.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The line item other gains and losses, and litigation includes the impact of material transactions of an unusual nature or amount. [note B.20.2.]",
        "label": "Other Gains, (Losses) And Litigation",
        "negatedTerseLabel": "Other gains, (losses) and litigation",
        "terseLabel": "Other gains, (losses) and litigation",
        "verboseLabel": "Other gains and losses, and litigation"
       }
      }
     },
     "localname": "OtherGainsLossesAndLitigation",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedincomestatements",
      "http://www.sanofi.com/role/OthergainsandlossesandlitigationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_OtherGuaranteesGivenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Guarantees Given",
        "label": "Other Guarantees Given [Member]",
        "terseLabel": "Other guarantees given"
       }
      }
     },
     "localname": "OtherGuaranteesGivenMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofAmountofGuaranteesGivenandReceivedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherIntangibleAssetsExcludingSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Intangible Assets Excluding Software",
        "label": "Other Intangible Assets Excluding Software [Member]",
        "terseLabel": "Other intangible assets excluding software"
       }
      }
     },
     "localname": "OtherIntangibleAssetsExcludingSoftwareMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other.",
        "label": "Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherMovements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other movements.",
        "label": "Other Movements",
        "negatedTerseLabel": "Other movements"
       }
      }
     },
     "localname": "OtherMovements",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_OtherNonCoreAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Non-Core Assets",
        "label": "Other Non-Core Assets [Member]",
        "terseLabel": "Other non-core assets"
       }
      }
     },
     "localname": "OtherNonCoreAssetsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherOperatingExpensesRelatedToBusinessCombinations": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "localname": "OtherOperatingExpensesRelatedToBusinessCombinations",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "monetaryItemType"
    },
    "sny_OtherOperatingExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Operating Expenses [Table Text Block]",
        "label": "Other Operating Expenses [Table Text Block]",
        "terseLabel": "Schedule Other Operating Expenses"
       }
      }
     },
     "localname": "OtherOperatingExpensesTableTextBlock",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sny_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Operating Income (Expense)",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Other operating income (expense)"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/OtheroperatingincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]",
        "label": "Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]",
        "terseLabel": "Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]"
       }
      }
     },
     "localname": "OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_OtherRestructuringCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_ExpenseOfRestructuringActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other restructuring costs.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/RestructuringcostsandsimilaritemsSummaryofRestructuringCostsandSimilarItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_OthersCounterpartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Others Counterparty [Member]",
        "label": "Others Counterparty [Member]",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OthersCounterpartyMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OutsideUnitedStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outside United States.",
        "label": "Outside United States [member]",
        "terseLabel": "Outside the United States"
       }
      }
     },
     "localname": "OutsideUnitedStatesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_OverdueReceivablesGrossValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Overdue receivables gross value.",
        "label": "Overdue Receivables Gross Value",
        "terseLabel": "Gross value of overdue receivables",
        "verboseLabel": "Overdue receivables gross value"
       }
      }
     },
     "localname": "OverdueReceivablesGrossValue",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/AccountsreceivableAdditionalInformationDetails",
      "http://www.sanofi.com/role/AccountsreceivableSummaryofGrossValueofOverdueReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_OwnershipInterestInSubsidiaryMinimumHoldingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership Interest In Subsidiary, Minimum Holding Period",
        "label": "Ownership Interest In Subsidiary, Minimum Holding Period",
        "terseLabel": "Ownership interest in subsidiary, minimum holding period"
       }
      }
     },
     "localname": "OwnershipInterestInSubsidiaryMinimumHoldingPeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_PainCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pain Care [Member]",
        "label": "Pain Care [Member]",
        "terseLabel": "Pain Care"
       }
      }
     },
     "localname": "PainCareMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ParticipatingSharesCarryingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Participating shares carrying amount.",
        "label": "Participating Shares Carrying Amount",
        "terseLabel": "Participating shares carrying amount"
       }
      }
     },
     "localname": "ParticipatingSharesCarryingAmount",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ParticipatingSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Participating shares.",
        "label": "Participating Shares [Member]",
        "terseLabel": "1983 to 1987 participating shares issued"
       }
      }
     },
     "localname": "ParticipatingSharesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ParticipatingSharesNumberOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Participating shares number outstanding.",
        "label": "Participating Shares Number Outstanding",
        "terseLabel": "Number of participating shares outstanding (in shares)"
       }
      }
     },
     "localname": "ParticipatingSharesNumberOutstanding",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_PatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents.",
        "label": "Patents [Member]",
        "terseLabel": "Patents"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PaymentOfDamagesClaimedByCounterparty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Of Damages Claimed By Counterparty",
        "label": "Payment Of Damages Claimed By Counterparty",
        "terseLabel": "Payment of damages claimed by the French CNAM (French Social Security)"
       }
      }
     },
     "localname": "PaymentOfDamagesClaimedByCounterparty",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of damages sought by australian department of health related to the apotex preliminary injunction up to.",
        "label": "Payment Of Damages Sought By Australian Department Of Health Related To The Apotex Preliminary Injunction Up To",
        "terseLabel": "Payment of damages sought by Australian Department of Health related to the Apotex preliminary injunction, up to"
       }
      }
     },
     "localname": "PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_PaymentRelatedToAttainmentOfGoal": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Related To Attainment Of Goal",
        "label": "Payment Related To Attainment Of Goal",
        "terseLabel": "Payment related to attainment of goal"
       }
      }
     },
     "localname": "PaymentRelatedToAttainmentOfGoal",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_PaymentToSaleOfBusinessPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment to sale of business period.",
        "label": "Payment To Sale Of Business Period",
        "terseLabel": "Payment to sale of business period"
       }
      }
     },
     "localname": "PaymentToSaleOfBusinessPeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_PenaltyFeeIncurred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Penalty Fee Incurred",
        "label": "Penalty Fee Incurred",
        "terseLabel": "Penalty fee incurred by Sanofi"
       }
      }
     },
     "localname": "PenaltyFeeIncurred",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_PensionObligationPercentageToDefinedBenefitLiability": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension obligation percentage to defined benefit liability.",
        "label": "Pension Obligation, Percentage To Defined Benefit Liability",
        "terseLabel": "Pension obligation, percentage to defined benefit liability"
       }
      }
     },
     "localname": "PensionObligationPercentageToDefinedBenefitLiability",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PensionObligationPercentageToPlanAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension obligation percentage to plan assets.",
        "label": "Pension Obligation, Percentage To Plan Assets",
        "terseLabel": "Pension obligations, percentage to plan assets"
       }
      }
     },
     "localname": "PensionObligationPercentageToPlanAssets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PensionsAndOtherPostEmploymentBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pensions and other post-employment benefits.",
        "label": "Pensions And Other Post-Employment Benefits [Member]",
        "terseLabel": "Pensions and other post-employment benefits"
       }
      }
     },
     "localname": "PensionsAndOtherPostEmploymentBenefitsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofPresentValueofPensionandOtherPostEmploymentBenefitsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PercentageContributedToFairValueOfPlanAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage contributed to fair value of plan assets.",
        "label": "Percentage Contributed To Fair Value Of Plan Assets",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PercentageContributedToFairValueOfPlanAssets",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageContributedToFairValueOfPlanAssetsOtherSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails": {
       "order": 2.0,
       "parentTag": "sny_PercentageContributedToFairValueOfPlanAssets",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Contributed To Fair Value Of Plan Assets, Other Securities",
        "label": "Percentage Contributed To Fair Value Of Plan Assets, Other Securities",
        "terseLabel": "Other securities"
       }
      }
     },
     "localname": "PercentageContributedToFairValueOfPlanAssetsOtherSecurities",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails": {
       "order": 1.0,
       "parentTag": "sny_PercentageContributedToFairValueOfPlanAssets",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Contributed To Fair Value Of Plan Assets, Securities Quoted In An Active Market",
        "label": "Percentage Contributed To Fair Value Of Plan Assets, Securities Quoted In An Active Market",
        "terseLabel": "Securities quoted in an active market"
       }
      }
     },
     "localname": "PercentageContributedToFairValueOfPlanAssetsSecuritiesQuotedInAnActiveMarket",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageIncreaseInFairValueLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage increase in fair value liabilities.",
        "label": "Percentage Increase In Fair Value Liabilities",
        "terseLabel": "Increase in fair value of liability"
       }
      }
     },
     "localname": "PercentageIncreaseInFairValueLiabilities",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfAuditorRemunerationForStatutoryAudit": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails": {
       "order": 1.0,
       "parentTag": "sny_PercentageOfAuditorsRemuneration",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of auditor remuneration for statutory audit.",
        "label": "Percentage Of Auditor Remuneration For Statutory Audit",
        "terseLabel": "Statutory audit of separate and consolidated financial statements, percentage"
       }
      }
     },
     "localname": "PercentageOfAuditorRemunerationForStatutoryAudit",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfAuditorsRemuneration": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor's remuneration, Total Percentage.",
        "label": "Percentage Of Auditors Remuneration",
        "totalLabel": "Total, percentage"
       }
      }
     },
     "localname": "PercentageOfAuditorsRemuneration",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails": {
       "order": 2.0,
       "parentTag": "sny_PercentageOfAuditorsRemuneration",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Services other than audit of financial statements, percentage.",
        "label": "Percentage Of Auditors Remuneration For Services Other Than Audit Of Financial Statements",
        "terseLabel": "Services other than statutory audit, percentage"
       }
      }
     },
     "localname": "PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfAverageOfQuotedMarketPricesOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of average of quoted market prices of shares.",
        "label": "Percentage Of Average Of Quoted Market Prices Of Shares",
        "verboseLabel": "Subscription price (as a percent)"
       }
      }
     },
     "localname": "PercentageOfAverageOfQuotedMarketPricesOfShares",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfCumulativeDevelopmentCostsReimbursed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of cumulative development costs reimbursed.",
        "label": "Percentage Of Cumulative Development Costs Reimbursed",
        "terseLabel": "Percentage of cumulative development costs reimbursed"
       }
      }
     },
     "localname": "PercentageOfCumulativeDevelopmentCostsReimbursed",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of discount rate above rate actually used would not cause impairment loss.",
        "label": "Percentage Of Discount Rate Above Rate Actually Used Would Not Cause Impairment Loss",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfFutureDevelopmentExpenseFundedByCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of future development expense funded by company.",
        "label": "Percentage Of Future Development Expense Funded By Company",
        "verboseLabel": "Percentage of future development expense funded by company"
       }
      }
     },
     "localname": "PercentageOfFutureDevelopmentExpenseFundedByCompany",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfFutureDevelopmentExpenseFundedByOtherParty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of future development expense funded by other party.",
        "label": "Percentage Of Future Development Expense Funded By Other Party",
        "verboseLabel": "Percentage of future development expense funded by other party"
       }
      }
     },
     "localname": "PercentageOfFutureDevelopmentExpenseFundedByOtherParty",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfLossesArisingFromCommercialOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Losses Arising From Commercial Operations",
        "label": "Percentage Of Losses Arising From Commercial Operations",
        "terseLabel": "Percentage of losses arising from commercial operations"
       }
      }
     },
     "localname": "PercentageOfLossesArisingFromCommercialOperations",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of operating margin rate below rates actually used would not cause impairment loss.",
        "label": "Percentage Of Operating Margin Rate Below Rates Actually Used Would Not Cause Impairment Loss",
        "terseLabel": "Operating margin rate"
       }
      }
     },
     "localname": "PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of perpetuity growth rate below the rates actually used would not cause impairment loss.",
        "label": "Percentage Of Perpetuity Growth Rate Below The Rates Actually Used Would Not Cause Impairment Loss",
        "terseLabel": "Perpetual growth rate"
       }
      }
     },
     "localname": "PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfProfitShareOnCounterpartiesProfit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of profit share on counter parties profit.",
        "label": "Percentage Of Profit Share On Counterparties Profit",
        "terseLabel": "Maximum additional profit-share, in percentage of Regeneron's quarterly profit (in percent)"
       }
      }
     },
     "localname": "PercentageOfProfitShareOnCounterpartiesProfit",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfProfitsAndLossesArisingFromCommercialOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of profits and losses arising from commercial operations.",
        "label": "Percentage Of Profits And Losses Arising From Commercial Operations",
        "terseLabel": "Percentage of profits and losses arising from commercial operations"
       }
      }
     },
     "localname": "PercentageOfProfitsAndLossesArisingFromCommercialOperations",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfProfitsArisingFromCommercialOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Profits Arising From Commercial Operations",
        "label": "Percentage Of Profits Arising From Commercial Operations",
        "terseLabel": "Percentage of profits arising from commercial operations"
       }
      }
     },
     "localname": "PercentageOfProfitsArisingFromCommercialOperations",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfSecondPartOfDevelopmentCostsFunded": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Second Part Of Development Costs Funded",
        "label": "Percentage Of Second Part Of Development Costs Funded",
        "terseLabel": "Phase III costs, responsibility percentage"
       }
      }
     },
     "localname": "PercentageOfSecondPartOfDevelopmentCostsFunded",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of second part of development costs funded by other party.",
        "label": "Percentage Of Second Part Of Development Costs Funded By Other Party",
        "terseLabel": "Phase III costs, responsibility percentage for Regeneron"
       }
      }
     },
     "localname": "PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfShareCapitalForThePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of share capital for the period.",
        "label": "Percentage Of Share Capital For The Period",
        "terseLabel": "%\u00a0of\u00a0share\u00a0capital for the period"
       }
      }
     },
     "localname": "PercentageOfShareCapitalForThePeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofTreasurySharesHeldDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PercentageOfVotingEquityInterestsDivested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Voting Equity Interests Divested",
        "label": "Percentage Of Voting Equity Interests Divested",
        "terseLabel": "Percentage of voting equity interests divested"
       }
      }
     },
     "localname": "PercentageOfVotingEquityInterestsDivested",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PerformanceObjectiveMinimumNumberOfPatients": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Objective, Minimum Number Of Patients",
        "label": "Performance Objective, Minimum Number Of Patients",
        "terseLabel": "Performance objective, minimum number of patients"
       }
      }
     },
     "localname": "PerformanceObjectiveMinimumNumberOfPatients",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_PerformanceObjectiveNumberOfCountries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Objective, Number Of Countries",
        "label": "Performance Objective, Number Of Countries",
        "terseLabel": "Number of countries"
       }
      }
     },
     "localname": "PerformanceObjectiveNumberOfCountries",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_PerformanceSharePlanOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Share Plan One.",
        "label": "Performance Share Plan One [member]",
        "terseLabel": "Performance share plan one"
       }
      }
     },
     "localname": "PerformanceSharePlanOneMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PerformanceSharePlanTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance share plan two.",
        "label": "Performance Share Plan Two [member]",
        "terseLabel": "Performance share plan two"
       }
      }
     },
     "localname": "PerformanceSharePlanTwoMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period Before Launch Date During Which Commercial Expenses Of Antibodies Co-Developed Under License Agreement Are Shared",
        "label": "Period Before Launch Date During Which Commercial Expenses Of Antibodies Co-Developed Under License Agreement Are Shared",
        "terseLabel": "Period before scheduled launch date"
       }
      }
     },
     "localname": "PeriodBeforeLaunchDateDuringWhichCommercialExpensesOfAntibodiesCoDevelopedUnderLicenseAgreementAreShared",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_PeriodOfShareRepurchaseProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of share repurchase program.",
        "label": "Period Of Share Repurchase Program",
        "terseLabel": "Period of share repurchase program"
       }
      }
     },
     "localname": "PeriodOfShareRepurchaseProgram",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_PharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceuticals.",
        "label": "Pharmaceuticals [Member]",
        "terseLabel": "Pharmaceuticals"
       }
      }
     },
     "localname": "PharmaceuticalsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PharmaceuticalsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceuticals segment.",
        "label": "Pharmaceuticals Segment [member]",
        "terseLabel": "Pharmaceuticals"
       }
      }
     },
     "localname": "PharmaceuticalsSegmentMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PlaintiffMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plaintiff.",
        "label": "Plaintiff [Member]",
        "terseLabel": "Plaintiff"
       }
      }
     },
     "localname": "PlaintiffMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PlanAssetsEffectOfAssetCeiling": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_LiabilityAssetOfDefinedBenefitPlans",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan Assets, Effect Of Asset Ceiling",
        "label": "Plan Assets, Effect Of Asset Ceiling",
        "terseLabel": "Effect of asset ceiling"
       }
      }
     },
     "localname": "PlanAssetsEffectOfAssetCeiling",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesNetLiabilityinRespectofPensionPlansandOtherPostemploymentBenefitsbyGeographicalRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_PlavixAttorneyGeneralActionInHawaiiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plavix Attorney General Action In Hawaii",
        "label": "Plavix Attorney General Action In Hawaii [Member]",
        "terseLabel": "Plavix Attorney General Action in Hawaii"
       }
      }
     },
     "localname": "PlavixAttorneyGeneralActionInHawaiiMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PlavixLitigationCommonwealthInAustraliaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plavix litigation (commonwealth) In Australia.",
        "label": "Plavix Litigation (Commonwealth) In Australia [Member]",
        "terseLabel": "Plavix litigation (Commonwealth) in Australia"
       }
      }
     },
     "localname": "PlavixLitigationCommonwealthInAustraliaMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PlavixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plavix [Member]",
        "label": "Plavix [Member]",
        "terseLabel": "Plavix"
       }
      }
     },
     "localname": "PlavixMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PlavixRelatedLitigationInFranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plavix Related Litigation In France",
        "label": "Plavix Related Litigation In France [Member]",
        "terseLabel": "Plavix related litigation in France"
       }
      }
     },
     "localname": "PlavixRelatedLitigationInFranceMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PlusHundredBasisPointsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plus hundred basis points.",
        "label": "Plus Hundred Basis Points [Member]",
        "terseLabel": "+100\u00a0bp"
       }
      }
     },
     "localname": "PlusHundredBasisPointsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PlusTwentyFiveBasisPointsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plus twenty five basis points.",
        "label": "Plus Twenty Five Basis Points [Member]",
        "terseLabel": "+25\u00a0bp"
       }
      }
     },
     "localname": "PlusTwentyFiveBasisPointsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateFluctuationsofDebtNetofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PolioPertussisHibVaccinesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Polio Pertussis Hib Vaccines.",
        "label": "Polio Pertussis Hib Vaccines [Member]",
        "terseLabel": "Polio/Pertussis/ Hib Vaccines"
       }
      }
     },
     "localname": "PolioPertussisHibVaccinesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PossibleIncreaseInMortalityTableInYears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Possible increase in mortality table in years.",
        "label": "Possible Increase In Mortality Table In Years",
        "terseLabel": "Possible increase in mortality table (in years)"
       }
      }
     },
     "localname": "PossibleIncreaseInMortalityTableInYears",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofSensitivityforPensionsandOtherPostEmploymentBenefitstoChangesinKeyActuarialAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_PotentialPaymentsRelatedToPercentageOfSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potentiel payments related to percentage of sales.",
        "label": "Potential Payments Related To Percentage Of Sales",
        "terseLabel": "Potentiel payments related to percentage of sales of alemtuzumab"
       }
      }
     },
     "localname": "PotentialPaymentsRelatedToPercentageOfSales",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Praluent (Alirocumab)-Related Amgen Patent Litigation In The US",
        "label": "Praluent (Alirocumab)-Related Amgen Patent Litigation In The US [Member]",
        "terseLabel": "Praluent (Alirocumab)-related amgen patent litigation in the US"
       }
      }
     },
     "localname": "PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PraluentAlirocumabRelatedEpoPatentOppositionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Praluent (alirocumab)-related EPO patent oppositions.",
        "label": "Praluent Alirocumab Related Epo Patent Oppositions [member]",
        "terseLabel": "Praluent (Alirocumab)-related EPO patent oppositions"
       }
      }
     },
     "localname": "PraluentAlirocumabRelatedEpoPatentOppositionsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PreFundedPensionObligations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-funded pension obligations.",
        "label": "Pre-Funded Pension Obligations",
        "terseLabel": "Pre-funded pension obligations",
        "verboseLabel": "Pre-funded pension obligations"
       }
      }
     },
     "localname": "PreFundedPensionObligations",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_PretaxDiscountRateAppliedForGoodwill": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-tax discount rate applied for goodwill.",
        "label": "Pretax Discount Rate Applied For Goodwill",
        "terseLabel": "Pre-tax discount rates"
       }
      }
     },
     "localname": "PretaxDiscountRateAppliedForGoodwill",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_PricewaterhousecoopersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PricewaterhouseCoopers.",
        "label": "PricewaterhouseCoopers [Member]",
        "terseLabel": "PricewaterhouseCoopers"
       }
      }
     },
     "localname": "PricewaterhousecoopersMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PrincipalAlliancesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal Alliances",
        "label": "Principal Alliances [Axis]",
        "terseLabel": "Principal alliances [axis]"
       }
      }
     },
     "localname": "PrincipalAlliancesAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_PrincipalAlliancesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal Alliances",
        "label": "Principal Alliances [Domain]",
        "terseLabel": "Principal alliances [domain]"
       }
      }
     },
     "localname": "PrincipalAlliancesDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PrincipalMarketedProductsAblynxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal Marketed Products Ablynx [Member]",
        "label": "Principal Marketed Products Ablynx [Member]",
        "terseLabel": "Ablynx"
       }
      }
     },
     "localname": "PrincipalMarketedProductsAblynxMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PrincipalMarketedProductsAventisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal marketed products aventis.",
        "label": "Principal Marketed Products Aventis [member]",
        "terseLabel": "Aventis"
       }
      }
     },
     "localname": "PrincipalMarketedProductsAventisMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PrincipalMarketedProductsBioverativMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal Marketed Products Bioverativ",
        "label": "Principal Marketed Products Bioverativ [Member]",
        "terseLabel": "Bioverativ"
       }
      }
     },
     "localname": "PrincipalMarketedProductsBioverativMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal marketed products Boehringer Ingelheim Consumer Healthcare.",
        "label": "Principal Marketed Products Boehringer Ingelheim Consumer Healthcare [member]",
        "terseLabel": "Boehringer Ingelheim Consumer Healthcare"
       }
      }
     },
     "localname": "PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PrincipalMarketedProductsChattemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal marketed products chattem.",
        "label": "Principal Marketed Products Chattem [member]",
        "terseLabel": "Chattem"
       }
      }
     },
     "localname": "PrincipalMarketedProductsChattemMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PrincipalMarketedProductsGenzymeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal marketed products genzyme.",
        "label": "Principal Marketed Products Genzyme [member]",
        "terseLabel": "Genzyme"
       }
      }
     },
     "localname": "PrincipalMarketedProductsGenzymeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PrincipalMarketedProductsKadmonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal Marketed Products Kadmon",
        "label": "Principal Marketed Products Kadmon [Member]",
        "terseLabel": "Kadmon"
       }
      }
     },
     "localname": "PrincipalMarketedProductsKadmonMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PrincipalMarketedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal marketed products.",
        "label": "Principal Marketed Products [member]",
        "terseLabel": "Total: principal marketed products"
       }
      }
     },
     "localname": "PrincipalMarketedProductsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PrincipalMarketedProductsProteinSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal marketed products Protein Sciences.",
        "label": "Principal Marketed Products Protein Sciences [member]",
        "terseLabel": "Protein Sciences"
       }
      }
     },
     "localname": "PrincipalMarketedProductsProteinSciencesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsDetailedInformationforPrincipalMarketedProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PrincipalUndiscountedCashFlow": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal undiscounted cash flow.",
        "label": "Principal Undiscounted Cash Flow",
        "terseLabel": "Principal"
       }
      }
     },
     "localname": "PrincipalUndiscountedCashFlow",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_PrincipiaBiopharmaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principia Biopharma Inc.",
        "label": "Principia Biopharma Inc. [Member]",
        "terseLabel": "Principia",
        "verboseLabel": "Principia Biopharma Inc."
       }
      }
     },
     "localname": "PrincipiaBiopharmaIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PriorAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prior Agreement",
        "label": "Prior Agreement [Member]",
        "terseLabel": "Prior agreement"
       }
      }
     },
     "localname": "PriorAgreementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PriorDevelopmentBudget": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prior development budget.",
        "label": "Prior Development Budget",
        "terseLabel": "Prior development budget in total"
       }
      }
     },
     "localname": "PriorDevelopmentBudget",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ProceedsFromCollaborationAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Collaboration Agreements",
        "label": "Proceeds From Collaboration Agreements",
        "terseLabel": "Proceeds from collaboration agreements"
       }
      }
     },
     "localname": "ProceedsFromCollaborationAgreements",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sales Of Investments Accounted For Using Equity Method, Before Transaction Costs",
        "label": "Proceeds From Sales Of Investments Accounted For Using Equity Method, Before Transaction Costs",
        "terseLabel": "Proceeds from sales of investments accounted for using equity method, before transaction costs"
       }
      }
     },
     "localname": "ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethodBeforeTransactionCosts",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ProductLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Liabilities [Member]",
        "label": "Product Liabilities [Member]",
        "terseLabel": "Product liabilities"
       }
      }
     },
     "localname": "ProductLiabilitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PropertyPlantAndEquipmentInProcessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, plant and equipment in process.",
        "label": "Property, Plant And Equipment In Process [Member]",
        "terseLabel": "Property,\u00a0plant and\u00a0equipment in process"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentInProcessMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ProvisionForPensionsAndOtherEmployeeBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for pensions and other employee benefits.",
        "label": "Provision For Pensions And Other Employee Benefits [member]",
        "terseLabel": "Provision for pensions and other employee benefits"
       }
      }
     },
     "localname": "ProvisionForPensionsAndOtherEmployeeBenefitsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ProvisionsAndOtherNonCurrentLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provisions and other non-current liabilities.",
        "label": "Provisions And Other Non-current Liabilities [Line Items]",
        "terseLabel": "Provisions and other non-current liabilities [Line Items]"
       }
      }
     },
     "localname": "ProvisionsAndOtherNonCurrentLiabilitiesLineItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_ProvisionsAndOtherNonCurrentLiabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provisions and other noncurrent liabilities.",
        "label": "Provisions And Other Non-current Liabilities [Table]",
        "terseLabel": "Provisions And Other Noncurrent Liabilities [Table]"
       }
      }
     },
     "localname": "ProvisionsAndOtherNonCurrentLiabilitiesTable",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_ProvisionsForDiscountsRebatesAndSalesReturns": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provisions for discounts, rebates and sales returns.",
        "label": "Provisions For Discounts Rebates And Sales Returns",
        "periodEndLabel": "Provisions for discounts, rebates and sales returns, ending balance",
        "periodStartLabel": "Provisions for discounts, rebates and sales returns, beginning balance"
       }
      }
     },
     "localname": "ProvisionsForDiscountsRebatesAndSalesReturns",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ProvisionsForOtherLongTermBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provisions for other long term benefits.",
        "label": "Provisions For Other Long Term Benefits [member]",
        "terseLabel": "Provisions for other long-term benefits"
       }
      }
     },
     "localname": "ProvisionsForOtherLongTermBenefitsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provisions for pensions and other post-employment benefits.",
        "label": "Provisions For Pensions And Other Post-Employment Benefits [Member]",
        "terseLabel": "Provisions for pensions and other post-employment benefits"
       }
      }
     },
     "localname": "ProvisionsForPensionsAndOtherPostEmploymentBenefitsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesSummaryofMovementsinNoncurrentProvisionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ProvisionsRecordedForFutureOperatingLosses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provisions recorded for future operating losses.",
        "label": "Provisions Recorded For Future Operating Losses",
        "terseLabel": "Provisions recorded for future operating losses"
       }
      }
     },
     "localname": "ProvisionsRecordedForFutureOperatingLosses",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesProvisionforRisksDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_PublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Offering",
        "label": "Public Offering [Member]",
        "terseLabel": "Public offering"
       }
      }
     },
     "localname": "PublicOfferingMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_PurchasePrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price.",
        "label": "Purchase Price",
        "totalLabel": "Purchase price"
       }
      }
     },
     "localname": "PurchasePrice",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_QualifiedDefinedBenefitPensionPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Qualified defined benefit pension plans.",
        "label": "Qualified Defined Benefit Pension Plans [member]",
        "terseLabel": "Qualified defined benefit pension plans"
       }
      }
     },
     "localname": "QualifiedDefinedBenefitPensionPlansMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_QuotedDebtInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted equity securities.",
        "label": "Quoted Debt Instruments [Member]",
        "terseLabel": "Quoted debt instruments"
       }
      }
     },
     "localname": "QuotedDebtInstrumentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_QuotedDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted debt securities.",
        "label": "Quoted Debt Securities [Member]",
        "terseLabel": "Quoted debt securities"
       }
      }
     },
     "localname": "QuotedDebtSecuritiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_QuotedEquityInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted equity investments.",
        "label": "Quoted Equity Investments [Member]",
        "terseLabel": "Quoted equity investments"
       }
      }
     },
     "localname": "QuotedEquityInvestmentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_QuotedEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted equity securities.",
        "label": "Quoted Equity Securities [member]",
        "terseLabel": "Quoted equity securities"
       }
      }
     },
     "localname": "QuotedEquitySecuritiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_QuotedEuroDenominatedSeniorBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted euro denominated senior bonds.",
        "label": "Quoted Euro Denominated Senior Bonds [Member]",
        "terseLabel": "Quoted euro denominated senior bonds"
       }
      }
     },
     "localname": "QuotedEuroDenominatedSeniorBondsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RPRUSLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RPR US Ltd",
        "label": "RPR US Ltd [Member]",
        "terseLabel": "RPR US Ltd."
       }
      }
     },
     "localname": "RPRUSLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RamiprilCanadaPatentLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ramipril canada patent litigation.",
        "label": "Ramipril Canada Patent Litigation [Member]",
        "terseLabel": "Ramipril Canada Patent Litigation"
       }
      }
     },
     "localname": "RamiprilCanadaPatentLitigationMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RareBloodDisordersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rare Blood Disorders",
        "label": "Rare Blood Disorders [Member]",
        "terseLabel": "Rare Blood Disorders"
       }
      }
     },
     "localname": "RareBloodDisordersMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RareDiseasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rare Diseases",
        "label": "Rare Diseases [Member]",
        "terseLabel": "Rare Diseases"
       }
      }
     },
     "localname": "RareDiseasesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RealEstateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate.",
        "label": "Real Estate [Member]",
        "terseLabel": "Real estate"
       }
      }
     },
     "localname": "RealEstateMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesFairValueofPlansAssetsrelatingtoPensionPlansandOtherPostemploymentPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RebatesAndDiscountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rebates and discounts.",
        "label": "Rebates And Discounts [Member]",
        "terseLabel": "Rebates and discounts"
       }
      }
     },
     "localname": "RebatesAndDiscountsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ReclassificationFromNonCurrentToCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification from non current to current.",
        "label": "Reclassification From Non Current To Current",
        "terseLabel": "Reclassification from non-current to current"
       }
      }
     },
     "localname": "ReclassificationFromNonCurrentToCurrent",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognition of acquired property plant and equipment at fair value.",
        "label": "Recognition Of Acquired Property Plant And Equipment At Fair Value [member]",
        "terseLabel": "Recognition of acquired property, plant and equipment at fair value"
       }
      }
     },
     "localname": "RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RedemptionOfDebtInstrumentIssued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption of debt instrument issued.",
        "label": "Redemption Of Debt Instrument Issued",
        "terseLabel": "Total debt at redemption"
       }
      }
     },
     "localname": "RedemptionOfDebtInstrumentIssued",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffs": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduced Amount Of Compensation Claimed By Filled Plaintiffs",
        "label": "Reduced Amount Of Compensation Claimed By Filled Plaintiffs",
        "terseLabel": "Reduced amount of compensation claimed"
       }
      }
     },
     "localname": "ReducedAmountOfCompensationClaimedByFilledPlaintiffs",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduced Amount Of Compensation Claimed By Filled Plaintiffs, Interest Included",
        "label": "Reduced Amount Of Compensation Claimed By Filled Plaintiffs, Interest Included",
        "terseLabel": "Reduced amount of compensation claimed, interest included"
       }
      }
     },
     "localname": "ReducedAmountOfCompensationClaimedByFilledPlaintiffsInterestIncluded",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ReductionOfSharesByCancellationOfTreasuryShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction Of Shares By Cancellation Of Treasury Shares",
        "label": "Reduction Of Shares By Cancellation Of Treasury Shares",
        "negatedTerseLabel": "Reduction in share capital by cancellation of treasury shares (in shares)"
       }
      }
     },
     "localname": "ReductionOfSharesByCancellationOfTreasuryShares",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_RegeneronMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regeneron",
        "label": "Regeneron [Member]",
        "terseLabel": "Regeneron"
       }
      }
     },
     "localname": "RegeneronMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementswithinOtherComprehensiveIncomeDetails",
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodAdditionalInformationDetails",
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/OtheroperatingincomeDetails",
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationAdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails",
      "http://www.sanofi.com/role/ShareofprofitlossfrominvestmentsaccountedforusingtheequitymethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RegeneronPharmaceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regeneron Pharmaceuticals, Inc.",
        "label": "Regeneron Pharmaceuticals, INC [Member]",
        "terseLabel": "Regeneron Pharmaceuticals, INC"
       }
      }
     },
     "localname": "RegeneronPharmaceuticalsIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RegularMilestonePaymentsForProjectsUnderCollaborationAgreements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regular Milestone Payments For Projects Under Collaboration Agreements",
        "label": "Regular Milestone Payments For Projects Under Collaboration Agreements",
        "terseLabel": "Regular milestone payments for projects under collaboration agreements"
       }
      }
     },
     "localname": "RegularMilestonePaymentsForProjectsUnderCollaborationAgreements",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_RegulatoryComplianceCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory Compliance Costs",
        "label": "Regulatory Compliance Costs [Member]",
        "terseLabel": "Regulatory compliance costs"
       }
      }
     },
     "localname": "RegulatoryComplianceCostsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RelatedPartyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party [Abstract]",
        "label": "Related Party [Abstract]",
        "terseLabel": "Related Party [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_RemeasurementOfOtherAcquiredIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remeasurement of other acquired intangible assets.",
        "label": "Remeasurement Of Other Acquired Intangible Assets [Member]",
        "terseLabel": "Remeasurement of other acquired intangible assets"
       }
      }
     },
     "localname": "RemeasurementOfOtherAcquiredIntangibleAssetsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ReportableGeographicalZonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reportable geographical zones.",
        "label": "Reportable Geographical Zones [Member]",
        "terseLabel": "Reportable geographical zones"
       }
      }
     },
     "localname": "ReportableGeographicalZonesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RepurchaseFromTheCounterpartMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase From The Counterpart",
        "label": "Repurchase From The Counterpart [Member]",
        "terseLabel": "Repurchase from the counterpart"
       }
      }
     },
     "localname": "RepurchaseFromTheCounterpartMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development.",
        "label": "Research And Development [Member]",
        "terseLabel": "Research and development projects"
       }
      }
     },
     "localname": "ResearchAndDevelopmentMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ResearchSitesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research sites.",
        "label": "Research Sites [Member]",
        "terseLabel": "Research sites"
       }
      }
     },
     "localname": "ResearchSitesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ReservePercentageOfPandemicVaccines": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserve percentage of pandemic vaccines.",
        "label": "Reserve Percentage of Pandemic Vaccines",
        "terseLabel": "Percentage of pandemic vaccines agreed to reserve"
       }
      }
     },
     "localname": "ReservePercentageOfPandemicVaccines",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_ReservesLikelyToBeDistributedInTheForeseeableFuture": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserves likely to be distributed in the foreseeable future.",
        "label": "Reserves Likely To Be Distributed In The Foreseeable Future",
        "terseLabel": "Reserves likely to be distributed in the foreseeable future"
       }
      }
     },
     "localname": "ReservesLikelyToBeDistributedInTheForeseeableFuture",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_RestrictedSharePlan2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Share Plan 2018.",
        "label": "Restricted Share Plan 2018 [member]",
        "terseLabel": "Restricted share plan 2018"
       }
      }
     },
     "localname": "RestrictedSharePlan2018Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RestrictedSharePlan2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Share Plan 2019 [Member]",
        "label": "Restricted Share Plan 2019 [Member]",
        "terseLabel": "Restricted share plan 2019"
       }
      }
     },
     "localname": "RestrictedSharePlan2019Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RestrictedSharePlan2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Share Plan 2020",
        "label": "Restricted Share Plan 2020 [Member]",
        "terseLabel": "Restricted share plan 2020"
       }
      }
     },
     "localname": "RestrictedSharePlan2020Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RestrictedSharePlan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Share Plan 2021",
        "label": "Restricted Share Plan 2021 [Member]",
        "terseLabel": "Restricted share plan 2021"
       }
      }
     },
     "localname": "RestrictedSharePlan2021Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RestrictedSharePlan2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Share Plan 2022",
        "label": "Restricted Share Plan 2022 [Member]",
        "terseLabel": "Restricted Share Plan 2022"
       }
      }
     },
     "localname": "RestrictedSharePlan2022Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RestrictedSharePlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Share Plans [Member]",
        "label": "Restricted Share Plans [Member]",
        "terseLabel": "Restricted share plans"
       }
      }
     },
     "localname": "RestrictedSharePlansMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RestrictedSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted shares.",
        "label": "Restricted Shares [Member]",
        "terseLabel": "Restricted shares"
       }
      }
     },
     "localname": "RestrictedSharesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofNumberofRestrictedSharesNotYetFullyVestedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_RestructuringCostsReversedAndSimilarItems": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails": {
       "order": 6.0,
       "parentTag": "sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Costs (Reversed) And Similar Items",
        "label": "Restructuring Costs (Reversed) And Similar Items",
        "verboseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringCostsReversedAndSimilarItems",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_RetirementAge": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement age.",
        "label": "Retirement Age",
        "terseLabel": "Retirement age"
       }
      }
     },
     "localname": "RetirementAge",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalties and other income, related party transactions.",
        "label": "Royalties And Other Income, Related Party Transactions",
        "terseLabel": "Royalties and other income"
       }
      }
     },
     "localname": "RoyaltiesAndOtherIncomeRelatedPartyTransactions",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofPrincipalTransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_RoyaltiesPaymentsMadeBySanofi": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalties payments made by sanofi.",
        "label": "Royalties Payments Made By Sanofi",
        "terseLabel": "Royalty payment to be paid by Sanofi"
       }
      }
     },
     "localname": "RoyaltiesPaymentsMadeBySanofi",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_RoyaltyExpensePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Expense, Percentage",
        "label": "Royalty Expense, Percentage",
        "terseLabel": "Royalty expense, percentage (percentage)"
       }
      }
     },
     "localname": "RoyaltyExpensePercentage",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_RoyaltyIncomePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Income, Percentage",
        "label": "Royalty Income, Percentage",
        "terseLabel": "Royalty income percentage (percentage)"
       }
      }
     },
     "localname": "RoyaltyIncomePercentage",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_SAR444245Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SAR444245",
        "label": "SAR444245 [Member]",
        "terseLabel": "SAR444245"
       }
      }
     },
     "localname": "SAR444245Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SECIPESASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SECIPE SAS",
        "label": "SECIPE SAS [Member]",
        "terseLabel": "SECIPE SAS"
       }
      }
     },
     "localname": "SECIPESASMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SPMSDContingentConsiderationAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SPMSD contingent consideration asset.",
        "label": "SPMSD Contingent Consideration Asset [Member]",
        "terseLabel": "SPMSD contingent consideration asset"
       }
      }
     },
     "localname": "SPMSDContingentConsiderationAssetMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock",
        "label": "Sale Of Stock [Axis]",
        "terseLabel": "Sale Of Stock [Axis]"
       }
      }
     },
     "localname": "SaleOfStockAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_SaleOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock",
        "label": "Sale Of Stock [Domain]",
        "terseLabel": "Sale Of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Number Of Shares Issued In Transaction, Shares Agreement",
        "label": "Sale Of Stock, Number Of Shares Issued In Transaction, Shares Agreement",
        "terseLabel": "Sale of stock, number of shares issued in transaction, shares agreement (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransactionSharesAgreement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_SaleOfStockNumberOfSharesIssuedInTransactionTotal": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Number Of Shares Issued In Transaction, Total",
        "label": "Sale Of Stock, Number Of Shares Issued In Transaction, Total",
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransactionTotal",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Price Per Share",
        "label": "Sale Of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share (in USD per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "sny_SaleOfStockTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Transaction Costs",
        "label": "Sale Of Stock, Transaction Costs",
        "terseLabel": "Transaction-related costs"
       }
      }
     },
     "localname": "SaleOfStockTransactionCosts",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_SalesOfAntibodiesFirstAchievementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Of Antibodies, First Achievement",
        "label": "Sales Of Antibodies, First Achievement [Member]",
        "terseLabel": "Sales of antibodies, first achievement"
       }
      }
     },
     "localname": "SalesOfAntibodiesFirstAchievementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SalesOfAntibodiesSecondAchievementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Of Antibodies, Second Achievement",
        "label": "Sales Of Antibodies, Second Achievement [Member]",
        "terseLabel": "Sales of antibodies, second achievement"
       }
      }
     },
     "localname": "SalesOfAntibodiesSecondAchievementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SalesOfAntibodiesThirdAchievementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Of Antibodies, Third Achievement",
        "label": "Sales Of Antibodies, Third Achievement [Member]",
        "terseLabel": "Sales Of Antibodies, Third Achievement"
       }
      }
     },
     "localname": "SalesOfAntibodiesThirdAchievementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SalesReturnMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales return.",
        "label": "Sales Return [Member]",
        "terseLabel": "Sales returns"
       }
      }
     },
     "localname": "SalesReturnMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_Sanofi2015DSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi 2015 D SAS",
        "label": "Sanofi 2015 D SAS [Member]",
        "terseLabel": "Sanofi 2015 D SAS"
       }
      }
     },
     "localname": "Sanofi2015DSASMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiABMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi AB.",
        "label": "Sanofi AB [member]",
        "terseLabel": "Sanofi AB"
       }
      }
     },
     "localname": "SanofiABMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi A/S [Member]",
        "label": "Sanofi A/S [Member]",
        "terseLabel": "Sanofi A/S"
       }
      }
     },
     "localname": "SanofiASMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiArabiaTradingCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Arabia Trading Company Limited [Member]",
        "label": "Sanofi Arabia Trading Company Limited [Member]",
        "terseLabel": "Sanofi Arabia Trading Company Limited"
       }
      }
     },
     "localname": "SanofiArabiaTradingCompanyLimitedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisAlgerieMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Algerie.",
        "label": "Sanofi Aventis Algerie [member]",
        "terseLabel": "Sanofi-Aventis Alg\u00e9rie"
       }
      }
     },
     "localname": "SanofiAventisAlgerieMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisArgentinaSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Argentina S.A.",
        "label": "Sanofi Aventis Argentina S A [member]",
        "terseLabel": "Sanofi-Aventis Argentina S.A."
       }
      }
     },
     "localname": "SanofiAventisArgentinaSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisAustraliaPtyLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Australia Pty Ltd.",
        "label": "Sanofi Aventis Australia Pty Ltd [member]",
        "terseLabel": "Sanofi-Aventis Australia Pty Ltd"
       }
      }
     },
     "localname": "SanofiAventisAustraliaPtyLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisCanadaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Canada Inc.",
        "label": "Sanofi Aventis Canada Inc [Member]",
        "terseLabel": "Sanofi-Aventis Canada Inc."
       }
      }
     },
     "localname": "SanofiAventisCanadaIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisDeChileSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis de Chile S.A.",
        "label": "Sanofi-Aventis de Chile S.A. [Member]",
        "terseLabel": "Sanofi-Aventis de Chile S.A."
       }
      }
     },
     "localname": "SanofiAventisDeChileSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisDeColombiaSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis de Colombia S.A.",
        "label": "Sanofi Aventis De Colombia S A [Member]",
        "terseLabel": "Sanofi-Aventis de Colombia S.A."
       }
      }
     },
     "localname": "SanofiAventisDeColombiaSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisDeMexicoSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis de Mexico S.A. de C.V. [Member]",
        "label": "Sanofi-Aventis De Mexico S.A. De C.V. [Member]",
        "terseLabel": "Sanofi-Aventis de Mexico S.A. de C.V."
       }
      }
     },
     "localname": "SanofiAventisDeMexicoSADeCVMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisDePanamaSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis de Panama S.A.",
        "label": "Sanofi Aventis De Panama S A [Member]",
        "terseLabel": "Sanofi-Aventis de Panama S.A."
       }
      }
     },
     "localname": "SanofiAventisDePanamaSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisDeVenezuelaSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis de Venezuela SA.",
        "label": "Sanofi Aventis De Venezuela SA [Member]",
        "terseLabel": "Sanofi-Aventis de Venezuela S.A."
       }
      }
     },
     "localname": "SanofiAventisDeVenezuelaSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisDelPeruSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis del Peru S.A.",
        "label": "Sanofi-Aventis del Peru S.A. [Member]",
        "terseLabel": "Sanofi-Aventis del Peru S.A."
       }
      }
     },
     "localname": "SanofiAventisDelPeruSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisDeutschlandGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Aventis Deutschland GmbH.",
        "label": "Sanofi Aventis Deutschland Gmbh [member]",
        "terseLabel": "Sanofi-Aventis Deutschland GmbH"
       }
      }
     },
     "localname": "SanofiAventisDeutschlandGmbHMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisFranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis France.",
        "label": "Sanofi Aventis France [member]",
        "terseLabel": "Sanofi-Aventis France"
       }
      }
     },
     "localname": "SanofiAventisFranceMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Aventis GmbH.",
        "label": "Sanofi Aventis GmbH [member]",
        "terseLabel": "Sanofi-Aventis GmbH"
       }
      }
     },
     "localname": "SanofiAventisGmbHMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisGroupeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Groupe.",
        "label": "Sanofi Aventis Groupe [member]",
        "terseLabel": "Sanofi-Aventis Groupe"
       }
      }
     },
     "localname": "SanofiAventisGroupeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisGulfFZEMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Gulf FZE.",
        "label": "Sanofi Aventis Gulf FZE [Member]",
        "terseLabel": "Sanofi-Aventis Gulf FZE"
       }
      }
     },
     "localname": "SanofiAventisGulfFZEMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisHealthcarePtyLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Healthcare Pty Ltd.",
        "label": "Sanofi Aventis Healthcare Pty Ltd [member]",
        "terseLabel": "Sanofi-Aventis Healthcare Pty Ltd"
       }
      }
     },
     "localname": "SanofiAventisHealthcarePtyLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisHoldingsIrelandLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Aventis Holdings (Ireland) Ltd",
        "label": "Sanofi Aventis Holdings (Ireland) Ltd [Member]",
        "terseLabel": "Sanofi-Aventis Holdings (Ireland) Ltd"
       }
      }
     },
     "localname": "SanofiAventisHoldingsIrelandLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisIsraelLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Israel Ltd.",
        "label": "Sanofi Aventis Israel Ltd [Member]",
        "terseLabel": "Sanofi-Aventis Isra\u00ebl Ltd"
       }
      }
     },
     "localname": "SanofiAventisIsraelLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisKoreaCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Korea Co. Ltd.",
        "label": "Sanofi Aventis Korea Co Ltd [Member]",
        "terseLabel": "Sanofi-Aventis Korea Co. Ltd"
       }
      }
     },
     "localname": "SanofiAventisKoreaCoLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisMalaysiaSDNBHDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis (Malaysia) SDN. BHD.",
        "label": "Sanofi Aventis Malaysia SDN. BHD [Member]",
        "terseLabel": "Sanofi-Aventis (Malaysia) SDN. BHD."
       }
      }
     },
     "localname": "SanofiAventisMalaysiaSDNBHDMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisMarocMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Maroc.",
        "label": "Sanofi Aventis Maroc [Member]",
        "terseLabel": "Sanofi-Aventis Maroc"
       }
      }
     },
     "localname": "SanofiAventisMarocMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisNorgeASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-aventis Norge AS",
        "label": "Sanofi-aventis Norge AS [Member]",
        "terseLabel": "Sanofi-Aventis Norge AS"
       }
      }
     },
     "localname": "SanofiAventisNorgeASMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisPakistanLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Pakistan Ltd.",
        "label": "Sanofi Aventis Pakistan Ltd [Member]",
        "terseLabel": "Sanofi-Aventis Pakistan Limited"
       }
      }
     },
     "localname": "SanofiAventisPakistanLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisParticipationsSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Participations SAS.",
        "label": "Sanofi Aventis Participations SAS [member]",
        "terseLabel": "Sanofi-Aventis Participations"
       }
      }
     },
     "localname": "SanofiAventisParticipationsSASMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisPhilippinesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Philippines Inc.",
        "label": "Sanofi Aventis Philippines Inc [Member]",
        "terseLabel": "Sanofi-Aventis Philippines Inc."
       }
      }
     },
     "localname": "SanofiAventisPhilippinesIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisPrivateCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Private Co, Ltd.",
        "label": "Sanofi-Aventis Private Co, Ltd [member]",
        "terseLabel": "Sanofi-Aventis Private Co, Ltd"
       }
      }
     },
     "localname": "SanofiAventisPrivateCoLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisPuertoRicoIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Puerto Rico Inc [Member]",
        "label": "Sanofi-Aventis Puerto Rico Inc [Member]",
        "terseLabel": "Sanofi-Aventis Puerto Rico Inc"
       }
      }
     },
     "localname": "SanofiAventisPuertoRicoIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisRechercheEtDeveloppementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi aventis Recherche et Developpement.",
        "label": "Sanofi Aventis Recherche Et Developpement [Member]",
        "terseLabel": "Sanofi-Aventis Recherche &amp; D\u00e9veloppement"
       }
      }
     },
     "localname": "SanofiAventisRechercheEtDeveloppementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisRomaniaSRLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Romania SRL.",
        "label": "Sanofi-Aventis Romania SRL [member]",
        "terseLabel": "Sanofi Romania SRL"
       }
      }
     },
     "localname": "SanofiAventisRomaniaSRLMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis SA.",
        "label": "Sanofi Aventis SA [member]",
        "terseLabel": "Sanofi-Aventis S.A."
       }
      }
     },
     "localname": "SanofiAventisSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisSROMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis, s.r.o.",
        "label": "Sanofi-Aventis, S.R.O. [Member]",
        "terseLabel": "Sanofi-Aventis, s.r.o."
       }
      }
     },
     "localname": "SanofiAventisSROMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisSingaporePteLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Singapore Pte Ltd.",
        "label": "Sanofi Aventis Singapore Pte Ltd [Member]",
        "terseLabel": "Sanofi-Aventis Singapore Pte. Ltd"
       }
      }
     },
     "localname": "SanofiAventisSingaporePteLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisSouthAfricaPtyLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis South Africa (Pty) Ltd",
        "label": "Sanofi-Aventis South Africa (Pty) Ltd [Member]",
        "terseLabel": "Sanofi-Aventis South Africa (Pty) Ltd"
       }
      }
     },
     "localname": "SanofiAventisSouthAfricaPtyLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisSuisseSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis (Suisse) SA.",
        "label": "Sanofi-Aventis (Suisse) SA [member]",
        "terseLabel": "Sanofi-Aventis (Suisse) SA"
       }
      }
     },
     "localname": "SanofiAventisSuisseSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisThailandLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Thailand Ltd.",
        "label": "Sanofi Aventis Thailand Ltd [Member]",
        "terseLabel": "Sanofi-Aventis (Thailand) Ltd"
       }
      }
     },
     "localname": "SanofiAventisThailandLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisUSLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis US LLC.",
        "label": "Sanofi-Aventis US LLC [member]",
        "terseLabel": "Sanofi-Aventis U.S. LLC"
       }
      }
     },
     "localname": "SanofiAventisUSLLCMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisUkHoldingsLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis UK Holdings Limited.",
        "label": "Sanofi-Aventis UK Holdings Limited [member]",
        "terseLabel": "Sanofi-Aventis UK Holdings Limited"
       }
      }
     },
     "localname": "SanofiAventisUkHoldingsLimitedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiAventisVietnamCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Vietnam Company Limited [Member]",
        "label": "Sanofi-Aventis Vietnam Company Limited [Member]",
        "terseLabel": "Sanofi-Aventis Vietnam Company Limited"
       }
      }
     },
     "localname": "SanofiAventisVietnamCompanyLimitedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiBeijingPharmaceuticalsCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Beijing Pharmaceuticals Co.Ltd.",
        "label": "Sanofi Beijing Pharmaceuticals Co Ltd [Member]",
        "terseLabel": "Sanofi (Beijing) Pharmaceuticals Co.Ltd"
       }
      }
     },
     "localname": "SanofiBeijingPharmaceuticalsCoLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiBelgiumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Belgium.",
        "label": "Sanofi Belgium [member]",
        "terseLabel": "Sanofi Belgium"
       }
      }
     },
     "localname": "SanofiBelgiumMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiBiotechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Biotechnology [Member]",
        "label": "Sanofi Biotechnology [Member]",
        "terseLabel": "Sanofi Biotechnology"
       }
      }
     },
     "localname": "SanofiBiotechnologyMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiBioverativHoldingsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Bioverativ Holdings LLC",
        "label": "Sanofi Bioverativ Holdings LLC [Member]",
        "terseLabel": "Sanofi Bioverativ Holdings LLC"
       }
      }
     },
     "localname": "SanofiBioverativHoldingsLLCMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiChimieMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Chimie.",
        "label": "Sanofi Chimie [member]",
        "terseLabel": "Sanofi Chimie"
       }
      }
     },
     "localname": "SanofiChimieMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiChinaInvestmentCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi (China) Investment Co., Ltd.",
        "label": "Sanofi China Investment Co Ltd [Member]",
        "terseLabel": "Sanofi (China) Investment Co., Ltd"
       }
      }
     },
     "localname": "SanofiChinaInvestmentCoLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiEgyptSAEMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Egypt S.A.E.",
        "label": "Sanofi Egypt S.A.E [Member]",
        "terseLabel": "Sanofi Egypt"
       }
      }
     },
     "localname": "SanofiEgyptSAEMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiEuroMediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Euro Medium Term Notes [Member]",
        "label": "Sanofi Euro Medium Term Notes [Member]",
        "terseLabel": "Sanofi Euro Medium Term Notes (EMTN) bonds"
       }
      }
     },
     "localname": "SanofiEuroMediumTermNotesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiForeignParticipationsB.V.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Foreign Participations B.V. [Member]",
        "label": "Sanofi Foreign Participations B.V. [Member]",
        "terseLabel": "Sanofi Foreign Participations B.V."
       }
      }
     },
     "localname": "SanofiForeignParticipationsB.V.Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiHangzhouPharmaceuticalsCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi (Hangzhou) Pharmaceuticals Co., Ltd.",
        "label": "Sanofi Hangzhou Pharmaceuticals Co Ltd [Member]",
        "terseLabel": "Sanofi (Hangzhou) Pharmaceuticals Co., Ltd"
       }
      }
     },
     "localname": "SanofiHangzhouPharmaceuticalsCoLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiHealthcareIndiaPrivateLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Healthcare India Private Limited [Member]",
        "label": "Sanofi Healthcare India Private Limited [Member]",
        "terseLabel": "Sanofi Healthcare India Private Limited"
       }
      }
     },
     "localname": "SanofiHealthcareIndiaPrivateLimitedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiHongKongLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Hong-Kong Limited.",
        "label": "Sanofi Hong-Kong Limited [Member]",
        "terseLabel": "Sanofi Hong-Kong Limited"
       }
      }
     },
     "localname": "SanofiHongKongLimitedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiIlacSanayiVeTicaretASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Ilac Sanayi ve Ticaret A.S.",
        "label": "Sanofi Ilac Sanayi ve Ticaret A.S. [member]",
        "terseLabel": "Sanofi Ilac Sanayi ve Ticaret A.S."
       }
      }
     },
     "localname": "SanofiIlacSanayiVeTicaretASMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiIndiaLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi India Limited.",
        "label": "Sanofi India Limited [Member]",
        "terseLabel": "Sanofi India Limited"
       }
      }
     },
     "localname": "SanofiIndiaLimitedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiKKMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi K.K.",
        "label": "Sanofi K.K [Member]",
        "terseLabel": "Sanofi K.K."
       }
      }
     },
     "localname": "SanofiKKMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiManufacturingPteLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Manufacturing Pte Ltd",
        "label": "Sanofi Manufacturing Pte Ltd [Member]",
        "terseLabel": "Sanofi Manufacturing Pte Ltd"
       }
      }
     },
     "localname": "SanofiManufacturingPteLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiMatureIPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Mature IP [Member]",
        "label": "Sanofi Mature IP [Member]",
        "terseLabel": "Sanofi Mature IP"
       }
      }
     },
     "localname": "SanofiMatureIPMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiMedleyFarmaceuticaLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Medley Farmaceutica Ltda [Member]",
        "label": "Sanofi Medley Farmaceutica Ltda [Member]",
        "terseLabel": "Sanofi Medley Farmaceutica Ltda"
       }
      }
     },
     "localname": "SanofiMedleyFarmaceuticaLtdaMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi.",
        "label": "Sanofi [member]",
        "terseLabel": "Sanofi",
        "verboseLabel": "Sanofi"
       }
      }
     },
     "localname": "SanofiMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofMovementsShareCapitalDetails",
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiOyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Oy.",
        "label": "Sanofi Oy [member]",
        "terseLabel": "Sanofi Oy"
       }
      }
     },
     "localname": "SanofiOyMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurAsiTicaretASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur Asi Ticaret A.S.",
        "label": "Sanofi Pasteur Asi Ticaret A.S [member]",
        "terseLabel": "Sanofi Pasteur Asi Ticaret A.S."
       }
      }
     },
     "localname": "SanofiPasteurAsiTicaretASMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurBiologiesCo.LtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur Biologies Co., Ltd [Member]",
        "label": "Sanofi Pasteur Biologies Co., Ltd [Member]",
        "terseLabel": "Sanofi Pasteur Biologies Co., Ltd"
       }
      }
     },
     "localname": "SanofiPasteurBiologiesCo.LtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur Europe [Member]",
        "label": "Sanofi Pasteur Europe [Member]",
        "terseLabel": "Sanofi Pasteur Europe"
       }
      }
     },
     "localname": "SanofiPasteurEuropeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurFranceSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur (France) SA.",
        "label": "Sanofi Pasteur (France) SA [member]",
        "terseLabel": "Sanofi Pasteur"
       }
      }
     },
     "localname": "SanofiPasteurFranceSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurHepatitisBVaccineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur Hepatitis B Vaccine",
        "label": "Sanofi Pasteur Hepatitis B Vaccine [Member]",
        "terseLabel": "Sanofi Pasteur Hepatitis B Vaccine product litigation"
       }
      }
     },
     "localname": "SanofiPasteurHepatitisBVaccineMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur Inc.",
        "label": "Sanofi Pasteur Inc [member]",
        "terseLabel": "Sanofi Pasteur Inc."
       }
      }
     },
     "localname": "SanofiPasteurIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur Limited [Member]",
        "label": "Sanofi Pasteur Limited [Member]",
        "terseLabel": "Sanofi Pasteur Limited"
       }
      }
     },
     "localname": "SanofiPasteurLimitedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur Ltd [Member]",
        "label": "Sanofi Pasteur Ltd [Member]",
        "terseLabel": "Sanofi Pasteur Ltd"
       }
      }
     },
     "localname": "SanofiPasteurLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurMerieuxSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur Merieux S.A.S",
        "label": "Sanofi Pasteur Merieux S.A.S [Member]",
        "terseLabel": "Sanofi Pasteur Merieux S.A.S."
       }
      }
     },
     "localname": "SanofiPasteurMerieuxSASMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurNVLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur NVL [Member]",
        "label": "Sanofi Pasteur NVL [Member]",
        "terseLabel": "Sanofi Pasteur NVL"
       }
      }
     },
     "localname": "SanofiPasteurNVLMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurS.A.deC.V.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur S.A. de C.V. [Member]",
        "label": "Sanofi Pasteur S.A. de C.V. [Member]",
        "terseLabel": "Sanofi Pasteur S.A. de C.V."
       }
      }
     },
     "localname": "SanofiPasteurS.A.deC.V.Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiPasteurSpZooMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Pasteur Sp z.o.o.",
        "label": "Sanofi Pasteur Sp z.o.o. [Member]",
        "terseLabel": "Sanofi Pasteur Sp. z.o.o."
       }
      }
     },
     "localname": "SanofiPasteurSpZooMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiProdutosFarmaceuticosLdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Produtos Farmaceuticos Lda.",
        "label": "Sanofi Produtos Farmaceuticos Lda [member]",
        "terseLabel": "Sanofi Produtos Farmaceuticos Lda"
       }
      }
     },
     "localname": "SanofiProdutosFarmaceuticosLdaMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiResearchInvestLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Research Invest LLC",
        "label": "Sanofi Research Invest LLC [Member]",
        "terseLabel": "Sanofi Research Invest LLC"
       }
      }
     },
     "localname": "SanofiResearchInvestLLCMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi SA",
        "label": "Sanofi SA [Member]",
        "terseLabel": "Sanofi SA"
       }
      }
     },
     "localname": "SanofiSAMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiSRLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Spa.",
        "label": "Sanofi SRL [Member]",
        "terseLabel": "Sanofi S.R.L."
       }
      }
     },
     "localname": "SanofiSRLMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiSaglikUrunleriLimitedSirketiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Saglik Urunleri Limited Sirketi [Member]",
        "label": "Sanofi Saglik Urunleri Limited Sirketi [Member]",
        "terseLabel": "Sanofi Saglik Urunleri Limited Sirketi"
       }
      }
     },
     "localname": "SanofiSaglikUrunleriLimitedSirketiMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiSustainabilityLinkedCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Sustainability-Linked Credit Facilities",
        "label": "Sanofi Sustainability-Linked Credit Facilities [Member]",
        "terseLabel": "Sanofi sustainability-linked credit facilities"
       }
      }
     },
     "localname": "SanofiSustainabilityLinkedCreditFacilitiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiSynthelaboUKLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Synthelabo UK Ltd",
        "label": "Sanofi-Synthelabo UK Ltd [Member]",
        "terseLabel": "Sanofi-Synthelabo UK Ltd"
       }
      }
     },
     "localname": "SanofiSynthelaboUKLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiTaiwanCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Taiwan Co Ltd.",
        "label": "Sanofi Taiwan Co Ltd [Member]",
        "terseLabel": "Sanofi Taiwan Co., Ltd"
       }
      }
     },
     "localname": "SanofiTaiwanCoLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiUSServicesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi US Services Inc.",
        "label": "Sanofi US Services Inc [member]",
        "terseLabel": "Sanofi US Services Inc."
       }
      }
     },
     "localname": "SanofiUSServicesIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiVietnamShareholdingCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Vietnam Shareholding Company Limited",
        "label": "Sanofi Vietnam Shareholding Company Limited [Member]",
        "terseLabel": "Sanofi Vietnam Shareholding Company Limited"
       }
      }
     },
     "localname": "SanofiVietnamShareholdingCompanyLimitedMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiWinthropIndustriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Winthrop Industries.",
        "label": "Sanofi Winthrop Industries [member]",
        "terseLabel": "Sanofi Winthrop Industrie"
       }
      }
     },
     "localname": "SanofiWinthropIndustriesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiaventisAEBEMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis A.E.B.E.",
        "label": "Sanofi-Aventis A.E.B.E. [member]",
        "terseLabel": "Sanofi-Aventis A.E.B.E."
       }
      }
     },
     "localname": "SanofiaventisAEBEMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiaventisPlusPensionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Plus.",
        "label": "Sanofi-Aventis plus [member]",
        "terseLabel": "Sanofi-Aventis Plus"
       }
      }
     },
     "localname": "SanofiaventisPlusPensionPlanMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SanofiaventisSpZooMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi-Aventis Sp. z.o.o.",
        "label": "Sanofi-Aventis Sp. zoo [member]",
        "terseLabel": "Sanofi-Aventis Sp. z.o.o."
       }
      }
     },
     "localname": "SanofiaventisSpZooMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ScribeTherapeuticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scribe Therapeutics",
        "label": "Scribe Therapeutics [Member]",
        "terseLabel": "Scribe Therapeutics"
       }
      }
     },
     "localname": "ScribeTherapeuticsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SeniorBondMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior bond.",
        "label": "Senior Bond [Member]",
        "terseLabel": "Senior bond"
       }
      }
     },
     "localname": "SeniorBondMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SeprafilmMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Seprafilm",
        "label": "Seprafilm [Member]",
        "terseLabel": "Seprafilm"
       }
      }
     },
     "localname": "SeprafilmMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_September2014EMTNISINFR0012146801Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "September 2014 EMTN ISIN FR0012146801.",
        "label": "September 2014 EMTNISINFR0012146801 [Member]",
        "terseLabel": "September 2014 EMTN ISIN FR0012146801"
       }
      }
     },
     "localname": "September2014EMTNISINFR0012146801Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_September2015EMTNISINFR0012969038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "September 2015 EMTN ISIN FR0012969038.",
        "label": "September 2015 EMTNISINFR0012969038 [Member]",
        "terseLabel": "September 2015 EMTN ISIN FR0012969038"
       }
      }
     },
     "localname": "September2015EMTNISINFR0012969038Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_September2016EMTNISINFR0013201639Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "September 2016 EMTN ISIN FR 0013201639.",
        "label": "September 2016 EMTNISINFR0013201639 [Member]",
        "terseLabel": "September 2016 EMTN ISIN FR0013201639"
       }
      }
     },
     "localname": "September2016EMTNISINFR0013201639Member",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ServicesOtherThanStatutoryAudit": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_AuditorsRemuneration",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Services other than statutory audit.",
        "label": "Services Other Than Statutory Audit",
        "totalLabel": "Services other than statutory audit"
       }
      }
     },
     "localname": "ServicesOtherThanStatutoryAudit",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalaccountantsfeesandservicesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ShanghaiRonghengPharmaceuticalCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Rongheng Pharmaceutical Co. Ltd",
        "label": "Shanghai Rongheng Pharmaceutical Co. Ltd [Member]",
        "terseLabel": "Shanghai Rongheng Pharmaceutical Co, Ltd"
       }
      }
     },
     "localname": "ShanghaiRonghengPharmaceuticalCoLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_ShareBasedPaymentPlansAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based payment plans.",
        "label": "Share Based Payment Plans [abstract]",
        "terseLabel": "Share-based payment plans:"
       }
      }
     },
     "localname": "ShareBasedPaymentPlansAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Consolidatedstatementsofchangesinequity"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_ShareCapitalReservesAndOtherEquityInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Capital, Reserves And Other Equity Interest [Abstract]",
        "label": "Share Capital, Reserves And Other Equity Interest [Abstract]",
        "terseLabel": "Share Capital, Reserves And Other Equity Interest [Abstract]"
       }
      }
     },
     "localname": "ShareCapitalReservesAndOtherEquityInterestAbstract",
     "nsuri": "http://www.sanofi.com/20221231",
     "xbrltype": "stringItemType"
    },
    "sny_ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of operating expenses and cost of producion to joint partner payable period.",
        "label": "Share Of Operating Expenses And Cost Of Production To Joint Partner Payable Period",
        "terseLabel": "Share of operating expenses and cost of production to joint partner payable period"
       }
      }
     },
     "localname": "ShareOfOperatingExpensesAndCostOfProductionToJointPartnerPayablePeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of profit or loss from commercialization of monoclonal antibodies member.",
        "label": "Share Of Profit Or Loss From Commercialization Of Monoclonal Antibodies [Member]",
        "terseLabel": "Share of profit or loss from commercialization of monoclonal antibodies"
       }
      }
     },
     "localname": "ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of profit or loss from commercialization of Zaltrap.",
        "label": "Share Of Profit Or Loss From Commercialization Of Zaltrap [Member]",
        "terseLabel": "Share of profit or loss from commercialization of Zaltrap"
       }
      }
     },
     "localname": "ShareOfProfitOrLossFromCommercializationOfZaltrapMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShareRepurchase2019ProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share repurchase 2019 program [Member]",
        "label": "Share Repurchase 2019 Program [Member]",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "ShareRepurchase2019ProgramMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShareRepurchase2020ProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase 2020 Program",
        "label": "Share Repurchase 2020 Program [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "ShareRepurchase2020ProgramMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShareRepurchase2021ProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase 2021 Program",
        "label": "Share Repurchase 2021 Program [Member]",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "ShareRepurchase2021ProgramMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShareRepurchase2022ProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase 2022 Program",
        "label": "Share Repurchase 2022 Program [Member]",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "ShareRepurchase2022ProgramMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofRepurchasesProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder's equity increase due to the exercise of all stock subscription options.",
        "label": "Shareholder's Equity Increase Due To The Exercise Of All Stock Subscription Options",
        "terseLabel": "Increase in shareholders equity due to exercise of stock purchase option"
       }
      }
     },
     "localname": "ShareholdersEquityIncreaseDueToTheExerciseOfAllStockSubscriptionOptions",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Agreement Sale Of Stock, Number Of Shares Issued In Transaction",
        "label": "Shares Agreement Sale Of Stock, Number Of Shares Issued In Transaction",
        "terseLabel": "Shares agreement, sale of stock, number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SharesAgreementSaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_ShelfRegistrationStatementProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shelf registration statement program.",
        "label": "Shelf Registration Statement Program [Member]",
        "terseLabel": "Shelf registration statement program"
       }
      }
     },
     "localname": "ShelfRegistrationStatementProgramMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofBondIssuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShenzhenSanofiPasteurBiologicalProductsCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shenzhen Sanofi Pasteur Biological Products Co, Ltd.",
        "label": "Shenzhen Sanofi Pasteur Biological Products Co Ltd [Member]",
        "terseLabel": "Shenzhen Sanofi pasteur Biological Products Co, Ltd"
       }
      }
     },
     "localname": "ShenzhenSanofiPasteurBiologicalProductsCoLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shire Contingent Consideration Arising From The Acquisition Of Translate Bio",
        "label": "Shire Contingent Consideration Arising From The Acquisition Of Translate Bio [Member]",
        "terseLabel": "Shire contingent consideration arising\u00a0from\u00a0the acquisition of Translate Bio"
       }
      }
     },
     "localname": "ShireContingentConsiderationArisingFromTheAcquisitionOfTranslateBioMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShireHumanGeneticTherapiesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shire Human Genetic Therapies Inc.",
        "label": "Shire Human Genetic Therapies Inc. [Member]",
        "terseLabel": "Shire contingent consideration"
       }
      }
     },
     "localname": "ShireHumanGeneticTherapiesIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShortTermDebtAndCurrentPortionOfLongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short term debt and current portion of long term debt.",
        "label": "Short-Term Debt And Current Portion Of Long-Term Debt [Member]",
        "terseLabel": "Short-term debt and current portion of long-term debt"
       }
      }
     },
     "localname": "ShortTermDebtAndCurrentPortionOfLongTermDebtMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesDisclosureofMovementInTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term Leases, Low Value Asset Leases And Lease Contracts Committed But Not Started Yet",
        "label": "Short Term Leases, Low Value Asset Leases And Lease Contracts Committed But Not Started Yet",
        "terseLabel": "Leases with a term of less than 12 months, low value asset leases and lease contracts committed but not yet commenced"
       }
      }
     },
     "localname": "ShortTermLeasesLowValueAssetLeasesAndLeaseContractsCommittedButNotStartedYet",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Six Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Nine",
        "label": "Six Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Nine [Member]",
        "terseLabel": "Six Hundred And Fifty Million Of Fixed Rate Bonds Maturing April Two Thousand Twenty Nine"
       }
      }
     },
     "localname": "SixHundredAndFiftyMillionOfFixedRateBondsMaturingAprilTwoThousandTwentyNineMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SkyhawkTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skyhawk Therapeutics, Inc",
        "label": "Skyhawk Therapeutics, Inc [Member]",
        "terseLabel": "Skyhawk Therapeutics, Inc"
       }
      }
     },
     "localname": "SkyhawkTherapeuticsIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SpecialDistributionNumberOfSharesConverted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Distribution, Number Of Shares Converted",
        "label": "Special Distribution, Number Of Shares Converted",
        "terseLabel": "Special Distribution, Number Of Shares Converted"
       }
      }
     },
     "localname": "SpecialDistributionNumberOfSharesConverted",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_SpecialDistributionPercentageOfShareCapitalDistributed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Distribution, Percentage Of Share Capital Distributed",
        "label": "Special Distribution, Percentage Of Share Capital Distributed",
        "terseLabel": "Special distribution, percentage of share capital distributed"
       }
      }
     },
     "localname": "SpecialDistributionPercentageOfShareCapitalDistributed",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_SpecialDistributionSharesReceivedPerConversionOfParentShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Distribution, Shares Received Per Conversion Of Parent Shares",
        "label": "Special Distribution, Shares Received Per Conversion Of Parent Shares",
        "terseLabel": "Number of shares received (in shares)"
       }
      }
     },
     "localname": "SpecialDistributionSharesReceivedPerConversionOfParentShares",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_SspCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SSP Co., Ltd.",
        "label": "SSP Co Ltd [member]",
        "terseLabel": "SSP Co.,Ltd"
       }
      }
     },
     "localname": "SspCoLtdMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockBasedCompensationStockOptionsExercisedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock based compensation stock options exercised price per share.",
        "label": "Stock Based Compensation Stock Options Exercised Price Per Share",
        "terseLabel": "Exercise price (in euros per share)"
       }
      }
     },
     "localname": "StockBasedCompensationStockOptionsExercisedPricePerShare",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "sny_StockMarketPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock market price per share.",
        "label": "Stock Market Price Per Share",
        "terseLabel": "Quoted stock market price per share (in USD per share)"
       }
      }
     },
     "localname": "StockMarketPricePerShare",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "sny_StockOptionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option Plan [member]",
        "label": "Stock Option Plan [member]",
        "terseLabel": "Stock Option Plan"
       }
      }
     },
     "localname": "StockOptionPlanMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockOptionPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option Plans",
        "label": "Stock Option Plans [Member]",
        "terseLabel": "Stock option plans"
       }
      }
     },
     "localname": "StockOptionPlansMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockOptionsAndShareBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock options and share based payments.",
        "label": "Stock Options And Share Based Payments [Member]",
        "terseLabel": "Stock options and other share-based payments"
       }
      }
     },
     "localname": "StockOptionsAndShareBasedPaymentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockOptionsWithNoDilutiveEffect": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock options with no dilutive effect.",
        "label": "Stock Options With No Dilutive Effect",
        "terseLabel": "Number of stock option not taken for computing diluted earning per share (in shares)"
       }
      }
     },
     "localname": "StockOptionsWithNoDilutiveEffect",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sny_StockSubscriptionOptionPlanEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock subscription option plan eight.",
        "label": "Stock Subscription Option Plan Eight [Member]",
        "terseLabel": "Stock subscription option plan eight"
       }
      }
     },
     "localname": "StockSubscriptionOptionPlanEightMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockSubscriptionOptionPlanFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock subscription option plan five.",
        "label": "Stock Subscription Option Plan Five [Member]",
        "terseLabel": "Stock subscription option plan five"
       }
      }
     },
     "localname": "StockSubscriptionOptionPlanFiveMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockSubscriptionOptionPlanFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock subscription option plan four.",
        "label": "Stock Subscription Option Plan Four [Member]",
        "terseLabel": "Stock subscription option plan four"
       }
      }
     },
     "localname": "StockSubscriptionOptionPlanFourMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockSubscriptionOptionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock subscription option plan.",
        "label": "Stock Subscription Option Plan [Member]",
        "terseLabel": "Stock subscription option plan"
       }
      }
     },
     "localname": "StockSubscriptionOptionPlanMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityAdditionalInformationDetails",
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockSubscriptionOptionPlanNineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock subscription option plan nine.",
        "label": "Stock Subscription Option Plan Nine [Member]",
        "terseLabel": "Stock subscription option plan nine"
       }
      }
     },
     "localname": "StockSubscriptionOptionPlanNineMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockSubscriptionOptionPlanSevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock subscription option plan seven.",
        "label": "Stock Subscription Option Plan Seven [Member]",
        "terseLabel": "Stock subscription option plan seven"
       }
      }
     },
     "localname": "StockSubscriptionOptionPlanSevenMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockSubscriptionOptionPlanSixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock subscription option plan six.",
        "label": "Stock Subscription Option Plan Six [Member]",
        "terseLabel": "Stock subscription option plan six"
       }
      }
     },
     "localname": "StockSubscriptionOptionPlanSixMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockSubscriptionOptionPlanTenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock subscription option plan ten.",
        "label": "Stock Subscription Option Plan Ten [Member]",
        "terseLabel": "Stock subscription option plan ten"
       }
      }
     },
     "localname": "StockSubscriptionOptionPlanTenMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_StockSubscriptionOptionPlanThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock subscription option plan three.",
        "label": "Stock Subscription Option Plan Three [Member]",
        "terseLabel": "Stock subscription option plan three"
       }
      }
     },
     "localname": "StockSubscriptionOptionPlanThreeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityDisclosureofStockSubscriptionOptionPlanOutstandingandOptionExercisedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SubscriptionPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription price per share.",
        "label": "Subscription Price Per Share",
        "terseLabel": "Subscription price (in euros per share)"
       }
      }
     },
     "localname": "SubscriptionPricePerShare",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofCharacteristicsofEmployeeShareOwnershipPlansAwardedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "sny_SuppliersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Suppliers.",
        "label": "Suppliers [Member]",
        "terseLabel": "Suppliers"
       }
      }
     },
     "localname": "SuppliersMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SyndicatedCreditFacilityOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Syndicated credit facility one.",
        "label": "Syndicated Credit Facility One [Member]",
        "terseLabel": "Syndicated credit facility, expires in 2022"
       }
      }
     },
     "localname": "SyndicatedCreditFacilityOneMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SyndicatedCreditFacilityTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Syndicated credit facility two.",
        "label": "Syndicated Credit Facility Two [Member]",
        "terseLabel": "Syndicated credit facility, expires in December 2025"
       }
      }
     },
     "localname": "SyndicatedCreditFacilityTwoMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SynthorxIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Synthorx, Inc",
        "label": "Synthorx, Inc [Member]",
        "terseLabel": "Synthorx, Inc"
       }
      }
     },
     "localname": "SynthorxIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_SynthorxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Synthorx [Member]",
        "label": "Synthorx [Member]",
        "terseLabel": "Synthorx"
       }
      }
     },
     "localname": "SynthorxMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofNetDeferredTaxPositionDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax charge on deemed repatriation attributable to accumulated earnings payable period.",
        "label": "Tax Charge On Deemed Repatriation Attributable To Accumulated Earnings Payable Period",
        "terseLabel": "Tax charge on deemed repatriation attributable to accumulated earnings payable period"
       }
      }
     },
     "localname": "TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sny_TaxExpenseOnDisposalOfInvestment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Expense On Disposal Of Investment",
        "label": "Tax Expense On Disposal Of Investment",
        "terseLabel": "Tax expense on disposal of investment"
       }
      }
     },
     "localname": "TaxExpenseOnDisposalOfInvestment",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_TaxLossCarryforwardsOnAssetDisposals": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax loss carryforwards on asset disposals.",
        "label": "Tax Loss Carryforwards On Asset Disposals",
        "terseLabel": "Tax loss carry-forwards on asset disposals"
       }
      }
     },
     "localname": "TaxLossCarryforwardsOnAssetDisposals",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_TaxLossesCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax losses carryforwards.",
        "label": "Tax Losses Carryforwards",
        "terseLabel": "Tax losses available for carry-forward"
       }
      }
     },
     "localname": "TaxLossesCarryforwards",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionSummaryofTaxLossesAvailableforCarryforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_AverageEffectiveTaxRate",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Rate Effect Of Fair Value Remeasurement Of Contingent Considerations",
        "label": "Tax Rate Effect Of Fair Value Remeasurement Of Contingent Considerations",
        "terseLabel": "Fair value remeasurement of contingent considerations"
       }
      }
     },
     "localname": "TaxRateEffectOfFairValueRemeasurementOfContingentConsiderations",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_AverageEffectiveTaxRate",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Rate Effect Of Revisions To Tax Exposures And Settlements Of Tax Disputes",
        "label": "Tax Rate Effect Of Revisions To Tax Exposures And Settlements Of Tax Disputes",
        "terseLabel": "Revisions to tax exposures and settlements of tax disputes"
       }
      }
     },
     "localname": "TaxRateEffectOfRevisionsToTaxExposuresAndSettlementsOfTaxDisputes",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/IncometaxexpenseSummaryofDifferenceBetweenEffectiveTaxRateandStandardCorporateIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_TaxotereMississippiAttorneyGeneralLitigationInTheUSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taxotere mississippi attorney general litigation in the US.",
        "label": "Taxotere Mississippi Attorney General Litigation In The US [Member]",
        "terseLabel": "Taxotere mississippi attorney general litigation in the US"
       }
      }
     },
     "localname": "TaxotereMississippiAttorneyGeneralLitigationInTheUSMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TaxotereProductLitigationInTheUSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taxotere product litigation in the US.",
        "label": "Taxotere Product Litigation In The US [Member]",
        "terseLabel": "Taxotere product litigation in the US"
       }
      }
     },
     "localname": "TaxotereProductLitigationInTheUSMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TechnologicalPlatformsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technological Platforms",
        "label": "Technological Platforms [Member]",
        "terseLabel": "Technological Platforms"
       }
      }
     },
     "localname": "TechnologicalPlatformsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Differences Subject To US Global Intangible Low Taxed Income [Member]",
        "label": "Temporary Differences Subject To US Global Intangible Low Taxed Income [Member]",
        "terseLabel": "Temporary differences subject to GILTI"
       }
      }
     },
     "localname": "TemporaryDifferencesSubjectToUSGlobalIntangibleLowTaxedIncomeMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SummaryofsignificantaccountingpoliciesIncomeTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TidalTherapeuticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tidal Therapeutics",
        "label": "Tidal Therapeutics [Member]",
        "terseLabel": "Tidal Therapeutics"
       }
      }
     },
     "localname": "TidalTherapeuticsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TopUpDefinedBenefitPensionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top-up defined-benefit pension plan.",
        "label": "Top-Up Defined-Benefit Pension Plan [Member]",
        "terseLabel": "Top-up defined-benefit pension plan"
       }
      }
     },
     "localname": "TopUpDefinedBenefitPensionPlanMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TotalDeferredTaxAssetsForTaxLossCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total deferred tax assets for tax loss carryforwards.",
        "label": "Total Deferred Tax Assets For Tax Loss Carryforwards",
        "terseLabel": "Total deferred tax assets for tax loss carryforwards"
       }
      }
     },
     "localname": "TotalDeferredTaxAssetsForTaxLossCarryforwards",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense recognized directly in profit or loss.",
        "label": "Total Expense For Pension And Other Post-employment Benefits Recognized Directly In Profit Or Loss",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "TotalExpenseForPensionAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesTotalExpenseforPensionsandOtherPostemploymentBenefitsAllocatedbetweenIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails": {
       "order": 1.0,
       "parentTag": "sny_ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total expense for pensions and other post-employment benefits recognized directly in profit or loss.",
        "label": "Total Expense For Pensions And Other Post-employment Benefits Recognized Directly In Profit Or Loss",
        "terseLabel": "Expense recognized directly in profit or loss",
        "verboseLabel": "Expense/(gain) recognized directly in profit or loss"
       }
      }
     },
     "localname": "TotalExpenseForPensionsAndOtherPostEmploymentBenefitsRecognizedDirectlyInProfitOrLoss",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesReconciliationofNetAmountRecognizedinRespectofPensionandOtherPostemploymentBenefitPlansDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesServiceCostforPensionandOtherpostemploymentBenefitPlansbyGeographicalRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_TotalOffBalanceSheetCommitments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total.",
        "label": "Total Off Balance Sheet Commitments",
        "terseLabel": "Total - net contributions given"
       }
      }
     },
     "localname": "TotalOffBalanceSheetCommitments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsSummaryofOffBalanceSheetCommitmentsRelatingtoOperatingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total.",
        "label": "Total Share Of Profit And Comprehensive Income Of Associates And Joint Ventures",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InvestmentsaccountedforusingtheequitymethodSummaryofShareofProfitorLossandOtherComprehensiveIncomeofAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_TotalStockOptionPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total stock option plans.",
        "label": "Total Stock Option Plans [Member]",
        "terseLabel": "Total stock option plans"
       }
      }
     },
     "localname": "TotalStockOptionPlansMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TotalUndiscountedCashFlow": {
     "auth_ref": [],
     "calculation": {
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total undiscounted cash flow.",
        "label": "Total Undiscounted Cash Flow",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "TotalUndiscountedCashFlow",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAmountofFutureUndiscountedContractualCashFlowsRelatingtoDebtandDerivativeInstrumentsDesignatedasHedgesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ToujeoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Toujeo.",
        "label": "Toujeo [Member]",
        "terseLabel": "Toujeo"
       }
      }
     },
     "localname": "ToujeoMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TransferPercentageOfPandemicVaccines": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer percentage of pandemic vaccines.",
        "label": "Transfer Percentage Of Pandemic Vaccines",
        "terseLabel": "Percentage of pandemic vaccines agreed to transfer"
       }
      }
     },
     "localname": "TransferPercentageOfPandemicVaccines",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_TranslateBioIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Translate Bio, Inc",
        "label": "Translate Bio, Inc [Member]",
        "terseLabel": "Translate Bio, Inc"
       }
      }
     },
     "localname": "TranslateBioIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TranslateBioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Translate Bio.",
        "label": "Translate Bio [Member]",
        "terseLabel": "Translate Bio"
       }
      }
     },
     "localname": "TranslateBioMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/GoodwillandotherintangibleassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/LiabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsSummaryofMovementsinLiabilitiesRelatedtoBusinessCombinationsandtoNonControllingInterestsDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020SummaryofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TwoThousandEighteenLetterAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Letter Agreement.",
        "label": "Two Thousand Eighteen Letter Agreement [Member]",
        "terseLabel": "2018 Letter Agreement"
       }
      }
     },
     "localname": "TwoThousandEighteenLetterAgreementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2021and2020AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TwoThousandFourteenAmendedInvestmentAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand fourteen amended investment agreement,",
        "label": "2014 Amended Investment Agreement [member]",
        "terseLabel": "2014 Amended Investment Agreement"
       }
      }
     },
     "localname": "TwoThousandFourteenAmendedInvestmentAgreementMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesInvestorAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_TypesOfAgreementAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Types Of Agreement",
        "label": "Types Of Agreement [Axis]",
        "terseLabel": "Types Of Agreement [Axis]"
       }
      }
     },
     "localname": "TypesOfAgreementAxis",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sny_TypesOfAgreementDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Types Of Agreement",
        "label": "Types Of Agreement [Domain]",
        "terseLabel": "Types Of Agreement [Domain]"
       }
      }
     },
     "localname": "TypesOfAgreementDomain",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails",
      "http://www.sanofi.com/role/PrincipalalliancesAllianceArrangementswithBristolMyersSquibbDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/Principalchangesinthescopeofconsolidationin2022AdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_USFDAApprovalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US FDA Approval",
        "label": "US FDA Approval [Member]",
        "terseLabel": "US FDA Approval"
       }
      }
     },
     "localname": "USFDAApprovalMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_USGovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Government",
        "label": "US Government [Member]",
        "terseLabel": "US Government"
       }
      }
     },
     "localname": "USGovernmentMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/BasisofpreparationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_USLegalRestructuringMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Legal Restructuring",
        "label": "US Legal Restructuring [Member]",
        "terseLabel": "US legal restructuring"
       }
      }
     },
     "localname": "USLegalRestructuringMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_UncertaintiesOverIncomeTaxTreatmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uncertainties Over Income Tax Treatments",
        "label": "Uncertainties Over Income Tax Treatments [Member]",
        "terseLabel": "Uncertainties over income tax treatments"
       }
      }
     },
     "localname": "UncertaintiesOverIncomeTaxTreatmentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_UniformImpairmentTestingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uniform impairment testing percentage.",
        "label": "Uniform Impairment Testing Percentage",
        "terseLabel": "Uniform impairment testing percentage"
       }
      }
     },
     "localname": "UniformImpairmentTestingPercentage",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_UniformPreTaxDiscountRates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uniform pre-tax discount rates.",
        "label": "Uniform Pre-Tax Discount Rates",
        "terseLabel": "Uniform pre-tax discount rates"
       }
      }
     },
     "localname": "UniformPreTaxDiscountRates",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sny_UnquotedDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unquoted debt securities.",
        "label": "Unquoted Debt Securities [Member]",
        "terseLabel": "Unquoted debt securities not meeting the definition of equity instruments"
       }
      }
     },
     "localname": "UnquotedDebtSecuritiesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_UnquotedEquityInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unquoted equity investments.",
        "label": "Unquoted Equity Investments [Member]",
        "terseLabel": "Unquoted equity investments"
       }
      }
     },
     "localname": "UnquotedEquityInvestmentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/FinancialassetsandliabilitiesmeasuredatfairvalueSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity instruments at fair value through other comprehensive income and Debt instruments at fair value through other comprehensive income.",
        "label": "Unrealized Gains (Losses) On Securities Measured At Fair Value Through Other Comprehensive Income That Will Be Reclassified To Profit And Loss Recognized In Equity",
        "negatedTerseLabel": "Unrealized after-tax losses"
       }
      }
     },
     "localname": "UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OthernoncurrentassetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unused Capital Losses For Which No Deferred Tax Asset Recognised",
        "label": "Unused Capital Losses For Which No Deferred Tax Asset Recognised",
        "terseLabel": "Unused capital losses for which no deferred tax asset recognised"
       }
      }
     },
     "localname": "UnusedCapitalLossesForWhichNoDeferredTaxAssetRecognised",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/NetdeferredtaxpositionAdditionalinformationDetails",
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_UnwindingOfDiscount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unwinding Of Discount",
        "label": "Unwinding Of Discount",
        "terseLabel": "Unwinding of discount"
       }
      }
     },
     "localname": "UnwindingOfDiscount",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ProvisionsincometaxliabilitiesandotherliabilitiesMovementsinRestructuringProvisionsClassifiedinNoncurrentandCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_UpfrontPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payments.",
        "label": "Upfront Payments",
        "terseLabel": "Upfront payment"
       }
      }
     },
     "localname": "UpfrontPayments",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails",
      "http://www.sanofi.com/role/OthernoncurrentassetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_UpfrontPaymentsForProjectsUnderCollaborationAgreements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront Payments For Projects Under Collaboration Agreements",
        "label": "Upfront Payments For Projects Under Collaboration Agreements",
        "terseLabel": "Upfront payments for projects under collaboration agreements"
       }
      }
     },
     "localname": "UpfrontPaymentsForProjectsUnderCollaborationAgreements",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/PrincipalalliancesImmunoOncologyAgreementwithRegeneronPharmaceuticalsIncDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_VaccinesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vaccines.",
        "label": "Vaccines [Member]",
        "terseLabel": "Vaccines"
       }
      }
     },
     "localname": "VaccinesMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentAdditionalInformationDetails",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentScheduleofAllocationofGoodwillDetails",
      "http://www.sanofi.com/role/PropertyplantandequipmentSummaryofAcquisitionsandCapitalizedInterestbyOperatingSegmentDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofAcquisitionofIntangibleAssetsPropertyPlantandEquipmentandInvestmentsAccountedforUsingtheEquityMethodbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_VaccinesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vaccines segment.",
        "label": "Vaccines Segment [member]",
        "terseLabel": "Vaccines"
       }
      }
     },
     "localname": "VaccinesSegmentMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofSegmentResultsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ValueOfHedgeRecognizedInEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value Of Hedge Recognized In Equity [Member]",
        "label": "Value Of Hedge Recognized In Equity [Member]",
        "terseLabel": "Of\u00a0which recognized\u00a0in\u00a0equity"
       }
      }
     },
     "localname": "ValueOfHedgeRecognizedInEquityMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksDisclosureofInstrumentsDetails",
      "http://www.sanofi.com/role/DerivativefinancialinstrumentsandmarketrisksSummaryofOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ValueOfShareOptionsCancelledInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value Of Share Options Cancelled In Share Based Payment Arrangement",
        "label": "Value Of Share Options Cancelled In Share Based Payment Arrangement",
        "negatedLabel": "Total, options cancelled"
       }
      }
     },
     "localname": "ValueOfShareOptionsCancelledInShareBasedPaymentArrangement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ValueOfShareOptionsExercisableInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of share options exercisable in share based payment arrangement.",
        "label": "Value Of Share Options Exercisable In Share Based Payment Arrangement",
        "terseLabel": "Total, options exercisable"
       }
      }
     },
     "localname": "ValueOfShareOptionsExercisableInShareBasedPaymentArrangement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ValueOfShareOptionsExercisedInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of share options exercised in share based payment arrangement.",
        "label": "Value Of Share Options Exercised In Share Based Payment Arrangement",
        "negatedLabel": "Total, options exercised"
       }
      }
     },
     "localname": "ValueOfShareOptionsExercisedInShareBasedPaymentArrangement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of share options forfeited in share based payment arrangement.",
        "label": "Value Of Share Options Forfeited In Share Based Payment Arrangement",
        "negatedLabel": "Total, options forfeited"
       }
      }
     },
     "localname": "ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of share options outstanding in share based payment arrangement.",
        "label": "Value Of Share Options Outstanding In Share Based Payment Arrangement",
        "periodEndLabel": "Total, ending balance",
        "periodStartLabel": "Total, beginning balance"
       }
      }
     },
     "localname": "ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sny_ValueOnRedemptionAfterDerivativeInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value on redemption after derivative instruments.",
        "label": "Value On Redemption After Derivative Instruments [Member]",
        "terseLabel": "Value on redemption after derivative instruments"
       }
      }
     },
     "localname": "ValueOnRedemptionAfterDerivativeInstrumentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofInterestRateofNetDebtatValueonRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ValueOnRedemptionBeforeDerivativeInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value on redemption before derivative instruments.",
        "label": "Value On Redemption Before Derivative Instruments [Member]",
        "terseLabel": "Value on redemption before derivative instruments"
       }
      }
     },
     "localname": "ValueOnRedemptionBeforeDerivativeInstrumentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ValueOnRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value on redemption.",
        "label": "Value On Redemption [Member]",
        "terseLabel": "Value on redemption"
       }
      }
     },
     "localname": "ValueOnRedemptionMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyMaturityatValueonRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofMarketValueofNetDebtDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofNetDebtbyTypeValuationofRedemptionDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofReconciliationofCarryingAmounttoValueonRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_VaxServeIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VaxServe, Inc.",
        "label": "VaxServe Inc [member]",
        "terseLabel": "VaxServe, Inc."
       }
      }
     },
     "localname": "VaxServeIncMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price Of Share Options Cancelled In Share-Based Payment Arrangement",
        "label": "Weighted Average Exercise Price Of Share Options Cancelled In Share-Based Payment Arrangement",
        "terseLabel": "Average exercise\u00a0price per share, options cancelled (in euros per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsCancelledInShareBasedPaymentArrangement",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequitySummaryofStockOptionsOutstandingatEachBalanceSheetDateDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "sny_WeightedAverageInterestRateAfterDerivativeInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate after derivative instruments.",
        "label": "Weighted Average Interest Rate After Derivative Instruments [Member]",
        "terseLabel": "Weighted average interest rate after derivative instruments"
       }
      }
     },
     "localname": "WeightedAverageInterestRateAfterDerivativeInstrumentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_WeightedAverageInterestRateBeforeDerivativeInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate before derivative instruments.",
        "label": "Weighted Average Interest Rate Before Derivative Instruments [Member]",
        "terseLabel": "Weighted average interest rate before derivative instruments"
       }
      }
     },
     "localname": "WeightedAverageInterestRateBeforeDerivativeInstrumentsMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_WithMarketConditionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "With Market Condition",
        "label": "With Market Condition [Member]",
        "terseLabel": "With market condition"
       }
      }
     },
     "localname": "WithMarketConditionMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_WithoutMarketConditionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Without Market Condition",
        "label": "Without Market Condition [Member]",
        "terseLabel": "Without market condition"
       }
      }
     },
     "localname": "WithoutMarketConditionMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedshareholdersequityPrincipalCharacteristicsofRestrictedSharePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_WorldHealthOrganizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "World Health Organization.",
        "label": "World Health Organization [member]",
        "terseLabel": "World Health Organization"
       }
      }
     },
     "localname": "WorldHealthOrganizationMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_WriteDownMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write down.",
        "label": "Write-down [member]",
        "terseLabel": "Allowances"
       }
      }
     },
     "localname": "WriteDownMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ZantacLitigationInCanadaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zantac Litigation In Canada",
        "label": "Zantac Litigation In Canada [Member]",
        "terseLabel": "Zantac litigation in Canada"
       }
      }
     },
     "localname": "ZantacLitigationInCanadaMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ZantacLitigationInTheUSMDLCourtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zantac Litigation In the US, MDL Court",
        "label": "Zantac Litigation In the US, MDL Court [Member]",
        "terseLabel": "Zantac litigation in the US, MDL Court"
       }
      }
     },
     "localname": "ZantacLitigationInTheUSMDLCourtMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sny_ZantacLitigationInTheUSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zantac Litigation In the US",
        "label": "Zantac Litigation In the US [Member]",
        "terseLabel": "Zantac litigation in the US"
       }
      }
     },
     "localname": "ZantacLitigationInTheUSMember",
     "nsuri": "http://www.sanofi.com/20221231",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CondensedCashFlowStatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Cash Flow Statement [Table]",
        "terseLabel": "Condensed Cash Flow Statement [Table]"
       }
      }
     },
     "localname": "CondensedCashFlowStatementTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedCashFlowStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Cash Flow Statements, Captions [Line Items]",
        "terseLabel": "Condensed Cash Flow Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedCashFlowStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sanofi.com/role/AuditInformation",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyCurrencyDetails",
      "http://www.sanofi.com/role/DebtcashandcashequivalentsandleaseliabilitiesSummaryofDebtbyInterestRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sanofi.com/role/Listofprincipalcompaniesincludedinthescopeofconsolidationduring2022SummaryofPrincipalCompaniesandtheirCountryofIncorporationDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails",
      "http://www.sanofi.com/role/SegmentinformationSummaryofNetSalesbySegmentandGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails",
      "http://www.sanofi.com/role/OffbalancesheetcommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sanofi.com/role/LegalandarbitralproceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "North America [Member]",
        "terseLabel": "North America"
       }
      }
     },
     "localname": "NorthAmericaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sanofi.com/role/SegmentinformationSummaryofGeographicalInformationonNetSalesandNonCurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/EventssubsequenttoDecember312022Details",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sanofi.com/role/ConsolidatedstatementsofcashflowsParenthetical",
      "http://www.sanofi.com/role/EventssubsequenttoDecember312022Details",
      "http://www.sanofi.com/role/ImpairmentofintangibleassetsandpropertyplantandequipmentSummaryofNetImpairmentLossesofOtherIntangibleAssetsDetails",
      "http://www.sanofi.com/role/PrincipalalliancesCollaborationagreementsonhumantherapeuticantibodiesDetails",
      "http://www.sanofi.com/role/SegmentinformationScheduleofReconciliationBetweenBusinessOperatingIncomefortheSegmentsandIncomeBeforeTaxandInvestmentsAccountedforUsingtheEquityMethodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.sanofi.com/role/AuditInformation",
      "http://www.sanofi.com/role/OtheroperatingexpensesOtherIncomeandExpenseDetails",
      "http://www.sanofi.com/role/ProvisionsfordiscountsrebatesandsalesreturnsSummaryofMovementinProvisionsforDiscountsRebatesandSalesReturnsDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 46
  }
 },
 "std_ref": {
  "r0": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "104",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r10": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "41",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_41&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r100": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_h&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS02_g36-39__IAS02_g36-39_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "51",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r110": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18A&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_g&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Section": "Disclosures",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_v&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "10",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r120": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "29",
   "Section": "Disclosures",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=29&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS29_g39-40_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "34",
   "Paragraph": "16A",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=34&code=ifrs-tx-2021-en-r&anchor=para_16A_f&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r130": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_d_iv&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_e_iv&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "135",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_135&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "86",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_86_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "86",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r140": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "88",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_88&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_iv&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r150": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "122",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_122_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "39",
   "Paragraph": "86",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=39&code=ifrs-tx-2021-en-r&anchor=para_86_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "39",
   "Paragraph": "86",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=39&code=ifrs-tx-2021-en-r&anchor=para_86_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "32A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_32A&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "76",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "50",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r160": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "21",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "39",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "42A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42A&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r170": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "42B",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42B&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "46",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "30",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=8&code=ifrs-tx-2021-en-r&anchor=para_30_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "l",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_l&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r180": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "10",
   "Paragraph": "22",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "2",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_2_b_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "21",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_21_a_iv&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "21",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_21_c_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "n",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_n&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r190": {
   "Clause": "ix",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B16",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B16&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r20": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r200": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "14",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "105",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_105&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "115",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "116",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "p",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_p&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r210": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_g&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "94",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "97",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_q&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r220": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "52",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_52&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "r",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_r&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r230": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "q",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d_v&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r240": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Section": "Disclosures application of paragraphs 59 and 61",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Appendix&subtype=B&dita_xref=IFRS03_gB64-B67_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "38",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_38&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "11A",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_11A_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23A&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24A&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24B",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24B&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24C",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24C&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24G",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24G&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "56",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r250": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35K",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "36",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r260": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_8_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_8_h&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_8&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B52",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B52&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Credit risk",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS07_g35A-38_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "16",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_g&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r270": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r280": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "9",
   "Paragraph": "7.2.34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "120",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "C32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "9",
   "Paragraph": "7.2.42",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39M",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39M_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r290": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39M",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39M_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39M",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39M&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2017-en-b&anchor=para_91_a&doctype=Standard&forcepdf=true",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "4",
   "Paragraph": "39J",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39J_a&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "4",
   "Paragraph": "39J",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39J_b&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "4",
   "Paragraph": "39J",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39J&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_a_ii&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "22",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_22_b&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "22",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_22&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "23",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_23_c&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r30": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r300": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_b&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_c&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r304": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r305": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r306": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "68",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r307": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "70",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r308": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r309": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r31": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r310": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r311": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82A&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r312": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "IG6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r313": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "22",
   "Subparagraph": "j",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22_j&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r314": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r315": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r316": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r317": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_g&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r318": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r319": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r32": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r320": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r321": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r322": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "21",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_21_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r323": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "IE33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r324": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "127",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r325": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "70",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r326": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "87",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_87&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r327": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Section": "D Examples: disclosures",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_D__IAS37_IE_D_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r328": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r329": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r33": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r330": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r331": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r332": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r333": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r334": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r335": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r336": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44C",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r337": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r338": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r339": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C__IAS07_IE_C_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r34": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r340": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r341": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "94",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r342": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r343": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE60",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE60&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r344": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE63",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r345": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r346": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r347": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r348": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r349": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "IG23",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_IG23&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r35": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r350": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r351": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r352": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "IE72",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_IE72&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r353": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35N",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r354": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r355": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r356": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r357": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r358": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r359": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r36": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r360": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r361": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r362": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r363": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_f&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r364": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r365": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r366": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG31A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r367": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG40B",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG40B&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r368": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r369": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "IG4",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_IG4&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r37": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r370": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r371": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r372": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r373": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r374": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_a&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r375": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r376": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG28",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_b&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r377": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG28",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_c&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r378": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG28",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_d&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r379": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r38": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r380": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_b&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r381": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r382": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r383": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r384": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r385": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r386": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r387": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r388": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r389": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r39": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_a_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r390": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r391": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r392": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r393": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r394": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r395": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r396": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r397": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r398": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r399": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r4": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r40": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r400": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r401": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r402": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r403": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r404": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r405": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r406": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r407": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r408": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "144",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_144&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r409": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "145",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r41": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_b_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r410": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "5",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_5&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r411": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r412": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "9",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r413": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r414": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r415": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r416": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r417": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r418": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r419": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r42": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r420": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_viii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r421": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r422": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r423": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r424": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r425": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r426": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_14&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r427": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r428": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r429": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r43": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r430": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r431": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r432": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r433": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r434": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r435": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r436": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r437": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r438": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r439": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r44": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "90",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_90&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r50": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "99",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "21",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "ab",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_ab&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r60": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_f&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_v&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106A&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r70": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_viii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "74",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_74_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r80": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_f&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_g&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "16",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r90": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_h&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "145",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_145_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "145",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "148",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_148_d_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "34",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_34_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>275
<FILENAME>0001121404-23-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001121404-23-000008-xbrl.zip
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M<@J,,]LSN1)C_ST8W.'['.X*W]-GH"HJR_F<Z H6+7DX!&^AJL+8)=GK[3=
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M$.&CQ-*.GA/\:@X4U"3-4?!,"8O"5B^1D,KR,"M;<-60)=1%BL\-XL-3"B_
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M?G*;L*"#+!^@?]>%5)RG19OV.5J(PZHQB "$0+(Y-'\/2_MMHH6>':1]VB#
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MK\0N6=&E92>7F3XE7C,\&49A92XQ*-[JK 4CC6_MY#WP/#/P/">Z+1\'5F)
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M*4R.GB%8%'^%3B;E1OFM4>?JTC1UR\6OCG_%(!5<9H]9B;Q=*3YO0N\RHZ<
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M4C@]+YB+27H/UTFQEX.C%V3 XB!=0E/%)&9!>28,)P,3>FX#>E<#,CCN1DI
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MO.NN93;#B*[LU(9DE%,C8)3=. &C:LEMN5--N-+^5)!R<O%NG'*UF7K852%
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M:(>_/;.=LZ6Z"+XF#XX3 & %X5EI0@YI(8378KKS(FX6L%-=7(\*>Q6+-+.
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M2MIMK^=<=*.X^5AP(=I^#G5!Y[,#!VGP((P> !<(YHA]R_WY"B@B7;QOT)+
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M)YFIYM;%JRJ73(#+?4C+:J'! 6\D@@\(32A=>&$[MX:2GG8,%I>5X)4QET.
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M\E#.,G3E;+Y1B*$OW1/?(1OQ(C%VUQ&+1$3WE92Z+/<T@^/ #N\[L"I<-VG
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MK^Q(8O3>O,HW\+]ELRI^^?]02P,$%     @ +E-85D7-_KV0!P  2R(  !0
M  !A,C R,BUE>&AI8FET,3(Q+FAT;=U:;6_;.!+^?K^"Z^"Z+6!;ENV\V6F
M-$FQ!?9VB]TLBOMTH,21Q0LE"B1EQ_OK;X:4WQ*[=3:]M-D ,2QQ2,[+,\\,
M)9_]</7KY<V_/UZSW!6*??SCW<\?+EFK$T6?!I=1='5SQ7ZZ^=?/;-CMQ>S&
M\-)*)W7)511=_])BK=RY:A1%L]FL.QMTM9E$-[]%M-0P4EI;Z HG6N=G= <_
M@8OS?YS]T.FP*YW6!92.I0:X \%J*\L)^R3 WK).IY&ZU-7<R$GN6+_7'[!/
MVMS**0_C3CH%YXMUSJ)P?1;Y3<X2+>;G9T).F11O6[*?I/R0'Z>#DUY_.$R/
M3@#$T?%I[Z@G#GE_F/PG1B4C% ]SK)LK>-LJ9-G)@?8?'0XK-YY)X?)1W.O]
ML[4IQ\T$11/MG"YP'$6;6TY7_AKE,UTZU,O@/N'KP^V^N,S8P9WK<"4GY<C[
MI5EWL4*JE3:C@Y[_&]-()^.%5//1CQ=&<O5CVV($.Q:,S,*PE7_"Z!17]E>S
M8.PQ3E:RA(7Q<9\LOK[+92(=B_O=>-.&+UAR^I?L7\WZRM8-MUKWH<T^\EJQ
MGVIA==EF*1@GLSES.7>O#@Y/QONK/:ZX$(CFCH(,ES]9Q$V6 I$ZZM"=YS0M
M[KXZB(]ZXX>?'UC.I\ ,3"7,, E=+BWC95ESA3<K;1S3)7NO38$)V'G/=,9^
MYZ7.)'KD] 5[I+_3(^^X13^@T<6<W99ZID!,H!T<TWA$:+"LU$A=N ^7)3IL
MSNK2F1I0>20SSVOH*LX*O")E6<93O&68+C"!G YR#P1*2,%:;N8D4O!;P'W7
MUK1X3Z RN*7RI(A[D$ J#9(@BI4X'3418-@LEVG.;$T?J_DS,- L0@84TBID
M2R+>F70Y&F@K2+V"M&Z%JFF!9DYQFF#)?-T-+QP!@\<C %@F2_0QA6OETS:&
M'\5QV*R-RS+#I.%4*O%[JFJ!:V+<UAS8QIA+H^:L0K<38@A)2JT@T43#WML:
M42=\#6Z31*U0 '&@,5A^.^OU2;G-6:;TS"Y!HHN*@,KI3E :56RO!=HN-'F@
MZ@N/]7!GK&]6CGEU<-*/C\>V"65#_Y0:.LLD7GJ7?6#<@(\,>EHF"LB)#! .
MB9(V)W$2*Y 6B!KH6DB;*FUK YXPC%8A1)71*0B\;=EK#(H #''P_/5=FO-R
M NP"<_&W6J%$/."=^/ UO/%3XT,1KL(E[@6F#-"@]1DE[!IB0A!)E[TWRC8V
MRG CLG,#1SA,Q>-)M7%P]*VQ\9J_V06.*[#89Z&G/(M^.8QM(OB4UW;_*<2T
M"6!(FIT"=^O:X *8E%-I?9ZC%)1^'>I&5@RQSC(&%/<Q;LB[B5.[H1\:D4@5
MJ(C52@K?<]LZL5)(;B1I+T-]\:17TC*U)<[W^6!]@?"L@$T]:H/=MI]4<416
M6BM.3(8V>0U6M0-GA$JT7D#Q6P(DB'R#\T$\B5^^ PPE>V)H[T1] *7]4WQO
M1"$*IU(0F7%L>#EQ&;<(,NHB\.:$&[$()F)+\D0JZ>943K9M2[CV<?<A#9#<
M$%WK0CQEWC4&5;6I$%+6E[\TU49X!7P_,H$2JYI"9.$(5 19$L%>*Z 'H2TK
M9*VOA)]PKOIO;8GYOS&DTIV0NIYR5?OT)7]#EF&/(*?H*7N_UB]+VAY$%"ZW
MEW\/'YR(/&)#AY'HVNW>?A^JY$MIH/8I^W+#R9)%8^8S H(;4!\??=K@!3.(
MV,T@P9D/@T)%N"G??N1AV!]!&E16=)K6AOS^D,8W(@+W3HA^<L[MLBY1OGI<
M@/!$YG5N2&:.1Y=;4,T)YYY\^VEF/!D(W[Y5/?R:K:H_VXL%?MJK!*)\+K1U
MZ+J43AZK7*),?$25VNPUEGIQ[#><-G99%2[H!KO4!1Y_'< NGGJGL>C0X)5$
MS6B%OV]W>8%'/:K1$B/&41UJRU,)Z.*&C9==W@SX+=%KJ)&>8'UU]\\3%L>^
M1P6NZ<G"469+8G*!$RTL\W)[D)N& .4Q6%BWVX'@+;*[K0N,#?K)6]+PQ-;3
M\=^!O'>W?Q?(T9G!=&BCR\%G*P;-/WIIHML.]"G+J593( XM^:1Y@F2:!(>B
M4GH..#K+=<AJOH$=C/73BT#W^WPN>X6.\BS WD-B:GHXUA^V_?N A<+.-Z^-
M,@DB$4P'=5*\LC!:?!DC$5:*ST>R])OX2>--TPY1HRFQ:<I5TPUZ9(7AYO'_
M\+A[>G1,;P"<P7^QV+AY.=#U+P<B)[:,#;J#WM'.X5XWWCWU,\N>#+O#T^%>
MRT9>Y: V.L8B4MZV!JW%A":Q1OWJCL6;73'EVGW?!+<\$QC\2Y=W\\V"T-C[
M$DUY=3#$]/2?ZR\>-DQ[Z>'ZA1>P;\":O/5ONBI4CQY2L(5>W[VESQQ!S]#/
M8%Q_T$?C;NC-ZI9.[/^0?L]KV&4N(6/7=Y#6=(9EOS;M\^OXS19+?2PC7S?6
MBN1SEY^XWSWJQ7^E_)R>=$][NX>WU(F%0..T@:_\GTW?Q;OKG1G<(SBT/NO1
M[Z+M0 CL:NH^AN=.V#O!$CG-P>OQ/=3GWXBO__B@TN&G%Z/PI'<*.W^.T&S2
M6TWA"4:C=KNG/$*]C<_P,PO_@X_S_P%02P,$%     @ +E-85F<UV3>N!P
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M4AWQ^&0TC$^?#./CT^,X@EF2@0"F9A$-X]'I8?STZ"1^<C3BIQ=@2-5P_,A
MI7/T;<RJ?L&.[M.FH[!8XH4V8"MT47FQ;(AC$)VQ"4-ZJ+.$D41!R,?!M"7'
M?]03GC49./V+))V"OTV?JHR+#&&PA>PM@J>@^U>""\&^;U.1/\:C>1H/GYW
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MZB?"2<N*,L-?\L44]:6/AA(2)B<K*)5T>^B507Q;(H#N#N0,J'\]$1([2V$
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MLM1<VQ@:UPEQMAS,/P3FV% ?C*@S/1QBY8^,*/RUY9>8G/+4S>:[OZ*8GL:
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M1<XK'+L#7FHY)7>*+<3079&>PJ+QG&5,RQW=LE;I)ZUCLR6IU$-V[6*(B7.
M]LQ/1Z>]W<+X5RDQ6?QT, 1;Y)X6C-):I\_O+V#^/%BNX?'@!-="X<Y8V#K!
M ,3FZ#!E478;\A4WA!D8D. 288I\];G>K?XENF=]W!6Q;2=EO1+;2OM:$7:'
M(H&@W$N+;6\_"7SPL7$5X+99*7RB7G%P?"R'G%S?F:$:>J^:A_Z>8*F^1'^0
M*HM8PKVO73:)]A;B8N["]KFU;F]K/AP$Z9\D!3?L3)<X#@4I(4$%LAAR )]X
M!RCLGBIY"U$)@-MT>>6CB;,"UGU_)^/?2NE@OP *V/+-P$Q!6$*0YHVA'538
MQ$[QW.^FJ&DG]1VJCKR,&T'H4^P)O=NHKW]#@!\$2N]R1:DT> I"<ZAEY'5:
M'?SA=Z/1\?,#^)$=(HSVEKM]^1;[LDQ6K9/C6K917EGV+6[9N*Z))_'($L&U
MU"Z8\A+][-(4Y6626Y2:ARDFQXJN>63)]"I($B*E!!^+_H*?L'9$P(O#$B+M
M<RB;39I <QFU'GL+_%(C12R3_N[#1T<'1VM[XTAIF6OMZ>:-022,A;!!,&XJ
M6/VJ-5;ZYJ:O)AX^-?'PJ9VG7/<]!&ER,.\=H6EQ692K\'NV6J W-,&YT;W>
M!]/W;_VDW9G]VF>6H@$V,Z-.*:K3HD0XJ7^:-L0H=FKVOM4LAPU)QWIA0?)C
MO9AA$$7=O)&:*N2 TUH-]RSFGT&Y)H/H6(\\LMUXOQ@[7$6_)F1T(GQO)SK?
M)MA1&?.Q<H09B<\ W86IKX_CA>\9#HXV-JU_),&]+@!+(JD"P(I^64C)KD3^
MA1"2<^N>C5"EGPX8'2]\KF$4=99F7FQ#8XEI'480_8@NMQZDL?1&$(.W;77T
ME9+;1$6><]([H*HLF%&0EU6 !0RB<]QB1,<DZX7[BAR-W/%A:<956C/0K#)>
ML#R)EB6R]>2*R$.U2X&CHI08.S/-.+R,JT+KR1ON.?+!%LG /D&;,,7$8?9K
MO(VI7H(%YY+B3W!ZK].BP7;6,H5M;A?]NE.V&LVX=UQ!GC@V]<:X':)X;/Q-
MF-H#+(R7Q G*782:R1G;I<G,-0$2-:/AJ@=!=5+@#CX:;BKY+=E&LM;*X_ZW
M\*UZ61Q0-4FOKF Z.9^2EJFF:.*6J+(#^_'S58SZDZQ6W%E+3&'UKF=-6:8@
M\X4<"-QO/LO4^]*H8SLU7A&1-I.&<\&"1Y8G8<_ '$ :/L&V*36!'*075TF*
M3:*[@Q=E"(<TMJS5"!_T$H(ETBQJ5](9.E7;>U2X_JR5V!30JEL2EQN5RCS7
M=]VAL'BME:GB-G!Z@=#W@K1Q)X]<%XNPTT)_^E.SM2'(G52X@",1IL97,U(<
MD#A0W5F+4[0'VNL%O^'"H/E,2 %H-O[&\1%.3_LH1"]\P" ,)+UFAKWUF?O;
MFMED2C\Y?7Y+@]H6^0B0S\)=+5C6!0,ZX$Z"S3GF9I!&T#X8!0@661 KN-+;
M>Y "C7DG/L2[G)BP  45<:?^!-\W9 P!B[_ C.C7@:'ABRO^LD621T#RL5D5
M8M=HUUKF*>7)D&)HD1/B9_DN];H$D%#8<N:PX*,A[>Y:*\SA;L$X7MV4.>>]
M%K4J>$2X^TRJ'O+ ]G#MF%:W/,<]'90[AAC#NQR-#;XO)Y 19^"(BM)-5-=[
M+;O.@BY/M>#HP;R+&VIN'$#LUKM)GC\^7%I+,**XCBZQ%J!5I4-"-PNU<>4!
MAY61VG;30+_0$,SDK$><^5V]]D(7C>TWP$$#*N:V-.T;WFN]'ICS6HADN3_7
MM<8NK,D=+A,U!Q"3XA9<^O%F Z^O4^T=+,AO81_ZHNRV["ZVXI?2Z/?3,+*/
MZ4?7=@<AUU4ZV4'(=Q#R>X60WXOFN&-IN,#"M]K$[90"MJV=34G,FB%/)1L6
M7%CD^OFLT<*<]E7>DKA%8P(6FM"+(7SR*S25ZNJJ![,?;]M=?ZQ1T%I26G(;
MWIP1-258ZUB-R&7?._CHU\ZH$/4B68RE@0MQHCR68$45Y(;8%,HN,?K5<]F+
M19'FTEVGV[YOMP'?8 -*EGJ"V'#_1Z^IDG8KW&W%5]\*#N:D0<,<=#N%Z2O\
M ]=$:4,PK8KR>HZ9M8$.!$8E5")ES07;_)AKH'>9_6][]#@@ K>1$J[!'R[+
M9/Z]Y?#/ WOR[J94XO4);IE540):;,KA>XDOKCD?'LR165/UB^Y=' 3.S<1B
M!UJFL*/_XE9LU8:V(=MG#)]O7@M-;^PLW:^M80CI(LS/2H]BT9O<M<FGJI-^
M!;N;_FOOBR04A*=+,@JZ3T%T?+<77_V,P-ISBH^ 6F""<2) "LE<DFJW%5_=
M(/(L706U"@;@#G<%136_[.(CO"4U)<[]MRU\\6"6?#0X/L8E4%K=FQ.PH*GD
M4Y0CPP?[[72QG#*L*"C*W89]^0WC,I<[Y<YWFNNKAQ0K3,^DU94Z#;Q++N&_
MNTV^^9X@?YU86+;K)Y.TV?*R;.5WL^#ZLEWLXUL5Q%P769/7Z"+ZO484-2KH
MO.\K '+!F;/U(0_FEA&:'+_0K]/FCJ(2^DG+W*<8=HV*^!_NZ\^ZWQ-DR97W
M:1(@$N71!*#4[KJ,*>T,D_%9\ -"+OQLY:T:LE*(4NR0RO@LI!R]1&N$&)VX
MNX$-"@D>SJ)[JG"Q'SYZYHXY\#,.YMM S(U8FL=^>CZL1]:*!%=K:J6$P^$:
M1(TJ$5HK=POX&1$.D*29FS(I*/UI9;^H;3JHI:'@*3U>(3D9@BBC^I=96DW@
MB8@K^Z[BBA_Z]P[+!HA7Q=M!NW4(I.N-*F_:2P(Z8O\H4VK1D "$:YA/-&U*
M=8-X#U[/ULF5A[64L6W&,.+5UY<(I4E.$FF9Y3>'T<8PXR3_6#:+>K+B\AB]
M4XN2@WQ-"9O(V59DG+W$I[N5(VZ:C6N"4EG,&16/3GE?98HE5%>0([Y P:+,
MO8%U(GQ4<"1,WNN7,4L,$A^%@^+ S(9Q[8+(7]M4$X1OA:CHUKFY-<AWY^U\
M]>1Q P;/O^'*8=R^1Q_1-2*Q5H$*P>C*J5TC/,)"E^82JW;$W)NSS:?[6R\+
M*0)#Q P^J"XNN4"9<-+V@ZZ^(; G=X+P3:@&BO)C122UDS2C;*7RVC8E:-O)
MBIW<VP;H=COQ>>%L(IG"DT1%<$P#U[,9#]_QN$79XL:$^AKC"*T#(OJ?@B/&
MJ%7PT;1:&RRFJLF$Y:"Q#=_AUVQRM$J=E!@6G5KV=EU]#+_[!:@X= CWP.@X
MSR^I>#Q+\LL&+) (+K=*G%FNQDB9::&8-A-^$#4LA:>??[I*QVG-4-?A8*35
M)&+Q2Z4_/ H[94LUX.'!*]*C6@B,#03X,?@>1>WL^] #,H:*JDJEOUI]1_M6
M3<HU4O*P7=<W;'3? $?>6D?V#"1M4::%]3ZX>LA)"@F3-'(J73F@?LSOR]#B
M39Z F!8U=VD!.37<IX9XEE4W<9!I76WN-C61OJD#-S>2@@5K, O9P2,YJ^@J
M!=U^0%606/U(!.33:\I=CE>.&A41=R:CDG8XJ;*W7_G:NN/)VTNNJ:-0!+L\
M.CIZWN2@%??OLV5>[!2RY<M0Q?ZPUNXO<$.@:&"!9G0&8H-N<O0/7LC+!&_&
MM]PGNTC+^^U#2#7)#VSUSO[Q]CZ7A(/2/0=4*-JEGWEE.KW.7MD@'S>YM1U_
MX=K>>UB+?-;4."X629)3&#)2P.._+:,?W+7W*YRXN-)[]^SG5])==S^V5#'"
MH.QE'\)26J5C&IL'KS/N7>I?US8$[=:J3:KD_'\0_]4!QH3HHF,K18Y#ZX+<
M?* $A1[[+=GP(H6+5:CYX7'3),9N5F4RLRR@?M9(VLTU8W$#_+IN#79P-]Z\
M K-)B!):->4VKX3.@[2V(B*03@LMB62 $08N 7$Y[<'/GU;R!["CL+*H+'*P
MF^2SCGT$[0!X\GZLA7KZ#/%B+ [<X\/BF85-+;R<&9+"F;GE/>$%T_9W2?71
MNE*[ZFD5]]-=]?2N>OIA-^#ZUD="2="M'NFADK3M;2E;5"+/S9S+D*Z2.G:W
M .8)4J2Y27+#%'>N-)G\R>#.[EX-1/2GQ'[(!#V?)X[(6*X/O?P]$HV8$W/$
M89HECC7*2UX1O!<.PH)Y:/)$-.HD+2VWDNW20T_B.Y"=7;D(M]?;/=,;'KL(
M8>NN[O5.)E9E:B'Y9HN88U)T^]$%:@V%SB.(_0V;;4[]+RFQ(U$V<I?3[(%[
MQCAZ:71VKXZQFE".F1373LVFVQX-DG1FF,TQWZ.T,B&;F%IT%PWA#[Q-4MN1
M_"(Q<FB[L\Q/)6U(0&U./;G&7&AT"O5G1RR]MFMV9#BS\<I_*+-9I:UT&',B
M5A\EK)9R@U@JK>2 <XF\004W_<(.JI>*8.HN!.G'MM?AJQ[%N//:JJI3CBZ.
M-'&5FK@KV%,/_C3%&!\Q\3/8&K,)5)3VP [)E%U)'![-XWY/2*H.H0<IY,B^
ME8D$Q-%P9'_G(/:'WU)[Y$34I7GR&.\)[HKD^FWS&7*J!)LX,*8##LVY:XA>
M*MTA 6V*"DX.?979DON]G!N=/7'M+)Q&;Q=G4@1'=G<V=V?S,9_-KCGZ&))[
M;]G:P(X%VYO">YUK@"D.5=2$+)E,,M]<$AUIG^)US(+P$:UG%TI=86)D:V\0
MG574RE[[I;)RQ,/48#>[8  VZYYXY>LM9D2!YY$20V-HFE9SV#"NK)_:!+ZQ
MZAQ>)8^[@L/*&4;\FQ+9\G"%$9_'_!T!5\_Z WCM&RV@,!"T>M_UM@FF*1S:
M?*>Z6[+KT\?T.NO*)TYLNB^UR%=+9G\K;WZGM'LO/J$)Y4BZRQEO"J5SUVQI
M7X$I>C";T$$KV3/B9_%C0H;1N^P3G\[=9H70,F+N7NU@QO<),PXPI@()MQ@O
ML-PQI9!<.KS0#F;Z]<&-T7K$\8,#'.^0KM\8<_R=E6W^ZG6/(M)YPN'%75O*
M%MR(?>:G=CG*\<#P(N0&W"L89+]C)HM#,FDJ-'"]8JR-E57HYA1-O:::"'2&
MD:X!P7Y1:L(6C-?:G2JI"FEVRLK,A; 0Y=?:T^U-&K6K>!-I3T&-2*FS$(HT
MK(=S1 2DL*'>MUT7"6L[7]1^MZSO*S.WKNI11!,!(CVXF(1$NF^=I2Q:8KC<
M9:'C!V)\MLCY1&PNN9Q3D$#"$1*II78JY0W!VM9^;^\&OMK0\V%:3*3#D(H[
M;\AUDF8$2^GSR+T.=.[[MPB/MT\8DQX[L;%! XD]] 4->-A?!S"VWQ.I$@E7
M)-,MP J<NY22;$_E:(6I+?*UW3IF6)5ZY;HVPT!O 6Q;=R8E62C?A3O>C=F[
MJW041 ".2<H9=T9,HO_^P^^.GCX_PUPY]_7!7'-WA5._K9R^PMM_V,/@JJ/
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M"-*SML;0)N?3_)?M54; =XA&7N[+%22\XT3UD?8$SS>H8M?[L0^8*S8$]6R
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MK0Q?.T+8&(RM#&U*[T2ARYE*[1KH:V2N/J@0@]4@$J-'@#K8#_L7V&ML&''
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M.$R<&Z_9Q>_U#B:_7ID8EU@@:LT@O3UT@3D_NDC*Z#K)&M_8'%GV<&Y&PTT
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MHB>WP8+./2;Q=N::5%VE;$>>6?ASD9M:241<3RF:]-Z+GU\1 >;*+SBC"K1
M+B;P]O^8G#\9_DYA#:F:F#SGN/T(HLM?<<MM^PSY)>62"\KN8\_[QELDY)3!
M#Z6V.P!2"KGF!0R@SLQU0F7-.(>"6G![/3SD\5+Y(>_TF@IX@]X;^U_$BPB>
MAHAA[HYGZ250M&[S/!S+9)]4$J[%^2\J"^?G9W:X&/HMJJK3=R%H"Y 1)+@4
M+#(6 L,OJ507NXI6S/0^:S4?0,/KAA%B-3$:AI.D,E80PWF3=@:OR=2V,- N
M!/5JXD*]%<.LC;1"10(M>..$B%A1R)&3-?0T%M1O):2I;@DO47&YHO=SF'LQ
M7RGGN:4;"DF[$'^/C55C+TP.#S@Z&A)QV]'O<794[]SKF'=Z.%#_N<NDG"JY
MD HLBSRN*;:1I>X0$?A.AJX;!$UB^'1.ZF'LHC/82;'W$;2Y2G.4EI-FCCEJ
MA)1S_271Q6/'P%G"J!@Z*LG.)?OZ:4S$:5N]@ =C9<\"[EZNKO'.F[BW?> ^
MD"M*?F6H9::*'MO5S7V#K?$K*:7XQ#44(!"DDA.$^[<-]O8:6D34SNU[L-(6
MAFBD2#V0+70'N^(CUH<A<*DT_VJF&-9E%BM8UZF9F9Q:(O%U@7W.J)@I7=CJ
M)@IZ:,\@O-UF!*C(_%!0V?L:<828C BO=?F%6)^K:(\''I;FRYU/]]K2)' Y
M(5U[DV0'"!B\+(JIX(S-Y"J'=;\D;I+7'Z)J56%'PAALG]6BQK^LB.<=,SV+
MFJ%W4T/$:7%TF<S'&=E'=?$)QH2="[E[-'T#C2CXU3[9;YTUM<5?J!@JBL\3
M">RL3)#9=0(O \N'AXI%5$K7YLT7J95P?$ML Q*SJXIA.8G-5HL$32E9L"N#
M_%_P*=1"09/6&"[N<HZF.K+)T=NH)A '/MG7)$)ED.>>5FU7!&*+0(:[(I!=
M$<BN",0_$Z >358LN'M'KT9&>E"*?_OJUU=LX[2P?P+]-EDA$[(H?/ O06;D
M^L [)T/" W(:RV*,[7:Q_QJEHJ^Q"C9OT"TAS0TJT<Q38<VD)KK_QEA%,V_=
M ZQ757]W+@I_*DQOIRXB>(=F2:>?'[%/=\'F:V=[#0UJ"X4%ONA#8JRAS[&V
M?1)3K=SM.MHE)8K$R58T!O(8*&+2^OV4ZJ%@*E)&I0L;*-!8/;V'+0SMQCU+
M2\X!4)S*4A>A9;&O!"2V8PHQ&=KJ3>95<"$JC*ND^BV,DT@U?0+S;THBC32?
MDKDR@'H-Y ?1ZUPH\VH,+'#<8\U*>"$'7C]B^D"V71RG-Q7.AAV?K%TE(A8.
MYF\'@BDTB2]A,3J+=X66E''AZAL&)P,@\YH(KAWA-<(!P-2Q7&*!4$C#&^V"
M69H9EB5;LK+PP["*TD0LAOG0SHT[V>,*CD-2"ZD%S,C4$KZAU$V=?,3 3)2D
M<^;E!>FHA6Y#IFC-76OFTG!"3BS>3=>.\3/C2$1'9Y-+N(B8;>2H2O"TJ^2:
MU"66%-DUN,7S.?;#CNB:6"6LFY5_;BE.O0+=86[U]'-R#X.R?4&)Q186OVYX
MP"4]G-=829W,IP7Z#[&<'GT,MG^:M@Z8]A-O#Y;GHZP%,X*XP"6#!PW/*_A]
MJ).)B$*C7J#8)B**CAK9R.F?(#5/38P34@VOO?80P'+R]+E;FWJ92A<<AZGK
M65$<O;](TD=1:( :O N;,B=\E-+O))_"**=U6'$>WD()(N<DP.-$>PSWD^_0
M1:2%!GT?S"FL"QH1AK*_O5>2Z#;BK/AD]ZK(B48D>O'V?UZ_/!@^ _\5M,*<
M:)-0,9;&2*\O1Q6-**W1X>B0^.I)5AG]Y"K[1EJMP]WMDPAL ^J?Z2+C;;(>
M)RL2))^&H>(P_@N_X.VELH3R$G[X3Y",SI*EG^]94L^!F_ 4?3W(>RN<PB!_
MJY4!=EZ4WF8S3'AB4=Y';6 ,VG5BIJB,,:UN\Z5,'Z/)!QZM='ZN_+,8KJ$V
M/Y;TNI#2WC XBH%H(S>8+O*P<P("!@%+!0<YS=:@\[;W=*!R?4'TXUYOA0K#
M"17;ZPYY%?*V!'TPQBO1HEZ:S:4?.<QF7"K<TX2;\QUT05!*JBL%,5_KK;>I
M]HL9N1-0HJ..A1772[!U\N3$4!HIA*+=O!S1GB9K66[>"XW=\&1T,.28K_^K
M(^[<T_GDT!;W_OQJ?Q#]>B7L=IZYP6>B"JZ!X>@D/CFD4K784P\!SD7GWM.6
M@,-O5.V<Y'#98Z]051_"JM-O<_OD.A;%H%DC661];VNQ&^2D<D&\?!7P?YZ]
MO  )>P5*HF&(CL\C7G$L\X8ML3:AN_-!2&?H'R((HY)8/;(8EFE5Y+;QI!@%
M)%NM5KKFWW1IPUJU#0#A"P2;#30/&4-DG_'(R$CM\J>)Q/#*_D/%X/3DP)<"
M;;3+KY$YP<)A113"UV ^,Z):XF^ [96%5(6804<"?Q@X)U^W097U@TI>4-<L
M24M3FIURK-$9S/L &YJCJ;4%LU^KR%'%EMC5P8=@P')L I,PDL')+;F!Q#N(
MGR2F0$8#("UT*>A+M/(57!Y-.LLNJ6QEG"!"-?N68H'!$S3 ]$![QA <.0-V
M+W8$\AIKX!U0E'"4\'O4):"1Z ZJE2(CAZCU1OJ/I-2;,6)"J)03M H[Y>0S
M??:"847(TC(L,K)FALLB]:5<[T )<C(V)](;1/2*"F.$CO]\42LGLS6W<.04
M.A![*O%%6$TJ:\NHMYCXC%($VMF&P[Z&LF/#%@DL2K-;=+NX_45\'?N)+,"7
M";)8TZ<LB(-DO""QQ!M#5E3ER3%O$@1#($"(9*.KR=L#L.3YD* ,U@GG>_*&
MG 6+?-O>3;HP&@12R>9TER/4S24GQB[&!@.-/1PY#G1YCYY' 8SPPL((WS@C
M]!V#M^3(; 59RHV7G]C2*9>>;L&,UPO7&]!Q;#B]' Q/!L,!2)&PX#7<$*G(
M4G;CO2Y82$9-4J4V* >G7L-OQ0I[.@@C-;:JBGB9P5? 7G"CPX-7Y"YIX4**
M+BNU14+S2RE2'_7QOB-EUFNQ3.D6#5R[Q[P(-Q7U!62X@C195PG5Q?AUC'IG
M&?D$D>JP<.D(PBAJ9L@%CP[\"I#N<J6=EWJ_B"U,J<M7X+:5! Q /G!K>, (
MN[17'(8-&"MQX,H3JO27/7Q9)JVO3-";!!$<#XOJ#9SQT='1\XS_<REF!*>0
M^'<U6F_W63&]KT;B@E"=CV0!%T5S7:3E_2X<!A"2$E-532T(<SYK'2W%5'D]
M0HRRKND\)_-$$TW;(>+_XBHUL^C\$UB(9#B^1<P3M>*-_8#2AH\Z#*&<<P+@
MXXOTM=6#VWMN;HD='"YY_W/^3YDTGZ*69#3\W^I>)>)17\FWOX#7WC7LX%-(
M; ?8_A9EAUP88%V@74^;;[3T?!IL<MXG3+"^_FXSOLUF$*D41T,P*SK)DHHB
M-QBS!XO0155V&/EOT5N&D=G6#>#T<E+7"?:.HZR7"W-=IM>,M9Y0PK7H9NZ^
M^(WZ_<&*NY&:':QX!RO^KF'%Z\-)&&;I,ZR<SFJ;NO5528W0I7@U"?JR2[#/
MAD9V5O'7-\TL.(.W@+LJ55<[0^Q>EAZ,,5-7KN4 (Z,^IHA3V6W(URXE9=7$
M#<\XD5-@1[3=TG_MI1\3Y0/8#I5< PI@SOA^,0BM'W.CX[*AI-%N4[[%IO U
M[T'H%V4Q2S%EAV6)Y;7A"DGA'#3SM)GO_,9OT9[91;&ODY*@_K90AO*I487(
MO)EV]IWI^2$$C&U]IMU+MC80^])V/2>,M^0;NHA7U?T$4>\(O<IZK.+/P-'C
M)\_;PL_9(?<L'Y<T*RU9]S(IL69$2?O\BA^I&:X-$ZOC_4.6@==,3E&NT3\&
MT>CHZ.!HU"IN::4[]Q61^54RF3&5&B(1B46__[LI2L1K8M5'\B].-08X7:]I
M+>9A]&T;WH(U/]8-\0+G7#_A\DB= *-M!<0KT.1)GL[QO-AY^Q!H>;EE(O3?
M=!NY:,O#(#I#ZAQ*6#E$B,[C:VY+=U>XM*"\>7<(>\XP?5U[1'FT4#__38]1
M%!P^K?6!_RDP2_9>RNSHJ1<>*(NY[.WWJ3I@:_706VDK&6E'R;C;>M*R4:I&
MQ]Y@62,8<4X["FO!FIY887+?UWC='-0Z+:4M1,N[11Z#Q"K(*R(DD34*_@P/
MJE&*E:?]V9/(MD0C6#5^AC0",Y9J%P1_^D1#)9B.\"AL.@*N?>KGK%G/'%,L
M8&,BL*J($)B8SE**:B3U+ECQ+;A^;"W Y67)Z?] VW=U+ &%)0KE,\@2LF>!
M;+$+9@CCT#N6(]5<DK1,JO6BNW,_'M5NCU>6S@8M*CS">X4 HA(;>*Q7"^.=
M:C G/$OK>#@\&,41UG ^.7U^>T[%?0L,[TI;5\1&QX<[$7N4(M;3$YXD2\3M
M:XI8M,<=H^5U&(HOD=AHBH&LK*E XKBZ+&&24OB#0[_;NL^=H#Y80>US';#:
MP>/X"FPX9[G!IL^IDI:3_+9G%-$75-($A(IX13#@"\,U9:$)<R-05%I*:K3<
ML-^X4GO,TF*@>87A/"G1L,.,2:CIESH/FSJB^CET@JAD1 O]CPY_#QJ\C(X/
M?[^/97=:[RB')4N67**42HTE,R DF39&P<, )N?*-EO/N%1(::'17[=5BO2F
MX2'_8XMA:V%GE"CL!N=W?0MY_/Y8*1FR:S(6,0;;^_<L2F:S-$O)'G?EL2*^
M?P5O9.'$DJG;J8,O=U"A;H'#TW[)W.(=8;*.5V9<NA[%-O"R!NJ-QVW*1]D'
MAE,MZQIDK$4T5Q'<8'!WX,M"P&[G*M3P![OVGI99NY^#Z!S<PI6GAIHQM8!@
M0+S'TDYGSX9N)B:])IT35# A?(G% .N_<GVJP^[6Q>( !N'W[QY$?S&K0MA-
MF'ZG7H)XN;Z]5(Z(UUU><*EN)OTD"L(L*_K8L:4ODY6G6C>^/=HSF^<?CL5.
M?(8;W0$NWF':^U(WP*^3_D^LZ'"JQ<+DT91+.?_>P"IO-]F"]'&N^U<DCHY&
M\=.38T]W$>E2#LH?K*B3IQ%=0M215/=/SH#V>%O3$._>.X4-XV>'S^+#PZ?W
M"?O6<DO0/;@%2#\TA,OU%*[TXZ!WF;>XUVD2O7KQ[ER"AI5TXN*+"51=RGWA
MUK;$G"$M$>Y0<!_AJ1)[P2].Y@36T=,G\>C4CLB.0'J <9GC%QB %EMV1^#S
M?3XH,3H>GL3'QX</0(@<=49@:RRO"A8A ]HF58(;BAUN;)J*A#;T/?+E]) S
M!3[V'LR4GD<JF%W[=ZY";RJI++^E1&ROBCU[Z)IP^#0^/.YM>OFM19@%CD$.
M=S,G?!7Z(%?Y%$SVPY-[761_=<&$Z[E$6-D^R/4;/8$+^W[73]<LN/8>^/T4
MC9Y%AT?W>[A]3J?=Q?1P+J;_"7C\@D*+,+[1HRDH3J9<^E./MI'M#W\;>:N)
M :_)4P?TP,7ETS,K&9N#>R>#"9XN#^0OR!U0-0ODHJ\*\"''Z/?O]JE'.S'!
M(B9HO]1>H>,O(V%RTG"3YKNM"\L%_ 92[&6W)J^$'QS (#XWEY"P,3\J,@KB
MULSAC2PSO.$PUN22XC.[RJ??;!(?[2J?=I5/N\JG.\.V\*:QV*TOB-GJ)N#@
M8B&N<>I XY&D821<LUU(>V>;/^-@ ]VIH%5'Y%=P!J"*V[SM/H*KQ>)+6M@!
M"STJ&U/.64<[-/(.%_5->J"UB?FO80DU*NURFD=/N;6R9%S##HR"#L#/#0<G
MGY<$MJG>M4EA@?@5M<?3)QYEU469GBWA^Y4CEOM.\*(7*:;R*1<CJF=$B>I8
M$)"+M Q*)KGA@2H<*=5@2AR$JUPE4Z;"M?TSK)4:PI[7;%E>@)N97\+CL/?'
M9I4E-07.\EVKPHI%K=#\4%'U*J@MWFPC_HK(/C+@1:<#M_YQ=&%RW."?K;U+
MQ_?<KI@>E_,!GQ/'R:B<BX]Y]>[(A/32?'?T=Z^[Q-:L%M;T@.X0XJ&+.S6N
MCJ(+&)<2 :]PHD>#:,I\:OM5;RI?$""#1VK7ID@JS;298+2*V>O&=I"]9#)D
MMC0U4KQ.':>,0%'H4?HUYVUV/\_#V?2)]:,+:T?# 3"FW1*LDY6$VY5E5F7K
M /XFJXFN+[G2RM*B[Y?6337U1IFR"YVM;-4*?B?1TA6?"3>Y+$G!XGB7:?4Y
M-^BW%FV4TX<_RM>N2T>L^,X)MIW&<B4TU:GS%9C'TB*^O?.XDU6C]0R@\6TO
MA_81:Q<YH"R&;;':SVX60NHM4%>T[[CU@^U2L^:VEL8#J!Q&QP=D.8HQ.8AN
MXQL%!1AKT$IHHHY.Q2P5)"LW ?'-GZ-]1Y"##^.CUZ.FJ%"+YJ]TY-CI:-LI
MGM]Z[6^&QSYLKV?%97U@5T[C)\>C^.CI85O^/$6%EF.]1./1-=B!W2;]]?<D
M=[ T^ )"-UWC+]H73^,)"LSV5=B>XM-^,NAW;1CU%LQT3;J?; \OT+'.S$AG
MT5+RL6L(8VIJ)+9(TBFS:%=7L467!KJ%.M51LX0N7)U'@2V7W(.IO1*(H)!(
M8YO@,=@1?-U7?4^Q-:/TP,OT6OPL\GKPYE5@8-_XI&$:/TFL(NDBHZD(M NX
M&XAX:?#-BA,*F.=0^).NJ8_P1HWL+YK6)&P('K7:08">G)N$#<.$UAD6?:6]
M%+&C87T KA?70, ?L7X<)M61:<I]4#N;&=AT&"V>;H37!=V7$^E7376I6BJA
M&V(KLE:VOUR&/?4H[G#>E$6.C<3>)65:11?4Z>%<3*]M4"G]!ZV[_)W>'=AF
MH;NH:K(N$T*4BCF*B&QJ @#/(VM=34P]9-($+*J7Q0&8 A**\>#@GV?OKZ'W
MI>1.@ZW(IF9A*-X'I@UH"?HC72923(R)/X?TY[;E%?>!1')X.1%JAW'K4"Z*
MT3X4BZ+B+D*T(MW3W]>-DS[*/4O6U5NH91XVD=3"=#X!.%8!-L(\8 (#OS#:
MD_B\0%$C_8/3@4<@(SD<1CML^%7*%DY/S<XM)8.;%H$^$=4XN2J*S_(,'LD9
M6L.@/DFYSF2CZ+J;@.-P/GFI30A0^[5 )=IKP]JO'>U.:':O((8CMUJ5XR*X
MV+UU>_>F>^8Z50?KB]00:M.W(W%8%21A##I2KIFH(_YPKPJJCV /)QC?QAQ'
MFEORB8WB$E&V+*(NKI6&Q1-14JJ$URA"U[&TOO);G/8LB5^&2+X_%BK]UH+$
ML",:E2:ZGFBWJ$E43>@5EHUNY75VI7N3"-^/:8^=1V)[.U)C<3GO+DKS,*9Q
MQ]@IM53YO"D\.&6RJ3F5-B'7B[45V2-T$9P%C>S!>6(>'F+X*<TE-7?FLH]Y
M)(_@?(8<$>G(3!KH@4CT'47A;R+=6R(-/2'RX%K(@DS]U,RQZW0:\/WX]W-?
M2,Z!*#W?R"]A'"/^J?B(5G/)Q8\@1LG4+C&5L9+%6F,8^%=C^2BTJQS-@7I=
MX@30"P+I3DKM%+J7L-S)S.AO=!VNX$6@L3BDR(ZF9[52_U\8+YN'Z0*YJ?;9
M!,ELN1EU"0L$7Y^'K3&G<^EXSM/\95&;ZS0A*]H%1I?>A"H#;\,$G\S(XN[R
M9&YLY-L/7LMAM-!:;.>1M/KMV2M%&J;' =%-WP?A]3#FE*DV\7(W6(6S&D3G
M[??OL&(6*W:\PXKML&([K)A_)E0Q5U?%L@H4&?ZL^3<I/6XWGR2#8Z!:DP.D
M1.DH\1G,X#ZL=D-[V#25^C\3U$W4*5QH-MYG<K+S:[-_WQ4L=)-X=U>0$:T\
M4+GW&;F,UMP8N-,QE65PG#G<*>YF6T?38L)DM;#1XLIAL&Q[W7<!X)./)[%:
M<?6",*[48\$2>X;U0.'[:GO[1C>N*/T>#Y"W2\7Z71J;JR2;4<OOW%I-'KT7
MN^_>[>]:4_IV@.U$;S_'!'?Z1#! .E98^!:F->F:%C>_6I_#[6W1=FUI#&O<
MI P($J]&(%HR0A%T#@ $;7-58VDGSD'T0;S8JOVBUG[@;E*#1 V16/+L&R:5
M"H:_O69;?R:T7F7!K7"IYL3IB3E8W1D?"2M# C%I:R2]55J+2L^;4%M4D7Q,
M^'"7A7E!I6/"\P1^Q971E#B- 4XE#H_L<RIE\8+Z8D<S!T);E%/C;CJ;&?!>
M= 8'7JS^E7T2:@.$!62:_'I@%QOO$*P<+%N2W?/MY3MLM(W$5S<2>*Y'"EQ0
MJW&O9@K97])JDA62#52YH30 39%D!GQ6\&8]GXH2E/ROV'ME@<8Z9H!(]NHV
M4J0H]??!*$ $]&4HZ*R?-#NH.1*5#)+QH"LU!KOCB'K[%DZYI;G])OQI!K>*
M\;\8<VIXC$[\HF3FF)ZAH>;>1#A,:LHEF=D]E@3I+*(<KLFGG&:AP\V@E;0F
MC*QM1LNHKS7S8\@^+T3:%Y< _UGZF<LJ)A/.*679K,EPAR2OA'\3E6%GC3><
M/@LT?4D#%R>ZNQP2 G 30]1: :-I8\@93H0,/6S3$"O6%]/?#T4-?/AM\=P'
M=PUM"H9.*=5(W *)P+T"\K1V<,R+=;,(;#N\ZGW+=_#SO-BV0H)'16 CC0UR
MNPAAL"Z99[1NA##T6+960\G]#OHIEI FO(&TM0PJ-!I^F_E[XSA0Q?L.%<-0
MP,*DV)Z3%43^,XTT=_&86/ _J\C,7"-X[,81;:^4G44S8[CX8:[YPI1N'67*
MQY4:E\5'5.#Y=9%=.[.0UIE+RK$YQV523@D+#$=]>65J[?WM?2PJ)I.FK!2@
M0#T&:NQ'I"9YQ&(OE2;3IL9F+ IVRE9V8,YH30DE >Y%C81BAF]>9%UD[T2!
M@ ^L<S+>J??;&CM%D#!R\@4N0&='.I .+W'E9YV^-++R?G*LYV@K34PR3C/T
M$A"(!OHCB\!2HE^EC_U*_I6]+8?RT)FM;-3D@9T4-!FX<WC-_X%S7>1@%-_O
M\2G*RR2GHC97E K&,QT*/CE<[C@OJEK=)BTKHS],+?("CA*>-SUW^*1?<MP<
M/ED7-6?F@JQ60FB>&JO:X*Y":(?D"XFVD3NZP0E'HI::41K\CIGW^$B>_*4O
MMVYFY<&(_QF'M9#'F#HKJ/N2XL[ +SDKJ<&$71GQ5R\C+J)B3 [ OQHP2*>I
M6 E@WR($47H0(;;MEPLY)^0+]YXC>,HO%X(G1->S(C=>GF_(Q9R8\*ZC").Z
MJW"T_F/(*$$UZ&&FV9RVKP^>@!^5\<0M&A$XI9>";;;,1QRFIDB4>-!7"1NH
M=9 *X$?R"R+,>8RSM+J:R^L3K'HO$:.Z\O5-#_JJOL)83"*&;YK;'Q>EI642
M<SN\Z58]A7RZNC,SY59 +JZ+JF_'R?X-CHMA"X6%G4,L%1R>Z:4D?<;B:V&D
MIZ&(O^2'+C&H7]_Y5.TV]1MLZKAD2!]L30I7)U(>3#1>UPJG>2+@&:585H*F
MR$+.,NSKFD-Z%T$HRI8<H&CL9.$>#GAWTX)K3W90;SUFND*1\D4'_N#IB5GK
MKO0O!"M&O_E*V-[ R1ND58<5P( 'FN,S.K:ZP)9CT0O?SXO<8) 3W04-AJWL
M,<7F9VB.RS&7"$O7#Y"3#AO4VIS8QER0G8<2'W9#JR+#;BR>>MBX:_"HHL'4
MH:$4\"7[.7@MB'#Z$0,OZT# .!$Y7 ECNTW;:I+475:4]:A\:#?;15Y?0/P^
M:*)<LS<R&E*-"FN1(>DJ*[>U$W4AG9DD"XH<P6?8GDOG%-VK<67\>74=I.@L
MU,&I</93K#5+/TJG&R(9Z1M3TAF5K2A ;^0Z!9&4\S0'::SMZ2+7,EOA:"=9
MDLYC3H"GLVAO:('ZL*[NL4D52IB,6(S,KI%-[T18#:-2$(6:5LBT0TN6,?^\
M&)6NIUWX',D6T9LX.32Y*M*)\S9%,TF+ \SK)LVTR912Q), T47*)DI9,-M/
M:./PXVAOY-4NV!69%J:RF882GI<;#NWFB12"2I.N10'_O^+R^9BS4 MN\.)E
M(61[:-2%TEV W#2EG2U3$#H5S,C>F<EM>2$,]:AOJ"D/%%^I15R\5%R;<7S3
M]&89)O8$<R$+6I1=V=MCKR(IQVF-IS]!OJ-]3?LF"&.9%',CC4AQX>UIWUY]
M'D17/)#V99/@L::6# U2DQ7S!>PEQZ=5RU\E)0(5L,P%SUU#>^D5H3 TID9?
M<IK,P2M$,#?_^AK%>>[VD9]"B5 0U5DJ* B*NJ;P!!Z@;0H9]H.46)0;?JQ,
M3?DD78#RV\&)+9SXI">0NX,3[^#$WS&<&$T5O M0L2R0EQAUOR@LN9UBO!0C
MO.'X/N663=KG$@],'.)0I(B0GFNF>L?A$<)Z: I;>[VB0D6JQ@%=GU/0P@YH
M62*^=GMOHR!.W;(HB:<';"H;IHX58M4?!G)>9*I. [-E6IX,MJ "Q]$]RJ4W
MU@856NZIUY:KGW\G#D(,VD;/?$)[JR+0V#1"^SK-+611@Q->?H6SUDI,[W56
M[1CPSIUI\8TRLZCC#=U>@<)"6<5NE1;I.2V:<2UP=/4>6_$F7KITOL X<CL>
M "90(PR.M]ET/P5VT\8SB*0=#]OHTZX->8T))RR1<XM*(TNN1H,X\"N<9QM*
MM72GIUF& BSCCS5+3JU/OW)6S47.=I3BH5UWNK/K=G;=0[/KOM&1Z >UO#R_
M>/'^];L/K]^^B=Z^BLY^/G__^L79F^CE^;NW%Z\_G+W_9W3QM[/WYQ=;>_M]
M("/2E8F-#7:I*<TL W5=V8N(J<0MJS0I/Z:O9+N+&P;/027 NRL-/E'%MD4T
MSZ(K1Z2)-][9RXNML"OZ9>NO3#ZR!?/KEYR_O_N9D#[1"T(1_B7)/\;1F\'9
M(-H3YF3]A) >[\=H3XGP@'L4:V&EM ]!<2!#W%7="Z/#GD(4%"A[]O+]/B/B
MBX\'6+Z_DJ(U*N6"OU(1O/\D13E0-M%1@KK*3V\0\ACW&X=>J*CRPB_HD4]9
MSADNQ-@K2A>2]&@RJ87L[9ZQKTNE 4]\%(&38VOF"Q1B%OWES3OZVSBI:)4G
M(!K%-$WR[ERH[,^;4))SU!>+@01NSAZ#SZ] I'.87Z._H(,*2[MR3'=*TB$D
M.FZ3Q4FZ,.A*1&=SC,"S^_J>ZE7A'R]%G9RI.K$4E]KH";DM5=JF]!W;@GEX
MA/2:PQ.:=2*/AU'0F^AA;XI!-)2O_;T!NWA$7QD=6CEM?=835RPVM"PDVFQ8
MW\+11SA2Y#/A?_?JXI)<!3;\Y?$==:DO8%)"MU;6AY>H)-9DV=[0LM<><@V6
M_NCI$8O9SPF8:*"^SZY-WF /U^%7R=^>8B[V%@G<CCE=%XN?#HX&/48B)NWP
M =@XX3YQB\+4D17(8P'/Y'__LR@_MO[)/PT/AT^>#=9'C1^[=C^+O ("ZL;E
M:^DN]X=7IV:K3S&E"7\ARAZ&R5L-XA<3P#1KZ:")Y\'U+_'MD@2N"IR>3X4H
M?'O^P%RM7.]%$MPC<$UXY-ZVZQB>W/!&LA.CBHX2?6OQK&V*2VVC])93I;+E
M"O:F=D3*7 @$=Y?C:U9B0LJ]ID02PPNEHZZN* B!R63$:.H]$0QC[0#@#\Q2
MMN0,=%$%,X([:!NLL_5T2F**!O)3N.PJ)9:P3%,K%"O?@)5O*4>\GQ?#_&M>
M!64X6G_Y(=CL[N-H$%0$; @I45]IWKUSBW#VGO\(4C.@E4$%%0QB_5?E>]46
M*[%0G9!)R$X*UR_<UK<AJY13ODHNIDUV9FEFV?O2RE),,*?J3-G;V/A)/..G
M5..GNS<(!9A1^;FU^B[.7Y!Y@P'!JW2<UDK@_JZHZH-SFXQN&SW8+A;'\.K@
M5!X)![]C.JG:Y<&VG^&&<_<1C'I&$$P*+9;F$K4JLZ0?PE@*(?.L65!7/H0?
M_YGH*RI_)7GI2!F"9?NO9HK&$O$R>\4 EH^2+?+P!-+18VMU@<B3HJDB.$,!
MIFN6EE@R?ZN-C*526$8/VB#+2+ET, 1">M)(:3F.AZN7CPY!T%:5\%;:JP^5
MD[@2! ;!J5+PNI@-<+FY3MQ690?%V%?AQ5$BWQEG4>J4U,X=1#7N"(NG5Q"V
M;; >436MI1R!6X@JIC#@O%A9!N,-;U9&[S6!AYM'88]MU]9FNWHKE.":&!?/
M.::3-RV399)UNIT\YLG?L6CJ)7@;<*Q78FQ5V[#QFT)[UA$G\H0ISYYGG@9D
M6&BI=PQV/7&.UL)6BV!O6,MMH9$-^9Q5\EX<XA=,1WF@3T2+S;2)+":*\DK^
M@6J[3C[Q^R;P1$8%$6:_0BSH?.'^7E&AMJUKMK_'1\?M8 2M@=:2<)X3VR>!
MOXWW>6\PR"=ZJ?SU$AH)CYE"%U<M*PN$$Y*9WB_7$:,:20L]9EF\XSE\.U8
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MJM[#3U_O&Y\F>_1=B+U$Y40K1[44:>U[RJ(JD^6LX7J;&7BK+8O>HAC1UW>
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MB6 7RTDQW=]A_9$./P#S'M"83#?O1[2/N<N&2:7Z-8\-9U")5S/:1W3M+P?
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M!I9=0DNM7@Z.5)=4O'E9Y#BU<U:CVPW*>YE96,34Y8,7-1!@N9ND31\+#DI
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MKU<4^(H"3_YYTY:'\*^[X;[^[G]02P,$%     @ +E-85OX?_B%- P  A@D
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MGA;YVS?>:6U>*/5;:?P'4$L#!!0    ( "Y36%97MH^P& ,  ',)   4
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M5CF*T.E:?[8V[[+ZA3C^#E!+ P04    "  N4UA6()7Y4N-*$ "A*L0 $
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M\%3 I:&_QG;@M>;\X0I#/$R-G0NQVUWT%1$KA>:=QM+(;<OP6D?^<(5#JM@
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M7:UJ*2%G:-"(95B.:W>W^]!D9(LU#VFQ&+SAG:FI\R<3/M2;]L)R<9+[>WA
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M_JMQ%SYR#\H[AWZ.E@PYYE"]T\K0NE1S9\H^H47Q.4D_"S#J)I?E^',TSXK
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MHYJ(V2R\UC]!DX>N'"'5#!&@2ZU$B+Z:2W31HLEQB;6-P/1R6D B*VF*(5$
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M8!@/23=!A2ZY&Y;@84Y>"LH-K].S@-O*:*/GK$01H@1?G1VU!W%X>S-8ZD#
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M#JK'LM>E<9\]<')* F,.5X\Z>ZWPT.RPOMW&#!3A,:+JRF!W.[?;'-83Z[5
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MPV.-WG(WXOY@72DX@)^]NW%Q<#T[>7: /-[_+'^4>/W@TM]C7#4.41Y8<&Z
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M9@D*N@R#\[R3VX\3,/<^!0VU7NI:79VXB#BQ*+0^_+J=^!GRX\WMS5MR?)N
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M(RH?N)+U2JNGO<(UZ[TFX#I?3.69N"51;;:N;VNQO2*K78J4GY<Q(IHNL^*
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M2ZXXL$A3(-IKBM7A/.SY\?4&3(Y62U5,'*H.=8(]JN%:*K!#M<7QO? CC5;
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M<%O6Z$,'SC@@*>::% +#R+MAK=G*-4%Q$80YX4JI*8WZU$>*:R8E.;=!4J=
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M+\;'\4>PAM;H.K4OK%@*'#%A9.R0H]JWTU#;]Z_;1_%'[V_M_^+7[?6L/5/
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MODSKP0@7C#GZ1'*]FJZU,'5)"Q4]$LS#-<=-YLN,/W9,#HD)BM!#*FS6M8F
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M?/>9IH$D7(VB_=IY=55T7 -C/%&'8@T2.F(O\@%&ZB_G\%' 4*U:39II7:-
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MR')**2%(8.7^W&S/0>Q-YGED5FF. B=8AJ)NO9I-C<@!P/,,]W]3\J%KI7V
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MAW9LXN@&\P? ;".@Y0!$OX93>*(WI%63MZ.!/ +,9TIFW;#^ *QKJV*-SIJ
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M48_,JLSYYH;N'N8V#0$]=R+NEXE\E=&T+!&23#?SZV]M63:&-F"CQ][[>&/
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M^3V9H1E.>8Y1FA; *IQ:DV+-%:9]SO):^T]6:H]M91Y \_.#.%T=/57KVF:
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M7#U+#L[>V[3*U94*3VM<.EBFCF6[$#U-7#R)9OXYKE[(Q0][@>@,^:H1#@J
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MJ#5'J4K0 %C9IV\V:890/\Z*QNZ\\JF6;I<%_Q"F5*-"ED*#)S0=<VK6:CO
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M*'Z@].D = )T<IV+U3G0D]*,U16$A#0/$,,.LDS*'(T7AQ'\C4R/DAA),K,
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M+5?QA_/+2__L[/KRRN/JMPS/CICC.J>#1^=BJ1<="*,E)<I<'-M @G)W ^X
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M/\:'+&,2\*]_-0YI0^S6-#@\OA_?;<'4YBA=DBYI=%B"]'_*IZNE'Q*SZRU
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MZ)TE= )2MX!<<J,*086B=BPH*9>>^X?%$W.I6<\6.C.BCVNICS>TX)R046L
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MAZ$7_&[D8[K YW.>=Z/+XBBB$.0<&(N%+_:A^S*[&P?_'7R^6IW\I"."_;0
MZ'.*0JU@-& D'V$<L:]=2THMD1"%.*_% [>PI/@OE'Y*O6"6$++@U6K&"K$$
M4"D<FQ8B#1;,.*>E*GUC$/K-Z\JF%JFK$"-&KED1!#)[98Y(N?BQQF*3,[/O
M3E?'=?7CBDWA/U[,GRR![3.V"^1:0HOJ6P? 7,8<;PXECA6%K#/;+G +O=*'
ML0!]HWQ:]W_Y!1L:X$I.%&MV(E"A!"?!N5ZPLKH*KL_+)]U:*/TKS/US[&Y#
MX608J@31^+8#KH')\GU('07-.?EY4>[_3M/??_>]T> O,$VYJ5%-:G>46U"+
M:=!*EERQ2$X!/8=8-F+0>YVNZ._<CDZ._WE_9S,Y=I3BS-48H4X,FJJE:JY7
MJ-%UH]D\KXFW6PNBW[RP;&@@:YI[UA1S@0Z>?8EEW&WB6GB<)9@7Q?XO7V&/
MWAZOWBUA[(^N _"E:2?7B02@>JZ:")(K/@9QN,FO'A?K0TY.WRVY_1^'#Y78
MV!5V,HX-:!"(8PV JSXJ%]CD*=N=4SY^<VARLW1I@=!G<" HOG0$<*4 22[B
MFOJ4C4.G;MG]K"#T[X8MQHC_V;Z>WK]0HN%HO1-&OT[VGKP]V[_73^T7?W?V
M?D-7*)6 %7.35BC!V$GBHF^J;CR,*-'F-UM_4/:]PU<FM!L<;;LIK,\25:@0
M\NAP+&G<G2]"X)WFDK%;)L>;'/@^H.J49<46!$=^?O_DZ$<^?O_%UBG="8B!
M+ZGTD"5@A*1>G*HT#R6J[W6CE^A^[+A.7XV/Q_PE5E#<"615]I&RU^Y=!T]1
M@%/6;-E?CRI]D\L%'YIN'^B"JAOW5Q29:BI06X":?,FI<,/1A%N)9%[^ZM83
M^=]O#/L-GI]O(KJZ"E6Q@)A5H%<N[+&J@:GGJ#6T6:'K,Z+A;XYZ?4K*MCBO
M3\P213W#.!%=$E3&8F2K]PA-$V3G[P"?_T"VWKXY.^7#U:<5!!9T?>+[3"PL
MB6OD:-I6';=]C7/5DBGGW#>YT> 7=&UI.]3WOSDIQ@:N+W!2[$Z@"T(KOA3-
MHA%DQ,EL/,P19LS!@N3&H^N#[[K/Q]R^2*OFW<!5S]G%CKD6,%QAM*RQ*41*
M'2G9]QN/JP]3=4M9ZT9?G,U9.41(C1BB"B=&8=>"\?@><9.)_-8HP+]]]XN?
M^K6UZ?FW]W_YQ(*OFREN9=\P]Z9: 3)WB8(%N/>D>9Q-W&!\?10-'^C]_=7A
M%]G;>R=PE7RO)?6@KB%(*4RLR#VAUSP60L\*5[>^O/4+E/_&QZ_.]T_>_G($
MYD/F</CF_LF&OE5C3J'&Z%#'_@)JU,!\66&-Z'/5>0WP_1&%F\LZYG_][$]1
M].*_/I'-8S""-:Z2$0"9RZ*H+L0 /FC#MOGK5K_2U8$1KC_@2Q:(?6(KEZ<.
M7@K[4J'V)-@)DS9P73KG>;T ?4;"^-7JY/#DE7W]_LE?%W3=6.(8!%"+9/4$
M'8*,E1LNY([FO5K<Z'6'^WI\;M^N0EF].)]PL>!W\64WF$:60)&JC'8NB*X(
M5D)@#$7(@<SK0>CVT_U]8_K[O/K^Q#[H[X/TQO+]X)7)$DK*4D"YB+9BK#]5
M<@(,F\SW'^EQY].E.G%3[]><?%-)WA>$5"N3Q\"Q>:J<F\ZKJGK[W=7O"FT6
MB(]D=7TKV2RAA9)S+04:U@X5D!KX&(*F4@B\;OYRQ0]Z_ON)07&A6#<8_5JI
M*;(W('4HX]XG%$E)/$#+,K/U"S/Q6;\^:6XHGXIH;BFP>2RC[5Y*M) 8+#:6
M5"7E>47!S^L'O?!62R_$C0VZ0NU:B:/O 0J(]"@:0F_LHK/,<(.1]5$0?/3V
ML'^]]W!!U<V@*B04$$K1/O1@;BIY$>(.O@'Y>15,9Q(!'[YZ_^/9LWO707B6
M> *NB<8^AW'+ T/GXG#TV5#MXY[ZO/#T>?'O0LU?Y(SZG?!4FH,W;I42A@#!
MTL'2R%L"&$-38UGSZG[X0ZT()\>O_F[?EF; &ZVR-W+!TCX%=9!=-D"Y4'.-
M+G$.8:/?='XY('QL7U@P=;,+14)6+<&XE /S6900FNNYQUJ\X!UP5?\,@A?H
M^NYT]9.)<@'9C3+WL41DE*^JXU$.E=QJR+WE:/R+],[,7#Q^<\IZN-1$;ZQ+
MJ\3N:@"/(8(CBXRMQEXU%NKD9)-?!'_!U=__OB#I9FYB>8.2N20#2P+%)C&R
ME)PJ ;K4YT6M;G]MX<V/&]NEH)"P:!W''17RJ'UBU19ZK9DK\IUY -SB0W[_
M9L7/'FQ_];<'BYNZF='HXH-$&">R/(1D;*H;L6K2 "KZNKBI/Q//IR<;N5:[
M0O8L00NP H7(7D-KF0H#<,1Y]>Y]5F?*EKY;U9-G]Q[H_1>+P[J9.VV80FK5
M]Y8*V'\Y9U+$Z"T/;!$V^>+Q1RT$S_YZ[Z]-[__UQ5\78-W,]3:+@2&[-,Z.
M0J^M!$S-%Y=9$S!N<NIW[_S,^.4+KF^/^<WBK6ZTQZI7WSJ50D;CJV,:Q[6I
M!^-:B=V\O-6\Z-5W_'IE2C[>T*RPI>";]XA,'J '+A8$0XUCTJNV/*^.F'DA
MZX%^Q\=\M*']QL4G!S6Q1L[@)+/DCL;<27LOH2[ ^C.!=?B=GK[=3%SY[AH+
M4*4(D))0K<Z%2+YGJ;%O<G/,QW'IK9Z>G7QO>>'2'GIC26'+P1P4C?H5D'.D
MK3E \"IBG&LC#GG=4I_UW?[J</7CCZMCW=0K<8R#M.=NP="!:"-FB95]R:YB
M[)M<SOI]5]]_I>S%>7UBPPQS0(./Q!8@BQ;E,?"<6RP:X>YLS'JV.G[%/YZ,
MS<JZ=#3<6$^RBXEC[4%:@9(K2QNGY &S-.QUD]NQ_AFAQC#[%A^_[5S/WIZ.
M)30[#[_=69X0;XC8MZ1,GEVL FPADD.)Z$OM$CG*O/S73,C7QVC^%'\Y2VAI
M$4Z.@%I.H)K*\%GFS5AC;[[,J_5A)M#:X=7/?+RQW33(K824<XF4@'PL,5OB
M6(W=H[;JEXK\GT?P=O9Y=<C';4.1Y5KRJ5%O/7J(J1;LJ35/242XM'D5(3ZK
MBOE"C_7\K1XNQYUNK*4FLO@&FMD)A.I* .P%$X5<A6!>@? SL/5BI6?'?+0<
M//Q3-L/WBC&4:GX,F"U33%TJMMIR%/3S>OCY(QC[ *YGEB_J_B_KX1>@_2F[
M_;AD+UY;$D#S8\U75T?5JV- G5?"^,W)ZOCLB?WK^<R^\ML-:X?\[N29X6;_
M[X>K8[UO7WQ[I*?_*J9^^]TF*A=#(:PQUIP%G#<6%(Q<^V),R#1:YN5%_JUR
M'Q_W4WZCIS\].I+]>\?M_LG?3NK^F[._/]I$G6;M71HU(E'H[$C%^Y8X@$D]
MT[R>;O^M3K?,'_/I)NJ/F@2?LO>.(VB,9HP,2;+$7,<J\@W1W_VM%URK^=JO
MKFM?G*46,2=P5!)S'*=5*G&B<9V@5'0IAWGEE_]>B\^^^Z#%#]QK$U69(G!K
MK8:>/9@>A3QV2J;&*%[BAC"@AV]/3_C'U>P5N'KW?Z=Z^,N_;G_UXU_XM)Z>
M''XLZ?%+_GIR^NI_@W/Q?S_\C/\=)?JIGYR<'9^<Z?_\I9^>''VO_<UHWXPO
MWLN#DY^^#=__M!NWWK:#AS_M/:*#)P?/W^\=/(];._7][L[AZ^WSIV[K_#EL
M/=ARVT=;[_<>[!]MG1\>[#WX9O5MW#[</3_Q6T>[?OO\8=PZ>HA[#ZK;?K#E
MGSRX=[[]8.]@Z^@IV/>X&YZ^WSTL[LF#^M/>\3?[>^<GYUL[S\.3'Q[BDP=?
MK^SW<-OGKV'WAUW[?'5/'CV->X^>^^T'KV'O/KG='[YYL[=S\FY[I\*31UM^
M^X>]U=[1<[?]Z&G8/=J%K4=;SGXOV-[9PJT'WQP^>?;AU_SCFWTY:H=/#A[:
MW_$5[)X_]WM'WQSM[3QU>P_L]SAX]?/N^5/<W7GEM\Y?_[QU]!S_<?[PW;<[
M6V=;S]SX&+8?W M;]UX&G]4IMRE2K1,T:1-+M>_4]Q)"DT3T/W\QKOWZ^_^L
MG0O5C)_W/W\Y.YFI/O;^L>_JT8MC_H'>/CG8,KWLF@Q?P]8/C^WO^S0^V=G?
MWQN?/[<_[T%[O;?SW-GG7O_C?/=\^]5+<1(TMS8UYC2!*$T$-4W*O@H5\;'&
M__G+R6G3T__W/\%\S__^S@@6JUBLXO;IXW.LPF3IVAC-"&Y*+N,$G,/$0:N%
M#+'_4R$W2/^T"K]8Q7^V"MP^W]O?LU^S95:Q>_#4)&T?=[Y?[3W:/MPS]-KG
MWCUY\#!LW?^]5;R.VT=?'YKFWIE5K+8?/,7MHV_VMQ]]\WHWO'B]91:R_> A
M;.WL_OR+5=3?6T5UU?O8:!JK82:P_TSL2IEJR!EJ1.S!+U:Q6,5B%8M5+ QJ
M_58!V^>/8?O!"[. [7W[.6[OAUV_>W#/[>U\=?CDP7-O#.GG)X^>N]W5[ZWB
M5=PZ>.6V?S +" ]-4]\?[AV\6&W9QZU'SXUYO3C8WKD'>V9A9A7N"@;%L=;"
M0<RA49N ?)ZH4IA23#1ZC9)/;K&*Q2H6JUBL8F%0=\HJGEZR"H12LLH$/G;S
M;U0F9NA380@$X_6Z+]GV8A6+52Q6L3"H6V 57[ R>\DJJNO$FN-4>H8)BN)4
MG,2)D2@Z(L)<%ZM8K&*QBL4J%@9U$UK8N?>K%MSNP=/W]O_?[QX\CL9^W*XQ
MFZ&1)X\>O]\]>OCS;OAFM?WH,>X]^PV#"H]-TNW $/[S]J.';GMG_W#W8/?G
MO0</W]FO>;\=]@ZWPS>OM]]?9E"[!P_C=MBR/^N>V]UYZI\\>K':/OCJ]=;.
MUZO=G<?1K"SN'CV-_SA_?;9]81$/S[;.=]W6@]V?7V:,>4Q^3\%5G:!BG4JQ
M'P6D#BERD93G9Q-_4!L?V\3WJ^T'CX<O6FT=5/-+WQ^8CQGV ;L'WYADOSK8
M/7ILO__AX3],:T\>/'1;._?<]L%SO_7@^<\OH\^MU**3(W#3N$,QE>I@HA9J
M\R$KUK!8R&(AL]+&S5G(T_.78#F;AA8GE\TN (NW&()Q2ER14+RK#>\2LYJ%
MA3S^^=N=Y[]G5CUCQFZDV"C >-T+8:) ;NJD BYHTE86&_G3H\AB(XN-S$,?
M-QA'_$OT@*[F-H7$/$%LEHLT#A9'/'BPM"ZU?I>8UFRJN9>[1'KN4 "G<1=B
M@H!IHIQHZMFIQU)0A.=G(TN&OEC%8A6WP"J6:NX\^=3#\ROX%%4GS9-.$>NH
MY@[_UI/%_]R+0O!97)R?5:R=3RTYQV(CBXU<DW.XERXQ-6Y]&LMP+)L3F$KH
M)EG?)'2-)+JPJ]OX*OCZ]S8"6&(C,$[EG)HZ*T[4M4^AL39%8\EQZ2!9<H[%
M*A:K6'*.6V 57W"*Z9)5M,*EJ_C)UQ'K0Y=)>LQ3\=H]FWW4N$PQ+5:Q6,5B
M%0N#NCNY]^[EKI&$Q,G3V!!3PP2189)*V;[3GKLIL2]=(W\D\W[WTJ$BN>8G
MM%1[@LIEDI+<%&/F6(.)EQ<+62QD7MI8ZK>W+Y)_>69UJ6,]U]K4<9RR2\:1
MG8:I<!3CR-P[N.P1T_QL9&%6BU4L5G$+K&+)PN=;L7UX*0NGTA.U.HGKWGAQ
M-5Z<G4R9"O26"Z>*BU4LL6*QBL4JEEAQ9S+OQU?UA9342XZ,IKJ+#3NI351"
M,D+EPSC\V@#[_*QB=KGW'8@<BXTL-O)Q!3=8_A9:*V8>/HXY_.3=1 GZ5"DE
M99 *LLS]W3H;\5?8"*BYM=APBJEW\W;53R2%IIIS3/9?=ED6&UEJN(N-+#9R
MTW$DOM3*41+IU%JU+-U5,!M);I)B@3M5[Y+'N\2U9C/A=*F#Q-4D'AM-F4>6
MCFA*#&J,(&576^2&,D.NM=2N%JM8K.(66,52NYHGGZJ7NT:"D>).T4U.AQZI
MN(E%FMF$NM#!]<YM?C:Q?C;U_F7MJ99&,C&.+0K<_,3>S 2C!E]2[9CNU!:%
MQ4(6"UER\HWH(+GT*A@EF"VT,CFG%W.Q,I4\* %G";FGG,)R86#)-Q:K6*QB
MR3=N@55\P2S\\:5WP,@8B77J0<H$6?(T_-WD?4(5J$7R,@F[Q(K%*A:K6&+%
MW<F\'X>/WOI,LUNO7H9J*:+6.@5JILE<QG$!+B-#C*EJCS+'K0EKS[V?PLN(
ME2&%.)7B_ 0$.!6U5)RD(3B2&G"I3BTV,C=]+/6IVQ?-OWS7^J6-GQR)G >=
M\IB(!8AI8D*>,H7FD86=7R:<EIQCL8K%*I:<X^[PJ2VXHK\P9X>HWE@41)K
MM3P)))VT>78%0R2G\[.*V?&I.Q Y%AM9;.3CO!Q?<D'H$(9DB<U&@N7ET=B5
MI)H\%ZJQP%V*([.IZ%Y^_8N=-4F<*#AC5\T;(VC&L[(J)<Y:JBRO?PN[6JQB
ML8HE$[\%5O$%.T4NO?[EEKMJHTD!90),>6(-%O5#R+Y&R0K+)>4E5BQ6L5C%
M$BMN@55\P:KM):NHP.B5_!2BL]R[BYI!($Q:5#RTU$*;83_Z8A6+52Q6<0NL
M8F%0\V506Y>L@H,D+CK5$-2L @=YRGT*GKB[V@###'="+[%BL8K%*FZ!52RQ
M8IYO>J./<.NW?81Q[-7)/840<*KFRR8H'J<2G+>46\Q<,J2 ^)=%L-<*]O%'
M@GWR]"7%)+T'F; Z"QP(,$GA,G4DD[=%D[H<9EB:F.^,C6R%*QH*>A3TJ?1)
MDFO#^=B/0J?)B93FQ3R3],7Y7"/8GZ\0;*/L<ZEQ4H31J<$\%6INPI)CEN0Y
MEKH(]C\+]NE5:^BT>9<"PX0$;"2REHFHNRE7GYKTX#O!(MAK$(M7]1:UWER
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M6*\8X5:..5,9RX?&W.;81U8TF8MEZ8YK]#XM3S'7I057CG"[T9R-;;QSC_I
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MIZA,)INZHBF&I=O,*:YQ\&KN[:4HEP>FE6FY+B@ *%T]&RNKJ)[L>9JG*$'
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MDFJ*ZGN8^:&JF,6H4VQ30$P9=D:0-[;B4>,-?1'% .OJ7@6,@35G>[)B:6"
M:%CTF2@&GOZS7=6WW#<N2UH(P"[3*U,]IA)'E9F#E3EL7<.:)YIL6D;@!R:>
MCW_3DGE% .N*$N6N9INV&>BRY7CH+R.^3'35D&U%<U7')Z#+E6!]!*PK2I0'
MNF)XKN+)S-0,K)ZG8H%'^*'IGJY96N K;]H)I@A@75F05%=M!]B=P3[%DY8(
M&,OH1L-"=AZQL<?&FS8L*01@5Q5]=@WJV8[GX3Z%Q>P"%[8MSY=]G0:FH[N!
MX[QA_F)! +NJJ+YIZX'A@GK%B(KY-8X/BI8.UK,;&"I1'-LWW[3H<R$ NZK6
M*S.I"T:>(NLFGG14S$ FS#!E1S68"3*"ZG8I"AX![*HF9H39C+H@"!P,]&!5
M2^+KJFP;IF$;KJ:;;WFFH1A@7=G+4 M<V+M47]9T4&,-(Z"RJUB@>9F.;?JJ
M$Q!2 O81P*[H96BX#H8E/%GW02TP4 (0!\!JNS933!8$Q'G#2%HQP+JBTQ;5
M79"O>.0&&^W!3@5BP XTV2>&:1$PN)A34NMC8F!5KP(3M"JB:8', LQ5"'1'
M]K!'G.<'AD\HU7WM39OL% &P*TKJ!X%E$%NQ9%W3\6"39\L.(9H,5SV/NDS7
MG5+->@2L*SK#!8$'>Q8>SW<5%\ :X&D&D+-.X%FVJ008LRQ<3.*YV)B/2=SH
MEUH-H'1SW[C'^;1OFD=79K/W'2M%PAA4A_%@KLT("/:^<?7#M2S=<GS8GWP;
M/8.6)CN@:^%1/%-E+/!=G>Y03*(8D>7Z:$4NA,M4++3LR@$S-=F@6";8!FU9
M4VP0WQ[Q:%#<XZFO!-@5159T0BW==@(YL!P"6R.OK. X<A!H-E5=0_'\X@;L
M7PFL8-$=+B9*Z[;I*"X T\:4*"P/1E3+DEV?Z:K%,&&J++CV6!+?H+EX(DW7
M&2$VLV57147.9*H,*K,NJ\S3 ENCC)7G)1ZCUHME(>!:'G,Q:J8SQP<A8(/A
M05Q?5E2F^4#(EO*6_K)B@!4WK:5B%3:C0)<^B%,37>=,]V6/85L?VV'$]%E@
MJ6]9$;T0@*TM2U=7(]1V0 /0?1-;I"D$6U)KLA9XH,\YGN*KY:;UJ!A8 FO@
M>,S0 U4& ,*FY8%T)8&G@?7!-$K (E'-XIZ5>+U-:ZEWLDUMC*/+S":8;*IH
MLN>#2:+ZKF.XEDYUJY2NCPN!I?* I@)JE6N#78S>!\M%?XZJRZ8)!H&O!#2@
MQ14"KT:M2X?^2SMK&P;!DHK%/,.P/4V5-:)BHBGS94>QF:PKOF\0S;$,O[BR
M]=6$0&MQRS),R]!M/Y!-!X4 5139#2Q/IK[BN6 H@%);&@2/>@66*BDPQW84
MQ31D+/<#6Y9GRY[K^;+NVJJO:50C6G%/]+R>)K!T?#I@L.5K5-9,70'S56.R
M@T<DO, ,-$5Q+%LOA<#C0F I?*[IQ*+ ]8%'%#R "@:6@8F@CJY8'K6H_98]
MOHL!UHME9XMG.-1SL=>42K"$I1;(1*&VK*L@61T7C#"MN#ZLU_.X+KD&?5,Q
M3-V3'8>";%4I-@U04(,-/,^W'9V6/H$-S(%%V:JH+G: Q?)? 9Z5I$"M+@/%
MP-941;%4E;YIR]V";%E+M>U-L  TR]1EE[AX:!KCD,1S9*)[AF8KBALXQ;6R
M7D_!6G)D.Y2:6)%"XQY7&VNHH*O%TW1;<8GA^'IQ%:S7"[LLZ:V!13W=8C)8
M5%A/R0:Z]0(FJP1!RAS%5(M;E.+5A,#2EN41AX!TU64[P-Z(3#'Q9)\I^[KE
M&RH+=+_<LC:)#RP=/RVEZW8 ^W41L+#E QPM10XPW&($!$0"J*UXQL;SF4IL
MS?)*P#ZZ;2T* M50 F937Z;,0$&@JIBH;,JN8P5^H/ CC"58'Z?7I;H)*G"Z
M;8+BZMA8:E4!\X#@T5!?]W6PM S+*R7L)H!=:@M;;EU;\0TL]6DT#!I@;V]5
MQS.,U ,9H%F.3(GEN)9+5+O P9=7,V*7@B^$JIK)J"T[Z,DV3 O$ ,!59H0!
MT0;,+;([^_7\KDO;UN^L#;R>6;#H&R@WK:UXLI;*KON.K?N>+YL>UJ[5%"I[
MU+%DW7-LS=,T72]P=?!7U 66CH&4B1C; >SET@GQ,BUS&VF92]N6[5.-N$RF
M"DA5@^J:3)1 DZEM6$#&1&$%KK;\>JD8BV#%SFRFPGQ9H43'N!8%:E4<V?$U
M#^2 IGAN<;N%O*(86*JJ6(:WMV(4+*4.N1KL^RH![57W\0P3&@5N()LZW/'Q
MP&V!VPN_7F1KT80M<[.W0JU+I2H=0W<]9LB*@S5K30+F 34460T4!\^):H&C
M%.[TXAM45!PU[G[H8  87J#+NH$G0>W DEU-=V3"=,,P#8]9GK-+IQ<[U3$6
ME,OKKR/X>W1Y7=>!GI5+H%7$2.ND/KKLU>XNM;_"YDG=G#G1:S2U.D#:OP:Q
M<=<\J2G-3C>ZO+Z\^WY4^PGOC)K:]ZBI_773'"WSQ.5U36]J#?A65;GL?%5;
M)]_"YO7GFT;G.+SLU'407?IE[ZO^G_N&L>H@B&_J@>H'LA)@P6$5-DG'YR6R
M3=LPB*Z[;UE#J3B 76[T0BG6' 5ESL%2/X'.9,_Q71GM9%-S7<NG;O'$S3/Q
M,2]NVF'SJ(Y[9]BXIB"XV]>P)Z+H,2ZO_P+8?KZ^[-5A_"CZ#^"M=513&IVJ
MTKR^4!M'7\T?Q#&-P-!TF1@ND0U?,V5'9U3V+(K6ATMUQWA$^(@K63),*<O$
MGUU&X 7XW0]O/_T+?@#5 Z1-+3!MU09KQP=^T$U'T0V+:KX3Z"X%O?P'_\#D
MG6PP0F3VPECNLO"J._BH*G;%UOJ#@[O0'W3A3^7_[LT]VR>^'\97<L2"P4>G
M8L*C _9S(),HO(H_7@^S01B,Q*4P]ED\^"CSIV"4K$_B3__RTC]A"N)W,9.E
M^<R^K5L/OCOS5KX"PZFH+LRJGV0A@C"'Y2U;NR0O&0R2WD=E^@KQLB0:#M:_
MTB/I%0 M?U-5YJ% 8>(LA3<&Q(O8]#.(8YDF443Z&?LX_N7 #[-^1$8?PQCX
MALG\I8/Y+R"8;UDZ""F)\H_P[XG;^31=IZ)I)LYT )0Q\,<?SA=1X8OX<^ O
MWS,JIF6MO:M4U+7W'AK5U2N:;FPT[)]\QND"*E6#XQY>!%@AUO]W3]];(,2/
MBJ3RI\;?V/31M_KDGQR_\[3_5"ZV'-N<,'(WG7[T"L1VRLB-3 *@P(\DNB.C
M;._/=\WMRY2^_(GW+@&>/.OGX=W8!M)UJ^*8Q<#YZ\I/ $5%$>!XJ@ %T>LJ
MZV\_+NKT!\1.OO#Q9M,?2$";H2_]0^'_'>3W!TG_H[9T<U-!M+C]+NQD.*?Q
M?9ABDGX<?R!(8K!O2"^,1A__IYJ&)/J?_8S$F9RQ- S$[2R\9Q]5D],2OW G
M5FW#^QQG8WFD(0POFO5.[4@Z[U0[M?.US/[6LSRO'5ZTZYUZ[5RJ-H^DVG\.
MOU1!:9<.6XU&_?R\WFJ^]M2=C>;]-P&E,KX:)/'^/_^A6LK!4>6P(FF*:;AK
M)SS/3-8:;><%EF"L7,*/=?^]6V(Y;K4;$CH1XB1N#GLP# 5.CW%:8".!Z ]4
MDSK,T8BJ68:E6:[FJB"/-(MIQ/0=]N-(4\ ^4Q55QE]435?WI)CT8.X^"S\>
M)11&C0>=49_MB<WDK8RN4^W[Z/)O:C7OJV;S&HRA^YN?#?[L%1BF-Z-&IPL&
ME7_S_?HX:AWYUXW.S:U_\LWPO_P5?=>B6^\ZT1M'-UJC\_6^U:G=X;Q:1^UN
MJU/_"<::TM3:O<;?%V L-WZVOCE@;%TH/YAAVQ;%KB.^IL@&V%RRYU)3]FV/
M&JJGJI32O4]PZYA;3U,LK%<FUF[GK\*E'QHDO9%:,?OC:1,LS(ZI55S;V;[)
M850<37O*/OR8 J_U?^+.N4H%6@!/+_3]B&V'2.R-Y. K")0VNPJS0<J=$><#
M,F!X<4\*DK1'!O"9GX./0?B3^;"J*"NFZ#D.O9,+ZU)KWGP_0M]._>?W:SIJ
MGC1A_+H*8NCN^_4W$#\W,(>_(A!!^3O?X%MF_+W3O[[4VC?P?+=Q?=QKWM>5
M2ZTQNKR^^-D\^MQKHHL;U]N[,&".=Z>=ZG+]<H/I*+),W<$#@KXENP8)9.II
MKFMH%J&*LO?IG_]PP2@X6"N_'K=%WS,IMVLG]?-.N]H!O4EH?HU:LR.=7;3/
M+ZKP2Z<E@<*%=X72HFH?O#^D5EOZ</6'N-(ZECI?:M*,6C91R:J'':EUG+_H
MZL8<S%;* :M0P&NECZ^H6.3P"I*M&L=#$K59/TE7"K1!.BSEV:/R;+1"GGG$
ML(AM.++O6IYLN 3+ABH4CY5[KAGXMNT8N3RS?E=Y5FTV+ZJG4KMVUFH_),9T
ME&&J^<$'8?8K NRUC?E%**PQ>Y)4&G29%(09($,:,9)*+/:9_QJVT!F,G/BU
MV#\B// ZP^$^7)%[\,TNOB;[9"3CW&06%Y+C?\5X^OKS!U-UVV>*+0>^H<N&
MI1/9"0P*FHA-&=$5E[G6BXKDPV&: L*..95< B(V1=INXLMEIFU@'Q9*,*)H
MZE3V%,< ]%F.&NB>YIG:WJ<C1EG/8ZFDJXLR=E]"+"Q>E5[;>[*9#)E1;DH+
MN+2 7UU/[*0P/1X46J\K%M[XO?_<A6\8E_>\@GRW>7*!'8!O&IV&WKB&;__]
M_::I7=PWCBZ6E,7&20W6T[T6%>1KRO?.C7;9^_JS<4_AFU'TO?=5_]YIW#6_
MK31^06091'44F5B> YN/XLH>HU36=<T(\(;C>+^[\0MV;_.\SDW?5U,82XOW
M?:WH%239>9=%T6'2@R6-2EGVB[)LE>'KV[YO!78@.X8-AF] #=ES+=#.3#!_
M*=%5FVB_NRP[_U([/<4@Z%FU>;D[]N]J8* 1(R6!Q&[ATU+*_CL,4T @V,1A
M)F7(CH!FSH]P$QGRG>K@8SM^,-&%I#ZWKGDZLR00\W(_I4'R\M]XGY '<=T+
MLPPA?AR"70/2 FRZCR_I/ZG%@W PPJ^)CQ5R+_@E$WOTPZ6>2HGAR[YC::"5
M4M!*51.K7YC,,P.#N<S:^Z0 !'55MYS-3>EY$U-_MYD4[SR?XL7)?QSWC =-
MN+-[+*#]T W3\$W-E&D0  LPHLH.\:FLN;9.?$MCAF'"=D_B) C?W)6T&;5_
MJ/TD=,!QC;MR.L&Q1& [[C,:!B'SI3"6PD$FT2Y)88(;)6"\?AI7\\_J>X4R
M]YB(\POS8/[G/QQ-M0\R@8$PAFV]%E]%8=9]IT!^<3%3CVF2@N(WS:\X3(;Q
M(!T=)OZ\^QM60#\R_XJD_32YI>*I7?1_W_]@9N!9JF_+A-J*;#@TD#W=T63;
M<@/*B,T\C%<< \515A3)]-<P#3,_I&.F"6<)0P+U.TFO2!S>\[_?*;<8UHOS
M2]7W4Y9E^3^G, 5UYSB@H?P@OA>8OHWG@A4J&YI+9=>G3+9MG\'F[#JN:>Q]
MRO-["1B?0R;Y3(J(= )< ;]5T]X__Z'I^L$2@^R_O&F18^\LR08D^A[VA:S;
M,2Q>J#]TS5$MW;1EUZ8Z5ME79:)K#)L;VDI@NBZUZ=XGVU14>Q%+ K.OA:E#
M^+65=I*['=QNE!^VJQ >'K>(XLB&H<-VX]F8K4=]W0@4PS+8WJ<S @+\[9@I
M5QN6589<4\#7=E%;T'^8Q#1]GZHR91X650H4V35=6V:V32@%O&K,7Z<MO/4^
MNT99R'&.>D(_!4TA[)-(8C\9'>(I-[@<A)1E;ZXE/,WE\-:S?;H%8*H^&,-:
M8&D4I(*B.8KB^XY#/.8KIJ;8CV6]P%A@CIZQ-$OBF$4[Z6AHZ#]T17=4JA!9
M5TPE/R#O!J;L.2K3-=!HX.?>IW8RDLY(GPRZ+/&3-!DN:?;[4FW" M^  :0S
M8)(0#RCN2R<L9BDP"8K)C$72/TFO?R!]8<1')CIE5R2"UP?=D&82*$C2YV$&
MI  L5@=\7Z4@9]\G>3ZL<O\B@98J]T19TWXXNF6BZTMFOF_)1H %'7S'A#\#
MP_5T2_<U_454[FTB<;=5[H;ZPS%452,&RAJ"$5J?8ITJ70Y4+]!!ZV:@DCU;
MY=XFIG98Y;[0?U!+Y[7N9,<Q@-ELRY!=&F@RZ-NF:1/"?-=XELJ]5125*O=*
M+C-^$!MS'TQ#]EVL#$E5+'FC!K)#=,MQS4 %>W>=REV1CLG/CY*BJH+A_K\7
M-W47]3#X_HX&/AOF#^ O2_<L!3O_@3*FNIC"XE(PGGQ/-1W5\'Q G:Y+JF3J
MDFU+ABXI^C(2.RQZ&A)_59E&ODP9V<F-[>+N!\.6(;KMR+9O@I4+%JY,#!;(
M5L 4UW851AA#O"W[PU\.)Z<))=%9-XEW-9'@XN</Q?,],[!L4!8MY"<L[FR
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M2\ZL91Q TQ@-K\I/WY)H&&,( 2MUI-G.\='7NQ^Z[MB8C20KBL.P$*8G$^Q
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M!_!UWCY(]!HJ(SJ%0Z-JKJM\47+R+I! 7G_W)^5G0 0G)V7*9?&P6#+R3I.
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M(:UGTNS,Z?M?Q>LO9.0_#=G2*2Y@G1MU0X)N_EE]-JZ=HN-:JTBM(&"I=#Z
M#1LP03..T]K//B"=^5(G[#'.G;N'75TM.G;UBO1O-I+J<9"D/7Z:]]FP,!Z'
MA3X/"@3--C<H=;,(7;4" (T$\09A3&(*5I_DDP'900JVBX*USQ7ID/0YB=]S
M0N52",^<>H#(F&4[N+L82E&P=UB1VHQD"< ,) TH#;BC( *'&4,5HI\FE#%_
M%W&H%P6'1X##,+N1 L*5O8*BJM[K)^F @&::KT,:=,D +*YA!'8707J$ZT/8
M$29[P[[D#;,01<R^E+*,D91V):3B/L,*&/$57AU& Q@JD?R0TS9LI@R]B=%(
M"M*D)S&N+G'!!?I3RN"YC$9)QE"&P11"U*IB_&S*<(+[<)E&0S3YI+MPT$V&
M RD*>Z$8 EY@P$A1E-SQS\^@!53S^)9E?&59-U]5RH(A3H7"UT,?62^*^!CA
M=..7,C9 YAQTQ8S6?8"S+8LR=M=E*9O,WD_HD"O\'H-!8'V,AGSV ).0SP@?
M)3&W&'#TPZ0'%##Z'Y@FH\,T'(2,3UY"0U<L,N$/XL<S6'R&&[;'8$K[TAT#
M"(_@+RD;>M< 67PX@:>GD,_?X]@EV?BKL,TS\3O,68":HR-.@ :&:0HK #C=
MQ,D=__XP0T3S,>YP3:PGA;W)%^ JCB-4J0'HP94-F6)CAGZ&4J@^4REL<W )
MOYQ 6\2N<)& [I1=#>%ZDHX0O(/-33E]0^7WF8)KLS-G9VGB#RGR#_'""(U6
M&I&PE^5,3_Q;6! #M!-@77@N&:;S',]Y&X@F9WC.PO&L\@A\)6BVH$)Q&4(H
MCZ0,)A<&(45I*41 DG(6[G<)2 W*AMSC!,OGK+PO786W+!;LL@3L6<I""(/J
M!LL&BD+V&Z(< M'*N/_2&TDQ&0Q35I$ZP+/L-HENA9B=D"&+;\,TB;G$N4O2
MR+\#N29]&/#'62KW4 ;!\/ :/C+S9LK^.PQ3[IR -?;[P!W\H[FT65C:>);[
M4C\"8; P+!H-^])_06SC0I$FLB&,"#+. \0*4OD#  !;!EP, 4H4*0E6WT\&
MZ$"!+TP M<\'R"4;2']X2FPF^*4E<,)T[W*QU"6W^"/VH_%N LL@&>PAN'/@
MVDGJY^L+TQRT^U)&@9[Y-R, 6016T=#+<&<4YE"/7+%,C.TQP"JY@U%0 H^D
M+.DQZ1ID=N:'=,(/?P)QP!XRB,:PO4I!I9-XNROU0 A)$+, [-%XEA=QB$(=
M70M,\)20X4!0/=@ (G(W_QDQ2#XB?("$,>PK*ZD1=A/)([B_PD YS)!\PQA'
MQ*]%(-^8C[LB[OI\83BG7",5L.H+QL@0.+#IC^4&,"F),I20A ,V?PQ #1.(
M,@%X/P60X1_P5=@-@>N0AC,2L6Q_#"\/M8WQA/D4<(N&C30%M8$,_?$7\0;0
M(< =O6RPZ:2^W"<ID$.?C!AN]8S="!8)>]X0Q!GGC'S3HTDV^7T\U7P".;SY
M5V9UCBE]TO VC' -- 7](X8K5PEP&&<]W!X$9C;=^=Z;Y/N;<?DSW?I]%K"8
M@X!(\;#GL32W3U9O(1\ \%(3@"5(\ZBB:152^6,L31";F%]*YIT-&1*\X!(!
M<K@+O#Q7WW2BI<SIA7](8Q;*>3OKY]I/A_R$::03-]R6 6I6S$4S865QN.4(
M'V[\LE9Q[>60$C(HCH!Q<]4V#EYH[IL2P[[T'<0?H24(GPU"+L2/6)^ -"I)
M\1?A.. 6%NXV'EHH8,9DPQ1$")M8)'<A&'+<"J(4M%6P\G!KG<HP& &VL[%X
MGS%E^(MH](!5QR8F%XI[(=?&)N"0JV$%%>ZU#$5EF'5S4$AH!4MH 4M,J/H@
MUX,PXAL^6=0C_'1X!7L=ZA%L! H^U_8 MBE0DB^L^G[*0(-,DUL..-C@*1?N
ML(7"6W?=$%0&5.:2F*L\J,8"JE _A<>ZP]A/&5<?QI?0S,\0\7T@5]P=*E(;
M#']8%PCZVY#=<:H@@*91%F;3W1TV:MPBX"-7J3#8O<3GAC:PP$ &)-VP@5 ^
M @9[%U\(#C69\P#MV0S!<8O0F:&'60_!G"J'RA3[27K]"'3)J;K <  D4?AZ
M2E)^KX^Z-PP@XV:%!@528I3$5S)L6+VQ 8:*.^Z(W#\HH!]BSDNN88Q)-S?6
M$P^HXE8HO ^A 4V(,!,Z7C;=QXF'W,Z-$2;P@DJ-A$;\C-]C[OMC97IL2) A
MX$OX+?9GD)UOZ+@U U3S=P6J4M+GQ(56!<R1W]J78L KXC E<Y=!W4:%D<.C
MCXKE<&IY)I22C.,'<,Z$S85" . ;XW5\9ZJ"YM2=+WU*#?D"A#N](AU/ECWU
MTDRPLK]>RT;YQ*7(K+GX?A2FH@JOXV&*)(,6)_=WH4W$4H0&C#(1&3[P&TA^
M "O:9  !08AHQ"!=#1CMQC#G*T#4'^(>:/D<M>C*B8)AS"ET?\X!.HS9.+HK
M[,#<2IPW=E:C%F6$IAQ\!I:D0#^<E5'<Y$X^L'+],$N'_0E?S J8R73!QAQE
M@%Q![G2$:OB@"V,.QEX;X99![I_QTW*/U=1=BVP 5# 43E.4N4#"?()@/7)/
MX@/4\1HU9-\@8<NR[&<E;&D5V]RL>-M3AC4KBO&DDG OF$K\DD6\-TNN/*\V
M6\=U29*>KWQN^/TU(J?5;DB:(A^_^/<?J=&R%4_X9FN>*Y:P:6Y[H:E,79>6
MOBK)[EU7F"ZS71\AP-\PV?6IRWRM7-<',JD>RV(MACY:C= \O>H*792;G$P$
M=[,AV&1@8("VS6V/0$0XEM1$;D#-^JXI2=.0>[17Z)1HCZ'J&7*5'R0.Z'17
MZ* - [ Q4/?CJB$8N' 18TK>  PH&(H@;8"1EJZ),_ @\]2Y ?KP #\"VEH6
M\D 0VID9BP*9+XW[6T2PF:*.S2VM))I5R".,*F%V"Y='/88@)[<DC/C?:"CW
M,"%VXH68F#4\J$:R+(&_<((<0LNP@%5PB,Y98$(UOB64HJX[T7G9O!X^M9",
MO,#5#(5*>29!'HH7]KV6V_>?*]+GL1[= EQP_\/"$R["<@PCG Y/$#G,49=K
MVG]P@(/!RGTB:+_?L1GXLGT^!Q%L1G1F4R<5U_0]1E(.1![BXFZ,:2Q&!,VF
M[H>QO8+!*AXD\S 6%G+#A;]!N#$K; @>W")@*%UQC3X/T"%4$-PKPKL5Z6B&
MZ/FJ)_=@5&Z)PQ+C251N]CD!% PH\]_1=.9.) &%-.-$AJX-#S\QX&0UX]?S
MQ9>%^2[[*0^U3L>?)H?D&1H_P4S.>&A&:H -B9_$ $^&SHZ8<@.?Q../CT/A
MTP#XF/;@D_F$QV8>@*</)CKE"T!' [<XQRLF$;""/Q) 1Z\#ZX7#7E&-\'6I
M _MY5#7B5N8X6@CB(!SD&2-@14>#$%-%QD@<^^L0NMQ#FP$Q\. 3EV%H&..^
M)F0%=W9P;K,/ *$#3M]HIR.1H!S@PTR-6\$'Z(K)B9@GN[ >SU- C]I4(@OZ
MN&(Q)C/ [,#2'PJ3%ET&@%.PBR<!W738PYR?V>#]#/?-QXS7.@8$<<VD1&TS
MY6(22Q6001*,9SA9\(L$PU#6G]V?\J0%/NQ8 LQ/*!LD] 96%=+G)O:\3;[+
MH8"ZR(_%S*MQ*L(<&AGLQ'DN_\1?@O[.*^&E0?"P@4C$BLC=_HS?L,]=HI3Q
M?1OD0'RU+W6'0&H2MV@XWNX2>!IW=N[\ <H8,#K)VA5!9R'Q\WRB,A=GC+W6
M;&X,Z"5=1FY#KF%PSS,Z/KDS[HJ[.&=R66Y)FB<; BQC?!OW//'K?D[F=POI
M+RG?])(\36(N+8>/Q/WAZ)K%Y#;I9!+XSQ;3PF:<X3 J?)1'KT1JSDP2"8S,
MXBNXPW,A0@P>\#R""6DPU$YH?G0(*.96# D:$.Q">'$$VL!<I@*_%9%QQB#*
M(C!00X^)5<-?-$ESAZ/X!!+^(O 6H^D]YO.'>$X/Q6 ,CUN,TS_W5X0& %&@
M(F.R)0\K <%RIZ, E4C3V)]\(M\+UK(-&<>;9E@'<!YF4>ZMQ\0%3$$1?,!$
M<N5<6A37H@ T"+]<T?O_V7O3YC:N+%OTKV3TN]5-1H HD9(LN_1>1U"#;759
MEEJ#?>_]\B(!),BT$IFX.9"&?_W=:P_G[), 9<J6+<&%CN@R10(YG&&?/:R]
M%F+B0A.^#+GN.MZ]H:0D-H/>C,YMG15Z*O*E+^"RR3-:<4I/)[>C4;^X*A<#
M/9C]D9ZN&]>1)E;<C)O8C'*P1#HYG0P"30A.)5J3!=N&>4O.>B81/S]3#<A,
M,W2ZWE'WV=/M_Z/Y48MFS9N=W.D%9_8?DV$;YF%>=7P*VD/-IB@ZV>VKM4%#
M'+2-['>R8<5;S6G=%E6%_W),8[4YLNED26EGZG>&2M+X<[W_%DX8#Q@7)#]]
M<!!Y[6.E+0:>S0)%(JEZ7A;5FA8L1X_J\4]X$30(\'@7A)>CI[V0,A2O3NS.
MO"T3S!@'EA+]H2AU^Y'(CJ(QF0T]N^#L31<&FLO>3E^C/M;21-7TNFQ.LI=V
M#&;G-"I'7S]^>7XLL<S;?V:/Q +A3_*[%T\?/\G.88[L3S2?5^;5X1-?DVDD
MSXH_\SB:+ HG.QX[H.&.-*Q[G:_+6N.Y9Q9G)9=9#-*<>55>4!S*$4)^[8;+
MV\F=P[*WA;/OFQ[3#K?482"*)=8L+: EQ>6\Y-+M\FLK(P<@5HM.7$\-I@I+
MCGSIX*S/N/1U+)7_.6"<DJA(JU;F)%L4-027&UL@Q@#[.@L_C@[4T6$V\:>9
MA!1JA[[AP*3*GN ++^/I]RK,2W;TS9.7KXXQBD^'ELX06?@O[:CQ&0YW@>^P
M?UX^>_G=,5F=G*N;=(6S.V>G^._C2_(@&2(C^R,M9I=7.87,[I%''L@VF)4-
M(\T%/4I=PH@KK/.E7HMMQF.Q&1*Z=;)%9P 7JW\WT+YMD=;J-QIPXF_^])-Q
MY9!-,:K^.^-%1RLA'+F6?F)3A\L*SH!-DB:J^I96P%(0D((920Y>CWK8#KPX
MB1 ]N*-B>C$5+&Z".3D6C+=LFH@Z\+M00P,<+L@8;CPN(*\C )D?1,^@K0!9
M?8Y&T+VCAS-7:</)#5M'MF3534J:4R8"@DXG: 4\\I8K&;-;(Y_9.VM+21IT
M#NUNJVZG*PAKI>LNGW4&N&&D>78QE M8_'TU'7H]WA4RNHP3(.^S&V9=:4?_
M7+.#,2NKK4 ,*DCB7E[:W&'(B)K9!L%2"7\Q8IDS)C1@9]G288*-HTW>!^,,
MBWVQ90$82V[W@J=DI_<DZ7X0AT*<&KZE!K](6O=&E@ 'A[WT05(JM!P!V2H[
M6LD%IR[5DL!8S&.HW^<_Z[.*+W8#JKD!.+RZDIC*0YRQI :\J4\2:'RONVLK
M > .R$F6 ,+43R$#T?55,2/[)"<DD!=Q#'>:3K((X\,#[U9VW5!T$XUC<)>?
ME7]"<NH=;(K?4F4GYPIO[B0A1U<&'D/C#B2!< .9##8BT6)2W"8!HO21T:!>
M (6"(4,&H^,_Z#Y<(?;H8B9T/F^'8H%N\QWI^"\U'?]UL&7/QD@[R[.?ZT<?
M>VQ4_-[KB(W"-+W@X^L6EQT5 KYC$T5O==[.RKX-QZ?M&IL]W&.$W[*6GH\.
MWAJ97*R(IE[X/.1HHP/I)Q4A.P]ND5255(<//_?5<KZME_E5TW*HTPP]+&.7
MMEUV130ZW U#C@X]2]Z&1!PO=#Y)R3TH4B"P%4Z 1V20HV[& $Q+@GG+-T]V
M)ZRWDZ[:G[(L>TL@TY5HFW=J=5SZVFS]T,E2B%GH)6:0+.I -@4Y;>UDHM^0
MUU?U%C2B#PB^ Y"?Y LL5N25=+SLKV @$&'REZRR5&T8 *=KCWMG5P;P8BL2
M(;/NB&=<9X,FH%5#S].TZFAQ^4O6./\FMHOQM(3BC2Q-=TBE_3TT)!=MON(C
M2\PS(N6JBD# I- 5&U<-<:M)UOI6>=9F=TWLLU!A_PP8LW\S/.3>]/X77WQT
M:-U7=Z=G=V]';?W'8>O^='#3GX+E.@ #_W6!@9\M4DY8  \XN0,KY&?."OF7
M1\HAGS74Y".C;=UYLN)^^T2$>&?<6"$/0=X;;$4@:@G^-)PZ\IN**\=<,^%L
M IP=) T:UWPOO?<:N-H?0C(E8C?(0?0=^]*^I&UJ+O])OFO1H[H<HF'-AK@N
M<6L.#U[V)(1@UA$%)YN+HE+JI#C]8M'$[$*@9I!WTOZKABM@+7G*B-R?&4 A
M.[<W##61Q\_.K1+"+GWVI%@6+5KL*(I%^PF/I?O>SN2#)35+04/4"TG:6/4]
MP$9F!3G5X+ID3@RKGM&'8T:%2]5<-XIY$7J"KXM9.]!H*K_BERS8=V>B*R![
M^UK>G]/3_/K2@>]F5X&4XY0SVF[;WAK__PO;0&%Y2L6 A X"._3*_<RI$(IJ
M_L?IZ?3+^_(PM!\JK:-SCH3Q7#&UY5+0MI0HLBOE>%E0[",?BR^RRA>%%.69
MJ6U=\,%D%60@'TO$;7. )(=Z8=Q&N?VIB*V0-. <>W'V13!-SY'0H5'-7L^K
M@J:X%&@G[9U:TZ2&..W<Z/F!YF3Q:+1I&<4!?L&E2$LR/:LY(T6WMB*%IFW?
M.Q'?,BZ Y^%;+O>_!I@2V3,)OQ!P<OHR7R%:W=@*Y!9=VQ(2YZZ*HM?=0D_+
M$V 3@8Q8R4.9X!IV F#W"<ST8E1&B$G7+4@;C>T TSBP[8A?.N:\G2.*\K8M
MB:UCS6$,;]'VTE#SP!4;,M6USS=ME5LTS(8UITE!EKZS7%G$7"V1,415TN K
M\Q+I8.&^\@5[7ZZD/ZXF<1G(9WG>%_YAU4[GBWS-;T[[M;[0G%"LBKN[[&GB
MZP6#OX6UXX8&5S74!E)D@B/T(//,7=*U$HR5EGUT4'$QV8%K((!0+/BY1ZLM
M\DM*?!:K3 99D4G1,_L&K%112C5>DE\,MPH9;<8ZZ[]TMMR+W/2:R$MS@GHA
M^T!2^D!O3[.GJ+'M>)*-G-.,!.,O@/XLQ4=)-@D0HU&[]*]=E6WLHJA0#4<"
M<(D.4QJ=BQ;#$OJVM8N9.PSB+%VB[*Z(8F$AXL]+Z9;6D+(%,<9M:B7B;3Q:
MD;80I"@TP>XF;XLJH#Z!MLRS/2B[=W^?D>5?EH$Y@(Z<<\FW6=TR7B;ETTD:
M\=./*52<G[!8!,J>;JLUP/8[+G'#_.]M[CJ"U''02;8T '7U:!O#>1+SR."7
M)^>3[.ES^I\?OWVA-IG\-<F(UU;W!I9HKK!"64(IF54KI M"F*C$3F%EE>($
MF!O+G0+Y7*$<W-W<M^5,G$U)18KIUARY/\S86(![JUGS :0?]X?<9=,QZ6UW
M[/QIYEY?;GS; ZU)H!3GS'B0>)STCM_3N,(I58^3O4T=+2FK"<P,GZ=SYQ57
M66@M?U=P0>SH\:OOCIWOAV\^*KFI?(ZIGP/)GIT[ W7TZ+OS8S93'8W#JB)7
M<S81)]!5:P#^;>IF7LF<T(LP:X7X><+>L @.%OM]YE'1V=<(7I$/64Y5\]*@
MY0IG]P+%O1I$*&6'+86$-D(!3=Z;S^0'S0:UC$1@O$HV9D:YE>&DTK>-BT#
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MU#T<A_=2?]*O;.D_&[#&/>&.14#[JQL= L(C6-9+5D%GIQ/$84&..W<XY$V
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M 9+ <:W92LU8"L/:2(L%J1/1+E*(SKYY^:([SH[*:3&5M7C>S1G%\W15=KD
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MB<G=JX+Y1(;:",Y.[T^_\'4:N8YD/;.O\[(:A&.RK*\T;2?*>;23?!O$F@:
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ME,K #7UE:[0LY2RT2$D/#3(<%MF,F\/4YPHD,ZGIB-9A^KZ!NV>AVN]ESG&
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MEV4G.5;MY:""D=Z*\X#1?PI:-BS(*G[I).F*&\ >C[]&S:Y0$I?'*VK&&RL
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M!.<4\UO1$6=E2L@6FC8YF T&(B7-WR3PGM&Y++'!-S3KZP,?^H$/_;-AJCZ
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M'PD<Y8@&Y#A !_&7/5V*YT+R:TMQ/5)D=D@4YN=_4LP+,.:9Z.'I5URAC8O
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MUF7>]2>KAIEUX-!/LV=:2Y#Q<:YT1(7;P-/@B=<M+JSR:?C]E3I:Z(ZNA)!
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M= )CT>8B7<KDY9&G43ZXK("B8+'S0%X2^9O9M,0$_PI)"BY;E4MI&+@N.Y;
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MZ7MWB^\*<*2%[]5)-[7NOQ39\E,?UDN4G2\1\DM/FHZSR3(DG17[='P+I[1
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M>(UY+;+1QWZ$LW\8R_'^#AUEH^$*_\3A\";_.0">GD(Y>8.C(0"=#J,Z/FU
M+P3&3;#(Y9WTHX"-FP_GQ#25*_$DUDP4SXZ*M6$)I1OY*VP.BW:K 3)&84JO
M5QG>M\#A/C<@M03[6XPYBA836I_0@.&]2@5L6/3H:*P'QK'R7PVL.!)9'^#4
MMP43&;9:8A-1GQ2E1H]7#7@,Q+;HY&JYX23:=-<O8N3 ;7G1M*S\.6\AQ<%]
M=BR\'E,#;+O1XY$]-O+HOMHD\C_&MM@5,G+C 9KG:X:  ]J/L)UIG[>F<^?0
M*8I_MHTEMHS,;Z2!WV.@KR!@W?$:WT^;<SYNR6=Z^MOLQTU*NW>G7^XH#42E
MW:.[Q_L$X/JZ&A";AL!7<8.;L6#";P(;[UBZ>QHYF*P-A<4=]GV"%:9AJP>*
ME=F;1/MX*Z'UAXY-[%(=C[.$QLO;S17'Y0AH$NKI#ID7Z15N@CH&7V8TT[.B
MOT9"*(AA&!3Z[?2U!J$+U-&$^#+[KYQF!,9S4]3R&^BA\"^&7!'"3FICA^:'
M:WJZ=S:]OT,3A?4>C(W"F-2SMS4=% MY(HY_:<QWV0YPP$-?J%Z<Z(I9\O\]
M_!/7S]E=B+VXT G#<O?>].QOG]I+T<%$O&5YHQ^95U>ZJH3$?,1>6-;;N8S[
MNC9>A%0+7C&F(%X5G%3&+U\&KLLTQ?'W\15T]\3LG2=<UWT6F/<GEIUB63IF
MB)2DZR0X*DB<CMGDO5[  YTD5?3!%$V_Y-_P*C^FG66J8"!(;L4GZ*S-&7#,
MN-0GH];[FRQK$TB*[6*+IA")#X$1-\ME5_2WOYK8'18<ZD9R=[N_Y<P!>@,D
ME9:*&*:TI<K@"$N#.MRB*-A_=?ROW/B OS%[;RF:"4MT7,^00V"BW4 <FPAR
M<9_AXD+;W- TH82/Y,O2NO7F"IZ$57B49'<B=XVDXI.$S,@-I24(ER%E>,/@
M)%97!D#6Z8<+][#;ZNL[]/=Y(6R8\KK^QO;R[ZOVG)[JMOOO 3Y\+U4#C/Y_
M,W^U_/M)V4$M3SS763/T8$H'7RV<L5_-Z2F*0D]F\OLRSD!F,\A'[D!->(_S
M3D1YW+_##L[6Y7\'V.,CF\Q[T_L?UU<\8_CAK7S%C_PJ#WYKS"S=F7&%&M]R
MIX(0S'VCQD+4O>+2"LV?4@)Z]O4KK?T\0)RD^FMR?L?,^Z/IE],'4PLR?S7Q
M/I$"\NTS[P>FUP/3Z^=#B7IZ[\#T>H"I'IA>#Z#- ]/KA[[GWL(V/_,TK)%O
M&7<5UPNT'YX%+3BH.7_R>J^8%KX>AXM)',=49[OX/0RN)"FN*!S..E(T!,(0
M ]8:9G$Y*I?R^;S>'"ODI5*ABQ1XXNA<]C0'^JVPD>+5>"28Y"<-634D?V&#
MQ;J*6$OIL$;2*5U?X7-(.*K 3Z+9'H;>?4FRI3:MA:]D84Z[7;J_+KF9)&OB
M95A()J0OK@LFUPD3/E$"3$O4TB\;ZYB-CS].JF\]R'N2K.GZ$V&4&Y>GZ$EC
M'\^+\DJRQ*)S$F9I6$N> 6L= 9Q"K!8%!R^Y:'O,(9'I7A(2OL!?082H,8VC
M;M<>NO'1H#683I^B4+\_?_WD_+\S%8E]7:!*:OF((_GC,0:?RVID>) (VYX&
MQS0AQFL3!D,2@IF0YP:%7QX@&0VLH:JD6'6A]>PV3-*5=K+GG'GFGZ#C G(@
M8.$P$ 4'MPV].#^>@0E=$FOGJA"-ZDU(8X5LD]0/N70YVB5[Q03PDKE$.AYV
MV#N><EKKX>5TUV+5*&A0Z9"1<"O:N=#5&E90M2F!\Y0QX:_+G/Y%[&<8"<%_
M[QP.X9=T@Y&Y<=!ZMY+R"LR(V=U0F^?1EK1CA&XQNIXQY(S=TBD1@O)26"O=
M]14>S#0X#+)DF;M9-V_+F>+QD8W!+-,/T$B*8G6X/&XD,-J1Q4&.IH*X]F*2
M<4=&Q\WKR"6UA2#"<"L4VD2K?/?=W2N8Q)*2DSN[D]F[@-(3?#H,X7HG@TLW
MEVOG5SGM8L6&,;XTR+P]JXTV!U@&?\50KDM/GD6)5- "]+2C"0>1,J.5\2SM
MH(;3#0PK=S?951,(DVT>K0 9<ERQWX,QX@O6_Z,W7"O&W-AUXM4G1NP2=*7<
M0J-;<L5%5AH?.TSYK%#=)<N*IZ_#JV_T!WM<<1#H;U%UV[UF*'"8658R77T(
M&QUIS<:C*,4*QF4A6G4;L0H@5V-VV+>O'4OK+AL#J L:&U@15X: L=2 R(B*
MHC6)!&GH09#A+".(O85+RZ@I;UZ#JW\ ;_7G*OGPFJNLQF47[;0L.4R>ZMN%
M0WT[-A!M5# L[JM_&T9!"-M%BW8T+$+T#&<>-+SL?, VL,606C7K%:*):'(3
M9F)K/$W*WIECC"BYP9(41V]#A9K8)/M.&7A?M/_^_YS=O?L0"#!V9Y@=K/?6
M>R*2$;VO?L(!\0T);439!O_,'!^AYN(G(H.*:P:6M(#/WWZ<N+>M?LCFO1/^
M^)2*)L?OE1-QKWR=%[M''(<8']&15$M62I!Z#F,:4&4LT)G8WD8C2GG:/=U+
MY[QOGI!Y9T'GNZ<317CL6#'LKW#Q^&?CO_QJ>O?+@ -1VN=DW"9,VS4(5)(]
MD>3[GRL,Y/2+Z8,'GQCP\3=;B.FR.Z( U4CYT!P[M!O=_L?XPFOE$[ZY&_:!
M5J*?,X'Z:^]&"J!?$'\O<_"WO?$E_YV-+MN7L4)U=D[';E7FVMRT8T5%_">.
M_,)@"X\:\.IB7=IQSB96HG/6]]EUK0:+;%"AZP9+50^(=&L' W[SUI[ D+(_
MTQ:@M!/-D\!HR.@4"G]4,KL-.AV!S9P6>5/6O:=;BYX)9T?4(8DS9LH@AE)M
MUXTP[!K<@GU@*=PFOK]1O?/&NLK?HVMPH,4YT.(<ZHW_JO7&O_ J.[W_X?55
MO$"Y^/_^K;Q_MKS_X/3!6?[5XL&]>W?O?WGG[KTOYF>++Y=WOYHOSF;__[TO
M AKJ3RO*WIN>W7>T<JU,M_QR"Z)RJ-4>"'9N?DV*OCYMF?;>-+N9XV+7BX_\
ME5-=S^\=C#L8BG_[M:U_8UB&4N^MPM7?4/G]XC>N#$\5<IL1_%"S]M4ND.=O
M+(C_QBC^[%;F_1D X O),^YIF*W70SXXZ&BIK)PT \XY()$9G5"@/&>=+DA>
MT)PCC!!).>D6A+!:Z*X 6C-OYY>35"S%=?<I^3L269%;O\W7Q="#A1Z._(>H
M4GQN8_O,Q@&AFI3\$BCL1*H?6$!"*+4LVE9:VHJ2HZW9AG-?3$U>&Q%^W=0G
M@I,O.!<.WI7LZ-GWWQ]S'9(^/VLQL/C]1-/G='GI?JE8.Y/B]$X;>:0W79F=
M139 !*[*GBL7JZ:3RH6V(\1K.V(0:6.RFR&!>96SSF2STCX+IHW6'R?26]0V
M?6A,"J(\K>OPM]))B8:&^2#+)RHC  D/ST)$<J0J7;;) _):#60LQI8BZ]/(
M9?9U=>GU+AFFT!884%#"KQ,F]']D+Z&BEL]Y2[&T!-I8T6N6?1OVMS03_0!&
M@CI2=GM!D=9+ '>%4F$Y^=]5D==.'R,BM[_T>3:F=D$*Y2@T)'@&E;OW/P3&
M_8$$*L?[.M$O4L5-;-:V)%<Y>S*LRY]I+/Z@=.#]Z?WQ,?AAK0M?/7A?ZP)-
MUX-[GY;J^=_^\V'V/; 557.QR?X]7ZT?9L]6JZ'F7SS,7F'=/Z&QAOE[F+VH
MY_X/CZJF6>#/',+0W[\1"YL]+Q8E[R3::VV1:KEL?^9[,N?)YQ[NVJ(/1UOT
M+85%[Z3%R7[)G]CQU43B1BPT_Q9EY%MO:K>AI5XTLBMC:[&$Q:4]R)J:C2C%
M&'H-I]&JJ<N^P6E'BYGVGXK)\0F3=R6?+:%]\Z$7%.G@&+"]+W)Z%=[KN(&[
MH^ISBG70DM'X>;?>?%_-P]>*HN#>F#Q%4%C[Z[9NK\$=-N2B94*#MJ/6PBX)
M3/*.9LWSZ=DT3;R_BNUL+V([6_*1_X7;/=U].XD;L"284.$]'SW](UBD/H?J
M3FAC=KZWTQ:W0E:NI65!HIC[;'EVF5Q]--LTZDI9S[/0?8G)L(;BWY@1_./H
M5VYQOOV>!_/GVT=JUKO-B?>IV[6/%C2LU;#*9Q0OS "5@X<U "4J*^V7/ AM
M8L&@EA<*1@6]>=VL+TLHTQ<=_91?T%"H%!;7P#IKPBU^7ALFM8/R,VA=^\M5
MSJ*=2K:%H( NMFB+.N/8\0NQ$_3[4]4JA86*:FJK9L$]_!3VG]A569^8@DQ.
M0_2LKO2K-Z#SI[_DQ[SO;C/-SK6WETMAV>MBW;/E4055TU4%6.AKG/[,2MH.
M%]FY8]U$S_O73\Z/=4?"@!T\M=^[; V.O2S;KE>E:]#SA-6IDZZ,:_@U&;\!
M%#\4,2_ 85%V2@$,7AY-7P1T=6(7)R:E;2>/QA;W[6 \3.COG]!9,4?F8M>D
MHCJ.V5BIEQQWDH+/Y<RBYR:?P7C;CIX^/G[/W.^K?X=.!K(FXJ^'<?CL#NO_
M6=3KYI?-JCB<UA_UM&ZJ<CTL<N1CJF5^TJ[GZ^/=9S/R@JB[(;RD(/.*B<TV
M'1U@V1'^]OC[U\?(OI;+HNN-:V))04&YR#HZTNN+9K7!R^-FX&IA2>M-=G3^
M^OF38^F7@.5DH3CFT6_IV#4[NL_;Z^GC[(*B1[8XT9W>\H8^NSWWM/XIWZR:
MPR'TVP^AHV[HRQ68$F<W;*O+8M54&Q0D\KI8E7G<",&%$-5/1G9=7*!H49?<
MBX"\47;T^/S)\32C_Y4J2YL+(8LH,C*YU67;0':75EQ3(OU4;-V4VY4B$G[6
M+#8*KX*,(W]%MSJ=ADQ; [1PWU-,VVDPR>*LV8R35O,"8@0B<CIT(GB!+I%A
M+:2+QH6NS]'M[^E)4:_EQ\1SI[W^^1ZBCXH-2(B&W\I@^)D>HI]\D]?D7Q97
MZ28WIE35WRZZ==D*\W2WH6./Z4RORI;VZ-&KUS\<9^@V:I//,0@^['-P^!77
MLZ95>KZR7H*--%N(HK'L,'%TZ7I9Q_(Q:,OY]2D_6/%?F>!R9VR(MJ2J.%EP
M^AD<W]!G@;$<ISAF;9/;A&7K9AWHP47I9U9@ K6(36;C)T!HZ?H4BSB([#F"
M__]=U!352/LQ+,WG[;/_4"Y>TB[H-_7!WGS,Y?BHZ'/IM9PU3==K]]NVT7G\
MXH=G3TY.OPHN12<YJM,OQZDO1E1/LR<%.D,DQ:$L5KIXM9K.9,?:?+:B"Y;K
MJF#U9R%&YJHH?Q0G=H[J^)6<CKS.<X5VX$GY'?2;&3H3+XI:[1H75KKLF]?_
M##X(,GT@P:?7^&FXHH]/LULMKH-EN\U2BBE-$=A)UU4N_.J)9;,U\/K\U>N3
MQ\T/)V=NC5U?-M+<B-4(+Y0%>K3_GUYS]>K[<^Y20Q<Z'8%T$/)*M;6RK[[@
M8V!+9TW@T(5B1]>IX+GB#HQ.6Z240C-YK+>, 2_*,E#[ICP:.R&P2X!/4I4\
M(?,'DLY%K&?2NF1Y,[Y(V2Y.UMSA8MU<K5!@HO0,K;7?"JN[?[8OL+KS:?9M
MV;&+Q5PI<1"MLGDCPG OUB&< U/7TFM;6PTK$^:=2-I)H\TBZF$)O3R-@>*9
M:&&>?O75/3$)GYUZ0M?,2VF"ZN4_QG/3U.]/$_X9<P#L'? (W*U;KCCW7P6E
M,(=W1'&=+"U_\*NODEK1ZQ*3\#S?6'7H])2):=FV!D6J.'MTU17:Y9&?0^;;
MM%[XU4SKY2A(OX<@7#YP<LZ>0W<L[#@"E&/!0NG9PBE1-7I&]-F]+^@5F<*7
M-A MG.P;X.**[+Q=R6S(_4_IE@_NWSE](._PDJLD]@?3,!.93!1*BJI87S:U
M]3;CGO^7O7=K;AO)LH7_"F+.F6DJAF2)NEENQWF@)=NE+LE62'97?_-R(@DD
M2;1 @(6+9-;#^>W?7GMG)@"2DFB+NE"%CHDIF02!1.;.G?NZUG_O[IKLB*D,
M,/]\8VZYMRW_W=YN._R=&SU@CH:6A#28<3%DI)NRF%A@9JOEB<:K<E<,F>V0
M@R\<D[2PGJ:J\1+Y !K@S<U--Y/F0[J3S%Y9*V<14QR!61E863JO^_N61LLV
MPAVG='""V"T,1OH&?7=M[_,_S$L?'FZ_>5?.V]_EX_\V<]5ZNWVX)7^^/;3S
M1[*_J2?L5YEV%A994<8$0_4J:E&PY#2%XSR?_OV77WA=M-\=)=<&'\.*@13L
M"5+K]\5UKQ8!LD3Q$;R<M)0K)E+3I0B!\1@NB -N7 QKR3LP[DUFQ3C#_F3G
M@@3WVIT766ZJ0UEG;:A8?0%\>ESPWF1-N\MYV&WH9Z# "/I&%5=)R!%]@R9<
MX=YZ<3[XY2Q&GN'["S@/OUV",X@W!KT%NI('8>)L3W<J&C^1Q.W4("O] X9U
MVSNB5Z8]&"-<76T40'UE/+* _N&$%;4!EXF8*XT69JH3^*K@ M8<,)/B<1Q
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MBC>O7T6&[7I?S'CM]5,UPZ ->0FL4[JYD\;>=KMLP/5:PR(54A#)\Y-%8CH
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MA'F\:V4B&'_ @@AY !$A/W;WIWC3GT&_K+,RY-D1;)HS\1G.Q GM1\V,LB\
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M"8BDA+S2Q%L^SN$5ZYA;S- IT3_I,)A!C-:0G#%&2>"B\$\#$(3"-YOBRA3
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M?SHB$?OR9S8$)Q&@HR3.B@G-\*\N!+A5"]&.F1TVX*8=K81W1(:'UD).*IB
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MDI9(%^2S=?:\ULEI9V_+A*K++WJ[_$UO=PMJ>HQ");E&B'[1 <9=Z<AD(8E
M ^@RDV\D+9V9]V\DO,$Y4.W=-!.$.SG>9]._<!L<F&TTE1( @7%PST$:<( <
MO(#T!*ZR7FQI&N:!:30K^SAQW&?FN!+D<'.MZ>[<;F];?* Z=@P:%9#IL RZ
M+N-AH.>DQR#GMC[7++KC52$@3*.'&_\R""&\4S9.;NK'J!O_@&9M&)HB";I!
MV8=WVT/QW3G=U7S)/!0\"6W/P0'*F4RR W'@>_/J\\E^I<6.$4J(R+8&6GFZ
M];%\/Z1'(+@3]6\ZN#EI@D8Z"\,S#^S.$]IV.:2%?@?@MH"6.,O'$]5V2Y'2
M"] ^CXN,+^+EBE4&:R^)9E !>%E<89E1=$9_J1%?+NTD!=F-"4DW\!E2@,4W
M"NSA"@QA(W;\=,A6)T#<=&<(6(+ RV;(24H.LS"<)D;0T1>M<H;<QWZBEQIV
M5)WQ0S'O5!5GJX2(3E*Y6>5A4QT+''7>X;O6[]:N]!/5=[T2!4&V*^UQSLX:
MUJA&/M8@']A]URJ,.)V$)0-B"JL*:??**E$&0P/3DA[G_C1%@$$*F7IOMI!$
MS_*R8?1;+"Y'@0PZ6O5+G-](%3'IEQONS_<^0;G$G,,]UGX%%,#<%MKA'PKS
ML_3)AW=TTMQG -<BV7<&LG\B\+#]DX&'ONC<8Z=S-]3^/%MD!.D?@]G$8I)H
M_T\]4>8@M2?)L@.)<2;\L0*G(@WF3[%E4I6-;>5 1AHE#Z'J! QH4I359H)"
M@?-3^N91)L>V5HP[3U&1F+$C'.;^V+JBV16BJ>E,2HY\>O(5=SZF.K ?%9ES
M7),$0+==[]#@[N:)]]::,&B(%"14I]<,VK4!*\IFDRFM'PRI(32=N0?*J/B,
M5R.N?@ ,(]X@&:+8L5(38J*#(*,:)TG0<(^O6,3><(\W?3)_H3Z95RQEO;<O
MN"^HX1YON,?_HMSC+\TB96"DWIZ#(;-D0XTC^7!'\CT4J#5&!7EQ9@""R^8D
MUJ]D[)];Y"B3Y]%(Y9LX  /UI/ZX] '),&^6:HU+56(QJ8)<AM2B BZE;S D
MMP+>O<RC0V%VIDN2*!.@#O0?M*(Z,C7T"<> I/\,[BWG@3FQ.S6Q2@,XV6:&
M\3':NOB^==)[N?5UF$$+&:2SWD&[V='/L:,YFA<D$2TCQ\\=N@XX GH[3$3S
MINK,2I)C;GN_+5>/C@I-)I(4(]TMI2$_!H6LQ713Z_EOE=Z59KX1\8>+^%*-
M5VHV%(598F\6Z@,#FDAW'G.%6:]7D6^FSRY!Y@X8TG2[W:S4&E;*-/$*DJSI
M+94PVB!D5#O? <09,.\EZS:_8'><:KR6_RABDUE[8\DKC07C^WK*NJE9V_7L
MPGF+L-(L7>I')P#-K*]GUN_1;ONK[94U6X"K&X#@D;AJ=N%ZY.$NC0IHRK(6
M@E;4=(GB0S'K7!*C=F9FWBPI8,%E=>':5(OMZUW4Q8UV6F=>.O8NZ8B=RP;7
M*A56<4Q99U0(+_%[:8$D\1;-8E!B5_(]Z+']8D126'HO!I^<DXJE,^2<H-+P
M>#-G*:)8=??M'$GV[K8U&IDE^VBU80&X>75[IYP@3EU6S9R=0WY\3Q[?R/'#
MY?BRF$R4,,V95@OOR"6R,V8F:5U.SDE]P,(MIE(ZSNL4)?&H0Y=-!.NV9,K:
MK2PI,M)<B.V[JFYYS-\$%:)3)9S-U!"=]73%,(Q6VT1B!ZNX@EHCMO"NH%;\
M>G8.L9\R;8(A(+X& $ 8-X[J^L0HU=RV)"CZ^CN- CI!3ASNUA!]\:VDW3,K
MN%C 5SV@[[;XDBA858=*727I*WJ <!X(U))%GD?51Q@S9Z-!DS:)!BL<>)?(
M@E:%+@DA]:&;;#+4W$@$NTKU_MFR%C"NDG2M2&=,OUYIU_I\=MYGFI.C,<UB
M8VFLVP\R:G!I.&BY;2%Q '3^0;P8H-P5%2LFQ4FX[Y;^=E9TJD<J#21^4:0C
MAJCG;G]IVG$5QE,<#R$::"S6OB5IG(*4BJY.R_88IP- IH$^/2CLN3JZPZ52
M5VGRN]1^P=[W@N#]>DF"ES"DOA(, 4LE@7NETG=C*ZV83,+=_T*'DT%!<\ S
M>0S^QU.Z-=WTXOATBUY\E# 92!);4*=&G!\NSB6W[LC:I8%5J-:\P (8J@@<
MUI5X?$_LOZ:V=NTQ2Z>\EWDV.[VY9(KS'SKU#,IMAMHB+P$?R(;]REIB2YV$
M,C4CQ!OH_QY5D"++!(^PAM"&E]BXO35VK\H6A(TT"K,JL+"E-5V0^>1!VYI&
M_%;T&;A(!+BM\3[6(X%F[F-](T8B(T["[/=]0 C!,',+G=\D'8;N\V=^5.*:
M&8M#$(;L&;.AMMC)7.Z1 _IYM9L?_"Z55JW^A)Z$HMN^KP(]83=.ZK*%#K35
MIYV ^VRU;6N5\,O)(2V'(\,NJ(H[QPPURI^AV3GN1&J@A>1\AK!G6F]/(N-7
M\+CH?LF@,)PX!N8%5([V7KR.%I'1X+1"\U@SA@:Z/%JW6AS%PI &Q@?=FRM2
M=B;3WP78$;BOJ'$N4H<QZ;Q8%/LOQAA9;80.QZY+MHCM1H],#J"<0N/)RBUE
M?O=W:/'U5752.7C"WH8 @=H&[[O='NM0&Q"6^[QHB$2CJAZLJI(!B'S*#D)&
M"966)9?VLPE_2QW%R^_0A@76-Y2J_!LV;KG+@/$Y$*P6T$][OM#K&_OG1LV:
M)5Q+S-:TO9Z<[OTB[8NV=[7MT9$P_ME.1M[]J48?6BT+(2J.&9]R QC,?1MD
ML#@$"9$ANI*6'GV<$U(N16K[1@RXEK+%*PY<\0\Z#0P+510.5X:,W)06(V[?
MW-!3O-FJZW%-;+71;5F%"E\O[:DO?IY4<S&')LRA@J##Y'#<425X9:9BB?NQ
MJZV<RQP7EL1ZMJ3BD43,K,=MH'&]?W@ZUG$"A<'I8D8U3;EY'?.>@" P"8-.
MH$$]RLX+/XA+!BL\D+;Z;%E2KXFRK3G*AL3=[4+C8F[ KZD)QWQAX1U2<FLO
MO)0H.+M7 ',J)0J2T.:^0CDQW'@VV=M9##1LMYD:83ZW)";T'$C!'98T\!%T
MU0^I>ALX@8L*_#HO$D^PC>Z;]=7?E:_3@<%[*GT1"324L9"[E4>][,XPB?=
M%0D(M$5';!D4@WVA9JL_?*O7;+3-G,C'HOQ;=0ZM-IH[)'. J!OR#>P)N,PW
MB0>WE]Q6-0T#9Q33C^M[\+9:UN4U O2KLF;K]F.;KW4.%JSX6W%7SI)42X#Q
M->RQYQ:097Z0E@BN8BH(7AYSW-GZNU(/,\RHI\(4KN\@3-@$3.]:P+8'Z@H&
M$56^XV8?*WP4AZ1#?2_Y#@S!UD?]^<M6^R[P&:.V-_=8G;.%;;U,4Z*ZYI-D
M!6,1=F7=/OS16F^S5Q;@)=;C<)2A"\?_H=@"J[^"4\V(M4ZP*1&O C$U,X;
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MV62^!"$@99%D^KD//=,-/R^/E:#1;01@;:N/0O^JWDW:,A70?#N=;4FT$:%
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M*ITNQ"1O$F/#;MD0Y>G)^P\77_\_[^C;^<EQ%=(\&:5JO=&^ES#+E<EY;Z?
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M^!&[!,C32_/>^T0(=0,!XUR"^X)WG[(2@1O!6^-L\_-M#][=MXK6X?SZ+!O
M;:*UV^TMB33=)EH;IFX;C?H8&E6P^R9)I/T"S$-U?3H#P(4M5^'RG%HEM,#M
M"80NUTN7^EG4LZFCW]03OA&Y=82C*F4V)&C&:/0.'5YAB1)4A[^H5*Q+F8;7
MHH/$UXN,C;V=K7L YVX_B][9;A)S\WXQ(K%S=]Z]Y<[+^A[+^Z<:Y4'X"P^
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MIGIZ:* G@4)J<+6>^/U?$*[62\&9VNON[%>BVZF\B7RXH T;/*I[]SQ/X%\
MD&KI>[Y61*IG!_RX4&4H:%,3@0 FX/<XMB"N Z3T$%P/D=WW"Y. =IW;2X,?
MJ3+HY1S\LK?B\#PG[?E[FU6LT<.XBYG[9@3>8-!^,/,<(V4 ?;V,%$>S+,D
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M)UCX$)44"-JB+",GYT8VME@!;5%8>P! *,/XSJS9#*T)2$U9R69[KF&R51#
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M]M*?S%W")VQ6:Y;#@D' 2[&B^WQ&<&.@TU(@FS-T36>HL'67G-N5'IWIV/4
MG9R<>"=G%U_^QS3)<H^C!+IPVXI:P/K5-4*L;R*TD*A1G$"]+;76L(?)BHI1
M5<J=T!;-@K-LMHVZO71<%_W?3D_ZKGW7O8EA^YCKHE8""U ,_"(G#8/X"*I=
M',F-:PKNL!M"OPY]RT3"QP;IHSQ4E4J%3/L)VX/1$ ] &'C338O[*-FK*T##
M).,9C4Q.*'XQ4[),-AQ"LZ(%,$(0HK>ZN$*,T6OUSTZ1G^5OH]ED.D[\&9 Z
M*U><GAIDZ1N53H"FD83 RP&<Y22)^&I:6KKVE15_G(:#7,V2)OKS3-OC_OEO
MCIS[@C\^[<MIA.!/)[V)?%.P*=O7&@%!6HS:$AH2I"2)\RP-$Y' :*?KS7W\
ML?:OIDD8YV58Z/RXT_-:[)JKR83T&+!V2;TK1"C@XY/8];9@?*+$DL%*43+J
M[NEP@6U&&L_CR)*R<,&DIY(\^4[:YZMQ-0'GVY8:1]297I.FXZ%R6$I?*S:W
MN;US#-JJT*!^;>KQ04?U)<UVS5;K';9=6M]Y7,U&>O!&6NJ1S?EB.E></O2]
MTMC)_BC4!'^P_),-[X<Q^VE'ET='6W ^H\0P,077*+0)/'SCK#0RU>E7<1 &
M7+Z,8?A%RM-'5A5MQI21M-UGJ<*!S['5K_< 9,%F,' YMX)E(=E?1"[DV'O;
M;81I/4QHMBZ_%"@;=2]YN:Y-\%5=JS#B1C&.G=0$Q=7O=LV_LZJ5S/1\@#<4
MX#.N,L^NX"OB%NFF:KY&!A\L@V5HR 9O5@F>W:[RZ/V ;C"GY2;OH>48.7[5
M>R[HP^5WCA3?F@;]40_20J6S:KCB/MUW%SA@(UR/<UJNM-CH0+I/J'CI^4H6
M 1?MM(D@*:. IH0]&>=)I+'LC)=//FLPTN-DA(&,;]2LDF9J_?KKR98<>:Y6
MC:6ID8A'53>AP;%8W,BK"Q(H:#.TAWE10;M:CC>O]?GRZ%1$!!P3\ ,,3BLX
M[N"DG/; <&'3AZVO["J<D^)(4E8(ESZ<$CS41-!E</O;_REJ[18;#:89UV:!
MS,(0G'"U/(>SKMEGHB=98PU?\K JLN\ C$[F!?)AV*>N:*XS%R^Z969Y"MTD
MT2UEUEHA<GS_:9PK=KVVVG8MO ^?/EZTO?[I;WBSBR^7/4^1DY):CF^W91?V
MOSQ-6M9NM8!OG4?F.74WKTPFW[;9R.NQ7<G9 +I2U4H%'-&;%X5"LP2:0DAR
M-PAT8:^[?W"P=GB:M[O=G=V]9\:G>7J D+VG $1IT'6>^/U?$+K.2T&;V>ON
M0"_9SU)Y$_EP01LVJ#3W[GF>P+\ +,W2]WRMN#0K1;0&RK\:I63/!!WSUD/^
MW[LFU+5))JM0CD2F]&RN\,QX.2YG8KHR/ISUF7CL]+\!*'+-OIQQ*IF/#&&!
M9>_U$D0&A!DJKGC2;VS#G7D27O)"@Y,S97R0F,;K:WGQ:S*GXQP ')B7(%4W
M:+^3YM^LF$XC;4@>WX?2O80QTUE"_G5_ZI!-N]YQF/E%5IGA5(]0]8$B.^.4
M,AYK4N09RG_-([Y=LM-G0.+7&I]^"4MSLJ2ZBM;EE6[RES#C=T6>GELQO=0Y
M6]I6 )&(BPD:"[</WTFW&D=?JK6$+KAD+ELMQ+00!2JC>1S[K8;T5HHPW14\
M^L'0G TI934&V#*TU&BZVP\A%[7LW7D H?0C+?R\2.4,"E/OY(L[57#M,V_4
M(W@\Y ;)=NB/4BU@*2T,\ZB/HIK,,T@I;!WT]NFC";#3 ^F7KY[&V[U#?JFL
M&&1"V!PQ\=Q"+0=LC&]<,,HA<)U.,H=L8FXN$PE)U($GHVE79G:<1 $HG/VH
M8+QV!\/E13R[#,*.%V4RX5=Z"CTM-1%@XAE!7PJ-RNH)LP<V->5N[E>>IK%7
M3.D58RCSF=7N__NM17^C441+*DAV=DRC5T5).KKPVIUZBW>2?Q_3$.8-*,&<
M@#C782.&C5 _4C="]>2_NS[=GNJR7B83T_?^]\%^?7TS16+0X0E""FM!*+B)
M"%726J5&TRZ*PH9O+WKCZ51JL[(D@M4"F88Y1.9"(\H/IZ&&C(EFYC-U'*:!
M]P<=SKDPNS@%!8A,=#1'%OR,U1[T5C)3D<!O]GK_B:!4>:C&.C=/:!3/&E:K
M747!8HZ46)?1FBD 5%.N!.8YEZ(?[FJ1[G)1%M)MC'X)+P\GNA.%$X:JY0MM
M^6/&(1Y<Y&P[?DYI2=V,0W]<WFQ"%MU0P62E_=F&9Y"GX:#@Q[:&[#'@>FON
M@D]',55MG)M>"CJA2('^ +[6AC1-_$-?YRIN(#.>:]/</_^-VKFW:4(-U)\D
M8]]UA-U:-W;0+2$@T*[_@/>UZ:#(] 1HT3%=CL(3J</ML!H1\XENJV*#@SE-
M]36'09B^U$0XN)9&SBA&NV0-(_H$O7P&<EG(P;A?,X#_G,Q@*?!]LH(NY;M8
M6O1JG<9B9(?<[CB\'2[C]BIWQ5 ,H;CP(;A_\4H)NZ/V;?"*H!NSI<XT"&GZ
M\X+$USS''9"$JC 65E#[9" _TQ]=KY'HM61 [JL-J^!!SI5 ]K;;]Z*25/KP
M>[VVI;,2H,#Y)H(].:I)4H+"9_FLHE$GP$E;Q)5&&9P\O>WQ;H( )I,IO0H/
MGX0N-5CJC<2LH8+7FL@Z9C+O.:0%7@Z)8DHU8C/E#YYR2+,9/V9\PO8MM"^T
MH?X^9<H#&P19&BPT0QJ[?*?Y<1@/8:>*89L586X;T4T<^E>5^^/.[^H[VO[Z
MM"75B-0Q>?-VHY7FKDY-$U)Y1);Y%!.?86.8[G*4%&GNSA3W,;W;,2W/#:+?
M*LNP*-Q/2):W]P4DC-I[GR179.YGV- T/GF-K-G;:Q&TFIQP$1#-<J;S7%*[
MI0]D3GP&8[+L%'I("D'% C)IDL)A*3#X(-43<YA7KB8E;S(=[^A9VON<Y.9\
M.>[N['0'7<92>:D),2X[L1$91L*-R;H)F>>$/N#):EOOD-%63NA3$_<][,KL
M,>9Z7'#F">7EK\SQ^TC6(.UW[;\>U^]Y)_27#U&8ZZO7,YT;YDFO(M#-6?-0
M&6YF< 74H*Q"=D6VF!HYGJ9II+*)\HJ4(5NN=<01@;GR"@/ETC8 +Q,#+<WG
MF6G@F?#+XU#3F8EVLXL8YZ%QY!V X\: $E_ PAQ$25*RMV<;JHO@+_/KO.?7
M.;:O0WX:K0Z9%II]?-]$6*0(X;"2%I4!_8U,$/^/(BR]C/<A_&UL"A:)_B":
MQ=]?;&%2*[-8>Z@OVI'_]';>R6?]KOSWUS"3XAMZH>,Z'!4VT)$4$/,=>N^V
M7ID9]B%*?-BDC=GP3%MUA05HSKS[(O X=Q!TGX[#" 0)C,[IM9 /Y.@UI]$^
M@CF!0Y &4<CQ6J&X&XX80.(Z(&[R_(BD!>TPYE8VFD]>)Z+/:1*9K!P'Y.G4
MT)JQ@_245&V@A?/0L2O,$4"ZD2JKB*KAL9!#G 8GUQSD1:9_[([\JR3N!.1<
MP_%V87+^K7D#4G + V^#F#%,IMH Q-3-!WNY& 2DW?.0 4+IX;-(?0\S27X'
MA:^EMC/EBC6AV%IXUJ867_RZ,-N<RDGIP&U[W]$G?47KAF 8@Q+8URZY3<<*
M^+'T]#^74YQ:-"LT$21J9-$//[(LRC/_>7)RTC99'0$!%#1L4([IDB-3[+V.
M%6?.:7>]/H:+"(6LCL:B)P!]O$68^!4L$"\>D/*-!+E9>%:[7J/('J[(<CV9
M)B1'(6?LF$!/\'DX>8*JYCO$ 9)4)Q;YMQ0L;^H^^UV;3$\C6VN0K6D:3D2R
M2BB-EF5N[>W1 <GIM[9W1"H_()^O7R!?&\$1O"1-/_9^2^@8:7M?57BCA,?P
M5Q <_I:LN1Z]L;XV2K#H\#,HOJ;"' !B.D6\VY9B^;6*>.$BO*%3,1M[7](I
M3A$XEF&>%A.O_]YK72:#<*MM<5ATF@)PIR2#T"ZU>X%."B4YQ3-NK/<^J"RW
M 8L) O$F)2Q0U2EXK88I3><K<^3Z$4[_\'OCR#W3/EAA 1I5<F\IU2WVS<F_
M-L:;>[]V;^Y]X\T]H3?W_AF\N9-_/9$O]WXU7Z[19<_HRY&N^W%/[BDPLIX!
MZ.7@X,U/ ;WL=-_L[Z\="FN_N[VWVET?#PEK"5 9MV2N%79E3L(;+*D7CB7U
MBJ5L9_\%8V?)8=!@8OV,N+U"2*QEK_F71L1ZEF!Q8[P^9K"X;,NX,V+\6=]X
M_Z-51)[E*PX?-Z+VTL+')F79Q)!_YC \(OT?7H=-"/F9]L+]\]]HD_N;<1%J
M"?\L2@+[07BM(@F7YF'GFE3([V$4Z4&*#?[1U I=__YQR_M,PP%Q6;,"CT'F
M 6@IQ*-U[$NQL(T=\Q4H-!5$KS29T 8-??LG.J>G.J8/ID5*_Z>\EOKZ]7RK
MZS4;9EWD4@+'(XD177 K>I5?JI[ 6%Q>6HZ-M>%^1/ DQ42RG*I.RM36=!YU
M]KJF_]@EC$C,/0M4A++[9&HBO621("750?\BVA0E_>(X4CL"E"A5Z"[2?WNN
MP>#27DN.RRM]/3)4!!%1;G4-GILHL_2(9(_S(D+7M4%4(L2'B9>1)0:RW_K[
MTX:[!G-<E-PPL*..="Y&T=8[>DT_350\"A-0Y-!<S=.\>JTHR1CC)BU?C4$+
M+%EC8!#],#_O:(X!H(#?,=)?Z.?N9XPHRWF[J4IS!V^'UZ ?,@U(2#>;TMR"
M&VA$:Q6HB1J1E:=9GHTPRZ]2%8H?,M9TMT:;K$&;H$=4,6,H,PEK"VZ'-*T5
M'!6,-2=N;4LH27 !^2NEES'??+]PQ,]FH5G6. .VL>G&1LB>$I[B%@"*)3RH
M[^80+>;9I7IO1<&8JSCRH<FS/#^3ZQ<[['<:C;(>^Z1"(.28+=&R- _Z83Q[
M2S=LL28FZM_ U.5<O).'\D>MWALZE-^GZL\P:I.<1"@R,2UO0YRLG_BD3KU/
M131DF!F!#\F!,M(/'"=J&;;P(E7$=(9ECX;8V^BK31)AZ*LRQ$4*1-KF !5E
MGF5"\IZ4XT["H .5U%TV\)?05T?*KMY7UW&-+#_43/?*PF<?XG^KV>0N",<F
M?/:88GG__#>JZK[P64:^_R0*)VKPCNUQG=*Q>Q4G-S$0*=^?_/.?V]MO35QM
MDL0)V>(X_!!9@Q?FY20A.K='L!\ILKE\.1T-%XAC4FT=G6^Y* ,P-4WU8<ZH
M^:VC'A@B$9'0 T>[BAL?G0,AD\XD.M(-SB;@,K/$#ZMX<=>*CG<Y]<6W+KNZ
MZ6[7271M1PFJ2I3.<22#7''S,@PCULC46B-,'3H7.DQD[C &JS&G9"KNG_T.
MP::%<((MG9V#+:!7(J=Q-(I0Q@J80T._T#KJ'Z_<M?W25!J-O5J.BMLD1=8V
M1<-I@MA4&3U:F"NDOR2>(T$2[G]_\RZS.R*;9>2TH"(Q5U>:ER7/R<#($!*)
M\O%L(63##U9%)K6,8>JEQ10X7^U22<@@LM! [#H:##KY 6R+L9!%*:C'B %G
M E(9>+V=]K9%<3=%K!*JD8]@S]N<'88A:($&?7E^_Y, #6$D>4,2DE&A#<0@
M$ \08$O#[$IL$@YTD>.6H''8P&OBVDF2XJ3-9YLJ.HWF6DLTJP)(ZL@,WJ.@
MS 8OOYIF@F,-2@^)/K3>?ST6PF>3GSX&"FSE"G([OQS3)0XW\>-Q7Z0ZD1\@
M?N;C0 PJMYT/:IR9BS*O/T*U.?FC0P8!)"W!'B_&KF_:YI03_$S&Q2\!7F_A
MTM[!3JXD!ERT/T]H2+*-^/O8EI/7-84 9IL.C8#V'_W.*89*]P-O5M)RS4F[
M)D?3+>U\H.J,3L4L3]D@^I6U>]L[154%B]WO.AHB6C%/9R_P]@^+MBU2F&VJ
M3OW*Q226+X2D%X>KI&Q,<=U1_^+XY'/_U#L?8X>@+3M0N;*(S/R#:3&(PFPL
MM2WX$8JE/L2CB$^UI$ACX2*QV[L:9HIFALZ]V2T/W2UZB.RF/_.R]Z=]UO4#
MK6,GZW-*M!H>GEOQXP^?_Z=/"B]44;LD'%#AA/NDTD0%.K:^ADFDVB1'&;%$
M+TX'I$WEN+C^2 WAQ$"&EFR:,/@__Q'N[PSWW_3>[*BWP9N]O=W]P^W=O0-_
M)S@<[K[U@YW!_SUX\Q\_&F)Y^S/H6[=7K2X@<"VO]?[$L.=1>:YMJ)JX+ %3
MC11QOM9/#(2M/?>"<#C4"&V+X4KK_0NI8_!S604!,Q;,-H+_/E;7FHG#."^/
MJ-H4R*!%##'%&3Q*DYL<O!/>E9X9;4UF^&4)R0KD+SJ>.]6'3)P9H8RO &SV
M0*7DJ@T[/C[$S9V[%0G8FWD%-=#@RF.0WS0(23%F?A&IU!K^[ 5DNO;VM@3O
M:U+\6S=*["&<)Y?DN/Q1- #'#YG#<U(Z(-9K)O$!DWA&]KSZHYG"!TSA:8*&
MSZ::_"%S"*/I/%+735'^0S#?-P6S]:@T*EY7+O%>RZA))3ZJH]\8I@_-)(9Q
M5M#GWBCBE=;>KHWMPU_)?IF<FC0B>[[(Z'%-N(J2$7R5<0%V$7.3]GT%R,X-
MF9!S$^9%)<38;;R,M03":\&1%5BA6@L5=/M;[R1V=>2U^N081[5O;#7H:G'*
MUC\Z9[^>_K[E:*-LJ@ML-64,E%L\8C5A%O93&GN1-7+P\W+PKPN:^"K5U_Y6
ML[W6L[WBY$:VF"D>Y.#P)$D-,L_!]ERQ8[L2.SP:A[$RQ6,5$JZ=[9UM!J.:
M(Y3?V6[;?>AV"@-GT>MGE6KK2JPR=\RH=^A>5KE)I#/?95$=L%5+ <KH0(8P
MTRJ5[VE?7^N-S<XWDK^&VI!:36\SHP\NS:1G77[M7S1S^) @ H+7] HLEM-4
M#]$O&GA3;9F=#05IYNWM5XU:+C:;MWL97$]SDQE8S=#[!1IQIV0-MI=WG43%
M1$N"'04R8N9F,%[B OG3ZMWE<>HU&#4/P(]:3[:FV3$/YP@\68(I?;AEC7K9
M(A^^S6.(O-UJ-RI_+8<HN.MK)^GJ*NSM]GTJC)?WA*Q!U2S7XRV7MA$..E,Z
M6 LD5,G6#T9Z*1%W]2>I+LQ*P]:F-;K,5=HLTD\OTFNC>;H_L[1A\>3GG<Y?
MCB+]7<4-:]9S[<\F4_K@8RA)O?NEN)G%^](<$$,U52D -Y(@+"8NJW'C39)(
M2RV4W,0;:[FR=7KV^Z];RV'A3:VVPV"O([Z3=69 H6NM"]G$E!,NP6;QBYRK
MKY)8I3,OF\4!_5"CX-J-W!"W2P%8S2ZQC=3<^A[22M$\TOM4WMK4E6=2G39*
M55 PRL8 </W5NRD_!0X(^K(P_B6MV.85%->Q(;!9]7MSG8KUHZ*RLJW1 XT>
M>!&S2!M5A'(^<-_;GH_</R^(N_U)Y31'N%ZG&X19O-?=/SA8.[K[V]WNSN[>
M,\.[/SV^]L%3X(DWX/1/_/XO")S^!8*UU[R8!K_]WNW-V/]_ 0#WI>_Y6A'<
M-R1T=6\Q[X9%6IXY<G62^>0SW14;WK#YW+#(55.;O@:']7XA;F;Q7J#L*)F&
M03*BP7N#,"NBH<JU"5Y5L#IU3&_)X#G3<9)-QP#U;/6/S[<8#F&:<UUFKD8)
MJC;IM%K"=V@P=H"M8:K+%$!?D@K@K@'>0#BI!NJBO+$!%&/X6'BJWF26<*>A
MBNCZH4JE>J)U=K+5MI<8"%F?)C9-KK0WWU5)DS8=<ZNI2H&F2W\XN)CS_O&6
M0?^K-CW*<);'TFA"CBZWNDW?R=IRHZ4 +<U\^IJ&EN&,F0&V1?EA0&MPV=]:
M5=ZD+F$9]@OBC]S*[0W#01I& D!;K;84F=K4FL6CI)'2!T[A+\>%3&+<3.*#
MBNR&X7<==(*$N\/+/4X;=NGAQ+N6=GG[@4?,,O2PVS3[S3B1I$@$3''@VUU!
M!] MQ[5!FJ%MJE;H5U(MR^?>I8@XS;.D4CW+R[1,HV(:(_<ES.)".M/E920G
M<[B0F_$^PJ M49W#I=$7QT]51:?/',96!J2^.D+N2:X--]5^5_[[15BYN>DM
M\#Z"UYS!HR\$;H;[F-,$^)BDHQBX;^>= >MRUYXS<F7N1M&/HI"^TG,_L!][
M_315L1" &[WW/H5]'77.9L#%O/RC" >#'T3G?6FZS-POM#"?!F?I)FG4TAIX
M 05$+E(W61$RMHS6WN<D-])^W-W9Z?I;*&)/BI1YR<FX#N2<=F++Z.DLA-:N
M1@=2[I6;I'?8E5W%!1!Q03]*-;!N7EE=W@K((TTX[E'#<0WTR\-#232L-/$K
MC&O2O+T,'[HUZ0_$2Z=W&'94,.%V7YVREK:M,)KIAJ"R;[2^8G"IA,ZO#MTQ
M'T<S#C,-H@1 M=)#0S=0OCT%43T%&&D.'<28/ 1VLF*0AU&8A?$O5_H[3H39
MU&BMMU[K_.CRM[=;<B9&R4TG *U2/O.B<.INUCH]/BW#7J*[ (1IL=WHFYD?
MX5\T"+JVO-3T )'JQ+?XRA^C49*&G41>!)S\C26T:7;06L)>I3\K%$HJ^#=Y
M5X*W&B(2"TQB]3V<<'$=F6RP'G7 9ZG4Z3$*+60> G^+FTNWI-&0T*$79$X.
MNPT.UAJ6TD$E5#!V[^KC]FZ2- I 6U:-,=I>*M#<H,O><BRS&%S24OZI4^%6
M5AD#^N&_IES3%59^BSDP;N_!73QHRVH[C(:R_;M9^S6L/;F9.O***>Q=.>,0
M0G([L.0QDG90>Q8HY")T)CCYV,6\4F<J]<=EIYQ;W6^V3+8.H?&V6JW;+.::
MP90K]=EUA5I-*RW'OX0&YZ-?H!,L\OS<Q1*=W%0;@,3UF&R=&J/:VT8,URZ&
M)'Z,]5&"W>#\3V$'D)0-]!+N]#-5P?W85/FZY);BFL(#B,F%YJ@T4,8SVF/9
M-"&C'9$^;->E8;K7()'/W2\_UQ52AMOF5P#TLPF.-)L8\)(BST*#(?/M\@'!
MUC"SH:B-";7*]TYD7R<%VKT@L$TTZS&W9H/!^^!85D![4P<*_W_+T'TG*!2:
MT-2&/KEPL8XD]D1Z35+'<1YV5)J.9_D8-4<(/^$E235P!=%<6GJAM@1A(O8,
M?,'0LO[['9504QK?]QD(OA$:HZ=EB*'%^;+;=QMDYK4;8<8]K[1<DEO&?O;V
MVV:^'SS?<E3.8X.I 6CK=^=9?U_9"?IU/)LDHR@9 (&E.4B?20)7785F)]^;
M&\+IF&,Z_5FNO4]F3FVA<1+-*BFBCB2.RLM=WHA.43KT#!@EN%"82Q!J61AV
MA-$PR0K2TCK+P-O-VID_G9"G$!D'@,SOO )7U?::I7Z,)$99E'<[DH$H<JF\
M2[7-_54M'V'<XW7SKL(@UC/AE9M&)!AM1.1,@7#,R1)7($P?D.-(^@VUX'7!
M@$'TI71#2VK)0$]US,%WYWKBA)DU$O*X$E)*A.$_FC.8%\4C24=0$DX06"N\
M6Z(!*DDQ15=F)3%J"3=]S^,_I6J8=VA>LR+K_(HBQV/;*/#I^M?C+8\[51'J
M2.#8TP/&>J)H39)0Y]R H"<50L1RO-U&K-8H5F5JI8K"@/))V> 'K]QJ/$O^
M3 9AU-B+SQ5XN7?^FUU\GZ4XC>BGWQ7.!5<)9.N);M&I$TPZ/25=;#Q;UC<$
M]H(B8LL2O?Q)//- /FUMPR'9E/3PUJ?.T>5'KF&T][]M !DN8C.G["@3#ES)
M0$21.;68RK$89/J/@H^:(J?'CQC&J7XL+&88XR2F@R<8786QH^^.9I/I.)DH
MK_7YUU-!6>7X%"BS)S,=\5=G9UM=KQ',=4/[_'4.E0O]9Y$F_M5K$)X-.T]>
MT]0_VX$RT%$Q(8<@""-SCM  H9#)-;CX<O3;CM=*QTE'95GB"P.KGX21#CKX
M#^O:WCN#DHSCP9:!DB*F-^WL +]O' Y".C/X^%E*K/Z/(BKS[[TJ/\Y2'B.I
MV8,^G^H@1#3?+X\#IM#H[<QS:"118%,1_CA-8OK)J.JUC.&UN/9F>\FG?Y;>
MRU"%49%JR4]X$5V8<_$MD]=ZF%J&A<YF./CHMZY,J8_)##G5@5:;)!XE7+V6
M>#K.<,=4CT#FXXXV20?3,U-,&S?<G,Q5,NWLH(T[8W;X89I,.$J41,Q1HH0^
MGL;2;)"';Y!LG-Q Z$V^2=QJ%#!CS#:;3TOK)RF_'ETK4F8N@;>E%?;&L(@\
MY,9&NMK#WY&6#5!E%SG (#.O=7[Q);L#7/DI$/"> =OIX.#-3V$[[73?[.^O
M'>ANO[N]M]I='P_GSMYB'GQIK4A+<]N@08I[X4AQKUC*=MYL!C)> X/W@^+V
M"E'PEKUF X+WK*[X91*%?Q3J]<1WGW<Z/>/=>9?%*YO7#8MSW"_7C1=WCRC3
MV?[+[B[J .\7YF8R5\ ?DU;C0-$3#$(1QR_F(8H6>/X<TOLWPV_=7I7<&E&<
M*/P>9AJW1R>@\CZ=GG=Z%8P]"[#W=;YUK]E"Z]I"M)B?:4IK74P'=\3I3(*F
M[",WH;D*(:X*-*U-KDF4*HVW(,I6&3<\B RU(IUE]091(6-C*=SR. I7RL<[
M6WFZ0+']M@Y:6&OW34PE,VJJ9(BA[TU (88 WS*BX-Z;=J-4UA"(-H50:%=Q
M*;PJ-7EL>G:W;FTZ7$AE3G0.BYB^^A'Y++F:0>@\X>>0 IOY'-8ULL+-9;$T
MV0@S=2X=S;@\!%2+#CF,.YA5AD&J+6:@S=JG,FX;.*2)Y1^R&(ZBPD\RW8F2
M&\VML$84Z2N+,I.8L'9MLQA!G8+RO=%]:R]MK_4+BG MDY^)CJ(P+S+;B5A*
M'Z^856S<%<;4MT&W427KY\LND]%[J]/,;*0'W)^&0=HX:L\&$'G?]#=;]SXK
MH'08"H8ALF#;J:*YO=='*"N;[CBZ';JI9(;]<1@%J38FPX+NMD53-1 FE9("
M"9#8B[P\G&CQ3N@J6VRM.*D[L7?E,=)/)YRO9@N@ZO.8\8MN:C52M YX&25X
M,BPW'E*T4C&0C9%L3;V@2)V3:D"QV+,8JBRWRU(3KJVNURS,XYW,BPQP)>;/
M:SND ](MR>CUG-+/.YV_G)@C@\X+4O@&:N'US.ZFV4#W2G>C)>\S@H!K_8-"
MW4SJW9.ZS(RTMJ;EZR6;\5<Z\AOI?<A$MUT *ZR+\$+DGPRJ1E>L-3)5*9P-
MEX"-O1$WA7\"_AAT>L!7DL)]=JR*G.QC"R(DC<,EGW6+?!Y==JR2D9:#!H+#
MLXV^6K>^,HOI@"J/DLDDY-Y<+&ZU9+KWQCJI['Y67%]IL\F*D4J7>+^W![XA
M)LM<Y!975^_.%U>K 3UL:_Y^/7>_9J>O::=7R40J\"H9H*!5M(PMGOQ<;&P@
MFKXR-^IK6EPW?M0C^%&*QI'FC1_US. J]XOWBU>9SPW"V&(SYRI.;MB8H2F]
M(/N_F=&?G]&*9[JJFGCQ<_KLEMY*GNGGY#KA:YJI_GE.0DSBANO4%^?>&SVP
MQ+TW[9Z/X68VRN>IW,S8>H= QEZOF]FV%7JWNYJ]TM5<T=-L).21_<Y[G<T?
M1U+?$(_SA-382 AECL,1?N8=H:/[$BVTM+S9AKH:<K^VE%!&$>VQM%)$V1]@
MV+S[WH>)GZ33MO>K5E$^WKF<Q<(2?9&0=##C[*"@_2M8=*0)8NTS_8[F>LO
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M$3V#+M)3V;U*N*Y N/Z' _-9K$L K/NOML179IV;BU6S3<'%-48B=D"C2-)
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MO>K47WKJJ2QZSH&_&V,>3.1 W"JI;6P2?Q#%8:*PPH/$<7V/X]S3-;-+3Y-
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M84*Q/U/=L+C#,4,I[R"WL=?=6;FXJ5$W"T9\^Q?_;AZT#^K82D J6XN>*1.
M6W\F$EE_&/HNZ[N))Q^T$+$HA,XQKT45X=C(8.1!/N]J8N@+!-+2?2HJ]92.
M8+'@#8FY@;-"T49#";$"W3TEL!P?OH0GIE$V6'.NN(/V21?MR#1,OZT$N]MY
MPXCV8_KQT^5)MYP\4_-3:\BO_:_?CK^=_OY*R^ZU>IT%UCV_Y_%P?V60!0MO
M^8_/GXU)0?'Z)Y@[YYVQE&P6BQ6P$D50&M_>4@;K'>R7AJE7IMGGZ/5%R(!D
M?,/P84'H&EF;)9J7H/PWI(QW4&>EPUA9Z2#6;:'N\]RH$:+TG>[NSJK+QY0N
M4<5!JB[H2[=;&F+%6=-WQN;Q$[""'$>B5%+D>B40"S#TLW+>1T4=GRZXG:E[
MJ/7/KLX__MYLDV&C_]$Q99_U<LMIH5$ ^'QE\K'(]6_!5CG"^F05Y,.;Z.(!
M_65:EJJ2EVK]9CU4H?L-/+B!"#.ACV'J^-YOHL/)$):!.7P@Z-U,N":MQ$ 3
M2@4/LV515=[4*LQ^=.LZ$(@+ 6&A6L+3-NRM8YM^?HZE+JWKO)W/4)XO7#7;
M-HQ^:G[[]^[.ES*&G4I-3)>XE_,/MQ,GK=_V;:P:%53EA-4MX&),S^@C\C<4
M/UN?/6&UF_/3LZ:>14GU,)G*RX !N&TW54$P!>J5OLR=.Q40S:X,E%S3K(R>
ML-JVX!4TO.WM[?]4PUNGM=_K+;W[M]?:V5WLKJ_7_%O2FTT=:4MM/ZO:9U]8
M>/7&[;-;3&7=7LG[KF&[<-4;_$QRV\+6X&4"V*Y[9_#F&-A715@Y%:[:VU^/
M?E,X#7 ;3:=2**C< B5'UE4$9NLQK#XW'B2>X/0#3[!;Z:&_MZ[Y;P5]E \9
ME1OE*53JA^+0CJGA!BLZIYP/@$LW;:AIVX[N EC70\A*DHOXBNM8@7 ^^K2;
M-@Z8: :5@$\[9L7*D :[)W2S)(P283_95;RN1U4 MDJ#(#'ASIDP""H7">N.
M5\T6:[N+BSK3J]X_D\]\;(PKJYU<?R]55.NPTT4F7+F8+BKZ><WVI8)G#M8L
MG=&Z[OY3,..KEO"%?OZ!P.;8K*M?R>*U:^T7=?;8V(=U(X$-P-E\KK5^9CEP
M6A$Z4<98[[8[G?4PUE7')K"9L!('$2ZX]"+50&DJ69O4K(HUK"!U\&E@U8)8
M$2#CX9XFN:H,=\4$;5:[.K_\M5U_LCWM%"=6K2LM2JPJ7_$IP?;ZPR;\Q_(]
M@@ N"]EG!G&A199Z$%/<3Y$GPYG<M9483>TD ?RW""=P+W1;HB3*M^ ]E3[(
MU=,__L3$L0CBXHYF0:L1P?EDPSMJ]NO'R:P_O]_97V,SB1ID%_;GIS);RHO.
M"G51',QDNQ"FG)&3A"FRT5Q?>\4,.IM@VSH%]C$WKE0U 7=W=U>MOM:R_W0E
M;:9SLLE/ZEXJZ(%3;\ROG9\--.C04"DG7O^!DTTS(1!-<&"EJ^(=JJT=2^!G
M]4MI4PP2V6/X8K.S4Q7>UGJ;XU:=S0R'7A$%;:&IG4XE6[5PHC"X"]1)O''2
MCG+:DCO -/8DA=$OJ4.< QRWIC3]#!?SK:-1Z[UQZR0,LNX'GH6:@2S+;/RT
M3+;H>*1XG:7:(;7^>4Q=3Y0GT;JJZ=+H)H'YHC\T2&*M?W%%.);PS<CS(U,=
M#Q]OJ>#:W5LY )VNHSZ_ZO^Z"P)H%'+;].VE&%,%Y"D>!$XZ,<("-1QEBCD;
M)E% =BDI24M??Q%(FU\G+CP?H;C,*A3<3HF+89S16?]B_4FHM"/C2?2FWMZJ
M2:B1&WM$V$E3(::;KQ]Y3AN6M$=-GQ49J.F(DMS4D4RD>.I1W"%8-87'ZRL#
MF9XW:Q_K03<4Z.+>B/ 3"[G:'/7J44/PVTBH5-8 P5_-%*TMI:7.X?ZJ^Z;0
MCAIDK<)56]1RVJ*HWE]U'0(7#!S?NN4*0928Q<P,TED8RV\:)#/DBQ0XE*E"
MYO+LTQQ.(E9^I[*YN[_W=J"@C\7\*XY:/D>E:$8WUU\N%1[XEV:[NXAZ>QX'
M;2ES[':[JS=<> Z>%E'"!N"!$QAK 1\&J"\%KU<-O.SD=/>_\XC*&AR&U9 0
M$$X4@6 -B/(-.C4:&F->5]2C\G,!FMI6*ED3W*I*A"Y?A)(90A+4V"#G7_86
MZ]G]"E:X6VCGJV0J<DNOMVINR;K>" 6S+$U!/CW(4;B6#EE5=S\-QG$JK#<Y
M] WIT"Z+):XM.3][TI+OB*G\>*>]=[#R'*0)/!#4BBNQ-YAH]HGJ]MKQS:_U
M7 PD;UW@[ \]>'D0<JFPWJ- (L_@.!J<BDQQ-A-U'6#4O:E^.^!A*'4WLG0#
M7;-C_#@"I8)OU&_IG_A<.'UO5 J+63K7(6L 5[G %OOH.XY_3P-&0IQA@C.@
M8M2-&E<?V\_-E'&XRS\39Y)CVE#\F>!3,#*8A9T1O;UAQNOH>(_V2G/]'REZ
M/)<$C^_(80HI2H7%N&E&?HQ]QV:U4%AA(I5T"'@2B3J5M"B(+P*>+LDK7ES7
M&[-H^=DPIT]G%^=?STWQ$^YQ_I,.#94>IX7/6;+38 T6<"*9 B&YRBT4"V-4
M/DF?1(GPT\&LLC-"P)^3[U_.KLU\KNQMU7PL;+6G+GZ,YL.R+JZ5X(9UX[8B
M4AD<$3CN+BP68_6XGR"O:2T7U^H</#\G>#-2XG=<.MB&0_ML!AM//RU_+%FU
MT:,O=7EV=7WV_5H-92@YF G[?G7=SQ<DQ7DQ,CO]:K:LVIU@8375S8Y"?D>D
M\$DU1>?F*-CJN08@BMKRF 6;-TR<?)A#X[RG$R'P1$6LIX>E.^< ^406#\3Z
M6R5;44@"Y/;>2TE*[3)3"JH*3#:@M** 4</FP].L+L/*V:V89&'5?%25<J>>
M4@!WOG-G1.OLL*7YH"SK6BUX?KYJ%B>%L7WR="/*7:I:EJ7(CK1&+X]I-%V"
M/0<.TC1D%7M1!<+.$NXDW#7PG8F'_B-<.9ZPVLGYZ>6V%HAU#SJK3FRR&I4U
MWGK^O8>5SJ=?O^P?'.CQ?]0[47 /%VBBD',ZD=V)'\.ICK'RDF,?AY-W;/I?
MKNNS)?UL3F>!;B9 _R:;PS5DZ::6+P&>P68!\;>4MO;:*X^Y3=-6__A+%R?D
M3@>N2T9QT)PJFD'7C"9> G2B Q!@"2;P)#6D ^R)>_C=D&"PC=.;XM[7SC]]
M;%\]W?H#R\*Y'>4T<\G#6WAF+H:B>Z>/IE$9GZ!3=/E"/I".'J=,4[WNA(>=
M+NF!3:%<E?K7JP6J*D&OL2A ND&X++NMWM[>TA&L#KNM3G=WQ1!6;X\AM%<D
MQ]?!3*H N-[X_=<(@&L- :D*%D"%4?4D>Q.^V3L J2I]SVU%J=J0=*2M_>C3
M*<2CK;'VOXJ'.\G_FKCB[0H_2M>X&84?JXY\/_=X:_R..R,GL6!W;<)L<H9\
M#5(5X/XX/NA&4+0N>--(?^!Z@3:S5.PM'5%<&*_H<@\[:)I[S6#L1^#>Q1F\
M XTOIMHT5=(&3A\/V<B96/Y(>&R02,=N)H%JN<30@2I<P[0;+.>1)>!B=86\
MR>-]OZ9I)O_D 3=^)3O#H),H)!@TMLK:!0?1&>WL')%/VCEBQZU>J]WJM)23
M^ 43_#CDW<.A Q']MKWJRJHYY87%\. EYB&-@XU!H! EMP$KLS!)3F4'''SZ
MH;3@2A7WH62F.G]N25L'#O),4_O4[]=;;!6R<ON*Y!8HT)C!Z%?1D2?Z\49P
M\9ZZQH5EC",L4)WXB4<SV\8^U@$P3B)"$8+TAA@\<A Z,!)QD8"V+[#W0WA
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M9.02@:9J&H3#%:JG%=P!3M@F?@P>>K.-G/-H45EI\5ATBZJ*Z@<C5@/O@B,
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M801C )=..B[8+BH<]_&T#QR(<\ H$X$7I,^5LZ92M\4^DGQU>.)98STT?7I
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M94<BWX6,\*0#T.@C4]E%F""C*F@-)J(U:2^0#0N*6M?=^E16>4J&.WH#+5E
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M%9J+D&AG5GN1\7<B+6,_.L&"A;&LSJ34]_84329XCCX\%@UO)\+*+L^-/09
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MN?<=ZCGNC_4FJYMHZX_W+]YL+^;D:LO:T4[(RQ"Z MKB5I).T=8_GY]L*_5
MW?.4=T"0U#8G@ Q!K,)36DH[14Z@<TW#_(8*95]7R1DL*/ZPZ-C3XN+?J5"<
MV@MI+M71BT:MR85P6O/9V)RHG2+ #DA4/C19(PM8-\;8U&#28N.3JA1V7WH3
M%[+'?DUO2WMUPO?<K,'*8V PG%I XJ"#5R+1?'TZH*MV;V]/5)(C_(XNC-"8
M&\4GS#_]*](.Y3>/:.AQRLHB,NA('3SZFT19);6&W#HH0.O&I=@L(HVV;/]
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MNPW/[3G/<;#IWUDL(<7%&)V-D#!>"JVO&%;+^=:B[$@9\P&+_U>4%W%*]DB
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MFQB=!I<KEQL8&_'G"\!\(46.Y]$<Y$0)M?7,Y5(\D;PPZ3C$Y(I)D819EFR
M^+0T [G0B6GX?K3;$VO[1TC@Y2O$)T?B]38#I02/2JW__.3H>!!M/=</:V7A
M/ K$'V?FV$-V!DD34.[SJEMQL<=<TTA($P<484$H6K9\;S],Y FLE)M#*:&:
MJ)>EV\.14ME932=?^7*ZH\?NY<?>2L&@Q4$!&OO[2$E=< 1W4C\351E^UX-A
M()O!)_WH=SV:\RJU]L=\*!#&J:V.T*)(V2X>=#2_69<?KZWY 6Y;!8Z'R66C
MHIHA%9*C\$XJQ[B30?B%SJ7CH'9T/G7D,@;Z]=;2!5!>T:6?V5? / ZSCIQZ
M\6<W&[FKST]]828][?2V?$7.RARP.YO(A:+H?(YEY[KS2F"B\!56  _L_0LL
MGC&3L)\ISE['.["7K;WQ.0_D=)BK\]/=H?_[7##00T!<:N4_^9_[_W//^F\
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MV,1D)!F ':VY*'WLD-@K.F@+SJ8'@!S)$G/+SPYVJP/70!LCZY%)!",,&'3
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M8ZZLV!%Y?%@[,X[VN^;5'45DL^'G:4M>23]Z1:,P7^().80]O!A&8-W$3"_
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MY/6  08^.;J2:!F>77&V^S^-U.P3O0*O616.6ER/Y0%E/BN/;K<B_7 NGON
M5T(3LKQ#%MV"W)YA@@F]U)[QA0A]"1M,4.&6B$U4$JEOI/0RN\ULW:B"76(U
MX^I;9B=E!<P4#AYW4<SSY6AL"S+WY0Y'MNRW#S<B]--%J#)CM087A4@%*&)
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MIUE3;N-)Q3B>HBY^Z^\MK,9M%R>?$^/W63HVHPQD>G_\?2,^MR0^1W2]M63
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M,%*D.47!7>VP9"8ZKABK CW.J;BX",OH [1Q#X^[."L!YRTOBI!/7L:&HOF
M*!DL90#H",60,8WE-RDK![81-&_]V3,OXR&<"N><'R_INLL*5[I.*S/)VHE
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M4'2WO[S?&^@BYTH=J8B@U\[+P=%KW[)EQ;N..I=_+WH3(R2FQ3 GMK]]6*.
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M $XONKSD21/XQPP8/'.03 K6K#?%S82)DAE.@=4UP]H\(P0&F<8UO,N,CU^
MM&DW_^'8\-.J8L/[8.VI'2M$0:*R-F:(/AW+/S6QXFVBGO(GZJCW>)#@X=9R
M_H+O BS#*VPQ$)$%JR32:A9)$YXZC%"6=?.51 HZ:9A226>F\W37+'V3A2_&
M%*3A[1?T[YL9.I^X 9=J@#!C$RG]V(!B6PX22>%_R?9@D@\U0*1VF1>Q<,?2
MOY9D(GF\=$M75+;-TM!'MA/N5H-':@?AY !>]P"[E*G#M!C< Q]T2"0M#DMM
MN[@8U[A4JD/++[!^6'E-!"LI)ME$Q&> [#YF,-,S5 TXQ^J7NNKSLF4.M:QC
M,_1-%4;ZHU X5\O=0$XJ,I)P%_4T% H=1FFYH^63A,=%4PMO1HK,)PXSBAK)
M%[GQ7 BPADZ0$HZ8C+>:$&($2*.(DP:9=X[JEN=*M9KZGBAZ,ST[+#79OL"7
MG"UQ,IPUVK 28O3.,^$SO"1;$@/B#,+@@$RB\B?R3>38D[34H:--L_9NM(L8
MH $#@XF.$1HCO-],^@L'Y$:[?2+7)2?'^086.DPP^UB&;-_0YO2[=]L<-#(;
MQ3D/L#E'#[0Y5B>F8=OY/4 X+<'1+Q,QF6#:C(+-BDK?YU?#NL-1W>%H;UH!
M#8[J#D<U'G>''8[N8]$&QJ(]&ZJUW^X.K'+KB-^?/US1H37Z]4Y-\:,T2UH/
M?WTN1/D]P+'L;@T@U#=94DH&F=+,2%Y[$,_@AQ!84 EB?)^M7E$'=&5&/I@9
M^9K-R$7YC%3&)?T_8>K$LS#U*9OF%BCC0"^-\7PE#)A6._@K#3A#3I'X1O6\
M)CX.0HZV($!GO"H7^5(D7:SI72G]K>CT?MEHANAL?X2P7S[,Y5D18PA&W8S%
M_!RM3*#3P;8T:MS3I3G=:)Q_^'K95&2>L>/%<<KX6%R(_(V&8^H!EK_^;2B(
MK7AX^;:I4NXX K@IHM+"*,[N9CH&_QY0?AX3UZI0O5C:7-55_+9N4V"F!D)^
M BO?P(P=^&%XI<Z9].)2>D&55<-_4?R#Q(F\^(JW!AXS1W@73*XC&4?"VR!.
M_011NTMXX&1"1ZY,:Y[EPA';IH; (D/9KO5CR34]/A,I20"F&O4O0):0AAZO
M^J#N\E'=Q?PF8U5G@LF1A)7CSM.J.M\-QRF5RE9TN7\/?$H4HZJZH3-%?'>7
M#^BR#8QL%Z9JGM_<P[,,ZA4 $3O5F0BET'"_B-BK[*D4;@%+\-51;7@/E\'
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ML$N4<VX2>?H8A,&E^%7F4[W*'8P81_Y]YB;CTRT'.I(*YZ,82<:^B)D%P2A
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MA7,&<3T#AU&P"X3L)QYR=V.5G\)-$)PQUIY^ ?QNXYJ+!\\9^^^-4<"(L3(
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MA+Z\\RKX/E].LC(?!X;"H?'^Z_]JOIJE<W0M%AZA0GV-1D7_&29/7Z7BNX-
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MVN[M!6JD:23F*KV GZI?3U(?3)5+MQE)ZB=\(R*7="PVZ<[:IRHKQ>V)/<P
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MWR]E="TM4Z=U 1^WNMKY@!L<X V6,- @Q6H*<-RCF*M"X(9FL&JZS% 9X2K
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MXT_QU;G^PP?#,J57VO%NJ"W1#K:#U5:$D<&\%S*AJ,6\%O/JBWFZF$1P8=8
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M-6UAY$^5M-ZT_^KS]X%=$T]&E+]B"2QSU]K..7SANN0)DQH$NP0N*2@G<-)
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M"IL(2G#EA)2"BB>(DCM+\USFZ_KX=YC$R55 9CA;4PL9JR*R:PFJA7: _+Y
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M7UQC.U!M'JPIFV+]69+-^(R8VUA19CW6D+T=UB$O-[0XZ2J1%CP?8N_'/#Y
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M=0K5XM#!; G*1\ #B0,UA5^N?1XA'(<Q!>^8()!</DB<$@\;'>HGFU;8PIF
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M#[ $[2N3^4"F^.WT_95?1F\%/S5$' *I?R>LW+4\YK?JR^AN9'&0LN'$R]T
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M/B;2!BM%<3Q / Q=\&T"EQOFSF0">$QCED/TA^Y\[XY92JC1IYQ-G6#H1LG
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M>/X]!B +WWWO+Y27^.%;NJ-4F02@3V=N2+0=5<S&>.\VXV>S/EP'2+5"_$2
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M.0&K=AK3-EZ S]2](XNMQC#@YKH"4KO6")H_/ C?4CE2]S'E2-6U9VNE2-4
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M#05UL+QQF0D^(7$%'FS+ZV4N0'!9MLP]2<$E>8&ZL)(3:@CF]&SIP8K/"K+
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M(9V>D#3E(THY/PZ]%<N9T&4("XR4SQS0A4O/C21FSL'B&=OXJ7X"-31!3B7
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MZ1FN%$LS?M24EQC-PZ((:GZ,^&@-?(P%Y@ :X[C1M>)YJ1?.CD +^-%TH2:
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MM)C*>J9<K7$QJS6JR/+2-FO(!1HRI)#I6+#R_Q/+.74UA'?U]0FK1L6*8&J
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MT6/2*@Y*TK^#CRPBMIE[B'-7 *B!'Q$LO^ ;$Y1A42@IO[OCCP&YBU:R!^H
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M4 &]_APGJ@- V.I ^&^X8WCE[*/W]:?\&@GZ!(T+%2]1%'3= ?H(F<EEJ.;
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M\4<^/-!;SAPTD (TUGW6E,:C.2_>_OY[IZ,G"UB8.+]D=-.%6XF<H(T0N6Y
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MM6L_D.])@JFJ7B[U;$&6ISKO@<6Q'@:3L^I85G29U?E@-4&AF(#&H!':E15
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MFR&H(&'CXE,*Z$END^>.&@2?$GAA*:R2A!H4WS$C2D9@XL8(+H-ZY()\Z;+
MXT7F5S/D&4:(88HBA$_P5<:G#$<+3H%@XL.HT@PF]P3!'S<R$.'#1ES<=,-!
M$E- &[RF$(;T%D2.)60P9*V80OJ@8;NAG<P0=,NN+HCHMZ(_9U <'P26HJ-(
M71\OF<31.N+Q$^>E]^YG$F6C.K(, K1))E]?#3:3U>BWMD,[V@E$R6JTMTR,
MWFG85J/7V@[RJ4XUN1J;26,S'0^;Z9BKWOI ,&[0F%@OV)<(R71,PHDRK0W'
MY&%>?I!2UJO#@#HZXZV+9/S90:?JA%>W>])>%(SCIWR/Z"KHR!,81RVSMQ[>
M16NKT["@VUK/@K/KC>JUAG\VA=-<K@^(EJ/,U+\BSEV7BA\>R?/N-+K/NM[-
M3='+3F=C])*]I/5=A9&&;@961^-_O50[=0951.4[G_KY?4W6\G-VBEE669"J
MI968VIE6EU>/2IO*RYZ8?=<*<L?=G1;MGX698'JT6Z>$8TN7>W U>5Y"]GK]
M(^"Q%:E5.T7YA:?WF: ]O.6F7Q75):-K-;:LH09;?:FQU1EJ4VL'@HER$,IS
MJ*BVL*]56PR:;:TM7F9S-&L' ;MM)[;>NAY51P+3%!!3Q:Z8-VE2_8?E/GHO
MV=.5Q!FE@A$-'5LOEC:'FZY0Z\G2-:BU19U$O2!SR&:$=M9J-=J=TH2F(K29
M?.Z(A\;:O+/R=*Y<\.,B9E0DJ]48#I!:2\HW3?DN9+O[Q6)^3%[%%NS<$46S
M-IOG2ZN7:X_GV $8T7L8 9<^FP59,S$87;@84//5M[F*99D%334-059]$Z5X
M#"%(B3O'Y'.LJ1 E["M1!I$[(R2AU;NEWK3Y+N/%7MC7)A3V)0M%N]$F0S"%
M+4NU DPUF8]#&"TM)P'>_S_#9E-E 4IL@I!/$@^K(!?X!6B.P.>%G[26M<02
M$,@$%$:< P'YU1W%;!&<P!O=D7#[^:>P]G[GS;'@,O852XE^LWXSREMSZ3RT
MTFOSD0?&0TF.<'[S-N<IOFFW29MQ9?B"%(JTZ>>VMD(TK;I '+%^=5]I,.Y'
MP2,_X/E^U>P]6BWFWNS];6V_>A/+:E3I$IS5/U ?;TLV!+]OM!I=4?Z4?O95
MPHE]S%6J%QYH-R1NHRJR_2TMLOW!8"AH6FY.6W+X KDYCOFONP9L5V]"^/[=
M@Y>Q8#."[48]7M> $O8<'H5ZJZ"DQMV_&-S]&DM9?[A[GX%=NCWU4BM;=R?8
MH(@ON3O!KD4"=6Q.<'4]"):NY5K6.F-V=VZW6GNR^^>&U3#>!CYY_!2J&3&/
ML,6B*>=QBL%:U2)WQ-U4Z:&($)VB-EH]L[_<98Q1-%0AOAD*[&T9/#0=HFE:
MG:V&:"TAPA7A)WMF9U TKRN+*4#D/C-<K:Q6.'/=?PX@L-\U6]UM1:V(I]H;
MFLUV:RL1$]BTB%QX%_AWA&"8 R)*X02+J$I9U'\,CEP01MNB$5@GB]K_ :_
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M6X.-10"R&E_F9ZJ6@_*GS<'6/VT=)-?N[_\S"E_]O:)9>]\"*A>*(LJ3DX8
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M9KF 8<!4P%PY!U24"#QR!FI:O&PA0>Q0MZHPHT]3F6&$QQ91(=)1N7WI\TD
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M'V%]H-/5+DOF,$N_6!P6 :-8G,#"I,RE<S"5#RR[M8Y18N'S3'9I'R_+&OX
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MX;;KB("X<-(2KFA*@^Q#U&_IZT;<PPA#M)E,PAU=(E9^K3@S$$UTV42D6 I
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M4T3\@N+ E*TL L%%7.8B5 M9QQ*^@8Q$-"-GPDKW1;XO\PI@2NYLQATJBZ
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MT$YTLIN<)40_&B,_R#,G!HA;$J+<>:1MJ!<1&@93CH"8 CLO!U:?V@;B!<)
M*%_.LAQ;6H[/*,>&#00+9MCA"!$]/%?T.L*V6 *%EOD/0J=E+HS\C)232RT
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MYA3PW0<^"A,6+J0_:IFJQ8K55OV)N"-A"XN75\1NX2<70#3%-ZV>&*@$R%Y
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M*SEP8;H>_!&X (<'X3/<",IY"]H9CV"_X4A%PB&'.#65!;O/=U:V#O[BES"
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M5%EI<&I3-L?N<C?8T[/X_?[+-^/C$:L5P(=:>YP27?8RJ];M^&VC-=_>?Y+
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M.X84KH[P7,@93B\@$,S"$!A0ZYHD4<D<J,X@%KEKOHBK(VA9#M8H1*TKZW#
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M:Z>'BQC(VME!K3SYZ^68,DG L9X)N8#L;7Y^N3M;,/GW6']Z)K>IYLOEFNR
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MEC<"!U0IETBE=ER! *S#;/79:?7SP@+P$>.\9KI\TW4N3C#XH@MT=V'95XY
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MJ[_CZGG/4'N9U+YNDAONRF62N\ VU%Z/;%_BFU'2O"-[S3YUC!>T3#+7W4#
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MH\%-:-/H.JQ-KB F\2P'5/.AW78L-BU%ES]^3@+_J!SNYY>=D]HQ)2.]#GD
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M:IFIV?5 QQE+-7&@"/>#?9O+9C/9@ EQ,'B+;>:Z_"WJBI, !^2[!X&R\)U
M]M5]8V_D/UR\X&^: ?<&Y%QP_D+V(MR0LFIUT[=(7WP/[]J'1SA,R M.),[
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M\GXNW:D)FZEJ[?0Q; L@)L)(^U%P"ULD+M@K<WE?-7Q&8$11; W1MFR^NH&
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M3,(M(><*PK2)T&L284GQ4&.N%9"51<%$NV=".*Y+[@:9/5*Y"XL-4%&>;VN
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M<ESQ;[BONDYF 9(M$HM/"^09-(-0PJ%#V,9^6%T*[".6R\0+3N=!G.@.@I(
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M]W,J6E10<D?AG3R^J;5OW ._8@+1GG/JJK6V)J"YA)LR\@=G?F!H^4%:UKT
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M3O*J3 EIBWHQ/')_7E>!Y@T5KUA0'/M=3:N+XZOD01 YQ])CL"SW$ LC$KS
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M&+BB 9IU2Y)XFAA\IAHUG?5K_B@KYKNYY7R4"E%!ZQ"6+LBQ ^_D1XKE(-Q
M*M:C!E+K&CA\#:%!?U2Q0MK/TO%;0R*D9H*S*@JN(ZVJH4$'?#$@)$-*=']<
MM+/ U3E(#'AVXM@%<D".;:6"M>D2>+#&)1?D(W)*+@*APOCQX\D/Q4 T-2ZH
MW@+PA/TP3A+0)YZ;<GJW:M^XA2<DZ#+I=9>K5AJ+2=MJOF0951V3>_F(#.Y9
M59#BIE)G0#%T-5%VDXKO%-8;=Q>O6, 1LQ.DYC&<P@:, LR7884Y M=;6/US
M\>;C^TN#37RATJP3K'"]N+VYO93H7OH[*FM,\/;JFY_>7S+)=[I4/@8W*(4
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MH#)M-7(X[NO)//6WAHKFMJ[,9F.X]%R,.@N?6$<UYZJ$T)M,:/B,&GJ4M&J
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MV;!%H]U3@B4<1>6G[ERVNFG9."[668X7M_<5+C[@ABYJG$I1817?3 \?UMH
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ME5O/5Q@3ZZGQ2%HC[DG.Z5U?U[:92,P+*9^JLF.E77;J/09JKZC#+^>4PTT
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M>@(^;G7# F$?R!A [U/G^V3J:^5R% 9\L"7/X[C>!7><9%PL<('ES97'YP9
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MDJV1 .FX;&1@'_!^&A&BU<5Z8[FTO'?*KA'7UV")6F6(( N/(47AXX4>PIO
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M(=EQ>Q= U_\5%(<TSE:(0 3 O^:5!1<&*%]P6;X=B" !5U/KF- .DNY59DW
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M)Y.[3WQN*DQHPX,>;/&XIB2!A%OQ58T-#Z+15?R75!U$*GV*0YB#>+9-$,V
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M$:V&&,I/I/]T++5)_YW@$F^..M8<WIBMKHGX7"*V<!8$^XFU<;1 3<[G5P#
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M_ISS=/>C,BJ X]^&-TQYT^T";WJ79!F64H2?I]R%%X0G>M8W++@/BZLDCMO
M_I431M<CMZEZR''(X0H75]@LG,769:X7@ND<,NSVP\;0J7 9F*7("C*8YS[X
M^%X4:"GP#1;-X7M_>#8UB\IW-]*6/#PX8/P1'$TY]3Q[*3BNV(T8S61>SW91
MC2)2%>;C,+GW8!-P'#4X,(L'4S;RW AG9XXP[T<-K63C1_A:\'X@M1+?1(IT
M>APG7#B6R?4&^R>U.21&NRX@@,<:JFXFIHP:RDG>PW=[!G]P%@P#Q>I+V;<.
MX&]\U456##"0GFF2:$&[(T'#YLY .N?( ^6)R_?!;V7]F0O[4CYB&KLZ*V2
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M<&N7H1T4W_+!K=L3#&X1!>K@5MIZNHVM)^TE];<WGNH05Z6X'?M0P.HE%VH
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M+F,#E.=\166_9'_4L44!WCW@R'8*2?N".H-6,-<R<6?MSV<BY'/?=BU[[HB
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MX.0E6125O]0I'\L1*S,18L8GE,$P51FU/&@DH8Q^_;GG:[E*;3HZB?JO@ZQ
MZ2\3 ;*I)TIAF:CTFC\:3,%H]AK#1$BE%&:H56&Y4UOKWO>"(+M!<9 1M\>'
M&2[]W K ?\&S\?G/S1NC_+1ZQS0_?D!MASAI\4=D#5>LL]T@\FE+S7TQLZ-9
M/#\>Z*92^KX>$"^W*NVK&= U9.-(Y%Y/LYNPNENI?-HP(!@J5M_I]0VSUVIT
MFZ]1+=?B<5SBL3S("'Y'4LY<H"QERK4>5#7U 1S[/A;WXQ$;\N_,F@+CU/PF
M61>!.7[;P:IK4( XF)[&UX7"6< Q1&8GG1Q9L<J45^1)%.I<G*@WDA.:5L^=
MTL<.7"C_L"*A5572G_DB.<QQ\I:D+9W\J*^!'/2QJZJ/@8_JW"\PYO*/Q#GL
M(MCRF@64G\*A>E@#CKT;+OOD@Y0!P9=+TPW=T"%M2B#77 VZ@^]=HU?JJ*+R
MWQJ:65=F\ZK=D;^]?Z]?^!9MORDX-"!5/DDD^C:5=V3NY.YZ%,Z$>C)@<TT%
M=VATHU+:E97-C'>3^ 9&XMW0H#Y<<VQ<R!%K)&58OZ-H86%S@9S/-Q8<_D _
MV8%*K?U_]MZ%.7$D613^*XK>F!W[?E@# @RT=R?"W=.>\3G3TQUVST[LO7'B
M1"$5H&DA,7K8S?[Z+S.K] *!!0:$H/;1MD$JJ?)5^<YX!%Q IFYJYI+M3;IE
MDJ>6&?HH1LD!'=X1F'7M%[C7";REUP,C3-PO1[7%AVE@3OBT_B3X+MXN@.*K
M7?JD/C9ZPZ-EN+"5V#:EHHNBJI)GG/CZ=*RE)8MU3M@0=-!K2(Z)*^O(W$Z&
MOYI,:F9,LWS8NE] G[;USS=VUQAU>ZV>P096K]-I=_O-=N?:-*S^J#TP+6/X
MO^UF[\VF5'V]#0$7I^VVFF6/0)QV9B/;AL]B#&?FZ )V3ZJ7M*1PB0918KW2
MF/\@9^PNWB5?+A4<4CU&O<=%O<<N_:1TC;@()Y9Q"T-\%P+#=>,_&X%"^XEM
MQ'@B*(E99@+-6NG8US7'_T!F(,./WO7->A6@ 5:)+QP( JC<96:8\7$D.I]A
M-&\^XWQ6^AU0Z;#GNFI^'[[AF<>$BQGV&8\01L!/.2B#EJ ]^ H]%U>>>T4>
MC SU$JP2BIW%?%21(7_6!AGI.Z8WPU1RTXDLGDP??KS5+L0$;Q\I6DKYRWB4
M+N(7SSN+C"'Z%, L_@"-*[!!MODXMY8F0V;5G8;4-86C[0EEU=3S<90M0*4O
MJ[2I?!$HP_?$HS!(P5Q\D52F912HWSRPU.!-L5*1:$DH9+-HZ-C!A ;@^B]L
MK!'/-\<)PJ#]6289BW &IO=-.>*"W']!! )!/NK9BQR+ AU#>'Q<EBE'/HO"
M2K&A=-GDW6\4T5="]#$9Y8_22)X8HDM *MAL.6 Y FH,;3 /,@/;+^Z^?+A<
M.I&+"%9H1^@K9@'8(\_>@I>7Y&GDTJQK/YHAUZ3JOR*4PQ-*#JF)@%QVM2>5
M)9ELV31JA*AMK X0"=TL#96 ^'BRO2@0CG^\C1S>*Y?6M5O'67@=Z8Q!&2@<
ML?(3142')R(0)Y1%@?B=,F!N1@J\&]A!F$RPGX!1 #H149@ES'_9,P%LA1 .
MKPO[4JB3>9H,^534-DGJ3*07H,.;@G3!>Y&&+NQX 1<T,A]]JD1/R\NAKU0,
MB:>Y\S9ZX5!A!EE(>T!M>CKU+'$+_X:WQQ9&2L7P9SP2&CX19]T++D#M(F,H
M7TI+N2DXAWI!+#^IV#^BJ/SP5.YX*)S@T"L6<F^+2N6H<4Y^QDA>CG+L'Y.7
M=B33TCXL2_TIBNP].E"%R4+Q^OC,!54-P[/PH""$=\$L&A$H>,IVWEW5K41R
M'+W"%U+O'E/WM/; P\AWM8LOCP^7*V++L(#GPQLP]#T"97[E82:+':/3.9\B
MR'F1Z(,0R"8\2(<[=:#)L$/Z(%!W?<ZEB@%"P9Y&T\N8K0K?+5BL=0QS4"D&
MO!!$+C=Y$  -.'.R",Q$#X[7X,NI2G3*%1!(*.UJ*[E?IAR(6I2&1B$;P"4^
MK""O((5FG(H$)NIJ\:!:F)0LT,=F([NOE\3.*%5T8=];-SW5 ^05^S^B'B G
M3&4M8Z":GAQ#O?Q!FIYL6B=]BCU/SJRUB3)R=F?D!#9JE9\<^\D&%?\=J+V@
MWWJ1'VH7Z.1-/#<K#-S+-"J<Y!EDNA&6T8C)(B([B'P$1K-U+?*5L-7)R(G,
M,)*A&>D'D& 1C?UF/C9+P9Q6I@6 >!M>BU3WZ8R989PQDP1D4I\39EV2QJU,
MZ\-3'8[?)7J@X=0C>QPA)9#'B%*3L<LF.40PR$'A#%_87+,(S,L V]<"B20.
M).EEDI3Q?4"^['!^A59SY.(Z@EB )!_X&+.J/!>NP@ZX,]^C)(>+@),U)2.<
M/^F&'E>;H&,+:X3$"R6F-KTA2CAXF<15!>;=/7PJ:P+ZNC#R@-9N1?KO ]GG
M2)9WP 9QR<#5W>6"1RMKB?/1"*0K>=+O[QX>Y=K7BFX/3[<^'Y//<(C!<_1O
MH"Q!$<F?A3V.YCE(+-GJ%;UW/,VM%PGU&& N<K1+:DMC*T@1[S]\$OF'<$-H
M$PO(%"_A:PV%.V@&Y#UE)H](/4 G!2#4GXLGEN[:7%'+L/?$WW8@?%.K<D>6
MTT%HY\5!KXM\)#2)\&X>VCV;P8$&W-GO[:-7TG7?4,ON;=E*9_RMLCWVV2=E
MA2:JIE95W\(&U;H3ZLB#RNE);<<H,S>G1MMIE1D#M)1[S'OPW_Y.^XSL>9_&
M)DZD4^KN]$ V.R;414&<9)S3],K/@3KVA@_E #)HZV4D[$GMN=6\UJ_/;M.M
MYCENNJ5W7B/33PL:1F>!!/84(ZYD=^\I>1X-[>\V4$J:N+'U;9OJV'6IU=:O
MU[9<>F7'I$HVM1JO]486',$*5S7!55/OG26N2ED]=>F("5K!>HXK:^-MVN;R
M"-![2D=^SIHK*!7=@W.B:@VNJ;=/;U?M;BDMO6:[ZABE3.OZ[>J@7K**M]L=
MZ!LYRVHE/Y7)E).M>O<L5;LZ(JNK<%4;7%TUSQ19IV4S&7KSS&VF^"V29".1
M//\:-_K*LU2M=(B53F.:&JAQ-J9 QP6 H@OCQ2/W0;G[@]ON$'X[I>E<*BWD
MN+>CTD)46DBM#&&5%K*8%K+@]5!;/L4MMYIZ&4E]:GM^E3@_J6%C@P6_NW)N
MGJAS\PJH_BQ],'5$5E_O*%S5!%<ME0]2?]_F54]OG[EO\R2._//+!VF=8HH!
MR-33VY2A[\/'5XM-G4HNB+%@+9=SD*T9'5LKX;J9/55^\R4LKLT@61?5\:KU
M@DVV,0&=CG9YD@AOO62$*X2?%L)?2GPY8WR_X%[=.2%4;F"^P/F[@4>-3="7
M!LRCPQT1?9C.4QMOEY8LW\KQ@EW&DX\6_\5L@+>%#?1PR[);$3;\NHW&L%=Q
M4[NEYX=U,NI.[]G4K S^P+Y/\/DCGX4<N^G%0\:I8=J+_9Q."_BK(6\TWU)S
M<_R-0%8\W2(#Z>\#<7'!P(N+>#!<[%R"W3DX[;Q!TZBI4UWQM LF!SC+]OZB
MVQ3U>X-M6YF%!]W%E?'27K<!,!7?%'4,E_W!Y.H[&;+UXS^&_@\_UG1<USN:
M-8G3Q2/'N5J<75,TI<8;4?<O^2(.'S-'@ROL$%M^/7N^8SW;%B\89O/B"!O1
M1EX.34I&O=,DQ,K'>:]!R>EWZ@-I4!;L2]-##>RK5:6D+,L)<HSB$8&_JP\&
MU"CQI0R=MUJK?:T/&AN,,U=XVC.>"ESP;T&@@1:K>HU6(,$*TX2SP]J5@#L2
MQEDAX)H /27@C@A/A0*NU>KJK;J.K@7K)TCT3U([XQF/0D5&P3%D@2UTX-0F
MP<_,'" :*XP;F[IQS[!3KA1$N6E^C96#CO)SKU O;M#HIWG\9\(V_)N8I*O1
MW*C5J%"SC/#!Y88.=59^NVVW69J0=%UJV?W-,CK\,)EV,T^/^YF>HT8Q'7C_
M1S2*24TF.LW)1!L[\D]Q-%'!>;K[L6 UF%E4T6P%.7;$3))!\BI?/!\AJ[^1
M]SK6S-1TA=T(G'9+[^]!)\.*(*$CJF5KM&Q_]:U;'#TEBNWK4]3:VD<N:96%
M[QJ%VIXH@/C*O;TTBF.SL_9@)?*+HKWZUQ/8Z*^S 4YY9DB=Z,AH'CT=#>I'
M1\/SHZ/6$=-1ELQK0T-F>1JJ?;.-NW\+CW5ZEB\T&2EN.350':=.<Z57=AO8
M8U.K=;G$%4QETR[ UI?Y;UHX\2)XA+5);ZL-C)LZ7/JB)-R$-$ZII<_[,G6?
M2P4(9;9>EZ3S06/06C\$9#-\;YI9?E[0[C6,U@M%Y K:NVN1T3":+[0C5=#>
M(;0'W1<&9BAH[Q#:_=ZQTO8.NF+5!0VM9N-ZL&7+XP,@Z'"M:P^@JR71Q$7-
M_A@Z=U4+FPNCT6NVERR<8C3OD-7K"*M!?Q_-F$X56KT7SG0%K1P?]@>'9\*3
MZK+5:O2-:D8(G%RCJR/K;5EQ<;W1TXU]3#L]IAKYTT$7CJ8=*&S5!%L#W=C'
M\!Z%K#UU^1V<)VN=E*)D-/6NL2=%Z?B,_S*CEE3<^T17.MZX]Y$-<U)1;Q7U
M5E'O,EZM9E]OEVJ[IX)5NP*WRC(X)+A;ZU5\!>X=AF*IWE6!^Y#@7C_[1(6^
MCP0/)Q/Z/A9/O@I]+[=/;NYC:-7)1BB;>JNG$@5*>;4'+WG8%+P6.+$J<)V4
M9Y?:FADW*@BN@N 54-:I!G_JB*^K?8M4A:U=YBQT]*8*@]<%6^<L"W>L+E5[
MPN]773H^C4:%PL]X)14*7V2'V[5-X^!_=U\^R&;$*CZNXN,J/EXJ@MC3.\=:
M77B"T+[67ZA)4M#>*;0'J@;_<%%"?:!H^V"T/="[QYKX<4ZA\:[>?T'$J,BX
MBHSO/]3;537A94.7>ZT-/#%P=?3F>O&FP)5CQ);>KB#GXJ2"XM>ZL>6)JHY,
M%1%?%V%5=<:UP18.,5#(J@FRNKJQ/CM8(>MX]G75.E<Y>%):4F]KOT,=T2MV
MFFT)KR+B9[>2BH@OLL6[*(#/@D!S>0AJONE->2[T#4]S;,]5D>]CC'Q7*U$+
M2.<\ ^#7C4%'!0D/!^U.:WT1EX+V+IO0-[LJN>-PT&YW5.N# [;\/]H!"V<4
M &\U@>I?D.@J JXBX/L.O'7;A@J E]+ VGOU_IT8M(R!RA;8X$R^KJKA_DGY
M=HU&RWAAODZ%(7!Y:HM[3J $8*,@>?G-ESAH-X-D7:CWJJ=?ES*#RE-0_?K6
MGA/"!R7SOA6^3P/?'?VEN1T*WZ>$[U9+[RN$;^7I.3%*,+KZX'6^GE,F$=*;
M?PC9T.$_RIGU\$_\4E/FCVV7G%V(:+G;*]S46^"P=B>/_3^C(+1'<_&1[5K<
M#=]>R>OVN%U:\JT=PDN8ZP%@D-N%76I&LS5XJWUR[">;^]H[G[F6;7J1'VJX
M-\VC0=U8GGT;C6%3@GS:+5W[S")'^R6R OCNF04:F\T\VPVYI<$?[S]\PGL>
M^2SDTR'WQ6VM!CU.UWZQ _I->V*^C1#/%8,WM!D#RK)=<9?1-)H-;0*K#CEW
M->:Z$>SO/_"@D>=35_59Y,^\@&.3=: M,W)@&7=,7_FX8J GF#X/O X1KT;S
M;0Y)H>=]S>!S%6Z^ -3P9L)AKD;?=DTGLGB07?7[0%P\LK]Q*W_YA?1S G3$
M(^)\!D"F'<2X744$,0V(Y8$JLXA/EFX,X@A9NCA>V^LVFO%(X1GW@5"FS(5]
M!Q/FPP;8,P-YEBQ_;N1A7A*6S<1V9FM[,\ %=SZ!;\C#9^3!!"?P2XNXW_+M
M)_ABYML ,MB%-IQKECT:<9_#C0&N@>P8/RBWOL.?N!,@]\;/#[3GB2<$$-Z%
M5S-WKL'-012@WQR8':_X$R0.MUY$GSRVNH7(DGCY\1]#_X<?EU>RK7^^L;O&
MJ-MK]0PVL'J=3KO;;[8[UZ9A]4?M@6D9P_]MMYIO7GQ^&YZ?(:C!EC2Q@AI:
MS9>2CHS%G@F$PB%W^<@."?[,<;2O0+<IAX0>0!^D*\A1+H6'3]@$-IIQ$P\(
M)()V210L@.!Z&Q#@O@$&+VV_F/8WW[YE^[!/[S6[7DMX.Q0(?=3+2@ !F9]-
M0<T+2^]4>P;Y"L#2+!YR?XIL1X+#!.JP2#8\V^%$G,8^'!3VS $NAL/"].TA
MZ@1#[XDG1SJV@C*:-SEDS$"=-.=TIB<O0M>U;AJTN!0A 7R%UX-LM4,'EGYA
ML67RE:N6%1MUH]D"Y %R$73Q-!J!A-Q(&OCCIQCJ-:9J/"D\E[L"-O'9D0(O
M)?8L/+25H-! 72B@XI=HKMSB1T'=QX;%6Y-T=T06D#%@;\I=2VQ[Y'M3 =HL
M,."/J1V&G#=6X7#*N5ASI-WQH1\Q?RZU3Z,A^",CU'"-D><XWC/>DJ>GO'IK
M7XI5$ W X*#5_,%M%Q3J<2.U3  *GB7>_+^8FSZZU4@X\R.+7Z?;2"R>-E#%
M!!0JT)0U?#=\O-3=21+S;S/8'TF#"SO[)GA#$)F@<P6>+TA+XZ"'@32@MTB?
M=BU>X6U)0C$.IO_^ 8_ QZS2=)9)J5C5(4ZX3GP=E1!T'F1]O4.0R)/+6VG:
M%!E1@'9IZ_2;3;1IM L2$VP:'^%H;B/B 9?&Y8V6S2<Y*$*7?4<6'[7-YLU9
M8SK'CB41W2=$W\!9P$F( *\[S*7+ M"NO"<;S[#-5"I<1YU"&^D2);0#RP,E
MU_5"/*DX&, :6:G%/JT@],ROFC<3: 2@+?LE=.U^6:6^_7@G,)P_#8.&!N]4
M^ *KCRD QQ,>:^BN2[1L?)?,&8*'1+P*_I1>'](K!9BID6OO!@C;]&;"ZP;O
M@]Y@\<@,(4TY<^71>XN>7X>+I_RJRT.HW;YJ7<<0OD-GP81.=.Z;-C#*>\_B
M=:6A=[&6#K! #3V6TFT"K6\'@*T$RB;S!;J9<*7XJW<M']+!V6$HPKW 1K"_
M]3GZ/9_XS;-MA1/IX\[>&'OOTUO8$- 6A:MOR<#3!&' ?:S-(^+.QXX K Z;
M!?QM_,N-90<@M>9O;9<@0S?=+"-L(2! SQ-?RW<:#/1^;X"O)7-:Y(/E&^OT
MQ@MA#'FG 7=V5W[=U%LKOUNW;$<?&.56W5/V:C%Z*-ZT2W_2BS5L1.2/M[]]
MNKO7-&W[LW?;& X]_^[3PT=@JJN[O3^_>/_K]MWK-PU^O8E#H-R>4=/+2X<2
MF<.UIK)6NU6PX8*(7?;?B9_"8,ROACYG7Z_8"(386^8\LWGPYH?\:0*2*8D/
MXJ1 >+55<C&GZW5THYO1I7V!.O'AD@#-J])TEE0A4P>]]E8RM:\/FJN_WI_T
M6Q<IWIS/^EM&3C[?/GS1[HNJV'>TS=";"4+;)8N5U%?NOWSX*+2R:SW5<4%Q
MY:X-F@LHJL!&H'^&Y'5(0C6;,.:)^U@S<=$&F \V'PEX?OC&S0A5,^V3,(^V
M]CSGI,=:Q\KF3)%":D.NN"-K%H%6:/K45'T_!D=DWOV8(:_$!,O9>K&A3TN-
M;!>,2#2BYIRM,2>.&PM%>Y9.E-S68Y,J2 W>G*]E['M!L,KCTFIT8N?:>I]+
M!(SGEW/^ _-K2WPOO2+:KMTLPA=TN> .E@ H3J^PB:XI 8#(N?D=2C"C"S\!
M,.BV6NFK:L26:@BDPTD"MN ^D7D11,,_42S"8D!2$^VOB.'NR#*E"_[") [Y
MM^G;0.\VJRMU?J%,!(]V#/L1X2($X9 % #1DR80+;4RL8B0'+@*&T5&@R>=P
MTM#>_7;?T.[>W\%OG^XUL6,!3'$% MCESQH+ A["@<R9.2$W4>22.$'2:#6_
MDZDON<?C$64#J=#3@881H>GKBF2?PJ]29P5N*9AXSRX<B8[W7#9<L!)5=5%U
M.RV])QP/.W4?=/5F2??!$;QL3V^V>KO0]@L22]OXWUUV7=EGJQ[BA$)&*5-U
M]-+FM^J$,Z+_U B Q@I)\W^V N'"]H^@$5"QQV1O9]2&C8)"..L#BC?0\;]2
MBA_TU<L;&J),_/TO[QO:O^#HPSTUM)_!1O.!F#YR.%K%1Q^9&XV8&48^GHQ_
M9]/9C?88S6;.O &*^!@?)3^]=U-H/,Z#D$_A]D<\+YD3SK7W<.Y=EO:R;4]2
M1U@GT.J6JJ5<Q9+;PR*.-A\5-%[DH(."J ;DLJWT;9^>]/W,O9DCS)[WD0-"
MB==3[OZ$$<G #D&(RGV J!19#<@*G^T9Q[O@0WLZ<]#@(![9@?Q\D2B.D"%Z
M^IX$Z(O .$H!^LD?,]?^3^I:G0FNJ 9$=: 7)4$3V/R$M2'>C,(.,REFZJF\
M?FQI%[]R!C8T=X3?[Q+454.[>(\E=Q9Z];+?W-E^@*T]M5^B*7,;(&.?/%1>
M'\/(LE'3?8R&4YOD+_QQ.T,?)7.*HC%G('%;AA*YY;GFW.7M,K6\NF?..8GD
M]X\/*P5P+B^BIS?["R'+*_ALV[JWO4AE"BJU]I4YO-U;Y3.)#?VZCQ#[X$XP
M*30)P(/ '_MHEV+H\?%!_,VF;[7WG_:TFX[>[6ZYH:4<1<$I@_ZR#Q]C%[C
MFQ^-H\+*FQ\UGCEP1R/,TL50QBW900U-RTI=;R239;6?'6\(Y_8OG#GA1/O=
MM4/MXN=??K]4/'1X'KJ?8O&Q\/\]\%D4DE'R%EAH[*&_T,?"GRB, VYIO'5(
M?1'<,2AF"F^'QQL&Q!T;Q=\/VH=P8IN!1&+BG+MW0S[V[7#^5G-8A%GD$H>8
M08Z_O_=<*S+#3?7CO9SYQZ@3[41_W@NTCE+#QA/W6 %6 _(JU6QGA[F!&R1\
M;)C\=O%_+K4[K%GG(;-%%XNU"16&YO,1]S$_Y@T)8.-&*YE\2!U1+!'9HI5@
MQ<*$Q*2*U"C.2EQ.3'HC,HCTU:=;+3,3/_P5P9%P)=)A5$[B=CF)8%A@=R69
M_ K7BN_[1J.[IL5.GO *$F8+B]WP)6_O/GR^^OCAIP]W='B+-\<4.:QWQE=(
M>E%D<LWB3#*XF(64LT399]B0RG>!$2^2E"@O\I.,*Q&9>7P0F7. Z,6+\='V
M%'UKPO"";7P!R<]$*B$\QHK?F]'&&#"IRQU9T"9+O0WQT^$,H:>-A4$P SA-
MF<DCDM*R$,SFP5OM=CKFP*JW0>BS_PN2P(15';.AO6-S$!RW/\-OOAV$GG/U
M$3X(KAZ!RH=# *>I-[0/CBU+[ !(<[%!66,F+OC98=^\1Z"*R7^36XB6_B]O
MXB*:A%85_R5N^,A]\ZO\_3?OB<&Q$M!;P!\>_ ,T$7QM:)]'0,F^O X?^^"9
M +U?/(=V_6MHZ9=US?.[B\OY'7@\FX$N:I+I!X27BM*$UX"GL*]6("@7Z452
M)_(!<AP+(C^6V<(>IAK_0+N@7,T\/\]\_F1[48#)FE_1!,&L/28;L:774UFX
MS!^5V\<G/\!-VGU*P3)A]!)?))-L/)3UGG[<-^V#:U$[-VUQK0L>X+%M!Q/D
M$% R@.;;5YAB'&],>!VI\<%EW&GCG33J2RW76KF<CC=>P4)?,>$<94&@/7N1
M@R<F)3[:(]GUC4 5LR[MKW6CH2Z"EX )GOW&H*IYRF$M^!8$U=WZK-X&U<MF
MWFS&YO36)*=@!\S&!&5*UB3?0%Q("^(/5A05N6X*<@+,V.=@>.)SL0+9USCF
MS<;@G'++3@N3$9@D=DH?WZ7X:Z7N>D#&^V.Q?462WBZPWUC%EFO01<@&K07D
MO?PF2%O;Y=M_ (A\=I7F\,:G3$.<+@#_9S!&)W3>+"4ZBZ\H2S=.T8TQ1B^_
M229MSBIN7Q<;2/DF#?T]Z\EK\=;2]^15V*870ZNMM\EJ6'+:O96I_83K($ E
M [ \C=/)D)!<S[U"12MR)7'!:0>""8@.,$V5&>$$F&0\*?3W;7+@U0W'AAYW
MGEC\]S/P(P\IA>XM_CL$B7?G>2%V!@/QQM$1(WHB4 .!%FD=& G=E^>ZJW>-
M4F13Z*=NB4+[@_NIRR(B]4O#82-AJSV)#JLU5KEB(4PZN!OZ7KPU*43?IXH5
M$^? L&"@:JIZF:+A'8KB3O>[&R'J?6QVR8*)-H*G92XF:QVOHL-"'K*+RM3"
M]2C@+]#WB%4UJ*S\(9LU3=E7GG404#,64OCD'^( >X+OX_.+K*@)Z,[8;E$:
M(F/4CUPREK"BF5I"1=FJH&<^!/KEVL7S\[,>$$)T ,(E%?M83W2G?.*M*.Y)
M,V@3*S#;CDH8:C6EH++F9<Y,#>!DCUQ2_/P(BW3(=@ULK/L"7< 2!,E(1<3:
MGZ$#6A*&#(2&"@H)V88NX%JV2"1[D^SN]X#3<%UGCU. IU!]\,NEC>=!C0V=
MJ9XN!.YPJ8D-T#UWQTSTI$5G022M(^QKQJTQ 1^S<)DI6^!07V#@:3 76)#K
M%<N$OX+#PLF]@,C0CZ9T:D_8$Q<-I1%;/JQ8OI'L@O>K9>S0U=7:TM7UB*U]
M3)[LIJY=''_C0#O ;,^(.9^(*(A K('!X]M<XHTZ*1![H:A<W+D@/VF$QU*R
MP/6%5E5B'"2];5.-$&4ZDE+LC54M>5[;D@=[YW1V7J5&C7ZN*V[)4T%/E(,T
M@5$=A0Z\_R/J*/1"@YU-VJ.WD_;HJBW/[FN5#]*69^.P\BGVY2DXA7??$ZM^
M#7N.0@5>"J,SGQI<"(4?M3F/5,LU(9OM#(#J)SG45-F/6[9G>[*LP8[$'X5$
MUCGX;72$/=G\641PUD;%F0@4N33H0ACZXB(1>T-+$^>7P(N5C-_6V;P'F2CV
M[A6V?0&0S)-.LX5M9:BCB.W'G6&*6\]8''ZW8K<67!T;/\*>-QG&16<^1W^\
M%LWP;2AR)UQ7</WRNXE.)O*ILB]V/A-G11><8&&@!04IA?W(_*^P6$P"NG:/
M779%S!%IXT^*U9'1:0^CF'HQ6V<=!<->'O--=#.Y$W4EG3NO2&<]AOBA2+D2
MWN$<!5!7+<'Q <XL0]IZ]C3NB-.BHJ;XVX#L #W4J\=D<7-U%J*;-<ZWSP5@
M,XEW%PNMDKK-[RXS<=LD'8.%F3[6\#>-I7JK97LU:6UL<T4'!#X1VS5AB!#$
MA+CJ0B9@I'V<DGR+=A?O!)G&?'PPR#DK6RX0A1BMP)B-[*-U]UZV_6[)*(2B
MR'I3Y&+OLPR%RE2U^*QRYMI%&XF43D.P,L5U^+%!M)OV5R\Z:BY"#TY!5)0*
M"'^G1TSU6! J9*:U6H2)>\C6F/GGBED_58=GI819//AE?[UL[F1*$S?%6<1I
M/#)/:;*D/D-3COV5:V-.#0LQKRN<4U!%F(:IV]OW'"PFSCS,!.AQ/R>=,#PI
M@RT+35"2(4MQ"-(4[2%0+!+EI'$B*1H_.VR.W_Z1R$8-\QQ#/I[75?W):,Z-
MM<K?E&$P(<G9+A@ 45,(W'E912ND0O6"CIN4P$Z&N6GZT5(;W4S$9J5LX]\P
M42M."UAA %[22,JXN6<O-R"T(7.]J#V4'+B2NP!?JL# J"EF;B4V *;'>8Z^
M^;'5'S3Z_5[%4GIE(OLS]_G"P%@JJ]B<6D7R^OKDQ$M=^\W3\K-B7O$&ZQ-7
MZTK4]Z+?KZ@(7%\X$.1+!T2'UDPN;C1#+P18?DFE0";',ZX">/?;_5$FIET9
M^J"W+C/MHC6XK)BOJ,Y"J"WDE4VK+)+DJ0RDOSP^H"L',VN2B@XB?]$:!?UY
MW&2@Y E?E% Q,%\SFE[1F#R^JN(G)9-8W8!#&SA,N C%KH47260*# &$_(DR
M@ED8S_)+9 -0D#CP Y%W+)7.L>=966T4.#.3R*4],2?"C?&D!7,N"TQ8!W/A
MN()'AZ1\6=RT@]BC+3-<@+OI.QS:"N^):?/\&Q/%06FV,D@OT,8"T>H9AS';
MJ)UI'%[>F]HF,,:3[7ND0]95$M DVZR77_ '"EQ/LG^&[VE2'J855N7?J=9H
MKM@VICJ0W^[S?)0D4$I;-8@MU5RJ/#*F'>1R.7U4'#UT(\L#E;PRC=B+$X+E
M#3PA1YPCPX,!@_Y9,T0C!]\#.Y1'%IC*P+SPMW3P2K]SD!M7+NZZ"KTK<8=T
M 0D;+"Y<R92IB61 77N765_XFG&VEY66,LCE&(F1I.1DU2Q:(8>&' @TGJI&
MO< 76OT+*09/3,Q!LCPPPPZL#R#_; Q%$#J\N!5#?!0YCJC &4>V2/83?>)G
MT="Q32HJ<P%79E9TKGXY\4KWHQ1)" F'.FKB2PS0,2:-2(E3O+U $T,6AL]&
MW-X@5V\ILWXU!Q\^X-_3KT7BTJ8!_UY7;_=WW^_;,/1.:_6MU8SWV6=;:N22
M)>;.N%;(!YRZ=6-O;HG*_UTF4NP= G FBHZ=)"F/HQ=A19T*0%"]0P'U=R>4
MU2R#3.^"XD0[8YL^T$VM'JT;9(GW(LEOOF'8*FVY^1IAL/_];M09KJ;T_<^R
ME+T?>;;_78(">09H1#$USH@I4"?#K.#JGRIZ+[I-[?_3_M_%.TWVL!IT+S5X
M\>O_N3P7O/^MWV]V4T0+U..''?EAJWFRW/WN7)"<,#<B<X&[6ZWFJ>+W K:;
MYV_X !F\O2%_O]QEJ\;$D94 &Q'#JZ!RA.2"+J>MNXLI#]]N/7S856F%5Z^]
MY-7;V..&7:JP;=-+CK<O2;@-*WKCZ$(RL9"&[=$X.YD(%F"I.);[.4Y<,'@F
M#JBNL57%2:^KMP:[GV-G&/IUL]RRI^& (FHN[8"Z.T$'%$% .:"RY_M=<K['
MRGSOQ>-=^:"4#ZIV))[8-[WFHGG3/UGKYO]=W,5FC=9KHEG3_9]S0/@_RR+6
M*-QI7615=[VP4M+H*(DS)XWZ2]((KSQ1<13[4E.AU">A9.C=<_"F)G+IA%&<
MV]KI(G+!8[K,Q,;)8OA.N467*0#0K2FGJ'**5NL4I1X'B4,TUUG^BYCHF,D0
M?N!AY+N)O^?+XT-20+K4?#+G6S6*?*L%69+\";N+R>QC;).=3JKZ/J FE\\3
M[J;=[>5M^ 65F7$_[700=TVV1(;Q3+2@_A+W/%]^>-Q <>;;HA.EA+]TK\)R
M/B?XR!Q(JDFC5@$S>"Y=%<^_$%VP%QN$!VO&,^49O)6P-W5P+'">9KN;--.>
M0]TFD??ZZ4^"7EYBEKC+T(Z)=;LQ;6NK#)"2*ZDRV&*(E*BY_,USK^[O'AXS
MN;&27$0[=Z99'+Z217L!3^H3[T,^%>='5T\TXD\SZ@I"?=HM[2Y9\H&ZC-"'
MGWV/"MF"Y*9D-M5O/,2Q"-Z42V96C01?VTB06O[M/OR _0FKB#YD&^X5H&?W
M':9*G:FJ$]_1=.([82IKM=N;MQY43037R-1C;B*XJ7?S%'L(GEFKP V,R>H*
M";$Z%-NX^SPMO=27IA5ES:\M!BB1O;5F(A)^O]^)(49+-S8:H'BZ]GFK+Z?"
M?%F!#4!P;NA2.A8(\X(BA[W5+N)T);)H SG:KI68 (5?H[N]R++%.R^U'U;<
MI,BB K(H8N*MR:*SGBQ:J\F"NCW@"BO)H[679+2*9''L0?*&,LLOGO=8/'.1
MJDR31D2I;RH[C!$=5^2&&M/ DY#C $TY)$Z,\X@'@,G-Q,7V\?#&W,+4#0"7
M?OVL1NWXQC3>E*0EY23>G9,X=4:5;DW07@2_(::E[Q[\N^;O_<Z=WP8-77U
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MF(]T478DS['!\Q-L$O8^ XJPA[9CASA;]AGV%^3WK]D! #'@%HZ#Q6XN\ >
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MS_I9DWA [/<<^]YS.(DM[\1 QN=(DUXXR>!R&WYDGU53*B8(3;TB&EB9JG/
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MF'7#/_%T(+. A(;FV%-@99$.&YN$(I4HX";<'\XU6,V)$S$!*A$87_%]=,R
MZ""B"M;=7:O#(DGO"63N3Y#)_<DX''P>@OU%C!)?.0,[JJ;GRI>,W93LA_D^
M.C7$V2!3ZDD;D4_/Y:ZRG(<^![LCU/\_ ZHT2TH]T/.;+6! ?^QR[6=0_F;5
MZ_7$<"_06PVA._,H!UI[X)CM'N+Y(W8XJAKBZ M!729F=Y_;[A,&?DBP15,T
M 'T2K90"G->P$5NINE6<2-8 ^0 65'H9QJ5BM50F%F_LNC@V.0+ZZ7]%+H_=
MS<=J81E&0^L/]!88-A63W6C!M?8\\6(E.TMJQ22%@4_AZ9.T*E6VE9*X(3/$
MV;$B!@L5^DV]_=T!I-K:%WD9LBL%<EUY5ZX7@)+GR$,_XW 6<!#G?Z82C,"2
M$9OP[911KCD#Z,VNHEE.SM45-O<4W3Q6K@%I!H=M^[IST^JT=3EA'![E5,Q$
MF6Y\QP8R$H02:-?->.;QM&J .0[ZJ)ZQC#5AN)>$>E+*44I;E%Y"N AKPF21
MS3IW4<S9Z#Y$[V!#/D_>N<SC]8J[I/8>Q9*\#<LYCDU0K1@ 0T[BAMAC@,5,
MV8C;:LK"FBR7ZL,"X1E$[VG^!("GB3TT\A_&\>'478UD@_?S7"DKGB['*B2D
M"F#H31%JKEI9!-M)4*G)9FB-U?4TQ1P'"D3EZJ&'6'.-]N'4"T+R9&%FQ0KV
M)&<+EB[*V#/Y\)HW]R&?"J)O-77QRVV:VG"?>1Q9I\:-N.8]96^0.B.JNMX+
M .>ONG>Q # HN(Z>WKHIP(=M_?.-W35&W5ZK9["!U>MTVMU^L]VY-@VK/VH/
M3,L8_F_;,-[LKH)N2WEIE).7^FX*WXZB /!1I%1_3%*J:\I0'TG:)WE-'[YQ
M,R)Y_I[:(83 /Q,/9+Z4_S+C2OK^I88OD_A$NM48&UN$'#E+IGK OEK?Q7=N
M)86.D0 ^?(.3#7?^B5*(-?1<!9A!N/(0K2F%D '3&HC(X#L/FY;@%N/J @T#
M_/P9SCOQX"0>E$NGFWD 5:$?8DVS2,!DF-WFF5]E%G:@/7N1@QFC&A9<@G3&
MU#-LQ!'[,RCOTW.I-P=ZW5B85$AKSYC_R;YR5W1L@2?!5;!/D6O$_2EA!G.?
MPOF5\#WGWI")CA^8ZH R6BHFE)WMQKU-B*I'G%NH8HA7"KRI/&&039"39'>.
M;U@6_60'"")TS4P8Y9.;W$<RH1,KOWG,('=E];AE.X(+^6@4MW68>2%&2^%H
MB5S,+:<P/*8)PIXX-0=0]::OK#?%PM#.SLM-J8KUNN)ZTPH*_CJ'J'!4Y;+G
M6RZKJD=/LWITXVZ%IU@^>I#2[?K5E1Z%[B_,V,^1;TXPJSQK =14R5_G_$.=
ME)HC^I1 +[366;QYH;Z24P7[Y86D>F^?NG-$^'V,AMC%3^QOESBNB[#OZ^W!
M[M5A(,E.;^>K7NO-07U6[;7*G:&;K-K3.WOHE;.?5?<#@6M0N<X;KGV@URHZ
M&^U^./GU2\:(&-#M1>MF<^]'V]SGAGY"URF<Q/\8^C_\F'$KB0]8%$X\W_X/
M6SNMKN:['OMLS>37^FV.)FMH;H2*%7G!8W\?[I-;K]OI6F;<V(K8)QBHXZD_
MHXQT ,/(-KD?K/$E;/<N;7U0XFT*/*"H>UX9>FM9HT)?,2[PYL<+=KDOE];1
MX@R]YZUF-NPN'?*B"CX(8WJN&2J'.T'E40F:QQ"[QEI2EO)OW#=M,-!FL)CW
M2C%S5/O\\&UF^W-Q6.!N3VIK,=)\D(^TPPN9:G998IME)^4=[?Y_2TY)&6\.
MA T^I I!^)Q TC)^:+=^R#F%=PN3^DCHWY;4"A,[,F!%Y4HO1?5O+5!YO.^W
M3& U.=7,\J?:"<F*F/1).&1<D)NXZ:4;#J'<1)^I1IU[M'@'1S)B=A$RQ2..
MQ&IE9./6FS[H@,ARN_[(YMIU@VC :+9:Y[=]WYQHW00 J\]&8QL 5#\FM!P8
MNKU.H]E]84[H1GC?Y0"WTX-W+LU5P7OO\#: OKO-HZ+ODQ:HZ8ER?>8GRAIK
MZZ0YKGNM=SK'Q&_K!H)*'?X$T=#I]1NM9F_#\9V;PT-A:%L,#;J-0:>M$'2T
M""JEJU6(H</%I(_(!J^;3K"ID5VW_6UN1==1%!B=9J/Y@AFQ/Z&K('8.$"MS
MW.S/%JVCW-G,V*SC#C>S)NM(]2^;BQ4HLW4$I-'L-'K&"YZNDD$L!>-B&+>[
M#:.O0%SU*;A7&"NKZNAIY-RLJO:IGOV=/AQ9764C'+6-4&^(&=>M@]NA]98[
MJ63MG;ID-4Y5LO8,O3505M4.-'X0']U>2ZG\>X1QJSEH-*_7JP$*QJ\4"/U&
ML[]>(BBK2EE5RJJJ_]FO(B\*8J=HA]9;[BBKJOY4KZRJ76G\O6YCH&)5>X7Q
M=0<T?@7B_Y^]-V%N&\G21?\*HF>J1XJ 6-P7^]Z)4,E6M?J5E[%<73/WQ8L;
M22 IH@P";"R2V;_^G24S 7 3)4LB0>7<VV6;!!.9)T^>/.MW]GT+6JO*6E6=
M'6R.^JZO:E5UC_7N[X_<]CV%<M9&V+>-4&^*=?KW%ZM9JVJ]534\=LG:/EK)
MVFETA]:J>@+QT0.5O_W(BB)+XQUC56VW?T_*BJ7Q#_)Q"VC<;%NSRII5UJPZ
M<K/*AEXLQ8[1$*VWW+%F5?VYWII5Q^+E?P4T[O;=7M\&JY[5<AUUW&YWCS2V
M5M7!\\BQ6U5_SR/IM+MFA;TCO?M;[1>/(]2;8#9650,6J[?4*7PYHV.7J^UC
ME:O#4:-C;:JGD![W@[):=?_'6-52^+D=L?NEL#6G#IY#K#EU'-<^:#36GK+V
MU-'Q6+WECC6HZL_UUJ!ZJ@!*[]ZD *OOVSC@H=.XU1M8J\I:5=:J>@U65=LF
MLEF*[?_.ME:5M:J.B^NM5655_MK0N-MR>YV^)?%S6E6#H=OMW].4SUI5K]ZJ
MZAYU/Y7=UE?OF[\U< <6I.+ #81Z4VP/+%9GF5,4&C6/6Z:VCU6F#GH-"_KW
M%(J^S4A[9@J/[I7,EL(_"$UAHU/6CK)VU/';4?W[\RFL66 -J;KQ6)VECK6D
MZL[QUI)ZHOC>GDM/7@&);>3O^-G86E,'SR+6FCJ&>]_FK5F*'<*%;:TI:TT=
M#\=;:\JJ^G6A<;=U;_,42^(?3_+;:_C/FE,'SR-X,;::1]V)<L<%UOOJ;_6&
M;O,>+$]K'NS;/*@WQ; 4M_7"/%9KL=,R%L<Q]DXOR]7VL<K5X; Q&EB;ZBG\
M5Z"+[K'@Y!60N-MUVP-;-_6L^90MM]FR%I6UJ*Q%=>P6E0VX6(H=HPU::[%C
M+:K:\[RUJ&R4JC8T[K;=WL!&J9XW2C5PNQUK4UF;:OO5V#[J#I2[K:_>-[^U
M#RS%#D$ILA;5&MC4=ONXI6K[6*5JO]<8;H^K6$74VE,'0N->RVVW;(CJ6>VI
M_M =W",1]FE/C>/$E\D9_^9-L]&#UZ1Q&/C.O[5A!5UO>1)'8G']T+H/D,_.
MYTD0.IWF@]"!7S$1VH\D0EWDSBZVRH.W_RF%O*6ZI?I+JHHO3O7C%;-52VZ7
M!A_'1H'EBZ;]>B^:0;\Q:!W8T=O!ECC.S?@AH]GNT\MYB=S^8X$U["Z]G#;7
MZKC=P]XGLNY_SL0XE/"G']S^Y_^"_^C)S41R$T1G63Q_@]16+SQ#L_U-J]7H
M=*M;\&>>9L%DP1\%D2^C[,V9>N[I]V"@]X"&?!-D, EO^ZZT<5=.Q"GOR.I_
M+^(97,RI3)UL*IV+:2 GSOOOTLNSX%8ZGR:3P).)ZXC(A_\MG'=RGF>+3<^E
M3IPX,SD;TU\G-.0'$8D;.0/".+_$(O&=((*O\'%'9/2$+S*)3]\D(LH:AFE>
MQ\Z,-^[,E:53B4[>%CIY8>X# [<[77?84[[9>)X%,4S&$Y$GPU#ZCI]+)XN=
MN0#9($(GBJ.S21Y.@I!X$^@ZE\DD3F;X Y#DD1_0"/<26HFKWEJR*@K^)RF]
M3S'2$^[%$ 7L#K0'1L3HFNNT1FZGWV;ZIEGL?7,TE>]D(AWY728>B!+?&2_@
ME,/Z C\7(7P[C?F)0F" V)D%62:E$1>"),8[Z=&_^26=EDNO;CCG8:@%RCS$
MA071;1S>PKOF<9J=T=' +[U$"IR2?GC-&]\XBD X$#[W023>E%_8P_>U8*EZ
M+0X(1V '4!([_>[;7K_1[;XE87C?&)U-8PS:C=;H29AJ#ZQPOF63X)* \P4'
M&A]IN</.P!WU1V5N2?-QZB7!G#=(L4XB9P+>XSMQGJ49D!:$%>RWN3]2,6/1
M!_SG]MM=MZ<'K3!?,)M)/X#'PH4F/-[PNQ*Z \LO"\[V)N$W&#;;LK^>RDA4
M(/ 2;5NM1\J\]]\#V.[HQOE<$DS74P&K_4QG8-N1J2F#?84=9S4!5Q8DTLMB
M% YW\%'JI+CX%*4X*!L9L(TC9_,P7DB9DEJ!ZB-^>X,''IAG!BSITR"P%/%-
MTD-YXDSR+ <JXCDN"?W4N0V A1,9^30<<1^1FPZPB_06YOY 9LZ"+ ?! P/0
MPW0QXX;!W"ORL:['_9KIC22@'8!3"M0M: YR/EN_83&3;RS2@)A4."$P,Q*-
MA#"-0PHGJ)\R2EEF&Q'=<#;P02HSV'Z9S(QX8,YP8;]0"T#BP]4-FY#C7WFF
M=+\7%_KRMI>_.IE)D0)KP&MOD96F"=Q0DR""YW#/%U(DZ6E==Q-IJO=.W:)3
M 0=%\#K/<'7.K629 P0*8M]U[H)L"KJ2$P([G^5S]7E=27">.0%PT$Q*?4X_
MB(42G/H6V\#1^@ (+1-*'(3$=$'53#V!C_CQ700,22R.# 1<?T;T?K,CV=HO
MIK?_ :_ UZ0[$W:PEK#H16OWC<6_E^VMDFP(JAI20K".ED=X-]Q- V_J='M*
M@QC+2(*%%8@D &GFA2)-@TF FYPZM*+FVVL9!2#>C1Z9TN>MMZQU%$Q1TGQ:
MW;[;[2@'+U]9;^W&'\+&@U;:7[OU49P]T?:W,9@)>NK ;O_!;7\9G+DLOI5:
M6=E2K9^L=W35]?[[Q$K3P&T/!FO.@>MTAS\Q'>YB4)LV+U.-VAV",8M,&Z>D
M0;U)9"B04&_O C^;*J=P^8?:N5O\1(S3. 0U>N-/2@3T@-ME E^3^W8I6@9T
M#,4\E6_T7][Z00I,L'@31$0*^M';U1U:<A?3^_AK-:?1J#$<C'!:*BM,O5C-
MN$$S7O)RJU^VX9>]C5\W&ZV-WVT;MML8M7<;]6EK@V:![X=RX_:0]_U1W'V?
MNW"K$+H^__CI\LIQG,>+H1W?O_Y477[Z\@&4Q[/+9W__^O5O6_?#_16[K7G5
MQ_"XK/OZ<%FKVUNSX#71I/)_ITE!@QMY-DZD^'8F)B#$WHCP3BS2O_Q<O3Y
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M0,>;RPC9PODQQ>ZP2?4N3W"): @LI$@<6#*L?"WIVFSR9C(JV,<YB>&S!+Z
MV7MQ,H\3-KK8O#UUQ!V8L# B_G(6IYFCR,WJ- A-X%/0;L.%>5* 7@U''4E=
M@5+@'^Y*YPZLOFRQM%>LCE4WS(3^[^VC!5:K]4B)=<TT^707P?K'"^=#U2/
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MU$U"\=3 0S?84"7"%J+4*)@>7"B"1"++$YYB*&_@+ZI]*($1+U$1?Z"G!G_
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M>G0[WMM)E]W/QMK]VV'_=M+T7G#_CI_D_4,[,L=/\M8A</F^6HOLMX,()A6
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MB0#S41%#$V%5&-R;<U+YN0*HM9R;CRFJ3)M 31FS;NJ:,[RTTM^O'3&9!&%
M!.<6,-%9]=,-+2>VCJ3:EO@Q;0\S+_(NLN:99LT2WV+V)FPR[PG("1DA?&0
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M*J<)0:F!,".D&P+[@F.&E5&D1'#O.M0HSUB3 34VI-VI*UW4>*ISF+K!@\S
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M+:*.)-TIWT)K\U[^C@OUI Z](!N\R^?!]U*O$BML'KQ[KO/_R-M_B418&OX
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M28LE\$B5ZI@$Q%":\+H*[Q:XYQC.8+M3OFYWM6[(7-&(X.>_??W]'U=75Y^
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M+XL >2CNZ "H6"+%.'][?U4*#3/*KMF67G?4:3;?CSY?]%KO/_9[_6:K5=?
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M?Y[ "4U))8OO(IU5B/9=G"H/,N4 O[OF V^4/!W<0)L0547,:J')*VWR6H(
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MQ():[<9P\W:74T+NV^R&\^[1''T'%P_'6;P8-E&AE98")3(!>L0)I]86>21
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M[O^^\+JM<?>P>=@2 _>PTVEW^XUVIS=JN?UQ>S!R6\/_M/O=%[L4\XJGF._
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MQG%;EOR<S-[1[\N^/D2]GUXWIT%K*Q/,#]3O\QUC1N&51!W"(85ZR?'<-:G
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MZ6O+I/[M((!;#E^:XXL3S1='>;XX*>6+:MD'9R^/[KS/K6;E][E3=TX%5O2
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M1EJZQ]J[N!<S!4U[[CG'N@B2_:5'.Q'?L\.<OSCLHUV[9>^/9!(($U?Z+17
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MMR./<7O)\!-CV.&^<^KYODZAEFD4;J;6Z!9$J>V.D;\%;IR&5*R>Y>/'4I9
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M49N#=H=XB<!"L"/#'CZI9F/_6DUAWU1">80 0V8[/#9+HS@5C#7"W&P0##+
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M.?P4O\YY=0_&WC@QY6[*TZ"@^IUW8^6<0+.;7U;#(-A?:1BE4R>SJ5W"]UA
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MD*OSYG;H!:^IK33*&Z4A5/1D74Q OJ]P#ZC.R"3OX<?>T/-11.6ENSD,4Q&
M(8]/UAWG/?%([C$@'5QEBC.HXV-1S<J/=_O\S-E!CB0)$<.K_^2>ZC,6 "([
M^&-4O&V@#",]Z*AS2'P>"\:S%'MZ0EU_&@,G:ZE8*ID^U<_KSEBZU'_2 NSP
MQ76F.UL- *E[('T!,TW]_!D]MQ""X!>FD:!U9/60M*8*RW[8?C<=$8R/V=W5
MI3\MWG$N)F%L?ZVVEC,LKB6VXV:*@8: -S!O!N5RPNZ&0VK1#7(QAHL8-T>
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MV-2ZU7#XT-QQEN%0K6OZ&"7D"!5O.LBG O/WJFJD8Z[82"^()=.4%T2=GM,
MB_90XY/8 QTEC/X:#/&8KKTH9+D&5T>$AUU90SS8JIRD168D\^^EULBY^S+W
MM;HC^5TCHX[R)2627YR]YKXR@TEB\7F*<5C[Z-++U>)8?*F!5Q"Z\*J]UCX<
MX:O0OU+7"=W@\$/,AYO ?V1P22(F3H=?V0)W5/=B7WYWOJ;NI3I.%Q-[@>HH
M+M@?@]$G?,1_]+CK,&K8UM'2VL\*HC<1WV2 $D)P2V.6MM>L[L![:BA4K,DI
M ;)@=L0P-24$J%6XG DT)_3,8C.U\@%01 2V%)S?M5"A\L&/;M0NWU^4[&+P
MNSYD5>D0M0MB;TT0^PES6?.PNW[4?A=_?T+Q]ULS=9YTF'W#B99;$V5?*SJ^
MLNUUA^AX\\[1\1&9K^0Z,:C7(3D0/+!E0>M67A7Y?#I\-#OU'C^YV2*2=KW9
M.MR$[+$RU1O(\SI7O06"OC-:-U?])]3<K\Z5))PM$.4YGMN:22J[G)T7*ZLS
M#[1U6U5ITD3SXGVY#%%2AAT/?_^O?KO7>=5JUGJ=A@.S\,D_GLR'X>I 9^V+
M SMU%%X&5!4GG$ FSB4Z@6$_U'B=;L<,QD8E&MJAXTUG N0X#C&:@$ Q7GR,
M-PJ?G6JXIQB:7A2+KCM'L>,2@PXY_G=&N0&OZ[UZLUYS3NJ=.@U[4N_65W:"
MU!;)7')/W, :Q97P?!*@.,LT9J<".EMQ2/C(6AV7 _J<)G$]D0&NT*$>Y^0"
M&'G1*)VBTWU$7E>7?$&JJC$;9DHQ6/D=KL6ZLV@_Z:%+> 5Y)HR+P@K_4]2&
M?VR\M!A2AU\<J =Q@]( 79Y[Q[]]BO=I;>P<GU\=+LA>3)8<LFQ=Y ;!6> S
M\!)G*FXH>$0#8R\!B\,R5S!'U\HNR6Q 9B+%DQ0XLV;KAS%,1?GP1!11WD[9
M*-PG(E9]&HIO9,?6;3/Q>,(3V#AI&C%@DHB#+FOI^!AM&(5Q0JZ?&/W92%OX
MD[\'&@)GU9U_6W_AH*[$A@]>P('KS"T.W^-R-+E@JU(L^[5W7[.&"7GG-H&]
M3[C;Z)92DH%"%!%R$F+EQ]I-%HNI=*8RF82<5,'Q"7+EJ\"!!RQ$D1,IT+]E
M!TZT] E<[1-C/SH&7*3KI5-N:8$%OPDH@B,*/,4YIC"+0I?<5X9+,RR=BR1@
M$&HZX^]U!A'0&VP FD#600.D#C?'D#!X$K]"S^],)EC+>QF%U\D$Z0073,19
M.S@W"O!$=D#RE:$=_>"5HE\X%%DX.$Y'(]Q[](4J)S-&*T2$U,<H#)PG/YS1
M.M7JXB+.]"K7S"VNO^VYGO TS0PV'LIGSS4Y3#JXHMF>_<CLXD8/J^F/LH[V
MC.?H=J]V34D3Y;#7#FX%>F <W39;T=FPN,\XPTOB6"P\U6Z;@[6 ==,$^.='
M=KR*ASMW#H1]*XHAT&4A'L*MBJUV])8H2 ^A/VV)0OE/H.B?TCER7<[,H:.4
MJ9BX"QCUI)C9ZN6L/YF66WG8%4DUOT\U/56\J3P<CN?0BO1R:,4$M#DG,&#N
MYSP'/0;%CE1,>-T8$EWSL0['E87;.>6!9A0H0 A,GJ 7\U5'3\69WI4M' XH
M0D90; _O;!W GFD=3(['+(8"?5EP2EN<TZ,S<6)2@1;*/$LII:EP,)U7HS*8
M^064F+=4&MD7?3:L7HA:_(*)+*1K+GF@AE(<Q\)!*'TAGTLP@P?ATH#-TO0A
MJF::2R8:IZ$K_5<Y,K,LYV=K&))+(S&ZT0+?AY<A8\&@C(I#BB)PBLBM7(U;
M8,Y;Z9:_!$IDM?,F&ZUD?^T!S;FQ)F"GV=SR<HI0V_D,-^;Z-912*@HI,J 8
MZ1.J";20VP(B,L;5\<"5<BHHEE=>F%I:%[U&OS*!_W7C+ \;78+!B'0HA']!
M0]->'QU\D'.< #H5T3=E#X#Q 3(ONJ$=K&E#3-,HSE-)!>W5VU02FQ$U?.*9
M!7CE LEG-%MBZ1C3<T0NX963WG*Q\%CKUB911<FY[]E3UJ\I.247EH<#,):4
MQH;V,LU3J32D*,3?P.SF(;\%X;4OW4NI\IRPBTI*YBSL^HUFYTPH%$\3Z;(E
M_+.X^\F*)?';Z(;]-Q^D+&^(@OZQ448C.21KU);"/!7#UT,TE% J*<KF<J9-
M2O*I1)O8 TG'_XHXTX.M'-<YA@]V7MZG[>5]%/5L]?- "IO=16\[C,DU%[!S
M#B\D#^)Z+7*A4L<.Y3UMM==QGX+ Q&3D&$GFELM 09?LE52 ]U>@)J >\!M^
M%$RUOD$_QN$N(S&-G3W82792:=') M-(3Y6!/PWA?K-4L'V3K*YL>UP+WJXR
MHKE3OU:VTND6G4CA)Q,>DD'?3 ZYUCM&L&?A5!=TN@A.YPU3+.,$[<TX+&&^
M^@K5[FV^.T#)A=>!;@^+0@\2D!%S">RZM8_\4U/^Q^F"*@N5? W9'+B')?O@
M1!2A#]9NUIIYZ&-*7\7-4??;980N479]Y<N_X"^3CF9KP?S;_,!UYT/^CJ3S
M=OOUYJA%E@4BFK5VXU"'#FKZT\/#;A:;@-'4QX-V)_NIJCB@PL#:@@@&NIST
MRS./:4$SCV16-($K8AQ%I0D#2[!_#KO?:E7!HI,Z!*_F*A;L.@5E9:'6!JSJ
MH(=+\5D8N)XI9B##3(PT?UZ:4T)IAH9#:YSIB#ND&)-55,,HKYP)<"K\&O,3
MR9RQE9C8 Q***'O;*U;XY7=D"5)_*4V;&$"Y1%E%-WM.;F'XMQY*2P(PDD;D
M204%%J8=@B[NH]^+F,Z<'MQ4C" $\$4-3G& ;C;5$8-%'CN@C5[-4Z&%V)HS
MJ+3FG."7K[0QH&9K6[S3F4R(T"BVO!';\NB#!49P%Z=?5MKI:CILW]OI6E"-
M/Y:HQF7%2LOUXX6^V<VY8PLG795GV+^TPQ9IH,0^UF5I"\PKNFYCFQS:QV$1
M",6))6JT8)FF?H*%$,Y8, Q A9VW%5$(B\[=:JJUMWFC5U1PGPF++%>!=S[I
M!_9)2ULG?JB;8[DO>\X5B@5Y:EI*?JM96,)[)=>T=0]@OH&5QVC&7[YJN(TX
MOL<4]R)4,*.$'98$(;VZV@0\FR)JAT[%@%6B8B/9C<H:IIJ-T3O9+#&&5@8M
M8:F+I#OADTJ34\^,?.'!B#-0]%FK+EW^M8B5-SB[ERU:H"41N;E*?-SU.HIH
MCW$=4)5/BKMBF%YSZ\*YE3GIM9Z+3^3H4F0Z-5QF)M[![[DKM%F](F8'=KFI
M2H?>#NQR5R?TB&"7N[*9)U0VLX.MW,%6/CALY39&A O.;>74='Q/)W42+D<-
M/DB\2W:59<Y7Y<U%0E,*LGK(NW\_GI\KL$  UQLL=^X2W>T\0".8=KW9O4<C
MF(>-]3V^EZA8ON.4!T*?>0BT>]\#SF!!*I-*V;&$7F&E(9N85J_;NJ6V9F$X
MMD4%+<U!O6VBLJUUHK*69:LF&G.FDF6(4T8R@HVE"67.P=3!S@[3:,1^><YD
M]Z5Q$.0+'_1C(QAB2("='B48&;<WNP@,TB4Z510$ABKO*)>4\_4DG'=ON? ]
MC(+2U,@!]:T U%-TQ&!,:Y2G%?NV%'(+;)'"U61$&'32T_-(#C\MI =AL0B#
M+H&\Y\1#30J/JX8TX9YH1"E+XY^(:"I&,F4,%)-Y!V3 0AA":J7X)WK1.+[L
M!2/<*,4 7H [BU$<.%9(XL*9$]'02SA,E6<F+\[%9K+':O8SUKGUY26BL)K=
MR[O]^"-.*;B9X6+\&SNR9$T+>'8DH\ *^EJ2@WU0-8I9$EYMRB^=R8CD"I /
MOK7BD AUQ\<KPHJ!&7JHO!$Z-RW4*^79XKC_-87\Z9Q@ 1%\-N4P%B_8S@>P
MW:O&E>IB'D)B0?80+";\6'@93&ILW&E($K67)@2'8>$LM0*QC1.<$2PUBYW!
M_"@8'DG,]JSILV-7QE!]%NURH$^L.FBNF(I+E7?@>MB(!X\F93.J\7<5,BL'
M:]>_Y&JJ Z(UVB))O4IAS<J!7!3 **0U*%?)$BE@,U]C9EUJ(W+*DV@ Z8P;
M( W:=0ZP2L$4JM(:5=5(^KN@XM4;S RZ@NU%EWP6T5!Q%!-<**3(7M!51>))
MB38[GIP/5L=4T:/&]+)#H&CN>]_@2IV$H:N@91,"]-:H9/CD8M?TM@6+MT1!
MG@L&[ZI\=A'5*D14KV[)4U]3P"\*G6J1:U>6"%5)73 (<H4GQC"@GQJ+0&GD
MEDV04VPHS4ZJ.G-M9%#,$X<JV3\;0F_=N*V]L7/106YD35O"K.$%>%\IS'F3
M@I:KV&"5$OUJ,<5BY6UU/+K>(H-D-21&5AN+JY K6K6H]V*;AC,@+=7<\'9G
M.S%'9S*,)E&87G)"YSSW\-SUJEFCFTZ%OBSSE@[_ $&94T*JC!14+1Y4*E0A
MNJN7*)E:C*K:V(?C,%J@4#S)$I-/6@%P$O'=-(+8.01W#L&=0_#1U9?NDIH(
M]+BQ[ZTY0&R9NWG?L+N\<17:QM.,I8*Z]--R*9'S)W9;MV'UV#X25CO8GV;R
M3G'PKRGH!J['\ &U#!L%S:%9B'60RIY3)E,2 6V%0AM06.6,%6^YY+0CSK*O
M\++,[*98TP^G@&7$(V6^81V#_0I>148!X8:S9"Y=R%&4RB"=K?Q]QH"'SV>1
MM&#!X>>FM8"5F5]WSHUAA9/)7JV0:BQOAV7-40LA\JF2+9;?=06A$Y?X36D:
M1DTK8J+@'V.0WN$UJ2J9I?D+DY[0R74S(?)<#J5"@F<:A0%I"-,PXE?912W%
MEPER?%(!-*H\5.F+ []2#@508T>3@ &.,_W%BXEGJ&=):AH_C-'<'9%'UL?X
MHZ_\<4@<)'O-)GE-<X=IYZ)=7Z\, #9W+C)K];0.18<4!(GG,M32'JD35GLH
M ].B:\;W:SS)((1%CQ4(CKB\1$6,QA[*Y%K*(-OYNFJ/8%OZ.62D(B7'5+!!
M[H.<ZYHPG&@GV7FATNH2PC#1'7"X" =4*>60S\N"C%=('T3=D:M[M!((ZCQM
MBG*,S$^N-+<2FP7HX_GD'=7W\:8MDLR;=7ZM6\6@X&0R<XU=1II5"*JL?.*V
M]2?(N0OC7*K>&Y8CUG9<+2C"9\>5+6?CG)0K$;9VU51BR_G*U#ULB6JW<V7M
M7%E;[\JB(!_F)%DAJ@RS+^>16$UT+?>LS,NC.;T/]:>\/T05ON9D.RI^&,DE
MY2]6*"#I#*=/Y-9Y/IGGK"0J89:TKJMJ$78-[Y."KRFI0IW#K($C-U*"=RTZ
ME[G(;@.7*=Y'2.C"YM'5!ON2QGI;=",AVC<,3"I?I5658"P2RVB@2E6.4-9)
MTM&+<@@I#'S"I%C5,Q>K+B&(8U.\GE2+D<*BJ<L6O-N^X QVC@NZ@?+04DBK
MH(PK)VH.43#G133-1DQ$K*C$&5\DC>U>>3'5I)>[Y&P7G*F858S"7597;AQC
M!<$7<-#"VUP[\AZI9Y"S.'"\E7ZWP:#>ZQW>Q>W6;M5;[<VCK#SDL*N5@I0J
MA;U5DG=50OCFX/ W4)G],G[I?,"2K6MLWS0)0;0>AWC-QBNK;Q5<\9LHB$$"
M-WN-5W\7T]DKYW.8HE*1P**32-X*^'^W'F6WV*S;W>WL'][W7X(P.$NG,,"(
MM ^8W4<Y_M\7WF#<[Q_VVNWA8-3L-/OCP:';&0[;C5:O,1SV^\W_G*![L-%L
M- _P'\U6N_G""<045N!*[Y<C-D?/X(,7H*[!@&[[WS?#D_#J]];'J\_MT]3]
M^N;JRV^#K^^_?KKY\O53^_1B=//YPO]V]N./QNF/3YW3D]/&V?3TYLO)9'KZ
MP__ZY>1?WN_M,__SC[!Y.OW<//OQIGTZ?=/]<C)JG)V<-M^?'/TX._GR]73Z
M1P?^M_NY]<?-9[_?./OZ[>I+\*_)EQ]A^_.?_YY\N7C][>SD3??SU\^-+Q>G
M#?CO]]/6Z<WGK]]^G/WY^?O[B]>3+\>#QI?_FS1&TW\'XL]!^OZK._GRYUO_
M]#>8VX7OG7W]Z)_^^ C_??/C\X]_>>\O3IM?OK[IGO[V]MO__?AV_?[DW7_&
M [<SZO;Z!RUYV#_HC)J#@T&WWSOHM0['_<&@WVVU1B]^O9UK<WOT*UWQR_9M
MW.R.^K+?$LU6K]-K]0:M01,.2:LG6Z+K]N5NWY;NV^E_!HWAH#-H-0ZZ;K-W
MT!F/A@>#?OOP8#QHC]JR-3H<'G8PXW>9?"WL&?74AD-ZQ4ZV,K5+N6]B)T9H
M'Z<YZ/=HJYN#P2"/2+.1)K,[L;64_7\/V;)\ED?@TW\&AV(PZ@['!PW9!='5
M'[D'PT%_<#"2P[[;Z8C14+HO?CV3J>?[-P>@_A^<2]BE1Y)5SWJSCOXS1 ;O
MM)L'@T9[>-"1@]'!<-R5!]U6=]QVQX-A]Q#NF0^(HWKPNW!._OY?H&R_&LL@
MGMNP&K:V#[#47_>8YYM)-YK?=8'<=8'<_OY\N^KNK:GN?L)<UCP\W)6S/^MR
M]ET7R&??!1*30>WDT,$&<T-[=^X">4]25,L8O.  P_E$1'(2^JY./L8/7X<B
MHMR8$R^2#(X(?_ ,:O?NC+X1!B<.NOVV>9]%<M_IS/%C#A9RK/"MB:E\U#E
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M:V]*;_O@X^1VMPSH-=R"1SDM8"FF_O5L^DZ>>7.B.CX]+IO_UB <I$. $!X
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M:@RZ'SEP;_C]S_CY\;!K+M+U'PSV+OM^F&FT2AI%,Q2##='41,8#*90"%,D
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MH;%_$%]H[W0.]A^:_D]Z5%7[DQ\BE#1-'_$$WMTVYHSN16,NSNH3GT+]0%%
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M\\\+3BBU5"K(3,$I\)I3'A6DE3EE\9S2V;_'*=%,5-@1":)]P:8E5IQ%@)C
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M)/0>/\859-T]<B:M\6)9I5B<3H2\7"YTN6S/:MM ")0X8 V42%VXO.= (\I
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MZB$E@-9. NU]_.$)T=I$:/(YJWEG"-;'[YDA6"L(EMVD)BZ#TDA@I R "F^
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M5X3; LV%H%G+FA'I'34Z((<-3]!DR;W D2(G01"C# Z&YU9S19]N*BZ7L$E
MT:?K!>U\CDL+&S0-%+&@/((H&3)&>X1)H%YR)3!W$SMX,_3I/;?H7#T^.V$\
MRQL]MGS-)M+I;<(XJU-<16)%8D5B34MKO!RF5QG_/AB-BC&S/&/FJ)[E4"Q9
M+%@;I*11""@ ,D0(I'U@1 3GJ:!;VX0^H7K!3$>!4R&@S978C0;Y)HKR?N._
MA<OOB<OG [TA"F>9",A0!0AL<DRUC0$18T#YH# G^FY<?BLT%,JZWWCM]W!6
MH+00E&J!6:&EX8D*$7:&Y5RG0YICA92G5H&FV&J_M<T6W RRJ*MEPV@%>[ 6
M=;4BC-4:X5E(WB)-(V-(4E<BH4UA&1##WD-280)\K-05NZ968'WJJEFK\E=9
MIO/\[BOQ5_E8MX[IEHZF32KZFOISC2SR>32+%LH EP$N UP&^*?K<E<0\R\K
M&59J@;MZ\)\ CD&Z9"4',,G+)009SSC22D0?L<36P<0"+[VH'Q$-%)Y_X /<
ME$*.POBK9OSY&@ZFG..24$2KM6O2 -*YJ,U2)K'.:0+&2@U'H\"ZWN1=@>BJ
M(5K+XBFI,.:0)E+Z"XR5R&KK$=.2>$H=-31!5"6;;$.V$RBE(@VAAQ7D'$M5
MR,\S0"WYJ#S'P)E%2KG$ ,0Y9"W.S9&3U^VE8H[(Y)9M2-/$8ATT!/XKR)46
MZV#5W#"?-&7&"2951%$H@R 2DUA"*10CE8XDJ\]Z45D'=$/:I3>W\.7!]5?;
M[?W=\Z'O6WF?]M;@8MP:Q%9NG_AE>^[6O_[Y#\4$//L>K;P,PVK?^^72RW[G
M19U?9D\\>IF>N#M,\C;#R^KFHZ]/,:447"CE%I1R/#Z8,S=^9Z].P_^^NGS[
MES]/3J+H_OJVUSE,USD\_OSVU\Y)9_<X/>\>/?J<GFOWM_?=W>-T_[W+@]W?
M8F=WYUTR5#BA6B#-C$=YBQUDO9;("PD"&' ?Z=8V:Y-ZN_><PF]5.Y\W."?>
MC)7.C\=9*O(N\B[ROJ_Z]!7D<;\H[5?!#8[[O5'P.Z/=WFBRO7EZGM'AH/NQ
M'X:C;GR9N+\_+C[#,A5\+<UK>3*_?%YCB9U P*-'!C1&5@L5(\9.!U,U@&$+
M%*P7O!9^+/)^R&&K9BFJ%>2VBJ):LZ*J[1BD&"< !&&M:$Y] ;(*NS2@'DLM
M(E&2+:RH2OJI,&IAU/O)!Q1&72^CUM(%1 @IF3"(@/8(%*%(6Q:0S6L[L:68
M*[])C+JB7E5KP>I+<WF6$)"#\'Z&F]9XT/H?._QE.PT$RF@=#D[3F<>M7@+N
M,(S&H_E!>2"ETZ4_1I%8D5B16)%8D5AIG+"1?7YN8_QW!OTK5LW^S*CYU@N(
MO4_!H\]A."@.P$(.P(=Z2(5090 'BBRFR0$P+B(;)4=IJ!5+GH$(.EZI^&E,
MEX6'PV_WW,5]J:@LZ%L(?;65O%(P:53RO(,E>1]TGG"8=U#!,DH:HI8^AJUM
MJ'?CNLGW+HKPH83!"N:6A+GYD)?@B3(%EL@0C1%PGS"GN$:,:I'KG$UDBV%N
MG=V$-F^1:;4HLS4,YQ=#=V)&H74^'!P/S=F&]EZWI?=Z,>>*Q.YM.9J.7C%@
MT3,'TE!+)15<&9W<F* PODL_ORD1=>/A,)C1Q6P!>=&T"VG:O8^_'QZ,#RIM
M>T [NSOT8.<=>!:Y5X!P8"K9MZ"1%L$@B8,SCC(>2/(N%:4-,' W$3J%;(K$
M'K;$'JW;N8I&ZT73+4O3N7E-QZ0@7B?]9AQS"!Q1R$9G$-!H">968:X7TW0E
M?%KHJ;GTM(K&VH6>ED5/'^;IB1/-#>,&>1TD NLLTEI'1#R.Z9<TE%HTB)Y^
M$/7RO='YJ;G,SQFNPV<Y\CZ/?$AK[BK&03F^EZO@)^OOT@OW1T]O7%=7?U.<
MW_/[<GR@A_Z0%-9YN]6%TN<N@?+Q3PEI,YA=I]?W:2H]1=,O;S^]_TK7R]?\
M^8Z=5'RO8^>JH?7L&]FHMN99"GN?PM#U1B&O<1V-!^Y#:W!>Y;]*-J")!N("
M]B%3(0B0VDA#@0,VH"-6$@<MP 6O[V ?[O==M@O#;IC\>WB2H']\,IM#W=B=
MS)UB+RYF+WZNTJ/?VHN!1,!<&L0\"PAD^J23B9\<6^ TYTBQQ5O;=6NQQ-56
MLHL144$9;Y-_I0 [I@/&$1,(F@"7D1<P-0E,^_-@BMJJP Q%AA"! (A%2GJ"
M(G$0G*/"YS;JH N:-C4,5"16)%8DUC2)/:C@['I31\5<6)FY4$LE&0 <F"6(
MR$ 0F*B1D=@A85CPPF/II-C:YO4&_&4U?F&L!HERO=FDPE@K8ZQ:=BD-'Y9"
M"T2\#P@X!J0M#XBS-%A)^:09# UCK!(,;EPP>'\TNC!]5P6#<ZW#L.?&P4_Z
MOXY:IN];?Z=O<[.#=$#XU)M\KAVYL:'C7_[E'TKX^*=[T2\M?#SJ7]ZD"JI<
MWW]RJF_::>-E3O3-9F$WOOHRLR;K$';Z_L_)!.S&O>GTFS^F:)/%M F^)O;,
M6#1!6(8TQ1*!)QKIW#!:AC3Z)BD EV//"[6OOP^[L00%5K',Z.<CWW.[RQ5"
M:#HAU.+GBAG.M DH4JL02"N1CI0F^TGP8,$I*_5UA%!J");LIBVM^J: L.D@
MK)7R&.:<2D..&,F=XC1)('2:(L&2U\Z<$4G_Y;V Z[M.%=78U,[L135N&"K_
MJ*&2@U(R6 2$1016*V0,1*0,4 V<\A#U]:@LRK'YX> BL1) O^>4W[WK@-+8
M:TFZH99'=%'&Y#5S9)/SC(!R@;04&D6) ^%*<6M-:>U5N' C1+F.9&+APDWE
MPEJ&$CMA"?<:21,) LXQLC1$Y(3$SC/CN6UDF\.2IFQ<FG+O[/QT<!G")-W8
M&E3;%9STSJLZL8U-/CZ0Q&-SZE865AZS>57]VIW-JNJGH@$6TP#DFJRB%UH:
M+QTR5 @$P6&D.'5)(3"K8I RL+Q&I40O-ZNBI<!LK3"KY>I<-,%C8Q$)-,',
M,(FL,P1A*046SGK'D]-)1"EVV5B_LDBL2*Q(K&D2>ZS1GO5%OHLEL4Q+HEX&
M(].P6AU03-8A @H8&3 "!2;38 9"#%')DI#U1MTE=%W(K$&BW(C0=2&S99)9
MO4+&.,&5YBA8I1&XO+I9B%S3%Z/A0&( UC0R*TW8-NC(DBAH7*+@3W-Z,>EL
M%89_]UP8M09V;-*IOA6'@[-6F%+NZ$''WHL?6216)%8DMND26\"*QYQS"II2
M  5&,A,Q5=020T4T0:\PAUBIG&Y\/54XW:F^>9'4S<S +^;\@N8\^_WPS;PY
M+RUQW#*%B &/0"B##%B+C.# 9'1$:[VU31<UYPOBFL-1CS4$L;YX:B&OE9!7
M+;!*A.$Q!(L(]C:15QI)!40@PKA-0V^9Q>0.Y%4"JX75&LMJZPNL%E9;":O5
M(JPQI/%S7"%A16(U;#"R6GL4,7 ;#<:,W<4D*ZM['U?0[M!\:H48@QN/<NAN
M?!):X6N3^LE4N;93?0G>%?5>)%8D5B360(EM1/ NJ9Z]B>;IQL.3\+53Y>NL
M;TJ[RCN9BG!-]$XPYH-4!L5@' +"'5(V!N2L4I@9&YC+31-*[&Y3*>JQ>KGK
MB]T5[EH-=]6#=UY:)ZA%P6";-W+DR K"40#F&-4 .M"%N:N$[@JI-9;4UA>Z
M*Z2V&E*K[TXKL$MFET#>&8: @T5:8HI"4,)PPB(%W"Q26UWD;DV [(Y/PK#E
M3DS_.#?;'O9&N;EVM4ZM][V^W!M:\.X>=L%[B1 4B16)-4UB]]O<\X=&S\W=
MBO;^[Z(WOBR6S6*6#;^F/R?3AGF7ZS[ >034)LM&>X\8<!X=#BR-;]E'M?#0
M(Y+88_5C[R,X5RA]Z91>B\ IKJP3FB*2V1R<!:0P2Y\\3EJ;,2&#6)C22P2N
M,%=CF>L^(G"%N9;.7-<TP932$QP0QN 0B$1?*F_3AS4C1MN ';'-8JY2@KQ!
M1Y;!VJ C?S!8=C#T88@F:'R*VSP!>#0X[?G6/RC)]/%L>D0.MU[W\UTCX-?H
MPND5;]*%/[4,]3_FM IMFW$K*:1P9L-PPG:,/&EE93;/>M>9!<N4U7+,AU6*
M; '#05&#A;2"4B6!4:T9UI&*)-80O"?\W?YM=_.=&0%7.V3W+\Z0'XS1],QB
M(2QD(>Q?7M,DE8-35'"&M$D.#D R#I2Q"AEF@:;IH*/*OLT33M0BVR\N9SK>
M8>/%9=/8,IV)PAHWL$8004CB8N""@&!$*<HB-B'Q!(W1P^*L48AA06*HM775
M@:@ 5*,T*HD8G"+(2*R2OR>9I]98%]76-A-UYZ'00J&%FVEAD0WO@#%&N!4V
M[T'IK%",0^"&4\N%3-/P9EZ8V^>N$,1/$T1M>T@9'(W2*Q1Y[H@0F$<V4(6T
M5,%P'Z(@<FM;XGJ#]9LVHBL@;0I(%]D^01JE(7AEL0?GE++>& IY,T)J",?%
MXE\O;FL)ZC3"R< 7."GVA%:()B!#\F;KF%H?B)%4V*UM@9\0J+=L+[J]T,9R
M:,,9BKG37FH,UGD%'J)2/@%=,:I,H8WUTD:]A$HZF=A!H2 -06 P1=9[CHC7
M"K1@C@FWM0U/""N!@L(:J_((J)61LZA=E *"9-;C(*D+45G)-(X_X1$4_E@F
M?QS5UL6Q8(P,$FG"' (>"-+<,42"36Y$&L*@R-8V>\+X[7>N;C*&;TJ2/C)P
M+X!M!\*")X%CZX %4#HZS"EV2E,#^#O>?H'T?4"ZOBXJAJ3[J4.4,YP@30-2
MUEED(X\48R4DB\F38$\(KF.ZD3;!O8"V& OWPR<\>1/>:9&\6@%,&8V9P0I[
M$85QEI&255@Y91S/4X8U:1P<9DC&:! $S)&A@2//A <2(O,Y:$A@0_BBP;10
M[(_%^\ (032UE'$.1$:C/5 B,2CB%2$E)+%F,JFM;B0Z*LFC1DIBCR OR3;.
M9#+Q3&N:S,E,)LG^H'Q#LI2-MC^J!62_C(T]#4M?P:S:/RS^I5E\K6^+>*_T
M/3PSP^->?R8B_BTEO;\8C7OQ,KU)]?AS_)V>_]2<C\+3V8=GL_5SO7[U"-5)
MS^IWF!-7=</)S\\^]OSXY*G6;2U9IJ'IPKOIC2>_DG;%4'.38/(;I6W&;OX9
MM\F-OWWOLKPMF%KZ566;4?JHGU6V->-+OZIN2[F*9Q5T%7)=A01D&]3M4+"B
M_@QKJ=3XUS__H9B 9ZUT\=.DK&KQK\5>\)X,,E'C\.M-LJK(XW_L\)=M9\Y[
M8W/ZH-YN)SUH-C#2:^57/#<]CWK]!_NZA[FDYV)X6;W@MPU"'L3[O0IY+Z_<
M(*7O6\,PW<TKF&$_-T1^4*]:]3BJQG':Z'ABJZ87GWR9^\5,VR'G<4;5M[G#
MBI_.]*J/TL.22=4D9P+>P=GY,)R$_JCW]X2]>OWT7;C%Z]ZV8.HN[;[G1;<6
MRAN/ASU[45G)-]KG37C0\6 R?T/EGS?Z44\&I\DUR1W)&_V8DRO-.;77]U?:
M1/A_,[,SYF<SJ#_HHRDM],?#Y#:F]YF2PCCDEEFWH<&[\$+#!'0X2 ;-M:"Z
M?<G9L@O*;FJI=D]59;^9_H497K8FY61DZ7&F:QJE7?=,=VZ49F[?*.VQ1HI+
ME=L=(L6?.H<.NK\>D,Y?;WMOS][@SJ]_T*.S(SCX]0"G:T'G\( ?[/YVVGT]
M'RG>2\]X#$>?WY"W9[^=O3W\ [_=3==X?_SQZ/,?_.CPF!Q\_O#QX.P-_^_G
M685;^O?S$3[8/?KX4&O<UI9K?G1X+_5IZX9T;P[2#[(ZK0"Z5)8]/FA?SD%[
M975E!5ZE)JP@;F_<>3Z'N(=:$58 7ZJY"N 3X.<=X@=:RU7P7NJP"O*_0?Z\
MW[S"*JSFK7%^&+ L%50/!8SSGNZCJY\J"KK4/CT2L'?GG>P'6?E4=/[:D5ZJ
MEAI- _.N]Z.K65IY1=*]KR]:2TG =+?&JXM06Y,%J!FODQ%*A[3.T]4'_O8]
MK.^/+YNQ5\CCL42+O(N\B[SO:<,<[KDFWG'"J07IB+)2!VO29X*-P+K:,(?,
M-LPAMS''*L9_?I7P]RN^+S;80C;8?CW?20VX@+U'E 2!@$2+%'"'F#4>! =L
MP&]M2RT7W!>G0*]0W8;*>Y&E4T)%!\(++%GR-(V14D3AM 1/(G"_5*HKON@2
M>;"VB)+3'! ,R%* '']FR#IMTA1CE!D2E74^KXL&75_VT5!D-B8ZU"C(*ANI
MIMA*;T-2=T1[:X607C-/L/:B0+:ID)U/&5$=G<7!(NT\RUN18F28]L@D4Q.<
M\I0KG/.W5-?CR(T-XQ0M6X>LE($&@JTA 2! LDR3OA66<&Z(,QP7AV)]J*SE
M=H+U+K@0D8O,(["@D#51(9?T*'@6 N15%804+;K)D!2>TQBYP1X3\-PKICDA
M/D3+P4A5M&AC\3J?A+$X*4H;<!JG*!#XH)'.F1@?>32>2^Y!5:N@\*(A@.8F
M0S8JV]$)XRO9C=9"B8U-9*'U[G)>)%8D5B36M/C_RV%ZE?'O@]&H6 /+LP8.
MZND X3T/GB1K@%.*(&1K !Q&6D;JK:!!2;&U+9Y0RA:S!@J:"O]LKL1NU9UH
M4T2YWF!IH?(54?E\>)1IAKEQ!!E%# )& 1GN'0+L)96..T;=G:C\MJVZ'CEC
MK3? >15F!4D+(:D6TC312<*51]QH@D!'B@RK&JQXZH3G0K"PM7U-E5C15IL>
ME"S::D48FP]# O% ,>%(1Y:TE=42F:@<(CR0&"0AUD\<#[EH_GV5VJHQBZY7
M68#Q_$<+K2<?FKO:>I7"F?HEC:Q&>#39ZC+ 98#+ )<!_OE2X>6'KDM&>Z6F
MY!_U&'8 #""(1T1QCT"H@(Q7&''. 9AQS"K8VI9/,,6;45586*#0?!G@)=+\
M"I;M%YI?-<W/K]@/S'('02/*I41 *4>:6H.<)<1'3J(%?M.*_<("C5SBV!!Z
M6$'6J]##JNEA/OV5<RE:4X.P=P8!%QCIR#F*0!V)$J0P9&M;/^%D0^BA%"4T
MA!Y6D*TKE0@_SP"UM)V+Q 4,$C%., +I.5+4Y>9R6A-GK0X&;VV+^K+F1L*_
M6 <-@?\*LHS%.E@U-\RG&TW@++$W19AKBP!;C9+5)U#T03N:[ 020V4=J WI
M0=?<8HM[WMEN]2L2=GM_]WSH^U;>S[@UN!BW!C%O;X>_;(7;FFU:_3U:>1F&
MU>[/RZ67_<Z+.K_,GGCT,CUQ=YCD;8:7U<U'7Y]B2BFX4,HM*.7-^&#.W/B=
MO3H-__OJ\NU?_MQ2$ >[>^SH\(_/;__:PP?O_W/:V>V<'7T^3M?LG*0W(-W#
M3B]_UWG_(G9V=]Y9S%A4!)"D+" @E"-+G4:<6Y/,3$L<MEO;K'U-T#K7 [6J
M?8@;O%UA,Y8(/QYGJ<B[R+O(^V?DO<@>$"M('']1VJ^"&QSW>Z/@=T:[O=%D
M%^:\)_WAH/NQ'X:C;GR9N+\_+C[#,A5\+:_,F)3:4XH8TSHG'#32T@9$:21>
MA2"-B7FG&(SK.\4T;[^(AX?7PH]%W@T,6S5+4:T@MU44U9H5U7SJBQ/J+*8"
M21(8@N "4HI$)(%H;:06E,F%%55)/Q5&+8QZ/_F PJCK9=1:N@ 3+K0P&&E0
M&('+5;4@ I+)S6.,1288;!*C/J3^2"_-Y5E"0 ["^QEN6N-!*XT!RD =#D[3
M2<>M7L+L,(S&H](WJ51H%XD5B16)%8D5B95N \U9)7P;N[\SZ%^Q:O9G1LVW
M#D#L?0H>?0[#0;']%[+]C^K1% "C)9<.4>LC2O:_0MI%@;!,;I]TF@INKI07
M-:8WP</AMT6\\14LSOTI5!;T+82^>CMQ);B6RB,?\B;M7N1E,3B@R F5!#A(
MFF.9]37\-[G=11$^E A8P=R2,#<?[6*"&1PH1\I00( I0PH$0<QX2JQEG.&P
M$.;6V8-G\]:75NLQ6\-P?C%T)V846N?#P?'0G'UGW?'//!2T.;_%<ST['XQZ
M>92?#L.I&??^#L]RA!+1-L!Y78SIN?,5$I'8VR]*W$2B+.YJD5B3E'%R5X3S
MDA@E35+&.AO G =ID_I-G,OOT@1O2D3=>#@,9G0Q6SM>-.U"FM:-#^9]2R^E
M9(Q)I*M=YUATR%ICD(LA:F%C]#[YEDS5MS^_?_-V$X%3J*9([&%+[-$ZG:MH
M35[TW'+T7"V&:IE57&B-L(2\*9PTR'!BD[*C%N,8@W&PF)XKH=-"3LTEIU5T
MHB[DM!QRJH6['*:2,L,0I;F]N]4.*<$XDCQ:[Q,YX;SG36/(Z0?Q+M\;G9^:
MR_R<X3ITEB/O\\B'M-"NXAN4(WNY]'VRZ"Z]<'_T],85=?4WQ?D]OR_'!WKH
M#TEAG;=;71!][A(H'_^4D#:#V75Z?9^FTE,T_?+VT_NO=+U\S9]O#$K%]QJ#
MKAI:S[Z1C6IKGJ6P]RD,76\4\L+6T7C@/K0&YU7FJ^0!FF@>EL#)"M=:8<,P
M9X)I)@)8)4QT!GAD$*RP6-UE5<=^WV4[.NR&R;^')XDLCT]FJ.O&[@1MQ;Y>
MR+[>^_C[X?[XH+*Q#VAG=X<>[+SCVF)PT2,A%$7@B4-&4(T8PU(&D4SLO!79
MHGO"%S05_BD2*Q(K$GL4\;?UY@:*N; R<\'-FPMI)(*B$!%(DLP%S32R!DBR
M&2QARD@;:%S<7"@9@\)8C66L%20,"F.MC+$^S#.6M(X X(B"R0X..(>4!(:L
M3+Z-)Q$+%QK&6"7BU[B(W_YH=&'ZKHKXY:7LPYX;!S_I[#EJF;YO_9V^S;7L
MZ8#PJ3?Y7#MR8^.#O_S+/^P8X0(*(2HIJ" 8 A>)3H+RCIIHB)*.1PEP:X4P
MZE_>I JJA,Y_<CYGVD/A9<[FS&9A-[[Z,K,FJ>:=OO]S,@&[<6\Z_>:/*=ID
M,6TR247/V;]:1:&]0Q9'DKN-J*1(L$52*XA>*B,<W]J&$BV[G\4<2P@^C](;
MIT\%DYN"R5H(VX'A).@TQ QK!-$&9"D'%%2PR6(7GGI_'2;+.NTE*\:EU3<4
M$#8=A ?S(*1$!AR,1TR[7 QL/3+6I;\"B<FD]U9HG=PLJ#?A*JJQJ6VOBVK<
M,%3^45.-.&H3)$,J.28(5.!(8<N0X5HG9:DUE^YZ5!;EV/R(;)%8B6'?<];M
MWG5 :9VT)-U02^49IC4F$)!T6B( )I#1W""IJ2?<6(.)*,V3"A=NA"C7D<\K
M7+BI7%A+$@)7S&L02&,<$'#'D8XA(NI-\(%[$$PWD0M+P=$&'?FCS3AK$R56
M?Q;=AG,\."_)WI\K[S@[/QU<AC!)VK8&53O_D]YY55*UL2G<V^\_>9N)^  -
M@_7E=6<3KOJU.YMNU4]%NR^FW3]?D[1E$BO TB!./,FQZ8 4S]M*<T>P)#I(
MQ;>V^<_J]>OI>J46^^, YM)*C HPUPK,6N8V#9D@#DN$610(+#%(*6R09Q%S
M@EF.56UM$\$*-)L6ER@R+C(N,BXRWA@9/X[@YOH2/<546J:I5,O6:"5<!)6<
MEA@! <4:&<\"BLEY 0U!V;S5!1$+KJ]90Z:FT%^AOX>7VRGTMTSZJR5H//6"
M6")1!.%S@D8B0W*6QACG9?"2"]XT^BME7(V+[/]I3B\F79O"\.^>"Z/6P(Y-
M.M6WXG!P-IDK80KET8,N>"I+UXK$BL2*Q#9=8@M8AXP[(IBS'K0!Q;5Q @B1
M/C)FG-$K3/!5>J<;7T^U3G>J=%XDG3,S'(N9N*"9B'\_?#-O)D;!DS,<,7+:
MQ>0E$X>4T\E5EFG0J3'<6[&U3:$4:&XL1SU6UW9]D;U"7BLAKUJ(CX;@8U &
M.6<) D$%,I%B%)S$S$<9?=Z)86'R*HNQ"ZLUEM76%[ KK+825JM%[B).EK74
M$DD1) */ S+8&H2-54J&] =8TUBM1.X:%[D[-)]:(<;@QJ,<OQN?A%;XVH5]
M,E6N;<5>@G=%O1>)%8D5B3508AL1O$NJ9V^B>;KQ\"1\[=+Y.NN;TJKS3J8B
MN29Z)[T)03N,J!(B-U=SR%+/DZFH;6!8@!;95%QP-7!!7',XZK&ZN>L+WA7R
M6@UYU3NC&T^-HH# Y*T*J6)(80)(6&N)9=9PIA8GKQ*\*ZS66%9;7_"NL-IJ
M6*T6O>->@Y)4H62 R41M/G_""@E,! $.FEK<,%8K/1$VZ,@R6!MTY.K"XFO2
M==WQ21BVW(GI'X=1J]=OI;=%6<4-!Z>GN8%_+VF[W,1_4QOWAX?=M+\$W(K$
MBL2*Q(K$BL2*P_\PPIC/)];8?K\SZ#__:HKMSRRQG6%OE/Z?U^GL]O*F2SDH
M4'HC+B<$ -<$-@,SUC+/4*X_1B"=1E8'BC"3%C 8@W.3EN;U1GPX9+< 0J4,
M-!!L#0D  6S>@D,*2S@WQ!F^E%9)=T1H0>*"2#R>1Z(05G/J 'D/' %V!EG!
M\N:KQ%$1%?&8;FT3)9J2('VL>O(^ N,%A?>#PEI(G/&D]Q0)20M&BL!KC33#
M$@7*G3/:6N74'5"XSIBX'0Q]&*+).4]QFZ?;C :G/=_Z1YJF&-RSZ1$YZG3=
MSPN&_LYZWI^&ZX$\O>)-0/ZIQ:W_,:?5)IYFW$IH"F<V#"=CPLB35D;B_-A<
MQVG+E-5RN&^5(END32-G''SDBNKT.+EO*G!*)#;)3#31V'?[M]T?>>__+GKC
MRV^-^O[%&?*#,9J>69AL,2;CU_1%34:A21Z=1"R;]\!Y;JJA>+(GC-8L1$=5
M7F_UA%-9X[+O!,27,QUO\ON_1Z%+IK%E6D*%-6Y@#>(=EHQX%:T&'4/2K)Z:
M@ WEPD1Z!]8HQ+ @,=3ZLE(7?;9>43)6D\MO0G(T?'3(@Q=*62&"@JUMSFBA
MA4(+"]#"(OL74LR" $>$BPR4I89$AH&8*+&F5/F;>6%NV\)"$#]-$+7=/ITT
M)E#-D#$^)A\H*J1!$&0%]9Y)CV.."6JF;[VO8 %I4T"ZB,4/DIM '"&<@@Q1
M*^>=Q3(8YES2Y<7B7R]N:_N! @Y&:H61(@FR$&2"+-$$>6NY%9(3R=76MF!/
M,*DOZ2NZO=#&4F@#!.><<&FPQ1"QL!$GI1ZT4#08;URAC?721JTPRUH'WA#(
M6S10! Z;1""<(259L(IA0@C>VH8G@.N;J!36**RQ'(\@VN!# *F3 PH$>Q.T
MM4$")E&:R$7Q".Z/(HYJJP0T-B$D=D@?+ (F(DK68.()'DWT%'M,Z=:VXO5(
MXB9Z!#?E:AX9>A< KR8LN8;6!6,D1!$L)5:'G"R+6#%9D@-K!G1MV0\'P,:
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MJ&115RL"V7P<DE$G*=$1298]#T8",IAPQ,$[280*G$-65Z"6%8=\4(NN5UF
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MK=! *5?^W?YM=_B=T<K5EMW]BS/D!V,T/;-PSD*<L__QFD:@6,9D-S% 0?.
MLKV M,$."2.M3V2$A<EE>T]XGO!SM/.=E<K+F8XWF1P+I;BNIYV5&B$/'>7,
M!2FTP &B X*C!HNCLH(%&7VT<7&4%R O".1:JU%ON5:,.22Y] BP=DA;PI!1
M1#A*I;$X&P^T7NQ18/R08+R(%X$]MIHX+RD$8$$8"]9:)[6BGC$"-^/X1N>A
M /J.@*[M!RD#84+:B+P'A< [@A3&'DEE$M$*+#P16]L2BY]P!PJHEJX;;6!*
M,QV2RZ;!4ZTM9A82T&@P5&I;+.#UXJR6%A)"Q30C+3+)74%@F$^?@""BE!0Q
M!"V-V=H6XDFRDHON+#"?9HACTI.@K ,,X(C17 =I=-*FW#D#Q=%=,\QK%2X"
M2VZ#T\@Q+'//28TLD08EPX?D_2ZX5WIK&YX(7E]465#^2%'.I:7)M^564PDB
M:6]JN??"Q^3G&H=Q0?EZ47Y4\X(%)SPDH]E4=6P41/*"&20O.'O'8"SE,7G!
M3X"3@O*"\JDNY\)2'!*LA8$0HN&"<$V\!,Q!D:++UXSR6K*?$<FX5111YP4"
M+APR(=GM <N(DY,EJ73)-88G4A63O<!\%K5.-I[%F+*8;':BE5+:4$]P8-(G
M;7$'95Z0O""2CVOZ.@&98V-1$$;FNO.(E$YNN,?*T>1*"0"[M<U$L<D+C*<P
M%C:I:)Z(/D8"U#A%=0B21RR] J'OD'PJVGJ9&*\M:TF YM$1AXC4/&%<*J03
M#2-- *>Y&F4BWZ2M^1/"2XYYLJSFE[&QIV'60>M*\[(S,SSN]5'>QS;#^>9>
M9I-+O[\8C7OQ\B?;FRV\S*VZY-/>.#V$^[ZP:96R,O]N90*(@\&X/QB'S43:
MV_^>8'?V9]_\I2^Z[P\^=0Z/>$(-'/RUGY[W#]8]/#EYF[__G.ZWZS^\/7R3
M4'CRX;^?CRX//KYCE@BPD2$&6".0,7FNE*ELV )PL$%8E:EJ(J)7@SQF)^/Q
M^=-??OGX\6/[DQV>M@?#XU\HQNR78?KYE]FQ6]O[?7=ZX<.HZMW6.SLW5UJY
M[;]XM?^\%7M]<]HRQZ'O3<6:HUS(G8\Y,$-W,H%#XE722N2<3W.#T>0:B9MC
M[_ABF*9A:S!LN33C!F?I]/1?<WZ>)H"I"'TTB../>8?HBU'PK5Z_95JO9U^9
M4?[?I!MDZU^OC7G][Y89#O/JPEQXWC)]G^^T<S[LG=:?Q(S'PYZ]J.Z2CK*A
M'V(O/=MXT#I/$W3@1U=VG7B2;Y8DX=(ID^?H) E-+KK3IFW2SN=-7K _&ISV
MO!GG'2J2>/JNET0T&J<O\E.-LMJHCKP,9MA*@DO'7;M2C+0K5IL-QQ=*>R3@
MMH\<W)_S*BOO=*04HQR%1F D188&AQBQZ3\.I =Q5W"_#J&:Q*/)I-MM$YZF
M\9-6]8'-/D"[@E'UF3_N">D>_83\XYT5@=C@'')2)FTC/$;&!8M8,L]-)%)X
MIN^L;4:CBVKI;*+=81@E=G:90T>YH4A%R]G>#HDR9[U^9ZIH[V(X. ]IDOR:
M.#R=-6K9BZ1(PFC4&EW84?B_BZP-IOR<B3F?F*9KND=FY,<]J_UCG]6=XW<V
MK[*0WB-OC$#)9M)(@Q,H&.*L5I8PQ^XZJP]/>J-6EGLR&JY84Q=5$]Q6^-1+
MLR39/%=F^<5I[)V>MO+T3-._,OU'R;'U:>K/PZ)UGIOK/.X)'![Y!+Y,M)SF
MJ.=1"62U#PABP$A9< A+JP4Q,BJ )4[@:1N.; 8GGQOE,$LZZ33/XUY_'/(L
M3:;Y<&+-YUW:KK#MJ+(GC/N_B_1SU?;I<4_?^+BG[S[M'AY4S]_=/?[4>;]'
MW\4@)&5&(T\E1A""1PIS@F+P46NITJ]W-GJKR6S.!A?)(/B&C_\VIQ=FY@OF
M+Z:$['NCB9N8*+?R-].$[*6Y5/F ']*T>I(K?4PK^9@3R^6?_U!,P+/O!29?
MAF'5)6TN0.F],\9;JH4FX"76C"4Q4,:-\H&I67TQ)QC-/ER-5-)ZH/*O:J8%
MO_-W&"8?O;KIR_R@%!/])42)-S1$>?=)=_RQN[N'#PYW<.?]'Y>=]^[S.ZF]
M(2P(%*/-=<#)Y[+*)"Y52DF#B7'@MK8)M*]9YI/C!9/Y4H4)JN#'Y<2K(GA2
M]-7ZURBY6_TO,8/D3[7_?5OBFQ(&J#;1F?@&$^)\.@RG:<K^'9Y][/GQR2PB
M?N7$283P*?YZBK&CP6F:S+53MO^G"AU^/7.8[(T<ICPUYZ/P=/;AV:S/5*]?
M<5EUTK,I,T]OQ\]KH<J*@R<_3^^L=5M)G6\^+06<WGCZ7.WJN>;BI],S:3J3
MW_@S;I,;?_O>9:&MZ>VNNMRV6F<)]Z?AVW&;C_S>25W=-:]2J:77.YWNB_U6
MJW7W727N&D>O[O^B^^H@ 0>]6/G]KW__[[WW-&A_[7WSS=*-[_3.WQ2'7K\%
MQ@.;92^0O.:%K\ED7/T[OT&EKSC-C7LE-=I+ ,859B <]2HR[3RU[T#CK=E9
M)\.ODCL.R Z#^8!,3,;J4W/ZT5R.MG[YUMA,?/8ELR/;DJ87NHEFO[%$H4WY
M%>MT.!GPR9=7).Y"-I2_-4Y5N]HWY;Z96+7IA/D69F+5UOCFGU?'F5>WYUD2
M1-4=[?=*N3_O=EYW?]_?W3G<VVV]V._L=)[O[_S>>GV8OCC8ZQR^OFF6-Z$Y
MXTT(SI/Q%@)X?C7?<27+D5,\9G32BJ>#C]\V;+P1WS>-YMU>@*@5//\-/ND5
MO-4]T/M'M&YKR>Z":$[:$ZDLU[9*7C?A-Y]ZU\NFUZ3BP5_U>[_1I%=N=^;J
M]T>[=N*OIR'.U =OI8N?)J_GW\NPJA9>]D33PX!;S;*GG+>[L8_(]WJI7-_'
MI;'O^=U^*9LW;#FI_[!>!__<Z]S)N+O;*T&;SQLTU[W5-=&5''!&M U0U[W6
MC$*^0N*<]]>QS(]Z'4TL@7P#G,VM5F6)M&9ON$0;<*5D%*I8ZN#LZYJ:RMP9
M#UJA6BG9.AF<IO>L;*K)36_#7;>3#<Z2N6.SMP7$OYR5L*L<A75L _(UTOQR
MF%YB_/M@--JY,@4.!]UA$J$97DZ6S/[O9!YTXTLS3$;V7G^\.>MH#W=F06I\
M]/Z/R_3_RZ/W^ZR[^P8?T3W( >ONK_N71V=['X_H;[W.K_O\[>LOZVBA0_<_
M=3[[]YW/QQ\[O^[ASN')Z='[HX]O=_<^I7,N._3M:8?^]J%S.;^.]I@=O=]C
M'7J0[K6#CP[_(-U?_^QUWO_GP\'AB][1X3Y[>_:&'9W]P?[[>6]\T,MK:-._
MGX_PP>[1QW?&@33"$*05SEN4&X6L8!1Y3AB)G$<;[-:V>L+D0I5MRYG*2UE$
MNSB:E[R4_I'2B/"<QL@-]GE;QT0<3'-"?(B6@Y%*5#1"9C1""HUL$HU<SM$(
MDQ1DA+R]([.)1EA$1J9/GBN=FZ '5G6[>$(IVPP:*6QQOVRAK0<046B3-)*)
MPF 5I&  #I3&?)+=QC.VP(4M-H@M.J_GV ([YBWC#'DG$EMX%9$V$! G&@<6
MB!(X=]6F3ZA>J-#VL=#%S[E!99.NM;G>=TQA+"'HV;EI(=ZM@Y]W%TD#FZ+O
MMAEMWZG5\KJ" P]SI] ?:^LT<:_,V_W9M"U*>"$E?%#W_+U)QG@D CGK=#+9
MK4*&2(TLCD$2AF-T>=\B4C?8BP.^05"]1S>\0'5)4)WWKJF-@G,K$#A+$!##
MD0G&(T-Y&D[%B1=D:YO76[8VR6@M@+QW3[< <CF K#FP @C)ZPD1<PF+8+5%
MRA&-DOD3&&/>*1IR?YE& W*E7N1&[1Y<53[D]&.R6JX4= 0S[*=W&$UJE'K]
M*S5*SN4:D5S"/QBV+JI"IO')=/'^-*MY%L8G []  OQG<I6;R)GWO#'5/&GN
M^+P.J1K/%X/AFZLC/^'343?N?QWSG=F0YX/S@$_"AP?5*!=&78A1_ZA[(^ $
M-3X:)(T!!#)$9"%X%***R@<KF$XF#M2K:Q[T1GO- N$*7(D"PG6"<-[/P,%P
M%Z)((/01@0":=[LDB.MDTXBHC8YJ:YO4]WIY"%L9-PMK*_ 2"M;6B+6:"^&=
MQ)K*B#2&Y-,S)Y"2.B+*!;=$**)#=B&87AO8?F"A/B0'8#><#Q-VJ@KO)[D
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M<1T/H=6I;IP,JG@U& X'YQ@;:*-?=WCV+!H4!7ZZ3AA-2:H5)Q1 %9$X;-#
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MC%P*>,9FFL8 9(10DEDN$IZD,K)H,,#9: W&BAB,.2@*QB'*L$R>"1PWXC1
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M^ >0%ZSN->R<=SVW XF\-:\NPL/N]%\C5E"50'\"+/'GAW_[KM^+ UCNJ^Y
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MV#K"MH&-Z5_[FY2^Q$Z>^A%,IO-/8=X-[;?11?^>P!';9+-%8XO[$^="Z5C
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MZE<S_2H!0D2YAM<NDYPR&:O$T$@*+(\621;34!^O*P'&6IRC(Q_FKK(Q[\_
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M'*I:>O4\\1^=:G&M&@N;/P*5"8V"U45J/:F_7ZNM7\N@[ZU-;X!6QV\>SNJ
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M26KF2AF<>X#(9CR6FFI#+3R(BW,3">HDLYE+DF6IF2L?_"X4_Q:5"O%M*Q7
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MMON*4C2;!:ZCA0$/72MD!G,L%IN<VZ[)O=!R'E24\ID6[R\X=/H2$7^8_X>
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ME:E?'JJ0VG)D].'W5\O3X?'=:'H"SSF_@O\:@^&'K_W+=Y<#9 >]^Z"?K["
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M(!)OA\B[N:"DON%%,[M:51=VDWC 6;$BIP\]..P=.CCTM9&239+:U"!&P%C
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M0?]&9'[6'@=%*TXYEY6P05=0';*\/39?_^DME8ZL"[Y7H_2J-J@]/"[CZ#+
MOBPKB';586I0$?(9./3I#)U$8BK)KV#R1,$;U:W,.V"V4LD.+XUJ97>GLXL4
M?E7+N)#3NY)TH9A[4<QSDZ1E[AP]UHN,."]J) ;CQ10F:,S99#Y6Q8J5T<HD
M# Z20K0BA@JO#_,V*P@M&0U?A"AD-@6C4U,>)?0;4>-37_I:Z)Z),%,1955!
M(^%D8&0*"_.POX;,,Q3%?C)85GD8.>"[*C=G:A$[G (':B9@7GA)1CJEAB0)
M4A? @9Q@19B(-C0\MF:UJXH2%C>B!U5GMY'.V9@:ZZZ6Q#(*"--29ZR4BG@"
M-\8XRLHJM[V;4A>"=Z,H<),QR?+YN[K.)[,0P2RB*J&R:O""<JHJ0I 7>X;E
M.188XU]QTAHA,)G(^'9/XJ&OMM;H6&/]%K%?DK6\[%GX3+/_8\L!J4)^5Y!#
MYEKDT"9#JF%X.;X1<\?E)N>.Q0,OT/3 8QXWXM@QG<#9 N30QY(S[326Q-O/
M'!0<'!VKPC]M8!P;_;O0&-Q=W?:'</_+#W>CX7ER>G1R-[KLZP-C,.G?'9JK
M_!<?S-%P=#>X&YFGP\.O_;L/QN!H,!Y,3ZS^Y2"!\9HCX_-=_RB:_',WPJ#C
M%^:AK!J\Y^@N5O[I0<^W(Z?G@O'K1%K,?7T%%Z-K(<B#'W+-]<$R#CR=:7KH
M<D>/ S]"_HDZ<$C.<*="5?<DN*&-DM:L1(EQ=VK<B9EFV5K@Q;9O6Q8+HL#Q
MP8M8YQ)L?M]&02S3F>T;7+=L9L56Z#N<P7/-R-:,$#;Q[G$-@G;0#SI(*H#P
MS%VE\%)RR,"8* Q9Q4" 9ZGDHF@0:K7B5K?UB%U9H^<Z64MI*<M ,[D -/'B
M.TP2CUDV92%?4)1$$2+DQ.B?HWZ07DF(5D[Y+0LE/.4"2;B*S/@-"T,DJ^@2
M@PL2]M-S,@YV+7JJ6 <J>;9P53%[=R/!;<I<S;LJ'Z[<8KJ';,T@2;M 2%A"
MM"ZJOT#!WEX,EBW &L\$EJAS.&.392Y>>5;,C7RGFR1JDOH?'9@V[CK))O:)
M7Y#@G<Q$>@NTDZ0)VUW3=Q62^.ZCQ"3J=N?5QZJX8&H;$U*Y^.5;Q97V6L8I
ME&S58>=5_DY%JYF7?)8W$H.F2#CD$BH!>5-EOL0T,7&'$L]; 6M1!!GPUP@\
M)&FO+\C=EW(4"!E:(>\L4LU3^!X54H%(E)J)S151Z#OID=^@VSUEEVDF83**
ME#+OWC<#U7=$]39>YKC78!P5KM$N]4%HK BA.?@$]D@FG#'X ;\66"VLW@8)
MAOTG?8[:Y.VJ6+X3@2XI;!3IIJV)CO!2R=)_8!WX(NL6\U>L!0A+@C S =JH
M=P8AR>$T=4)XQ Q2K&R"7F#G53(5\0ODX4',(ZW,Z^;,(R</FX=CH4VDRMO5
M"6^$R,+Z1@>E+#IDI%E>1+XJ!+52T OI?[B\JT6H/ '!(Y5KA7K.TPF%EZA]
MR\5,X!;+WU8OIV$C2 0A. ?8AX1T$[[:_1NT(CHM(T1<BMI6W2(D4GEPA:-V
M.DUR%4TKS1AIK@ARVAD7;4^>/-/X[6;+)\E$A>\&<\>S[8D1K#,!=W6[U2.P
M6=TW0X$L0G3BP,F2= %_7EY+:XVXPC*J\!8HQ4PQ;M/MT,Q")!QIS5)A(CP*
M?E*2K>*&DM:5VFT'G4^X6U:>0-36S4?\%Q0LS"/N-APC66#U!DL+T2.J8E+L
MZI*=S"3F>C%AH  *[42:28KG9P3'1YU/\P*53<Q:8A'4*K['CT0\'R>5?EPB
MP5^IA$\?CB!AP,*/Q%\2.(3$A JP^*J&I/"_,J$/.A]Y4(P$;C^3L>1VZU@H
M-7'_*LTVRS*D;!'V-AT'2F8*00*AP6UY.T[!G :3.A./1+N>"A"0+8;8MP,6
M7E4M_@*T3AY@C0FO5>V*T944:VN&>= A6IW"ER!683;)*8RN)@)3;C"#T^NY
M<B=PPJ2'4G%#&@Y*)N:4RF)*@F@6I%0JTX!!RE-0H!<+D#\9I_@F$RJ&*9V0
M!A:UW'_D&&=8T4D_WM4]!&HO5XI/[H\R8<$P"SI!SJ+?'_AZQD]KF'8&C\#'
M/.#0O?>()6_1>?.LIVE]RKP#BV:BG@YNWZU8852P23:!\<*+FO ;9'M"/RL!
M$SI;%E81^ET1RR(I[M)OJ?)\2@V4E(<2V6PK3]JX_5?]H#=[B7IFB9)JL]3X
M;(Y+K C+I%"@U,T;@B;=KFPA= 1GH$&EO*TH4;+;F319:B;^7@*>6P)63$IQ
MF-]K#G4[$Q2)R;+5PNINUDAELEIY^34])?E<E0U-890I+Z*/>[';?;&KA9X;
MM.%-B6DIJVJ%PE2%6@8M,4Y(M4 (T,'?@LP29@.?*QR BKE\@M$&N(7@X268
MB;J3&BD%I25-<!%S$6 D+FQ#\;MK2JC*0"693[633X 8R%LKW 49B&"E\R<,
M5-GZ"-VW"AXER9:BENR5"JCIAG#F5LN(RU^_KL&,*H9M+)HIJ=58OWT;=7 K
M:WE0%(FB83]G5X3?0.Y)D6PN.K.4$+H;/LD%_DJRN!/'Y#PO?+,BG(,V-U)5
MSN"*PMFKOA\Y!D46 .W_!=(Z4R42F"/D/U1RF*6HY%WIU\RSI:+L%H3)%'-)
M0OD6U9I7%6V2]-;86NH&FTF/>8]>%:8?(Y:4<SGH]+$ MBY.6&F[R(LJ1706
M44 Q7@Y_[=%[85JE&*)P5$(LM)H+.1;^I:#[1,=GGJ5++'=;'PUD(F!0B1>(
MV'VB%KI*81K7(KZE--,70F?+J :A;5J&G"<4U%70*R'JU%5LELK6 ;OK-E7M
M(>D^-9S/-;[GTR=-=SE=^LB1_834\KT+?V\00*B%[5O.4]$&8I7*84MBR#6]
M0Z?4LMDC2IB%>$[=)/Q6:#UJ*"_,U%QPVX-!B[JT%L.:HN[%6F#!C,$Z[(8E
M$Y6:+NV+0F\&?))P=*Y)Y4F:ED9.4R)':S:HW/-2%RBL=K?2"44$4PAC(0]"
MF( (S\#T&C_%<Z\H>=^'7)['3I7=95#"KL%2D%4!<3+A+<Z&/-7V/L4S^137
MUZ !:2\W_,863[,>V6K)J5X4?B]&KZIA^%H8O>RKH[R'-]^&E_V)5;TMI7ZB
M6NWGEZ9]<[TO%N9:3U[N2U7$SC/7^SY'P:7U,TI,]_7*+[=>>5^]^VM6[]($
M[LMWGZ1\=R/VOEF^JUDNUB;HS',L/70#,]!-U[$MT];TR/#6=M?Y#NS]WFA]
M.J-UG.38Z@T!W>2+5HD(\P3&P;(J=C6I8P )W#,7+;+1#(6_(YY#?*#2>63F
MMB6+]T[*SU_O9L2<VD)1R/PB2V\Q)2Z($E5(-6=3@K@J65!1T_W:_?RUDS"&
M,C,ALQ48LVE/2DS360*_K"'\1/2'NF;-D-V/%E_$H4 68 GH<]&T490[X)?[
M]7Z>@$(^YI.X,TEB7G:/+S<A+ME^87[ZPHB<6\DIJV@A9)Y.U-DCED%!I2,^
MA?_L:F[I$#L%8U&43+K6*4DJ,,CJB;^24U]7/668#YV7K:VY- XZ(J,A4=K;
M7WC9ON.&VUIVT#Z[SY8D(GKJ2&2!BDSV9%* ]"E/$\,G>;6@ [;)-6GQ6O4<
MDC)7$N.4>D?;6U5=-E3^KNJ0$RR'2V;4)%14F>:=5\EK20V=+MF$:*L51:ZH
MK /AX+/"7)E@M<-"5)Z"_3I?JF(#0D(D623 ]^!7P)W5K?]F7V'+W_!*&6N)
MRD?6HT@5\<$->G@#XCU?8#YLD6$HG;09W+ 8;%F)(88J,&HE+HRT8EE.(?5>
MY:X$"H-!)2%?'?RN+O#'U344$U,N8@U_VX BE"6> F<4B6EZ,!A^5Z>MD$\B
M5?I;%D6#>(@J8BJ/6&*Z)Z_13 F;@]?KRXA4JM0W]4J3LOZPFC$J-D-%YLE9
MJ,MDY[NWD2R@;M2Y[8^89^&[L7:([\9:RW>S*?+8B%2:863KMALZAAE8863Z
MEJEI%G<LCYM&R,T?QG>#M-B;F&[>IOG\-,9&EUO4)&MP]$$18">G9W -M:S[
MK-/]WY]HH\L_IN='?7OP?F3UIR=V_^C".F\VN8?/1\/P;F",K,'P\RVUT;O\
MF/3?GU_U[ZZT\\N+Y>CRZO84QOK/7=_ %I9A;#)F6#TMXF;/LC2_YWNNV8M]
M/_ ]!LNP2N7BV;:G<U^/O<BQ8/X#SS9\TS4MW=5@M;V5)O>B 8C"E/WHUL6M
M KQ1()MMKIPX#"S7T^/ M@P01MOW=1:YW(W]V+?6AMHWSLU6Z-_&BCROA4\%
MJCERAV0)+#'VMI=0FV06+?"X!3-4-I&1;#2(?>V6I"/486K% &K4#M2C=G"[
M7""B[WV(.OOS:B>;@E@0ZQ(YG+-A4@45D[G<):)%44*!-('7HD*>3;&!PEWQ
M\SR-Y[=P6G?1%,M3C"2*L74K=H.J^<82'7H#!5^39D&-Z>\A31\?V^V1.F;O
MRAEFKSO#-F[II@K0F>-$;F2;<,X%V(0O-$QLRN=SE[F>L16<;3EG63@^G$5'
M DB(8G8LY&6;SK90\;@9@Z,+O,;L7_X][;__K)V^'UR>#L\O3X]&=X-AWX+/
M[OIG'Z>#9G.'RY%V>H3C"Y>#L]'M^?"#-3+@/)SVK<%E'QM(P&?]K^?O1]H_
M=Q]NX6P+3=-S;9/WXM#G/<LWPI[/3*?GQKH7,-]W'%]?Z?]H!HX>>F[LZ([%
M./Q.CVQN1 &WN!D%*V>;6@$9>2S6X$FXW#9*8&/PL6-PWPSA?PZSG-@-X,2+
M0]NS='B3B*_M>[_QI7?(QRNCG7\<6!6JJ'4+1:$@%DHF5ZK""3!K@QVXPG0:
M2")?22M%5]<?81:/$%Y-,IN#XYT0K;-L-_3@NZL2 LFW H=/<DWN-R(=2^J3
M"F>@Y)1N?S5QRNVHLT[<5O*\%H0:]<92]>@5FTP2T<(/W.&9\H&+IBRKP/TM
M\H;7BN:6D+W\6 ?9UG;(N'#6&1<;56_3AS)L,S)U+=8\V_)#/^":XUB6;OB^
M%<6:_JP.,BFRHH/4"54L@8DA[8JJTRPN&<+ _IBDX=5SVQG#P\+..(7?G0^C
M<?_L^"M\K_7?C\S3(_"A+S]>CBY/C-%PD(SN+HQ^TX>^!/_Z[N_)P(#KAN]@
M+!]NSR]#L$O.IX/W@Z1_>3[N&W^BO;+\!_EH;[^PP..Z;K">!LO8LXQ8ZWDL
M8#W7"SS3-YD>LY7U#RR->]S5;<<VT1_UHHCYIAFSP (YLE?L#'&VE VE9!F9
M0!$H+?$4;:<WR66S[3284CHW L,T=/B9Y?. !9')(RT$(T)SUID<&]]_]U*3
M#EH;[>OT\X_@'Q2R7?=BSU="5G'/\S$UA(A%Q8ZJ6I7/3/(:_9&T'M89#_4V
M$*IV5T 1ZL&%@\[)7%0\%V-1<6U)VC8OLC.JO+L:FA!)%^1#4FD&-8AQ<HUT
MKSWD1$I%47,MIP-;7T0[9#Y37D]F9CW OJLFX! [1I8Y\N8LPRCO)!_)8E;\
M-4[!4+R8@5I$:-8%[US E,OIHBY\6!I8RC$QYHHVOJ]RSFO&O0?&_6L9B2DN
M$+=+"09VG>8P*)E-OF#*U"0NTLKW*S<VM(/7.P[$<$H@1CDW38/U%])W6V*+
M-Q/[]RB^=I=HK1)4B$725/=JO!_K#I@[Y ZXZ]R!C691PXS2=-<U'"]V+69:
ML6FSR S @?!,SXM\F_$MB#6>%'&-0PIK@$/P/DTCY%C9HDCCL%]X *-+>(9Q
M?CD87BW[ER?:X&ST]?3],48.EZ?@#0SN!N/SL]%M?Z5CQ'DRN/OS\GP*SQF>
MP+4?]//+8VLT_&,R.#J!YX5FWW@W.;\\_/H/>!"#PR^&#2L5F%:/:W[4LW@<
M]%A@!SW#89H6FMR,PW"E883NLMBS8T<#T]K16*!Y6N0R+=+PTM6&$8?5U 'Q
MLDVO69(IPJZ5L-.3N ,;Y;+IU@11[(8QMQR362;WF>5% ;<C0S.YS;5X;3>)
M39.Q>P>DB^[ 82/?T[)*.VJ9\3(M5439" M3,]F*8ZJ9^"KH< 2JK$QVK89/
M&];3T8&%1MD%'%QEWW?%$B\RAXC?*>%JXMUK;- \"ZDO6"7WUXR]Q8N9Y \K
M27=R#D>IH))*$*^=Q,GN@J&:HEFF(F6?![$>)<<PC+(R7VE60J3@KX(WH=N@
M\6:BI9D0E'4,.$6A4\$"5\@//5=='BR+1=EQV]E%V_EDD_K>2:EJN&RJRV;E
MK)).V"LA7K"!9W+'PGNGF$E7?1,R+OIJ$CCQ=4VLR >;M^F*LC[@0AHG74+]
M@C<H/U=R7M$YCY)QZ1"RV9+\ZXP\/-P_R&JV\I[[EN_[EN\[U8Q[3Z&P-10*
MO["4O>L9]N-)(QX31G"*,,*>:F)'J2;VC>*_A6EB^Z-FWKJHV<;H02/:X')F
M.['+@\BR+<?V M=GW-8CSC57TUWK69/H[\ 0_!M93C]RR1>(9N%I_)9> 7LA
MO:UV9OFKY&7<XOSZ2$77S/.SS]; ^(R?W>+]^\9@@GCU@7%^.;J#WYQ]_@K/
M7Z[V8XTFY\,+\WP(O[T\1(SZW<CXC'AU\WPZ@&>^@^^/S<'1GY-_[BZLP>T7
M0[/]@#.]YUBFT[-"E_<\D_D]C3F!X8?P@;L24(T]W0]LD\>FZUIZX# GC/30
MTEC@VSPT5_+KN%JRS79672]%%"=6K-Y,YTDB;!MEN-E'50]<6W=T'WYK.9Q[
MH<XU2_-"0V.&YQCK(FP;)V2'G,RWE-C+5=P@+M?NGM62E."L4@K))F +1,M.
MR+(L*2EZ@S2]4MY@@=T3Q6'4XZPL>%2M:Q)J5C;C85$6M@;H)QMJ)++A8;._
MC")G7;9U'2PK64W5V.8ZS>3C1>8'1X=^IVP:57*DYO4+JH&L#4&9K2Q1_K;=
M^J,3=X]\B5T-'-Z;E0^_:6N*1"39OJU;*4(&HWG1DR*<L#RGX*O8-C'LKEE(
M45PB-*>"\.+!\W&6+B[&S2VRH[/_+B'"F"Y2$]?0+SR.)5Q%5/#>@F^!\2[X
M0+%&%*'= AN!2J S36]4GQ[J?$#<JC21.%>E2LHQ%)N!1E-09L$I'2X[M5@>
M+\*T6%)3_$1U^D 51 EU4J@_.)GL[U RV5]G%F\\\E>2<*&N1RRR'$NW+,_T
M??C ,.T0YB8(GKGX\F,UJHMU:)A(_B0(KTXPY+]M)N^5,GF_]N$>I^]/OF)Y
MYNALI)T.QU>GP\.O@_?'M_TA/!.>@\\<K4!*X?OIB36Z/+9'PVA\?OG!/GW_
MP>X?'6LCO'YX<7=ZUC? ;$[^N3O^.C@Z_.)'!O/B(.CYH0,VKQ^XO<!U@AX/
MW-AU_=@/]6@%1. S.["=P-3 E(PUW>=@XOEN'(6!$S'-:*E=*9="% L(-AE)
M/T89F"<Q<C=*9-.Q"\*(.1XS=8];S+6#('#=V C]2(MM)PK6&;D;9V"'%'WK
MZF25M"MH_T66M5N?U$>9>N86'5&H@B+-+MBLDO1KY$8KI =(0[>X1F5=ID*E
M62G&HN"*&)7BH20AC!8SM%B75/U(W>JG.%II@#?8-XB[@[,,&Y]00^AB6!42
M1,';/9TF\TJM9]L;;WK;B(>"2$FU&*C8+=1&>B*QFK623L&EB#.?4%4I0:5R
MV!E@A*1H=M9R3L5G\ [4NSJBW^8R9U3B#\7Q6B($X1KL4U0\ *>Y'/".FBK8
MRSZ*)$-7 QA0F"X/$N>B&VLRO9Z0K2),/Q0D95DT!  V#ZSF!?9GG\$9%(H;
M'X&A.0UX)OPH.,7\SBOB^L?.$NDB%P[1  VBZJ_LUZH5XIS/(NIRHTJ50:@+
M?U+VA ?+Z&*2!L0>6!G0,J>,-J7A:$KB12;Z.XE]IKA >/F64K7-.G#2ZN5^
M_?_RSHS?@OA<H+-1O&J5BB<$SW:.+7]$F\=)"A./\2;4XIU_E_UFA16VPKM#
MB7LU;S"$=SS(%M0]DF;$ZN*(--C?ZC''"RQ\!C$#L8\(QE'M&:X\WQ).N*(+
MT-T66N0:MMR4A7Q!<5^XTP5(14*;_]7A?TZ:P-DG-ADI@K(C)J.AK3,9-QZ@
M33 :"SU'UT/;M0PKB%Q/X[X116:H6:X?<NWYRY'>8\H?3,6_2(?B'T"Q7- K
M;V^\]/)$<7K ?4+]=#@8#Z;OKOIG6/=\_/7T?1^,O_[MX/+XZ^AL<-4WP A<
M-CD]1G>#N\]VWS@V1F<?OE+=\_#8&MT=Z_V[0Z,_?#>&Y]V-[LXO_[F[,OJW
M7RQ=@X4.62_68MZSP.#J!8S!W)N1K9N69CI\!8W(8\=W-=<,#$NS'!,6/8"U
MCQPS\D-F^&%[/5(36B^/N6)EGL1XW"B;C5=Q7$.+3-^P S0"P]#3(S-P+(L[
M-NS].%IG/&Z<@ATZ>K><7'"SW&Q161%B>L(:[T>]OZ@(%"]FU(U1-1#"YJ6B
MU:(H\/G4Z"Z5S.$(#WF>PZ$JH/AD:F\.S.+GE!?&JV!H&;:=JJ#GPJ)141D5
M*R[&KGRB^>*^O]2/%*%V)MNV0J1FJ=!F"IDVL"!]JB!P<+^++%U<YY4/Q?8J
M,HRO.V,^$:T_D0*(LAKXXS)G4:&VFX)9)P.)M13$"H#O_['WYDUM*]O:^%=Q
MY?[N?:$*<32TIIUZ4T48<MGO-B2![!SXA^I)6&!;/I(= I_^MU9W:_* @9"
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MT*LC.6R<D,J*!W/(@ 9I#UK?K?*$7A$P5&=>7?<KZ8^IX;6+4M.!\5OM6Y.
M@T^QHF0R+AVQ!Z[)%+:H@OXT]]';M4<-Q!,V7J*QG:/H\V(F:S<?M&<F8X=
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MNU;PH0$J78K4-P02L,65IPXW4273M2>LZD*,.URV2:6ZU$X5].%6W$B'=2]
MJ5JHH@_%5]HLF9]@"84* ,S_PK"JM])_5-]=U=VZ,R7A;4:N^8IVHQ6HNS]V
M@F2Q.N!1YKDS$#@]<:;6YK,T-65Z?QII-:TOK<<W9%P)[:8IOWEU2!);+UT/
MHQ+J^E32=,I*QS80A^M(X^(@XI:*&^:I2L13@;)JB//* &%=D-!"J*,:[\%D
MXTNRX%H5FF.Q#+BH@@/=.U'4M;%Y6RQFBX]?48&49G)4[ "RAYOC6UGL]<*"
M4&GZ=E<+EMXB[;>IL,0VPK(L'2>Y#PL#YTU95U)I;KUM?SZ\<TA6* U/%J7A
ME]KQ4W8_=YGG!Y1R$H$1'X21D&X8D222,7-B.WD%:?B3'HB,BE!_U(6;IPWR
MS]>4D_]4YN3OSJ]Z?;C7X/A#%Y[!;?BO>W;5[YU=_7UU_N'S]='IT?7QZ5'_
M:)IK^.H(OO/E[OCK&3F[^W0']X3_GJ?'7P_2HZ]'U^<?/CE=]Y/?=;]X_T9Z
MGU-^X<#V *=.6([M$XOP2%@Q0=KA*$P( Q\,UFAZU2-?ALP7 77]@"0!7$8E
MK'H0P5: ;P33.7FU!);.$ICJV6=)Q2^5ONE4/.Q9PCFC0<2(*YTHC /?"X1M
M)Z$3!PN9A9>^[PH93W/68D&QG#J)*S@L5,B&^4PE:O"@V"HMXJI5HE3#O*K!
M*N\-WD(R&7+=)PRNLCXH2]_!7*7=5;B75*@%=(SU]8.27$V58ZO,I/)(.>+2
M&!XV1/:ZEL,6#L>*LV@0I$HZ&6?\NF-\ 67)KJC-WF@@!:M-E]-UAI,!D\I_
M07[<\:VE?5YL_IX54F/'%S,SLHGG?6%ZE##U6:40M976\)-5_Y*Z#_8N#4!D
MM.VGP&;TOK^4FBU&?=Z2OY;LY:FBDM:,J55_E#0OM_+MB*WBF*K'T.UL:/7Q
M7JV,.4_!73(>=6%Z=LM>SE;M0TD@JS6#FK?&4LX8RZA]AK5FFD^FO553-F8C
ME83$%/$XOYTRN[5X:7$H;UF#6U5E).W\JNJ3GY$V[4A@IY=BT1*-1GL%$E2,
M<XKS::D*4=-I],TT0-YG#,G8!3,K\0/I)\2)*?.2P'9BQ^,V"^V W&,,%</;
M/X[5&/_6B?2/*D+1*GT'B>!_B$E^ VM;R.'O:.U<'5X$W/9$[',KYM2W2.QQ
M*PJCT(K!!@@2GWIA C9KDDUR"TM=IJV4JE#!A( :P;=5W?"G,W(_*_.M'CH3
MJ1*FLD,IO$:=T?L^Y=?6">]E"'6(-]4;?I )V5^,EU5!R*DZE3+Z-ZIZ#J6)
M":C M]G!*DB#YWYQS_TX*K*^[JZLBH-F;MZP@'30 "M4RET[M>@*Y"[!KLHR
M:##SC*(Q6L,9BW^SL'\>*QHY3*8IX\$F5:TFFU5JJVZZN-N=JHQ2'>:(' -O
MWDM'_P0S!JT'54#5MC>J@R@?8Y'=K3),)DQS9FBYP9.R-'! VHJ)KFVB=?3<
MG$5UWS#,R+4<8^J!2[ (\9N%-EG:Y'1%9S($Z=(=B'K?)MC'W.@JA$>,U 9H
MG.FS'?Z+_ &]L\P+C:H>^R;4(^Z6YOE9\^^9<K/F>%=>RKWMSF?0#; PXVI-
M_R'2K4WB?.[;J091T_N\-KE_LLG=VI!HQ\+^DK6:F#JZZZT_T_@VE<MJ&:N=
M><;J8EOG*6;WU-W@0?<9PP[G;I1$<4)Y2#B8PS[QDM!V66(GH>!TB3&LE*1R
M4G:S 4Z=.IIW\AR3"2A<[V_K2XP;LX,2J?Y9&]$+C>CO1Z?7%W; /"HEM9S$
MYA:ADE@T]D,K8(3:(0VC@$1OWHU["/Z"5O1,W\VJ[M196WF!@@3I;IV)_YED
M>$GS)*_A)_0WB[F&]59MCJ+:JZS:&CY)U$&T]A9[JYI4:Q.YM(Y-)*V\N!%%
M:VMC[0:40ZX5\5;M"M16?Q<WK[5+\WXV;?-O=W2F:<X#=?_J=-RN=/:GZ\?K
M:%'1MH'NF0+5>&N^F!8::+"$35>0*-7TMM;+V/4+GUB:.N9I8K:E]KFS2^$*
M99?\A4V>R^+OT[U_CB1$$L>VX?K8$U%,'9?!+#&;)K9GOX+LTC[-$:>C@,-"
MG2BO*:'$R]/!.3_%_O_+F^/3?GIVU;7/3P\=."'NCC[\G9Z?PM.N]LG1A_->
M=Z;)\^]^][3KPC/\XZ]_IMV[S_WNU1<X(> >7__LPQESVSV]M,\'^[?_ON-W
MW9N+0)!81%Q:CJ32(H[K6%0RVY()9V'@TBB)Z4PS;Q)C"@KS*ACZ\F"!8Q$[
M,8^BB+AD)I]43CIN<[TUGR6=M%3<IHL>?0G7<-]V$Y>$H1,)XO$($U!P/ K'
M7D@ANNQU5^A(! L*]IV<61"-A36'A4#?#=U)1&"_G*/6L\D80:(4T&!#M4_W
M^S2.1F7+8NF45=U=V[(5.,,,+EPCB-,^6Q!UU@RD)_NMSL&]%%M;Q/*WG0==
M=L][@S&9#K%933]W2R7=)E/D#;DZ=&_+8UGW[:VL':4"BO@*NG:GQ :I@'8Q
M;M&2 YQZK%"IL@5#T8'#&&VDDH-"YCPMR@;1&D2WQ)W3<(0UC'';ZIIGH:DB
MV6%9D3CK>W%:].J,Q]P4APY%ZI%-!1[1$RO?8 OLQDG1S(16Q9H*20>& **/
M7E4K9_+ZV[[F](*L>3!_;Q[,:,V#N6YH>T$>S$=X79%=>5WKIK 5;0I;LV<^
MJ2OL]4<9@H4UK,O<LNEJ1B:)Z[JA+6)&*+/C,& 1=]T(-(/+@O@51!E.Y"6&
MJ#^7+M#KB3+ YR;*,.H?[5V2XU-.SMPSN/^U?3[H?C\;'*3G>_U^]T/7/_]P
M]OWX=(?,Q* '7^SCO4O_Z*YW=:ZB%)\'9W<'Z=G7/Z^/OWZY.;OK7Y]?[?O=
MO4OOWW?=[T>GEQ=$1KX=V<SB84@L(@)B10&15NB',A0AZ-QX!B$I="4+61A1
M#Y9*DHC9#K%C']2]1^Q$LIFR53WK3?SG9XDS+!6XJ7%30B.X.@YB+R&1'U'?
M=F)?N,06OBMM9U&<8>G[KI#+>&^2+.IL'%>EJ6;5L(M'I:MG%]&$$MIXZ=C;
MA^!^<]QWU0@RI'WP#H=4YX\PB$!K2"7C$.[V4IET]K]+KIW58VS)1'":FUYF
MPL\=KJZI*VD1UK10P7)Z+7.=*VNF/:LDJGD178R3#5/8_-. WSI<4 U7OZ8!
MW\X& P4Q*; V-\L+#&<4O&^P?RE#P/)Z5-7#<JG<9F%J"YISW@9'3(<M+%O/
MWR[Y<^=LHY).MW2DF]")=9M/5>:WLJG=1M7K0GA<,]5OGN%8F0N1B_G0(Q5K
M.DZJ75)NDMGLYG RJ+*;KP0A]]>?,5]NCVXN8B<B/*2.E9"8PQ'CNA:-?,=B
M1/ HH)[C.<RD.6<Q<F>WTA^=CST*<\WE1)FBQ5;G;U!I2/6A0U98AH/'2N=_
M*^2F595[5&)3;ULI8M5QEBI*"!5@Z_<[E[)LY8-=#\HK1^6FZ%^T=A@,,(*&
M3(8C$UR;PPAA@(,3Q+?JX?W_Z)Q@#S+,Y6UG%Y75QMYDE'Y7S2<_I<'-W_:G
MK=?Y]#HSD3:TI"UW.PYG'2[,2^(=D!K("<G+,@-A<]Z1G.3PO,O;SO_0P>AM
MYW PF S5!UN=SSC-<*Y(3?EQ/.3F#RC?ZH_O^UDF\!+EEAI N \:<*_3E7 Z
MX8;H;.QF!K<,<=S5+SNZY1MD(KO4'=6&7P.>EO/>%FB_;[*?C31*'+)2YIFB
MH<T4*!F<D@I=2TAU M:']@(Y-<28I=2J1'K-UE"S%MYH.HSZ ;J.O5\^8M2^
M/>(/EA*KX_I5,QJ*=)?>FKJ?>*L#BMV&.94*CU"C; \S18(E=6"Z'$6CEF &
M5-[=WIRN\+OGK1L/J%[VI$V285HU:BP)4]^9U".MKBWQK\N-7G?/%[7IL,I*
MKM3@/T&[U8?#,PK\-W/359[S.>?D<T\_?E</_?\4<Y]GIOIY%\<42YI;K^H2
M':+[894+TM!O-3L.5O4@?L.JON*IP;*=QR%4FB&FUU$?989+92?!ZC$0&@U,
M+[<Z'V4VZDMSDNY.^LA[N]7Y"YE%MSK[XQZRQ.@_OB]9X7!^+W.%[7/8\&E/
M, &'#S0X%>I+I\A2A4=PVF#@JNYT8KJVMO17Y)AO;ZHUTGXN.(U8U*D\2SKN
M*)8_ZP:95E6#YE9%05 [@8U2<^/\J=JOTMU#2;_,<E41"G<L?YTZ7#4X!U:2
M@AO85QZMPMDOT6&1M,Q@%@T&Z=@XQ6WTE[2$5:FVVJK*6G.-%WKI9:I955LB
M2"J\^I[D4E48>(XR)5SUKZ-6#2T+$_)8Y+[/LS,9Y=<H!D-AF1E(U/_>_L+Y
MV-[Z@13;LXQ@:5CCYY8"1MX*E0*&BX+T2V.:TT'ZB$0T"!+NL(1PZ424!R2V
MI6O[+F<^?05!^D/LYA&[=(0)H-<4H>^6T9/T:.^HW_UZZ)Y__>0?(:G#Z:&#
M5>+G5[W!^8>#]&SP"7X_M,^FZP 'AW;7_?+][.J\?[YW[<(8G>[5WU@E/CC^
M<'Y]]O7/]'SO[[1[]3G]]]V^?W1W>.$%A/K$B:S0"1R+.(19L1VX5AAC$B:
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MD=[OMZENCT_/+D)/"H^YW/*E%U@DP5A!Q(0E_4""#6<S!]&27#)=#M!1DU:
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M[X=.9$G*$XM(S*6+P,4.KS@)B!=Y(GGSSGMP(3ZG(]0NL,4S?MW94'4\Q=A
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MQ%D"UY&())2#?9PP&3@AF$'<?99NPU\(I=?0/#BQ.P,P]+YW/H+K-Z!<@=N
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M2W$:%41>29!75LG7@&1/@FM43="/>4,7AD'X8ZVGI8B,ZMT.:B>#CF><BGG
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M#^8,GLEOCJZNO>/3[MWQWJ>+.!:N1Y/0(E[L@@/C1E8L? >\&,<61(9$^.#
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MS?-;1:RHFU;0:>_WM3.Z_/1L68Y4:<3Z/H]7;T)P2@5SXR!VB CMV/-<#_%
M:"2D%TWG):8-R796%A1OCKW+I[T\FUSV=(/>;._ [9$T2+CKEH"'*,2CO<.+
MA'J@"3FW.,6T!2.!%1.;63+V(COVP;P,,'V[Y;JSD%53"5PE3S/!%#R74[0
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M;B+Q":4"N%#&1TC2&9@"/J-KXV6: NPFJJ!>]3IARQ;D4=C6U>']2>, ?.X
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M11==%]0(P;*$)),'+YV5(<40&5<L9%^\*X$WC1#HV,E-'AXK8?!3UQ&QC.'
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MU<\K=%=)84:B:?@:S/&KN:)1['MUK=4DTO5!I!5=S3?'O1T_FBEQ4\IJ\7"
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MOC/%]]AI7Y$5;3_D%$HVBNABD4>A,!*X- 3B$F\TIQ8"R[5-8]RZX/<VQ:-
M .O(5XX?P^7C\U$TT7K3V-^/B]1H$A]H^@PWL=0%2,FH $_O,J520Y2?'*W+
MSNR.C=?Y^WEN,M1,X2E;+4TBX(@,I%RB@+]'CIXD,,Y57&FVMLEADQG=/LQH
M L7KY*V-J6*]'X:Y&:/8'9PU/_VRP39^7-5&B_KSD R:F9_N;(7 1NSKK3,
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MI<P%XZO1GK8B!J _90"25=(@<0&3GA)IDB5."_P?6EB4H?@0D<"%SR!PZ4Q
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MK6 V1.-(8$(3&0-J3L1,@A7"9E'@M_21H<33Q0HO'(9S*VO/'X8=W!X&M^E
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M9NT ]<2 :A54O2D&PCQ.:#04YUX"";",I+@8<LK%>L=0X++S4$\/J">HIG:
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MR!+[N:G_UX* ]Z71WL5-F_%5P(;6-[B0AQ^.A_TZ>@\&N3K+?^6'M:P#DQL
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M3L\I)"&S$,ZA)CXU4Q+J$C-FV]9<0H]MIES3MC7OE%7>=EDE6>X1?&0J\<+
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M]<UBRY_L[4@,^6#GL_Z /[_BW<UM ,^93.QA%P9[<RQA;Y<,.%[(AIUMR?X
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MNYB,(*VIN!ZYH+!$:!R5!*ZHG+8N&%=D4=/N_A*1GH&X66<3!N+F@KB+.03
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MWNFZY]TT4W!_:O9#E>(&5"GNE!&^X1Z#34[V'A9X;188EF0]&J)! *LX)ZU
M&U3)&U+1Y&!#PJQ[=Z39\_'JVM2#+-W!E,? [+8P.\ERU!HM>9]4SLY(U-0Q
M:S(K8<VR"9*KGDK'+.B1JYRMVUW_0(,AJ+%-E$XG&GCCJT90.CE20)85IIR4
M:[$95VS@+@(]0Z\ZDAMS:6D8 )\1P"?)"R991TQ5V:";@E!TU[5%)?;<1#'I
M6 .)&XY7EX&;9=9B0_,BYZ7883^E^^&^3MT-V4%T.C9@ L^5:[+,P19()!C
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M03*35HV;]>\#_"N"?Y(Q"9PI4 RJG\U7T)>6DG6*M"R\11MLZ5I&?GIR='O
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M?$\/16SY3,1R^_O[9AH1UGJMZM]_77;((1<LU)+2+?5##DVK/B5/^>J:"<5
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M'W65$ 12=.R2<&/8(SL--0;J[RGJF5,B34+;N^2",'DR0N(U-$J UN,GHWX
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M>Z^S"^N:)S6RC^N?"-4S60T#U*BA:_V8:CE4T[I23O5U,Q6! ;W5H'<Q$DY
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MQ?.T*WE:5&@Z%"R=;' D!81)?'8 I86GB-.6[W:IXKA'?E41]9'@O+&B@J7
MN133B!IX, S8BK7)4(!"'VMJ'L(!,\'EQ5@Z]@R!RZ!R<$%!SJ5+<+&*9$H*
M7K,W7=%CSYA1<YBA@XP:2[08HL< FH($;:FZ"M6WUAC''+W9 G$R8DB;#,E9
M5;V6P+M[24)(RF$)GB.&Y 2(L"<A^$P=Y+U*KU;T(>@H]-:+(^PY".>-*_U,
M-9< ;=0<;@,*)S6':IN.6(.2B+0W7.>@B+CUF4,F.L08,(Y3"!L%Q:@Y;!L4
M%[F;1S*.717&QDY D004.F@5M:<<$N:<_"IB&_<F+:JABZD6$RV#A-:9#''.
MQMIHR-801\EAKA"8B Z0\:1K$V]@A"9%J@J#]RH6DU+O%7'>=YJDPXKIBU%R
MN+;N0!1.FI+$Q@EL0VX)0ZFZS[.QAMHH.<P56Q/FXVS*OE:E2XP*-("B:IVJ
M7%+1#5))V+%E8<@2?!*Z_C\NKXX.1[GA<F'4DK-OV=L2&>3_Q-IEDR1ZE<#'
M1S.R*;.T*3]-RPWL(_F$I$PP6O4)L8I3GY )OFF&ZG-SBS(FKGBH<.0V;Z[<
MP+4?<JZ0G'-@/:&.B5L)VN:H2XWC#,,<H#>I*+B4M"VLJ&!/9%JM$@G^BO?H
M8ZWL74^AX-29CWK"UCT@,QK+"$[7"%ENN :.04N4C5"!UCNV:'C -<+P8E3M
MFG8E^JPJ6NI)&Z>2A:IJS=:U%L6R+AIYXJIS/T<]81.IT^QSCKD29FO !<)$
MQ9#+0#H ^C+J";<!A9-Z0O24:VE=HK*7U]$("F,)LL%,L<53L*VW:]M13]@8
M*$8]8=N@F) S78I-U2A#I2=\O%&]O*::S0F3J;I5/40+EHXU\LT&GQ<E2H@<
MV)7"QD1.VM1:1D%AMABXR))\(%UMD\@,A2I!L*@0@U%"CB3LKLGDA5CW7O1;
M2'K>2VR)4=(F. ,LV-+:DVF &6IHT39H9F,%A7;P6RWJ73T^&K!:%5:36H)G
M[:S-JKE^9I1B'RHFGU%IC9Q&E)7=%0"A! M_F5TU81K21=2VAH^%=*N6&=KB
MSZ68NR+:XE*T/3LZY9=?[+P^/CC,!Z_YY<XK/OZEGM8BWSHJ;_+I]401ECR$
M]=B?33Z+%2Q/3;GH1"9% /!@D\Z1F"%32'+OH^PP3_/SR[3LX'Q*R4%57=Q:
M ??12=6#0HI]BF&I">KN?K![:*>3(]YC8V,;=;F+7#'9L]PB;33U>BOQOTJA
MPZ?L/+N<<A^@YB"1[MAO$(W!FC8TK&E8@C5:@HOQO253* >M;.I-#6+=Q1(D
M4II3C6A];;;/-#5[!J:'E*]>"!EH7+\WMI"")A\<$EA;L7DP58>$ "1.>GCC
MN6+P(AFPU+1++2FL1;RQM4ZQK8+!7#T"9ZJMCW$R>P&GPH'WVANO0$ET?\--
MO<:]MD,<"()Q'F,!](TU)%]3#-BB:UJ/7-],[= DU^?Z.4J3LLJMCVAN30A!
M:D%9YYTMMJ6PL$-Z+_II+?9>VZ'[C']+KF0"PJY'%$$C&F_ ^QC$*D2C1X/S
M7/$_F:E"!"P66[5DDW"!$!2';"4.\=%%R& 6K1AZS\%TJ,J]P_\B1_KOIRS;
M5?XN!__<_P_Y\/ZM7_'Q3P>'ZO3H]1<=Y^=OJ'H6] MC'CCX$/P_OSDY/6AO
MS[YU<%CJX>D7ZOS?;; FL7C)+PY.Y2+RQQ^V7>0*^/.=[Q??J&6'^UB8G^K)
M@YUG+^H.+XK6[Q9%ZYW7BZKU24?KCF#XI/Z>5]WY)Q^_W4GU]-=:#W<^5E.G
M6@(S:EV:!:Z9:V1'0;Q2JJ4$-QI-KF-C?OC?%SJ_^I]#_I[>//WYOWYY\NKK
M=T^^?V1_>/C-+T\??BLVYX>#YS__STOY_MOG/__U%WE/]_S[K]_][[M'\IY?
M_HBNI.(**G+&*&!7%+L@'S*4C.($N!8Q$1<KXF<HY</RT24'7Z(O!7*!!@0Q
M@3/9IL .:LQFG%7>PI+G'T'^V#Y7GY)VLN1]\;EE%9F-ET7@9-WNOO7+U[P_
MN),'O]OG^V$FTS(S^>$SN-@R,GTF9][F"[_T"9S?[/Y_I.-_W_^SIWN55UKC
M8\,'_L]<]^(Q?9G_[YN#DX/N,4YVCMK.44?BSL'O^-SA!4!W/JN_Y9=O^K[8
M.3EJI[_R<?U\1S#9O]'M0/<];P[[LSX]VOFW_P==^/_9>]>F-I(N:_2O*(@S
MY[@CG#QYO[1/$$$;[*%/(WR1VR_^0N059.O"(PEC^/5G9Y4$0A(788$$5,^,
M!R2DJLK,M7/MS)UK\3=S5>^SJ#GF,E#"N1%YZY6J2#T3\"J;+4![,Y'=A%%<
M/-9%<&D< 0TY//KKI _-T.^_[;9=LU-,EOT7SGI_(SRQW>\?#W@*A'"5*Q<=
MR?H'$FD9X2?.8-Z@VDB5UC:XFLY8:S"L6_!#26!R\5VM.8CM?NTT]F+MY#CU
M8)C4\J0%?QC[@VX'>(P]:T/0@;]I#H[@ ]!7M<_'T!6V-3BKO86A67O_UY=;
MX]V*(C*WP^6F^#0273&(!_F=;@TN\K/IXQ4DYI;[\XX/3Q\MWG^%2^3+7)=I
M3#?/5%),RUQ#4RK?W)#I/'PG76TRO<Z+EMCN?(>!V7V@.Q/K@M[IUKIE-/^S
M%UM9,#*^R?,ZHNLFSZ23R93MQ_P-10JG^');=6VC]JI_,FBV6Q!3'?K>;<<_
M7M=L;="+=I !7Z0R<#LPGQ\>MN O.P#^T.P#Q8RU5Y!C]G-JTSJ)]YF 4L38
MI\BT(3Q9[V0N+*51,XJ3-]4$M+(3$-UK[!;WO[?UXVRW\?'\@ 21,-<!"1(%
MXE@9I),32$6E-.;"A^S0K:]UN1M.2;5.'&1*U&P?VV:O&(#PV_Q#RZD40H*+
M,XNYE\H%$WCVQI+.!>MF9U35T%J]H?6%'43FJ+.&(R5X1-R+;/Y.)1(Q8BMQ
M$#AD!40YO45X96A!7,O<I193BA[B6J_;+EA,L(.8!UE9"I=G='M\W.M"4*N]
M>A==[\3VSLHORB/ECS>9&%4S_://](/HCSIP"X=GM6.89#-Z($.:/S)@33&C
MA#@<*(0E[F0@WFL83%IJH6D5&9Y(9/"_#K!)AEB/45#99X!J@:S6!OG\HL(Q
M.N?7-@2]3O)G%!F><MI2I&]%FG);ED)JI[9?A+Q&#Z[:RG'OKV:WUOY4WZS-
M@-=3;96MBR?&KVM]8+0YNN?'MGG=I1=#K1>!O_;\49'CAO@SMKK'!=?P@.RR
M^7RWW8Z]G-[63OKQ=?&7_8'MY=46%XM9HESXA]_O,)6\*=X?2[6;G9_=UD_X
M<)%S?X:[:37[MLIC[MWKKZ%) ]Q>[J#A]LM8%@.=DI_IN%_T?LIAH-L[J[5/
M6H/F,>3Y[3,8 VU;]G/153&?2.SZKH<GA@S'>[AB;3=V/I[8D)I51]V[HYYJ
M6-D<W^B[8=6VV8<1YKN'G2(V#)?*FAV? Q%$$$!_'I!CRVCY4D54J-V_9VY_
MMFN7\F<3P<FGG7K.I<,]_O+QN%R?L!,W.UHM+]!<]E.QKUVLML/M0J2 T92/
M$=?@T]WCPN:CVX%?@:2=P.=.CYHP.\SL24!<_&GS7-&"AFBF''*&EXV_CF.G
M'VONK)9..@716+]QWR\1X774U!(JN:324$-(-ER(U(J@XPW[?OW.V9];S;YO
M=?-6WUX:[Z^]]'G8 )N=4/#+3\73_W6V4PS#SZ-1^ \T:R/OXS?@EOYJ=?V/
M%\<J=\7>UI<#"(LX).>0]]+D%72&-)8$>:.8M#"8E;)E'M'LG,2PF<EYR/OR
M7O.4,,O'$1V1-G%+?)#P'PYKM0A<_1CZ:M [@>"["30-AMA9OUD.P^O&++S=
M/^J>=D8#KBBT ,[1ZI[^>>V!ZR*4PGO#6RR_M>S*VV[S/B&XO*=1L4FW%V(O
M%YH4$^R?HQ_>A&8?N.39G\U.@=_B0V^FKS Q7147+-]^<]H,@Z,_C8%YC>7B
MK.')O.&%RW?)>E&W-5$!4[XGS+HT\MJW\3JY]KV;OA;2<R*N_^CS^=J;WJ/K
M]([?^IPD&D<K#J,]M*F3(,L2 J%P?]P_3%%DGGSN\)Q/Z''(\WH<_'N/<R/,
MBJEE88_$U\6M*Y'XI@PGKP9>G^&\LG],E)O<Y51W.8'E"^!,/V$N;C5#;?2$
M3RH^O>WVBVRW;UOQ?H>YA[%ICD9YAEH3VLM@$K.2.\JUB\:)(+A*UJ5(E;/W
M6"7./0/,//?+DU_%+2NVCX_J] O?/]^!:\#WOH?_W_AROO\]?*]_W3W;:WSY
M]>U[JUW_6C_:>SM1L=W>9M\:1]]WOW^$SQ[]V/_^D=0;]6:=[A+X/E%OO&OO
M?=TG^W2;_Y_S[>ESW"8%18P5R$O!$)<V(L.4183Y1 JO.JS'799_4SEOO@BQ
MR%,5+QJ%DE$:J==64L<%38;2P*.E23),1?(%"LD(A7<Z:E6A\#=0.'ENRIB$
M79 4,>VSUSEAR 9N498D-5X)3[7,2K)SHK "VS+ QEP*5$/<),QQF;B./L6D
ML;/P6O*J !L>@>U.YYHJL-T?;%-*E5PJ'@+Q"'L28,J3'FFF*%*!.16YP$QZ
M -NT"^0J@6UNTGWEY/%S6DCX=-T>Y' 5^;?(^S,/50_ SD?=L=D)6Y>=L5WV
M116\Y@I>.]-\G1*5"K45[J-#//MF:A:!N:?H8C:7L7+\^-2*"5V_&(G%!R#<
M%; 6"JQ)"AZSJ1;T%Z*.2L1%TL@(8I#6QG(OO!&9@E]7&EE)E*X\AZ[PLTC\
M3.N_)RV"%PDEDJ<C2PW*7E+(6^,P=X021]8VYG1@>#C6_.QI\>?8:A6%<\"*
M#V,G]FRK8L1+8<3#GGA?=@*$G\W0;G::_4&OV(^I(M!](M#N-#7VG!@BN$9<
M60L12%ID330H1"F8MTRY?([S"=B@/7.(/0 WKB#V,!";UO+GVF2%S^@Q1YQG
M?9_$ ^(A.$V,#4GRM0TSYSIUA:358<D5DAX$25-T&?I$.8PU$BH!DF*@R"HO
M$,,I&B5-M +HLI[6SJ[X\L/ KBCO'94P V^NN/(RN/)NL^\A ME.[)Z4)_KV
M1CU2A9[[A)Z/TSPY,N!;TB@4%$] EAU#5B@@RXQZF[QP5+JUC>O.EU<T^>G2
MY+N@ZUG[]3PBZJ9*/+!EC$6"L*(,<>A2Y*(*R&AAK3&$2):6Z-?S(B'V /RY
MFL 6#J4I[NP4%PJ"(]*:*<23-,AZRY#BG&&./8T^SCV!K19U?A;^6)4%UN.0
MYG&[USNH8E3A9X[P\V6:/VL+F3H#_NP#).P\"8XL$##D"&'2FJ2E"6L;IK*]
MJC#_<%2^POR#8GZ2O0?.;<I[2T)F=_,D@;A+(Q V(2@AG$O>9(.=Z:+1"O0O
M%/0/D%Q4H'](T$_E&4D0+I752!8;RHQSI(F1R !=,X9CXX/*H*^L;!9BA_5"
M[3!V.EF;/):"8EFNTP]&.EL[[S[MO*W9P]@)M@@-_:'&Q6XN9+O04B2U;JEP
MX;O]4IH% E%J'I;R75EV%AJCVX9/ET):K9'4RH54QDF_U&6QM<\7BB_]_-M0
M^^S59VL__U&SO1[$G%)WYU4_QEJ].XCE;6RNTW6R/BD ]Y\))8U9KXSU\;!M
MN%XG)O?QU-'EH0Y#&8K'/C@4P<"7'[&NWVV=#*8_L@3-#:W,?30W#(5/BH6K
M6/!U0^_VK8O=WFLW0VC%J_TV&63NA<S[3N@% C]OUO?>[=1JBY>,NC5D%]=_
MM_=IMT8Q>O?@UY_]_#<]]S!8S[QNOAA<^%[/?$4%XU)<X!F/LG? 'JZ34[@Z
MXXW_FQ^A8&Z0,@I%%+4FY#5.H3'CTM.@$P,.0MV!Q'QM]*FCWF73'4;D>M'^
M0#8-8N]/VSJU9_VU_UR=6"&@7; (M:ZR;MYU<?;*K,O7J1B;B7MECY<OCC6Y
MA]DB]JY.Q(4XV>/+'^EU6H:^N4.Q7C?X^K>7H]$S/SSU/6E*?:^Q_;G6V*LU
M_G>[]G:O_GGOGYVMS<;V5NW=3GVS_G9G\Y_:YP:\L+M=;WR^PC^'S3$QPY-A
M]\^Y7CX+*M=J;C%XV''22.])_*X!/IG4EYR-_*UU\6C2=3L76N_P\T1ZN-D)
M'WJYNF5P]J%E.P/X??N_)\W1&0AXR68AS]71K_LXS!F/FY"WB;WW^[^^-?[^
ML?M^%W*\+[_VMKRHT_K1M\8/OM?(U]O&NY\G].O:?S?K6S_@>]^UX/M/]\\_
MP=]O\_KY#[9/W[7V&H=B]QR^L_'Q%^1_#.[M(.&H0D@,!9_E,$+DD.TECZ0P
MGD#?Z"3HI'X=AER0F1!)U)9+1@SQFCEG'72FPG1*OV[GBB3_M.YEKM@_'O;5
MZRPB//20B:/^NH=XW>WW>/69:%*11>>,DIQ3+ R52OEH=82Q*'"Z2>QN GAF
MP;C#=\+=:!7DB6JD[D NYCU,B+8#Z5<AM[^S^;E,M9A\73L</EX6.;0M *P=
MNE?E=/NXS %M_VAX\J,H:,M+5?W:J[?OO_0ADX,A56OE8U#0\;U>[!]W.X4_
M%GQ%SB0_'-E>V_IX4DQ&_=>UM]U./P^WVO]&VQH<^9$HZ+^EH&^_UH^'A:_1
M>NWK481T-/:+JU[<J.W @&RUS@J=T4M7BM=#+5#?S2YG!0H*+Z[\8"$"<0!Z
M,A0BCM8?C2XSRGB=':I EM8ID,(6(M-CGSPILEZ@$'YH\95OK W-U1]EV>FD
MD"HMVBNUNJ?](A.>:/W\A\==F"Z;,=]8W_>:KLR9+W/@O]8EY,!3:'R$R#\:
M[7^=750;?![VQWAP7RV%TF5$^)T#1Q27/ H4E<X>7Y$@RXE$3NA(>! Z.3<9
ML9].W"B,5,MX,%PJN@1@,>"WHH]M!SAFY'7IN'4ADSI21OV]@/FXE![PLHY+
M9CXOIV=\'3^$2*A8)X167TL(6[%\:34U39^*..8$(WA&3S:#VCRCIQL1M&?T
M2-/%9<^\FFXJF:GVV2]I=(S*NVSV;8GG6G"MI)8:F#5-3M- #G;N6D?WU(RC
M[D>@RVWU[J_]\QU:W_+TV]:WYO[Y%_QMZU\@S)[L??UXM@>?K\-]U\_]^;?/
M$]OJW]]]W_V^C^OGWW[4VW]_KS<^_:A__2+JYU_@GG<$$'!XAAT@V_763,E1
MS$,$KJT083HB(. 4:<L,<B9Z8I+C+F^K,_.:TVD=HQ>]L_Z284ZDT%0;&C'
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MIS@G7K;NX.CB;YO]W+:%FAH\X(G+?5 2NG[L9'&PG[G!;<>VSOK0Y^XLEUT
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M*H=?"IZFK,MBP-0&A;RT G'"(]*0SB/(Z F'9#X9Z)\-LRB5LH>#V3-'4XK
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M<%- :B0::9L2DD8R8#@22PXL1\YI(%")$RP[;ZC ] A@FDP9G."68@'9N^$
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MB[73_,^#4]&=^KOQZM6WW7:[66I:[=H0&]VKRG*=<"D[]VQ-)']#8>X4KGG
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MZZR+#%&<[;B3"<@D[O-!$D6"=,JG7+(F%B6R7S&.%:H4J1"U $1-,G5, Q!
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MGM*81KE()<!4_/<P"I.-[L"V[D5\9SSG8N+(0S[N4BCO3(7OJR2W<])&H3M
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M#6=_]7T3?FO:_*$K)L)J:#H[Z$('_XRM[C%\3QY8J0M7SE][W(..ST>34.P
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M*G$3,\TJ!#8^A7JHYUQ_'9O'OU\^Y._7G_$UU\CM_MC:6-^3660%I5^<<HZ
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MRG9@602:K60REJ;HSJ&FA^)%>NF$@7O]03493$P&91 M1=X;%2 9 *<$#%*
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M*1E)8^146;<RB*F?E@K!4@SNC*/&1*]0C,JL3-9*J9"]MUQ$+E8:"?G)24G
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MYJA=\)QMW3-^W@D;' \C<!MR2?0TVG%G8_*:LA29I77ODF< I# ,I,@M@()
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M%YV6K5UMZ60&=KN7L[&>XE.LXE-*"[1:"E\JVJA)FZQ[(-TR>8O&94I%,4V
MC":I)*W6*6OKK(M7R4+V@+D@8#II>Q]T<1:T4"$8 1Z42+XI #%^7%/]4=HM
MK>J^].5VL&(H(P-#VY(K6)>#<B;:Z((AQ*QK/^G</8:Z&?M:DG8Y!B%SZQ='
M18O(A$[$5CY6O6'_=Y>2C?<I8__+@\C6?[Z;OD]<= @%NT9KO3+25I .DLS:
M9QE+).E]I#YQ<<=.\FC>_GITS"F0!"K56@-.EU4A"Q_02!,KLT'S_20N'BKT
M-&2*7F93B$DCDY7<E#M+SA:R=*'V$A:W![%.6CY*'V4&$)&*$H#8^G"B$5YK
M!!4QHF(:HJ7KX;6@\/(8;(V5XV27 '3"$B6#32IPY*+U_<QV][#KI.1C,( \
MO8EHB 2XR"$T!D9A(65S"N7R"<,^)7_M>TMJM,ID*TUA/D(V.$!357(^11--
MOZ-Q 1#62<F7F"FY3")BU4T2%$5REB<V(*>QFJ!:F\)^5?=6@92J\L8SE%P$
M@)AR=I+_KHA)&;Q*9Y$>,!<$3"<E3R13+CJ+Z-PTV,J"V1^(H*TS6'D\G&(F
M&&T/EML!"^:H2ZI)E@Q1(GJIG8^Q4C#*.M?/.G</HDY2'D,J16DM?/*9PZE
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MK6S\.Y(3X!.(E#6P,9&I+I6:TVQY7&K=X[W'^W$Z#*--TD?M;08L.;#AR%S
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MK$W]8M;MHBFE*$/1-1H.S-#9&*.B*%.NS!B3M3V:%@1-G3R_1<R5$26JK5&
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M')G<9,(^4[D(SMC.;<F$MA@5V V'+"#5*$((42BFGRE'FY2[[/)NGZF\14$
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MX(?.CUYGKQ)(M$GF8FHJQ6E44'LACT5!TZ>"@HW-MVIC\]663CPTKG&["$Z
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MV;=>HU(8[5!52%3*5_:C]8!_H(!/&&V2GJ,ZFP%+#N"3S 4\,T"GU)7WZO?
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M:)/V6BC=.L+'JD5PGH3.(0?)),%06EJ-R]9T]_Z=5(@.AGM_TWC"UC'<&_!
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MTS(&"*[2TNI7]K9=HT;IM>R8[2WBVC9</]9;)>:JP1?!-F);LY8J N4H$NE
M@4A5J;YM'O/WMMVR/E-O)M?F.#8VFY9[3JZX)F$:'#N.D$3B 1 &/.4"GB<@
M8$IR52G37EAR]?<Q?4W"9]KK87=X/ ]/M>+W)DWV9[AWO'&4WSL:X&A_/%.]
M?W,X&H[+<#H<T_U9(^H*_,P4G_@0!SO8)$8_V\&5^2DD&NS1I)T37^-P;SSY
M)&:YEUM/BM>TUX2.FISET>R"AI\DZ\>,PSF:0M_I^,Q30CHM37(P8J<QXM/S
MD\MXR"/*SV$X.FY&,/TJ<]6CP3L\^6WK;= >[[AI4Z7IHWT]_)MF#Y#>-^T*
M_GBFOO]1-^KS!_W?0QI/9FUR[IRG=3:;K^^?[!3FQ_-X/.N=\=OQ4^ /_WU\
MS[T//FL_Z=KFTRTF3"E02@)E]!P,DA>Q((DF[>]5J15#7%J-\2OS,QO*7=*U
MWC"NWS#>/-W25D,%A2)#(=%:W;%A,(N3.82 )3@-K<?>G-6"4X9QEQRMMXWK
MMXT/+[8B#T.P*8I2@F%*G[1 H_D5^)PD<BQ8W-*J@:]0MYEMS*-JS0B&>X<X
M6WGZ; H_GC$AK*C8EE,Z^S^/-S//UC8_^^')&M&GGV!BSG XZ?[D#K9[!Q\O
ML]T[:OZEO?;MWK 2]?F.>KV)TMUA*3NGM K.MQGZ&_SLLBOD4U[V\O'ZQK/G
M@\'@*RN@UW/^^;SPV<9O:XP3\>S&SS___K]VW\<Y][GG;2?C$U_JGK\HQ/FT
M0_L>6]DS8=59>]*_7%S^_,]V"]/9QVKFULIKGB ]@+%!LN?-NH1J8BXZ;3D#
M2R>_VAY]>G2O2:01X5N!=4*C1[CS#H_&2__X,FYBA_9Q4=ZO>,UW=):?_6*!
M&U:T_6S1>S0;\=F;GSWR3$V-^LLU[VG4=/O*&V%%SUS?A5UQ6(GR[(_O1B+C
MXO ,E\P(K&]L/GTYV-P8;/[OT\$O&^LO-_[U_,GCS:=/!L^>KS]>_^7YXW\-
M7F[R&VM/US=??I'..7X<IV9X=3S\7WU$LCV@K^1AOK$"8/AF/\_/Z$OF6,X
M?CO>.9#_9$79E<$-:2Q]UF3I,Z6EE]LXHF.!T9/FE(_WRD9K[O'TOX?#R=&)
M/OS3]TV#&B?[HZ,[Y[DO3GCNV[7=Y^_7/CS^\.H#G_//-;GVY[.WK_YDSKK[
MQ^ZK/_\Y?/7FJ5K[\RFL=W@N'^M-:QBP_F9]\Y]\#2_>O_KSM^V_GCSFX_RU
M_6KWG\.US=_?,P<V__G0DJUK6X2^!I50\*-'P7%0$L&D.EVE1&6L\Y!F40L3
M5HXG)E-O#$XJ4I5'"W1UR8!E5AQ<=@Z+H=/B3+]\WE!GW :G]5FET?A8'WQ
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M33II+;51E"8(2MAD(]<Y>2F!&N:'LG9X6L#J:<'R"-TP+G0YC\D+*PB/*A,
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MW7\[J;C\B%)FP_6_=HXN.0>NW/4C)L" DUH?/)(FEJ7WP'-I8AUT!%",>Q]
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MC^..<R6L94H*)/>E\XC0D3AN)-%6"1?Q3Y,]VC=J33V8T[Q&1=\)D'?TGU=
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M@[]L?4,]=/(Q;?Y\GKV3_9\/^MS+7'[=VS_XT!1>X"*2J!W:=DD9XA+HTN
M=8_07"BWO.W.;]J?N F/OW3;".+^Q5*<R];FW*Q9RF9J<Z[6+-Q#FW.VQLT]
M]".?_;+7O<?7N%;+\[ H(1^S)?L%,"Q.2<6K6[9/+J=8&[<O\'"F:=Q.RV F
MD?RE'#F]VT+>A-LY#@G6Y*@&GC2JW[YT>DUWFA?=5+3O/^FW8L,2O@8PKME*
MD]%R!<2SFX3@9U1N;*,_:-[3V!']SI RM,Z[?OQH!E)+D<WJ^HK<B\"T#R%(
MM(&SHXP[ XQQDZ@$=E,6[(7&N<W:7%RQ_<[>UQ-<I[W\)[*_D_[M_--+[B9K
MO_][6^+[GW>^;\F#_0WZ_N_7<F_S]\/WGXX^'^P??MK]_I&]W__(=L;<9$A5
M/GW&^[S^OK-_=+BS^>;H_>9GV'GU\G@/Z<O>JQVQM_G7T=[FN[/)G:TU5PR,
M(B$(2B +20QR2*)]%B)QP[E,)4 6;.UFOWB8_64*T H03FE%158:$E)32+;T
M.LG1@'%971UTV\.!XF^SH;<"=#J COJQDY8ANDA+R+HA(( 2IVDDUFIJ+74J
M\;"R;I0<@^>OU[NP'PJ 4QL95]JE%<KGT< >+ B68C 6>*0.7';& <V)JP#J
MZJ.G.T&Y*N+YX7PLZ)Y;KRRP0+*QB8 #7Q1Q)-%(X1)0GFES4"P,/$VD/Z6L
MT%$*@HM%FG[TG:.C<@C4+CT+4J]_=07L)YK..(V4FYUE7"GE=CLG%Y9A^WP5
MJO2:2GI-ZO <F0U""<*"*@<@N4@O)XBAPL;2OU)%A=)KO%KJE:*KYK0N 0&H
M>)H3GL;*#V<&CH(F04A%(!E&;**<V,"3]TIFJ=#JGU @Y"H\W9^NG\)L?^H(
MNP>[O")L/@@;L[=5$BPK,$2C34% 6R ^<4&\<$)Z?,,)L[(N;T^K'QAA-SGT
MQ_3G,,1ECG9T;OZYGQ.=_<[%B+!IK.,)XYR/K+G/X3ZB\[WR^OG)F0F57ZWS
M(HJHB41#J\2A!N*R!Q(2X(HY'M .:QSL:ER9G^__>]N,5V6'3.77GRQ8[C5#
M;2DQOA#.^@KH:0$]:II;-.IT<)9HSY'J9F.)"S(1Z45.*N-*";>R;NE=N.X]
M06H*\^ V3OCG!\M[<[Q7)3Q/S(X9^P Q>&4B$;P<HDG/B;$I$Z:!HCCE7,1<
MG.LP(0-K:5%[.8GDBFC<)BP><7+>^+EP@!)_*6!B?.[@I?9)3"?]%V3XN7ND
MYE/&UO_B?FUM#W(F>DU8\GDR06[^VG[Y9ON/EON83J)K\-DK>,<W=UPW' [,
MGJ8S16>0A!$Z2+7+^R@$<OOC:;?X[CO=5L#)Z!SCM_%/]^4+/ML@.KK7R?VO
M)9WCM#?(Y'"MM^<ON5[Y*W7_:8?4^N6M<V]_;;ENMP39'^-DKI8/7,H"^9GO
ML;'&2[I'OS.(M&Z?N)/0=D<XWZ[??+GW(]'DK/3'QN'A)3932"7G<W -P59;
M96@CF1/_NI17,&MT^@U-Q1<[SGT?I\V[(YS39I%PM<]GKC6<-'Z>AU-:L[=<
M[I>C+?>MY9KLO?*-80CM-*IDIJR-J_((_SO%CZFWEW=3?_ODG]3K-[MB^^1E
MIXM#/=G[DKK-#NUME(??=]^67J7,GKNQS7?W/W]0)J,AS3F)(0L"$:?929:)
MYBP"MY!92BOKTHS7./OU/%"Z-8C+1!F R#QL5J#LA9/4Q_WR8Q'P]P$"\V M
M6IT?B]'ZI9LR;C/\^D^P_[YFUL1: V@W% A?^D,Q51".-TW_.-QV%W/*.BB"
MSGY=;5(R4-C$UM=V_W"67:FBY#F7'@J40<1]**QD+*;L)3AMU U5+^NNG'E7
MXK,??/# F&-6$:'!$C#9$V\S(UE2[8 [P8)'.X5-X!8_=F4CPX:)@B."C*'\
MBH.W9M@;UD< E95UKI225XZ:I)4 "& LE?Z&@@1U;]QA;WS:^:"S#RBS/&&.
M*P(A2N*C,\10'552AAH:2D?*\;)Q(WMC3+_1Y<TA3:WCSC^-#51,IFO\93<\
MSLT/<J4E.L8J;Y4]-_NCSF7F6NU>Z]BU3X[.6FXD5J4HF7=O6[%DVG4GF(N7
M4]$O[)7A#<"L,5L8Q5CZPC"Y:^#POO#%\V3ZGU]QOM<Y.NU?_94+NS"4+.KN
MPR<.VC6C[2R)@[!F.<P]9\YR?)['R&X[;L=XE*[)DID->C<Z;YI]_))(N'6^
MVC(-[.W&[M[+[59K_C+MQC. P<3NO=E!W4!>WOO])X__NG%/GZQ_NS%?2@<<
M29VZ[$>Y^/.P^W-_?4S$=Y/[3!J2^,(=?75GO95_75:I*&A^."#UFN;X;%>)
MN4M>&5CC\H*GICL8R>#%,7EXV5'3J(7'R*WF7,XB(INL[*O?GH\PF]H+/?V^
M,S/ZL7;W]K?>MO;W6OO_O=7Z8V_W[=Y_MC<W]K<V6R^W=S=V_]C>^$_K[3Z^
ML+.UN__VDH-R.!\C2ID-UW_*^())NW[$!!@8XTFY%*551L4$*6A?.ALE1H,,
M@5/C!U0"OY/B1G%R<TX3\X+1B.S!.NV]-;DX/P1CR2M_7:&$A2WJH==:>V@]
M=0>5$=)A.NFAV5.<1YWC]!CE/#9".#T^1>LKQ>;!_KCX7-O-8VU]0ZB?N'ZG
M>U9K>NQO?Y!<9\E"8>!!$'#!$\>2(<)[H1*NB8ET>6MZ[ S)4J]Q$"%CZERY
M7YNR1+W#SM>3ED]'G:_+5M?#KEDM9M$]BJU)<0\%."A>UCSR92<(__,)1W&4
M'GA<-Q06D;=;A*>4-W)U+8Y:A6.)AG.;*AQ7X&ZY!UZ+<-0B',,,N- _==UR
M2OW1M4]Z__H%;=)>ZOWZXBX2[:X)Q/-+19X%QX_[]#?LO=L/8YD_>?]UO:Z.
MHYDY:.9OO%ZYYMVD<RF@R=5O]W3N<!NA<#G&R*S9QB=QE:!HI6\EYF*0+?OS
M-'UXZIUB<T)^VH3@E!.+89&?X]0_[,36+[V4+A=,M6ML[:;*9D\TYW:*(UZ7
MK4N>,J^% 67 )Y$R]> #Z!RF#$KYL;*ORL+^IUG6C6X3-?6RVSG^HRDP6HY\
MSP.:-GJ]T^,FV*&WF_J;*>-0XN_I!'_I_Z?M?/NHE"C R_2WSO<&_M7!K_;Q
MRB?QWYWV2?\OW":G337])3\O_E%!^U-@NYLO/^U\__Q]]^\M>O#I,_ZW(79?
M[7S;>;5[>,#?'.WLOS\Z.!NKH'V\^_T=WF/G^][^#CO8?]/>P_]V\'D/OF]]
M/> O/[U_]>[;[O%?GR9F+IB08O8N$FV$(V 9)T9K1BAD$[7#'R5$1LDIVP#6
MS-YYH[;$XR@:I).2@7+>@C-),Q7 VJ"%GRIHIZ)VN5 [FIY =1""V42X-8)
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MP1*L'F-QF4"W?SR?$J^_*';=J>LQEA3W47K$(J@P'G0" TL%1!2S6H&5I;P
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MD1BYP,%VD811)SW3DJQM"-.<LHE;$EKGL ;6E<%/8N^NRN [OHHNF!.V:KJ
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M87IX.AAVTMGHI<YQ@ GV HT_MQ0XI=6.K_VUL6L[Q]VS1CB-C6&O,3R(C<^
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MU!P]P->UF%?8?BFB\2@@O>?>6@'IXD$Z&>*C?(H>4X4"9;D7MY!(.YL0,9:
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MGG..,,X&D7(!:1<U2B#N?>#1.:/7-LRZF9+27H#_7('_D]L]!?@+!WY="<F
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M^P]P\/[W[@%_10\_OV('?[SI';Q_(O[S^1T]>/_NK4031% 7"-#$T:#5GMA
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M"3S5BB8G4T1\M;/4*L"VK/U*!=A* -8J?F"M0H!Y8II4M&@9<0PD22H(KHU
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M/^&DC\Z*9CIQ?W5/SDYP+TS^XN8WQ,'DB>J&^,&&D ='K]XBW0;'@R*>64_
M!D>,BI*HI %ED(JQU-2 O1\(GY_W.H\N\-[L_O_LO6MS5$>RJ/U7.K3C[)B)
M4#)UR;K!#D5@@^>P8R2]V,(>^.+(ND&#+ARU9 R__LUJ"=OTDABUZ%:WI&+&
M0G1+J]>JJB<KL_+6A,MQ&7UH7Y:^+\V<>O^Q,"Y>$77\>\GPJ1P?W>?3;;.S
M]_)70T:)2A%B+1:P4N9EH1Q8Y75166%H9L#AT?#@\O.6,#E/GZ7#CV<J^]'D
MCZS9R6U5QYM[J(X/6;=J&R;OIN_WJ:E97RSXT1\GE70RW4KWRV]E_[/=\N9H
MOUG/4]=1&YN_G?F S@Y))Z.#H\GTN/_LSIN]+]VCR5\^].S@M!49.*;]_8]_
M'XTGH\.CD]'D-+XMZ:0=N+;+GO\":P#IZ+?"WY^T8]7#/*6*QH?MET9IGTZ;
M\XH?]-W4;?7^N!!?_>AX5 N_SM=JMWQNSA]/G0!7G3K- WK^2HO^"_,<E_SG
M3"4IKG1>DO[.LQ*G.=T'YPESFVU6?J/]4[8D#T?\9.5@:CA^^5A?U./Y4A)5
M:9(O7I%4EH60#2I(*82R19')OERX5?TI@YZ,)VG_:')Z7'9KN[?O/GY.Y7M\
M\G.[K=WZXQ\W]?1W7F"'=')T_'&O*?][?!??[1^E=_=.++T6.WO;O^;2MB)E
M0 656M2, I]LA*!(Y.H=>55F:QTX)9,W(52%!8WR,6=6,UB_R37R!-'&J+"P
M?]]2ZXY/9VJBW+&\>HT/C%]\ KQ_(+SO5[WO5PU76UEW(_U_L-E?)2Z7TKO7
MQT>L%\'Y'1;'__./+JP ,_?PG!<>6I,!^O[,K7OIL$AS^YYIY^@0T@7/=9>:
ML?SM_(!Y-$CO_H:%O>ZE!_:.3FA_O3)9E_FX7TU?O8M/>Y7^.W?G:<V]>EI[
MKYYVS0H-+/EI_?3(8I].9BHMW:/2&G\I4W>5)(C+=N+[E)9\0?=S-O;1NFQB
MM9A"]9%\C3[P2ZF0-E?W:K;IF,N5>5M#7\_S(L:O]M*G'?4"7W[Z8;SSZ;5X
M]<NKM[M[_-EO'_^^_?8=?];KCSMO'YN=\6Q>Q/_N[WS:UJ_VWKS=_J55]?YQ
M_]5!<S6DC_SY'W?WWASP9ZOM)^]4RTG>'N1%V%"22@@VD&X!:@EB404H:'08
M6SAS\X7Z36^'\;-?3XQ8 "3739?H10,NJ+1?C%)!:U3>8RK!4Z8H53O0LR84
MT>E</9WC&3IU,C9GF\%3HS.+#(%* :=L%%G([*K<V-*;7KJUJQC0&;QPAS32
MVEB(+'J3O,DY,W58DM36^&LRV#&;#[./,Y@I3+(()R%960 K?XE5*S!!2^>4
MI)#4QI9=P[(<';(A9%%Z5 &K(I$P*^$3J>(\17Y#BY#[1K=R @>)^ABRK&PG
M@&;)V/+\"GB?) @1=7&JLM@,;*MN=@9O!X.V%IN"LS+Q1I<<4436.RU9;YP,
M(G8&5\_@K"E8O,.BT(+1NK5[,@6"RQXB!L7&@D_"IHTMW)2V,W@;&$3>[GP4
M)0C,*&N*PO"?K),J1DM4"V#P@EB^CM\5\9NU]4*5KA2!#)US@#:Q$NIL EE+
M#*EH5F+"66Z:5(\Z@+<!0-(D+$KAI<!:DJ_!(EJV]4+1)OW'T@!]$UP^A;.F
MH%=.*24,;X*MPVGU$E@CK6 K.C+9D-=L"KI-ZR_+SEO;&HVWRB%S7A>&#M_]
MI3C,M[AF[KBL^5;?2PN:G8[Y=SSD?]:CZP)E+H&R/72PQ)J0E3 $$;0"-"6"
MIY0A*PI46$6KWK-EZR_+39S7N[*\S?R.$_2M_I%.T(((FE6,C9*2-U\%2:L,
M*&, KZR!ED:5,,N6F=1<E'.Z0#HH*W)B=% 6!,JL[FJ3\KS@V8)4U350$C/B
M'3BIO1+140FTL36O'[]SLB(_Q*6<]!.8A? S<$)8*0MO_QEJ;7E/B0U 4C6!
M]U%&WGM8>3/7/('I$*W(D= A6C)$L_:.$3%C4,UU)WU+<+?@@[;07 B2=)6E
M8(?H=GD".D1+AFC6Y*&2HQ8U0":TO!-5 R$4WHXTI6"$R:J5O>T0W:;3_&[V
M+ B66;/'(5LVUK+%@ZVD"DK><83A#8@2BI@J^M*")/W-<W('#^3[6?Q-YD&<
MR8LN*ZXG*YX/3^-]P21E4&!E;1MK#!"B*T!%!TI6B.S%Y74"^UG\+3F+[P0M
MC*!9U72J ;$Q 48Q-^@-0O!>@J*,5N7HV,"8FZ .RLH3"@:@=-MN,0 -D@W(
M%IM+!$>H "5_1Z@E>$_:LICSQOANV]VNH_J.T;(Q&AS69^>D09>A9MZ,V"#7
M$&RPO"T)DPM96[%TC&[787W':.D8S1I$PDIEC=(@(AK 4-@@2B:#DU;[JBOK
MV_VD\98=UW>,EH[1\,"^G?@$!"4) ;$4""4;B)ED+J)DJZ\;O-\Q6GGX?<=H
M21C-VD84DU)61Y LZ0 3A>;R0FAIV.V KB2[2N?Q73K/;UZHSS6G(^VW1B;]
M3/]&:AOQP._R,.1CJB>3[_=I,AG7<<F/)]_3Y,W3_W<Z_HV%R.%)/ZN<3YR\
M&)[V!QD<FAJ@&"D!V[E_-+ZU?VZU]HLC6]3&EK1SN@;[>?_ZGO=WNI9&UZS.
M*Z57+/LD[\[9 \;H(1BO6?$57K"A8@JE:]#5(5JY+V .B+HFO!BX9C7AZJ(H
M[2!&1!T 75% "AT43YB<4"1<Z@;E;?42=,!N&K +@OU9W3"Z0O MJXR5>B L
MK3US=N1SZ\G:@_UOK?^@ W;C@ V,KZ*2##8R4<$"AI# %U6!JD9F3^D8=0?L
MMGH6.F W#MBL_54+;U4Y&LC$>B*F+(!\%2"<KB(+_AY%!^RV^APZ8#<.V* 6
M4-N^G$J0?1"L(GH' 94%*R@ZSY:8]ZMTZMTE;\2SUH"J3*;M+\\:JI]U@$H?
M&9-C7NHGX]_*67_LT?_$XW]LG1R=-_/D]^/E_:_NJ./B;S=<&>CS]/S(L_/X
M,']_/C=/_IR:%SPS>T?;TREI#3>[])E+^KP<.B]JR3IFH\#GC( Q$T0E(Z2J
M5/31172M4_3P='702ZR[+9;%UB)J!G6VEL_6H*20C)9TJ*VVGV?5F;\$[0HH
M:7-RQDFGPEQL=8166$SH.@1UG7DQ9,WJS&@-(?&NA6':TCXD"*4H*,I8I%*B
MK[4;I;?+;]$96REC ]=%X.VI8,ZM/C3;I3H)"+R"P1EO2"51^>_.V.UR773&
M5LO8P/KR/%]!"Z"<V/JJRC-M44,R!2-/L@ZYIQ?=,N]%9VRUC,U:89DUPUIT
M 9NI BH=P&NG( CI7&130)3<&;M=#HS.V&H9F[7'))%J+0W ^QH!I61[3&,
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MH5W!._-+87[6E$?IHFF%C4CDUI4X(T32 M#;$!*E5#%>UA2\,]^97V@7\EZ
M:=&X#VQU5XAEM -M*0 FE!!Y9P?,U214(E7WE7* '?@._$*[GO=-?BG4SYKR
M0K#*;I4 1;JEZMH 05<6 B+8:*/(B; U/7=*=>;7S'&Y_.B!EF]XEI+5OBE_
M9A[>*F_F>B6.+,ZIV6:G!5E\+2FT"\QO$9BOAP[.XLG&ZC08C9IMH6K >V>
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M2"S'V=616"H2 X=8JD('*A8J:_>L'E("JL)#PJR"$D;*5#L2*W45=226B\3
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M05D0* /?0XR92"<0TDG>4;0%[U@5K3Y7U(J$D6)CR^G.R:UP'71.%L/)P#^
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M+@)N5 0,7 8Z9J4S6B@FLJHL,(-G/0!<JBEIYM^CV-B28I-5P:M'YW<.U[_
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M>GS#<1AK+M=3)IML,!JS:OX-3P*]%B5:J7,5_8QU'>7Z]E"N2Q3:5VFA5B<
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MRCUUKO&H<T.YS&>=PQRXWG[W92!4V^YX>'=KMPB6OCV*"[;'C!@2*_Z0T%1
MH0T$7PUD(376XJ55K0;<IO%SU!-2\^&P&#UPF5#,8R373&BT35+4A)E<S#D;
M)3*)XFI >3D5$WY$_J[CL3(\!G[_4H0L21=0-8CSW &;$EB+U?.T5LRI&<S&
M7.$@<<XM8I$.H[N!X5S5DEFOU\:(*A ]1A\33Z-RY%!J6_1"]J;.UYQ\;0_X
MPHRV4@7IL;8"3Q)BK0C*BA(,VE(MSIVKNY@E>!WKK).]?+*K,DI9%[0*$@LZ
M(E>B17[%9IW"8LCNV^HBL7\^B[V(T10,[1Q:>\!H""*O9% :(Y5H4@GZ&KFY
M'?R[#+[Q/DM+3L70VN0IREXE08("D@FRFYOK!_Z+6?!11)XR]*"$(T!R#J*S
MFI7J*JO*/DH?KY&+V\&_R^#KFJP1Z!3&, W'<3$D@57Z4%QQB]_Q>^;M-S#_
M<A",4TVH&14;S5DU#TP&"BE 0&UM5+D:;:^5>]NIO\O4^Y38:'<V:9-15N%U
M"-GY0,JFFI/MV_W:H9\&>KY&TBEJL"8$0&]9SR>TD(.VC@TYM%%<(]?V;H(_
M=:+]XX3B?N&_\_BWK<]CLG-ZP,^2MOZ'7_Q\*P=T_'I\"&>7>#@3;??V='(R
MKA\7'V7FFT?PZZ.HVBB>7V\\F9R6R=1W-AH?CBZE/YT>'Y?#]'&V8V\LI1I7
M1:T2%26O0BG.5.&R1QOJE0(J=J:A&BP"SCYC7"9-*CR;/&OWEI\=?B$$^(%3
M$P0?CH[SI!S^(0/$+94!K_[]1J2#GP_IEW"Z^_8E7__5VY=[SS]L[_TXWMG[
M\<W+M^]P^^W/XVWU0NQ\>B&W?WFUO_WVJ?[WIQ<?=MX^^U48%6JH"#5Z!E@:
M"RR!"Y1:C'!.V6D@[<F'HP&^H_3'>&^.3MZ4:9SY-+.Z_>./",O-Z4L\;T>\
M0'XKDY/):,S_I<O2L-LR.GES-"E_N?Z#T?ERFU[FZ'UIH4KGUWA_=,2K\_6(
MCH_I\'4YF%[CY&AT0(?TNDSO97)Z_'[_]"^?.7ES='P")^7X8+0_YH_.XY./
MH\-2\F1T5-MJX97.4)W&";]%QWP'H_VCQ)^91T>G)_QB^?.!/QT=E@=_2),_
MH&[+?'QX2F>2[B]8GU.$_H$,3-K[H\FX_<S#X[+//_Q;>?1AG$_>?-Y-__*+
MYX) _/DK%"='^Z<GPU]AB=:$S(S#/[7Y>#\I#S]_\RB/)^_WZ>/#\>$4\.DO
M/1K*G1FA-A5#9V^??W((#[P+[<//0P3./_C\OAY,[VM&TI[_IN+?-)>^+1[(
M2]_[VF7Q05!7N^I\P<__*7[A8)SS?OERWF;WB&O)[.OJ9&>R^O'.[@_/1J/1
M5W;<Q7S^Q7O%#[L_;H^4@!^6_OD7/__7GOM\>[_P<]N'\0=?ZYG;OC4C%:X5
M8GY[5MD/T)PX@R>^2.GYR]<WQW\.PNL"\;C0.Z#*LODA[7^@CY.-?WRI%;%H
M^D.=<P^<XGN[3&*>#RNT,621,,U8^/S:\=G<#=(86EAF.3Y[97R8^5\/8:H3
M;=RX4/4/U)D0FUNH^@=!7/[V\L3?UXS.^4'S\R<\3!?BSN[>TY]&>[NCO?_[
M=/3][LY/N_]Z]N3QWM,GHQ^>[3S>^?[9XW^-?MKC%[:?[NS]](4A<#X<,WNU
M/)_^.4/'+UKT,YK!F<[IE(DB1E\Q(^88B<UA2\ZAE-KE*LZ49OZ=DA\W+=;R
MRD<O4Y71H"DB6AG1II3)%.N-W[CD<V1@!5M':4@C1HM1J9H%RB2B<(1IXQ;9
M'WM-#SP9'_#O3'6Q=#0Y:<K;U!(Y.AX=EWR:SM[Z[:AI5OM-Q_O\ TT)/%<0
MFS):?F>=ZO2X-+VQC@^)E4[:_T,/++^G-TVU'!V/)^\V/ZNBIY.IW7/,>FM3
MVUAMG9P<GYZIGW\;-R'"NNZH*:JCR0<6#)N?]=F/G_\]N/[T]>F]\5L?Z#A/
MY[WIVY._\Y,0W_<^7W?Z4-,3S']\CMT__YSW_)!_:.!_?MST97[T]JB'YY&.
M#[\4U?//^XUKF,'IZPA#C0^,OUR+O*Z&Z1\([_M5[_M5P]56ULUMLS=0%NF_
M_\MKBX]&?/%]WEOF21M;]W2@O2-6,N[0\[ 5HN_6X^#=>AQSMQ['WJW'<7?K
M<?Q4-V1EN!Q?9/6L/M%U^9O7#U/'_U1;OFJ^S\VU#%S^X\_AG8U1N2R2*$H7
M5+:0G#:98XV'7)9"]6K(<_AHW^]O__,'_LS_?;N]]USL\G\O?]E&_N_#RU]V
MQOS[8O>?+]7NDQ_?O/PXXZ,]>,$_\S/?S_;O.T^>FYWV,Y_>\'_?O7FI_O?-
MR[?M/E_BSC]_>/OO3T\O:"8><Y#5>G"J5?XL*4!,FH!J-*A<,56WPH9V4_MA
M8<-U3 =?*TJ4):(4G$=CD:0,7I-&56-&%6*1G9+UI&2V?4! :BU?%*B<$; U
M$HRMQR99I6TUZ%5HE&SRW X@677Q[L[E!;%%0:8@HLO59BQ6$F]F5LA2J#@C
MR/9N?BM#;[9<O[-6F!H+9!0M54!:"(HDU")"T=HY;^/&UD6) AV\]0,O!B(G
M94W1$HJLHA<Y.J0DG4Q)]'ZZZTGEH+E>3E%%%VK+$[> P3KP% Q4'4S-,D:3
MZV4)/)W+]>-2D8BBV((F5)16>TJ4DJY).VKZ:N=R/;F<->>D]:2-\B!=X=U2
M) 2VS TDHFI\U:FZ>EE^3>=R_;ALS4J)C-.E(EJ18J6L,1E#WE:GEV5 WKD$
MF!M$<M9V-#F:)*T$*27;CD49\+DZ2*D6JTK2/N?+TU\ZE.L')0966S&'DELS
M<8%!N"BEJ$Z02;EOENM*YJQIF7RIHGH"G5G:84X>HE 6*$=MD\&H4+?L%.MQ
M[;A<J%/F3A1MOF(=^]OFL)ES..;)IQ<VUYJ$52ZA#"($:3*KC5XZE#Z:+L;6
M4(P]&[IP1! D9-%@<Y;0"NI 2%9 -#)[56O,3FYL2;T9<"C'>@G..W*E7J;_
MQN(PUEVN.R$5>I3H WKK0^7_%Q)$6HA0NGJZCG)]>RC70\&DG$X0H[& SD2(
M(67(;'S8&$RPM;0S5D1]';&^GE7U>ZW^;ZG5_T?XTCI&9JQ/H?XLG<-2:K+)
M(D5!%:66EL$RI1A_21\3=<?+]-^4J'L^%'6U."I9*K#::D"2&B@X 4D&1QA4
M)=/ZDEQ>@GAIRVT%-?K72J9T^^".7&EMML ;B.+]:\N:'LC[GP)Y4S)"><-?
M,$3AK0A$-K822T;''J*XCEOHBPNL!>^%K+K5\,\!,&G1BBIZL#EYGERG;9U&
M9/@>QSL_),ZQ 6VPJO;_8C*1M-&70%64I"-U2-83DD$<KU0J:E'9AK9,2L$(
M)+P'$4P3@D@\H0T2Y]W:>7PZEQ<<=:62*573*B.@+#5J(TG9*'F6,;K<XWA7
MAMZLL[5$QY,2"F3C:ZO\6R&F-B\Y*)^BL::ZC:T+"OUW[M:/.YU=DHB:5'9H
M=?$J5R4=YBC9@B^EAR6M&X^#"%[I5$FU*J!D,J 4$;P6'HQ4I:2B1,FEAR7=
M)BC)I*!<$,G:A*U>8U%:V&(5>?Y+88=R[:"<->(2;X*EZ 22K3A [3($&RQX
M)]N<5LPD.Y2W"<KB;&"MU"=%#K4H1"%IY;RUA,I3[5"N'92S1B.R' VZ39#A
M[1+Y*\2""J0I)OCJ"[F^4]XJ*+-R)I(*T1>)WH0H@Y1:99M4HF1#-QM7!M^L
MV4@FUTI* K)9 2A< -+" %6%H?HL"]J-+3WLOKAJ[GJ ;@_0_5;73"FLT+,=
MIHCU06="%<DDJ;*4+F 274RM1DR]O# &ET51=9"+),!$%D+$ (K_)&.K$C%N
M;)EP>9N+M74<]ROU -P>@#M?D0-9 T8V"ZS%$LBKJ#UYAY:JB/\_>U_:U-;1
MK?M75)RZIY*Z-.EA]62?HLJ)[5RG7N"U@^,7OJ1Z-,)B.!+$AE]_5V^!C;4%
M1B )@=I)V1JV]M#=SQIZK?4L4^7V \GM,"9J[KF4V7"BP&D"P@5BA<Y$9JVU
M9%8DAN:EE==W(UR,!-<'/_0'TN^2Z!E',-U\]GKD]T?>U8\0CRQU^6K.UGWR
M4=K/_=2RE[G0WB6N/:6VJ!0;4:DXACJ'<B<UJ]G+LU0BG]I*Q/F08XZ4V& 4
M 1<%,3(6-D69H@A.N+)'P1YY]O)8@?*$LY?%U)R&>J9[GVEALI=GN5Q?+ERF
M\H,HO3'I)M)1%7RD);+ME# RYY!DB,P'YV;&@E/3+^]%N/&Y49+?-X0U7D83
M456&&"P!G%7BE72$!6:!H?L5'*"JM*M<3U#4N&Q%;6-R/SPX;@7W4E)$B+2@
ME>,!#445C4FS"C-7A-P7(6]:+9.=*E0<E@1I) %PLF1H&6*I-B%QI[P(#8.;
MN'Y/XE'8DT\NQ+T@HL![P;B/O#"-@_ "U68T 5B(EG,9ILG,7]$^(=HWV@W2
M;8HQ9J(U]01*0K1S01-NP1FI@!HC5];5F+3HBO6*]6YDA=VS=$8W'G2(WAD1
M8](FIBBTKFI_407!VY8@X!F='!Z)%J7#@#&!E)PD$A5$G[/4CNKK")6K**BB
MH(LK!!5]=D8[ YH*S[C+&IT!"EG%J99"55$P35'P?E041&,3)"F(!$";(*F(
M-@$S)$H0-E+%'$W7<3A745!%0==GG4K'9D^+W2^RU=Y$*Y+541KN:G76 DJ!
MG5$I$*1UPF7T#!2W!(I[8+-C:!I0FKA$+T_QZ[/.JQRH<J ;L[&,%@XY 9 ,
M\RXKGT1(-B0?W33SD*I),$UA$$:%0:+&&2<U*;M_!#@O"?!H%PAO>:;!29]M
M8:K6_/H$TR43!0L3,9Q]Y<MO;K#7]&X-Y47ZW]/N/PBXPY/!8@43Y]![? +A
M&*R+H',P:&2#\L'0%"13*FB4A2GD\5DTWV1B-_<'))_V>L_*\+\XC.6?5]_&
MOLK$*<K$+V-"B2DKR9S-)$FN"%#)B'$T$FDMC2DGR5)>66>%S*6]>WI]5_HG
M72,W"4"4<4IE5HB/'%B#+BC^SYD67,2$BJ8"9+$ THHDLBARYDXB0+Q#HP%?
M62$<H0P<CPF]"$5O#Y"E,^)GC\8+Y^VA+:4ZWG6\ZWC7\:[C_3C'>PD+#V]9
M2KYPWNN$SSN)N>ZLX38:0\$80$/=<V>M\MYRR)*':ZI"JKG^(.;ZV1A_5@AJ
MM$R:@,N6@.61>.LT*=VQ 82FM/2)A%4*;0+?Z]W91:\;?)!JQ*<H$I>I%GL2
MN<@]N.2S5B;(0JB&$M%*IZPWH)VTH<K%!9*+YV/D8H;$A(R.:*X%@<@T,=DE
MXAQU+$;M&825=;FJ;9NSN<K%I9>+?^(#N>.C?JKB<6R#<9,3#4%[KAP &*LY
M!1]IB"@P$U-5/"Z0>*1CQ*,R.F2E$XD.(MJ.A7E(RDR<XA #:&&"*HFC3+;K
MCZMX7,(JTRER+3S&_!E6$JB?7D;$0JVPRFGV1,[T(X'HPJ>/_:/3PT@NEI4V
ME"<U35&8FS^S6:B;Z>36[<'N\*@3R[U9/NL<4V,N&69P>+=R-0MG;A;R,68A
M*TV?<] D--DQ&31Q/G(2(QCO5(Z9E78KJS ))26?# [3,09F"8KYY,,,\!'Q
M587'@\&CG1O#4F9&1L)Q_@@8#L1ZY@A/UE"J4W*4KZR;524G2(VYI8J89E#U
M:<!PDIQV4,(ET$P*!PU=2(20:(C J$P@IZ*;*KXFQ%>KKMTG)[P"26P3T6K4
M#ZY,DK3F$)6, ?+$=>W368)W<<XJLF>/;,JTXJACO:<2K1)EF&$J!\%X5CHP
M7:W.A8-]JXI=62M9,H%$<)0 LYDX9R31666O::&VX'>H8J_ ?\K CY$)UB0E
M:PV"24,S4[[TV T98G(5^ L'_%;-NDDZI*@"D;[PNN'4(?!%(E3E)*2/F3MQ
MAYKU"ORG#/R41.;&*Y<# Q:,#4E&*D-">]X*+:8._%JA?@_,MRK44;$S*@PC
M2F54]B(88M G(\%0P:G7D;MXIPKUBOJGC'KFN?,I)IJ%A^B4"UX%QZ*A2G.F
MIN/!5W4_3>BWZ]&=#MX#(R9&6_J4:F*% 2(CUU3$)&+.=ZA'?YK ;X)HOYPX
MWTOX;^S^L]Z,20%%]_#4#0=E.$B;IP?X<.%[P&0F@TF&.\85**XLMPR?B:O$
MG8QF/)W+%:QT!Z%W-#CMIZU<<//KV1L\>3\-3MZYD_3BY"_7.\6OWB$D#X[+
MS;S(^/6V^X3/_2($')23\L,^@NND^T]Z<S@XZ>-M(LPVV2;?+H^UC??Z:^\H
M?'JDB-K]SQX-!W\=N@_V=&M_!\^/ZW_[[>>-[7?=S6U$Q_XGV-C_J[O!W]/-
M\_=LX\-N;V/_E?C/^4>ZL?WI[ZP8M3('@HO&$] N$5L8FVQDC/ELP%JSTDDH
M=XYQ4G#X2G</7 B7R^_ ]3]V#\EPV3P;R;;;/QV<=//9]-/+3(D"WXP<7I"S
MO9<ZS>KM^-0[^MP9[!U]'G1.\-/&GOKE,IVD4])).H/C7O>D<Y0[AQ?!U8X[
MZ?Q3UE@']4+_ZRKKN++,\,1EG77<<*&5W\6O2ZW3_;;6.FZ 7PY!_#*%5/IB
M= 1;[>"29PWYP>6GPV,NOJ+/OB*^ =[D@SY\\N]CZ*%D$AX/TK/+%\\O.[=T
M#YOQ:W[TO'V%$3G17'#X]?//W7BR]\S:-:M%4:@74?>+"P^_96N-KAT17L/O
MP*X9*Z_]FJZQ:[^[Z;2,K3%Y_4^7Z+3\5J>=+,/VP;-J;\XC1=M=*'C>P9/W
M$+*3I LN>AI8$1M/Z'%NDW+U6)ZEB.TG]#C?3\W"I)C.7GR\;G9;&J/@QB2K
M)UTC/(%CK!4M77VYI$9 9L[())GSEB<*U+)A@@F[32K^<C&S'8F-\QVYN?V>
MH[W>V]Q^1;<^O.OM?$#[_3SBO?YUL+&_V=WXL$-W?QOQA/?#^>;^)SSGSI?-
MW]&NWWXK=W__:V^WW"=_*S8_[)QM\#=?=O???4)/>$S;7QDDU<&21"WZP<R@
MX0^2$6NMEUHF9;A=66=Z5;&V(_S0=>,5@V/;Z]T-AD^]O=X<0=8= 9F6CH:4
M#-$NH'?M$&[&6TI",@97HTW"(<A,N_IOH1+N9[_,K[<!EQ/=;0T+.;'(0&MO
M,V@C\!^I"DV"44:[[!MHTZIA'Q#\9Z/@S^!T5D!0XCH"X#5QCEN2@0O-A5(X
M7<5E6-6LW3"L:MB'QN!8#7LW&%8-.RV0;?[6,F.%HQH$R=8* CY[8@, 4<HK
MD:4+(B/(;#M9<ZDU[%/:ZGM]M23TMN[ZDY)48]HH\&"]C0I4S@#..&71H=.R
M1*RUO@A45W_\P039F[8_'A7SI3<LH3JITC1!#:T%YZS*GAG/$BOYIYI.Z([/
MSAIX4B :J^[OAJ.J[J>&DE&'VHN<60Z24(B:@&*&>.":>.ZE%=H;SOW*^J3V
M]*/7YTN SS$N,02'0I,)"!9T )\2,S%IGX-..KCJ$C\X?$==8@-*,@.2:*VA
M= A&):=R(I"SS313@^8ZPG?5VG:N=55RL_)I[X2CJN2FA9*63PN*R\1S)HX*
M1(F5D9BL+.&\;!IG)YRGZ-,NF8Y;F/#S+"/N+Q<TVKP@;<$<DXY&L"FX $P%
MDP2*+!ZT9AJU2:I^[<,*LXVV7\M32"JX2!(4E:\L)Z71*^K]Q(7CDCH_W 47
M#&H#L KZL2;*W7!?392IH7K4#T\@+0?FB0-!"^UW)#:BL2(# U-R_#U3%X1U
M2P#I1;(@%C*4OB#F [=>*W F99UPF7K+K#9.)Z^3LH*)NF/PX()F=,> 2Z69
MHXP$DYO^ IK83#TQ@J/?FJR@3J+Y4/;%VYM^3U'65/-A<O/A;KBOYL.T4-W:
MX9#%>.,(XQ"H(0#)D=+=G9@@N&*0F8^BF@\/;SXLS)[+(G8B?M)I41/U;YK:
MKLSRUL3/2QB_;>_0^.P8\R83QA7Z<NB^$<,H)[%,7E0Y),V*,%[EZA9M2A[&
MS)D>ZW1%]=2=I8KJ.:"Z%6I57DMK J$Q9%+$,G'* ,DA9A5-YI!UR918-;"P
M+90K _P-EMH/&>"7F:GGOB9)9>J9J_QZW[9*&/?!A!2(L#P0B%00A_*,9&.D
MC=;&F&ECE5!H6R5+1]1S1Q%W&RMHZ63'?0V?*COF+3M&;1\F*?6%(E]:$0EP
M[8BA,9$@#<XBDTD[5BCRC:H<7U,1'=?PA'VC!7MDG%'# U+L.!PZ]['0.0UY
MQX9$42@_AO10A=BI,\KIQ#N?\8L)<_ 4=8)%)4 ZT($Y[47B4AMOO3,JCF<6
M%#<%IJY2I3W^+>N[\YR]A\WS3W^GH+GET15V,TE !4X\EYE(;3E0!CG3LN.\
MUFY0_7\Z/N6F"><U[%Z'<<+)3MRKR"5CD2;02CD+PM@(W 6CN:F3?8_)EAO;
M.W\K4?:L6$2+T1B4_YP39Z,AP3FMN&,,'>&5=;[6;BOY?RZXW<;/]5KGVEUB
M%!G]<NP_. E%;EPC&1P*C<.O4F4H3/)\944Q3\9;)6\N[G[9%]'.YXW]%W^+
MX*D+,9+208Q \IX8[6V)405M12KX75D7:^T\W(63&'7*?SSEF]OA;\. <@^!
M1(43#2$*XAU-!(13T03.=*DN@K5V6/('<N-[)L?Y$*;^F0X'7;R3[LG9BT/7
M.QMT!UN'_SHZ_+B=^@??- >NB>*L_)G":1\/3X,7@\'I02%096\.0S^Y06H.
M&;Y\<WA5TPR6GD)U\^7'OZ-E,D<?2! R%9X'2[P5G"A*M9$IX#3"XZ90/>X?
M[:=0]%HQ.\A9<OW.X-OR^HXR]>1HQ%C.O=-P,N0*'A2WMRA"T>D66M2ATY./
M>KVCSX.EH3N58LUH/76F3\[6@$V?0+0Y[:(1B,XR ^*W/7?8>'R%+;A_0G M
M'WR_I*]/"7A\%(]O#HY1A0V!>'0X_/>X7W#Q9?@&@?T_OO_+>O<P'!VDX6>7
M[*K#=T^08O6&4;DR&+_\E+X<HQA,/P^/Z*=P]/$0KQ*;@V(7/SCIG96E5#R%
MD[/FXYNI:9<HX^;_XC_#@?/'RYED,TEC8V 9G/12*0X.K-,FJYRD"URQ '&L
M87C=[O1P>6_EH:C[WJ;;.OQW/VV[+V^:)?Y4]J+/-_;_.-A\^49L;;_N[OZ^
M@Y__=;#U^X;8V7ZWO[&-!M_YV_/-[4_GN]W1O>B-,[Q/NK$?Y,:'/S[M[K_;
MV_VP SOG<6_S]XTOFP>;^\U];V\>C.79Y!J=!V/0.LR:$T CGCCK%+&."ZNE
MH"F;E75K*@/8LJ+P*M[>#57((,4WAZ\:G?'$VT#-$9FC-4PQ6DA) XE:\1)A
MSL12;@FE+BBM><J%C."Z)E /#<^G1.'U?[F<P!!XXC)&1@9. $C##)XL69 I
M6&4HKE86M*J:?A'DR1@&+^8S6.,3B5&*(=FO#5P0J31-W,?D:&'P:@<=*K/)
MH\%1U=7SP5:+2)N*:(-#,'%:L.4L,3928H!GKDS4TI@[ZNJJC+^'&'GRRGB2
M+'BF4&)XE;T%E"4F>VYX9(9*;9R+FMU"B@SPB?%55<MS$!UC"$AD#. X\T2%
M$LKS0(FG*)@U*"]2E"IR/E8M7Y<$7S7R7=NGWA]+52,_%*Q&-3+#/S0I3X 5
M:Q?U,#'!1F*2L8*"5Y[>U7N>@T:^<- O GZ/?BN=W&DK_99/_U@DT21J'7R.
M+AC&K9' .#<12IU4Y"BC0@97U?I"R9\Q5:L.O3H=-!#GO"$0(Q#/+) DC<A&
MB0@AC]U7_T%MV^U%PO1WU9\8(.>+QVH:/!0T6R3=7'AI2]$%3V@:,)^)SV (
MM3&PI&V6T=UO8WW&(+U/.8- :%Q\4K;_;5,D,3G\K@$>HS_*7VB2MM+/G9+4
MU_%GG7#:[Z?#<+9Z33/KATA-'/9R_^WBSL;T<?^UR9]]<1B;ANYC.[@O?>KA
MQO[[OQ/'45;:H.I+:(E3IHE+SA"304KNN-)9/.[4PW;W]J^9AE<6=UG;K63[
MU<LT[))O?5-Z;K/.B_A)L:0OXKLB'89MXO'W.!;DZX6^7OTH=]*7XR-4*!T\
M1Y,Y6[+$CLK/NOU./CULQ)GK?;W)FN!8$QP7QSA[RAW2A^IC:$A\@_SP_17<
M/Z$G;O3D9 ^\1)F&KT[[1S7#\$?Q4NV]I%QD[@U$ *,%*RR_D6;@0-WX&J-:
M]C[B=QWW-@_09SK8W=LX?\%V7[Z@&[__\6EG_P7?_/#^?(/C:_2E-G_?$9NC
M9>\'[_G.P;N#W8-7YQLO__JT\?+M9WS?19^*[6ZC=W6 ?MC^1[J['^C85,-D
M? XV MJ (1* 0LJ,<T8\!!^\%UZ ;2A_<%X7+I^I0K(-215\\LXXXY,#IL#Q
MH"(SS$?* _>^0G+1(#FZ%2*LD-JQ4-"H">C2RL66Y 7TH8%IJ[RV#8L-F G[
MN=04PXE0]_[/3BP>4K_F-'2M48&G1#GSA4-;>/"X%#T%L-9$QZ\7*V-B'E6^
MS$V^C,DYE%XDBW^(L]P0H#P15 ^6 '>*-?0 8%;6U:JDMP^$U/R&.P,K)^DM
M,Z&)7[AL$% YL!"HUS38&TSH"JP'!M:HXG:2,I^=(M$I!!8*1V*D#,2 Y")Q
M'P(SI1TOT';7HED"ZRGIY#_Q3MUQ0Y3QE%7S! (DQZBE="[0C(([*6,3 Z>X
MABP8S=,W^)]<V'->(F-,HJ$*Z'=SDXCD2A$0FA(;T?0/4:.MQ85-V3Y@1M33
M =1$+-9:9<91 1O&P4MIK*2<ANC1]LT0;%7)"XNO495,@5L.!D@ GPE$A58O
M6E4D*R>$,LI!HD4E,SG?7-ZGI)+_71@?\:JIC]]]K HY)"EQR447LP>F\5]O
MT6?VC@&71LNJD!=%8(Q)$2S$2Y3R2!P NL012M=1D0C.::8Y62<"5(4\7T!1
M*H5+4-@+,TB(5C$J 3S8:$),;"J JL"9##@M34M!:W1SB342-6U 2]9I0.?7
MZ(0H2E1FM[(NY+1;D"^9LMU(7_!>#CO':7";\/03EPS&<_2>A):0&3"C3+*&
M"<4"SZB!@595NR@28TRW!H6&.+=.$A^<(P!"$$.=(;S(=UH*OB2OJG:^@$I6
M4<HLU5$D,+% *N#[Q)PVTKFJ:A\".*.JUEB9F322"%9R-@K_C!4T$(%.1I;)
M.,7<Y/105=-^CYJMD[W4OTS$[=Y X/BXA<,D&V-9)Z4%8]P!^K)1.:.-5^@7
M 96<"SW=C;$J)B80$SMC>C1ZEH!I-,&S! *"4>*M%212A6I7^"$9N6RW,ZE!
MWBEK59\!$DN.4I5!F&BB-$HRY:D(+%M1M>H#P*55@18+>9OUQ"AM"5B1B>4(
M'&-<+$T2+#@H:5</P,54NQ).]*A/JK.84%PW':BH5&!U]%Q:'JSW1@ +^89@
M5(U!/8!@"6-2K&V0V8E$7"S4%XX'8M%H)T[ID!B:3KK$H-0J6O2ULUB%_440
MR;H(.@=3]KF5#X:6EC)*!8UP3R%7V"\:[$?M"? ,@HZ",$AH?OM(B55&D!1P
M^@P$2TL:MUH%6QL*WJ9ZOKPO$.D>#AN#?%<->_$88-:8Q4<]/BI]1H[PTJG7
ME+5=U*=>P/#*#R]9 ;[]Q/G!4>_TY/J?7'FRD I;RT.4V1IM[U)F"VN6P]3+
M82W'^U$/4 Y[T(VQ=U&?/D7&A!]*\Z;4_#4IK4"OEF??K2ATX1[LSQ>;6Z_?
M=#J=&\30=*X_OH;_]=:[C0ZGY/7,KS_^^6]Z[@N9-_:ZY6)XX3L]<]'F8Q;3
M.+EXY>^]_K?U]3$1WT_N$VEH"YZYWF=W-ECYY7O2 !0T7R6^7M,<[^TZ,7>Q
M8DE9GB@W>)%,EY_UAT\R_+ E#X>?= \COGM&&N:&^8M(L\:YO(N(Q%]:>OW7
MTQ%F$YNEDZ\[<[GNFA,]ZY[@1<(M5N+FUO:K/SO;6YWM__>J\]O6YI];_WKS
M\L7VJY>=UV\V7VS^]N;%OSI_;N,'&Z\VM_\<5QX^HI39Q?S?.$8_; U\235S
MU0086J8*ES(8](69ER 3]8JAR1Q"=#(I(\W0LL;?I/BB&+LV6 DNZY@D0[-,
M>H.N-7/9T924*"U=%X72IC+97,]D<_[B;Y5"I")[PEGF!+(K6]U!$N&4HDI8
M%;A>5B8;UC#8E*;SJ_?DL>E4'IL)M(>&-6&GSV/#V!J3T^>Q:4Y;>6R>$H]-
MP?[3>AQ:*6@JW\7U];-1*":M]-8P .,\BY+F$EHM59AFF+'$ZD;ICZ@_Q<[!
M#MW=?H&6UD>Q\;)L;/[1V]E_07=?[O;*9NG.P5\'6R^#V&Q1?\;N[OZ[WL;+
MMP*__[SU\MW!Q@%:;2_??=H\>,]VMS>[A0IT\SSPL10T.'79&:<("XX1M-PY
M<3%8$E7TW >G-!=#"AJ^>'P7%9)C0I9""YMC8N@@053)TNR-1M<J>)Y3&):T
MTPK)Q8%DJY)=@W </2LPWA%P2A 3K2;:4_#:1FX+439"4D_:FJI2T%0*FKMF
M'S*N%(.8' 1@#DQT)G 7%7-,!0O7:_JES3Z<EP@9PS)C=0".,T.B (5RA!OB
M3<!7FAN7+'-:P<JZ4FV57M,/I\XQPQ@5C*?$LP(-RG$>K5,J4G Q6W^]0JX%
M[0\,JU8+G4+JYVT@2D=) "PC1B&VC LQAIB!1S26Q:JH'#,U\W]Z$B1:#\D)
M$!D7%DH0DWF6D=$<9+",\^GJWBI!IB5!QE#.."&-$EH1J473:4,1BPXX$4$X
M&AR/H'W#4L5$5<TS!Y967 CNT5?.#H22GH=@:1214J%CH%4U+RRP6JK94J:*
MOZQ<<9I%8,1Q:TDT1K@DM%&ENQU;E6-JX!]0-=?J@2><1NR8=#2"3<&ASZR"
M2<*B!Q:T9AK I;H[OE!290PA#1<T2!,Y\5*6QIF%82,[3;2TT04KI8M#-FBT
MRVH><<7]!86=]5J!,RGK!,9ZRZPV3B>OD[*"B;H%OVBX;_'I"*J<I8HP4_;/
MO*<$77]/F&(RA&R5"'%EW:P:5<L''G_SO?QS9\/U/Z6O[?;RUVRKAVBV-[R7
MBWQ$E %%%-24P_-7?QMM#4W*$>JM(6 R1VT<*4E1.ZF9R)FRQYUR>#"R#(?7
M:%AX]/-!LR)7F[6)WP74"$V>8?,B?=,-S8??$@Z'[].7T#LM4.^X$'!D8LD9
M;'H=KW:Z>,@ %4JO=_1YL#3)@HJO,;A=W<RB) O6',0'S$%LZ]"D\3]SDZN^
M:-E\_&DE)]9<RZ>1:WG5^KK33M(%$I<[\RN@R>D5!R=, LZB=3FP+ U5DB<N
MXH^JUKNY/R#YM-=[]NM1OW_T&8=J.?Q,-#K?T-T/K[L;VY_X!OJ;NWC^G0_X
M^_./7W:V-P]V?W\C=M"?;/N9'\\V\'.\QI>M[9TOZ%\>X+/LE8;M6R]?[VWP
MW4\[Z(MN_OY^?/8E=5FHG&-I/L#0SPR9>$4=T<!Y%LPF2^G*NESEO+V]-*'#
M-SE$:E;F%!.E$R3I(I<L6P1H-LYHJ5SF@*^4_V&B=,7FS+$YN@>43+0J,T\2
M+P!5+A(#3A/E10A">)8X^I>,K5+>SO9XZ#3,BL$Q*8PYA9"9RUH V,B=3%%:
MHP *O7RT/]J6K1B<.0;/6AUZA&59!"*%, 2TEB7^XHF73LF(D\:\;N(ODM*%
MP^#M#/A+#I3';L/_-=RS.NSTOU903\&4O^7H/$%IQ:R027$3T5T$%9A5*NEH
M@"I<U2S'L1O*UT63OE6U#PO?OQ6SOQD,3E.L8FQZ8FQ,.C87+E(7 V'.9 )4
M6^*2=CAQS%,0QB87KF.CNI>9?WOA,GTK8WFAFY-G%.>!)27!&5_Z 7+J'61A
MJ>2^@2Z[A.X/$D J=.<*W58DV%KAI0^$9RH(VO^46(X@EL%I:4'D /[:#)#;
M6" 5H@_2:L%!C"KQP$I?(^5,-)0Z"I0KZH0=AFOI)41_D*M1(3I7B(XZ"2(K
MHV)0A.7L"'! [8IS1[C."G(6R29V7;+& B#T/ND3BQC#SJ[;_Q;!;BAKNB5T
M?9+Z!_B#6,AS^BFG4M^1"NW-_YX>%0*<B]CW,3YQB5D/:7"\Z[ERV& OE8P,
M=U+X<YIO@ALT%[CX]556G9]ZZ9_4&TXMNSS^S>MW?PX_TIV];NJ[?M@[6^T,
M4NILXAF&7[U<8WSMY]4F8CYZFR>M9[N,H'?ZY;Z:4/PE6\_5\/OI8$CO<^ .
MW<?TC<CGZFWR.]SFVBTC]0N18_/QY\[KTY/3?OK*>71:&(I*ZD(N:0>=(5GH
MX<<R4LWPE/%L/DS?93,\3$8.WGGWY.S%H>N=#;J#K3Q\EO>'$8]"\QOOL23H
MO2Y/\NK+,:Y9=W+4/ZM9.^=O_@[<!)NA).PX12"DTG-*<,(E3=2@32Q\FR6.
M"1YX1/T<!$3M/!5)083,4M3@Q>/.\FD3BQ7DNX.RD(I<R4.@G%Y97=>AYB<4
MEX>A>XR?%KQ<2J2?Q\.I>3V6B"RF4M'28,T-.GLI?D3!=2&^ER8C"/@:-7+J
M.39ZC;+IYQG5LSZVL]H%2[.:93;+*"/B)(E'W[&17CV4F=L,PP4-[H(,Q+_=
MV86$19L13<IC/,M1G"31YU%% 98RL6[[Z,3U;O.@=T[96JC'13B+I7I:6*JG
ME4OUM&JIGE8OU=.:QNDI.PC]Q<RLG:T%=L>J[(?*I9WE8$P0&5 ^I2QUICDS
MX"X8;E/2,M,2?%?VA[V?OF4);1X=?O.V7W</'3KJKO>OKO/=7D/;/7;[:"F"
M!6=;VY_HYN^[W<WS-V>;YY\HOO^\L[TC=O8_G6]M?X2-_=>]C?V=L]W1QE#[
M>.[MMW3WX(W8V'\C\#6^_W5O<S]VM[8W\+H?SS8^O#_;W/_CT]A0O)>.)QDI
M*5VV"7@KB/,QD:A8T,($[4 6X;$*M-W"^8;2SNFLWJF4=BY=IN^"2 ZOD_!@
M!0.6(3MJ@S#">0[!*@<J5,GQJ"1'BY85C44C(9!H2RYB9H$X307QTB9A+>*0
MVI5U6.54/0[!4>7#G&DA#.76I!@\-5#2OAQ#_4.CU32GH'[8B/K^\J&*@,E$
MP&BF@8[6N) 9X28V],R:."DX4<;EC"\BDV)EW:A'8CE4 3!? 9!-I#'EY)U!
M 9"\YS0X40+3^&&0U;5X5-)A\[?1@J%@C0\Z$:H:UX)K8GV.Z&D("]8J+:0J
MW(Z&MKD=JWRH\J'+#(6L-+.^>*':NL28L<%1K[)7P*M\>%3RH47*CHX#>N:!
M<.L5 6XLP<DMK5:D!:-"\BP5]FAFVO6$53Y4^= -@CL.V?$<+&@:3>;60HXV
M*E[X"*M\>%3R872#P23N#6= C.&) +69>*,\H9EQBI8$+L%8*&RYJ?9#E0_C
M0A<Y.D:%%Q("2%!6*6$94QI4@I!4E0^/2CZ,[CY0F3D';4@(F:+]4!I/B) )
M?BHB\$S1<"QU#E15^V'1(KVSS[SZ]V4B\*,*^BY44=A]0[^E;.#K-(R3D%5
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M@-R?%R0;/3 GJ'8(?AZ=318+,*EKR764=;5? :$5TTP4C +G30\TT*XU1=]
MNV:@[4XY2C%YQBWPD#-@DL-R282<O,3B=(I<-]"NL_<[?Q:^>;\K1^=E1.JM
M5!@M"-04D9:D*"*U$I@(GN>41?:<(E+;O-^UPN0"J/*&R15ALD.7:Y>#9C)
M&>[9<]: MY8@*A3CDB>C6!W2*;MT^?)!N20J_&K5:.K_O2)XUK6VO;_K7MM>
MW6E[M=KVK'<^&C36.QTNP>V=#'J')V=GW_6^^=/WC[_]5_VA]TW_.!Y>U%LF
M6'_H'P^_.RF]U#^+]'C.O[VE-^0A]X;;2LUP>\]/3\[Z582^&^2Z7.#O_+QF
M3T!L(YYV3\.?Y?H.I+/"9Y$;'LUFYP@V9\?S'-($;<?SVE@!,6W.E'%"B:P@
M*DF>F3 .@A8)@HP!!=G^$LO6SLIHR5D6K3\J=*XV7] PN0),=G(%C"<DT4U
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MY5SRLH-\2J^IJ^HNR>K303ZK"CAMWE :K<V]EE3+;0+A_ >RL&T4]YOS<OM
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M>23DHHPJ+@1DAD7HX%+4>FN'JQ5W]#\9^,R-K&OP60!\.H2;"BF'P&S=99@
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MA1*BX3&*Q#+/7+C< +YD@'?9-O32AVR SH4#$JHA. P@K2^E,&0I4/BA!#:
M-X!W >YDM#E8@04% 5R&0A& E"Y$QH62L<4"ZX3^#@68HBD"K2%[KC1@,@&L
MJCL=Z%A5T,KGNLE!/&,-_RT66*PF81I529'SY!)*Z:UDVG-O&7=<B62:)EDG
M3=*A,2E&R-'5+J=<FYY\7;/D;0%OG:YU2!@$W]K1SW!*J\43U21?XUA]_.O/
MP<G%<8+QP\B&_F>?+X]\74*#Z&@48:]/'QU/3G,=TT9J87A'PV[167C8.3RH
MQY@?<B8X4:1#IR0ZF6SM)'?)"A\<V?LTS ^)R_R0F#$_=$,!\N@@7Q__6D]Q
MO_QP_0Q;&?*#U.W'*22NY5FJ+!P8Z22@+0@4QVDP)=K"=4FEU.$<>N:DT9RT
MS3Q=J@=>T2R^5M,<TS/+J@B)(NJ2.7),WNG">8@^)&V<D$US;(SFZ#*Z05%\
M+DA58*SM>A3\U>HY2$QI5HK-)M1VO=G3S>NB.9XFK.^ ZAB3C"'J3'$6JDB'
M3E@6VA7/G-7&SH#J^8*YE7;-">3=V7B2E#4*"9E)!#1600@N@"A,9\NCR#G<
ML[2KP7U3K+@)A&Z1D_0I(@O**Y&RS-F1&N"QE&;%-P;@'>+6:*[(D =@L?K_
MJ3APDB7@*?D4M+5,$,!-\_^;YKB'YBA<19NM\%QHU.0B",?I783.PJMD<],<
M&Z,YNBLJ6!3:9PLII>$, 0G>YE(W5G E8HJR5G3<9='I*E7'?3G4C2))+X$S
MI$E/K]#P$&IT$S78<JG/R:S2F*E^W732PW32IRELI@C.T_DPX)*QFCP2X*5U
MD!BS7HI42%JW=KB[XXB36=&_#*=EG:8OX+92,R#N^>G)6;\^Y>^&>W;Z?^?G
M596#V$8\[5XQ*:CZ#N1I^&]G'L/P5!74'!C6IJ 6IJ ZI"E/E@=&:JDV.D#M
MV %;ZA=O9="*O*9DMW;PCE,$EZ:?&M[FQGTVO"T ;QW^TAI?BK<DI!&QCM#U
MX(R5H&S1=::-"]G5JE3> +>F@)L#^=@ MS# =?A$YQ(ZIW1=7U6S@@+!H^,@
MA4P>,PJN>-TSL*Z NX,'_A!>\)&#=@Z\W^R@;069\T1TA^<K@F.(/('*-4-0
M5)V4ER4P%:H:SBEX1C'U,V'O.*IPH9A^$GS>9Q3T+L[[A_3"]-2XO"77,4YJ
MI:L3^.TLI^9./$CYL"F$G@^Y6A(.WOE<VT85A)(-!<W%%!]TR:HF&<SL>[#7
MT9-H7%Y34 LB\YJ"FJN"ZA!Z)?KB<I3@A]Y1),?(,J[!I,B=B3FP$LD[XMWU
MABM74 UPBV#S&N#F"KANGWGA@2M>(,GJ$4C-"' Q@ R\H+%6*^D(<-TU(0UO
MJ\?; LB\AK>YXJU#Z*GH,QH>P*42 ;-)X*(W(%%IY:,QS)B*MS4$7./RUJ6(
MKX%VH:#MUN89EKDW!:R-GL)FJ2'PQ$'[.@U2YJ(DUK37')IS&EDW(^1^R70Y
M9P2)VII\<7Q)V#WA.KR5<'?3"HCWRV_'%Z2)KI30Z*R::GJ@:N+_/WMOWI18
MLNT-?Q6B;CQO=,?3Z<EYJ+Y/1=B-Y;%N VT551[XQ\A101 O8%ORZ=^5&QS!
MPEFT]ADL1,B=P_JM*=>PP*/'$H@-;0CRDAC0)X1!EF*.E! !WK(QQ?3N@WR$
MA(/2H5<Z]-Z*0Z_D6L_*M>;<?-82ET,8D&-<(9XO(RQ0,%($V!73B4;'<K+#
MZG&M$H5/FZ]<HO#)4#CG^V-@SCCM(M)8A9R-S)!1AN>@!!.\B5Q(F9WM)0I7
M$(6/YOLK4?BL*)SS")*HK.$1HUS@'7$+/S1+"5'XW<#AINAL3K)901B6'L'5
M\@B64'Y6*,_Y"8T+2>AH4=))(ZZ91(9JBH3@VA)I8_ NU_ I_83/!\3F$+Z;
M@.)_-G?@RT;RW5!4X/PTU@^G#&@6AUPRHP<Q([HH>5=[)8'Q(!DDZ/0>]'RK
MDT<J<2V9)5$( 7K%JN;&E;K%BN:SELA^9F3/><^P#)P3[1$3-"(N,4:.:(,D
MF/'":<V!;;_[,%\9?C6 _49!^<P>M&MU?$IXOA@\Y]QJ7@9L13*(4)$0=]HA
M8R)%,FIN+,F=(RE8 7(%@^Q+;#Y!=;X2FR^&S3EG6U**!&PB<G">B%.KD)-4
M(.$4#D$K1H0$;,X7M'EQ:);Z\*KXVDIXKPJ\%S1MQF#H:HQ83!3QX"VR5'D4
M'+9&<<TT+_+;YG7CT@'W5.BLQW&E P@<QM&X4@3%Q% 9#RJQ?]0;G,98<=/.
MY:/?*O8P '9/.H=Y=3FN+W1&'M8_+GUWSQ/)!V>U-3NJS].3:@XV9N<TFG68
MSVSLZ]DA-5)U=D0E^[H;^V(+7':2XD0HL*]<\C,W>V/(<D$08V S$*PI<0$,
M^S=0;N]G4U%>*LBM!/1S GK.4R><9AQL#F24)+FI1TYLA1\J<BQ$H%@I7WKJ
M5A>+CQKJ5F+Q.;$XYY93AM'@HT8.QXQ%)9'5W&4O'9%"8A,UF/ZK5'2GQ.*3
M!;R56'Q.+,ZYX:147GFB$0C !(IN=$@# E$@COL4K2-,+LPZ7PTPEHKN2E6U
M*P']W(">;S,<F%1.2$1$-(B3P)$)(&&CEY)0+@5G.0UME33=)<ZWT!D=]>QI
MGFS\,0\H/WGUDS^%5_//HI.Y/ZV,LW>_5W3%J81.2C&_'<MHPU6(-@2AL/'=
M%[<MU8NC*>]='L3^Q0+')<$J$1P9LMAKQ"D/R#H,KUST5#)KJ5/ _DO'Y5O&
M]?/%&I:X?AI<S_DO)1Q7C)(B%1V@&4N-G$M@K"FL!/$Q$AD6-B5>#5R_44RN
M>*AAB<ZG0>><1U,:X+&:&"2U#8C[W#+0ZH02%0:;E+2RH)2O8-[@&\7ERU;N
M*]'XK&B<\VD&ZY10'*.4@@,=&%-D->C 2@<3.;<I$+PPM' U9&6I Z^43[/$
M]0OA>KYA1R(L*D]1,IPB;DQ"UC"&P,9Q5H!>C&G.HR.K!.SG=L$]1<&MVV%S
MW8^/[;!C>Y4]VX$1<PAA;S#*37FS0RXF^$;NL%)< %2.>O927<"RSM;3>>@6
M]!D_/ZK-?%+KA^&OXIP:A]7I*<UN:?[.9U0RKCLQKMK) J><(1A4#FF1HYJ
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MU'SP^T^-^5+#?Z RX&),0B6<$O -ZS4U,2J1L J:2_-@#;_D&X_)-^;\DER
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M1G5[UP3'+-8:::,<@E-@R'GBD54@(J+.O!Z$#9TOBW.SB^8',=$/=MF\S.7
M5Z!=T*V^Y$RUV]XWOKBE\18O36<INE?.HP@HG;GX;V0Z>='76 X0?K3)>Q"A
MG <G72*@Q5#I5$J:RF5E^&_(V5E60+C,TSGG/RPK,58X.  KD/:*(>ZX0CJ"
M3B."U$G2:%5N93D^&<Q+J?'IT31N?I&]^?Z6%$Z?+?MW!QZ1'W,3+YK'P&)F
M5&1'R]_O'R;V"$B\NF5ZC1<[,4OP_M]CV+;4N<@JGT8.9%-^9OWVHRU<NC-?
MT-E%6.7S10SUUJ$?]&/ES/-669_F,8.1P2N_;'S>^I)OXZ:NH[/HB<N1X)?R
ME<^C'^;2YB^"*GZ;18M/W5#9.S^EJWPQ-1A>NK"Z?&OG8>-CCC:_<F4'K\)Q
MX>R>WMP5'HTX:PE61&!<NM6;QF?,<NJO/GQZNS>=0N'(/@+3K>B=E,L<GUW3
MP:?Z:Y7UBQ&S R9?MNT56W%Q<QHO7QM>W(.&[)]P$:85+T>P@\X$*UVP<8/*
MX6"<0_GA@:=7?2I7XT0R-Y[&C^39'UYRZ/]V5A7@_"XQQ[=,@_GS]LQ\*]?2
MS*\YZH>#23Q\BOAZE6\'>9#2$\4I-Q9[QI44AF+F"8^E(OKH@N KC/MU-RGN
MC6<44:T%XI)YY!AVR%MN:&#.BZ#??9#SA:-O>U<XISC\7HJ(EQ(1<'[H3F*B
MX/CGG'YV>;@@Y::(0<B"8Q'7OYYJ/W??<.X+G@8UC#J7HA1&QZX[X_7V[&+"
MVZ.GX$&.*F:,)BPZ"3S(NH")200T5$LT(3?4J"MYT$-X$&U4]W9%"(DJBU%.
ML4*<<8R<DP1A:9SF7B7F<D_)NQC#2WC0J[FW^G>TO?&^+\1Z<7=2='3LI C+
M&AW?)6ESU6S*V7C3R_ZL#IUQF9OX2'$GM;]\/RY79[K$JJ8*31&8-A=A</62
MJA@<&$E6)L>9ZTSKD<"O!:/Z]2EX#U:1Q( 5C2QRIJ-)EI)$P3R6TGA3QDH]
M >\1C69K%W-MB6 ")9?[5">AD,M!N8DE^,6"+F3=NP]4+N ]OX#6?'=O_?U.
MNO36/_;QMTY@[KM2<L*H\B@P.'1N$T/6IY3#*KRS(:=[J'<?.)XO3W'FK?_U
M-C((N-1]0O65]$QH%J*1A&O/046W E-.G?'2NP>'ZI>U**:4D*/S*5<4*TZ0
M,+F)1:Y<8YRA2&H+$(_$106&T/RMS7WYP/W.=A$?..?FQ5$N]X663.#*T?O=
M0'4$O%.$F00FP"U!FB:##!RY$M[%( C(@/DR)%=XP!3TERN0/*+F^:(7,/^3
M[>-!_[7HS&_Q!N:LU!YHL44&P.6TLZNE]JX2W>SHID&WPY@*OVE1I]3Z_SWN
M3,L0S%(&^H-<OA26FXOOV:S0#HO\@UF)S^&"\*GBB<78^_:?G$ 2#\_<CZ-.
MUL4;?CPX+R-9W&,3L5;9R:I\3"E/9I9S!T/DI+O?+BG\V=%[.*CT!C"'8>'\
M+ J@7DJ9>ZUAP5_/O,.C&_;TM\O>ZLZL_.MY=N(EJR;OV2PNX-+'+^647$^+
MN<$!,U?PI?CPEW@TOEP&%$\/<.I*OFFP*R5=LFR<O9S-I$BMS"%V\(<B#A (
M9S13H%YM=<,,GRDPBP(V9P55YSWM1?')XB#[T^ .(.CIJ[7*1_A6@<'I&T $
MEVH09U-T/'M*'N^.1<T2I5YY;0P3W&'O# ^&8 4V3B!!N;M=NBY0,+Y-5_JY
MF/"%BOE3JY6LT=S>M28QP[E$$DN.P)!0R+ $]J72Q(M@HM9@7Y(UNC!H>WC'
M<PX^:I&B%9P$'KS5<+X"S%EA(_61A?*<G^"<8>X;N\QQ"3NL$9@!!'3(Y)&Q
M2:"<4TVMMHH0G,]9W'"3<H5K9OY1E)N;.NM/,P\IBC-?XM![G7_RV[/\Q6F*
M>F9#AX,\*(QU]5XQ<YZB4%T1Y'TIIMH#0]D;#(M+T8N<@!EWRH7L#O> $[GC
M<=8L"O;DBT+JEX;/PF?ZD!NIM:"1JZ%G*1B<K";!NGS3YQPUQ%@LG6:$NSMF
MF%Q<8:]?HL:?+[K#G^1+/4UM4I)[I+Q0B$O#D7;6(;!CA+$T 6MP"S/-URJU
MJ>RI]$'=\ON#G+!47+/G[3V[L<Z7Z44RV/@']'9S$^*GIH7Z;$8E39S11*-:
MVW4X@@ P$6D> N(^-^TB/B))++.,"6=STZX%%[U3W2^SG]&O153%E$L4_1KF
M2O,56F@V@R\2G&W(ZME9AO74 IEJL?]TLK)TEL)]-L*%,GK=@[\/CURK_'U>
M5QU(\7AT7$0FY+O?[]-GY&_!T=M.K_+W,'/*K?RWRB^?_][Z]8*^"XW:5J9]
MY8_.!=FUM+F9O=$97DNRG'5^./M2P5O#/&^]R'N?,=E?+Z(PSG.1P$C.5PW'
M1V?5^B^>/QMF&,%4RUE_TZU^DOJ&%BNI)&&>)4Z(!PTB8:&9B9:'Y&_P1ET#
M7GD#<4=@DEKS8)=BK*7F EA; &8=C4$V :<CQ@>-18R.*M <\*.$8,S\ :_5
MSLHFTO4(I=&Q&P% 9I5/%SD<+CL5IAK--)P@AT?=F!*W:A4A7T_=QZ)"HWCT
MPH^YG.3M1GVZNH\+RG(6-OIC^F;+NHFOK&[B&Z:RCTBJLE+D3U,I<A%AEH4B
M[U<H<EGAQVN%(I-Q$H,A%CU/W";B0@1[-WJ-'4],T+L5BKQ"ZS^,A[U'GRQ\
MSS-<SR6^AKF,A!V-COM'TVBKXUFL>C_:40Y OZ;/7FH0]$IUUHMEG]<-&"U0
MW.?3]D:5DSB<!JL=S_(.^O;03B_DIN%PL)&=T;B(>BLN%6#9L\+[TX?&61N,
MJ3J\(#']/.VX2#"]NL-7NKL]0N.E2X[ESBC?$L)Q-]+Y]JQ?$$4S@ZP)3_NC
M-_ '/YU=N,'K,*==EJ1/SD7$F39@&-*(--,8Y9I.1G(1G#;O*A'LYZ.L+ R/
MXX^8Q*K!HED40SKO\W!.[LZ.+JXM$PC@P4G1!..\<>&T=EU_L#>T1_M F)>8
MR6VSSV[<BV<WL03A]]$&Y)HP]-$MK'+4<M1RU-<VZJ/VPKBQ"3WY41?ZJ."_
M^GH3[ 4FV'66.#A:+( H*!/</[I-B^>L^!\L\]6LAKRIU>!%QMM-9#L3T=GJ
MP5GOJ!2=CBO_15DQQZ54S983]2T?\1A]%YYR9Z\U>/MY-^)ZQ?&?=R>^?BDW
MX</7_[G-)CSN6E^$M=Z> ;R!Q98@OQO(W\"1ET!^BXLM@?RS _EQ+(!;7G9-
M%WS//H@_=(LNO6$NUIX=XT4T70[S?Z(Z(GQ-+/70XEQ(9"Z*)6\RHD5)D3E4
MV%',([S[\(O]]5^_N%]O?4]^=]R2^YSLD]VO/\*IW[$T/TU>84\QB99K00T+
ME"C.K/9::7]#J20^GS>ZX.:ED<XH\'/.9GG]P7FMG4^C=G- ZLUUW)IXWFYN
ML'IU'3>J'_NMYMY)K5GCK6Z]4^O78!Y;HMZ9?><_G_9=/_1@7:16_=RM3_9[
ML#9XUC:O[;3W89[?:Y/]3HUNG<*XIZWN ?W/9&M<^X*__]7<&-<F+?ALZ^0O
M]KD7__WYM+T3CASELMUOG=1V-@2,PQJ;WSKUS1:M-?<[C<WMD^+U9DNT^QNT
MT?R6ZI.6J'=A#YLU4<^?W][%A%!NM$<D,HZX2 X9;S!B*4FBF72,DG<?&"!\
M0;#@>'#'H%!*)/&8)!^<X,PE@YE-4MF@O.+4^9+2WB:E\?K)+B$F1(P)<M1)
MQ!6F0&E<H:2##<0PJI7+E*864%K)^Y^*]SN"351.6Z4QCSK9E&^!@S4Q6="F
M:(G(ET1DY\>(K&UNG=8F6[RQT^[ .-WZ9K[\[^W7Z/:DW?R\7\O(W*EW6LT_
M%O'^H!(P?.P1-L(A;K!#-@$BJ0+F+[UG,:K'X_TV,,URES9L,+= ;U[F" ]&
MX>$F*5%2VMNDM,S[5;0X&1Z1=8XBGC*E<8E1X#Y$K;B6ON3]S\[[A4RYFZ(/
MPG-. [%1"18T33();*PL$?F"B*S_^6-$UJN@>3773QI-3]L[+5ASO=?8W)JT
MJU]%K;L-FECKM$7KW7KSXW5$DOK>+F8@\H-FB(#BE;6Q' 7F/=(FBJ"]4V
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MB=IB5T*@.B@A!*+2Y@LI+9$Q(J*@,)>&$&X8!^UN"=I6$ %+Y,V3@Z"4-Z\
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M6%#1HA+.XY0\)0 9_4/(+*@9>.MZ!2M19>!+KAPP[OR3R_790]L['76>I2+
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MOKW5#&'"@K,)_L]MOKTM@?LJ@ O2UE.1"S&PP&V0CN)DO.#1..= !)? ?:7
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M*??\=HG'I#3%DN2["A(%F%HK9%A?RK)XGSK?8T"3.!R4B+PC(N<<93K:)$C
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M/JU'0>2<3PM39[1U@$BJ-.*6":0C(4@JG6\9A)8LECZMYQ:(UB9EL754)VZ
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M,*( )S("YUYF%20*;DA7MP)0MPPLRXSF5C,12D"AI#.QE)20HU?(?+J^J&[
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M EJO()"Z(YE72&&04 ^V9GBVIB]KA\W-XY8--FN'S:PQ0FU<R,9"8=D#9A7
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M-W(G"ZYS->2VSLO=1*[BR_T7-R6VQF1+,MGY BL223U&70QPJ8C)@DY@9>+
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MF$EE(\%Q9=2)!#1;O&-,A$E3D^9FY&UR^ _!Q[.:[]//7*?L^UJ&)^.\=_V
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M8_H[]09G$P?0S#M98]=7JE-?#L>3?MS^/!@S9VL5.0N)G"LBU!..5)#6$2X
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M277,KJQAU#.0(GOJHK0R ?[/';65L+83-F^&F:BREKB&A2PL 24T<;$T1]3
MDS2<,LNKFW1UI>9,I#'EY)TQ0)/W)9Q7E*I=^&20N0+6=L :T:1&:$&%(BF%
M1"!2CH!%6MP>6@A\$:Q#P/0=)$3<,S>IJFY2;V-*6469M ,?LH_ >4PN0T3A
MX:J-V6[Q\;KI)M46I7^6@D@947P(Y=#&Y(%PU(--CCR*B9NTIE.M*)K4.LVT
M4-)1 QK-DT1+/)3PTLFL:SI5^P&;7Y\M1T7+TT02-X8 /B >P2+"Q"2R,<E:
MA<L+JQL1*PH4P'^,X3IY#E!:ME-N=)0*(#HIF*F$M9VP1O^0F*DRL:0$&R#
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MMG_D]Z8]R*T381<TQ>NY_G$KM6*8.KVV%V$20.#@\]P&]&Q!\NR!RH/W89Y
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M2#ML$&.:,9D<5GFKQTPIR#\F&S<E:\8%SF62QEK/+<@IUE%)QKGGVF#A:L'
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M]V=P__.B3F\HKI<(*AEG.Q-^8RV7=962ZM\7IO&B[L]U9'34U!(JN:324$.
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M&1/Y2*X*1)^(RW_Z$"][/2 \I1HA+X81AVKH@%Y>%6\NF>:C2XP'AJ</?]@
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MMXHS.=OE;ZTYWWUW&*0XKEK=,%1#3(/LQXO)F\=D)-.!TJ2@;^BCDN\U%3/
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M>?Q@9D;5=U=\27XNOZD$=^[EO*.UN3R'_L>@Z'_M-/7& C%64S/:T-<ZE]!
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MK^)#!*6Y=7MPYY4I.2"@-F/< M @8'3!U*'#HMU1&.)BI]EQQ\QA7)GS]^1
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M; MJ6YPSX*+%"V*D0V=?/:(>SR)*@\@W:DZ!+\*A4P@*LV.!58VR1\Y&MU"
M9D#I\J8BU% UHC.&:R_/3*:X8)*W;"#6,=EGJ8"U/@LL;HE%]'&/=_:Y65:,
M4]]85:<Q- W>NC%YY,8Q!K%5[ZP+I?D>P$S303]]TG(SJ871>669,/9D%F-&
M]JX61F5)_H+H>_,#8_L4$IUJ8D]A] B[<8RYJEWQ!+[E"#9ZJGW:3T87*7:G
MSL#8$F'LZ9P>JT:CY:AJ,B3(RKT->O9*+.. :'K<R@V,W33&M&O)I&I3P C
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M .T&@#8;KTGH30C%*, ^(B<ZIU+R247DEC)C;&1$Q\S!;"X#ZXH0]E7>@97
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MK=IEU#'VG@1WO9_O&7)!8]W+.;J7,E#D;#%TI:[6F8_\INC)]RY5T%KFC"5
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M=.77%265TM5-?WA\R#0UG&X;J2R?D4HA[RSK)\OY[O"0]\N'R=%[>GMI7@E
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M.062':_L#/:9ZP:&OEQ.?1EB;6)::MFH D5S0A^C]2Y@ P>Y#1_MZ@+UT=Q
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MI\A&%/W-&EH(*7@:JGOI5'=TY*"T1B%X@,K9!8[16>]3=C&,-,$5QNA<L12
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ML@0%W?35 %JK)*P-*&TKD[O[ )OUQJ0QT3BI&9"=R"!IR1QXS>KHN5)D(7]
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M^O%#9Z^D7)OS=287CKM7"O9'/?*]#W+W9V?BCT]]5/[^WG]O_MXCCC_T2C6
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M]G:'._U='/2&I?=?_\LI T]ON#'=5TIY01>R&_LX>+D[WA\=[/SX0<>W__G
MX\Z_=_&-/]C8>?MQZ\V_/VS\]OSSQIO?=S8V7^VL;[_H;ZR^EQMOZ"C;6X<;
MJ[_3=7[\YS^?_]3KV_&=E0H*!\W(XRL,I$W,I42_Y0!19J45V(7==WHDF(.Z
MN!_R()'4D"#\:S0L>3RF%TD:7N_ENA#=D*67N\3V^W4U>B\(LK20B<"W3^_L
M#WM3T49Z?93C\/UN]Y4J6W30FOT@^=,_AB3LCWN8_J;ES>/NP\/]#WG4&PP)
M>R2Q.[W)=*<*VG'W+?&T]],XY][ZD 1V==DN/UJ>F68SN:-U$I-1/T[^KK+9
MWSW "?'-HWY"%$_T0HQ/X;SRWV'T\\K)<QT[TA1WX):%K_PQ-YOG4S_M?SC2
MV<>^.#TW__H5#./AX&#_]*\<N\:8*[#I[8[7OAYSE/*H<NB @)Z?'/WR]&@@
M6'^W(XON2T_G'\(,CW;GF[P]O2;OEYWU];*FU;73$T^O>+F[XAERG[P'R^2!
MG/HN7Q:GOG?64;VDZS'G.NS5SC_;Z:<TR)>??W99TZ^C]Q?,NF^,<KJ?-_;Z
MV?K&BY>]7N_R$[8N:Z1,'NS&J[6>Y.S%M9]_\?V?==]3BVCA>>O)Z,27NF=2
MR'*!,"VPFH[__##Z*E_O,PNCC!\9%N*D)SCXA(?CI9]/$BX1S1=[T"Y;2==V
M&LV=L,%@6>IC=MEH<B>3%^?X\*19YI9U9Y3=,$6Z92GU92B2ONGYZ6]?#9E=
MV(>]N-RY2UJMZQN;SU_W-C=ZF__SO/?KQOKKC3]>KC[;?+[:>_%R_=GZKR^?
M_=%[O4DOK#U?WWQ]PI68/H\9I2RFZW_F,^+U"9WA*TQ^SA@3$^M28I$\*<$E
M:L@8 MF^ IW*F:?(75@ZP^90])".^1[F,N[#XL<O^+EP'Q_UGL7]@VKICWI[
M9%71W=$?N90<]\?5_-_-^W3#[WLX&N'N^]R9WR>9XH3)==(3*$+7]KD2A31@
MI/'2"X*Z-)D>5G+YW6HE'BZX8/67B4MPS GHC^-@.#X8Y8TRN<R-T;^.+O+Y
MY!HWROKD"I\=N\#-NG:;=!F_#(;QXX-S VH(XJ]W@#F!U8K1 @ #+SAS7 5&
MME+7GA]TT4N]3,[27C4K1P?Y+%$]TSR^0F^WX^MS2"YYMKT)IX<\&'[J]<>]
MO5'>PU&>>"XQ$L=7SV+BTI)CT;UVL-M)\]Z0V*A/7D>B^Q_UP^1+U:V8A"A^
M67;+:OG)J0;_.9_-C=OEWJK+*!TEEMTU&.:"+_.)H] .>X\.ZT[_Z@+S8U;=
MRD7J=C3\=%8GM.]LLW0#S7:G4;"C",E<Z]0O-VO.V&+(EOYQ9S68FEJP%[AW
M21<(\7IV%TYX!:??Z'VZ'_&#W0\_AP4LS1D6\*E2.E57U2[E52?WQJ0S4^_H
MAJ[2N[C.9_0UD-R%\,I1-+G["\?C?,R</3U^\J"?TJ"/H3_H[Y.]=)Y']0">
MR/GEY@$\C"8>33PN(1[?:L]YZ4=S]ZS'WT;#\;@7<30Z[$(I.]4-'9/C6H:C
MW!N60N+2^PE/-RK/RENYN"+Z ?L.2V4#R&Q#\!R2%+5HPCM'%RB"Q#Q);I$7
MWG)^U@'YV6[ZXZL0=XOYZW0MGTV6\I=N)3>ZA;SWV\_3M!:^M?,2-GY;DUOR
M=SKV%E^7O_<W-E_2\5]MTW?4VYV__MG:?#78^'4VK>55OQY[ZS.=I=[']I^*
MCJ77MNE>?EO?WMI..V\W7WQ8_^TO^,_GE_--/8/,-7\@LZ2%8B"#8QA"9+PD
MC=%C3D)5X]=<K*?P%=EPUYJ$]N."^2+C:@)Z(Y//)AE/: [.6F^$S*I.UE;V
M##0O&%?38'U+L)[MC5$R8"[.LQ@3,  ++.1$?RI M-H:R<O2BI+SL#YM4,T=
M1/2/!]R+%*=JG<!;@.0LD$+VD7 <3$XYYP!9=[@530O?2;C.]:C@NA1,N>I>
MS<"66F^F(DM%:@#O9'&)M+!W%]3"#9JWHE-SD@F")M-8"9!@'%<YQ^0P<V&=
MB:=CL^G4.P/2N9Z5M:%8]F0E<^4MF<K.,B\,,@=<!TY2XK186G'Z_"JUP?,V
M-&=2*=@,VFJN05H(O@3KO7;":*>FFO/B*=,-E#<!RKFA% #.YU"8R2HS"-8Q
M1XO)<I0.B^<V^DR@G&\UWQ3G'52<$9.-KF"IEJW%Z'PII#-S"4GRH,^ 9E.<
M=P>CL\XHH/8FI<"LL;QV8(LLU!Y,3MA2E(W*U%:NTL^W@K]%S7FUV>MW(29^
M% H_BH$OR-QZ^>SUA!>5?#3YY:?P79'R^TA8=S@4/J6G"3&]W'WV9?G>T.K1
MXBGYH[>;O2$66YN/E*<HHT'!F2H1:GU781A1, E*AF230M27G,!WWNREFPB'
M_^"(O7RXNR'VKB-VUNX0#E3.D@P-\O<8^"290R%9$)!S1(]27W9FYBT@]@<'
MYDW'LQLP;PZ8<^%N+#*'"D>7'0,M _/96F:BB+ZDVG:W39.^8?Q=/F;=\'?'
M\3<_?8D[;9043 1O& A'#GEPR+#;&%81;8*&OQ\[*MWP=W/XFW4E+089T5A&
M5.L9 "9&Y@[]T*!# L%#QH:_F\7?Y4//#7]W'7^SCJ'-0A<#A66!G$$"1_9G
M1B8T@9+;XLD0O47\W9EL[>O,8U_/^U\BTCCNC?+><+0_*0VN]<,!!UU8>OPA
M3_*U>^Q+0+KW_TU_C?<KB_LZ'^<-!ZUI]:8$]FS\:KIT+W<W/^1?)NOVNBY;
M(ZH+$=6?"[*S:PLWH15+EB,#I34+0GL6BM3&J&RYB8NSL\_H:W,U8G@E30=O
M/87T07##K:6#-Y:X%I:8-6=D"M+&Q%F0.C H/+# <V"8B]#6!T6\T9*][Q @
M;S@LWF!X+3"<C6HCH JY%*:Z!J"B..9XB2R;+*/P"(:[Q4G<=U)9-Z3?L.J]
MTJSQAOGKP/Q<)-UY,I4\9*:E(@-=&& ^"L,X!%ZD30;K<-&6$WYW%>Q5Q-T;
MV*X%;+/>L'0HB@3%K%.D8*,4#$M(S&)2J'5&Y]3"7.^F7W]4H-]:<GF#_+5
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M".BL8:X4P2 ;Q5"KP 3]R,K[8GU<6G&B*;OK5G8\N10XC^C0 ?@4K(E11Y5
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MP4:M]?K=@Z?V1,'66*.L@N0*@A):JF)RU-D$V^!YU^$YFV9;#*KL?629.\F
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M+'@2T20/*:B]/!0"SB+GN92$)OHS.CM;9KH;,RW[,R9/XA045Q!K@K.7HB3
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M%C*@69($@L51P!(E$\4B'IO\T5,2[H1K/&9730Z;/7C;[O9N*U%:436J+)$
MX?AB$-<%"V=5ZX^18#N^F@VLF7GK') INBG?M\GF+;7.<ELQV>#;WF+[T0VV
M?T"J<;DUU^[)7/N^++$S/9[TJK7FU8E_G@V>5Y5R$8IZ>CG84Z.B1&_2O7NK
M<I\?]#5N66$7+B(:(6I.OTG+QTT\VHH%O0"VPS4-QE<<=)*<-\_OPQ:_U^7@
M1=O0U34;8T^.[^/_(%EOK;$/4/)CW%%1XPFC76$5&/P&+P3Z0S_!8*-KX&Z
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MFBYZ45@'CE^,?29X,>$T!]#2H.<Q['B)'AY.Z:@N:X[9. ?'UZ:UNXJBU?S
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MC1D=OC\]OXPNJ ECEJDTP$1,0+/(!#R7.LB84B$E0L1,/WJ:QIL*MM;1U;?
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ML3A'$1,'VOK^56&G[&S.@-G0UI(#IWFD0Q;S+$T$E3K+PR@+$ZT2J1!0,+-
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M6.AV@4X,E'JA,W#1<V^'$\+#,%B@:G[=SAJTH^8?JI]WCZCD3H+>"I+<86+
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MXOXE>T6N#]5 ZJ-(V[HU1[2#T@HBE)BNBWJQ$:MMNI'6E[#-1!;G"5[V#7#
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M%@7LZJ4;-HD:%(M('8P]UK=8D/N)CTQYH!ETF7#BG4;D6]U_KFL8+I7W2OA
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M=J;*>X/3;AB Q@>4=4=GO91S]!.E7A\KT[6KJ.DG/?R9*\>>QC,0C<Z+P2"
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M+$<1 9P6>9O[-+D"FSHFAXR$'_-@1&"^M:D?$K!E$&!0"XL#.$1!Y/)204B
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MY,WMY-SI%Y<87AU]38GAY6%XBIS&.@^.D,P0EM'"VBH=4BPZA#5(2RD=.7.
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M/P/Y&$V0YA' IK%$RD<),F*6:J%<2-7YXO[K6.E4+PRW][=2=XIF]/VS;A\
MDK;?XS4I8]%C^J5YU4^[B3UV9ECO['PWS5;B@HS=7FKS<<V7N9-+IC1+<YDE
M-^U>@^BR#/PU9&4TB$<(^!6U!#G/273"&9,:[Y:%L<\E"Z?$V>/@;-+7IAA
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M'>)#N%]M]Q#7X?KU7=\\_))>__6MVJ[^.&K_"_>I-0\_35CV4[C_Z<=FK7&
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M!_#3]>Z!_-UM1K8KC\3K_RD%-O58G.?^#2Y;/>[T^UW73''93L?_U04G_5]
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M6[)L6;FLJK=A?%49>LMER\J-[/'XDEM6;ASSWK/JL3D*JCMW.P'=G!CDEZY
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M#X3_9TH?]#.]?SM&.F([QGL:$[=?[?T=-J YQ8QC[9/O!3D18X/:9;;2:GQ
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M/4\9N'T#P<,/+:411JL6,*86!* $ZX@1)R4=JYOV&;?=*K>%X!XAB*;,G2>
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M2LRUA8%S3?!M%HA;"C-*G7EX>;#F8>2G8EG<K#_VI+R)3G7U'V9B\11_C<#
MD;,UJE#;#OMG*@1W6EC6[/6AU>.\-0_[?4WB[82AX(0AK=0AL!X E+P[6([J
M8#G_'2E'MJ:\<!GP[_O=+Y_]'_)?__._?_;E?_W7W_]Z_8F]0.4#GIMTS4C2
MDLZ!64@LY]1:=@(5!?-N[SB-2+[\9WO'B\^__>7*_SZ@$E21$>*,R2NCU *7
MT8+)S+4T%NW]XK+F)W)=>GYNJ:T--[4!N4U684-2I#I91%4R2M<ZACRD-NSL
MZ@&%XY<;PE$.)E[\LL;06T07#JJ!63!,Q0C9,ZO(MCS:=6\YV-+Q0![MD:'/
MNA;P*,(<Y-D]Y=*U::1HL-.*4ZG#/SHXWJA#CX>&U"TE#91C#%@;!"(=0=1B
MSE$'*+LZ/)7) 5L;SET;UDJ#)F3&J.NB5B"-C)'7H[X<VUZ\=J;"\<<;PE$.
M6*)UZ35TR!(0IP3Q+#%X-C&I F/$L9[4^'^WI6-?ZQXSI Q[B7-"S<-0""@E
MZUVX)4]8E<<V<YY,!-ZYE'CQ^4LX(,:\@ \S%<\>(L:@/?<@3&/82-#'ZM_(
M^V'M)OV^#2=B5GC&U/VMPZ6)(Y]Z%4+IH _:J;5S@0>4@5_>E8%O7A]0I2DU
M"D:S!K2U0Q$T!ZBI638>T-:&DV=(:0O!%H)[A& (U\X),!OV:=2Z=K(.294S
MYQWR3\7Z5__Q+NO?_GS@5%43<I )&%!P!&Z8EV<#K#6"ULSS_OA$+@PVZ8]\
M-9AS68[>4M%0IZB_GQ"'Z9PRB&V'_/.4@3_>D(%R():28&*P.$? (1"4-856
M&LU9<J285OF?TQ:"W;_Q89YN8 ;(53I2Z6OS41M-9ZT5,^W^C=,]8?QG_\;+
M=/7GE_G%JP,1&%634-=. DP]!>YSABK%TP3_9P:ZN'1IV%JPDX)[FCI+KMH0
MJ-2!7*=JYVX:6ZI1DXYMY#Q3(?CB72' %R\/E0#9U3IDR[ V''+0.48 *Z[9
M;%1F>6,VV),<MA3<%_8'TQ#,?5T)=EGCW1QWKQ@F,!'N_HT3TO[EN[27JU<'
M$,*44PS-*'K8SS60# E1:6#E'J_O F!O,]VLW\=Z:H5QS6H18P_[7;#4UE53
M+@"CTP[[9RH$5^\(P3>O//^/6H#FL "NW0$170@HNA"D[*KM15RN;VX#>-\&
M_*O^C7R"_HUX_>N]+_)G?UA_EO>\U'7]:+_2QW'_R__#_.S5G[[O?WIOU\:=
ME^)\EK$\T"OV+U^?YW]7^>[['_X%'+_EIWAW#\N_^#$^N:TKCW&RQTPR367D
ME,= +ZM*&ZJ86TF%/>?B8FW[:$_=GO//>4;0RE3H,_1N'+#,'(2]\!6.5FOF
M1C N+CVON1/_GIHK;</ZGDLL2-R$<38;6 PY]U@\>S6OAJ#DW2]SIB3?'D8*
M1!AKI.!O6UNY; _*M, &:GZX4R9=FUGNV:RY6?XX6,Z6"Y682C('N2>VW*1A
MJS$1HNX&EI,WL/SO[46023#.D..$@! Q2!R\Z,5.ZZ'"VHGM[X -ZT<*J]0"
M,5V/^<\XP0_<T:2:^^I;G64'WC,E^?9(4(F<VP )T_(*O.J!%YN%PE#]S>]G
M7/.Z1(KW/#MZ:BQ_XLAZ&N6%[.PI9\%<&F=4[+'/F=J,V^]Y^A:/?U*9*,]2
MG$5 3@'3P,!KQ?1PN:V8>6T6787M76?WJ6]8-WKWIK:E9H 9,]>&%9?QLN?D
MQ4WS1)>A; /F>7)YNTSMXD5J,PUI>'&* #U(:C50$YG2YFQK=AX\RYO,IT)F
M-]!J.4;QHE.)F\ONJ+0B8HE1=U \=1/$/^%K$X%'K8%+J<&C8 O<1PQU%FO2
MS?%;-J>C$]6-WFG0,R\7D[1D,+J?;"$#P8A :FGTMZNL=U \.RYOEY EBHS6
M.+38-6#+*4B\OKM=/8C)6L:Y@J)C^[3(/)_V@#,CE^K:%<AK;=#:])!UIBZ2
MZFS%I+PE=_L%3]HF\,\QKR/-PL(],$W'<]WUT/"PF7L5BY['IJ07EX[MTX+S
MDX4O%BM##:WT>CTN<(X,61(TF\E4MH'O3,F\LW<AX:3:-(<XH 3$Q$&@#@<5
M 2D71KBN)A'OMO!L-L^1S0*CQB&%  <.R8J%4DE%K^.B[?ZY,S#2_Q._(H2E
MR1JA0QQ0( 5MD(-Y0L/1\IRI.G[W]-)N^,X1OLQ#K,1>>$Y$)X_9822EG+RH
M3+@#XYF2>6<S0>),O<P:)*<<D/S$)*48.%*2V533X.N'DGA^%>4GNB+@?\C?
M[+//O__1Y$?[<6\%.%Z]AI?/9-JRZQ<*1Z_8L(\<06,ML)V,9ZE>W]Y<&?#U
M<SC,F(?PR$&MC8 \^VK/FX%'HF332IZXDGIX*L-ZSL_'L:7C5L?"[ RCH*A.
M!!-JT;SRB*V,U O.+1WG*1WO+@WX^HM7A])Z2[-#L!Y[P-(IT*0>HB0_3NU<
MQ_72@%SWTH M'0\B'3EGEP48/;:UPK4S1VS21@?&8O$A!X-O=3A*'6XL#?CZ
M"SSTF@:QJT,4@(">%09EDS U4H/>.H$G%KR7!FQM>!AMT)J9YP"9/- U@@1;
MCG%"FC!8=T5RIL+Q[M* K[],!RX-<VLS9'\[!]3,@6A8J(551KNV!:\]CWC/
M;<J6CK.\>3T3A0 5BJ+98O2W6+S>.-1B*K'4U+$_I*-\*\0#*L2[&P6^_@(.
M5K#A&.J%QQHE[IE@4/021+.L+CQKR:Z[+V-](HL.MQ \\@"QD@O(>EZ-@+FB
M(,W$VI'+ "VPA> \A>#=G0)??_GZ4"/SH,)AMH:>*HP8J+8:HC&U+,+*\?KR
M$O=.@2T$]QD@6BF=VI16UL/UY.\:C5"$+$4J2-M.?RK6;^P4^/KJYX-9Q,FK
M<WN9Z!%8@V"98=HJ]C 5(+VX9'@B1<$F_;%#OM2AW>:Z%Q"ME&K3DELDSMFY
MWB'_/&7@CS=DH!PJ&5H?/=A:*():8] Y4[ Q7<H][G?&=3L J6XA>%)- V<B
M%)2SJ4>4FB<CILFSS;8D@9.7E;-L6]99"L7-A0/?P-5WAU92JHESL'EMR^H6
M.&,,;5BNM31$S=?7!/!$MH_NG.%QI4"&<O=$4QD)821IG(A&$W%*1=*6@C.5
M@G=7#GRS')I@(X(F#(FK!LRK!S[A"!230%>>L5VW+D#:%P5;"N[;2)Y$.5/!
M4GAMK. 42RX1(X!Y[?F04K!I/Y+V+V_0_M7S@VC63#&'THL%;-8">= /<2T<
MRX"&I5]<4MM/!S;K]UX*ICIJE]X$<.8N4"J5Q!2;>GD9=]@_4R&XL7(@O_CN
M4&?3Y'H=9LD]("B'Y3;U6F"-;+4<*]*Z+(CWC%S^1*7@0U<.Y$]UY<!#OQ2G
M7"CP'_8W>_W+?]G>*/ I-R9JJA5G&H(,KI*#^NAY]FI)1+3W;;(]@^Z=GU^\
MOOKY0+UD0H(@>:[;\"AK'*H$2\ \+(Z<QL5ERG<SW:=F6=NPON>Y5JT%55@[
M9'\C3,7IH YNI4@;9:__.(=^F3>P:I\]B5FHQLUS4",O2Z<&*[VSJN;8X.(2
M[EE_M6'].&!-_B+4Q-*X(5;L#):KH5A7:.7MO(T-ZVG;5][ 6J=+*5<.:[!X
MP P49&0*:F"U#-=<73W]][2O;%@_#EBIHPQ9 ^5)'='$D?SH8QY5ET]4-JQG
MT#+R!E:I4JB,&* :K!VS/6A"#J/-6(=E5?3ZL,6[?:A/#=9/G$F<5$!30NL5
M(W0B$!Y2)J_Y8RS;KWD&31IOF20>VF(-O<_AI2GD0&.V0)2,>NQ,6#R XAY7
M]330BY%7-V4MM4:,W"C&P=I,DI +;-WHG4%;Q!OT<#E=FT@@K&OE^I0@QCF
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M;PY6(IBF&C@V6(;J'"AV"E%R :Q*4=<RXF>%8&O!OS6I_+T_P=T6_M_8?O)
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MUCZZ"L@VM/1N)8PUMM2836[P,6$'(XL_4OCX -(W>[J!)7EV>:-E9S>CURE
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M1ZI*!HSSU4M *%$'621!4.P_\8?O\-DA?$8YE<5KIK9:A4Z.X5-+%K$4$"&
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MUH, ES/CK4BA9" 'U6?,D2U*U?7;/N)M*[6)W;V[*3"NNW?6A>I8BH*=N2Q
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M_S>A\)(%7(N2);HV,%/%]V^NW7%X QIX8_E>'7TWAK[OUM&77"D1HA4N>"?
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M$\(FL;+.Y90MFF8$G\7N)+Q<3,_5 5 P/6=,C_)^@9FW#EN$'4P8=U0#II5
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MTP8.%WP^"]=W:5^Q,&B.^L03TU(+8%+!1N!4&%ODB-$HVB2I]5%KQ1_:OJ*
M\SGXU8OR7"A"Q[SNE":OP(1%,2J-N$X>&:HX"CA&ZHBR,>1Z&FR5Z&+=/AV
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M'76 ""^"X<$BFTS("&7(F<B1$E$[HXU700!"9^7!?/+6U(OL&S>S<(*B=.<
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M@IO?V&92F(E"7I:UB.BM5O]_>V??U<:M-?JO,BMG/>>V:U6N7K;>TN=V+9I
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M_]D?3O=S#R])L&8^(!6/W<5CS.R32>I@O0&PWM%($X>0Y4=EG9<5CVW"(UV
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M-E8W=SYV:3U['5?F:G;6_)]\1;2\H$\)";//*Y+!7(A,P(53'J.B!@3E+MF
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MC ,:677C7HK1Y ?-&\>'6-RXA\<IO\CC<:["]Y67WP0O@0J%PB?N@@&C/;J
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M9FU]<V7SR?K*LV9[)Y_86-W<V?Y(GCA['5<F:W;6_)]\1;2\H,5RPJ7N?D5
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M'6MJGF?IJV>[*LEUR"NQEK963LKFU#YRD@Q[9GL]:Q[H1L'L8GW 94#6QQ"
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MS#IOI+[RM[]7^.BST(IPR1=S:!$^.Y&/='B35[:.UXG^B3L;VL''P7!,YM)
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MGG2_@HY&M-$1NEX6+*P!GW#*7C670*N^IG=D_I(N1D@D'O66^DY#9RL5';0
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M7\I@+CG\F;P0I@E][4# @MOUD@<!?\&3_QGFN:17 7E!'+/Z_)/:#K;> I,
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M+4W//JWK2OG&PZ!3CG!A*WZ#\02#!_J/&)0". =&ODO7?IJ8H*\3VY6>:4C
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MO4:U+]N*MC:<(<7 RCOZRN9\.KBBPR^=(C*K.IJ6VRLJ\7 27)R1#Z_G*[K
MDM.7U(<?TI2SK;B%'V@8>RAK&.B1N =&/OQZ(R1T2J/(4TH3_(8M&-YMCRMX
M  1K9??UB&Z4AFQ 2^=KJ96Z^;EVR$*]>U"W[$&8.C&!M;&,C.GS.FY#QH*5
MWPWOOI#Y'$3[4G.<5;4T?7YED8(W/,"OCR$%X0.=83%XD#EA$7Z@H/@T7++=
MB%AJ2;^%$6-MQD.^C6G>%1"@%N(DAG,:ZZXH?Z%\]@DDJ#3KN;5=N"M%:XS"
M4PQ_7Q'VP.$_U%].X"FR)G,!S4>\5NE+K0F8%@$!B)W#C1?5&34Q-DU=3*\'
MPT*8C)=2 2$BLEED^8'4*=PM_'NBBF2:^].&^X,H@G&D3B].G4<TGS>$W1YO
M0$N/N6)6$%+5%7BJ[V!:6A([H\IA1E-P ).D\@<]&G!M/]-FRF2")9!_[9(J
M>IA>3%89:M!4SZ78RO2D,V#7M@"PMFR*PU23Z.2H.<@PAMTVQ5A,%2,P\&0]
MK&Z?H[&[X65FB9 8-T;]4+K5LFS(RVTY5Q)#1,3_8+%G#+AJSC\\Z!CFX6Q2
MW,^$G1I F]KVID^&P7?W)(+[;DU\?\CH=_H4XJ8>IE?S0-8,2TG*++ )J&Z(
M[I0@WFJ ^EKU-;W"@?OW6"4/X+N:;@(*;S"QEWQWL.:HLXA_*A\XAH 6C$@/
MH+T&(?%VC4L-9_1NG1=1<:L0CM!0:,;.Z5IJ61RX!!X15(O(5VYG@4F_E/HV
M6, QD67=YI)<.N;0Z0F9WI;#CN!S]>U-KZ2@PWD>ET5N,"109!J1UTL:O5":
M)%6+]W":>MPKX_X HUA@\E5/X@ 82A!.$M05%87?H;I]B^XVR<=O%(]:Z@[P
MN;-$L'3%QJ);9SSS$LSY[M*Q]Q@6R$:-)UFD[:%]Z5)75;@# 0LN@ANXIL<!
M3++IEJX'SV[7V](;O,IVN L+C*H0K.SO=!Z%HEA 5UR PPYBJ5'RGD?7L*=1
M:8.EB,BNP5QXD6 GZ!)H6G0U?9!B>CA^QO'B)@XPQ%>\?\,!Z*O7ZXW'M[ #
M1,X\9M&SAKIUW0F9A>4>P37^##<^3""I+U,0:($27V]):-O=4K'>C71_ ''Q
M&>E<+ZO<SX*3/[4X^TN."#0"*55OGRZV-HRI*DKFC/VLYH>XAD0Z4.U*&OO\
M,T!HX>,:(W<D3%@H@G6J*GY<Q?21YTV[J)EGU5'RV;F= UV.-KX%&N!U "(+
M<_TK7$*:RZNRJ>G+*JG5_7.Q5O>'MS]__$$#$-VJJ^GUY641X\=]!'U3#PU1
M0!K.)PFM\<A+YHE.CH!]J!OV$V28Y?#Z4A$]&$@[F/%G*G[ Z"S/VSYAX5P>
M>RXH8D,2A[1HNVNJP76@ <Q&Z.)U +=!AC>'\P45'8ZF):U,HFR^6CK3LO1Q
M]+]80'R>&=7%,?\T;3X_-)UL.CERYKST7595' M8)B"QYA606+VOT.,-;L']
M^0D]ZB*DYA-6<50I/B'6*KFBJ&?!<!B,G(O-25!CZG?6/C1M5>IJ4]E[9L#;
MLLT42GUR2U[2!\K6LS@(156US$PL*]?DJI>GY1IKY> 0I.V$VU+3&\)AL.0(
M_-*<<5;;W#3S)6L4D'.899#5&PD:>MC)JJ(U>X*01ZTB-_7]C#.OX )&=4;X
M;^&Q'&ZX].SF ?'R.$6_8/WH+_#[.! QXX,PY.@^!LE4WJ#47]32 WV\X6V]
M$.HK.O_* TK\WW1Q$1T(6&"!2G*8DIPFA9Q8BBT26R2SG JD9#:'BT\93_TD
MYFB\N'YEXJ?=-@T CU]Q#K;*G7RW/%",4PA0:\]7O]*\=FI[V;I8&9BFKIOL
MME'9S9J:T_7=C,>YX</RQN,O H'Z26SZ7>$>)3[Z%!\+!5=@EJ09(KF C<;R
M2X<>RM)GL+#FX$5#_Q'#[[TM/#T\$H9LP21:<KX<@P:,H@\ITQI!_8TR!9Z2
M#5PK5^BL#/I>3#5D3*_[%E0'46WAACU+%&00WWL>I;^_QE '\0==REEG0A9<
MS3+?/@$TNI=Y9+D(8"Q">A-["R9L$H\K.AI,W[\;!C!JP AP>[Q8A+)7FK*?
M2T,3_FUH2KSZ0HQ?;P9VOC(2C]LM>0EC%H4/L4?=L8_%%/3 YM6=#'OKBC'V
M>-;A25<"GZ\R=G7%8NY+W +SV17=D-_AG:BL.GECZG0#FU?WQFS7VX(S)IN;
MM " IKV;VUK@<&U[2Z,'BE!HL^ARFUQ_@T@=1VW"9GO$X1UP- LV1,G+=DD7
MJ"\<(%BY!273BLC.PS0/2'Z0W/^#T;=4@2\4/$G+B&=+:YU/W]#9FM3Y3]3'
M>CR@#05D(_+=$]^ BDR>D"""UWJX8IOFK=*'DNFMDESHRC8N#7[POUZ,(=H#
M=\U\K.TB9C#DH<@V$2'J$\+<OH \QQW45B-*_7OND; 7XN_W)JRB88'"(O/,
M=-ZY8B/3>V+G>)?I6*J\TWB16M"W((DR ZOM1=&&DJW26UOHMQE+M+&3:4:G
M$/ O9!.._*?IU2._?GIHD]I4V\GTFHJQ6"$-GBF:U^<B\/"*+18T$%COXS2[
MHB*GI(6^W)NV!=KQ#K3/9^JYC_PFSI*P\CG<Z,70',I]R9F6E=V8Z^$?=+Z:
M!IID'5TO"VZ=!XQOH6[B)<]__Z%'V!K+UMTP+),,[&!^!*(;)F>5U$,:?.^'
M(6[I SSW/M$E])4:FA9G]63/E\-6U5EP5CV+;.]'U-[;O-*%FX:GU]2S' 3P
MAI.PF%E4>E<_<<]!;/V4I0J'[>L:HCYX\18^CX<QT/Y03%,4$@I5:;SF2HM?
M8VA+313#7;-"XBDM9YXW%/;L0,/2\WJ2^M2!=?6.^&(K.YTW>>U2)?91B=GW
MHHPFJ#L)O!Q\\ [)AD7H$)>'B])'W?TJ]!UE7 LT7KB@V/R:!#X&%>#>GZ@T
MRJ*S1ZYXO)!5]NI+A?6C=JRD!3%T^]=>[B&::N[MGGQ-/4TK/_E:ZD(W*P3^
MJ?1@$?'[A+=K4C@B6G%76O0?LR*[PN;6JFK[@4:R])+)GPRIUM+%PM_C!#K(
M.!:<.(4UM;]H^WRQ_M0M^$XCE^(3D<$-DH^\?V#A[V&V)+248U3D4P0K^2-Y
M?-[#,(\OU'NF=Z!'KQHB-@\ZB*6[M:JN8_=*D+:<YT*"4^S()#&G,?.IEOV]
M:%G*97PTEO9UJX2PJK=F?5#0@8>Q]/EP2Y?$P]#_ #@6$$_=[2+T])75)OQJ
MNQW&N^NRM4SXZ._=G<!F&X)ZJ'- %5N9WOP8+/P)0\3%AGWRF;;@67T'TVNY
M8SZFGRE-$9%"5?SWFKI#ZGE7E$0K58CV8N3GKAH9/HX9:X/YBM%GH5/NX@#5
MI[T=>UQ+#TB%6J['6"RU,RTI>\$(]')A[3F&!>KC3FH\(@6A<1J.9+(I\KZ4
MC=#4S4X+D7Q*HM:*F%?B@DU-GU<T9$L?K^><$51 8]5?\KWIV6J++M0R$3'@
MJ1HC?9.=H#QT% S#=0P0S?C=VW?O"L K']Z^_?G7O[S5G'UMNEK@Q[RG41I"
MD>B>B8DR5.%/J'@^^2_,=T4F76(IJ-=L]Z%IJ^!G>:]XWX\7CX&H=+C59#+J
MNMFZW&[5;VPM?).6)!&?ZH;,=0Z;^@Z&LS3@LSZS5\T;H]#&]+>O1LL<  WB
MP0F1*^O3@-+9GH2ES]]$H*1W/XYP"J[0 WK%"O0E=QSI=>F<K8G7)N8C5^WH
MZ??/W!,O^2ZXSIJ^IJ4] 4,0].YAXDW&C9K&UI@T'NB&!\+%]HGB@W:SPA)M
M_PM"K[D'6G0TS2AY#8L+J["9!(R "'/.?$>BJ%M]09;NE(ZES[;$C<VE7#ZN
M: TD=CVL=+O>=C[L:N&9+CE=X:Z@XG^\%65K7! \T8(L +$G]%,GVJ8W1CZ2
M&A'QRA[I/&X>)K-ILR^ZD+)3;-2U(VM5PG3C!:PV1G9.'J]O'Z]:&<"TO4VS
M/O\DKT;2V"_FI3--"\Q> B(7-,,''8]+[4QS<Z>^^W#%/#H==*H)O]/' CO%
MS@0G(#AKTG%5NYU,,TIE\]W +L!B#9=?+C7K:>A@>BWP')-Q)2,_'QF1UH_J
M&CG9FYZE/A,9$_M P]B+5.@Q/-]NV1QU=7_9%.'<W,]6 ]+=]*I&1;R.L28)
M\575]C!Q=6M L'O3,[TU:J:="T('=3J'R#Y>#-:QKS/V[$O5AC,=R,X#)LV&
M&#><!'G6/[GJ>QS:PM$M\C./N_V%1VE08AJ?(?,,&G)^.E XTE+;(7,KZU)J
MV,^7ZO[$&Y[+^HZV'F6[]103E&,109EB@^U42 S%#8504I\X=U]@:4DA1DW*
MQ9%&L_1>K'@;W@D/2<$KJDFPT'>W\W69%';X6"SL\/[=!_C_[6I"-'8U??.U
M NKH]I1L0\:&UV,,QQ$/0C3N:MZ/%2UMXMN4!L]PT8HP>OC\N] 8X>5VB =,
M/[M 7]H6<%B]Q48!Q==8*T]&8Q?3/)?.0W4[YP'*;@)]=>Z6G4VO<3JI?T6(
M:U1C3FC;W?@ZJ<]X<,E]G6NMU,[TS#]Y'&[>"?6)%VUO**:2XFGO7FX1Z<!W
M26.AEU:=;=4RKVCZM(&W6EIL<<(]-M_>\""%WAQZ; W[3)I'Y)];'+N'H7[$
M5V.'LS=+44JSEG1^R=H.IB5>VB@G!)YV<2!-&6V,FI4=3*]EL%P&%(Y^FOA#
M4QARZ1B%]PF<FK$'%SRBD6-M$+IF&Y2X&?(FWC OAI\1V424;V[*GSC.8&8+
M>Q8,UA/QI 'MZ#;J$B)1U<VT8!1D5NH$[6SW-5WL6$_FPQV!"!'UX3L$M;0B
M8'JM(W\1$,Q _[2>B5)I_#.?K\+HUT\Z9"Y=/],K>]HLX+2(#E53NB\Y6Q62
MY%S%,);YJD709-;0<+!D0_)8<_VF%AU-"VT:; )"I709ZB:E'QHRZAM[61H\
M"3=:0);H_6)N3#P5^B>3I^2F^D+@YSB\)@$6;HA8( B(&.1ZQ6$_JL9+BMPB
M*(@KS;Z9UZ >H+NFN5$O0N*KF](E_EX'$%W9V/1.%"9W#9!=OHGI^1:J1?L+
M'JSE533C<71'_HZ%^L*(KZFHA2$#X#%QJ344<W>:UB TP]2]F/I_D$34M*I-
M=7/3+"X\!*8Q@TW?*49FMXOI]6!.[8R[C(;5VI/&M-ZRM^E53G@8,@'UEU1I
MNL,H:@2<?I00@*(03?WEWK:_\:L+_XJITFDJ1T.0?'5;:V+DI_%FXS&J*S14
M:F9:V/(GMHQ75C'=POTRBWJX<=J0L<!C4XF!E*)LP282<3+[ "IIB5GP%0KG
M_1=&(U@/HC<2?]L]':>QOTV2GKY_!I['\.72N7910W\+N"JP \,K!$%O?."6
MVUD0!W;(HF)="B8>?5P[HT[2L!@5*2,N5_6%:G&L&OL83M/?!1!H/L#J6MMT
M7'V*"4AA1&GXB<%)"V^G!SJG;&_PT5YT+3C>"D$C$9Q>,FPPO7AEJ&2" ]HG
M$J4S4<N^BBPN5DB\JBDP]HB5Z);*!8P=*\ILW5_<O^M=X>R8D[#@JX\#MF3K
M]27C$9VO?.[QY?;3>O998PG2]++@&IYN_6C% TW<^6XKT\=FN<1QU]Q#G:WG
M4/1-?ZE,]VMZ=N^VLN;!K2[MUI6!ZMN;9H1(!I<(#JHHJG"/EA#TQPO04#AH
ME3)TY1?._.@+$(J; &<.0]Q6GV05GNH>U<T:^EMP(%=@@%[#.!B>Y1;P]L?^
M -XIWO:*>3'\#<'3ZP5D3ZJ6N@K%$RZ7"-C"+U/1VO3)4  &0>BHL9_\JDD!
MJ^]C*;>*>!E99GA]>E1##\.@&@FR60ILIGE*U[<W_(P6)>\_Q[X+G+]ABVA[
MAX8/[F-\<'A')'#!+[%/$=:N>7_U(F7!B:LB](<\V"AG4:N(_HKVID^29+\4
M,RJ: R,:^QQ).#N4J1>WT,$JC/2F9[C&2-'CCF9X'L -U@EVL[J?X>.G%D5G
M,/.VO@[ZKEUGT[LR?RZ"TIT_&L>+&_9*77Q6%DY) 23Z^,(?5SP.B>\^O@#!
M[0WH\>V/X(,-9<$1/?'B,)N84$HG^';1%0#6=3,M&HVE[$;^=,XW5%3V#;G'
M7)5>E>9 [E%J_O@#V_J8+, SI;B"NF![72\+]DB*)"]B*)JL/54MK;'XY$UM
MHA;RA&Q5;30L'O,TO9J.;QZ4!^/B[?OVE:*[4+. G]<@</A,598<XN.35=@7
MW<OM9<" @][=%K24Z3]B-IMI+H9^Q$R?CWG]1>1,WU": @&I1.*P=:RBCH(U
MD8D[!;%A-@I!3N0KX5'+ULPC0H'N&-/0A9P%?I>FN@HJI%LZ]&'[/I)799\?
M8/C57&CR\G?[.5"/,[ -7S=U;R3_+:7C)_:RK?";%R"I1/E*H.<*Q]TP#B+"
M//'S&'96%'EI/,5T0^>B3-C(?US!-PC6H8 310H-R:LV3,Y2!)7!'Q&=8R1R
M[)-P.KBBPR\:!::^@^E#/DWAE-K5G +U.4B"MM1,BXZFUZ;+P"Z64)-.&CA'
MDEIJN>/C4#G?>XQHP8F%.$GS-%YCY.?UN[$O2TS+-35"+;4E8>LC9GH]'$VN
MIX.IQFV_V\P"M;8(!>-CR.PSGN ^\;;P/A_[M]Q?XBE\R8. OXC:;[Z++O4I
MG8/6(K38,(S7:+NX2"X'T22Y)_(<[0,W9&):%NRM,DIUJT0M;3?39W!U'HA,
M_1-Q2:)4RT(56.Q8EZ*>C/&\BR'!O)Y)P. S!?2*@'1*8!XXHERFL22V[&R:
MMZ/U.O8Y:.<BMBJ)T];8!!K[F%[1,%['G@A=N:+/U.,;_*MXJ"7(-@VX>/JN
M=D8G%_(+!AYBY[<"1*GN89J%A;D]0">?D>G#;8<%E3N97M-.*3^%YMX.**Q=
M7],K?/+AGA9608RG$+Y!BA6\TNN] F-2F<TE+G4YW K1:'Z#95W2!SKWX P5
M[\Q'GH9HY< ^_\ 'J(P^K@>;L&B*ECZ,JV.]IJ"5D0V'BZQWN%@-"=-2F]8N
M Q4S!"5VC=>V/J)FM[EA[ YY^+4\(RTZ%2?2VS&>>0K\,,-:>.0UMJH&,.@^
MQ(PB.M1:EC.<UDXQ"GH:AN,5KN!5Z%+?#2>$N;J@KYK&AI<@@R7@F>**;-5&
M1V%54VL\A86:LL\T<&,J'7DXNQ"&"T-Y W:W '0A9\'+_8IN,+6&JOB7/!;K
M/0_PYO<5_FSS^=J=C@4&I4NRI<%T#I/#,T-8@@<:E++&+J;OE"H#K;+.MHAO
M;NYH>FV[82?C169.:QVK4NQDJXE6U/1&F$E-C%*YG6DF"3G*/3#P$9">!+5<
MTO2RE4URFZ29H+=\+B;1G%"OZ62:@=VRU1 0#EO!?_!M]PS/G:9"%8>@;:<1
M2L5U7]%!@$C?S->6&FOJ85H(T#61Y=4VRW-U6],K2-ZJ8W_)X:R_)2]AS!J0
M'6K;&W[<WDTG"C),0:;H:E[5-#?-CP+Z#4P--I:? 6FD)3HDP$(?1)VN-"W0
MO$7P"/%@&3)[ *@7DY;@\01OB:8:4%U(F 6J3N,M6H9EV"*XTQ4+ZDH7-Y1.
M0V3;$(M;7#*NL4L=;@ +'E39.2H]9(\$;K>H"<^XQ9'<GI05IL@DWCN&C<<?
MV)QK@Y'T_4QO@QV[=I+VJWF?Z'J97E6Y'&A:;*XBZ1F?)8\<T8"DF]X3+V55
M;$]3<.Q 8UB:G5LP?XE,:17PLE?EKI:4++C)\[-.@;W2RK,YUN=\:_GHWDZ?
M9;\!+/M:&5N3N/H,;2NWK/UBL/<?Q(*OEER'-V0-\Z7A;RM^PSSJ#H;LF7E#
MC["U]BIM[&OX[DSF> ?GU%P*=Q@VP_$U=3&=?9S5F$'5? [GO53(1V$8HRL<
M%%V$S4%OJL@H2@R5VL5V)V@8[J#)'U)O$6SL9*<-Z MYQ:0@JE7W*AH:UX2D
MT$CSZY $P?:2S'^7 8KUJDUC)^,QC GPF%[]+C>TX"D%#[MG\0Y\UB[@_Z_N
MVIK;QI7T^_Z865\R.3-56ULE6;;CC67I2/*DSKS1)"0AH0@=7FPKO_YT R )
M4B0!4G* ?4@JL=%-D  :??VZ<:CM+55(9R_*UA[&Y4F<?*/I5D2&,=<YP\].
M?_))@*UPCZ8_]?^"<=S&G<19>Y_[<[&W?.WQ<&)_\U]ZCPU"E2?SMKV/6LK-
M\=Y#F7Y\(VH2X0;S<S4,Q37:>GOOVW<_S+#2?,G6*1CA)O%?8QX.2,=2I\_K
MDHHB"PF3I,/_,*6WO?_S6J/"L)M%U9A+L4P#P/_.P]S5D[%,]B;-$&NC;"^X
MQ+M]SV$R>,U/>W.JYM$?!3IDEMNW8OOG?0T52J1L865L]W*8T5I?I%T6T?>^
M5:<Z*@<$:P'M>)?AZ<Y70/8HY-YWN1RY,V7.$N"*&'4XQ @X[+P/<=,<+$1J
M@1*&OG""?65!Y2 $6^Q($ EA,JW8S9:2]>T[\3/,AIBMU_"[N/4CGN\!#B&4
M%=[-/&B .4[<"5[ ?*.2_\3P^5XXVJ',*X)A6(?/L,5Q,DIO@"40P@7&[[C3
MH1QL3<T!YR,6@@FT]B?2'K&KC7*TRD-=4IAGD0Z/+K1D3["\6[EO$E4 W=8%
M4#(^W!.L2-IO490OR(8.:@CT2^;AP#YJB'B!(KYGL; \A2\3WS1+46!SVP-E
MB/0TK0C>#'B44@96*\@OGH7;![GX+(^SJUQQU+WKBZN+JTN-MG$\T $%HZL#
M)+HBN-A,JI":+0'1T^3YQSW<@9/V$ 49NC&\\,[SC2"NNRAL:]O'/4/R.[A7
MB5 KJ>6R&J49U"MLK>ZH5_-@-W5@98H/T0#WA#&]FZ^/Y9_8*@A.+ ?(SQ7U
M]GR^5H(/*M4SU-"/D=\6Y)7$";\]502XUC?KP<%1O7&V)S"O$JGD2Q9M@+ L
M4/]ZM](X67MP<.ZB+@"@>[1WKM,X Y(H$NX\V<-X_S?3)6FVCG?I9A2PS KP
MT%JX5YY!LQ7.0<++*>Y"]G:B[G2N1SF@*>4N\%PMR"UVS*4F8(2MO/?9D+OK
M9+[.>M7Y89B2("2'.\63^9@&GLDQZJ9TZ4 5!9$2E2HIT#R%D!F4U=B7IP-'
MY'F_CL$"ROVS[1@C]7&.7N5EQ5EG,B5/.9(FH>C<"DJH[[,XP"FBKX_W=^V
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MB-L)H FL6$L"T@.F%T6$*\R8I=<$Y\DA>#H*9C_D:8Y^6Y, O%+\^ARMLR@
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M0W^I2/J?_X8W2/PMV7G_^U__ 5!+ P04    "  N4UA6W,#P2B]&  !PV (
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MHJ_5/*%7/_^ZNMWXM]DD;>4=K.K[1L+X,O22$V%](E(*7JI?/7'2TQ1$=FC
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MU>=@OVW/UV:EX9F[E"R)(9K2"5L3IX 3RUF,25%)1;,$U">I[%F.K[>""F6
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M9_QQUCFZR5GT94U"RDLJ)6<:#<94"BL"^L!>X/_WBIM7IVQ@?F1?V#HS2YO
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M;5:T^0R=0W#B3F/WX[!3+;94T28;8E8M6D<H<VRP$ @*.$TD T=<$4NEZ#@
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M//O#/T[=ZIG&B@VQ5G[@YPB7!96?O%]>7J[CNW[VY8!9A)22Q(44+3$P1'I
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M!:)65:*,] 1_2,0DEJ)G640V6(?0=I"'SDVIKB*M4V<[4#5$7N,-O$WZ1 N
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M)E+!!.6(6JE4\C.\)YY#)&!H])DZI<5@18 /GL4W8L\-PW(O8>&#H&\.+5J
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MZ<?%:@4)5C957C73Q<S'Q1+GN5&UGYM9B1N\G95;+1<7D%[!9/(:_.(</UK
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MP05'E,3E7\>,MFR;:^U=<1R?\@W.3L5>L:L8Z&-WK7$2^!_TIB%1FZ3/I0=
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M1#EOE>(Y.-G&,-E[X.-3E?[EOT-;NMVO>,STOL_D!IJ-M9$2F[@A4GA!O+9
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MN*%TL:])'K/^/@O%V*'SG8+PNTM K'-F3O("9E_%W$8"#$"@F:0DRK+/-;'
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M= K0"!-<%TOWB5><IK;[DFF/U:26 3W?)HOSZ>RO5>..$GP&HYETFD97#YS
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M>U<2U?ZNP:?>&LN,]Y"+0)JHS4C9#?)Q!-SUR9F'.2W]ZVZ0\]-'X:WJVW<
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M78[2>@/T^F@XL-(&KYW]P(F**#1"/5GDJ98.%8$%3TNXY=HI@>"XP6;^_1-
M3Y1J VAID++:#Q#14*-'0=N\)%@Z<L[(B#0L<>^#]CJ[=O7#GN;*=HOU/Z\J
M*SZ4Y:';FR\SO+:$/HV^3#"?9:Y52MDS7A!K8$EFWGG)'/!,9C0WQ7;QTY]\
MR8DRO5_A/B2YWV^+)A'#>(GK,\XNSIRR*+/6+.9@:@$OI DG$BW:0"Z]4IYS
MT6FGO?_<$];M7B)\J,XPP)JEN24^T=HI<KU/DR:Q&+UGELP_X\'7\NPO;<WZ
M_L2EY-^/(-[<!M-P-3=::L;1D-V;R"<#JQ0CACJM?<JJR%;#70=WHA.A)VUL
M."'L(7AGBT)1R7/!G:AA<DAS%Y,@*8C""C@M@ZA!F2U;H[WT^OQ[6H;#Z.UX
M<M(&*_0CE P@+&=DHU8CU3OF%7',"ETT#[7&<[OXVM=<>&XK7K8K/+<-/]J5
M ^N"ZD?AN4/3H5M=L%UTV8YIZ!7Y*Y)L\EJ<6"=RML Z\KALE+7LK(3TH_#<
M<1-L&Q4V+CRGO$5ER?<CXY83-&L8C3BQ(+/7RH""U*PRS/$7GMM*D5L4GMM&
M"\=4>,Z:G%32J8:\(M-*UJ9I03$P#H7CQ8?TH_!<"VHUT-\P.U['MB_US$XD
M13B7O1@<9Y 2DJ6:;0*9,<1F]?"/,P?O$!9__[H[2*)=%X _$NT&4_GV7;]V
MT-=!$NV,#4):6UBT1C&M:7&/0@#37ALEC8L/[B=.C%"]=?T:E$_;J*GO>@)P
M$6>C_ 5_(SE .K^:X^(VX[X4X;PE.\#$V@@ G65>YL*<5U%QLA>P=*G>\=0[
MCC''9RMU3 >09<]AZ!]*&27\= D)GX8HZ;\$P A-(8C!LN ML"2CX3GG(%*7
MS,J.KSLES0\AX9XG^GN(TUG]_-OW3- GL=)"YS&&Q*S-@FG''2U^WC'07@BK
MO/+K': VLF';]YX2+0:5^4$S U?AYS!^-RG3V<72OQL@#?#)]PR7\]=]>&L)
M?J*8Y!S7(!1Q0^=H$@J9@2M0-AG^>(+?DZ]LG,UG.;I8).U0N?8X32ZSX#2M
M54:Y4!)W/IU8-M]RMBX3**_C+'XG?Y>>"U_PK&@'WCK#G.6)YF0,+'*?F1*<
M)V6-\)TR7#8__04$.&Q#AGN+W_[B[-D.^N6O2_(+:/$;+TO^?)Y^.I_.%C4*
M:8FU9C6\G_[Y+QA?W43;_#J=_<?Y*)U_Q#3]<JV87_["B\OZP[_!_"?$R1^U
MZ'!.UF=-R[;20C)M.&>QV,R,U5HDL,YWJOT^%+X3)ME1J'2@F[CY^8>K11E/
M_R3,UZ,Y0P_*B1*8L(+L1UGKO1 L5NHAFA1>1MNL$N\F@"?*M!ZU,LCYXA8'
MKK;&A[N@64I0@QMS3?"+9'#6)J*I>*]=L])+)Q"RM1^;!M+;$85LK4[7KA??
MY5&:%99\'..8S34?WZ%D@,8P#CDZ6T(LO!D#-^![$=<F6['A\6N3';4R[#W<
M-:B50]P!5O,@ITU(#WX?LJLNGV/''HIHR),<0L3H"C,I<D;N=V%!1L$<$&8M
M0]2RF<?:D!_=KS<&IL<V\A^$%N]ADFF=_.EJ-,YWNJ8GQ[/P]<IFF<LAHF<1
M9&%>%YL\8%:AF<&\&>)!PC_VU^'#3(;]%3!(7-&_D-R]\6VQ/&UK*'U"%FU-
M2#3H6!2U)! 7!GP&#KY9(NM]:*="A#T$WJ*SY#^FT_SG:$QV59[6TBFC>@S[
M9416%2QE\"F=8[X:X[3\-OUZG7@XFJS^T>XGW+V\=N\#[_X'OW;^S4G5-N7@
M'7<Z9@4)-0:1'1@@ ]6?]8*@3W^Y'@1-ZN7,\L#]0WF[+!XQ?W?[TN_.7BXR
MYF %0U/KI#I9BXC5 #GO;:#Q*A&:Q8#M-H1>.N;=Z.O&HICDU5MHJANNE2W,
MZMI$5JJ:.%DDXR[ZDHT6PK5LFO<8SD,?4@W$N(U-\GK1U4#QOM]+]#]1NNJI
M,3@)!75MV. P,HU\65>M,,UYRLFC"+%=3]&]A_-J:-E8\X.X&X_4?5D68[L5
MW./X48+"VFH$:Y0US47/O,#$?);>"Q>43,W.P/8;RJMA;4.-#W)'L%7!K*=&
M8H*.D(-@UM6FFA')M/>^,'0*?336*=FL7D!?@WKM+!Z6!3U6\NMFW"1NN4<G
M&(3L:BFWP'P@XP8U8"@E"][NU*<SZP9W9*ZO#E0)W *I2SJG:FD!QX#;S'C0
M"%H4D4HS(WU[^(>Y"&PV/0?6YQ%>##XQ/:X#[RWJ)*"PG!+Y*4DHYHL63*E@
M@HG*<]?,QN\*^CBN$(?@S^.W 7WJ<2"+_5& JZR>#A!;WS4^B_K@]XZ]*GZ;
M(XP]M'8@@M&,BC46B*502YT!%RPX,E!,$KE8HR17S?I"'(A8W2\L#\VK;90U
M3,6$^WBD4)B@1&9+3F1PZU@ST&JF;*$_()GBT,QN&XXI79VGGO7WL%#"[L)_
M]+2TX256S^D9>[UN\$NKG9,U@I3:< TV*&)+SEY$P0MJ+VUT1C]_6=4L9V,+
M!Z284KCPB8D:C*A]X2P([9GA&1%DB0;54?IW?5Y297)21F54#=SUE>(F\'N9
MFG"O4?#/L, S3DN&LX;,;:2M10L$VE4<LE*+H7 C9%HOG3[@%KWK*%[0:=8V
M;-VPBS?1\R#77[=G5=8+"T+1QN1JHH&V@8$)R"S0?[0699&:':>^P./0_0BT
MDQ::> ^W;7UN(?+,T4?,+.B:.&7(U@TZ!!:5XAB=,DX>S'MX@/;5,*A?O0UR
M\_/''.G[^U'!W\AN(?'0BO@[&3/3_*%\)M?L^2$(;T-$:9@S2+Y6"9EYT(FH
MH5Q)AG.?FT77[CV:5T/-MGH?Y))GJRYGSX\'2](%4;-H3&2:/!Q&IG]@**U6
M*BAR IK="_4[M%=#Z@,RHL=^3WN=V!>>;-$QLV0TV2J*IF8 54U9'F+BT8C4
MS! XP1N\_?@YL#Z/YP9OTWR[KEZKDQ1>T912Q9!K1?,J2AF8C<[3N#(9U,VJ
MJ3\&\D7=T&W%CP>$[$5/@[@\OY#OOO@V_SQ=P/C7Z6P3T%5Y[ Y06]_,=49_
MJ!NZ?A3_@$_#:NW 1"O>@T-%&'.AJ190$'@169"BJ&!2ENT*WQR88,_>U!V<
M7]LHJ^]FVA=7D]%?MQE.4M ;+;VXKL^B( .H/TDO7=')*]FEW>;=9Q["G!](
M\-,>I-9S':!E=\Y:J?JGT725\N:4*IJ82O2L >6*]EAM@*%SRABG!!===/CP
MR:>IR3TEV/-L_'TV(C/J<@2$YO(<9A?P;I)61<WK<I/(?->U@X*VT;*(9*PY
M4#1$X3*/L8-BGWC%:6JX+YGVW"3^T[?)XGPZ6RTB(<=@+'"6A46FP6?F@S.L
MY&11&"S9=.F_>/^IIZG0/20WR-'>HX$^#PYIKL-]G#?:"<Z0%T?$BY(%E04#
M[W/TT8:,S0X]MH/^BGS- 74Z4$[,,S!7,88=@!XZ,O01[$<7']H#%;:_A-M#
MCX>Y[5WMM*E.R!B8T"X18!.85XX($;EU,HK:"/E5$&[WN-%#\FT;]?5L$_\&
ML__"!>;?9]-\E;X7(,<8!"^:65PVSR:W/* IC!N+P8EBI>]2XGWSTX\A$+07
M54Q[E6/?WBNF\\ET//TR2C#^G9RP&GEX6VZ'\Z"C)R AU@+SBI-AB($5!:A%
M)BWRU$&_3[WC%+7<FTQ[GL7+<:X/_I>_TOBJUECZ-"V+/V&&-SBA7LLK&YAV
M-?4L.,E\-I(EKPLFFZ"(3NT;MGCG*7)A,)GW[ K_,OE/^'8QO74+12ZU760"
MM#5"W3( Y.23HT7 >K0F.RC_WD-/4;N[2VT8+WBH'J)*:(!</<6H:MDMR"QD
M+QA"!&Z#(->N7=[D2?>T;N-9'P-/&LR 53?2#JA^]+8^-!VZM1[>19?M>ELG
M+YW*,C'E72T5X2V+FFP]X5RT2;0]5WP%O:T'(-@V*FS<VUHFL)A0LHB*S$.I
M-?/:T9?B"Y22%6^8W''TO:VW4N06O:VWT<+0O:T?-$".Z"TY"I)QH\F[U%DP
M'V2MOU#(9.#%^]CLB.\)G"="DKXT<;25:C=ZKXW+UCZ)X3 U;+N+93U'6"LA
MA? NH]'<1"C.*A1<.Q&22+A;0=LGX?094K[^CO??.Y<H;JP4FN:1X$QG(+8G
MCPR*S^A2R=8U*X3="?'^R_!&J9]Y(W20PK*$B2P29\@B$=RP% J/0CK'7;,]
M>B/"0^=V],.AAVOQ_NKH^63]VG-_-_F4II<T[K?3R7PZ'N6E??MXELF#$5B>
M59&E, ADV&K@R *OO5HP"\Q2@G#^F66W/S2G19X#:6D0K^&N]_1\HA+9'CP[
M+9GEELP>;X 1PL(P^A)*QI!4NUK'VR _+0*V4-\PH2ZWUNY[<I.^%T=X=VV+
MT$PAO_Z\G@]\I;E%QE:']%#O;/!1(^,\D\%L4R2#61@RQ97.AFRHTK"*<?_C
M.U7F'IH*+R%3V)&E+XQ#)B,"6T:*0*E!EX*F<5;!Z79U8$XK4WBP]?AP!!@J
M,?AR.H=Q+6WV$1>CV;7O^#SRF&2PNB;M"X@D1JM84(;@2^415,F\7:&X70=Q
MJB1MHM2'=#0'+A__<#RI"&VT%2SR6+V\5/NFUDBJZ!/W6<<8&A:SZ7-HITK=
M Q+@(:'M8(1>9C;1,#H,@4#*HFOOWU@+!23A642?&3ICI,DV\Y;MCO8<S2NC
M[4!J?LA4-]2QI9,R@.*<N>!JDS[Z$BT&AH9,$T5FBDW-V-?AV++O@^SKH!JT
M43M7"G$CQYJ)!HQ^"+2H  F!6^O$41QB'[#RR8"F3(_*.9ZZ)ELF$DA/^U<@
M/J"QM(\508YOL;PVIG)2%&</T7CX!>6E]4"=?=/0ME'A0;.!N@#]D8;6C H[
MIP7MHL>#$B_39'3&D\^9I69::3*!HB432'BER.IP038KZ712:6AM^+:-^OHN
ME%+K+L\P?_SY>Y -..T"4[PVG\^JCM@#*\EF9]$ F=,=+D?7GWO,J0I;B7_:
MD^QZOAI?3X,C_RGC!?VRGF0M!_YQ].7\-CW.).O).3%,*2Z81C TY+1,M/2I
MA%(D=KD"W^ZMI\B! >4^3(SU].+R:H&SM32IF(*1@MQGYT3-UM&<F)N7+G5*
M#FS,N5F0XV:(IT:>7E72<^;:NP_O1XFV5"0.OYV.Z=/I[#J(_,L,\4Y$)H_1
M9,T#0\<]TR)I!KP6BHKDI^JD *+IL(QT?=^I<6 P6;^L5#AOK$L6,_,^T%(8
M0V*@96%)61^+%0F@W>)STJEP@SCSQT"+04)R-H:W=T'U(_/MT'3HEIBTBR[;
M9;XI);4*9"'FZ'PM8>$86"V829$[VOS!IV8A+J\A\VT @FVCPL:9;\8$'6K7
M" ZUK6P1FD6O@05I=+)%:B/@1^;;3HK<(O-M&RT,G?G6:?ZL5DXR&8KGEJ%'
M\F,YS17O2"A9I>(!A/>Q64[&;D,X$6HUT-\QI-)=IU[5$-C;-H[TPTT-5!BO
MG\(,ET^W(Y#!D^KZ$-!:9ET61J0<.+=1Z>0<% CH,,ND(1F3GLVLVQ%3F_2Z
MQ"T7VDF6P=$,$"&S$$$R88SR!D3.OMF5R:#I=<N4G.DDT>2_/ECX.)K_UV<:
MTOQ\.LZ_DRM)G\ 7/(N26V4E9Y"CO4[LBL&%:O1+*-'%:.TSLZ?KNXXWF&D;
M6MQ+>NI;PH/L]L\'4T'@6FC:&+Q(O!Y0(_-)%,:+BHH7(9)NES+R<F/B=J'1
M4&H:Q+'8OW<=%N&$SU"/28%IGRR)B)@ F+(W644HS1+F7GS/PJ&8V%;-@YSB
M?<0JSVNK^]8F7HUA'?]O9$C/1C#^/+TN^"ZY"&=@,P_%UHKNRTX8+C/P)$P)
M@&2A@].RV?GTWJ,Y5::V5?,@%RS/G]0K875*3I%S&,B D(H,B%CC#1S9%0ZR
M"Z)9,..+"Z?=CU_]*N=XPFD_ULR0Z[90P493#5/A4F35XV.@5+W+A&C "V-U
MLUCM6U3'?&^VE<(?+E@["7X08VX)Y;8K7 <TK2^X[@(\U,76COK:K/=]A#T\
M!30(4Q)/S/"R/)(T+":%#$U$! _1E69.X/"J?_;&:1#-;R/C033^TW2QF%Y\
M*$M4J]IM0A=?+#+C:P!C04YVNO-,D&\I:6D35C;SR3;@.X3MNKO2'G9ZW5/B
M@QP)?9Y>WD?D'1G!1&AF'+A:98^SB#DP&52.J&02IEGF[SJX%TZ O63=(/"@
MQ\MTPQV(F,B9PIH^K);A1"0H<$$&^IT.HMD%X6N,Z=K/-CT*6K2+Z>J"ZD=,
MUZ'IT"WD9A==MHOI0B'!)2\9:D';O3' O )D42B3,N1<\$"AKJ<9TS4 P;91
M8>.8+J4L\$";B,):"<%$59M>$33/I0N!2YU_5#/?39%;Q'1MHX5CBNDJ!I3P
MG(Q9I&FB(7 6M'=,HO<(V:/0L15[7GA,UW[4:J"_87:\+7-KH\LI!\E<K.4M
M/-?,H^',Y,!C+@*,;K<7GDQEACT-_^%4.,B56>>,_@Y ?U1F:$:%W2LS[*#'
M@U9F*#&I$&5F(J&GZ6@C Q4,*XF36<H5Q]@LS/ZT*C,TX=LVZFO3(%@9I[4V
MEF4C:CP-ECINP[@,R3LCO E=ZC.\O ;!6ZGB^0;!V\BQYUH-CT9 KU*)@U,9
MN6=<<,=TJ8$HB(XYB#X[%Y&K+CV"GWG-*>JZ3\GV/)T?A?8/G/S/MXO5C8"V
MP19#*QH-TS M2F(>A&<Y6>=U,C[ <RD,W=_6C@*]*Z>+TG>7;"O=_S3%<_KL
M"RZ_C,]Q=%';95Q=X.S?$,:+\_2]'H3(7(FZ5J$K))Z@:H<",+1J)84J.>1Y
M+V9L@>7$>3.45GJNTO$H_C=?<;(8K<3CN#2HBF<J2'((198,:@?L+(0%02!Q
M_5!P.][<>]N),V-WR?;H_3Z)\.TY+!9X<8,PH.#<UH*XFH:M1?3,6Z&8B3$4
MB,EZW:7C?+>WG;CN=Y=LC^T'GD1(WQ<XFGQ*HV6-[]6%F#9*E=H]O<A(ME11
M+-HHF50$- %Z4?;:-S:^]<2YL+^D>^P!\/2*%<??)G^MCJ4#.FZ")>TF0LD)
M&UG99 QID%(:<+%3N:9.+SMQ!NPLUQYKY3]MQ(RF7[&F(WY=U8\B&S>4(E@1
M-71)<-JM4G L%"N*%,[)]8B<+>W'M1>>. 'VDF^/9>B?!/GOD"^FDUM3->FB
M(F>%&Q(!$D%]J3F#5KJ@BB:W>B]CX.[+3ESY.\OUH>)]\UH*U_>(_[.\1YR6
M5=7!59^Q_\$\FEQW%?NT@,4RW62X<@J[8QF\HD)/8EIO5UP(K>!@ ;6F[2)8
M[X&L!I>R$]K'9XLJ[ ZK35T%;D";K!(K5B;:"P4M@U9F5KQ&$,B)&\VJ5C5J
M6_QV.E]\*)]@C/,SZ50![CRS)(8:()S(0Z#%P @@KS (Q]LUO+B#ZWBS/K?A
MRZ;:J;N)?I"XFX\X1WKD^9M)_AF_XGAZ6:??+W]=UO*>9UF1">#!L5*R8#35
M%?,J(1-9Y."SQV1XLZ2:IY">*E?Z4\\@-\J?<$P??OD'3LBL'!/(-_F")#]?
MUA3YBBN<)11CBI+,8;4V"L\L* \, G 9 TDBJ58TZ@;Y5/DT@,(&"7G_C62!
MU:# Z=7UC=N'RZ7G,OFRPBB+!XTJD.\2%-, @00AD('@UBDN _?-\KZ>AWNJ
MA.I94<.T\=VJJW;$X((AG]CR9):M UDPM;\V;<X!C M!MBL3>!I-T?>CV'#J
M&ZK'[C/ACD(E74-;F5,U4L#1W@TI:V8LAAAU=BJV;*;[LBIB[,>E?I5SZ(H8
M];SG9I5]2X[SE^ELA/-EI!D/2I<:SU_+'[(J,.:MM,R5;*UVJ3BS%A>_\=QL
MX\./.9)X*^U-^Y1BS^$7#P#]O%R2.T':'!3<3<'7KVD;O]N3 IY2YQ[2:Z38
M9*370D46>,W T3PRGQ(P88+QJ;8U[G3MW52AC\3'MM/G-D+KNPG9G3/-#V6]
M'\[]1DH?RANR7/(5N5DC&']8F<C3"8S_"8NKV\ <!(G2(K*$6I/%XA+S/A8F
M!'J#VB>!G?J8]0^M[=U(+^J>'H^N'CVYZ_$&Y7MJ%?UZ[?P=)OER-J6!$!!R
MU>C#C/]]-5J>)7U*YYBOQC@M;\9+QB_/Z%?F].ZW*,/BV?LFI:&XUFY3T"$@
M:!\LN<5@3,B\A")URE8:%<79L-#Z=&_J!<XDC<:CU<PZ7]8=>7?KC7TWVV4D
MEU_5UG'>+YM2>@9:6:;((#.)A "JV1'@;D/H(0EZY:,:X,[1%UH[?$VU%(7Y
M6M4OH.4FII1*:5;'^UA.#P;BTH8DZ%VT,,C=RU;#O_9O N'5P@"3==2:@V#1
M.<T265&F)!]1'N3HH!O\PYPE-&/6P/H\]&G#W5N$Y8.N;?J21%$0(G,ZT33B
MUM5VCV0(D7$DO<(:5=;N<N<[L.,XIAB"!QMN=7;4QT"7@M=H5GE1'?"T3F.^
M#_%0V<J[J^U1!NPA\Q9<2"%RK0E7EKF&FJ(G7)DSJU/(!G)RL5D\00L./)M
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M3<S(-:FTJ+HZ9LD\5X49G50*2<@2FMV"OJ!DB<$YM(U>AM^U5F'?-HCD"YE
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M?7'F;A'^(70WR(W-@Q O$^H>!SEV\&P'W =K6#*(\N^6$1I(<P>C&<,C4VP
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M)0++3#(AA%9=DR!G-IB):F!K9(L-<T\X+X-]A]+?!@[V\IZS80Z=-GS%QD7
M8(%"JF",8$,W6@54@DM:AFI$E^H$>\+XR;DA]+6!:WN]OSR _?UTO5/S+*X]
M*[$]PNMH\GGZ_AO-5W^Y.'$170B*(% KPR2= &S%+5%FS,[XC+=/Z6TIMP6:
MG\P;4'L;"+C7:\V#4VB;=:V4EXN34H,JJB#DR@:L<:I53F7S@%I;;)*:Z'86
MS/8,NQKN)X7VD?\&CHSP?M+IQEPK6S'4#,+2J@JO!C1%0]'%QQJDBF:TS@%]
M3.AE$/6 )-C Y9W?3?83X7D"; HFFY($^)P(^"L)49&%$EVJ6)2H:;06/CO/
MXC#Y[&-S=1PE/_FL=R>TCS8B&*]J>WCWD**3D'7@P[DDY<1HY9"><M;[@!3I
MF@B_C:J&3WSN@N9G(OQNRGLX WH7R0_/!T;DR&?/WK%P8- 8P.(56$')*"N0
MQ@M\>;J)\#W28!N!#Z+^5SF??3T[;2&&]^V)Z\1J;8,VT8&HDK=#:7C6M5H^
MN)42V:14Y&AF46?4!T]^WTK!=[@RC'8&*21WW2E8F7:KI5)M1K;A,N1@VL5;
MC8 I5W!51&ESS2&/EG>\$>'+,TSV5]0@E<7NP+H@=A=@8YLH]V ]E+72@T8?
M9\D>ZABH@LMF@-2"Y$310*6T$GFM_Q-I@J!L*#$6DC1:!;!1>?*H-3,F3;;1
M0M\IN0W&'[/EQ[/42G:P]7;ZXPKF>176ZW=6ZV+H)6@2K=NUR]2ZR;3@]5QX
M4T6?2,M6,[M+;.).HQ_"3.E%=;-1Y=YSG8,5XBWAFMIZ=K*Q+RNV2WI;(.9D
M(5F3> +.RMMU3^^GR0OER( 2'^2DN:R5>#VWFBX:^Y9LM"I6@TRM]D#K@9*\
M<9"TKU%+;\OML+T!K]X> /KR[-S>U-9C+O$5NEN@KLHC/@IK;&-W(]*#7<SU
MIM0[?.E/(X/L0IOA56$BV9)!E59;+^@"B,3P<C5"D$K6XA$2Y?&;N[%YLHTB
M^FZ_?CL[DW?2TS.&<;,:""TO.SHE3V@C5-&N+Y$2)"$C."F016,*QBX-L;8<
M]A#F2P^JNI.H/8R<>[9L;Z;N7%E221H,&9P.K32F$Q!ED9",IYB2"R9TB5K<
M^.'/7[W[RVS ]YEKX647P-@S1UG8;S()J4V3+>(0# CVFU2,H@8:K<3^/1B?
M-R?Z54'?-9$N(OU?3<O-NA 7T!)EGE]0(',+KDZ*)TS$2&4RQI*W3-TNL7P/
M#_.\%=RW''NN.7011+HA:O "FW .&0-[W;E&,-9E"-(ZL,YY';/#3%T2(!X;
MY_DKN5=)]EB=YVJ^'QG>I$XR3F\&$E\+:6^&*R4^BEJA%R-SBR(6!8(MNI4(
M]4Z09HMBM"?8;I!?WK7# *H<A'*_3I=\J"T^S99XR@OD"M[E%=_C $</#7H8
M\Z$N)890^5TC9 !]#6.P/@)4N:1Y4]7 _W&+G@D$,>K67MS4FJN2$M51$^K1
MRXLGP:=MU-3SA<:?])FF-+\\GH-S*@B? &6K)I53A%B$@.)5II"2EJ5+B<1;
M'WN0T* ^A3[K1V(]7SW\>C:?X;?).OPIZ:)-J9!5RP-PQ4%P;#\+P9.3*().
M7:X<;GSH,2EN=VG=N^9&ZUUR96'-ZL?E+/^S/>SE^615=/C]ZI\?3G'Z_FRY
M6.*T90/S/\]__NM?;,I-%E2&ZF?2)[:!>YP,)L9;?4]BCM[DUAM'92.E2*'4
M6%W1%=MMN'ND[TF?,/>XV+QFU7=#\>H.BM\NDT],,-(:%0"#8$N_\N&YRKC#
MY'WQ7E2K.UV(]@FJAY:^9VTS>5^O76;^C5W>9;NH7K7[2\@#?L ?[5>OYO.6
MG=B^/ D%0[2N@$SL[AB'$5"[ +X0RP(+&3>:>[GK),8[' Y+QPT=@\=0>\_&
MPDIFKQNNYI.S@;RZE5G]]%Q*BTLQ?9A/,GV@^6HJ)TY(I11E<";P25FR!,Q&
MM5Q96Y,AMHR[U'+?=?R7QK+1=#6(1[I>&=<$M$)V ?LDJ9"3UPZB3JZ5;TH0
M4JC@@W7)L+ELW&A9+X]@?6G$&T:)/3_&]"&F\ZO'8 .5& *48B(86I6)SQ9L
M#"8E6S+)+IV/>@,T=!;QTR#9X73X]#.+<RN0(PJXVCJ0A_9&@JI=C3NC1;1%
M:3/6UO@T,HL/2);..<9;*&V$'.,.:'[F&.^FO$=RC'>0_/!\T+[J;#Q"2@V5
M*;8]NQJHE1R;BFC)CARX\B1SC/NCP38"[_DF_X'-<1U?I9-5C(!W/"^!469
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M^_SW=.622%ZNT/+2)5MM1%T\)&\U%(W:N]@Z67?9$7UTH"-F>C=C]IQFN7;
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M!*UT23YR^,$QC\G)0F!S< @:!?\;G.AVY'6H+)%EHY%O?V%N(["-OW!P?0O
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MK%L*6<F"32G0MAHD.BWKS& K4.%D*T028B)MLQPM3VBW1SCTEN%(.K[K H_
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M@QK_KDCB0-NDWLHBHT((JN6@A, BKI&_**F#];G<Z6QTR&W2?@]:+O)',:E
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M92#7.W>[7]]A'3\UMA7I3:['5O#N7JRG0E5OKO#3?.SZI,XV)AL!72'))L_
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MYC=G"TR7Y]_>S<B9J)U.%_60.;&>,\.9 R9,N4YA]48DJ $'GZ(L'H?$W)J
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MA3%9VRGX_BKU(ZC.#D1,F+ARA^P3_<N;7LQX7:<@74BUW2'H+&B#=%%"*#D
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MKLS,((D(2E25=2OWP ?_/ "'PY</JS%NG &>S>>X;%WS9@1Q-";&\$;UDMI
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M;-&>@WS!ZZ[B[^#KLIHJX9G@;%G);_M)C(,ATTH$YEQ<A@4H0EW# J*V5BD
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M\BPE !,IU52<0 NG+IF9H ,=1[.*9K!Z=\/IQM/%4@=1C5V$W]>Q_-TGF%U
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MZED/N8Y11B7%4*;0'6S'#O[M627NF4.'4--+E.<-0)MDT@Z0A@X#OH?R6#'
M!_'WF#8<(/R!]$([+I0SFBEM$MEJ$E@H@@PV%V0H5DH[7/_8@?3AR;C?OM5A
M%YDW+VBV\D"_AP56F^MR-L-)^GK#,EMC=,9 %CXP]-8PS8-AOHH@D&6O:U2
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MZZPFO"1A3,]KO;S+R?*SC;E$]@MJ69CB5M4#!QDX.CHFD1</IFANNA15>G"
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M>J8Y]\2;;!GGAJY1R *Q3P//1N2,4HQ> ZJ'TA8&2]M.N.'M.2S.,'^>]SY
MMHE,_$P,%*2E:]M3YIU(+-.A(,>81>JCX)H0,UY).RI,'0'&07'E7HRZ3J>5
M(0@3L286!&0:T;*0M69<"&?)ZBNBUW3(_CL>.G?]B()R(#:_=O[Z=L#T%[BX
M'J6F4@C!Y<0X5AZE6.>F:L$@9YUDX?0WV_?6V5KWV*GFAX2M(][\(O8=Z+FA
MTK*IU^]!S1[3G!_N</PYSL,X_@AT ]AU>!!3XC%E"RRN$S,P%W+9<V0N2B.$
MMC(+\16!]\2\YD-BMP^76@]L7,R6M:CV_YM?S<YNR"%M(H$[P5P61([PF9$U
MZIF-6NJDHH5>T8F.I8]KB@WE]+P=FQJ_R7]<T/7_!]E^B_/YU1+3O%9(;Y*A
M0C;9@9/,!J.O&YUX24ZK@R0]UKRHW5>2QR:E/[K'7Q;'9HQ[]#-LF$7VTV2Y
MFI?+36I46AOS9+;3GZ=7&3.Q\AR7B8XP+V1>+>?325Y'*_(5_3]G%=';[B2W
M"59O-ZO +-/_/KG)I?M2&_.G^>+R9HKXR]/3O@:J!^>]?0V'>"JA3B24(+GV
MV2IMH@/I [=:U[*1#"!.OX8#M"R)/IF<S29EDF"VNM<:?]N=O7.6Z!K6I4C#
M!"K+B"N!!>"**25*L=R&X%^E8?)>IVC3T62^J)!\*!_^F-%-=SZY?$]^V(*V
MWMKURZF!R#,FNNMR;<QNZ>H+4$<S>G(ELBFA)',LAO6F^K7;%1Q.)KN;H+2'
M\B!]=/9ET<UXOA(Q)%0L<$5>;.:D?-$CJXT9N(H0N.!?ZR?[BOT.CBF#AP?V
MM:-*6ST)>YQO[0;JJFY]*'2H[.K#D&(^A<PP@S4*N(W\:,-+^A+]=?1..) (
M/6RQ? @H#U(Q_VZVFJR^+#_/5S"M#]-;!&Y\SAXD'KO7PK-4OUJG]H, _T"^
M#H/:JPE8<-*!9B40W!IK"^LB%1,VU F'7HF@1RY8S[=__WKDJC]8C>.&/\XQ
MG2]7/US$'V^(<89,30^^EBC4<!AR%I-UC-/E'866BNR+'F&G!PN_AI7?F/7S
M5GQK7=JSCGJ\^;UVM%U^AU>K93J?DF^_19V-DI2NE;6R,C+-8V+>TD] ;@9R
MLAWS;HU_=W7/LSN-"^;&G&W]4//-+[ BU_$"9K.W$_QF6QISI@O+6A:22'1E
MD2 &HI,9Q9&'X$1*SP4 G]YA7#@WXF3#$IT'TK=%$@09HT/'(-K =,R6^0R!
M[ANT0J'D/O?)7GYD^7$AVX*'#2ME[DCZ%J=GDZN+&W(D>)F\!B9MIEM$!LE
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MZJ?)Q62%FVM("9&*-9'9G&H_"2>9C[;.!A!1(DC]8'+[4U5F75N,"^%6O.S
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MQR87A^!SES@,[2%68''KQ2BG($M;6+8I,9TJ56 D*[+D6!+'XOKD6]U?=5S
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M" 83 &#A80!8.%@0'*0?]J2#710$ T8$^&YY\5S"PL'%XZ7@P,;GQM1[1DE
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M6VPH&36-&$3.O!EC>Y3R:L,_41/<M'.X],JX[\0_3U,:<NJ%0>.*H"FE<RU
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M,-GF,%"36S3 8>NXWTCFX2L2V5]>%W)WS@;[X G<9!@JH>^B8:4X_Q6[N;8
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M8Y'ABAS7B'HZ'5/:NI2.1W3$]84SS1$2HL9[8OWHVOSEX_QUZR]52^=>\<S
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MTHV2HEZZPMG04J)A3YL,$/5U(C*P\T$!0ONEQ^6MU%?C=& ETWVWX$]@T(#
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M*+V$-J&SPK<J%E+A-R9.1$9T"1>F_0Z*$9CW\Q;P?'& Z(QZTCW^^P%D^+%
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M;>K<.)5,V4 MT4:;W'AO;;D99PV]E,&VX'EE[U]=Q+L?CLA47!O=U.LRC*$
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M\A?_541M0^/L']1A,Z6QK=2!/;ZV3ZI,)"6\L1\B/6>H[@+HT;]A_V1"(?O
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M^!&%->;M$XF9U/I.U7]!VX'/+-VGO"@X%QGA[R61&COTL3;HL10 J*W=C"L
M@6 D9(4F3N4/!7XCAGT&4X9UF4>V4PD4<:C.QGVF%YFI+@/R0[>-W5T+(LWT
MEZ5-.;4M>RRODW83.(5VE33XMXN?]S':SDG[X"?>MSZM,()BB7YG#*?*=DNM
M_T6+@52+914B6$= /WY>.&@H\4$E]NCPV:NHF*@U\)V)*A+".+D-/X DB#3_
MP<_9UN+V2?G<'%I8D%[A[B:>\5K5:E;A,)L:P"U@FLX4@%$=5XQM[&/U<F5R
M1E'?7LMF*9ETEO7B.S+G$Q/:,:U@I'U<&E1UPW).0L\),6>SK&0HF)%=^4V<
MVC7GZJ'B>WXC/59C56'(_^PR>_^/00;=M^Y'T>.8XG66L&<ANW3KBS5MD[?5
M _7US'HTMD@33P=&!1+&1A>JP<7 EG5;0T/%5$>(W?VK:#Q>UYTK1GE%$ET5
M%6WU[&<DJB CE57&DB7WD:_F36@I"[YQ(ES5X,V7S',<6EJ4)IE+PB[XE_9Q
M9161GCR+=2CR.ZWT.AJ14G13,29*N7PYT'N'OVA.AR<G#?C5'*\'$"F@]=+5
MA1KH<&?E<Q-'DD'<V]*5'U32GBJ3G;[<EG,['L:)2<"^AS'&A6=%]*WFSCT6
M(:^*%H5=,']47\=B(/(^\D>EL&N+OFR T6W]18-?>%*M=DY5T*;UKZC/2FD:
M50SG"(4C]GS<ERP@5*GDM^W][8%-+8CF;$>I=2'E3/'KE*OPR_%OOH?)S%6$
MLW(2177Y4 CWFU?TE!H'(#*"648&RAPOQO28:K2"VGRU]ML2!]WBYPJ.-4SC
M7_ZB!3K[,7'M<^]@@G,$6:>:09!:\R/U9[$SQZ5=]-JI0L?6S+JM6L>S._!7
MX..-F:K\Y^;>1O2083*/(;:A\*%4E:CTW(!4CE:<PZDE$HU>/$I%!/;Y&P]2
MWM>66#O)ABOK[-N5O>R>Y7&\E$IY"QO*LZ>@,OO)EN_,Z)[*;PFS7X")P"+5
M:6<O_C>ZM<[[\[8X\B:S(__PDWI]%2F8/'&,H!G;OGFY!K'%@V'#HUD=WV[!
M;S5M:5]+\@QURE^7%]R]3A)<+?X90'#C,LC/9B*!H[06@J&#)H9ZR=^Y9A>^
MYA'IB(9&C_E2]1\CUQE>3=30L_8'GR=2?A3U0=/#4O'/9/O,^-)^SIM<&Y8-
MD7PS^5V*$(^L$4+'33U!KJM?V1XZ -UTU2RY>(((8+3#'ZG3;'1C?@@+D(_2
M)_*(#B'H])HOWC4 >2?A<;U%42VBL]=B2#T6D[%C%ZO@;-&"NL(OD;')\NXA
M_1O'1.\"12*X?U[4_H1_&]*F"R)+R1H0ZN;%VJR>I7\DR27)34O-Y4DE(=U6
M4>DSR@R4J.I<.KG--M!MTS<7V==X=M'W&9^RL$,,.:J$31+$&]<GX?BK)Z6]
MWXN;LJP7VVD5O[I DXB_//C#B G1AY=7%P!YJR-_\Z*TGC-<%IOI^\VC]HH8
M =60=Y=,6_>C<80RCQH=M]9VNENYWU<LJL:DKV] )IP9(%ATMVF0]:J.ZI[?
M9#[0>6'BG5PLZ[A+=Z8%E,2($!C/J1(+YZD\4*S%7%?GTZ3.]I" :P&27!,D
M_J.^EV@AP8NH1R>D$_LK_ZX=#<=NDN\N*:NPV AZR.)T$)WG,T#I=57 _YC+
M>]+2G4K6_'H7\K^W'8K>H4I# 286&[*K]O,6N,(?1D7V#V$M7YE^"&S&Q=76
M(@"<%" K%94#T$J#1ABY%MA:E>QM [D!ZN:SS0Z(SRXGJNLY>I8UTRXJW$EN
MX0>E&.'7M=X1+[%S$Y"-VN_R<.PDS#NJ@F)'Y#"0Q_WG*<<C[6J]:+$^-2G6
M(W^55H7Y<>7T OEF82'*>T&!O"!? 7V4K9JL%-&@$2L>:S>9=.33^13XB0'R
MZ9P4<(?C_\5,2M2=72V:2 :2.[:GZ?=_D?;646V^6[<H4"A2H%AP* 1W=RLE
M%'="<'<K;H6V6(#@[E H&JRXTR(A>'&GN+M#J=SV?-\YX^YSQNEO[WOS=T9&
MQGJ?M=9<<\UGON1QPU9CKFWV4>LF#3^38M[;0+!>>[VC)K(I"C$0UKXG2#')
MV+<>[3,:DEP*QZSWXSFC%F)^3V 6UNGLJ&];V-$[)VW>>:/2V1HS+5<TB2N5
MY%J0,%ECK\E)':7:;7U\,:&E&4U;G \U^(BFG,NAMPP2Q%\Q/WEJN"C.=G>(
MW9=KU0'6E>5O^,J1("\BP<45^+F5U%.Y4G$@[(?S&;%BFMN,VR [?1H;$HWZ
M>1NC8K.AXXC'EP]UZ48,Z+J8.!Q%B]*SKNQ]"2#WQETT^67Z -G7VXLG/\<[
MZ5X/\+6HWT3QBZ96?TAD;BK84%46 GC^ *7:^#^OY,H0]#RU>DQ=T48=_MA1
M*%"/Q$GHB=J:^C;&P7OC2&8!IY2/W7YM2 ZGD 3J8Z%R\QPJ41:$:#)1!I-I
MH3/+F6PRCF()G<,I-SHLJN6 70"L4SR-H.\ZZVL.)L]&_X6R4R!M-GMR[N4E
M4J]G/[!@@P7?\ODV0)7(!<$8V+4*GV[(6=LUS'E(UOH@>!3U/XP%+.J\=_.\
M$B@=2H*QEKU[&65)5,$^$? ?Y?(4 F2,63^H=S!(>>@;3MYWNZ4RY->]8?6G
M^0)[US3,%:K:@+:D)@S$:YK'P1*>QZ%[AU*"%=5-[';YIK3F1=(X$<0$-(!
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M@Q[:B:>+_[AH5I<(^Q>22^2I':=P2,A.?&%.J[_XL"*>0=NG28A-M33-](?
M&"DMO:4:AV$/#42'/G'JE&Z @I$,$-NC0CXT)#HD2J.T$7;$P3[XJB>7<*N[
MGQ'I;N1=MV.,Y:\34DJR[(U@?G4;CN%28DH=^,7<7<!C<^)R]W5^NYECU"^4
M=?N#[?D,JY N9T%XGZ;9,=.GU-J'C<7^#<1,HH63N$G,[G#JOJ>9&#^UL?OY
MBCO$W9)3SR216644&4_SCL4TZ#:6RB$M&UW'?<Z841:T45%/60-Y&2]B-.2
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M<&AJ?TRVFY^7*C8H(@(?)SOTJF2'QR%6UH*$$MD7:AN[Q/L&U<.Z7,;+=^A
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M#MMU<X9UZ?*]ULX3,\NX$5-3UEN,6-KC@JOOLIR5:L2K3FUW2VM2Q%W(8SB
MV4@)D7W0(+E)E"O>2!#&XNF$/UWG/*OJ>.(6]ST'-A/L13TS/$BP'MI^^D6(
M^E@6C4L$,?AZ31H367(*?D7N^FJ$9+ZV+NM,1ZR,P;7I!(7@GVB?"8"[I11'
MH[1UX[\&BIN@GHPPC?6QVA?G.<79/920X#^AS<76-[)&T^!%11_$SX\GKS0=
MRWJ-OS)[G*K(\BM6\ZHPX,5S6I]]*7VXI&^6/ML>=>(,K4>?GF_3A"BB1GE,
M!C0!W<4!&1KSEHQQT/VL2'O>,=K7TL:\_ =C2$-&(ITYS:_HQ"53V.\9C=GP
M>,)K^MB=*TIJ>\,[3^S'655KZ 928S\S&A-\&7 ,[1469I784UK1(,)%[U%I
M/BS2S2HO38JK%3=QYTGOQXR;,C"77L69^*VH9-,3E^JFP9- T=0:NUA!OB#K
M&"!,Y@SD/[(4^W?MV[Q+#JR(A$N@PMQ')V10P^KG$ ZQWY\JH';;S^0BJ# R
M"KR&SRAW5!P)1LQ[T9VR-A]]W>_8KAO!OGOF?VQ>3R[C1')'S@W=$9.6/E94
MI%QU#OJ0YN1M-]U'IL]@H:_-YCS:P/!0W%ERG98E9TV[1PBL2X) ('@@J?W(
MJ,G(W,F<46/Q"MJ'GQU*K7<".!](O%3LZP=,UEDB6RR$[YI6#LS-CHCWC[#;
MCSBY#UKO.8+X+U7:%;#XCZPCQ?9Q32M[U=^UO>_L#[\*I*XX$1#"[=]"L,?P
MK:^2-N=PA&SB6/%&4#U%,948N8GDC'ZQVW8FF2IIHTNJ.AI'$F!ANQ7W7QQT
MXQ309[%Q_0M@^)GNB#/10T/#4EV/&C6FK9L$$5SS3JEOTY*.JG0Q QMD;T2@
M\>'/)XI>-@^F$#_RRVQZBG@;D&,@\  _&?NHV4T.6=^\N6S3TS$ZTQJI]39R
MD\HMF4V6WE=Y7%!8] ^GO_(<#:Z^QJU?PHO'Y.-K%9J*#_SZ*/X74-!RT<?G
M)-?5C+A\F&$6,'#7SO;0=O<7\*1">)7(.X=9=URKR>/5N)<<1_-+$ M>HY[]
M?(8J+?S,QVIH*+Z<1,1,$*!2?W&<$IQB72M$X(8?D;AT=M? Y#@;;8]<_I$O
MN.SZU%!1RXV @,)TU]%\T UZ$KLB_&W [J<S7G,U.]1'6S:69+I\%"#NE-:H
M-/76%#&F(KC$Y5"J$Y;IHT,C9?99H[3[(Z1$UO93$O5W>6"YGE4K(X77B!%(
MG4#;^_WT0ZJ+KOW[HDM"?^0VOBMK)FW!"6ZO\_J49.YZ=/N0B1IIX_./KDCC
M.[B(B/A44+II,7.](C2:K\JE4Q$$9]^4>RLHBYKP&1%>Z=_%*(H\/7 ?'!9O
M)_\Z*)60GLN5[!ZIKHJ@&9Y^=T"*SQ27LDS7?[B/V;IY6%WS]V6)2#Q[X+!W
MF B>4>N?+D)4P?"CUN:]05OGTELBHF1J@!U62&MZC8^%Q5AO6L:Y0$ ,O%&'
M[8_,R4:>;^$!N>Z5U4<M"2#IWAJP-AM+CH <F6H8![IU"HF:;_*^4\7$#2)R
M?K]Q;,D(LCFW<V7Q+P%\35;E"D'<PO(Y/0<;^*T6M#CTAGJV4T_%25. 4F?+
MZ$WOZ59E$[$]K^UUC)*L6:-5NB%HT-"N?/&%_9+P_(59HZ<(.IS-UO?41'?0
M[J!*>.V(L0I!O+=22C?-*ON9U&9-7OX?U5'-NT#[ZYVV(I,RD=NX3^[EGTPX
M_P)D==\3_L\UAG^G_,Q0/Z$SF;&P'I53##X*#I,2^N&0\&9FOX=/O<+>5&.]
M*;H#JYO'+6O>1+@\KIBU =;/E<Z@.-WS%:MR.;4#6?[?T=M-O6"S?T=O+QSU
M]@N JYN[*P*ZW?J'$ZP<K#YK==^;F]A*].HI26*:\O!_"U=E*ODWVANF\2-%
M3"28;PZ!/\P1CIW%H541.W(ML+QV6%>3Q8X3;6*04/TY+XSW(EBFU0S(+ QT
MN942G2PLSH(L]H[7V.1=K(4*V?J=KC,D%424R1]$1[9>%^Q-2)@8PA/$,\)9
M2C-<-I(9*+%$<GN .P:?_0EU)Q"RN*==W=UYL%Y9</Y6F4LO7?=I+\V$=*BC
M8](J]/:9V)F\\Y+,TN:N_GTSJ'3>R>\23CQ029'BL\YB-GJHZK=]XVRMSD^<
MEDBM*_V*D!>U5BI>!'K>0D[F!&-\%\C<'1Q%VDDM;C@=$=V^V#@$L80ML]D=
MTV323-J=X.]G.BH2Z5]8ZS^Q3\;ITJ_^29EKPE'\$^ST</@7\,W+Y^!_KN&X
M,]54YV49'@-#+DZ?23N4G_J3]Y80Y >,&/I03V"<'4>27C(1O\D]ZDV&K&]5
M/H;4GFW7BN/4B#_THM7*Q__OH[PM>O5Y9=:]"LZ4F8FSL'A8[Z4N"^_VJ61_
M+/^\, ?I)S4:BR%")/=J1G[6I;'WI_^#L=MPJ2QW]!9,&J4W$S;D.OVY@THV
M88]C3D]K.2]O!,8J8!"VWY(_A$W;)%EEWH_W%[#'/>+LZ_H=M)DXH]IX?N*6
MD4-DX*J[GV,=C2SZ9U[H,=T^WB*SP6D%JXZY."/6."J5)85>ZP1VW$/6+6S8
M?,:IBZ(IQN_ZQ::MYO+>8C\\T_& ,-G[%&H16O>:@[Y9,/Q-3.A*B=/4I_C,
MZZV;S]=VQQ81Z@YO.?JNWNUJM6>+O&N4C1Y9?NOFWC[J'7>6RW'+OPU)?OZ(
M,+B8X;;-IYIKS+N+**A[%]FA(LYH.')(;3'7*%SC927-8XS+U+I4:C0S<YLC
M4.I7S^8C0KN1,-#BHE"945W>'G4?I\C9QE5P8*8/Z=0._^1'8;<F=381/R=>
M'83>C,$< KT\;,)BE=^S%W%U*E3U>SVH3B>!*XV+JR05YLO"PHDDK9R7/>>X
MRRYX2.MVS45=Z9;KFD&NT*SEEU:')5(YXWC4?%#W@, @ C'592GV,.\CU[WY
M'PQ75DY]>Y_-)^7Q!&V"M</,$[_->X#_&]\>NCX!"4KOR;JZDYP*"Z<@+,F+
MMQ^.]Q^".W%ED=52,@*3])T0*/(\V]>JU&PF[(WD,1L&_84/G6"B/QV/JS-<
M6EOBF3.L:W-7NU=YSJ[6FT[E(9)'J:^ +S22"_WY]<-/H9[;]O^_/R4*:MJ4
MVO'NU VK@QWV=7.CA(-?0M?J=UJ1N<@&8DV2&[N"URS<B >HFI0UKB^"1YAU
ML:VMY'[42_)Q<=A?_"C;@4;MC-G]E#EQ*F)WR'??7GY_2Z'\<;GC51![YJ,3
M-APG8._F;<":M\G(!WG:ONW@@#=G%R7S(^'3D7\*Z*2U9M-Q&SG1K>MQAP*8
M<ECP^V +6+J,\UIO$;RTG>N%&7/;I!CP#L"DWT^JOYJ@N@Q@@#4'>S!2EL>_
MKAZE>^87<SA;R5#%FFO=DF1SC&!5@X3.2R9'F:YE7"B5IME1BTCOD[^^?<I*
MO@M//\;7<C=8&VHB+\UD.DD?F4K3M- 70J_F2H<1**[C=Z')LN (:'*345 :
MX6NYG6ZFD_VLS\T@ (6Y$#R&^?NIA<^WOPO?ME8A6=)&@MU59^3P/?2J&/7U
MIU/$DV=Y>/NU^34^9U[?O[+E2\830$H39R$]'AD?JA'\S>8W<++UCJ-RR870
M&?7Y>U(*(V5RC6=S(R?R*Q]+L>8E;C<5EK&^QL(GHM9%6:/ *^^_ $CI&Z6Y
MOX!M_O^M.>U-RB)DEJ#WT%<<\>V]B\2/P_Y'LH C]7.=$&R2K(TO^<Z6D_[>
M0F8'<\W>=7;E6VP[ZI'I[IJ,6,FL<6.CO<2!NTU9U\R%4ESG,LNA%SD?,$XH
M5MF];/;.TS^]6?\9K(HTT2Q6_Y\G5/4>!-.X?W\<^_[@54 IOP$=$NS\4+ZZ
M48\6\:N'IJ.8=DK4H[&MKR 'O&F^FB- RXAX"IJ(>&=IT(=6:D;Z7C_OM5:R
M**YG::UV0*.DB<:Q<5@[G,P1#X@\!D 2'J8-IODP,9+ '&XYX<;=.1H>=&I$
M^;7]$ ?WW3-$[_G-"NB@GN&;T+C],6R 9(K #O.>$SU];(OJK?I1/*5#?_*-
M"BCOU6ND 0;8UXF43V,!&W5>Y%P3P:H1^I:5@AG!M:[58^Y/> GW3O?8MHUT
MMTK")CE)*/&O.4=W-DTC<_-^QS1=Y)'^!2@6;1OWQ&2*<GEIXW$3A20,-%/I
MVV;!*@C,]S;5 C"V;6GK11^%/T0NORJW_@NX)ON_6RC&E;RT8OU"87'/]2A8
M2@4M3D$<;SXT/EZ[51P];3W3!\;."KJ?7*8C._K]@-Y>_ZFXQO7,?QI:B14?
M"79=H#D<(2<J8'GW$4TEK\9IAC)QLC6$).Q0CP:$WKD0;5J5,-V ?WJ\J<,?
M7)5LD8';X1YXZBXUPL7GPN% P>$I+G[KM*JQLK;*]3O..$#AL><O("9R17SF
M+^"(]L/?;0 J$(@(?$/]%Y#>]ZV,E!C'P."'W2KU?,!!(0$U^#S*E:@:NA*
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M75GB+;TOS*TK$'/VNG2_DMDS-49?]W77(X,-JJXKN#YR=+^JKZX0GSF"% A
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M1AW*9/;DL>:D6G*'[UT)!6F]30X495*G[W;AV<#7$8/FD$$4O@9_C_.-;,1
M@RS<,U>V+YNYDI,'/56&CZ3&;>*. .H@#J^4+_BJ'<J0\!:&8T^6;Z*1%!3#
M#^$F)_B%0GM0J8EV4BM:2!-UL$:H.;P765P)G2JHPAT[BJM#BI.:^13398Z(
MB6N<)DF%9*&*A4 R(Y;XS6@8]U:4C(F75CW;3E4WKZ6<;2O7@=VR@,4 1I)_
MYJ1W[!'KZZ@VP4-%;9M@9_S6Z[L0OZ15=5$$([U<M68-$NW9+&W%LM_#NP%#
M\A>X%1Z*)+ZUFGW#&0X-,;_*FO=D!,LGIBYQCL5:;YUAK=A?YWU?>[Q^HJK!
MYL-W?R5EIN0CZ#'5C@I(<LU3Z'0S@4F6G-H9>(0=M )GP\M/LE&2-CIIAE%Y
M]Y?HAXL!O%/8SI7=E21P/P7<D\B*;H0:,^E0  "QNV2:H),Q3KQM(KQ=C=44
M"1P*9L_?1U2)8 >59J&SV2-FUYP0 CEL;JH$]6)4BFL8?@^>G%:S1GY(IGJF
M"&T1RGK+I5'YU>S]LT&A&D!;#YBF:[IX01!2Z(=V^[:NZ+>MO8\^=]U-.?W1
MAW2[BZ9Y T^0M.1B<(_?4=WS[P95V6J;B'E4,J VTX1CTHH3_H'Z3J1[:OX5
M6\D]-GHJK9$];9X5)SN=<Y&4+[YL25"S61@/GEAW!AV51?<T:_ZUY#M"TO93
MI,C(:'LF+2\RSD8-*D9*3:FHCSIZQ*0VMLRHGWWXG9/<TA!W;-_L<Q$%K2K%
MU_"9!>S8LY>W3G"IC$<JNP/DB@Z3?S^V$<$GF:.D  3+WEJH5W[BN$R[.V8B
MJ%QW87DT_>DFQD>GS?FEE =$/*6*8#S9<@3;LC2'PRA4E=D('[3W^<3(/'KU
M!R_X!V']D[$6&6Q,+ZOQKADAC37_M@0M%E"\#YG@*?W70Y 4#N_A*CH O0;
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M6]D-<Z,:+Z'O+#H>6'&OG=0@]I9U\92_16U ZPBT@(PB([&0&AP:ZQH-428
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MN\9YICD5#D*7$4%+R2F=EMI.8N6$5S=VZBV0M\Y#,VF?B@9*:R$X6#^"99/
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M_M)\?>Q9,7+R(@'(@&I/HZVW)DC!!*$I&#Q3S)]'HF+P")CT.S)W\H$9+F;
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M[,\\OT?(WT7X_IYO'OMAJJ.^-^G[#L0?K$#]JN-O\WZ8TK]::+B_I/FEEB]
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M^M;\HV__&K6#$O[&G[*: ZY#_-!]P/^_R1A_D/ ;RP_B*Q?\CX1?@#K8<&"
MX <L^6?"_T!P<%,^*/_OQX0=I/\7P?8/6S_N=[\_ 7Z0X,  _31B_S&,'PB,
MB)\2[;L8/P#4CY2_4(KZ>?/?\K]Y%7) "WA?[Y\#Q6=*^"^U_0)?Y?^]!^T?
MRH-*_U&@.+"N_WPG\..BVW>H^:H4]:W^FT!Q@/)?X2=<OYE(OSU:?@("^&8Y
MY)<T/P+QDS;4KU4?[/I9H/C!70?]^0/@/VT\0/]W%7&0](#&3Z/SJVWB!]Y]
M7'_$W^SP@UT_"Q2HGTOY@7<_UWY%OV/_1X'B!U&H7_#NX]I7^"W^1:" _XKF
M1_QACSN8U_VSC.+?XI<S'X+ZF=)_%"A^R$A_V-T.XF_5!YX"\3/J?Q0H?I#\
M;P)%R$^ZX0?JJ(,$O\XH$ =H?C/KX+\H?[7_X$:   [@)X'BAYGYPVYR$/M&
M:I^*GUH./]CP_R"CV'>C^YU)J&^%?Q0H#N*/PW&PB^S779_PCP+%5_PT.?DI
M?NQ"_:SK6^._.7H<N!OY!T>/GXG]3OZW,^__):, P7]L.X ?N?8I^NI_R$^$
M[R/X!L0/$K[Q_O&&^1-LQ0]P_>:"]'L5^ZOP[RM_UGZ 2TM3P_";0?_FLN5G
M@6+?C0<8 ?P1W\8T1(,MN?);(^I'.A ;#/2S]?+;0 $&P?]1QO*5"U3VZ6N?
M \KA_T3 ?IY?YW*_<^]7+JS"3R_0D?]$ZP$@]M7 /VO\7M%/\>WH8?#I!3K/
M_K[OMH]? [ZOMN_29A]^)^<KUY?/2]*_M7X7:?^4J/P\4"!^H/NQY0<N++9]
MWS-\?P#\1Z?F@[I^N!OY_;-\Y?KRM4_IOV#\BM\%BN_)4+\3\I7KR]<^>O]$
M+?#S.YDO^)7??O_*]2L7\K,KX/_0B._PJT"!V-_^^Z\OOW*1?79%Z+?6WUNS
M;PA0/^_ZO82?"R3=/QS[,^2# G^5_ #_:*?X";YQ?7'%?LF('\D_V[:O';ZO
M[Q>'E#\LL6]<LY]LR/BYY/W5 P+__[RC^/3!:O)?WR9^D?SW;?9O,EC$_L;O
MJF3?RN #-+^&(%NRV=\?2'Z>(M_U_O6B'/5]XQZ-^B^K?V'_/#DH>?_GH7(U
M-+\S$@QB2P8=O+OX$^ A&O]L-_\?_H?_X7_X'_X-#OWU'W#"/@)IK6T$^=%H
MO*CP"RL? K3#Q%3X=,C5L"QLG2Z&%")PWC'),)7F=V1$+,]P+6JOD_5QUN5D
M@\92L=UIN=9HN 3Q7G\$AO2CZX0$^1VS'=>KP&3I^-PEN$[7M!(%A&XHSC??
M2S'-UT0/'%-;?+AEB!=BR'0TU4#6N TN0>F8VH@:K)O#&D!EIN(M%X]P=6<)
M!"9NHTJB*?)7BA&(VYITQE#\^\\<FR4O#>946]3<QSO?PXK(P_6NP#4CFN98
MP"N+OH^DPD5ZNYJ*5=FREW;OZE^TYYTG/QK1IYJ#27!\)Y^]?-(5,,JB<;]Z
MB;[TR"UZ"F4<EQ!\W6NR)G&9-QV*KH[;K;^%J-*L&VO4D.L5K[,)]=51@),(
M7W03O/2N.?;6BA GE'^SS%"T?R Z!<7N%=4"+C[7,4_5I_@<*Z(.:D]7PDZ!
M20<SX)X(H.J7)!7C5$XO8.MECZPC<=5CEV0O4;\\R,R%HJ.S&PT:,.$7+DUF
M-!12Q$OE[:^\IJ"4Y9J+(R.) "@ML=,G<Y^P#] $.H<>\2&*\M:4E? JXABJ
M3QZXXG6HLJIP<5WMT),&7QR]W!HX7OR81\GC53G%<KM$'4/Z] %WY_5;_=D[
M::(4]*RLY:/%0A+O,1WLUR229M-S2! P")FU3<)]')WG?>I6*M/..L-PA^;B
M4:K<<S>YZD=%(-1RVJ*G)>UMN(YKFB_67GX5J=^ 8QVEI9A5 5'0DZ"F6^UQ
M)^R?HYB4KV)G\'P;DT!]337KMHM*F\!QSU?/EA-(RQQ,>?C/I@.)M)QN +U-
ML>6@45H.I^=T;$ V)Y[[R\-P96E<U45'['OVP@/%)!XF;A+>JL$A4:)DE[3B
M;UTZU_1@ML;*XA3G5?H+2BI>"5ND4F*5(^FL)VH,!A"/;/2FZSU:-G$;+#02
M+8O]%<.W35.Z&9+QCBVZRF113CEPRDZ+Y:(XQ*"S&3*:[D/'0*FG0C1QYX>;
M6^F9-)]Y@LX)P1^1.9N@'Z=SX4=4I"Z>>W>*6?2N[A#@11BK\)3U?OP%AQBU
M_F-!E"L9B6EJ95?4:D!1JRQQO8O&,V*VGMN\66+ZC#9G.DJ%L6K<U#+/6RWP
MLLL&4#>1V=0C#+-B+I1N(Q\3"@C1@$"^'O&ZQU]%(7$=8,Y/[=XNT(].-N>2
M2H!M2VRXT9&NTJLP,BY\\*AFMDD_$I=+X+ P7CB.E4@],MP8QE+1:]-!>;7.
ML'M9[3A%+[''"$,VSU-/W+[^E56'RGH6SN0FR<7Z.BK+US*<H+DFNF&  K#B
M:N8W[O8NM$/QS!LWFS,!(F!0.5;-Z)6(\8GMF/87;]6Z4UL9RGFL?=@)D(I@
MMO-*$1PVL"3V&H7"89>R7(D'=^P6W@BVW"]+"J.3/*H96HSE'AKHPZ7,YLFK
M"(\09#^21TW#T8SB=K[9*)Y5?"@\@S('M]T;OVR!"8X45\\G=S^F[@/PM($2
MCP8 [%*&^BML_C: +89D=1J;\Y[&!3;FPW</SU-8F>J4+;N/X<!NN 6+'O>G
MBQ IF*>>&87!T"ERJ)**C48ZW=N2C/RMH%10!)Z97F,GEQU*>=W\W'";&"7U
M'3JINYHKB9X 1/A1^?P4%=3XQ=H1.6RS<;],%:61A/Q';M@#^9%\][PH'B/9
M\1T[XU)'8N0>CT82Z>'F9D4YZ'2-J8^(K$?3+9M$,(<^NJ(>#]=OU/,:\@[&
M"'',UTG#ER^O0HYA![3-P6S90B(UFR\?Q5X\)A#D9,5U2@OP_5"+>G[>: Z:
M!YTV@LT?)_#B#*-J'"IFR=$C6<][5)$4#Y(:FB#C+>2+R2VH'V=(71_23$8*
M(U\"^&O62;+$I#*!A%[!'^#T:A>3&#@NCDG&CP;.*C0W1FV_B(;8\=\%JZC#
MA,0N5PI(A$[4*<X64[4M7;U#<0S+"_LN'_JA^>7V<$L$CP.OZDQW'V^=$."X
M##X:@'18=BD@[W<Z4O=@>C<.!F,"G-"\ 73]5(0)/+9-M#U:VZP<;]NGT^QK
M#ID_>C:0"Q\GSII[FO86BB&[MP%^;CO< (I,Y7"6*I&,O=MXB7=Z7O7R/7L/
M/'P>Z'99](VS,A6J^KBPZXZJ;"M!78HG >HP@]T\KOOY^@!OT<.7%V\. XPV
MH\=/@0J=^E"04$&D*;D,E<JM.>-K?,^:\7&5B4-=%?@OO(Z)6FCZ"!RNPL>%
M:B9NPUC,B^Q(PY7N8/(1=KWOM6+SG-ZFE&^45=IF8-G@Y.',-<11&[A 9NG1
M%A[\'>0V%Z ?@3-(^H>=-W+OP'K=\Z&G4Y/R;.%ZSG-W6:_,)(X\"&)P5M>3
M08G1],.OY%P[:H$M;"<Q59X--S":9J#H(6LHP[V^",^/'K_CUI.QJZ-1"3=\
MQ"<&T^Z9$.<M![(3$5IB^91N1E.G6)9=E]&.(UC6L\'UL+P!<9P7O0]Y[.#F
MC \89B90<'8G](NQ3&72C1C8<+2.,(V!3H0Z\MVPFCJZ:HPEN8@=42?&1>F0
MZ4WE'4?FHB$TEE3BB\L!Y3;2]<3ET3DU,C_* $E30"%%5B:G)+&S/I4^ C$J
MR4H=I0J4&-'J2M&[P)W&5.M*2 E[A 8A9+1!"<<'-0@()4[</>Q@GD&!+=Y\
M<F8]T]Z/% L)X2(S/D$*IC#_4!:Q]!%(;,DZ1"NKNX#MUQ)?*>]^&#8HPD;&
M<\*6-B2L?=+#/_FX5!883#3LGI7U5-C\08;A(':*$%ZZD&@&]@N2JDMOWZS$
M5^W >F18D1AC^'7#\L@SM-#@FLDQ<18/;P8>YB,MC2,I]?>=1*'Z1MK0>+O=
M1(( 9LT7/0J3NP"4K/>H:Z3!>5*8ZN,WA<;]7O M"N#I1R#T^+;I"\KC%$*P
MB4'T:Y\\L:NN26R#T25PP#.D7V4LL!Y[RCM<*4.U'2F5AL.**8]9X+1DTV-U
ML\<>08R<#B>7BG ^ABBAPRBNZDTYH5!<MY]S5YZWFH' 9X>!#D.YY2)@5-,C
MBMVIA H0'B:#.0LPAG+*<U"^2%R2SHX_736&LK:)O<!F^\(1![3U"C^1M"5$
MAT4ZG28?F!RS8.]*Z4*27R\JA3#5-0"X\6+-<R%=JA@0:<\-ARVE.,O()!4B
MFX:+1WM?I2QSJM(64DTTJR/Y4''"K$E9N/P7HXZIY06=H<"<1R1Z]Z.MC.3$
M3&L(&"97_&:.8;C8E<>N)0;P]S2  /QZ'9@Q529P'+@U7X0RE4V6%DVB!9R=
MV47ZS&K9M:CB;AT3F$+#>(2',XME@N7";(%C#.^OW< H4%A*Z<)%'W!C 81J
M^NG7E/7P:I_R%"=8XYQR8D%<Q*>C2V4KM:M8@^AO!..&YTF/E-8XKMVW?%S#
MJS"A::CYB*PU6B8\4 CQA _:M^J[#*T/$U+4#,#IA1/7/8VT5$'?Y\KS.>M&
M.W),J! =YKJRTR7&<'VV7F 6<UW%0HA&F LG9,85 =-CE;XH(7H_"LP#.S(F
M(:H#NCH OW;AMGF8]DDD0M?;Y5TIY_ IC A/"AT++?G+])34K$ZKHX%726TA
M*T8MFUT?"/"8J:,(N6P]C&]I0,:BUG!T8)Y<[EA*-CGH$5?%=\J28OVVNNM+
MSJ+/\*/E$AG7PM@>9Y'@C8YNP*X3D)'1&>-FBMQ4S"^R?0K";,C 3J6E829T
M=)KY 4X74?9(;0-N)2ZS"Z4DBJKTNC%\0K[75)ZMF;^8?O_L!B]?W:VO/[66
MB'>VDQSMS$7.NO)V87BR3J%?-SRE*7$XHFSB.!ZY2W\1BRA_I2++<-J(C%#L
MW.CIBX_KS1S2/O\X#?JEL8^ F4??6)V,?2D7JX:0H5HT!T*":7M)H=1#D*99
MTEA9KXZ4)N-#L#PB^\EF.P7;LUX--TMW@2>/^PATKY,"ICVW[RJ+Z;XM3*L6
M@90&!\:)9\Y"-E8[>9R)"DH\@E;Q*^ 0RL + %<-6<Z7;-$HH+VGC.LU56)^
M+E@?AX^$QU_"XF1M U-,4E@I;<MA (M*=1FY/:46)XLBXJ%Y>$HW56A,O4"(
MU%7_[@#I4V@S4WR2V[GMAV.7M6^QC]R8A7XPL#)N7D0%,-\E 1/$,C(B?=F"
M 5K+:!/C.HJ;Z=KC%ZC1]<+B$(!>KW #9=-Y*KT!2BZ<AS<?J+3+3E3.<P'9
MS+I0^!07A_"O;+8=9M=?D%EB;GYH,\_8:#(K:0E? 7Q/'Q&4/_]LS;"P/!>I
MI=@J6,.CKA^I#64)OC@61)'KO!NTOET(X*O:QTVZD="P(M-RC@5/HP$\^E55
M?77*'NS96@D" W((8H,YIO,IR[QSO+HLN52=+2=$09NWY HZJ0!S%PM8C'6J
M#N@QNNN-CL=!0.']2A;.6ZRN[/%Y I8;[->]>MX\-)RV'T[U49H2$TK4<;=H
M?Y-G'<%)JOTDA_)&76TSLV@7?0B-JJUZ7 =!<>CQC0YE$#>JM^*\KW&C,:B9
MF(CW1CX+L07OLK<_BPO,G+6/=TC<VY:JV.&Q,H8(&T5;WEENET2Z@2!VLSA<
M[K=$<3?)CG@&Q__Y%8USPQ=/ZG.57UTDXQ:^<[F=UX^/'X"?9%[ CG_JP0Z<
M+BNF[;NQHY62&3]"P^;F;%AS&M=^N1T'4U,-5/L'J$IN;4.(^?BB(_+FR63]
M,KGL7G90*PJ8,#U6V0K2+Y_7CR8V'^!LP,KN/PYVTRS(\:+&MW[T@*^-(A27
MO.FTX;#%-2#?]K5V*X6_\*[P.GDMRBY=RND>3-4Z@\TWR@/++*"8^7FADXUE
M<DP 3C\I$['%)(>!!*.QW+:\D-\-;*23.-7U4LL39$(?@:E9\2W@3D<8$BF&
M@YG=/!^.PW1IWF+M:G2!D[/G.1;<A\ ;6SS55*W$GD>BRUWEQJ^AQJ5JX!6H
M814I BN#?:"0M[O:18O?;45R?@  RN?$XG0Z24/#UJK.N"6"("5'A:8$?5DX
M3,RK^[-7@ZF%0.@NXDI<=4TV==,J T_2J!S)8CB5SJ.4(N5P#O0S$9[<*;^"
M6*W#4*>^:Z]=\IZ[8B9\</ \F#KH!4V(T1<)%.03B1>)ZLNY QMG<\^KAF43
MBS#,H<<%2'NGV/N<KNO@>>JYTUT=KB@#MYLT;<U\6;LH$'WAE0)-<CK[T;TS
M35,^24P-PMJ]L&YB%A UBD1VPPD*HZ">6^/^?F8TZ%G[OKM8>MQ8,CY"",C"
MD2,$7 2&3\%/]-ZRBG5:")@J8=N^]C:4%*5 #("\+[L'#\GX/H@6Y)+V.XW]
M)F97\]AF WQAKE@X+:3XV]Q9N!UZB0$-X%_!4F"X/02#2\WB"?*-1'*MKU"D
M-X<ELIMF&%^:N*&F\'Q)+*4;*J;"GM;HP["Y! !&GG0-BHI;T:I65O.M*^*-
MIJK:0N^88Z-][1W#0=G.HF=#.&AR'PI=9Z+5 K%7LN9$'QY19#T.0D&0$&[J
M1L<0G3ZIDSO"2JUQ9MB1BI[8%Y,F]N3.@X 1H1QU/%"R'P;4B$]CSSNRPHS(
M]S\JN-9%C)5!#8Q(%&!/<@2>U=T47.6[6F]W8O'58&RZW-;:2;:M2]CU-A>O
M"2= ZQ11 -9>AK;6K6O%\735U*25AW!FAW<[?JNI\<Y[MH2:S<8AXN?T:^0;
MBYIDO)8*8[SBZD8GP4"+\%RCNAX R#]NV;FI0,ZOHRW0&V:@;L1O%%QZDUTQ
M^99%8 0%255!XL1TKJ,,E/X!I.@9'01-X<TP@,*9:Y))QNEULANJ4("+Z$X"
MA_NM 0!KCC@TKV8!A=4ZF9'?+TL^I\1178LC5)%*T>2YDL\HM-Q[^D'(QGAC
M_6.7B6=EKV/O\S>).F)N!5RXK\7O[H@YH4O)1J4'%KAP.)-<=DWV43)^7Y0_
MVA/73@((XX3<C.'#*PX9\ EXPY4(HF42!RG>G*$3Z> "29$6HX<+M@X+*0=8
MK>I">VUH3*7;$M_QM>6&TN0&+;?>.B.L&"=/>F)OCJTSW)#RRN=4?/]H"!=Q
M0X1MB72X<I':ZSA/GM&<2+&"1C_Z4=O85,XBH0^FHA=?"Y67A)(F1!F7X^4P
MF>I&]Z+Q7#QJA562SW".I^U-KA"9"ZG*N"V<%N5)Q,-\H.,ED7N#U%BLJY.5
MJ':H6%4CM4PCI=:UL#I@PZ946;&SM+3HV.QX&;L2I350CET"4:%?01R31(F!
ME, ^NG9 NH*-XB.EYR/H@ L9 :PH96YG6W+UX[UO6(O.7=K&VACEH^IQTE<D
M]+]4OAK$L#?>! R#.'Y%5<7/O7-N%(O+,&V[STU9WLX,-^2H7:*R"S0)%4E'
M8;S3[3O8&Y<$XU%Z*/7L1,?H)/1<E"<4=B6<@(K]&?P#0OK"X=NEH-$//%Q.
M\ZGNGO[)27W81[.S2G7= ANNUI9&)2>46>DBYHF3,9;QZ;JV!&)'EO-8>WNZ
MZ9.4LFT<M7H/NY*H-TQ&7CTVHLB'IUA!;K!X6Y.^_@,OD;4A.H86'$;I0[1Q
M:3'O'&O(@-U;C=L%_A!IKQ$;T\=OR.Q]+KI<2J@;9#U,?(ST4D<^ZO&1O/;!
M6GI2X@IW\[XY;.?<ERLU*FNXF"=-BDJB/0N6JIQ!*M<30J])YN15J\KP\ (T
M.[[,B'-P5AQ6(9(W9@@:0AB=$*,-V$D.JDW5^N8990Q>47B)R!,$#'+?2NI3
MRE8V1PIY-DQ!3I#E!MB*LS/J&%V,T=E5U=%CD7H[QQ4J$%C4?*K]VK+2X(60
M0_,.L;B2VQ*T#'9 %M)4*D3*[DJMT%B9@68$SR403)?Q$;DWGCTX4\^3U8^T
M3Q7\E/A)?*;UM8%F\Z3TR"OQGFR5A>8ZTTYGD+Y>V, M+G5^_$!#%;(.7(7
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MUX?CG"IF7@R#\K%6BN#Z,Q?[+U[],/W^(X!SSZV863IIY!Z] "5E9>'9+IH
M?!S]F*#3,H0]UDP5GZ*=ZC.<O/OI8MX4\0_"]<%B3CA<%.$+_5_N3U&4]V0I
MS5/]]+NH 6&,SI-2/)D+T+56G3V?;]WQ\KIXPO><6+AOK?,;[*.G)E9L=XA7
MU ]S%BZ%TSOJ*M+" N-N1 6=I,_B7W:^F'_$V32DG6D\9Z,2JUIR%2OO"O#>
MLM9VI:0@>(R2$3(/.ZXMSO)F_?/,)YNS0QW&9K-QGA.=6=8-7*<XQ\]GRTD?
M&HZ+[.SV5L$_UG.J('A(I[O MM0R4^_<T9A/&Q =&FV7J%C3A2665E][V!/'
MO?GNW5ABA:<T3\1.J'^^: 0@6C/<8<.1_%<E2TZ>L+V,Q!NAT2":>@==C7EX
ML0"3MM(-5)EXWF'R_.P6Y5NB=@13MP^#+#?)V4%RP]E%FYL,VIGA4!2>[!)L
M!ML/3Q22@:+QE#'9BR(I46F/[O$)0DR*2<7P&AH]<_OBA.Q#ED1>**)6[=CH
M109$<LDO2;SDPZJ)5A>G\?%S? 35)9K#TTR\1F85 T\\V]MG+)Q-NIC#C  !
MREOW/\]*)?9;FS;R?@N6A-JTI'+8KTV/L;,[Q>>^B,G&4(Y=A"3;8/(\)>?8
MCP\?*3UE*J0@GL23P/=*=0(G=F]/NNYC8QA'U< "T5,0MK8"=YD'I^?E@CI#
M3BHJ\+L>W3#OD"+K/A<82_((ZUJGVQJ*\=!AM1*; F0GCKW:'%6\?QDW6%EA
M]*RO$1>9 7HV$@M_PJ?^W% Y[R4I4W!(Q)H4+^E5X>[G.C9"F==D58>YR8/E
M^CK!CF D]FTF%L5;1M8<8;V;$A8/;Y>"*+ ->_R2;UE\/O\9CK.P5G]^9S9\
ML5Q*I\N1WE&13Z2B#"WY-MRV[/8B@[% 4?0JQ&_INJ854JI9*'8<8X8#.H<B
MD1X4JO,\N5!R6*04%21M9OPI5$13&@XU9$K%>C*0G'HM>KL+"ONPRH(*3QIT
M7$[:G/(I+4,1G+&J'#.S:1<<5V?";R7Z"'BV0X;#F%8"9C]=_ 4;1&70 !RF
M2>!*6+-] HP"46CG%^0=T4]U@M@)E%4I5<P-851HR:9OQ568R@LMDXX7<H/E
MS@6P.A$E;O)IA$V70/#/];SWB*\CF?\\:PNN/;_]F%S8(A)JH,KE^>ZAL&/E
M8C]^X?/PBG>FV'W!2JM'3B(OYC-<F;!&W89T\L.."B,#R0"!RL2LQ!%0'PF3
MQ)Y57=D@;W 3PT.ZYM3N?HWHW%P?^J>QGM)X3EN6(M,:-&;G0 N)@4(F-D'X
METZ4JN0QAOB=%2()C^2$.A([#-J1)CO&MPZ[LUVG"S"*76R>>7XI-> D#TX4
MYM,J]^51KB4<KAMBLC\C(W$)B!.$XA'2K?><R0]]"DN(@77P18$PD]-7:;,&
M;6:M-X#+'P'Y=H"-A![6X1_8:5>(#H+OV;>)4TM(A 4D2,>Y)W%K3&9R&"J4
MBM-),3.I;.*A#&#6]!:&BHEB%-&=+9]OU]9(24=.(%)SCMKW1$8_A#B+"B^0
M0^<>HA\39VCP9<H\G9M,'>IP5"@_2V>X$+)9$%I%#!O-II'HX[%WGA-L(8O+
M9Z-0S2'7)C]J#<C<4ZNT;>=98ET@-=KB^N1O[YBAN>Z5KOD+_(E8^LEA#]'S
M]<<I&SG=HM)1]A+Y_"\3/=FK3SHQN:*BO K:)Q[.23L6H"=TU2+W3G&U7!+,
M!5N>#@]UB)HQHGG1GKX^2:![]UMQ^5%ZK#=T>S.S>"C]WQ]AF0JCB,.O<L_/
M<G^Z%"S\TMUE*[61VH8_6 9',$*4E9X53H2RX#^%;7,% N:384S\\IH68/7Q
M[UAY2VN.1X/C^#HXYU*0*JE6@(FY2OR)CF/PJYI1ALWX4;2:5.D&I0WMT#,<
M@4;(!*/J/F*H61DM'.TLU3\J/#*9EVBT>Y@=PLBYH"3IGDL[NR7TZ9'[++O:
M\94.TRO16?I)YT<2+,W0%AN[))9W0&"^D5L)9>C@"Z@WF?X+/5IQP%78.A&[
M%DS1.H&/47G-D!6_G-N,90V9G!=376ID$CH8-98FPGLOL/.^%K\;(TP/65^'
M'/%.5_>O,)!M3?#3 )&*;=Y!J=V.PPD7 524E_$Z\ZP)IV9VYFA;WLKBR#0#
M%*0,"1!Z#>#FZ#R3@Y_-9\DEI<IJ&E"K--RH<CK\ 'TG[5$(:BSAL#X22]C-
MK18.?E,"G_4K4^$'%QRW%#L63LQEA9T&C[*(:5?L4S ,AD;%)2)XX\YY,95B
MGWL18T2H.Y?>)P*.8/25RWR<NJUNG.F$DU,OGAPV.*VXDBF2R\QY+Z;K'*(6
M,G4]#*'H5O4DH@:3V[)5)^2BFJ1R\H:1UA+T+/)3O"*;D>2$:_#8(<PDC,^$
MWLOIX^8Z7JK*Y8@_#8%?DGQI;LH].%94C,773,E+P&;9;4,!>T%M3DOE+#(^
M''@\E501'<9=7[7*,BO>:DXV5>T33>DC.AD1:;B=.S1^G^@,L"(PR99/Y@"=
M8W8O=[15YQ":4^X12Y_%4[U+%E-QC'1%<@D#SD,Y^-+FA0SK2URBDF/86TEC
MBB\"*]L0G#H$_.48B_S4]/7G]>(">T'2"(4;G7]A+0MOQ,4F1Y+^(]!WULSK
MF3Q4H\0$QS%*#_]PQY5AX=)C*:?!Q.!#;X4^Y0^ZTJS#T$P#"07L#K%YJZ(A
M+\;'QS,WS3D<0$IG9?9T/;3(MNQT:$CVOW'%F:1PE^O*%(R=A"W3,))P#H<P
MQH4(7Y[\.,30"$EH.'J--A$/>"AKHG)8Z<7)0%'TXT@X+C9KV-W2PB1O#=BK
M*Q\!U4_11(F83V1;G/46[S.1$! TG@;KD2>-=E9F/JG1* FQ@9GK*4,NFFEC
M(9='C/(DRSO9Y@.4'NZ52A#A:T^=*!HV5Z9%2=UJ;7/A<V##;1K0U3E[V+IR
MYN0%S]23ZZ5F%=)0AP]Q".)9S*<3B5#*"?YB;WFN9P)J2;AG^S- V@$!>QM<
M'6?D!HY(@2ZNZ2;TZ3&J>,<^-F>86L20S@3)JXKY$[) GAEEM(9Q"GHQ7C*%
M3>"N"#-MVTAUXJ=]]8@ JL%6IC<JY#A11W6*+*'L_"X?E^>])XGZ8K OIVD
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MH91:I#1=00)E#D=@:BZRB\%C?'6PM<5H!'.#-W#C_)PY'*EUX8^(PY8 :?\
MC8#S;U"[!I/<61"QB7/;R1JJ_"W*&<14P!IOZP63K5+?HH#QCJH7HDIAC<[_
M /,C?__:  @! @,!/Q#_ )<HNA<@K]C.CZ9SP?=C\Z'>&9OOVW?<)HSW ('O
M%/G7HOME]D/*X !4P#==)"9&*L]+/NAU:,!+F1]F#W2<W.O0'*?L _0A4-Q!
M'W'&CU>^KO7:GV.B025Q>P"GE@]=%H'R$IU'8=$1Y/E8<1O.7,<D=>; %010
M(9+=S&L\N;FH,=BY9=J974OD(?C2JZ'Y;@!B.P<+A$@^55C<P_=7D%5L KMH
M5.'FI_C,<HKE)[-^"A 1$B(X1,(Z8B6 YJYMYKG9PY ?*JY; HS;">K,NF-V
M]K29(?LG1(KD@ZY=U'DF0]$'TLW/*G6".CEF/<+/6&C8!@-@" >@8[?[Q*-E
M/DZF>1Y4R)X]T%#U!/;U< 46G>R?@*\J8(FZO0"?#]QX$<>/>POPGE2(AS3[
MI^-OC@0$LM]R_?RQ]Q&Z/V?\>5(Q]W/K\CP,*S/NWE2@2<</2B>SE[^O ,Y&
MIT!5^QK?N3[I7Y?*D+N-72D3W2/OX":R7M_M0+U3KY4T!1$3<1HGJ.FE*A=$
M'T'[@[<,TICLLKX0]*AA\JC6&I^"?:PFZL4-'4 "(T1R(F$39[5H2X.>TO\
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MJ7JZCE1U0,>V_G&CF6]'\ _=HQ^2GW2^0-.U?FE?GEZ;?\Y;_]E02P,$%
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M6$;&+<:>AD ]R$NK#'^8L)\RZD@C:6O7>NA<H_OQG=6U.0:$%^%F)*8@!+;
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M JDG1Q;[H;U82CH%51Q_<5'Y"R :#MZUZN4J8)$$UK/_SXS(S,O13J54-#B
M=KT,D^#T:=^QWA*[K:-]]7]2L6'! JYT W>5[)ZY(\$L8(]$B%[=K[>Q/?Z,
M;<=S5I:]N?5K1N/#\QJ:?*?OYL-(9>YO9!3=L!\MUR64);9E8)?4D.%^#K?;
MT4*>4#-C((C;@1@=LD^'%T9%9])W.Q@)"7)_O&I%DO/<TT25EEC25!4A!;@3
MM?&0V18FRC7:U6EC$\1]L_3:0P=5S5>C6HF6PD':@W3=1^0@G6#6<TS#:ZW
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MI L%E9 [RDSD):&2>!F.U&:BC2TX)FU;BB[9RF91&%">(SUI0QK1RN\*O:H
MS/Z0)NF;V6D&&H2;JC"3!DF$&U>B7[L922='(9)V\;;P.";LCDG-=)!6N3"*
MG3O]P$G[AXA/5(]WPWPJN)_EPPO;4 H4O_72N)EY=9$1KHN0GFM%B 1_5EE'
MZ0_:.MMLF(KXBO5%K108EJ54UB%WQFU',SC^UK.$S^)^K9:O0\L2F0A-68G
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MC$P4;\D^,ZHN"\Z+#YU[X1ATH6EB$GU;Y%6"=_NSPOU1+>I^L5\&A=!J2&R
MF=5RN T84.TPH$30(5TE.4;AG#WR)>_,4BCG[D>6.=,EV&I.D*Z8+L@>(PDK
M/FHYE\6>"16;VHG]3^_=Y>PTQL'LRQCE;>SF;&FQWX^3^1.;F@V3#S(+_-,)
M\;U%&7*5?2:_@#OS&9F7DZ/D0Y2)?%ZK!KD30P7C9>P0WWK=NR>P]$V(]"^
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MRU!LS\FD/A5<FYB^N7UQ,Q @6R5)G79057XTWZ4+?YDXO'%),DD:HR1Q1R<
M!5I)00% ]A2N^)FR2UCM;AJ0,AE#I39I:?$P&QX[=\-Y!#:6]E=+&]U'#&\7
M-R0&,HV)+=>0KU%.F<KGTNW;5[JZCUNVL15*0P.J1D4!XNVP?M\1/M0#.F>4
M[32K-Y6$T4DKPB229( /47841UB'(TW(!.V=4CN+&!H_J2I"(Z>J 2 Q-"
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MFN5KT!SIMEIT0@5COA3J4,<8<4VIG'M; ,C@=:G GERU^M784FH4@=,^E/\
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MVIUVP!K/E+R_YM--=\HV=S/+Q262= TG)MZJQXE%IV!KG5_R_P#RG\L:#;W
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M9 @(6LKJC.K&K<J[T/AG0($E55!B8HVP?]8R,:YH\>HI+;.JF*8$.K#:GO\
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M/U/,LT,6I>6-5\O33,1#ZZI+#(0/]_Q,:;=:C.W^7_.!M/0FC(>"9JQM7U
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M!(+Q,S(&9ZL.-*=!DV_)_P#,R/S/HT-Y=6LFF.\/H-S/QV\@^"2.BKQY*=_
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M!K(R^A#:24B+E$D+!.510@_:)/+;_;Q&8I&&NCR%P"8S**&,$&E#OL">Q'7
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M3-PN5K<Q-S*@$KSJ1M\(&U,.5BED".2#R#(O&2@;D-PX^5<2G<-2,*!"OV9
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MS\\3X627,J<4 5V<FAY*Q%6[GXCT/MB,,D31Q^IR5Y6K'R4@T%2&!KMTZ;9
M=:OCJ5ZS*3]7MJQ0 ]>(.['W8[X4E,W'VK3'<<L+CN/M4X\#'A:CYY?'&E1B
M3+MB##$R,8PQ(XS&FF,.)MWWQ%N^ Y!2OMA5/WVPGN#3:F$\Q[[UR=?DYHW^
M(/S3\FV13U(X-06_E!%1PLE-S\7L3$!].?5?-GE_\Q['ZEYEU"BTCO.-TGOZ
M@^(_\&#G'KT;MMA)QJ?#!$0W'A@Y!@E!]V+J,64;XLJC[\6"G'@8ZF8C&E<H
MC&E:XWCC:8VG:F53*X]<JE!7H!O7/G+_ ,YL?\Y)VWEK1+G\L/)>H^IYDUA"
MFIW$#?[R6S;,I(Z.PV ^G/D38PBZ]&W8FLTT4.W@[J#7[\_0]Y(TV'2O)_EC
M3(%X0VFG6\:@>R+G2[+<!>ZX;:AI%EYATFZT?48_5M;M"I/[2GLRGL0>ASQC
MYP\J:AY5U.\T;5XF%O?#U+&_4?NY#']EO9Z]1A3Y?O[QDOK>*:1I7+++"QXN
MJD?&8W% #W%#AEYF\NIYGTAK7ZPK7^G5:T,N\R]RC-4-1J#_ %6WSD-SJ6HV
M<JVVJP^G>VZ$?O.)+<:$*2>HI0KN,=%YB+[Q&W41GU+D2DMR+$5=*&G$\MQ]
M.2C2M<C:W0RRQPHS<8HQ2A5#QJI%!Q->F2NUUZ%)+7UFDE%^WU6.WM1R6)@0
MP:4T% *$4KOMDPMKDO,K61F61A%/%<5K$4B(4@@\@&J"K=J'KAQJ%]?!$6&Y
M]>:$J\,JE:1^H]6H?AHE#O7"F\UVR]"[>X#A=-F#-5&+NTF_JA:@M2G?88>^
M6M:E6[;U+E)71R0JEE( 4?:Y5 8!2?"E!WSJ5GJ5D.$T4SQSL3)QD'VP_=AO
MM4['.C6$GUBW6Y281R+#P3ELK,2IIX>.2&(J9':M#$IY1D5&Q"D5/7Q_'#!'
MC$<D:+0W">FC=V.Y^$]J$UPKMKE+HJ.9C,">HP!7CQ?DCCE3]EEY4'?#<7,,
M4'*1^;6B^F[$<9?B ^$=M^M1D6GU"+9F(@D@E/$!R$XFJ@T%*D!CMVP+;ZTC
M>N(I!&81P3TB %J#U)J2:>&&)2?3M&FN) (6:-8XHZDM5@069CO4]2,@O'-Q
MQW'IFXY?'+XX\#VQP&72F40,0;$&\.U<18XDQ^C$B<3)QM?QQ,L/HQA(Q!C]
MXP)(>N%=P?QPBN&ZGIA-.XWWZYZ?_P"<2M"^N>:_,WF.1.4>BZ?'9QDC82WC
M\N2GQ"6[#_9?+/?.;.*_F_IU8=+U55^R7M)#\_CC'X-GFR]&[;82$;_QP3&-
M\'(,$*-L64';%U!Q8#%@,>!7+I7-2F41C:=O'&G[\JG;[\:1C2.N-QIIN3T
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M$&-M8NUH3VK#$=S[$Y\Z=<U_5_,VHSZOKNHW6JZE=GE/<74A=B3X5Z#V&$P
M4FJDUP!<CD?<FN 8X^+DL>^:[:H"[4'AA01O^(P[TV?C*(V?8[9]!_\ G"/\
MXD\F><;G\NM;N_2T+S:XDL&<_!#>C;COT#C\<^QT1%:'_,8<VS?/#)!U)KN*
M#!,2=P#UJ:=\'(H(##H-L!ZGI=GJUI-9WUNEQ;3H8Y(Y%#*RGL0<\C>>_P H
M-2\J";5O*R/?:/"3)]08&22W7NL7<J.P[9PR>,WR-?)&82C4) _>*OAQ%33Q
M[C#G3KKUH"%?E -D'(FM13<BI&YZTV.3FP2.2"5[2XGB5^ 'K+S)+4/P [&I
MK_9FU#2H);*7UHVC,H(8Q T"\:4-2!7^!SDU[HRQ\(82TK(0$BD)_94@4W[
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M6'XXH!C\O*\<JG?(_P"9?-/E_P H:7<:SYDU6WTG3K5"\DUPZHH ^9&?,?\
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MA#-&VO3QMM"I%*VZD?&>_3/J9Y2T>RT:Q@MK2&.W@@C6***,!41$ 55510
M"@R>),.V/]6N)L_(G!$0WSXQ?\_<[1DO/R%U-5VY:W:%OFEK(!^!SY<:)<>K
M$$=@W$"F="T^Z62-8)3Q<5H2>OM@N>U212"*TPCF1HJK3881:EI-MJH/P!)5
M%01M4YSZZT^ZT]RLB$I7[6!F6HJ,4C;I7>FXR7Z/YL\PZ&Z/I>JSVP0U"AR5
M-/:N=W\J_P#.2GFO22D6I@W<2T^-2:T^6>C?+'_.1OES6@D=[*L$IVHYH<[1
MIOFS1=617M+R-^8J/B!_CA^) PY*>0IV.6"6_MS&+D/\]\26SYR 4VP]MM.4
M$47?#>"R ?[/X89RV:^EN,CD>AWNKZE9:3IMN;B_U&=+>"-?VI)"%&_8;[D]
M,^GOD/R?8^1/*FD>6;&CBPBK<3 4,]P_Q32GO\3$T'84';)AFS9LV;-FS9YQ
M_-7RI^C]0'F&RBI9ZD]+E5&T=QUY?)Z5^=?$9R1<=+-#:PR7%S,EO;Q*6>21
M@JJ!U))SR1^:G_.:?Y3_ )=-=:;H]P_G?S# "OU;3"K0))_+)/7B/HKGS3_-
M;_G+W\W/S.,]DVK?X1T"7D!IVD,R,R>$MQLQV["@SRRT[,69C\358FM68GN2
M=R?? C2-L2>HV[G$*\F J>N4X^(=SC6!H <3I1"*=<2I0D=*_=@2Y/%3U/N,
MD.EPO'8V_&@]0%R/<G^F&2L5H6;<]JX_J!5J'OB3AS4@C?H< .'%?'O3$&WX
MC<EMA[XH(R5  WZG^.+\ B&9E^SL%&Y+=@,T2$!I.KRDLQ]S_3,:@%J$@4KE
ME>:E@NQ%33/1_P#SBW^<\_Y-_F392WEPR^4O,KQV&KQ$T5 YI%<4K2J,=SX9
M]_M+N8;J."YAD62&=%DC<&H96%01[')3;U)K2GMAJK'B*;5P9"YKN/B[C#*-
MZCK_ $)P0 :#P[X]5I3!\1ITZ]?##"*4"@ZUZGM@Z.1PR ,5[BG44]\\V?G!
M_P XW>6?-LMSYQ\GW-EY#_,"9O4-W)$/T;JDP&RWL"4/,]/53XAW#9X0T[R#
MK'FW58Y?SW\P:;Y+\O:),\ \LO?Q+]8:"0J9KV3U*>DY6J1C=A0M3IGKG3OS
MW_YQQ\AVEKI#?F+H.F16BI;Q00M4*.BJJQJ<Z7H__.3/Y :C-%9V?YM>7?K!
M8KZ,MT(7Y+U!$@7<=QG;-#\S>7/,,*7&@^8--UB*0!D>RN8I@5/0C@QR2#D!
M4@T\<65:FOC@R,4SY&?\_<M.Y^0OR9U@ _Z#YFO;4GP%S9D_\RL^-.@W7%E4
M=,Z/$>:+(IXE:$')/97RRKQ>@D'<]\?<VHD^*E%/?([/"]N_("@]L8]O!J,+
M13I4D4!IOG.]5T*[TV1F"EK<G8^&$!^$U[8-C;U ,7!XFAW\<5(H ZG<'J-C
MDAT;SCYDT)UDT[4Y55#]AF)&>A?*/_.2>I6'I0:W"S+T,BFNV>IO*GYQ>5O,
M<<?&\C61@-N0!^G.O65[97J![:X64'I0X<VT2\RQ'08?V:*\@'<8?P6OQ$TV
MQ2ZC"* -O;/1/Y!>0 DLWGO4H*,0]MI*N-P#59K@?/=%_P!E[9ZFS9LV;-FS
M9LV =3TZUU>PNM-O8_4MKN,QN.XKT8>!!W!\<^/W_.4/_.3VE_\ ..7FC4/R
M^'EJ^\P>=+>".YA,J&UL#;W )AN!,P/-30@\*T8,I-5.?)G\S/\ G)/\U_S6
MGEC\R^8I+70Y"::1I3-;VG U^%R#R?;Q/T9P)G51Q0<4)V7I\JXF["A .)MV
M+$=,3'&E1W'3$3]M33;]9QZ@D@$UZY3+M\CWRB 02.WCB14[&GT>(P!,AED2
M #XI7"_><F$2J$ "%>("]>PVQ0Q@M7<T'3P'??&C8T7>NV^/,=?L]_UX'=%I
MN*U&Q_K@<1LM2QJ*=NV+1P@U=WX(G4GP'6N!Q+ZLHE%1%'M&AV-/YC\\5*@F
MJBG+K[_=F%?<>.8+\52/A\!C'CY=!4'IGVO_ .<%OSF/G_R,WDG6KLS>:/)'
M&!3(U7GL6_N9-]SQIQ/RSZ$0*25ITZX9TKQ/>FP]L4C-3N:X81-MO]V&4;B@
M[UQ?FM.*_$3V'Z\4C#U)<_#VPK\W>=/)_P"7>@2^://?F;3O*'EVVY5O-3G2
MW1V52YCA5CRE>@J$0%CX9\M?SD_Y^?)=6=SI'_.._EJ;XO563SAYDM_@A2-B
MJR6NF<@Q$AIQ:9EH#]@G;/FGYZ_-/\S_ ,Q=;NO,7G[S]K.NZW)9QA94O':S
MC:2C*L,4#Q0VWP$[1K4,".YR&36T5U<7<%U=/=:A<BVMD*2_7XYI%"EB;B1F
M:H&_PU\.F'RV\*PZD BV\;W41 Y^II\XM]G].9_WKL":@*>A->V2.*QA6>S>
MYL8P9;_ZW)IS2<((XBJF)A<"K)S#$#D_2E=\E&A27.A3)>Z'YAU/08[>(BPO
M--9[2Y>Y9N2#@K S(C50L-Q7P.>R/RM_YS*_.WR+J-C8:Q?#\PM +B.6RU4K
M'J-M$>/QM<(@6JT;9P#X[Y]6OR=_YR&_+G\Y;-G\N:HD&L6PI=:9.0D\1&WV
M2=QX$5'OG?UV&_0Y\Q/^?KVG?6?^<=O+NI 'EH_G/3F!'83QSQ']>?!/29N+
MJ :5\<ZMI4IDC2M&&#Y%85*FC(V\9524X=LO.I2$I-(MH70)2@\AW5T"4E+"
MT T#*-TM.31##$AW*"4E("DI.33"4 /#L/F_:[W[[+/7V>><#\^ZG@_/E_N^
MKU_=UUI/>7'D5T>[ZD@FH_;%W[&+5FRR\UVRII_<"+4Q7NA3EU<2Y(M[>Q-B
M/I.*_D6J-/RJL?5P6&[%TB:27HQ8B8=I<1 SJ4 P.0WQ;_!XMZ,Q6<-1,O.<
MLXYC,?X@Q @%1T1EL<6K>"VT'"B.:W'9?P/R@^%L7N;FAC,&[B /!\X76%(:
M.W6"CCEMSQ=7V8HB9 CQ?\4XBA7^&\E*DZSTA2<)F3GJ>"0.B6L$BR>=%.J*
M@6;2&+)6;K *KAN;6KXUM]0W1K@<\[(:6\7@4) !"$JVG^#]-\QS)<4> &(S
MCU"&@1Y?7B!MKPLLFA. (I()Y LAYKFV;Z>3:8.%C-B(7[L_$1K^FTPT9W*(
M]&H//_AQ -?J;<D9/?]E'[ZYYN6P$VF\6%T:_5>HX1MS.!?)>X!IC:,N1OG-
M==T+@Z52&^G;'8#/627UO*YH>(CQ7R+%.TSWHUY\81C)9J"UE;..Z0+UV+]8
MXL]8BT/L/?96_TR+V KR?HVE0@^_R[X(Q2PEKJ#DUE:F\Q$^<.-X4GB$X[O>
M(DEYXQ=;R>:29+=(TN1;R[K_3.&-Z45?HU@;2/'- T#)\"9Z;]L':<1(2C2(
MC[:9#::>HM$(>*: ,0IJUG;22DHT-L2FI,!U"Y[\-TSPA&L[V8?\^C3?Z-P>
M\5H7E8<:G$(=5S2*=*<7\RJN:EU?"7U[_H+A)Q/I-<VMW'G=UZ;>-P[B2E\O
MU-([?E_&.9Q\R,![D:I *!YT_AY"*LV SU1-U]'LAWKU[[ORT)=4#(OFX\]%
MGBPS?O/=MWE4AV9_9*4F5@?>&!J.VN;L;AK$<J1[^[,G5T$91L00$F@/;G2(
MW;86<_=U!I"%!]8K'+0"Z4P;UZ-\ !#]D? T)!-*3SW09V:*BK?<:56_@2#3
MD)/(!"1LUQ>AM+N0RQ]T7&U64E;?G:[D[(S6R*^1M8I,I^.*G?%P8ZAMY%W2
MV!^]JE>@%VPEVZOYELA601L$:I.XT=\X+NL8D5@VSV:Y/3JI*]=B-?E./!?K
MG^_ D5>%NUX_(B[\X_L)H:Z)O/\G SO!TD-O;Z?O?GVSNM$8]-&OUFW4DY=5
M EPI=UP5<O;/^[E7'7M[ZV=@)U0Q.JY]<R/"$O=%6FZO-=5T8_;P3;FC;95Y
MF\XMU/9=;"^Q+,VR> ?#CB1<IO*2R\J^M:;+2[H0?I1W#RI;^_7"[=U4OU.7
MF-Q -:],!;_+N4+%P'1S802?>M;Z*<-7CVNJT9.7"75LY,\5_1J.Y F?[W8K
MF4PU.03M[)@'7*L@0.DG18%$>FI@1;IWGMUMA8P-;^8(I:V+VR]9T6Y):,\?
MP%]9X#'(^,]C+]"XN9#(1>F7L\^ZH0#":6[::JRKF5:7!KL' % V[..CA&DM
MP M!E8>W/!M=@ X#Z ,@?/(7[$OZW[[?I;Z_BHK>QV+#9$=BM*VA=%9F?,.N
MW0)VY452[7^WNUX-?QLQJ/FF7K19H@<]#;M<2I#^J"/;-PM_:GPO=X1K"*PC
M<QCM#K1*ET_U7F?H,]I)Q/RB5PY,\*7;^N$!%5E^=G'@H"@IHQ^I:Q E]X9U
M6]&;GQ7]R;]DQ$BGZ:V6[T>\'3I!F%3C7M;V.KPV WX(DY"/,77QU,[@+6S2
M,;'-E*,P *RD:@;'HKK/S7M3+SB..>JJ+'2=D9&HLO*?%4CM3])IZZ^R_^OR
MZ+^( ?(<#-]91T1.^.14H+:3=@JR1S<I+H,N2Y=?+2L 0KY&D'MK<[KAZJ@$
M*@]O5',0S:+JY<3T>J<SAK[,=TO810AC7XD,I4LZO66^E]@*G[HXO3W;4('N
MO1$Y&R(OPLRHB](X>X/[62ATF13C.'X&FS"5'TK[,6#EG8_=/^DMMI0(KJZW
M#$1$BJ(5+"',Y(SPBNF$BV&6ZK_B,V^?CWZ!='QF),T\P)P)6/",N-:5J ]_
MB9DK@74-18O&*AH=385BD.^?"()C'@"VS]Y6>,:[?&<8WG0/#;#-$L$.D]W*
M[ NSZ(<RU=A C;DZ3I?A&W%#0Q&JH3CBOJS#TN6/ 0B ]E=Q9E_8OOY:6TU*
MY%\HG-!;[INSZHPJ/=?YZWGXZ9U>\@ICNZYJI0%K"FOA@;NR#7NF"I&2=DGA
MCR1AY)CB>7!*URQ->9N==$0>6T"J )UA)P=PW'.@M^ YL@(1-7)[)+Z=@)O9
MC7O;\QD#5%5/5_(^Z=KS\VH$KA7DJ>09TF47R+76-"/KYJ46H^ZDS<CUEY;5
M90!#H[N!VZ5\N9_<HDC1KUOFF%-(_N5?,I+^1NU+*?'XM+[D'X84@JS578*F
MJQX;F&IG-<5R,J>F,^O$+[J-84N";"WS;\E*1@Y)C,U7^GY4Q6.>6<8-S'0[
M"<DZ0S6(^E=E1T=/:)[IN5<(!#ISFPQ36FHFR@=Y%;ET>(N^65Q:I3/>:HF]
MQ5LRDW"H69[JZLS:%-005IIETP]3!:<M!(FJ9>7X5V2>T^7+%*]9FD^@$]S)
M8NO'7+"H" ;",98WRW#E37":PMB;%%I!VKTEI<::/1&3-".93[.^*J:,*.[1
MV:!K57AJI>Q[] *LA<C>U/O(U?RR=:/%#FU3$57E'N$(@#0(Z07:,]85:56,
MX9:#F&LA%3\&,RBT!B5K?84W^S=OND)H[;/K'@!:(8;^=V-HUVF[0 8]Y3:U
M,1/#8AC-3?+O#,)F;/M5$N1/_M?\\&O4'7PRYSZ+IOFI%/&,.8$6JQDG2X%L
MJUO5'R1BYN6S[\\3YM+)TNZ)/5[&/_^7=S UO8$%4W"3J#SA5"<:F&K]9$K#
MWN+M0,0]ZS,H,F&GF"!>S]@% =",P:0I&$8.WS^79 ]UNMMMU2V-W(_[AE4^
M.]YY]9V,[X+A#"Q;^5YO:EOJ#)V-&;43/8(A<379!D2<DB '%LY=\YV1I\C/
MY0$6#@LN6C=F6FVF4A%?#KLO8A5__XJ,!GY\;5&G<-O\W_K]6.I3!^G/1@BG
M:Z;&R]@2^NSLK.1JB&2Q&89"W(!PX*-%)> #LHG<02: 8\&\NZ@B!/L?YVHU
M+Q[)SD )L-MWPSAG5A%FT!]@A\N]T - &/-($EQN": MO:?^VTE"L9^N3^Y&
M[2&!NAYR9R")WE]@T%S74G5)(F?Z6'T^X*=-VNV\T$.^9MRHS-[BT]J16&0K
MW_OS)MZEO%VD/G$>]=0Y9]H5<#];<"1!GS[B%;L7.J](\20\84O+Y9^3YXWY
M++LO('&U.NDO\? NQF$/=GMVF+.?LB&,X0&03C85F$? 0E:EI/4EH2LDKY$V
MXZFN-,O:'-*.U#!>(3#GB'LC1H <RM[.E&DV.Y/R\G/1_ON1GW.^S&CA,5=F
MQH-5+D>TUV!R5G'"BLNQ%GVFOZ?Y+ I6Z[!F-UU^6UM9O*KD[;01_6)KI?+*
MJGYR^NUVU&Y+-K)N6XIJO$/>T*R-PK4$='/=9H"IG#M0K6]OF\BNJ3ZQG"91
M$.K+=D'SZS)I?)5O[<"%6REYU?Q=#=&4:1\]P5E"A^#UWNNLE;V<NNR*V(,'
MP)R>&+%_ZL!GU)_?4>DPH$*PRB9A?)XRJTV+OQ:BY%Q-#<QQ*+"TQ'H?K!H]
M.DL%_)CK!Q\#3C(AAX%O0[1,'4QW9KFA>TL7RO5:SWY+T*7FY>#/SNK7_7%]
M $@B;#]P";'59BZ7J#%HP5A0[EATI#+0<AJS+JC"1$=T.4"3=CZ!HDG#("W=
M5@3OM&=1:$W?5G_C8*FDNR-.[T=@EHA@IA*? Q&N%JBYAY;W:*;IAXI-P<5
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MR;1V$QN=D?7(B HFI!$MSB0OWY#WC7?G'F-N)=VRW-C9E2_]6TP9Z7\  (
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M7_M2FDJ$[KIVLPWSY)S.X?O'DL3/,"WUIPPUJ1ZI:"%; D*WR$**(AR4CY2
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MXYZ7/IPM_>UC>\HG_:!/&J&%KUHP.XNT9U=\J+4\,@!A,::)SX=FU]K,=KV
M[R/Z*C-D *Z:P1J/-"+U ( $'$@[T1KM:L%_Y;J7(*VK/<O]53],63AQUZN
M!@TVOEPE.3)=M=4MWT78V-B5FY@Z=KCDT8;D6Q&8+9LN*];+$PI"]1-%I[BJ
MJD(!F*$?:O[\;]+XG^('07NDH=VBSI?1'D+SA^;-QJ@T9 F]Y1[:JBFV?C6=
M7+F9@QR:$8#!7!K7_)3C+U@*DK>>PI3=F[QF!^8)L4$&:/ 9\<V;?I$MGVG&
MR\S(_ 6/K4X8E,68+\FI7!;]KJV"$0$X;HV<_0D;4P#5+$G=431[Z.#?L<@I
MD09)):K:R=YO5A"D757^G+KN^Z(]J_VY!WWS!X^\?.Y(_/Z&4F&SSY53SV)6
M2OI(EYWM B?R[CCR[(43#GN"YK97'<CE;')O>;3R+;^NK$*D"#];E%-5U2E*
M("=8P=4^D\Z1DKU!$LXA'QW&AE, /IE:*.9_)<49:3CY:P58U9 J_9*LR3R
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M:1M5$S\ Q.T(B,T\B19NX]7#O_P.)2Y%4Z<1>)$3^K(.T^8F\BK5SC$<N%=
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M7 /BU\GYGBB +5AV%/LW7[7*!8G'*T-MMRL^^$I)Y_WT+\ ,[P2MW.31N3X
M&AQP0?M1[NZ93"I[!WU%*ZY$3J]/WZ(VJ.".J&E4[>>QCM7;%?^M\YGIW]Z
M(_56<7]3QVN8^0A'3RX$KA5T-8<**=4>QW&L'X!I7NP)7I-=8Y7?A%*8,I:
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M[W?YD?U:R%%^7OSGNJAD!._8#V70-.5^]1,"Y<7]W^98%_8D"T&?X1#NZ@=
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M@#;U(GF!W?3AY'N@,^R':FWPWQ7HI=5,[@$!VY?BP0_B>& ZB(WD)_9RC$>
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MK&TK\U(+RCOY]7.\XCS0::>[HWW1IMU2V+?]1=E75T,X0PMYA'[H_5I85+[
MK+0U\JH.T2 BS]K"-R<)\Q&*YS]AE'&O75.LX6 ,3.^,K=$(M6ZKO[32F6\
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M/M0P+'E!!S2B(*3$AM7XM9ZAENK%;PW?7^%@CK_5-G-!@?>^4F'YN%RZQ"A
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MJ$XF*7"E<=5]K&9(PORYHT6[;;BI)6U[_F3UP-0RU]Z>_#D!Y!/=C6:R8@=
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MF,&Z=$6]?E8["3<0I -450W>2T<YK;]RZDS_J($KM.(RFW^4FLN@LQ#(ODM
M7!:NR5:P7Z]J'684KU_Y5O4<\YCAF1"]J*]SCZ[@Q<TP$UIR>D'WT[W4/5*G
M0ND5SY.4T!".GV[*JV%AO1_O2[_8XS?.1B)T_J(-[@1O-=Q;0BALL;YI,X.]
MZ:I^A6ZD27 Y5UN\M3,HQG&+1H1;<Y2\SN%LC8K5DL-C*TJ%D_11_4B*&>-2
M8M8M.Y,([DA,:^$P8.2$ RJ<[_Z\:9M,M[0I FMS&EQ)&#GKT=9>%IM6 @ :
MXD1_)8>/Q@IDG0;FR_/Q[I B/G%S:4\3T*6VG44281P^6_MY,Q89]I8>BRH
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MXHF,-ZJT;BSJ?@FB.ZU!_:&?(?S!:R2>8]=,86..WU&[BA6OPI'%,Z*BKTV
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M!Q@U2"&^ '2@9O3D%/\ 6VSU-I__ #GI^>4^G16UOIFA:;(%3_2H]!DF:B[
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MH_/*\37&[TI7KFIX96+6\KVT\-P@I)!(LB_-#4?JSUO]9B^J_7*GT/2]:O\
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M>:@S;98'4YA\\Q!^_*WZ8[-E^)IE'Q.7[_QS Y?3Z<KY=L;2O>F43N*#OGS
M_,>3ZK^9WY[)Q8I<1I*Q/V59+PJO;H1*?GGA6WL9O,GYF^6]&0D&\U6W62AY
M<(XY!-(=J5HD9.?2J%S,"GIK4CU&4TV7>AV!IXGYX)Y+-(LIDY\(F XMRY>I
M1?A'8]OIZ9XK_.>WO_RK_,_\LOS_ +'2I-:M?(=XUEYEM(JDRZ9</)'(2?AH
M'CN9$-=E8J#L1G>/+/G;R+YO9I/(WF6RU_3&_>6:QR(MX(&HT<<T!8.LB@\6
M%/M"N=&T]9(Y95:.2'UU52&4\@S#Q6OWY/[+3[>-HYY6 81GDCJ*5?X3T[@=
M\D\>DZ4@$C0)605!<?&:J.-#0G8Y=W9VR0H0?3!4TI4$5\#MXY!M=@MDM7BF
M_=!5!5Q4+7QI0GMGCG\YOS+\M_E?IL^L:Q+'<ZK/&WZ*TCG6>]D(^$LH%5A!
MH7<[4^%:L<\\_D'^6^J>8//%Q^8?Y@(;_P TWC#4(K68%6MY+HU5F7LP1A\/
M["T7QI]<?R]M5L;>*%OC^#X74&A -2=Z]20,];^5>8LHY4*GBI%"0*TI6A.V
MYZ9&OS<\@Z;^9OY>><?(>L0>K:^9--=;;H&CNXJ3V[K6M&65%(SYV_\ .-?G
M[5_RKUBT_)W\P8)X-(U"U%UY;U?TW:WN+8LRI5ZL(Y48-&RFE:4&ZBOT2]*%
MC]8M71H)./"0-S4TV%3O4FG;%&D^)/W9J214]">_^=<53U93]6C0*WV@#0@]
M._'J2<4_1Q;@QA"\AQYHU:MW(/S'7&OICE0JJWM45/T =_&F1G4;BTTF![O6
M+R"QMH#S,L\@C0@5Y%BQK[;9\X_^<B/S5;\[=8T/\B/RA1M>FU;58);^^B^.
M)C:N7B6H^S#"W[V>1OA54 KR-![=T[0K+REHGE_RMIC$Z=Y<TVVTRW-.)9+5
M%C]2GB[ L1[Y48,1^(\AR+<>PVI\^V0Z&WO_ "YYROFJZVVLO'J$1I5?WZ*2
M/#KGH:VOQ]0L]4X<Q8S(94/5C6@'WXO96OK/9--\4T[M?SL1UX&D:_+F?PR4
M\ -LHUK\LO>AWR\KIMF[^&8["NYQK5(Z8U*=0,=X[4..Z@9O"ARJ5S=Z98V^
MG*KF[>'CC3M3-6M/;*(';*WK[YM\;3QVSIWDR:OECSK;5VCLWE _UX)5/?\
MR!A#YYF];S3JA!JL9CC _P!6- ?QKD3'3+H3WVS=<V:E3ME@=\<*"N52O;-3
MWS4--NF:E<L_JQV^,/N,PR_#*-<?2@Q, 4S4J:>)'XY\N?S'+WGYE?G?9VY
MU"[ADEBC:H,J65ZK2\*['@K!C[5\,\8?EU>V_E[\Z_)VH:XCII]UJK6,LQ7X
M5:^CDM$<GVDF7/H5:R202"%WXNGV@3QXD'HU0P[5VKBEE/6>2Y0%HE?X/654
M:3D*[ 'D!L:]OOVA&NL9&#2JDD%[%(7AF1&0I(QC/J*"P;E2A!^'L:M6O!]7
M_P"<:?RKUN];4;+2[ORGJDA+BZT&Y^K(7Z\_099HE^@"ORPWT_\ (W\Q=%B]
M3R=_SD/YETI8:GAJ5N+Q* !E4F.=*[=!Q&3?3O+G_.3%G$OH_G?Y<UI8T 0Z
MAI@!(%>(K]68UZ4WR0P3?\Y80R 1>;/R_N54"-FDL@Q4KL:'TEV^> [V7_G*
MJ>(I?>>?R^TY0I5BM@SOMTHJPL-NN<A\X0_GLUO,NJ_GQ%:V_$F:'RYID5NY
M3;I-(D>V^QWK[9Q3RI^3<&H:[)YE$&H><=8,H<ZQKTWUIXW6G B/B$Y^%>17
MJ",]Q?E/Y,-C!/=7I O"C*9""2SBM 6!W/2O?/3OEFUG%S'P^$<CQ4BH((!7
M?YDUSU1Y5M_1T]8I1P9@>*,*@TJ""-N@&&=\J422.C1<U4,.BBE3M\ML\2?F
M5^4>FIH&K^5_-NAOK?DZ>ZGNM)O+266WO+,W+%Y(XIX&5T;VW5U %-MN#Z/H
M/GC08+>W_+;\^=633X5+QVOF> 7Q5%H$C-S"G(@"GV@3[C#S_%'_ #F';4%K
MKGD/S'!P(]2>X2!C3K598%(K\\/[#SQ_SF/*3$="\CF<@<2NH6K+R/Q ,WJK
MV'6GT9)[?6O^<TKQ%5(?(FD*Z-S*:C Y IMPX6D]:'KW';!+_EY_SDYYB-?,
M?YZ:;I$+$<H=+2ZE8*:5*F.&Q7:AJ0V^![?_ )Q+\OZG-'=^=_S)\V><S*2T
M\0:*RA=MOYS>2D5_RQG9O)_Y8^0_RWM;RT\D>6;+05O %O+J)2UW=\2"HN+F
M4O(PJ/LUX^V/URGIF9%XE&^/V!.X%?G@"&'U.()K1 FQW+&N_P!.''F;2/K.
ME>7=4C(5EM4@) WJO(BA!VV.&.A^M<^7[P22@&(H]#N2*@> Z_+.B6D?%Y:B
MGI1P0@$4IQCY$?>YP?3KOE5VRJ;> _5ETITS?PS$ UVRJ;=]L:_B,<H/$>.5
MQ)!WRZ;;]\V^50^.:G;,?'*J.V;KX5QIV]\Q7QZ9B,;OX91-:=LO^.3CR=*5
MM/-T%?[W1;B3_@%(_P"-\)?,TGJ^8-:8UVO9DW_R'*_PPEZ#W\<KK[8X4\,J
MG7OETWS4R^G7MX9AT]\KQ&8^V^7U[4QQ [XWL*?[>70GVS= <<*#*(\#E4RM
MOHQI(&].F_W9\F/^<BYM2\I_F]K/F+3R1/I6K2W:"A*R12"LL;"H)22.0JP[
MALYY^<WE:5;S3#I>DIZ$SV]W#P0?&)"LR\2!6O<&M<]/2@&66>15D +T^SQ
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MK\<JAV[9MZ#?-0GYXVGT[[9COV.V8#<5VP?I[<+B1BI/^C72T%/VH)%[D>.
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MW!%"2M*T(6GOOX8=6/F6RDE((C9V(J*G9J&FP'@IZ8,;S/;R<5$O,GIV4#W
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M([@C[ML++66Y@=P[^L6(D]/8ES7C[[@#8^_;))%Z,\=JUU%^YBV8PMNA4@T
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M)/;Z)$ A8<*U^P!V\:@FAIN:8LUNL:5178PN:%JA0M*J7!.WM1<#<@K%UJ9
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MU5&W=0TZDWJX&;4H4M8%/^@3T(V>;EST,8\M)PH$9['>O%37T2X.Q>[R_>Z
M)]562[["_,"A4LV+I9'8>OHB8KCT:'1["YH)]>=&PT3"17ZU' 4U2@D9].2^
MOX_MJ\J(-P#U4%"PA8P0?7(>%,D624&!/0UT_9K#M Q&\>K@\ZV\:-#04!R
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MWXE.25B4Q::]*#9U'*PZ$>CMDZ_Z0_.BP-0G5]=Z"OD7H)H5MIF]GI[QN@K
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M)5LJZJE\-F[_)'--'2PI#'S&B#$&^N7%F768<-X]GE[-H1 ((<E%+*%, C1
MN"<WPO+NV9%Z"2KW!OIZ9)Q?8-<H7:RL+:\6% @&UZV_9+!]X^4FM6$4KX;1
MI+168"5(2A'%T1*P2"AHY?_TI?\#PZ&MRU*:SX#W=_++<8M>P=B5PO /FR&W
M8_>VHFG>S]$K6";<SM1D!V2EGGS:G-PF&02'8S'=0OAAN0Q)VH;"]'1R YK/
MW:#/U<%VG(SP!;_4X1@X$0/#")A?I?$N'-V)F5 J#I E5)VKWZ:O\98R\42=
MPM8X +&VHBZ-/9 UB,"H7(U\K@N)RI*!K&B9J/+&]S:*<-;?!C;@$7>J<PI4
M2RQD:J],2<1?'B?*E:,;# Q'EL:G_<2K'<ZL2^)AL<;78 1C%P/2'+ XY(9C
M:G<JZ$<Y7U>(_U2S&;5F[59@]YOKBN*P**4@_O Z,M#:+!N]W)\4KW:]QI*H
MX)$_F^]3U=BS@H]>KXLLI"E1U_3HF8-@Y<RX@A?!LB R5\X1SPNAV@5P'D<:
M.U2M^*7S&J&<++$X*#[W6*>T,I#;E@$=$9:KE6JH;C.)8N[2"KBZJ@U2^T<T
MS7]%L! X>R=YCG\^WN_"-D$[-/QQVS%E^=<^(]JPZ0F1F+5T*;GO_HI1WM.,
MB8G)7JO/9Y]\1U!TH2VIO(N+"_40 ;]*L9[8IAR%H1P P(X-_'^R_']OUDR6
MW6$-V2&4"KO]"W#R0,)2MU8G<S;+>[H="CL_0]@;X,0<NI!Y:\:RN*5,6J*^
MY*F_@+'IR=[10D'U[9!)+5!S' _>7=1C;Q5/(4*!,J#1U,RY$<-\0!=%8HCC
MO.'Y$V^WH"..1;6D?:F&U.!/3'5N?.HBVICO;AV'7Y&JA=K8JWD4&$@RF)O"
MD?JH0#1G],4^/JR4=="F6OU&K1):Z?+X(,"_5=D9H;-XP>$BT\2669MUMT*-
M]XPJ3IT"C;&@A<6K9T#2*--GWG1Y[(#J=V:6B!P)#@6%53,-FOF^3%[*(!.)
M1YQ#BU0L%&TES6%AM1S$L1Y1;&-@%&>^\"ZZRD*60;XW=+"<:8HRY;447ITH
MEK*RDZX&-+"^8#M+P:ZCCHT<3NBLJRQ*SM*;*.55N ]E>P$=MG#<._O>G[G$
M+P0P#D#3R9(O]PG7YF3Z0*6)]2+4 *H72NKTK8<*/ ,F&:.^*^A*'B9E 3SC
M(E)L??SR];QDBK81 9S"FKDH)R>W P:$R]'MG4_/]&[CY#!,,Z189OZR:O]U
M9<FS_-T"B@JRU=ZVY?WU[7*TZQ3?Q0QX(M7Y1W#^2>FS@..W?5CSLNUZ_C,Y
M*D^J:M5^!=]5?*N,L@RD"GZ:!:/Z>)'W%=77K@E!ZN7A8(ZMM2)?7CE9"]\)
M=J,?<S^^RTQUJ1/_!5@5A_SGGX5KCLG] W@K"^H'B2U"DMZUM%4W@H3M43.T
M.KV;!;!_2(QJ>4ZO\8T8V%;*Q'#"UA/L+2M$PATB(/SA-1;L;;R<8^_S: %V
MW\I!;9&AB!))32[MK>I4);>8JN5!_8>OFFN9]B;D51?V-X -7#EER$(5> 9H
M(RK3Y9$*-M2F@ ZD5_9C]V>:1Q-/,L,R8D\A%D41@^>,X<J.&JY$R2]Y'5)I
M%F#"['1P'\RCGVC2LDD2++2:V@98D+J11.(J[-#C#I9:("N@9#AKNT_OTQ=?
M* 0'Y@H)##8G1):E?#=38B'<M\5)!0(%?5RN:>6+*J-Y,'N*MY*^+F,&57])
ME. D+".;#^FEQ"Q^'^2"4]'7UF^8S-.53+]0?'5K%POVL0<V-K^9OP2L.?1!
M9[M#*Z/I;E5'>UP>^L\IVC(#\XLM_),G)=[/<B&O\4<.U2:#!^%:F@W 3E18
MH<-?P Z5[ [60_FMVK=@KX=^34NQ8)OPI@&&(9Z/Y:,<BL#1FOU)CL=-=F!P
M?[@X0\CO_S^*VD^E_ 5(/UG>"IZ+3OC^TCW?R79^F-H^E N^FCL5]_"XLHO[
M0D3['E93BJW?SB(##OFJ\1<PW1JXN?5!F%?L267":Z>.\Y.+\'"$[+'PA"'4
MH75= ?D#L:>A.>.>LM"T'?184>S(.E4^U765_2WMSEADOG2$RQE2FTP;7A2M
M;]X58./>3"2N[HHY):946AIV]:Y*DMKM@B#B@*0RNVNSQ*D)_8?W 7?B.7-N
MXTN)=-UVV1J)UD3(LOE$Y?!KUA]&866&CDK82 K@#/KS/K^;K>$9;N-<R-?8
MY5&X&38C+W?,[/S)E]3J1C08!XVWE7S%2 KGKQ:,X\':4I[X>;74:"!R,G40
M$#RV+\><61Y"P-5ANS?>U4.B+"!(8:%D@ Y!^Q7YF@RJ]D: '_XI$O'Z)FYC
M!='W; 6$D!+ #\;\Q$Q@'$&*"ZNN])+3.02N'9)_5DM*LI&LX9"J)E^T"7B0
MW>GQ>40WX<&TUARAEG*N@?HBUHSMR2DJ-0CNH_X"Q%A^8WWK90T<VRXT_98]
M]F3SH13K/4,-/*6\WWNWIT3]Y4'/ZU;B7UG%U;D19^)+LKR\G*[O813,I4L[
M+GK Y,#$ ZCS2&6THJU-6E3MX#S((AI0V3Y*/7*Y*K";5>:)?HJ/L4X%>A"<
M :#-\XK8SJ-I]">WN!>E^',+(+4(:>N^W\YS!3;0I(@Q9/DOGI>@R6:V*$E^
M8ZN;2!0\S[_]"?QR&X?!W*RBR>EIF:DH4 DP5#A4EI.Q#:HO?!D@)2=YKCB%
MMT][44<=34%/Q8$9($ !'[U\ ]"-U=Y_[E:6X%Q+FDXZJ=OS#%?1'1X?!0[W
M=]N\65?ZLKU..FR=DNMI6(6 EATI<VB7Y;&G1Z8)3!)G8N$C2L4Q.F!ZE;W.
M[>9T<@YQ0(=)M-K[H'JIX! 5;O0SPS*[6#NC%UURMKWRJ/2>D>,Q=N5GHNQS
M96BFN4P:GG6D*S$_A'0;<!!]PXAQBX.YB^KJ,1KJ)K+13B@4=<ERK\2-.DT)
MTC$;[^<?I.;YUY2NG'07=PH&'O[9WSS)AZ\/QR*P;^4D9PPIM ;[U_7IPBO.
M6MKYSH-4> Q'(QL%6*.;A8Z]'+*LLKPAX(>>SSBI0H9-EPH?#U4\67M[4E6O
MLP53\'U+0DE"[%2\ _^_7/NOK6:F#X__OB?_\/'?/3)<<UK0843A/*WHE=1T
MJ4=;+ZWCD*LJ&5U_(*.>(9BH?M1W.JZW0/8\O#??,HW48C_K#GJ^DUHDH"%\
M"&)-+6G#[MV[RG L9G1]Y14;TLM9?]+[48B]I1O[B8Q&4V(81DAJ'$>^H9"&
M H1R=/3)&"ZL&LR]E?9TT- !UB9["WF<6\(@\9,3(^\_ST7F^AE]^,9X,6G/
M8ZCPWB@G?* /ZO)41>DL;:?T.C8VL]T=Q@[$4EDEJ?1X:=!/!:<N5V@\1H7I
M*<M+ZG7S56R_PF+":&*D_:"]3_@@]R+&=L;E5P<05<1+QGR2/*>CBW&4  ^(
M0N]9D*'"0*DNC.DS_8]&KC.<#:X-1XVB5:/XC!JU9Y6&-FI3L[%GM%27$6K3
M%$&+J);8%#%KQ=ZSL8HHI95H[5$B-3I0(AK)I]=[O=?WZ_V^[]?]Y_PXYSSW
M\]SW<Z[G.NLZ"A61CU_4_[8K8G#P0:S8;CL:;O?I@<]DVFL^3<'5EYXV?S7=
MS'*SX<B,0UY6BK'HBT,-NPTD[1=Q2H1,\LUAK,NG$ @LI=5P]]V5SK;9A$?
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M\SWUN+Y#Q._T]47OF?IGCG7 Q0)&^&H,ES%SS55@'Z]AK89LJL> /X3^!7>
MVNTM'&?J)Q/YSIIP/Z35+JJUZOQ :+#<L-R.&S.K1_@9IF.G=W^^A>>-% N&
M%H6M6XC.D%O7S"]%SL^9P%A2'*(4O;]]%4+J\X]/%9%#1ZF.#6"E40@OZD2C
ME!H\RR"#GJ=P/B6QG$8+"-#_&:/_@'/8/0E.'C%SC;#=?D^?;@R15./-0@.\
MT*.6\3G[EL$T5;?,1CU](BT&+SQE=&Z<S)ZV-C5X()H0K!$R C\YO&(_1-DF
MP)+S -:B'=_;%Q3[ _HK7;MZN1U31=WXU3/M3^43_^<M3-!F_@U02P,$%
M  @ +E-85OM3YU+9_@  ^0 ! !0   !S;GDM,C R,C$R,S%?9S$R+FIP9XRZ
M95!=41<E^'"'H"&XN[MKD ?!W3VX^\/=-5AP=W>'X.ZNP=WUH9UOIKNKNZ=[
M9E;5OOO'/76K;IV]UE[[U/E<^?P+^"(C"90$0$!"0#! ,   GQ< !D4+>Q=[
M9PM[!Q)V)A8 CQA0#NH"\!]\^<\*  0 XK_ESTL IJBIO;$9P-3_/PM@ )#
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MTF>T]H$,:G$E7^>W3Q4^NN3K]":_L]_/*MHAW\N17BIL+AXJ,LR>.FSB6%_
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M/SJM,K*[C%-6Q5/$46J;C@$-I&H(ZZ3\U/JEE%5-D:Y7A*B9WNG[WD98RY1
M65SB;7>U]_[M((8.DM2?^:KFJ BGT'Y@KA($T>R%=&O_O:,CS1J4";M%92_?
MM]EBF.&X-^XBXW;JO)+BAF!/8(I)$5[(3E/"17T>9[6SN9$*7R<RYX \EHBG
M&NA>I* K"B4P=[MKJ/Q-NLS\+S>'$'5NW^K%Q$0T?@D9 #_2E7K@K8[&MA"U
M_AM\9$BAZ5E_+Z:NV(D9-\YCSA;N 5L%&08B^G4BBH7E.D:G4-U+)P$V'E]%
M>TX]O3I%=C?N=_4BY'B^-"MQO%(*&Q2?FSG:(X;*F-?!L@B 85/):I5#<IZE
MY^ IJ7Y>W'GD^Z\G0TMRG? M;#/VX<>,TET!M%BI*PR3U[Y9[,#PS YR&PO0
M4FN'!)E.H5,1$@8\G,/">C6.@0*%4A!=XA?'7_&G_,3Q?2F1''0WM8ELP ?,
M\SI^16-E;04G07$Z24SC33="28C6>AB:>FQUDEC8S(A3!>T=ESF]_$I9$L?Q
MG<3\7'=HO*LH72!Q803^[VK ,=P DD]U5NT/-,:^?&<DQ,!* ,DGH(['$L44
MJ)8'-?\L2NU2(C;4) 06JNV(U6+8;0E95< 0:YY0#RR,[;BZ'6591&?X8%:8
M35ZAF()BKA"K['6%S7#I]V/<Z$1S/J&TS8^*/<K K./4Z_#8^00<EAPLYAR&
M[8?]?FMX$;3CS,*#73S7C?6.FG$\6HET>9H.2\?0MVQYR8YPQ[HV6-%%J-*(
MZ_-A#M6<=NA%S9'W ;RU+<'6'%3$,-D9Z,^@\:S@5:9<U-: 9=QX'#V^)NRZ
M\0?<C1Q,=[&$'O6$HD^Y4S7UM:%^\&#'R+\+MD<;DCO.K\-(PDC>D]M;[82T
M(DM3.X8M53P?:;ZUWJ5T@'T.?:@GLW7;N%Y24FD<BKLS9[,*0Q7AR_G.I3:[
M4'T6WMKO'B/ J0>,S)/MF'-K[SS3=@/?&.T4T=2W9%1VE4%/6$9UWWC^.^\0
M72=_SHO,U7!:+Q7BA.O$N+OSDS%W8 "FL<ZTNRZ[RO5.6Z[&O%KV18XCN50-
MS/"1&:%\ZN['2>9QL7QXC4"[ 2#C &]8>(G'P9.[%?LD28Z >Q5<*;GF@9$J
M1[(.8P8AM9O>:L%: O]+RVTD:I&_@:BK!W[@L1@W/Z8//=9&2VLO5P)CFI ?
MTXN*O[H0SG+8"V?MK[#&/>JWG86U%R:@H1D*,O*L[C=HRL"&-8P63\N2MI*/
MW(E>)VH7YWG0A30QTH8 U;?OB&\MTWG"R2#L@^2JX.6Y(-\O1>NNFG10+]9Z
M0>D!3T?Y%$HP90D5IRRJX4O=_#3G<+%4>78G#%-^LW$X'*\*<I/>$I((S74>
MQEJKVKL'\;2F^<FQA0]6Z3.7CA(MK2'JAP8BE:7K<,:=]#).9)VEUMJ&"!C<
MDB^-MH05L:P59?O]11(B5UV6 521+@\4P$(UVC'Y"[5UT+S),I*IM6Q1UGYR
MT6]_>?A&1%5O3GX/E[ZVBP/RN60?J\CF3:S(V Q#_ @H&"/%W%)4M"]:DJ<.
MR+7 !\T^8DGUY A&,:E' LA$"00%/01+ZTF5(YGYFFF$R4)&AZ6/WRD**CL4
M*>NE%!K52!!G9,L%WG:;EGO=7[;9!&+(2>'[(\062\F=4/A,?[+%2RZ0SY[A
MN6YWL<U)F=%A>XP@T &QB8_V8K/$1:J(]F,F0<S*L#C<7R%D;HP>_2&+"ZSB
M"B =K#V1(R$.L0UB#T3/?6K%]26/8R,5*P-:8Y.).&YPD4]5,(\'15VH[&Q$
M:W#(PB4LW$ZRQ,?G1F9NXR$(,V %H0"B^;>""&<_?HT3!JZ3?]P""Q743&BO
MD^'LZ)OX'JZ"7+B ]N=;8L=S&P-CUF)]C9O68M*G""?9G6\=\R*4/M!>;#%F
M+GJC(M&2AUD2N(KF@\3@\;CQ"&':3P!?R2+#7Q9+4-5.PM".LA(IZN*)N,$P
MBG>>HW#R0X6<V^S:D70[JRQ?>O@:@K26XK)MQHZPZ+08.']M#FG;0*%TOF97
M)\-03EJ*D/[<"<;)7? Z\*BG&5V^W[=W1S76V^NA]UP.E;W]0C2P@/]J&Z5*
M9!2EM(IKU"?P7ICAX>AM3_APH2?%UQ*'+W/R _V.G (O,$7 MJB*K$-I/<;B
M@W97S?DLL;Z]@AY6'1"((@J7!\?\WWJ=I_.=R61.L:M1OM;XN/SL1@1B3JA.
M/+S)K4PRT<.4#.SZVTVOR?+-.+GMZQ[(Q/\D$H;0VVU0U8?ZJZC*&ZN];]H<
MGY<)_Y[T]MNK"?Q9!,O%/%3M:RU_-!1-WZH =[''W8?3RG IV'T\'5)ZG''R
M)%T]VML2#VKFL6P:X4\I@Z/.";--1/[:9NE^Q>MX1=@*AO4--+G=8K4;&K/6
M6.#6CFTTZ^H6?HF.*ZSA-#$\R5JE;I"VBW8V^!P%0C['//]D3D )M%1G]95"
M:<! YSDB(:4I,4D-MG%C__9$_Y;R'D%50WK$6!R XI'H+:6TC,(8+ V9>/EX
M&"LT@[Q.-S_L<ZN!@125!M7:HD:6P(G^K>P&IV3 @M_,X$67RE,?6!6%A3X4
M@JZ@V(A%UG46P="<*PK9.<Y@7!J"L"L@3NP<\$ /-'&+,<308UN8*)<!F1=Y
MXJE9;I,/;>&G*5U"HF.V1OB0"$I21>HR(O";6MUHBG+(#'%'&D?#<]"+6>N'
M'03O\!94L"03]@]$T]!)\!&]&M(2IO E%B7Q T5GRV06W)[ZBF-WQAK]@11F
M,B-!I:= HOZR 2:80F7VN\+HS"5]_X"KO0 [K0?X \0 Y-)R"33E=4ZIVKZ(
M\X'$%&2\+<K[%?4FD[9M\F7'^ L:@XVV^X6 6K.U'@&)/9H_^GE1CLK#AK1[
MN];)Y R,!%8R\W: !72]Q[X2&":[OBXRGWA,92$_7RBMM!]D'F&]A;#5@YH+
MQ+Z_"Y'P97Y$ZL7@1SQ;K%\*^-SH:.[&4+C]%#NGHS5(EGYC,RFX:7=M(#AS
M*/AKZU]\E+>A:*^_RHEB2<^0W<#@5L3X7$N56"0_X(I]S*)7V>*T3:&L_9UQ
MXA1/4ES5Z)]6P>2572EEG[_EUS:WS2PV4;BCXYH<V%CC*NJF&KMSEF)#&?VX
MJ7E[TQEQ.!7Z,?]V4R+6GB$R>+C;@S1\7:'D#7^UERWZEC-K\S9X@)N7G'+W
M8VYYIB!0<_T4 +T/@AJ!T!\PM^F^77PH2<+@#X^.R_UG%Z90Q,46GC6?+U&=
MO+)?KQ+."I;[R>^RNZ:PI>^INB1A][FQMJMY<54UN@?^MH[ ]DCBKREF/>6=
M)?++G?P2%%"E[F+S*RQEZ+!OV<Y1]COZUL.&/^&K8T!M]00K9SX>'U<.)'TN
MJ8.FBW/&%OL$5 QO"TK\U[X7;S#!S/%O>O*U-/+E2WZW/>\]K90:I'Z%Z)GZ
MO;>YDD)5:044=!]&^8AV()QZ&/87BFZ8<1\*F"> F_VABJPD,KB'O[L CJXA
M)K D>NYCY<*";4W01CU"-]KNAVP]\S?#-]+MDK^?3B>^2_SP:%WL89</,'=I
M;C=(KH3<:H)@NDO'4ME(/XI[8/SY\@G0YG:;:="T<!=@9%2.K&^4'52C_5 J
M!E&/H3/]]LO3/$T=LR-K^:6RD*79,.K##ZVJ)J@L."OE_<2<=+_ZG;GB]*OQ
MU-HI:$TL$F=WIQ=I1&I5$3(W*^F\(]#)0. !A@[&N))E^%'%9YSU=&%COT!A
M#BQZ6N&0;G1*[DYJX0X;Y)SHI9F;Z!9)R<@)60&C*-,&*VZ0Y>@CN;3YT]RS
M,-N8CB1H%['3JM0" &VK"X,2[9R;J*]^FPB9>LG%<;!\_,<=H/M5S<4E1C/^
M?K7=B5.0N^_LC&>-,U8)ZV9 L6#(8_;DAM;0>BY[%6W!ACQP2;,_B*!\&JOI
M2!)[)6<O7LO(0!YC:ER@\#IW%W9?]:(;?9.N8A$79"'%HH"=_Y![I;).!]Q+
MQ'*/'B)2QKVA4+%]W&[Y$:/K5RA#\7$+'X+ELI'(]VH4S!2K3!,.Y,D6C4%
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MKV#R3I<4,*W#,D?UG4&9&)XD$D1H:#WSUGYS_+>#6Q]:\P7NI7.EVC*UIH\
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M?DQY)U72/)'_ #MOYDZA%(6CLOWA@>5JO<3E=@Q.P6F>5O('Z0B_)VY_,_\
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M )FMH/Y<#\KX&G_Y6'^8MV^K^8ECBK*;YW5(;>-1T0* L=-N-/?/7G_.*'Y
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ME4/2N>E/RYG2'0-?G+5$5DXK\P<\\>0]%N?,WG%;6",S&>\*@#?[3]<]!_\
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M6W"BOS.1)6BLM4MH(XRT8L%61@*B0M*O)E'?XB=\6L(9I=6UE;L<E@,<R@]
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MXEQ::C(>;%1PCL;EWZ*V_%30=SW'7/0>KIZ&KZI#QX&&[G3B.W&1A3 @/7%
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MCG+;[7_/"32?7K/4%"U5U0JZ>Q!4[[]<)SYKU&*1VE?4P_2CP./BI2AH-@,
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M*["N&ING@5_4;F'8<R* EFV*BIV QEQJ,*H8V97D!8@DT- * ^-,YSY@U)N
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M=\C=V>N1NY/8FM<CMR=STVPIE.^!-LM14]J=\%Q[TVI7IAE;G<>_7Z,/K?\
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M,1U&RD61 14 @UPPMIA;P,9(A(:4W[>^>E_^<+M%MM>_/*PNO2K)I]G)(:]
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M4+::2&"6&^ 7T_2<!94*#]M32HKTIA4WF^TNKKU+Z=+=T5N,$JLDB4!4D(*
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MRQ@&OL,X;=ZH 3$2$!K\\);7SMJ?EJ\$D%RWI,:@5VSNOD[\]UGDB@OGXDD
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M3VN2"V@8&X$1VL9L6B%VR(67'0X97]-N9<]X>:JL;0;DZ.X&3;NGH<JB4:C
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M1[1T/XPF6M,+21)1W=!F,?-X$!7D<&GO[V8,=4[NMJ];BOLQ^@[>)E"<?^G
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M"F9C<I],O!Q!M5!&TJ0,#KD%"6+0=WVM\]+L54B50N5HFFK_!!V3+0W+6ZX
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MV=&\N ^B%(TA^%[V)>O5A*:.RIRT:YMK%V,*-/573O:-C;J+3UD0RRS7X1.
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MP$W.0;1XN0M2DG/]Y-XK>FS4^54&"#U.G9MEPZ$(E-=2*:;&]9: >W%Q1FE
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M^#"$-B;A'$!^<=Z'7.639PH*D@;(O L9 Q#8?UA8Z:(4W&"JV?3E]\2@[2F
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MD+IBWPG (K?VML;C?8/V_9,(Q-"A<U2K9_7?FKW-5 ;PJ8CTMQF:I-;B[,
MQ2[\[W)>"Y2[$F,&R]]\OS,H.97/$DC>&_ 715?>QXD^(\L"Z.9@*'/&N;MY
MZ?F4"(%B#L]@'=$F;[(JR2.O&ERMP=JUSDWAR@:VQC$%FX0Q977E90-:P=Q>
M;E)M"1=$CNI2\CPHF#9E.C791/6V*=0N^IN)NQ0ES0O.R&49;QI9,$7P^%AN
MCI0\Y!OV$$*CCE'+ /=K07IH4AAD4/#$Q(7[.Y NB/E'A[IZ5U"RL1_#0)/P
MA0U],@:>0 1S$K>*3^%Y_(B<S-%"[<!;.$$:2HI#<TJ@Y]]$J5[)%B;\%X6D
MV%NL(QA1L+1MN[&4Z<<*=F7@3K6#AFIVHJ]BW_&W@WS?VV6'.>;RQQ2R3X!W
M 6R* (X&>=$YB;^;$*F_Y66N<I<UHX7>.Z\SS'+H)X!0C18+6UD$@W:=DB"H
M3:%I6U </#0'WG;$T-VB=.$:H+!P;!.6)7.5?3I?\HD]=RT F0?]2LN18.FV
M?CRLV$_!0E]ELU=HZ)HC*<*5_"&2$<BVD@<D>4@3_ EN>LL-.G'4F_Z0C:VV
MA:[3N\0Z_XAA2QY7=XV:)2HO8;O83>I^/Q::\H-%90$):4=H+I:^FNW?3CLR
MT9OD4DC&#7NC+SHIBXS'_Z^T!''!&Q>>],.CTB8]\?S-+51!8'IZ,/(@FA+;
MTL,$ $#IN+_Y1^ /YTO5!STC+['[@0L_DDD.JV]/*=5:F<'7>,9G\Z*^[NY$
MGM$5MY57NV>C;4J^QI</P]9M\9JCN/WF$/(>DW9UO@K93$JRD#("  *@7[=+
M&BCB04IB$>> 25"[!3&#ON1=F%QM\<I_Y=28ZWD&X@1UBLC',);Y/., ;5I7
M9$S9E3SP330"#/1[GO%@.N_I?&LYTF(U:G^2R0N-G6\G9;>"<(CX*1A ?M(=
M_\W];HHFA[YP?:^*-T0V>5P:A!FJM:A4(9PV5H6_&4YF!0OV#%30OIGXA?;6
M\'VCNC%\[XK "4('TJ.NG?M2SH39GB8UI[=>#D)%1%18U"=QVWKS-/@QA]O0
M:%,'6%Z+*N@@2,K#<B6BZGVU2LD[^JO.,6U3:I$@%#BV4Q [UU5?Q6(#Q(8B
M?N\5HSBX'QJERBLWD@M,E*TPTA49J9:NT8DL Y&'')01?O$)X%C\LBZ@%0FC
M;109]86\MZ#V"&6; 3R*+-'>".L1=D.5'E$^!19-U[#/B3\*:<<N)?CMY_*4
M5V5=*3H6'=T ^RNQXH(63M5#P'WT6WKE."5P!O?MS\05A]C22A<"Q)4^"4JJ
M0"<]1T-[)KDYO+:C;MR9[!/1I3[A<^?R!DOP-GDT![D8)KL=YZOZ7)WW/M;S
MB_L]NU;:*LM 47+*(2FR+) [9Z/]ZZ4*?PSA1A(E+8OB[9OI>[)WQ>%*GR2"
M2,4 SXAI1]AL_^4$1VI0^4%__I'U7/0BX94I+^/7.5PJ9'7)']"5 ;DX9! T
M:ZI9A-2=B%93P( .1"I^,TU4Z'FH'H2D6R##;9+8$LJK@E/!J+N /;61JK',
M(V&H@'N19BKH P_?#$CM3K^R.&1UL:QVT^>X]).+6NND.)PR^</TU>QE@MAS
MR;>C7,(%*ZPP,;0]O$6'XD99^K4K[O<+D<N9Y?'H"4KZ20\G5],2_GG-ZD+N
M2L!++8Z*H5/RG0(Z45^W(GAT.,<:SP!'>HW?@8>!KC+1)YCE2J%MJ"^<MX<U
MZN5Y%W\71PM_X5?\KD#;R*)+%F8-PWYRWN1_W!'7A_;E'"AB?*,YT_Y Q3(4
M^/RB J6&/409>.;W0J0>7C!;MYL4\)"THP8^;HS__>H5,(MS=]\Y?^P=%1S=
MO.)@?4$%(_O>_)XO0=2#]_\L<HT")W4<H(!Q7>Q_U9E_ME*LV.K-^6NF5V:J
M4&-DC\[:G\K\-#Z(/&(A(:%3"OYAT*C_AGUZ38$7RH*A9J>VMXRS9IA%#[UL
ME[J&UI\RF\R&!W-O\Y!>G0DHWT:4M8]-QS:[(9^7D<R$7)LCBBE_]X5'5OL5
MB:Z^(ZTY17GLP#H<VFJ99RC'C<-<TX> 7/#@B90G,P>9>?&H[)KNB!E0=.@.
M@]&NL'F+H8>N WO&I=R C9'.[:==H:@?'^N<7HN.]1TCK6<@?O.1W[1MV%?>
MS/JT!3_1+Z;J>Z0Z\D'"V)K'PXI#]D,0A]>0!WQ?@CHP^8:*R8(Q*?,;XS+P
M<)-Z?/8)[]F##+G35MA5:^LE(8R_;%<MG@&,;154#Z8SV7A'AIR\$MQH>OS'
M7SOW3!$EZ)X\FQ4(%&,F*H=_HTB^2]W^7D7/4N#4(E-531H(@S]J?!*2@;X)
M-%^B6"S*==VC:O=@*2#3H3A!6"@&2JL<KI)/NE<FC.Q]H4&<#K-][IT6+H<,
MS-:D.U#_CACZ9([4N-5.I>%]%Z?DO]5:XGXMDY/=L%%2K- OK+;L_F-J[(^(
MAO29AT%G0A>ETV\'2^*>P,X>43_NDNS[ VD!M(2RG_Q*=LF!#0-F#!<;0H)D
MYC@X^^G.E:HU5'2+'3?1'VF+%(]I-&^_U8D+Q*DHV+?%)B@M[#_F27V,-XD\
MU'JT]/@BY=(1%D)9G;!+$'FO_G!GLXM4;F_UIW_M;J]X' *B=4-0%Y"IJ_4I
MOA)?K#P6L.K).#<X(RAQ8!-)T?R:=?8HFT]$5C2J#D=&[BD.7(AAA<6ZGJ"B
M]%M'SKIDD1[A2Y5="*)<6QRJP+-47C+5(7LG]?L"<&[D(NV_63Q1<'*IN7 J
MI 3ZV5 B-33A-X8L:W3>[1;<;&(H2'Z35.[3-!$D+0*V+G%LN=V>!^O*\6T4
M1;@HDCZR?YC1]$5GQ^_H"135@O.S_G90?%R=K\9Y(/%5G$>B"..HPX8<& [Y
MF+5-&EHO=;>4BP64&BF9LOO*RN'=DMXZS:?;O4&!]$!%IB>O/9RN]:N0X1WU
MR!\)+KJ:!]N1$+C)=]_Z<[='W70T5H&>B2+0:))#Z&OQ(!_?N^\^Q]&8":7+
M?-G6>('EMZ7:*BHOQTXT&.;/9TYLAH>PVD:[UNFMF?%97H(YY=H339OZFV/S
M<EB1(EIQ<\'5*'LA>>J?@%/"@%-&)OZK)Q)*?S-]B3*OG@KL^,HMD]:ES<)1
MTE=-GMD?S_J/12I*'6S_<T%-4N(%K4[FI??J+_$OGN2(N+[3*!G,ZE GKH9^
M+Q'Q(HP&"%H$8@BR^'OX>WEE/13IZ\6)=EJFN:Z3/&HF86(2RLI ZL19/6"O
MM8G,"V/7H91NLXZM'5KW.-_W7^XG0&NFEFH .&K7R^G2LT,>*!Y0A)CSYGCU
MHSEB(B>G^;3"JC6@O"'E.*RX;_9[O:!T'_RJMA20=RJH[ELT[.<AF$4:?OIC
MJWH<JBE$Z.X+C#147*#+V7R]2 (F3$MQHE0C5-+\Q@B2Q:<][\5,75Q=2ON0
M[ 46I527=%OAI45SG0&$^)$VAD,-L^7HU(D@4:5SQLK-498*\C<1KCEB/*Q)
MEI+H1)'D_RS#57S+]QM$M%@^K.P<=]:*^U+.]VHGB=5S.GS!F!T([91E*M:Z
M:9)T,9]T]UT%5STF57%RHT="<LV\_%+4CWYC6IAZ#7?[7-),N1_GCMV8(8E@
M,IGOGDD5R\$)QJ3/TH+@_N;#%)DT4V<\?AOC&\.$3@8./0Q6BY+LJC&<88:/
M+4,1;#,L]V^5IV#$%E\T9PZ!,\YK);$07>WF,QRO<N!6'>V*V 5[I#O*21^V
MM;*[T3$25__\UD5FBV6F*A.%T4OA\0=VG#LA!$-]G7TX4FO77#Z&]/F;5,R*
M7!9PTBZ%Q)S"*&K7KV]JO^UUP'8,&@>?M(]0W#>7ARJ6/FF(4:2'BL"!=ID[
M:!F\Z":=NR-]2,F,U4I)^R^K2 :J]1,V>%0/H=(MH,J$8 %AVHIJE_EY\/=^
MN3'I>DXE;PVS0J)6X_"%J2K%\4"U/?^0V*@&%[M&BR<&>"%S!S/HUJD\!CIS
MN6".XC?;Q9$,2P&4:VP;_M+T_.R966)IY)(2& ?9*\1S'>JR=E1@$SQ!V7<>
MS,N+1V^]\WI %91NHJ;A(J9VQHNS.*' 52'[KQ/A\S[^^/#!-X8+NC(['!MW
M)#V*+ZI\7=Q\3J=-)%B$5ADK\1_G4[L9?,<TZ+U_/_K:VM0X2A"N2Q)/0_!!
MDN#[Q@>R!"59G]J3;^Q;&BVT1B9>H!'%!B(PGODL9"6@IKG=MD#F_#TD\GE]
MM1 YW+T9KFJ3_6MB6:L-B%;M,&TU<,(AC&>+@KZ*SR^1-(;G@+XG@K_,DPDX
MQ>L[90CM4P'W@)>6O[0SIKT)97S3LZP;:'UIQ%QMG/!^##@1DG3Y'[7W ^X7
M>+; B^N?39X\,9!D8I!<*&3=TI=UARJL+*^P,!'6   58$%WI@^+#Z,&X+,'
M\AU]BO->[06=1:F%2M3B!.%%><EIAC!L 2Q?AJU<DM73#*1&SLL,U#0C5,Q6
MHS*#WR5L\/TW^DXB[5<I48IE9V-&N=V;<,G-7G45A*MV\28Z9O#E6!AF-B&-
M88)03R1YO#-=?C7;6\UR3#L5OC=/@4HH<"TR@"5(&=A CS+Y'C;AIOKONS82
MWWI4)(!QY+E\\0![6>1I&]N%'/$+WDI^I\W?5-40(8 H(E0HV<AYU2[/%E_;
MI)@Y\LB>C68[:Q6#Z#FG5RMKW97BORJ-R!4[(V9.CF0$SP17B\YP1L:".L1
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M]IYSJX$]A3#TTKW?T9(1>47%(<40$7"_";TIV8*0+F*O0Y-].D-MTX=MQ62
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M U$026F\(:U#.[O1;'0WSM/V Z3.15-(T+VTU:-OMO921+ :K%>BD8>^DF_
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MPCA]7]4,NBPM[].!1\LTT=M?&/^$_5)N5G%\/J$$_AE2D9#P8 <HOZ. ,\'
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MG?*"]_IRZ=,L#Q[Y?'[\JGOL<O\ 7F]O#-Q[Y8&W]<NF_MFH#TZY@-\\8_\
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MY\_0OTXZG7*_',/I&/ZCW.4H)QQ&508ZFW3,/P&:FWC7*H:TQPH"/UG/-/\
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MEZW@M]-@BB!*1*1R)^-VJ2[L?%C4Y)[21B5=_P!WQVKM0=?') MP4C$H&Q%
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MPCUFRMM2BL]/U+C15D:-[B+U(Y%5=]@R\0U:4R+Z3_SBW^<VD3M)YA\JP^5
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M*X(3Q/7Z/*,/\VY0E#%;WC7L/GB0-V\1EA(<_TNZ#EJ])OX)-9.1*;QX@AZ
MG8XLMS&T&='"%DDP,?!2E3%N+>>0R4%^K):Z>F(?M8)&7<+M98W;5BXN>F+A
M,-AZCO)[JSQ22T3S=X@=#'U?-J+Z9U<])=C9Y.[]F?+9\Q4F$,L9;X6./(1P
MP:/.K>LH*0<[NP,."*)"'LYG@.4DC;AK3L?PC8+;;'<NQ\]WZ(,_?(-46YG
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MG*]Z$/R!WT E58?2)H'_MX$B +< 8%M;<T[5ZR-Y\NU9A\H>?]5-UYB-PM,
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M'*YPT!D.W [2M;F0S%VJHJ]0K.I!N-\^"9[Z"^!JV4WND,'V'?].Y_$+IBK
M8']Y1T;NE 8Z@!WFZQ '+]"E'8T-1!8?;+]/ZU!XL_X%N"Y=,*+UT F3Z$$Y
MYGWKUC/77]]N?F\"U1JDDF?P66Z;#UONFBKIF\-64AZ@-#,@0GN<6267[,*T
M?7R;(TBF%=N;"1';)P*)97#P,;R#7P0YW<D'5#P0/9"E4W^F!OKS3A2?K:+1
MJ+G/ZU.F.!L@4TWTU3Z"5UQ!+ZCUXW??PT145G@&_@%>LHCN@VU"\*14'P:!
M,;CGF4F[50X+^;VL_FXQ<A%A6LXS[])Y,MNOI70=P#^92U/7,=X^NM<6(#=@
M$U#<O?Y]Z$!1 8=#_@0]P>E.]4+=XB=%JN8[!G8$B4OASX]1>,KRM^]RVP54
M2QU TD][15D^<IIC/8QV0,PJ7MPE(#_Q1H\'U]GY^)M:,Y[KTFLQK%P%A48&
M#R()K]M0V:HM'=-\NL?+78\82H)P'V"!@B@W['K^;F/C*!QCI-]6U;'TV/58
M^1BY^,7Q&$]KRO.PJ1Z9+<N_'][^;@0\D^']T!=>>Y)GNM">ZUVR.L$,Y8+,
M90%(NP/K0I*! F*O'T#*[N[]BO;W0JP;C_CEP:%.^R?A++6T.@[AR</1^D(,
M5/L-?M4?DQ]9)?BQT5EP/J] P,2NLKIX>9VM?NA,S;QO>U>I82\O^%;*J(WC
M]NS'=V-;/-1-;;]NXYY[GZ->E?M/GW[-V1-4=J,/YO.?VUHN[X'34L$9R[/$
MD.\2B3L#=5E-]4_F@^5GD*6H(3;1]B3?FZHVW<;]\>@E>LRS?/.&.YE1M=H&
MF!!<Y:?7+:'NVO(:WB,Z'26<"F90*.#CV/_JZG\+[]PY2- "QN?E\GGDM?+[
M66M[5Y<R"U5F49N3E6?-DJ SI-UN_C9O)<8<,ERQ[SY>CF% 6YX']HI+%XLO
MK^WDDMH&@X[@=GGVHO"]\;?<YMV_*4BNBT*YC"-Q/31G<<LGBQC/$AA_(#9<
M)$BE,;&PQ"SA#-(]N+_1)NQG*:-SQ(Q#>HVW&I_NTB'53.@#;0)$^(R$]W(S
M^-D4T9-6#LSMSK64)PGE@< W^G(0I[9/_[*LLTHYK6%QDT")=_^RC"7=YZ^7
M1^XT6>>;?1 QYL=1H);700.TAI(9H[P7!U(DSRG\S'Y8R%")B&P_P+I_6=SX
MUH+9]C5MO*AZ7'/UZY>W=(#/C><P8UY7LM[AY=F]%4:"G.%7;8SWJ@@EP>$^
M#=9(IXKCL[:L7\/UP%^ ,]!2^*2AGJ%6B!RRJ<7*Q?43_$61F+"O6:AW[)FL
M=_]4J 0I(_"0P0A]UEI,0?D6)TV(8>YJ.#H+V$9F7__PY:J5M<G7)$7A0A89
M$J=[(_OCW7BVGJROM^0(9H51 <&I0;,<?US=N2[>]F';ZB7/FR*5L@-*]J-P
M&6$&%EEERS-0?HX/0Q!Z()TBW7W2X^.3Y"B(]P$>4&X"LW/"55WL<@$7-FQ^
MQQZ$@:S43,.E;LLQKFR&::_XQ211UZ+!+90W<4H[XN1QI&T[;_1]0F>*'[Z*
MA1W]!3RAIL^W[@C\V/A+84H[Z=YK4"2?]9-$N:%%O&R"/^+L_5"E[0$F7P7Z
M;+F%L<1E2L?*5U*]('B4H9- +/00E>9+0375AQ#T&M +N/:SD2W["%32 0//
M7VS+;K-!,2V5I<C_TYAY1C6A=&LX"((*&$$I @&D2)/>>U&ZE A21<" $%I
M.DA"$9!>!2D&D1KITE2$("T4:88F >F=4$*-!+B<L^ZWUOV^=>]9]\?,^V=^
MS.QY9J]W[YDW* KD,$H/"08O= ST?6FHN\<_@( V7I%5W#7[@W^_JJ"=(16B
MJC;DQH652A"Y0UM?QQ4;*VADE:K+4\-S,:5ZSOP/._"W7"Y=&V-ICOR=^=&R
M$U%BVS$T93V0OY J<TNPUX];Q1D>= X8D'=1T0A&2P5J"-2KWI642M,0XNW*
M>63 @7+6=EI7A1&3,@#L("V[DJV=0=V+Y0IP,^V5)$D.,=<;5[]5+>D^LIQ+
M<<G,[/!N;)2>^' .".3<N5:"=_IY<#GF7J!BJJ[R1O@H= _D9<6.J>2O&4?)
M.SS(<PM#>[_U4GVN<)+W"O&D2\;C=1RAZH#Y]TW@HOVL^MEG['I2/>5O_IG6
ML#<]P83X<T"&P'%L/%0O%CNGW+5PTWE'4LMTA!ZXT8%,4%N(\[,/RY404\;<
MGT@"(H5IVSNF%E0W@!EL0+TML8W#IG@U@=?),Q"F)>,K4CA(DG9II8SAF^W0
MY7C=JX\4CA?NS?%_\[MJ%;:EN#*X3>R9Z7Z#=?Q*ZB2\2SI)HL%N,,ILG.T1
MI%/7><"GO^Y6%FQF5Q_KEKP19J1_'WN# 2X&U_9^%]>SRI=]:Y4AK'3JY=H[
M)]OAGS;T]FNI%@#7H\/!F-\^A)S[%2Z';7=Z?Q.65&<=O1HTN A]A+/5[("$
M(WS4]A)3*NYM[(><(0Z:++C6F??4F29Q&6,T5D6+3CO0?Z.NR!'5YF]'+NU'
M5_,K:?/=GYMY'X!]JHH6@9@'#2E.NH[.%Z%HPYG>\,>W2/8_-==WC?"E)Z,9
MI56OA@7YR??[B@H538@R[S^O,/\,&M"8'+"V+&S\G/2JVY_J\Z;Z%JV8F_&+
M8IQ]N!4029TX=#TB?RVBH*$TWRI>=*3NBJC[2N2\)=>7F \9,AS4!2B:DN7K
M 6D#Z,SLJK1*GI2A*>=!OBL>F7"&$_$?BM(R5/D#07Y5MC108_\9UI]O^L'-
M"L\<QIH@5P^G5DK. 9SH%;9Z1+_BVY??ER_G:1$8FI*Q86M3+C3-D/K%DEFJ
MYZGI'(XNHPL'"*WA.K0HU$_A;@SD>E81-+F<<6Q(]%8"TWMRS!>^%_Z*<\C_
M(/U7K:-$61EWJ:.=.H7IC:!PR;:9=^B].%?Y;WOF2PF?,.+EC7!;M4NR?L$B
MH1S'924$$T<53NR^@;GQ6(52,]21V]5_'&I/6Q@+/JOE?MWA4?C8><;5O;$R
MQ(N$)MA<5"^HPD 3(RYPB:9U3BB_A\?2<26?"T)R_QS 0X;CZVX:I_APQ.V-
MNR=M/<N&JE:NF9=QSXIA)[>/+==I!C 7_X++M\3/:$F%A4U>EG:X*[-K4\.X
M'+V@T4?JEN607GVQ6EE/(7$<KSE79><:BF0$[R3JSWK>++O#JUY$J[XNKB-B
MQ72]*7'6(4H>\D5-4YX#<R-5)CYIZ=1BHA E-#3VSA_' ,$=/--3#$ @CWE-
M^8O$T,9A?#$_3>EY0J,?D5'<T)H-5USISQO(ZTE;= >3>I9.X"J&(WR4SMP4
ME5E"R)QSP%>V;('3J&,%AE:XIH6RS@/]/B\S%15EF8&#TM9:J$1!HAM3_:7M
MW^^\ETJ0WRJK5@:E<<RA"T%.&E30=&GGD(UD2Z5"X26>-C765*JG& 9W=N;T
MSK4PC-?<_1FE=\3A?$G<5-1K0&NL28<3[!R02W<Q>K^06D;W9WKS?M@88PIZ
M!"=7%3I_I#-6ZEQU\N(&%? \DE5UVLR+2C\%!09;8$D+!0GM>L\N8S]3N4?7
MW*9OP3I@MQP:4]07?A;@!59_L8[[4(P*N])'-H<RAJL)]*')-V?"!F PXT[0
M0X]7*!I9"E^JK?8)8XX,9LQE;3WDR/=AW/YDZ.'W\/'DM3VB@[\M8;H!Y:3<
MW/G-GVX@DB=6W=27VU,K@&F/NB<M4-+:E7=YTGT]J[P(47>#1<D0D07\S?^"
MPN):L&\QCP&<]'#$MW=JB+9G;0&Y3'IU<3IPT[A!9JZJE#!OS; +;^U0X1*H
M<V*]RD?&>6''(*MIU[9^/W5R<K)WDEI1,:!"6!ABD1]^BP[#YGQA0?C_\M'D
M3/\&^'^+ _L>8:7G".Y>NX=UKN;+WK3/8*Y*9N#1^T;]]1)#KH!@N38GK5#T
MT[BVD12H^GC-=QT95%6?],.$3GCKNC8"ED']F!K+48UQ?%X)P\A ]HIE6N0;
M.MB%B7?XS[C1/_R[O.>AG O;)WQ_(+%"?JTO<.16?JLA.Y7!3GIO&-C9Y;I%
M6.Y6+IK//XU"M[T-R-P%PZN_0X(NOSW-1H:1@&&K")IQQDT@BJ.MO>KS3D=!
MYJB&7')PXD&OY:AU!+)^8R%\=*-!PJ3'*%'SP$9A$!P>3+WATU37E#"?<=54
M0<E#[NNG9'4*]JQYM!S<Q@9NZ0J>GJ#\0B@N$F4-S"X?J_1GW&-O;J%2=<T_
M_OJCO,ILP>!%U>G\"X!O/BMLWRD1+4;ZLDH\9!TS!*_O,/<'_4E)FX']DK\R
M]JUEV&"MI$,#WW!R DMVUS:<[3*49BV[WG$]#Z.T1'SS7OF@,/?9(O#NW:R]
MJ@&X;8[N:/%=R=4?AB,3R&@5+&+P\SE@1?@ ].RW:&^5O$N2]S)"R#K&)P>7
MR58O?%=%_*T#Y+"HD>)24)T/G^\S^)*-U20Q1[\179,2HF7HB78YTCJL>A+1
MD6 6KBG>?W5^-2@*]'K =WF:>ST3[.*EW<5:NS9H& X>1O\"=MAKUN13YG#0
M)., K>SH\>O<H2S&YI08IM>5_&.][<5>Z'YT'VPW,],COT:3I3/K3V>:S/="
M\->;$V*E)[4K#W8,*+#63Q[L&'G@;Z7(%7"C"H2N=]"U<.J2(PJ 2O5+26*!
M?19U0TJU14;E+D>O7N/Q8\4194TL@J5;/]1  R$JI*0+?*V&$*(M9<M&<G_8
M'?92'^FD1F[6':TK\]HIZU+M5>,.U4ZTQ_Z3S7^U(BP?8Q@9J"[I>XP4(AP.
M=LEQPK=$&_@5EL:+%?_Z'[15^F@:O&3"8BBVO3_/9B5!@X!\1>9I\7^ZEYOI
MV5ZJ#%U('Z9L6]N\/U+5]IN;['+&9!E7#!<L,CT6155#U2#D[J7\%J8CO95;
MJM=N-4@'8I3HH+1]I@XJP]+8!5L?9VP-J/5V)4Q$@1Z'38GMR.'B_/@-^-L_
MGW%3C^W@DFNO86SK5!.9[_4)OC#[>'SA[(2S]%4[T79*GNQ%A1,;7QU_9Z(F
MBT;?3#GR)(*-6P](0>S3M7WL=H2H*J(O]Y2.8<$2RFG__6>]NFJAD,BO5*]!
M =&4T<W7/:M^Z-]M2<2:-N0'"SQX3SLP#=UGBW:125DWQDUW )S W4<5BDX2
MH_M9\H:M#%9>M(;10>;RQ?5+-;X<3&!M&@/*:9G!VW /^&,#7QH"[@&RT%>H
M9B8(W]@2:-+[9^6MJM"WW:5M.>=/(=86A('WF6#S331+>77+S#.+/NY@ME,;
MQ #?68 S1W:+!N&LL<! $CIY4/MDLG JQ,)*UGDEW.->J^[-?#,&92$KMOWE
MI@_*HZ*;IB$NXKHW2SZ&%T>0\G&88G71S?PQJ2]X@X"I+HU465VRCXWU5P;N
M.X-X,R9]%KS=\&QEL^LZJF5N*>JLO +1AXFT0C5KZ$0V#)U'GM\]X8&N+"/W
M;E"936V7ZE[R.2 =2^Y+#'O?BLSUBAJK&&)W([O6J/.>90@1^'F"O(5(02JX
M( VZAUY^V9!=M"^Z!./3/^D:%4D[RKQRA<V=D]>2:.XD9=B4*I=7JIJ)R& W
M)%4-=Z4L*0N[-ZNAK;YEI-I,?SV;^CET<V18\Q:\^_:0]_\*Y%\BG2P[B*&?
M-ST^6>YCGDLW?.QM[@;U2CB@-"]5\O:F$G*S[P"Y! H45,Y%N[V4#,HC'W8
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MELE+;MW0JQGH!X U$H\7$UNG%(/T8=QFQ1_CM6VZVDNB#/:/1:/;QCX)IIU
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MCYP:HX&5D*6NYB]^E2HS^\K:H_ 2F[6U(/AH"9O$/^ST_-=_ 5!+ P04
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M1\-"L?-LG=MW6UI3;*-%'IQ2ALOHMW?3@/S 78DG]6G;HQPCPS;7_.%_6&B
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M+DE: \)6?7I)?=XO)S@7?60V99\V.!]F^/Z*WWF;<LP5QE^JH+:<$)/G+[N
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M7V^U3._1M!IWO.7J2NKHJ*L:"SPMH?#69_\XB9[R$;"5@<411]3&<#[@?SU
M-)]8NNH61Q 8%FA].$)7XX!>Q-)I/J-<5/;[=879[U\(3X!8:;C3(R W^.P;
M:Y9GQ1"@Z?:"G2G^$=!:V?\G-4RN?$)S@,7X>D2*]&Z7WSSN!:9 ML^SZ^R-
ML=G)J/%;!V'.SOBW_XRAY,JKDO/2B)T\)1%R46]5^QB]MJ8&'BO@GDZ3F"<U
MN8)U/D-P@']+N@6SMSDRRSBYA)DM/*;V06)=6,+RZZS'UC:QC0G%PNCO^D>
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MX7Z@>5LZ5IS*UV\>F*:7:QV*>MZ*K<W3>HTHIR-1Q%"3V  ICM:U>RT^QO\
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M_P Y,_E?=O-Z=IKNH/Y?N%K02?I:)[2%3\IY(V'N!GZ5L\\_\Y8^:?\ !_\
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M-PH*@D55C]-#L1B]A#Z,;>G4J35FVJ0!M] P[BBY.G.,  #B:[GO]^3.PA'
MMQ4*ZU! /(D[5IOO[X)%H7:B.Z]CPH5-:;@D;D4[9I%XRA>9^ ]QN/<@GZ*X
M4W3[;DA:FE>M1WKMD:NI6;]Y)(H@(H"W5B2-J8$2\M(0'E(*LW!%H*@'K7^N
M2&VO;46GJ1*2&4L>]:]0.Q^C"NXNE]-&CW?D1Q^78X!4-O4*:JR,O4;"H%:X
M&U"W9 :+56H?A%#O78_+([&%]0,OPJQ H3T-3N![X;P7J1GA)NOB/M;=J>&
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MJ4DME!**W9A3X@"02 *4R/7^O:=:HL;/&&- 06"L!XT^G"O]+12L!:OZ@*5
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MC?2,FFF:5:V,<7",%Q\1"[U('C3?.@6*J(C6B\:5 -/HV^B@P9R!_9(C8<:
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MMU-.V<VT/SM'?7DNGV$,ES=V4H$PCKPC!%5JXVZ=1U^6=ITBYN[CE+=DK*H
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MGO33"+<Z?YAU2V]($$1^C=S)Q!!(-*4V.1%:_/%ACA7Y5QX[>^*J?;?%0?\
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MQ&XAN)*>B!1CN :DTV%0,*+K0H[OBT\:DQC=J4IUJ".N%4WE:UC<E8^!=MR
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M8=*J<+O,/E&^L5,UL%NM./VJ"I53W!&<XDT>3F[VLH98QNG[5/?$M+O'BOA
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MS5!(2GN<:4 <L>@/;'< VWCO7*,.X /+'\-_L[';Z<<L83G4BO+IX4P#=;4
M.YWP7Y:G"W=Y 3LU' ^BF3%F]^F>W/\ GWM^6W_*P?\ G([R_JEW;B;1_P N
M;6;S-<\@>)N(2L-BH/\ ,+B9) /",Y^CC-FS9\9?^?IGY6?5]0\@_G)I]O2+
M4$;RMK+J* 31"2ZL'.^Y9/74FG1%'AGR)#8H"<4!)Q53X8_>G3+%=Z;[X[EQ
MKR-*877WF'3--0M/<*7'[(.^0C4/S+D4E-/M2X&P9NF1BZ\U:CJE4N)&A#?[
M[VP NF7$E)X[@W)8U 8U;.AZ) MG?6US/9/<ZBZ!+91L8WI3F3U%!TSZ/?\
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MV.'5W '5A6N%>GM)!/Q>A4-L?;)D(DD4$CJ,C]Y:^A(71/AZFG3(E?01R5
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M@D+]G!=[1A\(Y5Z>V0Z\DGCD9"E(R>IZ8#80_;XUE _9[X$$XF5@.*L/V33
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MI*J1V:/,'?\ EW8M^K.1Z'YG&IZ-?ZZC>C:W-[>3I4$$QQEB&-:'?K].3?\
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M5HCZD3M'.IJLB,584[AE(.3W2/S4_,ORZQ.D>?M?L0HV$5[*5![;.6&2%O\
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MT*[V-%L9O["ZW [ :1X+:A,4#M[;0.BO+8\8&Y]GZO0D_J+!!P;2P6*?>X-
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M__S__W\'Z0CD]#U 7 ?)C>S):LIO$T32C-X4/4\&!3QP(JMD"Y(_J1:-M!O
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M7OA;;)AY-@E/%TU2HD^BY4.6-K+!.0%(E.#5 ,MW-J3?A2%[UE1'"*+[C'\
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M; .B5F$MI"A08^ P?BIN * 7_XVF[:H$<O <EE^KNI+,/7MM+,RU4(2A)GP
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M+OROD@50PME]XL8D]D'&N<P0!6009FQ/-YCUS"HA&G/TEA[VGJIC[FY*D>D
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MR#DQDFIE-:Z<=;8/1.(O!QOQ>O.V88B_-QE\ +P,L! N*75JJ.C<^'ZKRFQ
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M)4[;0_;%CRMYM4W-X.#Q8['0HXQYUYV#@_M8<V\U6]Q>!2V^*KY8'XBKFOQ
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MUH)F6NN@;6V[)5F^BR5%PT%0@UQ/U&K=@9[G I24&V4[A<$CB17]J /L@ ^
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M6GT_/WQVVQS9OP^684S C:N:O<]QUS=?;+IE'KUR_IZ]LZ_^66L?[UZ),_\
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M]5GMVC]">\:1K,!@R@ K5UK0,T3$;'JE2=ZUF"WLEI>Z/K]O;AP:VU_; 4+
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ML*J/<_1G!M;E:&(.YK]8 (-.OV]P1X,3D2LD*R&XD X JG[P4%6-17Q)-*#
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M$5WI0['[\ZSI\(XTX\>(K7H2.WXG)7;Q\T0FI(&Q;MAC;H3P9Z?:H*Y(X(Y
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ME:2R$*1)RY&V=CL :_"3T)!^RVV:UN;"Y,T4Q6!>8H^X8-]J&1138UZ]CO\
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MU)_S\<</HQK4"LW4 ''4H*+V'X85ZG<_5K69R&*"BL(]W:O[*+M\5.^?*/\
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M*]:],#3/Q7@&'(;@TZ@#H1OD9U"CQ. ?A;X0 W0BNQZT!SF'F;RO#J]G+')
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MU7JQ &W3/;/DY#]5MV<%H6!\-M_LFE.O7.Q61:2(*JDH./,D; GL/ >.3"Q
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M%EKSNO0"*KT,,J*AAG"J"22Y4+X4[USW39++>V]A+=4C,599 *<B2.*RU%
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M.WI2:ZFNXARX, $/0(C 1K_L0N_RID895.H"0 RR(HD2M:<$%06ZD;KOOO\
M3A?>6337EG"2S4MX9GE*J"78%JBH-*<RQVQ'6M270[=;>WB07_'C#&15H^9^
MTW^42U?\]XQIUPMG''&C2%KF51*Q;LVY?WZ'KXYZH\GI'P@E"*Q9?4Y;@DF,
MDB@.357X\Z@N3Z=2:DU4;@]>F3KRUK=IIJ7%[,DK/4+"K1L3L.1XFAJ12E,%
M:]^:R:3"MO8@2R3?$\<LRQ<BQZT0D@5ZT^G./:UYLU/5G26:9;H.Q*6UDTA
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M47X1U[#YY+['\AO(JQ$K9SM'RJ) [*37]HA6_7B>H?DGY1E A%M=*J\@A9J
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M?/(O_.3WYC:!J9T[S!:6WF58$6299(1:WT?(FJK\?HL13_)KGM#R=^<_DO\
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MMN5!!R6:?HVA$\8K:BD-2) &4%COQH:BH%.F2*:,NIMU]8PGB#$B,!(4KQY
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M/+&:HWVZ5_S_  S*?A4^%/QS;;\B./2AZ80W=O%>PRVDL)N%<.3&XHLD;U#
MDC;?N!MMGAW\R_RVO?+FKKJ=BHTZ".?ZQI>LR!N5G-0+]1NG4']VP!XN1\2G
MN5SFGYN7]S^8?Y>7>C^8X&L_/'Y=R1W024J9)K2X7BYJBD-\-&5N7!PM4WY*
MOSHMHIK"]UFVBYHL#1S$@4%*\6/>M:Y#[^Z*7UMP'I0>K&:*0"$7@J"OL0>^
M>X?*;"9K.XF)=&16""HZ4))^[/0=MS].(R*(^0!6$GC0#N? #.A:+;27,0+
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M2P6VXFK)3X0=^M:$YZ%T>X7T:-3D.@_RCX[^^(:H!(]2*.WVO!2/#(E.CPR
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M$%7J(V4$ENC ^Y&V0[5(2Y#21E"0:@"JBO\ 2N$]M"57X"!Q%&'MX@]*XE<
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M;,8OL^H!U Y$ 5Z]1@G5+?ZYIVKW+QMZ%IIE[)R Y<IDC/'DNYIO\JYV#1E
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M7-_NFY%Q[BC [6]9*'8I ^A\##W/P%JO8-G[$3XR)?F-^?-F63 %790H/*1
M0ZB'6MQ$_!V;+0<!D+Y'\M-P8/<?,HI*_?_$DN.ZW&$1*+[QZ0G3EM4/_S6R
MN)DD#?99 3=E-\A?$US'.(E='T'<6K! YJ2L/A1X%=7#&3YG- C$1IA["\<0
M%UEE"D-48' RZ%5#][=.YO :3K5"@L[MU@F#G0,N@XH-7)9B<F&60=:;^Q]N
M[R728FQ%675\*P>KS48'E2I62G3U*\^+64[+&9:F&J>4975K)T)>J=)XT^"+
MN+3_Y!=W(_S$WT9-S_PCU)I[A>#<?\<[_+6"WKL3Z'\XU!?"C'312$;H":2$
M8L-2D05J<\Z=HD6Z55]Q-LB=5YAP[\C!K0 'GEITT<J-C7MQK7>27*2Z- @]
M(W(.2\S]M!E/DW_O^:9O$@)O?=;7H;*E1K^;@5#H(0ID?8V/L%2(.]'Z1N<2
MP?F2N1*[H^SY T!NP,JHY;ZC D"L_Q;&,A@T!6$T6C-I?&3-%CD/_0RJ*"E3
MU'!J7^OQ=' J8QY6+ F4%OM3>96^G.-KY[1_H8MKI[WZ0H;FB\R/=W/VG(Q1
M6N1RYB@TRM7I4[Q6[.*7@ L6"'-N7G26@]VP-G$H0Q<$PB3P^/YD=T&U*]^Z
M'<;&^R4Z<7*3)JU4NX*W_83[XTZO-ZHX6[G3XNN$$B_OR6<5=UZ;[8:7L?+W
MW:%I@U @<>(#Z[/T&S/))\!.VX\ZX0 AU2V_$R&Q1_6*8E9S98C=5VJ/]]JB
M;ZTQ_V*,$0*59C?7#9L4CB*\B?K3WRL-8?7H>[&T79/+0.W==39MR;?T*XZ5
MKNR? *QH'(*E?CS"X[F?2?_$+]/A3. ,;SC;QPD]R%[T^UR,5:<-M\F&!R,-
MX/OKH@JY+;?C^]R7D[I? ^Q?^:R#M;ZX6\Y1A40;_;G]##:_TMJI*[R6Y2T;
MY&6%E?LG L^MPI11G+*:7OA+>*C!/T\ #:2"2<N'/2GB1V=BB<N(K:);1I*K
MO;C,;I>+VV'N6P2<OM9BH#:$5I^NN@WYSY'24J(0@NDS2,1?3JU+%/_U@=4E
M#H,VYU:RKB/W0B7DN?,M>Q\TCO.H%S:L;.J+ILKQ-%30&, 1H%<CX% !) <7
MUEB[1 EHX=M54\A)Y_F@L/G=6E*^B%KF>5@6>OPZ*ER[_S0S+\.D;)HE]Z\2
M!DRP9BU%@%DD<J$WJG<91-EVIP5!J+4+KP+["_-9..3P$&WF7JLX%*C["\-P
M,PAZ3G5YB#FC(5SK=_%5B]@8%D0#E?!-!S/[JIP0\=%B4D?&(=I6"^*@7G!5
M)NUN"TH#(#&VS_E48IGC3?DJBZ/":T ]2Q'(M14<R 2[HOS9GCK/J!-J"Z"S
M OI.">\QO"OK5 WYC)N -T8G,R:M<C/-XR+CU0X]_9Q\*/J:?TB%#5OD5&V!
M10N)*%Y4OS;+V8G3EGO!G'& -N"\V\[61)U!+124W7F*DW\9YAG5,Z9X.H'0
M7L;*DV]KW10:GITEMK+8:FA%$VA-U?+3S$6+:TO9?V(D'HIHH).D_\X*[9-N
M+@BN:9A\79J);^-\8?D$(.*M7'CX6G;P+]G2?X2E";ZI?*;X*)IQN3_N:(S5
M7B$DJZ0Q7=C=^B4%$N3,3#"=S*=BZJ4WL8D#;B5KV]W+S+2/@YN$%:;_%VP@
M@Y,HL>$-V9-NE,1NZ)*R+654ZA<K<_X9"@7NJ"(/'#C;V^^3BA@5Z<&XE)',
M(CR4M7)P(*FI>ZC#O[=#_QC7A$^A>.71>T.Z)>DV]K=[N^&O\Q&9B!J;WE?G
MR9$,37*T)TK/9ONDA5R!IU<^B>6'1J_R*^81E+8!GL!/W_OXO<W,VHLZ9TYX
M'CU4UG2[74X5-+_/-=.]/S7^>YE.717M3(*0_Y@-Q%J@U18C.^9RLD1+;J>6
MQ+(D6ZL6LP 3[_%\X50\8?+!^FR.G*;))'!FH_/OWTN9DK'4C&I]V?>QL"V(
M-"7]IO4@8&>\[9>ZZ=G5"N==PACG.(/BNWDR,7N) ;^#=5O:.7>MV%Z:M3&%
M.D8^ :@%,N\&*C@M*K3"IM:+'6>1U1/W!=E?#TU<*+ZXTNT4*6=$IKJP!CJ"
MFZ*<$Y%,R^&B(HG2$4[WZ$)7WN0<(?!MN3#C"ULYVA&5%0VZ8.KC@S.4'/O;
MZIVEOP7J+O 7SW17S&HJBH(W'<?NMCA\G_$MN1BP)QV69']LR#]U+?:@BKX
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MA;:UD"2K-[S4C-AE-HK+D071I0E'#%F%>6L!J/*%VNM3)F3TD4IW7$JGDO^
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M,9Y\X^D4K7'C3_>)(Y./5(7$R0R<$I\\E1T^:TZ3TI5\*FYR]&#A,1DNVAI
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MSU9,FJ?%H@]4QGCXRNKK<:\:\(=?&VHF,5ZSGW*"RYJOS<2AE(\Z&/7U!4'
M5NU>D[;>+[-D$#3^MII"J:.]B3T&#_,\41NQY[P+$=.\8^<NFJ44\<EQQAG
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M=-/[UD[ VL -?V=P.O\S( !PK:4!"!!>J"^U^MT>+U85G\H?A$Z\;-!WU&%
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M7P9,M!*%N_/4)G)#G)W?C:Z8?+P /O[,C(\/,8P_+6:ZNM5%G/7)B[CF*7C
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MU>;#2'[*+8\#M2LX?-QRT'9<V6@US_)*AIG $]EMR/:"_ GC(X(KI@R26#.
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M3!2+F^/\;E.)"Y,@\CR8-<=#=F?-9WYLD5ZXF^J#>>TA9450J2K<<! W/8C
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MN/MX>O4K($1J?6&MD47 C(/,5)^Q499#[OY/4*=MJV$MN!.W)Q2:,9? M<Q
MD-W;&4,NJ<%I]+?JLAHSB@58B6<4,4LJJ%OQSM-YU'N+HS?DETJI82IW8>G<
MJO"_UL63S.NJ GGO?O")EIQ$IPJ:%'=HFG >[6FF/A^=@,5'W ^KF5DJ8#H0
M'&G-W($EJ^R9<*JE!A#F-FQ5'OS@(?AAK&OLK]1*6XI:1/!K8&0WHAS\,,N>
MA4_9/L(ET *2$HVNE_3[(5SL\^W08CZAZQ(_E$_2H+H9*R2>GNF-J^0'U</(
M96(->;M7^JZ/<LITB$\5CFY_"^?;DU5M]/3>;-#)-6HM?M8=HLT89<F7_X9;
MC(Y;4-P5R75GI7JR.*& KUB:5"/]8LP/:6W>(U#/Z^X->64'/&410AE>=U0,
MLFM;NL5;K%/>IFEQU;GSH61,(1AFG%CNE9EN8%Y\(&0>: Q]!BR_L#[5BR]T
M3^O?(782MY69=ME8;TEY-*D]55CF"BL5V3[/OI]WLB?JPUBQW 0:M8&3<P*D
M\ZN,Q[]!S: JLQKXS>#2D=?$X_U)<6(WL4B/1J3GWO0TYLAH7XX?WR'$PTG!
MNE:$LMY'Z:!Y%(L\V6N&J&6_G#HA9/-_H[,X^/&TA0FBX^I7Z=ZTL!-7)9#:
M\RQP0K"BAS&"$V]T1T<_> K '"R/N$4\P;3V8WK:Q6,?OUQ!<IB0\;,E-K;1
MJDQ+V<^ ;E;[E79986T,YQ^U9OX2>XV/ 3X-@S?C6*XPPWQ"8QG_(2S-[+^K
MO?P&: =#BL*5IB$K%Y)ADUOC7,L70UE1C6HWQY'6!@[8WVU9^XTZ#Y/5P&#B
M&D=53-!F1P/9$757/_4&]$^7#(Z3/EM?C'* 6GF%PF2D<:L"!5/CWVB.RIPH
M&:8CM:$!/H+Y%;V#TUAA<+#FU*%\B*[,>M*OR-ST!2RB>F\[['G^U^^LY&LB
MFHYP*NA8DLH'W@S^&@D,5GM93>-]&'/Q0?Z0&BIO%_JQJ$FV6\^'>2=Y=>-W
MJ7V:FHL<WB6*Y@!:;WEG&JF@/:\F>24Y/ .*LG[PE7.M7&7;L'JOM%_OKSTS
M[NZJ":4U::U NAHH]2'SU#1CYD^(&9YCL:'A2W*V+2%:\1D/(32W;9Q3FQ E
MW63;F'?W?P2OY[2!%PM@?>O/U&9S,;C.C$)<K\BV<$XM%U/2Q]X$4!Z38(4;
M629_IY?0:R S!S9\GDS%H405TQOP)(0^B2H>JGJ(]WQBJ3O 3I,C8X-W&!:*
M6SG7\Y<I)?L(P\"DQ L,F.9W6$R>-/72]M=3%&\-&(D#Z,OTG^ "\T+&Y\HX
MU60[^D;6C&>R3[;X!3'E@4$V&, 9&W5LN TWNPJ65WP(90Z:UPJMRL+M<1)C
MD!Y[PJ[>@(M[:/;9(++WFY%[H?K(H#U=%T/P.B5),QWV[71%&.S+)BQKR[TJ
MU#S4Q>GSVEL62-(>5T6C.(+#->25E+-L>D$O+7+V0>=_"4:F#2>8T5=$QN[3
M^REZQX6M.6\-5B:>H<%**W'.FH0L7V8,;1P;6=3.BTW8(VS?$G$)8^_I-)Q#
MU)8)IAUT:3&&,'NB:?#3"/XBT[_6N6A89(LTNIB"'>="!CR^PL8;C,5J89<3
M%T,H%==0Q-T(0;.LAM^#A_6YF4G@Z1<T-:.^&!Q%R??I[+UCE=O1(J89IJHT
M*1H1ND=H^J<=3@"E%46OO3@Q9N%Z#YZ3!/P?_A?QFY[2JU$:O<U",L8Z5!S'
MH]("V@^1^1.8]@A^!!U9H)D4Y<A+]%2+_"@]]V":RL$/&6+L5PP:7?/1A..?
M=GEF37 1^(1'[$1#3:S==@7C,U7 /5K1=GJVZCNI\(=/PSQ"Y!3*'%2 9D7!
MX_:X@?<25%$DN%Q<LS6Q6XU]$P.$AI3Z BY4?3T8*H;2$NZ;Z(I.=J;1?XYO
ME;7[[UT\G'VWZ-FS3[3Z_>3%294#;1O>D7*0KCZT7.D\EOC/=Q978)E+J !9
M/U9U>R@JF\[E)O W;(A2U>N2U@U1H[-D:^M($L4-]Y;WI,*2F;-; YL-*IMI
M4@JPG#_-,NY0JP3H"I,#_"/#&C!CUFG7<-@<.V8:&64W<GTVF;Z:RHIXXKPV
MJJ<28R]R\H-6?OJ4=33URAIU^EC,HJ2V_X9Q 3]IO5U@1HOZJYI[JV@AVM5Q
MVJ&4REHF!BH??TM^VX'<)15'TZ+BX$<Q.P83Q7KCD"+QZW,M? ;7(%>_R7<W
M_M63#&%$) GML<>#QFZ^T@R^C ,-?WP'/R"0B>I+H NHD+"TZ#PRC+N^[;A-
MAT%VO#&XG^Z;[W'V<O/:ME:T=&)C&$%MX?MGP#YIWSX'!K<,EXS C3D2S_W-
ML8A&^U5YTF1=J#R;S-&+6Z_#T/\I/E$W+4T.LXP"DXN]Z$#1GWD]O#S>HB>S
ME^K^.ANQ J!G%)+^6Y1-9O\U;Y]8S^BJX1?)ML*O8/R3+M?.7:K>3-2*V[\X
M:_E/?,K]E=_>.F1Q!DO8>ZZ6<GT-#*&RVET^G[)D&!!RX@)W_VL "F/$6Q_O
M1M ZA@ -G,*; Q2Z6.H&*E+":!18!W#_K?GQ=]P[-=S =L[PM]E.XKU3LUDT
MR@(:M!4UD8FV6X':IY<H9EBV1T3OU./=WKPF1)@FS[TP;5M\$#!QIX%9-35S
MB^5@7O^K>XO6C<29UPN$TCPZFVY1S,+4;.>)R6M_4REL.YB3HJ6:S@A>LV3)
M<>OS7A:C7Z,%GJ9_<.7*XP]T9DXPD;48"G3Q&V@N8ZNGENIX$^:0>M\;7N\[
M<%#/8QNS09'Z[I)0O4:!5%+<Z'#\B<:59;1@?5=V%(U#B,:O@9+&49GDR'\!
MS?R1(&8 9<(QQ%U3M)\T]7V"+@1K/Z&AD-'&7+9BAVBXM]G[2X;XA.OQX".I
MD3LX+7KN@VP"^D(RYJ&>;K]O [F9*K!?&5U+4O)>H(88PY>UI-1ERJ[.P"#1
MK2).>:A/GD#D9Q!4XGYOJQE!5I/:UYAZ&!T(6ICA5OH0V/YXP7&O<H:-4%;G
M83"",*MM&ODRH-'GC?3=_'Q_RFE/:%<@49X<L8,KYB'C !+'O69Z]76IU;,G
M *3[-RT"G=<TW&_T9"V+;TS?OC92@N3O>726M&VNQD*6_)E42+FD$W;C*;'T
MR;'U=E>,1+8Y<X)LV</'(@IRNIB57 ($/R;@=F4+7Z3X,%XW%B+B=#I/K>'<
MYG1_.WXJ!])RK^0=:3,(?HNV/<^^3>09N!LIAVYDJQVTO\0+'[2$CT7MXP5I
MC?\3=$>T/<OV+PE>ZG4$0JIQ4=5?O/4I$**A7E*D03B]?X3]3S=!F7TP, ,L
M==^RKQM1?.4*?\(JGQZ8]$MM'PCP(VE<6(S8$#4+#A7 ]=9 ^N\NAV7IW!UF
M2DIJBOH^ ]YF/]+6W!V>9C,$-P5NUUH>)_!J/"#K#'R9R,_;@_UI4"#<'5T%
M,7V<OJ>?Z3UZ*:A?+F&8O$A+CW)-N76@G!_-G<]>*S$_=C]"7H,X0;\=Y>J]
M2@]-I0:0MRKJ0!1.RD;R6KUPAGEQ6F$/;L5W[]3T8]VI'__NY5<,&U3@#<R;
M<KBOHKO+!IUF\ @/;V&#MWP):!B-;>W19_2O)$XT@.K\%"0]&MSN1Z.?L] +
M6(*6HE@"-;K7//PXR%2D*;>*/EHLG%[_>>6,OYHY3&E2@6V@4]NV5V:8^Z?#
MNP*T]C-V20U'-%WDA/!Z,&MU:V-GE-4>^H4K2I<H'/[X-[K';2"S<3!C)-7\
MT-)%XH/*F;6UDP+Y$7#-MOZ/LV+2QYQ*^\=W13M:T8K\>/=NU.L;O\=5% C1
M]:QA3P'3S &&0J"O2WB&VF=R-*?+'7<#^:Q'Y-_2]V3)*07B.L!O":9"7\A+
M6)U7'7:50"V+_U D YOQ9;()]R'FNW4+5@L?M:D4_=,K?[:2/7C*2.(;+539
MA=Q[$&@\/ .R?[ZOEY+WPI:2U>)OI_;E#&L@GK;&^*X[YMXMA%ZC@?EDC'OO
MVR#;6#>X_%;>1O@K[OOJXR,B%'76WOE=BBU#W-E1;*QB7>%CV"_+.F,*_#M\
MVS0S]'P<U#*7)'F.$R6-OC<W9* W)[^SQ&A)9Y,BF&Z7LVZJUD*D8$4"IQ;[
MAX/&ON1(2JHL$-OA'<*#>MZ=J))2!3JP22F[>3[L<WSW\4'\>LJR4LA7++[2
MI:%CM;!2!+[\)O_260+:*WVV^@S0ZLH:OQTW*%C=PG+<33 >M?/V*=8M0\66
M<(!:PH>)X*-X[K_<N>@D3,"B87R2[;AOJK%Q(Z_H0+S%VH!24O1PHNA'#/MI
MG?_;7;3_(])S'W:'-- "88%ZV@-?P^YRK>PC9A"!(5](T\U/9U<BT\) AD\)
M#%_4AU:^D4X.IJM6,]\(#0=];'"ZF=1:SZ8O;.3L?)<$":A=,*K420;LI@0;
M!)YQ>MBSG55P5Q2&LD/8 K=^MAX0>5W;% \Z7;4@V,O;)6BW+6P7?>C<'(NS
M]#4XJ/7H>EQ(UBKET0KVH13S)X:JZ3*&$J+U@_8_YTJ$U5(IESX+PU>NG=V-
M1_IA[3AC)F,L!XH?0I(\59H'VY4HS5ZNM-S';%9L,[>9>HZCUU"U$581O$A)
M?B)4<05)LZ6!M%YTHOVEPQ"A;$W-"HJWP.!P4Z;@9#?VQG>2NG(O6YEP(PU3
M3A@.?<ED1W!];GIOK^K"<R9E57-RJL\I2ZME_8<K\O-+GL?E+L<MWDLE843@
M:>1><[*!_LYB(VN@89$_6*^""YV$@_A+ &LM*68_R3)S6UL3;XUUF^-MPZ!N
M93.RX[RZ2RUC H^/D<*@8C H(MQ'XF.7WHT/=V2KWFU'<AG#Z:BSXZUGVDT5
M,S=UN ?=AV(F%]XO2AE:/=))]0-7._/*(W<N-*[MQ4QMJEOS=45MRK@AKX6-
M=,NHW0@7^MMU,2W5OE!726($,KC$!KL*0NJDHY2DYWE0=#:Z_4[CM?"J7PL0
M-]&%_D(*(G/P%[U_DS87W1ATUA(<O^094BUF8A)OR_K8DN"_\94$9)#>72#T
M:(ZE\UG$8W3LQZ+Y@5BQ>VP84?#^ZE 1_NAL%$VKHR+F!I>6VV^"N7.W[_4A
MKZXW/E#NO.6M*+3+![>BA%=.A-&>)<ZV4K.2,D>!^<ZP5VXWB5WOR@&;I.Z%
MVQ%FKLLNJFT-T$0@74N*>;*1O,!3C9-')=45E$MXN]?+^VZJ%VO]H7V\<<O3
M<H=7*B#J:G,*+),G^<W;M57CM?9?C1"Q$@E5]''LG>16?.DT>91IB&460S;2
M$K%\99&QK_5F#/FEZM7[+PY6]M^ZDB.=@4"M>)QCK3CB 9NW1?^E2U+[)F6D
M#@JS(!K+/<=[./[ !Y9O:J\Q4SSX[ZW;DUOO=SS)_ TKK;Q@\/UG@.1Q7PZ]
MVU+/_I[8DZO6A[QQ ]7K/XF$_'+$0B5*X9R(]NH&!=4JNN;6,R\CH=#+)+96
M+_W[/;;@1NL[^ZAE.K.F,$/N7JQ@8[I+ _CR;D(#=-G],!(%7_PD*+$SB6?7
M7FT6FQ&,9EYMFKCU-=!+:-&50H4YW3>!3_-(A#G#O W!-_(>-S'KDC]=525E
MT2DK52E(FU2.Z>+79NE@VZSB*PL;9O(W! $%?_ E5 @^)_D)$.F,VE!\!E^C
MN10XSLD)U:C*_"!;8#RA">UWA>);M:J^YZ+"#UNO9.106)NQ+@/K-V&7M>4F
M<O9S@E-E5Q)PC9CE;ZSDG(ZFCE+"JUF3+(EEX=;?#0540H"E B0,/\]0KX4
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ML&;4#MN,'9'.^<\%JF?8--$D,Z(140<+RU.([FMN<11<E+CJZWI-X]H=G3;
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M*R,];N@K62Y=SK#5?HB9+G?#62IY6V>7@[4:.@@R]R3!!_\+]=[<^R011E3
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M2<83%HG&BW_U<Y#3,)3B,WJ'2Y+2ZU3=O R,C/54'CV-GMLHX\(;[R.?B+8
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ME_3/M]_SA7YQ/FO\B=#LYI#)>>3;RZT*8GJ4B*W%OMX"&Y11_JYZRS9\,O\
MG,SS;_BK\^_-,4<GJV?E6"UT&W-:T^K)ZLZ^U+B>49Y6) \?EC=]^V)L>N)G
MVQ-C2N^V,K3^.4<837^W*)K^H8T^^-KV/<Y=>F_7-7+[]0.V.!IT%1BJGP.^
M+*=_?#&P*F\M.I!F0==OM#YYZ&\[2A8["1&:@LXR] >NPH,(/+A^L7,2!B
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M^GJ3G5[3C59DHD@H*E3Q7XMN]!@BW\\Z?J$TNC7D3+I6H_N9#SY&+U  K*:
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MQN_-375\US?7FI+9PAP:*KE>*J1M^UGHC4[A-*L;+3[:R"I;1@%C\(?;=59
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M;6PU*[,:>J2\TK$%W.Y)CKU(\,7FO[[5HJ0RMI.D; QI_?SH.Y?J*^& [>S
M]-K13;+&0R2JM'!7<,"-^6=-\OZS8W+BRU40V>HR;+,X].*?N#_DL>XZ9+KP
M#3C5K0DFA5B.*-[JPV.,CU9R:(HJ5HOPU^?04VQTP>\*!Y9&#;$ D ?0!3$F
ML(H7ACCLI[ZX=N(X;A0.Y[#(EYUU*WTQX]/1HEU290>)(X6R?[\D'C3HO<Y"
M;;0)M2C662#A:PCFA=2);AR?BDDKN#7HO;$=2MQ&B0=.+!@%-*$=,,]&CFF4
M&6JI'TION?'':Q$&C=.>_%JA=STK\QG _-^A?I[2[[3F4_6HBMS:.PZ31'DI
M'OM0Y/ORU\P/J?EZPM;EC%J.D4MY8G^WZ:"BD@=:4H?[<[K93FZMVB%!3I44
MVIO0'">XEO\ 3)))K8['[2T[?/?%$U5[Q!Z[+&Q&ZT_AA%J\$$W!)90 "&Y*
M.7WCM@&T\M6+7!DAX7#JG([UH/<86OIU\;J2&V$36OV[A95)1(UIS<'J !7;
M.;>8#_B'4)]0L7*Z7I$9MK?A\+[?MTKWIO7.'>;Y#-:A9XEBNTDXRL!3U%ZJ
M0:UKOE>1))8M,>>J2(W[M%X(H!3[1'$5ZFA/4]QA%^80NY8M+ADA*_6[I$!4
MG:I_4<KS#2&:SL(V BLH$'$;T) _ID:<]!T_' Y88B6 .)G\1VQA;:O4XDW;
MIOB9K38YJ@;'H,:?O/Z\W\,U=AVVRAX5ICP/ZX[Q[YC]^;+'WXX'\,QIE'OG
MU8_YQZULZI_SA%^;NGL_)O+>E>;[%4)%5273&O!MX%KIOQS@W_.?FK_7_P [
M;#3U?X-#\LV5LR]A)+/=7!/S*S+]V>'JC&-OB9(.,KT\,8<2/ZLHUJ:FI.)D
MFF^)D_2*XVOMF)VVQG?I7*Y95>G6IZ95?#'5W\:X]23[XLIVVWQ=:^-!G7/R
M?D0^9I[61B%N[.1=S3=*&OT5SLWY??5[77/-/E]XB>5RUQ&6;E5)AQ/;Q7.1
M_F#I-YY7UR[L9%GN+/4G#V_ ?"E:^ Z=<E'DSSE^B/,&F4C!;4K=;5U;G7D2
M*-Q IMXG)9YXMA.T*-4,><@X_:&_(!>W;(]%<LQ',-+9-&A9GKZD3J*\2*5%
M1UPZM9FU%]&EBD%N[W'J<2W(<5Y; BH.=GM;U;NVMWN5$=M!6"* TWFVJQW[
MGIX8,L8WBDF-R.9+<?4!^'V"BO3QP\C/)A%'(8%6@(WHO<[DU%<3DT5+TLR!
MXF._J"M?O-"#AGI*^;]-YG0-9=H$/%[>Y_>0GQK'(&4_, 9);?S!YYBY1-Y9
M\NZ@["O/C+:N3WKZ,E/HXXZVU;\QI&"?X0\O6((J7:XN)@!78<2PWPQETSS_
M *A&4U+S)#HUN:KPT:#ZN0I'>5VD?[F&$EKY?\O^78S)<3M?7;MRDN)CS=SU
MY,26))]\5EU>TN59K4CAXJ*>VXSGVK2+-J"0PLQ"FI4>/ATR5Z%IMPX<S? H
M[KN:X9:SHLHC+JOJ,/B5Z<2?8YQ;6X7BE9G(1Z@TI3<=0,CU]I5]H]]:>;/+
MC W %;NR?:.<=V'@WCXYZ"_+SSKY5\X6_P!6ADCMM<1>,NF3 QSHXI7T^5 X
M^6^=*N-*@EC:.4!6'0,HY5Z?/[\@=]I"V<Y0QK\9Z2;5IX9S_P Q0:BLAGTZ
M[],HA!C*@AF]BVU?8X9Z/HVH75G%=W?^@1PH&NKUF].-1WJ=NO6@&$'F3S%8
M-;W&EZ3<L-)?X9[R@]6XXBHKTHE?[<Y/"QM7FEM#R4BETO[+H>S+V.U<XY^8
MK%+F&*U(9;YQZ!8%1R:M<-K(3:9(+=[556$K$%D(+4 &]:GK\ZX&\WM]:\P^
M5+%HR(EE]>A\$'OD%UN82ZK?R*-C*R@'P&V$K,2.OX?[6($]2.G:N),:_1XX
MF3[TI^&-K7;QQ,G;KM]V-J#MC*_17&$TS5WRN1!\-LL'KB@;I[9=>G;,#C@>
MG?+_  S9LOMMGT#_ .<5-8,O_./G_.5^@LU%L?+%YJ"*>_UO2=2B<@<NWU5:
M[>&_AQ/_ )S!U/\ 2G_.1/YB.'!BLY;"R0 @\?J]A:HXJ /VPQWZ=.V>9C3K
MXXF2!]&)$[$8VM=Z[?KQI/W8PG[ZXD>]/'$SW'WXTG[\96NV-/N3C">O8XWE
M0TRN5![YJ^/W_/' TK\L47\?Z8L#N/#%U/>N2SR?J1TOS)H]WN56Y$;A30E)
M/@/X-GIO6@FE:I:Z]IY,%[;IZ<R?[^A;J*]R-B,,>4'FZYCN)2DZ00GX30L:
M[5-?"F0O7/(Z?78M0@@8SV\JLGI4VH1M6HI\\E/FB$6]I8RW/+EQ022&M:.!
M0L#OUSG0#1S"520UPK+2I!?@/M"OPFA/ML?EDBT5*V8,9/J0W!5&78D.*DUH
M=USL6BV3-%:F9P$1>?*M:FNY/T?CDP$L"M&$+1R@@JK4W7KM7O3#2U@>YNDD
MEA,8#$L#LM0.I&3*WB$G"(JS*=]^AKA]8Z9(KDI&54[[?KR3VFD>BPF+\2_Q
M$@?$?IQ74KF"TB1P_%.-2%%#X_YTSF>IZ_/?-+;V[,B(C$R'9:4VV.<CGO;V
M>2:/UV=>]:_$:;UPFN;R]A0"-O3%:%%)!/;?^&2;RY93/<Q7<[>HY(X\]QOX
MYURRG NXHA%$R1FK^D?BKX5P=K]W&\)*JZRQK\* <>0^7?.*^9;*666WDJ0G
M!O5#KW/V?IWSGTES=>DMOQ;]V2$X]Z[;U\,C:>5I;[4/60/&T=74HY5U:O[-
M*&O<9V_RU+^82I%%I/FR+4X8^/\ H>MQ>O\ "NQ"SJ5:GL3\LZ3-J?G@6P6]
M\E:)?%0 98[R=*^-%*-3[\(;O7?-,2^I8^5= T9Z ^H?5NG6AV8>H5!]\A=[
M8:YK?-]=U::_D!JL*4BA7P41KMVV))R+ZAIKI 9$W9!Q)/38=#UW_#(%>1/;
M\BA(AD1F=0 &V\003M[9R/7I!)JNB)/^]BAF,I-031%Y4  ['"[0;G4O,>MW
M,WI^G;_6&G8@DK2M-O<@8<7\BWWG",KR,>F6KEFK7B2/V>N<XNF!FF()(+MO
MWI7K@,MOB3'8[[TQ(U ZT!Q,MMM]&,+;=>OZ\19OZ8TL:_+&EOD:8SE4]*>^
M6-MNG?+J.G3,,>,=7Z,L;]L=WR^O]F7X;9O'+_AMGKO_ )Q;U,Q>6O\ G)O1
MN5/K_P"5&MWO'Q-I"\=>E-OK?CG(O^<@;YK_ //#\V9V+$Q^:]5MOBI6EM<R
M0#IVI'MG'S\\3:N)'&'<> QE<:???$CWZ_1[XPG?K]^),V)].OXY1/OM3;$R
M??KC23TKTRJT^77'#\<>OM]/],=7OBRGIM6M*XL#T%3[;8*@D=9$,9/J!@RE
M>M1TI[YZKMKZ7S#Y8T^\+>JT</QK4'BP%'4FO8C";0+JXTC45DBF86EPW%HS
MNT9) K]!ST?Y?NM.O[+Z]>*C3VSE6Y@!2*T%1]-<YGYYU>UU6><1+46P6(,M
M#&:$; ]R#[9S"WGLT]$MS07!DMR@!8+4'[&^VPVK\LF.BB>*:SM9N 4"O)C2
MI.]36F_3;.W:/$T2&W<"."(%>/@IWIT!'M@ZW6-KLK#(TZ*U"U Q6M!\(\1G
M1M-]3T5A6U5UC<*2-OM?M$')/96(#<I *I7BHV W[9)T0PA6 %0023U(P7)?
MI'&0Y#L152=J?JSF>LW_ *\S(DY>17^(=JGMMA;J%E-;Z6Y6:)9YT:JRBH-0
M=JC<9S_R[91:G80W$3>M'(61G3>CHQ0@]>A&^*77EUQ<@A0$)H,/;3A8/%;&
M'H:!@-EKL.7WYU;0=,A4IZ[QK),.6RU(PZN?+L$\3.]-C\#5W!.<2\V6;Z?.
M+5CZPD-!W^$>(SDDUM(MY.%'PL2>/X8>^78Y;/5+:=H@Z %/C'*@I6N=/:PB
MTV>*_L@$$VQ"-3<[_*GT9TK2M1^O6L0= & IOU]Z;X"U328+D%70,ZMR5J_$
M#W';(%JU@L"+P4+Q;]DT&_2O?\<@>JCC%ZC%?5+4?>M?:E-LY'YA(Y-)%R50
MI[U^G<&GOG'(=,>_\QQVB \EM9V'([4-!MT\2,%)Y=F\DSK<0W2B"Z#$Q"M:
MG<.*?=A1%++"VIZA&I<S1D2%NE#7?\<@3M4L:=233 S'<_C[8@S;],8QZUZ8
MB3UQE>N)DG&UZ=\H_P"8RJ]\=M].;,#T!QU:X[J>E,>"*9=:]?'+KE@T^G+K
MX;8[QIWST!_SCUJ!L]0_-RW#\1JOY4><+4CGQJ%L#<4I^U_<5I]/;.7?F+<F
M\_,#SU=E?3-UYAU.8J#7CZEW*U*[>.0SM\L3)Q(]<9['&_JQA\=CB;;$?YC$
MS7MB1-.XKC"=]]J8QO\ :Q/-7MW[9?\ #WS=*#' U)[#' ]!T^6+(:=L4!I[
MG%XV*D$&FU-C3KUSJ7Y>>=O\-7+V5[ ;G2+QJR!1R>%J4]0;':@W&=SU/2K>
M^,=SI!6>&Z42,]L0*H10!230;Y(]+T?49[&WL(YYHI@2DO']F-JU)ZU)&&OG
M?RC::-Y>AEA6A10&#$U()!K6N<5M;>,M 96*B)BRUIU\2=CUW&2K3RDM]Z7J
M2EYG:G+<?" 6%>)V-!VSM^DW=M-"Y@8F!D4,'))2HW"GO3)+:B*&W::W1G6&
M12P%>A  ('4YTBP=HHH&6HC<A^@#5/4$]<D$49Y_NT6.(?$.Y)\1@H7H1RE0
M60?&O\M?GD4\RZLL$((DXN-UIM6GOX9&M&M99HY+Z0@K*2R5:M =Z]:U/;$=
M0N9# PGCE_>#8A/L)T/7WSF-UJNL^7XKVY\J+#<13EI&M+A2JM(!\3QR#92>
MX(WPFL?S5\P(UJ=<\N%K>0MZPB91-!3OM\+ ?0?IVSJ^GZM;ZG%;ZAI+I?VT
MJ@F@^(=Z$'<$>!SJ&GZGRBC=^"D+0>WSPSN=4=;8\275C\1!J/F1G(/,-XKW
M,EP\W)F4JB-T&_7.4:MYCT+1KN&WO)_5OIAR$$ YN!7J1V&'RW\=Q+9+%&UL
M"P9231SXD#VR>VL\AA]/UFJNV]2/XXO8:VUM5@*B-J2HNSK3N .O7)A%K45R
MW)3NJ@!ZGPV--LC.LWS3H1&E/B(9Z[\?;YYS*]DI(TA+R6X<T6E1N-U(Z[>.
M<L\PD/&5C0JTIYMR^%E"GIMU'MG/]+F6S\US.4:14LF2-9"0QJVWQ 4I@#5K
MN:^NHX[@L1QXQ* -A6O$'J3D>UB86VDS0NY$\C^G1A0E>I'AG/68&I%<0=OH
MKB!/T=!C"??_ &L837O_ +>,KX&N-)/S-<;^&-K[CW&5T.7X9JY8QPQV_P#9
MCAMFK^&7ME_++KEUVVSJWY.79M_,WF%*J%O/(WG6!RW8?X9U5QQ->I9 ,YYK
M,RW6K:I<I+ZJW%Y/*KUKS#2,P:I\0<*CUQAIB1(Z[5'AB9K[91V[;XF?E3$^
MI\:8FQZD=L2)ZD'Y8PG8[8PGKVKC.G3-_'*)VZ],JO3^F6*CO[G%5.*J16M>
MOOBH-:$8JIZ"M?#!*-4]>F3GREYRU3RK=++;-]9LG/[VU<T4^ZFAH?HST#IG
MYS^7U:"6:>>VD  =#;O\(KXIR!I\\!^>/S9M/,\^DV&E2O<0J_IS.R,BLK"E
M 'H:GQ[9&+%N%K!3X)$)$E06)%31M_M'H*Y)Y_KEO/97_HAK=55BR@UY+LQ:
MM:;>.=:\MW<<]I*9I&9HF'J4I0I(*(:@]\Z/8W*0ECZZ^C'3FIVX$ ?:J1]^
M3?396N!%SH\2&OP[G<] ?#))%<<BU#\*U38]AV[# &H7\<:A5 56''F3X=L@
MK"36+SU98G6SMR1S /!B.V&IFB"JJ,D$B$$1Q_!UV)I0G?M@748EFAXLGJ";
MY5%/$5R(FVD@D=>*NO"KU5?AH*#>IKD?N=+_ $C6&:,R3FH=E'$NM:T.W;"J
M#3=1\EW$=UHK$PS<F-H['BP)J6KO3.A:!YZL;\R_6+<6.H( )K65@'7W%0 0
M>QP[N/-%G!#*TTYA5JT7E6H[@ 'PSC^N>99]6D,-@KVT+["4 ,S*W2@/3?KD
M8T[RTBS"ZO)5N9I6I69 P<BIXL30]]LG:6KQS1$IZHC/-./8]"">1\,Z18^C
M=0)5Z/,"H-:]-_'? US;FW/UZ*4%HSZ<M!0<:[,:=2/U'#:W5I%I&0B\=E!
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MKT>]^NV-LC,WI%>1%:?O/<^!PYTS4VL+DQ,W^ARM3O1&R;^H&HRFH/2F-Y5
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MQNU*#?B1G'=.-_8:I'Z#O/<79E-NUNR2NT(.R_$.:E*TH:FG0X;-,]P)8IU
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MSZY=FO!404V[X7_7+^8CG<,JGP&5*'4\'D:5VVH:[#$9 5'%5!)&_MC$MW4
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M%#]&&'U,\3 8@+HNW%Y4^$"O04)WKT&!I+.YFCE=.1>"0H0BJ5;Q++U['8#
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MM46PD-97>,_#0;[]L.$82IS2AC&]1^O&20KOT[T/?Y8%,*/LPXG? C6Z[B0
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MVX8[\:?=G5=)D'!17)A;'8;X<0],$\01G/O.GY8>6?.R^O>VPLM81"D.IVX
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M<*RD,*USR7^;GY%6=Y+JGFOR3;0V?F"[9[J_L#Q2VOW*_'(H8JJ3$#<U"O\
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M;XU 2E*O4T/3I[XG&\<J_$PY$&H +?,5P-+:MR^T33:O'KX8BD(8@D,M.JU
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M(CJQ)Q53SBKZ44X:E#:MZ,H5=OLG8UPKO+V)20TBS,*CT;V,QR@_LCFNY^_
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M+JVN$66&:)@T<D;@,CHPJ"K @@^&-Z=,K$I,);XT1LBL49:<GKODLLH: ;8
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M*)_FM(70<B4B+<&JY=80.U:Z\[[9?E)H]M>\5DNJI$YUS/QC##'<4=FMCQD
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MQ-O-> '5$&]OI],MH'Q7Z&X0FZLS..+*7('7953*BU00C2MH#=5&%0GH*Z=
M%(AX!H?W_Z^7_PV&R9.]=]7=(M\8_@%0G]J;7IENF;5+W9Z>%QHFI;P-WC-F
MJ#NP8.5-!;165N:F1L3?GEF'$55(A]4RV[5,D-FT\P_P.*#UL$$TOQZW'<'
MR+6(O21?01Q=Y$Y^DIF'#'QI?.\LQ'S%U,+1FZFG6/1H^HG,Q,GI :S0TX"(
M:#FXA*K]4OI^B7Q'FX:C')=)8].^WZ!<RLP759)F7(G6[9\-SP(\A,%7UF\V
M1Z@AG_\!R$SBS-A*V-H[3>O-\XB]IEBT4GZBW)QF#C54_][RH]UL@5"*JHAS
M()3Z +@0/=LV>BP+?.^V@6_LWA-+.,N/#DIQ6MZUJ5T5EZ+18\,"G_0EVL37
MR]/),0Y>.S#*GMT\!(/0_A?G]>_/_P902P,$%     @ +E-85E$11'J,( $
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M+U+7Z[_<NGX^RW,0P[E3W"#O'_KR3*7O\W!$=<^O^X['G\ BVJEG2U%C645
MM-JH9Z&U;.VIF0&;#%[*PRF6-W(LS-5L%%?Y1Y(&)@0<IS$*/T>]B)6]._-]
M#.5J?\YF!=M+8_3&^&2LA:JG?OG8D B(UO5$#4I\Q;3&:O2&+V%/[ V!D5(Y
M=ZWL>/]A[UN1_>].8_5'*5<C($/5X/Z]-9:GJYVEIM'%R.Y@$4(LW@J8H@/1
M-XZSPM:=F< [ 8P=5 ^*.>A3O>LMUI@P"O#/Z6J.T*\?P38;&C+<5:X5KC_H
M67O4M<29><) W:;<1905!H=#NY%KMU9*".YO[\T4$?W7P_":1IHTL:A]OQ<
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MW]AB(BH%KB4S)-,N.[U$@I$OR8[F4\3^#DC%[^Q$"ZB0JN\7P^<0(J DV5-
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M2BX[C.I*DIF:YP*<&2X$_5B"28K%;<B,2=UHM>E"WH=\*V;1E"K]> #<@G+
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MK<ZM&*><LC"OK5<PTD@B]OJ0^FB6\QU!BH.T'OY=<@B4W47X:^GK #K9PME
M1BPU87_^2RH%_\/K-Z%WOI536=K8@XFO(BW+)GM*AK=1O_@:.,S$R[-EF4]U
M XT(Q5TG4S-E 8D?@MNB>1RZA-IS\]LM7@#Q:C>K J5@CFQ^8S\?_<6-P+$!
M@B(9Q3Y377(#UR(O,I:YHA3!\+,W-U3F81/L/O1\$U/K7@SXB&]!R8%&,P3]
M$"G_'T=X7UP.+H9R*9UU3$#'NQ ,4G4M\7:K!?#UL,'J-XKN/YNWE^,EGUCE
M Q$#MC25W&,8XF'_"EF/?]4F$=->T#[R8?OM?-!8QW56 M 1<\+;2,.,ZPA+
M!$^]T[K4<%0TV>0O"GU19(/"C]TO9$9JTAA?I*GJ_RN1;I\C#B(.5I^M'G8D
MQ^,XS*NG$Q%AW(\#=4+VM3 (>^((J8<A28SJLT&9%ZK=UUXJ-R=01H[P)YUN
M8\_-UE7P]3A=A-MI+/]FZ]@,_,_=,)X;<"<Z<!N2=YJ.<JU/5%S 85J2$((F
M_R3'^QGOZ^4414#%3T=@YSYF86/X*P8:P_2?(_&%+7Q[@G]2;>-/,/H*BB@Y
MYL6Z/ Z<)\""ZH^=<Z!XDU?O];2CB+FH->C1^/:&/XF^.9R72+3?U(C0-;;+
MQBL$89! @E^+(F@!@N(21C\[V^!/CHK-TOCEA:VE*J][YS^?D(N7*=R<CHE\
M9#ZDRP&91I"#-0"!B-]O+I5L"/KD+-76NH@_2Q5+4B9)6>F0IXW^1@D<10Y=
M=FI['X53I\]?1H/7)^RO4&3 .J[\726<N9B'_/FAJ#VAR(<LJO)-P*2:)_*W
M9FIY/OZ]"9GE\HI@P:U\II\635YO$JH2F$3+;2A>$^O"@8D:=<?K-X<A2"W.
M8?D^B@2CR%I(& [H6\V+/XK66+DLRXRWQ>+>K'LO!Y6D150"N-)6]N081#AP
M1:AB12V2R>-$4"C*1 69_\H@_2:N[0/4F-?2MV([,7E*.JA_(C=P("8AOA^8
MJ!$>XD@@,?CE'DF>I",#E&T>;L;P9E*!9E32ZV?) 'SC8?J'4BP)8&F[1&4C
MI83DY311(='9,C26W8^0+87JWG$RZ5=[6)KGRTYI\CRYQO, /B?2Q>%QA]Q
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M3+J3ZA)(_)X[6&1$J2>1+E.3;]Z#YY*+;S7IVGVRW6G:')*RGFLDEJW#AO\
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M R@W'MMFKR()[8TC$_UYMOIS;CIE8T?*M=OOSC7GVU1[VYABE66?7+*.W*
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M)$M4MK>-K:WB,BF64*\H+* "%9 J'WJ3_DUS@>M^66TN6XD$#7%])(67FIF
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M3A;YVNK2\22ZLVC1IHZ^H@$3(M-B*#8GQZ^&<G\FZ5%=ZN\]O"A<PS-+,9"
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M&GS7T\\@Y;\6>.U9 U3_ #'.->;ORN\^?E!=OY6_,'0VT358OW]M(CK-:WL
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M]<ZIYJ_YQW?7KN V\*1F.5R?1 +QLIVY 'D-C7"^Q\J^:O)LDVD^O=:GI,(
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M-J'#30M6N= UO1]>LC2\T2^M[^ UI^]MI5E3?YJ,_4Q_B'3/\-_XK]1OT/\
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ML[C2[EY"%2%_55E[%0.!!Z]1XYXI\R>?(+.[OGN62<@A89 P!*C]IB:9!/\
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MQRB@Y,H +;$[D &GAGH_R1J3R:6)(%!FC3TG4@ N58&@KW(Z#WSO6A^E/8V
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MR^_\<K:O7IC6ZXT'+KT/;WQ2&ZN;1C):2M!,5*!U-& ;K0T)'S&^=7UW4_\
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MJS7#T$E:&7=GV%5]U>7/.DMAH<NB&=8GBT@7&FR0?N50V\<89%)Y*4*$(0[
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MXEP5D:A*I$26DA I\3&(+0U '(_:SP[=:F=(U<,E_--/I5K/=+/)$JK:7CW
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M?6'9OK,LZ$3/1O5MV>%*!E0/Q'+NWR!'G#5[-8'^KJTGJSVC06K&,I-<Q^O
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MM0O(85?4KR.-=09/@,EP6>L2D"O &I<T4+3C4]>RZ3JD7F?S/IWUFV2UTC1
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MLZ?Z%:DC961ORFWE$]P<ORA(Y85:CL6+!6,>ASI>VSZBYT9 *S.%;E/HE52
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M463Y(<.M':KH8BBU8=6O&^HI$?L3?G^.KD\Z'9$#BO6&XO[?EY@T*HB1'!K
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M,:+IDXXG0Y<WTV*WJL>J(*7PH0R:$0P?Z^"VE?]LL?8^F HUE?X#09A/"EH
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M*#?5> D0$%.+YV=G?5_/QX S,-(#AA01,$<4R3R?*S>%6KCD,J?K"'\=)9?
M6EME62^Y2,J,119+2$^TD07*1!6L#ZXJY/+GA^V[!]")U 4+?&<?D 92L8:#
MF/>F[\/$TGA37=P4\F.X/57K](!A!UF^USV\\8/@OJ2*]Y_/P>4)B<NZTN6W
MP#+E3A%E-W]ID"62-THR&]\Q7#90PW9T8SDN 5B:;BFX K9^KLD:.8#,2=\>
M"*Y1XQ&#;M1> DKV4N^H-U&F]BF.LB<?CK?#LY"9\)S53'N[>_;$K@E$_QP0
M>B*T+58$ORKW[6*^@M>7\L QKQT2K.1(_V=IN()Q$?B8"GSL'NG)52Q17UBR
M"W^O*4?S(>_!Y_ 2K>O4A<!D\%+:??EX%G)$%9=W2G[@FC@1S4#\+8Y]B59;
M]IP]>WYE*#CK'E.W%_[@JZ,4-ALZ&Z'.H6L1>?Q3>35[4<&R$0[Z8JQ ;YP:
MIY,P*D/^HF+DXE'-;>HJSU"6@R:&M7>/_%E,QU'F^7\.[SK]$!+P!7:[F\$B
M_SPR@_-KLVHY&HF_]N4]&"C=&9=Z9;Q*O_SMWF.IR9I?WGU$P$J,K\?G>_->
M<NE/]H?&.;7M!K:-"B*P)+\L([<IIS8+F@_X 5W.D?C@LX?;93_\FM]D"SJJ
MF\W[4V*IB=\;OJ"Z18@;%3M??^%6LBO#(XR3\592RL8M$>&4N0 +U?7R#J]N
M0\*A^J"]81?J?L[F]P4?PUGVVXMO<_@0YJ86''TX:D.5%WWE[V;%FB+VJ$?7
M9A3J:[<GJF/NLWD?QA1"AYAYIMIZ%7HWO81)^E[A.P"A'E35W;^,UQ:Y<F")
M)16>-U>W]QWSZ<!*_$'*'IP15?OT$<J#!8ZXW,V5M*\.^0=KDR?Y/+\L%2U/
M_L:W)'GGFM[)T0 MCY Y@V[,!&ZM$M=S,8:YF%5!F]T0G#9<_*VU77\4)W#0
M-S1V,G%)SSB]($+>;"8(*;P%JW@KW990D%H\/QH5(3$OPK;E'"V]4/[&9"GC
MX1I\DR'_X!+PH./7)DC.2\^Q$T\U_42T1ZJIB25M!4A?\.:IUJ)5)';[#OOC
MKJF!$(JJJDKJ;(JMW7=%.0(2^4/UJL;75D]5"&:4D(E.?C2=L+UM%6MQ_AGP
M@O.!T7V%&_[.E(S57O:%R=..D;"-9!'W0J[?JO(A\M-06LTRX=%'@9GF+T;F
M7FW_W)==#)P#HO.7-=UO[[.]:/+4X2(FBGNYXQA/A)BL8BF^)[0>[RLH$:_7
M[LRQJ<U.&S;J2LN?2MAHP>CEI<:HB8R^4:?L,$,DM&QA&#AP_RT($HZ&#(J,
M13^V-C_AW6*Y[=EAXF3);?TPPS/TK^ZI0&"S*W1?Y]E>_SLN5*9*TY:VF<-:
M,HH(+AJN><I=(JUO;!YT]D"JUBHEY9N/%FUW4W?SN;.363<PA%(/( (FS[\$
MD*DWJ^[?ES7M2P;'XXJD*%N<[+'\,/JD9(UIYF_W5-U##X:_T37 -N_Z89,/
M$QZ;WP%T-WOT(5W?35\"!.%<<.DKMG-']K"F8PZRQ9KH>*:>?5E=9M!^TKP4
MC=O?T>/B\N6U-V548G%JCKK*;1_"+P'(B&A(M$64]@C\K0_#IEL!UP98]*?Y
MI+<+"^_.::WP0Z&+MFKZ$5YUI)K*O_EAGFQ1_#]X@O\)"A8$_"7@$3OA)F'C
M9/FI^RJNKN,@B+W;*#R8B0%BN9J-R:=\:+X_JIEQ">BFCO0G;E\-(8P433)6
MW"PKV<+BS8;8,/G!RJ(_IY9+G?SFY#PP<IS5*\CJ9+FNL.>%8:6(Z\4Y0KPB
M=7?CV#EU:=D-!%5WZ*75C'VF_UHU6UM*#)T4.JG1/%]7_/-='_,,4K)N477_
MI9/!)8 C72NVC):!RT"Q(=AQ=>OHK-:XE;8]#(3<&>X.:&X >)(W02I@YC$Z
MXQ5P?(*<?@6B<3$CGMU1DFWWBP2T0O'@$\A(_VOMQB0TZ0Y4W>X+%DG$(O.P
MN#FT);+0IBUN8SQOM/F]A!:X;VQ6ICU?P;U/BF91*8QD)E4L3?;W_I)YC#KG
M^4$7;&Z7=B&RH'GP1XJ7_4]?N=!Q64+_<+0#JB*[3NJ]QYU2O/7W)CKYF&OE
M 7""U5>-.0F(Q]32W>%7EK=-V;!#VL]8U3Y+[Q:4X_^@ZQ!7R?LJ@'DW#;\M
MP(^0W&3)A=_G!5A;ZM0X76LL9!#,?MF ;8=C:8*W@R\!@YP@@PQ\)\ZR*+CX
M,U\.8Z2LS+>LQ6ED$N&Y$7%S;M,-U<C)BRLQS,N%8>D<["3J,9QO# UJV@ G
M>>;BZN>"\AR$]("EQ4S'E83'H4O>0GK_*-MS(9@PLK6[*E3F9*W<U;*]%\K[
M*#_WUA:V.K.6])U>4^7E(_GXI::P%T/EJ5W+?J;RFO86&_PZ=7O4G'(GY2M2
MA-]NV7S ^@EYLRQYTU)O=]A$R/DA;3L"TJB'"%E.'VJJ,_5[I'LC@34D[Z,Q
MV)R^).KCV<<7M?NB01'L^^(N%LF4DNU5Z$86EB).50#91C/3%MO<PT'EMW53
M$I6>GI3&]9@3VZ"Z"D#1KU3/Q:A/6:TW?[+JT6L$2*$KTF,!R)*;-X/2C S:
MA!3,6:N<]*BDR L6'5<^]"SG2/]E "P:3U@]5Y]+H^:GT#WO-H"\-E0I>",M
M=70)D%C*.3NRB*$=BG4W>J;S1_%A_LZM ,-=6I=74;]45XJ12O/P0O<I^1M5
M1KWB\Q^-+U@KA@_&3:/-X&-*)&]2P(JV&\$?/;SGROI&U;]:P8OZG=>I[L/E
MX3XNM>1XNI'TAAJDS26 'XZ=M]>>B"ZKB0[S\L$N6THV-,>6=S0OR+4NB?Z<
MT7\=4QYO-F4_4OMPF_2RR+W+9NI3D+C8-AN,[76Y!G?CY\^QHGN%J3 1?ZWJ
M:B5UNL#_1-C_XNT?0O<5;^L)K(3U+ /L*K>-4<U0*5VH(?4/"S,]\CEC/P]!
M.9&..>('@@^AZ1*@5(QWS1&3!@U"%1<)Q5,/(*)W1SYXU[VABRM#"S[+3@U%
M9Z1'$HH(V01A0AM!6:2Y^^UJ+FS\C>W,<<+R3+MB2EW7A'V?<TON17SJ!ZV3
MD93!.WE'K%5;'HN+Y/V^F$GR]-=0IP-CR><^9(S]AW@+%KNJU?XNLEG=M$%4
M(J4P6U$M&@2*/*>[&G-Z1901#J]J:92LKR-;)G1('CBCY);)K-O)D0S2.:KK
M6DZ,3+\2F11"K-N,LB"QY$:.3(Y<8KUD*)U\+Y15N_5554$(L;Y%HSDAYK=Q
MI:*0J8RC@LRX]K"<=%N29/9"A[4$7<OSBX=YNS".+ZTZ*HCPIV#P1S;'14 C
MJT@DE5?!*V+VE92Z91D^##_ LYD5N>>YT_%E^6.=TZX;4]R3M!N2T:C[QB @
MO#AT"<!G=N>;D ((),6[PQP^'0D8[;25L4?69X8^&>I,W,H>/,8JT 77T/V'
MLU=MXU9"IR.+5_-E8)B!QLF@U#O3HV8MIKQ-)SX5OY7?S@ X!]DQXB,@^1U[
M.#ZM$ZOXY+ 3SSG]-.EK30>77]SR=0%W)V")?^N?QU0P1":_51;GKA[*0C-D
M=R_YVH\Z<FVYN)J^['59ED7?OUMM6FMVNA[T0Z& O+P\J^ZG]ZH!8K8(L>.[
MJ.F2X$H*"L"8FI95K !"$59PX:E<$4D_NM/Z-UGT$0*^["E3H0>=B"!^%LSX
M(F1LPU-IM,!20Q6Z?13UUPD*FC$WXD&:FC4 PJ$-B.L['IGL!482GC\RF;:^
MBO0G*8K5F?]A678BVF(0XX:OKZDHC4+2KD7;[@W7K2@>/:B=TAQUOI;-"X_Z
MR@#*#IA52Q7HM: 5;@)7DQ71'(+Z!75^-AD VY:.60\I#^;JSJV!FW]>,%FW
M<XO)5E9)L>QV!K 'BJX4^>58&AO *QUTF(3#>"7U_EEU89)F%?&: &*O-C+O
M5<5<<L!G(O.8()YY+=EPC"W!%VVU2_(6=?%S\EF<GIZQ/\@$.7>X5Q#:L?.@
MP57"Z24 [8:90S6!'I5> O)@%X6FRKJ5S5,6J& [)8'G7+LF4@@ADDD!<;IQ
M65Z[OFGJ.%5I46]:Q.FF+<3F9X8JK5.Q-L=S"Y5#"NK-_SLK_X5GMHMW10VG
M-HQ0GWZC1,0F>A6;1KQ$)$N"K5)[+&F^I1PA-^'$\UV2?RC^T9*=+IH?)_;E
MT?,S[2&F5-$W3;K*YM=%,Z45GU">8\?A(T:$8Z,/4MOW.XG5Q(EIA5XJ_7+D
MIGQXT&X"X)_7@3XGE6BI?:<4M]=7YNUJ7IBN/AXXV&>S'0_%N'Z6>J_I)%92
MSC4CDAE";N,KXMQFC9J[^-7_HS;<S#Y<@XY"2,OUMSJ%J>'/D-7(\Z(K:AY=
M47/@*RW'H[?_K)FUWCTTR8>.[ME2,/))X=49*6"(W98U)-G53X0[CJ"$%U<9
MDFIS>%EFSS<H7>P]7-QZ]&:UY+P >WY4RL']O_*#63=LW4?=(?'FD6?Y/7=1
MM/M*QA,*/5@#4U'0< X47O74%Z,7GZ@8FV/UC-6<N1L./!Z_6I]<>(:2%O$M
M#A^.QRM=0)L:&V637>$:?$#6_ U+NA-W,K/S*47+K<;QM\KX[&Y\MMSXY@5Q
M11]GCBSL%@N:.MUJKCIQJ/DH^Y,GN;3TB::^Q G?+C?%VK@P0=M(Q^X1%[C4
MFTI0&V(<-);OI+B/]/\TZ!6NV)13Y7(/"2?/N_'6TAU[<U!OQF+=LB)IE:RC
M(SYAX",P9M4Q.81699=DM9KTO6C U54;&/K\2.Q'"&O17A=0;>9F0X ]J[&^
MK]=O#\COS[R;<AG#VA2G7O.6'1^?3C44FK_260=.=;N+&Z^RN@O-G3]@P53V
M@A$#C<\=$F..:[0AO]5.2OU*^ (8Q_I*K7PZ__08?^?U4&*Z:0P4J@ CPI+I
ML0%^N0XS+L+TJ65RM675#'$JPB=A@$\-QV46(?9-WI+U]<E30PM]RXJ"7.G3
M)G8#T/CZ>8176^W)#X!SIK/Q3O$#P>+XOW2OH7-^8)I(YP!Z_>_WP7&E0HKT
MEP O.*SIP9S>U EG (Y.7GT:>F*GA3-AL6R6D.[]4;\$UF3Z@M!A 7"<"F .
M_CW?)@4XC3NRBT66T&0T_E)+KR448T3Y ,DM9WP\ZULW[8\$ZZ(;_]!@5HEG
M6;BS/IVZ2X",PB6@.GQL/7FT?*M>+-OYKF<_W\@<\T [)^I[U)<M94P%&H0>
M1Q\+@3!UF*Z7&)M)6M>SE7G]2KF;AI(.8RYM_H:CW&.=_T_N_1>,A6.A0T9#
MJR-O+Y2527:$T#$^5J'[=>6+=@;L$'_W381,YK7R7FL.WA<X<=R&4;QJ\3;3
ME@G5.M-8.# =,>9*@0:,R1)^7#%B>)-!EB!N/WD)$(_$T^1T#%;:=LA8?<W^
MJ,_9KO/HG?"-%P-""D:<J0R>;C\O'$A15_+TV 3S?DT&*?XF$N]YNU7.\M/A
MD\6]T6!A+\;;?TJ0[WH*;*_*#]._CX==*'J5$%[B-HQQ8_DW<!TH8_5*;0YW
M6_>N,NEOV?/)@':HJ0?22*$3#1\^(/0B>0P^>LEX^02Z .WTI8^UK/?0UP^'
M0\SAI<L/I-)80'34OW#"I  '4H#P*"C_3O9,Q:SOOX<=/0$NR7V6&.GCH9"O
M7?Z:;H54O!3Q3L\MJ\99#!B*1Y9T71WHL^4/LJ B9+<S!RP586%6CH8GC_G<
ML /B^W%Q!X9-^V2GW[QY H^X[(ED?#(SK'?G?#O[Y)342A*)5.8W39IDBLJH
M_(RH+3#L0'Y 7#_6S+[P=)526Z#B)_#ZK6">N)(BIY9TF".S.5LXRZ<458X$
MA>C9BTN )2!#XY&?4ND4O>;8FDZ%:O.*5(_@O0?U_4=?9J)YIROOEWQ':NDW
MPGD)[;8M$>DB!'E[O(*F<E">(3(XBE<R4<HB3H /00>H":P@,)#\ZD@!N:-*
MM367 +#^"!NDH.;(?P8A"MHYC*'U(ZL<]>I/\FR"-06BHJVNW(4C?$S5"TK;
MY8CJJ$&?/_, VSGHAP;00 WEY3U*I.K"-0.G"OZ]YL D',+8<*5$4(N9E#<G
MSR:"_DH=EGA6CP;\^7:\NRUX-;V*-N@ZPK=Q0N^5!Y1Z6(%9""\FW8&7$I)W
MHE04A4[W;&91QY> 2!+[3@W#<)<#KC?9HP RT7@@[E%_\=Y <E98YU;SY/>D
MDOT?'_[_-O?_!N@"OTM ]DT;>/_J;_#<'^0ZPV14.++II ZW>WR.S9>N$29%
M]50K9.XT7 +&E'H?/]3F3L8/6P;@ W7!$P;,@74P%(CVY3#ARK\J#772#E>1
M3'DDXY7-\*F=7T/+*.\T $)WYWA;D!EP_#^V;T=,"!4#;/0<#P=I-GES%:/9
M3H+;M,W6G@HC2?[#I*@2$>AM8B\NJB,>N5*Q24LU<UKU]^26:?2S-4_XF,0E
M8+SE!S,(RY ;;M6";)SNON +[CEUP*<B\7O#5IEEQ E<5Z&U:>X]>",9#!5+
M]X\M$K964T'<^$,\5UKPY^L*P"G^Z3GL5]YDI9(IHE:TER%ZO#R%OW' _Y,O
MO[.N:(MK,-(<[CWIEB^;,?#T.DEU-52?1SECGTQT8Y=A>I6-2!S8PM#\;+.D
M<.6BMNELYN?,&<RM4.&J[*E= H:4#V\1/ZX$*RBK1"?71 .G=SI)XVOYK__S
M](]?_OH?4$L#!!0    ( "Y36%8U%YP/2E ! !-2 0 4    <VYY+3(P,C(Q
M,C,Q7V<Q."YJ<&>,NW507$'?-3BXNR6XNX4PN(;@ 0:WX,$M0'"-0)#@%B"X
M# ,,!'=)<)?!PN!N V'003=/U>Z[^[WU?KM[ZO;]_=.WJ_KVZ=/GW*K[M/BT
M#B#54%%7 :"AHZ'QH_$# $\( #_(R?.#IX^3YWOFEX+" (E7ZEH8",!_0/J?
M'@ T -K_59]. !2*[SQM[0'O(O[3 0N KO[Z"0Y0 J#_%S#^TS Q_@$3"_,_
MP/HOX.#BXN)@X>'_ Q[A_XJG'@ !+KH.N@X:&AG@J0\P\V]T'+3_ /!_ A,+
M QT;#8"#BX=/0 I 1\/ 0,=$Q\;!^'=#]T%#QR##!&"QD+]0U,6FL&'U^D@I
MDER(0U7[BNV7WO3&2VK;O^S>G\XXE$3U4XKJ['Q^ U]SI1;7B]$8O/O0.[.)
MR_D9#__9\R]IRBHE#48P0VY:Y-9YW^SVA;UO9'II8__<SJ6#7U1&6=/ _.Z5
MN*JQH__73'#SX,+>M82:B5- ]/?REJ'%_1L>2753Y\"8+$CK\)\#%*^4AIE+
M4&QV1=O(TN'MTQ( ]S^3D0?<H7+$W/[4.XS_MX+GFR\2Z#^:%.HZ)G656P '
M-5>6KRBYI#'H\.1BOW\""(=/&#\J!08T> >>,%CZ0MEFW$^$%+?F4Y7)OIZ&
M;&:OW>^=[EPV<R!/4RX1#HI76D=P$Y6!SBSV=I>0A?T)_:HGP$0X:L+#<?0)
MD'DK]AWGSP.+CU>H=N<;*[VK)X#<#YC>$^#'[/W5;."#ON',!VU#\*SHXG?N
M,R;SVW'G)"+51V^[<[B!LUPS*K/B]]L4HS%%)W\/\U S;@A")^.U1[CX$P!X
MB2,0C,K<S4D>:V0RZ> N>0+PWO:0%+SS#A=%95]*+*/B#-I <[JRVT@/+$EB
M;?^C+K)EF06]F&JNE$TS+(?D42".UA+8C7BT7\VPG/T"N/P$R']#Q.S 2'EV
MA)C__KNJD2LHM(;HUIC(=@'8\OQ=\WP-8@5W<]B+-0W\D<BJG0CZ!'CQ[^+'
M-6>21<7V>9-38$-\:?IX5.@=Z!+IT_Z$A3WZ.?<3,F6'.25!^.7J(9.^EDH)
MFQO;Y6#%*?KL@R? >6;X>5*VO428M7HP>>RMOQ]MR$8Y?NS0?,?54;WGFA1V
M^A- <@\U_6Y$R"VD$:K:+%1EJD5Q$DP77)Y&2[(CAX)=Y*-NP@II,,]Q=N(;
MIQ]:&Q!:Z^B?RQ-<G2OU-[<.)IH+_BU%2)BN"W^RJQ37]_O.ETPQJZMTY91Z
MC3N4C^#[U E80?B$3M@K5"K,G&FLDW=&'7 #5!+,>:7Z:B&YISV8_&6C<W97
M.M1<X"01LN0R[X%F>KR;$! M'2OCUGO62_@_L.M_4X@" QW!<*W@<%^B^-RZ
M\XS@KR9%\2&FRQ$X8WL_0O;^S=0+Q;2]Q4ZP^WFW_6:8R1!Y'_X6*K:TWN#W
M!$ :RY3N/@%0-]2=DBDDK"CB22WM.'^H#L=RI XBU)*DLB(9?OU-WB@P<^S?
M:TVUR@OS$!DL#[-V,:*NF\45_<R8'<&T*."4+(VQ/N8*DX"NK(P?3_H$>@%7
M9L<(4]]*J[.1BW%\SWW\H>!AF!9B@4?Y\&&,+DP3Y+_\@!&T0*4=&S#K:97'
MVV>42R1&M+%V:8O=18>/I,/W8Q)LF?+?Y,;>U@]M[N_45Z#;!/=:ILOOG7Y7
M>^Z_S:MJ]6>M:S$9:$U7OASK*Q\&C#!<VQ0M1+F)(;YM5Y!0@ KTR]?N![AT
M9W,?%6!GCY(JS.+XSA;_%BT=L1$O"@W,K7"2L^")%EE()?O[L9XQ9]:/2>5%
M.9_2F8"K5MO#8J]6/\;-,0 Q]4'6^Y'4J9N406Y#SVL 7,">^K/&H_.O0V;%
M81O'S*HS;?QJ>E .M#]M$K,XZ/BLCO'/:L@_ DL:H\YV0#'N>_!QLQ4>$V!Z
MHBYA400&QV^97O#QD-BD9J#F8QA9]2N[KY-R"O6S%-8+9AR]< EX3:'79<3@
M8Q#WI$'@RT<? B3?!+:$U1@R4/M*A> R7/B5.Z#&KT4E>YGD1[$L%]@ER*_&
MF>HQM=S<)>-E[*"/,Z\.02)5P"C/+3'1_R_Z2,CO<MUO@W=P=B!Y<-/S-U)E
MC5B*,Q_"Q)MMHOKIV7"WY&:D]B+#A>7W9.^/*AKFK3+;L/+3^.'ONKNWPH-4
M+NQ5"-!#LMZA]N([_J B]VKDEN,F)5#U^N<4V"2TJV^E>ZF";M^3LRFV_C%X
MIZO&6I!$&?)P=3T0@X5E'KWZN>6H^W"TE)Z:G7;J]&?A]:VTW5=#JAME+-G!
MM?31& CSY8T?W:/$R>O<+@ZHLJO25A?W-[QM(KSJQQ[WB\T4(  ?K=@X-!IG
MOV\YCVL3*,MWPY2'4\,KKGO:]+O50<%%,HJMQBS^7LJVDG,[UK,Q]-9OE)@V
MGWBOVTLC]M3R)F=X## A$1\I;S4=,]/IY+R,Z/8,^].*J(4&P6QTD<_?+J5S
MA6>LKLF4E2\:O$!LADC=^?6YJ%*Q4SSJ+ <'V-*/\])MXOA<^($/^P-(_<OI
M(N$GMS(BZ;PZC%_AK67PK>_X)WZ(A=.UO;1G!A@Z<7;7V9Z(S(%22#?V2=C#
MK?X+_3-T!9R@RQ-_<,A[@(&'PK'<X]PP3:;,SNX:YVK.*4]@JAYR!QX*^7"4
MY8Z*\#-%%XEB[*/=@W9$_B/8!@J\4TL%_G&!D)_,($NB=0;\["[EIM1"?Q;/
M<P=*"6X*#D?>/?K0(?4G50@TQSUTV%W.2;L-S]&A'<KM9^U& 3R6/W)U4)*'
M:HY1N\^J!78UH[E 9\-T.*I&5(15>)ADR[:M_Q_L^99A4A"K7I9L$T4EQ)[P
MJJ(B-L/6"0#P\!G,S\X_SPY/?WSM&O]RY&3M>YA-M/ 66 T"5AE]O.]D2;\/
M_U M;4"/FD-E_9N*(JH5]</#_9+DA7CF!=XOW>+]4JC R!. O_K9N(!SBS^?
M9>S+R?Z)[=F+@XUF*\)1.NHM[7<@H_:\=K]1NA!5GT6T^3SIX!L'.Y"3@L:E
M9;MQ*<E:? &@G=P$__0B]]9!H"]IH%'VFJ$K8$?FXY9^*]WL!TH(>G>4U?&)
MJ^XK^4CMAY?BOQ2<Q(M@+K-&Z=62%JV@$'Y5J]#)KV^+^I*6_1<]C\7/1K K
MT.S, O1I%<"LXD<S[:"+?9%].7(=K:/;1XN7Z!5%)>A^)X/ND'.)>0J1I%C2
MV S'M?<\&GZE,M[?!$:WLD8^SI+G(%;44%,+0M$*(S.9>%HHVJC5D@RN2X<-
M^L9X1UP7DN?*U.VI*DR")21YSM1.%GK*+]0416TT$DF#R$[D[DN-O)7#6%V"
M8&$/9PCRF4]?3C5R^_F6OF>2\O6A*P=AF"V$$_89D$V=$$DG'H_@HT$5"QX^
M0(/]^TQH(Z096D[4(66/EP.SL_A(?#FR13+=F:_P,A[&0[%RT4(@@WP]?:.1
M$7MVMK%=,TS[CQMU1/9QB)POX.$93./$GPKL_C6FINE%YD]*V:^A;5OH)_#$
M9,J:Z>X$7Z;1TXG$L<D15"_JY?A"FWNA[:3U,5>MMPZG@*L0A$K["4 *ZNUS
MG-(994)-0@ET;[MR494[5U."S[ZXVZD:YTVTSY4U.@06 \+9-'20'_,ND),Y
M,O5[LKP,GB/9B,SOHI K\YSG&09$&ND>G!6_VRL!JEXI]/^OPK:C,R&/&DT<
M#1^9A!Y(N6U-='E^$0E+@)585<*'T)8.][&5F6,I+;5)#"U;D0OGYH_>3.?2
MYW[.%&-F6Z;[A#V#A<ZET&,J@UD?A;&99I0>-=N5,TPBVB5$INVT:=UW>8$^
M..](ZZ#K"<#R9F@$AUF<H<TX?$.'WBL\NAC_)[!0VA,D1>+F+VA8/1ASI!!T
M7:9OO"%/A<L5^N\)XBR%U!X(6$EQF7BW6\5#X85[3LQ?2JC<MY(@6%N*.-SE
MHC3T['C-Z1,<!HXN9,!Q&W.I 1&)T3'<>C@K?MM6U>OH*6"K_J.87FD6T1GD
M$5J/+4JYF(*VVH"(&Z5,QI5]%]#I>VDGB!]#B1C6>26V%MK&</9)4<^X7)3Y
M] W5L#M4SXRDVH6^4X17]ADHS4&W\_D?C<]WO,_B%TFMCI@)GJ&)E=W1&H1K
M+Q9Y9\WCMFKQ=]M*I+4#28XK/JFOD2!D(+N:BRD!#>8M[L^$3D\H#J=A7B 8
M):1Z(%UNT=3?WA-<&9;<)3P!53%H;"GE:Z80?4_4=J(ZMGG%NOB1=KAB90F6
MJM FF1G#YJ!.?I\FOT-2POC=+\\TSS6\^L![6+:MU90<N:KI7  IN RHBD;C
M<B2DJ:>2)Z9QH65L+>L1]"7B/)F8B\-J=QHUE]2]$\<G5'4_&&E1!"EPS^VT
MI9_H?'PV\ JO>ON2LN#O:FY=1<\+B]_H\$]AM+#&$!7Q%$9S;[#2@EV7<*:T
MGR[(&>1WH/V5L5(OC#>UTQD>[J;+6V 481R.<7Z0=F_X$1Q-N18.)J]98GIW
MX\?USTRL-M0P1N1%Z!7W-LF0A]'@))TNA'9VGHEMNV@IHC>4\JHVRA-J2/*T
M+.-#Q2%TQCLI3P"NP-,).85YU@69G%V^-4$7#0/1#&_2%-;4U]EBVRG,7+Z^
M-HA\Y2< =_>>'%20J"D1-5@2AR.J?$Z<2M'PQH^^NNHKIQ7Y-/5:B;7CM 7.
MF!1-]H=*"Y_1H,ZRUA++!-"JR5CJJXO%B"&U<FE2?QR[+OK__;[8"\]BRNY2
MN2^?UF[>L_ 0$..1)# W>-C9@9=#- /0MO>\].N@8:S8(3_NC__%B-_GU[N.
M\Q=6?.I"R1U9XMSCG54-71T))4:[!Q+IA)UVKVB\JZRJ VZCON19<)-$(&)+
ME?V8T?0 BWKMQWZHK><*&+9H#,&)X-.19:)#;M>F!W^H#XV-\K:+8L5,^WV;
M'75DI5D*K[0_=L-1''=1K'?!03-(RB[3&P\[=])FC?Y7@'XFL_:OIB,-1/-*
MO(< ,V>W8$[\@%XE]QK8HRR]QN.FA2VQ=S:/K9I](+YK#>\(OM0)Z*GJ^>G
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MAH>'@ 5GW?;9%*,* RIU9UQ'N:OA_A>RH[9_UX)5W6&6S&X+NY#PE]'6=X6
MF#GC.0!(JFKXRBI)P'C\ZC8OIC3,!N7G%YS#E:#W;)H6&*2%-6OO;UB)0UGE
M/CQ+Y?%\/Y$7=04WF"Z<=9_$46.-TVWXCEPGM*Y*?_C)YJ7R4'*C928F06'>
M]BVH:?)0D_YMM7OVR^$'86?6=+IZ;KB='L]:R:M3W?09S3B^[;JD:-I#!_HD
M];\YP4T$&H/,)=[Y.S)=,WMOID(F&0O! I/@NZ\.L;>++<XLR<]**M0>RG-:
M#HF"C.EV<XD7QJ1<%]]L,!ZR7;J6RH1*)B&U7X/.PAGG;GT^/9JY+J6)N.1I
MS95=^&J)J38TM24[OR<=":609^6=UFA8;61J4!\ZW;5*AC;*:B],D&:QDIFM
MR!6#8ZBY'7C0HM;%)1QND@.^[W?$(BWF*_/,YT2M>,V7357?97_SDZI:,VIH
M;6W1EFO[*V(N?%OUUD(SXDNF_E\D-VT1G7_QLIEFU<M1IL*B54U'MD8[QVP>
M6<YXN^5/O 3&UOBG1E3XL5H\2JN=_F<H&&5"&I5HX5%SU]Q!'#'0*H)4Y\[P
M-MSR132.1SOHOC_LA_<+'R/TXG09URT-ATTGL?45-"BN*' IRY.*FQ)=YU60
M^Q8BFFJ?9Q JMKR%Q[SPWI]*3HY*>E.@/F1B("<4;NMN5%$7@?V[@5=U<K\,
M9YWB.!?>/!KTN=NMEC:VNL?[KD-\,)8'R/;]CZO&9RNT&T?8*:I/'C4RK26-
M!)_+&Q:'G:R-9L_!/HG?Z T<&LFS$.1?XMU)7IS_+\GWHV=-U<4H7Z<JJ#5A
MY/=OFI:6EJQ/JI2Z$$=_NY\ =/7):*OS-*OS9*FO>ZK?<S2F]K(GD:>CYRTP
M]T?NI5O[&ZWC XO%TX-/<IC2$6-_=J321!U8H<NP K!;D+RM-*)3[/KHC86?
M*%B[('AKMB+)8*% =*E;\-\1PHT+#32(U0]O[QU\B1]I@V@]=EWG?NG%H3TG
MG=O$MJW]B(KUW59E.=W:#*U,^W740_PV"/],=-D@]&*,XOCS*P5 "H]"Z!"C
MM(.7U1*F7CNB>2JTEE42!"C(/10_W8)AG-&/&R7@'LP4@^-?U+GA&A8>:7_1
M[S&P9Z-Z=_.U?RI<X_XLU<7/[.U\VY=)[_.E-XE8'60XCAF1\U^&P![  \57
MYF[Q*UI>-586AR(#U_IX$O5#/(0A84-T43)!OJ5^:P4JGM6FGNX,<Y?M+_$X
MXO&9D[4WG@\ISN2DA \_UX<_.*B5SJY;<.)AA:I?4CJWXH?P1T.5X>5T=O.]
M2L[LYA96!IL5A"*O*VPY&P@YHI205-\(A1N:6TUOX)K!%7UIEY*R[3JOZ5MQ
M[7'78WU95%:TO.VH"S'KX7^.]"<QZP8D"):PN;GE_:7KSKQT_Z;T^5TC:+%F
MLQWG]G[.1R('#37IQG,^Q?Z-LE>I[LGF(Y4Q+CBR-%MP\_WRPU2V/W+6.NAG
MC',HXPH;+W)0 /]>?I7GY$?SL.S<0&:%N:K 3MV1/(@7(APC5T^'9#&=8R#T
MA%TG"T,>O@D$NXL<BAK^Z*7:WN&O=O<P@1,L+E5/=T2;S>^8^T4I*MU9&[5\
MG&NQZB\[I(7\[!9DTSQ*<RILX\8E2WV>Y5)<+Z!RL9W^3+7&>1RRU%^^;%I%
M \IXE[%JDKTR]TPWPV3E%[/[*^<K$RS@FPCG2>>2P.Q),ST.Y!-@EY"I.*0G
MQ@ [(/$9$(O7I;Z7]=:G_":+7N(FPBW+N<O5]%TW,JS1Z_ HR,TCV^T;55E[
M@H$,,Z\3.P6<7"*Q:6BZ?)O,L#LS_+LZI*EP.U>KA.:6Q1>6M?UP.H?!B[L2
M79D3*%%)<55L[]X+M/6L8&(+_.6&&Q/2N%L)89R0CL1BF35)-%O^R42D0VM<
MC^X"BB 8>?2S&DV4.FQBLKH,*8LVA6Y[3< U6M+J^]E#YP><_Q0E^7XR4BE6
M?G.:_37+,8K-T]=WX/I-JZO>N+;,%%?A2Z\U6(HDY0LZ3Q8&M"'+^#T^=Z&W
MF=H=<B7&?E!_SS,C25$40\HA>M&7!G+DMK3NW;M)S?-WEH;GN:6Y<R--R7O,
MK(+;5+$(NQ(1K\7T=*KDR2#/K=R!!8,/@1=Q7[&!CYL@'>:O,3$QLFHK1-*1
M\HUO-L)SS-R6!!N+P^R<=XHM-4N/.-/6ZX4_31SD@*F^\Y,OH H]_T@$^H=U
MV2!71GOM3(!'G.UYDD3J:89<KVW,\-C\S!(^)_^=9#,W@\8W07=:V6.)>!=,
MU-WM,R2I]SL*S0)SDLT^$BA4_\P=A%RYOF69[]BRWQ5P>>Q]LU"B::"<+2T=
MK.TT,W'DX\.3+%C(Y)9G(?%Q/D+08-4PXTKGFL''47J80AHS,^U'I#-7$1FN
M"B64QFXIBZ EP97@L_O[?R;0Y7#D;*@D6\;C2R4+\PF1V%4_6;PZH[3G^5':
M&"X XQ5W$!/CW5;%GOO'35>+J+Y=8V6@-.@)0-1=)C'$;<)=+CU?EJ^R^HP^
M'<*@?M2I4 B5^O8Z16YD%A]_ 3P9[N9*!A+3G_32@+660P;^EE,>-#Z;R6/$
MX8NYB:BA,*Q>Z:R\L'L>MD"A0B4*=V&\D/7ON3>9/</)V,QUMDP3+=7&W6IK
MD0FX 1+W#MK!Y5K^)6S&\ F=YA]0A#SO$T"X44A_?%[X;-I7,_/F4@)$[KYG
M-[\)9,([8HU_!'(\?M[]?V9YI,^CC_RCMT1@RNTY,FY8''&+H][J%#(<R,1!
MXY^DKE/!L_B]\,/-$R!K "Z@,_E2A1+$S>W/N )9W RGWHDG[B/GL^P>[.*.
M+:\92NI!KH5GO@V;XP]F^AJ^<6'WR]J_YC<6'I- U,J+ PF]1N:\]A3L[1.5
MFX(D82C/:-!",\CKU>^H6(EC[+4$E^IM8E7(-=750,:1"H!":>,FK*H #2#,
M8NK/]K?OUJ@@7'"SW?\TYCALF*O7Y^%%#WX>@;)NZS*:&0R]PSYA[,=2!/DZ
M<</RK(WA?&W9@4B)65H*AI1,WC=?XJ'/J#D.,&L/#U_K(OUSK*JVCL/Y,&A3
M*B63>=ZF4P2+2[\M*9[)N0N^#UMZ<(1P2,94$'4E49K8WV6<P!)[ EXJ^O*I
M[" K_ @JN_V@]98J]YTH/-&=N$]\.$GPF!);+6=Z[P9G!I*(FO=^SP*9,AOO
MD!#/"JNEG*AMMJ3HZ3_-E7E*FT<6P[TF]S'XXQ0NWKW>_1KE;5\DS"[I^]6A
M_H75C.:!4K\<S)VM&UMC%M)_1KD4I2[,I.A43)*Q'RO:6,0F-ZEM3#&"KFB=
M&L^!I1 !L1SA+Q;,Y7IE(KA<[EU8!V;;;.;(MR)9:PJ!,JT5II3^:J5\G@>?
M\!MJW7[X@Z5"N(Y;ABP0U[D=M2(K+J\VZ=IC\,T/2:,_#UV :3!FF].$+3(,
M@0S//DSD[/QCDX#X^(N19O&D?4:_G_'NUJVOPZ=OO_8.=[42X%@W\M>8I7'&
MGI<:LPOL5:H+*LT&.HZGPMD7,HP%V.?]8W"+5'WVL9VW/-C9(VZGQ%5N-#[?
MK?@)Z+F+]//W94,1D%DZQ6RGC#/H1C)U8 /\=M!3O,34'@R\414SH><3I0V7
MM')"RH&+EMM7AJLTR];,(KF%P";?"H8Q*_)R!VDCJBOLY5>"(I $^WG!]YWG
M<KD0Y9?F* ]9WQ\IF^I5[',%9@;,1!SULETS['$JVC*6<4J3';M+8S*^Z@7)
MC>%\/JZMUC;2HV#V&%'QY*%T2^<)R93XB2)CC"^( :RJP G-3K/>R55+\X!&
MI]45H8VOZU$GFE\X055J@%%:/#L[A=%A(@X%)BAJ:\P,)S^DL^1(V&7X79=3
M(]O1&WK^H/0B*569N!XOF6*5)  W8?Z(<^_]PJZ ]I9:W3G6[[APT3!+*P9Y
MX\_)@:$\-NETWZ$,"CO/RR8J'I1BKYAX4&OW^CLF[\CSJPY><.9X?QM7=]^P
M-'+I#R27Q<OF_7RE03N[@5U?#>PO^7DP ^Q'I ]UPG8AY"TUQ<&DHFRIW"K,
MEUY#H866T#)4T>"YT)#8,.55KWE=K"2K(W%>_"&:J$$Y9LG'0!+BU[1>\&H4
MW_ESF84=_\X6$NSNXHSZ-G63&(&3U W>S2_3)0K=\G$%$^5 <QU@8) D!Y-9
M[3E124:F[C*(.BMMD%]G])V@'V9HYF8P_7:>QKR@*-Q4IB;0#]85&>COT'_E
M]VF=I3D+%)OT_)DP UZI'(4:3MX30(AN+%+HF*6EHYU:9.E6EY&P[KD<LRH'
MUBQOV6 1\NB'ILE]Y4(#_$_UI9HL3_&Z9\JJ2:@"%6E)"NDQ:2W$=\NB4AD(
M>4@+ZHQLH!BWOGX)-W2K/J*3QY:G*=MY7KFV^4\FKXU2#Z?A!R^K:$,1Z;TR
MWN.$O'3S0+M+/T/,#,!/3'_[M0UKG9V;A^>N4DK^%)CAE:'V6PIW_*G/;<@B
M?FE12ZJ#E:4W*.?%_0;(Q$OBO&@JZ?C+?TVE2/(0XJZH,4<H+D;,/:-5&.HF
M+2(N^>1L<4@L/KO5>D,RD;[/UWPY*NC'&SHN@[OV4#6I6RNCN$_26O \.^+T
ME3KKE^2I)X#C4=^2?,P_A0<Y=P9<,MN?\?+Z Y>G_.!K7<;1_*ZUD'+.?(2=
MBY8"77E!]>,#MBP9%FT:?)\2M7/L)#=5>-2TICI)_;.M$U:-$+HX@E35N#FH
M(SP$5HHSGMM9[Y_5W2M^!'R2<EQF0O5/HH9<=2;R^1E>FJ4SW_<BEPENC0 =
MU">T7\SW%="<^CZR)M:M?*K;J_#YOS]TR/@\ 22#_S6T)P!O_HC=2)=9)QGJ
M"3 ^)?QQNDM6KB<E904QO13Y+U)ROR2I53H#S:CX^^T-S690<8(A-:-,9B&:
M%A&4[NU$Y<Y;WX#LF"=^TA'$CRO.";B*C_H@+:G[]L?G'^1)F/L3^LCFVQD[
MD?N3KWC5I!E_IQU]6U?<EIZEZ'H":/,7I*A[1G63PGOO>&)YN#(;@P,>Y+7_
MV%3.@A(;&X-@IT<93EI2N<V%.(NS'[N;C,O'07I=>\=7D'OOG/?!IQJ@8YTW
M#5'J_H8.AFS)=%,>6GYTB(3L^=N"TI)EM8H2WK?$^:.CX8-X)ZISMN06)?-_
M:QF_A3Q[^S;[G@\_?=_Y*@9LYCW4(6<!.SWU\+6P#%<9Z;NM)[ E4&<]#Z]\
M90)Q (#TJT\M14MB)R<M2_NBX*.)P*(S)HJWZMYAI 0QU':OU #D8@R4ME,K
MDY7\YSGNQAJNUE!ZLC?UBGWSD6GFK^YH033 1Y?U4;8@/>KN<_MUEAA2 8%B
M?/QIM2@>]IK0Q9#Z2N?JUT[SC[XMGF^*:D7.+G*2\ GKV!5J;N=DH\\.C-HR
MZL%+/UL6H*=0-B+VZ5%G-AFL.'0D7)5P*][8'TLB]L7?WW&3+TNND,,,\1F%
MS@Q33>;Q<B=#<(T3WN32H8=9G^0KUA:3U@O3'XC(*T9K9 9$TR[ @PN6_=I.
M.$=GKJ$U^3KV@^]E<EHYG0]!K3W &MX.;^VJ%B(_-8CZ\_KOX=401T=M? 3W
M^3-+17YVH&;E]%=0D+5Y"Y31A,7^9Q8P^H>J,ULA#"BN#(Q=\M#X^08#O3!@
MP59,^KV55"".3F."A;%:*BA'G9BY8X\@-/Q-$FR]PV1AMNC\8:5'!<.&^5VU
MSVC[PVLE,,K.I%7MI-/ZT>2<H_T)4*AMODZ-$%"/=[CHN?A342U1,TCIS@X>
M[?Z>Z0\E29?YG7(0E)$<>AE'D-PXD5@.3X'Z4$!QZ?*L0_C+&C;-.<UV2WTK
MS0]O^[MR;*CKBP::5FU_TJ<L;<)SG=E=E**?%PO0EP?V+%MR4A:_AWJ:?5:;
M$Y)9* &NS"441,'&J.O.Q*V([#]MZC[#%1)H)6=7_/WAX?"AE51C]WY\]H,%
MB<H"PF-S7D#TCW9RN#.(K:W)UUD7UB/SYE?:IV_<*V^%/[K4F9J7_D$^#&6.
MMHU7:M'SXKUX/>&H2&6:>"M3V.VG[JND+-C(+)31L2%[G2$# V=HYG02&YZC
MFZF-O#Z)Q,PGPWR\DC>21'\"O.PVD@2>,WUW>PZ5F6-Q[230:VR:]IW725!W
M$[3^\F<50$F=(K$5_TMVX]&8C>4)D)Z=^QB_JZ4_*@[[SLYJ07TV?>5K/>[)
MRN4>L^EJ%1F65>1J7$:GGJ=N]Q[)GB;*$XC)EMA7!/[QOCF\&??(;*OC\^Y^
M1^=>'()=U';0/,$4JE>:'HFU3+",9<I.ALU 7O3#;V)Z)S3T0[B,JY]72)!C
MOKNEI"UD,W68+D@/0C?W2)NP8SX8MK/=+1WJ>QE/_0IR9 ;<'*#TUOQ2T,*!
MNY)8GMA\GK?%*N=^3O'G,)NZZEHN9J$Z<CFA7?H]B;TO62FOT:9SHG8)K>_$
M65%@]O;:D=3KE^RN7@&=Z& A74MU(U9\<G6(=-YZ_$_#E<C)TF ?.QFRCJ0W
M9<?"*9362L^F/S&^T=Z-UD&Q27#6V<3NJE&N'&9^OAOTVZ)WF;-8CI'PP$6O
MV)XO</]1=J(ER7FI]TPP#P?HTE#*X \D&U%@CO],&J(X$>>\9V$WU1RU2N#Z
M(&(N.7.%A\C8C))8TO5A1^/A58/\6HBQUI@RV':<$*-]Z21%#2YS]MXWREB@
M>3&.U1'OXTK6^DZF0%6 .6Z=:#!7/UW"V&WO$-;/165=E<92Q%S,AP^A(U66
M[0I[MLO#[RZL_,FDK>".R*(B)X3=W5 Z0+^,LZB3DEQLV?BT?V!O@[)4Y>$Q
M-6/T)R@@0HSYFOWJK"\KACWVO>&#)4.[@]\:Q B[^VN(&L,38+Y@S;W+3KC0
M%FY W#5+]VWN1N-X\&_YU5HO/P# KZQ8!H=UNC9/4JLR^./8-5W6=+])1^%,
M=MG<-YQ[Q.\Q\2__$S&US.^6K_MEW!N2WA2EQ\\F]1XL1OB</@%V/'>-,Y\
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M,66^ LD3J03-ZKNV4"U_[KJ4:3T?GV6TJ6<?R+P.$LN\[/\>]),=*<N^P:#
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M(Y8[T10/B&X-%SG\'F%E-I:"\2"6YD%Y8V4_)Y!%'10_#<B2102B,*'8,>;
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MA9XC59H)*;\)(V96]CXY^@GR;YLT?SUY6T+S?H$WKZ3Y@LX[NW)IR7F/BC<
MD!T8%6%=F!&27-FS9LV;-GP?_P"<J_S9?\VOS6U2?3[PS^5/*_/2=%"MRBDC
MA8^O=*.G[Z0$ANI0(#]G/-ZQDEBHIMVVRU6H!K0\NN]13[OU8\*I*'N>E*FA
M_5CR-V)%?$C?K[D^V4$ %*TIVK4C;'@)O[_,;=R?[,KBM".-"O7K6O09@0""
M?@.U>XIU_P Z93="14JV]=^P'MC=^)VJ30@?+I0^.)$ UINPKO3Z1MF4A:%O
MLD#>E.E!X8KT+5;K6M"=B!B@-3T(#U/$[$5\?IQLO!8VE'9O@C( Y4ZEO;P]
M^F<W_,&YU">6WL'4F"W 9CQ-'D:,. :$;(FU*[$YQFV:34[BYM%N;:.&V)EF
M%Z[!950<HD].*.0\'F/)N2T*J/M9,?+7DC1]!BN=7U;7[,ZI?EFNM2GCN2Z]
M>21$1DAA4@!?B%-S7)3;6&CW%ZESHVH63M?JI95E=+V[X@!A(US;05Z_"L;E
MP-V5QOAJ]AJ4MN;G6],O-#MTXR#4UG^LR(R,.),L3JLR43XE)$E.AH*9$=6U
M>!X8H;CC+JFH,T5G=CA)87JD,&2Z*S\RRA!6922-_4C+58 _+7^.;+5DM;#3
MH?+]DW[V>UM[L3VQ2AYR,*O;J JDDFM*4XGIGH?RSYMN]4=1+HNF26BR*AN$
MFXR$'D"JE3\S0*$ V"@;9Z/\NK#>-%*N@1W-Q&OP&XA]>5$->!$LDS,I('4%
M>(V&=D\L^7S!<<EMEMO6>.8I#*X03-T-%*J=R31N5!7MMG0K3R_ZH+LCRS2D
M/ZA)J%K4!6=BPWJ17I7;)99>28K@HUXI 4AR@)9F(V568D[?1USH.G>6;:$4
M6W2(1C8*#2M>_2N2B'2HJ;1K78&FU?G@Q=- '%5I0UZ5'RWQ%],4T !)4U--
MOOZ>&(RZ4L@K)&C+]GX@"./<4I[# T^DVI4UM5+,I0<0-UH=CR(V^(_+"6]\
MK6MT@]>$NS$,\I8ASQH>1&]6''Q->^$4GE.S@YQK:PW:I%)$JR"DD/J;D(Z$
M#CTH*#; 4WD;3GLYK=D"R2,C(PW>%E8%F0T:A;PI3Z-L@%[^6&G7$ LKNQ#S
M6<WJK,(BR2.N\96E2O"NXW\1U.<K\Q_E%97ZW4;Z6]@%5@A4-(/3N$6-B**"
M:<%V/AUKTX?YH_(HS2I=0VAD>#U%XR*6AFXR1-$31@Q6J5)/W=<@I_)2Z:WE
M@NH!-%!.&,\JA/4F]-$$O#X3\(1!6O:FYY9#!^3MMHUX9[HWUS;L0]Y&!% A
MXL&6- Q9F)*BE5 &YJ:G#ZP_+Y+\0W5[H=S?>M+"\+3W!J8H6D""18X$-*.>
M!IX=  1/F\EWR,_UG1(!-=C<FXDXJPD:A8^I"E0LAIQ7L!A1YK_+N?4HKR&#
MR_ILS)"AC]2)YDG 4U1G6.<#>I% 3X4ZYRWRU>_F;Y=UE&T>VA6RM5:,16RH
MD,$!8FKVKO =G6@% ]=EY'?/4.F>?_.FM031RZSI>M.T8:/3GMTL9E0I6CR.
M\;,14-55;D#L3\)/.?-,9=DN-2=-)G^(O;@7'JM7IQ62W944CH6D'<BN<EN[
MBV^LDR1PQU&WUJ-UD*J*\U92$W^7TX+^K66O:>UI?RB6%#^ZE6-6GM8W\"32
M2,'?B=QV/4YS>1+KRWK-C'?U2XTV6L4JDCDA/ %7(!9&5J+6A ^%AMDR@B2&
M)=,)+P7(9K=JTJR\6MF'0 L"4/SP,AY**;!P :]QTI^./:@)%".G;KX4[9JC
M8;[BE /?' D@[U)VKL#3:G^8RR0>E-MP5]O?KFX?LDD@[>'\OS^G*$53O3XS
M3OL.N/$: $FOP]>7;CVI3QRV"U8%J5(H>HQ,A?B*J :4VV!/RWQE"2.PV)P0
MK#B"U"Q)![UW^\;XZM:UI\-#6M #T]^N?1S_ )P-_-T6FI:K^4&LWM+?4E?5
M?+XE;I<(*W=LE=_C0"11T'%S^UGU&S9LV;-FSR[_ ,Y<_FJWY8_E)J<6G7/H
M^9O.9;1=,X&DD:2H?K5PM-QPB) 8?9=D.?#4@#>GPK2FW^>^^62IKL0U2>G<
M;U &.4 MUI_#KOCP#Q"DD=_\SEA& .S$J -A0&G;MC^M&!H:]2.GSJ,KB*4#
M4I4'W]OEF0 -TY,!WWV_$=3E%17DE=NN^]!U/?N<39>A(^$;CY>QQK!1Q 'Q
M&I&_7;, _5J"NP(KV^9![XD2/B^U4=CW(&^/4$FA% 1\A[UQ4*QY!B$ &QW/
M?MCC*PE]60>J:#<FBAE%%) H=NH IVR)^>XFN-*N+W@'N+2W"17"T E><A7(
M0;*$V6F_2N^<Y\H^5WL=.LX#9B\UN]<WMV&9N2H2H5%C6AX1[!W_ )OA%*$G
MJ=GY,T?4I;:77+@7,\<=8[6!GGMJAJEHX%,;\A7J'_ YUC2O+?EG3K.20V\2
M1(06BN8I(:4 /&1YT2A(-0"Z]M\AOFWS#HGEZ));2UT;2[F[B9@\5DE_)(M"
M% BM_KM&:I/Q/3KL-AD9TF^O=1MIFN);R#3KCTR\R::FFV$O*JJAM9)9 [R$
M!5?T@Q[(U#2?Z/Y83T8M-TO1OT>;GT_K/IR>F20>7 !HST)HQ.]:]QGH'RU^
M7*6JPR1?6'((^%EC/%C0<1QX!5]O;IG=M'\LQ(2?3#\:,YF8&IK0$J-^U -L
MZEI.B\6+,I9@O$  ?"#7H!TJ,GEEIR+Z<D@ J01M\1\#3L,DMK:1G[7?]IB:
M^^VP_##V."*-5'!/EQVP;'&@4 (*>P&".$:[\0&IX[;XJL?+8@;T/78^^QQS
M0+0#IX4/3Y8@UF*U !WK5NM.V!Y+6,BA15([\ >GL1@,6*JP?B"Z+Q4TH2OT
M>V!Y;42 FI5F/VJ=@=NF ;FQC0  %COQ[_(&M?#(S<::'>K!J 44@D%22*T(
M\:=,ANI:#%<*T$T*R+4T<UY<>JJ>(KL3VVR&#RI;KZ:B&HC4 5)6H7[.PZTH
M/IWR*:OY%L[]D$MOS*N>)H0K#<<6'0[$]L3C\FP"VDM1&R^D2RM3BQ/8U'$@
M]N^%LOE:,BAMU+J*'H3R%*5  -"I_#IA)=^5EE$R262W$B 2+ZD8+'C0? W0
M[>'TYPOS7I.J^7)N6GGU],4B*-#<36=U#(6V]"Y2:%U:FU"W&OS&'OE[S';0
M6B6^NWNK7>F6R)*)9(8=12)2WIBX2ZCLWD*-XOPXT(=593Q;YEUGR#J5F[:/
MYHN;"NX^MK2*4CJ4*(O(5V(7WV&YS@VI^6XK^0BTU>'4'>12L<;A2SE22(6,
MJL&%#0-L1_,=LBJZ=K6BW#?6;:X"J]$=N0<%MZ$=_<$'V\,#>89;+6(/T;J3
MM:2LLB)<@@>D9  "Z]UV!VZ=?D,AF272[0 F&_T<K;LLC 2,!U;;X21("_P[
M<64C;#*Z@ N$F">E%>Q1W48Z"DPY&G3]JHQ(JQ6C5KT-<25:T'( $4-0:4K]
M/@,<1RH"#5J$U._?W\<=2@XL:L=Z'H:> QZ"E26H M"/"M/ =J;9:L0RU4@&
M@J=JYFK0&O'L/U8&<&K"H/':K4!\-ML8*E>1-  14=*4VR]E )ZT!!ZU ]C7
M'<PPV-237;H![U_7C"QIR +@$;CH:FOTCY8;>7/,&J^5=>T;S/HMS]5U?0;V
M*^M):FBS0/S4,*BH)%"#U%1WS]$_Y>^=M*_,;R5Y;\[:*U;#S#9)<A*U:&7=
M9H'(_:CD5D;W&3+-FS9LV?#_ /YS'_,UOS"_.'4=-LKCU- \A!]$LJ&J/<QM
M6]F4;;F8<*UW6-2,\H'>I+;UZUJ :[ [_P"9QYJ2%6BUJ-Q2M#M3&J&Y;_#7
MIXT/04[8N#2E6Y =A4CVQ<!R"PW!.U:=?IKELRJM34*.U:CL#6F)<P :&K"E
M*^'?]>6"?$O2IIO2F^W6F43RH *FH[;':O4XGQI\^M!]V6!0@\>O7?>O6GMC
MMR#U.Q-"*4WV[^U<QCJQ-%'2C'H 3X[8S8$CJ3O0FE37K]'RS<7)H6 8#D"#
MV\010YG;XB#4%C6F]-Z^'OA9K5O'>:(L,O(217JP"., OZ5QU?XC3X&K2E.]
M2,'66F1VL*75^UK90.J*L\DJ0\A$:J%$S*[J$I4GO4_"&XAI\P_EWI;<+CS-
MI=F)5856_P#JT<KGI$+>VMF!%:4Y3;GI[FD,_D\QI=6D>D%55N,D$Y$W$@\F
M2*XT_@  1\1]05]\C]GYC\M>O<1Z7=VLC1(QO);>YM[V1#,:$O\ 5K.*,LU0
M*$UV-%IN.H^4=.TZ_9)[?1);:S4O+'/=<HY+J6O ,H=V9]AQH&$87M4MGJ/R
M+Y$:)_TA?J!+]J-G =E&P8U('7MT]@,[-;:.EL4WX1!2_(U+&O@!M_GVR76=
MA&L4-4Z;@="/N\,FNG6<4(CX50-UJ!4M[U_ADCB11U0EB1O@U& +5IU%/;Y#
M#2 <J,QJ>P_5@Q0:@4J*=_#!0 "K\5:> RU &^X8[;],5#MV._3_ #WQX-0
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M&B<J7155F"EN7$51J_"9I?1WOU/1GFCBDMK:)[6VOH 6CG3U'EX\]N17U3U
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M6\<$44)7B  .*T^T/EV&&MI$'D#A2U=JTJ*CP^_)%;IZLKU^-:#8;=.^2>
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M"JB5B#V93\_FJ$(^$^.U/#H>HS'E4DM6AJ!2NU>],L5 HQ&WP@DUW]_NQZT
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M:^)\?NPWB<LI%!1CM[=L,H4!WZ#O_3!HC WH!ET&W^=,HG&&G4GOC":BG8'
MSL0>Q_5B8KM45-=SWICRO^3O45'7;IUQ)TVH!T/RPGND-/LT['P.$-Q&IYA@
M6'@*]5KD:N8V6J[#;:I'T?YG"6[4DM\5:_, 4KV&^1ZXHC@'_==&X["H/:E/
M'WPHE"RD?$#2K+R^U4[T/3IA6$4)=IR(;EZB$C]H;DTZTID-U(6D;SS,O[H
M/*'7DOINP1MM_@2M30;*Q\!3S?\ G5I%MJL2I=*1<O$]HUX3ZB.)*-&9WKP*
MLP!66FY&_P#,/GMJ>L>8O)^IS:9)JD^G2AI)HXKP\["XH:R,0WJ1QRCD&8K1
M&4B0%5.&\/Y@2K&C>9O)5MJUNJCE-$Y2H8?[L=$CD44W5PS*3UKUSKODWS]Y
M=U%K=_*EN[/]GZE=W$DDT,M-PAGD#&G7X6)I]D,M3B7FB]M;W48]7:2ZM[FS
M5*6<C-'#RCD#,3%Z157JM.?7HQ^$Y*H!+-Z-Q)<-+-<J73U&-&J?B5&8E3Q.
MW7Y#?'R*RM0[,2 =M^0/AU^C&FA(V)K1:BI)'6G3^&6#7:H)6M-MCX9@^U #
MR.QJ?QH/PQ%B 2 W'PH.A_5X8QF!+=QU)&]!]%:9?V3RH10T/:O;WI\\>H5F
M K0#8C8T!Z[BNQRFZ5.X) Z]:?PWQA;N#\1-*D_1VQK+SKO2FVXWWI@=D(J"
M 2*T-?'IOB; $GW/ZN_3KOBJ*&&W4#IM0#L=A[9]K?\ G!_\PCYR_)JV\OWE
MQZVK_E]=-I,@9N3FRD'K6;G?H%9HEZ;1_2?9&;-E,RJI9B%514D[  =SGYZ?
MSK\\'\R?S4\Z^;UF]6RU349%L#0T^I6]+>UZG8F&-2?>N<PWH/#8;UZ>-*98
M9>5#T- W@*'L/[,OK0E:&G+??QW/7$^7$?9K6O3I4_1XX@6K]E_LFG\-O;?-
M4KT!(!(Z]0>E,3,@%%V)(Y'?Y=:TZ8X,:;-U Z>U#^(&46(>C;4/4GY=L<*E
M5((7CL:5Z^';YXY6HY ^*FP8=-]J=\$JQ4$'K78=3M7?*4\N8W)\*U.W3\/'
M%!N PJ">U>M.QS!%(+$E0._3?^S! @/$-+)Z8K4C?E0]Z"I[]\$(MO*R1F:2
M&9V15F$:TJ#3<<^M3U!\-LY1Y[TJUEN+5[=+KU/JB6\DBQ JR.24D(J"P1T*
ME1[9P_S/K%OIUK_A>&.TU"VMG5KNUG4Q23W:CD@D?F.2HI^QZC=SMMD>L8[G
M4KY!>VUO%<W1,*2K!Q]&.BAPB2%M@H&XH*'>H7.F>5R]WJ<<^GP-=O)*(+6B
ML9KHD$( YJW$(I=SMM7[*D#/H%^5UE;:%H-G;1,DNHZJYDFF92T3R$"6XD+
M5(^->G7X0"0=O5OEN1(+>*$N[O&BNS2%2QY*/B-/A%2-@!0 4Z9*X+Q:NOJ"
MJL:> \>M?NPXMI]V+BJNP&YZ4[!:U^=<E5I(*AR/A/V6H1U\03AY%( PH=QL
M*[?CAA&?B!+\C6M>NWC4$8.C)K4D&F_T8<P?92A^?B?QPX@ I[_A@T=M]CC3
M2H/CTQA[[[XBS$'M3VZXFS "H->V($U)/B/PQZ"H&VWZ\7   (- -R,3(657
MJNZCIA/=*.)HPIT]ON^G(].-C[]_GTR,7C@,4 *,*#J!0;]!7<G"*=@68L&/
M?X:?0.M1A'<M& &J.-#]DU(KMXY''FC;F OQ <B*&M*]" ?EA!/?A?79:Q/1
MBP8D@%M_ZT.1V^ 6Q^N1@![252>._P ?%DX@&HHZOL#WH-JYY\\XL)M.AT^8
MG2GLX60,5!26V=G]&=%8_$J>FPD0?$%SQ=YYT$:M9R:??Q21P6TZH_QJT]A<
MH3Q07"'9'Y$P3;48\'%)*'SO'=:_Y'U&".VE1].<F2)%"QP7R<BK'A(3Z4G*
MJNJLA60<21\.=FTN^T^\M[35K&06,\S*C136C.M5W$;O&\; JW=SN*_%7)SJ
M+HUG:M?6REIN)DABD:5PH/$!*D&F]*-4\2-OV1V+3KFTN](.F06%O;QK"9(U
M=IF]"5(5=$E:3X@35E'$A0W[/7"1I5E05B4'X2)%Y$_#L02SM4;C$014;5!-
M:5-2/#OE5)%1^T=B-NGR^>V9NXJ:D %1TIN.PQ,5J./(%NF_;QIC"M"KLM0Q
MK[5Z4VQ] I4$4"BHH-^E<4XD#>E*#;I\M_#'(C CMV'W^V(E1O\ $#RK0D]O
M#:F),058;@#H>XH>FWOB95@*$5!%*GJ#V%-Z;8@>OPMW&WR/4&H_'+#54@BE
M.G6G3OO[TSVA_P X,>?CY4_.-?+5U<&/3//]@^GLK'B@O+<-<6C'Q/PR1J/&
M3/M/FS9PO_G)3SK_ ("_)3SYK44WHZA=V!TJQ(^W]8U BV#)7:J+(S_['/@0
M"U .@(W^^OABE"-T)+]NX-._>F-KP!"F@3I0= -J'&<GX;G:HV_'M]^-#%^-
M*_$=O<#^TYB:J#[]QU[?=3$]F#5'PUKOUH*_/??,:DD<>)J"3U]Z=_#$@HH3
M6FXW;I4XXT.R@BN]":]^_3:N+I[5XCQ_6#UQ1@#T4]SOWW-33PRZ D[$*-J5
MIMM3%>)(8%BO3Y@]2=\<2-SO532A! H#CA7IN=B??M6G3PIBM*#[)!/8@=#X
M#]>->O&AJH#"A&Q'RZX8PPP7EG>V96-;R[C:1+>1Q$)7XLJO$[%44\J$*:5.
MZD[ >#]5\NZC'?:C<Z[;3V+03-6&:%T=VE((^'CR;D %"KNU#NHJ<D_E^U=+
M69M0N1!ZT2UL8N$K6UO.?2MH"J!P)IUYNP5*T"C8<L[9Y3LHY+]=,LXBSP*8
MYEC^!0\G$2JTI8L6W4$@J/LY[&_+N:'6=69K60_HWR];M#*XJL3,"8T6(;BG
M)6HWMR^R%ST;'.L;>B@W#!"4Z,U2I('4_9-/ "F&]E=%EC968!JFL8KR/<UI
M[;D_VY+[.8%#Q!^'HWPD'H.M3OMDFL9JL-VHK4W:C=.]!VR302<FC'%?M;F@
M/A4=<.HS\*"@))IM]/@<&1/0D@ BO;KMUPXMI 36OA]WRP[@;CO7J=L%"11M
M7<Y;2 4[UQ)G-.N_;$&DK2HIB#-L:Y1W/3Z!BZ$ #>F^+I0*W+;?J3@;E0L0
M31OETPKNB"*MN:[BFPR/7<JL&(;<@BM.V0Z[F#5H&"\J$M0(*?,C".YE'$.S
M<@I\5;H:<A2NWTX17CDPROSJM=FJ=EIT!K]^0BXO4A8UJ"W6M 9 34$ ]>GA
MD9N+\2 R?"2/AXL?<U0G84/0U(/? LA4Q7EJZ&2TGB>VGMWI5XI.@'2C D4(
MZ$?3GG;S4;B_74O)E_>NNI21&_T>_B!7DW$EASH.+ND?(4I\:=.2R5\<W^J7
MMY%J$E\R6WFKRK<R:7JMK$A"SVOVDJHZQO& \1 (*'C3]VI,(U.QLM9@N-/E
MB#*U;B*8TYDL* CB" W$ $THZC>C(V0/1&?0-1FM)Y7CLYW*.["B/3XD+;FG
M)1T(ZC._:;82:M9"SBE@MU@0<5EH0O%'541>K J.^P'O3.FV=_)<6D-NS(?3
M<"1D(8^M#^[9&<4J58;5'2GC@F6I.U"1U[#\",TL;1_'0\A10 >W<;C$PQ K
MMQ)J2:[GQQYHH9OL[UW^?B,I01L2U.Y-#4C^&6%'[+;>(%#N.FPWQBJQ(/3P
M^=.OL<$$*RD4%*;TKL*==QC#MVXBNY.U#\_IRF0;BI%-ZU\/'VS"(4H=O\GQ
M]C[8FT=*_#04%.7AUZ_/$?2ZB@H3N?#PV([G,8*DKL !RW]J'WPW\N:[?>5?
M,>@>9M-*KJ'E[4;;4[5B2!ZEM*LJ\J=JIT.?I!T'6;+S%H>C>8--D]73M=L;
M?4;5_P":&ZB66,_2KC#7-GS7_P"?AOG#T]+\@>0()0?KMQ<:[>QU((6!?J]K
M6G9C+-_P.?+LDB@!+ [5 '3'B4;CE4 4H.XV/;$V<&A'(+_+N"-SOB9<51E&
M_?8]Z5Z918U''X10]#3MV'\,OF #R.[;[]Z]:??3$S[;<MN0^5,H#?B1NVVQ
M'A3Z*8Y:;TH!VION=R.P]\6"]:@J17:E3]%*>&9O\HE13J-O;VQ@9CR/&B@T
MV[>';%U<U%:CLH/4?2,6Y]'9B!0["@W)RU)5@012N]?#IU.*\0 >*A3W'?Z
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M ]8G^,%=I!5H:UH[+6BGKLX!Z=\AUO,+AS&BD\'X(.3-R&S#XC0T*L?]C7.
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MM4?9VJ/>N(FYC*HP/&OP\3L/8D':M#B:W*.#PW9NK [4'OWV.V!I3*?A]0A
M13?8=J#I_;C%X@\20JH.O<U[=?OP4DG9HE!)^(#<_+Q&V"!,YIV!!H*FJBM*
M$DX7R2.Q;;DU2?$TWI_7 9N Q+MT/*@[T'OMU.%%[=\B*D_=TI]V1JX)-2J@
M_L**&M*[],CEX6:H#%^HH/BWZ&G?(9J$4LD<C, X '%3Q '6E2*$T_#(K<1^
M@Y9C4,VVP<L2-V%*]?&GTY!M;N)"7/)B82QXI&K*@J-W(Y,H V/AW'?.3:S<
MO<2>C'(4GG7FO(U)'*K<&)&Y/2NV_N:D5Q=A(I'!-(XA(&+$<&3TRE:M7LW3
MWR(^9[^%7AMIT5OTNC-$Y:H^L(.4:L.@KQ-#_K9Y6D1H)K_241EF<M<6YE!0
M>M Y%!4[*4*U]CX@X'\OFUNWN[.[C$MM?<+6\CW64PSJ/JTX*C9@1P:H-&4C
MPR;^5/+4OEJ6^M9U$%T!Z+7A(E"4H'!9F%7*E#Q5:U%0!3)W!%9I#Z-JDK,#
MR:6Y506Z'DB*6"UIOWI@X1LJU W/<[@#OOXC'!1O511>FX&_N?X8\ A?$'<[
MCQ\?GCZ;#J :[>U?[,>5)J6%"#7?I\OU8K3X210 >&Y)VRU 4#KQI]W3P'6A
MQ_(['D .E#N1^K*#D 4V-#6AZ&I^6,Y=QLJD].X/\,:'/V?B''8=O"I^BF*]
M]CQH>)IW V_#,"!T^&M#X$;?+&&K%2!514$=![=,3<A1\)J#MT';K3Z,8KKP
M -3V]MAW^_$7:E"H)&]!4U(IGVV\M>8GU_\ YPIN=82=C-!^6&K61F5ZOZNF
MZ?=6;-S&_+E;DGO7/.O_ #\3ULM>_E=Y<1]H8=3U*=*_:]1K6&$]-J>G)]^?
M-7F% _FI6FU!6E,2$A'L/LCPK^OME[D;U[[#V\/Z8X.RFNQ'\.F)$NVQJ=]M
M^A^>4&^+BQJ0-J[#N>GR\,6!K4]"36OL:"OSRN08[TJ112-J#QS%@#X5K4]?
M'<]N@&-C^S0FC@4K\Z[X^AY4 "+7>M-N_MC1N":@T*[CX@!X]=J92].5:&I4
M@[^&Q/C3KCRQ:JC;<[>_3'!#4CF &KUZ[_/WRC&66@!)/4]13V/TX[TN52#0
M^/<;5]_''<6'%OL\M]R/U=-SET!X *=^I8;4\2:]:[8G.[GTXU14ABH1&P#$
MLW5G_F)Z>W0;9%=?C>;2[ZYN+D1I8R)</-++N(A\% E*44MT! WV'A"M$LD:
M<:U=Z4VE?4PTT5W+)S8 @*7C610JN5/P,:",'F:_#0'=Z_<^9M7>RTV19Y;D
MQQ/=3U,<8:18H8(D!Y4 J1_-0D[D4]W?D\C?X8WAX)>.[JI-7:&!S'$:UK1P
M*GQK6F^='G5V;[)52M!2A4B@/PT'^3W.'=C!0M#QK$[%QM1E!%*=!TH!X'#J
M2:#2["&6YA8B(2F**.BAR]=BYJ%6N[$CH,C">==9U2-[;3 D*AE5*21F,!*!
MEIZ8:GB?X'!E?,T"Q75M=2!I1\2V[%!RJ6(!"&GX=.F^&"^>];TR+AJ+7T,;
MD"-O0$L7QFHY,J5 J#RV'SP;IWYRZO9QNL^KP1,CHG[DHZ@,U!17<D?8/95[
MYU#3OSX*0EM4MUFBY<99;1E94!%0&'Q$D5!/2O4 YU+0?S'T36H89X+V()(H
MJRL.!Z"GB*$CJ![TZ9+UO[>Z7U$*R1NH(:.IJ#W!4D']7OA=/=*.0#*X:O%0
MNQ%? #M@?ZPU2214="HI4[;G;I^.*-J#.0G$BH_:I\J[4^ZF"/4C"A04HP'N
M2#T/$;"IROK!-.*[]E4U)KL:'OT^_-)< "M  5J&I5J#M_7 KR/1E93R/<['
MB.Y-,#1,& *$(&V]J;[4H=]L0N."*6]0'EV .U*#;I3":4Q2KZCL%I522I&]
M#0BF$5S'$"TCNA7IN=_BZ4-:;TPBO$LV#M'-%&U6(CD9".QK44VJ-\YKJL9@
MN'1H3'&J,4XEZ@'XE92HW!)['OX9R/S#?PV32Q-,B*VR%*AE+4(H"1R&YZ#O
MG))93)+>7,:-+^Z<(' YD.Z)%QH/A(-:$5Y;UR.F\+6\4TCI*7E"T H.2*[%
M%Z$@EA3?Y;9S+SG<W,6BW$EO<3"XT;489PL0#.5,S&.3<;J2\HH!W SDGFJX
MBM[_ $?7DXSV=QJ(MI&A)JI=""I Y5)7EL3\2\3UQ72UDT_49(9E)DLW58F5
MRJW-A>D21JS&NP<-3IO3QSK.FBP6&<30RW-O(IN;>8%8S(5']T6XL:JB&I(W
M%"-R,%6R(-Z<2:D$#IX=SM@]PJBA/+CL.PIMC^O$MT/$@@=!T]^F- -!45XT
M^?AU^8Q1"*5Z [@FAZ?[>."@,33D3MT%17;K3%%I4@@ +7<^'C2E,MJT&]30
M= 1[XQZTI6H%#3>NWOXXRM*UH_'M6@_'++$D=WZ;[C[J;8UN/P@GB:4(&Q%:
M;=_#;+!8OTK5@/P';Z:X\@<2>>QK0 &M/P_7B35I\0XL.@/>G0BE/?&2G8,0
M5+$T;H17ITH<"EPM..X-&H?'KVZXVM0/BW7N-JU Z_1GU3_YQ[UQM4_YPD_-
MNQ:0,WES2O-]DJU'PK+IKW@-*="UTWXYPC_G/G5?TA^=>GV"FJZ%Y:L;9AU
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M$5J#1N5#MU]A]^)A:%0&H4[+[;^V)ORJ.)J!L:]STZ?3GKO_ )Q:U8Q^7?\
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M$DX,.)(X$, K4XD<@Q[?+VX=YS^L2:1!?:>)+_3;>.6*\BC+.ZQM548$U!X
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MU= H*FC,0#X"AST,GY3V5K!::[IOUF#4(9HAJ($SL;J(]&HQ^%E)VXT^\8/
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MJWVFI6HJ?PKO3%#NQ%2:U  %1X$[;8\J.X)8T%%'7VR@H6H&W+L>M/'OCUH
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M[;8]2& H :CH13H:;T)Q3E4LQ%=J4\:_V8USQ)J=Z!6VH!6E.OZ\W(DT%3R
M) [D>_CE*KT)%"Q->/=3[;X(B1JJ H"C8D5Z;],?\-0QH =VJ-@1\S7%(C16
MJ  :D&@J/]JN66I6@(4[?12G?-S5CO\ "3OTW)S U  ;D2:5["IZ'H>^91V
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M)#(LQ44H8R0.E37N#3 NGZ,OF"ZL-.EBX^I=QL_$47?D6IT ^S]_SP%YXO\
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ME:[FO4=NF%LZ)$U2*@T!IVI\55V\?P.%M\Z24:A+$$&G@.Q^C"@('D)4460
MU4=3_M9T325XQ ?R*._<C;\,@_F\+Z+J3Q$KA#0[47D:_+8G.0TC#VO/JQ>X
MD"#D2Q!X]=ZC;Y9(;*VMX$1T)2X=0&F8_O"#M0'L/E@J70K>?TY8X*$$TJ2&
MH#L0>)WVZXM%H[,S2,OJ.2&Y'D6';8AJL/:F![CRO'<'BVE0<202\HF/-NU
M#;;>QJ.VXP+_ ("TIRMS-IMI'*&JTDT:RB,[?80JZC?V]JG!,>G6>FEK>VNN
M$BI3TM)M!%<.>OQ2>BSJ.QH-^@R.W>E7]S<I=^K?I(C$F^O"A=%7HEI:,C
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M0%9> KP%-C3KUJU<Y+K5^IAEAIRC>BLJ+RY!*;*#T:G<#.!^8[_U+NY/$&>
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MG;<+R50$(ZTI4Y OS U07&HZ?HT0*0Z%9J)!N!ZDQ9SL33]K<TKT\,@1EXT
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MDAM;2W@C5M@58^D69>H9C7?."DL!4&JUV4_%WVK@FWD:":WN4YJ;*=)>2&C
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MP%?;//>L_P#.17EBRN6M?+EK?^:KQ6X 0H;> L"* RR"I^A",[/^6VJ?F/\
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M8DJQ9OB7?KX4%*9Z0L+@S05)J2O%@M * %2*#PJ*;8ZVD^K7B/\ #50J.2:
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MP /G7#OR9Y \T?F)K,.CV4?U:T*M+.5/(101T,LDC 450*5H._$;D9]!;O\
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M2:,$5J>0H%KU_"GX8TH"!0@"I]OI^?7&&-6- *!0:==OIKC.))Z5IN:U&_\
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M"Q\M:7;C3_+&B6FEV:T_<V5H(E/@6(05/B6-<5U.:6\E33;:HCE)660]@O\
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MZ_E#.U_% ;49"H?9& [+*;BQ?L .7V)=XMY2 /74Q&A8?%JJW.4Q]DTPK:A
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M%WX3C'?6"I(^)-P/IVN/>^-6ZD67.":0%NP50J!-ZF,B[0/W<GLYJ!!!BEW
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M:]6YR,:XSE5 Z%)CF2V3XNJ=153TJH^*LBZURV/V&Q$U\BN3/_#UAH!KB-P
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MHLV@ZNFUY1N>_SRTJ[G_ 5!+ P04    "  N4UA6FG,IKZ[P  "T\@  %
M '-N>2TR,#(R,3(S,5]G,3DN:G!GC+IU5!Q1]RW8N 67X-JX$]S=W=U)Z";0
MN#LAN&L:=[?@3G!WU^#!@SN\?&O>_-:3>3.SUSIU_KE5J^XZMG?5?5]^_PW
M4I15D 7 P,+ L,"P  #O9P 6=5N(*\3%%N)(^8F- \ OJ: "=P;X#[#^LP(
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MGN?L=9Y7U_UDTN"<S"J2Y_*+)8#B4[;;==K+?LY>6M)X;=RG'.ZM?GG>5?@
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M8_Y73YK^WH\&!4IF8J;@Q2AQBT5-$6D.,IC$;5.+&_XIA4>M-W^X*HFC@<,
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M8>@JK($,?@AV%A!+$.XWU%QD],32R\0AI("LPA20O/&KE7JQC^.*F*G,%]G
MUM.:FHJRC.@$%,)=?&LV55_*C\:?NV5<S,\W E'OJ*F%?X?WXR='QQV_2\1Z
M8OT;5^9=N^.MS4$C2!#Q&%+S:(B<ZR3D+1=*6D<E%YS*>&^>43,EQLG3:^)G
M0#*+IWXQV,T3%\[O51(P*7',8FQJB]7QE3].A8^"1G)E\:7^<6C_3()*_.SK
MGO^5@#%"C:*#W/'DMD6%_O'B$6MF^0))*.7%MD:PH2KJ>M>2Q?SKBD]\Y18R
M;/*YR*4#E58$?-BYL'.J*,#M<HLKFW5$#??IJM #'AJJM83#T/]"%[7TVM'%
MX\!CZ;YNM<R5H*'HVK]G6>!?LL8H8=(AY[\<E;I.WEFQ'0[+>VR<"%IC#*(@
M^R>+!@M0,<$4)2(!CT3_^D;0H=KHG,W^.X";9=/YBL5:NNE:P>B9\$EWUN-9
MOJ!0U?-,QGI+M/41Z1IWY!WPH\NL^9H]\;;4+8;+JE<\+'KQ:K:8)!P:1Q)Y
M8]&RKB-/9_?_-$%Z#&,++ KU3<'0JCU!]XR2_KGU]77!(3P-R@JA=BP P$W@
M:ND?0WESOM>ZMMOR$KMJ._8C&;VU9;LMJM2#!I\3F?^9[O5U=R?SC"S[F\/&
M3:+51S)@Y"\L+E+/\* /(UE0HA6)@, 'AKO?Q<+@INOPMAH D#:72,52F7D[
MP57Y'# K:D8CWI+3P"U^0W7CX1YZ*FXP^X;;>C?4^@7V'S>,[T\8OFY%0R4B
M ]UINWVV%%<75G7:<!F_/DG[!(("DI?C=<Z3(O H[%LYT,2%DB26? ]6H6M]
M3"L\6U0<;\?4^E.40L+? J\;12=LHYZ9M_ BQ^[+Q_ ,?6>21JF82*X-M9/$
M:Z$>0$LNVS:9"@4G)Q>(O:-^&87!)^5A-5T/4YXS\:KK7XZV3Q@EJ$5MZ\"F
MWW4M#=KFKT$@!Z9(!F_DBA2OO78B9MK;K:5\F7UBP3KUJMJ#*P[%FG"56NB:
M1%O@AG^TS\=O\42LKXAN&DOSGVTLL[F-<:V^5!E\CS=@[4!H2=;Q9]6JEPW7
M:3Z;MRXZ;[0GES]HBYVUXB@UBC-51#T;14D^%V:.>@>,]OI(QRTM6,V"QF9B
M9U=1\)(:]14&HW;5'4V:<W;8+J,>+I82FZG<S/,-2,QKP+"U</V\TK<UGU8Z
MTA#56,"2LI9=C=F%P^5KSFL+WI@ QLPYO6NZ6/6KYFN5NC**CA:%Q))<5/^E
MK00%-Q(!6F0V-V0;1VW6R:Q/J FM=#BR<N>Z R:I1JEJ6C:VB>("&/LVX4%7
M>Z)>)%USG\'I/$)*WTHH"859N\'DDMVJ']<,C5F*I/T+<XESXF*$P8#GOP>S
M2@0)(!(%:FU^F4H=(7O9#\CW J)7%YF^0_M*X<5S;BCDJ!CJZ[#:,6TA<\O1
MMV))8KPOG0>8JG.Z5OEV+.+,'**98748WGI;0A2T#J(_N!#Q]Q DECU(;,J2
M&N4IW"U- D7LMG#4^?+H6P8P<1H<-B0&<15U6F*3[X9&1WJTO.V-Q3OE'73@
MFK1PUD)J+SK=QUA.<Q'7LV)I.,P!>63EOH[,VLZ4]HI)L;J6*9]Y_M(TT1GH
M[9#)+F<D+N2MYLBJ!K"] SX)[S[J'3 (C^U5F9KPWHH;[&R<5>\@%I.D@_&G
MG\\QCJ74#U>FAC$?1Z;HWSSTBS/?<M*$G^V(^+R!L]JJ6#HE=2YJFH*H*<^@
M9_$JLDZ>_[TF?PH=U/ \^HP(XO\K:M^9<HF"/ZO@C] =]R*UTWQV77<AIE+:
MV)XO0Q136X_#6YQO+EMCQ89$#9B4*TJC<TJ8"FR*TY7W16H?P9'EK\EG6KJB
M(%28/'SZ:HM&&3LS4@AKF:;:1B06GIZS7%B7 ,-"%8*M^ 2M.ZEXR7<.#JO%
MDIJF9>"YZ!3.<@0\.?!F[:ML(9;DO ?/$ <\*BH.J'9XL_O 1P26!R?59Z4I
M<H-Q(H8W5\AW9-E#8+2Z8\"E8FWTZ2"7>P-]1#1N<$:Y?UK#EMA;R]F?XD.0
M73;(:[>Y8<YX=96@$-2;Q$_B?).<I(9>*I1)L3]!K_U[SMAPPUC)ZW5 A-N;
M.)6+K]B851CY25:>E=M/T(LVUE[LQ%FRJ)/$JPR;IPAXTV^MMQ[L;%_\B*A4
M8<O6T(G-=E%M]]Q=T;B]W]R;=X(S[>$@MX7.)ESBK4Q1["#6EX\SVFV2:< D
M#Q :^O 5'4F1#:\YS?<':1I.=[IJLW.@L!UZWE-;3! C:Q_C.\!&\=G"I"MI
M?_@"V-K<%A-&("=Y:>Q7KTJ>F*V*V0BZ[L&Q\R;(<;QK*TXIQT9[.[(/*\#^
MNPLL2<S>*<"8.L!(^]QW$Y#H)J)0*$8,AB8.9^IUBXFWZ_63U6:;&(W>SZB(
M%CSZLUZ4)%7NG#_QF&$H8-L\EUT$5CN\5'TL3@U(,]65IIGG^VB(?Y=_ ]0L
M5FKIH6E!NZI&".#Z$X2KTG#E\ -NN,CF*35)-#MZX<% NK[V"4#!$@V^7W0?
M86SJ3$7;1%7I3)(AY4PUF?\!0.CP$)B<V,PI'6-HO6GMS]LX;,-)I3='CL1A
M-&W?1G]IT_C,'F!!J)/;W!A1&!"V-\IX$:^BZH-UNMEX-CZ+H416&XL@\7LH
M:3:;B"+[F-&3OD28?>Z5+J"2HE@L./U$_SRZ&WU4N;Q!/50<[E5#;2'1CK%$
MO,*#_5P%)E9]V]:=FQOL1T0;8\HM8V,46/*;LVU8\F['G8<<22@M_AW Q7[C
MR;K3W>&G);FCTPIW8A@JK("_7BHB<92=6=_5V-7X_7Q6![KI2&2@XLY/';,@
MI57,FRGC?:9U+:"\P+R9%4LGSV(P^2IJD([JAABR'T&P!SOGM&[U+2M]7JNF
MB9(4SK2!>_0+FXH:.\9C3AQ6XY$D8_@G+)3B#4XVI;H2JL7T)"QYAR CUG"+
MUF6(1)0!6&]59K^XK&AKJABLBU-XM\0[RZW5QT1<F##\C:N6.C<DQ^@=<$C8
M?<CYU??!]1U Y?]E0ZKX<:8,,:>2C]#>3?=/W<B=+G-(+=SIL/\407YS]_]&
M7Q/8A;UVQ\S2_ WG?9<..B5<SVA4#9,6%0IYMC\PJIO*44<6'-C"T.PT'\8=
MUD#%!&]O<S3H%:\FT\]=LXCIZ/B3$^'K*=;2JP?:,"(!59X^S+0*SCIE,D.4
MP)M]XR9-8R>XS>X^7-B2"#S\@1876HD\$=ZCF)T%PWA&0]+UY6PA"E]]V= @
MQ%P'M2X#PWB)%;LNH(&<8?!0%U#*J3RR1M(1HZ+""$2 LZ6BRH&*?J0G\K'$
MY?7'(;K=N%*9'=UG[&/#_N]U?;3^-3@P;^=YM)%OXU;;%(VZO:Q2"O,0&\N9
MIA)/Y,2=JR<SU4U,K=/+[[G.)>)#%L\"_%?%"04@*O;J:LN6;#I6[GO1]-C.
M8%;/.G(66[$T(#0-VM!; R'U,,S@"I77Z*I!P_''.5?4AC2-=@VAW9RY:((*
M@C>O^N3D'"0G0<"V5B[4P-H!._B&.V&)D37P&RB%R,U>\EZA_H<G1TJUZY6V
MUC96_!)=PW%O-U7"JZ+2YT02'^:*'XHZ"C=%D0E9(W;MH8[]V;G;='DE)VI>
M9!V,12HHA@/'QW$46&]C ,2LAVA^L[$+7A,@G^Y3;Y]N_B][GIZ8S$"FT ))
M.7!F8L!HU\) _5#E\=V3=$+)_1+GB$ "IBQV/2UHI]M=AKTCKMB895HLB[ZK
ME0<-H;&P8 $NOX(#[U$+0AJRZ049,Z26H1U8+/H0#:(6#AY!IJB;E#TP6N?A
M@!IUTG$SEI@IA^>V-2]F*WTS9QS&QX7Z1$>"G<R,^T:9-R1M%2I8+CXY:2Q,
M,>"4+%M+WI%X4IE?]>&J$QMOXN\O[6!SY^JM46L9RWGH5QDR)_/LU=&TX(GP
M<I/?]J 5;2EIW]#\9&^DCC&8"COO80_B(6/SH0W<Z+VS9Z RM?4C +HN!\KX
M.G(;ZO0/BLF,CQ_^COGQ60'S:GXFZ$[,7\2J,3S]L,&&P=9+A]^=,IB)3X"R
MKJ'A0YVQ<0=5<JUL!:)J7DHSO'7YFMRL4JZ*^O XP^BP+=*C58QH9I+!*CN*
M _<MGT>J0QQ*K.?CSYS0?-K$2B(Y17O55K&K+UE#J>=%L29L.C/2D<U-]6/,
M:N;GMF1:V^0)9V^+WL&K5R0/-"T-\OO!.A]B<#D^5$W?"D2*,QEDZ2^&%PK0
M]\PF]\PJU:(&$;0GM99>\H>0&^& %EN5AQQH.C'O=KX^!ZJ.;1&&[ +/AM6M
MU'I[R/ZH:BGUO_ 8WO8_+E9-![WY6-*&YZ%/W_:OQ.[[!)!6YU?5_KT?=+&4
M9S9+I9:17SZUVXUAD=C,2W/T_C(/>1P0>QQG-P9MI6YEK);Q88S8YWLE'I63
MET0:F0W[W* PGLQ,^-/<7/PO(U[N9>X@"VG$&Z/H /()K $R9$O!3MW9T:HE
MP]>14?J$ UL*7\<-VWK)?KUTO6;V<G+-T-$6<]/-#&*GMEW5D;@IL(13$2#A
MKL;3OC'[V3GR>W_8P1S+:*L/CPM7\A50,T4R6JY/%BO<BAVJH>ETN5ANF,T]
M,5&NF'1)UDX*686?G_=\>+;2T$_$U)K#8],)UHU488[=TTZAM[A3I2-2THBQ
MV\+N[FB>8W%@9Z?79S67O!(0 9QD:U]_R7!C%SY60OPA-G\C(@@.P]\>;=>Q
M)=I;+>^N0!E*9Q'.LV<A=E7BN=V\VC1F(H(A1^N'AJPU8?=Y5-E= =/2N"2*
MPO8)$]#&F,FK/O  DU[&70K_^*MV=\8:[<\C1A35HK$.S+]55GZT%-=)7NRN
M)W[&332JHA_C);@DM&Y;.)M JG(R81O5@3N3GVW?&/9++O)U(G0]4:#]OJAT
M1YZ'!@'EL1<F4^<G-I3W!_+EB3Z<&*$=IA3._HY: J%&900['(:*YQ40V+#X
M9 U]A4J1W<^S2:&9\+#,AM/9XA?'QTL'XX67B2X\<1)!V!UV]<VOR2M*C56(
M$+=4Y\**U30)O!3+4&5OQ$7^(E2'E1WK!!^.[0S\*7)@XQ'])!10=J*@EAB=
M8_C(:FY[<4MD7G=0*/=A=73\LS7>\J>A?KTADE*%1X_BJ+#YFJ^[B9+ETZM#
M/&,<%HH*1VQ[ 54WF30F<F,NTFFBAE<#_4VI/87-SG_ ]O/H<1?59%@O$0*X
M2[Z'^QE.7."/:<Y >8V=)BRCGBJ5!-'*0(X["G^G+*6)38UVHZ@,>^JWQ4DV
M*KHNF1:N3U^E&2=-2\K(N 3$TED/V\*-;'73?OHR)2C %O6=-2(1EC<L0Z?-
MB81':L#-2D4@J&D:EB4U=E4=C(*H< _<^ME6,;N3S8$"L>?OA9KB1CST)RY;
M^[-"-SQ+(APV<=>5YN&31VNJ[./S(QS-;H"K9>5KB)+LUFH8(W=I27-@;YM?
MZ8']05$?(3FD 963=B%\G7&UDU/@YGO7Q_$:RO;FF$(-AH=Y5J:?L&JTE(G(
MO6,\.^@Q^RT^GYT4+.EJY26.MLW:@02"VLWPB@XTWV>9G.9)MF/6*2*QPMS3
MFK&WRN!\!:!/ A_<>R?YZII=I"E1/N1,,5?Q#_LUD7&9V;BPSAEZOUC;SA1$
M&F@3*5O[JBOSW>+NFQ'K"9HE^@ZO\MP(XEW+NW;J9!SC"I1&@B\<A@Y_9IY)
MC!2!HS$.DHL%5I!+(*02,@(</(:["H@ISW7T#D"],ZUB$:-MTC^,L^FDM0BE
M?)>/^][?&W8;93=4>;*_!</P_'%"].PI)8';:C)X"&6\:QX48I6<U[[H]E7(
M+-,0QXRE]F=]Q.X^'OR^5\BYYC<%274P0P&<ND^5!ER';5VGG*@(7>5<2^EM
MW;MO&BZ>K[U&ZILH#NU1N[\#U'/J<M3_Y_]*!$]W4RH_V^?=T-)/*UFH?**B
M(M*!3C+$J1[N0@  ,/.A[AT@P/K/T/P>AP[H9V\,]AM>.J?I+(K77C0:3W.=
M^.KS1%3?TFFVM:8_\7IYMC[HQ.[Y/48YV="7*,:FWXJ F1K6*(AR@:<EQ0(P
MP-IEONTH#)Z'9LJYKU]H>6Q*=;AY+H=<2<[6DU(+X12U:NF_-L'/_<ZO"?#=
MLDN1D71]^Q$\B,+F&:+H<9)M^S)V;;)85R::9B$0IEIGF2+UMYT1,+QWZK&B
MUSIIX%;55Q0W(RBLFF9;66]<H4T%:: A0^,4(\WPQ$A7W>?>AGB585:!/RH7
MH^&9SZI#$;-5Z0)O4?-+,%@;44A_ .-7?AC-.3E$T^&] ]PJ/E$L2:R[C^#?
MOM7K:SA0S[(6 ]:D>Q6J]SBKQ%P@VEIO]:Q\?7[$HU/J+9&'.LV@:/&/?%P\
MX^'SKUURLY*^C*>([C$48V^?%ZN@)N03KG[$"R&;X-4(?<I8SCLK8%LV709E
MR1C2,8?!'_<JLNIBGC('"796Z  >DV*V<I(R+1Y2":'"_:2A&J*)S#[T[DMT
M R,@WB]IYC!+85_C3ALV(-F"O.ZP2G9STW9GAL7"GZI0\%NBL8+JOG224]QK
MBJB^1JZQU]:$DW$,L\8"Q"KB5^J:JIT=.AUE;\3Q1H=ES6GNV31NXC,%Y5B)
MMX?_Y]03G=8VVJXR1P?T'+8@#?FG]5?&X2>GI2;71-^5PB-5UDK**]UX*QTN
MTR'6A!3 <:I[(O>5;L8G8M\K.+]"KPPCG7C;U>)&R[K@^HFW('NI;OX"J*X-
M4MGGA_;I+YQQ8XC_DJ_MY_QMJ1LR*]#*BP"Z96C'%=RAZ7(BV[VOG=5\HHS3
MAA$$%&OW[H.XPV,M&Q% 9+2A09.JVO3>"5W/EAXT8ZN2(Z" $I:/$GX@5NIL
M4/5^S<K3<K"9JN"I9WW2FZI<CFX7[Z6$Q1>+@E5C90M;JF8/J$HK,]^ I)K*
M'XY9/UZ0*:-UA+F==+APY;KD@C^3^JG"*>]=O^Z@7LI9+TNMX%.H/H$V)Y9!
M%'&"CH!*$8!@9Y-_4;=]FZ?>22=>C@2W_V:_J:^[K@?*FOPQM7Y]=;U_,;XR
M]8IV"F@G4+@^,T3],4:?%>-!A+N*6KS':*I&F60N0=M/%\^2+\6"HLO1G9M6
MXN_P6WOAQJHW'Q]7T6824_A.XH8(OP6-&QH^4N%FO_9]-3-\@)F2=39L6WC^
M"\_K<5"C^+,.F=!VM&[]@ LIMT\&8Z$.F),.$8_JOHA!\-DZ>T>[)59*^(2O
M@J\TC5$SBGHN*)WM8EHC%/E^<G]OBE.A$O1=:-*LJ!)UP,-D)504!>FS+MF@
M,L5G7;@(A_R6U4]^,6F=7"V1!!8_7Q^B.-<CL7R=,F,D8T,X*7'&"T,B?G3-
MH"FBU]$Y5VAV@MT' 60@M6^1+Y=!O76;0;++&5RSA?.W]'W$9BF$=\>R6NHX
M/>K8]P\[GTL<;?_%^\Q2^24>RZ-Z15+7Y$06SFJNV,_O'9#)\\]*1-V:ZU_*
M7OKGO;RZ!LF)R2L<;_UTX>$SO'ZTK<L6;#O\9-C:U33[$_L_DIX<YH!#KG^B
MB8K"M+OMI?#*_DB0/(6/@G-3<@M]8U[%K)R1S"HB;&AG)^MC0 YM^6[$3JZG
MU4HS&29Y6"?7^CQZ*.*>CV60;6Z(A.+#',NY (RX"Y4-;(HH?VY F*,X#2/J
MW$I;M&F[]IS]=W46\758(<O,>0:$<N]=A?U&=Z&SM</,W>M/XY \6[:F<\V=
MFW3U8#@GL:^1S_;&5[_LM0Q^2$O8%\3C-[@#9#O<O0CG42-OA3[ L?\YXZ60
MDK;R\1A^M=R1W>M8NNN4,HR\^!OIB1OYZ"*[T*C4'K[3U++HABX=MQEZD\H?
M5.%H=<FN%G[6;/;A#WNYK;^Q6?E1!074=P3//SHM]1)ACGL?_NUX56Y5@7E1
MDL3_!\DK/4+EK,FQ8>^:FA?')^00X3@*/85J=#J+-T6RYX0L9KFE6X,O1IWT
MHV=?0/"^YFT+%OH:<)!C"5M4\ML/ [Y*I-PMU[)YPI?H5AJO[+3RC3BC;!*(
MD7XDVOJY2/ZE56KW!]@GT$I#.S\[C;9LH_CRS<+88D)8:/CBIB"S?7._/J9+
MYJ[^M<KKS8AH\=)W%'$E,AZC5]X_W2O:\H%8@VJ*V@_LOMQI8\WN3VZA]]D&
MN>T)C_I>#AM$O8EKE2E?0,64\W=FJS2";!F5C]\'N#?H)6>T1FN\!UQ/ E31
M,M9B9>.$\UXE8 '(;('--IN%KORNW1RLHV#B):B(T*/-C3WEK+J)J=!L=UM+
MJV-VD6#H?H^;18**VKC%A8.#96<=WY/DK-US^P\>U[FUA'W@!%,'JZ/:51GE
M:2,1K!^OO8L&BT,CNN33VR>6I]"78#[Y<C05%GMM^;([&IFRM:Q/)29>LMNN
M[9ZW4<G3PHVP%?H@)TDT8RQ1DK#P2O_ZI@M=4AFPL*/@$0IB],47"Y&B>N.?
MKPY[/]@.2M6-RU]@&U$#]?Q.,BNTKZQW+AU@1_^RQ";D(JB/2!K\D(R5S?KC
M\>M.5"N5Q),F<;CG<\Z2QV?F.[5^6V8IU66(2Y&QZ8 #3:-/:LLJD"9@(Q%0
MY(%7;%&X960$A*4^<Z,>\J#2Z!FB>L;/XRE=/^5$_R*>)-?R<ZX:J#\K0)LH
M08@8&OR722\O]W(Y,]9.5P_[%T%S<;]]B@,J1VPF8?G,V-E=#GC>[:B1T^O&
MQ\1,2;"H? SBA-/W:P%=9_GT(#E/MWP.'!+"G5&\6%&\M2;M4!B4R/P]!B:+
M&N&;<])B>R0'T%V J/OJE.#N]*[T,H;_KX3F%*X;MCP*!3HR@Z^@IT57D(,;
MLU*VTSN@54831W!:C2C_1W I7.+2F:N8,+S]Y ]!Z?[&QJ7>*%HQ-TKZ9 >1
MD?*<=F";; U=3)6^ZB5"8[M.:)8MD92[.::Z#WGCY90DU@2QO-ZV6RE-7G^/
M>;FXD)6"_?U:]Q2./SZ,ZLWZ#LN-$.K2DR4K,T>NL)P:>7J2PA XT9O8HW^\
M$X]8:PB'973-F:[]68]PH.(WHH9]^.>\$C72]=)<N(O?G.MQY)33MW?]CY$I
MP(L'*Z#YYOQE_XF$5JLH.2'=[-V)<GO#_"GD<VU7?0H;:[7]1@&4R,I\^+(M
M7B<ED#)$(^<?O3K\1QP.J:NZA3J*GOB,H?P!G+[UL.BZ6/@(I_C(:7_S _GK
M*.5S?3&7F>F\^_X'03<L=IW:G6-U53%:,/IFW(G]>#T1SQ&T*]8Q=ZJ?G'AA
MWU>'0/T.8*IZQA,C@LH*_UBNQQU.:N79(I2OH=UL^=L3V$A"O&M==E0KXC?(
M2-*R@U*^LU#*0VKKGC>..MN)Z7(UV*P29^Q,SKWF$HGT($\F<3%W&(<!BVC_
M3)HWH$!O,?]!T4"7,%ON01)VH U0X&QW^FE0U.5:^LWKFED.HE5BI'!K)P78
MIR\4I;/>E]"C\8U:-U, NASILJ6F.K_HL8QW2,KV^!K-Q*B.&>JY&/->W?TX
MWO234]%)W D[X9L4D=\QPZJX2X_-JDCR\QC'S#_Z:9LZ%\=D8%Q#TIJ5NJO7
M)6/Z5]IX,!IC5+%*,'/__BFK(39'N]NVRCJ0V\Y1.4C_*]'#:U4;1.)9E)]"
MM:.VCK&TS[LM94\Z?V-C4 -'\>Q6/YRVRU><_!"(+9;.<T3)R#J0'X9!Y\JE
M)IS"8ZT*3#*<C@>=90DI7U4MQOTQWAAG/6>3UP)92S]EK0C-@M:;<>_G^K"[
MFJ^>UJ=$"P) ;'6* Z-INE#GI!GM9N:,4#(TV,9GYD;'^S%B9:CPK%?P;"^$
M:0V/LZFFLJQUL9&(E-Q,M_G!$&BA%L1H$C**U/?-Y3%XWZVU8*9JW<[CLMYD
M75FZV6G@)PSW']0"S@W+4!FAN@O1*Y.8K-"8_8%??$^=0[@!I2;#-$WL6&*M
M :H_.60V$DA*^OZ>KY M^0XYE??<+ZK<LI(?B:!5F?X-AS0B'\OE66"5QB+2
M1%8J8J&FLCFSU&VL*WQ!KTZR+\G@N\UO:9'ZLYJ[3&CE_%)DM2B+T $;?=:=
M^J8?-CU_FXQ9:C("-"UZG=X_5D:BE9^5'$@QJ+BT-PUTF_QEMZ]1?BQ:7<!=
MA1)3[? E_0>M(SI<.[:FPHK<1J)1#K,,1A1)^,/P05W)*L.I>&SR:VZANGL9
MOU; WI@MA=S/Q+4%*)WG:-E.3Z#"%_O![>\/.GR)Y#>JB7)]L\$)DCEH6@%:
M.R(H9"A;'^=>2JS0&Z-Y_[*PTW9D=F_TUW$_0%.JUV*7<36O3#H7TZ\R F*!
M2%&1++&%"8/!!;EEDU2'*KQ6W'Q:O3>4W./%)0FPG15U)IT_!;F]6+?E/.'O
M#-,(#PQA+AF8CQ'O92F&F%4:57A9#1>/F""%WVG#LV7RHJ\5U,R1\6KB=DC,
MIAV$ZPZ4F)<=/K3Q5@[:*36J^Q&)SDEQK&O%KV%0-X7H-@4?X#43A^Z,D<I^
MMM&-F2*BRO*,'ZX&%YS)F>T+3%VX7H/*4<XH$W_9!QH44#:D\C$W$SL_Y"7F
MV'[U][-ISM&YQF\;\OI:N]X0T'ES-&K;<YS\+.-#WHH.%4JK;9T]?Q40D_&_
M&=W=260+>F3;PU9\!S"[3O;MV;NYB9#C)ZSJTX@F1]N:D/G]6BF[P4Y2T,E?
M2^-?=Y8C0:0X7(+E-+D7VD$?VJ&<W_EP^VST2F+)\Q!^-!2036>-SR,<RP&%
M7>]:[)_#MA)G6""3%Q7E[]T[E;?T_40N[#=T/(;^]P9 JI2@R9]30'(,6*!
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MCL3*;!CH?3]49]Z39*Q.K'U;O=-R22DF^AAQ)*'N?6 U^#T9SG<S]X_H4L0
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M]Q%)Z?Z0@'(J"H;;[0/OT(RM!U+]$>9=.621?T=(S!D(-$9C0T/8&M3X9Z8
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MJ@,1_G7OB9LHU4EAS&Q(.X!'04PKO[BRM5D+DQ1=%<T)!%#3;WR/)Y@M/3O
M9(9T*4#QR<BIW!Y  $CQIG/[_4+FI^IP32.15HO3+*1V(8D,#_G3(U,NJREY
M)M.GB21BM+B-DX[;\'2GW$9%]1FU* /&UK SJGV9?43F/^*W8**T[9R/5-3C
MEG#%C;74+M2)P5917L:4(..^OB0HX8,C#XDZU\?I&1'7[/GS>(<HV! 4]JC/
M!?YSZ$F@^:].\R0QE(KD@7'$ @E/A;;??B<Y+K,G/3S;EPKV7!(S(Q)FCYN%
MH.Q",.OA@ZPN/7TU;>XD9OJDB30S**NAEZAA_+R !\*XR>.*]=+B&)XS.3ZT
M1 /&2M'*_1TST/Y8O1J&EVR37%;NW4(IEK4Q#8'9=QM]'3#MZ$4!! [^.)<>
M7Q5H$[>.!VZFAI7H,18C>HWQ%Z$C<\0.GOB)!!-=A3&D[$UWZ[>.(,[M0L=F
M.V!9#2@ ->^)T.[5QW(LOP[$'KF+-45;<[#QQY)J0IK3&L2JD4W/0XT..0J#
M0;?3BVX.PKOO\L<IXD@'K@H..G+=>^?>#_G ?\RCYW_(^U\N7MSZ^M?EO=MH
M\@8UD-C)6:Q<[GX0C-$OM%GMW-FRF945F9@JJ"22:  =23GYMOSQ_,)OS/\
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M\R6GUR=I$D]6\/"6&*@-(X[8H"&I^TU?'/46E?E[Y;T*.)?+^@PI,E&>[NP
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MU+*"!2GCX98''<&M14UQ<.WPGC]/?+4;%B:5Z_/%4*E@>E/'!((;8'H:8\
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MA-'*H/\ E*I!R1ZCYA4P5BD) 'T 14"ZOYKO4#IG-7T&YUV[>]NT)5 ?34[
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M#YX2IY\T!+];:WU:VDN%90UNDJ/( _=DJ6 ^8SKL<*M9P:A 0QA*7"4)J5)
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M&+2$F1&^UQ)-#7X?ED*\W:=;G34OK=!ZT+*S&/H5[\NE=L)--N$DNK=D<\#
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M2OTUQ$L%KU.(&K&J[#W\,3HW'<C;K[XFX:HH01U_VL8PKR:OL![8B0-^Q(Q
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M&&X([#&L *$$&IIC?3K6G;<DXGQI7]HG?+8$= "/'$Z&M:5WV)RC6NX)88X
M5-14=<MU0"I.[=-L^E'_ #[4\EG4/S!\]^>;B+G!Y7T6+3("PV%SJDW/FA\5
MBLW4^S[]1GV7S9\O/^?CWDPFV_+K\Q((12&2X\NW\O>D@-W9CZ.%Q]^?+,,
M>(K4'L,OX>5'W\/GB@%37KBJ$"B[48TIBICV(I2G?'HH7B*=>M!^O'&,[[U/
MABJ@J% 7PV[ 8*&R[;D[''T6FQ'R';+4 J#6O@,P!W( V[>^.7D&Y,=B.G],
M4^$G<5'7Y8]6H:'=3T]L6C"J6XUJ<$JZ$"@ )Q=6*_%7KU/;Y8NG+8U '4XY
MC4D4^6/Y5V*UKVS<C0\OA V![4SMGY6?DWK/GVXBO+N.33/+*L"]RX*O<4ZK
M#7M_E?=GT3\L^4-%\L:;;:9I-FEK:VB!411]Y/N>YR4BUC6OPU/7,T%*D=^H
MSBOYV:,]YY,N+A%+?HZ[M;P4ITAF1C6OM7.%W.C#](6EPB%HW7TP1]XR<64#
M1@5%5I0;5I3Q&2.UM5I^Z3[1J0V]/EBTUHH:C)1N@&(M9DEJQ_J_'"2YTY7)
M#J'[ @4!'7?(Y=:4%8L(@R]''2H[&F%-YH;W$=;:7T_%#2OS%<Y;YA\J7+QR
M")6:=SP[G[74FG;)7Y+_ "PBMK2-KF$-(U*L1^KKG7=/\GQ6R!$B5:[+3I[
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MP-*^&0BW199&)4$*2!X YSO\S[VWM=':,5YW+"(!=JU/;QSR'>6\BM-(L+<
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M(N-5F#!7,0_=H3M^\D:BC[\]2>3_ /G%S]Y;W/Y@>8X;(,.3:3I[\Y^M KN
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M[9R=H&9MP?N-G%54G%VWI0N7! TDN!,<@KNG**@$"G<)&MS=W8('"\$=@B9
MX>X2 E5(*-S= Q3:^8YT_SWZG.Z^>N[>BSWFFG.NO<=X,5-O5 )TWKV"5X4D
MPEK267OTM&YBUJ7-U&26_-:(8#75)=A3;IZ+<-B?./H9_RX;;Z8MIQY*JPTX
MA4?9)*/0RQCKTI\@ G9>7'+?$M^Y3D7&T'>@':)R4PTRQ)ZAT9%1\_)\TFM
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MZ5MS5['2US5)LHW5K>MJ#E1K<?J B9RZ;T%J(<.V2Y0$\KB5J=O#L;<[GP!
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MFQL+,^)9M]84G4\8\X[^?#)!WA5< ;)U'Q31 ^8];-$_[>6$ .9P/2@Q0QZ
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M8>Z\)=7F8( W&@=LG9;PZB@Y1P?<63?; !%%JI#9W\.VOB96(:2)E#88/B/
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MY71P[YNMZS/DU1BUXJV+UHE&W:X*;FS#7A.G5)[MUHWGK4OO5P]TIPQ91*F
M=BIYR-";:A47GO$M.TGSL8Q=[]M/ IAA;JUU-9C:"7N,;G)Z$$:5![9@R\@H
M2P&6:$ZO^S<O]/K?*7:?U)5!DI&F7%>Y9*0RBD8#RKYWJ]PTQ8Y'.,)7L5+?
M"5W3]TF? (EA0%J2#U.13P \? X[-R?/BP9'@AE$&*;&#X!0-8:GI,*KY:7
M:YC&7+5?7MES^PTUW)<,J2?KSJZHB5?6>,+4;]87P&?/K26;$&C[_)4\-)_
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M.+-82$-/I'IQ+!;G?":XM9$9_QC@1MV94Y\?,'\;8N+O7*M*\-X'Z7$Z 2;
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MK2FS#&-@F]?/3UL=6-IS6UJPJ@5-;9KBJ-48/&F;A!60"4IN\/EUTJ% 24*
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M>/78]3I2\]J_>VMVIK+@A-.[OL,X'C]=].!_9T<QYN_[R<[P7X!%W[QG8T!
M'[1E;V'1%)^%8IQ9MW@>["F>FRU^/VC(*X?6!]ZO(B2)RY<6\/XV!.]?&C1G
MVV;6.DC&T;6&W^> W.CY5GE^S>8J*Z5-X=&\&U*[(:RY'\+1X34#L\6#-2[*
MH]=ND9<6=7Y2]O:@#P#_1-X=2Y\<W3D 8+P/ !#G9>_]V+T#@!52*3L 7#\
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MF ]V!"'!DWQV8J*#%97Z? B%1J.,?Q?,Y[]PO<URV/3T!?9] >2P?'W]'7S
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M'1U(JH2MB>Y5(-]O[Y8O-$%ZU[O35;(Y.NJ;V&_#C8#D.[QH^^&B3"DX*K_
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MVU85%3M69Y-M7M\O0NL)%Q!JO>*J"],OI(-,:ETCAT"WI"X,W7@\+;!23>3
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M7V0(ZH^?K6D@=R+.,F"53J^F.IETP_$N)4I^)UW8E)K81SX :)!B9"$):P>
MZZSOVX**6=7IBIUR'!JB'($]W'<K6'7^A<DO:4OMVPUX%,QZ> "(A+$?H@\
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M:MWA:<6O^SJLLS7C=E:M%%BA4 &>OE("+RZN64QA/$L),C .]@L/'V\#,1J
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M>P6O!;_IY_2*VZS6B+N1F9&8<^KJ.?&IS[FE#1=<X2HJ*E(7]VHG>,'N?_Y
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MX_/KQ?;ZE(M9F2QO>$R FP:ZD['+ZG\>"BA(6E*G/&@@1$R.Q8JD6+8T'8[
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MDGGY7JWQ*.3)HI?877\UG-R8.V>S&<(-"PC9:0J/^\WTI]J49\ZYT"NK:&!
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M<0J\4>KDW+7$!W_H]IH"G$BH\O3C6<^42E2^L?)13E6-H]T=D'/[BY@^FT5
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MB97]11'R3_;^MNPTW1B<>+.;E)P,OHN<BP:?A-NKFKS*).:S$EQ*?#JSX/P
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MO;J@_5ZEDHF=U-G9VK]K!6+ L'OQW//B)8O_^=</*%BDCU:]RRR:G]_7RP'
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M'_GC$\UTJMU'+9FXN&$X;"0GF^'1FU1VIH. RN] 6Q+\5?K"U#=4-PKC1::
M/@9)L'.I?T'AO^EA,KX+VMR@0I-)G.(MT$6<061]:6/$D47MQ=RX!>L!>^J^
M7F:UI0OZ04[KWMX(;\YSZ3)7%YR0<IG+C12@:9JP3(.IC[FINX^JAZICP#GS
M;SWW];#KF3]'BCQZ[]:OW$V=57]D'PXT,<-]&3IA=&.M#7_%MI,;8K 5B(K
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M<$(,1.SFZ297]*#AX[%9NET+O%J"!8KVN*AQS6R_/GU9(6_MS=@=7;6P/,X
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M$^]R[PN79M*L0L#F2>-1-1,VVATA$!3:RH%N1;2MB=8PO[JTEG"2W^[5UW7
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MB'P"CC@,34B$MYK@@;LQ0AO;[>_PJ\?RSW !.9E]:5^\*T5'K!4$4@I*HB\
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M(7.+*GH_U!G<17'X["N"_$(K5/A;>D+T'[#=__6(^Q^O?TU:-UD"OG$TVC<
M\>_JN?KOM7S+2=A.PX;XUT6R:XVC>GR7.#*]5Y1AYC8=_Y<;;GPM+?H<Y4%?
MSBVR)F]P^)/N5R[.B[3F[KW(WF0(LQEYNG=^<\,I.6&1YE4$A6U$DD.QCF!V
M$JJ(V\ZA"E*RP Q/_ M$U5'Q1?KVCOBS1R3X"&_N5@H'%='530X6(RTUBY;<
M?)S/-0'R1YYK=>XMA=W/M2)<$&$5WD:M[W([KGECC0ZX(]:C8?.2DJ*7LG/
MB[%_E+5@,_G1+PBW7VWF?W1ZT^#8[K8SQI_AB,?OT+CS]K$_L#_C_T1FA.
M>*)S$K_JGCCN?1(:%/(UF.)E/8VC&>)19=D6EVT3^M1&5^4>.R? OV%OY4@7
M8^,SNOP^/M"7E)2,%*E42[7+R\N0M/-I:=9$=$E)D:(ENKD!DM(22*B]VM/2
MTK)4V]+:D+V$;TD!L[%'/&2L*.+907_H/Y^*/.7G%]#XSY'CY[H+C8FTCRIL
MNUQNN%*H_V:S'_[QWZ_.!9-8I"44=1ZM [[T8+^F Y.UM[IWQ0J8XRU)NA1^
MR$D<Y/MQ>\C-[K$VD49]<K5%N^L\;AZ1SIUHR)ZS5(4JE0F<J;QE5+XM6QV7
M1+;TS.X9H++:1OT"1CDYX=$UA86"SQ_MZ$6O KLAQ$6?]?>JNS"J4"ZHL@8(
M0$DX8#4V=1"-D?_XD<0FS1?T?$OIGW:.M_WY+LHH*.SDD?D9A[8UI$@4%PA/
M/Y=#P$+HRN.\B#@7]>]1?*HSETU@VLO^\&U=]=^EOH6./&QRS-3%&:VNX3,V
M/B'T$(I+=5%AO;X.]GH4 IB\2*J$*J*+&$GE+3TDC\U]@Z(:@M05IKJ#33J4
M#F@;(JOGZS/P(RYU$,4IJ-$?*CZ&L6B$U]>%"UX5:[ZY*]$O];&UFE""@&P.
M>_!\\2MZ=!/[%C7D"4/GTC P(V2=NSX)A=ZG;X>P 2/&U[9;"[RW-G_6E6W3
MA)M2FJL9TK:EWS>_RF;]S"!_W(1@YHMDEUC#7"B).O'<9@8%=GS"Q==-8S62
M5,06[>0=[LMA)Z!C';JJ\5%-/O'0.S@;CV9KC'<B<J-ZK'2S>'-1O;ZAP%FR
MTFB<9(04XO6Y884)F=I\#31LXLP+WV3$-+#.N^$+@*XZ*LV*9'S@060GT-%U
M_$WP!"_.>Q7;FO^2].?<T;BEC+6H3'>/YW=3V^,?.E;!:RS/CG<236^S>4\^
M5'-3J8S$\DI!;20X?-WG^JH*U4(?"T,$N_(]OAO]@12LR74Z\;PB10XI4M2%
MO A]A;,*-&:#R9N/,&6V1N#D$E;BBI(\-9KD(?SJ7)ZGY>T#Q_F9KJZ9'_QA
MD&0(S!C .I;!\\L(9SFKV6:(MYXJ-]-2B4S/F%FM0E9J&:OH$!):F 2#QB0E
M\;M&.>W_ZRBPQVNO&L=*[4@E+Y5:4_-Y&4K")"4E\_\Y,*257-"/_UT8^UW[
M+F]VJ9CIKU_356'-?:>W3N[V[_Q#N.&0N6\ HVG[KS;OW+^K/Z&MA]._/#+Q
MASS)FF..4%)X1G.)_3-9[SAJ$:Z6AJ MN[/+G.#Q^?[WD;75M@G]7)$F]"NY
M^[T81I:2A^8HFI9>/4:8"\1]7Y8/P'7H5,2V\%;7]7Q/$3:A2$,AN+3)G9PL
MF"_S5/@AVMSZZUT]D\A0'?GQW;Y!B=[3(3R3E/WAY;[!\@V@97Z)\JOX3DB?
MYB^W$7$)8YD"40^#V+O[#EPL*4)/YQ?9XO7HYJ,9X05+VCU&))=:2LT7C&:
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M(C&V"3W$AEKY9'P2^^?\XQC%-]L)P&&\K0LCT<+[54<O*"B%ID_Z7F:7?YU
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MXW:D\E?%4.0IG"><+@:W*T['3?7U1^!:>\2BFF9T27G;B6!F:^QF0#:JE6$
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MPE7_0F8_:$W4O 6SY.WTQ#_-;^UMGO.)SDX8<@S::MH\4EEP3%^#]-9DNCC
MF[*6AEG6:/WMW"6<([%;V@7 8HU"@J2ED+,X^RU.6Y:"5T&^V L&1L[P8JGH
MW-W@6K/@((4;Q&)=UK[GZK\!01**(@-K;XI'_S6V'UV:5<]\OEOWEC7DHC9Q
M4&(],:'H\O5C>Z6&ST)JTT+[K?;$!<?!Q@M$D$=5&%R,N_=R-I!SJ49^YPV
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MY$X_2:[H_T%.3K#XB;$W<LL"S-[<39J%5CM[;,^SRO0]BG0AC=\%W*\Y?DJ
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MHAK1J<M;B'"H!CGQ_-?)2=1;'.[]/V,YVM?%NZ(E=CJW$VZ]OF5K )G0B?3
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MJH$0R<Q.=GU^H^I,BL:IS%:DS0Y8;L.E9%([M4A7(.4!7]Q9?L T\1^ZV*&
M0SDJV^?2W>>=2WM3/W/.)X]E&$^@=]+C@$BKNK6Z'@33C?PXU<._9>!!X0@$
M&6$8M;5(V!(7U@-T.A\]$!SGS "1WO-#3])[TH<C\ADM3]*'7O7LT>!SA^^]
MI\&PW_J-1AST"U^R/7_O-_H[#<[]O=_H-QH,*>I*K</9+A:E>,]0>+!N-AV!
M)Y\5Q8^WUPJB"6;N+IY0H,MPX!X'QM9$[F59PPNKU))*<% '5JT_>H\8_T:
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M%6WWU:IE^)#L]#P!ONH0"*PC[,"X9]+]6"%C]8M @X/-MZKNEITSW9)ZQ\L
M]0FHEJ[9M#KCCGZ5)Z[=?#H#[D%E6]=1[I>,EUE>AOQOT,GX+\+_-JS.Q;DD
MJU*BF[Y%&GR;XG"W_-+FA.3R$2U7'/]4PUIRT8!"/$<U874?>*2& %J.TX.^
MRBSV#+HNBB+>"KR.6CH..T4.K9,\]M9.43]HBLP(2F>6)#(06RW;#F "1(W:
MT@\FW.P#1RO[J!P8D-.6%D::S:OE2;ZZ";A_29)P'E'=6X]#^M&U6PY;]08P
MC"3%E<J3?<,05?3?K.N,_[G#2/_<+]XYH5:DV1V]B->69O.]]6=#]A@=G9T8
MNJ0H<]4P'/?N&C</C8+C93K3+USP[.FPY86^G>%,&FVCV5'141 2J_AEI?UO
MF0B-(<F[?8E*JG:+LOHY:G'4G5KOQ=^Y?!O\9)TFP.@GK'N'.!Y+',,B>U_M
M_#0U@\Q@9)%6)QA.DMON',/E06A8!;[:JH!E]D08&)#P7Z1X1V;^PQ2O\O](
MBO<[CFLM< ?*LT-@KL&2]'6^S@G2Y2A:=0XDQL>[5G;GSI' A A0GS+R\RHP
M$>GH8I5 J\Z.=\2=Y5!2&ZI@S8ZK'(Z>XL&:V=^P1Y$J%;3BOU5MA(+0>O!6
M"G&)6'%6>!1:DA4^1'QTK%F[M/0"A,7Y7LP901>I(-*6-Q@WN1X54<R 39-F
M%_8&@VI)4BX_0U1E%>F4:IU04(1SE*B=.GL^F]N],RXS.0-@WFY]/&'8ICC4
M?>'S3&5*QQPF0?7TL<\K[12N=WEW6E)\I,>DS<AMM/HK_ZR"X'ZH\=H&,<1&
MGXS:GG&*8P;(H[ M5YP=$HP 4[N9(C&H/FH:OS/"':T/:8.2ZW=M%D',99(G
MB'L_B%3D<"+W96A8/,.F@E1GNKJH53(P#ZUK?0EJ5?/Q@Z:",J(27/S4RLO*
M#U_3;''SM*(&.]+]-!.HCJ?]8!ULL6Q]1F3FT1V$QPK2 DW<Q\=4@+YC%FK8
MFC!(=.5>PLD;ZX'/UP7Z_=Z4&Q:6E)>W\6_,3]93*,O\RS^X:+\,U&KWQ87O
MJ29Y%%+_@CFB;$HSSETKP:KLG-:]5E1!E8-08RAFK@-/PG?D5^J6V3_#V0OF
MWJ]LL5V03D-E2C)95M7E8\HTV7N7C8(KZWB/0&)37W]C=.7[;3KO1Z(SXT%U
M@4"UP/Z6P-]IZ'I%!<;M_2O)FI32_JVCR5&^P;-=]2,C"5ID!IT3Z,_K'CH&
M4:5"WI:U]LLHY"$-F"<)\!.6Y>EQ=@CN?3@V69J08&:U,,]GC>13%7>W'1P@
M7?!(<?/'VVB]3F/WP.T(D7G+3*!AHR=Y,6 J$I_DBT=C:T6KC71\4S@M>I&[
M^Q&O\Q2W=)E2V'SBL(5#:O69>0SL+3]IRP;CG[O1;T$_'E;42!M.*^VP[Z&D
M*8-%(56<#0I52,.-%DRK332&__22%_>,ASE/JZ8^1IN:5]Z-H*H".9/!K@=$
M=UXGO8 ?\7$-2J3#DF4Y"3*=FW$.?J1D![1#1W*Y8.@VP*"\F6)R7!&JQ7,'
M#;D1'?&H>2KRR@2^C^*3/]_A*?.R*.LMA?7TVP>6%QHX#18G,D ,8MX>BS<)
MJ*@HNP@J(OTQX?POAVK?UJGM6UVW!R"%Q77;WNT_RZE(7MV.L4UGD"> >6D#
M]WW^ N\$!+!KS6<(6XE-&>8^6K[^0[GFR6W>HSWW&N;&>1K7[F98[^KL<.=)
MR#CI*KEM);B@Q%XJFM,E%:V6'AZ+KIV;F'I#:3,OM3)!;32_E4F+30'#,(GV
MIL5#\2G>0C<:UCH+U;I&/7Z!=QI9IQL&4C5D3Z14#;OV%M=-#!ZY^]^B9:W_
M<5KF8?J?IF6?_FFEC:<S]&Z?0\)115=44[QO!LS@4I7F8G+<_2%L4LAGW^ H
M3$-]RHL,K;-QQTY[8+P,!][4#,[?X#>DEAWE+58:_:H=I:B4'KHE2]4C=3HB
MQ+;4B8)"]G D-Z*R^9HNW#>133^9&0>=>#Y++%4E8[4L;LL1]Y%^K5*@')@0
M,&^?A./J4%$<U "A>'*.(YQ'7<E(K,2<'TS7W/Q(^F&_\=V#&ZPO:?.C\7,&
M;8/ 6 V.M89V-V-51AASM+%O#J F9!2C(.[YM@T.=R<& @/#:RIOU+&:I_KM
M4WN%BT.<:U3,;5%>T=3R\EB,EPF6SR9-BE14@I2#^1S=,7M/Z_47 7FHD'C7
MIC[.ZEI6$L(*ULJ+M!4;C)E;4>T7R%%T=_ZX(0/04F1T/,W[JB'T8U30'W/0
M_R,X_C'?;\ U1SL)) Z7',2VY60VC!0XPA*BD]@Q6IVY-4?!Q#9>=1WKU1([
MNFV #;^F1CRF]!@XRV9>@[-]#!W]!K97%E^/5I".=6"1>@](*X ,/UY[H-CZ
MF!6Z,?,6-. %9*0TO3NH*ITYKCME0+G+PY/R9JK+4XHT$BQ:F $O2H%OVBF9
MGU:@/$:)DUCWT59H?<U/(=!=AQ#@IDA!6>0-]X@")HB4'>YD3$I#2S#SKZWU
M0L.V+ 8F(4.YN(R\S^XWZ$RZ]S)DT#-^XBZ^H+A>33#KW&?31SFWY6AS[_%F
MXXSZ.#E PAQ8:&\+A-E#Y!F)52R;!_T%FN"+T_QVHD]R%AH9BG[+2AA35@YZ
MW<>*)MKQNQY=KD/RX0%_+.2XZS"I47Z?&FY^[/-EK\"!-?4'_9P@7JO_="&>
M$?!%\O>O8D3-IV%-XNC\N?'5\;E3C\N,C.HZA/6H&%Y1RN+?=MABZ[U\98-T
MI^_E*^.TD++W^<J%,8'WV,M7%7L7[%[""DN$G4XU*GOX>^GTMRV"&6'OQT5
M# - ,R\#\^,_>.V##FV=U)GYQ5ML F.11PWC0.[QG1B%W:Y#YQ628)BU+#Y-
M5,,B?-YI]+R+1*A[ID=\R5Z#/FS-3WU*[,JNK)TCGUMXM^_CE*&1(),4V GX
MZVGNH:LBN>WB0IR,'KU9_\E<RT0@>QR6OY-R-A#_J*+9LM[+>":XG$U>;-MC
MNNUW2SW3SOK-#A5%L<=2-G(Q;J@1/+[/L]'^0GGUYMQ6J[1[Y.GS&22>%C6&
M=IW>J;T#B&J+J&G^E!*^A)>;FJ:U1:*K4A)"EL?\:+95N!-#YZG+-04-WS3P
M4':*NXI3J\ZW3:HZ;#MZ['BHC5!)!WPXG$5OO%@H.\J "U2.+];[?HZ$QOI6
M4+^D]VQ_-ZU5;L.%UB!('T&<[1]NM@Q0[J/N-WMW\PK!3EM-HY? /[QX^I<_
M)+C^Q?A$957E):5"&MJX1J9R-3@ZS>N:AVJ.Q:=>FB^1&#] :^0U)8D2#D-<
MMH*+PP<O0\RL96H_T!),S)FA1Y3PP6MVS<4D!"?DBOBN5O5DU1?3.0 ,P^AB
M+M9(Y7!L9ROPTHU>-WS2PF#,>)M581K6'\V[]<8N<V'^6=]*AQDF(RL1::R-
M8LDPEZY8%4+!N85A5HRP(U%;EENS8LF9U*DTQ(_/!A.C"A$6(6&2F+9.F=*'
M"+\W+R@;E]^<-$FMPY[[, ,2=2#H#=Q*.NKH"3^P(;OPZ3?Y&GV*:(7*,N;+
M"VR2@WQA#>V&A:1M^ 47#:QYF@13C+,6CT$@@4X;:&=@T>89J"2 S/<KVC;N
ME34/+712JB4W^UP&6A2:%O5-H*;=C)K(++>LUK9+H(K*B@^\Z_ZI&T+#A.>:
M@[Z4^M=V>%V*Z'65'VC^!.K/K5M!&;5J]D4M+MM2FKI&R,+#$JH_\T1#,?8J
M')%TI#3#KNY4>+/ VYX]&')=VIYKBYG!G%AEASC HBNI1;*E412(?=1ZO2"2
M9J_P'JJMH;!IH(EBQ*$DF3Q&E"D?C6N!2H?3K2H9<OJ,1Q)#_F[?B[Q<^?#W
M<YG[,VTS#HV'WB!OY57V;NE-CNU4S^!NY]TV+Q!X^LIT0BWZX5KSQ&.<UQON
M_5:7#;R8ZL4-3JE%0>&/I'TD^F)USV&T4A):^2(EZV <6S2UA&T/,-3:.KV!
M">]CF!6 !$T>-RBQ+?:!W:C=&"-$,Z83!VJ,8#WHT7F^D3<$;A*;:8LL&1U9
M5TJ1$.$QO<G6@SW-UZT<#<P")VZF_+9^IK?H%Z%B]^S?U\^L R?GI/YO37Y?
M/W/YR.6Q\XY9MXM4!U_&:^P"D>4E"PG\Z54[B<U@N8FHU,!]E,@D\Z%(;PJC
MLE(^]&W4*"8)Q2ZD24KAJ0P&GH8%8V)I]0&5VVUFSV<IW_XA(?4?A%X6K3D_
MZZ"C)%]IP09D*+M9;5.]$/!,!D*?V#8IS7CXQ-=_*0%!"@P.LW%WT'!/^3%?
MDU8K;X&Y'F9/[%]NS-.:]6[ F*<8O)Z284[(BR:P? 8/ ;<C)DR ";O!:8VE
M4$A@)(/(-3!M'/6]V-/DE36UZR$>>86:G5O;'CEK&,!>8&R2HP($A6&3_,C(
M2#BK:U@(O<I=ZWF3L/<I=MCT;!4">",^Q"OQX9.S7+?NI($_!;9[1HZC^+@.
MN5<SGC*T3%R9"CQWE3[?\BB\Y0?@V'"[1>!.2G%![HH?$Y:;WEFLKC)=V2(;
M18:$M1 Y$<7=D<3[0B*'U;$RS**KXC2YA@"L>=#5H:W!&U,A,:(0 3:9=$=(
M35"Q3R<1=[06W^TS1(7AJZ/&C3(+AA6^)J+OEN+:_VG+R0Y6;'I:_'4W'@T!
M-@;4=! [V\LZ3$W$7^,J;Z _K6FH/($Z9C37$%.//O5;]3.S>< C90U$/$TH
M"-MC>&V'S<W-WZ_G]/!(\_!^TKL5P]A L70A>\^4>XPE0,Z#K'ZSC*YI#A6\
MVV<G'$4<"H!;.ZOF2]POQ;Q*WBT$]9.M+8=(+X+3W=C^&F"];+#D%*X:?>I4
M%ZHS0>4:#'P>M',Q4UNK?69B&I%U^_'^0].L$#G/9 6NK(),U+% ]!ME8]98
M>)_7*_KJ,]6I\;,1%8OSA_XDW7X2^G!YI+!>[PF+#5Y_49+$7,]:4\/XY^_V
M.G_ALD?J/&F*_R:I\_M/DCK<_W](W0>'N/K.YA3'[:Q9LPV-SPN<9E<O*$8N
M)>W6,,^63; @*H.>0>=0HJ8%?.ONVQNSZXJG+35Y;38;"5KF+U3)\:' (6X=
M]_'HB50ELKAL%+BR:TM-V>K>?MWN&UT<!\@VRE4.N,F\ E BJ>M5MGZK;\=9
M:*A.RF.TY.[$3(@AF+V!*0#,)9&RW&^U;<EV&^E:&4EXEF[93S;EVM&I!_CR
M2&^6]G<PORKK2V9I6A#_U@:ASD]O_=FY33<P*C4Q2<'3DQ &(I%WO6&IRPZW
MM!O=@1*#^8I!VFI*>:\38*4<ZD=TS&JI8T/MO6(9 HHP*:7*(WPF2E 004@3
M'<D;KV@$UYVZ@ODL-KDG>B6XFNJJ\>+&W93%-8F]ET?I<4%L^;@!_?C(_>4F
MKX>YQ1<:B:7Z_V"^_40AA;!L.LUNL3_D*]#PNR&>FB+?O=!8=[T5J(T\$:HI
M%39PC^43N[H:CAHM3IQ^1.^#7Z9:^5VSE(Z:EG<@2]N5[GE#HX@+<@CU9H=>
M4*7\&#A'56\&*['"M2WG,H'>3UQ&'^?TS%MKAC#88G?KTQKV%X@4]_/&.HW6
M%<6OBV.59=@5#6G](-]$"KB_.#)D_=DKOF:RM\:OP=!'O UQ=%E1!$:'Y3!L
MG<2:Y=?@;&O<#V1"*NUJFOV.V9ZL>]K1( %DGF1#T1[DSC?!^"A: -GLE<0\
ML\"_6E=I@F<WGO0FGA4++S(LE02A.;@0(-GXM%@52Y5=L"7/11HFE/4<FG]D
MN\'@EDR%Z>U=8^9+Q!Z?=<FU1*_2N\*B2B'-N<DRR+6A6RO4[6<08=G3YJSK
M$82=<55ZXI>[/U6\1!Z92$+"A]L1\5*QY\F':[2@U\PD>4X2@FE5WJ$<NL^)
M3^?#1D8[A]([[<,B(9=H_#1S>D ^J-[+,6D3',C0/9Q5NI#J!$F-.U<V6IY
M[B%NF5@3T6_S*M>;,HDMM1#M^X?_O]V\^5_#G_/7&F<AO<6VN+6J 9]0DH"S
M.IPFCA+MXHM8XQ*;$EE'C3%6?KE# :FJ;T09R7%V=:,F5I92;_5U'ZJF?L]M
MI[;M_MDO_&T]<7./J*#9<;UBC@>K0X!K"\;-.7NVR]>9017&%A:K!D#WUNWN
MF>JJP%@IQR;="J#W"3326"?2@4HM7G7MORA;OU3&2=C^?JOX#8*SW+W[4]0D
MP$YKD3V%\/;W3,"\KJD)C7>/EDU?93"JO/)2^S0O>Q#F8WD#UQ)"S[ X,VO>
MC575*XB)T9QTT=C BL:0=(=GR9A.ENFII=(O[GUL55V?\0N.;,DYR<]W#0DZ
M2A@S15J\RJCG=$%E=E'[3>K:VFFUL*TTDR;Z2<CR6SS7&WCE:;>;[)^F631:
M9@U?[B]Q^C#Y +#Y/)0SH&*>6EB>(?38^6H^3=ERNN51\&4HN/7&V[)/?R(1
MLQ4QT%:U*^QPDXQ7'45QWS1T&8]3("N'BAPWV._V=9#7\$N<V5H>A-1?NT<T
M0^LB)^/!YE9X1EMZ@'&ZW[C]LPE5?)C6[.1.#T>IT[GF3Z!=Q)2C*)5P#T'3
M.#=<<)PQ9E4-  4;F%5)!U<%/,1+IP]U_C(0OJSH?ED%M&^<2C.,>M4_$BCK
M!AI)8 G!X'*TAD;F+PP>L0T=D$*H>82V_R:F03;^YX9;J6]SELP$>B_?[?-F
M;U?MC!BOHAT)[_:=&YQ]LMVU$6@<A!R&6U?7@:M\"<+*7A0C]T6Y_MPZ]3.D
MLI_\8K)3A-&/2OAY>%L#Y=J[=VL%$0JC5#<J<IEO\",/"/4-QL9/GS*^_4,.
M^+\03G%1%CG,,UO!.3=>\6[Z?Z%FK;1X-!()P\)3TJUUU"$F,F_CAX-<]X_+
M'#2*6F]UUJ-CWN8??=K0M32'MEL8G%J6/RI:4]>AS@UBLC#Z\+G^(B+%H](L
M&FMTR=> 21:9!S):K EUNKJ1H1[^K>*SS$\^8VU)HK$0_TH"UN*);\OQX>'A
M]ZTJ3O>>&K[:/^\F'X,"#KPY,+. M\K@[ >O)O.+"65+GXK.JMFY.SWL<U=7
MEV7.^'VY]@D=<8W<KW+>S%KMD8^L\Q26*RA86=U28\FY&+![Z.S0[3MY2_G#
M@66UG9KW =9,]Z38EGZ!%0'D%)P9Q])W+4H_,&:[1=G,K5PG6,.%]4T>7G.<
M09E7!Z0);,Z$C5!5-8?Y"1K:H-\$F\H0SM6#H;\+-C%\S"N'(TQK_R[8%$5^
M.=]JT\9\+]@43S-)\@L.FAAUQ#9&M4U)V8Y!63H%V@>ROTBB%JC9,RJDO-HP
M?*V1?_[X@Z;SD, ^W]_&!R^=]M]C9GZ??,:H,/+?,TTN%G+XO6E<7%S A[7O
M:]_;PKF__0>W?;JYN;NY;S7A%?=7I#JYD21]7-.<=>G5N83G(*=%HGQ:GSN^
MAK:DZ?+WSNBRI FT[E,V>@W6YSCS'1QZH[0@[YNZ#[>40LE R*FMG>[)%J\%
M"2II'*2Z/@F-]YO=W9P>Z+&?P MMK5LR<06\00PTKLKKG@1C*Y/$;BS;!MMI
MQ]@_OC128<X".+N5.#N%9044!R>B6)N+;L'&?=X?;H>L(+T>^TC7FIXK1#O]
M&#6DSHUPD<A"ZZ>N,0D=,:J1O&'U)"#]8;5-HO+YI.OPT:%+6XLB[$\\=(J/
M>KFC:/[=/IL$E:'4#TMI'2^ &S=85Z#%$<1UP<XG+!-;01PF>RJJT?KB3JG^
MNDN<0!+"DVAQ.9TS_:M7# /#\E"S5$']B^*0BFJ  1TK4@C=;QZ_D_^7/R:\
M_A-PUBA (H=21:9OLI<82\>@8BA.MP:)+$A]VV#T(_H8N,'N)Y1]9UU## ^U
M1TM2%HL?RXL-/.R,RU7K.B%[-ZQ'7U^?4$5%N\7<J<5<^-4N@U%;,U%9X")4
MT9[$$%77UX12D;1XL)ACVB\=K7(^IFS7VP72LK]BOMLW',<L>;=/O6]B,='!
M.," #C,[<0OE) EN8##R3I7,I2<M]!$&:7_95)%^M HK=)*P*>>%XI!7U)6-
M\/9=^@OO8#VU)4;NM&^;!4"C@\S7[9"*S_":?&TPX:G,CF[$PK+=3JJV-@7%
MRJ(8:8L?E3H_R=TM-[N&'R<,7NK[OI(3O'EBX=!M=F$:YEY&1 7S=)R971M#
M^?DQ&*)B:8?1 ZJBV+Y&/,7J]H4W?X/GS:!^\;H^R+H\JI, />0H_64^W741
M=C2U.Z<(2-U&:PVDT1NMQ]>"D#/MS=X"&1T\>&DCW6I(RS_>>SG5K"8PN3U-
MMI@B<MIX$6=4(CW./3+L9^T<[.28MN$"$:@5@F$,5F F>_@?_U/6<3]0.0RI
MO.O;VQP1[W]Z]W-]4.6+Q3-,IC]I0,.\H"M?>>QA?_ARQ"VY5@DUY(7+K]X'
M$MV_P/L$J\+]-.-Y,&NDDVM4>?&\.6CT^6C1Y.K<8"!7VP/1Q%@GFZ@ QS<J
ML8W1*%;;'JLT0P?YMQ_%W@9 TM6;&!/OR[,5XY#HZO>5V0J,6[$;$,%S6#W3
MT=*L0@\]8=,6#-K,9FLT;AG^[1<_.#*"1B#=[(5,V_/53HE;?YBFJSO"J_L#
M!Y/Z-B[W+SQYX ?8MC+;,-E,!HT&D7GKRHLX'C#4^5#IR?/0IF%:Q_:4@;%;
M8=9:D#P_L9_B%4,#WY(B7V9^A)V;;@_KN^ 9"<,3\'F,C XSV$7Z;MS:X3JR
M>E[N$[8D=/*F1J2*>NM2Y[ 3#1>Y//MR-OE EF%$Y2\14OD1A4C2DAJ4*+=6
MER70E=%E1L8U..<7HZ?RYFUWWNU3(0\-K'980#LUU5'A_65EU%(M'ALX+E6K
M?<P%NG@@9U77WHP2:% *OYS:\400PS(@-E&)!FU/^G;=<B9O<K_^8^+U7P6(
M]T-*<*+9G0SO$K'WU^T7DP AK#AX1U & =\97)\X%4%$+^H\ Z-VFK=\HP#W
MZSC-]<P*K(EN77?!H BKBTJ1^>63W+CH:#$IHYJW\T"\Y>X:XC[<?P;ZO*\O
MU(EG0M%,>=:4Y5DBJZ!F5YYE58CNR48A"1G<06;>F^<CP<,#Q$HT"E37HI)>
MAKG$L-HFX@6!OHR*IE]MYGOXZCV4[]O4NV*#:*\Y5J#6RZ.X==GG)ZP0&F;6
MZE>#043M2=KYH$31U%MQS=YE9?]-SN&[#;;DBI-=^=W" HDB1O'MLD[]3+5=
ME6 HU=# [NYT=N"%BK1&>CI0,T%%GNX3@&*?I+7Q\WJ"A?D3+XI@*6O]03IA
M<X73@BZQAI_[(C[-QW\<DMW3A$.7@AER1A+>-^QA[M4NZ#]JML!R[NAH<'Q3
M!03@7)I[<[/>.+99[W:,6*LU;P40^@PH3?B8/.,'5.USW%V)-,F<0_6X];EF
M/<05I9:*-K/S(HI=MAJ7'/HS]\]ANR4AWY?2 DMM;;=5CB$Z%]U0Z[-Y.VH.
M8/,UN4K!1]Z]:P9K@<#/Q._V?9T\&BZJ-S-'.VV9KURO[T>MU;74@M8@]ID9
M?+P\"6*N@G NAOTM5)6D]7@_.=;Z![G\7IE*0(212$OX^0TO=4^:_[0;' R?
ML+_ZB,M:\@FX)KIVX<(23Z]"6=%9IE$5+9QCV7LI;BFF5C%5(LPMGL1Q?W'K
M^6=R$Z)[.FW P>7\XXS.HJJH@O3+MF /A\R"\V8%^HUK)H>0PF' $,<GH^S3
MZN*/HRNV;$6  &/S)P.QZ-*,C,RC^72W<0BXZ%GEND7,MW_,H?_/87\Q5Z$\
M+PIV ##)E?5"I*P /R6]T1+CD'R\U[DY$OH-6J.CYF58Z\V@@.D,\@(^H?_:
MU;2?T*=./D9!:E =8MN#;Q:1?A4OI@$$TO2R'0VK6!%;;YD4F#J K2IK!>;1
MC#8KO,O>S3*!]XP,2T5JR>1W9^A9U(C!V\BBI%H!&-MH#Q9$CX/\*_.489&&
MX]?\U][MDS;\O-@X+(/]I>H+>XHON)-,EG*?QZ^Y-7I3K3>4ZTG--^9/=@Z^
MB<2E?,-WC$QK' +K=Y8UQ"?_<%ZUV;KJC5E?>=9SG/;4&H>#  8RZTA$NN:%
ME(UU)7_\_I&AXQ["*LA1B6IM6/)4,W+!+82JN#UZRXB*H-@-YNM=G EKIHK6
MMSH>7VQ?H#A5YN;N:(DL(EP=0/7=?C6(6$P0PB8D3NL&^<:.%3=&2?Q0KSGB
M&;'$#41\R0;.7[^]\873N:F&;B [,P+?75!T,OO2V\7\3B+EM>3@A 2GK@Z7
MP?3:YC<=N548:%DE?,/%A56&\E@/KVM1IV8^JA"M< AX#WV=8Z^DCQ@CI!P5
MC-IB1%:$E&42G"&U4!%$[R1%N?MF&.CZS]SO?/,/KGP(*WRWKVQ4-].1Z)!N
M>GPU;E@J,2Y1DGL?)Y^^<YGW3=E<R*GNR32YE3Y9Q,@A7/.\MJ;_PV4#AQ.T
MT 5BVZ 6B2$-7;(16% Q/SQ*:N]^Y7IL7M-?D;R-/@Y)S2W.49-H>D*Z7BR/
MFYA7J6%^&KK$UC\+\=KS5=:'7&0JK4P/-L+H DW[ C( #X>"P\[Z+#-YS4(3
M_ZKSS2]F86B*3>H"\[(DXU#WU'Q\A] Q LD%1CPIT)HDPQZ\9(W9"+I]._6S
M$F19">(7T(=XY5VG[X&I'82NJHJ(N?RC:\Y_W2Y^4S2'_IPBLZ$2!I$[S-0B
M Z7G@A&XB'2LQG*)7L=\D5DX<(I36JZJNU'U?8AX&?UF&;N]W-ED$>1;N94*
M$1:<=E&"LR*[P!;NX+0^ZC60/S/A.#3OCXF[?Q%.\.;E?/4G3H#G")2OWB,8
M)-7FX<!$2,]KF?J[?4 3A[O9IR D4R9+3DR2&ASZ</@AVUW[;)[NT,+7J/P?
MYS32EDCYUS/.9GR-:'^MIGC$D/#A(1;]I1[=0OK<=&*(<>DG \3"LPOC9@$T
M\]BC)@$%M%67&Q2&=#2_LTA!TQ@F ^-FL)33=.U.2V)9W5',2#O10.%I9 X(
M9-D;W$+[I$9Q.!$RG$^'@S*9Q"8B>SKQO?X^0CPC$9L65,B_1+\\_CQS^?F;
M#5(X<QQ^).2983DZM6PN8!'G!J%PU38Q+>DVK([N<\^3K[+@#\:GS+:FVNW"
M'M:V:SSJ<EF@I30E 2]BLVRTC"YB=>-DS-B;Y-H!O_PW*P,F)+ U!KH*O)A'
M<<_L6GL"<;JO_:K/5U</R#[&_<N_MZ!L!L$@WV%7)1M^MS2C%[,,8#O8M.1.
M) ZKN8-&PXUY:$ 2D&?NR_2[=NYC1T5M*2JEZ)0MOV&I;H^CC\L/Q2>_VP>&
MVZ6*WW)$*6+UCR"E>Y\%9^:>( ED/H&1<?^X$+R^QX-ORK>S>PM8[(S!R/[;
M41<9S,'H6M!&)/VPXKX($S_CK,TM++(X''((G_EMZSV^1) ]9'B#5U;P/$%A
M]? U<?6:J3.A?=@DR V%^L7MV<8D!'%_:F=8,V'$:Y75\*;D2>://5^9C(@[
ME:$_V]9_\FG5E6G*HKK Q+]B7*F%\_: 1^?13=<TY]_BJ3//Y_,Y+0D4RH^M
M$052<F% K55%->/2ML]QY4U>.U^X8QU(PV,F!5 #DZQZ05=.B-#V_;+?)+*.
M)_.TX/VR7\SM?F'@R.<ZYY/^ONRWM3]L^6W)I??+?FN*[!K1F9B0U&LV9L.K
M.R\&^?Q.$6,Q8SC.C%F^9YBUR*'4]:7!<GTLDGTQ=XE0EP%X.M@U(VYG%TAL
MIN(C9^:KH4@6#.G-A@1&TIW+(D/^SYE!^M OO7Z%^EY9$XPWT[7O_DU9,_&-
M3!OT=V5-%RE7P,:=;?Q=67,LZ'F_\WME30+B0)_JH"KR7#\E8M4[._75&L=Q
MP6(Y87BW7*W' MJ!0WDB-" ;84-:%N; P!X+S=$08]Z@*BF\FC!#[F4YO.2L
M.%3-4GI4LQRT+\K I9I"8!K2 -1 8=&@A\T]=.YAJ,TO0X^]'4GVN_O5(JE<
M@'1KAN%N6J<( [N[77KA<"WK!PL;3=?.N$Z=8;O"/2U"(;('00EO2^:"@FL)
MJH.>0SM.NU]3G%:#GR=S2Q_OAR*JYPAWB>2>!$2 );JY'*48&8D,B^QH3S5
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M?)YOZ]P67_J]^(QKK;P[ C)*^K?B,T#LJG^?C'Y??!:6@2$-74M\7.I"O ,
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M5QS&SX>5 E=6?0%GCDT,[[DO'](31W4!>M;0M+(SO-6Z$([&*9>(GG<I2W9
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MQ.QW^>ZA^)$&FQ>C%#W:D:1O1A_PHU\>$=VX"_2W 2@ >Y.#,[:3-34.YE\
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M54.A(V?9LW(5+/;%[NGY!JNU71[)RA\4T,?3DT0&^Z]'88-C)P<*RVW=<#7
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M5;.]1JYM^LME;64W=E?WE/J_&"AL8X1&C5H%4)><PDBFOJ-UH-;4M:&\/26
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M]8OK40KG2].KNM:<.^9HYNUAEG4X:SC::PG*SFI&^QBE#2J_'[#:30( I "
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M_:9-[W$>TQ89"8-HVVM[;^TI?88*6Y?U%&<(RM0D;>['L<Z-]R<:0#EFV>
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M'+74-"TLR)P[<:-\D9UV[4)-^PFII'%NS>K-V(9)8A8T>U0 OG9-4"5@LQ&
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MC4'S#?'H$(/U!0V(JY?7N9,9LF31.RDZ=NLB6#8:3OX/I78!Q ]G$CB,
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M"Q=,;-YKS;0)F[H$R<:O("6Y_/')4K1#=J^[D'X,A1CBF'H_V_Y2>KIV$HQ
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MZ?H(?4.>ZW&&0$ZNJTN6_6ECCWR3Y6S*1#)QB6(CRNC5>)ITJ@]']"ZT]UY
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M+#2VK=&M=+RW1]J[ZD=3O!/UT]6I</QX#/.OKZXP=5+D]'X).8845?IUZ\J
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M'&3PD8#9,_-F"P25&VI_XPA09U+X>*R")]Y2ZHW.=;DD]"]O9@Z7)*[+E)R
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MHQJO.$VJX;'XH]B?N@Y/\CY?7@XF<,K 1OI1>;'RJ7/^TQ)+@+N/Q+R9>0(
MR8(#O1Q]T+!5+T"[D21<YGYT<L<SA6=!B%G3F*='H3$E>UN8C3'"]FO7=98S
MUQ,'.QW+NOV_-N.AAYN8K8AE7?2QEX);G*UAN/,%B5UVY+(.]:=84XO @FN"
M;%C8<@&Y8"D*A[/V\(CZ=7:OMWR62.?T VY,:$DY,\#O&4W':_?XV_?%^THS
M(<9SR^E/";WF;3/#$,]^?>!E1JI53L6=MN&=YHY !90#OT)R".\OOI7J,J"I
MHYC<%4%'L]HO,M<#4(4I:-"34N^ 6H:0RT(,BS18,&""_=+>'Z*519'8FYC6
M%-,K<4KM>BM>X^ G_D$1"C1+!J;C@W4:40EN"$@J!'&B1.Y+5NY/C$P\\<A;
M*][]3,+6\O^SQ?0OJ?\_7$R_T)0?O)$H3]_(D#-13?@I,2IU<IOGX<MY[M<5
MWV_C/_W0<52NEGP)96J.>1A.4Y[Q#^%.:$_<7S8/^BXHWDT[80[URTSWRTD4
M@R#1F9@&0:8=DX28]^$M(OA5MH?K-DA;$!A.BRH/IT$%@\ ;K&:9EM\YZEN[
M"X[D4T4(N&Q+;[T-6>_$U!EL'B!$CQ"BAUFCYI;'P#W?Z'R==/Q'WA7QC&K'
M1&K9[]^]8VS4*TQM'H:7AB;*+@=$]2Z7E(P'@[Z'I1[YPR/\$:D>XLP^#;N4
M[N.C=3TX ]/UA9#*7V,76%>M_;Y^A\==!]*;07BNYXR><X0F@-4:/>P9%]K%
MLI>&E(R93/@3G&F2HVBD;,\4&EEGZ=U;H=,Q<H&P-8X9LT*'-]E?)I9A8PD:
M7C. KC\M%XD^Y9B[#%)1<''I/RX-9TV)=^$O B)^:2V'_DI &AKE[N;?\YZ$
MO*CF+ F W.<O&.B> CO]T@IH;GM!QYG9W,67CA@!=6:U)W0U^!\SMMN;!1ZP
MF/BH7/K[.680\&'P=:N'DQ9N<;.8G((.]UN!K5;5I12*=E;\^\Z"XT7XSN !
M.SRU?(R/&PQ.S.XVJ6NR5-'H@ZIH]/Y:^C##+9%=HJW"HGZ[$?&]Q.K8*]9R
MZP]3=*OF=D^X"5UGX&7#\J4ISW@8_$6T':6!QJ=I%;GUT[N#:,&(-;?$U)]6
M(PL4>?W:&X-)!Q,$[^8W9^@$>HW)"3HZ&!%KGN@:>'>!9C64&Z&79J9]'>C*
M,L[ZH-B^4DP\\*-F%3CJ53RU(Z3G@V8)F#K1!\V4[?\U#MSQHONU3PCM_QO4
MJ^ CH%>ZBNBM &1]U)1N^SN0MIDE1S?$\\O,*]:[Y>W+XL[CSQMGC9N:@'F.
M5+BR9[5AX/GMJP\(9,IZO\GX*/-=YKODWW27@/T)PM1AE-/6]*W^CID^1=)F
MJ(F#9P,.&D5R3#4R3!M.B[68H^&:<DLP"V_Q WMGDX9CY41F!;\_+EP!\0[H
MSYM240GD-DI7!J%^+..O?UX?A_W)COS9HXZ*)IOJ]\LSQQNVF8>L:3U)7A/W
MF8F.EZQH!]4QS>)U:^O*F1!O'S7*-(QX0\%.CO^0[U:UQ7E:);AI)R+0\LB$
M]ZA"KL.>9"5(2GIC.X/W'$@O5G&RE?K"8LL'2-WB!B_'Q!RJ!QURI2)0+\6Q
MP:#U+65YIT4_A4;@SI(\N,LX<,"84ZOEQ\^V85?7X3Y[5,JIM_C[;[(><G31
MY59WYU:>OV=CEYV&\DZ:RZON3[5W(EUX,P.ROT*$5]Y2BL8T+R187D4XE6B\
M'AEK%PKY,TW#\*H=&B.5.XC<5_HFOM"6$(%]TL;=\!2U38$KTO.[(U"&H28Q
M&)Q_75RL1<30B8;AQ=P%2<@R/[D%$;F0W,$B5U?Z;[#,[S0S+MON>D:PR[+S
MPHAB9>W RX)+:RJ?$$4GO5_UG+;OZ<\HXRD$E+6>?[YSRLQJ.5=<HG$:>^Y)
M9]$U$X2&L!MLU8\[95(,?LTX^N1^CP4-0+:\V9](TVV\%@_2WE3\JY?U6-_R
MLN['5E:W<RH?6UF7!BM,:DP^MK+&8."U=$C &(GTI%KPXYMVT_GY]W>[/.WE
M4Y):U!,TK 4REE"G#PQ,J-(SNH(9TYK*N)SQK>+[.0_J"A*<0MZ=9%IQ'?(C
MG]D/O-Z&#GO=;XA'F2S40U+K3\8I'F1$/\-:/I&%%JWZS^;F@MN(;>1[8^K,
MEA\=P(N"YR).I0%U8WC%[!19P?4U+DZD+.9NNS<+N+/Y4/++B2B:"G*8:QHT
M978;=6]R&G[G?>% S((P=A4 <H;DFQ0;EF>^$;2T:EN5-0.&1= 0UA_6.Q%O
M_C>F/%2]^8\MX#3517&#YLZ/V[H@R>G.J;Y70)MHRETS-@.%22"Y0P7CH\OB
M76Y33(EUN=Z"63A,JS+"_(\U]];@:>LXMZ/.+<Y/;.$N2<2MD8/'''7\!<^]
MI]=$@9=7GK#XB&E.0O/8-G=ER\Q<GLYBXRGP<O)X]2UI"9-JRX5;6^$<L%^Z
MN&5>VYE$@XJ+(L="46DFEMKJ58FY]-FT;R#<@F>3@?6=7>^X:KHP9M*TTX.7
MS3';N[O4FX>J?@\W$732YLU3#U\U('>V=I)+RM_A<]L%'Q*O1:%MAA]Y*YAV
M< 2V!K/+KX>&TK-,(C#F8;5TN,?8J K0-S0T],Y?;)">([WQQ>'=M'1@EU\Y
MKR3G0\I@#P!X-P,\QNS96I\0U)^= )EBM<J./\K4?)$R?,!YA/VJ&M_Z>GE7
MY07;YPDNN3TV]$%Z3V!$"SRRE80&+ALC-4Q22@+>YFD7UX_)&AMS#[VI]MD]
M@W*3[&&[T'GQ/8/(E+7'W1=74S*,$P0LL,Z:-E0-0V^K\-R& H'6IX9^TC,K
M*J6UI@/Y4PIUBG&Q4WV*]G"_S:6-*N-E?& ?U"FE/G%,+V)\J3:-8Q("PU1:
M@X.&PS]RW16]C'P?8/QOKKN.?N'%J8?!XW]RW:E3EDOL95]]Y+JK\0^O:31N
MR*4L9#W=K5Z+?+4LC=/*"$J5G9*R#2]0Q$#!8,%&WHV/MPG20EK5<$V6'[T2
M87#;]L7L="@^70WW/H00S6G]X"RP/S'B(Z\3R]#)T.G.6E#I?RB  KZ0SFV=
MV%>*+%C%]E6/,W;)@-3#9:1=VJMYN%,7*"0YV'J#,]NM.AW2"[N3)?9(T^L+
M3@NMOO;B_6Q[PU16Q6 TWKM/?Y&_>R?)*;V5P\W KXJ7+>7E8#QY1MJQ ?+/
M'>8:#D1,+>*:E,FD)2/\OI(AX9^.XDE0Y_2E9/=3GJFH^T9"-S#;E!\,6\Z/
MF(P$TIK=7>=E#%>SGVL2+GQ"!/W/\IT?P^B5(U5KL]O/-W&D=QN>F:H?635N
M]8RP%MR/&4N;S?.ZX/#%<Q@\YLR#&)W0[+B[@HMDK:&C-'5V7# G/MA_L;N=
MOJZ_O@NZN.7LT$ A[2O9/$?&;I)/U4@#:.V\Q$184@FN!FSJ!(GAEB=PL,;:
MB/ QFQ-+TWLGEOU7J(+=,;Y@Z<WF%DZ"K[*S$.$OW%39FEBOF,LWM(>JDK 6
M5@NUZQI5M__4]_#S/;M])<V>0>H36K53YSV9'#_8.Q.Z_<6I9*-&S_CF5<0$
M#,,W;!4Z._/->]+LR,];JE&(M^<:KV6TA3D_'B//&FUH[X"%/>/>40OL>X)X
MWQV<2 =#?ER%$(=RM@6<O21_F9<PM%4*VPT]7KWS#\4O77L&B.2]52[/*-Y\
M>V=4%)2F$*&Y<+)AH7B ^!7N>O,G=%<Z*NOV[]$I1X03+^8OO"\7MF8-+FL>
M@.I;66_N7%8Y&N[L;OR82FG9O!@PZ0^\>H&XICA74Y"ZKU0X+-C<E9CTO.Q'
M4%JPA=/"^@O^BQI\0T!)[HTG:%0+))?EM&9^''_D%#E@D<1EP2F#*3BH3NO'
M&_&NJ%9+Y6/QF1=[C-H9CZI7%I3K0L(((1:)7AZG[XQO[R;.(W96;"K3EB5(
M$/3W&;I6>F1KX9K!R5?SI ?I(7HAWS3FQAIT-8+<=*_H BIT&WB#"KX5(#4=
M\UI0)Y\"U^PK);?4-1%>%A$L5PE>Q>50I)]S&GTV4OMBOU%/;E=\%B$ELZ(K
METLA6^70X0\R@I#@HR:ZN):&H+[A$.E$,^M<K6.=XG_?*/?YD.X7+A=:-P7D
MMUUVJX<C93M(WMK7+R<J+L?*=2$/%YW67!Y3>KI:7X6MVJ@A!/;\E->@(1.^
MU=4@V^F^RN";KH@9/KT_!I6,.GOSU?1E^,7-?258RZ,DV]#D27.6K,> V'\%
M![MVP\2&!WL6R"IW!5KSC$YP6/T_9<N%/2?]L!Q^IZUCIB+YJ!7]6M_PBCE+
M3R]4SRB((E)676>M%U1%0*^$/+L<%?H)<:3T>2FVL&=@0B.$ML??M6OIA3];
M";@0>WA02T=7%W'BI/;"Z0LGNR-)304L#$)6-K,Z2T&D8NSJQ[#LK39*4T53
M5_=PX33[+7/C="RT8%_IAV !I2*.ZY@\U#L_F((9(M5ZKL58D4J),L($%JXQ
MA^W8F4:L$F#FK#'!;R'?5O'XF^BAD,C$!ZVP.IPYCC#0FJY#;;45  7HO'64
MSR8TEV#U;>!KSS_5/<[AS<Z.S![NO"HD=A#+C?.@%:G0GV9YLU\MEIQZ4W[^
M6=&I7XJJS]<WILXV1@L*4A:6=L)H:&N'T"%_DK%K?Y/YQV[L#TMV[<>&[&V
M2PD.'H"K,6S]2&L%7BYU[[F_K_0(Z6W?=?,E,!;Y996\T,DD,F]443#07K<+
M<E%M^SHPVNFIH]_75PUHDA737HR9$%VMMQMWF!-5<++]058EHYG1L$P]LEJ?
M7FG-6Y<N6"%74A2N[D/]UF4DU&. JRN*)6.J1LXJB,\!'+GHQ6=;< )LJHJ.
MA)G34[3G1@ JVQR1/?\(9'DKWM[7B#U/M\)4A5\\^_/$MY\2%O^#K':.2'_=
MJ*YHD^GL/@<G>AI=_6W>&M44-NPMFQPV/'@XTF3/VR#5;*R1\H#%^JIQ(3>E
ML:-=P/2T\F%HQ7/>IQN93'>-L,D4;:HGWZJ; ;"]*,B'%YMZN$&NT;A0@#N^
M4&>J+!L3EP1T8NMWTIY/"DC!0FC_N6L#'^-.-GJBU S[R,R")''8J5TV^X84
M:.$_;>T;9<4CCL?9[/ 1OVR4'/#(M4*%\,O/"UFG&AN7!/J/9OFYMRO,'G56
M5[L,K&VL2]X</X9P_DJ:K"O8LT;,\4)SZ%W3-[I=TGCSV5M;#1M,W:,79Y=8
M$R_SCAJMJ=E,SC00E_'<ER_%V[ 2 KM$JI$^S&+BUR1R-VA+\PTB.MX#6%7Z
MIX$.N6X6OO_B].H7\Q$]=9$QDK/O>!T*)Q'5TGJ,#O-;J6I;W7M2.Q7,#0&O
MB->TT:5$P2DMTMKU^,AP^LQZD)\/EGSK]G;;V@K_-V?CZ7B@YAA24+C$D::(
ME>',8?<0X40YKQ4=6<"WAZ;1+<*V;$UJ(Y;R$?/'-AO 22.>PE/HF:H!BFP"
M"RK(=#C3U]?'5HW$AX(]@/7%#2&$L=:C#WI%9>F^W2VA!,J% X<UP0]>OGG/
MLJ9T.6L>SR/FTD[E]H,OA/XTI)U/"_C.]>)W1T^X';EUT^V$U%OK[AJDBP>W
MTQ:&?/]HJ-AY7\G9(VRHU "7_I'M \J3M]%;D)R/'=4P*&!X>+A)8!K4^9#$
MJ&91D1P8-##BPVF1==M(JZ6E_?"'2Z.96OQPZ\=/A]RO8!FN?"-$Y.HI,S2O
M8,II^K+:ZNM,(^L+@))2M0# 3.7F#N_PKS&2S0>!/:L1V[S#T[N^+YATNZ]"
M:1X^%L PDRU*3R]ML8A[E.KB(A_@>O*B VV#[/1&H\%M()W@W:;F#'H R:DY
MI!5_CC1+L!HDORIQ/B =?T,+V1(B%DNDYFTX8@XN,I#K2-M 6 :ET82B(B<3
MC_.NI)]_^3_H#?)^HS['6WN-;^J6QG?(SKT(WE<:.ZD)I8-N#WFC4I^(0_Y)
M;&2HJP&-2GNH/5CCSJ@IA[+FU2*/8=69R9E)AKNZRLU')?8ZVUO;$;VS(XL-
MCQW,X"<5!RL8T0O]!<:!,<FRI2Y!O3V+X$D2%L:4A79?1YLZ;@H18TD;;6?7
M,@L6N4&/DXV4"XQ?2LS,TUAZQEF.(B=S_^Q<P:"R=>WE;FO<AZ^C*J$;26W?
M?"IG*OW[D<1_-"3A\RB)V#NW8V15ZAFL-?N"&3Q_S4D-4X5TN>-L:8PN 5[%
MM9CL?5@G.B EA_2J-3[DB,&J3,^@9.T>QIIVT\BRHI3<RH>.Q-C8RC73QYE-
M.D&^>6-2M9SFQ:B<<HX)\#*1&-%J[MA=H$@>@"/B' Z/.*T<>=)MI@$%^B8V
M;XM4:FDO0D-1Q2K'P#WZU&.Q+KI[/ZP$GZYN7#.I#\J<3_:.+?5Y:8)L\1/&
MK@A^"S,+(Y$(#YR*CUK53G;U!0&YHUY>KZ/?U#1=-:DO99HQL96VF2XIO9$\
MQ5_K32-Z>#L/.!VT&3)%%#!TK1\'J;33FZ"3R<'"NW-U\*BAH,>X'-G!5)B#
M@&P>?_(2?L7YR*8 -"IL=K]UN=7E2V*>H"KR39LKXU:@_O?<J?(_;7=T9Y.Y
M=B_BO<IKNGX'88<7=LE#$O)D.JV*>"LM"=_*8, ' K/?-9Z"[H(#J&32L* =
M7=:$E^MJJ;)E:T'7#>]M%[]'GUKH495TFB%&T56T^@4TPV55<_BZBVDDR\6]
MO!5%A:75F,\312 ,( FO/&<ZPI7WQ AGS>J2B;N&AQDB2[\0[(YFWXB#J*47
M4E;P:S/-*]\OBFV3#PZ:2=CAV82/DX\<TXV:(#E:3?MMIN^U/P>+5R<!O//;
M7S7]M*;Y9""XW_'K4<:EJR<>3]!<O$+"M[S,"M]L.7VD41@DS9-25S_2*$2T
MFT?TI_Z+1H'8;0;TG<#ZMP&N=<@=8 .,^.+(SCK""B%DO-M$(Y#<3(<!716&
MK2HJ.HM9O+O_WY%YJU[:>9R^K_0T:.*Y\U\2ZR,T6I&/;6?XKR"X5$J]Z&A3
M8+# TBF^1HK03@>N64\\(C>9%.9A:Y]/3?E+=\ZV0-]"]Y4>+/R(>[6*V5F;
MID18 ^VHW)P\"+/8J2D=V3U2+*K_"G"['TXG 3"[)2^_+N[QKD([Y-,5W$>U
M.Y66MK*.Q;H6<ZNA8F_X2Y71 )DG+A-U&G#_M<&O?VJHT)#U5' M-YW\ OMY
M$3*G"O.'[(T=4WL-O,6I] \GCB09JX/A[N\;NGIZV@O._BJ0302G(_:5C'->
MQ6F:&MW!/IE[P3RH3>I-;X\+2:AW3!'9=(N=E\8(UFV*&D/0A:WWXKN@>$K;
M37A!,300I4=LAD(P"CV]B&"K#+/TKW]/STQI^#7Q3,_3.86'T^*,0RNL'W@3
M$,![.?12V\^VPGCK;/W::=RB=<9#+^NKMEDKITF-DC*3^<X24T?&KG<J$[D@
M.0]W(/4XJ$/?[,D$=T-0")CY\/H<$?RV'D8G,LKUFVK8#T&6!H@;S. ]=PE@
M1CH]E7I%U*+I/2I>A.Q,^V ] $B]+2-!U^4.0'\:3C7G2J/#\V\^'48^4P>9
M\#(%>RY=-R=M@E3GJU#SDSVI->O.&L*SIA!!3/M/9A/)4*Y'A>/]N@%=O+EZ
MT%QM[NQ7XA:SE#9":?FY+OG9XGVEJQF?3Z<J7E=DJ*,\:&#IC /^ID$$=/NO
MF'=<W]'H0 NXA=]<_[,HJF.F@U-BI9,E80<T*9=4"VFM=!5%/IEI*!Q=?.\N
M%'PDS@YO2W#M$P5NA%B]&TMMC(BWRT>;/YE,TL)[.&!'YEI:[8:%$=NB<V7#
M0HO2&_RPU?:@JO56WEQ<@.:4J#Q5B&^/*.EHPN.C%ZI#BF1()ZQV:S]-NDEX
M,WF;%I1" .,@:!U[7^-K-YYDX\Y=Z_,E-KM!_;.SL^_?F^W/@^=2+OJVO;S6
M#PWL^W Z7X^8/::GIW\E>SU[/8L>!_KV/W;3A C(/SG?2;US06M3(6"')1F:
M"OBS3B3N<:\>]O@0+%EFR?6>T@P?./@=J:M E/NK\)#%+<^]\UXHERNUPBKO
M.1?[S7O]5N3MWU9T; IF_#SO>GE7=(Y!)U0T'95+$ZW*%YVN/X!*_=A OR!P
MM<1K7)R-G9G9XQ^XLAO&;3)KAK:\K@5>&*C>K*\FR 9:KXZY/'0ITVR9XB?#
M8>O[2NZS>"==!+IOHDQ<Q>G=T1J2GTSWM!^H,&LH2)E%1X863_AI21D-Z#J?
M[X_)=CR[OO]]X\URM5'9@HT/VV-N"WF42/V8%'*S=[J!5\8N,0-8^M?C=:^C
MFEI9E<[LY*Y!G4&RUY'X[1)RB/<FPGW]!O"7/9.0<P+"#FUJ[_+6(?*\,T/=
MS:9<NR<H<<#EX<\_#'E%+U3&]CZ3U?7[)LNU:,'-NLG]20DW?;[VC*<'^;G&
M+/2<\#Z_8J,=3.!6];1R-GAIR3>[>*":".?@-&GD),U'W[^;&H(Q#(4"$!I>
MW;S=*W)K#Q$MQOHD >J,,3(-8&X0</ '5MGL@,7-;H*JS(MSVT4;^]#1.9!I
M4"B*?<59%G?O*R$_PZX<'>.J9$J GG_)3+9N0>(6HA0!X?51NWF3&2]HWJK;
M B%E:9R[K]3GL 1/;:-RX8.(SB 6$T"A[+;-X4MRJLL809/4LSG-&V!RKR6S
MKJTM=&MG;2Z&TJ#C-,!77?#.I9C3G[)!7I1N%*H8%SF&NE1E:.&^<2C=*]/-
M;#<MU6A?B6IHM[-#;>H9:U%89NTKV5!T1:V#?&KF.JI!?D!W,E,+GG^$+<+6
MB[1[?]W#;6,G,R1)([X+<K!D=U^)N'M<_J(W4H$>17$RN!MFXZB,"1>$9!>Z
M,;^3.6NV8?QB2S=UYJZBY\DH>RWII&BM(V%IJT=O,F&KW!LTN!68Z#VTE5&>
M1'%4S#DZZ5H:,LV\RC=N-R<NBI?>E4,F).\693M.SN60?27PW@7M+Q_+,XO,
MSB/ON6_O-A!VGBZ6@Z*1&6@_OJ*GTS)AH5ON$N*$;7@ZN1V_),_H:84G+<P6
M\[G!+ODS3;V2'@=0^XJ-@W;BSHQS0IP&9%L"]^O\Y<F'$'XC7>CDDFA+KX?'
M]A@; ER>;>TKN4Q)9*(MY7],]^2K5W>H=F&.X28[(KO%D*S<IWUODH:JCL<6
MS9;;-OJW/U]VS#A^HT:C:8%YHG(AM;&GP9'MFHYR?I'<FODU]HNU*7WXC&9&
MY$]#UAN#I5\F^^M9K5?CZE87,'*.L[@66<\3Y_?M_EWF)9O1*G'BO>;L)3X[
M=:YA:;8"M &>WZM]K::@]8/.=$&H#WI[[!U:.ZJ;GN'$4KFB_I>ROC=Q;'7K
M='[_ 97P(FX5TLY&;=R/GL )]K[ETV^B*O5$7/6T='CAV"#(-+A=1;L37QEI
MHII3P813:,6FMK@.P[@[>>G3UR?,:^?J0D>C.5:X)DMR2NR\>.]M+?]G'HP<
MZ#H\X,!B-;LNXIZU^* 2=M[E)^:@K^;?/>R<?/L_ <BBP5WN<GM3PD5ESLSX
M878//K=GAA&F-IKSKR/B8?TS#5;7G0HNCS7^6K.O=+R44/XOCI#9BKRK<[GX
MC">K_9W\5H?,5ZBZ5TG>"6^W=@X:D$A:XVR/!"[+Q".#;.C@%@?N2F,:0*,V
MLH##4DT=9!ZC=_66:'+%G&ZF,SCV(4U=(49Z^*)8V=CX7TNSG&]MR,M#[#9:
M"H/A?MP[\BX7JPBK*7Q[YR#$H< T6EJ1\:2DI!.0WAH"Q7 AO]0(*E+T>X@R
M^.D&\<KIQI:+(7>DD7=3P*^Z2@L4Z%E>3'P&^I)??455]ZP9>5I0T-3G9WT.
M5U^55.DGZDW=*I,H!SE-<8$KHPMRK>.G1:5']S07:\-HSFV#H(#U[@A#<$#Y
M2!MFJ9F$:"[[E/W2GQM3@YT=I9G?[)F%;3P\6E>IO3'1TQ@[<[BZO#)&E?%\
M G+\%*_C5=@+50X3C)/!'CAK7FT2"CF'8ZJHSML98;E#90:/>Z[J_E#1TB Q
MFIV3R[L[CS]^QXTK>XI/Z)]P,4Z^=L-DHB(<RC4 U\BHFBL7;QC'C*8MMZC)
M>5[]*_8K\<.,0^U,'2&UIZ*EMT3/BK49$3&Z:'FI\G&^X3;-JKG X73V*U!H
M',NFK*O>='5!NVA@#E;_XA7XA=I-/U@J&!49[^JG5EI2JNRC1;CJ:44+=F3Z
M:<73')W.P.2:*!ZOHKMNL11:\F'?XN'V+"U0#_JOZ:%M $^8BOD'L;^@J7,M
MO"YNM@VH6F-H:.1?AO4O*ULO*]O(04,W^9'_<4;P<2EIZZ]/8>-Q>U\FE<1!
MK'&&6@\$@I7OC9"(1%/XY05>]W2'4"<2S81;YR?2EE+>;99?JZ>%S+B[_:TW
MOV&Z'M27N2B;]C;)8FBW_*2?QZ-;[^#.^3>#I[?]X)U51BP;J]UCD,5L?$P*
MSKI;;LG\VOF?2+6DSL9DLN:5?!+D(?+7[.S%P65:*9.[IO^F:U$CA(C!5%:7
M]/A86'Q"Q/P/8L4>,C-8-SO>E;;,UT/J8^I9'8(O1O[^T*WR_7?%4VMLMO4F
M+O)6'QNQ=[ZRA(:EDML*.BB-V2FE&*B 6T!-F:P^*VUQFM]7^D9:[2CN-AZ,
ML]MV#J^)*$/XMJ9/K;JFK=_I!\Z5H8$)_<;20&UY3)),T=$^T_,%;5$SOW]]
MJ0R3ZZL'0W*]$XU5((J$,:<(+9*BMUUQ\%4!=_G8BAC $,W\8PII(&.\F(/D
MY4%C8U>VZK,O(%B/)X+53J:[/30/#  R&9>XG.^T;JVM/\WZ-?;5\@A?N@!!
M[!9S)C/</QL0-V4=M6+-6&U4A/#Q@T7,&,S'>7X?DO/PL" ;9<*;E"XM%TVO
M_ *^UHU"<94^U])9$9A(;.!#,'("\%S2M_]EJ<_9+OE\6J:D6I"YP(A^BTKK
M ?'"B' =<_9HFKBU<_YNR&RR<U^C3FQ4O8>3VD :@<)/.IP=_IKGC=#^87JV
MIK'QV8Y[QB^9"$IZQI?B&$Y<Y?USV)+NR*O]Q!R\)Y49;.01"U.NL/%LBGY#
M0VO7;)+]LA_R?]#>DGO6(?4?]LA'4O)6ZIV(M&:@CEDD^0PM^ /&ZZ !K/8(
M]:LWO];_A* Y+G@UA]A\B)(!35"1>?VARRMQ=H[5EX6'+V0XZ(9_F6Q3RF:7
M6O7#()$0F.H-CPM/;KHFW*3[Q-.TXH?$9.Z*#3(79OV8&LP"LA[7&5MW2R#9
M.*A_3D4@TURUV75XN,\U>E= 2R?C+_A4A+?UN;I"+2T7E95U6BV="Y7%\59;
MH+6&TPL]I14-X:&KI:7:+O6*JM11VW9QQ$ _G%T&Y#X[.RD<" )R@GO+^!9K
MT^'XZ$YTWKL[E)]&O%"=MF#T&'L,>R]I[X!49XA$]G\6(N%!.N<D:GG#*ZN^
MA-50J76S@"/(?5,+QI9";QI&TWRA'):FP'2X(4Q&TG$Q"+4+XM=-#WMUS+>Y
MOVP&T+SL^V[81]9'F*1L= T/E%\E_>=1NL\ACJJ;IFNZPPJ CKR"%K I'6W/
M=!O6+IY*LK%8MMN!6ZR=( >J^W&G)Y>1!YD%426''SZ>O. YI[7FT[U#O$G7
MZM6UVXU+2>ZUBW\/O%"ZHK/9V^S%B(QZZ-]23PAFR4(G$4A1]%O\@K,#Y-1%
M7R/?IQ)ORR1L%$=QP;IJ7\G2^VK_ W!]JRR,;GZI9<K\RF :8^&&4Q-TL_ ]
MY(U-KM4LZ:OME=BMY8<)K-2_RD<V!.KD4?00$"BEV=CS"H]9]U[N_1Z>Z>-G
M[4,'(XM:B[.79F7M>C5>YZ%#H"#GM%5<G%3ZBO8%%Z,W7M5RBDVN$&!D$=-T
M2?N@9?"Y(N-2':W""5U#8G=CWNZH,$2^$D7Z*T/3U'G4?%4V<XO5ZCPTQXH#
M^J^32G F&CO**A?+-)%(I$.*B<DW#U@LUDF<&(>;K3F,1*:<K3][^Z>3S^IM
M[SRP3ZDOAPAR(0T%M@)TS>FPP6)KC_ A" D(H.,L+3_6:(<9S1^/[6&B#P[*
M@4$P'VNW8HPB7.%R_,U'OS@?8S2*-$D'#1I7TH0'8UF6%T?AI6SK=&<7EW^\
MYM(N^9WXKJAW'K8BE?\QBCCZ-0) F/!6'?4$>;=HQ2U(*QN,?H=+5RNM%YR9
MQ;WV GJ6@32\=A@ 8!H8DIL7+358H0D8=!A5 1M9B*SNK*KWF)T>2\0M0G!-
MSO2/@Z_7U]<?JZ:B-U<W?>;<J-"P1<<$GG'2_1VVW5\E:7LL -IGSJRNIOHL
M>3#1:6:7I/E9?D/V9KTML?WYW5ZZS]5;EO$;#1CZ6WZ?/MW9<3 K7Q)4.!-,
M*- K#IZHJ5CR->)Z;D!C,'!1,S<UF(ZK]36[LI'/X&0DK>P=&.>NJ15XYS>[
M0DH2Z,JR@:@<8H.XDE 4.=5\WD2([9-C]HY,AUET_\):@P6#H%:WN,DN@2CA
M%#N1NP:J.15?>CV &Y& J5NH/C?K.%&5;W&5<:DW:!JQ).1VF6\ W[;8"FA$
M<<$UZVY&U"9%O.!UE->1-G">WJ CU.?B^88!V1M=-U!?%[>E5W&"YP-G!63E
MO**R#:YP#).X5V]5/K<;E$0J%&=??GW%^C\!Y_/?==&EKW05%U/UC0JT[Q?*
MML&#TP/JAPHHU3T >U#BVH63598.*_1$;2)>]RZYHM+48U'UAA]BQ#HVK$#S
M:DI1C\O?S)0RFR5:[H6=F3K=\]R3<6%=[F3$P**=S<FVC\\[\, 2VXRSV0T\
MB"IQE06MV5F8Y \X\W?YD^P04$$=SEQWM2(3&-;2&D T6G^\P?3&:  XEWJ*
M[OWQ\R>,O$I?&NPKZ7L77+,?2KTWPJO[C7X9S4D5I1NAP,WZ%,J]@.6=AW%[
MZ!X?^)?=B-GW#NM)E5P0PR#AN\N9V51BO/,->_6 S424&[>=XI!BUFG9MU89
M<FBPG[>F;$>Z5;95$1R12 UNYK:HAAHRB4MC>A7 :[=3CO<T%$YYAZ^6HJFP
M9]9<P*)*NOG6))'-FB2R"#H]9J DNR<!O@5%W_Z7CE\8)?3<A5-=9+00N9^?
ML)XM7WG!(3@DM1;EMF]F20A^E^@A+D9?=LDVPN[:58#B&/KAP1GTC?M]K%7I
MK1ML;UM&JBSK"_[NLU=)H/BW^;3/!L5QL+4;">QZ:4.P86B:A8"$N3B7O=1?
MTC9X-<_7T'X%E#L57QF1H5]4"P)3^J-#G)Q*T#$ 45V3?6")C#6JAO;/NB[Y
MF^,O?Z0/2KG-.UFBCK?W5*AO;K</B:;#_OF:#W%(Q#D"88&70Y?^"DLM-L!%
M1)4<"VL\G-F1E;URMJ"L'BV:7QOB75SHLIMS]J9U]ZK >+V.;)V0G+ID6Q/I
M[6E!,[VM/B9>;<PD-B\17.'Y+!PN]XN%=WI73]]UV(TT/3SLR_$$&QBQ,,8J
M+76BVL7F17M6I'_)D%63SJ>$SW\G)V [Z)WM/3\%]N!;=. R*)XUHYSJ"R=M
M$?:.4GMY-VG)X6I?":.?-E5T.K>P3>VRT!'7]!>,2ZBYL_9S+\CXO-]V[-(/
M[?RP/+T7OA+<XQT7W[:%/-82:VIA2*HDYF=HPN/=_?I57/0/'!:T^3E?:1M\
M?S L8QZAOL+[7J?R@<S^+E2,YUVJ_E5A9"4 ^;-K'I</NXE5_#<PM5?^U)$C
M.93NP4_GKM[$[:3^H5=^.+_5(%C(?H%J6Q.LHPX?=N>+N1F!_F]+#D<A**_M
M<L<P[05YPW7]N"HKA,EP4'QC%WN^X.#O&=9S7?<9PT =IJ[7$:?KZM,K+](=
M4%1;3$X;;VVB"-HLZ UJK[<WYX!/28Z]FTK*A,?:B=?[V*H)=5;Y<6'DNG,@
M<L &J9P.4:.6^P9_;Y_YS%[Q2T>/ZR*UD1VSX=4ERH=K-D53C$WMA!5!L?8Z
M9Q5Y0^5[Y%.. UX"C&F+)/9\T=*>#!)KA+]:5]31]7MR9I+\8$:RLZ(+V81
M\>^N.E0L,$KX^.Z%8&/E14!"_KD\[= /+PA:&WJ-10A*;SE'%6Y=F"8;%<5)
MY*<,Y6T*(6I4YU7SY<+ @<+ /E^"LO*11S3ME$^(GY;D.0\A7^&04JB.MH\
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MO]L8%2_!J7VV]C/9@'G0EZR^4)^YST,P4-U*VB>TMI97G"K\L.?1-=%+H9H
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M$6]+KW"!]6]C!V?H.,=:"_I""HWH4GIZU&!S7).A,)J]N]1Z"6I<JU/EV]"
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MR7;4*&2\Y6"M9B1I=#AO=B/$-C^Z;:BEGWW3*]1&_.Z[(RJ)<"67'W6\<>I
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M@EO-DC8K\F[E>[1U."W[1H]H@@[!=K]GW4BQ?+IGVKVQ=VQU7RH')3M!FMI
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M,@3*"BSHFJMD*AHM>E^ED@5W7G&-,Z=A,J(31X9++NJ6AD:S,)RZ[M Z?LO
M!OONGI-*KFZVCY>35\D^Y!.]DG:L7Q ?5M8NKP[9-O<VOUJ!;SZZU:K\5K&V
M"'K3"0-.[;NCC]FB1IV.=J^A0S%ZGYU1@_Y*Q1EW\M"E4I=&J9X!TO#[X[&]
MUSO;JKYHXI]M*#K7+'B!=<-^#01L"T=F?.4"Q*W&,/G6L,]*<22<J,FL0IQ=
M%PL K;3MFT7-7X7>H%%N%RV^7<.D"")"99G;3^MARA2>HZEO9N=&P80$%^HE
MEN""\[W<7H1?_ZSYO_[;/&$PNY^J3K?'/I@S6Z ,<\K[5WC)9<7Y\T'Q@#<#
M@M9-HWQ81Q1@OIM.KZZ(4]]9KU%&CC]>+.FN+^J>;\KKVD!NG/TY]/N=,%G5
M4M_)5/1CD1Q1W\\1VQUH(>,<S6#6IX7PDZZN9NW'0]U"S$RP6Z$09Y!^PM@=
M]\3%@BGS*:?-Y2$;BL1:QA[;CK+)S:F]_G&Y-_'OU&;7"N.)RSTNVPK35NG3
M:G/<B]2RPNK)A+?NI64,CL=7+]BL^*_](XPZ.^SN"II@@357DPT3]FHRGZR0
M\DR;2#;E+\M3/*+3]!CHHBY37;'>H:Z!/*5-#@G#,8?1">-NX[Q32O!XJ;;2
M_)J;U[3)W;4_K1,Z9XM?)!Z_3;JVVA% =DJ/?&<OD(IT7W:Z1+OMYJZ3UVA1
M/<[RG.C_-]T:@9YNQ!V"O-'GAL#+#K12FU.,".3;0D C-29!'72$?AC]EQ&A
MYI2%5Y83 FUXOX3@WJ_]+% @"4OF<6V4,REJQUY9$18\T^/?[>@#0F4CLZ:G
MG1)?#85U+H>$E!=:7JF%WID&A=ZN-7-$'Y%G.F.R[T^/5M><@I:42D^'E.4'
M).?FJOK19N:K%>6?MS:'#4F$0/;CI2=9!:/-^!%8Y1W TOR\J !_[+.$@E[B
M1Q)Q'B2KNCEDB\AR$.<]V4$>:%GP$7K/95U%UO#A52($TOT,9^=8,9Y^:=PR
M'#SK:E<(GK7X4AAO)5=-JH.2MX.AH8+(J^-CVJ?9*YZO';E/_U:%WW,B\S,G
M$B!+EEB)S?3E<%*?V%L^8;OI+Q@88 [63KLB<VB4/"!H0'!D ?V2*@@$_4Q\
M_(48-\4]Q]W]NK,%U0/Z*Q*)*F!D+I(^)!77#XIC&$,P+TURBPQVW&@HWX?U
MW /[Y @5,5UMN$2>P!7G0>450]D (O:G=;'OQ,.E$VE9/_[?0?F/[55\CSO;
M^R>"UF[:GM]'=3)'G!F]&=1%I_=OC*0$5GF?^C!S/:?73W:>.D!LO6 4+'-H
MK&XQETXHO,8$;I>N<VW];'=#M[#;RN>1%NA1V5T5]Q#&+#'1^HX\W9P(>113
M!,!?<@N-*.3.@D.F:4SX<>U.9]BSVC5NTI)(W&C846L&[^1?@DI6^X*J-],U
MES)ZH_M'KC'P7V5>S4Q640=FLZ^)N]6#\*BNMC3*<MC/4RE?:<(+)Y(4.L30
M^-5/X"JF#;_L9?H778/2K4KFD$5I4=KR]+S%$87@=>^KT0FVUYZD]+X\WL>$
M&>E\AH:.:&*WMLM4=%)0?B@?6IV,[W:'U;,#([9? 0D,RX*6R'):I@>R'B:
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M_U;^=#+8(C4,F!C^AGU_7FIGUKH,GF[N$H.K?N O@B*+:GL[0N#+,D%1(Z6
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MS+5Z&5$E]DSA QGGI[PN%3\SVAYC-6WR>O>LI8?5E+FB80,H$[:L>N;RK:Z
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M%YU=Y_C5%3_(]-;$RLP3Y<+GQ:W*X7DIL*^?WFT ']/VE__6,EIH/S0[8#T
MF1S7_OY7N7[ORD20O8*:N=6^K"J[[.$*E6P/)?>W,M5J4,W6%$KY!_#^J/_4
MK/V+E^/IK4C9![\N_5AL\^5$]Q.=&O2.Y^JU>)0PU.47!LQXA!?K7--G9^1!
MS"J=R3.:-XSFN$-NCTF#Q@B3ELJ4?KCMKGYBQK  N9*TBU])BP<0DDR*HF<F
M/2OUSUE(;G@CT$'V#=CF J.S(8/9X<^(2C9CMT'84H9;<M%[HHCZ@@$M#(X+
M'H46=$>"[5O6"0W+0>Q? :5FG^UL45NYK2E+DWY"K6]\DHX7+-UH 'ELK*K>
MA ]1L?J]NJIW;'9@MUA!EDQH8$#BV_3VJ&BY-%8;,0JOV/NID_PFL'BVW4/U
ME?Q*AW<!WY?+"$*,TAJ]B4&$]4P,CO'<@V^$CBZ01G!U$KJS:55-)@ZY++W8
M7JBXC:%FA8;77M^+-]RA< L;W> 0[CF?D2#"_]@1_^=R)\U@)V4TI5&JH*0D
M+EW<5UD#M<;MI%.C46XM"0GV>Z Q#7<_ 9G+N::E-F_)JNT?-+GO4:8,G!QW
MEXBPJ9VQY9O,EUJ\[)WO^[:.4 ^BO8AHT*NP;(D5,3"UA4WMJM0/U1$=:KHS
M8"Y-Z2SF7!L-XD7%TH;'%ZP[Y;W[*G:"^SE]T&H@?7 T7, I*(P  < XKPIB
M@-,T1_N1J!LF/WQ57JNYKO.KQ+- Z3\>_=L@@T4]%5_&"3SU6M(!J<S9<0;W
M/R N$0U%V5$F!GG Q&V_WM_2[B7@X5LG6MKVY,N14R[?S5+&6.G;D"A<LB<\
MF#O+?/!^"BKP'J'!^7E3E&;):]D$^'AH;C>8&9UG=DWN5;B<A48TV'-'5EH\
MD*6$)[2__"M;82=TE;1X*:UCF]FUO;BZI# E3)AK1NGR O,%P7OX:.;B:4=T
M*_NS:QFOHV\![B)U=16"&Y@#5CM"M/=5QAW-\I5&A4O@F;K@$Z\BU^X,B-6L
M).A')E;KCTM)ZH-Y::""(GQL_8(M"O_PH;+B5-K991M;P@T4N3$9Z%+?*(Y@
M=XQ\ME@^TM55G["OXHE(2'@@0W;@H0^2Z<J_5CY;7C&-)%A'NA&]R[RN- 1<
M2#?NUX!F+YO=W=XFK+PIN+0YTW%)A#8NE_(=27<4:,-QQPG(*REH1QE84:@*
MO3L0D?(*X>HA&E ]8RX8CXPG5/F7%D7(''T7'LU1'9W7+"=AS5/:7?KGPHI+
M%W/30##[!N?M(8_D&Y?,P_W_R6KYW\H'7SM[=+Z@OH/W@@6KH.N_%"9E:&J4
M_%:LUN/VFTW7L_9H:[/;;>VM%?:$*&D'"RR/VOXX IV#.QKX;L2/=CXEEIZ*
M3?FJ<%@G= :I:4KN$9Q?L9%G85GQ#BBS"J,'%?53-KT41D3?^GW6C:$X+N<,
M%>UP:W)N$@?6X.^^@LDLAKRP=YF2Q .G,,71#K,:Y665CEX87)R9F5F;0=+:
MYSLZ.K"@'!PN"UIQ<"YYL1BR@ 76%T!J"X@1]?7M\W_4GA?75]$ZCK:2'/60
MM@95]4;7 X&HJNKDOS_$GY([N"V-OF15_]QS>N.J\F^DJ5-_;SAPS:9/\6.)
M3FP2GKL;7,1D(<:V&Z=>!<=.<#Q30".\Y/*Y,JJ_75B5>,@[:AR'<S1.X; _
M<_?<B/5F.G[C-VJSZ[N%UWW4:360X,P[[]>NN*EPMJ=C=U>=8.J#JJNY%-N!
MMG*4?K2; ?<=;\]K95$.AT39:?EFSC8Q!P3,[GFAP8VT37M&$Z C.<1I!<N5
MR^7Q[X# KXX1"(WF( $(Q'#5D,O?W?3XMN=#<V^/A[U'XZ2>EASF2<Y!<,74
M=<?L8"Z'#42VPZP'(7_\YR$\ (/9>'_@ XH2@-RN6BX&YR&Q<!['4X*;W^W]
M4Y4'L-,CH_6['&K!!;%?IC*:>?I#J+&S>>BLG TA0QAE+-J88-0O:A1XIR'"
MH3XWF;'Y;?,"]?O&[T9B$<>\W1A(9)_.)VOPLO:&AT(G$:F]5@<S$14#>,6'
M57+>#:,85;44:B-'W5XV2X#;2L&&J64-K4BS-AH[R<'K,-SN'!8Q2^W-T0(T
M$V5B->=F]5SX@RPL-Z[\HFQ-4X:?.X'M?K:Q\@B1)&*B-X3!(TI<35C4]"2U
M,[*"!O5R<$AH(?+7MH<;["7SG=8..8Z>" #[U.U@WK%.Z>049^IO"X\=S=9H
MC_ $AXSNF2)\9U0T-UX 8A+H<Q2J#S2*8#D1MH69,5++?NBV=HNC2W:T$)3_
MPJ%/N<*W6'KK&"-=,RUE^*RH/,0@..S&1C!G&NO*U_^4 VG[\K\@]#-MZ<":
MS42:-HJI(:NZ8<WFXARY&DY=O]GPUD!W$H:.M11)M2>KRT:B=8[$][A'FR0V
M$E3] M5Y@18WK:IY&FM,TM/N.J_A[<PE\9NME[FDF.40[FNXQ)\21 2Y$V Z
MA26PXA R_D/^N1'59,_+')WK;\IW7SL"4J46S4+7T-GHON&CTK,"[;I)Y^'&
M^%%[,8E4W<>HI.1E56@GY8Q61,?5?D#K<'?93M?]7,Q<X@]_W9 8/TP7?$Y-
MCZPM;YN9QL)_;XZ<C'U*Q#90NBA$!QSD K78[I)L8%[W1 +IKPX\EWL*RHF2
M3J9TFN49_M'JAT,,&TWDD#O806QN;GZ*F4AQ+*J]#B1_@"2UVN6QYLUZ92?%
M@\% L-7;04_4Y5 \*GSO['!KBUOEW=9C_OW?_4Z<UF][41L@E,V<Q6"96^L$
M+U\( UJ/W>:,N")&HKL0NL%1BO@G'-UW2>DO)'>)?U[<5RF_'<UA!5,KP 5[
M64F!9<S1!4C4VJAA!"S!UC(+DVM-VQ7R*1L*?ELE1^<EIA3M]F@3&0N;RFWK
MI&1F/0XP%,M#V25:@/60#O;<D]LUW]S_ \AY[QE JYZ85  XD7!M5@Y;43Y2
MXY5XR]2KR2!@@HZ#P6\V"7Z.4T'C(,$X7P"WNF:YPUND9F-K*C%&E:6+:%U?
MU(&EW7ZX>EPCGWC]H6*2:]7B26 *<=M<>R@$!XP?42=BP1QU3*,'_PN7B]&%
M@XG[*D5\/^Y("\4?'1S08UYQ[@ _IBS9%2)Q/LB#&^IBA[ =_Z!PAUE#\^98
MN:X1G@7NS>N](Z6./Z9\+:J 4)_WAYK<[^KNJJA/K"=^WMKZ0\?B0I[= @?P
M_G_A[;,VI13-2UZ>\RE%S+S\Y=;5!P2H;C&W-'.G:?LNH] 9^*97+9+:XDO6
M&<>4G]/;N#]@U*(8RH#($T+C4T$YPY>[T'28<A[P..]6BO";Q^E3S^_%:PZ;
M-?N9?Q5;TCFSH.='0UPXZ1<=S+W^3(1MGY;8M+9I=T/CF=H"32]TAU1PC,XM
M/_DX[JU@IO;2NBBKE!EDJ&V955H-\<=D D]H-M5I,F&;2\ 4 OV3T%R]6LN:
M$')-J'\C1"=?3;R4Z)X\_\<Z&6,VNR/4[G>*5H[U1UJ5R\V^E:+#R#DFL5[.
M >^0UIQQ5)"&?F=<@KHL#9Z4SR.?*8UHHU:)W;HO,R[$29TLKX&FLJ;,/.O^
M:INJ@R%Y<F7MS_G1/**>J9:FT])LSE"*&O#^ +7EEDR2BN,V6V(:4[=S)Z^8
MLOBP<[+ ]J2S  ^H]%9I+ ):5]T'?+UP32$VUSU.1M[7^.6/\3#_XIAZ9>_*
M=JR(5'=!F("Y.ZXT"T_?8SY-3N_?<XB4;U50\O+.TVB%V:;G>R"VAJ;G2$9%
MQ$MO?\A^FWY6GX85"@..K(O7Q4*7F]HB+=W#:JW+A$:N8'>WP9K1RH"L$T)'
M+Z_$] &_N)/CR@^!)]5>NC<0*'N./%R\*@1:(VW+4N+MLM@5H4!1H[)J?*R
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M6/IZ[\*TR;!B7T7W45W#1T>[$P?D;@]3HDD"C8&3M17=Y1)Q U9MM/+%KW^
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M.%\6NU[Y8*OX.'3^ZOGL8(\R*-X@L82Y%[(LB&?^E+CDL.<R4Q:/S[">NM#
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M;$HF';1C&RU9[5K')Y \0WBE<M_;H"V=K9_7W-GM<,O N))R75$-F*$>M]*
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M,<>) >L/R^'&0L*KG=Y7!W$]6L<L6]RB:ZK$_.8O4G=XA6)X+?GHY+)-NEI
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MA":6AX5WSC;+D$.!G_F5%^NI6O;Y.DIB=;LF!QC4\D2#INRHL;!&CP1GS/X
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M ^_[;GTW3@W>.C)._<,&@LX*Y*\J3WE]^)K42>J=VV94V/A(4J*.E'42"VR
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MQ9@_4>B"W)N(A&(MA%W,/_QWC-HJTS-$XZ68]@;,, R<T% _(-,E,NZ3*P8
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MAD>!>C;JL7SHB'_!6'PWGPN:,$GK_PL*0]B/417DSZ>#=C:BL+M+7OO73L"
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MQ(2EB0;<X\J4I4G/6 IXY \752%S@B(MCH6502)7'FVM&2U]6I)^QS^=%C"
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M._/.5E7XJL,>/H3Z8:FM-A73PN.:I=V@5$0XH&M^?B![VTH[5Q_R="-XB*E
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MS]MOT1?E3=B@$_!1$W./K K("#Q4$*XU8V!;VC!SH&;Y9E5WY79<:CUWJ>M
MK7+!?5< M]D;U.8\\MS<=N[ ,2>3O64#QV:\OU:Q/_RZVJ YB>E4"HRJ^=R
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M[_H=W.<>K_5K)P=MKT6VT.)KAWCC2'B<*N\$=Z:-6SDU?S8^@<SM-*25/";
M)CAKWB!"YV>;6:I<.7SN:FD##A3!![G32<W]]9.FRDIWIR:53Q-V3NU!NP44
MM!1)$WV++?_1T2#.DGT3>.E29&EWNX.NJCC,PV_XW"= (,Q0'=5H?(&;9:G=
M%+#FZQ?(2;+%&W1R&IJ'=%[N/0QK!D"#3:6'"IGAAM?F)EJ&UUK'R%&>I5;$
M"1FCJ0'L?,&BHHCJ]P(90[VSP_KK<I2V^MR^O59DI,Y2SG:?!Z"AKC?N-)7D
M6:-8>U :A&@J!X/ <6#'NCGEX/G@<:/><<*0W\#1NV,05POE02.+D2]^&_&Q
MF/8*!?M9@JD:(DD@WJ%"'(4/]2^,;'>A3YH>"=;3,_/H&:+4#F;[3_=&3E>@
MQP#*6B,HHG:A].#[_ZH@JI83U'GA% +6#G_(HR2N:?JU'RJ4WH"#<0L&^_JW
MB>TEG;B6[K3F8H3<?VYCPT??S#>FK+6WG1M1E\UI0MKR_KBI^"@K9]%;%09[
M%>I-?<+=SXRR='9'T/,+(T"8TE!Y5JE2[<) J99WC3=.[\Z4N+=S0&9%7=.0
M,E27@8+:<*=+8_+8\B(3)#,3<G.:B$&_)VD_J"GA!";Y;VLJ3IRXFH1G=N12
M-?4A=\NL.]G=8_.^KE\R2ICM\FOX-+@QH'%;XA[N]+2WQLS/+[S0)H.+3O"=
MT,[M3]F8-1>SE>8I!F0 @*+910 GB1A!F$?JA5[WCJR(KU1V+WKJ@EU;.*2B
MDQWA$XJ<8G#2T@+GA(1*>9\[8A$+?SQBYZN'6<,7QJ_WX!0;UH+S[@!L@(QO
MF(1>GM?,*O^5@)54\Y2\VC61KAT&H;A*U1T?=O628RX+2NQ>< -U\4AH \:I
M/]S67]]D,'F_?V3I'52(7XX: ZY/EA_GJ6PLD3,D_)%"74!FB'L!GQ )A^<O
M=C&3B/:%J[*9U@_#SHP\Z/&9U _CDB:=2R*U_D\<(O]OY0?4*\ 08B]_ Z##
M.K=DG(BZD]%4TK6Z!U'U3Y-9,QR!I<\&S[*(H3[ZISWBBLBWC8R(]J]?-"-M
M\\)V4UPAF4ZE_1NRS>DLZ/(7\!>O%A_!^^<#!:T]3)H*?K,Z8";DVA9AO8S!
MC"I >21)Z#I-88RWF/=(Q9ZFX20CE9E-R"-S[)A+3%'<'_GK5<%Q*G#'3GC+
MRO*KK4^>_N/7??PSE2=;;)9?V];$2@Y@YV5A/W EBPV>2^?QG-FRL).CFIK4
MFPN\);L%4LF$XTVG>V]2),^28@9&_< B\BUW$PRUF:.<TX2R3X+NYSIA/NXR
M2'+3$&"OKC J.%.0J4@:)EODQ-Q:BU<AMB1,?;)#(1SM;_N"4OC]KD3HU]5D
M>,ZB7BI5.ZDWIU8V7*GC+AWROGZJ?>9_!^K_F*! CSD&_3.R@6R9<"_)=VN<
M"P3)%)M6<I>%K7Y2D]L>PX3O^X:FO1;_.LU.^(T]%V?(-<@H*PP-G;I!]KM!
M=GAE4M>O>JB .U2PO1?V<R=9G'%M;E\ PP)\NH!1RS%XG]Q)%:IE/=.NB69-
MO3XVY-U2G<$B]A?!EUNYK0%-<6>=DD!>48N1VT+5K1H/_IG]*"^0DAV@J<*<
MAAC^QR*/O<LY>^KTA=]ZTE>;C:3J)O44#NQBE]5#"ZGTR7Y#@*3LZN:@:?%P
MQ VJ]8\'TC37 "F)O@G_^E!AI,G=X%"A^G5QCK*)80AF4UN=&^YTJ""W_X%U
M=1FB9(7$K4F?$.W"VS:HKV;WFK@]F8<*V3%8^?F3V<]@F/0>*8>PX2/KHVB/
MC0B<.MM<O"*C9C<B^>BQG FF*MS?S/;[?Q?_4\HSU4\8O6Z_+)+6IN8EX3U3
M]_XBWX$WI4SP(&,GG9 9RY->PSZ&*0" )VV:4O_U=E.E;C/&X!FZ<1FIR0&E
M<>ZE@XP*?Q#"RP3%2VT3%1M 4815"+7_^DTCH [+O/X)*J@"%6!^A[*^XS6=
MYI"DT2DKKS;TA%0Q<VX:*CLW.;V2-1U;SEEH^2E!=<=+<>!$@A:%^0(=8HA9
M6<W2NCF(%_TF=OEM/*6.O\F^DP9_KJL) =]2"[(#2Y7<W512@#DGPC&)O(&(
M7*KSZ *9"F6D.(!4:H-[TJA&1MT] F6ESCG7Y#L#[B@/WR\61^]6HBKOBQJO
MI@70V')(PGHWXZ)0R@2H9_D7C#J7ZGD977=CG5YIIPA>7'H,55PX5/C1R3]I
M*DWMQ_VVCC0\[<#7M6AXY,>&K>ILYMIUO<[A%;L^.T/-$,]!JD.6NU^9WNO7
MM,IL@CP;#UVNBA$=*AP%"VZ?JCV,TN--17#W[9Z?<'8OFRY <, 8<:+\4;%R
M;32U5.]#L+AP_FL;X[FW\K@XV4E%0"&0N$4WT%:I=RR%39!&@(YVS8 0'Z_4
MVVEI:_^D\H^N:&MK?W[@#YU.;UY+/V,X429B[FZ>6^]&99"I0.,<)2$%;+$?
M]LO\R)W'G&RNK0U2?7OG@>(Z6%<E7'S9\F_Y$7]Q#L(8;L0:44Z@'&V;ST^5
MJO"DC,*KE]%C+J 4NI$7OO0<Z[0D*3,S]DIJ."FA;W>3DRB-208:9K!3IE&>
M9Y;TZ]GCYN&6CS)AL6UX+PM,D9YN!DCQP&+/=T,YB*<]U>7& 4$_MS,B3O#F
MHQ\XSU;YA098^E'"0ZI@L!-QI_A5^=N4.[@6J=_D:0A5@Z'5C>"KC7-N9M\2
M<_1ER"U.5M_GFI(!BO 9.'$#YABEU98XZVBYPRI<'%$&^)?5.SV%Y#GR%HR7
MUN&4").JAI@@>H7IGDW\H<(#[+AP73!B1<(.>09<'SZP4%?\5QYP3GO3_NU2
M]>9'7.GBU-D5K,B^NO\@(%7*AX2*;M2EY9Z;6G,X_JW4 P#@U]+%5^;'"\=<
MR;UD2)1)+/XS@VXD\RZ)1*MY:HM2V'&.8\L_Z0L_QV'OY3*[?-AI049!H]?)
MN,!',TN$<1(I[()Y5!THGISXF B8T5SL7LWFD<=NTUGNV^:\(F?W7)KFC7-C
M69 I$R0$A6Q1=C2_BXGJ??!3DJ-?;Y)FW$R@^GA(YF]IGA//20#2WD 86_W.
MKQ'41Z]YBV53@"I[%*F'A$?'W'>_C:ZI S/"5'P#G"J[<VK>R9ONS\I,0''U
M@@<<8<N:U<Z+9F_/((!:'==(Z2Z]3=FRW7^Z&I! ?A9YV2>JCYD,NQR*_)NH
M-*9&$^0QW!5,+ (X=7D"E%<K"E#10QZ4[O2O_PZ=ZA^WM7?LRX=.+C^G8'BS
M3JSA[+4QW]/I.P;&@O85)*/G&7-4D<22?SF_WT<B[O<$/IW7F-2XX>=7_VWG
MSXC72U7YQR2S6R,1)FF).Y^W$>?#/=Y=$5C6^AOUS=!C9]/$6$;HC"41WBZP
M:K\:UG-3-HX$OU^WV%ZQ;\K?G^>"!7/V=C =KY0[1;%O:F))]6U9*0)ST<T+
ML1)^_^;]OV0<N4<!C/-\ES5B_!.GRYQT[\O5^?39,V=?JFM=\K[[+.&N[&W?
M\&)+N:6;B<V>M+>RC?0J"L]OJ+R\+KR#0;VC>%Q>#9>M^:C+L@?[[-W ]DE<
M7LIPJ#4JD.&.$[$MD3U!8.9V6U0E3<^07;;5WNVM5KE@G_-D8$P4\!2VW[O[
M O3>TRO644*(!63*C8(J:MQ3['<4-P+:G)Q[<F<RXZ#/Q";8>=CLVHO58&QD
MR[#T:I[EFQ\#E][>9\IT3MJ;1EE @A=$DO$Q>OH-,77CIS)V/-QPWQE*)?;L
M\^;[H?=2/!VJ4\E]3(A7<]N\:R00&0MP[[-W(6\L(K86:N6M ;H&=ZH+V5GI
M6?=L=H!EC^<H@U6J71.7T0#+RHHCK3)#O(R4]RV"=:ZR!BK_VQ#QASM]6GU7
MVFK..\X/1T#:1B)[HE>>EAV%,:+59U^_YNW,@6RVPH,@5U^@VW-MMJEQ.DMV
MF\FN*5]L][CT4+U2YSSB/%L^7CE46 %%;<EGG5/?@5 FI;:AZ?64TUL1:Q()
MCC0K8L9F^QO0KY!?)"Q3 X\JGOKX^A>;S<4OI2:G-HDI(>FJ2VUG !O4453T
M4F^<A"!Y7U!0R+9+19.WWD_G#MZ1C#D9AC-: N=4/SY6U#)X>R,#H!X:KGTB
MC\PD1STB1[:4F7X3@QSF87]Z=N:K7,2%W$L&SQ 9#4@;Z!LVR/HI4ORA4?AW
MGHT/C<+T#SP;\1\:A6,9O4)S0##-BE ?&QO[%VWCT.Y'1"J&W@=C @'!L4"
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M)S-:WJ%*,''K5]Z'VTN28-"^9PD&$XD.;E?UK]*$4&3G0O^<=6B=?Y?T#^>
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MEP,B;Z]=@A2TAX3NZ&RRG2-1/L&\:GB+[5&Q&1C.9K,GV)][7#M/(!!R#6$
M0,8O]X_>?6: .*J!+L4CS]Q!8@SJT1E<=/Q1]<%[W_RHTBQV)+$3:#4:7_E[
MP1,75%DI^?#4!)45$' P+YRY524]%M[FG-@?]^Y?!^>/;IUZQ>$E]-)"#Q5
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M(=/6X7ZTL2^J,I;:/=RUM3?RW@Q1^3.M7]=Z63)<,@8\*51TN7 5?EXLF5<
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M[T(&Y^Z^60#/-T7A3YU9PESXE0=1%*RY_[ECF<&;_MG=ID@7]_#> X<8J?T
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ML $+X<_+^;??135QFJ<S_:+C3+G3(E#)#\Q'F==:8Y=$*TU&WRZ5\\:_WM[
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M4MK=580Q(M6,?FN_M!N<=DV<NJ^R &[5@'C0>LP77M'X^RI5&,(UJ,P](U
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MVNIO"OI=G"-U:5 [U1 D;RS%='^;-"+16K&]<J7:YX-R&'K=LU&-&",O64>
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M<D#WQW\>?T<,%X+0:4&+UUU@::K3229L@M[+?G;>$/7H_5?%U #:^1,^^>A
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M55;1%:0IU! YCV^6\TI;1OQ(+0.N4-^</*]@@P-81.Z427)E?Z/PS,G)-S
M'MB-96 X'IR&7DT-^B]"[Y_A=W<D;\]29UGFXDSIX=_=6Z$P)<9=9FWBIWSV
MI:[1Y)3==IRX6=#<9$UJ?Q6=@0>Q/V2ZA558G6AJLD:CC$@F_8?>ZB,$-I)_
MA:V#'R)OK:?8*L^8!>>^YWDY:+&F[N]RQG"U#=V09?4)VYO[*HW'%K9!O9*H
M"/*KDK/P7,?F%J?+M'86U+W487+<E$$.NA5A['3IY6^B87KBQ;WHP;VM%3W%
M.]%?^AB;^O>BN(LE%U>0T.CV8L@4!"(4I9Q&?&$Q_7W^9-O:< C"/S6E^!4\
MR'SWHB*V/S5GRC^Q0*E>NNK@QT3?&U[;EI%Z@P'1'J4ZK,YGZLM6_4B\WU6%
MZ[-3"MOJE"RN_-#AKCDK#XM77:]2$9'YX;V>97E7W>OH$<[7*.4#42N+->+R
MI=#E4[!@\/;)6$6)LDG(;<"5D LO0-?+!<SL]M%[E[]S_KSH^W-6'<,?ZAJ:
MC)I0X&94TE*U(^0MUN[U.I!,E]@EEM&LD=!,H3'7P28GIR%:"Y!WWL#@3# D
M^2!"S\2C?7X)AR6DH!R1I?>Z6YCQ#P%MO'91WC@3=%4H7#;];M/MV> _M>C_
M!@XY[*N\Z1\ZI<0RNGDMU%E7AWK^M:*?A<,IZ1?(2JW$JL*3B6E2 /B\AG>\
M_[1'V>"<.*EHS-7LGLW&]8TE3%B?I+^=IK'*^+U'5^)/N>LSP[U#W9C-E7R2
M5A6)K5L[WI6.MIPOAY@%C,2#IOS<@GZ?L /7+= IN340TZG#&C83M@XW?EAC
MI<WB>OFN:9>3&5U_L """+])I^[Y48-_7N]J:M8FZQ6&1D]L2%K.[Y6T+*9R
MIA$1@=3F@,F0KE%&Y:/8_J,EMV:?OY!I108W3^,%1YRH_X>V+XU*,\O:M;J&
M=%4&RS)J$J>.2;2,46,,3CAT5<68Q*D3$QQPJ&B4($&"BA."-<8I0JF)$P[=
MQJ&B@D$&!U KI4B,(J5$4%!,P"&H8! %%8>;=%??N[[O?D.O;]W[K!=^O+ 6
M9^U]]CE[\^[S/.X^')/+)^\RED2#)<H%GN $>WG5V[5:,AAI?QCE$SS(!4>E
M)^3F$JZEE*V^I#VZ5-]^9![>PJ>_B$Q06+]$ZR*_/UCKC-9>%/:06[TED/.R
ME5P6^!J$=[D;@QJSJNT;6?SP?VSULV^+UO3WQJJ=H<Z8?/%.5>-Z @&R]&B]
MH-T>@==JRZ3S4;PG:7LZ+>41V0XG,S$Q;4^^FU=$:7,68W>*)TR79K'Q58P)
M9ISJP;Q]X^LW,82U_I&J=(3,+T2"Z3PG+%M:H0(CS;^?!WZ?;GS("%Z:Q*CA
MCU'<?$10-:@73G0(T3Q_$AF'#>@:\>2=:MP C O*M[NS4)"H1 W(DQG7'2LK
M 6<@J&(J:W9/)VQDAT-+YL)2*Y@L3,L:TG_@]+QG^BN(I_'VN4Z/@?!,=J7K
M%;BZD(>84KCMI,-E^KP.<62-O6%)+E$I)R\LM2SA47FCGQ56U:\M=70W,U9L
MAX.,ZK8+F$M0C:SX#-L_N>8RR6TF9'OJX<,P)GY5.XBWH]].F3G!*+XK/T.L
M:5YCA',X#5ZA3]$/D!=F&!F@7F@.#]7:*<5YS#QY0M=T[M"V.G>:O97<'"9,
M$G!N*A#7@:DQHO4NB$S"-MMDRYNB2OI@!Z=Q"9L 7M.>N'39[GT:&DVCJV@O
MG<KH$PLB0"Y!M.OIZ]\6%9AZHS$P"2PZ.O/-OW&9KE LEJQ*]OM>LGQ'!O9W
M08CFOY.!R?XN"!'_=S*P=X(0[\C <"[2Q>U;@_A#P-BAVZ33_9QWTG/O>$RY
M=>]X3+<N>)70H*&T!@ORL6%NVPGYPV_=#VQG;->MQA<DD=V_*T$<R8@Z#NC6
M.*$-W7QQ"M%9:C@FMO$]@>9\GUGIH2O ])LX;7214#(S=4]A$OFEL MS=__;
M)"?'/I\)@7,1:;LG.K5<$_^,)^(3!4^+ P,)7040Y/ER8J/AF+VO+#-X&K[:
MO_9:O*YJA:N79R?N7C7!VX>4\2D-XA+>^F2,VA^06R')S1V#N3H(/>Q"7VF^
M\3R39M\R_;5[^A+8 VU32J%1A)KM\7Z";K3B>IA P1[HHT4A-5X0C9<T[0FE
MEGOT,'.KEO[HH4MZ%K?GFJK4*F)/YZ=.&X53!P+VM5":PZ**UC,"GS^-"B!Z
MFA.*$N-H&-NBWW*[!3.F0V)T#G=$865YVH_C ')#Q@BVPGP:NC)0X":563$T
M(<:?_*?_+L(^\,WLSH2_\OR2F5XA M,HY%6KQRTJAM&E9?U@O\-S"0KXUYW#
MZ[@PV/T&>Z./S+.*]6$?&K6CD@).JUT2TA9R.CIQT)BU_'7S[JW,U<.W9HGH
M#55)SQGWDL\+,FS ?C%B:4[]BJL3N4A=F28-WYC?V-/QFA,2O%C5?^9,5"Z#
MD8X)^U  DJ1'7)9;1HJ7Z3O>B0AR#-O%Q,'DLK+YG2=+F]V!7I7C*>$1\_HQ
M_*2C'EE?_SI[LVGF> [G52N$'8M,Y:_OZ7RR?VB_%FI1@LN" T:YYJL>QLKM
M>T,E$U_/I4U1N>R$NSR[,P^JH,5F5UBR#&Y/>PNKV7.C[,'NTYI#2Q\Z ]'>
MZDUK0^(COBWX(JVLIBTZ^J9RJOW%[S8Z>J)1BWB284P]'S"[2,Q375_V[)AT
M8 0T5[4MX.)I@S$-DMYV)KUU"5'<-RO??,>Z(2FW12PWE(@S3MX+_;S91+$[
M)M_=EA=H(*D@,:%'/)LB>%ICT!OA.U#!C^&76[M%&5X9?OOB60)!Z\1'WSY7
MHLT0!9S^U32I71\2!WT[9*L9?7G^!1F "@50O9L='#Z362L+5IT%61:8_3<9
M,7._+$6,/NY#Y"E&?F9'37&0/R\TE<SO/Z.V/%"@-VN77/5<S",,)^\V5]@N
M-H&/VEEV4JM)F2\Q_ABW5%T>&WOK5:I>3=(DH9.@9"SQ+9R/4'/I9XK]H<95
M3-'</.D!H3_8 \DSC/^R-S-_ KC[Z[R<,F@TV!];3I\YWP_-V/+C"S,N^B5Y
M../],?8&><+C)Y]-"7YY9[T_.+JS-W!OLCG@3'[P$[=&XT?J>Y$PPB:PILD6
M61$<'3YO]WE#Q2H:,-[@&>ZD!61Z>P-4E91GOOW)6]%%=MB'R%-,X#IL?F;_
MK3Z:?#?84DL_VP]RD:^W=@HONM0,]X$CS\&C >5XQBU6! 0,4LJ NM3M1V*/
MO\5'3RC@A(*Z"YB9\R-^5T,TURPSR'LZ&T 00-W?1)YKE:+FC:[L/B)OK-?P
MMQ^-RG?%'>2R,NAOZ$1A.085D82LFU\-WIH/&^FKOHW+14Z*\D4D+&WG!W>D
M3,)C^F_@-K[O]HPRG37M6:!M,F#$U4 QW9"G2IZ2UB?%T';B8*4PO^2U5BYS
MJZX=MO/GE$9[7OL"M+A '-!#W['[6'M^,"2?#UFFNQ Q58G?8%9:G7>)DZUK
M),YH^Z'.*7+DS&)%B:9EGG:08+QR5?&59L/TNR'SAQ3-[87QP$X#3Y(7XF/E
MTU3=]Z9-XCQA]%21IT_V4.M%#.D.^KXS;RPC44*3P:U$]8T75R81:O<2,6,$
MZ&0[,"8>DG8C+N_X@N*LMCY3*J:?_Y_EX*,PV>Z/"NZ?4CP!=OA%[*_R@NS<
MEIN= Z_=2A"0UJ,#%T./4[LXW#Q*)^T7*:SIX]--"O4EVUJ<M0WIRFU<U^-^
M;6\OT.:)R\IT@F:N8]<*/\8SFH:P[]F/ZCF17+IK)Q%+>H?9AMT-XT28$_7"
M>F6K<]\;=%9W$K#%./Q80'')>D,7.IH,S:5NL?M"RLO+<@KB#,\K]RN+5DPE
M4EU*>O%$A[B([[$X-[A>$RZ^Z5S]@MF.ZY!JC])?GWR^3FH$< ""4T9W;[3Q
M O5XWJ ]G5#7IM.+JRN2F$D3,_<I2+;+<N6,5<,#,<*F&$YN&?9;ORB.,5.Y
M^]3YVVI<J^)B+!_FT+]3M/Y<;0P!R[6!"/C\0J#?9/3$F_Z=;GU>R1;:#3*'
M1BVNK5,7<FK,/$^F>?U0V_?7C!K=>Q-S% D7,$G8=WAY^F_DJS?<D<B!H*1G
MK!L[Q*KQZUM+3]B\F/L-O2)OVB?MJPLO[$N8T]U5[*S$20IR%-N"=H_ZV^1-
MK9O36C4AK.?94.E\'&]L\I0QNK%'^XB9A%(1FF<0^L2[@I=]410_I,S1G =N
MVM.!US,.GN[[>Z!]\%FF8)LXF6;+-TB>"8A]53ITB/^+"DF<9AG@OA0TKHGR
MQ6<00%W7V%0%VQ-M96($ZI+7%0ITG0LOIR-9?PE#PM!NV+S=AX[I0YUO*SB/
M5_=B6.X@C",H[D7[\8Z\]6!HWOA8C($E%".^5-8^1+LK'=N$V)F.2G2/SC W
MS:<3PHI-R?2>4GQ(Y:8%X/Z-,C7(P\JV%B4KJT\FH()J0!#'L@G5T8CLF\]G
M*9W;BBM:Q\J1. 2IK?S^2(PURE8=:/-P<,;70^%SJK"[NK.Q.GZI! IKZEJ<
M)Z7/O=X'H4PJ1>[A6>;Y9@?O'4"Q\PW=^&5*:?W?-6OSQAZT>,/"^D&TG+<(
MN!-"ABN#/_J$7V8=0H2%Y!!A>G4@\K&_TXR:%9K]M$GR_6=-?X V:GI\TO-R
MRN[WHU7>K1Q*BM4M2.TOL+*?.YMRTEHGJK6G2@:G>";,F#=NZF,CTN.%C*;J
M&,H36D7&GLZWIN%DSZT5K$C9>QNAE3+:]>ARL?,'<YST]2I 'L_T1,C24.FI
MQ_F'7*H28[NMH\!?M<QW5GNU;[1L<VW2V$]$O";U[OT+H!,SL+!H:BN=7Y:S
M7AI@_\&V_9+]!^XIO"TK$OQO75U/LBO97R>T34X\)2S;:D[YGUM(>9OHU5?5
ME7[*MG(/E5H0IHJ&].%P. >E,@*,ST-&JN,4"&"Z;OI,! O:<*9X5<VX36LT
MX\$"_4*0+.+MW+(=2UCPI<'JS7/)@N8&&THWD%&X$HFV!_26YPDSD#'\#&0T
MGE,?'9>\6Z$RKTJG40N2"P:@\_]6+.T_PGVN2X^EN[NJ_>C#9RF'<@_EBDK_
MHAQQ9G;Q1::M*V_$?1P#D:IM3Z?(]]X,DJ8T^I1S*%(LR8#'DPB^^9?3:S-.
MMO_@V>+^]"5QQ+87L=*($5ZOP=\7^Z_*XRCR3:_#MX1BP"+Q2>1#0G] >/IC
MHNT3K?/@CF RW<8?!^6P^K?DJ\,BP^I=?&1+TDIN73^L\0;\&!^:OA#\JW/9
MKE'$@E-X9'OZ[+Z+4DSJV929L*\5L0QV3$Q^[JFNF0R%6.-,EGG!V09) /9G
MMQP<@MCFX-WXA8JTSMZ/,'<V4H<WGB 91([+H8W!NH"^]!*+=N9(801) <,?
M6H@*J)#E>S1&_08]-MRQW'M679,*(F26GX@9%HW=C:-"'=4Q0PYAMP33QT"J
M'0L3WL>T7_ZMZ8S)$JMGJ26[NO.O>U^;30S?I TB7)@<5/53#M@Y>/G&>+#)
M5-(#WKESXS=AZ2A_S[P5Y7K(K.R1^FK25U<VDV1+_3T)DP$SO1V5KIU'&@,\
MYNU_6[F[4V6<YW.C.>I.])#J[-+2G<1^8",9&,6\NY9$"(M"ZM4G!;_DO%U1
M"I<<S,=$337P6%C-P:Q3,^9 H)P6>'9MB&NJ[NI.]IX(JSS*4?V\.HY<;/*T
M5_(-@W>^K1,'GGSPU>$H.*%M]\.DJ2CA*%=/><,S9AO _%;D$=Z:XTQ5F-G,
M4+DN=,9V%L)[)5Z>"LC)I1$%],&EP^SOSVP''46WRY:JI+0I=</M&7G6?"N
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M+&!/YXQ9<I3&*<98DU%SO\+,]TXM^CYB\8@8;929I[DRVF+77"J#0M+-+*3
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MM*W=B#A>$*+EZ5C4[<!BEWV-DVH]P<.&6YL'B7T/\,_O4+H4ZDX;7D60:UA
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M*@I@M^7"CYE<S.=F_RE2/^GN M:VCC+"!\0Z1^--^9>PVW?%)&4MEDI[U<W
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M9=4"WU\X1F2=U+YOW[8T-T>K',41T>2&JJ\:Z8%AVR\49M'07K#(\M!+);&
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MKDNV#6ZR?YA!0O5$#1[C;OLJ8#1)_38XE.0:S%+$M, %IA752ZV1/Z/W-9C
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M(3W[AR*ND0TK1M&3)TM^M:RKG8#<[2Y V ]?T]>>M8@UT3VM[YD&43&S,_=
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M3DRK$&AE]&"V9GS9^X^*:9 ?;I!2N.H<R%N<0]_VGLC6(:MR=L"X2 PWK=K
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M\F[[K[3RN2/4#Z#_]2_]9P#L(3TB.:0W[Q\##;R?7MY\BT%[LM=^F'PR],-
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M/]DWW/9F=PXBB)IQCO#(0<%"/ X;9#U]O(Y*%#)*IZ+R;_">JZ[[C5@-E*D
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M0KWHZXG?I8G^\C\,^?^;G%%;R^9;[MME9.WX3CX%]=UYBGJ>;&QRN[T<;40
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M9/&J4^9R?%6LY5A6&#V#W[GK0J6HNA%Q(\7UNV!3F?F#F+WZO;8N:ENCFTS
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MU97 <-F$XENCCNZ>GNX.@A'$W<[];E-)8$036O]9;4QSK;6P-A3:(X!W3?N
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MSZX1JI:W:FFSQ(O9QYRD>B;A_$U(<V.F7L7J9X9%XP>5DEGIDQ[3F2&HH.;
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MP:2YOK WR2L6C[) PU,W[:W@SH_I$6_;2>T*Q-#=I;RF7S:OV=]V<S7G.EO
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MS*9:9]6[C:%7T)H]W3+!.P'.N7](:C??7V.T;.??2;PPY%-950+*&4WRJ>0
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M4Y2FJ*!;<RPYFS1K>YI-1"&^^6\L\CKV'?[^_IX#*[OBH=PP0E1H]4++P,#
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MC?%D3R.HS7WY%@]DOA.<WJ,(_]2LT,(5-@3.R8S &X?@+9J3$;E-FU++HW9
M9^6^UE^<9+Z4>;7-,]!+3_\Q89*_LP5?Y8S)"UCBF &@_IN#E<^:Y.DF];)#
MQ+5:.A<1AE/2(*TJ.:A]3OD)*67ZRSM._*;LI?'T).C;I>*'B?%'H8Q0)=G@
M2C_B!LSX=I37X7&N\07^#.T'P6Z!P! UN6:,6D+)C!M4=]ZP?!HD:\67Z!7,
M[(FIC0DPVMJ\RU;XF@2VM7D\UW56%UGV<.'%/']M/;"\0>R#;HN?L:_<PM<E
MD@N+0Q/-3Y4>$1/_W6"7B[QWXZ>4;'_<,"GIG&JLZ]OVFA/54PZ?8\H-?_>
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MV'C*3$*Q9ZA9O,-*5?LEC*VM<0X,A'3!)V.P;>NBN-731Q0:;]-EEP'1P?-
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MP(6)$-2&>B%L5.30&SR0I9TFC'=9.@X_-1(-X"AZ;LTD)7^2-W-%3%@OUPW
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MJ$6AT_0'+ES- U[ 2>G/,V]*R.C-KT=G-#!B/Z27.3@9U]9<-"'\5$]HA+Q
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MU$'Z/+ =#5/$;64::3CT'7(>P/0AJK8SI9T3-9:@V]L,3-/ER>>H'6]W@=:
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MO/DB>+O3G=%\8QG_V>E)X\'N>LL("HXUK=&\ZCA"<AQ>M5#3*[.YG1MR,'B
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MH4.VR_[L6.64<-3+/340V3F&9JIMR2(I6(MH3*'N'=:T^$Q3Y;L,GD @>W!
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MC3W=HNZ#2M& <68>(FRE.).X8N"=7ADY!+EIVP6%IE8YA<*]STOJMB?$&!&
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MQ6LK UC=R7&9\SGVB2&%)HLK36;FW>B-7R'"Z%47=#:(1MUEA=Z![T;T+[[
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M%KK<0^Z:H:5]\/OHC]O3\&E1'_UQT/R&<?#?_''V>-;JB3\.[/X F/9^DU^
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MB!*R<TFCH(&-_5R[>5@OM*<64II>TJ&F:F$]Z/EDOC:57F@[NLE .Y@=+?5
M9O,>#=W?V]N6(X["79"F9=/[I-LUO4<4ZDK<DE$Q<FK9[7X< D.SZV-\!YO?
M\+9<VBKY5H=@HOEKMMJ<F"/29^5;9(FH125KX=#U:[6/.5?K6FC&.Z-7 K*T
M-Q5HI1V]O_511Z]:1![F[8,LNK&:;;](W[3<U@N2/=^JCN[K-H5P]$FM/A!5
MYRZS3_(E+;95?E\^K+"U5GA0F*O$5O#.Q_()+"QVQB!,_]+W\TW4_Z*;GM?9
MQV/K#D[.9I^HETS&)EG!89CA=^N)[9E.2G2&J.6W'6WM*$33RVY"3:8 ]TUC
M:X/>6SBU<@*O1Z$I<LMU3]?8L_8L 9WU41(RT0+ 6,;F9V^)Z(^T15/Q3/6H
M$#)!7]]U'KO]>!V<>QY_J?>PG\[K?8<IOL?A#D7 Z9.,6:5M*0P!*ZW-3%@9
MGN@)%F^*WK4XY<2W-+G&$:[&O\ Z-!08[(##(6NPU8T_C8:&8C+EZ\N=',<'
M&P^DL1V>^9W11>3V20=62OXHT[:"ZMMOR_QJ<4^39&N+DCH@\^Z-CSR;\"Y5
MNPC1V$M.Q,/$G6RV7_1J&3GW!_PSEZ%+ME9J@C-[X.1/J\IG1SL3=-)?"-<>
M&DLD:[7:%'&W>+>I<#*ZNP$'%>*:4.\%/:LO< 8MC7!7?[';:EX^=V0E?5'Y
MI9 L()VW2%38L2+C0A@4[G)?T)U)*HZNGU+0Z=.D-BO-[A46$0T,PX-^S8KS
M>]B=Y$?+M=-U A@PN18-[3:LB$LZ.KLC>]B^,.Z"(CTNY5C%73R[_U,WZN<-
M8Z[3FZ\1P7L_E>BD?WKK$Y^NCI5"K*"1EG9?1$ D9@BNUK84=&/Z-W:QN[#O
MZ0G(TI%D[8U+NN1*5J5.\PBUH&"B+$FJSS\-554XM/KLB M9]P<S\3^US,RS
M($,2*F+A2!)Y7:@XHBV&Z"/U<R,J9I ]PS^_SCE[8)D1\I;G.Y0^:^-=#E&<
M?F8["Y"?F+G\>2M'R:$VT N>R=XU"0UT TP31-+?=#_<XG%"WVC,!,$"_Q L
M+BTP@4WP0\+ORQYSC;YX+=W<#,-GUA Q>K+KP@E0,$K:SKTB2XPB1#7I;(21
M6U5+;'<Z@PBNZ9BRWMX^$C>N>RRL5=W*\=W@[!V.2\H32J7/5A8"8G5>%&FZ
M)8BT+K/^%O+5/YD%?C6>OKRA]#IX=921!*('EQ-@=2!Y_/K&VZS<A%<D-_5C
M%:,JO]VZW+!H6!W$[3]^X_>Y$'-(N#@@<^.ZT6V_,=HM/%;I"!3O1D4<MD^8
MKO"79$:[O+/B^E\*5MY]^J=_\J>_5L_$[AYE^"^K\SP2Q84F4QI*RV,5:0/>
M9K:K\LL:VNMH(Q0H7N8RJZDF?-"I#++QOY(=D=@6L)#[Y6)+XYJ@)\[N\=%
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M\:VVTM*M85G9SI,_FYN]/Z"2:[NZSU\">.L#WS"U2,U<#&MYD0XS(;]?^(#
M4,L[[TK_ITERMW\Q2?ZY4X?Z1LDR/VK'P];O,66C5AB1U\IAF3FKV!EO&Y=
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MB'(X@+.=*W(L(LYU*%_/2KL+BP]=<AM?WB16EC0!YC(!P#1UE,F5AJ#B#$,
M:-.CG-S?VU%EF\DQ[1(Q#TZ7[6OHQ,]&-@<%A"G@0S:)=*^ [TD+D_;;[YZ_
MO $N)!)XX92#G@JCUS8YZ;,O\NG?KDXEWK/U:RQWZ_V1_U:=IE15-@3V#(_@
M1+<X$^VFISM!/>K(KKL;*^CZ2(06Z3GO#2.2%I:X9&O$"JJOBJZMD;X>^>E_
M3?U.PP,HX6R&T2SG%B_<)^.#:ZA,[1E=<JM=&#A9%1MW-RS(*C6>H77-0[*5
ME]%[MNUQZ[6@Q+QV,CF5"$(ED!+LFRJZM*<CL,N-%76S)7L1:T8!2O2K0'/
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M[#T*=Q@M4GAIGW*9A9BY9@?B\0@P%W3L!FU$V[;6))0=!38K-#C6+:JHBZM
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MKXY1N\4A52],9G6RUTE1QI3L7+:Q\:D'QX5-_UQYZ-.Q$?L:K;VC!'&6Z4Y
M3EK,MM>^1@QY;.] G7(4IZV(7$4-[&OD>F^P+VU?:OF;F?W;%>R%?0WNK?=>
ME=UNR\Z-J.\RLGO5#@F]F8Y&O+,3?,R>__F,_#=['>'_5HG]//B?/QW:]&#/
M;'-#=.1[)FA+FQUL2&?_6(8>]4(=L8Y/Y [YI0+X7=1G+5'DLXG;HJM/>QYR
M3&L'PGR]W*[9?.&]\:0B1QAIN75@0%^E**0_KL2Z/FCUNI>4Q#L6Y[ET?.UM
M%^A8''1)ZT&1I"JW$)36*>/+L$@*<JY#_XA C1D8\&J=@*;F<(CKK;YPHP?C
M+FCPE8UK6?,-;V@]7>:T*37T6=TPLC?_0DG&M9?+RJ)K-Z8J$'AB3G1G^?.-
MQTG8V;$#NOIAD]9H(W_'F][T\^$7P?XL/%Q/TK)4_'QGLA#VWO,*2]=]\(+I
M=8[+4ODN;&0WPNPBDO-HI1.=82UK9EC](*:+Q,X-+4K0[K(BX.8%G=9O6R5'
M2W>/A:C2&Y@O6#(Z'!=YE?'+U0JK7_Z#M-]X 9P E]")0EK'L@IV2;1V:Y%$
M7-,ER+!U9<*J"20LAB\LBWL)CBH*EBI HFXXPKXMKUB?-7I]\J8VNBAQYN+I
MU&W"=K+4YFG"J][/1@++L8O<"960-FY4PXLIV1D9]60HVV,L]?( '0->$E99
MB3SLX$N#^X,JL::K^^M+ /^C0.D:1 'NHK_ *.F0;!QKSN@H)(T-KJF[A*P*
MV#*=3,M*2NJ9RY_=EB.'6 _ZQ+:4 '_[-=^ BQC<JV &$-D6KSRI=)$V-2;<
MP8O&1"Z"HEQH7:4A7"UN[JP;VF5U+8^M3<]/J8[1S2^%!>UK9-)JGX3.#SYH
MT1TL*K0?OH(+C#$SC9QA'O[K^:K%V0L*T(?S55LIL7L+#8"1P/$ET*7F.R4E
M%?^@9/.W5NFD])\WO/_H0H23[:&C'K>VX,7]T\.-R1SBHORSOX#$,-EINFRV
M"@61@K@A7-"@+X-Z!)>]V@XPI36PX-$>_'&[O4?8']YK^2[R$:'8HAROL-9G
MY_%Z,]N=;N1&V5"G [D,$J2T5F5WI2^K[C2TT '@197G[=P85@V)'F<J;>Y3
M)*BE$<FQ$8<2CN'QJI#2JBO#-1-E(#:GR7--*>N123-,7.WNR*RELVL&6=.N
MCQ:<.C]EEHG8SN0SN6>L2&>7FS>7H&<OZ6KFM^9FGUT^"Y,V-DK?$;\TQKM
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M:: 0&A$JQ@-VG/7(XY)**O\\[?.1O.(R.]ZQ)SDOEQV=(I]<.V8]9YHWYH^
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M[FO$+84%.U]9[)%#M&V#\^<:><G4IIJ=ESFS47A2;&)(K>VPYLFM$>0@3_<
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MTE%DN*_Q[;02\]W>G.Z?^V[9IJR&SY\O!7X_4_"W('M ,B<\#$'7=[4VREI
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MUVAI?3_;L)20Y;P-_T/KU[#__.:?/-QYOF8D"?Q3IHE'?+J\3L$II;0L^:[
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MRMT%+OW+L]'_-HY8>3EXW&"^71,.)\U(%0;"J)^4MISI>VN"1?@Z'0EC:!Z
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MK!)1[8=E%./$)&I[;W-Y5G'[?NYC#N)J\42(7G3\H1:<E1--QU*495U2+Z/
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MUEN*+LM;U-'?=2K&" /\?&EZMVL%56#AW%W3X50(MH9=>;X,"Z;8R^QUWA"
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M0VAXB6YW_G7)HL:!6GE3"NQR(49RS$:J\;CD-C\U+W4XR4QJ]'")LW228$I
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MX11?[TZ+@%M8P(A!K0$/-HR?#X7!\V?3+?M)C,HIN_WJLSY\0LF!6N7.U2*
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M"A[DESH]K$33'?2N3@^P)$'T(R)""O K\<^F18+EMG#-%8W9EU1(Q 31JQ4
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MQEZ]8T_TY=X3S=2>KAI)@ZH),1JK;@H B-;JQ$CTC9[M=E%5QL;HUNI;% %
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MM.#&%L63,T'Q^] YA>=]H B*3;OF!S<K?3J4/Y9\*[>\O#(V%AD;"QS_,+7
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M<Y9[GI"O3HJ6G*88/I0 /G+"2=PP.E0G6)=6)VJZ6SL;*>UR.9M@L)-T;?E
M@\DOI]PF;T,:J=BRBNAR[B9PD6U:USG'X:$Z8VXMIR\M^$XI/$"&R9DY/T@,
M(]S2=+B5\"G5B;SWKX,D066#/%&&/["Y>\BY)R>*6@A+"]%9OTN6!O)C7(!M
MZ*. R5%NRENI9)\KZN)T=I=:<%^)-Y9!LRS*^-BRSM"910NQ?7\,\ ]"M3V4
MR\D<"0%XA(W;S)(# SE]+*L"KH0>V$0S-^@KE#O.OWKG(&$]K(H#N2^,3WU*
MS+_T<!\2T)_245BH<]9%<K?]@=D/2YL145L.F=*['1VB9Z=N7-]S^IXXUY&X
M;5R7@3I'R)HU-DF9GE[/Y@B,XI_VMS'X[D0S[?'$CG[LQ_%<SI/]74K@\R:G
MN82ZWRP " AAP@3*PV0(CC$>-R^&"M(*T\H'P\?MJQYY^%BO5O@#HRY$U (\
MW?0W'-9T"I9[ONA @R=MT76RG+>F/(D]4FQJ>>.+\ZVTEE^V3]BKW\QMXLE
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M8SH%&%;>V$ATPLD)SX+9^DAA1:C">^KX,Y")R[\^]OXJS@5['7()$K@1MAA
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MF$*Z"LF@8.J9(T-^69P>,KU_G<E(RW$L_##SH8B_B@0N)1 ]KG)0KEY(8R&
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M) %A6Z6RA7:IZC7" R1:"Y9NU30Q:)IYFSQCB3IY'J3,%CXP,/"H4A:4B,V
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MM5&-O-;9)Y!8S6!\1^9GKFM__^K7EGQ/%7;6B@18\OA\FI9SCP6&VT:8U9$
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M'ZM&IW<U2!FRU6?;PDZ3;=U':AIE5^.41X=R@;_%6][5>/>;4LP&RH,'?Q/
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M,1A]BE)7F=D^;KOTE#5S_>?(Y.OC,'N&6VO7-?W4%X'Z/GWCD[.HOLIAMW&
MQ$473%<PC#+&K"X7*%;<D*B MJ=I6WXI32E+C9EB<) <A+_TK53S!W_9K&"B
M+3S$<4G;< )35>*&S'8M/*3(S+R1BPG-9?N9*I]NQ\CY=->X(]6Y(G?"(B+R
M1O6^\A2(S=ZO!V;CV^=_:FP@'NUT<;9Q:L>UT\)411%3 2<>A_72 I/[KF?>
ML()OVKR,O#BU(Z.V4P-*!IM\+RW 2BU.V2V*-C,D(#K:G(TT,0!KO7L6D#O2
M2Z66".S *KQY?B$5$A4]'T-Z8LOVKQA:8_O%76ZZ<(FH&'3Z(MWW_]SO#D;W
M6*$XP'G/U=XB]>F^;AND\:X&,3@.M8>IBKV8NX'?=!6@:"9;8A.D2>@_U^;]
M(<-#'R7Y8GQ7HUP]J3Y%..?1!]RIH ![]30E)2#HNRFZ6;E'_S(JPO+; (\_
MG?D_4MBSL>*XE TT0N8.ADS.68?ZN#Q."SA:2+ZC-"JD\UY$D.8*UJN&_\R-
MF)SF^ER_33MI=^6D3K)?>#+==5D%4>H5U DJNY_*\E/SUKNM?/R@/JPH< +'
MU)3<U.<'T=;6UK)V[LE8 >J(2W7JVL'6UM;.OK[O"W(T^08T^2*T!O@>G_88
MN%^X@G(7"78U(L7P[6_'>3[D=;>'W9Z$P.(2X<E4]TA%-K7T S1C%F]YELF&
MF5[EJ/(K-M'/VG _?#;OI#N!#?:X8NA*=K[5S7B9E'9$6/<%M%EOVTWK4%-T
M4Y+00GZ5@"9<[LV*T!H_5$&3'6:T!9Q2RO;8X1A%C.(/H_T?,%=%=85:(0^Z
MKX7D-($.58C$=17<D+TK"/EM1G2S+)EJN+GG(,WWTX$S;LE\\BW!JJX^8#35
M[7JTRN%RG_Q>]T"DO.^+<Y!4?+0%J%0<3B&,!H\YR81&M#TWV@;\,*6J[+15
M4$X57Q=$=62!C0P'DXOG@QYM-(.9Z14[SD%MD/@-"BH)>?G+@?C>:<11>I-Z
MD%S=T-_AB=,O67P_+#R@5+D9%[MS^'"KF;B'U49Q[2_@VF.=E'!/>^^L()/X
MEU&SU)_)B)?'50TSXP[;P0Z<;+J=/<JK\=[82N@,&N?&,5D0TP\["8&V&9V#
M*LV>C-6*R=OV.,>!X@^M=*9O-#%\_9'-6^E'HAMG\F/H81S4618F:%=#(I5*
MJ(LO5ML,Y@WZ:%&L6O]RD+9(+B"7UN/KR$T7&"TW&YNK7_['6*@1:B,7;YIT
MOCVX<+]WA#N)I'XG\Z4S<?A57>LK-UA5C&1/VQ# .3@L=>\$&/E,,EI0;?AY
M6]UCV9'-Z#I>[HJ-%X"?8\6\9ZE>FES="X*09-F:FLII6-\ZU/$M-B^6$+HX
M3& E!W%8<6!E'N>VG_U:4_8J'B,>@6E/9T5Z[!!:ZD51!''E'Q&Q42:L#92[
M&7,-==:L(5K_HN1AV-T?_V^[P:^ 3PS5 9GWW_+24V,GP?=4Y@;,?C=/V=FU
M:VL8!R*X&\,)F<*T!]NM#@>73=\.=PU4O\H0&$:]"R ] I>RCVSW\%UU7L&<
MDE,7)M/MA?5&/8;Z7+='HOIUAV&]?$^*0+R=6[^VT+DY7=K.X6SQ-4V0YCL6
M5OG[Z6NFNQIG4<&!4)8]_\TO7!:'9^Q'O^.YVLB-4@;/QT$?<K>CW_K5G(2B
MT?&$Y1B;G<"&F_CCA+QY@51@[HBS7*P['5,2)JI!.S9TM&^M,AYA[6"(;.VA
M*NY/$E,%9TE5^?"%5U<?#Y2/Q!K$,K5"*GV#3)DZ3;[BV@N9YAY=]J\GE=!3
M1)J-(^&V2\7[)2_M^!#VY1SVY?4QDW4]1Y9ORJ^L]C'Q_$?CT"<;C^8,)>E@
MNQU<E1"?)@FVMU\?-:#-4;M9E?:1X) 3I=OAR>&>H.%#X\'+&8W53@L*>[.<
MC*;'LA($\%M:!KT4/A6>] DG*M;<*;T,1JLS8469<H8\<6@5*8W%4WKJ$9MH
MD%(4I=9790PI><1"70O^/+UAO>(7%G_H SZHICP8R;J75.ZR9=H@]I>GOYNA
M6%G[#:5X%G<L&=:\/HD3H!T7\G/@O9#@%+FGA[]C<47"KL8!5W.&W'HVW<6H
M?KB$^T?Z*U[Z)<9!O^C0BF!0S]0E;,SVT)$%(#%$V>KQ^I+0U+"O%UV1,C=+
MN,I_=H3(9RYM/ .^!>];_OS&QW_YE97]-R3W;+(V_U0SM*MQRM)9A2,61VZH
MA$.3!US\BU@*09/_:I?J(8V:YC"INL4=/Q#Z)]1EFM=Z6YTOY+XN+-A3=X46
M\#WT>TP]-R..-BX]*'AQ:&7O+9J#7@XI>AY"YH!)G%2P#?["]K9\>2AVT+$9
MD)7'BT/=<SF,\"$+D3VUGBX].0/%(>BFC%V-63E8HLA*Q_A9)97GOLTM<_-C
M"?^#IU\P'?MBX6'U+>Z,2CO^'M0H"S'0"T5AEJ:9!TZR$.G/*_)]?G@JAGSB
MLQ0$<"F@$KJ>A-@X!$[>B*VI:">W=12=.B[019[;2=KH_,G))DVF&R_5_$Q0
MWJP 9!6& \">@;$.E3\TRP7=D-!\B.BH@UV5>ZQK( GJG$_=IG.1E> E>Z:>
M-(UH[0CC>@NQ(3N6?J:DLK(Q&+OQ1'8'*3<W?/ G1JYLO^M1"GTNLZ=YAM/Y
M5]8Q4+LT>U#E1B28M\UC+HR]D3XEDGM!7PS279E#&0"78[68ZE,5[>W"\6$'
M.':1,D2%#12#I[8?2A!1S&4YU[U)S\]N[0$IW]]OB$Z)Z/<E:(LOUV8: ]/A
M+IV(5RS:2ZF9KIZ-B-+;; W:N0ZV']AJMX"837Y:%),$?O/?L5^?GAVYJ]':
M,X19N']R.S W,W;KXJY&+&Y$O;=>,92O+0>NP/MV-?(\UUF7MBX1_WE#_Q^7
MLQUW-3@W&G<U;':(V]>B[J!R>E1V23WW[(VX9\9X2'7 653!&W5'Q)^JLS_]
M[ZSO^V!>><#A;TL6<39/H1P<I0O4:5 5(KE_=>J+C.[2T!&A&)=K3AAZDQQ$
M:6MZ6G7;TR^<YAHXRK"5,YAB^L'!G'EX-G]V>37\H#B9,&^O%-.PT)*-Y*BN
MS-3H0?1XMT7M4&K0J#N5;0+NG$Y,/\1+O#W;VTEW9JVUCJUCR>0FVA/4&5_S
M<PLH81PSHASZD)]E/-P[IK=&]$$DCP.R 1:EHB&^W94S1$_\[$W2L/381][2
M%?\$ 3;]9$X=]L*G82&T 'S^Z>5@P7E>!*E8=\_\D/;PLI96F(R\(1?.6F_U
M79BK!1CR4[U9MNSZ@_ J:+$EPC]WWR3P;ZX4@X2ESO[BKHD^T-%G86PWE/ 2
MJ2XD9_MA#QD"9CS!&E[,&.#QS!26YQM=OQ)'%#<K5!Z98,?DH$!Y[J0U+"+@
MIG]O_=*GB+:(3D!;![G(429?G0(DGTFE#X=[74RY!JUV68F+V@128,J +V\#
MDGQRJ(4@>OQF&=0N/ZNY_Q33=/]H:.[C4+"/R!KR;E(WU/@&D7]7BKP+M]2$
M86 D+-1W^WJ5G6@ ./)48&H*CL\=BTH9BPHQJ.K\^[_L4P&FPD.GSJ6#7%F4
M(.)%&"09:G$K'#!U+N)LKZOVQ<"SYVW/7J-='P]P#?0+AS'T=X /RN3S],10
M\&%:?!DIUC@J*MHK-W>MK&RM#.MU?V6\66S7>H'U[C6%+[+HK7*9N+)7S3,T
MB][5R%KQ2.9W:V\91:1;=0,;5F^N1]_<&9 XN5."KP9N?R^0!QLA(K+I>#?T
M .)O%R&TGL:1.!;J*X_7 8]6LH71HB7+]'GIQHZ'@R;="#Y![PU1KW6+5@3.
MK9QY;FKD9';L=YJ#W07;WE($<JSC5B6OJ<W]5::Z6+/%(ZK2,X"REDYOKIOV
M^OJ":</_;*#]G^'0Z^W&5 #"C?]3-Z^RO;%C(C5R93R6T)#G2*%0F+=W@*7D
MSCQ_C_Y N]G*UZU> 1XOZLH^7\!PAWW0V^;MX>5M_FLSIH5'R"J<C2L@E!4'
MPR#0XV4*4 B'%84DVE<AORL!^NE5 N,&E];0C^%I2C;?IJB]T7I'L_18=E/#
MW\C7_^7M7E^/NSN8HZ0LX,;7Q7ULNS1R-Z*,?7(^ WZ'>C8S345)<&HX]00'
MG_\A?NC-0IWSKL:+$UG7@HV(I168IA&79-J.OS*;FZYU%/(R>OB8/V&TC2-1
M'MG5J'%<8<6Z,9L0CQ;FNJE^E,+V<'C*XN/UGOK)8@,KX*[&I5'\I'NNQR7[
M]E]9VS]F9S4ME;L%"[\9WE]M^D-\1\=; QF@M'Q&D.G4GQ0B3=T_;CL:[ KS
M'9\A%C,-4#-H?U CAMN+VC&'<9.N+3H0[;EMY;1(%+C"MLH,#T5U1:N_C:&%
MEBG[";(X=QNN<$JYJZ&%L>RVIM)1 13]=?:NQE@36$&O*=O#?-+_EW_2^ ",
MH8$_*&F7[&I8V>= W#+.> #6T7M.(F7<:XI)2''<9(LC((",2X":JKAN5]4]
MMQT7\SPH6UZ!=L%&.N,!@O(>3K3$<%0@0SI,MEM(PX)],H6]]P^<!33ZEXG(
M65=JA\(R24V^04RMRL5@]]/R\"!.W!I[*K;U4K$X[&HAB#TI<L#7CA#Q=1W^
MI=[7_FSR*^O\;S@.7O <:>S9[^KX\H:M[X+(8&[6;4X9EMJJ&*?U^WR /P^!
MP#AZDJ:K3+JK6B8N_5EH,9_7$4<<C$M,.B5HB,*C35$_\[^QAE<.A2B[I)I5
M$SO=WC*'0FNWH[>'AA+)Y+)=C:IA0"P)8N#T!80H+,]MM9?=0UAV3T\_&NZN
M!QYXGC-<8C8)!EO?U]_5Z._RFS<;>TW/5,V,Y+XM=/O%$(V/_KI(K5^J7N:G
M4O&+?E9N/3)NFC=;YRM6*O<TW@IOB:M'\\IC\=7QI'XAI*$T3PJUK+TW,F)X
MN@0>G5?1*#225HLEU)=OTMT8TYU3>@?W@-#LP4J[#G 8RS0% \'#F=[1M0!3
M'Y!W$*LL]\U*.-:H=ZGE=GA=PI<3@B8.NTNDI75,W32D:M2R;]T*,HV[.)-]
MUETC$]N?:<>;7WGU6#--.?S%B^+^^-N3W)BM;QINZX>'\";84 CBP.VT@Y+<
M(D8U?""<>="2T[Z(YHQX?7;?Q,(8Z;N#3 <62=J6^(?\L[6?S\>63E^LJ]Q9
MMR5!M.W*"NJX)P"*8W[$2//# Q6D 63W#4:AZ\R <O^L !&-C_L);.UD5\:H
ML"VKBO6(HD-09^VZ1-K@OC 8#3T^\O-G_RW_]Y3)!OF*TLW"[>79GCR"E2__
M<L_2^"3_QS7U9&%4MKDZP!$KOZSN>,F_S,K^YU>JWXW/*E\[U#R*C,I+_%N
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M=LO.TVA/J;MUE;%C5\. F3^YAV7KTG66A@T\_ ,19\HQN+TTN/D'R?X:19S
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M,M3/-4/2D$W4X(D-HS<#*%(=A,7Q&8.6L.-R@P8A&^:#AX/U+OP[,%@G!X0
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M,6/2Q!&Y6=N%_4>'3UHDQWGULN_&KA(Q1QMSRR'"16?QW"1Z%)5V"\+)W;F
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M4_5O W\0T]0U9@\;X6*6$@TAZ1FDX(E9QIZBW+/%F4(3'6R-70ME: 019-!
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M'I^(!.'U9(]V%BFY<BC&VP\7;L$'Y1:D>J9>#ZVF@HQ'YF^E+:R:'3CG77P
M$G*#84(_\!2[U'*.4%84<)+VWZS]3#/ZNVL_I[[WVL__+^P#%.<>32V- E0
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MY=Z7N'5GZDHK5"P+I,^%9SJ@B."(G@#F^O'@\#>9^;^8&>Q^OU[^*_OX<Q7
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MIP)@[RL744HR<@(EGU+&<63+2C6Q11O-=+Y+GU3$ )?>(+L:58!6E$3],CH
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M_6[Y5"._G?D<S8CK^LE\BYX%@D0N<V6T!O/1P%K1O1'&YQ"99\=QC\.%M>1
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MM2A"P&!!@BHE$3P-_QAX>'XARP]L$B$68QB34GO[@@P^+,4Z[DU?E<,-&A
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M\[7"];D\M5U@SO1FYR[()(,7-K&"JG5-O"6@^E.*LTJRH55^T@JM,)>>P?O
MQ;N3</*X&,B!-]-3VLL&'U8;F)-J>55>1" (0_WIWN#PYM.-[@5(1P;0;"8*
MVSRSV"#&7R,NC"L+N>P2Y\6IV3; Z$X]81UWQVEJ92NHZI8G\@&%4E=')5UV
M2/$,. \A[6;OULB;E.T&^_\OYMX\*NUK7Q^VIR?-:9O$6J-FT'AJ$JTQ:IQ'
MY+2)FL3I),9Y(%&C041BG%&TIVDT:I2JB0H.M'&@<8 841RQJ2(Q#E0)H* 2
M43&(2! %!<'7GN:^OW?=^UNWYY[;]Y[[+/YBX>+QV7M_OI\/>^_GTYY:&58O
M"AXC=J6PCU\U!6(RCS=/$0$VR!#7<RRQ1IT_U")H*A-VW[GPI7_7.3$J(0)U
MGVG3.E_!Y%COY1R3@+9ZP^Q3U-J07;7>1/'WNVI5RH%=M<=Q>-6)J5VUM3?R
M1[MJ^^9WU6 +NVKD*/V5CU]D2S)\5C?W/LXR:]ZNWAH2"E8LX)QR0 9^$5"9
M'EU 6$V90[=VX#*<V'-0P51&2"BMO2#ONUK]4W<2]ZU.B.TL*.10IK.N1Y,"
M^X:V B'<]A:4",W.)Q 9$4:1<;J%#09T7+])9&4"VB!:;$$O:J/1H0;&)9#"
M]?!3Z^9:/JA.KF21TJP:L*9:U0U":#G;YL<$FL<81EXQ7B;04T1UU,"J_<A9
MQOLFA>,WGIT3)R!';HA:[J2-*.!=/'3,L_YG91DA/Z0WUJ1Q&TT:,7C]>;<Q
M'C6=L@9[QN$.WTTO2B(Y/VHW#U+\XHO?MFUH$"PST^VT]-;=;+=D)*%9AH9[
MZ38F$&%T5/(/S#A=2E;XKAJA?Q2YG'MZQR\/'BUWW56+QHVK]F.EHP6:8M!Z
M^N"N6K[[)L--[M;VJYO1']]FV>^JL6XT[:I9*=MV?".^SK[?K[")[\^QU6>?
MG9Q#J'PLLPM?J[K#_E23]4G@;U#00*UO<A]E74_3FM5+SQT:*.405J%Z_?2?
MF>1^'2T1(!F***D]7H3FSL6:KH=XMR:4_C0 :OP($03T+*'HV- 'R^2NZRV9
MYY>+=#I3448Z[_4.*S!]%4R?GGAAL)=(P\+*\VCM(=Y$/=;3D5%&\#^N3JX>
MTVN:8WNI0KQ2'*#K5AE)V^G1)X,F$1'E^5&8O6??A?%O>=<WNI^^,V_2M'BK
MPYY,!@X3+P<-VRS:%[$'1(CSE=SQC&[ &ZE>K B /Y\,@9[6B#HKF+.)"["A
M +7.J],*D-BN@[KB@ZJ^#+<^Y@9U++KY:FJF-Q2WJZ9_S3^I*JBIX"R#D8<.
M69N6\&TF&4ID>.7TD\Q9LKO10M\2U^".$(8$)-]70KD=DS'30#/9)C)HAQ,U
M4NL[_OC]K_X[<>8?Q!](F!(&'8;/3%RPT P>2S#<7 P(BNTH=0T[/'$C 8R3
M'A+ZT<DVNVH?782TT^KOYH-5.ETVSKMJ=XO\W]^*2PAR4/^AN:<[W"0,&2]*
M9!D:A;@^$]K.6DA]_+D=#(1U,Z7C1J^J1LJ@<A@CFAI'4H[B@66&4ZU\_8EA
M37GQF3^:#]O]^"N5]_9J4C);_<'=YZ15*OGFP:-5F$=L[Q.[:I_YZ"K)#*O]
MKP 6&7G/RO!X;$6<6<=QUL)"D?UR/@XB5V;U(CX?$ /GXF'+AW1N9(RNBE,:
M#CS"=A-'^A<A)1/;T-! ;O;ISPZXU*XOUJQ/OT9A'H5;EMV776"[<$V!$_E,
MT*M[#^D=R-];\9_-'YF"?MGTW*[-&_+Z==,SEW I;*/TUTU/6T%93GZ+<.W7
M3<\QO3YGVB^;GJXV3#U=>IB3A!_SD"W6OX) ]<R0A47*YX3G&H%Y-7WC%]F1
M* 9$SR*SO7*\FVQ TP#?;UX^83-#@W!FW$*+K8(X7"R67<(Q(TTC+[8_CEF'
MU'G*'1  I^9_:WN@_=U.8(I^ATAT)AG(=.%LXFIH*?JS^%=*/+T_Q>Y20C\N
MJU!$D^VJ]7#Z.#"9RVPV6(ZMI;O/*$V:0&0CY';?758O_L7*MO/0@L[X&^;2
MCI  6LH<<]&OE&61"B-YF34M1DN"0.:FT=VFNPMV8<<VXM<#\#YC @K>)Z"G
MJ3;,9JO;9I._T?/IH^(__LZR_]^P#TSR 'YFAA=+,V7>:8E#Q-F^ 8CLR"@G
MAIE\"(1-,D&)-RY=J#"9\:/?EH8/W["AZ@9H]4YP6XR0:,,:[D4>@3NLJ@2J
MDY;7]YU+159D27Y*N4<@ <H]%Q;MKNA45(R$,(QB<B9.E/7%N%P>]3(NZF@(
M^K8&\#;@]#C9(5ZP7>ER)@D]3\.Z7&1N3MQ2'C3RB1N<FW <]#<\V\#\-BLP
M_>12])@A>Q&8**IN>J@8J10<#RNU,5\;[P?,'KZ2Z%9;'_FDE488<=A"(OU(
MAC^]Y-1D]<I=>B54.YV]1^/AK05R9E2""V"^0]>?^=@$<H.B[W0V(*AYS<YN
M92;>])@<Y!):+DL&?U+FK!.7LJL6)U0)?A2>@[:"-:PN[Z30IIDER<,EV:9"
M\$Y+1IP.7.W@8W'M&-#8V86:4"UF=Q/C.XOB'AX-)>&1+R\AOH^3?7M>2O!J
M?W,TW)R@+(J-4SV=L)FM:AO0"U7X4:BT&IO<DEYSKLA\U65AT47GY@M6Y_()
M9UE=0').&\#WB-TU_LR-(GP^!'D: MZ1LP!'EF]+D5"9OWHI->[MFJ&)30O/
M>N0B!G37-*D/@$AJ>6R(:#7![H!WMC<HY>D'U'W2C\:T;"D7#_E,/1W@9-6&
M(;VET?%<.+>#'.L0JG);WU6[,FV^PK,7WMX.Z2F"Q>#N0\WCXV\^GO785;N:
M_478$A= RA*)Z3+ \ZDC[1V7-UR[#I;9WT>1N!5/@M?.,1FPSN=%&+-6NY%<
M;4>V@4'ZQS\Y]T.N[N#?<[";T4NN=$,O#P1*69O-%\*+!59P?\?(H':3P,JS
M!OB.@M^>COLM..7]0G/)R>WYX6RMB' 4J3A[NJFM_V]\99O!X$[ 3DT"D%NL
M3"XF%3?_FB&_YZQ?!)16Q.ZJC>X-WMZ 3WV'X9JKQD+P\X6YTA%K(B:[=!2S
MD ;$E7]IA/E&^[<8Z':I/#,3B6*?\?Y3<E\=\,&BUKNK)GU(-P+AV>.AH9$O
M5DU,S'ZD6=A:G/?SIP_@(6P;DF,W=X,RRG@D?E-0XY"/_*N^EXOK\)+/!RD<
M>#S>;E$BWASH:F^Q;2>&>(1 .H?!F'PCLU#;,0UH#/9TEHE;63MR2X(A)J:
M]$<64=5C;UTM/<?;'!(\N<-@V8Y_'8?)]'!O5L2XAHRAOOH[22N[(@#*W2/]
MXY^5E-.?C.C[IMH%2*.*9]BAX>QAM]R>UU+T#S7CD[SQE;5C?#+B3+[QXY++
M601:F+.$''J#Y"9L2L4BT]?&FT=#RN:)/?85!/^(U)"X3IN"8--@*H4/\9_0
M%%A8O%E)5SFF9WV<,3C4O=:!>BKWO* JU7O"M]+4V)Z;SKNO.,U(6-P.O/[?
M"4#_*)IREVS:.*PT^H(AZL3E(ZTHU3HU3I:6_T,;CRO?F]0_WTEK3KE\1E!0
M=>\<MT4&^:&)>X:?TXC_7 9NQ'W&J_QRQ\Q^]&AFZ<S,6.OH6LK.B;,VPV)P
M\)K=M3Z^A>9$RS+4P_V:%X$"L-*P8UQ$V J?Q,\OIB8&53V<]B^&A1F8EYE:
M2#-]BPQM-K=B?.#%!:V>?WY'+0FXD]K>6Z.^\'[3L]2- 2_<TE38P+,;Z?GQ
MIW"]-W';#U^=;N06V2]4IG>.KA"3Q.[ \'1D_MZ,W1?JO*'Z++.(C=AT>@E]
MZKDSB]&GS \W@S4RH.#.0I>I[73Q>']\Z]H7ZL[Q%KQUVV4]FQ7RW7VF\K8B
M<[YTQPZ_D?S-_/>:WK^SUN^KI8-PD7;ZVKV/7B5>\PH_'OOFT +3\E7(V-]/
MGRV'K::-R/]<4^/0^&%C>_??;1W3&_!8X+J5Z/"Z4XW^2P!Q9+7A9'K[\M;.
M%"\R4$#N&8 +3FRM-$-.;*56MW4.$]:\@<FY/I4%B*\WF0P;7+ G1+_ID _2
MO\GV'8=]WP"/Z;7)4A<#['(5ZKU*I;B_S0;8J< 3E2:KTIK.N:Q=M6D%6*68
M48XJ0!"Z.FT-006Y<(AA65FG0P/6D#32P>71-XK<A%4)GX8'^1_DL6O#(K$^
MO<F;8-@HG\9=P17([[&4"T^?E#?Y%+^X04)#Z"V6"S0V7V'8+5=8TYB!_25W
M?_X?:";UWE]]:G;5RGN'3(P(6Y\M?$"WM?2X!;M]PE-JIE/9%%JMHRE>#4L:
M:BU;F&IDG#"-;2I$K["9UV8\O&U1/W"K'EB&]/\<,VE&3>Y@;3.'V<%++0U=
M:= &[TK?BYOXDY7Z^&N;8)DCZ"+><RVZU(K8=]/]F]Z  C/G,/Y,VN,)*VU6
M1$?I,?>V!+A"F1V1)P5+K*L31GWG87G7?F'W<=O.@<P^GE/; ] ]ERM0WYL9
M()W"QX?NKC[HMPM(#Q_Y<=X"]?$JKJ!["2*SKTRAOYV:,Z)$89>9Z-:BP#6(
M0@$_-7P5R\S>(_@,:X[.O-'^(.Q)N6%O U7?"]PV4K*! S!8Q0V5<=/FM,J#
M"-OIZ X*J+B$SKZ@;K/5IJ-.GU42\TV&@EEK"0$7<2;!$2:E>MD\$7AR SDE
MK&,XFEH4T6*);C_^ILS_"RH^M:ONZR7\']KWLG?GVZ(,71A[8+HZX.DF+UK*
M,+DHQ%LA IY=J6CO?B&&16J-!14\,+IY'N8IL_M4 FAP^?QQ0SX4LAF6/9\^
M9[OHC)A!%&",_+;& [1%>E#;RH 3"O61=G!+0[^999PPO<4XO H%A7AASX+/
M955V@:G/[^B:"IN%,IN1P.KD?![6<Q#BF$1N]>1K' NF65G1/VIOT3CUEU]I
M)G\C/@_O%.Y%@-C5D2[+J[,IYG_9X&TFFD5+>XLB/ I[<)MC7X,MNSZ$E'CL
M/+H3Y<!+;VQLK"]'-R[7I"^OK#]:BO]8'[+MWN44<SCR06@J\ 44<D1PF*)!
MG.61-2Z[%0>#?7):-;1PQ6O^/HEQ34,RH\\H 0TF1$X,1<^B/JDAA#F/3(+#
MW;N/;G_5_3_1[/(P:Z=)^@ QQYEW>:1K]W I60DCI12,Y"_<?9#9J1PP?C55
M%64[24OP&TO]-O2-+-G'*^&*J_4E=>L D$W 8*K.5D!"QH-0=[C$'XU@)G1Q
MW_H;Q.#,B0V[:J=Y$PW%087C]LWDAN@(.3G" 'HV"VW+Q#$KYCPI+TE>[08
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MX\>4S"QO\+G9,(;#B2%J8,A,@!=&E!H38T1F/2]I;^B^U3D<85-X8BX#+FC
M1QSHRW0/.+$QDY@"RMD?L;#0FT'=5D_(;^U=<G",$P='.)+<1@Z'TSPR(E!6
M\;"00<_DD'WPQW!CXWL;\S\Q83^*NE8?(2N[9H;.C%+P;L<$CC[=IIFEFM*Q
MDZ"H,US"X6]_Y1?2+XX00>Y+3EQ-&RD>]CK=,F=W300%JON1LV$Q"<CN6KSB
MY&FM>C^Z?E\QTJC1]=1#7Z_PRF![/+IS W[&27QQ-31E6MI?:KOUV))FF&65
M4'J1,0%7"F(N$8F7O>P8]U$5#(D%EMP<+"^=A]AWSG$I@2L%(&@)"S[JF3ES
M!;](LQ[,"J+YA,4;8E]=_4T]_[5W-G\9T$_U'>%A&?WD\H<='9VK4*E/^-#F
M$+^H\J1>OPWWS2M%XOG1F&?V[+R%DA[G<L=')+>Y_,<\U.DB^&NY_&93T4WL
MSTR;<,T59/OZTG#)7A+JQ6.)+U6;.TB/-Z<]2<LK:LS<)J<70+30##GD(NW6
M5F3Z<> I<4=[2VBZ:;DN'X\//_"HV3-C 0=Q(15;: IS;2FUF__6DNA-SY8"
M>D1YE]O_O87M[3G7Q-K5:GK34E-7T4=_[GP1)C,4=U-L'7_ &9:$.":$W",D
M^YF>8Y+)G]+(NA->6LQEF%B-*]/-IIL#>L:LJS*$1#V,KG]TM'$X$-I106K5
MT!:PY_;*%#W-(&80FK$OG0K-/'&9<[-WD&D+Z!-@NT]^X)Q%JIEK])1#^!8"
M7*OFY9R#%_[9M?-?P/O5L,73[2IQ9ITL_.2J"U6F[L.O]EUS$:P!_13CC?14
M3+\TBZ7>*MU5RU0Q69M>FPI8(I/2)9QXD_U6SNU/))6GA2V/"A0J23$5ZUVM
MY[2JB"],KFG)$C'I]=E K$]N(XWZ/ 34L\6)*6\"8<H3$-8TK">3@B4RI8#D
M#2D?V]#V(?\']NMWC 1]#2M;2OV_TJV;/9GE1UJ (<]7MD8>//C6XUN,/IXK
M3+!-!'E 86"HZ6('XR'=] I92RN ZDQS=4;8+[R06>T59B10\E@\]]$LS,XA
M<<Y8\W#!4M^SX%\N[/UB3*@)\71#CU(;6U(S*D5V0:F_A-O0LM[!# .H%9@6
MA*(%;3!B-L.+&9VO_Q/=_BFMT>ICMOAO::J_[I &%WEM-3Q1)E-Z7]!:DGX=
MJ]^;/(?JYM[ -15D@.U[B>2X3R@)/H<EKCJ'F5Y:P^Z'F0'U/K6'?&$CRG/2
M'!%4!^<89_FZ@G#!)YR=VLF.JIB$ZEEE^J.]N\<,VRR"4,V!H/M$Z]FTA?R1
M(D.3(Z8^(.*)T KA*FJCTC\::(@>]'EL-HEH_?%7:E%9E6Q3:[.YE1:>:F7]
M)<5SM5 _KJ^/DF#N\+&'5VH,F6<6WYR6T\GCK<\==VPJF/"S@6\M\*FZK>-B
M[C/);.W+MQGPR6U9;_SR/@C"T31N"E9D DTN0E5>" FD>27?=H"V$'O]EV]>
MS"-!29<O^#R+WMBCL%B-"(N?\Z#_#]QN=QC<443=T>DW(7FSPT'A86SN63E0
M+X_8U85.2ZC8SLQ8Z264V;^IQW6N-B^^C%J+C\UW,:ZM+,B+6D:&/I)0:_6_
M*R1QU">Q<8L#EWT-(>L!PS;-%^;$([!6,M[B&&OB\M5B, -N'"RHCS! ;+GK
M&2^8.;YJ=L4[Y1$&P<U*@4TRI@,><3)(=L']V6>'P-^P7O^=UX?K._&)1YUC
MAFWN/;JWRNCH47>3-NC;_#%43#ZJ&Z4%2=]JQMDO%Z7SCEG9.WD4V>^)WK4/
MN(Y(X^W+.LD&="SS^PWC-@INLB65NA4\!*%W9]7WUDX;TNQR5GU]'>D[B\CA
M!4&X6#,N8\86OX@IZJ:H#K;H/[%\\^?O#A_[3=7^]4^-XQQSS#2&!Y0 BU6V
M@Z=2)\T5EZ6I;\G ]L48E8GJKUL8<:>J8SR2ZMGTKF_?>S_GBH=48P<CM^>%
MF(60_1CD($A9GPKZ4:$N3/DBVV57[?-T(/E<=HCQ_!>VC_[I"?6/X[U1G:7L
M.,*,ZF+O^&A06'C80 SG> TVE#CC,?@J[$W M?^D<H$GR*_^4KEXZZ'^7KF\
M3MGFFC14.S6.\\JJ@6&QO (0AVG+#&+X6RR8MG34 +D6X0:&*8&BO<H%B=*4
MM^GD848LD4E?Q_SE5S*VZH.%H,]ZTX,6#!_]8OMJTIG^X:2<9+EP\I0X\O6+
M.#UD"S>.1RICS:WQ3.QQ\?S&X-K\8'YM47I#?I<\89RTSC0FSCO[S<PPULRA
M."IQ6U>6?\&+5]&1_DN,M<DCD*---&,'Q]&C[DV/UPK';!%M+T26@^-G0PZ2
M>2?9%J$!!'[S(*0.#K&0X_ BX\:7O[O@B1,[!9M_2L:70I=MM(])=$ WDD%7
MA#([IO6B\=U(]$B0\CG6JHBWWMTB:/N:XX[4#["M\H7)M#\54T_LJFDF4K_C
M#!#+^T]O4%NG03:63.12JB*M!6XSH#TFPY=G80()X[P[E%&&\B@$^WQ"PW'G
MP^YJ2M';^4IR[0?+ (.3/G=#=N90-&9052FL@.GA+DCZ(CC1SOX=.\=72=HB
M4'22SV6I<U=:RH<9[S^!+Z26 F '^_I(\7UX[X&8II'G,# , OFCPQF\<N56
M_N<+#>@M+MIX86_]#U.RWCX2XN2\GCN=,;!P8-D<M/;PZ.C"@^,/*DBA8PT,
M%-;'<ZS%RNK8Z*B\:7_E-$5O#&:_5;?W@>9.>4P0>B.J'1X='1WC9;V)PKP<
M\?2B?_6[C\"_P_N5(BI,VKH=LJLV9;ZKUMZ&#2\DW<V>=F_/WEG>51MR^*/J
M+68]<BA[VUU57JW.A[-^I?3ATYV,E/Y9SL.:AX.(W+DL%5@YUHB@S"+Z^: 8
M>HB_1*:BLGUD<\MK,2Q%^ ]9F,0U^+94V3T/XGY,SGJC-).$4%$3LH/+>ACO
M:KB<.&4[>TR@YXA8P#=Y9,5X8W3\DO=7I_2GB4D2<W_,2;,Y.1COW_4$Z0/#
MKJ(%@M6][#KR<2GU#Q_\YG_XO^'7FT)1.765*M'?QKS8^[.(3YWV8G5]AM-6
M!(:U;K6KIK47^#)]MF:R0V(LEAO\\GZ56.W-^:V%[.B<UIVW>^&ZY2Z5PC57
M3?;@7R-RI3U_[L=D/W3&<"N +0_??E=Y^:M_;OC_2U@D+\;O+8_TCSEZ2+-P
MO:_#?UR+_WEVD1HR (/!*O&060EJ9?WM7LG-8CT_=+EI5PV.-LBWYS>0[!OR
MT_86R.;=A9I/^]H7YO8337)2-A>VH&4L"\_1<?OG'>2"I5$6%(Q.VAAET:PL
MFO>R0*K]P:J$&>T19+ZW_7/" +(A&85W<V0V["V0))I/$&JGV7JT^IWR'Q[;
M*IC\?%6]A'KPJ66$X1CMQLQ4&*?@<\/.KSLA J>SY9&4\L8>2 'X3"ZH]!I7
M==FAJ6*QB-5XZG'WF<;\6CR]WR[^?7Y;;RI][(B1T<%2*-U"4_/XB&^,_0;!
M$U)FM?-#M4U>KU=TQWW"=9>K<]X42F_'K5[?)G <?+Q483UDA@G$C OXR$Q/
M@:;F"O]GR5G<[VY.M4]W5\T8X#]'&P'IR6+C&W""&V)F]2_WT&L+,C(03L]D
MH7WMKZXFJ"R?X$_-U3^^G*XZ:/W<W3EK+C9,-)_^<G&,&S\_;UA\I$-)EG!9
MXVU.A35LO2:+U<G6]N9!13344?&9I4LET;8?(I+"W;T!NVKAI.VJBE9&I%S?
MS%H9Y'\Z>OCP.S*','M+AETX)!$_G\^*7:Z"608E'<K#^HZ;H+?;%5D]E 2F
MM,IC+2R,+G]DVSVF&YZMGI_6*T-8NU,F'9W)RFMOM[: /\Q)IB.VJ^V692%(
MI'=+:JJ"3IALWW)L\QG98"YM"" ^9)NQQ;'ZE+!=M9%YO'\I:;B4*Q649<4I
M:FDA.\!7?('+]+>V7UW_\??6^C]@^?SV'U>V#^Q_F8M8PANVE7'2&/* 6X,3
MT%/T,1B2P._3]RC1+;1D#^@&/+II\S'*N,&QH;82SFU";^$:W]1.F,_OJKV$
M;JO7X_:#<\R/VCK5N']PB7#APMQ,SG*BII=A-&2BL\YSU!_.G6@HUB9(WT;S
M4#N05O+%B@[=ROP04.9X)@H 0%3;W=^D,8QH7H8WH%:5O]K7O&?$.7"\<*AP
M/9O[02R["O9IN%0[TKNI"F\CADB5>=\+9[-3!\-GZ?6@)WZ0M@ RYNTVMI(*
MH5^H0D3B+)31M[>VJ0UFHNF;V]76"^(UEX..[:SX#D6CH 7Z-OD&$L7'CZQ,
MTC'Y-M0RZ:.YK>5' _$M)_?=R72938AJ")3Y-!"V^I\P&8!6F@;O^_#KOZ7D
MO_S*C]IG(\LCM^_Z;N'773@/QGC'33K#DT]@OFD<:O[&-VJ9M.:E;E0U$)!X
MP]WYBYAO:0E''>/M:SJ%:Z9;N(^ZFE#@HJ[<#9U!4)F\7CB*,41U]#C"9$<=
MNPV-M19DU\@E!G-LWX32 [0&P\U^[XN3QK8XYMLR1FKXY07AA XYWVJ.Q><W
M'"@. ;M,/RAK0$,L'$-FF_^_]TWTCJO>.[<U&D,V+TSMT/XK:S;.P4PT&HTM
M*$K#GRR]2U+8O:<EI#A+J%I>;L?W@V&4O>I:^AJ+?*M,7QXO9XY+$KODC6N>
M#B);,I$RM$#17*TW*IB^B:8L5J'N@#:AGQ]</M!EF6[U;3TONE- ;,D^A6 ?
M)"!W3(*S_6]:WKKSZL=_?IG\HS@ FZFDKM]XI=<TG9V02U#Y.'+2Y[)$-\J%
M;[7[NX.'?(&RH\,JD?[J_+P22$\$]>]O.'1F>::6O[)P<G5-?8LZ.Q, 3>+U
MK^6>[F G<0OOL)=Y#:86[EZ;PP#X54=H"V$K9AJ0J_E,.;&4,I-5CL%T4I"7
MY2RX2&NRM6XGG%13*E@K/Q70LN_[=XS^ .T_4>C/N;'MQI_I9?J&##_F T;:
M@\]K'?9S59(Y07%P+W^B5L#.Y[^XV95EG<%NA2]:BU6'TK]$#NH_&J8HS27'
M+U\U#9/*D,_!J&J(UMS\S*8[&Q "9U[:F*2Y3.5@)!V\*6=8#UE#\VC;]3K5
MQ0>OAINSW77=5SR[#9W%W]WZ3Q7[)_"'>OU'\4T)Z75I 3V^J0>UNZ7TN>!F
MALT5D)V.SO&BDTW/I,R$2Y2M[L_:D*YE^?SE+3\_@*Y88;\4UW\OU02I;C=7
M=6HRQFP!,A13 #EV ;H.2V"UG9B%.C6.^CPS:,-W?'J77YL8#'- U)322[7G
MY(K'%FR;:&"MY*3/JT<V.KIE?WE'Y4WYED08<%R=3/7F&A)RY@ Z*6MA_I.W
MFG#=(J'(R2IB=J6GLZ'_-<5&)^3ATP0OX'/I/!;S5C)"U>>JDR,75#\X%,Z:
MVW8H;E*6"9YNC]"K3X7=D<*BZCYHLUP 1D9]N3^=#0T]<7%V*0]5-74[//O4
MT+'(2>#W14:;T;[Q]PXZ_][B_@=\=$#E*2<!0=OJ=$M&8KA'8F\:A<%V"RY
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M0D?06T,>T^K%D6-O6>T$V_X<IXB,4I*M;.38:@J0XV"3-QFC5[O$!$6WE4
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M8DW^8_2'\V7H6O31VB9T; /.H:$Q?;DH30Y,6X\:*'G762[DPJBGIW>KA85
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M]_88,[)N8\@$C-#TV=\*P9I'YCP0I\QM7_O4=BU8&GR+L6,&F:NYN-M$J%Y
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M\EUO2#4-ZO_-8I:NEVX7.4UZ<E&LG;>ODN%KS= #>;C>&3>P;H)Z4:T(@OJ
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MA,Z(N/U:\>IXX4PW7-P[NE1 :5,Z#S<F'^VM*]NX\6G204OUT_';F?&Z8NE
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MT6=_99.19U'=MS'L[#2T KHF<J/<]!,4H);KRU]LP[?OS9,3IF!*XTYHQ;;
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MBG;[$#\GB!4:BM:D'J7WDH1*+M37N8)AI.U5N^-"C"G0%_1_S1%DQF9TS(0
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MX2&&+*.+\C1NX1CNYD>,\HX??UNBTX".GFSE$2@K :8=/ +K*N&4O6#)\L/
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M;O32R);N\,H4\+B%OZT7P(9$]LNTMK-1-+8N5*5&9O+__%^R?'I/IC%VN[H
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M.-9B%(ZTN1L,I2/])_3L4@ZT.],MF2Z##'5@HUL7&ET5[R;-*.ZX _8X-UX
MJ?8;7O@FW.;M;\;__Q[O%2%I;8E9T$9D"FVY=E2.O<)U4]Z8R9&X#1)V6.<G
MD@4>XI[#KH8U?W^ZS;0B!7[A?6+BRJJD( $O9[DXQ::+<I:55L?;';NVYQ[-
MK'6[0ASRYZ?G6/>Z_&6G]0A2G_;^Z%S7:(>*F%Z59K831M(OB:KJG);T'X,0
M.ZU#S_^R,Z,9]N;/D$J?S]AN[%V@AFZJ3S]\$1D^DQQRMGB8U[D/_>5:PA+<
MFD2R@I9+EI:7)*'UY2%GFCLM\9CFN=K,N8H6%%,,;Q=P(.T--C#$Y?:&T\&$
MTQ?[O*"A?>?>%;EYA.AWM;79<2^<E.5WE7@VL$#2<N[<.8BN[B_N.Z6_' NY
MA@O;OQ(R/8H6X<NZZ J5':&C1$@>T; B(N=B)&$=)TE7N8Z&'N1;$C[2TG?J
M%7V;^TR$=%![ZXY9-U59HH%G'F"=5@\*'19Z/LJ(3_:35^]YOYMX>IQLZNEH
M>4V@.$R)AJJ7I?/%:1B%?F'8Q9&3XIJ'"..*%\FFI,:AL^ I3V.%?6.KG0DV
MG<C<]BBUJP==B:_X$/:[Z/Z'PMR'>ZZDX#?N<HR[(=<=B';4+$>CD[/"2S?F
M:8,P82Q%!FOC]"/3PBO%6?O!L&=?G220ZJ8:74^6H\]T2CJM+=[V+SV?=?_+
M\!HZO!0VJC<2$,H+A?H93A^9,_*'ZJ(L@/LG'FMXS7&0$(ZI?QR<4W%:4_M2
MJ IJ#_ G:IJ/<X(;$X*@Q[Q)!/F#Z'A!2Q^HMS[H;JS/)[\&>.!.#WI/@G=/
M-NQU*O/&9GAJ[JWT^Y$I'R)"O[(^7+557 (/$U[J,TB9#I\:39DBL\ZIQSX,
M'_J@]0K(_BN_1QL[6^>[0Z</OLS)@8+&U-G H8P6_T;7ULN"CUL4P07\X[$A
M&"[,V+&A,1KND&<WMV2;#OPS4[G:S6XTZMK40O7NQ'#-S**_Z)/K <OTB.1Z
M4,)'[96_BQ+_%@[>0Z"/LZ%J^)<5?UXV)-ITQ](_G=Y97$Q/X]T5IV;__:W_
MH1#85TE/5VZHR&$@:[U B+73D>[!XX^KA\(J.V16Z;3\+=X,[F/UV.BZYL%@
M^R"$-/(,/@[+L,_/KT$6,R@-DC%CFP<,E]:^X==#Z,U0VR2>\L#KA>T%>(=Q
M?VMHG*O<\[![*4DF*I.[:EWK?+GF68"0U<O6,Z:OKKPPU5U:VZ]M6$@QN;BR
MSZ L?&J6LN^D4 .55R8\?J"N==OS9:\@PC\C_N_W7*4=;,GMVH$+W\N69/MB
M;5'TC)B5[56I]" @6O#68R[;@R+FU@=-:HY:1J"EYJU12G^N3TO0E'DTA#K*
M*0? 'Z&U5:3A]MZ%*,?TN52P":N"XKR3'.-#6-2]?Y*!>SP(*3873;)0 #T/
M!ZJ_:^,>3FO7GW\;#3Z*>X,S<>L>9&B.<CT^YH:!;R9-^1 D)7J$8"1U_4U2
M?"._J)95W?V ]U[SM>OE3(\%].7YD9]$N->^#H=4HV>=F/2[4T"[5\D:IYQD
M9*3UW7X]NS*']NKA\XPC""Z@ AA2PNZ]5V4K0EGZX+ROL%.F/9,68,_5R*(P
M&#8ZQW*T1:YHL#S&7]-:7J T"3_KC&)%21M>8ATV]T W2%:F=#=7\<)RY5(M
M93-BI;$A;<<+><XMEL%NR3!^4OFTX\X/]??F*E<'CS\(;FCK:>+78A";][?.
M==/H.2H^4[]HVC0QK+EB!O!V.42A"HK_@,LQ-$K/+_1Z0EPRMTR0/?,(EIEG
M*&LW L)(18M_9(ZBL=$IHXT2E<+T@S[Y/;))JPTQN#*_D,/%.P@$@BG!,PCD
M T<J]6D_' :#ZW\:)A \\[+YZH-/^_UM>O?9</KM.2"C*_[N")812A]79NXW
M!:@ -$[![!S;A]]!86<')/]R*&S1:Q02A-(8QW$='J7&+U8L;'E^_=LH^A_C
MCP4;G$4?5[STX/.-A?JU9>UV+7;B-O-,P5+'C9),X2WG18S+3%LWN5RLJ&,]
ME)UI;OXALT/B>@)]8;[9M:'G9QX4W,5LU"97U44T_J0M7MV&ZNE1!;',HWD4
MF-ZVVMGUL1E@;,*! M.]R8\\(HTI6W8R#=OIOY,<AXO?JG7S]VAUW2FKB\K!
M#/OY)<AF5F[_/Y>Z02PI?.)G9>YQ;O>C89-FUROU6J>G9Y.@TL_]_CI+GKZV
M^>#4\0?CP80S](Z^],#5J]YI?:6!^R[S_$T64L'G]FQY:Q]O&7"P'8GIXYE$
M>&P[):8NA%4H4\KB 'I)E8/D?CW[\3'H9?,L6(+@ NK/R5?:%C[F!Z$RJH>=
M&ST\'1DAJZNKXX "9FN]PD;/U:]OY9._FAWX733X0ZOXH??EG.7UNI^%0U"8
MQDEX15@1BA6FAF@?3$(]"$^BV*4]99^S9[)#IW94JTLF_ Y&?F8MM+)YE=47
MKCI9M7/$0Z"MGDU"DML$37LL?P)[Q. O4&'HK'[+0_):?#96)%$E-:]P*XH!
M$WHA>BNO7Z#$G32Z?]/%I'3$[=4U\7[I!0XHY,W0@S2N?1[.AS=>//2CWS\W
M?L(*5>&+M8"U$L#FF;7-8\U#U[+$U#1Z[&6I6<?]8N3GM1P-],UW*Y>J>N[-
M87%1Z*[MRV$A$_I&J./$.<7)BSFGL4TNSB/CRAKG.;\03?4^WKA:3PTI1%!;
M1GJLRDPMTFR.>2U[-7$G^M_VBY]$6N-A_>JK+5M.0W?4BJ9^_4&TP]8DI^XL
MJPW6HHUF5OSI2I?%U[^+#O\+?%X]:OK-Z,$MGG:[^V#AKDY\TD*'=@@W:X>_
M=23!QLWDHG)L5)@.CD+95#*&QJ*:+Q(!24\W( WXDN3-CO6UC2K@QYO"9<U=
M9I0>?6@K>J%YA36MZ4P.\+,G*=*1/6@M*N9"@:BZ2+\EV]F,\U(0\4@&G%\\
M@"6&H79U[A<?GY%1NI[H+O57<!';&/_DR\>G+N "7>B"]31UV#/EQ%I$SY<[
M5S93#)73NSH #Q^OG;$G,:VMVS>T!+'^6KH6%(EJU^_W[Q^X/'(6-#VX((B*
M2&'AJ^^^Q7$-[M*%R[=%QW.U52(7^Y+IQ2W>1T@1RC6=-U]CR(AOAO@=!> >
MNRY?ZR?F1TSM@!</J-X(%E.V!>744DWVYF6U9YP;U'ZH15%_F8,Z'G;Y!]+%
MH!>_!>4F:L(FK:V[$-HZUH7[R[2;1?)@5F8;UQZ584F6R0KPA<B I%Q0+U\X
MW1^OWS]]U<<CE;,O>Q!$)#K/CF58I*:+XU7@.3=2+EEZ.SL76YV"J43TR1TY
MI)-X/4@!/[K5#C*>FG^K\X!OB22=*UK.5,'6'JV)3^(O:LU3N1Q=8JFK-S5U
M)83U+&J@NE6SEVZRJS,7,+&%2?#\L0=?WZ6Q1+]8 T;CH%6 A73V^!^7LZC5
M\>$[8J=/I;LZ00R,&".10#_>:+RIL!O)S?=,NK5.?FNRG[\C3]ZA;(\+QU>F
MI*OCL&]@=G[:0@C)JVVK**W'7U9=E#4^)F  OW?>;H"W+@Q'W18B@:IR\A'\
M&MMF,^J$?*$Z-<C"9WQUI1JQKI5Z?[F._SXLK:(D(JQY-:[J@^F(Z1C*D$\F
MDWWC]AW+**XCMO"DQ\X0;:ZS_8YS9L\+463DQ+Y+K&'ZF-<AU>7:/R^#<S)!
MM;24S#T/A<ET=EVC-6:,@\:PF9'[[ M>"R3S5;07STI,G"F$FT1J567GB.:@
MTW3WU$RF<"1B9"GF0O5H0TQ$%N3"^$,BV8YSD=LU/((9)I?M2?WQMTB!_QR:
M]\S^1> >G 8J\-"'Y^Y[!,/>9:2/Q!P]U#%H!7!6")-8(*Y2^5US@=KQVQF7
MA866]$><J^DT_=!I!/@S\'ZC?JCG71)D1-K536(FQU06-YE2)V/H_1* ALZ=
MCB/$1U5 FJ:?^DNBX1>8'N84^JI/3R/3FE0VLX$/RO7ZQN2346*9&NYBK>M9
M[9J-\6>0C_'\S>)#(ZT@@%]9> ^QJ].?\J23QG6G*<,$'S<W 6H5.8W<Y32O
MLGLBD[2M'.0M88L9CG?>\','EJ%CSXF'63>ZR(UG7#997J/C%S.VKKBUV2:C
M&B8GD\]W/(4[;3PAF,?+Q(?%,$@Q,-8,&#!OEE9PHQK40"A\76!ZF=X4-%?X
M&G)S'5+A(>5$%4!+C.0;8TWG@TMNA(6LL5& @2?GPG\7+3ZXELU>=3)FJ:IF
MRS^R_"/<]EA3)$O@/#5?>#2":UV+&Y&X6=CD7@=>[OB!C&%$A?[C:J!DWM<M
M__O" D5%GJ(,=UXXY8%;!?"1VAL8F";[[PO6Q\2-NSI=1]H25=RQ"U7MYQ,G
M2<'MJ><O7M9@^K/J8FY7/-P>7#8UJ(79E%CEEMHHZK<V!?K1T1X]Q@H;4GVH
M6?R%XI@JZ7A7[Z]!OF<GUL&21X.V:E8H=_NW)K><8->0!Y^0D[VL0 56SNSY
MD/UEH4\[VP<N6<]_*H9C:LVL3G4T50>?:*[&;-1-2BY^WL0;A;!24;;J$)6T
MJ'K$ LC)19N?;LFFK_1BQJ##J?[IG6I!*"CBL85QM# EY&7M+<FN3BH]K9L!
M/3Q$89Y=7<M*%9W.S,?%52HS5U8KN:VDH+*QTKF(/_PNJOPO\9YN9-36B77C
M6=Y\IF*D8^><UG9YY,*KA<C2.N,F?\ J4)A.0YI@_>\.E))SBPL+K$Z4_W2V
M:&T5[.54"EX<,J*I#G)[L'2?9>J13%,AD=\@B8<,IBV962H.$XU95Y-N;0:T
M%\Q2SXC,./=4$V$PJPGUGJPU6L G2< -UKF=_@Z>11/S=%GP(&A0%](24#9F
MT^)_C?YXZY:[4 [J8:\T^H*62_RIFQ/[7;&Y'8RJ<S;;!%M0+J_[_)=2@RAB
M=P'CA]:0!49_ZE<1@=ZF0/09,LY@YWBDGA)4T:8,1X[P9(#%C5T=<9A'//X"
M4?FAF:K^7%H8D/>A&4SW,*VEKVBQQS,]PYISOY(8Z93AR=DI.]@S55ZJM[1:
M+:W/&B@#=OW%^EI:4\RJ(PN(XV-SN],:!;#]!@:NM&L)G4*G&!KM0<@K=.;;
M:N-[3A:''$9A)XT"KX9?82,F6$;;D#FYZ^T#LXLC"U+\<#KM\[:9CNJ 4AP4
M=UBZ;_B<7]^-7NAXG-F8JQ=E/!KU5NAF\E7)S)JJ6YKR>AH6EUHH821?CA<T
M!9K'3-DH-73?KN0?__^JW2WZ8NO6!EZVO_\A5O]G-VIN<#?&6;&0N%J3!0X)
M[6>GX]*<#&4"*]/(%_XE5#I:$N:>S:LZ]AV^X#&M#/.DD7!R1OG#Z-[;WQ@K
MQ.X[0_#!<?,82 &G4\1/I?FA>!_<&+K P-L3_2BL>P!YXJ.\JB*W#NVN3KM;
M$-F(J]WO9&/:&I03!UF3;[JFA3I45A:&6OJCJ"6!9=G>6]<HB5ZW&7BVB;0:
MUH6&NG5V530"E0>)@5Z'MWP1UY^N!<3Q]]^WV*>QU5[V*F)%UZ/S7)K=^!O5
M)7$T.F6]9KFZ:U9"M^L=X!SJQQON>#>9P]+&K0OCT?'ZYI;&EUS:YO*K(8DV
M8QX(;1>PSLDE6I TQC]_1FZC5LNA6I1Y!][#1J[00T9:1(6>KZ5&J=0#!TVS
MKXS'*,0FKM6@>4+8%J9;@8*;@N<%'[+KD[^"E0JH144T0<!<Y9V/7=#5TY3%
M1;$NZI3&XUV9IX^?.6B1^?Z+FI>:@]]VPN8L7V2MC$!W2O1A-HZ-X@_-.AS7
M93$AK&],W%&1#-?A%^YJ!FLDPU&MW%I36,VE*.I%.<?ZM-$/BT^CNS97QBE$
M9E?"Z#[=\:]_@Y/^/XM3[V^<U'S ^-NR\6AX+W(IILNT:66_:SCJ4,28/K&W
M(TRX5GYQ.2 ))BD(&]HZK"AXW+6H*#\8QS^3B<]_@BF "]Z*%S]Y:PJ*&G#C
M^+/<AI-HNID816)8)O'%(W1550'/2N#>%VF9A!>E8OS-XP]R-/J&)GW;/U=N
MFVLR*LR9M126S;WCXZC2Q(PUN>NPMOU1#F>5_N=?<WDL0[6K(U_OPDDMFI:3
MIU!H:*=CP$]+^[8BNWU04RF&@)&Z%I&6FV%@,Z@1YC9<EVV"V79?*=;J'Q=(
MFVO=%[=1&E0W:3ZF4G!Y&VEE"FN7JD#]Q\Z[V^ <4MO/L0(4*1VD1@H5&UA%
M>/Q7RQ'WEN6<<T)I_GQO.ZOP0U0/H3Y2I=!=&"H[@2I;S*]\./[]-Y=^%Q7>
M?Z',2C=MM2\>(JV9F./?H\]W'\#62 2%D4DNO0N3A<-6H#QG)H71)DM*)$%7
MM#^S#?!RQ>.NG'8U_VWX@)K6R<!YLN2:;;3BL/0P(S1[V,7R 6:%3^4TMY+\
M\3"/\OS5Y/0P>O=^&6!M/S#'B#(8D<9I+B\\W^4'HGIP]-;\7,Q@H3)0P-2:
MA[>#GWU<6OA:3/C0);B3P>&5&V\S]Q;%;G\! AE=<;<7AO+Z'50LHT 0![<1
MV>[,](8-(ZJ3HF+MW#RX^S);AP?*QLI+LQ0F<GD[U$0>:B) E&1065V]I!=#
M%T5=FP'E>95<S\M1'X^@OOZ7?Q]+O+/P8C.,T07ND#R&W)A/XBO0PV@W)!0I
MR+?\66/DR/'Z-$0X/<47LB."20TVOO:7!L'C&'P3.A-?!.I!)C#DDW1>?&BT
MY1#"C5TSS(?J&A*8?L?8^,.4&.DJ!0K)6\VK6DFK$1L;]>RE2^+]G<+".U!Q
MT9X^Z)>KE?F56\K$<\.H!PH7]'/I\KK6B&J^.7JZX$6(X :BRCUMV*!C"PU<
M^\0J4=D"!^#+^4LC2_S0&P7!\\WYI_ %OW2-E%:4+0Z($>W349#N!E52:^1+
MAG4(09XUW(]/&#['G:BL_,<]B=$Q@==G6-E@ZED*9K9E^!_V%G(;&V#K+R87
M"[DQDM_C(;9_#_O@? ^7EPQQRVACAD7(&U13<_AV9EGDPG[0'EHTI()WZ&'X
ML]B:5L8][O+1[] 7Y@H+S N"WQ +GC1C,J7'%W-42R.#,XKAM0R+'LE&J-9V
MT6[V61DH>!Q6,%$=%!UG3N526]AQYN;1R -.Y;/.J+ZD=>P BCKO&5&PUM!S
M.8Y\C-72U[?IY]>W>5&O6Z/J6]]:K+)UB:1^T^:>,6D-!VYB4O<W,DH")) E
M.>[S<UWENSJ'60Z4FK<\ZT_#I&U'!$B?,W6"NJF2Q7D,X^YZ4>:[24A1 ITN
MER+O7[^8NJN#NE;D5FS6=3D&R+W5Q[=H:MYHC6->*$P+(XIM'7=U/IX3;4@D
M'9T?"Y1OST$V0U-OK)2 2@S.DQ>X\#!V741\R/R73<D[7T1&SCM]-IU*0ZR,
M)K_^H3JOKM!#^VS",+4=''5H##%P>$F X)ZZYPJD^+)<E,FXJ?Y#@ZMS<GND
MD\I%96"-MM$T'1Q^*Q@DDIV90=H/_+S)LJ#T#4K5"DE#+-N4DWK@",]+6'P7
M"63=+ERTE6^*:EYN!_Q0D[$-&I.O#9N54'/.Y'AU^19N9(@_158OM-X:2BL;
M>K.Y@FK]&RLD3'IJ..*&-?7 $[KPB_)*@=LGVU>F!Q%^GX*]$(,1MMX1AUXP
M.9L_;&8H0UB1>[K7X=CRZ'96YY";$:U=A. ^ZF<2!2=)T*R@4A_*8VA"'W>B
M:HH>]4"[MU)>7&'9KFB7ZP_"RR!5M95YQ)LL2!7NQCDHL$RWOJ_]BB<I?M6/
M(GK_YC.9 WWQ?JMF,GS'5G.PO$V+OPF',97&I7=$R^*ELTO'RSTCC+(D#S =
MFQRPD9KA:'2O]Q'_2F[_7&_GY ROR=R29^Z6RH<F58_'D1L>0UU!#8^C4=$A
MM?O6G9SK@/R5P7M\><)P*+E>[NH'U:OOZ]L)'ELVHKW\CY/\WX7?GF+Q1Z:?
MY_A#7=';+3>/F91QD2*3T6L3;H9/W;PO%;Y7^5,4S^)PYP4;5P^9FGXIWAVA
M.IO&RVO*?T7,-UL="W17?THO666M;$@#0!D_)B.W=S2=Z4<)A4 .I&W4!3%#
MQ%ZMJ<8L4CDWJ^2516K.38R@,?IZL_:;86&^H+NHVW@@>Z/3R  C/GS6:9Y0
M)]!++"TQ8<K7MW^Y"5#/;MRS\, ?3,D]RYXO:@:\)]YHM\'UJ8*S3N25S12+
M*:5VNE/9J0'V7$1EO8PL ?%P8#S'STD)[[?(S:&;N"R&.Z_PFCQ/=E#]<T8(
M1*X-I*G'?Y;" _D[8'V'43YS6,B/B(>D*=2 #VW+N75%OEV>^UWUJ#'S3TSW
M[-@'^\KSI?=P9-@7VBU5YQK;R9CTE'6"EINB/^*(Y?M1]X;3R048@ 2G'W/=
MJ17D#@Y,\W5(_@GT^7;$]I<;ME1!"H-%%R#2.5KQ]4;6H3ZP3^$VWV:6'19
MP\P-EC.NR'7UZ\$!:M%5)5.2SV+,V$H% ;BZ9XW'M/;C.5'^)+W%2@;AW9N\
MO'S ^0'&;S;D_:=@U+RE6!RRVE#;O3 1]4?THKX6(8?:;/F$&=,8MH%K(A+X
M9:\?YHE-1I41K&]BGIJ>/7C60*_7OK;Y#;$K04)$@6Y;MY/3+>YU1[5G7*U!
M;I?L(3=FC0:U=M38,R7V#,CMO-%$3-!+ OY8$%3OV%ERVWKW6VS#@"HD&HH[
M,*0/UR,U!N35U$[FEZ!A]7[G^K+\OKH:%ECV:WCOM]"*(\"FYV\OCAE;&^6(
MER]QMN&\LI1A:L5G_AE-\O6B_:L3[(F[#<78V7<H*O-WO]7OIP9?K;D"PK]9
M_F:F5D[+SCR(5;H%]'31!]09)N5Y!4M.1VVYK6&A7 (TS L:0FFDY!')CUN1
M]\MJXVM%R^I='6D8O1.EDB/Y8[IZ=C:Z>KJZ=J[>C2V3/V%_IP[#,JC:XJ7M
M2L]@;CE&\ZD($4--/X=E%-$[[RR=LK7) %H8\H_ZM'(B6-X&Y>F&)AQ4S-72
ME*OVX:&^^N[;,7-H#P#*2).&')7CVS<.-&=O-QD:[N620S @XP?:,UX2LH<C
MU>C(<E^8K[]MD-KTD-]D1GYG\.Q69O\<UU4%VSG7YY>%$G'N.7"F["X&\4'$
M\GQ-G;%YV*>_AF?\EYRSR#N1:^LJU?%6(CSWTO/IU)V# >P;+H^7\N%K)H0.
MQKP0O3Q7*$"&)-"[1N05^J,1AY#Z[,# KP)OJ;W2,O,VZQ<_6;-^:9V^)CN3
MS6!D%G47I7+)^OV, N4MKFO<&"<\K, K.K[94M<@CQYJUIE=UN^]5YS=9!HL
M9QEVWVC)R@+;GT\X![%[-T0?0ZZ\6S[WYH;N_^;KWT>/?P<'G=HA7?=4)??U
MNN8QHM<%-'K)<7@1_XO;C&],/_KRE!7@,?/>* ": =.?">(EL_S:.?VI8X!4
MU>@X\?9<FV2C-NKOTP'*N\*D="3^,L3I6?DZR;XJ'\-NY9,=J@AQ4+MZ=G0J
M]_/G@B1-F-M(1&UX9=LPQ,[7/RYF_!U9>HVM>DTS]ZI@.(-<XS#<9$[K:W#Q
M6F[C-D^P(U^-)'R/Q&6NB33B'6DPM*=Y$\C%09<8RAA%%.V-YL1J4H#E?.[\
M\7L;N!1E@+1G6,Z;4Y*7VN6\@!*ZP,E[#@3V!H&;@A@.' !_P[0G'1ME63%C
M@??/4D=9D*/BAZM7M*A43I1_VKC]1/:[4V171W6ELD\H18A<9 Z^0[B8J=%7
M;C2&53+7A#UL-[CV[:)Q<=LUO/:'Q\U'/;2GF:4^8/NL$Y+\TWSD05)/<W'M
M4C66A;@NO$[LD@P-J$K1?&ZT:]-'G -1]^( QBZ6JG-IT BHB]5!YPWKP\&#
M9;E^[<4YAK U5<@*AU>G#Y O%@-,6A4M4+WB79WN8M7WNSK5QKV[.@TUI!V=
MY[LZ(NM5RQW]WIV?6;LZ10N>/.6WNSISCKA)RW=+I?PDSR,'=2PZ:F]V@X?P
MSC),2$P[;>$ KEG$S;=L[@*\:E9^3R0VW_LD<X4SW#9H8:]B-3=W;JI'0DI4
MKNI%&VZYI/O\6EY>=0#G6RY'=[&V]C*%BR)S@HM1I;IO%BU7#<6ZP?D"1(J-
MR50_+F2+W"@[OO/'O*T2EI:4\X=<@O(+S]&=BEV=^QKE]EPM<OO-XD$^O61C
M8GL'(53N[.W/C9[.?8@3(M_J;<,S_[:3N]*SY8E3NJO%2N^;.1,SN2--:K0R
M]VVDI?:P=*M^1R'^&J= #A]\-W(U[.J\WMK5R?RE+5R6VU=KI.,[:9XU&<A=
MG3NJJ$F:Z:R%)G+K@UV=,-&U7-RV]:[.P3GMJ+M&.\8WI62:JI]L2;O%6P8%
M._T=NSJG/;LTKRPV1>KWWWVC/'<]UU.4.=<C0O^\C7_'+Q8T9RS:U7E%!Z\!
M6!L^V[R>]SRYFDK3N5T=WUV=WHT=]:C'SDKZ_<5([ZWY7.<ES:[.AY*>UB3/
M%Z EQOK'.S3ZC[LZGIM1.Z:CFMI,I::NW3-AV7/NR@8KHV?=6G^[$+%S.3=-
M^2-HE2';L[&K,[ZK\W8GEZX>S648?Z\%E^[JN.)&W!B[.L]NDQ;"2I;+_A6U
MZO\WLR__F]C_)O:_B?V_CMBKRVK:]Y2#1]P92M'7/R>'F4<%S#.6U6!>6QA*
M9KNK$T=G"::"I\<<X]1[[_-48(,:7@K8:.+#1PS3 .>=/::TVJ3WGT5HAC;<
M^L+WY*9,KDUFHL'7PS<@-(+\'JTZU)X57F4KLFR(&9^R]GQDZ69=+<PP35C(
M9*\B.!F=SPS:+YN??K?">]M/@)[+0BYZ-K^D3MYX]8^Y_N.SZS5O!2W92\O:
M_3\;=V/%#FRGX]\K#<]M6'6\@*X78VKN46)@*=?W@:L=233)$W*Y3Z<D(;.M
MN:MC,PO:A.,7XP)%,4NY']XN=,I-1^^_)ZUD]0BN%<!/5YB;%'';0^,Z4A:5
M$[JF^[:>YVGZ*,JR;G+I G.BQZ6?\Y&_,$7:6!7-;:RHRE]ID,-R1@LW/VLG
M_6O!YKO^E;[GE?^=XO^7I?A_$WL=*U9%O<%OVFZEL1X)*<T^]C]/_ V?,9:Z
M]&.=(=R_GP'6C97^*$[#AG0V4!I#3STXUKK".ID*9NNKO&UX5;=P!6#4-:JI
MU#0!X=;%M9!M"U(Z^.PYGW'$2*@2&.[5%1<]5AYG!M73LTE8$W@^"4@H PD/
MV$'+S8#6%67F@'@?3E.S7>JF7.X1.M#: FV![('D6 $O7S-['KZZYUN&Q=2M
MJ>T5+C4,;8>8GQ8%\?GC3PA_(E-;6Q>R3[@4W9T LG7#9ZZUEV">-'<W0U:S
M,C*@.Z> UF*!B=72XA*\F+$9S16(X0R6KW][.Q\&J_5A7=RZDG"=ZC,>W=&8
MRK.1YM2[P=VY=&)O)JV*$\)R5@>1[11V=LX$CJZB)0@&?-X,0 I>2V=26/CL
M\BLIJL+T24I+N)-!V6($.-*:^L6*%'"J.8Q.F6#>1=6,OD906[W#'PR6MI%E
M1WZ075QO!'KX>$WV!)L&Y/QEL!#:FP$<@@W&M@=] 7^L-<*F8RW1Y"[BV1!K
M2&7!@%&5*\$F=%@PUG8[RC)]CUN"E)_LC%@"V.CZ\5]3R0LM 1<(,+N%O 9"
MRZ8WZ;%CLO/"O>.?H_*'@D71RY7=0S7IOH:E5,S0Y^CG(?X1E-GB5>P[>D(C
M0\.]KB;WG[3G&:>J_<,1HT9O'QBB!L09M$8E)"OV'QXQXV,)D>5Y&#XUOY("
MT],+.S?LY^<74/Q-R4G;\4Y$**!@3$]/K\4/U.+GE_7NZ&-1MN#DE?]9?NW]
MZXY[E 5N$,V[_]:P*P6([ED /%CN,:&>O<L:-_9L30\K4,)=N;*YSQ\5<$?#
M%LZ*'0;S[G#%59E\V\^\1S]+>;#ZEZ">/##'0E5=P)XC#O>2/%F+>"WA7JFB
M@W\]CY#QB'#:D0IK]#B.@(J;EH+Q,*@AS/K8EE**$QI3M.*\)LW:/H2FN2]G
ML*"T/C:O0.'4'^4[/((S;P7BK'VZ/WE4^L%_:4&J\UY+3D+&/L9[$NL'##8$
MN9D31>P"M5(]XJ1C&5$\!'5BV0:2+L);(I^\TBZV09T]E-ZT/9U+/FP;3F!X
MHGCOVEVD=@A%F>J$J!UK2IS(O1B@Z98H93Q#3^4?G77KO&^J@M N;_%O-$NV
M^EE25[-4ZYG?GA8]#;>YK))KC43 &YO#Y^0!3S@"5\BQX3>SMJM^Y'_&EJ09
MH%U)$9EDKY=R5R?]RUBS;D/GV0O.ZV:#0Q&RNKK8&+'3J3.D@^$AAL[0"0?\
MR(DN=,?.B.?55;"7[@3XF.^\;_?Q-O>]0@8KO+004?C-M*0_$W,.#)25402C
M<C,(I&BC5>Z3OU'68&8.TW7.^#83-)WT?-;EC^W@D^DAEB%8#^L'P$B7=8:%
ME)&:SVO.,3:/][[L7?$(_CNI<4J]X;6R%<HJVP%J8ALJ^()T'DAFK]AX0^3P
M!Q,CO,E7$)F9)ZY.@[]M7/9 MB&"5GDG+CV[^H577R XP@[A+]PQV!8G@08\
MGDV%P"?*\F4V2Y;'PD*CQ:_'*?F<NL;D!;7(#.!8&*J^F8>!VC!K7$*FUV3:
M^^T*&'&IT\P#95F+.8>TY^#UY\;CTJIX%RJY3Z'.%W[\-;S($M6=I3!4=Y^5
M5 Z9N=<RZI_AI!CS-CAT*3RT!*I8X]V.M#K55!)>!B;+.Y=NEQ-S[YHVHIVE
M@DWU>7'^:-R,Q+V[5]/HW)ZX46LXZS="UL/%E$/+0*G>@].PG"-K =3MC'K;
MS2()C+)$:+*.R E20CCO)J=[G,/O7MXW]P310C0M3,+5K-^)__]C[+$15_0L
M6JN/;[P>S-6/CJQBEN9.X<D]?Y-OD\WZML!;M0A/2>EV6BFSM.5?MJO><S=%
M>ZY5)NSJ#._J).[J')K\#B>QWF&'D5X7WU\;LJ?A<LN&<=+;GL2*+RUP?S_\
M__FYCUHW]KS.+<@)E,ZT+NM][RHFRYI')#^)K[%?_8DB;$VON#4&1QS>F]L;
M6"1R4"8[Q^SHH[\4$<\4N';,%=358=+A)5OL69#^TG'/DLXEWZ*F\$A$S)"C
M('*BJK*F.QR+3.SR&VT,!Q<#;JZ%CKD8?"@4L@5.BE<T07$[5,^!0&'9F;1.
M%/"EM!XU'CBEC8VT!G@>">B8ROWKE+O-HG:$-C2TMBI8+4D!?3O5[IE1$IZA
M*W5:L'+49O 6-@KS9B2%0\9W$AHUG@-CQJF7]O]]O5KEO 1TFE4Q8R6G!V''
M(S+HJ5<.*$")_FN=UA'4,&@+M,1JO#42=P=VN%J9P]LLFG'<=LM9Y ](#T&)
M,+J7;8X_(C3&N$E@NK_U/";+KV]X O^BYZ/LIK?XN*;P9>L?TOU-1,O+81[(
M%/0I-3:-!O;Z#.1]C*F]2]2$O(@,C#4U^"P8U7_4S1G?M$3XCE1[4S*6#9XS
M/;S15%3KS<IF"E /'A;&"H9' ")QQ/$5;7AI^$O2U97SD?F]#\8\+<TOK/I8
M32F!_*7M'I'S?JX[-X\[N:OC!/ 0F[A!;A>CS/C^ ,]JJ#?^LN!ZV=?_%-(3
MBBPL=,NS6K3 <.>Y-XD (FR6N+<0F6?9&!Q_YV9SXX6X>Q=O_V*R5_ $CW:1
MXO"J,A/WR<5"0/0D0>]P2Y_?/[9#@65Z)F5Z\B]V0BF,.&H>9AAB QPL:8LP
MV3FR<TZBEO8KSF2T4&J87BLL.1^$"$4! -:.E4_:FXK!5("*R^&=2T=.%.ES
M4&Q=P5<F62,[E;!7%!FO@"Y#Q:+<PWYD@NAO;\--W&19&G<4TQ+\P6H.+L:I
MLAA&;>^3<.$0_LPSI\'L'L?H]S;@3^?:D.B<V1#T^QE$/SV%#2BJ9-^P5C7,
M K4,2RGF,,?Y\6N7/F[^6N>_$A_F])P8>55(VG'/+:N$H^@E2,U'?VOR13\N
MO#C;Q4O5%C+'!R-]V&QZ6W_\=>RXRAX<P4" E.%>((>4_5<N7=W9<M)^.;VK
M\]):A5[AP9_=TA+Z(N/X8"N)95M#3&.T.;>_<]3&H!#<6($U4_D4SZYL]P=H
MF;LZJ>:>WFW\V$$2J:'MW/6\%5PB[^1VUT I</ODGT]N-OTSOK.7UD=6]X6Q
M:MW \9&]\1$XG]3:B8J!(?O#%0:W8&%<;]W'THTV;9ZB=FAZHJVJZT;G-Y@;
MC3B5NWHXA<=R>+W^2)/6 ?I@$1G_@<@N)5NT+R.OVBO^(WZ5D]/\>"JU2DZM
M;* 4YSBOMW)##><-'V%QL='2)W8\NN@R66%C?$0R91'AT6,4,V[!$2^V6+=_
MWV[^.RD!MER^*7^2@?LH-6>2%9,S=W),.$6*G&T#3DSC&F\R[N>_D'?F> 11
MG2[]12/HXT^8=.?#OMLY6,>[.M%KG&ZY?E-3?-O36=E]!5'6!!NY505%8[BN
MFC"_A],Q6XJ@^":8X>#X(P8C;?RT 25CCM,#, 2JV0,WJ)6::C>O& [/W!)\
M$D4^)B^1:<WBQ8VE=H=L(Y>AOP;WA^?BHMS4:0@0L@;RCPAGGS](=XT_B8#'
M'YK@> TH)S:0'O??]V#3J\)\7:Y3.,N"D^Z!_@2A\#-?D*[ZD'Y$(/O6CGE$
M10GF;8^AR!FOQWSM@CG'CW8HIFJ,6V/S*AL(>K !#UR]V,2E8!0<(3UT+G<S
M7V))7S3N 0278,G"/K_M2G40]&:^O&J5@4 J(LS2N-%XT:DG>__\.^GQ?XK_
M:D]E$_@M3MJ!G[@IKD';S0KD0'7KU 1Z,@W0NZ=P*JUF"=CUYD&WT<@>!RBR
MX$4([T3JQ/"5_@@C-<AH&TB_M="!CJ]8W $==/AQB>9F$@//H8>L;<#O.UJR
MFH+<.Q;#QOE^K$"8GF(QV;&;P64A_&4L*S\W>@H![NMO':*%)@R'6BSW_807
M_\FT. ?;RH]%6OR8.+H4-V0Z'1FYOJM#E\4S.&2*SUD'E<G?F#*KAA<)!M^.
M^3&KS_9G[K5\<K*N($DUUK_R8)S^_GJIVB@]/((VU^*)DL9?Y#T2Q!0LV4#T
MCBU1.Q2'IM^E;GCU[?X'I7IV]Q%0:,CI=[/'7\,8##Q+PP"FB\>/IZ!;CUKN
MZ@@07'LZJ*D_H/I\V=L;52M-FKBTC.B5D46L LT=IP8P113\8&)*%I-7T-4[
MVQ)7<%$J8<*6ZNJ6SBYY&$U\V!?.@R,,W'WTT\8"'5+@$12A<;<HW.J =#%B
M2?#M*XU]8<SHG=5!])@-$<.-]SW?%5H^OH*%)O0_OG[F]I+O]:%$^7-$5>O<
MU(UB:%8H(&2G"&GNH7+U ]7W^3[KYMG_4S<X;:"GVLWT;Y'@-\;"V,B+VO,/
M(&E6XI<M2;-W &0"]8 S9:C_A*XJT"D3$*>89,?<G./TAQBEV@>"=<$6^C?A
M3TP_08@R5:#/IURD)L!D,[L%.WZKW3>9A1*6C=U&.SN20(6L<@Y ^<>;*94_
M97\SI<U96ZS9\MB$,O(4SS*+LVQY7";S#1V*?C=LA\9Y1!M[."Q^\S'UVA?(
M(,I#,EM1[6AZ]"ETHR7UY73,\KH?^^%1HZ#+ Y*25Z/QN==3C%K!K(7F@O6Y
M'7"5R5<E(I7;UA;X9,&ZBS$5*AE"JQI4,RQ(@_RF)K0\GU GM/F"6+1N!TL1
MPSI:. BT.BP(94YMD=^LU$9'1T==[\W^5VG]^^(]G]P7H"["FLF6BO1=B]7W
MF%J2PKBNS>XAW_]<C5?E(O8>9V]LT1#B0%#.J<&86\(HX^F_LN/A9QVG0F,;
M0W[HDE02R6^[%^@UN=<S+'+F6OJ6:VKWUUK]4,DSZ=5O"UU?K8?ZSHC8@(09
M!BQ;+X0 *(A3OR_OSJ,>T/MVSEK/-'.:HY^V4_%A',=A'566R FI;.]CVX^;
M,RFQH:X^OP;Y!Z5G(?RO0\1UWDQN1GAO)LPI(>,CQO<AEU(^G/Y4]-HU]RKI
M-*R<%6B?&BJ<8F,6BXH;KGS%#D?U%[4&CC9;-QVJ6/]>DY9I>F)M[H:$ @BP
MO#_41?/CQG6Z[-O60V^" F%'UIR3O6!-S\JI);[0+]3SWH^*6;=46QYQYHX"
MWQM8<P] [:9_O%B/<X\ZCN+FER2,G?G1^W>2Y*/B[,K4K0C5*X-R1CR[8MYI
MRJIL.MTCJY<',1 E>63&LJ+ECJ+M[7["(Q*#-E]NKQT?/'=K&Y6M9AVBW>>
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M^N[U"T+0(6M*2V$[5?"C(G%R7;0:TON'8TKG1QYNCHF^NE>W<I_PUUQ<R(O
M@.E,S*D>6B<-#'8*3IXEA)9BI?!18L\H$8]UP;6/MEG?I_#F9V%3G8=?BSOI
M91OFSFW8YC@\)K@2%4\GQ&1-5<(/7)WY:(YX)#7[AW!W;LK:D$NTY)L@6AQN
MC=!8!SNRKXJ4Q&$EPG.>>7$Z\I=#:Z_$H3NFVT?NSQ9[#F #5GG7M%-7.8F0
MT^1<EZ.+ZU2>G@\7H@,?V- ]".T4+&_II^!\>Z3RINO%JEK@P7.)%BS-)\F@
MJ">H"_A:X"$AZ-7Z%H18F<>-;YWMA1 O$T<PZ&()M02?5X3-B(F9#KOVIY(J
MZ<\?C#SX9N<"8FYKXZWOMZN$2P9K%XON+1Y"B<KT8$M9U7]+K?D^!'ATNRR3
M-#>!XD$"X&[9,])X2=TF(G(MP7F1_"5*=EZ2S=6SDBE%1"JC;;XC \K'7"4Q
M!QGWS >.BT-2I-A69,CLD.YP2N3&-_=1U[1MN=V4 ^9%71%\L$$P@U-^:#6$
MA=9/H=HA"/AG_/J,FU'J25;_)UK_A=A7L33,5Y1O%&^_GZ7DMYA[\R]3)!-3
M_)]7=Z:*([),=GSM4+++.UTO^9>967]_I/8H56_+VSI;F$W(SH__QE>FN:L2
M@V6]'^S;BJX*H5.&A+ZR'CV6UX]J]%\._K-W?KZ8=5GW-&<M/#<(>>I%0+(G
M.0U?6VJ>>$-[;/4E%+BK LWIA6@D]XTPMVDV!I;1.:\NV3H.T_#X^KEC'CM^
M82E!D+=#<T]J'@NU>4Y\H,'=Q2>J1=:L-WPPJ-2,/69_M;A4AW@<')Z+VS@_
MPEE-#.;KJBP6W%&RL@Y:4;F=9U,&R9+)ITRJA71[8?2*=P;(IFYDVT+MZ_TK
M1A]:RAT\DF55TZN1.[\(:UI:0G3KKHB<Z*$#DQFF=ELDJB>I3V%V89Y?PNOF
M+YM>"J4S) .G$X>6,F9GR!'/&$!^GL>MD)KWND?F>GV2WV?R^-926:8#@I8$
M-C_I.I!E.@AND@.,(C'H-IT EBOB:YD?29*19(5$1O=0TW\["JD_B;9B^8;P
M-9OZ1^+JXIJ:1WZ\<?I?Y1%[Z2R<<IJWN>/M>( J=[<U473NJN@[^ 5-F"6.
M>4G"IF]EN%FF'AG+=GT<F;".&V5%_O+FW*)^$?QB'<:0^G[V7M[;DEZ7PXM]
M.Y8;8F/H8B(TW@&>3ZLE5C#QTPDI[&]Q-=!Q9E\IM*2L:K;IZHE5[+R.F.2,
MZO"=UETC&I=TO9D$-Z>AXMV]44_KX)',N/BRO(IV#X]68W3$7X>7?-Y\L-+;
MMO? I4 >Q;#FE.'$][:;?*^^%M@HO;\]9"BLYJ1ZH0;;7]D#2^,^QOJ%I!+@
MP/G:VS,G#)!5=3FW<%_FU_UE4[S4I3!GQ-J&!AOK&=*NZIH?J>H'P *J$T"6
M(>/LD,@"F&0AK\8D(T2;=Q)#<^3>(3OQW,#6W 1A]VTX(BM*7&+LF2?O"Z7$
M>XO4U(++/:A/VO=]/%7\M98K1'H3&=6#+OKQYW95J'$.PHG7(3JOK3+FJO4F
M[>P4M)ANWEX4_JRMGR]7?/U O'-8VZ=D=8)N[:EW,&#;#,Y9)$UQ>8[T['OP
M%[V4OF#493+CW!L:0\$QA*6A(YD9=\2ZCUN]E38K>B:/9M.TZ.CX8_3+VQW8
M,82+Z3/3F&Q#Z[4K9<,U7O]H)Q%4(*M? MB+Z8?6?*/,T,].S+I<ETR>\W]T
M+330;7"%N;JK\N5Z077^3-'EFSD,S[[X1[(;Y/STDHRX&4J@XS7#]!U#G<*$
MF?=7CRQQF,;)'"Y!F]@^XCK(25?.E[2H65C:<&>G1A\S4YI&!HMM<+F;W[^-
MS9ZZ,9?8GTG+62AKW\R('-XT<<W">44H0"(UT5+!^R]O?O:7CZ?!_PT@WT?.
MX>O2MX1[X1'I1Z<J= ZJ.5XT@TK<1E:GP1R\XNP?8[OZ1">Q1&MA:NBCS.FO
MO)]\I7F>K>R'<CT/^<.?Q#<?3\M]F14Y_XS8 Q^,Y2^*K38Z373L;"9Z1@*-
MYIW:J3FEC+BBYPL4GV<ZD%NB**=.=L]:*H3\]F?I$NJ<-Q1@<"6RX&IQ?#DJ
MIUAD#[(?+57/0[EY;S_?KMU"W7H9@]]5^5-&;LC"]%5*/<[D!?SVY[971SKR
M\Y2+%YCL6DL#W_ %6*G'P/F)N&0@_;!58EBFC[@$&<':#EZ/5$ TB7TOT^'E
MW.4G39F!['BCU"V[&JN-5'H&0NP4 6V/JHO'6C+4?$R<DF $\I/U0OP95!<Q
MV-:A&=SR+:H\Q^5Y]4@FATII</;>,O#1A][CC6V<7=GJ-+] A*]5Z"C3(=4Y
M\$S</J $?.\2 V*Z:(YKO=!KE/=C&,@^^KR2-AWJYV-SC.%J13WLF'C,XIKK
MM#0;S?\D-54[J$/WUS=G2O_0SS +0YLR9]K4L?J1T"X<>+ KP+IRV-*F&@@E
M+8$2G&VI)&3_.'Y2%G(<;PQ@3S:6GO9V=:=8G@LW;G5!RVMB.9:6W[FP-2G9
MK-P[V2+SE%V5.8;SKDK@]+TM:M\.@Y.=#$-UA.JMZS*VCKAL!PS(;8>H+XTO
M<X.\6+5 V&,LSNPX5C:ITYCZ,M7]621D/W1(6Z,J/&J%L/#-)7%I[6UTM=F9
M9O%J8U':IC4_%6&)<%DC.#Y:U!U[(RT_-\(W.XRW29=:JJK9<"4[[NDH7\\G
M5=1NCTNOTL0MG?ELV^V 5WN!)=@[,7_%)7YV8"Q]5T52VCBC.2N=K#CXT+U1
MB+HA@'&-26&D^7CY83RALPO &0Z%7DJO$F^)?\*;YM\RP5V):M1)OH<IR/IR
MM?=<>^#(K['#E!Q?"$0FG,NT>#4["4EA=NMLCX+Q:'THSFD"=/%]_Z:W.R A
MMK$Q]'%3OY\W+)"![G."=$IU:"]B&$%]M3'KPJQ7<P_$.'(5U-TW+.O+O$+3
M @'L$>+@'#TD2$%!(HK_*@';+]QN:HX>]#(EQ(:,N/E<\/V.(^_Y/K53Z>=T
MR'_,G,WG])XCC+LE:JIS:,?P$WK%V^'\VM.+7@K,#VG<;9A%T$(34#]12'4N
M+H=4E<8'R[S%P)Y ?(0L/E4TY,5L078X0*JE"5]S8QV(9#Y,M0DD#F%MW@9:
M8\6+"TTCKOW,E'9O]ZQOS1[^%Z/WW[$KJ/+)' QK'BJI,4@2D_ITCH1?YT/#
M<KW8B;:J Z9DOU!VHF:%(\\^#5-TZW3.V@G$.:A?F/HUFG4RU3&9*DGMT;1^
MJ>#;MBV:Z9U^.T?0:@IY<D(_QJCR110N%+:7TN=AQ<%[_TPG(^V:LI5$ZI(%
M1%%6E? B&G<%X-3RVU6H0B>$D7[HW^!BC,)%K[N-8.\"GDE(U<5(3(E?#872
M(LT<'M9D#":LJ'^:P!R/,VYXF)#!9#MPKCPO"9HCU-J_*[ER%MU%"D[5@\FF
M=U6F0GWA,ONL^65NUN$)?5/-=P\GQ>E4D*L'-9]AMZ2F7L4C8!M#7/N#B9^]
MDFZ,ZH%&I"D;6DW'AE5Q75"FJ77EJKQIA,DKMMB#VKO^II:I[WYGR18N""&D
M[V6KSIF7)?E+PL%(&6+NV4T;[>__/#N#HU_C);6\@S^27\M]&EHX:W6[VG3^
M H#JBDK7:_C\)US>64R-H=R0G<C;V;_(X^+LACN&>Q>39NH&C$Q18,]IL&"U
M]%C3:*;=:L](9N>XS,(Z[Z'#2\?P17I4TI/, -,2SKFRIJNU1*J>I78FL%@V
MWN4M8KAHM%@T/C<8?D7\[G]^'?DO\(DK:HA"GN%O4\7 ?&H8?)VO9X\S>=*N
M!XTSGX*$=2?'MLV]W0*%5.>!G:;UCF*]5CO0GXGEFR1*[%19R/BV)?P(]T!N
MNMD&-Q"3S-5N&KPH:H>"4U7C[>9# O39"4D0D_<^C2?C)EBL*SYZF(0_ISIA
M.H2M[I6VG!H3>U^<HZI5<U,_:-,K&ND38:40-[G%,[_^X8L/UG709_K&G4?W
MO4(9+$F4X3\)K7C%$Q"EGF_L*N@,C+1#Y\X7(>B=2CB@F4'%C$D1Z?*,YZL,
MUDPI;QJ^,R$;/2A:?K]X\9R<Q5DQU0K#MJ_%+1.+FW$D8%6<_8#><^?(T.W8
M3SRWV5%<H(O =WC Y5?1\*[*T=F0^NM?$CX>ZX7F%;K?E[]L+H(8KS8AFJ?C
M,WBYYO$+C]Q ,/@/I;:O;<NF<XULC\9%@N!0:,74G2JE4)]W-J*QTN1EAG-[
M!BEER+?.;+NY:.=I=V05-QQ3Q%T2W$2%!+0_A&]RXC2'0  \SO'B!0$=[O/L
M\D SKL;R18\_C;J/STU=7D'SC;*+LX,>B.AJ!2'>(ZX!97B(93/F*ID\)+RQ
M2F[YAY&Q2^H.90(JTG!3L^=O);<-%G#L7]?B']U)#//GO;D#UW5>BASP]PY-
M-KTC/'\LE#WDH]?7<+%AIC9M7C3\R3(F1K"L69B^2.UQY3R>@87<]A;5)\WU
M9;RE--===21IYJ$N5PV2BTH[.ZI6IDFDMUA5W#RH5#O+"U!Z#+6M%7=K^\6"
M[/][1?7'A__?552/_O]'1?4_=FVX;3B(78J<ZW*-89#8KK5!96P)4<1K:DB_
ME;,C9.1_T<4E!DM!1?/J/XI9MJI;/=="8>E>R/KZ9JOL1V'!0[LJZ*-HX-SF
MP\4I]@Q>$9;W@F3\ S_N))/ !!$Y;D\CMII:U!A-5QV/L<R"4&,SM);M1 '.
M@[+A20U^XFCV61Z]6I*GB*2JB>++'M0XX>LR UAOL1OL=,W9<FCZ378E>7Z)
M)C:D0#9>@L_5#?$&XB(C"_H$SW$/$_:%]0I,)>_9B@-Z_?@)'>P35;>1\6&G
MS$!'AE?XCW2==7[KMA][TL'V!<%.H?WI9_BGCZL!K*%L^G"UJ7#JPARY6"VS
M#-\% K@_JC<)GOM9L:NBRM$&VQ6I';X3'V=I[]YF&:=@,RNK 8PE/#KV\H-"
M$U75>\%]G7O$Q><6. >O$7-J&@L6C_QUNME:IY8AQ5K:J&<LRFM8P *#V)+N
MU[!0O>YC%VD08^N'F5Z:#1=GYHL,B66?O2L"6-,?]?A.DJ.DH:0?^9RS">O#
MXGC8-I>SM]!>[RXDA!DEQM0!,L!U3'YU27D=N_17F'G\'1)G,"1__OQ@6(_8
M&A4MXW@^(#MD$61-(N<6YV%79HSQ,V.J\4O^U<S\E-F0T<)S]M1H\9\F@Q1K
MW_##J<FUOZZP+%C]L-229+>>RFEC!\,>_$QKNYN;VIC;'9JK[1UNR,!\^(*Y
MB-&35;,UF.:<9 SEA#S'$[0VF: ":'Z;.,2C*8([D]<4VVM3V30"+,T,I);\
M:D#I/E F,0.DPE\^>9+J6=E;:W!EM@F.X3!*NJAAUJNK%95-3,:IEZL___Q/
M/?#?L?N@HJ*MS#Y]I&3'FWP)M_7G5PQV?_HG$QG.RK#^&_!45 ^;1J('QS;]
MA"DZ@REX=2ZE!R&E6LE6<4VYZBOT"X& G5V5(U<5.Y8()S]B<G@8'[+<78,K
MM>?,"BMX,\1M('8P-(4U=1S=HAK4D+B^KT(Y)KD\"80.MW!G!S"4IRLG&EV>
MX[P"7&9$D@=_L<^T3?O=IGU;%E/:.0:G(LOZ^<#?2W3%%]D:%G5^*-'E1JN1
M%\[A$_]>HLN[V$OG!DLG1>;O**-K)ZTOVFPA>+PMG^DSY:"RLGI1QL#S#("1
M:4A 1,1$N_= XUX08JEVTN6B!</4]._%2]343O[>R,"WKI]:U[\5=L>>D4*4
M%'6(=_K;B3FC+,0XU&></<[;>8@E8<F,NR]&+T$^O6YG&CETZ0\PKI_WZH".
MI1]57>;CF+PJ&((DO9]R2.[8.,(;CB.'Y:PY\YA5-"/&/=,6;YH1V*JR2FQ=
M[<U$6-=8^_-/M1/U7L9. F+ ]ZQE(R,I(S13:V9D,&-*PDQ1W%:,%O?],\D^
M"CYYE4VKE3\;0IHYYB_!0Y[CWD^7<D**8#?*9DP>F)T9>_:*5O@K%I.S8)<0
M437LW?(BIP'TU+ZCP3FK_=JNBBWR1NTQ"2B-T5_3/=D).L9+[+G*UTC+RT/V
MT/2W&O>&I)%I!V$O1AR)<YY2T,H5V0>=NMF<(QICJN40/#5$A$998D)+3V9D
MS%;[$A#D*04>VC9U_(-M]O[;QJM@BNMVW/K80]R@5OQ\]$+;6ME0NN:S_!5-
MG4Z$S713>.BU([XF$%=F#2S]_@O!6*B_OTZ-M=<ARXES*1OMFZ^7'M;(Y<;<
M[HH>3N3@XK.'?<$L[\073>"5 .MZ8Z\$<>>P6./!DU)UDDB]G44MWZA.!GX]
MF^0Z\I8S5T@RV SJU=%\L-JT.?>P;&V3'6$4Z7FERP3_MX\FQ[[U93M)5KC>
M;U7JIN8L@KT<GJ3ZGB@FW%W3*Z;R>C]4J?LS)VQJFN/U6Y4ZZVN&ZLD^H7LI
MQ/LM\)I6(7JFFE2_M#=;R4GF7CX0+V8$Z#;;R(C0U.\#WO-X50M[2MIRN+JX
M7!W="=H;$_:_E:?KI_Y>JPZN_;?,9Z(0BG8F<LDYM[MD6;!A*/7AN[90* KR
MDOGW+,5!L4ZV@WG;X?;0'=+=(IZB-B[?["(ZZ^+J[[X0 #1?\@:ZR^@'^&D1
MCY7,&0*G,:!J;VR4JX/+CX$L79X.VU+MV3R\@DZ(9Q$V,E:V/QVN0A>O80F.
MI:H2+#:H.I"_06#NN0$\^J]3G*X/I!SP1N4Z*TM_B]I.$K:+W%>,VQ8 B# /
M8FA4UJ+W]Y7DYSTH+T(WF=*-J4UB5=8D:][\H6RATDAX97%C#;2V7E:5.:Z\
MF:J>"9.K<WO<.3H6B=6D>;Y"=K6B+I(?8*L&8%):6+J@N0& =^!EJH[%LK#4
M>FXNZ\]VNCNS-AUB=<[<\(I(%5US\>D%;U</X0#$ILF]&.-;ER(Z<]$]INO_
MJ.C_'#[56][7W8[2ZO)KZ^:W).S0?1:F7<P)0B=UJ@YM5T6DV-Y!W:/">V3:
ME86Y)J<U-*ZM[*H@NCN+D%OH\$F=4EJZ'BEM=$#*AJYHHU=T#V656@ [UY?Y
MOD'4_.+X3F-YARANS0%X-)<'.V!!>)NJBEM*+FMOGCI)QV(VJP8)[5N-:F;
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MTM3/,0+C85H9'@/BZJ!ZK'I.QS)KGU/OI(,2=U:>\$+P<%UI%-MX2,XV4;7
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MONV;F1)6YO9]<S>8FF77"G_A;DB?-X4\MM;EGUB9Q^%!KF+QZ:JL\QL#F":
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M[_2H#<"0H:G;0]1YC4"V5Q(S=<:2&RAG=ALZ<PT!69\4CUML#D6X0.1'IN'
MHL?1C6@EM+EUX/(2F!D%<Q8_@^8Y%-"Z:,2">.-CN3UU'%S]NQS-<S3U>WCQ
MG5_H$'Y_JV(!:N_U;)/5-HP7'(]<HWE5 ;0XD8EDM^I)H-HKTN"1Y=CKO@DW
M4A_-U@23:OHI9*A:C038Z-,::21+RP*L_R,D27LV6B2;J48B9A^FO;UUQ\$
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M&&JLSYQQZ:T7]CN>CM._Q;T#*\,L1F@L69QI,[\\*V\3@QKJCIWAHZ[N(-P
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M-E51<W)G&<C&M2NU@!IN/:DTV24%WFG0!DP(<8)G.NM,K(^9"_'#-<-%-4I
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M=XDP2MV<("+D8MP<?C)2?6EVIG]H@LY$WS\*SAXA>E$(25R];C+YK8H/!DQ
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MG2L_RW;S!->=;OVV\&7OH)WG\=F$T,A6JXG)6=.DH9(C0Z%15A4-ZO [64O
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MG'D5F]1]?(50:*R$!EM'L7@OP[[\+;CP<1 03?M8C^?2\4:CW5(BVL%C+.Q
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M>$N( )OAWZFDB7_^MQG]Q+#F?!IUA[K0R+%1?K3:.[ZPTAM"(-:^D#=O 7K
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M3Y>NB$3MT[OF>\'FFCH!W7SDY8'.)Z?J?7VI0<740&=@87__XHO%PNZON.-
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M!Y!G ]ZDOX_]N*-JS<)70I7XFY7E0G">IQDL]R)+O7F,[Y/<7I_M^IG*8!M
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M]E#P!_1>#=SX!-&X.>I!?YV1_<)NPZ*>WFEJR,VX:/C)J(IZ^RB<%[:NF>^
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M9_,[^6M-/C0[R"#SZ[Z$*-3G3?[R%<?D)V4H<ITA6-H">@K<FT84'=UEKZ@
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M243TN,6@N<-_6[/Z3W"9X=LFN*W'/'WX]M%VS\@U*0N+0'Q+#Q$'PZ/MB"I
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M6V^K2R'AQGAJPZYUSP^Q<OU/*UY5,3MZO,"YO5#ZB?0B=:O)_J83B04IF*9
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MI04$X\_(UM]7Z%W*0T-R=60-6"+Q#;AN)[59M#9?@JV]!1^Z)!9EQ,T"13%
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M-E,OV&1%3:.65W<Y;[PEO#C:8/(#P_^9@]5_^&UWWSBV]_HJ(Q616W7]GZD
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MZNGI^3-]JJ[S9RYU,59[X\J[U*]>@PM+A1X\%":>@Q%6WURAA\LR:@O62,H
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M*BF9[?+CB%&)87UT9&F#I::UO(&--+="A6QTMJ9U&M'?:.Q0MI;PSX.^FE)
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MA-[M/LFPPP5^>->1YJ%\*],FIC:*UH\IG1%.9R>)D'G+EI.B3%X;=G N@RQ
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MEXM"G&@<BKCX>>RQDY>BC5D7 6 ;YI1%)I]L>"P*85 CYIY9)T"/&;^<:Z,
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M92=OT7QMGHY@RDU"6[FRUFTATH7-$)66?I<CET3CIV/;6J?A!1*(7VH8LU4
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MWBZVX<Y+K,MF<4IO34\JA?BT6)745"WJQ5[UA]_V$@<$ /E!  3G1=?G$[X
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M=,/;YXOK0/-1AGT<ZSA1&-/!BS8@\X(W26_K$;)VSF$.ID?$/@'#(@>=.<.
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M< UKP1D"]197A85PGF;-70KV0&F?/SF;%Y96>G'H\<.NP5Z@YO851%NK>G[
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M0RX@IM_!>HBG;B[DSO)PHS/3%B>;5B*O!=/ S0]]*>QL#7U0ZS(&[/FL$HJ
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MLI.QT*Y@RFGWN=\0C%'K-1!]IE^"=! /Q9-C.3YI;4VM#*HAJ>I)C7<"M8;
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MI,DD53WA%%N;RAZ!X'H-*/@Z*LXE)V?2/@\J;A0$O2?ANU2(E.G4R37K=+U
M_7NTL1U-QT9UYE9"=$0)?K-;F#K=Z#)7#XCF]P6V#UK:1? T+5LDK,)Y&\N
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MUGHL+ XZ;GFXWLF^2['L>4-U(\4#]L>6N<=;VE_SD_P#[/W<7%&;@RC)Z?C
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M5!7>#Z]#$[#5(>-M;H5 )X&QL7%M_T[_CLN_Z>36_P?8C3(T6%Y9))$JU8!
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MF8O((X<-KO=;JU<TF>V7K%#MX%;ZQ"6:L#!+<I[HX"")?Q6C":@=M1^ >"]
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M4Y4HE"(@,L^G2A"5Z2@R)0PE02"&$"-#@!"HUE+F4( "84BZD:& )!@@ R1
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MH"R!(1('$H.50DQ]73>,PT:CVB7LTX#.SI$L.;5Y\%Y_S[B+9'7EZ#*=_>$
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M85A.JY[?</#9@Q>W+%\MF\O1(U/"V-%E$D'@9EG/J\+0^-2:9+",'SXE(B/
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MA3JN#-*)O?HF91+[^<_$\U7$!N.ZLF19AE$40PP7]0=GZ)<8'MT[\HR=8^H
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MDY#:[ [62%M5N?'.WIG(2%%,D8MI@E)8-&>[N F16VP.-_\HAN_ DZ\L?SA
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M.<;83?X99IVF%PI8E@U(4Y$NO41!+47^TAOMH8EJ#XL:AC' ^%LM+9W!;4;
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MR;O&S;\1U=3N;)N5T^/>W 9)<:<8-S4(G4_M7=.[B*@4VWBM^(8PEF%)[=O
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MFI1[>V3GQW3 -^R77,?KS#]O()>D*X+45'38:\P+)2MV8HKB6+"Z:1PP%&X
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MN1]D[@5G.4'OY%:E9 :<'$FLKIQ94\8I:U^+UH2-!(":/02JEPZ1<SC^3AV
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M*9KW-JY3U-H_'WT!,QD_=X5(;3G82L^Z'B@XJ%ENHH4P&?#UT,Z,XKT&LT?
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M( Z(*_,OA]THILYG3]FH>M9LCOH7P[>$^9F;QUX[ESL*7_)3^9E8CW6,.:P
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M=[L:Z+;.X6(BR%^^3$&Q7TG?:=/CNL5K4P1STX.TLU7KD;'1)TYC#6!(P/"
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MDCTQR&9=?\322S9,C@VD-".H3[IEJ]RX"'L^/\+\^KJ9?Y44]-ZXVEH=!,=
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ME];'3;^K+A> 04R"DU'7RP*E+RNCPYMH>Z< PL\*F>HX*,5L+1#-NJ9C97-
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M))T;O(K@&'!7QCXM^Y>JF9^VLG==U##X_)P:-/IV=LG?TF)?QYT1%<[W _;
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MA__<W5SX-2[ N382F]CI=%P2:)(<9%=;^-(/,"PK2,KUK>2.VT:6;6Q>*HU
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MME?C;6+L_ZBGJ[RR#N-Q1I*W2, MK'(LM[]D[]0J^G+6C?9"D4O<]37!I'(
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M:;XT&79&+OG'B,SD=_6I(2=B>3N"@:SA#^^2L&EI%$GRP8IA,@,\M/1SH \
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MMW97/\4U78"WNNRI.W[QW4(EZ*(9E36*NZ7$&HW]G9T1,\]0.8$D;8I0_C_
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M12LQQC+.*'JZ*XE)'.C$<A:I0!P(HB&* XIT5;J,<:*,%<>H51HA4<$XX8!
MIQR(<6I%04$A <4@(D%%%$2NZ7.'[W[K6^O>;]V^ZZZ[#K_%7_S#\+Y[/_MY
M7]B[1U+U;*764_Q6)QXI/7IM>0A!B1P+1!F_;]_]O_7NQ@XRN[J>)73%O;]3
MSZ+:R7.+TD\,^['T %P8&CU?>WIKPL\N_?!/,?$J<LSY/EYR D5HA;@4QH=&
M!SY+[.Z(X,%>Y_*N)C4_G#Z;66_60.S;:<Y(P\],UF4=[6+Q0?-C8OX-&++
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MVO'=V;EE;++EGW\0T8Q-=ND(!>_^)='X7],'Q[9]": /%G(4&[2I15]>K1[
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MUQ2KHB]XYA3QNI^=MZT/3]JFO)6/>A5\?*9A*H3>"+PL)O*XAQ_A/Z;$YR-
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M8""HX\F=O_]_?*W%P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
MP,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
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MOGIB$$]Z0DG_*V4"!=_+JW'2N5PY+M$/8/X<'M$[ +=WBDD''#N X-Y2G,X
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MO?)[QR3+>"O*+,?=/# S:L71*N;QO^,]R]T^I[/A2R'1)1_1O^EAZFP*[57
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M6CK)1VSP& R!3O*]?7RA(8%.]#_%IJ3^+C%4DA.;,FIWRDAXT0-3MV+%F@=
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M5#X8M]1$;>A/:"66+XG55*H8Z#B2XHQ&Y- /IP[AL8;*)IWOVN+:$_698E/
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M9/BK3?Q[X0:A')';M<*9'D29P*4+ ,Q 2I%:_AA6YEI)+-2>@/PD49$!JI
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MBOQ$4[9R'4C]6NFNN()9SU;<&M*>_M3(-J>HM&+EE"%'242KRVDXCNO7MTR
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MO8S":YC,ACE=(>3>G$V_[07E_DU'?.I^2]1/F74EU+5$B6R@#NQ)^&WMXJ$
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MGYF7$3-Z6EV<<$2E3R$8];U7'@6H.H\!X9ZCTJ*WUAM0UV8(ZQP26RQ<JM+
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M\WAMCJC?\,K,=R<=6E*G^HQX/84KE]&!\?;&FI/;YXTM[5/ZCF!.U:#/F_\
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M:VEY5P6H=P&  HP[$4P%H/E?4+R]&H:'9Z/;/;+(PGN$=KCCR(XGF6!--A3
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M(VEW.ES<S&L<JJH/$!0>0)6N_3IX9Q?\UO+:W,B7<5HTD\)6LJND<_I'JH)
M((.>0=8@GLIGO9;^=Y(91&D5PX=S6,CCRZJ-SL!].5Y"OYCYN:";ZI')?A$N
M)KHD"+JB*".P4U/6NPVSUHK76L^??\+VSPVMMY;TF<10QCG#:W8128(G:K*H
M9=Q4CP.=LT#5[)HM.U6"#ZK)J5K%)<\HJ(LH8QRJ!N:!U8#.A:9Y6N?,-MJ,
MUQ;^C!'ZC6RQ+4..M7ITVW]L.OR6T>RTGRC=R6N\E_J]\\DAK5A'*8U K6@
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M9KMW)%)2ERVP4=K*(\.)D)>M^.O">\?+_P$Y^7[7:>ONI R>T?AMZUYDE5&
MFX<Y+V2B]1!M:,S:)PYQ8CH>@)B2%-Q/_%7V8+[?@)B:--2_S"U4X9 70E#)
M_2:2YB<*+(ZQ<HP<Y9]V]WH.'X?5PQEJ"V#MV;7 >0>CX -!Z"$H*#F<)Q)]
M]7T)?AG=MGF?VS:% Q;-S9L^I'R/G/J7(H5M""$7*,IQYD\TGL2=/IB=+Y=G
MK:X53\WSQ/ZC>BM[\UO%&;W@T@@*Z-(C8%R2;MG_ X)+'M9::&C9$CW?UZ'Y
M<&FB(I\'^JU$V08Z?<'Z=_3TRW_-S[?I$9#3BRQR9$842K[]*NH@80(/.;D"
M2Y^O'(:0^%4 #+]S"DJ2)A=L\0X-5@E*NO/'^W_[Q=.QX;!<1:#%T\E2L=O_
MI<^-KELOA6J870(ZW,?XX=MY3IEM?*M:]M\ZAP^Z (R687@14H>NA>A!V#>]
M@$B\>I%<U9]\(=PQ8YQ!NE3.UWD@T!=/<'($O[C<,<W KQ/M@TO#B6K[!L1W
MV\3M:7B!R%H86=Z&-APPWVH==^L>0W+J]'VFNL$B%.O< Q,B-@VE1DR*'OR"
M(%Z/57X.!:A,6@S,8DA:1WLJJN6RGL"F6;RFX0K3&QF$)'#3S+HK9E:<%18#
M#J)*!L6V$ 5B.?]%\KL=3 'OUP_.(I[VCP H,("Q)/^N#<Y?(GOOY26??S[!
MVQLP94_FF_P($%9QW!LT?*\M9^ZYGWA^91Z842:7;D;C.4RH5%'_:D9/SMG>
MT?'*WGS\FGN,*R)_/@3Y^L58X7PTSF)2H$Y,+D)VDEP'+DS8\MJ.#C*.7ASM
M0ES,&K\L&KPF#1%9#]JK8[^ Z.D;^@E\@A1J^6-@9->ZCQ+=CHT->=$JH0=B
MY6;T5"'C?@2AYA&/^!=6BO>T\X7IY!W*Q#+AV[[ EU$-.IC1[WOG4%]H$5#/
MYSU  _?<PQ]9#5_")?-Q4(A]*[/*JH0[ ZIQ_UO0Q([.]Z4*-;!5K(]!W.?&
M(B#VZXFH=J8#U=881=#8[R+%/ %S-46=ZE?*>%D9TJY[5YUY%\_I^964!X$:
M-=\!:/0DN)L&B3)$=V9O4LXWY'"IBL@,NH;YZE_D;B3<[-H>X^\%*02.YH7=
M"J1=J]A[/%=ZJ52:IYPT.S.OF5D1A7]5JBJB_<S8*Y:379P9*Z2C"/[,,-/+
M*6$&X'UC]1KY$S[8VY>3U@\R<.2<D4KJ &J@C*2<]$&'OYQ?9XN-K'Q3-Z.<
M%7,>(6HL1.>P3:UDC-WH'Z=M6VA:;2==Z Y]XV')ITMTJN8S# L?T_22E$_;
MW)1U\R"_C:<E3H68OV%6?@1(G[I6&'NE7?1Z/UQ\#/DFPL$:HE,%#I)&KC44
MPXY&;L^@DGE\:P3C"Q%M,US"#J41V9Y$C1A>(_1FZH%N[G?#*P0TB%<RR!98
M:W[:)9:?D-G]R<!T3_NK$7,;QL1XK<EKO+"E$ZUM<%7JH?26O\J]:]"#]X.9
MT8.>/\AK?"J>7=)PYA(JP,+O.>['3]<2$=0_R%OK5^4*UV9O4@4FJ]*K\DT8
MKXU:6IIK3:@J 7.G> 7^&[)?+J=WRY&[ 7OMN]L0PW7;@&U'S@&9MMS:9E6Z
M80W%8%C99SXB#16:A_>WF B[)X_51^@B$BE)]+TC8(*9;_3S<FO'$K^?G:.V
M+0[':.&KRQ$<=+N_OS2M",0@<OK#T[#Z0GZ :IM\4.G-79951\ _E6!V*IMR
MY,R"_4C8QGS3C.8O?"V-8=>O H! [$A5Q?I*#9S*:1_+_TJB+$>F<WI*BQ%'
MX^33*5?[[U<L6QUFE(9RMNVSA,V!+Z@$45+F*LC.C^"8([<;N^W95_G,1]4J
MO9RV<B+!])WMCE$4$4>FH0OA=4-5'IBT(;FCXA<]@ZRB7^SF]H4__.#3;E?W
M]?J(#7!4WO(=E'YC ](O'Z>RV%ISIZ\/=2XLIHE')>@33#^)JE57*X;&$G34
M>]_YD?D.,DN,.[8'I(<9VG945HAW6\")1).?3M@8%A1!Z[5U_SLY\4UC0]W_
MOG%/#I LIU&2Y Y  27/IDP+^'\*F-) 8(XZNI;MUS_P+_RY\310+!HE#?0<
M=4=C*0U8,VM?FA-3143_LZ,.$8F(2B?W6R_(>IT.W2E7F?T1)4PO%DZV"QSE
MT/D=Y(!9CY(C^L]3*GS0M%VX)=@;W@WK]* )6Y2#.T3[\847#3L&H-<,[[R6
MR'\$3(_U<]35%<P$O*WAR#RYW+(_W2%> ])@T!_G#NUH/ +>BK[<B1]U%(SU
M&=LH.&60KO'21'?VSKY=B -'!E[$'WNB_.H<A3X/Z_725,TKJU>QB[AI)!14
M4[J32H2??]="M&O-U,4(GO&7U?UQ3EU,T;=0X@^=FB5XQF>6I$(]R9P>H[DZ
MR)Y>X*O[)_B/XT%4@DX'1FHMGI-:,Z*3HS3[)\=V3_8F]^TK]GX4&GZLRB?B
MX1>'$5=YK3G6G''4UI=@Z.EZ16P267C0=#D3?Q+1?UZ*'(\;I0\3G85G''A1
MN'@G&%0-_:Q6/13=-D<NSUDT)O1N#?V%722^L\C4CGT9)*8^,&S6R])'/(@(
M&>?.L_'SD:$WF+7N%8Y5)<L*#21U\T DVE.^Y*_M88]LB7VCJ0ND%89K$ 1N
M."RU2'C,74)(*71[V\+D/5C-8\M30Q5T34,$/[+ 1]0S) 6^%/"T3I4L-F$3
M//>19[66+F>D<*[7S/. 2^;P2_*NC8J/>SNE7LYR][X@#U2_')ELK;E.9NAM
ML33\O%\,J918WC^C09#,<E4=7O-U&'DB9"G?\61B%Z:I4_'1A9>OY96&_"@&
MJ3K1,9+]!LGSXWR(>H'F*]_M5B9W:<IUU)^9]^5W3_KNKF#[=4^)D=2$$*BZ
M,LLGMNJE%]YT!&I)4+YE/\,C@$&L'2&Y^[=U;M.0W^C:L)6M^?PVKFY3\_5?
M>CD3YN*"(ST@5![L2"PM]4-14_7V!?W!]6>1W1S +$XJ,35G"'6WA'C ]& _
M?]*=+FQQ%R.;=9PJ07]"Y%=Q6.G _L4R)(]#0XO1B_3MJF*(U838?T>6?YI<
M".S7@PL;G!?6 ED^R&H_Z.<8D+)_I;LK7E7NC.9"*.,]-_>Q=2VU^8@ N46]
MYY[[3^4'"G&DL9$P!?<TUH",WF@;)E9Z6-B7_:(#SI;.LOKJ)NJ2*"[4C+%Z
MT%^RE1R _,/+#*Q75*L,#K(^8]O;H^K'.,NC5H&3U'ZY*#%5;N#R_L]@IGF>
M,@W5!R6NO?Z4 "5K]]$'8=B (V?.]V=V(Q+@MO<0ORJ7N%YJQQ!1RALH5S5N
M/.78*/"+9N(/W%)5+)I3K/,A!Y3UEC$M]Q-9$&7357G_^P)5==N3:XLL 7 I
MBY;H-ND%IG>"^EH*L++^<+@9A]S!5UUUR-),4S5B"$97UH]O3EM(1'&L*"RO
M$R=,M@1T#IXXEM)%J[3D _CDP*WV")"[KQ-ZBJ>FQVO$SFHJ:9/&U$BXL^HA
MW:R;;:+>9F%@!M>!1T"&9-Y&AFE&D9&JBLX]<>&HYBV;:@W)<5GW>VDNSF'_
M+PJ!9$/P_YKR;2@\/.UK_Y3Z:,=FIM[6W"0(KW:+I)RP7>!B++03M;]%8H9J
M,C\O^D34Y$D8^2,A'7.M0D"+60<J%J+XZWJUU*APXBWL(K#[7A^:N 8,=*C?
M:+ST/M[>#V=*7'Q^00Y*&;'^)YA YNV0L:#JXG%!4U_+ZS8X/JJP'$Z3YYS3
MS]0*>F@.VI1D4M=4QC6H/*75*R9X,_ORZ[&.N 3-IX2$\IWM@RD\B=X]>SJ5
M;HH=.Y],6>#6%B=/ ]/0MWUZ^F^:_1J;CE::+-47B>&\6V#1>Z']*W$9H=U0
M1P9N-:ROENQE+?S%.FCM)AVDTZ*$D[QIXDKFVG%1>WOX,M@[(6\+_PS:"A[)
MGD4/5II^#Z+M3J)I+2<I7%U(I9CMGB,43/]BD)VI9,GI+["6_<G[BG^ V'!$
M1VO"&\#J="J.@80HB$)$LC-)2*5O;"?[KJC>-#<@7H]BK/B$]W",X!,*H4:5
M.)[!+J9U]DV,%4\*MZFK*GYWRO&ALOHJW[. =))GOOY2@=AK3W2MI^YR,5F?
M[!%PFP#2O+^HO5/&V#N$.1%@)5=3)ZQEX-Y6/P*$[A!HA?[O]UU6%2LKO<:-
M603::[L>_GH)U]+%M;+@?J75\&FL)E1W ',%N%N[>^-GD]=?I77B=^<? 7GQ
M:T"]4J() @BH*/QI&?G.Z!':$_[V"XR77S<XEU9M7RV4/ **AZ8/*@Y59J/5
M2N8D>:D<X&J-T #>HW4'^+/A!;=\;E/5@*]_&C7@W XOPZUH7[RH:+W109GY
M[/'_R83E9K.XQ!+;K(?J,FL05:YS]1%H'BP@0"*0V++X6E 0O_$7KF8!^]3I
M#UVI2B9)LPUXT", 'G%KBMQRW#FIBZU0> ;=B\_I?:,]Y9WB2_F\H/SW7$&B
MW'N2J%T=,#QAE*; J?ID]7\#QW]^AIO^"$C@0-OP=T!(3#4HKY=GUIB9-DRV
M'V#-X/V0W-#N/Q/MI!;]YL*Q"(W;O<'O8Z(8T;_![;HT#>AFRS>^W27$DR:J
M[^-# N>EZP,.X@@]3S%,WWH<F5*J*6U'L5AER85AZ><D*?YX280WSOL"@(!F
M]CP"GN*/ZDX &]\"E7X,8E%/ [/2X2$OEXSOR$GV-0U51 E5SH_IEU[7\&0X
M&IRX)-YT(8N#)3OI0(\&LE2^7&J.JS)3*YV8\6T&ROD_(3"_O!XQJ.H"F>B'
MQ_4G@V*?5L,P4JS:O$SY3[)2RX# JTIZ[TB.#'+]<MD\@Z<%W'@R<RJ_F3JQ
MC5TC/E/>?6;XSPAFAYDS('K]S^<HNA6F4=F!:KXCR$AX?WEE?9+8CY%P=KX#
MJB*#M6<FX.29%R6UWB^'.\@.[?F>XYD8%(7)Q1D"K<F^L_Y0'Y#%"Y7> #:M
M,%8['J@,8@X8C,R;4,2I2%'8-P\'Y.3)=H=QU=&-?6[=D:IGSL5 )ERC>UQ,
M<UI.!M,W=Z?J;K5FO3.7&HN1EAC Y?XVOC(_7N)LT_PZ05>GGE!A[GV.34"J
MR<?>,*/J!([:(D 2J]*.-4O;(T!J*K7@P02R5%)@@^?IQT]5G<<Q0DZ%BZ?J
M$_6%1[7<2PUZ_<DZE:[-,L%[J$@"TX&@[5*"3/0W!XI2/3W)13DGUB7[6*UQ
MITXPF/COJ'LV09;8P9X= >.#\4&2':@72?N9>\2_U I[N<YQS[0A>LEA<@95
MS>\3,@09#'L$[&(DS(KBV4UFC>HO7'5JQ[2[NNALDL^'.)63;)(?]ZH:-(IO
M[=U$A=!P%VBOE/#Z=^K3"VK=QJQ&>P-GB__:K>?3=4A7*']$K\7!VQ=8.K6Y
MA(ZJ(V[TH2*WWE8[=;&N]"K<[0N^O^B$_M !6E.S 4K ]K,<<JW$EZ LW^K_
M<8'_-)?JCP")PJ?%I4H>U_/V0.XR[;7%F2^Z19L$I*^HKGZU$V4+I6VMU SU
M4]JV-=(W>T4F>$7/<JW_KRX^N0P27:B@7P!GWL=2)HX4)OX.)3-4E49_,^0;
M_-3QD\S+\<J'->LG3_;IM7GU<[E5!\O0I8FH#H3UZR<$W8^_NDN3/!0<(,Y_
M2O> ]M?4N)ZV2?AK%2[1K7@*RGM0L%Z/_"/@EZ]3@E]5<@QG2ZG?WY.@T[-:
MOCNC[!/Y4SR)L='WR:NK(PT_R/'&Q>)D@N#"N_^\DIO20YA+)_E)COPUW9J4
M>T[;F],C\N4+JP1 :)P?Z^2'XMH':(S8&:(4FC_!LHR<K)MTM9KH ?E*=C1%
MN^@ L>48[*0F]2[,<^[^=ZK7VP]^Y7N53PD[8G@9V2\D)Z$,%R@L_XE2*7!M
M@U]0\S.\IITG[DD>7=+KSGZ:9\_"WKZZEZ.5)N83?5'64_E039WFR_7T.):?
MS'+>-[9^]<$)03+PJ^S>S,%MQ/X9L*4+.NJ&KJO9S"]N'(2G(-8IRJXR\@C(
MU/-W^GU\Y=X9!]&?Z^"X+]@J4)/"E^&N4&+1L#L!4U[ZM20T (R*D!*9=(%\
M\C%"+WOEN%>@J5^NL@VU3DF3GJ=^'*CX(VD7G-@!=*,.\]HV0,; 5M:5&/IR
M1NK/%:OR<;_8:?WX#@2(Q.!1[UBE^M$"HIC2/VFFRB0.)&@.^F^]G9-'?IO5
MXXM2^9SH (2^DP/AP% 4/V']78*JQ<.:%5M:#8 "#2*5UG(34L+E*S@]&=0]
M.TY>^@IM<B0LMHOS9GR;TG(XZC*7A1"T-XS/V;PXB[L)28C,?GS6<Q=%EP.0
MU$N]C1H;7!Z O4]DU_).&M2J%[C:V='Q#?[#8FXL?P8.\67XS,.-6_$(($9%
M45\YE4)\#H<=P:ZG3+.>P W33VK9WYX[!H,.;X_'0,/O;8*;O^#<+C)EE"B[
M5^SIN-TB$&P(ZIVST3-.A6*$P]PUG$>]8F/565!_;B',9@>@&S78 &"-34')
MM=U$T WCR9)SB#@.FS\"G@F\5*<%5K5J_U6#.'@^L0=V:'/G<[J@H7X \&$4
M$E XO);C ;>:[M+?K4] _H;66E27(UQ&3^\EI,3FTE[^<"@Y&3,TUO"%PS7W
MZGF/3+["J5KW^KG7^PIKCZY=3(RG=K)&:>N)T;/HHE@KEG6>4>#2_!N>5\E/
M#O=$Q!3.3PR MF?D.*4^R<%2C$R"Q9[=$J>.)3XP@T\V?+YJ"3:'IM_3WHKZ
M[WKYWPS>IKU3_&T>*T,'J*IB!E   ,.6_^IU2;]V/TL]XS)75F;QZXV;*KU.
M:.UIK</K%!?Y-6GJ"'HG#PKH$ %BI!\Q?&\',_U@=R(A[,9%<R2(;N,=6<W?
MG-70U"793!=UX9#$O".(7[TWY1M4OD)7XK.=)>-1!BXDG?E3P<]',W-]]L%.
ML:J>/J&2/-W27 Y'$)CWW3,'KOXD*7?.DGT;&)M@5?4Y;HF:4Z]9RF7 1!Q"
MZR:]]$])EM T'@("9YH*R!"TA$[<@A>=V.#!0SSF3>UW.I>UX'-T#/K$9Q&'
MPS2=_ROILR7* Z9K>PZ(P_,#>,2"7&!/&D>\KM&V-+R$8;;,N@1%B?H5P[FH
MN^I(P717VT583/+Y-YGU!\H@=/W[CY(+(_DY/85F>WZL9TI@]J*>UOY@16#8
M5P+*1N72-SC"--4LA2@1$F2([T_ S4,&P0F0VU9[7 LMUE;J#';:8BL,FXQR
MH4&[C/G"WDFC\U[W+865'Y%^: A1Z(CO]JXQSRVI.,6]V#T(!K0/G9#2CGX+
MR1)DJ%4X3F[S5E'L:N[Y*I%"\,+[WJ C-G78C<^![V@S^.R4:F7W9#M)M,(D
MBL1@OL3[2I,.[ PQOX[A,&@Y,-E2)/YSB</MT:[+7!0:Z,2Z/D_T0Z_^V0Y/
M^P)]%S5I:F&,?&@7:A6*[=G2'XKNM!=3D8YH*Q5LFM@\6=J;%VB.E'NOTY+D
MA[8>"+2SR3311TF)EF516HD<+W0V\>Z[22D.9RD64W]15P]-%">6ZA?4A[^/
M!HO_SC/\&(8U>K,@K29K(;^>8G+8.E6-T$?PUC^XVK[]8#C.F(H(H! 37%G]
M\ON#L:+1MQ_E]6^N*VR"BK0B1ZN'#\L3Q()V^\?_*7IT8:;Q9=M3*,_1F<JO
M+Z,6S8A-J,U;?I*V%&U</4ON_"#?%^4@=?EWZ5*Q^KK9S&)<I[NBL)#^9_^K
M^(&Z5ZO.H$")Z64:#PIFQ,.^F>[<B^Q39@_,[PF8:\,2 @'3 P$BU)H++?VC
M?H2W<NV_E6WSK U&=9-@[_2:6KU?&,W&QL3@*3"IKZCVF>W]"QBWV$^^1_9D
M_'L!B'$N4<;F.LC:?D#BND[W\SUQ9TDWALO#(NE2FYJQ'U"G,0NS\U]D.\/9
M[Y+\V\6:=_.Y$+SC*X(IR.H2T#Z5$>PJ1X_<(=>*-.ZYG341T'FHN #@)ZYV
MX_5O\K6<#%DW@_V-W.M]I06#9EPNN?F]T@_YX6$C5*48%N* Q3HFQ?H]3 \E
M)1AE.H8:GO"DU58> 3MMC0SW4=,U#R:'+G/J\T+!?R?FZ6:O(U ^4S>!G].L
M6:\F^LY2E45ABPL0G^2H3#\"\O/D8!3JYE=E<)+>-PK[)]RI:0*%!7D[L%A!
MBJ#1<!@TO/]M@"CR"A&\2)+N 56 (6MD#D1\^)R:="Y>M7J]MY;SHN(GQND<
MAO\[CBQO2$)?^]X_ ECGX'>P[DD7Q<:EP5JY<M/FT8.A-N\,.XI(RLL2&Z?/
MA2M5(F[3\Q*)7+4OGE4"K391^]7)7P3\49]TVBW (V.3*NJ)*)5<UE1^!/R@
M04#QD"?(+%@_E"FQM9_1*VVI-Z\:VV O5M<RV&*=+=K=WQH86Z$7%EZ(3LC[
ME%J469-?([<VH(SM"'M$*"#YW6*:4!%8@=FL(]+XH=2/:E)*R7I-J8C$-OE7
M@'ED\>S.7&D:F45;!X5Q@>YE"=/GA#A:)6KI49W;VIH#G*Z!9-<_NBPL5Z2Z
MNAK.E+U#Y(NJ:5.>;S@7MOCOCZ,!C'SH.HHMI8)'XPXI(S6+SDMI3:T\2L+F
M]_.="2_5E[D3U;(3YW#R=4.U) WKWFN_Q6*X_Y$4%A)*; DXDZ<Q8]BHP84-
M7[E2=),6A[)* 2O=/QG,W%3<NCRKM_5FS">>\(YK^IOXB[KFKQ,9E;S<8:/"
MH'=NI"WNL6ER/CQV97HO=S(]H^?.RN\)1#_IDQ;'7SMCN;V1J==R7/,(6PV5
M[ 3Q/BP_UY74^<J!,RS7V-8Z5UO<'#:+KE@8BNX\D#@TJ$DL!2#0  !&W_[Y
M-6L<3I=*19DF"0X'3 V$;79KM-\.1TL>)7S$O%\S2L1)9?S68%]M"C/[69TN
M)HM1/<"J8+P8)'F!EN,#MX-3J")KD/UPTWS^.)X5A.U/I86U[/ %AZR$%4A8
ML<8XMURM0*TK7'POG^=PW07.V;LWZ;U]!%K,Y#KEIUCV0"GK3"SQITF6>U91
MU(V#2_LOK[JV0FZ^1OZ!YDE".<7^I&N70E/[&7NZOU;O2?)%5%A8;)V4'5C*
ML3! JO'E0VFT@ F$YG&F"V>[9[O7R?VLOJF[&^/3X_<X&^,FZK#2@N:YKT<?
M/=_E9*YE9C2+)2D>PQ0'FKMY.]D'=J;_#Q"?&K:%%F.F"6_5A]"Z@W/;+OG*
MY])N-BY!6VD"AZ34/50%IX+34_I(9/Z#LSD\'Y9$YGN$<'3VJO[GM\HJVI6,
MF8=XLO)9#K;F\\K-8FVAJO39G]'/,V5O'9D&)O[OC9:;K_XIQ+<C$B3Y)!GZ
M.7L.V!]Z3ZN+?CE6]E.AM#XG7/ (J3Z1%</7ZXTHMBK?8LB4U0<_/\=#: ^@
MRL87-'R?^S723'O3;Q?)_PCXK(/Q" B6S5/X;ZEM TM'[KQ.!LY>*<ZIP3$R
M@/GO%C9C02K/TP'DJ7R>)5OHC80]@>B:\V3^?/M4?O#XW=?93YJ4Z1$@2I>M
MVC?+<&E_9?,A@0C_K>)GBY*VT^+-]%J1,Y#'\UCY.V4[ZP3&QK*1T!-Q*G0Z
M@>V0;Q%%W\ =]!O8)<C16:;NCCF:!L]R3RT;#CD(-IE.HLG'U*]O%D\\)OHS
MVN+J'9I>1\E?+B@"N2A0_A9=Z>5C[=MH0ZB+5TW63%0X,\M>'/_4WH>S*][H
M9V:5V*]J \E3:\%VQ#WM96S1R?O#I0?2_HV\G3=>XL(Z:06' 2E6Q0&,_5 R
M#K.>N9XUJ ^:0#%1HJI]B8KH!R/(2)RA90>GI,_;K>& (!]4.=>-+).4-DTV
MK)\C$63IMOJS#TT[L9XZH;2!+MAEEYR8A_&D[C$)$@*@N5;/Y-N= 3RT1.4@
M!CR?P#_^%0U5+E@X4"]B.77O*I;=1P ]_C)E7\:0,(P5&U?=>01&_Z!,W2W!
M_@AXXAVA?&.X92Q"J>@0_2!/3WV6ZJ.BZ9,3=Y07HW^+#7#&VEW(*>4GULSG
M=_V7<HD/F'K^='6?V.X_VTZJ((A?D_G&,,<=RVRG4:^:HH@S_D@ZH'A=$D,L
M^'<X&9,%<U@!II.&?PTR=L>1^<$0H2 %HTZX?*[.AI =^QMM46:3IJS'3*=E
M<#J8N;8<W=W)>6KXY/[);)/9_W^75]Y:?U[!V-H5)IIME['"4I@J.PQTP&D2
M:: )QL,21B"?_&G_B3ZTE-#L\K/SX='DVJIHKKT+DIP<B\F%E3:6,U*K]2=^
M[T\%7[S2"?1]V=G6T=R1-WN*S>%P\MG:,LR"!>A"RSJR__W%]Z@7WI^$_R\*
M_D(?_,RA!_7(3.CT."2R-+&GNOI'M6'8)UV.*X-,*N;OJR@,V=R -QN%=7Z!
MD3,#Y>845*N>+H@S,LES)O3\"-8D[++Y\T< 4!CSX=EYWR%@M>KY>Y+<\?R"
M\^0'ACS!I\%G/-E'6#ET(XU:?9XN7A'.F5-W*]!)Y'O*;FE+6%=0+@2$9/&S
MS2M^)/7EA#NF!@@] J!O^$7KV;WNWO7<OW2JM;=R)II8L9A-X[,SVM5BUL6^
MG"8!S*>Z9ASY!]CK_K]"KC.LR2[;1E2:(B(@ B(**DU$A8 4":!TZ3V4B"B]
M*-50$J5*;\$  J'7 -*KQ )2 PA!/FJDA0Z2 !H(R0TS]\[<Y[ES9WZ<9_]Y
MRWGW7GOM=<I[]!JRX\QE;XC^^!WGN6(ZYG+GD=,^@?F*O *1*0/H=KA=]K"D
MJWRJLP;+)7<&>/@E3XTHR7^:K6E"YO=JSBCQ,>P9Z7JF8UJ!<Y/">'KQGVNC
MFY*G3(1P# N(G[=<P>@!9R:3*>5(F#%\4%9]B452J9MP6$_BR;ITLI?#N-]@
MJ>Y&UE6 X-MKQ4#_G3.-@:%3FC&SW,RR<Q^*]^;PJ\BS<3K,5S>LFZ+N:8,V
MGG:^>FG(OWFZ:O8:B%#F7<@ZH$91D=W=.#.ZIQEAHM,O6*RQA3CU"D$#9!9_
M<6LK1\Y/?TUQ(TFJ@7XB[P<LRQ%@J62K12EI\J$YH[4'PWB6^2&QM3GM2-'R
M-'?9FK:HL8LZM\@3'Y)FY;I"8GI#)62 K^MS^]C>U%2\QH$W0X:G9Z'+<V\N
M@+QB:B/W/T67\G?X(%UU#54V')_,,8Q_#R$EMWK@W\$E9]ZM:Q/CBG5M36SC
M# N;LG2TW9R/(LQ=+.8A>JQ:-$!AMK#62#"FR&7R8EC1I'/FS40/[NQ(E/TI
M_Q^-C;]*M?)"+Z5Q<' !RG,!LI<<_@_RCV?SLE"D# AIRZ!OB-QW"2AU'^IK
M3;6!^1[<R">=KH>L@.N3RW;G?T@6E"@<H=!7]PR-.\KSNU#IH"'V'D&L%[G;
M2]X&*DR"]"&5[7"(-BO;X=Z2M1?73J[+\CQYD2EM! [6,> Q>V'Z$OV_7\VT
M:AY) YB.NFL0B&N7&,>H.V.!'@LH53KPIL";@V_(>P0!!BLSR0:OV[;7O^?$
M/\B>H7-]U',7!2KO 7=-4KW.=*R<P&K/%>7K,0W*]DC\6:.5DHWRWU=?1Q%4
MG(=&&,6$SG/B&%Y3Q'^>/D2EP#]]^,)F.65M;3,S._BN\9T1;TESLY?^?0>[
MVC8M%5.NF;!AIP$O+)X\($CNKABZ!R9S[ 95#X"D7,?#'N/V5CSRFHES+F<*
MIKIO=9FO^S%E5@/8'C:PW>\HHU<P"/D$N:P42V"_1DX%4QH_2,OP!!K@%MOC
M;S]D3,[GO*)3KRCJ:'(HPRL_?/QYF)1)->OUS-\$GJR4P4GG+!N9=PHVDGTJ
M,44YLYIY()<P246^;90&2 PD!+H-NE$?KZE/=$S9GXRLOM,\!N3OS5P[6"W[
M%2WR%.[/K6VF(V7,2,;Q\43*YH<)G^P.9- 9'C]"3!A-\TB*V<FX)OGG+@Z-
M'EE&WF3..U&J]DNXNJM+>)64-'\OB>AMBVAP#0#PGO'8U8RX-_!=[;1\2O;0
MBVP:8$(W@D?.[((0T(I%;/=B$?PGC]!DQ/PWAOB\';*[<L(UV,:?41H =(:R
MP(=/]TWL8[NYHNVT%,57W&I2 .D+M_X$7^ REN88J3VW_K\XOC<Q"2[5ODDN
M(F"%>_#('"L,"?[>;R)$0E)._VV_Q+#93$)?<G[HD'#2V]RZ#X;Z, 1\F9X5
MRS]R]"D(#Q&2!&GR 8C$1 (S-)GSJ25"'@X_YR\0;WWCYYL=H@G1EZ5NZ@H-
MP#XZ_E^"/S99"R038BP13VKJXYE5IXP0XZ.R@NM"=OC=<'2!%6V6\\-7XM:%
MTJ<7M28L36.&LRC+\$$P/2>+,/?@X@E%RP8]+%(86;A4/L3.@R,-,G#@2K$)
M_7I!"*\A*CI<WK]C\OW:XZ@%RG"_UZT/!IR?E6Y_[[T<8_8=]ST-,1S*//T4
M^L^NI$!N?$LA=_>]U)*XW(H-O2.<]M!&X]P,U6K#@/P-UT*LIA#D$!Z(=(^]
MC 9%8[CCH_<&K0L/:T#MZHHQXU6'RRM(U=:]C<W,L'C&&9BXZ;!9 #V5PC:\
M'9BOQ46VX_S^M)R8K6?0\?^#6 S =KP@#B4'MY62"["!8]7(>K;;G, ?>7[B
M71=$K\)?,9L_U3JA@]OE7UZVIGJ/4GW@@R"47-.L(3%B#$^G0;&GB# 'SDN>
MP$@PNSDEC[J57\8^<52R./T*:M&+>H_/H#ZB 32)45E  5E>KD>-[>\()SIF
MLWC.R+B&C*D.J2:2L1BL&%IF95NDV5;_"\18&^WIT-C8QH ZN[_M(KTKN-5B
M IOY($?PHBS]J"3'+F*=>BVN&"?HZCVYZC9C3'6;6! U2RM0^5"^(U1A[.P<
M4!S(27VQ0/79VB;.?E6CY%$(*7HFQ(,12,5*CC,Z94T9$JK"9?TX5[ZY%FQD
MGE,H;GGM&0O?$6YTSXW-\4NWY:C4QEZ\E&F3[CK_D?*SYKK6IC2P;^;DJW[A
M F_P'1FLZ*Y1U(5U8]X(W9JC::$&&N#Y&ZNO<D!!]ZC-IJ[KX:9^A\(,VE*G
MGAT:FT0S>7P1W][M#4>.AZ)5;E%:1)ZH.-H;D"^V7$Y1JU*YH2:0^5$K5W"'
M&Z3O8S!0K;@*07;HDJ2R]Z+95X8D+?M?[83*Z_24C#39/3KG#>0(6/,AR1'T
MX,8D2#H0(^TFS;+G=0=BX\KC*<Z%]1'6HJC>#*W\4/75_<8_5B]40,L7Z DR
M@\I&D1#>EN3XS:$ES)),/)8R@;9ND:NI"'\^(BD>[SM6W=U[[;(E+S2!:7>.
MSEC+]%9)IDN#^RU+_L3MI0#DZ8][Q*MCE,\P\P7+,;N[=;8V.SJBBFBC\D>%
M*:4L3T-X_V5._<U\I0%("!#IM6 2A(2X,[MV0(BFLE+Z,D ^RU)2WY)F>X5*
MN(ZNG3YE$5T;ML9N*AZA[<!+'J%+DDRZI@J #SZ$#\I\W&\(R1,< /7'>GHG
MRD(=Q3RO-KVQ*IU,J^8$YK&><'PR'/H*/>B6<_Z?;]8.3N^C8[O@'@NWW_L+
MAF4O/MEH&G6>UPN6R/G]??=K,7S0$J:#GTHS1=E:/FZ/)CRS8NHB\5NL*,8=
MUBVYO%*_=3IJ:[KLP0GNH\IT$_CDJ:"XG'ZHFXL+<&;OBS78ZIMCIM5;YN1J
MDQ:9ZAB@-"F,+DH_TANT_/@,07*CERC4<5Y7L"]1U$Y7(-QYOK6AT^,3WN#S
MA)4RYTK\$">VZ4G9S_;C^AH"'^2CW^/J2O=3XN^*19 2/^H.3,]-3FDI5*$7
MFF<@[!U4J8P&^6^V_]KU:D3 ;&@ -3Z>=%^O>RN9!AE*;>A)-RID7#*%I(_;
ML-'U\F.Y )*Q__DM[MR:ZBF&.S;#"3<8IU4?R5P7/<$Y9Z2#2TT^[$TG!AJK
M0-.\WC<SHM:J-*MXTSJD8J.G?0_Y/6@ (<QE\72>19ZYDW-,N3)_H/!._> 2
M>BP288YH/C@"+N:[WLAC08_06V#S@K_Q574QAS-O?M6VM2>J^3OC1HN#T_\[
M"H,+Y.-YHCDRENX8 <+=)4R?P?59:(J6P$4:P/B)Y.Y'^2LEV9N[[?:)<\9F
M4)Y #CY%#U1>]?$Y:KN8)9$EGI5M.5A OPNYGQS&Q&NAGR)+ YQ9)2:<"O2O
M+?^X('96?OH$+]/1LKGAQ-Y'#F'U!"#S6X;RTER .^"DP/^/2'IF*("6K\./
M]TB2$D H/&1<)D28:DH#$+CQ8B!]LAWS0GUS!L:3!M!!^Q-Q*0/?TY_[SQ0]
MD*:/N1=%*(<@JK</\8J>IFD]L0WF!KTXW!Y;3=:0O[V8<)HPO2TSS(93<M W
MOJ,9 <)W*P>?-TU[8H88#JLY]?Q_EF,;P^[12[QD9VC-YQ /X9/]&^AR@XD_
M;?YXY71KQC8Z]F,HF<],M-J_NR\U4JW8H '5B;##,)2;K]GN=E&)X33BM:OL
MI@X?I8F\.\A#=ZYJ$$$*"'UH1JDEVI4>"% KO+J-<?FE;J^6N1CN\JH.5'_M
M,0X?KX*] -VC :3VI/H-9*:A$--W$M$_HV]8Y2U]>13X&F=O".,T,LFB 8Z[
M"+^\WTV9EZ(01#(PRP)[/>T?JS^.TP<*(GL9-,!T<1P_HC6H1U/B2"[YSW4!
M.X4(A+OSM"W\4:!@QBZ[W H8DAE<5#5!1O:#<0QKW:8U<&.6T07_O#7>2R_]
M9)X_,7LME#Z5%"ZJNHKF!\K^=6FL-[=,)KY6_EY/NVWJ G]M3N<IU\3FN8N5
M0<\+79HF&_/N@5</S.J;D":*1D(QLW)._LH =1-4!FC08,!Z" L?P-\G[V\T
MZP49I>C>SS+\[,"[NRFT8 Y B^8.[Y5M9_7_'8\3Y+O'[$:>.-ZB59$M3*_W
MV^8D:*19Y+9AI)2F;JVC^0LI(.^ _W!*N4Y%#V^9^EG_H184*9Z.$P+J)C1@
MS>X9/3AI)-"?=7.P-I63N%$WZ;R#BGO9BBF4"^#GEHE3X7YSJJ=E/[8OQXC8
ME.S+IMC7H4O<REXRD'3A.# 'VZ5Z<!<5LFH_O7 IC<LT1;M(^WHV4?W?0?78
M+&*&X.3/- #Y6R*Y)SDHB,[/_;&*!L!9'P="-D.F><-:L]%:_TN&\)8G%V-N
M&YL)()5EJ:_HX@0)ND=I]VI([#%0_@MFOQH]:%G/?F=GQ"^I:,PADC^OK\^?
M5=LI:8JM$3SLU+N-%>S!#[+WZNG5H[!>_2'PGO&;+E<C;?4'M39OVPEKRB)C
M^&;]!+%<<1U,\N9_ZURHY'5+S\HBCW=B1H.+[FB6&2V0/WF/D]@2V7:<\F2O
MDV8=%57U/?#>!+%GZR.1KW'N,\$^FWPSQ6D>I:ZU)<#:-\7BLHO]^YRKKDY\
MN%O+MC</S3H*UL#)0=&+3,@N48++: /S;YL_>O3'A3Y"9;Q\O/[-O]$WY% "
MQYY;9S*9L?CW[=D/Z"&ZCZ1?Y$60(G<+P&RES*PQ=V$FT$B[0$($AT4.R_UA
MN]4.='*A3XSH"RTKPY>!YQ-0>082T.I^Y4!B1_(R2,3-?-:!V)V^B>V*+'#M
M#L\E69@;G[R>W+,D<(E1X[0EXZDG_:5F88BKM[+24YLNA.CU B?C/_#^9"</
M8;#:("D:X&8Q<?"]4#>:ZC2M75 J$EN<7CH"T2I5M[R3[*!\I<CGYS>ZTQP6
M8K0+M>SCB]Z9,[]]72?-J0+@3_&9I0%20*1-*7*_X&"=4XA@4N)22=I6.5P/
M.H/2L;OV,$P@.D&7?++BW#G)(UE0XVFM0^#QG_;*]+*3%4RI"WK@13*G_B9A
M!O8':]$\/;XS#"(:FCHNP[K74PW+SHID+_@I=DJO);Q9.CK9E_D@"ME>G>]"
MM1Z6*3WBEY36;8P9')Q4>#?'ULZ<G(]+50?8=_Q[0/[-7%SGDTTD2-X^?$AB
M3'6J6FG-TCB#!1F&*E98OWV/]OXJWJJ0\S-4^A/\/9RT7DWN9,=:Y.Q/]2 %
MTR;'.G,*\%"^19>:G'K5DGZ!L=!*/=@9/]#2\2@+1"9&$:IB;GZDY%+&AI7(
MKLGMF(*]0VB]XI9J(K/]J_>&36DQH_,!X18?AK(%,S"D"#R)+D419P) .32
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M<-QY@,&,E9<W3@P2 IJH_A#TLG/^LO<)E*F0FBCTM8J\YEJG4%/WEU/$FHI
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M6"#5#1*-R?[Q  3P77X>O95S8#OZ.V<DQ^!>>%4YH8N]G#"]EE<1W<C3DBL
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MI.KSZ+7&PY[X]Y,#N_LJM#7^<C.=X54, L(Z]O@<FJV-;B38\C9U9='+% %
MF"F)0S^-AB5V>CO)56IO=Q6+71B,U.8\JZR"7(Q>0FRWW 36JH:_Q7[ZBW;1
MQ05[4YPD2II7R0UC1/,%VZUU##B;)L)P(3@Q?O.*C1O6\>^ K]8IJQL-BTN?
MIG3F;.E&!GQE&./0!GKG$@>YV"LU&TZ-."1GK72+)D. I!$(9HRV5.XQNE=8
M0J-#CGZ9-QYQ_+/O +V&T/U(E(J*.LP:N9*2*H'6[WZ9IU6-U2%.90T#UDV;
M>+._N>,-6Q*9R+4^#^%]B/3^"+!K$?QRS$_!U'? )//'$&G.^-;TTG;=>,_,
MNC(T)#-OZ=54@*'^Q%I[S$JS_+8:_48JYVWZ/POPJ13_ZX\\NHZ3,OK=]E)T
MY7;YBE T,33.Y=BTY.'T54A=D\@T_.<0&)R%Z9_SQR3 I& +B\AI?@ P-(>E
MKR-)DPON-LG][U>>;^U1YZ6K$7$V'I+Z@MU-.6UQBQ.A:74X1>[S=<"1[@MN
MJ)VM6@N+GEX]@:O+!8[N&::S%:_6>N:U4L;+1"FP7"T!WKRH@31(0=RQ3S<C
M\'[N+@9A[HSA1D[X@AD$+YC'1K(IW^WO348B%"+9A]J1M^?K?RVEFC$XJ%%W
M]=H>?DO?^@B_'N09;F84&2WR@%M)TXG$7-WP^<:!T9H%Z#\\#9JGS.#3^W4X
M[6NJWB;2D1",)>>I_H+.W-NX6J$S97(E&>FVSZA E7*X:FNBNW_[4!JHC 9F
M4Z2EF"X+-(1*=) ED0!VZ36^-%V-8RI@^*7,!^E:X_O0J25+F,: 7*,!NP>E
MI"CC2EEN#N/>S*2CJ1GS$_M& IOU1&R*T<*0'C"='L$1S/@QA!.P9[=>,'^(
M+3Y0/J@S>_;TP-9[J\R O5DMW?SUDX,[.'92_)/ QI!(+Q7U)ET =VS&K9W+
M!(*M4]D16YA.]O[JZG-(0#,R$GNY5;'5*19 CH=57X KKEG12##'MVQ+:L^?
M>JUY87]W:0DLI'#^A4X)9(W.T -0G>7ACST=CH ?U'ET4+BZK1,I"+N-UMSM
M2,TH@.&\I&.YA2E#+,\69V:5C5F?H/=8%;Z='2_-T?IU7TQ+YTD!^WIR>^9)
M3.>>2U)?CWF,;X93/V)?YL!DEFZ:-?*ZQ 019:,;TF1\Q$+J:KB68F!USI&<
M7.I0T?C7>^2S]>$PABJTD^K/V>6[AS \_R<R!KO9/P%+,NRY+7G(E@]):BV&
MA?>D[MTCR";<C(5-"<[VN@GTJM)1P:KB=G?\\'1K^'?LI#FJ5\_K8DZ,)9CZ
MZ_GZ%2ID$AG<NPGD*BAC_2@,P:=W ^H!GPZT<Q1K?J-.(FE'Z+<MI CS+ K3
MZM)*'M^%5<M^DS[19)2<W+S ;EH8">;-UK='#P]5O]P;9I02EG ?.4BRLR=<
MM\(=C':,9L ZI/TV.C/_P>8KA%>3H9H4.QH+CM"<&W89;PTX1=RLN:D\1V,^
M%0:HO]!_W5%YQB JS9Y_J5LX;?S$K)YR+H^^K#^(J5+;I"2?'W_$7HM2S@[-
MUV_[S#K4=MG=E>ZGVSJ=9V"_*.=]Z+H8LT\_?/AW<UGF[E5E("Q& _L,HFH+
MX7-O8WMU"4?=H9HT(Z.H_N&]4).)0@*KQ]L)6O)A/^VA_.YO7ST#"_A;(B:8
MD-RHY@*TL@'\FMV"%<+3/Q40SQ1P0+AQ2#!6R*Y&JQA!V;UUP6I!=S*%0&*>
M47%EL9Y!\4"\6"P.:#NT1\%]P).X9;:EM],)%B\<KQ?E2]]WZ>A#>4MDF=2_
M0WKK&]KK:YLK^C+60&NZ">B+VACI74GDJJA"-!%L:->I*O_KF ]UL?@.^$6L
MSXG?4(J:S0Z?9*,<@&8@45>Y*TM#TQ_PQS?E KGU[__483!%X3^I_>;]#ABM
MO*JYZDIEAC;TOM9')O6<&@(M)ZC*=;;QH:DR7Y5MU8I=-J28Z(1;F*HJ[N9@
MQN#E#L#XO7@.P/[[@UT6I8ZL(TD'<1X9.-=$4]#WWX_T\IQ4"VEVVCG\8GVN
M8_=1TY8T%M9DZUN*BB(=6Y(P,,K;SS>33K.=KP_2"^<=0J,+-41GX<&Z/G1<
M#[$F7LTW>")8G.XXY78.7&4&0^44*.36N@'JS2=!"@+- A>6*3ZEY6_?CLAR
MO\R-S:R_&AJ(*OMB'/%(JS;LBIZ5\6J"!-P<7(JU@7Y](\1*#5;\S<@YAW5#
M%W*E!B5_M34BLDG97(NP_=#5IEV)4!Y&K*E!A##B*8M5-S%4] U7DHWYN38Q
M%C]LWGJF-*P\\)D3V=,JP/9*WWU=L'SZUM?QV4UT9X,BC[Z">@-%MKY?QAZ0
MO.Q2IAI:)C#B2/V^MFOA]:@22?C$/K)((+WZNV@]^$5>@AS@H9+YR>2W=SJC
M/8_M[^_74)4EAN;Q(AN+,H'5Q6A^%Z5Y4&$F=,X23GNM+^T.A1M<!27 % T7
MB[H<Q4D\4_>HX;A!03SC/'4-J,2LL@VTEJOF!09_V<=$E52%F?F*YJ5F^,3-
M#6F]>^4UW6&KLPE1U.6H[[3R,-;(3R=:;9R1(,[H_'1H+J'/*6^/*&.W:P6#
MN0G2$N ?73&*I_S-3^1PR=]BCI7EM#=TA-%4,TV($- E#+K20S<F7=I1F>5@
MQC>-GU:,*^HG3(_F%8#TW!&^$LE^XRHH7[L1UD/I[SPB@04R+;4M-<WAI>BQ
MX;*PT=I/UBVD-]"G.^!E:^MB;>UEN1*_*#::($8N^9]S?X*T=Y.D9WZ677%
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MRO2B>S:\SEOV61,^S98P(?TNESE*#?'DG6JBEO6M4LU) C:H:"J*6Z%84I;
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MG$=[.T856ME%J%4[<HO29*^-4 J/GB-M>Q_6XV])6)M3N":'8L4J=SWI@'S
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M3DQH  !WVR;MY=\I6=LL=Q?Q@=%9BJQDCXJJ6<<NO:HZ8!OM,\J01%OW8=J
M%A6I[*.)IU[9SW6/+FBW4%S/&L#O0<@/$]MAM[YY6\\^37M/4XA/1/)J$<BN
MU3P4"OXYYJ?1)(-3C*U*V3F4<!^Q&>>P8=B,YIJ5DZV<DK+RF@1'F!W]1H&#
M(QV\.2D_+(OI^H&YUK280X6/U%MRH-0@ =*'WH=_GAEJP/UBWB;X_3,D;$=
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MY-7#3071?S&\IR2*7$NH6DDB#9N2/&@!';[.?89$"H!6H%*?(BO\<RKUQKC
MSC S#$&&!7'7 S=Z#I@=AB# @XD?# [# KK@=Q@=AB##KVSL_P#SCIKY\N_G
M)Y*G:3A!J=TVE2K6@?Z]&T$:G_GJZ'Z,^PV<6_YR*\P?X9_)#\RM3#^F\FBS
M:?&W0A]1*V2D>X-QMGP8 QX&*BF*K^O%!BH&PQ91BHZTQ8;XNN+@8L@]L$+M
MBZC[L$H,$(-L$J/#!2 ;8*08*0#PP2'$(]5ARXTV\<^9/YF">#\P/S&61RK0
M1$0UW'"0J!Q[#>3.'ZW&TMM%&R$O+(J@#J:CI\\G$$"VFG6$"BH2- _#N><8
MY'VY+O@71D<:\_*0*(;J.($U)4N[=/H.1[SJ)-0\V2HC!Q<>I( QIS#,5ZD=
M04^[.V?D[:V2SRV]I,9[.#U+E'CKZ:43XU'(#>II6E-]JY[&_+Y&CU"-TF6W
ME8*NS!I.1H*+44KX;9[E\NJL%M"*5:BU8FI;M4L:D[]3W.3U[B1(Q-"Q:-/@
M=E) !;M_8/IQ>TO6B:G%GC)W[)7KO3?YX<V\D4LBRQM$CQ[+P!.VYI\)%?NP
M\AL7G?U"T3LU/C:*0-_JT#KAO!I B&[0A.I6*-@:'P^(CYX;6NEVVQ,@Y'9D
M#<3OTZT/W897-O9VD190BSA1\! J2=^H\ *?.N0+6[B-X)(W.ZE@G$"JCMN.
MOOG,9/@ED(4QE_;K4C)IH-Q(8GI\<;[! OAUWH3FUJ1OJK L3R/$ T '+;8#
M]6<^T^+U+YJC93\5-S1>HSM>BW;QHOUBDE>)^+<#IRJNWM]U,DBO;R2 P<;@
MN.#<@5J "0"!0$MM0U[=L3DTFSN>!-N"&(0<6!5MJ4(!%#X"M/OP/-HQ0JZ.
MB$;*@7<TV--]_P"&$=T2R Q<@HJ&^,$>[#P'89$]1B4+5VDD5MP69J;CP&12
M\("@245 H)4;TKX&A R*7]S&H84JA)+5W)IL:[DU Z^(SA'YC()=/N E"\)$
MB+7MV&W4]J_3GSI_/2YDDTRWD@YPW37,<:\2"69JE01[TWR$>4?J]UI7EVT#
M56ZOC:MQ!^"= SJU34T#=_Y3DFM51/*^HQ(6=;:\WV)K25):4^0.0/SHG^BP
MW98K*DL5W0>,KUK^.2?R);->?G!Y)@3_ (^+JW>C"O5D9A^O/KT!4$C?XC]U
M=L<J'COB$@ZX$8=JXBPP.XZX&<8&8'$&&!67$2OMB## [CK[8%88'8?CB#"N
M"--OY])U/3M5MMKG3+J*[BWI\<+JZ[_-<^YWZ7LOT+^G^9_1WU+](<Z;^AZ?
MJUI7^7WSR!_SG7KOZ-_)[3M(1OWGF/S!:P.M:?N;>*>X8T[T>./[\^0@_P Z
M8\=L<N+#%5VH,67;%1BBC%T&"%&"!7%E_'%EP2@\<%(/;!"C!" 8*4':F#$
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M,95&!H1T)IG'-5A,3S#N?LDUV)Z4PDLM0UK3$DO[(M)Z-?W8W) W-,GWE/\
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MPJ_$O1UIML>XZ?3G1]'\DZ=N8H]G-=D^-_ .:CI7H>OAAM??E]9R2L?JRNP
M8$D J0-]AWIUS@WYF6GGKR[!%;>2O*5QYBG=F"B$HD<"_P S/)M4TH *D^&>
M!_/WF#\Z(;B6*?RY<6ERJGDCDR%?\E%5QR_SID+\GW/G7S'%J[7=TR7EDR!8
MO16(H65JAE*\NH[Y[,LOR2UJ\\N:#YA\N:BRR7XMWF0N3\,RH6<"NVY/3N*'
M)Q=_D5YXT^RT:\L=3EF@U2\,$I+5DB *AGXBG\P(!R4P_D[Y]"P1-YCDG12.
M"M 25I6FQD('7MC="_)OSIK$-X;[5KBR2QNY[94BC!YF!N#L.0(&XV%,-/\
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M2 58@GBM***5KR(W/\,X#<>8KJ>1Y99 >(-*DUW W8^.V134];N'"I&5YN:
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M^"%."4."T^>#(S@R.N#$-/IP;&>F"T^X8-CZ#'W%Y;6%M/>7DRP6MLA>61R
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MUQ=.N"4[=\%+N,$IX8+3!:'[\&)@R/Z<&1GIBLES!;0R3W,R6]O$O)Y)#15
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MHQ3P7,$DM:-6&.H)-/AK6N^$VC7T6J^6O+6N22ZGK$\ GMY+K3)3'<0QV\W
M,P!D62-CL"R\2-N6V!Y[&]UK4I[K39=-\S0QD.DME*FBZU#6@,8A1H^9XGL&
MY>^'&B75Q:V5S9V&O:A^@]-D]75/+OF",W<]@35A-1"K&*IJQ%'7[7$BN2/R
M;?"P\S-=V%C%HOF6Y 9D)6XTO5K:4G@(I_A*-4;-QI^RX[YT/3M)5[DWUQH&
MI:,^E3%E@*1B:(1,6"B/U'#&-F;A(C;*>%"FV!VUNZEOWCM_-]UHT+Q$2W<<
M"F6=#3T9+JW,H*HM>+2)TH*E0<?=/8B\_P ,?F#8!;V"2--.U:2XF*W"S_%Q
MM[\",(6K3TI>IV#'8XC:Z1Y@LKR\B\G>8(+FYMP1/IE\\D%\T +A8;FVN 4-
M*_!)&8Z^).^$]YI$]THU7]!R0Q1J1->Z7>027#4&\@BB*S-7B>6PIV^+":]A
M5H8_TPI\Q:!?Q!8KN% URUNU*,"HX3  ,2P FB+';<G"*;R]JOD>;],^6]>G
MN/)\SM]8TZ.^>SN(C0JYK\<;,O533M0C.B7'Y@>3;3RMHVBZY^8NB:]=>8;'
MZQI-G+=);:M"\?+FFH-+Z<,#J5^ LX+FG$&H.=Z_+:ZO_,GD:374G36+'1+N
M/3M0N8W1Y+=YU,EK),%)HDR@A7Z<PR=0*F]\K*IFI3L0VX/@<+X712?W15#W
M5B=SUPP#?9*\J,=R!3]7CAC#,RPEJ L-B1_&F!IKM:$1\OAV\ #XGZ<C4MT/
M6>C@5!!'4$FFU?EA1<R@\7X@N3N7[#:F-2;ES4 E>N^WT^^!;A:#DQY;T(4'
MMW)R(:I* ]5%#\^A'>N0I(Q<WR/Q,K,Q&_MUR5WU@BP +N2HY ]J]AG)/S!L
MI+30)K<"L>H*87%*=PPK].>3K?39+9X+M%/&R9+:Y7J%1Z^D_P N55)\<C/F
M21]*LO)WYAZ?&6N[.^CMI+CE5(+[2IDFB6@[NJ@BN>S?^<GOS3T?\UOS/T>_
MTE1I=K8V=]YJBMG*@B?79H;V55H#5BZ-L>N-U P7,GEV* "22Z6+91R'%RS;
M>- :GYY [N2XD>^C@/K-6YAF(441>:JH#>%<,! ;:>Z$0;U)%A+3 ABL905%
M1T%:X6),UW%I^EH?0MS?.5;K&_$D@^]"*X;:=9W+:3J.KR74BA;]EF56XAT/
MP%V/L!E:I8VCRVUI8"*Y1HA*W*AC:*E A7L37(CJ'K!(TTCE=W5DC+]7) GC
M@;[40KL\?AX9*_+GF#SCY3OM.N?*&L2Q6E]")8X)FK"MPN[VLH.P+=L]->5_
M^<F=#NHXK;SE82Z'?>H;>25%+1"5=BK#JISOVDZ]H_F&S2_T748-1M7_ &X6
M#4]B.H.#6.(L1@1V&^!'; CG? [G[\"N<"2'KX8&9@<-?+'EZ^\V^9-$\LZ8
MI:^UR]ALXCQ+!/58*9& _9059CX Y]Q-#T>R\O:-I.@Z;'Z6GZ-9PV5LIW(B
M@18TJ>YHNYPTS9LV;/BI_P YB_EE_@#\V[W6+*#TM!\_!]9M2  J718"^B%*
M;B5A)TV$@&>401BRG%E.+*<64XN" *G:F ;K5[>TD$7*-IB!0,X507;B@-.3
M58]-M\AVO:Y*]P;*Y34-,NUB;DB1R\&A-?WL<PX1&I!_:KFT?RW<>9Y96GYZ
M@-*0"6\UZ^6U2*+DI8Q_5H:L.-6"HS#W&= D\I>6=%EU70] O)WU.&PMYS=&
M'E/(D4Q$EK!9PORCF1"LG*.3U._Q"N&&JZA:^:%TV[L-3@UO6-'CMKWZO<6*
M07,CQDI%+!)&JNM&/%R"P!V=1\5.9Z[<Z+KGEN'78;5[SRYJOF2UN]7L;A&M
MVM[X2<99HVB,94\G"S<3Q>IZ-N8'K46F:;^87GCR[?W]TEEK>ERQV>L2(9?J
M]I=*447:TY<('4QN]:A5KOA@VCF/1?*^JWD%U8ZK^7"3:3YHL;.3A<65M=,K
M6^K6].221*W$EA5&4@]*G)%((M1EUK1)=/M9O,;Z?ZTYMY%@LO,%@[5@U"S5
M5X6UY"4!+*U.8H:JW)>>ZI>W5_Y*\T:XBGZYZ]I%=ZDD*NEQ-9W,01KV&A:V
MNAW>I62A!-<2M(=,U/SKHD5O&NG2:UH46K3FV_=?5M7,+R+):A5H!*T:$I0*
M:L.F^3;2=>TZ;2_+GYBBW2>$^IY:\[Z>%51Z=P988I"H-0B2,$J>B,%[#(GY
M0TJY\F6_GGRG92^F^B7EIJ>B:E9W!$C6%P[("@56)$7V9%.W('VJ;7=KJ&JH
M]P39^;-1(262":**"^<2,P,EI< @3!0M#Q?D/"NV%ES)?'S'HJZ'>W]OKEO&
M;>/2O,MI]5EF$FWU:&>5^,JD?"%)\0*<MY&D>AZ99VU]:6\5QIDTXN4T#5PU
MO);7*NJ7-M8W;$B@DJCQN4=5(Y _:R8^7]8=[DK;QZKI@/VK#U0C31;$1P7,
MYDYE2U.(<L1]FO3):8[K56&B:@T_F'38Y41IO3-KK6E/6B.&=.84\N/(54]&
MH,)=6U'5O+PG\OW=S'YNL+0-;7.D"/A<&VX EY]/G56?C7=K>7X>H6E "V&3
M2]6LXK#3=?U%H+-?2L.</Z8^H+,I1HH=0AX7T*@&OI3+MTX]\E>G^4]7T?T;
M^+5+6#7X(Q%<S/.DD-V86!#I<Q,2 RBO%QSC:HJ>A;J BL[C]-1VEYIEAJTJ
MF[2U@9['ZRXJ9.=O(8C6F[HU:^^076$NIK^V\TZ?::=$]Q.]I>36?_'.NC+T
MBO+2X >UG<?"LC!HV- S+49 O-_Y=SI=7'F#1="&H:7& ]WI5W&IELYI%_TF
M,6TGQ/&"*]-@1VH<Y3IUZWEIOTEY/FO?*,[3<C<Z7-)+;L1NMM-;%T!0L*@-
MN#TKGOW\A//NI?F]IT^D16WU_P ]Z2Q^M:5"JQS75OQ!2YLT=U,IZAXE7FO6
MA%:=*@BL]4M[RYTZ&9+BPU&YL99P33U+8I')&(R!3A*'4D[U%.V/ABDV$R$.
MA-0*['I6G\*8:-"[*&'!7 J2"%_V\(KJ.>A7[(K4@&O(@_/MD9NB8)6=R:MU
M]AVK[X">5GA')2$ -/"A.WZNF)IZSGU#6@7[6^W6@I@B1GDA^)B@7X1RZ^_A
MD;OK*20N3%\ 5$"KOP(-VVKU[#Y86Z/I?JW+_!Q*_9/L3L1\\E%UI^W+AR$3
M#Z2,YU^8.F-J.B7(5 C0.LA/=:'M7. Z/J$'DO6_TI?>4H/-^@:/++=:W935
M07NBWJ+%?6[\:\ C?O8Y%JR/0TI7#'R1Y>_*V?5_/OY5ZSK*:A^5OYS:>Q\G
M>:;E2DWEKS#$PDTN?4(J'=7+07%#0J>8^'.-ZMI5UHOG/2--U:.,Z@_EZVT6
MYDC0O6\TFXD@=T+4(# "GBN>@_+][YAN?*1NKFSCM?JEU]3ME=!S"+6(NI(!
MH"-OOSG=VKVFH:[ID0J4=%+C[()8<POCTPQDN;B87%II-I/<0FRAM)[CAQ_>
M<B5HO>HVPW].&WO[,!DCM+.T::22G-?7("N%[&AVV[X6V#_[@K O$Z.-31VA
M/Q>JI)8.5\ 3MFALQ;WTDD<_J!KN2"7B=B'Y$4IX$8$.E1W%K?ZB8GM;N65X
M+6;H4$7@1\M\RDZ)96VJ:S TMEJ-+74K2%J$[!HKR/P8'!#I97BS73WUO=1
M+&MU,G$R$?96\4;J]-A(, M=>8_)EQ'KGE/6&T^=1ZUQ8H_+8?M,E:.O^4,]
M,?E__P Y$:7K+6>D>;1%I^ISHO&\A-;:0G;X]AQ.>D%ECGB2:*19H91R1T(*
ML#W!&!W)\<!N:?+ S'\<#LV!G(IX8#<]<"N>N>UO^<,_(!U'7]:_,2^@K::
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M%*%HW%G,>U70]1M9?,/D-H)9X=&TN^\R^6;VO*:PFTU8I62U(+<H9@P^ &J
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M2".WM':I^I7 <N.(V1:$$#J<9!9I;VEL^HQ?5K+2M0FM+Q9OAWD!>(NM.IH
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MGA9.*[4>'S(#M._L* =9+MIL6SMHM7WP)VZP^);Y\('J/66Q?R?;*GJ.#Y^
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M<K#CSO<UZ]E:F+^;675T#2U(&TD=R=)L&W$?QNJ'AHHNUV3^%J,8*U-L/.=
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M ]_FE3XJJJ4^%5@Z&C^Y]P]_RB *JHM7K7N1/.MJV)MDHG4;ZS7VM(<N0!A
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MU#[;;0]"]JU"%-J2ON)IQ<8K_O[7-(ZN#5U9/\#KB/LD_1_VFL4AT<8&HBL
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MME/$:V$C0T.D_:/M8&IH-AH_PJ8<9>_%)+UX:(I'33,LS%)NYP<=@$._QJH
MT7:V[)[./-;/,B<]NDOHM_VD#VF]S R:#C,.36RD8?GVO )Z-TF]7=W,[8!I
MZ8ZU;@#K\\8JP$8+C'!RI(M6[#O8?!('\UHQC2I 9L 7JDN8*3U9IIL6)P7T
M/P<8OJ@/GEJ)&)SU;SZ,WW&L^Q#I_\J;'G!V=FQ*$O3GT,7Y%FMVJW: KJEV
MXE'&Y!Y:6M]1^(@2] C'4Y9I*\E/P3;+1/Z0AE7M3<YU#%2*^[4GIP5&]C $
MM>;8#H$;=J;@M6=Z0Y;]N#MSGN1+S@ME&3!J)>V09WN2(73<A"S0,@]F:[_#
MP!<)M?A)GFA1?1K[=5W04T+#QT4AY_T5U+/3&*',=QQ<B4!#D^5'CXRMBJX^
M**5NY_K:5&?- @T[">9AA6,52NK/T^:,+!5>ER$L6)G2V[E\&_M8!3EPM052
M!I*SA/L#+J[^-;-[;(;,/8FIE82BBT^RQ(FP-))A->N U:[?\5JB4@-6VNT=
MJ&.ZY&;1;7M(\Y0LV>S8S2<LX:9P1NYQ[,1.U<G3!T;L&JR7)LNS2:.,Y>$N
MC4>]#O52K7*B?F$;U;'[;$E)OD\RX,)>7.>WKHN^.W@GZ+4M]N\U'/I7 6LS
MI/5!!A(G&_G5'%I:?1U\!DS\=W9SB+W5+NZVPK^Y5D.VK9,H]7QXQLT^G5T[
MG]P I\]M^_RMFXH!Y+R/7J067=(?FJEO\P*'\HZE^RA9YR(UGW?)YS;O]<0Y
MYRX&*DHJQ40)8M3TAQ=4N#+I'JA3F\)Q?O[E-I"H_0LE[4EE7T-YKG=<*=XU
MF3W:7C9'_)V9&;^$]&VG^ ?N/;V>18P-E6-Z63X:R.8K(NAD'FRKQ;CW=>10
MSF4I-,1&ZHAR4'=XP#$2Y=],X@9=%E_@_'*C^:^^.05M.> TUM"=8IC.)LL
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MQO,R)G]!X"N<F:!![KVD^)_8_:<WDT)+F5GF+[:O;R-K/(A$(MLVVK?B'^G
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M$EVP3P)K(JB$B:^<9''O\[X'\V=;[3Q9Q?QFR1M[DSHJ1/\95^H@_ E':6P
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M@PI,]7PJP:/X#K0'W!BP$Y3PN-C2R:,378X9UOY&GFWV#!)WJLPGKG.11-J
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M!AOPW@^8^?=V))C_ /#? 8\ !XL( T!"1D%%PP+ PL#!P<+#(B+!_7O NL#
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M$_[*=[H=:M.W4J'O EG_T][LOO?06.!J^M246 0M*E3BG)7M 7V;PK<P<0?
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M($]5Z*2!K\K>AGT)>T;4#F&T:9J$(W:#V2V;N,06E@%)'XCD$4B5:NFN 6C
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M #8Q8V];XW[5EV0ENX*HW>6?,)]*)4'MT44_:",?@Q,D*HQFA'%5]"%(.E@
M,@(6U'Y1'I+4I]!/I:C>Z:JW?SOJBOR)L/8=&4#"Q?-TC:A>!$AA;/7A6^6:
M$4*4\GZUK5219JRX-\HRJR4#(L')RNKJ:B]2C@7G=-ZN0T,<.(<HKKL7=7Y9
M;5&+QJN?/@85A'=C@QFD(%7./N?;P3@A98E,N)LI,,K>IR!ODS!ATS(Q:JA'
MJ<3Q5&Q7(\4LUIBT^TJ],X92A+($UQ!QY#9)=&^952U :![*1E@8WU<C/36G
M/%A4AK2"8"WE?2K_&=,5D\R@S!Z/!)9)8:&>U#N:M6W+W+G\^1&7NWA"64*J
MOX%4Q#Z; +GYN^/!MZ? ((_C+L4"7P3.ZC7J,G"!$6*?L_OA-8&4"Q:+N+6S
M-<P<P)*1:WBO,#MG@3"E1@VRZI^TZ7>%1DV?8-SWQSS7> G*8^NO3HA[34*B
MF.,QEF6##2RE[*2EN"?^_O7:(#.]&%RJM29UQ#)??W>3/\6F.MB&70-8_/9E
MU[VQU._I\YT6&9/TG):<B_3C@JS,=Q=A3!0>/*8F_+]4Y+'VQ\ 07L$JY\:C
MZ<,W(XE686L_XAW0>.PE#NG64A3J+TCE0P?3)?9B)YWL1X-7)ZCB'W-8F<L!
M (3J%S6.@((DG>IB4YAI]2JA#BH,& #TJRU#\/5UM$\L-SA(K\RJ.*SS)@I+
M<R*=^\!=T-^37& =)+G=/ GM5+LFC<UH;REX3%0$-LQ#DXT:2L%/,L3DN(YJ
MS]%Q__<]W8?[?YI$]S':]_RQ)*!D^;?Y-'\RL50]JC]^LR1TI\"^6*6W8QYW
M/VU^C#1FJ;9%X(!![,9S>\R)CZQ3X-*,SY-LJ<@3%![0]24M#\Y6'Q,+9FW[
MT4&XPSL:F]"TR9:<.'C.]>(X:'HI7G_P0^28YX-1?_'MT0=&#)U.4D=A1Y_3
M6$W<5:C'$(>W2MU4L_XDMJIBPVEF^"29PTQ%O9WU;OVI@4\$<V7^G^3.LK+?
M^4(J1R]^C!\'DXZL-@4]'SW&[T#'Z0E>4C)R/*R5)<U=;59FR9[Y9HP_[4^R
MTU4T?UA8T,IL(?7VS\K^E)JUF'O9W-MV@NA9X]19)6O:"S"E$:G^/I)6,//Q
M[&5#""=LOM"X*9^<%OJE8U% EP8\'\<PJ\^VO]:KL233;FQ!V&N:#>(P,)!W
M_R/DWL-5P'Y-C*U-NA=AOW/5\;/B<J!"IH+S&%TD+80LI#]4XUF27J.!\P$B
M JSHV6KMO";/JDP>8?EB6WE*1J#9T=XW:Q1L9*F".F6+)/M=2>*6I4#7^;.7
MN$KA#K:!<+7RA]N-\.Z'S /GKT&Z/FC>-75:V_ZZ(;LM$%+W4CA:(E>1!=PX
M]F9W!)G=YHVL>YJ=Z^'3PR-!XS <@:_E!+ 9^+)!$M9<AS]8H52AF>Q)Y@6P
M'DBQ(C<[!6.LTT-NSO/:!(PA='E4P6>_<XKU@D(PBD5J2P:&@W6FIE3]KM1Q
M0:U-96]Y%A;* 1;UN$4"C4-/9E@JRP4Z"VW<#8*97\.$0W4ZTV&]5%>-;&[^
M/#0_)9")UP765Q'9G4?)<4Z+FL5\:H:9]_LV@8)7X%>YJ8CRW5TSC&#9BXQV
M\6_Q39$,TFY,["][XULNE>IC,5G/,R?).,Q06OI@9UZU>Q;9AS\0B]C37+7-
MY!OX![NIYZWQT8D5&2PX90:Q\_\+/D#!OU.WT8QY.14A?BJ6(7M7N *$^_WX
M*MR3R#"IKUZ@[5K0T[?ABKE0I4Q%02&!Z 'MW)%/'"R1):R/(W-* U6A#+N0
M?GM]XPHG177FA4!*.HK4#M52!N*=1A-,TD=1(.5#\--Z5WVIVPIN9UC3CLRL
MQ)'TUZ87O(3O4N:DA32H(V%:UPBOW:9U0J8Y22W)=@:;A3D&N2Y:=)DX%W)B
M0] RDCD"*$ ^.1W50MQIQ@YA3;W435!J23ML#OWR%:@#Z #1D\?WC @ &@J0
M?NSQ/9Z/=?\ *PM8T[3Y+BSOA=RPVC02A24>3UHBA?I_><3V'VJ4SUE!K'UF
M]M+.Z(M[R\CB2YAHIYR,!%*K1@_ R2QAE.VZ'H6(+U)"(YH/4V .V]*GKX8U
MT<[T^[^PXPJ=OEW&4:J-J;YN1K3&L/'**BFP(&) 'KX9G (_AB8'':E<3:@V
M[=L2!&YKN,]I_P#.*GG7_CL>0[V>M*ZGIH8_);B-?^%8#_6/CGM#-FS9LYC^
M<GGM/RW_ "U\U>; X6]L[0PZ>#ORO;DB&WV[@.X8_P"2#GPHDN))W>261Y99
M6,CNY+,S-NQ).Y))[XHC@'<;[]<5H2>5=ATKF+U((.*AB*5-?#%?4!('?OX9
M9DX\3UW^_!"RUHXW_MQ_+XN70C^.#HW-*D$=L70FG7!D9^*K'8=JX-C?J0U"
M.N^#(V+G<T.#$;H.O;%"QXD(X1^S4Y4/C3:OWXQKL0 ?65$)-:2*>41(%:DC
MXA](^G,UQ!<P\3<10>J"B,[J8>9'PGGR"FG@2,\P_GQKWK:-:68G>*TUJZ=;
M>SCC4ZC?N$8<K=$Y%+<%N*/1 W(%0P^+/(.MII_DG3ETBVLX[G7+Y?5CL$F"
MLUY(#234)5<!!"#\,()9J_$(E-<,O)_DV36M<U.^U[5X)8(;BSBNY5N(7G?T
M8JRJJJS+&#Z?#DU @Y4%  ?2/ECS:VLV^DW*1&U?S-YDTWR_I&DJPC:*P:X+
MW7Q[FKV]F$9R:_'U\>U2%-,\Q?EI;PRS'5(-1O9;N15K&8!=/<WSHIXC]Y)9
MQPI4 '?_ "J0_P CW>HWNI:Q=7L:F>:TT^98S7BKF-(V*KVWA<D=J@=1G4HK
MLPWU@"ZTD%LTJ'["NY)5F/:I;[ZYT^TMG6Y?XN9CD$KMU+"0'X-C]W@,E,5P
MB3V<41)>0T7C2N]?&A%*9,_)UIZ>M:M/Q6ETD;R $T95J&-.I.U/&FV&!>._
MFNIDC)1G1E8#H&);8]J=,'%WAIZ:_'"]/\EN7V>_A[9.?+5S$9/5+U,GQ<N1
M*U!JPKX4%,ZQ&6]%9%(*T  --P*[^%=\1E8J!04%34KU \=_GC9)"$^$\A(P
M44&Y^D],%0LS%R>18_#0 T/&E/##>T=PE*M*ZFGPBJJ2-SU/Z\$12"-%]>54
M85H:BBCL!2M*UQS26ZAG44*MZ:J W;Q/$^-3C0 6Y++&LCL  S&K[4W#;8*
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MO&.A)].K!U)\:@^]<\+_ /.1,JWFA)KXLI!JNJZA'$L<]O*'@L8D1;99%8!
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M\\FF3AWC220E?C5+@ ,2WPK_ )>$.DQB?3'OPKW5GJTMG:W<44E;BS= YCE
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M+JW]-#*8FN?6BD@F 4\D=D# 'D!3;HN=!LED%C;?6 $=8E*\9/6205*@QR
M,O$ ^U:=<<0#6AWRAVJ,3>2NU-NF-J..WW8F^XZ#$N)%=Q0YCX@]L::D=*C&
M!2/BKL/PQ)_O/?*1>0J17'%01[]AC*?2.QSUY_SB9KA@UGS5Y:D?X;^TBU&%
M3L ULYBD ]R)U/\ L<]QX'N[J"QM;F]NI!#;6<3SS2-T6.-2S,?D!GYR?,FO
M7'F3S'KWF*Y%+OS!J5UJ4U2"?4NYGF:OTOA'Z@K3K7-S)(VW\<5Y"H [==\4
M!X]#T.+\JJ.NW;'U 6GVJY?("F]![_=BX*]!WQP<=]NE3TP2C5 [@]\&1-XF
MM/\ /N,%(U2"-^F^#8_BI38#!\4G0>'3WP>C4/N>WSP=%(RTH":G#-&'$46A
M/?!L;DCL<$0QM)(J(I>1CLJ[DTQVL>5M4U&UFMFBCB6;BA60_:C&[H*5%6!I
M7/G%^8__ #CW^9.@S1W,&FQ^8-)L+[ZZMG9RO# P/*(*0W U,)"T!J2NS#EO
MQRUU2[TG0-4T:^;4+>ZT6)IYH?3-K=P65YP6 HM%].2)X(RH[';H3B\GY@ZM
M=S:1J%K)+INN>7(4:5(OCCO[1?[JZX$E7*Q*L<J4*NE'4!E;(I/YJ\T:=?70
MTC5I--TS48HY?0CXRI)&Y]1:^H&H58$;="#2F=#L?^<@?S-M(+>"34K*\2V5
M51IK0!J( M&*.E:@4-1O\\GVG?\ .4WF>'ZM!=:-INH71M8;J9U-Q;K$S-(B
MQQCU9>5%4$L>YZ4&_1M*_P"<JYD7_3?)22H34^C?D&HWK\=NWZ\DUK_SE9Y=
M-K]4O/)>IQT.TL-S;R'B=Z'EPZ;4]L-T_P"<I/R^N+-+:]T_7+()(&J88)*
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M3LV<_P!<_-3\A_-'J6VK>5;K1+B8<?3N;> ,>U2.<;;'P&<>U?REY-GNC?\
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M!(%:@$'MG$/.,5[<6FH^K<R+=V\/U>2VEC26J2#@[<B68@U!-'(Z>V0?1O\
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M+U C\R!( *5(-*?3GSY_YS4\B'S%+Y#\_604R:#+=:)J<3,R"2PU?T@">/\
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M44-;:66O9W]E"V#'Y9)_^<RX-5\\:7#JI#P:-HUV18V6_!2>49F8;U<[@$]
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MIRBO'+&%?>AY#J?EVSCK0&-5A]1SZ,?$,U"S*=PQ/TTP(P^KE9G YFA8?$0
MQI\.U.PZ],UU4F$@$O&P=2#U -  ._7.U>6ICJ'Z)L.!%G;%[B=D'% ]*4)V
MK0>/?;)SK^J"_D&D:<"MCQ)9@3R?BP!! IM78YT?RY(/3]*@'%.0 _R/L\1O
M[FN3_P O/+]9CB#JZS-S1:4XT)ZDU.V=?L;"&%7,<91I@)'<="Q[#OMTPV@5
M!SJ %-*@]:G;Z3BRQF,,X)A,9/%G(^(]@#]/MA3>3*BE^"$(>0)4F@!INM-S
M0TV-<(9K:6]FIZKOSH.'7X1T V]L,H=&M-/@2YOX50)\0(W%?HZUKXYSKS#Y
MQL8/KR:= K2K7]X6"@L :*U*]OHSF0O-4U<_6_2:I3[(^+BU>U:'?]62=+!(
M[-X9%;@5XD$4W45[]2:;9S&6)HM5)1216G)@352: D=J^.=4\KWL7UKZK=\B
MY)<'NB;UK[[TKG7( ;A(U9@B\*HI^S13L1[C(UYIDC>%9;=FDGC!?DHH" P%
M1OT.<=ORIDE%O'Z?"-R*=B?M#;H23D@TV-X!;W?][$/3!ILP9@ :[;\M_P <
MZA'/931M',JF1V1E4[+0$$%ZDTJW?V\<D]I]5D4L:4E5F*]V)Z!0HH30==\#
M7FF@LQ5N*1.>+$;CD.M/F!A!J=G$L@6;B/5<)$.1_O1OU^2Y#[C3GK*>0<2U
MYQLO2IV8$4\3G/-4T^[M-5M(+9P+"ZJ9P !1@*$DGV(('B, QVT=]YBTNPN8
MFDMHKE!(>%%>K'@0?HSNWDV3ZA/<Z9. %MI3%&>7Q<& *['MO3.<^?\ 6?T5
M!K>CPT2XU.]!8KL?26)023W\*YPIFWIB-34G\!B;MVI].-4]SMFJ#[9=1E=3
M0B@&)D"M*[XQRHJ .V)$[&G^9Q,[+_'$^M?'OB;(.@ZXB13;OFWIM]V)4]LD
M7E61(-3N9'#%6TC68Q3K633;M!UIW;?/ 2/7:OOCN8-%Y;>V-Y$=/OQP]M_'
M%N2@ =6ZXZO4^'ME5J>M/QQQ^$[;=*8JI! .^^+I2M2:]L%(X )Q97)WZ4P=
M"^X'WX81$,:> P="U2-Z^V&<3CX>5#X_TPRB'$X-C.VW7[\'1$TKX89QL0![
M^V#X7H#OT'?P&=L_*_SI'9Q?X8NKH6YN6>6U9CM(M3S5?$J2#]/MA!^?WY9Z
MMYMT:RATZY@%S=WD2PW''X8R#R)8@]@#L,C<OE3S-Y=\J"*SG^N6L<)CFD>,
M*\H0 .03RH*C)5^6'YB-Y@T.[TJ\D4:KI1"3J05/!J<' KN& ^(G>N1GS,JQ
MS3+S @#LX0[@ DDJ:]>X^6<6O8N5_:L)>5M*K+3W^*F_>H-,:5(O!!(CB((&
M .X8@?"N_A3 ^HPW$$8$3,(44<>.["0?$ .Y&P&="T+S#;:+Y0O+^>BW$[D)
M*0')3BM>  VXL3DI\K7W..TU#FYM[H<7#CXN]&93X@=<[IY=C0S3(M6$:5)#
M%F(=N5*T_P QG4M&L3;W%O);<8T:O)0>B$[<:]*"NV=CTYO5CH5,:1@%5:GC
M0 [FNV&D2A&/P*"6J-O';:NV^+SGU \:1UYJ?A&W(5I6G(?3A#/:,2J\>=#O
M4"H%0 0 M-B<;>7]OH]J74#ZR3P4UZ&HW!VVVV&<WU74)KU)+B[F81<2RJIH
MFV^Y%*U_7GGQKI=6UZY2V=I;*W=X@JL2LLA;G5B-S3H/GG8-%TU3;JZCFHX@
M#==Z@&E,/[RS#&2&,']V"@0&G:O4UJ=\YCJUL!+$D):*Y#,OIJ>0&U*LU/ 9
M,O+?EFX].6695]64@/0$OP.U%I3KG9;729V2*,1U.V["@%%ITVKU/;$=9TST
M()7F5>4<9C4Q@TX[=14^.],\[S6BK=7*J.2SR$"NQ2OQ E=M\DNDW@LXY--F
MC6='8E33X@XH16M2:4V\-\F\6GK=F.2S;:4@E!3D'I3IOU(.XP=!<S65S) T
M'IR1D,U2M&I\)V!/AL=A3#J*Z]>W,I5D=5X>GUJ$)6GTT%/G@"\3UA&&^,1.
MK+7<,:54G]61V^B8\D0<BR<6^=*"M:4SF]^EQ-*6*<)HCZB.U2K=>0[=:4PH
MCDE2^TJ[<>F/K,04C8 !UZ@>S=\[AI["/S!>"'C(TB0&52:&M6H1L>PS@OYL
MSB7S7(44*H@78=-RV_X9RTMN3C ^^X.-(!%2=L9Q'(=N^.I7V&,.Q]LU2:CN
M3WQ(D_3E5!J.^)M6FW;$P/H!QC$!M@<29]Z;UQ*N^YKF\=Z'$7IR KO7#?0I
M4CO9WD;B#I^HJ-OVFLYU4?>1G@,/6H7MEU.YZ[XHK=CUQP?J:;8[EW/^?SRC
M)W[XJ'!&_7?KX8J#MOX?Y],50GZ?X8LKDFA&*KRI3_,X+C 8=37!<1-/'?#&
M-A44.YIM3!\+>/ZL,8=C_D]JX812 UIL!@]"2-NM,,(6XT8FM?UX8PN:\CM_
MGUPQ2M ?O ZY+(/++^8O+[3:;>G3?,&B71N;&X1>7%R*T8; JW0COE6_G[S8
M\<>C>8K%[.^MIU,Q1N<<G$%><;$5 (-?'/0L-]:7NAZ1(X$MC/:&TE%"0LR'
MH>_Q#IMUSSYK7E_2/*WF%_->G7!AAGBDAFXF@DB< LCJ.ZL 1X9S_4?/%EJ4
MAA@F27B:55J\J5#;]#48A/'%*D5U;@.'J4)6M&-:&FU-_#"I(I3'$UVBEI=@
MRFIX;;DD"AJ#3$M7NEC-Z$2OU6$,% !YM*:#Y<:?37"7S#%J-C8>7],MYR]G
MJ10SD&E*E>8XTI0D]<[CY2MYK\Q6W.L,T7"I&Q /Q=.E1MGH'1V-IZ**Q"UI
M3B P! (4]Z 9U;2+D&.-9.E0Q3KL>@SH&FWD-FS+=2^@@'PFE?UU-"?')&EP
MLJ$MO1:4/4"H\#UP<MX@JG.B!CQH"5()Y#E0UI7(UK?FFUTNUN+@3(C(&<F5
MN) 4[UW(X[9R^PO;GS3<+>W*BWTU0'BCD'$R5%59EZ!2#4=S[9O/TUO;>6[\
MPQD-'&?BC%.+A2%Y!2#O7/)?D/7CIUY=?7JL;>YD:0$CG4MWWV^&E*UVSN>E
M_FUY1#+:G5+6.Y4!(XGE4,S=0>)(;OVSHD?F;2;]6:.Z7U2JFF]*#;K3I7(U
M>W< E62BN-V:N]??J/IR:^2/-MM/%*C1IZY?@0230^(]CU]LZU:ZK$OI2I+2
M,]QL1Q-"-O:NV%GFGS#83VW*1R."AU /7@6)Z=J[9YMU?6;5M1D$)YS759#&
M@_N]P :_0:8_ZS$KP2+('ECB]1C6M"*'Z2:8<7.HW.E>C?QNXYN?4]$ 44[J
M0#4#8[YTRPU"SUZS^L\D>\!7=15FCK0';?;OM@M5,$CQONJ$@\C7<'KM7L#B
M<\C3QL\7Q*HX%11:@"@<=,*YKB/U34 -LS%:$<NM/PWR+ZEPBN(V"J(PQ8 [
MG<[@=^IZY ]34P:AIB,?3B?4+>56I4<.8>10NW8$9T'R]JS//=WDTS/<:A.T
MI/6BMLJ?)1X9QG\PKH77F:Z(;EZ*)&WLVY_CD#-"2>^)D;8F&8GK[8[IN<;\
M1!IW_AE$,1L>G7&BH[[YB:=-\8Q!W'^?W8PDTV/7$68COTZXD>Y/7MB!K6IQ
MO3?H,U*CK3OB5/#???!U@M+B3?K;7(_Y(2=L\$ D;TI3-R-.NV.!)IO7W\<5
M#4)'WTQPY&F]1WQZK7OBP !%!RVZ^^/ )%:[^&*+4;D[=\$H-@>XZTQ914KV
M7!/$BA!I^."HVV\<,(@#3;#.)N@&]!WP=%3>F#D:O3!L+ ,!TPSA^(]=O'#"
M*M0H._?OAE&QKX5SHGD6^>"^FM.0"W: ]2#4&E 1TV.2'S)ID=]=620A?K[O
ML5 ^QW]0]J9,= B5=#O('J88)FAFCKN"*$.#[?AG)_/_ ):-[;W2+(1;W'+U
M&4'XG(^TU*48]SGFA/(%YH[>I;OZUF[_ !!:HX!/V^I!W^7ADYT<36UI/IMR
MQ9[6KQEMF],]A4;4.QQEU(08D+#DRAV WH.1%/OVR/W$4]PMXRT"23)^\%*_
M:XN"-]Q04&+ZR8[_ %S3;.W9C%91JD@ZCD *, *5I^O/47Y7Z2D-DUT0AA@C
M"JQ-:E%^%?OPSL-;$NJ701B([<@$FGPUW.PZFISK&C:@'1&9?3:-J(%Z'P-?
M<>&3>VU6WN@"S5XMP)92"*#L#2H_##7],E5^.XH5Z$=:]MNF0O6_/T-CSM8Y
M);F[?D8XH:,['ML*?><AL=OJNOW<-]J]%A)"P6K,3&IJ=Y6Z<O#I3.NZ5%'9
M0%> AX\0RUV KV H:^W3"O5.%Q#/ +:J2\O6J.(E5J?%0@#J/[,\Q>=/RGNK
MNXO-6\I:FEO>UY36UQ589P!NH],LXITYT/TYY.\T?EP=6NY[#S'Y2GM+Y6+"
M5%]2JJ=WCF%*]>AH1A!!Y>_-_P#+&6.;RAYPGU#3+9/K#:-K;M=VWIDJ0BLY
M66,\6[,*>&=.TC_G*RRMH?JWGG0K_09C\+O HOK4!E%2KH XV)V*]L[QY,_-
M#RY>0VNJ:1JD.H6#OQCFA?D 1N4(%""/ [CY9VP_F?9B']Q<JRAO3)!'4[[]
M?'(9KWG^6[XPQR%HY*N\KUH!7H-_PSGUUK4A6>73IOJ\LL;?Z1-0GD?V@AH*
M#Z,0_+:+SEJNI3KJVJQ:EIT;_O-251$)$+'X(XEK5OV:CX1U]L]+S3V_P6CH
M#'*.%%Z1BM-R1].1'3M6N?)^KI;W$O*QN6Y6<H+%?3KN&WV*@^.=WAO8=5L4
M>-E>1APY*14[$TVW'TUV[X6Q+)9HT4DK2ER>PXD56@! !H,*[FX6M46A/).0
M/Q CJ=O;(SK_ *<EM'*?M1$2=:'IL/EA9I]DNJZOH1*EXI4DE;O0I'0$>'7I
MDMU&.#R[%,D48FDG_P!Y8P=P:$M4^ ZYYHO+J6YN9[F9N4L\C.Y]V. )"P-0
M*URC7KXXVNWCC:DFOAXYBS=*=<HL0M1].,^FA.,8[;=<3%30=^F-)(ZXPFH[
MXD>1)7MC150=]\1^(_+*^(>]>F,W&X[8::/&9[R52>-+*^DK3_?=I.]/IXTS
MP7J%N++4+ZS#EUM;B2$,>I".5KX;TP*2 0M*98KO3I7%5%*'I\^M<65A7I\O
M#% 36E-\$ J/M&@S ^ I_7%5 H#7%U([;^ Q97%>G3PP2K5'6F+H:?JVP=%7
MIV-/GAK#M0'?#%&% HZ^^#864U%*D]AAC&G0T P='TV^6^#X0:]*-@^/=AS[
M=,.K"[DLYX;B&HDB;D/EW&=CT-H[]S>$EY74(6!Z*>@&^U:BN=*LK)+*P>+B
MJ+(P+F@I4[&OOD#U2W1[>505DH&$9Z?9K4&OL?NSC]W:0^G--Z9/[STP/A!#
M'XE)!^($5Z?CA-JFDB"EPH(E0&5F0_W@90K TV--MO'(9<.&2$"/A(I45/8=
M_#OO@*'T3JC,/499"JOU$=5%%(]S3L,2TX >:I;7TC*;BW-X9*50>BYCX%O$
MM3;KMGL[RC#:Z7Y+DO)Z1PQ0R325K165%>FV_P!/WYPOR#J=QJ%M'J+%0;YW
MN^;; I*Q*M^T.A%/;/0=EJ%;2.%*K,8RR%0=QW^=#X=/#!1UQ["T NIP2BLT
MC,2%HO4]*Y%)?,6N^:$M[G2K>6WTIF:+ZX%)DFX %EBC)#5(^R2N]#\\GWE#
MR]8V:M*?6F-PWJSR7)#N\@"KR#.%93MOO^&=$$$4PC$8:%XG:(QMQ592:@H5
M*D'9:_/YYD_<AD:$0^EQA*<B0*DT*[$D$-0;;'$)6,7IR*0RE5Y$5Z=F->5*
M4Z5.V$][(\,K"Q@:+X X6A)!9B"*&A!W)\/IP#J?EZRU&2(2%)',!/.5=RCL
M"U5)'6GS\,*I_(6C75I/'-"K0+"5<E?BD1C4_"-J #;;MVSS[YP_YQX\N:C;
MWTTD15EK(2 :N&%5H@'05(!(KUKGES0/RC\^^1]4UBY\K:9+>:=<N1<6%X6A
M(X4$;*0"0P%1N#7Y'.\^4/(WGGS T/JZ?-I,LAX"/UA(6-*;>F#6M?;.QQ?E
MU>Z5"8[ETEG5':02@I*E0/B9"#\(IM\M\,[+R?9S1?Z9:I<PJD;UDH>0 J:#
M:HZ;=*9)K"WA@3C;QQ(T$M%,:$!1W0@ !: 4KAO%J$"VT4O%BDU6<DCF*;TW
M[84>:K*+7-*N;=6=)I /09!4QN  '\*>([C(7^6'YCW&G:A>^5/,4:6&MZ0_
MI313C<QM7A+&:DE&H>)^CKGH:[U",QP3([ '=0M#7DW< G8^&16XU!X):E3(
M\K'9=J 5Y$_*E*X3WDT4^F3\A3D'?EO4@&M?QIAMY1F!O()3QM([>TE9V8BA
M5#&"![UH,.->OK=H+BY($IM[62C,-F+@LY'M7;Z,\Q(HX\5% #6F]-^V-8T-
M&%0<K9J;[>V)G:HJ0,;4=!WQQ'0^([8PD$4KB#G;;*6@!J,8:5-,3W(((K\L
M8S<>F^,J"?8Y9/'M7$68&E*U&.))&^)L2!X_TP^\M0O/J-PBT#+I.K2;]*1Z
M==.>E>RYX;\]V;:=YZ\YZ>8A ;'7=1M_2!!">E<RKQJ"0:4ID4(WKT"]QBBM
M0]MZ8JC$;$T/SQ1:TKW[8LA'T'IB@8"E=QBRMO4C<?CC@:&E.HVQ8-L >V*J
MPWVW[TWQ=.OSVK@N/C4;]#TP<CD4([^&^&<+U&_7#!-MZ4IUPP@/(@#8U_5A
MM&""._2HPQC0+0]Z;_3@Z(;D?KP5&-^M:8:0A>IVKDO\NZ\VCW"Q2T^K3./C
M;]BOCUVK2F=KCN8YTCF^L<8XHV+1J10@[DD^/AX9';D(D-Q'(YC:8N5^+H:%
MEXT\/U9S%B\VHRQS(@CAK)*4J0)*$"AH.@-<+-1NQ LC,4X0[ ?LUIX4'3:G
MSSFD]Q%*R20.&!E<F@ZA201^.V+P1*J3CF7E*EMP*UWHNW7I7 MK&; 6RSR&
M225"K%-R79MF)&YSV?!:"[_+C6(HV7UX-/G>)9OA#N8R4W/PTHVQ.V>:ORSL
MX[K0= @1QQM[.VC9J5)?TU!+4!V!!J*YZ*M=$U2YME6/D(E4-(K57A_E*S%>
M1_R33Q&1G1=%O_-OF-TD4OY>\O7)@*JU3=7<8HP8$BJ)6@K^T#_DYW)M&MK*
M%8!&EK#%\2AE!'/<!2:5!J?"HK4'!,5Q/90,EU']8+R<D85>@Y ?%3E0_$#4
M=>M>N'%G<^L)8I$I]6529%;=F*\F*L*>'?'V92>Z5UD*7''B8V #CC6IH:]?
M"GXTQ0V?J.6,JQ@\@=JU+#D.1K]XPO,91V!B"W$JI$8P>14@D;$$5)%033K\
M\0U*7ZG^]A0S?:4$"@#=QR<J!0#<$[T[=AL5S!>"-H8PBR ?O#5UYJ*%=P*T
M((KTQXTZVNX3]=C04<.4>N[T^#@PK4<37_/>[C1;5H7O+:VB#SCX9)CQBD*+
MW4!NM"-AB^BZ7IDJQS)(4O C.X15+5=RQ((8AJ "E>@H.V%FLVE9W,2O$JD2
ML)-R""P  5@#4MO3KTW(R)EEXSV]$CDCHM58?$PIR2OQ&NY%*UPNM!*D$+/$
M\+'C#\8H6Z?$0=]JG"J]F2V^M1R(TI@X#F@Y*06I1C3%BYDE9(N0D>K@$$KS
M0[*=^F]#MOTSA?YZZ%J\*6GGSRU$XUOR:/K=W;@@?6K#8S6QZDL!\0ZT8<<Z
M/^77G:S\T:%IVJ&8R1W$4<D6[ #FH(.VWRR6W>J*\ERJ%B#50Q6@J13?IU!-
M,"QNRZ/<2/5%J56@J>-: CYT'TY)=%M_5O)+9F)C2WBB'#L)'#DDBG\F*^<I
M#96-[%ND4L+(A[;_ &A^.<$J2?LTQ)R37:H&-!I]&6>+[>&(L"*4W&4U30XT
M*14G8XQB >F^)UWJ/HRB0 1U.)_/&MTKW\,3'?QQK5V-,2)(/3KELP!I].5S
M![9-/(<0N=;U %"R0^7/,4K4[%-&ORI/^RIGBW\];1+#\[/S=LX6C,,7G+6_
M3$9Y!5:^G94J>Z@@'W&<KZ&O*A_SZ8\4!Z4KCP>M>^*J?$T/A7%J]/\ /;,"
M0:=:XJ'"D5-:XLLA)IU%,45RVU*'%0PKO@I&H*#!*G<;T'CUPPB -*-4_/#.
M':@\,-DZ ]._AAA$#0$&M,,X7/6A!_5AA"?YOH]L'Q47<X,B+[E=@U=L'1%A
MN16F"T<D&HJIVI[8:6VLZKIR1K:2^M"#_=2MLOAQ;<_10_1@*Y_.+RE!.VF:
MOJMOH^HPR4DM;Z6*&3DU".(D85![$8$7SGH-I&9WU:V83;NPE4@[DU!!WK7.
M+^?_ ,W/+&EQSB+6+4O%]GC.GRJ?B/3.._E-^:=MYRU3S9HZ^H\6G-!?6;R?
M9E5PT4W$;-13P.X^?49ZDTR8O93W !>1^"H#ON10"GN!7([,\D&LH)78(L08
MDU(+*P++4;4 WZY[X_+Z5M8\F+'#,?4%N%*\%)JJ\"M&84IX@YY7_)T-8VNG
MZ(Z<KZPU:YTR=@G( 1W+D-V(^%AO7H>^>W;I(K;RUJ^HVD2M<6UE/>($C"_'
M'$S"@!:E2/'?.?\ Y;Z//IVAZ#.+0R>M813R24XMZ\M7D<A:U^)C78>%*BF'
MFJ>:DT28"_DM+&QB Y/<-Q;C6I ,@4=Q05PN'YD>3+Y6 \UZ0K-_<P/=Q>MQ
M&P-.=16O2FV%\_FRUMI2WUVW,<#JGJ(ZL74G^8&HKDA@\U:9<)"PN8E?:,D2
M<6XG<"FU:=<DK:ZLT/*!A-#17)8CU.E=J$=N^-@OVENBWPW$TRHT;*PI1=SU
MI4T/:O2F2 0VTRM(L"5](J')(!(*\:K^!S0Z:]Q(QYJLC *ZD]-NIIQ/0;'[
M\,1HD2(@]2Z>%.')&XBJI]B@9N/(,H(%:]NF^'<<1FM511]1;FCFG%@>AD7B
M=Z,!V/3$9].1+19[&)(+B%W5#1@Q!!% #MQ//MVR+36RP\Y$#.IAXNLA)XA"
M3P!*DGXB1[>&$ ]+U=0463".,1)!T)E! #46NX0D?%[T[80W\JV_K$VWUAK=
MCZI8@%FJ-@.^Q'R\,B\DR-/;^N&97E8%0?!30GQ(V^G#2T @'UJ1Q&D/.*F[
M*QK6BUVIV_VLC.JW5O/'<02H7AN&]-@X%#^R.--@NY\>F<2_)GRZWE?6?-WE
M<&=K30M6FCLA1R19S!;B+BI^TJB;B" >G7.[W]@ZW!!']X*% =A45#?%3>N2
MJ_TM+32=)L;B)6FGEMTY5*EN3 L$! (&V^'/E^UCAN-4N(U9DGN51&W(K$E3
M0^ +82_F7<Q?HP*T@]:5THM=R:U8@9P@'KTRGH/G_GMB18'8#$2:;=\LU8$?
MJS'D!2E,::[@'>F)M2M/#PQE-Z_CC3QIX=L2+=*_?B5 3MO[99%-J_?B#'M^
MK$VK3P(.40=B0=O\_?'@#N:YTW\JK99M1\YRD@-:>2O,4H!--S82QT [_P!Y
MTSRC_P YAZ?^BO\ G)+\T+=EH)KZTO%-201=V%K<;&@[R']6>:@QV)W[XH'^
M+^)QZT -:;#;%.8XD&F.5@0:XHI/B1\\L%MOPQ96.PI4]/'%$)/4[8*4#OT)
M[X*4@4';!"/2@'???!\?2M<-86JH\3^&&T5>._6@^6&4)&Q[5W[UPRA-"-_A
M^0PQC%3X>'@<%JP&[$X-C=B%-:$_Y^V#TY'OU%/Z8*C8*-A7CBAC:0-QFDA?
MEMQ-1X_9((SRA_SD5Y?T35=.$VJ7D-OJMNA-A=WT*(&I\(B2YC=&45-2&#!?
MM<0HKGA;R+IVHOJVNPR:M+=6UG#Q"Q7#2VYFY<_@HW$CBNU.QSHESY6ENEEC
M55I.H*U W!W7I[=?#)_^3'DB^\L>:IM0D!6UN[&6W=2*'D6C==^FQ3/='EKD
M]O*AC+NCU"BG(\5KR _V6%?F>(6;6]P0S0(Q%-@!ZH"DGZ#7/7WY'7GKZ=%;
MRW#%R*OQ/P@ CF.O4TW]LXP;=?+'YS^9])=U:#4KZ#5($<!!RG'I2$ &B[JO
MAX9[JL((M6T"ZM2TGU:XLF4@R,"O*)JUJ"":MT&],!_EM81_X7T^V"TDM85"
MLXJPH*&@(VJ1N,5U"UA:[O+&^@3ZN"JUF7DL@;XJ+UK0GID*U[\KO(.H6TMO
MJ7D[2[[U0S<FLT9EX4)8D)R%5KT)SSQKO_.+VF2//<^2_/\ YD\I2W!/&W9H
M;[3T84-##,K%$7_):OW9Y]\V?DM_SD!Y8AED\N_F!I&NLI8L+B"X@Y*.HI%<
M$@]:4^[%?+&L?\Y+:5;3IKGER#4VM7CXOI6H+)%*"-S&DZ1,IXKO4GY[TSI'
MES\Y/,=LYEUNQNO+5Z':B:K9RB)CL-IXTGC/(+7<J/89TZS_ #IN[>.$M>:;
M=PQGBCP3Q5/, H1&36E*]!DKC_-FZ0QO;_5R>0X_O12I%70J!Q+ G;IDBTS\
MZUF>*2]LIHD!6HW?TV<4J:#B%-"1N<ZA+^9_EB.RCNI9AO&>" 5)INRG>@('
M7$1^:F@:I2*TOXZ<F9J@ 5 4[<J"GQ]1@6?S5H;.D=U?1L2O-W#@\@I'PE@3
M45/;"\^8-*O;RX>RO;=5+!6:-@0X4"H K2H4#MMA-J%]9R3#A<QDGX>1('-B
M"2?L_*IKD;O);47$<LMQSG4_:- 22=SQ[445.+2722I D$HE]-B56(!2Q)/3
MK2HZGWP/!IXDEMEF]-9#*6(X\A0$'I[=]J9(]#\NJGF6^U":U!BU"1)A,M%:
M,T*$$_#X;[]^V&-_I?K:S:0 "8W,Z@K4*O$5=Z.?%4(J>OXX)\S7"+JFGH@4
M0PR%J<@1QC1B6I[@;87CS+IN@Z1:13N%FN$-P8ANU96,A"TVZ$#.,ZYK]SK=
MZT\XX1KM&G@/?WPE%6)[#\<:0:U)Q+D*Y17:M=L:-NG;-SQK;[]AX8@U /?&
MUK5:XB?#J/',!789B17W&),#])Q(C?IOE,.A(QI[4_MS$UVI2F=V_)&S,EA^
M<=^0"+7\O]7@[4!F0,/?I$<\W?\ /PC2/T9_SD$+WC0>8/+6FZAR\3&]Q9^)
M[6G^?7/#JOM4;C]6.._0_+'ANF_7[\OG0;&N/1F\10X*4[#?Y8JIJ!^!\<5&
MU:U^6"-A0@]=SBH-37PZ_(8)0@D$&OSP9&!0$'<8-B8A@*].N&]O04]Z89PN
M*T-/:F&,3TZ"H/;#*)ZD ;8/C<^&U-\,$IU/]I_SK@U:#B-AX>^#XN1%3T[X
M-1.(+$\5/B<#RWEU$SK;I Q*UB,W-0YH=@R@U(-*CZ<\._F+>?F!^82ZW8Z9
M=V#Z9!)]5(:%H(2M*. 7$S,0K L5W*]:#C7E7D7R,WE:6[L+B]BN:W_IRW$"
MN%8%1'55E 8 ,*[C.]^6?+MO*)@\7*2VFXA-C5=B-_#;.WV.AV4>A22V\'[U
M+3UXZJ0:DDLH!WV"_P"=<EGE2BW-I(\[I- K%J='1AQ97ZUIR!'AACYRB5((
M$6+]S(U"I H 36H(]^OOG6O^<?M8:VU.[M&D$JJ6*$BE P!I7W-<%?\ .0_E
MJ+2_-WE3S=:"16N(_JSA:*#('#QU;KLR_=[9Z0\CZV+ORU:S_6 %N(ZE=W +
MH7X@<MMR>^U,F?E!?JD?IJU%=B5"T/@>(K]/^9PR\QP<2\S\F8+S'$T<DFA^
M+QP@T^\5K0)7U)1(X8\B30$]26)_K@:6$3);%>**:I,O&E"?B+5 &Y^6].V^
M1FZB@-P2\"O&C$!)11^0) W(-:[9'=0\O6<_/ZO"+:XN9#ZK**!B?Y0!M]FE
M<+;/3V22:);-#')-\;RJ)?AW ";$"AVK3!5S^7OEC4Y'DN])A21@.),"?;'N
M1V]LANL_DMH4OU>2'3VM9+2;UX7A8B-9 ".9B8M&?M="O7?",^3?/VEK)#IN
MIV%U [?$ES:-$63PYPR\:^_' FJ:!YQN%)NO*MI+'Q(YF_(9Y*<10&*@'T5I
M[[YR+6_+?YIZ;=7#^7-&L]0A0JD'UNY.G@?#N95B,U03[MT&5IME^<0B:76M
M%T;B!R^JVFISO1P-OC:R0M7XJ5W'BU=B[7;O\Q=&8B7R3Z-QQ$@^K:E'*2LH
MY*RAE5#4&HW&_?(A<?F+YPTR)9?T;K,5S&I86S6XE>I/PA#%SC ^'^:I[X=^
M5O-WYL^8)HGB\BZE.)$9XVE:&)I$K\= TP-0-^(%=L]!:'/Y\I&-;TY=,@%
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M>I',AY)_-3>@^?2N<'U6"UT6VL+=9XA+<R>A;1W)6*!K2$,'ACN47U **HD
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MVXICK*&26./TGXR5(92J_'Q&P8&M*'WR0IIWUCU4E) A(84 :O3K6O?KM^.
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M_(O4K1U$M;R\:216J@?F59 U3T(WW(SP'Y4D.D?F_P#F+Y-GC810:[--''4
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M!N?B[4)B ^G/K'FS\[__ #G!Y,_P9_SD=YX$,7HV7FOZOYCMMJ<OKT8^L/\
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M7]>1R5U:6..(-&H5U]395<L0-Z&HH!U.%_HB.YCMC\?)&D#&A!_9^)O';H,
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MQC?D9N-!0H30?:H>U!@HM)#"1-&'X]R*C?Q!KL0!OXX2:K?(*/&WV$H !L*
ML2<X[K5U%)#-SK':Q2<F(W#;@T(V]ZYSG2?K&I\+8MZ8GG8 BI!4,:D"@Z5V
M\<F^J:RME8Q6EI"JA5,4*L!V'VFH=J'KD @@](,68RRS,9)96ZNYZG^@Q=R2
M-L9T[],NM:[],3!I0^)I7$V()W^5/;&5"UIOB7>M/[<:2*[';*KO3[Z98% *
M[8FQX5IB9-:G$GZ5/7&U)&W7*4FIQQ )[5K]&)-MVWIC 32I^G$F<*?>NV49
M0U?'IGTL_P"<7/+AT7\L8=3ECX7/F>^GOB3]KT8R+>('V_=%A_K9Z/S9YO\
M^<MOR^/YD_\ ./\ ^8>B00&XU33+'].:<J;O]9TL_6>""AJTD:/&!_E9^;A?
MM>&*J*[$5/\ G_3%E [#?%0*#KN<4#;]?[?''!@?GB@)WVP0C>'SK@M?[#@J
M,&@[@?QP5&-P:"O>N#X@10]37;#*(KL*X:P,!TK3^.&$+'>K=?'#:(BH-:&N
MV#A+126("]VZ#;QSG7F;S!=ZI%=:5H_JQV%L475-14F....0E1$DE:<C2I]O
MGD*L],@C66%$D9XU<232<54@2")1$R,H4<2#7;85W!PX@T6JP2R6DENY6>1F
MG< !A<2+.SKR "\95-0/V:G#?2X;"W,=--6\C*R6F\C'THS#Z;J9!L./(,&Y
M;D5/7$9[::[N9R\DL=O"IH("JJ(V9(W,KE03PD<-P -:FA[YZ@_YQ-U6;RM^
M;WE:ZO7:.'4YGT.Z5I'*EM0$BPT62AY&XM@/'<@\B&]/["^>/)&A^??*>N^5
M/,-H+[1?,FG3Z=>PD?;M[J-HY /<!JCP(&?G<O/*>L_E=YQU_P#+?S1*!?>4
M;B;3C-1@D\"L&M[E*@"DD;*X^=.N>I_);#5=#M+UW$<T<7IW)52#&R_NR>7C
M\(.3:XLVNH&,92!VKQY;CQI3I6NY [9'#:L?K%L0T<@"K+S%!R(^$H>O84/?
MI@>XTHLLUSZ(2XD3F"E:<AV4TK7X10>('N,YAK5C*_JK:J(V=58DUH5DV8_,
M-7<?/;.:!M2\K7;36DL@A9P9[64U64@4!K39OA^UM]/?KGDK\Q+*6[C5[IX9
MBG'TI=F0]B?$'IR&=FTG7++ZMQG>HMYG9%#5JLC] =CL>GRKE>;@]RAEADY+
M.X0.IKQ9!R <&@XG;KT-<YG;WLNDW]K>),5@=3%*JU XUI^%,].>2_,<5];+
M;B1 \8$D; T%2/L@C<$%=ZYV.SG^M6[W%O< DD.JC?BZBC(P'V=_QQE_J4OH
MTN)&MIV56C+%AS"@,R-VZ@]^F2#1?,,#>F+B=9E,7/U&W(05V->^^V3"SU2T
M:!9+6X1^2"5*FC485W7WK7-:Z@.<D<\C(\Q+(>JJ23LNP[[@8O\ I"+T@A=4
M>38&H&Y_F^D4PCUBXMH5*23UH!+UJXZ+QJ?>E:[D^^1*2[6,B@:OV6>E65OM
M<6.XK3P[>^ -7\S6B6]U%]:*%05H*%B&*\0N]>OAWVR$:AK065RSK%]7MS)^
M\)(:1ME! &XKO]&<>\S:T;N5;",K#$I/K '[3$5I05-*FOT8_1II+&W6>>5
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M(YI_K2T59'9N8"KNXH%H 17#)F@T^ZLS)#=BYB8>A$>'K<453$1(W'F7/Q=
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M0L/L]Z5\<Z(JA1OV_P ]L<1T/AE<@>H[XF2 3F)J#7;&$]_\SB3$$**TIC&
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MVQ@U/2;R.]L;@522,U'R/@1W';![+5B<9Z9Z^&(%2I!!K3KEBI/Q5 QCJ ?
M8FPJ" :8@Y*].F,;?_/\,1)(V&--*FI^>-##[()IB;_R]*Y0V%!]^5NO>N;H
M2=SWJ??PQLE*;=L#L=B6Q(J&/Q&M-ZXF:!@-ZGQWWSI7Y4_E[?\ YF>;[+08
M3)%ID)%SJ=T@V@M4(Y4/3F]>*^YKT!SZV:?I]EI-A9Z9IMLEGI^GPI;VT$8H
MD<4:A451X #!F;-FS9LV;-FS9QC\Y_RPC_,'1;:]T\"#S9Y;8W.ES5=!+Q99
M&MY#&R-Q9D4@@AE8 J5.^?/J/3B+FWDDCN[(V!CB8W"Q(\4B/"OU<!68!U%M
M1@H"HJL5+A;13%KNV"R%5NU2"UM^;V[L$DGC#6ZED,,ZNRBGPA34@T1MHY%B
M.IQQ1W%O&8%2.XA<PQNQ9U#(C1;I#&!4F/B8^% T?HKQ;3N)36&2'35NHK>Z
MTUXX0D800RR2E*JX:V=(R:G]GDM&'&39* GE2>4-IKK<6]Q'Z811ZA4,T<3"
M)8$#5 6(+1.5!'Z?&FG4*;:[:SN?T?*WU1%7G%."EN/0D(%/4A,9)H0:(W&E
M.'(<29;J6H1W>F2BR:>6*>T0P+*[*/2"H45FCCF *B!2#%&M/24PJPM[19^<
M6EHLMN%$:+-$CL;2I"&4&@]/@]P8?39J4=2RGX>5!7)3 PT^S@-W(5N1*T#F
MB"0HH9:-4E10"0<&D91QF61BD5Z]T3W<ZF6Y:_LKNXO7AD>X!26VD=ZM0.LR
MTDX]'Y&G9R/WE"S4?7E6%[N#])Q6\D,T4LTC&2,(9(E2&.3BQ ,[TJK,>;$(
MI:Z] ;I-S%!'+ [S1*LJ1K;$45PZ,BAA(V_(/Q*D(?B85A#//$M>7OU\-'=P
M12P7%TS5 DDN*1HW+E$8@"I,Q8G@BEFY>D/42&#G/Y:B'3/S-_,#R_/<7L$-
M_'9:ZD=D%/,I$89Y&>.5?3H\(J>43("[++!0I+WRSMX+4Z28H/2O+-VLI5A9
MC [-67C&CVKT^%24 M^1WD>T-/KH:D,NGVSW;,;A%'*2G"3U5EAF, 1U>:/C
M+Z3B(J[K3^ZGO9B(EDVGWTL=O=VX]*[%K'<7'-U/-(A<01F0DND=(F"DL_%(
MZGZS) \@A4IMKZ%%N_@N;@P(\LTL:N"@AA>212']$J$MU5PY913][,8T=,.X
MOK.FZW=1W-LD4-M([O%)4H?4,5PAD:8QN!_I%7#\2D9WHA#9KVYLHKNX'Z.6
MPMKN0(T4;_N@P8QL&9P[?8<,X(/%>+DE6C;.U?DAYD2W\P:UY?N7>&36+>/4
MK:-@>)-JL4,]'.Y?C-$6#4)V<#XB<]JZ#="JBI"]_G_G_GTSHUK+R5=Z[=1^
M&&(WR.^8]"MM>TRZTZY%$G6@=1\4;#=74^(.^>.=9L+W2=7N[2^M3;W<(8F2
M$CC(P.S#H?B%37Z.P.$-TZO$RED5@7]2,K1DDH3R4TH#O7P.<ZUBV,]O)<H\
MUGJ5N"KH\8DBFI561E6M=B-]C2GAG,3+*MQ%#+"5BN%DX1QU93*H#$$_#Q8J
M 0P^6";2)-2U..VGA,$#E"JGXF6B)\0;N10-X5&3/3/TAI=S/931(ICJ(9OL
MQR59P&3?I3^F2&T$RW*/-5O24@ D\N1/;8;U]LD=M(QE1:!R6^)%&PIL #[=
M\D6HW+0QB)*!@O52>***D?0>N>>?-VJ&6Y*1GUKB(%>9%0@?N16@I]^=9_(&
MZE\ISK=:I#%^C?/-XNC6ET[\;@W< >41!"NZ,"Q+5I4=,]T69/'C0#MN-]O'
M/*G_ #EM^51\Z>1AYJTJSAE\R>1N=\A>-F>;3=FO85],ABRJ@EC!Y+S3=#7/
MD!YH2.YGT[7V61],UN$M++&-O5M^!Y R;59)%:C"O&AXYS"+2I]7OS9PQQ6U
MQ([O"9G 7]VI9C\5:M3?;;)GH/FO6?RX+7^A7AN29@US92-QMI8D0F0>DI(4
MU8#EMOTSU[^7'YL>7_S%MF%LZV.L0H&N+"5@&![F,G[0^6=1H>AQE*=0=_;$
MVK4GPQ*0FG(;;8&:IK[XPH3UW&,9:?V8GQK[8D4(V'<XS8'K0@=,1;E4[=>^
M50UZ[^'?%*T'OB9:O?&.*TW&_;$COMWQ+B:UZX(L].O-2N[33M/MY+S4+Z9(
M+>&(5>21SQ55 [DG/J[^3?Y8VGY8>4X--8)-KVH\;G5[I=^<]*"-&Z\(P:+X
MFK;<LZUFS9LV;-FS9LV;-GD'_G(G\J'GM;_SWY:LY);H*'U2UMP2S%5=!<I&
M""6"R-R"AF/9&?BT?C&:8/#>M!)+>1BG-%D5I'1OK$B'@\SJ:\5H>9ZIN=I6
MC\\:3133-907%S];=+NVX+S,DE 7<J]LS\A./A8*2' _=^N!91<$C1;HQW,$
M?U8S-&EMZ[=>4M1Z;L2&YJR_N5#"C*L:L  2Z?+]6TWZW!,9+PF".$A)';@R
M\"514##_ $H[44?'Q9P]Q&;8?=HL#$20VYGO+:"2"7D"W.,^G4T,<A1F7[10
M!P2RJBNJJ5WFFV\\=M.([B225D@7ZO)ZR,7"_!&G ,69GC)"N')*%2LDEDD,
M;;DY"SK"MO#,AMXY8X[<;L#Q-PBFW9 C-LBHFP$9X^F<D$37RZ=H]P\TBJMO
MZA/#U#')&T9JPY.%JL$;@A**$0BJQ6T=U$]5-Q-+:"0):3I59"J@ (C21^I6
M,.5KZ)!#M(%*M5VIRP7=VDEA#=/]36)I+%Y9Y&/!X9(S(44QR24"@12<Q7B3
M'(6=A%>?60.F336^I:S>0R0K%"K(UO!Z9,:M\7[Z.[3BH!)5O415 J91(@=6
MF^K2VVHV=NS7!NF"AKEY(6=D<,\9$?KI*X;D64/\,@;ESXR_I!EXMI[S:1^=
M?EI( Q.JZ#=Z>I:5G4F*:(HBKZMRXY)(5XI\>Y"QBAIZ U4V\$:K"C7$=P7I
M;7,8DC5):..)BYAD,EP?4Y@CF4Y[K3!206NKV<UE#<MITD]T9 9"'"Q708OS
ME+<AZL=%E<#DXYI,9XU]'!UC!.M_8Q6K<YTB"1@N%B:9418BSRR0L2I:L9'!
ME0?N);*/]T26VMKZWO)XKA0Z2C]T$B# 1<+F(D );I\+/(8_L492T9M7,E\\
MBN)I;:1+Z-I(@-.MY69.*HDD/[\%3%%;_$SVXEJ%C/+]ZI0@ZFMWDYCE6,I*
M9;6X'IJ_J<8X_734%XT],%N7-B1Q(8/("C!M4PS\IZE;Z%YN\IW:"00P7D=N
MTS2*$B@G#6K5 :E&HTAV *_O%616?4+CZ%:!<D2!3L3MG6M.FYJK5Z[4_7A^
MC5&*$5&<?_.-EV50&U#8I5.DQ=U=@CM%BKL$=W>7XL6= D4#!*=HL>!0W(N[
M)D#QXM)"(4CQ;K_=69W]=O;7^7?GWGG?\]QSA"=YJE9?<F!G+TU0YU/5]=N.
M3V'*0H^RW8Z?N1F8E[A1,&P^I,#C>+DSB/6K@"OEN OYB=,@<25MTP"'O&7@
M_H;RC6R>>XQ1B+*3](,X_RL?ZIY&&1^!OJ98A4P/*RB$%REF/]JPW/7:$">D
MGGJWS152L:>9S& SF,Q2+A"#45"MTNH4].%BPJ*T?C"#7[$"B3HJPH7*MP1:
MLD'=.";;W=I7W?6*2QT=V/Q*';X83>&H 'N/ALL:,<@@X&Q131S:M7*09OG.
MA<_8V$P>7$7I]@VY?SPEY&J%LE?%T3!"-E13&^26&_^E&>_UHT$A^?%? ,<Q
M-M29\/B/,\^QO)AY%I\ @8(!Z$?)P=02TT_SN;8@5<30M'!06[9D>JT:;DY/
M.U]CO\Z[YHN7TS#4G)@T-$:? IT '2<:8:W3;S4<'EI!46)'HRES'I,!3Y6'
M_?POEJOKO?5%58J^_5P:3;$)[S:_<Z(L]]AX:UU_>9G8K10W#;F<H<K:-G3U
M:[QQJW#$:D8OJ9->ZW__:&= [_]AG,;H+V!!^7/BO)(^4D3R1R2EU6TNFC]J
M\#J>ZU6[QKZTCV/L3]B$*7&I_J48;JVO@]H11U?GE&/JM+.(,=> $@-J>3 ;
M#W>4/E*"\U:_7Y"O8X(3Q*G<N"356TF6W"@@2NC=XK-S'"]+V-*HU\_Y7;>^
MH>*+48#,)5GZ>U<57.HF(0%)LI0@<.^EL)>T CL?W5C'-MDP^#' 1AY6?\3J
MSJYQ]YE7L&*,@#\O4KWY^%]'D=K_>=S6^&)]GP<#UT$57G;.RFF)6WL^!L>^
M*1VOW+F0>S'8&OJ?0'[_?44AS9A:KC2JMI8=30Q/9J[0LH@6,C1)NK+EM,!E
M5S2Y-B5F]N",_TS.F#9A)*#^6(%SH+%-,CUIU.TIUH(H@3'"Z?NS3L^E+^:<
M+JI-(QK$O)+ARA%AERN)U77&267D'O(A]]=B#JT=O"3\FYO* WG&0!!5%T;_
M,J, 9TUG&*<JP8X=OWRY.]6S63?33&,7/D"VT<'[A_)  2,=^B1\/%'1KI*<
MNQ"I>QU:D25&[^-%%:6OJ5''^1;$J#P9^7UF')'1G*7S"Y2V)NR?3&I3840R
MZF_Z,Q92PYN<^R*(34B::32N5OLE.K1?TR$/5!?/0Y=E.B,KS+![OPV_KO ^
M!)%Q!('/N<HXC1"ZIS6"<D32/ZD<A83XG,L/VK^FJ[>\]82\FQ)T1(N0E>"V
MBK=0GI$QK*&WW 8YT+_VS2T<?\?F=J,$(;-('2\>U=;)1YVF2R6J))8OEQ"1
M$,*-DPLD?OYJKLE "<543%K,+"115#3&C[.IR"J+TL[@M%Y.=)'\RJA=N,RE
M*-P6)4:7IL2H>9IA%"88#;J(=[#@3KS-Z.(%-'^U4FVZ*2LD)#)(,HZQ=JK;
M!?-6B* D5.B!>;ERPUCVR)(S<DF6'3KV"ZVO]YZ&GKKRM7]D[>FT/0R%W=$+
MC1IM/W8/<X;28;G7XZZROH6OO"U;<Q+F;3:+L^57_BH>61Y3%F_G[M.*#B:S
ML=S*TGHWXL/TSIJX?*1KDJ7]>CIKD5Q/=E]K@-/L,!["JHY7XJ@/;H+^N#"%
MSR["N_. ;9EUSV^: LJQ%A9V03\B2[DO'R(_MB3TORK-4W*_ZJ<GMVOW&O"E
M&"W2:ZUM*C)^%WU= >$ .QOG> 7<-7)B4,@_V7D6WR*650,LS@_1TRS8!HR7
M2E,S\54FY43SO%FQ7T]+EYL#JMX/7YGRDV&7I?,&E+'7@[\RYNSO>'@.([PZ
MWA03T>.;8]MJ*L%N[',IG'_1Y>ZF?5[D$L<^;:#;%S-0[@0IU(@BOH^2/:9/
MB)[^%)6,J1]VRFO-[/TN(9PE&%;0+K+U(1CL2OD>6YA&X"67)^94_-6 B^MO
ML_=Q9%I)B.S#=LB*;&>Z.>R''<R7E.V#-54O2WJ3Q0!XIYM 2?;MC*3-#1>^
M>U_U\A^2H8\YQU_TV;2EC6(YFO&O9CVO-CZO<J5&U+FPM'EG,/-=,E(8[C!U
MI*E<UVO47=>@+)XS7R\&' 4<,<)?+=BK\%'Y?;D@?A*U8PXU63Y\X @$*1B(
M!X$,N(;BB;=+&,$?^GE<'GS+7 68)YV)]7,2$% 3/2YU=C'?":ZQ@D53Q:C7
MC+>=ET1O6H,2;BK;O'L]M+J662!'"P2#-5]_#Z<*280;2#?<*"P4?^WHV.6Y
MX3A^?[8@2@Z4D);()"KJEO#,*\_(R@NA-7F8,F(88ZKKQ.B#(B4,V<+=^OM6
M&:-NKU2*U*_@)$?+"PRN;CIK>&>GSK_\[8M1-]$/=%M%="6D*C=-3TD,5K*^
M<MZN>'&FB19*U[@+DQ_1WD]83DV(PPZ(KG!R^L^#QW\S5Z&^H1>$JFP.#M9H
MV5I8&9[1U2FN7K9?J2IDB>Q=<6?:V< $F91Y2F+IR82UE\CW8ISE]%@-$C7$
MXTI0KMH72CC8NO)!%*Q\L!W4&#*P;"M@_GUHHV2E^Q?6NK0A=71^\H!"%D]9
M+\J(((S\Q%#MXNM"^^3.!5SH.F+[C+48.2QS=NX^_+X&&BB57#!EYF+R?C;4
ME('C&..Y8]VJVV/8;\XV,'PZCR>/DQ$NX#K<'7EKQ4J-+8S5"GWGK8F_4L^,
MZO_3HB.W>+TA1*UI[=/OX8UYC()+_E8LC3>0"+R*3\BP,1L?7D$B,5B=%S.-
MF"W.>GB!5\;);@B?!*2N%;<OZ/.+UPI"[7[T@5;TOG#EQ==<R&1U?5P(SLTH
M,?"3@/>N/[>/>HSSX1T  &!]_=]A_5\%>7/-U')=W3$08\/4C W$Z*7U[2^@
M<$S2]<7O14']@&/J\Y2J71>B;H_3SQ^77='* )UB?8YSF.'!!4UV#(9YR8O?
MNN/!OW[\$EL#)2\5&H!L'="!#X!\*M4(?@XS?-$G)G81!-.GZD,O*0*E#E73
MJ7C)!L81KM]U1&G]0KL12J=D!Y#$B5!9=$ZT PNAOP!3LAD#UKYF'X9)8!IU
MK].6-,8EAS&9F>S8V6L6^*8K"%/#W9.N,].$)>%'B/6GJO>V4IV0)B^FPP#S
M,OS+TA!4HQIH]&:;Y.%\3UR=-Z?[46:%# \4HDJ.5<LH0PMU&4M_K6ACF5^Z
M[)R&!S8Z<QLM\*.FL/\!I5+&('Q<"BB#,'.JS4:$_3[+_*[J!43KP?4G*060
MK"S@$ (;.>*UU(@>DGXMZZ3BGI'*_I*[L&Q,;D[ YS28H8J+=?<B5OK2@1<A
M5\8]L+3&+F";ZT[$)0RW':Q99ZPL3_PBMJ:D*]"H209FS6"A:#'$I8CH?@^@
M<DFZK!8K.(V=Q'F[/C[AZD/?TP9)6T?+7KP)U;"V($Y)SIHAWZW!L\?)4FE&
M6 J;LEWY'P2T\6Y2%@DH4 ^)>RMQ,I]O'0HEL;<.1:B^OIYJK@F1S UO/39U
M-E3(Q]8Q: /CZ*)"KR&R4-K%/*1O3<+.XR0X &TZ'4_GV,E])8Q-LI=6%#<4
M;Y"&I:ZQYM!H5)Q)0FLQY? "Q"B?EF>"TV5>#?9PT; $B=9@RK409GZW&Z;V
M:VKZX3UMZ<"',%YM3\B(OV]X,,OK^(+\;*=)Q7;LQV\ZTJ31AOPHS+[HBVQ[
MMC<V3#>8QF[["B"W:*Y1^R\*SW"\YKC3-FE.AYK.2.TRF\%1W8EE=8-3(\E.
M[E(O+/R-6=5->OI0S+%#,I7&S.L)XC>PZ[D1UF:'A^E/)JB_F@?I>(V51X4X
MW>D?FI6(>T@0*JU@3*MJE'ISLU%&"_&1KL;N[/FBM(?43H1"VV<&-&;$V<U6
MADU= *<.:9Q!XLO/M& D*2=D+0GC@\>(A8I'G.V&AOOG5<GVH(0/E:=# B[)
M#[M[7C%=645NT#5-1W^D?\8H 2MOZ!L;N>,$D%YY3/ '\FAS,V2%,I^*#G 6
M4:A 07Q9S[D&+56/<B>5:(F:SCP_$EX;UYI3++"XRQJ5:Y^B86,#OA-+*2JW
MNKF@-OXKO=?H+N.U/8:Y]H>UI+ON27HZ!3Z9ZN4_^8(:4YEC^8P<T,?^."2Q
M%^.5FUY\F["M!^Z 0$0)2IQR$50IBE7 )X1AQ5IGAS+WOC#AN,@$D706]&3N
MFW#\!$V)0RA07A=)EF- U%T,5K5>X5DTG<)]FI>9=Y\P>;;44SB^O)P0OA4/
MPF;;19/"N-0:JG@1D7C*OVH]+&^HL6!</T[E= Z!N8VZ1+FXSG,?]G/^H:ZH
M<8/B+KKH'8_R:$PN]0T/1-1"4@X8NNV:$8^&FIPNS?>*MWZ)4W\L/M\'.4L;
MG<K<N!%#OT 5])4?@>[^E=X=B4M)":_7/0I#0OX"\M.>.J2R^S[ 9W,K-\9*
M75/GJDZ\F;!;^)%)!:DZ+S,QHNFU/B73.YNF$Q;:=R-"V_J+4\2<PCNZNPKU
MNV .:2@R\,M,[=OK,=%T\X?GS IO/U]2WQS&<0+(J!(%*LK2)ZOB!=<^.D%6
M=Q+6RH\9;>]WV0&+*O5A=.35F'XZK[\;BVZ,C=A&K*'C1T6 H W#Z*>N,!]=
MR%\ HVN8W3Q/?2LVBT[4I+RECM,Y1:I&$[)RG)82@Y#V7E\P[81ECJAF?NU
M_"),+Z'&RVX:'36HQ:&?8*5CXC?/JZ;A"90 (?YN+7 .=8K/>AN#1:_H+O!/
MY5P?7SLQM9>D'DOG3S/;7H6P?&6X85J%3B^N^DO@5C\PG.EW_UM?>7BKD7TS
MPN SSX/9CPS7*B+#TPM!C@T?ZUNE,'E'6#<'A[K0[(IF8QMX=G22*1:-7BMM
MC )075UJ!2#C$/K?@/[JE"(47&/O4W%JD&9I9*%H4XB>(2I*4_RQZ&V_2#^0
MYR^ 1[!*L-NUTW)"6%QG^4:M:<+I" 9F=2^+9T:I!F/\BC0"F+74,0IGZ1]U
MI6NU1>W"6PCC\P<GZ-G8')()X;&"^T^,J"I:;C.]Q/D.L0)P,W0U(=C&$-$I
M0T$H$T;Y7X#?H'(!E+4D942G2E//',\1)R70GV%&)#A9# YRKQD4#B#=3=\M
M))%541I'#RR7ZO,"?$Y[DW=V'0P%NKX[2)@'W-XB.CF;9"==>: NYD69F(H8
M%-Z6M920F,8QG%S!P4T%DA)GWU?Q*-SU$[T6BE9S%)'4KJ?>*,CZ^)A) OD#
ME:9JG+M9H#5\/(A06CY#MR !,[]6K*Z%,AFOAUYN4D?%9U$S.4>B>*[-8YU4
M&KY9,E*(0#*$T3V@>G;/44^\3'L,GF=J8+8Z^BO9+5#BX]IFU_@*MU"@M1(5
M4+\-R\QC(D_(*A!MP80,GJ":^#$0>XP2:C9&)QTH&ZIG1$SM=*[5!&;WLF5E
M8):_(9DD#^3Y?"X?E'T@._H7H*7<LUU63!#)'PLNS7"0>?[.&H;VK/R''3."
M^EG=EWAOD_P\IS95ML)4\94:-C((" SZJIRT4-V AVA4\3:-(XL9OKXW@2UT
M_@!$79?LUI$[ID:CDG_A# 2B9#I-E[U.'?.G!J)ONOA4KO!P.40A4RJ))LH1
MH*0D\M0<DYN3OWJ5)Y^^:,%>>]E_/C"2_+S?UKQ^:J"M$/SXG:DE7&=SMX/F
M:ZM:-3[MG\](U0%@<XP]4P/]-N<#V$LK&61Y7P"U5W:RBH ?H,4#F#F9?R+Z
M'BF7,,#4XY<VA*\,),5O;1ULTC2,FFSL"F(%X*==X*AH-=KA=Q[%4OCVX"Q[
M#G@SJB@QE$HM99#M$- G2,LHT$#M[?!3R7*F-<S7+/\"WCWZ!]H?_@5,:_*8
M^^AWIV@L[Q"\HGS-P91?+-^B8&):4AU1T<V>P/I'.-O]&WO9_$?S)R7SJ\K5
M7EG:50E)HT#:]T05W;;):+?CV9][6LL#2Q7Z%GSCENH\OM@!YT5)=$I@F:P*
M?G/YA58(YI+] DN=Q5:F'4Y4DRVC_N[N%NN+&9H?L=B=U'IP/1A]N] ?]0]R
M+>U>O-?U85/MZ"2?+X@%=EU$=S*$#$$NLHR:1!$A["C!7A?K7IJ52 /6_'P5
MN4#/^=1BI/54US$7@,SO6$_%+$3WD,O!.=J^"HKVL*_/2O&P( @BYEP1"$@@
MLCDJET9)Q;7('6M1=[XI\.90K2F/Y9*A(EL%/?3EHS/9,EHS-HG!^H),YB8M
M=*^(6TA$U7N"['!Q2T=?@>Q>;,:@8H6]DDF"B!"*MOC:#:<5C@<=+DG!!'+,
M14Q?XEVCWP:,C;,+7@[M!ELQSW,-G"-,"M$9^%.THV7M)DBL8;]^A8%6BBP7
MALP^DI3:G+GY)<-['/)'I*O;M7QR7L+#3$S"K ,EC4R6=T,MIQ O68M]T!UF
M83R.L&-O.Y1WT$JFJG)RC?M+R2VGI\JC,[FIO!97FN1#?=7/MD%)-8[OJ,;M
M,L/=/I%BN; 9Z"B@^,\^<,U^KF%:1/; ?NQJ2F:ED7Z%G,A7:9(\%W\Q[@&O
MW34JR4JBNC(>4>F@C*3%'[\4HQEIO-V:Q2P0/05%AY>9:%E%%&E'J*=P#98K
M?J-&< !C[#G>DE-Q>()ISQ-Y$HGK)P$"E#O@9*:M(H; J-E+MQLQ=/8TI0OE
M85A20HN@/B!*"NM6Z6#ED"D[__HBO:-MN<1#PXD\P*=<$VB9M>\WF[T2?O4N
MZ5/'V3IR<]9Z!9 @D^YF5%",PC#$UJ#P+NUUX9L*9N7??< ;6Y7KDX)^A"O"
MT/!I#IYU>N8 $R^QY7FPOS,AC_OI\=Y(._^/6#1EP5W50^B7XR[+[ \UU(0*
M7U,T%Z^_1PO=7F*PLV[<5 $A(!9O$(M/;.[_0N[_$"O51TP)G=DC#;A;:4]3
M3_*70G0]?E'>$A2J^XG[U7\F.?(_,#?9FY&T:.]:%B_PBW&,E;I.+)!($'W%
MH*K+R63V!3+@K_?YCV1).(UD>C"5J$=5$+=DLS95\D0%!T<F/[(OH8JT 1$3
M>R!4_\:AB_WJ[9B';<78Z:9\>HLB&FJ/)IDWFD,5&'^X>,U.@3E_KGR.0QM6
MOYV4Q5<S7)CC_"P6KZ,:B.62_'@\'8.T0:\$:7@<YI0PKN^X>CPSM^IKZNBV
M-\W9-]K+($(A>N.8#[KQAGNT&*6Z4/ZXD7G;V]/:ZUH<S\FOT=2PMIL/U4O1
M\*;J)8D)?&/B!>SQAEA73I$G,W0U&_HY8UV-GU=$D3 5JMZ-TR)U<C$\9S+'
M;G+W&F,MWQH*$:Z;F6Q;Y.QS#P_Q^=\Y<I.]E9B1S^0ZY>#_?=H\\=.+IRN6
M*5$3^^=?0$5\EI2"6@;G;$)3"WOMR4S"I5;UR"3R:;^8ID3@3\V*FGUST84U
M$4$>@=7Q)$V!3'E^M>Z/ /M=O2A;Y* OBK5-*>9CU)MMN6Y4XF$MM;>_,#HS
M#]Y&#BJK-&'MDUR788JQ5I8.[5K9["X&NVG3Q5"@?U<B-/UJKFCCTDS<0#]2
M9E!]N6OF)KNDSU,GV>\L>.V#676.N[Q(-Q(?IM4\3I;&!V0D>"E.G4= %+1I
M4& $@;ZHIM#.M6WI>/0,I5&ZQ?7)!1([HP4Y%3NLA>J/CQ/6[6M>P+SEP/KD
MZ"R=$>":]Z@)JJ_/["QY*G&J\J\YLC# 0^W>'M(-$9')[*[RUNCAQ/!E5IFB
M/L$0:T%]POQ;=4*?K(UJ[1S))Q/'US""]@"F3GLP@LEI$N3A2;BDZ'U[T<G,
M( 0QSJCRNS/B?*\P]L!!=8]I2N%Q6)E)71Q@!:]U?^H[HU;H9ZCQ >B[,Y%1
M&A.G)N?PYXDJISU6*G7P3;:65!77+S5X5(J1I'E^52P6E-[>L*MGP)8\M<)V
MM%Q\ZK?[LU8P5DZ&\H7U@+-6B(/"H';[T&<.$>:]%5AX>J4,([MW.7FUX[X?
MZ@:KY*,O/N<8U@\)WL?]AVML1:>R#CC0W-XD*[NY6]R;I/+<<;,+=O>C7SS0
MQW#Y*8;X[*:V;67+D,>+?ZY3:!C7F-';R6F<S*.C(;0YQHE$DZ %$:0S(4(_
M"T=!DF.(8&M7DP!3@C#(V7S8(W5(/ZW115IL*JD1>E%'.\TV>Z9E1EKX>M9M
MUW&8,7:1XBNB0UBD3_3$WB7Y$E//Q0_6>'!LW'\[7:["Y.JM+_#Q8M._D^ E
M)FV(]Y+;?@>.*?[\)N]Q\:".-8!C&*&+4IB_/G^-KJ#%MMWF_Q? L+[Y#3LK
MK[Y=^$.[<7Q-@V2/QIZ5O^3U[&<?#V?70(\OS@0"2JKQ=EUT)!#5[+NXM!&7
M,*XG<6__RADJH6J/5 D8S_D>9:%$BB=I2.JJV>9Q4"W%PYL<M+ :'Z?\@H/X
M I4N.@&MS(T[_[7<M4VK_E9P &V^;O$'7SHX]4-R\S[/T^'<_CWBYI?D^T:8
MZ9-$('WJ')YL5C;XQL[G))?1P $5P!2VV$"!.L=O:EY9\-1PO#&"G7^[$,.&
MGU:6< @OI/F2>1?I( %UG2_,'U9NYE@;<!W]X,<E&\B(D8"@?HY=>K?Y[T_<
M,E%TAYC66_&F'9<!R#_1:Q535_L#=VD<(L_M@G-^J$OXOKE!P6.3(P.7R!C<
M?:(=_D'FCEH>QWHH(<O,/AGM36S9<NST[I98\. LT3FO;B1YI*(LFT4S;WG'
MG40'Y%MU5UT:9]VT'Y9T.Y8F_M/UB(M&+,-IK_]C@ME@@P[E_> OV79M;<@?
MI!;)=Y^OUWUVXFC,1X36R7"V!,Z]RJX%[I- G\<J0Q3NTK17AB1P[SGN\:O#
M;,T4ZG[6"&7N?Z>)M;Y0#YI:%@N3?J+[-:>"$U71$Y;A;&)04'*R'*28[DA2
M5'%RB>9VMD.EC1^,NPS:*)B]L_[\O\=QH???E_5][7QQP&CV#,4?X?B%0D__
MN)0?D. JEL+W8G9\^>Q";M?5O7 V\-I2V\Z88DD$Y?77YDS,\=A<V[M*EZ>;
M%>L8G@K74@$=(S/EL)I@PL2X VG\>84 )!)[VPOT=VZ74>5-JM\IX%RC!5Z!
M^%T6>((M7]4*NX$95(5&Y+W:GKC,2*!0K3.EWG#-;)<HCL?6#"6&;>#0QU&I
M<(FAKNY(9"BWC.]>-RL4ZTG5MG-+G;6QK8OURK0[9Y]K_'V,<D:6P"O]*@:2
M7067$T;KS/0-=6<4B,D46ZM1>7M ;MW M;SW Q_(X2L_SS>RU#($VCXY8ULL
M2#C[7&YSPP2S'96++M_4LA9##IFN#(>:6$L44D*=ZF4O'?!VTA?Z[0_[<C;?
MAN(?_4Z&4]D4AD@!^:F;(QDF+94$)G8R=/TJW)4*#Q%7/\36B^.+Q?$R8@Q[
MV/\AJXY@?'849-OLQ6DWZ>#O2+B4F3HI<\.LS3A%%9;5UM4=*F38$5GO]MMM
M<9$T&2)E])!UWAAGI%)?CZ\L3?-V/ V+<?>5CJG(?D]W<UMR*T=+%*"=((-!
MFZGZ#<XBY/"KMNK$Q& D,3SQPJ9IQM>A[7)C?7AA<UUMPNL;XX/?5N=AR_5X
MP!"M7K0&W27D'>F?Z >2ME002_D;LB^Q9PQVI1.\$#R,1;Y6&;ZB-9M0]L@Y
MK*U@L<-88OR!4'%7JA1/XJ$KO.Q ":,YIAIOERAF5N-$78S":?%4=1^"^+#U
MMX3T@4#'/(,/'<Z8KY-2#R)O6"4\]#&^,%F7;:QQ3C/SO W_4IM4,_!1S@.Y
M720.!?S*95,O["J#;EV)^DH@N3R(QC[!%AC$7.5<9=K!4D3LM"B-"3:355*/
M1T'=4"00TRPQ,2BAWBS/O.E^$W7*>A@?^Z,L@5P]3$F,-/LW\6Y2TZ8Z.O&Q
M6%%_>#_QE7!1G<";4/8%U/,V$MY+ZKTV@H\GGQ/PPMA# +Z7Y!."=;+GP8E^
MO86J,W): H%4*W&5*A\ UP!=S)NYJ:)%H873+MO>OB9'$$,6;OOD9ZV$@/E]
M?]6K82$.R93[& ^2G!.C_>[<@+6O50#Q:3\-^5_;CAN.Q0*F/W]2^GZE]^UE
M5[BSR?VH0E#(U9R$615F$4@XS25^N!C.O3UGH>ZA/-_OQ\?+&N2A=DAC\Y2T
M\LLFZW%*N/'GY;!(HD3=.=6K#AV0HB1ETHZA@;#0'Q^34U&[+K>9SV&W(@-@
MA?2G8FFQ)/-?>]Y?T3 YPYUKM#OJ-+<+=!$.LV]ZKX@_*RCUM2LO3.RKL5I"
MTM?*(Q_>YKE:J%&0YOBN.S-B92/BHQ)P0,.*1SO$#< JB9^0<* SH?/*M)T<
MECJRL*!.B5:,(P99NLSW.X]M)&>3:+[ TFDJ_<)ETW((@T')$AQPLU6,%Q0J
M(@J^R.WKIOJ021&3@P#B?/Y )$DKGGWB[W"J"1JK\>HL%ECW,:Q,V? I#M1X
MX.(/O[C^JH,^-6$GB[8K9_Y#;GRY(-;PT#!5H&&:EMWEQ7 9.=%<AZ"P5BFI
M<5P89&N]:?3A6'',M@@0<E!RGXZHF7VQ7KQ!,5775.@G\4_]EX%/10)!*&F?
M*&O8UD>"J'^F&5NPUI>'\HWTUCTF?GK543T)(AC^A;/ @6,:,&_?XCEM04BI
M(%SY.)&K$H4'^0@SR4-R8?<?#%8U_;D*Q+@B<\S@(&$JLNIW2S::]U"/<>(U
M7\YK0S+2Q_)1NL21YE/4GDK7J9E?RED!2.2#99PB5$=ITB%&D"\]@Y<-+ACS
MA)\D]:[ I?N]OJUV!T <%'_M)J),4*F>07Y6ZWI%<#AHJ?;F3!2F#ZL@7+-0
M!"I2^I[B1E)?! (P_(?S";7\*]64#4LV]HQH^E>OAM&J!#;!FW,+A7U/V?^
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MI^:'ZF8Y7V1TFP_?X_&65"E^*;F!??Y1?I/ ;K$52ESF+YF1\*[L0))^0D9
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M:HJ_ )U8$ 7E27D*[&NK1^OD+D*Z*5MLZ=7)/&'A]5/G/TH@(\P+?DE:/:W
M36<>XJJ><>T634^J3:%9FK'.0=B?*GKCK MO%UK,::>Z[ L3BYW]\KC3*D<9
MVKXVQ="UQ[Q14-[#* Z))3_\?Q+ILY#/G-"+WOV;V5%GW]_<IJJAHIFNQZ3S
M7701K(MCPQW%E!)*;8'A<[17B9+6PBM=*QD]$S0ML+)14PE]0*<7PZ4]2 ZH
M\S8VS**2V&JK0(<YT^[RTZ%PYE\ W[6Z_=G3WL&,KG1+3'E[* AN%NJLM\&+
M9YX3-0F>TYF5<6G.Q ;ZW5Z25[8O<M&U-$8XPU0<?=L4\R<7FZO23D<J?CS%
MB[=_9U\(2$(^9-WI_:C62DJ*SR!S.3KH"*$7\S8JE;?0XSS*&MKEZA9FEV:.
M;PDV.BJ4JEG/L1 ,E%:43_Z&QIP)S<3"Q..PQ#? :L\ZJP=&OK1Z$=_EY#+'
M'BH;: C8THH0RQ%,RH7-%]]I@$J[TC7[%+.VV/:ZI6,9L?AS[F((V)OVFXBY
MI,5>%MMMV[N\4)J!?A>K\I8_O=:G3GM<F4""+B2>K+618P:A<R-T/&P3X0=%
MXO>ZTT(K;\5%)6M<PR^4Q-:[ACS3B7QI\A*X3'.YAFE^(!?YO9)551PH9:Z6
M@;+[O^[GU,+)_/WDM>]V-<BEJMS6%Z5<GFQ,AN?"L?+N-7CQWW!6+/3@Y)^R
MGT8F_P*4<T\)T&-(=E=STILI1!/^B"SY4LKGL</?F ^\;#"VPK&X&3J8R-Y3
MG:,1/YI[*Z%>4 6RY_G7PV\%2R8$"W9?83(%O(W@@(=)KNYC!Z';7M'F3P]\
M5 IE$>($8%I(KP2E)#D:/)4T-2'&LNM]$^/BEWM. F_^)(4'<*7)&U1O 11[
MYA[&1&M.A=\2,.5R&;9X%6IJ^OS9O4488\2"#5EJ&EFV78K>"[>X:@TSS_P8
M_/3J/E&I??G7&B .!JWV>>3J#4A?]VKVU>V8$S_5LCCV'UVT8Y@YVH7P/X/9
MM+XN=B-,/DFY^C0)#&$SWVUO@(A(*[0IDI>>-1,R]TD/@Y#5CCW9QTZ&2=H)
M(5444=_R]) VG$VPKP["GYY(K\2F#&D<$"P'-"FUJZ<F_>E'V:975$(0[XZV
MWEP",2<[%R(-OK>%=(@-;VUM2[Q V^F5%[/EO8#]/"\_R ![8[C60Y&3/(FB
M>R_-9QINHDPBS2N>J3]!!E6N-90BC(N^4EM*P$:TFE/]#$[K#;I]M+T%7-:N
M,;./SB0K/I9#KHY4[8:DTNL*6'+PW'Q]?5;D=@8Q#[4_2@>?GG8^'8T=8M<7
M!4K&A7RJ4"N>\CGT%;J119,LR'%V5\5SP51,"/\LF1"F$SZ+_J(79E%7_B>/
MJ>-I=*78BR_XYJ$OGXEH\WVIWR''FF-::&RPQNSDG$9KU)AF2^S@Y)*LG(<'
MQ0B1BR@[ Z X^%64SW]J]O\A392)P<$=3*U=46*?G>%E32HE"TMM[)/?HG C
M9PD/+>]'4R9Q^:9\ W&S&!&C-7[E%H]R>\[,A]U* SNON^%,H5<S?7[_&,6S
M_-/#:W^;;_4G!P9_:UL;3%J)@7V2X09_ ]:9%/![)'N2QOTIX0F."!TM]:D.
M,W;A<Z[%*JPO0'(1&M<_!FI6"2ZD[*1;P8FKBD5&L'OP'_(^+&H*MD:W<%#Q
M=LN>HJ>5078#X$U4+BUW8CKYWN;5YFO8M*?]7[ZH%H@@*P\/>"H1-50G:M4/
M .M4L>>"B+^U4<S,[!OB8K<TC_CE)W''ZQO=ZS0H_:A3 K*Y_05DM0P6"<I5
M;727#QBMW?&OHPTG8G085 ^3V%M?PKV#,(K6B"LW-*<VK?]E>_I %I-,"I%6
M:IQ18XC,2)8V$K!ZZOLG@S?,DWZ26W\!9WL_3>X<M+MQ*T5^'^)FU/5,E4&=
MOO7"RD@-O@)$.*!T$:'PM#1S@CT]\#*',96&;34QI"=2BZW751;M76T[R>74
MR2DO)N]>*J3D2_5B<1Z2Z)EEC]7!)]@KO:N88YG7Q0%:>_V+UH))OYM,*#X(
MOOD]2W]_57$*.^%UW;*(*=PS[VQ;Y!Y\8B9G$B=P9K/XZ'"/]?G>8/;!EHKU
MR:9=/N; 2DY'$ -?R045>5WT!IR?R@38\)>4TIS"'F9_$P0>+/#A1];1RR*[
M.\? J\7&E?6LM(35-A37+@\Z;K!1.TE#43Y0NHO:B=\[@A#G!<[>B1Y$?PB:
M"E4_D3Q%E&(H]_B;Z'V\;?]=Z/ T\6\1VI^J$"V%'HBPF*-'=8Z9Y2[4YZ6^
MWH#*:[?673:PF&N@.;%=AX'5D[2@=JO&ZOW04V?VG.2_8-2I*B;A,4?Q)_?<
M,5TO^!T+W,/]G)L\<6.<$63GX&@#8N@^@F\SA\_B_^M4BO=;8G0A1?;[7()
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M-D^(UO+JRE3/>'),4G\':5T_P+%_J;3T:=NH<K<)*:/GW8;1/Z%%P$I;X.Z
MXBP-F%?F?BO?4Y,K_^-CD6KW'-#X^],46L_#R52LUR^:>LVB1,Z\.#\312VK
M=/KY$4-:[56"(2OV(6C]#.JS"P,>.9ZHI/DKQ<A=6AI<N6_2JPFK)7+27SX
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MWR7 DH8&:)%]<]VTWXQ?OYHU<RJ6^/$G+-CBE3KE?0MORJD)]TL,H!<Z7W)
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M@M6_U =/4P5/*Q;PZZ^]Z_B^  \.N^D[;+KR!A?O^8&?C[^.UER#5NZ39#X
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MVG@D9*[PAZ3O-)8(0SX+*"VVV1A-2M03CC_SMCZK@5*UO*-FL+ =_*.7!^F
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M/77"7"1\@?D[0>1YL9/90(26C[^VS-I;F5U1.(+N&D]'I.9UEIWW_>OSR0>
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MMW%$S<JD%'>#K.#%QY*,G,@OZ4X=Q3&&4RW/1OK+Y9\GTUB/HQ$) <;KC6L
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MVKG0H8FC$:RRM).R*K/L%<J:M0] 3OAY9W$1D,: J :\R1\!._@*=\FMB97
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MR!]J9?C3*V!J=ZYB<;7?KMCP!3?ME'+^'*)4]\96F.Y"GCE!NAQC-4C?IF+
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M7=-@M[N3],H+B58U(=N2D)R 0J2=OBK\\Y-YBO[?4Y)4GUXF*(<7')9%9BH
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M7IUH*ECX'QPAMM+<+'=71_TFX<B)3^SW+')9$B1HJ1@!5% ,6!Q4-WKBZ/\
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M)7Y!)(ZCD>@'N?GA7<VSUE$J<7ZFORI4>(SEFK6 M+J2:(<5D()%-E)H 3X
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M Z=<JUT"T4\YV+<:?$O6@/T_?DTTVQM+-3)%&33Q7>F]#ODUTO3KW5)$CT^
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M!T$%1$H'*NQ)ZD^^'<-JJE3QXKU-:_2<$%$6C*"U!0>XWQ_%5%5%7(_7V/\
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MTSR:"3\\#SS+!%)*_P!F-:GZ,*M/F%S.&8E2W6N]:U/X88ZE"J0,6'QD5W!
MHN]#3(JI#LU' 1FY'N/ >V"PI)VH!4,2:;T&VWRR3Z=;N]#SY@?$5 [4Z4R7
MP0HO$L:*=R:^'^UB+H16B@AA0C:OCWVVQJ6XC%64L&'0#QZ=/E@NTM'+,0 !
MO0L=^HJ5KDNL[=D6/BO)"2:'Q^=,.E 52"M#0* 33<[CI^O 5Y(@MR%+;J 2
M:]36H'O@.SL3'&;EE N9ZJ*[T4T^$ ?/?#!2L>TA*T6I*[FM:4_"N(33&IC6
ME* FNXJU=OF:8BBNI!+*K.34?3X^&+7D;&!8PU$J* G8_3UR/2!V+!:\WI0
M[ ]=L4AN#ZJJ:@D[?$"#MX&F'9@95(/Q @GXA7?VIL?;"Z]+U$$ #SS[#D"%
MC'3F:>';Q.%SV*68$<;F1ZDNV_(LW4EJ;DX -NADJ%# DL5V'2AH#T\<ZS^0
M6E17_P"<7DVSDB5_WEPRCM5(7=3M3IGU!\T:<14 'G':QNI_RDD']<@>I0LU
MJ+I4Y-$"LJ>*,*,/NSTI^7'F+2]0T*SL(+UWO[6%0\-S*TLQ5 %#B1]W%*;[
MD=\DFN:/'KEN\<8":A #):R=/B'6-C_*V$7E&TL[V+5K34+-7,/I<XY5!X-\
M8(%1UP;<>4-*9VECLD16V44'08DF@VL% L*@5KT&"O3@@7HJJ,CNHZR &CMZ
M#K5ST'T9"[BVNM6?ZK&6$3FMQ+W*_P @^??VR9:9IHAC6%% 6,<0!L,%7UNE
MO;RNXI\).>0/S9UV.'1;;4+2Z1KBUENV2):L_K*KBK+3;BHJ&/T5[> M%LY
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MXF(*$OU'*@&_$'C].V"6@5"28@R'[(-2-J@T.Y!';MB'I4X.8I&?DRD'BY4
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MY5+JIU]TA.Y1NIB:#JT2LYE(X;I1/V;L;.3;+D+*P[< -XS*UC"<^D,"YHF
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MW5;H;E'G6WM9.FQ,T S41HYU#!Q6B$[Z6W]O&MV(25KGR&(4H3;TK_\MU?L
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MI;E"E\^=ZI&[M$WMVLHO#Z6-,TQF:?Z7;/KVY25T7) .&ORYEM1\] S(!D5
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MQ;NJWYPSN3<PC\W'+V5J9,Z7-/KYP\[XCX_?<^O[3<0,E&!YP]86/<.D&:%
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M1T4.Q/FH5C]7Q@F$#=)^4]6UY\ @75TN<*ZH^81>T0GP9*V*I?EBTZ)4',5
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M9K$27$,TV^4W,M\UQ#^T/@-<^!9*0\,OG?-9]%,X>S8D99HT;=.YL<F*N&<
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M1\)-.W1JIHXN3]E684^ $O=3WJ(O0)G=V0+F;^XER2O?OZN2^9?$D=G?J:5
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M.L^/?OE<&U%V]6]WL."+ZCX?CU:Q5B6>M(2F%NXQU^^;!KV(%,DX61[\X>Z
M&JWVO%?GI5D4\>F1M!F)(71<&$G48>#&#,'%C0;MQ&0S>U7K;.Y[#_[^@VJB
M;S<2&Y@NK)NV#Z*!/IH=5\-/7N]-;UH9F."N%DW+IN9'7GP1Z3_[B&1.;&S>
M]'\G_,5B2(O1IRL!S>]I(&:14,*)V@G(G>&Z.=5;(-0[8FI VV3%H.L3$J3T
M+8,;38(6F OAP?KSCSZE-E-33D<8T<517=+/@"QO*9HGCX&K=E,NGF!>;\>T
MM\!$55O((8C$LKZK>ZOSO>E_;AV'V2/J-L?2\_/R*>87])=O=MHH.[7^C*F<
M>^E+#!6=@NRNPWN[J)QDODD^?/87C'@S4&JJ#$CZ2F9RIC'-=5,5$]C<[>_R
MY*%W*3$N_2UV9V?^3/ORC0O)N _E38WL1"/=\,.YQ%!VR:$X:_62X[)Y>:I#
M@0,.!W-[3&":D,Z=]?^Y"_Z?@.D98-0P?'CY#.#*1+A+X(D6Q!_=P"M%I]4U
MI' M%9X!']EYVS+&5>F%+!D,"R[:F&^D&$)U!*V=H&HR]>C16C,ZB\.?$O8;
MSC.> ;1T-^8"&0)%])<$Q]]PKAA&+*^2J-=S2EZ6_L;;E9S7]\A#D:Z[; ^E
M(A7Y\GK)VG3<2ZNU)^B2U6V' -Y_+,=0$;SCB[F2O7#%-=G]&&2N>'PIQMHR
M^[*MA!_\[G6?C,0L].\G]S(]%NJ"_.WJO2WY@L=*JX,CG@']9 T#]^Q'+^^0
MF7L9W(/_CP4'/R_]7U!+ P04    "  N4UA6"L"Y"P_@   ]X@  %    '-N
M>2TR,#(R,3(S,5]G,C0N:G!GC+IU5%U!L*]Y\ 0-[GX([N[N[N[N[N[N[NY.
MD(.[:W G> @2/!P@\,B\>]_,?3(SM5;O_J?7ENZOJGY5:[^OO_\ ?)&1D)8
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M5J^C%^;USR@*@D/O1.=T?A?PS3N?_^JZ'$Q/MCT;1'MEVAKYO$$NA"G9IO#
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MV$^:$Y:9<:!5(>RB#II&"J XD!0&5:P0\T7M[M&56/TN$H=5E<I33@/0?'S
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MI7:?;:":^&W[W.3Y)AX9\8FU3:&[4JQ&'FB0Q#D&7'?T<$TB5G9TQ(KMHZH
M2FM5KQ(RK;I6JU0G72X6$/G> 9/XF%7G_:+YV++?6GV]WCJLEFIO!='3\9/;
ML.WRMG[Z\)+5>22-E(5J8K*1-W,;%M'79XE_5B:(_&-EHE',C\,9@9 HL=:K
M3-CV4#<1U\U$8[U6KR!-9WYGG@N=J8@6;G)AOR-E\P2W6WF:0K&:32#K;>YI
MA1F:]'T9:B&GFI<X T^XQAJ]JTN_FFZK+ TVUQVNC]R#?N.S#'RS#3V,E3C'
M;JY], C2IJ_,CJJ,<00 Y;R%#@HWOC\6-QIW0^@7?K[!-3_\Q#>"ZN[@UA@9
M6("ZO:/;.^C= !$;LY! FG_6]/OP,)S34R.$L]V$<!KR..A%I)?'\WS++@0[
MY$ B/9O_LV+9:;Q&*-C/9WE??S7;$JEF&"+Q#T2<GLVV>HT:9Q,YN2M"N0<=
M39U,DP:=SW=I@Y7?2;.*,IR3% .*-8I0;%^U9E'0!% G[,2%,;@AELMZE@XR
MIE5@?;WUL1 R^%23*XE$THEK21_CV?Y\56-S%T&L6C9N@HBD[R!_86&LX:F?
MF;(I@2OE5OIL48^A'@W0*,F%MU2Z;>3FZZ[(_IRBKHVZ$05LF7A@QW'Y< HF
M_ H8XP_?0 R*^?'9B=Q$W'.JXNM'6=Q.]E$[D GDF)B9.[^<%RJ_ TYW W,D
M"LQ?BU<8:N#H/44U'0K-&8UD7A>%BMX!_7CYKK_^]7PLB5Y?7R<3;W-O4^<*
M/-"@E^GH=/9D5?OI12ZBZ#V*J[2!B,-@M=.36^UR4(;V:?I)@:4U,$6"[NK"
M9F;&1AIXI< /"Z_\9%0UL 5;-&C5_3M$S7S)3UF"H11+.9;J9G3%O]E=QZ3(
M=,CW0TXQ,$<H5<JQ1EO+,8N?%>B_#G9C"[BO'6):?/NB"Z_I@%I=N>L"04O:
MH44XD$Q0(,#/2<1E:BK(?2@#F1QA02_TZ8HV'W[N$0*ONY8OJ4":6,/-!0*R
M )=]41]S,%F6MO1+ZT_:ZU31A;C"L[BO8G&*$D^=(5+L]J,XR7UR]'1D] 0)
MLMWP[ KWRLU%CUO U>\2*9_.F@@Z(90 ) N)Z*FS++[L-#I5P=(P\2K]C13,
MV]JM;BP4.H5FRT0K;,.&*C-C2KS*:K]UEJ*K .\ 1);6#'06TO62NO))N&VE
MT,T^7/8EAN%P![J7[]RH;?Q-&\?[?&(2T=AX4UJW]L_VHNV 99+F=.Y91)L+
M3QN 5["2=&6?J$4;\TRTHR>)=6(5N?&D#'717AOOP0&_2TJP+4$<38WZV9KS
M8[=%KN(=TH"..$S-BHTVF)UC-Q2?,<V\^\@=R< E"%[<_J4-?_EWYV4PQ2UG
MYGJ028IU[73J+#DU)GD5601(W?MHCYZ/(45[\D4XL9Z*_6_1'J9U^UZ$1&+R
M/01E/>;L<>\@L3%#7DGC%RNH9374CJB)L=*C>+Y577N?-]YH(#U.BC+0C?Q
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MKOM@BL<H'(=4:#2HFO!:AE$.+39$W4FFWM>DII5$%4O] L9)Y"O8,R>_(I/
MWFDEPT2#2BW!!77?<"VT]5)NVR>@9=SQW"Y&VE3'C8[CE<48$N>D0QNN8K&)
M.=6 @?:%TN:UZS2X)^UKJO*=7)R0QBH[M 2_1_8D;-]?9G\K28SFYRBU,:X9
MK9 97E00OKW\#3WD8J#V)@ 1;5(I3-6#,-*1(%-_8Q*=+?GBCDJ'L _5(*U1
MYLDX([LZ5HMH([0 7LC3)J+A(']<[^>;5I?PXZ$W1!&:A*<&65"0U%QO$3AC
M==;4MC]"B(NEB73R8F4;JL-/X"^M<17;];@OG\T(%W(>"/7WA/T/VPXYUER-
MWO:.R 6WSF ,6$3-C)T^K+/DEWY>/>M8ZI3%A2U^K3$M5R6?5[$ULG? ;8L]
MPU?US"5U5>%1$/$7Y/O*/AS.O-;S<!9JYJY"^7@;(0'R7MHH]J<'#5WOI3^Y
M"_E=2L9Q/D56_-35U'$/-_S4A[?<++>]/Z)F TQ(30G(&'5N!>U"]7_R&&]W
M#3HJEZ7'&14J)@ZI/9P?QFAYYU>XLVP#--HP?PH__KD,/;V#3-GTD2'WN.JV
M7S/Q,<I<W<3'F1D=;AS@OE1N-JQLW,][=N3<WM:;AI33:B:K[\38##V[#+5_
M.#/)X+HB5Y&'PGJ1D11:N:D4CF@^+Z@N/'#!P02@415="/,'7 "[EU<E/:-U
MM%5CL@Y%QY./O $0U]MY0- =U) Z??D#_=CM5&FF$)R23VCSD.T>LWSUCLH4
M-=%7U2&MY)AOSC )*_CH6U<3<\WL!:6X";<NF7H88H"RA(-P@.BXB4;ZG&;M
M7L=J8WU:T/4MD.H)0*M3[NM6/&=.'ET6@I-8?;XM5A-#*]Z(!42#\^^'*/B>
MPE0(&4.#3((\8$0I!T/V@ .I/G2FB5".,70F@37!.3#JW.,YEOS<#$O$[PR+
M$VI"V0 <]C,>6\)S6ILN,.J[+<RZ1V&SML-6OKTJM:W>3%U:;4W_JJ!VJ;8G
M*(L'VV9^(H\@=H>535E;<?Z(M1E?&@\6=D>;Q?>G.42ZLYQ6!(,=\^-T-(_'
MCU=:]S ?9N>S'$MAP^B[_FHL%'X9L^Y+GT\Y"T'?@J&T0\MB(0<-4T7=#$;?
MC4:V,X1>#<(C?U(.P?#'H8!Q4D%JDF&4;U)IH*L.0>5O$K/N&^:;!<>?JC7?
M81XMRLOZ<UBT"?GX0=B.*#W8O%[#)H+[RV7LZQG9O[92@&J12Y,;:0I1$!\,
M4WL.*\$)"+38/0F/MF-6AT7WZSY6VIQDZ35K]G-.O8X2S;=[.>Y(K(IQ.O0C
ME2J2T)@L<Z-E?!'WIJJBATF%3"1.Q_2RDAP+(/YV(!I.0N0PK4R,K*,T2(V+
M:D3-H?\+8N3XZUE*IZPBHCV (?6*W"%JK.WP/O[E*$"6FI9&FHM "I@3JGI+
MQ,V]T" BE23S6BK$_3TT0G2W\/.SBS>\[BQUY[=NE>1P$=RN@I5J07\GU7-9
MJ*;3!^U(=0<9A1WA,SG@<L\EKX1QQDN:2635T:=KMCGC$\<9?V8T]:[^&)@X
M(O$CA/N8O$//PMP 39:LA(JZ0/-#27=B#H1('\D3@T2/29B^AA3N<LRL:K:S
M\70>2^6FNYF"G% G(M;K)(4?7J&I2(*S 24ESP.20KA' H3C\[R>F:_?':MT
MQF%Z8@(:KTO<H8JO/!MD%O&[)\,LJ%%JQ/FYIIDHBXJV_)(X4Q@S)G_?G\VF
MW[NG?L^#B?\)<:B^3=Q/,EVSL[DMB]P(/^R*[M#B#E<OBA0EL*Y<!X[Q)@^,
M:>)5B5M^DJXF_VLP3J(I8/5M24G:4?#WJJ+,/H)&>/L#Q%[#RL3#W@E?+&W
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M\:9\B[CRO#HLDM]=07&H232JL5M$HXU8T4NQH H(-2<3AF\Q7]Y#IL=O::7
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M]:TJXGT^_2 <7XV\SA=S4'C0CI7.[7=Y#YI\OV6O:=;)!>DGUXCQ#NRFKN
M!0DCH,Y=YDMQ?())X_2^K*9!R!H>!JXKMN!VSRYYUN(H_-M])$T8MFE7N&8C
MB"#4@FF^33RA*$=)T;A&K4XTWVZ$ ^.>B?+D]R\T5S>R![")2!$0.K?9-* Y
M.H]1,MQ\7,D+Q)+;4.U*#MD\TCT'B8(P-2/4)-0P':M33)=;S0F9&1 9"K<5
M.WIT% V^V3:TD,PMBJD%CQ8@;/T.].PR:6EC&;26"&U6/A)0M& 5/+>H(IMA
MI"H@MF6:K(W'DS*13:E"M#C)+A;>&>XB9A$''I$&O[M@.04GKT/N,B/F%TE@
M6:-@TD3O(J)1698P*J0/9@03V!SD_F<2_NS"_.7D09"!Q=&;D/$;@_?D;OI7
M"(OQ*K+PE%3]L]P>WX9#9]->\/I"#]TDG%223]D4^>=$\DZ4MK+$H7X0U652
M01^.>@90_P"APXJK  ,W4[GP[?1GF#\PK&YFYK%^\='KQ!J*U&].F^<24W<6
MHO,W..(MQH%K0K3?8=0,](^4+OT/JZ3>I-'0*O$FBK(.1Y+W^(=3G0/73ZLR
MGA'-$&99>"D+2IIQ IU^[(IJ)L=:L%CN;2UO0A1_K16.21J@A2$95?L>E<"P
MP6%S9V]O%#^ZA8.9II'F1N-01SD+/%3Y# \NFVRWCEK:+20E?2>0K)$Q-=T8
MFC@UZ'QZ9'=87ZE%=)JMJ);%D9A=1@#@0"1SB2AIM]H5IWIG$-:\N:9JLDLT
ML4$L# *ADKR/+?[=:TVVWR#:AI.GZ;IT)BMOJ_$@U9G?FWQ"A)+ ?3XYRO5+
M,7VIVDCP@/"LB\3L0"R$#:G]N3#R]Y?,/FS0XY(U/)99 "">("C<CV:E<[)J
M6CP:YYHTORM#&)-+LD^NZLOQ<)(X]@K;A@7<@=?'MG6I5 V  5:  "@ '0"F
M%LO?WPMEPNE[X72G $AP(YZX%??M@5]R<#MWP.V!VQ!C@=R?HQ X';\<2(/T
M8DWOB#Y]"O\ G$G5WE_YQX_YR\T%IV,=CY4N[^.(\>(-UI.J12.O<G_15#=O
ML^.>;_\ G-C5_P!+_P#.3GYFR*X:*QFTZPC ((7ZMIUI&XJ /]V!COTZ=L\N
MH1@R,X,3<5P4F#4."4WWP2F"T-<%Q]<'Q##"(891#88,0=,$I@I ,%H,&Q]L
M'Q=!7!\8Z8/C'WX,3;.&Z?:R0>=_.6A2\9;6XO6O$A<#>&Y42DK[_$V^2_R-
M'9"[@L[IF.EVLY*(RU4KR?AL? BIP;^;VD3_ *&OKG1C%-+%$)HO2XC92:&@
M'T9\[=?>ZEOS=-:4618G"_RN *IL*[$]<FV@S("D2[+(@<5J#R%/A^__ #.>
M@]$NE>&!&++) :R#Q.].OSZ9,-+E>5@>0$H>HH.JC?C4],Z%HLCQ%JJ$]0<0
MH-14C?Z<Z#I4MMSI0EG-).1V]@!7[LZ;I5O'*H*N K@,%7?>E-NGW9T"R!CA
M,5NXJR?'0\06[ CJ:]C@E5D>LRH0ZQD\7!+$#8ACTVZ81W<L:%X1ZB12G[=1
M0ECV!J/BKOD.O[RXL$:&=>8M7Y"1*#TQ0H6<5Z4--JC. ^:O-(M[IK9 LR/4
MQ<2***_9'?;$+6>1H())Y!28<N!-0*']>2+34AE4/_E$A1M7Y#.B:!HS0-ZG
MIEHW ),FRA=C3Y$9TK4)UDMA:!O3I!\+=MEY @;>&^>??-K2)<GD@C ^%R1T
MKT(/OD!1]/BFC>ZBC!N).:!ATD7O7Z,ZCH=O;M5H#$]:<67QZ+Q(/AV.V&5V
M9H[A)/7J7;XU7[,E>].HWZ>^%LS@4:*1>,'QI*5/.DE4X'<[CQ/3&?5Y^(DC
MMDGF@1FJM0[OQ7;:NU-Z@=-\)IN:H0ZG3_51@UNS"6)V-0?A)V<;D4IA3J.G
MQ:C'!;Z?(([92L4YE^*%.5*%/B^$UH:@A:[=\YMJ&A369U"TDE4-$K!(U4&-
MR":\3TWZC;;<#;(1KSQKHS)/(K3"-6>-0=BVQWZ\2=ZT_'.3:=!]:D^MR-5X
M[@0!@"*M\/( 5[G.K:;;C3O-6EWC@1^E8W!Y> 4(:@= * YTK\O-.?\ 1E]Y
MENXV6_\ ,\YG42?:2TC++ N_B*O].3&<=<*Y1U\<+)=JX6RX63872'? CGWP
M.QZX&?K@=L#/UP.V!W.!V.(MTQ%L3.)-WP,_?/8/_.*.J^CY9_YRDT3G3](?
ME'KM]QWW^IPR1UI3M]<\>^>=?^<D-0;4?^<@/SEN&+$Q^<=8M?CI6EI=26X&
MW:D6WMG'4/3!L9P9&<&H<%+O[8+3!2=L%I@N/!\7ZL,H@-L,8\'(.F"%&"4%
M,%I\L'1C!\0Z8/B&&$8P8HVSBWGXIH'G'1O,'-K>+7+%]-G< 4,L#56OOZ<I
MI\L'R7UIID6GZO8)+-!ITPCGBX\ZPR5Y,M"/LD]^V2/5=106#3V5^FH6$M74
M2 \HJ;A33<TKWSPMYOE6Y\P:J*(.,H>1Z <68"HXFC4-/]K"""Y^KZAP#>D#
M10".0H1M05[9Z)\LW320PDM\2J.,:[#8'<G.D6,I"_"Q3U"%:,DKN.]:Y/--
MNHX9$##XS0_#6@K[[[DYT/3;E&E5K@>F@!/J@;?+?YYU+2;FVMU0%V95(<@#
MDQW'AOWSH]A=QRQEX_36<(PI(2/A&VU -B#]&)RS,L+(?C+$L%D4@,&&_*A!
MWIU&0^]O92)D1UMFA!XCFK@#P8=P?EG/==M+Z\BD-N@DE1661@:*R$;@]OE7
MIG*;/R3ZEY+<ZHS-Z$M%!%*#P]\,M52"UC@B3BG&AH/GMT_#)/H2QM(CK&9&
M*C9@-Z]",[]Y52R] (WIJ-RRL.1H:BGW[8:7E@6CN"I1UD.RD <4H02IZCKO
MGG+SW(]LCI&GJ);GC)7?F*]_NKG#=41M2TR:.WWNHA*R4.Y*#D0![TR:_EKJ
MMW?:/$D,),\1"B+F5!/<MML -Z'KG5;TR0VXC=2+B1: 2$^IO0@;?JPC5)(X
M8+@JJ(6;G7KP)V)W [=,-(6<R-(45F4\E0<@U6 5&3N?E_#'W6BV\C![ZY+Q
MQD220ASP* ?%4[$FNVQ_#(WJ,4+13F-CZD8/I(".,B$#U!6@K4&HWZC.8>8+
M@HK(7+O8T*2UH9%X@H:=?GG&/-M]'&B/\*AI5*H-_P!W(O$C:AH'W'A@7R%:
M07@TNSX>M/=WLDS!CU#.0".G0="3AAK<\VL>=-1T_3W$%LJ)I5NZ?::2Y<1<
MR*=0H)VSU%';16EM;V< (@LXD@C'^1&H5?P& )QUPKE[X5S=Z862C"R;"J4]
M<!L:UKB38'; [X&;; S==^V!V.!FQ(_/$R,8V^(,<#.<]!_\XY:B;+4OSAMP
MQ7]+?E'YSM2.?'EQT]KBE/VO]YZT^GMGG_\ ,RZ-]^9/Y@WK((S>>9=6G*@U
MX^I>3-2NWCD.0X.C/O@U#T\,%H<%J>F#$/08+0X,C_7@Q,'1=O;#"(],-(?O
MPQCIM@@#%4/;QP9'@^,#!T8P?%VPQC[8,4;9S[\TM!EUWR=?&TC:34-%==4M
MU3[;BWJ9HU]VC+?33.?^4;^/4M,CA6=;N&Z0LJ@4)0T)KX[8::K:IIEG((2
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M&(A-6DM5V4E^14#^&+2W<1C0%U]=$ ]2M3NPJ!X==]\!WLQ6+]X$$A0,K$]
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M*U;X2I(W[[]\+XKU43C+'0E JL]>)4'=2=CN.F03S1:1SP230P".4KR4(NS
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MNJ>15L+F]DM4](R!71AU)XT/X9Y_U[\L?,^M7,]SIMQ+:W;-R"VG/D .[,I
MKD63R9^<N@-Z@U!=21?B,=[$"6 Z 21\3]Y.7<?FQY[\OJD>L>3KB$0$_P"E
M6H-Q&OR- :;=",%6?_.22QMRN(?1)^WZD<JKTW['OOUR;:;_ ,Y&:-J,D<'.
MS(044<MU[[&M>N3BW_,WR_JX?G($4*>);XJ@_:H13"">#1M029K.\2X9F+\:
MT8#<@'?I\LB6J:5I5D0SSQ(1QH20"2>PJ<CT0T^X?TH[A64GD #OQ'^UDZL+
M2VDB5H^#K".3&NY-*4H<E6G\+4*@1T,B$R-0"JL.F_A3KDDL_-'U1[6"*E-@
M02.3?%0**DGW)[9U?3=0OI;47+VA:7AUB%4"_M<=AT'7?]6<,\VV @\T17*0
MFUCOXF+<#0>JM*%2%%?A/3 5W-]6'Q@2R.-F&Q( &Q/?;OU]Z9$=9NU>%"P4
M 'CQ84J:]&I3OT-/ZY -0F"JT+$IS/4M4<&V[]:4.$%[?&" -\ 1/B!)I4!:
M _/OM3/H]^27E\>6ORK\I6\ENEOJ&K6@U:_*K1GEO6:9.;=25B=5%3M2F=%E
M>M=\+IFZX5S/3"F=L*)F&^%<S853'K7"N8]=\+WZXCC3@=S@=C@5S@9CUQ!C
MB5<HMMB#M@=V[# CG S'KDM\AV[W>NWT49563R[YCF/([<8=$U"5AL#O1#3(
MO^8%F=-\^^=].,0M_J&OZE;F($$)Z5U*G$$$C:E.N1,8LN"T^6"4/3!2FNV"
MD-*8*1M\&(>GA@R,[C!L;890N=L-8GZ5P:C8)1\&(U<&QMAA$V#XVWPQB;!\
M;88Q-[X.C;WP8C5IGA__ )S0D:23\M+.OPC])W!^=;9.OT9XJDMF2UN& !].
M16HU*_ :'8^QRF<";DI$JJQ(8=#TK3EO].3G0KD"WCJ25%21TW[@FG7)A<GE
M#;R%Z*6&W0#VSI_D^6('TE9F,@4@BH)&U: CQSU)Y16*/@PX_" 7H:\CXGWS
MH&NV4=Y9J]>=5&Z]03WZ]@<*K#2X[>VBD6#@(/A5$6A)\"VU:]<=K7ER#5-/
ME6$+'=!6,9/0FE:'B=OGG!EN/JEP]C=VRQ_5I#ZVPXBOB.]=L,HO*OD36HN=
MSH\'UF23B9DC7B4/1:4I4GO7"B[_ "$_+;59EBN-!M^4\A5)H5$;J=OV13<]
ML*]1_P"<5O++Q(?+GF*_T<I4_NYN84>++(2!O]^<LUC\C_S$\MB5])UNTUV"
M+FQ:=6MIE *C[<9=&ZCMG/;SRI^9 E,L^F6,DY6H9[AVW_V24_#(7>V7GRT5
MY1I<%5.ZI*Q84[[H/U84#SMYJTNJ7FDWL/ T/I5=3M]&2#3?SAN!)344O-A0
M+)!)6G@ H(R1Z=^9^G6EPM[/IM_/*Q"KSM9#$"3L3^UWIGH#RE^<)NEC@M[2
M63UOA*I'(0:; <2B4I[Y-+VVEUW5-/5U$997>01@KQ4BE2:-5@>H&%.K0QVA
M>UNDI);,0Y-:&NX9"-Z$48$?+KG,-<GC7U4,0-1Q(K4478$BM0?X9R^\N0S-
MQXLK,K _:;:O?P[X$TW2YO-&OZ+Y5M'_ 'OF"]@T]>-3P%Q(JNVW\JU;/KIZ
M4-M##:VP*VUI$EO"IZB.)0B#Z%48!E:E<+9G^C"B9_?"F=^N%4SX62MA;,V%
M4IK@%CB>,8X&<X&8X&<X&8X'8]<3)QI/7$'.!7.!G.V!V.=-_)^S%[YJUI61
MGCMO(_G>X<K^SZ7E?6&1C[<^(PH_YR!T\:7^>OYQV2*JQ1>=-<:-4)(6.2^G
M=%J:&H5@#G(P>F+K@E3X8)0X)0],%(<%)@M3O@N,X-C;?#")NF&<+],'H^"5
M>NV#(VZ8.C;I@^)NGO@^-J881.-M\,8GPPC<"F#HG&"7N(;:*6XN)5A@@4O)
M(YHJJ.I)SYZ?\Y.><[+SCYB\N6-A 8X?+MK='FY_>.9I(CR91LH_=[#<^.>>
M;FWHMRE.7-0QH-J,O;KTR.1J0>)%6K04%&K3YBN2/1KEHN,?#C)R!K7<GI7I
M3VR>QR%K-75B?0?<=@ 30TI7H<Z3Y7?A=Q^FQ9.0()- *BI^B@SU1Y5OXUCC
MC5B9"M>2&I.=9^N\[2*3TQR2E17D0"-ZC$[>_@XNC.@->C&C+4[$@^'MAU:3
MHA =065N+#KMTW&Q-1G)/S1\G+?27=QIK&&\3]X4:G5@'''B!GGJP\T7UC=S
MV6H((61?BC=>)--B1L/#.@:7YRGB1627ZP@4%00&(IMM53TR3IYV0)5N"*5X
M@KQ+4(J0M.Y.Y&)IYXC=53T_4C,;<N2@A*]J ]^WAD.U*\TV\1C_ +RR.U2L
M;;,WVJ $4 /3(/?6T%P9/3V+T!*A2U!UJ<CS:;:C@)?3<QD,* 4H"#W&PVQE
MIY-M-49;F#3T"I)N64':H  VZYT^R_+RP%I$LD4 G6&B!D'"I H&!!)Y5P_T
MOR5' ))T@^JW(KR=!P 91]@U %1[Y-/*GET(]QJ%TCJ6B*(NS<E!JS 44C_/
MPR!>>9K>X+U7@UL?@EI5N!ZU7N*"M/$9YV\Q3LA9$7B]&%>@*@@UZ9SMWXJ2
M:JQW._VBI[#]6=Q_YQC\O_IC\RQK$B<K;REILU\>_&YN:V]N1X&CN=O#/H-*
M_7"V9^O;"N:3K7MA7,_7"F9\*YFZX62O2N%LS=1A=*<!MB1.)L<#.WA@5VV.
M!G;WP.S?=B+'$6(^G$RV(LWO@=C@5S@=CG??^<=K#Z[K/YJ7%*_HC\J/.UWU
MI3EI$]OT[_[T9O\ G-#3&TG_ )R<_-:V*T$]]9WJFI-1>:?:7%02!WE/RZ9Y
M@'7%5P0IZ>V"5."$."E/3!<;=,&(?NP2IP9&:8.C;IAC$^#D?!:-@V-NGA@Z
M-L'1O@Z-ZX.C?!\4F&$4G0881,6*A02Q- !OA!Y^$UCY&\P^9YR?T9H-M-<&
M,5K))$I->P-.BBO7/D1Y;U:[\S:WK.J7\YFN+VX<$UJJ#A142O9:[G)I=Q-_
MHTJ@ 2P\:$4^R ?X[9!YHQ!<R@@T.YX^X\: _(XO!+Z6W DB@(-#52=MZ=:9
M/K.]9K)E9>1D6KEJ5('3C3MMG0_+L@:.,J2!(H KU!'CUSTCY1O62**,J-BM
M5Z,>E>WATSLUG=E;9V/Q(U5([CL.OW8+M70LR,H=74#C2K%2=Z5K7?#A&IZ:
MA6C!!*EMNQ/>N_8X.N%-VB7!IR@Y03*X^,JP!4D5Z"AH<XQYZ_+VQUDF6(+;
M7$!#1S!:$&O2H!V-<XV_E34K*=HQ*?@J"0#Q'@2"#M@I-&:&'UI+B621J\E4
M<55N@I0_PS1:7=)&PM;AGD Y<@"**.JFAKU[81WEOJ, $O(7',U* $TIT-!3
MZ<*#+J3H$CLI/6D8%U0'X@:@"E-R,/\ 1_).L7TL;:C)'!$0&,0Y$]-@25'4
M=1VSKEIHD%A%:V<*H"A55-=P#U[>V^26*&'UXT^*5_'NP7>AZT'CAC+);LZ0
MHO&2,\B=N)C\&K4DBM <4UC7+.PLW:W^"4P@(R$<@HKL!L"!WSROYF\P->7C
M25<&9F/ FBDCQ%=JYQ?6+ARY8U)J: $G:IZ#(M?S_O#"H("BK58]*'O\L^@'
M_.,OE)_+GY<KYAO!_N2\^SKJA&X,=E$IBLTW ^T.4A_UQOG?)).N%DS]L+)6
MZ[X5S/U-<*Y6ZX5S/UWPLE?K@"1O# +]<#-WQ!C[8'9L"NV!G; SDX@3B+'K
MB1-<38[8@QQ!CUP*YP.QZ]\]>?\ .)^F^MI'_.3^KE:KI_Y,>9K45ILUU$C@
MTZUI;'<89_\ /QG1OT7_ ,Y$_7PM!YC\L:9J%?$QO<V7B>UH/#/"*G[CBPQ9
M3BZG!*'!*'I@I&W&#(V]\&H0?G@I,&1G!\;=-\&(V#8WP;&VXWP:C>_3!D;C
M!L;X-1\'1/4@"I/2F<L\_P#YZ>1_R[]:TN[EM;UZ$;Z98,M8SV^L3FJ1?+=O
M\G/*>D?G-^;/Y_?F-Y?_ "[T+5&\H:%KM[QO(-#Y1R1Z?%^\N7FO/[YB(E8;
M%!R(VSZ8?GWH#V__ #C)^9MGI$)C_1?EV<0QI5BL,"BN^Y)"*=\^*?Y8QF(6
M2UWNWE<>--AM]&=A%KZEGS J8)&0DU_9)'(@CI3:F0#68&@O0P0\9%I0[BHZ
MC\<+DFX,H8$'8BIIMW'S&273I:,8RNQ!Z$"K4J#G2_+%VH=5>79%Y*OA\J9Z
M!\I7L9$(F9PM5HX%>HJ/;.TV]R&2.,LHHHWI10OC[GZ</[4P@QIZBPM)R(=@
MW$$ [  ]SDKAA>2&*99PK0E%?CN!T!8\@10C'2SQ64LRS-ZUN2K>HH)J&8 $
M!2>XP->6UU.DGU>PDEC6A954E@O8FIV^C(GK/D[7YX4=+#UIW *DSQ(W$^U1
M\/X^V<[G\J^<;9Y5D\JSSJ&W:.2*0D5_U^_N,#6]IK;7'H3Z%=V42*162%E4
M-7<$D=#['#&VTA;F=9)(:H@H6CC;BQI\(#,HH:8)31(!N54,Y/;X0 -P#4G^
MN&<*(5!5 JHM5%?;K3VQ:..,W'K-(8UA'P4\2#6NVPHW6G7$+HSV\WJQ1&;X
M/3'$#[96M!2GS.1C4=9DBO*12L@56+,_0T/C0#N<A7F77IFLV*R<%,985-0"
M:[U]S\\XI>7:*OJS/^_$;.JMX4%17Z<YY?7BW$DT]*<B2H/8+L*^]<,/RS\D
MW?YH^=],\MPF1=(Y_6]:N1UBTZ)@9MQT:0GTTW^TWMGU=I#!%%;VT*6MM;1I
M#!#&*)%%&H1$4=@J@ 8 EDPNE?"Z9_HPJF?KA5,_OA9*^%\C==\!.>^!'/7
MKM@5WZX$=NN!F?K@9VQ!FQ$M]&)%L1+8D6[XDS# [-@=CB#'KGT,_P"<0-(*
M_D#_ ,YC:^ZFDWDNZT^(^'I:5J\LHZ]_53MDF_Y^B:$8?,'Y1^9U2HU#3]4T
MN1Q7X?J<MM/&#M3?ZVU-^QSY5J?;%U."%."$.+J?IP0I_#!*'!<;=,&QM@M#
M@J-MQ@Z-^F#$?!L;8+5Z4P6DF"TDP9')]^#HG+&@J2>V>4OSA_/"<-J/ECR;
M?M9V5IRBU/6(6I),XJ&M[1P?A4='<;GHNVY\!ZOJSW<K!7I"&)4>))W)[U.?
M4O\ YP"_)NXTG1]2_-?7;3T;WS7&++0Q**.FFHW*2<5 (]:113_)0'HV?3Y=
M$LM=T/6O+>IQ<].URQGL;A>H,<\;1/\ \*QS\_U_Y*U'\MO--WY.U%&6_P#*
M^L7FF2$BG,1[1R _RNG%OIR<$4%U$H'IN_-01N.=&!4[>.XR$^9+0+$;M5;D
MC!FY=MJ-^&1)XB4!IN#6O<#Q^6"=/N&5^#D%XC0G854_,'ID_P!%O8UY1.I/
M(!B5V([4%/<9V_RUJBLJH'*1E1P8> /3.SVFJ@Q(WJ"H B"[5+#K0$'KDYT_
M4;+ZO&HB9/5/)N;44-2H%#6M:=MLZ9IVHZ;+&J<:0.J\:N5+,=R![9(@VAZ=
M"M[;0FX:-2@;F6H:?9"MV)K7"F;7[F[:Y,'P(@*T&W510D=1T/\ MX!GNKMK
ME!-,##)Q4Q]22QI[#)9''#,L4=!S+5:5R*K0T"\3L>G4YO1$[EHI%,?-C4H2
MR@'X0.M=OM'"#60=/=BC<8&;>@!4L*-0#O0&O]<@D\NGW+U93 T;<RL0HKEZ
M [<:[,< P:7J,[RQS-#96]N-VY!Z\J5%!N21N.V*3V]G;HMF:%FY O3][R!Y
M%F9:!E%=NFP^61O5&N;:#FW%"L9:-83RY [%EJ-CL:^ \<X_JM^EW?*8YFF^
M#I4&FU6-*[]<B>L719Z;.0GV>@8]>G<4IG*-=O8P3QY<Q5*5- H--A^H9 9C
M=7MW;:?IUK+?:CJ4\=K9VL(+2S32G@J*HW+,3MGTS_)S\LK?\K?*2:=/Z5QY
MGU4I<ZW=Q48&8 \+:-^\<() /[3<G[C.G228 EDZX72R#??"R63KA7,]<+)'
MPOE;K@&0X!D? 4CX#DDP([UP,S^^!G>M<09J^^!RV)$_=B3$XDS8B6Q%FQ!F
MKB)/?$R<^M?_ #C#H7Z-_P"<%_S[U9TI)YCTWSA<(YJ*PV^BBV4=:;/$^_O[
M9._^?EWETZE^2?EKS#&@:7RSYIM_4;^6WO;:YB>G_/58L^&RG%U/O@A3BZG!
M"GO@E3@A3]^"4."T;I@Q&P4AH?G@N-JX,C?IO@Z-L$HWO@A6P8DG3!22=/'.
M)?G5^9/^'M-?RIHEQQ\PZM$/K4D9HUE9N.I/9Y!LO<+4^&>(_-I?3] CC5 C
M2 "J^#'J=_GVR6_\XP?D1=_GO^8D&G7B2Q>2?+GIWWF.[0E:PECZ5I&W^_)V
M4K[(&;MGZ!-&T2STJTM;2PM8K*QL42"WMX4XQQ11*$C1%'[*JH ]LEEM2,QN
M/A],D4]NO4=<^=__ #G+^5BQW>A?G%HMNOHF:WT[7Q&* 2<@+2Y:F^]/28_Z
MF>,) T=S2@3U8HV*#;B%-._<C VMVL<D<\)3FH2M!T (W'XU&<IBC($D-:R0
ML4XGL/#[C@68RVTD<RH3PVXMU(!W!.26RN./HRHQ]*9>2L-B0>QI^.=*\OZK
MP$8>;8,&4=ZCH1X5IG4XO,):6%H_W#5_9/)02O2M=SMG0=$UE9A;DS)ZG-#3
M:I"MX=NN=8TW5DECB+RJ:H$"]06:O3[\E4FK0QVMLO#D8J-/PW)7<*!QH>YV
MI@C2+B*\O;CJ.7+AN0>/3E44W_F^C!]Y+&'C:21)W4T+5"GI4$DT%:'#2#52
M"M6XSNW)054JVU&#4[D"F#K/6Q86\372L!$&XL.%4Y5J=_#:AR):]K_J27DT
M0BFBD7C$A%69I O8>XJ33?ID*9XQ)/<3/Z<D("$\:#DP&YWV(XYK+5C-'=K(
MR&L4$@8DUXJ]"%IO4AM]L+M0U$QU8J%EBC*JP)*4/VJDUI385R#ZQJ[_ %&8
M-(IY+P"+0*#\ZFN^XSCDVJR)<W%R2H$2D,JC9FI2E!6G3[\BNIZ@UU%)*" *
MT+'KTJ1^.<JU342KS/,U?3!<\B:!0/H[#/</_./WY/)Y/LK;SUYFM^?G#5[?
ME8V\J_\ '*M)EVV/2XE0_&?V%/ ;EL])O+@627PP!++6N%TLG7"R5^N%LK]=
M\+Y'P!(_7 ,C[872R8 DDZX#=\#L_O@9GP.S5K7$6;WQ$MMB1;$B^(LV_7$6
M;]>(EL28XF3C&S[M>0_+O^&?^??^HV!3@]Y^5GF+5F-*%OTK97]^K&O7X;@4
M]O;.H?\ .8'E>7S=_P XV?FSIEO EQ<66C_IB,.2"OZ)FBOY&0A6/+T[9@!W
M^S4 G/S6JV"$;WP6AZ8N#BRFF"4."E;!"-[X)1L%(^"T;WP6C;X,1NGC@Q'P
M4KXNK],$(_3.?_F)^9%KY)LE@M/3O/,=\A^JVQ-1$NX]>8#HH/V1^T?:N>)I
M[J]U*]N+_49Y+V\OY6>>XE8EGD<_%4T%*> &W;;;*\Q>6=:\SS:'Y<\OV$FH
MZUK5S;6EG;Q;M)+*_$ D= .52QV J3L,^Y__ #C=^16E?DC^7&D^582EWJLQ
M-_K5\HI];U&90'>I /IH $C!_9%>I.=ZDA4E0P)%.E/#Z:YIAQC5D% QH?HW
M^_"+7M%TKS?Y>UCRQKELM[I6NVDEI/%$G5507%VTK1MW#>[!W8(%E^#N[NX!
M@DLCP9U@@6!!&@GNVKB[!PT>')I&&KWYS[EU[\.J_;BKUAISCF_LJK6GT&IQ
MG(YKO6F,6#9" 87H]?ZF,N0-,-GZJKL,%UC I?8^?#])O+LD--=QSU*]"1Q#
MU_+I$N]0VE0WPH,B+M,<0;LURC-1"\&Q_,.UG7%EQ5:)0L;>PJ"ER5RL)>>
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MVR?X -=6$P-:+37)-()P5(#&?#:V# ;3H/*[(2>4/<APOXK-E=9?=2HS0KH
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M'&XM'-;P(,<--U%>XO+?M8RVR+FM1@]DKMLTK7=;W[TM=8_O7=">&J>!N6^
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M7(9-BJ:' V)2ATL6D@X+'/1KZ-@^O"?DLYQ+=$*[OP?LF^L%!/A<<Z?IF[D
M +3X0+\)<SQ)MIY@B3? #X3GWF"O,7&'Y^;N-G]WT5(??DHQ>JLC:/!U<66:
M*KQ:=</9QZ..DG SZ:^A:.5, <D42LHANM6H2K.O% [<Y,: 3S^DI)22<1V"
M6\G_L)4C_DBI)HGC2G;?VTNAU%=*,AH%8P15M=6ZA&\:*CK3I: EZ.^4 G-K
MWFT9E<R-HD/DR_D)8?^8-!8H#F0,Z7)[7BI<?U?!'E3K.JMC.D#R9(%S[X0.
MW<QR*]0?\*0)B\&TE2?7K5 "LI3]UAP?'2>2_F1_IJ##NQ*@CX*FS@KNU8'
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MRG&3C>/A]#EDK*</K%-J'W; B/Z=^@=T;'&10FTFYGNZWDX1*\[(5)DX "0
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M?=M=">0/"K%K]"[P3@SJY1VYQ[N)K%#KNE&2_+"L32OW_'/MWXZ>94L5?8,
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MSBI*?UO[*LY\JV<LSM1/>0IQFX/Z9"=.YVX?A:C#?0L$UR>(07$RI\?X^RR
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MEY_I/7.O43FHYKC[_<^H&X3>%=,9*["68ST(UW(1\=9Z(U0O\./#IJ-D$+,
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M".'[W[9<MI^WG[>GY"6H4AM.;_HNZ*K,7I56,L<+7/)(Y?7V^*#!/5FKI!S
MKVCSSA _MQ!C0/&PZ0\!R1[7412*:0(!<+'7GSR,Y%#=)E^[1ACWFGXF1RJP
MAM%7,-(*18K;GZ_5W^SO<$#=NKQ7LX/5-<WZ4*SX09")-F,3!TR.=K/UH-0E
MCD3$@_WYF=EW\6L,JC>/T\;JO4T=P)-T3>I+M$J _;GX@T,YK%PP#G3&/!Z:
M.(KT#H*,G*QX/89"P7<?#QV$TKFO ?.1$Z?97#\V*#JZBS-P5R./7WAQNI3;
M3E7++2C^$(\2L<7($D0WZ&I*.6UWL;O>-<J!?6Z@1F,-K*=X\/ZIT%UOL2;
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MK+$1?1CCTCY52LWQ ;A1G@=8 .IF.\1-H_:E&SJ28&'E57DUA>H&>.X\==U
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M'8#+ZGVRZ=>V;COME\:?/* ZY?#-0=.V.X]AF K[$'%HHUJ[N PC0L$[,:@
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M %-S*^[.&K2-4;B&J:D]]CG';2+ZQ;>9I41;E=&L;?3'YI5+N:\F6>C,JL6
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M[V;D?6EMM.O"8XI>-5$A"1JV]:BGAGO2?4YK/5Y;>2.-[R\TN%HR9*K)- Z
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M6X%!0#XOA!I3:OTDRT]_3M%A<*7"\".Y4]/ISP[_ ,Y+VH@\P:%J>_QSQ1W
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MA9?4#(H](5H.-26J!M6N%\UP%=2$#S2,=_#C_9A_Y:U"1;J\G6W>ZCMDD:8
M[(I4J_&BFM!UKL,*;Q$G$CQRLHD(!A8_8#=ZT SG/F4&U963][4@$1[CO7?M
MN.F%-A<+ZYAE7DH4U"[#8U%3XY*+'DI CH5<@\J M0D4V/8?/)%<6(AED"S1
MJII1%8TW3F.6Q)Z5.V):6EY#<!R>7+B@8@-3XMJ&IV.=32V21%+(T2+0J%
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MZ8F4:O3;MB91@?;*,9%#3YXQD.V),.]/\SB3)L:8@T=16E#_ !P,\>U*8'9
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M=^@V%, RPQBS 9U"TY@=8U/\I()-:=!^.>6OS5\UMH]O/;67)+AJJ U**O\
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M.IQX )ITQXZ^(]L>%.]<40^FR..J$-M[9W#3)([RRA99&9I(^2MLQJ0"10^
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M).*@^V!2NY\3TSVA_P X5^6?K?G#S7YIECY1Z%IL=C$3T$U])RY+[A+9@?\
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M^* 4[9J>WMF(J?#PQP\*]<Q(\.F6"#CQN.NV6 ,<!C]]ML4 [MMCO#MCQR)
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M9]'$:3D:/UN*"C^:6/V#'S>K4"T_/$^\[#-=(@W:KYCL0Q6!\R[7U;^ \;\
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M7'$:\7Z1@[',44&!D0I,\6@WGBGO1U!6:-;*E[0F?A@1WJ,L1_(>&'R#I))
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MS>S@H_,$ACE<4HM,=9 \*GU:I% 1S[6*UZ6LLYLG<@]@?]YYO5R]?0^0VZ/
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MYM6J'RI2KN/\^9T\JC(T<R7TZHQ>;<28B7Y4R9%VXULS6U37RXWLIHSW77Z
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M&[G4IG?M$&>A1O"7SEH;<@+O86$ $CHAM(JG_#48VEL)@M;6J\3"RR#,8V=
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MX^SA[&[C[$+)Q<H.X)=44($Y!_P'F/_) $ !H/Y'_+@ X$A8.IM; 2Q#_I,
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M^P#DK&7>=:_Y1%:;2BU%5]:]5&(7R.).0=3XMXCGCF?,'<]D>X$A+^@>%+(
M1SV='U"B(&]V^&;?_,@ ;XM$#)J:23U?XHS#X8:7691$OZ_#)"_FS6#\Y_,_
MEMS>Z25LDHWLU(<2@_E*T]N6S;*\O6;+YRJ^&(H7EIL>8BB)-VE/X3?!-VKR
MZ/<4.<1_'(G,191^?2.)<Z*UIF ^)*"XR>F[2<TCVXT#WV!=L"S/CWB#3M8
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MR,VP$YM98\($-6/QGY6OA<1>E3"_QQT_ ,?XB5]U5U>=%_TR3F=3^[491(+
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M!'?CSF"C/ ,0:$!V"ZIV6%VWR[)S0/Z3'?QM9?E9VZ^)EE*GU&A)7-A" '&
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M<:YU&EU>P[0RI-G[DEX4WWK0E\F"Y )8"_9D"\&9)$X\Y&(<$8NEHPK2_I]
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MJ:]?#;#VVO(N*I&:;,>1-0!N2QH:_M4']F#;.E4#2)]DGB0!RZ5W)%-LJ/\
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M_P"7O/\ IOF>Y\QQRS:GY=6/UK[0&@DX+%>"X@B0F6I9#')N%-?V2>M^7_\
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MQ:H(8FHIW%?'),=)+4?1Y/TG97-.* U>.,G[-6)5D!\>G3IDML-/MV@2/4-
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MYL-Z>&=S\OV5C=P(TM]><C4 *WPFIK0@ =/GAQ?>6M#O&2*:P2<2$A6G=I7
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M4):1 >) 'Q+]U*TPDO'B8(8I?5Y \:D"G>I  \,+]%F+ZI<6AB2YCG"2<9:
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ML9Q<0R?O%GC8,K;\A1E-#]&=Y_+WS1ZTPC9P%J&IX5'6IZ],[W#K;",\SNM
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M$K,=R*@JQCH*"G6ASTIY5F>.XL20LM4"IRJ*,&J"?< #IGHB[M+?4+6V<)S
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MN,&\HPO*M6=N*TZA00!7^. 99V5GC'&-JT4TW%.G;P. DAF:2JM(68$U4;,
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M !4[#;L-LA6NZG(&6UMDK,Z*"P%>18D\?;IO@2Q,.G6TT4H^*529"XY+52:
MFH_F/3"+5K^.6%I&Y2\ >-% #L0:%1N?EOGEO\W_ ,QSY1TZ2.RF]37=3+1P
MQO\ %Z0I1Y&Z;(#L.A/M7/#S:U=DEBS,Q)8L2223W/CDV\@:O<OK]L&)(.?4
MS\LYVDM;4FNZC/66AL?27PIDF4_=A;J7]RP]L\[^?/[F7V!_CGA7S@U-7;;>
MI_7@2R/V1G6_R^/^YB+Z/UY]$?(?]S#_ *HST+IO]TN&YZ8!FWKA+/UP&V!V
M_'$&[X@V(-B#'$'P[\J6GUWS'I45.2I.)F\*0@R;_P# YZ1S9\K_ /G(;R]_
MA_\ -OS)P3T[?6S%JT/O]93]Z?IF63.2QUXXR3IA;*3@(TVZXD_0_+(/K@JK
M'[\XCYAV+GYY"R>O;)-H!_>K\\] ^6S\,7T9UBT(X+WVPS4[=:8H3A?<G8[Y
M'[DU)/; "FK?C@U&%!OC^5*;[X]7R6:/* 5WZ_V8(_,'\SM#_*GR3JOG373Z
MEOIRA8+56"R75S)M%"G7=CU/85.?#SSQYW\V_G3YX.L^8[U[K4M=O([2U@!_
M<6D4TBHD,*[!54$5\>ISZLZ!I\-AI>G:=:IP@TZUBM8@!T2% B_@N2FS3U#Q
M8;C;$=8\N)=PNO"H89XW_,+\K;O3;R74M(@*_$7>- !0G<LGS[C.2+ MV622
M,17\0/)/VC3JRT!/;<8@+2299!0,X!)3H&%010]O')#H6H)I,W"2'U()E_:)
M'!5K2E*T:IST_P"1/,D=Q)';R7$C.:BBD, 54%6XT%12GT;9-?.<J3:>SJ/C
M20,)0O&O#X=@22*^ ZYY3NP6O;R>VN4D-X'1T;X4)#;%01V^70YU70+PW,5F
MCD)-Z<*(S4X\F(!^(;C[-?\ :SL'E;6/3MHGN6)6'E$T9%6#\OY@#3X:4^_.
MZZ/KADA$T+)*\B\XPFPV%&'$#<U%1_MYT'3;Y&D]8LJ+&?4"QN3NU0 YVJ*D
M[4(^>'ME*HFGD6B*2  PKO\ %0;DU%3^&2&"X#M%))&AC!*U<G[8( !8=>IV
M&+_N9R$*LY+<J;J""#Q"BIIT/^W@=8 JGU K*K,P!%"$(V-034[C[L4A)=D6
MA]8CD5"D5  K7?O0]L;/#2-N(K*P(8#O4;^]-]_GA+<<S;\G]2(QD@D4#-0;
M#OU.0[4I88R99)23 &&U12O<'N-^F0F!&OK]$)].*+8M6G6O8[]#3*ULBV6,
M6TIBB(-& JST -!\1W.<:\]^=(/+NF7-V[EXC\ CY\)I7?\ 84&M*T^@;Y\^
M/..JWOF#5)]3OY.<TQXJH "QQ@_#&BC8 5^GKWR(>AUR;^0X..O6Q(H?'/J7
M^6)_T:V/^2,];:&?W2?ZN2A>F%^I?W)^6>>?/?\ =3?)L\*><=M6)\2?UX!L
M>H^_.M_E^::Q#X&GZ\^B/D/^Y@V[#/1&F_W2X;=L!3CKA+/U. 6.!V_'$&[^
M^(-MB#=<08X@V=%_+.S]74;^_856U@$2_P"M*:U'T(?OSM&;/$W_ #E_Y;+1
M^4/-T4?]V\VD73^/(&>W'_"R_?GBV/IC9/8T^G"Z7? 3=37$'^R1D)UNO!Z9
MQ'S#U?\ 5D))H??))H)(E'SST#Y;/PQU[9UBT/[M??#)3T.+5[87W/?(_<G<
MU.V%X8<NM,%J13;+Y'&^I0G))I,U.(KOGS<_YS,_-1/-GF[3_(VE7 ET7R:&
M-TT9!674):<ZTK_=K\/SKGE_R(0GG#RO*VQCU2U;[I5S[/>7[,/&-N7PJ*^Y
MR3"P,,NRTWR416*W$2$#<K3(EK/EI)ED22(.!4[CMGG/SQ^35AJA:]L8C9WZ
M?$LD8XGD.A- ,\VZKHNHZ'=-;:O;&)T/[NZC'%&/@XV /OTQ@L/K0(4$RBI)
MV(/7>IVP_P#+>I7&AZG;SAFCXN58+L5)'VE;8]1T(Z9Z$?7(;^P]*HN1=6YF
MH0.2RD&A KW /3^&>:=2U 65]-) RS(YW!6@*$UV%*@[')5H^I&&6L1:>. J
M!S 5"K!2#\@3]%:],[3H&K006*W:<FB>20NA'+^[HI!8D+7BQ_'QSKF@7DT4
MT;QD?5[L0O&W(5WY )X5VZYU_3K[B(P](UDD<*3MP8-R1B!2NQ^FE>N36RGA
MYR ,&!#@<:FK @MN2.GB1O0Y*[&(B,$$L%(Y+QK2E34$^([4_'!="'=2C1\A
M5*M6C= !TK7$RJR^ERI4A?4J2RF@Y4 K4;?AB8N8Y"[6P:8U($M:)1=R3N /
ML]>HPGNK\.\[,\M%(14'<45J+3YX3W.JAQ(JI6.$/4J:[FG[(KOD$U75 MM(
MYHD3U(!!!-=R?>IIA183?4K LY'UBYY$%Z44"M-J5SG/Y@>=K'0K=[F]N!&W
M$QI!7]Y(2":1[UWWKX>.>&_,GF#4/,NI3W][*2&8B&*IX11]E4=/F>YR :E#
M5AA8MO7]G)GY+AXZW:FG?^.?3;\LQ2VM?D,]9Z'_ '2?(9*5P!J/]RWTYY[\
M]?W4U/ _JSPIYT%-6V\3^O"ZQW_KG6O()IK$'AM^O/HCY!/[B GP&>BM-WB7
M#?M@*;"2?K@%L#L<0;I@=N^(/WP.W?$6.=U_+VQ^JZ EPRTDOY7F]^(^!1_P
MI/TY.<V<I_.WRQ_BS\LO-&GQQ&6\M+;](V@7[7K69]:B^[*K+].?*J/H/\QE
M2$4)ZG"V3\,!L!OMTQ%Z\3VR%:W]A]J?+.'^8=B^0<]:>'3)%H1_?+\\] >6
MS\,=-^F=:L_L+X4&&2G% :X#N>YR.W)Z[G"T$ UZX)5MAE%_?$6DH=R=\@'Y
MJ_F;;_EGY'O]8#*=7O%:TTR(G=KAU-'H-Z)U.?(.^O+C4+RXO;R9I[N[E:::
M5FY%Y')+,3XDX/T>X>TO;2\BKSM)5F7YJP/\,^V7Y=:E#K'EK2=4MW]2'4;:
M&Y1_$2(IWSL*V GMQ*J].X[8<:);%R5(W7;Z<-KS2%F3F$WIMD-O= 4\O@V/
M4'WSD_F_\N+/5H)$DMP6(-#0?TSR)YH_+;6O+%Q)-IW*6RY%C;N*J!WXG]GI
MVV]LB,.JVDS)8ZB@TR\)"QB8<5-#T#C;Y#)7:7=SI8]*=2T*TX-38  TJU16
MI/AG.]9D2/4'G3A03<F10U%)W>NVXH33Q&W;'6EY+ITQ,4Q>( B$@@J4<!:$
M5KTZ>! [9VGR7J]L\AB,C+%(JO)$02@(V95V:IHQ((ZT]\ZY9WSV\MI;QKZG
M J*$"C#>04W(^R.FV=DTO5UU!BJ$3.R$R4J!5E4!E(VIX&OXYT6Q8%.(B;G&
M$,4J.*R=F8\B :D"M*=MCDQM[IXXXY4?BW3@S(.##X:E %V_SIAC;Z@Q<<PT
MI3BO$=2 6((!X[TIT^C'I<'F\<7,0(HYQA"Q)I4E6J?BKU'W850WPCC,:3H(
M0[L>#%F)(XEAL!W[_33(Q=WK-<F:K#TUHJ+0(*"AH0>]-R3A+^D&".D8*^JY
M)--^Q !Z'?8;Y#]5N%EN5C"TCAH\CH?AYGL33YUH-\ 74FJ7T6H)H.FW&L7F
MGV,][/#:IZDH2%>15>1 +4V KUSP9YN\S:GYIU%KN^!MX8F=;:UJ2L"F@8'E
MN6/$<C[=@!D1"5[?.F%M]#4]*^V%XA[T]\EOE*(+K%L0-ZY])/RU%+>V]E&>
ML-#_ +I/D,E"],!:AO"<\_>>@3%-MV;/"7G84U6O>IK]^%=C7X=_F,ZQY#VU
MBW[_ .V,^B/D$_N(/D,]&:9_=+ASV^> IL([CO[=, /@=L#MB#'M@=CB#'\<
M;'%)<31P1#E+,ZHB^+,0 /O.>H;&U2QL[6SC_N[6)(E]P@ K^&"LV40&!5@"
M"*$'H1GR-_,/RJ_DSSOYD\N<2L&GWC&U)J:VTH$L!KX^FZU]\@TG3"^; 1IO
MOB3C9AU^>0O6Q5'SA_F(;OW[9 SUZ[Y(=#/[\"G4YW_RV?AC\-LZU9_8';;#
M-3T&* X#N3L<CMT:$T/?"NIYXL&VQC/3OA-JNK6.D6-WJ>I7*6EA8QF:>:0T
M5$7<DY\N_P Y?S-NOS'\SRW<<DD>AZ=RM].MV.PB!-9&'\STJ?NSCM/'I7I@
MZV!5MNM*$T'?_/KGT^_YPU\WIK&@ZKY-OIO]-T0?7;%215K20@2*/]21J_)A
MGT0T^P*:>L@7[2UZ=Z8/T>R"W#$"G(Y-!I/P%>/7<?KR.WVDE&W6@WZ817&C
M+(*<*U]OED!U_P F0WD4@: ,&!VIGD_S]^42,)F6T$L9))6E:9YPN]'\R^57
M863?I+30:O87;$BG<12T9D/SJ/;$XI]&U^Y6&PN3I^M[5TV]'"X8*-S!6JRC
M?]DU[[;XE=:;=VL066$\%->7'^[8$ ANXI08;:#<S6CQ+PY)6@2GQHR-T;P!
M'?M^.=_TC4([VPMW>=6:2JNP^!X]R144/0D;D?QR<Z!>RV=VLP+02EUB]5"'
M_=+0 ^U3O3W\<ZMI>JQ,8&^L<V9_BCDJI%00U*4K\0WWWR<6VJJ]N'C41\E*
MLD4M2M:#EPXIN/GWRVU:=!"L2R<E<=&.Y!WK2IH?G3'W-\1,7>X5;@'8;T(H
M12G0_3A?=ZW&D(2&A)!=>0HM* ,2PXJ *X5\ENK9@+T!G9JC<,P0CIOL.^$=
MQJD=O%)!$ZA:FK\M@1LQ%=ZFM!A'!;2WLB1P47ERHY-=N['J*TSK_P"7!/EB
M]?4H;<G3HZ6<TP!HK2T8DG>M>'7/.'_.7OY3Z9Y<U/2?S$\L69@TGS=)*FIQ
MPK^XM[Y0C(X-=O7!8TZ54^.>*5CH:'M@.\AW&V%_I#PR2^5TIJ]MMWSZ-?EJ
M*V]KU^R,]7:&/W:?(9*5 [8#OS^Y.V< \\C]U+MV.>$O/(IJ?^R.%%C3;Z,Z
MIY&--9M_\^XSZ)>0#^Y@\*#/1NF?W2[X==L S81W'\<+V/7 [8@V!V[XBV(,
M,EOD73OKVOP2N.46GJ;AO]8;)]/(@_1G?,V;-GB/_G++RF([OR[YTMXMKE&T
MJ]8 TYI66W)/2I4R#_8C/&,G3PPNF%!UI7 +?*IQ)ZT/W9#=;V1JYP_S'3DY
M.0$]3\\/M$)]<;]\[_Y;/PQGITSK=F?W8]AADIQ4' 5QT->]<CUV=R>^$Y8\
MO88ISV^>%>JZK9:1I]YJFH3?5[&PB,T\O%GXHO4\4#,?H&?.C\Z/SGOO/=TV
ME:.SV7E6VDK'&P(:[9302R#J!UHO\<\[K$SG>H[;4S!&Y"M-J]0#V]\7@0A@
M1MO6IWKG:/RF\Y7WD?S;HOF6Q^)]-G5FB&RS0FBS1M_KK4>QWS[^^1-:TCSC
MY4TG7=#E:XTS5;<3P.Z-&W$U4AE<*0000?PVR0V=I]7NDJ/M,!3QSI-I9K*J
MGCMQ&%NKZ2*B@W.U/'\<COZ-)H"!L/; USHX9#\ H??(+K7E..Z1ZQJ0?EGG
MGSA^5L5RLSQQ(KGH:KGDOSG^5JJ62[M4;BX9'#+4,M2K*0:J0>A&<L>V\]>6
MYPT5P/-NB !9+#4)$%XB*?\ CWO'W)7LLO(=J@9)_+TWE[S%J_Z-T>XE36D@
M$]UIUQ#PFMU :G-U+6[@<2:+(?;PSIWE_2KR&ZDDM%298UX.KL!1?LUJ:5VK
M3;^N3BQ2Z9F6X17E@^,)U  H2#N005)R8Z??7, ]2%>4$1]56)IQ!KL!5B!0
M4 ';)I;:N5C_ '<Q)JI6NU&.X!^'>M>N&<NH7+0I<NQD:)U0M6C-L.0'R'C@
M5KYI1)*6=0@"#C0^!_:H03M@(ZO</;*)$8$#8LP>NP (V^G"WZ\MM^Y0@2M5
MJT)9AL.U!7P[8ZWMIKEV9HPR%:*6H*+4T-!WI_GOD_TBVB4L[+5Y%^&G\HWH
M>G4X=^5_,]K8>9;K0=0);0=:C2TNE"D^E<O7TY5 'B0-L[2WE*Q\Y>5_-'Y9
M^;$^L6TT?I12#=D#!C!,AWHRD C/CQYV\E:MY"\V:SY2UI$&H:-<&)FC=762
M,_%'("I(^)"&IU%:'(3=Q>W4X7F/;P&2#RS'35K:@K\6?1'\ME(MK4=?A&>K
M-#_NT^62E>F [_\ N&S@7GD?NI:]P<\)^>Q34Z_Y1PELNU,ZAY(/^YFU '?^
M.?1+\OS^XMS[#/1^E?W:8=CH=L!3],(K@=?G@!@<08'<8@RXBR]<29<0=<[-
M^7NF_5=(DOG6DFHR5'CZ<9*K^/(Y/LV;-D&_,KRFGG?R1Y@\N\5:ZN[8R69;
M;C=0_O(#7L"Z@'V)SY(7$<D3R12H8Y8F*.K"A# T((/@<+)?UX!;:OOB3=#M
MD/UH?"^]*=,X?YC!_>'MG/21R)KW.'NB5]<4--\[]Y:/PQC.NV9K$O?889*1
MM0XH#VP#<L*'MD;NFW.^$CL V [_ %6QTNTEOM2O8;"S@4M)-.X1% ]SG@O\
M\?SG;SA._EKRU<%?+5H_[ZX0D&\E!!!I0$1CL._7/-+@,.1KN=_>GT^^-"UY
M   ]:U[5RQ&A/QD!:5W_ !QR+2O$[;DTI2A^?OAQ8OPEB*L0^WW_ *M\^JO_
M #@Y^<"1W;_E?K5RBVVHE[K1&;JMQQY36X->D@4NH_F!_FSZ=2VBA^:C9:$;
M=]LE^B@O'1QOM3]>&&HV@EB)I\:[Y'S9\ARIOB9M0ZLM/OPLN-/!4CC4';(I
MJ7E^.9&'"OT9QKS/^7MM?)(KP U!KMGGCS!^44\;NUJI(!^RPKG"O-7Y,_I%
MHI;O3)([RR;U+6]MF:*XMY :AX9DHRGY'(9/YB_-?\NT+:EIB?F1H]N*^O,'
MM=9C04 Y7,"GU H!W*,3WR:>6?\ G(?\NM841WVIWWEBZD8QM!JMK]:CCV6O
M^DVZR +4D?$J]-Z9WG1KNVUV!+_0-8TK7;69>(DL)!*/&G*-V"'V91\L,%34
MK-C6QA!6F[$DGIM6H:OT5^65<WFJ ,PMHHV*BK.2JFA]SU'W_CA%+KTT'PSS
MP/(K&$K%S=@30#[,A7OEQ/JT[I!# ZQ-O444*I%#7C4G[\DVFZ&54*Z%I&[4
M*J#V[T-.IR?6NGI&".-&- 30[\>@%<DB0J!Z:#:,4KL**1XYPVYU!G\YZI S
M?N);LJ"":40! 0?;CGMCRGY@DOK'0-7F-;RT)TO46[N5"F!S\UKGG_\ YS1_
M*Y;[3](_-72+?E-9JFG:SP%2T#M_H\Y _D9N)/@1GS:NX""-J87F&E-MZ5PY
M\O)35K6O=L^@OY<?[SVQ]AGJS0_[M/D,E*].F!+X?N6S@GG@#T9CWWSPIY\7
M_<C_ +(X165-O;.F^2C36+7:N_\ '/HC^7QK!;_(9Z1TO^Z7#SM[X"E&$MP-
MS@)EQ$KB##$F7$'%,9;VLVH7EM90#][=2+&/;D:5/L.ISTI:V\5I;6]K".,5
MM&L2#_)0 #]6+YLV;-GS/_YR/\E?X3\_7.HVT7IZ5YL#:C 1LJSD@74?S#GG
M\G&>=9, MU]\18;';(AK0^!O#.'^8Q]O.<MUKUW_ (X=:,?WZ_/IGH#RTWP1
M[=*9UVR8^DNW;#)6QW.F%]T] <C%W)U]NN>?_P POSM\L^2O7M+9QKFN1GC]
M4MV!2)NWK2 [>X&^>%/.WYD>9_/>J1R:W>.8$8F&SA8I!$-R*)4CZ3OD((JW
M()R)(ZFI[Y?'XO>M1385&4%^*AVJ>WZ\4$:N:4).WM_GTQYB-115KXC?K@B,
M,-UKOO1?$=,Z5Y.UN]T'4+/4-.NY;.\LY([BWFC/"2.2$ADD5NQ4BHS] OY,
M?F=I_P";/D/3?,L++'JD:BUUBV&Q@O(P.>U3\+@AT]C['._Z5'2/F!MAP])%
MW\.GSPKEA"<E(VZUQ!(0:4'7K3&26H:BD5\,1;3N2FJ\L)[O0TD!'"IW[9%K
MWRC%+6L0H?;(K=_E_;RDEH ?H_LR,WOY3:=>*5FLDD5MB"H[_1GG;\R/^<)O
M*?G19K[3 _E[7F!*7=JJA6;_ (NCH P]P0??/#/G7_G'/\Q?RKU"-[RWN;>$
M.4M]7L9)!&Y_R)HPC(2#]EN)\*X_3=;_ #.T^T%M;^==9ME8% DEW),IVIL9
M2Q!'S^G%],\V_F!;:DO^(-:OM9MYBJLMY*\J@5)4CET[],]4^5%M]7M8+LVW
M4!AR'*A[[*.N=KTG28(HV0"K< !Q"@T4>.^VYP24"S<GC]6,<N"@_"O&E"?H
M&&MB/7<2E3)$O+B6IQ+GX33Y4R_K+6Z3RE2$@3<..O"IH/QSSLXD_2PNP*-/
M,S #Q9B:?CGNK\K=-5]&O-/F_P!Z=6M8YT\!-;\BM/<A_P ,Z]-HUCYQ\HZK
MY9U>+UK34[22SN%(%0'6A(KW'49\1?/?D_4?)GF?6?*^J(RWFC7+VY8BGJ(-
MXY!XAT((/OD&:"E<,="CXZI;;?M9[[_+D?Z/;>% <]5:%_=I\LE2],"7W]RW
MRS@WG=?W,WA0YX4\_4&HC_6.1^R_9SI7DP_[F;3Y@=?<9]$/R]/[B#O\(STI
MI1_=+MOAZ.AP)+A/.-R,!,,28=AB) IB+#K@:09.?R^TKU;NXU:5/@M088:_
M[\<?$1\E/XYUS-FS9LV<3_/SR(WGG\OM02S@$VMZ#74K  5=S$I]:%:;_''6
M@[L%SY6,U:>QP.QW^>('OD2UK[+'.'>8^KYS=^IPXT8TG'SSOGEIOAC\.^==
MLGK&#[8/#Y9D%/GD*\Y><M \G:<^I^8-1CL;< \$.\DIWHL:#=B:?+/G_P#F
M9_SD+KWFDW.F^6UDT+0W;AZL;?Z3,IK3FX XU'[(^_/-<QGD+N[5=OM5WJ1N
M:^^^%S$QW-LY H7"FO3XMN^'RQ,1]G8DD@#85I2FW:N-:*A:K?9J*[>';?$A
M'Q9:[\B!U]P3BM!44!!H?A'2O3KE?%45:A.Q%:_(8M$&#4)K0TZ[["NW7K7)
M)I:B)U9@0XWVW-0*=Z]SGMW_ )Q4_-H_ESYZM;2]NS%Y8\U&+3M36M(HG=B+
M>Y((%#$[48_R%OH^Y6ENT:""1>$L9XL/ CJ#ART8K4?M=,0FB#  C?\ K@%1
MQ-*;BM?OP3'&'.^^^&26U1T^G%UT\-N5QWZ&5Q]D;XW_  \K4^#-_AI#^QF_
MPPG^^Q^&!+_R1IVIVTUGJ%C#>6MPI26&9%='4]F5J@YXO_-3_G"ZUO%GU;\N
M_2@D8M)-HUVY$,@(^)8)RQ*'P#;5_: SQ/>_E_K'ER^_0GFC0[W2;^U!X1SJ
MK *K4V+;,K$=02I\<ZYY5TJ+3XE9T/H@"KPRJO+?92&<4^_.K02I&K);O12*
M<V;U/]C5N0- >W?PRYT=A+$A$:["1@:,12O!%V&XZG!ME(B1J$%(8:;#]HGH
M/OPL\QSO%I]RH4QRW'[I? <B*T_'.51V(DUNQME%5B96:OL>^>W/(BE+:WG@
MWDM'1P?&E01]U<[;90)!?&2+^XO!ZJ@; <MS^.>1O^<OOR4;S+I"_F)Y=M#-
MK6@PE=2AB%6N+%=^8 ZM%N>FZU\!GRWDAV[&N+Z/'_N4MC3]O\,]W_EV*06^
MU-AGJ;0_[M/D,EBX$O?[IOEG"O.X_=2T[@YX2_,  :@".G([9'++MMUSH_DX
M_P"YBU/B?UD9]#_R\-;>#M\(STOI1_=)\L/J[8$EZ843]?IP&W3$3X8BPQ%M
M\8L3S.D4:EY)&"*HZEF- !G>]'TY-*TZULDIRB6LC#]IVW8_?AGFS9LV;-GR
MM_YR%_+P^0//ES+90&/R]YFYZAIY"T2-F;_2+<=!^[<U [*RYP:M:XPY$]9'
MP/G$/,FW/W'?.9R$\F^9PTTAJ3CYYWCRT_PQD;9URRD_= ]ML%M,J@L6"JHJ
M230 #J2<\T?F9_SD?H'E@76D>5I8-9UR/G&\[$FU@91V*U]1O  T]\\#>9O.
MFN>;-1DU36;V?4;R0_%)*U> J>*HH^$+OT &1AI)&56>J@F@VH-OX8C5R-@2
M=^GWGI@6XBDN%=8T:66,\@!4DD;BE,D=@WUN*.=0%$RCDI'1J$$'M4'%94H4
MI\1( ;;IXB@]O? IA:H#* ?PKV-,:8Z-R )[D?1B84JVVY!^$TIOT'6F"4B9
MC]EAT(^0K7K[X>60=&0$_:-2U?I(ZCVR=:-+)'(%!V>H()(W)\*TS[F?\XA?
MFN?S,_+Y-!U.[]7S?Y!1+&:21@9+O3J 6DS[U)4#TRW^2M?M9["MV$B*&V85
M!!Z@^!Q.=2M ,+IAQ:HZUH:]L$6[ -0C8C<Y(;;B0N_^UAW!&M!0##".)=C3
M!L<"4&V+BW3K08_T5';$GA7L,#_5UZGI^O(?YL\A^7O.-D;/7=-CND0-Z+$?
MO(684Y1R=5/C38]P1GA+\Q/RYN?(NL1)%9P2Z1=EDM-2"G@SJ!S@E^VJR[]*
M4;JO=1&+..6X'I^J6<$<?1 *@=&Y-Q!^0ZX.NK)9BL4<A$*\:+'N0QZDL:_3
MB\QAMV$01@J<6)!VVV%#3J>F1W6[@7DT<A4I%$/4*G>A/0?<,CNB632F^U0C
M</1#3PSU7^6D_JZ=Z9/Q#C7\<[I:W%+>-7Y*L,M 5%6X.*T[=P<E AM[BWIZ
M?(L*$.K$T/8[#/DS_P Y6?DW:?E]YFM_,7E^S-KY9\TN]8$!$=K?"K21KMLK
MCXE';<9Y1TM*:G;&G1L]R?E[_<6_R&>I-"_NU^62M3T]L#7G]RV<,\[?W,VW
MCGA/\PMM0!_RS^-<B]G0\:9T?R@::O:4\?XY]#_R\/\ H]O_ *HSTOI']TOC
MA^.F!I<)[C;<>. STQ(COB+XBPR9^2M*^LWKZC*M8;+:.O0RM_S2-_NSJ^;-
MFS9LV;.1?G9^7,?YE>1K_2H(U.NZ=6^TB0[?Z3&I_=$[?#(I*FNP)#?LY\D)
M4E@DEAGC:&:%V22-P5964D%2IW!!&XQ,],BVL_8:F</\R?M]-QG+W/QM].&&
ME,!<*>_4YW3R[)18Z==J8>>:?S-\H^0+#U_,.IK'<E.4-C#22ZEZ@<8Z@@;=
M309X=_,K\_/-WGLRZ=II?RYY;=BOU6%OW\HJ"/6E!WK_ "C;YYP*2E09&W)J
M#U-?QKB2\2 5C+&M**#4_/!,<+@\Y66(%=^6[D5K0#Z/;%Q"B*6"\PI%3)ON
M:TV&W3M4XV::9A3FP%/LKLH[[@ #$M!F!6\M*GU;2<N@ )^"0<P2*] P(P]:
M#>I%2.W$U-:'M]&)>BP)'$ BI)WZ].X/AC%53]@!:#8"E:?Y^V)&-B=B'4BH
M8'8@;]J#<G%(H]Z$@4!6M:5IU[8<6B"O%@#4"M033>NY)WVR8V07GRX<6#"F
MP!JPKMMX9Z(_(G\TM2_*3SWHWFNQ,DEE&1!JEE&W^]5A(ZB>(5(!-%!0D[,H
M.?H#T;4M/\QZ/I6O:/<QWEKJ]I%>VD\1!6>"9 \;;'K0_P .V"P0Y)(V)IOV
MP+-""378#O@,*T;BGV348;VTY3B>F26SF#@##F([;8/C/3M@H$8ZOWXV@IO\
ML3:/NWT#(%YD\R7%HXMM.MC<K4BXE1N)4>">_B<BCR^7/,^D:KHNJVRSZ9<*
M!-972H4*K0^I&WQ<)%(Y*PZ'/-?F?\O+_P E2 QA]3T6<TLK[CL Q)"3\?A5
MQV %&ZCN!$ULU!B+*8@AX/38&IZ>V%EZ\<3/#Z9J=E;KN:[;^&^^0O42%L2B
MRB65B>9K6I8G)-IE@L&@(I'Q,*GW.=F_*F&6?UXDV6/B7)Z ;YZ&.M:/IFF3
M7OH?7%1>-6V25_V42M:U/X;YRO4_S!\S7A+PRPZ?#&0?0@C!% :D5;D>G7"G
MSSI _,K\J_->B:CZ=Y<"RGN;1F^W#>6T9FMY$\*E2IIU%1GR L 1J5MR%/CS
MVS^7S?N;<CP&>I-"/[J,>V2L'OB%W_<MG#O.O]S-\C_'/"?YA[7PZ?;R*V._
M'.C^4=M7M*=C_$9]#?R[_P!Y[?\ U1_#/36D_P!VF'X&W3 TW0X47 K@(],2
M/CB+5WS0P2W,T5O"G.69@BCQ)-!G=-+T^/3+&WLX]_27XV_F<[LWTG##-FS9
MLV;-FSYS_P#.5/Y6GR_KB?F!HUOQT?S'+PU)(Q\-O?D5]0@#99@"?]<-_,,\
MAEN]1D7UD_ ^<.\QG>0C;KG+Y& 9LN/4K+2E:]U"Y2TM(1\4DAH/D/$^PR'>
M8OSNU5HWL/**-I=NR%3J,ZCUI*C_ '4I!"?,[_+.!7]]/=W$MY>74M[=2FLL
MTQ,CL3UY,U3A<))&-($^(5/PCD:>)Q9+)-O7D/,$55*$FHV^+YGWP8@*H1#&
ML1ZU!^)J=/B)Q)@&(H2%/4 ]S_#$=UJII7IV--^M?HQ&0EDW('4T% :==Q].
M!-*G^KZ[ I:B7\;PON?M)\:[#N:$?3DV/,JI("\2!0DFH%"*[=\:5(D 4%PU
M5VJ.NX[^.9EHIY+L!WIO7Z>WAC9F,@]21N;=.1W)IL"2:_KQJHQ44;C3:E#2
M@\,&P+)S"LP![GV-:FNW;))93-\"FK,AXFB _?TIL<E%G*%DCD62C^'38=*G
M<?LUZ9]6?^<$_P [%EBN?RDUV[Y%1+>>6I9#0GK)=6=>GC*@_P!<>&?2^:'F
MIN$'QK_>*!U'\W]<#LH=?F,"-#1J$; ],KB5H? ]<.=/=N7RR4V[5IWKABI
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M9D:<[<!">+7 \UF>R;Q ,9-;_LLOUL>/1HBJ]6%%;C/L6&5^W*)2,]B.Y T
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MPJQW+@29*.J.,FCP154$'(0S2@87RVP1.N<:[PV!SDY_<>7W,)Q*$_L$.YA
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M8/'$5#F?XO7-<XV0RMCUI414_B$-Q8W!0:T<<"2?5]7FQU.TH7MG*ZAMR5(
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M+*?B0UPEE&I0$'_.<[Y16\VCPDDU>K*V*^_WI->F]9:42ZR>\B:5NJ?H.#B
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M*/OM!N(;7M4'(,LYP0=QLI)],H24N%P37[X!#^QDWZ2 W@Z>6/>:6A+'3$0
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M55 OJ(,Y"@(;X;?"95/"17NOL)B#!*,XX1'2ZP<X(1CV5W2%LT/O5<)91;@
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M-Q8AN8E,&OX :M<(+Z7M9MK 26I*Q<9P^@@>"MXM:PNWQ[9Q4O/URI]B9%1
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MS4YGQ7K'RXQVJX\SQ=V#KP$[@6P"3K>&WM36Q*&ALN9EJWPV?4C\PHHU_N&
MO]?:;##.B_1]I#/-A4='QL%76!89GZ305ZQA_0M(GK^K:QG0QK2/A>/L9-XD
MG(YB!BSUBN)9T,DZPO^=_6^SS/BZ'QXC'SHI([&-_P\2PG_7_P=02P,$%
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M2A>*A^,"?>&)PQK3V):K6E@FG\)/_N#R?GHO&Q<G11G0B_CG]$PR5BFC,$^
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MQ\2M?=$;1!]AGC@<,4)JUQ;WJEIP;R#4.'VPUF3'>06WI*)E:6=DU+'D]@O
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MMNOQFQ!0+K/M-LZG;1LU/&\FD_O;ZBU&#%)A?QM_@MU+ZXNG$4M#$G/+Z'3
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M]">JG^ $"\4M*0MJMB7_)@!BU272YB"ZD*'Q2+^:L-&/[JMW^&E84&BQKSL
MC/01$<!/TK'L_%T^Z='C,/ F4W8P,W(2I8\/:4^43)W3RA>C-7\W-^@0-LN&
M"@H%9&3D5XJ%68#XMD*H(QR?=VTW@]BECZ7T2D\KH\RS_;,TF,; PD;G1VM
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M<KW^D_G/?&ST_YE9+O*O$OJOA\K_'T:&# !@ =%7BNJU,A$* *1AT0'8>&D
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M5_UX;[>Z_AV-H/_7:.1O9NG_ %!+ P04    "  N4UA6$:F(KM!!  "B0P
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M=3\2WW+:"--+YJ_HR6&.G+3O.T<V,2[V=#OC51,H!4$$%67[H: 3B9B(RCJ
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M>7^$,UDQ\Z(RQ! ]OS^53?P(%-7,*Z8+"4$9-XSEB6M+#ENCBI\\LDE0J#*
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M,6E27^?-LK#MK^.C;(!ODN.':L*#PQ1V>,NH0_MI6"F?R0KE/J<N85#*@[&
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M(O9@5_^7)0YX=R,TH#WTN>-L.YQU2*C*=R4&95!D7 86T3ZR2A37BE$5I=%
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MVMW(:%ALRN=1L1!H@K/^9B]%_W-HC+-^@+7/99^[5V)O0STRDF)O9OC>BLZ
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M)&AJ;,S5) 3\\[_>V@'Z[Y_EJW__+/]S;LR_?Y:O_]VY9JK#F/T;7?^M265
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M9C5G#6]5W9[G]UGB\!<KBRSAB,[^-B7 <2[KRP? G\93<"]CY_ARR*KT,28
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M26CVJ(\ :;6-IM5[C_F;E'[48*P!\_8W\JCRYK6,_M"MNMUGG'"+3;M^1]/
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MNI# (X6@8:"C F(=^'O7W1@THA-W^ 7T<;>][J3Y^_[01'5I-.\M%;0Q1MV
M94^*V:+&]H"J8M#YMXRVRE\2^.F#:_(K4VEKYOZ=9;LA7J<T;).9*&F"R^UW
M!&QM-]? ;\DB>2AQU.<6G:8#+) >EP9QC>\QA$_G!'?'X;N6FWO&X_P@AI&A
M@V#]GA#TR<UWPX[N7C>BXHPH[ PPHRJMGJ9G;W$C"DW )3K3-0CC@:,G<6Q5
M*J5G>&:!F/4DJS#!1D2:Q5C)\CN*)^ZLWF\-:+<Q.;78LU3';JIJ)AMNAO=0
M<O(Q+*ISDKM/Q/B04[(L1"=?&B9%OMV*,*6_E*6*^ES!S-G%^:L/'&3$.:8)
M#/28H1_GX/WNE0V']%[O2<-,5]'W8\,XES-+)5M7/3K<1<,/?]56 B[V5;.V
MF.GRNE<<R:QEIX(Z,0Z1HI\E:\,6"N#''W6.CL2DZE2-XHH@<-WK^^NKDR=3
MZ-1%;!JW4!JYMA"4&'(MWHZB^R:5K9LAX@X]8T53P]=]6MG7HO*'294=/#VX
MI24CEO.-D*#+CBK420#%EAQ'3A%?Y!.+($%3^FWJ+6-CBMGI>]KLGO] K-4&
M'IJK)C=%P2^?H=Q)O=IY[YE8<4+K4%^\)-.G_+=NK&AU,;IMU@OMB'F0GGCN
M><8%+O/+1WZTE:;NU<?)F+<<@]\$FY1E.[QM<O](8ZIW;[R]10BI+5@<OE/E
M^RBW!>9LK*X^]<6OM$%AR.-V7#*)O30.MR:V33&J#3P8<880C]Q<^8.ZF+O
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MY %_1["YO_U\#I7IB':I8<)F&\?G"9C4MD9$O#B:32!MGJ(@WG7.W0<5DY4
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MO?BN1+"XD,XT?9X4\@)J(O *[)Z@$6(;REBL"VLK:XR$2[67[%:WATXJK -
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MVAK*:&7;[YDM3""=ZK#.,"S5,_ H[AE:N)-NO 1.'SU'GN3,OV I5HG43T7
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M^Q4XR8:'S^8A#O5PP#%%W&0RKD1#W28<XU5CA\L?3_ML9<_U;>]*U;*:4EP
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MA?/\+)CM0 GJ#-$P:L]/?T*I(\EPD_/\V/K16#>+FGA'2HM52[7O*4I9Q;(
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ME [QYNO^F&%"7QCQ^'&-*_)[<HG]4K/7P'TU5#/&#0[<F+8LZW5?='![KP.
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MB3=#SO '-F8WM;DY:BGO9!_"$-*2=FDYXJ9%T:NZU@9>Q,!\0^-Z*&2Q.T:
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MX]ZR$0RC:8MI<N)=[U_VR]#\:4,?-!-1]2X#:F(DZYGOVIZ"A7)H=T0K/8N
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MTJW_CY?[GX5&)S0G*G(WHMJ61(2TT7VLQ/ &.J <9["UIMF]@/*K'']8U<<
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M[0V?7Y!@>4LD8S3O^>_%*WJ_WD3UIJQA\?*KM;TE4LL,D(L_L\U!-#^="$@
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M)!QSE]-'X[E;J<_JZ5$==O:/*5?EK)*0HM\R,A@]V>-'4M@SHCJ(/ ,G\(T
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M/K?S7O1V\RWIV7.-Z#2!T]:N5DO6CR+/&.<,=H^GM'31,>7*,=0A7;B5;I_
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MR"FCM#^X5#\.FJ(A?>I3IF/%1>=B:D./GGLFDS\&&KLB?)"[6F9\_TY\]HY
MW/P[EDFRY5DL9)S9F#8CVW9WUI8MP;5G;:@%"4<T/4/I*Y0:TH2%-)/,3$O=
MU6IW/DF+ZI#/:H[,!B8^#(A^OU#)##$/KNU5.ZI*[LBWA(YN^7]N?_Y/R/RD
MV_A$5FX:XITFKD#SH^CAL$%PF;1@E!VP:CC9GI0]%.*#I%,=/*Q.6OCJ4<IO
M,=_C=[4 /FC/*M!]?6MK L65U^LN%CT2J91Y ]5%^<D"7H3FX/:AQ>F.^I1
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M<_/[-/VN]K![DI4)"IYZH#G._91GV0.Z5=#\-&NR-JK=(<4&NYIV]UT/[%O
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M?+.KQ5'^NOHM;Q5[=/OV<MB<^X;IXQ:GOFIZM>?2$G\MGW]OW]0.S]6C/W!
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M?IR,9NO[%RE6GEQ TYS)MAW-_L5KMY%*-8LF?@S4,:\PG=7"K;[*SX4GXE7
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M22^EZF%*04Q#F\"R;THP(G-B^5NS'(L[+H!\A60^UW;%RF(RH1>E1ADYD,O
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MY!"&*4V!Z<"6X0TDT6U:^:LA3Q-FP1N M\=I2:C:'=8-N$:D!OU [M$J]+F
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MZ_-X0!"MU_RZ!;+L#W4OS!.GW:06P & M&WOH+<<"W8-[.D0I6&M(73X)N.
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M+%7(:?6$!68_M@9\][R\31N*V;>BW\N;'7WZ-IWF=NZ],J]BK*0L]X_ <F%
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MPM_YVV'+"<[&ZLLPFC?-&Z#(EIU\NVE3V5@ @U G5\2!5%.2L;<;Q^Y2R%!
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M_<Z,IKG'Q+PS7O=O] 4_J%YXOV+UMGVR .V2U><HM;O.2#]M9ISAU^"Q5E4
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MKIG7=*Q/>4RZS:V6ZM8/\EV;:P3T-HY$8C 7,W=4UW8N UFW\:JJ?.7"3W=
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MHITS<F;? !F"OD@AM2U@*M1Z2$/P3>43S)(33/9DL:>+NZJ:?ZS,S6Z+4Q5
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MQEFNU!:\>]&&];?& ]^]: .6UH@!%D2P;DB(?UZM-.;YA( [WQBD+E7COZ:
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MJU?]UV@FL2:$F)73 U'1^:C@E4ZN8N>;?PG#Y_USR^*]VJXA=8@5NPR45(P
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MO@U/6!QZ\2MZ$*%]AJ[A:QYTQ6'!0GPNAYG]T>OL%_LF1U'@8K5[*QCTKL>
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M9%XK^SX^]RO1&FA!$A*ZBU!//_Q<2JE"(TO7\CK#P+Z_W^ME5 <W681K&T\
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MTYB^_:F__TGAL1\4,U5M-'GAWM[J-.T ,,A)&\-'X)P48263&<7&#UY%(@X
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MM68#$::(,FFZ5+GZF [,8EJI].&2I1<W<N)@%XTCF\K"IBR'ZAOT?L7EIQT
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MG67O^=CP4;XNLNK!4H&Z6K?[K9!OC+L0GB;$>%FGP_XB&]+OW7OT1.!FX\A
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MTMO41$UUBWZ_M3S7J'[5+2:2,QN?@^([R%?D5?^(T]_IB#T U"2HER]I8Z9
M>)"QT!);G1A1X7>20R[-HQ:5D$$J"2&=33^DQ:^-VJ/4E.X 1;H"6I&Y0NOL
M2*H[1%G"]L=8C^=D7AU)&<#8%*S9#<Y,5930)P.E+XI8VU"FPZ]34FRQJ9.5
MC3TGTR+=6.&EEVG%+4\O7U[.J!?DIV'RTP1T+PUOB@9\J>[.O'75V7E"C\/O
M(K'(.KCD\[ 7]S3 [FDM#*,;OD[G&3JV0C,Q&HU^F!]'R RQ Z/"6BA!@?;F
M^8>GUO<Q^"GM*:7S(HT_:[$^ZIX-X2C#'#-WS6J3HAJNN6EBW2SLE&+CI98/
MI@=^2^ZYS/T\<6K7T<6<)2GJJH]9@3</T>R]'G3=+>^0RE\_'P^]'2*<DY\0
M>JP]2BA&&>B=VB3808#AJ8'#_?(+-^NH4\$&%R$NJ_.U?(-N@L%)2=.EJ30O
M))^?ZD"8OIHR3S&KFQ@V=< O,:\+(2-9ALH[[Y8ZZ7)7YLR)B3T#CRW?[NCZ
M9$$0)&TFT.=% )QFSN+!WXA=7I$ZFR3PXI&(59NB9864^_QBTUI4"3=CH3S
MJ&%$4+H+^R5=4+Q&HKPFJLWL*NEV]F3M0N5"3O)XBZ8A\D&M*:C1V12$->5A
MP4"&4??#1:OI6;V*DH4-SV %[QQ'6C48O9Z[XQQNGL\X_-/!Y^;F1MRU%O[^
M(87] :#RW_*^ X"?=!_9^:MD^^GZ+R\(RZ<GGV]X!S;GYSO5X]4_;5PQU<2"
MCF?=]!.RDAN#@/P=F>N&6.-*HD+)>G>W"U^UM+1M5WQO 9ZA1)6PICTEYPX
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M1Z["3*V:B\;MNO>=,NPR>^*GFR#2+4$W<NW_(N[-PYI.LW51=E=7V54.-(6
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M>N% @]9015;<6(.?<<-[TT4#]7 'X<K7ROSA^ZY:N%[DQYPY?%":_?IHH@?
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M8SVNRI< I.AKNT^(%3<0]0&>\'\QI5-5+GOW\-$0]NPY&5HWS\Z#/NQL/&[
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MZ=%<R.A \CQQ>_=+JD,,>2KA0U*K44]W [G4AU-&MMDN6=TH+N+R;45V3O(
MAXT4'W/Z9/E"#WN_0L'UWK,<3/#E"/?2<=_'AE>%YHXS!Z7N>0V[-;I6\JQJ
MFLW*^W!AVO5:$MHF_DWX?%[1$P%T7<PM)JO%K[_J:+T7:!_Z7L8Q*=C7JOK+
MACZXW3O4C<'B[<*$+][ [98'?6-F]S2/KJF@B2*'+>?0(BZ;F$AK%(\*;5UI
MR(R)D;$@XZW*'[+XU3L7FG]<MO25\J")89 @WK#AK&$;3*'U\WEE]W3BB["E
MI27Y4FY_[VI?7U_-O\_XAF'WO\M9^_<9WRT/H?B'';_,^%YM:1%BLX7RF@LR
MP3"ZIS/,IJ33,')DGXQ>?F!H.&5A^=0KK0B^QB:UA74:AI=96"X:[EZ2%2S\
M_!^[PW\@!Y20KHL'+_^1;EL\./#+/)6*69-D/U.D4\4ETQ^[:DIKW<0GQQ.7
M_J]I*M46%:[/.UQ%2RW9 NR%%1D/KE13J<K:OI!S'%M;OZGMTFM;)/](<ML(
MK?5V=6E8W"\3,1T+4B'X2+!Q)*TSTLKJES$0(GM[CU_:ZP?1+L1\4? ^UG4@
MJ6?XO=KF1N$;=#>Q9O#\,3/^6*SO3-VL7U3J^.C1'@'F"R+]X5(/U9Y1>_?&
M=Q>6.["V>H#G?/ KNV3MG_8<9H\I$ ,PA*?M<B6F_-RKQV7-:5XC^8&>\57Q
M-8'$Z&YR177)Q++V [E.3KBL2O@Q;+='@QR5&YG:?F<I@NFX!ZY"=T<OTASL
MS5WHX !5^D[K^\H*\[_ +I8)-=0,-H0%UU(W?)^\6DJ6Q[ZGR]([F%O>?UDM
M@+_;&H8@TM/+QF/'F7@W<]!F*+VG8#1?M(8AC*TK@6*#XD7QWJ"GM=555MM.
M_&SZ/$32%M#%?\2X>R2'ZUD?3'RCM5_%VB_TT JW-=&NVBASIP:@VZ(>8-SG
M!8,646W,3^)O':IY]%\0%?[G4N!BK-RI4,Q%OSPTW?[N/)?'C?+V4NX8*]Y>
M#_F#^WG6=>0EQW1DP/5INN-TD+N,:;X?*_RK4D'G; )2V7'[)7]Q<3%[WY2_
MO#:-[K23P!,C;2.J2(&=]K)BS2(#M6'S4W7>0;GB)B<]"4'[,#B[JRU_.T6+
MYFW&.8G5?"@S?9G(3SDUY-"!)(;>,CC"BV:>,_//GY K/"8>!8N.KN\L..T,
M/5/R,&?*AR:SL/,X:Z,CQ6,5W3KC#8L^GV3IYY?]H)%A_44\2).;/3O^97[P
MZMO505N,Y^J<PBW:/MGSQ-Q;\W,QN'N1&M94YW'+T[ 3859Q96>Y?SM7$T57
MOLFF[*TVSWA^C+B(FO3QTP:1]VQ6@U0[Z>Z#5^TV,A[<V C]W%!72%I^PHP$
MTT<H+L"V6_&MK$/-FWCIV@T1\&<Y#T6]X [\H.8S"JVYY@=5(F #CQL07]#Q
M"1CV4,&]6H"#76'OYHPP>S &>VYM9M"NYDT%]"[R*:J@4V-2KM*\*Z9#ZRT\
ML5^J9N%' AO_:0;_>^*(6W<;'["^JSN504?%<A+.T>\-*PC;6&-%36)CG.10
M377*7+Q=;4$VOK75#;S7\CKVK8^"=;^SEX!1EDTKM]<\I/W4[A'58;Z=24;2
M BC[X9#4[2O7V)1\5#\,I K'Y^0G58F!QC?>8VUK)_(:82]9X5R^=K;=?'XX
ML-<Z]E6\9Z0>0.F&R%(E,QD'^;.X23CXW#6%2^?Z['WLRQ?Q70ZA*3^.KRI<
MB,NIO7[B$CV@)G=<K:X^73&(*@OE,('K5&"*IF"\>.;;I1[>]9=T^ N6\5=I
M96<P9JZT,[^\H!%FT8UY9?$%I.?K&W/O\5Q$.'[!U**[+:V$W=D49RDO*BK*
MR_S;>=(#9'%,/[<?^8*$;O\YQ2$A,WEX[D5D?&O1704M^Z"2_I!,@]BN$62,
MKR^%3D^[C]G&EEA@2EI;L6>:L=%V#[,-C)9B@%0Y.O>K;Q>S)!W1HWGEF_BO
M'&OY:9H$,O&I#SCP@6F\B><E5/>2\GBO[79#K?NQ]H=*W"M2,8FI-IP"'O^P
M%KJ(*3WA<L_,:3L3O??YUQQ(X[<0P8W)$*^ZZ.23DY%]7;D= M2I[3'D]5GM
MO=7L&R5]:_@WS%E2Z=O?# 2_7>'R!J>$'HQU;,A,WC;>04ID3M%8% 29+H>3
MMXNF^N)HD6QV4?%8^9#M]MA#9<V\?.$T/SOSQXULR3JS *;IUM@+"/Y9@D"<
M;9Q%@IK-9K6W.[AY3:\G_?/<\$ MS\7V$B&];E(\!(_D8_#BBO2;&::4.Y-Q
MV^T)O\$T]%EVJ!VPC.B(N,Z,--_3CHJOY&]]3*;IYCBFN]LYRWLKFKOEPZ\V
MW:(GU56\6*+QH4&;54:%@D,Q^RJ]6PJW2"!W5XLV4YW[ ]CJE  LW=B?.U#>
M!+W*D$(UK9$C<PE*KZM4,ZA.(#WFZBKX J^B?5<[)I%/);8G9\!RQ66QS?;G
MZ;$-R=_.+G?U3FRPO)GFXZ/GI^K2WBEHUV]>U.1DOT#XHP)C$[)'W?.81"3]
M_AT0^L.PTWW-O2M5HHYC) C72P>,5-00I[@H&G7 YV=/GPEV_Y#%0 KW3%E<
MN6&>4C<'.T+7 ^R2/VANMQRH7+BM@V5W_SA&YWF\K!J]'6&0^F4?K%TX]+8/
M/?6F5]"+?B,->_$Z(*4G#URD_68^"91=][U[*./SJ!3S):QMPCL@C%^QA5\X
M,@ L'*[$TI\R+0=*-C*5)*^1N5[IE;*AM, */,MLX0BIN Z9_-QI:9 B,S!H
M2BB9N\:=TP.&5EA6V;A[G=EE]F+S8[2H=-Q]3LRSG2M6:?\U!O_XQ*9" F,0
M_O5V]W#Z@41&C;@?^J02V[#.S=XI(&_YI'B/D%43T8QM;$+PO?U8A"^X U+U
M6BT-9K=TP)9JGJ,'WZM#MYK[X?G"RI3@PM=P(W/"K#^<4C/A[\67@2%,)Y&3
M-O K6;2%A2/;^E_D0Q$J5-7$ZDK&VP -7:6*MU]10=LFO-A[!>;7*$4:TH=N
M/: PMD<Q@I9K/PJ6VQVJDMWM)%"=*R,&2%L2CS.YN73B02.PU#@E4IB.>M>T
M<[K#??"L28$GD'9D62A$WUQ]GC^LO4CM?J\'Q%9N\Y,\@P2DW5:,2?[AJ]UB
M!R,RB6M<\'JJTRU/.5Z17B-YKGXVOE+P9SGZY%#Z3S%UZ%?4N&XT8\1'0G=E
M[Z650;.[F]L@A)<W3%$W?H)7^<>,MPB_5COWUA(++7^8<=+45R1\7$GGA8@I
M@[25%!9O)G:6&21K"'_:4=*C!_BXMRI^%.QH G?L3KYYSR OWXF!EAM'@LW\
M,S%E"+^1R K,*+FH2G.C@?B>V<V #ZY6TGN>BA+GK,AM]%$KXM,1W5CAS)V%
MW__7V/I_$$.H<O?]#T/8@M_#(V-Z2T<9\U2$BP=FZCCLV3.T>*_\B$&S1Y,,
MY>44_;9LW0-6O'[Q+J^!54<XINY5M2[ZJ![%WA[<'ON 0L"SL3[GKFQBKP)]
MQB!M$YP/?-0/O9)JB70N7C(^_W1YS_P9#0T1@Z/+UYA.E.]WPVSY2VRT>8JY
M7TJX*@.\DPK=Y!S9(O=E9N1?Y03N(@-[*#W$'NS4QL?MR>WQ%?S5N:6S[_>_
M^ZZOH>;CQ8J:F_=NWVS>=\:."RTU/4)TEH9J#1G#.+NNT&Z3;;P"X$;[<F)D
MA.[[RP&>J1LWCG0CPKOCK8@G1NBO((K")>W07_X*P03?/9.L%EAGIE?F;Z,#
MDV(DT^K0>^/%#VV*)4]><VD;D?';$_49T\%?S9@2_B4]O?3U\.X6+SPFX$AL
M#4QX[^2ZW6_>YU<ONN/^O.O\Y?@K>2WXQIB1H8-OO2W&R4ET_,ZM=H<;E-'J
ME*FW["_>*7CGZ*][\ND?OV;;$GE+-6!\7] HI0Q%]?.*(:HB.X%WGPLQVOFG
MNY93]1"^-CU3X<B?8LE.)IMSHE*C9@J>(.AKQ]PQW4Q[>A6GJY-Y(]?<?-NF
M'_JE'I JYPIU1HP< 2,;^!OYV0RD28S"ZF"]E<5\N?P6GII@%AF0*L!)(=0$
M61C]XK#4'57%V^Q7L3+)XXE@>;UU4Z.VO=$O#'5BPN]K^P/7_TD.]_?D5\5Z
M0"]P(A<]*T> 97ZAC$O(OZA6RBAOX#]#-F UG-.\W(KSGXK7[%H;L%]MQ$]M
MJ6O]+O0T/#]+'!A\_=+:<7S#QU2H!P0L! IDP(B-_-8WBS4*G<]#**5VQ/LY
M72)U(B!V6D^6T5)ODCL-R\T\J&*C&&[D[?Q!57W6D.G8,K?&']'[J?^U>-?1
M@TC[$P7VVW;&)(U;:Q32U+&Z/7'LL[]- P7;*!FJBP@BW$T/J#?]X<_WQ$>>
M!F1.4PW- J>*;Y>G#Y#(_>L>:G-OFN'XYW.3OY)S#]W(-.]'.%8GU:'&/7 F
MK.OF[RC\XQ?X=C<^+)@QG>81#?W\0"BTN*P;GBAQIDS%6SG<:M\Y#DWFAGT-
M;V=7-X?3=@Q6P[B2%UGQKQ3'D5[Q/!%0FN)PK#,0)YRS/MWJZN]MSXR<1_[@
MU/#-/T+Y/R4?C2BM;Z5+@]<NPM4D2CZ(X%CWN:<N-I&GZ)E'?H1IQ%[<"DDI
M?\.;FV,Y;J>(2CS/KOK"A"6W\2V]@L), =]EV0P\'O<^+_96WW)VFP+O?C(/
MM$\,5**KWNU/\^+3ICK9\9:MU2_VPR5^K=_,Y7"4>GSR,=Z5(0'.'BG&27#?
M%YQE9Y>JJ_O\"*B8=^ZNXO[)S3D)-2S#M'[(I_Q=WT.V%)/+^;&38[DZ_,(%
M=N$4NFKW7E_WF_BEP)OHM98OFXN3RED++#_&P-TMS5!/]HD[=:&#L'4RT5^M
M!N$?D:$;<Y)V>P>/MR=[.QZ XXI)RBO S]59JR[:6H(-\Z1'VW;=!=)@-N8-
M@F-\$8<>HK$"K/J85^NS04*71[K$]7?K!=Y*Y=@ >);OETV /A@W,^CH/B%N
MN/*E$/3S"U($[$+_FZ2G2WP_/0 3$R@_>V87Y,"A.RE@V-:MS-9\V]$@4_&@
M);QS+,<[=</*^IPT!5^NR6?[DF&</C?!T;P;="BN"6.2YLL\OLD\(3LT)%(=
MZG!WKIJ:!>;N%^/FN-/= Z/4N#Z:#; _DGZYB3QL_8_L>>#Y=%KT0DY//VDJ
M3=*:TO?B7FFI& Z*&5]W,<Z0@R1T#]Z%4K=>V\6'@1Z.T[$F(8S8833J'.&Q
M,"OP4]/SBEQ&!]/8MZJ=N$(OL;4_,1&6&MGI8,B.<_T@2,[L]W@<QYWHZ0QC
M/0V01(XP5TQ9)XBZCUXB7)P' O HT*;P3=E_;_1!'^1.Q"$*;"?8(*#1:?2[
MY*2- J<5T@/?#P2<5^=T$+#DN1#]M:D>,*"UIB5+7ZRXTVED[GI.)F1\/,E^
MF9 >-[W1M&-XFTTT+H.TQUNY^KNZZQ(6U4G$N\CQE*I?1F#"V9_\^PS,VI'1
M3GM[M748[8:N=G 26>WV54!E83WN-],:WA]^W5N\;9M[W#M/QH@*S:UAKE=-
M.+N:TX"C?L5+&#2JL%7!/)0YH*:I;\U("/V,59-;G9"R>/O1/$J5'@##&)]<
M'M"]"6.I30_')N6(#U\<+P#!G=I@<IH$N-P.=<:M%U7')QV0Z 'JL(E;[?:S
MYB:;>TWU]"%I@D++?9MYK-8@?@XJV+VSIBWK2H#M7J/YVZN-0PI./\3"MGQH
MJ2'WI#J=;EJ9Z[>1H?.N3:_I@Y8>/3DVZ@>[72RI4_M?& RO)NW<)(P;<=M)
M;=O'M0*Q?WBSE8=6SG?<A5%XWLT=]6ZR:U1/A_;&IVGLM.+Q<!07J0PH'YL-
MCYE)2Z;"TET,@VHF,II"!/;OD'1W14JN\4?@R7A8X7Y^1=*H3^4%V?L+56D4
MHZ<'=(T+<#6\6[$X-IE\GNUT/TOI&J/8#4M=I:&MM?RK=$EZ=<%[CWR,";^"
MOTSRV> 81&@?S.=PM+5>!>Q /:!A1[B@W1D [I><N@]ZP H* E0'>7RL!WSG
M/J2;%@SMKHE1V^A-S![GL1[P!*X'[)Y^;+_07?Y:E*(\?VL )[+YZFE%QO1R
MFVR.O_.(/G?3YEX)P;8M%>2<57J_K.ZHR;17R!@4%O4NA99^R=Q=X7V!+-A[
MFK/67\J!"DSFE9VYWK9YW,B8=^Q<>*)WE[>M_=.YSH>R"+:%LHB=P\.EYOTZ
MYFUI&3_0-L&W5E!<I;&*LWIK9"\K(HDVV05VZ_LK&%Y8D#\72=4!\\!MSGZ]
MD!CT)SU@E6"O!R3!AW;,,=J;*J#F>/_^E9!X\[TO%[3\(:T8I;-/NK1_+44/
M>(W2JO6 G4LM>@ [00]XA]/NP[O:K/T<H9/&ZK:'](!CQ/_7E7_0 ]J8>L!S
MX)Y"#V $_3]NF:";1N@!/^Z[UHX>L'%7#XC Z0'74-O[*;$&MQ4\I*:BU&P]
M0!/'U+8LZ %?[-],J@?,'] 1@;JG>H!X_ZY.!2[FW19+M=EK),6KXQO/[T6V
M/^F1H?O!V1T7&CINE.16#=P=>,@_?DJ3<OT1S?9Z"--=YATE$PEW,'LM@KK'
M]P<_=J*U9?HC@Z%%G#9:0DF;_TB>!3R\6M26%]NBG6##37E?T=+%>&D$2^DC
M@L2NLX'=Q< /+W9V-"TYN3I69I VO0(E\=TTUTRO B5E%)U@?_GLH/W5O*P=
MVK-R84P4L!&G_S(:X_<G.:+Q?';-%ZMM^?<@OQGZ5E8),L=ZV,?<:NO,/33]
MO3MK5UC]95=OZ[[?YES4Z+*6]\W5 FPG]#:YZ!PFXV8G-$IZ):QB&S/9(\D+
M)>G&QJYH"7B[7CNSN@?'51))"HP-2PJKPLQ&U(SH 0EI*-@Q/>!MKD*J4_/-
M]0"N'I"&D@]U(;3-V._WM3.+W3>3;$&SG0'<HV?Y:&%O]("?R?MP/Z1EFW-S
ME2&W?APDDH>WL#%S4_+5N05;M.1V''WE]]_E+)5:0LS !TK?T!-R34W\CK@X
MLW=,@D$FOI^GZVX+SNS_4#"3S./FQ(_5U@X_W&IO-E4ZN#R=\&+87I#SRQ.9
M?@%V.3 C+NQRN0<6B-K;VVJ7Y*_8VALYU7E 8E_EPIW8GD9/)PI"[*>+D>;_
MAH.%3]2O_%!9EC5_C\U.CKOK5+BANWOW^(-&] 5A:>D%HK;V[L1; W>%2E!:
M>N641J;CR%3".DK"CD+9VLL-\42<&J.,WV:G+ NR?:G6<M+2["VZ@TYPNE'9
M[Q^SN8WU3\F5&].AF'GR K*M8$PRG*@'=$(Q<Z^R<<T+Q*^.C(;-J8>Q7*R_
M(^?GZ.E[W2^3,A0@=$?XQEE:M'AVH*DCX_C90ER<WXD-R[Y]=G_O^846;#8C
M Y6Y #^YGM7U7F%FU<TX4J/UNS5L?[2H2MH1E48^4U9P>_SSFL#.K+81$2].
M22 XA)&;;;N+!KSH:7/EG,5YX[8 5!+8%T,/.+'3E>6QBJ^]3W"BJ/Z\8MQZ
M#WT;+AY/JO\7[C'W6T>/FBC\?P="E;]KAT-K<GJ$)6=6AT*C9)H+*R^RI)DY
ML56\T?$BN1YP=!YA904Q,P-!*O9\1G.A6/84\#CK2F8_REYVB!_4V+V2Q>M-
MXY!KZYSK+06NWJN1VYUK_9[UY:V?4F#5$I"#U]<\4/',YNY!L\#27/3%EH_7
M7HQQY^9##F[)F(ZA#+.:'H$*.?ZMC-=\? +>F#N2?">9C'0P+#]\]1:^4X9>
M"VAM*[#O>"'-4->3I>;LN65\5*1HWL^[,5PUVNE@\+W0\Z=_E/EY!L8#._*%
M8?=Y? A]<IWGJ/%R>1@3NZV=W@8;@(2MO2UF=KV,;7:F<"W3I?*%MR1/)6D8
MX[X-C>)&#5LO#3H9D/(/K<6F)A&ZE0<^)O*35Q]$)K?&-E%I>.I04&8IQ0,6
M@94VN9!/3GC=I.=HVD!C[M8T#>6@0)B1U;52-75^)&.U W>8USTE,_3(C8\O
MUZY-I(%]7@7QGO^L;=V[7+X:V*2+V6G%Q+'4CY\/5\WNA3CDQBYA<G3#VBU^
MW\)*=(!7L _P."_/_FW43H1;X@5-2LC@NJXV)G-I"%R[M2K5?OM>W#[D@TU9
M7.YD S\!+W,1;C CYQI=I2T^KHH\:\N&'*C*'T1&)10H1N2Z_ELGF%-#<)<C
MF%D/^Y4IUPDZBS3YN,/MZEA?P<JS#&/BO?DTTU8PWW$>/5F'II)%NQ,QXVW"
ME&U.5%KL#>(,N)47=FVRU[(%>_J[R _"FFR!8E?P&)&J<;$3:+#)1[%S&QGN
MHWQM]9UD^]C#22 TM=?^9CO"#VKO06X+BOT.F$RN;4<OJ3V47U5E9@G]KFW7
MQ!!W(\E%I*#UJL*GZ1T7_DNI_-_D5W\>ZO'[*5;.7!::74[G]^]E^F;;9Z?7
M#BV-ZP&0],!]9X^D+GSM>&F"R$A(Z+UDZG:DN:,%TK$FM?S-0 IW]JW/T46M
MIW8_Z1POZ-(#2@D6O/P@)UD+R#1W" 4\+N? *A*NE((1#FY^(B/[JW#YS>ZN
M>-($?PM4NY_+8MPT=U'E_56"!IL3&@1%=$Q"$%S0 UY1!-RH#!*#<)Z0\Q/W
M;QML40=^V2;8#[WFOZ;4[2?'ZVI$@^ZF'K!7N>-VI7/G['X&1;(K9#(]8#JB
MY;K+]M=;S7J C5;T<E$/<+@QIJ0K=:5(.'"%W&NWSSK\KG@C>C &>L!'#.=T
MS8OD-#U =M%:%^CFKP=,+MXY\L>&%_\<R/^>?'1-LRHG1FRVTM!\N1T$/RD7
M^K!7,/X<PNF.$N<-VJ3OY:-_G-YM^!A"[6!:=_&YFEU;50?8_V:F2PSV]G>#
M65Q/]':L]08.FF+6+\!OT0=Y(QO[S$SKR?H\,(!=T.FT@3^Q(/+>ZO!G88S[
MEN\%+V(=>G[IV#JW>3(_KK<+]=E;[43H;E<L(2#N@4>GAVUV>X%SH6WT.&*V
M_U/$'$7"<<CNW' ;':OC*N<++4./+#OT.X^7]S$2B"[3=*\T4/:C-_QQ]P%6
M@#LR.D]W0: U"'9W,1S-T@,,N]]G13ER-]6F9-O!@]=%_N%WIGIDD(X^)OQ,
M)+MO8JLHPI@%H\Q(4I(RTN[G^E\07PWS_&6L<R1]O63$"P5A]!_]_5]Q.GZ7
MKGLP/_!@8[#S [J/M%M;"4T^5N9G(&[PM6T#?M,CV#ZXZC,GJ+8<%L\\$PY1
MRS%[CYM(^R2R-\X,M<JSZW"W*5<0+(82#&CK\H0QM@5\UMSJ+&PJ]=8 Q_B"
M3NG'!AX-G42>!)HO[KBS=6ES\,Y(I49X113^2QNRJ6[,*.MW:S_\,@)<Y.F2
MUAR^Y1,=F>?ATIJFN=Q4N/W6)--%#VCFRO;N(2TE*2.I\<XF;>4+_#&Z-FQC
M]>H^YW+OWF=YM<@8NB(F:'*@1*NAGQD8PUE'5!'R-%7/">'TD@=1X0)UCRA<
M<X2PKP?S]ZLN^WJDSV^DSBDUC1&_Z $+W]?C5>?O)@[^8?J?YH^,C9,53SA]
MDPGI"^1VA \K?=RUR^TPMR?!/H=-_([^-MJ0DU_-C.]HZPSO=SWUL":[(OMV
M(SI1@&$*L::5AL.INC^,+2YFF78(\R>2[69+?[MP1!$_GBWF8HQ=YW;(#QRX
MD1-;JHLGH_'B_!X\$U)J!>?[3I&:XG=(NM#V.+B#VN)T!,$=E9H9G(YC_NS^
M>\ZZ>C@-LQH9J^0+;M0,IUO]:@GCY8@*N'%3:$#..+T,^IQ!0X;N!9[%?ED"
MSKU__]HTS1C\ 2>BKO#]MG;U@(P-NY>;1&YBDK.27HZJL&[3)CW8_AIN8\]M
M@HB%]0C_*N5.6\!3X _Y@_(!3+)Z N'FT>Q[_]@JF7E;#T @:JH: USS=E2T
M5C2DW<>]4F$P%O2U\T8FT"(7D;B>][U#T#G+(S_V-]"#V5_BL%D="]=9*<$S
MXA/+3L$J_"#<-NXA@G[$[_IC7>+JG!8FT@/ .7>+=0'B26L8'2XQ/'[^&G56
MX9]G[;FD2)IMCNG<MKM->/4@_,.C&(\EK,=2?^S4';<H<![2W*G!B;JE03R<
MX^L!<I:]^?=>3DU=$?_Z]RQYB"3&_&I@5C+6@.D8")0;)9 ?RJ6F8?&<YQ1P
M0#SG"PBF^0P2\F!.'IYK"SN:[?WH <<?Y)("BG7P]G8/C>IDA37+@7DY(2//
MG>5V-C)MQY4FQ)9DB MV>@Y3>C__KMJV9GNCN+C;?LZ2S'(P!/M#3 IKLU!'
MC=QT03?0;PT]B#@3?ES"E:JGD0C[#FH<$5_N,&4=H!03N!+EGP?!P]GEHGI0
MVWK'DV'>+'.&^OP)."H(5MG@"ZM(\FRLYCFHJCL-0WQ<*CC*"LJ#4.O/0PZE
MAIPV_("PT/W%/"GJL.\P>34S"ILX>77.N=;TW0C89 1ZW.684M5UV9<C6C#V
M$U05D_C=-8P7];_\AX#L(K',I.>69,[%>^&I_EX<;;?X*K=?301'$O%$^Q/^
M4NM8W7ZAD1KZDIZ8[?*V+RGT9FO)ZN#02\1\950XVO9]B]L'RQE9?D# Z-76
MEJ>-M5=;2LY"&FI4/<*:7729^7XQ=1T%AK<BML&CV8R506SG7EM_=%U@0$+D
MQ.*@'G U0^0A,R9-, KJO+S;[R$&EP=R38+D?+?<FMR<?'#<L *VN6OM_ "/
M<XG@-","$C)R=I2=6=ME#>-HCKRRE^)K>4]95Q:=^UQD"O&>'JG\;!I=\<;C
M(9K7:GZHG> 8[)@:B@P=>30=[31,B_()?"PW7WNP;LL@Z%JRA@YUM3%R@2 <
MDEHSXI5):S;XX+;*9L/L/R\9H<7;V<]?N+=?0 ;5CSEHB&5S-\H@0:UYU:0R
M5_'LEA,[?0H28/ET1).00@KB/MDN?Y9GL';(O-O-;W%V#)ZBS>36G@-N1XCW
MX].#(=UL"L=S?AFX >U6L35Z0%\)OEZ(>E;)H]MM RNE/1UV@[+;VG/#A]06
MP-Y8MHX0R12X2(=6;L?E+N2KC=+GMQS@Y+G)SJW-:[FHF_F(5I8Z'3?'#3BP
M9B"^U*X'^.JPFPO[?MF8)RW4YJ/',PC4/<S$KGDK*NV\NE#,7Y@DS.PN6"_M
M093Y0_%VEYN%@QN#*WGE:WK UPHSB#E;LJ&UE:VGK4M8(EVIV8((QC5=\",.
M@3-W,A?ZCR[DALSD%69R5BCI4E9LD]/P)BMPH3$J?^@PM0_&B4ZOSV@.D4%&
M;3^98@]?EM&?;(V?M)E,=0Z+Q'V3KNR'0G]<C;1:W6-S#0@1PXCLB;>LV'YO
M=]!:,QH%Q)X@/E96$K/7R3PDUH>)0/+K*\CY.JE3>X"CA+0\#JT1.9@27:&L
MRTY]\EA+_AR"NNS22[!_RE"L#.S7<LXDL7DG]IAET__G,8=U3.\SG6+P-+4=
M+UD2HOO+VK^?YH5SX=&GV;6'J/4CCW*O!<$.QT;TH_E02UUD2R/Z["IND0F\
M-[)$I4JPGYZ6;V*#E\'NO186[)=C"/N !NOPTD#WZ>HB;*<1"Y1/EA.^G(V$
M$Y<IJO;;4_&U][NK,6]R$2>ZP6E[R7NC"[=?T^LV%6U)T#<WG[[A*9IX<"HB
M"G2-YXN\'BYRE=Z:?CH"R7H8DX6?9%5]]0&#ML2?^Q)?DS479<>WXW$^2LJ8
MV2VT?I@"*?%9@_Q6;M5I&(TX.7!1<'H+W7L^\V8UFY4LJJZKA$HP<>MX8N%C
M'I=,[=RVJ,Z!-L>V^NT$J6$P>(ZX-3ASB)N[W4[9]SF1QB<C'3$Q@%Y=V#/J
MQK\N>'P0A0ES'5;7?K>.2)U$[(1&Y]6B@;QQO^0[L>^0&WY%>Z@)ASMUS;>L
MB'OM]T,&$]1*K7$TO@+SZLQLT&37FXP8/4!YF$,1+R3T3CGBGA<&2KG RS-]
M>D#\ _4)%%4WS7_P.D\/D%16Y#]_EEOY@%.JZQ=+_#H'S8 8.A6.T@(KUA;>
M$4[I 4AWE'$)</8>GO]^J"6V%J[#[3&6\L*D5_UCM_H'U(%BG3%AFDY=;RMP
MPN[B%(N/UP=7+M[/'YK(HI)CZ@NPX"4VZL)&!]Q2&92I)!%SM.V>UP0;IYK;
M- \^F/9Q[C]>#PZ@AF=81T>!"AOZ5/0%7SA!G-]HDFWS3-5<W7ZAHN<OK=@L
M_%+RA:6.3)_?:(/SHWOH1LM\%Z;DO-9U8I3-#>#E^V*PG4F]Y!#'-C&W8*:[
ML4V [[L<W:5^*!O8)U2#[@7J(_T0S45:A=O0,39G> KX*;1MG]P<,E@W^,L0
M"?Y9\4;[ &I4.C,>!3]^LJTP5HF)N-5:TM=A_=U TK&#'=-WN:G97SXK*<YN
M8)JFF-N/!^'[6I:NWN;S#BP0YO0 M\2E,>;R3#*\O(LTGT3I68)<P>Z.8WX;
M]?E3L1/'*C*PNQYFZ%0;WV^>F;.0:P]&M-\]Q;UROP<)VN3$K$V]*])XPKS$
MY@;W^LQG8PRSRUC=O'W@-6"IY.Q^R*LZ.Q&_A\N\&]73,;FP,J_ S I>C1-N
M?4$FZP&?]=IV-*%K+@BQB9J4\=RLA?Y\C]4CA+W.%9/?[M@V6(L$"_!F1^]F
M,E65<.K64T:?5\SC:FR-0PQP(B_H<9$N>BP)&1EG3>[MW!DE/H4%;GQ@YWCY
M>W6G$V>/_?TT+0N91)S1G)UMF=&D223E/I2!@1+%#=:I"G=A-'SZK=<=T.3;
M)_'/J.S4RL<1/HR!3#W ['Y]7>BT+/E; M9&$*(.><MOWPDZ;I+9>:&,K#Y]
MQHG64U0'I@[V,3==PE=[G\>(I'71BL+3#9X=[@_>WL]VN9?%J93H 4%,2<HJ
MZ?+C,74O5*6IMFE:<A([L:%0[=J<JVW_HO7&]0\%TUI+7X7U-3W +G>:W@G5
MOGFW.)&D/5--)<A\J*@;NCU$-$+>@6_XLA%W?\/SV(>.W+;Z;I.""\]1&:@
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MCI^G1Z=S1&&0*ZKI^82QOSV0YQS4M]T/JR[4XY@2W; LI4;7M,;_OG. J =
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M:XV0,?!*43[>BP8]'H.Q%6X,?OX$0Q34#/9?'<NN#<.=ALM*\CKM38]9?\%
MFI 8O0%\(1):59^Z,AC8:=H)]&AN ST-6C3U//B,5O_M(:C<<@)CK D8]2Z7
MVU!==UK6^D;GX^VK/.ZZF*@K,H_?FG@4'2-V-;:X7R$A73KX5G'47="YXZ[F
ML<S-F:&.BBYJMFCAMCH6Z8:(WLPKM#DR%I4Y7FHRNG!$T@Q')G<%.,_$QZ7K
MSD7F]7%WXN+/FQT8T92/R0,]#]S"(9L:B(D<57JUREL.]D_3Z& ^@4._/IO1
MO)&Z>3>XO]R4'8U8,.UW='D0'!-__W#WD[7*"WL-_3L=;>>4'NCH+K_70K39
MF>\$'\.\@\=#8[:=@B4<QSSP7GQN?P7M).;T<H^91;DOKODB,IE(V^YX3+VS
M>-\PHIC""&"L6G6:EAMOE%%'M7V[Z+6AD >\)'*GO9K*&<O"UEN="60X<MIN
M8COQ]>EE#CQ@>L$?KS@X]QE\K\RH=(\)O4S%\MQ6\^X?$2R]#F8<O5CO]^F[
MF5[+ 2HM&&3R\K>)+;;)IP2XG*6BW:6 \1'450D546CGL4H9]&2D+G%E*;[2
MFH(-]UV7G>)V1#,#3@H0G<B U,*B*##EVRLUX/P)?TY0#8D+Y03]@$A23-FJ
M)CT[S3^9V.*T$W:N[.9F;P*?#.3)AJ*5.M :;OJ.,D.H\$"=7,PSF'*1&&PM
M8$2U\SN>L51Q(TN2<W;'^< 1K9V'=^$:REUN8,F#<6>WK&]1)*J=3&U AW@H
MMI(2.#EO';/Q02+-&(+S;0.E;&GO0=PA-T^TAZ>K>!YCU;?%"IQWU:2+OE=B
M>,^5%U_<_&)@9$ZUT\CU3C#MSJJ/;7-PR5(7?\ N178Y^/9)W>Z%U8Y!:JI:
M\&XUMJJ&$Q?Q9V&K?6)&SY"H6RFB2X2'-W1_&!QSJ;WLK^:E#WB-^-R\S(53
MFI/\_4<85GMSZ21Z$JAG/^MF'?XDX/RD'N"$3]\83!RA#S=ORJ;Z"CSB$MJV
M65?N@[IUBW:D^M+W!0_F<PH*-W6@U[I'(FS+@!:TG(=($.H!46O].,IF?@F5
M4"H;\MPN$/:J,&\?R6)98DDF>@_7MIA9J]/->PY9#A+B:\2S>TGJ_-QN](9.
M#YA'\Q=J^[OF]FS8Z@)I*W$<%^THY<6CYYU4^6X"E<Y5O%GF*";LEPLXB@2C
M"QU2+VF2](#WKON5XO8A=; >P(C5[2K,-9NI>L!2$!NH<M #.EQ0VTA=P0(9
MN!NF!TA+9?L\ZT\B/> 98@ZC2]0#=IA5>H#PS_NU=4&G'O 2ITWIUP-:<0JE
M=O_C&XH>D!=;AM,<"-)>*GB'4H#T@,$\NA[@;J JW\;H#NH!XK(%;=3_H!%J
M[:2R40^H&=(J5H&[[U$CN#;49L(^.,EZP)KT1DO!+R!F"G6$?1!W%9YV=%WK
M/HA$K8U @\M]C[J4V)?0JZ#NY2\\EJ/,&&8+E-URSKO4H5\P?+"':MS'\/"D
MI*#0<I!2T ==V*M3E[FE8?F33#YV0UI)*>[; K7OF [Y)53^=A_B'H;'G$BV
M5SFVJ7%D"5S%+/_N%MT*KK,^9VDC:="%'KWF5G2[Y&1 :UO&2;?<3SX0.*&T
MIDB?;Z&44,9IX#C(:-RQ +<50@?2BN5#+(B$\R/]*OS\KO'H='4U^="&34!C
MT ]#(20>Z(J*#H>Y:N(AC:T\+55U.&<DCJP''!S10&N(#FKKM;@Q\W6O($F"
M;>S.U6PP%%/CP:+;F1%WKQ).=? 5H)[ULDOFQL JN*AD+BD9#.>?LQYH6*J&
MM>0D"QI:;!K07S377.SP-W^DJRQH&>\IO3/HLWPRGW#3B^.>M'.T5NPZ9X?Y
M[9P%T;3S2!W2WMYAP?YVR1871Y8>[U[*R-5J[:%LNV,$UVUQ.Q1MX<AJ3M(Y
M$*(M$]-1\['/HI>M,&F;M3=_BA,1'_;G,F('4VH+_AA5: 1F'2'-\"@AMY6;
M$1S$]>YI#Y=44$!:L,_OIFEY'+.V%6!3IETIPG@QCP/OF<\<"4#*,KE39YZ*
M;P]ZZ%;CWWKL*Y-B9.2P8!1>"@'CR&734"/BJOW".6J<&OH4RNGH9CZ,3]]7
MIL"!$& -=T3P..]_.R:3*!DV8X?[!@0&AR3:R5AOEH/JD_,+:X^B;Z1DSC7'
MK3I0=-4)#Y^=2[;/"/;[]9'0V-^-A?YN^GDO4X23\EWZK8]099,^!NR:J9X=
M\/V( AS#:2Q'. >AQ3PP3 SQ] MC%Q'RXQ#'1G<D"Y/.>UQ8+887,G2E9'D,
MG+$]Q3I*BZ2_<BJBXJUR8"?&LUT5&^5B@R[=Z6-!MEONIHSI53?34,J-)9>8
M%ZK*7B"LZ$,_==T4 J8%)\!.#=;6SB7;T+E[B2V]JD9TXNW]%*NV5]?*.G;Y
MJ@H]P--U:H<#+8=3-]J=V+!H?!)G@W291'>\3V%;D*KKC\7K >\*1@7==;R8
M7+9%0E08O38<\\8^1LE&?2*:!_Z0CI#&[%A_HYQO<M&&S%$1LV2G"/H#_ XA
MLQZ21FHU=^R^=&C;Q94?<MK .941Y!ABU_HV- I)-]%%&KQV=QL?\+,3:5I+
MEGLF9-G-R5)X+2)951;?%]]DW6?9QA$8<BX;#BYEQYR;K\-R4RB#?=!*4]GD
M4$5ED5A]_ NTZ^;_S9#_Y5ZN ]W<+!??=WK#LU"$G7UXIKW#LISH.G1EP0:]
M](:_.C698S-W)SOR6<T46WZ[H16SBKX(PV.SEEIZA.=E!$CNIZ_$3IL;N=5+
M,/O;5;/23+?P*A*MW6CK/*NI/7+N[69UF_]V408O$S@I,VPVHLY+(+Z8]ZMC
MF*<3_O2Q1$V\18*BZK]Q]^91::?9OK=]JZO251EL2XU)G#HQT3).H9P5I;NB
M,<:I$N.$4R)1@X@$9T6AJU))'")6- XX8)=Q**-B'$!1T$H4T3A02@0%Q2B*
M401%%$?PFNIS[GO><[O7N]9[3J^[UMU_^M=V/_O9SV?S_)[OSAW4#L9MNFUA
MIN)O!H?87OWIWOQC#L>X/6 M4/PBV(K$UK &TD*^U,8*;Y%+!%TOZPH%0?%%
M!2X>:D@S-;J+VD#NN?WE_7))O0=D8 E#PA%K=:1PXK1+?-^UYKP';*!38A^K
M8.3,?$1D2P0+QTA>BT=I8LOU?BS;$42@XB!T=*N*+G5*(\=B6269T#E:,OP"
MTPJ":>0&@+_BUP*KQ?!3GN=)-3>ZS+W'[2.RQ%]UD%]N@/4F?EZ.>O$8!?ZI
M\JO=ER]_RK,3OB3;$(KYS[HMY;<<'A';CDJWHUDO0MC8)M=)'WT3/VX?%@F2
M:D>8S%B57S!15<]H8,'AW]'3!Z4=M8I]9)>[I.%0Z6%:L1WT'/JHR#JJ$EIW
M^OJ@YV" G*,:$#DJNO!VS8 56'1M.YCRQ[W&=?_R6O,7,7[M:OZ\X$$UJ\#N
M8YHUSB>3K,8XM(M=GZK[6-+4_9QN(HV;!YN^5%3SL@12;]@"US'NT2!46+@#
M$"=N85=8^G#24'K?L-.(2)TS[ R]W\"1@KEA2,P#A0:% EEXL):8B!/";I$!
M?3 5"1TZN([#9=#6,\<CXC.SN^?W!J2'2C_=[R"OSGZY7ZKYM+7DNEGB281O
M47,"[-R'#CKGIH]LBJT*+YDHLRY*N7Z>E!?8J==52+C_N.YR9;=AOD)WV_R#
M&9"(W&$4/IBRMLXHF1_!6^%$JAIMLO>\:R=8):Q"XGP;CNZ?2?'5;[77RY09
M/)3&J?/)'M4M[C!UJJ)@J8IQ(WR5LJQB#E!G-;/B6>>LD0AD)-*A>EH5/ ,>
M,:&.$/M\7A_][=,$9PO57A.+P1._#GI93'@$(7TLD0PMR2[B1 I 0 _J:#Q-
MNY_96!D6%@;Q_SAU ,#2MW,WO\QI;P"WJ@;DA$'F +N]__1INB9N;KN"Y[UC
MTAH<>9"R6C^"TBBF$"F<S1,3%)1R<(P/YZ;(9;3WY6R<1!%Y= (?S]ZW6]U
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MU"2PY8>51TRJ5]6FET_"DOM6O_EFCD:#Q<%G^?63[-NQ0<Q,=O.OD$9QK!^
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MWU@LAUE28&[CK'=ELX]2(K%'$&W'W[8!]'?RH%;T\0B#G38Q':3\9O:DP1S
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M\Z;/E1<,T,^1TW[%X)WD8%XOO6-9C!UYS",-6I2"8;,=,Z-+%^]EC<!@[^7
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M_:"[O!OO)=YBKX3M<&L10P$LIMIH4%; /ZKV2DKE7K]3[!TT2W0W/92)9DW
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M$3U,%]Y9L^#M2ML#J655*(KF+#)7ST&U=P6E'NAUSM97&S$#9A;PK89^,HG
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MSSYB3GN*;P,8 KY^A'6Y:G(,X*-"!1O6FEO].'+.=DT72%^RD7@%QS-76)"
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MUJH'O_S[VOU1OLT]5*J,>SNK&,,HODRW*^JYVR.WY!D=*G%!"LC&R?IED-P
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MS25B++G99:D1LL*ZH.<YW6KN,*;B^6G?I>1_][%S5E0L]9Q%K)3S7\N[SI]
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MO/$9)?).:@R&1=Z.CF\:1Y;'A4M>=AXM7/YFINE[65C3[,O[<C$,P=%-"WV
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MK_;]#O*52_L@/"F"D%$V C4#_!G]VM=^;U;Q,IC.+7Z7XKDTKVGXLY,^0A@
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M?61@)"Y0 ND155VKL'F\9A?5I3 F2$X$0BW.,$J-8*Y72_G^)95Z2<"7J2>
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M+5,98<;3 &>C%09RJ9:M?G5?[, ":,#ZMC3INCSK&<;+^[."%XP=>8,;/^!
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M91ECXMC1J$F<8IQ'NCIF,&KLQ'+$(7%&1$(4)T2KDHICQ%(39['+ 2LJ&@?
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MK$YCX1[83"0\ZC&2>3F/'=!0QSY&J.C 5P2K6I"U;@UW1-Q%T9^U+.4#6_I
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M6O'U7-NN,.O@(X2M.I.D6D[O%Z(E/*YC-H:? ]L)O1O19OH6=5Y_Z7%([*:
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M$%D$4MXRTSX(:E@<MY$BNOGX7EO.WI.A+G( 3IR:Q^S0?3S^_E&G8A  22?
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M:9^@%TFS'&#(@-7,48B+BDT-(GS3UZHUXV568%A\Z[\U!>[H&NY5+=.^ZDL
MB5VD[+M,JX(P'?VZG"V4P+D[NBV\LO5J;=/\A<K/+?M]DZY?P+#9E3_759X[
MI(!9S-."?!=9;>L>A3,8CEO//,*>$%;-W>RRQ,+ND@,*G_7,1M##3WYYR\*6
M.#P^SGR"E7"?$%+Y@XYCJ5ZF^5EO.VYZ+KDI7M$[=ED#?9OT/EGM*C8,8MTJ
MG=MUW@U;:^_07I(>DW0&'GG,9J:U*+J7>R*ZZWH;<2BPL2>GH[W5KAE;F#2(
M*^W[^<$S#.5N>.G/)CU+?6WMYLX?[W<B?]X*Y=".> KBG0^4.N5VCLG5/Y Q
M>J868 @>3MARC&7K&4X&+LU2PPU!.8_][TT4!NU0<M:=JZ/HO7OY!E9CM>U\
M)FP^=W\<!D 5I9=HLY;5&O]?FR ^&4$F(4VV+PL><8W@K_Q#$OU0)8KXIC5M
MSI%DR>:80]B#ZS^M(!WF@R(WI5+C'@SZ4O48Z/N\\C6[^4W@SW:=I3K[0_N"
MG:%)NZY[_4%/!,C<T%*[?7S@YAM\EZJC:/B*$"^B1[_;7)@+C-9=!^4;,=M^
MEM+BMP2/?#E.205B@+;^9XY7G]1N;UYG6BPWK8'B2K 9U[']\Y*0$\CDE($W
MOC6??5S?[>A@LTMT2JFA$/#G3"0U/Q$GQ]=#YFY5SMCALUJTG.3,2?>;%W[)
M]XB #VD'?3/^9+=Z4MXW^':@5HP*XQPHV?*X*7E1U57(K-,X&V!\2>"^DP,M
MZ3H6&T KA5:&,5&*&5$.9%&1NI !Z:_>FTC=-PGMU_D"? KVGNX(:@>Z>E"0
M_>T.M& 'VZ+ZZ9B_@_=8F0!P@.Q]N2Z]QUM/_FJ*L__(.CB87JZ(KLO]RYR-
M%GRU#/AD$I%\25H@G/T4-^&-3LUK217/=W66]F1 OO8V<J$C-4NXBC<SZYHK
MM)V?*!1AJO&RI2J>G$9.VG 83EZ3L,L!::9!OM1*'&FR<F)$!LT"4M/;3U*L
MO"2M*C*":M/N7)0590L^!LI+A^=1Q2K.)<=C_-35U<M4Y^9HUE-3K^FS0;.S
M[D%R=755UK==7D[TJ6]+/*V>)OCX^-"L??R<I#1 6:-'RL9;2I!_BQK9/^?#
MAB@]_>LY.<L?9-(<7$W,<%ACM597W\-K6ZX9?]X+);S_.P)($QM-BXXEB\#-
M@;S1Z(3MV:<HS2,/A_SG(BU/5X_<7C'6BC)6>]R1AYA%N>LCG+]Z\8F5GPF=
MY7G"^["I'RH@<N.V1.B0RS^.%7XV])ECQ%B90<NA*_2N#\N_#GLO7T,F#F,<
M>/CG<W5)O3_/F<>G;V(OWNX"!S)4 IGZ 3A,8DY.#C,JS15>]@VIJ;T)Z_W7
MN=NTGET431F_#<6_74$I% Y82?G-I[]$FN[;5MXL2?7JAR9W!G/&QNW'%YRD
MPWL)/D^?AA[E5IT1B ]IVN'GJ9QDG*F\OKO$3BL#504RX9B;UPR,%F?7P'1P
M5I<V!X(C)6/B)F7]YPD/=9B;> $UV7)XPS(]Q#QO7[\5"(M!5URZ-G)>E:5C
MOY4XP"==;UCYRYC'/SZ\?J='Q.]<65=^M>LQ<7/P6=<[[O@H@G Q*?KJY<B&
M8&EQL7M5;WS7CN= =TUJ=\:SHA[Y)77U4WWW658;5 O>B^"@T6&"S)9+(SE[
MEQUG$[';- U*PTU:254\>$9%+6]^EEJ?_+"S"'.!8?6F8=GF1;$^KIL8.NL"
MX]M@[&8GI*AVMZ$>UED0W:K-K;;%4\^J]<JN_D9C?1TV)$S!U;4BINPC8I?=
M$8#S.[33*_U9V,\F/)(A;'ZJO%<@@'M2R7.*- FW.;PP!RYLI;[>&QVN!DY>
M^QJF5I>&V'F4%CX=VC1/9+(VH 9C$MH*5GTZ<!^0C%0)G&^5H45S-N_;2@)&
M095R-]T3<E*.=*XJ/BRZ8 '"V.IJ^[QVIE)/K\,Y.@A'4<'4,!S OTO52KJL
M\N/@\&(KU"+5(WAQPM&@X"7',_)'2H0)IHTM&=F96,II,S4W-=-KM@\KK@2C
M^E(Q;8>E*\7+=) /_6W4>N"2Z#[]PR,&G+F[JR<$Z#H>B,_-Q=9%&1H:&ET5
M48HK0'\3[LK-9?XV9)U87BY4U57?&*3]H_T?+B,#[4N;XPIE'V9'<L5 8=1X
MN/5^YE%45LOCK%#;BH&'VGGD:<[D'H,;RINEG/@6MA?;-FAWH!0YO&!_K$SU
M.>V5) #T$,6Y.QC4:^[@K>,$K^)NUO[2W>J)!?S@.K98ZZ+==G0M^60>9(,.
M 7M=QX(UV%&9YW(JRJYG_@QM,P&P2"B;\KE2AB9BP2CV<BX;T1Y&R&,&="3/
M!L#,C%LM9C3=]VJP:T?:FXD]#Q> 8ZL+YHL]?4TH_>(+^M)\>8+\-''WP::U
MW DB\6;-?KOP@G*WHON*<*Y13FAL<?<S$^/QJP.(CK V)V]L"R)0">%%DVRS
M /8VTI@W>$8L9-E!5I 1QU!5L8CK<UVVP(+5VD<,H_PGK[3^\3]!^NB/O%G"
M8*;/?LZ\=<[6YD]"99T=@7?IA4NU-N<[3S_>W"#1,@T*+*Y<U9& M5\QOY@7
M5!B7:OICED@>3VYI;V5Z9AS9]N-,Q-^<@XYN?R9U\HJ.(UO,<R!A19#H%5]3
MPD#=G!Y^8!F#JPJ$(@?B2)YODF=I ;-B">]MTPV6SKF"S $-?@4+4V*ID5CQ
MCY<[1D_Q9FT3]M.B18D##YPH\2FD4F)EJ_QV4.2[AV<PLQ'M*;VD68<6_1_S
MYK7,PLXW5LX+5(+_/-]E/6JDF@!),#C]^S/BV0.EF0.EK/T7JZ94F#0[=S/I
MPC4Z;\2^,E[O*;T?*3MO86\Q?@7DL7&21LAII5_BMXHDL87A.TTY4J)J_XL9
MG,2!,H8V;HW(*="KJ+-::_]%;Q]:>)W1UV%%^.;X XEJDU.MT$09^CYD]_M5
M4^4[63IW7]TUUZ_DJQ6UC=#.)+3%]4S$\L^TBOQ;TG\ 6)Y&:JGC<6Y>7U_S
M:JZE*J6*VXD4IHMG[;"3X&YMH2!)ZL PB-)[OX8SKCIVV$7;'*6:OI>&5X43
M73?9B4\TEK;,@!1[S8T@YM$W7'[MH_K&^H"< :.W:8%A"&A )>=F\?BX]>OO
M_J=T[9_:_]W'K/8/]G]**8&]C:X*9C!L\/?8[UBGEQ$?/[N 7QJ$I*X,K"&J
MF<\*\BN62E?<<!H151\GG"7>&F>5/VNLJXWM66EA%'*4\;#=>GJU>44DD5/=
M]GNV>+=[;3^)J:^#F"A2RYD%!4_I]6WR:3?&Y5?J3*)9.K="S=;W:TU!%5RR
M2RDR P#4N@(%E-$89UW3C5-RA5\7,@^4HO_^ZTO-&P$7S)Q\=S]9;JW9W[-)
MT[VW4/<./3PO/Q-BJWU2M^/^R9,:F_&2E5Z[Y[AL?^Y=,H]J356[<N6)[0GI
MMRX"DM:M7;HL"@#:)TD=XTXM[8F54:G.31 ]>775C< 9&+,O.3 !TN1R@5ER
MLKJ4XA!*Z&13.%SK4(-U"-?!-QK1W;X" VG0DLY5X,)<+'F%@QTJK#ZP<R(]
M[<].<\:K_RIR_R[3\4N;LY[ TVW-AF<O79RW-CWJ,YWLV60*.WL+."^C E52
MJZD+T:6I9Q[8Q7647AKU\6%Y:GE['3(8K4QU\(M[Q,+B! 1 ^^W&1#PPLX^,
M?X'2BX)6N=R8IUS/R:VH"IG*R<FMB6YP+^F<6;,_MF2:1>]",M-QE!N4$2CB
M"EBE*:3+XOBMP2O)(92%[/0D.1)2^NMT]&["<WR-1*X&=B+X^CO8:.&H,M1
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M_%^KISZ&I&T\L6QS>M7TKSK68&//T1$UP&_U1O!/(\#W*CYF4SDC7;#YNN"
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M>[*)A^_Q/5V-EZQ10C0-[(W*)OAFSN>%#L-ZA76LY70O)T/?9\6+-5=[=)A
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M:6JC%MNE^VGP? N]?G4K)FA"[![IQN-2]P]]H*70H'_*3Y.TSAF'CPH&=*\
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M62RKC4BJ'&2W)=Q=.EV E00R*H7EN1&#&C8VHLD'6[6$,ATUL>_I#3&S=.Y
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MI/C>V.S)'KB>O;_1^DTIL[G)U-3Q&',&-A4*3RD5Q4"_IKQ&/,XY)F:,:S9
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ME0E,[?QI+71%+"M,V[<JG>D=K".BHC-?,\W.N#V;!202KHG.!!L'#V&TR/]
M"/:_L M'%)5*S_U'$A1Y0P%@[-X/7<K*N[P";C!QRF!%PX4ZPRQ 5\>#X&\:
M3)=]VLD/N,?U&JZ[O-^<&NCS\W.W"&W>9,I8TIE/Y[O<!NYRTE\)J]FC1%UM
MK.0\'D,NW][3GL8C$:Z^NZ%ZQ'MY25Z^5.@W>] C;>NA])Z"UIYQ^IE,V@*)
M.6>X5Q=44?UQ^I^VY'B,$D3.U][_U4&@Y%2GQ&E.4CAM/*_3[LK1/%Z_8HR
MM/6_.O<M!_O+)'_D^'B3G^.ZMQO-P:<%EH(J\KFPQ= >][O!M%KW#KGM/+;F
ME$5R2F"F'J@4EA-F2@72VWE#7OV7*(0V"Y":FL5#RTBF*J'8,KN\O")GR;'L
MQU?S59]+'TR!-.2!QM<J]E?KG#TWMV5A1LGH_LAF=_]C-O?9R"/?CR-6C2R
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M\:M@1^B1*Q'!T1'D)B]NA%ZTPW'#@JD$K;J9'.[53OQP:D2SHI%KI.9RO)!
MM#!3U8Z.T'JB !-EXI55$[I8>W?C[!Z/A(#@,KD$_)UM2CR0,L04)ACZ.+,X
MYZUM)^*:8YYR^9CVI_PO[Z%P"_59C2?4UE&&KVGAJ+7]SXO1C^9D@4EM1B Q
M*>(5JNW%#$2_0QK<QY>>X8]98XE&EG/;J\TG^E>W\?G>2<A82_HU+)%WG1X9
MI 1>$[GDBUSR=%H/_[OL\-:SW<B7:=FKW3U+.HV]&5T3VF6M@:(S;/L7R12*
M4"S!-&(5^@@_JY$[67V!O<;3J_20!.^NFJ\\ W1S[2+X4&&&BXCUU;PC[VU"
M^O%#!3R -7@)WPD>-;I^H((T\/2&"6K@W9[^+>Q0J,7@2K*.J8O90#@QDLJP
MH7WT9]O570#V*6G*L"Y'T\?&7O6<L.>]RM1*1/U)A P$UZN>$%7R62LC.E<R
M5ZK()3\"PD2ES;G?%'FT?A7H!@6Y91!BUY-**3]+F:<W'=\@>Z=T/"2FD= T
MQ1N)F5W]$N2^"&_=Z9A$>L^++$C,K@GF#)C5OV,6FP2A5HH(:/.-[BM#.\JI
MQ:\MI+YQ]AD:+?Y HG8F,:@RLQH9/'/6,PY3F/??KV[.SJ^:;UL/&=P*YKY,
M3J\,84XR44RPXG/S08L?!P7B"YLA@0MF01HFL:8KB_7; 2=;.&XAF?6HD&&7
MGV;6':9"RD[AK'F%KY*['=N:8U/,^,ZG:Y?,8H)=COA'1*Z5<3Y/4X2,3T&:
MTY"Y/F1R-#AF*,W ^(R7[VI.@-KP@0HO1W"@D@18L,&=B"^?T7+X+JBVJ]C]
M;49CT0<F)NB;2@[8K:0FQ3BK*;I(>-UH3J!^^HKVT1L)1Y.Q=L4Y3UO0;IDW
MT"YK3>5M+M"Y@?F,WWK",!TN#,QFE^]TXBWI7=E-7DE RB4VB;[:6=X<194_
M0BJJ9E=#<27LJ:RSJO7O4!-3MV0B^P ;'TP8&%3!CM\<C?G=0OA#YUO;?L1;
MA!3U=PX&:&A*BC&VJYUQ,F6X@]?X-,?P64%X^FL.LFG!]&(K.B_GDK.;IH-M
M8_T"X'*XXPB]<[>9[XR7^VHZH@D[Z13%^0NG!ZD558"N[@[W=5F[7ON+L*65
M_*[BK/-/,TJ]"L<O.@*'E.!!V8'*\_<V@=)@?4#DWA1)Z9R6-+I^9C,/9$G:
M7\5K!Y?RCE;]'7%>0 YC%%>"3?1LEMBTL5;0J$G=Z/VP:?ZE^CG)O3X80INV
M"4^J]C6+LE8,/!-VS-*PC4=U+>F&NULWQUR_ZIUIT^TR]=NU[D2=^#Q\,:.7
M@8^\0R$EO1_@6>CBI^!U_!9[MQ:VN1A.SOS3R8J!T!N+8?QUW-'\RHN K:JM
MU/2C"6=N<L&Z ,/7A3MLAU8XNM@;HEZ^5BGB]4/_Q3+&*BQ_]$E>U!L!Y!(B
M8WP"1!V0^1RH&).JII 5RJUO+WL3;/(:V@E:D/RDM@]V@MP765-;'G[:BF;Q
MD<F,G47#GZ4%*ZRSZ/-XRL0<N]*IR0M4=RF8!5>D JR#NL'PG)ZXDFRP4 <^
M'P;IVO.UP "A "]!;VCD:>/4-#*G:6D4"JID+=9?E5@6'__[\?[)[W'(KD?N
M87LA.Q=^"'C)C:(&IDJ;[[?X1L%2KG[754^TTD@Z<C'E\86OB96[!CPCRP3O
M'V CYWY8IX<,#B4&F'33TU+YE^67!; 8;UGEA6GQAE>PD67^6>.^.6I0#BFC
M[KX_.+"BG"32;@%?'=NDO$;LOQ',10!/:PZ6<KVN5I=#>2[4[>)KY05 #R6Y
M7+BV&8][__^8EYN8) %Y2\PA2.RMZ>7OJ,:>9G=>@L\Z]V3"\ICOB<F=V>+U
M':^P[T:O_9L.K*[#Z.EO[="U$6:]ZV&7Z7&VS@G0+$2O>(UW.M8.K,XHTYX#
MIX:5_J4WFIK:<6<)B#*SVAI+;5LJ Y46 _YRBS'2(R=GR>S;GIYW 5/B1T)A
MRY^64%M#[Q/#3<R^'<E[VM\3J?HGB2?R4OKX?*4_^C-+1M0=\HTH=&E(]W&T
MFV4 P\;ZI!024BJSU)1#92!6JF\Q2QAV+,M9\:X]&CI]9GZPW[LYN/_8T!;Y
M)2+,B#HU3#13.DHU(]HM7I\ I1:GSRHJ-Z:,32OI>'L1F\T;&G*/]MAF6I7G
MWCU0*>EAJH)9]E]8_OG_=^3V_V%?K"ENKE]%FSN>$8MK7O8SB_BP;1VD>L-S
MTMQ<I]A!__+36.'GK_O/)ILLMU6"R"C1[T+2>DVMKA0WCWPHXQ7E')$15P&I
M"+Z68:G8_*KS"8/,46@=-VD?#:^[1"$-<:Z] M4)#3LL*6?DX+!EGL-6<[%O
MSDXIZ^>NIYU&X4O1'&_GTO#2,?LAT*3]74Z@Z!HGD&U8'CD63__EKQX>OAS.
MHR[XRJ6OC'P:6,(FB5RBGG1]ERUFH)PT8U)99D?;]QL'Y_71>X!99>:[-7_X
M2!^<<[HSH-W;;_V'L93]_2?=30<JWW<M95Z<N-/M?/BM]0@-W\,_4 E"19Y6
M:!NDRL&;B" ]>';U5-)0P/6;1Q6"_IZBE)J-Y M6$QN!^TV^\@QR1L@XFA&*
M- <(.*8^U7K([ZUJ?OEO8/WGV&>A/0F+Q3:I >AIFSE^5PF-V",Y]EJ*G(&L
M-.9E0^T5C3$M92<>,&^%9BSXIW3_,C0Q#VE#Y?;8G%ET' _5ND4WGSQ0V61L
MU9F 63NX>QL:+]*T#(8[0YMXH>!.OORJ5]MF@4/+*FRA-SW:V7OF&H5H67B@
M$I?A$+IHU[GAM953QSH92;?8CF(VPQL5X%Q*C6@[:MNW_\+13M?>O]'3,)+8
MA6ZU27<@;"H3)].IZ5SRJJE_'X]QB:KIC08-3KY?*_^@]\"NOA0\5;UYXY;W
MR8!0/S^&%HSE\FI<2N-H"](,I&_:\PNS<B8@\>*$^8KLW#NO4)/Q8='1>GHD
M?%UTM/XUT;<"**(RPP58EME)N@5^>*HU;&PM]R81["4:JW$=;+3)GSY+2&8)
M%GT23S>ZNCR#NX2)["$V]^DG'87QR;1$2Z#,L^$VE93;5#J"(RSJ(T+-W/O*
M;&X&+-6/;PO>,EJ5@D)9P$L[M--"=&;08+PF59MHX>)31MN[9,6&.)6;)=VI
M\:Z_?K.E::F!J,RKF$HYX= IE-OOA;*1\V/*B8H=D#:PUJC6B)V8G3U>5>Y0
M]T\<!OX.XC(QVU3;Y;GCS76U*")-\K9K"!B31+&I]"IUJ9U;W(G;THYY<:^]
MI6?58TDYDF+UP\#Q3G='QG:C(<NE/@@WF37IW96SFQFC2("D)JM[KB39B&MW
M-/?%:5Q03&RD -5B!IE:BJN\AWYW#7<C-2-EGV6P496@9<@XKLDVA.V$':C\
M+M]L;V+)+L-E]D EY]K18:!9B]"\\WAOR;_IP&5 NZJAF="_ZL !*]@ H^+N
MTK_JP!-\'<<YET8Y?O!Q9HCT[:H,Z833)M(9Z]LM[R=N,T*26R+Q(+2._<=D
MZF9)-O["]3Y_<I,;.# [._M'.CWO],RI^[?QH <EN6QR=BZ[Y8P;6+7&U?5J
MH>JH?HTSN&CW[Z Z8KL7NC\#$75E?O=;%1Z8PM _<;,[;R^S[MR# Y7051,&
M]4 E;;5K^FE[3<O@5@;5>^JTU-W[^X"2M\$! 6:P*.WO0P>"< D'*N\./5B#
M-L\Z_SQ 67#L=O:BY7LGQ%(2-GS*+?,B^<+52G:TL<:W8?H="<&FN2V\B?V-
MR?M=2I<LGLYB":J4-3H!\_78<;9BIAM$I,INSNCLY#2%9OVK:%6]@;1R(FP+
MB\-_L#?! YF/.Y\OVX*/?M[UF$1((2SDZ>;V7X8"H1NF)G>QP2^>C5MN<,ZG
MC8?"_9A&TOW+PSL!9K@W:64I[3/2RD:Y<"K.'& 24CIJI(;D1X_51A@%5HR2
M\># W#Y75VV9 CD@EO3,Q\^SN@;L^7(2EUUM*0*Q@=>RLY5/]?1K_G,I)!65
MWSLI<AW_N#^\E[Q(TH)+^B>4.3-6/LWDI]^D\SJLJN!]E6)!BEL:GSL"!EJA
M7APWG_.-$V%!;V&ZJK?$:=F&P,VUM1-;O6+UPTYM]0AM0>=1!<]KN&27D\U=
M%=5#.O&G6;'O"D"<3[E0IQY?@^5-F\-*WO!2]\"959F&*2;39 ==CW)6:Q*E
MT*Z2]YCP)5X<DO6O2_]^/& B5<"Z.P]4R$[ S$5#T&PZH5?LZ+A[H.(A:'ZZ
MY=&TN;(Q.36/L/]&*&SX>B@I^N8PQGB9P,]972NU##BZ=:44:W+!=#=O[_6!
M"C[,$SVR;UP9KC,KO1IV?0M;T?Y%GG]E2K55%=(^.'I='3.34#K>I:?P2BI/
MD<PX[@/?<'J3>:*7W##CMO+]_62VOFZO_#X[=6LT/C@B,L2OY*G?'U%_<_30
M>EL;E4C%BL7)$ CD3NF<4#@7_ <JE?H@MQ:3(BQMB'RL$5F/:6@@)-=ADA>Q
M*4J7Y/5Y9E%;BS^D=$PUN,]K:&BX4%65'0VL<8579((!82/!?<RZQ&QT/FOA
MBU$)M U-<-$AF"=WL0:F#2,G80DA0:R&+3]-GXG!]6(2H8W08A-PYA0JX9-'
M \&#VK!!G:LR5G;4LW*1L,*EY)SR-\F"V&+"=CVN#:K!7VV;(N==3=\<BT2W
MCN#C_6W\Z67GC=74@GK1AO!HXT#,5JR)^KASYC"[W;HJ*1:)=/4*MRX'URB-
M58O 8%=E! @ UHZL_R%4%BXN6+_U&:R0O(S3[1QLB2%F&6MCK\301CLXJJ5O
MN &6R1C\>?(@=+(R[7@XYAM"8V7>%U#(TV:I7XG?^A#HLB!\]$"%6[F2O+$3
M\-/]M,0P&//%@\YJH5<BR75>G!?)%52U;97GWC)NX8^,6?HC*_51"NA&[#B^
MW4DV"&WB!-;<'8SIVY=U<$Y%CRN?C@65[^W9DP3W]L:U<8B?'GL;]>)/A--O
M ;753R/=XU8<'G\7DJ4VY6<\9.?H4_B,=QD82KYQP^M4L$>HU4AH&C/@U+HK
M,BMOO]39+ ]J):3U9K9-(X;H+V/-($LG1RV;Q@P6$RSN89<JKU[+R<E>R6EB
MMG91>;[:P5Y0NUCY8+-'W9>CEDMCGG<'+.Q%G Z7+\;JB+DRW6G]A=7A*V<-
MZ@6+!=LA(6&X\169!M(!^"8\L\#;+Z.RJ%_24=!M)(4R+&%B;EB&T6+N@0I:
M*]7N;?*!RE+*LB,@K62!]O"--*Y>Z1!177HFH%Z^E$Z8@W*:!XMU?7 Z!-9A
M'B+/O[2 K?BI.VAOLGFDQEW6)Z#QFA=B]L/)*RY+O@BYLJ0#N3]%]=T#O<M<
MH:SI*I>%+JOIU'U1SH%*(_#P@<J/\LQ-1TCA6"8\^D_I/Q&<7ZWUWF>;I:5E
MQDF]Q303^4_-XRXGIU/7V[NIHLKDO<I,)FS?9%D.%HRPJ SG;BN&Q9[1CO)L
M,A6]@V7!.T1XA%:<-]Y9UZ2,09L>$CD9;L-XVI$=J?;'9G@^NS]S(@?G!HJ;
MO2J1D>A)=GL\BR'8V-S>VC[G4-=SG\/&Q4ZY1U;/((\\BU=72_BLMCE^:V&K
MMHN>%L"T'#= $* *_<#^*Z%:">%?A<T$,^@NO9BV9NP%H5-*V:9<4;SNF("+
M?"G8879% @"H:?:8:OUL'B(4"Q[R]3:;HXG8>I&-AQ:ZU%9,3(AIMM]"87WP
M*LV(:)>%^'XCELR?Z#*_7+K_7.)3*LD_Q]/UD'$ ,OZ7' $,^;.H@!,ZM6HV
MRK]EY<^>]+!2%GPD"5&4!DJ6F3B]:&NXN"3$7GQ*L,W)"'C/![VOG!#0.#GS
M;=5;G9T@&B^:QUT/M<)<#0[H;L%GQ(!#C8-R1B-#PP?6IGJ.8*R5_1P8F6F_
MI F;T1K&::(^%$0VP3]^,V*?TZMO_]^1@B-_MFY9^U&3,!&O\&/+"VPBB8W:
M+Y<!CT^HMXKLIM+A(^>3[*J.Q[#EIWXF$JXM-9;7YW;8";%VRHSDV4F8%LM4
MH,3J@/\T'9?DV,_?VR:N;LP<CPU 54]L",A03Y"%]CC)-SROD#PMICCD0JWM
MXN],"ZK!J<&@5-8BP#]BQ(5B<.I7J:YL(GF 9[V#;Z0;%Y\7E.XE6 U_-W/C
M;<A=N4G5FVEO-RM.I%O)IMSA<=FQ\<53 7T41!D[*7%@Z+Z@JR$2Y?#5IF1+
M3P;,F>^E(P,@Z#?;7_;=1)S,A>Q\Z6\H[VP\Q1,;D$<=XB,9Q>?Z@A6H)3*^
M6^DK/O*FK?,69'Y"]"8V0L]@717MZ+[8Y'K+H' [F$PFL>/!3<Q@&G7WB;3L
M]>Y&A<G$$JT4V@PCAL'<X[9^)$NF(0F1D5#FT$[>%,J<[[A?72![WHQ)F5B?
M #7.V2_/N?CJ8B'J[WK@6+3<"@:AW:I@/'QC[@:?@$9N=K[ECO$T1)Y#<U/A
M0069'I6P0+8>I.E#D;/IRLRQC0\$9PM$,!2OJCPZ\WI0S:+&7P](/:=T>=U]
M3:1]XVVAU_;?"/2LSW&YUIV1$HYX/, 8MZG69J>8Q@@SAB2V4,L\'UBK&R3E
M%/N01QNEN,4:/6[&T1$ZS_'4?0R$!-LYSP_?-.;8YNA,*B8W=1M@T3Q 2;W=
M?-M6]N1Z<2BS<RZ:&-)93H)\FQ1F.0@05FT61+>9>R61H3\CLUXIHZD,AW)^
MO-621M+NW>K4_M(!M<T7-?VE.3UI&2=)FP#$:]\G,U^F7=W3C^6MN0C!;>O[
M=-;6#&1VQ>#=R\EO,K64>/T775-8_$/98JY1'C*_IF*%7,#4Z01_:%L<HWLJ
MB!+BM#-O=RI %;<7M+:"82PE:1IK;MS,[&R?6?+:@>>03;U4R:^*BGG%GVV.
MJ]-ZI\/"%YP4H?@#E3*8-=L9>\0W_=G& *YV=2RPO":R]EGM"Y>3$T\ W__G
M&? E(^-#-W/O<-_PPV4D<B8G96)ZW60RX:C=S*.$HE\^<H<E=;_$?>+FZ%G5
M.U:]<C3T7>MX.#$* 0$S?_ []W)<N^) Q?- 17,ODV(G,1KP43HB#FD86>1U
MD 9I4W-DJ":P[A+.$XPM:7)/\D(,UM!!R:0<Q7U!=T^QI-WA*HFWTJF_P-:;
M;/6/B)B9IL89];GWCU?"1PT,"@9_\?K; 3UTT6<O+L5XWC"[,ZML^FM\9H(5
MBK;JG=>$B*.-K[9JF@R]K#_<N#7,TN$\X!@;QQGPOMVX,J'E#O^LC"![FV>_
M*-3\@]#CZU\S[LAU1=!P)!2X;&H]=:!R:7Y'Q^BX'-+)M*P;G@EPEAQ]/XAA
M9[\J,@3AC8N]4@S/W30-J29WJPXB#S':3"_0YVC]OF/BA-47E3J H:N:XN[@
MI&"IV21T%JP&+9T>"8W@NGXXFV'Q=UJ?3S9?3E;UMY?38^UE ><?L-ZW^MM5
MZ20<2X?G#=TA:G0^;VZI"/'WZ0\TA4U>@J^<]/YTC>/Z<M#-:B3@%(QA8BT%
M$N>34I+WKYQV5!S=7D6;7"K!K\\S4IE0S]$1JR[3( R7DH-OM%!3^VIG@9X'
MRYVP8%-?I3(A %=O2%"! 26';6!@Z)&S9#8:P-R-4%3W[F1E]29/SZ. 9Q]L
MX#XKD%EU%67FY?7*9;KJX!^*[YJM,;Q.!XJ'&4&7?VAWO/O#R"GE#P'ID>ZJ
MZW!PE&MX2F9T)>M[J 52EZ,1#]R*2\,(>[4Y _2[7:3<," @/ KI%7 <[,4[
M5?<ML((T-X@YJ8"^JTB[9:Q\R%@";X^OXI?.,"GLBH]I,?#HT)(G*WCX9YJ(
M!YXH"/,^KO)/LD,8W+1ZWLEDG.QW4\']%S4@F]A1S'&YZ,.=IW,FQN3A@3=1
M]6\%MH]3A;+97R3EM&'G$ZZM-T+)-? #E2P_ORNZ-3U$4Q" >Z "5;H8=I)X
MF+FYY*ZIX6("I-J,;MH$:EK@SD!+N6P#4Z0[4U6=_' 7/0 <4)X%M0]:.#!)
M&96FO?AUMPCBF'(E 34V:L^-;.Z/J+UX]M)?'50C*U)H?V[[ '7>$I/?SL^V
M_JJL_&4&'A=C]!Q<Q'<:[3^+1S>9J_I!&0/H\["7DP,_/L2F)^U7K50-NNOF
M1C\^DOD].C!2ROHNSK$,G L=WAY.E<"8T7I "(B@O6H87@K2P)^M3#,F<%N"
MJJ/+1O=EZV^E&:K%/]&#JB7:R<Q09Q>?Q+I[HK%K3?T>RLRL,[[]AD^NL!J^
M_.,_BX)_:,=C,A/YWIP%W8G,E%AKNR_BSP#]YI]_".LJ8B_S]P=W$QK%&QHK
M=*&+/OCD]_-FG2?NA '-V:-CHF<3;VYX?^7A9CD0\)&>$T&<\8_TA.CJXK0$
MPI20A+=Q<^,8G@@*]A3@ET 5M>L0(\JKU.'BZ=QH<%!%4Z#+<UJ2(_076:!I
M$$&2$/YN@6U@V&/I^O$Y:T776#+;8<.SL86G+GP_>?NOGN(DO K!,09\A^,>
M?W>EKM)K'>G7-4T0"NV76RK3IU9:N9GA$83Y[5:&USN&=8 IQ+?STRKFHSF"
M'2'W[K/R(WMNZ=7HUWOJSMH46D#%1L%XTGA!9(=U)S)R*DX2*,X9"WQ%I<FX
M#@@+-9X%X"I:OEC(R5KK6; 5ZB,&HO)A.WN."2$5T?8'*FTUF^5CAK,67WWX
MXL]WM?^)9/CKBSO%'3,,43JN#_=54G)<Y]SRV2K3V*3^T\*<U5U_?NK%Q_);
M[R1W&IX+5U\\:\28$)XO8N"_M95.V;LE';9G=@\Z#YJG['M3*>E$"F;[?+1Y
M;)*=7D2*9@Z[7<I.[7]MB+_@A"AF9XYDSGYE^L[Y"=4A-N/&@H;0-K"<HF6-
MZLQ1FGZ,TLLS;NPK#E3Z/GZ>C=/I](4^.2*!"8?#+:GJ-C9?<9SH]+ZM\4MC
M+$NRW[DQ[_,AXWY^"4P_/Y:CE+6 "%P7]*(^)H-&N2T?DT'7OVQVJ(Y^S-A=
M$[.]8MBD)O\6U< "/?U9U9TKZQDS?W=_[A/$@<K3 Y7GQZF_IN*::4,;OFY9
M(#%3ID$->_:.TK;4^6HKK" = C^-;_4FK%^::"*LMD<0E@9[K?9L3D481[?.
M:>#-54/>U:"[?3M9YQ:5S3]MSN#E8^0U_*-Z2 _K 3)>0K7"#*>955[KLN8A
MV?>#V^H*L5O,F30>,O)'>[D-V>Z8W!#71\NT%,RN^8ZQ4A,IL85F,SX'*GR"
M8Q)J('=IYEXW,38A,/A8X+WY_\3>EV[[2\<7FV]O6##"'I.Z'J=E!FZ9@%OB
M[W/# (/T;@:7Y]H&_5,I]4%,[</SD7\4.3@\?]96A_E 'A@[ESG@XCB>%#XJ
M[P4S=D5O:!(K@TZ4;RF#5,,EGIF=F,VO?E=18% Z2!OP](Z.@#X&QY&R<Q[)
M9OJN'C^4R>0;F,?9^-'5S)Q CZNY;*! +9:=4ZX$U6PU$(PN>_S-02B5C7ZL
MZ>*8UB/RR5;>Q2="4P4(\26Q*5:_@].!NX493<<BD0U/VNMUBR8(A-5O T68
M)UBC-$(8NSVRX2)X]DGW@A.3LNG[/,74?E^[G:D/8<SU!"_, /.N:F!$8;MW
M\/%QQ)O&0=U'-<$ M[HFPXF,4/1K6@",F4;L&C5[WZ0TQNS*7!G>$2VG!^ZQ
M#4">KEX^*"Q&UO/CNS4-IX!@^N2L%1-X(I^SI32Q/P-9W\XW.//V:)*1>B34
M?>,5\,X=B-:-&XRUNEQ;P5Y6A<Z5G_@;/*6R^7SISH[V,'AAL$B*W[@[ .J2
M@)00I!=W;'MHJ/&9<QJO23XE-K:9NDOCLK%$<#"<-+2?8&%A^G*V^U__#9IO
M77[*\-U6S&&+#>^DG.#99_K%S(@L Z=B*[[L\9\P@>BCP%5)SQH%3[NY",>^
MWWOTE01%Q#;';>=)PZE+ FSR\%ZF2/<V\A8&K;,E4:,MI/A4CSS&]=(!7G1H
M&RN%<*S;KGS4'#B UD7XK$9_/7T_S&XXQ5JZJ76<8[*8,!98DT;.V?:6V-_2
MAB]-(_T[-CE^(8[4O5_5M3@EX\H+2]F1J(KF2Q&KJ*W'[8V8F<H,R(L!43JP
M27BGCAUGTM" O+#1'O1":*^_8\NW(US[AF1Z\T#%*P06$E+?D5)1Z>4_UB(P
MT-.#<XC64FL[,6K:J*CM6W]X9;KQ<"& >RVYAU>22%@<E"<0"EW<(3LB0ADS
M=6MI=.2Z>R@R/C'/&^R(EB('34WB?S^S<XJO6(SJ!2\+!\-[>BBO0;9+X,J\
MG#A8ZN=XT,.1];)B3S>=>?;V]D)1>41=0WO=-]MU TX)2Z:W=HNAL3J=[RE:
MD%7%)#AHH)WF"E)-9R.CIO@M9Y8 "Y@^[IBJ&M+KC?.A7EHD_87E^Z1 :ZG+
M65?O5M_9F@4:[QQC00V4S<ZTX_CQ/(K^^)&W0Q/WJK-ZMN*8=SJV2J5M\.&%
M7+F+)R_1N]+J>>S$3"HZ#OHG+$<"VP&X)*'2K9#Q8\N"[?AENQF=]X[/\@=>
M[U@S@&_6=A(EKSIZT;#'NW#42A X%>"Q#0X:H?-7K!U+^3QG]^/&_:,S9^[6
M0CWVN5P#0^7+E]1'N/83 ]V8-L8RUO_.G0U <S*F?)Z+W^Z/Z6(\(!-Z%HN.
M5M>2*2T=5R#NCE+O[JM\[D9,CY9?X5.L[6RXSN)^5091>BG%+MQ/B#NS<<PJ
M7VT&AQZ$.*MY!D]2I/^'N3<-2S/+VD;MKDZEAB2V;33&B2X3M1*G$.>1MRHQ
MQBC:E<0)'"H2,8A(G <<JE(5XP@531PP0E7B4%$0%04GM(PB,:*4$D%!,8)#
M%%'1B#@?TUU]WGZ_[[SOZ;Y.G^OZU@^X>/ZPGKW6L_9]/WOO>Z'[E)34>%RF
M*+SV\E;BCTZ)161ZL&6R9%.0/B--U20*U2U34_;C2TD9[-F[%G_LF)>7#3GK
ME$^QZOKZE@K\+Z&-1I_=KJ7W)GAEF[TN[$&?F*WRB#7W5C\^H6@<1B6[,;"=
M<Z?MFUO*<L[/Y]Q7K#Q+*WZ['[ME7)^T5!8Q4YJG@[\\,[[\M$'=DC[A&EIJ
MU! Q*.=$10:-;K<LV&25D&==3L\$ZW3L 1SI-+LF#OPJ;ZP14=7E;82'@F&0
M=XQX[&)?O;"J(O27_W6*^[U51^EVYO;N6F-@74A]:@9O(U]BMEB4SEJ,0DKU
M^CJ^I\=/3LQ=]$'J0J1EP:$KI;58:-Z<X[F@Z%'6SL_B&GMCJ7<[,6.[KH5&
M '&6$P.-S!]2IQ880H5K: .6"&VW.79(5\[1!C,-8&O-8N&GK+3J>1=+#6;#
MU.U^*J5',T,"XX(-&J;("_X+0"V95Y?0X1?0#P<JS;7(QF+C(KE?OY-+ F<O
M)C+XH6C,\8GF]8]^;J?-#;T*9@Y'-K8L,6;&%HPDI?9\X ^[)3 )T3.6']2D
MW%C9N"RF^FER!>FV91^BBRQ:)1?[()Z#X6W#31."8I9_AU_UXCJTD4>@L30&
MVI6 5KUF<4M',8YAP0TL0[H^FW;@C/1;X_O:XK;IY4;IEOZYEVSOIEU(*W[7
M06^&[_I,V0:B*$]_OC@)\C6A/WW98SC)>*P^?JOM0.6S<L'; Q7]>6QRCD3O
M"/./W,!1MUXK'V-UXUZ7=1=!QU!3?O'C2!MH&;+.Y=)BI%&A1ADBLJPFM'L5
M6U0%O8X"7FT2A5)I+134]GIQUK83X9B]\4[K3CUB))S<R$2LXO(@L* S0>&7
MT2CMJ*EG,Y_U+N/K^G\.,S>5O!1*$O+TO7_W Q%@RM<<#KD47M3<U%(T!,UU
MAU5!$',YM3EM2?/KWD[19UHZP[/F%.OMTXE0U!R/C@>OAE5!7,4&<&ID0I/K
M4[, /%NJ=J?<JB1\!R7B)[L/4 =PYI^7&R'N-%U^5VY-8B,K>A=V;LWKY1Z2
M4&=:+J\<)[#/VEBF_FH;Q>0,6#]N\G<^Y3,D&\\VO^AWTU_R(^XT9>RV!1*_
MK[AV*Y/P^=SSL-J<<Q)\J^2!Q]"6!3:I<RA9U6C&)C#AA0'7/C% CI+W7F?P
M2SNAU]M\&VR:I)5([:$?IE>2]4'YS(TM766"TL (TQC<5/=0FRU%9"WHA:]A
M&PO-"[:==RQ65+/CPR4$&.F"7_!4*V%Y@F9,<E%M5<[ABI^'1V6T3,DRG$9E
MM\+>I61HI)^?(]CGZZ,VVQ6CTWI*:K*FOG=:4!RS3]+/6.;N3BB?O2..3[;6
MM4FU>SW[.N:<6=(A'<A4!GCHSOZRB#9(400WO.L:[P<TV+@X[/-(AA7*W:['
M(G<1_/-GXW4'*I??1NK9U2+.2@#'"MQ88>@$O^+8<7EQP=6:I^5P'@+UF;@M
M+#-@S^97RAAQ5!U35&I#J)&WW2KEF;3-7MP4G.D,-7Z'@?HVH*O5[I2*@IO[
M$:21C:I6ZZ/.FV?PPY'!EBRF\6I_*SUN-V/.?\[ F.Y^H*(=:N:  (;@,W9O
M;X^L9O0ZR+?,?Y"ON_=$:;U%W<EMM(%B\E<:D]KNB?S-+982P7T2ZU)^U:M8
MY_B)GNRZ%T->$6+"9U5VXJ=9'R]Q6KT3,3&M-B+TC,[$Q!5W6KN3I4X0,9+M
MZ2M,ZX"QBLY5N)H1+LY@J;9E$!X-MV9Q*QGWB-FPKK/$%PC"E3=+6+GNA(=V
M<B829;5@FPL!.</AB<^?:?G_+X7HDZO["YTLXKF9Q-P]UYOT)\([>\:-"4Y_
M\4/@G@%T]ZH9DU+;/PE#6'Z+=-M"-VY#M)-E-+/CI-OQOZP/QG"4AT_> EKR
M2+ M[=]M,R#>2!N<'F<S*;8E8S(DWF"46&"B_M(;5;LN@,O3'_65@%!/4F%O
M[,UO7%T>[*BRR)/NZD8G\4 )9Y3K%:P 7OR"A@_Y3K;!;[Z=P'9]&11M&[07
MG+1G]LZO:,NKNV,)RWH)#9R4K/PY1_= )72)!IEI66QXM]ZKF:SGJ);?7G.Z
MHDCLF)N=5%BR=:#RH87]@4IZL)OW9SN$M4^^QD.1+&XXM8)')['%@ENT.UT9
M?:\G;@]BS?S)1H](_#87S']X)\2H=2E<ML\![>JOF'X%5 >TYQ2FQ2O9MYNE
MI,N7>Z_@=\.A^Z_3L]HX UG4<J%$UV'*:\MPG_J8<RO=B:87/7F#BT"@70EP
M 2_*U,JL!X]R?AFKZ?M$.#7A9VC_.;(NX[59 DC F?(KV"X:<S(9ITVLZ],7
M/ .L<U?LWBXW;<+*W!*DZ'4$JM/S8>K-G"&!/#"C>N"'%/ZD$RX7;)=A\*2L
M"["@06N;%6Z4\JC.,3!IQ0B/UU#-+<G9<_PJMMF!V)@"2AMWZ**]ZU!\VQ5A
M;T+RS0@8(]50.ZEMS02/E,K,3OLZOF%^:XTYDM;17(!T?)E<Y6]8</XYI:Q?
MCC:1=]F^21!YBZ$3.OL?)&+IS++C[;41 H,XXOWG27P/28>?D2/2@T?+SBKM
M0!NSUG5,4XM/X4L5]DA-\H)#;V]?EU =D \W&"44994,XP(^^(?M7JJ5F>PY
M:W:?R2U^8ZNI9L:1@@;VF_42I)04##M>PIQT3<M[)6Y,N-B-P?;#*%\_O6.<
MV6:8"3E7E]-2B[6/II<Y$\]0!UAK6@WS8^&LR.3HVV0TSLB1]]<M0>2%%#9O
MM F,"B@I*2GFF)M"\WR["<V=G_*0A^XC(]@(ZR:O!B#0P=/;'5O0B>:>FE@&
ML)U<=/I6SL;:39QZI#1%-Y"7"G<#@P%=]<IV2$799[A,AZ\;60D)#J\^J>R7
M&%1E4<1/VZ7:=KC<6NAY@YV!'2M1RG?)96/[+3V%H-K8&;Z-UG*GEXFAK.+Z
MNH-@QT00VA(+@8^1@=\Y#59K!OY:+4RO&!"7HF?T01XA?104^BH/16OBO$BW
MM(.'7PM.X<55S@<+@WLCUN[\N]1YCB!!,9LYUHKBG#9089O(YC0M0UM!^9;N
M#=!<G0S< (6+0NM/4=T'_^B75E(6./7C"S_T48J02GUY.PI4C(O%DPJW(W9\
M.RUDX$U2JVEAL&6_#4.85 YOZ!SWW4*J\>FZ<,'0G 7*NK]04P@(D(U\L<=(
MMHKN!)>Q$C5+A#%:S=6LJX.99G=VXRCIY_I)NZ@("67FZ;UUKM-O'@(P/N/K
M B].751*W;5(&\[/\_4[+JW%]"KM96# TH=?3ID\Z/_"M3<6RK?&?CEBCQ"W
MF3S#/Y>,LIS2D^XF>UG>&I27$70>L4ZW#(J.E<3"RD,M<LV,2L]9JJM7/D>0
M%H .WN[9J8F.D3J#-'#57$,:#0(I/N1AT,N\88=XJ3IP>)3*7-[BI?XHGZ].
M_?9U\KMI#/12-RHU8-TU>N#!0!!$_F%_W00W*$:^;EV.%:T ;*W<37T\4'[
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MPR?9-;.Z9&1[4S4\^>SU71VP1=V&D\N7AQRS&GN.VA\9'1(R[ W"/]]*E7-
MQ146#2L IF0JT@684UY(3'P0V]X?T<N*I^MT;)V;I&P^SXP.+55Z<]_6@\"1
MR/H-EHX_M\OL8E@32V)_431,D>4D\/=]_K00.O[F-V\8%%F=_(,==_$<=U9_
M.*^C:=*ID!T;7LM- S3X$+]ZF[BIG "/-C=?CXU6W8"/^UY9K)E]BC6/))/@
MN=C0FNRS3Z<6W60K&W2!3HB?/!F1?JIO=3-<5HZA[]1<WS*QK"I\=R%-&Z'N
M7&I!*!J16Y,L=NZM4>8([K@^!2];$/V.MQW/=[F:W>2YZW(M@7^U=(2;1&@
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ML[ZT\VFG8TAD+_A*XC9>8/HA+&EP4DK36CI0.<G2]%/-Z79'(\-,;[JIVOS
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MG1H''V??[ _2]9'U&UK#.SL5QJ4I]%<7DG'WT.O1NXH3#U,\P6CWDK+00:R
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MNKY#[Y3A7%,%F*SFI'^C8'QU(B'=[V$';$PFAQK*MGP;2 N TZ7*PV\!W,
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MUH6*+;A5[MO1SL&P9.9B4;;U^;\\H_;:/>D%IQ?7J5A9FZB8!?!P6<*,NP]
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M6;:+@4[M<32GW?.NK[;*ML?)VXB^QEK8 *<Z%JDY+CK\D(2UE#" 5IG.TT:
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MA37ETTYYM/!F.*XQOQ%3#J*[Z_9TQ5EUU)6ZC Q5#L74_Q3U<C6BLGUCD%.
M[-J\E$K774E%9 UO/U[:BV >D!,;<##B-"5*9TX)RXT&P1\.=H?I@)21ZM,^
MQIR\:D*M_.PNJ6\0_C'CACJX@9@0 ABPSK;3U=%K6)Y4D(#.3BK0LWL"R754
MV$YT;!J=5@MWW;OQ8_F\C>+-2>_BV7M;=\F^2E!OTYGPQP3F];N5_D_EHU[=
M,HR#='>6T[9HMRX5#/W461*<DZDZFQFXI&'0M^UPBA'.3!,>:F9?01_+A;W&
M1[N&3Y7,F4X5B%2(:0B:5EBHK65\=/&6O(6*T7@D\D/BPP]T/D+0[,TPT2V=
MUA_R'AVS,!\_P?]C:I!^:DA#7>WN.G.109__L3:*W/?EV'>"[)Z!J9#P^W19
MT_2"[XQ2(B0H!5OK,WIW'A#:^]4+Z'LD"(EH*F=DY$7^PH1J/!0U#'A^-,D"
M+#2!IT-KIGH8$]9,':I]@T;/2MSYI()X8Y_7!X_SJC$)7NJ\[_<WOX<R4E_0
M"QENX2OS&<\X!>-TI6.Y*0HPOJR\QWCE0G*A4Y2U5]H>$Q^Y=BSG$1/$>WW^
M;<KI,\^>F<.& <ONX<'.2E#3)%$%!6L3E\7Y(U,) [*2O]@SN70X[PW*^%W9
MMG=P@Z\]6/KP3; [7].8*;&H>E,W:D/D8FTF*C>&'8]JGM%VFYF?Q@(KY#T6
M"]D8<#.H<03&4"P3S08ZG'PU#]V\'PQR4#?0_(%GHF#>PG:]0W-.CKI44PUJ
M_W>;]7^#A/W#;T7PH[_LSZV=</<+7**_^U*H&"^%:IB35\/!!_R>L-*$U^\I
M*;)J'OO@QICQP97=VXY0W^3BRI]X+/N8]-3#4''J4?R!!?&(:(>*#TZ!8AGN
M@A78BD G97\KX$,(5!H';^]RFVFLZ52NP7:J[A++CN6Z@\_WK*-,;-H).UM\
MZ^EUPI$-+5HZ3'WG/)$T#*+Z_+F?;?$;P4_FX:#2LC]%I7>^A"AM[9_Q\;JQ
M;%Q';J$MSSP:&&SP7Q%1K.O9D:4L%PYQ<747_]"7"%@X??;;&=^,W_4>RQ7.
M)"2J&\/O:@8QH]>#[00&K0X[0>+9HQ360H'C#3!&T  !\10R(F8*[6.=6L&M
M=MV@K7'?(>VLE_=-"BL6888?PN:3YGKTM>IY+:.2* D'?A[#S[B!SP;<5C<M
M!B=T/([ZAZS#?X:/ DN7%]:4B$$2$!5_IG P1RVWK*[N$_^!2,X("/?+T,.B
MJ-7* H;UI4*1:0;GNE]%C3[K)J^DH'TGG=\X="7C(.;#$FB6990^VL8O1*7(
M;"8\R=7D6\)!>>F(54UU?06F56Q:K!,5ECS?%WCS3'^V/.Y#+D&:B<A_FG&Z
M?^KP6C15/?E8C@U%F/*L9=:.XW,*Z>W-OY'[_ZN!_Y>PA=_;/$CUCL'E1J4H
MIY-\YI+4(2;]X%^=CR(5F$-]IJRXMC7X>1@ZA[/%9B_1J=[&WZKUS?BR\MXB
MA]K;ZME$B7SXJ\&5AN(T\4GAX(R,J\&$Y"!2(Z8JYV[=T2$K%8.-%4'N(#\*
M!>VC$U[5LRC<MQ,:VH2Z3.))Y>@6;7<PR.-)R9#CKP_W\DJ+IJ\_]:1K+K6R
MQ7J,.RNL2].@>LO=A?65TEO)XC]6&Z!@!1D9@8"1#[$ ,?K*+ROQJ@#*\*0C
M8/**91'<>&G,.UF4G Q[.R:X+FC*/4Q[GS:&*[)I"$\P[1Y47S'#).=C>@0I
MVS'Y2.;O EVP9>")X UJ'FJ>D)-U0*1F>/[3:N-@6(V5=-Q1>&VB3_,\@D5$
MC:F;D8.T(&"(M3,8^*\[%?Z*0QJRIWX%FY7HM@#MBTK)PMGE4LRFG?!_FH,^
M(45O*4NZ[,V_$%[,8>2C>E6@!$\SJI.:MZ\&,HV]/?7P54*&O&+1\K9MZ\VQ
M"?#5B)G:BWQC-[]VBTE87GZ=_JV9MILU\]:.4^S!Y3=+@M[X/?,"<,\=*KYM
M-8"B0ZDAHV[FUY>T,N0E@W]^3R1XU(C&/DF4O^4QO!!3&C/[8C-1?G(T&F6(
M#3J6"\7NW[T-T[#0'XC<O-B3 [E;6:GV K+/S1N W=^#HRUDZ^(VDPWP;K0Z
M3/WU["FOUH&4@4Z #<"+OC4C$HC815AD6851MKO9<&?T]'"%0^6^^>9+$T>*
MR?J^OL,RP:\@K(M'#IC'%+HE83#]+!KG;S'(O\##,\OZ[.0L_BX/$[^8<1YE
MSE0S[]*\SV['=# *"XL#2C/N;NB[Q ZVS<V:C_DM@F8\W96<#;Q#FU@%'=PC
MO6C-G7VQ7::J\ SH9XC1659F*:BJ=#2E3Z$^B81&I^QN8N-N]W=-NX=9*%.T
M]_B#>*4UA9_W&0;U@8Y@V"F?%];\YI ]D:?G!"2D3?.<[")_GVA+_/%W&__-
MG?+1[GM5>?C=J8#HW4Q.>.#L8L:QW FS[R89JUN4D,LTD'Y#?AG1$P*#;%T1
M7BSP=,I,9Y5WP([(OK:)XTS1H;PO,"M7[Z$\-[S"8P,&!%0+Z#&8C/8TQ&QE
M'AJD;J!@3/EZB_3P4^[9-\OS-5?I[J"80I^DNG"_NK"DZOQ2^H66U!^SM^U?
MI2L'^FEMXF97GP=FAB0&;G9%V%4I<2=PF 'N.IA:OI@2?3 S_%6@JX ;OGL=
M&@3(UFT]WUB0#1/;B.G<)QC!<W(NDXYS6P[B1IL)NYO67_B-D)JG@X<$;:X^
M/92*]$#_Q&S$[IZ%HDE/<2N,RJ5[SI']JGDWJ6=<YL,!B13M]Q2=E*-XZ5R0
M9WTC\?1ZR+?@(%B%.+: F\9;+L9N=P8%)T+=;R\'\7!J![*I[O 8=$='+(MQ
M+.?@<(WH:>O%JZK_^@&#**O6\'V&V:OOY(J'<^A!X>"7=U*6^$'6A-1SX89J
M5.%\^*@R!=]G;-(=/NJZ?X*>J_L 7#N1NMC'IK;:BBPW%=I^ON8U5%4'MV85
MZ[*[DI\9E00GIA6NX_%WTC:9*QE+5I^M5K[+"IC2-3^3A>Y[D'>QZFLX-= ;
M>S+SV01Y"]BV-E-2(A_!ZK!$(=XB$?=4>K+4!:-WU@1BS8]>0G&PZJYHC+8A
MA5)37>";^F II7_4I?X5IQ;8S&L>GRWF'IF\R@RF)=+5#C/3>2K50J()M3FR
MF:Y&\OP^.-IC"'CU/]P!?\<Z5_QD"  9#=< <@W!'$PY\25R>IY7DG&PY;T
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M"R<&DE;9$1&3\2$@=D1"7NC3'%Z#*>@;"5V?EP;*['D#O9$#.<O:)K9NX(7
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MQF]___JN_8&*9JIC/CRPG[';TGB['G:C6@\=N 8:.(S?:MU,;NBL&4-#NE:
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MU=N!UQW)^C-U'"FY++3%8!'U/I&OI/;#AF?)G%B#6:P%'1))3*2@;M'LV#@
M"X*$A12"HUB>HF%Y\/?I'?<*NE:':(!" *V9$^4_:G>;;G5EH[02F!G8S+A<
MF6$'UG"N7C3^\3?GC!@?Z<_#Q4TMZ)]RX"%%/RX*!C'IT85IH Y,IG; !<V%
MEXE;1#R:R]E12PU7?05,6G!+B9("#[-N;/?L;S84Y])-WR,@G1NU,=,[:A97
MH"EA[7A1Y=Q0/*OA1:3R(*I,6!7 J F@'I<V-DC-;75-FH@,#6SZU$5V92A
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M!4[B,4V,Z48--F5#K2@7^P8PR.8H%1UA7KA."U&-KNBJ]LUIT>[C' XN1"C
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MJD?_R3G+X9\F69N(WI)I7,R!FL+T[<1IXMULU"/3%[L?=[&MM-CA.$JH?VS
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MFBD/ $4.>0X0CPRHJ9V MF<>&2 GD;_J>_@(!>U\-#J.@A<5MV?R$?/F+\)
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MO8?>.#'^TV2X0ZWIWREW=,IX>AE\'L5<$$/BM;'P:?DJ_T?"?>=GW&1LVN=
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MZ60VW7.Z7?6CUX%:'>0'(B:T +%[!548F0F/RX=ND=\>J"7+VP?V#T&%.59
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M)O9I.O&8E-$:2O>0<7W$+@AJV%6?;G\VC>0!^5C6]@8H_6[GR&(](#-=;/R
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M7!1E)AZJZ>MI]!X9NE^:=T/(C/RMA\3/S.#5-?\1VK85-JMP+N(G_D V7^M
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M'AZ83#&=?=<C,*UQQ?(6Q$EQ7=ZLS/=9*K=8BY()NN)9HJF)JYZNQ[S^?[
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MA^XPH60?5<,I\Z@VS(7D/*DVO#X ONZK:P1DZ.K^O4]!Z8C4+QXH:-N!JN-
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M<**0)QQ-U,DOYGT!>_83$M-S' "R8?.VC\QAS]]I?@AO1:5 P3UNMI-K[W.
MQ+TTUBKT*ZE::/U1N)QF8=XN,@W(A-@:F5KP3"+I7&Q&X\,&'$@?O7NXN9!F
MTJ1L?@!B.X$LII'7FVT9Z0,,RO=LD:IA3W,'W#MB6U@'?<%U\!LI%LX*UX6'
MVF_,M-';'IIEPDG8:/+[_Y+/YY_ZI?A"379T9#;M0F4-=J'XU][SBVMR9*Z!
MI[UYIGED*]Q:IZ[WK^6EU:^-B]^/R].4"49%)2,]\ZK8"GB2\@;:N+;W;X>
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M_< 4I? [8*-1>J2+571A(:7O[%K0XMAO QI_;+<[)%&PZ3K[H-LUUOX&S;&
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MVBU7>M%@U#B8+7T=3%_I ',S5[8S=X]]=TTYFKTK7;6X3BYFPRI/9H71GL2
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M+L-'$3(Q%\HRZ8S/+KX*=Q",WHI^_A_*_$_QX>%-_?&G&\U$9]DDZI;-"PS
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M#9S)Z%#6BD:]6[5#R 3B4=&]=0,"<],IA?]XM;DDT2HS9' [:-QNL[K^QLI
MQMM.##$[/RNH,W]?([5/:M8A:HP02"5K78X3!<1E>J0)L/_"-+9Y^\Z6(9T
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MHN;]2:E\D;J._I$34._U+.\0Y.ZS9'V(=:HI=^M/Q3^]O(59/4C8WSZ_(&9
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MT]:(GKNQMMJ3._ZI]&&4TL;'8/V8/'CK@2C @32-B=O4?"A:5\ %]-Z9AI3
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MU(/I=*Y-]'V2*=H!4!A.,SO=6:.I$]U>BBXF(.EBXDL%<\EXEQW)ZH4+N,C
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M9EY((3IL$4])R?C>L,UMZ\7J%QLE\+G:[;G9SLA'0T;0&4@BDZ'NU]U$U^]
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MZKO2)+6=%&'6:]U[4'_&-VFHD2+?L5'YDH1,9M7NOMS?N%"$J7EK,"./TQS
ME KJ;)BO7?L8*N^KAT.IYDUV_79[$E^7#<:T IR(:U(P,E8&B>!PJL7K+_X[
M.O_O=FE^Z=!@?<:Q+HL5_-<]=A?XZY7:?.[5JHBSZ#Q4/PO7$*?_Z;$\K9I=
MI>]I!+Y0"X5\4F@)"2EL3YPYIU=7V?=>PV=6LB_7EJ@1**$0@%-+KOS@,*OX
M4KU(V?/E/'=">J9U@4^>'87?BB,B^^=01WB$-;P>\ZZO\S0%J:.S1+I:/E<9
MEV][C74:Z]HLKQ;VS9#VS,S,VDQ*9SN_HZ,#"<PK+\\!HS[\E[Q8#)I'^M85
M@C"%N(BZNG9^7=T\*FE^;4,#H6YM+LA3#&ZKEU?$VGTPT#^GY%C:.5S]\4,^
M61/<FIW;#Y+7^ +Q1B-/LO?#;VO_5-A+,.LO=S&N[K0:AA0=66"E((P2Z#;0
M1QVYOJ&$Q=W3.O9 R(#VM88GF$Z;YB9L&Z%S/D?G:5EK:6(MNRXG$?<HXSF:
M$".VA0PDI\ _%)7)6ZDFG!5=GWS][LFQ] >WX0O21H@^%U$33DQ)0KU'2OI6
MVO!G"2NE[$0,9U_N/?O:E<@F#7ADP9I]QPXH-PY_=0&9;F144^,1F__+;R#/
MBF4U)JEIM8][+*(**$F>[@#>^  ^">KWDQB1I_$L_@J[>( "431=G[R>9#,@
M2G#>\-*/];"[*[(_#G-)'4S(&%MY-!FZX56P2LA-+X'.RJ.:Y6W$:0/4SZU(
MM?[:32J1,._<_G[*1KE=OV=(&C$*"CW%7>*?7G#/4,K9B>LYYQDGP!2<%-2Z
M#<25+=3<HM\M^)T^N47PQFC;=]U;1Z:+*2?"Q+?:.D6(ZB68Q<-\G[]>5&*;
M'L3?/7D$UREX6',\@,-Q: Y>?E\\TQNH9$(;;O'24J3Y!_C9SB3FK09LBPTN
M3H"(9#?MV0:$FI7FX[Z2A!*#+[#N<PWA1T04D'*\'2FLM11)@B0MT^,#H$-"
M?@&\Z?6R=FO^I5R@?H/+AR<=[Q*+Z)LV4E V,\%,_*D*\$DOUX%5HWXC7I&1
M:W.HV06 \'='H8Z(@_O]_2XCE@VHO\SBA%$1A,X7;YP0S ZR:UMK7H5S15^_
MDO2:5B_\N? ]V8TDW,W:Q0+']P"!X"0^2V])W>LOKHRCU_JY"&9H#429_C9O
MFK.L2=\634WE'68<J"K3B<XW2=,5.(JZ'R29F<%/5T[=T%'3E\<=-LTNI6N;
M8"(+C+G* E^0H[!EMJZM_B3TCW'=G^R6+L5?-ORIJ7\F$GJQS+EFCF"EDD\&
MNJ3\]'K6,*R*-3(P,,+*^4W2 &->!4?6%W:T85 6\RCSU 25_!X:-(VSO$YJ
M)3D%;'97M=3H*7SLWI7WI6N&T<NRLW/**C4JRG1SBX>*1_T\<LK**C]VYG_4
M;88W&Z_&2K=?KS(TWN&SU("C:T ?6J]+>(!TDJEG.8U\V!L%D="]K-Q4 X >
M%,(UJA>AM>47;__K+AHZI[((A1V)A772^>&$26K;IKIX4TF7O]&Z+_<3:5_.
MB7R#1:9-0/BC]^>(OD!KMK9 7SN\V92G%9P2K$A=<M/O12:%S9?EH'_MW[66
M!TR]="RM=10H))6'MJ0K=5=9WN'2[]]Z]Z<BW_][%\^>>\X)G*DYI8QX[D\I
ME"_92]U-G6&F;"P$6T$)_4=35SGS)?BD=#'W5)11!^%3#D,-<J9%-O8=V/X&
M[&;%N)<MQ@;T+M6M?N=@SL:^W$'C*+,<9LA+(.L2 >AI,H048?L#;7UZP*1P
M@GY2;K^GIN:;U)0'K"WNP=9W!-\1+CBS)0>=CP$DBS4><&AFI? "8\O8#]M]
M^=O?"?M\)#%E)NM.4L/LT1P>U]TG6<R.FRTY57EOD0.ZZVM0^1!37EF>R,0@
MD+J$OG?8C/Q+8O^O CB.T-"#N$7^%P)Z.E="?)@,9,A6;DE#UR<@NO((Q;#3
M!O/1Z:7Q$\%Q#&U@:KCCPT2>=B0RF%0X3D[%#VYQOWPG%G=5[,M]=ASDV[_#
MO.AV+:1V'NPFU?-N%=: 0?!*=8/$*3KG=*PA<&MS_(2Q[\(4[!]YIQ2%PIM#
MI4QCLXN#/S%-=W9$-#OW<$+7[CAIE]%J%S_J!# "DHYTR]L[E$'OI&@,VA#G
M*TH:4W&BJ) "JAF2@;$VG]$LC=^J2AXX?[+>^>9R61>]FZF?6MPJ]$]WG%7-
M>B1.@2<4M;BN1*?%(J9J0FIT R4M6'LPKME(F15&,[:0_M!QX;^XVP'[WEBE
MG$ KA;%TD.#DOAQE1$D\ZM]DHJ0A%)F56!Q!UU]<GXBV/^Z^&E-BP59AXR)P
M/NEAMH;DX_;D&78O1N?#4;J"7._5*=I*ZEU!#5SZ4(4U@++2$)T\\8U.O]*%
M:L]>MVAH_IRN[637TV8#<;^9J12Z5Y15NUFE65:/%V:3(\BOK*" 4^YE=Y_[
M_8[JF"-&*#,+$&[C=FO"H"84L@/S0DIZ32.OKNIAYJ$P^HOX=NS1L('VLX6Y
MAD9)P+.U><CG]7"]IPBJZK[<$P;,VN'4K.H5P3_XC;3HOA4",UXJ"FRX.$UQ
M"AF"LT VQ)H&(,AH+)0\)8R7"7'^\+6"(E"YVO-DZJNW72X0G]TBGU*T,"Y2
M5-[52M6V3ET8V1T'9ZU'30BFPF,P8Z>"RRM,W73AF5U[Q+B;2DK1[H7CXG4_
M'NX]QL<<SJ=?L_%(SK"6>D@"[Z_9MDH.&KWSP[H)S%&73;D=P2&+-TK0-<@.
M4GBSK<'PVS(LV(D>FQ_KF5!PEXU0GT](U9X/K&^EIB;ORU7* _1YU;'=L=W)
M5YJ,+(V+#L;^\J=BR;_91R'H<L02Y+,DP60+BFZ80I- S+0,R?=6V&3A2>"D
MUBSZQ'QNPW+:B<UQF'"0?,EK+[<WR[H3H<Y/4+>B+J7>!RDO$ZR&K7*O-/M#
ML[1B/*V>-B33+<G>6V0OPZ#.GKZTK+0\G+,%J-!R@5Z<Y^ M4 OA'7605MBZ
M!0S-W3U5;]'$K%"_)CM63)Z,)BN=.&4=^I;@)8&)W$S<^^G$[[WL_:*IULG/
MYP1.X5WL&!5KX.YCGC;5UG*6G+CE6X+U)2"8$</.Z8.^ZJIMXAE<JO$)TD<)
ME=6/NBH @H;)8-KO2W4DTP!!OG$ES/DLMI;0,[:O<"EOK_MI^8)6[K$2=K(G
M;=ST^.C-F^->9H\#HPI$4#? D#_YTL>);U3KIV8<!\3<&I3@9LAKW*2(1"U3
M.TT*-IU'1HYL;#!DW9U)*^B'[ATAV,O^,G!(E /#&L=!"OR[0A>DMP:=:7LN
M1B.]S5[.M4B/Q!_^YP_K_V"Y*YWZ8EG21M(<)@!N,U1!1V/OQ-/7YP#74#Q9
MWD1'?'[*L$+T\37_G?.>Z3.+0%_0OIPO\=[5Q;K<<W770@V97I_M->Y2$U$C
MR2%]792.LJ65[%UM6G0[K@EKGX+/?=3 3W=B$;);^CWCO6HE@7@)0"DW([X,
M6ACN*K0M/E]V.C 3R6J2!SP8=O-9L*:ABHJ__!W:(?-TAMJQC4 #ZQ^6<BPV
M^FJV-D>>'U><V;.[>=MLK^]MS(5 <G%=P-D!#G#BCMGWUY7DQ_V'S6Z(2;'N
MBK&#/KWC!U&[AL\3CZGBG592[PN&2>ME& 8(5>1(KJ7Z$!:+R\'R3C<JM2$*
MWL+-;[JW PR;>#Q>>087UQ%+RA49L;?Z1[PKXQ:,U'2\Q]:NV5Z^]1\1_<EU
MZ)3:+&4J4X>,_G+5 C@48<Q]ODF^S7N"._MU+VG"CPM*"_S+FGV@64)QW)Q0
MXCA'+,K5;VM[T5HB.M\T.GQB:M>P&Y07W;FF$045W:#=;\YC<N+*&H2*DRMA
MFB$$PD-8<P-4F=NL[0OV986<J99!12RNP;[<&QA=&X1A']^)+<L>1(:LY@@K
MKBNHQ;8^K7;>_*\1\O"/;[N#B GAH#B&VQW3N]SEJ:>=8.7/Z\%Q9J3F(AM"
M6.1JXIL72J@<W::!OK@4EP0S17?*B55WO\<9^M9-^W+GU])U7G4%%HB/)HL1
M/\Y(?(@^0N_EEN"7<":4Z1_2(?8=OE%@R:$IPIN/'M-]+4Q,-XM^LX(!-[.#
M>H##<2B6)\32@6?I<'4G_.J.OT^'"J950]TRL'[;[#+\SH9!_5C<KLXA+8:U
M1U(*]'YCYI@?[N\]%GSDFD]>W9F.]GH$R<3-)%5$5H61C^FI)_']B(U=U$=B
M>'QP4I172@FL4$_66D$LM]>5NJO%UISF*6(CL'O0XBG89,]\&6=ANV$$?)N
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MZ_%+5#KZ<9*6SH:1TT*1DI+"I:$I>9MQW.895Y:)-&8:LUP96WKG6'I2[5K
MISW&38/LP35Y@+OCV#C[2A,D5B"/'#7?E].[<7$\54OAR9^,1N>Z915=77OY
MBP9-JV3?KO4P6>8:K=7*(!O:W?ZUH,'8Y(QEU#G)*Y7<VRCJG:7#D24%#!-5
MDC.+N[9=OV?$\EH?WM 0(PQF=X<&W?U+CCE%QB<SO"LY/%77F8VN@8)(*^"
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M7[RYS;9Q#T[R2W_PBD__*/C:->?$D,RL=)'F! TSJV0"A?;!&[;E%5G 2,I
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MJ5DH$%1_TRD.9%W4/-<50\I6F96_# SB+ B/M3(X"_/E;XOS;D9NE=X.."U
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MXXQUZT"KN9 6A]3%:-P1$]OU2E,6J](TCI_XTH;9L5QE@<[O*9ZM45N$L>/
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M[(.S'(X.<GH5QK>.+"A*18O!KC*]]880:5M]A#_=QKM9^<"S7JV__C_=[G_
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MX "H#ADA$PV52"UG6\0 >-J)UA[_H(TY'#J8&<'"L\*G.6.XK;H TSMI]J)
MLXI3S:DN>,+JY+3W&4?7_EDH8YV*W-%'$'0+3*3!FL/HPL+C']CL]TR;D.MV
M*B3KG<W;O1?-_&NNOV4Z)2YAB5B>!NB[*,OVMR)EX 3,[743?W'9!IO?H=MH
MM40=ZXL=&X:) OT0-QJC2';J?7;P93=(YSS1%E-=M9C %"QG1;LNLE10FWF^
MF6VN_7ZEO;W^X./=\Y9Y[NHY/"G?X-RROCNGPV.<JBIDN#F &JIBZ<DUERL,
M7!I/A_[']_\;@1,<:"MG#:['IH=("(,^3P*6C0Y#5\[*@^;/[]XM#2+G35W
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MEFP9],9!22-)>0K]LV7)H_,;@DV3/:7D1HJG\0NR;1K8'9]!R*JY]L^<^_\
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MF%&K$ 6:'I(A+/N+XPG_OJQ_B"/A\G$-K[Z%8O)'51,1!]4ZMG(M@#<L7S-
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M9P3X,(*\F534X(P1N1"] 3OE Z,OH 7K"UM:S9/+B+?VW,,KA6B3CL:B/E7
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M(8[2'QD$U&6R.,'Z,5]TG>)_X/=)/B"N.M:I6LZA;K8LX["._'=9N $M'=7
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MBB26*\?E[($:RY(/%/_DW%G5CNH4[IP4:WX[/P*FG'.!A-F9&^OHZ>4AS"H
MD/2)$HN(6$IS9TNM5KKO3Q[$83\7[4F6-<$)UF>BSM)!B#))G>K2F;G)KDQO
MJW@CPZ%"6R'_M4>*F86H!<(/?>,AC*E\!.;'M(#-+AXAIE^95GS\> JL"H=
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M0B=.U0[W<-:.=*))?,?EEPJ)W/1T%O)._TQ%99P+%!B?W->4'S7AA/3CKT_
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M W#1P!Y1$]_0D'(N[JD@AQIYJ=S[6\,X.J-_#0ZFUZ77L1F$/G^.!O?T/&>
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M]I<]TK(K3=MT\[)@&&%6J4<T&G.R&.DA ^J&% A;BET"O@ !]QWYIR8\H%\
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MI(?J%8,VU191R;WJ0?,XSJ@R+6^281I0.*V7_6BI^&8ZZIZTP%NJA?+Y0YX
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MO8J@'=QEAXNQ[KE8120UQHO/AG6VY86"EZ"FJX/ ^'(-L?Q6$?Q*CA$X8!>
M9C<VQ3 #B>W;??XGZ@+R06Y:3?_):?S!/N7'0Z$PJ%/MY.^G@J;.FY&'V_JN
M^T#CH4Z:;N?4>\VLW,]9NON?&_,*3O3ZN9B09TOF!G)/),RV[E4)>XOOPV+[
MM1>"\ L5BU5;/599Z"I4-_@2,Z+;K1K,="U_96"94?P#[EDWX2)MX1@WO>X8
MC#KY>,Z>DG3OOKCNL V[E6D=*@W,6?#4VUG4C7?K]]%.]'6,]^'GUA&(E#C_
MJ1[DC'+E',.NNR+ZD^W'(L2PF)==!A,1/).'+72>!*C.]6)T?7P1VYMO0$.9
M'C'#TSZLH*K*ZG,"E*YLNB9[.>SB0)!*@WSS!]'R\-]_NY?QF/FD.5B^KVW&
MG@_K'DHQR#^229U#N82D0^*DZ?O[4V9YGCDBEG9Y]MA_=<8.GGPG;"_6+%T
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M9YG0VQN(MJ*>DV#FC/3J:(W R4KNZ3GT?W4;^K?M-YCISL5=P'>FNX""TEW
MPU%H&&./@_/I*@9<$7(R>X*R8[,+> O?>52WQKOZZYA#/=OLO^X"UJ/E\;L
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MS>_(^NC&UK$)]T&#^2.K1^A3!)=&3 .L<?3H&T%W2I^R<:MR"NDWR.GN&M#
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M(]S<V#)'YB!0O*]NYYV;;8CL21QCZ63+/GGP&XBPG>("Q22(/"Y /+ND2":
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M)JG4-]6[^]B?LC$;#GSUS"4,N3:&0M*JZ..>; QA45L'4SS11Q'0W&AB[,P
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M2=T+<AE;Z +5&7X@MEM-)_[R9PW:!TDH*J3EF#\>82-M+G8LTRUM]X]ZV8^
MP-TGY$*Y9NBU%NY8+\*S\&),7F^H;T*\M5OZ7ZE9;>8BK%ECY0DO'EB((.\4
M+D^4E[,-G$7+HR:<W)ZI$R #EY[!GA3P!MXL,I]X@V,4'75LJ7$EP/!9:OG5
MUB!29S7,M@X$"V-&]L$!&H;W!SV32@"FM>3<[_\AUE_> LFZ>VK9W/UX K&G
M5FCY[=08:$_M+5 UN:>V<UR++D(K/]I3&\,I<VD?_WSQ_V^.ZSW6T<W/?V,,
M(PV_8D((JC.B>HX2^#VK>S&\>]F&JQ.(&3E4U^8&.),D>1Y;'+#S8.Q$.%*
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MIAVG&Z0\TF[;J2#V6S6^=GU2L[$;M\1%TAT>%ZL[YS<TI-5A;S3H+H(O]=V
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MZM_)WE/[8#Q2A0/^K].!?_;D N%+U:PU'F:!6I^C@#IN;6H7IS@Z;#U.^6Y
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M\BTJ5PX=&4 ;OTW@E8BWO/&&!+Y&WA,<R +J[[1W?8RN*W'2C:&=[I>8[)*
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M)/7'W^J\?RK[(T'H+=T4=T'\P)ZRD W<)9;Q<!G-.2HXYI.I W.F^@ZQED;
M8#_R1K^>=E$'_A&#>2"&3MB3!L_I.D4H:>&.\":J.5$D^74Q&%T2J.]<\T5"
MYL[1!"XCJP&&MA?!%Z4S!?@EY(/GX2S#H"#/CY8BXFG\L^=:C2V:^U"CP6X%
MTV&D,.('BZ*BBCY#0YLKQT:GF[_]U32$]GW6C%FTQ+UWWP6+BZ,WR<0OVW9!
M_Q[LAN?!_TFP&?K"N7@[4)6BNW 2?$D"GU40(F),Z^-G)WB=L=@^V[JC-.[>
MF,'X(Y:X+]X*7RQM1$6UES(#&O!W9H*]51.Q-U!0SV__&TY]A8,LF)9L9CM<
MX/UM5V4)ZON@7T31S=D3P:8E^U^A,2C[ZV(/OPMP^+[8<;IN#+T:YT.KCT/C
M+DPZV+^8O!:--).4[DU8,M )D-=[X(.EK+$#!F1_>DY0?\6;N,-?];*!FRW&
MWMBLP?GZBT[2@?S[XZSAKW^]_$<A)BQ!:C^=9Q07-MM4TF%I1M6KT<#\4)/C
M8$^ 6+.G3='I3845]+ITHB"6SUKDYEAS2Q!U"A4H=6$G;,]5$@3$:;5]S\QQ
M5.';U5MXD([[H9Y<@HO3"KZ1FZZD?)\DQP[DV%F%W0MUP+?:^!X7%Q'V]?IB
M^BT)W>P]$U^^^F<]G7^5VQP<*'#Z,^FN=_'*6+:WL5T*&]O40:R7H[4S&BJ2
M^+HKBJLGM;WA6PGW>%_@Y\[>R,PB'_)9;.KO<03A@EHS&,N<A$0CS@QJT0!(
MFPLPPFV=+RLD\BVU^V^S1%%.;E./LH.*GVLB?VK%AQGJ@)<X.5M1MP8[C(=1
MW;OGC;MG198L5C#_1BED;"CP[<AJ9B]\,N]X6_X6 P&-&9%P^-UO#(B1/]<Y
M"59,EFU"4R3&@9YQ,X=.AX^UFWR24^)PNJUIW6_&E;!2\,V4XW;.(6DM\DPE
M,6-I8784"F_'_KGKH?S!AAHPI9WE9#5KW55A1JD"^;_H!RWIV%'2MQ#UGF8W
MFZE=.3Q=-[M<3<WU-::A;DS3ZR3)/0G!:J/,0QY_-T,9<4@-T-2J6<7E3CN/
MHJ.]YIOOXMB.S_TUD*'_6'D_X&_!L1_A]DWK;XYT_M0>Z\F^:,?J+QF-V_MP
M_ZQTF(!:Z$BY9NS\C#08#*^K&/)D7AWZQ".*9C>RQ<WQKBA.,'B(WI..VS-\
MOK/0N'=P\Y+]\.F0#+9BV_5INQYWM=.0G+945S_?XG8<QU)E%K-O3@EBF923
M02.:6\P 4@7;)UU9=TX6)2_;5(9R]E2CFL9?2#T>Q4!]_3:]KCMECF]>7I$]
M(1B^B9@..^&9&#J45[#@=KK6SY%!^=AR/?%V8XE;LH=G84MW=>!'_;>&!K?=
M'^&LS'M9'7';R%*$);/J*]$Q1$O/Y;31X_96!:0:GZ$KZVGB^8K(=CTJL7U5
M.2@050XB)/"D1-7U(>;)XY#7XH+0%*LT7V0?R%+A+='YS"&,YK X)C\4D5S>
M*8WQ;N[(U^J$QS'-V?)X'?W,TE0]\LV591PW[51;P5BF<^0IPOEY0NUI;D:+
M%%EE7[4D$,2E4#_$E\6>"X!G6M1ILQ9(L8ROA U#J[?(N=/F!,ASWT'?\7I?
MBVR<XP>5RRSJJ0:H>8"2":8B30FV@_#18F,\T.92FV/[$_/B-(;.?V@E_REM
MPF)E]^3W;^%03PV-)GAQNW7#)!YSH\\G]$YQ4C+5(3-3M]KX^"=##Y1EZVK
M'V8+;!;KL.OB@6+:FH[*")V9-]NTP(X^;Z)-*]028 UM::_?=1H"79P^A ^"
M4S[??D^O@)>T9Y-$V"AG!KE^".&#_9[ZU#E=V7":CZ+([RC"A&K ^&:@E@0T
M7]% 2)9W+YD$B>Q'BP=8RFMHT(]R$N^N0:Z)G;LPJ*K" &%@D"8N6WNA!ES!
M7*T(27 :^9!<E:H,$;.6 HGXJ&AO_BIS>6F=XNOT 4<:0"D%@U;,5+G\34+*
M=$7>V%;.:YMXOM:4)V@Z1>@*,MYY5NAFE*,>;^0O@.ZU[BFVI=4A3_[\O.,)
M_<A4FUZ\+>;J/+\D!5@OX\'(C>26<=$Y+_U:1(29M"BIG';0PR]NW(FF%0/'
ME<F+UT4=T@WB]]&/<M!-;8HXOFN7&J"?.XU\[XH_PK\\BBR$YT<]+.F%GH ^
M<4LH;+"##)TZT!,99,6"GS\' V\HPN:*BSHN)B$RF)5)AJSUVSHI9O\QS_IR
M/--H@A.EC-W4A0YGGV&#?",DWM[2S6\X@?V([SA?68YZ]<;'Y<4X]B8 V9_H
M]9)F&YL=_>]X^=\9NLC(]X,.Z'?-JJ;M;(7'>VKN\XY9=KF0,J$WN_%!DW&M
MOV2L+5G'388:'UEU?0(\H%TY!C2=(WS&F]G5NR72M+6?N^3@I M^3S^ ;V!A
M/I/%!Y-S.:Z)ZT5%S9XC(RZ])J8V9L/[RWKCPRY$Q(20V$MU?;Q8Q:!GD7+L
MPB2"FP,5N"2\\@V\];2'5\\M23\OY;4TMU'R;#-]>.0"ZSI)CX #V:)7)M&L
M'J 66*;1YCD*GZ@A(GGZ9G$1(9D,]<S/UZHVM&$4G[I-MFNFY9$KOZ:?%KN%
M];3"5Q4SYPD)V?!P_OFU:RG:-%B:L%YAT^MK:$C&(S0/-+L&]+W\[0?H)Y>[
MYKLR$&8%Q<13=I_S1=A&J"*K$"Z;K^2>) !QI^<)Z')Z#:GN]WR9_&0WL:(4
M/T$%6_\>-@N^:QYPU;]3V9Q<EBR9GYCO618EKNE-(9JK:853,\?N#%[*I<R9
M!03[F=6L;A8C+*DPP53 G<%;K[Y,=A6B?WF%.V3&IY0?W\\_H>+-8^UY7&>5
M$.I&PA4;PDS#W>_]5Q,^6[+^1<+GR0?_JX3/?Y!=+S3?!-5]_5N]>AC]!BG_
M=K-0 8D+4WU D0/Y(D77>S5 W$=7+?4)$DQ4 1%JP$H':/UMJXE]T)E_:SU]
MZ&LE$;.5+-U4A<G5 )6-'<;+:,-.#?C9Z( :,)+"5 .*I^J^3J9AYB[M_#\Z
MJP:T;AI_^+)\SV\U])^++BUE1@U8+]S*50-TK4VVQ],30^6.:L!2^*I( 8%L
MASJF;Q/5 *<RB#+=0*&5VY5;K_A5<_?[Y$3,_.9[D2I!WQS#?7HEW* %I/P=
MBJ8&_$67K@:84<YX_=+/^'BQ&D"%=LLKCM=J#EPCO?SMMOZW<S T6#UJ0+SH
M-&86[;H#*$8]?-6 ZQ6*[\2!BJB6'0?_=%0UIP9L.?5A)E&@)7C#*9\_?OV?
M&?-1AIQ8F?CTS7 3RR:^_6X6Z.8&>3[,M>!5?6A+6XY.1E!!9JG+P)F'-@L#
M)@\&@R-GGZ!MY3J9<+9MQJF"SX+S2L*YIU:[+=>Z_5%GF8-VQLFEV#77<GE#
M*(V]0\ZI=>$!P)WSAQ'::AI2)9ZK'#)Q\0S5J] 8C$[Z]#BVX(,D\-,O,F+Q
M_!K(ZYWU#P\?O$M":/[UP],W'('V(J]%<:IEPA93N4B/]\HZZ(K.:WOK&S37
MSDF\KS>$2DJU[$S-HHIC^IP\7MVL?[H9]RR8W+C@AIH5S@S@@C:)2,%]$::G
M<PR+G-6'GS\?& ;V?%Q%U&*M:8_IV9(+N\J+U^::I2L(J_X:F8_94F3_<SXV
M.LHAT"_)RW2R:<W^V#'#NU1<BC?SX'!) *-X;.\@6\$.)/QPKES ^ <_[A+!
M=3SIE;R&=L_B!AY)KV*?A=?A;*SWX*VOCJQX4._T(_UD4WVG9\>^"+:(DW@Y
M63B>M(AQ3!K;4L30]VL84<5E,SU&VH."%Y&RP9%JL'7#V%GC7C#843P#=+G4
MH%GU)-@[7=;#;64C*$5 \C2WVI_$=;FVD>DY(AZ%WR["=2:^?HG33>%BS[:=
MX^ZIVSJ"[=NZP""_8 ?SWH0:IGH*[?SK/9AZV@ST>'9YGQFL9.:S5L+M)F]Y
MZ<#V3SG8=PC4@G/XMPZSJG+]2DD6JA7B?ZM_5N6,*J6:]O*X(E@V&D$F/9$=
M"S7'DR=AV(.^8]M);9ZY3Y.:?@X #C+DN-\QN*C/BHLR%#)#S"F:F:8KYC/:
M;7QL\7;<T@%8]Q]39NT^EQBO#^H_9GLFHR<W&5%TDVN;GWRU6!IF98$N<[[Y
M;7_@E%>U2/N1^.,\^6&_<N7TH7<QYC]?@/#$GJH9.6BSIL:!("^91;Y)H)J8
MZJA _HS],R50X"F#9VRO>J_VF-1#UAW2:YL561%KQ.M;->F;H3.(,)">9@WS
ME>(*;(MUS*'ZO.Q2ZRE?_JAAR)?/7C+_'KS_LR^ [M--4[[MT%_#; @JB*L4
MW%=2@M=X['[ZN*7EX\68>>O-;BL=[:M^0\$$?Y^A0073/ &>G;( >_:DC0!:
M?C1@E6R_N;&#Q[Q5%5D\B7N_PDM[X'P\@[+\I-PFB-,+M4 <A?E,N<=>880>
M-Q .Q1MDH'L&.V*:$%T=T78AB7&AQ=NY@6];N=#>]5&C$R%IV<&4#U6^'=W;
M>A(:M>*=5"_FLAIPSCX,ACIQ!S%]/"1W(@X.UT]NPT=*S]97'XG/0M:>O56[
M /U]] 1?_PMBL>C4TZ)EPDCRA4WV8@4L^2PHEX.IP[DD7ASFY)%,;Y+:-KWV
MR[UWMDGNY8&((]'Q%]WW#OH:G^CPF@[0FNMLL3K27;AF9M#:4H0WQ!RN1J[R
M5D>!YB12]BFS^HM?34&G?*8@L/B/?VDZZX*,041I_=IT]JKKQZL#KG]M.CMD
MX>ZEZ^'J%T.S2W$W^1?C[O91_M6X.P" #=G7P1!U[[:-T6+;'R'/!,T]D1@H
M0Y[.3'.<?Y)&_F&@M,V::=69,K.P)ZFSXM"6#@X8"2J0Z)@KZ&%G-,6]9>&8
MJ&WH2R5WUB<),FSY:,"G2@V M.+A.O@":)P:H ,O@)OEL$;+U_E8"_AAR;5U
M1GWP@-V%[R4.9Z<"S3* 1R%C_0<,W/?50"KTJ@WA-KUP@_:$''8OS>G/@01D
M\PY:3>EI+@V/!>-QF3,M?O:=O!OKGJ_R236A?2X'HQSSZ; \YT$MD:]N_(;8
MU5K'6U8REGZC6K7'.>QANIU*24W&R_<(^"7-:RW$KE6_R>IV-X@6<!VI:69.
M;4ECKK.?U\//$^U;;9'G34J:.^MV)\D9':)[2*,-B[(IH,@T,\8;UZ^HR^>N
MK\&4D^7 RB'@[?2B_$>A\!]_^^GW$51$(3ZU1[[M7E8#3BC<:3[+,Q!_N;5_
M#;$KTF#73YO)O2"CLG)1-\8U.Z>&51P>DD-\5]V>JI5?HK&Q?!,W&_'8TDJ:
MN4GM3R2NXRC2:A=A9[ K['X\._\L/SM]K+'-JVU2>GZ]:-NBJND#OOL[*UI.
M*8RCJM\\R^U+*<1N6=08Y3@-@-M\)RW%8Y='+4H_$ /SC*TJ(?UX^.%W05-W
M!41B7&?FI9G8J;ZJUG"?3"4FC&&Y9T]6 /*34NJ4,^P'ZKSI9A0U"H:"16E=
M]W*\*Z;KKG:D&!3-=MS/8$O*]+G[1:G3'PA^U@V^)MBSMKV^A;^V\-LYX=Q-
M8.ULI'1BL_W,HX'F@<ND7[O^U8/!=XN*4)2@N7_IN_TM>DZ-MS;//N/K=5M<
MMUB((W2.2L&DN%4Q$AD L<9SH^,W_OR)G03\Q_'8V$#S$9J=V!64 YI G5F;
ML47T;'D9]48\"0XCS5F=C^H=;IK,M%CR#Q/C6'U-LK=$:]<N^QJC5M8'YE(0
M/>\QLWX).GBI2?G#&W#RR]\:[/^'*O_OH<IB9=9<E*R;R+$21L<S$OBP))<U
M'3T]ZL;@H1^<?QC8<)A,[YT8 5*C:/X+[L;H?:0.OQ@^;C;\^-.,NEJ<]51%
M9'MR'Y^C.H!%N,SUZ_OTS@212L'N^O+=X(*BM&)!E3%\AO.'47+SX$5P(^<C
M6A(NIL=++Y21XPZWN0@?;7T.AT!>&VN:@;Z_.+B>>J;PV4;>M[^:]KO)0)*7
M1TO'"N8<)3'RPQ-FP&@BTJ.DK]9X87:6&STLVD+#6RJY"ILO&K&.!>FG>%NU
MM8G67%G4M6>@6HPQ5B,G ?F9>?% R\S:D5E67ZY.$M0OKIY&@[HM-VFNIM7S
MQ=\'R0NF&&48S:91=&,H/1GS^ZQ8J@]V37EY3'XRYH'%DV_^<\<I(H$"$9#7
MW'Y/IP[Z+(322F[)2!<(@;PGSZKO)814/UMX>'MYH>1Y70ZL%H?BXD :,W;%
M7\T1_#Q+YNM[&2-FFG^M<XU-3^?O((! %NM=LV^3Z>WRH&"NYM;K!H,P#(7H
M*&R-<Q.OYNB"O..FF:UY]+MWNW?M&]?[#G-RRF)J)ES;3P)'CK-/,-;H_G=2
M3KX*=+EH[G[(DA!YMKH)288L[QF6><3-'!#V#_7+'IM7G[UBVX@DDS*&'T]Y
M+90+#Q?5.W;Y,VR&%A"M:;2,/!-FP,;,JAC[4/)9%R\SY_%4+#GB:LWECMBR
M=TQ7H^HK?4T$2$&#2^3@LI"Z5,ZV9>KAJR+*DSOA7GD3"QO)1*W8U 'OH8./
M:=0D]K23TYNFEO68Z]H'8OP[>_W$)SR8CM?'AX9ES$<)HN([+798:GQ[Y(7[
M4Z- K,,>IJ'MQ;XVN$\Y\.A2.-1E-!9?=RC]^U9N*S 5V%3S15\HK2(DSP*_
M=)L4IFC8X;5!=XMP^0=,=HO\?O['N%Q)3<-$=R7(XE=7VX@1 7%8*#3I<,*R
MD)]_?.+H4'9V*BU#1P]JA,Z]CQP],]N8T?*,U#N'B.(4H_)<8">J,YYG!DS)
MSZ]#6FPW.VHTW4SZ@=,@/#>HU(]!(A63$SWS*5,LA"FL*\EJ8(T*+R 5IS.Z
MW)>1?UCKC(F,:R#/&05R$>M45#$3/WN\Z02?"1U%C%UNOE1W4?98GIMD+R2.
M;="_N*-CE%G:27OSQ _G&TX15K;5FC@=ZH *)\"(A[3TCFYN!I]P)N</,V^9
M6*J!0WCKAO$N-F@LDZW2WK V"(RTG+GZVLOU5 [(I9O0W4E@GQ2DGH2-'IN@
M>/6GD+</YJ1QYPV0*J_>^,CSQMPY<E3-%35@CUU*(K=Y"'A@BWF"Q=%_ U$5
M=L+T\@G!E/WM4R3_S6L#/7I]1K!1J>ZE,4((<#[#>K9"K_353&"PR<V\SYX1
M2IX6U**>$*RY%32[/YE8O(I)L7HS]T&1&=8V$3T1&FRX;_A,D=FUH%!#$RP0
MGC@(!H-=@V+3L:^>4DJ!/(,6\A@F\^R^<2,7]U]:@BG,2UC'@HD\C>O+93?^
M/71'+\R',4T>=MV&3KMR_+^HY<5-?FBZ=W;X)3OJ>5Q5\_EEZTP#Q+"2* ZI
MZ.=&!-76!C5T%PA?YYSF*33H7)P5LK9K5DE;*GM<\YT$7:_K&CIF>Z9I0VI9
M.DRI&)T74EU8=TM#J'ZH, @GU,&,-^,S:YGVP:H81DHOWK;$*<R(?2F/2?5@
ME66])X?DJV&L!L"%6T0JNC$A;#HN^;N;VF]*<"^$JC,;Y;1,.-K-^.%>DV!X
M@FQC7Z%I;J=B!.PU@0\?_;T:4%)7NZ7:<WH#LF'['K7'/7O3:$\*R&[) ,]%
M-R'DU=-AAG0+7E2JGC$#D>D@.5E3&83-^(N,-A4Y8-?'&8B+N2>I$9.W.?I-
M()V@CLW1!H-L9,$8:/K!7;NT5>Y;B&9T5+!=QF+7Z^6VR$8O[Z30F!NOG2U+
M<?T3XI/QGHG#6VG$DY4"S0M[DP;H2Y-[</8X6#YVKK:DM0$4@,X<GV&RW7C,
M))[!VZ$HYDEQ4/^!%JH+C!W!]LMU'3Y<7 [*S*BP)"D7B[(W7VZ%96\Y6/>_
M%-V)O%OO"X=B/F\ ?=9E"\NK*!SRYH_-,@KZ;_WI[WMOERA<[DE_NI+@VG-E
M0L)*8>-OX<UL%L;J%LX=5=&^'?1V 4NM_0R1FE&P?.JM>M[3C%G<9\$%-K(=
M@L0M_/31K&PX)H?>(X%&Z P;Q>1,2&[0<XKOS--NC[[KQY[8P4-/J^K"AT)M
MP ZVY60VBM(UALHICFLUMN@T\28!?98L2 C-0^F*7P"3_;.4#Y@F!,2G!QZO
M5_J38.-#_5)#33![N\>G>[+QS@7_)*A7\9O@X%[H'/)/E(6TUI;:_6?/GL>F
M&Q%\EO-\/U28*!T<)K<B(58GL5F<%7Z)DN.$[!SR,R^6]=D$1+L:F^';CTT_
M9E+T8)?QQL^M M(W9OA1R=2X+;$C+^!M:,<UD,,$;BFMF%_==JG-\UC;Q;"L
M>&&B_'>-M(G)J8W"=!2ZU,46#L\B.Q'106<>7DOXTY-3T58CL^@![8R<->D5
MZP)?!!XOD!$("3E?+BJN]GW6HBI2?3O4TA615%%PDX9FC>24=F:-YIJ9':R?
MXYJ@\,%5H9N=ZVE"4HT/+M^(77$_0-H9KUME;&:FE=5R-QOS>R%[J!G[/=P,
M5#:X<0OHM>F\!8<A8]T$W.Z<]GWC,5<]LEA$^\(:*)LM=IJ]3, WR@D;)^?&
MG16PO!U^4())-8^A2TR%7ML!B:665R"?S3DX4J@'[$<JUM'IQ<Q*QH24[5T/
M$Z?CJ\,(#:MWXD&(&1.TT^*F7!$[1L2,]IN!&N%8_8K)RIV-!5I2 ]JZO] ]
M#/>7OT;;MN.0IY[>I,.4$@>;/YBNS1DOM)=95I4L1U3F!?@$U=7D_*G"PE7;
MZX"$WHF\6!:E_\F &G!%T$DL-=FU0*EV&(H*FHJ*0HDR4H1@V>9Z&IY('/)O
M'CIE$W>KA!^)C96..)>R@P?!7I ""AO.A#P@^HE'$;(^AUS0'G#LY!!D\[(L
M%251 PA)Z+4+_E*5R1)F],Y&#D]BCS%:4*@!#*OI/>L<[%(J2ZH*[.03QP6)
MIS8M"HV5)O;MJ3NW<GQ-0W<*/LW9X*$I EF<--F>P.\.+&T/&)X^[B9<$M"L
M A$S[FZ<$62+HD(/K2+;.QR%L;&&;1O,@&F;I-@E<@E2J+O=P;*G,^1A2?P*
MQ_+.(1##WWJB<&9E+,5^\"Z&/66X*>MHWC$FW2.@- 5CT _$O'K>6K$DV+3O
M@VV?-;KYAH\B;H.^:";D&NRA+Z\)4J I!XYR%,L]AZ>WCT_(D:MQ+59ZH:#4
MBH.80AF9-HK1H$G2(OM2I6$;DDF?_5$VA44J>_JC!8EV#JEO06[B/[9VQ.]A
M* S10#YO;/]:LBOJ18"?WP6!W--\RLLQEN::Y#[8( YXS.MB.;RW@R.WNZ ]
M'??: P9FF+2FH9:J4SG'D!%D-O-,4/U%_G0!3/, ++T(W]RSV=4A(3A4>,7V
MBKB'\LTLJ&AJ4&<HXOSLB'<:']^LN"MS*\7B!;Y]\UE/+9Y%).C5[3LQ!ATI
M8$@.*Q;.M6>F)%0G?-G=Y^?_U[()FM88-:46Q9.)>R#1=H%&/<*PD %!DR ^
M]X 9UM)VMBM_%<>F(BI5FM5Y5"L=Q/"8T<AT<->9-C@[<2C,6>:V R0ZWCO\
M-OC\^Q2YP_9W2Y 7G9')39IN!K5)A:]]IIT)<0Q;#>1%Z.,X66*$J4UAI'LP
M4B(%1F:LX(]1NA60_)X+VMO$5@TS7XA)RH1*J& *)'E$S?:R*2(^9J:A]&92
MOAF%:10'EN]?$O24H!M]95U^MIE062<E(Y1&2HX1N 6_LCI &N"TB?F#\>]+
M(:L;9'+7OK K@?AJ^&BQ80K"R,6K@I?7]54\)FWZ>?G2S/9(HZ\G]_O2BM#G
MS[>\];!'_$T'PEZ$0S_IU@JVM-NW_OF(AR:;Z67J-?3-$-CKP("6MIB/#$N
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M?D&"G1I#OQC(WRW1Y8.+!.$!35N,\2)2F+2WMZNH*>15GMD-TO."IOI?VNF
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M.I!<ZX[67Y[\R[+U_[-)'T2GB4\%RV)Z?UT'\58",S95G$DAIC@*730R>X9
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M"@T=HV[LVDI/;[\W3=2VPX[@!,T&B43-+)UCAVE7"Z 33[&QZ]G,21B&WR!
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MUST]E";*Y,Z7A6_ZCCPL&"#5AX%RB3I5Z6AJ0G-<\/G^M&(82S8KP1X>=&;
M26;0Z"2O6:!E5MI%_YMB1")J)08,*2 7SS4]CR0XNSB,^)Q.A#1[&JWX>_5$
M@Q_T3),(F%5+]QWB<2_O'V5WQHH848.LV)QOB^D;4ILICF?Z7;/5K!/^M+4
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M]E<<2E !ADP4.J3W0**>I0,*TJ8:-9ONJ*]V@X/8-AH "<!N*@"Z3MG"AJD
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MWC\]VA%-RC6XMG%R4L7KFQ.2X.)@Y(^X&R<&IAH5<:$W 4Z?H6A:@>+D&%^
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ME4V3^TV<^<X+RERY])720'?XU;I7=.E6GI63.,BVM;)T(V'CF!D /CAR_\*
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M-7VF:^-T6FNMVU!$5+8I"%01*;*OF8X@REI%]B65:#"&$,,>MG1JJP)"!#1
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M#_77!K$N\,5.SQS.^!9L[7J%XF!4T1W;VA#TH$%H+M"@\GO(+<^MG!#D]$;
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M8[#0'%ZDF1\/<K/"[!+Z>Y7^-:M)O2R@(0C3.Q,Z9Q7J[1R;;VV6W_&=PK"
MP7_N,5RQD3='BN=%3D[SO'T*O/4#+YMH(]ZW-G")7WO<SENV*\N5V">^?Q7*
M+:X1V_ZC85WH?2RW5>MH0Z_/.[O54%ZRDB/OP[1&D$K?OY%[3Y7_WQ_NKZ)
M M5_GR5N<3$'[TVL;D6F7^L#);0?6+93'BQ_/A\+BR_)&#$\!;7(]]=^W _T
M<,5XZA:TX-ICOKMEGG.SOBYG81Z'?#,PN6)?GBS3^9PQ-W '=<<D/GHPGXWW
M09ZZ2;+T9D>_/U._]6[N$*I,34T-?4+C)6L<M_UAI0LWW^%^WVRO(:SUQ#O8
M4"W]Z+073V? E92 B$F8/&IE]6.V?LRM>>@0NT?HNC'[]2W'97!5Z?+L@FK>
M:]XI<:GX9=6E4S_->$<9 0LD$\P'=[FZIR3ADB?;]^-=XGPIWROEK [!>J-+
MQ##4NO)H40WH89\7<_$4K]I/K UR37=N%4[-F,BN^&ROS(3GT9I7U0CK(EAU
M4%<[&D?_/C.M%_69S9A;#:C;AKTQ8%?6YTC."XX9E;OP*SO%I1( C-T2G I#
M!W&_W#J( OT$/F-2MW\I"+X/0VD;$+0$)8P.?_;<Y?*@?D9"WU7IRS?MW0$/
M1 Y+>HS]'<^I@A0'<=&AC..GB@]%).=!,Y!6P\_2PIS8XVUL4(-7L(3B#)OG
ME]%P7C>XLPUA[R\F2#$-8>2&H3"SU9+2[ P=1_E_."]B1CZ\Q4"T+/)V-;Z;
M_@&'%9M7GT_A1FJ:^JUU0(N\J9WDMB77O8:1O05]1YS866L\ZVL0G<^F? W"
MS<S6GL<PCK" &Q;K66[VCR;2!QE-'LE="XV#13E!1L8)85R>[_AZ=FGY1'UF
M=SB/3"K7O;71#6&;9/9LPI*5Y08Q3=47SK".I3AY*F?=1\ZTUFYM9#.@?@5:
M/@@VY_>^COG##ZB.UB;S2:IBM.VIV0 "+?;73QQ*E <GAH^"_!BM$N7\:.%
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MR0<?XZ/<;N2[5%2,!']%P>^_18MJN&<WSO)O=$(*/MO5^!IMH$Z1#[R$0[V
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M&QDEXEK'3,8'YGQ#O_V](:/&*1TE/N'8@ HC+?I >_9=/E=QO&((*%P0519
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M@Y8'PMW9W-;;!M;#J[A+YI'+_3QYZ"NH6K$JU<SBC\VGTR.V<O34C[2V3GG
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MJ;8R<\#-?2B99VK..G$$TWMDLV98X;\P%051(;RN<1QE#P_DN1;<X4-"ML,
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MV+A5F?[6':?,VB"=[@/7#"\!/BO!)-"_ ?_=]PX9IK)V)WG>&X?:=[*$NY
M4.1FY&2GE7/8X#@LG],Q!.D-F/NNZ!4STXBR>1K/J2BS:B0XMK@B^E63/6-H
M7W@1MBQ%Y@LV7_<BXR["H725D6OZ_LX05_6I4SIG^W%&*7JV1W#ACUD=X89W
M& !$*&L*IK93>9P=3<2Z ?$2$JBNR?5UJQ\"TPUSA1L!-$/";0-#-K-,K_[Y
M7U?;08U3/S'S$9\[L()Q/_"HI6-=KS5RO8-JS_=DA"$"B_PSGMPWG$0VZD\8
M&M0P=\0S.]EX[:+/JE[.+[<V-Y2%8)!O"E%@0!1Z3ZD-$#K'@8EF*%USJZY3
M&%A9]\16*;6%&D$+-XY:;'%;9I-ZTR[S,M'<VLN1LU[2HRC+]<^Y=-^<@U"C
M%-K. %'*4@V_@I&WG(:HJ/C%!UDR]:.@I>4CH:'#87&:Z?KY([R-=OV5D1B+
M4DK'JW!CBP>UK\F3UGAOO92+DG:-HFOBQ$4,LA'O6XMOX#>6M?.*JQ48.H@:
M*8++4R\FF)XT8FE=].'[A5)S"K/&'M>&Z#O?:%+%093]F-K:VF>^,V\*X<SA
M#ZOBOKK1Y,=LVO]:YSHNY$I&1L:8MJ5];#HM.OB#MRFYU0NFWSDEI:^ /*9A
M!BF"&&K%L5A!>6&\*1G!%1K'F\(1BT\>S@G5?:'?#3N@IZ5#[/Z+SS8,3B(;
MZ\L4#;\T''Y_V8XU(5W1(90&F#'RUC5W9V\!#7RZ0G'U\6T]D6P#<YX6YUW0
M.*X3!+]>854U6F<CHE%5WUC$Q5:8J<NE:]<*3O>'I.)X0(1 0)T$9U38UC@"
M$;&7D.M?_^4?+_4!^\JIPK<5L]\B;>ZO]WH/[%CN*0VZ6$&.-'2Z^/S<_#S^
MT]*?FOIG'4Q,1QT_!C#9M3_AG2T;Y#3D(](@+=AZ8YN''MM%[\[W+\PTT9<Q
M[KI=>TH/9UC/I\'H,*[DE$'B,,38>"=23#F5L0V?H[#SE#55' 6R(<BKA 5Y
M: QL4V@;#L;R39_G,XQ$?+G5\!CJ<R:\3S^\^?@/'R@>G&&2<)6NKW8[ZU>0
M @^S 3.K-*XQ+OSRR8N$DRG5!_.8I@'>RR<[L_U[&'$&$*/X',I]EB!P8AKX
M<2OK.''4^V#^G'0$!-G1"H7>CV_>*6E.L9Y8*JKT..H7WILZU-\XFVYJC83[
MNZT@P:Z/2X@0(]$4E,3I"G:,SRF]*_&:)F/]NE^W!A6-A83ZS1")(*Z_O=^5
MDO\Z-^8]/DT5%0Q2N*)#;5M1&^]H==#0>*;NHN6[@LQ+=ZVN?;IX/6)H29:F
M7?ISKE4#+_1>612TH2%K"9_!NW<]ZLF]A&> \$1Z;W?G6P[AX,9#;%0;\#5$
MY;3W)0UBYD[20PI0%P[J-S9VZ7-U!3Y-G%5==8G%.'"[W!^++!*B0,=O3\[G
MKA - )V)_@0HG^"TRV;KMD30'6%X]R9*N>SXTDMRQ6D?1,X0\\RS)H'P":4G
MAV?SA(</)60(!6<7LY'&'6YQ+DA(?]B=K"R]JJRW91E1;]O(V2.HJ6!.?8FB
M<_O!6O*\&W^ [ &)--O"LD[P54$XJ&;H"=YQ8*CM9ZVT\)!-]!S%NNA[3,H;
M:_(/T8R6&?MY;K/KR&'1:>]SH6N5N5'.?,U-5KU39AD->EDCU_7P?QN)#MI6
M3J'8^:NSMTN[#:?D_K$H]RU4D,<GRH&]:FI(.6(5%A#HU">)X03,N,,FGSD&
MK'W[B77OQ]]ZNIOTWBS<.;!;3C$(.BCH/6A2+[*@A"9U,L-;;-H(@3]Z7<$"
M(2K-K?U04PP_:-1(+:MO<?/8*75 ,"->(5A<-0U,3-8WNJ=38]]G_[9T+#QQ
M>*3#+>\/X/GI[S]06_IHTX8%X%0VTC5MI-U8O$3Q8B694+>Z\%QORRYD94_I
M9Y>#ZXQ^,@'8-)#T3+2]&0#7XU72K;OF%6(D8*=?8C,?[(9@K]@YM=0/<8PV
MXTI2L>[;LTLG:!S80$7/O0-)C8\4J":)HD5N#7!1303+2IY.*WKZT$MV19D_
MV.LV_._C^M]]?LA[I=*N:-+VA?74RT7\+G2AIU!3\'T:+(0].YHY;J47,KYV
M C-=\Y6#]Z_/;PE^EEC4EX:)%=&> 86>@4%5J1R2NIN90/(B3G8A[A8Y&UX:
M;M*ZIZ1B2S^:3&(RC#?"!I/ !"A"@'4(T;Z8RYHP@LK5TJEI5VI$:$AR>"ID
MKE9@@Y"R&9;).H$ZU\=.NTV[?IB$_.EZ2MA^&M6S8O<BV<T48G[)P+I\"5?E
MO%I3]F4$]9UL1#UVZ*J#EUAR.08)S_X5J-EMS>A7G?)T,&%I:HP'6MH)0Q]S
M1 !8$*1SJE^0LVO\\DT&UIZ>RH,60'- OMBX_G4FS))_/-O5H4Z[)4VF$@,D
M_+!Q*MJ>!LJANU5B7..HP0^HUXE5(#&DQG43H85,]I+^<S'_U[ X%1?4"*L2
MF^XIU; #@2A(?13'JQ&: G=0G@KRYT]RY/9F'E0U*9P&UZQ7'0?:#?4';% !
MS_F@@?: \M4<N'S&[YIU)ZWHL!CK.NP5/8=WPKINE622\HQ9#M5P#AJ6(%<?
MLO>:O#NVH;R620QA.XHC1&Y+PQ\6WP#@L"UW(XMQ<T&.)O%K6&&,9NW[M5_D
ML8K8.X8M6\F?U)/!A]<9&QOMV7=L1L!S7W;3 PJ_U33Q=G63S4]$;1L241<Y
M*T]GR]KB?,--L*AC!_6:Z45L=HAM@,\JU$1(JB!FMO:Y/9.8'N[,]8LN61L@
M9]TB#^@LU'&/"&QBI5XMELD@H([OF*8N!N;Y;^D[3C>S1&.VUB2#(U5I+R*+
MW)/?S0R]@)"*1F\+HRPXC>.7XRUCUWQO\:O/Y971(\@M96@?!>K"+]*LAK-U
M';\TWDET'])YGM+#M0U,SLN%/N.9(F/\PO, WQB/F2F;#JHX.SQS<Z;QW%YB
MI&6TD-'\!-1Y>?$KJ= +JDJ]GY3&+!W3::'HG'7EU$"<6B%V1Q#,*^.O?EA^
M&/;K!X)YA%^$4X1:VY?)#ISMSK*Q(4..3T[+JT%'ZN)L.>BN?Q BD(8\';5Z
M$0H>F!PG,V*N$%ETT]>]JZ/V^0X.JH[!G<%?$,H4;=OQRI-JM/3,P:X:MPZ)
M:"-PT\$* HGG;&XX,W5XZ#@_B+_KP$<"K4L6N4H+IAWV,YW^X01JX%W7\(=7
M,BM +==SJ4&3)9FEL>^01=X^_TS2?XK#>O/!CRJ"YWI<82FB*>3L;[%:/;VL
MQX-#1_Y$?_QJ>O#<B;:',4%-97/,!T6#30N@M%<O9DM#Z_Q+G\YU<'/'SUD0
M\(J4!:VQ#8/T>PEQQPCTZ%-5CS.9YYW[XF_3BD9/E-WJO4YR)8^%MV*7_/V=
MZ?!?[P84YZ]+S8-T*V0KDC&["]0!5NN2Y8T\',[2+4^EQG7I:-AN'/+))"5^
M6Z4MGAP:0(- 4&8G4WO&JKHHE9^Q.DZ8-E0]A_A ()U#;8+%?%N+KL&A8V1-
MH=_B(B_KR[F@+^O'5JL4QES;S*U%^O/DN*;D-NYR%-G8;P XLZR(7APTP86'
MZ$D3(%"0UN>AU.FHF:5G>TJ'1%I6+]HT BZ]T(;Z"(<*K@N'BE")XI(,EIQM
MORO0)C)CF;$+;;[_5^KN6<$342JWT=IAQOK!!/P1>\7613A3$<$M;2Q;=FM<
M;F_N&#GA"YWGY8[5O5PM1FLF4X''-Q @U?(M[W.J5_MB/17.W96YKU+(35LL
M0!&,*F4.24=K'$)3*%GA@\I&,A$0%Y>''1;?)D78>XVFOO.7')I'S'?5'SMP
MCV%NOF)GG0KP-X,*6#)VZ(-O"6_!W;&9+/]_<AO9QXB41FD!>#'^?C=M_,0$
M;%RRHJM%&5D^>BO+M]FK^\D3=M#\W2)IR5M2=WXCC:!J(NX)/MX;B/!;6*S+
MM2]GG/M"1Q#,L4@Q$>ZJOUH/W[$^FCQ;-6]2DN4?UD$$%T6[LILX]T39B--L
M;4-R#<>OCQDSZX=TZ'(9)I57$":;NG=S4*_NSI=D SNHSO[DBXB<UH>(AR'(
M_]RS]O\&-#XM*%0"N)_"PTIR@8MU),H [4C:[-.I@,%KQ(F= '+<QF)K1<-8
M65A.<I2;N?GB>85J0*CP7=;R;)E>FJ5T/&AA<S4]J?>YQ%9YT3QDXK(]!X;1
MUC.EQZB64-N?1Q6HU=!I@2'M<%K3[4QJDCW7UG\NV;WT[J1YE%_>E5:(2U^R
MM!EL%/"X\D6HZ&$L$8$C8H<M0Q)*%\P\D<6CENZHV%V/!;XZHK)N3^E(?$Q.
M\:TQ$L196Q'CS,$9D8M_XYJZ:HPQA/W#Y:*+7SC U4R>6]_P7JSF:.'6"<!M
MIN37Y!XUD%YKSV!^4T)_>R\TM8@'@S!;DBU"]$CL9%(VEU1<RU?ES>^:#$J+
M3=#W%R!UW..;K?;B^9I=H;-K'\0E564__\(NW2EY^ B29OO?.OR""P\ <YA-
M#=DVF3I1X#L50J:LK%A3NDU^%!?'%2ZW1A:++8N-@B:<#(JNBG"^;+CGL(FG
M)BVX%,P3!1^[:?M(I)X J.\"]5WNYW=,W$6[(D-$$6SCD=,<6V*KPU,Y)-C9
M3QM\VBOQQ5"R619&I=]<>&'4J. H716*=75'W0;NN/ML+T[K89/M/FTD%9S[
M0.N@+UTC<812).(]V8GV6RQRJUO"$/@69]O:R=UM^=W'KC]?'F?9+-02*W!3
MX^-9\O&+?^W7*$R-J,M*X&4EK*>LP,X1RI(.839.]SD@HT!)71E9M! =1/M0
MY75<'1.;K-"'^(58N@YO>0'L7E(-1U:1=QA YJII5)X1H&\0LIE96J)8_7%X
M.#5Z>/C?Z0^=SYPJE;NQ.--/6[^[M)MZZ/;*0Z[=3Q3Q)6AJE)Y1R\)E<W[/
MPZ0CW0L]+UO:JGJB?+A%N?2Y!G!C3@*7F9X>:9;LG2$*"-JM=$\A<>,FFKW]
M.&1=ZRNU_&G?LI&BS(<08U]IWS#"#Z!R_Q(GBP-MH49%)B4C6B$JM8W7,Q^&
M^E3HVAH9 PHT+O^]<^WCQA3M")*LF W*F,A&MV.Y+6QR14/ISU69^GBNP[+M
M\VF!P84Z]X4Y=1DN,>-LHX)H-.A]94])R]P!U;U?=A\3MR]T=MW,9LL"24=T
MPW6 S#TE,(G8D6J"]VUU?!&NK5?MEY0> ZW'M;L2,TK+?998ZX.5)RPJUQV(
MN9RCA;FF6?]_9UP']0&V"!G08P1U>:LKSG SP$OM5>Z?([^:H)PI^B/VV:,X
M$LOMA/Z=Q5U4^HYWR[ J2DL_O2R"^WX&(G++[%W054/]=ZM'YN-/I9+X9MEP
M[\&4D/!)O=#[RZ[#L<)5H3#W!;NOS_4BX84Q)^9MN1OW7.?Z[$,.L)Z+JS]B
M151TL_DROR+.X?*_L?E4FA($18U6AE!4PW8/+@<;#QYM&+>U>R5-G=U:'+]5
MG;RGE,0-3-Q3<MZMV@YBU>>B)L4*^([B5:S[U)Z2JIPGF*69HCR6Q F+,MON
M;O9N\2=DFS)(\.R.305;WCW-]G>;?*'()2J"?XB6=G;&<C>" TWVE(X6%+@_
M2)6$E^V>YM<LU6Q]@;SG_<=_1]6CWU)"$'IB]5>K.CL15K#L4.;TY*0?YHN<
MBWM*;EDI(#72PJUQ@J!I3\GX#*T0XQ$@)7_5/[P1HW&9X6XR3@=@4KP244,H
M%OVFE%?"GM[>OJ0"JCPKB1\.IWSNEDB3@:<CPE=K<9Q J&^%SIL6N^,+=A52
M.F#(E9\R0%<5L((QX"!IZ9A)":7)N 9BM 9)"NU<^QLU@,N1DD'^9+(7ZA#2
MU,KX_J#/HI'%H=2$N;E>O0<=6>(7ZT<CYAH2RIC+G^N_'W69ZVEMSJ%A.(\F
M%R9@X%.F2!%'R]G]Q>ON<!)V=\@K7$_LPD.?L);B[E]Q: IJ\;>7Z^I>*:D4
MI/OEH%>P[C%;QSSCC_[!$/0)1Q-6'>=U A XC&'J)3*-DJY9&D:+>U61>F10
M877N31)I;$,J'S^.2+W#':262)FKO=:=A6L*N036AG>):1FTNP@I@)1)#2V]
M6%A(A+MP9DN.N\,WN3\$WT[(\8[I!_'1D+;!K-EC,U1DC5QW5$1X:PQX3._/
M/\DE_//E^GT J'DON:*3LA62WPY=+:M_<FH^&FG]</B$CSS.]M7G0I@A@7 )
MDL4>&QEC7Z@I\KU0E_&NOJR!EV/.*^; R%-1DN-LZ/GD3BP9=][9"YHTPU#V
M8S:IF!+K0O1],DM+,S+&9=2<;5B 3Z/I$/@_.FA ->\[:$J7E %JUL$=/:VN
MZ1@;NH*TO"+@:9W?W UQCH680S"'M(:G<7=>A<)DZ3JA\0\&;O\L$;5;P*7^
M_H2XQHOQG2;65R]]LWS)YC-%D>(95*'RMH>O]_B[>GE$S,G0+=,*78X-L:Z8
M '#QDM0L)7I?FML<NQPFJ)&P8%D,J^ZK_ >IJGVHK^:? OBFPLJ^R@=OJ9:N
MWV5FEDC[_,\.5##'+ <L7_VGWB&E3]V6@NHXG5QR(JMVT^I4LU7Z'2%[,?=[
M<IIA?)8AZ6(MR13-)]#@CI^:G=+8"IBFGX/WPJ#'\X<"E4<]DT-MP0OE[O<2
M<L\M)@NO4_O@21<YY2W&=<1>IQYHHBMMU>AX;8@NJ[O1C\DLR>2WIWI 7L"3
M<H*3[N!9T+1M [OF?3-/C;$$^V24EI9D9):.CJ-K$XN_?1=5Q0\J_FWE%A6L
M"*SAE]G^8>9D6WKI1<14(,ERGP^OR&G=U^G/#8M"I'X^)/MI39$?/[^CD?>*
M6H8$&?!2 P>1E5;YT='R.HDI[^(PO[8E",8)RE-VMN\_[Y.!.^_').)"M/7M
MBA?, F;/MRU(2.@HL@4AGR&#&ELZ+BCC"S/^AH>G+!YTO/D=&SMH8M=A>.)+
MD=V*2AOQP<VO.$LVM5<T5UF_]3KT!?A#*@H>#;D7#L /;]$$O3_,&B'+D[4R
M;U=U0J[S]R-70T.:G1,J/&B,3-R=E::ZQX/))OU]HJ3V"KT CF5H5K /PW>(
M2)DU(&)=@\2Y9=J&D(-;@'QZ@=24$5,4'H^^HS -3O>?R^H'U6]/\#3K:Q"M
M^W5^O_--T]^KA,H(-7M*S?[T3^291(:5RG=EQTYUDL_=NK<"2<[Y1K89U#W!
M:U"W5H/Z3'R[[]2,T(@J?>OAQ]3^^).IR 8*!#_"+KL5/U//204@$]?E]%SH
MW,S06R/.I3&PLP(X<Y(Y&7>B=0F<S;<P%1G7QFOJD(QOE[X.FMU26--_J)AY
MD6?KT(+E'.]SC/-+AMX#<2VW2.:LVIUK>4F6%ZV%/__U=UC_7XS#S&6);C^N
M\0?Q;XAEZ[/GJV(K;RUL+35M3+,#J<1!?+!/1$!ORJVSWFU[2B,T)+C?^ZMQ
MUZ+7NV'UE30-T\H:ZVL4I!!P2G2XR04:+Y]A:/ET>8V7*Y>1Z#BHBO^>TJ?D
ML:+,[)%"3/[@?MJ6 ]LOB2^,JN2:;NRG;?944/)^VN:TK3VM5R.W4[L :OBD
MZ/N_$?LHQK8S$>^VO$'H&R'-V<71K68U$4D5N9E1;XJZ/7PF(L6TWFSP"LX0
M=&]CQ_\@<H5%TW"TIV!NX\VE#<ZQLU-VCUDO%*<6,$[&=9$:1X5M]<[#*<D3
MN/LPK-]X)H$UE-MAPH1@O0R@^N;%F.AO^Q*"S[]$I:(O-@7_*)=@Q\KZAF-7
MB0AYK/3]= <@)D#U7[_C[".J6&M2\<G/,"OZKPKO'6/W21)];-?[N<)E)_Y0
M4HD48,8-2K8K75/TQ$\6<[82NU53;:PE6C;]*%N>V!KP>B<8-W/K^2QG>G*K
MV1N BB(*!4(6N:-CJ:Y)%"U6#V:N/EOI[$PE^7D$FC HHX&Q3!/&^P_Y5'80
MB9GS@<5GKQ4=IQ5UH!7.M9=3<[O)[$I/\>+S6_$K0X;OBN,MZ9LXI'L :@@F
MG%AA^";R=X-2@ZL5Q)L_T[>^F+^\LCLIX20C4RO,DO&]JGRLXVML^(X(J,>M
M?<;2S6-)$^7:?J&S2$$V"]G$G&XJCKG7 N#9!_>X<YAYL.U U,%O>)5GC__+
M"OYC'#3N:5? ]!H4E=NH!T,>1]2\ W]*G]2>^ZP-DP-'%Z7_(I#Z-> QYG.E
MC;V@/S<XVS$TRL?=[:CIM:@66T?HJY2FA#0>V-B\D3K?:SE0,$N>CC+=MAL\
M9>2GC3HYAE)-2RR Y\;P,?JZ!DFAGSQE;5#S-\E[2C_Y,C9R?GGN-/!A/,J!
M\N1;DZN;E>>2D5,BY)=W)VT<NSK0(&J8\,N6_%E5U/>SST[YNS[>O!V"!@28
MFIUX/.2M,AI@S7"W[4#6;_0>%,>?NH_>(C]:XV!CT-#.-Q(I+,>J"A;0&=!*
MU 8;I4!/E%$C^XF512&QL3..I+H-*EGF6HCF#C73G; 07-4$SC>#0?"IL$3(
M*VX'?:OZX-_1]*.*/26AQG*4Y= *O<GX-Y^K.52)>]!6<23W#2G[% RB9_*F
MD1\Y+O]K*&2Q0_<55!.&BHD)'%>>=D=>9'CVWW2R+]PYL8N9\;4%BAG4R,NW
MR]$Y:H]F5@Q-T;1JUZ8NJB]ZH.!X;U>_LX,N. !1JQT"B6#&[^@\W@WE#Y\T
M ). F.0)79!OY<P.\2%HO<ZO#XQU"-'AJB@??-HQ]=T'EN^HFT>F2(K.K5)&
MV^[M-%<Z$$3&ETW8Y'Q9E77IJU.3I@_C+*NJ<]<6JZ].P;5X)C&T&T[+!=+]
M7%D#.2&3KDUA="0&PU':!NJVH$\Y>?WX%N-3\&L:# (7T, 17I%K7R%($'_)
MC1>9SG6G=PZREJ*6<FT0<ES0$$HZ',]8SZF\!_J-]O1?%?D3NYZ[5#9L]Y7T
M('>7OJ>T39V?62#,]VP=A5KZJQ?U+MIMI<;Q?=_L*?%.[C3L*4W^\<26PM:6
M9?="PJL4H,Z_)6V#%=U3#T7SU%W>IAJN9Q&=D2NUM7^ZZ8[KB:=M#Z/$NE:.
M,JM,7*.B\IM1.UZP?.B\G/SX_R'L1Q:_2@#%MXJ+O]MN)X5V6_*\)^=WR$]K
MVXE9A,H)*[<+%^(?B"V150W7[6HWDXM/+C=FEZ6LLA:JQW>/M\9X[BF][ITJ
M:>M1XRKT^N99>0N&0.&N/G@[KL30KJX_(7,LE;18Z:?-%N\6D1@\;!]8EK'.
M%K1-:0&(Y)UKBZ&F*7IOLXIV-</MM.1YLS5RVW)W[A<=#<7*O_NDYY/O>F((
MV7M*K""++<="<ZND0>,4Y3:G:F$LFYU$*MQB1=#"(*&E0S,>KOE^^X5%W*=Z
MZF%@=]N,FL9;:):WB>B(]21]\Y4X?MTN9)V"G?7+:^;%P=LY$G^7:ZNA)XA-
M7,)U,I,]3RLXN]5Z;:S,$9;<]T"&6+<;C9$13M.,-N/;*'4V(,)X+Y8& >2F
MZ@<QY:%+URI,"K6*8TM^_1W61W^P([/H@ W'N4JQ7D*/Q"J]/\GZTXJ++&_,
MULSLZ_A' 1S$R!! Y=O#8T&0W[BZO\Y_F3L/5S4U]39VZ2O]/+3J![M?#E:A
MYGK8E7S69[GN?UI'+TS9>W5XPWJP?<*UD;(^[XLSG5@/FPI&@:FE!QEF6F*Q
M:O?YGI*7'+W-'.F !SSFZ%U?<A4968 9:Z2F_(XE H*O7&<3GOI7S9K_QDP/
M!+M//9GRW)*P:GL"?*>N;B3QVUL-S,Z$WBS:#'!J!,\^C:N[JJ.JPEW5+U+7
MK'1ZT:OWIR&PH6K@*+W]9K+38=)'"C-K6\K7DH,P'9KOCO6Q(QU3-]AN>97P
MR:9:/1>F-C0]IKTUWOM<+-6(<T+0;5;)65517[7"?".R01O4N>;9Q*X.UIW,
M?9 ,+C@[T'1G&U37X?K7,ZE.E \$#_TAE>-66?S,MK=M!8SM'HZ_NKF[I]36
M_PC?V:%-G-C?7-UP Y/4?F+?MRY(U+WI:.*H0_\7SU<X+M['129?L5S_L%NC
M%1STD8"O"*C=G(KI&F#!KF3@2?UD- P&%F:6X*(%S^QINB1AMXYOS8R>8\JO
MZTU-:^X+(KN^&:$HE%'OQRVE&3-ME2-CI6#+X=33+_:47GWV]9O_33#X+SB=
M+3[0ZEV;H+_H-0I#IP>^#+$.7,U<*\W$"U;:6R<6^$<P'+\Z9E+#T^SR0F9J
MTAVHSJX)#7$6/@KT' =:"WK^(D(L=O/>3@6YJK1Q%M=S+ET.S:)U/AN0'%X4
M9FVMX+_L)MA]/F8 +LDH#;,]1GK(*Q5906Y$A_:<(V5[.U6 MYZ:L=Q?Z&/9
MJ#]FEBX=]5KU.'3^[QY8:@?)(3SJW#"FD*\OMM2K?2_*/=\XX\\Z.W7[W$NH
MHI%I$1G)'/6 >7;'W?5_)XFE>T:/!IH,'CO^;;"J]S"B5O%7))!B"%RS-JC:
M4VJ80IH8,T-TFL^3)U;A,P:6_!.E4]RR/J^0$$,L,T1[E">\&N,L+1H"&=EY
MR1\$Z:V-E<1X(?CX%@O]>O<7B)(E'.]Q=-IW_[+4_QB\&%FZ27+J1X)CI&9F
M3) +O.M.BD5KV"_M^:??DE_Z(9C'7'(T$$;^O6>]$"%;A\ 7ZISK".BLA<8L
M:57#E]6_T3?%"V8:Z9QC*JVTXP^2-/>4SMS78.KJ@J$S@<.TK=),<NJ<2$79
M9R5KH*R/S:".JJ-Y6P,LU3GMMAA>;:P\))JC%]2CQ1^.9;SOR"C]\0H[ZD\?
MN"$F1DT;4_C7&?%)+DY8@W@#[R V#ANE7^62;962K@PJ3AM#:N^704XX;M=<
M5D/]-K(Q!\F56C_:Z/)R.X2>N5L*.W5Y1>)[UV]411G<GS^Q.*K"U [OZ',/
M5(5V<_S#NH9:6OMQV09/C0&?E;$A6%14[LWE\G]'XD^^Z4&H 5W.I6=BO@D5
M];QAS\0= T(G41%"PC!Y;2X^M7- -CHQ?DMMKCQJU+ .4J9;L+&==F&I*K&:
M[+X$7C3!<X=L4MH&-V;0;E<_M8&LU<QSHE9K.!TH5%@@Q F+2ATOK?'S4!#7
M1]46S"\6\8VR;?09:T)J4:KEKGEH#1CP8("869\_._;W>[Y/R!2-"@8,2"V<
ML9R=Z@6^7GO7S6CP99AH!+C (('BAQ-FESFT0LG9M!D76G@&G]2T6':AB'()
MQ"W#Z2Q6H1J\?YHO3SV_XJI:6>L[)9H4U"RIW,'SP#XE=7G&JC.N_>L0(Y_R
MV*6BETV2\WU^D(&8UYF"S$%RU^[ID5*C:]T].:5$YNR/<2Q)[5W$U]H__XO"
MGFD1)JU@AGZ%:>+O)FK= &SH3_M,#72^CA-]&YJB6Q &_&IRQ::QZ%E;9]4O
M3Y@XV(7Z8\*O8SYAQI2<+_H,=ZNKKO2A&"R>1L\&]>)EF'X[$?3%/!6-,M[_
M%0ZN*1+.UK<<@7CIP6N?1D [%\EU_F]+.;8U6UOR6<P##IN^T]U"A&(2J:\K
M']YEAMCU&,F!NKI&_)K^NIR84HV<JX:/*$-A!,+E4M?:A1''<_DOIVA)CU[.
M&X;C%]=W=M87VZ,NK5X2GFMP"LMO:,SO:&_ (WD89*(>1R"6 ;M-T<X>)UBJ
M^LXWWK=:8>W?CRMU@/AD9+UOM=+6ON*>G+"45=B?U13@^?X\05O;TM[>\7I&
M3I[R&DI]1?%WC0[_]'K:MTN2'OXNQ8Y9XD2RD37'82^AG[Y]@C<W[Z*!8$^:
M6A>7UQ-_(0YPH0W%,YV=F#8!5E"=#VZL^I+?^  U9%U_?RWWU.PV*I_WD'Q@
M0! =93Q?4BJ@9K5 XI@FQ%6H%9R+!:X'09SMV:,JSQ<L#"J/4$$+2/4!FYQ9
MU>:@V4+(Z9$\46GE3Y#3M+H0;=WP,Z\;>^FG30#'Y)!E=\W6D3-H .LTKLY.
MOSCKZ)\)( ZAL4"_'1I_/(:*+R798':65[,N\"K#+<!9F!1E!E4KL/OY"MZ?
MLSNXT)T^S ^DZG001=Q2YE=O\(\Y;S*EX/0CX%P?Q1)V)I'MV;Z0>K5CG7!F
M.H;3':K+O4B#B%9JDMN6 ,+SRL$<(V-1T9!)X^_.5#E 2/79--5[=>QT4B]U
MA7HBMI<]#6M9+N$,[0A#6WM76#[;((;X?$1+E7^NU)CD/WG[/#=C8=]+VN9^
MF:_'W&G\;J>:;I;Z3.S^&4]FN[NKG]^+V:KQ@A8<@2FW]6HRE.61*@7'MP@N
MFT20BV,25V,F6&-=L](B.S".DQ44<H7Y.G.;SZJG.Q%3C412:O\K=^/T]V>U
M^(],0/]Q5AM\:WU"EF/^M[/:HE>[(ZGG%_]V5ONN,<?B_5EM]\T5"3KJ*B@;
MU=QU>Y)'#2A9!1RZL97M-2HS\,W,G=0WZBW62O:DIX5,$'R(X;8J*J?[J.+>
MQ7;#WW/+_&-/9PWM!H/+;1S9[?[T3)9,=;["FV/-2ME)J;5!4*8G?&\WDS>\
MX3!H(.9)&9'*0U:EIC0T]#.V-S>6\"4+DL!E.^F[S73#N4Z_^ U9XC79K=HD
MP4XW#A9Q(T_95#@52@K$$[>KC.D#)IF_VE3,S?)1:<*VX6_Q,HV42!N3RL8<
MW9"F,9 _$YI;'UPISREW-[ZP\CML_XY/SJ!B@^-1'D@ =_5KGYDDIN:WX\B'
M,J/#)KO:Z>&"A_?01R_"0KD8B_QU:@"_4S]CNS$G(4>C>#V&>MGIA0!5NZ?T
MXY[2Q2WZ(Z0P$5Q9N  7P(>IOKU-_;/3OG+]2$[7XPI;TUZFK=^KD)2VNWM*
M]6_,IJ:Y+D*R27^PY"0$WR33W8:J;-,LY6>\$95G[W[@=:E YI.8=C'^K]L>
MLS&]H"N<]-O@[JM9;?A#SNLGWW5P?8IC)LZ0VA=M80+LAF=<W>6G[^8H9S"=
M?T3R<B+2<Q+J#)<+%IA3R/@LJ995T/D6;KRZK ]855RQ>(<SA[[632+9_;:8
M-5(Q_H#\,,20J9,RN-Y24,@U=Q[N"^',T^\P8RL;4?6!H6^-@ZM3]+B:C&U<
M=,/C\/]=)/[/+J,Z&]<9O D:)Q?[HG[8*1YF; H\N')"NF!/*2@._]/O/[()
M,YQT5Y7SA-E]<>^?V,#,3FT)A*S-3DTFKP4(D>TI.;9T!A=W=KJ .5;Z#%GP
MN$PGNW^:4Q=0S *B>GL+="M/*H0T$[D)RXGAM%B^6?[L^P^<_./%OT1(9=T]
MM(=,)\+Y5_R=V:L1XKA-IX,GM^&R- ]2]*0%/J1AIK%L]<_MHX+S]QK.567=
MR=_/*B@1U27+P3N_K*,?!#C^=)>8E5H,;U\P9H?K40S)=;V:VBWX]T,FG5J!
MX>$A9< 070,URH+$#,]*G^QS'*, :8LH3?!)_=,(AM.#(E;]V].N".9\0ZS]
MFW]9WW^,;^TD5R%J3"W8)H6S$VDZ 2WHGX:I''6^@%TBG,,PD]Q)NL..\(]O
M) O#G_6MF'<DE-V15EWGUV7P&]GX,D.[G5O1"<8[CF5SJ34<)&G]P:1NP72M
M4?C$2JA&WW#<4F1)"QT*\BE!^^E0=!E7!=08%VG<*F3:N!AP+@G,JH6E'XLJ
M6.-'S-:X.S'#+0>(.%_MKS]0^Z@A_GM9,D=R'Z,595:*MKE_OE*46[7:,@DY
MW21_'M,2PRQ[[6^C2LVNTC_D,@1,TR^),N!6V1K@=?"7[E27653G7J3LS)W_
M-:EGV#S9'$9F"^3H OS%N%7F5[LM5]Z6H/E)7A-U1;6+($J!O\3/ ,LDH*&A
MH8L!^+''92'U.FU93,22.RZ5GNN;B2]0L>2KJ&#YC=#3I=G?_S-%_QN<@4B4
M8N6!35L%4Z?,L90X2)W8K5MX^..@SNO=3^_*#$C5+4$R5O&)4>K:OJDCAH'2
MZK(Z]*C T0$Q"+0>WE-ZYFY(SDH9OBN#S+:$#4/)R:F^V_4^@VDQ;_&%F:7"
M:2AIBU\+(2#J]'V+IC?C]:U!3:8EBTEWA:*%Y[!<R5.SFMA,Z0(UQ^Y+Z7#?
MU0J54>W$#__G#X&V#V3+03_)SK]S G5()XZ^[1K<O#0(>-5)VLZ+"S#R73;M
MR4[ZQ4"(DM3Y?%<CQH>VI1%@&\#C]#YCAR]LI5U'*4@QA^Y5*)Q=VZP_GY8$
MB9J<'.;8=###[7Y;;<]9!D)/;[6.P5PB9J/7\F@[LA3ETSRV?11X3,^]FKG!
M-,E],W*=J:M'H )#$AVMWS;^@VL__R?X%+"ZN\DGG.H(;4KBD:+WE*H0>TH^
M_'A_K=1E6RB2TKGIK8K1_^BG>V+A"Z;L-MLX/FYB*A#GX;"^;G:WMS\@1D^C
M>4_IP!I,6QQ<"I_Y;"XAM<=N4 A)5P5UDCKZV-O10 C$^Z@&@A+)RN(LS5&3
MAET]V6O)E_:47K:G]'S6S^A):1\\CD6,V:G[L>V';Q1F=O.<!+CPV'<+>TJ+
MP44V!8O4/)N?YLU  30MC[N#,4?;L2*4YZ[^7T:;B$ZPI^\23N^:_ BHXT^,
M)-0Y_4(B-YY).=>_N1D3@[!!)"(V9QNL86.4+JXBB6N2R5X1\=%F,*C$'[UD
M(?%-A;BG^F]ET59/-EVS/EY9FY5WPF0NR(@J17UT_X=]]\!<D$L8+F&#-K#\
M:1!N/[#0H2&MF0)<B FB9?+DWR7\ ]>.U,.?6U4!EV[L*;5NR2S/T7P78U'J
M!LU_[;=UYJC?)">X]0O4K_-SW,?VE#PWW?&ANG-MPEHBUX"?F^V/1H+J"<N.
MDH^RXXN/_=SE#T?BU;E3&RI.);6$VFBHJ5=%:$^+GW##VZD6M@,TL(#/X\VK
M)9_P/(<B$NS4\V-K6+K"_9UE;.(9G<=A&'#?JFRV8I;9^E&%UZLF?G_E%UF2
M^UR$EFG*P_@HNU.A1])JIV)\M@_47SWB#<B)[#1-_E$&FSOU5"PX<[_5""G]
M+NUTXSVK.]5S.3I<^4D%0)&7I#7S4A;[UDP=/>+FGYX-]\^LL$L*._Y ,Q17
M%^?-9C-;'>K$K9Q.B>"[H/+US]:/'9B<'P23^& 5TN":].W8>47'VW*/]^_Q
M(EA<(^VBAS__'M4EV"9M?CK50Y$8&\XI?'D5U8D0FO)K9 <Y[>2.MNQ0OF%N
M9G_ ?,0]?13DW+,[,;>:-QP#8KV!OL<V!]WK?/>3IOF=$0I.=I]G7E%G07VQ
M?DI_$&J"9>H=E0049T&,<491U?![+2I&1MFR%APD:(8MFA 1K&8$<"]("_W.
M5,B2D68ID5AEPJJ-3G&VYRMF>]]^492-B_SGOO51B2&;'H\JL7NVJI]TXA"]
M(B.;>)E]E S73&UTVL(\);?R+VIN_60=\RZ+;GCK*2/)70/N;C(>XXD0]14R
M-[GBQK=V(I1X:PYCE1@7Q<NB=M!4 %?"9X'D=@AJ9$* @=.IUVN\]$AG0K5:
MWNXIY27HG7K6&K=008R>L=.2,RQP*C*(V7Y*H)LW=D9KZ>.1[__&Z\#8_R'M
MS:.:/+>V\;0]UM/C="@J(M,1!*H(B,QCVB.*R'2L,A-0$!!"B&$.0])3J\RA
M@C(*6)G*D$2&# P)58:($%*())! $ )A" %"@(0DA!^^;;_?]ZWUOG[KZ]DK
M^2<K6>MZKGWO?5_[>>[L7;2D5E>SA&VJ/"4L8@0I6Y+Y<,S,D N_<V'KKYTN
MH8."CIJUUEB87<*TC+:VOBZ]/?O5W>VT:2?,]>5&:C>'5L0<(O/LRF*_WY49
M/EK0TD(Y!.4G6,'>TT!@)5/%4[<^,@2B,=6QS6@^L;6JZ64-#8ZQ/F<S\RJ?
M:+"^M!GA%VCC");[=&TQ0D#FHV<,?OZ9\?7_0\[Z/^T?*6+U_6ND!_FI.:AL
M5>Y'&!'TZATK_=56,O)GQ4FO/0!B5TVXV,A<05Y6_"21T_< OVI5TM;EL;;
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MKKP1.C@D::J=13:EE,:WN?()?=&5-ZOC!J*;4>:96$GEPQ3L^O/>?WS$H0"
MTA=BT/MY2IG#J:CMTK#/HY@)FTU,^YIW">-\FS537W9.?/F-:)NC-J>^RE_=
M@##]7G1 (-K<4DSLR4)U9+L+MH66%+*);4^8@#\3IK^&_YQ;J&"V>6M^1<*Q
M5[&F-6"U*+IR"KO&8L=4 :E;UKJ$3=^)MHU>.SXC?GPJ=FCX:9/K'N#8!?ZH
M0[G"HO*A8:)E>M63O?\-WU^:D\YLLGE:Y9:G2 5'&MSH4UKPP]XX,?1>R"6K
MKJ/!K_UF9FTZ^($-9?L"((0:>^+;L2-]3Y5FDC"<:YA+%ALBC1-]6LF[W&3D
M"'%#V$F=C-6$.I?N 0PG HL&42/*V.6-K;[6K.''D7=+)I>2V9K3NK9H4 B/
M/"'T.(S&[\3TKY5DTC<E87ICE3N"#N;)<O-L<$&3&XQE7DS< _Q0Z>QP7!(J
MO3JRJ[.[N6J7V!R[.RKH5#O<O>3[%<E<CM:YMNG2&*DYM"D5K-IW#K5I+>YL
MW:]#QN_R9763W?[9NT$;QD<'FA#9=\ A:]5[@,38=H;IJCFJ"$-<]^=NGCEN
MUS.I&31/8D,;I49Z4PZH+TK%3O,%^FO3V_VX_>^7?/%?#5 /4L;CY7H3WPU'
M=AH9T2PQ4>.I%=TO[\1<I,/R!F=,+6YR6XB=_.0]0&&*K>Q0B78A"OGPEC=-
M:Z7]&?(,:391\F&ZQWJ,;=2[#],]7+@#J)$/TSW\"C-PX>O%F6GWPZDXFMLP
MA^[6;]O7>&_)'!?N-^2QH*QT<;YQ@99CB5"'IW$0M@/4.6*N\OU\MTM2Z<_5
M[0-;V]30<-P];]'D-V<98I7\97CC]>B&%]BYSA=^!K697V%LTARE*A/CI+YE
MHV/C\2NYG#U N!(1'9]1NW8$_2#^6F9&<5,X)3]"60-&A2A'#OE%Y;VV0Y%]
M9SN-DLURVH7(+W5F5"-,71\K"3/6T&U[ '!U?[.):9V@Z^UWORV@3QC*?4=>
M3[^4^PD;D6T+NIX8T:_VUD1_SQ(>*O:$_\I4(B;LIP6#H43O9E$^SY9COY]_
MZ3=7I=TGF!11[+P!:]+!0W,[+_^^*J)R;%PD?\29]@BJPVAPHF(GT&#[4N8\
M U<QY> C,= ?V"X<A^N?:29 $S2V4V/9L@ZZ(7]C$U5N$X>J_,%4]$G<[8^%
MXD[[LW[3P)[YV)W&<=AXE*:%S*3P34 LU6+[U%!H$X$@;AWS..'9:X%_Z0T*
M$%+LI!'S Q,K8KM'HI,]H<X#7;1\HG#4P8(D.($.V6;1E;3P0:Y6+>&# :>"
M(87;60P=KJEIM2,RJOWK'?,I5:"V/'UU>'LPUMP2U#S!KA"=:%N'@0-M52N&
M.8$S]S=9=.2369:ZT>EKACIY\Z!8]?MT#U,7FN9\8!,I?*8,"DH6_[ .JJUT
MR>1:R"***Q9)PF!TS-U505W<W,#) =,)MS"Z_=/=\=8@C5F3=?6CM(=]==%,
M2)YFLPW?O.D*&O,8&X]K&W[<1'OM</CTL,:;WUFP<=Y5CW/K=MR-D.S\I?A-
ME(4FNW\^A1U!S.)D)XM4-,K2AIW^-3"9'#'K7%O7*+A_LLL9Y#EV*^&=PGHV
MS^WXSB^R]Z*FBGBQ_IRJ06$,3.Y^'5:L'19FTO^65);E-*,D94=CJQT=W19
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M%1+P[F*;FZ::YR\S6UUN*LJQ,-A5TX-YA'Z?&W9;L+Z;5#<T6MTSR Y&]43
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M)7\%RMRQVP.L7GZPVN2?-Q,FQZ3%,YI;!;MVO1$F6'X,)*2IU]&5I0=1\H<
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M&7:.J6?_&9*_V@/(JFW#<],':!K)@1R%6F<@=ND90Y@(A1I=BC:!K[+8-93
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MWP.P//8 X!H/MN4>H'8/(,W; [0\4?B_O?6;KP&?U1U[IZ7(V0,<!<XB-?8
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M\$BZ+ECSA>*):8ZNQ?#2KO9P\NCF8P1MR7^\FU1HH.!>)Z^9'0PSDB54X<O
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MYPT/6CQ]SH'C10?=NN'^V16J.I/J+='B'*JX$4W@>=/!+M0 \'X0^?NK'X\
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MZ7YSD6W:;D"3%=%!#G4@,/#,_E.VG7?*)-H:VZ@A@=U)C(NW/9<3,!/(!);
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M59G#@<+G(0\&H0=PU7&8IZNCCK &X1/\?$FEPQU7LZ>:2U7SP5^F+F:G5IM
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M%_+\B. P2=BN;BX[N(?K/%Z$S'Y4#@<OT&<>2VZP75]L"?L8BO+G* ^#R/?
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M38Q<?UN6\DB_O+[-LO8**;X$S:,%N[_WVX<G$G<]-'*Q9FZC=WACM^9^O)*
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M;XW__<U -$M^1"?EDU .T 8_@1L+@81PAT*.Z,@_ ?D\8[PW%N!S?V3_ TF
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M.*^R[MY3X[GP\"^]/U4K=B/2ZU;R!A$1]1!D"YW,$U14]?MO=N,<K" 7W>1
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M6 UPQR#"1.6XL%=Y,-QE3LU,V-=ZFM^NMHR/Z>(W!S@U!BTEP4/K>QJ/V%_
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MS/\[Q?.-[HNU8YWG7^>!Q<$@@YH'6GY+&IK5_FD5,5F!$X_Q,[Y!H;@XNRW
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M&2V?5_Z" KD*<UH/U"O6?,-%A+D/[7!=\W-[\V+]J&H))>MC[UMK:AC(B^5
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MB2SG>_HZAA&*!Z'85-Q3(P]8VQ TT=7\_A^\1OPW<(:A_'$[N<"7?KY(6NV
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M7/8BOQJ *PFW!_48AY8][M0[L2HIREV!9!XJ8B4KTZ"S9JHVA%&.@E1?(+&
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MHTXU.LX^F/=\M'L'M-9T(4.4[R+GM8\&/AE#<ML@^2?UA9Y=",V&Q4U:4D1
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M0V<O\K1-WB(=*)*0TY/"-K'VE!=%Y>39['L]N5,)@M322G"1T2+[^BSXR)=
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M:$7%=)@'O#8V2=/X*?!^9%.\HTG\R;A8A+*YK$+G0; +G7?GW2O7W;#X<5&
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MV$[M[J:V$PQ!KC:N4?6%?F'UF/-5V.@&K"4?&P+NYD([I[V Q)IU4<LLL<;
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M=%IZO2?: <#N=2^'#&I_D+0)"!OUZ3]?)ZBWAA@WQG/2S* %0^,[K6WDOKO
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M[9EG,$*Q.U;'PJ'I W;*63_C.%@7;-+RW<]-)OB9Z0$0P&SBR6\,99']XB^
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MZ'%I?K+#<%$A;N\9KKSQ/<,%E6$D5G:C?P+-<&_]H>V>[[:F#/!3DGOT_*6
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M3]:44:CJ9 :QJTK07;53WAO-&YB0-A?'KK':^*-8KWXPHBUEM;/#VY-4UH2
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MAVVU&V1=Z59,05E=]-?+.K$T#K:X='\91GTUB7HH.L)MB 7$MD8\3+,^]F_
MVO1GY::\ROV!WC<!#S<]<BJ\U]YZ^2]7U>R[3VSKZ)"X_D1EV 8KM?4>DA,O
MV(ZRET-"9Q((9[ULN$$,&-A$8V#)_G9?]_/,68S8P*+@REIT8,$N(<EOW<'B
M.B;%2=4'Q,PQ+=7O)*L7[+^.I_D>O3&+B\HDSTQE%BAT5X6F6TW+)04SE?,M
MXZ"R[-[JS,"J&%5Y$@:*>S'L<:YPBOLM90G=]H>JNTR2J DI)@5=3Q^GNOO&
M6<5R<]A!8DB>_]#ICPA36B36RL#>9FX@[ZQ+B;M.X;-J +@3] M6IQ+T)/<B
MK+8[37A8YG9 NG@UC:CJ=<9!=7!Z,S< ^Q&^5F'OAHHU /[O:QO-+HN@O,OR
M]P7.%^+V3)-K0]+V-I2/;M18_''KKN0RELGR#@&-B#!NU=MY<>RMH[*U:T*3
M%9J"(1UB<MC))1V>-A_,?<[:")^8C,2'3E2&7Y&?A9Z=I6^F9U)#OIA\LQC#
MS\5*0 VYJV@^;^X8F9W1GZ[QLGO*Y6YEWUK8)O6CRDX+ _(\WC>1N"!JHD?T
M_-*+ ;530R-*R\K8^IXI!#AL6^T'Z(9&=8]V.TME*HX[G%267R87L<\7//4N
M+&I1M3ZA#L;2%@7?--_X9Y;_/\I9;9[^\(^O71LW2(/ :ZW5_$6 F!MVT>)Q
M12"(NJ@WP'8,"XX]3FHC%N<-(L(R06;OYK#7:_D5)[ YQ_@-)QXB(T/"IDI5
M=5(S]!PT)&ER0=;'BC#I@5 7E/;\Y#SWN"G-""FZ]0+^#"O:3,>.61D;W_60
MPA^PTLPOAS)EU#OF%S<BTKT:U=U:0XU-&BN8(]\^_\OO?IA0,U%Y:Q#PQID_
M88Q?N=IZN$#_ZT/BQ<P)7&$):[ZST:@"O_K:RV_&[3,&N!DW6>0843RUX>[G
M=\GDH"];[CLE.07=,,JKDT]=ZQV,ZDHB><(P5%^]3KRD6GQU\,@9^F,2X,S9
M1JN#F7-6?&*F#D1C(]8W&73?I [JE-8D7A);D\Y7 ;T[P$<X=9>/$?\>-R/E
M4'BK@299C?WGKH7[W7%86<F]"S:HGX:?-@\ISL%S(^8N6D3U>2"!8.S5V$8I
M]9W#!8E9HU#FZ4RWT)]RVE8;WE:#N#*5BT9Q^H?Q^2'ZQ[/I/9/*B'&^^ GK
MU%E(W#A2& @NDHY #S8IK6KVR85%:_U\4%]$[GRCFRNB@JV)C$DIMB.I@L_6
M2ZN,&G)[KO9 JZ^LJ<K(O3&MOLDF9R@VH_;>.;\EVDG?Q)L=[9@+-(<;N'D&
M3F;%Q#PFH0ZM%2WK(*[8]-*(@>(3<S7E4*N=TE:B,5I]9YP):^[5)55Y!KR[
M"6]*?M1R'5NLXQS,JSSI:P5BZN&JA^,G.?FC:-?QJC>\1BEN-^7PC<MV(:_[
M4N-O^CO5)HD/-;*^9H?&7*3QDD?6+-1##>M.Z)S\>_@R60JE=NGGP<'?V(R.
MOAX&<   2HA26UN#[?G=\P\M?:\4>UD_3/"R9E)M_-[O]C H%1A[IB5PS %G
M$_R-(3O!XWU5$9W^OJJH+CPPBPGVAX"RF\ZU6BUE;\Q&'L#Z<.C<L&_9WTO"
M+=XQDG9?##VM[WNX]ANO)WK<,=M$ (<.] L4CT$AZ:1="7Z4D '78%X('7GD
MEU_Z*7I]#I^(BQ<LUG]("\<UUE R3A]RV%:S;J);=%2+!"DE.64D1A"&U X\
M/])F%DI.I=0G@H'=O(E=C"Y)WXU+F584N-UDGW=Q4?*FZW%6LOB(-_A<E6'Q
MH76Q@S'8NA*;%/Z7)&H^-SG[7?P],0;:M)-I/UTM8G^ #6:[#W;/L49>(5AP
M4Y@9#WI]W (3]R5:?+RHO?,E5W5%9CV22-5]&C.$4-&Z2F>"R*U#:WH,$X90
M%->.T>"$B8,M^741;4O3& P(K6M-S3-(HAP/?/#M7/M0^$N2<M:AJ]]K:(=U
MZ(1EJC<Q(. C_@]RRD<>Y+(ZA@KW_MJG]YW:/Y9/?E5=4>DS,SL1B*X)H%"G
M.;7F:N]#5H?;M]7OAKKC;=V8V!,XQ'@+@@>(G!-S#=-_+OV2WJ/?V5F.:0(5
M?8;=\OPB40*4,,I5]Q0?V7=F>/7<25"@XSV2-?&@K&ZWX1M31)!.%RTU0!OI
MF80-D844YHFF@.G,7^TR84/]$_"6I3%CTF3D2+IOX):>R86"QB*;7+&J1:N[
M1"*IAE3=Z5EP:>R*URL?"Q+3Z].GB)Y#7%)<P,8W9WDQUQA3C.)7,T=S1W3
M3LA"6$+H%<J'"=_L<\LUJLT]CJYV^7/:MMH'O:NXCUJE./WG7KC=S1P@1[+$
M#)M,:_$_?O',1#2S+L(0 B)@'"=8E9ZT,2TJ$"^P#6R3W#72'_S8<>3!_23,
M#IJ.8JLG[OW1[W_WM-"73/[T!W:[OS6H#<=,+4<)E,KBUB7D@9>,/]]8G42G
M\^9\4H3?B!U.Y)D]O9Y$H25MZ%*VU;#.)?$%#%Q>QT^$XM4Q*<,UTW4]4] C
M*!XS>)>:'[,H9Q?,=5EZGBOLX)UKDRT0V'/4L+84YM)Z H(@JH[X<T^'R_=;
M1%G-JS2Q^-<XJ&50P;V0J4Y$#;&%5;:M-B&^OKFR]%/EQ5O_XV3Q7^2S3[=F
M%K;5'N.=ERARK5/+AY>J'>2HGJ:PTQ\JM0]>(B\^8/;,%X]>*2EA#7MMNCQX
M/C&@JSG)/%.2G!!"]E@ /,_H8:;^"A'HYPS.<AJ".Z<,9Y;GFFAG/"7$GK=M
MP#HTT\"_LK)OXKC582-B<=ADN?$B9W&W,_0NX,& QF&2JC+,)KM@6K"EZ7:X
MAI=?K.$(UA(= 8$#ZJ[2W_VNXI[*+5;8_;;^Y,4'KNZ13=%\E\Y89@?\$KF4
M_=%!CBB0P^U,G>/EGD(PD?N_%=]\,4Q[-N[K^46@WQEM35GHZTN^X7)W63Z\
MYL_2@A )3H_CA17\..EO7<Y.3)<H)C9J3HYT9M!$(<6V^2UVU,!\?_Q%5=$<
MN!C9OW1HSH:29PRG2@8L/=-71$^  R-F+#.-V/Z'Y<3@7]3_=PN5_V_D@^]\
MN$Z_C8Y"^5/%8YQ/,MK0$^LZ20.C9[OL=-D)9S/NL&S5 [3L\IY.HRM#.R[8
M5R__PF^L<,D&S7GDOB,A15!A<G[U);'>T(6%LN>O("*VER'R0A>^;XIH,C=V
M)D60@P?++2Q#DG,N*<;IU-2C@G(S1YIO(LI1Q%P-JA?4"VX;712[P.OKKOG<
M[3[Z1T@Y>4EU7:4((\D> T4>\_=G BV,.G!NN2U]O<OO\%WS^MA<0;-\XZ[D
M<^91C$'=6R+@2L* W<'TV,Z581/- ,E F,'KQ[\VSF3>Y\"P>Y.JE*B;;;BX
M8@XW%*T @DH>LCT0JLJXZ(@.\2%Y!2V@HT-G0?L.ZG2OI>Q@DW>\6V)091++
M,IJI6>NFWVZRE^:^UD%+8EG@?\8;_SL@UUW=4F02XIUM%I_">QH) Q@$:+%)
MSN7I-_J$C"UT2CS>XEH!!F%>=$M??3N=4M2$\/BMW(8>S:!+R1!M768!%IOQ
MIXR\S0&!TN![Z@]KY^8LYK&[/P(7=Y[O7@0&89V=VL28151TF9U_MJ@H(9(4
MVO=MXGKXF-_RD,::V]$BDY<I5[*)/;IMP(M,"TF%^." FS!E IGY^:DJ">MO
M2O)\< 6.G59BU4L(O!T?NWAJG<YN_5X2WX%>-]6%1EY/#'5W47P!6XA[]K6@
M5<O*W8ME]>499WI,LH$NTOJ+R=/F!:KO5V+NPU7LSH)]0L,RF*.X%-@IJ0R/
MZ<BE!7QU)K@8D9)3$4VQE0Q<V#@5H">ZM\:^E\!+^'6&G]KAFVA@J]L!MG\&
M>A)L:&S3M&$1FH3W61L.0I5R=T_IA<\P+HE<N,Q*E^IQMFI!?R_1P CRE?/D
MA$> ?OZ]/0Z@@ZU^V>-?:Z\,@'Y\5EJ3/K)PA(\KH%O89,+?[)Q5'S/>JD^9
M!(<7*@[7ZU\,-B$.2]$A*64%3[/,D@;ROD*T6TX0444X;^C=&7+J WKO\IA0
M2_71'#%GU6<VEJ%\>GUD%)]$B#8^_'VVXT__4^M_;KE3BZ?;^&"<MSYN(H]-
M=%JU=SP^CWIU+/[HXZO8%TJSL0V^N>D]WG7)]#W7GH9MM=S9AF-K1?T5]KB*
M=[6Y0N3*W+39J\T!B7+XWBGWP[U0DA6H+(>BA76I>9U=GE->SCUG9JI5=<I3
MQ-'"Q_?\95Z8.'\B.O=LCP^>7AQ68]X2$CK,QJUV==E4F5FA"ZUTU_2_U_AC
M"KWVW4U,</>W3(J;46J0<6NC9C/L4VCC.&?XJXT9PY>@S82GL\\20RA^7;:O
M@Q@0<K#O1U<\0I,#="<#SNKZNI^Z;"$_,VN[EM$H>&06L:W6P%G=$.)I[I',
M!#(#51C$#L)[<[Z:,&Y1U_ R9EII9KG==*H #!!U['/6\6-><\A]%B7R^X[B
M)F\G,%-ZWSA=%#,*-"K[S^@=*&B.L]_G\^F#\92F.8,@]M<EB9&)@(^?%S_K
MO69Y2)6>D:H][HD]!P?OV6-_?,MF\.2#2SX&(F&658% N4%4:NM0KM+;9Q)Y
MQPNT3@",/4MK[H)V$K:BY@4AIWSC2_GS.ZYBFQ15;+@Q7U8'#JP,9KI]DMO?
M:J4RU+16'=WL7Z7YZ>SV3OM@?NY4<N^/O4+GPB$!3'@XIZ.6WP@R?1<:<_RC
M2T)CON.).>>ARP995&>I7U<=Q9F:2,%MDK;5O*N&WG&0ELJ%MI3AV$A*+[^'
M4=21ZBZ674ZF'*&!2<^A3U<C!U'P%EJU?%OMIV=1CQ"D1V#/=$HCODF.!^&D
MBP:=JH01>,\0(7WT.XP -MEI%3]FM_!B(I&#E1!FZFEQE?Z,!V1Z3"O,J3I-
MB;L9Y+06T]%160'B5SLT8-/0N6GHFO>7G[1$+VX@[.XG.&7NIA+;;$/,F;K
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MSQD\U!4] _AVV_*0PJ&N5MYW\(<!\R>%6)"!\N#<5%2SXT08/+MXAWB@;I,
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M<(DN=A^VICIV:6<]5;LDE\M;(WO-VAN5C?2..H-]AXAT#94H644L\\DRX8J
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MM0YPH=L'4,K0D;MVO-S3[ZN4/2E&&\:3KS=ON9\X--7G[2=Y$(6HAAWMXW
MRVM PE^'M$Z.Y.%3E MU.9-J$I $\+<.S^$VA-%/RF];L*'-]'D,YUI<KR')
M1F7/O19J>8."\=@J**]SCOW@8&:\<.3-PX2$Y.XA;T^?D([.2M/R6NZ*H[4>
MYC-'*T_HV8#8MTVO(%A+:NQR\+W8]/@NQM+Z#)(7*P-@&34&$ B6L!Z&*"^)
MW\ZU6*WWTNB=[3%^.A_0ZP9'<F)]XU?8T3$G <A5G5Z.CJ/'B5J>9M'CLG:H
M0U5E%HW_8T7_8SK5N1L_[D/52KNWFO[]*[^!>/<'\04,%+<#&72WEA1>J6@\
M5E[1&'2Y("?LER@"W7M\OVI#X9H_;?#)I,-S9(+V,TM!K- ];"TH&8^C)_6Z
MGP(O7J*\L.-VY:6$6UU[0W#Q:*(T" @A3)=$CAXE5#RK,1V;Q =NLBJ"9@D5
MBT5]ZZ\KO>*$]9M+"]J%I%" XIEE-[_A#84G0YP 7IO/3#Z.[GLVX>M7$2+,
M50AJY4$.=V)]@GNEKD1'I[%=V%3Q.Z9?YO/J7AZDBT5+Q/5<$\5,O.MFQALX
MV[[K9B:_:V=&UX9I:6EIVY4#1UQP+0%>N2$XV\%!H:PL74O+W,4E/AN1NS,+
M^L_> 16'='Q:9NDKR(<'X)6\#/<M6*4%?:?[U!9<<X$M8L_>?1LS\Z!K:.N@
M=)M.?!UT/R$P@;_^/+2Q;Z&]J4*K'5&AK[F^*]$4,O>(G"#'N<JT8(?\_I%@
M?6:A'QW/C*XUM8B8T#'!1'W%;[0* :*U]%P2<H%HR/Z9;Q&7-JQO9#6DFFS.
MN+8.%\I<; LO5K8O!C2$/\"X6JN$8-' 9#^KC&_^'9HW-J#TG>_L&\.H)DJK
M[;NIY8/*MS?\$MB0^^>V3[SJ:86HU//X[C<_5?A#8C84-@2/^.>U'@N T2TH
M85'6BFYS/G;1YN&N0YW5]]B-8REYY/)4/*F]WZ2"QQ891(Q%$7RSJG73F<P2
M$7&"XN);BXV$GJT;., 4K8TE*I@-CQ&;1HN*S;WU=<I621"$XXD/<!1U>XEE
MC3.OV5SNCA.YR^XWI[RU%OQZX_'LIO(3+]_KRRV++^?62TSI);N6JD/?C-RR
M#0C]RN+\I?4SH[Y7:G7:<X*^1'X)JO5YL#DDA(<D$?'=!D!!KQ(R=DWI(#;"
MM7FZJ 3=6/YPH2F(W-[F-;4J8X*)CV_ .*)%(=8V5&BO^^ ]_DXN9=M,B )?
M\M/2"IG$I<NC:\$/A)>&6PU]LZLNC:G\[:K__8EP5@&#T174U?V6)0^\/8._
M.I31CXK<.SP<-C!]1.&N:'21%@#)9QS5VW'=N/:<BK<G]9F@("E^AB0]E'Q:
MKOW-+J5795:Z:R#2]\4"*E@U(/%=<>:GI7=BLRXNU_=[&EEPPD@;A]<8V.CG
M"GEGS2<5NI9V_>! +>(UE64:#,O<DEQJ9(RIV:]7V@\,V-S=VI2-A>2S6@D'
M V#MT/CN1 _GV$0T>V;406%;F:%'_VS)+Z3DV>=%]"4!]30[DPG_ =:3?'HC
M2%<(Z0GLI0!P;#(8UB/PMZ<F&V?E\%&VAU<[O2HKO" W6YP6A@I.I=K0E58_
MF$UO!L]6#F\$[_BF&SHB^YSUJ]7%:EW1A44:/A/C$73@7\3/_R5+_-1S/ZMK
M11^YQV=N5EI@0,!UI;2)O4HENY[)!L4S:9KH^9Y,XGSO908@T#VS]$Q];%9G
MR9>-W"L;G]*\+Z3B&"[\(V3Z:<A7^SG,6-]G&!4>Z]SPT1Z=YC@2,4R#N+U%
MT:_9NU(9#5$1$GO.QJ5M"BAV3^T[I#>U%6)P2;1]\1JH.B2NT@5VQ;XSG,TN
M[FTUO'1HANQ\(*C?O%1]]P\FD536MY,QJ[.A9:XTUH%_'-Q]._/>I%4,>T!!
M(?D@OO0O+":)+%_,"N"X0Z:Q([:RC \M!SYHHWD;#[C$_S*[9+Q@_"9]QG#M
MI!:4K>2;^+NJZQJR<K9G*4W^MO16BRN#S-;P%;PN0"89%VX#CX&V;AUNUW X
MT6M<6M.O6#-^"MG%UNUB?H@V:C"\7JCR(1+^0^A_"C#=5$%^.V&#S::>0Z-1
MUV8"9F:<;>6WM]=NW<&Z6TY,NCP<.!NWX>EYDN_33L(CU29S5=6RO,U;_@JE
MC?E7^,P_&ITWLPJP!B(PF*GK4XX;*Y01EQ_\= N"5YO1 X(AN)W=-Z<BE)].
MDDWW5A;G-V]Q["#YW,[+N!&?S3OQ&R#-82<SJ[_0\!2[A-<>KC%<8&6%Z%JK
M?R*3L;E++=5B3*D>#D0F-4?P60^QQN6]Q?(-'6:[M3J AB:@;RZ9 N["&XWB
M<?5;F%H(&"A(XQ;[#0ZU+N^!;?+<!+SZ=!M[\P.-J\,E0T9'9'ZLDBI0]\6R
M64!)HDWU2'!8;#F9LD7W )23[^LW](XLQ'18+()Z7LZWF6(91AN4P!B*7KQW
M8, DU1(M &&GQ2S+ +A:KNJYC+/QI%QY<WJ9F-<0@FO0\7FW1=4.[#?HA<\Z
M(:<JG]8HL?>I3^AE[_IO?++08)EZK]9+MK:VX2>YK/D-?H?!C_^[+4LW9 R$
MF5@.ZP8Q6GVOKL M3E*5NVM)8"54(]"P[%6@'3!O**2U!.">6C@2"@'57OP\
M(V>APF^Q-B>Y&7G]7=)2HX(=?1FC"'TS=9<461XSCP]'J)J_ SS=+D/K. V>
M)(-#8)_R\JQ,JGZ ?YH7%3G9^(E7%-@O1-=O$&SR3FDRE\C4FP5M;<=2#(%H
M>$5_[M"B]8#11XXS"!A]VTZ*#_HL]9-]S'T$(M?X,U!R!_;5W<Y9Z?@+DQYO
M.[BKIBMVEV.F?<5D#X9?[['44>V1VMRQE ?)2A<A;35_:V)_N1"RT [B9^<%
M$AH#^4YD6Z%[$V%B$A_+WWTF(QR#[0^* V?@65Z5[(.X*CIC<W/G:*58?O3!
M877[9EE9SQY=WX:WFJ]RAMOR?10]R"H^NGFR(E06F@@M8.AI\O>-"[D?H>$^
MS(2K3R3[^K-(_L1'<_QC*=WDY-0[  >U:QMV%SR&+/;?GPY*%EFG<%R753WB
M7VV8%$SU@AVBS<$F>TE?3>AF0G([PV:=3UDF<>GXVDYF6 C<8MYRMF@55"A(
M-$NTZ,A7AUCI7A*RG.R?-)PDU,QWO>)Q]/O_C63K@\]@)%A?A/69Q0[KXB6E
MY6C&0HGHVY9<YR\%7('B1)+R9(VE/T0)+C_AX6WA.8DZ</UV,-;3F$$U"@X4
MNS9]:@<W3Z=:_[8+3XZ]WLT8?58<O@0K2:KT SJO^T)9+2P("OZMOT.T$%H_
M&-^?&T!+?<-6_7DK2$B6Q//-_%@*>??Z?&F.,WY8AHKQT;R[2^F!^42?:1RM
MQ@MD6#:UH1B8>>_5/+;C8,5IW[!J+ S2TE:>-P;4B=?;=M=].C+K;+7BH%G8
M@^QH0D8(2\+!SSN7^"W)"V]/_PN'PBWR7S@4[X=:NHA!^+31U2CM'U/@"NO;
ML,Z-27AY%^'E*";<C]( 3>_H%#&26!:+K16<\XKADOM\Z^229'5B;HX ^:60
M83VU79JS!^E/[(4M[*9>IS18N\17V >.@<&;!%8*9S*7/PJPPC-.0J@FKL'@
MP5O+FI$DZF=SL;%5:!R+6_ TNV"YM(9-NEF>#X'\:KPH8U*M*PN@Y0Y2Y5.:
M!]RR)U).-XGALCZO(P^]=RN[(N/\SPNQ@>,*PLH6=F(^MC53NPVDE5.3$ 3D
M9?U8H)O47ON1>@'"\!U73U.+QXB_<[5KQ3YRB:\<TR-<$O[.%;WBWI#L"5=\
MW*PFOF<UO(6JO1[D/IJ,FA'H1B4J@AI"0$05#0ET0@ODY+V6GT(^"0,NY.7'
M 8"U?V)[_TV2,SJ<4+4/"#$R4$GS' BDR/DC4XW9_I/R$CPKUDOCUJ- 9SM2
MD-^0NT C?S0LMB/U^<\EST-R!-*0X N.P1<FSV&.I9QG X'L#8Z=R&I!%X#M
M1Q2P7.C:.Y79>?O-=-I^*0DA_XDM78OF.NPD]",/S:^RX.\%=+&/I8H6LFKJ
MG$1BX:4#!O*@6';'%>SGX(95P(%E4*[7%+XL^4_#*%FMPZ@EKY]9KOP1W2)J
MK E:)#^=_<%?^0>/XJUI\:2GWT(<JZ*!9$=^>,/[0>#=D.+*9W<)1681!<_K
M6]I%_&QX*N<71/ A<6,7X*?[,O:B<.A>]O+$;,M*(]>H6VBX=V4%K?(4SP7+
MGUAGY)/)HWD!O#!E'Q9!MH>Q@6#7..$6ON6F\%C*+*_XTDG"!9Y0CU+15'TH
MM_<_E_\_(7ZEQ)DGV(W;5UW7?1^DUA2P7%V$W)ALYK+FAL9L"#O%$10FRQ]Z
MN=4.]#U[Y=K46YA<RI6<L8KV1ALJWJ%^%2M]%SZLS:HI6-UPZT8H$8Y\:S!Q
MDF6C_@):E'K8M,GX8SU\?FJ;BPO+3>CC\'/'K.#HO1=4^([]K-KB*B.HW=J)
M3!5$0IW=^O)[#<5E&">O5W]P]B$9#D84U3P/#[J1]+1R)&75V'+8L'OOZ)5
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M.8/FY++*RP_4592.?DS'OE +JO[8I<L5C_0?49W&#@BZ$/<W?=V#L#NM1.3
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M% %10 BQ+Y'2HJ>E6W^;(+-DHWHLY6TI?9\X$L3F<&M^'J$14K'A$4-U/'9
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M-7AE801)&[P@])'3S[5\IDW#[ MTYM-U=Z_H]6.IT];* 4AF,=C63NR:P.I
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M4(W1-MRR6.# 6O'3H)^#^0WT:<!EH_71(D98B#LJV?^ZYUFRWV#8'?<P_\#
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M%*3?( E-9+O>&&?41.C,;V9>>$?*\!1,+G2^VU#$HO)[8J#<XN, ZD)*K@O
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MI=<O@\'*:IX.K51O?PE:[OMX<^;[V_;5!JO32T<>_HI @\[1*Z:).*BJG=L
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MX.#^;EP:>S2U*CG<=; []K96*O!OLZ+^$,E8@KNB9;VBR2YL,@H[B)\+JO
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M9$_)ZANO,^<XP+6@0V,7A*^C)C>FQPT7PQHJO-3&"H#^%3GA5U:K!!KH5ZP
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M?L*5;EG%UZSM%)LS 2&Q^VD'KINT_[\.J+&?:V+[,^?(VHY&Y'E2 4X QY;
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M%W(O+!2Q$>3I2*D:"VZ4W%E/QANY^!QL&E()8#2K'C29?,"S>/AP0D;-W4:
M_>HLAZ'[3O<#\)I3;$G)HHJ>IOF>$K'Q0J/=^OJ>4O+R\F7?,]%O3G9-O$_1
MR>K"[8S/,G_?-WKCVO(-KNGS>\F1KLE#(LL@?N;3W"6;R!!2T9[2T^?<"M?>
M.ST_];]'_W'9+AR5K9/<&ZM7.R<,8KN3_2'^E$WC^B!,0-S*HD7K>%CA4+ (
M +RY2UACQ?MFO>6U,)I?S:%?M+5"@=9PQ>S[K<$+XWE5(QX%MQ6+EU]=L?QO
M*?6B5UAK!?+.^#S3G]A8?:ZDZ$E%-3Q.ST39??50M=F-Z3TE>,0I*;1@<I>P
MS01IY[.'!E!M\G3SDMM<D(>CVBG%Q92I/:7CJ2QTT-I4ISR8DK0&(J6"NY[(
MTOP3Z.YIGFSW,A]1@UT;&7AU993QE6QAQ+$BP>FNK:M@4%3^IMRPFJQ!7Z+M
M*6F-FSFYP4"^!@75#!5?]J4?LQN)P2V!AH+&IR; #61XDY0*\5\X9W^B<G@D
M^GO+U%DJW6&3R$8B$4C%H6KP+&@XP<G;R^$/7+^SE0UZJ9UU4$=)HX0SFM*_
M/1^G(61O&>HD^R?8OX&I'L?-6$X:7D5/1(:0&ZQ;W9'7R:.W>T.1MR9W6S=W
MQ;2$MCX;WKLX,2C2/(U8LI\M%%11WPRIF 4F^IQ&F-DW@Z)35X[]MJR[N*Q#
M(";Y1HP@[#.Z^"9 ML\$MHW+.U,X!$9>TJWM5KN$@(9#$6IQ$A))1(&%P]3N
M?J]]EZH=LV,E0A\7[2D=%BEJLK8:Z,>H5-(%B,:1X\]<(%6Q\EA, !T(FZ7#
MYKKQ!6?P20%TQ[956\A !!)9%O;=S<F;53Z/ZZ'J#_>4"H# ^I&1$588'%I2
M4G0?U?#WZX(OCNW,[<RM.C9[\+(OOZ[$^ G<0V"'5V=7!((O3.[:Z'[&=]G.
M'1]W@)'1MIWA$'+A(Y_O,F\W)+YO@-:ECVME/WS&G Z>#LY(Z=R*$9?-#0J&
M4-?N+%NJM_J:"  0/-X^7(.M-AKND%!/"0EYG#W?8Q?79R>CM57\CAN>T%4\
M]'(N\]'QTS$D5V>>H^YT+,-66..1IV)9RD@TCR=PPYVVH!-^/17O=0QHUQ@
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M7N@Y42^8&1I?(FX^OP6Q."IGXR++#QE'_;^7=O^-Z"M'3:W:N.-P8H3W51T
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M,CZ>2MU7ZL?1DGNJ77D&:Q6<"CEFN2M/GH7:Z3!1',-3_4.H&A2TKG%(KXG
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M)@(#I#+"H@-\WN&EM'*Q= LC,U2\)$W92N?)"HT:XZ,^>J<3LFI/W\BJM?D
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MF)1)KAL#MX&!!]J%(]#:F9H(^Z>@ON62E[#JA9-(\^],=60: YY] 0]\<+M
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M7"P0.T65FH;P@.E=,%0;.C8=NRHB#Q_9ODB=J%E=S'7UGS*_3K[*+J;;?R?
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M93ORM->4%8<^1;\IU$J74Y>:<>_TB!0%;FK,2=/:[:H>KU P 3G@25-]AVR
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ME;1,0(8,27:MO?%1R+JI>K67122;B!2$T<3:S53,-&"FV""I='*C\HG9_4F
MW5[HGG]=[ZL%60HDMQOC8Y!BG\8Z+1L^T>I#MYOPL6ORS.5OCJJB^OI7NZ*U
M'8R@J/;5-WVH]W4UU7<<3T7K>#^L":N!^%-";2Z>&.1 B5.B)?R4H-:DV88"
MONIM?)5I<PGB/W IU/'SK*Q[?7#LS7_UHN;U[<+MKSEV12W^4NV1TX:(?TK>
M/:UZ%;7K@]2#^? 4;?JT[B3-(\9/9UNT2L=3J<8C:\X:.^9.#T?\&5[>CD>Y
MD+1\+Y(\0LX:V&9V88.V[SJH["L]BR\#\;QC%]D2$C/T=:-KL-XBPLW0)&?L
M?**\)&]?R=/ '%KE@+@P8QNLEU>AE1-4NC5SKC=2U&O2+:P><*(%E#Z9M7S?
MI&!Y8CSPJ*0LL;(^0?RT^2T;T'7O-7[&136D17ATD!P"RWUQ\UE)5[+(;+,[
MR&'\?)/HM,B$7YOS;=6'3QZ'?AZ!Z[3<C^M"P2NF03,R[6[F<#D Z":]-93R
M.]@?B(D?&1EYI1,C1U3N+1K*$05;22DPP._SO[4)I1^^QYM>$0;\=0-O2I]^
ME1&'+MY7FJ%_NP[32DBKK.06"X+T%Z :OD,KC!0.8C[3T:"8T-%1Z_!U^;;'
MC3I="$6-%0Q@D:Q^&Z9_Q;@1RRU>FUY7W:YYM\O"6[OZU%G.E7;=3KI<V:72
MM.*:F,7RW=[:(ZR7H';B^U*%SKG^D;N]FRU2LO;07'G92,S6ETMNJ>"[.B/>
MH0Z.]HJFQ@&(;S75.;MLJO'GK__C#QT_>H</- U;SN>Y"WL<=0'!4%YB$\)E
M @>0#)L,>H:QXS:2[0QM/O\%!9XODQLA#]U@7-)@>7G%4C\0@R:DK5A2DWE?
M=$O/A)T(X2=J!W15;!F&'BNY'48,*/[P6+G)&/S^9]QFY#QG9H&'GIKGB46'
MV&\HT<7XG6,?@"EMUI;4S-_U\>47( ZFFS)&KV.47>JS'L_';PCNIM;-'08C
MMYJ@R=CPR>:HYJSVK7( -3;I?GG.\9Q3MSH:L@0HU,DJK'$Z73;J,;7W8L%N
M7^F]O3.E73L=BOAQ,P$!WY]I0Q^^=R",$@ABBJJ3_)E,AK^>$TULA\;,R,I;
M)"1K$=*1UD@?\MU]6.V-8T9<$5K8^\W>L?G^KXN#?R.?F8F;:UXC%G_M,JZ1
M#Q^.L\F(7++50V-)96<,%VQU<[7@J/IMUA:_X$#1&>>E#CS&1E#&?7=X/J?S
M1%79YE"WZ; U[!.IV&ID\W0ANI@O;T\Z7VOD!LV4I'/B2\J"CH%31]Q@+O[$
MI@8+]4F)3JWPIWG 3N\K1B"38VGNG0$%&3GO\./'/U"16*BKJS]Y2$]( ,S\
MMMLU%6C:ZTM#3=MT)4ZNI>UVCR$"?)#-\V=B"<'^>\9%UI*.\V]J%\:3A07:
MN>"PHE-"5"=D<<+QYZT(]<7TXX-;V$\+S&-U:H</+AX:$-; KYMR8AZ8I;K2
M3/VR"*9 [XFFJM#3_5GS@&Z>%FE^PSL7FG0>7-"F,%&S\9@W:R[*SBIY+]GY
MARF%MG\^9W/7^LVQ1*YGNC7<O+[77W9/^S7W^PL1$]H/D^26?2C<S+?-&RN_
M F"7#DDNEAHCB=)N70U:H.:J7W12'&OG]37Z/W)7>(SV7>S;7>K]V,T(HZ+D
M 0Z25#;@)B)BV-+#&;>,/@V#F_F6 PT9&L>K1SOA,WM&P<=7I\N7#Y7'542/
M1J=>;CN_?3DU(WS<H<Z]+=HK:W.XZF/ZU;^0[N:#.&KGON\94D1GWF2^8[X[
M A5#FX]5(1"Y*6_K3_Z".0*NMWY<9M-16Q\E*(NJPR0OHOOE:$-7:^-BC=H.
MB)DEWG5@8$"HKJX;&IHZ0/4MWB 23#0;1_R-?$LV!_9NURMSM$2[5+%4%.24
M_,V=MA<BZ5X-#H8YS_;Z%*,>W=/>=6=!9LS8<?/J0;65K TGQ (^ZSA)G8EU
M,Q.T$PO*3&*@$2*G%5GL"Q^($)NZV!MSS/:L* 4!B2XQUBAC5F26<0 .#YN2
MKJD7E=%(Z@5MUK%#9%_%H.(\Y7E*S8+"=[Q$[LE\G96=U9R1QR5_GE>6Y$0U
MBH=$,3PM,D<@I7G-/<_XK;ZG][XT0&:.WI0!K'R[![7-<CN+J$8YKP2F57?D
MN@74H+X BS[+0RX'\%Z7XB4^.JOM(HPLXN6R)$XG/2!EXXB$97BZ7004#*'6
M<Z^O]8 @J4%MFN_W - [-!1D<!IWB])."=@T ;[I"9T@@ R)C8.XJ!'(^PW0
MZ!I?(E0MF^O]X5]=8J7=OZ]DOU.]&A93'"D1MIG[;S@:6'XETD66R"UF;G5(
M/  [J<3 4](8L\*YIW>8):%#G+2 GD8-']V>Z1O.1AK@%5BJ]@17P@_+W5 ]
M@HYMIQZ].2-@:,IADGTE9;CO2@X$3'C&(W\JTB"Z^I0QPPY)6[Z0D"W8@YQ*
M#LOP*G6HB'PF.D-_>D@WU$9XKA)L4<UN,SL:('\.FU;C\QX"-BNU7AXQZS5-
M"KPM:!0N1HXX^;C'=%A'+GPAMK3?D L8];38!%5S6=[D>2*?6YYUD_0R?([O
MOU2+1B)_0#@QCYC+,!\=L7OR@@^#O0G#+FA'712J82&!Z=V7(DA"*$*Q4#Q4
M"",V,MN^LN.-]3H+BHCRN^*Y]GQ0^M5])7V=M%!3E.7*N$T2GQ5HR*P]/ZZ^
M]T.^WG\5WM8/=OL" @*1I2GY)B.R &</Z R0<4+*LHSG3+UY5E1TWS/@T1^,
M'!>O,?:866__N$>?74*+E/7L@J$.N@%>.<SDLM$':FI-K7.$NCH!Q)4=(7A?
M\S*]#=[5,WN[^:$X-?V:[*4M6I.%XSRF37&MM4#E3X=^X;T-7XT3C#I:K"%A
M8<]IA4MGZLL8^*[>!83-P@LNQ%?[Y?SSMU8RGTN  MH4XO3ML' \/[)9V+_W
M)$&Y879H*6=?*3EHE?IV7\D-UG'&UBY4%N-MTBJ :&8-!4Q!S(H3?+/%65.S
MY:#<#8Y.C*-'KB'6OU/H =EZE&8UT!8#D.?(M$LJ;).SMZHVT.6GTQW[:DFY
M8,N5[0322G^-94]/3V7W^_+YP@=:S]\IXZ[]3NOI^3ME'.-W6L\/E'$?:#UU
M8JFS"SQ#U])6X!F@6^L?@ REI4P0*'5D9/U]17-JB]"$<&NR +Q?2[=PK'C"
M6Z8N*U_>7I%03=BE968=>\-3M1T3-A[-XL5"5ON*N9]S+$7LSAY--E=;LGE$
MKI59)%RZS7!-ZP=?')OALF,#[BC :ZK6\B^7HX-,VBK*,XYRO"VDP,X!,(ES
MJ<H6#,BN%L-'VS?62O C\ODRH.8!1H"0A5'IEHVF=X/.O(O=Y)NV#ZOMZ=G'
MCQLFH)^F;,52@SK9H1 7,$VYU58_1;0KCQ$=')Z* Z)V>R-:M0%3;;<:4%W+
M@Y"3]CY:2>;7/KGMS^ZG>*5^0[ISOJGI<6W68U36KU4YR%/)/-3M]&^>B^S"
M!HF3&VF?]7]Z]DT_RHBD9W/Y42/$ N(A@+"A"#9(_N&U5TA%AGX;G^C;SK75
MC8V^??WD59]9_P&PVA9=].$%V(>[L2"#&>N;?T:MRJ^KPOYFH2RW<U7W^/AY
MU=<61U3=+X"F6@]-7WBZOE&G,G!VWDJ7>O* 13KV'E7QFG'I$".0)J+%<H!.
M)@,XJG>37+4]S7A<3P-+Z^8X,J8$6V=G:PNQ29A04#FRQS",;+#V_H]SPJJ!
MABZ>NB:1@]TMKS8S5&971N!:(DK0PVHPKV@[GHIRU/90:.1#P3D#PS7%]X)T
MX^ON]IS\84GOP?,/?[P=IPV@W:_E0MN>)0XUS=X[V2ZVOA)R;_W X(6IVK)O
M:\M,&IM^1;'9YYOX*)NT2<6]:0>(>%_)DK[ A6+?P<S32FXS?/OP?>H6;KW<
M0HLI5-G[DIDF#8(6&K04;.!9Y$=;P68+ 90M5.CN%'3\83["S#.H1$*=]=U7
M C&:FBS I= +WF:__#='7+J5EN9&HFQFAJ[2U-1H/ATP/>UR47-C8_7:C38/
MN_$)U]O]!^)E7EY>]$,,#QT9W?'>BIY=::N/YBE:*_L/')S2\=\)>M>R4&VF
M(@B$;>Q;BG^?$B2E.X^#3!TR;B_F[P&F;W6N#"+L8(7(CA" DU;A\%2X*6[&
MNF8^6LA7==N;^+3NJT2=U\[TAJGG+EYY#QE>&N&/BS!AOAZ/,^I(N-T':*W[
MBE-;=A$#K9=,71-K8"]CP)&L^3X  WPT7CSC;3XPX@IM<<ZU(O^4>OREW1T"
M;^L !\47J9GY955L&3L^,LSX>;<CK$NR#=>]\4**'5DQL*-S0;RT+-'I#1GR
MXL3$759'09Y[?AU;IOL/IY"Z)=].:,+R)^<X3I>^HAW2-]^H1W(ZFHV:G2$=
M:.]M")-;^D;X?%N6VX?K,]L)Z$2ZC?+90L!T#&RF^+3<E0:!(.UB[4N>OF\2
M'YCL0 :Z$0.)L:UO$E_WNSE TC=<"]^?BLY,IG U&\/>,=9HO'BYF8@X_J]^
M^4A.0/I$< %VAM@:2*FH'SH5YUT"A7M/K&ZIW VC+YC.UWZIXZW^13:I:V@^
MSJ>015'[[I/K+@9I[[.1;/CNJ[B*"&5JQ()UTZ@*5IU(C2YM6QQR]8T-:X1
MYH8*(%>OXYA,0A5.%Q2L.[H(;>/PDKJ'7($!"1^NIKT?-2;\CKH^D&YAH?9E
M_>XUI))0UW'PXY>FUK=+=&4$ZTR>46V\)?WP;F'SVN?2PR]O;?64@A'YY?J=
MB9H /K_]26N.\VIRQ_&%&&-R>ST7>#1 T:#8GMOI3=(CKZ6G*50UF>#V>6/>
MO:3.LJ P4D04UY3$#CIF8FVB,;V8G>-ZDWKD).8;A157&^/S[G:0-F)68%DR
MU)$/+CY3N-IO9B.@F!VEU1XW>%\O/Q+GLNU]?N7^3VN[?R,?!Z:1I,<#)%:#
MO?-28W".=F.$UY*U[AW6$?O7WC<B$JV%=]7JA.=FW$[$7P",$><:8\=D5#N6
M.(!!.3?AP\<D&CU%IKQ4!$_9635O=I2)4P)%9OX2/SR__^C<-$B451EV\._A
MPXZ9#RM!Q_U0"LJF+K5PZR#C1P[DB)5UU?MB8H,A;PWVV'B8ZY\1GO!V'C:)
MX-+8P#W95%?3OM*[KN*P&&V G#AOW_G-K@N((_/I^BQU7VD*+;D8;&%\O\C#
MS?$%UD=P[RE:[TT[7>L-P,'BA6 [P%&WK9_0YY:PW/\!>:6A<1W#OHYK$52]
M(FJ;D+5Q_=1H(0?/X=?:.,U?]39^GT5.7+Q [4KZ]C^-HGENE]A[8D:N7#Q%
M/[&A8_52N*]TQ+*K=%5.BKUD\$A^&\;T8>\UW=(@S./OAV?4$:ZV63N?R"0C
MCMQ''S%UP(!R:A(RKJM&\R6JUVZND_7+25@IE!9F +'0;-$G$.(6\320(=;'
M<6EUP-\6'EI)2Z68JBC+/Y[7X'=[8QSO;,,Z=![,J$GR#M>:I#"-?,5D1O7%
MM9Z($^E?]<9E?5_]%_K_W\FAC%U:[XGI2,Q_)+!*;$05=A!=X8]MPKWG!6<@
M"WP6P4:HI5NK;H ,8,1ZG!4%0F 18+#.(?A  B1)8]A'AZ:E$4A=&]T8=4AZ
M;JW_?9P5=B%-$Q%#Q-F H2BQ+/IA\P-)7W=%<3<[/9(;EG.18E)-421*<U:2
M[:DYBZ6[[J]DQ5KSY^-&B5G[2K%%4(@K/;C!%_U3_78;/O\_5506P6)C(V(_
MG:F6?2##_'TTCO [&6;\[Z-Q-WXGP_PP&B?QLHREVL&WTLW#J.6ZN%N-0(VJ
MT(F2[.SL?$-#H^H/J(I+9_?\"3T@8E;9"-C,\0OTJ\#OTMO27I!DA?U!U2O
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M.RH9#6XQ,780ZWJ.Q6;<H)[=BYHY6T:U6:TQ&/GSH85[\][O2TC&F4(+/)E
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M)P3K(=L"HF[D^?P:7"R-"M<B%4?O2%FOLORW]A3NKX60-DJ"-U:Q@C;#2 \
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MZS%I2GVQV[F*-O1L1D0BI'+ Q+'Z)WF!8Q%SRC&\.SD]O\-2N&&=0>SB/"H
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M?X1OPTQX/H&MZ,<V,\ 95,D$:+R^62^*V"+*K2OKC&]QRW]Z\E\=BZ^.:D4
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M9%A8)-2)JH;*0_V9K7'5Q?-&=U"@SY=.& U'NXRN\2AJVQ(J*90W6;Z/FP9
MUYZG[>,F_*-:B+(9Q&,?Q/7V9_5[/&.XA_?<W@=UO;W]^Z NXHM.M$L ?L,$
MLAJP=NJ)Q.HKK>>.+J*2 ]V*?"5=XL.*D&Y@WQQ4R2+\<UNE5203P ?)+D]
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M]HQ6A+8A%S(6NB/P\;*2X?S)J\7;@;%:$ ]  Z_%<O+^@6AR;CV'.9U_JK%
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MBZ8NR;Z %NYWG]; 2YF";5LU!@TUY RSOS3Q6R&L1+5ZAHAV3+6K(T\T503
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MWH"H2#]#7TIKJ$-&G>&P6,75==B;S0F>YUU#@>/!WMX,8"WD+3+_+9!2,,1
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MW^P[*=[5H)UN/C+\57M1P5IV7-SY#(!#?Q?&)&C0.V,E./C6BF2&YGIY7$T
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M*6>3.?UN]H\S=_GP81CE(GG+PHLH$]+3!/V8CD4#=E==@,B"%?:6 TW1$[,
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M1KZWV-687WB[OW%[0:Y[J:G*W35J\+K82[%LUJJP]CM+>9?]&%'P*7H(.0D
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M78V8X34K&E#]O;#$(T* !^%J4]5F[%RE6ND_(:YVY+ZU7#DOTEI?E5*?P2Q
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M-UN9/@0'ES !,1?.]Y,+CWT,*WP?[!M09H8O*BK:>VS>Y $NW_E'T<5[-]U
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M5!7O:_V8/%MFN/="SC1EI*E?2"[=H$9!["+?C&WB,<^VQW]<&-)[?90:#<L
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M3!P/Y>AU&D^WY,, US[P[HQLK7TPUCJ*5@_G'/IP*13*O)G788@>2.S@=X/
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ML10.@)L>M-C9^.!%Z DL7[,.FB([Y<<!)$I<]32^P[Z^M;R,+/R!]H75=4\
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M;+C3D]8PG]CSS#;-%/D=)', -)2 9.A=#3(\N2X8'?!;\V%>F J\ZG)=XIO
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M)8*_RF+W4;Z 0N9X:!0LB:T)21XC3,=P+H/(9<9_(*2R1=4-C==_V:YYNC5
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M60VMO;N *UN+WSFQ<8FVI7%)+[;K%Y4",]>M3>;Q2FJL7];$%'=X7.\L$3?
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M.5D <#*FL#0D'*\&K67UHZE/EZ*,"\B.J%7S5BQ/]W*$T.N7I2"%9R5?_<R
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MO=\*[66TKY0WND5?OMQ3J\><'5@1W:RHVX&/"&"V9<97:7:P[AVDMK@D^W)
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MZQKQZ8Y[:M7X9>7J1]6E.,_"?GJWC[/T]*)'\C;\P2ITMPZT8L2NF-2XL )
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MI)0HRI$ C[_^0\!A'QBW19I1&?8A)/ILD,%2P0LBOVLQ4=+&#>HX>"<](X)
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M\\(YALWG1/).M.*18&)J=6/0;G[_4Q) [V&]-76E=]/07DW-U,Y@P&1N7T]
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M9;8G4RQI/:"MD]GC7.>M:S0#[+$&"!:J6J+-&HU3GZNZ?#<.;WP1BU[![:@
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M\>"J#GNM L$]VYJ#(5E=81OP7!/GU;Y&^:/L704+O;,)-=/++#0IV=://?2
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MV8!87GXQGS]I;9!=#*TL;I5U!O4G-!Q8!!0\C1<AI6V#P"C7U?->889MIAR
MYDP-OLP&[CN3Z%9_IWB@IZ1OT6;0*"4M3RB[J&P][[74DGP4(]'CJBT4KKJZ
M]BX5G*]H%.RUU&O84?DF[NQ/#,^$?.99X$2<>T2!9S< V> MBI@7OKQM<IM
M:$RURSM@7C7:V>L/X@Y=N_8F_%UEO3.@IF!X1X5;T7DQ)26Q!RS:^%O-V;"N
M]YNIG';J#+%5XDN[2L%"2JWT1^A$(DIT;ZH:?H?F_P2;OKJW"&8KI)I&';N
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MDJII7E2XJZL'4=NO[;R0O6=%HV1N4X,JZY^>ZSJ!@A I9K5O^]<&H$=+HUF
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M.*:NU[IZT@M+FTU9AJ94F=];\=JNRDU V/'&%1^4+X!"I_?B?U>^,2X7%'2
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MGC8W%CQ%1 Q;;%Q;Q5;NTJ&YG:[P@**A$1)*DU^7TT&HA_6R\H&L4U9>J_7
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ME!@9L!!"%EV(DM@)U8@ IHJ2V)08$%BH4"1!;! R!D% 1@())"-1#$*  $F
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M#LDVFEA"U5*9P2F3DM,+4RC(ZJ:+3^<P+$3/OQ3C5=%VR/AW\E+.6FL"<',
MH(R:W1\>LS59A-;\]'Z/WU2HA49%W[5%8ZTPX^,/<-FH2;2['LKQ3\\^LO0]
M.\KV/':=$2#IR:7P(C?%54$7?AS(^Z3G$_O; R7ZC1Z)DE$\E"<GT"!7? Q8
MQ#IC8._@H(L3,EK %9"29=ASU_!0(%,%R-+S)];%9F9FLL*27.)*+CC7*3<L
M&7ZWZPR=2*F_WS.3W"R.=*S=XS]LYF PR_5CT?&)(FYJ90]_/0$9SIAS6C,-
M&^:-2XXE3.C2NK\(X(QSO VK]I4HPYVP%2JEBV<EF%@'2WV/EX]Q1PVOK.!'
MV4UK&L9<4#P/SR72"SL1(>S3;+6 +03K,P5\PI_"+JJRSZ6*A/;0P6M6HQ9!
M!B$Q',NL47"='=<?FPHSAG)P-K]<8?[T_J3^/X1RGX#'6^,=!,5?OO6\>A<4
M__+.\^K,NZ XXIWGU=N@^*WGU4%0O+HK["\\>F66!FD&#GK"5-^FGGM[Z7ZE
M53@ 2W\7BW6_V&BAEL5ZZWE08;N[.[7K.;5Y=;Q5SK[T&F[J<'UIDNY$ONSX
MI+NU\GYIYXLIMY\G+QQQ\/3**$@W/<U>@0JKP[<D[..HIUSOM#3=V_RX32I3
MB'N=BJ@JDM5K9,CK_?; !#K0Q^:J!5-ZHXR9@'9&U0FUXODFY[S,O%%V7<%/
MT:IE%-="V(*D>E_I*YI?YG;^OI)#7CIPS]'<MX9#^#9V,VKU=P*^\)?>ESF/
M.P=JBS^9!^N (Q=RAP73J,>-D6L.(!IN^JOFYK.DR"/4R8J0:;[59P;-R;&C
MBN2 "P$R<\_#-M'N6I&*"D6T9%^IO?KCMB-5=\4. ^%3A6@>IWQ(JU Q'LT
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M$3$^4T<[NPEVBLXDQ75Q4 /WG&(X"'X>E2QK)'X39=O>-XMKTV*[-E0'J@0
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MAHR]==$V]"M= +!TK?I3_L':%=^Q>8YN1$JTK-[&>O)V6YIN0G)1O3SFE[U
M2TD,S9(&Z5M_')-P-MXOZGF/OZNGY=C-J]Q0\>.ZH;6&Q#K6XI#I[G#*T\VV
MR>"<%(=J;_#2$;1]ZOTTKJ);,Q43PU6-Q'@4EY5E9G4=&ISK46T.\"=VXW81
M?5MR36[4I,/<R>'?ANM[)-M(2U&D3[6XW$/.5(QU7US^7[O_%2/_ _>_'_W_
M]?YW'846-L0M/\'![8=H&:\(4^[*:4\C%4[/TN YS[]Y6DI&FJYI>-3]=?DR
M5GQ6;")HZ!0U-Y\7HK5+E'O6NKY^*=YT4H9C$@:CUGW5M,XWVO27Z,\97[GV
M;A< J*@<O<2$=/"7$4LDOY62A.*WJ:>WN8K+;\U0S>=%\D/R0\2M62(O=MXK
M*,S*[ NKLS1S/S\WSSXSFRE_2B"]83A^JFE1UFQB17;/;,=\>A^#MKU?942E
MUL\IS@E75L0?BC_,WG ][GUN_?-;4PIH0H8[T+++R5Y;.,>%85DFY2..Y$I&
M&JI9RV(#M=)>D?I$ZL5]3AH9B![QZ+I:7!E>PX;[H]LEP\_A *;!Y4UIK2'>
MGW*\WB+FV]\I>A'H/89:28SW*GE5&8R=(8D5:</^T,ZA#X]#'<?&9J6S >L!
MHTRX%A$$1I (;G'(F&"M"^'AA_$#-P&N@0'@/=]9!^7O$WGR@>3JF#S(KY'G
M0-:1;00?(C;MCRPPB,<\1K^\U7J;"+F, 9Y*=*C6;YW>W)FLUR]H)YTWLJ%B
M#VC4Y4K**D_A),0ZXY.#/37J8\,L>.#NW=A9WB<O][2'R:@OM*PO=-H;V$6!
M<2]O(Z[R;CX8LU08EX,+M6L61T--(:3FRV^H+QAG2WP=KB[>8S&'7*<^G6S[
M<;=O*]=F"S<T\#QQH=_+/MS.\XD[ [6^;!(8HJB07/$4&""FL= <W?B2@6(E
MA=XX:E_)>?:QH^A\8K+J':Y@ 1O"@:(&DZ.#+[/=Q#4N/IT+UH1J/<V ;_^I
MWMXO/F>DO$ZQG-JR4H,/#*L_[9*G3:^NLB=V;Z';LLO)]9_=)P@TD_=P6C>N
M!Z8\^8'VM8L6YR8C(#SRI^RO4FQ^HVM+BW?S=X4":>73I+R)+<*JUD3]!HA[
ML,CSELI@30*&Q:BUK9E%U"9SH\,$R@]0)SZ]G.:%"NNRMY3 3W=5:*_L:#&=
M5U' )-9!7(WQ$+4HINK"XFH&1W/5U>1J":J<P&=6V+&F4>XD-^!BP,'?_N1[
MX_K7#N9,CQ\9AQ^N>]X8HQ^_[JLE&=8MFA;VYUG;S=+ND(Q=/&&J;UU<W_D;
MH'& T5OFC1$\W,&J'V:5E?<]?5Z9IDC[R^\DN,E9<(X-8O=NO/[N\B>C4;T+
M)D,1MY>J2EZ$W::!6TM&N-=AH>T1979-:_F+7)+=P==.+H?59NB%NJJQKXZ]
M(5:- G8'4EHV$R;A>>">;@J"!VO-M4[.!=!6K@S*0?"JRE<5"NC@(,U 2M(J
ME * ]JU,TPZ9+G:SVGG<IVSN7,P)\"8HLR669<6")++L)</^3+]RT%Q3'RDG
M]I*DL+^K8DU>;Q6U_H91IUU]>6)ZSNY-8:88S^E*XIR/&%A0I)\JJR_\F/A-
M355Y%*RAH?/,H_;Y>V[8L'O(Y'64!2L5O&@&F$ITKH"%0QGB<+]2UC@^A##,
MG(2M051*/O'+*@\Z96!@XLXJ@R3Y?+JECE[CF0R$3G=47,]#HM-(;4U[XH6H
MRE>D2D,%]$[.Q4:-K6\[S_US4?V?B0]>*RX0[!2UG8I(<= 8]]RV3="=<=0#
MV1@QO-FVK4^ (.V,N#:T7/SB[XZ&VE0LEA(]%13HKO4GU].CKMJ!*P\2Z3\B
MZW^$.?C2XLO:>!>Z&">>?D,[R=>?;Q'6^! S,4&R<J:V<>3?;X[AVG1X1XK,
MU.(!+9F[PSXX*.2&,9W73IVR*BLKS>[U/%CFS.?),J+\$&<O#8;L:A]IL=!&
M"B[I <(-<.P@#,B#MZ^$N-?>7JA+CD^9K2<C$I )"!,;ZW$[T],TL&TVK\63
MMJ1KW?VU;D3W'1VC-Z;&G^:O/^QYH8!::UZ"\1F1*+\!%75N9"/L%+')9511
M5A/.F"JPHJ?O*_T57\]*?2)TT(5Y74 =&YY5KY'/BJQH:IELG1-5^2K:A@;Y
M*%$4L99\ZK_-,"5YVGMQ%(>@[S+]@S!R,;?TOV;ZVU^&K7=0:GO_+=/?IIY0
MDO %\VVFWV%]V)1<.G>^15?0IC5OV]Y#F):5PDJL(TG98!HZWYJZ@O*X^-;[
MJ*Q$-X',C;2>L"%//J01:&[$%<C;.N*_FXG'FFS?W7[T/"5-FDSF0X1Q%'G1
M5'ZX)RJU)]33]DS2\,W.]#Y4:CTK1FLR8&(R&360&A7C?^CDEWEZJ)OG)($,
M;%&-=$NBZ%4T\A2*?N$]222FLKNAG;NO]%C0UK\]*,6XK.#!HR8G62CKS5;/
M^J/G,8/@ 8R)\<>.N*5)'J(_-2>7="5QB)=Z9=@;F\@.8#?G YJ\2D6P,**H
M%H9R\<P^3GQ_\OZ?X?.'*?R4K[A+Q8J6\JH_B_[$66(]G2'Q% O)VL0_@<1J
MJU=-+]AS')%Y]\K!&1'I=K<[&(*0^NSH5Y+ *:RS,R_GR\CNV]5)R/.3&#-W
M14*<M1!F^8RV9AL6=G=P\+K:0 )2=-X@MH[K6!^@6J>%WTX=$,]^6I_2#:,^
MW<PHNEW&':19<W.\@=[/VZ.'MZK_2$?N#A6U]=>,EN>@W?_\CW%>5F>WC/.1
MNW&RVJ%UEGD/?D'3X=RX+/AO\RO+8J+V6A^GK)T^Q=:GJG_Q#:GI6,EQ=M[+
M9\=COA85:'Q5SH*(9W_3O9L6575$KB(8>[U3;GBP((;!\'P!%E8-A4+X?EFC
MYJ\'5%1*/L8>)Q51P\H@>?IWX?:K.IK#B>,3:X#S\M+Y %N1B@W=0H+N3+C&
M27Y5-IKDX0$TOO,&][]:4&7/^X\55/W)[.7.]=)57LB.,\!KDBAR[Z.605H\
M2N<E3?M*>'\6*9/@8?USXXG?_NFL_Y^)P^#)P.&Q5"<IKX?K.$)YG21JEM[Y
M!F-+6/*U HUSUA-BCE?F-@$N:,D[M(HOR9*^)!%(V5!,66/=^<?-78G""DS/
MCL7+E.]F[-..K3+0J:XOVJX#<CXY*8+&]W)8965O6Q=XMJ XA+<MLEQ<!G""
M1+1[)5\H//_ 9A*^-B@;S6\:RF\:GE9146GBA)W2:QJ\4-7-M>':?+.;(5.V
MJWLR!+XD";\TZ.D<'+>QCH 7<%M]=CRANK?C7>+Q[K"$UD"N>[":FI:O2?,7
M+."C[">&!8N+\[_Y<M+>)AFIB6^3C+YO5JB/NWI4R%.]4$^JH;O7<+AU9OET
M4V]*0*>/ L,R2VRV$]#0<4D]+$W=C\;W&N,F,/T6US<[4@&7J[K=U:@A^<[4
MJ,("L/\H#LC28AXA_OH[@:DLF5R]Y$] X-=68V.O1D!<$(@6(%=75V5[_.W9
M1X#K-PH]+8L0GI9,NM5-7P<$7;=$:."1B.":@BXB? Q@D-)W[^S#DEQ<XLJJ
M\I5GL4 ?&"2SZ1+>8C5S9S;%N;:EKL(P<_Q(6G^WWET2LOLK6:1# J<+GP;W
M['.F[QB$#6Q)6"/>KG6IK[IQ'7-:Q'TEK50 P3?PAVJGJJAF^%=I*\XKNB@Q
M=4_(2NUD).NT<,/*YQENHSO-'O$+R-+-2,B=Y6<YN]LA'>N7NMUU3EP5\R/G
MUBKD$MX?UKTUZ2EFB96&,1'#?;&;M[)R(<$K&]1])3+0KS90_/G[D^W_%$:5
M<MA&X:[N;N"<=SHG;T=Y7REHPG[@<1Q9=P^_K\2=FE488Q%J#].DU7N\Y*&3
MGSOSTN8Z"?4;^TI)6BDO=A^^==JVV36L=Z23]Y6Z]I5,=2P*&?!-U^?M,M1@
M<?7!+^046OVN7MU9_#9Z8%F_OG[WV79+K2#5OV37N-9:D3.\LG><5LS<W5?J
MT7';W2LBR!=LGD2/%_Q?BHHUXZ9+,-3=U]61_O$M%V$QX(BJR%C-KOR"9BA6
MLY6H.%1FL%<U^31V0"OA1T6"Z@@,J0ZX#1@+<-.O667?O!GSQ'%@P?D#>7UV
M,"U9!-$XA4-RHR"U"?8.I,R\QK:!&D:X7Q-?FXP+RV9U0))Z74)XH.E)W7)$
M85^,WR..RY!#/M/ V"-59I^J^T<6'@NON?@H1%N=<D3QV1O=ITZ-!-YVH>U1
M9P0-C"B(3[@Z"[]5&"LZR]CUC=_QG]5[9)\4/:XI:DK>$4:S)!)8"MQ;:\Q#
M7<L3IES9@MKMVI+_Y%"WHU[\NJ+"*: DMWA?23O,FCL9)ZY:],)OK+':6EC/
MD"LTR*C!YEP9_ \4]C/D\"<S]:$OK\$(Q/HW\TUIRE9@-Y:3(RFS=*5FB%B]
MWEA;GU0.^-_Q\=K_ @X;SACFIP $W;[SJ+PN&XIS\)OSNB[F,VM%_?H\7R,'
M&U4_$6?N%"MKC:S37_"(%01;.OMS^1P0W-QE)!,6-,0$!R>M#%)K9T\XV#^S
MUN@XBG+VJSUUBE#C<;%UKA]FE''$8(1?HM]X99!EM4P,0:$/?3N[4U)0K_K\
M=5>*=%_ICYL^=E H)^E:?A,4ZN$"56G&_VD^7)8AR^!4@P.?T!C#&B9Z]"D]
M_83=QXO.)9X!(,1-<TX,9<6!XZY?'/X4;WWMIN?-ZS>*QW,@9_#XAN8SG9V4
M#5M9CZQ'P(^J,MF0[#K*G]J,B[8/O@3X2K+)-JPM]B).#."<"C$XM;6B@K&\
M5(J[5174+J5KOG: PU Q,66-NL%.U;KT!2$;B_!):X4#^&G+K/R(AYX__H.X
M0QV[&BG60KN,#^NV'L\Z/;&<8I:E5\@]X[R8#^9T[% :-T8163Q9Q4VQPUAP
M>)C)G4<KFG KK9AFKJ=6Z_4^GQ8OZ\*NS2Y)@E-@-R\)/$9NSSO4X^R>S_^F
MJWO0K";%L_EPT68DCAN ;/'?5W*GPH"#8G#@H*/<C&0>W;&VF9<;FBDP<NQ8
MOY9&KUX!US[>G<.O\< [_EF9U;5[^H_'DG)?OS=5_3^ D88<L\$M7-22S<[E
MY9RLL8@EA47@IP;&[$@6F<B%I<J_T?M J#&<SXUUSQ1P:><C,J6(8HGH(\=8
M%M"]3S10SW-;%=H*&A<9WQ.^D >)FG-@'DXQM4^IVMY7.E>'WY!UK(&FJ?1
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M@Q(90@@Q,H9 LJN[#&&JH Q!H$6&"DD0R,","B%B"*E$$D@@: *)$!((84Z
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ML )#!_;[;;QE^-G4H:#WA75@=G;I_0%JR6&A9OP;$NS.2H[?Z&X0;3U.;;3
M_=(Q'P'AG"&%F[]:[8-52EM;:]L=V0@"'X>/Q BX(G[0FS9*VYV.B(P40TS#
MS8SHF_68QPV5*0W8-F&EG:KWF(60D3_6PC;#O)\]X=J_RW -C9%P4$W_<BG:
M+(C?"G3UC+0JK?H;;<8D>>O:]EN3M@A.%UKYQ[&>$!*Z_CH19ACW(\:A+:)8
MQM+)[U^+./SJ/-3ZH0T+[<RA'6*XG8$;^I5)"H4G/-VW7J.]N_P)0N;6'RCS
M@SH;R8[6D9&MZL#0C7.3D9%FECHV3A#+N$G<B$D!U (RCL+@!KSBGS7/QI$'
MB069SR.A% ZA8T>M2V4_FW,1(P0N_%?ZVC_E_1-];<W_'_2U/YY3?JRTE(LE
MG>=S+,<1>G/#/X^9KG=(^/?82X=?R7AIOJ&^(+]06;M!1^8UEM0P X8T0^JU
MAO@M]4'<&*..0(6^\Q2*F_[=VGZF%WV@>;MHP&9-.KD4^!C,@XHIG;.<2SCQ
M1)!A=YL%,\%-DD:F8E U43W[),/)3-O6S(*F$6'S<%GRD>S-A-FFV#2')6]/
MXT .SK..M/%PK8NCH+V .2&_%K8@Z=%KL?-;]!!SPJ+VA'!3V;2H8C@V"TE=
MVB6VNITOM]W"C$XDAPQ<5FRD%*<^RC\J7#XX&^;Z?HVB>9C68CJAK*F6XM#5
M39F4M8#5;1G%^E8XL$XIG'I&*+&J"=HM ]RS4OSWO'6,A:MLG,R=;D>0BTK,
M.A*[B?D5]E<[KO;^#6)I60=]0?_+K[;;,_2+9F.WROXWT4:&WJ^:C=TB^U?-
M1I?+/R0;S%\D&S_.]Q74+;R7;.S6V/_0;#SZ-\W&Q_^O9F/O/S0;-8E4#-I[
M*KT?\%ZSX?L/S4;URB^:C=T2^[UHH_V]:*.73:ID1*Z^NC;WOR<U^2N,XE*K
M<X2!0]&F*C3V5^;-U+D<U+G-E5MGF%Q:.-?\#=RMQR!>Y)%J3(4]#.CS))B[
M++CMO\;2(7A@I.MW)'K.SB.HY8VIRW$V_#UBOQ[EZPU+@!N1M.9XDY\ZS9MU
M<>9T1&Z0N\E$ .\T%U(T%SX1MZ/FCT0CWZ[1GL?[V'6%<M97R)Z]R0-CFZJQ
M%4E:*D %+?!(]EO^,]\*2L>M2N]^-6\&=*J-X]9=3G,>;)A?[QPZC?RDB"PN
M2*6?R.W%[&L,;*LCG!)B'@LQ/S5B'JM83&U%FLK(K@]AKD$1=R$3[R*?R^0#
M +M%?KO%S1J5F0<[DES05[-<6EIA:*@!B>KFWG8(1DHS+D>.S^""2FJHC=%5
M X;V'O^?H4IJ:H U]I$)3O(6>GI^>3_ALY+XE,%[@SZGP_"PI1X^K5J1V&^S
MAMC^:3A,[I@R^$/^J<BBO7#&N=SO$OP]K0."@R^A 5;*<J7-8A4:VL24^]'Z
MD):Z3A8+QIZW9,A$K& JG%"44E:&BP,3TJY86!Z3"PF?O*X<6#$_*#XJ3B=C
MI8X8TL9M*@J 3<2(<&!"[\>#>DZIJ"W(H?+%%,:,B^L&>G2=,"G?47MR1LFN
M_WX9.'V#B,U*TO&P[;?RC&^4<>=)\ONC9(]STW4=^+A'C\JN$QRR3A5SHR,+
M,YQ*YJ;L5PX6S<CU7(2*6$1L.M@F^V&@7&(1S(M]M135!\[.ZC9$0@_34NHN
MAS[X6X^;,)B#6?(3; P=Z>MH"N"LP<*>KR\H*37;B95%^"@/U_Y8@S#[/_]>
MO/[O@3]+"EFPQ'?9/@*]8^K4/5UM*EH^GXX9"H.?L OYH.;VK0D@D.'UUI?8
M3&N.^]D]A&IQPTRD"@@YOS$8KW>(!8Z_[A+3"^JY)#.!=HG'X%68E5PNA1;B
M8!O\P- 0M+S9/ZQ#9$8EB5:VS<SJN&:X&5K75M0LX3S=2,^2Z;;*M\-Y@M9N
MRPPN5;V5*-O$=>V&SM'O7XY6^\<DT6ZN92A;DC*ALK+=7!3%:_$/#-YF-(>.
M(M(1B8F.)9IN^[7A;@1;+>BUKE?0*(BV3=(M.> ;-^UK+/<CM0*^L1"E_E3:
M!>HG!]AH?\32 ><<.+[*)N%<(2Y:H8HZRB""#"AFKY'PEI96*7S+@K>K >M\
M\_UG8N%^)D%7K;*R\ES(D6@M  /O!+6T;-1MV7ON5\OI>>S/&(I%Y/IU-X6W
M!$YL)Y\ 93Q[L\BV#00,1%G<[\#0CF&H(-/PRC6#PA=\INN9K_9KTJU(++=#
M"G_'6T*8;;FS0U3)]]-GA>^;YN-G9P9C?FF:<]>ZI19!5Q]DD_!@#+O9TE+]
M8&5P&WD=7^74"#B$X[*)[_<OLZ'@"OWW%\LK[^E$).^HU3;5_-25L%VU1*%W
MQPPK>D^M+J7[C]J=-CL;L%V24R4B\LA!X031P(X:R:A>'O+0:O1+>ZFVW$B$
MJW)$55S20^RHI;)7C>:<?.><&+-O0L ]4SX=)=-1RK$SDMK'S049'@ W2CP^
M%5J-OG*@NU/VB5BIBJ*V &Y5?3;^**"")KZ<9GB&ME9?,[..SMP^\="W-/_I
M[T;J?Q9__,*9M5UCWS0/N4(<:R[[#.:/,*H31A!''/QS??V+'3XZ==JH_>Y?
MYLL]C/_</3C7RJ<S;2BOE)PQXUH",D6FOVM764@Z?HN+\.8UF:$<X@N,C"7I
MHHMD,6C% 8I1U'A)HB"N[#)!LT)8.0'$LHF#L4D$QW5R%3[]T6#*@;FD#1,H
MLV"&W'YF#6Q-N;C95I>8U>6^X)= N)B5XQEIDJH867#.E7IK(7U@LZAWK\\&
MN8>#CYUJ;A_2O8R-$1!.U97A;I=VOHLII%M^.S1^R8V1MT*Z#0P%7G)M]O?5
MA--_AMU%,'.0!E0R*NIM^1!R06<*M$ MKIH/*L'-QB+@7,,R>*C^^H(&T!4
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M:>U+.X ^0EU*$QO<S7R;-+[VD"P^ 7_[[*[.DHA>R*H%%^B>(RT@O2^S2>6
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M@Y08-XR!@I+9AE@EW@'YAQO@>$IT,L?Z_/#7(UDR$TJ!0X,81*G.S3B%B,Y
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M6%48'HPINSX@OZ;-VU'[1G8L[':^:?-AA0_<S#K>BO051)NC3IMJ,V_;4?M
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M3".\^VI4^^.RY9VRQC*([T9P9LQK)@0(R<</*6:1#=QRA/I[.(#D[,U3J()
M'DWQWD5S@W&JU0V%;9J7K"H!?8XF51(/(U(>'"*.1.X=*DT$]SG/O(%[O9U>
MES+,ENMYES)U3&HR\PV;QF"845=W2)#?A3L(LOVA4J>\?#6X+UY&BUBMK)P^
MUS>:&G" 6LE1Z!>H^Z4VA]^W:;3!?8WN)45"D9:^'3T@0KT=?:XQ*[P !9^'
M.IU\YZ0I]-(:6,C\E KJ&#]R+'!A(  E3&&T%9F(K(8QEHV!%&E,KWNG?008
MX:XO.]XOT;9O;E#_!201$2UV?)])*G7M<7$,9L_@=5(/BS%I61Z^'2KZRS\8
M\=S^4--9^[Z1JK?]R6M_?3]CPH2,C5')=RWDP:<Z\VK*]7NFK>8>\'(@:/[1
MH3\UONH4&S>4 Q?*PNN#LG5S>H[-.(VO5]^!$9%?2\>V'4M//R!;[K;R^V[@
M+YU](1@KH9LI![HL:W"DP5""<!)^^MFZPF2(6\R7^IV:?'9 [%&HUD7B1.8[
MK@,\.U^#R!]T&*??GKZ5D0:\#RJ_=_\ M]B;,,[P*""VVB#2%NC CH&I\)*W
M72B,$%F-%T*9B%15RJ'2PHFJF'-(!KD#]GCRLV/[%?O=TK .IUNSGI-)D%!"
M/^*ZUJ,K[IX\]\IIZ=H^@&05*Z+>B]AM%HG"YE-#P9@+6MO6!-L"^UE/IGHF
MD_K2?.:!B?/@)(NQNUEIFEE<UA086;8+K03%?>=B\.KW"O;_2_Q!FF03[T1]
M\D;(/F6L6?DS $*:CN>?-H\$/A_@W]]U"XA/A&'Q5_:,5EMM9O.?;PTXJ-P.
M]KX6<M?/RT)*.^5)@_?P2&6=IYPONVO*SQD7J06G$*Y$#KM=>YD6VJ96MQS[
M<0R> %(V,_MZ+V*D%%S2N1[XEN9VK?'>**4QMC)BJFPR(B+2OTRHPE#];/_N
M ;EXX/K8HCI3<13XJA,MM.W<Z8OS(%O2763GW$O UG3U4C^&9-\*,GSZSRO:
MS"M)6I_?SBWI4ER^TIB\[Z_X@4 F<OIDVS!L7'!0YCW6,O::48&.7B #$.0>
MU(V<JV\+F/,E['67/5>TR[#NO'<]"Q(MW0Y94=.2<J!85S?3$4K#HY=M=?6Z
M=6O.G4^YJORT=W )"S:#NX<LC=OKY[]F>T0_I49=JL>S-H;VQOE9>!-3D\NZ
MKVPC"M% 5!>\'F\C0,&"'G,AI#G1<C<KM#RE,RYH<K,]L+2NQH"(JXDQ"7+Y
MUYT1*C5W>,/N[?A@W]R(=I??E!@9!@9V'S=)%.3N< 'O_]%/_S*= 3UXMVL[
M?^R]5E+G'">5BSJ[]@3U!&_54RHW^+5%.=W8$TG8KQRUMKWD4V6O"?!0F[9_
M(_XZ&>)EP1X !+<&)WVFF%>\)D>+N6_A.B=OW7<:&IZ#<[YM6$\-,.SB+G?#
MRNI$"%;,?@7$8U2H4KC;>(MW[[3CI@"U6X#\LCUK6KK-R,3I+0XGM,GC(;7N
MH[3@8OJ%0Z4TL+)JJ.8 TDD>*B7=;$B0[#>O;LP$V=M<)HZW35]L[]_&/[HP
MP9(&V\>4CXGF1GTAP7-T\/4[0T&K^E.4SUV!"&<SYG*M%R1-94:1RV_(DBKL
M=HBD'N91J7I*"&I%%\0\RB.V6)4UI<^/! >A[P#C.R"41JSM!NU/&\['.9FE
M%?V6%',S]RG&=&(Z,LG@F<:RQG:@<6%++:N8H5E&C_]?E+S^\#(S9+>/E_IP
M+B,L''ZL;T;8/)L9P=B4 Y1C[(]!R7*IEUH@JNZ$)"R*;.F]@U[Q_);*RH3Q
M^0L:<%[)S)9.+;E O/9%@<[6H9).!D7(M%K8X[% C8J4=*E*())0FQH]O$Y%
M22>>PTA/X,?*UOJN]G];4:33!]^%1!:,R^@W#IYIL+ASV)]HV\:R_$5:A=HN
MOG52B/FA!TK&& *2?EP)<"M8$0_\,G?;Y+GO06-'_ZCZ.8?XG=VHA7C]1U9E
M<*=K=^<FD'>MI*XP9,*A4I1V^R;*7=MC=#!),5A[9Z*+=F-/T[UXDFZOU2,\
MTQ.J1THJ24S0(QJJ-E_;N$,W_IELS>O5NI=H3[:>W71QC^IQC3%V#;G/$RJ;
MV<45SC'SG0+JB=G?/V<F_)/=/H=LC6V%+UI/IXB OB]S>B;2C(^7D=I6M;>F
MS4HMA#:O:PJ-$F%:5VQM'E0*TU%#O1<;M("&?V8E75(-H\6=66=>B-G/V:_=
M6F,SC\<N)=(S! '-8\2*&&.F,#3&P*@48M:T3&R+G4SDV+>F<+[VMGR9Q@S9
ME;5VF/[+#&T%=*ZS<1*@QFK3DNX&&7[<:K9/UV#?S/&EJRC_>G7 ]$]=Q_J=
M&EI7\#E37P[1'6QF9!E<?1=K!"TZ7DUM\NK!U4Z 48[M9;[LLB&>-7Y9E\I[
MV5%H?^/+FE<=_+\[CHAI3K*&8NZ;'F&JK4$;C UZB4MA._B65=>1*%A*Y UL
MF'YW*Q_-F $C7-R_:3*1:B>-V=HN[F+;0 :1VC;+!:HQR%0MY.GO@1\2_J0!
MW?QDU[WK_TN?\7S$HZ:V@KKQ;*E0Y_FJA_UFYO.-!YI.P+;5V5 -U'VM;,<*
MA]N162*YE74NO"UTU<P[3BU3VW@T\H<%4S_U;4:+OX^Y8J97VB/\M3LOU'$T
M(P'(,,\P:>V]N==]HUT^8R,O_5"YF=N:$(B8=(9X\G[4"&@0Q U!)*'7<YGA
MW6L<V"(MV!R,.>,U-&UBMWVH5&DCV$FI1"8R,#]Y+-)RM40+QV*CTW)?G^H;
MC<4D.#.3"DK$&@(F<=;0W.\DD5:[>OOVN'$<8^T"ZI51%Z&P5[<JVT2P8%P6
M\]B>M]70WJ/.YICECO0<>3K0NY"8W.,;<>7=<*U'L_@^C?;0,B(BIC1+C&7J
M&^RLN;'B86N%Z[T^0\SG[Z1T*\:<H1>GKD\CJF'MCF0WT&ZH)!]H9MX$>K#V
MEW^T'R*A>Q7_RXICMTH?-&&- .6+'F"X@Z# F%1]/*!E2TK3[@)MP!HQ0:_"
MJZH<KU#'@JDFYZ4>R5->#NO+Z4^&Y,@16$7/Z>?QQ)Z"XU46PP\A.>4MH<XG
MXV $:$&>)YJ1-CBX=5\FSQQXSF)'#H=3J@&PR;?#_F3 ?L2$V4&1I* _H;H)
M/%N9-\)\N++6?"G8QFWOQ]8A?[AFC5"NR$= 57N>CSP5@4X?][H2'M-7J)&1
MNC=748(TR+01G . /)*H=YSOA]%3D]KQR*\V3P70'A@P2<J=(_);C!B+>BJT
MJ/X&UGTY%UYX)<47L&7;ZA$7VRD( W>:7=LU/=K.08^.,_5[8_,SSR8&R=H/
ME:Q-:EBN.Z7$9U:=$[)*ZS9++62F<*SA2'><?:C5B2$2 7C.S8%QS#JO4[[O
M5S9;^7T;:^[JV%VIEP/=SX$>8NGMM_ *SLMYR=]Q @QU@JA'%NV#]R\#XPHA
M_'YT";54B\<+FIQ0PRH<(['N[D"5S_.ZQTK64'-1TVL2[BFI:CVI;@%X;S3S
M0_K7?CEE\_/OPZK_,DYCRD?GMT:=_,*G$SMFU8Y\DM\[*C OQPB#0W5./J&P
M1C**WBPEID[V1Z.&>-@?\'$"=)?NXXL7\5T=#2AX8@K"4:#70Z%*=EH!7,%P
M,*PE$M=49.#&,K[U<49_#>'N2\!ZX.*RLLI+Z6J7NO,(_0^(O0C6;S.J0/=E
MU8\K=,WM7%P#JIXV"J9)8BNAN%E1O^)U]-+Z :X7 O"URSP8@8QQ?5=293IE
M^(;)^]#;9^:>E0U='0MFS]&"SWXE/NATM'7+O/"@VV$_15'I],WBH5+]!A?&
MM5;]62:CJA<L<018*#8A46C61H73^[0BV"\;H%#6(GH1F[]N^LU:IT[#&W@%
M%]C*#*/[U0,'TYWJ^CB-SOF1P44AD3LIDQ.>I]Z)4=,;1S+&4IY 4]2F9KJW
M^RT3%XF@;I.DXMYM>!4BRZQLSZ!Q8;[99@5O7#.B!= B/\ISSL+-YUR,>Y&;
M)3E]0N*E].[^#O619#_4_._LH><#).H9?)>+QUK#6)')9O8PY@+[<A PO910
M'Q/]1'404J']I@*L_%"-&WEC^9:OL<Y) X"$T."%WBXG-.#J 8UG6P$1_^C'
M/PY7^SC_59-4=!LX)UT2]0Y/'1R![*6 [PJ[$Z)^V79.C+QL8G*E8_5[YI6!
M8)9K$/_+KA>HA)V&O*%;W&R;MH7Q<I.-BYS]G_:E\QD $/5!6@X[P9O6R"UP
M$B</M_'6U BF-[+*\L>EYQF9'DBOQP=MZ"2/1-#$_DRF:&9G=7'>P1<BAK]F
MD$:<K2ZIJ%B6T0^D)LG5I3(CNU39<CQP(%8KHV;+M_([(:>-OD4^=FT*N]O,
MA&JYG@S_.[.944RSG&V)E/B_-ED5*:XMC1:-^%BDU5<%+C9]W$W261N*?&W+
MO<@WWSU=N&9MKTB"9LK9^4-NT2.%K&L?FN-15C+V&E#%SI>  RK[9V4E]7+!
M<,<YF1P57"[K- SB;&,"Z?65(+O1965EG><N+LE/FI/%7_Q.G/OO@&7!FT.E
MTPX9TJ#&M33,:X_/:0D_,S<N0^53/<61UEKJ]I<<7$^-O%AEO)7+U2)875^]
MZH+)+JU%OI@FDSH)^!O&,[TO/V2]9D>3Q<T-6ABXJ9T[5#R"BNP#=U)4L/.S
M\]6EEVT9R57E9J,'[K9FT3F+^&L\;;]QV!/]\]6?5$$ RVK8+6IA'S^J=I,
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M#(NF@.Q)1NO7=R M?_]'^R$2.H09,I*L$HBSZ[M- V.V>84O5+ K:>-.Z?5
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M= ;C$:>B2G0O67;W;[3"!EUV\]8RF)B+96@UG/YE8U:QUP,^3AKIY+ L1;5
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M3WO-R0!\K-X5;%D-W-[67J#K%%+FIF\GJ:NQ#)Y4$'NWZ,^KLS?\;E_U46-
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M9E&UH3M;U=4(-ZI<_9/FJ/8$^')!$>CF[@M_ADG)!#:BODA%0[Z=S2AN3_4
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MEYW'9DVQ%NAUIJ7[;-R@'Z_:BDSL#:/SV+QAFYHS<&JK0\$X245.-9Q<:,R
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M8]9#6&Z(_C0\E3UF^75-P:S=$@SFZ9K+S(MM'0( Y5Q@@$KLKP1[N?LF5(R
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M#FZ,!4DPKJ3X$Z,^]?>N]T2$3K1'&"*B1L"!;5J6^VCRFJ&G^9'/MU?,-H^
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M#!V]$!<D6FV80G-XHP7O!ZI*Q1RXN=M=H\ME[H( N"#XIZD6=UO&Y>;UT?;
M))G;Y&S5!+(#X)IGVV59*2YO&$_:4Q@YKA[/VHSPCU4S64Y.3OL+]%KJ:X&U
M@+XVQ[M=HFQOJC!Y4#]HAL.9;4N5PAE/?T7DAP.M]'!]SJAK8X['O=/A,0_D
M0/^!SDY/?'G/P+3UZ$XM:[N.K%<6;\Z>+C[#UTQ]Y-F4" 3.F>B]MX"_3NV?
MP]N[^<2;(^X&#^];+9?C9XV?'Z?_^5^LH-&W,]P;RE!!.\'@DE)[P>1&>>'"
M@=:]O685/F''O2)]!S3$VC[0:C+OK)(G3\?0#5X3:N;[>G$Y:OMT$1CE\.D[
MC&?Q(M1%*@%4+40%\U?92X,Y#(+"V03?7#]V+I.<=$5Q[;$_^+(XPWBH)(<%
MQ,K<CZ)7/PFJW%V1<\7B[DW&H%L8W@WD6%34W*3[JQE>G_^&=I=G0]#?"&N:
M RU:NB1O8I'@]^P2Y[L#K?E(B.;+$ R.: UB2#W%U&]4<^Y==]EO2L[*T951
M)7R#>F3@T._AVEE0@R&[OZ:Y9;&^%&:[ /MT>8'B]%7R%2Z8TX>N&;?W?-=I
M-]:QHN%Y&"$[>^<7-^X6Z 2@KJ$661%3!@/;Q8R QZWLI,RBDI&_;I,E]Z7A
M$#G$?:*%<@_=;:]"B?J;+\9(C@8QV.JPN)W]=HUL"HUZ_ 6Q32<OSX0E%*[W
MGY8O%2[[_>X3+MU !!=+IM[O;VI/BD7M$\UUO?MR5K?7%63;^S7[2@BOKWW\
M<KTB]D KJ!]3HX)MQ>!(2V1*(-=EWU;_)5S-^PFIWV0.P?69M7J/$3SQYTVL
MY<@=Y;(!P2!<F<A0'BEC]7W<41.^[\(Z36PF[X!P7E^BV$[]:0RD]"^O%H)M
M"<EQ1$B@+FOW000&]RV\G0,84B,7H6>E7@FFW/[LQ)<ESKU674E-JK*GY!-6
MBZZ6(,7-<M'DC"/5%K0^&,?R2G\)]J@QH.!<=ME/]]Y5+#*B:Y//F$7V>(/3
M"%C?B-HRZ:WJ_SI^YH"B%+SV^$;*6AGF#(9L:ZA/7BB\TO#%\TO<;' P5*94
M&MK<,WW;.[K>T9SS3)9 PW7 ^:C/YCQ&F%<%"]2UC:")W8K2=*,R7*![^LUA
M=PB1N$^.>CY,1G'V8Q_;V;<&V!\#_-6#T3R3,^B<764R:$#T:G;53-8A[ ZT
M=F-^]Y(+[-<>70SCRB?^T@\D41#.QST8D*I%FSN>(6U3,,<3X]]6<R5690((
MY<%,:0/.QJQ!)R$T7/\)32_3!SA>DI0#W!Z6%UI5UNTK&ODY94_H4X$]B;RT
M^%-07=W(,M)OIR@I',>%Q"*<'['%.K@MGSR<WP<W%[XM@,*)[*4ZT0G^?'<*
M2V"8T INRZBE]H.2$D#RR?/9/(F#ZIBX%X=O0CP5(4U>A.QCD&IA/600>KMO
M;)$=S?8#(XE9 1S4Z$#[LNHQEV]]7O&G\>.9/C%ZL'#'R:%?:YKBH+%G;J<-
M%!J<68Y:E]/WDOBP[TN9LSV@7B<86=(UT2I8N+EP[2W8I^6MG0YI-_@/NQ8&
M=E7(F+$#+8<4X.BX8VM 0! ^("XX8JV5*1\("!#I[EY$0>&'N)]T24-#O$3R
M?J.<.3$!]]PQ<)<(FN>?==?SG[MV/ RLOK;'IQU./GI!9NPD?_P'Z&^ 1?R6
MHEU^LSF@Z)-L>#EP*#'6_55.N7,)V^=4/R1K]\54BX.H\ATVZDQ[("2OFBB&
MUC,; B; TFB#PR^7'AI[,:"D41T=M$<FNA_99*?CA!I+8MC;,Y,2"^<1Q'^^
MM[[<S2G>:1-"&V;>(OZVZ%K[.N5X+"SYD1A"NN4PV$5CF2PZA2]<)"7#285)
M R.!X<;<B.\%;VZ*/ZR6=)"V931K73&]+S@P]PJA<%KYT$79UY[IY'(JVX@C
MBET7W=,G/.@SV_>@U+U\()NY</O5?OM<[)FEM_-3DK488?V8(;C*89OI=44T
MKZ\1=P=: N]7$SX*Y.]V>>\4)V(FWJ@GSBPG+24?);ZK_Q)0*K9M/W>AAQ4]
M*X4'MHU$D:1''[[SV9#!LDOQ?>W%EA3:E/& KTD8HG2O4@5X(Q4N44,(-,&
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MB@R0T!R'RR^ZP>J&8T1U+L*N8CT/*4T_?3UNW7(-ZH:S<9]. );"O\!$U"V
M&Q(0[ R&Z:8> C]2L--)&2:/7E[;@5J>Y&M4TF.WK<A"RN[B]@AXQRO//J7)
M ?=)\.X+[S),XH'4L[KS.S$H/_I-8@P]FG[;W<OP-F1K3T@O?/V]_1RF9*F<
M7W0A(J^3BO[CV&VQL&70LMKMMK!D%R/=72T/F7BXXC(-O5'Q9(GLXIR7=(ME
MFNIJ6:/'-X]/JK-T:GL64<LDV&$#\FY0LCA-)-D7V>X!3R9( ^"HS_[+7H:C
M&'M=5KO?/W79^!_U*WR,^\KJ$XW752ATQLL[VSD\P5I87G#>,#E>'!$#$O:F
M73" A3Q^)^[.$$5&W*),Q 2.9#L1?"4+XW'MLS'1,MS^\+N"3OD7G553 X@'
M*\Y.Q1687O;WX\VGXI\V3\K;F:U3L)G^F9UF=ICC#/Y88;44:KB:!)E,=6IH
MK#+,OCGJ'^OFG3% R\\-,XOH"7JL\_$G<D:-Y/>J8R+;XL2YFOSPY2]/V7J'
MZVVR/0<)A+S+!UK&(3[5""PN@V)HZX)NMA3R%8!''8- #];HW721]Y"3IA$%
MC0WD-=!2WNQJ))FU:AMA^@T)2H:')L#2>#2":?15DU,$O7(F3NCYJ_>-Y>2Y
M2ZL)U04 _]/<>@U;^+"J?:,3HW(H+XY9ZUJTFYG/P9.:5 + S5OD1E58WSE6
MJ!BT>3-^N;K!WQ \X?M@7B#**[\P+3"+&0T%A:0_JI]A%ZGM8\;#'1AZ'K2]
M:"5Z9MX^1[L*1MGPA 0@-DZ2LHLDY(^KYB>YU^0E6=XWZ^,[-YV8M1@=>ZP2
M2N+&'6?O \S(4\$/PQUM2PKLMQ0AZR.3EU!.3TN#J%:_J[9I4J'W)B4=8O'Y
MYNLI;D&@B(3J58.%L#HNZAD@NEIY&&<M<0IZ-?H^HZ'N>>%)"TQ#0-MDQGCT
M55DXQ<,A_'C>\,:P).J5*)7#T^=N9CVVUQL"I$;_Q#V5$I-P;$:9[5@&-<P/
M.%Y71.T1MPG[:=4[!B]VBQJ2!.E)HUU^+QWI71%E\;7H>3,!@'JYR;')H;BV
M,C_X[COGA3.XB6<0$'<-%ZLI,'WY?-4.8?K-IC103R:]VXO 3'Q]H'5\/!@X
M;@$<;@8J?^%-W%D8^C65;#0-R7:WN82BEGI9+8W'*:Z/@]A>NM**EUWDJ$#F
MA(-8T=M]8\%WC(R=>:LF]GC35-J71=%W_O-Q[1;K3GYMSA=_D\;*YIM!V\U.
M*I,/RCUY7^]\EJD@6<*.XKW<RFCN%X Y2\JP\*L3VAVTBERW76%%N#&YL"B?
MB)!-BX-WP"-] [47"B31' 3$23[#B&2D4_:,X&)B$HEA,6%G!SE9HR>BNPC1
MP!H88N(:[W"<,9_FF6014(>PG(F/+TBKDGK'96E6*[2WNVH29CS]%DR6GI 5
M7EX7K8.,GO<T?!(@JT6#7@G687_GF*BI CD%@&[.6:T(!]:G5&MTU1?RJ5-9
MR;*TJ,+W<A(#E+#7H)Y">L($>^YP=1.ECYG)NCR3G'+G0"NM.71@9G],E$*@
M 4]T9>4]5A.[DH#R"W3E[]2+0WW(:>Y?E5F>/MA/DNKW_&6%E_Y%W<[ .0ZQ
MJTM& YC9#04_8G1Y=N0(ZH&&&\ II; KW%@:>$'Q"HGN:MD]-JF)Z1.ZJM^E
M+ ;4/4LAD5#5GM@06 P2L$W)8 1:1#9AAM74G%B:_U:=,V(#]1!TH.5O?*"5
M"/.^6;%W[N<#+4H>7_;KUP=:-=K9<+,%DWNE@PJO2_CJ18(3.]AT<W5Q=\_&
M7 !HCU3UR':[YO$5L\'&,/IJ28Z@&+'D]6A'&X>P7?)R'I:J.E+0J8C4K(7M
M77#_N,$G33A,.;?F-IE9!PD"#.>%_WDFIP"8<N]TGFUT9B-J9?Q68Y4FRC&F
MI^Y?#5'\V\V!/^Z=DS'>B/(NO87_?/%OGG$U#R@8B(SBVL?<['9Z\M;XQ=0/
MHMJ?42^ZSR_?:"Y.E4C.G<.'/YH5E6SA7#3G19RAO,'"G;" A5B3?9DF^ $"
M0A0@TL.JF?$)-I(DIR?U 8%W$]#1=5*V._3!F>?[F 6-KL!ID%VWFC\>EM&(
MR+?5 8J[#[3N&V:6AEF#F;F!W]Y&'AO\\X"I]-ZV">K%>7)S<!;.BI'I1&<S
MG9[<NI/H(D<:&&Y>C0K,QX'FAR>-PX_ &\I^%)[$X/K3@.L9HV%>2ZH]!9(P
M='7LSLGG E.KFI6'[D91.R%!U N;0JMZ9E-&CWB-V(;1T:U0H-^VOU$O"6-]
M>:0YKHODPJ+[^4FU7]=*JJQ-F+MF7V[G/?:8(V7>$8O%&^+W/3T_&D5%1<23
M221R29&U6/R^I?;G'[^*1]<N/3BQQJ]/:2^W_#P64@[\RJ?*/&#>NL8:/0^Q
M=^KYG$SU?]L51%8W$CL1@9WV3G7,I )[8.-0\M+^?SX(_'^A?M6IN9CS@P#P
M=#?X;WE%:];:/9T?"+A7=(OFD?W\+NV4&.?&='TJY<;*F 3$0V-_FF6$WE<3
MK_M9.#+H>@=:]@E["@YW:B=(L:,9$"KV8_T&8M^-5D6?M#:AWA5W^\B50W?Q
M=I]H1OPI C;CIK'V4[C!PZ2]_6,R+S9;9!<%]@\.YM(@,-X2@!JY9IBG]Y<M
MLGQ 8'-V/+790-$ZI^I "W/<"$-GA:*3'^KY<,G/P_)F5-'JMXE'GPXY7$Q(
M1OZ96IF6(VAH?.JQURI\0PU5!V>[B"O*%,Z'3MJEM&[V]HD'\3IZC0TF8T$3
M@>U1B>.EF>56&@6I^6GQ80$0-F_ER%%FO;&.<6CDI%5]+"K?<"9587>(F&H\
M8)&V:Q6XO/G#8$Q.9E4E[75!Z6*/1S(5\D6S*/").R J,8G*O[(AQN<_QM#K
M9M*V0BX"<!A3V]ZA>^4Y_%NG,*@KX^K$3>0U1"'DI!HQO4%6-9E#2))&]S<^
M&:6!<KC 5-A3W&1F.[,7MCLC+W_^M: 9S.>&5PS]P%VB5_G5T;J20&O2NM$<
MW.4*^2*5L!LP?#4*\N3/_W(QM6\\RS(]T&*>5.43.K/+AKN<&H#)_-1^IZGZ
M=P3YD*F<<>80;?*]+4QYPO-AN=?A$L\+L+7FKT0":>AQ&>WJ=([B5\NJP[!8
M?_S\EG',CF2X;[C"RPH<=2V35DUN%?FSJ["9G9UQ/TT&&R!>S&VY6(!?WQA%
M08"&-]N@D4QS"Q#;W$O7[N-N .W5M4C&@58V,&G14>]IN?WX8E7^*W:N>L'W
MSHU,'*/Z0$N6 @-K3['E&Y<NO@#.MJ**=^7IOU-5^?I2)%?76WYAK1QHW>2E
M:A+!JPN[TYP;U*%A"T"5TYBES*>=_.61)^R=(K&2))\A>%)),V^[X''!N9O5
M=8-![J9'&.H-_4$3MY'M-NL3_6OMH*#']NBJ6<M\7Q6:0COJTT:&YU"9GO<"
M?[>/:&R/E+@[AW%GXUX3^!Y/LXQ,4+<C8P+UGNJJ2%)6BLG(UM50/<Y;7X=P
M@SSR7G2.UQ9KXKTF>%PJL\>&P,G#5%Q]%,CG(R?A]@@;S($_K+HR,L(Z@[8V
MY#Q1098( 9P'RV07-Y%.@XF][ZM<L-^P'2O0'($^91'1,XVW6/145>__FG>F
M^\7&I$%61N+^X!#JR=SVA#4OJ&=_<<'WT-CX#C,AGK.)?/=+220UXJO\OM-"
M-T_N6<5W#POBU(YJY<LPY3X8^/7T]Q6+:)-1$J<T#V_?Z9SS42R2!3#[TSJQ
MWJ#%?OE8WTH!=T"0J%O@IO(4 []"^]$J<R_UCX%F'K,B*OC3>,/I^@]5$K3*
M\J/1@ O^6><^^<,"^J+%D1#!SKY05OJ6)'IS9BR\%E?KL+@5F RN!'MDA(YG
M O0+5E#D&'N&249HL$[IA!<G?V=)MY+KRX\66@]:U@Y&1X$E=\+BI14X ?CD
M"V^03,=OK_XFT[SJ5FT=RZ.]:X#W0-)\L93+,DGV(\*FK_C&<OOL% SL=K%D
MADU+PY]?;$"4(B9R;,06#]:9ZR=PUCC(2@L"40K_@(Y(_O%61X?KS_5NO1WU
MSU?K;[<WNPI0PU>6:57'_.,G(G&@R5',YZPLMX" X(C:YBI=YIE"-JD-32HN
M]5ZS YY O8DC?-3\)P*I1Y!B/A\V.Y<K-YW:.&J!>Z%S$0&S24>P/X+*3=WS
M,CNSY[\6C6\8[*J^^_9%=_ES-*9>;><3[#A+/RZEVVS^*.TRVRI;AFGL:9MP
MD_VI>#O(G<2%FW542HI.0"B52$1;13"B0!EEB9/SL(7",S4?8'/V:?:3(UF"
MMBY(4D;1#-Z>F>N[ZOFM80Q!\<-.V;MH'ING=/R!*W,*\?]-3@&:E<4=%WP;
M0PIZF+@89N1%_JG_;^L/M*?"C_O9@,Y*.A.$_K?1.[ZC=X-'-*\UPH%^NY67
M E>YN_M(P#)/^)*P47H-&KOAVAV>B=UN';T#2H&7+)>DI.!>\=6N&[$AI'>"
MKL+C8]1Y<0 (;#C60WUFL3%C::_K%A74[Q,,+5B3_$SS<3#YFD^^F:8;F.RI
MKXSE+A#+>TM-'N%F@JQQ2:SMUY1KV-DFXH&60WKT\>4-JV935T'QSYAF5_[U
MG(IMTI9X%%-%]\"4S<_8ZCK,0610\^W22\2'E.(YM3NH?RUEN-H*XMC&=]L8
MM!(3GH[;I4&K./RB6F:O'<\&WQ4A&=]&)"4L>5;/(+_V,;BK$:#PS6]JSGQ9
M6KL^6#@2@R Q_[3#BXM<3<_:U:1MMI8V8%>3%Z%/IFHK7ZV[PR6=UJEG5QMR
M$\D/V$%@X?/P)1X#)6:-B2HLW N?KI(S9R#NU$5\0H.<:4'6?T.)L1O%.'7:
MYA%D4W?CK.,=Y@>"_S)PJ**$@PB<5IS+1&&JP9%-9DO1=A4K3/-X4D->DK53
MF8[[0FPL/'C9Q$!?O;CLFYY5?H&?8K'ZJSZYS6S];">F7@#(MG81!ZU:A!%+
M'E & K$+- CX2(&X)W,O_WH(_1O*L-IWG1?'[O.PH/6FV:9'%.U1\M%'X,)3
MMA&;=% ^>#+\C*AS,T5,?19C?7Y^(;@TA_6%71K@1@_G9A&#8OI=F&PFH9/O
M+IYA&$ZA,^HJ?B+.XDW^I;/3D?M,$W]VS#PY\H.G)RN*?$O"^CB5">[X8#B6
MG$KW2P9_4-;]%E_K[L[Y!49R& \,-W!D!.AOIZ]7]J=HSB'']PFC^U;%0YY"
MX_*)TB789-B\(A+_?E2?1.W9G+C-A$+,+2_7$5?;XI.?W7N]U0C5)C8IK'J'
M2?/,C(85:DI,\I(A.]X1]<K+?M<;Z\,_)&[9"B8<: 6P\P@+'S5NZYE<WYBQ
M^UWT8IXJW:RL8@$7F]@WPN5F:I[)!$+;"NOL>? O\([@JAMZ5Z7>3U?$F^LA
M(N2)O8&XY_+(@=*G)4$-6'P5^$7;:J##PZ<X$8SCN;CS,,(28K4MXUH[X0JW
MNGKC  (*B6OW0*5F-ET 69?^)E@.,K/>%F&S9@@,DDP7"P*.V&*TO\ZS((_$
M91QH_2GA;O[]D@?]8(G76,=1#M'6IJW%I7VHT!.1 GTXB^[]T? LSOB+\E/T
M9A<,*KFDM;IC7<49RF@6*<("YCR&:L9+:5OT RTK>:Z8Y(@-F R#A3'RI+KV
M=A!FS%CP3]EKH-$$Y%.$U:3'*U:[53\QRPGUT0Y<<<1WR01O[\R038 Y\NVR
MTYZFM?\G6%3\BP)6F)735J2*SRZ7?T]%Z*/=E-89W?I'*H+>_W"Y_$<J O&S
MR^7G5 2'69I'.EV;Q(/ULM,L*>S8SQ&-43/;/9\C&LU)G]T9;D]Z,]]^NG1T
M=3&*BC/2V#X8"%Q-T-75;1VA1=36BG1UF>9>7UW?0GW0%6V^7A=.K>=>\A\K
M8_MA>KL<WWZ3\-'P$_H!34MSSFWEWZCJ'O^0E<.!!E_(O5-=ZU^7N"H[M\/8
M?_YLG3>$ZM6.9E)LHO(KQG,BRLP E@83S4V9#2$(_Y!,,'TX9CIPZA35JIPP
M2QX <TW3_^I]8S&IRXS "%J<)@UD,I/LO<?\ZG:1W\R?,EN*V,4$KF2+V;*:
MO_PRGFKB]^6A-Q##-VGP%@'N6=>OYW4B9F$>YQ=Y.P5WY0C,\SYT+;R2\_7C
MZ4" ?0'2>-2XDG%3TZ'YF5LAXR0(]DGS^U&- YEE"^J81L[ENL[L7HP>MD!>
ML[#$"4,4V('#JK[U2.9Y&4U-W;E;5>",L/LX(8MG75X[B3'T%;0NXUR:@*Y%
M?RCGH<5J!"$IHU,5.N^03XL>P)B\6(\JT+;H3)T[=__XU3-9KHW';C,GK$H'
M6HHM,;7M)26[?)SK/M)4MZI(F%/Q[X+SLNAC(LC@DN+XYB@*6EWW8J5U6T*K
M,>GT9T742CK1;GE1-6 *>Y.TS4V]*YCJ&3=D;O?$5E=,D[!32<#4@ $._N[_
M:@LEX@B;7/G:;5%-NSN&U%_OE]376QE$V,BG7<3YEW(08/]Q45?8)+\#!Z9$
MN<17XY#UE_DM]7V?[68>!H_G'7Z9-X./LUO*:0;A]8K*A'1H?U'))!L/B#/9
M"V,2,8"O&@)HD361KS\VVMH:WN5XXM8=BC1.Y^!NWI,C>3OD5TE)0,NZ_9D_
M,)&(N%LF*3&PM\L9'.&%2%S:S1%Y4MG/D'>AF>E0"&2D)VF599W%N07YA8C^
MI;/E-2TYX&EXW'G9]:>RZ["M.#R49'L&"\J[ZV146\*\D*IP[QR0CTRNN0@<
M7P30,T:[4NTKXT^Y\ZTBRI"O]^)8'@_!'GG?C^OH+!::7\DHKE-SE:VBKLCZ
MP)X9QYEOSU"35;^X<_1\\K(!)9[^@WZ3S@ZT\,A-]XJ0JSZCV?JSD1/1B,"*
MC-G3YT$,QV]HH]=G'2JOQCC21O5\3Z=NQ:V!WU,POGM-*WFD5_VL.":$I%(R
M_"1%C?J"GCIR*C.C%NO-C&?<(F9NFLE9KU90*L:XY,4EO,;) [Z7XJ99%FL^
ML?U=[X 4-]$WCBQ '^LEM8%-W+ A;.EBNT3*S(ELM6M[6OWDU8MK0B;PW9V&
MID':F9558]E^XPUUK5*P.[&K.;NVC&18<8V3^O*055)-\&^R1L)%:4Y*=+*B
MG6#.O3,*5FJ>]2-_6W#DT"-5ILQZD#0G<3*JSUCC59D<:$']$^I3 /LAD?N5
MCDSD'61D$R$&MLY-R+3Y[A=AWX\XQ(55SYEWZ3%M5.(D\:HM;,G!9>5!K^0Y
MW])RM7:UJD10WH$IOY)2/N@OOZ>PY6>6WFTVF4@L+J'OF<#NVK>AP88T0%6F
MG1L3T9++=""V6-V>?.]1T4$M'!VC-%MDICT&OBR1>-G;::2IJ)J(W9$4^]8
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MI<7UEB]) E?#3=CSCK73)P58)GKJS=M!)#3+X ^Z1LP F(N5O6Y$D$):7+P
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M0N^?.#/=/PIJ2TQC)5WZ2(R.6X$<-^),9M-R5C[4^WI%QT7CB\:ES'SNZB$
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MTE8#2!XJ_/T>S'A;&/WKYP4N31X77[67@PH=Z9KJJR1DH(V__LKY&9G?(8-
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MN5Z(NT,&9=FZ&W#MYJXM1+HB8\-3;X9+EXY[!P$
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M[\52M/NGVMPKHI&\<6Y]X50K@NLCU$Z 9S>QQR8TSRS]N$(![O6/],;VV?)
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MRM(O\%7FX#SEJ-VT!VM\4 ]YCWDLOR[<%F[^TEK;"6\]2R*U+,ST ZOB- J
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M_Y.F2]&]1T@F.>:D$5(ZJ>H:"Y/&@EU++Y ]K :V5TT1N5?*=G&173D[R4I
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M0JT)_;RTG/SGV>;XGI@*_4/R-+7#=B88BYF#J7.*4+/K/+%9"#R5$,[!9M9
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M/=/0@EEIA?)#K7'6<HBYP?_3#W$#6S]NK>]N2_<U-NF&ZL@WNXXR)-VIE8]
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MH;J2Y4\*P7?.TC\I=+[[R),#A5!KD(!/"D5V!B7]0Z%A(OI H;9ZDG%Z&^=
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M(7,#<J4CI?[Q>KOW\F2)"STA>,C+-=D52F:G)P\-C7M-P0CUP5[)PP@1>0B
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ML3P"1A_331S.+[*TM/!*S)]J:QY?"<AE1F6VSR.@)';T#[W0.H=P]ATKPL4
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M^Y6OWJ;66NK$;"-/QYMP[3:MUM?3[(Z_=T8(?%B7"GHJV)M&WDFQ(7\D/]Y
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MQF9%=?EXQL 7MULYF+E JO +L5F2GWV^J=WMTDDN,;AUQ_30NYWKDGQH/S*
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M2V.>3@)4=6C#K[BZ9:E%@\G04H_F>%1)2E,@#SO3\- 5($Y7#?F>=\I#DF(
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MT&IE=RF6WNZ^<(C[4# U.YM4]2_(=C4:9W*9TXX,!N2,:&MK$WU @7B\[ ^
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M958B]&Q <1#LV$3+@D_W^DM4.M?Z=T@4T;PX!UV5726MQ'W3V)\Q(LYJ-*+
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MH.OJT=(*A\UO4WS0EZ:I%RFE,\2AX!;M@ZCI/Z#X;!G0)2+X\2@%8-/J$WP
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M;16BI8U"_]DE:!]N")7 XNW9?"3OGB8,Q%PVJNFA4Q_X_*3%=SO=\P*]57V
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MH&7"(T2NU,J!%0'PR?.P!._P$!UH@,E?JEA $&L;%*'E> "..6B12:FT["T
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M$/ 2#M(8B0=X>9P:F5L(8B5V.SU#Q4R/Q716;9^6$^\BD?8IW,;#FCP4D58
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M:7$PFQVVZV>U-0\^)=E?[?M_2V\*^7]$;])=_?\OO>DS34%*"F/C\7LOO%O
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M5')C(YE::0)SLW>[\SSO3!4>:U!9;ER;9R/*^W,1DCX1K3SV,3RI;03:I_#
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MB(K3FE!$:Q'<J,$/P4EW\-!%*2U^'B(J)HP740RI)5^)T/'"<M^K["_;F47
M'G)V!-DB)3Z+!3?EN'*##3LLLXJ'(]SYCPM__*=(GE*]3$]T,@-^3:>]7-\5
MJ=]:_^+&]X,7:^PO$_*Z:EX>U.SM)D-IUP3C<UO*T_W@"ZLLF[9B@A&]+LLT
M2IYVYH/0;&MVJ>##GAII0\J84\2R-M$%8[U1;6;1X>$&5R:\85&05ICF#J.P
MSX]9GV&EJW*75)BOT9A +AF7EGTWIM43]] .;+2G%I5KV!)2G;;M46F9'8CM
M)Q6\C^APRM2-X9&@WF,MK9!.\Q_X+\'N"IT)(+AP(!:Q$# :+UC6Z2C<E_J@
M!$K"W=EU3P@6VMD6E,;YIR8)BSL2-TS74]YNR5 $N@%VZ9RY^:8+U)>CZQ!'
MI*5 <6'C@]C$P9:$M1)I+K.6K]'.&S8]NS3:VTXQ0+VZ'IZV>T8U+AF.$7'A
M&!E[N!H$0AFG.'O_?[-3[']#).WLJ;V("ZSCD"=_'L,]H/WRH952<4QU=)(6
M'O7=2<7)X9;IYFS_!V CAXZRSG>!_JS/;XX$#5BL#.EH>P7$<=C(WY+VU.QG
M_7O4=9>)Y7/I@]$-8QD(&BNJ)0;BVLPTOH+S?)I%P1M<Y5(I>)/#9GVCBXGM
MY3+<(?NC[JJ)@D^^D$0H)_!I;GA<9DD%5C\\^:_/!.^=8LJ==#;D/AO[[FV[
M&+@(Z2ER??LO]WWA@W/=V.#SP^TJG%_W.8F"C ;ZWP9%41LARP ]0%)]9J3P
M*A'R5H^,0-*5NAX267HBK2(QO]V3<T[5YT(=5?+KG%,ZT(I1:B)%%>$S&=+N
M$>R^8=TUNY(0XXA$3Z1?'J(P$35.YWA65S@T,5984N90 G/0U%\<'%H,%$^2
M.S#C?%+OJ#VW#P50(.Z,K]!\'U+6AGO]2Z\-,-\]W7$HZV0/? =A,H\JEI'=
MR&N7CG! 1X=$@:8BAM:K]\MLS3$X?5<=?H4$/&[LGR31. FK";9LGB<VP!$H
M+K=Y//QZ1IXH0=MSL#3]1(;NP4*;X>::8 IFT84:,5O"_<2);-?JB/VO?XCA
M9S@[TQZ9:@4&J[_ZX5#5E#TL)..#Y/4X-'E=X<W9!T]'KA66 &K-G>.FXX%
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M6OR,G _7>Y73AS\^_\4.=*0ZG%.<U8.P@+S*Q7DSWS;PUV>['MHD@KL[%AI
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M!$:J0E  _KE9:9@0/9:C?&[=WV=RR^Y!R]:(>C7%P@U8H[8W]\ELXR^(Q"R
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MO;2O7)FCHQISP*;U=7.B_1/)3C<E?[HN<N[*\/*1@)'Z[Z*!UXBN%OY/W]5
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MY!QVS:L>[!.P*%=D)J'NIP;34V\\&)][X$M^.&.\TG9:?<,JDV7=<GY3)P3
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M>*3-H<KAY]0&KF>_F?$Z.ZLO#>)&>.P$G>D\-5T"F9EDX'6)H^4$>1)A$7U
M8A9:=HNTQ9MCH]KNK O^)?/V,KJELK*P88Q=3ZP,XTYJ&0#*PL+:Z_PHU:@H
MR^E@]A3NNR2#7AYHA+K0K=9J5?$SUI:X[&\Q'1J,C(:K5!<TF5_45 U8CK5[
M_>>OR41RG@8L*@IO\[@6;2/*7WK_V[0)A/<^"C&+.]OZ@IFRPC$P_Z$WV#AD
M\;?)"T"80%9!6D6!Y406(;JBPI-NF"-* =QW!.;T>M)[3WO#C=2=879#^^U
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MAT3W+VLDBJWU[BQ[ZYU7HTZ++"!/F[\E=?ZZI7I)*&X;A@<%7@4I+\PTNSM
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M?'9_3^U1:R5F]?;DLN5R(B\T8'I$BU4]E,@ G.9Z.SCL[K#OIGKC#WVH[]G
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MH=57UU.O\J:F>$P50G73U1>?('LUD6/OO/L=PIG[9DP9SGBVV\->1WMBYD'
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MG$X"[\M <+<I$+6@8)*QR 3K],$QB7#WM^!I.!Y/I8<G9'M0Z@,:O<?WXBY
M4E^_7V:9>COU!AL\:<VD*F?V0"X%E$G/Y;WA,:Y?OGI<H>\*<<CVY*HG\($
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M2$XMD: F:JZ:[J^YV.-)90 ,"@H@XISHW==F"O4 ';K!C+"A([HF1+R! C[
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M!X2:[,\<3$I \#0/E7D1$28O+_]-"=*9QTDA42EC@56^52#;%XET9YAW3D
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MQJ_"?6K?N/REH5?0_M?!R\:@*>.YN[V02]L<KU[;'H]FU3*/GQ9JTEZ^+&A
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MHHCZ]A67:Z;M_07L&P2%S-N';V(M$@OP!@%4KTP(U>'V8P7<'SLWT9#',YO
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M70Y_D1R%P?X6%WR^S0M1QC9SK(,\M?>X?VUD02UL;M@+&L()8/<5?#D:7;S
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MJ-#+&ZFZHKWKS$W/3PJ*)B*C29I-<''%3*\IX!&FV Z"C 0TYGA@357P12#
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M;SX*V,EMZ(4EV[_:"9_#]26R^%O?3!=WLV O78RL[;C?"6&GRFN+ZJVV"U'
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M*]D_>%"5AL85#Y'O0?G'QH2==4')T++6:W+:6\O5=$U<=*UV@0P.>5L:O_C
M$7^"6SVIHTL.MN@)@$0-P>I=(,@<9&^RL43_WCQG_GB=41UTIAR)S$&\J_*+
MN'.SIL;VEV*[IIKBI[/%4=5X6V'9W8%$(.+<]#^K]P#RA_C9BJZN]:RL.5-
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MM/SI*TW%OC+-%M;+M-:ZXZ;VTL\/EK33NUT/$6586@";01VN"#?^^1ZWR"R
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MO8NJ4:8QK&$Y-N:%(:$%W7_=I%+N9*<RY#WS'7DIP_/:I^;5L '@A+:>*@W
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MVN2LB;0\T]]FB\AULD]]O4)@+&N= P???RR\RP;IM':YMC1=CZMT11D?J9"
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ML\AREVC:,5I*BKF3"]708%)<9N_5GL*X)U[0CAOV9CCH="O96KBK4GJ3:R7
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M]:DLDWJ[CCX43?S@3B#_8&%!O<F"%.0WP9W!UT5F2-O1B@.)EHI_'*G3#=X
MSZYCZF,6C,(;#M@F _B@'_OT5A<;"I:'B>L%GZ:[W?A3.?I+8H_J^B?#MA[Y
M#J?')]7&R'B_2D4AOFBD6<] K0\9K/RI _1 ;"H@:#-T0R%O&'NW'WULK44-
MTN>$716#(N4^+!+R!$4X)H;8809#LP2AK-RZ;G 3!F<\QT',EO,UKVS'V_&
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M@M2H3_>11'=-4MM1QTYV\>B&M:3B6F9:7VY].Y7;?1ZEYX(+S34EA(?B7BF
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M$% :QJ$"X7]]<L:TE3#(2XIQ_K('7Y4?1B2DG5+-B4H)I:>)+S82.E8+WBQ
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MJ*FE]"U@>BIXAP'+#\:#5!>U>ZUWU9J[H3O#KG[K.7+<ED$![/FNVKQ*;*2
MW^=R=M5B\R XF;G5VHN_L"G<GD#&+.Y4NE4K\+FC.W<%G-\B%(V:S9-[7M2+
M9NZ*:C9VIIXI:IQOMZ0=[HM^H3S_0R3@67:6=$H4('Y^"EN:6R33FN]=;5AF
M%L<):^/\(3"<.FV#.*14]JPD'!/W8HU&8X(NT<Q9C5C6PI-L4/S0I2W[9!Y7
M5<)['&NFD0'!C8<7J:QNXBIO;_.GN UUO002/;X\5YKWCS\8QO<JOY%;*.R7
M'"I7]Y-=EA9^%LZK%F*Y&03<LWS R@OY2#6>4N#(<?O4/:7Z=O*6W[&TX^+F
M%(*.[W4/"\W4)ZJ*]79%M&I2(2B<5;8XS7Y Z9B6/9247^%!4$PTNB%8M5B*
M")4!!'A#: !VI,["U_'I:ATK"37OMS R65H]*:E\*_=^ZJ^*IXM51B&FGHH'
M2M?BIU8A?XU _R-@Q]J<7T? I^ E#O<C?'YA9<V5'I]L7@C1?R![EJV1PXZJ
M*Z]L2 B._,&WF_KIY)K]#/WND.V/99TZ3QKNXNW*LD[4#;K_W%$3X 1>M8IN
MF&FX&'9*+L$Z(&OZIQFG$W#/H]M! <6$M+'$7IO&&=9W-AY-\2RHT[;6<E^*
MR_WP[M;VH+P1KZ][>1)OJ,&W[5L=GOI/"%[L! G*2VIU:+]9ON#KWXGR+?8Y
M%K"3,3.FEU4:=V>-SV,0;>'+.A>--!W/AL9L:*X63S5M7SNVT#$F(41P%NL
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MA*;]8]M8 867%LICCJ*A [+QY#$80BE#3G@4YG '\H+#KJR,H]?-<8[\*!6
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MON::HOG#<*O/C^B(E]-.ZD/<2>)\[9P.I!(K]HZNJ95SC_48&>E9#?YC';W
MH?(PWIKNIB[@NFZPIOLR^D1C7<->#KW#3-R^J_:<,(^9R$U,IJ$"&EV[HH2L
M18*QJ7>$R>FC1H?[O=+4$VX-C?.YE]&V=\Z/K>@L&K)"TJJSFBG2^466%; 1
M31^N<,!05N/Z$W@5I@77"G[^-T%UOG!J:F#JO;G%U%8J_M_FAMZ=$DY](OFW
MN9_G:O^42_S-W%-5MT7OS3VU%<G$V3B$]_G3S%V[JRU_6Y3P\@)Y9&+S-(9N
M;%&AJ2S8(>O"H??A,SC?6IOL*:2J+*> V)+%A(0#XNCZU((K S)D4#=\#]VA
M/_D9HDW6^"G?_4#C5Z.QB5I+'.]#3-!A)O.7+!>Q?":=V_%1'8E8J]*Z.U7#
MB>Y9%CST-XR*2JL%$F0P*TA1$4TX4FME956S&2VPKA#KGDY>?+RX'MC5 V!(
MC2'DUDV&#-$OY9'M?ON!K!1Z"T_/^>;/R/DWPC_SUQKET8I*Y=J"8ZR!UCKN
MZWA%B9Z4-W8!I@ .1=HO"Q?68KK\.P^4""\NKWPM;5E6YM-H6X,A/1<]8^W$
M9#/5J7R7/<[/TZT[/G5TGDTI&%_2[=Y5,XE5$/G=0&3@VUX(P>\)&3 &6PY=
MXYIEG=LT2<@I?;>KEKN3D\+EF 0ESB<A%3'T^)QS_6X IW!#\WPS2)'2#[!!
MCF%?\OSP#YYZQ[=SMGYL6H8+.BM5C%[6#\+4<]JI'Z))XF/'\0Y81B.E\E)+
MV17;,J_'P.VP1R]Y@)GK6YPP>8);0N_I:Q[@8CA6W>M<:K1\7S_JX57<=[,F
M=B'D/"L-G;8@J:4EU\Q:R$%J,C4J$*AJ5S]:;;A::J\H7S[A.*[T,Z\7LKD(
MR<K-HK5':^=9VN?K>D-''SPH_)Y>9N[WWZ_0?L\)S$MR\O902(-0!WYVI2[!
M)536IKS,A[ZCM$^_XYXM*/(_F]^$=',Z']G \QL<#?3QBNL%O)$/NL:!?<_[
MYB<;/(AS3A>W@[Y'V.]\-=.R7R?0RP\^:E?OEY<[G(G[*:O!SL+*.FN(1JT-
M[.I/+#;5;)ZURZD[0.5-+#1P#E_!2R9NU? C*B]WL6JYAH8F4>'V+1>4^FL-
MB?F[:NW*6&GZ.GEF1'"?19>U@*X\2/]LE+8UO/"2V+$:L7Y5BWLS[K/>98[*
M3,70=?)/7MO3D]SQ 45.U#)HG5R7$?7(GT#KHO08]E/=(=$URJ$G.6DA1R O
M1F'KXUA]A^C0<=*$IN60\^UKE$"FTM!0WTG0\OGO@6F#"]2GFL1)%Y43!3HF
M1Y9Y#F,HXQ H#[C6OO4B.*$T;,S'I*_PET&M7XIBE/H]N6@,*VXE!!T,=?31
ML^2L##N=W"8)G^_XKV!-AT*!U@#*I'(B>'R(,2*,?>IEN^RU"<B&:/9=(C\:
MI7,Y$%G6A<4''<8;$U94.88^=4=FN3E&,3")H:R:P]N" P//JZP2>*3\/UU!
M[,==M3$6?2Q&^#:06.F=<E*^C1"1,^Y-O9Y2MB!RHZPV_;:;(JUL!?KFXGUV
M=92BMGV>63NAQH1BC '0<= 5[8/>58O"[<'EK'Z8U.<54<(TF@ZJ*1GTS^YQ
M]+=I-L,JE7QS=$K<-6M9'9WV2 ,*M6'HV_@*UFU">(-KA)P=3^@A'JVQ^U(-
MNZ^<R\7E.E3.%($3;N3\?GKFPY_@@I^:0?6;D>_6 Y V*9<VUJ@.2!"MGE9M
M<)T_K=5FH:/PC\$=B?=!NDVO.705?9+<)J[&579D$^U6[3*PCBI,6;";[41F
MCE)9",\:R]!\,>9=.T&"D VJ-E\GQ>.[8$\/;]+-)K+XV\ZJ0C.ID&NS4Q;%
M.HP?P-#V]0]T@"ZCR.]XI$='ISK<2=12WNV2Z]J0;_Y4R/]&V&OA@BP]<G))
M-'!0)=&-/-M)\I?YQNI!NFNU#O,[N8+M]J#$IQE9;55SS<T$'^9,QYX6?%V&
M1FC$33+1^?+SU-3UFXK+0DJJT<\JFICCR%)V@(5)D'$'5LW !"(7E>H:S7"I
M&:*L-:]<:^ :1Q!+4DZKHC-B6A[F6;45AR[:M$(7$:";,DYY$@LS[=X;U 7R
M^[ZI[X_NVWL>,T873U9+7<S7.G1L]D]S6PM^V/ :U8O0=E3NJEW8\)>FF?1'
MI-S-;HG8,&LXIC<0:U=%FRVR,&ELP%Z:GK*MODO;&>KP,I]F/)YWNB1:<FN!
MZPN[K4(-48RG[1P]A2QSX2&J2D:BI!5*\ZRK;Z\%6A@X'V^/M3/0?CE]U$RC
M=21J:.60_69QQ\4$CD"0:]D/':) ^[V@EL 75^\>_>^7YY-WF#[]2[SA4,W;
M)1H/&'C>C>7H%[64T:-/24+B&7M!U73W@D/8X3%?,/ ';[_)A)H+K+,<T&<"
MD--G'MV:R,-<8V7,!B+LE*(R83:HU6U]5TU;)%XMXI%6,%J"MY*U!@,P6<GG
M1],4%=4!C4D^F"VG]:VXM+ "?)]_L6[BQX7*U3Y"<+QD?O,5RPF3=\CRF"+K
MB,4]ZY__0^^#-6I(A%-;S(:XJ$H4U3^_F8A2KX$69J?^5"8R)[*G 7)_=(SF
MF,<!ND98Y!E1%A%*SK*M(CO')HM$?=^]CD,=U'@XMN)(NM39 SL;R2*<D%IZ
M^3\']J8\R"PQO\RJO%0T9._:)VH9>SLJJX]=L_FM3BB/7CD:R#7A%G'J+F42
ML;5$BWB;AJE=-9R3@TCYE,FZ-U>BOJ<*D<)*Z#T3 8!"NS9-NI&^\6Y,;HQ
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M']T?6]%(FSF!C!#F1-U5_A'+8=E!=JK,>KS4$A@ G9 FLO'21&:U'/+;YMM
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M_977"BUAL.@2P,IX/FN\>5XC5T&6/B+29TMN^(AL=LMHD:IK;=OJG^,G0(3
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MY=K;YK[&N;G3-JMD3&XJIB:D%.EA"E%:@Z 0<4QQ_J (':V*[_:O<F1<=+W
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MD'^\+@^^^TT)*KN>]A -)C3J7)+ ="\3B #-24Q6_<U63?J>4GB28M!7C@7
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MXJ-U?.2("P"UGAY,9G=W-*7"X!ZDPM>M>Y7LH_V95>#ZP+Q\0)O@[5/0B.W
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M@PYC9G%EPJP0(#=FW7O81WO.U!#-]I0[09_8<0E]K9*&@#+/D<I&*AJFW3H
MLV,>DGE?_NQ/AG6!%%^2N9R0O.4,Q 2>,I'/T<;FNF<>69_]\8%O@G]]0AC#
M@SXN) 7GA>2-EWVM^PW;86S2U\C=9W$XZ-K7]40?.FXJ>B_P^=DRW&I42"R-
M#80UM@/!T (<I(?<(P@?A>)@9_E;?(ZU*YB+/Y:^C8F=] GC*:_.K.4" P[*
MM%UE![&02#,SBU19P_+1S,6OOWK70?@=R:F+5<3+RATM"_?OE;YGMA\PB!L=
M1.3[!RV-ICR.)+FE*6J?@RZ1'UKO/_A%@B*),NK]]Q2&4=L);X<@;W?VHFI.
M.K:@W_?].E0J,JZD=JW2=&*)O3E[<V;VDMW#+) 64">2'$KDQ)&)(P//NYGW
M,\2&[EZH^>.UIZH$"6\D]1#Q!6,8%"-"CPR,C/@-L")CO^,)NO_@]IZBF^T]
MDE8*?FT,(?@X=&W3A:1(_5VZI'N<LQ*_06'=8ZZJ[ FJ[8&O8*V%^O0<_<M^
M__/#(>X7?(S&64:NT8=GTW)MI??S*Y)UM!]+R6&:L#AX^$FP0$(&CHCXP6V"
M,QQ.-0[<NIR_KTPDD69L;J)RS#\4[UT$AA6@^,%PUY%E5)D"4Z:H OJGOU<X
M[KAI0OB6N+Y'CY(_>.E+LB>5R1T%75WY!MQ&KK^ =&1.L]AA@G,^S3;EOM']
MTJ#?JU"FAN^(E6N1V[D7\O(R:9,SM(C*,9)RJ)R-%)#;=$O@]J[!9FWS!06O
M6^;7%I4IXA0,LB.F]^W,[Q29*+=O@&JWLMK-S&=R\O<NOH-H_W6<PR['>B1M
MI$>Q+X7UQ<),Q1;C&Y[C\XY^_H4[Q8?WWFR*DH4K27=0NPMPN,Y\^8J;M5P&
M7\,^PB4>G<I'RV>\:NO/F/Z=YE@\Z'G0/?H#\S<;3#)\QC?-WX(C5*;$-8SX
M":(FG>@HBDR_T3JC2 /5V_MZP3C*F8UQ*M.L)8D=F_P=[W?99LA:-ZP<6P.'
M=0O''$?W0X-Y_\7 ]XI67BUF2?L7'+-V46.H:';HSXF<#)/!!R[6$FM\NQ!<
M=5[L@N;.S2O:=4#J^0'>[N/XS[$?)SNE+8XSW1G^%V6V!2R_I/6^UQ2OE^,-
MT163";@JJ+TV+KT'>GLC$B" G;>M,DZ*(9EW7YT:"N4 [(ZGUZ].9[<,.$_:
MG R868V;H,TDY 6:1EJ @<'6T )N.Z>TRN><_/]S3=',?U53U/=_O*9HGS55
M-I$[,.9\M&\B ]WZX=*C>=>TE.)$0&;G[+X.D.V779Z?2=8Y*\,U7>U4PK3Z
M1[1M[:NET4@O@TQ%QE%PIG12Q*J7+J]O,U*+DXJC%!XS1O>&_)%P(%08RB6/
MDS'#)]7):<#>GKTS@)6]'MM&I*'(5'9W9?&I;K] LN>9PC6L49D3+L6R*6'#
MY"$::V#OBD?:X6-_HM06%V<=RW"_.7ALN]JR"66%,4C$P23H52GJ2-,KUB8A
MW"C:G#QSG$FQ;:^IP\@_=)^8 9^9'SY-32TM1\(-&$/6)P2)=LJ5"4UHJB8,
M"N1&530^L' L?5'U2TK]I3]&;PA]"8GW'HN*SR#PTY.S,G!>--?GFLN$ MSA
MJI+@A?A!R8H(T-S7\[@=NXB+7U\HL$9G@%&)4/PCF023*;VPKI)PEA#>FTWT
MME,]N-GW>_%'R04:]1/D2RZ93$'0<&X/2$1F:D%AS>CM3(JA.Z,@.1N>ES#<
MSM1=V=H\'X>6Z;BFTU/'+.)<K\S=7WR*^^H=A_=W&+!G$/'GQDP^S[05Y(4Y
MWN-&+R,@\]69\&3* 6M>FINQ%^!Y&[B4&?YU2DK!4 S9  =7X,&H[I>8<&LI
M*K.QG6JH@F7VM40Y2B++LB/R7=K[RP&GAT/[X8->.3 ID9Y\OKIG(<MO()R$
M'E''>!X>#+2?-DK7;_!/6;@ZQN< C"O*J4N.-05$[]2:0DR;SB?G$4'6=G^R
M^_L#I&UJ I6DA$MR=>[G<2;F!-.ST)C9RD'ERK"^_D58&.UG^I0MC-2$L<EU
M,^F+1<#<>]E[77879\7/8MYFQ,-=@XB[(0/;!S<)R 4W>R59EW?>;!Q'<)N?
M6*$T(FD;;UR2H]1X\OV@(3MLA1W>(V+J8?'R0@53V+CX\K8=QPPBCNK$FD<C
M?B5A0:XK=!K$=Q9-ROHO)?UOXB\RW_\DS%-Z?/Z6[>1NYD;"O9(95TDTP#W_
M*0.1 W=L& ,O;K618]N<7W@GG4P.@5301?TI"%NC[ H!\^3=E"#="RS/A]O&
MZ88YW!],M"O@63$,$\N!L3AR\<EH$\:'[O=J"JN5C?+X*!I?1&X=\/.SJ?HY
M^8+EC:L<QA42N)@_V.:JQAL$C[*GBT\.,(;L[#PN8^%/A[_Z]P3?ZXY (C-3
M+X\"2RL,FP)GNSL>$EOA./6*AC_9_\-H3?>SF./]\E7XB7#6.+P+S@,4.T;J
M58Z#56P>X_.[W!3W?R[-$1GJZ\L52;-N7OX94>!=5C,;DY6XM![C] LH8E/O
M<$52K5Y/#O5+*?>P]&C\5'4AWC6F;Q3DU10%R(7IER9HKDTNN>#L#KS9UB>;
MN>%@HFYI0W#?621!K[K$&AAXJI+B=O1_HSP&X=D^0W#J!>*F8V&WFR0>W[$Y
MJ<LAEY8<62_$9^[(AY&^@$#;' =N5:;A,/,&?G8@4A@9D>2=?O#@T4QI46?3
M; MS89#2V/=;K8X=F2?19.^RRWN&]#<GM_E/\GDJCAFI$5:<;GC[6J-C$>AV
MU%"=69_')15AE. JE-*CA"AE;D<QM@P;5D,%-YST3J;+M4V>T?/. ;ZXSWG7
M&?1^=6D/)(C!CIK"7(9>]7DM$&H^!#Y67)( SX#(1*5[FCT%!X!WMA';*90.
M$ED$11TX_G"&4H0&X9NM'S0?6>:]J9EV6C+-W[=OAN ZU;3/O[')]R1_,F?A
M,:FIFU-#:H+;PV"-"OLK10-T$)UJ.S5;N;RC5204X!Y"(RYX9#W_QWT=^]:1
MD1$I!Q+5P3$SN^83?J+CYS_II5:J6DCF"U[&W>;=YA4OMJS?W@M<,9I,T6WL
MO2-4&N2:>^3 4F"7TW,@D$Q(9L[G]E\;C;'__B+(5#=H<3/JFYPS*EB&UT_9
M"[?"'3;OC2"<RCALG4B:U.(('Q#/X>!:0DEPQU9^A]Z88[#M'55%?XI 9):W
M495>I3_L884,MK  68! 9J X\U#Y0Z<OFP+^*RW__^(FH7,W\8$\.L%S=M#G
MSJ:;K<#0,DR=^&DX @>PZ*PR[Y:L*/)-_^[LF'345[77W/]9O\T_DRY. KF?
M]WUB7M3=7+.CI95KB_A\M?85Q8FQX'0_0)!)'3(F$T]>@&<?(-A'W9V?5'X9
M3B;?6RCB+N!"ZWI>IQNZY_\D\*N(F@=&9'8 &YZCP>A@2&!<S;'S( BVVX=\
M^7GAZS*/K_X@^%[L FE'J[F+[_Z+,E?8\Q@M/_A":.CTZ7-E=?LU@31-R>2_
MX4S43%-)>'<$SK.E&7(9Q9'/JIO+NT /T;@NO.OX1D!O^_&^T\<1VO1RZZ[I
MKJ?#\7)_Q(W8&Y]/%> >(!H@+!)1A$X;\0:XQBB(6:LETYXX26W $7+!4+=(
MXW>- [U567NJ@MNX@(H#\QI.LL;&$*<?QAQ[%_K_-7:<C<0YFG7\0DL.R_WF
MHY\6C@^D^<SXQ,.X^F-T&TUE;=R][TO=#NN>@$)TG=)J!VT!,$3@+]T_42@/
MBZ;P 4=:ZD^)_X:Y4/SLK57(,H.J:<YR-Z.VT.HBP8>SGTL*.1R,'$ZXKL&4
M.5.Q)-RU@GI1<7+0%-5E MI$%6R,.!6L6=0 !(NL,(9#S4;';\OY^<M4^%?_
M-[WW2";',TY,5U6Y_*/5/?5UR5+[*]):!G7"Q@;P&!W@&CXS([).P.YH$84O
ME[-CI\9&HYOV#O[+)09[,!Z+@18%0,=I#[,$,J^&VJQ9M4[=1!*%(I*0FBQF
M5-JM3*=.ZZJ4K $HKKD(IA,_,.(OURE)V09+30"G^SRH3R@U*\%Q\/+<2+"N
M&<_",[-HY%3;TB#9496GN,9K]PJL7=+ILU$/N[0J++9,E_=<C"5_--N]%M=Y
MPVH".;CKMMZQI8/Z)K?+PB\M<I8"(X-\4F7T0&==]EPZ_[M!^ 8YJO2-\^1,
M,=^3](S50[>+*G/@P]LW!)REY0<\Y^.VX0/>;>E1.:(;BUX%6S2/JZO8P>0H
MB[S=7>N.LOEJ.DK(UE$4DL_ZG4S%=RPG?"?9T2)SO]\VR?'0>%\SJ?].8-9!
M)-:V.7VDU.32.Q\)ILMA!11CVJQ]U2^YA],#=28%4NNV=GRX^=HE;,%EK.N4
MVDUR@D,(=7N<R?7J9=']%5?X(+2"7$8X72A02$W<Z^ZM.]"N#)=;.W&6G'L%
M7V6:_F1R>3J+C1;'TCAQ$&&(7\;#Z KAF#40:FR&$,(=Y:TC3%^:--!C1RM
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M:(7[+P.*WKY0:I-8LV33*Q?< [1L>G22NUN1!'2>C6O1>-SH<G[/,Y/XG^?
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MAWRE:\8>=YU5&%M<.M)*<@$("B D_F$:K8]6[J$N]H;%DM6:ZN,WJ,:YZM'
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M&RQ6N!.7QTYMIL#/VI=TX7#I:J!(-^6?Z7X&ONXQ=G?<0-]01HU#A+6)NP3
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MX9%X**DIC5O")I3BNU8Q?:7X?9ULG;B\0D:RM_%^K$?DL51()SMAII.W!$^
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M@TF]GARP2C^U:O.0GX;>8ZJ;L4PASGZ2-A_P<%T7P5S= LX<\B)&E+GD0T9
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MPW]9D"CGCL',+(&[;##$?3(5%@H964W'QSEYFLM[6>FN5/"-_MZ_UE)Y0/<
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M;[LDY)FK@.68\F0U%)@AEF?7K\RVR5PT.B>#RT&V!NFF"KQQ[E%/J?[NFFN
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MUZL[C9"Q >K!Z@&9C8_H]$18@!V_=J16B"G.7M@>_D;Q4#LM,E\E_=<T%U_
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M(Q'OWX"W&Z\-AIV/4*.1)_O]X2&AH][7J&?Q^SD/W"\Q87468^*"AR,S5%D
MTP])17^48GW>7J_AA<.LR"1Z?FM,UA^E6-68')9A(D/?P<1UR.;=^!;,N)5L
M:==RV['<C4X([VP.9%_(8E\0U7@NV,";2N?^1^;^]\6ZGJ;3('!?$0WJ<!@,
M+3G6<0 MY6";XDUPCLC!/&0CH;+'IHBJ-W#A0T<A,^=, V9\?T])*#-QS1XI
M36GB)EWCUU$] G+/6ICE0:R*JO6C[HD3PA%51K0^IQ_@$Z2<M=1(7"-9@F/*
MV>8&A)HA9+AI^1.6Z]4 8]N&)Z4__0?%7RB@.)MF#Q ];'AL>:4(%+S@8K;<
M.B9$M'7@Z(=;A-TFS^$VUR1(=U<?:.%;"&.F^H'#PI;P;D7^S7JT06,Y!+-D
M.V/:MJ[W2- "SHF:W/+@F**Z],=O"<;%:\ YQ3JC+.)S3K@5ME[;FW+';<X\
MBS@TM5)%X+7G<,U/YQMV#1!JX>"V=>F0>[=AM',1MYF@\>:ROMJGX?B_K>&F
MV7/">%:1<6Z3K9Q'3"@KIW0Y50Y,P^U-!G6ANXV^\W]M;-3KB4(47IHI9)XF
M4D'OU5W;$B1!@X_1QK]TMMYM:-);W%[_@E2[7>12@U#7G%ZAGZ1Z/\;BER9N
M7UV7OF-8Y5Z%Z F",DJ\GW 8[ZBYUE.V[;^&*>NZ3UM.:VV[=^0[C-S,9GM7
MH.(=%&,4.;1+L1ZQGT@@O_N.U#_Q)T@-A!R6WMOKH7.Y6)+9^L(E7SXA3=;<
M4_(*C%H->[+;\JZX)(12,+$$(4Y5='L-_S[(E?C@K_7IJ5UO^J;C 0*[]N2J
MSVE%-;HWHV@KS-RM!^R:_%E?V+DU6THZI"(S5N1#?-KK,3H>4053C6$FEA@Z
M,LIL6BR5G3,EF+=.56F.^:1NTQIRNRKP#@F17SKK6W0"XIQ*_V :.^3>@OVJ
MZ?-;_[>U=,";W]5Z==MY3ZGOV*Q( 1@V=>W:<'V]6_)'9]T0&RATZ15EU#4_
MV_&2R)CK1$UGO9HM4JH"5.Q8(#?9 J7_AL <7E[?)DGRZ/Q)&3^0TD,9Y];[
MTAM$DY/.D]LQ89-04Q?-Y%"Y+BB**P\+)6ZPN6*3XJZ8>A]G7I>(W3VNF?@\
M=:SPXX!\)9USZ66MFU5%7.6^Q7QUL2AN:9M_ZJ=RV(]"_O1@; 5NM'%VR=FQ
MXWIQ\R_#'Y:O;]C5E]:N[Z8LX!R>XYJM>D]J'>-KK=K.R-.7'"V!A76!>1#7
M>W3"*XP:OFDH_6R0,=1Z&4<D9+5YNR-2\??,^._B W1O,B0=N<CPC+Q5Q@:Z
M7 ZY6>7<@BNJ$?W-WB.ZZQ/S_?EM9)<P_OLP3D8D'Q@5W7?1U5OX8C3T57J8
M0R=6ZK@83TS.:9BRO]%P(8'0>6DQ\IZ 9GMYPN_8M='^2N90[N:%<0$_[>)F
MTM&.:FO(D(#*M<[M]]7DF\)J^N?ML!<&U:6,&(WL;%P+)A68TTG\<2HFECQE
MFT@HTMRH\7G*R4RPF%1=\X8P/2T>UMW/^0CJ+V.86%+SS]V+>TH6R8'"UGJU
MYKET]T8>D/WM3N3I-_%:Q\7% SY0-9L-8 #X( &5[+T18*K&#/EYU5UMU2^-
M<BTS-MFXG2S0U7O-,=_ #NPI9:);570*?$BF!$=R?6@XT[$R(3!GR-M]HWS(
M+=ABQRL^)LPQ>WP(0"2ER;*WK&KAK$01KM7>I!Y0F%@ZCZ4__CW[FT]#^']5
ML*U\F.-<5K-.#XTG8L>VN,X0=]$2S 2_=+)[/B+GB+:O/LNK,?_FU*6Y[=Q!
M5%$6]GT].JJCHS"K>JI!5(=&BC56<9"AGMRH*9+]73DZX><)YJ&CB=EE!._B
MG($N2&U$F(B3>J4 $AS><DZXVI,D*>9_$-AM^_HLISVI-=$SQ3IX+K@AH],+
M5"R=3PUB:,VFMOS_Q=Z;1S5]K^^B='>W[FZUE**B,J0%@2H"12:9=ZN(RE1%
MQC"4V1A"#! @A*'5BHQ)$64($%IDJ!(2&9(P!%)EB!A""I%$$DB$,(4A$(9
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M[?N.)K(&NX9C=3\DHX2,U(?09T*V%5<^(%6R#AK8S=9V0G#A=?V"E(5JL-F
MQ@VNE8,P^M5F4+?UO='$\6Z'$JY5!=H\R5@9[M2X>&Q_'@EJ_: +^WB6TA\9
MEQ3'M">N,>)<];WCF;3B.A/37&&KHSGDV<J6V5)K!?9 \M>A-#^\O1_LJIF0
M=IEV>?A^ SB =A%W_ML^*QZDBPE!1[?4P)9@5UMJC([[M."<P0$]2-U&-37
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MS8 H5DV8'M"-F]9L[N #$_J902CQ:-[WJ+&S4C\C/W;T9<[A,#U_=O1%=,P
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MJG+\K2"Y:<V9*>\J2:'C:H_'(Z1:0MW>\9*6)E^(1L%Q=MA2GTKXV_0P0X.
M9Y>)?CJ* 0\G*Z/'0_Z^N7)36?]\TP&#WH+^IF>@&#3^-M0I062=H7/P7#8Y
M(&)@8/:^R.GG?S;3_S#]IX- W^V<<W*QK<F=MX\,L)9^T72\5@9@:L@ ^3*
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M/Y1^JO?:_PTNEZ26F;8:*41Z\!,J);[=76^(=3BW;S;RTA,BHT'PDT<4#(&
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M^\=[BAT_(6J HB1^I5"=C%P;=O.6/ (N*J3) ,<C@8,/#KZ_T]\D]B+S9F6
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M7!P+!%?Z#6JZV5>+&1A1<WHT:EPI\M==EO]LT?\$^AN&'D.2 7[VD 'RM&6
MZM(IPDN,#  $BE-E@)7H1QLA,@"/+@/ 9("-"YA^F/W'4ZWH:<%-&<!1!M@-
MS!;'+>']F* 9MC0XD2@,E '>\JJQ(R[S"OER<\=PPW/V0"]]6K85LAHN&5CX
M=]X;61%@ FZ,G1!:?AY.I+;@-B>< U\FQMJ3%R(J\.WX391%\;LUS1SSJQOB
ML*KB9@;:_%Z2#!#7 UF^CMHAZA#0C$\R\'E-D8ZQZ<.3^-2:^:NIPZ^-,5>Z
MB;;4SQ/;(E8GWJ(G1KG*-?-*Y=6GNN?E?P:+A87_K^*EVQ"--+?>CB7#G.XS
M8;NZX=3,CI*JR4'=F-=^OW:@NZBB#M/8U=>B UIU;*>TW6'5 NM[(U'2*3.Y
MU,==>H)FK=6@D5Q8+=[Z[!.29TJ&KDE/&RV6-*C6EN[CR:X-M,K5/<#[ E^'
MW%+G593:U=D5+\(:]V?927OM,",I =.G4[[_1'+]*_O$K8Q%B\^57)^&FM06
M' W]A6I\S]KETJBAUX%'3<29$X6@HWQSW_*U'F3#C:'GS\?M@NLQ?4Y[HDCB
MS% -(A<&EN[6R>A)%&>RC T"B3]2A">O-%ZX6Y.([ZC0\12&!&KX[C>,Q)+!
M335T: [/FW)JL%;N\117!@9LS FB#GA.B.1Y^ZUBED]K>P./]JC>L)7[(WOE
M_,6]P6"]R/OX 4&LM\IM?_VCGP<ALY1 5LH>T2ONQUZ:@9L9J?$M.9!S]+]W
M[E;13R:Y!&D<\0YX8^U=B+WN%1BSB ,99@5G!JZ7,<:''"C7@TH,9U&S(E*<
MMPO7P0K8]?;>'@^H8B0\9B]^9FIJ+*6H[N"\H9*O'UDI7"*I "]R4E*C&R(^
MUK+=<EFA:9U6O_:(_SGDL BX9:WD"T9^8.]"+_UP*'L&OJ.54=&O6[L0<S8N
M6,]".YEL0%5D8A4W"677^])O_5AV8]/Y:CTIBYZ"9&+)&ZNL7E,U-&PV'NSC
MI%OA5*EB-;H22L&GD[5F>!;@=L&\<<8(.YR^+7!<GZIA)3GXED'<8,\/<N<-
M#)7*&\";E/7Y4SU/')TMHRIR%7," ]]D0&;OKQ[ZD[3C?TO;+ GL"+F#3[Y1
M6,BMF7TYYB74R6[O/1^U#;;#,>E"TJ_XW@#?,7* Z0FOV4CH/N@SW6B>S<CX
MH)/JRD ,S^DI(L\'T1,KC6G#Z:OXT)/EX1ZZWS_[I1/;)ZQL/#M7=;SA%$7?
MKC"E$:1C?:!AZNA@<#&IM6C<QKE$*XAM:*"T6)2""PF:I1@+GC]PB+*_](&M
M:*$ \S08UPFF[X2.5;N4MK>\0Q@"=UIWX$BDU'%.V?B)?4GE9>0>%^I;K#)Y
M,W&DNR$!\^W=UT>,S[L4<M,FI>2<C:P5J]Z7D@T0*=+ <?ZJ6&O'N?<=BY16
MKS,Z8LCX\3CW$*R2,6DA,M$GZR?SQ,)0[W/K1Q"Y&O:Y8U?9E4]&"JECIT '
M>W/NW$5<NO]IA6XF[8#5?B@)#U!Z)F#(8_1;]>(L 6G)*>T+2:D,P!]IE7J.
M(G_!.B2().I7Y!O),\EJJZ*E^)O_R?Q_3U_Z(YY9L]T1-V&H97UB;:;*I.'V
M'-S#%QVL+Q!!B*QQO*75Z@$5_XINWRXPT#(H6CSXR[X#U2AX,0AU=-\K-Z<]
MWA-D:%1 J SPO ZBT763BOPIENP<:FWAHHCO\W'?.#%;,TP3YQ5E538301X0
MA^' 9C!W)N3ZS+WKC%<D1VY#N26UA&C0UA&ZT,Q14K+WUM*V>NC)3ACH-2N<
MM^.R3>K!/RD_R?T@-<!6\_@Q!O6*T&UR$O:JPR499= B4$Z@*X$&#3S\T/L.
MV/:R+!I#RBK19KBG[/U70PGM!>@DHV?;?%U[W%:<+-]*RQ)N,I+RXUT.L= >
MQ<WQD<#/9IL"RG.D YX&1/839I]Q3V:G;NW!>45#-=,[4>W(C&M"(<&9YU3Q
MI5,EJU&D8R\6=#36!K$P16]4NND'C?05VA/8^FJM]-0*2BMC:Z]U>\?L5Z=S
MQU:H5-,#?BA0_WF(R,U<-PN(@,8=V;/B]A5/7_$\J5)-%<H\/(*\T,+UD)R>
ME9SA.^GT73<7229#0@JA[@V.9@8#:XM=:8U$)2LPS;1IN+$ZMT^<C)CS76*@
M9XTR>F<V!=T#/3J*>\MUZOOLN]VM$<9HK&X:J.F'/TE/_O<*Y"PATT5)/!^A
M^D3GVO"1-Y)\^J)"'O(X6 88+-<GJ  WB7UR5"@WS<^K-H=S/AYNJ/W4T0'\
M3?MFISQ<Z\UZ%V /"]^X*46+&5)])I)BD0<2TD60 1G@V)(,,'32=,MOGI_V
M: ^PV\YO++D7-#E(B]^I>\]LT40!VS1AK:T!(1K11H,,4.[N+Y\/?1G.K&J^
M1:$<_*XR$\;"Y*/5L8DZL)992],4.A=B;EJT,5CG6( !UR?NYX!<)G$5(4F+
MM=N3^W.!2CA2<<@8!-\#<A2%A.05%4F\@K0<%[__X\<="QYK!6G?7O?FU;U\
MS@?Y^"6K3&XDOE&,(NZY KT3K1'"FL&^1YFLPJL#;SEZ9HRL9.NR/3) 'X]1
M&,-;P=(BD_8FYIHDG'W"X4-;# 9$8; Y$\^*U^NAZKYW)0X.KIO3Z>HNCL(=
M4YK@3!K<8\F%<HWJ*0.,X1ZN:?FIJD?_M.<3B?$O?9^P!:"^D<3&6Q^(R6-E
M(8X\/F-Z5U+]C^(ON!%Z^H>:Y_7:AD9G:T+I+2\8%4TYI,=/3I[O3IC#G70]
M@@LP<8;DF^E>[L0@/POXLD@2S ]/N,FDP6W+V]WC"VM+L:KYW+V/KHX+_+5T
M&\MB)J<" WD5X\7C0LC-^ 3S^3QQ4W9F7"'1@.$#8I=UAS7W>Z7>]G9NG<F*
M]"+;S6>>&JRX^[?FYN;V9O32$JRNKJXB_WV6L3=+_AFZM;P8QLRO*BL.*ZLN
MKJJJ@U55M;#0L(UZJKIE/)2J?*P'ZJZI\[Z2<LJPIN:I]TDHF=E?='E3\M(H
MFCJ*939P3>NK2?JTS8]BT.]<W,K!V:9+#KOD2AKJNQ02UY<^'V+[8?N"EG17
MK(+?["/<.K/W'SD6+Z_F$*W:[?8<<"Q0/>\$I;F&0CSZOW4EN^T4(Q)_]'DC
M YA@'!-=H6'+UENMJO/?M#M;+4E;AX6!H!H?Y7&MT6MKA:BAB.Q:<&;@UYO3
M"Y\)-0PVS7NO%$V;F!8V=G=33>+G3>8Y==:-E?Y8.N3*2* QS.C3ECG_]]!#
MS*0VSF=2"&(0<IUJWOB!IDZMX)P0;M%1$"BD6>#/3L'CTJR!$14@<R,O4$X=
M,LC-\#51HR"M "[PAWJ=V'2:M9R8TE9FO.CH]K"C:$.PM"NX"D2QMZE;2E:$
M4VA A)9M5^SX&QY"NN+)Z>M<),^E$M/5*I!8[F&7-WF![A'9WW]@96%L.K8:
M6KH1,Q.;&Q>W2T(I8;C8+#294E8]U#KF>CM&QO&:H.;#N8QOKTW8A0U&DST6
MF^6;'XO?7ITP^)+!0ESB$R![M=5U63E\&-NKL*@F>(K5M[<H,]= >3CD5'@-
M5V^""I]+1/,;C.O\;:/B4P7=/L:<,FE%;3[(_1.?(FS-K;P[NA/_:):;W4I(
M(K\S;*4GQ@JV&@>Q:7X(91^%48O=%D?"UDQ<?<<F),9SN.B$;+MOW<361B-N
MECR2=9V5+IUC'N#8'G5W-& J(LYR=Y>>15CX>E!?8T^"#_ZU<@;(X)2WYNO%
MPM1WV*R#I/0HQKTDUF?KE_N>/ L?RCU(&:TV..6<>[!;I*69%/OWT,@/^:"?
M-<+WL7BGZ*U-J3#5$?IKKPFFA<.6G5._#I)(^>.;^MBUQ&V5E6$[^>0UX41/
MHWJE$6^/?R7IR$5;)S>R$L'<1(7@,!W0;R(Z%L>L4\OWR@!IW'S6MXB=P^,+
MLQZFJW$J.BAD?(-)82I%'7NIOWF5?)=XR[C==5='@\8YU&W3QC7RF/? /*?$
M*"/TQ^AB6(?'VT\D\+\T-,W 1&&@A#;!XCL?">V0WO;@I8PG*K<][-;.G9,R
M53+:K!SQK_Q93UX%_99["%PVCU]/]+\2*JS]K;FJL":H^19SZ<OF'.#.SMWH
M,SP%5N&&7WLH+3YD.%"<OYF7FD'0U0*EJ]+MG5E0X_5X4#DSVX04$==S:WG4
MNB1^MPQ @K4N\GIXO/T5NLV#B@<O=(3H^"4X.^:J-6:VQK130%[))OZC'*?U
M=@OM: [AU=A)GUA))ZL^5A<%S&M%+RSP-_EU9J7[JYISO&L;FFG>AW%8_$/T
M(2SVUG>:%84/2]%6A^(KTZ]9*S+@^E_S,O!6E5L>/_,U@UYH\*;@A*$_9D#@
MCO0CK/DK?2#_%9/&@5&- [V+S4E A7V]C#K=S"_/'GW__MUV 1X2ZM4H H>A
MG+$GB37_&/HH/*7!12=.-93I@3@[*7E8YQ3#</F!5:NWLM=/O,QH4\(=#VP8
M!)7 %(S/7H0=C]2T0$54)!T+WW -]JMM;(<Z_Y#6?$-#3>/K>(GJLODR9M]$
MCY4]Z[%WLR@:Q3$Q004-MJ'E7EU+_R8H++/EL)[]&FW J+)6_8%']X;+"W'D
MCUF'IH8#6^'0RR6@Q,[KX#*RJ@P GKPJZHM6A8E.__SG*,P_H6T*2>]<V.MO
M@'*P^;VTV/)G?^)8LN1OUV4 7A);XM>CA>G*$BFV2MWZI1"\NR0(+/TP<'>C
MM:4,L+C](3)["2L#O&D_W$?_#<A9-Q<WR,W&_$6-7MS["V 2OYT^?7S@^.F1
M3\SX''QIGR1)/"/=4'>0 9Q4JM_4=[%6OW@K RPG[Y+6T8X_? 8<S501ZH1)
M(1F5G/:7/_\QSFY[H_9FP09$_)B!O/[DQ1PO1F[X_D'B+.1RX>CV*LQKEJ[4
M#DAW(Z<R@_U^_C2\_K4SD2D8O?;:!>27F_NB^3M:3KKZA&_>,Z&,BO5,46&Q
M?N2PE_VKK=*B1T%+H4V5A]$#DXDP.5[O"0O;LUZPMR<,;/EZL=[.ZAB_T]MR
M)7A>!D@.2K^.:BDB.+#WQXX>51N+.\!5M"ILH"XYU>>\Z<K4+= ZY7.(!SDP
M*^Y$=3V#&J=.S!45-;+',O/8$06%J<.XK,5QLK>[%J7&Q0AIW-['(9F+N&"N
M]=C+*0^M"_RE?ELR\BOF^C:*MVH<U?2@-+4.>K;B%!UE>5:NE]Q]OCZG3>SY
MCR#:C")6+AKQW:;N.U9J@MI;N,MVGN7%M)ER<,M$;.S<U%(%[G9;#=U^93(G
MZ)TK8:0K\VBRJN#"X\?U7_&L];O,''U-]WD.-RCE:A7[F#AIZN9(0F(:B3]2
M O.&\^:_>H,?O?+VX^H'M]OP K")0US.#J*TZG&Q+W,Z)XMW3Q(O8HOUTG^C
M.6U745[!C@2IQ7A?NJ:,A;JY>5Q,ZABX0[/U,"3M-09!/*PN\##GVK<C65*W
MG,-!6*(U=Q\"E!N#?FW- B>W)N7[XC,T-;7QV8GXS('80F)[95\\]^NW*ROW
M2DI/S-2_KFM0[H.))J*I-)#+PKRB"3JOP)F[SS*2#5%LW5<KAB^D'ZB-7FIY
MVG,[32"H"AZ(*$(577D1@4I*BI\O/8JE^2<MS$C9PZ465\LQA;4SMZ922A\.
M8*K4'PJUJY-@?0DWY^+2HU0S8>V4#H-IHN*>KJ8>)8K!I1[OP,KH029NJ0\T
MBZL/7^"[?#-K68F:B&HO*8V#I[/+$!P=M:/V,D"4/$YO91LJUE: #0TQA3L>
M_BEZ_$_I/]?CG2V$0""AD&WE95^];R:QMP.':[_X>S.)/3T[OSJSU^CW9A)[
MR$Z64"<C'E$5N@Q3Z,O5BLCOSR='X#^\EXLI*D*_?R(76O.RNA;D3P8Y#E;$
M%&$B2"3]L0WDIY[GCO60+L:)I%E"R%A@Q/1C'*9=T-[]^#31\KR_R^4Z.K"X
MO3JMI1KC<[BHCP35!BXR[<)96<D:V?.=TT!8"SW1=",2/,G2\EZ.-^@FX8^F
M^WJR-^\2[8>MYRX'2@N#^U#D)2UA"/CJV(6.I'"V-U&@HZBX?DC]Z-^'GO[!
M0:1I$[BGIQXC5>@'6U+X;G/43.4UN\]P77[NZR7/*L?]GKE!1YQ\NV) 5E [
M%_$XHZXJ_'V\?PN]<8N8I7_?'^*+2W>WM"THT=(,\N:)TMT3Q+C&LZ6(!@,E
MM<MIL#D09#LS\+621LZZ*Y5U^X"6MDB)8LU^Q.@/QW\B(?ZERT(&3<GAV8Z'
MF[3?X9E!:^;-^Y<@?\"S&Q3*4.\0^@]X=BSRNI=.%>-W>!;2WEXLAV>/KI2B
MKROLX47"!\6YP3/^!OB^-M:ZD)V\^Y@[&.1-/SZO5'[4$S7;+E&-9X.F G%%
MF<@#O5Q8YIGWZ SO)X#WR-'9P !I :YY6([.=#Q1SME?,QE+R4MV!%'&.D8E
M8Q+MX#1?>U"E7<$YYK;PZ%)\]^6YMGR?P;80?-I2HE')KWC>?-2=_&&TYHWQ
MJ?&7J=H5U/2B#G7Q";'9->!NM()08Q>/:]F/,.Y_ 0G,5E_YUEVS+='0^'9V
MXS/JI/O*)(BF%U:KK=]6_G,"=%Y*?!H/J;H 0N4/&D0(&U.6\"5'[89UEQY1
M\;J4$# L;; MT/""U^.G']>= X% 85"YN2OY^?DY_6[N;B0H%&H5_;NY&]L9
MD>T\WIM[E)M;E-S<>4DGKQ"3U9[,-7KL#0RA%*6DI&2$A(26V=AZ%<U_)?4>
M*0^A%*9U@PRM7V2A_?8@\A#8X^(=[[R;G(G/NC3N6HUD$ ,$X!ZJB2D5@:@[
M?;R@4/VWKH"Q"?_QKET9%\BPXAR*2^ZA/&;:E;JK$<>KLD@*O5G=!(B_Y0K?
M-#.T:+7KU[Z$B-*.D3JN4;>'GN@(>&_C8.,]^-5V4/KG6,_R%5;Z]R2/CC.=
MJ"CD1087^!!EX7@YA7)8EU6.]=;23) LF15N&E$"-2&(D-H=WI^XO^Z_A[:;
M=S8K!?6QK-Z(?^D-&-GEWAJ[O=QX0%_Q3'?,Z]NM\U9;(_-1:1LL=*06RQ#G
M-]*3*#:?L0ZKE-Q=7CV_O)4(Q@-W6 -;GBEQXXJ$Q\>,2P(A_@XQ31G65]?C
M#7HQUEA^9>>#ML1XA-'H;$7'&*2YH]/=]$ 8F;EI5"^(N7NBP@?\\Q^<"#K"
MJFA<OXS[8:9QKI[>2Q;XZJH)NL]KFP+E6-'NV"Y%XS>*_7_T-?[]L %6G6G&
MXI\*.#)W_9J_^8NH^$<'3BX*O%8H6$/%L)ZT,4VL 44SI-61Z*=J;1L%+M#
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M,7.M^U2][T<CRZSN!(PE*+@E;;&^#/NOO'(&EWX5^Q;750L$HBOPLP#PEGF
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M91 1K+W<W69_@^S?VDRJR-'N[;;85:$058&O]V/&%]N-VU)COC68B%R*]FN
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MOL&AFV.9IW!ZS5$CI3DX[ -"JL]=<IV\W: ]O]B8VI3S?<[=PRXO)139KDH
M(FQD?9H9#5NOX:K/(H]:D.%MXDDJ[R9F;N #!;J.,51ZG10YG9=2DJC5/"W4
MLQ$AVW6=?,E6D^C\D^>[NF8V$,(FJ$Z%RTDELC)\PA7V-&)4D9T#:HZBZ:+O
M\.("'O/#0L?B'O2<NSXBV\C:B, J34J9,\2S*ZB Q]-KLH!&UIF\WF![F5?
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M;;J:L+P6$]YMM:OR]0TS[67),LA^\Y#2#H5>"3ZHU'DL\S1-V/%)I69R&P,
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MH7N[HQ+15E#7>[KZ%VO\4L'JX'Y[OS[D?E #G]19^)R!T[TKP%G"=V+F3M4
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M@ZQKK"NNNC7@/[C,,U!Y'^6P-[;Y.$RG<OO(\+WAUY8!+J0Q'',AX8@?KST
MXQ=AC5\BOIJ>8;D_/GQ_Q)W*\[X^2=65CO(4*K)IUIT'4^!9"6'Z<9E>9VMO
M/*0SK%34Z0WU=/4IS6E1&1L[N'19+G&@#<N?R/G45#ST<HU9,-/$X]U5>'.
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M"%:[MG+HTAZ\N>?-&6H("X9F\SJ]Q @T+#2X,^MQ6$<<^>0QNTSUCJ3%^P[
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MQ<?\]C@=X&W%V&85?@:'R%[:<>R^6CN7%YO%COBV"!V!,W%[]OY28N;W>U7
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MO(Q()I<U#[]_DN@'_<L_P2>'1X9GY15?Z)M]-Q)PL; WRI(RF4X&"M$Q%/I
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M4>"0L<"!0DW@5$$X:'?LPKQD.J.V+24+EAR%D"7L>4UQ4:*I2>W/*Q/<ZKW
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M5V9I=U-+"B*)D9+C'[?3 O?4:RN 9Z8C">UE]=WQ"U14313=2QH9Y5.XG37
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M4N?JNCY&QH/Z?_['.?^7ES;_+A;U0K:>=*!&CBJ=6KR@N&5*7P)7&>9-GN[
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M=PR2JB);K'0UETVEN#'.B>FZ/4"1K.J!%J!'N36JY,(I4*2$0LC)#,(4YC\
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MEA>[R^RU+54)'&F,F3QSE_<DBX#QR35AN^>%N9Y+<H$Q.;NTU-_OR+"<]O7
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M_^V)B;N/[%$:!ZW*8Z/M87O)Y +@HY7["RY9(+^QQ8!QS)X?'J#M-\ZT]$;
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M&-FUW1WC9N;&:,^.QF^^6W3UL:[OX_5SKF_?V5)O(G<TD.W;OTYLLM81VP.
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M*UC#)EI0$:-ZP#?)@^Y_:SU':-JYN'"":%=&ZT\.I#(_6.X1E8D#V8NX><-
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M?DCM>O-C'^\&\7(R3)['0QF&&D0ZU'L.M&0^U?-[>G/I&/A)>U^0NUH&LV$
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M%DHT!2A++.C,P, @ <:G?6&7N?]1K]F>W'825VK MAL+>X$/7U@7N+-VT;@
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M8-MQ<92RQG(]60\1K?/NIK>D7(,JC$"_>ET-X?I"%:+ &.)6VT9+$)$$XKO
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M78,.#J.CCMYGU 3Q4[M:B3,(Q=LO*,6LQ-GFD%FS"L)@P0CLX92DHI<79_X
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MIQ&?@?E[A&J[NV$BMMB/[),'1 _"X=&3\/M'"]'@LLCFO,PCZ"@+53L<-M1
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MQMBUC"VO&)\B)]AT"$^%/RLK(_<,%'71-^DZ5GY%]<X3FZ(>Q M+P/'%M;@
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M2Q.> ',;V@WOU%M,\^,P1\0]P8SI<ORDFZF'VE@0SPIJJ-=0!H%$R[9D@%1
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MP^BT&"NPS/TZE+G=\QR^KV((3CQV3&Q@!/R:Y\RM=KZ%PJ>_F],97Z=$D%)
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M$N&+.]U&]M<3$KS4TUWKAC([9^,*?XN!I@%^\@C9M&67"V[QD5B=^B7@MJS
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MF&CEV@@A7:^LTVATZ_K+:3%4A<()NM;SNM5AZ)QO),QU4S0 K<MA[NI$%BI
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M_H7%;$[AKPZU5*HB@602C0PR[D5D6L2LL:S(_'%U]2<?*&U>&O9C;)*&9EO
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M9"?3JJ=/5W7$!@J"A,HLF#/AS:9:79UKE@0O"JS,-*9OL4(GLR"QY@1W5^8
M==2OF)JODS9NIKEW1A$(*9=1#.ATEAD1IMD3;G@,F*\]ND\(@<?R#=TF B65
MZ<P_9URI!+M*RV6J:[#9WELH>(O_;I?7HY+,!.!G964&GABP3\+"E6V6?'],
MCDZ^\'1WD]_0N5W\=,$]1;KJ^]EXB!4XR/+Z@0K'?U$D-OL9DU8]$Z84[J:I
M]O(BX:$[4IYIU,1D1NF!2A:\JJ*PPDR+%U$]F.M?#)<=FW<NL%O2-Z,29/ <
M!WFD,[;LO$L_"&:^Z9@2"30.+,K(.6T4+23V)[XGKCX\(D__J95PSA&U;&9
M778*-(/=1?&\R\9,R7;WMF -P1&L==.HGZN"G9K]IZ32BY_* N,&;E)?R<[$
M71^]Z5.Q?5M43JC5_^G>?EI_VFPR:?_\7B?LE#F+$]X'A+Y=Z+,SA[B1NA!
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MY4N&CWI*_[@ =;:]J[NKO?#W"U!1Y&N+PM)D467R&]E,C/6.1\\&NHNIR=8
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M%P;W;>H6F_W?VLY48!3'DYH2[:I^N=M>"8!6N9=MPJ;B/F4DZ=Y4C&I^Z@7
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M>;UX&ZB8^^Z;]R>/;U?:O?J=60[/EXJB7I_??_+,T;M[:+W6IIB82EY6D"D
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M]O/L.O"OO2,\&V,?7OPNJJHA6W""3?\L0+;:26@&CSN_2#7K45+*^NK.#F_
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M*BJ<SZZ=R*3I@CUHZK_?FECNV)QHX_A((N89YZ933'X-9^<('9(PZ=%K- 7
M>6"5Z_5Z!SWFAK\C0%;W0[2NWI<=6S (G'NVF3JV+5WO#&-4[R #>O_Y;C/2
M1P<*&O(I :1_-MR$O6>6;@F,[-6OR[-^1"/HHPL=)"5Y:@*I_9AUC>4<H#B$
M35(E?3<M6_4Y;QYXIS5ZKX=\A6,7M7:GDI5Y1_CS5GTE$N_AJ"A<ZV6T$[ZV
MM<V*"_3<T$^98-;$L9IK VTJC$)+9!ZK?)C>.&2$%3JNKL? (]$4'9%U]_*P
MVPP<Z2M37VIQ%=R(F,MBA>>;LTY'>))]]_I>[;2YK%-NKS&@L\Y'^)U]]QAB
MA\LY&FYG6^W@:$,G>Z%(#WGFZ_TOTE^DZ ;Z!UWW4@OBN.N.*T8UF RG6D?G
MEYLA]K)@AY%NI!GM]1:P$C#V27P6NKLE:P#A5[(TY(&^>".B2_\:IW!BLM@?
MK#&TM$6V. *@<WO#.@8""PA%U'%U-7-Y +"00J5F9$B.QKR8^3/_2/&P04QW
M;B FDZ2F%BARC+W3T'VN$I"NYW/BSE<0Z];\UM%;2&NK(9>"ZZBLE].7'0,G
M/0)C@W0QR:(]7%>)T);QN= F4-7J01G. $L=;F-D[D46'8^"Z <F,MVD/8 H
MKALN_X+3"JQ- (];2BK(+@--2=U9V,(:(2R*,5,ZTK_?\'/1-TZW)$[QR8TL
MVJ5;@&C9J: '8[.?]"X6)OGPKM>N7^@QUG3P[>G/.U#IWC-XM5M4J#N\6A@8
M-M_2FAK OX7%KMW/7[.9O.#.Y.U1RF!MW7<XHE9T:F/+L-[41;&>0PM;/UCP
M)'!*[FOO$Q@<*RS#'Y4'T0]7AF\VCD T%BPWBDFLPJU6YENN9VX*QW!J9K L
M]._O6;?_<?AM)0YA>:_RP^3<J0I%DEZE*Z+N[5IE'6O%J%;;.N8WSM..K)!F
M4>;;^JPLQV,_U"S$[9OE6 UG]\\P#9SJ+&/'UC<1:Q%H26]#8-)WH66S0N,N
M)&W4CSVS]"QQ#((=#FMME#9"B&!K#/*N=+)T&RNTZV:__.K>8U97<(=%L+/_
M@](DKYDR$%LO8JY'0O$(?$[5NV]#C5"4^0X7=(\NH:VAQL^B3Q&S)P/O7-QZ
M]\66+OG&MK!WV@N5EH8\T\1FS-=W;HGVP747G/'3L0Y'=<$ZF<6V4JIVZ  N
MM\9\ENY78^*W97JMW[=1[N)R'OKA48? $URXY 1WMMJW%9<;P+(DNF#&U=14
M<?.T'_]PRC1"U?$NM_L7N?=3QT2F;:EN.E3J6[Q+#CYG5YD#O=Y8!2+/M\Y<
M9QB<_5I2.I S*3CAP]!OR?76<-R5>]/MN2S5&^V$JT#K^9Y+"_%4 8[#V92-
MB.V:N=?@JRX[":.EK^A$[%(  FAZ'OUR-QTFI $[16TIGD":22E[6H#:MA4;
M*%?,0SK4+9;2O6-:)3VN/V]O7%WD'5$__HF;9!1\N#:J_:&3[CC^%TDQ-]KW
M(K]^7]?'\16'PQS)FY21_>WJ.SL6ZCOFY_N&'-,+Y8+/^5NNP$*D(A GN3#K
MY+8NN  ;7;''Y/(B)PQKH%=QN1]SYFQVR-YI97F" $0WHW#:+'(+CBI[%YJ8
M0,,Y'#Y:K/N^FQ&=X.P4=VMTT9<X:94]Z/M;,IW#E88DQ^_)8P^?;@/23UTF
MFS6T<1=3HY;):7J_8JPD'1U;G[?NFFH9Z"+/3@:2S99>*1F:L]G\%-6Y4VL\
MZ4H^JG\#M'<>O$S;@(6$07EW#E1TZ,'4WEY>0+AIYA?G4_4Q$VW<^=4*Y8'*
M)VY4.+D7$.$_BG.Z*FU[ ].?7AER>EGO0OW^IS\-U-3<074K*(,'*N>^E/4]
M2[2-[3&9:WDE7(IZ&0CAAK8&+[=^=W(M>QZ<9*!-^HD'@#>PC3.=;+?+)-W1
M>9.@Q&XYA=!B^%OF-EZ<G9(SNP,+4WAIXW8273A;FUS0F$@K&KLFE=[EL9@;
MQ8W+,+^RL >92NZO3UXX(M?N0W'PD5@94:QN3>-'K#Z> -*6(_C]C*;6(35U
MZY#&?UYU><]T_<?A.-;YGD$%./7K+01Z0CL5N;@-&>".4(NROWO9WJLZU14<
M]6/;TF@MZO9L)N5 Y:/>9_C#88L^Y[^^CFLOY<X)MU/OK!U:/?PVW P$/%M7
MACSIX,A\:8*/1;5XI>IEPQP<U=0W*N74BC&/T]26>3JH="<S<0QQJ?L"S4XH
M&XD1UYD-78X#,:C%*6/:KJ,\=3M ;3YP,@LV'?2YAV/9LS^M#$J7$E;S%3H-
M26G6&]FN-<V)(I92]#7VCL%'2_:,#Q[7*;J@K4J3S?&M^0ZH24L5)5V#B?A^
MH=YNP8&<:DE:?YPRO85\:1V<>:^D=389QQ-\P06:=0][R3#6S$TGOB(/.FTS
M(S;7')CX?/<2*IUM=][)H)G6A267(,5.,RS*;]4'*JLR1M+BG(35\'7]I/8O
M[YFF#])WOQ'K&0_I%RPM/UR">!&9:'>OX45_?-[#N8YGN_\4$/H4Q2M@'!1O
M3@F#?K?_TC-- 4X<?[?IRAO>/33:0?%T9&<K*'J]$>8#*^8B.BL4,.WLI;$F
ML95/P+/.I';I20U,6U]OY8CP"IT8V&W[F/5I6,HNLUI)/%!!WF51\87-7\VC
MYXY<7>;;)(5$Q+N&<K#Z\Y-=#T)NC& *W/1:#U3>;.CN&Y334[ICSQ1CTS7.
M:*W?0!ZH5+1TX'IWZYZ&J"ABM%ZE?3SK**$C!'WR,D>43)E1ND%G#F#MKX#
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MY'<V_WX8Q<(64IHF2S+$%\ TK\VMKN2Z.=7H3=G4]0,5L9=/S*EC,<+MK$@
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MS+<=F@OR'Q[K%5#H#UKKHA^S QXXDK8:YKV?\/-X@%!]3#D07U@?9M 6R52
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MKZ9$>2J</F( C69WJ:7L75K@6# O_>CM]->+'T4;_Q$X@4S;P4US]J.19AJ
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MVH?-G6ZU1Z0SDP^4CE#J5]G:Z2%\.>"L)!756.^7MO[E=YB/UKC^?D1Z>/U
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MQY4BD51*=47E$W/O$+^"X)Y+69N/5YTRUG;8Q\4_PD2EK=@#I<?PG7*(KI]
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M?+]=U:Q _QAF<APF2[L*#3&4V%TLKI^K 7+JK\4@@D1\?F?^Z<812LL,^0;
M8D7YRN2F4_Z,Z#($^FSOV*;0^]7=%D;\M69=KS87V5#CJD3%C&^9);(;LSTL
M' 5PICGHGWZ@C5((1\('%NP2V],'U":GR5J?[6X.$!T#H0:MS=3MU/Z4>7S
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ML?5G')SW&CZ+VBD4:ZUW7N%L[98/S&9"X@0)-L%A'#=HY2:>I]-S;WI 8%Q
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M.<> L:.FJ%F46[)3(?UFWZ SPB&(5;Q$SFA;7YL><6N"QZ1M<L677'JNLD'
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M-*'Q_:<6]NM5>:L(<J="89R@7P>ACN0D>G%?!:5MQNX:4*4FDDHVV</68\]
M?_GKA_/T_R$ =&!;%<[;G#%X<@ST%B^;8;IRNW\L;RA8U]G9U2#:^=M>_TSR
M>*]=86?99M#F7:VF</!/><(UX5WEC(S&QAS9X,?Q1D]WG\R867VQ2D/9;SV!
MM,;YD1UWP7!V#,;<;4$ZL1,"L(M)Q]8JJWK5G>F-\OXSU8]OG.5"ZZ&!-=R.
MJUB08RNV*19;=[O)>G H)RYI-FD!05]6&C>13[X RS[5CTX&R%" ZWW0IY'G
ML/[&/;@6KMD?N]4U<$.0XM.@'9@0I9$W(/-%&=!C?U]D,,5Z1D]Q_-[GS'$2
MV8?G#)H=2=R'7@PR*LMBQN8<3N XH>?3CK]J#V+=IJ*&5W0W^T;.J\_,L6H3
M;;Y;!"'O!J_)C=AU9ULB5"/Y+'1D7U\BDT");9_S(%]RQCWXN]E.K@1]QBU&
MQDTKG&-=ZHJX<$G8(/!-K)?KQQ!ROZU67@>_Z] C*8&/;V]KQV?89C8VIBMC
MV[ 9=V;SC/WS[B;HJ*TE*ZWV*$WMN.9'K"XFPOU3HF;I!3&UIC:.2'<L6D^F
M1N,\R9;=(6*RL"!S;9LGXR(Y>4*%6D%1W,70DRNCFWY6Z^\W,$@;%I\(65]F
MG&(O<*2;#CIV\\(#:\BH!9[<!LI0T-'M4*12*;=7ZJ"!8MDS?NRJ-"MS26WV
MG+PS%^TE-36C;6D$];QWN (*GKW"3^:#J$E7S'%&[B!$X:-PG7C!IFD_%MV>
M&7%<+A61%C2MH:%ZN9_HDS."5XNC_U/IWL'-Z<0CB:=9!>F]+]\49UU,"JF(
ML$,J:.4-2S7CVG.KO)+RF[_^Z6?6A_/P_S?H6TW>^#FG>>MST9[!J!G9,/X,
M76%>V(5L?T>^\61HHU9@[S)V$(@VIT(,EO$M-X+M"T *\\,*2^6>SC8 +P[;
MD[,"26WV3JQXNS7ZA:772_LM>4-[P,JFA=@.2.MQ6\+?R1#V&I:5AD^U&:_=
M0IXG(PW-BYN_V\&KO"$LF7BA\&S@N]G>J9HHP0(#T>7=M>6/*V%.J7FP-_"&
M/:K[ <M67W;GAKX;$H_5,HT0?A%7*SMV\F8_;G\0$5!2=NMMW<Q\RF?B+DR<
M\;4&MK D!%/R+N]S0<J\[)O,X>.,E%0;#VTD*6#%N:>F;BW\;>H64KHFZNV
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M>',X/@L&M>0@S.&PK7R2G5DO@W?;*,DW++J,%:=T";UKXT::M8_-<%R(7%#
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M%;#2W3:#HH*?<(VJ_V!#:94E^(K<E#=W(O/,:=]4%4Z2UK2N*]YDJ ZUR^
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M['BG:.WK@M[ %[?G;<D9-YM5>?V__H'&SQ8:$N<B%VU; B>;)5 &%$1^E?W
MD"  ]MP4G\"]#1$TS0VV]4PO:=Y?8$7H5!>B9@L;IZHNSA923<0,Y?6$R>.=
M* /9Q@\)*; 'Z+="T8#-J/'-IL-$8P=VF(61L7GX>_EI65KJ?O#9/N@[061X
M[.9\$22W'C0DDB>4)5U/F]=-VX$F]B@.L.5KAY(2HR"5 K5UKV.!J^YR,#]@
M3(>V_#/?*]IW/^J]RFXS-T0E?JY,+Z$->GU]W<"2N,"6A<,U^QNV1#H;,9$)
MGI0 V"?M)''&-BIR14)NR;PQ89;/7W4K]:$!^S<$D?T1P8;=R-")F5X_S_2
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M'JY^H78*LSSO>7:V(*'S+66L\4#JPMADBWQX8KTA'@ DET^-KH+;PF Y\L!
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M. $%,4W0H[J,HP#\J"XC3 _DT,4:-)8]1-DM<"^@@>CGE1'<X/ ;-RPM+2L
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M0=T0')IV&'Z6^6FGTRWM8NN3&:S@03SLP:DR^Z7YVZR-M,5SD5=KR^'.X 9
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M NOV;\V?Q!,9Z%3=WYL_*ZZ%/7:..VK^3']5C;'DEV:(<E1M1@6_E^;)X[L
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MO92D>^[S[AD:<XQ[W8;DX=1W4L9;,X'I*.=)N\'8.O[Y5*M=\OE5_UEN4(<
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M_U1HJJGS=MAB0O.7B(V5TD.J;NS% &0;OW;M2F6,X]H0?S-;?_PM'U_>^BX
M"8%<B-G*4'/7^&O.KL1DDJ8<L^M:\S@Y*]EJS5A?36G5/I&^':KHO4"AMF25
M!!N\7#(*& 1Z-P^:<Z?9<F7-X&)Y4IW;U-HRZS2L4\_-_LDR+VZN?J)_7_9,
M]%X9T\H!9FB,X;""36I"^L>N8"\D^"W7R+1H[539/%Q,D/@)S5XST:'R;M\0
M[W*U5(%5F)/[/]>!IYO?P./.E9<U4JO>3L65-6% *%39U+G@LHT]B_4K;_9
MHF948.5X[FFGE(8-#M3XW.5I3'T&\K'(K]&H"QK1WT"HR/%[+J3% YG>M-V<
MAZLXN];2SQLK^%#CE_-#PY0-RLOY.Z 908-#/P!HBN\:^ PRL/0O''X=^@';
MHI9G]Y< 8+#5)"P%M7!:J['J0.I%BWHX$?*/%YE9$O,Q%\%-:[]'N>Z.##^&
M"1.)Q!1F0"/*9T%](,96<4^I?]*9Q OKRZ<D24X-)=B\>956W( .-MKVN: \
MBO[J3@32P1$VEEL?/U3K9WEW;PW&,%FC=;?R<O*>=%N@_#5<>_0Y,_.*#H$^
M^;T^\XI T]0LG3MH;_B*&L^^*]E6MW;8=&EZPHDGVZE&9]H>?N0S&T5) #&B
M8IU <QJ-V'.C3S@=T$LD1QC@G(^@K J%#TK'P6ZFU 0>3R)L2X-6=Q__QTRK
M>KW]+@WBPE6]N"CCRPO.+Q)H,>^P]%#D+]O*GC'0 ZF)L[R<+?>'7<+Z(7,_
M$W?!9AD3V%,KLPRK:"05I+*B7_9W.<[&:V:= 7;]2?;^GT(<KFN)V+9@ZZ37
M'I.[7+4^FW,_A=TG .%BE8C?(]>B:/::YN=L"'0"P=C=6^W2#9&WD4N@C8>C
MJ2=#V;I=5=3^]U4>2.'8U(X>6X,.*3'\P)VBAE-*\YQOZL$UN,85SS'UABI^
M]!2U]AESSU%18^0<+^ >P9"%@.Y=PP/V\3L:,[=>C*L)O\L5ZCVHMI'JC#<3
MQX]R2R](,DW'S2,YKE#-K_W78_W#!)>(AK'/QJ\[79[>L-"M*KR=C7T+)?Y"
MU" 'IBS71S82**NE@5&P;)/6NSOASPN[RP;+8UM:8QH"FATD01R@>AC,'I2?
M 6[X:24P913/GVZ=VN98]3!57KA&;X3U^>;G,[D #[%[&Q-(=S7/FHM<HK=\
M/]ER LJ(:"&SLTL-Z^ @NYMB4QQ]6HCBL]IZ0Y9G< L+$=#*]+C9JJ:I0IVI
MPJ0S(IHR\$#JRXX5GFF78%--E?-A[&X+ (D]?=*$:.,SK_I^Z'DJ 3PSKQ(6
M!O$M>%8RMD0NCF&KTH(P^3%QU7+E.C) EL9T*N;)*G&P]X_']%D+[_1.(DIE
M[D J^/K+>S&D4V=M3%BMB)*?ZZ/00>Q$- P%3XP.#>C.JZ]K;R[2?%ZI<BG&
M2_ZN7X!?+XTV7?:59J&>YF)RU_%*NQ_CUJ*2D$T%DV$$:G5=)S>1)QPI9/'F
M5 C ;IU)W]X\S5>8I\QFA$GYZV4C,>Y8QX::WVRD.[75O:7355O?-RT5Q^GO
M@OH'PV$ +XV9@ORT3U\*U@5H?BPEMX1>ZC=E;],"-H6H4,4\)<]GGA'6VI6V
M2VL^00);=)^*&NA^D3!XJE.)KN:A?,,3K3<N8AK]N/]W.^TVI\V'L[:2IV';
MI>E!K0/<K [H-E4EN-:L%ZX+'X *A)(FTE(1\#+SE)[)MY.6ZVKO;)9C)]LI
MS7P=*SYW*/FXVU,6\Z6;RT"A)'#,V/:I3\G7_\!<^K/<ZK\+GQ'L;L6E_6H'
MB7Y^(.6)^NQG<.Q)Y=?3%]^$)5K R0(%XV2PYG-KNZS:J+^R@?OQ0X6OB(6O
MIEQ@6+=\81!.NO BV;N<2D1)7@2X8M^W'DO.@5#3*MMH>.X7BRKPHVITJ^[(
M*8I/?HF!?]AH#68;:*2FN(J+ZFI27$U010?3955&-IB:P=%+O8&AU?:C^6P@
M'5*50IU->M^V_L%?&%N[1HWT'YE:BT)&(\;(9S_]-+J]/;2]S1N@G>)L*EEJ
M5O3<CJ@!D["F$'<+_*/D"\]O!)D,CSFAU4ZI*=H=7^Q15K7LWZ$J#&]AQL8"
MQ!:Q,80P5F]MWVW,IT(6PCH\9UETE93&<'9#N[J[VP9\M.$\XTL26^PUF-<[
MC0E&_0[]W%.5W"&M0VLKB>]RG;*>E?-PI/SC7QC< 8W[^8Y_&PNU85&\ZAV1
M\"B$WET_T/BW_D:=-K*.GD973(P\NF^-N-MXNOHA&<J[@9GYHEE:N"],OOMV
M/BE,_;=:[K1Y0\.AX'B ?2X!X4LH.\SZ .YUX-GG]UL_WWG86BPJ%<<2=S.G
MQ+V8;%IR$S*YJ/E :FZF"IP,GU6\;#TC&+XK](J)<O=,OE[K$1OM=X^&^.+J
M ,_JFZGV/?2.W9[1NL&BJN,\&Y*%(KJ7<S'MN_6VVS#+&!)^@,=*35WFN.K(
MFO7F((HT*Y@O;"9_K5%9-4"U?S#A-V5$#]7N&Z"VT+5=2:<A.^'^)#8(I"(P
MUBV(2YM+R>#=G1^&X^QB(M2"VRGU4V+PXGA)=X5:@TF5;3S<<BYB,*PESR"K
MODI8XZRTN5EZ+C90><^T?QS)N A?C_JUU&-/9E8[;?U8)IW2 =OX.#&DEQ/:
M-#^Q>:K?RY WT>X\6DDQL]BK5S%U:-=9J=%8$4R.H";:1$,0Y]#4HJ!>9N#/
M.6YC)59TB M[?>3Q!],3<G^2(_TG\*UV*6^/JAN7<17BL*!4C,A)G(-+FZU]
MOY:5_M;M]7"=S;@WS%:)#0;;RY%J-%.K+'7SI-/35R4%'[=!KPQ'O!=I5HE_
MV3RU[C[2$C27T-QD ^D@6 WX#RA=E=B:"-.X< .A8"S')UUHS%6UXZ+'/<<=
MT7K--FJ#]IJK!162YQG(<9.!MC$=NVU11:U0Y!X^'U$8( ;.VXYD%D)-<.)C
MC&0=FSEN&<?FT5)_;B>VA^[7W!X8M >0]H46>])I:F:D<E_Z@-')Y]_Y>YYL
MLBZMZIOXUE5FW+_/ 2ER'=Z^\LF\G)>"-.[>3NP!<X5&5PLD*).^MG&T?<0X
MQWJVD*7G9[+4X>)*P,IIL0KR]G4_VIE_+/+EW@7%\WMO;Z/@:_4A&XG[UQ<-
MF3XOH==*PDAI!6PWT*/G/_R1Q;^\564G=>[5S"Q_\*=/9REI.V]RD:N!4Y=>
M5+#/<?Q)4,94S-I(]6@(H4X.RAGWWD!Z:[GKA(H#.2[N%IMA98'5]]OMM/>M
M;3R&#)(_4HO=N(7KZNU.FI7-.WJ/J _W58<+$\$F+%9J9XI6?HUO5O?\G9WJ
M3^TW]J!\&^_V--&!5&SKZG_,0Q<M[KI?WXZ255W=!LP[@SYQ[+\T-.2:OYSG
MY2^TJ\4O!RQ$Y V^MHUFQS<8=SX8(7'O$);@J):FW-7M!6A8-GH<XZ*!MHWR
MFQCO,Z7WCXQ<J/,.M!'3%;=2"K;<?U&]TKC:;CP)F4[(B#:TC)HEDRGAA_E=
M:BI!Q[G+ZUDYS-GKMQZO\WEZ?:M^P@,I;>V^62H_.1?<+"D)NY>E;G<T(U>]
M5D9&15W]G&5F\X<_Q^;_&Y%D+K\AR15S_#M.C1"&C;CC7#]'APV)O'CPEL>W
M-D;,6U%73**C7&^-T$P._[DBAMKQ955 ?J2WOJYKY-'6XH*TW];/6W5UK:=A
M:@T$\#M /=_\!K=:0T':UD=OZ<@#*0KBNL W*I'VX5$%9:3M1W,ZNNB3SB+V
M\Y$=^# E-B^6W:RYE.T9Q&I*@S:6?8.\1SO=1)>YX> ';IQJGFXP>%S38%XH
M GY86?9'-,U8?+6GG/#288;W >]%(L1ZI@IYX"PM."Z,VP:'M@JUK^&?K(G9
M67/GSDPE#$5&Q!@.M912Z=>&U#4NH"/9%?6)$ /? DF)NLZC]O6-]1$0!EV#
M-G8?,U%9]&J=Z@P>CEDRW3\6U.G/_JLYTO%)=\@'2BME.\,Z?RZ]ZI>ML/O
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M%9F2$"J1,808PQ22P*JVC)(44*9(TLJD3#&0@9DJA(@04H(D0" H@2"$ "%
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MTB/9[DSQJKOM>Q%1[([+-BW([0F.H<B#XYA"$'2-!?:>0):WMSK_!OA:YI!
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MJT%@:&B=GN[2)E,GO%JH1[$WS,G8_$&$1&7#_-@$EIO?G'O\W1^BV'\B/GF
MNU_>3'UUZ !P:&=(U$P+>^_P&9";*XR?]V3Y<86R+Q1O>Z3R8FK5RQGZFS%1
M4/Z5U^ZXK1/M7XEY1QF#P2=LT['41^O[G=)ZMLU_&D<_WI7$52#;KY4SA$:1
M!!#1PU]PRD@O)SH046MY8Z@H8SZQ+CCOK9HQU?A@(WYKSMM=,!BX)K=P/E-M
M3S@'-F(1\S.(F3_B?MAAB>/+81A&ZY>]O)8H^C>XO%>)6XVW[:38ERX(E-YV
MI\CAT?S8Z.+%,5\YVL#!>"7P>"0Q\U1SCZ=MKWXS'K13NNUM!C4PEW<?'[F;
M!RRW"VISYM1[5L"#)!+Z.*MPTU[6N7AQ-&PP&A+E W%+^7S]^]&%)X]1Y!L7
M%\)"3L41G?<CP[U?2HF-*[.UL^/7A&$(XJE:?U:V?_C FJ.$VBPO4C@CA?7^
MB4B2W^C%C4,I\%_#SI^I.C#OA_HBG\WHF:SWPPSPOGKA>+U7'X_AW%2^%JRW
M^SR8N32OQSW0]*)U,N&2/.\P_H1)P6%H?#8"C[7@/4L"VPN'&$)XC9L;DNV
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M'%YA#\18)BYZK6>SN&=FM7L;"Q^WM'47>[]3!QJ-T&#O%Q\$*=/T*PA"1_2
MT79XIR.BRV9/P_^M3>/2*-S]]M8\>R.9XH[ 9B=QXC+]DM>8Q&QW9*K7[ZC\
M%[!3QPYYFZX:A?J),[J2TY*.32Y/9+7/SY^_XG8^!JZ[B@%/Q=AW@F>6MA9X
MK?0J8>(N I?EZ*USW1<%NB*!V4G32^3J;O-R@_O^YEHMO TXW_2:0AI?9&++
M31YFGL*19T6AD 2_V#;+\'G&[8J),[%%0@/T'/=!H@<$D;^G 9%-&GNVFUYA
ME@#3><GT5., "ATQZS1 _*V5>Q\V(C%-_*3..U2P^<-(T(S90?3\3D?KT*V2
M^0?JHYRNN!&7@LR7W2+HKT/^7&HG_0X8XL]_^:RQ&.;D%:$2'<E W=PA3"&H
M?6ITUGV.U:5XW9AYB&-07):7';.6;+ZK!M;#[#E&CRAO@"KS;[<+^FTUDX//
M^X<&;AZWD$-]M]J:^R03XS"D\^E(_:\^^^W@\3]$;O]D1+B20:.[9[&*.O_0
M\='/+% VQ\4M^N[LU1-848NQ3WYB(_$+P]Y1Y4J+C8V@*MD:COGV-OJ-RM?W
M^J&O5%T/%ZDNH-,$OQ7=G >[6J\\EK"6?B-K)Z22>5675X,6<<+]D&)9)H8<
MCA08BIAQ-3()8.Y(7J*7M".-;U7/?(*ZMZ?AKKVRMG-"?HVJ4/)0RQY]L3=P
M_#T->+"9HRG-JC4J8*0U_;WNM:;\"]WR>9<AB!?M%J\-H_(/C>NRO&UEOV(S
M)N;/W9X__?I61&9Z=6,+LW@R"QQ3^9LY$7!M)Z+.X$A^CX'3C*@NCS$^16OD
M(V/W-+0D'CX&@26("CUZ&L:&?,4Q,)(X$A:\[ES3;CZM]*3,#3R?,7*.ZHV8
M;Y57OJU?J64*K<N?% &%IA"7L%>^GL?&?[^*^Q4H-#H<_?EXF0H\#N9I<YB\
M5N8+- K]>6SOP25/[9L]!W_K\=;V\754^@+17$>,,MD2SB7KTT-K(-I/0H8*
M,_YFLF=<UL6]EC%[<1?,; MCI1?W15J >DC%/KZ3@(X$"NC"CD$'$\E*=EME
M.'^SW[XRCI?S>GZX13>X,C,&&--?WYB&HK=27@O3X5)3&$8?Q>UNG%_/;997
MZ20U+>F^]WZVLYVFP^C(QIYIJ9Q0TMUNM=76<#M&P,:H*$ZM#16M&\V>/<83
M:VH^Q5<.F'^Y[(E1T+T!K[P:)M@"!J._(R457@\/%+W'M7C7H\HNFP$FO3OV
M-+Y/O@89>;>U/X;,Z>\JCD%.B1R>S(WVNK?,9!I1JON<8\#7O?(.VQR/?%)<
MU>__UZ:JR;J(S"\B*C.BJB?\DC]Q2ER9.*.F.#-(9Y7OL^&V^A (!D;7;[(Y
M1JWAR>(*LQDQS[33R5,U_.@/F<'9%6=>:_)@ 3S3SNR'*VU;B44]@+O#QDO%
M>QI+.U.10J36@,WZ/-'9G$3O#4'5+!?6E)>P7$_D<:$O<*17TL7OGLCZ-[N7
M1YN0=?,+BO**J^7$JJ>YF8U5%*R48O>7[.X)-&,L.+*E7!E#A[UI,P^LG4WJ
MXU1']5T6#A7^W>$D!.Y'[2&NTSYDJ<"/9DB%@H\^EUVK'WU/0-PUD/FO?X",
M_S<0!1LZLI6TKO&[9I6OZJ8%2;03<8?>K/<&W3\%W3*(SSI;5CQ7$N[=]>=<
M<7S&+T] B3+'N.P^JK/U(,<9>%/9W[6B$@3?(/A/A6>M+*9*EEN*>2%K',^+
MDV0/%\*:]/3@ON,EA*:[-ZR%<0(C>/M;?/ K/!6]&K,_DHS)-3(,HZ^8TAHZ
MSC#*G?V$Z1N$S$9LEMHQE-8!&'0\->?]PJQIHV8>U])DPFKM]=_3H*3*ML!S
M^#C_2]6 ?#>3_.Y%\X>MJR&TG1D=;3P&<.S^>_5('N/%@AT58H<BY"W6=BMW
MAKC+G@@R(5DLKF#VDO8=)+!(+Q9H)P-/._J\&]1VL$V^U;S(9L6O S-W7K5'
M"L)ES$BW66=<+KR*KJ^>XJ9@7=C76S?VBW'LZ&C64@\BNUF,T8(%O(VND)VK
MY,J/GTVF?E(-CSF36G2;Q06/OC@]<>)<:=&YJKIH\:\[UDL ]_6BMSO.D_%0
M;]W(+%BC!0>9/U!7P,N/ZZ4HM8!9LC:%MH!N$9">H?,R4;U?B@M^=@<"=0AJ
M[6\X6I<7N6&T)D?TX0Q15A;ZP('[@9U-OR/P$XICG#*OK?7Y/#3%+W%/0]AB
M?!NIICP0_?0NNGI&JW9RNOG>Z]JT.\/&*\^;B6Q4'$;O;O"4,9LU&7B6E-F4
MVWRV^K-5K3?\SU=*N7>QWM1E2(QM>@4]L"="7433)N-JV\^*C/"# 44/ JIQ
MLUI(0R:#Z\['ZAR0ZAZX"Y5)#280!OVSF_XE0 4WN+U-9AAF&E D,(H5&/D[
MK:UOQ6T:_S(IVK+JE3]PSM%G'RG-+:U#/'\2D_'FPFD&L9A>L XMLX2NM4V7
M<"U]?;N]3*$W'XH\ :F^-Z%0=T_ GYPC4DJPXVP#X*PV)E&=T<_8'(/!\\8N
M@Y-++&^$V  9D9H>5GAEF5ANH?,X+@,4)^<#>5Y>#IR0K<,7DG#C*=VHDULA
M X,'/2(%>;8D5*M<?,R5S68WL.\)!/^*1")O94I&1R7G_NW#9_<R0U+_]>O,
M8GCJ<7AE9F0%Y5)%<:*4>&G=-,W(HZ@><@'B63\:AOPXA;/HXT2WOK[5(DK#
MV1T$>(T,#D-:U?1MA25CD_F=ZW^(E/_I^-=SJHEAGZ[%"\ZZ$_95W?QNRF)3
M0W.Q7O_]'[I'5BDC13.B1J(4)Q<?0#B S"UU<E4\H8]VT*.51STWU7HPD?=1
MC%W;OG7E:K @&/WKAN?B5+LF1&AL(#^C:'U!*O- )B20(:Q'I%_N.][F:&IZ
M8#XD>F.[6O+PO'5V6&\>8UG/T8.@QRKBN:UD6TP7%0E.C;BK_9P>S1.K8%BJ
MXL5TY?=BP#N"4F1UO2J(UP56(V?O!B'UO1GHF_4OM"\IZK)T[2Q.F)2Q:<7H
M(G(T+%@@S< R)D^<RFTI7@F?M!6D!#4NUB8:G])Z+0#V/A_CW$$]7\F@;&LA
MKKA=]D"04?AUH)"B;F?5N),T57L:.JJ@CM9W"9JKA:3R^T8/>=X%M4#*>[EZ
M7;8BJHRG6YP\)XGN^U]6,:8@R^!=>\AZ*/80S%F=.E2->,.[7%"2\JA*%"/'
M/X!.^*=@#XZ"!E"/?@WPS,F/3"Q>?FGJ0=+S#+88<PT*=CX)'S)/ZW!M"^V,
M4.UJ(9JGK 4MS0G?26[@<*8632^L>R/*7'#H:9:'\Q5Z='Q-1!>^X(6C3V^D
M17^T,I1?Z<$4%L$K<M;=/)'VL0(6V:<,$4C,NK2>IP:]US7C4!ID:5Z>0E']
M-WSM^$KW71-&Y%V8"BK =,/KK/QMR11F=N:H?40%XGQ%CZ-(6\FU6>*JKGF&
M)36LP3';,0[+R0]4FCVW,O8T?EUV*DRP"#)TWM_*!2M4L+"PL*:+\W)PUVSN
MFJ!!O[7T'9_ KEEP=$W0S41L>4G=;@]N/6:F<[&B*:;%95=Y1=)YTF^2;]=5
MT_L:NL>E:G0$H?;'RIE)58F/ R(NO[-7/_:Z+XM3R^>U<VLD^#/$]J]?@2'N
M-V]PC8^J+C_T];VS,5-A\$O2K9[=JZI=0 H'E12_M>U7YYACO]I9#.PL;C-R
MH-]NPU5'R<<AEUT74%R[1;TQ@O_CT7!QV(:#W )"&)VH-3>0,!G='ZUR_IO,
M$/@L&HM:$+UEI_I.7QRGCB6.E](MM&"!DC@='PQ\V"DO/(_.EDUZ>.%T2*_$
MMQB/'S[&N%APJ1U=RF!+'[[>-A5XLP=P+5F+@%G-;V13+#JG1M<7(FJK.R82
MD#;QY957>S+595-C ON^?M$Q@G7A8)!A_)&LS6!9,D2;QT6:D6XE9CS88'(R
M0\*]YOJZQ*?QJDSVFG?O@)^W.6AJT;0E30ZD'5]][)RU&4L-BC3JG)O<TF5B
M;'P(+K5:R7:/?_US;>2>AF_H&<NDQ.W8I@.ZI-[#7G41%>U(@,"Y(4% .S(_
MU>8Q)EM.#G% 'F>T#\*) ^4,=6)]/Y*+? *'-E5GF8'V-) G>3?<.>T ?'CF
M('HJT+PG9M,;!0U .!DO(F*VB[T]D8FUI6)27:92L94_,0RQ"8^;8-7F)8[%
M.[RN=S@L9L]8XB[P2E[YNVB*"$7\L#K:W2;WU^^)Q=A\+()&,9&22%/O;D%=
M#W5]B*DGTGY\&]^")!UA5X:=U\7?[$S3/D6+<0R0@V\T]_&1"$W1L&0KJ$($
M9U?PX5D&^A67!(SRD(<U^*':$%--M>'7LO&LWWO^?CI[Z_E(-LDB4\2<]W-W
MH/9/U=P9=C0XV2TW*>R3619<#Y!:!-2$/O"13-T-U!UY_R$R/6D*RV^.>$*)
MFB'J(66J<&[T\K)>*C31YKB%V C:9 :&<XF/_C:,].,%M(\OLL!"H["0KU6]
M!<<FM!MFF)'W'I'!PL),(?TDK]:J[/+E*PU6@E,U-2+%GL;:V_@.%#BDQ8J'
ME\&?K$!HE2W=JX?;/&M*^!3V9&!3@:IJ\>M([#VY@]V3BG-/4I\N8P--ZMR,
MV5R1B_8UL$$'H11F,FEW=UWT9/BBJE415ZO>P)42.?97*),,YMU%,ZWQ8PPO
M/4T+B(_1)(OAY[#!I6V':R/0DJ_=4 GT&B\<8C6)K];4.L:S$ 4*'Q+SCK5Z
M=$'#?VZ]\WY"QWY+?ZCM$V'Q1,#[]8F1@<Q?7Z#-)'^9H43):HB=ST,OW-4U
M&"RD9>YJPZ;J%A;F*HDF,J_(#Z&[DNJTJMOO].WR0<KUF;'\F;P/_ZN.\UU^
M.3L5YV]FWGI!!'DDHJ5<K1I.7)&+ 8HJP^<18MP?C]T>6S3;E$>6N?+ 72XF
MP0N18-&"%?S+V+=_A.3_*P Z/% EU^UN(@^J@S"?-D9!+M@L'J+/B:\  ,\1
M1=M.V[Y_)F3RWED*U8E]=3;+7VX\"3#.O%I62DFLHB1BUMM]\MYNZ'T\AN8W
M3+-&3#\>0YMGV9Q_5/*W8VB4NS!).,0 &]>X+[+&%N)QF3%K6/.L..) %"R_
M6,(BTJ-&&[0"2;DA(;<"%AUVQ8>?S?<^J/QNW:4>GO1-5/Z)F)BD!%1C__0F
MS?:GJJ;*XJ"4V_EX"?]G7@+T\;99FU[^!4KRU;>9W2=3SA1M:J_E8/VSX1SI
M+@M9C\%#/?Q:4R46\(D/84_SQ)TN>&=S9A=A3R->;U X8DY9S@%I*S_O40[5
M<?O08BPK0V E,(4.D<(%%8\J@D"$R)3H4=2Y>]C]TOT?V^."N,6?=CS_UAY7
M!66W]Y#^HSW^=5-/E,,5>\A_M,==?1>,UCZVQZV3J+9Z2DY+4LI<0N5NU1WZ
M%(BR+ ;Y9\V.7T*M>_@Q/(3D!SJ9,^*IPFRX 3YQ.7Y5(0BY47IO&72DAY42
M_#8A@.T04\PSGO4+']$IF\7'#]*0<DBDR/.X?DG+S[_G\9,Y1IL\04X@Z3?&
M2:3,"$B,8<2"A8-7P?/I521)!WV4SC^Z/B\YO,PU#K7VZ72)'3K*&/*,_6C3
MF?AN2 75^6+J<;P7X!4+%[2GH55L9/G=V"27>FCR0T6[OBQ\P_#PZ.H2PJ\5
M;GP<QQK^"JE@3$QRJ(B/A_9@29X![^-4AUG52WSKMUND5MYL8/1SIXULX?;/
M Y.;B;>;^0/[\D:/_>EZ N^N/[Q9/KRI/!&<72;P\;7S\)SN8G*/O)1=,,G+
M^,Z_:B+<O!06"5G</F TTVW7) QI9([-USHUN\:+S7:F00\O=[WE$W.T"&AP
M6%NS:\_.)\H+,#/J#RPO6ZRH/.6+U"1\H\)I2%XI@=%/\@<HQ8'A'!0A&$4R
M3OG\A22>]/X(W3(?WP-Z)%%"9A/7%W_>J9L;!(P H=#5DCT-&GII\J7=75:1
M[N;ITNF&)Z@;Q^7P(>?OJ>D C[:UK2,Z&S@N/?CJF#+/@<P+KT42*#FM%3E;
MT:+/E2&%K*:*$C8#MQQ\Q5'.=5#Y(%<5/X:O\5A-QM?6/"8%5J[>[87EU4'&
MD+Y(JXMKZF/J_*6@4>^/UGX64 A4W/MW:S^/Y_S/!GS_9NV']@7Z\#]:^V&X
MSI\Y]Y",]/+_/G(AR^\#*R&QA844NH63T0=MW1QEE5>P,K(NSUJ AJG%P0U+
MNW_ 5O(_0X5+G7X:M]!0-)Z@J(8,K(S?[?^P8;,63O3!F#5OZ2O^E^,FPC C
MU=7G_2[T9YRNH(12P&>EQ8U2J7(F+;3KSEC'3W<3$V'[$4T3&-VLM9 7; Y^
MI%Z2M";E$%EMBC*/-6&#DQ/QBBBR>2+&I&%XLH><D!M;:Q+8IG &(@+('CNO
M,OX]O " YJ:VG8#Y!+S'Q^->FRV_1O2:UPJ-I#?G<*;5N.3$BFOJ;6;)T$+R
M2=KMTO2Y3KCY_(+A$W!C"^F=3K43X<R6O1-<53PYM;UH=$3G+4V;'1.AWI)_
M$*0N-+X6[1WM16_D99TQBC28&Q4W)"1V_ P+[.,D. X]ZYZO,(SM&.196"V'
MU'3Y5[(E,%9&X::5R*T=BUB\-3.3/Y'^#J/_;%-?3EZLK%Q!#-R11!06G65M
MS*Y/K]&Z+(.RJ9MSV(KJ:D0-+_'U=&EF*2.--%RS*$#=Z_CW'2,U;IRJO0%_
M]8RV/F,,'+^=G;*P%.\3F<6NN;$B[HZHF8UFKY6ALC;__,[ 7$P^)I;C-N7K
M0?U%9J(M<.3QZLH>"U*'-[+\J]F0D;>_Y^Y?8*T::[#EP?[72^+LX]CF;WZ^
MJX7N:QL<ON1>%]$WC$%=WH;%U>4 93I6P[_U]#$&]*=\ M]%Y1;!9[[V&/#7
MT=0133R8N+9SH"[& .-J.S,LK=1G] 2AQ4$.">3".@_<M6RC</WJ/(PFD#TD
M*Z@M;NAW@BI3#F0IC)2M,Z: =;P?J=1^M@):#&YL5X29Y7D:C\]:F#:L6R@@
MDZY_7=\Z7^ [&_R8P/8#++7N:23$K/H43EA2?3Y#3X=T8H(!/\Y>PO\8J^+X
M)3Y%[EQ-!E\XW51%]2F^N<J=) _18&P=,=9+/2<Q/M&B1+>@7B@BR_H$=Y,[
M,+DY\ST4D6"TWUZ:H4A/D2678UW)$O0RMFU"9Z(V?GV7>&EP$=<.S2<I:%9E
MJS7^P[E'T=_]UVOKOPX7/ZSNAS180+DZ:TN(D^S *]?RR5B5:!TD3F>_(GS>
MEZ/2F;SDF/;2L:ZMD A*UI0,>R,3='8O/ZS?T_CB0Z4,7)$65^8DFANW3FYD
M1JY[G# J&="BA8'C*J 8T!@6@8_?0%P0I<W8D0"2*WL:/XY-BV.DJV\^%%XJ
ML%,^C0^Y+$P.\/VT?T^#E>($1S^<!VBL-6(*^V_E+TBY"[_QOX%3[DDS9;39
M)'G#7>B+U)Y.YZ\X>C8.9Q(W:Y^F7CO=.S9TYD\#"-"/A'+<P77EA]]"PUU[
MT20TU:OK/2H^VIVSPL:=0^3FG00C"\)/A*BBA"T>Z,"VLHD?\=]\UX:@J_ ^
M'L6SNH^!PF;\QIUN5K9]GU@GOKGKRKE9*V# ?'_=/*QHO*$-/3KJUR,2"YE8
M,R+*?U3I'X!G/ABX!L7[\]K>Q!)<2K@]O&^A+KQXM2:F*\<_2-O'WZ9$"KLN
M;0]]^7;965NB:#I\!'.5Y;AN#BU4:)V<K0V+92#*GR'-KPE9-6"CK_R)4RP]
M5O_CM!/DCPZ@0G;YDR'J/+<>/IWQT4O[<JMN&^;?_Q?Z=,LG]S0:$XI@^E"X
MX7NOC7$FTE\WEVS,!]^NUU/H^Q. "OQ0_J2<9@.R!'=IA454%\=<4" 5M%WG
M\SE\O0'.F9/P-WL::317IUO<? GVUWDVM,X#[5UW@R(E!-0D'V$GI#58=]O)
MW6!JCJ*6/IK/1*9O +Y?ISX2#O+FGT^-C3;CAHE] Y62V?QB&"[9;32LX[0P
M),SHU>[YG8'C[K27JWR+YI,J+5MG3R1FU$D[SLL=<+.>H$^SQ28_%YLK:#7G
MW]*$S<V-]/X)=YZ>4N^8MJ^WGC\4](Q0Z# &4^>LX"@5X#AF/+0$9UZ6 &$;
MJ#\/8S-V3MXHBA^NI@G:)PV3'Z0L!Z<='%H82Z2LF>F'75R 7]L(=Y.5>7AL
M&1H.RP%F-%%Y-CY21>LBF:.7QA,W)*,&.X^J^/*ZE<9ZQCN<CC;R\K%!;Q"$
M9K4BM=4U=8B)>4:LKJIISWT669=YIKKXW+J__S-8:A)S]M@D.NG[%Z@UW8 .
M9(*5-Y;1*K?0)"5D=: 0WM%]-RQQKVJZ>"%&P-^2OWF7?'V27:QJ.;]N@2B[
MK5C@1 IC,Z?K&F7AGK$+"X/7"K,A$6_ZH/_UFO]_L"]OPWW![%U!:DZ0.$&-
MF]WL'D&&ZT\%(=(IA X&ZFP+HWA1FW]R7^UA"+P[4-:8-L7J>/5-^ -9>^+&
M0D1I9I4T+BEH:5%N7I-?X?W)6S:Y[IRHN%]U^LI$*$SL@MH%4M#OVNCR6F4(
MRV.4L.#@E6.7EKVND[\1S6ETRH>2 TN<%$],4JU+S-8A:X*P#C.$30<OD)+)
MPP:K_XPB?^;?/)%*, D7K7VU<]EZ+25!%=X0XRB&@M&7K=XES4!>77N*"'P0
MM]C='-K^>IZ5Q]TZ61LQLUS#%E ;M+Z7*KS<A5Y1VZF)@N3R;O4ML=JEN=M3
M%G5%:N,@*A,=.T1QXP?T@KI2E:0TL_POLKGYB\9.4N]?%:L53B&$_-[$Q;8P
MD-N@]I.4H',3V/W3:;D@OV@!LOT;-6ACM,F[IJF=SARQNK$;+5>-#[CH6$?9
M^]F3]1T\&JCIZQNU2IMC?MLJY<S4NHKO.#Q1N?MP$ST;?$+/N[+5IC-S=,T%
M&7U).A&:*0>6=,MVQ-F<4E@!O^#,KI?"4'=/XYZ2!%"6= PEZE<<8ID9&D4&
M5R*=2C:,H47&"Q(AM5G$>I'P\^_9_!3C"%K:_SK%/AY1LY_DA, ^GUQ2Y[-P
ML#V-XD823%YKT]+L%+ ^'%^] *+*0=0UR?GS[UM[>G7TAK29>.N)ZMWV3<A[
MU(D/U<%3Z".;K9HWS.=(=-?T^()#DG?S"UA;\PX EXM^5]L,.1.:@0U^G"A*
M14J='1H?8%%:UIR A=X\;T6D?JRH,JXE4DN /$!9UU_;7*^<G/D-I:]82;Z9
M<##%->Y@"_%?#H!*WUQXMR&3.2'J8F+NWIFWS>'95L*^<0*N6BI11X7"@ V[
MW.+94A&*\>F0]TVGF2_>MNV:36J-!V:W![+V--"!LW7(,1=C[;!3 1QFG1V-
M,)MG,]G6H&G,(V"64:<71I::E:TWY8#[C'X<MV%V.ITXO(%#<V*%(:*>DY'.
M9P\+_@"U_5<"6-F3<L01H?KT^HS'LO$S((S+[3RH#+%L.N V'Z\(:5J?*5X
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M\--AO8-;?:*I<<9[KI]UX@J66)B^U=8H/*.E$;:!#O-/\OKSBR1FU>Z0P?3
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M" 'QDD,$J!H<@0R^UN8G@L7P/8I:0#%V7^V0)2D%J+[LU::NL>H!.'<V_W1
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MAUJ,;OZ1SBDC*/5*NY=V-K;PY,9!J76 4 ! Y;$&%H;L#9IC7^R@58^"\]]
M#M3$ OT#VFQTXPA)W1)WCP+8\ JW:J%-M&_G?K*2D6Z6[#&XC3K2N34V OZA
MSS=T'HH1]& ;]I*$Q)D]5;Q9N:'HJ5D0-^ILU7Z@7+&#X=1QS IZW9+>!<YG
M<I*']ERW#][B2.ZR-5SY+>:0<\_V!X3VV69HW%4'C$91_E8H+_=AT5YFWY!
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M5B#JH&';\Q-*D:!AQY(#["K)RCR9RA(D#9DQ*KF1]55:NW'7#YAC3POO!Q?
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M#QO2%!\V =H?G<NQM OK=U3N PD6J"[5B8.-\(*8BK,IY66Q]L#J!5'"Y0E
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M]O]YL]-]SFR>ZE<MU13$=Z<OH?,F^2UZ$5V/4EN$"):5#<2_EB4T1WX@RZ[
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MW^QX8A.,UOBDT+?IL5MC<6&'^EM'.O[O#S*61IMJTRJABDDYR>[MOONY@\!
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MTH:&\GV9(RYC;E<0?!"5(\>R($R,HM(/[9GHXAVO:.X#;IY=(G9]XOR,P(X
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MR3[:L!LNPG/-D,@+E!?;9U*P_3TK*97861(#N.7.U>> 7,GES1"'YEH_/?W
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MU^K^FMH_%#6 +[M%^= S\/<FG@C6/;%[JA@HN99-[2=P+K+AVL9J6Z1($Q4
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M\TQW#>>/@::(MG""T<U2^U,AOE4\3$&2$8!E<*I/L[DNL%,K-3A/NQ]S[(5
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MTZ4+]-I<L@^P'(:D-=C,31BZ4T("@"S9T#Y&<MU<DLXJY^W&@#.P.1T^0;9
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MZ=5!0[AX3'J?7+?4%QA 7TEQ6G\SC,R=R1P@& U!UNY*.%"<3GJ)45&"F44
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M6;5*QJ!Q8+H2AGG2I"YXI[Z-; 7"!;]6%DS4!^J]=C?5V+=ALQ7^Z.UP!>.
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M,]^BV[\8/^?318B(5"WX);!:2+$>C&X8=8:6WLZG]HHDZ=UM_;=(<;?%SZM
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M:^U"W:Q=J66(=7(Q'C[(@;]CC]5VT&#+^VUZ$2VC4SN0JMSB]E\%&KL+H$.
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M4LX-S3+?A\7L221$9]]# ":14.LM+2I#/N2VY>.#R]U3-Y@UJM"JCAW9Z4.
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MT]^GQ-$'J#3O>U'^E?.7WX*#?) /82G=,2]64U?&)D;&I E H$=58B\2 BQ
MTN]_FC<9XL8:]$\! 6)"PMO%!]<4XW$(&7<N_D8'J8G,4^W-!FN,@=LRS>>=
M$^B/W_)TC9]!]H<]$=T#>6&4,BD91?=[YN QY(1.XK+K@DR(6?E^H6^]UOG=
M6F_[&CPPEG1@KBB];M W93-@#71P_?*T3D& "M;]*'?YLGNPU;ZW>DKQ-P"3
MZD_A<>] =--X-^LXGQLL#?]6:KZYV4ZW8&8W;W033):8M+2*H9XE? *LC@-'
M5$8R@CQ$(+\=(UG0]+M<9MOH^WF@;K)>A[^Q2]],S"NAP.,NV&Z[= L&W)1G
MXUP'V8'99=D%4=\!58I3LB3&6T*SJH=1_6[F"9;ONUU>14;)W&YT*7GNE6A6
MRP_"SV&IX&H"4(E*3[?1+_ITL;#P^R_\/7U@K0> WN+-7R:84\[MM&A%AU#(
MLJ/&=A,]FU*%W3.C\$%H*N=0K7$_ 88@-'O$ #1:CU);A/F E!<=V-2 +=]>
M+# R @X7(8K9ZBX083;.X[H'[UG)U_\2P%YS"U(8(^*'@CP.U;P3B8\2;B8B
MBCG,!(*L_4,7%.T(4WVY[U%"?$Z;\]\,7(JI$0A"7/Y(",<7OF.$Z JJAJ=F
M:^=0MR:3LLX.;?9H*RW6;2:3 @0@/W:]Y?AV ?P.:&S[7;,2IOW$_I1Q[I(4
MA?&'4V8?%OZZ1/=XL36H--<L] S-L#% _ZTT)D>5A:8[Y K.P[LDY=X9(C\D
MB XT),4W0ZC!O>'68]M^\I[,[[VJ<,1+%T-<ZI.>$8U'XB9HOG2K>"5XX$"I
M=$[75?4 P+TVPZB?X_R;1QY-2A!V"TJ4)9PJ6CG7;1"_2L^\*H*$DNOQ+8TI
M1 /'8R]:6CH&*L(ZCQ:_K(O,A&T/ 6/],GXX*!X&R,F1'KV2OZ+'T!^]HL$P
MFX[TN;>KO407=YC1:TY9OBUTM7W8LY[""2>N7=OZH&/6%^F\3A1.@ZY7E9_;
M*<1$8,N;&K.A?-R-0[4,*9DJ&*Y^+TB!$$F/:;WTXK!JP\99.U%TAL- R5AP
M55PP+VHZM<'D5G;.NS3^0)8]I8SQ,X*LJDRW9)>0!S(\A 'EJNF@>#;(0W"4
MFPP' EL_X.+6CSD]+[GL5;U9W"C;115BA0F5!\$B D6'7RW9I!?^.*[ZBGYW
M>IT*RM.F(FZ.]I?87RC&?9?TN>_%K]:)F?W.>^3FI?53W*5$U9W]Q.@ 40^/
M.]72US(TRLL_N]$!G2BR+NT+FZ8G$WY8[NU;#Y[+H5P>DD!SG6U;PLSL-G*D
MC%S$K0T<I,_"0MC2,>=7^/"'?PEB_^N9-9ZZQY"":*+42^L'>R( H;O\O-F5
M#4? V,.AV2)*;G9=29H7]B%$PL-F:IL9+G>W1#<TX/PP]BL8&%[PJN<T@V6U
MQV)8K0&.%2]9^(6:8D]]ALKU&!F\Z<FLZ;08$3K<V/2+;)A&1PN?;E3A9_KH
M<#MGS HRH,KH7=V6ZUX)P^$>-6=KVEEC\\X)IRQ559K/V"7&@E/2*N;M^D@]
MD7,]\M7*XK<_*97*(#-QR]IZ=.3P5"2%5V%O:E^]_).DU6ZJ_^Z)D)?+T(OD
MRO3@_?/!44@2K4=V^H4@^61+=\1DK.NZ(@%35N$WAIDDMSVF>!I NYDA.OPA
MDZ"EF9G3 T0D(K0K1<SAA^7&<UZH@ $;9:6ES=PS7MTWVXJD DM!W8T?!MZ:
M=R)F0-U=770A+Z98,$2Z.",%..))MW98X*G7Q26':OI#/O%S!(KN_ODO%[8>
M=E5H! ,^:[RP@H%_P 2&$6)W,[90:8YRL'_L"-RV;X#AFLQ_R@*NFEKE\FL1
M9 )?RY7E^Q(L[20930_=)D&C)#&?O<6\6;"BKFO"#P3>7BB5A0/4(8Q^3H1O
M"#7G6G-%#:%&%W"MCN9MJL@PW!.QU\^S/>;PKLP\5!6^U:99LM0V Z)?D='_
ML-N'.52[5%RB;=Q51#5I#(8N='VU@@%:(Z5E3I_ $U>@THEY%:AP*K;7,S+@
M->EU'B+3*-0@PF*^Q43#(J @M%NH#O@)WE*H3Y=6)$_'=EX5R]L<:!;W.H4:
M'[@-S]0_9&^G5E^:M7_PK\/L,:2#QHPCDW]N@=0NU#="^7B]"=@W'UM-LE\?
M%6OR/K28MLGG,-_VO'X%C54&J,Z9[NP$I ?\&0-,MW*[826D[NVD;GJ/\$"V
MJ$36V=XY?E.34^@N=776CR0FB.!V21HM8MA!TS:'1.UF6^8@T5E3LS3+]# ,
M+YP)3^CUK[THLK24@Y$>U65ERG6/$66$S[-?<?$A3[7?D3O7#7O1HO0)FG2+
M_"I:#UHZLAW,_4,"9'H_(OB ;NIUJ-:\IO5T*O6@JK[#SBZBN'1G^7%G0W?3
MM_N[6R'R3RZ!)$Y=DE/NN;,HOWS02+)BTB@5SL:0Z3+P9).-D'M)W$4*:PS%
M'C$#6^:>W1-4=F7E<54LF2%PMH>!WVUYO<@A=O>%0:P[1F]G<]^D657P]8'O
MS6, 6UMKR-F"5T?"IHV[]>YNYKHSK%(3N!KH?,?L$6G6&B3NOT5I)Y7D9O@_
M>QNV5)1CTEC:?[&#]JG3SSO'=O+7X,@U.S'E2>P8<<IN9$Z^G<UN,*6P(-1E
M^&/N@.854DY.3G]!Q'12U:9C_PX"<9P/4"$$8OCZA,4F#"/U*+8\. E7K]M1
M6I>BS5/''8W!]!B]I*ZH'DD]-M,QWXM=OV97@ ?_ AH^@Z0!'6V_[:4.!0]<
MU+@+L78SO2^[ 4;274XENYZ"?;.L0CQC#"@T60FM2ZTC0QXZE8%7(^H&1SQ"
M $&<[=(C*Q\4:0 :7LY%4RK3%WB>!U<Z;>]7F7J\()EK?!B'/<XIU"\!O)RP
M^_E?!]?_*L;&_;GO]=Y7THB%%;VY@]L)F )<1U9%7@NP<J3"2_5Q_]EA+8UA
MKC*<3.NY>Z+X+Y?4)YA9PQ>?<3V=9+[6L4/SFX=J\ZI1G%4L-W:RC\)8)VM5
M7>Y4Q'X+LZSS>M8SXZ5';M/0L%A/R"XM&S>R'K8#TB0'B\V/YI/W1Z,U'&YZ
M5><C78S[&-9T40&:^,?2LJT?W!GZW9=?;EB%/.R]_\&TJ74SO< "A-"C/2./
MD6"@4;.O&MWS/&W!N =3B6!XXG.VIQ,XY+WQ0N!7*^7I 9T+T*4E^MC?9U$J
MGY1EO M)()\6.<8 B[M84<)YS9F(_( G_*; ZGQ0X]:@JQ>YNF"*=ZAV2K<Z
MA1"SS ]]71BBFVP0%QSF[;K8[VGBL/=B6-L-'[CQ->O"_AJ:WIN/-89A-X]9
M3)23W42&>(\/%3$.%*UP*"H)GF#]'4A3&XK2,8RDV<2^IMF?6!*'>*[>8(+9
ML<A!-G>8_TU_EHM94YX9^^N!7^)*E9$KNI5[<CD)9ITWJOM,YPYHN@*6!\<X
M*.'J&H7Z-R7OTWY8._5OEZ-!VC%)UNRUBC(%VU+=@NA)I6D(+-<$1$RQL"4^
M=P_C=@'[-B3\%9=;YM%P;W/%L(CQ*":B[^VC.*UV?V0*&IV"!%.TDK!)7TQ<
M?,7P]65 P!/^3C*64[T9'T&9A@L[IN^5DCM?!MU[WNSWO#[4@-02:G Y:-#5
MKTW]-ZL-#Z-[W"=<\<U=:'9U=86JJ\^KJP-^_WW(T%G;_U<#EJ$'F4&3QG6L
M='!>B1&[$Q7AE(%L.:"?9UF."?J)>CN4,(V:T1,_Y_HAKSL]8_RAEWNB[3;D
M+-OWK"_=;B4^,0FJH)R/T>E-9F:9T$#LO*1O-=-2=[S:P*0.OS$+#4U"24N-
MJ8:&N@5W$^RM-0)?@0[#-V(2VY6Z'2VBW3;-G/$T@]"P(2.#L"&-VP+*#$3R
M"?ON7W+6\DNR%C%=6D1/I\3@GIM:L4=1Y.W%^>SD\'4BF+ R1JTIJ\.:1I9T
MEC@L%KZK%9Q],G#ZZ@&&_V?'7SBS\F7G0S7XIB7^4,VX/ XN=@Z:/A(E*+$U
M@93[GO'-B]*6[DAWVK:^\Z)Q6!S;/EFY(E!HX%=M5NE H(. P<5G?7?#]%;.
M>#SN7-F\E"<)V<"]6OB&3MTV>RNM=?0G0IC[HP[K%*7R7&W']H\U>M]>'[C;
M!PX&0^Z"G>[Z->E:[8UQ1_I-[Z5>]1YQJ?4?)4R3VN6 ]0()I##S11ZW<':$
MV5%6"6HN)N?2(DR;$0WL^AJ39G_B'1G_-&2>/L+_;IBR^$198W0U?.M0#54T
M)S$PI&]#<1[0#YRX5'^&N?X>YLWMUBV7N.U^>*CXB)KLE9O-9DZ:2;](:^5N
M3<U 7LR4@4^NG '3_*\&#_QAQL=45^;]ICME^;0"7[)_J+8T*K<[4,UWF1DG
M(%H*."=*FXJ<TF*#)W+#"6V/5^DP_Z 16+-7.0(K/D!^S938MS0(8$5HP&9)
M,VB5$^$ !V@( DLW<,\JSOG@_]6 _?^W184\ R;MH!;2?*2+6D]G$=P44,;U
M,NO+E330)P]D>DP\]S7R-&@U<5>L7!YU]X(2<P1#W-/RR9U=ZC4Z#10VS#+H
MY<N")O9P<L6EMV(XH4R@WST-TQ265BVGT$AY-TB8,J:F'#Y?#V^X^[,\)$'A
M1)\SS10 [?=U_?%:WPGQ?;U'O)OZDDK5V/1Z^M%BX>S9=SO:YJUS7\5K3DRF
MN-PL;:%@%M[R'D^36E:TSOI>HC54$+Q;HWO,;'KN0!NJS<PW-*177B"9+E?
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M)A2LNE$JIKW)UHK<08/$,KV I8N$;CL"]<N%.]L(VZVZ%-0W4_W?5A%')**
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M>@;*J\_ADR4#6]]OCCX>^'^;J/Y_!UV[^2/=5@\/#',]45DJ2?WW N-."J4
MI]R^J,JC=;4()$B]S!3I7P0VE6_R3-(#+P$C[WQL[\!%G-MNQA3&M;C-SJ,&
M\FNC[Z4LK$1_D5E?7,/MI(QH"F!G8W304TEFAJZUFIMX/YO*<R'0)E/X5=)=
M05V,JB!U,4\;5+$;CD9EPZQ%9;EYZXH(P54YNCF8P!X(+ZQF;\>HOH/7_#ZT
M9^91KCF8M_G-OH?M9GZZ MR9Y"J(C$!XV,QF+0#?7OL%&EZ:*AOJN4M]MT(J
MI^]48^,7UMOJW]4W:GPOE@;XC@8D[#W*&,^[.Z2\+5!Z]H),%79G$34&R[-V
MM!_ 3SK%.N#??JIM7YOO>&W=M3H]M] +V32@$NAM@0V3<(/T-GH+@19?/^;3
M'7TE,W]NX=EV/[VW<)6I(.#B>W$'(SIU([F U@+*D]9WW971X_?DH!0I?%Y\
MQNX4^_9MF+_Z,/.4G&;TQQ#+>=E30'AF4,=V0>5STX$2NFUQQ%;[<KT)J'G@
MXL*Y&43-LH6-TWUA7*RE,ZLD;\VM5=#77C!US\55+V'Q!1.*E1H:13WAS_4W
M 'K88MV=".'$Z-Y_:%@8+WSKB&0!$1HCA8L*\A.Y[?[)4/O8BS@!@C_?)ZWM
M(TX/ <1@!LB:KZ3ZE$#?WA'Q*2W@EB*(I-I)A-,M[\[96P_L7#9Z UC^8#\9
M9Q%/=YG29MH1F+'R @-9!<0>VX@SMRLJ*D*/E=QWDTWNW<Q7G0@$(=GJ;H"=
M\LRBJD)T4QS,NLT/BJG3$/VTBMM-=V-23F283^PHL#NQHPNS-S,OCDEA":(_
MWFHULMP(8MWFI*;EI?'>5Q3#^LPO?.Q"BGQRKWY$%9UK<$OW'M=;8PG>$^13
M!28,"1Y38XF,K\T2=:K#5(QVX-6J_IMWJOV-LV#VU=Q[ ;XLU,5-=7<'5M>T
MT"WLGM M*R, GAR^G5H"L3;4L'GA]S"UDD_L%^9JLNYO9S8O4^L_!,W=F[[+
MU<&RE@'YU?XU.G<[I$# CUMP]EZOY^W<:%,9=WN[ GB5&NAU=7=JQ@?\NP*\
M$3@-J4#@^XKO"&4(Z4YN&#S1\=)JCW)GI:O1S3GE(P:8FLK[<B[/),V6VQNH
M66G&@R1.MJ("9:80GSN\&/]6;5Q=(6&Y#2Z+S.T _"%AS=-^OW_[:[Y.1-NJ
M%"?N%MBY70E7-KT-0H ?TV-3^RZZ/1A?9QMIVBN# '&KPFAH1:!/74(Q.L4(
ML6\:G7V_LOJ>RXD9T69?*C&NRV;5!G)J_#W53U!%2^ K'(IP,P;+35".M5;-
MA[V"P<"LU3@0Z(?;)%J;'\17>%!F:LH;9EO;B&>1G8;J^.;P/RRCP#&)=6UU
M%F7@ 6KKNVO'YZ>5IS;=]:P0WS%X73N(SNN6Y*05/1IA,P48I+@"C]($"J9R
MP,7%9@M5ZKM=!Y?R3%TPY:ARV8E0S;AG^!VC;O&"SPS.U.QV"<P:4G\TVM0J
M*Q?)K<Z^H/V3(H81X&-*00*3P]"%N]I>)SV6%U]')FO@,;DVA@P&[S75V>A3
M%Q,LWA[\U,O$YR)*6EC:R%:]GY=T-W]&M1H]? 1,M$399VVZ&,"9=<9"T55I
M[':>;Y9%"WJK&9DYVY"Y^JFA69S*D75O&QRJG>U9[MM1 4LI)<HY]/.*I9%L
M5LBUPAI!%-Q: U+U2+-OKMO0YT#U> H\=9<+CJPD+@ S^*D$QC*DL*H^!BLS
M./KP/\&X[JBS2/J\7#7QG%CV#^'K;OH=>95>_+\)7VL*HL-FPJ?&_DWXFNA]
MX4;09^%K6P[=-9EUDC2#Z.(GF5/XT5OD,#QP?(/ W>B+,R5A&V*A"0P/[IBU
MM;6&1JL*92*/[D9$0"LZ-30T7@S22_W\,@8'MP;I/[^,0DF5'V9@.QUIVD6&
M;BO:[%RS;R2':@FU[AJ=P9HHY@9IIM;1+\0!A!F]>'X!=:4$=Z85-<QT71,8
M=,M_MU  @43/K H_"#[@0] 'N5U4 YB2O7HY>BNK>7<5^8O2UTR\N]#;U7<6
M] XN'[?;S-WT#:*SW;0([)A6#/;DR@R9+CCYZH"4Z'X]R2#P<?]>&K 4%9Y6
ML7QR)+MZ&_IH<^1H[QP9^ZEL.?:I#:O0(I'^)!9O;R-],V]C'#\*ISLWOL_Q
MWU1Y.CRGLBH$8M7U4\(5$GM%O,&=M'\O /?WE9VUE%5,@@-:YIHDW.<\I(+-
M@#UZ7)E:DHKL<_9*=-S75/JW#[FP;F9$Q+$A&[2&U*K?#NB[8<Y'S9<.WD??
M5'V%DN\$7MFDLVVI[S<. FN6]V.853W)W)UZE"%J8&X#H+\GQ-/7X4E3.S>R
M=Z'-:Q1B1JZ*!U6X#2V </W 9BKRBK^[Y^*2,L4FVET4^)S>/!-@ ZEAXWN&
MRT]*<O/[-[+VG?<]\M)"^=L2^SY/YDR8*O1?-SVQ!(?+;% U97IG%]2/*T$]
M&9\QNFN*)RQ/,1$P%BO&P0D:)L*+O35#Z6]PZ8=JL'VSNL#[6KB+"[.9!PZ6
MF+.M!FF"7KLRMY=]C8!C/9Z]9QN_E(R)FW+5G\L/U=3[FNMB>Y&L7#*!D<&U
MGG^1D<%@15G. M2;3,'L%UFZ1R:CZ=2/!J H1J70"DS:NQ,428-5+$=U_F7F
MX]OK4+CR<B3PMAVS3@$C/_(!V-)I7&?^M3OBN8;/LAA.,[5D.66--L7!WDOW
M.HZ1Q)HB9)>22)W7"(OJ3C:W<5^C-UA>4!IH*.YL>-Q>_O.\R'5K]0 ?=(>?
M%W'$#TW@IHS#LCS-EC:$L6>'[AKN5_T6)1WGC&DC-O"P5-LG3!A</[>*IX<L
MB*S4)JD<TNY=]V(_H@5'\M)(R;Z:KGDM5T6XEHR%XH2%HB\%4;L3?8OA9'!R
M9*!E6(G?*"N3/.WA&6<!J4<\.= DM@(#&TS'-,271K=6X3_.BZ/-,HG37N7N
MMT=09@_]/%CMT"S36+.Y*M2SHG!0YW\<S7=Q]3+<BGP7)(9]/)A8N=@\D5D]
M!'U>\0-)HBQ>SP$U/8'Z1DZ=;AV!1F[:%S<_J<9:@>KX8?-/BL4M11:8MD#*
M[LD.RJ$:<I<MW LT&D'L1!C7M)U6>#J+C+ETAS:!YIYQ[):$W,;]%.2<(F3G
MLUG'O&2X(AH,_2'UAVOCE\?)[!@_+DS#KOX/FZW_"/^VO^3WAN^B]YJ7K=XH
M9:99AVJ!ZU8A/RQB<?;/_:\K40D#)U6U!'*E]D2-_J.2]ER#MLO^GL2PQ%S:
M].!SN>7^*07=]E\#;:EE[A;9-<)UPXC[>J/3\Y9M0\>J96DV $Y#>V0%9N%D
M,,;"H6PHXL9C T=+:[<(E^X\PVSHXR66H'M]Q<&FC6:YF0CH'C=FZYBW+>KN
MCGC&NIK;+':<+ %LU@D/@@ZT"X94!O6!:5]Y+_XLQE.X)7F];Z_E)F_<&P 5
M"JR2%I;['JPKSJ8S^[!83+1?&2TEF:7U7AYL9'<_LVDM2/[%/+Q/F)21K=#_
MR@V\D!-'Z?&$<FP2T19ATR(L))HR8RJTOF&F#$?7VAZYO^T^$T7D5)J.IV?K
M+F]&D;I!5WE#[PM+B9]U6=X7TU7"I^V"*: 0^#H=XNH00OXK#0%+AEMJ?-IC
M>5X><-7P#+[./#;&H=WD!'X6=)6S]/?4O4U=T?>!6A',^]PXR_!/=5#1>&QL
MSF<="[,ADS88\ 8;Z$%K2$%_ZC6&K2:W\O\3*>-_/S+[!NZ_=U:%,U8IFQSL
MQYVD;G"(]VU!^C&)503W7MB.18.SK--IA<.IL- &>SP)"KS,LCR%8$8BY%N*
M@0Z18U),EY.KJ]47Q"E9=QEMQ_J60$1-G(0#W!SE("P^&Z+A9M?&*OCY+5_J
M )32[+/UPVV2U@.>-5DX]#7/8:$:D/J7ZM^>7I]9M5YK;8A_!\W5]LI^%_V&
M]&C]M"G[8WG84DY2"%]<DV39:5!43VQ8MCZ>HAA<8^)C%2$.U@BF>ZAFI)RE
MT?\NIA$_6K=#NNA-!1^!INUCP]%3D)K<K @[GB%;LP?!R(6U4ICDD6MR5>BC
M96G^&9?^ZNI5)QS2 62CN\N"VW)!4=#BSJ:\:Z5D>GS];^_:#<-W1=O;\Z'B
M+BN!S6;9<B2=P\_C[1O15NN79G%NI_M/C,*-PE/[P0#<^,DG.ZA!RY6D?<CB
MSE7I_(9Y9XSYP1]<?UC'3\&IF[E[JWYN]ML\$W87^QS4+8,T;<<7+Q*6D;F<
M=?'BBUW!'7QOE;; T'_3&Y82M]W/ROPC!*!"8 (3W%+I+T"X<@"KTQ[WV"TH
M?LG#DD:CS0^JTI.9J:FIMF1M!X=O>&XTVJ"2<X'-LB4&GV/[FT1R@H.3F<'!
M+%<%BW:Q74S_?+NO+50SUOA36!46EAD;GWWS>;D:ZP40L1::;1XA9Z\6;GCD
M_+070][XYZZ2'^=B\-/(W 6$8XT> Q-DG@E##HD17';TW&6GHY._D#K;VSM)
M#< 2R@BE"(+\MA'3,H?#F7\J\Q:01@9#8CA!,)-.Z;.&(6[P^F3Q6'.?0286
MZC<80BRL(F)BC8WCP-X+ICZQ3?_7OU!QX*N%*)VJJK7"0GE5_95,YW+!%U-&
MO8"* (I<@W(QT8J*JCDFX;V,3,5TYFL>JG'VW9B/V)/W$YSGE;6N$\.#G;34
MR$O)3'W?8/UA(U;C+EF4/KO;X=PZY3;])M3-N:?]%DN/\;YZ8UGK=6?94(*
MCZSF/X9F; QN"/P<GBKTVC-@H/QW*R(E+V)<7B''5 ^RM:-$.:"K:&Y."N_:
MN%]/C;1>L9 N&E)TV$>7+2;F_$:[^)<!IZYY!_^>=Y32N^DW@:]+?UO3Z;NQ
M W5%V49,)X^F?;NX'_E3,,+3=N=Q,P7PI/],QK7A K+]U()=5Q&ZJ1VV2'H=
M7T)+K5GM$+/"B'9][F,PFUG@D%/5(B^G>=#A3N+.2[I8*+OLL>6/&'(.*,=T
M.ED"A]JEWA.27/7XMN475<H8_NMQQ[>?J+OWI=2?F[ ?,4]:ZK.YL?P'Z;ZO
M;\ 9$E*55$-NZ=WQ70*WO-PF_[!T!N><\>B/O[2TB+U3]LW=I-T$7D=V:/'D
M#=O"VDTQ8!/L"P3ZW_,::&[IL]9<)GLVL'D9Z.+ET4!1('K8^=Y>G.!83G='
MC#W51MSD-E0]5*<[6HXO79X]-PU>L9'F<SF\U!A4>9I6P$M< NKL9.WWU)7W
MWT%3X; C]J=NW9JPSGKZZG6DIN^I<?&+WH9KK5O^ZWM/Q_1V*\7]HO1NB].-
M76=1 D@4I),OO<?@=]IPG,":BL'1=F!(-TB?!IK@M8!C[@-2M\O>>OO!&[]R
M.SMPXD(*-Q9,;\7 Q;AR]7C<8T/=Y;9R)1WE]@6[KE+J.3;MSLDKX.P8$>GA
MBUGNC<I#-2O>3DR-HU],L[+?S) \,+N4X[A-_79Z*N^62I4!W;NXX(0,:FV.
MJ8,[N-1F <@QN4]V-@X*YI3QO*D"E]'[_/T-89+*>1'?QRPW:QQ3;M9[M\[%
M??7GI;_]5Y"T;M%DW>^V/*=N7J??R:C_S<7R_5\%$0/H\E;BA20Z' Q&)*?#
M4>3)M0E&V@"\K$&R'NY$:EA"G\=%=+<@,ULK!%*\N^O*RF[@6G+/]C[)O"8"
M,:1R6V-BU<-[9X>S135,:-ARM7^#L;&I[5W7]&Q5@:;[?G_Y#*B-P0JD?G[]
MPS@. JEF+*KK+N(?9C3B.P^F\Q.%;UK6_=,]5U:KNWH?Z6;6M[D$N2#\B1P=
MI\O:#IMI44TGX\26$NJ#_A<XPS_O.&)?BG][I).AO'&6!/CI4*TH::8X]/$,
MXOFHL]\6/,VQ,8)I_!@(O.MBP0@!"3U[^N;Q^"A9X.TZN3!GNZ!]W$8B2%K6
M.%1S>]3>!GGA,6J4;-/,@^)OLGA^] =.V=[2B%]]?Z^*LIB7Q+Z1N*/&/V1[
MMUWH6(O:J?I#EY@G2'6K_]K4Y:,\.)2U=(\<$X3P=,V/;Z!F-GAN]H]7]3<M
ME_2Y>)_P2U9.I@$%H.K%:QNW6 7G8EIVLM)M/[Y@[";K @'B/)/D05IFWOD*
M/&XBV3]E37EC@]3#.EBW1<DPKJ!L0IX@'R']1F<U11!=OMICOL6#@7C[-4-'
M+&V#[Q@3D$XB::]1A,A29DZHK'GY+68G#%+LO-@0;K+]+<[KTV>XKRV,"KNV
M:Y)S+K!^Q%(FLZ<0;AH0=.VC*,DU_,T4C]'S?)BUC0^OA</:FBD\\:N0$9KN
MPGR^LW#1L&7';DVE-0(IRSD[6<2-C3.V0Y<!WF]*%?BF.^7(8;D-]5(((BOR
M6FW',K8 S/FV(IM"^=:R>\K.Q56"59:S[L;87E'681$*C^=!C/O>P3>"B-0S
M>Z4RG\'-F;1[3HJ GEB23$M_QQ,*J:]9(%W8M]8J@ZWNQ*:VL8)AZJ^ZA'LK
MU&CWW7SSCKY#M;[GQ*8]8U-P@P*X*%Y<9$>!V!KJ&-C;D7_]#WS\=[UU5KM/
MMMMG%]B3*:%Y2:<-;EB,^';WR&X]8:4OMQ;#J&$2<DF 0-KI6&HF"GF*^)(V
M=+E$CR]J<*_(2GBDVSAV ,YQV+98.!*2M_/!/G,[O*E5K_<ZC+1J)R^J'1(B
MYH;'X E/F4X(&H8_'JLJN=U'GS]4 ZNBR1*2([X'C581>89A/)[,W(Y(J#]=
MH@R-RK&M*NJH+S%*L2^K:M _666@_61\/:],'S%1JQY98XA-SS:AY;OK "B"
M];65GB%[+AOII,0F W^O\&4-+(J:E9$A,]4Q7MI.'43R08 "K:+ \K<#;IP]
MD<4].]"83J8[)D=S]X]O"GRX5, Z^P.J=F1-W#=@4T]0$9FHF/=D $UDJ[S;
ME&5E WA)+S9V]P3\B-S+7#]4&W*W6*M'9<BF>XP@P#&PY[[$YHN*G5S\24B4
M?8[\XL +B?'0:L3,2,A?=,]C#M[P6\Z5%Y\7%Q^JW<#E7^K]6>'PKE;&<!V8
M==B+OM8[3AY!1>I8&D2?)CM*=G-FPB%%M JYM48\US7B:)TT6B0M%8KK)A<$
MP"AC6!0$(M^9>L8SV-=0DNK_P/MM\JLNT(?_"I;[7PF[].%\VSW@VJ':%Z/I
M;^N6QK-$U]H[YQ&ZU"OF!IO[G9/?.=@3F2WQIW%6Y.-(73C@3SR[IN>OKIBY
M9A'I='J=?4$%U7>[47)PJ"8!1-^C"+V(PZ?7P4VFE$A[]%(AJZ<_8.;8QN[U
MR"H+J#<WA/UAV"6;D%W>T[E;=P1<@U"/Q^+5,>?]MG8S84WFL^(FK(;UQZ*0
MH!%XS]$SP4+PS37\BQ51.XK329"N*EJ@)11\M45-N&S-(!A[Q_+S</WV180J
MTY7#:@T<*.F]F;/WFR+.,"CW=$T&K>"9HK&Z=Z'6$E:@\R*$:AV/B]I,\)L)
MXU8A9@5!F%05L#4CRM@E9O9=K>V4*F\][J#J-7FM<,//LS/:+"I7"VL]5/_S
M,.";-MY/PIAMI_D\N%QF[-*9([6HMK+H[Q@"=\P$MLRNSK6LX^[R",]=PZ9=
M@-L9;_T];2?"@$$>]Y,]71'>;YY5;&?/GZR(OKE"O3V_\/4KD9QI7$&]D+4P
M'+:X-M(][# 5M_..,1I)KD*7!'2*?MH[F; I2[RMTC_!^HK? [&)6,[V+N#=
M(75;?43A"%M#U HRR:;_G]KSJXPE(ZV]I[+MVXTOLDYVN43HP/_<CC_[<ZJ0
MUWG[ J:+@ARJ7I]<B;XH/OIC9_%2M'FU:%5T-,-QBV.9$D1WE3](3Z\& -..
MPY(V%[KRSLNOD;V6TW\XX>L1 L.XAO;>&8:T02- 37BX)]3&^D3EL]4 X0<1
M&#T#LV>KVV#\"$W-5WF3;8P(=G.#A8;-4I%/P5_W*<+Y_<93#L 3!=Q]H]NI
MX"^5M3/PM#C3*O #R;A+5WS-<:Y67VV[".XD"CB+$QZ\XXJ^[I(4Q3?6.6UY
MXE9W_G*@2XGETNBR[8MP-RL[8IJ>:[4'#=-I79X-J]!_ML:U*C%93%BT)1(?
M$>=SMM85956X8[ME\Z(XTTNWR8_*FWEQSVT)62(HI AUNLI'%IC;VO-C&RET
M>G^^;KCF$;Y>;@!J[MG5:?4],IR.\,OW[$NJ@KVIP;]L%YU?VE9.Y'[=@D.Z
M14!$/0W-Z?OF.=2(F2.W-NL$7XJ7;>[K41:*N.WX$ $,!6<W]30.I">U# :V
MV]B5W7VWYY.$U0@X64*_IHP!A%.IZHMT9-?&>.K&W5K0M;4-$XU?<A_L=V35
M?7NG;S&2#IN?[7S >CX#AV=?'+C0;_(BC1<:!)W0ZP->;5&<L=1GF>3$=FW$
MM=8WBTX?G$*<=J&(>2)0C]1N@'E;E%:>2:9,P.Z)"KGL!.[E>5PNR]\X*];M
M4(T8ALKDP2$XIQB7WL$Y26S-.QC"C['Q@>ZSHRQ<(L28/OZ(@@\!*.%R'ZOP
ME-"K&TU-M +_E(5@I4G9#%.9%G67UX/\$9*J&%D.56KQ<6<UC\VX3N7L[;U7
MR%L_4?E=[=T::K:@[SX/(8RD6XR F[F"; JKAYA2=O8:ZXG"\!/P7W7-9>)
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M*R.XU2*,+Q_]4@.:PC: ^ PR0MH-C[N-)._-N%3.) /[1I?/^2W*[D?(H^+
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MSRB#\JL]MH5(O49,2GQ"JL6;".Q'/VXIZQ//'6A8()=\[)[<G;)HB7X1WP<
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MO7]ELR'3)-7B9<[J>S;S*$41SO;-LQ<1?7<&-J"HQ]SJ0[72]69D=G>W(SJ
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M&=#PBX7]QH\?%+VK2BF;^!!S;ZW_-5/3\O-@U">_5CUD?\9"(6[!GL6M:<R
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MS:P5K=Y\ESFY9^2I,+EQ8(&>I/T,5L4FW!'99CX:%7#6ZMC]SP[5V!4<T'[
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M=3ECE-8_/4RB#&; B)635<9;K1>VHDR4)0]G)GG%?;+<EG4G;^]17WN5#>1
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M5:0,%%[HY2^/? -E:JN/5^1_$(O0=D+HS3HIUOXBL^USIF2OOYY.%Y@@BWJ
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MSLNZ@.9^8&RV4;X^MOCJQ 8U:K(3TE80'UQE;!B]4)J+/Q-*XAVJK?K3OR,
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M[*-/?LG//U>5$STM3#DB?-OEG_F2-TEHY<7:.>,<+LB4&])<#0>I36GU.;4
M-LNFK0\$ K+;&#61MT-I$2TBFR?CT/'FMQ,1>>>N^1D!^SLW_*P^U*3I@65E
MBA)4LOQ?!MW\WZW^_V[U_X@#5W>ZE J%WO#G^LG:NV\VTH9IQ[ V*:%#G(W:
M0-GAY)QH26ZZ.0+C<!XB;Y3%-$BJ>D][*BWJ]U5,DL=(_D\RON@&P_4H>;3O
MER=>*%CIC>5./9$3D9NIRG4,FBO(IN=.BEFO.DZ7)I.0ZVY1D=*WZ_XU@JB@
MFR32(Z%IN^25049WD^>>^[?/TJ-W21C/U;'^BR"%M[5JX22B;^RJ3@-TV-)7
M[G0,E[179:\H@=EP^^<.$[045/\3TES00/W&BI=#3HKD*6'3?#4?'B4(4"A"
M8VYBN/+#5A4*#A9%!SN;I[(GB"L07XO1#:E.91_SWO5D%':WB^[7%2I^KMB6
M ;JMNP]YORG-[G9.=[_$=AF^UM657DY:DS/*1DDR_ULCZ]KQRXW)O77@#2<,
MH?7[EJ/7+ST=%]^U;P@RQILNYYRMP8=CSAN)<MHE4YLI 1"U(87VR_Z;XG9M
M-@_9*S_'R04(32QOTJ\NS=-*M''NG(#2>5R-D[.)@C I@_%2(3;V4#'W5AXH
M%6CF[D8/\HMLU?4S" 6/=_Q+K@Z/+W7Q=0=U_TPZ:9/_HR"]Z% 1^=%*G%2[
MQH@L\5^TYKT,:7-:X/;9;DRTDW-.[0'-%.M^)^W>B6:JQ&C[>DQB4X5051
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MF/B0V0F_<=G]#+0R#H0758*V1XUM'N8]RX8_.@'54*Z,@3R/3O)#Z-0$CI<
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MF'1[H':]#:5MO31/\CR39O!;!^I'74A)KL!L[]-QG:^O1LWLJR1<C (Y$1$
MC5',DS?Q_*WCWZ7'WBE9"@F6'2_E83&?601.1.:(';YJS]5$E6.BI\O)FUM?
MDYDKCL(E[1^/R_(9!)E:K+W).AV*ZF]>)-U ]W\FL&J;XOD1GS.:>0GM-47F
MEA3RBAP@DHXOI2KXEX;ZV]IVIM<4*,C9Z*/9*)W'4'5U7)3^E(OR/9*7@,!O
M#N-PC>:_MU5=TE JEZ[_O:W*XV[OYXF*#VU51UG>6E":[E_^,E!D$%M,+V;%
M$LO*@1^^&9+*RK G/UR*LCM2(*>-R[*,KHR,8EDNTY7INK_^(3SZ=^*4MAA%
M9&;KP*?TVA8Q79O$G:0*=JHP-MKVR3SEY\81:ZOK- W$7_PXR2>ECJGG)*,O
MA@-GFPO\_2U\P'W8SS8$ H^=*W#"S&5EO-)0KU:M4!'+TV8@]^@V6&%XN=\X
MSJ6*3ARX;UUUIK6H]B5:B2IU'ID([&SWV%=Y1ZR$9)Y-FNH1<P+00UNR_#?D
M+8>V)9]RIBZ),\@\#NB!O<,V+C^KK=JBUU6S7JA/* 4_1ZL.V!Z-I22 $XK*
M;[;FGZ0X6)PXV51?4@Z/[&BAT882.7>[+^U^J>.[^;-\PVOKG2QN$8/NB[.@
M$C5SO1^UPQ*./O8KRXO2F&^?IB36./%RDSRNR0=7F$1$46T4([I_N?4YLG#$
MS@R BC#N2V0VU9[U]PPW2BO"_Z0)A4"CH,[5?/4/RE83"H/0Y_N[LC7)U4J]
MU\3J=V6KU9AG,-37&LK44BB\@^'F8EIP.TZ#>N?O;O$1 :6E2Q_<X5&?/I+C
M&E*I#>;6I6P#9W5=8Y?CLG_QW-+X6CFY_: +2S/[=:N<WFWC_67J->&;EOY%
MK._EB^1.I:#'JPOHHD$/">KEGII\_F; >_1VW,U!'@VJR-0+H>"Z;3IG-O*W
M -NV0V$9DYCK.SS2-IL+W XMJSW95<HV 2QJ1R8'XDYYAWX6])$8'08Y:3'#
M[_]AY<!KO!Y6.NL8-+D SU94I$:3Z(">R&: >&5*]IU!D;DHWP1T*Y>42$M)
MTBW01F;*O H6#D-:MO95G.='\B>2<N6F,D -#YW2U2]\&7)!.&VI<<R?:JOA
M#_T&!O%W\C%.3-@\^K, 63#9'0K[.(Z]&.>2T+^R827M15-LYK X2J0UWB-Y
ME67@&*0MZB>67MP+>S1KI[VV(8CXV+-["X,.M:HT'#$'Y/HA_1H946,6@X\#
MV7\,>?Y3\64OGR;4_)G\Y3.3L=WKH0>[=\J(:/&K?16/_EG]HLOSVPV@;&.Y
MO>QPT3'&#06&T/D(:,\QCMSQRZF22&-HU_7)15XNC[#WCNRL=(YW83M%+@=F
MJQLT\-.K6?Q%T)U<MZ$7PKV8,31S>)G#]P Z#\49=!AY,F8E16G"% ;<U+OI
M-J]5S;PP8J&L*B)@W8KT+M)JV^39,]KX>I%&5I5A <835E(<4E8L&]Y;T*)]
M']<!\3H?!]G#T-4?TEX>_5O0S;5*F.9AS"%@+X_ZD<LAA%'*G<(P=#0 _KSP
MVJ(_O<EX6W<PGTOEAMRG38DV@H%,SR2B1TE96459:RBXQ.9J&1:B+S,_]1W%
M"@=2=_]!)M DVLTKTG0^^WZ",W:*@0.4$60.[XLYI$W9J)/>E:RL7Q=DD_\4
MP@/G$VEN2F&!]OU'\]T%TMVBENT#SO-C^6Q"KDZ<?)-(G$;CEVU9G!LV=H^=
M'QY3^%)E_!? (!;SF+N^5KJ?B0"YR T-3=Z+FUN,NPCN7SIA)66@)ZWGL;CJ
M<&NB1_&JCXX#3U_RBE"61.ZQI"XY:BX']Z=]:."U)<^=8E:=<;9IVVH(*/>N
MUX_;5_E3-Q=GYD?J4]IB>)\[R@>,[18>8K]-V@O=ZW7_U=U7:](S:EQS-B_9
MOK)7_[@%[7-V2ERL.9NCL0SU5'XGB#E?\XR\M745CO<Q")U<UH2 ,S754X.>
M3$;@2/81H:5$#N@.T9EB>)40'^<L!['7.!]S] T,3& ]?3J+":!81T.MM[R^
M(2^)27A\T!C>. $'I=6$3S@TF9LO1+1Y$9^.K()M&]>T,[Z1,H(./)]SJ+'Y
M'$"JEY[H<C(]^.ECXL:67PK_]H._ ;F]5-^$][SUUAH+\?7U[Z_OD*"[Q)O#
M41UP,,V9[]BX+0#!"N,CF6CE0(F^A 42L-Y'@?RAY]LJ*^ORI'@=]EK> B%M
MFI7#B]\_7;$AU" 3+$5F-^8KOO]CJ/;OAEJ2Q*7-+%,G93>.WA-SO!+)CP_<
M=2Y)7'O 'M=N 4ZOG26BP%1/,*P!DIS&9!REAUX>)E?:O$DXC)/5'DOC7]U7
MT>LV39M>-GR6]];VR8RC@QFN7;;@%:R&+["\I[!F$HAH1L21*[VV&'*[Q=RS
M"&44&CDQ 00K[2-<U/&M) :N;BW5I#%,:^[=NS:?,,WO!D/ADH7FV7V5^S=B
M$83AO^K,O7,RYJBS^)/P:#.K\+ODX%2_DMWL9P-0!/8W<?WY7\1B;ZQ>)JFP
M6Z]6S\SE"+RCZ0S RNGGE5>\N.,:\"G$NM4EI'R2:SU0Y D.J1&?:2==QU/4
M:DRHTPZUD(!5]_S!%1@!,0A=D,(G5F!9*&AQ>B<WI=\8[1J/O**$F(OD4U_4
M)7*__Z>X'0 [75K)&- ]V/5Q_BO%2@:9$]F^X=H\MPG0'TI22F\O36-BB;)K
M05F-%F$F6FFG.U&E%AI8'3BQ_1$>/ENWPU]VIZ,<N](1&4-' .4Y_K0CT^B(
M21EN5_FY0CTFX^'5>6K12)&VZ.5CF'=4\KY*RD)ZQ/#;QP6Z@2G*>!&VN(05
ML-7LP!96-3:5RWH7342P]H^J,4_-7-IH!7<#F0"?6F)CA;]?^5^2"WEN!CZ-
ML%,XA=(QKZ)-X.;K]U?7J')2??:F>#@HP(Y2G)6NEW[$B;9\T&2S?E]E'6LJ
M2\F)/W'.FGBNS8-JVX6$@"G/:A+I&@-$LI=+J[_)+N.T=\:F)U\;%2UPVPK[
MDV5UPJ@56MKT*#9U2(3]5%D%SD=BXTR<U2Y\]6#LZS]D6?\GP@FO(,]1HGY9
MT%R_*;/3-KPZ9MXJMO%LB!H,G+IKYW&;U#M&'KBU./MW%[N<%'%]N[A^O@:=
M;NU+TU*2#0\.K9N9D-XB$" L@A&W?-G)[L+HA,4,><OHFM_[2BSL0<HEC^$"
M=5,OYNVN&5B TO%S&(-,OX,[=Z4<R +\DJ5X>H$RDCX5@B*"E4=RER[J848Z
MV4I-O@U'6)(R=]=1OA(!O1QV/ ,E'8J[;!K/U6@H;,8<RFII=;O9NF+8FZ-'
M2]!.\X[?5_E<UXVIS87;[*Y(\$Z:\MGG'(,CIJ3'72&$*JB@9%)0)%\/G+M#
M,+G76G*[]C$O84S[KT(ZZ@QQ)Z1Y)60.&#ES)OP-[]):.,V<96X?Z5Q1DIV=
M_=SSQ4YK4< HSO_X\>,EZI.3S _2C5%^,)_O_G?IQHU6;Z?1L=^E&PF^OK[,
M#]*-%:;+L:H(&NJ(PS0U '^^SQ7T81S!J4N7W!Y\N%(NG<T# ?V, K(:+Q>H
MO<O:/+W1 _FG@<BJ"[2(EI-I#_,-U2/@3P9OFYDTC_/C'+@@_B.WTPAK#7:R
MC4WR&W<H# Z#FIA3CR:.!3\=HUHIF$Z*7E$['ZPL1\C7834F^// =8KL6/6Y
M@#("+KHTYX/*IVWHTB6/H7<[,P,>-_Y'G\WOQ\ZBWX^==2PMWP4>X(EDG,6X
MC9*P!:89WE+'<>VL(/]:?D>1;K"SC,2CP;2/19@M=5R)(,WG.M+C]!O**RI@
M@0'S56B7SVO*4MKS.P!?IO^T1UVX)G<$#9Z?DNLLY$6OM).]3Y+*&K<3!ZZ6
M"8&MSUTO,"YXM4(JAD:AO*]A'*R3V:&3=O*Q',CFE:7USGV59]\EKE*?T:SZ
MYJ:NYGC7"E(2&72G.PI;6I-JFZF#D!;7\NM:/\'JM]#;4IHB 8F96+[[S>KJ
M;2*EW B*Q(XOWZ J:K)-Y?K3I\Z+L]KS71YJ^:#*0D&;]\7O/W1WSJZH%C%?
M+_MFXP'=Z.G>JY51.I];Y4SW>J9%FH]2?&2A8,A1#[F.1()H0*[W8OAAT/:L
M4GRG:[2ZP^KHTRR<WKR?7IB'%&"2 R)]^T=Q]]^//W_JM*(\K#"C.R@!O\[G
MVJ6!%K4J;(^3(ZV";S<ZWR1$V9$V7&TD'(T1GFA!_)I_G>H?^+FAW79=5+%[
M ]HLLAYO5 FXE):ZV3SKG,P_F"1 %+68>_A/RB'1@K?4IL?@]>(R2E7!E$<0
M%G&-;92K-?7<S>O=0I-CUS.BG@ZMJ&S&+F;(S>LJ%GE-NJ]B6YQ4-@H@=C@T
MJ*D!&7HC'F:6N^U.;4N.$3MFW0[B&&OWCO;<4!G%U!WWK$Z9?[XXX$RM-F$D
M(LI 3]^J>&W%R](2G$O?"H::V51</!OO'[_GL7-YTUM"TE[!]\V$PX&7.Y(U
M2_&'E;J?E$E?VK3=>GZIOX.XSKP?$KV8*HWI(\ET]E5DZ6N\[>'C4%W[+.6+
M6Z-E=5)%3>N8CDM8/L0SS8&0G37BMQ+Y_3]%<6\HV>UTUNN V69;SN^NSCR]
MO($(?.3?79VO)T0A(^#@X+^[.ON<_8[F^\'5V=?;*8&FU>V8URV$D;I9L&NW
MN;/5=:FAS3&AQ=FY?F.EI02PNGG,D(>'1U\_:M@CD>X>3@\@&GWXT]AL#E#_
MGS\;G^*1S8!IC[UJ4]((!ADB )^J!6 LPY8C/S.+U\S_N,-47'^B"Z$*UG[#
M2]?)BKN34\$&9"TG%_!\UOPF3DD*YP7UZ09[*)-,DQ!F&OS3:V!XF.;L5 W(
MLSO$Z-1P[UE&!*0HH-Q+:#RLR9!,WN)1C7+/WEXY_CI-\Y>!(>6ER\Z<&I[W
M)S2(ZF:N5Z7&$F>2!P1&31#MLG!XR]HXA]J;,6CYRK/8 "3)DW=7J?EQ<ZMT
M7;GI80#[] DI?U'W"77&Y&RQ0#XL%P!!59WG)?DIL][!--5!Y;Z*4?O;348W
MN-:\C1$;^&*VD65@_*0,-Y<*/ /Z/2YG\A>C.\;CXF-)[8NYL)R5H-$1\QBN
MX=4/0]JR__\_).J QPYGA4;#_KFS6]2"H-]9;3)S=@\QPR]I<6<<#[ZPU+KH
MU"Q:(VN5V.RKZ%?J>ON_F<%+2?T3>[7943573^=[#LPT%0!NPA63QV3=-*[T
M$3HHH8L^YEG#T6E63YL(-PSR:A[)U JS\3Y9;4"@-!0K,V\G4&0#;KJ]$>P"
M49$)X7% PY0($0T  ([B2:1ZJ^Q2R;I<3_YL!M:>/^GO2+P<USWG ;C6)=/]
MV3IM3-;_[!$>]9VC\? $XEW$^043KH!][9GH'!ST>?)>(S^ .TYS&O'/<%%U
M.10:O..D,%\OT88?667D&W7,6HH:HP;4G_-T/I-FH,$U(^IR<P$+><Y^64)T
M !H>O[D)^C59A[-[I!E;2DD<Z*"$FT&*V_*B)B/*%.\:AX8+."!&>+CE=X$O
M?OW'"/[)4.<OVY[P"(G<1_/I;P34T)%B_'+[BK:B9^)6HU4JN-$B." 2U_;Z
M)NG]R_\%T=UA&N-@8@P(NF9V>A5B9IPB*8M^+$C;\=^\/J/#,>!@^+M+BU>>
M>P',0#%!";BZL7Q>=MD<]R:14#90$ER4/YER5U(Z5PD3"**2:1$BHHG<.X,^
MMR!K]O#RC+1NG%&PCAF^2L7)$H?;JG</]6RHRM2GPWX\0=<:KFN\.#')>T?K
M#Z,X'M0%9;2-6#LQ_9\]#S^+7SG,WN"F=.)1CRS0$'GXYAT*N6MU6ISCMB*=
M%C%0 )CMQ')7G<C1,' ]+7)4B3_LY 2S/V-4!,^(-%Q@V=6!HXYHA?BQM6$D
M=,B(8,)00WI6UHY$5G:?*ZUM6'-/"3+>2$=-9+.CKTD=!H&FA!=_T&K_#^'
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MG<^31'J)J<BD54)HPBC+@>RR<B#+@8&S;!P:&FZU%%F*S)Z+ -__,6S[C^)
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MIVZ5(_O?EWPUB]&I'TH^B/OHR/N2+PO-)69_*/G4@RY]J&V\L@^B]"U&.Z!
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MM+2T,B0D]"!;].O9A@1QN;^V ?& B,J04);*VJMF]+P#S+AH\M(\ M]3'N4
M2L3MS<F"(A<,\W:3FIH%T<U-HNZN[I&FIO/U6H0)7=2,N_U#U )'OSKK>89M
M4)UAB5KRZN#&CW$!&'_-9_-Y^-B AOQG](>%M6$*/@'BBX-T-":M7.QS1)9X
M5+)3Q(CHS@;_6)O!9CM2Q6W/S!4KJO!1HQ.X/6N1D7_V<M: \@[.5H>[YVT;
M%J[7HEI+_'"(P^-X15M)*,L,A[MOX3C@>NZQW)N\EYRM8YG'X/Y_X=/4KJ@6
M/1"L32T:2D+1%^JKYU!'(@KS(ZLZ(T7S24KOWG4U9/9,VA'(/-B6W9CUJL1\
MVZ!$[<:265GM@JG?Z(A9F^,2R'NLS:DJ1'>8CFR=E3V=DD[$S$_<S0.G (U
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MM#E5C3W:_27@U/]1D/^3\$6L/$P>MK0"4Z+.WQZSZEVQ]X19)M<M2:CHZ&A
M9[ZYL P7NIS_.I\=T00UZW(I;9AYU9LST\G@.]V^Z:6AS \ N3K\^.'0C_OO
MMGZ2'*>2FZGCVP$M#.4N?A\821.ZN#/#S;-SP]I<$9.=P/)(H$D2T26$5@39
M#I[+4%#E4];\A&DQV4)A'.0H"*7S0SBO8(!-MO11C/4P$<6>E'9=:;,YW(DX
M'"4.'..9JC.#5ZQR'\G&".%-ENT#]UI]-&XZ,WP&'+UEQ8G%4F<8! +3\"8F
MMCC_69G^50S=XV?[<7'^U#)UBIO8'"F^N(Q A&8 [O3D7,9:.Q<T^Q%PIN84
ML3G5A3MQ"<@Y^-:5+R3:7J6?/-T?@M7,..,$OM'_Y*"F-#6U'AH:8F##V ?Q
M,LDB1?3]_\W@QQZ%'K+,5)E2UUB 15549<$X(F!>S=?(Q[N?\60@P(NN;<>8
MHP_0U;:&["]-Y329P"0U&6]>L:WGVXO/A3;=B!D62_;'E^VG)N$^22O$23@,
M>GZLQ!Y!.Q]TV]M,2G49?D;/>1)5!C.CYQ=3&OS>Q58TJ[^*BHU-)48AD!GG
MV!SR@O*:8XJ(9:_:Z,AE 8!]0WTFW>+KRS^SM8[ZA=@4=)S_148J_KK7D%BN
MVWV2= ;FP9TU3"N4'^84PR=[M#SL;&,'- 6T!(CJ_$4.@U*1^-@K@2'^*M5K
M-Q+N@/;#)Z:'(_8-WI26Y@:C2R=CU6H[&TK@D4N7:2K*EK*GE)9-9S(CBO3H
M9L;7R66B#X=T!/!NE;Y-<5>(?G]1S5TFP)K6.I1BH*7B?],T -G P!J,V$08
MCK[[PT3_K\/%#X=2X[5O;IN.*1S<X8E%F5,I'PY%X0MY.IF#W]%N<?W7OVH!
MAE_T^](>M/OY0%9]]+W6U\#KQ_@U4U_.-*']TD/@*XG;8+YZM'2Y4@+-=&@C
M \L S)\:&MT.*F*%U?U9EFMIJU/+;/-/#1?%28&PCS<AM(UZ11]O0K"-_#;H
M3<0"IQ<PIX8(%-=6[X2N_*;,1\S\\UK9\/CB&U/-EIE*QAQC%G37F\PD;&H2
M!#=&.>H_B T@$0L9(/NP 2<(&$VL*G<9.#>?F]58VW2NENKQ$R9/:72=!7E(
ML,'>E]I'>C_QZS%G?;X_5HM+[3K?MJ0V6DQUPXEB0[,5FNNC)$(8LY@:+44N
MY%2$ZXX0)!%9^7GQV.2LLO+@LLTM5YZ&PJL 5][GVJ=>]VGL[Y@[MBO;E9]>
MZ8X6O&T76*-%S!"6>?K/K<N2FHDFDW86:=*M8BSNQ!A2HXWQ_23@+PR+:;_2
M\X4@*]WZ[)#.ML*94>3A^0^'>IN#=Z_(:$GN2SC9[C"GGF>T?ZIYV+S#2 L@
MOEJ6N*UGL"*3E3YZXHL*4@,*&:XZ5,3A'U>&S<U3*]SM!';A2BF.B*%$#&-G
M.7%UB6[M5&66C:LB-3NM*)%I"QZ6G9Z?\/DZF-TKQQ]OQRC,\8_K!9KX9N)K
MZ'3Y^;IHR_:P\M7=?@<VMMX 6R]NAC;DB[C7H7/Y-\CB[=Y9><KV-X(.A3[E
M)8(B<H I14(L+9+TPLZW\P0AUM*IZ]G9650;6LLL[M*ML2P5/O+%4"(,D*9=
M6N<.W!J5-E\%0J:+-':6'-;8";@J(Y5CSR/[+_]A0O\OX'^XV^D7*[U=UEI8
MUL03$#Y10S"[3++(V)3G/89NGQ'J%@_XQSAIFP7I*H.X?EP039."PY%C@!-<
MFL9?G#4 =$W['Q6A1)OT5D4ZF$MI:.MM$8OS3]$>?GYNM'1!RYX2=N HN/(V
M[K8)Y.X ))#=-BRQR1^7JFOXAY_.*4T\!5:M-3CC%.*P,32T=.!VS'\;R'KO
M'7\)]9\$'FM;Y;U"*]8Q)$" VPCJF>C6C17 AT-H$$U<NY&B[7>G.;FKN;(
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M>VN*<GZFC\"ZO\1<4[*5DM843#X#7&QP2C;)V,@9\GZB2G^],[-NAMD89YM
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M]7_$7T+3^KCI/\S>9?8$IA3?W$8DNYZDY0\GB&2J Y;0@DS\4L[>QG&(##Z
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M<O,M\UH\*I!Q1;>^_%Q6DIB2=^_.\"Y)KD=%XU=,*U(V_$3B7>FPW*(A(6(
M,X+W.EW;@!IT@!!@(>$1KWXE6?H5-B;P)[O>)'::9Y=,KZ+HTM/ON7WD!D50
M8>.[VGOOB]Y7!'L%Z4:4P,KWCR5.?1>RB5L8'FK>IKE,C45V=*.;%0,/EEQ.
M !>6F]JI1G1[1KX%>"'%U4='WWHH @D(AB\"^V%PMZJ5LS39LKF;T\DC21M#
MVW;/%GKI/'ZW&3M!-9/A=*EE#,-;?SN@8M./B9#$^ALX!GC?V:Q0G]+4=XAQ
MC!_0\+=UV%X*M,XL80T$KHV.3$?M%F3[69=U%"?]@[-#4.>OY>JMSJJK9[Q7
M#]4;;.,&[6H?"Q*,LR<:[N]E<R<\ZXW((>I.UM>#MQ.1WC\\0"&WTM-^[ _B
M":]KQ0)'O!TKAEF&U#"6FSFB[*^3%NP,VV+;K9FF:!Q@TOA>=WNOB@6A=BQ*
M2/?=;(,5'N,9Y]U]BLB(@M/GN^Z^W?IFM'"C2:@'#!]0=CEM_$Z6 S*PP=0!
M:JV4P?$<6>'KX9;5@1?).YT=6%,%^?GXJ;1&,CY@[N'9QP.!P8"<<5)I;ZOL
M6U-&1-#PA" P&+ZZ?</_9.WQ&Q>"8_W%:8,L,VKA&XQBUND(%8XB0K!#;*B!
M0;$%3U<1%U%4G,G$J=;FE3OV /$R(&<L2RHU.Y2[C(ET._+&OP;Y8-N[/VH0
M N1$A$"2!X-<X,3\JIZ>R/3/%_[T;U3X_XY/5+67RV<UYBF%&&YQJ6F?G?&L
M(>C"]]QDN[]0UXBZ6$,M6YF8>O1V:[VXCN!_@42O3'XASFI[?0=":M[G:LJ#
M@6^PCU@99AXS*H..T9ND_NP!J248ER_P#RBNDMAO%!'VTQ*BAL(3L GIEN(-
MPM6(_N;=QJ7CS!3Y2+9U$$U-&,Y_FCL]+6)GM>SM7\FQV3ONV"BRR>+C0-TO
M01N#^W%1$[&%Q70L:/#.QO&'-KDE]4_3P^R*Z15ZS]^$!?MOUZZ8KTCO% 1M
M[9+\PSZD\G/)?Q(I]@I57G;UPMMJ'V+XM_$F 0L:/MK."5DWGF-]P0%9')?K
MRD<_[7IX@GO8EI_<:ZM84"5$O#(.ZGO^!)NGJWM6)J#\<_/T"72*(N(E!HLO
MA,CG7R_[LU^%FY_M5_3_&%W$;XN)+::>EA6;^*<)NDS>=_?IJ-I\Z=%PW=E2
MGH#H#0Q8R,I&0WN'/'?3=OW](R@"Y-&Y84F(- K@4,8YPPDO6E:O5OQ4E%F!
M3!I%M #]7VCV<=B0.P)1KSIM5>YXGFUXY_[IU*$D-B(O7\,],H#,,_0F4AZ)
MBXI&.\/+0!/&P+S:$97O_HWB^<WP225CVO6S]; VG3_-.^:C6OMF*)IHN_;0
M%TL+%L_#Q,D#\7FGWF&-(GOI0M?%G4,%>*$3FFQ7O$!AD&=*VD793TSQ&<A=
MUZV52=<_(39.++]MS#<_F0?!IC5GKXF$RY610< @(6D &\@X-FD5[<_1"T8,
M>(K+LH6TPHBX9W.V/A"HJ46P(F&TO6DWO\'+O;YAR!Q/JG@/O5<.9OPY7AVD
MZ!*@5MPW]C^#IJ$E@G6QBM')\U/7,6_XW?K!(MN0V/FSD=BV-XM46[>BE:;"
M\J?QDX'>FJ4^WD.KL@6G >G><H45U>GVE,N/Y7::ZF<?M!LY<HGY%LO30T%!
M,B\%C.@\OHT'YY&)+?CZS]^V,YS:%*6:7-6D_F;6Y=9DFX;MA:3,(L*"(V>=
MDPQ5.68Y6/;R']1]"J4_H[/,G(])%^*UAP< S.Q)5EX+:>I=7HDX@Y@H3<T;
M.,GWNQ\XTQP(^2G:Y-:V)JF,8K'G^^@9B_7E4 1,]2\O1-[3^3KE>_F:F]$S
MV#=IQS$<WD+5-?D14C3N**#1*P$7E"(]5LA]80*PJ;::;05_R,]H'8W)[V4,
M4;W.*Y=J$#QM!2RR[7+D&6L,KM]@$PLP%9_3JT<TA#/"5>%1ZI7I#E)'NG$V
M!(>\5_[AM62C@M-O2\[58>Z!,,1S^#JDN*1V'I,T_U8^E*_MY6":;0IJAUBI
M?;RX]V%/8N'Z8:BHB+[\*X=0"R94AH\X>GGC#6<+EW;=OOLW:O9_PS%_H1:+
M*W1:U[F%0$2!W#Z1[+=R5L@IA7H7@P6"/?V:KT8.I]NRLWZJ.U"R*.PL,?8T
M3D;.U&>WB[+*4VW>OT'IM3@]''1=%NT8DE[N[*?E";@G-"#5R021+;WS E8K
M?,(R%&V$(;<J+K1,M^5LNKRY-:W@):Q03NL^PUZ$N!87K_LU$0BN=3VLVD$$
M*\R:JLXR_QJ1JA#.TICAS79YX<G\BXV&";F]ZYTA$=5$ESC?ONVQ/3M.BMVF
MT$_\.6'F-<C,C-B6KFTP<\[%"GEREAFSI3S7QVRR_P8/X#A> H@EE:T,.2(I
M<ZA\^Q+=<>>4$21TG+S6FP5#5O$X^A,N+UXN$:>Z7RU5FA8TC14:Y*H4FNRE
MS'/QC"%=$*@UBQO(#F3;SM[]X1^4?4'> &Z0^[=6!.A$.]!,LU_YN;6-Y#=0
MB5X/VAT\P2]P]'(-YU8WF"?16AD/- L,]IUHZV/5EH"(K+PG;43>APD'O_B-
M8ECQ(Q]Y?&*J2S@Q@-D'RT^9GHF"$,A 5)]7XBPT%.<'*C:VYK&_[HV-S Z%
MY&M/V3JP]V.0N=CFI(HB.*=ATTR:+Q5Q,S37_1 J&E[7"C*)COS+I)E(3[_"
MAC7'[MLOM\4Z?_.-B#GZR8.^\;_[1A#-3Z9WSRR'_X=OQ _-S @XYR_7/_I&
M*%]0_6K$W=F'J>F\ ;/##7L@"[^?M9QE=;+R)BSG^B%A!EZ%K;Q-^K(5Y&-K
M+P(8%\2VLK+Z1J_0+*0/&,F"A+DLVY((5K8D_(=Y][$I6ADHLB^R+^Q*'_KG
M?YO ?TO\S@K5AP+>=NG:1N34?]O<PMRZ/F://%"**AWC^)6ZFM]_%9=VS<."
M<P;0(P-$#)7[E<P7*L?9_=CG9A&BR84?+]WL=.Y7N"@JA;MNB PA,76S?PYF
M7.*:@FG=+.3/+KQCTKN4+6+J4#:"&_3039B**A,]_GZ!3/M)KF<7OMII.^7%
M)U/LL"D!C3=%Y!)_&UWGA,9'H7JA=9!JT#J^5$+62K.KG9>7$ >R::^BDX<C
M#!N73@4_M0'.6IRFV2PIEHAFV\+.L6^1M].@7]\88<WA.QQ$!TIZOQPHZ;R.
M;H>FG_#/&?#:39P_;CG3?X53;#';$%K8L"WYD$"V2#(SO9U/OY>^](FCM(;!
M\G*C>,[A8ZV0P,PM P,#':V!E#_]@R=UBYTD^HB;@RPI#;8O'][E:_]^>+51
MPQ;].*UN$&)/@R+/[)>WU_%/ [X*C>+8[]#2=1=7Q<08D[J\5^7WMH'V>/Q*
ME?'TPQ60Q*YB$OOP0(D224_=G:[9%4*$1M?^W#'5U[Z<'"[PT=*K^=K?6;(2
M%Y1KQ4HS<X7F[<FZ??:TY3I.5:GI<L=+29P4]6("3!5[%)RF73\(=/?YZ>=_
MGW[^$W[$"HY(P]3S]R@GLUS<<-N8K'?0O&T TSS"MXH<4BQ0[,/N;R(VD&<\
M!WB6&JE_O6W-L5_\:4:(*WT\MKOJ U<]M15!7_G./+T>&<'S$3<BWBZLE*.@
M 7P1Y2;P+C.L1A\<%41Z)X@AJ [@0MOQYVY51VK5P($ F!Z-5BZ8F6]O#P(/
MP>!,:H.$J*E276E@H.=5'.D9QJX.S]6RLLLD!O4"_]F1Z9..T$-)@ E7U);6
M3_&A#R^."[SD%\J6EA?KKTIE>W$<CCJY*1KE/AAV2D3M3T9\Q9M9JLLS,U\M
M_,.W-[_OO9G?BW?>EC>2=]-7YY%3SFM< RFI%&C:Z _81 WXL3,.1_9! .&P
MBJ_=Z1R-69K?1M;H.!:UF:$SX?Q9:&1*=7-/_#23F%]HTK-VP_7R>\[&:#)8
MK<P@W-C%DH9Z9]8L>UAC;9:]>.R8XWX&M^V,LX&9]MFF%WK/V](=D?U+5*UA
M5Y8.[#F/')UA&79GQ>748@>]_(H#O@(W)QHR+W+9$0@C$9@#)0:JTUGJ(+S@
MTAR:0''7C1SO3J>0Q$7GV5Y)\'4O'RU(2"3 5S0L1V/AJQ-;1#]Y/JI<#EY;
M"%B_D6ME%73#FF#<L,;1/5V<WO']OU-;OR%4$S<W-DIP5)O=&ERH \3-A\^+
MT79%=5]X%1BQ7+64<O+0W>_;"YO@]_G ;F314LZE8?L?J \ZJG&FC]*S;LUG
MXSZ'KC0<*+TUG&&4/>_LG:TIHI:7CPA!%71J YG6QTHH^/4)+Q0$:MM 90,(
MGA?]VNQL6Z>"D2OYO\.N>@PJIN7<EJW=$G@@;!^;Q[:2-@>%N_PJ<?17G0]L
M4+A;>DF6A-"K%\Q&SO_\CXAU(D+'K9++TXZ0((&>@P;,!K$%[K/.$B; EW%!
M&=<=VI7;>]<DYIN]F^H%ZALC ZKHU"#("TS:JGUIAD[S'/FT@NBI:B7CE]KU
M%FJ)@NXP\UH\1T<D!(D5T(-H<'N5]?"$Y/ &/ZMW8\O(AA399PJ\5)")S0L'
MZ8]Z\[P%#X,WC\MX+*N2MKX9VB.)/7Q[!1FE5OZ<=N/.+'[&V?PVA/-LE^13
MMU) ]F5YH:][G]K-4?<+X^L].).-M3M04DL[$8SMGBI"3"S5YYL7"DJG[$ZW
MD5LL+H_&0BWYN_L<3M:@Q'7SV,S0$F^3B>E$__)AQQL>Q\X^%B10FP'QT?FB
MZ>FQ+/;>OD.9S9ZJ(VS:MH3C.Q)"^#=JZ'_A$R7AKG N/PD^0J:?_!6Y\N/J
MA<[WFW#^'1-#YMCWDA,OZF9$JDTQJT"6^V0O(P+:3FE[=:M^+4*4]>YUZ 6X
M5I^M_5R%SJ<ZQY_)LQGF4RG\AXT#Y8=L0+^VAKU =8Z:9T!55 )*DW3![9,>
M-Q77IH[+^-IB#GYEU6=@7#H,0A)OE(5T-M$@*BKXZ&WW>FS J$%KYM-BY\C]
MF/Q XI6B^:7.5M$_HT7%4"0Y\Y3-28_Z;790?XS3QE8Y4^)8WI)9Z;C2<KJA
M:HW/ WH$KWX+@9Q4]94/P9US@< +@-@A?>7K(?%K]'X!6N?>?2?&O#1DV*7B
MDY==Z GYG>(%)N:C!?U%'GN18*Q&7[:XZL<IRIR)U4QG94W<G6W7?-[;U'6%
MO@)SAR@WL ;<;N@:@.*?9!8_B6_8H&]LL^DT6DQ/PE"%+9(X+F!D1ZT<%PL=
M1+NS@JBLM*KN\>LNR^OG(<DN.?/V_!.ZXF^DJ5=@45D.4G&UF#V#FCE4I'@D
MU[&#@R3=/)QK@V8,#V0H6%['-!04$1*&VDDI&Z'$6GQKMQKI_*COBM@-+=U9
M:3/M9+2*+"  A@-[G#E-J'EEP[B"H4(:F(]MBAJ^_JMFP&\@'4RC#9U-LW]O
M/OU$2MB6FXZS _EWHCM0!-D&/Q(4+%IQM0&&A8@,7L^<#QHK&PR."_Y2'&O/
M,[LGJKA0["!ZFZOMB3;=ZIUG;H?=73+*ID!0-P3IJ_*'D>J->!+-QR"8D_F>
ME*B( QA*9AHV6YU)TN&-'7/E!\8O,XM*MT#@= ,7"Y5J A(;'$%86W_74).V
M]TOJE67_PJ(5S62WAF1LJ!@\0QE./-X7T4HI)KQEM!;T;7-PGCEVWEV E$B8
MJ7IB_C@(C,&5@]-%63/XY*7NEZE/W4P5-&L!,F<X%MUYMLIKAG?)I8!G +E'
M@HZ=R>D+(.!;/+EF0A"8(%OCP7N>O-W7I*9!+_>S5NR<&K8OD7I5N[&!F1S#
M@/X\GA<34#F^S@XDYK.5<604#U4E3?M6P2P$/JZ8[O1=.U J24;XO@NM^;#U
M(JP?*!7QM*F*QOZUUNTP7TFRCL:>6_ZO^>(\@7^7]ZN5XRNND3PGIYWALI1]
M44H'NR;$T36N8VADG3TVPAZ;'FL$Q(^CP@QW*;P$%-'\JW5P8ZC7A(O&MHO8
M<VT;'<\..YXP:KV;$)8\%0^UG9'.*\^)EY'Z2];?VCCY-7)08_2O/,)J 7X%
M.$;N2]XX8"ALH^K!D]FZBE_E_LZI'BO/%2:*,+$%6VVE-?$FP0#DTI<BY204
ML7ED?EP6!YMG:J7L:J'1":SX!DV9Y!@79G4KJS0VH<?G=UJP^J TRX1'I?%'
M)H_,EM<C(S&K3B^VF10;J<$#XZ?S8<$@1PHR78B2M,,:B;74-D'K[A+'%J%\
M'0P^G*Y1;$2>*28Z$(-J*JT0FR,9<YU&Z3M8,^2P]Y-9Z^*GP#8FG>_5"U$E
M)$? VGK56H-@J+L"+\ ZWK6DSX$;/-]=")."'>R/B^<A%5=&V\/;FR3*&A?!
MIU;] S,76_D&)1+544?04.I7.S5)\/D:IO(H=5ULV/1C2_MKX=KFG8AEDNL@
MF3FQ>ZZ=T=IW(7?@+1GH=*]]IGVN^T[L3>!UEG:GA9S5%;@?O_M!RK-NVV')
MT4:%%&CR*"U]6%X1:4>I)-/8VL&VQ>\)B%/WA^8ENJ]7)O>#-B/O[!46=JF-
M>_5<0OO8=5NY/BD>)5>QZBS]2K9)E^N<7O[QOY]T2>4]2T3ZHHN':6=BP4K=
MNCC_009W8!E8CCA#O 5?BV.ZZ=N==B8,$0A6WOXZ)M=E_I:>8<X^[C:^+$TG
MAG"9\58J!*H?XNV8<O6&(LLLWO)G&-&4BM!G54$\#WPDP%C;RD+;#-2-G5K%
MU2TE"1SB5LP=_8HD=JW[=_P,TFQ3E"5^ P-3[2\J.Z0B\]JD;,Z$V<8XU*"2
MH_UZLOXU6,M?*][?T,XNJ<'\O <#^LO( ES5VE/[,\>MPN)[Y5?U9HH;,MZ8
MO_!@H+*UM8%##$^=PTRA8TTD.2L&P=;P ,#R WG+X@2<%P?AH^6B5@UB6W_O
M4O]>-@23 +CQ4N/F+HO&#B;>:^J&*31ETC7LBWY7#4!X9,##X<&==#K+;J?=
M@+OC?6%AYXO./^"#W0+7;9^[5/\ES!WVU7V/[Y<$:7>B$RLRX,?1_('C:XBO
MQES07'TT6[W&#@5YMZFX\];"W>&$>=K ?..E8CO<WB P:'!PD'TWI?Q,@D0K
M@6Q4U1NN2^+L ?,QJX8#93GQ+#*+2@,O@UCY8<=3 B)5#<." 2!GO<M8K03L
MEG!OX$"IP./^@=*6I^K.EQ.=(^K3]5M:W0=*2W?V<G-3K^[2=E5:#Y3RIO#0
M&O^4WG*QHT'0T>4!M"15TL=&]G#M0W]>S'$[]#O.<Z G5/^9.MWS-H>R<:!D
M&BMSCO4-)OG M73<:D^RCB?C.EPQ*^GE"'"TIFUWWC3""F"<#V8([A91;GH%
M03K)JRWO%HJ>-  ,XA<Z 9+LU= _;R'IO=:\6X+H5?!T=& SD!F24,1R"$^]
M@CWY19EUF8$AK ?;'MEW0M _LW[28,UK\^G.\27;Q-:8C<U-K9Q?-P-#DV:$
MJ;'^BD%;M_OLVZ^%ONY^NX"<UP$\CY"TP.^SGJ2 ;U%P89>8Q9/5Y(&!K4A&
MEX"68L I:^78XA;9;"U5AN?RILI5B?K"4+;9E:R=,CHA-6LA]9T")74UUZ*$
M4$M*,9\75R L3K6XIUA4 6JT 7KL:@GD6MDI<>3E)F(C"7*FK_V1P)J /=06
M!32S95L1H8Z,")V7D.)=E]V;K(CGKT R._6D0:+MZN\51*.W!9>K7I0[X(E)
M_OY&O:MH';V*##%Y8@--YNLWB;LJM&2@WKR6ZMI\[<N$A636X_JHWDJT@<;)
M.+)@:5.=![.84I-HX2G5$ALZ5%L%Z#>B$H@-]KK8O6)_\KO?8+554JI,Z_0G
MJ6O;Q 3JG$\^^<EQRI\2;9.S4(8^/7R1"7S/:;QX8%B/5'@\\^6#-SA7^B2Q
M>G^]\ILJ[.EGZZ:+1/N8Z-LS\OU#C'/S@^5G=)YI[;21J#N8KOV,BJ^%W%G;
MHGK""P-/0 <%%<6DV+9>BW9QT#5%(U>LW/K=K-(>.5W=J+%#EL?!O)M"V58.
M,C_G9(*CI% S&00R6!OE>7%6"5']7_[S[N%/VK1_C\P=9WR!U*M&'N(FI$1.
MNUUO7 DJE4]>R)Y*ECB8-IYQK7E6R5EDCZVGYAV5_'Y6W$:P4K-%^'H8_MBK
M&J7CO%NV/.7BW";<.'*?Z4%GF_&=W4$[(<)O*.VL:W5\@",AV^12 6/*+/IZ
MU,[P3[TH=NN&U@)_J\WE0"G#KX"9](2K'2092>(8SI7PO<_<X!*;QNIK/"XB
M,H!(_5\U3B+7U5*U<,0=O4,GTH+?,'N_ @"T:1L.)M>N\8KUYW7*N2VVB \[
M@6K?./VRO89?_+?;%I$%*\374F_3G<ZT\;U)2AD%#F^?5XOR?@JI"BHV<O0(
M-6E;]FJ+O0C.5UU(5@2I<H?N"S)@J^V*&+]\;!KEP\S;>UW4ZDTD-_36PMSK
M+2RF35I[)G^+5.W_#8> NY35AT2:O6RG"?UX:0>+Z:R\+6EK>O4M @(N$"1"
MAE,+@>S[FI-CO5^";#6KGEWP<#-%?ZM>ZUR:?/V*_QF=-V$FJ.QA\_/V*^;4
M\,Z][C2<YYT2WOB& K(,$MQ=D#U-JE4!KR4 :[0BB>N9KYW"*'9[$\-0A9FC
M*ZMD&X W@&!R1>@"]II-3N3B\'/LZ8SS80:TITLL$^K 2]0.Q7(J.X;^UZ+M
MG9)PS#<6BF# <YK])"*PF__M5\K Z?4&U3+Z\TX=\WK]/VSG^WX]UJ^?6HIN
M6960:3\MI;J]1'FJ=TPG[;K8<$"P?'T\#&=[I;BXM+B9MV4NJ@)T@%6K(0%-
MF,FW]M+QZ9?WT2')B4E&56ARZS"9CD_@<%N':L8T%C0N7KQT)#+FGY7WGR17
MW#H)29M9YG)<[VX64-?V)'Q'05,"IJF8I)A:M_,3MU=>C>6JM;"'3DW*FTUT
M,>!S-9@8V;C1O=:ZMKNT?I[L4II.VE=NSUS?=N:G8-L6EV(,XU3H0QCA\($2
M"ML]V?M"LD%U\N+HICSEU_&MW249T(+;V'+M.RG[4\#6MNB2]]3@"A ]LMLU
M:O]#,FPON]:D\R/Y,@YLX948>!?X^<:_7CCGJE=45Z@(]@0]OS?MBS@%2MC+
M3$D]0G'B\9XT;Y0A\RJ)T!5KQLO&L7KU%$; %0#\SFJ+1P(DHUY,IE0V8+\$
M8$@G'Z[\-3ADJIF/K)X/G;)Q0AA>"\DX;66_3*W!4W-6,D(2R3FF&8=!A8)+
MQ99!MO*@F#N=S[4]_9]W8]M1KPIS'K>2C[?N6!6X6.3;O7NAN0V^7(3;2\!;
M+)PV0A8/BFV=^_QOC\>VFTC3G/(8@_-6Q3A) S["JNA-B&=*_INY6,0H"Y7;
M?P<6203/EW3,E00M$CO:Z\N1P1Q69(N(G-2V[Z;F?.;8*0E6S22!8"%B7NT%
M7[W1I%IM%)#%(3TA0)25E?]0H&@*Y\\0CZD2SM]H"N+\W4Z/$&[]Y,F345UG
M7>>S?_?.23&QC;0@@BR )^C/^V^U*$R>8R*/E':'A83+3T7WF2T:+X'\5?.;
M"HX*$CVU4(=5OG6V&3&Q' '$^_8&PP=R:!-+6UKEH6[?]V)=NUV=(@:R]2%H
MI(6P!3BZU@J ?>Q,3JB$1 WV]/0PD/!P03CYV#KA?6C+Q]4*Z!=QA5"9D)F9
M.1J.-G#6CYL"3:5 ,-S^Q7)#).&E".KTZ8PFB,3>D^464!V=U+8Q1BTOV:B@
M#>FB9P#UZ%E_:P_,H*SG#^+9+:BT5F3HJS);^T*D_C9")PI*285LF5+Z4S]M
M00LRU"]G7QOM#('V]9$:@A*?R4KY:5'\>UP#H[)6@.V(X1#6P+@O8D"P]R.&
MW92)F^=[8#NP7K/=RAH[/ZWQ=9Z*L%&=$9RV95!=3^1_JSEP11GC?H+.=R%?
M%*^<X(CE1OJ(9Y*4M!?AQC/.*[=7"LEVW'%"^"MQ6R2E)U .PY3,'"CIN:A>
MB(C\W7/91;G\<.M._NO&KU$4UO!N]X16_4A6DW=*AV!6UMO*XXP1Y*%-%@ZF
M!(E7 ,0BNMTTH+C:<=7'=(DQ/.<DPM4<[P,'L!O-/%-B3. 6:C3F(UY"41;'
M&0I^PM$#>C@=*+G0^YPS-X\L%6\(!>.@OGL!T<_7Z'?924XE+T8Z)*HNL=</
M_^&"IEI"-/4FF;1+F>"_DS"H=<1[V(6E!4K+PU\HWQ\HG1"&HMT2)Y/*1_E]
MH2A;Q[[-[P="$$[4OGPK*RM8W -3#1$_O*CW\A,270SNQWV]LE3>]1:ECLUI
M5,>8TND14Y&M*?FF+]B-3]=\P@C,P(5&?'*C+;U5GQ'X4DGI4R]ZQ]XH+7-C
M30BG+3HL%2R,G'9><]#N>Q<MO%2W'KU'&QD#YPU$Y4U>0/EE4'TAOC8CN4RV
MEETLCW_]^ZQ5H<;9&>O=BVBS+:3L2-?LSO)#[0%&TZT2J(-7_(ZK4>8BWED6
MV#A,G@SJF1ZPLI>@"_C\$YY#\Z&(E0+!R90E@KS._Z1-$#@[+F!#XEI$6&,+
M([AK:ER\ ?M*-?[NB&>?M\%VW("P=(S*>F%;E)BB%YE1)*F\ID=F16U)[DW7
MF]=(3V6!RKW4QA[D)8/;R75U[^JR1.5?&)!*OIB3=XDC"U)$<^I)4JH.P[:%
M)-YH:?""1 <V!45.2FVWK)\,/#2Y.&2NK**B5BWQ:J4;'W+*IB!C.'/-[P7#
M1DP:TPT'Y*22UR@9OJ8UC_:A4.5[I BW\^J7_O7_IDI*)XUI[[:Q(##5.Q3&
MV[>#C"*B3_@$\$BT'AV?IT-OX_QBQ^_(*+EH<'U1#"&RKAQ94P*I*4^-BL(3
M[><QW(?BK1B>.)'>_;/4$NI *$@&=>$T%]!(.,_4DY,:Q--%)V2N>7EY=><W
M"V/:EH4N^TS])MAYH;DG)[Z$]X&GU#OMI!W"#GPY=7+_0LCBQE_$5BDGQW4"
MF]8PZRGNO7/^]E=CJC [ER?BO@IO*JJU&W+TSL.]?BLJ-VAN:Z4J/-:=>W5>
M'"@]#GO",)XY,\"+1<Z?.+$CVKZ_"HQ:"+&,[^'&9>B$K)P)Z8'8BZ> >>WW
M)3#$&.33558G>7*KZY)8?C4NP!HOT@1K +V//6N\R:+V;Y^N<*\<DRUPPI<-
M^9K_8.J3VZS;YG%M-,#R&_1=:4K^.W3"RO$\7JEVF+Y^U:GRNF4!RU[@DCZ0
M^WK@I$H >"?>-G%\MR%O"%#@&/3'SL:BLYB-( E?-#"=)X1L%,Z9M]A.IMY^
MCP-OMBVHE>*6TUUI!=U7+RY ^X10=)LNJ;0X//968\AR>E.E\]+J(JHB>U\9
M?FJ[?;G<8;$!,H8[G- ZJL?-*QFJ5=;RP]1=:K%^TFGY^"__-UR4^(2%F(((
MLA7BK4,[@/7T.(ESG&S'(J_W;209.TJ>HEJ:&?0L4^<M9?IA81E-6\9]T\8'
M2DU#U5:3'EOF[2+LGPZ4/ITZX9;;:7Z@E.[">OAB,/1MM^=<9EDDI*7,\A9O
MH:8E3WB:8K&PF>_E)^M2L:KI3_OPU@?!.E,QETKB=A8O\@S9V2>Y/CJ_MBK"
M#!5!?JE-AQ;&)__XCP"/?H7Z_0[P0$E#^$OVFVM2;@I,*SGL3E.AW\]B:(H7
M+':CX%Q4K-IXL8D8_U-LB7:V]5^"Q6 <MNKUI"<,*\XN0O9['$Y")Z'_LG^5
M&HXF+I4QO8O0P[R1"C,G<*K3W:1WY,NM2>R$CDR2K3P,=ES/0!3LOT5J_)&V
M)-=36/6QH.^WK.<I2?/$L0K-4]!I6^Y8ON'3"#:ORKT9$K@99\?["T_E7W^8
M/M?>Y&Z:O$X"C-CO5R_L;DXSKB"&RO8*3AK==?[EKN- P[M*:?>=I>S3R^_J
MJ"%YB]LE\*1S[40-43M1O&WDBD94FRPI3BFB^5O<J4"G%NI[U)2IX@QG GPO
M$[^))$ S(N\5;[SD=(@%BB"#7.SA>G;;(G%Q-6Q D#(]!'PV!Q[C[QAEMGI!
M3K<D 2R\O/&YVD+O:TVJ57W%-A@4ZT\+?[?^<SRR<W0G+PSY_!?*GCX_$-FL
M_6?%>D[?Q)2X$=(R(VI.)LZ$PK?QTT.VLJ!^ U107M;]"6)4UK4[=;@S$V;Z
M;:\!%ZT/R:;>3S_L']YE"B=KTBVV4@0.YE$1C7XXES6/T)3.ISP]M7O% NA:
M*UBEXCB<JRTLH)V1-PYL)U;8A49D5_D_F.*!C#46LJV3IG0PC*$#I9M,D08J
M/JL7WC.X]8//Y>_^*[N'AJ3 ]!9N1_I89TP[SB4.,+).$T^3EQPTZE_H/. D
M-(1P("[%#*+CUWG9SJ'GW@3.B4NBYK.^F9]F.N][W.V&:U;<C]T)/?*X.X5I
MP1#,\-_V>I^9&RI99V9K)8PZ-J+\2)R(OMNO>5#$F66.*68X/Q^!TP=_;'%+
MZX4$;+> GV"'XHPV3>7LY,U/5H&1RYJ3<W.%01)N<4A$52LV=-\YII[[RQWC
M&ITT,S/QAI0W=9\/);RE#P=[]+K2N5^Y,S6!?#Y3I_K#).P\JS#_(YK$VV"\
M>=89&V/D)2B8OSHDEXISN0%T2& 9XPM<!/]&P@*>7!9[IQ\2D%%(SV]>BA$R
M^Z:?E%_XVGWSM'4.K""BS^9)9LD-$ 1C.*+!X@:Q+:3?>_UM>_-E[_(1J5&3
MXO#LL)K$)J\D37L'HI_^*VH@N "<U/JRSQ.NCU=OL7CFX]7:72ZA-CQ&^,IZ
M$N0I6752UOJ7WL=[:=<55 5"1-M=9=N:%CAR![4-M0',TR6ZCH2D)V1 V9[&
MS"0G][(,FU!^7KQ1[RGJ;T#_NF3:B4Y<EJ0W:4HY9(9PO[W,AGSZ0.F(R:7R
M"M">G>Q)";\*[Z2''1 MQ8[C),YX8Z-(:&[?'1GW?*AHU7YG_)OV%D83C4P$
M0JA.5# XSRBBKN[K2N*YFO*D>4SH?;LS*7UL> I>6MC;T8NZL4;_V+K.2HU0
M;_$A-PX/'ROZ: Z<X[N7KR4+'6_F0 I:_M;D@?FHIT?Q87AY_[B'S7[_7Z7U
M_S^.7Y?[=._7R_.90\P?4*%]VM%Q?^E_SDXL-SU'>[/.# \0-?LE4V[?"L?(
MM;YN-_E=L0,X;VKQ+/9LA$OOL[%D=4O9,&<U;$BZL.HV>+PB+;%Z?FJZ""\Z
MX@^PPWF&%K!:!ZR /3XF-UK4W[7.# 0C:[7E6B#+F%^D1,\6I"!X_C184K4V
MB^_P-S,JPLU0'BF ET?CBPF5%&S42[''+!>34CP#0R:>_-.&V/!]&;=1KO-M
MW,T;[JYN-IET2H8^<6D<5:1?;OS4=> !C4*GS(O7(RIAUZ(B2C+U7K#5"U+#
M-[@E>UCFYB;X[B;-_&Q&74=/KVRV8<CJ=K^*LD7^B: IK5WKXD9?@U])4%M]
M/NU 24NP:WLB+IOBQW*QP1:0,T=_;;U6$E20V;!= X@(*"K^3U:ZYIU+ZE(P
MZWG(M[L!J/R[N+.S'I??ID0;1%@A\U^+J?ZUT8;-+UO'5U8IN]X Z5A-R!VH
M;$+G1FI,S'(=F:JX$F:7P+S@IMUY7'DN$K'O@W*"GMJEB>4+^=J.HT4;3CON
MA&CKZOB%KC:".>[$\W?,I/[LB2>]:H\8""1B5V,N[1'ZFGWC(5HG*:C'_?Y\
M&0BLFF.-OYQ)C\\Q=O%]CRG"*=?W__CS;R&D_Q&?A+#25F*#G,,6-&BW%E,>
MG$+-=]ZW*Z"JBNW.PF'%$K,?Z.NRK>"UV,"QBP4.RS.7:WI%2'$'!,/##62E
M!NH^J&NP>ZL^S1!&;K8BRR91*._;[T]+HGWINO 5Q/KH6J\%-'R</&(SA'L5
M#K.'#Y/(EW-DLVF%<@&:^1Z;S[1Z%0U3"2C*)$;+1*JR-:[.XY5ID8OJ&N#9
M'\,LH?\,TRZ?/]"U)V>Q]$FNW_^JH/5!+))1'M%2SJ^!W&N/.4E+CW/P""=-
M!/O"<6FX&**(;N*TRO3C0@7,H9OPPRK]VEC%(SGUKZLG!Z!3J-C)TT@'[HEN
MJ$O8 G!@E-.;!6JR"D[(XAM AG.#XULO[@S<('>C5FB)(;G\"60.IT# :GJH
M*=GP8JO8-&94-E7QY-/5X>ADO&XR)/Y Z4;"YH6$U$QVBB]Q8K$,R=40VOF-
MW?<+CANR;1/$.U]?5R^TV8VQ1#XM8UJ&A D%OOIC>TNC N_@?$_]!&2%=']9
M>F)7FK*9M.DWL\.8GD78L2I,.]U1PQU^>J^*%C1\U!Q[/CS8VHZ<YX1PZE:H
M3\K0:F![C/?7<U-22\ *>'UPN])%.2!'E_1A/"&$Z^J>/HMQ_-?_2WTR<* T
M>>9--M;">6X%\Y;2F;[CE1'5)MDG;)L\1FKZNMSEDOH;HMI-@DE73. 7VCPB
MS%)G[.OK?@]K9LNU@D=8FO(%]G3:F\%4[RV=KL1TK[AK('[ )"RY]JM.%B(9
MQ/+LR[5R0I(22;B+0?!;S#%EQU=]-,IRW48-:*FMWB\"8?_"#!KAB5IB3,ZD
M]7 L+K*P ./&+#?@WM][RAS?V'B]6KG3W6C;8=7NRH"X>.;4L:XL*8Q>!XJ@
ML(Z!I/)CGTT,[4X8_;'/_\1G1XM6W[/C3&DZ@3GI=>*'62E!UG8]K.=%SM.K
M/J5+*PCU.08$.OPFV13ECR)G#CS$&ZFDQ Y>$[*O\H0K-C-&*<FFC[8R^3>E
M#)90YF+AU)C@<%[A-0AB:MUD>^M$A8,=+[( \Y<K+JX?0S[V/_7?$&J<LFF\
MY?/]HOF7UA7:-L'<:9QY/O!QC]-%OUW >O.Z(9"-&5HBPR>!N\_#/Z3*@N;D
M/3J::Z@9*EJ@D[?T,>U[3F>V;=$-_$T$#CAUOCW8=3-GN:STVNDRQX@TFH29
MS@[D-DXN+W30P#H1 _:6"7XCUP@'2N\W^3?GG%[8N;37^$UA>K4TMEWV0R!7
M1E-<[$4FVRZX>&! $;'5-?05^+N_A>FHN<<0WAB8M?LNF9Q32J5U3#J#!J^P
M3SN8ZU'K%ULEQM]83D8B($AK[GE Y.VZT)'TRG.0RLMN1^8QMS'G?B"&N51<
M/O)\;'63-<1U:*HV?K5I=FH6K%JRXY0=!%\QCNKQ"^>P @4 O(&I'-M(FI$%
MZ,U70)F'A%MV1>%ZX-?L>65\^6D#4'MEQ*L$')/&[3-L9%N-*3M\X\J^]2]7
M_0=\JD9_M]<DVT^)]Y['ALPL3:\^K#Z_55H3&'J]QS9NP^!0B4,_*/FA>4J8
MQ05SD0]0;OLIL*/MH5918TD*$ C9V8HJ/E#ZS$W%"7L6)5EQNS]'VXH8 C$!
MRY' 2VPS^JFM8PFRHDVXBU.="-/ 3\I<&,C_3-A$0;^0J^WE#J'9:>!R@3"T
MJ<3%(DN8-=^0]I!8K,NP92Z2:B_'$5^+FD\]?;QA:!J!S'X3OF(&GS")N<2#
MF*0[G;UKD\@ML.,@K-WA8"08KGI]X*MG[. $]I -G.D<U_W+QA2<\D$>5%YH
M<6([^./YQ*"_V6H1*C^Z-_1P1JP^NM)6(D7]7JW$8+_L\-:+/3T2%161BHKV
MAV%AL9!V9FGO'RP=Z_I%:V&<885P"T&P?.X>*/UNZ433A&FB\^%?2R?C(A"K
MUTW+_0^5/'@C?;6X ^2=+T38"ZH)5N[K29+V'\5$^_SR@(RT1+N8K<()&C8<
M =))^SD6!;D]$+"P2&Q1PP?'1?%(0QGZ8-QQ,7D3"1^5J=@D!,\??2DUTX._
MBGTF&9?"ATRU-9A$,K')0KVZTOS*:#(TH,Q9R\7YF]5- DTDXWNLJC<H2KIU
MFB_8VH'&8#'?=+QYAQO6+0J?6!-4]_XAB(VP-5@,@E#:9[X!,YI*CM9%5&;6
MUF M7>.WW 7E'EL9C-6=]H[8&%NV>G=Y$QO X1NT9, O<R8M\IHLHA*"X'>)
M7CX0@ &HPZF3U'YB:+[E?C"FH!^34#UC3?1*W![,U1@NN[Z0$XD?B9)8:9#;
MZP)>_T_"^RUP* 3=O!KVY_<[3.+0JF&S0PD40CSO//M-3R#K=Z==*EQ2XF!9
MG 0O $*'5]L?C=R1H"Y+ZK-^RLA$%C!<["7S.9ES'@6T3=S^+5EY:*+P^6R[
MYI[VZHB5EWU]("-Z2]<Y^?P,8=7+(Z<C_/D&X<0.V0F5,ADLG?JK:"VG;V8[
MP<NKUUC9EKY<4_<\LW6W ZQM=2+,]<K6T0E77P3B]B8W&F0P&)/RN+QM( 1^
MD\2-?-QW_3VY*TH1L"C"F-YW[-,X91(](\+FG/_6VR;.%SWF[UJV2UG=(>\V
M+)6[O=SQ.7[_O2#U<V;828C^GD/<;,7(W:$\:*$^/;%UH>KBQ8 IV/O@-.A]
MA?TURUP _O?N$7.MVU 4FDPGD6KF*G(?!G:W_X,I[?I+(QO200$IAOY+PFX!
MEQK3OA3:5"=)2G)H[Q?+)^I?-U@4\;])M68/<OU]V-Z:8T/6/DPWFV"9MZ:<
MZ3\<A_:&WN<3I^<IIS9*S08.RR.'\N+QS@&2#[_>31^BXJHQN*UK #K;)URQ
MI26R#0Z44O+:R$E@._JRHSLD@ -*L]0ZM]?@0E^O@.EHP$-2;I*1Q&EAYS$!
MB@MK$;=#+5&D@'U=;-#/+%-K@$%%9;=S@?WB8N4YXJ(8Q:M\X-DQC1VJZ37L
M43>4'17[A;Y]PM#^97Q]63%$IYD"**$M.)-+36=R!GON#BC;/H6//#!/GB8L
MAVG?17!$C)UT_K)!J9\6?+G6M8C9R.4?*"'S+Y/H+JY#NB!C%<N@'&CROUZL
M-H@AZ0AMP?L$NGH9[>>G:99VX9WV^'A"\#/Y%/#ZB;G(*E"GE1Y>I)X0D9<.
MH==1[2/JOGB+R_RZIN1K3.-C-/3DU]2PD\G(;MY>;4>O _G,?EI$MHNNL943
M*@:^.Q-/AU[)>KM94$2"AN@F$%Z\BKTV+ (/(B+/]-UMF/HL94-#J'=E1W.V
MD?:^J.A]S<WA)HNJI)YMS1KA3YS@_YA.=14/0BI8\4G F<9[ .3Q?>_[[[3K
M7B_YJ[V??4L1Q60#>L:EMB^O%Q&CG]\?7_8K_-[GZSS6(EM'E6W2.N;U?"M<
MSB;KM3C/2XGCU8;:_$C62FVZ =A*:@C/XZ.\J4_PY*[HQ*(L+CX2#[Z2V>!7
MD0R?2G:BYHO"#=IDL!;W\/CB=YL%I7$NKMK6)<.YRO@/4^H);^._-3OZQFW3
M8D/;&RS?\1O5KX1$VP7$G\C-?DFI6\G.1@V6CU3PR8/DV&]<"W[?8-!!ZI\(
M]%>W8?7>%-W+SVI;=\!DSV];[Z"@O5N'.\0+%M!Y0Y84!EX8A7B=(BLL9HH7
MRW\BU.9_#;RZX(#O\/:^.=2849;N0HF8$U[*+XQC]%LY@BV^(A@%;4>&&)C>
MJSC96,3N#B0N=I]Y^[?@/KFW0L(UPYI2KV[9_:J\/94.<SGS8 G',,*P<&G$
M1<*.>D,$/1"2WO!8)<4M=C(YOE?_#V/>K,%6KN]YN7M8RC=[E(<)<Y3HS936
MK6%FZ4!+8PYI80H**]F^Z'VQCY9@@[O(,[Q6_ 37TW>@E&GF6NR$PLQ%>B,S
M4-'7%[A>XWCYNHN]7DA$V*62) G"W>#'=_^5P'\!/JV8NL\D%1XHW47OR@Z4
M @Z4=F=780"NK'-/+_O:0M_,?47:?D7?9(+S@=+^H;.^;GO?E\'"/)B].HNA
MWV[N2V8Q9^ %!TJX,6:8@5?%S.ZKYXU;0S3O R7SG'/H3+FA!*57VK^3KU^S
M'T+C<799\ #L2NW>W,U]X)N;W_TC"(/\"3M!8MAAY]P,_R43%CMI6H@H*HML
MB>JD4D5G?A2_*VBS*6>3*=BQ=/,N4)N8:^K_%?INSU (>G>=QV?W6"C&%'&-
MY:G!WD9\13*M[^U"ONU )4DR&5'$M>T#Q1=OYFHEZ85%ND "1MMCO1;=['8^
M=6)3YN.:\+3]-Z9HQXN0/ 9N^D/:=!0 %DTG/7F?'3@2_O^YGI#Z/]83^OU?
M5T_XZ7?[!TK"&:ZV+_*H?\X>%)<^_X/S?59H(#<ALY^+>KJ$$6%XT:%#;8 A
M&BW"K*DC6-WNE(F=]8C-S3B_J^+LK.G7(U_9S;\_^GX%^X9E_F(P=;;+9F5?
MU 6,GZT!;*#1//,,F 8S!-96PDYHXT!4\'S5IMX-.63H0$EOY_=T4E?:YPZ_
M]XHK?:P;WPJV?PE1\4IUM7 PT#/P]MB=!#79BT&,>B78/]L"'1Y-G>R,OM>:
M V*SRJ5=@0(H:EB;"CNS/EB64SU84EZ&"LZ]2PT--:LLA[CDQZ:[5;WBGOQ1
MG_AE?7%[790E7 ;U"KL,ZQEK9US;__/&-10W:UR<'7>Z%N)G)36N$HTSO7J
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MLV=\8D860'6*3K0ZC2$_&-#!,">^=2>5Y>24D92!08$\H+L7W%W+>D3K*QG
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MO/28%**,7>"M3G=CV=%-&VX?T9L:@+G)(4T,P#13?C70;+RAQ,X1FB6="]5
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MRP4BPF>?E^UOV%7 3S_-XT5SC%^ENF[M*F1%6]I9UED VMMJM4(UNNZIB("
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M-U>GV5C<2WVL$K==C\@HAMMO\6;PZV*G'\7OY]\KED##SRU*I#AO<J)/3>K
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MQYV2. <7J$"^[YD]%E5S!'A6I[3'2YYG^1/\\;X7J#1O66V0[#78%>;<$6'
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MT *P^JM.N;-WY( ](^4UP+8!^W.&>V_LS-+[U]?HWL[W(!,Y($.8JMIA]U.
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M]F>JZ'>>>?_*B[Q;5[D.JJA<YW<A@Z)U)2TMZ[C6:ZW7FL;]R3MB]W\/7G+
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M3!ELK4!9],$"L<V3RC-,9)0[(9$<^X;#HQ(9!=WWDETR51I4,(_%INTS)Q*
M79YIJ.M>6;"$G?+%_^;QY_-R !)"X-G*"BS(DK77#0KG$&E6K+ED%B\TNP8E
M!]SB@2("I6%#S7"=D-<[I>@_1^2T.!M4UGU'JK!NRG84_ (:&9%ZX;JR3>6
M>E>+I'LRN*&,/2R[\56RY;&R7T?\7W18^#CMH'!&H0<TE\_"^\GV!JU)(V<@
M+C->JF0/J;;ID4WV<Y(L?BFFRQF^Y_R, !K=U+&5: :2N"A%^@M<G+]TX:_!
M5BXR60O^;\(L6=0E[MF]3@;1=6T81+$?49"T00D4\' 4XEC.#*2D<*UP$:4C
MS$61)3K+J*Y.5*Q8WV3"&!68/ WE\BR&FJC9T+I*-D9U\Z3"8L(?W:L -,RN
M)%2_*'J!>FE3P?_$S*,[B=AGEG7/5:9\!Y^Q8=E'UE/>]-(\J2?N#N801B--
MISS&(,0T ]&],#/F3U4ASM:21EI\]X*.Y0(W#OF<M^&VB:U(\"L>,#JR$5ML
MX]"KVTK,I/<DQYQM<WY8GAF+"?/G=E+H*Z9D>E WD!L8M4AR-,@(3+G2[[6>
MA*58?[D4G_V&L2H2J^&TMX9/9[SUI-T.+[2*'E!MD60#-SX_&\JKA>O7Y$UR
MA[B37K<S/):JTT_59%2QMBEK?MYTWTQX\Q0DF%#.#VOP?==AX%FWF##06Q,R
M8$,9*RC !A[W\_/S=PV=)R:YX_2P10NU PX.P1_;4AI^S",H*7U ^,_]ARHZ
MY@_%5?%@2*%&A# VS./VC_UW*$>X">SJFF8FO68["OBF/E1CCZP/FIC9%O;U
M9-B+MD&JCI%=K\MM]B;P2H?93VLS*TT+KDFH5= #CGZ?.7'H]BM!QQK8%U,2
MUDS*PZ5G+)KI7J#91/4]Z_:M@XU!/;KR.IK4*R<(P+/K13R8<V*Q3[2P-;G&
MAJU8:1.,=-1Z_:2^J78@KDS+\G<-/_LIT3@N51)NQ5]*=C<.6K>&C5&?""%W
M^,9(ZO@,U!KQA.C+,(9^",#GO05;S\#1ZNEMI5YSK!5V3:$6LTJK(J.4V@<J
M1C^1 X['A[D$I)3,+YRV"B/91TVVXF]TP$N:E%0RMX/F8FOM!G@C61FF"';H
MPPJ"VA#W4,_:IF91Y@<&DF84LG-524I*<7RJ=Q2[/1B#54Y?0?GHE82Z<G?,
M%Y_72\ER0(MJ1E?%@6$)Z6$PY!*>+V[K4N+( 4EOKR:9(/#FH*EM*NE]/3GZ
M=-)O@T@RZQ1>A^;63;:S@/QYC]4KV5<"=+H0W=%H41\K36V7]A>O$RQ&VE$U
M?]DQ1?\9/AF.Y9K)<@^\6 .]FZDS'?Z;'&!KNQXR*3.;D;7>6%S=M]E.%&-
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MXW<O[T\QZ6IK9Y5%^490;@7UJ$9*U[A)/EWX3H(32!.O"%1"ZUVJPU0'/OV
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M*DW71^E3;5F6)12%B,K4A0HJ B+S%,H61&1J1>:I)$(((<0 (4 8NLLJ9HB
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MU3+_X%AL2$;@'7J<)^3DM2%5;XL%T$OM?OG3WL7$C*R]K6E+&%N]UWVLFQS
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M6BI2C$)2BXN,5923D=F\]MJ!I8BL\="4;YA[E<1%$(8+Y=G,38_'$8S\FIL
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M>$;A^E/ _;"\PT9-6J/OA:G?Q6G.8CAHCQ&-^_B>F"<-,(#2>%S!&#CI*E2
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M&:)!NX<,YWP_LPKFP 'V)U9O]:": I->S%:#::@GZ,_&'N,A_K3OO/5.AP5
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M2U;WCG#.BV:L:K]C1B?R-;ZEZFW&YJ%H-%3N6)P]KBKV(X'(ZS%']_9\:)?
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MW!P+&^7[X17=4*23#.">WQT'A4M6>R-MX9&Y%@=*WT>E/8W<B/3MT>GV+@Q
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MSUD3G>RG(O6&?JR.F9GI.;'6/_*@^'/RF95))'8UI%]'U/6:=T?6Z>$U P]
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M_8HG4;Z0J'&@Y#2?-(48N@X)N$)O&I"( ^.7A+EW>LC$-0_W-@+[D556M>.
M;N:QF(1=P<XW P[@*;&HB#RTEZ89-^1MR0CP/#]<ZQ9N1D-G%%X]RS+XY#>:
MA@#Q[ H$5:G0&EL?+"]GIK#2A8!&KSOO"F;)\"?S8FD\C)PZWM=(%UXM:'2H
MO8YJ+9ZK\]T:&'"R9VB-[=Y:&%.;:-_IG*$CAF;[ M8"/U9 J30S%=8)P8&2
MY92WB3 '@>\5# 2E1$PQ&:I1UVLHBAG(&_G'4"Y$M7U"0,.TU*)=Z9T#*@Z&
M[NZ=ERM3]%+-CF6@@8MG?C]I_F %Y'4*T-I[9.3?N%]TE^GB)NWDBN<;1M&B
M]EQ#]SY.01_KY^!90^) 6,SY-=\C"6D+1MI]JM(@DKK]L&OL^.4_73V3IM+Y
M.2]TUS&!=A@)+PQMFS.FTM7'(B4)*H .PA7B1:?G19O/,R(MQ_;E1E;5_K"@
MA_,1G]HKTJ2= &^3ASI)PZEQC*I#D^$FJNK9N6YAA:>2-B(;(.-: SHE1?]8
MI8[LS=:Z!28KSW5_O1ZM,AR86L_QURDL*#@&J>D\?RP63&-')_O7Y6+/5FJ!
M_M!9]OQ<U48<[6@@@V:_:W,+%)58Y&"*)"YTSLI48HS?YR61JC5%@[E'Q1E8
MD*KMQ?4;>D@#Z*E-.W?!?/U/<KFBM+6_$TIP?;0!]7<=<]C /P4O#=;W [31
MO>!EN$V9IGVPL48$%-4/-F/^[ >63NQ\^65;2U-32UNE,<0%X'+W.>K+JAJ,
M?B76J!9EPT?IW+36S.]?@:?R)(I!\B B^'WLP^H2FUN]#[O-(?[AX<S27U#A
M55QX=HTW>9_]/O[YM?^+GO>/%K"G>^C<U?]2R7^=2P"[1G?_3-LBSGC<BUM/
MHC=.-Y4D[^C7W,FQ@72UBKM.]9Q.K_?WNQI[)D'>C55G!(E(GCZRV&,.YO @
MK93RZ_3/#\\@AL6T FS<ZMY,-'7EVT&,%3+/=<B;<W3XN:N\U=&5(Y"=4,0U
M1(X7PU &*>%^K**]\32Z9*_6V$HXZ;\O<ABPN>CJ)(B3XA*!MF' !)HO[FC@
M2VRY]U>_49Q/CRH:AR=7)S^O'H\\JDZ6CX]VWK1^RPJQUM#01.FWPC6L"FAT
M.?ET"]HIAWR.O^'E!43&;MG,N#M<0ZNAE:TGD5/!$1?XD(%W&.$I1^A:=+/W
M**@""JAWI%7J-=767+>>#8'ZPVSR!2WCA>JSF)1*,\[1RO3.%<.0H>^)XQ:Y
M[_X9T^:8(H%5IY\A?+9@1?T]$< ^'HE%ICP.N6SQ@H'F 0H)<936MYXP.-10
MHVB3LCL6,#X<..K49^$5]/GUOIM>Y_8_:>_J-I6ZL /<AGCMP@[N0G9#KT<P
M!\V5P'M%ZJA2ZKD^OEMXX=WLAB%_*UAA650,Y<VL]'9I3K\K:74+_FZP@%J"
M^Y089K@$J>[=[, #SYP__G=J'TWO3Z*5S3"Z7\-T(J*M7M [% 078U8%(O:F
MO2Q8]?DZ\$$]L*#3A7 W@V# !1@?-=%XL7L65;+1>6ZQ,4>$R8G4%UZ0/8RE
M)TIH P20+%CS <V-)[%<':!RPY9ZQH,B>J M WXT6'AX8NGL>$F.?RBKUR%^
MCB=+0KC\<0AJY44(;-J31S]A8FC[*VI5-4C#0%)VOM[9?[Z+Y)_ 6#I<\J!X
M8.6C7:S0Y7R\( 30NA$,,:X-@Q\H^0SS/%_$V4(!RH0FZ76PE[5G:LQ&';BJ
MSBZI\6T-(5)@:[10LL0-.9:Z\TMY5HS:&"[XM3RK;7W2]-?RK$DKEY?2]4MY
M=M#,O*;P5%^]F7I>SPO;U^(1&;\CEVV4J2YH*F#4/,HU:&^FHS,S .SX50:C
M(260&%SI[?@;QR./&*E/BH0HWA)AYJ?+HHB4JF:+F#>O>F2<RTOSK4$XC58P
M>,,T^F);'%)10K;9'(3$:NCJYE^_ZM&/@H](Q?C:9#G:>')G2SBQ1HE9B"A(
M?<[0$1U=#8[#/X\<(^'P729K_BU\K6,!Z+Y!:0#6V"%#FSEM8)R21CIK4+B(
MH5?RGF=O&0 O-+-C)K^;CC_JD\PD4$F!7$N*SF0C#VG$7UHMT[G ,LLA;UX/
M?"P5301?#IFKQSJ8RI.3_R)(JECY<%#2#KK6I84:C"W^V/] "5%X]+VU-E),
M_-".QJJ)Q.%F[IW)&'VW?JVBIU5S1 /(W?VYWBY]//RGWTUX->>=&D#G*J%&
MBJ9!#M/%G+8M8H*$!CF:?N8%?WOGD$YMPRB"IL6X690,V7_YVD=;MZZJM*G;
M,A!^$[Y&A%4N-*?%<RN&!3HI"$V3C*,9FJY);HKD"% ,KF!"U-JG"E)EE%U9
M)19$S) R%91:?7JP_5?O:C[S&!^,Z11N0$[4JVZ8UA)NM@4N!7[S=T9_Z,%!
M?1P')_:3YSLSEDPS]&G!]6QS.2G$A!MRE-9L$B$*M$3W\];&> YUX^:(/TY;
MK$_1]L2K-;HWZ@P?=%$+@K<;8Y)5<END'MLA\/OM9OY4^H&2:4LK[&) ?UNI
MD(Z&!!E;X&!^W:YNII6@+[:>\7?.4;PBECOWAHW-9K:Q1GEMN!.EJUWPRQF%
M?"'#G[W[1NWK/_]N"OQ[?/!&,:5<)[;S&#Y0,B;WG-0NMW$+H (,@#'L?K_P
MC$&O-\NL+>Z-5^1Y8O."R&Q;X,[41!FA&36S=L+*NL59S-*&\=RAN/F5D#,(
MSPZ%.0*6&'AL)-9_5,6*[FK9AY6J0!#6PRYLS$C+U0:V'KO7[S+XOK<  ,B;
MNP^Q;8YNBA_:7O%W@H%*5\MZAY)$U?UDCX<>G.0G?Z=GXB9OG KTY/%\_#WM
MW[+I;S&6O<RW@R'JLD!_B753@,=Y>R_A@"4EL8"A'2@=ONEI@H33M;Q\^ANH
MCQN2%IH0GN>90'$R=,BI-3_,A/2>0:J9JF7#4(H!Y-3VZ5/4L\8A%,J=5M0S
M[NW\U!1W&Z9#9S5DZP?R;-'U3_YKP_WG^!-0H76@Y)Q!WPY=@K$"UI>W[1P:
M""PIZ$!I@TSR^2%D1,=AJO1 :2 3N/"WN-^*R!^,6_]$:'_X;-= "B!4YHP8
MYX-IU)JVH7%4Y^L0L*0-TF6L7,A>L[*VO0;N(M"-6H*Y4WUN\)[>.)<^"R>U
MXPQMD!]R4P)0P"I265/>92- UCV8&$UHQ8LR.LL?OW1QLFST^HJE;6)FQ828
M6[4.L2$^71V?S@-Z"J>'AE@&!TKV+-^LDNK;K3<,]'M\J[T-^^,9?J6XDQSO
MFK!W_R)'^V]QS)_*YWZDD0>*2P:.)?B*[)T/>XM=F9[NO1.IAF-@NQUD#N/%
MMDA73=W2"Z(\>K<SV,ZNJC8':/=<@ 6C"+8HW'6']UL"S)R2_^N6L$7B$(Q_
MV1+&QU-Y3.BO6\+SI:EW[[<$0I-='UY5O4Q_^=A]!+K%1A(F+Q,,MC7<;A4U
MS-,(YUOX?'Y!404R?ET$*OI_%7.E0U>FP:"=7&H7D?RYGX1:>TLHLL=]'?TX
MU>LI?72067@I\AE[UT02T=YVH,2MV/_,XYH D/Q\ V0Q>M.^QX)Z;]^F\Q@W
M4WJ6[OU$.!&K46N4D0(-?L9SY  I$!4'X>,IFI?!>(4]5"-WC'B@M&#ZJ;UA
M"6 QB_&Q!!SK\6E^JB)_H=\"U^)\A6D [F$0FCY?RC[J__LILI"K.*I(%),D
M5RE+\F*<UW>+J<J7ELZG_I4E;:T_[6Z7]G)25 FRY:-,3:R <L&K6?+S67+=
MBUD<VN*ZKNG7Z9=)MP^4_DC5LK*OB8J#)8OW1>FI8/:B*+]&.V*'$\IFF.@9
M7LEK :D3"SM?HW170HHW$ZWSS6&Q<W2'"YB=NO3[D2@373Y$6/H7\CWK+WYC
M90J1OXX[3SZ4J?V$UZ$9<NGLG$:4"S0+)XR9V>9J/,,W6N8Y'BAYQD-@VM.U
ME' K7ZK5A@?L<NW:-I:$/WXS8+TT<3[Y0,FFG=?/X=1#.;LWW:\L-:Q+2++
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M;?'Q\1S!W%]NB'Q6<V#%ZYB@FCJCYR]^_EO<H%:^%KI,00?NV^Y+AB@_OYV
M3=!*Y<TF^M$;)F%9Y14+H J+VS@#F,O,">HS#ZRM[Z2HE@A?1D7MIEN)!A>-
MB^R1";C] W D&IP/?[IH$C:B(?8ZY&C\X$Q@<9O;S:WDD,5(G!5"KUP88Q**
M?]60.7TGO)=/3ZJ.-)TP+=Z48NL4(1C(41&F(^U>-$Z:3-A3::U:\-K&'96D
M.DQ4+2\>''40(]S:Z6(T3UL>D9:MZ-]5"TWKI_S#2[WN+>DMZ2WI+>DMZ2WI
M+>DMZ2WI_W>DW$CA4>'1^;220'6.S*%*C+R/) 8EG+C?XL=<*SF^W9N]K($+
M"IBY7=]P.C;1-)X,BHO=N+XNI;^XG@+8!>R0%TEE4S9SO>NQ4NFYE%3>H3&=
MR;MS."/PL>U3S=9@79/5:/39E"<"P;A@-<Z6?,$KU%_CC DH-Y(VKJJK^OZC
MQL>?_O$A+@CQDW(^*,;.HMZ:]"4YNK?]2K@';];8;^0Z9++8.2OY8I(=5"N[
MK_8]+G&A>+YVE48\@T-9+M2G:N^I+'U)2E  '%3+2+"[*<01R, 8!?9+C$E(
M\=P-@ZKS8%87R>V[3889^N:/QF<6O=($.W9CO"-VN*X1S&E>4T3&!+TX)\0M
MS^>HC&3/ + =[NRI_&4Z:'W;05$.^+ /GY36+5(^?K;[#?RA$AJY+5/&_H?0
M&_X/K$=O26]);TEO26]);TG_3(J#6#]D:3'=NV/FA[A*WRVBGJ'%CX"3 G+=
M+>XPO+OB4U[M<Y88_[0DP=  OGIUP-\]/#86E)]::=VP/"]ZJ9A=3Q,93%LV
M=G)LW/+(^)QP7*B@\]^Y&46\DK6[,<;7N#I!MVOT#=D1Z<&[N,?VM^YLE942
MC6-3KN-0NF5*55Y1?W1!^I;\NJ93]DJ>=H(3H) TM=1L08.#/&^,,?6RA]E-
M7_62%F,E3Z_'A2-#X!!_ CTA,6&"^LD-DL?-JX[^'FZV(HIV%8H-[6#$&+?-
M3DC;O7%1@858VF9O6/ D/NP4.&H4Y/M;H3\@L$%E&"7%1?N S49\BHJ*)H)#
MG@<'I[R^] U^59(&I?^O*W+_2<2Y2!JX4(;#3-^+0W9M#OJ M!FC[KK#L:LI
M<P%RZ$)T>WD!] JHR7>5R6W'$GSI2P4_I:;5;9VZIP7_&(V^.K>_E[MK(8WB
MYW"<P3WL[3C2[1S[=HZ&$:%?<Q!(F_6+3C)N#&; -EF283]&M-X+W2 AI; L
MQL]M^DYP>6_5HN1$6;SB<#",Y.OV@%BN3XTH=DR^0?C[W@/K0/F%Q+\$C/-_
M7&B*:IBK'X[TU0EP*+A7;Z2'T3+^<JE%)^U!2T66%B+"P>O)JV:ZJ@?EN$M
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M<>O9Z'5WLS07BP_I'J;]@Q;&FWZ)R+AM$BSAB!\72=A3@?X24CV(_&EFH9P
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M4:+R)RU%Y1@-$G^[B&,XKN9"T+S5]'BU'10_88KS:$,?>4+U^"$6<2@E2(/
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M%#TCMAI%6LIM7^8M86.?3K%(COA>LC\9NM_4*6BIKK"A[UQWL(WA"&I?J\Q
MIX.H%8K'0TSQE5/F4E%0T]0"D"&.&F5MHDH98>/SAE;\,1NA W0MJ5&_E<"X
M-0BT!O% ,"S/;#L,ED$+>1[N@W9^M_7AW=]=V_<Q#!!X6YZ([R(]6<>3_[;,
MXLP;!15LE_VQS&+A][3IX/M-V-^76;2I1TWZ!QZGG-E9D>[.A"B8,S8QX_Q
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MA)'C>6=%_JC/DFL% W1)TWU);YA,(T=!0:\U^TS<S7[M\\=?B']49JL 6U4
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MKTG7!.CX^]V!?NR*!*/^+W>]V=SUZ8T71>-$G[A67_'EBH*O<1V<ATW=2]0
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M<<Q<LV@:P;"LWK.6=T\<.KG?<G?44N4ADYP,A_-++'1.^E(E3*$O-TT$I>&
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MS22QP7B)$\(^6?WSI7E6U_,/V8 =E@\9F8$\BY&[PW&$ZC%SSB(:MT@!>7=
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M2+@O4,L@X3?+MX3C.X[^CJ/_)3CZUZ<D-A%Q^8;7/'2=+D,2#5G$VPA4T;-
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M(E VQ:V\$RK  5PQR.+ \A\'&H.0<)6Y0!,4STP%V%IB+XI<T56<2_91DE6
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M&Z#K-T !_RDW0 $?7Q1?Q[O')S H38\%GCUPS11\.&D@<.O%\XXJ0I6"^M+
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M%?RAU*@QD[A4@UB5R 6/5H'D%MDJSA&B,CH^_V%7).ZV9SE#LJ*+Z$4TUW?
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MZXGMZLB[:=S&^>F4<>R$I_E*NK# ;3-9>82^LH&MRW2UG>[SG@&-4RI1X0/
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MGO&"Q%1W96R?5V?X$XM+LBIXZH9X?QWE99_+?:JKS>8?R4Z1@'( U=I&$5U
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MPFPRX+OV>*GNO;5HIH3^N30=5$C7RL>_9@[;Y3=)4"&:+7@Z#GH_W82;'DC
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MNMR=HKR(6VT:0X=:KSJ=7CM=L_!VP+_F8M<N3W&I8GOJ[D+;JF)7LS[M)Z7
M.<((E!93MGK[MBA8#@@)1=?KR>J*UJ8OB-XQJ6G&I]2LPC(8I6U-Z4'S/+C.
M@K3XNQOPDPSV>-MTP=30&ND#*K7VQL=E:UMWJS.4'')C,KTAW%MEXV5ETP(D
MO_,1 ]&R2VV(..1P?UM-\.-N:*!8$V7@A]7!UW:+74.]&%"J9RQTATMBLD20
MMTFG)2>NQ%RO6%,$F\I9P1%;_[$@A-OY$W\0??PKV(>>4\0/@$($NE,.4 0D
M,]X1L/D$"G>^6@X0H+?)^$S]JC:9V0([+1)+TJOW:CY7\<L[UK^B',)Z1+D>
M4;[!?U!$6=X2+@?,;1S#35T/4_B.HV[."L<:-8=K$Z/9^K>PV["SO0HG"$S?
MB?4\Y_V.Z<,BI4=92_;1Q7( "BO*F-/*QV)T>9XCWBL!8BSF:UTS</X<1(81
M4S^X=/Z3LN_>F[!O\*]8E#JQTZ.]T$+VHN#J#2KWZ>4U=L6UO=KS7@QL25=P
M'JCGYC-&O&&80XPQ;6@Z:WGM)OGB>2GXV;F'976BJC+4[1X9%7AU!:."G"+U
M=,)#^QO<R>K[30)OC;B%D^UJQM(T?:@#E3X^A.Q4]N?U?.?D,0(5[$_B&-X[
MCMW7?SO%GH3YI#E.,Z(@SK _O.%"]LT][TDEZU;KO[5:^BLAK>."0BY(W=4G
MN*2EX7H-M]OFH_V(GG!?PUF;*Y1)7-!852"GCWRY.F/X+&4E.OT(":B./GA<
MXC-OQ 3>\%KH:6SR;0_1UVNCW(-G@?:[\%:)G;']H,J[.//!+HQ2ED?E8K=3
M#2%9)"$T:[O(9DL.@BH:KIKW:3_Y_7/JA<]]1->/!D> #^A'+;7:57&^G[+#
M;.EV0!R*X.C$0KY^Z5<VEF["R8NIZYXFAO.MP>HQF.0@6;N'Q<XXP*(93/B,
M I]]9"L>*439;+?S/9/"O#42H@')M&#%A>&Z*F(SV,]'.LQ9;L$(JE>%\_ %
M=IY9*G%A-3Z/+FYXML=!A_!6J/5VZ/\GVZ$#CC0*(;)77D=DV<9@P;%=Q?&[
MV>2Y:0F$*!4</KPP)!M6:#W45XHXN_RR>.$=C^G7XD_0EMQD;^&4') $&HOI
M%"W*\",#<H _NEZT](&@9K57P?9:$5!\I;GQL]P'_Z,$_RPV%($FF)H&CBL"
M 50KLRI()Z3)<VXDY-BEA!P>5ZL^8B7JVV=]CCL%Y..MF@$G-NH[2Q,YDV7U
MDGQC>*NW6OT$ZF]B;5AM8CY^+MWX.,_4^C0[*@61(:[&["K1H)M:5V:O(HF=
M]?.*K:5C>O\6DTT>)V<2%;L^SY4Z@=VL0WS@]_-W;R7YX!4XR%@.4&]Y$]LL
M696I3CG) 8M*,J8<P#^I'6<K!XB490I#T5_UP8.+[ZU4S'_,A]0C$<+S$5^L
M;J_F&S3/Z@2/$5X2>Y].VR[/[HY>"U41K&BV) U':+OG)Q@C_/QJVL@#JV6O
M$A*UB.F-0V639[1QR2$Z8:]KYQ@P,;;13$4'=\(8N:U$#MCE3W]= =,?9W+Q
M@=3C*5<*YA@Z(64L7[6#VM%)^:%AH[C;J7&8P\\8_K"L34>7TP+.")T(9MVG
M"TR9;%]:1%)A]D*M=8WMH:[BMW;F@S@24W:_>48)T6TO!]@5#7-,M1XBM9!U
MSP>6^UQ;,QAZB(ACQFK=*RM1NQVN/-X=_Q/RN!']\Z=M/[L.VUDY.L(7'3\@
MW23-MCZ).S'Q2I,O*(S*')KU*>QF!/X@:&E>RK.Z=YM 58/%6M42;,-K+:],
MIQWBR@&'[3"7W'TKD#USO-TFF&WA1>+5 DV?\*1VEYS$ LV!I 5"U0^?;OCF
ME]^I=>,N%)>4]SP(Y+.L%-8.F^(5=/9?NR1JJ!H+]*L?:2CW?3XT<Y.\\=OS
M&RL+"*5$'E9KYUE/1SL/O*,=<%],E0"4BN(S%UF04&D>$OI\03(\,968F,B$
M/^H?] _PA 52B"QHI<_!ZC-)6#7-J%:LCAT]**0N";N45K((*RE,C7FH#/&J
M,8CU6XX]OK16;O\X_,>W@KGKSGI/0U-ZR8N-S2%'+]^C>_6'AY2T79E()H4<
M.V:\?W9EM'IPD&*'*OALB'QOK*CQ7ADJJ*R0G1LC<O#^])>U"XTUZNK#L_8=
MY%O4+$3S\/SB!<WCB<RQ*O:VRGW0RM*PPL-ZII;.FM6<C]OYAU\XY:/W/J-1
M!S*,;%<P%T^;=IC:D@>$6<DR/_SRL9"2VG._7Y'KKSO_6WQ*C>^+WFI'^3%>
MK=8N4,"])KL(K=L*$^+"(%2?2/NBV9GT(.K4@]R\$R2"X.(CW,M;IL68*=F.
M 3O#SO9(R-(EN#!:,L,U:?"V2P^A]60N]Y-.?#6_LI,<4FEZOZ1^L>.FGNLT
MK<_ K?L,)&'K*I2EVE,+&81W>%'W6:<]Q'[D%+$DLIH=52[B<:IN%N_*RLYY
M\DZRJ0]G#DF5"P^CV:6R+\1)7"U.UQH]REF:(^-R?MW22^&:*>+S^[*E)]D[
M3P;]\MX4\@8?P9$D]&ETML+P2C \P@$-A1=0@0M F93R8O8JXD]T+U!97 7N
MK,D64(^TO1/X7S6;?PY_JCY*H1(1N&9KB/Y5#@B6U0[^@NW7E;H1O=.-@%6N
MQ4U2&5P?Q7LJN]BPPUSRMS]PRK8[DT;1?"%71?(J1E?&,'9^Z)V@B)<5P=%B
MPC;9'//H_6IPTG[CL<K2^3@8&#9Y\2U;G1(C30X@X^0 ;;1T1]"--<<6R74Y
M@" '2+Y-9BN#91_) 27HI?+ORG;M^NYW@^XSG+,:P_#[%[H:8S]_IFU*/#I'
M7'U*"V/;+-%HTIP'$/7V$BN+>0,F&5/3/7'4I&/$@]X3[L[PZM+2ZVP''W)O
M'27W>#\GYS=IH4(TY8"8A9!XVJ+V/D8D,C'?+"EYR@#I6UQJ>'B?W6/?2I\!
M>IF!KJXX3Z0QT@@*$8"/E]CG]ZD;F,!GQON/%_CC"^LPGN4[*F(]&A^;S-S0
M.!"?U.7"\EG,;NS*C[11O4G([3J0_MS5SA,_D;9<T+/#P\W+S</J8FC[H>-T
MM7"!G0>"LG]A24P<A@F1L2$K626>56Y.2\TZNXNGKB95EE_-27'JTS.LM6U3
MX'7U3,SAS#M=R7W!3HG9V04^/G$^/K[/?'P[-"UT.?'87WY;?/$*SW9SFW9Z
M"O]#B_%-0XEY0%*,7>$CBD]]0Q7I$'&J1U][&.V-:+]=S>])96X*T,Y](3@:
M$6:W8CH/=/1 !Y7>V2K5\ KAS&.-'T5N5L[5O^99^<,@CEJ2\3Q$DS@B/@]Z
MZ4.V(VS/24-,DNL2UZ9.>H,;RYHH$0[7&2R=QYQ 0T)AT^KQ?!*(E$M7.XZM
MQ(=:5SEI.&><^OVC/+"%S6Q3XEB\RJ0T0K.[NA,"1%TQNM>"$+Z<Y:K0W-M?
MM5]F#'[B6P;)4KBB!J1@MGI^Q'!GU/?$&Z#H$E>3,EC<1S'-JWH"*O39XHE
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MIFB&R5%3YFB2Q)VAAUC50=W50[)1?-()"9(:R@G$:<%%B'=U5%J+<&3XA2*
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M6!:8:%HUPAOI^UTS+<ND'_< %<#>G%]V;=8YAE(S"7(G&$66].\!? ;JZ6;
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M@DV\*.6#OOF(K9+GV&S+;=*=MN7RSG1*RL-EUPB8<@:\@W_1(;HL,&9#WFX
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MX?/%A$<M:SC/\%S.B9;^BLJ6#<QG-LN/1A0;G' XJ)H[DS$%>NYKG&NV54!
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M3VO/Y"0@ES]4%]5F%<VB(;A/<9>51$(NLOO=.X5F6@&C3V)\UR*U<&CT7*\
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MG]ZRRKS.=CO7=N0=>HKZ7!3 ^5LUL+/>LZ7%;5"&8(/IY+LLC_('W7PNXFD
MF#5UJ=*8O H"M-.F] &6P#;F"2RV4,D5JNJ:EYY;'6RTA60?+_=YI!I"B0Q(
MW"AN'4.7$FZ.*^PF4T:@BH$Y4"AC8O,TB>9(,"YH;:<UK_J>VGOV2::!>WEI
MU%RFE?HNSEL0[T#BW:)[B9 _]+A;B[9-@2/DW4=O\'8L(*B*<RO9<L/$[X-8
MP +[&/EMOAG1-]AV+8X[\^V_DX^.M'TWF N%</?M^I(!.(9W).1]C-_!4HF>
MZ2VY#]L_< O@JN/0,=OYUG_\\M'R4SB<]+*W_2:,4&8S';6ZE6+<1.MZ_#(E
MIJ&OVL>^B>0>)VP"=UQO]X"Z.8,ML@\XN\=W._I_^&%\ND2KR N@!2,B5,,'
M<^O@:G6>N:I .>1ZY8IOQV0+] (+#LF663EPK0]@*LL"-1-&1Q4,-+D?>:KG
M^D2DG7E,G/<Y]G6RE_N=^:^S4M>FLXRFBPRF4ULFG3[M/%2JA$/'X^8.GTVZ
MG?J@_1;Q>7JWLVLCM0O8R'D%"./!W0<;S8A$$F6NO52F+"KL6%U'- [@X[C0
MS\M.Q$.J1SO;K.=04OE@XY&AD%C%RR-#?AB]:8J>P7)"4@@Y-F\6>W\E4>_P
MJ76/?=@,![EC-;VH9DWA1P/ES\[/K='";^P"$+P&[X!\7C;?V@AA!Y=HY_%;
M+-9LJ0'^/55E'99QG""<^1!J%Y.,W45U?M+'[SQE=6QZ4C9+9U=SJS?2<MY'
MX7=4$([RBE<CGDO%E0JWM5\R,B$T%$_\9=N5D\V]7!=D4BO/MWRAV"^\M0\)
MLH]YOGP2V64^Y.72[GTE)4CYP4AJ.$KIRVL_&1,8:<V91&((K1GN+F)@$/FI
MQCJ;[9&TY@% 7/&!GJK(!#'63.<T#U@V10C0U#I\(I>5&_)%J8'VRESYGW94
M+)X-=#LSJIT)[R=2_AZ7^"^3$2*/>="B WAI:-TC_^+8\[;(?Q$MF!#/_Q7O
M"/T$^Y#N(8*\^"KPJJR/R?A4RJ'W%@GG]\;X*IUX6AO(H/X&/G*STF*AJZ4K
M]W.P$'X-1<]K:H<E@'/KXL&4^BJ  3@J3DMB9R_&'+2Y$PEANS\FFYYP[Q8%
M..\R70?=@H*5KE%;]'^\'?M_S(U#[7=;FZ0SALH?9'E&U46W%Z?>\["79O-:
MOB%3"73/9VVU!Q*,"44_)!,(-;?FBA*/+I]\XOUA=9AIOVZ^>H">5?YE4'VX
MCSZGS!,!5%6#;2QUDAIE3 ]X$)1^*77%V7 ^Q[L.<ZMWP-EY0 )(K-L4V<.=
MQE.S!U(OO FA_%[T.%@\%(\+ZQJ?N/PCP[_K41?4SN[[KMD&Y2XOZM@V,R2'
MUM4OSE>5P0@%D<0P4GKS+I5>"Y]]H"0MQ] 546<[QX*12^>0Q74%2[I%_(+S
M8$HV(<#9'>^'&N\-++ N'<&96?1[4 )\(&RUHWMO>-R(A+Z<^A__N!CNV2<#
M2_RD@+X%VOQVB.#\VRZ78<Z-&XI+S7<C#9^6A,W^O&"7J%%+J,ZRK@K_,/;Z
M=$[V(MW0PHLY.R4,><=\Q(LN/QCT<PO7??"T=.W<8,,SN5@9D$D#22ZZ^Z26
M!\(<R<F8R\WT%ME\>E]&<,'+\/C-9EEPWH[*,L$6US#]X&A)Q ^_^:%E.I4X
M'%6QEC:=N(2&66R1BF>HSF)?2TLY2Z=GEM;!M:4$PR^=S-\(C ETA3*.#OLN
MQ._NHO,R"VK)N(\GNF];- 4,!L[RXSB&=RD%A>F#07DX)"Q56I!&:505/-65
MB,G4CIJ^11$PX): :IY6[NSQG-_*G M?&)75UKW[@\+Y?T*>]]]\M,LQQTL<
M.QYT,*"RYG%=+9TC5L</4D+7.<<?/*=6EQG58GD;8S^0R2GIM8*L<%(K;'5Y
M*]\0VLB/UBJ*H!Q[ >7?+#7*UD%@N8E71AHLF[8NI>6S-;1;9!>UU<DR;FSZ
M"" ,.I.:??RB%0;+VHB(/=6C.!LJ@WA/4(R-:.6EZ.JZ&(<&I$4W2F#=?J]D
M.__&XZ$(P/,4HYYH-N8)A5#T]^9D1^.6NY=@N0[9'VY)#2:;A:V"-CCJA:#^
MQ(;D^U$%4!686*@,*/:*N=W$OE02?_9$@(Z8G25O7PS6>N-T#M/:Z]&IDW^8
M#PFN6PX$5F?ELG,@)T75*1Z&;/]28^ W&$EY*_:[1OGB)DH:<&>T P024AR%
MX\];H:S-\OMN5O65[UE1Y6EX5P;^,Z<SB6S6VE_*RWWG<[@V?QM+<J$Z%5=;
M%>"'&WE"4G.\F.9!]^5TPUK&!SE/00U<%'>2$"!0),!S> &IJQ&3(6[+XV4F
M2::6J^+<$-*.2DF?9(4]5OZ66$\..:3//E0J6A)+_"?($P&"C:A]K-$#S:'I
M0>@*\@$=<+IQ%M_Z=#.91X%G,E_45175AN?0OAYTU:LQ=/HROJI 6 &)L_J'
M:Q?TED^+E;9G8DS2Y<('XV738_.7"TM-[QU$*.)2/Z0N\-R%JG4#C"H>Y+[L
M0C]?5Y_#G<24&8J45L7K\B'8)7IZ(D@[QM:UFEWGJ="$*="(N84Q;$"#<I Q
M*I([XN\]IVS=BV4,B[P]8G!C0;D&.9V$X=HL&X+ <*%%D)WNN_<:,(X.BZ#M
MO09\+K!^__$UH"G-Z8AK0_+C^A1"U\M&BGV43L_46N=QZDLJ;_=D3W]"#]DJ
M<G;=3KF')MW^#^6M0W+F*'9'Q0\J5@R2^5:'V[D16WK/QF(1Q18U4'%BF8)]
M:C][[HYF\^8#W617O<]Z]$Q*<(TO=7"XTQ5E\0LV@_QW=N4W(HU;XNP<+V30
M.OS0ULCY'@0\W+-9-K)2"L->0V6?X ZON'=+T6V'L@WNQK4G:_LKV,*J*S[R
MTM!0%+$"PC+3S78>2#AE7/K%$EWBQ5(%"V8E6$<11^R8/_,2S>\\O&'2Z09#
M0.C#D7'YX!V5L*!UA0*Y?+:FA#!?/%]<+AYBG'SDU>GX*4T+NS R[IO<>:"S
MTZ<EOKV1G+I )BZ*Q8%MMD++LE)+5F4"3/ZX$E[7TGD*1YNKBKXX%(>9#X$C
MHM#"PO*#,1I=)]P'BR K,-W4U+1,H5XK]A,KUN@>Q(+HR#;+=R%6UNRM0CG-
MZ?#)=8==B+5OA5_>)0 Q7_0O;TX>3@S)GZO515-9B,[JX*0S6,)A#Y3P91]"
MG W*):#():TB$1L:9,ZA!QE<C]$[5"@(^*!=:BKS0F;!=U3.!.+!6[5.K06#
M:4JR8F3IEXH,O9E$ZO!8*RWDEW^@F\Q0)RE)#I6SLXXD1E/,_I#QW01YGI>5
M6&SFU&]5K1/RY3RUR@\S&?*9TY^#4F T =7*ONJ-P_'XOLS- "X1=^X=!Z5K
M5;>!31 %$RZ2JRZ3?IEK+U_>_U-A24FBQZ">-V42RNDU$!F1_%;HU=KQ<,=T
MWF67?T2 MSEI3<R%M0''OKN=\NT4BQ_[QL* 5IUN,19/F$,W&]CC8^-;%K--
MCR[+?)E])B@OYJM:C"#U9:= N>DCV3CL]3F"LJ%;ZB<;&I7YUC:$RZ])-3+A
MP-LC]G @<.K<R-H'*._6+N(.T0T7$A%J 1<;=A'WL]X&(%!NZ/MO2#7\:V?!
M_Y@6X1@+90%SE@**89Z+MB%T$MLIBQD'/S5+T!B9!!A>'Y(C0CZ!";D7/O7&
M?W[@"&)_#<.^_VSU<I]WM+<W*@&\:C6*L)Y,]OR5MUC#2AY'R ;@L T ?A"W
MAB!60;G].0IV<)&([;=+*_S0CYN!B,V6Z8:I3",[#'7W9YH;GRVHKQHI9+-.
M"$]<?/@@MC#BV]_<VL,$A*@.S"XF>(1&6]PGS>YB@@6JU<C*U5,]I;2N74R@
M#V\VV,4$N0%T#".6[;N (619_X8)2)X'=C'!G/3:^5MC"HYA&;FP(,/3- _W
MR+] FEI(R@5^Q 0,2E!-WY*Q*CQT-SE3RYT9=_A<T-S[/Q03_.\HIRD5])LF
M'1Q<:4M[0WL3M7]L)=%5#1F#,/]J1BJ-5P['%YYM&.IW4>6/T1_W!O*\37##
MKIH:,CK3R1XEI3_5^S&S=]+J576$H"LA!* EN]ZGWN0^M-P?]<(E2M5VA.TV
M)/4?2C@; *NL",.O&>3DR_JSB*9JX9[3IJJV0B=;!L)PIJPP;0COI?:^X$+1
M#<OFWQP[>.]ML:Z9ISCR!:_1FW%1RWO1]"RDWS?JB)7F4<@Y+,#*,"GP*R^F
M.LC"DD)>]M".H5MX?]B%+,9Z$KY=S$!<O6%W1(4AIE6@M$9V#S[BY!\2!D&'
M=7PRH<.'CQA1^]H$5G:!MMCQYO/76E<O4IYUPYV*SS2?/97>]H>%]O]SI=9_
MU?0R>WHZ2MN5Z)@N.!Q^D*II9?5GUF<='>U'O4W83'.RU\=*Z;"W=\Q>I=1^
MF?ER@YX-B'C2D]X802E(']$/"PN+3=U%5(7E?TJ5%B;! X)9X&Y&56QJMCNS
M[T\S2V?1(9%1>DZJ%+Y]C0@W@M:1W[E,D*,FYJ.@.RH:39O!MA\T\[;@T,:Q
M=V9Z_O>+^%?.-XZZP"V0R)B31QGJWJ]I]-5+J^G+^R9FWVT$Y'0U]+&!Y5CP
M(A#;AFU1DDMGG_/..)8\:??\<I8LTBSQ;A]B'5<>FHU*BNFP'),6I]^@Y'**
M##Y+@%9ST_K-BWW=G.G.8,2)E6ZA[84=%0Q^*$CSQTU7'4%GELZC,:M'6T%/
MJGJX=H?W$SYH![)6V[\*JY,>^]).TZZX2VIB:49'Q/AH2.:.SU9X1LRDE]W*
M+\U>"48/[JA,2.R[)(Y6F5T.EA2=/).V\0XG2"$]HC 1EJ'K87@J;"5ST!;<
M1,;+HQSL?)-7(^<:5V;F6P[1^&5JYET!892R 4;8B-*;2&L%0/@^ 'T(R?"5
MEAU/HJ/4%O,>E%(*6V$.GQ"#/9#:Q[)JAQK0QQ. 3WQ#AG@3D5IBNZS$!X^1
MN#(BW[8=>MX-9'%5&S@L1 +;--_+5V/$VO$OENU,EYSZKC68Y>);VB'%0K%'
MW$9(\?3[0DZU[FU&96P&6)%%&9O"I2X>/DVF+!U&**;U+2@1N>H<#C!;KXU4
M?BJ*\RPA#-JCBB=.E@KX+8YF#L/C#J4\&UM ;?R9#<V$,>H)L3$A_9?IXB]C
MUHQ7I1_H.CB6]ATO;21]/=UHNLQZRG3#]WF;7D/<I-DB3>_!=!P["-#F0=%I
M!SN]4EZOXX?APA!F9HZ[']/*WCLE5@>R)Y!:'A2.;A$L0P<H6NL GMCR+PV#
M]N+\GN39G?OW,_M_V\TLLL23+WS05+A=)@Y^O?!@<=*06"0*FH>RHH?6XSB*
MJ^N%IB%&&>WU,XUO)ESHO;1$U<!^D%Y-#LV&;I??V.;:KGCT?.FP<>9LG,4*
MA(]X+FGHI1"KKT K12>XCZE/137^*R/F[Z*U0>K]TWL5EJC6+KV?^[,*C85I
M*\&FND7=VQ'.ZS^?*553[M_(B7W;$!#1D5*ME'1H]CO'!\\-(3GH.-9E- :-
M/47A5?0]C?3US=?F+[NC9J)DYWCL@]==U8%7!U#.6>OK3H[:=KV-N9D"9<G^
MKQU+2N+FY'4#/N0ZST-O(^/D=;$B8(J&<3 ""U[&9%PDSK5GR'94\M(HDY\'
M96&V- [FJCJJJA+/8P>0JM79+G"SNH'!QEI(@JND8"&B?A>AJ0ETUYXQUE,C
M*8X5W.?X>]E%X.V]$ETCQ97#62VV7B#LE>CZ/'J.+GL[5@9*3^S!M)B)XN"/
M);HN+.ACA:[-K3MIKT G:3%UK"GQ@]<)'8!B"R?@!]Z;T+T"W3WSA)JRO!ZG
M0@X(JU%.L'B&:TWP.L1RE.J.)WX_#@$F0'-;/5M>S (^%C#!YTM!^?.&Z"!5
M\/3' J;N/HN<UKPK'PN8\VIN(:HLQK7$RB,;HG<[*M-F_8L8=" S(@IM'WF:
M4>W8"Z/167XC8Z9: ;?ZLYZD%C;-T;.K=JFA"PY<722K[EP]S0,L93%RH_P*
MBZ?8%K'9'E5 !M$OVYTA"C+HQ=E? V6]%LA6-[0I@'6F4?H;?]Y-9*$]:F 7
MRV<Y*KX\$[%4%V5*R.-*!B5<\,UTOX7:M&\(Z37S93:"QU'C"*661X^BN#5$
M0Z0N=AN2%_'SZP; E+IN#X1_6H9/*&#7+.";!4OIBIZ\QD!R85I:YD<%8<->
M@.&K4/R115S(C_^!'/^? ]RBIY06W/-:2<U)Q<<C'EO>"01C;,9;VV/]Z.9_
M'<YF*4L&\].*6B//G+DY)Q-H_ICLEMY,2#=NKFW]I<+6IBH=_]VFF12;:# E
M>D$IAG4T3%+B%Y<M"PI%X^(&2;0S3#VK@!;@8N 1^LBOL*F;&W&OOX-LV9'2
M-4TWLRBS^VPS,;! E,-/S?X3N<I@ 58WL-J$:#_^>PO4H05%UW"DE1[R[)=
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M:,]F:CL?5NS)YIY)6.)/4 >0&V X*:(X(H\7GQ [ <D0BZOKJTV$)]Q7W2U
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MG)-QNDYQAK(I?!USJ*<3N&R2W]S_)_%L;6LXH>"7Z80I#FY+N_PKAP9XF+A
M\'^Q]J913699VS#575UVM0I%(8,R=6$)I4Q&YC%/ER@J4RL%" %2$@$QA C(
M$#)0I:5,0DI0I@"I8@@R)(B0A"FAE"$B! H""200A  AA"2$*4 @?-K=S_OG
M>_KYOG>MWNO\REIGY:R=?>]]7>?.M;=+1J1V%A879TX=(3R=F,A 2,\V^M(
M6/M@6H2IB75<YO@TYV?#+8;W;%XNY5#MV.5NR,")[BI&2.0R]G/.%:+$YE2:
MD&!ZA-#5(*]ZBTRM7>;OK82/YU]!5'C'%="A)4-;ST^,#I%9SSF6%[2%:QO7
M=8W=KL^ +IZQ3>P+93$,Y.^^2BGZV,,=F1\S:Z!AV1=H=H4NA.)TS'T[D">)
M?DGYIBB3&*3'R.,.,MB2Y];S&Q<ZM$H%W>&P"@S%P?N#0_=Y&U";8_N_A>G]
MN\@ZYC5K:/8KPIA5CAU%_XK%G?EU^W%#P?BV'NSK!P:Y9-H^*A%:U!,ZS0OG
M346_=/KS'/UE&^ED#)5&S?;+;RI:%%JL^FX)N]IE1BYT).1KB#"5-F$SC_-@
M6MKAH4;7V%#[OL*"6 14IW'64!(&"0NK/3H$;U,'P9GQE&Q9\E3$%F?4QJB4
M:Q(11<F%WF';-0Y!YQ</U98R,@]*YC1^YG&PM%^/-.2SX>=H;/N;M[)G]>G+
MB*,-'4EN,JU/':;.P2RV]8_&04GLNL72-RM91%,A^X&OXZ9X80071A;"BSJ-
MS[M$<&%46Q'S<524,FS"')Q.'K )20)IUU[I"B0/7B6$>%Y:::X8E>:Y=*5:
MN,KTG2$#I\(K2ACY)LYR[OW<J!9WK>I+55Z>/_4$\*[F?RQR?WC#?VW$"P9^
M@USI&9#^SIDK8&!^'+F.Q%*&!#N=+R5&L\W9_ WPA(08%S//%O^Q9B)1'6)I
MAR$:, V?%YT?O#2]#@H:873W/N8-JO<,+&)CXTQ=>X1K/G!'&0M69!Q3NLB$
M>I)#._-PL+5 YVA"8I2X<9X16FH^?*AV'K M_#QN6I#@-RO9LBUI%#G>\VV&
M#C&>@$P+\I[.S3G0F^T:0PZRO_SVK_]+2OF_LT_J,.C;"7K83_?'!R/@30"$
M-S@+XWD[OMTB:8@=?"SYV\':%'.<BUA_\.Y\6VM7:UMVB4FA<QW)633_<<Z[
MXR(%]1-/HL"D)8>S4JY%<A>EPR9%-6*=&E'<1;@.L0$ N/L!<DQ\(",E6;DG
M/6]#".&;\X#(1I!VNT^CMS=42PMO\'^ZD(4VAA,*O_O7R8XZHHG<6C8"N6"T
ML:7"+\ER-^[B'QU8CVSA*]#EORRJNL48 KYVWV%#@[5).W4 ;]BEI[E9%UX;
MVOO[+CAQ41>^AI&!RU(,HL4K>[.X5>K-/>?[<O$NFQ9VG35**%QA-_/F/9-&
MN3S#(K^5LHSPCCTWOL%SEH]KDJ)4W)3A5YFTUI6/_7WR/^;K?YKV V5-$NK1
M;#;&*:Z9&>UK#E[_4A#4125=W7GK]?.TLR!V$&)*R<:E$1M:'O \.PEI#879
M(M*5U,KLG7HZI 5?*7O&F]\(:ML!75(EM4EV1H(S\S()LXB'AO,L4G-,^;!3
MXZ4H4Y,]9I2)Y6EW?:IM4R)\.U%+!G^9T[O72@@)3))S@LN>LWHFG(=2H9XU
M,Z;_?5_A;'S0R3/U<Y+\.#$YN/=K/<=GU6J.O=9U24.3<_F"&/4.MLZ*!QML
M,'NGEY(;.MJ:\!FNGDS;0[6("J,TS,]T%UCS3OFB@Z,)6KJ!%6S<9B=ET9);
M>?WXKY%=>@*_HN"M7S+P^JA45/_T H$6?.][6K<]H,_5W2_JN4KZJLS6).:W
M_Y"3/_MD'=[O6[:NJ+6O>")S"S'$7YF:F[]FCBV6M'#I:5RGNMZX4YCP%]$%
M?R)_7UU13R3%$#K.5;;_M<*)&%7Q>:+,8G](9OQ-)P,Z:XCM*&]R()>;FH$B
MF-DLHPUX&Z/Q<NC)"!/KJQ_"FBBZ&UEC';Y!1>842N) NC8]D67(H<1=,BU:
M7)>VDW2#F\I8"FG1R>8Z32F?*&\BCDL$G6$!Y/DF!U(V,\K*8D])2]J/9(8,
M^YZ]71@:=20QS]VL]M+LU\U5I?6,L*M##J@^MT"MF;Y/)QC+B7.<^8+!V<QP
MG>:^2 *#_G(N)VYGB-I$K^[U %OQH_W*)!&LZLCJ),A*=31!/_QYZ_JJ\84V
M*^44@TG40]3?,+/BL@SCUWG&57P(9_/Z*<X'F-@"T-(379C\X0/?/K%VE*<_
M +]7SK4 WWS?;;O7K8O0UA])D>HX'45KW&PE^.7.5)R[<FL>-G*O_M2Y>9[F
MK2#FT(0G<YH=2 Y*,4C=V)B'#H(S^#HI84R\$#U26+ 1YP"_Z_N!CVW#4DM8
M<"K'MVL7XEM,;2>@FO6(/RH8Q33:9*?3P-M9_KH]MEDB'_+U&JF'J>#&@\@T
MLBB'=VW$ Z[>Y2SR.Y+F_\F8V^D?]H$:V-T$?7OFSP0^K.5E\@!Q+N-LF]3I
MRJT,^;'^BZ.$TF\(I9:-Q!=Y7*XC<3[/&;6!Z!%JI.W.\MN5/%J+DKGD!U$_
M!=6S+S:)BJ'RQJ+2 *S@DI(2NA?SU6WR>CB[V' &S1E**0)@(,7=@:#4&T^;
M+I^#SF$-TAJ,U[E)9 +,QO+%W?[_91(EH#LRQ>SOF_VF%H=J][:;0%ON?X'C
M1YG)@1N-=]I*T"ZXHV?=+/)&G_4%#XCXD;"(ACDP\/.XB%K\Q%5/@P4T>6IF
MAH]LGTQ.UQY(Z%S9BU_=GJ(&GP[ACA+/W]C.A7KQ1K=:6_?,G9,-TK7>K>^B
M&=J4Z;@6S^5X"-TKS11](L>OL@58HN5>YV&6AGY#Y\TXA4T\IM+B9K;*J(_/
MM;\4T:R69"<O]3&[4G1&KY)E#FF7FQ./V_IXV@Q DM#?&>R/)WK:,$)=O4C]
M>^[TTYW]Y)&!V.10]7XV'O[S=!^\VKMWZ'M>4&*IV<V*XD'OZ_"C'GV6NN6U
M;W:UEXY8:J+[#5PL;-S+=DW,KI2;33).6AO?L-3FO$D:B_C[QDSW?08L$D-B
M,.!ZFVZFQA,]L.9DZ439JL5/HQRY((=K1_1UI[_LY7OZ@%_D=3V^9F1>FUV_
M*Q(6L_[X"I-3P>)N1F]HM%.5O!V?EZOG([@WS)2SZ(J4Y('@K:&('IC9%1$^
MAMR6_IAOK5,D;#?8K>5XGR!]LS_<J9QJ1=\DFBVPQC*LE(H?%"?7SYDW8B0+
MJEVBN @<H)U6Z^\5/>YX%:"@%-D[I**>E2-@34N44+<)XD+K(+RHZ^UU,^WX
M#13FFGMPQF3ZG\'J]# N+D^78J]?<9EF(U/(8:HK-!@HZ,SIE-BVM05B0S!Q
M#=('J'U<R@MK>H,(F'0]UK>-2CZ&RV3Q1DC(#]5/!XNT)UIJ:5:/D5D3HG)(
M^NFG;R/7=:=BR5M+_F>?=;6_77@5K%_2E'#2X-'JQ#0?# X/Y5CVS2S.])*O
M6KP*"$@("K(+&''=&#FK3^5)MG%I,/MG!$O2N<!G->;:-6=O9A*A-S.SV<V:
MVHT>'^W.I)Z<I6V>HQW1UJ"IJ7G*PR/5P\/SIX\KS;A?"?RO?Q_4QSN6X9_L
M#Z\GY!REY\H;*-0A(]^[EHU4/3O0D''X8'Q8O_UL\;E5=-6:C_K)ROWPSV\3
MO'/M+L$"_#E]YZ]__6S%5[DA'FBRD!3HHE*LM5[.1N3"J&5;@YV98QM-0VM(
MYGBOLC/0]/Q0B%Q/ .*2RT X&69,,D5&5%R$/K2#!#,<<B)95\O1$\ZO,(\C
M;&N?* $"@-;Y&?WM=X@F.L;P9VG%;R+5PY[I S.. *C5+7$[5-,78S3=.*JJ
M\?F64;A['GM]!3@.,T@KHF#PQOSUT91>H Q;W3,0=X0/4UICEYPDBVD=UJ-A
M>>P]Y-NFJ40FU6Z%'./N8GT,X5R[^JS,QW]HWR/Y\6"#L>;#%/K@*9'S90/_
M+2XRB/,U%!!\X/F&PA%7WBWF_Z2,1IF(WQ+A+IWW)'XF-O$'UNS@T,7NNT0=
MX5@KA2 <_4VD&Q!7V!WP,P'AN+,ZMG<OR" 4!<UK7\HHW]U\OCLU;4\Q&IB2
MA]%>59!PEX'XN"H0J#:TLW2?/V,KPJI\.[B6<&+KC=(JW,YCF>$^TQ$%@CTV
M-C0UE[WR?"*2W,:F.%]^NO<,ZCQ2&6$"2?-\/:NQ?V_/J<.KGX\7KQ*Q YM*
M=[.K/=/262[=J&@<'@Q%/5Y$B!+E2]B0O>Z/@WJP&7:)(^<5M"[9!G(HKB.%
MFI!H\)B])\XP%9Y)YKN7V[<MX=+$8E'?J?ZG[IK'KW_(F$F)>PS V[@- =['
M,G\4JRP6 _* [8'C=I!3G]2JYM+7/A?J[N-WK55]BD#^#DJ%41H?JCFLS<H,
M6\ZM^@FZC^]P8I0"_>?B\?IW_XJZ^S]N?ZG*&CG1+6,=JGV)[MTHD"\>0#L;
M5$.':HGRY3\)HS?*!P[51@_5TK[W_LM7=OX@96W/B#8J9VM19FWDG-ZR;K.7
MKOP;>3E$HN+!11AM/\7CN4V Q'$V\)AA]9<';@OA9#+MBZL;%QEO)P^*A$=*
M,6&;G&9E1K' ?HNS>M,AN.[!QW'GW=^]IQ<4G6G@Y,TX=/$[PM-*CFC.H =_
MBS&P/U1+H3",?R5X73(3TQRWEO'Z(9"0X0(;@&#^\?"6,@:EL1HB?67H5B%I
M,KJ0U',B\&:C#C/H]AWVUBC<(& Z=-[%6)[+E<80L!,-V<E7(/-UYO.EJ;4+
M!*><R=FKGA4SG2$29?<1K6F7.R4XL)5QB33*-"K"O"!:NCV1F27*34XN-S&-
MBJZ'41S!F;Y;DQZ0Q1CRK(#3SZ[M&'!WSZ18E<6O8VILYHS<RV\).NF3Z>=M
MFQKI(BN>2+76!]H_5//##@84K\"XAVI*U[[-'139Y9]CH^1@8K/G^L2(0?Q&
MO+R^Y,<IX%7J,U?.9?7M>42>1A+,C@Y,Z>8%+7),@8EM^#I6:SDD['ZY23)5
M0Z[+[62>'8*E(%T+1*6;0H8Q[N[F[4.U@A.':O'J:(5$L"1[$A\6GI+R9*:N
M]I8%ID%L/QBK(4S.@6T&%CD=Q8,P8V93MFT'%N@G"H-]^*&:Q1=7S8Q/G2;5
M1QG?VO]VUVP)UI#Q"HG+YL/A+-:#A/W9I+B&P.<L:/L3ERSV-A%X8T\<V!UV
M)XN[;X9)3HGW]L]82)Y*!/F<M5\><![R0.=\[6]&B'"GL@!&)8]+J*<M_Q<\
MB6$K='52O@CC^MD1)QI'0T&AO,%071W%%T'>+T<^'0WP_IEY[)D\P,Y_1-L_
MR""1 =05F+HBFGDZ(7W-(::6P9D?D.)81 3JHS;7[,VM?3(TC0G3M/OP&5K+
M^.MJ_U]I/+=>5$+E&T83JG+5(H]VR\Z 5;?MO:.:Y)QKWGL2J]!#@GP9KZ;B
M7CKRZN.?>:[U,6_9GO "VJ]?#-T("DV5=?\TDH$'P J ]Y*[C;$_#Q@WK,XK
M#69"PD^?(;903BW2TI8P(Z'D5G;%.I7D[/%]Z.SS@XP19A-=<"_(K4HLAS[>
M$P%T2OIL<[RA352=K#':=<#-S.*X7&5U)^>3G627MU@#Y]E7L8(]+W-:3L.V
M@2)HU0!T?<=#:ZD)<'+/1?=/I4-I?^>/G"%3'4%>)<+LS-V6O'.TF^FSQI>$
M$/C!DF!P6+#0-LV:N#O'G^^C]4UL7WV2-)"S5!(O8,>SK5.G%VJ@2-!LB)Q5
MC\ _ENH" WV/_#P-DPD WA.DNV*)=Z E..DN1QQABEZL-(E*6T*9.OSJ/F\=
M%S>7S1Y)YBI&C)*=Z(7\+GBL**7HIM>31\F%K#"5/G5KH9.N8^&J>V/P1% P
MYM[68*_KQ'< U*;_=ZZRD:J1>?,6"6K:BG5KVO5^DE]X3WS(0O8EHK:8)Q7
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M6IMS1L<Q5EV'/:B=TU)Y]5Q#YB_9V8Y+),0."K$8UM5M,Z@X8H8K%5)!Y0I
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M];N&1615M<#9X=/(!W58IDL@L#=G;D5;LF(_B5#T/)]M]]_"G+,J*>76YS;
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M;%E0]%A;T-;F0KWO9F'&IEOO&\W.ZD.Q6OC6LJU514<*OHDA3^%W^N_U36K
M<57;=[MYY\!*7O@[I:.4'>VZ==80ETUDGG)>&#[QSN5J)^!0K#9C89BON6(R
M)#%L;/FV,'Y7C4VP[TBI$JUFT"SF)QG<%\,=-2EQ_HV]2=92%ML593?%6[F0
M4'/ZM8M\Q0V3OW?2@N&6*U UJP>[74,D*/+0T[//X^[*3CRC$%\% W[*/#H5
M^!&NNC$:UG&>G,/*)$0?;SN ]$7"S6#EW>?!.T]K:PFUM<(:0V%-]CC_&,]Q
M!^%+?QA+5B5/CH7 2HP!91*8F5G8PA3" "34\UE-'WSAZ.@8YML+SSDS*/EE
M>1M+\8MD%>DF <(5D[F"QE2_EJ3<G3+?!-"-L*.Q+9__%S'UQ<DQT#O>-.\K
MI:8R9J8@W"F=NG.!/&&UY-Y]5VS&\5P5UBDT12%3B['G$JU?;F\,>WGZ,0/-
M-YQ.L0UT=$$R<A^DAUV@C)88BV>JX]R#'BU'W5*8'[R;@B8@]DV<9+?<&]E!
M<)- M:-#Z*+Q4C4B?STQ;##0W<07%1CX%)8*L,"MM>Z$WEAS.W)#22AW7N([
M8_C4KV("[WJ[K[M;ZGS5LZ35U'+MC,[Q^\U4X1ZADWT%<4&4$S;CFCCYS&2-
M?GI?)4*4$^P(DLK_#FP7V*[&GD&L=Q'B67KZ8GVCG',XS[K1C2Y6?4(T%6B)
M.RM-NL),HO6F?$!FE>K34!U=R5E&=:FX$O5$[A#&I4$?HZW];&#3BOO3\M2[
M=]X!4K6CK[K2QN'Z%>MUA(')];/N427S!!.RVI;O(@8Y4@9#9G];CTG":-])
MJC<;C;.WTB9J]KA=%5'W<AW2(Y=(;O;=..RR!+3&8+1P&?J115F]6Z&\I)E1
MM!C;_#7AJ!=R#+D))2!JVKM!BHUG)1[!21J?J:J'96GZRL-,;/F KL(BMKCF
M5.%"/=N%%1(@3^SOUMY-HHUFS_-R%ZE59+EM1.1%L5(5REP_]Z6]YH,NHK!Y
MO#2&!+%#HZ^K,4I*L@:JVSH('%LAH6-^AJ +B$?G"D\4:F1,RFA6OZQ/V,HK
MK*#U$PLNK(V36&W781.OECP#)Q-6ZXN T9LL_7MU-@'O16BN8B04W3X%]0_F
MS5)F[,V66 R+>F?/ULQ>1YC)R9-7QM^4_:>S#Q^"E6_V5=ZKC@!V'-8#E5F2
M!LKJSJY2ZK"'F.[FV85XCN-HR1IK!(:LW\J07>/Y[)_'+7RX=%&I6GXIA5^]
M=T&1(3(0#,K9<1!ET9Y(\.O1$;K(+F]?I7)O\^?"4W\+__$_.?$'&8G0'^6'
M*CSW.NNJ.WY3X;G[N6^L<=;O*CP6D#ZOTZ%KY-]4>'8(-G^I/53AB6;V^2$'
MKRP'*%=R^B9W-YIW<L 9D\/$$KB5#6DC;%_EZ%1 4WSA:F&KFUO\P69WRZQ$
M&.]7+DN?DL2V6[#]? #8P.&%0O9BKUA56_5]^BV%(@[3WIEJ6#=L<)</1(\+
MY769IO[N'0'^]XQ-3W/\>L*V\W\:1T9N>[]:]7<]U<R9L>YA SY?<S=SVF![
MWA&_VON!GDZ@$Z]N0"EIC]9&&5H:2@KLZ26U>FXELK6,Y#)@D>5%IF^D-WJU
MN(9Y9U>_0:_Q)^_V614]0DC77H3A-)TJ++*CJ8"XR :+=*)26+S=N_!)U J
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M;?B*=;E0HOWQ:*1&8@?W.O4)&N!+%XX9X/E%#PNOR1*49![?'N?$%'GW3/"
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MQ^<#TTC_(Q#1>:7B4O0=A*^+/S+5!>G''* ?][V=$A6/RIKMSKR]205D,M=
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MV4!5(+52IBBK67>L():KBM4K6-H AN;H<!PXD,TY:J4-KK+)Q$**EO(7?:%
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M1GWR#]4U'X?^:[SYG^"F.T$2.EA"H6]M;GJ;&<;\(K+KIAQ5)"*08!M'7/L
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M_/^%U15/GOEK@20-PE([+4OI<IZ$,^)=?,D\* 3A,I3JU]][K06"//?H)7\
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M.M[?:?<7GB'85/@WGYBSYAJ%RG@A>4;UWQG\^"^)_-_:!_K")3T4>)PA8,1
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M,X7Y#.ZV6HDXMC-W_O*+;T<?<U!+$<&"R<!Q>52\?'6#=3M6L-1V+K^<X&6
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M.&K4\(9WP8IM,\G0:O!OEB0']*)[G6VK\W:\FDV<S6](S *DBYX/-TLF2F&
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M@X-;(KZ>(7&*/]BX8$T.ZPAU X;HP#V^)\8N%B\7_SDB"7_W=V[607*CM<A
M%V'!3(IJ6>HO7*&UYCSX]GQA_]B([*PQ)+*3]#-YUAC27I<+(ZGQ7X7"($ B
MW=Q7CDB*F,_]9@:=3-\.DSD2VF9"NV0D:?-!9FK@4QU#B'=>2R\*DN33($@9
MSCXC]E_P'8PL4!.8FB_PY\\ ZXK+*J*:P-G 6ZB3Q:CHJS/%.4BM*:BIXC3=
M8O-ZUN,C'U6XZK^*#;G*9TI8P>9PL#UX;<.PX%C!SV&-2$1I<%,?_WP=Y?:^
M=W\+@0S"7K1U8E#7S^H6HE#]O]:*M>*54,2R9.\]A4-G7_80N- V3R,;,"AF
MEG*WVY!V%SU2F%%NJ.2WZNJ:8-=A.L<.KYW_?)5/2<"&7RXW]&/H7]EO*(<^
MRMM99#=X,Y<X)=/\[-:,6O26!?WEPN9;Z$;7#*>LOZV(^'IVXV&V &3 .36S
M_K:GB)%V,B4XG>JHG SF,2H/#$7*TQ]-2+=3>BYPH? H (363!C>'U UNS4%
M)D'55EETYB@8I?PL$I^ EP-!2VKRQ^,-^5T+S6X"E9R8$I3#5FWH;$EB^-W9
M[W[38^+843EL/6V%0#DZES^_$)G$)E@S(X>9P_/3HQZ-,^N3-]ANWX]<^K"B
M,>$W9TZMQZ&#_E1:/%U8W_$,D[ 1C0&^WP_H\T]M*1/TYJ 4ET><FQ1-V^B3
MS0\D#T;=ZV/]2[J,_==\0-ZZOJM=1P4SNSOKU%-]?1!D/]708+H9;X9WZ(.H
M#05?R6"8%Z]V=0)?-/P73X[[O^.0\9Y"#%?KN22=VG-FJUD[O?1P/6W<ATU*
M!P_%:_A2JN(<+L#\YRJT%GGHQ9[^]TW1V[R+1>\*Z\-:\L\:\._.;B3%;("D
M!SGAB5^P VD=PP&3=9PM(=Z;85T7W5;"XN.N4AC!ABT(4;F!4@ 6&W(VHA$R
M&!6'0+5>%+F<F9%7PD^L>*21I"H=8HN,5;?:[B2PEDIFQM@M[:;=D=\XGCS\
M7*YO2PML8MCVU&_9E^UXC?L'WQ947M,P!>W:5D463U4>$Y#A!X:)+W=/9:/X
MM9=GG]6G_+I!/3EA7EO$88_'%T6L(']Z"Y&U/>7);( LUSYYTXCZ]$!U7U_?
M:E!,<7%QI4/?1@>P3OMA(<\2Z#T?7!IU[S89:6MK==8,AP;;958Z]#:F!\$N
M'J7^8A8U^$YDU^R]9&OOQXEMZ/%^RUM\J1ZE,FB?UK$FP2=^%</!V9S2#+8E
M2E_Y4'@.3VE4Y>@YI8X$VSV%R&BYB#4'&7T+EP^Q(^ECH[2B@RXA VI![41P
MDBLXB3&Z=:Y/H.C+WBE,L4&6HJ:<2LM.PG(E/#7_0C3+K#ASM6\K1'\NH^AE
MC.A/'V/?HS#23L\890ZVLQ_:I]OJ@G)(GZ76HR+V%%BIXMQO[8D%NY$)U"UG
M,?%#J@OCW6^=_#X3(O844*3]]+]@/V'=:4_8Q7A42S<?S=A+4Y@[4V_;#_7%
M2W0A&TQ5,?+MQE7]O_S\[U?\7UBK3Y$)]WL:I(J,?^UI7=3S20^#@$T5VLOL
M_\0B7=E3L)H,W]&5U<9;SE?=WOF=)OTPF[;["5#S[]MNU.S'24]6Z))#VSLR
MRBZ,G\JQ>0J1<27<DFT(84>2UW'D+^0_?XS>J5K.NJB^4''K!$0 ##)0#8_.
M&YA=L;S@%RH9EW]CT$DDD8B=& .(BXW+W?I\O]OU:-UG%1&_'A-3$0PE<>&$
M24]P>\V*J)737G/6#RM&N#I"_/M<68R2C*80O; P'5T?L9;-7#<\I)%M6*NC
MH^OW:S'!#$E)R7(&RN7)L2=(>OQL?-[./%<5S@'ML@-?$,1Q%JJ[1?29"Z4'
M7R&1S>]K5L,ZLU$_W[L.FO DFPQ2CN^G(;:IZYUK=^92[\RLS ]6'&NY,&PH
MJ\MB0Z$1$%J!WGDO3$!+H\-.T?G@TP+_#?:H5D9;$'O&X.=[ZD8J:(_AN'')
M$.49HRG$$.;#!(&2=&D?T@Z%1WWX36@LYZL$.?6I5O"&Y!<3MEMLYE+4"+-%
M?MO[W>QF1]U?^H:#*./Q?_3*R'+9"&L;?3GQ!;BP(B3WW/.93KT'YR!H6Z_Y
MHF+%.=@3VUXNO=TGG@(O@3T(K_(HOXV*;L^4%2@7X^;US@V'UT.5:/Y!M.,X
M4TZR>!F"C=^>=74*)+%H;C$T#FB<K$2?YN73<X!A2$65<IVD>N#+!M>/L>A'
MX/Z [&OA%9N&D9[S<OT26Q!0G!QG6/BE>PCA@?^:6^@MXKO5W:B;W83NBL/4
MX4C-RB9G98GFU]N3S@YPB6O,%FHC01BQ'IQ77L>&JX6]^EEH6&C>2.D9SNJ4
MJ;E!?-'R[4[K<+>P+K=:!H-VNSN]GZ(XD1RLO64=V>+6K23DM" 6 (K33 A8
M0*.96@\ME-XW^7T^0-OE2/K DE6R]V>'PRV<3<L&?*<E%^4I%_DS^WE^05?6
MV]<C1\_QT8GHQ<6D;^IR$WDH-$8#RI="*4LK8AG^,0)X0EAP9G[4_WH;Q#^E
M!J)DNG9*.ERD]94W%1W2\<(/6XM45%0;HO(O-=5Y?4C8;1 <[1!\Y6$1&[+%
MN_3.# CU70JXZ(KTW;D41($PDL>GH34=^#X_*2RW;@R;>_4#OFI:TSR:#+R_
M$CX%7.=U(2KS1$AN\$BGYBXO-H4PXK(F,N$:=K6Z.LSB\!4-0PZ<V/8^UWIY
M/H>;/QNOD1N(%/%L5]S;Z-8<&IA!JV;%5IXLEJQV\WZZ]]V_R+;_ =%G9>F+
MG4FIDSV#PJB.7=^XH^\(0A>_%X6B!*,04;*W,4XO_W#VH(OU[*HQ_NR/A>BS
M]2>,=/+53N<7;V":7;4/[=""Q!L1PJ-7]=ELB=<XRZS1U4,S7WXB,XO%@@1V
M0_U*LOT+FX3^PUTA?< 7L[RG*]*L2><Z+=8%ZC.SS>ZZ8\_TD+XSH4P P%01
MDT&[8O'Z=V:'O/84_B /KUA;EO7;3:%W(PL]DC]PVH>7?.)-9D515NP&.J"0
M_5B)P_^FZDP>FAJ!)Z8UO+!+K:^WNU/;>1:#7ESIG \'4T(V>R:GJESA*.C+
M><OBEPR=/*T94TZ<5)EB>M7QI;N-HZY[1D5FUG!8B[_M-'EG3D1RSLHBP]]S
M^$TA9AD?!"44@/)R#MB\7'<4@W9"6^0TC(__B\3_M+ GINA;Q^^%P1K PCY>
MXW1Z,FU=JWK22)B2STJ,3M)RRBFZ07SSBGQM<A9FXNN&VV*58KXI*A9*KETR
MC/$D8\T#Q*.)7!QGO1F^"2$,)))Z$[-3\4U=M;I:BQ7SMF [\QIPP4&#87,,
MG@IAZ(6?[NO<B.+/6YY\$[<.<AWY"DO-U?=;O^_L.*,_JJA2$^YQ)$P*4!)>
M?2[POO+[EGQ-Y9WO"+NYR^L<@<:9N5E+D/%?YG$I>2,T5YGRI.>=OW4^O#VV
M6,CACW$7IM,OL5IP>=+C11>N>-4D2PQ-X(9$K7B2'>'@5)Y$<T!\;XS.2UPZ
MD7@^2+'.V[?,IES/T'I(]#)LP/::B\/M'(CYPD#^@<WI5]0C_(/SYCJAL.X:
MRWWMS=MC;DLRRU,&7%BQ&<6+J"-FV-JFP_Z/_KFXO]]%MMH=/1C]T9UA?#G:
MMUD7U='5_%RNQ2*4$I%#IJ^R&3T1YVHHE\(]5"U4D@/6;C_Q.L+MGVG(.E.4
MB_SB% _U;8\S#$XKW0@?ESQ!NW6D^*2V5: Y>GJ;I-0:/D<55_JA&&<?<M:\
M41[;%;OYQ1LGZ2#1)J&8">ZD9L5DYICW]$B8K\-=1WG!1\Q0F,QO_:,M?ZNT
M_2E+.X(9=-LH?D_!V";()=A%^1%MJ[?YO+B.XK&S\P/+%&0WD(_MO[.8G1V5
M^B7NG:$!"?>,!.$)# TP%1?YN8DON#6F'7$;'4='A5>Y@0PH7Q8?0>9-U&HD
MW!MC4C"D29&)D\$0>!V(S63>N+7QE,O#4+)X.K&#R9VM0Y /6=Y/,M%;R!?=
M7>';Z@Y)3!//^V>^^W?=_N?KJ#H5$7T"/%@I$W8A$ M)T/YXMWYS*>EY"X$R
MX=:G:=,JV"%$&T;??E'/(EPT;$\2=*15BK.SDR!91Q,J.C:O>#P4\>H@R:YQ
MJ?KY8.7!M]M45I-0;>7$_24=G;,\E9+)ONNTI>M2T.UUG>'OYYQ/:<"*R]QG
M:(HJD_+F$R4[086OM%":8?<3/)[I7\&W?<V_L4IJ^?T66@]MF?B*]!>*4F8+
M\>T=DZ+"\:4H2TVHN>B2[@_=Z&R(C;JZ3<29#@*1T%%8/)-E'8&YNCB#3IBO
M2)B63$99R-VZ90@"386I;(C@K&>-/6G<3W[:AQPAOIFE_F$Z.GIA,2GW;]>>
M QF!'.'>>G^OJ+R?_>PG0:B3):O6[V-K&^#/UBC!"ZKQ][A3X"[W%_637-!H
M0)P,K[;^9:^B^:3BH"3_8M3I-GX7N&$MP).J$;T9Y((H>DH9D6F?&IZIYI&)
MG'FJ_U#?<*@1Z';6$.71D&-[">J(5_P;$:1[UE1LH.0_-XSH\ZC5892"[4L:
MV-;.7WW,T_7Y#00C?B?%%@%+5"RE<-S"6]>=#M*J8Y.:YO&XCGPIUBB!:?'E
MCQT=[=VK82V_S Y.T8;@$OMA&$71!:9O-NEXSNXPXB#I5K)SW/H@_"HWAQ?-
MSJ<VNCTS:$$ALWVS?7QQBQ8;\WX+8[OT^SX!<1,I?UV&CVS^[65OODZ<'#$R
ML]4W!$ZS%C0Z4.KT'9/#/;1/M"-,AZ\M&-Y\_QO#\_3UUZL'$,U/;7MF]9Q&
MP!>F-!D R D0^D?\#,=V'M?,;\56&)1$?>C$0-Q,?88=3]]C#WH<YUZ[T=J[
M4Y^-IFZYR;>(QD_+G(O8"(9EV;R^5:M36Z,0IYSMK]<2:(;CV7%&+;K# Z*5
M:W8:0G/W%!239R/E$,BKT&(9>Y@:6.7'G'J?$][K!KP?K-$W1&&,Y-F9@H:^
MD1SY\\<H_)_BDT?;3X67MTPI43)1YNG5/86(W,JEW-[T7)WVCGQ(M[W'X'PC
M%-H$$RU%BHV-C<^'IITXC3X7CNX*Y=>GP++-5]C8)J[6K>7 $E^FN!G0QO+(
M>:9#R.D'>K>SL-@&?P8-XF\ ;@J!5G\0V2 >5X173, 5]Q0$(*)O-WP:P6@S
M!2@!%)5,316MG7-SW8Q]!O^MJ/U!.0*T%H@<%FE/B[+)95;J08A!M\FV$X)&
M+U+$H"XF%CD56-G&:SW![GR/Z^CG"EC(=Y; @>$8YP.QS*%HN$=-4-K&3R+T
M.JR7F1#='8TRYMCV<S4%B92(, Z3[PMS8>B-)LU-7G]'NU+JX&WHEE3UA50W
M/U?_Y6:@J V4/*AG/>0/ 22/BL  0&,?N=6AOZ)DS!SE&OM5XO<^_[*U@_^
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M_MM.#BIY7;>=?,U[>"\K+?F)K&-XFH=L['17N=,#,.8++<>IOGR_+\)N=_4
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MAX& 7FJO<VF@KQ/I$0'M:43X+AV*,X\B-CB?U[C\?[O?_X>VCTI*-U;'%2-
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MV5Q@X/>^3WC_%KN?@\:TC5_O_SDR $^0XVG#*.N+(U_A'8I:R>'0%I(3^3P
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MA!4M!QO9B2!J.4,&@U98 "=>NEBL&7C9@XK_%#M0Q8R;J@[:BW5(;'/+PH
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M#UG<KRKE7Q/\VW+H?X;MI:WDL9O)AZ:='VB/P^"6/>9MJ/)FI,,A\UZX9:*
M!(GN'9M+FKO3R1+'SF>IXWP@4%WS0*'[;#> H_V^A'XXXU%:-<QT%R>3]_;Z
MXV?R)DGEJ1TN+EZI26>"%$/D7O]RZ3QU3;3.X];C3EYCVP-SJ@Z32%J.-?H&
MPJ@\[39NSWJ=Z\P+J,[P-B:A-#_B!?CDW$C!YB_F'1KJ#EM!'0U5_^N+4?:#
M_ID+OC:I7DX3!;;M7;U3\IJ69ZW?YE(P5>".CJK<,Y*J)(FT*4LSF2J$[SAT
M[LDD.IR/[6_W)J_Y/L(*>-5/ QG]>U=25^^POE5OE9;@S_I"HZI=7"ZWFF_]
M,.\Z% P%<8/-7Z==S%O+^'RNJOGG#J'VVDJ()VS-SJHIAV?L^&F<>=#4Z:S9
MY81=(N!4H0^@NVRND8!VV+)?#)GBB(*G^Q3I\Z$5*]2J^>2T\&9'8,66.="_
MSE4/09U7S\8">(S+/V!-0#]T&??%4H+*=M@#,R8!?$]$+RH$P;VRQFG4<[KL
M!3+Y][J<_L>(UU=DS-G9>8]5]Z5](QK2]$@/;<4L]-].K+[.1EL%/\]D;#3T
M@FYN)%IPCU3R)HR)<%>W\T#/(W?=@AZY,A$IH,U+<B&2T(V,BMLRM1X+D^A'
M)),J@X/2/<JUH?4X2;1L/HG8T+A.A$5B!>'GW%_1;R2C3=MIPYB(TXDB*8(;
M?#=P)#6A=(VIAZ@^D9/GX3*0/7KUXY]^->_07[H@!>):NB/-X?)"QI.RE8WT
M4EY;__0ZH_B+L=M658W;54W".'-^/+K';_ZV59J)/+H=8Q*.>6HK/F. SC4H
M[#=E'HH0-CM]N4,FVX670/JE8^%8%Q?OCW<\-SZ[7$R-\K"_C\B'#IN=%+21
MVG#PK0<,SJ<3J0VZ=:[ZR-3'V=PK&*CY#?VKU:X7?!WM-I,87LV:\I_[3_U.
M]'^ VP]+\&PHK#JG4%P,8D8$<Z(0(9--;PR[,($R,U1^CYY8<IG3I^97LHW9
M'1O#86&S!4]K"Z[AVC'T=*_HR>;='Q>Q]("MVI^0<ELJ2+P53$]M]M3C"WNN
MY ]\78I;.YA;^G+!1N8J:9"3C M'7TMQ0EIOLW3>G$L:D]!J',T+C%4>TG.V
M=^.CY^OZ(9/B:4,X#!X!=ZP?4PT<#V0;T]A$AL_S@VL?(5PM5+N-+7H__[D7
M8#'L&72P<H9SM):74YZR"G5B$'VY@S&^V66"@T6S@>7[;<)ST,=+EDH"\J%
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MNQ<5OD(:=5&.GQF973W"M^U4>.ODA;&*1II#^9)";:/D[-+L<@^WS-S113I
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MF^D #U7VTPE QNKLK<S?6PS2R.,_%B=V/BV97:+'6-"O!9Z!\,BLAU"/1WG
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M!+&6"=,-E;0IC5OI-QUF9'1F+R"Y92*N/1T>G% J""L=@UE4E;-N0N'@LOD
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M-J?4K,0V%'0E0[VFZN=?/X\(_QF^J-ZYOWPD\'K\XPFW'V#HAG<A")WJU>+
M"FCR<K&OX[#Y48^P1.$) )SE"#XTIK%JJ %WSN7H5-ZT]>C,7J*K,ANWLN=Y
M"4'BJ0C%?&L;@*CU[D,;PKVF.BZ?TB*XH=O"18G9Z_5]#J[U4&NH2OD$K63
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MCIW62;:.]F?TGG5[0XY8E]^ %XPU;B5]V0T3\*>/'KM?6V$*$P0NU!ZITFP
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M4+033TKF-]@1'OP PK@UK6$(! 4:E#R3-\,/GFCPVQ3$_.TT]D#)651PY/5
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M(/C2H%BKH @%Q]N>G<'#A*C[_-7X207;^;6B/%:ZP^CE& _&=DQHX]3LAJZ
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MS A-[#CES[QH4Z3.=86FLV*:5+U:HV_X0%T:TI:&7T 0/];E 8JQ0)(P"U"
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MI&WM +9"I\N/BAL23=\;],^US/)MU#_MEW@G]Z_$D?WA"H_5Y"D*X<%N\;"
M<*=A%'$?A/^!)Q$69,/ #W;0T!P2.T[3IGDR<)PO;4U]W7^;0*@I1\UDO>(D
M=^OXK+)=;JPS5ZF&*.<CP2QJQ+4!6JQYJ#?(/[.4Y/$,8OM"/8O#[O; *"])
M?=L#QR%768# X499&MED I/>T?O$@$O#71'JN.:1>M5L/E281(>7/<.YYG
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M!#W^=1IWKZ#M= 5=,ZLIZV^MM;5M,UF7UC\D'\SMJ93.;3B]FU,&*ZU06WD
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M@G^GWS[W<@=\M)<_8HYCZB,R6HV#;4S*+7C'8RKG7Z$)N1L# POFSA5F+X6
M^[\2U[\3*!SD*S_O4TD9O4O+)0'(!"*.V3:R 8V:PT"O.%O(P>_;QR.E&MJP
M,1K\2ATY</92^WLJ]9RCZ_K7"%<2Q\9OXW)*O^& L].:1+"Q>AH7-24OE#6>
M,^QXU:)SK3^L+Z6H!F9=,,B=-"T[AF_TZ[[J=1O(+ H\5"H+W28O7XFWG=A9
MAP7BL,)3'FZDEV!6#*>?#ZSR; )<V+U7Y0H%):1( ,]6O"\B?* +&9\^6 2Y
M18 TOFKO9FC?KGPTB_T*7=$:7][[Z5$1W?(OC,E;KL,%F_CXX+#@6R[M_KYJ
M,/HH$YC"!,.?<WD V?*PR$D1)VG?G*5[;YNZLQ,)CETKJAY=;2KI*;F8>@,#
MU4.E+%$J_Z,0%K]W(T@T$87%XS(7, VL8+]TT\"Q7[HOM7S108LY<MQO1P&T
ML&&-..'P0FTTW V+/.$^ S5-!E0M3F>K06!FL#G3YDT8KW8\EQ[L?0KI'VVK
MZ0Z$FH0#^JVMZ#O5$"O9#ZTZ!8=*SPH:HV.)%$]X>+>B1EQ9VO\."@L;U40:
MOMU-US#G&J2P4=&F]8E<OZA:AXIR'DW'SG&2.C SS TE%K>4D3PM11BTTX!W
MHY9I(*K3NYZE*O]R;?\N,I_49'3F;[]2D/R[^(T7%!D>]0Q/"8;+JJA."=)3
M@.OLR;TG"RLI:I#3([\577STU7 R'_6,&GQ]*TOGTJ=Q1&>@U#4EF9/$+$8W
M0>9[9M_/9!S/L+"IL*G2T2-]F-HEBYRN2D.R@AF# 16[VOT)"&Z:A4\ K7.H
M%4BYAF9'5!CE"VY+#!RYU-@ A&5W1^)\6SN>"?8J+4!6:QA$OQW=[,)L=H::
M;P49<^Y$$O7_>&3FJ:?C2.])IQG*$C+\0V48(E- 6"[!&O^F=8G@&Q8>%AKJ
MK46V& YW' 47#/)\S=2F^*&W3M=4._J:K-/4K/T'G:>=.#SD\[^M(NIZ4[IL
M-(^SM-K*;,");'RKQX)V59@,_8)VD^!1.O8"@S%7?3/7#7#.GGPXU^WQX4T[
M-1#?!A_3U;7>FZS8]-.%@-9:/48*"P"L,&X:D>C]YP/5DI:+K[<_G_Q!&+\O
M) &C>[NH[G!4F;Y-7\/BO>G1T]\\ZHG$^MU$9D04IF,VBJ?I S .! P2^\SV
MS7J_V,J1,&M6@ 8"^JH%%%7 "S,^E\<WTDBQVTGB &8_Y"=N>CZ.R'O0RAT?
M*C,Y+G-FF#(S9!F*<WZ DU#+4(I=3NY8XN(0TMFM"*R*[CS;YJD7F!\TALU;
MB?EU(D39F!Q7*0X&72R+B-,X#[M0^K1YV0'-*NTJ^A(C31-A<D@C4>N6=,<?
MWFC:!- U'C8W+Z$+C1IKX>)"9V/\QZXPMVX[<EW<VI;8UK1O.H)WGZ9B:3M<
MIP\#OG1Q80RW/1IP<1GIG/EB;IF *+P.SW^ :Q4DU9G"QMH7JOBC00,@H=#R
M#_.6<TQX;(8'_,04<A?/L14ZM4\$7YGW?3E&MST?&^6C9YUZ.H[=M'IEON%B
MR\<O";2@._<Z9%KXUL3TS?0^;:0/'#2QEU)*"5_;?TIU26?F"M=6=NIUG>87
M;BJZ,2_][&7S2\/PO$$BN?$FQ[4\67*:N+)Z$O06@E,$AYREM2E8*BMAZ7J#
M<K9\K2 J*O$^^_'JG_YQ!\4YX^F#%],+$>]TKG82OF%Z]9ZN^SJ),49SI:EO
M/WMYK4;0&7_6QZG-,?!AZ^NI)3:!]<:VQ1?K)?]J"YU[;?,KGX4_R1P,! ]X
M!]_$0JUK!G@OI@<\!KL6[&QX7Z4&<U]UI*\J,"TL3O;I%LM'N^8IL]>[5E#'
M:?BK#!JI8FI^$QRT">S75A6J0A&6JA? MSU2:4]I'U9S/_XZ_/\K_ ZGJ) 6
M]1GMDQV8=ZG F;[I'L5%\'0-<C$X>#K$M7VS[$-D!V%B,;I4,#84>T%SLMK%
MXHZ^&LOO^NX7/C+7R_5;-C(+BM_>UVOI!,EEX0S\5*DPY6@S5<U&H.T]-W+9
MY<0[1.8OE3%U1V-L?!)P5W$VF8-<)@9"K"?%N)7U+8;;#8AQ8(WU&M8[!5[@
M?'UQ@V:5_4KM^V__8>&9[$,EJ*!$_< %D;G -? [ !?L#CJ^F#9[347\4+\J
M%]_!Y4L+6QC!P0F7B3;GSR?2)]9L<'3F8B,'BP08Y><9-3*]:9*2"D>23 $?
M68%14\^(:)J%1A@#/!9Q5#@#*\9T)Z-A@=-AP-%0/J"IRA-]/[O6"1]W@F(A
M@?GI =]QQ&IC5CFD7;L6RT]5B'?5Q8TMIDG2\6LQ+JQO_Y]=^_\.5M 1*-3Y
M(OF-_0[30^(9M^XH[]Y,2%)$+Y:91R!.M$F@W=\M=;^=0Q-)K]_-K.-X=UQ%
MEGI0.*IK&U26\U-/%G?V],Q<RH!A^:&2\OZ;C.AVHE5-EAAMBS#9K*[R' >W
M>9->>D(\7K"CM6-M::65PVF8O&US@<7RR.[JF4&!ER1K2%MH4*LX+6Q1#RA(
M7#PJ#$?;.M,\(=KFK6Q(X$M)1>T;/BRU,^7YR"=[@?3'Q?S,YEI!PJ)CZ#2B
M$##(-8IJK.EKTN_JX\)2BKZ&F. 3<HJ="[/L0;/N[_6+RKM[Z@P.G!Q_D+FI
M.Z&<N@].*D)[(I)W=]DV"AS#;0=PH%MN%E"! 8I5\'101>5,)3NV;/^5&!JE
MT =G(XLE4$-[%R'3?%44O<O8<36P+D?%F0=%AQJ9JW[I_4[8<?[94[FA*1">
M_SY"<@4V:1)W@PLVR7*X%&F=S"FU9:=8N<) <!!,[0[][ M62!)KV!I&<TQX
M^PBBN(CD\ZO(KQ;*P*4E9#-WUZ:T(%WP?\ZQPWEX0E3-?VG^:'/@^()^>YX:
M0S!V\?#P:C<''*W.F)L+5;7+I!3FSZ=_DG:^=39V[!GF/2"E?UJ1O8;,D_+>
M*V)Q_=X%2\MG.\:=-1/:Y6> ^:<=CFV;1HDJKT!C*J$W>B+J>Q:V@X@,E(-C
MRWIQ)$1<KBGJ1PV=K?(_UN&J@$=8[;N!4"VPLJ665I8FFWS'IG)@<;#W.Y)#
M-/[U2%@*_+MC]=9YGO7QO#T/7XX^V?P3]GDKV/QDRF[B?D_-@U&-9V9QVR45
M?U/4149$#4;B*:UOW!"[7J!MA/%/'6?#8^_.W>\8DI?>YB-2FPKYBWSZYZZ.
M3!<Y_(QQ5L CAUF]!975C-U)\8J.X57QQUVP2;@V1![8)C@]Z. '8F49V:#?
M%ZN"JL:V;2V=5%$V O0F*4@B '1K@]6VL*Q7\A!D/3B=S1+P.R^ / V ISP\
MELQMACY5"K2+5:."$0B$0ZJIZ1^SV&SV><P*!C-;?Q*!2/T2_>7])^>;T-<>
M9-FGHBM!PCQ08^$U(>H)KN-?%&UW9MGX%1L<@QL=6+'!V.O8K\O^W]J ]/\6
M?L(IX,K\ E//C* ]+;4U_(M4031[T/UNKD?RS.1Q(E91DC?R.T@$[O5;*=C0
M]V';R^\J5^.63:'+<08ME4OM]8&1W2(:18OR0Z%T?>FX )?.H=9U.=PN#O))
MD1C M3 &+)NJ8,-[T*: &B.4J302$Z%K.6SL<>LW$P!$_-0Q<RF2&2SIZBK/
MH8]CA5I)-4E58$F]]9@Q"%/OJ"M34;NG.H3Z3?I;Z6>7X) YY3]#*[UTF0MP
M(?P[+2\F.R51,.RB;C4I]VNY G8K79^]!6RL D";R$^Z8^IC@$78+X/[2FN1
MVU^+Y/P*Q&>U$]"4E,5#I1M5NS7S:<#@I%C9H!/#3]< *>ZI3L[C?B"WJ!K=
MX4U+N#7CA:9O)*^CZ/;[J+!GHXW/EO+V[:Q0.N!&=&)%;GE!4 :/\=.)%2@4
M!H<=>_52-30TU%.-C,>3?)DP&,PID7KJ#]?5K&]9L6[YGV5Y.B;X^B;0-&'2
M#(N'M&RMHW#P5XOXSQ&P.07_G/>:KJM##\*U<EDJ 051T:,JZ^^!CM?DYK)&
MNO&S*REF]<-"SKVY&<([_PDR_0'R"84\,.7OWYC0O#E]K[][6364Y[/$O>5X
M?@_RP?J.X3G<Z.4D7^7TV2WANN7[=#C!P7,C13DIHJ)Q^-J2ORFX2&_0<G4O
M>:N^<WDNCW?E49!I8+\-IM[:+1D^/%G3'CQ#K;3=JXD"3M\OQ[DVC*?W-7%N
MK>%<N%)[VHWVJ[W.W_*YVE:[<! GH/:O;\-BM;Y[/<D"DQ57Q%Z W=?)7=VU
MQN^E?Y@.#.0&+@4AR7,JX]#<]L)KW1N7BA9[>YOM>K O]G:V2F2&LZKE:$FO
MC 7E[2(V(:DK?:')Y8:WVDB57#8!,L".,JTS&2:W<-1@$;B(G$S^P0.%,G)5
M:&:<BJ9I+J&..P'5'*T6QZ*BM@VLV?**.HT\*MC)_-*7.V_^].O<',=2*<)#
M)>/9!>BI=O*QOY W%)E?VMR^:@OKAX%<V%KA+YF%$RGNB\*V7.SVGK]9F.$Y
M3RN:UA<\?FC"DL^]$#?3ITA-RCT>V7%^2-"[ WZ;/,CC'UW5*V)O.<44GU1@
MO Q4;(NBHB*VI&XNU)X6\MY?5G+G=PE3_+1#I1^E73L-;],3'K*[A'-R,"?3
M8\&Z+;NP_>M7&^B)?UJXZ+""GSU4DCJNU?UUYZL=_HAIYV>-M-?)E]FE=9Z^
MM(A518I#AE!M8,S'D^^^YD&)(D62&7MW3)/]KOHL]+M:]>N4,7.5+?M,M),2
M]C>?<&J- >LPB"Z;XXGFMA-Y#!>$E:)<.@@>ZV%;1)(VPZ*@CP2RS[H.E9XB
M9RBB)DN'X/D%:NL2V@1VEM;8;-\2UIVSMHC;8BQ9DC#:_;\2#?\2\2L*"VG*
M5NUVKP!I].#!QH6DK)DD_&:UE70?#>CD9\H;/%X_\8K#SG7M\:D/FZATTR2?
M$**ZA>_PV?0,+R? GM7VC]OAZ]Y_D80.>L,9#R<YQ]>1"20>\CL8J+!R ,%C
M"=CMJFKHH %/'#L601^9.U"3)]/*R3W$9.K9X4.E0=KRPSH7T+@Y1V4QWP4,
M*,TF=OYS2MA_K"%)!X&'2N=0#K#0X/;HS)-+=49K&TEA7OQ5R8+4*CGR!6N^
M!V%L=>^Z"1&>3UHFIHT_U4SPU'3'^0Z'%Z,*KGHOG%BO6W\Z%Q;V2?@:P9]=
MB6517K)[YK9KZLW7S^:R=;N6\LPE%LQG&\OU>G,UIF)B+/)@N3<^."T)NL7;
M_51> %F-GF2&-P6T>04C/<P;?E1EOCWYZ[G_E"&WUCIUA0\;TDE,=/.6]S4M
M) Q,9[-W,F923I7*RY+5B3;$R677S?F:^9J:C=$W5A9WK,[2_57&O8?IUBM0
MB_3^981KKV6-Z!K&>HT+M;V8QO!L ;NVY.L?933CK5Q"+@;=/J[:T"5TR*Z=
M:0S30_1R#Y76.OC/A>:6JFHXEP&&"\,#9'\#<_L@QCGV4&D.QCI4.O"B9] )
MS(V>K9*# )G.;NJA$O#AH5*)]]5#I9-QATKS;0MALNMRAGQ[*23;#N+>C]+^
M^!X&SW_'G>M$@K"K&J?\KI^V(E[C+:N)9J)KNS@2TU6#3:?@"Y@E;(]>,^61
MZ,OMAA_%%/V#/SJ4065>P23$$UY8_M@'&FF8^&JA2-<L!,_CG8UL'0"Q2LU4
M5&-R<O#X&6AZOP3[Y]JE)#I4K%ZLJD9/<ZWGJZH_2PC >:2"(,BTM.C021JP
M?>L9LM!0%1B=3XU87FF?8$39<T^:9#CH1!Y39R?;V"1_<(6 HD$0-7/JV426
M2Z(/U4IZM+WTWUZUO5C G]TE3TO*DDKE9 G"LPW!C8* @Z*BV#C&,,;R%]BW
MGZHP*Y732UFQA+\G).G_S$F09LOIX=_^>L'Q;R/#5EVN*)5Q0]^<'L=\L.!-
M\4)<7>0*==GH/9^O'2U8]Q*N6R4E>-X;IUF->SM*F3HG)-H>Y?'^5XP]X]D1
MX)B*W-Q<]C__LAS4W\=@W%U;+-6/UIS,G4VL.E^3"7O_L6+<T^% S.8[S5D4
M\6]E)I4/;A:VMXC6_>.I'M;TLN%'A/,>6.!NJ&.Z44_E(Y 8A=*$,>?C,@1;
M*)D$+TT7/%T]^$C#Y[D:%^Y.3;:/M=L/ &FUDT8H&N<V.WH4<*H/*#J!D.(5
M"(!_9LB="Z[1UI( U!H8CO,_5/*[5'"H5*G,<][63#Q4.E0J[A!T+!?OA*;?
M/E0R@:/V29GMW?\U/H-]/@!,MS@_JUQWN[FAX[WI\?/D&V"8^Y^7R#Z!P_PW
M4)!6@?5\YQ8IE *UAENWAOA84Z<'%.<T]QZ5]BR*:^'C-=,B5(73/CB8W+T*
M+'G)AXSV3(N'"SMMJD H-<DU*=O4GEV^$.0_&C3@<OW"/**X"SY4(;+ED1D>
MC(5B4TD .TD.MK1N!7_*&W!)J]>8>6+_S:]%N*8 *4WO/+ .RTB._A@H&+3G
M-&1HZ7 .E6ZE;)X'95I*H,X RW+)[?.F5PZ/3L9VZ.AO:A/')WC<]$XZ5%/'
MK 'Z1-GH4$D_XVMI'>#-*J*X^E!I-1C;O% $@ 7M\=0V*_!(/KL+3W,"2$S7
MEV[/$3RC%<7(]KT+RP5]E$:W2^1#I9OT5A"TPP71PT0#&S7])]<6<+R ?,\?
M#LK^S_>]/@^1WY-F;K$068G8$WK0Z"3TIOY\Z#Z%)PC*T(.DM&UF>:NDY%"G
M@$N-5>Y+C@>[16^%V(:NEAQ T6I0,SH\^P_N:@ KTLA>Z9Z3+'B?W!8&+&WD
M8UK9T^K8T!4+?_U9Z8K?! $W%?F2;<"7:448] POM>[Q5YT_<B*@EL** OXB
M %(8D5A.B,$%12#-K:D:IJK:3KXH-X[;[>BJI/1O?RU*_@5^BZY+M,T_&Y48
MER_3^^R4<^X"_*L=O?9KL_FY9G&;D$(/BH #!QAO;^'P@TL73>Q: BF."2:L
M9?6CNOX#U?\MY^"9F16F0VS'-$R1UU5!830CW(8KN.X4D+>ZT,@)VGX]PMW<
M/PW&#;45_&B8H8DH?2Q)(3?61D^+VD9@:5;Y+'0%<+Z"[#1%:]93HP3X7(K/
M??0/VY3;VV(UR-[.WW'QK:]$JD!VPOGA[\*'@>AFP:6<X9FV^^]F.TIMSV8T
MGZ2?W(V9SZ,XFUJ/THYN0Z_KJ,EXWJD]?_V\BJV5D8NS]$(IQ@(X%/AJ(6:3
MO5F!:>"H7MV.?I.=]&070HW837]1R>T4JF,:W%UH0^:67RS"/XJ+ME!7';]9
M4+X$2^_7XMP'7=N6DQ(MN<Q!U8Q^F<$)Y-L]=C7+K:&0!RM[\?7PG3>72RDO
M2ES/6>\D;D-D??10\0L ."$C/ Y?'9(AESZ1J:/@^"%T*-8;S$D_1[,9@ZAD
M-%-7&N^Q:?!D>=CX*E)\K"RL6J.Q/AW8HD9N399N@ZPY@Q&& >S$<?SPW<$_
M_3<$P_\4_.9'_OR!/S?UP0PT.276GY#<6T(@ GX<+^6D?-'O=QUG>VW^[2-G
M;TU-I*OD8XKJ4%G7$_MZK+O)D3Q_'B$LC&Q I%O#?<I&H'9;8>_Q9G':O/(I
M*+I==;2#QW@X!;:<"4>HG#<"Y;L\'/:..E0*MFLKJ^F,6UE=J5,VM\15/T]G
MJ7SJ1W$I/5MN]USN&B2-<5"?;WB;N>?GY]-S5U?%E8N+BZ"X*W%Q^EA$?G[N
M4G-@8RWH4?,M=.7M[N;F9G%E<TLM7%R7SV([IJX)L2:^>;.M+G[M*D?X9<S0
M+X?;]W^F&0>-M0<-N$98Y:!<W(:4J;N9?_K']:<Y$\!41&&']+OV]*I)DTO9
MSG-1XY!LUF*=3J@MFQS)5IV7W@D+%H2Z:?[<CXN;-*FSO'X,\/W/L\NBYEN/
MMK]\4D I$EA)%;854RFEZ<FW"/W$Y,YBV"LAFC>]#"2QP8'E%?T$M'954%I+
M[&236BO8[E+9@',\Y_FJ4U_<RHKE=P_R($C#MPE1>;Q;.0<R39];=>>K^%8H
M#7S9>#/J3_\=0< ^5#+;@[^%APMUDK<DM3OVIKONU^GW865E&SZA:!TP<:/S
M@E>_F>;DW%>-,FC\X$0XR_</0_IJP3!?S?2]NQ,'WVP_):\W,OBJ#*?LD+E9
MQ=8Z'U=C6OP?2ZB$/*?F# R1$N*C&I.;OP :B_PAN<VIBN"0'\V\SVF!U!+*
M49Y-@)';.\ EZ7#+0HY4NA;_:B)IC]]8-_*H]\H5V>?M2W;/:OM>/XB_.@[]
M82!JC=,I[.CJ73HJ_GR/S3_=QSUW=W,NK?PD1NVA[CEF7NJ8)YRW"[,UM93R
MJJWH^?J&00]I1>UI89U+F"7S1TRL@7YDE^7,]'VT&!I#$>CKCN-2J2TQ[$[5
M=0\/#X!#Z<ZW?W?*;P69X$.ETDTI;.K@[(I&8'/AS2A)6&/>SKH@/Q6<1;+I
MG*SD6U35@GI$X.8H:N3]CB?-PMFC= M0HRES+/G@/98T;QJM<UKL?2Y/=]1\
M$(K&UT096$1-BBBU(R4LP,F'.)<E".%*4V$>VWCOQI$DKCCT00(XX5518X;A
MH^%'7U16CBL&2:6TT.C)G"[[OSZ_]]\1#/]3<+9LMWJ/V):P&H99$P2^]]PZ
MX0F,63X8:2>2B$7O%1TIU1[W0#:!QE_9%8'32ZLXQ(30X/%P<UG(1=_,"W:-
M<RU5K3L6>Z_:3D^2&JM#2K_</E2R+$H.-O:,,@VMY5W>$WW +:AZ#J[B7\U:
MC_$N; UL_OE^NKV<!+E6PTR.,]8^5$J!)F1%&090"P4/R^M"'M)55!>D_=J
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MEZ<'/T:T]C_[12AWU#H=YNKC1G/D>$M@&\';^:'D%=QJQA>[/[U"EU"TQHW
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M*M5 P4LA=XX^W4[3WZ3K[]U*.=>[*Y@D\9WA\-;TI5.QN/)-GIC V_"?(^^
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M$AQ%4)H2$;#;0QN"L-[5OMS&E7N[6UJ!U?7#ZQG:3[2A3)9/OY\&+!5\]]<
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M;?84&_^1;S9D6B1171#=6P@"#-0U.USC(2QU: <32=F?LYE1>'(F:.E9WF'
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M*\<.UAP[P86:.(#1B4KKW*3(KLY?U.B90XK$[&\_?IWTM7T\=>-/+H5(28+
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MX.NF/-VPH-#A^/N$'FZT*:(?$7OT7! V\5EJG>-+,)I]8!:4U^_$XUF%%,P
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MY-#4O K;V^ O_ELM_VYO-CQLFL]*3P?84ZD=HU 8#&K^11B?_^K:G7& S"O
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M_O^^WN[[CZZWI_S7U]O_)O_"PD+\:N'G>C:*:W\1L"SA]H5"+OPLL<U<"L*
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M8(U/9LV[R9C>: ^S7IEA,JN, B;')JD4RLA06#ZL'(J9! X"5#$DG0&1.U9
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M(LU4P":"BQI/B"79("LE):MPS9;VCO:6@B)NEF4XYNH"]_,PU\2IM8E(TQT
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M*PXPXQA![1.;@B8/[26HLSP>3&FKT-(-(SD%D4!AWA18',/GDHO/V"0V52!
MHPZ=ZE-N->F_LW?L["7.F<6%XCH R&B*$4Y&#Z3?&C."AJ19X"):G0;99&R(
M(?3K[I*W%/>^B_K(038U]]V,/D9W[X:X4"PV=-*#[0-KZ\O3UHD_0793!S+'
M;G);)FYTD\$--(5SL8]U$*J6))VKY)KF.GN0ZLN,AT]N=J>#[B'!Q$ D+#:+
MWC@ECPZZVNO0+RO[_9; 9^'?R'S+W(%V.-:_I5I"5%#E)$H<(U67%[$3JI.D
M64:D&_KWEVS7I5V[&7D&E6F![8\I)A"IS"L 9>$:?9J7];)^^M6ASB>NIK4S
MC-SB]J!;!;H3?K0\UBD//9..""X1NMLH6^UN,\%C3F>B#J1\,8UWZ*<"J"YS
M\"^Q^N2;S9</I/*:IS+H@2GTDMGFL'EX,4;785]DK642^V/2YM__\9^9]+]7
M_G9XPF&*1,Y5/9$Z61*OH+3_=LU',V5,T? BV+?5-]WE=L16\[(S&'=M5#FV
MYV<XL^=V^15)35'$W818LNLK,^48VWV$OGFC)&E6?U6WB&*^$]/6R #)&LE>
MC98C>/0),5B,-]ZO++ -T"2  *JKRI5ZWJ8NU7\YV94D3BA9VRT+DDO<,2C7
M]C6RXX$BKLG.XZ\N3AU+R]YR^>N_-?P"+(-WHW2]%K&[5YV2!G8-6/7<%,)P
MFK<=>9AU=VNL*V)9G?R!'S:]&^/1=[&\F8#(0*.[OGX'\*28<&9><5[T]-NA
M(-9IY:6J:AN/"R_WY,\C7(X6HHHCP56YJHLVR[C^I 7B/@3W(LS97S:=JX'=
M$S$.)T>\$CE;WIR85_MG\U[ZF6TB<I#7/(2U%<HEGVW-0^:>^R]P57ZV(ZX'
M+=B*!)B7!>\B;A.#6'X(1E-0I#YXW?/$]@:1;(1F!-M>'O%>CN(WURK-CQJ[
M,Y1Q;I0;HY]8P0#=[E:"-)30F.B_B.;I)=EJA[9GDT)R$R>6U_@+64#UT>RX
M1?GF2W3M*QE%W@=2A[O@;@_'UR$&=R:6(<%T]4!M=A!Z,Z-,RX3AIV6"N/A#
M$SGD=PHV>.(5NV2BMGZY_&551T:US>2^.8L2AB#Y><8=8H1N:ADALR48T&AT
MPD2/UNPO54[,M,W+UU?@X)OWS)?.ZU4\GY_^1$ SJ;_8#@N36?#U=>'$W?(@
M()ZX*%^R1!"/-,J6/Z.;2F+K#J1>W"0O,^EX6!+8=KW-:#!*,Q&S@%R?D+E,
M1145%]&<+68=:1B-3:O$E!1=GI%1,C.T1M]F>&_E@^J5./R7A&2CU-<B![^E
M]T(MW:#7 +M^YP_75#S-!_&FVT>LAXCE9*&>\22O24%$$$7'K+L>C=NO=%!9
M&2-R9KJB(ZT<.DU/;K&Y+)?"G@(-/VT_??@F,F@@:]N91\D2D_)L:OR'N8]*
MJ4?>B0ZD3J?J%G>G=!Y(*>_<P*,F2@:=Z:.H]VRL27-B[Z A[7C<S3\P- UE
M;+VTQNH^UM2Z%"F:.-W0UO9H74^W?G77+8\#/6)VZ/',)%X)V&WO:>@@W5M0
MGM-J-01N-+U^Q4'1S"#&3]F]!5:\KC]H9]->0FP?:[?HS\KWGA T097\JBQP
M( NC8-2W1=EQGL=L.R3J>H(U5A4SN.SY.$R<O&[0, 4!U!Y7%>IU& 1B&H^#
M6 N@NNMM;+:-29GVU6]W<G9P21H"153KFPAO->8L>=<CD"L&S$L#^5YK)M>D
MEYH"8\HR"WC3'1S"$:CMZ>I1U$B?]X"*^Y@WT-.$Y!80U5/_)JI030;YW4KB
M4AH,>B!U_@2&ET>5M; &R>8KT-3HR_'"R%?S]1X1SXHPL/' (FY^3 .L?GF_
MM_MD@^>L\LPKV7Q(HHBH.@KQ',Y6'NJ412\?KURYD]5KGWP=_V=.[LL['2Y"
M_;>H;W>T6-B.I*5S!:BG>:!CIN#HR/#^.ZS]LV]J4?E?=H8G_ #)&8-T/MRC
M?-_O*<L)6FC!0)6R?<I_+"^[Q>_*3_5/&F7%+Z,NM.Q"*77VQ*$[(C,K'U;U
M4KOOFDIB/3K,-(.AX/7"S=:Z!?>"5T9E^LHD0H3DF#'=0M7\X;3+SAYE-G4)
MB%/4!R!5$WRN(KH6';+;.;Z_2OQ2()_>1 OAJU:M>ZH\SDO)KL86KC*BFM9N
M@=SI#H$+L ^X88_)7RKH9V?+AZZ>'N#IP . W^H%5FQS'Z9JIGYOM3,E3DH-
M*5EG^]SNETU_0KK"D'%O"\M.@:NG1A6 #8#3F?BC-.,Y8C1SS."-W87=FEDK
MQ7,"GA\C"LATLPGJ*QG*]1W=.X1;S;[<W-E864$SKB-6Z'K\$99;ZQ;*J1IJ
M*04# =[<-:]VJU*XJW9NZ[T!-3AY_.]^E)G-S1D*Q ?HS?2QOY$WH'EC6$5.
MZ.Z[1E9>WP&+=AZSN4A I7YA7,%FI<Y52CV4&?@Y21/R6T% ULC(0/945^(:
M1^\3HP@9!QO(RI[Z/#OKDD/.(/7!I61W=?&5G72P :K4[\BRN C[+B!FTPO0
MT_]N:0:IAJA!E1]]F.XXQKDF9Z'[+H17E&8AF"H8F.9>7;M+[2UH=5Q^/@6=
MVQQHDW2EPOYVJ_.<ZA"@2UHA@[@7VZ49/DC1K<8)S\5C ,F@-J)E]#+X1QAA
M77W<AF/&,2ZAO1D3E6Q1,=H0@SE$0&L=B2B;!ZILI-CA_Q]=-?%A_-^Y:O*M
MV__959-_R_^[TZF>O=JKWY\BUM?/C+;I4L\5!"4/)VY;JQ*G0XTG0G8.>_%!
M'2G/"FUPSH5VWNV@Q!W+RH)9$WDSI4.V*(IQTJEION/" #=A3L1MW1:TS[[-
M28RW7L$5ZLM.(<*05]ETR:-<&IX"C:4C00#3?,Q3/!N7Q31)>CSMPDHYF81Y
MA[ZP @.#ZQ]" MZ$I) ?%:T8O;AL05-$/.!EC$0&54=:5M\*+Q$(GT=XI1
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M"7SKW_]K9 '.-9NGD21=*._Z=6,[((?D  :7X^[5#B3.5V7JM. ERR_>JZ;
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M8ED%[Y8L5">,5O1/6V),S=M[4<NEM-9V1LFFXL5(9D2:<5^*:]<\(A.PW+'
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M':8&)=\K,#(I,N;SHT='3O567J]TV>OW4"ZL1'VC8)0ZTL<K<>AKSTH+:!B
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M;W5!QNY-LT3UI_^U0LUG.S&[W^XU=>I!Y<;)?4C@QIPQMG&C=>SU6MA,IT_
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M(F]*;J>E?WP#Z^P.#Z32R)3V(DY+H7%5/;;+ML6!X#+\$@&^M5G,7FTZ;]*
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M9BW_(/"+T"Z;PM@7A-B+<&G\&FV&[V!2XF)1;W:Z7&6N8Y:]W3*E;)OZ%&[
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MEJM/K+@[O;,KCID$Y3_%[UA-1>A.,5Q*<5G' 6]5?6(6J*0RG?Y!:BX.10#
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ME<TK<54\0U1+4SS/< +PW5,(?28Y\T;2[EJG?*W]6D>?N5;+TS!'\S.#*P"
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M:3= DQ,N^VB'AU_V_ ,;F+R"L!A\TV/:I;!DG6.L9E*L52D9J\>277S=OO3
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M+-L\O9GRX9_+HD9\R0_"SU &DNZ;PS^M1?Q\?J,RCOL8'EY5=4_90^B0&*6
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MS@B^^8>2:42FTQESO3K%#WR02.3YWPK4@UP9C-YUSF\%ZJ.G.#XFP$\%ZJR
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MO#AV8;/3[KLRN<K(S7K8W3[I6^1>Y:KEC-E@1N;NNZW%<1JN2\]V)@5]@"^
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MP@?-#@(6FI/YP63/*^4"^R/B)<S1=J7&2T5W[O7G8LU[<KJG*X2+>2"&9,:
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MIZAT9:=,W3Z&T6+,U6+?=71W771^J;#I1.F<BQZ+ ,*!4!AE$&@[%X)Y6LO
M.+#2S2(/HV&>??&U!ZI$OT> -C41A6/DEC@E^]T8X5M*_T;QC[  ":U?PXTU
MS.B4MD^$+V:@D 8&GTL)I[3?%OH&-4!124&,MPC]"^APE>?<P#DT0K-S>WQ*
MPP,GQSV=9[ZU]Y(IP&$.79SZTYJTM2 !\V==8XL8U5/!KBSTC3!&U0,$-,M6
MAXK?JZVECIPI=LIDK?>E"1ZYI5\A_[-2V80I?*\VIC'X7NWLDM7D-NWZ8-KH
M[^.?)R0!9A1C4A3F]>2*(@B:Y$;^]7'XQ',XOK>4P0]2O]&6['9,UT.OSSKD
M\SW Z+]1]S95JXQ75!3F4V*#P>T-B1W9KMZ4E9 Z;FA, Q6PHZ(MQ?3*8&LN
M!.0938?2:$]&PN5S68FI[-L):2&$4VQ>;%=@['=B2CX$_4!#>[[:&R %UO)@
M&'10E-SB1>3)G6]^K_G=$2G-3VR .5I/5>#"9U,DE$GQJ<^^[#<'P82$/735
M94C9M.0FU% RI1WWS2-N' 2J[>C6;ZHBSD66.:<F<3FJ.X,QDS/-PHDWA#%E
M]TTOUH 37=1UY4%P5=E@8O.XH6'2C<$,*.#3+H?>#E0ORF$)!4\@WZO*=6_#
MZD+6VVO3+E9AGO*4.9CN4#0H;/1<S']Q,#_!HGR?=C&IE@ES(1O[[S8J?7XF
M]KK:5?K>?C$>=XM?\=P(.#X)AV0<:Q?&$"E7_9WJ)AP9*7%)>AH7OKD][(V.
MT6N9K&2/ZTJ.S,H.[TD+YI1<(-9YRH@8@R?6-8V&8!HCVJP&,0*ND3$X7= &
M<-RS>3B3!IVUTS=U#J=OZV[;,, MCV<+HKD:^EK-4JU[I:6E97=<G7[;$^S>
MC=AQ;Z7^&TL$'<..3L2@T5- :T#"!S>V];2^A( Z:)82??U9R$Y%OVXPE?,K
M2EM]-/*$SKA1_><RQLNCM5CLC-,45*7*QGE/U520^7H-A_?(AC8HKQ02$22M
M'U?N!LN:W=DKO#;4Y8B!S9^>5S=@EW,OGJ/G3$8WK_D^7@\+N%?.J8_=7&^6
M-G377FP+,.OQ%FYMQ++F0<JFUOAM3"<RT.'Z:_*.OF_H^+.0/WQ;<WDQR59W
MM*4X2!OI]I5_$,!74U/>'Y:TLD,U<\^1I&'>B+]3A!V10NEO-XY)^ZMAQ67/
M9FLW4Z*9&%Z=M-DK)9"KK_^P6+"D[);1;'"Z'0KH^8LDFIEVW>/9EB9@"+9)
MP\)Z,>S/_S>*.N#IH)_I/DA:=^:-31GO1$$7SI250>=WA7,W7<+C U4GSJXM
M;WB/;)4#CA/NU&I,N-W0\Y^%39-+\DP]G\:OJ5[O):BF9DL*PRRF"-^I'!T\
M:!:VUJ/;QLLIEMB3,O+HMM'NTQ:SPJ@.0.A:A0H>F%[*2$:4)"I3.7-HI:2T
M/BJV5"Q@%D:/8G51@?(18VZ=*5 OM=FGJ6$;M:VVR9^N.^[<O[P%IWL@V ]Y
M(0[@-NN4O=<G]7T&ICV;0M=DYY7'9\9:?_ (-[#V=%AW3 JG7A&,CWGT5=59
M[/P)G8$LDM2U*9>O#?D(%QWZGP(P4[N]*9ZN@<,=$Q],<20Z_#M9NJ/9S5EV
M%<T)H$&GKBSI2W"+MLYXEU]*2ZO*MITOE8YD2"YMC54O ^;G2TG+)\$N[SX?
M?O-?N>M3D F;\:/]R[;OU31$ZWDH%P/TGVG4'F:$,O,1(81S3W0[:,J1;Z5,
MQ1T>,N;$4+NI36605\^MZD%E-R5/&SH>8SW+JE<VY"1)5J&^]*<96>:;Q3]<
MZ9"V?DB?8H17Z.H*LSZ^T3,>21F]KZEH_P/UR]'54 I*8\A<O"BJ+);$93SO
M<XL^XND%TG5_/#$SPKV4LY+K%5J>;M@V71M7MC>A'YJF1]S3GM)+LCI9-S'A
M1D@5E1CQAE]ONVMZGE/WQPC>$=N*U O+/=-5#2?*R/VSN^:V)3B?4X5VIMT&
MQIFGT0T*(4;%C[H-<&PY'=9]F!6T?_OH+U[K;W"AYZ\81H<)47//\>T;M!12
MU/54;):R)UVV.W>P UO1APH^#_9ZO;[)#5G &A 8-O5TO="^OO@F9-L_&5(P
MB([DMVW'PK1;;G8X#K")DN53C.LINUDG4&7LV55M372QTI8::'\0M[T]N+#S
MT.U8"C_(94Q<HG%_QEK7AVEA]&JNERQ^=@569 [BZSLF8[T)*%;@(VQX"T!=
M6L)T1NN$64\DPKQ0Z1?)I(]CP.FQ4'M7]]&RD#BA0C:P9/YVQX&XP^]A)5N$
M,5?#HKL(7SC=R>"W,A@C;-<R46+":JDYI7?2S>KJ3HECN&3W4BT&9.ILEYLN
MC>2\5ZN-;-MV$:7.%7:L*";[];6G8O(R9+W.K[VBYDGGE\\'1IF$HFCDXI:F
M:AO2)6R&8FY9HS\%OOMK* PA?VO70F#/SV]-&IL5#Z_;P^<! -0FSSQHV/G#
M6^27:P&;TS6:21&$$?@M8;^^2>BS-?QY(.A/WJ033E@;A!$O"\+QUM1-']>M
M&YW=[8]L++ZY,%=U53P5<1U!*:M01DB6AWQ37B6%Q,;>CB43+Y7Q'Q^Q[X=?
MZ]=8[[C%U3_K?@>L_N9>!=^)A=#:FL#:=# [1:%Q NKF1;K]%6(=.+*P/9?G
MY'>(U1M^Z;^P@4_55*>GY[Y7)?'XDWXS)J W*!V?KG*<\-M6N">TC*=0][]Z
M*V[]<)&!$3[K*N>"9DK_>J#VEYYF[85")CM5X:F)W"C1CT?,/:P<])&N;A=R
M&$F:&)RWL8E^0I+8EG(<IM5??6RH^!W3,]!"<S"BXF%=DRCUO=KMI(R6ET%%
M;RC:PJ5IRTI'2/I[-52Z#XF6D6%]+Z<T[V)Q3FD]K.. \->I\%-P8JK[74J(
MQ:FN<I'.(JLR)4S=791>4&$UP0FTT+O7+LXS%V0+7MG;97N%:XWCGL:LG>[W
M"-#UMGJI^G3M7JH!2BQ4SN'6&<+)<3#>=K*/)<?E>;FF3!G16GX1<)W\JF"4
MNFB\L+&_Z\RY;0,.7:,4[^S2-=U]Y$JLZ7+*>S5WZB;*'RQ_WKP5M27.D5<0
M\0] %?^_.YK.H?Y['4U?P_^G'4V7M']Q'H\(12JJLLU+?H]EK(^2+X>ELB=Q
M%.W0]VH!TB30!:^-XH=S-TD=78(DWAI[GU74"EFELXGLRO;,>4/&-^5:'JCL
MT=#W5QU\AD-4[74ZY(Y-;Z9-4GS"E?'M\R 4_@G^D']=/3 1EJ?991&62K^4
MG_3S!K:TDC!^W!B)ED-W^*%0^7P"GS_L9-]WI4TLFRGG)9<V"X:Y-DBE0ADJ
M!SW703M+$7EWJ8YW?])!Y56)IN"!VEI;]?ZY9F=QF+K7=35S!C47#O<3K-SN
M-W:S?YXMCU>]A$,MN'X>65]FG=@#JZ1%-@?SSJU410AB39\)1,-V\RWMJKVT
M4OI"K)DL*H=!XK53V'-&3HN]]&T%HA,UPA_G<=O>Q,:>WN_@Y2UFK*,V?7R_
MD!/:\EZ8/&ZTK[_^^V[C'_^K&/$/\HD/I]-_XM^F3L,):0=&MX^-/,?BU'M4
M>O![],=Y)Y8?XQU+PM=C_>?Q&9YEQ-MN6H.%I"J+B_<:>P?=4KR/M5^XE761
M?]_.>G-#/V/#662H.FW,S\E_5/6DN8^+H-<3:]VFH6V]Z9RK/)M'[6X6'M26
M3?0B*AKOLS%#[ L=3@ %MZ?UI9^7%$3W1NI>+:V,=5KT @. ?OLZC/Z#&N;^
M,F3J\R1]%!+^:\J^']@&H#<2RN*11::[V2C!6B\(/PM_N'A<:+H=>K:0XT3Q
M0&J=UC,QT+_619L6ER,Q7SBK+T^CAB:K[XNNP+;IQB8=BCY9VD22)B5PV\IB
MB7!3^&+LF1NT@VE04V_'T-"B!9N4[HKS6E$@%]/FC!6JCQD-;1+&:UYC]6U!
MO(V5V+"@!NYW\\,81K3\^+:NC_$ 1SNW?UP832QEI;1K!>^D.K_Z@UGS8D*"
M[$FN8&3H0\D5G?OM?'W.NX9<L!AC*[Y;!AT0P[LG(A'=M-6E5A&?M@PF+:.\
MV"T0KX]36F6D^H^DN'$!*3.#:,K??_ZP6-*_LK$X__6:SXJ>WOEO OR_*G^8
MR!B(V.\GHCL%JV!\P<SXD7$Y0^>J#BU-B,JKR$;]);/A=-%0@..76Q6#1X,E
MM_UC=WV+R\W@B!,AM4WEX(99XO)C @>5:E-JLUK280/ MF]CC;OCJ?W@O$?S
M=0 PL+Z(QK@L:^?%JIZ2ZJ)#*F,.W,^0.EHX.!'H@YK3JH,0;$A.[E)R#K[H
MO1J]^:*3$R(?_@=#BP#+/__]"??[S&>^F4)GR3"T)3R![4U8GKQ!BDJ5Q1EI
M)LF/\J/PX')JIL]!I&SAY9LD:WI=U<577;LZTH/W6F:GG]3AJ^!5"MF1 SW;
M_O<7Z7.].IA/BP0S0DGM/,%;[-/EU;=V@P$]?WU0?33/#%Q8I/4A^9WHT6R=
MLV7MN!M=HC/@N:^I:>EF^J5E?,_ 9)+9?$N-F3[@2$W$<97O8V2U.#((J?ZK
M]V$MAZ']SJFZ>E:#;%XU=1K2=*)KGB_GN"(LV7\>@S;DGH#4E,,2=G4ZZ&GF
MAH4]WT7<5H&&D$")[YG9.:>0BFU=Q5+K9O*2];@3C3S==I+OU=$""B4";5=3
MINEE !$Q+%PH! T-+^EQ/J7=D_9FQ8J:2V5B[#?@M[+ J%B7"U"(?6B;>KMW
MQ,!O_WWL_]_R+W^M,_1>C<+HS_H6?QZWX1;6.\U/#+MP;N3"$PA/.\.N?2HI
MC&_%?)8RV6#[U&KGT5H%]ZC-IF?WI>OUC9+R%UN1=W4Y6$/Z?0O+'0(C[\?E
M<DZR\E&LH0F\>'3FNZ!+!8!$&?\$.)@GDB9AC5H Q^K1QQ+W7BFXG:A$TIC"
MS[%$6V/+P2NN-MVIHFUT5'U^?A#DM>D:<?_)W1+1:$3BIN=F561'>J["A&^[
M/6A6LZ1/Z1(CI0X=WZ[-8T\CBIYEZRY5QZ6<J_[FV&+PHE7?*)<SJ.V(MI-,
MH'_=?++J.]23TKZX%U':G6=DR&4LFRJ@LW&,T,"2LOX.4I15NPR8>":X6L<]
MUS^54)91*=*S[6AY'905SY^X@464.]>Z;MN4KF\WS>2LO[(?T?N_VE7_+=;1
M7GE606$:_&:=0"_8B=@J JQ.[(V%#QX:"R.);+:]J@-:4NYRM+;+MH0>\^4#
MTPM\G7L]>=7E#N_52E9_[:EPT16YJ?R6-]E5VYL7)DO1SF &*X8!VF3X0)<Q
M? /O&DCQ0WK"9LO;A).;5A8I*LYX!I%/Z<?-[=0Y.O&.WB2Z&"DRZ\*-+=M=
M1>O5WMH'5BZ,M_7V[&N1HXP-KM[MZ'[Q*IYP<TGT^T!T:]FBT\[5"WTI*3Q:
M@,WQ(QW9O%"C1AW<V6_826Y]#WP?=.1Q:W)_4O#%.D-''5MOB!&XSK?;AG*K
M;6$K;3[/*#8NLG)VA4G%77QP,Z94"+DLU)_2VVJ);Q+1$S8BD0(ANC,.W.L%
M5J"! )#[GE*DQ21D$Z& 35>^7EQ(6;2;%O%?'')P=:FSVB9Q[F(;Y,^K.BT)
M2EV\X= "Y^K4"N4KR&1>_7!*9)/)2>5H-./UKL'K]VI0R8O5/%9,JUSA"8TT
M&YP]4$T'(W4&A5FSRT8?"EDK:<)VV(,3J3A,]><;'69O1QO:EN%#CJ.$.[<#
M3\!N(ABWE;'322N@>XQ<A08Z$-,<8KFW5?067Z47,$]U_R54\PL%3-:[&EWK
MHCV)#F*]5SN!Z22O+[U7LZ0=]#J:\F;QB:IV+>N3]?CGL"E?;5W_A:BZGT\E
MF;A\+J^X1?$U<GY0;8::FEBA@Z_O'49HMA-Z>.-I$\5KD.7DC>[PN-$J<O^E
M+1FKSB9.M2N<8'Q(!< ;W5G.>NELLK):3N_6[S&:ANA3<^6RK<0I?K=UW.4I
M4GB1^T0*\Q51>*2.\F8UG<?^Z:6?VU=!T66_25H26CNZ7WU;6-Z9F_:$@#DK
MKKX[^_9ZF#NP#W'@Q-WR-P@0=.-H1T/$N6UT._NNF4EODWY8*LDB/"JZD5RZ
MLD:A\Q&D*>@\=6R6@0,76K7,Q]/,#,R@(>6LC. R)"5JYA_1&H>=='1<]6<=
M[BX ,A)K!=T&IP[][E;R2BS[EO@Z)==D#A/?(=@XUUQL/]!Y^"KZYN.\[B>U
MN+=L@+]1UA^0/-$-Y/-9RD-=WZGJ[U10@AZEW4O,0*7$L0'S^3KI;FVQE6B3
MR9'A2&\)<9K1?;=K&T5*[7&8HP23-R5.Y2PI:GZAWEZ*>J^VT->7+CF5$'E@
M3Z!/&C$E3NZ\G?A55I#]10N^Q3ZO9;4LWP($@O?3VD?=R-  P77$X9KXY;.%
MF&O$G;-"S&EQ^4QGC4]\_1/JTM9E5 D.[Z,QJ%<A=\RH@4#W5DM7828#T6''
M[5NA*ZY\CX7!Y66Q?9 NSSC:(&WG^U6=EV1.&]&'_UE?WQQ3DQPBKVZN)]<Y
M6LHI89N;;K%6(0S\%I^0CO7K>^<$JKU)0]:^^74-<!)?]M. M%0W0U?.X 30
M@9I0",2+.\I@GZO@L@KY'*N@@( DSEGVDO[,TA'9;*MB<I@V>=N1A^0;9PR
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M*9H;C&DNKHR-9B0A."F(E/4Y1-GYM_=X'>++483!>GO7P%@G=8@;H:%^9&(
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M,24,..1&&(43GDA, \>3IO#X)G9.6;RW+[\-P9Q'(P]_@0Y1MO@-+P*D($=
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MZ8]: K?+B[G'*_XQ70%(,6WMC*"SFWUVT?5[?E0=/BV5?B62]>L\8&("/>.
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MKUYUK3_[/Y??\Q>)%S?6F@[#?\.[?>;$8H_06[_U]E#ME:?MY*8OJ<D)\"O
M,[R7A.?%C8]L\-#8E\.CP\$T663O"5Q]#7KY;'WG_F-T5J 2.0E?\(;$5E<*
MIT^O3S-, 260P>'ANY40P!AJH<$A50$AJ%8,.T-7)6>.C<;N%AS[:?\XO-/
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M[V<V?Z+R,%O_L:C*J$#FHW(2>S*7.1G[IGTON7RG/'@U6&B\YR(4XU5RY[[
MOS;\6N>L\SMK_<RX,0F23"DWJME&/63N+"J+\8O-U=M?O2HXGG1CZ7?[/A['
M7=S)X[UKC]WG[E44Y@L8"PLLZ##*V)[1%MF&;F4IMCVF\%=CU]>\T>F4\@N
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M$=)H:%-U5L&I4TZ7GI]7H7*^>=K#Z%*\Z=UJ^LSV:_#GX/.FHL^]I3)Z<!X
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M>7YD9^<^2NLO*[J]N#!"S+JO<2;\I\[KA12I1;^#ZW*!"S HCVXQ=R"9MPC
M^,):?KV^ZJ7O?S=834#<4<?.GMRX*3U%'@F#1.[]/%VW8U+1X(?(2)T'(Y1
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M\(V5\8#>E0''<%>&%[HGO75D?DNUZ#!IB0=W@BT/<Y:(V,/9.(<Y2T>4/3>
M>OB?>[NZNNA8M-^H'_7$&G')IP%Z$!%!W6#7B241R<G)@WZQVE9:O[J/,,=V
M;LJ>.W:'%Z-\81'.>N2"DV>\1ZY;GQWNG_]E/&1S8CKZK5E39E4CGXB\(PE9
MUTRI(F5$D[8Y*43S(MW3UJ)S"9_&MC]I[?=9DUZX-[;EW,8&0FT0\:8&]M%(
MV@6[V;/D56G4!1OGQR>: U)\K<[+?-^T\0)"I;UH5ZK/<%_"9QQ/ 9\SGK$=
M_P#>J;H7?X9&X9@6DL\&W?]/1/C_>@2=+@9'K4Y_KWH^6YKQZYNKF+I[/[^>
M:*XF(;4RVG+JHZX1S3(%2ND-:R69)TY=N3Y. &36YB.7N<^6MQ!-^5RA.'+K
M^*1[]-:.R SG0@4X1L]C' C2L1+8*3;29!"%"P*8H^2#I4O=U)Y,G8&,O#!8
M+TZS?BMT4X+H1E-R.SQ3 WJL/5/5Z$#@''D&<",&B<JL0[CGL[/B'3?4<]J8
MY(UBK!08LD-GF\H/V,1>1_XPM&0RZ.BFZ<Q95G2TBM9W/ZJRYH)$.KKR7"-8
M5BN.$4:RGAG-'FN]'<LW!OW\=6N8%(9XA81YY@V.8/S)=JVCH5>"%'+ GDD$
MH9^&ANX-M]S*&VX=+5&TZ"+N!/K^J,F7S :F.@'!CV_>H"6Z2BO2]OT1\AY$
MF%S#=.2_B=LH]!W:>S@&>EBYYNX:C$V??KE1P* ?<QVZ;[+K=:]^1#=#MW:J
M8IJDB[.WM(\N;6QN;LS4A5IZE!9A-1^;7ZHH68B?EN[W2/=$$5%NBZ>8-*H9
MW"!V"WX#5AH=0R% . #(K3K$9%LU7A6)<VMX-8E5Q<O7];!6L$&)=Q]G(82<
M4C?-#W(.O?U/Y.6!0?]L%W%ICP1J,C(,7?BA[BVQI'M>E==Z%5:T0&>6O/JT
M%GA^T6Z:\A:@Y MBO(WY'^R]>53:=]X_:J?39CI-8JW1+&ZM1JU1-,8M[L],
M-8OK)-85ET83#2(2HJB(:"=IXT+41A,77)BZ5F6)85-1K%4D1M J$10%$U!<
M 9<H[EY-YW:>>\]]YC[/>7YS\OS.O:_C7WB.<EZ\>"^?[_O]^O@4>JV-!S'9
MG88]:Z$1"=K7P_@ZNM"]+UST-Q59\7N=@**[D&V+*'"D)"D!A)$P"443-PF/
M@B?DB>AIF@\9%]6E28&YUW6F/5?(E.D)1<(02'YFMU48 Q#CP><C+W^+9%>6
M^52J<;VC3=4O1.<"4OZ)"M\)?J?J/(MJO+.7LN;443V2TAYO]8)0^],4@>)8
M@@= ZF2[D;V"F<^-K\]<<.*#O>U-""U2[Z05>1M^D3A=\)'] \$ZLL1(T57,
MO+3ZO'(ACR\O;[VP&=P?4YO @X!R'X"]KMMM--1V9!$?*'3T+0HUP 7-:26@
MO.W\%ZX75M8#C;6AAF @E1:8U0ZVDEM8J2D6=%W.I-S"IT&"T)>HM6"G-Z2+
M<;VM)2\6QH^;&MX;?/4L<#1.JFH5!4>S;Y!.T1OB[J;@"!>VOK" C9G!%S4.
MROAK;D_[W;\*]-6 #:K^B>XL'7PT)IZZN-.RNF@E(7@%PP2TP]M<-6OG4MF\
M-QW1 &! -!77T\/V@(O[T;"<UJ406E<JLRF6[0T)SHT<*>$9&1D''13\R_^7
M'OI(XQ MEXY3 H!/R3KW#1OC!0'(DZ1YNI%N.N19BM>ZYHKI3K3'"^AW7RW;
MX%^>&&%IP/PU8*S^0&WNH%/"R&JYL?I$N^T"K57&<)[\N*,KS7YI*A=4J.G!
M@7I>[HMELQX4ZI:4E&3#:'1GH@&Y[^ED%"&L,M;;PO-2<ZS N@3+R73K!&&3
MXAE*U06YC3>QW"5WVC8W\T%ZU\*LD712BQ8%V7S \WF^D"*O*Y(J@/36HCR+
M17L"$&?XDLP$7/^3(7YDL-(5K?KMWJN-5+DJHSV0,8D(8W LR4(V&-4Q [PT
MB+ Y:*MP;MNXMH R3 #T"L%CFIGWX29V^L%VL]VD@V!-*FOG;VM&> W'L(2W
MN#];J*U1EQX^.M-;A X@G<G,?:?W4?V+,9)AF<:<\SV2ZN<J% JQ.ZZJ^9O-
M6P.D_$81A/0TJ0\O+3M9#QIMK<M</MK[Y5!CXT)C(P"'_[% *KV"%Q=X)&$+
M1;[)Q(K=A?O/D,9'VD4WUU>C&<WW0?>,]+=SF6+C:AV;K*RLLJEVOJ[#I.%"
M<!_2CV*?MR(UZ5YZ,]\/U1+!9YG>:7=O8OVC]H ^3W#>=9]SB -86V348/K>
M*))+,<W4\EIBW1NR#H4(.:).OH/-M]S^[)&EE8EE[>*$U.)#_YX1;?^(*7,C
M+/=!3O4]B\M[ES9-!)5?)AV?;*:'&)_EQ9@OP%.9=^5*VZR'I2ON\)S>1R>8
M>49#: V03Y, @ PZ&9V4<7K,2==%*Y<G\ WP*E33["](G.\@OTG5-PV+J3NH
MK]G>]3[ [YY\\W\2YPI&(M']60# 9YCY^?G;;SW2"4@T.GOA5X_TQJMU&(^6
M0X]T3&-3Y45)/GJYT,CIHJP84-72I&Y+9KNYN8&MK%S4U'2MK%Y_LA<R4AO-
M*\GI 5NY9.47!4ZOVZZ7T)96_TQ=\6501F^M9)">VCZ[<?YT>]B)R<3CQ07W
M%DIM%CSBT\%HEY_'FY6/5K&81OV6IP\P,-BRGO;-<QT_0/-4T4<K[R3P5B:?
M*C7SS5+8ZP]+8:)41!C'J.T6M5)3\'5'C)22C9DF#\QS(4G+#SY%]$E1="+2
MN?/GFR4R#F6F<01[;.!*R7J][T?,J]G*:Q)-[#,?!LO]NY&EH<_>G6C_ _P.
M5[DK&N+K=.6-.DTN$P,Q2LI2T&1/VC=#RTKXB/F^RH\+*;<AGT_"0YW_<K5G
MG$I\T#ND^^>!CZ)V_'2@7M^[A^WX^Z% >N]A-5NVOX315BZS*U[Z4:RF9L4T
M.QR(,EAV5I#4N@(^ R'=;!\P*\)M/^1C1,OWABZ>Q1:$W^;G]/D,R+4?:=^2
MU8V?9<T'=E"4R=3.!A$7#[%T/EEA%%FX>/T&')3^V_M]7P3/N)VDZIETO%[0
MX4^-MH[O'B)I;LH"8W^:@$$+>J;P&X1\#+8R&R)?E,NF"T3S/+$]! JX5?"1
MI.#TV3P"NG4[BK;-I2E134*@EZ-<-'FC/'CI5BZHH% R/WQ0L+LWI'*@>6L$
MKR3\ O#RQX\D5"<&R^)TG[@.\B#VH+"_U'P;NVMIZ>#EY>4=K3]R$*@3H>M-
M2N<%*$RW_-F:PK*-7W#FPR,:JHEK]1QOHE7X-9V.[UA1MWD%'#.E$-D\-;_9
M4)TSC?TXP<8VT-]_F=+6OEJ][+O4-X%5=9:DY]R<V(1U#B(D-&Q8;73T$&E"
MH*]/;[=>*AVF3 R3RDY<*H7=^(9Q:S/A>9(>P,']6=(><ERZB7+1M3KUS+<)
M8+!J</9R6.)ZT]5 ]R3R.U36OQ8?OK<"[6.4+W]<;UNYJG"NTXFZPOM<[/!%
M?I8\8?Q2JM2^L0>TE:[?\+="1TK,S7N-$'Q#8XY)5;9QY17(C<H4DL)LAZ30
MLT.RP*.[^90*OEU;171,B+@[AZ2["FOIJ^DU.U45"45DEY;B38#3'2;QJS1D
M<I&\$GCR6'=D>1F[</-);=0"$9GR9KAM8U :T&R+X2&ZMO.0V4DS+33X0106
MNI:%H7[< V3-,1J?M4D5ZGS!@(]XV'/,J.W-WW9B[HQE'*446Q4V.MBW%8F^
MJ*[2 B+!*:C3._8[3DG%W;1;&4=:3#8'[\3OBGR^1,6^F1)*:T),U<)BA+*E
M-1$]S=)JZ&0''CS=5VPX,_-UDM[)T5!7MFW$S<E;<]0T[AD@0&SLJZI;GLB+
MTK&IT(^./O3'=![^J.(?%-(RGAXA5YQV@>NYIGW/^Z%8[RB/?@0MT(PVS8D_
MUR>Y !^)$9U>#"5_Z?67L; @KE&]FZA>?610_&;(^X18?NO'?97\3K0CI#IY
M2J]8JS2WAS?:BN?9YSI87)F7P,*-X&4!7*TY0H7E7K9M:07/@4ET<OJE/%W9
MO)UQMO=J-F'5,)%[-5^G(V:^9Z[,VWK7(R8"$=2"P:I=>7>J^@_QP6?.F\Y5
MMV?9O<D<WS.4A_&N-4G:3[#.W3R!R$',,V\2)-B%9\XP/GUQ3MI,6Q#6 V!N
M@9I/N1#-DP9.B5UZML4GAF*2]7[G>E)]4LM)UW.SL*VOL(.Z(5-V(C#+H,FO
M66'ID *N&DCXBJ4>&\Y%QI_G<9&7XA+LZRP**D&^5CD5/TS8 ^*C=&(F;K7W
M;,\'V"B3L%[3M5%!I;R[UXVB4YOP\QLD<NYO[_B]HC:K]FV_7M'+EX[5M>L[
M18]&,9<\RHM4[7,;,2U-.0V-6HOAUWMC;SYCOTJPO1X(044EN!7QBX8#3Y#]
MW4.7>K9GFNE =AY/E!2#6%Q6T)-1^=7FIOLJ_<#AH=KF:=9MM+C_*EK2[MYD
M:?GI_&:E5J[\N)V%6K^8<! GYV(']] !*!M*3"\UUXBD9NG09H$,1_ZP%M'"
M]U]-@/3:75GY^$JO('V\XO(:W)]#L_'7J-<:R.5,/ N7IBJMD(;67'__JPE9
MK05ECB\:I4W ID''"/7)H\[<I3FAB\*X?1*1P>B#ED"WTNE<:%E\:J1I?G)>
MLY6EVHG!*^6CD=;]Z*-_7-7KS_-\BC O@T>_6@U!]:*<73J3"WW_.(U+OQEN
M0,!6X0U-3H:,_I//_7]GO)>-'&S?(O:*FL:WJ]ML=^(?\5,OV>**$NP+&AM;
MFS"-=5K:X>:]9VYVL&=(=L^N0:*B(&[%=L47KIWXRC\L]$Z_HU8SO9Z=-S>V
M'A,=MP*EHU&%U9KG,OH/FN]:F/C0S;$?D1-5XXVW5+L@NQBO52 _[GE2K2>2
M"MD#@T)8>V4A* U\5"^O0K]9W<K!_L5V-;(TR;AE7P4FB"'&&7$=/ E2MF0K
M E_3*/!<#'<T-:RP=R;>Z: V7EEQI')US05-&(,"NEFBY64PA)-AI@Q,S]D[
MN7<&B7S=3R(^[2ZPZY ][W5<<7S.,T4. X;N0X$@Z_&ORT0F5FJ%-OBX5@=X
MG9F?I#_#PE;GKST#?PRQ2C@M)K7T2VKKVN8\W+8LN<'<H/EVMD  UL!]72.)
M^@=W3XV?72;G3F(<1VC?.Z\1I69.P0OL'BOQ(@$GII$5N2S5#!:Q?HR3 +"S
MF4T!9KF$RJ;.]^EP0OUS[X482Z7 BQ\L-R_'H/LJ_RC\ZRCRH;W3T-1Y=O@(
MF=/2P?#8B >HG;FT<-:''II$]C;PYBQ8*_TYU>VO5__<4?VL4O7;/L]DH]04
MM@^)RKJ]U.>0@NQWV\TC65INU?3PZRPRT/_%JX;NW;_PS\R TO]GF@']WW"$
MPW[]=%M7SY08=Q$7G_Q>1>_D#5*)$R>7X*=:VCT-N-7<)W[6TC];_^RYY*ZM
M'__HDK<[S%L#?BW,Z:#OMG=TEJ[FB2*G+NZTGH<NW7Q[''!XC QX>QP04EQ;
M!0 &1(Z0W7IZNN?0YF&,D)DNL)\S0!/?9*6)KX*C PZ?_^5&1O4:]VHK4;.H
M^@3=(TE>'5TCMJ1;:?ZRW"9#GV:W:T)O.!?I\F=Z.44GHKRUN'2^[:=5L-?$
M FW%,XS)K, 5*4-'$J!K=I5_W3O*,*6F(Y,FDC+A(9:(^AX92%$7W1S^Y3%K
MEN/$M3.)T_-SFZ(O<-=;+4)+R*Q"X>L*EVN;%>B.E UQJWV.TIQ_ KYE/7AE
MF+'5/$]M0PIZ0)HE%%19XO!1O]S6?_N-MUN$APJ7E\LTBLWQV3E4IV%-DM&C
M@GK#^P-1L76$<^+&V ?;)Q\W8TK-2!>U.8^?C$<$30P94J;)3Y@ C6N!3I8N
MFXOQO%4#"JVB5(1T0LJ%DU&S_3G[*BN\-V10' (FT-]X-ARYH5"+97NYM3%B
M'DB0]W/[>^YN-)7=P+2%D/95JD:PWI#@97SU55R/EP\!+>)7SJ("Y38C:1/C
ML-QAIWO#EE0L=>;:;IA_ H3C[P[J7:U.2#8K;JWL8(OZO*U'_*^'BLUOU@VL
M-+8V\N97!_@]RF[5Q!V'9%]ZG\).%*%X!I1J[6$);\:EXY4E.1*A!.?%=G.W
M&C:V/95[0=S]NW;6BJ1@4=>S3AC<XL3#PK"^OD3A%/?G5K!>Z<FLA?K9IJL>
M[CSJNQ/WOQ(?6LK3Q0N=>JE$A#QO;/3&2)N"\-3.49-;COFXC &)@\SGG?J!
MTDS*04[D>1H@G0)X1;\,A?+MK"Z?2%P-2X,->(]58"=<OD[V89$<_:".!/%4
M O_XT6N6X4T^)"MP2"2YUE2S0P'*&7Y".4P%BREYQAD#*T$I>5;:TY-RBQ.U
M\"Q>S'3IL+Z^?C3WH'FW<OEDQE2>*<\45$K"&IB<P=,  Y;0P#!Y^]J:W@@W
M4'/"WXM:KG <M"WHNU6Z:':@2C__KT8,J?H"#]SB?%,.@4!TUM@YOW-^G=9=
M#T:VIRM0T@^W==(S.N>V%.X,"'4^B^I<Y^CFY=83X2RVBL[B:II9S?3GFU\4
M=4E2P=RR<DZ0<O/-FZU=D7,:.(>T68C(H^\](*._JHK[YC?>/L7++LO*VK>S
MD],T:;PQ,]6\#GA!;[@R?E\%DJ#KL( VQ0:(!]VYYN9FS]1$\>-F22,P9GCN
MG2BS#8)44GE.*OCX1^)RX#*@:\=IW?O9*ZK37N3=BXIP.W L9V'DC#L-F(6^
M#J9V6^E5H:/[ZIQ@]1T, $@*+4&Z=+^6OL1,5DX$1$%SHH)X3L9&5[)S+;D1
MQ<!Q#_X;O_ \(81_QNXOMT/R ]<J2;E<LH[J^_D\N'.,FMOC(/'YT183&H6:
MUSI5.3\?#ZK'2%LJK\;'1S>V1A=<!1/:VF>4QK#5BLG!^&UL:[*]7?G>OHKS
M:@RG(*K)R'. 2IY3"V$UDG$!CW'N)B$\??W?W=5^L/I$-#W5JEW4SQA$="B@
MWG@KW&"?WO6W-B8'0,9<>?W-?ZC =PC5(P*="+Z0RQ^/\4\BU&>*4E<1W1-?
M)^$#G:&<7CM ;HLT9R^$X2%N(;>36W(<T< FA'X;J2W'_E6!?76>!U(T*D]_
MM<AX)4@.C)6OQB$SHS 77@WF)#(<69G$( I$W:8#H%GG$3*Z$O"2TN0D<GPT
M"=-:#,6>+MI(WH!JUBXX>$>[OO'R JNKJVMF'VY]W.!,"K7&[9J=6QSSN.\C
M,VQGAL.R;6,^']XM-+0=FKQE.=I@-M\W7_;=$XHE*T](N;U2]'*"KYT8?/-&
MD6-3_!>;]13R&_A2YS)@?%*MHP*UIPU[IHAWL.0^&NLEA80OQS_<1@*#&>-.
MPZM72LM+(,#(OI':"]/8/>!FYE/%GE'"<'-F29=&;J^%CJDMWW,XAINWY8,9
M]#<RHO*O4*H_,-8Z]1M]'X;,#JS*?+60?G^1YQ6/KX1<C@2=/G<WR$EJVQ@K
M)IRK^Q':C/ \W5#0;_57]MC5,,I:+N=38#CP:NCU(7^-A&YU166O#'K!$8@8
MJY@AL1@RX;K+PQ;BO@H ZGFIB%6L4V6!!AA9Y"UKXGIZ/)ND*?%V+1<GVB];
MY+123S?5-KEN 8+?\$:P9P36&+9;S_QLAPPASQQ)EX0%<CBT4T*#YP #+=!V
M/%QO9"30=F+DJX!RJ(.=W=T^9.G"!&?Q,=?;W]]P0%_J$:<XUX3!QQ.=9&F^
M:>>5OMWUB=OME:NHZ;UM0\:-P[CAS8"TSF41G$4./>P>-S]G_80;65QSL_.F
M[ QS>_.NJ3;(2-E]#DAY^FW<\'8R+6K>?)22UY:>0WY<$P;^^MUI_%^'(_=E
MQW]9D!<MR$@49&!<]ZP047U#;C4>,%+9(IW4RNX=7W77LXDP_'0B3!0VX:G3
M@<>WWQ6&AWEJ?W+Y[/!EG3!%7!+K3G+]'8AC("6IE";L9G!./?V:>6;2<(;%
MKPF@9)6%KV.X.J9QI8"0 %X>5(<%;46MFUL]9*:-[_ /,DIN--=UZZVK44E.
MS]M.8P8MY\@YHRZO=^\/-#0FE RU!P^1U'WY0I33!'"*NOBD4SV$-:;S2 <W
M/!ZV6)PTS&=^EZG1#_Z64O1C5>/5J;:VUC?&2]@E[/B^BFI8IY+_1.FHL$X>
MC;1#MN2":#5SH+%%Z9!ZJ$U)/K+88S(AE:G08(4&-0\HS)R>CJX;L6: A(?"
M/@SV5O]<CMO&-BYD@ZF?WB92+X@*'FX.X6ESCU%^^HW!^.)[NA\K];"[,^@Y
M0CTM4RL*<C1XH'?1B?RI)WZ-6NP^84LK^_!ZUM0]KTH/A*'X:/R%TU^T/!>.
M,%VMSU^#)4#KG-96^TGM]Q;3.J:%2>6E,BLTB,RR/$TK*\4)6AJLU$_4N,&C
M.;<Q8M:9N;3"?$VORQW(P>S%]#,3-&,K,/N-F!F\OC+%#<*E)F:]$:V>"6 T
MD'G4N5L2XX<5]N*3/K'"TT,8LD/O(]R7["=\8\N)&>K#-?8=;O&$W=&.\UU&
MR;$#?1_8A$Z,>)_P<U?K^OT=0??OU1#-JU;L@>75Y/;DL.5)K09A K)A6-^&
M8':QR4J^OIV6RH[LRC&*?)Q=6GKP"3. HG5BNEAN#FQ#Q+4/6A7=A5[PE08\
MR<?7FDJX'@NO]<K 7@((:)#]P= W[TSL_Q0_N7AO]'$KP]](N4,5,TU?DN:T
MG)RNNL-6=:C(P$'@99N+N=V^_2-'5[ZFXDX4COA3.-9\]Z\"SZJS;'#<+G/4
M-+:T0C)],D6&E#0K_2C2=5)-ST)<<'-(E BB/+66U7_?S,U]SDI=7:,#X$6N
M71 E*6!WA?C^2&E*'"D?D9=A2\/MPBTBCC<"?4_M] =$#AW\3ZQ+VB=R5Q7'
M0<#+W1_0F)FP/N]'+]8"HT+<#5/Y-^=@8<LZ5#\MQ"Q3^_3BS83NXU%:$2<F
MH@@+DI5 B V>R:K)_SQM;5'ABM12A:_W!A$-\DSR461R3_28/+J-8Q$6':,A
M!4 8MWFML)ZM"W[F3DG'QG3F>I2L8^&^N>1+J3V!MB9;.\'6R]GY83%7,1%#
ML3M%OPY>_O0;<?]_!OG_<@9)<?E%=IPQ%\\8/TP ;)=</L965^),@00OY$&6
M6\HAG=;75OU7K@&8PFEA3_.X0##. HQ,OVSN^OU=[[.P$=$Z*R[Y2&KRA]R#
M_ ,J0TTX+@ZA/SQZ#;\2GH9*=0<'95,4(+SE,+6O8*06<ENZ/)&T73P9*;G(
M#N1T<E+P)D$\B-5!!ZIO$%Q:FH5S$QQ> 9#"6!0M"N_+]4:=YC'U]KE:S HM
M2^M=%)_+83(\X_N RS8XU*,Q-0$'0!'U)4, :4%!L%!JBV=P;,ZYFDK/IB;L
MGS,^VE?Y:+=S:>T@BZ 0$0F,U<NH!P;)]"Q>6:I/447E $3-ICLX2]F:B%?:
MX<*70^%,M+9\I;O_6'YD7#J\;98S4=JP'LHHJ?'-;V,2'UXW7L"_MC>RJ3#5
MP-_@G!\/_8W"#].7"WM])"O*EK7XA[.<$ @V>4PJ]5@H+ 4\=6!\*+@"ZI=K
M/0@OB<G_H/%5=26&$!];US9/:'EUSYY0=^^C.WI63NQ%Q1=T1_BDSG);+O$C
M2JZ^@><M3M&0BP)*8^%\0C>CC4RNE&1E412QD;6*\,(6.CI;%F]L8<6>?HAT
M@FU2.^H70!X;\'!!RF6I@*N!#G'X"S(C1>=E^J3PHWOSX6U/2<\AK1\[!?C1
MZ!?H+I\-K"=M?I"O%B&-;RIHE<.V1"Y2A/AG<4I1"ZP(OLKB -BTP$#=^/:]
MU7%ZVIZ"O3LV$6R1G\U*>SP:MT5A/A-P*'4.<S41-F)3R$!Z"37N$>$QRRNH
MF<]/4Q)-)IV$F]Z[=?003O6'.JCRBVM+N-2ZU3,^GG-XV4J :8C"X/+37_Z)
M)-\EWJMW2=SP?KF'?'.\>PC5X#8JJ,<XK6=W1$$ !.KQ5E'<YY5F/D-9.3,E
MDO9,;DL!;^]%@W[=OHH>S%K[ZC'X92=@YO-)AVWB\_B]<>4@V.MF3H]8"(&"
M" "1@*M>^.%5 BF8I[_QS"T$=@MOP4UE-L212([=A8N5"7I6O7,0@WHC^]*<
M:98#_+H@U5G-AEK(O9T]'&E$XA2S?3^AYW?MK8YN:=$M/QE=#"J)9"]L3D#N
MAH*!TN+OZ0QR%_3,DS?-W8;2(Y9&MBE[GU[38>*%[>LT-6;"[X>&YE3[]E7L
MD(X#\M[QY)E;T67+8]&P:2;*P):?X,$;2QI;4+<,;1&O83_"3.K,%>O@\PT!
MMD<$%2,]ROQC^66O%5;WN-S8P>^6I[*RJ8ZLQA&><7<0A@,)/FB9X'#2V#]Z
M$E7$R.X/H\Z 40=L[%K 6,D07?42&SA#"6MZ'W;P_54OH(G;7&+34PUI=!*=
M5N2); )F35/:*457C/.NW"QP:#.?D>5-*GPFA>M$..2\@HY$/8#%=!79U'GX
MYC==Q3=9'G1M-@Q'7JNE@(:':)M?SAM=V=9NCS'.*:6>;CCH]\XPJS+>]/3,
M65I:VI2@ R(C#7^9$<0(RX@=W5O;N7[@&=5JA'?UC=?8IZE;'[72>F6CX^DW
M*(7/'$2.#;6M=)Y<?JL:O7T<7+3P$1Q@Z?G5]U?!\(09DKC[M6N+BR[]OH*H
MH:") J$D+XA=PIE)*((W1!)Y1^JW-JFY+)@_J9,^*1LV+6B%1=USB=F\P5CT
M5@Y0.Q!TJ,T>LYAK7;JL#$Y<0O>@(.T&9R\UUU:-X'I_D'SU#F7_+X*E!4*)
M]=\8'T%F)"9?FLP==E!<Z1TI&(BYX.\?:)/@_U5W%)HYVNU5W%J^'KWN <#%
M07XLD*Y(/?1S<IJ:\D['1"79)6X^$CJZL!<YE=Y*&/198B33=Q."%"02G((6
MU--:H99>B=F4.GVCL/ICW7?#NOHBQ1<?!ARD%HAIT+X*%^Q;1<&E"+@U ?K1
M,9>=.A/SDT03RE,"/+P?[#A 7N[V9H>+9H7!4!2[&+$M,+?XC 5%%3N3*8);
MR<=AZG[:MLW^1JZJWG=98/:3?A@\8?;+U\C75F2&3DO377NHCR\;(CW#3^C
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M53(RY4XG7SDJ(Z1GF5/B!PWUS&G(V2HT[A*+&.$+!1MY D>7$YC(&S#VM1$
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M%''SCC"_AY\K,=4<M"2$\K*4I="%4JR.J=[?:GR]HZ;) MZPIBSZ'P3^BY?
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M]ZA"KT]7SS(=,UX3J6M92J@5PLT;G)NJ\@*^^X/4_B_CDUBYA?SA^U"%%]L
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M B\/4XX6#KPH'_'PX93/<[R]C(MS**"P_O3B+KZ$.33LW=S,SI^OV25RR$_
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MI0QNE4BKLI,*2ICU7O4^?[:3J\'<AXW]<\$PG Q[4WX\3<R/>#5;'M[ Z!Q
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ME?U"!Y]"OT>,F\CM=$Q!D#(FZB$]PGBUV680;R<X,97AJH/^LZI5"LL:-SX
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M2Y?V3S8M]TB)T.8]_PUWA+'&=R2Q7+\]NGUSS<^)#8(@'JP]EN17!A^D9><
M@?V&=%4XW%"&\*&*$D>W@:'&(:$P>UHA*H_.D)>D0[/U[!@!T0^W%,F>W@Y=
MCKVTB7E6%;4/F 1#4J,$&TL@M;#6A->8&*=!L'>1.\?A$@\<FD%ZJ>#DAGV=
MMC!]<#$E*[717N3"2#[8_]MV3.FI1^A<D\M=W>*N[^FWN9<WB*S\R77JHY)V
M!30S^B)G?$(W"1; TGG$3@\+A^=.]8)2>H\IEKP.]+[Y&^NU9CT#4)J32[HX
MN=RP(JX'V"FB6J&!%:/5UBV,L5?=!V>[TW@)TZ;IP,E9KEX%*XM( PZ5%D8"
M>&<B ZLMRTK48_#3_Q#"SW]^Y4.1EQQ\&"I*G@F(V>](MS9^(;M<K=TW[0<G
MP%S&8$<?@BHU_#<1^F$"-_J0^Y?TD:VHHHG%D*F0B94M5X)3AII#@U)TPMNM
MF(]:DN?6N]HZMB3-KU1'V)Q,QNO. ,<L2GIWC)>$++06ET9M7L[8:.V0P?9F
MR\O&;4[6>63NN$N/C^@18NV$#L;I>/ZK5$IC3D:Z:.E2C__4;O"FS]@4M_R-
M['EW^P"D:M;C0^2,LBYJ'W"75IR=MRC(] Z)P^;0(9Z)X8&!B98PI;L> GD.
MWCWG)#+8K."A5I=Z*8A>'V!PU%.V^M*>N +!K+G>P@6(,<DVE;X?(14>0:H4
M[@O!PE(EWUJI.7JE$-@(RS-XR9Z0GY6V!5\OC%"P+5IN;HY'_T^YG?N +M__
MH7;=O[IFR90Q;44[[#K1LM4W25JF6-S^CON$4\Q2J;\Y=[G;=GEI^:!V57SE
M#*[I -18DO-&V"3%U2#0'Y"W!8OB2RF;D+A-^X/$Y(P">U2O??3(0YX7SLC=
MA9?4XM5JKN5/)+::!Y:CP^B1M+G-I$G89#M0,%=MY.X/ 7M7;/E;O=,',1G7
M<LM7[GDY]A_,569\R;/#_.KI,G[]EDT:>/9\ZE'49V,?TC75OW*4^][I_AC8
MM*C5"JIMCNM-SXD5NL\)J\(=;F@P4_I6UM?N1E5"$&06=4PC%^^^LHM@,(8>
MF(<>+!;I6DRTA'_$@6BY)L^ ;0:#["<S53E<?2/!9J%5_M7QHD7V&/;<NS/#
MDF[QNG'*(:;M9N';0T]2\1/3B3/WIBJSAON@P5X2S=T3,^08J'+W6(PLYW1G
M7DA6@*'CX#R=/<5W^_.MB?"1HVHW='5\78^S!]M7=/N>IA!4?R!3P$#2Y%T$
M(.DV?UG!/7$QF0,Q=[]YIJT5!P'E<#C$5E"E)^.%"IH>/00Q>B)JBWS:3M>Z
M^:C%GUB8O-("4FMA,/8Z+"Q$9GK+TS_]^P1J-[RV^4[@!I=/6=YQU/S%R\E0
MVZHAF L$WJ8]D<9WTV>XK(;$SC@88-IMJW@:-NQ78LJI+&AX>TCM^JW/_(Y;
M#)\H4Q)8!%-DUG*WA"*! V2K_K-64Q$5?#B%AK)ZF@51'PLJ*RB76_7G-[4A
M'X#'20.(?MK6L6'1 8HQGS-R!YN:U>,=TJ'7Y!NX@CG6//H(W]9:&]-FL[\A
MV\ KZ'S*C4:EH;[JMYMAD=JN)8I9Q-43+V;C&3?"U88162^7:,AJ1T3]=*B;
M9Y5P289[*&)G5TJ;%[[( GQI*-06EC*@.?& C/THLOY46H(7:3KL:$G52;%5
MWAP+8J2D,?QC' _<_8U:11]=U!A.9^C)69>[#_9F,G& NW?72%T;+SN9QJL
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M<>H;7=3[6?&_204=[/7?9\6WGW"3==U4_CXK;C7=%JD(?&[R;[/BU^>;*IQ
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M)L\9)B\'9ZDK+JRFS7PZ>B=YE/34BW[<%3QDZ/JK*X;[2\4SGET$>C$-V$=
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MI_K*5JK4PA,)39 ?GO6X#:,GB>N,5GVA3]_A[P0W0X*DY=6K4%W$IV(]<%V
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MG3+@_Z%ITSD[4<I&NX0XP&K+!F*'UL0=@F<+O#7S=XTN(0^Q(_@88\^N?T)
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M39EOH'J(H=K$#/:V(B3%JV]+,=;9@X&UO\WLE!B#6.%U-4#[B4RYU_+%NL
M=U-W+>3+7\E*I3)M/2+BN\-X?*L-@ < T+QTE,KU*WY_??&)39#?[8$O4V3^
M]BSZ45:@/IQN],D?&"6F"67#9:P$<F5U1-P'I%96UNE^O&25MW@1'"*790>N
MC0.Q[.3#RBRC7W]_3_X=\5G#=OC;L7S#>+&]&.>]>832&SD]/0QJ2X333#7:
M4T^8$\+?"4+G;I.F$SJ'7:QO+"SX:CPIT4VW/+H73-R ,_77ZL[NRA2^C,0
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MYJFQ'W&#_BHQ3=?U;FU]T.I,[=,Z UAX?L24LK31G10#U710=2IN-,28ZX(
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MP^'+2[1;9'.OOP]U>GPXG?\XVFE8_D^CQ8$OBR9GZ;RHDQW?=6V(XF"UX60
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M*XUNIK\_8*!JHF[A/,L$&T1OIS ;85[JH#<> PLGFV]YT61,6#@>"O!NT3(
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M1S+'AK&F'2<"'YW)##&.LV?YF^70/;NL7P2P*<1GDM[TZQG,#L[A\F.HU0P
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M7OM+\I?M X'Z=&!ZQ;L6(2$/3.@ZVVR&^&'=?'UN;MJR6SWL9G;R%HLO"_<
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M1-G%)N+LO](]0YOT1P-'6(Y5?CN@2P_.2Z.M4+5RD%GJ0RE!M2KYK7GE5I-
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MC*ECND6C[WKHLPJR.%AQ]!<5<EB:0$N\HH7V$[!?0K;[_LX$,NT&4N3U>S!
M R'Z&EI#Z;VZLQ4D.JB4PX]7E'0W-"EAR\36;TBCG_99?YU\TH^.[.-W^B*
MFF0?K[O^':^\[KJQ@^^ OD[RO"]F9!5D61H1J0INC^5<BTO*^X4-G^O#$FUV
M%RHLB:L7-.R20 2HJ[6P4RF-2PP=*UY5'_R!?SUDSHM]86JDAD;MN2[?1E5M
MX$$YA?TI%7T5E)SD0R.B^$&,7:0]2K*7KB_CMD\U-FQFVK2N[$R?LP\+GLP
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MF"JCNLHQ<%O6J2S#_:,VJ@@5BVP7B;FX)]@$4S4@N1E0G)J *BSK\GZ28//
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M.KEBBI\(R28)4,PP:5OL@.>$[ AXS6\<[[D7R1.M47 A:UJ"]:1(=A?>"QY
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M<1+.*X,1SQQ.7>.^I@CEY<N,)]S0%MR5':R0*PM5#G0/A*"QL'F3R=D9LMP
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M N76$QCQ\UBJN+I-,'LF*P/A"RG]079ZGDUA:6*CJQ^)]$^X&D-AEHM,3TM
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MGE*D]"VV^8SY[-5V I9Z1D9&YDQ H<H_CS'5^$@ +I1J 0Q9FRWD]QZ&=>X
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M([BU-FC0S^',%IW#WWPD\-:?]/*]#;H%&_R*.WB;'6EU*T+O#4;7]:N>3 $
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M!:Y$M2NQ9F+;!>8_25Y4H2?1&<7 H;EO.M>1.XH.% (EZ^IZKX3/OA@=GR0
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M*;/#<.92LJTX\!C\C2*,EC/ P?\GE5_9O.MYG1<5,?\YS&49F F72PX]PX?
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MM]^EZ@?F+VRWW$?#QMTF%$QFE3?/]<9Z/_EA4,?R^LA#>V&)S2YG;%J^O37
MHZT_IZQ?;#[%Z>C8$-: B1/58CVS?-7?U@RVW& $Y MZ";EGT);4E388]]%B
M.X.N!;@I$5?^=&OGTY]QX<D? :F841$P-85CW+^@+JJ)EA0U\/V6E]JI]&8Q
M]8:\+;Y"\'/OI"'UUW337TT9]BXAEYIP%^,>I(\OFF:%5G;;=J;Y>2++QG-.
M*#Z2N71!1-0:1H;$&H<CPB=U0[LX47&Q\O YWLS"8!KN>AQM&.9^J;RLC&TI
MPD;0.-']H8Q6D>Y ?S#?LN0_XGUP*3<Z7C&5E)H6]HG9Q=J1A5CAG%%>_]1L
MS"9R1U\^&O9=W+W[)W>  0A?)\6@U:W R!.NST4PVQH75RA&=J1QQ4G/"=ZR
M&=,!OLD<AH1&=6"; 5_M+HX6?&(_BIO$?\OX\VB]&[H-,/^YKI@<UY?DMUFA
M%_1,B(V!T'JP3VU%L\]@Q:OZX22;[FZ]D&L3 =.VZK';ZK%O+59PE6LM)!FI
MY;=2[P=QPGRZ%K<GTX*N[VC8>?ZQC&X+[V(242V%<UFH2#RG$*YP6'H*!7@1
MQ[PG'O5P.BV\VJ\:@D8C+50/VA/3G>D^'0<GSM8J $]8_E,-VWD;[#^;&6^T
M,YX]$),[J*]]?[@,W4'M&DUBXHXSGZ:@LB6CJ!BISVQ=>WFYK7XTB=2FLTWZ
M>L[2=X1ZBCT)L_E^XD04/OAI%[ZOM+).X'K3J&(&\^+N6L3,8KHC-Y1KLG[%
MH-@QU/R!I 6^K[@@$N='M&8(AQ*?M33G0XB2$R"AYP\O;0C'F#*DMJ%6 @6O
M.R*Q)+ICI/@NL"4QB$T<&$R>O-)[7CFWE[9=,2Y0FI/CTS^H*%@H%Q;MI=$X
M*;A$D0KAFVIG^(+"MEAI$W:E-=>@9HJ_K]Y5R2.MF:S7>0;2K:+][W=L(PQG
M^W3X>UZ<\TO=#T9K\%GTX=ZZP8S>\#1Y5.5&]4"H0S6U\GV,H^\:@)_749@G
MU<X<N]XM-674_GQD<RAW%>QR"24FZS@]D L%WSC8_II1T;10;'BW[.*3E8PE
M36>4^QV$3LK]5$<?S-G]@<E!UM"="B# *U ?[F^-8.H_S.U=7")41=R+J=EA
M.@\G=51Q+G7.Q@[GMY'H#+W(V>C<^C/YMUNU1?B6D&&D[4,%IP;A.,M9LMZ*
M&4(%N5XK<[;>?S-PW?7J:8__"/;_?Q?6(&J/_H:$OE MH3G=%SNO7X*GNWP/
MS;'@5B^@PBJ0R*3(.=\Q_KWHN#:XZN>U#E^$_^DL\Y''B#L]0-8BU&5<T3=F
MV$^,DIY86E+JA4Y<.M,J4_A]U@+1(:(*0J<P^0-!9>,MQE;$@6L19CW=Y)]R
MR3JOUZ^*<G/%)- 66.L)2AO@_]D&-NZ5LZ[Q>H?+C":T5VUO/['1^W)\1S\C
M\"4K(C7;TQ4\\)P7_G+P=-!!;_0T%3 ],^/OIAC7W_ >_6N S^U^SVL!8?52
MV!.(T/7O[1@UJU^1MA^5B7R!-P/;$"4A4Z#[6O$#OA  ".CMPZNH)#*8(J=#
MQ8?1KF(D#V8FV:%%M8GS-FJULXVCC*.L\[!G.2;)$U?V8-+PN;5#O*3!J8VM
MM B0F+7]KIR+C&UG->ZZ8 LQ'6/3A/O4?QPRHBV!5U[Q,EPOH .^[',.8YKN
M>8N]WP&2A>LDM@"Z)2ZX/Y4HESG0NTF3+VG,CA7VM)@H@TVVX&$1E04)Q1;"
M@&B,V2@\':ZVIGS9,40FA.3'D)RM-B:<%SOD\B*G:  %\W?GL0QJS5[!B?+?
ME1P](ZM6KYK5Q/ZW;>BP6PR_POM/1[,[7L18.V^J]7.:?0?UW7.;;IBG+W57
MW]V](,RSX&49N7[9.WY&OKS4)G<<*=$^L[/GH]K"Y?4V3#]GNW#:?$W*)G'&
MW G:TD%@U10Z$F<8GA1N39?MA5&P+:S\;79_2%ZOL4KD[UFT5;5!Y =SK/9<
M&187'/R:6?R<?^FN:6Y\GJW7W/Q><1-WG/T8CF;$VDJ0T\_V7R[IOF$D0)6A
MW[:TR!Z4_G;%1+10W-6YGV?*-XS=A0M:_=]EN?8GE0\!0KF07OYR.Z^]L)S@
M<;F\/8*V9)'AX_XL4L_M^CWX+)._SZC/H/)]1WC)N8,U!LO!Q<^*S,!U472
M+D1+9/FE[IC!_W)\S+\+TR>>;*R_D>VJP0X0YHFUM1H]<N-2H8# Z4X,"/GA
M,I:3:83(:N_/WY\9G!8HL/6Y^,ZN_+/VV?1+S3CP\CS)D3JF^2U*LZE7-(,V
MU</5A8I8/2]]V%9B2?Z[FCT)KS=EM>42Q/,.Q/#JBKV?1(K3#E[L/(X3R,EM
MZ/8"%9CH[M"U%!W,,3:)#O;:N87ICEBLJX\#_S)E16\5ZX%6,INXRMFU9EV8
M?4<I8TS- ?5XAD1W P#YU>LU7;^J(=THU'#ZN]*:W%]%^>DDRQW8A,'&-/\L
MF2K:Z:FW+2]CPRH3I.S)4QU0G:%>.LM V.L<GK:>@&QIMEO/.E.$>).N6%PW
M2,=_R:];;';PIPTZ0(@#X@1V-H7MFT(<C35QB$4G/S;$[P&M"S(3+%#<8;0R
MM!J?3\11W\["L-S=;(%^769/D!YE'C=-H]6<RVZH+_6R5CUKZRJK+SIMY<E\
M=JJ[3>RSL.GAXUS$"[;T*QNOR>JAA\>"=7TI?'1P<GX,-[AHDG#1V D>*ACK
M6'2YB+19)1P;G* ;GF:50T6$;)J<4PV&W;F/^PWK&XN^>!V/^:FW+2.UVXQ?
M7#:4*DMDZ-G]-K)CLUS'?X#KAJ1%X80[ 0Q?4HIT8?ILPS9>Z.-\BWTQ,."X
MI3L+7Q"^*%^4FPMTZ/IH@<OY^ZC0.",#ZN /42:Q468X>0TR^(F_;_*,VXB;
M[Y)26<VM4+2-N 29/!8 (=FQF#JZ ]LW[I6Q@EMNM>519<UF UPN>4LB:E8-
M*P>&_R:6-4DR"2]]-S.F(CK&.XI.:UL0$%DHH^;B27E:L[WS?VOOSJ/2NM=_
M\7M63]O39CK6*3$.W\1$FQIC<$P<X/8TT1A%FAK%V4:,2A )(N* >D[3&&>K
M-@X8X50-1A&(D<$!]"1JB!&T2@0%T2@.09P0Y_':WGO7=[A_W'77[WO7;]U[
M>/VYUU[LO3;L9S\/L#YO9S[U'6,W>G;"BL]$;]=9SI:UC'+E,MEL6]Z!5F(<
MI]2RG5YMKL948(OLJ0BG,->E:!'C:2HHZ":OJI',FKH:"RWM7=H*Z9-C":#K
MI>=7@@:T%1Q)JE[F[IO,M6_. 7BA_ZDWQS^+=[1WR]:O: M%GC2A*NR7]=V:
M]E*]>4=N5+T$B>?IR61[#J/(9@XR0P"NQ+&%@F"7$-71(G"(KQ!JC^EWCF)R
M-M75+Q GVX):DQ:((OL=/5SYPH, *H+>S%UX1"$S&X*JZ\\V:@.TCU;G+<4N
M3<AK\Z8VFAL/M%).T>U6KR$&;.W$-S+%M?Z9>=I-(Z38,%;LUG7=.4DZ,IYY
M^QNDWG=8$G(VCMD;;&!@ZXD),^:AI "5_3Q&J,OQ 0-41G888X"8_UA\SAFA
MT-LL?4^U?8NZ0KQGCG1".9RLT];1UM;>:$_0>1II/B2*Q#+6P!1AX/QQY_[^
MR^L^M-E+XB0YB/(]-15@8OK]$Y,\^X+0)B?^ZT)M[@CI7I?1P'6Q=](#^R^$
MQQC?W7&VK8\NR5H$5LU6],XY5 :A,BC^B<QZPW#&[ G[X)[K6%\T3T\(_L*9
MU?[S:"&\>\SU%YV "J^(D26RN=D-1</[?C:Q;FZN(FQ6+\_\+$"IXS!LA.NB
M,A73S<^$ >O/9];@AN[7%7(YC;51.%';--' "XO:8Q.GG*R@CQ7#?>6+96<R
M3N<XV1WO9[T,"T4#O3VMJ^N/#W>O<2MI-_O>$E"7+LS,4$+/4*8R)I.:9\X]
M6BBHP4WP*K/= <7E$RA; *HRIM8*\?2L+' >Q6'6(1#YQ0,&<WFH_)_7RY>,
M9P^T2G=D9CCD6)_0"<+M=,@<M!<'._3:Z@#YB0AZKLBLV\3UZ4+EXD="FZDK
MX[M?+^4XNT#$F*(^)>$X+&WH8CA/-G07C<$T1_]Y?IOAAX5 7I_:XJS&FLUF
MG:UOGB/3(JP1NYY)'XWY\EP^Q2U#!:6UU?I(D2LM!:P<TCZ=^FZBWT&HI"QN
MUSF)5$'7.IWE^,[YM$!+M0GTKB.+X+>%R%8W(+1U>P=2XU=YWHU G9I-.S8@
MHU<YXLR_E*Y7]'(&+<2@?NJ:N1C;6.Y\)/_*).U[SG-N]A%*0#.9=G6&\(%,
M?P0:CDTEJJ/>(.NXPW=YI*@B>[)7 E41O86XQQ<-K(5'GDJX.-PDSQVV"IID
M(/0;NKIXO3HF7VS1//]S_FDKR:<MH_C$.<*?MMG=?9NC"S2@Z=$^:\KZMGT9
M, ;?<B.M#<'M#E3ZCU->Y!#>;^<TMU<3ZJJLB:T?R-0@F4EBTM61>&9;=>L5
M8^+- RW!> K[B7"AVZ+V8U2,6,%0Q.8F?!B,E%R/A!E.M?4R-C/+IUJL2DZ[
M?XBR=YKE03Z_3E;7;,<W*.2V-==J$'7M8R ,4##Y"K\1LK;D"5NYW(WYY!M6
MBN/'[@#)*,RRYVNK?0/JL_F\:@-[K.HZ-4'LH!WZ-=9"5W TWN=\O+OW_/9?
MT@Q3(N-@PW$NC^R;>;8!Y,Z[)5A&Z 5 <$7/R 3G&B*1:R,UKM.QXY(10=^[
MU!+W0]$RWY<DH/I\E$?N2:0B:S">%8;UV,+F@"/-7D7&9Q7%TG;\6)]%_J!L
MY7 ZAX-XR]M/3D"Q#Q=#$1T^IM9&VZ<C1YHFON2EFGQ7?W7/3U\YA_Q *5C0
M$_/LW!8_;/LXZ#YM3 B+GNDI2F-?VD@)1H=8FSPY>7FJ8LTGS&VFTJ",%&OF
MB5CTG(3^\9HX<Y*.2*96V$$AIB$7/!$-Z4MF'OO;9J\]D^D+_UB7_@HKJ!0>
M&36>0/=3@G?73:,C[NL_Z;5_6F,T@$"]<W"%83ZN9';I]7_\!<2%X^MZN_?B
M.[2QG5N?8MNMW6Q+"1D+W@5]5O#*;*;BJ[NL0H0WJW*/W>C \/(3ZE'C&\!P
MCPHOY1BD?^FRHW _*Y7<UT['9E@!RTFG^J]6188?SN>9RWEG+4(BY/6[1Y8I
M-37Y2HH+]$/J-Q<,*-VGCY4&S+%3PK1[<?!T7[9SK,_I]";?J.L+N3JW3CCB
M.XU^&O#5%0I<,%V1BR2@RX>E>WV7%(O$E"1F); ;.9/\7F1Y3[EX(7EB3L&D
M.'R8*V-T\;MZ0U9"%F2[7?$KP<2-2Z"E*/M)8E9>\MEP@L+6<%4)L*4@ \MS
M_OJ?<B_\<_J(MQB2]/<$!Z +Y$ZT)&TC)V?.]6+L=,-$0BX^'?JI@SBTDAC[
M=GNLH(Y-*9O:]-ENO;J5M*G:,N8=&W4YT(I=M,!)=Q9F>%@G1&I[3!G*U9:*
M93G[I9:K"DP_4Q486,,[QF.LEQ*NOICH<4J4<^N )@!Y0-8RZ60T#K;S]4YT
M0BUE2S#1 9G<0]5L'6@A<F.#:H&FU]7)P-*%ZZ4#>R=(,_NR%7S'K2W7,-)$
M9TK";+>XBXZ ;S1QDG);L>GJ4MZ;5%QM&$D^JJS]@!57KSK9>H,$D,N;,B"J
M-W:!W%$OP&RG;Z[UT-^)!^8&3+F/U_L2/V+?P@!S&!L;/E-7,V8J_G2YK;V#
MB2@,AJ#G.B]]<[IU[FK#WJH#&L._[7X\<+#^V28F!"M642H/M*3I'E$DSG6*
M-P[QCSAI*JP^#OGBO0"@7=-MS1J%=0<P=GP<7A:=Q5MJFV@_41UH_5FF8I;1
M-O1YV )_,<6X+M5NS=M9U$@G1\)1==K'3LR?8$(!>A@9-JS<7SH\W7,+S-)Y
M[A2K- C)-ZU(VBH*6*_$/+=9G8Z[);ME[.+N;?+V*WE1?0N-")LL=Z3_8;5V
M?B%P<I$HZ/%T QE5A/Z%G1,ALLM\68$HD TB&I3.N259F7GF5K;!8IC**CO<
ML@?MD)6]*=5/K$32-TJ[0\N$8:9)<)&KB=/KOR5\*L4L@LD#KH'3C]S6!;=@
MT>WYP(Z%FXW,49DOVL7^SM]GF?;MC/PG/Z.[O3A#YV^-;,<)>3KJ,+T!M]WW
MP,*EC/W(H7QWBZM=75.*<EE,\B1ST&(,PL>@+*HB(UNO>8,13H.63VNO#._^
MEZ34MK*\;G9;"+)VY+ZR!KXV?J<==0*:P1(!V6#S^$>->S7<M\DODI#KJ&/.
M31?..9:4V ^)#:=<NS^U#97/]7P3#'6]GL()@D1=9X(NBG6AOEPN[]5GB*JT
MQ+RV-LRD<(+="C]UI6]E N '1Z23(XG >.JVN;GCVF]K?KQFE.6,D2*HD40A
M0+[[Z\I.429KO&1$9&Z>UIN._E#I>DINU*7\4.#%8VK;J^"?*$25>:(-_?7*
MK+_'2O2&1L7KZR52,J5RB':)!O!]J?_=D41,B;X-V,'!\UD=D9 X\^Q>$=%2
MGG]/+F]+C)U>Z)/S8KC<-S'LS3J]BB 423^Q(=0<;GN%&IW)\1,&D(Y<\R8H
M+O+@;]"[#R.E1S<QAY-HE+$R,9/5ZK7*WXZO!(98N&?CO/W_O]SJ5[$'6KG
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MXR)#S$5DKW><[^RS^9+"F-,_J4F]^4"+T+_8WATTM\PQ"5(V*-8&(#@=$UL
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M]8^U.T9EM/+FV#T5G9"3HN('KY%RG1JXB:'7CL=Q)>@.";'/HK75[^(KGK_
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M817>A!953-8HGRZ_[X#F-^ES)C>*=3YL;Y85?,Z'&]Y;'%KO2TF8=]0O#G>
MG&?X+TS0+E#M0]\*Z59+2EH'L2*GE1W[?#3V&<$IW0?R9\^CZ=;K\%G26XD1
M=#! =8(GYSJFQ$K& X4Z^OU-HWX(PV1+-7)QK!5"3J; Q0, DZ/%2-6Q\3)+
M0*FI,2$RU;&[R!Q8D\(9EN_[EV]3H:/ H?PZ+GNF\B.^R2M1;,<7,X&1HTZU
M06/(S<[=TF T3, RN*_L^:H'??Z^>BV-KHWQPJI6#[1.79AQ?=JY=X$[],"<
M<Z 5C=YY$KH$=MB9E\(W"&+)7 ];QG.K#.5!_)H"-HC\[A<AM5UT"\_T6K2_
M#;1V'V6OZH<^RF>1PTY FLCM@(7$1"5Y9)V:L%<I$Q@ZEE:B&H=O174GX)RC
M_.>W0T:W3MQL3V*UO.B<E\X[E.#!W7;;J\&0,#NU(+2 5U!:F=6=>J&RND(/
MV9=0<)[=[S@X\"#E$=J?W!$2%-')K @"1Y'A_N).NMAX73P)S>:&XSA^<N,U
M578D^4;F5CC2*[G_W2#(GM(&E5Y=/$\/DH SAW?A8S7-A&8R8RC%$MW4_+R*
M $R.O30GV^;]OE+\'MCEZXN#^/&1VGR0930ZS".JDW>F:%6VT%8*"^SR"@+V
MHZ(9R@]T ;LM!V%2/D>%0:[Q-VW ["['.[.,U\'X_).9J^/Z5[.V"Q?5$:2M
M<+,YYE+4^B<;/F+4"[_UM"ORA-$T)\.HVJL-.&L/,:RP^H.\C? DUMEY^(H5
M,8E*H3V[FM^ C_.PPZOT;&X)],3/$_L+"AX2W3]Q*6\K,!>BB^(W IKW;UIY
MS!%X(2JDS41FV:#D=4!F R]8%#Y@O"CM.]"R<M2ETM\$Z7MZ5SJ^;!:YQ*L(
MDTRS,&^NC[:.O$:I3=TQ98*:]RFY=*OBY8Z.16HTX>35G.!?5X+R(83964)T
M?>ZEZM<8VV [-6]NBGP<5E#0ZQM\?W@4UPWI++W0DD>6<C8_GRXK%SO,523#
M37<$O%:>SLHU:<#:M1?'.LHK_];2L]BXLG.21=A),C-*7P@C=XR* ]8N?S(P
MZ?Z8 /R+D;=2;O$3(<UOLL\EK]TV6I'&^[?KADMD3_FLN%&)I[&-$&+G&^PK
MY($,D^2Y.SEJQ%L:"N7<;M#2EI[$I,X4XXWR^ZW.JK1M U@NHDS&=8IM0&6X
ME0ZY^/@24F;<Q*F9'EEQ/MI<%5].ENM56;R*%['+Q!Y9PKG.3R,OCZ2F6"0]
M[)]\X>_2YQ2+7#GYI#M/9&MQ!\TS\N4;E!@T?HU%..H.\5R$(;I#R[,[1^51
MG)&5T_=0":?0LR-3>?!B8TIR(#!0TF3/2/4O?X3)<;BX*7<XXK=)-?P]%&^E
MB_=C.Z)H^W]=V[<WCZ6 F-/4RX;M)P OHE![Z;^\>@\H;<EE+@U*P2F8U;+Y
M> .#4E-(%.K<"_S/F)7KQKZ893(Q29[5,>5@Y#>XL^\#-&;Q3"H#;,::5>+Z
M@<"U4+5>'A+@+\(C =KRRUM1_0^0V9A%E%<B@LQB=",,^PH;^@H-^5WN0Y6G
M#L>+Y0X^>&YL<>F&"M2#?/L_H@>S%HS_1_1@6X4V)=3]/T0/_G6E'9,$>AE!
MOH1JW4%$E9[S$K5LN99<8%Q3V/KW$)L .A.V)H:MKOVX!/+;@9!9"U[X;]&#
MB_=_CQ[DW!M!@D;$H])$TC'4P^4EYL6:OA%AZEV_B==,\?.OCR5NKP3?*F\9
M9QV[)PWF3$KRX3/C9T*H/ /3/UVMSMJ:!&+IUJH'R_VO?!S 2XEH*.W(JG1F
M?P=GZYIJ*,^C71026ONXB56KA-1B2I4Y/P4[TU&:<H7;%">%9WL7#XA+PXQ=
MR[J#!/*P$&R>*S49'Z17O\<U^2 ]QGTWDE8Y&!]@-5/U)=*!-JVT;,O9_JIZ
MMGY21+6 C2*C,YPZ?* ZO4=)CNL79@O>BO'TP1/+';RIIPY/7F^D!EWC2S\U
MY3;X85>#9J\DK(M2 <(@-V)YUG*\,\F5PWX9G1O$&:F"";U.59G-03CDJP=:
MAT6<$LT$,>4"_$,9VYF4L,EK")]IFH%/O8I*^29&,"(;TM/KOGOIDKS!/C>X
MPPJ+N?;"O:B><+56[E['<XD;VF4/ID[1QO7:U?<K!:TRO^UK$=TO7N8/B5\/
M)([-<!(3119'O90+\;VG97CWA RG?H$#/M^K$&CLVWF3CV]]C9"JS\*W6AUP
MD)W;-E]\G=$ZSAEN8K1,KA#6C8Z3?A5.?4\WU?]+NR6K$]E"&^GN,9Y>_"H[
M:3)IF7D+@;9P27;4=>?9((!ABEM2T5;C?=?'*?(/0OT0W@5=8DNM..)EP9U$
M@FA[QWZT:ZR0'GJ5]9B'"_MB-8N;X.(BB%]'IO81G9*1-]^3_L2NMTGL2D;8
M3C "Z9+Q"5DE5^;<D;YE]5P&M=?S%]2/K254H%"H;M//SK:Q>M=$:^>GACRV
MX$59WY,)Z19VF/XY0L?C[6\Y[P5%Q:_N&S/9W=JNMXAMLBZ^<L*>Y3HFLC1,
M#D? RU4BUZ,HC.J,#,? ]\-X,!K1%5UQCK_G00M.3HLLWJ(RAM+&TA&5R9.+
M,1W>B])WN#\/Z#I40./6[U9R'\9#U4-HN%]A(YSM*S@/JJ-D31- I3NZJO[I
M>[%0Q:>;?Y\"#%9XP^XV,B,CD0\*1@*1ALE6ZB?.V0J3,@4U*LR+GPC(ZR>.
M140UN%F-&=GJ*,A';6W7+,9\_EOJ#(N 8SJR/\E#=_<9O-K_&[<X%W62=F$T
MW@L7'K1GK2?IF5/#AXUB1,R(=L1-4,?5:N756H)B+>T+C^YD4MEFW6;>+&"'
MNI2D7J5SE =:[K(PN&M@H-V<9*<B/L5GW35UC&LKI"+(UFUJVXX-ID+0NU3E
MU-K.*T)[MP,Y(3JU!:(]5'7G*SLI]S1Y^T$#\' VGZ.QE?TUG=WTP#18M.3U
MT]7F(^DUJY<3#K3^&J[:SS<Q[7R_956W^37D%]-71.#--,.")TLFBXMI] EK
MRYXXXZ1:JW9,BX!$N;B&*$E=6*)Y*%ELTKUDJESN-"D="WH\A=V9:!F-$NWY
M+-F$;DNP(N&0[<+A,[#V=9K?#5@^Y_]\F_U/ZP^;HT&';T$_'/='1S_VM[TH
M#!*MIR,=#>J_?@O\Q^5>\"W!T8$A@;T/U$CHZZ+FN>!-.4DV=WJ"FZGVO0%9
MU*I(<W,+_[(R55:6*JO@9.DZBVFEW\ //-RVVK7[_&7Y@9:^RQV)RC'Q6#7/
M)&/D,G3_D?@.9N]K\<B_+M8PG\]%1Z%7-TI4O:;][J!SC4*HZ>=U<J)MWB-"
M:*0JJ!6UV2Z?94GGDU>GNCMD\I[0>@%2F'PWQXU9WJ  VA]6V'+<%>?2YO41
M&%#ZTYA<$!+/Q$Q3J_T'X\L87@@= .B[^#NNU5)+:>=]7F=N;R)$;OR485 X
M?LN<+@QT*/BI/O'OS6QRU@N)W^FPMZ,!:F-!\!#JW%"0.$P7ZFLD-M;S(:C2
M=4S_S'&;Q#E[KRTBIICF3:>VC/MF"%Y=RI,;5__#*IF+#F/AN!F1NM@ \$9
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MC'T<<HL! .T! )RP'H3*2J72 9R)%1]]H@Z8'XI=7AX<!G2Y$3;7(/5V*A&
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M.<+02[D 1>)]&;O%T>69RUD#PEC\ZR6!K&HD*=_-W P" WJA]X9Y]EF[(Z*
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M!RDH.#A<5_A4X=_M+RHHV43"$+$*1Q0^/M@..-@U>13P*"+B,=#0, QC\#
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M/D)%H#"/4(^_N&5L /CB2_!#&#SLCSW7_E8%# 8ZA&$B'H;! AULK+0.]AC
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MB !6[L^Z'6(#K^*Z]=VX9N=WN!!+QHUG6+VY\V-QGVZX)Z%QM^5!N75#TNJ
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M A\HQPPXY')'02/$-.5S*X^C!IN1\IZO+]%$#:'Y?WRSRS*RW?'10,#:UJ<
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MU=S]A6;O5A[S!A_^*GRSJ9,9&NYP*0'I"CG5!6X(2:ELC$Q&VYG\(MO SB7
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M4C'021W]LK/L(8/,%^;OX!1G320;2U5TC:.('8R.@UHZH<R6*M#['G>^GLT
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M*=OP]JI6N-@V9#P]<AC#FV4'T5S!-2!#BU;?',S0(*57*4E3:MNM5QA6\+*
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MH:\;0:T82AD*@^J#+'Y#X]]5JF:L$NF9+LFNW^=GO!XNM5.FS]#[B$BUS7#
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M^H>W!^OB'H'EDMPKB^*ZA#_FVU;$3QNE;'E-. SD=;I6_3R>U(1$1K&[!'Q
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MG77,&L.1 #;2]K6.O9Y+!1D"]K5TH86G^[N<$)=+7POZH^M/7 ,2>22&0VM
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M)O57T;  F^O>I3I]8QMK>:<<3N92H!N;5<<]TM)&%V8S6]:+IS^;U0M4,AX
M=GZ?42T#WKS7V(T@9%)72Z/$'Y;]DK?7 "AQ94P;H[_'_#0B4H99[P6C)SQ<
M#A6[55T^NBO;"\[EN'C.3L[V=?7HK$Q.9YUAAW%HUZ+9=U?P^9*XL9E=[Q6#
M? OV<IHKD"-O"FM_I;$E=]"]1W.%T1,2V:5]K;2,FQG9Z5OKA4KKW(A7YTV8
MH@))S.]PA]W&AC?@ %H93-%2$9M&#8DZ-_=B@J,+&H,&GA[KT^5ZEFL>HR8
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MK-10IL<>T(A=3J3*\R_F)]C%6^;K"2IO9SFJVT75G>$T,2I"*XN($7,2 9<
M7U5JLFI/2A"H_"CLV(NWGJE9M94^J!&ZXFO16<%PH=S&#UJ6^4PAP1OO:UG3
MJ^Z+!U]57M_JF0LNG5A*5#S=95-23Z=/= $.!Q=TNAU]V,CNM9_<&6;\'9+:
MEN^A4U P3+YOOY&*B9P>"3"V<:.ORL)JG^U=007/\MX*C,^G0\F&B4^)X:LG
M6!UL_4UP,;)LPO&4Q0GU6)^S.\^Y5)52G7Z&"57"$I5%7_8(-+XA9B,U9$DB
M39U"!;+)=_G]E@X+#;N^EWX%!A;^NPUTOUGG8MN!%CDZT$:Q/A.&M KJ5A(,
MCH77) (KA"Z6@T3BY+R%43>N6W-^.*"HN H/7_E-7%)?7]9&S&V7G)!W;2UW
M]4YXFPKI-(/>9>@8%RN=/RJDE2TTW$@6,E+S(:O@1@HERC0T'R,,*!4[A=NT
M21V!6-(I_L''JT2<HNQ%^D( -C/ZG"?8X^/IJQLBU*J@*=K6O=X:J)YN$&(J
M^H8,AM\$"<8]XD1AX5.7D+C1#:?UD [8OY%RP&W-+.EKVD^8K-A;F)#9W))@
MJ=ZPXZPU&'B>0XDND/M?J[BN0^V3.U0@6SUYFOSWDF[?WDEPX><BN$^*.L"O
M'OS^M*IJ]VD?^_7JT[991^T&3PGYLE54E%UYJ0NT6KV0$#V@4TN[^M@_"]_M
MIW=_%]I'V=="00TK9HOB<M)S%8:_#(4C+S]T1T:;T(K$HL_X6R?3\D+;!@/M
MA\(#6UB&QS$G(<2 ['/%W\"&CI77#LMG";>7L>13 K1S!20C.E^Y:$J*,TF6
M+[A"O+W]K(B#+;;\]++-H+8-CNNB'AUU!-P3+8"K*2LE#7$#,OY5:H@*,5,=
MP(M"\J*B0W+9"A_U@*0;ESYLXZXSBHU^KZ3WN.E=_#@9=^R3PG<C"/;#X, X
MV]34E#@$(@*12U$71$P%G"D/Z^D+1/3>0K\NIN\,K1\>BN ,:I8(LUN)';V]
M26FGDD<+0:2J-!RO/%W,2!NUX349IHT"["E<>C<<,;47@&;#'%WK(3I&ZV<;
MM8D=*;QX8@?$Q2O*Q+[JA77R;<7)_U>HQSL8N^V7D;YEK/N>\5 \#Y0@:![V
MCJ*TL)!PI-E8_S7QJ'34C;(7W$A"5G4!61YEZJ<CQ?C_B[PWC4HS2]M&[:[N
MI*HRV);15!R[,F@9HX8X*V)7Q\08I\[D/"2.,8B4LPAJ565PBA@U<4"%KL0A
M3AB5006T$D5B%"DE@H**BD(400$%%8=C]7O666>]W=\YO][N;YUSK?WK6<^/
M9^U[V-?U['WO^PSX=A%M^,V@1Q*S/V?%^<[>SX@NO"EW>G0P8H)=!_(FXZ!K
M25>:8FA!\/=T"3BNVBA%GB?5C*MD02XQTKPM5:L_E!=DG^LD?,V<CRQG>)X.
M2P_K"MO5<(BQ=&M>LJP9>.VVNJ]66]^:<#LD$GA7%OI@W/SU$Q@D22)A TC(
M2]LR<+Y7&+$>,?;J8[N.Q&:$)[#GH];\*Q:%<S?N!"52$\:M58>%5R3'\ UX
MN2.!0"+? FA/Q7>U$BE@#4CT JF"X<'&K:ML ]/9? \7D5;!V[?;Q3Q^.6T*
MD7(!S[(>))+YY07&M.D%4;['"&:C?!X8[1WQS9GWZG_-NHG^<8O+FW7<?,"*
M[3GFC-AS%OR\DE6)"JUNFO6_WVOQ1-RU=\(F9#=A5R*%>E.1A;G2!TH[U.Z/
MHE=,:%;27=66LJRXI]=_,7Z$47>F?H!;G1![QI]0%/IB8R?0V]LCV5;]L-"U
M;$KP?"OZO5)354#/8*$9<9Z0GYQZ&/#61R.HJZ]+&:+)W5MFJ3]P+L(*H([W
MUD#P(YB!D#D9*]0:<DQ,I//;+P;.!.Y0J_L3:*NCM-X3S\=I!%2GL"+RS8*-
M'G:L<L\"I#]",Z+8 T*Z -PZ9F#23(EUM9FF_QC"3%.3_]7DIN7LU/Q3%9AI
MI NN;0(\&"FI60(T>Y5H:J[S71= Q.5_Z5"_#P Z;#3(B7V];ZR'G2.RCNRZ
M/U%">G^*6T!"6C4/V6(>GOP@"H0.$'EXYP[Q_:9\77A0F5TE[(%RH:VSOC![
MV$N>/9I:E/D]?,\5-K#[23(\XVS!%UR,J-QD^,3J>+&=@^N<Q*W9O)FVVD1^
MQ3+XN$B6W:YJ;8TO@\I";NZ!]M4.]^,8HQ1@?*C_=@,J>3CMBD@<:-%7^/K(
M.\-OS2]VE]U=: ^Q4#RYKGN_YFT*9<^FA]0SQ B^/5[(@L<Q*X'6_0"I)-ZE
M:\@IP7^A=2I/9XM?"/D;C/I)?81W 2!8)&49@(3BIXF6IU*LR7$BY)EE>:S9
M>+$1(AG+-9+@<Y;Q\TY%^20@<M5@JD49J,,NYH,MI6_Z51/-"-NW#ASG</WV
M?M>GP\9&,_,SLIDC)+>Y;GSW$]-\<"7L/OK@6;I)Z:E9U/E&Y/TH)/9\72-,
M@&KX[?J8B8=;@(6^XHEV%KBT _!;HW6/WZS!U]2< X  9M8/.*4HCI&99DV_
M*BSS46_'9M8/_Y8<\K\!-M']*UC*LI.K66]*Z6KCAJ#DIVS^HJ*%X5C OFBW
M;<_')%0^1?L(6*R*^J;"E&\WFRK.M:)-7J(:A4@#'C2%]WTJU"S_1W%&J:A(
MT#%2O@:1AMH$,OIJ3;0)1>(*YG7:TV'7_)6)>-7>K>3@0MUL\XQ%X76F?I0"
M,Y'7SUAAM(.T(H'<[7('XE55J.M:R;6]DS;W>YPP:[T3*?Y!A_TGO&D40SH8
M54AY.D6T2,1 2<'3?N[I8'[>TOPR**-J,JLXRZ8U*1$MK)2WPI6O"JK-E+TQ
M#R)G0IPH]D1#0RAQ.QYI:UO.,IX. )YUC=Z&+1"K=4?6Z+)@\A*(?X(U6;\4
MLF<GW5>3J08W01<:8Q9ZRS.OPWXD)G9M:7+AON$+WZ!@\5\W/Y[6=D"VN>S(
MJ2G;=95Y2)H?^YO&PDAK>0SX1 G<KC&@II7K:_-VL;5D+Q#V7?^N0";/Y4BY
M<)>K'L];?1!,@T%&)YEK$\,><%H4:RENFAI\X<B=;N!.-^&WC#_#4XDT@+1%
MHV6UO@]1RE+NJPDJ<C9/?T,W*W[_EW]AM\-_3;+-G7&'?5?*/\;?5W-5N((]
M/1=33E;HW_)['PRV@W>*7Y,:S?*_1YMFW/+??>FW-=_\6(P'RB\D21G6;JY:
M8,F./'0(>L$&<V%U#UHPWS!ZLL524)L8T<P!8_7)'D(Z7W,N7U\XS\EX@:,]
MIBN=H2D""_@(U$9UG^F7/W-:49"TB9-2=I*W48SVS$?U#VF%=:8?Z)(+4:'O
MD6Q1YD-J,**&W<TZE*M*?!,;UC@F@ ^9?KJH[-0_Q)$Y]OR96.<>I+AN #H[
MMC>4$XX4?+'U6([:\GT;:,X<&C$M%BKO+.<)A@!O. 'I+TT?C%Q?G/:,HOB6
M]["/D4V\OZ"TY+LGSKPD14?:4'\1I^JNM&'+B"R ]U,7#\^7DU%6K*2J),SG
MA<>BP$X]UMN_VT[9W%=3Q 5&B(9I18XORB:)6D+XD-G5K-#Z;V)4D-4/&SW:
M[#_^''QO5;);M8,-H0&"_^3J$40WUJ/?_M5V&!,*^EFUKS8#L9NYK!ZWIA05
M)@^$5_FGF\V%M C<(Z=]SX%5E)Y@LF<=Y 3V>5Z,^9R\K]=^I#D0L3X!,?9;
MXK+K.-X=083*R'R7S.72N@Y+!]<G)>JUG[I= \'E8F?L^K3O7S^V_8D&S1W'
M4> :3>!R4MI+Y.=_I]V[F))B-_1M^$\ZW]:5S]>AOZU'VO$G:9__2$\D\Q(2
M[.V1\S-QQ!U"3,4@)K',",&NJ*BH7!@"AS M#Q!3'14]]Z!:H(2]CS,C\1:'
M,,DP%GL0'"('3?]VH$VZ?6F[_OG6#_^V=).VKP9-VQH-WE=[5!DLD6!$F:Q^
M]VBG FVNI/K'R=KVG^8K[!K)GI*; _,'$@JFE2 _:ZM=_#8>:MM^K>FEEUW3
MTUX<XI=5]-L9=M$*.K1XGAB?1B %#P0!8@J EWQ*\Q::EVH;B@FU35*(?_.P
M4XAIM: 3.(K)GI;83(:%)=.*/[*]UUX:G1Y=\P@P,@(:&?VI:"&:&3-;#PZ<
MYJW7N;XA1TV*GB@KO:R'QU<C[EOS@F]X X(7\0:_#(;&6EZ.272E7"$XWNWO
M6Q-A07;\PL?#M\*'6JL>,D#C@Q[Z2X6%DKA+1I00E7X*'(MB%,1+;'#8;RM]
MWT$KP6@.%=+,\ V9FW7ZB[+^U/UZBR ])->/C6W+-R]:\]E\:<HW/"8-2<[!
MO&K6@IU:Y\#8X[8G4W=-BT0\H^0\(XJ 69!H'<E2B;5M\,QA7QC$]<TE'X=U
MRV"N[^HHI&#B$A-Q352(M!?.)5X0R$3"/\LLN]N8A]/#%QRC2\I;?7MH$ &[
M<90?!"]H,2L-(ZQ5"CBSV)) L,;X:->F^M^<R@99)D-L9_VN,6M1\R*U>4>K
MY]O*-.\^Q.T"(^-/2Y]GO/V5,LE7T$9J9_2])X*]W\BMUVTFIE4WZ2*MA4V:
MNYYMJI^;C)#"ZEJ!:'GKWYZ>='/"M0WI)[G=^>K&G5M@G*.\G;2OAE2))_6(
MAD/QVSY1JJ!-^16'^2C\X D<5VO'R*CB-+&9-8X/&R\OH%(3$<[VQ"W?8]UO
MN]_6@.U: Y=:V\VT*E",1SN!+A[_N.M-YN.W_LN_<K6O-.;5&YU1,U\M (K6
ME=]'74K7=IZC6GBFN"A5C!O3DS> 99?\ QZPMSZ/L]I70W66S*!$P:2^"*-Y
M]+=8?ODN3FZ(F%FG'*P6< 1A];CA<7.X48<><L24P&,Q-33 T;5&MOH '9]*
M,OSI'584@$KVLTB&03GZ<^[>IKC:5,*^6BNU#B@%T:.D.A%C3D6E7:8&$]@>
MT_A-_PWMM'R>8G/7]WVGD=2WH_%)^0)E8M5H(CWQ;C>R,#(A+%7EK@MO\0'G
MW2M.%\L5/CXIN'$7C05HE+ PO18AW"*1N2MZ%?;>YF+]<:Z#2*O/C_H^K)G1
M8<1BH80Y+-.3G(7!8KDVA3 18Z"12B(_EJ"/LZ;6-/4P^JWM14QTV[Z:Z8EA
MZOI:03R'A='U<OAKUL9N]N\(]P!P\Z:JOA6.(&Y$#WGR+EN6XE]E%&H8[]T+
MS<C_P*_O>M/;@<:07-K<@K7B][Q@?_&Z7,B3.DZ1H:8/;;A%;V%U'OXQL3#
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M(X<.)3Z1??9*=:8QJE&6?P2(9#='F"574:=*QZ>9VJ3.[[0&&CHR1T]4R7U
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M?377\M((]/7]H$U+<6(@M*M6*C%Q""#DMC0!Q+G-2P#GZ_=4Z@5;_]XL\I_
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M'R[1_[JAY"RKI#B%'9.JG@H]$_F+N!6UO0/.\ +&B]E&;F/X-84+XP[E17Y
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M KJ%4LC Q@U]H46)#D2E7CDU.[<M8'8,U?&C;:K3ZVRV7GZD@8=%\+FG,#.
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M]P^3T;4W#\A[B"%IBC=NHG*T9S1KXD%#+)<BMCSU2RLY)%:?E(]&5^671 H
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M0%B8)=\=ED&<BEXFS[@$"%Q3M<(+V=:H/$PWH2C[K")P\-YFWJ1*K<NU),O
MCMWBZ4SM+#<9?X0LNI4PR&""[BD+^-M>:R"Q%7B3?[5@Q&8C+KQYV3U#@5C3
M#I HI@,/'YMW7_""W2WT6D,%*\9,HHE[AKS,\V;+<VS24C]R#B3)!HP>F#B2
MN<+9_=S&PN93LYE:YQ'M<*U#XFZUM-_UKS*#SD+OU+6O?J"489::-8$:NF-F
MO2.N-78O(R\<L(XOG\SIH8PC3";K#N!)H3 ;G!S7;\3UH#R&>@6U#3TH&0/!
M8HSB=N6\?>45=AV*4O-@Y8Q@-A3F.S'Z!-:?&VM% P5-."\M1?8AG;[*'XZ,
M2N785?7AS#=%.F5#BV!<^W!TN[I?(!@:C8B#N 6J5U94JOIKMWEXV]## >Q
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M-C9^FPL!VIO35VNYH>LZ&C$=A7N_)R:@0\.HAF]_'UWO$[^PP+EV&+$Y-[>
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M3:$1BE6#E!<\GA\$:=3(GP][R(D[M7QQ XWQZ;FAK"*7513A$W^;]_T?AW^
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M^*U0G*S &#:B5W<<K^A?DUZ832YI+&IZHX@VQATN6Z07\4?[\S0NWC#"1A
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M-_2DT<G\"0/U,XP;M9"0[24,31YIZ)U\0=H-Z\!*Q,JY$[ 4^'1T1.&>I;"
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MZJXDA-Z!>S[AU'0YY"ARX^BZ^VI$UUESZ-Z!C'8QL_U2.+U=XN#R"?IZW@@
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MJ7<#S@="73^9/.>ET;[F^)+.6+M'MI!C4I?1,IN.1@OW17\6I?])+T8KL#F
MHKW.B:,E P(HP'RZT;1.A^Z<I%RK;;-_!2@X,<^'&+J.V*WPP2<W)4\&3?4^
M9E(LB8_&"'5OK!<+EYC#]$?%<?Y9KE';XA>[L2J^%YZW7=F6SL*Q391R(UMK
MG?VF[Q_L"+=Z:O!\<K]3\MI//6# .8%+KSIO*CA6L10R<B\Y*7'!$%-L^F(K
MMG5PF#2'\$]?(H$?H]J84,C-:"-5!PM'R*2OP29R[#CZVFW=4"QL0*XAC>$9
MHG\-HQ=1554E1=RI^3J/]3"\CN4F-9V35P<AY8]>1?SU#]+ZOX<#=EO.\Q$7
M$V-'MX;F9+1IK:>1FT\C\)KX^MD1<#6&=1D)&"RO^ 6Q%@0-BE+Z>A9%;B:\
M6NO]2R\8HVG^#?S06F\C\/EJ SUY1MJA4S8.U2X9\C;N$6Q#SB$;$:I(AMC8
M%W'O$\O[*)06!('7016L,U$XBC*"(*5[EGI]?G<"8U7$B2O/CN>ZTMWA9FXN
MW1:2,B-_<I61[>1V;M(OBHJG F4$IF7ER'TV)-K]M*/_^L*G4FD@2#^+()VE
M3%#$?=?E2-H=@Q-)R-,O8M5I)%7T:0U?#HD5VS-U:/OF>O?X7IF-ULS,QC2F
M8$U''_?B.A%F #[9;).PD;[-&#%W$K20R9)HPF"A,5O/:67UW;[^'*WG"1;@
MJM;6J#%\2OFPCN^(/N2*(SJKQNY1V\# HC6YBCQB<27@^:^_XU$C?9VRG9RP
M)U1.R5"V*X2<SB77/3\C8IRUYG$PKMG^"%=NK3J)XFI,Z^>+@T#R''A5R8WP
M+%C'8P+VW;Z)AVP4.M8?]#3UIHE^,_WR.-WE>O<+##+I6<G#$4("SAUG8-48
M78.R5B\+1T7RX3E):3(+6S-A#B@,NTB>31$=G"BH2KUB2538.3^?K0@O>A2?
MW:K_9L#S[&9:]N88<?1\BM8'<Y605TEKOO\P5[FM0EQJ8YC\A[E*YY]96MG/
M,_]AKA(IRH1_,%>IJ9&/^0'7W'>F;0<4IH 64?N]^ K<8/2JI\?$6O"$^5R'
M$HGCA7,J;C.23Y[4OY3^HY, A4G.$1LHTW*WJ 3D^P#5 @&)F"%4'$_Q?IG\
MZ[_0X/]X[-_!:B<XFN+I/?-U4:M%=95E0_:&V2_XW^#P+X2R[^MYJXSMH84,
M9/VR5%)98QN:6_PT-[.UJMY66)Z8RD]A".$M53(X;G8JE(9R'V%#1S:*BGF4
MC ]+!?](F>;AV2#3=9^EQ<R2N(!P P-#UP\6%T4K&1DK&?C0ZN"J:4^*VG7E
MC'3:2WG0 ?%]@P2XP!)&7S $TYN+6_+FPVMS2OKFL%4ZGJOPEM;"4I-OQ<OU
MV(*BNE/,[D.^^3Q155KI!1QCIZ*I8Z\O9>@W.[-K"V? L;#T)?S>TROEMF+5
MX9"'L]6=F\W)&Y/!\OXO8OL[0<W(W6F5:8W2(J 1>/(BM2[QW3Y\^G:+W*6C
M+G[30V!J8969@#Q1SWJ\C*4YQG,M>*E\8EC]6[XND71M]<0>\X<!?_>KFN-U
M C4 "I[7&U8G>EQ\^E;BXP*[35'F,V%^UTIR]?$A]+AMCF;L;6R/%,TUT-XT
M]S;1;I&<X&RNPDJNK),2.6,D#HQQVBB!7T990X$%K-/FDAC?#Q[YD9!FH0;Q
MP[K9IH%!:,@M9<7O(U_EX?W/,?4UDS<=[G!P=_M^ED'((NMMZ=33!=1;K2,G
MI"T&I(+ 5+_C#K3YSH& R;Z/2>R0]O-?<'62?9SCO5D/6/)W^SZ9"@2E"J1!
MY?RT+NFSX1)4"S.PI<G/G^2\F%@\5)!.#H=!>&1R.$#5;%5&L3?Q@J?<T\_2
M32FX-+)."QTC(1KN1_B7&9R$O?%P8F:;WEX\([[S:.L!_.Z;BE/1&_3GJPF_
ML=2R?@NOC_$]EF+_0JOU]&TMYZ%:)-!&Z8!I,C4UR,K8>"$N*%D\M2 \+L$3
MHJ*^JA@K?&2"Z9ML;1?W9T9C'8V;0DZOPC*A!L+,.J?I:F"/8((27P>MQIH%
M,%6E"L<39RJ 1FL7^@9E<-X.%\4 LZ+?1W)U3GP#GD-;<'+XYB-+MO$B6Y6=
MQW07_'96>>-_U>P!VK$<E+A>7:UP"Y%SD2&[OQ2]2%XPK=MF:6)1GTY,\,,T
MUMTO:AUV(GG)4_7T5F8+ 04%9R6-!6-LUOE^-(!(9"RM&KXHWUA3TM#R"KA0
M@0.F6 M0I@&E6L9J=KB!8C@W=QO2<LYW.)F;D5X,JPIL6=U[N5P/HV,S5Y*#
MDM!^KH/%H4GGV"$UU&'29N\9-:+HC2\@4@05X<L=N$O[IS"[9+[?NWT1,ROO
M]MEFB4'-O8) KV<;.=4.O5\,W^V^#/A+RH>'_JRR_WIE9E9IV>#1M4$S:"\"
M@7KU;M\#D)/<[R>'?#Q)Z:77(0A;I*]ADWHB!*)TMB",'9P=QQGKND4IOO9D
MP&GZ].I\GX.]45-+*F-&W+L2O]2/-+2"IXL'4T UT]\V"H\^\7R(?PPG$WLD
MH_V__I/" ]5Q,H^$ZI^",AKBK=W?3$A[E\%5\)FN)9Z$;*W)#81 W;$I\>>;
M73\IL-?*:;K56A\MO7Z7QSMQ-C?@J\<Y6.%QV9$U"<I4B4-/I8CH7<P$*>=D
MC&@0:13\+)/3J*J&$,B+B&?<> I2+R* D(Z=I)HRWD(/E5:8%I>DW/TJIU80
ME\Z)2]\,#P^/R^SQ&-AT\FA +(:\N3:6>FRX 1/RT]77N-LOH0'/^D(1]XJ;
MRJZQN7\)]#&Q0A[I-\QB!H4K;L!G,\)9(<Z]OGELYV-OD*V9[NTO 1ON8GQ;
M\CQ%V+336;KCDL_)R7[@J(9[X<0HO#_V#,?5Y24C@NKMX;G-%JWT2V3TM3N"
MZ]C!/DS4W,PFB-: '("C;ELE%JTH\M3, M,^AM7MW.#$@,F9(VFO5!__^J\$
M^;\ 'W^?E)ET>5.X=+H>C6GML@[$1&MI>3IZRL#>QZ]C&\=YO-Z\6JT&Z;$L
M0I1$468P_65>S4+MYR;&#5_5ER>2Z:3-W+53I>LK2PT#*"]M?.L,41L?MM#'
M;1%:",:Z$1 XMQ"5>Y)-F1P\<S2[T:-HP3"PQ7R=70U+T"1TO-MW36J7D*>5
MHROG&O#6S%P);.B5X3IAG]F)>"=(Y\P5WL6'1]8B?D7I=WRV7+RNNSYJ<%LM
MMUA*U&Q^_IU@>H,*@TF,A+.32TIM"F5EMQ*N_6 ,E]56-7WF6D_C&/!H[_DO
MW%-UW; ;\ZP*!ZJV H8R0@KLN/-0XV:(S*J0VM3ZMK<J"6!FAG<P&(]9YYW)
M1;ISFG'-RND?9-&.\Y-6_J7D=$41\LGU7HNWP<6L'S?7!9:5I#* A4;Z+$=T
M_==_\KA?"9T,#)C\!@,'<JB^S<YH9"P*<#,0.OE-D'DW4,W9Q_S">7/OWJMC
M7D ?<"":I:T,87@DKL'^(XD+I%G5S,SL24_/IH='HH?7C]T[9$32(%+5LF@D
M-"5/[UL_H_5[&V])?!!SI9V%'&%I-J_(=0_4[/PXX&)LL_NHAL[JXD5.=>9F
MVEYC+.>#!RV&FZ=BU?/GM?N'W/P-\5DE+]$;L6],3=5E'<Q5K>O)'1'<&%E+
M::Q:LJ-?P83\*"&#KF-9M_QL+$][?:>86EFM>ZQDH2+7E[>A.! V4X+<LVQ&
M(B35%':RZEOV:X49L79&.CM67@QU]G[ZZ[_2UO] X/4N=UZFEZZ+%_LP90O^
M":G]$S.=C4NZOS1VYO =Z!'$QX\S3*1SLUD9YR">?W9/KWTYC\AL^^NCMB_O
M9M0O4*D%WV['K2\*0(_L&3:@(X8(/C2 2%4J?9%9B$SV#(3YX_7)^732]UT:
M&:0>P9K'U;[<5M'W<A7 = <I2HZVV5R.5:L ,LC,@$W]B;%<GI>SY<H*H:@.
M,EPZ_5 0H* 24FH?2H_L33582<IE"\ASG*-*>?%0?H/[@XX^2*2=K\IL_Q$5
M* .<8JCJ+',%=JP-4+]@.<2XASCK^FYYC=/!\GJ35\LZ^5:EU\]3W'=]D4/^
ME7 D0V3RP#8VV.A]Z&(4\HSI=L7H4OG[GDC;%([.GVT!FF6A3H"K^<D%(R=1
MN=-M'^P0?G1I:E1/3U^0,W"O_\G>G[[N^'2=MVH_JI_R^*.Q$SOCH+;N,**D
M_6!;@G'*<I)&(<)CDQYC=5.PXO&7*"7)9J .8S6N%;#8T9)3@\BMQ:%2%QP^
M$G&?J9BD@-Y:=$II/1%2X_&%A-($+0X&6@)/S0(G1QSAH5PK%7YUPB<]G,8\
M@R+);45GD?:!T&7:NWV&B?2]#4(O]0FSH\_.,Z]::B964\L=9JO-O'^UYI^I
MMW3+0?9)R?&D-C_W[PW:>5;'T*MRO\AE'V]LA]S$][<,>G!4&4M[IUYS?T[-
M@J>QF<;1;V!PL(^KC_E4?VR\HZ,@:?O.FLJH2HR+I0"77JU))0LC&KM7$OAN
M(>#0!QL!YM.7%*VK@TV"4",UCZO,+.WC,D^EJ%W\TWV1:>)]BFU%_-WR8RN^
M*6TN%$Z9?HV<PY$G^AI!%-X7S_VO&DK]OZ#K+M!1'=5UC:>D/6UG??.KW"5H
M^=6*KE\@J]NQU6/T\FFK":"G&P,''**5,]< /I PM$*#*H^)E76=C]_K*TAP
M2<&D%>SV4:52YK1(B,M"VK&MSMR/*[.L<H, \"9&BZIY1R A&I<VJ96/NY9N
M3G*-^#MW;(.U'.3*G=@55)!CN\:'",FQK?(1XL;;HJ++]T85KW#4G:\?.T[2
M[<?*I>_V:2,7VE]<1]X@WQ(W;^<='^S]T6H4Z=^O^V5>[*_LTY(098@FG&GU
M_)M3A7+Y\.6U+X(=JQR#RAXO;%!V2Q;T6F;>5TR$&P1I.8&2559%?"*I0ZXN
M^K_;9\W*$_+&Z@\1D"!ILVE_A5U+_5(Q&JBXR*HH2L_@>MB*7+F/(G:".D"/
MY"N$]$JB!5M]PW\_]H??T6<L6?Q(W%CTYNR*KLW6LV81)>?!IDV'(S1A:M(O
M0(*O#FVBDGHG$%"'OWA;0;\7'ZM#+FYA0Q^)]._6X^^!-35R+SOG7T_J6#=M
MEO$6UK3Z4NH/-^ 0R26#=\);GJ^JP<F2DD-#12NH<+9#/(E]9-:P!HFW#(]E
MAE@""WL'>UOW7C$]DAG-42WZ;FQ0LU4).R0KD,?*]GS8)R$0'X4KDKK#;RIU
M]=2?BR<"HS$?E3'&%VYB!RPWZKU5"-WS@% ZXSHZP/YX1-,+88R5]_!YM>X@
M-%@]CNL<R&9I/S/"-@O0_(&.M"^S# [O'2I@%FJX\0AF<Y55U,K%&Q^RN("1
M4"?(^Q WO>A"1TN39)7_:1*/L @GUMXH(B/5/FR0\_#P@)N!S$!?[!H.[/SZ
M!ZG\OPSGAAJ]&CV?[9B-$$UK( R3]E=J,G+ZK<MHFK4/<'(-?(47VR$#\MQU
MI%H--[F-8V ?[ZL86US14G-S33F\K:WY87!1RCF%UU/ZHB)Q=X'9OYOCMM.9
MQMX ]2>7(,?4 DLZ\HN*,C*J_NP1/JA6;QQ \2K4#8P)VNV+X]:J'+@[+%M;
M7-Y,$3@D PJ&E6:7RMOW%JA#]SJ4+#(P5P+N;+-_C.J+WLUHGZOIB[ @G'U6
MG9E857RML7=V^5J5O;'5@</7=30X5E:C+L@(I(ZJL_-Y;^:1#)Q68SNT/Y4S
M(8\(CUI9QF%@^,<:9]-2N;1J:%A_+MNZOV#-N@]; @D/O^Z0&*UU7[)GK:G:
M$UJO<_?$(H3Y;I\6)(5"KF9PRL+9%A9V'?D%#E__D[./''7S4^_N_K+P9#Q5
M)-N4>Y:OQ,K;Z^)*O[%2:[;/,2I-]AOOVU[B6]RE/7_^:J%JX8SA>+U^KE:-
M[>RA.#]U'X?![ ,;7N+;%&!A5?3 \G%^K.Z-1,Y*7=C$RAIT$*75RLRE4);L
MD.J\*Z&C%?@6BDTFC/4$V+^6=U_R6:=JEY(V'8,S9-8>.6SHFMT,=1KR^CR]
M5TU-=S(O) LZ??"975KMME8#65"S2%.#BG,ZQHPWF[HBVRA6V@E6G'*L0HHR
M<1BR;>E;,,=HCZ%Q:?&GN%3%%3^'GJ;!TS$^3KO\J=T/ZVHMTOJ5Z>B_KZO5
MFB0K2@33'_M:?EA7RV=F/@A,?*;.S,FO1/C?*:TVZHO%+9=6 $H,A&D%\629
MW<#N9_A;1JHSD \N#NIU3DX71HX)67^8R/^;X,,?TU]<&;7'R[)H'<<8U[;?
M[:.(MNKJ!U]-3@HMI<W+]@T3DZZQ/T\&)1>8$JD')\[69!+#BP$QJW28Z-V^
M<!\/A:95VB).]*=YI?W<;I8H)W#R'MROJ@@+-BW$DAJ:]./5E^AK*/^1T TB
M-5%8N[>FAM>UU9OO+"^I-YQZ2Q,A1+-"-W;L$[[55W)X@7Y ?PXHVVF^ ;_)
MRH*,="<.4TV:^93#!YZ3H^3Y[9&$,V^5!K7-L[)SK<L&GOQRD&6!^_&THYJ^
MS6APH ]3W9NI?ME/W5M276Z[\,;&,_:N--@0Q4J0BS]5W)D29A?%SM!B0OM<
MY9#"ND&DWH$?WP_M/?/4/H]O%DAL=>H=Y-VG+:)6/^1W#!TC>76KZ7ZQY?=T
M^^M_\O7Q6I)STI",KKJ\J5LD"QS"):WH 2R/M1DC-K>2%<Z3P7,F#:=XI,0S
M5>[\7=_VR1^;YM_&X3;\7("3X]Z]@U] I[]1\=V[;Z-G;S.P.S\^?C,JF=>K
MEOJ4K6OB:>3&.1<=\1N9Q;Y4/QUKY^3%61N8+9[KJ@2.K.;!!%J(U4G F7MM
MB!/B&8CTY$G]QZ>4)[>=G,W35J=G!R"%"^*<OE?M:1<Y.(M:^?*1K9^E-CSS
M[:&)NKF_OKS6)+?L.Z7>AXQ'^5Q=L22.?O$-^G"RMR5YX,H%P%%WG3CO;Z>8
M_&3%C=B2<IXTI2KEGF/SWZT&7*L\$D8,W7U3#_J&CI(0T)$QF@'B!N''TGMZ
MM%DJP4;JKOX6U0BM6N]X'RZMSZ9F?\AJ\O=\F(5\H OC#]/U?PU?]H^5C)4T
MT(!VRC+OJR*5CBUPQ\Q"14/;-K:UA;%DP\\))^.;[$_:!SQJ)7$D)J$-60>/
M&&6*K>/5+SM?O>D2'X\\MVNX[255^8[6I>#F*_AZ1A3;1]:XEONF+1UP^,3R
MPK!9%"<#CRMT]T:Z.\LT^J+\FY!IQL#GTQB!<AY:W^% O?MN7U#_<LE HK(.
ML@E> -4(S'(, SAL"!\8_4IRI$M:WL6W]R,G###6QG%#H4(',C) G&-B'A"5
MSSQZ6>8CO:Q.JRRK[+C,Y_'X3'5B6=WEKH_1W=IH]JN*J 0F2AZ"DGRXORC!
M@=;8?>SY][TGO'7TF3,<),)CL $';LB54SP*R!*$AU38(L&K-O8RT$7/[EV[
M^P!RI?&)K_Z[?=E_SX%D 2>0J\+#0SY5A-SX)X6.$SG,,/.M@]J>!HRU,P]?
M!D-AC2V3\21NZZ&<;^61@+KEJ"C)TX)9Z:IT%@++_&JQIM6H-A,N+,<*[PE;
M)I'R$IQ4@:D"U)^%*&@2]<HS'YR!X$69G$8U*]* DY/'P)N]F+"JLU 3J#/:
MUR \/"X]?85 J/@L'7^<(#>Q6+1?WX&]14?27;!K]1/S:S$I)4TW@LW#9FXI
M/\^B%(]@OV^5[?BZ'P^T#61:@ ^M(U3[!BL;5+UU?6LSYUL8?&]NC2Q$>7^#
M&ARX=;"%KO,P?F8J]CRAWGT <A*623,EFBUJU,G"]4]O5_']F1#AY'RF;@1V
M/IE=^,-R=IX'Z'Q?._Z@A_@$@S?LJ$$?+V7K>->WM(4:Y7*X5"JUF7IK9.0S
M)!)Y+5/ XPG._O7];[<R0^]^]F5F,>SN,5AU)KRJW*:J.%&88R,_BS#P(#2]
M?U%P$R\<^<'XC< )#T_^\(E@7->4((+9[TNL*IY0$<4:+I2GJ;S]XVK.?Q-4
MXY=L%UV%K*=WGUE*A^$[>@J&FDI03M84;[Z,&- >&259)<]L$ 6,2WNZPE^8
M^7UKP()X/Q1.!1B[6I@P_47PJ;R],@<?[)U%47ZV]O6]S02#Y"EHN;4E42JJ
M@<LLD$2U^NGX\]4>8>D4^T3<<H =@MVH/# PA'FN, .3E'L:"JZ!8,W!HHY;
MLRG::S!X\ 3*:%;6\"^Q'5%FR:=6M;J"7Y74 G]@[S$Z6K?X]]W1O_7%/Q1+
M>[O'!X]Z1\0%%2",5,C&PJTB;+D@$1#CZZAK9PI SM47VW:R##N65Q4L$#=G
M<?FPB-X=7,2B]JE7R>"YPQ;'J#:AG#>DQ>@2#K>[L(I]S\2MYV5,0G7BS2 1
M@WFZ:U[\!*[)1.J;&'E)8[P#1I(-73.*H:[%D.$3K0#*<9O?<5C8X/Z^:QE=
MG^?7;TR6.Y[F@:RB [ZJ5Z36B(S 9?+._,(B0/7T-D\JMUUN++FJ<1G=.Y9=
M\2G3_M#5;]"G.TC0$(A3R-7R7"5TU$_-TP69IZ>Y<)&ES472%2D^_9<X,$0'
M,1R0K ;?).C7FO XY!7N:63>IT$!"W[YDZ@T) R=,\;'?'IV$6_MV1BYR6KK
M5WTR:)!:-4QL'!C@ -0BH=]*LV6@VE7WFHTC;Q93.K7:-P2R^]6G;P_!(M\/
MO!>*:^XJ-1\V%A?);DXL6R['\T/\)X=U!LL&XGL!1[E>0-M563E#6@%05F,G
MRD3-?8U20(YG=DO#[K:@X#XB3\-M($0#XL$^;0 (*"IZ>'0A,=J=NF7<X6*:
M.8[91%;6.NX  N00"OX$SS++J:?GS4:5P>JO?Y3B_TOXEEO#K3.]FKB_)GQ;
M>+&C6ZY7L)7L4%K,#,)1_1+!?YJV1Z$-'!.6E?U>=U#P"#A*W=IJW,Y$_^7<
M9H&@(4'P,JWL4<2VS_K?IE)35UOL\:55T?8O VV)QZEI&JW6WIFAII0)7]X'
MD\E*A85KU[WJ4X@\2X=>BJP@]>IJRDIK]9>TK->2I."DU4WGIL%P2^9=0T9X
MQ&\Q\/-5!2MD\;"M+.'>C025./F1"1ZMEA)N7=XMB-4\+JF-9 6BT;G]8?4V
MC_!)#3'I1(FQ!#";(^!P!#;$*$EHSF?Z.<>$.>5_4\(H]FE-RC3X^_M)W8T2
M2<ZQWMN??C52M*CK>*09 0E'XGC(Y$)R4QBY 0&)<-%A1B7>SS&QR.[UL#]T
M/G,D__[)1KV=\/#X]XUEB<<@T<+"_#_[;'RT.&7/UGDVIQF*F */;%OA&G%J
M\.+$FTF4=B2X=X.K43 B" D"&X]\<SV'(:S[N1Y1TDZX1J'<S7Q2X/:5L#R1
M@>ON4$+[]P23F!"L[#EZJIV<7MJZ!G7CUH22WX<#/ 6MRLCM"H4F,8-PPD-U
M,8#^E0Z-;D/#_H6JZ6N9^C6*LI.692=!QPF$LI.-:A8@536CU>VKVV<W0F[Y
M+X=$R5DVNI.KY5(M]S<)Y>@QG[HXD;4_W'BU6 1UQI[*#9FKS?LR_C"G%^BK
ML$[8FTN0RR_OI)I\Y3?F0M1=7&.C"\GV7M,KNKXCR( N[H;T0O4I"(&:YY].
M/%\) %<BDV"=/DUA@]$9S,_?1UVX7)E'@="&3FM .@W$(5;6%I&A6W%REQ_!
M:*<!W_@2R%JUA^AGH<</?YCD__OP5N]T\O>+>B9)#?9LVL9C(2;(WEK%\=-G
MS[8"Y=2\1T_GF\?C=6X=.=,G)HB/SSZJ,:36EY]^G/E+,0$Y5W!V30;H&)*A
MSMA7'TA,T%4:]!=UH71 5L:C*UFAK,Q4@RC?C*)B@:'KR'KQ'!$5$DMMQQ=)
MHMU*&SXO'L?$54P0A3-$,4BSCMD%8D7!;V1D[M\NV[95%%8SO/4[0VT[)"C-
MU>/IQ)L.1-@GG<?!( ^&V]XA#2+/'P=Y6J)>-'OLVKWLCG.7?WP1R%)7Y7XR
M,#IQ.365X' MP?&I3CUH/V:X%UN&/\0W8; =M-*9;D.!2N."MW2'<,Z6 ]&^
M]"I1<J,O)Z\X_-V^PF#$VZF-G';M-F1[#HDS'A[A46:FAI@A[?JD- ];R(Q4
M+<PBF8'=Q=>L?G_<-Q?EZ>5=OKV^O'RIZ01XAQ_AOMPJ/H1'K)?[SIZ]:1_?
M834FK.[_'A5!:6]A8Q!1R0]W#MVO.,I&!Y$[,,-!_ L>VA??[;N<2L"IC#JB
M/*>+F5J>:_SOR5; _),I4D%XDE 7TL.QUH)W>/EJ%P^>W +<&H\11'-W=^>Y
MGT^W?\[LJ N=7QF!'9EM7'EF)V;?R$CORXG@N^,L22,(..$&36B8EV([+_.,
MG!(-EWC8@QXT=P_$#QNJ\B/(R1NDFV.%;,4A9PLO@X.17:X.YR?Y/CYQ/LYH
MUL=YD,&/5]?("Q$%*<)YS41INQ[=JIF\(&^N\T!$!31"(J:D5EOGT_MO&SL-
MFJJJJ6E4BCU(-*,_X;*HV&C.?-/;R:$SS ZF8S.4DUJU3KWG ZC^<6\0J7J#
M#)LN.MC]A\G]OX"_^(@/B@_6)&K5!,>)/(.OR:<!\DD'<W]_5S#=^_.1%H_*
M3EI$>S0G/AF*H^5*!<$&7:\7A.6&PF(4"KYE>OO(M[%)7Z__[>66["6[P_XW
M J7\BL0"CKA(ZGLQ]V0'2>$)U (MBQ8GI8@-D,U-%EU,GX[=\I[W%-$P9OTQ
MP\E!#9E[%D*-28@A4]=6WGLRV3P,'W'_C$/2H(5\$J/3\)Q"R\(*$HP9_%9D
M:];N[8@)^4%E=A7*ON1EH"OFIY?7S35CW-$8+ 8-\.$&Q<>R@*N=0WKW9MO3
M,OEODW6GC[#O\:[5&]N@?<_@->R<?!]6&JFJ$T-/GCRIAH>3^%%6XW*H<5PO
MJ?<2\<S[AO+OAR<3G9Q R#?T'_[)4CSW;K J1E%6UGA]+$B]!IQ;\WDC6ZJD
MNV40XZ+)7)DT[)[L7LR0]]$'$]UO):)ZWI#)Z1=AD=1<^TL&]<7/A%>P_:*(
M[[<T>872^NTIA@TIV(H?"4<.K0%"#:>0*P@U. >AV1==ZA\Z1H&.-*O94!,4
M^ ,3R6&KR1S_^D8SO';B7/\-_#-FR#W^"5X<T3*#U.-^P<M+!6SRX[I$;&-)
M_!.#%2.)ZBU]('?!+9"5VJF2=G LH&R08=*?&6U>:%=P#QF+OU4+5*?-<59\
M#EMXG1X3F4^YLM*>AEPIVUK2:D7VQ2KH+/)-@6$$ ]:/D%"&56]D\7][4!%O
MAKL('EOAR+/ 9ER-8_5GNT [:P=+9$,7,5IB3UWSO TB&6F!URWN\=AT"CG5
MP_)UK?,0F_D3S]==>F3__*]_E++_._'!'==*#]8]'R^YI_Z/-#/+5K$'"(W_
M)\T,Q1;HZW<\Y>A_I)F9*?_\Z8<T,S5&U<58T3UVLP!E(UDPN8#OS_OTW;Y/
MW>9Z"W6('D6K5X8C@POK>I\E04Z.D<,!4"</#P]'CX 8R2H7=!!"6+SQ/K[_
M,!%?!VD^\?[2ARRHH'.5]VJFV<J*I6FZUU]WU+O"K?;(>/Y#_DXRJ4;AV'YC
M>&U-86O,"O2S]+YN?1C$L9FI+@7[!(5+SM;7S-9(IP6SG#<.9[=WQC$N?1WT
M-19(ISK&JX>_2EGLI4RR>C-A B<XF#[+MJI(4P53+J5G730N]@R(GZ\HM[$U
MQ71ARA:S?I)[Q]OYZ7J%.<?L'.T#.>IUZ]#RV*B:FM61W.]^1QOFWM]T'^E^
MO8U+N&//_&Z!/LRV4!35V'L]L[C"]BV;2#2.&XD%$T6=2*Q5>U/ !;3IQ$3M
M67A'4R[]1FU6EFLTTN2\5P6HO*-SXQ.^VF^8!#W,@&0Q[2?9"G.+P0+,@BSC
MBAE15D4-='X8@9E[TL!! !$.X@_*HKM?MXOO;^D9>99-G12('-(8H:0=,Z'.
MU3+]6ATZX#'##JE.BXM\*QX(?KB657E.9VK$]MT^TKDM%8Q>,\+VS\09OITR
MZJ[@>%-Q@C#K+IS.&H#M65I>#K+T0^*0@1BK$7>4<8S/4$,IR O3D*LCKFC"
M\0^T"V";F['> 5WM719F8(9@396;L_V^U)Q7! #\:7AN0=W7T6*))ZP9F_5V
MI]<NALLHO)]DS@XY5"2:J7NW+[69^+[G*(J_X&OV\Q^E\_][_/_]QO]-O^'*
MK*JNY,9OY\@/;Y0W6 L.N,,+"QH3(F*OKU U6SH\V"N'UI>*\^]8\MAD6:&O
M&MI1(XYUF%9&/3^( 0+=D<X#X1N&2VE--%OYKD4,>G5O77"%W2QL%!@E/SC!
M[&2E *169%*<LH_8D+O-/FQZOM]F8[HH&/9V]V^-65+8].K6HY2A/P\X\5^+
M.S;781EOET;"V3/^90#+5^+>"C4[PV[/FM[U=_N^7K1*RFF$KW*Q)=NT?EI)
M_'@H,T 8+9=P;=\^*K%M"IMIQ!.N*V"W3&QFC1)_OI4^^[B<=;YC7-9@:U]K
MBE'(Y4JZYS97!U1]A']4P*V?1F8%9/O#K<J+Q5;4L3":S*JC2W=>FHIHQ]K'
M="S ^UO*0AN7J^S$%D>9(9,CEF7ZC @^O,1C8/UVH-G__JFL?\!7.);U"G-I
M->9^5F>R4\_W2<(7[82?7RS3L)_XWP^ILT^"2$TJ!^=K<NSM<4$7FIOR@[R!
M!+V,B_9&0/58G+JFGT582Z/,#=1NVVE,I"[K65M$S"6WUX'/246"",&ROAL#
MF#18Q;^?;Q?>>,]U\!8%'XL([0637J@8)R\)$I:%KY55BLF;JFI'^QW\!F__
M9H>0$.C'V)>JRJYF;.99UL$N/T:S*70:3P[0PG)C3Q3,/PLWW=BM\!\W-C'#
M=FB@--&GJRYH/F1.,=5[*^<K>WPN!ZFSF<#8WU9L4F&9TB-&J*&;N&Q[NA[F
M;NO-A=X;=&"+3/5#AS;P84DY(\.#6"5#=O)A@N4F;Q,VX.0H+=R 4L=H-#.;
M,3NW17VT_4^N/N+K'L *IU(KIKC7^$'N:?*[>E^N)M('Q,#*^9X3%1&1-P/]
M (E1@ZJ7'2>VLM.8!8&>D*]J6QF!7#^@-Z"#ZDL]X<="G<09L:0O^W@I$_@I
MF=E&2$1'96CL<O, 7&8FK@ZV7X2(NA#.%E=.&L!SBYJ$/?;<II;4K1E)[VK^
M8G]0Q)$;Z>+N%%!-Y\7F&<TG0X7X7VX0:Q_[W:'').Z*"GU<> XJI-W'<LQ$
M@;W@04%F78*$H]1UT;EX0986V>/Z;I\81GD!\4%GO?!!6;^<!+^]/IL3#Q2M
M.G;NI$N?25*5/&4GEHNL%VEO2*A%<&PUK2O7<2M\L^$H*]/4"Y=3%K_TP]34
M1(?H>DPL8\V_+8E<BC42X@$GXY;>MZ464'B26,?G/BSXUTB-LW^<J/\O\3]\
M-<4>+$KDMUO$\' '4\?-H<&2-E%3"6BL*=QP0618P@IO.-W9-]<0+O?VL@@*
M\O()7/$Z.NREK22M] +13)TC-Y,-U?B!5EQJBP[=H?I@4Y>'S3GA_0\=12_<
MC?F*&*K/#*B(&A@8J"[HCR +*45R+>WXWN;N2Y5G_$>,((P'JLJ__.=%Q8]L
M!7GTK*D\44XHE]Q^"U#[;,>G%ZQ-BEH7(IC+NWWQA[EF@:^WZ1UDLF_']\C(
M6_XRN<FUMF9JR^,2:*+4!-ZZ96.[U,Y!(;?4FJF1\A\E6-3YU9Z>&;&XF\E!
MU%T7,&R7%!1.<Q9\S*/@B7*R@)F#5DHL%S EI6G70\LM,DNA]?.DE(MM[(_A
M,U%3%@U7-\%HQ/_#WIM'-7UN_\+VMM;V.)6BH#(=4: 8 B+S%$Y;$)6I#DP)
M0R$,0@@Q($,(0ZL69(R",@\M,E0@(&0$$C@*(4824H@DD$ B!((,"7.8\8(]
MI^?<=7^_\][W7?=<[[WK_2SX@V2QUL[^?K*G9S][*Q6L<8MX-0WO]JGY#6PG
M]H\D/EWQ< N+2U1I- ZW:3_@-G#+=$L@1IH+DF"-(S6B!DA&6T];6B"YM96<
M ZGK>1I8ACI;=/EL[5VK\I;-NU2KN[$C/@-MK':9FCRTIQSDQ5TW &E\^A#,
MU01<<0<XW<8BQ=A0,/?/[_:=>3G7DBCW=<WM21!L\8I]Y:7!'-NM]WMQ[Z>_
MWZ+PQ2;]WMH/'XSB_Y.A )Q.G#+BJ%?$WU[?,<?-S&E%PR-F3G*W"8C#M\&^
MG&/+HL%IF_R0H$/Y5D?*M=A?T@\-7_>1G:IKB0#&Y:97XUOR0 7;GK'Y-=D!
M;4<Q+U'PUF'N)NL>,]K#<XJ86(HU/$%24#,*FSFQJI!-7EQF7M>W*9]@%VYU
M^,O$![*3A(P<'?W/Y?24W(3KH./M14[TU^-3Z0+7@QXV<V>W;LJ2OT0C J;T
MUS@(8]:<SYJ9M:#'.[:@1/[E:F'2JZ&5\ &2B6?("H5PGC<?\7-=F6Z>Q9_S
M[\M.%YW8.+ H8C:PED+PQ.V9P>)7"'-@=U.]'4];[S&G\4A"U$)3,+T^^EJ?
M6!'"A6<O4VM<$:M'%494?4'0GWI.$KVL3?8*]K5[4ZBI22?*[P1 P4RGM5V?
M^9=_*&\:<X1"DW4<0#=^-#)RIGS3UA"SBMPTQ3VH'8.[/HNV:#A=K%L384X.
M3I4> GW[AN-VG..F;.IA[! %/^NAX*!E2>K5T&D#].Z\8@_92.\*PQ<3$BR>
M5H;P0^X75(L1J+2W#.=@;6WM][-02'2T.[)A-Y+7H)#1>Y%\$V0WDK=<\'/=
MC>3?X)/C^[!P1:^"T/UO8LML=*<_[L]3([PFO=L7(C%\MT\G8[87]\H7PB9&
M9P_94"-Y*<R^XU\D_I+Z,N'SH*Z)BO2,\%+"\2B:H;=]- S1ZU FM%MM?& S
MDXO?Q&E0AL:GV]FH*\SOA6_2.$(HSS?S$9? OL,M'J5T.8G4%H(8^]"\YI;L
M;@EPUZE-T^"[3BWM+<LYJ;;CF[X]IX8O?^*%Q0H.G^OZ8$3_'\2W^75F=69^
M\7'1JY;53WLU4(O%J$Z6K5_T\E(4,NLUDJ3*@FD$QMC%X.RC0K%\;YJ?DI*J
MQW%NQ/2YBO1?WV1/3_/]-UR7RX?5?T'?G6L$S!%!'N%1=A&KR%-^R+A^#FZ(
M51$PA%547]7/J^;G90B!.8--@?P=3Y1_^QQU]17))PZ-.+S3EC]D5K"PZDF8
M+V8FNE&@JBXX;#6!&#?R"U_M[HC-76),8YBT,&ORV6H)K1L=QL?Q5+T#FX<
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M)IED;'ST-0Z$=VP.Q!9;">XR.B/!/*_IO0/IP>:+5+.&=E$XK:X^VCW8)*T
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M]]#KYSD?N\[R7NB4"!&F"3%L@],O@^AW_>^J-0?UY Q46\=->1'FT/P ?!5
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MC)9AW@M8"DX- B>TUW2:WEP=.29XWFA"X0ZO-DCBRK01&80%OQ?6 8(,N[5
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MI,(#>*-8T'I@X8J!&?S11GB(#.\<[_B(;10MF3&(RS:VNC(L>Q%\E]%A OT
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M)TURK'I,J,S")AOS_@;0__%9AC9J7PDY]-NRV;T,< LQ\SH&>*]XK/VFIBN
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MHD(J-4<W=$J'G:9\9U1X"9=#F)J8U$3[4X_5V<=Q.$6,>@8P*>A$U%.#F5/
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M7K='7.KVTGN/HN4FS FZH3#Z*]-\@,GTMKX-P?SNGE(6.@81P)LJBZD?6?*
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M*)RL/U3K3ZB.6 /6G&ML#;/$RN71H23XA>(14VA'KBB!YG+HTV$:3UNU75Q
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MFL7--\3W'S_LOUAV,OA%28*+5<$;; _?2]7"",>U#1\!LJF"$!+,HP)$QM>
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MV$TE )L%-]C[#(DO8?'O.,=A"#2(<>YHHD?YH\?4<%,4H[4'6?Q1*I@<=^C
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MLD39X<Q_*S[S.9=5HVZ:,!EO]:O1UPK![XQ1$53"),-IAMF_!O,64L^YI?:
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M>5/W+_@38QU'X\5BFL]:7-L90_(D^TP[QQ2!>OZ,38[A\-YQ>,WLB-EZ-@.
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M:YB.=-Q"JG6@;YIR"@*4MD,VE<TT*C,8N:TX@PC6I_T1]$=8S=WJ+<.)9)?
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M"\ +J_4#IF5Q7,3YV.,U)/+"+.42><KIU$"*Y4 D\D!./R1G%9;057)^H?-
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M8HSL*1BBD\'1\&/1]+0P:-DKY[";!MSU9IXAM)R/C;=.Y!6Y?Z,1&67[5I*
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MXO5OWH.@7FA!_2V7W9-2BS)+BW5T=9P1T$>LYF63"XV[JMF<.RENG(SQOI(
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M>;FS?VO3EX^7Y/,BC#E(^O&YU41W5Y/Y_G#NFQRWAR:N?6W+5VEN!JJE)_<
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MA]]R'#>'^G9.F:)JNPN"M$+CBK>XKJ:HSYAG%L)\,DOZS^X<^LMO'1>_X!-
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M#)\HZ8*U2KR91XI3.C"#QB:WY3*Z%C=Y''!C/;UOO48 W#^[J*ZQ[FW827_
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M0)'#ZFJ0*K2\Q^W]LCZY;E#19+V?%L(QML!L)\K= E/NT)M]"DB#?D.- 4&
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M(%L=5#]_(6Z\6&17M5NT0Q[UWI*RSNU&2"OE^.G61BJ10L;[@]MMVR,B'AN
M:FM/E>'/5&.2YY!?ML<V3T(L-=C10H1_O7>3B3,3G!+4:!K);E0SWPT91KX/
M"W8Q]D,#B&K(.>S'B&.&_<3\L/3K+3IRX/AF\(__VY3P/X?!Q.K%Y/) JGO9
MYFNF]/DH^-$#ZGVQ<W::T3N"V#;HO#+#*TROZ>X!8Y.P#KH4^YQ"+:(F/[ ]
M"VD^H3R#Q!CO%;R0>;5:3,[EV:&=%"T":]<<MT;-PPIXJMR*-/@T:WJF-997
MCXCH:^U;\@OSVHB5W";;+]Z6&-E[8I^\RV1-V%]@!(8EY.I/^36AHCBZU*RR
MO;%7?]WCFM"<H77IUJ;K<E[99E:OP^.VZEKEWD^?AYL6P/%GXV!BBPC#GI@B
M1NE8G.,^,\@Q-^<OD/+^H7-*X]3''IY:JW:B&"L*A0,CS$*M9[F"6"8L"*AW
MUKLOJ#9D\M)E5SS8VZDPQ[8HI/^=E*I/*R#G'5$DW;%28LD*R@&G>D3UQW6^
M)/"AOE6?1=,=%9U37EPM@):6D=?SB9S=PI$6OM3\_*?"$0E2_ZYY[N?"T8<0
M9?)5+=[@I\*QK TVA]PM'-^]DLO"=S/GPJ3C;#=[P3XT_7&>&">,P-4!W<B9
MF1MW<&?'&[[JCSI:!D:CB]CZ''7UBI[MGDXG&?"W)\\(UQ;19W+3+F[D)@D
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M87?H2"\:,8XG9[MZ;ZNX8;H>KOD\JS,8?Z=_<9/TX[\SFM[J>-T+2M'6EQ.
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M3IQ+YCFN';_:V!O#IJY>9BV/0(@$,\R6.JQ0,V -*3Q+%5;C[*O.3HFP4\/
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M#4CKZ0AS8Z%IR98MLH/S/E$+4[*)HZNV-P#RO;OEF@8OXZL%\(.+URC1/MX
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M74<^,)"EK^N[R?8@UX)&:GH[O8FO$[=5+$9;[]CUJW^Z*)4!WS'N@#;,N&D
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M0J;*)BJKUZ@*-SG!?[8E?1G\?0)\Z/2(XJ3H@Y2I;N6,.[QU9A_!OQJUY\K
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M?JE4A*0_*EQ-YX>4%:;*Z$G, Z*W\N -1ZQ_J.'6M!P**L;RSD_4!.M5XM,
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MR#R?5E"9J\@\*8% " '#%$("M%J9(J2 ,H6AH@0%$H0,S*$((5((%"())$"
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M*R\\_2TXP%NFLVJP*@HM]-N6D;R#K0_DYMZWHWF2 +>>HXI]<]B35I#TXD;
M"]"AUV;J.'G9?C':J%B/E)?_?//AIVKX+R#DS6R(>%37C_:3%RE'5U[C.TW-
M\UNKN)T?_H]P??SA]4197VLQ-<I2XGWIP?!,DY=%F7K<B90$U. ]PIGVEPV-
M)0%>;GT^!M")*PF"TZZ?K+'L7P\XF(QX*T)I!A@X86+=RKHC[3Q*/24=F4@K
M4G)B;JT#.H'-U<L1I=-%]72(OSUSK"0K*RL5#@V9#"$?W\2M!1'\O484_+T
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M2NT\:ZWA(6RU^J+F 3X)FP1J(STO?7GH!VLK8S2VR!GYUHF<XHWG1/,<@8M
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M4.KW[2SHPS9PB=N"38IG!6[,H&-(P]-&T;50K>AX-"M8UH7''T3##_QTM32
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M!_?OU)+7LJZM.^;9<O_&7S2/[,!X]FZ)>C6!52C)2?F-AEYMTGE.G8D\N=C
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MK0=&GO90!F^40[.N7$-P"&T#YAD98S8OS8G7')\/0IL'__*G(.>53(FGB#\
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MGJ#*F.W,-JUFHN1==[J&U1ZG),H:>]X&:ZR6U#9_CBEU +:/M(VF?I9]OM/
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MZI"O5[I_PG[U/5[-^CPGPQISMK/C8<DF)N%%/KLJJU="'3$RM%N8AXP@D]]
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MJIBL[1+P/=H19))I1P-+]8WV]7VELSGPO.Z&Q&&G;G!Q\9@^=&@Q.)I5)FH
M$C>RH%8[,1WER142'?UTCRVOP8C!X'O),$5^A>ES,\%?1&N5;;]^.FS+82;Q
MM./&IY]"'R6M7MFH4#Y]XLLY'S0%2+MHMR@+1'.UPG_NH$1VC3AD&+7&5WYZ
M$QKU2YX[N'Y6CNQ+ZA6Q)R74-L*N=':+ ^N%;QKD2;&)(F,MY>/GV&^SN+1D
MXWGJN')2 1:1C4#:B2RI<5SERI(EV!F9KYY%91B^\N'3C**L(&D-.!!4Q_B2
MH?];Y6>)3;\%:YGOY?*OAY'(!9$6T8,SHJ6ZJ,;=B<*)U>0"6$B'C*$>=V9*
MFTJ!H%LS,[7;6Q[:1&[FC]OWSXQM2;FPV"WY\J<<4G=!2-%Y^Q$ZS'>L-+ &
MA@+U:4[B-DA-I1<QX3I ?U"MNJ>&/I743<T3I<3K&K\>=C1[3T$#:E4O%9<P
M 4\VAZ<8'(BK0I_A*] I"OGZOR/<3<#OO#VRL((\;5./0]@!I*S2$4W.Q[C(
M3GY*M'%G%)1JYB,<%_JH4&J6:OIOS?C/ @=5QLO?WJ)_DDM3?^ IE%%CY(=#
MY9\RNKI]XDM!,[;JHX6?)GG6B-EV (V0\797YGJ[?[$>!#0(O,ULV"7&:Y,7
M+"<Z :8&:Z(UMH$+,[9D./4@C&+JZ.@8*)NWN[KVF5?>,?+ 4AE#@^H] >P8
M9 DO>8@;UYC#CM9^Z$!VLWGY_1;1?O?+H#FO3P>KYH+@V3T+02%YW)E,65'5
M0^&YP O;=S<^ZMO^4<(Y ;_[OF\6!2A3+YC2"9\1FE64/2O&(OHZL<DRPXI?
M,80^"]P:V_O8$C5)8"LB\'LP3Q?%8+<!*];"/?'8Z/PYQ@7GP%BF]D#),/,6
M.;=AYT_0#G7O%= O1. 'MS06G$*VSZP,]F5*/OY'ZW)IIGZ!;.B)]P^3[,FZ
MNGH]3,D;;%#'W=K'W,TXEHKBXHN2SH=5>[$>A@;YT.D*:-2*J15FQYO'5CX)
M1 CQ05I>)U6WHOP96 399@?HBJ TW;;OL:!2Y4Z7Z912:"L]O36Q=7X[92ZY
M87.@S7>M>).E[+F@]W^:GOA33AR3P&K$%4X)HMERY8(%30,4J"'>_IQ^,7=Y
MZDF<A_TC8MNK,+TN3)\^K6'"E18GAP]*" '.%TZ-#YN(J9W>\*5*I#"I2WKD
M1Q'V@!)F+,H4Q8_1+TG&H=A6T JO]LX]JBK5F.46PM! ;/\J0\47#OX6,PV
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M=U5[!/"7&FAX(!Q]/*>%@OD#D2-6N^<3M:8I4 ! N7-?KBS";(ACWW!_-YM
M(1._FO8@Q-;VK5YZ;9X.JDV_O.X),K& =3/]W&0_3=@K*2'.<[FH8*1[' -P
M9?=O$H"M %(8DIT[T,H>;C66J*B9%"VJ)NDX/7D4#5(XQ=9L"EMIRQ]9@!I'
M)I&V="5WV$?B3,@ C:./;;V; +]GQL!WS7%#TJ%J:_6BO_P9*<M3AQ;T2\0:
M.FBJ?R^J]ZZ0,/$8_PVW D1XT1^D&T+L(5;4Q=<UGFYK>]"Y?"#:Q:G:0GKK
M!#_AR(+NHU>YN0EH31BW.@F2Q-+QIM#;,&=LRGJ<S%I"!WU/!$(*Q!F,LVQ#
MP^IKR4,M'GR75X-QMM#8ION+7*DYA[F:M=C2^JU,/(JXA-]LG3=YG)?R]:M>
MI=" CH2\INP(=_Q(]*J8?BQ&=I[;D#S,P]8"8[.5)F1?+(\+?2/9H:AD(W V
M^%'1!0MO)@[L;3_F+]XVP4FI:*%5\N6S&6R8I]5]7JQ4Z,'>-%LZEAW!0N9+
M@:%OAV3^D;]-Q__]Y3^,L/ZL^]Q>H3_XKLENJX(XU26>*K:%"-"&G_7W+\3^
MIC>_]P4NLRFQ^.=<'K7VI-;M6<[L15Y3LYF*+'RW;!" 5]I>%;5N5Z_[V"J0
M@1(D=Y(CNM<V&D.R4O3<2EX@#63#'P@?%-942D7\%\&-Q*]?J\/C4F58UG$6
M#TH?C++VU%^R,<:@ P8TY,G5Y#.!<.SZ[9'5@@R7^*^N_).83C*VUZ0.NPH(
M!HVW77%V=:]L/92'8O^^YRW_,*L7DCM-WKFTI$SB77FI,9[DXF)50R1VW_'Q
MG(UF*+].2LAH"KVZ]\/.ZAY^I^!E7U0'<3%>3.L:CVP[\(L^=D_^6P<!'\IY
M4_V&* "1G&2^6[JUOMKH'.+,WH;X1Y.N^LVHR3B7PR6TK.>U# - K_"YHD-Q
M.001AY/=^V+I&?O->T6ZL41Z-1A#@<(][K\Y*YW@/%O-4FEY\4(F'MGQQ6>V
MSHH?1Z1\+>[5";7O2<BLRH[ $_1A//'8L3Q9V**J0)W%BD.'K1/1/17EV3K]
M_-@$;:Y+D<03^D!4 W%TR>_>=5Z"/@VG/4:H$C0R"V<)5NXIARVQ)"=W\:[+
M36?M"6-T".F+]&U%=0;.FY^BV+8BM:[Z($XDU<V5?TR;@1Z,6TW#L]'*WP;#
M""FZ24?:Y@E#$Y,C ;T%9O-5[-6Z=]$ LSG!3^.14NQ>LEX*(([$!I(NY3/P
M2P,HNB.SKM6X7%?Q% /8RDLO$KH?19R,G1#@:6KFS1QP&$/;T3VFB&&</AK$
M5M3?T'@AG?Y'29/_VY72F!['E<6QHJDIVA$LML%@TG=RTO&:LEB\=NM.*\!J
M=,SI?N_A&)&;FQOM&!V@*J+9]%=3LK4B\LD9K1'XH@S&NSS1F+1W_8O1GZ<)
MBP/'L$UAV$ @W>*:/3[T[3=?=M=M_]A]2,CGZF(W^\'6\Y]N996 +S9THBS#
M+?B<[2]Y6XN9_'%J]*?$W'X:1-?M:D+CU>;>.WD("R(-XG;+O+M^BX20BCY3
MO^S8OO:&ASITSJZ3( )-48':R[%FFX..Y,HSXY)8EO>9Q*J S\MI;/]K$H*E
M-]_\2]>L"6]CI@U)'$29>-3)TM)F^[9FQ B%TGO@%WO/H1>B$BPTEU-4.C^[
MV0LSGKKM&:NV+Q<8F^Q2GRAMV_K\V2 X2?N6]XAQVQW T&ATB)NA4%/5]5K
MT<:0XEVBR"_!#\]VMFSJ,-_EBVXN06IB2R^"U?Q<^:)[TZS 9#VGI-]*EB#
MW5MT0JQZ:1)4W=K<YBJR]/(3;H;^O2P$7$K ) C71BVZC= GF;V4M6G7T&?
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MJ;D:TV<QV$,E/_R;:OY?D+U'O=XW=G,IM=EYR"2EIJ%%&!&:,I&8_;(-USX
M:X-KD@G!LPWZ!GYL/T3YPJ"D5>M,QUEIE!OX2<GE<ZCBB_7I"DM7>W3G:<_\
MF7R5@-J@W)Q&&@R+/291D997. 9GL(ANO8(JF()%7X"2+AW4<-5ZO;>TXB.2
M=&IGN C2_MA#6(1Z+#3#FHP&>=;Z^I^!9X$5J]\..="]_Z,M =_?0'(=0 &<
MW@80FZVH;DQ7<6QQ]R#D8U4_CR?]=Z/Q<1T-UNYM ;/2CE3C1Z@DA[-;]?[!
MJ/#GLV$=B[.N#[>*)TJA^@CB@NQX7&WG?#NUGZ45BKF :,?Z)EAT0NEFZ\Y1
MUS8"'!H =B0,(G)V5E^T<U3TXV"MRPHD5[W5 F320(8TYM8ZXW NN=64%F36
M/?W_>6=KG7^SL[7Y_TN=K3^X1:N+(X()#"L?(5H#?@0V+V(')/+P;G90:I_2
M2OOVQM'NSHSDH,;EHL@EEDGBN<H2+JKN:55)>V[%A05+\!96=JK#W.:M2 _F
ME7GOY</'+R&A#H^96^[\UE,;*P&PEJ+B]*),EUS/XN6\Y%(S3_QB#E^E;^6F
M*\1!.)I8RYG/?CHSD@J(D-):9VH_G/WZ#U]*3OGZ=G#G*:)L:(\LT)%]'GDE
MV1:N.W="QGI&R.&JC?L1$K2:FD0:Q\W8/3\>8:2FL[B--[3;.F:;HE 7<[Y<
MS"Z9V1I*XG=_ENL;%_1FP'@Z[C-=+R(B4 \W[FXXSW1D>C6N:/4'ZOK0G4-O
M<MIY"OMRKP&F*NJC[+77N'Z(>%DKB.) ?F#!6RT2!^-/IA7ADD)_#6PASF;\
M].<6!%_I;ZJ+E1(#,!4I/I5B\,VDZ([.JJ:0!SHZ274&,4'0J*DF<GZ?R.Y<
MT7A080.HXT"I43>K"1CU<(EF8TEM"I7*'EL@.O"V+E3[QZ-4D%WII<[ W$3N
M^.:U:WW^0--6EU*PPO'2I3'OH<B>O\0J=(F^+$U/0^?P#$.87EG&&3.,LS/[
M<FJ8W :0H<UX>NAO;Q7,?_D[9QH)8^5)I3S2\ KJ.>.Y1&Q#G38^2F2^E<*=
M!4")\T,U[.QSJ9&;W6T9<^N\5!*_B K?E]-NFXD#W(_H<L2;JR_/=9OQ#>^U
M3\T+Z2M)" ]JBL;#V5%$\F?D >@+(2*6FSN9,B66ZA5,BV ,*'1/03?4R$_/
M=P5RUGF%:*MV].SMW]O\DAS'FDV$9"62GN]8LW*\E9;%YS^C3IQ]-'@RZ%@,
MW>[8"-GHP%F&42:CD,,BW^RHZ*3AV04#ETB?E,[!#EH.$ @MM7$,&4@H+BXN
M]7\7ARH/[0_Q3)I:X/[$"9GF\TRG0@<C"G$RH 3'HEM(I4-#I.?S-G?_248(
MSOSS&=.IJ^$C>)^ <J:I,]3\^:IR,BM^JUN+DMG9.P]!MHUH6B&2#@V<E^%$
ME .W7%O/\=$\H5M>KVW1C!T39:D[?$F*W3OJ9-IXT^>-V+O99ARIXLR %*PH
M2Z 6D5?FL"NVW[PN:@N5Y7XU$(?;EIB^+B\?WW5MH?,CD"$DR&[2BUMKRZE3
MU*6D3^U]7M'7P'6=E1*HL 7&%]&LZ'L <(,+@W^D,%9,49ORA6:K#:R:R+K]
M+7:AL(SBY]RU'1]*]J^M'%-D:AX7OU,QO2=H?^G4MB]7FM.<^*X1+T)E"OGS
MW]_UR"?)I5,"00_=1Z%I9W=^<<UGJAQ;B2 .I1Q5]6 IWNTRG=,?2[*-;,V5
M7M^JJSM8*<PN>*=L^.[+(;AEQSG9M[TZY.-N(C=F3"RQ8 OJ]MG+@P=?^F9D
MW24M>^V"E_3;4-INX0#B)2FY*#MO=6V.80NO=5<+7=H% \;3 .&?XHK^@?K_
M;#^'K7Y[BSN5? <NR58SQTWO"C86'^_:,M1\F+O1C[K;FX[ "WZWV)?[HFI.
MIA-<5_<76>C]B>2A@O:ZG.P?TYO1\[KMXK$X6$(-HG%=NZ6[@7]T1G!43^.5
M):4C(8LO@7<->$KR*9U3P9/TT%0V7RQ-7%%.*X^>;R(-K)*SCYYF(_-[Q0Q9
MRB"D7F >:1]7:N*+3UO.F!^,>))1P2F+81C3^\6HKN0%W&SL<LB; XYMVXAD
M<GG?\=A<*A@.-O)09IJL,S\A$_N4Z)<,7QJYN9XSO*IIY>9\1T2^,T91%=+:
M=H(IV2:6@8.>>)UKY'I]Q;_/#P<S ^6'/JF3[: [H8$QHNB5I:4]H;^A^13Z
MU.,9!T"EJ;58PUE;2ZWJU^*WCBI^T0XTN.TZ;/]B(Z+&%,\"[AK1?1W@A;1;
M+EH^AS?V>&[12:JFKF[DA"\O1,^OE-(Q[ ';*T+)\? WCVW\XSZ>&R!0;DA+
MG:D6H;"VM+0,+GGSU3R+^:OUY+3266=BS2=6BZNJR'*:1TK_[0N_"# ,BJ<X
M<."4BY,_52<@2YFB\6:(877A NUO_<5_KO3KOT,?.$S7)>W9QF,/S)*@)QG5
M?+W#F"ZR'I-RH1*C&LG!BE?^8,5+YN[+M;HA00Y_U.L:_^*WP/J__O&(C^\F
MT@0>:O"EE/F]EQ"MF^8&:DFI(^'U2DE^/S)-=JM(R]:A<:JM%%^X1U8!,[*Q
M=!Q)XE'1!F0/56& 5;2V]<DU3UGF:T$8;"M(E:EQ.A<N7%%N[-)MY"9YI97'
M=/M %5$<5O!2-\AXK+F[>L(C9<%4Z<&4A8=U"R*,8=R+VJJ2==)G:2\AVF^
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MU"=V4:TC;9MJBF\8;IX!S^(81F(I69>K4 WB8IJQG+R\U+O_I@;]%_2E!.E
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MP$ H*/U=D<'L$T5BHENFU2__WT^R4R)M/[7]B\O3W2M&\GT]/QU2V7JQ+P=
M]&Q<A6_99QR(R<6V0M9$]DI^RSZ/(/Y ?W^78^W33^TU,C?]A#:+VLA0%+Y
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M97Q&2:2)*C  IH_IN4C%3(-.#?4_L6QH/Y!Z47IQ&J[/'18I7M1A^]7V+&"
M!G?9/E6 ]<)MCIY@KNU,*%MA-1W]Z?.C7F,-___8")/;SC,> D;3'Y25[RJZ
MP6OC]N4\(N+] TN+WE9IP[,F-T^"VZM0YK.SZO?9;E-6MVBMJ',+)3V#@"\D
MHL@HR_+L9].Y=XLD/L,?):5J-3=0=9"D6:-M1<&5H/+D1\UKA-3:J7XGZWTY
M_E*MBQ\JW$=\!C;=^Q81[B$KZ;4E[VC_O2N0W$>=1'U31^1'KTU[U3+X')5,
M[^Z,Y=VHQ=+,;?T"L;L,3PVJH194K'M>/ENI>B[I,]/\6Q['Z+I7HC6,*>2
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MI@<6;.">2^3*J6( C+^63_I0!)\%  !. 7+/!G:#($Q8L(/8DE0'L"15Q!0
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MJ'4!W?%#<785W2]RI*ELA]KFHJ]KO_N-F#9UKH'EI[VK-%N9Y@ ZYNT!RY/
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MV.!JB]2\_)0<SQ:MV M''].Z9FH19FCWP)D!._V,USR/L,>,T#,5!.YR]^:
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M@08'0%EWJ]OU0[&NNKF,D9D&*S;:W??J ._DHQX!X0:5,1TM?W$%"<&"T?
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MPN!Z&R8P(+NG0.<,>A%*%-G$+'$JSEQX0XA$2UX**+E%<<>7,.GK?4S? X5
M;GAX.*<.ABY*B"<MK3E#RPI^2^MV.%C5YH5^O]/_B^)^'0 )*Y"#X/Z!O=Y]
MG<Y(*03_,O@"%DH?+ESAP+*ZQX;57[81BU--ZDW*LD[\1# RKBQ,:K,#W5],
M')U8>WCG70;SDQ[X';A,D)\WS\AI MWEFI-, ^,;IFOI4KYQO#NPP6QIN3"2
MF2]HD@9DG#1@1*>-+ 8_!UW,+E.$@'E[OW^MT9X:X3"9^733*G_'8C7NB<:Q
M7P;![>_ LS=?L@(*QZ&* 8/6A@)"49+6BBO2?>1P,A?U8TZK4<4:\]TX??%E
M]+%GRQNSIL_:9[,=0Y>+@Y##^<P&IJ/(]*&G )XM$%-4\]BM8?0([G!J/B.[
M7G6E![>:-B'A<_FQF5$2E/:"5Y#F%BCAA!F/H?,MJU/@&Q+NA(3#;(%-1]]Z
M!'7__$_SJ]4FC-NCF:QCL9;Y1'/A%P[X^8W0V:"7PP&%@9&: \#6:+QOT4VM
M8Y>0UT:WDX6?5^2DG:YXPQ0$]DJ^1IQY"E<V:*^;M1?*#-.797^O[<:NH>0M
M";:QBMM)NLAFXL SEMII[G!MGZ=[T?$J@OO3VNFB<AYH0"+1IGS:F"KJ3\I
MW->Q79_NL5U/V ON7"5UY6 04._.I+B8Q<=T-L4-O%MH'^/I;(_:^<+N\ "
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M@&;QTB,$''P 5\O) $^F.S._=_99A4 U?B-Y<&#;E.JD5C-E&AMG,9S;&Z;
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M<BUODPNF>[-DEM3%7R\T[D6]3[7&)7*[[0$/B5Q_6;+,AV.XX7"8NP@ < 0
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ME ;='"==[-OO:A:K'7[0;VAVCSXM/4]\!5G![K1.MQ([B:V9M?H5[0GSF(3
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M!A<PIQ+S.,C!/M3A\<ZD:Q?N9U1D%L\2RLY6M(LF* T?K)X00)SJL,75!R[
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M'0G*://!3B0S"(0NH6K6S.3=DL;!_?D]VP+T>O5 Y>5'CDFZG_CB6EW'UVY
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MZ'5O,5H6ZI\+W6?3;*\)TX!/YREMHZC3?3VEX6Q+J/JM!FSF4II&;+A5?>5
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MP5RN$+Z8PAM/)JM_/V'9_05 EL]CIL+AJ16,#;>I*=J)D0;IH=EH$,BGCHU
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MXAJKR<BBK??#\4KII>134 @S&05Y4W%QS-_SCEN%A7TP:\<R8,(3C;Z%V.!
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M=,YL-WHJGSK/O=)U23A2IEGUH:[9:;1^5J B>/FF>#5QTL1^,%:\TY7W:<<
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MVTC#DA,L<^09$Q8N'+"\MRTV[N?OU#P=!%#)%='W**1,8ZR.1NNF"U8Y:2#
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M-C)W-C-U]C0;!?G%_$]QEW0Y)7$UI#NW)<H'4O#Q@<$ $.A"!  $*BH"%6V
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M)62I%9.#R%/OZ0$8(8X\^3[CMJ'/53\-Q6#/VQ03NYTE3)36.D!E&2\F5G<
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MK:^_+>M )4P9>?<2*<>>'B[?QD#@Z%\M&9:L#;"/ZV.4?5A*?6M,;=)E[T=
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M4?8#U4]\KN^C'<VT/0)1[$Q1GRW,.KQ5R"8LH(3E3LR6A)2\2?)L2?EE:ZJ
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M7ZXUSZWLCRO/.LMX/U&R?VB^@W QCK'NI:=@6$IP@HY]F4 P8I_\8LCW[<N
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M/]Q.3@6DIN+TS<:]K0]BR6L7BS9+VWWP(DENO^SLQ!8E=]?NYI833(>_V20
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MLA%VM[$$C8^"]-GU1PLRB[Y]S^U7K?DFRE2D>O$S=@,-KA]?$TL)^M9@>?-
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M[S\U!3#E]F6!-7!Q5=.<@GS$"DNY5;P^H4*XRE;[0O_V9^39#99?-]/>5V<
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M@SOT*2D %H+6IQ@)*8LCYA_=&&N3,YHEPO2-* 0X>H0%&Q'E4@0P"$M?7^?
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M/?&=&$#9U>HQD+&J(PI88Q\DF+FQ<S#I)]_*)LMNL%[2H/F^??>[(7$4.:<
MXYZ1X"QY\06-<C?)OJ=F980Z$_*3A BX1*"6Y4EIZ]L*"0\?/#U2[\K05"%
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M%FXT%HI@5=KN?_[+/Q'@_Q2_7U+%6\1&VT4K^L1L<W'&$9%&+4:D@8)(/'6
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MH$LKX62M<D[$S\7TTKQ!HG!H"N3608/[[)^I_VEHJ,,N:OVALTID'*6M^[-
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M[P^Q[G*OD4^:(%VTL0IFUBX/2G1DY4D^ZNKJ"GMJN'#JL1 T,,O,A^M3[/*
M:.U">7>PHV:TZOV7?V3K#Q^L[YI0MCM#/YJH%(\-20%#M2X/5Z )F&C7B?CF
MX=,9^#SP6L^NH;8?*^F]L/:JY&^M)[]=_>QMT8;#S=F.\UI##F'Q*$Q;]-N&
M"AK"UQ_-!,R:_])0(?.#JY?VE]_\9P+\CR%+G]N4*$E\I8 .,58B:OTRNMA[
MX^&"@'%8"JA^P117['PA!&_42@'S(5THUHG6GWX=MN>&6LDQ*2";(P7D(J2
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MJDP)!!D$0P@Q3 $2H-539 Q%E"%,+:,""2(D(8PBA @$4H@DD$!0PB!#$D.
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MP]<^,T7 5UO7U"\2(*,3HY +3\-(2&>)RFU'^]'U%S.4O7WG3/V=A1-Q+:N
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M)MSXXR_6J8!%V@+>X$%;VGWQA=(US40:I&KL)&D\VEOCDFBZI:K^K<=5\,2
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M&3CO 8+D%"@*L#-\*_(/78-(=S8BQQIFI.XITG3#BA4M(1T'87Q%Y0R8H=&
M(%WZ[+W9M8KSVW\^/E>%^G%4V/^<&OLD*F%L+8$\,8&&4XNN"C:=4%<=G'E:
M-0L_)S%OC^@TWY<JFO60*REM,FA%)6N6CPV@/4:XMLH_0AB$1[/6H&1A?!4D
MS P5AC>5Y=?:N[@4!7$Q8D]:<9M97IT+R#U\BE:Y?U;3?ZE%<H>LB0O0U$X#
M"Y8'.Q1UBONA EJ\%CE#M\O1+LH=?[:YH]%2UAPGNR: 5'//R1@0A#D:LU9#
MO!%FT=0S4T]68]NWN7;8>2CGYN0J.""B8$@U#W?4MPX?B6G&X?:NINH,KGKG
M6'QGBP"RP D:E1ZF&4\Q[IZ%8E"9FG<]B7!%Y8I%T\HK((HAYR41;B)X(>8*
MM>-STZ?%OH?WPL59<D690RUM5^[3E(QWP(@APQ!Z=W>[^+7M%W_HW4H("S:Z
MQSZWX7//KX]_V_.@LJG,J' P"(%'QF!,-55@@#57O8>]DX[[<JR.8Y_>H505
MA[Q)/?JHNGEAJMAB9F5I#3UH'YN6R1<',CH8]YO$_C2PKXY3;N,[ DE%&&\M
M#P_S+  Q%12,#)C*9UO2B9UW2.UHCAZ(I0.'.<TKO2N[-K*TLT]G_,T(OXI;
MM>G=_ Z%.5;Y?>Q]6DPOT^(L_AYHZF1-&@2%Q[K>3(H@2M9R)(YJDD#^W0*,
M6H2;3\S613<W9V6IBE0\LK<]EB&<"A!?H'7&ZX!.L=;T6>2PC)XE;G=.LC4%
M8/6<[+JO!M=%F"2G4Z:T@G6LCP(4&7V^^L@UH+Q5T8K[!+4%'PQH:Q<6<U[7
M,AJ<HWH-5SW6X:"K_D>O 4B_.^F\.O!ET=U)FY]+(R?=8.0"7[\UV]Z,$:*W
M4JX:THWEJ&UV!$.=&4CHQP1IJB*Z<SVD9"5[F-_-@V1%MIJA@X_Y'$J*0*QI
MAB)::,WD(YQHJ3JI';,!E^&NF@S7:YCUQ@[GU;-T-L)!>6(6FP@#[M?K"XUQ
M,3,#]$ZG@P^U6[0)@!_9=RH("M[9#V;:2'W'P3(L8Z8]@S2OK(KG#KWDU)G&
M;HM,E@OD;T?;*RN3-@"+T=7LB>(\PJD&4D>9*UNO&!RJ_F"+[5:!=_/P-?'V
M]NXW,$DHLY8)#;Y)\ L2#GK4(3K]%JBTI4V!,1?>W&J2TLB>46W$2RWTRB%B
MA6,!-"RQSF573A2_*Q<O8<^863)O.L/N*C<89FJT:QRCH_O771SM1URR-)6)
MR:*>NS=>O;/=O]*Q"@.U8+XKIWBH;,=UU6QGOCU27A*9V.7.%O?LRNT,/V9.
MJ[R1:.X8 '?E?#[1=.F9?S_LXV<N%Y1 ?XH&_R$'<=8/:8&&&I>D.[J @-BT
MOBE9 Q$Y9AUTB8,^FV3UY<VV8'S=642M\%;J[/#R\.R9LIS3IRN;%JMP(7QL
MS-P]#QY(:"KKT&\ZQ!M>Z2?V/P]%. X/A4!R.%,X#BDE;V_Y4ORU'LK))<U*
ML/2@_UEH^%0C6(D4$Z2CZYE7&)7WCD0X3YR2":.JUKR_&/H H/'#QI8+>0$_
M!;$W02V[HRRPP\\NF#VC4*3+7-^+:PEUWS6N1__(  "!173P5V*+JN32]>*M
MA]^JFW@XN:SV/IE8ACR4-2">5D%"7H_=S&/5K[:J%??;@F'0Y/6F>AX'-@*W
MA"E"DXO\YDP/MF0"+)QB L#4<URN@AC:U(5VQ1;WL8)=0^?+8987'*K,JK?^
M#%O_L]3PO1MAYU$CK8S^\*7!SV=RW4D-W1O:+UFQZ5*7T/:9!TI+/.[Q%-%F
M6D!;>\N3AC3PA('6O1GA7$YF_3*2&N&, 8_$[WM)7DE9 "?.2SJT6BOJ"OJQ
MH'5Q^-&H1EE)AH+/SC$6J7&6ZPYG8XDE#_P*^'G2K#OKI-R'"7YS2RX(9_I
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M"XQFE,%7VV<^GDP^O7'MCF]V-L$LBV2Y@+>L1DJYN8*>]F^BS+.Z<=@R#!3
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M7Q&M7#+9,_1KUI3?B!Y,K$GH7?JI9&F<^Q(<V5X97UF8/=Q8'\LVL0BXTT5
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M65SF4UT3EN@-EF#TI4AEE2H,1-FD::!\G8'62P[V@2AOH(2K;. U<:=!4I-
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M(Y\&['!,V1!X> 7RCW:F<,5=RHIM[E/7551719EV>NQ3"H%L]#2)5YYKTQ=
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M+@H_^759<W%9H[T3[A,] K7)(/#UC3C>C*JN6=Z%DJ% F(/F1O"\4@#;CQU
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M=EI#KPUQ[3:;)[U: +X*H7Q'\XJE-\0W>;>GO["=H PDI$\W%>>7KOF@1G8
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MK<@\*9$AA)"&.4"@6UN0,2K*$"!4%%"&((0D3 E5AH@AI!!)((%$"!"9$D*
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MDGC<)>*L=J:HD;/3ML9;@82E'%<]'8[5V2&!.!?SQ\EXG@&6=LD)=GM3;=W
MEA@,\2SJNX/'<@<'8&Z#RPQ#3XY%+>CC;#;1%+0E;7 9'K4#JI5J^!X>MJI,
M.J_Y<4;]->Q?"-WC]7FWOOK@$K)+HTO?0DHCI%FW51Y^)BO&B;!3YA,CB[Q>
MA;F(<9L57A@5U#;1<WNE5-=?3JR%@;.XP4$!125]0E1S3]LH?]C:"P'CKY3
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ML0T55"CI_M_ZHS3Z8_[>/3%=*<@T*TS=;4+"VV>>2UR]6HF[[/$PP)_J@[J
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M3]R\L,=KK(F$%[F3YURNT5PKBF"MB3ZMH7!BM8_G_9S05WDVKRJPT^-XVQC
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M&?>GX]]G./#_N*U+P1RX11L'R(?#B<LX,ZU,0O.SB464;L'1^M4Y]!VM$7Y
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MX]<0%V^=UZ1W8!\&"MI3G"L6VWNK\;=!%Q<3+XD:"ML2GR]^GV6$BVWIWNG
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M7UZ+'(FBMO8$X)R0Q),9H_'1KW'*],=1V H:7(X1VKLP WG\Q5NUJC_&>^B
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M5M4:/FP&FA=M$G)K3JJH%5N$*'M'\!%X2UMRA5;Q)-Q ;A28J87,[\K$,3P
MQB,+;=7WHJJ_$%1-*;M<Y*VD)Y#5#C"ML@8!7SGOZM3\^VHI?=92/W*07#HU
M5SA2<4/YL5HEGR.ETE9,XT["$ZFL:_F)*;C.Q=L3]I ^<%A$7-_7$\K;,M!4
M'GHC^>']U-5,^V,ND\=%)PL;'YQ4M73LXJ>^-&Z*2QACDQ>-G;JFU\P-DREH
M5^,3WI:P4 $UA)CES91;_Y'/0?(OLJ&@>5@=Q<F<@*WTT;(GXIOSTIC:' .%
MJIFR#$4ECPZ;;]].Z']F P.K*W%2<L]2UZ*L+W;O'8HGKZYQ=C^8X@&W'31$
M&G.JHTOJ>]QZE>06TXEI3A,.?:;E*2?J[_D?J4A=*VNYTGB_)I%$F(;6KZGX
MJ(&UM2W\X%4L/^E>SL'DJ=SB5F>A8Z+Y&?LJMJY?8#3@]L8K81M%T"AOA*WN
M%:RRIY:G V2?E-_<H.F\1H;4U+WL?3(PW?'S;\S> ]>6&3RJ9&[.SB9\-B&Y
M6E=T1UC#4B!<=W=?/!_;,&U1EE),\?7UCU0RB?YF&.H[L2I,/5IV_$I^L4Y9
M15-:O@Y^TG!N>L'?5CPB,K<1Q? $3PQB&SI9'PGA+928U!E&"!&>A0Z$>>YT
MWAHPQ5_\[Q'EFF9)9$F=?!:\O:R^:O7"ZH)[O]QL$5PDW1>H$94K9J[][>C7
M/[V5SG^Q640964U17](4_<C2R22/E7+?4-+=NV-E6!$,'=9EAX'#,FY\4@ -
MZ].8P8*?78IDNJ_4GX=CP$:D.=(IUNOQ<EXE)SO:(V$%EV,I 4W.AMLA*8M-
M NBA:_Y0XY)>[Z$%CZX\A#=T)RV]0[:@O3E"PLH9D#_>M&\Y5D\)D0,C584,
MV@\$6VI!KTJ\ZX'*S'ZCHB.>=X+;'JP'F,\'-K4/;5K.[\WQ\W/8_[5 [[$H
M#5K4>K[VB&Z$ ZZ^0Z+>#M_/J;H$NRK(#2W;.%3O/S@?J6^BNN@BYQ9$=H^?
M+.J@@JG4V"=/A&,(FP%M--41MKAD8^,_;)P7?"VX!ZYB(Z#54Y5M$T:@@Y\!
MB*0S\Z_=6Q-GAED(SUQ<0F-NZ=)J\%"UE5+#1J*NV./EU&J@N@F]'#<H^\TS
M!*06J9?$CA[A!>DV]UQ-H+(\9S&?>KH<<,]3!\]N3OH&);J8J!;V0%T41T;.
MVR 1D0JDQ#D%Q_V[)_<L=?3,;:T<[H&O5A4=:&SE(C9:^3Z=M(<U/8H+19X3
MAFW+2XZ]Z-8KZ<'&Q!XZ1L_DX@R]A4XD9EB9?1&4)Y90F=#L%M8PR#QFTZL!
MJO^#=%3?W9KF(&V)&=Z6B2F>GQF?LEO;B?2(D8#N^<;UV07J:[PT +7YWM93
M_RI,?LY6E+A>*@;4YI0")CVDP[T8;3P+DFU]?5MF8:/]I:SHLV7PYHOVF?)T
M_$KR5CSIV+:,>;ND#[QF*6VUK-O4WI;)X6[+R&"NY50")DJW9?PLP[9EVNS^
MXU,GEX?'<:/6F^3YU0\VKI,\MV6,]->GA) M@76 _CGKOMJM^ERIBW4-_21F
MS[;,^ KF9\"(YC1U[2&&Y:)B/2^WOA9W7HK$S!52%V*WHF/!JR[;,OJM4IE_
M?%,<JV< MUBY+1,V89U%GZGO 3S%K"7P7^]>V1-7)PT-6&9TT3<Z$\G^MS%%
M 1L0X&8QQJ_84RJ_+=,CVI;YUKK)81"W>&%;IJ;8&,,[LKRP=']S>EN&8X8;
M6WPGVCO1WHGV3K1WHOUWBV;6_AS@V&[2!OP%J'9WK-9^6^:C=3WT->HKT\+)
MUQDOT$FTN3Q'O2>/A@2)O;^@N.7 W=2.:=9B?*SN*V+Y2_0=>PJ2ZH0&],A>
MD-K']M GYC"ZS>UDWXE]12M>P'@<IG'JB6-NG8^V_PST!]6I+-"))<K$XF"5
M.]3'\8I:\X0V!!6^O@F'PT'G267'>T(WJE:72KP)!= <-1US[^5T#:28Y:01
M]5(B"?XM#).]],KY^AQ>NQ5R\14O?1"TM>& VD#-!WALH+R99,8&FUEOD0C?
MEH'-K15^U!JTX"UZ7R3<%(@ *:\351.7".=M/9,249,A:V VFKPZG\Y_A@X
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M4WQ>_TY1&;8.0LXE@*?R1OL:-6\/K3_V<X -^7YE-4?:BCC/R9OE0REH1\D
M3?7:F(!KVHQ5CQ4X7!TO.W2\K.5$.1:2$(#:ARYXT1BSX-9VY68\@9A/":Z3
M?T3!@8T&^N4-[#E13J2<?-J,@8\-#15;V8ZUZP7Y(.05I[C.NH%:UIWN35$#
MB4FM Y!A ^6N.O.2(I7\U;<3^Y]!'<PE8>S"ENCA2-];X'#P++F.WR)U"*.A
MY$9%QT8(OL3FBX>\=#]O;KFOHFNF'YT8B+4W3<MO+LMOEB#ZG(9]MUI=VIJP
M4]6/W4?@V@2NC7 @PF9N44BKUF!XTX3WO9<=[=SS>^W2^D=7&%T1'/]S6OT6
M"7V6+2SG!RNH:JE>RQFRNG+OF:I,;G#UA[^3^BSA%67X(C+@(3UY>$UTN9%
MCU98\1XY'QF)@$&1 6'3/DK>X.K2-0S<1#XRCUU=24PEFV$KGQ]>(14BY@3
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M^3Y+6$9(N]*M3M-VKO(.,0!6S<C)*[_X*OSXN=_)?=*^I;OEU$<2:F<D]"/
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MZ=BTAZZWL,'XZ*"76WW.=<H0.7/_LS>3(OX<O?\CJI1&E)BKB_M7$=()'"X
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M=$/I;TJ;?_;92*/\:QV=/G%]8.,$WN8'K@?(OQVI-A<C"1[)[NHU4HK9S%K
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M,IM?XIH7<*TE5I9(>, E*DZTU$D[I_%- W\>,WR#N(]LS!T/WX6*R\[!LR]
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M,FEI1#C17A.IX (#C'SE*=HZOGN:_?P-%/6LN0)R&=9JA&Z/A *NW7&ZTZN
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M9K6$Z_7<L5[5D?/NL$L:F?GUO<Q?CEB%8[26+#\,5EFTE<"W1M$_+XR?:/P
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M_"$VQWH\RJ,3=R :KG'[_ O:4Z7"TI(I;%"QKKS<KVGHE>]E/OTZ[O7.^8V
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M[UE]3GW]_7'N7;?W>A=_L(!W\]O#L_=^GG=OHJ;4:GYNY.L35N[ZQZ4_I#0
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M+S:HU+1TE7[.NB43T$%O40U _,0"Z!H8!/5'XL:W+SM3U0IP^/Y97$K*^#+
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MU4BSVND> 4LMP+%2_;I'6%^TD3HGPHK0'\FU4)W=N7N+UL[P)/UAD5XB"1K
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M<SM5PK7/B5N<%KP+#P&F'>AFL<4)_!)@?,I4TUP$CI,\U+?J-O1H(KJY&:.
M3X3WRM/X-7'WAXX:9_Z\AD75\*0'"WB0D :D!Z"!M<;"JP)%TE'0?0C"(/E)
MQ84HZMC,6+.'WE$'[A-A_(KSUPQ0HHCL;._*G^7H<2V[@!Z/V;V-943H*MN_
MZRNWPO]>^0_U[P1TA;=)#!E>VTON\5&V% L78JBL/, UUBHI0,+.*DY*PLU
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M:.8Q,JP9Y#=LJ8VO!D'NE&5]B.&(,?EU,],2K>HQO(:%A<-O4A,]C!]^TYU
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M+O*L_+6#XRZ,'VU00E#W!$?M-BK&@^"(L-:>>UXGM2U68S:Q1:3VF2E$4ON
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MT).[P%D5"='3=LC0#N:8JI3A37"+,CC5;2'FZGK.-H U+;DY!,,F<><%%>2
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M)$1 " $#A!!"H*NL$AE3BC(/+2 H0R*0@2&!4@@Q0DA!) %"$B5 A)!@$DB
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M4[*X%*VKD_JX\5/'DU\;E=:QE"7ASZ>./?62A7)_:,<O$SU B.]  &;H1EH
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MEL^T"U]R1J@N4$W2[GK!@N>/DR-#$CEJ8_751&8&M^F*CY3?9'&)M[BQ/AW
M]:^Q]*[8LM U(]+"36"Y68@.CD&)]LS"P*O-[CQF<OYX>YQ/M'7D\/DAD:9
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M9$^-'T-%]+,A-SD@Q9+&':=DC;5F>S(N_JUKR'"OZ,)POD7T?ZS<?TO4[24
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MZ34P=,G0$L0)\FR[57)97+PQG9P2$=])SX%6#9\P-828M^.9<Q,[NG&[L?T
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M1";/#B7:!V>HUN,U'8R]55Z>P%R/6PM%Y-AH"VLBH<,M,)XS'W@+:#M53D!
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M0/HWM)4-?UJ=YVY(C-SKM?H'@WPMV2W5X=$49UJ14SQQVB=EZ ;+5(0@&@K
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MIISH+^J?K7T;&.W+F$*T%52"9BOJ>@5[PU4/7$JFO*QBJ= A:H:H%2;-**_
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M^E;Z9^8#BOU^^A.D/B>.7M.>V/W6&OWE+^)<P6?^"4;J,_S<C:20UN-+P$W
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MQP6Q@MQ[#^ZF\LCY&MPVP6,CP*UK$^#D/?WMKT>Y4S'>,/*"%@'%&@V%Q-[
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MBSB"&V_>#7]*.E3WY<0M-E(;UPY!,!V@G"8S3J"#;?U2"[7^+/(0VC&>KI>
M</5<>NI",_=@F7FSB.]Y"RYILYN R5E9N_Q R79*2$@KK>590;DJ#7=H,4_E
MRF)]_/5U?%T]\-Z%-]QHBH86VT@V(,4FINO!7)S)E$>TNH@M>$0F=C34>[8+
MLZV3V7DET1A#=24&W-PB)+Q8E+5:BT*;"+8-;H[J:(>P:G:$H$$M(<=%+^0^
M%F,EQ*;' LU&/ $O6Q<27P:=VQ";[Y"GVGNFIPW)LPE?,2*=*@>SS2!8>'JM
M?GRI]7S>T1V;H?B,LN S1-*FJ"M6)ALNYX'5Y%;!PXHV:Y,+,1Y!FZK97BFE
M21NM(XW:O[6:ZKO\3&3P4H^BUGZNE]UKM\(0Q&\0\_:KPH6LT\WTH*C"<PR.
M]7QUP:7/Z1<P2R?/&"V+]1J*HB3>E%R.:+JB]7!'S*93'C/H<_EF2[LIKG7C
MT^U9$CY^H>,6.R0Q2U<W3(I^--MI%Y])=MU8&>H\_VHO5H:GXIIB)Z&7*7J-
M%0]",F3]UP'4H)J&LT_PP>:DQ4M8B/,^FY/[_UCA_W2:J,(^]:V[2:Q=XYWS
MJ_OHVRZVMA.XN)_%#6U[V8L$(O[A$O,Z$DUMJ*TP$-,'S@] Z?O"#[WB\R.F
MAWS!N<7':UL6QLLK[!A[CU&SHKVW"@SD<,X8;#& XY8LLK636%DF>] ;!BF,
MW%<$"M^+Z(NO)-^C--JF[XXL3V"MP46\*99BX24VFCD-+KRT$3[!'5;<.WJQ
MQ#U//7P<-.X[#@0G?LBF>!%=8+%0N/(M?]#XEP'7W#Y<8;B=OV!VWH-I[N&M
MZ>GF'TNW0P9<#.G#6MC\\D#-#?J^C?G8;WKB2:YG<LGX197Z'G:(3Y',%:V6
MJBI[^^LC!97]6[?:<0^KVF<[YL>%?X- 7?HF]!==,9.XNHRHI*4R"VH.\<L7
M$\\T/9[%6UJ]C"VJBS:<!H!Q)G0S!E![+8;S5F' =+:,RGJQE9A&UP05B')$
MB4KV)A:;V@)7C5JOL&"(5JH^"VW.IB+8Q*G(-RP':@(BA8D!'0I.]$^(Z&NX
M3VCKJSK? R3;H2?F>%/ \&[5C:O!_ZO^U#_C0.*CLWN/808-INB\P93/IXS#
MY@X]_!JR+%K]Y!%A9CE!5%O?6??(=YQ&X[1ZN?BSS\1X:\9^I?/TCCVPU0"P
M\\ C-LA"]=UJ)8 R@*!V/$(1T17B:';8\=IS7\L1<HO,><Y#"\B-FKOM4%)Y
M;6]^<:%V*3*F)6E7'"?,D+<25E&Q*[13PZ@\;6T&'ZP]&6W-MM/U_-+OI=NO
MT0WI_#Q)VTY5M[>S2<U>NCFZ.]<^5=@E?]D05@E^U+*DX7*L.3ORN*!DIK?[
MQLC&DM9G8R/>'8?>W_,YCC&,$W'2G,4[_3OE8<EWA?:]/GW/5F(UO3B7BC)R
MJO"KQ<4KV4P*99P9XPB."EQHM,!#P-]HQR1J4;.[+-$JV5%DC]6H9/1!#\!J
M2GEKC7[!!F18T53QL\)FI\B??F_2_6N+9'ZP@]#$."ABW]-BZB5)]0%E \X&
M>2_&GX5BZ2%+/_Q*BVG!X\^(C"K_3HN)P&0A:AN2!!A$"@_=*4ALJ1X&N\Q.
MA': KUPG0OBRHO<^),4DO*FB7X]K?[_C18)8VW:V QY<SS.JUM4][ON^=21#
M\B[?&5B(4=?5R5-B.Z94M=WNFUIP+8=<5EOO'336%R!7#&F;O$:BC*PEW2!V
M5:K#AX->FUP+XE_HN2H9N+@\[1Y1W6HH6S\T+WXY#G!#V#]/^- +L %-Z$!2
MG=TI_/#FN?%^;@EMNA46Y2,:@=4+Z#[-[*=-VCVBVH3"R*@-JPSY1F-\:,41
M34IQ)U!--@]Q@]BP>O A ;J:?N-+OZ7UL\PW@NGO H,0F\-^%R,9<VUO%1K$
M)Y;W?DZC(ET8D!Q;O#&<(BORS\F?LW-*3!]/1(Y;[)>5H)NN@1_D7DD1??)L
M48D)03C-Z)@REPB#K%4SC&6H#9>HD3,+ ]VLJA/XX]"D1(W26(!2WB$(X#..
M=E2BG8P0LBPO"J]!EP. Z;W!(?H^13A'>M.HI-<U?\/FB2* 73@0.?+FCU7^
MOXS]M]!7M4^,^\RUA3"AD0/:\.(7-]Z4#VWX<]QZK!?58FT=_(2+V0(76H^U
MJYEZ]H'B3DTSD">V"5ORJ%:(.=F"Q:DR2Q$R35;N>/[<K)4^PKZ@#6R%MUH1
MFRP^ IOUV:*:&\BX7G]V1GU(<?/3M=D)Y<Y#DQ'1^NA9@UFKE'37M6&CE(*"
M$K_COIQ:Z91R6:05N;GRM^B.)6QY(E)W+=IU%\Y.,6:6Q-L:ZN'Q[-UNY>;R
M'799\4/4@8-E_(LV(1A#$+/[(PO;X.IC]@N?4_IISA0>W0[>7U.+/9GZ!&AK
MG<+B!G<")AC)8JO-YB10>"M[#6_@B_.&%9A"]8<?<;>1P.[:MG:&*$CNT)[H
M[W6:F:!2Q+@3E'X8J):Q9>(2/\V9*HT]I>R<\,>T4_\\A:UW^!BR1PX\Q]L@
M+>A,J)TQ>F!Q# AU@TRVZ3U2'(0=:M A1J\FVJH N"\/@$!V*99'QM3Z13GW
M_@KWO^8#^A)(R>I8.#FO.NA=/&8WN+;^7$RAE)9RE%2FY5[%Q;B;8U[WTZ1@
M$AXY,S8)S3/"5^$+Y&7Z9LVC!@^TZ-$S2_;54<,6?&APPI@^*IZLEO&H_QUX
M1P6D:E38L /1Q":?6?I+F-O1S4N'L$^H.H1M#V"Y!I2"MX1Z/S6'X++T<OF3
M(<.Q9 WMSQ""VTCP8MJ9<HO3M=.9QPDE27.8TS455'KV>/L^K8FRUA<)%!-?
MBE)?%%$4VP-6LDI4PZ>?<.SWTPTK;+[8:$(@&XQN6A_"3.8)I!)J2S%W^=RD
M\K0]T36_!.06C[W)>F;DWZ;48L[Z]V27)]3NZT)M\^71Q0F7E%[>!;2*2VFH
M!N SEB'@LX5EM1^JVPL^7A"Z&+9%8D[IMMV^8HBQF:_-0EP7#_S\WD<($?UB
MEO3>1TA=1BFN?^\C1#JN!S%][R-T_GHP5*6J+I([4E1</P#+&K^%ZEU,FX"(
M9:WBK' W\S?-;"-%P51$!@D5IO\.(;1%5[?9;_ZALO_\$XF4Z'"3>YRGF_Y[
MD3+-!(U].9W]H4VJFE*WCC13=8B1:'=IW8/F"3^$KU?F>-O!60"176=9.2OV
M!<PDRN*K4ES_IB%6ZS@/PA_T8P/*\":*:[-;-VAY +_7W4I1E&:O1NVQXC+=
MX[+0_* 2[2]G[.I6B9T[WW7EKCY&.C29;G:D\/>$2&I[8#[$W@KZP4=&M)Y;
M# .^[/X]^NCPMO]7$K<N30_-. GMZ+K]#*MP._7T3MUK5.>SHXL"JW&?5::N
M(6@9JBV-+]#5#[9?%F[&L')J0!O<87PUP];Y=DV4;(!^N[I$1%['5Q^_5)HG
M:>)=>JMPX 27/R;;#N<*+?IO_C(]#_^THMJ+2B_<NQ%G@&6S4ZTS)BC]<=LL
MNPFW&VXUOHM'&:0$SUG+G[V/%LCO1VR EL]L5%^J*Y<]OE'9=C,7XY?.ZCHO
MV[NZ^24K<0^T%BT#'>CE3=/:*,7-SX@$UT4EW_$9FM@\VPE.$T<R(>=HR,D6
MN(P0"6MEN!??>EV1.-702I"87,P381&1ZTGN^>PP?5V_<A"/-\9[!@9_:$$F
M/Z7!H%"8\E_?O??,R>3"AW^EN9ET'S09IID- S4]_FY^@=0DS_3E6;B$,L!D
MD"L3;_J+L\4OMA8;_77!;)+(HKF?&^Y;+.O?54\-7WG[CP/B/^#_@N.43[2W
MOMMIW\, CMQLJ_L+8G7WV]E0(;!6TNZ$7BU,0,>'@\%(GK7?YUG3&CB>;:G1
M;L/^:8Q5K7&B/;UGN_RE85F%Y>2#5+9EV<9V7:I[PP<DL-OZ.L$32B7A ^Z:
M%Y6P1_I RT\ *AR(/<"&F>A]/P O?ZO07M<WEY-@=_,B>(5M<*:_]]BV66:V
M4Y-S]WK7D8?J8IM][M_\ED*43C6UA_4:VS-1TV>/^V@55)-+-7! %B:R*X[H
M[;OV1M5R(^H( _5N:=Q('+/HBZ&0D(T@22I$Z][.3L034EZ6P>:+G=&W"DC4
M*'<3UAN^.(6$0-<7V-RAQ.W'U:X=?HY.^/0/OZ8+(-MU \G.3G-&82K)MY=3
M.\M8V129G .F"S8D2E/6JSU^W!TELQHG-''8-&FE_/'_]H3Y_T<<=I'6]1XT
M*-;63X1AQC IAP9V:\;1\S,MM26GG\L.4V.AQ'596.UF[N%(XM/QIS+/0*>>
MISLCA;V4VBLG"VI;>("+B+*.U40F1JG?OJ*7_I3OW%6SZ58=46K;GM*WP>;-
M]*F)AJ/OE:GK$LTR0K6*QQ%48*L,)3,^]IJA!=]3,>QYMSS14:=#X@;RJIK)
M>><81TS3^Q;'4 T?F(=;V)K>Z0NZL3JZC;&:GNXVN-=6\')O(.64L#:IA+VP
M_TT=QGH.FUP><&E)CHN^$)Z=VM1^<VR.[E\DUF9<7\_V&ES#^V9BJPSUNPNU
M49ZLM.!1@@\IS#[OW7:7OM0M#7+YE5.N\-'W )R.L<.W8D,R3$T&8J77(+Y,
MSQ8GNU#%=T+31(&MM#EID<,=IY&>!*^NE&.O-C51%8<KBCI?.-U+QZ:61-1D
MS6R^:'_X5@%E5\M#%/<.!X:038$=61S0S=%E<;:*6W(P%)8GO&<=XON&EL7#
M;4# $4>NOANQ'#)<KL)W&-C@[4"/]X[&,"&PFQ# \JY*#LK0MP^@;3AULNS
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M7_(RNP[R4M(8WVFI%]*_!O>_&C03-5^8]:0PR["X_,Y.8Y_0^'&@*;KE$>L
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M:C+;U$+F3[$X=\@^C%O#=+'9NW_3,**X?MO.*  ",)D"C(8:=("1.J#E;6S
MLMI\HT;T75*43>!P9@O&I\$$J8TO;'\FE S3[&ZQCK)];=6#:TO>5+9%UI1;
M"S I@MJ& R4":MYW8W+5([FF<-O=!J.!@_=-3%#6$LY9VYZ>?E>_@OIWO\
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M/F1 ;W>/,V0#??L\U]>(\*5<K2-?$.ZEC>4WY6K45N:RP/SS1WTO.PYZF'E
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MEATBAX_ /CB_E$\R"V<K %H-!Y835;*@DB$H!/B=%RD':NKP-UW]T+I]&7N
MURA/">X1*ID#;7SJMQX>^#J^OZK7(+.ED0D=Y^U6=8A,=GJNNGW%2Q&E?O^2
MR;Q&$[LA@AP.8ZSE5K,P)N&<Y1YXLY"Y>><%3Z]IM33-_]6]DOB09X2+G _G
M38]!92.TVVUNS0U6F#ID6+/MPS+6> >M?2Z66<TKE;4[=9"JVT)JTKJN80PO
M22KVT^]M!QSEP'Z?!/^OS__\4?P*(9Q<F9SIU:"A#8VE]K$"!_JV://R[O:9
MN?@YO.XV4H"R:<T2B/=]Y._S>'?9*I?W.< =D#)G.+K9VO[@K4*,'8DI+#1/
MKVFA%@+A(SH:.AI9P\O-G%Z 9V&=W8XJ+8#4^>'PZC[BGE2VOEV("+#<P90=
MVX90ZG>"1N4%;.D:1&T6M)Y#^9]R-4.$P<+NEW86*\YUZZ6T>O9N/N]6-S\
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M'27+BI+[B9I<MW7/SP^: EYD,/UC30&*/F5QLMZH@>\+/OZUZB-=+IP\$TA
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M?9.=PH_F\6WGH6(E$S )\LGN%XE'5R<$@3K*E0GMT6HUW_70.QC*?;GQV$W
M0IZVC5_>4EGPF;.$M,S?GR'_\C?[D[SUTPC*CF%B;]44.:]P,T>5WG6')/-^
M"92<(09PB%/O]HIG].6G2]B+&Q:#,:5?:C9R'+^?,6VUO?QFFAIM7_BM%(HP
MV%N0Z8L' + C0.OQ8Z_'UB\6T'NG^B0$;8;W+*XDWBU,WR@;0F9<GN^SZ:\
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MP31+ZRP]SY7?O*K4OW@.XS$@L"=7^G_( H^IXUV S8H0R^(\:)+OM&BYK'P
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M.ZW0],''JI"$#)7'S[@45'(N^B#9\R$)[%?A5X;ZZ;>K_;?@8QN0YA8U%''
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M1,OHQ.O>ONG#J]8G$!F+UB89T^4_LCN-/^G_INOLS+)/$=N6[>AXL E[93
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M!Z'Y1AV5H_KIMWO=;\+']NARD>JHM. BH])<4[YA_3UNYY4E0O'MMQ/7X(3
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M2<A9'$^>WDFEO I E]1;64--IYM3G3:NB^K-*:17H6,Z]DE^?_;:C82M [>
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MR1_;ZPRK7DPB7/@IXOT(L+XZ/=Y$5!Y9C3\9SY!LPY^Y$-!2[_$AE\RL^Y-
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MI>MM$JG&W*E\>KW3K?NP.XE">36U4''$5^<ETQY]SMB;C7;#]<;CI90D,:]
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M@28LINRUUY;DAWY[F932\7Y1-(U:$?C69^=8:WV<H('C6">#%Y;VX;*R+.^
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M-&/B3^@G++_("]OZ:? ^7.UWD,ABP294WD<X4+C(5#;Q%3KTH0?LC0>8AN!
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M#'+C9AWX9G9*&I.0DH*'RLN#NSX:A%U-_YR6F??2R[U*D;J_@Z0,:VB^T=
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M*G7^7GP&4FG^#&O17%X9RL>&5A3'"3'^6[0L+97LOC2&%V&_,-?:+\*C_ZS
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MT<JXR1&&L+54]PTTU.9U#_+FP&;)L*Q;6&Q=\XT+53AI2APN#9+,4X>#?+#
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MZ*<N^^2)]N0&##KHHY2.L#A=H]>+07!B^\-97U@=.-A#1#4J;S RJ7 4=C/
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MF6F2BGH*4!2AXI4VLZBGH^CVYG!D<TVO524/FCKS+KZD-T2G4M9,2A^/&@F
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M3&8.6?=L*E7OSN5DZ'^T$ -<DAW\9OF73RBC?R_4'+@[4TRNR>K!'2ZZ%??
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MI!))_WS(XAU(<"MO;/:;7PX,*=V<3CQS?7D"3JHNM(AH*CA'F1S(+-<I(J7
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M<R%><Q9L@-33HE%>,J,<N/"4[\:O&0.>6%621%>R(.P-'Q<JKB-(^2B,7^T
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M_<\$W_ '* J>0\;]Z[U]@J*>& _C!"4CA:?152&V8(%XNQYD[P()F+]\LR-
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M!7F#O>_$!*&Z?+-^73N[M;DJZG.T"I%H1HM[9#[PN"B#5.-DL"3]ZT.>(E
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M5D@=F9&[V^3-[?4E,GS]R'!'0BV[=XX[HF[_QIX#M,Z.B;>'B3VO]-F&QHY
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MS7@>HZU]7RM\>)F+^VRTP+IY1?=198YCV(9H(()B?CJ/..?>LL_+J<.W=V:
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M%NL&OIITO>M#=4CJ'^7;9!IWVF"IQT8A;\6;2(Y&."T'$+ZYQB,=KG_&#ZF
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M J9)Q]O!'$4')?::KP$37V]\M!GDXNS0!8-(@YPR?-%& 7CL+VS!8MBYN+B
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M9<!/KJC_W.G5G+O-/^KTKF^E]']RH'34Z8WALOV/.KV5&=6C-@5H?K0A)YP
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M33O.]ZY6?\?.J,_(FB.L/F;Z.;?'^^%!H:"0$&]]RO7+;IK7P86#;!]3BZ
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M/DZ/BX8 NB0;MBO])/)EF=H4(M-Y&(+C3TZOZD8TLMP\DR2  /1P)WJE8C*
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MV7:(K19O"_[9=@B<#OI9P6NNHG(:D]K!ALJGK8)F[@YW#+MCEP^_8I-9[<#
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M6C+>[8#_D$_PRVZW@2"_@-?M]R6W3V9F$5?H Z$ QO1[.1>'>_N]]/OTS45
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M]K]X&*(5H79J'\&*NF#[TQ[;[]!ZUF.0/O:?+D!U>%[!>'&SV+![E,$_*%N
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M3$ _GC^?=&[>R'GR7["\_/?"/:#4J$!R?$-!G%YJL?%^V7Z6/U#K:8_!J.W
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MU27_F"/78VGP]< &T.\%,#+?55R3@I>NLVWU"'7'VY ([CMJ8@ZFA0L:X(H
M84).&KEQ U3VZR&5*7)#_28A39>+MRG?15S9(=?_D_^)/L'PWK,D@T.UJ5.J
M-#PNN6"@P[;*[?%ZE7D!'DR\O-\Q(N3>_WD'/?9;I6'AX_?W$6NA-V7##(JS
M!H?1U7)Q 7NV6BK[K$>A+::4@?"S]I3ER:SX+ -TP!3I^3+6#.XY548T"9+C
M<,#[HWXCU.D8I)XF<?8;,8M4![MRB]RVK*F)@VD:#)<K4,:@F8OY<LG2EUNG
M/BXBRO<[7MKTGR%^I?Z$W/H9G\NLD<56I^DDVYTZ#J,<N;,0)+2PTND4Q'LG
M!^>-TK7WZ#I=NL_J7[1FU=Y#BPYJ4,*>9+U PQZI#&AR1R5TLFG%MD,U?)(J
M]A7<[F6;J6@R@URU!030&RW";K*0IZ:=1T-4H:=L3[="78(L+,,2L@L0P Z]
M &LYSA0;!F$$3YF8,+#-AVI#-:\O@\\.FY>M8,K'6.M)9)1K@:L;T7'7(8K0
MTWJV[ V=Y4C:^@%?N_2';3*!0%\ /Y.HBGR8EO$V#S-&+:IT1ML-9I+3 1NA
M<*O.#O_6K'B=:=F\\?@XIGAKG^3E 4Y=O\\BMFTNA[AS+X;9L%+C9?K/>19P
MF4+59]E&OP+-LB!9MZ6%.WE?[>5R& :Z@RF+FBC)H5K=@?:.Y_I?$_R*:@*I
MX'6WTU4N=JNY+J!.,$:]2 RH>\]&8,-7_K#RL?CLT0R#-M@W&V89ZKG4@TM-
MV9ZB@V^1K+F,<-]=*2T0U,5H"I#PQV#/O;>B#2_SQL+:>#="4D'6O$9'PF)Y
M!;MO :1,ABW'0K'\#P/ 6-_:/J!Z%HTQF0?\HL9QB\V87OG]TXB?_R5<M,T/
M!<SP6,G)SK8DTLL11'P\PNR/ ![OE<<MIO.&E[_EP%%+-M/?/]#YMH]S/,M9
M92AT1EK=_W=GBX!.S7]X)/QZ+73;_5K^R#X.AO* :MI63!BYX-W^HO']K%L;
MH\FNH&A6C@(6I@HWR!+7V$L$3 6Y3QK#[SF:)B#6?J<>7SIIU#>^Q:<_*=/;
M\T(/ ?6!I%-1$MZYQ)N#U>O*\?X7'5=,\Q+I2;(%T&#D8MV3=:LPC'W#LFWC
M=48MM(>)&3?0X4DWK@T]'RLA!'=V&UY$J;J->I(H1\N32.SEBOEO.)XYY82
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M>.8.\EY5KQT$*T5.#20]\+PE8 9-S+=F?Z3C?8S&#]7L@$]U68\,5>2E//E
M\ [%X)%<270*WS5,/XD_K0 !E]+ P4B%7%]:=G(7I0FBX;&8E-9RV>5.O"=+
M;UP%U),;A2O\F!GS=B;C=?VHQ[GBE[[%]HKN]56\.]J&#!S^9HJ],E5A%>!L
M(DF9)*9D^.H=2+PV4%+25+&JVI\$/1A<EC5K;HHYV8IMU1_W!?VWCKQ(!N\)
MRL($6T#L=D[:-F[YEP146A5XQ].ES]]#AL+')GOIKCHTMD>+Q2.&V!:,2_4X
M_6O$:L/"_3U^;2T%\LP.<;M$=HP?;;6.&_TP,&GX7CQS52AP4[_JW1.!CF#;
MU):^^[#WMQ5?)Z]523QMQ$"$*HKV22]Y..3 7@R9VDUE/-)390V[G7%^_,:_
M>-5<)O7E]NR\[<!)5HZMWN=>ML2CT36#=^XA'&(*QBP^AT",'ZSF05'V=\G$
M^OD;9^IS3>=KP8:0'?B<LDR5PDMR^X*.L-]U!"=10NTM4B8*K8J-'3W6N>-8
MP[#U$$[?!!X5$G&>9-\N>M]]"44[#2%Q.3XF E"#<5JA'!>4%P)I[&4V@A-R
M*BJR<O"![?])LCJ=IF/5T+T;3B;'.K!I%XFQ)_T(+X;NDWEO[G$<>9_;Z06:
M<1Q@RV[F;N'UT*^BEDJ]@HQK#WY]@?)S:8@$0W69+ZNCW4+:D$C ;Y"X=A9*
MMKM(;!N#S0<I @52A,?Z8G1Y6_AD^P5YU2S.%!IX0A:^+8V=8-@N))=W@A>G
M+*\Q1N!/V9A>WA#:B*T!S(1I:%H^,%1WK3"OG3 ESNQ-K 13.JP&OYD,#-PJ
MF:<W)!*)]*1-1+*V7SS&VR("]D<&PA_X6\J-Q+?=XMI+1;G[LJA&'/K]SBBJ
MOPJWS3*V__@A*96U(U-TDYV&"R"-T>3R8<(K*]W$JYX"1CX=;+U4SA&DUR/#
M9GUYA"0YGMZQO3(>6@&V66,;#M']U&, POV+V =OT_S85/]Q1U^K=D=(A_7!
MRW&$P5:2(ZWX;PSH=&7L?<P%65R@[?;',ZKO+'_:/C&9B$*,DI/CY'+CHAL[
M\^U0:*]JH)>R7#G"3YM[L^K@&F\W">'/T4)K+*UL&L ;+B<7V^B6["8#Q[V0
M &+V#^C9G7"_2B'@ISG\''\5+J5Y^>":7FE8N6IA^5/6.-!KHS/_XPQ?_W40
M9UQ,<T1?V3 WI=0>?"QP@_#,8R3XO*[./_J]2"JHT2XM#HGHEF1,-@ZN()V<
M+311BJE37W185@<R#/:)"?'^SK(.4ZH[<F16T(Q]B13,<W)Q\VS\L&7W#*!E
M''JH5KF07QX=4QF-[F[%VM;=+L(_'[K'2U,)J V6X>JH,H,I$V!B=-Z'&@@@
M[<'^G1SRP ,Z?--,4]SF5B+RUH$LG[A/<CM.P9Z>F7[3. \()T@/U8K>)==>
M7NZNK3234Z8N<5U,(H:_/?8P'FA7FKJIQ?8FL@.U$'HV,^02H ,K)BZ)P4 .
M#,Q*[*QT 4C&5JRMX*:&)*W=RW?AF'$J08FT2\JI=!]D^"\;42#O(/H]E5)5
M1S2,Y(G5Z[:AN21@3S&BE24Y\MVJR+K[T=+R=@OT=O^L79[*)@3[D[X3+=$W
MMB.^RM6V3VNRW<3RQ)- ?SM'&>.(CNX\$R+-O.%09Y@<K_XU_1QZDH[@^-A:
M3J=#=E#S&:>4HI<.!5FF7?(EY2EH3/F\]1HS,X&9*;1T<4!,"&QQA$4B.%GY
M!1^MCI >^+^2K<4^W'/1SB&FES1_2/7#OY[,F8A(*U8_ H%'_:>Q-6S(&IW;
M6JFIA?ZF9/CNAOUB]S\N[7."1FM^9.C%^VG.B&:\/I]LX]\._/72/CL07[=.
M@\VS(&]@'5TB,:,.4F1-<R[!+4;M:N/JH5&[MS756>9ZP?(QO2V</,2ZDFL4
M ?KH[??#<Z<F:KB+IZ.3(,]G74*TTK96=6[D2;_:2XZ7+!(D*V^1+_%84B>O
M>AKE>F:0KH<.XD#]J5I>@S;71C?B0U&KZM>%U4XB0+Q+ _T>2[H\$["7N$MS
M8Q!6+,CYI9SSC9#+X1:6OMUD#\>'OH%O618[=?HB'5+#H=KK 4UR#1H-X?NZ
M-F^SK28U.S)[%W5O9-U*NVD0N PTA?*IZA-IN'NP]83 Y)8P&/4V'D@W9&YD
MG#^X"CAXQ7&-6Z[XT[8_[Y[TZ>/L5F5]687]O#U1T&^K7N)<%A ^MM!#,W7I
M);2GOA?=:V/YN0<4AC7&5B[&OJ")%>0[T:F;HX"0]=IJ)P@"UUTCVX A.:_E
MWN^PX,JKY1W/4Y;;/2NFG$%^IVXNKC;WO_9A"_#2]E[96.EPO(SCKYR>#F>\
MNY!7AS>:QQ(3VQH:9_SGK 2A'!GB^VUG+E=UJ*8C\?+IUX#TN<:(G.QA\4EU
M9U_' ^ 0O[YA/!\J7PC/?T<Z7F-ZG3,7%I;,?E:/+\0A@;Z"#X3MO7 )I(^Q
MZ8C+/513E\$U?:RS#]7:.(#HQD+;&R9^NTVI*4H"*4 0/]?OQ[\?YWJH=G+/
M7%+=O23(/ @QEUWN(>$Y3C=&O,<$X?YFN,3QS[6W?$(-5MZQ1VW&PVX^INR;
M[?ZX$B*R0"C*+,-H+H[K,/E5I58$5'MJAA3 C\ E$-RY<*T\J&=YGP\H-(X&
M2!9]I1G[79Y@R%$%PW16=G[0;!,=G6V[AB6'V:PI!@?Z$#-ZZ4!#4.F@*'C.
M,MC+*09C98+I>:0T+&0(7WDP:[8*YHAQO+ 9 <_+N]!+W__F>2V$O_,&PSEN
MW*F )HGNIK&3O<2""&IS:C@>,+%5D1<P69Z#:[6T?##ZCP&LS=3824SMC&SC
MF($C(D">OZJX_2KFME9>!]K'TO?^2VE5'2M$J?]Y^>CG0S,SJ+$Z3B6QB;Y#
M+4/.O.PM_2UG;J5]_?;>$,0-A65\MX:8WI&9*I]+!(^^,%V8\=&*9W2^4BC=
M^*I=>1BQ4QBGU["Y.$ :*'8%0!],6#-RR7W+J*G"YRG<R0Y2A,GR3(P='Y/"
ME6_'+?!97>6+4&YB>?8$,:<N9A#E@M>0/HE.5L>Q&OU\O%"@XO5X@"@^J7;A
M]<"F0B=2>J'+@$=!1=.\H.\Z=?8S#F!Z>ZS H='OY&=R^W^4FRJC6CP56?7P
MV_IS(1!>TMC"O:Y^LLF9XN-#T7+P^.1CUQNQ?6#'=',A-P34VMC+M=71FE66
M5Q,\Y/*9;^[5"2#$;Q8_6$F\N%>V%YM^-/$LYUR7NZ_&[=^FWKX'-^O'IILI
MM"<3K9UO'P?U)%'A?R8S^/'7M/PO]PH+@9&>Y9DY]LH4;#ZNP/\VB[K*9ADL
M7*'@TZ'I2ZRB*\C' KUTS@D_C*O3[V'OA#:*JS#6&XG>HJ2C>T3#5=>/B.^N
M\ZFND6HO("^?;-7<LK^(QEL>JKF9]"[NU^:E'7,]X94<^"YXZ3LN21FT[P59
M-OAA*'3 Y@EARPX(")U;Z*S,;].2FV?@U_4+"E\.>\$+\X1]0_&8RHLQ'XI$
M<TOSP+S+*(MYV::$VV/:/4?BU[GTM-&?S:EZ\A%1E=[1>9$^#6;7*WW+-U!+
MW!Z+T-IU1\>D#(U9B[*]R&?&RP8+:44FP(ZY\O9^':4]Z(0W5%,.YVAJEY,#
M,PN=>,);R(NB=28P.7GA81+ABM O[:I3VHI/!_AUL \B^?S6G8B'#MX-0SI?
M0;3>]4T>HS;T::\A5AHO76C"V(L#D[ E0D#2,6CX\/N4]$ORZQWAG.C'Q[W<
M TS;O0G/[P]'MT5#9ZD=<!C.RLJLAIXD@C]$: RL)%5%9V=S#"[=8C^/EN,T
MM F+TBKOT3TKB_]5D?G=0 KV(W2!5?(N0O%EK\P@<QF=;XO\ WEL2V+Z(K!P
MD,]',.P<A87'KQRJ(4>9B'L^@;:WO.Y%%O1ARY?$BNRY>M^((U7AW>@?UUMF
M4K9G(;4RY_@'OIS\CWR/*^XHJUCP)@^437HRK#52;.NPA(V'WII\4/MQHZS+
M"0Q[9#6F_*EM%$4E^VP2KG7MV.0G3J#-&G"I8_U?@XVU2^1G%^?6H(Q4.<HP
M!M05[I^D[0AUXEYQJ8->M<+A.G"X;4QZ3&_>J8SDO[V5P,^W][;@IV5)%U(D
ME?82Q1W4WB2G"FA_K=;@'L="GUMAJ>B S^8%1'>1P]<G*Z8<R4I<W,16@=$5
MV$4"87OY@XOE:<HS5NSZ0CTO_<JDQ-8VI^";L1ZP,=J&9:G=QL@:HI]LXFTF
M^ J=]+&#H!6$?=5IYW!3'0@,,P2RG/HE&"2?5EVX0,)W=N))]:90+R>OJ&;,
MA6>-E6?K:R]^"JP$\T< HIL?J]01R%;1E#8R<17%A:&$;"MH"-O*EM@(AD57
M_(K)AO7[- #/'.#3Q06#P8D5%?**BKI3OWX4_=-[P+__EU+=_TGX1,N[&W^6
MFH$/U6ZL"$[[K<#L3-<.WKTC4R%?D9<=+!X#![,6UIP^+_U."[G6*A$VB3T"
M*2S!AY6'80,L1;\)ME):H]C S%M"Q^N@5<8B&YNUVNING!<G2+$8-;FU0E;)
M[!!A"_I5YJ)D8*1<^*XOG?ZI NT/_[FLY%#-]TAF&%M+AOJY"V"2I^JKL[1.
M*M==$/32#AY([>L=+0C4K+-7@5HKE$S'YE:=4CPY-\=8P1WQO[EQ8GV]:4'W
M4])+?;+2);QDMR]TW7GF53 IJ#5XD2]NHO33*W+RMZ^$@R\VA@P"6I.2&'4"
MWJ#/P_A$QG#,GC-LJV]<LG:_+8$W &QM:$S %A@X3D%'W+[K<'/V5R4[[9TZ
M5#L>!LW:H?1_^.S9#I7OJJTK>C^BP,1?VW$*4QU9+RU6*2?WZQ"@Z#5(Z_PL
M.4\R&5E[>U>TKL[T0W2J%I38'JL$SFQ?F:\HM+@M(8*_!8 6MXPWVBL)(\4M
MA;+6(J'LG%L,<GA&?V0\:\[0:-;B.0HW5'Y@O:<UW"8AX0UU)!ZXMFO>(:DW
MOT+ $1"$2P-?,T00PC2C,HF#_J\^K7V>Z&&M.6!F/7STEV$_ZTF?4(3_KR_#
MY5*O-J3E/".T&Z=-C\K!U4=\JNY!Y>5KY>7R3S4^DXUK3?T4!)M?5<"+#:\:
MTO?[_Z-HZ_^'(TV)Y*1D.Q]@6O,[_9X9@7^Q.-K<_LT6246,XH@L;:JG%R$[
M5)!97O?VA$1V_U$+=37UQ?T6#%+Y8 &#J)U=:6>N7C8\+SLXFS^7Q'5/@-MV
MV]E,F.ED+S(Q\N?A1N.ZT=K99))1>/*9 ;DST45D2N3%(A8;*Q"WST6W]T:G
MCJ(B3!2@.\6)P/:ZY@5_#_TG!M>$\.E<5[-0L>JV[P2Y^7XMQ<O+T:08_.9]
ME&!G6R.8[6^)>"(65;04W9"T>)YK>2$0N&92KR3[-]FHXJJ.\1?E"J>",:Z1
MT11A\%YC,"^%V6@LE'0TF@81/@W(''Y9L4'H>CPGUO6;R%W[N/N,M=%]=X!@
M>UGZD>-C9&QTQL0E<,LO.>E*T$?9JE9O1V)F?YX[V26P!R:X9]8_2"',GWZQ
M0OI(2<UC/7G9F/K@<56V:\0#26O.SXVYS>U6R7Y,V(Q3)9-BTML35B+QS!;!
MUN 1"3AB&^]W*XZI.+9E;%Y"@)F^3D5..V5VW_;ASMEPPV+^A[JG5?I6T ^N
MNFQ^=-NBY/FB[K8O[6N?*</;@=]3,FR3TK*>*Y4W9\]E1L-7UQTQY)X'MD1Y
M<?T45\BY^ )&YH6M3( :Q4N^#UY]JY=Q/*BYY<9BGF1(MK!#<%:*C78H*-3?
MXW@IY;E35?D\M *30V V=[\*U<KN2[A:U>J][.4=8+ROJRK<7!52PN OF9T"
M$.>UD9*!7)L"1VSF7L/2L>W>8YV.[M#G/R5FM=HU*N&3D*LU\R;>7-9/F=%M
M4KL]*>NFR&_TE+W<T-0G*R8HVJ[Z?CL\LFE.ZH#-:WV!W/Z%$>HZHS'2LW\A
M%2/] [4'PYJ'><=K0&&(JP>=.!.3P( A7N6F1T3J.G3<"^W%)6_C,M[LW)L_
MHM4FVZ[A3^$E]JVGQ,Z.1,[1V0(C%Q+G>MT7Y75'4.]MS3*@@US(%GK>\/XK
MX%Y&(?/NE:3@?)_5MWQF9/QZQ>4$I6VRFQD2=NX6JF1#YJ5_9V.EI39%\AU\
M>_]038M"&WCRJ@I&8S0%.!-(SB5+;2'4.WT>ST)&0VRPNJ/>*=[?5&];2;O&
MCC$ML#8)4Z0<W+.@*9N<7\5 RG=OMRH,3Z__E]#U;W9Z\L<,PX?"Y_$[H;'J
MQS!95?F9 ,LT:/Y0$(#-.C'I(MU?>1G"':#[(Q@V@6'6*N2AFNGBS(JR.G.^
MRBSS<H6RPN0&B $(5]0]#9DRGJIKT+BR;WEOI.[<O5< H%G3=5P$&)S^@WO*
MR&,*9!+ ;GK>0\M+6U<U(JETIEF[E^:SE2N*(90^$E[\3#T12^/L-K(2F=S[
M;:O+2@BI2%CQH3YWMCT7A.E=% J:%H'OKJ4..3UT>3JJJN[4;O09NS MIH*+
MB\CM85ND::E7X! YCPFS"ID"3[7Y0ND[T:(^AO=*-T[D\2R(=$-5.>J=Z$['
M^SJ.>J.,33S7LFO 9TY1F[=LMB\V#9\O T35R'G*)WN7),/!4%U%88NGCEUR
MTL;XV'<Q,W>Y47WU7Z6:U&,['7*[%YYA(NM]S]7GF'%%MAFU:#K(+0[>;7!6
M/=_'K,I\X?\A[\VCTDRW/6'/K5.54Y5*<BT3DSB>TD0K,<8R3G&^Y\3$) Z4
M,8KB0*E1HX@$9P6TJE+E&*74Q $'3JF1B@I&97  +4N1& =*B:"@&$$QBHB@
M HIB)]V]OG6_Z=[;W=]:O;[NO?B+]2Y>WN?Y/?NW?\^[G[U= #XQYHV?G!^T
MJZYN8[[.:H#8G,9,0*%Y(_OI4I_Y5/EY10@(]2FM$SRG8W2ZB04P=!^!M %^
M'"FW3N4MWJ\LJS'P#TE!EQBZSSR:GV-"PC;5+R6HP9K.>L2=+W&F!3WTJ3>J
MVS#+JZV"AW%]#'"(^J&@.K*B/E/Q^N347KL+68@/I4GFD0R+++XEBT1_C&8\
M+/+8>5!TT'>!/:,BUV9V@!D@;E=SC6GAS@*/EUF4;) K3;:V=HK"?QV(1%44
M*-G34;]G08-5D1'G7.EBG_7HA?NAH)B#7Q>(;=[E=RS)5CCHHS#7<+>"J];*
M4!YOHPY1]%LBYQN6_37W]!KJ\_&GC- .&?#W^GB+\CKLNR$6()K;0P[#=_(W
M!2:6V7^?R_P+=3B\=])P02YI=0I/569<TK'VBINYZY/FH+-RMK+6@_Y2UIT<
MS1I)GN@2+UFWL:[P#!"QZW':A/+F#AWM+G)B2+:ZIG<NO:[UP;S">3%V,E8Q
M+@)$3BRH+Q/ZW2 65;W4_FX%\&*H9M(W6Q*Z?:15>%OFXJ#]VT;KR!8BC#Q6
M@GLC&"RL@G,T4&LV"?T 8?HVX02!!>D<TD=57,E(DVW@+4ZW9=,AVMJ'JQ.T
ML__OG';*=SWQF82OXK6EN%6*PWC$],^?3-V ?3>U.]Y,1WE^H3XXF-F]SHL3
MCD1]6W)YN7Y3]"L>OU32$UV6_XY L*[?D/I.;?B:FSOSD15C10+KX?&5>5&S
MWB0&"=H=]Y':6)]Y;L*A-9/P,>Q\K//3%56_#@0JM>H>(G/9+M R6=!A/CLJ
M&/N7PI$N&VMM'9OCIS-*=\;VCL_N1"K:KZA-/_H#1!^W3Y]YJ(?27?B)=];V
M_6*>$'2=[6!"_['F[Q7%/#.4>D)$OY"DCL*\+LE8"3>"(E?XX+253EFXOZQG
M3^-+)F4'=-= [>WJW"QE[,CTD*JB#% %@UB +O9F%SQ,?+=[:A"^#:4D0*7]
M\\/CB'F,8,C(2"=H.FE9IACFG/;.H*\\=/^"9HDTV:)L'.!\4D:,4/M#HLM"
MLL.Z1H.XUD- O;Y8S_AVW#. W"ZA%.;W%!V'/J&T%&:*?MTKNP,I>WDPMWMS
M%5:KV8;P72;CMQQMC[2LN8Q1<I9GIV61@;AF)&8AI$;4WZ6M6\@N#1(N&#U0
MHM-3HU8HZ<7/B/N35OBEK7V[]N(#9.JH Q;7Y.'Q8Z/XX_]/G.C_;\T L&*%
M ^2&1]/3DQ<7M'$;ZNB)VC1X6J#)I[LGI[H:IJ<AWD #V#YQM@YM'ON3 );-
M'?K23F13J!(ND@DE\;BZF97T7]&.R!J2M>*4,Y4K"Z!RTS+-'/0M4D&6.=NA
MLO(3EN4^5I5GX"+6>E)@2M6X,VP 02$V6PQ*DX3<8?$FWAIITR:&X<$MI?8J
M:!!>\U,#,J!?7K.6/L$]?-&9D;QHG_DP;J^F)IP@]0)U]'P6B5Z]VDT<3LO&
M121'Y&2ZNG_"9O/5'T>=.B,;+U]D^81NWRS>"]G&)G2J"<Z31I^HVI="8!EC
MJ:S@M?9 GPK$S1=!*@Y-EIC$ Q3Y4,>1T$->>.,6#P=;J+G4IO(0\7P[MFZ1
MAS(+\A7C$TF@[,]80R,]X5X9EU8&\H,_Q2,?OZO;_AN=E2FWKVGJ;ND*2WW6
M0X!4??M89S;CL\XLZ.X*4Y=TQP?O,.#@'> 7!O>GIZ@30L; +@?/M]-AYY$#
MJVGZAV]8+;R' WT+T[8%U:/$L:EN?%2+">SZX3S7S(1E[03C\Z6^G,V6F]V6
MFY_OI;#ANRDK;7%Z$QTAWJ7:!,S.CKC-8[+$"YKK^V_.KAL.P*=D4\?A+]_I
ME\PTQJ[E%64E8[*'*MG)IWFR5 AJV.#!%J4"2+U!ESRU0?0?:?7)(AH&8FDW
M760KVP9G/YUW=J<=:)B0_EE(>^]\)*/&B&9/H)VWB!>S(, PNS52X]RU/0K"
MLOY(ZVSW8B2]YI/>G64\+"REBN/EP>B,<8^,<3N;O8MM,WY1Z>\7FD6I6B ]
M:[Z=^&UK_7CO8+H/TB\=#DVVO']G/L-'?KNYP0N447@W4W#;5-0M;,%<*,,0
MC9/V_[8SM5!1E%17-RRHPC#WZI)D4_A(B![#N!RBHP?*:D!:.H&F[/$Q7Y=X
MOFZW<KS#21Z60(0ZNU7DQ3D=XUU=Q@XR:LZF:;)+NRDOE?%F836WW?8;*?<4
M&O5+48M\4[09@@<DO+&'?7_5K0;ADN9LB=\LA; KTBIE_O  _R7"YD5!3Y2*
M*+L?<,.H#RV:D)L_;5K\?E%Y[&SO.SSD#/,Q/"^HGTR3O0=.".A-==/-]'-K
M81:)U55$\$?+KLYI@2*S-$>E.J'7XU;E\S4).P:"1/G;&!F=M]!><D*D_JPA
M[?^ZC_LRC!@V)/",B/>3V1&!E8>0.;W%",[%@;$CK7IP2&3:DV-!_I\OVC$Z
MG>^V0W!+VY(6(8_1^>ON/-8.FPH50Q1Y:3)U7YP-2&J?22[5::>W+0]6(MI2
MU+!S@E1%U#3R:]\;+*#Y[6I!C_?YV#O3UP3]5H9($ZA7C,J5O(8VGN_;QF?_
M<J3E#544)=H<5LZ&W4Q-/4&Z'YP&O _MXAC.3#!^VSM>LTDD;R#MB'_ F5]X
MV:7?GYLR=ELLE@CKK_^!&MW.VL>\A<)^AE-SK J[W/5C^P>U[?(Y+1;4NGHO
M#[5)QYU1FZ6I#<ZQ99?\[;-1-IOV*H>  JQ!\(N-?$[0DZY"5GNGJ2\^^\_?
MIS)^M7J,HFPUBA<M#Q"S5LU[_9&_YWS&S3:/:;$P3A<1LG>[,D,3&3ZUH0$,
M=^.:\"];T7WTT*T_#!EK1UK,D]/LA4%NV"!E,+PN"9D'1SKQUJ,6A<^W=@$J
M5Y3?UM GR\[ZU&Y:+(HNE4W;JOBK%U\(-TIZV7'MTQP@2-AY_:#?C6%9T-_U
M.K*S(FW.( 9@F/SQIKLIFO9#48VS6'\L?H7<U]5'KJ@VJ7!J:;A[6="2N?J>
M-E\H]5$C+#BJ>;.2WDM'W-NAQ5">BVUT\:W6.B&!D9$S'[J#%A0'C7BGTQ&1
M8\$$T/CP\$CYARK?.D(=G25K-X;:N$CU/^32CSU3N&?MH'UO6#(3E<8!NV%4
MW;3J\[B-[-_?I&1$,!:7+P_/@KVN3E32IPSK-N^50'^IK,]H\"IQ+*G/;$='
M79),CD@3MZA1$B/C9RM)($73+68<-MDFRY\/ZC@'Y\?,X!@D5 >@V%I;L*/2
MG*U::;:@2QR<:[S'XXK.R#.&4[V1=YE/@"-1;]'&D:Y]7NQMUJF6BZ^"'QPT
MLI4&-#337]>J-97&Z6P8!:#[6EX_M%;;/R<L$[/ZKQ"W[W\Q\327+S*Z7G;)
M HV)%_TM;: ![(_BA&:2%]I[YB16++RRA\QS; JG^3D,8>T<W+27XCD?MWLA
M0P(M=;3KX/V^>\6C=!BZ>+3H#%$V@<P@LNUDSZ7GW6-,RJW==+2_DDD +?K#
M=4E]?;Z-[_KEDN.M#Y.H-U&='-QN2=_/U%S^9UO4(#ZKDF^O!^_1QRR7B"!/
M?*B*%#]Z2LC\-K#/^R<)K.;X!.$6<6R!NGJ,+B"R0$O%(TH["QNW[99^*;2(
M\&PZ#A1+2_(>#S%SM:N5/MD1+NCG%R75+%1PN^RV<-2)C.+8UJ U1EBD;54^
ME4XKCU?[C7+!]].?5JLZ=1?^)N3<V6URP+J>P&\*R^<17@Z%Y!YBB_Z=C<T$
M6*_P4_LHXU3@2$-(;8JB+-G'E@,)<%/23-1@4;]\("(A$]'7G=E_=V>M!@CS
MZ1\SE.BRIQZ2TJM-#<6R&.)$:&G;1-+P6C-J9!\FH>J$)/4=B@11/E$&44,A
M'W(6O:,IWHS<TH=$1.2K18E5R(#_Y&S1E]'E<O0#5L?915?OH'X\QY9 K-0_
M^??IUDO_8&QP2_J*%U0JOX");[SL[T&*XGH$MYL:[L:U%NAS-06H:VG/.T2\
MM'Y>9A_.E\(7S4M-MKU2/19/(CF\#.9/K:%GGHMET."V<=_?A,@Z^>H3S**Q
M/OHJ:$V(V;LF;A(+O?APS?A-$S,7,S/ML5E4#W>AK[S1CF=8-QN&K2Z!].7+
M%_)Z$VH(OD5/\G2)B\R;FM&RT05_.XG]UW"[4*#TSK M8GY[TW^C%$7CAK5R
MG>/FTG#G&;(:Q\)A(1>Z)7EA[4NH6ANZ"[R[&])L.^V$;\:,N<W"D;%GT?.R
MF@3]!)!'BH#A#6^"-,7=SM]BI^SK,:<RQ7]%_?9OK,(+8W3CVV!7E]\:]:O$
MDY6C<=R3=Q--BXB([+[ZWJD6BD!P/*[S.E<>:+.A]K7G][0H1;\+KZ6H__ R
M=)N+:BDQ!6#Z"=0\>>Z</6IH(HJ?K&H,GH,?.M,F>[WI5J>)$8.9^<46/1.Y
M*21+I\"I&.HFS%9M3HJ9I:A[5Q8#W8??LJ[ZI%1/IU0]-\O.]6+Q=#:JGF$.
MOMF/=7DHOI- !E]"?/1 KA_U>$4D]/G-/YUC"(:ZI"/G[]Q4GA.+BX4QARU?
M-3:W$^$5NW[WY^] S0>,K0-S,(N.L=5A8R&R?B!<G<@7XMN0C5:^VPAKNVFG
M++%^@IM-7)72L5WG-&:%4%'$R%[=/3'O\B0$QLNPWK#?;N=8-H>REG"Y'>?6
MMIAOPE$8D&U=@M4;FL6;L!._SKY#6;%[ < XU;O(W,4_-8JK:&DCOA&"@>W6
M=3C[CSM/1P$72*.N"Q/^8:$^%Y/&+B8!PT(YC+1T7'KZHF5YG=3-"_$Z:<\L
M)FDS&6S7&.9FF26*?)J?7SA="KK7 6)W@(9O%:PX9OO7+(0@QC9M$M,#L?H/
MJ-R<2+OJ:=/?33K>"X+W=H-5-3;Y/^2 _U>P_\EYTRLK#O]0XACEQO$Q'31X
MIO!(ZUOPP?A!HNO9=%AKU&I_^:IY;MM &)\;[;2Y.=E6O'AM(3FVA+&<^!"7
MKZ*B2[X2%>2MP C,;]Q "'S%:AG._;>H:3? *#N9;V%H[29-#_%/#TD!-M=O
MVX?>KUY7VE=7U;7SPE/3.;"4I='N8L5(KV??_# _90M=5&%V;7A-SS- $J38
M 920_I _7L-MZ[=L7LO$&MK3S$>+W?CG8KOHK&3(#.T%TP[(<'CIU29Q]"HV
MDQNDV+W7TXM1HG5EOEAY15!>M408IK[<&Z76;]9FD+,CH>DTTC@HQA)E29M5
MNUT923A=/!&S;637SVPTZB!  BVSWHOIW4^YM760(BR]IF1A?,VF232T@R.4
MGC<%YYKK/F/;44>Z_MF<YVK!HYVB@!^BIMA]%&#BN;7GN<(_42'5/FG[_29*
MQ[U6O:3 /SS+1Y@&Q#L?+Y#N\4)O7/R"?A'.N1G*O,J2^DY)^\V-G>=J*\:>
M"JYY>$?S8IKC1WH/0E*\)ZQT='2?"RC/&V9([P.8XCFZ_ #L0"(H\^<CYB50
M(UU&!C%[^/W_8CSQB;WSH?MY56559VS#OX.P4Z1IM55'+U\@D!*4A[R_]_9A
M?A=LKGIQNWI)])F1RSTK=";<_J1FY$[SR&BJY3<!0)>9$_<")@QD$Z%J9'@L
MN2^Y6\8Y^TBFMM1<OME FO^67F]Q-K]H^!:(:V)UI@UD^ON4-J'WQO*"["#G
MRR#"D=8G!KOY5?FC=_DFELT=AGYN"Z;@QJ;XS?[N7>2NU?K 3\HND>>C:+=3
M$VKL[VY>9^:S%^N4V0YTS5FX,X.A=%WDHHZT$"L:Z>]*5RHQ%KY_<V=FP>EP
M>V/36)?FKG1Z(-3@YG"OKD&)'"4HCJ/&!X&_7 %7UE8,?"5(>\8!R/P2C)B:
MP80LE*OKP$D"?\KM^2F_PUO\_+3/LHX1'S3J1T<%\)4S<P:H84H@T<]C#[,F
MMAPCX#-&'\3C,,W-52^ZFEMZ5-_<9'25V%8Z;R=F):W(?51'6@,'8;$7\2P2
M?UIVAJB*0E=(E&GO<)U=]K7EVC)I'#OV)'\?M7%BAC0HEQ!3O=?0MMYQ[CW[
M"I>N)J21*_C6M-1H8+^E2QOX<7M\!J285A+Z+#54M'^DU7.U(W5V:8_R.%_P
M.'#V_1=6OL"+AC-?!(P_B[G20'"\A"N\)'*++_=(/M*RRYV<(8>SI5>>$J.V
M&+U"<0;9)S:X5I4>=+A@UGNKE#+ZL*J:'3EUYG<*'P/W]NGF@Z:LP9^M#.K@
M24=:)ZLA++VXI4V)$X/"N"TIH>W7'NC,?=5)7G02OB*01\=.;/0<K[8+LTJ<
M:1/G"D )$HF\VU):7*& \'Q-V^LS?[]A<&_F/G)FPI9EF07LSDX8<+W. YM_
M_$HAO4@N:+MGZB:$U4]9&_K;CI&4=H6\H",M*A<:5.3A,<[NSCW28K5G0470
MSOD$AW."J-OB42]FWI,)*+K!MBY';!9C6^>24C(N/M(*,_:J_[WA,TMJ_<AZ
MII.,M+S9X?K]+VF)=>%N^9M_)1,FD7R@;^,]ZB@\C'X&_G']K?6[0F4KKB2N
MQ/<A"WFD]<O ?<,!2(AYPH,%2:/YS21H>HCE<'B,65:CD>OP*M[%S*DSHLEC
M3:>)VW&]0CV*O6:O8Y/H- ??C=.EEY_T0=IQFGN<!"ZNY*9;_<:?0[A9L!HC
M?87Y@&_!2DZQ&OG''&]Q 0196&#WA/Y4_)S3E7]Q-*I-$0SKZ-\-55-9+O 9
MGVQNIK"P>S6W2H1\MEU$(=:GDYS1L5[A<2'1PO2GS_'@A'N*H3,#4^RN#R<I
M<$7_O/!>62:X2ZFQ7Q::Q9A *6-!U>C$<MOIG!Z;G;#K;.^4_PYZ.2;K[J9T
M4>HW-S.@4&A$A4 D$H#^2J%0?BA\CLD45;1$Y9Z+PF%:6@@9S9B,#XWPW*D9
M\IC1T*!6^[&X?'RD64Q,[.W\?%EU]58^^GRE&L15%++-H#9-'HB8[!\=0UZZ
M;&[A6MYAZP?E3$88:/USZ/F2K_=."OYHF=WL* L%Q!F*'(+(D_,)C@^C>\@5
M3FZ![,1XPF65D#=Q!F&/_=,RL,Z5%7^DU7>(FP]I"QS=/%RY?LCIP0M,6"$B
M\E?TDDAR&S-,W 3J<IOE7)Q5@-/E_L9?"I1[%O9KZT_..YFD<.Y0V1;@3PMD
M50K&%-P](FLG*W3W,)W\-/.,_6[%2\SK2]8H!)M6_7+*[BQ9%@:'1W<"7@A3
M:MY!(S#8XN'@N\LE@"RW.!41>-.YE4([MO^/5;$WB]?1P7U0Y U.I\Y%5F'&
M.5X13Y3S;*BUJVM0I)DMF6837#L4L8RKUG]7Y/O[UP(BH"2T&[)19XM)G;S-
M><O&>&>(FX:[@<C]1JHG'6$JSC$^^''!K%%RU[PR07/*]G-4$N_@,OQ:$*"$
M1Q&+BUR>A8Z.DY@0B!WI]!13VRL@U<]H^VTV1&I/ >MW[VD6Y^YEF9D>>ZT$
MYM>AEL.M'D."2"Y.D10:S,;=J$/;?EP17J-NM$)_V3\;@3[AY+H9+-O'1\85
MFD0-^9A%(I%1/K&/U<;K]=(-'%WS%VK@VJ$Q3X[]2.4Y3_%]H\I>I6T?:9V5
MQERM52W:2(1OU:[,[S=6^:K^Q1Y:7[*(O&%(P$K34Y/UI2V<902*S C+Q@%0
M+KF8;#%O9BO%)MR=%7L,#>BOK9<Z4,"I:"/CV?V!G T5JO?0_%@:[(WA>N9L
MCO-)4TJ*!L=XX+90*-1GAX4\_]MF<,PA]\O.S@G8]875./KAXV,TPY]F\ >.
M?SG4/"@3!+\HN>M 23A8[*]V1C2H)TTSQQ*MU2^*I.E]U:K90S+9E:28M9+&
MWAGS$I OL9J[U^Z08NV$U"+Y:D33"G=EX4&[;WF-/0":?9[@R+BSCM7W8$/<
M7K7=ZG Y-JO)VNOBE7N91^Y%+9LQH1=7FF_5VG$2-LF8"<+?&<:!5[EJPY:H
M9%T0^ZJ\Z-*%AA=0O FA/Z:BMZ>EYT$+?H]7?V/O$O=^H4(:GZ;A7+CW1OEL
M%HK'O"'MBRA,9-I$UJZ'=^">I38KZ$-;0IL2]TZ$>U%^<=[YEXR'!26_#I;
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MS4G,8?@.P99T=L?9V$T4Q AP3I5]ZI=KR[35]>?K!CGC.9_T?ZFXQ=L4F?W
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MV-,$(W.H]1VVT[Y<+&P?J253^78JR[8X6<K:5K+1G.B]"I"^0AWL^2_GKBJ
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M CN]V(P3Q.:)A?&;(;'//Y S76:&5XAE1$>="%YRZ%K/;E&L$!6W6P)= M6
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M"$B;5-UE02'!L!E2OU^B3E,L.IS9T=/P?;VLLX9@'H55FF#L<O,EAUH>@.3
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M=X=':A?D(4+PU*!FVSMK9;$C)D>M%_*Z7D.,R*>[N#R@BCQV=> A:B@0AT\
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MFO5V79D.!#63$XF9I,E]=L_+O]R*-7G<_,PN9A:2WQ[[+(%85$3NKZUMO[>
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MXTFQ6DIC4A2&3VER<U7?E+$IG\BX27'0ID@:%?//F69O4MPT_]L?3
M
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M&2:9_FB96IEI1GEFB6J*-J:;<<H92)MSVAD,FW#>N6>'>4+&YV9Z CHHH>%
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MD&NEKNNY4FL0,BN\BJ:UEHV\UJL%H&M(Q:J^.JN0J V_'NK :I2__BO 9JO
MYBO";IFWMNJ]-JRN!NQ&,:S$VM7##F/$7JR]:H>[P@K')FO&CA:]AJQM;JS5
M%.R<JFQ$@:O)LBMLF W+IO^IQ1J6R[XLS**)S(XLSC+ S";4S?9LP@K'SO*L
MT.I1S0)6T![MQ+9KQ1HMTSH6U"XFRD;MR5*LUOQLE29M7Q6KU<*JQ^+KU JM
MUO:3UWXMV&)MRG*MQ)8M/U4MVG;LN':-V_(HV](5W,:MW#HMW8XMSM[M79ZJ
MWH);WA8-X.IKW<93X0[NU1*MUR0NBD*N.BTNX^*CX&;MX<)KYKYGV%9NN5TN
MYI:KYV+LNY87Z(YNRJGM26TNMTIN.9TNZM)IYU:-ZSXHZW(5[,:N["ILZ):N
M[EZ&WRJMZOYNVCKNVHKN[]:N-\TN\1+N\!J-\NYG]&+3\S9O\6[)\2)O[-ZN
M53'_K_4Z[]S2;O B+/=&5?5^;\[BIZR4;ZY.KS2=+_JF+_L>UORJJOLV$^_&
M+[W!+VV-;[W6+U'QK_X2JVKT[K;&+P 7:O@.\/XNL-(DL*7>;S+E+P,WL/&N
MKO^:JP0;DP-7\+M1\ -G<+A"<*9VL >KFPD'#0D3K BC50J?,/CR;0AK[^!N
M,#"], S'<,R*+PW'[0K+% [G<.IB+P;[KN?^,$L%L1 /<0'O50LW*Q*GU 4O
M\< IL<M$,<T^,>[*,!57,1<;KA:W;QBO*!%W<<--,1CWL-5B,4BAL1G[FQO/
MU!B_*AMWU!>_,1S?<?^J<=36<47%,1[GFQ[OL1'[\!Q#_]4@!_(')W+,^'&0
M.G++EK$B2QPC7_$A;RHD.U0E3_+G2K(<\S'97G( >S(G(]PFJTPF1ZXHCW(3
MEW+(D7+/I/*(RG)!P;(K>W$KIW$AK_$J^Y0MWW(>Y[(N@^SHTK+9"C,P7]PO
M-W(OKVPSES R)S,E1S,A'S#C&O/;4K,TF_(.#S,Q7_,S W$W;_,K:W/-A#.9
M8K,]C3,Y<QP[?_(N]ZPZK[/.MO/*O7,U?[,A@W*U J$]QZD_@\H\Q^= MY,Y
M_S,NF\ID\7/;HK,4'S1"!W,BK9=#+VE%IVL]1[3)030J7[3=>G0;*[1&3[-(
M6S)#_VM!OVY&C_1&E[1)6_/7IO\T.:TT2Y>S2W?T2?]O3C<61]>T(-^T9X&T
M*N]T95J93_>F44N*3"?G4B\O4!_U3T^TR!#U" LU1=$T5+OS4X=,4^NF55^U
M5&?U%P;T;WVU[9HUT&ZU6"]R6"M+5\/F6[]O6Z]U]R4UH<5S0U-U:LXU7=,?
M7PM+7(<F6B.46O<U6Y.UB VV].JU\-JU80^H#6-)8%_F9$^P8S]V="*VI2@V
M07-V-E\V9H<H:!.*9Y]G90?37X?V_FEVI9SV8)9V/J6V:EM?9%N):^?E;>N2
M;,]V8*KOI\#V=.9V+>TV;^.>;V\*<#NG<-/2:!=W"QYW8C,V'4OW<;*V<R-U
M;4M.<A/_YW9/KG5?-W9W=Y[A];HN=RPU-WB'(W1O-G6#JGFG$GJGMWJ_MV2+
M]VK:=SC%MWQ?Z'JW-GX+=GL';G_O]VQ^=Z+\-V4C>#7I-X%_%X,_&GFWKH++
M]8 W>'A'N,5,.&+2=RD9N(5G-H=K=X"S,(875W9_>#_#-#./N*!J.#-Y.(J+
M]HD[B8O398AW$HS'^'/7>)SPN%K>."?EN([7J(^G"9!_9)'WDI /^7RS>+H<
MN48FN6Y7.)-#=HE'C)1'998S]XQ7^3I2^7BKN$X[N5B!N9?GHIF3-IFG\Y:[
M4IJ?^8Y?^56U.4[2.7QW.9SS-)XGB0 *0/6_G;MDGW?XGN?Y1 ;ZD/S_.4D:
M>I 3NJ#O-93S^9IO+:)GTILONNDJNN@\ND5C>O=:.J7K%:?_6Z0O9*A;TJ=W
M.MZ6NHV,>D"J>B--NJGSMZ9O"ZO+8Z.W>JV_NLW>>J''^HWJ^B"A.JZ7IZ]?
MNIQ',*\W%; 'NPL/^[4=^U"+^;="N[)+=+$;S*RCX[7_.K-/NX [^U17.XF#
M>V-[.[=?([DO2[9G8[HCTKJ7>[>+>[]L>S&V.R71N[LON[W+2+[;XKZK4;+?
M>U?)>ZJ?NX+V.SH1/, ;-[S'.\(O=L.+\\,G_.49_,11/"9:?!@)O,0'O,;'
M",8[XL<S5,AO/"LOO+Z,_!^B/$^I/,GG5,>O_YO)?RG+4]7,MSS$QWR]U'P8
MOOS!2[O-Z[!8P+//VV_$WVK1_WP5ZGRH''UP,SU&XSS2LZ'3K^_4<W?5&ZS2
M1WV_9OVP7;U7>SU8@[W6%SC4PPO7#R'/ U39CWW/B3VJG'T.PGULK3W;E^+0
MEXS<OV#>2Y?;USV(Z_.*W[VQTSWG$K[?<UK?"W3B2^;>S]?B'WZ<UTHL/_Z&
M4_YG"S[D[ZVQ"'W0#VOC.[[A9[Y?8W['?'X$FGZ"6;[H.WCHDPOJ'^#KEY#J
MPV$.M?CL*_7MEV7LJUCKTSH!R7SNMUCP;^7P&W3O*V/R:.GNAUOQ'^7R_]CQ
MG^(J #_I:\SSD]_U*_]9]*=\WF1Z]6=X\PME]MO9]ZL[.W@_X =^^F-R^.?W
M]J/]03SR^U/T_)MV^SMU^4]B3O1Z_1- ?$Q=;G\8Y:357ISUYMW_ Q!'LC1/
M-%57MBU!.)9GNK9O/-=WOO=_8% X)!8M+F12N4P:G4]H5#JE5JW7&U.[Y;:P
M7W!8/":7S6=TFM%EMY%J>%P^I]?M=WP>X^;WWWK 0$$YOT)#D\%$Q47&1L='
MR+G#2<-(RTO,3$TBRDZW3=!0T5'24BQ/U"[35=96UU?8Q-39I5C;VS%:W3_<
M7M]?X&!AH-WBE6'D9.5E V-G1.9HZ6EJY.=KE6KM;>YN[Q_LZ^]QZ7!Q<O3_
M=/5U]@WSY_9X^7F<=V-Z_'S]_09[?VA^ 04.)%CFGZZ""14=1*C0X4.($<$P
MI"71XD5K%%%AY-C1(QZ-(0%\)%G2I#Z1G4ZNE)*2$DN8,642=#EIYDV<=&H>
MRMG3Y\]^.T4")5K4J"RA?HXNU9"T$%.H4:4Z<JITZE6L'ZKRR=K5*[JM.[^.
M)5NV0]@V9J^B3:O6[5NX-=BRB5MWZEPN=O7NM80W*5_ @8OZ92+8)V$MAA4O
M-HNX,&/()1TKB5S9<LO)52]OYAPPLXO.)C_S"EW:=,?1H$^OSI?Z&&O8L26X
M1BO;]FU@M+/A?J@[!6_@P<?Y1B'<^#3B (\O5YR<_RUSZ-$7.7\A'25U$M:U
M;R^%/3MW\*R\CPQ?/NIXO^;5KZ>"GKTZ].3?SZ</)WY]_-.]Y^>/.O[D_@(4
MD /W!J3F/@,35- '!!=T,)?Q'I00OO]HF_!" PO$,)@&-_3PPP<Z!'%$8B(D
M\<1>*L0.11:W,[%%6#2$<<8%9:3Q1A!LQ'%'1E14D4<@87LQ2%%$)/)(\'1$
M<LDUAF3R23-\E'($**LTS$DK'S$R2RYCV[++([$$<TPAIC13.3+3S$I,-0'Y
MLDTXFU,R3AK9I//.IL[4LS@\^P3*3C_C>#-00LD:M% / 46TT#T;96%12$7;
M+U))%*7TTL'FQ%1"2S?MTO]14$GS=%2:)B4URDY/55524U=],%57=PQU5LIB
MM54>6&\MXE!=>^TM5U_- S98#&DU-C%BD]5F6&5WX+59:''5-%IA6Z7VPF.S
M5>5:;G-CMEL9G@5WW&6G)5>Z;\_53EMV/U'WW>[2A=<=>>>U]Q5Q[\6M7GV]
M;/??/OH5.!)^!X[ 7(,3%J]@A2MCN&'& ):X$H@K!LE:B\]".&..(=FXX\X>
M!MFMB4M^:624#<(XY0KR9?EEG3Z&.>*59][+9)PWLGEG*$3FV&6>@Q8#:*'U
M\KEHG')6>A:DFV:P9J=#.#IJJG,@NNK&H,::J*6[WF5KL&&8VF*9PS:;AZO/
M7E/_:[57\OKM>]J6FX*Q*RY[;KQSK#OOF]CF.R*X S_G;\*E7E'MM M7/,2]
M%S_);\>O$WSRP2/'NW&%$[?<<LTW3_IPSR6G?'1L0I\;\X0[-YUPU5=G"7+7
M#R1]=G]B/QOUU'&WO>G6=R<)=M\YI'UXAH+'6O>![S:>;^67=QMTYX4G?GJ-
MHG<:>8&;MQYQ[+?'IWOO":%^_)3"%QK\>WLW'VGMU[\(>/=[)']^L>*?&7U[
MU;??9OWW%PA^_]V!?@-T2@!9AK_\(=" Z6O? @L"0 >>@8 3W$H$0:9 >#70
M@B_KWP:E11T/BH^"(ZQ@",D&P:!IT(07Q. *EX%"%PZ!_X0SG$L,&]9"=770
MAMG#X0ZEYQP?8H:&0\1+$),'PYWIT(CS4N$2T]%#&Q)1BHYQHKZ@."XE5I%<
M6=0B<I#8Q0E,48R9 6,&O\B_*Y9Q5%Q4HS+2:+\QQC$U;3S7&[O51#IN$8]Y
M]"+T^ @!.0;20G_DEAT+:4A"$FJ/B7SA&7TH2$CZAI'70B2UV#A)6RT2D\.H
M).<B^4GB;!):G1RE)D79*U.>TA>DS!LH7>E'5>J*E<JZ9"S7.$M;!@*78'ME
M+W>9RT3],EBI!":I:EG,>,'2@[YD)C&1.29G_DR8SPS2,:D9BFERL)G;_,\U
M717-C('3FX@2YSBQZ<C0<5.=/O\RYZG*"3%KMI-.[Y0G)K*9NW7F4TKU]!0]
M,^=/?JH)H &E"CI/IT^$FHF@F!JHP1JZ4"X]%**#N*<>$WK1,TTT4A+M%T<U
MNJ1X?A0IRF0=1DWJ*)&2LZ*W\FA*J]E2E\;,H&@\:4U1&M- P92)*\5IAGC:
M4R?H%(LV)2JM@-HGH;XKJ4=%T5*9JK*9PK.H4SW64^?YTV\ZU:K!C.I6%X)5
MI%)5K.SRJD"U:E&2EC6G8%4KVKI:Q['&M5UM)5-(__E6NA+IK'EM#UZC)5?
M2HROG]HKN H[V #9%;%0!:%4 _O8B2W62HIU*%LE"YW#7G97?ET59#V+,\U"
MB;)'Y&S_:$^46=,& ;5,^FQKEY9:D*[VK[*%;9(L6UN-E7:MKN7M:W'[TMNZ
M,[B_]9=NB1L&VK*HM\N%VW%Y-%K2IM6Y81KN=.E67?PP5[N"L^Z-NOFWY'97
M.- 5KPRQJY[MII=RY871=YEW7O9&AKSQ!0=\T:5>_)*.ODV=KQ7MN]\K_1?
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M;FA[QF8Y/F@JF2A^[F=F!LI,@^A0EFAZ*6B#AF.<RO]HC4[G=CTUCR9CD+Z
MC9ZL/GXJDSYID?Y@.5)8E [9EZX2&-Y/A?8_?Y[/]UMIUVAI LGICAI?Q)II
MFC;G;*XUHBYJH\Z G7X2T@TMIFYJBJ;F_XOJ.9KJB:9G$?;9W\IJK19KD/Y
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M<$@L\G3(I'+);#J?T(YQ2O5%K]BL=LOM>K_@L'@,KIK/"[)ZS6Z[WQ^T?'Z
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MTTQM+2T6U.#DU4+-'T3MRR<M4%>-U26]IUO=U+,QU5/BUA@+U\8KI1N)U/0
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M2_[%,G^SY"7W5/E+85Y'D,/$G"]I&<I3W1*7NG2FCHS9_XE@1E.&R*3F-9<
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M")"I$C#M^&\:],V; ! +#G#??JVX<&\"0VT!(R[_7*;=V,S]@BP"=0 #'<4
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M(C'5T2[?8I)00 AYR#$94P7]D@4M\S(98S/I9S$M1=6RBC!KTC,YLR@A<\A
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M.-5S36Q^,YTA*"<&BZE.U+'S<.XT)2\-=DYTOC.?0IBGYN*I3RIZ$Y#\K-E
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MN9(5KR:_2T3WLM>#X>7I8T-67V*J]ZCQA>Y\K0G?_;80O1"]+UZ72\?\ZA?
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MAL3F[O;^!@]?UOX4-S]'(M=%9Y]4[VL/>Y\?^:,_CL_7W^?OM[^_YT_@0!D
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M)7.BLO\)3,8,,TTU>2BSA#5QPO)-.>=,K38Z%P+SSBG0G*E-'IU<3$]!!X7
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MQ<,_&9D^^SN_ 70@_=N_WHL;^1LA]NL> 43 _R&_\L.IXIO C<) U#N[0W-
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M:IO-R:Q-: Q.X,E-W12DS81-G'3-I;C)XP2AX62TY)3.9S1.&[HIX7 _WZ1
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MR0X^?!7OY*$S+X\^O?KGT]>[AR4^OOSWCX+33R$_OWX=]_N;;N]?@ (.F!>
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M4A[82!J8@O% @A-$HRX8?"N8@V-/@U]D23X8.CJ8A/= A-6D!T_X.$J8A?M
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MMK.>_2QH0RO:T9*VM*8]+6I3J]K5LK:UKGTM;&,KV]G2-HH%   [4$L#!!0
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M>"L[7/*>EW??1:\%U;M>]ZZNO>]-8'SE6]_0T=>^HP58?OFK.OSV%[?[!?"
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M=UE9FTZTFE7$F;3IF5\)FI^)FWIAFL(9A;J)_Y&D*4S'F9&Q:72OR8O/69Q
M09S2&6B569T(!IG^Q9MT\WO:Z9MOB9UJ09WB.8[-69X8D)P9M9P6((>A"1/J
MB9X@>)[RZ8;769]>]IWPQ9TG!)Y^N6KTB9_>Q)X"BIKW6:!U.9;6QI^*X9^=
M":#ZB:!@1J 2NI3QR8,7ZCL,NA"SR:$H%*$5JDP4*J&W&:)7D*&[LZ$RXZ"]
M":'1::),5:(PJGXCFH\HJCLJ>AHLVIWP6:,S^I@^*J R^J..%J PE:/[T*$K
MZJ(*2J3 *9A.RHTWRH)3:D5!^@#N&9P]:J11:DE5NI%#VJ5*PJ4JA:3>L:/]
MR:11*:9T>*7U&:9L"O^29!I29HHT8/F>8KFF<9JG3;JG@O>E&PBHJ5.G^8&F
M#:JF4.JG?*JGBGH-Y"F;@CI";CJ!C(IA<ZJ/+]JHYP>BFIIS!]JIB3BI'$2H
M]Z"D.HJH> JJ4BFJXOFHIQFII4.J%&*H'HJJ6JJJJWJIN(IRK+J,L(I&O6J@
MG"H^P2JLF;JK57FLR,J1OUJ S8HYLNH.IIJD'ZJLRWJ)NGJMK)FM)OJL-52L
M@!"2B2J4PZJMQ_.IYBIJWDI_ZQHYT?HBM+JD3QJ>Z<J!X"J<KBJ:[0HY[]HU
M=WJKR5BN]0J*^UJ-^6J9!<LX_2H-TWJFMOJ; RL_Z!JQ6WFOM9BP@[.P<A/_
MKZ<ZK_])L19IL9 *IR!+J>.:;1J[# UKIQ[[H"4K$B3[LO\GLJB(L8"3LLJP
MLH7ZL/0JLP\7LSY[HD ;M!9JK6B&LTC"L=3*LQ]+M)LJL$X+B31;BC;+2!:;
MI1"[I5 ;M5-8M1<[M$'KM5)UM>*:JB-IM%RK2F);LV#KLVM[-TB+##I;JM7:
MIVG+D-QZMP<[F6_K-G%[./^:M8L*L'<+0&U;N  YL8B;GE-;/W]K#',[JTSK
MLHN+#GNKJI<[F'W;/V2;MU@JLINKE9G;J:-+EZ%[-H\;*8';LP&+MI5KJ:?+
MCX?[LK$[3IZ[>*[;M;EKN+?[NA-7NWE8NFH)O%F3_[J]$+G26K>5ZKOT2+QM
M*+QGZ;Q58[RS@+SP.KDMRKS8VKM."[V&V;B>N+4B*+X0R+W,9[[:NZWDF[Y
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M'GS?&"VWPBO&\(:_+>"GE/CI!DYM8P>:W<7$>,;I#?$[1_GCO=6WR)/4[P,
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MI$*K=I[J:CJKIU;INNCHK>)JJF:K9PSKN6YHM:JKGY8J=G:K.]HJL]:HLBH
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M\UX_LE@[L&+_]6*G]6-3L%]7K$A/=<*^=>0Z-@]O]B3?M0U'MF2[KU6+]E0
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M(HS+^0)APKZK< \NC&'_/GBLS_7P;1T<X@)M6)@=MJ-5_X&7X7PBF)<H3C&
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M+X[T7V7 ZH\QUYNH[6.UXMLZ]]N_TH*^!+2Z!61 ILN^??(^T9*_^&N^:2/
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MO]M$MBN\Q4N<J&N\-A6\R<N\39FXS3L&N@N]TPN\R$N]T4N\UZN]52&]VRM
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M;=*+7,\I;;P<S=)#X-(O_<(H+=,F$-,U?<(TC=.GEM$[K;\W[=/ZO,]!C;E
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MQ1V7O&\O(!?==(<Q%P-UW7T7WMK8%2/>>NTM9=Z?[MV7WWX/RW<"?P4>N!&
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M_??I7?[TJW_][(_]^</=_OC+?_[T/_W[G5W___SK?__\E_W]==U_ 2B  TB
MC_=_JE: ":B "\B @W> F=: $2B!$TB!=?> B%:!&:B!&\B!;'>!>-:!(2B"
M(ZB!'YAF)(B"*:B"&6B"6;:"+PB#,4B!+:AD,FB#-XB#$DB#.Y:#/>B#/]B
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MJ3^FJ9JK&8FH*3^L"9NQN8BNN3ZR:9NW:8BT.3ZXR9N].8BZN3V^*9S#Z8?
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MQ1T7K&^S(!?==*$R=QIUW7T77I[8;3?>>NU=:=X)[MV7WWXORE=??P4>."&
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M+:WO'OSP%_Q>_/*))-_\]-6?#_WUW2>U^??EGW^]]NF__T+[\=^?_^/T[Q^
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MD3R"T1A)T1:3D1E)B1B;D6&6$1JG<1B0D1JWX1FO41MCP1JW43FDT1O#L9#
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M,)__RY[[^9XE^9^%>)ZIV9\+^H3A.:!I<9_QRZ ;^H41.J$5.:+)V:$K&DS
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MFFBJ^_^LVBJLL;HPJJRUXG>JK;D2LRJKNIK"ZZ:^"CLL [02>VQUQB*[+"K
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M$@LZQF,I@",]"L(Z&D$[-L<QY>,]MHH]_J,>#J) TH(_IL4^0M:3'&1!NE5
M-F1B/"1$S@%#2D%".L4;P.-$@I%$;F2S)*-'>D)%8L=%\@,=:&1(\A9(IN0D
M$B1+DJ(JJF-)9E@=H/_D2SJD2]ZD-<RC3GJC..+C3/*3+(YD3\Y01Q:E,ZXD
M4G9+=G!C4&I2(=CD4E+*44[E(U2E5;YC3 +E4W(0YW1C5I(*5H9E<"@E69;E
M3VY"0G:"5)YEH?"D6S)'3L;E56YE)?0A3-HE71KE7.[E0$*(7R8E6*8"\B$B
M40;FF8PE8LH!7"XF,.AE/?*=BARF8WY)8U:F%EPF9M+B=*#&RWDF9&XFFVBF
M:)Y/7Y9F'U!F7EY;2Z8E:O*EA;SF-9BE;,KD8%(#I?7B;=:FO2@F;VHE;?ZF
MO^RF;EK?.K2E<-Z3;R9G\@0G<_8C<5;(HN$#<CXGF<6F=:JE<V8G<+KF8PC_
MV]M%)W=:YG:.9TTNIWEBHGB&)\$Y76BF)Y.0)GR&07G.IT\V90S>$-F]IWU6
M2GWV9R[])X BY'INX>05CVH.J),)J()"YVDV:!8DZ,6Y(UI4)X3JB'Q>J!L^
MJ(:29($*7BF5UX=V*(^@)XGR(8>>J$7RYQ%9J(IZ$X.^Z'TJB(QV)WY:F836
M:(-DJ(Y& (^^:(X^&XOVJ*G$*)$6@8D>*0-Z9Y@-J9)B2)(^:548J90VU(@V
M6I!6:<*EJ):N*)5V:3@XJ0ZY*)@Z2)26Z0.<*9AFZ021*9HN%I>^Z1%\J9P^
MEYBZ&IO6J7FHJ9["'V#V*?;<J0RY*:#R!Y_VZ:%J_VF>/A"A%NI])&J=0JJ4
M+FJY4:JCFEJ<7JHPTJFF3H"E$E"C=BJZ<:JH$F&FEJH'?"J\J2JJ4MRIMFK,
MD"JL%HN@OE"HSFIVR2JN:N"K[JJIWN@?W:JO8BIV#NL_Z:JQLJH(*:NQJERQ
M-FL<]BJT=N"5.I&P3BM)(2NT2FJ5,FO]7"NV%IFV-BNW3FJMYIJWANMIE*NY
M/JNZINJYKA"XOBNO22N]SM^X#FNZQL^\WBMSY>NNLNN3[JL=$:R_@JB['NRO
MTJC"VFFU+E&_-JRS_JG$KB# ^JK!FD_$5BQL"&R/>JR29FSY;"S'BBC%EJR/
M7FS QBL)D2S*=EO"OBRMQO^LS*8IRQ*;R-8LVZFLJ()LR-ZL![FLSG(9SW:J
MSQYISH:/T [MTMFKOQXMD2;MR4DMTVJ5T])KT>(JU?K0UE8ME61MH4)MU *M
MD#ZLU^*&V%YHVNIHUTK/TIYMJEVMNH+MK+;M\KPMW#85W>KIWK:JW?8<V>8M
MPI[LT*XMVP9NF_ZMX#8>PU:MX=:HXB)=Y"XN6#RN??:MWR*NMDTNY=H.YJ[I
MYY8JYT[=Z'8N5E@N?*(ND&HNHY:NZ:X?S9:LZJJHZ](.WKYN8<PN=X:NZ+)N
MI?HN[AJ&[EKG\))H[;;.[0;O?,BMOO)NSP(OJ!ZO\BZ%\_YL[)JN]*9=]D[O
MC3#_[\I>;^=N+]V)+_?^1/$*Y_EV*/G^'?26KU]4[\?"KZ:NK^8DK_OFF/?"
MJOS.;_L"D/W>[]?F;^:";_CV[[(:,  ',.%*;/JJ+P)_*_TF,.0)<.]2<,5&
ML.)AL 3O)P'/K05?\ ,;7 AO<)1]\*7N+_^:;8MJ, G36@=C:P,[L H#T?^V
M<(6:<-CB<,.R<.7QL W_H [S;1 ?K ^#7A'_\/B\\+8.\=..<,$Z,1(SG!(G
M*PJG,)/*40U'\5DQ,9I6L14#*QYEL19+\11C+!??ZQ'WC1B/L>>6\?<N</FF
M\>K),1LGR1DKJA>?,!1K+!W7\0'><;<"\KOVL>T1LA]#_T0,+V8>Z_$,CYHA
M'_)#+/+E"K('-_*8/C(D;P8EC^TFP_ >CRPF9S)"2'+J=K(G6S*>?K(HYY\;
MHRHIYS J#VHHK_)WMG(%P['[SC+SZ3(M+Z,IK^XO+W$LVRHO]S(&VK+1!K,P
M7W$<K;$QLS(N4S$RYVTQ:XTS/S-=*;,,1W,<J[+25C,VN]\TP_(XGRTXB\XY
MAS,-<O,;-RX)I[/37+,Z#YTV0^@K.RH\2TT^S_-QUG.#WC,Y@W&3#C,_WW Y
M"_%!>^T^)XT\%W1/ #3Z^K,T,S.;+;1#QYY$]R=$ VI#7P^%7G3<)G079[09
M6S3P?#1(ZZU(E^E&(RI*WQF I/_TO+ES\ZZTX\;T&=&T3.L-2:=G2[NT@7"1
M3>^T5OQT:1IUI+(S,2LU45LM4R?S4!=N5$?<4S<U_NITW?9T24_UU&JU5:\$
M4E=F6,OI[5GSCW[U'W-U_*JUS$*8V[@U6E<;6T.N5VLMZH R7,>U>V*U*]>U
M7>O)Y@*V7BN;7T?T7+_LJZPJHPPV81_VB8XU64LC!"<V8^^L8QMO8>NOM%"U
M9%>V9?/U\U9U-X<+QP679R_O9:MM9FNV:;OMP)PV:HMV9*<VQU(,X+XV;+_O
M:K\F9,^V;7M=R>3VI-'V/Q,W",N,ZMBB<#LU: =T4+/QU=1O="\W<S]W7QLW
M Y.-,IW_#757-TY?MVQSK^#,L=UTMW=W-/%B=W873O"AHGE_7'B#;GQ/;]]I
M'^B\-WS/=[OJ=_#*G3[+#GXK<',C-'_C+O0 C28&^.FHMT\S^ Z?'<NXCX*_
MQ6YC9H6S]OJ,#"-.>%OTME5Z>%(SD#E%'8?;VX4C)HC[-@8%C'Z6N(D7^%K#
M^.L6D2<:G8L;]("_Z8D/L!_N51C=.([G.$L[^(/#7&7I$9"7L(P#\Y)C[R*)
M5LDE>5FD>$]2N8YK'$#*DI0S[G<[]TM#]\-=D#-M^903.7/N.(]'DWBU$YEO
ML9D;MI"_<[[UYIRW /\_ ,!Y&S?Y-L?Y!L/4F,R4G5?NF_.FE5_YN.7_T5+]
M.1E;-U#K^9Z7E8VA%:+?.:,C;: 3,7A*&V-%>E&C>5@..J%SX)O-EJ9O.I[;
M,Z>#MVUMJ0..^NE6.FJ>.JJ'6H4!(*N/WJ3'N*(?,H"YJG_5.NR6NH+"^BTS
MF,D2NZ_;>JX/N:LW,8RI=+,?.\X!.X!Z^J<C&85[&;1'^ZW+J+ /^YPA.YUE
MN]5)NT8O.[.OFH'6FKBO6[?K9+M#M;CE7KRO.S0G.QZ;.QI_9C_K.[UG,[F7
M\K]3KN&UR<#WN[]O^V/C>[[''UJ.G\$?/,+G>9=G<E?V6,I6O!\]O/DJO%^^
M.[QC/,B;E,;3<\#OKL=_<<BG/&&,O(QP/%V>_SS*J[S,DP;+MWS)9R?,,_+,
M[[Q7U/S&N[Q;YCP^\SS1@Y//_WS$F_K-"V[1-[TT'3W' #U9"OW0.[W50R74
M3VC2![O45_+5?[T897VZVSNE+SW3@SW:&Y'89YW9_R;5>WG:I_W:5^#63WO7
MAVO<YSWXS'TAMGUMOCW<Z_W5\[W6D_WA^CW<"K[>$_X$(SYOWSW>*W[<,W[C
MU_U\ CY'2[[<4SY-8/XX>CZ!:_[@<SX'&SZ3F[ZNBS[8DW[I3SRNN_XJJ_[J
ML[X+._YF@G[HRW[1TWY^HCYFV[Y"Z[[5\W[M^[[$?WGL"[_3$W]+X/XQ.G^(
M*S_1,W_?6_YX0K^*2___S%-_]1N_TEL_ &O_[G,_$(-_>@-_\(O_SI-_^7M_
M<:/_3:O_]K-_$IO_F4/^(,O__-,_2!  ?$Q=;G\84Z#57ISUYMU_,!1'LC1/
M-%57MG5?.)9GNK9O/-=W7I1^8% ([!6-1V12N60VG4]H5#JE5JVT85:[Y7:]
M7W!8/":7S6=T6KUFM]WOPU4^I]?M=WQ>O^?W_7_ 0,$9N$*&0<1$Q47&1L='
MR#[#R8E(RTO,3,U-SD[//\I0T5'24M-3U%355=;)SU?86-E9VEK;6]Q<F]8T
M7=]?X&#A85]>-&+D9.5EYF9G'N-HZ6GJ:NMK[&SL9^YN[V_P</'Q9>TN<O3_
M=/5U=D=SKO9X^7GZ>ON,]WS]??Y^_W^ 9NX-)%C0X$&$"1,%C*#0X4.($<LQ
M="#1XD6,&37NHMC1XT>0(46._++1Y$F4*56NG$4R#DN8,67.C.'2 $V<.77N
M+&;3YT^@084.#<73Z%&D297*M+G4Z5.H]7Q&I5K5ZE4<1+5NY=K5ZU>L8<6.
M)5OVT52S:=6N9826[5NX<5E^I5O7[EV\VN3NY=O7[U\+;@$/)ERXA6##B14O
M%I;7\6/(D27W8ES9\F7,!1%GYMQY;5//H46/YC/9]&G4J5639MW:]6M,FV'/
MIHU2=FW<N7674-W;]V_@0G</)U[<.!:7QY4O9W>;__ESZ)F#3Z=>W7J^Z-FU
M;Y_MG/MW\*^\AR=?/NQU].G5KQ]EWOU[^&;'QZ=?'\]\^_GUFV3?W_]_ +W8
M;T ""\P(/P,35/ &T!9T\,&! I1P0@HKA/!"##-T!D$-._00@P8_%'%$8BHT
M\404JR-Q119;="<Y%V/4D$,9:[1QD!1SU'%'R&[T\4<@F: Q2"*C&[)()),4
MDD<FFW12."6CE')*$(ZD\DK7K,1R2RY1^(B")\,4TQHPO^SR3#1MU#)--A-;
MLTTXTS2S@C'KM-.4"T"*<T\^'7RS3T _@S%00OF<,[ [$U64#7P.+?112+D+
M,5)*X?JS4DQ7=#3/13OU]/^<#?3,=%12<9NT5%2KNC155A7<M-%/8Y7U$ ]$
M;?567!=;-5=>)=JU5V#->U6#68N5-01;@U5VV;)^9?99>IR%=MKCAN7 6&SK
M)"%9:KOU5B=IOQ77FU/'-7<[:VO-=MT<3^#V7'CC]750>>MMIUQ[\]4MW2K9
M]1= %=[5=V""U\&W8(25"3=AAN7BUX=_([;NL(<;MOCBGNC%>.-<%N;XXZLJ
M'D%BDE=[06"04U:9$X]7=OF^@U^6.2V1>2OYYKP(J7EFGGN^HV6?@WXB9J&+
M?FIG$W!6FBN./#+Z::CE(#IJJJ^8NFJL8T(ZA:6[)DD'E+,6>VSDOB;[["FN
M1GO_[7D[ZL%KN -Z>VNVZ[:;3HWOUCL'H/?V^QFZ78A[\&R0"/MOQ-GN.W&_
M%V?\<6 "AX%PRGE9XG#(,X_:<<W7YKQST&.17.?*2Z=DZ-%#5_WBSU?'6FW7
M8Q\F]1I,MUV-M&F7?7=[8>?]<=]_%YX6W1F\_7A0J\!\>.8'#KYYO9^'?OI,
MB@<;>>PAJ&-YZKL7MW7O508_?/*ML'[N[+//@_ORVP]V?/=9ESY^^DMS6I+T
M"?>#_?K[+Q5^_Q4,@ $D8%;N!XC\X4P0_"M@ PLU/P?.#((1I& 3SA>%!&)K
M$0RL8 ?EE#</0FV"(23A#BZHO S>"1(<+&$+HS1"%UH,_X8QI.')#FB)%/*H
M>B>L80\]-$ ?OF^&023BMFZHB1Q*R!,L+&(3101$)]X*BE$L(0_MET05B<Z*
M5.1B?:;815(-$8QCW"("L6@:7#!QC&LDD!C9""TWOM&)95S(&<$2.3K*48_/
MB>,>@=5'/_8PCXVPXQ>OZ+9 )M) @%1DJQC9R"H><2*%_ <WU A)3#+'D)G\
M( @Y^<9!=H*29!+')3]YRGT]$I60VN0JH1=*68P23\V!I2MMJ1A5WA)0N=1E
M_VJ91ED>XQZF[&4Q.\-+8[8)F<DLWR\;$TPA.(28S*0F+CU932E>$YLT=&8S
MH*F1:6Y3G'U9YCBI5$YS#J^;I?^TG=;6F4YX)J65\631/.F9N'?&@UU("><]
M_8D5>_[SA^@4J.KR>1 F ?2@!66H;;394$,]%*+^6R@X?;.7?DY4HSLAZ$8U
M)5&/NJ^B/ D)9S(:4I3.!:0IW5)'6;JWD3+F)>\YZ4MM>J"5WE1*+M6IXB2I
MT9KV5*@*">A0X5-4HP8MIG(,:E*=:@^D/C4\497JRY8*RJM65:NSR^E68\13
MKXKPIQ-M:EC-"@ZPGM4]:56KS[*ZQK*V5:Z3',E<@<16NUIUK!"-:U[]^@N\
M_M5(715L]/;:T+X65K$M">QBJT58QWKNL Q-;&0MNPFJ7K8UF=4LO-Y*QL]V
M5K0_@^S_:+U86M-2+;1=K&QJ78LCU+Y66+&5K=!6R\76UE:W>FCL;D?36]^:
MZ[94S&UPC6LUVAYWL&93[MB&&\7B-E>Z3@#N="M37>LRZ[ESW&YVO>LE['Z7
M,.$5+Z^Z6\3HEE>]QF/N>K_#6?>.ZKQ$3&]\[2NXY-[W->35[_\F6]#Z]E?
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M(TDQYK@>BCKVJ"*//@8ID%-"E@ACD9+$0>.-3#8)$9)0]@9DE%06.&656++
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M; S&J'S+T%+'1+C+EOG+6GQ=!K5NUU>9I.S,R-R[QRQWN5S&UES(T*R=D+R
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M!Q3QUAT<&79I2^=P=@-KSYV7S">__9_.?0\>R=>%WP_GXGG376KD@5'>^4;
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M%_9A+C<X'"!I,#%T4UI<F_<PH_=\4RMV"W!'K[>CQDYA]!!\BUMLV[=:+_2
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M\U-\KR%>_Q/[_?V[:>\_ 0<T"SD"#T00'OP2O*T^!CM8,(;])A3B00LOI"%
M##?D<",-.P0Q1*H<%/&.""T\,20*5V2I1!=?K,! &&>DT1_<:L0Q1S]2U-$X
M$D7D$046AVR@1R-1O/%()9?<Y4,FGX2RAR"C!._'$*<D@4@M.:.R2_6<]#),
M,7<$<_],,\_\ $LT6U!SP#8]V#). ]:D<SD9Z\0SSZ"2U+-/.M_T4P1 _1LT
M SFW##11U\I4M%%'55SM44F9+'32"RJ=#U,?#B724D\A8_1344<E)%123SU0
MTT]5=0]33K5$-=:Y[I2U5D]-M377+ZW4U3=>.RSTU2%[)18K6HM%MDY<DV76
MSE^;#8#5]0 5ED5HK^5I66RWK?%8;K_=3=I)Q4VOS6I7!#==D+Q5MUT8V74W
MWL[(?93>\J8\ET)Y]XT(7G[_?5!;@ >6R]Y&#>Z.QWPG)+CA? 1V..)[(9:X
M8J@03A3CZTY<>#^+/T;'7Y!'WIABDD^&26,_5:X.OXX]1CG_YFA$EKGFWDRV
M.6>)6-:3Y^BX>UD\G8<FC$^BCV8/9Z27GL=G/)U^3KB@PV.Z:EN4MCIKNFC6
MNNMXH/[SV0U+FYIJK\^^A&NTUY[5:+;?3@?L->56#K&RL88[[]#PUKMOG-3V
M._#@Q&:6[N'N1GP<P1?O@V_&'_?0<<@G=\1P,RV_.7'-E:&\<P E]SST@P 7
MO?3*"4\6<]XV9_TQTU^W@G389T=(=MIO;U#U+G77K77?E\$]>';<%K[XT4$W
M/ODE-ON6]Z1_AWX,Y:?/#WGJK_?%>NRWGT:U;9VO+7KQO>"^?$@C-3]]THA7
MO_W48KL6?-K&I_\D]^]/DWW\]\]>_W_^_Y^!V9 EO]G4SX!# 6 "8Z0]!3:0
M3/YS8 2O(+1B$? U!\2@*"2H0-MMT(.#8. '^<>P7EEP41E$H0@Y"$$5MA"$
M(72A^M"5*Q.V!H48C.'_.IA#'EH#ACW<7J=D54/3W+!^0-S?#I&XQ-.PD(D2
M1!2JB#@:(T;OB?C[X16U6#TG;A& <CK5%$%31=]YL7U*-&,:B=-%-=Z/4Z,2
MXV?(N+DVI@^-=<1C +.81]%5ZU:H0](<I\9'\]V1D(=<@2$1B;M\C0N0 1/D
MRQ89Q#U.TI(+9.,ED]>Q>CV209%<F":OITA1EC(9E31EWH)V,$\F")1^3*7R
M2!E+6D8+E?^U/%O9,M9*!+WR4+C<Y"V!6<=9#C-PB>M3'#WCRR@:4WC%=.8E
MH1E-N-'Q:;Q,%3.M1<UG"I.;6YSF-W/).F5ADT#:)*$X&>E-=3XQG.W,VN_F
M9DXWH5. \*3=._'9QGONLW/BNQP]!61/=OHS9_HTJ!D1FM"#CD],RIP709G'
MT'P6E*(N7.A%8V9 +T$T,Q)UC$8KFDF13K*?)=4;#J/D4<R 5* H9=M)89K*
MC,ZT8BE\$DLOXU*TV!1V-?5I#($:5()5<4DZM0Q/JT+4UPV5J1^4Z5.M-L<C
M(54R2E6*5$L75:TBTJE=;5<D>V35R&!5)V#MHT71.D*UKK59K\S_$5E!95:3
MN#6M)+6K%KF:5YEIDT9R30Q=.\)7S^V5L&G\ZF$+A\YWO910@AV(8O_95LF6
M+[&5)99$7018PT!V'YB=+%Y!RT/#CM9A+@628_OC6<69%G*E=2T2+QO;6/$4
M1)P=#&NQ0=O74I:WP13M;]5EUK&IUCZZY9QP'S=;Y4X/MLT-*UTOA-O (!<8
MT%W<<[$K0N9NUU&>A>1B2F3=67@WN[XU[^RZF]Y Z=:5QBT7>5'!7L&ME[[J
MM>]]RXG<<\*7//(]A7Z/F5\!;Q6]!0ZH=0?JWY(!F!0(]AN!(5S8 T^XHP!^
MK'@_Z>!26+AO$O9P;RL<XIQR^+@,CAJ'_T-!XI2"F,7G#>Z+1:7B.;4*Q76C
ML3MD7,T1[_C#+O;Q6',,@&G=.'-#9DV0UZ9=)1<2R$WN%I*);![J2D7*288R
MVIB<94K&F,N[E/+$- R?*QOBRS'M\9G'F68U7ZG,4V[P6S+U9CNT><U>MG/P
MMISG9-(9SC\S<A'];!$^>VW/A>XFGA%]ID'7&#I5_ENC^;'HKCV9TDP[]*49
M+>E'!SJBDOZ"IBMM:5$3+=.E#A.H'7TX3R=5U:%&=3Q)'>N&*IK64'KUJL/5
MZKGF&@NWUMJL@=U780_[Q+D^LIREX^N=&+MJIW;VY* =[:HR^\_SXS5VK.T1
M:F.ZV-W^V+3!'?_7;3]/V3C>=A/&[6TVKQMDXG;W7].-[3&O+MWJCC?2X)UO
M'K>;WV*>MPVSW;9[5^C?1]OWP9?\;84ON^"Z_O2YP_?P2C3<U RW.+\2GO'B
M4GR, P<+Q2O.<9UMG.13Q?C)T>WQB+.%WB+'B\IK;6N9!SOE-;<WS*_=:XE_
M7.<QQSFQ_1UT=YF<Z/W]N:OKW?*?5^;H-3/ZTV=.<ZGWLNEE!?G%FOZ7J@N=
MZEV_^-#!WKNM!S;K/]EZB\9.LJBO'65M=_M[TKYSO4#:1G-/2]S??G.]9Q;N
M?=]5VK6]]-SB/>^ ']G?$7]3OB]>CG.?S-EK8OC#.S[<C;?\$#&?^9;_XCTO
M=F\.Y5/!>;9OGO2D4OSIM>-Y@O>\[J+/C>HMEGK9:]STM<<ZY LD^8_ /O:X
MEQCM@5]TX0^_T[H/.>\QXOO?&[]A%'3^LV\?_<(C7RN@-P;SZ4[]@16?^]SR
M_O=77O;K*Q\BVA<_X\6>_C].G_V#%_Q5L-\_W[\_8M"W_]31EW\,&7XJ\W<&
MYN._^W._ 0R;]3/ JV(]I # 6T"_!"RJ\(- 7<&_"7POZ_.)!GP%[=L^"R0^
M!/3 E2G $-P:#(PTP@.*!R1!@)' %:RM%G3! EK F]# >A# &/R7"L1! AS!
M'=P]$WR)&J2/^O-!VP/!(D03&$1"@0-"V#"__Y!1P26,%R640DG1P2I<K1EL
M"2$\'2+$PBFDPB]DI2,4P]=KPN5[PO7QPC*,+C)DPY4*PS?\*"V,B334C!N4
MP^&*PSS,DROD0[FCPXG@0D&(PC\$%S\TQ.;IP40TED \/SM$AD)D1/!;Q$D<
MKSVTQ-PC/T&$1&+@P$Q,%T0$Q;?"Q%$TNS,TB$%4#-@SQ5"LQ%;D$%&$Q81Q
MQ'Y011/!PUG$%EG4Q1(JQ5ZLKEJDAUN$ TD$QL5ZQ6.\0#=4QJ\0QJ_I1 ?,
MQ6:$EE^D1B7AQ6MT.%1<!V)4 V/4Q@JRQG#4D6PDQ^.+OV&,QJ28QG,<H'%T
MQRA+QGBDP6<T!V^,'?]PI$<:@L=];*QY],?)LT<U=#V.:,> ]$6 1,@B4\B%
M3!EN##T4[,:#=$A^9,:*M+J&Q,@M',B96<=/T,>-?$&-%,G5Z\>23#Z(; 9\
M')XU1$D*/,F7#"22E$F-\+]R8,DU8L6:3,B+Y,EC\\F?S$"5+(F/3(20%$HX
MBLFDS"::9$HT),K!D4AI0,JGG+&EM,H%<\JLW)F.Y(6<S!"*Y$JEW,JQW+6R
M-,N'N$EF $L)$<NT7!6LA$LR,\>YO""OE,:I],2JM,M.0LN^O,N_!,S:B<I8
M:,M$>LO!="3!5$R?"\K&?,C"'!&]_,K$A$R_?,S+3#'&U,S#P,M5.$Q9X,O_
MS@2SS"3-\8.?TP2.M0Q RKP:RU1-1:G+V#02_:#-U93,M#'*@'#)VUQ,T_3-
MLP3.X*S#W'R$T(20T23.GI'+Y43'KW/.8#3.M=A-M^C-Z/RNV<3.?^3,[9S(
MZ3S*ZJ0"Y?3._1K.\A2T[D3/N/G,A1#/Y8'-];PF]93/$FS.^G0)UAS"@O0$
M\L3/)-3._P26^Q10)P3/QGG/(O#/ DVP\V30G2+0!^V]]GP@_HR$!9705 O0
M# TO^N30B$S'XTS0*HG/#VU0Z#11H$31%%4+"LT#?,10%MV=")719=K0&N4+
M_40$8HQ1',6U&_71_P#2(/T\%_4AUZS0G232/O/0_R75.AIUTD<\4-ZT4$#H
MT2@]JB'%4AN#TBU5RREE"B1]T1+U4BK1TC(-/ =%TZ8QTB824SFXTC45LBZ5
M4_A3TSI5D#;-QS?]G.O$TQ-=T3]]SM045*4+43R M#@M5')KTD6-#SIUU(?1
M4_CDTS10U$B5-TC%U!8]TTW=BDE% L#Z1$\%T$8E50,UU5.M3#!5T!&%$S)5
MU=KLU%A%34*EU>H[U&]T55_QTUN%0TWUU?)+U6#-!1UUTRK=$U@E5ARQS66E
M2V!UUN_<Q#!%5L90UFB5QV'%5H=HUFV5SEP=SUTME5[UUBS5UG)-B&Y%U\AC
M51FHH5%=5S.=U7@](6BEU_][!%48L*!+O=<!M==^S99Y!=B^R%<V$4]^'=C^
M$]B$M=%_95@0O3I*K5:=%+V'_=5SM=@\==B,[09CW0'5@5>.Q<:%%5E#O=.2
M9<N"%<U*=4MR1=EL/=F7+4Z,E5G=;-<LL4.$K=F,W-B=M4F2]=D@O-D0@)J0
M#=IR!-JCM=- 55J.'-KD9-G[N-:F[3B:I=J.5=>K=4:5Y=6)-5B7U=I+[-FP
ME5*K)5OJ?%H,P!BC/=M,-=NVC<2LA=M&3%M,\MH3T-FYS;"WU=OL2]J^G=EI
M/9^><M>I!=QEC-G#]<RQ55SZ$URIC5JH5=+&Y4Z^I=Q59=S+;4UP7=F[S1^P
MU=S_JDW<T-58RR7=)(U8(8&OO#U=0,S<UI56TX5=/M#38#'<V172O\5=*]/=
MW>56%WT3MO5=?Y7=X9W,US7>#6Q/-6'=Y*4RN77>;QW=Z#W>Q^U:EQ.4VZ7>
M.4/>[?4&F/%>HNC(%!'>\)W)XC5?2P#?]$6[9XR0YF5?D^S>^%W)WJ5?23U#
ME]'>^TU3].7?1EC?_SU!< 6:_17@YYW? R[*!%;@"]7"WX#?!@8T^Y7@":7@
M"B[=U"4; \9@6KS@#CX+Z 5AH>5 IQC7R1UAQ&7:%+9@!F9AM"WA&%Z)%^Y0
M_Z5A!/W@&SX'&>;ABM#A&E[A'P[A'!9BG.SA(]:&(E;A_R!6XK*UX28.5R26
MXO*"XJ9\XBJ&4Q'&XL"=XBXVLRU&.A<&X_[4XC$>8B]&X^0P8ZT4XS56WS)V
MXZY,XSG^M3C.72*VXPR>WCQ^(3KVXZ/@X[V]XD ^UD$FY%;]XT3FDD/FWC9F
M9!@VY$?^6$5.9$G.0CRV9"/&Y$SV6TKV8DY6T3T&90"&XU$F3$_N85-NY$A6
MY5 MY59.150N85A^5D>F9=1EXENN7UFN6%UF2%OVY=P!YF#6!U[F7&*6WV%&
MYBQ^Y64V2&,6.6?N7U&69AQ6YFJV5&@..&P&.%;F9B[:Y&\N5FU^-7%&X&LV
M9RKUYG3^6G*F,W;N9FJ&YU$(X/]Y7EQW1C)[]N!PUF=<J.=^5D=\=C" WN=U
M)FC$;.:#WF&!5C"%MHYT<NA[1N>(EEB&)BZ*;IF$QFA-YN>-!DV+5BJ/WL:.
M%FDRUNB2AEB0ABN4GN")9NF6=.F7AFF5IBJ9WDR2MFD'/NF<IDJ:-BJ>9HY_
M!FJ.-NBA[@*?/B"C#FJA5NKO9>JF)DBDEB>HKM5<IFH;Q.FK%E&IMB:M3K:8
M]NK"W>FP[F2N7B6RQLVQ1NLF4>NU+AJS;B2WSKFLENL_@.BZCFJXCA.\GFNP
MYNOI>.J_]DB]%B+!GKBV-FSE1>S$WES"IFO&%M_ ANS&+NK)MEO'ME7+#DR_
MUFR<7>S_SGY-S)XHT-YLSB;MH_[LTX8%T49.U;Y#TW;M5TWMV&9'UEXJVJ[7
MQ\9M79WMW=X.VS8*W\YMV!9NM97LXL9<X!XLY$Y/W69NZW3NYV9FY8XLZ::B
MX[9NFXWN["Y&ZK8'[G9,X@;ONP;OO?3NN"CO\*[LR=:7]#Z&\_X%]U9O>99O
MHL7N^@YM^%XQ_&[8[>9O1.[M_P9)_88& 9_# #=P1+WO!%=L E=C!H=0!(?P
M[E[P"?]M!R<?"X]P_]9P$N7P#D]6#+<?$.<Y\:[O]B;QY!9QH$OQ$E]OU2;O
M%A_G%2\2&3?9%S]M%+=QMJ;QT=MQ333Q_X[Q'\]+$2?R#0]R__[6\2.?<?UF
M\AO'<=<>\B<WS/.F<@6L\"N?[@_7\B@6[2X'\B07\"D'\P8WZS(/\RBG[25'
M\_SVZ39/<_J^<C:'\RI7Z3IW<37';3K'\]7&YSZ/<ZL&=(H5\T'7YD'/<SD'
M<SY']-JFY$9/=$&']!Q@]$F_<#JV]%.4\$SG"C+G=*SNXD_O+$\7=74N]$R?
MXE+'52Y7]<_=]%:G71F&]54_=0N?H5DW\U[&]:75\^>N]%W?3ZX%]O;-\F&O
M:%8W=BDYYF3GU&)G]O=Q]F??49B3=EY7]#Z_]6K_Z'O3]APE]6Z?@E\']ZWV
MM7%GUU<W]Q?(]G3O!%5C=S-$]W=O9_]DE_<;&+1Z+])HQ_?N^?9]#\\P\_?6
MH_=W%_> =T\5,_BZ*/B$G^1^9WA"Q+"'+QB'EW@/'_B*;UGPPOAFC_>-SUZ*
M]WA<1JV0%XN%)WEPOOB3GW>"4OF2-_F6S_B.A_D]9:R93TF9M_GK3?F<AUQ0
MXOFM!?F?1VA]%_HC_>FB%U:<1WH+6/>EAWB<<GJZ)?JHM^^@IWH*/Z*KE_J=
M#_BFUWJ[!JBOWWJN]W>O%WNP)Z>S'_M>GW"S5WMKUJ6WE[^7E_L1</NZ%V9.
MPOO_L_J]=W6E]WME/Y? Y_N^)WR=K_60?Y7#+WS ?_N[9WP%AY7(CPK(I_R/
MG_K+A^[,U_S_,W9\N;?\SL=ZMA=]5S;\TK_LST=]>Y?TU6?3TW?]$U;]V$=Y
M<:7]LI[]QP_]V]^;R.5]J.1\U]_]WS?UIB#^R(;]V]^FXU]%H6!^Y _^V!_^
MY^=ME:!^Z,]]O%_^ZQ]3D>#^%*3[[Y_^[Z=6@2!_8D]^XM_^\\?%[V9_],_^
MP%__]]_R9Z!_^(]_OY__^Z=G H"/J<NM :.<M-J+L]Z\^P^&XDB6YHFFZLJV
M[@O'\DS7]HWG^L[W_@\,"CF.HO&(3"J3PZ;S"8U*I]2J]8K-:K?<KM>W#(O'
M9./WC$ZKU^RV^PV/R^?T>J>,/]CW_+[_#Q@H.$A8:'CHE:>XR)B __@(&2DY
M25EI>8GYT[C).9;Y"1HJ.DI::GKZV7F$RMKJ^@H;*SM+:ZIZB[M0N\O;Z_L+
M'-R;2TPL?(R<K+S,W+Q;K.<L/4U=;7V-G1T"S<VI_0T>+CY.?MA]OEBNOL[>
M[OXNB@L_3U]O?X]/C[Y?EN__#S"@0&'\"H89B#"APH4,W35J"#&BQ(D4*^HP
MB!&)Q8T<.WK\F"*CR"(@2YH\B3)EE'XJ6[I\"3,FK)$T'\B\B3.G3H(U>P+8
M"32HT*$)'1 ]BC2ITJ4V?/9D"C6JU*E6G-:DBC6KUJU<NWK]"C:L%*LTQ9H]
MBW8JV9%IV[I]"S>NW+ETZV);*]*NWKU\___AS=@WL.#!A L;/HPX,9&_!A4[
M?@S9%>/&D2M;OHPYL^;-G,5-YM<YM.C1:CZ#)HTZM>K5K%N[?IW#]#[8M&O;
M-B%[]NW=O'O[_@T\.-;<YX0;/YZ:>#?DS)L[?PX]NO1IRKE-OX[=;G7KV;M[
M_PX^O/CQ4[87(X\^_5+SQM2[?P\_OOSYS-GGHH\_?T?[]_7[_P]@@ (."!9_
MMQ"(8(+S&'B@@@X^"&&$$DZH#X.=4(AAALA8>*&&'GX(8H@BC@@)AYN0B&**
MH)AXHHHNO@ACC#+.Z *+#]&(8XYRV,B(CC[^"&200B;(HR)#'HED>47FD623
M3CX)992P+<FDE%;_7OD"E2QAR6677GX)9H%:>A)FF696,"899Z[)9IMNO@E1
MFF3"2:>4<HI19YYZ[LEGG\?<>9"?@OH(Z!*#'HIHHHHN"DBA3# **8F./AII
MI99>BFFF.$RJD::>.LCI*I^.2FJIIGX:*DFGKII?JJJR"FNLLL[JI:M&T8JK
M>+;>FFNOOOX*;(B[,A!LL=$-JXNQRB[+;+/J(6N3L]+N!FVTTUZ+;;;:NE8M
M MM^NUJWT8!+;KGFGMN7N :@RRYFZO[4;KSRSDNO4N_6BV]A[\*;;[_^_@MP
MG/<&3'!< Q>,<,(*+YS-P0P_S-6^$$],<<46G^+PQ1HGE?'&'G\,<LAP_W0L
M<LDO26QRRBJOS+(FZK8,\TDHQTQSS3;?G,',.._,D,X\_PQTT!J3+'31]OAL
M=-)*+]TNTDP_K0[14$]-==6]2FUUUM0XK7777G_-*-=@C_TGUF2?C7;:78JM
M=MNRL.UVW'+//:/9=-\]"MQX[\UWWT3:[7?@D>S+K^"&'X[X>X GSGBCBS<.
M>>22VZ;WY);O^/CEFF_.^6.5=P[Z%Y^'3GKIIK\U^NFJCY7YZJZ_#OM1J<=.
M>P^$UXY[[KK?-/ONOLO0^^_"#T]\/<$7CSP)MR?/?//.1]WZ\](O%OWTUE^/
M/2O'9\_]]MQ_#W[XAG@OOO3+EX]^^NH/<O[ZZ_^3[W[\\L__!/ST"]_^_?KO
MS_\0]O>ON_P!<( $+" +!&A \_TO@0QLX/X6Z,#5(3""%*P@ 2=HP>)A,(,<
M[&#Z(.A!T&TPA"0LX?- :,+-C3"%+&PA[E;H0M@1KG QK*$-78?"&T(.ACKL
MH0\1Q\,?EBZ(0BRB$=M&Q"-R+HE*;*(3J\;$)TXNBE*LHA5W1L4K,FZ&6NRB
M%X66Q2\>+HQB+*,9&4;&,_8MC6ILHQOGQ<8WTHV+<JRC'0D6QSNZ+8]Z[*,?
M?<7'/YZ-CH(LI"&E%<A#@HV0BFRD(W&5R$=J+9*2K*0EW43)2TZ-D9KLI"</
MQ<E/[BV4HBRE*=F4R5/_&HV4JFRE*^V4PU>N,I6RK*4M(\3*6Z(ME[KLI2]'
M1,M?VHR7PBRF,1]$S&-F+9G*;*8SY\/,9T)MAC24IC6O^:Q88K-ET=RF-[^)
MG&Z"LVCB'*<YS_F:<J*39]1<ISO?61MUPG.8P9RG/>^)NGKBDV+MW*<__ZD8
M>0*49?T<J$$/JAU](E1A EVH0Q^Z'H5"%(\-G:A%+RJ3BF)T8P7=J$<_NA.-
M@K1B(AVI24]:%(FBE%X=7:E+7QJ1EL(T93*=J4UOBH^2XI2B*MVI3W_ZMIX"
ME5PU':I1CRJ-HB+58DI=JE.?R@N=0I6E39VJ5:]:BJIB-6%:W:I7OSHXJ8(5
M_UU=':M9S]H'L:*5J&5=JUO?6AJUPE5;;9VK7>]:A;KBM6EZW:M?_\J#O@+6
M7-2LYF /B]B+R#6QRQ(L8Q\+61 X-K+8*BQE+XO9$E@VLU1=+&<_:]?)@K99
MFQVM:4$KVM,JJ[2J;2UD6>M:PJ8VMK3%ZFQK^RO8XG:W;KTM;W.EV]\*UZO!
M'6YE?6O<Y)JTN,I%)'.;"UV<(C>ZK'HN=:^+4NMBUUC:W:YW+=K=[^8VO.(M
M[T"G:]Y1%=:PZ6TO0,GK7EK!-[[T!>=\ZPNK]>)WO_.\+W]/I=__"MB^Z!UP
MI0)LX 0[T[\*5B^#&PSA3B(XPE=[,(4OW$@+8_A2$__>L(<]J>$/1ZK#(BZQ
M(TELXNJ&.,4LUN**6YPH%,-XQFU\,8T'M5[VWGC'+K8QC_LDXQ\+N8E!'K*F
MBFSD).O0QTK.4XZ;#&4?(CG*(YXRE:]<02MC>5%:WK*7+\CD+[?IR6(NLP.[
M;&9!D3G-;.X?FML,Y#?#><[6DS.=G6SG.^M9@WG>\YO6[.= USG,@JY5GPN-
M:-4=.M%GRK&.&0UI&2XZTF$"-*4O_;I)8_I+EMZTIT5(Z$]#R=&B+K4*-6WJ
M*Y$ZU:S>(JI;#<M0PWK63'LUK9^TZEOK6FZ=WC4F>^WK8'<-V,)>4ZZ+C6PH
MVCK91R(VLY\=-&=#F]/2GK;_M6-6[6MSZ=C:[C;,LNUM58,[W.3FY[++G2-N
MHWO=3!TWNYVD[G?+FZ'GGK>,XFWO?/?+W?IN-K[[#7!V_3O@N!XXP0^>+8,C
M/$D*7[C#&UOOATNJX1*O.'#Y;?%T4SSC' <PQCM.(T<_&N0D=W#$2_ZAC:-\
MY6$[.<LS)/*7RSQ3*I]YC&)N\YPKJN8Z?Q'.>P[T/?$\Z"D2^<B)CG1#?SSI
MP!PZTY_N;Y=#74$_G[K58RWKJU/=Z5KONHJJ[O6Z@3WL9 \YU\N.(:.C?>WW
M7CK;TW[VM\M]0'&?.X34;O>\P[SN>M\ZW_L.>/*,/? 3_SOA#X^=P2->1'A?
MO./E_Z/XQWNH\9*OO. -;WG_4#[SG$\\YCO?JLB#?O3"$3WI)[3YTZO>-ZE?
M/86,?G37RUXUII\]J%IO^]R3IO:Z_]OG>P_\O? ^^ 3"/?&/[QCC(Q]!L%^^
M\Y,__.?_I_G2K_Y@HF]]_5 _^]RGB_*[/_WO@W_\7A$_^4./_?.K/Z*_7W]W
MMN_^^*LE_?)7G/GKCW^<P#__X;\___^O$OX'@-DD@ -H@!Q1@ =X>?2G@ W8
M$ GH@+H"@1%(@0"Q?Q4(>1>(@1N84@S(@>^G@1\H@CDU@2/H>25H@BG8,!ZH
M@M<!>['7@C&X@BPH@]#Q@C!8@SG8#"&H@Q*(@CT(A+7 @_]!"!XO2(1'R Q#
MB(3>881+Z(2_T(1/N( T*(55: E*:(73<8-9R(7:\X-="!Q;"(9CN")?2(:L
M%X5GJ(9A989K2"U8Z(9QN =I*(<N2(=UB(=V<(=Y>"Q[R(=_V 9P"(C&(8:#
M:(AQU8:'R"U^J(B-F%>"Z(AHR(B12(G^ XF5R!LWB(.8R(DU,(F=&(:?"(JC
M"#R72(J4(XJGJ(HAD8JK>!N%Z(JQN *M*(NTH8FUB(NX88JYV!JWR(N_> >[
M"(SA HO#:(P24(S'F(G)J(R_R(S-^(K/"(VQ*(W3:(N^:(VU6(W9."7;R(V8
MZ(W?N(BT*(Z'&([ER!K8B(Z<>([_ZTB,Y.B.<MB.\9@<ZDB/ACB/]X@:FKB)
M^@B&]NB/\020 >F& TF0W9B/![F$!JF0Z<20#5F%#PF1Z<B/$_F/"6F1H<&/
M_9B1,2B1'4E['PF2-2B2([F/)6F2)HB2*3D:%<F2/;B2+ZF1+BF3'HF1-;D9
M&XF3*DB3.XF0-^F3\M>30>F0,4F4\3>41SF.0*F4W9>43=F+3PF5]2>54QF2
M56F5ZF>46:D9&\F17+E\6 F6NZ>38ZF56VF6[E*6:>F4:,F6E[&6;UE]8BF7
MHN&5=2E]=(F7,ZF7>ZEZ<>F7[^B6@>EX@$F85SF8AQEXAJF8]=B7C;EXC F9
M)_F8DPEX_Y)IF619F9DY=YC)F79YEY]9F)XIFIWAE5]9FEH7FJDIF(G)FDE'
MFJ_)&:<IFW87F[69DZN)FV5WF[O9E;KIFZJYF<%9&:>)FL2Y<L")G"U)F\OY
M=,KIG* )G=%I<]-)G:;9G->9<]:IG;.9G=W)<MP)GKDIGN/Y<.5IGIEAG.D)
M<NC)GG"YGN]9<=\IG]+IGO7);O2)GWQYG_L9;OKIG]@)H &Z;@-*H.39GP?*
M; :JH+_)H T*;0\*H6HIH1,J;!5JH99AG,>9H:46GQUJGPD*HAZ*H2,*&1O*
MH28*:1^JHOPIHBVZHB4*HYZSH3,*:RQJHP(JHSD::#C*H][IH_\_&J,O*J2(
M@:)%2FDUBJ0AVIM+FF9*ZJ0NVJ11ZF502J5 &J17:F96JJ4(NJ-=:F1<"J8.
MFJ5C&F5B:J;J>:1IBF5HRJ846J9ORF-N*J?P2:=U.F-WBJ?%N:9[NF-]ZJ=>
M2J2!:F" 2JAD^J6'*F"&JJAJJJ>-FF","JEPFJB3VEZ2:JD:BJ(IFJG8A:F=
MRJ>?"JKQ):JC>J*;:JK\5:JI2J.KRJK7Y:JO&E"H*JOF%:NUFAB;NBZXNEVT
MRJN(&J>_REN^*JR.>JO%>EK$BJR4&JS+FJS'ZJR&H:N<&JV#I:S5:J?0BJV)
M=:W;JJG=ZJV7!:[A&AG32JZ<-:[GVJK_Z:JN?\6N[3JKN@JOC/6N\YJKYFJO
M@%6O^6JD^,JO=[6O_WH8TTJM @M4\FJPQAJP"8M4_LJPV;JP#_M3#BNQWXJP
M%3M5%(NQH7JQ&]NP'>NQ%ANQ(;M<($NR'#NR)[M1&JNRY4JP+7M3+ NSIRJS
M,_M1-6NST(>S.3M1.\NS]^JS/WM002NT TNP!5NT!):R21L81XNT3'M-1 NU
MTGJT4VM04FNU^E*U68M/+\NU"KNT7ZM,7BNVS*JM96M,9(NV$!NV:WM+:NNV
M(FNR<=M,6TNW;-NV=UM*=JNW<INW?:M)? NX*#NW@RM+@FNX+HNXB=M*B\NX
M 8,:?.7KBK6/>V*.*[G_.@NWE2MAE(NY\:JYFWM(3NNY8%NXH5M(H$NZ9ONW
MI]M%IJNZ>)NZK2M%K N[?ONZLWM$LFN[A#NZN2M&N,N[BNN[O[NZP2N\D'NY
MQ5M%3ONTR&LPRKN\S-M!R@N]HKN[T]M#TFN]J%N[V1M!V,N]KKN]WVM WBN^
MM%N]Y>M!Y(N^NANYZYM SNN^U'N^\<M \$N_VAN^]UL^]JN_X)N__=L]Z@O
MP"O  ^QF!6S QMNY">P^_,O YCN_#QP^SON\$IQ/%&S!\H/!&8R_$<S!)^3
M'\R^QRO"@X; )6RY(8S""G3"*\RY*NS"R$/!%1S#;C'#NUK#,KS!.>R_[<O#
M_T.TPS\,P3XLQ$L4Q$4\PB2,Q*<SPTLLOTKLQ)USPU'\Q%!,Q5/4Q%?<P42L
MQ7PSQ5V\Q1X,QFMTQ&,\Q&)LQG-4QFF<Q%;,QG/SQ6]<Q5PLQ\.6Q74\QVB,
MQW:\QGM,P'WLQV03QX$<QGI,R$LSR(?<PVZLR+66R(U\QG0,R?1TQY-<R(9L
MR31SPS2<R1>\R9S<R>U6R:&\R(Q,RMRTR:<LJ*.LRC7SR:V,I:D,RYHLR[,,
MK*QLRR7SRKF\RH#,RQ?SR:#\RS8<S#@\S$.SR\=\R[BLS&A4R\V\S+X,S0&3
MS-,<S=)LS?42S-FLH]O,S0#CS=_<R\PLSGSUS.6<Q__$B\YL5<WK?,TP[,[;
M4LSQ+*7G3,\)%\[W/,[DK,^KE<_]_,[P#-# 4LS"/-">/,\'S5T)K="QS- -
M?7'_#-'IK,X372H%;=%,*M$932H8S=$:W<X??60/+=(.O=$E#2D%;= H#1<J
M/2XLG=(>#=/U?-(S'6<D;=/[_,@Y+70RS=/=[-,_72<N+=2:2=1%#2='C=0@
M'=)+76E![=1 #=51C25*3=5,W=17/6HJK=64Z=(KW=5PQ]5A;=1?3=9-8M9G
M7=96K=8_DM9MO=9C#=<X\M5@/=?-6]=V?=?T\=9['==3[=>,Q]:!C=4U3=BO
MU]>'S9QYK=>*_1UU[=BMF=C_D8U,DTW9A9W5EQT@>:W9DFW9G:U]D W:B,G9
MHZUYHFW:I(W:J9V!G\W:F)W9KQT>I2W;GCW8M?W8M(W;JKW:NYT=C.W;4<G8
MQAS<?:C;Q>V8P]W8R-W&.\W<7@W<SQU.QRW=O-W;U?V&U(W=R3W<V[V,VNW=
MT-W=X5V4X$W>?WW=Y[W8Z:W>ULW>[4W1 @W?XAW=\QW0]FS?MFW>^=VO]<W?
M2ZG<R_W?\S?> _Z3 6[@1EO@"5[>",[@3:O<#XZ* ?[2$CX7#F[AUTCAQ)WA
M;4'A'1Z-&R[@(!Z &$[B&K[A)VX6)J[B*)[B+1XQ+ [C!_[A,SX<,F[C-([C
M.4X4_R_.XR$NXC_.,34NY$ >Y$4.%#Z.Y$9^Y$N>443NY-DMXB,>Y>W0Y%4N
MY5..Y2AQY5O.Y$KNY1O1Y6'^Y6!.YC%EYF=>YCNNY@.AY6W^&U/N"'#>@5!.
MY]\MYQQ^YT<SYGN.YW+NYR28YH&>Y8!.Z.]@Z(<>BGFNYXH.#GGNZ(3(Z(T>
MZ=:0Z)4>')->X9A.'9?.Z8L^Z9^^-9XNZG&NZ91>ZK[ Z*D^W9K.ZF7SYJ]^
M'*>.ZK(N&9!NZZU^ZKD^"ZO.Z_5!Z[]^Z[@N[+KNZL5."J&.[,U!ZYN^[)6@
M[,_.[,TN[5<8[=4.[-2.[27BZ]ON',WN[-[N!\<N[L\![O]47NXN<^WI/NW@
MSNYSN.[OWN[N+N\C0^[U;H/GCN^!>._[;N[GCN[^SHK]+O#_KN\%GP7!CO!V
M>/ +3P4*[_!:"/ !'_$8H.T5S_ -C_%@ /$;G_$:[_&;TO$A+_$33_(W0.\G
M_]L33_$"G_(J#X(L#_,M\/(S'_,F;_.Z>/$YSX0LW_+>#O(\W_,^+_0>$/1%
M/_0RC_07 /!+/X5*[_00T/11CQX^7^LP/_547_56__.EGO5:GQY<?_41C_-@
M;W]<C_5?;_;N(?9CC^]EO_:M;?48#_5Q#TUMO_!$;_>A+?8N#_=[CWY]+^]Z
M#_C]A_?E3OB%O]EM[_:O/O>*7WS_C-_U,_[XD,]\DH_LE6_YOL?XO([VFW]W
MDC_Y"?[YH(]+HC_Z^2WXIH]ZJ(_IJ\_ZK>_ZAP[[L2_6HN_GAV_[DX?ZJ<_<
MNK_[(-+[OK_;G1_\3=?[7@[\QR_8PQ_EQL_\13?\Q'_9F!_]+C+]C4_ZT'_]
M/I?]+8[[W=]VW]_AX2_^9D?^#V[^YT_7V4_]5[W^[*]Q[L_?LR__0.+^VN_;
M]G__!! ?4Y?;'T8Y:;479[UY]W\"Q)$LS1--U95MW1>.Y1BL[1O/]9WO_1\8
M% Z)1>,1F50NF4WG$QJ53JE5JW.6U6ZY7>\7<!6/R67S&9U6K]EM]QL>E\_I
M=?L=G]?O__DW\!\P4'!PI<_P$#%1<9&QT?$1,E)RDC*)\!(S4].DLM/S$S14
M=)2TU/04-55UE;5U<1,V5E;0M=;V%C=7=Y>WU_?W:59XF!@%^!@Y67F9N=GY
M&3I:>IKZHO@:&[MZF[O;^QL\7'R<*=O\?)!<?9V]W?T=/EY^GGX>_1Z?MGZ?
MO]__'V! @0[R%33X8F!"A0L9-G3X$&)$B:8.5K388F)&C1LY=O3XL<9%D1=!
MEC1Y$F5*E2M9MEPU$B9,ES-IUK1Y$Z>CF#OOY?3Y$VA0H4.)%DW($VE!HTN9
M-G7Z-&=2J<2@5K5Z%6M6K5NY+IGZ-5M7L6/)EC7K"FQ:36?9MO]U^Q9N7+G]
MU-:5-1=O7KU[^?:P^S=07\&#"1<V?!BQ&<"+"25V_!ARY*&,*6^1?!ES9LV;
M.;.M_/E+9]&C29<>!QJU"].K6;=V_1IVO-2S9<2V?1MW[E>T>7/2_1MX<.'#
MB>?I?;Q0<>7+F3?'@1RY<^G3J5>W?IT!=.V^L7?W_GWU]M[@R9<W?QY]7_'K
MT[=W_[[L>MKPZ=>W?Q\_2OGB\_?W_[^D_68#D, "#3P006D$U"[!!AU\,)P%
M48.0P@HMO!!#0R2$+L,./?R0E U! Y'$$DT\$<4=1#PNQ19=?#&-%2N#D<8:
M;;SQ0AEYPY'''GWT0T?&?AR2R"*-G"[_R/F.7)+)'I-<K,DHI9R22LR>'+#*
M++5L\$HHM_P2S##%S*K+U,8\$TWPROPKS3;=?!-.D]8<,<XZ[81MSKKNW)//
M/OU\)\\9_QR44,("5:O01!5=E-%<#J6LT4@E)?/1KR:]%--,-46D4B$W_134
ME3JU--1233T552A&!2S55ET5:%6I7IV5UEIMQ2!6-F_=E==M<D6JUV"%'1;5
M7_4D%MED;S&6)V6=?1;:/IE%--IJK7UDVIVNW9;;;J7,-BUOQ1WW#7!C(A?=
M=-4]T5Q2UWT77B7:'2G>>NV]%\!Y9<67WWX]T)<D?P4>F&#K -ZWX(03/M@B
MA1U^&.+;& 8V_^**UYWX((LUWICCRS#6MN.0G?TX8Y%-/AGEN$@^-^6675U9
M*9=EGIEFJ&"6J>:<);T9'YU]_AGHFG@6*>BB[QRZ)Z.57IIIB9 .N.FHJWSZ
M'*FMOAIK>JAN..NN>=S:'*_%'IML7\$NN>RT/3P[++7=?AMN7=@V*.ZZ#YS[
M&KOUWIOO4/#.I^_ V_N[&,$-/QSQ/@@'//'&G5N<*L<EGYSR,R!/NO+,8[M<
M&,T]_QQT>3FO.O32,QO]+M-57YWUD%!ON_78]WH]==EMOQUW!6@/._?>Q]H=
M%M^%'YYUX+4A'OFFC%\K^>:=IWSYO)^?7NCH,Z$>^^S[MCYR[;WWB/][3+X?
MG_RTPQ^F_/07.O\2]=U_/VKV.X>??GGD3Z?^_/7/^?Y9]O__&_W3!P )6,".
M"3 6!E3@,A 8F 4^$((*:V#P(EC!6DSP#Q;4X ;OA4'F<1"$G_ @&$)80A.*
M:X0?/.$*.95"+[ 0AC%4E@NO)T,;RH&&+[SA#GE8JQRVKX=!),,/N2!$(QZQ
M5$1L#!*9*#HE9J&)491BI)Z(ORE>40=5U (6N=A%/FG1@5X4HS7 .(,QGA&-
M:"HC(-+81MVMD09NE.,<OP7'#-+1BW:,(Q[YV,<AZ9&$?FPB(!$B2$,>TD:$
M# TB;ZC(0C(2DI$TD2-U*,D04A(CEM3D)C/_A,DN<!*"GF0!*$E9R@>)TC*F
MU!\JDZ-*5[[R/ZS<(BS+)\L4T!*7N;2/+:&HR^?Q\I:^%.8PS0-,,Q(S=\8T
M!C*9V<SK*+,VSE0=-+DC36M>LSC4W",V)Z?-$G 3G.$$CC=A($[#D9,$YE3G
M.O&$3M6P$V[N% $\Z5E/TLCSG?;,&C[#H$]__M-C_!PE0)4FT'X2%*$)+8Q!
M!ZK0F3'4H1&5Z.P8VLJ)'M"@%]7H1M]2T89R5((0!>E(22H6CWZTI/;R:$I9
MVM*KG!2E+D7A2F5:4YL:!:8QO>G(3KI3G_[T)SG5*5!OE5.B'A6I,Q'J4)-J
M*J$V%:I1/<E2F2K5_YT]U:I9U:I&J%K5K?YIJ5\5ZU@=TM5,DO6+847K6MD*
M$+.>M:UJ[&I<Z5I7K;W5HG:ETEOUVE>_L@.O7OWKC? Z6,,>-H"!S2MB7Z18
MQCX6L@I2K& C2Z')5A:SF57&9.&JV5->UK.A%>TN.-O9T?JGM*=5[6K14EK*
MLE9-J87M;&E;"M?FL[;?N6UN>=M;3]P6M[YM#G"%6USC8@NXP3UN;I*[7.<^
MMX7)?2UT3R==ZEX7NWB0[B.S6]WF=A>\X87#=KDK7L.0U[SI56^,R%O>]:JL
MO>^5[WROT-YRTO<L]CTH?OG;WW+HU[W^?0J !5Q@ R,!P $^<% 3O& '/_\8
M" F^+X2KUV *7QC#0)*P@C/,D0WOM\,A%C&N/LSA$:^OQ"=6\8HI4.)MLMBM
M+H;QC&G< !>_N,;NN/$\<]QC'^\8QS[V!I"%7.0? WG"1I8LD97<Y!HC.9I.
M1@:4>2QE*\^8RD&^<BNR#.(M?_G$7=8RF/TF9C*?F<5BCC*:*:'F*K,9SB-V
M\YCCO(<Y>[G.><[PG>FLY_'>V<^!EC.?^RSH(1+:T(D6,:'7K&@K,/K-CI8T
MA2%]S$G_M]*7UC2&*]W+30>ATY'^]*@='&I+D]IUID;UJBEMZE.SN@*N'@&L
M:?U@6<^RU@NX]:QSW>L%[]K3L :VJ'U=; $/&]?_ET8VL8W=[&,O^]5YAC:O
MG5WM4D\[V&#&-K.MW>UG;SO:108WM[U=[F^/N]%I1C>YS=UN_ZX[E2&&-[O=
M7>]SSSO=[\8WO>W=;WWO.]OO!3BU_5WP"P\\WMU%.,$-WO"#+SSAQH4XPQU>
M\8=//.*KQ7@Z+=YQ>6_\DYX%.<<]7O)%CSSDAD7Y-TW>\D&O/.5LA3G+75[S
M,,]\D5;%>35MWO.7[SSF.P4ZSWU>])\/O9(D1?H)C-YT+"_]C@Z%>C"=7G5U
M3YV-]<0ZU:W>=1AOW8K2!/MBO5[V%8]]B;E$.]G-WO:SKQV(FX3[=-U>]P[/
MO89]Q+MR[=YW&N]]$V,$_[R)_5[XJP]>A4%$?*$-W_BW+SZ!*X1\OAU?^1Y/
M'GT/Q'S +=]Y(6^^<.\#?<8]7WIQC_YXOT0]Z4W?>B.OGG2R@WW.75][*\^^
M9Y7#?=1MW_LM[YYN>@/^ 'U?_"\/GVM70W[<C=]\,B^?7OR#?MZ=7_TS3[]9
M&L-^Y*W??3AO?RKX G_FO5_^.(__6-5"O_3,WWYIKY]5/H0_[]Q??S_/GTY4
MQ#_C[-]_0>]_/-P$ (G&_PHPT0:0/XX$ ;// !M0T19P0TH$ L'" 2M0V2;P
M2?H# [W$ COP C?P4*0#!+'$ TMPTT8P6T0#!=G#!%MPU%:09-H"!H/$!6MP
MU?]F\&^4"@<KQ09[4-AV\'S: 0@GQ@>+L-:&D))V PE?QPB;L->6$ JC$&&<
MD IS30JO$ OYKPJWL-BRT N_D(*X4 R=#0S+T R#;@S3L-G.D W;D.O4$ ZM
MS0WGT SCT [KC0[S< GOD _[30__< 3[4! +#A +<?\&$1$;SA 7$?H2T1$[
MCA$C<?0>D1)+3A(O<>\J41-=#A,[$>HV$11MSA-'$>5"T11]CA13<=].D16=
M3A5?$=I:41:M#A9K,=1F$1?+SA9WT<QRT1?-CA>#\<-^D1C[3AB/\;N*41G]
M#AF;<:Z6$1H=SQFG,:.BT1H[CQJS$9JND1M;3QN_,0G_NU$<:P\<RQ&,QA$=
MB\\<U]&#TM$=JX\=XY%[WI$>RT\>[Y%SZE$?W0\?^Y%J]A$@_<\?!Y(( ](@
M"Y @$Y)9#I(A+5 A'S)/&E(B31 B*U)$)A(C;= B-Y)#,M(CBY C0])3/I(D
MG5 D3S(I2E(EQQ E6S+X5A(FU= E9[)[8M(F[9 F<S+M;I(G!U$G?Y+S>E(H
M?1(HBY+IAA(I0]$H?S(IFW(6ES(DG5(J?Q$J!W(JKS(:J[(<L9(KNU$KD;$K
MP](=OU(5Q=(L]Y$L%_$LUY(AT](-V1(N,](MKS NZW(EYW(&[5(O>1(O$7 O
M_[(I^W+[ ),PN5(P9Z\P$_,L_P\3\133,>V2,;?N,2<S,2-SY2@3,S'3,@$N
M,SO3,Q%@,V/Q,T>3-$$S-#.M-%-3-=_H-)%L-5\3-FVL-0DL-FO3-@EB-CGK
M-G>3-R,@-V&J-X-3.%OL-[5I.(\3.<FH.#$I.9O3.35@.;7H.:>3.CL@.B>H
M.K-3.T'@.I=G.[\3/)^C.]DF/,O3//UB/#'F/->3/4$M/7^E/>-3/HO@/;MD
M/N\3/YVH/ADD/_O3/X-A/T?R/P>40*<@0$&F0!-400_M0-EO01\40M6@07<R
M0BO40LME0@GO0C>40_\L0#L41$-4"2-31$O41"NA*$]415>4(A*215\41FW!
M&6.41O]K=,H8T49S5$>I 0MWU$=_%+#P#TB'E$@# O.*%$F3U,-*44F;U$EO
MPM6>5$JG="NVBTJO%$L/PY:RE$N[=#A0QTO#5$PQ) #'U$S/%$W35$W7E$W;
MU$W?%$[C5$[GE$[KU$[O%$_S5$_WE$_[U$__%% #55 'E5 +U5 /%5$355$7
ME5$;U5$?%5(C55(GE5(KU5(O%5,S55,WE5,[U5,_%51#551'E51+U51/%553
M5557E55;U55?%59C559GE59KU59O%5=S55=WE5=[U5=_%5B#55B'E5B+U5B/
M%5F355F7E5F;U5F?%5JC55JGE5JKU5JO%5NS55NWE5N[U5O_OQ5<PU5<QY5<
MR]5<SQ5=TU5=UY5=V]5=WQ5>XU5>YY5>Z]5>[Q5?\U5?]Y5?^]5?_Q5@ U9@
M!Y9@"]9@#Q9A$U9A%Y9A&]9A'Q9B(U9B)Y9B*]9B+Q9C,U9C-Y9C.]9C/Q9D
M0U9D1Y9D2]9D3Q9E4U9E5Y9E6]9E7Q9F8U9F9Y9F:]9F;Q9G<U9G=Y9G>]9G
M?Q9H@U9HAY9HB]9HCQ9IDU9IEY9IF]9IGQ9JHU9JIY9JJ]9JKQ9KLU9KMY9K
MN]9KOQ9LPU9LQY9LR]9LSQ9MTU9MUY9MV]9MWQ9NXU9NYY9NZ]9N[Q9O\U9O
M]Y9O^]9O_Q9P U=P!Y=P"]=P#Q=Q_Q-7<1>7<1O7<1\7<B-7<B>7<BO7<B\7
M<S-7<S>7<SO7<S\7=$-7=$>7=$O7=$\7=5-7=5>7=5O7=5\7=F-7=F>7=FO7
M=F\7=W-7=W>7=WO7=W\7>(-7>(>7>(O7>(\7>9-7>9>7>9O7>9\7>J-7>J>7
M>JO7>J\7>[-7>[>7>[O7>[\7?,-7?,>7?,O7?,\7?=-7?=>7?=O7?=\7?N-7
M?N>7?NO7?N\7?_-7?_>7?_O7?_\7@ -8@ >8@ O8@ \8@1-8@1>8@1O8@1\8
M@B-8@B>8@BO8@B\8@S-8@S>8@SO8@S\8A$-8A$>8A$O8A$\8A5-8A5>8A5O8
MA5\8AF-8AO]GF(9KV(9O&(=S6(=WF(=[V(=_&(B#6(B'F(B+V(B/&(F36(F7
MF(F;V(F?&(JC6(JGF(JKV(JO&(NS6(NWF(N[V(N_&(S#6(S'F(S+V(S/&(W3
M6(W7F(W;V(W?&([C6([GF([KV([O&(_S6(_WF(_[V(__&) #69 'F9 +V9 /
M&9$369$7F9$;V9$?&9(C69(GF9(KV9(O&9,S69,WF9,[V9,_&91#691'F91+
MV91/&9536957F95;V95?&99C699GF99KV99O&9=S69=WF9=[V9=_&9B#69B'
MF9B+V9B/&9F369F7F9F;V9F?&9JC69JGF9JKV9JO&9NS69NWF9O_N]F;OQF<
MPUF<QYF<R]F<SQF=TUF=UYF=V]F=WQF>XUF>YYF>Z]F>[QF?\UF?]YF?^]F?
M_QF@ UJ@!YJ@"]J@#QJA$UJA%YJA&]JA'QJB(UJB)YJB*]JB+QJC,UJC-YJC
M.]JC/QJD0UJD1YJD2]JD3QJE4UJE5YJE6]JE7QJF8UJF9YJF:]JF;QJG<UJG
M=YJG>]JG?QJH@UJHAYJHB]JHCQJIDUJIEYJIF]JIGQJJHUJJIYJJJ]JJKQJK
MLUJKMYJKN]JKOQJLPUJLQYJLR]JLSQJMTUJMUYJMV]JMWQJNXUJNYYJNZ]JN
M[QJO\UJO]YJO^]JO_QJP UNP!YNP"]NP_P\;L1-;L1>;L1O;L1\;LB-;LB>;
MLBO;LB\;LS-;LS>;LSO;LS\;M$-;M$>;M$O;M$\;M5-;M5>;M5O;M5\;MF-;
MMF>;MFO;MF\;MW-;MW>;MWO;MW\;N(-;N(>;N(O;N(\;N9-;N9>;N9O;N9\;
MNJ-;NJ>;NJO;NJ\;N[-;N[>;N[O;N[\;O,-;O,>;O,O;O,\;O=-;O=>;O=O;
MO=\;ON-;ON>;ONO;ON\;O_-;O_>;O_O;O_\;P -<P ><P O<P \<P1-<P1><
MP1O<P1\<PB-<PB><PBO<PB\<PS-<PS><PSO<PS\<Q$-<Q$><Q$O<Q$\<Q5-<
MQ5><Q5O<Q5\<QG=C7,9GG,9KW,9O',=S7,=WG,=[W,=_',B#7,B'G,B+W,B/
M',F37,F7G,F;W,F?',JC7,JGG,JKW,JO',NS7,NWG,N[W,N_',S#7,S'G,S+
MW,S/',W37,W7G,W;W,W?',[C7,[GG,[KW,[O',_S7,_WG,_[/'T*   [4$L#
M!!0    ( "Y36%9-T64K ML# /&'*  4    <VYY+3(P,C(Q,C,Q7VQA8BYX
M;6SLO7ESW+B2+_K_? J\,Q'SNN,:W5S [<QR0Y;M'LW8EIZM/G,G'"\JL%'B
MG"JR#LER6_/I'\"EBB55D0"XJ";BW;AS6I9((/.7X ^))3/_Z7__V*S!=YX7
M29;^\Y_L7ZP_ 9[2C"7IPS__Z??[#S#\T__^E[_[NW_ZOR#\/V^_? 3O,KK;
M\+0$USG')6?@CZ1\!/_!>/%7$.?9!OQ'EO\U^8XA_)?JI>ML^Y0G#X\E<"S'
M??[7_,]AQ'P24PRQ1Q!$A#*(F>W V [LD(6!']OHS<.?0R<(8XO8D(>,0A0X
M#$:A'T(W]@(/A\C!GE\UND[2O_Y9_@_!!0="N;2H_OG/?WHLR^V??_WUCS_^
M^.4'R=>_9/G#KXYEN;^V3_^I>?S'B^?_<*NG[2B*?JW^NG^T2$X]*)JU?_T_
MGSY^I8]\@V&2%B5.J>R@2/Y<5+_\F%%<5I@/R@7./B'_!=O'H/P5%-"Y]B\_
M"O:G?_D[ &HX\FS-O_ 8R/_^_N7F;)?1K_*)7U/^("U[Q_,D8U]+G)<?,>%K
M(7W56OFTY?_\IR+9;->\_=UCSN/3S:[S_*A5*64DI;1]*>7?G^OLUQ'B3R1O
M^5+6"82KU/T\E8Q]F'Z>3-Q[P0]\?H$[W8P6N1Y0[U.VU-C==S5:]/DEGFI8
M9"5>+S L#MUT1%[+7WP4/S7=R(9ZR+3JIZ'NCJC\1\E3QFNV/&H:).R?_R1^
M6A7IT^HFI6*Z*_@[7O_W_C'/=@^/-T6QD\1^&W_A19DG5$C[]1'GO'C_MUU2
M/JT(BR@+D0T)0@0BEWL0^XX#:1RBT(YX@)FS*O?#?L53^/O75L)*C-$R_$D#
MG_+,=RX:RW8Y/<R0F_6I:4_,>'*.#']-\8876]R\(!21SD2MV[_<EH\\!_11
M_(X7 .=)(5R-VG5(&E5 )D;B7AE05-K\TZ\'4.8QUOH23+">%_U6 _!3J\//
MH-$"M&J VQ@<% &U)F] K<O\9F"-AUFY1Z]MCB-AEC +VYNE;,S2^U6\ ;S2
MZ9>S=LGHD=1KZ7=F^7-$,SH%HC75BX8$DSN.[=2>Z-^/:?G7%X/L*F\UPCD=
ML&'SQ*\T$WUL2WCT=4G.F4SU,IML7-:&$J+_"60YX[E8EIV 8?^M)7%>P'BW
M7J_>)<4V*_"ZN$K9%UXF.9=#M[C+LRW/RZ<[,>1*\2?9VU;^915Y 77<T((\
M"!V(PH!#'#BAL)[ON2'!0>R35==G./LYF@NA]#4..DA3?HQ[#0!.&<BJ^:K]
M+!6GH1$VZ9^%9L9YF4GH&.#\(/P;L&W$%S])!:H'>*O">(X;#]^1-UM!)]NL
M="_QCRS--D\"2,>&8BWNH%^KON03AY\@S?+5X9&*(4?(M0A!CL>MY<<)6M*C
M1TG([S@I;U+!N=5<?O4C*588^YS[V(,4612BV/-A%% +6K[M<C\*@X#ZJI[Y
MR^8OS>F6$H*#B.";%/+_5??E3@ X["V/@V5N#IH>$77'=1PR"_FD%4+) 2%[
M(A_SO/(][N.)EQ;S#,\+W'7Z>I[2)ZR;VX\)Y6G!!0%>9VOQZRROS'WUD/.*
M)S_Q#>%B'HFYRV.&843=2'AP-H78=3T8AU84$/G_N3*-J79Z:>1V<PL:P8&0
M'!R)#O:R:RQ<5<%7V#"8 =*Y=PB4T 3?:L$U&%,95HT-@!G@76K%/V[0ZJWJ
M-6'J6\:K-K7<NEU3N:.%NNZ[^DQ^]5VTDA1W8IV_P9]PNHLQ+7=YDC[<W;__
M>/^N&?.!2UUJ"QZW'"^ B/D1)!2+Y;@3>;;G"#L@JLKC:EU>&HLW4H-:;/#3
MD> _@[N2_P(^EDR=;Q21'R;QZ?&<F<*?07DD,A R R&T 8$K JI.W],#NQ!Y
M#XW5&N*)_&4]E'JX6[&AQ9A;3[$N;VN^:;R?*ESZKYR*ALN$%RU3ATYD8P]!
MQ[<91$[D0Q(Q"AT/N99#0^:K,75_-Y?&SM5BL-@+J;T+>@I)Y9W.D?@LL9-P
M@ 9\VPP0J\EN90\$L^](GNI[Z5W''OU/["SV/:U'!HPGJZ:II_<_ZE/KSV(P
MK(B%'&PQ&\;("2&*PAA&<>1"Y-HD]&/+$?]0H8%S'5P: ;0R@E9((*54XX&S
M(/8SP!30S/SM:Z*B_.4/J7[XYHOVHQ<,],M#]OU7\6KUN?\-R1]A_6/U29]M
M=)&/>4BE]C,>?$Y_#59?T+J-J\/6+WPKK/^("WZ79P\YWJP";-G8Y@CZA'&(
M[(A"'"(/VBQ@B'BA3ZQ0=>W5W]6E?=2UM/)B076; .1[@>5!G)18?74P /+P
M,FLZZ&;^Z!O4;N/Z:@PXR KN)D9-?2TU'7H+K:&&Q]Y$ZR<U9'K630,-++9>
M4E.DNTY2?,-T??1;EK$_$O&#0Y#E.MR'S+5BB) CUD2NY4$2^('MLS@(8JRW
M)FJ;OC3&;.7270#MH5)=])@ ,#/O#>INL+!YKN;<BYE]?PLO8)[K^7+1\N()
MTZ_R$RXKYZDZD[9"#SN(46AC-X#(BV*(,;$@B9GO1Z&#2$STOLQN\Y?V=;:R
M@6]8_33_#'*J'ZHI'C-_K*I0&'RSIS2>^[L]ZG/A;_>4OB^_WY-/C;C)2==9
ML<OY;?PA27%*$[R^*@I>%O>/N+S*^?M$WDN\PT7Y;L=O\YO-%B<Y9Q^3E-^4
M?",O.!$26UX(/3DQ(X^+CSX02QMB$3O"CD]M3_/+'R_4I?'%02/IA\:M3@!7
M2H%2: 6D;\HKO<!6* ;83CR<@Z31#7P3LG&02/6T"6<",RMOHBYJO+FW7)>R
MF]G%THF 7N"JZ5A)E[]\.A&V)Z^C3M6V_@[5;SS][Z<-?[^3EU_?_J4Y(.$N
MBD)$,>0.MB'B/(0X$L:D.(AB1!T[L"+5C:F3/5P:'S="@EI*\/:7OYS? U#$
M<'C?:30R<R^[GH'RE^$3)D5LU'>71F.TT*;2"ZPFVD/JU;]GZ^CT>XOM&/6*
MW=THZG_08,<]3P1_;O'Z$\[_RF6,=)ZQ'2W;HU^'(A82F;^!$ J1BSP8N9Q!
MXG#"7#M 'E&.BQWHZ](XKHIF_C/8ME*#32.VW/:LY-;8/1Z 66'3?3KPYMYU
MWP/6B@I:60T(<0@YC8WWZ1!<:N?]_-";:LM=#9.^/?>!%I;;=%=3Y6C77?$5
M?5K]F&"2K)/RZ0NGV4.:_#=G7_A6C UY'2I]>%^4R48&2%YG1;ERB>_%)+8A
MPZ$G.-;R(;9C"GWN,L?W;&(AY=  G8XOC7#WLH-\+[P\;=I++]:+8JG8J@"H
MT$&=2+1,,LS'<P$],SD?,#[(#;J"@[WDX'H^?-59>RZ<%Z+PX3%]/)XGXG43
MU'I(7JNYQ1C?1,DN_1N]KS\7O!>MR>MM5>C"9HM3>=4-I_B!L[=/;_.D*+/U
MIR?!KU__MDL(V=]>Y=0-8PYCAXI)(8P<**:(&++0QS[FCD=<Y4G!2()+FQU:
M):I(<]JJ(3RC2@] GD"CB7 [I2Z@5D:=P,SL-#Q3S([^S%/&'O@Z_*D%OE$!
MO.T W\'=(&S!S #J4\GLAEAH3AG^$DACD$UED*)29Z*9912(/5.,6;N+S36C
MU.Y..N,:&K'!\WO*DH)FNU3.:+AX_+#._EA% 8VP91-(0L>"2%@$8H9=Z#/;
MM[%+O!#I;^^<ZNG29I.]L 8[$2>1U-C!&8O/8OLW74&!E!1(4:="S&#G9BQR
MB^_;[+H(4HE@+$2>>O.F#Q:5K9N3[R^_<=.GQLEMF]X7]*GR"Y>;/V)D-/<P
MB[=/US(-V'J-Z]_>R\Q2N_RI_NO*L9AM<\>'8>0+\B3(@SAV.71]*Z1^&,1>
M8*U>9$SM'>F:(BB-?;4,L5.._[T6($F;2\,4;Y-2?!#".:$=A>2M@+)1J4F4
M!WYJ7RI^5J<:7=L-T_4<IEB&P _PMS??"^FE=Z67?VGE;QZ9#VMUHI\1\X6H
M?V+LM>8#0_1Z9@C=%A>;,PQ5[<XBIDT81351.?(>^&W\EZS:6JK22-Z(>4OF
M"2W>)=_%?SA;!9[G8&Q',/;$/((LQ& 8N!:T M_E3A1&PCG7"'!2Z_7B7/.]
MX')V^)[5NZ25[&(^:80'K)%>*X)'T0P*OOP<X,[MUQ]P%0Q42]WD"@9[N<&[
M&7'5"I*:'M_EXJ6FP%DW=$H/K_XH*L6VE@RHTE/O66R5YLLF%)_B=?GT@?.;
ME.[R7 QVS"FQ_4@L!US;DHF";!AB%T%.+$H=@OS(UPA6?=[\Y9%V)2&(.1<D
M7<LHG?VO.,WB1(=,7@"IPL9CX)F==FMDA'2@%6\4'CHL.@:7Q>A2 Q]-4CRG
M?B_[O7AI09H[)_ QGYU]RCQ_3IRDG+WEJ?BAO"7KY*'.KE;>U<>A?\'K'5\%
M%F?4(Y9,IN-"1","PQC[,+1M9'LR.M_5SJBCTO&ED=W[S7:=/8GQ*CK;)&F]
MJB.U#@89=Y2PMT+7"SQJ08=%,42!2V#D>%@>"J, ,12P@*Z^\YQDKXE^5X#Y
M\/]4+<SJ])9BB9#M!9\)^_X9:$X\9YZ;&H';L=M!\@W )6CN0H#O4NQILR3I
M #5_WB0E:1;/I*2#T:G<2EKOZ_N\MULN<W"F#U_Y0Y40_HH498YIN>)Q["#;
M<2"1>QDHM@,8NC&&0>QQC&+7MTFLZOJ>[>72)H6]H*"5%'QK9=6X!'$>U6$_
M>!*L9J:<V6%2=X\G@6LA+]D,-BUW>1".'J_Y_+N+.<^#XG=]Z.&']?FPBA>Y
MC>.W>"WWD;\^<EY>9YM-4E8]K**8^3A %N2^3R#BM@UQ2#R(/9<(%\[UB'HA
MBX&^+HT;*W$!!"DO@3!EF2=D)[^7 CPDW[FBVZ:"\3!'3HC<S$Q9@R9$!8VL
MH!(6=*2=#CAUUIP0P(6XLY)XHCL7BMKW4.50"XL1IJ(J7=I4?<5T'^)S5N]H
MI&4=SWV;M[6'?LNSW;:X7N.B2.*$LZOB7_F:?<CRKWC-5PS[+ PP@P$5;B8B
M'H,1]RBTJ8=]/XSLT-;<F#"4Y-*(MQ8>/ H)09SE0,A?)5?@3;Y&W06SJ8%4
M5] +P#XS:PL-8*-"F^5"X,T:+<!#I0:@>SW$0\?FF7*=/1+.N1?>IN(MO!(?
MB>++I?G8!DWIM6J7%YVT&8<Z2/MX6L^V+<M',&*V!Y$?4!A:S(,A<2+& \=A
M#M*C4H5>+XTV]Y)VRFH5;^JO5C.&60]]59Z<&-.9.7$<G :\IP'/W!RG(LK"
M?*:!SDONTGG9H/YC)[>/3 Y_CXGP'@*7$<MR.,1Q&,@4[C(Y&I=!"[8=(!H'
M/.3*)2!/]7!I_--)FW4;@ZINP;=*4)VZAR>A'%X@CP9H[C.+V;#1* LY%J.E
M*D,>I5]C*ECI58CLPZ&O2.3)]Y:K$]DG]E&IR-X']>GM>K?9R>NEW_EUEA9B
M!.1W>4+Y31HWETZ_\_S^4;!+4=X+^/A_<IP7*]N);6H'$0P($2Y9@#B,J,,@
MC\3J-J91X$3*-XF,)+@T>CPH(1R*1G"0XU*,<B$^**7@X$E*KDX)9J89IM/9
M 9^9;CM8MPJ 2@.P5P%('8!0 D@M0*4&^,\EX%=G[-G-L!"C=\Q!6W-L*W,<
M?PD3;7>.@JUG C!K=[$)8I3:W0ED7$.FZ_R;E,K8!?Z.U_\536>[A\?K:LNO
MN$D_9#E/'M*V:,L7,5Z*S[P\OC&PSXY1[5&L_-")B&/[8I'CRWP47/C@2)94
MBSWJ^XAR/]+<8IU!RLN;J.0N#WT"98[3HOD\61+'7/Y:OSK;'(95W7)X97/-
M/,VUVH&?6*/?SS)X41Y8LF>7I-;[E#X_51N\/P,AR&Y='<Y+&@$U (5\/ZY!
MV>^W5]Q<O%%K=\H=D1FM-_<.RARB+[SC,B/Z+W=HYNS,./]$@M\FV;8J RKD
M:W8[8XK\,.8.Q#8E$#G,@L1R"0RP[?H6<VU7._O$J7XN;5;8BZJ=2>$DBBQP
M7<)BN47/&$28B)F9$0R9'Z @CHA++$OM9O"$."YS$7@O+-A+*V,(-')1]P$[
MO+B;"*R9Y[9S*!FD:.H=A[KY/,;"MFPV#_5!9I+$HP^+X10>)]]>.H%'GPHG
MTG?T/FZ0F!\G:7&;UK%\<E3<QFTVUQ4F<1"QP)+!U @BV\5B[4(XM!$BL4LX
M\JA2"=B!?BYMGJE$!=6*HQ6VJN*7;3C8R"(XW""3=1_.PX0Y$7HS$V8-W&T*
M#G+*LX:[2<'2R.D_#6A+9?8_/>HF3ERM@$E?MO^>MY?+^3^LPE'F?X7'S>/_
M"IHGVSKOQ16M4BJ)Y>Q=MD[HDU@OW,EJ WGY="<L75ZE3 90;Z4,[W]LQ:^D
MG9Y6;NPCQ"P":1A:P@_% 21^X$&7N)Y@6=]"8: ;'3A>K$LCY5;F-T"*6%8Y
M''DK-\C^D#L"\G=KN713#!2>V)"J.T)+FV?N@^6#.I*P\%XAL*TTJF[H;7O-
M]ZWD/TI Q!?^UVE+54V(]/S1=!/(NGBLW73XGHK$F[!U4XJ_PT_5%9W;^*-D
MEG9_)^%'MPV;2SWIPQ4MD^_5GU<6BWP28PHM[E1Q*])[CAET;)M848 9\V.-
M-'<3B*1$&J^1]F[;:"3YHR+P_:9NHK_9;VXQ50*?UP +;6[T0?[FV47KN%5%
ML'NKRY0\/1K0N<G97,"%&7DTDB]I>'R3^KL2-VDA^J#9)\X2T2AOMLI"VW&"
MD ;08U6 =$1@1#""4>A;N$KE@&W5#8G375R:V]M*"5HQU1?19S <WFP8C\SL
MAX[/0#'8D3V#COKNPGB4%MI84!]"6CL)_?KW;"*<>7&Q_8-^P;M;!P-/ZM/:
M%14N:L[9EW?-<+.\&$>N@V' 90DK:KL0Q[$#P\B.?)L$<6 IQS8_;_S2J*R5
M#WSY![S9_N,[]6_U!6S#'#8&C)G9ZSD.!N3U A!UVAH#S$*$I3Q0M/CJG.(]
M3/7BE<4XZIRP778Z^XP^+WT23S\*]:WWG^X_WWR]^?SABV79KF=YMH6:(>:'
M@ITHBZ##7 J1^!L4KE<HJ H+W\OR;6P15:I2Z._2V*L2&4B9@10:2*E!5VSU
MKU<%[6&&FQC#F4GO&7S/Y37@0!44U6EQ8C078LH!5*<A3@UH>KA4I97%Z%5#
MI2[CZKPV+H9O?^FLL]K^PM?5CESV=E<(9[0HKK,-:;(HRK)(]YF,CY998K*U
MZ.)AGZ>WBKZYYS_*MW*#?14%EL-IS"#S/!LB.XIAR!VQG/:)'1&'^P&.3*("
M9Y3YTB:#K[O-!N=/<N_L4_:=UQMI20HZFH-&=5!FH%4>=+6OCD#$'V7B@^L#
M H=4UV9A>7..G.%)Z0+'P]RG7T=AE8W.PH@GQ\+]N;$@2P3>5V.!GAH*3?0A
MD " M_W'9*\V.LS"0"]DE"R54NF1RYPFG>#2SJ7WS@8\R _L0=H10T^P1RK3
MIG2&S+[0PT3W118VE6+LZYR2O$HT[0+0GHO/7:+K<<[079Y]3XJFZ]ORD><=
M40_\XV(?^4$<0CNR0HB0AR!VQ$]![#.?,4JXHW2/QJS[2W-1#E*_D84%Y-W%
M$O\XXAA)(9G41_^TU=!$>@[$], OZ@L<Q*^F]TJ!(Z_@V^CI7!%VLYEY>O@7
MG&1%+TG^?*[='BQR<NS/,&?J@:@X_2DV^BHSF9["YR8ES59,+_?\6R;\I;^(
ML2(Z;5-)Q2$.$/4M&(M%O5@>(P1#&SL0$==#++(HLY2R1O3V<FFS124B^-[(
MJ'OCYA2,_50_&3@S,_HQ+K/DW.H!8.Y;+:>Z7OB^2H_V+V^B]#T\SL7\;8=S
M+)Q87OPF$RL+TOG"*1<_LLY=PF?K79^$GFO9TLOD+D3,DU&8S(.!ZX8VXSSD
MEE)D_P2R7!J==/;'KC;RVJ;\Z: 7J!2KYN!6-3/_Q\1L>C[HS,98U"%]88"K
MC@% 1Y_)MIM,[&/FK,YLIU?;'GHXV.QA_]'DC6HS^*LC<%1T7DUZ>!5/=@04
MY]S:,4W.%:/T'N>I^'=QQ_.J8F\WH@71V$'8XC"L[EMZCO2%+0)]CP8^]^S8
M#94*TDPBS:5-<JVH8"M6D57A]:FCCOI,H^I?+P3XW!.92HP1?V&05PLL4D#U
MM>.)^D2\L# B!33UHX=4&C7EW'V.WSI/^<JBC(6>YT&71G)K.O1AQ)$+8TP#
M[O.(>KY2(MZS/5P:-]8U6.)]_NHFH_^F+D#(9)&\&"?Y0(4\1715J7 $9C/3
MVX=G0$U)56>TGIM^GG>[,*6<T?HE39Q[T.1R=RG<N[JEW:8AGB]<[D/+I</5
M W^;E66V$;^4)VZK(.*1'4<V=+"'( JC&)* (AA$S GMT(\Y4\[BI-GWI='%
M05* '_@;0"IAY4R?JU=;,;'!\&; C,C.3"I[R<%!=+D-T %;2 ]J\:L_S(NU
MSAWUV3!?:"$_,* G6K@;XM1[XUVOQ04OQ!NI>GQ?WJP)O9F \63U45AM??>8
MI?SSK@[SB2R'.3:'GF]9$/E>!'%$/!BZ%G:B"#G(5EI'GVK\TKB\D@]4 H):
M0C5*.0E</S^/A6-F M9 0OFS[U/YX-(5K4]7</K+0_;]5_%:Y<W]#<D?8?UC
M]=6?;'"1S[I/E?:[[7UFW)'/US*C?_VZ(X=58O6_,IG$[:XL2IPR&<V<LOKW
M[W_PG"8%9Q^3E-^4?%.L0O%-A[Z/84Q<\54S9,/0)SZDOHO#T&,H)LH.W*22
M71HE')?3**1ZH.CH![+Z/W(!#K*#BO4MC?IOO-42?%O+B-]$*FIX+#'>]'J'
M2(L:=-$CI4HST%4-U#H J1SH:%??@:K_]OY@2ZDBN'E56YH=."UJTU<I>S/Z
M.U6QK?%!U63X*QY;C>_O50ZQ)H/IW)'6=!WH3^=?>%'F"2TYJW9P99^.98?-
M#2379C@@-H$>\2.(J./"$,481IX7T"!T.+4LU>FYMZ=+FVX/PC:G(-7W*N55
MI]A^:(>GO\D FWDZZV!5"5K/6U)4S7J5PZ"ISS.3@;?8;L<Y$"?:Z% "I(?(
M^]]?C)B5U.@2K=H+X]9![W]LN>SA/MD(HKZ-VW1/-ZGH7?[I-OX]C7<IX^R.
MI_).;GLE]RXKRO>;[3JK7F@*($@9B_.W>P*+4MOR0^CS((3(]AT8<HM#$B"9
M:3J(B*><4OK5M+@TPJ^5EC[;AUV5GGJ?W"U)0:.__&N+ &@@J/RV.BY!H@#Y
M'@;0X%!]R88Q(<L.++T5V<4.ET57;RT*H!E ,FBE'3DWAY%S>V+D7!V-'/#^
MS,B9Y5;AL@/+;'EXL0/LU6XR\G:PE7NVVG9H*C_0U*X=;-L.3=7!.ELYV#HT
MU=: DL#,$;[S*F947)$N*]NKK%Y?!?YS*]W7$<:LHL?'K"ANTVLLT%XW%1/C
M^[RZ??-4N9+%BG(2. Q[,.94>&)<WDGR,8.^)5Q,[B$;!<K+8[4N+\UMDE*#
MGX1Y"UF*CF8/:?+?@G4$X=".%I*1RD:/>CVM6<A"P1;#SLOT",_L:=3@?JS
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M;9<S/5W:5%.+"9*#G+J;+><@5=U5F0"HF:>#EQC-4O=E (BY-T/.=;_PKL<
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MS9YIPKCIQ::4L<IWIY_1;9EN:=ZL,14_X:?D+_P^H3CGY=77UB6.;1][D5Q
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M'0IC4"_@JU+>YE/=0QGN5,N;V'<]]WU2N7_YD";_76U+MGN865[=)=7=65$
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MSV!D12'$'J'8"D,G#@+#R@0O.E,:@:]1>> @:5NL7+_JP$MH5=>/ID@M535
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M=GNTVV[UMN39.*\_*'"5."Z1&I(E6_/K7P DJUA2%0FP2(I[CC^TI5(1R'P
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MQM3]E2O1! -*X^0FU\?6ZA)+INZR/&.RV>4!3K#C."&'GL<)1+ZDOU@P 9.
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M:,Z>5=U2K*6SJH]#[4A6]9$-C?#!XTQ.K0MUL2\M/^(,,WR9T7;7%J*$$)1
MAZF*Q,@7$#L80Q\+A[AN$OH.-_:L]W2T-J*K986-L*"65D5LGEZK[8 U\&9/
M!-?</FHM)GB-U(C]7B]B%I[DB9!;RC]L/]?L_+P&</1Y;_L>7\XG:Z#$@:?5
MY/MCR'+#RRMQ(5LE.4MY^3DMRNJ"WJ?\B:NYTN9_0C&-$4L@\2B%2 0AC'GB
M02QHZ"!!'"R,\S\9]KD^"I5BJW,-O!/\/1!*=(#WLMN0@QGT)LPZ.:"SDZS"
M\DJ BPZ66FK0$7L4XYJ!:D.^DX.[& ^;@#P5)UNAU$O/9BTMR-16JAV2MMVC
M8W*8/I B97?\%UR6DH:V):_VWJ6(XSAR8LC#Q(6(" X3!Q,8TL"-@B .0V&1
MQO1T1VMCZIVL[\&!M#9).GM@-3B<F@BLN4^A3N TYIRI=QY:)#:=!KC%<IM:
M3C3+[*;#8/0F..UY?,$<I\-*'*8Y-?C^B+MP>?73)M79$C[GQ=^X[.""4E4K
M(<WNFFE*./5"+XBA1%+N<1T/08P2"AV<Q(['N8\BX\($!OVMC36ER( W,NL$
M2?=*:KFW;<6VN IF@/8PBTZ,X<QDJN!KQ0527J %!GN)1["J"8X6U^NFQ7.I
MJW9#TW(BKX(%.GW7[PQ:6>XJGKE*!]?R+!X;?7+52?C_G>,RSS#9/'_+RU)U
M>]E4:+W,+FBUQ45]:67[\*CG>))0S!&FT.6!NJ07"TB$$\#(58D!G1AA0BQ/
ML<9+LS86;X4&;95;==B"6[G5);%&<.M3KC-&S/C$:YEQF/OTZZ!,2;'3 SR>
M/39CSKW.QW3V,[ S1%SZ/.Q\-(^<C4W0Z C709Y5A9Y]FXN[@FM_A.1[Y:SX
M5N1W!7YXX.PCWVP^<5S=RX\JGF;N+4$X00BYD LG@HCZ 8Q=AT(1XB#R<<QX
M8L2^XT58&^5VM "X54-O592G&#[N- %4J@*8TD6=?RME+"SL<<-EX*R8?1#F
M=F-T\-]IH+?@%R_P5UH K09H]9A] "R<'[,/Q%)ND5D&Q,YW<A:6?5Z5<0TO
MYV\Y2_$#3\QY+8T(L>W<T?S"[V2W&;LH2"JEV,CF*>=,&B#EC;HX<HL$PX)@
M#!W&/(@"G\$$L0CRD"9^Y+ D1.;AMQ8=KVWQ.;S,K*77$>RM_*"C /A-JV 3
ML&HS),-+S5Q S[S =#"^:C&^>!N,+0*&9\)ZJ6#B@WF]V<UKW&+^N-=AJGCC
M$8CUQ2+;-+=<G/(()0]BF,<\/^9<L[Q7EPCE_W[ZYS9]PAO>B9KW/.(CD< @
M<(7D?N)#PIT$4H=X)'&1_&M@?JYYNJ.U<;T2LKYAJW[@>W%MSNEZ<#4YV)P&
MK=D/-B4^^D*Y^J$CZ:B3S;Z9:'&R.0URBYULGIAJDU5N'(:C]VRSY_$%SS:'
ME3@\VS3XOCU7_O=6;KV9N@;WB6?Y0YIA^>LUS]*\^)!GK)VK"8WBT/<CZ!'J
M0N2&#!)/[ITCCT;,24CH":-*8.9=KHT_:ZD!5[<\V5YN4&K! 5&2FQ.#(>S#
MI#H]F#/3:X.COBW;$1G4,@,M] BF-034G'.G!W8A]C69J!,1L1U&/91LV-!B
MY&RG6)>F+9\<G16/"UX4G-W@/YM[,$WZ2D8I#FGB0(3]&*+8\2!6138BY+ X
M8DD4>Y%E!KP37:V-H%LY087_;"^+66>Z.P5K%"6<1ES B"82UM##D- HA&[@
M^C&*B4N)?YM)DT:.]B+ )C6PW2Z7@79$^L!3H)J>[$XQ ^?V\AR9?.!=G23U
M=&6$,1D !["8/=O?J?Z7SNPW@,.1+'Y#3XSE8K4E_[S)_]#!+KN-1A"Z2: N
MN22Q!U$2^9!$GH#"Y<3W7,&2P+( Y;%NUL;!VO(34L@ZT,J:*HY":4H3YP*T
MA%^A@\TL12/[,)B;&H[VO3 M].G_FA)ZOSV6#HX$6ER)7SA+*=ZHO&8W!<^8
MSBMSZ[AAY C7@TZDTL"(A,"$<P0I$MR56S?JQ$:^R#&=KXTZ_L;QIKJG*CN@
MS@&89F)3%R)4&9/>,</Z0J/&P91AYD%W9MZY.!(CIHY%'FJY:[0K)?E <K81
M=&0/V-PD92'1PM1EC]5K0AO1QEB:^S7;EGHS]24O2UY^SHO_N4_I_=>\L\_2
MR>*_<YK?9:G\\BWBB>NBA$$>J4L2B8L@%NH )G1#(2W4(&&6%6]'2+$VXJM5
MT(;#1BNAH[_^4&J 3+EP.I:%+M, BITNMIPX9M!,R7'FH9B9)6<9A1&,>0:*
M<U/G&-$6YM ST'M-IN<T=EX T\5&3Q7-WK61*KOZP*L_.,\^;F776761L8X8
MO#XSO^%_5A]4T8%;'/N",H0A<CUI?OIA"(GG!)"R"+L.]J.8&B>!GU2RM;'O
M]?;A 1?/:D.TUTW]5FL'I IMFG'0Z D:1?41Y\[Q<V/N&IM^N(?/B=YL$.=V
MO!V$5W6&\.I@"%\.W<6KH6MBKX!2$GSHK]PQ\VB.B]-:=%07.LNZN>> '01S
MX8.7M*E(JQ9ETHPP[;R<[,!O/4.DUV28&X:"G=_?F\2*30;3J6"RZ3JP7[A[
M MD^Y0\XS6Y)C'&,5,YX',L5V1$N)'[ H$L=EJ D"J/(N&3T8&]K6V"'(EYK
MJ2VX=ACOX=5P4A1G7N'> $#S!6A2(!=:5%K$M(4WA.[%GVDY@8?>"JN>Q6"X
MC<4(WEB=+FF;/S3F3N+# R]4D<)O^)$7S3V3R^S7ZXOF),GQ/2_@F$.1(!>B
MP'-@@MT ^HXK2!0FV N,H]@&>UL;$>\%!H]*8M!<I5+WB*70-G?9AG >)N!)
MT9O[X&X/G!86--*J"AQ2WC%AP8,(VES\FQ#)Q>[X]4[%J<*$39'IO;$WU,:"
ME_,,U3F\AV?ZT B^U1MK^OR)%^F3G#%/Z@@5JPTYZ]2'O75YR(7<]$(:<0<B
MS_<AD1-$[7XQ2K@?D-C(Z6_>Y>J8MY%:VJ,[L<%#(_>+FLOO2L[!U[SB__YO
M;NC\QZ<?/>='PZ-/BS$Q(.C)D9Z;I5N0.Q*#5F1P40$E--!23PZG!5M/#NM2
ME&T^AZ>B;RNH^CC<K*'EB-Q*L0,VMWMR[-'N3UF55L_E35[AS>>\^+ MTXR7
MI5Q+B(IGEO.L#<WR>!(*[+N0Q5X$D>O$D/C,@=B/7#>,8B1<:G>@:]SWVDB^
M%OPO):B4Z-JV)(WP@':DMSVR-1\,TX/:62">F=U-T9TEJ,X:L+E/8LT%6OC\
MU1JIUZ>N]DW8[US;K$B?>/W_F_LBW][=ZX*D'^3O[!O6E49T-9'+LMQBJ;]*
MKU1614K5A0[U356H]._RHS2[NQ(__9GJGUY^YS8BB4=<Y, H221%!A%6,2_R
M5S=Q@SA)G# T3GFTH-QKH]=6FSHK6BLK*+6P^K#GJ59)?8$W2KW^IOG6;\DY
M,KP=7^G(S\SZK=;@7:OW#Z#1'&AAH=8=-,H#K3W8394K ?;*U0_4I<(;#-07
M6A1>?W.=4\7<U%CIE%G(7ME/';:;.E4S=3050**GSF,S=73),)!.PS(364!O
M,((]9M22TBQFB[T!Q%V#[BVZM]LN,9XV6[++3.ZZ'_1K^T5NR2XK_E#>8L^G
MF(0>%-1W("(N@X0*'_J$Q6X8) P[1KN;_F[6MAFI)04=4<%O2EB@I34\"!A
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M^#REC&>L_(93=M5<N*SO(WWCA?[A5A*UB[TH@-1C(40A"F$<!@C2,&8LC*-
M)$9'LE:]KHVP=R)+"RAE[U]<3I6?REV6_E&G#_[IU^_[3PR33-H-BKD_:%*H
M9W<)&:(\K5?(&*+Y'4/#HBSN&S)&YYA[R/SA,[-T"?$!;U0%RNM[SCNYP,HO
MNZJ%KDN1X"Z'0>@E$,5(0*S*+D6>1T/! X0C8R>09=_KH[.#-$U"@$8#H%4
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MP$W.#;6<=WJ86I*K'?39-T"O SF9VMOF;<RFVA6_CCXJ&@0 >08:@_> [E
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M](G?$LY"AH60%(I=B'S%HRA ,/*1[[F1&XI0&)_U3R75VMCUZL4%\_> -TJ
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M4V@.L_,D&,W,QD?A&759^Q1.-M>S)\!KL0O9HW"SO(@]@$?OU>M3SRYXV7I
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M)0Y,$A%![OL.#\(PP<RR2)))MVOCW$\O:D4>M3\'"J*=,PJFMOW4V,[,RU/
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MQT.HFGHYSL9JYM7"'J81#HU>$.9V8QSO?&'G12\"KUT6_5\_RRMZ]<@+K%(
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MF^KV]U)P?=]"JB5)HP#\3WJOK$1;J^2,T3.U6I89DYE7YNYPI(T6ZNXS:_0
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M ^G><)_)',/A+:8)[9D[Y^U1O,SA_')%*E7J:!4[48*#B FK< Y1P&2%,Q1
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M(OJ_RED3HJ,V6JXHE7=S./M<E)_^O<GJEZ^\?BCZCZQHY"5>2GS(HA!!Q.(
M)BQE,(W3"#F8N#AV=>^IGBN,T?2U0 1AZ\ZUVXXU_JD.8+.=P !W2JEZ:!OI
M?307F92"X%%I:.H[GV'-!*<H#"('ABB0URZ1"Q,GP-")TBAR><A\I)U:;E%K
M+K<H_'_(FKIKS&5LM,PBM#UI$<JH>YP]6<%6'U6YLM$(-"KUGUO00*9KV64,
MM>QB5_M[VON*^L_-Y,K,!?'HHOF,+A9>59\/QN&R>X8VI[@Y3:[D'[CFMW_@
MI^H[?OF GS+A \@*][_=?KR]^?SC!Z<\>^:NX[>+"NR[F) D@6&*4HCD\CP.
M C$[>FX:HPBE :+ZF5*F"6'RY2Z3+F6;*5PJ I0F0*@">KJ(!<9'(+4!?P&M
M0L#]L^/_+Q-RG60RG3G/MAFLSW33\9^P)I]H").YS;9!%IO1+'P8AG/8.5 .
MSER3&EYPOCI'\?U9ZJR6S.>F=FU_G8MY\5&-T"M2;.IM1<MMW>'JBE1UB6F]
MBFCH>00%,$T"#Z(4>1![00A3%B4Q3A)$(NWJD^;=7]K"K-N#[*D E Z]"K<[
M+<#OG1X&'#C!1N,3D5WD+4]"EPFZ_J1C%_R%)ISYC6 TVTS'<&"FF=#H8K/,
M=(7[,\P9K4Q)9BNFJLVZ2TV D!\F@9/"*(BQF#D\!HE#??$?S!*9,#T-#1+9
M]IN^M%GAL97.)$GK'E3C!#X= ,ODW.D^I93#/@@F66JG@K$068X.",/4M,?4
M'4Q+N_?"@BEICPFZGX[VZ!,3HA_DF<ION4RUUNSE=#? 5Z[+P]2)7"A<5091
M$C 8!Y$O_N,*7Y4GL>OZNJ=$)WNYM.,?PZREI]'3"#28 Q/;@0121M 7$JC\
M#U+,.5 RB "8 ZVE3O@5:IL^:K3+FC'7&?X8'$-G]"??7>X,?DS\O3/VT8?-
M:>]]5CP+AZ[.GN\>Q)]/?%-GM+K.:3N'QK&'PY"[PLGB"**0AY#X"8,.0E$0
M8)?A1*]PWGA?E^:$[<0%?7G%@H6>'KS& (_SXXRP66;)(<0F7#@8@TZ?-&>$
M<"'JG#3XC)A3$Y,!_AQK83$6U52ESZ6ZKYR9V.>Z*C%?]W*CQ#QU68Q@*BM5
M(X\Z,%$)VTGD<S\.:<"UK_8.=71I7/HJ9XJ4]D__X?G!?Z[/R./S&MQQ*IT+
M,LL\^BIS3R-HD[''>$T\/!RGI>HY [FWR=&S0]!&;IX3<.@FY7G]^MMDXSFA
MQ,DT/*>>GYI_1^7*OJHJOKWT[:5.D$9)"/V485GJ)8(X]7T8I*'KH!!SA%RS
M%#H'?5P:32H!3?/8'"(W3(0SX6&9 YLB!E@)9R6)ZTGE;2=P.>QXX1PL)S4_
M3*-R^M&IWWD32'6'?_+J.\[8#YYN<O9A+0R=I1EG5]7-D_++]I*()@Y/<)@F
M,(XC(JB 8HC#.(4Q#PEWO""(B+_*^3T6B^([$T:8(HW61Y(T'\F!3#8#.%1(
MHHQ%?!*JF++()+OH$HTUF!<-SZVE_ I<\$NI5/CU':!;+019@:+3PU+JUW.
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M:>)S2IC6EOA4 2[M>P__]!]NZ/QG731_NE[SYZ-2Q)0 #&VARQ+V$+9,)4K
M)IU5E?T$#:CJ)#$O:K#>_;802[07H8&5G:5I\-EF)T.I%J:P:9@=\MS$=LP/
M 5^G4[G.OY?%<R8/'X7+)(<:NRN^EUE1-K6L;O%:EI/!/(Z92R&-L-P+3X6+
M@VD ?>KB@ 9N$C+ML.A)$EP:'<H;KTWB(AD/\-0I(%8@2@&YVGB2*G2EXRJI
MA/YYV30KC9\X6L?>,E'NLDE]W&:3NL[!3@G0:B'OD"@]0*,(N%W" /J'F=8-
ML=1!Y_'OH!K^$&8Z CT+Q('CT6GM+G9T>I;:_6/5\QJ:ZHC+I/&9&#!YW<O
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MWXDP0:YA^2R-;B^-OV3P#.L7BGHJFLJUYC>#-##774+.C:1EZMM/J]^'4X8
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M#8:'T,,XPPQ11G/E/A+'ISDWJ[FG5*@2L*55\T[G!*;S7O\R2%E6P0-('_=
MNC ("$Q@I1X<6 8S1X&"PPMLJ3N?\U!,Q! F7G863YAG8!Q;4'A:7R=^J,JF
M$(^V"^&FQF63\[J6)5(^;TKVC3>\?N*?J_I+R?A#6>0%;9]L:["N\3^%(K\-
M8II@*NMJ<\^7NM.7-4X\&(4)#Y(D" E3O@1_.CGGIF,EW=(2DX0W8+UC25UO
M+""C>5WL%GG+.GN/&3#B1G;0;"72,P0$1^ %2V#$DU,AJ6\";H7E:+.P+S2M
MW64YC"=VH04F<;9;+0?(>%=;<%33JB[7PO40_DGO97P5CW+VH4TMWN5?#C7
M\SP+DY1"Y"/9;\Y#,*74AWG@,R_U8^X1Y2I>NI.?V\[6ESUI]AB JY8#T]1L
M(Z',;VXVH;8=A.]0WJ<==L2#CGJP(]_ *]&&6[<HC1W8G=:K485_R5HV^K#-
MEKG1&-)Q!1Q]9E\7QS$8PZ"Q7='0526K'USFEWE^S=<RP'J9?Q83E[+86'_/
MJF2CRL>[@\(XC@.>X@QF'A7[1YK$8O_(F,P<"1@-(AYRI4N3IY-R;KO)CAMY
MVBCX:3I^Y+^V'/7-O@ 6QN"(*8/SW05D.;_MN).0[6.(G7 N6^& GA?YSU?2
MN7@I'<D2^.)6.AJ-\YQ)R547O;U/J=K[E/*ML/#N4QJ5SU\H-+<,IE-=]4Z;
MP%V+O46 V.NWM\R(IY2,*X7@Y1W)),]S@J)0.$)4N$0Q(6(W\R,8YBB*PC3E
MW,?ZE=[ZT<]M@QJ19E)';< ,4<Q0[ <PY5$BRR:$$$<Q@C@D,0E8R&*<WZ[E
M-6+;F&WGL(=9>QWZ%+14LP ,,; =ANS;DQ0*2\>P)-L+IEU44ANF?(,":"^X
M/5RW[.5#)Q;[_?6!_+7W?$F (X;2''*Q%\G+1!G$C&(8)T&,DICB6*-TV.$Y
MSDWKO:C7*@DU+&H[PE$U8',2.F[B,F-@3BW[.T+(L/"O&5)N0RECQ&P4_WV-
M@6KYW]&;;U, ^#7I1TL 'WC4X$;E@Q#5-A?T2SF^4'-97M6RWT97O_$VY6&6
M1#Z#*4IDI7-/6"P9SF'.24QSE%,O5PY<J$][;MJPHQQ4)7BL.91M=,IM10"-
MJWGJL,]K2CM@6E:>/8ZRL7M+-OA2@OW+D9<E$+0#V57JBSUX->X[6H'9U2W'
M?MD.6?PRA;38N_G8K>BV,52WFI>ZWZ@-V]2M1O7!W-UEU&9P[P:C_ML&*3ZX
MN?^\JKXW,N7RCX8S.4^73#RD%W\I>U=E6WE&Q@_:8K[;L,*H_J]P8F,_9<+G
M9RB(( I()%LA!]"/L._C,.815T_Y69R\<]LU9-68W8?7W%?U&HIY'P#C9-T&
MX+I*WKO8W*@,N$8&RO)RGM]^WE9ZMOUWP1QHN0.2/?"39%#L1S^#@4?PT\"E
M_!T8'/X=IVTPO&M6NHN3?SD3\6HD'+VIF%TE(+VAN/52DZQ)8RI5:?E)W:4N
M60-L+Y7)WBRG'51_Y&M<K"0]>54_='6$2;59=U/V)?KE98RR$18'6?%;>1(=
M1YX/:1!PB/(HA"E&#%+N^7F<9CD.E/.<3J+DW/;R_9/0@1TPX@>T#/6?/^^]
M%]#S!/YLRR,9'H/JRU'OC-JJ=)P>49^]8,R.IZT*R%48D-YSMEEQP#K&NL)P
M.RFUC8F[CL*L9;?9G5MO^]O\Q#LF?[9P7FT,LN)QM?[X;W):;0S#L<-J\P%-
MSZH_E>MB_=RTIY"?J_J:W\GU+3..JU7!6@K:0_&AFZ.7X9#D!,:^E\KC;-FS
MC <PS8(XRL,H0HE211]3 LYMK^NH_X\&M$?%0$@--!T'@(Y9Z!*O-$\_C*6D
M>B1L#WO+.]G2L!N<+)MA9_OP69,JQ^?39IB]/L(V'.<T#^'7#:YQN>:\Z<P3
M2O+0CSF"*$P(E/>?(2&8P"P6X* H1XRG)O;_BWG.3>/M&Y$[8L&?-R=8AR_!
MU3/*3X#,J<EM"RTS2_D$U-QG:>JA9VS8'L%$T6Q]^?:;&*5'6#AF<AY[W. 0
M9=.LA7E:WWRO>CL$LP1'?AI!EN1"3U+D06$^8ABF/&%^ZH>4(^4SD)>CGYMB
M' @$Z^^51LCZ%6@*!PJG0&'[/&! 01!GD.SS&@Z- /PIL+B*GX\6R4)^^5&V
MIP+5K]YQ%V<^1NY>F/CH0R9GNT73\*NZ>,!%S3_B1N@]Z4S_AE>8%;Q?9G'N
M1S$)D&QYFD&$TA1BWZ,PH($7!2PBQ%<J$:D\X]FIKY9H,% -/LJK*AW=H"=<
MYR!.!7.5H].%D;1^&OH"Q%<8&MP^50-3YZ!R85"=G3W.KM"E5*H.0I/G@2KC
M.#SBTV!K_]1.YT7C#IJOSP;[ [_R[H*NBZ?VFLX%:=8UINO;+*%I'J$4)CD)
M(,J9!TF68V%F<D9RE(385ZI'9DK ^2GPYA[D[=%\6Z7PIXT\FB_*GX>DF?).
MUC?LN0!_XIX/_<:<>G)2#4;:0]^ZTE\:>)-^GT;H66\%JD>5ZRZA1I@=:"!J
M-HY1)3)YD9&+D?>*1'Z0=5Z*\OVFD875FX]%VY-^+?S[X40@P2BCU/-ACB(.
M$1:>.,;R7AW'.2,IR>(DUBA 9D;%V6G,,2/[)5YIQPL@/3. C;C1JGAE*# %
MV]B%&&RKSCT)]$QTF64]&V#@ XP9,;&BC46A57/,ODC<E1JS)!K=$F.G03I=
M6<QP;)<%Q4YC_T4=L1,'T]^R_E&L[W_#]3^Y/)YCA5RS_6>51SA+TB2'.4F%
M_9X$!*9IC& 2!HC&E"=>JEQ/^.@LY[;E2$+!0TNI/*GN2%578L?1G-\O%L'(
M\G[0PM,1";94&BC[XSBI*_-%\'*DK _BMHP"GH5A0L$>?]>9 ITE?ZP@YQ\V
MC6U\Y'7Q)!;!$]_F,(]*C]RB)$K2F&,8I(D'D52(A+$4XBQF>8A3S",Z-.^X
MT2E\,3VOTDK>;\9QXZHDQKCBCFZ$8@9MU8C$ N"Y:H$Q$#JZ(*6"GT&@00T4
MVX&%&2H<!Q+4,'D=.%!\3]_JNGSDJQ7^*\>K]3W%-?_<AFNO+ZZ'@WF:QAGV
M?.BG;86=E,,,TQCZ+":1EQ-"O4S5]IJ9Z]PLL(Y<L*,7= 0#0;&Z@3$'\+PY
MMB!LEK7+%&(&MMD<=.H6VH(0.K+3C!:?EKFFB,F$T38W@C/339&5L0&G^HJ^
M1OU6/8M!G_O<^RLN%H18+7?\-HU3SF*6P-#W<HC"F$'BQP&,$X11'-"$1\J)
M \<F.3<=VM,)^ALF[\#CEE3PT^[GG]65PE%XYQ7I$J!9UJ #7I\&O'94+@"1
MNL)< BI'FM($,BU%.8?%A(8\^JHSU3A'_%@GSCYK4/SMD4M;]6/1K.N";.1*
MN+X7ZK;I6XDS,8OPH)^$*A)_NLROL+S/VSURF^9)CG.6P\3+*418%DR*J?!Z
M&6*,!C$*$^6XWRF$G)M2_7TCMRAYD:]IZ0-USX-L;-C_3D.CGB2C>:WK"GG+
MFKEG XSY> <Z,L' BM0]8,>,S$7OV.D?="04C8)WCH3CZCJL52'IE=%; -FI
M6GNG#.^N(-\"(.Q5[5MB/-,2IE>X6?--??WX_U5#RCD-Q58DFUQF>19"E%,$
M"6<^]",:YCAD+$2^7@W3UY.<V^[35Y[L"077C[^ __FE^F4B25T=3X7=9 &4
M;.\4+P'J\3%N)W, *-V2IJ<!YK:FZ2O@EJQK>AR(V<*F!UYU7-GT./&O2YM.
M/&N<=MM5V_DJ:^^,3TG"-"5Y['%(>>Y#Y/E""P9Q!#F/*8J",$LRI?NMLS.=
MFRH<2E:MVG)6)QQ#'4-6]?QI ;PL*T5]J$Q26Z=AL)[#>F1ZU\FJTR@<R$J=
M><' 8.+U4T%YT];BNKG'Y;78.S9"?,\7&U:L;QD*N'#J ^CY/I8%D'-(,/-@
M2/TP26.?,,]7Z=N@,)>6SG!P9#V0VY>I7 N"03-0#+ D6<,^F,%9P9Y:#CW;
M9M4 7%<14-(*ML2"BV6!T["OE@/0E9DUOP*7,KG4L)FRO&9&<&> J;&R9X<I
MOF)JCG5AP,O\<K,6XBM94=ZUGN[EHUP_S2V/?41IA"$+HP BYH>0A!&'$::4
MYABAR%>Z4Z\\X[F99[LX:=41"*H=X?JQ4G7D,<MB' <AC BB$ 4AAQG%!/($
M!PB%2>A%_/:)UZ1Z$^S',UL\P=X1^@YTU/_[O_FQ]Y>1/"S*0-5T7A!7RQO@
MB[#_P44]X"G,*7FU[!$_MZ6N<%W+BMGRYR7M;47L;-O=<V0XMK\547EMAZN^
M:+IA_%I737-55[DP<'C*&&91!E-"0X@2G\+,)P'D".6(\B3P8Z+7.6TT^KG9
MW"UIX+&E35?/C$%3U2F&4%C6'THH&&B! ]S:_N+'4SK^N@]P^_I+/O20<=2M
MVLA&%H^X;N^&_BB$9>=CXF48PX"C# HCSX/"L. 0^V$:>"G/B-J%F*E)SLV8
MVZ<0_(D%C?H7TE]CJ1QB.PDAV]$U+7!,(FM'N;<>5'L]L^MXVE'>#X32CC^K
M'T7[&W_^#9>XL]NNQ#=6E25??:@>9'Y.&R2XX?5#4;8_ON<E%^JF;56[>7B\
MWCQ\X^NB;M\=_G8;\S1),S^!C,C:12F/(<:<P,0C+,Q2C&.>JYY7+D[=N6F<
MB[N[NKW* M8[1@#IJ>UZ/0M>8+-Y /66F]T#PA;/\5/56NS_Y,_@88N6S(+L
MX%*/6"V_&.:#@V\J8LLJ4_ &=LR!+7=@S!X8\0<&)KJ6[!V+8,?C]N]O*5/U
MN.6;RM91I/-O1[XZ0$=LOIO^O,&1SWNA$*DU,4P$59>?TUD8UAI<X\"MO4GT
M;8 V5%S5S>]BF;?VJA?D:<Y9"(GL*(,"0J'P!0*("4VC.,%QS)4O9+T<_.QV
MX)X^( D$?UZHF_P'H9O?\$X!Q/)^M3 6ZAO%*9@XTO-:V&BIYV/,3VC75Z\X
M4X['B!WKMJ//F%YTDFY.WW2K:SKRK6LY<R5<H.>;&@N-2;N(O$<X8YSZ,,ID
MC><PBV%&:0R]E'FQ%U,?8Z9W_TEY[G-3;%OR1PTK=1L?Z\(_K_TL@FI9.>[P
MW+4,[(A_!WKR04L_&#-@#VO=BU96,'=Z_^K06GZW;3_UV&*_'C&RD/EL"-_L
ME2WU$1W?Y-)F]?4%+_TA]/>&W>6QR[P]P_J 'XNN!\O-O;Q:5E3LED8Q9EB8
MLIS%&"+&,ICY:0C3"/N)[]$ Y8'JAJ RX;GM O]G. _O_ML>W'8_TH[XMEV1
MD)/T7 7]ZOI*"?[Y#6%I4"WO CMRY9V>EF#04PP$R4#0#*YL(*FN[I=&U)&.
M'R&[33\XO$87TNLZ.$TH<Z5AG&EP':;&:EOK/=-CQG_PXNY>[ (73[P6,WWZ
M(28MVE+>=)BVST,8I2=\Z:Y?M<DF5UVNR<4NU23P_.R6!5DL#/L49HS+J[LD
M@RD6IC^-Y*%#$G-&V6VW=J[78@=2/;&T1*_.Q_>2:HL.;L<DX#V7W2[Q*'F5
MWUWW1;X#A-\592GS@ A>M=5"9((5W]15LWM,.]/*ULK(<88BEOB09^)_4$YB
M2)*8P22D8<0XSCG#_<KX5++_=>MBH/G-5P7O4L/^5RR)E,1>E,20IUD.4>(E
M$+.(PLRCC(>,H53MQO]9+0<GU4)[-@%^L29 MQQ.3!H\ZT6CFL%Q!DO!L@%L
M>14LF5!B61BVLU)LD>\XM<6R%%[GQ]B>T."JVKJB_WPOAQX?\+6_[2D9B&0M
ME<+<;JFY91$.(A:)[\4/9))_Y,$L3SA, Y+*<@ )Y^IW_PV).+=MZ-.^OC'?
M-4Z2S'Q@PP7>EG5]2RQH>=A/6>G^T+,!MGR EI&V]DG+B@,Y:%RB<R /5[?K
M6OB[/72<9@*:]@_#SLNW<GEAKR]U]>Y$1*?NY)D.[>ZRWHG,[]WB.W4L_2WI
M2YFO-KS\'_QW3*ELM##T00C". W2$(8>B\2.@X3#'*<91'Z 49!3$D3*.\Z1
M.<YM0]F2"08ZU?76,1CGMX<%P+&L_5_C8E!=YAA ZGI[ : <J>77@"VD:&<@
MF-"CQ]YTIB9G2!]KP;E'#1+;V/_;-&LI^>9S5?]>E7T5BJNZ>BID]:[M(>7N
M;^/2*$F0LI0'"<S31"A#%/H09P1!3#V6R*!R%GG*>7"GT7)N2O-WV3+F7OI'
MTJDOJQ+2OOK*XY:AT6']^ 'M&C9+B')>(3L4D&7%/>*D/9/\?03^CIM1&LOX
M@:]O(1V-3$%W4G*56#B2ECSG%)_*W*=TX$M::*=9"-ZIU,439W"7Z;@,%'N)
MD0L-:5I=\N))#%@T%QO9^U,LGJOU\]<UZRTR0B*?8YS"F,J^Q7$BST5H ',O
MX1GV0Y3XFG4FIZ8[M_VLHQCV)(,MS4 0#035NO44)Z%6"!XM"J#M,%%74_$H
M=N#/![.BE),@ZI:G7 I,IX4JCR_(12M6JF S6[MR<A#'52Q5&'I=SU+I+8,D
M=ESS]ZNJ8A^+IGUG<())FJ"0"I4;^AZ%*,]#2%@<0I;Q- DHRKQ$J:CEU"3G
MIF@EG: E%&PIU4B2/@;EO$I= B#+BO00-@8QEZ,@::2,+P"6J]QPG06EE_@]
M \)4AO>Q5]VE<L\0OY>S/?>L@<%Y7]5K>86QK?C9?*V^_QVO-ORB:7A7!+2]
MS"A_D'V 92?ZYD/U\%"LUYR]WZQ_K]9MSAMG_Y>O;X,XSIB7$DB0YT'D$PJS
M, RAQ[(@9CA#A"F7%%B2L'/3K1W]X+OLOXK;*\<R'6,EFV*W%1C] #P(INZ;
M=V!5?0=/DG& )>==S=S^1G);/I<.W,L3IHY]0#9KX7ZNP7/;+_A!?-R4ZUC&
M2ZX)!1OZC21MV]J6;+5% T#'Q3L@6 ,M;Z!EKO]]5T.@%>:60;#E$ @6@> 1
M]$P"P>4;B5+#DG\CD;JR^=] M'K>@@7\I_R*):=SYX%8 &G/5[$QOFE*_Q6N
MV]FW"1D\I93&PIUA/I?E?V@.4QPP*"L*1#R01<4T*\*^G.+<=EU!7[^5;A,L
M%LEE?07M]):W#&"6-Z\#6"V9\7F,<]NIFJ_F=9QC>8SOU\F11Y\T+AV(F_O/
MPIIL/@NZOE9-4=ZU:J=:7>;7&](4K,!UP9O+N@ULO]\T\FA7**D/*V%Y%GG!
MV47SI7SBS5J\>D'7Q5-W)A0PBJ,P#R%&O@]1$J10_-N#E.(@#GV4A*%2$1+[
MI)Z;0A)>W&/5X)4T_L42:JI5P=HKTIM22':-_RFH[TS]HF6F.WO"E+:%Y5A[
M"B5YOVOOW/%_;8KU,WC@Z_N*O0.E,$+$N.*ST2Z,:&NEJ.K%<Y"_9?TJ602Y
MY!%(/2'<O%:.M&.S3<X?,0IDX;CV4)%L>7T'Z)9;X1OV2T0.@K<,+UKUT;)0
MK->.M$6_ZPJ4EN5PH(ZE[1E-M[2+E:!*WF/[7-4?:LZ*M:"NV::NH3R-4APE
M,,A\*C8FF2)),UG@,@GC,$.9GRCUV%:=\-RVERVUVBVH9H!5U>/+P64[$6<@
MM-U2:4NJ5,G2@Y\]$S70I6K V-:(,U0XUFMJF+S63HKOF>J8ST4I!B_P:IP&
ME8=^%&4)A3A.8X@RA"$FB$ OPCG#*2<DB?0TRZ%ISDV?W%1MB8>!TG%6D[ Z
M<;.II26R!CDN>N=15^\<!%M5VYP*H64=\_D0;DLJE2G^;:N2@W,[5B!3_+]6
M&Y-/FRJ+UOX9)8_=5-^XI+]8\:X!@%1-MV&<9XQQ F,FLPFHE\(L\S!D)/,8
MB=(@334=9J5YSTV=="FM70L*Z>#(_184:_[0'XR5%:#22^)YSJEXHNS^V3E-
M=[SD=>LKDV=0/<J?%5V?DT2GJHL6%XAEY=3) H\R7-<5J >2!R'])$5T/#QJ
MH+.T<+*MQ-2(<:S5M!!ZK>;T7M=/'_A8W$FW[HG_@Z]6TNOK780TY"A+A+,5
M!QF&*/"$[^41)GL!BY_#D$2^\HV,(W.<FS[;D@D&.M6/:8_!.']XO@ XEG7+
M:UP,4J6. :1^)+T 4(Y.EW> S>*D=2@\@\#$^>ZQ-YT=U<Z0/CYUG7M47\?]
MANE](<R-YXN2??K7IGB4:V!8?S@@1&@V2%/"(?)S#C,>"F47^!SY*?)9H!1C
MFIGGW'3=EM3V=((/Q*I_SU.8SBN]A9"RK/AV(,DLD"V=!MIO<@4J:\"%4'.D
M!8^@MXPJ5(!B0AU.O>U,)2JP,%:+*H\;E/:M"V%+/N+5;[C^)Y=U@^N*;>BZ
MZ3/TATB\, >C)&+0EQ>5$ \32% <PYRB*.5)FH9$N4^%VI3GIC![XC1JS:HA
M.Z\KE\?+LMK<$@P&BL% \O;JDOY%)44\-:KW+HZKJ_J]6WP?!GP?!WQQ1_M2
MA7NU()HJW:LVD+OBO5J,[97OU7O3Q"%OZ*J2L?C+O'7^OU;EG4Q"W-U=O<%D
MQ6_XC_5[P<\_;W&"XD263 B\/($HRQE,,44P8(QYB<?"2+V2C/;LYZ:GKS</
MXJMXE@D874QL1[B.LZHK Q4_WR*RUB,  ^VR%GN'JR2_RZ >53KXLV4!2!Y
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M8C\77FG,B1=%01 G5"][\O!$YV85]50*9;,E$_R)U3M_SP*KJFU.A\NRBC%
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M!K''Y6T@&L(,9>)_@H![7NSE<:+N1&A-?6ZZ7!(/)/6@)Q_T]$L#2YX:=BR
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MKUP:?(_WQ=8Y2?+ 2Z(TAYPE$41ICF"6R9S[W",TR2FB5*ECCM'LYZ9D! .
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M!O.?FU)L60 ]#Z!E O1<@)8-,/ !)"- <J*N%DP$-*].+<-N6=F:(&[@1II
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MD)W/*K!L=^T60,\IV+$J[:>6V38<U4M^RR\8&.ZN0N:@YUG^*/?: POA;!:
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MYHY/+6)[, IC#R+&$<3(8M *F.NX8<B8[YM<^XZ"\WQWOYUHMRMX&-YDGA>
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MAGGN_.4VSUE*7LJ$_56Y4+ZPS36_PS^OTXXL7>YZ,:,LAE;LR>8"@2-T;.1
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M.JH44/, =DR4&U*+#7 YFP",BPE,((BWJ2Y0Z'P0TQ0<T,12O0*!ZL!O59)
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M-.UY\\&NVV<_-90V:<! RAO<XC3CB;J.,))*OZ*=&NN)=; D'^SI!Y(!4'(
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M4FEP4B]@@:UTI3HWX4O3QH?'YRV^ 9:,@XISL&,=['D'N  -]_+X1/(/2@!
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MMSRUD*IAA"POA*JL1?\.9!4;@#5\J-LR \32;QM.#/4\JJTJBGC-04DOJ/D
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M?C UB"Z#S CSS!Q3R2B=:;P&FS4'"M4J(J"JR:P.OZL.:5:_+8?+^EL0DB6
M<U.6J5B.2<T2M=>T9_L@6V(\[.M<;/<!PKLX1@QQS"7?^0E$?D0AIK&T#$HC
M^?8&**78C/Y.CK,XDCNW%VG*;J=1U>6PT5C-O9UR .8=P-M.B']*(NI%86ZZ
M.3VX8U+I1> U=?1?;MTG@!_.JXMF]2I7"->;54Z?Y2+VLBQW*MF]JA#9K62/
MTB E":&09IYTH9#\'_&D,Q6HM9,?!*E/,L/F 9:B+(UF?I-R-;V?)<TTI4^-
MFPG8VD67A5R@/3-1=52HCOWOE0!/E195A"VO]&C-,%\[@I%PSMZCP%8^UXT+
M1N)XHIO!V"=:-)3E@J\97F^K(Q]9YO$T"!',J*^JS:G%9B)BF,1^G$0H"+&O
MM=A\]>2E$=]>./#GA?Z!FM> ]5/8*!AF9Z1I$##H#&J+A*L^GKJ(F'79/*5U
M7T_,H^O==; \)>91O\F3%UATAZR*P34]*\MO_$F:[T%MJ]XE29I0'*L90?X/
MB<"#6*0!9&'($,N0_$^[D<K9499&1'\8MH@\B]XP$TV"R<RL5,NX[Z]<@HZ8
M4Z!DT#AR"K1<M8_<E_TL:]2*@[A3]9(<@J.OH^39>]WUE1P2_ZB[Y.#%-N4E
MZN2WC[S^\_:AV.SN'[[R[:<?\N'K>_XQ%X*KTA:\O"XVW_-296))IZ\M[RP%
M(4T_WQM5U/4;W^Z*=7GGD2Q"61Q CV:H/E^=L13!( H]'\41CJEV89_9I%P:
M[>[KLU1=]%;5]PG803>3"@YS&7:8T1=AKIEGA'V:]$^MEC^#1D\@%06MIJ"C
M*CCH"J2R^_X':CJIU 527U I#!J-EV!PDWH?"S"\ZU)*9S[5R:J%S QI;ZF1
MN<9V6*=D9OB.BYS,/9AMC/I&?@U5//5*M%57R@NBZOS1[5U&0R^B"8/8)QY$
M7!T5Q32!(0JI)Q^8,&RXE=\WW-*FW+VL=:BYJ?6CZF@T AM7->D%6S>X/!6$
M,T^#(]"S"!'K@#)W&+A7!L>A7AT\7H=SM>ZRJ(:/UQN1_X8E8_'+ZS9-2/K\
MOA=@F,35X98@5#GB!(9AE'$2IB*)M?;)SPVP.#:I9 2UD.#RVJ (^RGXAGWM
ML:#,S0\O\+"I3G\*&(-:]",!<E5YWA@HLVKS/2CTU98_=9N[2O(]0A_5C>^[
MSKY*_+6D2>F27:Q6_)ZSU?/E6A2Y=.+87<"](,8>A7Y&(HA2EL"4Q"%,2$;B
M.$1)@IAIE?BSHRV-X@Y5XI]JD0%N909Y*[1YH?/S: ^3X*08SLR(A\+FC;1@
M+RZXG ,^\SKQD\#HMDY\_]LXT5I<&Q^-2O'GG^&\4OR@.J<JQ0_?9+/I7^3?
MJ\KSEVOICE:O3[O_GV*4)C#R4P*1I%E(4C^ (O5C'JKNV9E6^[Z^099&LP<Y
MP4%0BTWQ,Y .D^H40,W,I3-C9))#,!XK9^D$>\SRO:P3$>00#+WY!6=N=9AJ
MT"_\<=;!P+46A39OKO_ E.9K_F'S^(37S\U*Q^."8Y8%$.-(2.[CRM?$*8P1
MXFF6,<R$=J6?,V,LC?JDF*"1$S2"@I_$IGCDA9S5?_OP&Z#UOVI6?.B#=Y@'
M)P!M9AH\A9=%S<PS"!G4R1R/E*O:F*\1FZ@69C\$??4OS]SIKN9EO^A'=2X'
M+K4-'EX7&[;;;LK/N'B4AMMM<[HIOS#<O(D!$83R3"Z[$?4A$@F"I,HK$"Q@
MJLRP8-PLF-@_X-)XL8D1M4*#(ZF!%-LTJ#: MV[T<3H4W40CSP,X?&#0#DG3
M<.5TB+H-7YY'=JJNF0;P#,8U!Q[C.,ZII]3KN*?F?>:<_/MZ5^[3^K]LRK(J
M,_]?#SE]^+I1>;=%P=DM_E$=J?K&Z>9^G:MDQE#$H<<)AR(3TF.-_!ABSQ>0
MHM3+PA1[<:H=';6486G,7:NQ/T*SJA2I#M?\I50!ZPU@C3)@BW_49P=!L=='
MGXYLC3;,]0Y,,3/]-U9H5 "U#E4F5J4%^+H!K1Y *E)7-@;?'%I!?YYP8 U'
M4\=L5C&:6$;BV3/7V#[9V?0S4O7NC#3V4>:3U*<?3WQ=\BOQC:M #-WN5!CZ
M@F[S[U7]SF]<E89@MQLY33[Q8ONL#@%O+]9,E95ZJN(V:_E;57]J+=^.JK:R
M\+T(>2'T Y] A'$"<28X)(*C("19G*;:T>;IQ5O:U/;A 1?WO'P'[G&^+J7=
MVMEM8U8;8"9C#L]K;VNBF:>\1CFUW7BD'CCH]PXT&JKZ_JV.56G_;96/O%>S
M^IN\IJ/IFYI6?[)\6Q,[FD=;4V\$*(Y,C?=ZRE_4EMYN5$_WVM)/E:55(1V^
MM[3\?7Y0=J*UVWQ6Z)E]9QC4V<0\'V#=.7O&4:Q+:N0EE;/(KI!2W>321Q Y
ME6-VBH!>KF]VI,Q9CM6 7_(UO]SRQ_(NP9BD<:"6G7$ 41(+.6W3$'J(LL1#
M*,2^84U::UF6-E$?%*E.Y'5$!G^N5" \5U(;9SO;VZI_:G9L@;EWJD>";U-/
M8RQLLQ?4L!;0=46-L4B>**DQ^I'F2Z6_<[S:/E!<\ ^;[UP53ON2"[6!O2M4
M(<DF5$VB@ DOC& 6T 0BD24PC4*Y#O)0BOP0L5#XNJL?K1&7QI,'H4$E=>7V
M*KG!7G!]MU</\^%%RN1(SLQW&B!:;%'KH:F_+I@<54>N_B3H&OGN1DCUN.-Z
MSW'F81NIU76:S6ZT2(7LS ]?I1[58=/MX<S@P8MB.);4' 50D#"$*(@C2(*,
MPR01/O8\@H-8>[=%>]2E<7;'O;H20(H.&]F[1Z[-O5PS2PRS^"SXNO-<:VC?
M %F#1,PY$':5F3G92VR6M&D*65\6I_:SW*5UFJIWE.=I?+-MR.,#WO+[*GJB
M C%5Q.4:%RK^4J4B!P'C$<TP1#B2+)]Z%&*<^C#T4DGQU(]33XOE=0=<&L$?
MI%7KYS9@W0ALE/&M#;EN>&(Z(&=F\F,,VU#P4XLAGJ:XG"DP<T<9!J1P'$K0
MP^1UO$#S/IL"4*+ )2^^_WW#Z4.Y_<:W6)(:Z[1 ;+,OD0BX=#9A$(0!1&$L
M8(I0"KW(RYB7^"F2C]0NZ*0YZM)X:"\X:"27WU$M>K=YITG5'EWXA[W+64"=
MF9->X]E*W>TX:Y&6J0^L27FC&0!VY%SJO;B3%2TR!*JW")'NLQP6%3)4[[A(
MD.G-XZ('MP5F_!NG//^.R8J7M_S']KTJWGT798DG, TA"T4&4>)AF"72Q23$
M$S3VLI S;4+7&G%I9-Z4LE;;XJVP=JO7\QB;Q00F0<YI/*"2&'1$!G\JH<'[
M_O+PEFC:Q0$F0=413=\^<,".]@JW%<*'-W0JCC9"2'/)?_XY;[+<'U3KW%)_
M^,;1;=8.?8I>-##ZG'\_ZNN5T)2&H7*[$:40,9]"DB0,1IE %&$1T< PH\%8
MAJ7Q]J'56KAOM19-T6I-VRBZL8%9H9Z9Z#OMUKHMU4YT7!/J,+F#AFNF(#IK
MN:8MV%LU73-%KJ?MFO&CQKFO'SG9OG]NBZW>*CJ^BP+A15DD8!RJ+2\6!3#C
MQ(.A[R&2I"$.8^V*_ -C+8WZCKTO)3!X_PSVM6C_K(2V]+M.06WFOXX$T*GG
M.C]V=M[J2 S?9*_*&$MK3[4''4T?]=03WL0[[5'EG%_:=XOUF7M<;OFN^+)E
MC6\38P_1. F@0%C%>9,49A&.H<0T"GSJ)5&@'18X/<322+4]O%R+":2<QL>_
M7X(XS)OCH9F9+E^C8EV\\Q4\QN?A1\#D^ 2\"5PV1]_/(#%\V/WEC:Z/MY\1
M_,2!]G-7VE+<A3J9D)>_WWSY\J%Y ;.,>3[C'/H(JZPI%D,<9"%D/N$BHY$O
M4D.2>SW(,FD.-H*"WW^Y^05(84T_YA-HZK+=.(R<\-T!GAL%CG5!D!,HF9+>
M.+2<TMX+U"8M]G$>AD'..W&K8]8[+_QKWNNYUC;<>,L?GS8%+IX/C2?J(]JW
M^$=]/%LNXO?_\J'@+-\V"4=R#9UXF,#(\WQ)D)ZJM81"F/D>3CP1A1XW; IA
M+<O2>'2O2*?=RSNPJ\L8J.H=S0%H%2GK_"NM-1I*M)G<DKJQ2B?VF9G#YS6-
M1>QR-*ASQS#M!70<RQR-Y.N8YOA'VO+R?_'\_F'+F:3\ M_SNJ/?712)-*61
M=$5%)CDW30.(/8*@SPC//)KQQ-=R2@?&61J?-L*!];Z4=],N<K/;EEOYJ:I#
M[#_EZ^:?-8M^#H'-$DH1#Y#J3((@HC&#*?4C&),D3#G&@GC!G;R#;!S"W1WO
M_S; =>>AT2#./,>T\@'\"D9) OE:S3X-GM4$(W&D>$5WJD6<Q)7@,J> XV(M
M_U:")WEG=?64LTXOA'//**<'=SQ;]"+P>B;HO]RFDOT3_D>^YE5M/KK]DF_S
M^VHA=KF^^2O?_HL7\I5J@V&<95'($8>>4(4+_ C#E-, !HF'DB"-!<%4O[J]
M_L!+FP=:V55I$B4\6.VE5Q]11WZ3VNX&AM#8[)H)WKEWOEID&[G!07!P>82L
M18C7"&*3DOKS0.VLS+XNY%.5WC>'J[<<O\'C');H-U?RN&R_Q?WV#:2J:415
M<:!%3CB[PYC$/DU#&*>I"CHCIAIM(NGD,\*BR ^S4+NPW)DQEL;I7U^ZF.5>
M5',/LP_;8>Z> +&9:?K0&JJ2$1R$'(^/>1>H$3@Y[_WTZN6:N./3&2PT^CR]
MO--Y=Z<SHI_JZ73N4HM]MP>^$M_X?:ZZBJJ78-]S5%+O?8$?&W< >]R+4Y72
M*G ,$<<!))A1F'G"9\B/$VRP#:<WYM(8LA(;%!VY0;EOJOM42VZP^:0)O,:.
MW?1PSKV!5R'9%1D<VA,W0MND,&A":K"]-SVTKG;[-%[6J3;_S$#JVPO4?)*[
MK4$SU8YV"@UO-:?NBQW+I57*K_(U: ,421K0.$,P"R*5$>;%, VD!XM9AA%&
M"0F)=H#B]>.71LBMA$"):,$7)P <9MMQL,Q,K#,@HD^6XY!QQ(N&"!D1X7D
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M L^U<ZHZP!KOL4UE4]U(XQM8:N;)X+B\U%;I5.T1T+U65411Z04KQ<!3K1G
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MA*1OAU@*,Q8ED*=>&B$_Q;ZG3>S3B[>T2>#B44FNO)]:&]!5IPHCJJSSG4I
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MJI5$+;9J<B?E-M@9F\12&AN=KO&?FV4/^JA]S(-&H):YJM[;VD=>T*@%:KW
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MT9D*1DAB\G5UY9GOX]J?BU?:@$H=T.@#.@J!2B/P-R"5 OXO* 6-7OKD-L:
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M#$DJ"3D*L!?[7BH]9JJ]3SJU=$MC\$9!=92I*0)92PMP1TFPWFR!V*L)Y(5
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MRU=CJUJ$W/R%G\IK_/P!/^5;O%)U0'Z_^7AS]?G;-TZY'-@/VT3/F#)?A(F
ML4<Q1,+S828\!&/F<28(Q1'5)F0[$9;&TJT6=8N=2@\@%0$=38!4!2A=P-]
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M!=EHE=_I'\WD@^B..=_WT%3"Z!Y<_JGD7)5,YO_Q/_S8^\^/OP3>+R9U<08
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M'++0)9'6%+\(;9;F&.S7H&$M&%6<5I\'_T%=T6U  ;A2K4-'57&R6NWFCQ_
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M?N/.K"W9>'B+=EF6FX^4K\5^Z)_:_JT4[MH2*)5!JS.HE5:1@+7:=59L&\&
MEH;#N*"'\P^+LX4([H4&J@WP>HBDG2'RIQHBZW:(X'J(D%=5_TH-$54IP4)(
MA5V;: 9A6!+B+&$;=@$]%NAAN==115JJI;G$[IK\@],R?>&_I>OT:?/4GFW<
MR*]0"7>/$^R@ &,H, H@HMR!B<M\B!D/_9@&V(^UTY8;]+LT3Z C.LA:V3^
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M1_2_--9K50"K2@=09H!4*^E6C2J>6BZNQ4X3("I5])VU,78:]HDMHV^9$K?
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M'*+]7$+3-S]BNJ[+AET4!2^+-MPVQ(E#$@9I@CR(,!4P=JFK[E@X$25>Y+)
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MS8]*8'UB.H;C./.?B<["Q*ZD4ULI)=\$NCXZNK39^$QT+)'M"Y1FVEH,Z#Y
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M@T#\CZQ0""F/$Q:%,0^I?GW@641:&Z<W@LO[BO)V0;:77=;[Y8WTH-B);U
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M>H1>X>*@$0P(7.KRL0E\0S)&0@S )I=IW0[ @6,K>0E*)9H]IY69%B;K,_;
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M1Q#3@,, .RE,D8P92V,_)#3!-#%T2)O?\;7F?P;,X*+W*Z@\B@0\L0\98H&
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MC*9]T&+#%$N?OW19C5LEY%97K1"VH&KU4"F[E GZ1MJ;9M:CF7,A7?S$9K*
MM@]RSD7RR/G.V4U.+:!^\;[+*^D$<8P$G_HD#F#@1;&\@9["D$8A23$F::"=
M5_*PZ;718UL-^^*]:8GP'5;CJ\;I""S,2COE)Q=*WZ%@6B1]"AIV"Z1?O)^U
M./I+A4<+H^]>L%P4_:6@KPNBOWK"G&\^%'DE;%G^C:%M?4=0R;ZQVUZT%XD3
M&J4\@6DL$]LZKMC3QBZ':<2Q&[FASY'V8?)(7VMCI$Y<L)=7_ZL<PW6<K&9$
M:^DUU6N@0"LK^.,W4SX;0TZ?X&9$T!+C'4.R:F2>B0,U,1D@Q;$6K+&DIBI]
MVM1]94K.\*PH+VY+QGI#U?'],*4)@J$;,;$;CI'@S8!")Q:;8<\)F>9N^%0'
M:V-,)2- G9 FV:6/H#=.D>=BLC O-G#LY)O A4=Q,<FK?1X^UC)G'^ T5U;L
MT[H/YKT^\IK%S-:GA3[,73WPG#EYR=O6XH4[L:/]R)[8MGCH#;>4^AZ)'0]Z
M82A6@#[B$(5) KF C<>(8R?1WH(.=;0V,NMD5>X@NI=67G3Z7T9,KD(,XCM.
M<W.AMC#=[0"31[\]02?PWB!@^OPW%W"6>/#4B)MIZ:>#Q@ S#KYNC2%UE.@S
MI=;S$VYGHRPC=YG8AO_Y7'1$F40^QQ1!CY%4'O^F$+N"**G'0B>DD?@/T[YW
M_;K]M?%C*R)H9#2XD7L$NG$./!.0A:GO$(L)A'<,%(,+R.>!8^MJL=Z ,;LE
M?%KSH?N_1]ZR=[/WM,@'=W8''C/GJ\]%^1V5M#G1(,_7PJ9W,JCN,K]!V7>4
M?RRV6U2V \^+D4\CF3^0(@H#2BE$C"?0XRR*L"\,K9\_T*3CM3%<*SOHA <[
MZ>7MMT9^T"B@_Z4;66*<%Y?"=V'"-(!V IL:8:Q/LTMA;8E_YQC.1N0\!:\!
MUC9JSAJ=3U&RS_.3WI]6"/3K[YO82SR,: "]2*Y14S^1Y\D^#%,4IRB,6$BU
M$C#LFUP;:7_]_=NWRXLOX/.GCY^^7MQ<7GTQ*PHJ0!IFW6FJ+[WWUM?:N$#H
M7M&S"X2*IJP6"-V+_K) :.\OYQ4L$AO+?M OKNH2D5JLH5P7.QZ&#O)]&(1.
M"A%-'!@'$0HP#4.B%X2KU]W:/L)&5N7'Z(6V3ZLZ<P+@X8]T?M@6_H"/(P;^
M0*VHLR8$T,'$3DF;$S*\2:&;83Q.E;\9>6LJN<C4@-NB>BS9%5<7S';E*JL;
M%9[,O30*')F1E%$'!L3U($K< $8^]U#D4-<W3:4TUN7:2&8OKXQ :*YJ/NQ$
M!G_44FCCQ"2CP.L2SYQP+NV^.@_)"0RD"\[2+#0JAV4FTL7E-1MIOSDAVJG(
MVZNP'UF9/2&96J[+(N8P[*($(\BY+-?HIQSBP$5B?X%\UW4I=ESM^.N!?M;&
M/4)42-JKY'0OK$%XSQ"FF 2^PPB,B"<PY6$ 4X0$L#X/XS1@:8R=S1,K<6$1
MU7Y__Y?B.NY-FPFKA>FZ#U)/S@F.LB&T#$+-YD'-5L#9\2$VTR&K!A9#86<#
M;]L+/AM7X2 $3>-Q\SE'36%MNTW.$K'0;O_=7V]75_R"B(5XE<E1\Q'5;.,3
MAX4$8Q@FL=AZ\T1LO9/0@ZZ;>(&'9+)K[>.+Z6*L;<92FH!NX,M]9M[[$-I,
M/Y,V[&>::YR5[1AA8=)N\._"S]JL5_*F3/>K?D[%BTH&Q/:4 5(;*^;0IWT[
M9K$T*S3F.?X9R(Q78E^$>N:@0HN99HSS81R84,YHW-I\<SX _>EHAM8FW/[>
MHJ?LQU>F*M/\*EJ\5</U,O]<RG+;7?9KG" BKT[ZKHREX9R*B2GR8,A]ZJ%4
M3%+Z%X2T>ES;'-0(#<I&:K#=B0VR'#2"&]R-UL)\?':9'<F%)Y(6Q%9@L)=8
MGN(V,D^Y::Z%IL'5\[E1M747?1S=F>ZGFP T=&%=JQU[-]A-U#JXTF[THCE%
M7^:"X5A5?Q7M[V8$\MS;L_Q>,7I3_(9R=,L^H$I>&97_D6[^)[050V_C,8>2
M.'1@$*72V15AF(8.A=@+XMAWN1=S9Y.S6Z7"*/',()'6!Y0V'U!?KN6^GTXI
MH/)9R(44Z:Z;]#;;X%'>.JD+<*]T T1HU3PL?V [_0QV('/8=WRRL&4S.U/)
MSEA2G=YF1!BK[U>2*H&; C1* :E.\[#\8:^875OI3T66;69IHIKW0YMI+S,C
MU -3WAR]6)L09X2D/UW.V>Q4[YRZ2I/M',8X)%$04@ZY+_UN(7)@ZGL.=#!A
M#@]#FJ2&?K?##M:VFU$RFOID7F#F!<1U/8]"$B)7; D]%Z:$!3!QB(]92*B3
MI/I'/>>B9N>,I_5$=F*>B:"N^W Z*G8<@YU\$S+ ',7%U(\W'1^K'KK=L)G5
M^W9<^5&_VHO7+'O,C@O]VA=VXKDY;B9=W,O&J\M<K3WH^^=/>9W5SY^+_>V#
M*_YW]MS,0G*07 MB+O*<;;^Q\BDCK%(/4OGN-_: Y&)F_[!J34C^Z<>#& K2
MBL\;2CD)4C>!ON.$,(@%62*>.I!$CN?&!+DAX=/O/=E7:&VSVK?'^WM4/DN'
M]\7M;:DVC:"%!;2IT.2"4H  ]HJ!'0SGW+=Z@^$T/'VL1<P535>'=\50.S"R
M%@N GP%3:*@JNKM+9/+9/\6(N=^/F(<.$U"UH#2/TZ:5JL6E_PIKD0%_U.Q'
M#;#@PS\7NY;V=E:V>>GM#;1\PRMU;V?3X0M[;RB7^>;O4U5G]]*5V)2-><]R
MQK.Z*\_X>RY:N6:YE%EL.9NKB$55L_N';:$>Z5X0HE0;2G 2!2B$:1B(36.$
M?(B]*(6$DDC^7\R#4'?3.*=@:YN6=[IUM9=P(^R^MNFCU$^PJE(0[&K*@@>A
M(]PKN7]1JJF_R9C5ZN.;MK>RY<*SY]Z,;7FS5D[0:0:4:J#53;E9FXW/H7K[
M]][0BOI;S+>RIJ6MZ4(?YTQ;W"7 ']@:S]J=M2WU$B#UM^*+M#_'%OX]JK+J
MBE^7S:I!K30^9SG*5:IK\>6H%<3A%MSWX@3[,:0)2V#@4.GHI0C2-(T18SAF
M3&O.GDN@M<W52@.YXWG8ZW#.MGB"B:9L:Y<%WNJV%!^Q@/PG[]0!U4X?*YO)
MZ=C:W Q.D/(--W/3,1W>C)W1[E1"%ILWPABM/@N5+ZOJ,<MO5>'[:N,X7AP1
MF74[360*64[$_BCV8"RV3:'OA0'V#&O0G^QK;30JA5.WV<2'VZ:"KY2@IEQZ
M&EU=FIP%LX49L),1R.\&9(V48XA-H+51+)9FK-,"6":C421>\\SX*^;^F'^@
M[:.@+=7.U8/DJ^KJL1837$Y%\Y>Y^L-[F5.F76Y>E*48.(K%-AY#'J)>"MT@
MPF(MQU*9Z3^!D>.&3IK0V'?9YH&564$%]97UN!?F''%,/J>70BWW9=T4-=J^
M$WNSVRS/Y4>%T=;LKO)9)J)!S%+NBD4V3U,8\,B%.(PH].+4\1R*?.:ZK8D^
MY1KW#NT:J!-I<?,P);YEVXP[LFRAO?#LHM2004E*7M!J GJJJ(JPZH]*F\ZC
M!7KZV/I@M/U2MHQCR0_5&$DLE]2L#XK62$7/2%G>_A$K([4.*H#V>LWD=9H#
MV@$OTUG-6_,JS0%"WXLT2WM3-RF_ROS)8F/T&66E$N1O&2ME;N7GBQ]9M4D)
M)D'DA]!AL0,#WW$A"E,?^HSY81)@/\&&&:^&.US;=J615GD9A+S@27V+=YW$
MX \D9#;.1C."N>[^93XD%YYFS@-QPFY&#YFEMS0C4EC>U^AA\GISH_G>A")E
M3?AF_\YS[Z)S>REI@_V4B:4P@1'#@H 8\2'"00R1EZ*81D&8!MK5=K1Z7!L#
M'88$]*, ?JH8 U^*FOWG?[B1\U\?_^(Y?_G9H"27%O[C:^'945V8C;K0_,,X
MF7YH3"OSW% :U#B;&U);E<Y::+.38[:MT#M7W3,3G(:JGVFU8Z\&FHE:!Y70
MC%XTI^P+F=2XDF'U'XM[E.6;F!*&'#> * U#&#A^ #'U*:2A$XIID8:^?J*P
MEXVOC8@;^53.#O!'(Z+!=?Y7T(T3ZSF +,RA,V.ASXSG8&*)!(VP,:*[4\H/
M,-NK5ZR1V"EA^WQU\ID));:%."H4PG/<Z--O-U\NOUU^^?S5<5Q?_L9/NWH^
M?DS"$&,8)3&#@2 HF(J]+>2A*S3$$7-#5[OVMEZ?:R.RG=A 2@FDX$!*#OJB
M&Y2JUD1^G/ 6P'-A'CP"Y4N9)Z3MT$74H"KX_,C:*A=^>K""O?ASU1(W@VFH
MR+AF2_:JCYNI=E"6W/!5<_+^)\MN[VI&+YY8B6[9IQ^L)%G%KLN,O'",?I#'
M0-NMK*0Q>%H@V#S!$4XAISZ7-)]"C$,71M3Q$R^)G2C$NC0_NW1KFQ!:Q0!K
M-6O\"0]2/QG0TYPMO-N=/)!.2_!3E@/V6!;5_C$#!\3\5A^?8M[4E@M/1IUN
MH+-GIQU0ZKT^Y]NIN#OE@S.<\LUO5OUY[DW-:VE&?!LS&\VCBYEA8,:=OT]K
M<_-B</5G\>4ZF9!I)&?OL^U6=/8Y>V)_>\QIR>AOS6_>%SFMY"TJV?^%F(2V
MTM3MBM=U(I(BUX6(.2D,G!A#["0I])";NB[C-&):QY'G"+&VV5OH 5I%@-0$
MM*J 5A>@E'D'&G4D!RB%@-3((!W%5).-S\DV#+'PU'N.#29L$"<;PR!_B 6C
MV,HQLL0'8I:/Y$PPAW*63&W:7EZ3,Y4_R'UR;EN3K\D@0>4W=RB_^5[\#T.E
MS#_\I:CWOQ8F8NH/[9?&W22,,?'$!A2)#:CK1Q AZL,8XXAZ;H"C(-3+ 35=
M")-OT4Z6*"D<\(WORYB"3YP@]1ARQ>?BR_O/"8+(1Q122B,W0;'O(*W=OQWH
M;2P2/)G=Q0?/4L+%X1^>\NV NO"$KV0$M1 2U-^+!M>V_D(-MKT_2A7:/X_F
M )MRTVDBA(O??3*5R_9MJ(FX';D?-;6E26=<)>+9]KZ;8SA+0N+$,/ ]"@/,
M.4QH*,N1)C@B41)[@6]PEM5O>VW\M1//Z!3E "VM\Z>I&"Q_SM1(-NTTZ0 '
MHU.CJ7C8.QT:&1:FYS_'%!X^YSEXP^9YSC%17YS;''UDZE7-@T2T5P],AM'F
MM^VH0I&/,$$$<NZE@HO$4A>' 8>4,#\*PYC'1#OESWAW:Z.GHA//],[@(*;C
MC#4O4@N3V-$TY#MQ)S";!H2F=R[G@M+JA<O#[.#RH*Z5>]9KECK0C-ZQ'&S$
M\@5+'85>WZ[4>LN<8ONY"BYS7I3W:NA<X.*Q_@W];U%^>*SJXIZI]>6'DM&L
M_II5?S;5BY.8A3Y)?,A\7ZP&$\^'B9>&$/O4)1%-N!=J7Y(_1Y"UT?)A_I">
M-D"I Y0^8*>0VL U*@&I$_CCQJ#:]-E6'*=[6[99>"+HF>5*QRP7;VH6_2G$
MEGDL32Z'7T_6,Q-29KI79B('7P]IS%0*M6::?.8 =6!:.JMY:Q/6'"#TI[)9
MVIM048^)H2G&[:W,COHH&BW*K^S^,6=-1I[/12DS\3S*[#OJSQL>N)$,\X(N
M3<7$AJ($8AJXD.($\8"F8<P2[>)ZAIVO;3+;20>0%$]%A'?IE-6G5^15L<UH
MD[+P2$ZL=_*65@N!00TY4YN-3V-+6F+AJ6LONJKEV@@/^M(#(3[8VTH]LB#:
M!L7[%D3=5AV_/?HR37F+?ME'7R8HKPZ_E)DFHJGX#97Y,VW27L6_B<H>%/^;
MVL;40UI9">GSMOBN$C')2DF7^6Z#=D'$ADWER]Z$(6*,I&)2<8F85%P94IS$
MGC /<A*9H9JD;%/+_#.ZIX-Z'1M-*+ONE_N:OK"ZJ1C6R]#_UY]4;;$L_WGO
M10!HIX+IT:&F170/#.?'>6F7EX272XF;!&X3T9UP,&@&U=+'@9K26#X$-,/H
M]=&?X?L3_.[%_7U!52M=M6G$(NJX##).$ P8]F'B!QRRU$]<E!(2,NVXAE>M
MKVW%VQ/0P"G\"C,--_HY2"Q-(7O9IKC(7Z%AX!$_!Q5;#O"]C',YNT]I/>3;
M?O6./5?V*7$//-<G'YIE#U_UEW4;E_'(B5TQ$2"QQ@K2))!^: Q1(/^2.CRE
MJ<[R2J>SM2VIVJR%,^VS#W&=M*^>C-9;[*.K@XWTC-"=M4F>#*&M? .-F/]O
M=; 1?@?46 1[A9;;!A]%R&S;>]C$6VYSCRHSLJT]_HXYM_Z-T5OV^3&GNUO$
M7N3Q*(HAB; + T0H3/V40^KPB*>AAQ#2SE;PLO&UK?:4?(!+ ?4__5>(C;/D
M.3@LS(H-!$JV"6N]5UCHT]XYF%BBN=[PF(G)3BD]P%RO7K'&5*>$[3/3R6?,
MF(BR;/.Q->IUE^Y9)FG9L"#F280P]$-/)N-S951]FD+$F!_3E* P=73HZ&0/
M:^.D3DC02 F$F"JQC]Y'>1K(89::!9Z%J<H8&>U/<U3[O;.JZKQ5%2-_N2V>
M_BK>57ZJ?P7R1]C\J+[>TZU:^81'E>J^X_$')]P;1UL9XEL7Y,\VX9;C8=\A
M+(7<E7LTQX\A9M2%+@V2D/+ 9TC[MN:KUM?V$4L!552\%'%"NK+7\(TO,LX"
M9>%/=WX\#*Z4GX.+K4OE?7QFNEA^2NVAJ^6OWK%WN?R4N ?7RT\^-/7\[ENA
MBC$Q\EAF]?.'0E:XQX\J)\'&2W&,@C""CIMP&*1A !,J5B*N[[J4^+'+Y*&=
M24C?0&^K8["BN<K1R@K('2IO90;@+"?;1U4"@#*>Y8Q"TM-C5YI2%9[4S,RC
M9P[=$[N90%Z:$5_BVY=SSE,Y#3B6/HH;$L'R^9L&&J\/W71>,E\B?2Y*F8NR
MN^)]+4;6'5(G>O^-'E#.*O8_+&^WU4Y*Q1XH]"&*4P0#BD.(PAC#U(MD:G+'
M2U.NNW@RZ'=MI-2*#D@7@_#0"E_)% J=^."9&7AR3<PPO@A;"-R%R:C#=1?;
ML9/[):X3?$0F .NOZA8"VM)Z3Q_P>1:#$] :6"::M&9M 3E!Q?[2<LKK4Q>=
MOQ0%_9YMMU\9*6[S3/1R45WQ"_*OQZS*Y,!K/%]1&(8HP)!ZE,+ 3T*8)LR!
ML1\EU VQBYA6J+5AOVOC_$YHTZ6D'LBZB\K9H5N8T3MY0;D3&"!5#P?M909T
M%N_91)267G7J"6-Y_6F$T.N5J-GKDS?%W?W]*_[A3N;>JR[S3Z*+^KD)3_*0
MP-S!#J28BM5H0A!$'"<PB6653X<2Q%/#C?%PCVOCI)VX\H,BC<"R(AY3(H,_
M:H-@,7W8M3? \X&Y]";X/!RG[(;UL%E\1SPBANU=L1XJ1W;&FB^>4<^<9_6O
M155=X*HN$:DWODM2SGT$/1+)0N91#!,>NM"GKHN<,$PCQW!9]+J3M?%-(R'X
M:2MD_!G\@5HQC1GF")RZI'(>2 OSB#$^T\J5GP# 0IWRESW;+U!^0O>CE<E/
M/7L&"]!'4LO T&^L?,H(JU35R@1%"4E<%Y* 8;$.00%,PY"('5*2<#=%:>P:
M.NA/]+1"/E!BJB#,JA5T8F704^ :$,.YD"W/#N9H36.((20LT,31[NUSQ1 *
M1PEC\ 5SS_H-^B'YAU4?4%D^\\:S4VVPZY+(P6*]X'(?!IX3PC0(.8R2%(<I
M<4,6:FU;3G>Q-IX04H*M$A.@)Y1MY9I,A:L2*35LQ=9WY9X =MPM?CY<"W.$
M1*J1$!R(>#8V^A[M\S&RY+SNC2K2%W6F.Y+#. RXI4^\:,T#/2QXW]D\\N3$
M6]S5%?_"ZLO\B56URKYP*0.>67;;A0@6>77!98Y0]&.3!D%,/,8@3AQUN8%#
M3+D'>>)[J4.QXY%XD[-;F=KAQN"VMXD06F,[;<;V*U&6&]^-'M(ED3-96':G
MBG1-\$:9+IAVZ+!^!BN-,^LRH%N\>U[)>T\R+KPGOCP$:Q4 >PV 4@$('9:$
MW/ &^U+0V[SBKC_6 5(F$.O5.2_$3\%P[,:\49MVK]1/4??5G?M)C4PHFU-F
MM]G]_?NLJ!FYRXMM<?O\RSW^6W=>3\72F7 .:>C+>RD\@A@''@R1[X0!<[R8
M:U_J'>YJ;4OK5EIP("Z0\AK45!D&=YS\YX-L8:8_C=:44C0C8U*_X,QL\-DJ
M*V,^Z,R*QF@!,E0:9K@!>P5@M!0Y*/.B]X8Y@U[F@HX$27^5):?W:5Q_8TCF
MPJ,7]6>4E?] VT>VB7%,4L)30:0H%O\32#;E+G1Y'!+DIHRG5)=-];M=&[-V
MD@.59JZ791C<M\(#5 ,NQ =/4G[P4\48^"+LUA01_?@7S_F+04U0 P.-,_(R
ML"_,SCO$I=0'J;([N<%%#:3D0(F^"+;ZM+T,QI8HW'1TS[3.-L=L@.4-&K/&
M^.8*]ME_PMM3#[,.\Z#68FQD>,LNJHK557//PTD]0APDR-]E1$P#(84)I0AR
MA&D883%%I,3L6&NTS[7- 8=Y@"FK4;956<Q>)@3.=MH I-29>OEFW"RZ!V*S
M@KTP\R^(\X0#-&WDECY*&Q?$\J&:-C*OC]?T7YT0Y:M*^/+FR/^JE#YMF9=.
MYGZ2I7[1-ONW&D17_/]'V[I$#^T6+48L"IC#!?B(PH"0&*+ "V2.D<0G'@[=
M4#O'\D09UL9X3?UL\1$^-'=9BE*=L30Y',E+9>2#K3H&0;03K36^ZK5@@X6)
ML"U?SD%[E>BJ5,>!0*H!7NDA'VPUF5(=:Z(=#$*>E[>'K<#HJ9_%3.OF,Y$<
MBK6>V+*]B.SS5#^(VSZS*?.9Z=<BO[UAY?UUR1Y01C_]D'')K-IPECB.BQCT
M0]># 8Y2**NX0X\D#@H8]9"O=65LH(^US2Q23"@ZNA??D!(4L%92?<HZ!>?X
MU# #2 M3OY002!%!*R/X-!L^^I0] TZ6*%GA=70\S<2Y(U ,<.JI-ZUQYHCH
M?4X<>W2J?^%S5X;C,J_J4@V(8WZ,F[NR>+R]ZU/R>T;08\6:VBM[+\AE)?-,
MWQ2_H1S=LGUEEG95$F#&F$]CR+'@T2#P?)AZF,*(T"#F,8VQ;UCXVK(&:^/K
MG?IBT[W3_Y3ONVY >+D\P@T076VDO9L19!50">'K MPK./KUD\;K1:]DT.GZ
M8E8\E!:>U58]BB;XAM[(DDM[FFRK9=EO]496>^T%>RM!IL[BESG-GC+ZB+:-
MI^ZJE)4?;EG>UGKX/<_JZI]9??<MN\TSGA&4UQ?WQ:.,Q.N"A*_*E_X^^8)H
M6>9MRFHF%!!]_2H/.E3$!PGBE"0)ETEF. PX9Q!YE$ _35-*/8?R2,LK]Z9:
MK&TVEPK#O<;@4:H\,53G+0:%[DR[<E,O/-M.LO*$6? -45YZ)GP+U2S/AF]H
MO=<SXEL*,Z$LD9!-U@45_Y'QY6+9VMQYE==?&97']IO$0SA 801Y&(0P2&,,
M$]\)H!OY8NYRHB#@VHGKQ[M;XSS3U.24/["]T._:6]UBM5YJIY'6A'S<_3<O
MD!98O*G\+'_XU,>PDUA=D9H50X/B2+-B::M:TJEQ>3@LYZJDI W14&FE\4;L
MU5K25NB@^)+^6^94_)'ANBU(LB%^G+* >#"BD>1<'$/,40AYDOJ8)M0A3/LX
MI=?NVLA5BK8KL610 [Z'U#A53M1_Z1M"2O7K<U0WJ&8_#0);Q>F%=-T@F*O2
M_&N%APK']YZV5P?^M8@'9=V/_-F<4SZ)WF0JH=:]F_+8B:+4A6D<4!@P$L&$
M$QF<BE+?32AS?>UTMX=-KXU9.NGTOZP74(WSRG0 %J:63K )5VA>@*#/,-/!
ML$0R^J 8$<UQO0>XYL4+UNCFN*!]QCGQA#GI_,+R?S_?=V.(8(?SR/<ACOQ
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MQ 0B#SLP\5D@*,YS?5?[.%2SS[617BLVZ.0&2G#IE6M%!U)V_4]=%_IQ5EP
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M"RXDW]H6,7T5)6F15DE0M5KVDLZ52E'Y%)+7RSI=A;E!L=<6Y$I=XWW5K*-
M>\_Z5K:UL^=MS"I6,9U^H%-0)>E1*C:YSRKYU(6\)KHSZU4)>HJ"1M/I^^99
M[6N\[WXK.]O=M\__&<_K EC""N,NA%E[M>V"6 *R(RZ,1;J9>I8N+Z26B-2]
M3.$;1E*/44PA]7@$@R0-8.HZ"8Q"/_192+%+J%G9X".]K&UV[D0$V[V,IB?G
MQ\#4/30_$Z*%)SDC="8<E ]HO_09^;&N+1^/#VC_^F1\Z.'S'*%73ZRDC^PK
M(RQ[DAN/ZI>RJ"I5[^J%HR*)!?E[R(-A&F(8^$16;O0I3"-,'2?A-$F]*5Y-
M?1'6QA\]%Z42N2WZ)SV6C4Z@I]0TWY.!?<S<C<N@;M5W> 3D SO,Y?\SL,$T
M9]XRMG@SSUS1VJ7LV>56V4654US NV8.H*:KS*#A-_%[F2M^RHDUH:4I(0[2
M/<8.$WE=WHN158O%[SZA5W65RW2:N;"^7$_%09KZH9="'ZL\SHS!E*81]-,$
M1P'V<.!AO3N>TX70^O*LWOUL]:A>I\/+E#)J"]I3!ZBHQ9U")C?E)UEM?#Y:
MT!*VHA:4 J\32S9***=/WP)7.;BT: &3"(6E+6$M+N&LCV*FN>D\. >C$"8U
M;#'VX!S%#R,.SFK)?&ZZ03_:/J_RKNI!/ZOSQD<THBP5V\E$7A:.*8&8APR&
MR/7%;,0\!VGO?\8Z6]M.1Q8K9RW9B2^&MB(?ICG7Y[-1K,?GCCD17'B6D.!U
M,X68 3II#[/\SPB>/NW/":*M[<998!JQN"XZ WP]VH0U9M95IL_!VN],]41_
M$7(_EJ5HJJVO%*.0"S8-8,BH*W-LAA!Q-X'$15'J\"A%H6M6Q/QE%T;,:J-8
M>9'#5D!9(D*[G-4 B+KNYW.@69@R#5"9X'D^I?C2;N=7_5KV.9_2^[7#^>23
MD[_T-AI!W8II[W-^+DK.,K%1OFPNRZB[7-?H65++1:EN8JGY+'#<B$5BS<61
M&\ @]<3V/^ <)C)A">/4$\LRTQ#/,^19GR=@'\S5W&ZKWG4_ -[I!'[*NJMQ
M/QLSS!G&TR:CA0UB-3YL=SWQM1DZ*\#FYN)#HXW8KN[4F97ISD=U<5(\0T3;
M_'D^FD>H=H9&SSL#_ W]R.X?[R_N98UP>4GA:+XJT;UT U_D]'-6WO<R7=T4
M[Q^?KQYK,6>H<\IB*_J\O<S%OE2L$YN"1QLWCES7BP+H,-^! 6>"OA,_A0GB
M/HO=Q$.I=FX:R[*O;2]^> AVWP  D$*@N9QT(F7=0X."NJO$!0[R&M,NZ5U=
M /SX#(K'&N1R\;5'0U!6"T=[HC;Q&,W&,#,[ UW9X+%Z>-KJ#AKEFTN,)W);
MM@"H.XT2 M!/EGA3 (&"#,T!7UZ,F\O_>\;-M'/;E8T?>V6 WXI_;@9#O28?
M'UNTH^:YLPV)WN3 VB+4ITZZ;8I@OC#[C+)2';I?LU*M_2Z^(_$J%4O"&S%X
MV/\P5'YCY5-&Y!-906^*#W<9XY]^,/)89T]"02[^5FX"-^!.BF+H,X+$BLL/
M(.9N",5B*PG2V$M9HGU<,9=0:UM*2;V:2RDRYU^[9T.-;G+/!FJI'7@6ZH&J
MT4\^*!1\IY(#2QUE!%FCI" _I:7::K/'LJCVK6KNN6<= >.+H;>PZ\*K'&72
MYO[7M0S(4"9MU0)"+Z 4 U(ST*H&KEN3R@3?RJ0[_4"KX!M83W])\A96M+36
ML&Q-HQ7$W+ /+ UFZ\K:G#\W./W)?/:V)\S212G[_*!\Y.2YRUQ&+_/?OWT4
M*P)4=@660Q9X*4Z@1V)7S,))"K$71I XF/I)S(/(3;5G8<U.5S?+-G(#T@J^
M*^NJZJ+__@TTPAMPK"[Z&C/@ I@N/<.U<'8R@YW0L@K%#LX)58RU<368FQ;
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M*Z7.IZG5^)?@MA?X+<=CF'I]H#PS)?< 7NF\I-N=Z-HG^E +KQ/VZW]\LQN
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M2WVM3927:KO)[G0-V?>%E$+;POJ7UUNR+E?U/'DKY&8KKLGW&T%"FJ0R@VF
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M 'BS]:N+/M1*6.R_?<X) \_)0D=Z;G^+Z$[T.L5_U,&(NDQYJSQHM=\YP)_
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ME *B4#*(<(Q@'F8!I CEH4@153_<5!OUJ.G1HKLP5JO%3J3Y/JY6;+U>*)V
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M3'0:@9L\X#S#00BI" 5$F"!($YI"+(60F+ @3(PO]SO*L#1:;-4 HM5#[Z=
MJ;70]Q> >-QN>K^SJ/GE.D;COE,/R,]^&M6 WJD ?M!*_*BODX):CS>@KXG.
M%MCH4@?BU=K,/Q VE2!G'Q!O12'G&QC+@I%G03I8.]*M98]E),]2_;"BY'E-
MG5=@^)='LE6+H!"]NQ4)XT&<Y!Q&),L@"A&&)&44(A((AM7O&$]=:@H?Z6MY
M*TW_"'XO\ 15;8\A;;*.3(:?O^B%2P_0N=4 /A/"5RG[>[N3>89"OP. &-;V
M/=;"JY3S'5#E5 7?H5?<"TDJHA)EI6](7JM&NH1)B3+K>9AC2"F-(<H$A1F*
M$XA%R)6ECW&2&V66&>UI:9S:B=G<6M;MEV<48#P.KJES8@+(9J91)[2<"A<.
M(C%_Y<'CW7LO'3B(PK':?\,OG&>-[9*:?BC69,T*LOJ\*0N]V%S7-J#X7KU5
M"OQU(R0+<,@QQ&D00<12#FF02*AF%XJ"-$1IDKB8:*8"+(UCKA[O[W64B%HN
MW^TS".^4 )T6;O:'\;#8V7-S@.W5R.N@_G@,:O#G=;/]5&J 6@]'Z\\8?3>3
M<(Y1>!4[L9<Z6^Y&XV$W&I4>!SH\#LYFI"V(AK:E<;.O8G#:*GW*"K5NQ]4T
MO?@JMN2VS=M1?!5M'H\;G. DS=1"$@=Q !$*,,R2G,(@$6&L_AJGD64E@1,]
M+2UR:B??+JN.K4%Z"E)3@W0"H&:F_%;"-MV0$58.YN@(#G.;HZ>Z]VR.CJ#P
MTAP=>\'>'+U\T,3S=V7BZL0]==S:#4&I$'F8P3!.0XC2@$$J,F5R)CC()4$2
M869J;1YI?VG&9",B^-K(V ;OU2=-3X)L2XOSI6-@CMN(9T(T,Q^TZ+3B@<\6
MH8VG(#$WW,Z$QI-==G0"3>2\&T!@P*@Z]I8WFVE Y+Y)-/28/8]]$0]J..](
M*70-D>L[\4XG(Q/;![+M"D:&""<\HQ3F:1HK6B,$9AG+89")) SC&&4X,*6U
M\>Z6QG)[B9NJ/#I.F>V%MJGQ/HKT..=-B]_,%-B#3DM;)U'NR>MP>\@ 0W.2
MG!9+3YPY@NDTY&F.S "7&C3BC5K-%>HSK<5;S@&@;0<Z6\V)8*MW*U*6A2QT
MO-7'=;M8ZK*K7^M0QILXH4F84PP#FC)]8)+"C.88II2DF9 T$,@R1^/Y0BV-
MQ"^8$KSQ%91-?J:!.$;KX-#SQ]!T&^QW9&9>'CIE1@?D#6 [I71L:=&II5.S
MMWI-&F<Z&<JSQY^>+ZGON-3)L#T2KSI=VP[G4X)M!:DS]K9_CF0@^"+*QY7N
M7B\NG\E3G0[FXUK]^D'H]&57HJI6HO[ME?I-+?3'M5J%KL7VOKR4ZB>MWD@O
M-S)+@RQ-U**  PQ1'C*8$X%A'L6$AIF(PAS=K,6M3D%C< BV3"V-6"UO6*VO
MZXSDIOX&RKURH.RTTP</>A.AZP/6BU%]\U$];G'LL\Q1,#G76Z;D"UH5.X3
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M>+*WY1F*6C80VAHSI^',"<\5RT=0&80Q1 C',"?* ,_C3.81"@51#5G9B).
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M@YWO^1#-O=?MH_-E2G1LR@^>C9*W\G_'Y])4^]1A( ;+X!U_TV,9ND'1#\O
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MKLO3F6(CG*EI%Z201"B#2)^C$9F&$(<"XSPA%"?&(0'G"K.T[<F5VBGRQZ9
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MD5EWBUO^]N]^:YEMK\GWHCN\4DV+V<SKT!NXGI6X([)&&N!FFVA@*OPNDW)
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M?H(]GP18E[U2VV_?HS!-&%8;<1HKGL5Q@HTBC0^;7AJ7MM*9?_!OH!HFR/$
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MYN[8TUK!O?-,^[?/WL?J7G3\=;/9""E/B4<2&$4T4@9?C-5.UA.0$LDB#^.
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MH*A"V>J8Q_ISK?([P4H77>^F<MO8&=QV@V'JF)D8XIG7OMLC*)*.P+-D0;:
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M/2R5IH1 E*!(V>@R@MA+$,38DSC&G!""Q_M"[ 5:&@WN;[UW:WA=W5)G8MD
M?=8A*IW4]EM9FUQ;GV535U3MR2=(CC!B9,?X1^8=+Z=>DGF&ZDR/R7A\7?I-
M1DAY0>_)>$S[?2AGM#NF>JK>L^:;JU56ZD6;T,9?<_7T(/*OZB?M.]\T!?*N
M\[M'\7L;CB8\POV8<9AX.GDN$KI& Y,P0CQF)&0^)\:7A\^08VG,W:H"?MHI
M\S-L_:1$ZZ,X8%.?$[4:M96??[^UJ8DY?NR&;6-'(S(S-Q\?C/;HH%(%U+J
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M6SW <Z5(Y3A9-R-2MKJ /S;:R*,3&7F3@CJ[V_H,$5W[LL]'\XB#>X)&1UQ
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MN<[U<ZQP^#U'@A$624AB'"@J(QXD7IS".$J3.,$QB851:O1IQ%D:Q]4:5?&
M6YW4Z.ASA*U6;1X,\*+U JRK&""M9A:9,,\?U.'-JMNAFIDUFU&JHDJVHW2C
M TDZH]1H!"J5P)Y.X.HBHV21T=3I:+G*>3K_J-FE19T,Y+[$J>=WXBZUZF2
M["5?G:Y5^P7S/U^*C>!U[.VM8"]EE:FS<7-1+"@+/029SHJ-6!)#S&(!HQA3
MX@6AQZEQWKB^CI:VR-6RMD'LZZVTYF38"^OP8C056#,O,PU.M9Q@)^B(8Z!>
MP,S7A:F <\3XIR;:1 =")FCT4'/OZ\Y(UT2)+IT:/3]^9U$59UI?K]<O@K]_
M_?1#E"QC:B_SB;#'F^K _IY3SH7G$>AS?784BQBF?DQ@2((@BC!/?6R<"\:\
MVZ61Z&ZG4!6H6X.L$A[05[5UK\6O4DPK!4!1Q\;\E.7-PS_;VYT& V.^"Y@6
M;F?6?BTVJ.4&[U]!*[G^HY8=U,+/@JZ]]3XMRLZM]+/1'F6-FX-F8'4;-.;<
MNC97\)@5;?'V>261]VIQ1,I*9C)*H1]QJN_Z>I BG\* <YD*&H5):)G6X+"3
MI1%\4[=W1'&87BB9%\=8Q#&,$YU)#5&BDU7[,/0H)M@308CH_:;8D)4C*+==
MS0?EG>YC NQ,SP#.0V3FY<QJ7HTN_WRZOLM\OOPC/5^DQ'-?.1BC9\<RYU5.
M5J_K;*TO!5?UH7/^Z<>SR->[ N<4I8CY@D")M?N="@PQXQ&,.$,\DCB)4B/C
MV:;3I3%K*W%][;ZJL:%O&HE::I.JZ./Q-Z60:5&=F5+.!W0$SY@C-#?O&$CB
MF(?,L3GD)8MWQ_+4Y[9\4<U['\A&/!3E:YO"+PX13@)EYU%]55*P!)* ZHJ!
M"9;,CU$2&)T0&O:W-';Z_*;@TSO &GDM_7ZF>)M2TF0HSLQ&YP X@H>,8)F;
M@OJ%<,P^1H@<$H_9:U.$65WGV4;W4U\HKF\!W3:7D-?Z=$A]Y\^EJ%T=32XW
MEGAAPC"&41AX$,6*D"B*?4AHA*1'TL1/SPC!&B'1TGAK/Y0HJQ5J+VVW=_/:
MJ][K.JAA3ZLIDO&-&5E3_G,X7C,SY/Q#=690V!GPN@P8&R/F!8/)SD"U/]#L
MG(;MCXJ^Z /[]>;#RWJCS-.R/<6,0H]$22)@3!)M+*K!(YQXD*>>[Z&42<*-
M \N.=[$TQFVD!*P5T_S<X02&PR<XYR,S,[>UH&PE''$7Z00ZYB<PYZ/DZ+3E
M *UI#E/Z]>\Y.#GQHK-#DG[!NP<B T_.EN?Y2Y:+ZXUX6M\'+/!\/XHAETD
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M#@2.$JPV?PIZBA,!)0L]&; 4\\BX6NXL$B[->MNO*=)1$S1Z@KL"M)J"KJI
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MD'II*'"LK'ICTC;M=&FL'7A^"FI)P594<XXQQGJ8N.= <&;F5B*#5F;0"GV
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M(AA&:8)%3!(2:+?H,1W\U$AS*S\0&P7>@XT*[\&.$OI$86R5XS3K$FO'[#N
M^9,&S!;$;(RW/E^[Q-T3C1OB/P^QV^(VPO?&M_3F!FR5'7H'ZWM,J..EXM=\
MI8IJK]9E4U9;?JAOD@C3/,<%3$E!(4(D5'M0!(8L9YP*%HE"VT<<&>O47,*V
MDA=O!;0H074 U>,</R-6CBE]4'2JE15NA 4?YP;.HGC7= #]5^\R!M*N?-<X
M-#KUNP[<P7\!KW%5]E;P.G*);12YO__5'5[QR[;DP\>??$7+6J7X72R;/Q!<
M<]:E 0Z.B]Q$.&$DR!DD*<X5WR*8)XS"@ I:A E+TSB[>>(K4NF'D"=)9/*B
M#.7RP<O50Q>@[#Y(HMYH!=Z52U KQ>K#AU2=F##%"98N,X<!BF.(1"R-24,.
M"0_"# =IDB5:.?YO8$ O9WBV@K\'RY>V?#NSZ>X">#.&'[\MH6_@WOL.];:
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MDVVE$V[P:0'G0856"?"N5^=OH%,(M!K)]21H=&J+S VT>M]E(6P5\VHID]"
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MNZ!H+>>PWU;5/U5$],>2J6KA"_G-JCWT?78K1VR^=B-GEU2$E,,X5FTD@[B
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M/(EDR-MJGGZ]VMP/L  6*/K;U N,_6DDB'U)C#-)V>0MSZ?;DONKM@*&?2'
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MU3*<PRJ]SW?OL?%0\=+IP(E!KYI(5IK,9!\)"U)9&P&4&:POQ6-$CMU48H#
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M66**$Y\I!C'6"^)T,L0DL!"2AR0':[W8CN0)OJD:Z*3O1HM3O<[:AN![A<A
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MP'V;:6?'KM^MU6L$77SF&T'OC!_>#_Q(N9,,#W0%D1)9VJI9408T&IVE9A#
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M?)X^%3'BCW;%^/HJ;9NYKZH-(8NX\^1\YXB\W3J<^AS+KC$!\*R4H13P!4W
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MNWG3S>,RW#X!WI$KR'7*Q42(7I&O7_-C7$U,-LR181*HM&QS7]C#5EHAT_U
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M6"NR_TDC2SD:U>;R\[DU>JM N4D3N5WL_?T,^GMGHIX\&0-H(UGM&^#!.>M
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M3).PR)_H)U?O2D-.O$?.J^6RMBNIO]Q&AI8)JYS)8%SM/6MB;;F-#DS03(G
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M>D@8_W3L&9OZ)K0;8[R<K8@UOY#P[CBS:U"\F*_(S]$)G0L01<T<,=F"-Z(
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MO\]GMW/7?R4^9VD2IIM8R.-;M7/O;.%D8-,)(VM7BCHWRV@%6-.'<[1,!-X
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M2L=QO&\O*5X3Y[J#C4&5>"B04W)T1G'R$HOB(*777D?IF.TM$-F4Z*$AVC6
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MQ9R<Y\=/J0:@Y"J$',DSB;+V6PH9?'8<,,3 C.?DNO17!-D1DT/O>OW[CV-
MRPC7S=:@<,+*+!)(9VL*DC,0%=D7W-IH$N_W)F0'@4/[ ^. SQNH/D"7HT#D
M#MELZ_U2,)A00$1)]HA0"IRR]*6X$DK)DJ7>$G9?I')<V#P$!,_++EO1R"C
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MN(3:XA-9RHSUEK'_@[2EW L0K[>EW$<[H\+6MED"(W.%.5)WT:&&_,F0,:5
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M!X<I@U3>B92)>RC&>L<.W7SK<-1 @!Q)F@WQFG%V]HX(N]QP<--7@CCAI;*
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M0Z*,A_!X$I=6Q_8EW*(0(04H3ENBII")+ZR!I 46G7Q1Z3F.PYV*.[R/YW0
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MPEGR@F#GI*7'&CD!,$H>G&1BO$9JQQ)QRGUY^T9X4&Z;9Z=$ZW6) ;A4A6X
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M9-2$-^/(>"R,+I':BK^X8(2NK'6C]=:9?BRS%7RZQ=D/D>4D$/E$5%=*H>N
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M\(6>$(N%6SH/4HEPD/@WWVVG?Y\BFP=%? 2C6@OYRW)V*5G5!G;74Y#&)U-
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M$W"M=2"S#.BXE5EW"0Y,L!!K-$P<P\HI8H+[+2',,B[K)*W:DHDL@N3!)Q?
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M+'(+VCM1YV4%<"@0=*C36SW/:;X([\-;; VXX\7_+*(.D$7KI*&-3?.9')Q
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MWG^^,T7C=TS+17T+")=CL._&0;XL*U/QT^*&H5?)BKF8+$L!+JT#)9*H]D,
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M9X'[XK&24[RG@VX57?U<)(B!.V:\IZ^A3_.RYSX+^\!EG#X+^\BQ"Q7^@2X
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M%-J[.H'@*02MO$,;.@C]SU1#V(<GX]<0]@&PB?>)!^N)!/ID-?,0Z$(A24*
MR*("S7U,)4BF[S:L^E<-X:3LZ5Y#V ?*)DC9/=,1'6-:.@O,"U=;2/ Z^[9
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M^" :9'1;.T64SQH,'<_*^N25[)(J=_\GS^W*' SY  J;&^[PU]W52X.2R1)
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M#W7TT6,#R+]^LXB:?%FA!5B+M =R2.!(4(C))EG0&96&"W'-'^H8!_F>>FP
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MDE!49%IR+47J]AKU''H]] )YWUX/?33>Q$FUNPMH9I@BRE33'.L;F,O@8PR
M/&FC@W+63=98>O]NO1.]'8UT&1Z.3)L$N\I["=K0<5U !BEK_S$!(2#M&=0*
M$_-9F<DLKB?5H;<7 SIWZ.T#1P.=&]]^6M1&==K0BH-3U1@P!J*K8UVP&"NT
M1;7+CWQV'7I[ 7>_0V\?+3: ^^LWBRPE9S([0%7?Q7E00)ZL VUM=DG4E@M^
M,-S;[=![".X]M=@ [E\_+R2C$RXHLMJ8*1>/UC$S7S,?"GJC,<D=GM.SZ]![
M".X]M=@ [G^\7%BD^\XQ!MIDNN^T2Q!E1$!79<DJN;!C-LRSZ]![".X]M=AB
MAUZ912Z%Y"7!:^9;2>2]!0O"&8/2<*_P3KKID^_0NP_B@^BO";_A$0_K)F+*
MN$S)&@Y.5^4DJR#ZX, E8WU@VI,ITT@\X7VO=+&) M)CO>6.@5\3S'QU,;_Z
M5E#SL0F4&1VO\P0!K24167VWE'0"<[0J""XUF["%0-_5S^WXC$.D^T7AHZ(Z
M\Y5:AUJ>UN&I>/JI-M:IJ2';?) 37.5M%2.)7P/KV]]_V'S&L[/C[7C5A;**
M%[0)4BR9[AX;R%%P=''$'*WS(>74I7IX_Q7,[8"-RK\)P>E/07]!P14>;1<U
M4%D ,1I/SRZGK;[;)I#0K\?G>;DZ>I%/EJMEC5]7?.LFK,_N7\)?>/HQ+/-C
M.](+CL8'#B'5*FVO$_DUTD")5F5I,I.F"U?'7&/C-__A;&X&X#9LA:MDO!I!
MNMC6+W_67S^&S=DR+;\'VM*/2>VD5,6; #)*\MV0<XCH)7A'GAO99C7\.9GY
M,(! <[O84UD44V-_Z E_\.'^I:9\7F[\M]>)?H]$3C]A6A^MEO^#^?5R@^GL
M^.>[U<?-NO9XWM1;<6$]9X8S!TS4)ZN:".V-2%"+['V*LGCLTJ]BE,7-_78P
M^G$^/Z2--.FN5EI=^X?5)[*]0E5Y%?G1EJT+KF5TB07 5/,.='3@N?#;:4M,
M)>$%[HA7C!3HW%.(N>OQ)SJQ)\%X]E/Z<C=786E'?_F&'W&S7#]J>_&<B^&.
M0_:.]FPI)!Z/JCY':A:L8!%SAV-XOZ_/7= _^CD[ 2C/I)+CEZVYOK4UXX6&
M+AME7ZDIG9V'S3(<;[UL^G$7CO:$-1R#KG>.ZHWQ%#Y_W89T(MJ( 1QYD'5Z
M6 3G&8*12D2EK$*S8\SS/V7=!H:2T4<&PM8(HF2>/!%%)ISTQMJ8$O?392X_
MY[J-/IS<LVZC#Y9-O*/L3H7CUM#E:@6P$F5MAY(@%)^ KEKA,QKNW72F]=YI
MJG/7;/0B0\<TU3[(M$FPJZQQXY+0J3ZI)Q(D>@4^UC%^NF2GG&/A;OCC7VFJ
M_1G0.4VU#QP-I"^]_;0HJ@@;E*$5*T\.@4:@$YW4DI.72BHZV>U] CV[--5>
MP-U/4^VCQ09P?_UFH;W50IH".F9'GEE-L=7< *,CU20I4V;_#&FJA^#>4XL-
MX/[U\\+HD+A("K3(F6[3(,!QM,!TQ-HO/+&[(]2>99KJ(;CWU&(#N/_Q<J&C
MP*1\ 5I:S=8K$:)0#&I44IFB4,8=0;IGEZ9Z".X]M=B$W=CY8=!A"#X*#T:G
M "J@@2!%JL,KM%,8G<7)7AH&35.<N\KN,/=E%/R:8.;^P0R3DK+UV'7)D$(M
M6>Z6D>EEO#8\5=M]LLZ^HP:L6DA:[$6K 0-6/3">-0!;8R.O,=4;IF817?[S
M$?$^X>GY<9T>^):@^?5!^N(U^L.JQELV2UPE?)'_S_GIV3:W;L%\X+)P!LR+
M7,?YDEID=5J9R[5*0@7W6'Q@T@4W?D ?1O-VH6_B?-\EW(O-\O12]E??PNH(
M3]^M7N/)E:E&&CH_^;Y]BW[L@#!&<5,GJ&?#JL--.HE6*>(Z&M32NZQW5%V-
M<PF,*NG<#M1$-T4[;&DDGZ>K0MXN5V&5Z+_KH0ZKH\_&T%E2,[(5C[JV&M%0
M?*%;M@2AITO8'%'.N7W0QK;.V$P9<./,W(OS_.0D;'YN4PD^;NI_?ZWBJMTI
M^VMV6\DL/3/W4-+\^12N&&(F"BB:Q_IN1WS.+$(*.=7<)V?2L\VGJ/;J;K#>
M_'55_G!ZNJ83XFS[W?]OO5R=_9W(1 ?8SI39BV&$"]*;2XESJ),HZ8P0!8*)
M!;C/D:MD34#9P2D986ES>]F3T/2V.S(WO(,Y'HU< !\OOK_M4$U_^K4Q\.[<
M\CENAP.6.>O5,91ZY[]71!'H=>: *C)0WBD(FHREF 4OH5B3S(ZHVO.X5W8;
MO(]8EI=OXT*['"4#ZS29NZ;.$-"*@^;9*2F3I.-ECJ!#E\4_V<NE#U=_'Y 8
M'.,F'J[J0+-Z66XVU7&Z*&K>Y;]MTXBD38&S4,A!8M5!P@!1!0^2I'-,*AGY
M9 9EGX7/S=YQ:72/M:-A^J08>Q4#IQ,@UK%:D65!\AD/P24/J0YGLSP'D2=[
M.^VW]+E9.QZ-]F;L'I@VP=G_^+8^/O[Y85.+C8]_5FG)]WA0O& 3X\QHL#(Z
M4+HV1Z[M15%&D9!G&Y2<BK*]5OY4&+L/C>YQ=CQ,&Z+LUU5Y1#"K<N!&*O N
MD,>L P.')H(7$;VMTNG)*E$ZKGGN0.T,-!T6QR8(^H@AM;V5"J;(=$U-5IY?
MV%$AZEJ]$X2VM N5G2SVTV&]<Q-S8CMU: 2? BVOIH5G9J**$9PFKJAB'<20
M-?B$T@6#=7QT(\1LXVH?G"M]V;@'<$WP\?:SX]U;YD,\7AYM0;QN3!I4$+7C
M>'2D023&!(41;"$+193DK)ZL-V*?A3?.SGVX<X^?HP'9!$T?\BM=RLGKG($+
M'4'Y*"'(D "M\D9YM,[DJ1AYR.O21$E+$]S:0R#5*N4N=T^=ML#IHQ!2W3U9
M18AD'0,6+:U0:+V>+,#1K+,]" ]ZS 7K \I3F@LF3 FN1 ]>%5$[#!@(PEO0
MM"=IF^IH<I<TY^<Q%ZP7R/O.!>NC\39.JNXG_/OK/+N2C4F69TBBOLB2[LCN
M\*1/Q6TV.FLQ791V'P%:2FB<XEH=&^,FF/RK(#M?O1;">5;J*ZE(KI;#T/:/
MRFJ(3AC)&:F23Q:QZ;#>V0_3T8ESCZM#H_ALDFEO-^B\&:Y^>CO+Y]YT]=,7
MQ]N=4UMXG?T#<771I?DS+7[[-CQACM68RY\C]VHR..;/R6(FZA#(X4]9T793
M+H(SW(.T:)+*T4@QV8-B&SE9#]<HYY@QU'ZW1:HZ&[: 8T%"M":2L6ET89.%
M5Y]U[[0^G-RW=UH/+)LP@!Z<IEVB]:Q6:26ER7BLPR,8_5(P^9*]"VRZ*J4G
MD$4U#"&ZS[SO@4ZK-+MT?E-@:+4A>Z\(!LH:A%@80E)697)?9.;_>ML:A <]
MWK;Z@/*4WK9TDEGX)($.?$=. /K:049 ;2SOA(XVZW^>MZU>(._[MM5'XVV<
M5%WK1@VSY#N2HQH3R:-29E5] B2*4K126:A9TN>??L^>PZ[,,?!K@IEU(-*'
M\CD<X^E"BJ(RRQ(RC]N&%+2+6<E0&]^9S(O@:3+WZM:Z9C_L1@%_Q_">_9!H
M@D:?"!1:PC<ZOE_C#SQ>?Z_']N6KQ *CX"2-!>7J2*&$$8(+"6)0PO#:6P_3
M5,3Z[4H;/\J&HMIP:#5!OL]X3/_RZ _2U"8<DU"W9[[]P"NY;-*%Y^(!E:%-
ME>AWGDL.7 KKC,+H^61C>[LMN:6DBQ'I. )^3?!R:\A^^(Y5C-71Q1/KE3 R
MRZ#1&,B)F9I D,!+KD!KEGPN-HGI9AO\9ITMQ2='9.!02,T^:8E.]K/->3H[
MWY <VV&7G^B )TIGVE:?ER?+X["Y4!C7%G4Q$B339!#73M=!VPQ>"$?^4V#:
MNE\)N--K[?S!)S.W;A\FC:?Z1GI7770:V@ZI/EV@EFAEBB"+)2LAN0R!O"O(
MOG 5<LHA[&@P/U*UX:V%/9F9<8<=5GMC,?.CVN[!C@?.=7226V6]@)02J3($
M!;%6:%I;1'9>"G.W"7:/49T33.IL88+<OB?>[( ^D_ER;T[/EB?U^G]Q4ON2
MGZ[+A=YHU_TRT??L8DC[-BHY8<+$(<N;(R%B,'7.G_" I7B6"@-G)-F>QF>(
M.BHHSFI'6U9[-UG M(V$A[=AN;FL#KE![^*)UR:O//H"@EM2%N8Z"-,;2#$)
MQ[Q/H4SV?-EMR7._;$["R]^_I@^$9Q/^_I^A&O]G/R^F487D7; 20N'UM<)Z
M\"9F**)(1&L4!C<5&V\O;&[.C0'^/8;MC403/'IQ=+2Y> _XLCS!EW3%704^
ME74J9])%8BJ!8KF EYA A*P5TPY%F*QT\<%5SLVP_<&_WXAW$"2:(-7?UF?O
M29#-EV]A]6&%_XEA<U6Q2>9]C$J!#;IFL'%2EO86"C<^I<"<3).EHC^XRKE)
M-1 3[A=D#P)+(Z]$N^<R6L-HR:X *E_=RUHRXA2"+C9)EE/A8;*XR_XS4R>*
M^HUV)1Z.31/'V$-3P$1,)0:+M1<7[4)>AVE$FT&S[(HM'J68+,3\I*:F]F)
MYZFI?>!H8)K>VT\+S4PI3MCZ'I_K[G+@!.G!.LX#_17W88?W^.RFIO8"[O[4
MU#Y:; #WUV\6S*44#=**??*@1+!T?3-#KJPA1S8E9N*.@^/934T]!/>>6FP
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M1T G2&#M! 0D_NLD3#:\N,#T8+BW&S@Z!/>>6FP ]Z^?%U(S&:1QX$7FQ,]
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M/]8FN><V9,&-,$PY26Y*R>2F9".8*2(A@A:E=/'<>]S2Z#LA'8B9@UI>]BO
M%X/;71?/FZYGOW\C^:]6Y%G7/_A0/L.TJHC%!:[([B0-$:R+3$K FO$2F=<&
MJ_&9>!1)Z]"E<\ZI]C?ZK,HA$7U"T8X0WC_%<&KKTOEW7/RXQ8YU:[_+2URD
M"4RWK],W#6[/LZ,;+Z)@BF[!^F(0&<@26?;<!B-()IW>_T^PM='G.IT&U$,*
M=(1XOGU./^'%U;3^^Q]$\_K07G=A7I)+<)L+F$EH^8JNKW,,PA1/+ILH]0V,
MHV.>?L*R<CH*!4)TZH=PDLV-/G_A-)@>5JB-4?V/J^I1?BC_H(,[_7P)T^FN
MF=QKF.5))I:05_L*MT<:\^^S7'OQ/Q2+/T<ZS=%FRURL07Z!=#')0**((M/&
MC4NIRW-HGWL:_2/J\1AN)L+&T/W]&S'\QH(Z#Y&L()LX*QQ@D[X6E +:?VUC
M[YPLJ8LJO?/9T;]U' ^@8Q@YPDOYWO #4M0[=_$)Z"]K.1W&)!Q+D6<RKKTC
MV)/N-@(5H200$P^]BP_=T^C#4J>Y@@<1X1BAN\F/VH_J\YQH:RY+QE%KIIT5
M+&C@#,C\\%S6ZI<NY;6];:A-UZ7VH#VY\$9B*WZ8I=J!ZL<V*/$4=5Z#CRHD
M%DWM4.:)OR%KS@1ZE%D;HWV71@#[K]RF"U03N^]$XA@)V-Y=7E[-UO1]6+R;
ME2E<;H:3=*$659UM(YFS=4RBL41WID/FN;!""1TA=-&+Q^^D46^J)F@<2%[-
M+^]=N)9^MYP036M:'C-+9,K>E9HUKXMB6J%G443'HK?"^PQ<JVZ6Y3ZK-NJ-
M-? ]?#(YC$3_;<_-EZ^P^H44_>4W6"[/IM,WD^5FZ/""?CGGW&:GZSS$5#L&
M.:<8>*V8RM%I+C5@IP%_^ZS9J!=7$YW6NPR::Z][LV#)6KT5M7\]7])I*1:2
M""B9KSU%B33Z70E$5@ B%:.$3FGLW59KU-NKG=?0#]];(^GJLL;'B9*[5+R;
MI<K!?%Z3L8L5A9@%GFEI:WDS)D9T$,^*,59VZ0GW_$J-^H(-BZ!^^3V*].1W
ML^^X7&W'E/[4P>-<.!EY36TDY9F)35DP,A"!N6QX"%)&70;+1WY\FXW:C@T&
MO-Y%U3HG$1>I2N@"/Y2W5W7[MP[3+W]^JU-UWU[5(9>O?KRNMSW]&] %$7,F
M9T0!TYR<9BB>W&?IC(M"*RFZU.\<L'0W=+WL%XA32^1@P'W'19P/#+G-"$Q8
MK'Z<:V-JFU].#@J9 UH(R[S3D;F0,1A31T)T"9\=MGHWX+WLQX<!Y-(<>V>7
MM2OE\B/\J"G$E8 9J=%WCSK)' Q9GR(PY^(Z)T<1F34G)VIKE0+0G<)F>R[;
M#6TO^]7@E))HW1+Z*ZQ'D'];1V!F%]NSLYG5NUQ]*-ODF!H)G*\MARWY.V;@
M8C+/-1],I% "XXZ3\2ILJ $:R8Q&QT':@+K3>)A>=M,-DB_[$:&!W!HC]<L"
M9DM:];;J_PBDXB\GZ;\@U1[,=/*4"AXL.=Y1JTUA53 "F*I=,+5027=*!>BR
M5K=TZ)?].- [SYNWO%[BXCL^20Z"5\*+R)*OI5F6&!8C'0[OA46#11?=)2;;
M8:EN"'K9@?Z^.3Z*R,?OL[R /V:OYHO%_ ]2OF\A;1EV7OMX!PV!@7-ET] @
MU-:E]-/D==**"!HJ\O'X-KLA[^4^ O0NJN;.P(=27L&T=N;X_!5Q]4!$>EU1
M]0T3W?UO)LMO\R5,E\3L1+[V]N_4>W]M'SSX]O9A]F9R'24ZYR5ZD!R9BCF2
M8>#Y>H0!0QVE-"*7W.EE:N!M=\/URWZ,&#,21A0@)(++9+4QDV<_SW?8_-&Y
MKT.9Z[7CBB,O+=11K3'Y.NZA)!D#1-.I"=@^BW8#Z,M^ZSB=%$8$K\<?=#[A
MY#)>T7KY'+CB$5(M^",V:D%D>>NQ7CC66U"U(>.>".NR;C>0O=QWC9/+HC><
M_>^_W1,!D?ZO]1^M_Z3^JT]8_E?]]?=/[W[Z_A)F=$+^(\TO-Q\GQ1\WBG]9
M%7^Z4?R?KRXO8?%C7K;6SFO:[V1U8^J\P15,ILN?R5M.+K]-G\L#.'[-O]T0
M>Y<-VZ7O@>_$A..?*ZR1X?_G"&ML'5*^QOK-/7H+XS_=KV?+):Z69W&Y6D!:
MG?,45?&I,&5J4I,7BGF.JJ:@D%$JA16\RZO4D=LX1A?6FM'I?'E5@U#U--,I
MO,W[']NV%SHC5UFRS&T]>9;H+$XS%T2*Z*)U6G2@L]-B[1HN#(F&VSJP?QF,
MPKO^#597"]K^NA=7S(XGGQPS1M1>7)$L@V(Y Q"RJ)RM@<':.]_>6#NTG4#J
M][SF@T4P"@"=75PL\&)=W#&YQ%<PR]<CW<BWST8%(J4V/(5L6="\,*&M4ZB=
M+C=FT:G1].@N6_=".USX]W#4CR1& :I_S%?OB9#%EZ] #C+^-\)B-\V/O&-3
M'_H,@B,/)F<6LLADQX*(4A0C^6"C\![=96M0]82$>PCK1RRC0-A=.LADN$W=
M%\+.^N<[Q@51R#G6L68JFVHV!&*<HO-IBM!"(=&AA\+=GGMOW?;O5&@\I0C'
MA=$;4N[0^);<\-LDJI"RTFB9$<'2,2R*2(R.G&\A03BOT0QVY>Z]^S;=@0;$
MZ4G$."ZDWJ5$&,%STHZA3\"TDXEY!;H.^'5&19=R&6SDT%&X.^&D[)/C[ABA
M-(X"/^=_W<0V8PD\"L.9 4E^?0S @A2)%>XQN@!1YCNS:P^*?EPOV*Y!W^E\
MTM-Q?!1:ZHGGZ9!D#5E;5A*9!41+I".A:M2:JU0,5Y#+4'KJR$R")G&0 U&Q
M3P;!/B)ZL6\*F^37>?GU"A8P6R$N?R7E/:,[8??>?-+GA>[+#_/2<" [1O#H
MH+5S"0PI75<?\NL(.&^58+6PS"KPX$27]K(C>72XX?_F<G%8%!J!+(1,EXNF
M ^GK^ 9K.%ACG(/2Y:WUB25>[@/#/I)_[.(]AM^CN&I?3X&XLJ1KXD'VK2<E
M&F&-5)HES^L\+)0,<BU-$I;X54<V@!OJRGU^N^.X>H_"Q?VIW/T*:1S >XB4
MW4!@#B)EP9G7!>H,:<< R -"YPK7&HP1@T5'GMAGZ^AQW["XC[N>9-38-[TY
MC#MC9$M#EE&;Y"(S:#+YUW0-Q%P'P4:1ZN3/VJJGP^WXV/>;XZ,O\<U[YN5H
M\+ V4K<$>*Z5,$4SC#&1BDZDHB'2R9%%>W3&>\7W L.MC[>[E/J1UX, .)1Y
MHY'^VG;,M=GA*YC]:UVY.)OANCKLGY/5U[MI4[N3X^FVYDA4)A!U/&AF :TA
M#4N_!5V\=WXOG!RTC791K1,BZO0":8R]M<OR\ FJLZ>+E[6^IT[!0N*>#XDL
M1(XVE.(L\MP!5H^OT&ZF0^^(Z8F-(PJ9WQ!S$Z #!)V\2LP!DG\:-!"N/7%'
M6/HYV&)%EZK-9Y891WB\#W^I;YZ.PDWZ9;F:7-8GI[>3&<SJ;(9?2ED7L3QH
MW9UG!0EUH8.D0F":&Z2+F.PZ(D^"UC(9-9CKM.?>Q^:Y'XB:^Z-/3RC"<<;/
MW^-%C1=G6,3):@'3;YLR*R+UB*3[#A_M(=:][]9'$,$F+B5 'UA";ID&B R2
M]4S$(@FT+BC_@B+8:P'0.F=; 7R\$<#F:BA2T.E(FIGBR7-59"^$'#TKCL=B
M-%B]__OQ,VN^W!CW/MAX]'&Y3XDTMKF>H&4=+S."%HS"D=KEG,Q'(UF4MC!O
ME"-2-/I.$S.?668<-UV_<IV?ALGCQ<N;^25,9N=!@@ ?#"N>+FH-LC 0QC,9
M(Y=8? C8I2'HLPNUPTROXNP&DP-XV[ICU-J.^ C+%5XM_H[?2#*KR?+5MIO'
MSM]-@J-!0:9R"I539-EQGIDD71Q-MJ#O9GT^W ^JPUJCA,LA8IV?D,>M>S>1
MDT5?PFU3JO=$S<5:1.]F7[[B[Y^W%$DG2TG!LA!59CH6RT F1__I;5KW>G==
M4--MM7;A@-/AY@1\'@ER?ILLE_7_OWV;G*WHK\_PQZ\X0^+>8T0ZX:P3.3$>
M0ZI5WX[Y4OL+>2-KSKT'T:7V]. -M(M"GAY?IY5&8\C]OT!R2O<)>?/^]?QJ
ML=J] Y&;44 ')D"3R:A-KD-/) M.Z"AXD:93%+O38NT&NIX.2OUS>:2PV1"2
MG+5H3+V=:^?93"<!!!V"7&N_(<MD0Y>K[<E%VLU,'1XF^W-U=/!X#3/(L*6D
MEBIJ4PKC(@NF2W$$=$GW<D"CE!!(_W<0/FZOTFXFZI  .9BOK5_)R,[_%YGW
M#QAO;Q<U)WFG$XO* 4I][K-DO<$ZZSQ%)K,UR,GV5YWR>#LNUVZ2Z>DP<PI.
MCQ<\G_^8K/Z-BQKKORZ-QBR")#LL0QUYE.K82IV83RY[ 2F[3IW"]UFSW6S1
M)C ZCN<CQM(W8MB6(FUXC$Z15N4U&P5CM<T\L"2XB0BD6%.GC/M.J[6;"]H&
M/P?R>;S(>873B\G5Y<X=C)#JT%+F(->V(NC)';2167(&C=760.B2C]IUO8:#
M/)O YW!FCQ= O^+B$F8_=C0EB2$+S8*N;2,3: ;>U/;CON02H:A.K16[KM=P
M)F<3 !W.[.8 FEU\AS\G\' (]"/QN4:M9M<YE3+IJ)Q(+*1*$0K2KMZ11ZFB
M<PX%>ATZ 6F_=1N.X3PEH$[(_-:C ^!R\FTQF6Z\RX^P6J<F[.C;]7.QRBJ?
M%#/1.#HHI&0]+XGQHD2H57:HNP0%NZS5<.[FZ0#4.Y-;=PPF[ES57)7IA'AT
M=0GQ$TYK@MS9Y07.[M)W)[85/9=&!A:$)S)-[;PF4F8)K'&I@/+0!4M';*'A
M8,[306PHD8P5>;]\FV^(_/#MVWPYJ43NM+&KC4:M$<SPPIFV=31"SIIQ:PL&
MFS/][S&(>WSIAI,X&R"M)Q$T1MA_XO<5J>DM34\?'&5YT:2I&4*MP?.HZ,:/
MD16+4G*53<8NE41[+-EP^N;I$'4JEK?655/X/OGSAI ZTF(^^P-ANOKZ;G9V
M53,\IY-=1)^\5NX%"F8A5F]6&08%-7/."RZ"YO'N;.&'M=0^BS8<J7E"_70R
MMH\"3W<2$\[2YHS\'?Z R6174.=T3?NL6<+D=6B52VV]6+O;>FZK<QM$=RQU
M6+#AL,Q3XZAO=H\"0UM-^^@#42[DIR)=U[5]6;VNZ]P2H$.A>%3%2@>I2X9^
MI\4:3K4\-7;Z9'-CW)PIS5^]65Q=?%Q,$C&(6'6Q@,O-W3R;$)6?26C7 1 T
M06EM-!,R";JER=[SWF3F5>$H)"=_HTM.]7ZK-IQ<>3HDG9#QK2'UG9@Z6;Y>
MS+]]3A.D8_&IUF?-ZH&YV^S"RU)"(79%6_MHII(9<%*S)A-BO,Q&Q"ZM'?98
MLN$0RQ."Z40L;XRD=[.R@#J/\^]S3%^7J\>)LM:D(JTB:.@:8Q.1=*].#((#
MCZF69W8)!71>L.% RM.AZ#3L;O[ \NBCT;L%WDIXT,6 RN0A2,W)V,O6,DC"
MLBPL"D<LM:Y+1EO7]1J.?FSR0G<XL\<+H%\7"*M7B\GJ)OG!":ZP&GPEEUKD
M4@R+GM-E[8+*+J484I<H^%Z+-AS2V.:Q]SBV-Y^-^P1I_Y@O:EWQG=.2G%3!
MHJ73$L5VX+1PAM&-;64!:3@>F3SPX+H-YS(VP=7QS&^NJ@K.,LQ6Z^I/::Q$
MZQ)S!B2Y#$HQT,AIXS:'D#DWNAMJ;GUT'#UI3E8??3@#QR+YZ[D'R)TM/#$!
MM55)M)D%K27+*8@B??#6=9G8>/>[#>OC#Q?-0P(^A$^M_>IUB/+M?/'/KY/T
M]9]XML!K<G;78% &!:&=2"JD%*-FD=04RSHHFY)S47=)M7]^I1'@X" )SD_&
MSO&!X^.4[LG5I)2=S>U]1A,\TUP8IC4 G9EDF;&6DZWDLLD'@N/.2@TOB1."
MXQAVCJ)AV<_CS-=J5%BKHR'EF5TF0HS6#'+,=?!$02G!.W7'6SEE.^>[VVM7
MD7QR8Z,WJ8P06=OS473D7H-CL*Z@KA''X'UBTNMBM>$ZF=@&6V/I 7V<X)]!
MT@%2:/^$^9."51$S6NF935;7:36IOJ=Q)DQ,Y.5YU-BEZNN0RVDPL1\BI7D_
M+&LL[=<P62[)"Y^0-T^6%RQ)VZZ?4&$*>;)[2;52TU$PU>32M9:HMG;4L3"%
M)D7EDK ".F"@TV*MAWSVBHS^V3N*F^;5U;*FXR]?SR_C9+86SD9U@M'>.7((
M0W1U()]*S#L@>UW[.E37!GEW8,#I;IO'-MFN+<: ]DPO$AH%UGXAS;KZL?PR
M7\&4/(&'"-OYB5IDT'56L_.22!.1>43."OUODA)SC# 4^#KONO5%V ]0[O?T
M/8G46E^6NRZBJ9J*B\FRSO4CGK[&17T$V1'Y9O(=ET0^G?.;:2*:2]1$6JV"
MTZ%.$[%TF(UP,?,DL%O;GX,WT!IE)X+#?&C9C$(C=AAKY')$4\<%6.X*TUG&
MFL8MF"=#A0P-)T0<+J+0STBRDSQP#1EAZ%=JXT#B$P.4=,XA%7*"9%%U?"IP
M%DN*C'Z,A<=4,(?!(/BB9Y3M!8N]9I3M(Z/688G=0_&])"@0H63%&=T-ID9K
M,JL#=IG--KDBZ6B6+BW2'OM^<WST);YYS[P<AP+:G9YW))39Q834]+;!^RS_
M.I_G/R;3Z?H,Y< C>HQDOCK.M)"F7O*"J5(XRH)&QL$<TZZ;;M=WK<6UV*<$
M1X'-)PC:Q0F#SXK\*)9M(5N7USAAR, $D.7ID@JJB*% ^>QNFRO"DP#E'A[[
ME5KK2W-=ZWE=O$!^E#2DV$O4Q!@%->6<[HSDK352* VF4R3_]D=;HZ)G<<W[
MX-THM,\G8@MNSH,$7HPM#'Q]C4CKI,P(S- 9\2X8E[@:2LM<[ZI=?\@![[;#
M9# >^.S GWV07B"P[)RJ_7(SB[7^*90B@@%NY< (&HGR.5"^#^/D$&:WO%X6
MJ_/?)K/)Y76_.*(_9X7(B/#$M*?+%S@7S)8,/CEAU-VY4W6/RQU,"BSC>I?T
MY35"_H;3U;+^%]N @6[P[25T=^E1X. @^<W[8&9K%,"?MS:>BE.96V!0:M=2
MI2T+GKAAK/')BW5[[?Y0<'OIU@_'_:#@8&:.XMKXQWP&^7^NEC5D\4NMAER>
M%?K^)_PV7]2??<3%9)[7*I,@S:V5P'@R=+5R7Y,DO&+1:#+84%E;'@#*:2Z5
M[MMNUY!X0+OE1%(<*4)W9TU#*#8 BUR4.J'=URO<,R>3CSG0GQ7=#H_CN.A.
M!8P."#Q 2J/ 6VV/4RO!+VOCKO(;_,]\<:\U84++,P1R*5,@ZQ%JI]VH W,N
M96F<*;$,EKC08;_C0^$AX'C@H:1?2;6N1>IV7[R_'N+,2S A",<<:&1:>,F"
MR8HY*UR,"2+O5C.[Y[KM6K0/4\MV2C$TAA@=Q-=7B\KFZPF\;^>+.Z]+/SY-
MEO]:WIPDHG\]M)=\YJ3(+T:68\0:4JN#Y6)F+FIR;IQ4NE.GTJ,V,?I!LP?B
M8MY"2,TKNA\F]9?9]\EB/JMJ?4WE.:EJL(0B1INO7E50Y%NKR&R$"#)%=+G+
M%(%NJXV^5/=4"#N*[:T5VU6][3^4UY/OD^F[6:9?\M6N.]WR/$ A&Q8**Q8B
M,<HABP$-F0(Q>*N"Q-2E1\G3JXR^[*H'X/3'YI$ YL/L8DZ\>0]_+*\FJ^4Y
MD(I<<R;DS)D.43,(@:P&,E-ER1&%[Y*<\LCG1Y_)WA]$CF'L2+!Q726T/)>9
M>\Y1,7*0B1O&U-SJ%%G@SKF@C2JBD^ES[\NCSZ3L#Q$'LG,D8'@_K]G/LV6-
MFUQ=WJ*%8.TQUE$I BW35I$WBR"9\$[;J(WC=^/G3T+CL75&GUO4'U!Z8?5(
M8/,*I],_$*II_F4Q@>GR[SC-YT(8+<!Z%I+03.LZ>C!KS[PAYFBHW02[M&]\
M<I'1/]CW!YCCF=P8+=M'I(\X@^GJQ]EEK6C\/+^Z^+IZ]>,&_]5&A_3UOR;S
MZ5J.YSP!-[R.22XUS[BDPJ*IKE_Q2BA-FXQ=NLH>MOKH'U:.Q]< 8AF)FGH-
M2UP27R]K]6L^#[XXI41@1GG%=-2U$3,7+"84G(,H>#?/\6E_Z:>OCSY^V*.?
M=#A;1P.,6:(/GBV7\S2IS;O_.5E]O:9H3=]Y+*I&6CW+QCFFG0[$)9%9BH$0
M#T5QO1]:GEVRX9S'!ACJ5P)C =;\\MM:A2[?3J9T-J 8!=D7EE*=8Q(]9^!(
MAR)JZ6MC>*X[Q?@>_GS#N8[# ^8(SHX%'#5U?!-5N@X@9%W0*_(4);=D_,OZ
MGF-4)(P[*02@EYV,G2>6:#BK<7B0',GAD0#E(\Z_3?&7/[_-Z_UJ!3IB0F&
M-87!DO45K=/,(OU<IYQ![Q.\^^GC#><P#A^I.9BK(X'%#M*?KD@!?IC]AHO)
MZESYZ+21@H4,-<-/ (/H'<,D)"&^1JKWB>$]M$;#28K#1VF.Y?%(L/)VLEBN
MWLV6JVIG$3&52^=<I> B1$;,2,0<(QEHIU@40A3CR7)W:@^L/+1&PUF(@V/E
M:!XWQLJM=_9U$. C_%CGF(##*$(",JV4($_? PLZ.A:X]39[H^C7#C!YY/,-
M9QL.AI ^.#L610*7D^D$E__\.E\;WF?K5U(RM":7YZB%YMHA79HRU)HVRT!
MHO]16**2)J0N0.FP5,,1AL.KE9XX/A( ;1O9D=V%B]5DB9O?+,F!XZ0<36VB
MS"-=JLG2]5JC2%RIK$UTJ5-WZF>6:3BSL(&+?#RG1P*:WX@WB3A62ZV7-7>'
M_+@DL AO6,F>_#@CB8JD"\-BM2H2 #LU 'U\A88C"@>'RI'\'0E*?O+HKM7E
M)_R_5[A<O9TOWLTR7LXFA4A=/V%DKSWI2<=,),=/2W+\? T<21=#+,!%=OO<
M5WLNWW!P85M?NV?)C 1\9_ER,IO4,<.KR7>\Q<5S*Q(OI:K:J'-M,U]K3CC=
MV5:(;+R.RG89M?+L0@V'%PX.J'ZX/1+H;+/(-J_ZYYD,.D]4L&RM)Z? UNI*
MJ0G[R4914@F=IA4^^/&&DPE;Y>8=P-61P.+C C>Q:V+/:I[FT\TSF*YS)03M
MOW D2IQ)-9B@&)J(*2N1=-H''P^OTG  X?"7T_%\'@EB-AL'F5.=M<FBKK-'
M9%0L!@L,O;2AR)(XWP<@>^#AKQ'SW9^+8Q'_=6!@^6'V:U5^YT7I(KBN?6OK
ME2A1,L^%9,KP%,C"%\[NA85[*S0< ]BF(.!P_HX$);_![*I JKV&%\N:9O$;
M+/Z%M6KU[&KU=;Z8_!NVXXU^Q1DN)NF_Z._1#SZ4.I#\/,?L07#%?-&!Z5 [
M%$/F+( #*"$7E?9Y-#AN-]W0][*#QPWDUGI<V6PU29-O-0WHS=5B3159_-^^
M(1ER:]8N23UG%S7/GI!5ULGUG'D3-!/&.EZ,JZ7]'6#88:EN&'O9L>:^.3X2
M5;=IEK<MW'HWFZS(%9C^V"0,2:.1*Z68%9$T=RB6>96)7TCZ/)9('.PR/*;#
M4MT ]->(.??%\5$!:'DVG>(%YNF/=[.RJ&V/\WDM&858)PQK5].(HF6@<V2<
M^\BE$P'S/N'G1Q?J!IZ_1A2Z'VZ/!#H;._'=[#M,)_D\ >8L%"?#T!-KO.8,
MBA4L)5V,]-%JU67B[H,?[U:2^]<()!_.U9' 8HOQU_/O6+&];7AP+K/0Z_ZO
M6BO/M$IZHQLME\6K0-[G7J]9#Z_2#2A_C0!Q#WP>"6+>8%HW+UB^6RZO,+_Z
M\>4KOJFA[TE:O9Y?+5;G1@$B)P[1 2#3'C&RD-&R)(6E37DGO=L#/,\NV U'
M?XTH<K_<;YWAA;.+U=</91T3/X\8D2PRS;@U-?N(?$,P$9E'H!/BDH30Q0+^
MZ:/=H/&RX\:'<W$L&@5^;#KDK8LH<./M?9PO5U\6,)F^6DRPU-A63+8H@YFA
MJ8^P1M0*/P(VE]8[7C?7J3'[?JMV ]!?(]!\ CDT[^S_8].G[@U<P@4N=W6D
M9U?UJ78Z@=D;K"-,-W_I[PC3U==/.*UQAR]STJQGW^8K_//C J>3R\D,%N0"
M_,_5;.U-_O[MR_Q<<)LJSXGV[)CFQ(4 %EA.2FFQGMK>Q8P^\3:[8?AEQ\3'
M).G&H/^$9%IBWJ3V;BK3<+9<RWOMKE2KX>V$G-I\J\N#C](5T)*E7,BC%<DS
M7W)BUAO PL&GT"7WZ)"UN\'S90?-3RZ3%XBY=S4;%&N)0II>9<SGQOEBG>4L
M1DZF"R=Z0ZV, R&2(E;;9+M<\'WLI1LF7W:0?7"9-<;HK]-Y)!9N^DJ\120:
M:C\^HO(-;6:6H::9VJS *EU8,4#T..(C1(NL%&Z<M@0V[%(1W66M;AA[V7'X
MWGG>VJ"\1\FYT)Q'7_O<Z$Q:NH:!/=D*]46*[&'E><=Y4?>^W T?+SO4?B0_
M6Z/ACM%YK3:WI0[5X/QQ;J2-.5K'#'KRET K4I%!,_"Y2%U"2IV:+'1:K%NO
MPY<=>^^?ZR.)@ZQ["?^45O%N]GT^_8[YW>QV2G'THMA8<[]<JD,#I"-?)#KZ
M3Y#:R.!*IQ;D>R[;#5I_C6C]*231&&2__-^KR8J\VCK8O1Z?S_-I_HB+5(5X
M@>?<.B'IO#"R"#G3N;AJPGE6./>*"//5*'X>4T^OT@U"+SM0WR.?&R.F=H.<
MD$C6 OJR@-ERLX4O\[=7L_R)A+?XCO>+97ZG_URLX%\U5$@<M,((SH*,H184
M<P9*!98*1Q%*0F^[7'W'[Z0;\E[V.\# \AI']\:-]_IE_@H_X>0R7M&G,]&X
M[;1.K'Y[517XK3;K,*V%I[,EDM]A,_&YMC*%4!D-+*I$C$9A<N1:EDX-08_?
M23=TONQ'AH'EU1LZ__??[@F%F/&O]1^M_Z3^JT]8_E?]]?=/[W[Z_A)F\S+Y
MCS2_W'S\NO/_LI!4B?65&<L%1E@A_=V\A"G2?Q('9LO/5Y>7L/@Q+[_-OZ^G
M[4QF/_WS-[M__NGZGW^N__S3YI^_P15,ILN?^;&<U(>=9S#=8)-_NV'G749O
M]WH/\&-C+?ZYPEF]O ]7:6NK\V8CI,]K-C5M;S=_9()U<O/-S[?#G&-]XDBK
M\PS"J:@+J]V\F7:),W*D31T'(%-*D:O<)89_Y#:.'P9V6R?=V<QVRI IZ*S6
MC#M7.P;8N&EPKXR6EMO G;Q3P7JZ26#/;;;=[)PAX71_3EBO0FP\N_5V8.$?
M<(G;T7T@LQ&"!1\*TUXE^ET=9@Q:*?!%9O7 N.<#1[@^M(/6 ^;ZE?"\1W8W
MALLG_':U2%]AB6<7"UQ?,'=)>C._A,GL7)F<$+ .+/:::51 EG?1#.G@J1@B
M:/& (CL00YVWU4AE]2+Y^:G%T-KM67=&F>3MI$6C<O8E)%9B4$R;Y%@0-7:N
M0I11&RLZY7'__-5V\C^1R.:]\&\4DE_@;L:FD9!JBE]2%NAV)C\L1@U,DAM6
M).3HNHTA^.FKC<:P#2CY@_@WBA&YO^+\8@'?OJX;(RT0EFOE2'=L]A8E4RIP
M1@HQL6C)'=<*49.1AL(--A_\P1VVGC=_$BNE3ZF,$US;4^)BS1H7G!GO M-U
M<)1/"9E)@H/P!;.TS> UCCG+/2#@>50=((Z&N%H'3Q8_SG__?!Y"#EX!G2E1
MNY;8;!GD0O>ML/0#S;WE3WE)2TS_<3'__K?M%S=&[O8_UC;N&B,WZXT.#(<(
M;GX4%T>A3]:=[G%9F]GLM.WZ6&0,A0LL#'/M8F*S8%"X80JY=<98.A9\*'WR
MR![;3!0=[,+J0S*C@-@=WFP/FI7!*ALU*YY.F_:2K$.0A@7. VI!NC>4H0#V
MX Y;:ZA>Y'\/5<<+HW5R:"W,7+\WG<WR9Q)(;>)'JOQR1XOA,FA?:UV$R/7A
MWM1)8Y$A>8H:1:9#V:7/S'/KM(9'#X*<GXBKK?UOF,%%G?VT0"+FUX\?[I""
MB6YD(0+S,CI&3"&'$B)G6(K4QGN30Y=<AV>6:>U.]8N//GG:.EOF*RPN,$+Z
MU[M93?:9?,<=%=$7B$;5KL6^&G\RLDB,8B1Z1]X RB2[J(['5VAMLO0+BIXX
MV;PB9OUT3+"^?DW>$A%L]-):0>J.U\Q45+5^LC#KG78"=,1.D;M'%V@S[_Q4
M:.B'CXW!<"M[8'?QB>24=(E9M<X##((%!8G5)I]T\07CL$LCQ'L?;C/:_%3"
M/XYOC86^9L6;6F2UNL4*(P07RD=F;!W $[UFWM6)&4Y++]'XF+N,2WOPXVW&
ME9]*^,?S;SP6XW;SY*:G9*)@2+^0RB)61%>0D7\EP2,'WW%V])T/MQD[/H!5
M> #?1A&<>"*(\_XZE=)$S$Z3-2-%KOF,MK9MI?M,Q$0J+B9AS9T1,TW2F*XW
MW-JP.'%DK'>9M:Y.N][^V_LIC6<_IS2>ZV2QA)KJ3:>+D?W$F;>6'"^KK4AH
M 3J%-_99LW6HHW]YSP=@_L&@^H:+R;P&81:KHZ%%CEE]W, WN/GUR]=%[;=!
MGMOL M_-/J?Y-ZP5Y;/E?#K):YF^NTFQ[< 1Z;T-BCLFG*ZV?2".D&5'WIZ6
M*3J00G?):SGU/EM'8TX*X5$)N;$NW?%BRX-_X!_7A%YWD=G6,'S<G+-*Z#EW
MP OJP,!*3<8JZ,VT3:FU-E(E$SK-QCAL]=91H4' >4*!C 1RN^-WZVPMKTG\
M2*0M;A.(QG$9N:7C1$Z1+D*R& H9WL97 ]Q"*EVBT <M/F+[L']MV+\X&N/M
MCIK?5MDO?X.,>QDS,8H4,ADS'$K-S^.>19EK#2$9X2H8(T47G=?3=EK'PTZ*
MR18BVQ^E88/2&5ZL#\E)E./U-;#ZY<^T-E#>3 IM#F<)EWOQ A7YD!& Y1!(
M%I;N"E^;1V#BU9>,(=OG"NA.NL'6,;X6)N? 8GU)?GN.!DURF6'QZWGNGGE?
MQZ*"AY)\M *[P+5W!)XPV#@>OWT?YA_IM_\RRR<K2B;4SF<SG*;Y<G53&[OY
M,4Q?UY\>44V\Q]?[* ,^E)@>ZG=_(7;,?R"^PAF6R:U*2AF\0H>*B5S'HF>A
MJP%8NRQPR;5RW(<N;SZ/??_X</4_:Q^E#;IA,:E^$HBH-><,.& =>&M8U%DR
MQUT.DARE8AY(VSU-:/KNYMI5U/8BX/N!YZ.X/XKGCL_S-('I9TQ7B\GJ1ZTH
M7DSBU?K9[IP'%-%KPX0-ON9L6"+& "O&6O+%9<"2AX+2$_ML5/IT.E3U)9-1
M &S; N0M,>[S5ZA='9:8M_[.NM4-;!Z)ZQRZ'3]K UV#7-6INJ'F# 6)+/)
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MX7P6[YLPFNXKYF(&$^OX*$<>K*O/Q1J%)K_#.+E=+OCT$_F#KP[=AJ;_J_L
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M0^P@J].1N>(3A& C6*\(TI:,(-&2I?_*,DW \.<$C#[Y.KB>*-/K//LW;I%
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M=)!OB[2=)B[5^>ZU+Y^*&GS*'C176KKH=3E=_<LS>QP:=L>$QN.W[1[D- K
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M>94CNSI&FWG)-VZ4\)Z<]%QCCCZ3,9 -^*04,,ZMH3-:N&GIS]J^XM"&?L]
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MYNJJF<)6&8\80.*&'@@K+KCD E&R#(VIIDRH;&UP.^<N/R2HDC'C#,)VBO+
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M1;^D>/I0Y>H7Y5/P<_CO__A_4$L! A0#%     @ +E-85A \Y*&$(P  T-0
M !,              ( !     &$R,#(R+65X:&EB:70Q,2YH=&U02P$"% ,4
M    "  N4UA6/EF5^$9(   1/ ( $P              @ &U(P  83(P,C(M
M97AH:6)I=#$R+FAT;5!+ 0(4 Q0    ( "Y36%9%S?Z]D <  $LB   4
M          "  2QL  !A,C R,BUE>&AI8FET,3(Q+FAT;5!+ 0(4 Q0    (
M "Y36%9G-=DWK@<  .@B   4              "  >YS  !A,C R,BUE>&AI
M8FET,3(R+FAT;5!+ 0(4 Q0    ( "Y36%8NB?\DX 0  -<0   4
M      "  <Y[  !A,C R,BUE>&AI8FET,3,Q+FAT;5!+ 0(4 Q0    ( "Y3
M6%:S%PTT 04  ,L1   4              "  >"   !A,C R,BUE>&AI8FET
M,3,R+FAT;5!+ 0(4 Q0    ( "Y36%;XZCH/F(,  "]Y P 3
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M '-N>2TR,#(R,3(S,2YH=&U02P$"% ,4    "  N4UA6.G,TWB>,  !5+ 8
M$               @ $;7Q$ <VYY+3(P,C(Q,C,Q+GAS9%!+ 0(4 Q0    (
M "Y36%;<P/!*+T8  '#8 @ 4              "  7#K$0!S;GDM,C R,C$R
M,S%?8V%L+GAM;%!+ 0(4 Q0    ( "Y36%8)H7>=1Q<" -Z#%P 4
M      "  =$Q$@!S;GDM,C R,C$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( "Y3
M6%:5G#S^MED! /S. 0 3              "  4I)% !S;GDM,C R,C$R,S%?
M9S$N:G!G4$L! A0#%     @ +E-85FR H"4!]   #/8  !0
M ( !,:,5 '-N>2TR,#(R,3(S,5]G,3 N:G!G4$L! A0#%     @ +E-85FP!
M0E3$#0$ G@\! !0              ( !9)<6 '-N>2TR,#(R,3(S,5]G,3$N
M:G!G4$L! A0#%     @ +E-85OM3YU+9_@  ^0 ! !0              ( !
M6J47 '-N>2TR,#(R,3(S,5]G,3(N:G!G4$L! A0#%     @ +E-85L2"<MA%
MU@  ,]@  !0              ( !9:08 '-N>2TR,#(R,3(S,5]G,3,N:G!G
M4$L! A0#%     @ +E-85LF2UUOF[   *^\  !0              ( !W'H9
M '-N>2TR,#(R,3(S,5]G,30N:G!G4$L! A0#%     @ +E-85LB,.)*L'0$
MS!\! !0              ( !]&<: '-N>2TR,#(R,3(S,5]G,34N:G!G4$L!
M A0#%     @ +E-85L)01:^K\@  N/0  !0              ( !TH4; '-N
M>2TR,#(R,3(S,5]G,38N:G!G4$L! A0#%     @ +E-85E$11'J,( $ @2(!
M !0              ( !KW@< '-N>2TR,#(R,3(S,5]G,3<N:G!G4$L! A0#
M%     @ +E-85C47G ]*4 $ $U(! !0              ( !;9D= '-N>2TR
M,#(R,3(S,5]G,3@N:G!G4$L! A0#%     @ +E-85IIS*:^N\   M/(  !0
M             ( !Z>D> '-N>2TR,#(R,3(S,5]G,3DN:G!G4$L! A0#%
M  @ +E-85EHT5)R>F@L I!X/ !,              ( !R=H? '-N>2TR,#(R
M,3(S,5]G,BYJ<&=02P$"% ,4    "  N4UA6D;,EM3T8 0 Z&P$ %
M        @ &8=2L <VYY+3(P,C(Q,C,Q7V<R,"YJ<&=02P$"% ,4    "  N
M4UA62Q'5="U8 0 %6@$ %               @ $'CBP <VYY+3(P,C(Q,C,Q
M7V<R,2YJ<&=02P$"% ,4    "  N4UA62][>DHX^ 0""0 $ %
M    @ %FYBT <VYY+3(P,C(Q,C,Q7V<R,BYJ<&=02P$"% ,4    "  N4UA6
M^T&-OWT  0"? @$ %               @ $F)2\ <VYY+3(P,C(Q,C,Q7V<R
M,RYJ<&=02P$"% ,4    "  N4UA6"L"Y"P_@   ]X@  %
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M2P$"% ,4    "  N4UA6$:F(KM!!  "B0P  %               @ 'JFC,
M<VYY+3(P,C(Q,C,Q7V<R."YJ<&=02P$"% ,4    "  N4UA6+5T<0CBO#0 .
M[!  $P              @ 'LW#, <VYY+3(P,C(Q,C,Q7V<S+FIP9U!+ 0(4
M Q0    ( "Y36%83UTAQA+@' +U/"P 3              "  56,00!S;GDM
M,C R,C$R,S%?9S0N:G!G4$L! A0#%     @ +E-85M#)(\=EE0H 'H0. !,
M             ( !"D5) '-N>2TR,#(R,3(S,5]G-2YJ<&=02P$"% ,4
M"  N4UA69<*-8HE["@#=CPX $P              @ &@VE, <VYY+3(P,C(Q
M,C,Q7V<V+FIP9U!+ 0(4 Q0    ( "Y36%8@>/3<U>,  ,'C   3
M      "  5I67@!S;GDM,C R,C$R,S%?9S<N9VEF4$L! A0#%     @ +E-8
M5@C5$C%TYP  8.<  !,              ( !8#I? '-N>2TR,#(R,3(S,5]G
M."YG:6902P$"% ,4    "  N4UA6JN&;][3:  "@V@  $P
M@ $%(F  <VYY+3(P,C(Q,C,Q7V<Y+F=I9E!+ 0(4 Q0    ( "Y36%9-T64K
M ML# /&'*  4              "  >K\8 !S;GDM,C R,C$R,S%?;&%B+GAM
M;%!+ 0(4 Q0    ( "Y36%:8NXQLC(P" -5='0 4              "  1[8
L9 !S;GDM,C R,C$R,S%?<')E+GAM;%!+!08     +  L $0+  #<9&<    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
